IL-2	DNA
gene	DNA
expression	O
and	O
NF-kappa	protein
B	protein
activation	O
through	O
CD28	protein
requires	O
reactive	O
oxygen	O
production	O
by	O
5-lipoxygenase	protein
.	O
Activation	O
of	O
the	O
CD28	protein
surface	protein
receptor	protein
provides	O
a	O
major	O
costimulatory	O
signal	O
for	O
T	O
cell	O
activation	O
resulting	O
in	O
enhanced	O
production	O
of	O
interleukin-2	protein
(	O
IL-2	protein
)	O
and	O
cell	O
proliferation	O
.	O
In	O
primary	cell_type
T	cell_type
lymphocytes	cell_type
we	O
show	O
that	O
CD28	protein
ligation	O
leads	O
to	O
the	O
rapid	O
intracellular	O
formation	O
of	O
reactive	O
oxygen	O
intermediates	O
(	O
ROIs	O
)	O
which	O
are	O
required	O
for	O
CD28	protein
-mediated	O
activation	O
of	O
the	O
NF-kappa	protein
B	protein
/	O
CD28	protein
-responsive	protein
complex	protein
and	O
IL-2	protein
expression	O
.	O
Delineation	O
of	O
the	O
CD28	protein
signaling	O
cascade	O
was	O
found	O
to	O
involve	O
protein	protein
tyrosine	protein
kinase	protein
activity	O
,	O
followed	O
by	O
the	O
activation	O
of	O
phospholipase	protein
A2	protein
and	O
5-lipoxygenase	protein
.	O
Our	O
data	O
suggest	O
that	O
lipoxygenase	protein
metabolites	protein
activate	O
ROI	O
formation	O
which	O
then	O
induce	O
IL-2	protein
expression	O
via	O
NF-kappa	protein
B	protein
activation	O
.	O
These	O
findings	O
should	O
be	O
useful	O
for	O
therapeutic	O
strategies	O
and	O
the	O
development	O
of	O
immunosuppressants	O
targeting	O
the	O
CD28	protein
costimulatory	O
pathway	O
.	O

The	O
peri-kappa	DNA
B	DNA
site	DNA
mediates	O
human	DNA
immunodeficiency	DNA
virus	DNA
type	DNA
2	DNA
enhancer	DNA
activation	O
in	O
monocytes	cell_type
but	O
not	O
in	O
T	cell_type
cells	cell_type
.	O
Human	O
immunodeficiency	O
virus	O
type	O
2	O
(	O
HIV-2	O
),	O
like	O
HIV-1	O
,	O
causes	O
AIDS	O
and	O
is	O
associated	O
with	O
AIDS	O
cases	O
primarily	O
in	O
West	O
Africa.	O
HIV-1	O
and	O
HIV-2	O
display	O
significant	O
differences	O
in	O
nucleic	DNA
acid	DNA
sequence	DNA
and	O
in	O
the	O
natural	O
history	O
of	O
clinical	O
disease.	O
Consistent	O
with	O
these	O
differences,	O
we	O
have	O
previously	O
demonstrated	O
that	O
the	O
enhancer/promoter	DNA
region	DNA
of	O
HIV-2	O
functions	O
quite	O
differently	O
from	O
that	O
of	O
HIV-1	O
.	O
Whereas	O
activation	O
of	O
the	O
HIV-1	DNA
enhancer	DNA
following	O
T-cell	O
stimulation	O
is	O
mediated	O
largely	O
through	O
binding	O
of	O
the	O
transcription	protein
factor	protein
NF-kappa	protein
B	protein
to	O
two	O
adjacent	O
kappa	DNA
B	DNA
sites	DNA
in	O
the	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
,	O
activation	O
of	O
the	O
HIV-2	DNA
enhancer	DNA
in	O
monocytes	cell_type
and	O
T	cell_type
cells	cell_type
is	O
dependent	O
on	O
four	O
cis-acting	DNA
elements	DNA
:	O
a	O
single	O
kappa	DNA
B	DNA
site	DNA
,	O
two	O
purine-rich	DNA
binding	DNA
sites	DNA
,	O
PuB1	DNA
and	O
PuB2	DNA
,	O
and	O
a	O
pets	DNA
site	DNA
.	O
We	O
have	O
now	O
identified	O
a	O
novel	O
cis-acting	DNA
element	DNA
within	O
the	O
HIV-2	DNA
enhancer	DNA
,	O
immediately	O
upstream	O
of	O
the	O
kappa	DNA
B	DNA
site	DNA
,	O
designated	O
peri-kappa	DNA
B	DNA
.	O
This	O
site	O
is	O
conserved	O
among	O
isolates	O
of	O
HIV-2	O
and	O
the	O
closely	O
related	O
simian	O
immunodeficiency	O
virus	O
,	O
and	O
transfection	O
assays	O
show	O
this	O
site	O
to	O
mediate	O
HIV-2	DNA
enhancer	DNA
activation	O
following	O
stimulation	O
of	O
monocytic	cell_line
but	O
not	O
T-cell	cell_line
lines	cell_line
.	O
This	O
is	O
the	O
first	O
description	O
of	O
an	O
HIV-2	DNA
enhancer	DNA
element	DNA
which	O
displays	O
such	O
monocyte	O
specificity,	O
and	O
no	O
comparable	O
enhancer	DNA
element	DNA
has	O
been	O
clearly	O
defined	O
for	O
HIV-1	O
.	O
While	O
a	O
nuclear	protein
factor	protein
(s)	O
from	O
both	O
peripheral	cell_type
blood	cell_type
monocytes	cell_type
and	O
T	cell_type
cells	cell_type
binds	O
the	O
peri-kappa	DNA
B	DNA
site	DNA
,	O
electrophoretic	O
mobility	O
shift	O
assays	O
suggest	O
that	O
either	O
a	O
different	O
protein	O
binds	O
to	O
this	O
site	O
in	O
monocytes	cell_type
versus	O
T	cell_type
cells	cell_type
or	O
that	O
the	O
protein	O
recognizing	O
this	O
enhancer	DNA
element	DNA
undergoes	O
differential	O
modification	O
in	O
monocytes	cell_type
and	O
T	cell_type
cells	cell_type
,	O
thus	O
supporting	O
the	O
transfection	O
data.	O
Further,	O
while	O
specific	O
constitutive	O
binding	O
to	O
the	O
peri-kappa	DNA
B	DNA
site	DNA
is	O
seen	O
in	O
monocytes	cell_type
,	O
stimulation	O
with	O
phorbol	O
esters	O
induces	O
additional,	O
specific	O
binding.	O
Understanding	O
the	O
monocyte-specific	O
function	O
of	O
the	O
peri-kappa	protein
B	protein
factor	protein
may	O
ultimately	O
provide	O
insight	O
into	O
the	O
different	O
role	O
monocytes	cell_type
and	O
T	cell_type
cells	cell_type
play	O
in	O
HIV	O
pathogenesis	O
.	O

E1A	DNA
gene	DNA
expression	O
induces	O
susceptibility	O
to	O
killing	O
by	O
NK	cell_type
cells	cell_type
following	O
immortalization	O
but	O
not	O
adenovirus	O
infection	O
of	O
human	cell_type
cells	cell_type
.	O
Adenovirus	O
(Ad)	O
infection	O
and	O
E1A	protein
transfection	O
were	O
used	O
to	O
model	O
changes	O
in	O
susceptibility	O
to	O
NK	O
cell	O
killing	O
caused	O
by	O
transient	O
vs	O
stable	O
E1A	protein
expression	O
in	O
human	cell_type
cells	cell_type
.	O
Only	O
stably	O
transfected	cell_line
target	cell_line
cells	cell_line
exhibited	O
cytolytic	O
susceptibility,	O
despite	O
expression	O
of	O
equivalent	O
levels	O
of	O
E1A	protein
proteins	protein
in	O
Ad-infected	cell_line
targets	cell_line
.	O
The	O
inability	O
of	O
E1A	DNA
gene	DNA
products	O
to	O
induce	O
cytolytic	O
susceptibility	O
during	O
infection	O
was	O
not	O
explained	O
by	O
an	O
inhibitory	O
effect	O
of	O
viral	O
infection	O
on	O
otherwise	O
susceptible	O
target	cell_type
cells	cell_type
or	O
by	O
viral	DNA
gene	DNA
effects	O
on	O
class	protein
I	protein
MHC	protein
antigen	protein
expression	O
on	O
target	cell_type
cells	cell_type
.	O
This	O
differential	O
effect	O
of	O
E1A	protein
expression	O
on	O
the	O
cytolytic	O
phenotypes	O
of	O
infected	O
and	O
stably	O
transfected	O
human	cell_type
cells	cell_type
suggests	O
that	O
human	cell_type
NK	cell_type
cells	cell_type
provide	O
an	O
effective	O
immunologic	O
barrier	O
against	O
the	O
in	O
vivo	O
survival	O
and	O
neoplastic	O
progression	O
of	O
E1A-immortalized	cell_line
cells	cell_line
that	O
may	O
emerge	O
from	O
the	O
reservoir	O
of	O
persistently	cell_type
infected	cell_type
cells	cell_type
in	O
the	O
human	O
host	O
.	O

Distinct	O
signaling	O
properties	O
identify	O
functionally	O
different	O
CD4	protein
epitopes	protein
.	O
The	O
CD4	protein
coreceptor	protein
interacts	O
with	O
non-polymorphic	protein
regions	protein
of	O
major	protein
histocompatibility	protein
complex	protein
class	protein
II	protein
molecules	protein
on	O
antigen-presenting	cell_type
cells	cell_type
and	O
contributes	O
to	O
T	O
cell	O
activation	O
.	O
We	O
have	O
investigated	O
the	O
effect	O
of	O
CD4	protein
triggering	O
on	O
T	O
cell	O
activating	O
signals	O
in	O
a	O
lymphoma	O
model	O
using	O
monoclonal	protein
antibodies	protein
(	O
mAb	protein
)	O
which	O
recognize	O
different	O
CD4	protein
epitopes	protein
.	O
We	O
demonstrate	O
that	O
CD4	protein
triggering	O
delivers	O
signals	O
capable	O
of	O
activating	O
the	O
NF-AT	protein
transcription	protein
factor	protein
which	O
is	O
required	O
for	O
interleukin-2	protein
gene	O
expression	O
.	O
Whereas	O
different	O
anti-CD4	protein
mAb	protein
or	O
HIV-1	protein
gp120	protein
could	O
all	O
trigger	O
activation	O
of	O
the	O
protein	protein
tyrosine	protein
kinases	protein
p56lck	protein
and	O
p59fyn	protein
and	O
phosphorylation	O
of	O
the	O
Shc	protein
adaptor	protein
protein	protein
,	O
which	O
mediates	O
signals	O
to	O
Ras	protein
,	O
they	O
differed	O
significantly	O
in	O
their	O
ability	O
to	O
activate	O
NF-AT	protein
.	O
Lack	O
of	O
full	O
activation	O
of	O
NF-AT	protein
could	O
be	O
correlated	O
to	O
a	O
dramatically	O
reduced	O
capacity	O
to	O
induce	O
calcium	O
flux	O
and	O
could	O
be	O
complemented	O
with	O
a	O
calcium	O
ionophore	O
.	O
The	O
results	O
identify	O
functionally	O
distinct	O
epitopes	protein
on	O
the	O
CD4	protein
coreceptor	protein
involved	O
in	O
activation	O
of	O
the	O
Ras	protein
/protein	protein
kinase	protein
C	protein
and	O
calcium	O
pathways	O
.	O

Ligand-dependent	O
repression	O
of	O
the	O
erythroid	protein
transcription	protein
factor	protein
GATA-1	protein
by	O
the	O
estrogen	protein
receptor	protein
.	O
High-dose	O
estrogen	O
administration	O
induces	O
anemia	O
in	O
mammals	O
.	O
In	O
chickens,	O
estrogens	O
stimulate	O
outgrowth	O
of	O
bone	cell_type
marrow-derived	cell_type
erythroid	cell_type
progenitor	cell_type
cells	cell_type
and	O
delay	O
their	O
maturation	O
.	O
This	O
delay	O
is	O
associated	O
with	O
down-regulation	O
of	O
many	O
erythroid	DNA
cell-specific	DNA
genes	DNA
,	O
including	O
alpha-	O
and	O
beta-	O
globin	O
,	O
band	DNA
3	DNA
,	O
band	DNA
4.1	DNA
,	O
and	O
the	O
erythroid	protein
cell-specific	protein
histone	protein
H5	protein
.	O
We	O
show	O
here	O
that	O
estrogens	O
also	O
reduce	O
the	O
number	O
of	O
erythroid	cell_type
progenitor	cell_type
cells	cell_type
in	O
primary	cell_line
human	cell_line
bone	cell_line
marrow	cell_line
cultures	cell_line
.	O
To	O
address	O
potential	O
mechanisms	O
by	O
which	O
estrogens	O
suppress	O
erythropoiesis	O
,	O
we	O
have	O
examined	O
their	O
effects	O
on	O
GATA-1	protein
,	O
an	O
erythroid	protein
transcription	protein
factor	protein
that	O
participates	O
in	O
the	O
regulation	O
of	O
the	O
majority	O
of	O
erythroid	DNA
cell-specific	DNA
genes	DNA
and	O
is	O
necessary	O
for	O
full	O
maturation	O
of	O
erythrocytes	cell_type
.	O
We	O
demonstrate	O
that	O
the	O
transcriptional	O
activity	O
of	O
GATA-1	protein
is	O
strongly	O
repressed	O
by	O
the	O
estrogen	protein
receptor	protein
(	O
ER	protein
)	O
in	O
a	O
ligand-dependent	O
manner	O
and	O
that	O
this	O
repression	O
is	O
reversible	O
in	O
the	O
presence	O
of	O
4-hydroxytamoxifen	O
.	O
ER	protein
-mediated	O
repression	O
of	O
GATA-1	protein
activity	O
occurs	O
on	O
an	O
artificial	DNA
promoter	DNA
containing	O
a	O
single	O
GATA-binding	DNA
site	DNA
,	O
as	O
well	O
as	O
in	O
the	O
context	O
of	O
an	O
intact	DNA
promoter	DNA
which	O
is	O
normally	O
regulated	O
by	O
GATA-1	protein
.	O
GATA-1	protein
and	O
ER	protein
bind	O
to	O
each	O
other	O
in	O
vitro	O
in	O
the	O
absence	O
of	O
DNA.	O
In	O
coimmunoprecipitation	O
experiments	O
using	O
transfected	O
COS	cell_line
cells	cell_line
,	O
GATA-1	protein
and	O
ER	protein
associate	O
in	O
a	O
ligand-dependent	O
manner	O
.	O
Mapping	O
experiments	O
indicate	O
that	O
GATA-1	protein
and	O
the	O
ER	protein
form	O
at	O
least	O
two	O
contacts,	O
which	O
involve	O
the	O
finger	O
region	O
and	O
the	O
N-terminal	protein
activation	protein
domain	protein
of	O
GATA-1	protein
.	O
We	O
speculate	O
that	O
estrogens	O
exert	O
effects	O
on	O
erythropoiesis	O
by	O
modulating	O
GATA-1	protein
activity	O
through	O
protein-protein	O
interaction	O
with	O
the	O
ER	protein
.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS)	O

Mouse	DNA
interleukin-2	DNA
receptor	DNA
alpha	DNA
gene	DNA
expression	O
.	O
Interleukin-1	protein
and	O
interleukin-2	protein
control	O
transcription	O
via	O
distinct	O
cis-acting	DNA
elements	DNA
.	O
We	O
have	O
shown	O
that	O
interleukin-1	protein
(	O
IL-1	protein
)	O
and	O
IL-2	protein
control	O
IL-2	DNA
receptor	DNA
alpha	DNA
(	DNA
IL-2R	DNA
alpha	DNA
)	DNA
gene	DNA
transcription	O
in	O
CD4-CD8-	cell_line
murine	cell_line
T	cell_line
lymphocyte	cell_line
precursors	cell_line
.	O
Here	O
we	O
map	O
the	O
cis-acting	DNA
elements	DNA
that	O
mediate	O
interleukin	O
responsiveness	O
of	O
the	O
mouse	DNA
IL-2R	DNA
alpha	DNA
gene	DNA
using	O
a	O
thymic	cell_line
lymphoma-derived	cell_line
hybridoma	cell_line
(	O
PC60	cell_line
).	O
The	O
transcriptional	O
response	O
of	O
the	O
IL-2R	DNA
alpha	DNA
gene	DNA
to	O
stimulation	O
by	O
IL-1	protein
+	O
IL-2	protein
is	O
biphasic.	O
IL-1	protein
induces	O
a	O
rapid,	O
protein	O
synthesis-independent	O
appearance	O
of	O
IL-2R	RNA
alpha	RNA
mRNA	RNA
that	O
is	O
blocked	O
by	O
inhibitors	O
of	O
NF-kappa	protein
B	protein
activation	O
.	O
It	O
also	O
primes	O
cells	O
to	O
become	O
IL-2	protein
responsive	O
and	O
thereby	O
prepares	O
the	O
second	O
phase,	O
in	O
which	O
IL-2	protein
induces	O
a	O
100-fold	O
further	O
increase	O
in	O
IL-2R	RNA
alpha	RNA
transcripts	RNA
.	O
Transient	O
transfection	O
experiments	O
show	O
that	O
several	O
elements	O
in	O
the	O
promoter-proximal	DNA
region	DNA
of	O
the	O
IL-2R	DNA
alpha	DNA
gene	DNA
contribute	O
to	O
IL-1	protein
responsiveness,	O
most	O
importantly	O
an	O
NF-kappa	DNA
B	DNA
site	DNA
conserved	O
in	O
the	O
human	O
and	O
mouse	O
gene	O
.	O
IL-2	protein
responsiveness	O
,	O
on	O
the	O
other	O
hand,	O
depends	O
on	O
a	O
78-nucleotide	DNA
segment	DNA
1.3	O
kilobases	O
upstream	O
of	O
the	O
major	DNA
transcription	DNA
start	DNA
site	DNA
.	O
This	O
segment	O
functions	O
as	O
an	O
IL-2-inducible	DNA
enhancer	DNA
and	O
lies	O
within	O
a	O
region	O
that	O
becomes	O
DNase	protein
I	protein
hypersensitive	O
in	O
normal	O
T	cell_type
cells	cell_type
in	O
which	O
IL-2R	protein
alpha	protein
expression	O
has	O
been	O
induced.	O
IL-2	protein
responsiveness	O
requires	O
three	O
distinct	O
elements	DNA
within	O
the	O
enhancer	DNA
.	O
Two	O
of	O
these	O
are	O
potential	O
binding	O
sites	O
for	O
STAT	protein
proteins	protein
.	O

Hematopoietic	cell_type
lineage	cell_type
commitment	O
:	O
role	O
of	O
transcription	protein
factors	protein
.	O
This	O
review	O
focuses	O
on	O
the	O
roles	O
of	O
transcription	protein
factors	protein
in	O
hematopoietic	O
lineage	O
commitment	O
.	O
A	O
brief	O
introduction	O
to	O
lineage	O
commitment	O
and	O
asymmetric	O
cell	O
division	O
is	O
followed	O
by	O
a	O
discussion	O
of	O
several	O
methods	O
used	O
to	O
identify	O
transcription	protein
factors	protein
important	O
in	O
specifying	O
hematopoietic	cell_type
cell	cell_type
types	cell_type
.	O
Next	O
is	O
presented	O
a	O
discussion	O
of	O
the	O
use	O
of	O
embryonic	cell_type
stem	cell_type
cells	cell_type
in	O
the	O
analysis	O
of	O
hematopoietic	DNA
gene	DNA
expression	O
and	O
the	O
use	O
of	O
targeted	O
gene	O
disruption	O
to	O
analyze	O
the	O
role	O
of	O
transcription	protein
factors	protein
in	O
hematopoiesis	O
.	O
Finally,	O
the	O
status	O
of	O
our	O
current	O
knowledge	O
concerning	O
the	O
roles	O
of	O
transcription	protein
factors	protein
in	O
the	O
commitment	O
to	O
erythroid	O
,	O
myeloid	O
and	O
lymphoid	O
cell	O
types	O
is	O
summarized.	O

Epstein-Barr	O
virus	O
replicative	O
gene	O
transcription	O
during	O
de	O
novo	O
infection	O
of	O
human	cell_type
thymocytes	cell_type
:	O
simultaneous	O
early	O
expression	O
of	O
BZLF-1	protein
and	O
its	O
repressor	O
RAZ	protein
.	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
is	O
known	O
to	O
infect	O
B	cell_type
cells	cell_type
and	O
epithelial	cell_type
cells	cell_type
.	O
We	O
and	O
others	O
have	O
shown	O
that	O
EBV	O
can	O
also	O
infect	O
a	O
subset	O
of	O
thymocytes	cell_type
.	O
Infection	O
of	O
thymocytes	cell_type
was	O
accompanied	O
by	O
the	O
appearance	O
of	O
linear	DNA
EBV	DNA
genome	DNA
within	O
8	O
hr	O
of	O
infection.	O
Circularization	O
of	O
the	O
EBV	DNA
genome	DNA
was	O
not	O
detected.	O
This	O
is	O
in	O
contrast	O
to	O
the	O
infection	O
in	O
B	cell_type
cells	cell_type
where	O
the	O
genome	O
can	O
circularize	O
within	O
24	O
hr	O
of	O
infection.	O
The	O
appearance	O
of	O
the	O
BamHI	protein
ZLF-1	protein
gene	protein
product	protein
,	O
ZEBRA	protein
,	O
by	O
RT-PCR	O
,	O
was	O
observed	O
within	O
8	O
hr	O
of	O
infection.	O
The	O
appearance	O
of	O
a	O
novel	O
fusion	protein
transcript	protein
(	O
RAZ	protein
),	O
which	O
comprised	O
regions	O
of	O
the	O
BZLF-1	DNA
locus	DNA
and	O
the	O
adjacent	O
BRLF-1	DNA
locus	DNA
,	O
was	O
detected	O
by	O
RT-PCR	O
.	O
ZEBRA	protein
protein	protein
was	O
also	O
identified	O
in	O
infected	O
thymocytes	cell_type
by	O
immunoprecipitation	O
.	O
In	O
addition,	O
we	O
demonstrated	O
that	O
the	O
EBNA-1	DNA
gene	DNA
in	O
infected	O
thymocytes	cell_type
was	O
transcribed	O
from	O
the	O
Fp	DNA
promoter	DNA
,	O
rather	O
than	O
from	O
the	O
Cp/Wp	DNA
promoter	DNA
which	O
is	O
used	O
in	O
latently	cell_type
infected	cell_type
B	cell_type
cells	cell_type
.	O
Transcripts	O
encoding	O
gp350/220	protein
,	O
the	O
major	protein
coat	protein
protein	protein
of	O
EBV	O
,	O
were	O
identified,	O
but	O
we	O
did	O
not	O
find	O
any	O
evidence	O
of	O
transcription	O
from	O
the	O
LMP-2A	DNA
or	O
EBER-1	DNA
loci	DNA
in	O
infected	O
thymocytes	cell_type
.	O
These	O
observations	O
suggest	O
that	O
de	O
novo	O
EBV	O
infection	O
of	O
thymocytes	cell_type
differs	O
from	O
infection	O
of	O
B	cell_type
cells	cell_type
.	O
The	O
main	O
difference	O
is	O
that	O
with	O
thymocytes	cell_type
,	O
no	O
evidence	O
could	O
be	O
found	O
that	O
the	O
virus	O
ever	O
circularizes.	O
Rather,	O
EBV	O
remains	O
in	O
a	O
linear	O
configuration	O
from	O
which	O
replicative	DNA
genes	DNA
are	O
transcribed.	O

Identification	O
and	O
purification	O
of	O
human	protein
Stat	protein
proteins	protein
activated	O
in	O
response	O
to	O
interleukin-2	protein
.	O
A	O
key	O
cytokine	protein
induced	O
during	O
the	O
immune	O
response	O
is	O
IL-2	protein
.	O
Following	O
T	O
cell	O
activation	O
,	O
the	O
genes	O
encoding	O
IL-2	protein
and	O
the	O
various	O
chains	O
of	O
its	O
receptor	O
are	O
transcriptionally	O
induced.	O
In	O
turn,	O
secreted	O
IL-2	protein
serves	O
to	O
stimulate	O
the	O
proliferation	O
and	O
differentiation	O
of	O
T	cell_type
lymphocytes	cell_type
.	O
Several	O
recent	O
studies	O
have	O
implicated	O
Jak	O
kinases	O
in	O
the	O
signaling	O
pathway	O
induced	O
by	O
IL-2	protein
.	O
Following	O
this	O
lead,	O
we	O
set	O
out	O
to	O
identify	O
transcription	protein
factors	protein
induced	O
in	O
response	O
to	O
IL-2	protein
.	O
Human	cell_type
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
were	O
observed	O
to	O
contain	O
several	O
IL-2	protein
-inducible	O
DNA	O
binding	O
activities	O
.	O
Similar	O
activities	O
were	O
also	O
observed	O
in	O
a	O
transformed	cell_line
human	cell_line
lymphocyte	cell_line
line	cell_line
,	O
termed	O
YT	cell_line
.	O
We	O
have	O
purified	O
these	O
activities	O
and	O
found	O
that	O
the	O
principal	O
IL-2	protein
-inducible	protein
component	protein
bears	O
significant	O
relatedness	O
to	O
a	O
prolactin-induced	protein
transcription	protein
factor	protein
first	O
identified	O
in	O
sheep	cell_type
mammary	cell_type
gland	cell_type
tissue	cell_type
.	O
We	O
hypothesize	O
that	O
activation	O
of	O
this	O
protein,	O
designated	O
hStat5	protein
,	O
helps	O
govern	O
the	O
biological	O
effects	O
of	O
IL-2	protein
during	O
the	O
immune	O
response	O
.	O

E2F-1	protein
and	O
a	O
cyclin-like	protein
DNA	protein
repair	protein
enzyme	protein
,	O
uracil-DNA	protein
glycosylase	protein
,	O
provide	O
evidence	O
for	O
an	O
autoregulatory	O
mechanism	O
for	O
transcription	O
.	O
The	O
cell	protein
cycle-dependent	protein
transcription	protein
factor	protein
,	O
E2F-1	protein
,	O
regulates	O
the	O
cyclin	protein
-like	O
species	O
of	O
the	O
DNA	protein
repair	protein
enzyme	protein
uracil-DNA	DNA
glycosylase	DNA
(	DNA
UDG	DNA
)	DNA
gene	DNA
in	O
human	cell_line
osteosarcoma	cell_line
(	cell_line
Saos-2	cell_line
)	cell_line
cells	cell_line
.	O
We	O
demonstrate,	O
through	O
the	O
deletion	O
of	O
the	O
human	DNA
UDG	DNA
promoter	DNA
sequences	DNA
,	O
that	O
expression	O
of	O
E2F-1	protein
activates	O
the	O
UDG	DNA
promoter	DNA
through	O
several	O
E2F	DNA
sites	DNA
.	O
The	O
major	DNA
putative	DNA
downstream	DNA
site	DNA
for	O
E2F	protein
,	O
located	O
in	O
the	O
first	DNA
exon	DNA
,	O
serves	O
as	O
a	O
target	O
for	O
E2F-1/DP1	protein
complex	protein
binding	O
in	O
vitro.	O
We	O
also	O
provide	O
evidence	O
for	O
the	O
functional	O
relationship	O
between	O
the	O
cyclin-like	protein
UDG	protein
gene	protein
product	protein
and	O
E2F	protein
.	O
High	O
levels	O
of	O
UDG	protein
expression	O
in	O
a	O
transient	O
transfection	O
assay	O
result	O
in	O
the	O
down-regulation	O
of	O
transcriptional	O
activity	O
through	O
elements	DNA
specific	O
for	O
E2F	protein
-mediated	O
transcription	O
.	O
Overexpression	O
of	O
UDG	protein
in	O
Saos	cell_line
2	cell_line
cells	cell_line
was	O
observed	O
to	O
delay	O
growth	O
late	O
in	O
G1	O
phase	O
and	O
transiently	O
arrest	O
these	O
cells	O
from	O
progressing	O
into	O
the	O
S	O
phase	O
.	O
This	O
hypothetical	O
model	O
integrates	O
one	O
mechanism	O
of	O
DNA	O
repair	O
with	O
the	O
cell	O
cycle	O
control	O
of	O
gene	O
transcription	O
,	O
likely	O
through	O
E2F	protein
.	O
This	O
implicates	O
E2F	protein
as	O
a	O
multifunctional	O
target	O
for	O
proteins	O
and	O
enzymes,	O
possibly,	O
responsive	O
to	O
DNA	O
damage	O
through	O
the	O
negative	O
effect	O
of	O
UDG	protein
on	O
E2F	protein
-mediated	O
transcriptional	O
activity	O
.	O

Cellular	O
and	O
molecular	O
mechanisms	O
of	O
IFN-gamma	protein
production	O
induced	O
by	O
IL-2	protein
and	O
IL-12	protein
in	O
a	O
human	cell_line
NK	cell_line
cell	cell_line
line	cell_line
.	O
Interferon-gamma	protein
(	O
IFN-gamma	protein
)	O
is	O
an	O
important	O
immunoregulatory	protein
protein	protein
produced	O
predominantly	O
by	O
T	cell_type
cells	cell_type
and	O
large	cell_type
granular	cell_type
lymphocytes	cell_type
(	O
LGL	cell_type
)	O
in	O
response	O
to	O
different	O
extracellular	O
signals	O
.	O
In	O
particular,	O
two	O
interleukins	protein
(	O
ILs	protein
),	O
IL-2	protein
and	O
IL-12	protein
,	O
have	O
been	O
shown	O
to	O
be	O
potent	O
inducers	O
of	O
IFN-gamma	protein
gene	O
expression	O
in	O
both	O
T	cell_type
cells	cell_type
and	O
LGL	cell_type
.	O
Although	O
it	O
has	O
been	O
reported	O
that	O
there	O
are	O
some	O
T	cell_line
cell	cell_line
lines	cell_line
that	O
produce	O
IFN-gamma	protein
in	O
response	O
to	O
IL-2	O
and	O
IL-12	O
stimulation	O
,	O
there	O
has	O
as	O
yet	O
been	O
no	O
report	O
of	O
a	O
natural	cell_line
killer	cell_line
(NK)	cell_line
cell	cell_line
line	cell_line
that	O
responds	O
in	O
a	O
similar	O
manner.	O
In	O
this	O
report	O
we	O
present	O
evidence	O
that	O
the	O
cell	cell_line
line	cell_line
NK3.3	cell_line
derived	O
from	O
human	cell_type
NK	cell_type
cells	cell_type
,	O
responds	O
to	O
both	O
IL-2	protein
and	O
IL-12	protein
,	O
as	O
measured	O
by	O
increases	O
in	O
IFN-gamma	protein
and	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
(	O
GM-CSF	protein
)	O
cytoplasmic	O
mRNA	O
and	O
protein	O
expression	O
.	O
In	O
addition,	O
when	O
used	O
together	O
IL-2	protein
and	O
IL-12	protein
synergized	O
in	O
the	O
induction	O
of	O
IFN-gamma	protein
and	O
GM-CSF	protein
and	O
this	O
synergy	O
was	O
attributed	O
to	O
an	O
increased	O
accumulation	O
and	O
stability	O
of	O
the	O
IFN-gamma	RNA
and	RNA
GM-CSF	RNA
mRNAs	RNA
.	O
To	O
investigate	O
the	O
signaling	O
pathways	O
involved	O
in	O
the	O
gene	O
induction,	O
five	O
inhibitors,	O
cyclosporin	O
A	O
(	O
CsA	O
),	O
transforming	protein
growth	protein
factor-beta	protein
,	O
cycloheximide	O
,	O
genistein	O
,	O
and	O
staurosporine	O
A	O
,	O
were	O
used	O
in	O
analyzing	O
the	O
effects	O
of	O
IL-2	protein
and	O
IL-12	protein
on	O
NK3.3	cell_line
cells	cell_line
.	O
The	O
results	O
suggest	O
that	O
activation	O
of	O
protein	protein
kinase	protein
C	protein
,	O
but	O
not	O
new	O
protein	O
synthesis	O
,	O
is	O
required	O
for	O
IL-2	protein
induction	O
of	O
IFN-gamma	O
and	O
GM-CSF	O
cytoplasmic	O
mRNA	O
.	O
In	O
contrast,	O
IL-12	protein
induction	O
of	O
IFN-gamma	RNA
cytoplasmic	RNA
mRNA	RNA
appears	O
to	O
only	O
partially	O
depend	O
on	O
activation	O
of	O
protein	protein
kinase	protein
C	protein
.	O
Furthermore,	O
both	O
transforming	protein
growth	protein
factor-beta	protein
and	O
genistein	O
,	O
a	O
tyrosine	O
kinase	O
inhibitor	O
,	O
could	O
suppress	O
IL-2	protein
and	O
IL-12	protein
signaling	O
but	O
CsA	O
was	O
generally	O
inactive.	O
It	O
also	O
was	O
observed	O
that	O
suppression	O
of	O
cytokine	DNA
gene	DNA
expression	O
by	O
these	O
agents	O
was	O
independent	O
of	O
the	O
inhibition	O
of	O
proliferation	O
.	O
In	O
addition,	O
IL-2	protein
but	O
not	O
IL-12	protein
induced	O
nuclear	protein
factors	protein
NF-kappa	protein
B	protein
and	O
AP1	protein
,	O
and	O
regulation	O
of	O
the	O
nuclear	O
levels	O
of	O
these	O
two	O
DNA	protein
binding	protein
protein	protein
complexes	protein
is	O
correlated	O
with	O
IFN-gamma	O
and	O
GM-CSF	O
gene	O
expression	O
.	O
These	O
data	O
indicate	O
that	O
IL-2	protein
and	O
IL-12	protein
may	O
have	O
distinct	O
signaling	O
pathways	O
leading	O
to	O
the	O
induction	O
of	O
IFN-gamma	protein
and	O
GM-CSF	protein
gene	O
expression	O
,	O
and	O
that	O
the	O
NK3.3	cell_line
cell	cell_line
line	cell_line
may	O
serve	O
as	O
a	O
novel	O
model	O
for	O
dissecting	O
the	O
biochemical	O
and	O
molecular	O
events	O
involved	O
in	O
these	O
pathways.	O

A	O
functional	O
T-cell	protein
receptor	protein
signaling	O
pathway	O
is	O
required	O
for	O
p95vav	protein
activity	O
.	O
Stimulation	O
of	O
the	O
T-cell	protein
antigen	protein
receptor	protein
(	O
TCR	protein
)	O
induces	O
activation	O
of	O
multiple	O
tyrosine	protein
kinases	protein
,	O
resulting	O
in	O
phosphorylation	O
of	O
numerous	O
intracellular	O
substrates	O
.	O
One	O
substrate	O
is	O
p95vav	protein
,	O
which	O
is	O
expressed	O
exclusively	O
in	O
hematopoietic	O
and	O
trophoblast	O
cells	O
.	O
It	O
contains	O
a	O
number	O
of	O
structural	protein
motifs	protein
,	O
including	O
Src	protein
homology	protein
2	protein
,	protein
Src	protein
homology	protein
3	protein
,	protein
and	protein
pleckstrin	protein
homology	protein
domains	protein
and	O
a	O
putative	protein
guanine	protein
nucleotide	protein
exchange	protein
domain	protein
.	O
The	O
role	O
of	O
p95vav	protein
in	O
TCR	protein
-mediated	O
signaling	O
processes	O
is	O
unclear.	O
Here,	O
we	O
show	O
that	O
overexpression	O
of	O
p95vav	protein
alone	O
in	O
Jurkat	O
T	cell_type
cells	cell_type
leads	O
to	O
activation	O
of	O
the	O
nuclear	protein
factors	protein
,	O
including	O
NFAT	protein
,	O
involved	O
in	O
interleukin-2	protein
expression	O
.	O
Furthermore,	O
p95vav	protein
synergizes	O
with	O
TCR	protein
stimulation	O
in	O
inducing	O
NFAT-	O
and	O
interleukin-2-	O
dependent	O
transcription	O
.	O
In	O
contrast,	O
NFAT	protein
activation	O
by	O
a	O
G-protein-coupled	protein
receptor	protein
is	O
not	O
modulated	O
by	O
p95vav	protein
overexpression	O
,	O
suggesting	O
that	O
the	O
effect	O
is	O
specific	O
to	O
the	O
TCR	protein
signaling	O
pathways	O
.	O
Although	O
removal	O
of	O
the	O
first	protein
67	protein
amino	protein
acids	protein
of	O
p95vav	protein
activates	O
its	O
transforming	O
potential	O
in	O
NIH	cell_line
3T3	cell_line
cells	cell_line
,	O
this	O
region	O
appears	O
to	O
be	O
required	O
for	O
its	O
function	O
in	O
T	cell_type
cells	cell_type
.	O
We	O
further	O
demonstrate	O
that	O
the	O
p95vav	protein
-induced	O
NFAT	protein
activation	O
is	O
not	O
mimicked	O
by	O
Ras	protein
activation	O
,	O
though	O
its	O
function	O
is	O
dependent	O
upon	O
Ras	protein
and	O
Raf	protein
.	O
Furthermore,	O
the	O
activating	O
function	O
of	O
p95vav	protein
is	O
blocked	O
by	O
FK506	O
,	O
suggesting	O
that	O
its	O
activity	O
also	O
depends	O
on	O
calcineurin	protein
.	O
To	O
further	O
dissect	O
p95vav	protein
involvement	O
in	O
TCR	protein
signaling	O
,	O
we	O
analyzed	O
various	O
Jurkat	cell_line
mutants	cell_line
deficient	O
in	O
TCR	protein
signaling	O
function	O
or	O
TCR	protein
expression	O
and	O
showed	O
that	O
an	O
intact	O
TCR	protein
signaling	O
pathway	O
is	O
required	O
for	O
p95vav	protein
to	O
function.	O
However,	O
overexpression	O
of	O
p95vav	protein
does	O
not	O
appear	O
to	O
influence	O
TCR	protein
-induced	O
protein	O
tyrosine	O
phosphorylation	O
or	O
increases	O
in	O
cytoplasmic	O
free	O
calcium	O
.	O
Taken	O
together,	O
our	O
data	O
suggest	O
that	O
p95vav	protein
plays	O
an	O
important	O
role	O
at	O
an	O
yet	O
unidentified	O
proximal	O
position	O
in	O
the	O
TCR	protein
signaling	O
cascade	O
.	O

Positive	O
and	O
negative	O
regulation	O
of	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
promoter	O
activity	O
by	O
AML1-related	protein
transcription	protein
factor	protein
,	O
PEBP2	protein
.	O
The	O
granulocyte-macrophage	DNA
colony-stimulating	DNA
factor	DNA
(	DNA
GM-CSF	DNA
)	DNA
gene	DNA
promoter	DNA
contains	O
a	O
consensus	O
sequence	O
for	O
the	O
polyomavirus	protein
enhancer	protein
binding-protein	protein
2	protein
(	protein
PEBP2	protein
)	protein
transcription	protein
factor	protein
,	O
which	O
consists	O
of	O
alpha	O
and	O
beta	O
subunits	O
.	O
There	O
are	O
at	O
least	O
two	O
genes,	O
alpha	DNA
A	DNA
and	O
alpha	DNA
B	DNA
,	O
encoding	O
the	O
alpha	protein
subunit	protein
.	O
alpha	DNA
B	DNA
is	O
the	O
mouse	DNA
homologue	DNA
of	O
human	DNA
AML1	DNA
gene	DNA
detected	O
at	O
the	O
breakpoints	O
of	O
t(8;21)	O
and	O
t(3;21)	O
myeloid	O
leukemias	O
.	O
We	O
examined	O
alpha	protein
A1	protein
(an	O
alpha	protein
A	protein
-gene	protein
product	protein
)	O
and	O
alpha	protein
B1	protein
and	O
alpha	protein
B2	protein
(two	O
alpha	protein
B	protein
-encoded	protein
isomers	protein
)	O
for	O
their	O
effects	O
on	O
the	O
GM-CSF	DNA
promoter	DNA
.	O
PEBP2	protein
alpha	protein
A1	protein
,	O
alpha	protein
B1	protein
,	O
and	O
alpha	protein
B2	protein
proteins	protein
bound	O
the	O
PEBP2	DNA
site	DNA
within	O
the	O
mouse	DNA
GM-CSF	DNA
promoter	DNA
.	O
PEBP2	protein
alpha	protein
A1	protein
and	O
alpha	protein
B1	protein
enhanced	O
the	O
expression	O
of	O
the	O
GM-CSF	DNA
promoter-driven	DNA
reporter	DNA
plasmid	DNA
in	O
unstimulated	O
and	O
12-O-tetradecanoylphorbol	O
13-acetate/phytohemagglutinin-stimulated	O
human	O
Jurkat	O
T	O
cells	O
.	O
In	O
contrast,	O
the	O
promoter	O
activity	O
was	O
suppressed	O
by	O
alpha	protein
B2	protein
.	O
Coexpression	O
of	O
alpha	protein
B1	protein
and	O
alpha	protein
B2	protein
showed	O
that	O
the	O
promoter	O
activity	O
could	O
be	O
determined	O
by	O
the	O
alpha	protein
B1	protein
/alpha	protein
B2	protein
ratio	O
.	O
Jurkat	O
cell	O
extract	O
contained	O
PEBP2	protein
site-binding	protein
protein	protein
(s)	O
that	O
cross-reacted	O
with	O
antimouse	protein
alpha	protein
A1	protein
antibodies	protein
.	O
Northern	O
blot	O
analysis	O
indicated	O
the	O
expression	O
of	O
human	O
PEBP2	protein
alpha	protein
A	protein
,	O
alpha	DNA
B	DNA
(	O
AML1	DNA
),	O
and	O
beta	DNA
genes	DNA
in	O
Jurkat	cell_line
cells	cell_line
.	O
Although	O
further	O
studies	O
are	O
required	O
to	O
determine	O
the	O
precise	O
role	O
of	O
PEBP2	protein
in	O
the	O
GM-CSF	protein
promoter	O
activity	O
,	O
the	O
present	O
findings	O
suggested	O
the	O
importance	O
of	O
the	O
relative	O
ratio	O
of	O
different	O
PEBP2	protein
isoforms	protein
in	O
regulating	O
the	O
levels	O
of	O
the	O
promoter	O
activity	O
.	O

IFN-gamma	protein
priming	O
of	O
monocytes	cell_type
enhances	O
LPS	O
-induced	O
TNF	protein
production	O
by	O
augmenting	O
both	O
transcription	O
and	O
MRNA	O
stability	O
.	O
The	O
induction	O
of	O
cytokine	protein
expression	O
in	O
monocytes	cell_type
/	O
macrophages	cell_type
by	O
bacterial	protein
endotoxin	protein
or	O
lipopolysaccharide	O
is	O
a	O
critical,	O
highly	O
regulated	O
host	O
defence	O
response	O
.	O
The	O
augmentation	O
of	O
LPS	O
responses	O
by	O
interferon	protein
gamma	protein
(	O
IFN-gamma	protein
),	O
referred	O
to	O
as	O
priming,	O
is	O
well	O
established.	O
However,	O
the	O
mechanism(s)	O
by	O
which	O
priming	O
occurs	O
is	O
poorly	O
defined.	O
Using	O
tumour	protein
necrosis	protein
factor	protein
(	O
TNF	protein
)	O
induction	O
as	O
a	O
model,	O
experiments	O
were	O
designed	O
to	O
analyse	O
in	O
detail	O
the	O
priming	O
effect	O
on	O
the	O
LPS	O
response	O
in	O
human	cell_type
monocytes	cell_type
.	O
Priming	O
by	O
IFN-gamma	protein
was	O
primarily	O
manifested	O
at	O
the	O
level	O
of	O
TNF	RNA
mRNA	RNA
accumulation	O
.	O
IFN-gamma	protein
pre-treatment	O
affected	O
the	O
magnitude	O
rather	O
than	O
the	O
sensitivity	O
of	O
the	O
LPS	O
response	O
.	O
Priming	O
occurred	O
after	O
several	O
hours	O
of	O
treatment	O
,	O
and	O
the	O
primed	O
state	O
was	O
induced	O
by	O
either	O
IFN-gamma	protein
or	O
GM-CSF	protein
,	O
but	O
not	O
M-CSF	protein
.	O
Primed	O
monocytes	cell_type
transcribed	O
TNF	RNA
mRNA	RNA
at	O
a	O
higher	O
rate	O
than	O
freshly	O
isolated	O
monocytes	cell_type
upon	O
activation	O
with	O
LPS	O
.	O
The	O
increased	O
transcriptional	O
rate	O
correlated	O
with	O
a	O
marked	O
increase	O
in	O
nuclear	protein
factor-kappa	protein
B	protein
activity	O
in	O
these	O
cells	O
as	O
determined	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
using	O
a	O
consensus	DNA
NF-kappa	DNA
B	DNA
oligonucleotide	DNA
.	O
An	O
additional	O
significant	O
finding	O
was	O
than	O
TNF	RNA
mRNA	RNA
induced	O
in	O
primed	cell_line
cells	cell_line
was	O
much	O
more	O
stable	O
than	O
in	O
unprimed	cell_line
cells	cell_line
(T1/2	O
increased	O
6-8-fold).	O
Consistent	O
with	O
the	O
increased	O
mRNA	RNA
stability	O
,	O
the	O
duration	O
of	O
mRNA	RNA
accumulation	O
was	O
longer	O
following	O
LPS	O
stimulation	O
in	O
primed	O
monocytes	cell_type
,	O
in	O
addition	O
to	O
being	O
of	O
greater	O
magnitude.	O
Finally,	O
primed	O
and	O
unprimed	O
cells	O
possessed	O
a	O
differential	O
sensitivity	O
to	O
the	O
kinase	O
inhibitor	O
H-89	O
.	O
H-89	O
substantially	O
suppressed	O
LPS	O
-induced	O
TNF	RNA
mRNA	RNA
accumulation	O
in	O
unprimed	cell_line
cells	cell_line
,	O
but	O
had	O
no	O
effect	O
on	O
primed	cell_line
monocytes	cell_line
following	O
LPS	O
stimulation	O
.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS)	O

A	O
Myc-associated	DNA
zinc	DNA
finger	DNA
protein	DNA
binding	DNA
site	DNA
is	O
one	O
of	O
four	O
important	O
functional	DNA
regions	DNA
in	O
the	O
CD4	DNA
promoter	DNA
.	O
The	O
CD4	DNA
promoter	DNA
plays	O
an	O
important	O
role	O
in	O
the	O
developmental	O
control	O
of	O
CD4	protein
transcription	O
.	O
In	O
this	O
report,	O
we	O
show	O
that	O
the	O
minimal	O
CD4	DNA
promoter	DNA
has	O
four	O
factor	DNA
binding	DNA
sites	DNA
,	O
each	O
of	O
which	O
is	O
required	O
for	O
full	O
function.	O
Using	O
biochemical	O
and	O
mutagenesis	O
analyses	O
,	O
we	O
determined	O
that	O
multiple	O
nuclear	protein
factors	protein
bind	O
to	O
these	O
independent	O
sites.	O
We	O
determined	O
that	O
an	O
initiator-like	DNA
sequence	DNA
present	O
at	O
the	O
cap	DNA
site	DNA
and	O
an	O
Ets	DNA
consensus	DNA
sequence	DNA
are	O
required	O
for	O
full	O
promoter	DNA
function	O
.	O
We	O
also	O
demonstrate	O
that	O
the	O
Myc-associated	protein
zinc	protein
finger	protein
protein	protein
(	O
MAZ	protein
)	O
appears	O
to	O
be	O
the	O
predominant	protein
factor	protein
binding	O
to	O
one	O
of	O
these	O
sites.	O
This	O
last	O
site	O
closely	O
resembles	O
the	O
ME1a1	DNA
G3AG4AG3	DNA
motif	DNA
previously	O
shown	O
to	O
be	O
a	O
critical	O
element	O
in	O
the	O
P2	DNA
promoter	DNA
of	O
the	O
c-myc	DNA
gene	DNA
.	O
We	O
therefore	O
believe	O
that	O
the	O
MAZ	protein
transcription	protein
factor	protein
is	O
also	O
likely	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
control	O
of	O
developmental	O
expression	O
of	O
the	O
CD4	DNA
gene	DNA
.	O

Erythropoietin	protein
stimulates	O
transcription	O
of	O
the	O
TAL1/SCL	DNA
gene	DNA
and	O
phosphorylation	O
of	O
its	O
protein	protein
products	protein
.	O
Activation	O
of	O
the	O
TAL1	DNA
(or	DNA
SCL)	DNA
gene	DNA
,	O
originally	O
identified	O
through	O
its	O
involvement	O
by	O
a	O
recurrent	O
chromosomal	O
translocation	O
,	O
is	O
the	O
most	O
frequent	O
molecular	DNA
lesion	DNA
recognized	O
in	O
T-cell	O
acute	O
lymphoblastic	O
leukemia	O
.	O
The	O
protein	protein
products	protein
of	O
this	O
gene	O
contain	O
the	O
basic-helix-loop-helix	protein
motif	protein
characteristic	O
of	O
a	O
large	O
family	O
of	O
transcription	protein
factors	protein
that	O
bind	O
to	O
the	O
canonical	DNA
DNA	DNA
sequence	DNA
CANNTG	DNA
as	O
protein	protein
heterodimers	protein
.	O
TAL1	protein
expression	O
by	O
erythroid	cell_type
cells	cell_type
in	O
vivo	O
and	O
in	O
chemical-induced	cell_line
erythroleukemia	cell_line
cell	cell_line
lines	cell_line
in	O
vivo	O
suggested	O
the	O
gene	O
might	O
regulate	O
aspects	O
of	O
erythroid	O
differentiation	O
.	O
Since	O
the	O
terminal	O
events	O
of	O
erythropoiesis	O
are	O
controlled	O
by	O
the	O
glycoprotein	protein
hormone	protein
erythropoietin	protein
(	O
Epo	protein
),	O
we	O
investigated	O
whether	O
the	O
expression	O
or	O
activity	O
of	O
the	O
TAL1	DNA
gene	DNA
and	O
its	O
protein	protein
products	protein
were	O
affected	O
by	O
Epo	protein
in	O
splenic	cell_type
erythroblasts	cell_type
from	O
mice	O
infected	O
with	O
an	O
anemia-inducing	O
strain	O
of	O
Friend	O
virus	O
(FVA	O
cells).	O
Epo	protein
elicited	O
a	O
rapid,	O
dose-related	O
increase	O
in	O
TAL1	RNA
mRNA	RNA
by	O
increasing	O
transcription	O
of	O
the	O
gene	O
and	O
stabilizing	O
one	O
of	O
its	O
mRNAs	RNA
.	O
An	O
Epo	protein
-inducible	O
TAL1	protein
DNA	O
binding	O
activity	O
was	O
identified	O
in	O
FVA	O
cell	O
nuclear	O
extracts	O
that	O
subsequently	O
decayed	O
despite	O
accumulating	O
mRNA	RNA
and	O
protein	protein
.	O
Induction	O
of	O
DNA	O
binding	O
activity	O
was	O
associated	O
temporally	O
with	O
Epo	protein
-induced	O
phosphorylation	O
of	O
nuclear	protein
TAL1	protein
protein	protein
.	O
These	O
results	O
indicate	O
that	O
Epo	protein
acts	O
at	O
both	O
transcriptional	O
and	O
posttranscriptional	O
levels	O
on	O
the	O
TAL1	protein
locus	O
in	O
Friend	cell_line
virus	cell_line
-induced	cell_line
erythroblasts	cell_line
and	O
establish	O
a	O
link	O
between	O
Epo	protein
signaling	O
mechanisms	O
and	O
a	O
member	O
of	O
a	O
family	O
of	O
transcription	protein
factors	protein
involved	O
in	O
the	O
differentiation	O
of	O
diverse	cell_type
cell	cell_type
lineages	cell_type
.	O

Nonradioactive	O
quantification	O
of	O
glucocorticoid	protein
receptor	protein
expression	O
during	O
differentiation	O
of	O
human	O
monocytic	cell_type
cells	cell_type
(	O
U937	cell_line
).	O
We	O
describe	O
a	O
method	O
for	O
relative	O
quantification	O
of	O
specific	O
mRNA	RNA
using	O
a	O
nonradioactive	O
assay	O
based	O
on	O
DNA	O
strand	O
competition	O
between	O
identical	O
sequences	O
of	O
biotin-	O
and	O
fluorescein-labeled	O
amplicon	O
(probe)	O
and	O
unlabeled	O
amplicon	O
(target)	O
during	O
hybridization	O
.	O
As	O
the	O
target	O
quantity	O
increased,	O
that	O
of	O
the	O
double-labeled	O
probe	O
decreased	O
in	O
accordance	O
with	O
the	O
mass	O
action	O
law.	O
This	O
technique	O
was	O
successfully	O
applied	O
to	O
evaluate	O
differences	O
in	O
glucocorticoid	protein
receptor	protein
expression	O
in	O
U937	cell_line
cells	cell_line
before	O
and	O
after	O
the	O
addition	O
of	O
potent	O
differentiation	O
inducers	O
:	O
12-O-tetradecanoylphorbol	O
13-acetate	O
(	O
TPA	O
)	O
and	O
a	O
combination	O
of	O
all-trans	O
retinoic	O
acid	O
(	O
RA	O
)	O
and	O
1,25-dihydroxyvitamin	O
D2	O
(	O
VD	O
).	O
We	O
observed	O
that	O
TPA	O
treatment	O
was	O
associated	O
with	O
an	O
increase	O
in	O
specific	O
binding	O
of	O
[3H]dexamethasone	O
and	O
up-regulation	O
of	O
GR	RNA
mRNA	RNA
while	O
no	O
enhanced	O
GR	protein
expression	O
was	O
perceived	O
with	O
RA/VD	O
treatment	O
.	O

Induction	O
of	O
Sp1	protein
phosphorylation	O
and	O
NF-kappa	DNA
B	DNA
-independent	DNA
HIV	DNA
promoter	DNA
domain	O
activity	O
in	O
T	cell_type
lymphocytes	cell_type
stimulated	O
by	O
okadaic	O
acid	O
.	O
In	O
contrast	O
to	O
the	O
purely	O
enhancer-dependent	O
effect	O
of	O
cytokines	protein
such	O
as	O
TNF	protein
on	O
the	O
activity	O
of	O
the	O
HIV	DNA
regulatory	DNA
region	DNA
(	O
LTR	DNA
),	O
we	O
observed	O
that	O
okadaic	O
acid	O
(	O
OKA	O
)	O
activates	O
HIV	O
transcription	O
through	O
both	O
the	O
enhancer,	O
responding	O
to	O
the	O
factor	O
NF-kappa	protein
B	protein
,	O
and	O
the	O
promoter	DNA
domain	DNA
of	O
the	O
LTR	DNA
.	O
The	O
inducibility	O
of	O
HIV	DNA
LTR	DNA
-driven	DNA
luciferase	DNA
expression	DNA
constructs	DNA
in	O
lymphoblastoid	cell_type
cells	cell_type
stimulated	O
by	O
OKA	O
depended	O
on	O
both	O
functional	DNA
Sp1	DNA
binding	DNA
elements	DNA
and	O
the	O
ability	O
of	O
the	O
TATA	DNA
box	DNA
to	O
bind	O
the	O
protein	O
TBP	protein
.	O
In	O
both	O
transformed	O
and	O
normal	O
lymphocytes	O
,	O
OKA	O
stimulation	O
induced	O
intense	O
phosphorylation	O
of	O
the	O
constitutively	O
expressed	O
Sp1	protein
protein	protein
in	O
the	O
nucleus	O
,	O
a	O
property	O
of	O
OKA	O
not	O
shared	O
by	O
TNF	protein
,	O
phorbol	O
ester	O
,	O
or	O
PHA	protein
and	O
interleukin	protein
2	protein
.	O
Responsiveness	O
of	O
LTR	DNA
constructs	DNA
deleted	O
of	O
kappa	DNA
B	DNA
elements	DNA
to	O
HIV	protein
Tat	protein
expression	O
was	O
increased	O
upon	O
OKA	O
but	O
not	O
TNF	protein
stimulation	O
.	O
Our	O
results	O
suggest	O
that	O
SP1	protein
phosphorylation	O
induced	O
by	O
OKA	O
,	O
a	O
selective	O
inhibitor	O
of	O
the	O
serine-threonine	protein
phosphatase	protein
PP2A	protein
,	O
facilitates	O
the	O
formation	O
of	O
a	O
transcription	protein
complex	protein
involving	O
general	O
transcription	protein
factors	protein
,	O
HIV	protein
Tat	protein
,	O
and	O
Sp1	protein
proteins	protein
.	O
The	O
formation	O
of	O
this	O
complex	O
would	O
increase,	O
independently	O
of	O
an	O
in	O
synergy	O
with	O
NF-kappa	protein
B	protein
,	O
the	O
low	O
basal	O
activity	O
of	O
the	O
HIV	DNA
LTR	DNA
observed	O
in	O
normal	cell_type
T	cell_type
lymphocytes	cell_type
.	O

The	O
role	O
of	O
shared	protein
receptor	protein
motifs	protein
and	O
common	protein
Stat	protein
proteins	protein
in	O
the	O
generation	O
of	O
cytokine	protein
pleiotropy	O
and	O
redundancy	O
by	O
IL-2	protein
,	O
IL-4	protein
,	O
IL-7	protein
,	O
IL-13	protein
,	O
and	O
IL-15	protein
.	O
To	O
understand	O
the	O
molecular	O
bases	O
for	O
cytokine	O
redundancy	O
and	O
pleiotropy	O
,	O
we	O
have	O
compared	O
the	O
Stat	protein
proteins	protein
activated	O
in	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
(	O
PBLs	cell_type
)	O
by	O
cytokines	protein
with	O
shared	O
and	O
distinct	O
actions.	O
Interleukin-2	protein
(	O
IL-2	protein
)	O
rapidly	O
activated	O
Stat5	protein
in	O
fresh	O
PBL	cell_type
,	O
and	O
Stat3	protein
and	O
Stat5	protein
in	O
preactivated	cell_type
PBL	cell_type
.	O
IL-7	protein
and	O
IL-15	protein
induced	O
the	O
same	O
complexes	O
as	O
IL-2	protein
,	O
a	O
feature	O
explained	O
by	O
the	O
existence	O
of	O
similar	O
tyrosine	protein
-phosphorylated	protein
motifs	protein
in	O
the	O
cytoplasmic	protein
domains	protein
of	O
IL-2R	protein
beta	protein
and	O
IL-7R	protein
that	O
can	O
serve	O
as	O
docking	O
sites	O
for	O
Stat	protein
proteins	protein
.	O
IL-13	protein
Induced	O
the	O
same	O
complexes	O
as	O
IL-4	protein
,	O
a	O
finding	O
explained	O
by	O
our	O
studies	O
implicating	O
IL-4R	protein
as	O
a	O
shared	O
component	O
of	O
the	O
receptors	protein
.	O
These	O
studies	O
demonstrate	O
that	O
a	O
single	O
cytokine	protein
can	O
activate	O
different	O
combinations	O
of	O
Stat	protein
proteins	protein
under	O
different	O
physiological	O
conditions	O
,	O
and	O
also	O
indicate	O
two	O
mechanisms	O
by	O
which	O
distinct	O
cytokines	protein
can	O
activate	O
the	O
same	O
Stat	protein
protein	protein
.	O

Control	O
of	O
I	protein
kappa	protein
B-alpha	protein
proteolysis	O
by	O
site-specific,	O
signal-induced	O
phosphorylation	O
.	O
I	protein
kappa	protein
B-alpha	protein
inhibits	O
transcription	protein
factor	protein
NF-kappa	protein
B	protein
by	O
retaining	O
it	O
in	O
the	O
cytoplasm	O
.	O
Various	O
stimuli,	O
typically	O
those	O
associated	O
with	O
stress	O
or	O
pathogens,	O
rapidly	O
inactivate	O
I	protein
kappa	protein
B-alpha	protein
.	O
This	O
liberates	O
NF-kappa	protein
B	protein
to	O
translocate	O
to	O
the	O
nucleus	O
and	O
initiate	O
transcription	O
of	O
genes	DNA
important	O
for	O
the	O
defense	O
of	O
the	O
organism.	O
Activation	O
of	O
NF-kappa	protein
B	protein
correlates	O
with	O
phosphorylation	O
of	O
I	protein
kappa	protein
B-alpha	protein
and	O
requires	O
the	O
proteolysis	O
of	O
this	O
inhibitor.	O
When	O
either	O
serine-32	O
or	O
serine-36	O
of	O
I	protein
kappa	protein
B-alpha	protein
was	O
mutated,	O
the	O
protein	O
did	O
not	O
undergo	O
signal-induced	O
phosphorylation	O
or	O
degradation	O
,	O
and	O
NF-kappa	protein
B	protein
could	O
not	O
be	O
activated.	O
These	O
results	O
suggest	O
that	O
phosphorylation	O
at	O
one	O
or	O
both	O
of	O
these	O
residues	O
is	O
critical	O
for	O
activation	O
of	O
NF-kappa	protein
B	protein
.	O

Regulation	O
of	O
transcription	O
of	O
the	O
human	DNA
erythropoietin	DNA
receptor	DNA
gene	DNA
by	O
proteins	O
binding	O
to	O
GATA-1	DNA
and	DNA
Sp1	DNA
motifs	DNA
.	O
Erythropoietin	protein
(	O
Epo	protein
),	O
the	O
primary	O
regulator	O
of	O
the	O
production	O
of	O
erythroid	cell_type
cells	cell_type
,	O
acts	O
by	O
binding	O
to	O
a	O
cell	protein
surface	protein
receptor	protein
(	O
EpoR	protein
)	O
on	O
erythroid	cell_type
progenitors	cell_type
.	O
We	O
used	O
deletion	O
analysis	O
and	O
transfection	O
assays	O
with	O
reporter	DNA
gene	DNA
constructs	DNA
to	O
examine	O
the	O
transcription	DNA
control	DNA
elements	DNA
in	O
the	O
5'	DNA
flanking	DNA
region	DNA
of	O
the	O
human	DNA
EpoR	DNA
gene	DNA
.	O
In	O
erythroid	cell_type
cells	cell_type
most	O
of	O
the	O
transcription	O
activity	O
was	O
contained	O
in	O
a	O
150	DNA
bp	DNA
promoter	DNA
fragment	O
with	O
binding	DNA
sites	DNA
for	O
transcription	protein
factors	protein
AP2	protein
,	O
Sp1	protein
and	O
the	O
erythroid-specific	protein
GATA-1	protein
.	O
The	O
150	DNA
bp	DNA
hEpoR	DNA
promoter	DNA
exhibited	O
high	O
and	O
low	O
activity	O
in	O
erythroid	O
OCIM1	cell_line
and	O
K562	cell_line
cells	cell_line
,	O
respectively,	O
reflecting	O
the	O
high	O
and	O
low	O
levels	O
of	O
constitutive	O
hEpoR	protein
expression	O
.	O
The	O
GATA-1	O
and	O
Sp1	O
binding	O
sites	O
in	O
this	O
promoter	O
lacking	O
a	O
TATA	DNA
sequence	DNA
were	O
necessary	O
for	O
a	O
high	O
level	O
of	O
transcription	O
activation	O
.	O
Protein-DNA	O
binding	O
studies	O
suggested	O
that	O
Sp1	protein
and	O
two	O
other	O
CCGCCC	protein
binding	protein
proteins	protein
from	O
erythroid	O
and	O
non-erythroid	O
cells	O
could	O
bind	O
to	O
the	O
Sp1	DNA
binding	DNA
motif	DNA
.	O
By	O
increasing	O
GATA-1	protein
levels	O
via	O
co-transfection	O
,	O
we	O
were	O
able	O
to	O
transactivate	O
the	O
hEpoR	DNA
promoter	DNA
in	O
K562	cell_line
cells	cell_line
and	O
non-erythroid	cell_type
cells	cell_type
,	O
but	O
not	O
in	O
the	O
highly	O
active	O
OCIM1	cell_type
cells	cell_type
,	O
although	O
GATA-1	RNA
mRNA	RNA
levels	O
were	O
comparable	O
in	O
OCIM1	cell_line
and	O
K562	cell_line
.	O
Interestingly,	O
when	O
we	O
mutated	O
the	O
Sp1	DNA
site	DNA
,	O
resulting	O
in	O
a	O
marked	O
decrease	O
in	O
hEpoR	DNA
promoter	DNA
activity	O
,	O
we	O
could	O
restore	O
transactivation	O
by	O
increasing	O
GATA-1	protein
levels	O
in	O
OCIM1	cell_type
cells	cell_type
.	O
These	O
data	O
suggest	O
that	O
while	O
GATA-1	protein
can	O
transactivate	O
the	O
EpoR	DNA
promoter	DNA
,	O
the	O
level	O
of	O
hEpoR	DNA
gene	DNA
expression	O
does	O
not	O
depend	O
on	O
GATA-1	protein
alone.	O
Rather,	O
hEpoR	protein
transcription	O
activity	O
depends	O
on	O
coordination	O
between	O
Sp1	protein
and	O
GATA-1	protein
with	O
other	O
cell-specific	protein
factors	protein
,	O
including	O
possibly	O
other	O
Sp1	protein
-like	protein
binding	protein
proteins	protein
,	O
to	O
provide	O
high	O
level,	O
tissue-specific	O
expression	O
.	O

Overexpression	O
of	O
DR-nm23	protein
,	O
a	O
protein	O
encoded	O
by	O
a	O
member	O
of	O
the	O
nm23	DNA
gene	DNA
family	DNA
,	O
inhibits	O
granulocyte	cell_type
differentiation	O
and	O
induces	O
apoptosis	O
in	O
32Dc13	cell_line
myeloid	cell_line
cells	cell_line
.	O
Chronic	O
myelogenous	O
leukemia	O
evolves	O
in	O
two	O
clinically	O
distinct	O
stages:	O
a	O
chronic	O
and	O
a	O
blast	O
crisis	O
phase	O
.	O
The	O
molecular	O
changes	O
associated	O
with	O
chronic	O
phase	O
to	O
blast	O
crisis	O
transition	O
are	O
largely	O
unknown.	O
We	O
have	O
identified	O
a	O
cDNA	DNA
clone	DNA
,	O
DR-nm23	protein
,	O
differentially	O
expressed	O
in	O
a	O
blast-crisis	DNA
cDNA	DNA
library,	DNA
which	O
has	O
approximately	O
70%	O
sequence	O
similarity	O
to	O
the	O
putative	DNA
metastatic	DNA
suppressor	DNA
genes	DNA
,	O
nm23-H1	DNA
and	O
nm23-H2	DNA
.	O
The	O
deduced	O
amino	protein
acid	protein
sequence	protein
similarity	O
to	O
the	O
proteins	O
encoded	O
by	O
these	O
two	O
latter	O
genes	O
is	O
approximately	O
65%	O
and	O
includes	O
domains	O
and	O
amino	O
acid	O
residues	O
(the	O
leucine	protein
zipper-like	protein
and	O
the	O
RGD	protein
domain	protein
,	O
a	O
serine	O
and	O
a	O
histidine	O
residue	O
in	O
the	O
NH2-	protein
and	O
in	O
the	O
COOH-terminal	protein
portion	protein
of	O
the	O
protein,	O
respectively)	O
postulated	O
to	O
be	O
important	O
for	O
nm23	protein
function	O
.	O
DR-nm23	RNA
mRNA	RNA
is	O
preferentially	O
expressed	O
at	O
early	O
stages	O
of	O
myeloid	O
differentiation	O
of	O
highly	cell_line
purified	cell_line
CD34+	cell_line
cells	cell_line
.	O
Its	O
constitutive	O
expression	O
in	O
the	O
myeloid	cell_line
precursor	cell_line
32Dc13	cell_line
cell	cell_line
line	cell_line
,	O
which	O
is	O
growth-factor	O
dependent	O
for	O
both	O
proliferation	O
and	O
differentiation	O
,	O
results	O
in	O
inhibition	O
of	O
granulocytic	O
differentiation	O
induced	O
by	O
granulocyte	protein
colony-stimulating	protein
factor	protein
and	O
causes	O
apoptotic	O
cell	O
death	O
.	O
These	O
results	O
are	O
consistent	O
with	O
a	O
role	O
for	O
DR-nm23	protein
in	O
normal	O
hematopoiesis	O
and	O
raise	O
the	O
possibility	O
that	O
its	O
overexpression	O
contributes	O
to	O
differentiation	O
arrest	O
,	O
a	O
feature	O
of	O
blastic	O
transformation	O
in	O
chronic	O
myelogenous	O
leukemia	O
.	O

An	O
interferon-gamma	DNA
activation	DNA
sequence	DNA
mediates	O
the	O
transcriptional	O
regulation	O
of	O
the	O
IgG	DNA
Fc	DNA
receptor	DNA
type	DNA
IC	DNA
gene	DNA
by	O
interferon-gamma	protein
.	O
Expression	O
of	O
the	O
IgG	protein
Fc	protein
receptor	protein
type	protein
I	protein
(	O
Fc	protein
gamma	protein
RI	protein
)	O
on	O
myeloid	cell_type
cells	cell_type
is	O
dramatically	O
increased	O
by	O
treatment	O
with	O
interferon-gamma	protein
(	O
IFN-gamma	protein
).	O
We	O
observed	O
that	O
Fc	protein
gamma	protein
RI	protein
transcript	O
levels	O
in	O
monoblast-like	cell_line
U937	cell_line
cells	cell_line
were	O
elevated	O
within	O
3	O
hr	O
and	O
peaked	O
12	O
hr	O
after	O
exposure	O
to	O
IFN-gamma	protein
.	O
Treatment	O
of	O
U937	cell_line
with	O
IFN-gamma	protein
for	O
9	O
hr	O
in	O
the	O
presence	O
of	O
cycloheximide	O
led	O
to	O
super-induction	O
of	O
Fc	protein
gamma	protein
RI	protein
expression.	O
Nuclear	O
run-on	O
analysis	O
revealed	O
that	O
the	O
rate	O
of	O
Fc	protein
gamma	protein
RI	protein
transcription	O
was	O
increased	O
by	O
IFN-gamma	protein
.	O
Genomic	O
sequence	O
upstream	O
of	O
the	O
Fc	DNA
gamma	DNA
RIC	DNA
gene	DNA
was	O
cloned	O
and	O
subjected	O
to	O
primer	O
extension	O
analysis	O
,	O
which	O
demonstrated	O
a	O
single	O
transcription	DNA
initiation	DNA
site	DNA
without	O
a	O
TATA	DNA
box	DNA
.	O
Transient	O
transfections	O
of	O
CAT	DNA
reporter	DNA
gene	DNA
constructs	DNA
containing	O
various	O
Fc	DNA
gamma	DNA
RIC	DNA
promoter	DNA
sequences	DNA
into	O
U937	cell_line
cells	cell_line
revealed	O
that	O
a	O
20-bp	DNA
region	DNA
surrounding	O
the	O
transcription	DNA
start	DNA
site	DNA
(-7	O
to	O
+13)	O
was	O
capable	O
of	O
mediating	O
transcription	O
initiation	O
and	O
that	O
an	O
IFN-gamma	DNA
responsive	DNA
element	DNA
(	O
GIRE	DNA
)	O
was	O
present	O
within	O
74	DNA
bp	DNA
upstream	DNA
of	O
the	O
transcription	DNA
initiation	DNA
site	DNA
.	O
A	O
17-bp	DNA
sequence	DNA
between	O
positions	O
-51	O
and	O
-35	O
conferred	O
IFN-gamma	protein
responsiveness	O
on	O
a	O
heterologous	DNA
promoter	DNA
.	O
Double-stranded	DNA
GIRE	DNA
sequence	DNA
,	O
but	O
not	O
a	O
scrambled	DNA
sequence	DNA
,	O
was	O
specifically	O
bound	O
by	O
nuclear	protein
proteins	protein
from	O
IFN-gamma	cell_line
treated	cell_line
U937	cell_line
cells	cell_line
.	O
Gel	O
shift	O
experiments	O
further	O
showed	O
that	O
the	O
STAT1	protein
alpha	protein
protein	protein
bound	O
to	O
the	O
Fc	DNA
gamma	DNA
RIC	DNA
GIRE	DNA
in	O
response	O
to	O
IFN-gamma	protein
treatment	O
of	O
U937	cell_line
cells	cell_line
.	O
The	O
Fc	DNA
gamma	DNA
RIC	DNA
GIRE	DNA
is	O
homologous	O
to	O
the	O
IFN-gamma	DNA
activation	DNA
sequence	DNA
(	O
GAS	DNA
)	O
of	O
the	O
guanylate	protein
binding	protein
protein	protein
and	O
to	O
X	DNA
box	DNA
elements	DNA
of	O
class	DNA
II	DNA
MHC	DNA
genes	DNA
.	O
Our	O
results	O
demonstrate	O
that	O
transcriptional	O
regulation	O
of	O
the	O
Fc	DNA
gamma	DNA
RIC	DNA
gene	DNA
by	O
IFN-gamma	protein
involves	O
the	O
binding	O
of	O
STAT1	protein
alpha	protein
to	O
a	O
17-bp	DNA
GAS	DNA
homology	DNA
in	O
the	O
proximal	DNA
promoter	DNA
.	O

Constitutively	O
activated	O
Jak	protein
-STAT	protein
pathway	O
in	O
T	cell_type
cells	cell_type
transformed	O
with	O
HTLV-I	O
.	O
Human	O
T	O
cell	O
lymphotropic	O
virus	O
I	O
(	O
HTLV-I	O
)	O
is	O
the	O
etiological	O
agent	O
for	O
adult	O
T	O
cell	O
leukemia	O
and	O
tropical	O
spastic	O
paraparesis	O
(also	O
termed	O
HTLV-I	O
-associated	O
myelopathy	O
).	O
HTLV-I	cell_type
-infected	cell_type
peripheral	cell_type
blood	cell_type
T	cell_type
cells	cell_type
exhibit	O
an	O
initial	O
phase	O
of	O
interleukin-2	protein
(	O
IL-2	protein
)-dependent	O
growth	O
;	O
over	O
time,	O
by	O
an	O
unknown	O
mechanism,	O
the	O
cells	O
become	O
IL-2	protein
-independent	O
.	O
Whereas	O
the	O
Jak	protein
kinases	protein
Jak1	protein
and	O
Jak3	protein
and	O
the	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	protein
proteins	protein
Stat3	protein
and	O
Stat5	protein
are	O
activated	O
in	O
normal	cell_type
T	cell_type
cells	cell_type
in	O
response	O
to	O
IL-2	protein
,	O
this	O
signaling	O
pathway	O
was	O
constitutively	O
activated	O
in	O
HTLV-I	cell_line
-transformed	cell_line
cells	cell_line
.	O
In	O
HTLV-I	cell_line
-infected	cell_line
cord	cell_line
blood	cell_line
lymphocytes	cell_line
,	O
the	O
transition	O
from	O
IL-2	protein
-dependent	O
to	O
IL-2	protein
-independent	O
growth	O
correlated	O
with	O
the	O
acquisition	O
of	O
a	O
constitutively	O
activated	O
Jak	protein
-STAT	protein
pathway	O
,	O
which	O
suggests	O
that	O
this	O
pathway	O
participates	O
in	O
HTLV-I	O
-mediated	O
T	O
cell	O
transformation	O
.	O

Nitric	O
oxide	O
decreases	O
cytokine	protein
-induced	O
endothelial	O
activation	O
.	O
Nitric	O
oxide	O
selectively	O
reduces	O
endothelial	O
expression	O
of	O
adhesion	protein
molecules	protein
and	O
proinflammatory	protein
cytokines	protein
.	O
To	O
test	O
the	O
hypothesis	O
that	O
nitric	O
oxide	O
(	O
NO	O
)	O
limits	O
endothelial	O
activation	O
,	O
we	O
treated	O
cytokine-stimulated	cell_line
human	cell_line
saphenous	cell_line
vein	cell_line
endothelial	cell_line
cells	cell_line
with	O
several	O
NO	O
donors	O
and	O
assessed	O
their	O
effects	O
on	O
the	O
inducible	O
expression	O
of	O
vascular	protein
cell	protein
adhesion	protein
molecule-1	protein
(	O
VCAM-1	protein
).	O
In	O
a	O
concentration-dependent	O
manner	O
,	O
NO	O
inhibited	O
interleukin	protein
(IL)-1	protein
alpha-stimulated	O
VCAM-1	protein
expression	O
by	O
35-55%	O
as	O
determined	O
by	O
cell	O
surface	O
enzyme	O
immunoassays	O
and	O
flow	O
cytometry	O
.	O
This	O
inhibition	O
was	O
paralleled	O
by	O
reduced	O
monocyte	O
adhesion	O
to	O
endothelial	O
monolayers	O
in	O
nonstatic	O
assays	O
,	O
was	O
unaffected	O
by	O
cGMP	O
analogues	O
,	O
and	O
was	O
quantitatively	O
similar	O
after	O
stimulation	O
by	O
either	O
IL-1	protein
alpha	protein
,	O
IL-1	protein
beta	protein
,	O
IL-4	protein
,	O
tumor	protein
necrosis	protein
factor	protein
(	O
TNF	protein
alpha	protein
),	O
or	O
bacterial	O
lipopolysaccharide	O
.	O
NO	O
also	O
decreased	O
the	O
endothelial	O
expression	O
of	O
other	O
leukocyte	protein
adhesion	protein
molecules	protein
(	O
E-selectin	protein
and	O
to	O
a	O
lesser	O
extent,	O
intercellular	protein
adhesion	protein
molecule-1	protein
)	O
and	O
secretable	O
cytokines	protein
(	O
IL-6	protein
and	O
IL-8	protein
).	O
Inhibition	O
of	O
endogenous	O
NO	O
production	O
by	O
L-N-monomethyl-arginine	O
also	O
induced	O
the	O
expression	O
of	O
VCAM-1	protein
,	O
but	O
did	O
not	O
augment	O
cytokine-induced	O
VCAM-1	protein
expression	O
.	O
Nuclear	O
run-on	O
assays	O
,	O
transfection	O
studies	O
using	O
various	O
VCAM-1	DNA
promoter	DNA
reporter	DNA
gene	DNA
constructs	DNA
,	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
indicated	O
that	O
NO	O
represses	O
VCAM-1	protein
gene	O
transcription	O
,	O
in	O
part,	O
by	O
inhibiting	O
NF-kappa	protein
B	protein
.	O
We	O
propose	O
that	O
NO	O
's	O
ability	O
to	O
limit	O
endothelial	O
activation	O
and	O
inhibit	O
monocyte	O
adhesion	O
may	O
contribute	O
to	O
some	O
of	O
its	O
antiatherogenic	O
and	O
antiinflammatory	O
properties	O
within	O
the	O
vessel	O
wall	O
.	O

MIP1	protein
alpha	protein
nuclear	protein
protein	protein
(	O
MNP	protein
),	O
a	O
novel	O
transcription	protein
factor	protein
expressed	O
in	O
hematopoietic	O
cells	O
that	O
is	O
crucial	O
for	O
transcription	O
of	O
the	O
human	DNA
MIP-1	DNA
alpha	DNA
gene	DNA
.	O
Murine	protein
macrophage	protein
inflammatory	protein
protein	protein
1	protein
alpha	protein
(	O
MIP-1	protein
alpha	protein
)	O
and	O
its	O
human	protein
equivalent	protein
(	O
GOS19	protein
,	O
LD78	protein
,	O
or	O
AT464	protein
)	O
are	O
members	O
of	O
the	O
-C-C	protein
family	protein
of	O
low-molecular-weight	protein
chemokines	protein
.	O
Secreted	O
from	O
activated	cell_type
T	cell_type
cells	cell_type
and	O
macrophages	cell_type
,	O
bone	O
marrow-derived	protein
MIP-1	protein
alpha	protein
/GOS19	protein
inhibits	O
primitive	cell_type
hematopoietic	cell_type
stem	cell_type
cells	cell_type
and	O
appears	O
to	O
be	O
involved	O
in	O
the	O
homeostatic	O
control	O
of	O
stem	cell_type
cell	cell_type
proliferation	O
.	O
It	O
also	O
induces	O
chemotaxis	O
and	O
inflammatory	O
responses	O
in	O
mature	cell_type
cell	cell_type
types	cell_type
.	O
Therefore,	O
it	O
is	O
important	O
to	O
understand	O
the	O
mechanisms	O
which	O
control	O
the	O
expression	O
of	O
MIP-1	protein
alpha	protein
/GOS19	protein
.	O
Previous	O
work	O
has	O
shown	O
that	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
,	O
a	O
set	O
of	O
widely	O
expressed	O
transcription	protein
factors	protein
(the	O
ICK-1	protein
family	protein
)	O
affect	O
the	O
GOS19	DNA
promoter	DNA
.	O
One	O
member,	O
ICK-1A	protein
,	O
behaves	O
as	O
a	O
strong	protein
negative	protein
regulator	protein
.	O
In	O
this	O
communication,	O
we	O
provide	O
evidence	O
that	O
the	O
pathway	O
of	O
induction	O
in	O
the	O
macrophage	cell_line
cell	cell_line
line	cell_line
U937	cell_line
is	O
different	O
from	O
that	O
in	O
Jurkat	cell_line
cells	cell_line
.	O
Furthermore,	O
we	O
show	O
that	O
the	O
ICK-1	DNA
binding	DNA
site	DNA
does	O
not	O
confer	O
negative	O
regulation	O
in	O
U937	cell_line
cells	cell_line
.	O
We	O
provide	O
evidence	O
for	O
an	O
additional	O
binding	DNA
site	DNA
,	O
the	O
MIP-1	DNA
alpha	DNA
nuclear	DNA
protein	DNA
(MNP)	DNA
site	DNA
,	O
which	O
overlaps	O
the	O
ICK-1	DNA
site	DNA
.	O
Interaction	O
of	O
nuclear	O
extracts	O
from	O
various	cell_line
cell	cell_line
lines	cell_line
and	O
tissue	O
with	O
the	O
MNP	DNA
site	DNA
leads	O
to	O
the	O
formation	O
of	O
fast-migrating	protein
protein-DNA	protein
complexes	protein
with	O
similar	O
but	O
distinct	O
electrophoretic	O
mobilities	O
.	O
A	O
mutation	O
of	O
the	O
MNP	DNA
site	DNA
which	O
does	O
not	O
abrogate	O
ICK-1	O
binding	O
inactivates	O
the	O
GOS19.1	DNA
promoter	DNA
in	O
U937	cell_line
cells	cell_line
and	O
reduces	O
its	O
activity	O
by	O
fourfold	O
in	O
Jurkat	cell_line
cells	cell_line
.	O
We	O
propose	O
that	O
the	O
MNP	protein
protein	protein
(s)	O
binding	O
at	O
the	O
MNP	DNA
site	DNA
constitutes	O
a	O
novel	O
transcription	protein
factor	protein
(s)	O
expressed	O
in	O
hematopoietic	cell_type
cells	cell_type
.	O

The	O
effect	O
of	O
Toremifene	O
on	O
the	O
expression	O
of	O
some	O
genes	O
in	O
human	cell_type
mononuclear	cell_type
cells	cell_type
.	O
Toremifene	O
exerts	O
multiple	O
and	O
varied	O
effects	O
on	O
the	O
gene	O
expression	O
of	O
human	cell_type
peripheral	cell_type
mononuclear	cell_type
cells	cell_type
.	O
After	O
short-term,	O
in	O
vitro	O
exposure	O
to	O
therapeutical	O
levels	O
,	O
distinct	O
changes	O
in	O
P-glycoprotein	O
,	O
steroid	O
receptors	O
,	O
p53	O
and	O
Bcl-2	O
expression	O
take	O
place.	O
In	O
view	O
of	O
the	O
increasing	O
use	O
of	O
antiestrogens	O
in	O
cancer	O
therapy	O
and	O
prevention	O
,	O
there	O
is	O
obvious	O
merit	O
in	O
long-term	O
in	O
vivo	O
studies	O
to	O
be	O
conducted.	O

The	O
interleukin-5	protein
/receptor	O
interaction	O
activates	O
Lyn	O
and	O
Jak2	O
tyrosine	O
kinases	O
and	O
propagates	O
signals	O
via	O
the	O
Ras-Raf-1-MAP	protein
kinase	protein
and	O
the	O
Jak	protein
-STAT	protein
pathways	O
in	O
eosinophils	cell_type
.	O
We	O
have	O
shown	O
that	O
the	O
interaction	O
of	O
interleukin	protein
(IL)-5	protein
with	O
the	O
receptor	O
activates	O
Lyn	protein
tyrosine	protein
kinase	protein
within	O
1	O
min	O
and	O
Jak2	protein
tyrosine	protein
kinase	protein
within	O
1-3	O
min.	O
IL-5	protein
also	O
stimulates	O
GTP	O
binding	O
to	O
p21ras	protein
.	O
The	O
signal	O
is	O
subsequently	O
propagated	O
through	O
the	O
activation	O
of	O
Raf-1	protein
,	O
MEK	protein
,	O
and	O
MAP	protein
kinases	protein
as	O
shown	O
by	O
their	O
increased	O
autophosphorylation	O
in	O
vitro	O
and	O
phosphorylation	O
in	O
situ.	O
Jak2	protein
kinase	protein
has	O
been	O
shown	O
to	O
phosphorylate	O
STAT	protein
nuclear	protein
proteins	protein
.	O
The	O
activation	O
of	O
STAT	protein
nuclear	protein
factors	protein
was	O
studied	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
using	O
a	O
gamma	DNA
activation	DNA
site	DNA
(	O
GAS	DNA
)	O
probe	O
.	O
We	O
found	O
that	O
IL-5	protein
induces	O
two	O
GAS-binding	protein
proteins	protein
in	O
eosinophils	cell_type
,	O
one	O
of	O
which	O
is	O
STAT1	protein
.	O
We	O
conclude	O
that	O
IL-5	protein
induced	O
signals	O
are	O
propagated	O
through	O
two	O
distinct	O
pathways:	O
(1)	O
Lyn	protein
--&gt;	O
Ras	protein
--&gt;	O
Raf-1	protein
--&gt;	O
MEK	protein
--&gt;	O
MAP	protein
kinase	protein
and	O
(2)	O
Jak2	protein
--&gt;	O
STAT1	protein
.	O

The	O
retinoblastoma	protein
gene	protein
product	protein
negatively	O
regulates	O
transcriptional	protein
activation	protein
mediated	O
by	O
the	O
human	protein
cytomegalovirus	protein
IE2	protein
protein	protein
.	O
The	O
IE2	protein
gene	protein
product	protein
of	O
human	O
cytomegalovirus	O
(	O
HCMV	O
)	O
is	O
one	O
of	O
a	O
few	O
viral	protein
regulatory	protein
proteins	protein
expressed	O
immediately	O
upon	O
infection	O
of	O
the	O
host	cell_type
cell	cell_type
.	O
It	O
is	O
a	O
potent	O
transcriptional	protein
activator	protein
of	O
many	O
viral	O
and	O
cellular	O
promoters	O
.	O
We	O
found	O
that	O
the	O
retinoblastoma	protein
susceptibility	protein
gene	protein
product	protein
(	O
Rb	protein
)	O
dramatically	O
suppressed	O
this	O
IE2	protein
transactivation	O
of	O
various	DNA
promoters	DNA
.	O
However,	O
unlike	O
another	O
tumor	protein
suppressor	protein
protein	protein
,	O
p53	protein
,	O
Rb	protein
did	O
not	O
have	O
any	O
significant	O
effect	O
on	O
basal	O
levels	O
of	O
transcription	O
,	O
suggesting	O
that	O
Rb	protein
specifically	O
interacts	O
with	O
IE2	protein
rather	O
than	O
other	O
cellular	protein
factors	protein
involved	O
in	O
the	O
general	O
transcription	O
machinery	O
.	O
We	O
found	O
by	O
protein-affinity	O
chromatography	O
that	O
Rb	protein
in	O
nuclear	O
extracts	O
or	O
produced	O
by	O
in	O
vitro	O
translation	O
directly	O
bound	O
to	O
IE2	protein
.	O
Our	O
results	O
suggest	O
that	O
Rb	protein
may	O
regulate	O
the	O
life	O
cycle	O
of	O
HCMV	O
,	O
which	O
is	O
endemic	O
in	O
the	O
human	O
population	O
.	O
Furthermore,	O
these	O
data	O
may	O
provide	O
new	O
insights	O
into	O
the	O
slow	O
rate	O
of	O
HCMV	O
DNA	O
replication	O
in	O
cells	O
and	O
the	O
possible	O
involvement	O
of	O
HCMV	O
in	O
tumorigenesis	O
.	O

Expression	O
of	O
the	O
nucleoside	protein
diphosphate	protein
kinase	protein
in	O
human	O
skin	O
cancers	O
:	O
an	O
immunohistochemical	O
study	O
.	O
Expression	O
of	O
nucleoside	protein
diphosphate(NDP)	protein
kinase	protein
,	O
which	O
is	O
homologous	O
to	O
the	O
nm23	protein
gene	protein
product	protein
in	O
a	O
variety	O
of	O
species,	O
has	O
been	O
found	O
to	O
be	O
inversely	O
associated	O
with	O
metastatic	O
potential	O
.	O
However,	O
the	O
relationship	O
remains	O
controversial	O
according	O
to	O
the	O
tumor	cell_type
cell	cell_type
types	cell_type
and	O
experimental	O
system	O
,	O
with	O
conflicting	O
results	O
from	O
different	O
research	O
groups.	O
In	O
order	O
to	O
determine	O
whether	O
NDP	protein
kinase	protein
expression	O
serves	O
as	O
a	O
marker	O
for	O
metastatic	O
potential	O
in	O
human	O
skin	O
cancer	O
,	O
we	O
assessed	O
the	O
levels	O
of	O
NDP	protein
kinase	protein
expression	O
in	O
9	O
keratoacanthomas	O
(	O
KAs	O
),	O
26	O
squamous	O
cell	O
carcinomas	O
(	O
SCCs	O
),	O
and	O
25	O
basal	O
cell	O
carcinomas	O
(	O
BCCs	O
)	O
using	O
immunohistochemistry	O
.	O
The	O
expression	O
of	O
NDP	protein
kinase	protein
was	O
intense	O
in	O
KA	O
and	O
SCC	O
compared	O
with	O
BCC	O
.	O
However,	O
the	O
difference	O
of	O
NDP	protein
kinase	protein
expression	O
between	O
KA	O
and	O
SCC	O
was	O
not	O
statistically	O
significant.	O
And	O
there	O
was	O
no	O
statistically	O
significant	O
difference	O
in	O
NDP	protein
kinase	protein
expression	O
between	O
SCC	O
with	O
metastasis	O
and	O
SCC	O
without	O
metastasis	O
.	O
Our	O
results	O
contradict	O
the	O
hypothesis	O
concerning	O
the	O
possible	O
role	O
of	O
nm23	DNA
gene	DNA
as	O
a	O
metastatic	O
suppressor	O
gene	O
in	O
human	O
skin	O
cancer	O
.	O
The	O
mechanism	O
of	O
overexpression	O
in	O
various	O
tumor	cell_type
cell	cell_type
types	cell_type
and	O
its	O
biological	O
significance	O
in	O
cutaneous	O
carcinogenesis	O
remain	O
to	O
be	O
determined.	O

RB	protein
and	O
a	O
novel	O
E2F-1	protein
binding	protein
protein	protein
in	O
MHC	cell_line
class	cell_line
II	cell_line
deficient	cell_line
B-cell	cell_line
lines	cell_line
and	O
normal	O
IFN-gamma	protein
induction	O
of	O
the	O
class	DNA
IL	DNA
transactivator	DNA
CIITA	DNA
in	O
class	cell_line
II	cell_line
non-inducible	cell_line
RB	cell_line
-defective	cell_line
tumor	cell_line
lines	cell_line
.	O
The	O
major	DNA
histocompatibility	DNA
(MHC)	DNA
class	DNA
II	DNA
genes	DNA
encode	O
cell	protein
surface	protein
proteins	protein
that	O
bind	O
antigenic	O
peptide	O
for	O
presentation	O
to	O
T-cells	cell_type
.	O
The	O
class	protein
II	protein
proteins	protein
are	O
expressed	O
constitutively	O
on	O
B-cells	cell_type
and	O
EBV-transformed	cell_line
B-cells	cell_line
,	cell_line
and	O
are	O
inducible	O
by	O
IFN-gamma	protein
on	O
a	O
wide	O
variety	O
of	O
cell	cell_type
types	cell_type
.	O
Retinoblastoma	protein
protein	protein
(	O
RB	protein
)	O
is	O
a	O
tumor	O
suppressor	O
and	O
functions	O
as	O
a	O
transcriptional	protein
repressor	protein
by	O
binding	O
and	O
inactivating	O
the	O
transactivator	DNA
E2F-I	DNA
.	O
RB	cell_line
-defective	cell_line
tumor	cell_line
lines	cell_line
are	O
non-inducible	O
for	O
MHC	protein
class	protein
II	protein
by	O
IFN-gamma	protein
,	O
or	O
very	O
weakly	O
inducible,	O
but	O
transfection	O
of	O
2	O
different	O
lines	O
with	O
RB	DNA
expression	DNA
vectors	DNA
re-establishes	O
or	O
substantially	O
enhances	O
class	O
II	O
inducibility	O
.	O
Therefore,	O
we	O
examined	O
the	O
RB	protein
status	O
of	O
a	O
series	O
of	O
B-cell	O
mutants	O
that	O
are	O
defective	O
in	O
class	O
II	O
expression,	O
generated	O
either	O
in	O
vitro	O
or	O
derived	O
from	O
Bare	O
Lymphocyte	O
Syndrome	O
(BLS)	O
patients.	O
Nuclear	O
matrix-bound	O
RB	protein
was	O
detectable	O
in	O
all	O
cases,	O
indicating	O
that	O
loss	O
of	O
RB	protein
is	O
not	O
responsible	O
for	O
decreased	O
class	O
II	O
expression	O
in	O
these	O
lines.	O
A	O
second	O
E2F-I	O
binding	O
protein,	O
most	O
likely	O
DP-I,	O
was	O
also	O
apparently	O
normal	O
in	O
both	O
class	O
II-positive	O
and	O
-negative	O
B-cell	O
lines.	O
We	O
also	O
examined	O
the	O
IFN-gamma	protein
induction	O
of	O
CIITA	DNA
in	O
RB	protein
-defective	O
lines.	O
CIITA	DNA
is	O
a	O
class	DNA
II	DNA
gene	DNA
transactivator	DNA
known	O
to	O
be	O
defective	O
in	O
one	O
form	O
of	O
BLS	O
and	O
to	O
be	O
required	O
for	O
the	O
induction	O
of	O
MHC	protein
class	protein
II	protein
by	O
IFN-gamma	protein
.	O
CIITA	RNA
mRNA	RNA
is	O
normally	O
inducible	O
by	O
IFN-gamma	protein
in	O
class	cell_line
II	cell_line
non-inducible,	cell_line
RB	cell_line
-defective	cell_line
lines	cell_line
,	O
and	O
in	O
one	O
line,	O
re-expression	O
of	O
RB	protein
has	O
no	O
effect	O
on	O
CIITA	RNA
mRNA	RNA
induction	O
levels	O
.	O
Thus,	O
the	O
block	O
in	O
MHC	O
class	O
II	O
inducibility	O
in	O
RB	cell_line
-defective	cell_line
cells	cell_line
is	O
not	O
due	O
to	O
a	O
block	O
in	O
CIITA	DNA
inducibility	O
.	O

Interleukin	protein
12	protein
induces	O
tyrosine	O
phosphorylation	O
and	O
activation	O
of	O
STAT4	protein
in	O
human	cell_type
lymphocytes	cell_type
.	O
Interleukin	protein
12	protein
(	O
IL-12	protein
)	O
is	O
an	O
important	O
immunoregulatory	protein
cytokine	protein
whose	O
receptor	O
is	O
a	O
member	O
of	O
the	O
hematopoietin	protein
receptor	protein
superfamily	protein
.	O
We	O
have	O
recently	O
demonstrated	O
that	O
stimulation	O
of	O
human	O
T	O
and	O
natural	O
killer	O
cells	O
with	O
IL-12	protein
induces	O
tyrosine	O
phosphorylation	O
of	O
the	O
Janus	protein
family	protein
tyrosine	protein
kinase	protein
JAK2	protein
and	O
Tyk2	protein
,	O
implicating	O
these	O
kinases	protein
in	O
the	O
immediate	O
biochemical	O
response	O
to	O
IL-12	protein
.	O
Recently,	O
transcription	protein
factors	protein
known	O
as	O
STATs	protein
(	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
)	O
have	O
been	O
shown	O
to	O
be	O
tyrosine	O
phosphorylated	O
and	O
activated	O
in	O
response	O
to	O
a	O
number	O
of	O
cytokines	protein
that	O
bind	O
hematopoietin	protein
receptors	protein
and	O
activate	O
JAK	protein
kinases	protein
.	O
In	O
this	O
report	O
we	O
demonstrate	O
that	O
IL-12	protein
induces	O
tyrosine	O
phosphorylation	O
of	O
a	O
recently	O
identified	O
STAT	protein
family	protein
member	protein
,	O
STAT4	protein
,	O
and	O
show	O
that	O
STAT4	protein
expression	O
is	O
regulated	O
by	O
T-cell	O
activation	O
.	O
Furthermore,	O
we	O
show	O
that	O
IL-12	protein
stimulates	O
formation	O
of	O
a	O
DNA-binding	protein
complex	protein
that	O
recognizes	O
a	O
DNA	O
sequence	O
previously	O
shown	O
to	O
bind	O
STAT	protein
proteins	protein
and	O
that	O
this	O
complex	O
contains	O
STAT4	protein
.	O
These	O
data,	O
and	O
the	O
recent	O
demonstration	O
of	O
JAK	protein
phosphorylation	O
by	O
IL-12	protein
,	O
identify	O
a	O
rapid	O
signal-transduction	O
pathway	O
likely	O
to	O
mediate	O
IL-12	protein
-induced	O
gene	O
expression	O
.	O

Temperature-induced	O
down-regulation	O
of	O
the	O
glucocorticoid	protein
receptor	protein
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
leucocyte	cell_type
in	O
patients	O
with	O
sepsis	O
or	O
septic	O
shock	O
.	O
OBJECTIVE:	O
Activation	O
of	O
the	O
hypothalamic-pituitary-adrenal	O
axis	O
is	O
of	O
vital	O
importance	O
during	O
critical	O
illness.	O
We	O
have	O
studied	O
the	O
adaptive	O
mechanisms	O
which	O
occur	O
at	O
the	O
level	O
of	O
the	O
glucocorticoid	protein
receptor	protein
in	O
glucocorticoid	O
target	O
tissues	O
in	O
patients	O
with	O
sepsis	O
or	O
septic	O
shock	O
.	O
DESIGN:	O
The	O
effects	O
of	O
hypercortisolaemia	O
,	O
hyperthermia	O
and	O
cellular	O
composition	O
on	O
number	O
of	O
glucocorticoid	protein
receptors	protein
per	O
cell	O
and	O
their	O
affinity	O
were	O
evaluated,	O
both	O
in	O
vitro	O
and	O
in	O
vivo,	O
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
leucocytes	cell_type
of	O
control	O
subjects	O
and	O
in	O
patients	O
with	O
sepsis	O
or	O
septic	O
shock	O
.	O
SUBJECTS:	O
Fifteen	O
patients	O
(age	O
25-79)	O
with	O
sepsis	O
or	O
septic	O
shock	O
who	O
were	O
admitted	O
to	O
an	O
intensive	O
care	O
unit	O
were	O
studied.	O
The	O
control	O
group	O
consisted	O
of	O
24	O
healthy	O
laboratory	O
employees.	O
MEASUREMENTS:	O
The	O
binding	O
capacity	O
and	O
affinity	O
of	O
the	O
glucocorticoid	protein
receptors	protein
were	O
measured	O
and	O
compared	O
to	O
clinical	O
data	O
and	O
the	O
plasma	O
cortisol	O
concentrations.	O
RESULTS:	O
Hypercortisolaemia,	O
in	O
vitro,	O
resulted	O
in	O
a	O
decreased	O
affinity	O
and	O
a	O
decreased	O
binding	O
capacity	O
of	O
the	O
glucocorticoid	protein
receptor	protein
.	O
In	O
vitro,	O
hyperthermia	O
as	O
well	O
as	O
variations	O
in	O
the	O
cellular	O
composition	O
did	O
not	O
influence	O
the	O
glucocorticoid	O
receptor.	O
In	O
vivo,	O
there	O
was	O
no	O
change	O
in	O
the	O
number	O
of	O
receptors	O
per	O
cell	O
in	O
patients	O
with	O
sepsis	O
or	O
septic	O
shock	O
as	O
compared	O
to	O
healthy	O
controls	O
.	O
However,	O
a	O
decreased	O
affinity	O
of	O
the	O
glucocorticoid	protein
receptor	protein
was	O
observed.	O
There	O
was	O
a	O
weak	O
but	O
significant	O
negative	O
correlation	O
between	O
body	O
temperature	O
and	O
the	O
number	O
of	O
glucocorticoid	protein
receptors	protein
in	O
the	O
patient	O
group.	O
There	O
was	O
no	O
relation	O
between	O
circulating	O
cortisol	O
concentrations	O
and	O
glucocorticoid	protein
receptor	protein
affinity	O
and	O
number.	O
CONCLUSIONS:	O
There	O
is	O
no	O
obvious	O
regulation	O
of	O
the	O
number	O
of	O
glucocorticoid	protein
receptors	protein
by	O
plasma	O
cortisol	O
concentrations	O
in	O
vivo.	O
The	O
decreased	O
affinity	O
of	O
the	O
glucocorticoid	protein
receptor	protein
together	O
with	O
the	O
negative	O
correlation	O
between	O
hyperthermia	O
and	O
the	O
number	O
of	O
glucocorticoid	protein
receptors	protein
in	O
patients	O
with	O
sepsis	O
or	O
septic	O
shock	O
suggest	O
that	O
hypothalamic-pituitary-adrenal	O
axis	O
activation	O
during	O
critical	O
illness	O
is	O
accompanied	O
by	O
peripheral	O
adaptation	O
in	O
glucocorticoid	protein
receptor	protein
number	O
and	O
affinity.	O

Integrin-mediated	O
tyrosine	O
phosphorylation	O
and	O
cytokine	protein
message	O
induction	O
in	O
monocytic	cell_type
cells	cell_type
.	O
A	O
possible	O
signaling	O
role	O
for	O
the	O
Syk	protein
tyrosine	protein
kinase	protein
.	O
Activation	O
of	O
cytoplasmic	protein
tyrosine	protein
kinases	protein
is	O
an	O
important	O
aspect	O
of	O
signal	O
transduction	O
mediated	O
by	O
integrins	protein
.	O
In	O
the	O
human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
THP-1	cell_line
,	O
either	O
integrin	protein
-dependent	O
cell	O
adhesion	O
to	O
fibronectin	protein
or	O
ligation	O
of	O
beta	protein
1	protein
integrins	protein
with	O
antibodies	protein
causes	O
a	O
rapid	O
and	O
intense	O
tyrosine	O
phosphorylation	O
of	O
two	O
sets	O
of	O
proteins	protein
of	O
about	O
65-75	O
and	O
120-125	O
kDa	O
.	O
In	O
addition,	O
integrin	protein
ligation	O
leads	O
to	O
nuclear	O
translocation	O
of	O
the	O
p50	protein
and	O
p65	protein
subunits	protein
of	O
the	O
NF-kappa	protein
B	protein
transcription	protein
factor	protein
,	O
to	O
activation	O
of	O
a	O
reporter	DNA
gene	DNA
driven	O
by	O
a	O
promoter	DNA
containing	O
NF-kappa	DNA
B	DNA
sites	DNA
,	O
and	O
to	O
increased	O
levels	O
of	O
mRNAs	RNA
for	O
immediate-early	DNA
genes	DNA
,	O
including	O
the	O
cytokine	protein
interleukin	protein
(IL)-1	protein
beta	protein
.	O
The	O
tyrosine	O
kinase	O
inhibitors	O
genistein	O
and	O
herbimycin	O
A	O
block	O
both	O
integrin	protein
-mediated	O
tyrosine	O
phosphorylation	O
and	O
increases	O
in	O
IL-1	protein
beta	protein
message	O
levels	O
,	O
indicating	O
a	O
causal	O
relationship	O
between	O
the	O
two	O
events.	O
The	O
components	O
tyrosine	O
phosphorylated	O
subsequent	O
to	O
cell	O
adhesion	O
include	O
paxillin	protein
,	O
pp125FAK	protein
,	O
and	O
the	O
SH2	protein
domain	protein
containing	protein
tyrosine	protein
kinase	protein
Syk	protein
.	O
In	O
contrast,	O
integrin	protein
ligation	O
with	O
antibodies	protein
induces	O
tyrosine	O
phosphorylation	O
of	O
Syk	protein
but	O
not	O
of	O
FAK	protein
or	O
paxillin	protein
.	O
In	O
adhering	cell_type
cells	cell_type
,	O
pre-treatment	O
with	O
cytochalasin	O
D	O
suppresses	O
tyrosine	O
phosphorylation	O
of	O
FAK	protein
and	O
paxillin	protein
but	O
not	O
of	O
Syk	protein
,	O
while	O
IL-1	protein
beta	protein
message	O
induction	O
is	O
unaffected.	O
These	O
observations	O
indicate	O
that	O
the	O
Syk	protein
tyrosine	O
kinase	O
may	O
be	O
an	O
important	O
component	O
of	O
an	O
integrin	protein
signaling	O
pathway	O
in	O
monocytic	cell_type
cells	cell_type
,	O
leading	O
to	O
activation	O
of	O
NF-kappa	protein
B	protein
and	O
to	O
increased	O
levels	O
of	O
cytokine	protein
messages	O
.	O

Inhibition	O
of	O
dexamethasone	O
binding	O
to	O
human	protein
glucocorticoid	protein
receptor	protein
by	O
New	O
World	O
primate	O
cell	O
extracts	O
.	O
To	O
determine	O
if	O
New	O
World	O
primates	O
express	O
an	O
inhibitor	O
that	O
influences	O
glucocorticoid	protein
receptor	protein
(	O
GR	protein
)	O
binding	O
characteristics	O
,	O
we	O
examined	O
[3H]dexamethasone	O
binding	O
in	O
cytosol	O
prepared	O
from	O
B95-8	cell_line
lymphoid	cell_line
cells	cell_line
,	O
derived	O
from	O
the	O
cotton	O
top	O
tamarin	O
(	O
Saguinus	O
oedipus	O
),	O
in	O
combination	O
with	O
cytosol	O
prepared	O
from	O
human	O
or	O
rat	O
tissues	O
.	O
B95-8	O
cytosol	O
inhibited	O
specific	O
binding	O
of	O
[3H]dexamethasone	O
(P	O
&lt;	O
0.01)	O
when	O
mixed	O
with	O
cytosol	O
prepared	O
from	O
either	O
a	O
human	cell_line
lymphoid	cell_line
cell	cell_line
line	cell_line
(	O
HL	cell_line
)	O
or	O
rat	O
thymus	O
.	O
The	O
inhibitory	O
activity	O
was	O
heat	O
labile	O
and	O
trypsin	protein
sensitive	O
.	O
Peak	O
inhibitory	O
activity	O
was	O
found	O
in	O
the	O
150-200	O
kd	O
fractions	O
after	O
Sephacryl	O
G-200	O
ultrafiltration	O
.	O
Scatchard	O
analysis	O
of	O
[3H]dexamethasone	O
binding	O
using	O
mixed	O
cytosol	O
showed	O
a	O
diminished	O
GR	protein
apparent	O
binding	O
affinity	O
when	O
compared	O
to	O
HL	O
cytosol	O
.	O
Kinetic	O
studies	O
using	O
mixed	O
cytosol	O
indicated	O
that	O
B95-8	O
cytosol	O
did	O
not	O
affect	O
the	O
apparent	O
dissociation	O
rate	O
of	O
[3H]dexamethasone	O
.	O
These	O
data	O
demonstrate	O
that	O
B95-8	cell_type
cells	cell_type
contain	O
a	O
competitive	O
inhibitor	O
that	O
prevents	O
binding	O
of	O
dexamethasone	O
to	O
its	O
cognate	protein
receptor	protein
.	O

Disruption	O
of	O
a	O
GATA	DNA
motif	DNA
in	O
the	O
Duffy	DNA
gene	DNA
promoter	DNA
abolishes	O
erythroid	DNA
gene	DNA
expression	O
in	O
Duffy-negative	O
individuals	O
.	O
The	O
mRNA	RNA
for	O
the	O
Duffy	protein
blood	protein
group	protein
antigen	protein
,	O
the	O
erythrocyte	protein
receptor	protein
for	O
the	O
Plasmodium	O
vivax	O
malaria	O
parasite	O
,	O
has	O
recently	O
been	O
cloned	O
and	O
shown	O
to	O
encode	O
a	O
widely	O
expressed	O
chemokine	protein
receptor	protein
.	O
Here,	O
we	O
show	O
that	O
the	O
Duffy	DNA
antigen/chemokine	DNA
receptor	DNA
gene	DNA
(	O
DARC	DNA
)	O
is	O
composed	O
of	O
a	O
single	O
exon	DNA
and	O
that	O
most	O
Duffy-negative	O
blacks	O
carry	O
a	O
silent	DNA
FY*B	DNA
allele	DNA
with	O
a	O
single	O
T	O
to	O
C	O
substitution	O
at	O
nucleotide	O
-46	O
.	O
This	O
mutation	O
impairs	O
the	O
promoter	O
activity	O
in	O
erythroid	cell_type
cells	cell_type
by	O
disrupting	O
a	O
binding	DNA
site	DNA
for	O
the	O
GATA1	protein
erythroid	protein
transcription	protein
factor	protein
.	O
With	O
the	O
recent	O
characterization	O
of	O
the	O
FY*A	O
and	O
FY*B	O
alleles	O
,	O
these	O
findings	O
provide	O
the	O
molecular	O
basis	O
of	O
the	O
Duffy	O
blood	O
group	O
system	O
and	O
an	O
explanation	O
for	O
the	O
erythroid-specific	O
repression	O
of	O
the	O
DARC	DNA
gene	DNA
in	O
Duffy-negative	O
individuals	O
.	O

Activation	O
of	O
pp90rsk	protein
and	O
early	DNA
growth	DNA
response-1	DNA
gene	DNA
expression	O
by	O
pokeweed	protein
mitogen	protein
in	O
human	cell_type
B	cell_type
cells	cell_type
.	O
The	O
present	O
studies	O
have	O
examined	O
the	O
effects	O
of	O
pokeweed	protein
mitogen	protein
(	O
PWM	protein
)	O
on	O
the	O
induction	O
of	O
early	DNA
growth	DNA
response-1	DNA
gene	DNA
(	O
EGR-1	DNA
)	O
in	O
normal	cell_type
human	cell_type
B	cell_type
cells	cell_type
.	O
PWM	protein
regulates	O
EGR-1	DNA
gene	O
expression	O
by	O
both	O
transcriptional	O
and	O
post-transcriptional	O
mechanisms	O
.	O
Transient	O
transfection	O
assays	O
with	O
EGR-1	DNA
promoter	DNA
fragments	DNA
linked	O
to	O
the	O
chloramphenicol	DNA
acetyltransferase	DNA
(	DNA
CAT	DNA
)	DNA
gene	DNA
demonstrated	O
that	O
PWM	protein
induced	O
EGR-1	DNA
transcription	O
is	O
conferred	O
by	O
the	O
CArG	DNA
motif	DNA
(	O
C	DNA
C[AT]6GG	DNA
)	O
in	O
the	O
EGR-1	DNA
promoter	DNA
.	O
The	O
results	O
further	O
demonstrated	O
the	O
activation	O
of	O
S6	protein
kinase	protein
(	O
pp90rsk	protein
),	O
evidenced	O
by	O
phosphorylation	O
of	O
S6	protein
and	O
serum	O
response	O
factor	O
(SRF)	O
peptides	O
,	O
in	O
PWM	cell_line
treated	cell_line
B	cell_line
cells	cell_line
.	O
Taken	O
together,	O
these	O
findings	O
suggest	O
that	O
PWM	protein
is	O
able	O
to	O
initiate	O
an	O
intracytoplasmic	O
signalling	O
cascade	O
and	O
EGR-1	DNA
induction	O
in	O
normal	cell_type
human	cell_type
B	cell_type
cells	cell_type
.	O

A	O
conserved	DNA
motif	DNA
in	O
the	O
promoters	DNA
of	O
several	O
cytokines	protein
expressed	O
by	O
human	cell_line
Th2-type	cell_line
lymphocytes	cell_line
.	O
We	O
have	O
recently	O
found	O
a	O
novel	O
conserved	DNA
motif	DNA
in	O
the	O
promoters	DNA
of	O
several	O
T-cell-expressed	protein
cytokines	protein
[	O
human	O
interleukin	O
-2	O
,	O
-4	O
,	O
-5	O
and	O
-13	O
and	O
human	O
and	O
mouse	O
granulocyte/macrophage-colony	O
stimulating	O
factor	O
(	O
GM-CSF	protein
)].	O
It	O
contains	O
a	O
core	DNA
sequence	DNA
CTTGG	O
...	O
CCAAG	O
which	O
is	O
present	O
as	O
part	O
of	O
larger	O
palindromic	DNA
sequences	DNA
in	O
each	O
gene.	O
This	O
suggest	O
that	O
they	O
may	O
interact	O
with	O
a	O
new	O
family	O
of	O
trans-acting	protein
factors	protein
.	O
In	O
transfection	O
assays	O
,	O
the	O
human	DNA
GM-CSF	DNA
element	DNA
has	O
a	O
strong	O
positive	O
effect	O
on	O
the	O
expression	O
of	O
a	O
reporter	DNA
gene	DNA
by	O
the	O
human	cell_line
T	cell_line
cell	cell_line
line	cell_line
Jurkat	cell_line
J6	cell_line
upon	O
stimulation	O
.	O
In	O
DNA	O
mobility	O
shift	O
assays	O
,	O
this	O
sequence	O
can	O
give	O
either	O
six	O
different	O
specific	O
bands	O
which	O
are	O
competed	O
out	O
by	O
different	O
parts	O
of	O
the	O
sequence	O
or	O
one	O
specific	O
band	O
which	O
is	O
competed	O
out	O
by	O
each	O
of	O
the	O
inverted	O
repeats,	O
depending	O
on	O
the	O
reconstitution	O
conditions	O
.	O
In	O
different	O
genes	DNA
,	O
the	O
core	DNA
sequences	DNA
are	O
separated	O
by	O
integer	O
numbers	O
of	O
helical	DNA
turns	DNA
.	O
Considering	O
the	O
strong	O
positive	O
regulatory	O
effect	O
of	O
this	O
element	DNA
and	O
its	O
presence	O
in	O
several	O
T-cell-expressed	DNA
cytokine	DNA
genes	DNA
,	O
it	O
may	O
be	O
crucial	O
to	O
the	O
coordinated	O
expression	O
of	O
these	O
cytokines	protein
in	O
T	cell_type
helper	cell_type
cells	cell_type
.	O

cDNA	DNA
cloning	O
of	O
a	O
NGFI-B/nur77-related	protein
transcription	protein
factor	protein
from	O
an	O
apoptotic	cell_line
human	cell_line
T	cell_line
cell	cell_line
line	cell_line
.	O
A	O
human	cell_line
T	cell_line
lymphoid	cell_line
cell	cell_line
line	cell_line
,	O
PEER	cell_line
,	O
dies	O
by	O
apoptosis	O
in	O
the	O
presence	O
of	O
PMA	O
and	O
calcium	O
ionophore	O
.	O
A	O
new	O
gene	DNA
,	O
TINUR	DNA
,	O
was	O
cloned	O
from	O
apoptotic	cell_line
PEER	cell_line
cells	cell_line
.	O
The	O
expression	O
of	O
the	O
TINUR	DNA
gene	DNA
is	O
induced	O
within	O
1	O
h	O
after	O
the	O
cross-linking	O
of	O
the	O
T	protein
cell	protein
Ag	protein
receptor	protein
complex	protein
.	O
TINUR	DNA
belongs	O
to	O
the	O
NGFI-B/nur77	protein
family	protein
of	O
the	O
steroid	protein
receptor	protein
superfamily	protein
and	O
is	O
an	O
orphan	protein
receptor	protein
.	O
TINUR	DNA
binds	O
to	O
the	O
same	O
DNA	DNA
sequence	DNA
as	O
NGFI-B/nur77	protein
.	O
We	O
also	O
propose	O
that	O
the	O
NGFI-B/nur77	protein
family	protein
can	O
be	O
classified	O
into	O
two	O
subtypes.	O

Aspirin	O
inhibits	O
nuclear	protein
factor-kappa	protein
B	protein
mobilization	O
and	O
monocyte	O
adhesion	O
in	O
stimulated	cell_line
human	cell_line
endothelial	cell_line
cells	cell_line
.	O
BACKGROUND:	O
The	O
induction	O
of	O
vascular	protein
cell	protein
adhesion	protein
molecule-1	protein
(	O
VCAM-1	protein
)	O
and	O
E-selectin	protein
by	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF	protein
)	O
is	O
mediated	O
by	O
mobilization	O
of	O
the	O
transcription	protein
factor	protein
nuclear	protein
factor-kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
).	O
Since	O
salicylates	O
have	O
been	O
reported	O
to	O
inhibit	O
NF-kappa	protein
B	protein
activation	O
by	O
preventing	O
the	O
degradation	O
of	O
its	O
inhibitor	O
I	protein
kappa	protein
B	protein
,	O
we	O
studied	O
a	O
potential	O
inhibition	O
of	O
this	O
pathway	O
by	O
acetylsalicylate	O
(	O
aspirin	O
)	O
in	O
human	cell_line
umbilical	cell_line
vein	cell_line
endothelial	cell_line
cells	cell_line
(	O
HUVECs	cell_line
).	O
METHODS	O
AND	O
RESULTS:	O
Gel-shift	O
analyses	O
demonstrated	O
dose-dependent	O
inhibition	O
of	O
TNF	protein
-induced	O
NF-kappa	protein
B	protein
mobilization	O
by	O
aspirin	O
at	O
concentrations	O
ranging	O
from	O
1	O
to	O
10	O
mmol/L.	O
Induction	O
of	O
VCAM-1	protein
and	O
E-selectin	protein
surface	O
expression	O
by	O
TNF	protein
was	O
dose-dependently	O
reduced	O
by	O
aspirin	O
over	O
the	O
same	O
range,	O
while	O
induction	O
of	O
intercellular	protein
adhesion	protein
molecule-1	protein
(	O
ICAM-1	protein
)	O
was	O
hardly	O
affected.	O
Aspirin	O
appeared	O
to	O
prevent	O
VCAM-1	protein
transcription	O
,	O
since	O
it	O
dose-dependently	O
inhibited	O
induction	O
of	O
VCAM-1	RNA
mRNA	RNA
by	O
TNF	protein
.	O
As	O
a	O
functional	O
consequence,	O
adhesion	O
of	O
U937	cell_line
monocytes	cell_line
to	O
TNF	cell_line
-stimulated	cell_line
HUVECs	cell_line
was	O
markedly	O
reduced	O
by	O
aspirin	O
due	O
to	O
suppression	O
of	O
VCAM-1	protein
and	O
E-selectin	protein
upregulation	O
.	O
These	O
effects	O
of	O
aspirin	O
were	O
not	O
related	O
to	O
the	O
inhibition	O
of	O
cyclooxygenase	protein
activity	O
,	O
since	O
indomethacin	O
was	O
ineffective.	O
CONCLUSIONS:	O
Our	O
data	O
suggest	O
that	O
aspirin	O
inhibits	O
NF-kappa	protein
B	protein
mobilization	O
,	O
induction	O
of	O
VCAM-1	protein
and	O
E-selectin	protein
,	O
and	O
subsequent	O
monocyte	O
adhesion	O
in	O
endothelial	cell_type
cells	cell_type
stimulated	O
by	O
TNF	protein
,	O
thereby	O
providing	O
an	O
additional	O
mechanism	O
for	O
therapeutic	O
effects	O
of	O
aspirin	O
.	O

Activation	O
of	O
NF-kappa	protein
B	protein
by	O
phosphatase	protein
inhibitors	O
involves	O
the	O
phosphorylation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
at	O
phosphatase	protein
2A-sensitive	protein
sites	protein
.	O
Activation	O
of	O
NF-kappa	protein
B	protein
by	O
various	O
cellular	O
stimuli	O
involves	O
the	O
phosphorylation	O
and	O
subsequent	O
degradation	O
of	O
its	O
inhibitor,	O
I	protein
kappa	protein
B	protein
alpha	protein
,	O
although	O
the	O
underlying	O
mechanism	O
remains	O
unclear.	O
In	O
the	O
present	O
study,	O
the	O
role	O
of	O
serine/threonine	protein
phosphatases	protein
in	O
the	O
regulation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
phosphorylation	O
was	O
investigated.	O
Our	O
studies	O
demonstrate	O
that	O
incubation	O
of	O
human	cell_type
T	cell_type
cells	cell_type
with	O
low	O
concentrations	O
(approximately	O
1-5	O
nM)	O
of	O
calyculin	O
A	O
or	O
okadaic	O
acid	O
,	O
potent	O
inhibitors	O
of	O
protein	O
phosphatase	O
type	O
1	O
(PP-1)	O
and	O
type	O
2A	O
(	O
PP-2A	protein
),	O
induces	O
the	O
phosphorylation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
even	O
in	O
the	O
absence	O
of	O
any	O
cellular	O
stimulus.	O
This	O
action	O
of	O
the	O
phosphatase	O
inhibitors	O
,	O
which	O
is	O
associated	O
with	O
the	O
activation	O
of	O
the	O
RelA.p50	protein
NF-kappa	protein
B	protein
heterodimer	protein
,	O
is	O
not	O
affected	O
by	O
agents	O
that	O
block	O
the	O
induction	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
phosphorylation	O
by	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF-alpha	protein
).	O
Furthermore,	O
the	O
phosphorylated	protein
I	protein
kappa	protein
B	protein
alpha	protein
from	O
calyculin	cell_line
A	cell_line
-treated	cell_line
cells	cell_line
,	O
but	O
not	O
that	O
from	O
TNF-alpha	cell_line
-stimulated	cell_line
cells	cell_line
,	O
is	O
sensitive	O
to	O
PP-2A	protein
in	O
vitro,	O
suggesting	O
the	O
existence	O
of	O
fundamental	O
differences	O
in	O
the	O
phosphorylation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
induced	O
by	O
the	O
two	O
different	O
NF-kappa	protein
B	protein
inducers	O
.	O
However,	O
induction	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
phosphorylation	O
by	O
both	O
TNF-alpha	protein
and	O
the	O
phosphatase	O
inhibitors	O
is	O
associated	O
with	O
the	O
subsequent	O
degradation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
We	O
further	O
demonstrate	O
that	O
TNF-alpha-	O
and	O
calyculin	O
A-induced	O
I	O
kappa	O
B	O
alpha	O
degradation	O
exhibits	O
similar	O
but	O
not	O
identical	O
sensitivities	O
to	O
a	O
proteasome	O
inhibitor	O
.	O
Together,	O
these	O
results	O
suggest	O
that	O
phosphorylation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
,	O
mediated	O
through	O
both	O
the	O
TNF-alpha	protein
-inducible	O
and	O
the	O
PP-2A	protein
-opposing	protein
kinases	protein
,	O
may	O
serve	O
to	O
target	O
I	protein
kappa	protein
B	protein
alpha	protein
for	O
proteasome	protein
-mediated	O
degradation	O
.	O

Sp1	protein
functions	O
in	O
a	O
chromatin	DNA
-dependent	O
manner	O
to	O
augment	O
human	DNA
alpha-globin	DNA
promoter	DNA
activity	O
.	O
The	O
5'	DNA
flanking	DNA
region	DNA
of	O
the	O
human	DNA
alpha-globin	DNA
gene	DNA
is	O
highly	O
G	DNA
+	DNA
C	DNA
rich	DNA
and	O
contains	O
multiple	O
copies	O
of	O
the	O
consensus	DNA
sequence	DNA
for	O
the	O
Sp1	DNA
binding	DNA
site	DNA
.	O
We	O
investigated	O
the	O
role	O
of	O
this	O
G	DNA
+	DNA
C-rich	DNA
region	DNA
in	O
augmenting	O
alpha-globin	DNA
promoter	DNA
activity	O
in	O
the	O
presence	O
of	O
the	O
far-upstream	DNA
alpha-globin	DNA
enhancer	DNA
,	O
HS-40	DNA
.	O
We	O
show	O
that	O
in	O
transiently	cell_line
transfected	cell_line
erythroid	cell_line
cells	cell_line
,	O
deletion	O
of	O
the	O
alpha-globin	DNA
G	DNA
+	DNA
C-rich	DNA
5'	DNA
flanking	DNA
region	DNA
has	O
no	O
effect	O
on	O
alpha-globin	DNA
promoter	DNA
activity	O
.	O
However,	O
upon	O
stable	O
integration	O
into	O
chromatin	DNA
,	O
deletion	O
of	O
this	O
region	O
causes	O
a	O
nearly	O
90%	O
decrease	O
in	O
promoter	O
activity	O
compared	O
with	O
expression	O
from	O
an	O
alpha-globin	DNA
promoter	DNA
retaining	O
this	O
region.	O
These	O
results	O
suggest	O
that	O
the	O
alpha-globin	DNA
G	DNA
+	DNA
C-rich	DNA
5'	DNA
flanking	DNA
region	DNA
augments	O
alpha-globin	DNA
promoter	DNA
activity	O
in	O
a	O
chromatin	DNA
-dependent	O
manner	O
.	O
We	O
further	O
show	O
that	O
this	O
G	DNA
+	DNA
C-rich	DNA
region	DNA
is	O
required	O
for	O
the	O
activation	O
of	O
alpha-globin	DNA
gene	DNA
expression	O
during	O
erythroid	O
differentiation	O
.	O
Finally,	O
we	O
show	O
by	O
both	O
footprint	O
analysis	O
and	O
functional	O
assays	O
that	O
the	O
ability	O
of	O
the	O
G	DNA
+	DNA
C-rich	DNA
region	DNA
to	O
increase	O
alpha-globin	DNA
promoter	DNA
activity	O
from	O
a	O
stably	O
integrated	O
alpha-globin	DNA
gene	DNA
is	O
mediated	O
by	O
its	O
multiple	DNA
binding	DNA
sites	DNA
for	O
the	O
transcription	protein
factor	protein
Sp1	protein
.	O

Costimulation	O
of	O
human	cell_line
CD4+	cell_line
T	cell_line
cells	cell_line
with	O
LFA-3	protein
and	O
B7	protein
induce	O
distinct	O
effects	O
on	O
AP-1	protein
and	O
NF-kappa	protein
B	protein
transcription	protein
factors	protein
.	O
We	O
have	O
earlier	O
shown	O
that	O
stimulation	O
of	O
human	cell_line
CD4+	cell_line
T	cell_line
cells	cell_line
with	O
SEA	O
presented	O
on	O
Chinese	cell_line
hamster	cell_line
ovary	cell_line
(CHO)-DR	cell_line
transfectants	cell_line
coexpressing	O
either	O
B7	protein
or	O
LFA-3	protein
resulted	O
in	O
distinct	O
cytokine	protein
profiles	O
.	O
We	O
now	O
demonstrate	O
that	O
B7	protein
,	O
but	O
not	O
LFA-3	protein
,	O
strongly	O
costimulated	O
IL-2	protein
transcription	O
and	O
mRNA	O
expression	O
in	O
CD4+	cell_line
T	cell_line
cells	cell_line
.	O
Maximal	O
increase	O
in	O
IL-2	protein
transcription	O
was	O
recorded	O
with	O
CHO-DR/	protein
B7	protein
/	protein
LFA-3	protein
,	O
suggesting	O
a	O
cooperative	O
effect	O
of	O
B7	protein
and	O
LFA-3	protein
at	O
the	O
transcriptional	O
level.	O
Gel-shift	O
analysis	O
demonstrated	O
that	O
stimulation	O
of	O
CD4+	cell_line
T	cell_line
cells	cell_line
with	O
CHO-DR	protein
and	O
staphylococcal	O
enterotoxin	O
A	O
was	O
sufficient	O
to	O
induce	O
significant	O
amounts	O
of	O
NF-kappa	protein
B	protein
binding	O
proteins,	O
whereas	O
induction	O
of	O
AP-1	protein
binding	protein
proteins	protein
required	O
costimulation.	O
LFA-3	protein
induced	O
moderate	O
levels	O
of	O
AP-1	protein
,	O
but	O
did	O
not	O
influence	O
the	O
levels	O
of	O
NF-kappa	protein
B	protein
,	O
while	O
B7	protein
costimulation	O
strongly	O
induced	O
both	O
AP-1	protein
and	O
substantially	O
enhanced	O
NF-kappa	protein
B	protein
binding	protein
proteins	protein
.	O
The	O
CHO-DR/	cell_line
B7	cell_line
/	cell_line
LFA-3	cell_line
triple	cell_line
transfectant	cell_line
induced	O
a	O
further	O
increase	O
in	O
AP-1	protein
and	O
NF-kappa	protein
B	protein
binding	protein
proteins	protein
compared	O
with	O
the	O
double	cell_line
transfectants	cell_line
.	O
The	O
level	O
of	O
Oct-1	protein
binding	protein
proteins	protein
remained	O
similar	O
in	O
all	O
samples.	O
Super-shift	O
analysis	O
revealed	O
that	O
the	O
NF-kappa	protein
B	protein
complex	protein
of	O
costimulated	cell_line
CD4+	cell_line
T	cell_line
cells	cell_line
contained	O
large	O
amounts	O
of	O
p50	protein
,	O
substantial	O
amounts	O
of	O
p65	protein
,	O
and	O
marginal	O
levels	O
of	O
c-Rel	protein
proteins	protein
.	O
The	O
AP-1	protein
binding	protein
proteins	protein
contained	O
c-Jun	protein
,	O
Jun-D	protein
,	O
and	O
Fra-1	protein
,	O
but	O
marginal	O
amounts	O
of	O
Jun-B	protein
and	O
c-Fos	protein
.	O
Our	O
results	O
indicate	O
distinct	O
effects	O
of	O
B7	protein
and	O
LFA-3	protein
costimulation	O
on	O
the	O
activity	O
of	O
AP-1	protein
and	O
NF-kappa	protein
B	protein
.	O
These	O
may	O
partly	O
account	O
for	O
the	O
differential	O
effects	O
of	O
B7	protein
and	O
LFA-3	protein
costimulation	O
on	O
IL-2	protein
expression	O
.	O

The	O
Ah	protein
receptor	protein
recognizes	O
DNA	DNA
binding	DNA
sites	DNA
for	O
the	O
B	protein
cell	protein
transcription	protein
factor	protein
,	O
BSAP	protein
:	O
a	O
possible	O
mechanism	O
for	O
dioxin-mediated	O
alteration	O
of	O
CD19	DNA
gene	DNA
expression	O
in	O
human	cell_type
B	cell_type
lymphocytes	cell_type
.	O
2,3,7,8-tetrachlorodibenzo-p-dioxin	O
(	O
TCDD	O
)	O
inhibits	O
murine	O
and	O
human	O
B	O
lymphocyte	O
immunoglobulin	O
production	O
through	O
an	O
unknown	O
mechanism.	O
This	O
study	O
investigated	O
the	O
effect	O
of	O
TCDD	O
on	O
expression	O
of	O
the	O
CD19	DNA
gene	DNA
in	O
a	O
human	cell_line
B	cell_line
lymphocyte	cell_line
cell	cell_line
line	cell_line
.	O
Northern	O
blot	O
analysis	O
showed	O
that	O
TCDD	O
treatment	O
decreased	O
steady	O
state	O
levels	O
of	O
CD19	RNA
mRNA	RNA
by	O
67%	O
in	O
the	O
IM-9	cell_line
cell	cell_line
line	cell_line
.	O
Using	O
a	O
gel	O
mobility	O
shift	O
assay	O
,	O
we	O
identified	O
a	O
DNA-binding	protein
complex	protein
in	O
IM-9	O
nuclear	O
extracts	O
that	O
by	O
several	O
criteria	O
appears	O
to	O
be	O
the	O
Ah	protein
receptor	protein
.	O
In	O
addition,	O
the	O
Ah	protein
receptor	protein
complex	protein
recognized	O
a	O
DNA	DNA
binding	DNA
site	DNA
for	O
B	protein
cell	protein
lineage-specific	protein
activator	protein
protein	protein
(	O
BSAP	protein
)	O
in	O
the	O
promoter	DNA
region	DNA
of	O
the	O
human	O
CD19	DNA
gene	DNA
which	O
is	O
similar	O
to	O
the	O
consensus	DNA
Ah	DNA
receptor	DNA
DNA	DNA
binding	DNA
site	DNA
.	O
These	O
results	O
suggest	O
that	O
the	O
AhR	protein
could	O
interfere	O
with	O
BSAP	protein
-stimulated	O
CD19	DNA
gene	DNA
transcription	O
by	O
competition	O
for	O
a	O
common	O
DNA	DNA
binding	DNA
site	DNA
.	O

Inhibitory	O
action	O
of	O
nm23	protein
proteins	protein
on	O
induction	O
of	O
erythroid	O
differentiation	O
of	O
human	cell_type
leukemia	cell_type
cells	cell_type
.	O
We	O
recently	O
identified	O
a	O
differentiation	protein
inhibitory	protein
factor	protein
(	O
I-factor	protein
)	O
in	O
mouse	cell_line
myeloid	cell_line
leukemia	cell_line
M1	cell_line
cells	cell_line
as	O
a	O
murine	protein
homolog	protein
of	O
the	O
human	protein
nm23-H2	protein
gene	protein
product	protein
.	O
nm23	DNA
genes	DNA
encode	O
proteins	O
that	O
participate	O
in	O
tumor	O
metastasis	O
regulation	O
and	O
in	O
various	O
fundamental	O
cellular	O
processes,	O
although	O
their	O
mechanisms	O
of	O
action	O
are	O
still	O
unknown.	O
Although	O
all	O
nm23	protein
proteins	protein
contain	O
nucleoside	protein
diphosphate	protein
(NDP)	protein
kinase	protein
activity	O
,	O
it	O
has	O
not	O
been	O
established	O
that	O
the	O
enzyme	O
activity	O
mediated	O
the	O
various	O
functions	O
of	O
nm23	protein
proteins	protein
.	O
In	O
the	O
present	O
experiment,	O
we	O
examined	O
the	O
effect	O
of	O
nm23	protein
proteins	protein
on	O
various	O
differentiation	O
induction	O
systems	O
of	O
human	cell_type
leukemic	cell_type
cells	cell_type
including	O
HL-60	cell_line
,	O
U937	cell_line
,	O
HEL/S	cell_line
,	O
KU812F	cell_line
,	O
K562	cell_line
,	O
and	O
HEL	cell_line
cells	O
.	O
Native	protein
human	protein
erythrocyte	protein
NDP	protein
kinase	protein
protein	protein
inhibited	O
the	O
induction	O
of	O
erythroid	O
differentiation	O
of	O
HEL	O
,	O
KU812	O
and	O
K562	O
cells	O
,	O
but	O
not	O
the	O
induction	O
of	O
monocytic	O
or	O
granulocytic	O
differentiation	O
of	O
HL-60	cell_line
,	O
U937	cell_line
and	O
HEL/S	cell_line
cells	O
.	O
The	O
erythroid	O
differentiation	O
of	O
HEL	cell_line
cells	cell_line
was	O
inhibited	O
by	O
recombinant	O
human	O
nm23	O
-H1	O
,	O
-H2	O
,	O
mouse	O
nm23	O
-M1	O
,	O
and	O
-M2	O
proteins	O
.	O
Moreover,	O
both	O
the	O
mutant	protein
nm23-H2His	protein
protein	protein
and	O
truncated	protein
nm23-H2	protein
protein	protein
containing	O
N-terminal	protein
(1-60)	protein
peptide	protein
,	O
which	O
do	O
not	O
have	O
NDP	protein
kinase	protein
activity	O
,	O
also	O
inhibited	O
erythroid	O
differentiation	O
of	O
HEL	cell_line
cells	cell_line
.	O
These	O
results	O
suggest	O
that	O
(1)	O
the	O
differentiation	O
inhibitory	O
activity	O
of	O
I-factor	protein
/nm23	protein
protein	protein
is	O
not	O
restricted	O
to	O
monocytic	O
differentiation	O
of	O
M1	cell_line
cells	cell_line
,	O
(2)	O
the	O
inhibitory	O
activity	O
is	O
exhibited	O
without	O
species	O
specificity,	O
and	O
(3)	O
the	O
differentiation	O
inhibitory	O
activity	O
of	O
the	O
nm23/NDP	protein
kinase	protein
protein	protein
is	O
independent	O
of	O
its	O
enzyme	O
activity	O
and	O
requires	O
the	O
presence	O
of	O
N-terminal	O
peptides	O
.	O

Lipopolysaccharide	O
-induced	O
E-selectin	protein
expression	O
requires	O
continuous	O
presence	O
of	O
LPS	O
and	O
is	O
inhibited	O
by	O
bactericidal/permeability-increasing	protein
protein	protein
.	O
Endothelial	cell_type
cells	cell_type
stimulated	O
by	O
LPS	O
express	O
E-selectin	protein
,	O
which	O
plays	O
an	O
important	O
role	O
in	O
mediating	O
neutrophil	cell_type
adhesion	O
during	O
inflammation	O
.	O
E-selectin	protein
is	O
induced	O
within	O
1-2	O
h,	O
peaks	O
at	O
4-6	O
h,	O
and	O
gradually	O
returns	O
to	O
basal	O
level	O
by	O
24	O
h.	O
rBPI21	protein
,	O
a	O
recombinant	protein
N-terminal	protein
fragment	protein
of	O
human	protein
bactericidal/permeability-increasing	protein
protein	protein
(	O
BPI	protein
),	O
inhibited	O
LPS	O
-induced	O
E-selectin	protein
expression	O
when	O
added	O
at	O
the	O
same	O
time	O
as,	O
and	O
up	O
to	O
6	O
h	O
after,	O
LPS	O
.	O
Delayed	O
administration	O
of	O
rBPI21	protein
also	O
affected	O
LPS	O
-mediated	O
activation	O
of	O
the	O
nuclear	protein
factor	protein
,	O
NF-kappa	protein
B	protein
.	O
Two	O
to	O
4	O
h	O
following	O
LPS	O
addition	O
to	O
endothelial	cell_type
cells	cell_type
,	O
when	O
NF-kappa	protein
B	protein
was	O
already	O
activated,	O
addition	O
of	O
rBPI21	protein
resulted	O
in	O
marked	O
reduction	O
of	O
NF-kappa	protein
B	protein
detectable	O
at	O
4	O
or	O
6	O
h.	O
These	O
results	O
indicate	O
that	O
endothelial	O
activation	O
requires	O
continuous	O
presence	O
of	O
LPS	O
,	O
and	O
rBPI21	protein
acts	O
to	O
reverse	O
LPS	O
-mediated	O
endothelial	O
activation	O
by	O
interrupting	O
the	O
on-going	O
LPS	O
signal	O
.	O

GM-CSF	protein
and	O
IL-2	protein
share	O
common	O
control	O
mechanisms	O
in	O
response	O
to	O
costimulatory	O
signals	O
in	O
T	cell_type
cells	cell_type
.	O
Antigen	O
complexed	O
with	O
major	O
histocompatibility	O
complex	O
class	O
I	O
or	O
II	O
molecules	O
on	O
the	O
surface	O
of	O
antigen	cell_type
presenting	cell_type
cells	cell_type
interacts	O
with	O
the	O
T	protein
cell	protein
receptor	protein
(	O
TCR	protein
)	O
on	O
the	O
surface	O
of	O
T	cell_type
cells	cell_type
and	O
initiates	O
an	O
activation	O
cascade.	O
So	O
called	O
costimulatory	O
signals	O
,	O
mediated	O
by	O
other	O
cell	O
surface	O
interactions	O
or	O
soluble	protein
cytokines	protein
produced	O
by	O
antigen	cell_type
presenting	cell_type
cells	cell_type
,	O
are	O
also	O
required	O
for	O
complete	O
T	O
cell	O
activation	O
.	O
High	O
levels	O
of	O
cytokine	protein
gene	O
expression	O
in	O
T	cell_type
cells	cell_type
also	O
required	O
both	O
TCR	protein
and	O
costimulatory	O
signals	O
.	O
The	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
requires	O
sequences	O
in	O
the	O
promoter	DNA
as	O
well	O
as	O
a	O
powerful	O
enhancer	DNA
located	O
3kb	O
upstream	O
to	O
respond	O
to	O
TCR	protein
-like	O
signals	O
.	O
These	O
promoter	DNA
and	DNA
enhancer	DNA
regions	DNA
are	O
mainly	O
activated	O
by	O
the	O
transcription	protein
factor	protein
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NFAT	protein
).	O
The	O
activation	O
of	O
NFAT	protein
by	O
TCR	protein
signals	O
has	O
been	O
well	O
described	O
for	O
interleukin-2	O
(	O
IL-2	protein
)	O
and	O
IL-4	O
gene	O
transcription	O
in	O
T	cell_type
cells	cell_type
.	O
Costimulatory	O
signals,	O
such	O
as	O
activation	O
of	O
the	O
CD28	protein
cell	protein
surface	protein
molecule	protein
on	O
T	cell_type
cells	cell_type
,	O
lead	O
to	O
activation	O
through	O
a	O
distinct	O
region	O
of	O
the	O
granulocyte-macrophage	DNA
colony-stimulating	DNA
factor	DNA
(	DNA
GM-CSF	DNA
)	DNA
promoter	DNA
.	O
This	O
region	O
is	O
termed	O
the	O
CK-1	DNA
or	O
CD28RE	DNA
and	O
appears	O
to	O
bind	O
specific	O
members	O
of	O
the	O
NF-kappa	protein
B	protein
family	protein
of	O
transcription	protein
factors	protein
.	O
Human	O
T	O
leukemia	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
infects	O
T	cell_type
cells	cell_type
and	O
can	O
lead	O
to	O
increase	O
GM-CSF	protein
expression	O
.	O
We	O
have	O
found	O
that	O
the	O
HTLV-1	protein
transactivator	protein
protein	protein
,	O
tax	protein
,	O
acts	O
as	O
a	O
costimulatory	O
signal	O
for	O
GM-CSF	O
and	O
IL-2	O
gene	O
transcription	O
,	O
in	O
that	O
it	O
can	O
cooperate	O
with	O
TCR	protein
signals	O
to	O
mediate	O
high	O
level	O
gene	O
expression	O
.	O
Tax	O
activates	O
the	O
GM-CSF	DNA
promoter	DNA
through	O
the	O
CK-1	DNA
/CD28RE	DNA
region	O
and	O
also	O
activates	O
nuclear	protein
factor-kappa	protein
B	protein
binding	O
to	O
this	O
region.	O
However,	O
other	O
transcription	protein
factors	protein
or	O
coactivators	O
of	O
NF-kappa	protein
B	protein
are	O
required	O
for	O
tax	protein
activation	O
but	O
these	O
remain	O
to	O
be	O
identified.	O
The	O
CK-1	DNA
/CD28RE	DNA
of	O
GM-CSF	protein
shows	O
a	O
high	O
degree	O
of	O
similarity	O
to	O
the	O
IL-2	protein
CD28RE	DNA
and	O
the	O
IL-3	DNA
gene	DNA
also	O
contains	O
a	O
related	O
region.	O
This	O
observation,	O
together	O
with	O
the	O
fact	O
that	O
both	O
GM-CSF	protein
and	O
IL-2	protein
respond	O
to	O
TCR	protein
signals	O
via	O
NFAT	protein
,	O
implies	O
a	O
high	O
degree	O
of	O
conservation	O
in	O
the	O
regulation	O
of	O
cytokine	protein
gene	O
expression	O
in	O
T	cell_type
cells	cell_type
.	O

Danazol	O
decreases	O
transcription	O
of	O
estrogen	DNA
receptor	DNA
gene	DNA
in	O
human	cell_type
monocytes	cell_type
.	O
1.	O
Administration	O
of	O
danazol	O
for	O
over	O
one	O
month	O
reduced	O
the	O
levels	O
of	O
estrogen	protein
receptor	protein
(	O
ER	protein
)	O
and	O
its	O
mRNA	RNA
to	O
approximately	O
50	O
and	O
20%,	O
respectively	O
in	O
monocytes	cell_type
.	O
2.	O
Danazol	O
did	O
not	O
alter	O
the	O
degradation	O
rate	O
of	O
ER	RNA
mRNA	RNA
in	O
monocytes	cell_type
.	O
3.	O
Danazol	O
decreased	O
the	O
transcription	O
rate	O
of	O
ER	DNA
gene	DNA
to	O
approximately	O
50%	O
in	O
monocytes	cell_type
in	O
a	O
run-on	O
assay	O
.	O
4.	O
Danazol	O
may	O
release	O
estrogen	O
predominance	O
via	O
the	O
reduction	O
of	O
transcription	O
for	O
ER	DNA
gene	DNA
,	O
which	O
leads	O
to	O
the	O
reduction	O
of	O
ER	RNA
mRNA	RNA
and	O
ER	protein
expressions	O
in	O
monocytes	cell_type
.	O

Functional	O
characterization	O
of	O
novel	O
IL-2	protein
transcriptional	O
inhibitors	O
.	O
IL-2	protein
-mediated	O
T	cell_type
cell	cell_type
proliferation	O
is	O
a	O
critical	O
early	O
event	O
in	O
the	O
inflammatory	O
process	O
.	O
Formation	O
of	O
the	O
NFAT	protein
-1	protein
transcriptional	protein
complex	protein
on	O
the	O
IL-2	DNA
promoter	DNA
is	O
essential	O
for	O
IL-2	protein
transcription	O
.	O
Using	O
a	O
cell	O
line	O
that	O
is	O
stably	O
transfected	O
with	O
a	O
trimer	O
of	O
the	O
NFAT	DNA
-1	DNA
regulatory	DNA
element	DNA
linked	O
to	O
a	O
lac-Z	DNA
reporter	DNA
gene	DNA
,	O
we	O
screened	O
for	O
inhibitors	O
of	O
NFAT	protein
-1-mediated	O
beta-galactosidase	protein
activity	O
.	O
WIN	O
61058	O
and	O
WIN	O
53071	O
were	O
identified	O
as	O
microM	O
inhibitors	O
.	O
These	O
compounds	O
also	O
inhibited	O
beta-galactosidase	RNA
mRNA	RNA
levels	O
.	O
Similar	O
inhibition	O
of	O
NFAT	protein
-1-mediated	O
gene	O
expression	O
was	O
observed	O
in	O
a	O
second	O
cell	cell_line
line	cell_line
,	O
which	O
is	O
stably	O
transfected	O
with	O
NFAT	DNA
-1	DNA
regulatory	DNA
elements	DNA
linked	O
to	O
the	O
reporter	DNA
gene	DNA
for	DNA
sCD8	DNA
.	O
At	O
10	O
microM,	O
both	O
compounds	O
inhibited	O
IL-2	O
mRNA	O
and	O
protein	O
levels	O
in	O
the	O
NFAT	cell_line
-1-linked	cell_line
lac-Z	cell_line
transfectants	cell_line
,	O
and	O
in	O
human	cell_type
lymphocytes	cell_type
.	O
Both	O
compounds	O
inhibited	O
the	O
mixed	O
lymphocyte	O
reaction	O
,	O
and	O
this	O
inhibition	O
was	O
reversed	O
by	O
exogenous	O
IL-2	protein
.	O
WIN	O
53071	O
inhibited	O
IL-2	protein
production	O
induced	O
in	O
the	O
calcium-dependent	O
PMA	O
and	O
ionomycin	O
pathway	O
.	O
Conversely,	O
calcium-independent	protein
anti-CD28	protein
Ab	protein
and	O
PMA-induced	O
IL-2	protein
production	O
was	O
resistant.	O
Both	O
compounds	O
altered	O
the	O
NFAT	protein
-1	protein
transcriptional	protein
complex	protein
,	O
causing	O
its	O
retarded	O
mobility	O
on	O
gels	O
.	O
By	O
these	O
functional	O
criteria,	O
we	O
believe	O
we	O
have	O
identified	O
two	O
structurally	O
distinct,	O
novel	O
inhibitors	O
of	O
NFAT	protein
-1-mediated	O
transcription	O
.	O

Transcriptional	O
regulation	O
of	O
the	O
vacuolar	DNA
H(+)-ATPase	DNA
B2	DNA
subunit	DNA
gene	DNA
in	O
differentiating	cell_line
THP-1	cell_line
cells	cell_line
.	O
Monocyte-macrophage	O
differentiation	O
was	O
used	O
as	O
a	O
model	O
system	O
for	O
studying	O
gene	O
regulation	O
of	O
the	O
human	protein
vacuolar	protein
H(+)-ATPase	protein
(	O
V-ATPase	protein
).	O
We	O
examined	O
mRNA	RNA
levels	O
of	O
various	O
V-ATPase	protein
subunits	O
during	O
differentiation	O
of	O
both	O
native	cell_type
monocytes	cell_type
and	O
the	O
cell	cell_line
line	cell_line
THP-1	cell_line
,	O
and	O
found	O
that	O
transcriptional	O
and	O
post-transcriptional	O
mechanisms	O
could	O
account	O
for	O
increases	O
in	O
cell	O
V-ATPase	protein
content	O
.	O
From	O
nuclear	O
runoff	O
experiments,	O
we	O
found	O
that	O
one	O
subunit	O
in	O
particular,	O
the	O
B2	protein
isoform	protein
(Mr	O
=	O
56,000),	O
was	O
amplified	O
primarily	O
by	O
transcriptional	O
means	O
.	O
We	O
have	O
begun	O
to	O
examine	O
the	O
structure	O
of	O
the	O
B2	DNA
subunit	DNA
promoter	DNA
region	DNA
.	O
Isolation	O
and	O
sequencing	O
of	O
the	O
first	DNA
exon	DNA
and	O
5'-flanking	DNA
region	DNA
of	O
this	O
gene	O
reveal	O
a	O
TATA-less	DNA
promoter	DNA
with	O
a	O
high	O
G	O
+	O
C	O
content	O
.	O
Primer	O
extension	O
and	O
ribonuclease	protein
protection	O
analyses	O
indicate	O
a	O
single	O
major	DNA
transcriptional	DNA
start	DNA
site	DNA
.	O
We	O
transfected	O
promoter-luciferase	DNA
reporter	DNA
plasmids	DNA
into	O
THP-1	cell_line
cells	cell_line
to	O
define	O
sequences	O
that	O
mediate	O
transcriptional	O
control	O
during	O
monocyte	O
differentiation	O
.	O
We	O
found	O
that	O
sequences	O
downstream	O
from	O
the	O
transcriptional	O
start	O
site	O
were	O
sufficient	O
to	O
confer	O
increased	O
expression	O
during	O
THP-1	cell_line
differentiation	O
.	O
DNase	protein
I	protein
footprinting	O
and	O
sequence	O
analysis	O
revealed	O
the	O
existence	O
of	O
multiple	O
AP2	O
and	O
Sp1	O
binding	O
sites	O
in	O
the	O
5'-untranslated	O
and	O
proximal	O
coding	O
regions	O
.	O

Synergy	O
between	O
signal	O
transduction	O
pathways	O
is	O
obligatory	O
for	O
expression	O
of	O
c-fos	DNA
in	O
B	O
and	O
T	O
cell	O
lines	O
:	O
implication	O
for	O
c-fos	DNA
control	O
via	O
surface	protein
immunoglobulin	protein
and	O
T	protein
cell	protein
antigen	protein
receptors	protein
.	O
Expression	O
of	O
the	O
protooncogene	DNA
c-fos	DNA
is	O
controlled	O
by	O
three	O
main	O
regulatory	O
pathways	O
involving	O
kinase	protein
C	protein
,	O
cAMP	O
,	O
and	O
calcium	O
.	O
Kinase	protein
C	protein
mediates	O
its	O
effects	O
via	O
phosphorylation	O
of	O
serum	protein
response	protein
factor	protein
(	O
SRF	protein
)	O
which	O
interacts	O
with	O
the	O
serum	DNA
response	DNA
element	DNA
(	O
SRE	DNA
);	O
cAMP	O
and	O
calcium	O
mediate	O
their	O
effects	O
via	O
phosphorylation	O
of	O
CREB	protein
(	O
cAMP	protein
regulatory	protein
element	protein
binding	protein
protein	protein
)	O
presumably	O
by	O
activation	O
of	O
a	O
protein	protein
kinase	protein
A	protein
or	O
calmodulin-regulated	protein
kinase	protein
.	O
We	O
have	O
examined	O
the	O
function	O
of	O
these	O
elements	O
in	O
Burkitt's	cell_line
lymphoma	cell_line
cells	cell_line
(	O
Ramos	cell_line
and	O
Daudi	cell_line
)	O
as	O
well	O
as	O
a	O
T	cell_line
lymphocytic	cell_line
cell	cell_line
line	cell_line
(	O
Jurkat	cell_line
).	O
We	O
have	O
found	O
that	O
stimulation	O
of	O
any	O
one	O
of	O
these	O
pathways	O
alone	O
has	O
little	O
or	O
no	O
effect	O
on	O
c-fos	DNA
induction	O
.	O
However,	O
kinase	protein
C	protein
activation	O
(	O
PMA	O
stimulation	O
)	O
combined	O
with	O
either	O
cAMP	O
(	O
forskolin	O
plus	O
MIX	O
)	O
or	O
calcium	O
stimulation	O
(	O
ionophore	O
)	O
leads	O
to	O
greatly	O
enhanced	O
c-fos	DNA
induction	O
.	O
By	O
contrast,	O
cAMP	O
in	O
the	O
presence	O
of	O
calcium	O
shows	O
no	O
synergy	O
in	O
c-fos	DNA
induction	O
.	O
Okadaic	O
acid	O
augments	O
PMA-	O
as	O
well	O
as	O
calcium-	O
mediated	O
activation	O
of	O
c-fos	DNA
,	O
and	O
has	O
little	O
or	O
no	O
effect	O
when	O
combined	O
with	O
cAMP	O
.	O
The	O
main	O
difference	O
between	O
Ramos	cell_line
(	O
B	cell_type
cells	cell_type
)	O
and	O
Jurkat	cell_line
(	O
T	cell_type
cells	cell_type
)	O
in	O
the	O
regulation	O
of	O
c-fos	DNA
is	O
that	O
cAMP	O
plus	O
calcium	O
is	O
strongly	O
synergistic	O
in	O
Jurkat	cell_line
and	O
is	O
without	O
effect	O
in	O
Ramos	cell_line
.	O
Analysis	O
of	O
AP-1	protein
activity	O
using	O
gel	O
mobility	O
shift	O
assays	O
confirms	O
that	O
the	O
requirements	O
for	O
synergy	O
in	O
c-fos	RNA
mRNA	RNA
induction	O
are	O
paralleled	O
by	O
requirements	O
for	O
synergy	O
in	O
induction	O
of	O
AP-1	protein
activity	O
.	O
Signaling	O
in	O
B	cell_type
cells	cell_type
due	O
to	O
anti-Ig	protein
stimulation	O
involves	O
both	O
kinase	protein
C	protein
activation	O
and	O
release	O
of	O
intracellular	O
calcium	O
,	O
and	O
results	O
in	O
c-fos	RNA
mRNA	RNA
induction	O
.	O
Our	O
results	O
indicate	O
that	O
synergy	O
between	O
the	O
kinase	protein
C	protein
activation	O
and	O
calcium	O
is	O
needed	O
for	O
efficient	O
c-fos	DNA
induction	O
since	O
neither	O
of	O
these	O
two	O
alone	O
induces	O
c-fos	DNA
well.	O
That	O
synergy	O
of	O
signaling	O
pathways	O
is	O
relevant	O
for	O
the	O
anti-Ig	protein
induction	O
of	O
c-fos	DNA
is	O
supported	O
by	O
the	O
fact	O
that	O
cAMP	O
-inducing	O
agents	O
and	O
okadaic	O
acid	O
further	O
enhance	O
anti-Ig	protein
induction	O
of	O
c-fos	DNA
.	O
These	O
results	O
suggest	O
that	O
cell-specific	O
patterns	O
of	O
synergy	O
are	O
an	O
essential	O
feature	O
for	O
c-fos	DNA
induction	O
and	O
may	O
be	O
relevant	O
for	O
c-fos	DNA
control	O
through	O
B	O
and	O
T	O
cell	O
antigen	O
receptors	O
.	O

Multiple	O
signals	O
are	O
required	O
for	O
function	O
of	O
the	O
human	DNA
granulocyte-macrophage	DNA
colony-stimulating	DNA
factor	DNA
gene	DNA
promoter	DNA
in	O
T	cell_type
cells	cell_type
.	O
The	O
human	DNA
granulocyte-macrophage	DNA
CSF	DNA
(	DNA
GM-CSF	DNA
)	DNA
gene	DNA
is	O
expressed	O
in	O
T	cell_type
cells	cell_type
in	O
response	O
to	O
TCR	protein
activation	O
that	O
can	O
be	O
mimicked	O
by	O
treatment	O
of	O
the	O
cells	O
with	O
PMA	O
and	O
Ca2+	O
ionophore	O
.	O
The	O
gene	O
contains	O
a	O
proximal	DNA
functional	DNA
promoter	DNA
region	DNA
(	O
-620	DNA
to	DNA
+34	DNA
),	O
as	O
well	O
as	O
a	O
powerful	O
enhancer	DNA
located	O
3	O
kb	O
upstream,	O
both	O
of	O
which	O
are	O
involved	O
in	O
the	O
response	O
of	O
the	O
gene	O
to	O
TCR	protein
activation	O
.	O
The	O
proximal	DNA
promoter	DNA
contains	O
a	O
region	O
termed	O
CLEO	DNA
(	O
-54	DNA
to	DNA
-31	DNA
)	O
that	O
consists	O
of	O
a	O
purine	DNA
-rich	DNA
element	DNA
abutting	O
an	O
activator	DNA
protein-1	DNA
(	DNA
AP-1	DNA
)-like	DNA
site	DNA
,	O
as	O
well	O
as	O
an	O
upstream	DNA
nuclear	DNA
factor-kappa	DNA
B	DNA
(	DNA
NF-kappa	DNA
B	DNA
)	DNA
site	DNA
(	O
-85	DNA
to	DNA
-76	DNA
)	O
and	O
a	O
CK-1	DNA
element	DNA
(	O
-101	DNA
to	DNA
-92	DNA
).	O
We	O
show	O
in	O
this	O
work	O
that	O
mutations	O
in	O
either	O
the	O
purine	DNA
-rich	DNA
region	DNA
of	O
the	O
CLEO	DNA
element	DNA
or	O
the	O
NF-kappa	DNA
B	DNA
site	DNA
result	O
in	O
reduced	O
PMA	O
/	O
Ca2+	O
activation	O
of	O
a	O
620-bp	DNA
human	DNA
GM-CSF	DNA
promoter-	DNA
luciferase	DNA
reporter	DNA
construct	DNA
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
by	O
65%	O
and	O
50%,	O
respectively.	O
The	O
major	O
inducible	protein
protein	protein
complex	protein
that	O
binds	O
to	O
the	O
human	DNA
CLEO	DNA
(	DNA
hCLEO	DNA
)	DNA
element	DNA
is	O
an	O
AP-1	protein
-like	protein
complex	protein
that	O
is	O
inducible	O
by	O
PMA	O
alone,	O
but	O
shows	O
increased	O
binding	O
in	O
response	O
to	O
PMA	O
together	O
with	O
Ca2+	O
ionophore	O
.	O
Although	O
the	O
binding	O
of	O
this	O
complex	O
is	O
not	O
cyclosporin	O
-sensitive	O
,	O
promoter	O
induction	O
is	O
inhibited	O
by	O
cyclosporin	O
treatment	O
.	O
A	O
second	O
weak	O
inducible	O
complex	O
resembling	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NF-AT	protein
)	O
was	O
also	O
observed	O
binding	O
to	O
the	O
hCLEO	DNA
region	DNA
.	O
By	O
using	O
recombinant	protein
proteins	protein
,	O
we	O
confirmed	O
that	O
AP-1	protein
,	O
NF-ATp	protein
,	O
and	O
a	O
higher	O
order	O
NF-ATp	protein
/	protein
AP-1	protein
complex	protein
could	O
all	O
form	O
with	O
the	O
hCLEO	DNA
element	DNA
,	O
and	O
we	O
have	O
also	O
defined	O
the	O
sequence	O
requirements	O
for	O
binding	O
of	O
each	O
of	O
these	O
complexes.	O
We	O
found	O
that	O
expression	O
of	O
a	O
constitutively	O
active	O
form	O
of	O
calcineurin	protein
could	O
substitute	O
for	O
Ca2+	O
ionophore	O
and	O
synergize	O
with	O
PMA	O
to	O
activate	O
the	O
GM-CSF	DNA
promoter	DNA
,	O
and	O
conversely	O
that	O
mutant-activated	protein
Ras	protein
could	O
substitute	O
for	O
PMA	O
and	O
cooperate	O
with	O
Ca2+	O
ionophore	O
.	O
Co-expression	O
of	O
Ras	protein
and	O
calcineurin	protein
,	O
however,	O
did	O
not	O
activate	O
the	O
GM-CSF	DNA
promoter	DNA
,	O
but	O
required	O
the	O
additional	O
expression	O
of	O
NF-kappa	protein
B	protein
p65	protein
.	O
These	O
results	O
imply	O
that	O
at	O
least	O
three	O
signals	O
are	O
required	O
to	O
activate	O
the	O
GM-CSF	DNA
proximal	DNA
promoter	DNA
,	O
and	O
that	O
the	O
signals	O
impinge	O
on	O
distinct	O
transcription	protein
factors	protein
that	O
bind	O
to	O
the	O
hCLEO	DNA
and	DNA
NF-kappa	DNA
B	DNA
regions	DNA
of	O
the	O
promoter	DNA
.	O

IL-10	O
induces	O
the	O
tyrosine	O
phosphorylation	O
of	O
tyk2	protein
and	O
Jak1	protein
and	O
the	O
differential	O
assembly	O
of	O
STAT1	protein
alpha	protein
and	O
STAT3	protein
complexes	protein
in	O
human	cell_type
T	cell_type
cells	cell_type
and	O
monocytes	cell_type
.	O
IL-10	protein
affects	O
monocytes	cell_type
and	O
T	cell_type
cells	cell_type
by	O
driving	O
the	O
progression	O
of	O
immune	O
responsiveness	O
such	O
that	O
Th2	O
lymphocyte-mediated	O
effects	O
predominate.	O
In	O
this	O
report,	O
we	O
show	O
that	O
in	O
monocytes	cell_type
and	O
T	cell_type
cells	cell_type
IL-10	protein
stimulates	O
tyrosine	O
phosphorylation	O
of	O
the	O
signal	protein
transducers	protein
and	O
activators	protein
of	protein
transcription	protein
,	O
STAT1	protein
alpha	protein
and	O
STAT3	protein
,	O
in	O
a	O
differential	O
manner	O
such	O
that	O
the	O
relative	O
formation	O
of	O
homo-	O
and	O
hetero	O
dimers	O
varies	O
between	O
the	O
two	O
cell	O
types.	O
Moreover,	O
monocytes	cell_type
express	O
a	O
novel	O
IL-10	protein
-stimulated	protein
STAT	protein
protein	protein
with	O
an	O
M(r)	O
of	O
70	protein
kDa	protein
that	O
is	O
recognized	O
by	O
the	O
anti-	protein
STAT3	protein
Ab	protein
but	O
is	O
not	O
observed	O
in	O
T	cell_type
cells	cell_type
.	O
IL-10	protein
treatment	O
of	O
both	O
T	cell_type
cells	cell_type
and	O
monocytes	cell_type
results	O
in	O
the	O
ligand-induced	O
tyrosine	O
phosphorylation	O
of	O
tyk2	protein
and	O
Jak1	protein
,	O
but	O
not	O
Jak2	protein
or	O
Jak3	protein
.	O
Selective	O
modulation	O
of	O
immune	O
responsiveness	O
by	O
IL-10	protein
in	O
cells	O
such	O
as	O
monocytes	cell_type
and	O
T	cell_type
cells	cell_type
may	O
result	O
in	O
part	O
from	O
the	O
differential	O
activation	O
of	O
STAT	protein
protein	protein
pairs	protein
.	O

Use	O
of	O
new	O
biologic	O
markers	O
in	O
the	O
ovulation	O
induction	O
.	O
Biological	O
markers	O
of	O
ovulation	O
,	O
after	O
a	O
great	O
in	O
the	O
past,	O
have	O
been	O
fallen	O
into	O
disuse	O
for	O
the	O
large	O
diffusion	O
of	O
biochemical	O
and	O
biophysical	O
ones.	O
However,	O
the	O
real	O
effect	O
of	O
hormones	O
involved	O
in	O
ovulation	O
is	O
expressed	O
by	O
biological	O
modifications	O
on	O
target	cell_type
tissues	cell_type
.	O
To	O
explore	O
the	O
modifications	O
of	O
not	O
reproductive	O
target	O
tissues	O
as	O
ovulation	O
markers	O
we	O
studied	O
the	O
behaviour	O
of	O
Albuminemia	O
,	O
Platelet	protein
Factor	protein
IV	protein
(as	O
indicator	O
of	O
Platelet	O
Aggregation	O
),	O
Type	protein
II	protein
estrogenic	protein
receptors	protein
in	O
42	O
ovulation	O
induced	O
women	O
,	O
undergoing	O
our	O
observation.	O
33	O
of	O
them	O
had	O
ovulation	O
and	O
9	O
developed	O
a	O
LUF	O
syndrome	O
,	O
constituting	O
two	O
biological	O
models	O
of	O
an	O
opposite	O
situation	O
for	O
the	O
three	O
markers	O
observed.	O
All	O
the	O
markers	O
considered	O
were	O
sufficiently	O
sensitive,	O
but	O
among	O
them,	O
Platelet	protein
Factor	protein
IV	protein
was	O
the	O
most	O
reliable	O
to	O
the	O
hormonal	O
ovulatory	O
situation	O
.	O

Abnormal	O
regulation	O
of	O
the	O
IL-2	DNA
promoter	DNA
in	O
lpr	O
CD4-CD8-	cell_line
T	cell_line
lymphocytes	cell_line
results	O
in	O
constitutive	O
expression	O
of	O
a	O
novel	protein
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
-binding	protein
factor	protein
.	O
The	O
inert	O
quality	O
of	O
MRL-Ipr/Ipr	cell_line
(Ipr)	cell_line
peripheral	cell_line
CD4-CD8-	cell_line
(CD4-8-)	cell_line
T	cell_line
cells	cell_line
manifests	O
primarily	O
as	O
an	O
inability	O
to	O
proliferate	O
or	O
produce	O
IL-2	protein
in	O
response	O
to	O
TCR	protein
or	O
mitogenic	O
stimulation	O
.	O
Yet	O
these	O
same	O
cells	O
do	O
initiate	O
early	O
TCR	protein
-mediated	O
signaling	O
events	O
,	O
such	O
as	O
generation	O
of	O
inositol	O
phosphates	O
and	O
increased	O
intracellular	O
calcium	O
.	O
They	O
also	O
display	O
constitutively	O
high	O
levels	O
of	O
p59fyn	protein
and	O
CD3	protein
zeta	protein
tyrosine	O
phosphorylation	O
.	O
The	O
generation	O
of	O
second	O
messengers	O
in	O
T	cell_type
cells	cell_type
normally	O
leads	O
to	O
downstream	O
signaling	O
that	O
results	O
in	O
transcriptional	O
activation	O
of	O
the	O
IL-2	DNA
gene	DNA
.	O
We,	O
therefore,	O
compared	O
the	O
activation	O
state	O
of	O
the	O
IL-2	DNA
gene	DNA
promoter	DNA
region	DNA
in	O
freshly	O
isolated	O
and	O
stimulated	O
Ipr	cell_line
CD4-8-	cell_line
T	cell_line
cells	cell_line
with	O
that	O
of	O
normal	cell_type
T	cell_type
lymphocytes	cell_type
.	O
Levels	O
of	O
the	O
octamer	O
,	O
NF-kappa	protein
B	protein
(	O
p50-p65	protein
heterodimer	protein
),	O
and	O
AP-1	protein
transcriptional	protein
factors	protein
are	O
constitutively	O
elevated	O
in	O
freshly	O
isolated	O
Ipr	cell_line
CD4-8-	cell_line
T	cell_line
cells	cell_line
,	O
consistent	O
with	O
the	O
activated	O
phenotype	O
of	O
these	O
cells.	O
Upon	O
stimulation	O
with	O
mitogens	O
,	O
formation	O
of	O
the	O
transactivating	O
complex,	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NF-AT	protein
),	O
occurs	O
with	O
normal	O
kinetics	O
in	O
Ipr	cell_line
CD4-8-	cell_line
T	cell_line
cells	cell_line
.	O
Yet,	O
the	O
levels	O
of	O
the	O
activating	O
NF-AT	protein
complex	protein
never	O
reach	O
those	O
observed	O
in	O
similarly	O
stimulated	O
normal	O
T	cell_type
cells	cell_type
.	O
Furthermore,	O
nuclear	O
extracts	O
from	O
Ipr	cell_line
CD4-8-	cell_line
T	cell_line
cells	cell_line
display	O
high	O
levels	O
of	O
a	O
novel	O
specific	O
binding	O
activity	O
at	O
the	O
NF-AT	DNA
site	DNA
,	O
which	O
is	O
present	O
at	O
much	O
lower	O
levels	O
in	O
freshly	O
isolated	O
normal	cell_type
T	cell_type
lymphocytes	cell_type
.	O
Upon	O
mitogenic	O
stimulation	O
,	O
the	O
binding	O
activity	O
of	O
the	O
novel	O
NF-AT	protein
-binding	protein
factor	protein
is	O
rapidly	O
down-regulated	O
in	O
normal	O
T	cell_type
cells	cell_type
,	O
but	O
persists	O
at	O
high	O
levels	O
in	O
Ipr	cell_line
CD4-8-	cell_line
T	cell_line
cells	cell_line
.	O
These	O
two	O
abnormalities	O
at	O
the	O
NF-AT	DNA
site	DNA
provide	O
a	O
potential	O
mechanism	O
to	O
account	O
for	O
the	O
defect	O
in	O
IL-2	protein
production	O
from	O
Ipr	cell_line
CD4-8-	cell_line
T	cell_line
cells	cell_line
.	O

Cross-linking	O
of	O
CD30	protein
induces	O
HIV	O
expression	O
in	O
chronically	O
infected	O
T	cell_type
cells	cell_type
.	O
CD30	protein
,	O
a	O
member	O
of	O
the	O
tumor	O
necrosis	O
factor	O
(TNF)	O
receptor	O
family,	O
is	O
expressed	O
constitutively	O
on	O
the	O
surface	O
of	O
the	O
human	O
T	O
cell	O
line	O
ACH-2,	O
which	O
is	O
chronically	O
infected	O
with	O
human	O
immunodeficiency	O
virus	O
type-1	O
(	O
HIV	O
)-1.	O
We	O
demonstrate	O
that	O
cross-linking	O
CD30	protein
with	O
an	O
anti-	O
CD30	protein
-specific	O
monoclonal	O
antibody,	O
which	O
mimics	O
the	O
described	O
biological	O
activities	O
of	O
the	O
CD30	protein
ligand	protein
(	O
CD30L	protein
),	O
results	O
in	O
HIV	O
expression	O
.	O
CD30	protein
cross-linking	O
does	O
not	O
alter	O
proliferation	O
of	O
ACH-2	cell_line
cells	cell_line
and	O
the	O
induction	O
of	O
HIV	O
expression	O
is	O
not	O
mediated	O
by	O
endogenous	O
TNF	protein
alpha/beta	protein
.	O
Furthermore,	O
cross-linking	O
of	O
CD30	protein
leads	O
to	O
NF-kappa	protein
B	protein
activation	O
and	O
enhanced	O
HIV	O
transcription	O
.	O
Thus,	O
CD30	protein
-CD30L	protein
interactions	O
mediate	O
the	O
induction	O
of	O
HIV	O
expression	O
by	O
a	O
kappa	O
B-dependent	O
pathway	O
that	O
is	O
independent	O
of	O
TNF	protein
.	O
This	O
mechanism	O
may	O
be	O
important	O
in	O
the	O
activation	O
of	O
HIV	O
expression	O
from	O
latently	O
infected	O
CD4+	cell_line
T	cell_line
cells	cell_line
,	O
especially	O
in	O
lymphoid	O
organs	O
where	O
cell	O
to	O
cell	O
contact	O
is	O
conducive	O
to	O
receptor-ligand	O
interactions	O
.	O

Human	O
MHC	DNA
class	DNA
II	DNA
gene	DNA
transcription	O
directed	O
by	O
the	O
carboxyl	protein
terminus	protein
of	O
CIITA	DNA
,	O
one	O
of	O
the	O
defective	DNA
genes	DNA
in	O
type	O
II	O
MHC	protein
combined	O
immune	O
deficiency	O
.	O
Type	protein
II	protein
major	protein
histocompatibility	protein
complex	protein
combined	O
immune	O
deficiency	O
(	O
type	O
II	O
MHC	protein
CID	O
or	O
bare	O
lymphocyte	O
syndrome	O
)	O
is	O
a	O
congenital	O
immunodeficiency	O
disease	O
characterized	O
by	O
absent	O
MHC	protein
class	protein
II	protein
expression	O
.	O
Four	O
distinct	O
complementation	O
groups	O
have	O
been	O
identified.	O
Recently,	O
the	O
defective	DNA
gene	DNA
in	O
group	O
II	O
type	O
II	O
MHC	protein
CID	O
has	O
been	O
isolated	O
and	O
termed	O
CIITA	DNA
.	O
Here,	O
we	O
demonstrate	O
that	O
CIITA	DNA
is	O
an	O
MHC	DNA
class	DNA
II	DNA
gene-specific	DNA
transcription	DNA
activator	DNA
.	O
The	O
transcription	O
activation	O
function	O
is	O
provided	O
by	O
the	O
N-terminal	protein
acidic	protein
domain	protein
(	O
amino	protein
acids	protein
26-137	protein
),	O
which	O
is	O
experimentally	O
exchangeable	O
with	O
a	O
heterologous	protein
viral	protein
transcription-activating	protein
domain	protein
.	O
The	O
specificity	O
of	O
CIITA	protein
for	O
three	O
major	O
MHC	DNA
class	DNA
II	DNA
genes	DNA
,	O
DR	DNA
,	O
DQ	DNA
and	O
DP	DNA
,	O
is	O
mediated	O
by	O
its	O
remaining	O
C-terminal	protein
residues	protein
(	O
amino	protein
acids	protein
317-1130	protein
).	O
The	O
transactivation	O
of	O
multiple	DNA
cis	DNA
elements	DNA
,	O
especially	O
S	DNA
and	O
X2	DNA
,	O
of	O
the	O
DR	DNA
alpha	DNA
proximal	DNA
promoter	DNA
in	O
group	cell_line
II	cell_line
CID	cell_line
cells	cell_line
is	O
CIITA	protein
dependent.	O
Since	O
CIITA	protein
overexpression	O
in	O
normal	cell_type
cells	cell_type
did	O
not	O
increase	O
class	O
II	O
expression	O
,	O
we	O
propose	O
that	O
initiation	O
of	O
CIITA	protein
expression	O
serves	O
as	O
the	O
on-off	O
switch,	O
while	O
availability	O
of	O
downstream	O
interactor	O
(s)	O
limits	O
transcription	O
.	O

Monocyte	O
tethering	O
by	O
P-selectin	protein
regulates	O
monocyte	protein
chemotactic	protein
protein-1	protein
and	O
tumor	protein
necrosis	protein
factor-alpha	protein
secretion	O
.	O
Signal	O
integration	O
and	O
NF-kappa	protein
B	protein
translocation	O
[see	O
comments]	O
Adhesion	protein
molecules	protein
that	O
tether	O
circulating	cell_type
leukocytes	cell_type
to	O
endothelial	cell_type
cells	cell_type
may	O
also	O
transduce	O
or	O
modulate	O
outside-in	O
signals	O
for	O
cellular	O
activation	O
,	O
providing	O
an	O
initial	O
regulatory	O
point	O
in	O
the	O
inflammatory	O
response	O
.	O
Adhesion	O
of	O
human	cell_type
monocytes	cell_type
to	O
P-selectin	protein
,	O
the	O
most	O
rapidly	O
expressed	O
endothelial	protein
tethering	protein
factor	protein
,	O
increased	O
the	O
secretion	O
of	O
monocyte	protein
chemotactic	protein
protein-1	protein
(	O
MCP-1	protein
)	O
and	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
)	O
by	O
the	O
leukocytes	cell_type
when	O
they	O
were	O
stimulated	O
with	O
platelet-activating	protein
factor	protein
.	O
Increased	O
cytokine	O
secretion	O
was	O
specifically	O
inhibited	O
by	O
G1	protein
,	O
an	O
anti-	protein
P-selectin	protein
mAb	protein
that	O
prevents	O
P-selectin	protein
from	O
binding	O
to	O
its	O
ligand	O
(	O
P-selectin	protein
glycoprotein	protein
ligand-1	protein
)	O
on	O
myeloid	cell_type
cells	cell_type
.	O
Moreover,	O
tethering	O
by	O
P-selectin	protein
specifically	O
enhanced	O
nuclear	O
translocation	O
of	O
nuclear	protein
factor-kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
),	O
a	O
transcription	protein
factor	protein
required	O
for	O
expression	O
of	O
MCP-1	protein
,	O
TNF-alpha	protein
,	O
and	O
other	O
immediate-early	DNA
genes	DNA
.	O
These	O
results	O
demonstrate	O
that	O
P-selectin	protein
,	O
through	O
its	O
ligands	O
on	O
monocytes	cell_type
,	O
may	O
locally	O
regulate	O
cytokine	protein
secretion	O
in	O
inflamed	O
tissues	O
.	O

Functional	O
roles	O
of	O
in	DNA
vivo	DNA
footprinted	DNA
DNA	DNA
motifs	DNA
within	O
an	O
alpha-globin	DNA
enhancer	DNA
.	O
Erythroid	O
lineage	O
and	O
developmental	O
stage	O
specificities.	O
Transcriptional	O
regulation	O
of	O
the	O
human	DNA
alpha-like	DNA
globin	DNA
genes	DNA
,	O
embryonic	DNA
zeta	DNA
2	DNA
and	O
adult	DNA
alpha	DNA
,	O
during	O
erythroid	O
development	O
is	O
mediated	O
by	O
a	O
distal	DNA
enhancer	DNA
,	O
HS-40	DNA
.	O
Previous	O
protein-DNA	O
binding	O
studies	O
have	O
shown	O
that	O
HS-40	DNA
consists	O
of	O
multiple	O
nuclear	DNA
factor	DNA
binding	DNA
motifs	DNA
that	O
are	O
occupied	O
in	O
vivo	O
in	O
an	O
erythroid	O
lineage-	O
and	O
developmental	O
stage-	O
specific	O
manner	O
.	O
We	O
have	O
systematically	O
analyzed	O
the	O
functional	O
roles	O
of	O
these	O
factor	DNA
binding	DNA
motifs	DNA
of	O
HS-40	DNA
by	O
site-directed	O
mutagenesis	O
and	O
transient	O
expression	O
assay	O
in	O
erythroid	cell_line
cell	cell_line
cultures	cell_line
.	O
Three	O
of	O
these	O
HS-40	DNA
enhancer	DNA
motifs	DNA
,	O
5'NF-E2/AP1	DNA
,	O
GT	DNA
II	DNA
,	O
and	O
GATA-1(c)	DNA
,	O
positively	O
regulate	O
the	O
zeta	DNA
2-globin	DNA
promoter	DNA
activity	O
in	O
embryonic/fetal	cell_line
erythroid	cell_line
K562	cell_line
cells	cell_line
and	O
the	O
adult	DNA
alpha	DNA
-globin	DNA
promoter	DNA
activity	O
in	O
adult	cell_line
erythroid	cell_line
MEL	cell_line
cells	cell_line
.	O
On	O
the	O
other	O
hand,	O
the	O
3'NF-E2/AP1	DNA
motif	DNA
is	O
able	O
to	O
exert	O
both	O
positive	O
and	O
negative	O
regulatory	O
effects	O
on	O
the	O
zeta	DNA
2-globin	DNA
promoter	DNA
activity	O
in	O
K562	cell_line
cells	cell_line
,	O
and	O
this	O
dual	O
function	O
appears	O
to	O
be	O
modulated	O
through	O
differential	O
binding	O
of	O
the	O
ubiquitous	protein
AP1	protein
factors	protein
and	O
the	O
erythroid-enriched	protein
NF-E2	protein
factor	protein
.	O
Mutation	O
in	O
the	O
GATA-1(d)	DNA
motif	DNA
,	O
which	O
exhibits	O
an	O
adult	DNA
erythroid-specific	DNA
genomic	DNA
footprint	DNA
,	O
decreases	O
the	O
HS-40	DNA
enhancer	DNA
function	O
in	O
dimethyl	cell_line
sulfoxide-induced	cell_line
MEL	cell_line
cells	cell_line
but	O
not	O
in	O
K562	cell_line
cells	cell_line
.	O
These	O
studies	O
have	O
defined	O
the	O
regulatory	O
roles	O
of	O
the	O
different	O
HS-40	DNA
motifs	DNA
.	O
The	O
remarkable	O
correlation	O
between	O
genomic	O
footprinting	O
data	O
and	O
the	O
mutagenesis	O
results	O
also	O
suggests	O
that	O
the	O
erythroid	O
lineage-	O
and	O
developmental	O
stage-	O
specific	O
regulation	O
of	O
human	DNA
alpha-like	DNA
globin	DNA
promoters	DNA
is	O
indeed	O
modulated	O
by	O
stable	O
binding	O
of	O
specific	protein
nuclear	protein
factors	protein
in	O
vivo.	O

Nitric	O
oxide	O
-stimulated	O
guanine	O
nucleotide	O
exchange	O
on	O
p21ras	protein
.	O
The	O
protooncogene	DNA
p21ras	DNA
,	O
a	O
monomeric	protein
G	protein
protein	protein
family	protein
member	protein
,	O
plays	O
a	O
critical	O
role	O
in	O
converting	O
extracellular	O
signals	O
into	O
intracellular	O
biochemical	O
events	O
.	O
Here,	O
we	O
report	O
that	O
nitric	O
oxide	O
(	O
NO	O
)	O
activates	O
p21ras	DNA
in	O
human	cell_type
T	cell_type
cells	cell_type
as	O
evidenced	O
by	O
an	O
increase	O
in	O
GTP	protein
-bound	protein
p21ras	protein
.	O
In	O
vitro	O
studies	O
using	O
pure	protein
recombinant	protein
p21ras	protein
demonstrate	O
that	O
the	O
activation	O
is	O
direct	O
and	O
reversible.	O
Circular	O
dichroism	O
analysis	O
reveals	O
that	O
NO	O
induces	O
a	O
profound	O
conformational	O
change	O
in	O
p21ras	DNA
in	O
association	O
with	O
GDP	O
/GTP	O
exchange	O
.	O
The	O
mechanism	O
of	O
activation	O
is	O
due	O
to	O
S-nitrosylation	O
of	O
a	O
critical	O
cysteine	O
residue	O
which	O
stimulates	O
guanine	O
nucleotide	O
exchange.	O
Furthermore,	O
we	O
demonstrate	O
that	O
p21ras	protein
is	O
essential	O
for	O
NO	O
-induced	O
downstream	O
signaling	O
,	O
such	O
as	O
NF-kappa	protein
B	protein
activation	O
,	O
and	O
that	O
endogenous	O
NO	O
can	O
activate	O
p21ras	protein
in	O
the	O
same	O
cell.	O
These	O
studies	O
identify	O
p21ras	DNA
as	O
a	O
target	O
of	O
the	O
same	O
cell.	O
These	O
studies	O
identify	O
p21ras	DNA
as	O
a	O
target	O
of	O
NO	O
in	O
T	cell_type
cells	cell_type
and	O
suggest	O
that	O
NO	O
activates	O
p21ras	DNA
by	O
an	O
action	O
which	O
mimics	O
that	O
of	O
guanine	protein
nucleotide	protein
exchange	protein
factors	protein
.	O

Interleukin-2	DNA
promoter	DNA
activity	O
in	O
Epstein-Barr	cell_line
virus	cell_line
-transformed	cell_line
B	cell_line
lymphocytes	cell_line
is	O
controlled	O
by	O
nuclear	protein
factor-chi	protein
B	protein
.	O
The	O
regulation	O
of	O
interleukin	DNA
(IL)-2	DNA
gene	DNA
expression	O
has	O
been	O
investigated	O
mainly	O
in	O
T	cell_type
lymphocytes	cell_type
,	O
the	O
predominant	O
producers	O
of	O
IL-2	protein
.	O
However,	O
B	cell_type
cells	cell_type
can	O
also	O
synthesize	O
IL-2	protein
.	O
In	O
the	O
present	O
study	O
we	O
analyzed	O
the	O
control	O
of	O
IL-2	DNA
promoter	DNA
activity	O
in	O
Epstein-Barr	cell_line
virus	cell_line
(	cell_line
EBV	cell_line
)-transformed	cell_line
B	cell_line
cell	cell_line
clones	cell_line
which	O
are	O
capable	O
of	O
secreting	O
IL-2	protein
at	O
a	O
low	O
level	O
after	O
stimulation	O
with	O
phorbol	O
12-myristate	O
13-acetate	O
and	O
the	O
Ca2+	O
ionophore	O
ionomycin	O
.	O
Transient	O
transfections	O
using	O
reporter	DNA
constructs	DNA
with	O
multiples	O
of	O
transcription	DNA
factor	DNA
binding	DNA
sites	DNA
from	O
the	O
IL-2	DNA
promoter	DNA
[	O
distal	protein
nuclear	protein
factor	protein
(NF)-AT	protein
,	O
proximal	protein
NF-AT	protein
,	O
AP-1/Octamer	protein
(	O
UPS	protein
)	O
or	O
NF-chi	protein
B	protein
(	O
TCEd	protein
)	O
sites]	O
were	O
performed.	O
In	O
EBV-transformed	cell_line
B	cell_line
clones	cell_line
,	O
the	O
chi	DNA
B	DNA
site	DNA
exerted	O
the	O
strongest	O
inducible	O
activity	O
;	O
the	O
NF-AT	DNA
binding	DNA
sites	DNA
showed	O
either	O
no	O
or	O
only	O
weak	O
activity	O
compared	O
to	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
An	O
IL-2	DNA
promoter	DNA
bearing	O
a	O
defective	O
NF-	DNA
chi	DNA
B	DNA
site	DNA
was	O
completely	O
inactive	O
in	O
EBV-transformed	cell_line
B	cell_line
cells	cell_line
,	O
while	O
it	O
still	O
had	O
activity	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
In	O
seven	O
EBV-B	cell_line
cell	cell_line
clones	cell_line
or	O
lines	O
differing	O
in	O
their	O
capacity	O
to	O
secrete	O
IL-2	protein
,	O
the	O
activity	O
of	O
the	O
IL-2	DNA
promoter	DNA
correlated	O
well	O
with	O
the	O
status	O
of	O
IL-2	protein
secretion	O
.	O
Similarly,	O
a	O
human	DNA
immunodeficiency	DNA
virus	DNA
promoter	DNA
,	O
whose	O
activity	O
is	O
controlled	O
through	O
chi	protein
B	protein
factors	protein
,	O
was	O
found	O
to	O
be	O
active	O
in	O
the	O
IL-2	cell_line
producing	cell_line
EBV-	cell_line
B	cell_line
cells	cell_line
,	O
but	O
inactive	O
in	O
the	O
non-	cell_line
IL-2	cell_line
-producing	cell_line
cells	cell_line
.	O
Electrophoretic	O
mobility	O
shift	O
assays	O
using	O
protein	protein
extracts	protein
from	O
EBV-	cell_line
B	cell_line
cells	cell_line
and	O
the	O
IL-2	protein
NF-chi	protein
B	protein
probe	O
revealed	O
the	O
constitutive	O
generation	O
of	O
chi	protein
B	protein
complexes	protein
in	O
IL-2	cell_line
-secreting	cell_line
cells	cell_line
consisting	O
mainly	O
of	O
heterodimeric	protein
p50/p65	protein
complexes	protein
.	O
A	O
weaker	O
chi	DNA
B	DNA
complex	O
formation	O
and	O
faster-migrating	O
complexes	O
were	O
detected	O
in	O
non-	cell_line
IL-2	cell_line
-secreting	cell_line
cells	cell_line
.	O
These	O
results	O
demonstrate	O
that	O
the	O
IL-2	DNA
NF-chi	DNA
B	DNA
site	DNA
is	O
indispensable	O
for	O
the	O
activity	O
of	O
the	O
IL-2	DNA
promoter	DNA
in	O
EBV-transformed	cell_line
B	cell_line
cells	cell_line
,	O
whereas	O
other	O
transcription	protein
factors	protein
appear	O
to	O
be	O
less	O
important	O
for	O
IL-2	protein
expression	O
in	O
these	O
cells.	O

Latent	protein
membrane	protein
protein-1	protein
induces	O
cyclin	protein
D2	protein
expression	O
,	O
pRb	protein
hyperphosphorylation	O
,	O
and	O
loss	O
of	O
TGF-beta	protein
1	protein
-mediated	O
growth	O
inhibition	O
in	O
EBV-positive	cell_type
B	cell_type
cells	cell_type
.	O
The	O
normal	O
cell	O
cycle	O
is	O
regulated	O
by	O
several	O
molecules,	O
such	O
as	O
the	O
tumor-suppressor	protein
protein	protein
pRb	protein
,	O
the	O
G1	protein
cyclins	protein
,	O
the	O
cyclin-dependent	protein
kinases	protein
,	O
and	O
their	O
inhibitors	O
.	O
These	O
regulators	O
are	O
targeted	O
by	O
negative	O
growth	O
regulatory	O
signals	O
,	O
such	O
as	O
that	O
provided	O
by	O
TGF-beta	protein
.	O
Here,	O
we	O
show	O
that	O
the	O
presence	O
of	O
either	O
wild-type	O
EBV	O
or	O
its	O
transforming	protein
latent	protein
membrane	protein
protein-1	protein
(	O
LMP-1	protein
)	O
results	O
in	O
the	O
loss	O
of	O
TGF-beta	protein
1	protein
-mediated	O
growth	O
inhibition	O
in	O
human	cell_type
B	cell_type
cells	cell_type
.	O
Chemical	O
cross-linking	O
with	O
125I-labeled	protein
TGF-beta	protein
1	protein
showed	O
an	O
essentially	O
normal	O
TGF-beta	protein
receptor	protein
profile	O
in	O
EBV-positive	O
and	O
EBV-negative	O
Burkitt's	O
lymphoma	O
cell	O
lines	O
,	O
and	O
these	O
receptors	O
were	O
shown	O
to	O
be	O
functional	O
in	O
transducing	O
signals	O
,	O
as	O
evidenced	O
by	O
the	O
TGF-beta	protein
1	protein
-mediated	O
modulation	O
of	O
junB	DNA
gene	DNA
expression	O
.	O
However,	O
TGF-beta	protein
1	protein
did	O
not	O
induce	O
dephosphorylation	O
of	O
pRb	protein
in	O
EBV	cell_line
(or	cell_line
LMP-1	cell_line
)-positive	cell_line
cells	cell_line
as	O
opposed	O
to	O
EBV	cell_line
-negative	cell_line
cells	cell_line
,	O
suggesting	O
a	O
dichotomy	O
in	O
the	O
TGF-beta	protein
1	protein
signaling	O
pathway	O
leading	O
to	O
separable	O
gene	O
regulatory	O
and	O
growth	O
inhibitory	O
responses	O
.	O
Furthermore,	O
LMP-1	protein
was	O
found	O
to	O
induce	O
the	O
expression	O
of	O
cyclin	protein
D2	protein
;	O
normal	O
B	cell_type
cells	cell_type
or	O
EBV	cell_line
-negative	cell_line
Burkitt's	cell_line
lymphoma	cell_line
cells	cell_line
do	O
not	O
express	O
D-type	protein
cyclins	protein
.	O
Taken	O
together,	O
these	O
data	O
point	O
to	O
a	O
potential	O
mechanism	O
underlying	O
EBV	O
-mediated	O
B	O
cell	O
transformation	O
whereby	O
constitutive	O
induction	O
of	O
key	protein
cell	protein
cycle	protein
regulators	protein
by	O
LMP-1	protein
can	O
lead	O
to	O
pRb	protein
hyperphosphorylation	O
and	O
uncontrolled	O
cell	O
proliferation	O
.	O

Does	O
thyroidectomy	O
,	O
radioactive	O
iodine	O
therapy	O
,	O
or	O
antithyroid	O
drug	O
treatment	O
alter	O
reactivity	O
of	O
patients'	O
T	cell_type
cells	cell_type
to	O
epitopes	O
of	O
thyrotropin	protein
receptor	protein
in	O
autoimmune	O
thyroid	O
diseases	O
?	O
The	O
effect	O
of	O
treatment	O
on	O
thyroid	O
antibody	O
production	O
and	O
T	O
cell	O
reactivity	O
to	O
thyroid	O
antigens	O
was	O
studied	O
in	O
15	O
patients	O
with	O
Graves'	O
disease	O
(	O
GD	O
)	O
before	O
and	O
after	O
thyroidectomy	O
,	O
19	O
patients	O
with	O
GD	O
before	O
and	O
after	O
radioactive	O
iodine	O
(RAI)	O
therapy,	O
and	O
9	O
patients	O
maintained	O
euthyroid	O
on	O
antithyroid	O
drugs	O
(	O
ATD	O
).	O
Twenty	O
subjects	O
matched	O
for	O
age	O
and	O
sex	O
without	O
known	O
thyroid	O
disease	O
served	O
as	O
controls.	O
In	O
GD	O
patients	O
,	O
the	O
responses	O
of	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
)	O
and	O
TSH	cell_line
receptor	cell_line
(	cell_line
TSHR	cell_line
)-specific	cell_line
T	cell_line
cell	cell_line
lines	cell_line
to	O
recombinant	protein
human	protein
TSHR	protein
extracellular	protein
domain	protein
,	O
thyroglobulin	protein
,	O
and	O
TSHR	protein
peptides	O
were	O
examined	O
on	O
the	O
day	O
of	O
surgery	O
or	O
RAI	O
therapy	O
(day	O
0)	O
and	O
also	O
6-8	O
weeks	O
and	O
3-6	O
months	O
thereafter.	O
Reactivity	O
to	O
TSHR	protein
peptides	O
before	O
surgery	O
was	O
heterogeneous	O
and	O
spanned	O
the	O
entire	O
extracellular	protein
domain	protein
.	O
Six	O
to	O
8	O
weeks	O
after	O
subtotal	O
thyroidectomy	O
,	O
the	O
number	O
of	O
patients	O
'	O
PBMC	cell_type
responding	O
to	O
any	O
peptide	O
and	O
the	O
average	O
number	O
of	O
recognized	O
peptides	O
decreased.	O
A	O
further	O
decrease	O
in	O
the	O
T	O
cell	O
reactivity	O
to	O
TSHR	protein
peptides	O
was	O
observed	O
3-6	O
months	O
after	O
surgery	O
.	O
The	O
responses	O
of	O
PBMC	cell_type
from	O
Graves'	O
patients	O
before	O
RAI	O
therapy	O
were	O
less	O
than	O
those	O
in	O
the	O
presurgical	O
group.	O
Six	O
to	O
8	O
weeks	O
after	O
RAI	O
therapy	O
,	O
the	O
number	O
of	O
patients	O
responding	O
to	O
any	O
peptide	O
and	O
the	O
average	O
number	O
of	O
recognized	O
peptides	O
increased.	O
Three	O
to	O
6	O
months	O
after	O
RAI	O
,	O
T	O
cell	O
responses	O
to	O
TSHR	protein
peptides	O
were	O
less	O
than	O
those	O
6-8	O
weeks	O
after	O
RAI	O
therapy	O
,	O
but	O
still	O
higher	O
than	O
the	O
values	O
on	O
day	O
0.	O
Responses	O
of	O
PBMC	cell_type
from	O
patients	O
with	O
GD	O
,	O
maintained	O
euthyroid	O
on	O
ATD	O
,	O
were	O
lower	O
than	O
those	O
before	O
surgery	O
or	O
RAI	O
therapy	O
.	O
The	O
reactivity	O
of	O
T	cell_line
cell	cell_line
lines	cell_line
in	O
different	O
groups	O
reflected	O
a	O
pattern	O
similar	O
to	O
PBMC	cell_type
after	O
treatment.	O
TSHR	protein
antibody	protein
and	O
microsomal	protein
antibody	protein
levels	O
decreased	O
after	O
surgery	O
,	O
but	O
increased	O
after	O
RAI	O
therapy	O
.	O
The	O
difference	O
in	O
the	O
number	O
of	O
recognized	O
peptides	O
by	O
patients	O
'	O
PBMC	cell_type
before	O
RAI	O
and	O
surgery	O
may	O
reflect	O
the	O
effect	O
of	O
long	O
term	O
therapy	O
with	O
ATD	O
in	O
the	O
patients	O
before	O
RAI	O
vs.	O
the	O
shorter	O
period	O
in	O
patients	O
before	O
surgery	O
.	O
The	O
decreased	O
T	O
cell	O
reactivity	O
to	O
thyroid	protein
antigens	protein
after	O
thyroidectomy	O
could	O
be	O
the	O
result	O
of	O
removal	O
of	O
a	O
major	O
part	O
of	O
the	O
thyroid	O
gland	O
or	O
redistribution	O
of	O
suppressor-inducer	O
T	cell_type
cells	cell_type
.	O
The	O
increased	O
T	O
cell	O
response	O
after	O
RAI	O
therapy	O
is	O
probably	O
epitope	O
specific	O
,	O
rather	O
than	O
a	O
response	O
to	O
the	O
whole	O
TSHR	protein
molecule.	O
Synchronous	O
recognition	O
of	O
peptides	O
158-176	O
and	O
248-263	O
is	O
important	O
for	O
the	O
development	O
of	O
GD	O
,	O
and	O
the	O
loss	O
of	O
recognition	O
of	O
one	O
of	O
these	O
epitopes	protein
may	O
be	O
an	O
early	O
sign	O
of	O
immune	O
remission	O
and	O
a	O
predictor	O
of	O
euthyroidism	O
.	O

Circumvention	O
of	O
tolerance	O
for	O
the	O
nuclear	protein
T	protein
cell	protein
protein	protein
TCF-1	protein
by	O
immunization	O
of	O
TCF-1	protein
knock-out	O
mice	O
.	O
Molecular	O
events	O
that	O
underlie	O
the	O
well-defined	O
phenotypic	O
changes	O
of	O
the	O
differentiating	cell_type
thymocyte	cell_type
are	O
poorly	O
understood.	O
A	O
candidate	O
gene	O
to	O
control	O
thymocyte	cell_type
differentiation	O
,	O
T	protein
cell	protein
factor-1	protein
(	O
TCF-1	protein
)*	O
encodes	O
a	O
DNA-binding	protein
protein	protein
.	O
Its	O
mRNA	O
expression	O
pattern	O
is	O
complex	O
during	O
embryogenesis	O
,	O
yet	O
restricted	O
to	O
lymphocytes	cell_type
postnatally.	O
Expression	O
studies	O
on	O
TCF-1	protein
protein	protein
have	O
been	O
hampered	O
by	O
the	O
difficulty	O
to	O
raise	O
antibodies	protein
due	O
to	O
extreme	O
evolutionary	O
conservation.	O
TCF-1	protein
knock-out	O
mice	O
,	O
generated	O
recently	O
in	O
our	O
laboratory,	O
have	O
strongly	O
decreased	O
numbers	O
of	O
thymocytes	cell_type
,	O
but	O
are	O
otherwise	O
normal.	O
We	O
have	O
used	O
these	O
mice	O
to	O
generate	O
anti-	protein
TCF-1	protein
antibodies	protein
.	O
By	O
immunization	O
with	O
a	O
recombinant	protein
fusion	protein
protein	protein
,	O
we	O
show	O
that	O
TCF-1	protein
knock-out	O
mice	O
readily	O
yield	O
antiserum	O
titers	O
against	O
human	O
and	O
mouse	O
TCF-1	O
protein	O
.	O
Wild-type	O
littermates	O
remain	O
unresponsive	O
to	O
TCF-1	protein
while	O
they	O
mount	O
a	O
high-titer	O
antibody	O
response	O
to	O
the	O
fusion	protein
protein	protein
,	O
Maltose	protein
Binding	protein
Protein	protein
(	O
MBP	protein
).	O
Subsequently,	O
TCF-1	cell_line
-specific	cell_line
hybridomas	cell_line
could	O
be	O
prepared	O
from	O
the	O
spleens	O
of	O
immunized	O
knock-out	O
mice	O
.	O
This	O
study	O
illustrates	O
the	O
almost	O
complete	O
tolerance	O
of	O
mice	O
for	O
human	protein
TCF-1	protein
and	O
demonstrates	O
that	O
this	O
tolerance	O
is	O
readily	O
broken	O
by	O
gene	O
knock-out	O
.	O
Furthermore,	O
the	O
usefulness	O
of	O
knock-out	O
mice	O
for	O
the	O
generation	O
of	O
monoclonal	protein
antibodies	protein
against	O
the	O
gene	O
product	O
of	O
interest	O
is	O
underscored.	O

The	O
transcription	protein
factor	protein
,	O
Nm23H2	protein
,	O
binds	O
to	O
and	O
activates	O
the	O
translocated	O
c-myc	DNA
allele	DNA
in	O
Burkitt's	O
lymphoma	O
.	O
We	O
have	O
identified	O
an	O
in	O
vivo	O
footprint	O
over	O
the	O
PuF	DNA
site	DNA
on	O
the	O
translocated	O
c-myc	DNA
allele	DNA
in	O
Burkitt's	O
lymphoma	O
cells.	O
The	O
PuF	DNA
site	DNA
on	O
the	O
silent	DNA
normal	DNA
c-myc	DNA
allele	DNA
was	O
unoccupied.	O
We	O
demonstrated	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
electrophoretic	O
mobility	O
shift	O
assay	O
with	O
antibody,	O
UV	O
cross-linking	O
followed	O
by	O
SDS-gel	O
electrophoresis	O
,	O
and	O
Western	O
analysis	O
that	O
Nm23H2	protein
in	O
B	O
cell	O
nuclear	O
extracts	O
bound	O
to	O
the	O
c-myc	O
PuF	DNA
site	DNA
.	O
Transfection	O
experiments	O
with	O
c-myc	DNA
promoter	DNA
constructs	DNA
in	O
both	O
DHL-9	cell_line
and	O
Raji	cell_line
cells	cell_line
revealed	O
that	O
the	O
PuF	DNA
site	DNA
functioned	O
as	O
a	O
positive	DNA
regulatory	DNA
element	DNA
in	O
B	cell_type
cells	cell_type
with	O
a	O
drop	O
in	O
activity	O
with	O
mutation	O
of	O
this	O
site.	O
Access	O
to	O
this	O
site	O
is	O
blocked	O
in	O
the	O
normal	DNA
silent	DNA
c-myc	DNA
allele	DNA
;	O
these	O
data	O
suggest	O
that	O
the	O
Nm23H2	protein
protein	O
is	O
involved	O
in	O
deregulation	O
of	O
the	O
translocated	O
c-myc	DNA
allele	DNA
in	O
Burkitt's	cell_line
lymphoma	cell_line
cells	cell_line
.	O

Identification	O
of	O
two	O
novel	O
regulatory	DNA
elements	DNA
within	O
the	O
5'-untranslated	DNA
region	DNA
of	O
the	O
human	DNA
A	DNA
gamma-globin	DNA
gene	DNA
.	O
Interaction	O
between	O
the	O
stage	DNA
selector	DNA
element	DNA
(	O
SSE	DNA
)	O
in	O
the	O
proximal	DNA
gamma-globin	DNA
promoter	DNA
and	O
hypersensitivity	DNA
site	DNA
2	DNA
in	O
the	O
locus	DNA
control	DNA
region	DNA
partly	O
mediates	O
the	O
competitive	O
silencing	O
of	O
the	O
beta-globin	DNA
promoter	DNA
in	O
the	O
fetal	O
developmental	O
stage.	O
We	O
have	O
now	O
demonstrated	O
that	O
a	O
second	O
SSE-like	DNA
element	DNA
in	O
the	O
5'-untranslated	DNA
region	DNA
of	O
the	O
gamma-gene	DNA
also	O
contributes	O
to	O
this	O
competitive	O
silencing	O
of	O
the	O
beta-gene	DNA
.	O
Utilizing	O
transient	O
transfection	O
assays	O
in	O
the	O
fetal	cell_line
erythroid	cell_line
cell	cell_line
line	cell_line
,	O
K562	cell_line
,	O
we	O
have	O
shown	O
that	O
the	O
core	DNA
enhancer	DNA
of	O
hypersensitivity	DNA
site	DNA
2	DNA
can	O
preferentially	O
interact	O
with	O
the	O
proximal	DNA
gamma-promoter	DNA
in	O
the	O
absence	O
of	O
the	O
SSE	DNA
,	O
completely	O
silencing	O
a	O
linked	DNA
beta-promoter	DNA
.	O
Mutation	O
of	O
a	O
20-base	O
pair	O
sequence	O
of	O
the	O
gamma-gene	DNA
5'-untranslated	DNA
region	DNA
(	O
UTR	DNA
)	O
led	O
to	O
derepression	O
of	O
beta-promoter	DNA
activity	O
.	O
A	O
marked	O
activation	O
of	O
gamma-promoter	DNA
activity	O
was	O
also	O
observed	O
with	O
this	O
mutation	O
,	O
suggesting	O
the	O
presence	O
of	O
a	O
repressor.	O
Fine	O
mutagenesis	O
dissected	O
these	O
activities	O
to	O
different	O
regions	O
of	O
the	O
5'-UTR	DNA
.	O
The	O
stage	O
selector	O
activity	O
was	O
localized	O
to	O
a	O
region	O
centered	O
on	O
nucleotides	DNA
+13	DNA
to	DNA
+15	DNA
.	O
Electromobility	O
shift	O
assays	O
utilizing	O
this	O
sequence	O
demonstrated	O
binding	O
of	O
a	O
fetal	O
and	O
erythroid	O
-specific	O
protein	O
.	O
The	O
repressor	O
activity	O
of	O
the	O
5'-UTR	DNA
was	O
localized	O
to	O
tandem	O
GATA-like	DNA
sites	DNA
,	O
which	O
appear	O
to	O
bind	O
a	O
complex	O
of	O
two	O
proteins,	O
one	O
of	O
which	O
is	O
the	O
erythroid	protein
transcription	protein
factor	protein
GATA-1	protein
.	O
These	O
results	O
indicate	O
that	O
the	O
5'-UTR	DNA
of	O
the	O
gamma-gene	DNA
contains	O
sequences	O
that	O
may	O
be	O
important	O
for	O
its	O
transcriptional	O
and	O
developmental	O
regulation	O
.	O

Coupling	O
of	O
a	O
signal	protein
response	protein
domain	protein
in	O
I	protein
kappa	protein
B	protein
alpha	protein
to	O
multiple	O
pathways	O
for	O
NF-kappa	protein
B	protein
activation	O
.	O
The	O
eukaryotic	protein
transcription	protein
factor	protein
NF-kappa	protein
B	protein
plays	O
a	O
central	O
role	O
in	O
the	O
induced	O
expression	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
and	O
in	O
many	O
aspects	O
of	O
the	O
genetic	O
program	O
mediating	O
normal	O
T-cell	O
activation	O
and	O
growth	O
.	O
The	O
nuclear	O
activity	O
of	O
NF-kappa	protein
B	protein
is	O
tightly	O
regulated	O
from	O
the	O
cytoplasmic	O
compartment	O
by	O
an	O
inhibitory	protein
subunit	protein
called	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
This	O
cytoplasmic	O
inhibitor	O
is	O
rapidly	O
phosphorylated	O
and	O
degraded	O
in	O
response	O
to	O
a	O
diverse	O
set	O
of	O
NF-kappa	protein
B	protein
-inducing	protein
agents	protein
,	O
including	O
T-cell	protein
mitogens,	protein
proinflammatory	protein
cytokines	protein
,	O
and	O
viral	protein
transactivators	protein
such	O
as	O
the	O
Tax	protein
protein	protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
.	O
To	O
explore	O
these	O
I	protein
kappa	protein
B	protein
alpha	protein
-dependent	O
mechanisms	O
for	O
NF-kappa	protein
B	protein
induction	O
,	O
we	O
identified	O
novel	O
mutants	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
that	O
uncouple	O
its	O
inhibitory	O
and	O
signal-transducing	O
functions	O
in	O
human	cell_type
T	cell_type
lymphocytes	cell_type
.	O
Specifically,	O
removal	O
of	O
the	O
N-terminal	protein
36	protein
amino	protein
acids	protein
of	O
I	protein
kappa	protein
B	protein
alpha	protein
failed	O
to	O
disrupt	O
its	O
ability	O
to	O
form	O
latent	O
complexes	O
with	O
NF-kappa	protein
B	protein
in	O
the	O
cytoplasm	O
.	O
However,	O
this	O
deletion	O
mutation	O
prevented	O
the	O
induced	O
phosphorylation	O
,	O
degradative	O
loss	O
,	O
and	O
functional	O
release	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
from	O
NF-kappa	protein
B	protein
in	O
Tax	cell_line
-expressing	cell_line
cells	cell_line
.	O
Alanine	O
substitutions	O
introduced	O
at	O
two	O
serine	O
residues	O
positioned	O
within	O
this	O
N-terminal	protein
regulatory	protein
region	protein
of	O
I	protein
kappa	protein
B	protein
alpha	protein
also	O
yielded	O
constitutive	O
repressors	O
that	O
escaped	O
from	O
Tax	protein
-induced	O
turnover	O
and	O
that	O
potently	O
inhibited	O
immune	O
activation	O
pathways	O
for	O
NF-kappa	protein
B	protein
induction	O
,	O
including	O
those	O
initiated	O
from	O
antigen	O
and	O
cytokine	O
receptors	O
.	O
In	O
contrast,	O
introduction	O
of	O
a	O
phosphoserine	O
mimetic	O
at	O
these	O
sites	O
rectified	O
this	O
functional	O
defect,	O
a	O
finding	O
consistent	O
with	O
a	O
causal	O
linkage	O
between	O
the	O
phosphorylation	O
status	O
and	O
proteolytic	O
stability	O
of	O
this	O
cytoplasmic	protein
inhibitor	protein
.	O
Together,	O
these	O
in	O
vivo	O
studies	O
define	O
a	O
critical	O
signal	O
response	O
domain	O
in	O
I	protein
kappa	protein
B	protein
alpha	protein
that	O
coordinately	O
controls	O
the	O
biologic	O
activities	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
and	O
NF-kappa	protein
B	protein
in	O
response	O
to	O
viral	O
and	O
immune	O
stimuli	O
.	O

Growth	O
regulation	O
and	O
cellular	O
changes	O
during	O
differentiation	O
of	O
human	cell_line
prostatic	cell_line
cancer	cell_line
LNCaP	cell_line
cells	cell_line
as	O
induced	O
by	O
T	O
lymphocyte-conditioned	O
medium	O
.	O
Human	cell_line
prostatic	cell_line
epithelial	cell_line
cells	cell_line
from	O
an	O
androgen-dependent	cell_line
LNCaP	cell_line
cell	cell_line
line	cell_line
were	O
examined	O
in	O
response	O
to	O
conditioned	O
medium	O
(	O
CM	O
)	O
derived	O
from	O
phytohemagglutinin	cell_line
(	cell_line
PHA	cell_line
)-stimulated	cell_line
lymphocytes	cell_line
.	O
Addition	O
of	O
CM	O
caused	O
a	O
greater	O
than	O
70%	O
reduction	O
of	O
cell	O
proliferation	O
by	O
cell	O
counting	O
and	O
cell	O
cycle	O
.	O
These	O
cells	O
showed	O
G1	O
phase	O
arrest	O
and	O
the	O
clonogenicity	O
was	O
reduced.	O
The	O
growth-modulating	O
effect	O
was	O
dose-dependent	O
and	O
not	O
due	O
to	O
cell	O
lysis	O
or	O
apoptosis	O
.	O
The	O
binding	O
of	O
androgen	O
to	O
androgen	protein
receptor	protein
on	O
these	O
cells	O
showed	O
approximately	O
50%	O
reduction,	O
underlining	O
a	O
proliferation	O
reduction	O
mechanism	O
.	O
The	O
prostate-specific	protein
antigen	protein
(	O
PSA	protein
)	O
was	O
downregulated	O
to	O
approximately	O
75%	O
during	O
the	O
process.	O
Cell	O
morphology	O
showed	O
dendritic	O
processes	O
extending	O
from	O
cytoplasm	O
and	O
other	O
neuroendocrine	cell_type
cell	cell_type
characteristics	O
.	O
The	O
expression	O
of	O
several	O
cytoskeleton	O
and	O
intracellular	O
proteins	O
increased	O
as	O
determined	O
by	O
immunostaining	O
on	O
slides	O
and	O
by	O
ELISA	O
procedures	O
.	O
These	O
included	O
vimentin	protein
,	O
correlating	O
to	O
cell	O
shape	O
changes	O
,	O
cytokeratins	O
8	O
and	O
18	O
,	O
associated	O
with	O
differentiated	cell_type
cell	cell_type
types	cell_type
of	O
prostate	O
epithelia	O
,	O
and	O
neuron-specific	protein
enolase	protein
and	O
serotonin	O
,	O
associated	O
with	O
neuroendocrine	cell_type
cells	cell_type
.	O
From	O
these	O
cellular	O
changes	O
,	O
we	O
can	O
infer	O
that	O
the	O
cell	O
growth	O
was	O
modulated	O
along	O
with	O
induction	O
of	O
terminal	O
differentiation	O
.	O
Activated	O
T	cell_type
cells	cell_type
were	O
demonstrated	O
to	O
be	O
important	O
in	O
providing	O
the	O
modulating	O
activity.	O
This	O
growth	protein
modulator	protein
was	O
semipurified	O
and	O
had	O
an	O
estimated	O
molecular	O
weight	O
13,000	O
to	O
24,000	O
Da.	O
The	O
activity	O
was	O
determined	O
to	O
be	O
distinct	O
from	O
TGF	protein
,	O
TNF	protein
,	O
and	O
some	O
commonly	O
known	O
lymphokines	protein
.	O
The	O
interaction	O
between	O
lymphoid	O
and	O
prostatic	O
cells	O
in	O
growth	O
and	O
development	O
is	O
described.	O

Platelet-activating	protein
factor	protein
stimulates	O
transcription	O
of	O
the	O
heparin-binding	protein
epidermal	protein
growth	protein
factor-like	protein
growth	protein
factor	protein
in	O
monocytes	cell_type
.	O
Correlation	O
with	O
an	O
increased	O
kappa	O
B	O
binding	O
activity	O
.	O
Human	O
peripheral	O
blood	O
monocytes	cell_type
responded	O
to	O
stimulation	O
of	O
platelet-activating	protein
factor	protein
(	O
PAF	protein
)	O
with	O
up-regulation	O
of	O
the	O
transcript	O
for	O
heparin-binding	protein
epidermal	protein
growth	protein
factor-like	protein
growth	protein
factor	protein
(	O
HB-EGF	protein
),	O
a	O
potent	protein
mitogen	protein
for	O
vascular	cell_type
smooth	cell_type
muscle	cell_type
cells	cell_type
.	O
This	O
function	O
of	O
PAF	protein
was	O
observed	O
at	O
nanomolar	O
concentrations	O
of	O
the	O
ligand,	O
starting	O
at	O
30	O
min	O
after	O
stimulation.	O
The	O
PAF	protein
-induced	O
up-regulation	O
of	O
HB-EGF	RNA
mRNA	RNA
was	O
accompanied	O
by	O
an	O
increase	O
in	O
kappa	O
B	O
binding	O
activity	O
.	O
These	O
functions	O
of	O
PAF	protein
appeared	O
to	O
be	O
mediated	O
through	O
the	O
cell	protein
surface	protein
PAF	protein
receptors	protein
,	O
as	O
two	O
PAF	protein
receptor	O
antagonists	O
,	O
WEB	O
2086	O
and	O
L-659,989	O
,	O
blocked	O
both	O
the	O
up-regulation	O
of	O
HB-EGF	RNA
mRNA	RNA
and	O
kappa	O
B	O
binding	O
activity	O
induced	O
by	O
PAF	protein
.	O
The	O
antagonists,	O
however,	O
had	O
no	O
effect	O
on	O
phorbol	O
ester	O
-induced	O
up-regulation	O
of	O
HB-EGF	RNA
mRNA	RNA
and	O
kappa	O
B	O
binding	O
activity	O
.	O
Pretreatment	O
of	O
monocytes	cell_type
with	O
pertussis	O
toxin	O
inhibited	O
these	O
functions	O
of	O
PAF	protein
,	O
whereas	O
cholera	O
toxin	O
had	O
no	O
inhibitory	O
effect.	O
Pyrrolidine	O
dithiocarbamate	O
,	O
an	O
inhibitor	O
for	O
NF-kappa	protein
B	protein
activation	O
,	O
markedly	O
reduced	O
PAF	protein
-stimulated	O
kappa	O
B	O
binding	O
activity	O
as	O
well	O
as	O
up-regulation	O
of	O
HB-EGF	RNA
mRNA	RNA
.	O
These	O
results	O
suggest	O
a	O
potential	O
role	O
of	O
PAF	protein
in	O
HB-EGF	protein
expression	O
and	O
provide	O
evidence	O
that	O
this	O
stimulation	O
may	O
occur	O
through	O
increased	O
kappa	O
B	O
binding	O
activity	O
.	O

Mapping	O
of	O
the	O
interaction	protein
site	protein
of	O
the	O
defective	protein
transcription	protein
factor	protein
in	O
the	O
class	cell_line
II	cell_line
major	cell_line
histocompatibility	cell_line
complex	cell_line
mutant	cell_line
cell	cell_line
line	cell_line
clone-13	cell_line
to	O
the	O
divergent	DNA
X2-box	DNA
.	O
We	O
have	O
previously	O
described	O
a	O
mutant	cell_line
B	cell_line
lymphoblastoid	cell_line
cell	cell_line
line	cell_line
,	O
Clone-13,	cell_line
that	O
expresses	O
HLA-DQ	protein
in	O
the	O
absence	O
of	O
HLA	O
-DR	O
and	O
-DP	O
.	O
Several	O
criteria	O
indicated	O
that	O
the	O
defect	O
in	O
this	O
cell	O
line	O
influences	O
the	O
activity	O
of	O
an	O
isotype-specific	protein
transcription	protein
factor	protein
.	O
Indeed,	O
transient	O
transfection	O
of	O
HLA-DRA	O
and	O
DQB	O
reporter	O
constructs	O
indicated	O
that	O
the	O
affected	O
factor	O
operates	O
via	O
cis-elements	DNA
located	O
between	O
-141	DNA
base	DNA
pairs	DNA
and	O
the	O
transcription	DNA
initiation	DNA
site	DNA
.	O
A	O
series	O
of	O
hybrid	DNA
DRA/DQB	DNA
reporter	DNA
constructs	DNA
was	O
generated	O
to	O
further	O
map	O
the	O
relevant	O
cis-elements	DNA
in	O
this	O
system.	O
Insertion	O
of	O
oligonucleotides	O
spanning	O
the	O
DQB	DNA
X-box	DNA
(but	O
not	O
the	O
DQB-W	DNA
region	DNA
or	O
the	O
DQB	DNA
Y-box	DNA
)	O
upstream	DNA
of	DNA
-141	DNA
in	O
a	O
DRA	DNA
reporter	DNA
plasmid	DNA
rescued	O
expression	O
to	O
nearly	O
wild-type	O
levels	O
.	O
Substitution	O
promoters	O
were	O
then	O
generated	O
where	O
the	O
entire	O
X-box	DNA
,	O
or	O
only	O
the	O
X1-	O
or	O
X2-	O
boxes	O
of	O
HLA-DRA	DNA
were	O
replaced	O
with	O
the	O
analogous	O
regions	O
of	O
HLA-DQB	DNA
.	O
The	O
DQB	DNA
X2-box	DNA
was	O
able	O
to	O
restore	O
expression	O
to	O
the	O
silent	DNA
DRA	DNA
reporter	DNA
construct	DNA
.	O
Moreover,	O
replacement	O
of	O
the	O
DQB	DNA
X2-box	DNA
with	O
the	O
DRA	DNA
X2-box	DNA
markedly	O
diminished	O
the	O
activity	O
of	O
the	O
DQB	DNA
promoter	DNA
in	O
the	O
mutant	cell_line
cell	cell_line
.	O
None	O
of	O
the	O
hybrid	DNA
reporter	DNA
constructs	DNA
were	O
defective	O
when	O
transfected	O
into	O
the	O
wild-type	protein
,	O
HLA-DR/-DQ	cell_line
positive	cell_line
parental	cell_line
cell	cell_line
line	cell_line
,	O
Jijoye	cell_line
.	O
These	O
studies	O
suggest	O
that	O
the	O
divergent	DNA
X2-box	DNA
of	O
the	O
class	DNA
II	DNA
major	DNA
histocompatibility	DNA
complex	DNA
promoters	DNA
plays	O
an	O
important	O
role	O
in	O
influencing	O
differential	O
expression	O
of	O
the	O
human	DNA
class	DNA
II	DNA
isotypes	DNA
.	O

Restoration	O
of	O
the	O
Epstein-Barr	protein
virus	protein
ZEBRA	protein
protein	protein
's	O
capacity	O
to	O
disrupt	O
latency	O
by	O
the	O
addition	O
of	O
heterologous	protein
activation	protein
regions	protein
.	O
The	O
ZEBRA	protein
protein	protein
has	O
a	O
unique	O
biological	O
function	O
among	O
herpesviral	protein
proteins	protein
.	O
It	O
is	O
responsible	O
for	O
the	O
disruption	O
of	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
latency	O
and	O
the	O
induction	O
of	O
the	O
lytic	O
cycle	O
.	O
ZEBRA	protein
is	O
a	O
bZIP	protein
transcriptional	protein
activator	protein
which	O
binds	O
as	O
a	O
dimer	O
to	O
7-bp	DNA
response	DNA
elements	DNA
within	O
EBV	DNA
promoters	DNA
and	O
is	O
directly	O
involved	O
in	O
the	O
stimulation	O
of	O
virus	O
replication	O
at	O
the	O
EBV	DNA
lytic	DNA
origin	DNA
.	O
We	O
have	O
employed	O
the	O
ZEBRA	protein
/EBV	O
biological	O
system	O
to	O
test	O
whether	O
a	O
heterologous	protein
activation	protein
domain	protein
can	O
substitute	O
for	O
another	O
activation	O
domain	O
(the	O
ZEBRA	protein
domain	protein
).	O
The	O
ZEBRA	protein
activation	protein
region	protein
was	O
replaced	O
with	O
the	O
potent	O
acid	protein
activation	protein
region	protein
from	O
the	O
herpes	protein
simplex	protein
virus	protein
VP16	protein
protein	protein
or	O
with	O
the	O
activation	protein
region	protein
of	O
the	O
EBV	protein
R	protein
protein	protein
.	O
Both	O
chimeras	O
were	O
found	O
to	O
transactivate	O
model	O
and	O
native	O
promoters	O
at	O
equivalent	O
or	O
better	O
levels	O
than	O
ZEBRA	protein
itself.	O
Activation	O
was	O
not	O
target-	O
or	O
cell-type	O
dependent,	O
nor	O
was	O
it	O
dependent	O
on	O
the	O
presence	O
of	O
virus	O
.	O
These	O
activation	O
domains	O
restored	O
ZEBRA	protein
's	O
ability	O
to	O
induce	O
early	protein
antigen	protein
and	O
to	O
stimulate	O
origin	O
replication	O
to	O
levels	O
that	O
were	O
equal	O
to	O
or	O
greater	O
than	O
those	O
of	O
wild	O
type.	O
These	O
studies	O
suggest	O
that	O
the	O
specificities	O
of	O
some	O
of	O
the	O
known	O
biological	O
functions	O
of	O
ZEBRA	protein
are	O
not	O
dependent	O
upon	O
the	O
nature	O
of	O
the	O
activation	protein
domain	protein
present	protein
within	O
ZEBRA	protein
.	O

Interleukin	protein
4	protein
activates	O
a	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	protein
(Stat)	protein
protein	protein
which	O
interacts	O
with	O
an	O
interferon-gamma	DNA
activation	DNA
site-like	DNA
sequence	DNA
upstream	O
of	O
the	O
I	DNA
epsilon	DNA
exon	DNA
in	O
a	O
human	cell_line
B	cell_line
cell	cell_line
line	cell_line
.	O
Evidence	O
for	O
the	O
involvement	O
of	O
Janus	protein
kinase	protein
3	protein
and	O
interleukin-4	protein
Stat	protein
.	O
Germ	RNA
line	RNA
C	RNA
transcripts	RNA
can	O
be	O
induced	O
by	O
IL-4	protein
in	O
the	O
human	cell_line
B	cell_line
cell	cell_line
line	cell_line
,	O
BL-2	cell_line
.	O
Utilizing	O
a	O
IFN-gamma	DNA
activation	DNA
site-like	DNA
DNA	DNA
sequence	DNA
element	DNA
located	O
upstream	O
of	O
the	O
I	DNA
epsilon	DNA
exon	DNA
,	O
we	O
demonstrated	O
by	O
gel	O
mobility	O
shift	O
assays	O
that	O
IL-4	protein
induced	O
a	O
binding	O
activity	O
in	O
the	O
cytosol	O
and	O
nucleus	O
of	O
BL-2	cell_line
cells	cell_line
.	O
This	O
factor	O
was	O
designated	O
IL-4	protein
NAF	protein
(	O
IL-4	protein
-induced	protein
nuclear-activating	protein
factors	protein
)	O
and	O
was	O
identified	O
as	O
a	O
tyrosine	protein
phosphoprotein	protein
,	O
which	O
translocates	O
from	O
the	O
cytosol	O
to	O
the	O
nucleus	O
upon	O
IL-4	protein
treatment	O
.	O
Because	O
these	O
are	O
the	O
characteristics	O
of	O
a	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
(Stat)	protein
protein	protein
,	O
we	O
determined	O
whether	O
antibodies	protein
to	protein
Stat	protein
proteins	protein
will	O
interfere	O
with	O
gel	O
mobility	O
shift	O
and	O
found	O
that	O
antibodies	protein
to	protein
IL-4	protein
Stat	protein
,	O
also	O
known	O
as	O
Stat6	protein
,	O
but	O
not	O
antibodies	protein
to	O
other	O
Stat	protein
proteins	protein
,	O
interfere	O
with	O
the	O
formation	O
of	O
the	O
IL-4	protein
NAF	protein
complex	protein
.	O
Congruous	O
with	O
the	O
involvement	O
of	O
a	O
Stat	protein
protein	protein
,	O
IL-4	protein
induced	O
robust	O
Janus	protein
kinase	protein
3	protein
(	O
JAK3	protein
)	O
activity	O
in	O
BL-2	cell_line
cells	cell_line
.	O
Cotransfection	O
of	O
JAK3	protein
with	O
IL-4	protein
Stat	protein
into	O
COS-7	cell_line
cells	cell_line
produced	O
an	O
intracellular	O
activity	O
which	O
bound	O
the	O
same	O
IFN-gamma	DNA
activation	DNA
site-like	DNA
sequence	DNA
and	O
comigrated	O
with	O
IL-4	protein
NAF	protein
in	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O
These	O
results	O
show	O
that	O
IL-4	protein
NAF	protein
is	O
IL-4	protein
Stat	protein
,	O
which	O
is	O
activated	O
by	O
JAK3	protein
in	O
response	O
to	O
IL-4	protein
receptor	O
engagement	O
.	O

Does	O
activation	O
of	O
the	O
TAL1	DNA
gene	DNA
occur	O
in	O
a	O
majority	O
of	O
patients	O
with	O
T-cell	O
acute	O
lymphoblastic	O
leukemia	O
?	O
A	O
pediatric	O
oncology	O
group	O
study	O
.	O
Almost	O
25%	O
of	O
patients	O
with	O
T-cell	O
acute	O
lymphoblastic	O
leukemia	O
(	O
T-ALL	O
)	O
have	O
tumor-specific	O
rearrangements	O
of	O
the	O
TAL1	DNA
gene	DNA
.	O
Although	O
TAL1	protein
expression	O
has	O
not	O
been	O
observed	O
in	O
normal	cell_type
lymphocytes	cell_type
,	O
TAL1	protein
gene	protein
products	protein
are	O
readily	O
detected	O
in	O
leukemic	cell_type
cells	cell_type
that	O
harbor	O
a	O
rearranged	DNA
TAL1	DNA
allele	DNA
.	O
Hence,	O
it	O
has	O
been	O
proposed	O
that	O
ectopic	O
expression	O
of	O
TAL1	protein
promotes	O
the	O
development	O
of	O
T-ALL	O
.	O
In	O
this	O
report,	O
we	O
show	O
that	O
TAL1	protein
is	O
expressed	O
in	O
the	O
leukemic	cell_type
cells	cell_type
of	O
most	O
patients	O
with	O
T-ALL	O
,	O
including	O
many	O
that	O
do	O
not	O
display	O
an	O
apparent	O
TAL1	DNA
gene	DNA
alteration.	O
A	O
polymorphic	O
dinucleotide	O
repeat	O
in	O
the	O
transcribed	O
sequences	O
of	O
TAL1	protein
was	O
used	O
to	O
determine	O
the	O
allele	O
specificity	O
of	O
TAL1	protein
transcription	O
in	O
primary	cell_type
T-ALL	cell_type
cells	cell_type
.	O
Monoallelic	O
expression	O
of	O
TAL1	protein
was	O
observed	O
in	O
the	O
leukemic	cell_type
cells	cell_type
of	O
all	O
patients	O
(8	O
of	O
8)	O
bearing	O
a	O
TAL1	DNA
gene	DNA
rearrangement	O
.	O
In	O
the	O
leukemic	cell_type
cells	cell_type
of	O
patients	O
without	O
detectable	O
TAL1	protein
rearrangements	O
,	O
TAL1	protein
transcription	O
occurred	O
in	O
either	O
a	O
monoallelic	O
(3	O
of	O
7	O
patients	O
)	O
or	O
a	O
biallelic	O
(4	O
of	O
7	O
patients	O
)	O
fashion.	O
Thus,	O
TAL1	protein
activation	O
in	O
these	O
patients	O
may	O
result	O
from	O
subtle	O
alterations	O
in	O
cis-acting	DNA
regulatory	DNA
sequences	DNA
(affecting	O
expression	O
of	O
a	O
single	DNA
TAL1	DNA
allele	DNA
)	O
or	O
changes	O
in	O
trans-acting	O
factors	O
that	O
control	O
TAL1	protein
transcription	O
(affecting	O
expression	O
of	O
both	O
TAL1	DNA
alleles	DNA
).	O

Expression	O
of	O
erythroid-specific	DNA
genes	DNA
in	O
acute	O
megakaryoblastic	O
leukaemia	O
and	O
transient	O
myeloproliferative	O
disorder	O
in	O
Down's	O
syndrome	O
.	O
Acute	O
megakaryoblastic	O
leukaemia	O
(	O
M7	O
)	O
and	O
transient	O
myeloproliferative	O
disorder	O
in	O
Down's	O
syndrome	O
(	O
TMD	O
)	O
are	O
characterized	O
by	O
rapid	O
growth	O
of	O
abnormal	cell_type
blast	cell_type
cells	cell_type
which	O
express	O
megakaryocytic	protein
markers	protein
.	O
To	O
clarify	O
properties	O
of	O
the	O
blast	cell_type
cells	cell_type
in	O
M7	O
and	O
TMD	O
cases,	O
we	O
examined	O
erythroid	O
markers	O
expression	O
in	O
blasts	cell_type
from	O
six	O
cases	O
with	O
M7	O
and	O
seven	O
cases	O
with	O
TMD	O
in	O
this	O
study.	O
Erythroid-specific	RNA
mRNAs	RNA
encoding	O
gamma-globin	protein
and	O
erythroid	protein
delta-aminolevulinate	protein
synthase	protein
were	O
found	O
to	O
be	O
expressed	O
in	O
blasts	cell_type
from	O
most	O
of	O
these	O
cases,	O
indicating	O
that	O
majorities	O
of	O
the	O
blasts	cell_type
in	O
M7	O
and	O
TMD	O
cases	O
have	O
erythroid	O
and	O
megakaryocytic	O
phenotypes	O
.	O
We	O
also	O
found	O
that	O
mRNAs	RNA
encoding	O
GATA-1	protein
and	O
GATA-2	protein
are	O
expressed	O
in	O
all	O
these	O
cases.	O
These	O
results	O
suggest	O
that	O
M7	cell_type
blasts	cell_type
and	O
TMD	cell_type
blasts	cell_type
correspond	O
to	O
the	O
erythroid/megakaryocytic	cell_type
bipotential	cell_type
progenitor	cell_type
cells	cell_type
.	O

Expression	O
of	O
Ah	protein
receptor	protein
(	O
TCDD	protein
receptor	protein
)	O
during	O
human	O
monocytic	O
differentiation	O
.	O
We	O
have	O
previously	O
found	O
a	O
high	O
expression	O
of	O
human	RNA
Ah	RNA
receptor	RNA
(	RNA
TCDD	RNA
receptor	RNA
)	RNA
mRNA	RNA
in	O
peripheral	cell_type
blood	cell_type
cells	cell_type
of	O
individuals	O
.	O
In	O
this	O
paper,	O
the	O
expression	O
of	O
this	O
gene	O
in	O
blood	cell_type
cells	cell_type
was	O
first	O
investigated	O
in	O
fractions	O
of	O
nucleated	cell_type
cells	cell_type
,	O
revealing	O
predominant	O
expression	O
of	O
the	O
Ah	DNA
receptor	DNA
gene	DNA
in	O
the	O
monocyte	cell_type
fraction	cell_type
.	O
Then	O
the	O
expression	O
levels	O
of	O
AhR	RNA
mRNA	RNA
in	O
various	O
hematopoietic	cell_line
cell	cell_line
lines	cell_line
were	O
examined	O
together	O
with	O
those	O
of	O
Arnt	protein
and	O
P450IA1	protein
.	O
AhR	protein
was	O
expressed	O
at	O
high	O
levels	O
in	O
monocytoid	cell_line
U937	cell_line
,	O
THP1	cell_line
,	O
and	O
HEL/S	cell_line
cells	cell_line
,	O
and	O
at	O
moderate	O
levels	O
in	O
promyelocytic	cell_line
HL60	cell_line
cells	cell_line
and	O
erythroblastic	cell_line
HEL	cell_line
cells	cell_line
.	O
However,	O
it	O
was	O
not	O
detected	O
in	O
lymphoid	cell_type
cells	cell_type
MOLT4	cell_line
(	O
T	cell_type
cell	cell_type
)	O
and	O
BALL1	cell_line
(	O
B	cell_type
cell	cell_type
),	O
nor	O
in	O
K562	cell_line
erythroblasts	cell_line
.	O
Furthermore,	O
a	O
specific	O
induction	O
of	O
AhR	protein
during	O
monocytic	O
differentiation	O
was	O
investigated	O
in	O
HL60	cell_line
and	O
HEL	cell_line
cells	cell_line
.	O
HL60	cell_line
cells	cell_line
were	O
induced	O
to	O
differentiate	O
toward	O
monocytes-macrophages	cell_type
by	O
incubation	O
with	O
phorbol	O
ester,	O
showing	O
a	O
5-	O
to	O
2-fold	O
increase	O
of	O
AhR	RNA
mRNA	RNA
.	O
The	O
incubation	O
with	O
transforming	protein
growth	protein
factor	protein
beta	protein
1	protein
and	O
1	O
alpha,25-dihydroxyvitamin	O
D3	O
resulted	O
in	O
a	O
5-	O
to	O
7-fold	O
increase	O
of	O
AhR	RNA
mRNA	RNA
.	O
The	O
HEL	cell_line
cells	cell_line
also	O
exhibited	O
a	O
similar	O
elevation	O
of	O
AhR	RNA
mRNA	RNA
level	O
,	O
when	O
they	O
had	O
differentiated	O
toward	O
monocyte-macrophage	cell_type
cells	cell_type
by	O
these	O
combined	O
inducers,	O
but	O
little	O
change	O
in	O
the	O
mRNA	O
level	O
was	O
observed	O
when	O
the	O
cells	O
were	O
induced	O
to	O
differentiate	O
into	O
other	O
cell	O
types.	O
Treatment	O
of	O
the	O
differentiated	cell_line
HL60	cell_line
cells	cell_line
with	O
3-methylcholanthrene	O
,	O
a	O
ligand	O
of	O
AhR	protein
,	O
induced	O
the	O
expression	O
of	O
the	O
P450IA1	protein
gene.	O
These	O
results	O
indicated	O
that	O
expression	O
of	O
AhR	RNA
mRNA	RNA
was	O
significantly	O
induced	O
during	O
monocytic	O
differentiation	O
and	O
that	O
the	O
differentiated	cell_type
cells	cell_type
were	O
responsive	O
to	O
xenobiotics	O
.	O
Our	O
results	O
suggest	O
that	O
AhR	protein
may	O
play	O
an	O
important	O
role	O
in	O
the	O
function	O
of	O
monocytes	cell_type
and	O
also	O
in	O
the	O
eventual	O
activation	O
of	O
environmental	O
carcinogens	O
.	O

Neutrophils	cell_type
and	O
monocytes	cell_type
express	O
high	O
levels	O
of	O
PU.1	protein
(	O
Spi-1	protein
)	O
but	O
not	O
Spi-B	protein
.	O
PU.1	protein
(the	O
Spi-1	DNA
oncogene	DNA
)	O
and	O
Spi-B	protein
are	O
closely	O
related	O
members	O
of	O
the	O
ets	protein
transcription	protein
factor	protein
family	protein
,	O
sharing	O
similar	O
DNA	O
binding	O
specificities	O
mediated	O
by	O
similar	O
DNA	protein
binding	protein
domains	protein
.	O
PU.1	protein
and	O
Spi-B	protein
have	O
been	O
previously	O
described	O
as	O
being	O
predominantly	O
expressed	O
coordinately	O
in	O
macrophages	cell_type
and	O
B	cell_type
cells	cell_type
,	O
but	O
their	O
expression	O
in	O
early	O
hematopoietic	O
stages	O
and	O
during	O
the	O
course	O
of	O
myeloid	O
differentiation	O
to	O
monocytes	cell_type
and	O
macrophages	cell_type
or	O
to	O
neutrophils	cell_type
has	O
not	O
been	O
extensively	O
investigated.	O
Here,	O
we	O
report	O
that	O
PU.1	RNA
mRNA	RNA
is	O
upregulated	O
during	O
myeloid	O
differentiation	O
of	O
human	cell_line
purified	cell_line
CD34+	cell_line
cells	cell_line
and	O
murine	cell_line
multipotential	cell_line
FDCP-mix	cell_line
A4	cell_line
cells	cell_line
,	O
suggesting	O
that	O
PU.1	protein
is	O
upregulated	O
as	O
an	O
early	O
event	O
during	O
differentiation	O
of	O
multipotential	cell_type
progenitor	cell_type
cells	cell_type
.	O
PU.1	protein
expression	O
is	O
maintained	O
at	O
stable	O
levels	O
during	O
differentiation	O
of	O
myeloid	cell_line
cell	cell_line
lines	cell_line
U937	cell_line
and	O
HL-60	cell_line
to	O
monocytic	O
and	O
neutrophilic	O
cells	O
.	O
PU.1	protein
is	O
expressed	O
at	O
highest	O
levels	O
in	O
mature	cell_type
human	cell_type
monocytes	cell_type
and	O
human	cell_type
peripheral	cell_type
blood	cell_type
neutrophils	cell_type
.	O
In	O
contrast	O
to	O
PU.1	protein
,	O
significant	O
levels	O
of	O
Spi-B	RNA
mRNA	RNA
and	O
protein	O
are	O
found	O
only	O
in	O
some	O
B-cell	cell_line
lines	cell_line
and	O
spleen	O
but	O
are	O
not	O
found	O
in	O
myeloid	cell_line
cell	cell_line
lines	cell_line
,	O
neutrophils	cell_type
,	O
or	O
macrophages	cell_type
.	O
In	O
vitro	O
translated	O
Spi-B	protein
protein	protein
can	O
bind	O
to	O
PU.1	DNA
binding	DNA
sites	DNA
in	O
myeloid	DNA
promoters	DNA
and	O
transactivate	O
these	O
promoters	DNA
in	O
nonmyeloid	cell_type
cells	cell_type
.	O
Therefore,	O
although	O
PU.1	protein
and	O
Spi-B	protein
may	O
bind	O
to	O
similar	O
DNA	O
control	O
elements	O
and	O
have	O
redundancy	O
of	O
transactivation	O
function	O
in	O
vitro,	O
the	O
lack	O
of	O
significant	O
levels	O
of	O
Spi-B	protein
in	O
myeloid	cell_type
cells	cell_type
makes	O
it	O
unlikely	O
that	O
Spi-B	protein
plays	O
a	O
significant	O
role	O
in	O
myeloid	O
lineage	O
development	O
and	O
gene	O
expression	O
.	O
In	O
contrast,	O
PU.1	protein
is	O
expressed	O
at	O
high	O
levels	O
not	O
only	O
in	O
monocytes	cell_type
and	O
macrophages	cell_type
but	O
also	O
in	O
neutrophils	cell_type
,	O
indicating	O
that	O
PU.1	protein
can	O
activate	O
gene	O
expression	O
in	O
both	O
major	cell_type
myeloid	cell_type
lineages	cell_type
.	O

Identification	O
of	O
a	O
major	O
positive	DNA
regulatory	DNA
element	DNA
located	O
5'	O
to	O
the	O
human	DNA
zeta-globin	DNA
gene	DNA
.	O
The	O
function	O
of	O
the	O
zeta-globin	DNA
promoter	DNA
was	O
studied	O
using	O
a	O
series	O
of	O
zeta-globin	DNA
promoter	DNA
deletion	DNA
constructs	DNA
to	O
drive	O
luciferase	protein
expression	O
in	O
transiently	cell_line
transfected	cell_line
human	cell_line
erythroleukemia	cell_line
cells	cell_line
.	O
The	O
promoters	DNA
were	O
used	O
without	O
enhancers	DNA
,	O
or	O
with	O
enhancers	DNA
derived	O
from	O
the	O
beta-globin	DNA
locus	DNA
control	DNA
region	DNA
and	O
the	O
alpha-globin	DNA
HS-40	DNA
enhancer	DNA
.	O
When	O
transfected	O
into	O
K562	cell_line
cells	cell_line
,	O
which	O
express	O
zeta-globin	protein
,	O
comparable	O
amounts	O
of	O
activity	O
were	O
obtained	O
from	O
the	O
-557	DNA
and	DNA
-417	DNA
zeta-	DNA
luciferase	DNA
constructs	DNA
and	O
the	O
alpha-	DNA
luciferase	DNA
constructs	DNA
when	O
no	O
enhancers	DNA
or	O
the	O
alpha-globin	DNA
locus	DNA
enhancers	DNA
were	O
used.	O
When	O
the	O
constructs	O
were	O
transfected	O
into	O
OCIM1	cell_line
cells	cell_line
,	O
which	O
do	O
not	O
express	O
zeta-globin	protein
,	O
the	O
zeta-globin	DNA
promoters	DNA
were	O
at	O
best	O
20%	O
as	O
active	O
as	O
the	O
alpha-globin	DNA
promoters	DNA
.	O
When	O
sequences	DNA
from	DNA
-417	DNA
to	DNA
-207	DNA
5'	DNA
to	O
the	O
zeta-globin	RNA
mRNA	RNA
cap	RNA
site	RNA
were	O
deleted,	O
up	O
to	O
95%	O
of	O
the	O
zeta-globin	DNA
promoter	DNA
activity	O
was	O
lost	O
in	O
K562	cell_line
cells	cell_line
.	O
Reinsertion	O
of	O
these	O
sequences	O
into	O
zeta-	DNA
luciferase	DNA
constructs	DNA
missing	O
the	O
-417	O
to	O
-207	O
region	O
showed	O
that	O
the	O
sequences	O
lack	O
classical	O
enhancer	O
activity	O
.	O
Point	O
mutation	O
of	O
a	O
GATA-1	DNA
site	DNA
at	O
-230	O
reduced	O
promoter	O
activity	O
by	O
37%.	O
Point	O
mutation	O
of	O
a	O
CCACC	DNA
site	DNA
at	O
-240	O
had	O
no	O
effect.	O
Electrophoretic	O
mobility	O
shift	O
assays	O
indicated	O
that	O
the	O
-230	DNA
GATA-1	DNA
site	DNA
has	O
a	O
relatively	O
low	O
affinity	O
for	O
GATA-1	protein
.	O
These	O
experiments	O
show	O
the	O
presence	O
of	O
a	O
strong	O
positive-acting	DNA
element	DNA
,	O
located	O
between	O
-417	DNA
and	DNA
-207	DNA
bp	DNA
5'	DNA
to	O
the	O
zeta-globin	DNA
mRNA	DNA
cap	DNA
site	DNA
,	O
is	O
necessary	O
for	O
high-level	O
promoter	O
activity	O
in	O
K562	cell_line
cells	cell_line
.	O
This	O
element	O
requires	O
GATA-1	protein
and	O
additional	protein
unknown	protein
factors	protein
for	O
maximal	O
activity	O
.	O

Analysis	O
of	O
the	O
role	O
of	O
protein	O
kinase	O
C	O
-alpha	O
,	O
-epsilon	O
,	O
and	O
-zeta	O
in	O
T	O
cell	O
activation	O
.	O
T	cell_type
cells	cell_type
express	O
multiple	O
isotypes	O
of	O
protein	protein
kinase	protein
C	protein
(	O
PKC	protein
)	O
and	O
although	O
it	O
is	O
well	O
accepted	O
that	O
PKCs	protein
have	O
an	O
important	O
role	O
in	O
T	O
cell	O
activation	O
,	O
little	O
is	O
known	O
about	O
the	O
function	O
of	O
individual	O
PKC	protein
isotypes	protein
.	O
To	O
address	O
this	O
issue,	O
mutationally	O
active	O
PKC	O
-alpha	O
,	O
-epsilon	O
,	O
or	O
-zeta	O
have	O
been	O
transfected	O
into	O
T	cell_type
cells	cell_type
and	O
the	O
consequences	O
for	O
T	O
cell	O
activation	O
determined.	O
p21ras	protein
plays	O
an	O
essential	O
role	O
in	O
T	O
cell	O
activation	O
.	O
Accordingly,	O
the	O
effects	O
of	O
the	O
constitutively	protein
active	protein
PKCs	protein
were	O
compared	O
to	O
the	O
effects	O
of	O
mutationally	O
activated	O
p21ras	protein
.	O
The	O
data	O
indicate	O
that	O
PKC-epsilon	protein
and,	O
to	O
a	O
lesser	O
extent	O
PKC-alpha	protein
but	O
not	O
-zeta	protein
,	O
can	O
regulate	O
the	O
transcription	protein
factors	protein
AP-1	protein
and	O
nuclear	O
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NF-AT-1	protein
).	O
The	O
ability	O
of	O
PKC-epsilon	protein
to	O
induce	O
transactivation	O
of	O
NF-AT-1	protein
and	O
AP-1	protein
was	O
similar	O
to	O
the	O
stimulatory	O
effect	O
of	O
a	O
constitutively	protein
activated	protein
p21ras	protein
.	O
PKC-epsilon	protein
,	O
but	O
not	O
PKC-alpha	protein
nor	O
activated	O
p21ras	protein
,	O
was	O
able	O
to	O
induce	O
NF-KB	protein
activity	O
.	O
Phorbol	O
esters	O
induce	O
expression	O
of	O
CD69	protein
whereas	O
none	O
of	O
the	O
activated	protein
PKC	protein
isotypes	protein
tested	O
were	O
able	O
to	O
have	O
this	O
effect.	O
Activated	O
Src	protein
and	O
p21ras	protein
were	O
able	O
to	O
induce	O
CD69	protein
expression	O
.	O
These	O
results	O
indicate	O
selective	O
functions	O
for	O
different	O
PKC	protein
isotypes	protein
in	O
T	cell_type
cells	cell_type
.	O
Moreover,	O
the	O
data	O
comparing	O
the	O
effects	O
of	O
activated	protein
Ras	protein
and	O
PKC	protein
mutants	protein
suggest	O
that	O
PKC-alpha	protein
,	O
p21ras	protein
,	O
and	O
PKC-epsilon	protein
are	O
not	O
positioned	O
linearly	O
on	O
a	O
single	O
signal	O
transduction	O
pathway	O
.	O

Differences	O
in	O
binding	O
of	O
glucocorticoid	protein
receptor	protein
to	O
DNA	O
in	O
steroid-resistant	O
asthma	O
.	O
Although	O
glucocorticosteroids	O
are	O
a	O
very	O
effective	O
treatment	O
for	O
asthma	O
and	O
other	O
chronic	O
inflammatory	O
diseases	O
,	O
a	O
small	O
proportion	O
of	O
patients	O
are	O
resistant	O
to	O
their	O
therapeutic	O
effects	O
.	O
The	O
molecular	O
mechanism	O
for	O
this	O
steroid	O
resistance	O
is	O
unclear.	O
Steroid	O
resistance	O
cannot	O
be	O
explained	O
by	O
pharmacokinetic	O
mechanisms	O
,	O
by	O
a	O
defect	O
in	O
the	O
binding	O
of	O
steroids	O
to	O
glucocorticoid	protein
receptors	protein
,	O
nor	O
by	O
defective	O
nuclear	O
translocation	O
of	O
this	O
receptor,	O
thereby	O
suggesting	O
that	O
the	O
molecular	O
abnormality	O
lies	O
distal	O
to	O
nuclear	O
translocation	O
.	O
We	O
examined	O
the	O
ability	O
of	O
nuclear	O
translocated	O
glucocorticoid	protein
receptors	protein
to	O
bind	O
to	O
their	O
DNA	DNA
binding	DNA
sites	DNA
(	O
GRE	DNA
)	O
using	O
electrophoretic	O
mobility	O
shift	O
assays	O
in	O
PBMC	cell_type
from	O
patients	O
with	O
steroid-sensitive	O
and	O
steroid-resistant	O
asthma	O
.	O
The	O
binding	O
of	O
the	O
glucocorticoid	protein
receptor	protein
to	O
DNA	O
in	O
these	O
patients	O
was	O
also	O
studied	O
using	O
Scatchard	O
analysis	O
.	O
Dexamethasone	O
induced	O
a	O
significant	O
rapid	O
and	O
sustained	O
twofold	O
increase	O
in	O
GRE	DNA
binding	O
in	O
PBMCs	cell_type
from	O
steroid-sensitive	O
asthmatic	O
patients	O
and	O
nonasthmatic	O
individuals	O
,	O
but	O
this	O
was	O
markedly	O
reduced	O
in	O
steroid-resistant	O
asthmatic	O
patients	O
.	O
Scatchard	O
analysis	O
of	O
glucocorticoid	protein
receptor	protein
-	O
GRE	DNA
binding	O
showed	O
no	O
change	O
in	O
binding	O
affinity	O
but	O
did	O
show	O
a	O
reduced	O
number	O
of	O
receptors	protein
available	O
for	O
DNA	O
binding	O
in	O
the	O
steroid-resistant	O
patients	O
.	O
These	O
results	O
suggest	O
that	O
the	O
ability	O
of	O
the	O
glucocorticoid	protein
receptor	protein
to	O
bind	O
to	O
GRE	DNA
is	O
impaired	O
in	O
steroid-resistant	O
patients	O
because	O
of	O
a	O
reduced	O
number	O
of	O
receptors	protein
available	O
for	O
binding	O
to	O
DNA.	O

Interleukin-5	protein
signaling	O
in	O
human	cell_type
eosinophils	cell_type
involves	O
JAK2	protein
tyrosine	protein
kinase	protein
and	O
Stat1	protein
alpha	protein
.	O
Signaling	O
by	O
a	O
wide	O
variety	O
of	O
cytokines	protein
,	O
including	O
interferons	protein
,	O
interleukins	protein
,	O
and	O
growth	protein
factors	protein
,	O
involves	O
activation	O
of	O
JAK	protein
kinases	protein
and	O
Stat	protein
(	protein
Signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
)	protein
proteins	protein
.	O
At	O
present,	O
not	O
much	O
is	O
known	O
about	O
the	O
molecular	O
mechanisms	O
by	O
which	O
interleukin-5	protein
(	O
IL-5	protein
)	O
exerts	O
its	O
diverse	O
biologic	O
effects	O
.	O
Human	cell_type
eosinophils	cell_type
are	O
one	O
of	O
the	O
most	O
important	O
target	cell_type
cells	cell_type
for	O
IL-5	protein
and	O
were	O
used	O
here	O
to	O
study	O
IL-5	protein
signaling	O
in	O
a	O
primary	cell_type
human	cell_type
cell	cell_type
.	O
IL-5	protein
induced	O
rapid	O
and	O
transient	O
tyrosine	O
phosphorylation	O
of	O
JAK2	protein
.	O
Moreover,	O
IL-5	protein
induced	O
at	O
least	O
two	O
DNA-binding	protein
complexes	protein
,	O
using	O
nuclear	O
extracts	O
from	O
normal	O
human	cell_type
eosinophils	cell_type
and	O
the	O
IL-6/interferon-gamma	DNA
response	DNA
element	DNA
of	O
the	O
ICAM-1	DNA
promoter	DNA
(	O
ICAM-1	DNA
pIRE	DNA
)	O
in	O
an	O
electromobility	O
shift	O
assay	O
.	O
From	O
supershift	O
experiments	O
it	O
was	O
concluded	O
that	O
one	O
DNA-binding	protein
complex	protein
contained	O
Stat1	protein
alpha	protein
,	O
probably	O
as	O
a	O
homodimer.	O
Both	O
DNA-binding	protein
complexes	protein
were	O
inhibited	O
by	O
a	O
phosphotyrosine	protein
antibody	protein
(	O
4G10	protein
),	O
suggesting	O
that	O
tyrosine	O
phosphorylation	O
is	O
required	O
for	O
complex	O
formation	O
.	O
IL-3	protein
and	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
induced,	O
similar	O
to	O
IL-5	protein
,	O
two	O
DNA-binding	protein
complexes	protein
in	O
human	cell_type
eosinophils	cell_type
,	O
including	O
Stat1	protein
alpha	protein
.	O
These	O
data	O
show	O
for	O
the	O
first	O
time	O
that	O
molecular	O
mechanisms	O
of	O
IL-5	protein
signaling	O
in	O
human	cell_type
eosinophils	cell_type
involve	O
members	O
of	O
the	O
JAK	protein
kinase	protein
family	protein
as	O
well	O
as	O
members	O
of	O
the	O
Stat	protein
family	protein
.	O

Infection	O
and	O
replication	O
of	O
Tat-	O
human	O
immunodeficiency	O
viruses	O
:	O
genetic	O
analyses	O
of	O
LTR	DNA
and	O
tat	protein
mutations	protein
in	O
primary	O
and	O
long-term	O
human	O
lymphoid	O
cells	O
.	O
Tat	protein
is	O
an	O
essential	O
regulatory	protein
protein	protein
for	O
the	O
replication	O
of	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
).	O
Mutations	O
in	O
the	O
tat	DNA
gene	DNA
have	O
been	O
shown	O
to	O
block	O
HIV	O
replication	O
in	O
human	cell_type
T	cell_type
cells	cell_type
.	O
Several	O
studies	O
have	O
established	O
that	O
Tat	protein
releases	O
an	O
elongation	protein
block	protein
to	O
the	O
transcription	O
of	O
HIV	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
);	O
however,	O
it	O
is	O
not	O
known	O
whether	O
this	O
mechanism	O
alone	O
is	O
sufficient	O
to	O
explain	O
the	O
block	O
to	O
HIV	O
replication	O
in	O
human	cell_type
T	cell_type
cells	cell_type
when	O
Tat	protein
is	O
absent.	O
It	O
is	O
possible	O
that	O
Tat	protein
is	O
also	O
needed	O
for	O
other	O
functions	O
during	O
HIV	O
replication	O
.	O
To	O
test	O
these	O
hypotheses,	O
we	O
studied	O
several	O
tat	protein
mutants	protein
,	O
including	O
two	O
stop	protein
codon	protein
mutants	protein
and	O
one	O
deletion	protein
mutant	protein
using	O
replication-competent	DNA
HIV-1	DNA
constructs	DNA
carrying	O
wild-type	O
or	O
mutant	O
LTRs	O
with	O
modifications	O
in	O
the	O
NF-kappa	O
B	O
and/or	O
Sp1	O
binding	O
sites	O
.	O
In	O
this	O
study,	O
we	O
show	O
that	O
Tat-	O
HIV-1	O
with	O
wild-type	DNA
LTRs	DNA
can	O
replicate	O
in	O
HeLa	cell_line
cells	cell_line
,	O
and	O
the	O
virus	O
produced	O
from	O
HeLa	cell_line
cells	cell_line
can	O
infect	O
primary	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
and	O
macrophages	cell_type
.	O
It	O
was	O
found	O
that	O
the	O
propagation	O
of	O
the	O
Tat	protein
mutants	protein
containing	O
wild-type	DNA
LTRs	DNA
was	O
less	O
efficient	O
than	O
that	O
of	O
the	O
LTR-modified	protein
Tat	protein
mutants	protein
.	O
Large	O
amounts	O
of	O
viral	RNA
RNA	RNA
and	O
particles	O
were	O
synthesized	O
in	O
infections	O
established	O
using	O
the	O
tat	protein
mutants	protein
that	O
contain	O
modified	DNA
LTRs	DNA
.	O
However,	O
this	O
efficient	O
propagation	O
of	O
the	O
LTR-modified	protein
tat	protein
mutants	protein
was	O
restricted	O
to	O
some	O
lymphoid	cell_line
cell	cell_line
lines	cell_line
that	O
have	O
been	O
transformed	O
with	O
other	O
viruses	O
.	O
Thus,	O
despite	O
its	O
essential	O
role	O
for	O
releasing	O
an	O
elongation	protein
block	protein
,	O
Tat	protein
is	O
not	O
otherwise	O
absolutely	O
required	O
for	O
synthesis	O
of	O
full-length	RNA
HIV	RNA
transcripts	RNA
and	O
assembly	O
of	O
virus	O
particles	O
.	O
Direct	O
sequencing	O
of	O
the	O
viral	DNA
genomes	DNA
and	O
reinfection	O
kinetics	O
showed	O
no	O
evidence	O
of	O
wild-type	O
reversion	O
even	O
after	O
prolonged	O
infection	O
with	O
the	O
Tat	protein
-virus	O
.	O
The	O
implications	O
for	O
in	O
vivo	O
HIV-1	O
replication	O
and	O
potential	O
application	O
of	O
this	O
system	O
to	O
the	O
study	O
of	O
alternative	O
Tat	protein
function	O
are	O
discussed.	O

Functional	O
roles	O
of	O
the	O
transcription	protein
factor	protein
Oct-2A	protein
and	O
the	O
high	protein
mobility	protein
group	protein
protein	protein
I/Y	protein
in	O
HLA-DRA	DNA
gene	DNA
expression	O
.	O
The	O
class	DNA
II	DNA
major	DNA
histocompatibility	DNA
complex	DNA
gene	DNA
HLA-DRA	DNA
is	O
expressed	O
in	O
B	cell_type
cells	cell_type
,	O
activated	O
T	cell_type
lymphocytes	cell_type
,	O
and	O
in	O
antigen-presenting	cell_type
cells	cell_type
.	O
In	O
addition,	O
HLA-DRA	DNA
gene	DNA
expression	O
is	O
inducible	O
in	O
a	O
variety	O
of	O
cell	O
types	O
by	O
interferon-gamma	protein
(	O
IFN-gamma	protein
).	O
Here	O
we	O
show	O
that	O
the	O
lymphoid-specific	protein
transcription	protein
factor	protein
Oct-2A	protein
plays	O
a	O
critical	O
role	O
in	O
HLA-DRA	DNA
gene	DNA
expression	O
in	O
class	cell_line
II-positive	cell_line
B	cell_line
cell	cell_line
lines	cell_line
,	O
and	O
that	O
the	O
high	protein
mobility	protein
group	protein
protein	protein
(	O
HMG	protein
)	O
I/Y	protein
binds	O
to	O
multiple	O
sites	O
within	O
the	O
DRA	DNA
promoter	DNA
,	O
including	O
the	O
Oct-2A	DNA
binding	DNA
site	DNA
.	O
Coexpression	O
of	O
HMG	protein
I/Y	protein
and	O
Oct-2	protein
in	O
cell	cell_line
lines	cell_line
lacking	O
Oct-2	protein
results	O
in	O
high	O
levels	O
of	O
HLA-DRA	DNA
gene	DNA
expression	O
,	O
and	O
in	O
vitro	O
DNA-binding	O
studies	O
reveal	O
that	O
HMG	O
I/Y	protein
stimulates	O
Oct-2A	protein
binding	O
to	O
the	O
HLA-DRA	DNA
promoter	DNA
.	O
Thus,	O
Oct-2A	protein
and	O
HMG	protein
I/Y	protein
may	O
synergize	O
to	O
activate	O
HLA-DRA	DNA
expression	O
in	O
B	cell_type
cells	cell_type
.	O
By	O
contrast,	O
Oct-2A	protein
is	O
not	O
involved	O
in	O
the	O
IFN-gamma	protein
induction	O
of	O
the	O
HLA-DRA	DNA
gene	DNA
in	O
HeLa	cell_line
cells	cell_line
,	O
but	O
antisense	DNA
HMG	DNA
I/Y	DNA
dramatically	O
decreases	O
the	O
level	O
of	O
induction.	O
We	O
conclude	O
that	O
distinct	O
sets	O
of	O
transcription	protein
factors	protein
are	O
involved	O
in	O
the	O
two	O
modes	O
of	O
HLA-DRA	DNA
expression	O
,	O
and	O
that	O
HMG	protein
I/Y	protein
may	O
be	O
important	O
for	O
B	O
cell-specific	O
expression	O
,	O
and	O
is	O
essential	O
for	O
IFN-gamma	protein
induction	O
.	O

Heterogeneous	O
expression	O
of	O
Epstein-Barr	protein
virus	protein
latent	protein
proteins	protein
in	O
endemic	O
Burkitt's	O
lymphoma	O
.	O
Epstein-Barr	cell_type
virus	cell_type
(EBV)-infected	cell_type
cells	cell_type
may	O
sustain	O
three	O
distinct	O
forms	O
of	O
virus	O
latency	O
.	O
In	O
lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
,	O
six	O
EBV-encoded	protein
nuclear	protein
antigens	protein
(	O
EBNA	O
1	O
,	O
2	O
,	O
3A	O
,	O
3B	O
,	O
3C	O
,	O
-LP	O
),	O
three	O
latent	protein
membrane	protein
proteins	protein
(	O
LMP1	protein
,	O
2A	protein
,	O
2B	protein
),	O
and	O
two	O
nuclear	RNA
RNAs	RNA
(	O
EBERs	RNA
)	O
are	O
expressed.	O
This	O
form	O
of	O
latency	O
,	O
termed	O
latency	O
III	O
,	O
is	O
also	O
encountered	O
in	O
some	O
posttransplant	O
lymphoproliferative	O
disorders	O
.	O
In	O
EBV-positive	O
cases	O
of	O
Hodgkin's	O
disease	O
,	O
the	O
EBERs	RNA
,	O
EBNA1	protein
,	O
and	O
the	O
LMPs	protein
are	O
expressed	O
(	O
latency	O
II	O
),	O
whereas	O
in	O
Burkitt's	O
lymphoma	O
(BL)	O
only	O
the	O
EBERs	RNA
and	O
EBNA1	protein
have	O
been	O
detected	O
(	O
latency	O
I	O
).	O
We	O
have	O
studied	O
the	O
expression	O
of	O
EBV	protein
proteins	protein
in	O
17	O
cases	O
of	O
EBV-positive	O
endemic	O
BL	O
by	O
immunohistology	O
.	O
Expression	O
of	O
LMP1	protein
was	O
seen	O
in	O
variable	O
proportions	O
of	O
tumor	cell_type
cells	cell_type
in	O
two	O
cases	O
and	O
EBNA2	protein
was	O
detected	O
in	O
some	O
tumor	cell_type
cells	cell_type
in	O
three	O
other	O
cases.	O
Also,	O
the	O
BZLF1	protein
trans-activator	protein
protein	protein
was	O
expressed	O
in	O
a	O
few	O
tumor	cell_type
cells	cell_type
in	O
6	O
cases,	O
indicating	O
entry	O
into	O
the	O
lytic	O
cycle	O
.	O
A	O
phenotypic	O
drift	O
from	O
latency	O
I	O
to	O
latency	O
III	O
has	O
been	O
observed	O
previously	O
in	O
some	O
BL	cell_line
cell	cell_line
lines	cell_line
.	O
Our	O
results	O
suggest	O
that	O
a	O
similar	O
phenomenon	O
may	O
occur	O
in	O
BL	O
in	O
vivo	O
and	O
indicate	O
that	O
the	O
operational	O
definition	O
of	O
EBV	O
latencies	O
is	O
not	O
easily	O
applied	O
to	O
human	O
tumors	O
.	O

The	O
activation	O
of	O
the	O
Jak	protein
-STAT	protein
1	protein
signaling	O
pathway	O
by	O
IL-5	protein
in	O
eosinophils	cell_type
.	O
The	O
intracellular	O
signal	O
transduction	O
of	O
IL-5	protein
in	O
eosinophils	cell_type
is	O
unknown.	O
The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
involvement	O
of	O
the	O
newly	O
discovered	O
Jak	protein
-STAT	protein
pathway	O
in	O
the	O
IL-5	protein
signal	O
transduction	O
mechanism	O
.	O
Eosinophils	cell_type
were	O
purified	O
from	O
peripheral	O
blood	O
by	O
discontinuous	O
Percoll	O
gradients	O
and	O
stimulated	O
with	O
IL-5	protein
.	O
The	O
involvement	O
of	O
Jak	protein
2	protein
was	O
investigated	O
by	O
immunoprecipitation	O
followed	O
by	O
immunoblotting	O
for	O
tyrosine	O
phosphorylation	O
.	O
The	O
activation	O
of	O
Jak	protein
2	protein
was	O
studied	O
by	O
autophosphorylation	O
of	O
the	O
immunoprecipitated	protein
kinase	protein
.	O
Jak	protein
2	protein
was	O
tyrosine	O
phosphorylated	O
within	O
1	O
to	O
3	O
min	O
after	O
stimulation	O
of	O
eosinophils	cell_type
with	O
IL-5	protein
.	O
Further,	O
the	O
immunoprecipitated	protein
Jak	protein
2	protein
obtained	O
from	O
IL-5	cell_line
-stimulated	cell_line
cells	cell_line
underwent	O
autophosphorylation	O
.	O
Jak	protein
2	protein
coprecipitated	O
with	O
the	O
beta-subunit	O
of	O
the	O
IL-5	protein
receptor	protein
,	O
suggesting	O
a	O
physical	O
association	O
of	O
the	O
kinase	protein
with	O
the	O
receptor.	O
The	O
nuclear	protein
factor	protein
STAT-1	protein
(	O
p91	protein
)	O
was	O
investigated	O
by	O
immunoprecipitation	O
followed	O
by	O
immunoblotting	O
for	O
tyrosine	O
phosphorylation	O
.	O
STAT-1	protein
was	O
tyrosine	O
phosphorylated	O
within	O
15	O
min	O
of	O
IL-5	protein
stimulation	O
.	O
The	O
presence	O
of	O
STAT-1	protein
in	O
the	O
nuclear	O
extract	O
was	O
studied	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O
IL-5	protein
induced	O
two	O
proteins	O
that	O
bound	O
to	O
the	O
gamma-activating	DNA
sequence	DNA
.	O
In	O
the	O
presence	O
of	O
an	O
anti-	protein
STAT-1	protein
Ab	protein
,	O
the	O
band	O
was	O
supershifted.	O
Thus,	O
we	O
demonstrated	O
that	O
IL-5	protein
activated	O
the	O
Jak	protein
2	protein
-STAT	protein
1	protein
signaling	O
pathway	O
in	O
eosinophils	cell_type
.	O
We	O
speculate	O
that	O
the	O
Jak	protein
2	protein
-STAT	protein
1	protein
pathway	O
may	O
be	O
involved	O
in	O
the	O
activation	O
of	O
IL-5	DNA
-inducible	DNA
genes	DNA
in	O
eosinophils	cell_type
.	O

Reduced	O
mitogenic	O
stimulation	O
of	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
as	O
a	O
prognostic	O
parameter	O
for	O
the	O
course	O
of	O
breast	O
cancer	O
:	O
a	O
prospective	O
longitudinal	O
study	O
.	O
Immunosuppression	O
has	O
been	O
often	O
associated	O
with	O
the	O
course	O
of	O
malignant	O
diseases	O
.	O
In	O
the	O
present	O
study,	O
the	O
proliferation	O
of	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMCs	cell_type
)	O
in	O
response	O
to	O
mitogenic	O
stimulation	O
with	O
phytohaemagglutinin	protein
(	O
PHA	protein
)	O
was	O
assessed	O
prospectively	O
in	O
90	O
patients	O
with	O
stage	O
I-III	O
breast	O
cancer	O
.	O
Whereas	O
PHA	protein
-induced	O
proliferation	O
of	O
PBMCs	cell_type
derived	O
from	O
patients	O
with	O
breast	O
cancer	O
preoperatively	O
was	O
significantly	O
decreased	O
when	O
compared	O
with	O
data	O
obtained	O
in	O
healthy	O
control	O
individuals	O
(P	O
&lt;	O
0.001),	O
the	O
degree	O
of	O
the	O
defect	O
in	O
PHA	protein
-induced	O
proliferation	O
of	O
PBMCs	cell_type
depended	O
upon	O
the	O
tumour	O
burden	O
as	O
manifested	O
by	O
tumour	O
size	O
and	O
axillary	O
lymph	O
node	O
involvement	O
(P	O
&lt;	O
0.003	O
in	O
each	O
case).	O
PHA	protein
-induced	O
proliferation	O
of	O
PBMCs	cell_type
dropped	O
significantly	O
in	O
patients	O
who	O
received	O
adjuvant	O
chemotherapy	O
consisting	O
of	O
cyclophosphamide	O
,	O
methotrexate	O
and	O
fluorouracil	O
(	O
CMF	O
)	O
after	O
an	O
observation	O
period	O
of	O
6	O
months	O
(P	O
&lt;	O
0.01),	O
but	O
not	O
in	O
patients	O
under	O
adjuvant	O
treatment	O
with	O
tamoxifen	O
only.	O
After	O
an	O
additional	O
6	O
months	O
(i.e.	O
12	O
months	O
after	O
surgery),	O
PHA	protein
-induced	O
proliferation	O
of	O
PBMCs	cell_type
was	O
similar	O
in	O
patients	O
after	O
adjuvant	O
chemotherapy	O
with	O
CMF	O
and	O
in	O
those	O
receiving	O
continued	O
adjuvant	O
tamoxifen	O
treatment	O
(P	O
&gt;	O
0.1),	O
but	O
in	O
all	O
patients	O
still	O
significantly	O
decreased	O
as	O
compared	O
with	O
healthy	O
controls	O
(P	O
&lt;	O
0.001).	O
When	O
data	O
obtained	O
preoperatively	O
and	O
after	O
12	O
months	O
were	O
compared,	O
it	O
was	O
found	O
that	O
out	O
of	O
23	O
patients	O
whose	O
PBMCs	cell_type
had	O
experienced	O
a	O
drop	O
in	O
their	O
PHA	protein
-induced	O
proliferation	O
,	O
14	O
(61%)	O
had	O
developed	O
metastatic	O
disease	O
within	O
the	O
subsequent	O
24	O
months	O
(i.e.	O
36	O
months	O
after	O
surgery).	O
In	O
contrast,	O
out	O
of	O
59	O
patients	O
whose	O
PBMCs	cell_type
showed	O
an	O
increase	O
in	O
their	O
PHA	protein
-induced	O
proliferation	O
within	O
the	O
first	O
12	O
months	O
after	O
surgery,	O
only	O
one	O
(2%)	O
presented	O
with	O
disease	O
progression	O
.	O
We	O
thus	O
conclude	O
that	O
PHA	protein
-induced	O
proliferation	O
of	O
PBMCs	cell_type
derived	O
from	O
patients	O
with	O
breast	O
cancer	O
depends	O
upon	O
the	O
tumour	O
load	O
and	O
is	O
a	O
good	O
clinical	O
predictor	O
for	O
the	O
further	O
course	O
of	O
the	O
disease.	O

Activation	O
of	O
transcription	O
by	O
binding	O
of	O
NF-E1	protein
(	O
YY1	protein
)	O
to	O
a	O
newly	O
identified	O
element	O
in	O
the	O
first	O
exon	O
of	O
the	O
human	DNA
DR	DNA
alpha	DNA
gene	DNA
.	O
A	O
previously	O
unrecognized	O
element,	O
located	O
downstream	O
of	O
the	O
start	DNA
site	DNA
of	DNA
transcription	DNA
in	O
the	O
first	O
exon	DNA
of	O
the	O
DR	DNA
alpha	DNA
gene	DNA
,	O
has	O
been	O
defined	O
that	O
enhances	O
promoter	O
activity	O
up	O
to	O
eightfold	O
in	O
a	O
position-dependent	O
manner	O
.	O
Mutations	O
in	O
this	O
DNA-binding	DNA
site	DNA
abolished	O
binding	O
of	O
a	O
nuclear	protein
factor	protein
in	O
human	O
B	O
cell	O
nuclear	O
extract	O
and	O
decreased	O
the	O
activity	O
of	O
the	O
DR	DNA
alpha	DNA
promoter	DNA
to	O
a	O
basal	O
level	O
.	O
Significant	O
sequence	O
homology	O
of	O
this	O
element	DNA
was	O
found	O
in	O
the	O
DNA	O
of	O
the	O
DR	O
beta	O
,	O
DP	O
alpha	O
and	O
-beta	O
,	O
and	O
DQ	O
alpha	O
genes	O
,	O
always	O
located	O
downstream	O
of	O
the	O
transcriptional	DNA
start	DNA
site	DNA
.	O
The	O
nuclear	O
factor	O
binds	O
to	O
the	O
DR	O
alpha	O
and	O
DP	O
alpha	O
element	O
but	O
not	O
to	O
the	O
element	O
in	O
the	O
DQ	DNA
alpha	DNA
gene	DNA
.	O
It	O
was	O
identified	O
as	O
NF-E1	protein
(	O
YY1	protein
).	O
This	O
protein,	O
previously	O
identified	O
by	O
its	O
binding	O
to	O
the	O
Ig	DNA
kappa	DNA
3'	DNA
enhancer	DNA
and	O
the	O
Ig	DNA
heavy	DNA
chain	DNA
mu	DNA
E1	DNA
site	DNA
,	O
thus	O
also	O
appears	O
to	O
be	O
quite	O
important	O
in	O
the	O
regulation	O
of	O
MHC	DNA
class	DNA
II	DNA
gene	DNA
expression	O
.	O

Transcriptional	O
activity	O
of	O
core	O
binding	O
factor-	O
alpha	O
(AML1)	O
and	O
beta	O
subunits	O
on	O
murine	DNA
leukemia	DNA
virus	DNA
enhancer	DNA
cores	DNA
.	O
Core	protein
binding	protein
factor	protein
(	O
CBF	protein
),	O
also	O
known	O
as	O
polyomavirus	protein
enhancer-binding	protein
protein	protein
2	protein
and	O
SL3	protein
enhancer	protein
factor	protein
1	protein
,	O
is	O
a	O
mammalian	protein
transcription	protein
factor	protein
that	O
binds	O
to	O
an	O
element	O
termed	O
the	O
core	O
within	O
the	O
enhancers	DNA
of	O
the	O
murine	O
leukemia	O
virus	O
family	O
of	O
retroviruses	O
.	O
The	O
core	DNA
elements	DNA
of	O
the	O
SL3	O
virus	O
are	O
important	O
genetic	O
determinants	O
of	O
the	O
ability	O
of	O
this	O
virus	O
to	O
induce	O
T-cell	O
lymphomas	O
and	O
the	O
transcriptional	O
activity	O
of	O
the	O
viral	DNA
long	DNA
terminal	DNA
repeat	DNA
in	O
T	cell_type
lymphocytes	cell_type
.	O
CBF	protein
consists	O
of	O
two	O
subunits,	O
a	O
DNA	protein
binding	protein
subunit	protein
,	O
CBF	protein
alpha	protein
,	O
and	O
a	O
second	O
subunit,	O
CBF	protein
beta	protein
,	O
that	O
stimulates	O
the	O
DNA	O
binding	O
activity	O
of	O
CBF	protein
alpha	protein
.	O
One	O
of	O
the	O
genes	O
that	O
encodes	O
a	O
CBF	protein
alpha	protein
subunit	protein
is	O
AML1	protein
,	O
also	O
called	O
Cbf	protein
alpha	protein
2	protein
.	O
This	O
locus	O
is	O
rearranged	O
by	O
chromosomal	O
translocations	O
in	O
human	O
myeloproliferative	O
disorders	O
and	O
leukemias	O
.	O
An	O
exogenously	O
expressed	O
Cbf	protein
alpha	protein
2	protein
-encoded	protein
subunit	protein
(	O
CBF	protein
alpha	protein
2-451	protein
)	O
stimulated	O
transcription	O
from	O
the	O
SL3	DNA
enhancer	DNA
in	O
P19	protein
and	O
HeLa	cell_line
cells	cell_line
.	O
Activity	O
was	O
mediated	O
through	O
the	O
core	DNA
elements	DNA
.	O
Three	O
different	O
isoforms	O
of	O
CBF	protein
beta	protein
were	O
also	O
tested	O
for	O
transcriptional	O
activity	O
on	O
the	O
SL3	DNA
enhancer	DNA
.	O
The	O
longest	O
form,	O
CBF	protein
beta	protein
-187	protein
,	O
increased	O
the	O
transcriptional	O
stimulation	O
by	O
CBF	protein
alpha	protein
2-451	protein
twofold	O
in	O
HeLa	cell_line
cells	cell_line
,	O
although	O
it	O
had	O
no	O
effect	O
in	O
P19	cell_line
cells	cell_line
.	O
Transcriptional	O
activation	O
by	O
CBF	protein
beta	protein
required	O
binding	O
to	O
the	O
CBF	protein
alpha	protein
subunit	protein
,	O
as	O
a	O
form	O
of	O
CBF	protein
beta	protein
that	O
lacked	O
binding	O
ability,	O
CBF	protein
beta	protein
-148	protein
,	O
failed	O
to	O
increase	O
activity.	O
These	O
results	O
indicated	O
that	O
at	O
least	O
in	O
certain	O
cell	O
types,	O
the	O
maximum	O
activity	O
of	O
CBF	protein
required	O
both	O
subunits.	O
They	O
also	O
provided	O
support	O
for	O
the	O
hypothesis	O
that	O
CBF	protein
is	O
a	O
factor	O
in	O
T	cell_type
lymphocytes	cell_type
that	O
is	O
responsible	O
for	O
recognition	O
of	O
the	O
SL3	DNA
cores	DNA
.	O
We	O
also	O
examined	O
whether	O
CBF	protein
could	O
distinguish	O
a	O
1-bp	O
difference	O
between	O
the	O
enhancer	DNA
core	DNA
of	DNA
SL3	DNA
and	O
the	O
core	O
of	O
the	O
nonleukemogenic	O
virus	O
,	O
Akv	O
.	O
This	O
difference	O
strongly	O
affects	O
transcription	O
in	O
T	O
cells	O
and	O
leukemogenicity	O
of	O
SL3	DNA
.	O
However,	O
no	O
combination	O
of	O
CBF	protein
alpha	protein
and	O
CBF	protein
beta	protein
subunits	O
that	O
we	O
tested	O
was	O
able	O
to	O
distinguish	O
the	O
1-bp	O
difference	O
in	O
transcription	O
assays	O
.	O
Thus,	O
a	O
complete	O
understanding	O
of	O
how	O
T	cell_type
cells	cell_type
recognize	O
the	O
SL3	DNA
core	DNA
remains	O
to	O
be	O
elucidated.	O

Interleukin	protein
(IL)-10	protein
inhibits	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF	protein
kappa	protein
B	protein
)	O
activation	O
in	O
human	cell_type
monocytes	cell_type
.	O
IL-10	protein
and	O
IL-4	protein
suppress	O
cytokine	protein
synthesis	O
by	O
different	O
mechanisms.	O
Our	O
previous	O
studies	O
in	O
human	cell_type
monocytes	cell_type
have	O
demonstrated	O
that	O
interleukin	protein
(IL)-10	protein
inhibits	O
lipopolysaccharide	O
(LPS)-stimulated	O
production	O
of	O
inflammatory	protein
cytokines	protein
,	O
IL-1	protein
beta	protein
,	O
IL-6	protein
,	O
IL-8	protein
,	O
and	O
tumor	protein
necrosis	protein
factor	protein
(TNF)-alpha	protein
by	O
blocking	O
gene	O
transcription	O
.	O
Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSA	O
),	O
we	O
now	O
show	O
that,	O
in	O
monocytes	O
stimulated	O
with	O
LPS	O
or	O
TNF	protein
alpha	protein
,	O
IL-10	protein
inhibits	O
nuclear	O
stimulation	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF	protein
kappa	protein
B	protein
),	O
a	O
transcription	protein
factor	protein
involved	O
in	O
the	O
expression	O
of	O
inflammatory	DNA
cytokine	DNA
genes	DNA
.	O
Several	O
other	O
transcription	protein
factors	protein
including	O
NF-	O
IL-6	protein
,	O
AP-1	protein
,	O
AP-2	protein
,	O
GR	protein
,	O
CREB	protein
,	O
Oct-1	protein
,	O
and	O
Sp-1	protein
are	O
not	O
affected	O
by	O
IL-10	protein
.	O
This	O
selective	O
inhibition	O
by	O
IL-10	protein
of	O
NF	protein
kappa	protein
B	protein
activation	O
occurs	O
rapidly	O
and	O
in	O
a	O
dose-dependent	O
manner	O
and	O
correlates	O
well	O
with	O
IL-10	protein
's	O
cytokine	protein
synthesis	O
inhibitory	O
activity	O
in	O
terms	O
of	O
both	O
kinetics	O
and	O
dose	O
responsiveness	O
.	O
Furthermore,	O
compounds	O
such	O
as	O
tosylphenylalanyl	O
chloromethyl	O
ketone	O
and	O
pyrrolidinedithiocarbamate	O
that	O
are	O
known	O
to	O
selectively	O
inhibit	O
NF	protein
kappa	protein
B	protein
activation	O
block	O
cytokine	O
gene	O
transcription	O
in	O
LPS	cell_line
-stimulated	cell_line
monocytes	cell_line
.	O
Taken	O
together,	O
these	O
results	O
suggest	O
that	O
inhibition	O
of	O
NF	protein
kappa	protein
B	protein
activation	O
may	O
be	O
an	O
important	O
mechanism	O
for	O
IL-10	protein
suppression	O
of	O
cytokine	O
gene	O
transcription	O
in	O
human	cell_type
monocytes	cell_type
.	O
IL-4	protein
,	O
another	O
cytokine	protein
that	O
inhibits	O
cytokine	RNA
mRNA	RNA
accumulation	O
in	O
monocytes	cell_type
,	O
shows	O
little	O
inhibitory	O
effect	O
on	O
LPS	O
-induced	O
NF	protein
kappa	protein
B	protein
activation	O
.	O
Further	O
examination	O
reveals	O
that,	O
unlike	O
IL-10	protein
,	O
IL-4	protein
enhances	O
mRNA	RNA
degradation	O
and	O
does	O
not	O
suppress	O
cytokine	O
gene	O
transcription	O
.	O
These	O
data	O
indicate	O
that	O
IL-10	protein
and	O
IL-4	protein
inhibit	O
cytokine	protein
production	O
by	O
different	O
mechanisms.	O

LMP-1	protein
activates	O
NF-kappa	protein
B	protein
by	O
targeting	O
the	O
inhibitory	protein
molecule	protein
I	protein
kappa	protein
B	protein
alpha	protein
.	O
LMP-1	protein
,	O
an	O
Epstein-Barr	protein
virus	protein
membrane	protein
protein	protein
expressed	O
during	O
latent	O
infection	O
,	O
has	O
oncogenic	O
properties	O
,	O
as	O
judged	O
from	O
its	O
ability	O
to	O
transform	O
B	O
lymphocytes	cell_type
and	O
rodent	cell_type
fibroblasts	cell_type
.	O
LMP-1	protein
induces	O
the	O
expression	O
of	O
bcl2	DNA
,	O
an	O
oncogene	DNA
which	O
protects	O
cells	O
from	O
apoptosis	O
,	O
as	O
well	O
as	O
of	O
genes	O
encoding	O
other	O
proteins	O
involved	O
in	O
cell	O
regulation	O
and	O
growth	O
control	O
.	O
The	O
mechanisms	O
by	O
which	O
LMP-1	protein
upregulates	O
these	O
proteins	O
is	O
unknown,	O
but	O
it	O
is	O
plausible	O
that	O
LMP-1	protein
modifies	O
signal	O
transduction	O
pathways	O
that	O
result	O
in	O
the	O
activation	O
of	O
one	O
or	O
more	O
transcription	protein
factors	protein
that	O
ultimately	O
regulate	O
transcription	O
of	O
oncogenic	DNA
genes	DNA
.	O
NF-kappa	protein
B	protein
,	O
a	O
transcription	protein
factor	protein
controlling	O
the	O
expression	O
of	O
genes	DNA
involved	O
in	O
cell	O
activation	O
and	O
growth	O
control	O
,	O
has	O
been	O
shown	O
to	O
be	O
activated	O
by	O
LMP-1	protein
.	O
The	O
mechanism(s)	O
regulating	O
this	O
activation	O
remains	O
unknown.	O
Our	O
data	O
indicate	O
that	O
increased	O
NF-kappa	protein
B	protein
DNA	O
binding	O
and	O
functional	O
activity	O
are	O
present	O
in	O
B-lymphoid	cell_type
cells	cell_type
stably	O
or	O
transiently	O
expressing	O
LMP-1	protein
.	O
I	protein
kappa	protein
B	protein
alpha	protein
is	O
selectively	O
modified	O
in	O
LMP-1	cell_line
-expressing	cell_line
B	cell_line
cells	cell_line
.	O
A	O
phosphorylated	O
form	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
and	O
increased	O
protein	O
turnover-degradation	O
correlate	O
with	O
increased	O
NF-kappa	protein
B	protein
nuclear	O
translocation	O
.	O
This	O
results	O
in	O
increased	O
transcription	O
of	O
NF-kappa	DNA
B	DNA
-dependent-genes	DNA
,	O
including	O
those	O
encoding	O
p105	protein
and	O
I	protein
kappa	protein
B	protein
alpha	protein
(	O
MAD3	DNA
).	O
These	O
results	O
indicate	O
that	O
LMP-1	protein
activates	O
NF-kappa	protein
B	protein
in	O
B-cell	cell_line
lines	cell_line
by	O
targeting	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
Identification	O
of	O
the	O
pathways	O
activated	O
by	O
LMP-1	protein
to	O
result	O
in	O
posttranslational	O
modifications	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
will	O
aid	O
in	O
determining	O
the	O
role	O
of	O
this	O
virus-host	O
cell	O
protein	O
interaction	O
in	O
Epstein-Barr	O
virus	O
-mediated	O
oncogenesis	O
.	O

Identification	O
of	O
human	DNA
TR2	DNA
orphan	DNA
receptor	DNA
response	DNA
element	DNA
in	O
the	O
transcriptional	DNA
initiation	DNA
site	DNA
of	O
the	O
simian	DNA
virus	DNA
40	DNA
major	DNA
late	DNA
promoter	DNA
[published	O
erratum	O
appears	O
in	O
J	O
Biol	O
Chem	O
1995	O
Nov	O
3;270(44):26721]	O
A	O
DNA	DNA
response	DNA
element	DNA
(	O
TR2RE-SV40	DNA
)	O
for	O
the	O
TR2	protein
orphan	protein
receptor	protein
,	O
a	O
member	O
of	O
the	O
steroid-thyroid	protein
hormone	protein
receptor	protein
superfamily	protein
,	O
has	O
been	O
identified	O
in	O
the	O
simian	DNA
virus	DNA
40	DNA
(	DNA
SV40	DNA
)	DNA
+55	DNA
region	DNA
(	O
nucleotide	DNA
numbers	DNA
368-389	DNA
,	O
5'-GTTAAGGTTCGTAGGTCATGGA-3'	O
).	O
Electrophoretic	O
mobility	O
shift	O
assay	O
,	O
using	O
in	O
vitro	O
translated	O
TR2	protein
orphan	protein
receptor	protein
with	O
a	O
molecular	O
mass	O
of	O
67	protein
kilodaltons	protein
,	O
showed	O
a	O
specific	O
binding	O
with	O
high	O
affinity	O
(dissociation	O
constant	O
=	O
9	O
nM)	O
for	O
this	O
DNA	DNA
sequence	DNA
.	O
DNA-swap	O
experiments	O
using	O
chloramphenicol	protein
acetyl-transferase	protein
assay	O
demonstrated	O
that	O
androgen	O
can	O
suppress	O
the	O
transcriptional	O
activities	O
of	O
SV40	DNA
early	DNA
promoter	DNA
via	O
the	O
interaction	O
between	O
this	O
TR2RE-	DNA
SV40	DNA
and	O
the	O
chimeric	protein
receptor	protein
AR/TR2/AR	protein
with	O
the	O
DNA-binding	protein
domain	protein
of	O
the	O
TR2	protein
orphan	protein
receptor	protein
flanked	O
by	O
the	O
N-terminal	O
and	O
androgen-binding	O
domains	O
of	O
the	O
androgen	protein
receptor	protein
.	O
In	O
addition,	O
this	O
TR2RE-	DNA
SV40	DNA
can	O
function	O
as	O
a	O
repressor	O
to	O
suppress	O
the	O
transcriptional	O
activities	O
of	O
both	O
SV40	O
early	O
and	O
late	O
promoters	O
.	O
Together,	O
these	O
data	O
suggest	O
the	O
TR2RE-	DNA
SV40	DNA
may	O
represent	O
the	O
first	O
identified	O
natural	O
DNA	DNA
response	DNA
element	DNA
for	O
the	O
TR2	protein
orphan	protein
receptor	protein
that	O
may	O
function	O
as	O
a	O
repressor	O
for	O
the	O
SV40	O
gene	O
expression	O
.	O

Detection	O
of	O
the	O
chromosome	RNA
16	RNA
CBF	RNA
beta-MYH11	RNA
fusion	RNA
transcript	RNA
in	O
myelomonocytic	O
leukemias	O
.	O
Karyotypic	O
detection	O
of	O
chromosomal	O
16	O
abnormalities	O
classically	O
associated	O
with	O
AML	O
M4Eo	O
can	O
be	O
difficult.	O
Characterization	O
of	O
the	O
two	O
genes	O
involved	O
in	O
the	O
inv(16)(p13q22)	O
,	O
CBF	DNA
beta	DNA
and	O
MYH11	DNA
,	O
has	O
allowed	O
the	O
detection	O
of	O
fusion	RNA
transcripts	RNA
by	O
reverse-transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
).	O
We	O
have	O
analyzed	O
CBF	RNA
beta	RNA
-MYH11	RNA
fusion	RNA
transcripts	RNA
by	O
RT-PCR	O
in	O
myelomonocytic	O
leukemias	O
,	O
with	O
or	O
without	O
eosinophilia	O
,	O
to	O
determine	O
whether	O
their	O
presence	O
correlates	O
with	O
morphology.	O
Fifty-three	O
cases	O
(11	O
AML	O
M4Eo	O
;	O
1	O
AML	O
M4	O
with	O
atypical	cell_type
abnormal	cell_type
eosinophils	cell_type
(AML	O
M4	O
"Eo");	O
29	O
AML	O
M4	O
;	O
8	O
AML	O
M5	O
;	O
3	O
CMML	O
;	O
and	O
1	O
AML	O
M2	O
with	O
eosinophilia	O
)	O
were	O
analyzed.	O
All	O
11	O
typical	O
AML	O
M4Eo	O
were	O
CBF	DNA
beta	DNA
-MYH11	DNA
positive.	O
The	O
single	O
case	O
of	O
AML	O
M4	O
with	O
distinctive	O
eosinophil	O
abnormalities	O
was	O
negative	O
by	O
karyotype	O
,	O
RT-PCR	O
and	O
fluorescent	O
in	O
situ	O
hybridization	O
(	O
FISH	O
).	O
Three	O
of	O
29	O
(10%)	O
AML	O
M4	O
without	O
abnormal	cell_type
eosinophils	cell_type
were	O
CBF	DNA
beta	DNA
-MYH11	DNA
positive,	O
1	O
of	O
which	O
did	O
not	O
show	O
any	O
apparent	O
chromosome	DNA
16	DNA
abnormalities	O
by	O
classical	O
metaphase	O
analysis	O
(2	O
not	O
tested).	O
Both	O
cases	O
tested	O
also	O
showed	O
MYH11	DNA
genomic	O
rearrangement	O
.	O
None	O
of	O
the	O
other	O
leukemias	O
were	O
RT-PCR	O
positive.	O
Follow-up	O
of	O
three	O
patient	O
showed	O
residual	O
positivity	O
in	O
apparent	O
complete	O
remission.	O
These	O
data	O
show	O
that	O
CBF	RNA
beta	RNA
-MYH11	RNA
fusion	RNA
transcripts	RNA
occur	O
not	O
only	O
in	O
the	O
vast	O
majority	O
of	O
typical	O
AML	O
M4Eo	O
,	O
but	O
also	O
in	O
approximately	O
10%	O
of	O
AML	O
M4	O
without	O
eosinophilic	O
abnormalities	O
,	O
a	O
much	O
higher	O
incidence	O
than	O
the	O
sporadic	O
reports	O
of	O
chromosome	DNA
16	DNA
abnormalities	O
in	O
AML	O
M4	O
would	O
suggest.	O
Taken	O
together	O
with	O
the	O
detection	O
of	O
CBF	DNA
beta	DNA
-	O
MYH11	RNA
transcripts	RNA
in	O
the	O
absence	O
of	O
apparent	O
chromosome	DNA
16	DNA
abnormalities	O
by	O
classical	O
banding	O
techniques,	O
these	O
data	O
show	O
that	O
additional	O
screening	O
by	O
either	O
RT-PCR	O
or	O
FISH	O
should	O
be	O
performed	O
in	O
all	O
AML	O
M4	O
,	O
regardless	O
of	O
morphologic	O
features,	O
to	O
allow	O
accurate	O
evaluation	O
of	O
the	O
prognostic	O
importance	O
of	O
this	O
fusion	RNA
transcript	RNA
.	O

HIV-1	protein
Tat	protein
potentiates	O
TNF	protein
-induced	O
NF-kappa	protein
B	protein
activation	O
and	O
cytotoxicity	O
by	O
altering	O
the	O
cellular	O
redox	O
state.	O
This	O
study	O
demonstrates	O
that	O
human	protein
immunodeficiency	protein
virus	protein
type	protein
1	protein
(	protein
HIV-1	protein
)	protein
Tat	protein
protein	protein
amplifies	O
the	O
activity	O
of	O
tumor	protein
necrosis	protein
factor	protein
(	O
TNF	protein
),	O
a	O
cytokine	O
that	O
stimulates	O
HIV-1	O
replication	O
through	O
activation	O
of	O
NF-kappa	protein
B	protein
.	O
In	O
HeLa	cell_line
cells	cell_line
stably	O
transfected	O
with	O
the	O
HIV-1	DNA
tat	DNA
gene	DNA
(	O
HeLa-tat	cell_line
cells	cell_line
),	O
expression	O
of	O
the	O
Tat	protein
protein	protein
enhanced	O
both	O
TNF	protein
-induced	O
activation	O
of	O
NF-kappa	protein
B	protein
and	O
TNF	protein
-mediated	O
cytotoxicity	O
.	O
A	O
similar	O
potentiation	O
of	O
TNF	protein
effects	O
was	O
observed	O
in	O
Jurkat	O
T	O
cells	O
and	O
HeLa	cell_line
cells	cell_line
treated	O
with	O
soluble	O
Tat	protein
protein	protein
.	O
TNF	protein
-mediated	O
activation	O
of	O
NF-kappa	protein
B	protein
and	O
cytotoxicity	O
involves	O
the	O
intracellular	O
formation	O
of	O
reactive	O
oxygen	O
intermediates	O
.	O
Therefore,	O
Tat	protein
-mediated	O
effects	O
on	O
the	O
cellular	O
redox	O
state	O
were	O
analyzed.	O
In	O
both	O
T	cell_type
cells	cell_type
and	O
HeLa	cell_line
cells	cell_line
HIV-1	protein
Tat	protein
suppressed	O
the	O
expression	O
of	O
Mn-dependent	protein
superoxide	protein
dismutase	protein
(	O
Mn-SOD	protein
),	O
a	O
mitochondrial	protein
enzyme	protein
that	O
is	O
part	O
of	O
the	O
cellular	O
defense	O
system	O
against	O
oxidative	O
stress	O
.	O
Thus,	O
Mn-SOD	protein
RNA	O
protein	O
levels	O
and	O
activity	O
were	O
markedly	O
reduced	O
in	O
the	O
presence	O
of	O
Tat	protein
.	O
Decreased	O
Mn-SOD	protein
expression	O
was	O
associated	O
with	O
decreased	O
levels	O
of	O
glutathione	O
and	O
a	O
lower	O
ratio	O
of	O
reduced:oxidized	O
glutathione	O
.	O
A	O
truncated	O
Tat	protein
protein	protein
(	O
Tat1-72	protein
),	O
known	O
to	O
transactivate	O
the	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
),	O
no	O
longer	O
affected	O
Mn-SOD	protein
expression	O
,	O
the	O
cellular	O
redox	O
state	O
or	O
TNF	protein
-mediated	O
cytotoxicity	O
.	O
Thus,	O
our	O
experiments	O
demonstrate	O
that	O
the	O
C-terminal	protein
region	protein
of	O
HIV-1	protein
Tat	protein
is	O
required	O
to	O
suppress	O
Mn-SOD	protein
expression	O
and	O
to	O
induce	O
pro-oxidative	O
conditions	O
reflected	O
by	O
a	O
drop	O
in	O
reduced	O
glutathione	O
(	O
GSH	protein
)	O
and	O
the	O
GSH:oxidized	O
GSH	O
(	O
GSSG	O
)	O
ratio	O
.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS)	O

The	O
use	O
of	O
glucocorticoids	O
in	O
acute	O
lymphoblastic	O
leukemia	O
of	O
childhood.	O
Molecular,	O
cellular,	O
and	O
clinical	O
considerations.	O
Glucocorticoids	O
have	O
been	O
included	O
in	O
almost	O
all	O
treatment	O
regimens	O
for	O
childhood	O
acute	O
lymphoblastic	O
leukemia	O
for	O
decades.	O
However,	O
optimal	O
agents,	O
doses,	O
and/or	O
schedules	O
have	O
yet	O
to	O
be	O
defined	O
despite	O
extensive	O
clinical	O
application.	O
New	O
data	O
on	O
the	O
pharmacokinetics	O
,	O
pharmacodynamics	O
,	O
and	O
molecular	O
mechanisms	O
of	O
action	O
of	O
glucocorticoids	O
have	O
suggested	O
alternative	O
approaches	O
in	O
ALL	O
.	O
These	O
suggest	O
that	O
prolonged,	O
i.e.	O
28	O
day,	O
glucocorticoid	O
therapy	O
may	O
be	O
unnecessary	O
as	O
exposure	O
to	O
glucocorticoid	O
induces	O
down-regulation	O
of	O
glucocorticoid	protein
receptors	protein
.	O
Dexamethasone	O
may	O
be	O
superior	O
to	O
prednisone	O
in	O
conventional	O
equi-effective	O
doses.	O
Blast	O
sensitivity	O
to	O
glucocorticoids	O
correlates	O
closely	O
with	O
sensitivity	O
to	O
other,	O
putatively	O
non-cross-resisting	O
agents	O
and	O
with	O
outcome	O
after	O
multi-agent	O
therapy	O
,	O
suggesting	O
overlapping	O
mechanisms	O
of	O
action,	O
and	O
focusing	O
attention	O
on	O
the	O
determinants	O
of	O
the	O
threshold	O
for	O
apoptosis	O
.	O
Increasing	O
success	O
in	O
the	O
treatment	O
of	O
childhood	O
acute	O
lymphoblastic	O
leukemia	O
has	O
led	O
to	O
increasing	O
awareness	O
of	O
avascular	O
necrosis	O
of	O
bone	O
as	O
a	O
potentially	O
disabling	O
sequela	O
of	O
glucocorticoid	O
therapy	O
,	O
especially	O
in	O
adolescent	O
and	O
young	O
adult	O
patients	O
.	O

Epstein-Barr	protein
virus	protein
nuclear	protein
protein	protein
2	protein
transactivation	O
of	O
the	O
latent	DNA
membrane	DNA
protein	DNA
1	DNA
promoter	DNA
is	O
mediated	O
by	O
J	protein
kappa	protein
and	O
PU.1	protein
.	O
Expression	O
of	O
the	O
Epstein-Barr	DNA
virus	DNA
(	DNA
EBV	DNA
)	DNA
latent	DNA
membrane	DNA
protein	DNA
1	DNA
(	DNA
LMP-1	DNA
)	DNA
oncogene	DNA
is	O
regulated	O
by	O
the	O
EBV	protein
nuclear	protein
protein	protein
2	protein
(	protein
EBNA-2	protein
)	protein
transactivator	protein
.	O
EBNA-2	protein
is	O
known	O
to	O
interact	O
with	O
the	O
cellular	protein
DNA-binding	protein
protein	protein
J	protein
kappa	protein
and	O
is	O
recruited	O
to	O
promoters	DNA
containing	O
the	O
GTGGGAA	O
J	DNA
kappa	DNA
recognition	DNA
sequence	DNA
.	O
The	O
minimal	DNA
EBNA-2	DNA
-responsive	DNA
LMP-1	DNA
promoter	DNA
includes	O
one	O
J	DNA
kappa	DNA
-binding	DNA
site	DNA
,	O
and	O
we	O
now	O
show	O
that	O
mutation	O
of	O
that	O
site,	O
such	O
that	O
J	protein
kappa	protein
cannot	O
bind,	O
reduces	O
EBNA-2	protein
responsiveness	O
by	O
60%.	O
To	O
identify	O
other	O
factors	O
which	O
interact	O
with	O
the	O
LMP-1	DNA
EBNA-2	DNA
response	DNA
element	DNA
(	O
E2RE	DNA
),	O
a	O
-236/-145	DNA
minimal	DNA
E2RE	DNA
was	O
used	O
as	O
a	O
probe	O
in	O
an	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O
The	O
previously	O
characterized	O
factors	O
J	protein
kappa	protein
,	O
PU.1	protein
,	O
and	O
AML1	protein
bind	O
to	O
the	O
LMP-1	DNA
E2RE	DNA
,	O
along	O
with	O
six	O
other	O
unidentified	O
factors	O
(	O
LBF2	protein
to	O
LBF7	protein
).	O
Binding	O
sites	O
were	O
mapped	O
for	O
each	O
factor.	O
LBF4	protein
is	O
B-	O
and	O
T-cell	O
specific	O
and	O
recognizes	O
the	O
PU.1	DNA
GGAA	DNA
core	DNA
sequence	DNA
as	O
shown	O
by	O
methylation	O
interference	O
.	O
LBF4	protein
has	O
a	O
molecular	O
mass	O
of	O
105	O
kDa	O
and	O
is	O
probably	O
unrelated	O
to	O
PU.1	protein
.	O
LBF2	protein
was	O
found	O
only	O
in	O
epithelial	cell_line
cell	cell_line
lines	cell_line
,	O
whereas	O
LBF3	protein
,	O
LBF5	protein
,	O
LBF6	protein
,	O
and	O
LBF7	protein
were	O
not	O
cell	O
type	O
specific.	O
Mutations	O
of	O
the	O
AML1-	O
or	O
LBF4-	O
binding	O
sites	O
had	O
no	O
effect	O
on	O
EBNA-2	protein
transactivation	O
,	O
whereas	O
mutation	O
of	O
the	O
PU.1	DNA
-binding	DNA
site	DNA
completely	O
eliminated	O
EBNA-2	protein
responses	O
.	O
A	O
gst-	protein
EBNA-2	protein
fusion	protein
protein	protein
specifically	O
depleted	O
PU.1	protein
from	O
nuclear	O
extracts	O
and	O
bound	O
in	O
vitro	O
translated	O
PU.1	protein
,	O
providing	O
biochemical	O
evidence	O
for	O
a	O
direct	O
EBNA-2	protein
-PU.1	protein
interaction.	O
Thus,	O
EBNA-2	protein
transactivation	O
of	O
the	O
LMP-1	DNA
promoter	DNA
is	O
dependent	O
on	O
interaction	O
with	O
at	O
least	O
two	O
distinct	O
sequence-specific	O
DNA-binding	protein
proteins	protein
,	O
J	protein
kappa	protein
and	O
PU.1	protein
.	O
LBF3	protein
,	O
LBF5	protein
,	O
LBF6	protein
,	O
or	O
LBF7	protein
may	O
also	O
be	O
involved,	O
since	O
their	O
binding	O
sites	O
also	O
contribute	O
to	O
EBNA-2	protein
responsiveness	O
.	O

Lymphocyte	protein
glucocorticoid	protein
receptor	protein
:	O
predictor	O
of	O
sertraline	O
response	O
in	O
adolescent	O
major	O
depressive	O
disorder	O
(	O
MDD	O
).	O
Major	O
depressive	O
disorder	O
(	O
MDD	O
)	O
in	O
adolescents	O
demonstrates	O
resistance	O
to	O
tricyclic	O
antidepressants	O
and	O
absence	O
of	O
hypercortisolemia	O
.	O
The	O
efficacy	O
of	O
serotonin	O
reuptake	O
inhibitors	O
(	O
SRIs	O
)	O
is	O
uncertain,	O
and	O
response	O
predictors	O
are	O
unavailable.	O
Abnormal	O
fast	O
feedback	O
and	O
negative	O
feedback	O
of	O
the	O
hypothalamic-pituitary-adrenal	O
axis	O
implicates	O
a	O
dampened	O
limbic-hippocampal	protein
glucocorticoid	protein
type	protein
II	protein
receptor	protein
(	O
GCII	protein
).	O
We	O
hypothesized	O
that	O
lymphocyte	protein
GCII	protein
is	O
altered	O
in	O
adolescent	O
MDD	O
and	O
could	O
serve	O
as	O
a	O
marker	O
for	O
response	O
to	O
SRIs	O
.	O
In	O
an	O
open-label	O
study,	O
adolescents	O
(n	O
=	O
20)	O
meeting	O
DSM-III-R	O
criteria	O
for	O
MDD	O
showed	O
baseline	O
lymphocyte	protein
GCII	protein
sites	protein
per	O
cell	O
(sites/cell)	O
values	O
of	O
793	O
+/-	O
106	O
versus	O
2,563	O
+/-	O
499	O
(+/-	O
SEM)	O
for	O
matched	O
controls	O
(n	O
=	O
18)	O
(t	O
=	O
3.5;	O
df	O
=	O
36;	O
p	O
&lt;	O
.001).	O
GCII	protein
was	O
bimodally	O
distributed,	O
with	O
SRI	O
responders	O
differing	O
from	O
nonresponders	O
(t	O
=	O
3.9;	O
df	O
=	O
14;	O
p	O
&lt;	O
.001).	O
GCII	protein
accurately	O
classified	O
90	O
percent	O
of	O
sertraline	O
responders	O
and	O
80	O
percent	O
of	O
nonresponders.	O
Only	O
SRI	O
responders	O
showed	O
GCII	protein
sites/cell	O
upregulated	O
after	O
6	O
weeks	O
of	O
treatment	O
(t	O
=	O
2.1,	O
df	O
=	O
10;	O
p	O
&lt;	O
.05).	O

The	O
role	O
of	O
NFATp	protein
in	O
cyclosporin	DNA
A-sensitive	DNA
tumor	DNA
necrosis	DNA
factor	DNA
-alpha	DNA
gene	DNA
transcription	O
.	O
The	O
tumor	DNA
necrosis	DNA
factor-alpha	DNA
(	DNA
TNF	DNA
alpha)	DNA
gene	DNA
is	O
an	O
immediate	O
early	O
gene	O
in	O
activated	O
T	cell_type
cells	cell_type
,	O
in	O
that	O
it	O
is	O
rapidly	O
induced	O
without	O
a	O
requirement	O
for	O
protein	O
synthesis	O
.	O
Maximal	O
induction	O
of	O
TNF	RNA
alpha	RNA
mRNA	RNA
can	O
be	O
induced	O
by	O
treatment	O
of	O
T	cell_type
cells	cell_type
with	O
calcium	O
ionophores	O
alone,	O
via	O
a	O
calcineurin	protein
-dependent	O
process	O
that	O
is	O
blocked	O
by	O
cyclosporin	O
A	O
.	O
We	O
have	O
previously	O
identified	O
a	O
promoter	DNA
element	DNA
,	O
kappa	DNA
3	DNA
,	O
that	O
is	O
required	O
for	O
calcium-stimulated,	O
cyclosporin	O
A	O
-sensitive	O
induction	O
of	O
the	O
TNF	DNA
alpha	DNA
gene	DNA
in	O
activated	O
T	cell_type
cells	cell_type
.	O
Here,	O
we	O
demonstrate	O
that	O
the	O
kappa	protein
3	protein
binding	protein
factor	protein
contains	O
NFATp	protein
,	O
a	O
cyclosporin-sensitive	protein
DNA-binding	protein
protein	protein
required	O
for	O
interleukin-2	DNA
gene	DNA
transcription	O
.	O
NFATp	protein
binds	O
to	O
two	O
sites	O
within	O
the	O
kappa	DNA
3	DNA
element	DNA
,	O
and	O
occupancy	O
of	O
both	O
sites	O
is	O
required	O
for	O
TNF	protein
alpha	O
gene	O
induction	O
.	O
Thus,	O
although	O
the	O
kappa	DNA
3	DNA
element	DNA
has	O
little	O
sequence	O
similarity	O
to	O
other	O
NFATp	DNA
-binding	DNA
sites	DNA
,	O
it	O
appears	O
to	O
function	O
as	O
a	O
cyclosporin-sensitive	DNA
promoter	DNA
element	DNA
in	O
T	cell_type
cells	cell_type
by	O
virtue	O
of	O
its	O
ability	O
to	O
bind	O
NFATp	protein
.	O
The	O
involvement	O
of	O
NFATp	protein
in	O
transcriptional	O
activation	O
of	O
both	O
the	O
interleukin-2	protein
and	O
TNF	DNA
alpha	DNA
genes	DNA
suggests	O
that	O
this	O
factor	O
plays	O
an	O
important	O
role	O
in	O
the	O
coordinate	O
induction	O
of	O
multiple	O
cytokine	DNA
genes	DNA
,	O
starting	O
at	O
the	O
earliest	O
stages	O
of	O
T	O
cell	O
activation	O
.	O

Regulation	O
and	O
specificity	O
of	O
MNDA	protein
expression	O
in	O
monocytes	cell_type
,	O
macrophages	cell_type
,	O
and	O
leukemia/B	cell_line
lymphoma	cell_line
cell	cell_line
lines	cell_line
.	O
The	O
expression	O
of	O
the	O
human	protein
myeloid	protein
cell	protein
nuclear	protein
differentiation	protein
antigen	protein
(	O
MNDA	protein
)	O
was	O
observed	O
specifically	O
in	O
cells	O
of	O
the	O
granulocyte-macrophage	O
lineage	O
in	O
our	O
earlier	O
reports.	O
The	O
specificity	O
of	O
MNDA	protein
expression	O
for	O
cells	O
in	O
the	O
granulocyte-macrophage	O
lineage	O
was	O
reexamined	O
in	O
cell	cell_line
lines	cell_line
established	O
from	O
patients	O
with	O
Philadelphia	O
chromosome-positive	O
chronic	O
myeloid	O
leukemia	O
.	O
Cell	O
lines	O
that	O
expressed	O
MNDA	protein
exhibited	O
myeloid	O
cell	O
features	O
and	O
granulocyte	O
or	O
monocyte	O
differentiation	O
could	O
be	O
induced	O
in	O
vitro,	O
while	O
cell	O
lines	O
exhibiting	O
properties	O
of	O
very	O
early	O
stage	O
cells	O
or	O
multipotential	cell_type
cells	cell_type
did	O
not	O
express	O
MNDA	protein
.	O
Cells	O
originating	O
from	O
cases	O
of	O
Burkitt's	O
lymphoma	O
were	O
negative.	O
By	O
contrast,	O
three	O
lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
(immortalized	O
in	O
vitro	O
with	O
Epstein-Barr	O
virus	O
)	O
were	O
weakly	O
positive	O
and	O
MNDA	protein
was	O
up-regulated	O
by	O
interferon-alpha	protein
(	O
IFN-alpha	protein
)	O
treatment	O
.	O
As	O
we	O
reported	O
previously,	O
MNDA	RNA
mRNA	RNA
level	O
in	O
adherent	O
monocytes	cell_type
is	O
elevated	O
by	O
IFN-alpha	protein
;	O
in	O
this	O
study,	O
we	O
further	O
assessed	O
MNDA	protein
expression	O
in	O
in	O
vitro	O
monocyte-derived	O
macrophages	cell_type
.	O
Three	O
additional	O
agents	O
(	O
endotoxin	O
,	O
phytohemagglutinin	protein
,	O
and	O
phorbol	O
ester	O
)	O
and	O
other	O
conditions	O
that	O
affect	O
function,	O
cytokine	protein
production	O
,	O
differentiation	O
,	O
and/or	O
growth	O
of	O
monocytes	cell_type
were	O
examined	O
for	O
their	O
ability	O
to	O
alter	O
MNDA	protein
expression	O
.	O
The	O
results	O
varied	O
with	O
the	O
agent,	O
cell	O
type,	O
and	O
stage	O
of	O
differentiation	O
.	O
Changes	O
in	O
MNDA	protein
expression	O
occurred	O
slowly	O
(hours	O
to	O
days),	O
suggesting	O
that	O
MNDA	protein
could	O
mediate	O
changes	O
realized	O
over	O
a	O
long	O
period.	O
The	O
results	O
also	O
reveal	O
a	O
discordance	O
in	O
certain	O
MNDA	cell_line
positive	cell_line
cells	cell_line
between	O
steady-state	O
levels	O
or	O
changes	O
in	O
levels	O
of	O
protein	O
and	O
mRNA	RNA
indicating	O
that	O
the	O
regulation	O
of	O
MNDA	protein
expression	O
occurs	O
at	O
more	O
than	O
one	O
point.	O
Changes	O
in	O
MNDA	protein
expression	O
are	O
consistent	O
with	O
a	O
role	O
in	O
opposing	O
macrophage	O
differentiation	O
and	O
activation	O
of	O
monocytes	cell_type
/macrophages	cell_type
.	O

DNA-binding	O
studies	O
of	O
the	O
Epstein-Barr	protein
virus	protein
nuclear	protein
antigen	protein
2	protein
(	O
EBNA-2	protein
):	O
evidence	O
for	O
complex	O
formation	O
by	O
latent	protein
membrane	protein
protein	protein
gene	protein
promoter-binding	protein
proteins	protein
in	O
EBNA-2	cell_line
-positive	cell_line
cell	cell_line
lines	cell_line
.	O
The	O
Epstein-Barr	protein
virus	protein
(	protein
EBV	protein
)	protein
nuclear	protein
antigen	protein
2	protein
(	O
EBNA-2	protein
)	O
protein	O
is	O
essential	O
for	O
the	O
immortalization	O
of	O
human	cell_type
primary	cell_type
B	cell_type
cells	cell_type
by	O
EBV	O
.	O
EBNA-2	protein
trans-activates	O
cellular	O
and	O
viral	O
genes	O
like	O
CD23	DNA
,	O
c-fgr	DNA
,	O
latent	protein
membrane	protein
protein	protein
1	protein
(	O
LMP1	protein
)	O
and	O
terminal	protein
protein	protein
1	protein
(	O
TP1	protein
).	O
Trans-activation	O
of	O
the	O
TP1	DNA
promoter	DNA
and	O
of	O
the	O
BamHI	DNA
C	DNA
promoter	DNA
has	O
already	O
been	O
investigated	O
in	O
detail	O
and	O
appears	O
to	O
be	O
mediated	O
via	O
protein-protein	O
interactions	O
and	O
not	O
by	O
direct	O
binding	O
of	O
EBNA-2	protein
type	protein
A	protein
(of	O
EBV	O
type	O
1	O
)	O
to	O
the	O
DNA.	O
EBNA-2	protein
is	O
able	O
to	O
trans-activate	O
the	O
expression	O
of	O
the	O
LMP	DNA
gene	DNA
in	O
several	O
cell	O
lines.	O
Various	O
reports	O
have	O
delineated	O
the	O
cis-acting	DNA
elements	DNA
of	O
the	O
LMP	DNA
promoter	DNA
through	O
which	O
EBNA-2	protein
mediates	O
trans-activation	O
.	O
To	O
determine	O
whether	O
EBNA-2	protein
also	O
trans-activates	O
the	O
LMP	DNA
promoter	DNA
by	O
protein-protein	O
interactions	O
,	O
we	O
performed	O
a	O
series	O
of	O
gel	O
retardation	O
assays	O
and	O
competition	O
experiments	O
with	O
LMP	DNA
promoter	DNA
fragments	DNA
of	O
different	O
sizes.	O
We	O
determined	O
that	O
the	O
protein-binding	DNA
region	DNA
on	O
the	O
LMP	DNA
promoter	DNA
was	O
within	O
a	O
42	DNA
bp	DNA
fragment	DNA
encompassing	O
nucleotides	DNA
-135	DNA
to	DNA
-176	DNA
relative	O
to	O
the	O
LMP	DNA
transcriptional	DNA
start	DNA
site	DNA
.	O
None	O
of	O
the	O
DNA	O
fragments	O
investigated	O
indicated	O
interaction	O
of	O
EBNA-2	protein
with	O
the	O
DNA	O
via	O
protein-protein	O
interactions	O
.	O
No	O
significant	O
differences	O
between	O
EBNA-2	protein
-positive	O
and	O
EBNA-2	protein
-negative	O
nuclear	O
extracts	O
could	O
be	O
seen	O
in	O
the	O
gel	O
retardation	O
assay	O
under	O
conditions	O
that	O
clearly	O
showed	O
binding	O
of	O
EBNA-2A	protein
to	O
the	O
TP1	DNA
promoter	DNA
.	O
However,	O
analysis	O
of	O
sucrose	O
gradient	O
fractions	O
in	O
the	O
gel	O
retardation	O
assay	O
provided	O
evidence	O
that	O
the	O
LMP	protein
promoter	protein
-binding	protein
proteins	protein
form	O
a	O
complex	O
of	O
higher	O
M(r)	O
in	O
EBNA-2	cell_type
-positive	cell_type
cell	cell_type
extracts	O
.	O
These	O
complexes	O
were	O
destroyed	O
by	O
detergent.	O
We	O
deduce	O
from	O
these	O
results	O
that	O
EBNA-2	cell_line
-positive	cell_line
cells	cell_line
might	O
indeed	O
contain	O
specific	protein
complexes	protein
bound	O
to	O
the	O
LMP	DNA
promoter	DNA
which	O
are,	O
however,	O
too	O
labile	O
to	O
be	O
detected	O
in	O
a	O
standard	O
gel	O
retardation	O
assay	O
.	O

Simultaneous	O
activation	O
of	O
Ig	protein
and	O
Oct-2	protein
synthesis	O
and	O
reduction	O
of	O
surface	O
MHC	protein
class	protein
II	protein
expression	O
by	O
IL-6	protein
.	O
Terminal	O
differentiation	O
of	O
B	cell_type
cells	cell_type
to	O
plasma	cell_type
cells	cell_type
in	O
vivo	O
is	O
characterized	O
by	O
secretion	O
of	O
Ig	protein
and	O
extinction	O
of	O
MHC	protein
class	protein
II	protein
expression	O
on	O
the	O
cell	O
surface.	O
We	O
show	O
that	O
IL-6	protein
signaling	O
leads	O
to	O
marked	O
increases	O
in	O
the	O
synthesis	O
and	O
secretion	O
of	O
Ig	protein
in	O
clonal	cell_line
human	cell_line
B	cell_line
cell	cell_line
lines	cell_line
and	O
newly	O
isolated	cell_type
polyclonal	cell_type
B	cell_type
lymphocytes	cell_type
in	O
vitro.	O
The	O
IL-6-induced	cell_line
cells	cell_line
resemble	O
plasma	cell_type
cells	cell_type
in	O
ultrastructure	O
and	O
in	O
reduced	O
expression	O
of	O
surface	protein
MHC	protein
class	protein
II	protein
.	O
Enhanced	O
Ig	protein
synthesis	O
is	O
a	O
result	O
of	O
coordinated	O
transcriptional	O
activation	O
of	O
Ig	DNA
genes	DNA
without	O
promoter	O
or	O
isotype	O
specificity,	O
and	O
differential	O
accumulation	O
of	O
the	O
mRNA	RNA
encoding	O
the	O
secreted	O
form	O
of	O
Ig	protein
heavy	protein
chain	protein
.	O
It	O
is	O
saturable	O
and	O
subject	O
to	O
negative	O
control	O
when	O
IL-6	protein
stimulation	O
is	O
prolonged.	O
Coordinate	O
with	O
temporal	O
changes	O
in	O
Ig	protein
synthesis	O
,	O
the	O
DNA-binding	O
activity	O
and	O
the	O
synthesis	O
of	O
the	O
B	protein
cell-enriched	protein
transcription	protein
factor	protein
Oct-2	protein
are	O
regulated.	O
Thus,	O
differentiation	O
of	O
B	cell_type
cells	cell_type
with	O
IL-6	protein
in	O
vitro	O
recapitulates	O
the	O
hallmarks	O
of	O
terminal	O
B	O
differentiation	O
in	O
vivo;	O
Oct-2	protein
may	O
have	O
a	O
role	O
in	O
this	O
process.	O

T-cell	DNA
functional	DNA
regions	DNA
of	O
the	O
human	DNA
IL-3	DNA
proximal	DNA
promoter	DNA
.	O
The	O
human	DNA
interleukin-3	DNA
(	DNA
IL-3	DNA
)	DNA
gene	DNA
is	O
expressed	O
almost	O
exclusively	O
in	O
activated	O
T	cell_type
cells	cell_type
.	O
Its	O
expression	O
is	O
regulated	O
at	O
both	O
the	O
transcriptional	O
and	O
post-transcriptional	O
level.	O
We	O
have	O
previously	O
shown	O
that	O
treatment	O
of	O
Jurkat	cell_line
T	cell_line
cells	cell_line
with	O
phytohemaglutinin	protein
(	O
PHA	protein
)	O
and	O
the	O
phorbol	O
ester	O
,	O
PMA	O
,	O
activated	O
transcription	O
initiation	O
from	O
the	O
IL-3	DNA
gene	DNA
.	O
To	O
define	O
the	O
regions	O
of	O
the	O
gene	O
required	O
for	O
transcription	O
activation,	O
we	O
generated	O
a	O
series	O
of	O
reporter	O
constructs	O
containing	O
different	O
regions	O
of	O
the	O
IL-3	DNA
gene	DNA
5'	DNA
and	DNA
3'	DNA
flanking	DNA
sequences	DNA
.	O
Both	O
positive	O
and	O
negative	O
regulatory	O
elements	O
were	O
identified	O
in	O
the	O
proximal	DNA
5'	DNA
flanking	DNA
region	DNA
of	O
the	O
IL-3	DNA
gene	DNA
.	O
The	O
promoter	DNA
region	DNA
between	O
-173	DNA
and	DNA
-60	DNA
contained	O
the	O
strongest	O
activating	DNA
elements	DNA
.	O
The	O
transcription	protein
factor	protein
AP-1	protein
could	O
bind	O
to	O
this	O
positive	O
activator	O
region	O
of	O
the	O
promoter.	O
We	O
also	O
examined	O
the	O
function	O
of	O
the	O
IL-3	DNA
CK-1/CK-2	DNA
elements	DNA
that	O
are	O
present	O
in	O
many	O
cytokine	DNA
genes	DNA
and	O
found	O
that	O
they	O
acted	O
as	O
a	O
repressor	O
of	O
basal	O
level	O
expression	O
when	O
cloned	O
upstream	O
of	O
a	O
heterologous	DNA
promoter	DNA
but	O
were	O
also	O
inducible	O
by	O
PMA	O
/PHA	protein
.	O

Expression	O
of	O
the	O
Runt	DNA
domain	DNA
-encoding	DNA
PEBP2	DNA
alpha	DNA
genes	DNA
in	O
T	cell_type
cells	cell_type
during	O
thymic	O
development	O
.	O
The	O
PEBP2	O
alpha	O
A	O
and	O
PEBP2	O
alpha	O
B	O
genes	O
encode	O
the	O
DNA-binding	protein
subunit	protein
of	O
a	O
murine	protein
transcription	protein
factor	protein
,	O
PEBP2	protein
,	O
which	O
is	O
implicated	O
as	O
a	O
T-cell-specific	protein
transcriptional	protein
regulator	protein
.	O
These	O
two	O
related	O
genes	O
share	O
the	O
evolutionarily	O
conserved	O
region	O
encoding	O
the	O
Runt	protein
domain	protein
.	O
PEBP2	protein
alpha	protein
B	protein
is	O
the	O
murine	protein
counterpart	protein
of	O
human	protein
AML1	protein
,	O
which	O
is	O
located	O
at	O
the	O
breakpoints	O
of	O
the	O
8;21	O
and	O
3;21	O
chromosome	O
translocations	O
associated	O
with	O
acute	O
myeloid	O
leukemia	O
.	O
Northern	O
(RNA)	O
blots	O
of	O
various	O
adult	O
mouse	O
tissues	O
revealed	O
that	O
the	O
levels	O
of	O
expression	O
of	O
both	O
genes	O
were	O
most	O
prominent	O
in	O
the	O
thymus	O
.	O
Furthermore,	O
transcripts	O
of	O
PEBP2	protein
alpha	protein
A	protein
and	O
mouse	protein
AML1/	protein
PEBP2	protein
alpha	protein
B	protein
were	O
detected	O
in	O
T	cell_type
lymphocytes	cell_type
in	O
the	O
thymuses	O
from	O
day	O
16	O
embryos	O
and	O
newborns	O
,	O
as	O
well	O
as	O
4-week-old	O
adult	O
mice	O
,	O
by	O
in	O
situ	O
hybridization	O
.	O
The	O
expression	O
of	O
the	O
genes	O
persisted	O
in	O
peripheral	O
lymph	O
nodes	O
of	O
adult	O
mice	O
.	O
The	O
transcripts	O
were	O
detected	O
in	O
all	O
the	O
CD4-	O
CD8-	O
,	O
CD4+	O
CD8+	O
,	O
CD4+	O
CD8-	O
,	O
and	O
CD4-	O
CD8+	O
cell	O
populations	O
.	O
The	O
results	O
indicated	O
that	O
both	O
genes	O
are	O
expressed	O
in	O
T	cell_type
cells	cell_type
throughout	O
their	O
development,	O
supporting	O
the	O
notion	O
that	O
PEBP2	protein
is	O
a	O
T-cell-specific	protein
transcription	protein
factor	protein
.	O
Transcripts	O
of	O
mouse	protein
AML1/	protein
PEBP2	protein
alpha	protein
B	protein
were	O
also	O
detected	O
in	O
day	O
12	O
fetal	O
hematopoietic	O
liver	O
and	O
in	O
the	O
bone	cell_type
marrow	cell_type
cells	cell_type
of	O
newborn	O
mice	O
.	O
The	O
implication	O
of	O
mouse	O
AML1/	protein
PEBP2	protein
alpha	protein
B	protein
expression	O
in	O
hematopoietic	cell_type
cells	cell_type
other	O
than	O
those	O
of	O
T-cell	cell_type
lineage	cell_type
is	O
discussed	O
in	O
relation	O
to	O
myeloid	O
leukemogenesis	O
.	O

Effects	O
of	O
glucocorticoids	O
on	O
transcription	O
factor	O
activation	O
in	O
human	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
.	O
Glucocorticoids	O
have	O
an	O
inhibitory	O
effect	O
on	O
inflammatory	O
and	O
immune	O
responses	O
,	O
and	O
this	O
may	O
be	O
through	O
the	O
modulation	O
of	O
transcription	protein
factor	protein
binding	O
to	O
DNA.	O
The	O
interaction	O
of	O
the	O
transcription	protein
factors	protein
,	O
activator	protein
protein-1	protein
(	O
AP-1	protein
),	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF	protein
kappa	protein
B	protein
),	O
and	O
cAMP-responsive	protein
element	protein
binding	protein
protein	protein
(	O
CREB	protein
)	O
with	O
DNA	O
and	O
glucocorticoid	protein
receptors	protein
(	O
GR	protein
)	O
was	O
analyzed	O
in	O
human	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
by	O
gel	O
mobility	O
shift	O
assays	O
.	O
TNF-alpha	O
,	O
IL-1	O
beta	O
and	O
phorbol	O
myristate	O
acetate	O
(PMA)	O
treatment	O
increased	O
AP-1	protein
and	O
NF	O
kappa	O
B	O
DNA	O
binding	O
by	O
up	O
to	O
200%	O
but	O
decreased	O
CREB	protein
binding	O
(38%)	O
over	O
a	O
60-min	O
time	O
course.	O
Dexamethasone	O
produced	O
a	O
rapid	O
and	O
sustained	O
increase	O
in	O
glucocorticoid	DNA
response	DNA
element	DNA
binding	O
and	O
a	O
concomitant	O
40-50%	O
decrease	O
in	O
AP-1	O
,	O
NF	O
kappa	O
B	O
,	O
and	O
CREB	O
DNA	O
binding	O
that	O
was	O
blocked	O
by	O
combined	O
dexamethasone	O
and	O
cytokine	protein
or	O
PMA	O
treatment	O
.	O
These	O
latter	O
effects	O
were	O
due	O
to	O
increases	O
in	O
the	O
nuclear	O
localization	O
of	O
GR	protein
,	O
not	O
to	O
reduced	O
amounts	O
of	O
the	O
other	O
transcription	protein
factors	protein
.	O
This	O
suggests	O
that	O
in	O
these	O
cells	O
GR	protein
within	O
the	O
nucleus	protein
interacts	O
with	O
cytokine	protein
-stimulated	protein
transcription	protein
factors	protein
by	O
the	O
process	O
of	O
cross	O
coupling.	O
This	O
may	O
be	O
an	O
important	O
molecular	O
site	O
of	O
steroid	O
action.	O

Differential	O
induction	O
of	O
the	O
NF-AT	protein
complex	protein
during	O
restimulation	O
and	O
the	O
induction	O
of	O
T-cell	O
anergy	O
.	O
Stimulation	O
of	O
human	cell_line
CD4+	cell_line
T-cell	cell_line
clones	cell_line
through	O
the	O
T-cell	protein
receptor	protein
(	O
TcR	protein
)	O
by	O
high	O
doses	O
of	O
specific	O
peptide	O
results	O
in	O
the	O
induction	O
of	O
a	O
long-lived	O
state	O
of	O
nonresponsiveness	O
that	O
has	O
been	O
called	O
anergy	O
.	O
During	O
the	O
induction	O
of	O
anergy	O
,	O
T	cell_type
cells	cell_type
are	O
phenotypically	O
similar	O
to	O
cells	O
responding	O
to	O
an	O
immunogenic	O
stimulus	O
.	O
The	O
amount	O
of	O
TcR	protein
at	O
the	O
cell	O
surface	O
is	O
downmodulated,	O
whereas	O
the	O
CD2	O
and	O
CD25	O
receptors	O
are	O
increased.	O
When	O
restimulated,	O
however,	O
anergic	cell_type
T	cell_type
cells	cell_type
fail	O
to	O
up-regulate	O
transcription	O
of	O
the	O
IL-2	DNA
gene	DNA
and	O
in	O
consequence	O
do	O
not	O
produce	O
IL-2	protein
.	O
In	O
this	O
study,	O
we	O
have	O
compared	O
the	O
ability	O
of	O
various	O
transcription	protein
factors	protein
to	O
bind	O
to	O
their	O
appropriate	O
site	O
on	O
DNA.	O
Factors	O
were	O
isolated	O
from	O
the	O
nuclei	O
of	O
T	cell_type
cells	cell_type
that	O
were	O
in	O
the	O
induction	O
phase	O
of	O
anergy	O
or	O
were	O
undergoing	O
activation.	O
The	O
pattern	O
of	O
binding	O
activity	O
in	O
restimulated	O
T	cell_type
cells	cell_type
is	O
consistent	O
with	O
the	O
pattern	O
that	O
has	O
previously	O
been	O
shown	O
to	O
regulate	O
T-cell-specific	O
expression	O
of	O
the	O
IL-2	protein
and	O
the	O
beta	O
chain	O
of	O
the	O
TcR	DNA
genes	DNA
.	O
The	O
measured	O
binding	O
to	O
a	O
TCF-1	DNA
site	DNA
is	O
the	O
same	O
in	O
the	O
nuclei	O
of	O
resting	O
,	O
activated	O
,	O
and	O
anergized	O
cells	O
.	O
The	O
inducible	protein
factors	protein
NK-kappa	protein
B	protein
,	O
beta	protein
E2	protein
,	O
CD28RC	protein
,	O
and	O
AP-1	protein
are	O
not	O
expressed	O
in	O
resting	cell_type
cells	cell_type
and	O
are	O
twofold	O
lower	O
in	O
anergized	O
as	O
compared	O
with	O
activated	O
cells.	O
In	O
contrast,	O
anergic	cell_type
T	cell_type
cells	cell_type
express	O
approximately	O
eightfold	O
lower	O
amounts	O
of	O
NF-AT	protein
,	O
a	O
member	O
of	O
the	O
class	O
of	O
inducible	protein
factors	protein
that	O
regulates	O
IL-2	DNA
gene	DNA
transcription.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS)	O

The	O
number	O
of	O
glucocorticoid	protein
receptors	protein
in	O
peripheral	cell_type
human	cell_type
lymphocytes	cell_type
is	O
elevated	O
by	O
a	O
zinc	O
containing	O
trace	O
element	O
preparation	O
.	O
A	O
trace	O
element	O
preparation	O
(	O
Beres	O
Drops	O
Plus	O
,	O
BDP	O
)	O
elevates	O
the	O
number	O
of	O
glucocorticoid	protein
receptors	protein
(	O
gcR	protein
)	O
in	O
peripheral	cell_type
lymphocytes	cell_type
isolated	O
both	O
from	O
healthy	O
blood	O
donors	O
and	O
rheumatoid	O
arthritis	O
patients	O
.	O
This	O
enhancement	O
by	O
BDP	O
was	O
found	O
either	O
for	O
constitutive	O
expression	O
of	O
gcRs	protein
or	O
in	O
experiments	O
when	O
the	O
lymphocytes	cell_type
were	O
stimulated	O
by	O
interleukin	protein
(IL)-6	protein
.	O
There	O
was	O
no	O
significant	O
effect	O
of	O
BDP	O
on	O
IL-1	protein
and	O
tumour	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF	protein
alpha	protein
)	O
-induced	O
changes	O
of	O
gcRs	protein
.	O
The	O
effect	O
of	O
BDP	O
was	O
greatly	O
dependent	O
on	O
the	O
presence	O
of	O
Zn++	O
ions	O
in	O
the	O
preparation,	O
since	O
the	O
augmenting	O
effect	O
was	O
abolished	O
if	O
BDP	O
did	O
not	O
contain	O
zinc	O
.	O

The	O
DNA	O
and	O
steroid	protein
binding	protein
domains	protein
of	O
the	O
glucocorticoid	protein
receptor	protein
are	O
not	O
altered	O
in	O
mononuclear	cell_type
cells	cell_type
of	O
treated	O
CLL	O
patients	O
.	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
mutations	O
in	O
the	O
glucocorticoid	protein
receptor	protein
could	O
account	O
for	O
the	O
increasing	O
unresponsiveness	O
of	O
patients	O
with	O
chronic	O
lymphatic	O
leukemia	O
(	O
CLL	O
)	O
to	O
combination	O
chemotherapy	O
.	O
The	O
receptor	O
was	O
tested	O
immunocytochemically,	O
in	O
steroid	O
binding	O
assays	O
,	O
and	O
by	O
a	O
mutation	O
screening	O
(	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
)	O
of	O
the	O
receptor-cDNA	protein
.	O
The	O
receptor	O
concentration	O
,	O
as	O
measured	O
by	O
staining	O
and	O
steroid	O
binding	O
test	O
,	O
varied	O
considerably	O
but	O
showed	O
no	O
clear	O
correlation	O
to	O
clinical	O
response.	O
Using	O
a	O
highly	O
sensitive	O
mutation	O
screening	O
assay	O
of	O
the	O
DNA-	O
and	O
the	O
steroid	O
-binding	O
region	O
,	O
none	O
of	O
the	O
treated	O
patients	O
revealed	O
any	O
mutation,	O
suggesting	O
that	O
the	O
glucocorticoid	protein
receptor	protein
in	O
the	O
CLL	O
patients	O
tested	O
is	O
not	O
altered	O
in	O
these	O
domains.	O
In	O
one	O
individual	O
who	O
had	O
not	O
been	O
treated	O
before	O
analysis	O
a	O
silent	O
mutation	O
was	O
found	O
in	O
one	O
receptor	O
allele	O
.	O
The	O
results	O
suggest	O
that	O
mechanisms	O
other	O
than	O
altered	O
ligand	O
or	O
DNA	O
binding	O
of	O
the	O
receptor	O
may	O
be	O
responsible	O
for	O
the	O
lack	O
of	O
response	O
to	O
chemotherapy	O
.	O
This	O
conclusion	O
is	O
discussed	O
in	O
relation	O
to	O
the	O
mechanism	O
of	O
corticoid	O
resistance	O
in	O
mouse	O
and	O
human	O
lymphoma	O
cells	O
in	O
culture.	O

An	O
AP1	DNA
binding	DNA
site	DNA
upstream	O
of	O
the	O
kappa	DNA
immunoglobulin	DNA
intron	DNA
enhancer	DNA
binds	O
inducible	protein
factors	protein
and	O
contributes	O
to	O
expression.	O
Expression	O
of	O
the	O
kappa	DNA
immunoglobulin	DNA
light	DNA
chain	DNA
gene	DNA
requires	O
developmental-	O
and	O
tissue-specific	O
regulation	O
by	O
trans-acting	protein
factors	protein
which	O
interact	O
with	O
two	O
distinct	O
enhancer	DNA
elements	DNA
.	O
A	O
new	O
protein-DNA	O
interaction	O
has	O
been	O
identified	O
upstream	O
of	O
the	O
intron	DNA
enhancer	DNA
,	O
within	O
the	O
matrix-associated	DNA
region	DNA
of	O
the	O
J-C	DNA
intron	DNA
.	O
The	O
binding	O
activity	O
is	O
greatly	O
inducible	O
in	O
pre-B	cell_type
cells	cell_type
by	O
bacterial	O
lipopolysaccharide	O
and	O
interleukin-1	protein
but	O
specific	O
complexes	O
are	O
found	O
at	O
all	O
stages	O
of	O
B	O
cell	O
development	O
tested.	O
The	O
footprinted	DNA
binding	DNA
site	DNA
is	O
homologous	O
to	O
the	O
consensus	DNA
AP1	DNA
motif	DNA
.	O
The	O
protein	O
components	O
of	O
this	O
complex	O
are	O
specifically	O
competed	O
by	O
an	O
AP1	DNA
consensus	DNA
motif	DNA
and	O
were	O
shown	O
by	O
supershift	O
to	O
include	O
c-Jun	protein
and	O
c-Fos	protein
,	O
suggesting	O
that	O
this	O
binding	DNA
site	DNA
is	O
an	O
AP1	DNA
motif	DNA
and	O
that	O
the	O
Jun	O
and	O
Fos	O
families	O
of	O
transcription	protein
factors	protein
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
the	O
kappa	DNA
light	DNA
chain	DNA
gene	DNA
.	O
Mutation	O
of	O
the	O
AP1	DNA
motif	DNA
in	O
the	O
context	O
of	O
the	O
intron	DNA
enhancer	DNA
was	O
shown	O
to	O
decrease	O
enhancer-mediated	O
activation	O
of	O
the	O
promoter	O
in	O
both	O
pre-B	cell_type
cells	cell_type
induced	O
with	O
LPS	O
and	O
constitutive	O
expression	O
in	O
mature	cell_type
B	cell_type
cells	cell_type
.	O

Distinct	O
DNase-I	DNA
hypersensitive	DNA
sites	DNA
are	O
associated	O
with	O
TAL-1	protein
transcription	O
in	O
erythroid	O
and	O
T-cell	O
lines	O
.	O
The	O
tal-1	DNA
gene	DNA
,	O
frequently	O
activated	O
in	O
human	O
T-cell	O
acute	O
lymphoblastic	O
leukemia	O
(	O
T-ALL	O
),	O
is	O
expressed	O
in	O
the	O
erythroid	O
,	O
megakaryocytic	O
,	O
and	O
mast	O
cell	O
lineages	O
during	O
normal	O
hematopoiesis	O
.	O
To	O
gain	O
further	O
insight	O
into	O
the	O
molecular	O
mechanisms	O
that	O
control	O
tal-1	DNA
expression	O
,	O
we	O
investigated	O
tal-1	DNA
chromatin	DNA
structure	DNA
in	O
erythroid/megakaryocytic	cell_line
cell	cell_line
lines	cell_line
and	O
in	O
T-cell	cell_line
lines	cell_line
either	O
with	O
or	O
without	O
tal-1	DNA
rearrangements	DNA
.	O
Tal-1	O
transcription	O
was	O
shown	O
to	O
be	O
monoallelic	O
in	O
Jurkat	cell_line
,	O
a	O
T-cell	O
line	O
that	O
expresses	O
tal-1	DNA
in	O
the	O
absence	O
of	O
apparent	O
genomic	O
alteration	O
of	O
the	O
locus.	O
Methylation	O
studies	O
indicated	O
that	O
the	O
tal-15'	DNA
GC-rich	DNA
region	DNA
behaves	O
like	O
a	O
CpG	DNA
island	DNA
,	O
hypomethylated	O
in	O
normal	cell_type
cells	cell_type
,	O
and	O
methylated	O
de	O
novo	O
on	O
transcriptionally	DNA
inactive	DNA
alleles	DNA
in	O
established	cell_line
cell	cell_line
lines	cell_line
.	O
Five	O
major	O
DNase-I	DNA
hypersensitive	DNA
sites	DNA
(	O
HS	DNA
)	O
were	O
mapped	O
in	O
the	O
tal-1	DNA
locus.	O
HS	O
I	O
,	O
IV	O
,	O
and	O
V	O
were	O
exclusively	O
observed	O
in	O
the	O
erythroid/megakaryocytic	cell_line
cell	cell_line
lines	cell_line
that	O
express	O
tal-1	DNA
from	O
the	O
promoters	O
1a	O
and	O
1b	O
.	O
HS	DNA
II	DNA
was	O
weak	O
in	O
hematopoietic	cell_line
cell	cell_line
lines	cell_line
,	O
absent	O
in	O
Hela	cell_line
,	O
and	O
greatly	O
enhanced	O
in	O
Jurkat	cell_line
,	O
suggesting	O
that	O
this	O
region	O
might	O
be	O
implicated	O
in	O
the	O
cis-activation	O
of	O
tal-1	DNA
promoter	DNA
1b	DNA
in	O
this	O
cell	O
line.	O
HS	DNA
III	DNA
was	O
weak	O
in	O
HEL	cell_line
and	O
Jurkat	cell_line
,	O
and	O
greatly	O
enhanced	O
in	O
DU528	cell_line
,	O
a	O
T-cell	cell_line
line	cell_line
that	O
bears	O
a	DNA
t	DNA
(1;14)	DNA
and	O
initiates	O
tal-1	DNA
transcription	O
within	O
exon	DNA
4	DNA
.	O
These	O
results	O
suggest	O
that	O
distinct	O
regulatory	DNA
elements	DNA
are	O
associated	O
with	O
the	O
use	O
of	O
the	O
different	O
tal-1	DNA
promoters	DNA
.	O

Erythropoietin	protein
-dependent	O
induction	O
of	O
hemoglobin	protein
synthesis	O
in	O
a	O
cytokine	cell_line
-dependent	cell_line
cell	cell_line
line	cell_line
M-TAT	cell_line
.	O
M-TAT	cell_line
is	O
a	O
cytokine	cell_line
-dependent	cell_line
cell	cell_line
line	cell_line
with	O
the	O
potential	O
to	O
differentiate	O
along	O
the	O
erythroid	O
and	O
megakaryocytic	O
lineages	O
.	O
We	O
cultured	O
M-TAT	cell_line
cells	cell_line
long	O
term	O
(&gt;	O
1	O
year)	O
in	O
the	O
continuous	O
presence	O
of	O
erythropoietin	protein
(	O
EPO	protein
),	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
(	O
GM-CSF	protein
),	O
or	O
stem	protein
cell	protein
factor	protein
(	O
SCF	protein
).	O
These	O
long	O
term	O
cultures	O
are	O
referred	O
to	O
as	O
M-TAT/EPO	O
,	O
M-TAT/GM-CSF	O
,	O
and	O
M-TAT/SCF	O
cells	O
,	O
respectively.	O
Hemoglobin	protein
concentration	O
and	O
gamma-globin	protein
and	O
erythroid	RNA
delta-aminolevulinate	RNA
synthase	RNA
mRNA	RNA
levels	O
were	O
significantly	O
higher	O
in	O
M-TAT/EPO	cell_line
cells	cell_line
than	O
in	O
M-TAT/GM-CSF	cell_line
cells	cell_line
.	O
When	O
the	O
supplemented	O
cytokine	protein
was	O
switched	O
from	O
GM-CSF	protein
to	O
EPO	protein
,	O
hemoglobin	protein
synthesis	O
in	O
M-TAT/GM-CSF	cell_line
cells	cell_line
increased	O
rapidly	O
(within	O
5	O
h),	O
and	O
the	O
level	O
of	O
GATA-1	RNA
mRNA	RNA
increased.	O
In	O
contrast,	O
the	O
addition	O
of	O
GM-CSF	protein
to	O
the	O
M-TAT/EPO	cell_line
cell	cell_line
culture	cell_line
decreased	O
the	O
amount	O
of	O
hemoglobin,	O
even	O
in	O
the	O
presence	O
of	O
EPO	protein
,	O
indicating	O
that	O
the	O
EPO	protein
signal	O
for	O
erythroid	O
differentiation	O
is	O
suppressed	O
by	O
GM-CSF	protein
.	O
Thus,	O
erythroid	O
development	O
of	O
M-TAT	cell_line
cells	cell_line
is	O
promoted	O
by	O
EPO	protein
and	O
suppressed	O
by	O
GM-CSF	protein
.	O
These	O
results	O
support	O
the	O
hypothesis	O
that	O
EPO	protein
actively	O
influences	O
the	O
programming	O
of	O
gene	O
expression	O
required	O
for	O
erythroid	cell_type
progenitor	cell_type
cell	cell_type
differentiation	O
.	O

The	O
role	O
of	O
cellular	protein
transcription	protein
factor	protein
E2F	protein
in	O
the	O
regulation	O
of	O
cdc2	RNA
mRNA	RNA
expression	O
and	O
cell	O
cycle	O
control	O
of	O
human	O
hematopoietic	cell_type
cells	cell_type
.	O
cdc2	RNA
mRNA	RNA
transcripts	RNA
were	O
detected	O
in	O
immature	cell_type
bone	cell_type
marrow	cell_type
cells	cell_type
and	O
became	O
undetectable	O
along	O
with	O
differentiation.	O
Peripheral	cell_type
blood	cell_type
resting	cell_type
cells	cell_type
did	O
not	O
express	O
cdc2	RNA
mRNA	RNA
,	O
but	O
it	O
was	O
induced	O
in	O
T-lymphocytes	cell_type
when	O
the	O
cells	O
reentered	O
the	O
cell	O
cycle	O
in	O
response	O
to	O
specific	O
mitogens	O
.	O
In	O
contrast,	O
cdc2	RNA
mRNA	RNA
could	O
not	O
be	O
induced	O
in	O
granulocytes	cell_type
and	O
monocytes	cell_type
even	O
after	O
the	O
culture	O
with	O
the	O
appropriate	O
stimulants.	O
In	O
order	O
to	O
investigate	O
the	O
mechanism	O
of	O
the	O
regulation	O
of	O
cdc2	RNA
mRNA	RNA
expression	O
in	O
hematopoietic	cell_type
cells	cell_type
,	O
we	O
isolated	O
the	O
5'-flanking	DNA
sequence	DNA
of	O
the	O
cdc2	DNA
gene	DNA
and	O
found	O
the	O
putative	O
E2F	O
binding	DNA
site	DNA
at	O
the	O
position	O
of	O
nucleotides	DNA
-124	DNA
to	DNA
-117	DNA
.	O
The	O
binding	O
of	O
E2F	protein
at	O
this	O
region	O
was	O
detected	O
by	O
a	O
gel-retardation	O
assay	O
and	O
DNaseI	protein
footprinting	O
in	O
phytohemagglutinin	cell_line
-stimulated	cell_line
T-lymphocytes	cell_line
,	O
which	O
was	O
coincident	O
with	O
the	O
expression	O
of	O
cdc2	RNA
mRNA	RNA
.	O
E2F	protein
binding	O
was	O
not	O
observed	O
in	O
both	O
granulocytes	cell_type
and	O
monocytes	cell_type
.	O
Transient	O
chloramphenicol	protein
acetyltransferase	protein
assay	O
revealed	O
that	O
the	O
region	O
containing	O
E2F	DNA
binding	DNA
site	DNA
had	O
a	O
strong	O
promoter	O
activity	O
,	O
and	O
introduction	O
of	O
the	O
mutation	O
at	O
the	O
E2F	DNA
binding	DNA
site	DNA
resulted	O
in	O
a	O
significant	O
loss	O
of	O
the	O
activity.	O
E2F-1	O
and	O
DP-1	O
mRNAs	O
were	O
not	O
detectable	O
in	O
granulocytes	cell_type
,	O
monocytes	cell_type
and	O
resting	cell_type
T-lymphocytes	cell_type
but	O
were	O
induced	O
after	O
the	O
mitogenic	O
stimulation	O
of	O
T-lymphocytes	cell_type
.	O
The	O
induction	O
of	O
E2F	protein
activity	O
preceded	O
the	O
appearance	O
of	O
cdc2	RNA
mRNA	RNA
,	O
which	O
is	O
consistent	O
with	O
the	O
role	O
of	O
E2F	protein
in	O
the	O
regulation	O
of	O
cdc2	cell_type
mRNA	cell_type
expression	cell_type
.	O
These	O
results	O
suggest	O
that	O
cdc2	RNA
mRNA	RNA
expression	O
is	O
related	O
to	O
the	O
cell	O
cycling	O
of	O
normal	cell_type
human	cell_type
hematopoietic	cell_type
cells	cell_type
and	O
that	O
E2F	protein
plays	O
some	O
roles	O
in	O
the	O
regulation	O
of	O
its	O
expression.	O

Association	O
of	O
alterations	O
in	O
NF-kappa	protein
B	protein
moieties	protein
with	O
HIV	O
type	O
1	O
proviral	O
latency	O
in	O
certain	O
monocytic	cell_type
cells	cell_type
.	O
Human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
replication	O
is	O
controlled	O
by	O
a	O
complex	O
array	O
of	O
virally	O
encoded	O
and	O
cellular	O
proteins	O
.	O
A	O
wide	O
spectrum	O
of	O
levels	O
of	O
HIV-1	O
expression	O
have	O
been	O
demonstrated	O
in	O
various	O
cells,	O
both	O
in	O
cell	O
culture	O
and	O
in	O
vivo	O
.	O
Molecular	O
mechanisms	O
leading	O
to	O
restricted	O
HIV-1	O
replication	O
may	O
differ	O
between	O
certain	O
cell	O
types.	O
It	O
is	O
now	O
demonstrated	O
that	O
HIV-1	O
proviral	O
latency	O
in	O
the	O
monocytic	cell_line
cell	cell_line
line	cell_line
U1	cell_line
,	O
in	O
which	O
only	O
extremely	O
low	O
levels	O
of	O
HIV-1	O
expression	O
are	O
detected	O
in	O
the	O
baseline	O
unstimulated	O
state,	O
is	O
associated	O
with	O
alterations	O
in	O
nuclear	O
factor-kappa	protein
B	protein
(	protein
NF-kappa	protein
B	protein
)	protein
moieties	protein
demonstrated	O
in	O
these	O
cells	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSAs	O
)	O
and	O
in	O
situ	O
UV	O
cross-linking	O
studies	O
.	O
A	O
predominance	O
of	O
p50	protein
NF-kappa	protein
B	protein
moieties	protein
and	O
possibly	O
p50	protein
homodimers	protein
or	O
closely	O
related	O
species,	O
rather	O
than	O
the	O
p50-p56	protein
heterodimer	protein
of	O
NF-kappa	protein
B	protein
that	O
is	O
the	O
predominant	O
NF-kappa	protein
B	protein
species	O
in	O
most	O
T	O
lymphocytic	O
and	O
monocytic	O
cells	O
,	O
is	O
demonstrated	O
in	O
the	O
nuclei	O
of	O
U1	cell_line
cells	cell_line
.	O
This	O
pattern	O
of	O
NF-kappa	protein
B-related	protein
moieties	protein
differs	O
from	O
the	O
latently	cell_line
infected	cell_line
T	cell_line
lymphocytic	cell_line
cell	cell_line
line	cell_line
ACH-2	cell_line
,	O
and	O
from	O
the	O
U937	cell_line
monocytic	cell_line
line	cell_line
,	O
the	O
parental	cell_line
cell	cell_line
line	cell_line
of	O
the	O
U1	cell_line
cellular	cell_line
clone	cell_line
.	O
As	O
such,	O
these	O
data	O
suggest	O
that	O
different	O
proximal	O
mechanisms	O
may	O
lead	O
to	O
restricted	O
HIV-1	O
replication	O
in	O
various	O
cell	O
types.	O

[Regulation	O
of	O
transcription	O
of	O
the	O
interleukin-2	DNA
gene	DNA
in	O
B-lymphocytes	cell_type
]	O
Since	O
most	O
B	cell_line
cell	cell_line
clones	cell_line
immortalized	O
with	O
EBV	O
virus	O
can	O
be	O
induced	O
to	O
produce	O
interleukin-2	protein
,	O
a	O
typical	O
T	protein
cell	protein
cytokine	protein
,	O
we	O
studied	O
the	O
role	O
of	O
different	O
elements	O
of	O
the	O
IL-2	DNA
promoter	DNA
in	O
such	O
clones	O
by	O
transfection.	O
It	O
was	O
found,	O
in	O
particular,	O
that	O
the	O
element	O
TCEd	DNA
,	O
which	O
binds	O
the	O
transcription	protein
factor	protein
NF-kB	protein
,	O
is	O
very	O
active	O
in	O
all	O
three	O
B	cell_line
clones	cell_line
tested.	O
This	O
element	O
has	O
no	O
activity	O
in	O
T	cell_type
cells	cell_type
of	O
the	O
Jurkat	cell_line
line	cell_line
.	O
The	O
NFATd	DNA
element	DNA
,	O
which	O
binds	O
the	O
transcription	protein
factor	protein
NFAT-1	protein
and	O
is	O
very	O
active	O
in	O
T	cell_type
cells	cell_type
,	O
is	O
only	O
weakly	O
active	O
in	O
one	O
B	cell_line
clone	cell_line
and	O
not	O
at	O
all	O
in	O
another.	O
Different	O
elements	O
thus	O
contribute	O
to	O
IL-2	DNA
promoter	DNA
activity	O
in	O
different	O
cells.	O

Regulation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
and	O
p105	protein
in	O
monocytes	cell_type
and	O
macrophages	cell_type
persistently	O
infected	O
with	O
human	O
immunodeficiency	O
virus	O
.	O
The	O
mechanisms	O
regulating	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
persistence	O
in	O
human	O
monocytes	cell_type
/macrophages	cell_type
are	O
partially	O
understood.	O
Persistent	O
HIV	O
infection	O
of	O
U937	cell_line
monocytic	cell_line
cells	cell_line
results	O
in	O
NF-kappa	protein
B	protein
activation	O
.	O
Whether	O
virus-induced	O
NF-kappa	protein
B	protein
activation	O
is	O
a	O
mechanism	O
that	O
favors	O
continuous	O
viral	O
replication	O
in	O
macrophages	cell_type
remains	O
unknown.	O
To	O
further	O
delineate	O
the	O
molecular	O
mechanisms	O
involved	O
in	O
the	O
activation	O
of	O
NF-kappa	protein
B	protein
in	O
HIV	O
-infected	O
monocytes	cell_type
and	O
macrophages	cell_type
,	O
we	O
have	O
focused	O
on	O
the	O
regulation	O
of	O
the	O
I	O
kappa	O
B	O
molecules.	O
First,	O
we	O
show	O
that	O
persistent	O
HIV	O
infection	O
results	O
in	O
the	O
activation	O
of	O
NF-kappa	O
B	O
not	O
only	O
in	O
monocytic	O
cells	O
but	O
also	O
in	O
macrophages	cell_type
.	O
In	O
HIV	O
-infected	O
cells,	O
I	protein
kappa	protein
B	protein
alpha	protein
protein	O
levels	O
are	O
decreased	O
secondary	O
to	O
enhanced	O
protein	O
degradation.	O
This	O
parallels	O
the	O
increased	O
I	protein
kappa	protein
B	protein
alpha	protein
synthesis	O
secondary	O
to	O
increased	O
I	protein
kappa	protein
B	protein
alpha	protein
gene	O
transcription,	O
i.e.,	O
increased	O
RNA	O
and	O
transcriptional	O
activity	O
of	O
its	O
promoter-enhancer.	O
Another	O
protein	O
with	O
I	O
kappa	O
B	O
function,	O
p105	protein
,	O
is	O
also	O
modified	O
in	O
HIV	O
-infected	O
cells:	O
p105	protein
and	O
p50	protein
steady-state	O
protein	O
levels	O
are	O
increased	O
as	O
a	O
result	O
of	O
increased	O
synthesis	O
and	O
proteolytic	O
processing	O
of	O
p105	protein
.	O
Transcriptional	O
activity	O
of	O
p105	protein
is	O
also	O
increased	O
in	O
infected	cell_type
cells	cell_type
and	O
is	O
also	O
mediated	O
by	O
NF-kappa	protein
B	protein
through	O
a	O
specific	O
kappa	DNA
B	DNA
motif	DNA
.	O
These	O
results	O
demonstrate	O
the	O
existence	O
of	O
a	O
triple	O
autoregulatory	DNA
loop	DNA
in	O
monocytes	cell_type
and	O
macrophages	cell_type
involving	O
HIV	O
,	O
p105	protein
and	O
p50	protein
,	O
and	O
MAD3	protein
,	O
with	O
the	O
end	O
result	O
of	O
persistent	O
NF-kappa	protein
B	protein
activation	O
and	O
viral	O
persistence	O
.	O
Furthermore,	O
persistent	O
HIV	O
infection	O
of	O
monocytes	cell_type
and	O
macrophages	cell_type
provides	O
a	O
useful	O
model	O
with	O
which	O
to	O
study	O
concomitant	O
modifications	O
of	O
different	O
I	protein
kappa	protein
B	protein
molecules	protein
.	O

Glucocorticoid	O
-induced	O
apoptosis	O
of	O
human	cell_type
leukemic	cell_type
cells	cell_type
is	O
caused	O
by	O
the	O
repressive	O
function	O
of	O
the	O
glucocorticoid	protein
receptor	protein
.	O
Induction	O
of	O
apoptosis	O
in	O
lymphocytes	cell_type
,	O
which	O
may	O
account	O
for	O
the	O
therapeutic	O
effects	O
of	O
glucocorticoids	O
in	O
various	O
diseases	O
including	O
leukemia	O
,	O
depends	O
on	O
the	O
glucocorticoid	protein
receptor	protein
.	O
However,	O
the	O
events	O
leading	O
from	O
the	O
activated	O
receptor	O
to	O
cell	O
lysis	O
are	O
not	O
understood.	O
A	O
prevailing	O
hypothesis	O
postulates	O
induction	O
of	O
so-called	O
'	O
lysis	DNA
genes	DNA
'	O
by	O
the	O
activated	protein
receptor	protein
.	O
In	O
this	O
study,	O
we	O
show	O
that	O
an	O
activation-deficient	protein
glucocorticoid	protein
receptor	protein
mutant	protein
is	O
as	O
effective	O
as	O
the	O
wild-type	protein
receptor	protein
in	O
repression	O
of	O
AP-1	protein
activity	O
,	O
inhibition	O
of	O
interleukin-2	protein
production	O
,	O
inhibition	O
of	O
c-myc	DNA
expression	O
and	O
induction	O
of	O
apoptosis	O
.	O
Furthermore,	O
we	O
show	O
that	O
retinoic	O
acid	O
can	O
also	O
induce	O
apoptosis	O
in	O
these	O
cells	O
through	O
the	O
retinoic	protein
acid	protein
receptor	protein
,	O
whose	O
repressive	O
functions	O
but	O
not	O
target	O
site	O
specificity,	O
are	O
similar	O
to	O
those	O
of	O
the	O
glucocorticoid	protein
receptor	protein
.	O
Therefore,	O
the	O
primary	O
effect	O
of	O
the	O
receptor	O
in	O
glucocorticoid	O
-mediated	O
apoptosis	O
correlates	O
with	O
transcriptional	O
repression	O
rather	O
than	O
activation	O
and	O
could	O
be	O
mediated	O
by	O
interference	O
with	O
other	O
transcription	protein
factors	protein
required	O
for	O
cell	O
survival	O
.	O

HIV	O
type	O
1	O
protease	protein
activation	O
of	O
NF-kappa	protein
B	protein
within	O
T	cell_type
lymphoid	cell_type
cells	cell_type
.	O
NF-kappa	protein
B	protein
is	O
a	O
nuclear	protein
protein	protein
of	O
the	O
rel	protein
oncogene	protein
family	protein
capable	O
of	O
enhancing	O
transcription	O
of	O
several	DNA
cellular	DNA
genes	DNA
,	O
including	O
IL-2	protein
and	O
the	O
IL-2	protein
receptor	protein
,	O
and	O
viral	DNA
genes	DNA
transcribed	O
from	O
the	O
HIV-1	DNA
LTR	DNA
.	O
It	O
has	O
been	O
reported	O
that	O
HIV-1	protein
protease	protein
may	O
cleave	O
the	O
NF-kappa	protein
B	protein
precursor	O
to	O
its	O
active	O
form	O
in	O
vitro.	O
In	O
this	O
study	O
the	O
effects	O
of	O
HIV	O
protease	O
on	O
NF-kappa	protein
B	protein
precursor	O
activation	O
were	O
examined	O
in	O
Jurkat	O
T	cell_type
cells	cell_type
by	O
introducing	O
a	O
protease	DNA
expression	DNA
vector	DNA
into	O
the	O
cells.	O
Increased	O
NF-kappa	protein
B	protein
activity	O
was	O
observed	O
and	O
this	O
increased	O
activity	O
was	O
blocked	O
by	O
a	O
specific	O
inhibitor	O
of	O
the	O
viral	protein
protease	protein
.	O
Viral	O
transcription,	O
as	O
measured	O
using	O
LTR	DNA
-CAT	protein
assays	O
,	O
was	O
only	O
slightly	O
enhanced	O
in	O
the	O
HIV-protease	cell_type
expressing	cell_type
cells	cell_type
,	O
while	O
secretion	O
of	O
IL-2	protein
and	O
expression	O
of	O
the	O
IL-2	protein
receptor	O
were	O
not	O
affected.	O
The	O
limited	O
activation	O
of	O
NF-kappa	protein
B	protein
by	O
HIV	protein
protease	protein
appears	O
unlikely	O
to	O
have	O
a	O
significant	O
effect	O
on	O
virus	O
expression	O
or	O
T	O
cell	O
function	O
.	O

Inhibition	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
replication	O
by	O
a	O
Tat-activated,	DNA
transduced	DNA
interferon	DNA
gene	DNA
:	O
targeted	O
expression	O
to	O
human	cell_type
immunodeficiency	cell_type
virus	cell_type
type	cell_type
1	cell_type
-infected	cell_type
cells	cell_type
.	O
We	O
have	O
examined	O
the	O
feasibility	O
of	O
using	O
interferon	protein
(	O
IFN	protein
)	O
gene	O
transfer	O
as	O
a	O
novel	O
approach	O
to	O
anti-	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(HIV-1)	O
therapy	O
in	O
this	O
study.	O
To	O
limit	O
expression	O
of	O
a	O
transduced	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
(LTR)-IFNA2	DNA
(the	O
new	O
approved	O
nomenclature	O
for	O
IFN	DNA
genes	DNA
is	O
used	O
throughout	O
this	O
article)	O
hybrid	DNA
gene	DNA
to	O
the	O
HIV-1-infected	cell_line
cells	cell_line
,	O
HIV-1	DNA
LTR	DNA
was	O
modified.	O
Deletion	O
of	O
the	O
NF-kappa	DNA
B	DNA
elements	DNA
of	O
the	O
HIV-1	DNA
LTR	DNA
significantly	O
inhibited	O
Tat	protein
-mediated	O
transactivation	O
in	O
T-cell	cell_line
lines	cell_line
,	O
as	O
well	O
as	O
in	O
a	O
monocyte	cell_line
line	cell_line
,	O
U937	cell_line
.	O
Replacement	O
of	O
the	O
NF-kappa	DNA
B	DNA
elements	DNA
in	O
the	O
HIV-1	DNA
LTR	DNA
by	O
a	O
DNA	DNA
fragment	DNA
derived	O
from	O
the	O
5'-flanking	DNA
region	DNA
of	O
IFN-stimulated	DNA
gene	DNA
15	DNA
(	O
ISG15	DNA
),	O
containing	O
the	O
IFN-stimulated	DNA
response	DNA
element	DNA
,	O
partially	O
restored	O
Tat	protein
-mediated	O
activation	O
of	O
LTR	DNA
in	O
T	cell_type
cells	cell_type
as	O
well	O
as	O
in	O
monocytes	cell_type
.	O
Insertion	O
of	O
this	O
chimeric	DNA
promoter	DNA
(	O
ISG15	DNA
LTR	DNA
)	O
upstream	O
of	O
the	O
human	DNA
IFNA2	DNA
gene	DNA
directed	O
high	O
levels	O
of	O
IFN	protein
synthesis	O
in	O
Tat-expressing	cell_line
cells	cell_line
,	O
while	O
this	O
promoter	O
was	O
not	O
responsive	O
to	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
-mediated	O
activation	O
.	O
ISG15-LTR-IFN	DNA
hybrid	DNA
gene	DNA
inserted	O
into	O
the	O
retrovirus	DNA
vector	DNA
was	O
transduced	O
into	O
Jurkat	cell_line
and	O
U937	cell_line
cells	cell_line
.	O
Selected	O
transfected	cell_line
clones	cell_line
produced	O
low	O
levels	O
of	O
IFN	protein
A	protein
(	O
IFNA	protein
)	O
constitutively,	O
and	O
their	O
abilities	O
to	O
express	O
interleukin-2	protein
and	O
interleukin-2	protein
receptor	protein
upon	O
stimulation	O
with	O
phytohemagglutinin	protein
and	O
phorbol	O
myristate	O
acetate	O
were	O
retained.	O
Enhancement	O
of	O
IFNA	protein
synthesis	O
observed	O
upon	O
HIV-1	O
infection	O
resulted	O
in	O
significant	O
inhibition	O
of	O
HIV-1	O
replication	O
for	O
a	O
period	O
of	O
at	O
least	O
30	O
days.	O
Virus	O
isolated	O
from	O
IFNA	cell_line
-producing	cell_line
cells	cell_line
was	O
able	O
to	O
replicate	O
in	O
the	O
U937	cell_line
cells	cell_line
but	O
did	O
not	O
replicate	O
efficiently	O
in	O
U937	cell_line
cells	cell_line
transduced	O
with	O
the	O
IFNA	DNA
gene	DNA
.	O
These	O
results	O
suggest	O
that	O
targeting	O
IFN	protein
synthesis	O
to	O
HIV-1	cell_line
-infected	cell_line
cells	cell_line
is	O
an	O
attainable	O
goal	O
and	O
that	O
autocrine	O
IFN	protein
synthesis	O
results	O
in	O
a	O
long-lasting	O
and	O
permanent	O
suppression	O
of	O
HIV-1	O
replication	O
.	O

Chromosomal	O
localization	O
of	O
two	O
KOX	DNA
zinc	DNA
finger	DNA
genes	DNA
on	O
chromosome	DNA
bands	DNA
7q21-q22	DNA
.	O
Human	DNA
cDNAs	DNA
encoding	O
Kruppel-type	protein
zinc	protein
finger	protein
domains	protein
,	O
designated	O
KOX	DNA
1-32	DNA
,	O
have	O
been	O
cloned	O
from	O
human	DNA
T	DNA
lymphocyte	DNA
cell	DNA
line	DNA
libraries	DNA
.	O
We	O
report	O
here	O
the	O
regional	O
localizations	O
by	O
in	O
situ	O
hybridization	O
of	O
KOX	DNA
18	DNA
and	O
KOX	DNA
25	DNA
on	O
chromosome	DNA
bands	DNA
7q21q22	DNA
.	O
Pulse-field	O
gel	O
electrophoresis	O
(PFGE)	O
analysis	O
showed	O
that	O
these	O
genes	O
are	O
physically	O
located	O
within	O
a	O
DNA	DNA
fragment	DNA
of	O
250	DNA
kb	DNA
.	O
The	O
genes	O
KOX	DNA
4	DNA
and	O
KOX	DNA
9	DNA
,	O
mapped	O
on	O
chromosome	DNA
8q24	DNA
,	O
were	O
found	O
to	O
be	O
located	O
within	O
a	O
DNA	DNA
fragment	DNA
of	O
450	O
kb	O
.	O
From	O
the	O
present	O
and	O
previous	O
data,	O
eighteen	O
different	O
KOX	DNA
genes	DNA
have	O
been	O
located	O
at	O
least	O
two	O
by	O
two	O
within	O
nine	O
DNA	DNA
fragments	DNA
of	O
200	O
to	O
580	O
kb.	O

Influence	O
of	O
age	O
on	O
the	O
production	O
of	O
Fos	protein
and	O
Jun	protein
by	O
influenza	cell_type
virus-exposed	cell_type
T	cell_type
cells	cell_type
.	O
This	O
study	O
investigated	O
age-related	O
T	O
cell	O
responses	O
after	O
in	O
vitro	O
exposure	O
to	O
influenza	O
A	O
virus	O
.	O
Mononuclear	cell_type
leukocytes	cell_type
from	O
young	O
or	O
elderly	O
persons	O
were	O
sham-exposed	O
or	O
exposed	O
to	O
influenza	O
virus	O
for	O
1,	O
24,	O
and	O
72	O
h.	O
Immunofluorescent	O
staining	O
and	O
flow	O
cytometric	O
analysis	O
were	O
then	O
used	O
to	O
detect	O
T	cell_type
cells	cell_type
producing	O
the	O
transcriptional	protein
regulating	protein
proteins	protein
Fos	protein
and	O
Jun	protein
.	O
Fewer	O
virus-exposed	O
cells	O
from	O
elderly	O
donors	O
stained	O
for	O
Fos	protein
and	O
Jun	protein
at	O
each	O
data	O
point	O
compared	O
with	O
cells	O
from	O
young	O
donors	O
.	O
Flow	O
cytometric	O
analysis	O
also	O
showed	O
that	O
at	O
72	O
h	O
of	O
virus	O
exposure	O
fewer	O
T	cell_type
cells	cell_type
from	O
the	O
elderly	O
produced	O
interferon-gamma	protein
(	O
IFN-gamma	protein
),	O
suggesting	O
a	O
link	O
between	O
the	O
magnitude	O
of	O
the	O
Fos	protein
and	O
Jun	protein
and	O
IFN-gamma	protein
responses.	O
Thus,	O
failure	O
of	O
virus-exposed	cell_type
T	cell_type
cells	cell_type
to	O
produce	O
Fos	protein
and	O
Jun	protein
could	O
contribute	O
to	O
the	O
increase	O
in	O
illness	O
due	O
to	O
influenza	O
virus	O
in	O
the	O
elderly	O
.	O

The	O
regulation	O
of	O
HIV	O
by	O
retinoic	O
acid	O
correlates	O
with	O
cellular	O
expression	O
of	O
the	O
retinoic	protein
acid	protein
receptors	protein
.	O
OBJECTIVES:	O
To	O
analyze	O
the	O
effect	O
of	O
retinoic	O
acids	O
(	O
RA	O
)	O
on	O
HIV-1	O
expression	O
and	O
correlate	O
this	O
effect	O
with	O
expression	O
levels	O
of	O
RA	protein
receptors	protein
(	O
RARs	protein
)	O
in	O
T-lymphoid	O
and	O
monocytoid	O
cell	O
lines	O
.	O
DESIGN	O
AND	O
METHODS:	O
The	O
effect	O
of	O
all-trans	O
and	O
9-cis	O
RA	O
on	O
HIV-1	O
production	O
in	O
T-lymphoid	cell_line
(	O
H9,	cell_line
CEM	cell_line
)	O
and	O
monocytoid	cell_line
(U937,THP-1)	cell_line
cell	cell_line
lines	cell_line
was	O
measured	O
during	O
acute	O
and	O
chronic	O
infection	O
.	O
The	O
expression	O
levels	O
of	O
human	protein
RAR	protein
alpha	protein
(	O
hRAR	protein
alpha,	protein
receptor	protein
for	O
all-trans	O
RA	O
)	O
and	O
the	O
human	protein
retinoid-X	protein
receptor	protein
alpha	protein
(	O
hRXR	protein
alpha	protein
receptor	protein
for	O
9-cis	O
RA	O
)	O
were	O
determined	O
by	O
Northern	O
blot	O
analysis.	O
RESULTS:	O
Both	O
all-trans	O
and	O
9-cis	O
RA	O
inhibited	O
virus	O
replication	O
in	O
HIV-1	cell_line
IIIB-infected	cell_line
monocytoid	cell_line
cells	cell_line
,	O
in	O
the	O
presence	O
and	O
absence	O
of	O
the	O
co-stimulatory	O
agent	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
).	O
The	O
retinoids	O
had	O
weak	O
or	O
no	O
stimulatory	O
effects	O
on	O
HIV	O
production	O
by	O
T-cell	cell_line
lines	cell_line
.	O
HIV	O
production	O
by	O
PMA	cell_line
-stimulated	cell_line
T-cell	cell_line
lines	cell_line
was	O
inhibited	O
by	O
these	O
retinoids	O
.	O
The	O
9-cis	O
RA	O
was	O
generally	O
more	O
effective	O
than	O
all-trans	O
RA	O
in	O
inhibiting	O
HIV	O
production	O
and	O
in	O
combination	O
generally	O
more	O
effective	O
than	O
the	O
single	O
agents	O
alone.	O
Human	protein
RAR	protein
alpha	protein
was	O
expressed	O
in	O
H9	cell_line
,	O
U937	cell_line
and	O
THP-1	cell_line
cells	cell_line
,	O
but	O
almost	O
undetectable	O
in	O
CEM	cell_line
cells	cell_line
.	O
Human	protein
RXR	protein
alpha	protein
was	O
significantly	O
expressed	O
in	O
U937	O
and	O
THP-1	O
cells	O
,	O
weakly	O
expressed	O
in	O
H9	cell_line
cells	cell_line
and	O
not	O
detectable	O
in	O
CEM	cell_line
cells	cell_line
.	O
After	O
stimulation	O
by	O
PMA	O
,	O
RXR	protein
alpha	protein
expression	O
increased	O
in	O
H9	cell_line
and	O
U937	cell_line
cells	cell_line
but	O
not	O
in	O
CEM	cell_line
cells	cell_line
.	O
Human	O
RAR	O
alpha	O
expression	O
was	O
unchanged	O
in	O
H9	cell_line
and	O
CEM	cell_line
cells	cell_line
,	O
and	O
elevated	O
in	O
U937	cell_line
cells	cell_line
,	O
after	O
PMA	O
stimulation.	O
CONCLUSION:	O
The	O
effect	O
of	O
RA	O
on	O
HIV-1	O
expression	O
was	O
cell-type-dependent	O
and	O
partially	O
correlated	O
with	O
cellular	O
expression	O
of	O
RARs	protein
.	O
Endogenous	O
or	O
exogenously	O
administered	O
RA	O
may	O
have	O
a	O
significant	O
role	O
in	O
HIV	O
regulation	O
.	O

Functions	O
of	O
glutathione	O
and	O
glutathione	O
disulfide	O
in	O
immunology	O
and	O
immunopathology	O
.	O
Even	O
a	O
moderate	O
increase	O
in	O
the	O
cellular	O
cysteine	O
supply	O
elevates	O
the	O
intracellular	O
glutathione	O
(	O
GSH	O
)	O
and	O
glutathione	O
disulfide	O
(	O
GSSG	O
)	O
levels	O
and	O
potentiates	O
immunological	O
functions	O
of	O
lymphocytes	cell_type
in	O
vitro.	O
At	O
low	O
GSSG	O
levels	O
,	O
T	cell_type
cells	cell_type
cannot	O
optimally	O
activate	O
the	O
immunologically	O
important	O
transcription	protein
factor	protein
NF	protein
kappa	protein
B	protein
,	O
whereas	O
high	O
GSSG	O
levels	O
inhibit	O
the	O
DNA	O
binding	O
activity	O
of	O
NF	protein
kappa	protein
B	protein
.	O
The	O
effects	O
of	O
GSSG	O
are	O
antagonized	O
by	O
reduced	O
thioredoxin	protein
(	O
TRX	protein
).	O
As	O
the	O
protein	protein
tyrosine	protein
kinase	protein
activities	O
p56lck	protein
and	O
p59fyn	protein
are	O
activated	O
in	O
intact	O
cells	O
by	O
hydrogen	O
peroxide	O
,	O
they	O
are	O
likely	O
targets	O
for	O
GSSG	O
action	O
.	O
These	O
redox-regulated	protein
enzymes	protein
trigger	O
signal	O
cascades	O
for	O
NF	protein
kappa	protein
B	protein
activation	O
and	O
transduce	O
signals	O
from	O
the	O
T	protein
cell	protein
antigen	protein
receptor	protein
,	O
from	O
CD4	protein
and	O
CD8	protein
molecules	protein
,	O
and	O
from	O
the	O
IL-2	protein
receptor	protein
beta-chain	protein
.	O
The	O
effector	O
phase	O
of	O
cytotoxic	cell_type
T	cell_type
cell	cell_type
responses	O
and	O
IL-2	protein
-dependent	O
functions	O
are	O
inhibited	O
even	O
by	O
a	O
partial	O
depletion	O
of	O
the	O
intracellular	O
GSH	O
pool	O
.	O
As	O
signal	O
transduction	O
is	O
facilitated	O
by	O
prooxidant	O
conditions	O
,	O
we	O
propose	O
that	O
the	O
well-known	O
immunological	O
consequences	O
of	O
GSH	O
depletion	O
ultimately	O
may	O
be	O
results	O
of	O
the	O
accompanying	O
GSSG	O
deficiency	O
.	O
As	O
HIV	O
-infected	O
patients	O
and	O
SIV-infected	O
rhesus	O
macaques	O
have,	O
on	O
the	O
average,	O
significantly	O
decreased	O
plasma	O
cyst(e)ine	O
and	O
intracellular	O
GSH	O
levels	O
,	O
we	O
also	O
hypothesize	O
that	O
AIDS	O
may	O
be	O
the	O
consequence	O
of	O
a	O
GSSG	O
deficiency	O
as	O
well.	O

T	cell_type
cells	cell_type
from	O
renal	O
cell	O
carcinoma	O
patients	O
exhibit	O
an	O
abnormal	O
pattern	O
of	O
kappa	O
B-specific	O
DNA-binding	O
activity	O
:	O
a	O
preliminary	O
report.	O
Recent	O
data	O
suggest	O
that	O
the	O
poor	O
induction	O
of	O
a	O
T-cell	O
response	O
to	O
human	O
renal	O
cell	O
carcinoma	O
(	O
RCC	O
)	O
may	O
be	O
related	O
to	O
alterations	O
in	O
signal	O
transduction	O
pathways	O
.	O
We	O
report	O
that	O
T	cell_type
cells	cell_type
from	O
RCC	O
patients	O
have	O
two	O
alterations	O
in	O
kappa	DNA
B	DNA
motif	DNA
-specific	O
DNA-binding	O
activity	O
.	O
The	O
first	O
alteration	O
involves	O
the	O
constitutive	O
expression	O
of	O
substantial	O
kappa	O
B-binding	O
activity	O
in	O
nuclear	O
extracts	O
,	O
which	O
was	O
observed	O
in	O
the	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O
The	O
magnitude	O
of	O
kappa	O
B	O
activity	O
in	O
unstimulated	cell_type
patient	cell_type
T	cell_type
cells	cell_type
was	O
similar	O
to	O
that	O
observed	O
in	O
T	cell_type
cells	cell_type
from	O
normal	O
individuals	O
that	O
had	O
been	O
activated	O
in	O
vitro.	O
On	O
the	O
basis	O
of	O
Western	O
blotting	O
experiments	O
using	O
antibodies	protein
to	O
kappa	protein
B/Rel	protein
family	protein
proteins	protein
,	O
the	O
kappa	O
B-binding	O
activity	O
constitutively	O
expressed	O
in	O
T	cell_type
cells	cell_type
from	O
RCC	O
patients	O
is	O
composed	O
mostly	O
of	O
the	O
NF-kappa	protein
B1	protein
(	protein
p50	protein
)	protein
subunit	protein
.	O
The	O
second	O
abnormality	O
in	O
kappa	O
B-binding	O
activity	O
in	O
T	cell_type
cells	cell_type
from	O
these	O
patients	O
is	O
that	O
RelA	protein
,	O
a	O
member	O
of	O
the	O
Rel	protein
homology	protein
family	protein
which	O
is	O
part	O
of	O
the	O
normal	O
NF-kappa	protein
B	protein
complex	protein
,	O
was	O
not	O
induced	O
in	O
the	O
nucleus	O
following	O
activation.	O
Western	O
blotting	O
analysis	O
did	O
not	O
detect	O
any	O
RelA	protein
in	O
nuclear	O
extracts	O
either	O
before	O
or	O
after	O
stimulation	O
of	O
T	cell_type
cells	cell_type
.	O
The	O
altered	O
kappa	O
B-binding	O
activity	O
in	O
T	cell_type
cells	cell_type
from	O
RCC	O
patients	O
may	O
impair	O
their	O
capacity	O
to	O
respond	O
normally	O
to	O
various	O
stimuli.	O

Hemoglobin	protein
switching	O
in	O
humans	O
is	O
accompanied	O
by	O
changes	O
in	O
the	O
ratio	O
of	O
the	O
transcription	protein
factors	protein
,	O
GATA-1	protein
and	O
SP1	protein
.	O
BACKGROUND:	O
Understanding	O
the	O
mechanism	O
of	O
developmental	O
regulation	O
of	O
hemoglobin	protein
switching	O
has	O
scientific	O
as	O
well	O
as	O
clinical	O
relevance	O
because	O
of	O
the	O
influence	O
of	O
fetal	O
hemoglobin	protein
(	O
HbF	protein
)	O
production	O
in	O
adulthood	O
on	O
the	O
clinical	O
manifestation	O
of	O
thalassemia	O
and	O
sickle	O
cell	O
anemia	O
.	O
We	O
have	O
previously	O
found	O
that	O
the	O
normal	O
developmental	O
patterns	O
of	O
globin	DNA
gene	DNA
expression	O
are	O
recapitulated	O
in	O
an	O
experimental	O
system	O
of	O
primary	cell_line
cultures	cell_line
that	O
support	O
differentiation	O
of	O
erythroid	cell_type
progenitors	cell_type
.	O
We	O
further	O
found	O
that	O
high	O
activities	O
of	O
the	O
transcriptional	protein
activators	protein
,	O
GATA-1	protein
and	O
SP1	protein
,	O
are	O
associated	O
with	O
normal	O
adult	O
erythroid	O
differentiation	O
.	O
MATERIALS	O
AND	O
METHODS:	O
In	O
the	O
present	O
work,	O
we	O
have	O
studied,	O
the	O
activities	O
of	O
GATA-1	protein
and	O
SP1	protein
during	O
differentiation	O
of	O
cultured	O
erythroid	cell_type
progenitors	cell_type
derived	O
from	O
cord	O
blood	O
and	O
from	O
fetal	O
livers	O
,	O
as	O
well	O
as	O
from	O
beta	O
zero-	O
thalassemia	O
patients	O
.	O
RESULTS:	O
The	O
results	O
showed	O
high	O
GATA-1	protein
binding	O
activity	O
and	O
very	O
low	O
SP1	protein
activity	O
in	O
the	O
fetal	cell_line
liver	cell_line
cultures	cell_line
.	O
This	O
pattern	O
was	O
in	O
contrast	O
to	O
cultures	O
derived	O
from	O
normal	O
adult	O
peripheral	O
blood	O
,	O
in	O
which	O
both	O
GATA-1	protein
and	O
SP1	protein
activities	O
were	O
high.	O
Cord	O
blood	O
cultures	O
showed	O
an	O
additive	O
combination	O
of	O
"adult"	O
and	O
"fetal"	O
patterns.	O
The	O
progenitors	O
derived	O
from	O
a	O
beta	O
zero-	O
thalassemia	O
patient	O
with	O
high	O
HbF	protein
production	O
showed	O
"fetal"	O
pattern.	O
On	O
the	O
other	O
hand,	O
in	O
cultures	O
of	O
2	O
beta	O
zero-	O
thalassemia	O
patients	O
without	O
high	O
HbF	protein
,	O
"adult"	O
pattern	O
was	O
observed.	O
CONCLUSIONS:	O
In	O
the	O
present	O
work,	O
we	O
show	O
that	O
human	O
fetal	O
and	O
adult	O
erythroid	O
progenitors	O
are	O
distinct	O
in	O
their	O
transcription	protein
factors	protein
,	O
and	O
that	O
the	O
commitment	O
to	O
fetal	O
or	O
adult	O
program	O
occurs	O
at	O
a	O
very	O
early	O
differentiation	O
stage.	O
Our	O
studies	O
also	O
demonstrate	O
that	O
under	O
anemic	O
stress	O
,	O
recruitment	O
of	O
fetal	cell_type
progenitors	cell_type
may	O
occur	O
in	O
adulthood	O
.	O

Transcription-independent	O
turnover	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
during	O
monocyte	O
adherence	O
:	O
implications	O
for	O
a	O
translational	O
component	O
regulating	O
I	RNA
kappa	RNA
B	RNA
alpha	RNA
/MAD-3	RNA
mRNA	RNA
levels	O
.	O
We	O
identified	O
I	protein
kappa	protein
B	protein
alpha	protein
/MAD-3	protein
as	O
an	O
immediate-early	DNA
gene	DNA
in	O
human	cell_type
monocytes	cell_type
that	O
is	O
expressed	O
in	O
response	O
to	O
a	O
variety	O
of	O
signals,	O
including	O
adhesion	O
,	O
lipopolysaccharide	O
,	O
and	O
phorbol	O
myristate	O
acetate	O
.	O
Within	O
5	O
min	O
of	O
monocyte	O
adhesion	O
,	O
the	O
level	O
of	O
the	O
I	protein
kappa	protein
B	protein
alpha	protein
protein	protein
is	O
markedly	O
diminished	O
but	O
is	O
rapidly	O
replaced	O
in	O
a	O
cycloheximide-sensitive	O
manner	O
within	O
20	O
min.	O
Accompanying	O
the	O
rapid	O
turnover	O
of	O
the	O
I	protein
kappa	protein
B	protein
alpha	protein
protein	protein
is	O
simultaneous	O
translocation	O
of	O
NF-kappa	protein
B-related	protein
transcription	protein
factors	protein
to	O
nuclei	O
of	O
adhered	O
monocytes.	O
The	O
demonstration	O
that	O
NF-kappa	protein
B	protein
can	O
regulate	O
I	DNA
kappa	DNA
B	DNA
alpha	DNA
/MAD-3	DNA
gene	DNA
transcription	O
in	O
other	O
cell	O
types	O
suggested	O
that	O
the	O
rapid	O
increase	O
in	O
steady-state	O
I	RNA
kappa	RNA
B	RNA
alpha	RNA
/MAD-3	RNA
mRNA	RNA
levels	O
we	O
observed	O
within	O
30	O
min	O
of	O
monocyte	O
adherence	O
would	O
result	O
from	O
NF-kappa	protein
B	protein
-dependent	O
transcriptional	O
stimulation	O
of	O
the	O
I	DNA
kappa	DNA
B	DNA
alpha	DNA
/MAD-3	DNA
gene	DNA
.	O
Nuclear	O
run-on	O
analyses	O
indicated	O
that,	O
instead,	O
while	O
several	O
immediate-early	DNA
cytokine	DNA
genes	DNA
,	O
such	O
as	O
the	O
interleukin	DNA
1	DNA
beta	DNA
(	DNA
IL-1	DNA
beta	DNA
)	DNA
gene	DNA
,	O
were	O
transcriptionally	O
activated	O
during	O
monocyte	O
adhesion	O
,	O
the	O
rate	O
of	O
I	DNA
kappa	DNA
B	DNA
alpha	DNA
/MAD-3	DNA
gene	DNA
transcription	O
remained	O
constant.	O
The	O
adherence-dependent	O
increase	O
in	O
I	RNA
kappa	RNA
B	RNA
alpha	RNA
/MAD-3	RNA
mRNA	RNA
levels	O
was	O
also	O
not	O
a	O
consequence	O
of	O
mRNA	RNA
stabilization	O
events	O
.	O
Interestingly,	O
while	O
increases	O
in	O
both	O
IL-1	O
beta	O
and	O
I	O
kappa	O
B	O
alpha/MAD-3	O
mRNA	O
levels	O
were	O
detected	O
in	O
nuclei	O
of	O
adherent	cell_type
monocytes	cell_type
,	O
cytoplasmic	O
levels	O
of	O
IL-1	RNA
beta	RNA
mRNA	RNA
increased	O
during	O
adherence	O
whereas	O
those	O
of	O
I	RNA
kappa	RNA
B	RNA
alpha	RNA
/MAD-3	RNA
mRNA	RNA
did	O
not.	O
Taken	O
together,	O
our	O
data	O
suggest	O
that	O
two	O
interactive	O
mechanisms	O
regulate	O
monocytic	RNA
I	RNA
kappa	RNA
B	RNA
alpha	RNA
/MAD-3	RNA
mRNA	RNA
levels	O
.	O
We	O
propose	O
that	O
adherent	cell_type
monocytes	cell_type
regulate	O
nuclear	O
processing	O
(or	O
decay)	O
of	O
I	RNA
kappa	RNA
B	RNA
alpha	RNA
/MAD-3	RNA
mRNA	RNA
,	O
thereby	O
increasing	O
mRNA	O
levels	O
without	O
stimulating	O
I	DNA
kappa	DNA
B	DNA
alpha	DNA
/MAD-3	DNA
gene	DNA
transcription	O
.	O
Moreover,	O
since	O
inhibition	O
of	O
protein	O
synthesis	O
leads	O
to	O
accumulation	O
of	O
I	RNA
kappa	RNA
B	RNA
alpha	RNA
/MAD-3	RNA
mRNA	RNA
without	O
stimulating	O
I	DNA
kappa	DNA
B	DNA
alpha	DNA
/MAD-3	DNA
gene	DNA
transcription	O
,	O
we	O
suggest	O
that	O
low	O
cytoplasmic	O
levels	O
of	O
I	RNA
kappa	RNA
B	RNA
alpha	RNA
/MAD-3	RNA
mRNA	RNA
are	O
maintained	O
by	O
a	O
translation-dependent	O
degradation	O
mechanism	O
.	O

Distinct	O
roles	O
of	O
the	O
molecular	O
chaperone	protein
hsp90	protein
in	O
modulating	O
dioxin	O
receptor	O
function	O
via	O
the	O
basic	O
helix-loop-helix	protein
and	O
PAS	protein
domains	protein
.	O
The	O
intracellular	protein
dioxin	protein
receptor	protein
mediates	O
signal	O
transduction	O
by	O
dioxin	O
and	O
functions	O
as	O
a	O
ligand-activated	protein
transcription	protein
factor	protein
.	O
It	O
contains	O
a	O
basic	protein
helix-loop-helix	protein
(	protein
bHLH	protein
)	protein
motif	protein
contiguous	O
with	O
a	O
Per-Arnt-Sim	protein
(PAS)	protein
homology	protein
region	protein
.	O
In	O
extracts	O
from	O
nonstimulated	O
cells	O
the	O
receptor	O
is	O
recovered	O
in	O
an	O
inducible	O
cytoplasmic	O
form	O
associated	O
with	O
the	O
90-kDa	protein
heat	protein
shock	protein
protein	protein
(	O
hsp90	protein
),	O
a	O
molecular	protein
chaperone	protein
.	O
We	O
have	O
reconstituted	O
ligand-dependent	O
activation	O
of	O
the	O
receptor	O
to	O
a	O
DNA-binding	protein
form	protein
by	O
using	O
the	O
dioxin	protein
receptor	protein
and	O
its	O
bHLH-PAS	protein
partner	protein
factor	protein
Arnt	protein
expressed	O
by	O
in	O
vitro	O
translation	O
in	O
reticulocyte	O
lysate.	O
Deletion	O
of	O
the	O
PAS	protein
domain	protein
of	O
the	O
receptor	O
resulted	O
in	O
constitutive	O
dimerization	O
with	O
Arnt	protein
.	O
In	O
contrast,	O
this	O
receptor	O
mutant	O
showed	O
low	O
levels	O
of	O
xenobiotic	O
response	O
element-binding	O
activity	O
,	O
indicating	O
that	O
the	O
PAS	protein
domain	protein
may	O
be	O
important	O
for	O
DNA-binding	O
affinity	O
and/or	O
specificity	O
of	O
the	O
receptor.	O
It	O
was	O
not	O
possible	O
to	O
reconstitute	O
dioxin	protein
receptor	protein
function	O
with	O
proteins	O
expressed	O
in	O
wheat	O
germ	O
lysate	O
.	O
In	O
line	O
with	O
these	O
observations,	O
reticulocyte	O
lysate	O
but	O
not	O
wheat	O
germ	O
lysate	O
promoted	O
the	O
association	O
of	O
de	O
novo	O
synthesized	O
dioxin	protein
receptor	protein
with	O
hsp90	protein
.	O
At	O
least	O
two	O
distinct	O
domains	O
of	O
the	O
receptor	O
mediated	O
interaction	O
with	O
hsp90	protein
:	O
the	O
ligand-binding	protein
domain	protein
located	O
within	O
the	O
PAS	protein
region	protein
and,	O
surprisingly,	O
the	O
bHLH	protein
domain	protein
.	O
Whereas	O
ligand-binding	O
activity	O
correlated	O
with	O
association	O
with	O
hsp90	protein
,	O
bHLH-	O
hsp90	protein
interaction	O
appeared	O
to	O
be	O
important	O
for	O
DNA-binding	O
activity	O
but	O
not	O
for	O
dimerization	O
of	O
the	O
receptor.	O
Several	O
distinct	O
roles	O
for	O
hsp90	protein
in	O
modulating	O
dioxin	protein
receptor	protein
function	O
are	O
therefore	O
likely:	O
correct	O
folding	O
of	O
the	O
ligand-binding	O
domain,	O
interference	O
with	O
Arnt	protein
heterodimerization,	O
and	O
folding	O
of	O
a	O
DNA-binding	O
conformation	O
of	O
the	O
bHLH	protein
domain	protein
.	O
Thus,	O
the	O
dioxin	protein
receptor	protein
system	O
provides	O
a	O
complex	O
and	O
interesting	O
model	O
of	O
the	O
regulation	O
of	O
transcription	protein
factors	protein
by	O
hsp90	protein
.	O

Induction	O
of	O
transcription	protein
factors	protein
in	O
human	cell_type
T	cell_type
lymphocytes	cell_type
by	O
aspirin	O
-like	O
drugs	O
.	O
Aspirin-like	O
drugs	O
(	O
ALD	O
)	O
induce	O
calcium	O
mobilization	O
,	O
an	O
essential	O
component	O
of	O
T	O
cell	O
activation	O
,	O
but	O
do	O
not	O
induce	O
the	O
biosynthesis	O
of	O
IL-2	protein
.	O
To	O
understand	O
the	O
extent	O
to	O
which	O
ALD	O
may	O
mimic	O
mitogenic	O
stimulation	O
,	O
we	O
studied	O
cytoplasmic	O
and	O
nuclear	O
signaling	O
steps	O
in	O
ALD	cell_line
-treated	cell_line
T	cell_line
cells	cell_line
.	O
We	O
found	O
that	O
ALD	O
induce	O
a	O
transient	O
activation	O
of	O
protein	protein
kinase	protein
(	O
PKC	protein
)	O
but	O
have	O
no	O
effect	O
(in	O
comparison	O
to	O
anti-CD3	protein
antibodies	protein
)	O
on	O
protein	O
tyrosine	O
phosphorylation	O
nor	O
on	O
PCL	O
gamma	O
1	O
tyrosine	O
phosphorylation	O
.	O
ALD	O
-induced	O
calcium	O
mobilization	O
and	O
PKC	protein
activation	O
are	O
independent	O
of	O
tyrosine	protein
protein	protein
kinase	protein
activity	O
as	O
shown	O
by	O
the	O
lack	O
of	O
effect	O
of	O
herbimycin	O
,	O
a	O
tyrosine	protein
-protein	protein
kinase	protein
-specific	O
inhibitor	O
.	O
Although	O
we	O
detected	O
no	O
IL-2	RNA
mRNA	RNA
in	O
ALD	cell_line
-treated	cell_line
cells	cell_line
,	O
the	O
nuclei	O
of	O
these	O
cells	O
contain	O
proteins	O
capable	O
of	O
binding	O
to	O
three	O
regulatory	DNA
sequences	DNA
in	O
the	O
IL-2	DNA
promoter	DNA
region	DNA
:	O
NFAT	protein
,	O
NF	protein
kappa	protein
B	protein
,	O
and	O
AP-1	protein
.	O
These	O
binding	O
activities	O
are	O
expressed	O
only	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
.	O
The	O
expression	O
of	O
AP-1	protein
depended	O
on	O
calcium	O
mobilization	O
and	O
PKC	protein
activation	O
.	O
These	O
data	O
suggest	O
that	O
ALD	O
cause	O
transient	O
but	O
significant	O
changes	O
in	O
T	O
cell	O
transmembrane	O
signaling	O
,	O
although	O
some	O
events	O
induced	O
by	O
stimulation	O
with	O
anti-CD3	protein
antibodies	protein
are	O
not	O
induced	O
by	O
ALD	O
.	O
The	O
signal	O
is	O
transmitted	O
to	O
the	O
nucleus	O
and	O
induces	O
DNA-binding	O
activity	O
by	O
several	O
transcription	protein
factors	protein
.	O
However,	O
the	O
ALD	O
stimulus	O
is	O
not	O
capable	O
of	O
causing	O
complete	O
T	O
cell	O
activation	O
.	O

Protein	protein
kinase	protein
C	protein
is	O
not	O
a	O
downstream	O
effector	O
of	O
p21ras	DNA
in	O
activated	cell_type
T	cell_type
cells	cell_type
.	O
The	O
aim	O
of	O
this	O
present	O
study	O
was	O
to	O
investigate	O
the	O
role	O
of	O
protein	protein
kinase	protein
C	protein
(	O
PKC	protein
),	O
downstream	O
of	O
p21ras	DNA
,	O
in	O
activating	O
interleukin-2	DNA
(IL-2)	DNA
gene	DNA
expression	O
.	O
It	O
has	O
been	O
reported	O
that	O
PKC	protein
is	O
an	O
effector	protein
of	O
p21ras	DNA
in	O
T	cell_type
cells	cell_type
.	O
Data	O
is	O
presented,	O
using	O
the	O
potent	O
and	O
selective	O
PKC	protein
inhibitor	O
Ro	O
31-8425	O
and	O
transient	O
expression	O
of	O
a	O
constitutively	O
active	O
ras	O
mutant,	O
which	O
clearly	O
shows	O
that	O
PKC	protein
is	O
not	O
downstream	O
of	O
p21ras	DNA
in	O
the	O
induction	O
of	O
NF-AT	protein
and	O
AP-1	protein
transcriptional	O
activity	O
and	O
in	O
the	O
expression	O
of	O
IL-2	protein
in	O
human	cell_line
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
Reporter	O
gene	O
experiments	O
demonstrated	O
that	O
NF-kappa	protein
B	protein
transcriptional	O
activity	O
is	O
not	O
affected	O
by	O
expression	O
of	O
activated	O
p21ras	DNA
.	O
The	O
signaling	O
pathways	O
involving	O
PKC	protein
activation	O
,	O
calcium	O
mobilization	O
and	O
ras	protein
activation	O
combine	O
to	O
provide	O
the	O
necessary	O
components	O
for	O
production	O
of	O
IL-2	protein
during	O
T	O
cell	O
activation	O
.	O

The	O
C-terminus	protein
of	O
the	O
B	protein
cell	protein
activator	protein
Oct-2	protein
functions	O
as	O
an	O
activation	protein
domain	protein
in	O
yeast	O
.	O
Oct-1	protein
and	O
Oct-2	protein
are	O
human	O
transcriptional	protein
activators	protein
that	O
bind	O
to	O
the	O
same	O
DNA	O
element	O
but	O
activate	O
distinct	O
sets	O
of	O
genes.	O
We	O
expressed	O
these	O
factors	O
in	O
S.	O
cerevisiae	O
and	O
observed	O
greater	O
than	O
5-fold	O
stimulation	O
of	O
a	O
lacZ	DNA
reporter	DNA
gene	DNA
only	O
with	O
Oct-2	protein
.	O
Transfer	O
of	O
the	O
Oct-2	protein
C-terminal	protein
domain	protein
onto	O
either	O
Oct-1	protein
(	O
Oct1.2	protein
)	O
or	O
a	O
nonactivating	protein
DNA-binding	protein
domain	protein
from	O
GAL4	protein
created	O
activators	O
capable	O
of	O
greater	O
than	O
15	O
and	O
10-fold	O
stimulation	O
of	O
activity,	O
respectively.	O
Thus,	O
the	O
C-terminus	protein
of	O
Oct-2	protein
is	O
sufficient	O
to	O
confer	O
activation	O
potential	O
to	O
nonactive	O
DNA-binding	DNA
fragments	DNA
in	O
yeast	O
.	O

Glucocorticoid-induced	O
apoptosis	O
of	O
lymphoid	cell_type
cells	cell_type
.	O
The	O
induction	O
of	O
cell	O
death	O
in	O
lymphoid	cell_type
cells	cell_type
by	O
glucocorticoids	O
is	O
one	O
of	O
the	O
earliest	O
and	O
most	O
thoroughly	O
studied	O
models	O
of	O
apoptosis	O
.	O
Although	O
the	O
exact	O
mechanism	O
by	O
which	O
apoptosis	O
occurs	O
in	O
lymphocytes	cell_type
is	O
unknown	O
many	O
biochemical	O
and	O
molecular	O
changes	O
have	O
been	O
shown	O
to	O
occur	O
in	O
these	O
cells	O
in	O
response	O
to	O
glucocorticoids	O
.	O
The	O
role	O
of	O
chromatin	DNA
degradation	O
and	O
endonucleases	protein
in	O
the	O
apoptotic	O
process	O
has	O
been	O
closely	O
studied,	O
as	O
well	O
as	O
the	O
involvement	O
of	O
several	O
oncogenes	DNA
in	O
glucocorticoid	O
-induced	O
cell	O
lysis	O
.	O
In	O
addition,	O
the	O
clinical	O
importance	O
of	O
glucocorticoid	O
-induced	O
apoptosis	O
in	O
the	O
treatment	O
of	O
lymphoid	O
neoplasms	O
has	O
recently	O
received	O
increased	O
attention.	O

Interleukin-2	protein
induces	O
tyrosine	O
phosphorylation	O
and	O
nuclear	O
translocation	O
of	O
stat3	protein
in	O
human	cell_type
T	cell_type
lymphocytes	cell_type
.	O
An	O
early	O
biochemical	O
event	O
associated	O
with	O
T	O
cell	O
activation	O
through	O
the	O
interleukin-2	protein
receptor	protein
(	O
IL-2R	protein
)	O
is	O
tyrosine	O
phosphorylation	O
of	O
several	O
intracellular	O
substrates	O
.	O
The	O
exact	O
mechanism	O
by	O
which	O
IL-2	protein
regulates	O
transcription	O
of	O
different	O
genes	O
is	O
presently	O
unknown.	O
Here,	O
we	O
report	O
that	O
stimulation	O
through	O
the	O
IL-2R	protein
induced	O
tyrosine	O
phosphorylation	O
and	O
subsequent	O
nuclear	O
translocation	O
of	O
stat3	protein
,	O
a	O
newly	O
identified	O
member	O
of	O
the	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(STAT)	protein
family	protein
of	O
proteins.	O
In	O
contrast,	O
stat1	O
proteins	O
were	O
not	O
tyrosine	O
phosphorylated	O
after	O
IL-2	protein
ligation	O
,	O
whereas	O
tyrosine	protein
-phosphorylated	protein
stat1	protein
proteins	protein
(	O
91	O
and	O
84	O
kDa	O
proteins	O
)	O
were	O
translocated	O
to	O
the	O
nucleus	O
following	O
interferon-gamma	protein
treatment	O
of	O
HeLa	cell_line
cells	cell_line
.	O
Apart	O
from	O
stat3	protein
,	O
another	O
cytoplasmic	protein
protein	protein
was	O
tyrosine	O
phosphorylated	O
and	O
subsequently	O
translocated	O
to	O
the	O
nucleus	O
in	O
response	O
to	O
IL-2	protein
.	O
This	O
protein	O
had	O
an	O
apparent	O
molecular	O
mass	O
of	O
84	protein
kDa	protein
and	O
was	O
not	O
recognized	O
by	O
stat3	protein
or	O
stat1	protein
mAb	protein
or	O
antisera	O
.	O
Since	O
IL-2	protein
induced	O
nuclear	O
translocation	O
of	O
the	O
84	protein
kDa	protein
protein	protein
and	O
stat3	protein
followed	O
identical	O
kinetics,	O
p84	protein
is	O
a	O
candidate	O
for	O
a	O
new,	O
yet	O
undefined,	O
member	O
of	O
the	O
STAT	O
family.	O
Taken	O
together,	O
we	O
report	O
that	O
IL-2	protein
induces	O
tyrosine	O
phosphorylation	O
and	O
subsequent	O
nuclear	O
translocation	O
of	O
stat3	protein
and	O
an	O
as	O
yet	O
undefined	O
84-kDa	protein
protein	protein
in	O
antigen-specific	cell_line
human	cell_line
T	cell_line
cell	cell_line
lines	cell_line
.	O

Human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
Tax	protein
activation	O
of	O
NF-kappa	protein
B	protein
/Rel	protein
involves	O
phosphorylation	O
and	O
degradation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
and	O
RelA	protein
(	O
p65	protein
)-mediated	O
induction	O
of	O
the	O
c-rel	DNA
gene	DNA
.	O
The	O
tax	O
gene	O
product	O
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
is	O
a	O
potent	O
transcriptional	protein
activator	protein
that	O
both	O
stimulates	O
viral	O
gene	O
expression	O
and	O
activates	O
an	O
array	O
of	O
cellular	DNA
genes	DNA
involved	O
in	O
T-cell	cell_type
growth	O
.	O
Tax	O
acts	O
indirectly	O
by	O
inducing	O
or	O
modifying	O
the	O
action	O
of	O
various	O
host	O
transcription	protein
factors	protein
,	O
including	O
members	O
of	O
the	O
NF-kappa	protein
B	protein
/Rel	protein
family	protein
of	O
enhancer-binding	protein
proteins	protein
.	O
In	O
resting	cell_type
T	cell_type
cells	cell_type
,	O
many	O
of	O
these	O
NF-kappa	protein
B	protein
/Rel	protein
factors	protein
are	O
sequestered	O
in	O
the	O
cytoplasm	O
by	O
various	O
ankyrin-rich	protein
inhibitory	protein
proteins	protein
,	O
including	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
HTLV-I	protein
Tax	protein
expression	O
leads	O
to	O
the	O
constitutive	O
nuclear	O
expression	O
of	O
biologically	O
active	O
NF-kappa	protein
B	protein
and	O
c-Rel	protein
complexes	protein
;	O
however,	O
the	O
biochemical	O
mechanism	O
(s)	O
underlying	O
this	O
response	O
remains	O
poorly	O
understood.	O
In	O
this	O
study,	O
we	O
demonstrate	O
that	O
Tax	protein
-stimulated	O
nuclear	O
expression	O
of	O
NF-kappa	protein
B	protein
in	O
both	O
HTLV-I	cell_line
-infected	cell_line
and	cell_line
Tax	cell_line
-transfected	cell_line
human	cell_line
T	cell_line
cells	cell_line
is	O
associated	O
with	O
the	O
phosphorylation	O
and	O
rapid	O
proteolytic	O
degradation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
In	O
contrast	O
to	O
prior	O
in	O
vitro	O
studies,	O
at	O
least	O
a	O
fraction	O
of	O
the	O
phosphorylated	O
form	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
remains	O
physically	O
associated	O
with	O
the	O
NF-kappa	protein
B	protein
complex	protein
in	O
vivo	O
but	O
is	O
subject	O
to	O
rapid	O
degradation,	O
thereby	O
promoting	O
the	O
nuclear	O
translocation	O
of	O
the	O
active	O
NF-kappa	protein
B	protein
complex	protein
.	O
We	O
further	O
demonstrate	O
that	O
Tax	protein
induction	O
of	O
nuclear	O
c-Rel	protein
expression	O
is	O
activated	O
by	O
the	O
RelA	protein
(	O
p65	protein
)	O
subunit	O
of	O
NF-kappa	protein
B	protein
,	O
which	O
activates	O
transcription	O
of	O
the	O
c-rel	DNA
gene	DNA
through	O
an	O
intrinsic	O
kappa	DNA
B	DNA
enhancer	DNA
element	DNA
.	O
In	O
normal	O
cells,	O
the	O
subsequent	O
accumulation	O
of	O
nuclear	protein
c-Rel	protein
acts	O
to	O
inhibit	O
its	O
own	O
continued	O
production,	O
indicating	O
the	O
presence	O
of	O
an	O
autoregulatory	O
loop	O
.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS)	O

Activation	O
of	O
NF-kappa	protein
B	protein
in	O
vivo	O
is	O
regulated	O
by	O
multiple	O
phosphorylations.	O
The	O
activation	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
in	O
intact	O
cells	O
is	O
mechanistically	O
not	O
well	O
understood.	O
Therefore	O
we	O
investigated	O
the	O
modifications	O
imposed	O
on	O
NF-kappa	protein
B	protein
/I	protein
kappa	protein
B	protein
components	protein
following	O
stimulation	O
and	O
show	O
that	O
the	O
final	O
step	O
of	O
NF-kappa	protein
B	protein
induction	O
in	O
vivo	O
involves	O
phosphorylation	O
of	O
several	O
members	O
of	O
the	O
NF-kappa	protein
B	protein
/I	protein
kappa	protein
B	protein
protein	protein
families	protein
.	O
In	O
HeLa	cell_line
cells	cell_line
as	O
well	O
as	O
in	O
B	cell_type
cells	cell_type
,	O
TNF-alpha	O
rapidly	O
induced	O
nuclear	O
translocation	O
primarily	O
of	O
p50-p65	protein
,	O
but	O
not	O
of	O
c-rel	protein
.	O
Both	O
NF-kappa	protein
B	protein
precursors	O
and	O
I	protein
kappa	protein
B	protein
alpha	protein
became	O
strongly	O
phosphorylated	O
with	O
the	O
same	O
kinetics.	O
In	O
addition	O
to	O
the	O
inducible	O
phosphorylation	O
after	O
stimulation,	O
B	cell_type
lymphocytes	cell_type
containing	O
constitutive	O
nuclear	O
NF-kappa	protein
B	protein
revealed	O
constitutively	O
phosphorylated	O
p65	protein
and	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
Phosphorylation	O
was	O
accompanied	O
by	O
induced	O
processing	O
of	O
the	O
precursors	O
p100	protein
and	O
p105	protein
and	O
by	O
degradation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
As	O
an	O
in	O
vitro	O
model	O
we	O
show	O
that	O
phosphorylation	O
of	O
p105	protein
impedes	O
its	O
ability	O
to	O
interact	O
with	O
NF-kappa	protein
B	protein
,	O
as	O
has	O
been	O
shown	O
before	O
for	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
Surprisingly,	O
even	O
p65	protein
,	O
but	O
not	O
c-rel	protein
,	O
was	O
phosphorylated	O
after	O
induction	O
in	O
vivo,	O
suggesting	O
that	O
TNF-alpha	protein
selectively	O
activates	O
only	O
specific	O
NF-kappa	protein
B	protein
heteromers	O
and	O
that	O
modifications	O
regulate	O
not	O
only	O
I	protein
kappa	protein
B	protein
molecules	protein
but	O
also	O
NF-kappa	protein
B	protein
molecules.	O
In	O
fact,	O
cellular	O
NF-kappa	protein
B	protein
activity	O
was	O
phosphorylation-dependent	O
and	O
the	O
DNA	O
binding	O
activity	O
of	O
p65	protein
-containing	protein
NF-kappa	protein
B	protein
was	O
enhanced	O
by	O
phosphorylation	O
in	O
vitro.	O
Furthermore,	O
we	O
found	O
that	O
the	O
induction	O
by	O
hydrogen	O
peroxide	O
of	O
NF-kappa	protein
B	protein
translocation	O
to	O
the	O
nucleus	O
,	O
which	O
is	O
assumed	O
to	O
be	O
triggered	O
by	O
reactive	O
oxygen	O
intermediates	O
,	O
also	O
coincided	O
with	O
incorporation	O
of	O
phosphate	O
into	O
the	O
same	O
subunits	O
that	O
were	O
modified	O
after	O
stimulation	O
by	O
TNF-alpha	protein
.	O
Thus,	O
phosphorylation	O
appears	O
to	O
be	O
a	O
general	O
mechanism	O
for	O
activation	O
of	O
NF-kappa	protein
B	protein
in	O
vivo.	O

Treatment	O
of	O
HL60	cell_line
cells	cell_line
with	O
various	O
combinations	O
of	O
retinoids	O
and	O
1	O
alpha,25	O
dihydroxyvitamin	O
D3	O
results	O
in	O
differentiation	O
towards	O
neutrophils	cell_type
or	O
monocytes	cell_type
or	O
a	O
failure	O
to	O
differentiate	O
and	O
apoptosis	O
.	O
It	O
is	O
well	O
documented	O
that	O
treatment	O
of	O
serum-grown	cell_line
HL60	cell_line
cells	cell_line
with	O
10(-7)	O
M	O
all-trans	O
retinoic	O
acid	O
(	O
all-trans	O
RA	O
)	O
induces	O
neutrophil	cell_type
differentiation	O
,	O
whereas	O
treatment	O
with	O
10(-7)	O
M	O
1	O
alpha,25	O
dihydroxyvitamin	O
D3	O
(	O
D3	O
)	O
induces	O
differentiation	O
towards	O
monocytes	cell_type
.	O
In	O
recent	O
investigations,	O
using	O
serum-free	cell_line
grown	cell_line
HL60	cell_line
cells	cell_line
,	O
we	O
observed	O
that	O
all-trans	O
RA	O
,	O
at	O
10(-7)	O
M,	O
did	O
not	O
induce	O
neutrophil	O
differentiation	O
and	O
that	O
all-trans	O
RA	O
,	O
at	O
10(-8)	O
M,	O
reduced	O
the	O
D3	O
concentration	O
required	O
for	O
monocyte	cell_type
differentiation	O
to	O
5	O
x	O
10(-9)	O
M.	O
In	O
this	O
study,	O
co-operative	O
interactions	O
between	O
all-trans	O
and	O
9-cis	O
RA	O
and	O
D3	O
which	O
promote	O
neutrophil	O
and	O
monocyte	O
differentiation	O
of	O
HL60	cell_line
cells	cell_line
have	O
been	O
analysed	O
in	O
detail.	O
Treatment	O
of	O
serum-free	cell_line
grown	cell_line
HL60	cell_line
cells	cell_line
with	O
5	O
x	O
10(-7)	O
M	O
all-trans	O
RA	O
or	O
9-cis	O
RA	O
resulted	O
in	O
sub-optimal	O
neutrophil	O
differentiation	O
(up	O
to	O
25%	O
mature	O
cells).	O
As	O
shown	O
for	O
all-trans	O
RA	O
,	O
9-cis	O
RA	O
cooperated	O
with	O
D3	O
to	O
promote	O
monocyte	O
differentiation	O
.	O
Culture	O
of	O
HL60	cell_line
cells	cell_line
in	O
5	O
x	O
10(-7)	O
M	O
9-cis	O
RA	O
together	O
with	O
a	O
wide	O
range	O
of	O
concentrations	O
of	O
D3	O
resulted	O
in	O
promotion	O
of	O
neutrophil	O
differentiation	O
at	O
10(-15)-10(-12)	O
D3	O
,	O
a	O
failure	O
to	O
differentiate	O
and	O
apoptosis	O
at	O
10(-11)-10(-10)	O
M	O
D3	O
,	O
followed	O
by	O
co-operativity	O
between	O
9-cis	O
RA	O
and	O
5	O
x	O
10(-9)	O
M	O
D3	O
in	O
inducing	O
monocyte	O
differentiation	O
in	O
the	O
absence	O
of	O
neutrophil	O
differentiation	O
.	O
Similar	O
results	O
were	O
obtained	O
when	O
HL60	cell_line
cells	cell_line
were	O
treated	O
with	O
5	O
x	O
10(-7)	O
all-trans	O
RA	O
together	O
with	O
a	O
wide	O
range	O
of	O
concentrations	O
of	O
D3	O
.	O
Cross	O
titration	O
analyses	O
of	O
the	O
effects	O
of	O
9-cis	O
RA	O
and	O
D3	O
on	O
HL60	cell_line
cell	cell_line
differentiation	O
were	O
undertaken	O
to	O
determine	O
the	O
boundaries	O
of	O
the	O
concentrations	O
of	O
each	O
agent,	O
alone	O
and	O
in	O
combination,	O
that	O
give	O
rise	O
to	O
optimal	O
neutrophil	O
and	O
monocyte	O
differentiation	O
of	O
HL60	cell_line
cells	cell_line
.	O
The	O
observed	O
cooperativities	O
between	O
either	O
9-cis	O
RA	O
or	O
all-trans	O
RA	O
and	O
D3	O
have	O
important	O
implications	O
for	O
the	O
use	O
of	O
combinations	O
of	O
these	O
agents	O
in	O
differentiation	O
therapy	O
.	O

Isolation	O
of	O
differentially	O
expressed	O
sequence	O
tags	O
from	O
steroid-responsive	cell_type
cells	cell_type
using	O
mRNA	RNA
differential	O
display	O
.	O
Transcriptional	O
control	O
of	O
steroid-regulated	DNA
gene	DNA
networks	DNA
by	O
nuclear	protein
receptor	protein
proteins	protein
results	O
in	O
the	O
coordinate	O
expression	O
of	O
a	O
limited	O
number	O
of	O
target	DNA
genes	DNA
.	O
Although	O
much	O
is	O
known	O
about	O
the	O
structure	O
and	O
function	O
of	O
steroid	O
receptors,	O
relatively	O
few	O
cell-specific	O
steroid-regulated	O
genes	O
have	O
been	O
isolated	O
and	O
characterized.	O
In	O
this	O
paper	O
we	O
describe	O
results	O
using	O
mRNA	RNA
differential	O
display	O
reverse	protein
transcriptase	protein
PCR	O
(	O
DDPCR	O
)	O
to	O
identify	O
and	O
isolate	O
short	O
cDNA	O
sequence	O
tags	O
from	O
thymocyte	cell_type
and	O
prostate	cell_type
cells	cell_type
under	O
various	O
hormone	O
conditions	O
.	O
Using	O
this	O
technique	O
we	O
have	O
isolated	O
several	O
differentially	DNA
expressed	DNA
sequence	DNA
tags	DNA
(	O
DESTs	DNA
)	O
from	O
the	O
mouse	cell_line
thymocyte	cell_line
cell	cell_line
line	cell_line
WEHI	cell_line
7.2	cell_line
.	O
Two	O
of	O
these	O
DESTs	DNA
,	O
GIG10	DNA
and	O
GIG18	DNA
,	O
are	O
rapidly	O
induced	O
by	O
dexamethasone	O
within	O
2	O
h	O
of	O
treatment.	O
GIG10	DNA
is	O
a	O
novel	O
sequence	O
and	O
GIG18	DNA
is	O
the	O
mouse	O
homologue	O
of	O
a	O
human	DNA
expressed	DNA
sequence	DNA
tag	DNA
isolated	O
from	O
activated	cell_type
B	cell_type
lymphocytes	cell_type
.	O
We	O
also	O
used	O
DDPCR	O
to	O
isolate	O
DESTs	DNA
from	O
androgen-modulated	O
rat	O
ventral	O
prostate	O
tissue	O
,	O
one	O
of	O
which	O
we	O
characterized	O
and	O
found	O
to	O
correspond	O
to	O
the	O
3'	RNA
end	RNA
of	O
prostatic	RNA
spermine	RNA
binding	RNA
protein	RNA
mRNA	RNA
,	O
a	O
known	O
androgen-regulated	DNA
gene	DNA
.	O
Modifications	O
of	O
the	O
original	O
DDPCR	O
protocol	O
,	O
which	O
we	O
found	O
can	O
potentially	O
decrease	O
the	O
frequency	O
of	O
isolating	O
false-positive	O
DESTs	DNA
,	O
are	O
described	O
and	O
the	O
merits	O
of	O
DDPCR	O
,	O
relative	O
to	O
other	O
differential	O
cDNA	O
cloning	O
strategies	O
,	O
are	O
discussed.	O

Activation	O
of	O
human	cell_type
thymocytes	cell_type
after	O
infection	O
by	O
EBV	O
.	O
The	O
discovery	O
of	O
EBV	O
in	O
certain	O
T	O
cell	O
malignancies	O
and	O
the	O
expression	O
of	O
the	O
EBV	protein
receptor	protein
,	O
CR2/CD21	protein
,	O
on	O
a	O
population	O
of	O
immature	cell_type
thymocytes	cell_type
,	O
T	cell_line
lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
,	O
and	O
childhood	cell_type
acute	cell_type
T	cell_type
lymphoblastic	cell_type
leukemia	cell_type
cells	cell_type
suggested	O
that	O
EBV	O
-receptor	O
interactions	O
on	O
T	cell_type
cells	cell_type
may	O
be	O
of	O
importance.	O
We	O
have	O
shown	O
that,	O
within	O
the	O
thymus	O
,	O
a	O
population	O
of	O
large,	cell_type
immature	cell_type
cells	cell_type
expresses	O
CD21	protein
.	O
EBV	O
altered	O
the	O
activation	O
responses	O
of	O
immature	cell_type
thymocytes	cell_type
in	O
vitro.	O
Triggering	O
through	O
CD2	protein
is	O
mitogenic	O
for	O
mature,	O
but	O
not	O
immature,	O
T	cell_type
cells	cell_type
.	O
However,	O
during	O
infection	O
by	O
EBV	O
,	O
ligation	O
of	O
CD2	protein
caused	O
thymocytes	cell_type
to	O
proliferate	O
in	O
the	O
absence	O
of	O
exogenous	protein
cytokines	protein
.	O
This	O
function	O
was	O
a	O
result	O
of	O
the	O
interaction	O
of	O
EBV	O
with	O
its	O
receptor,	O
CD21	protein
,	O
but	O
was	O
caused	O
by	O
infection	O
rather	O
than	O
surface	O
signaling,	O
because	O
neither	O
specific	protein
mAb	protein
nor	O
the	O
P3HR-1	O
strain	O
of	O
virus	O
mimicked	O
the	O
effect	O
of	O
B95-8.	O
Immature	O
thymocytes	cell_type
were	O
infected	O
by	O
EBV	O
,	O
as	O
determined	O
by	O
the	O
internalization	O
of	O
the	O
viral	DNA
genome	DNA
and	O
its	O
transcriptional	O
activity	O
.	O
Consistent	O
with	O
the	O
activity	O
of	O
B95-8	protein
,	O
EBNA-2	RNA
transcripts	RNA
were	O
identified	O
within	O
infected	cell_line
thymocyte	cell_line
populations	cell_line
.	O
In	O
addition,	O
components	O
of	O
the	O
viral	O
replicative	O
pathway	O
were	O
expressed	O
during	O
infection	O
of	O
thymocytes	cell_type
.	O
These	O
components	O
included	O
transcription	O
of	O
BZLF-1	DNA
,	O
an	O
early	DNA
gene	DNA
that	O
characterizes	O
EBV	cell_type
-infected	cell_type
B	cell_type
cells	cell_type
after	O
disruption	O
of	O
latency.	O
A	O
second	O
transcript	O
was	O
identified	O
as	O
encoding	O
the	O
recently	O
characterized	O
RAZ	protein
,	O
which	O
also	O
is	O
associated	O
with	O
replicative	O
infection.	O
The	O
consequences	O
of	O
EBV	O
infection	O
of	O
T	cell_type
cells	cell_type
at	O
an	O
early	O
stage	O
of	O
differentiation	O
may	O
lead	O
to	O
failure	O
of	O
normal	O
T	O
cell	O
repertoire	O
development	O
,	O
autoimmunity	O
,	O
or	O
malignancy	O
.	O

Effects	O
of	O
intranasal	O
glucocorticoids	O
on	O
endogenous	O
glucocorticoid	O
peripheral	O
and	O
central	O
function	O
.	O
Glucocorticoids	O
are	O
among	O
the	O
most	O
potent	O
antiinflammatory	O
agents	O
that	O
can	O
be	O
used	O
in	O
the	O
treatment	O
of	O
rhinitis	O
.	O
Their	O
mechanisms	O
of	O
action	O
are	O
multiple	O
and	O
complex	O
and	O
a	O
number	O
of	O
reports	O
describe	O
significant	O
systemic	O
effects	O
of	O
locally	O
administered	O
glucocorticoids	O
.	O
In	O
order	O
to	O
evaluate	O
the	O
short-term	O
systemic	O
effects	O
of	O
intranasally	O
administered	O
glucocorticoids	O
,	O
14	O
normal	O
healthy	O
subjects	O
were	O
treated	O
with	O
two	O
doses	O
of	O
either	O
budesonide	O
(	O
BUD	O
)	O
or	O
fluticasone	O
propionate	O
(	O
FP	O
)	O
for	O
2	O
weeks.	O
Before	O
treatment,	O
at	O
regular	O
intervals	O
during	O
the	O
treatment,	O
1	O
week	O
and	O
finally	O
6	O
weeks	O
after	O
termination	O
of	O
treatment,	O
the	O
effects	O
on	O
glucocorticoid	O
receptor	O
(GR)	O
and	O
methallothionein	O
(MTIIa)	O
mRNA	O
expression	O
levels	O
were	O
examined	O
in	O
peripheral	cell_type
lymphocytes	cell_type
using	O
a	O
solution	O
hybridization	O
assay	O
.	O
Serum	O
cortisol	O
,	O
osteocalcin	O
and	O
urinary	O
cortisol	O
levels	O
were	O
also	O
determined.	O
An	O
insulin	O
tolerance	O
test	O
(	O
ITT	O
)	O
was	O
performed	O
at	O
the	O
end	O
of	O
the	O
second	O
week	O
of	O
treatment	O
and	O
at	O
the	O
end	O
of	O
the	O
6-week	O
washout	O
period	O
with	O
no	O
statistically	O
significant	O
change	O
in	O
cortisol	O
response.	O
In	O
peripheral	cell_type
lymphocytes	cell_type
,	O
GR	RNA
mRNA	RNA
levels	O
were	O
significantly	O
down-regulated.	O
MTIIa	RNA
mRNA	RNA
levels	O
increased	O
significantly.	O
Serum	O
osteocalcin	protein
decreased	O
significantly	O
during	O
treatment	O
with	O
both	O
BUD	O
and	O
FP	O
.	O
Serum	O
cortisol	O
decreased	O
after	O
1	O
week	O
of	O
treatment	O
whereas	O
urinary	O
cortisol	O
was	O
not	O
affected	O
until	O
the	O
second	O
week	O
of	O
treatment.	O
In	O
conclusion,	O
intranasal	O
glucocorticoids	O
at	O
clinically	O
recommended	O
doses	O
have	O
not	O
only	O
significant	O
systemic	O
effects	O
on	O
adrenal	O
function	O
,	O
but	O
also	O
have	O
an	O
effect	O
on	O
specific	O
gene	O
expression	O
in	O
peripheral	cell_type
lymphocytes	cell_type
.	O
These	O
effects	O
are	O
receptor-dependent,	O
reversible,	O
and	O
according	O
to	O
serum	O
and	O
urinary	O
cortisol	O
levels	O
and	O
ITT	O
,	O
leave	O
the	O
hypothalamic-pituitary-adrenal	O
function	O
intact.	O
Finally,	O
these	O
short-term	O
systemic	O
effects	O
were	O
not	O
associated	O
with	O
any	O
of	O
the	O
noticeable	O
side-effects	O
usually	O
observed	O
during	O
long-term	O
treatment	O
with	O
glucocorticoids	O
.	O

Biphasic	O
control	O
of	O
nuclear	protein
factor-kappa	protein
B	protein
activation	O
by	O
the	O
T	protein
cell	protein
receptor	protein
complex	protein
:	O
role	O
of	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
.	O
The	O
regulation	O
of	O
nuclear	protein
factor	protein
(NF)-kappa	protein
B	protein
activation	O
by	O
the	O
T	protein
cell	protein
receptor	protein
(TcR)/CD3	protein
complex	protein
in	O
primary	O
human	O
T	cell_type
cells	cell_type
has	O
been	O
studied	O
at	O
various	O
times	O
after	O
activation.	O
Only	O
p50	protein
NF-kappa	protein
B	protein
protein	protein
bound	O
the	O
kappa	DNA
B	DNA
element	DNA
of	O
interleukin-2	DNA
receptor	DNA
(	DNA
IL-2R	DNA
)	DNA
alpha	DNA
chain	DNA
promoter	DNA
on	O
resting	O
T	cell_type
cells	cell_type
.	O
However,	O
immediately	O
after	O
TcR/CD3	protein
cross-linking	O
(after	O
approximately	O
1	O
h;	O
immediate)	O
binding	O
of	O
p50.p65	protein
heterodimers	protein
was	O
observed.	O
p50.c-rel	protein
heterodimers	protein
were	O
also	O
detected	O
bound	O
to	O
this	O
sequence	O
at	O
early	O
time	O
points	O
(7-16	O
h;	O
early),	O
and	O
both	O
remained	O
active	O
at	O
later	O
time	O
points	O
(40	O
h;	O
late)	O
after	O
activation.	O
This	O
regulation	O
takes	O
place	O
mainly	O
at	O
the	O
level	O
of	O
nuclear	O
translocation	O
of	O
p65	protein
and	O
c-rel	protein
,	O
at	O
immediate	O
and	O
early	O
time	O
points.	O
Activation	O
also	O
induced	O
c-rel	O
and	O
p105/p50	O
mRNA	O
synthesis	O
,	O
but	O
not	O
p65	RNA
mRNA	RNA
whose	O
expression	O
was	O
constitutive.	O
Interestingly,	O
all	O
those	O
early	O
and	O
late	O
events,	O
but	O
not	O
the	O
immediate	O
ones,	O
were	O
inhibited	O
by	O
a	O
neutralizing	O
anti-	protein
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(TNF-alpha)	protein
monoclonal	protein
antibody	protein
.	O
Similarly,	O
cycloheximide	O
prevented	O
the	O
p65	protein
and	O
c-rel	protein
translocation	O
and	O
consequent	O
formation	O
of	O
active	O
binding	O
heterodimers,	O
at	O
early	O
and	O
late	O
times.	O
Cyclosporin	O
A	O
impaired	O
not	O
only	O
early	O
and	O
late,	O
but	O
also	O
immediate	O
events;	O
however,	O
addition	O
of	O
TNF-alpha	protein
prevented	O
all	O
inhibition.	O
These	O
results	O
indicate	O
that	O
the	O
regulation	O
of	O
NF-kappa	protein
B	protein
activation	O
during	O
T	O
cell	O
activation	O
by	O
TcR/CD3	protein
signals	O
is	O
biphasic:	O
TcR/CD3	protein
triggers	O
its	O
immediate	O
translocation,	O
which	O
is	O
transient	O
if	O
no	O
TNF-alpha	protein
is	O
present.	O
TNF-alpha	protein
,	O
therefore,	O
emerges	O
as	O
the	O
main	O
factor	O
responsible	O
for	O
a	O
second	O
phase	O
of	O
NF-kappa	protein
B	protein
regulation	O
,	O
controlling	O
both	O
translocation	O
of	O
p65	protein
and	O
c-rel	protein
,	O
and	O
new	O
mRNA	RNA
synthesis	O
for	O
c-rel	protein
and	O
p105/p50	protein
.	O

The	O
transcription	protein
factor	protein
Sp1	protein
is	O
required	O
for	O
induction	O
of	O
the	O
murine	DNA
GM-CSF	DNA
promoter	DNA
in	O
T	cell_type
cells	cell_type
.	O
The	O
cis-acting	DNA
region	DNA
,	O
GM-kappa	DNA
B/GC-box	DNA
(	O
positions	DNA
-95	DNA
and	O
-73	DNA
),	O
within	O
the	O
murine	DNA
GM-CSF	DNA
gene	DNA
promoter	DNA
is	O
required	O
for	O
maximal	O
induction	O
by	O
stimulation	O
with	O
phorbol-12-myristate	O
acetate	O
(	O
PMA	O
)	O
and	O
calcium	O
ionophore	O
(	O
A23187	O
)	O
in	O
T	cell_type
cells	cell_type
.	O
GM-kappa	protein
B	protein
defines	O
a	O
binding	O
site	O
for	O
NF-kappa	protein
B	protein
,	O
and	O
GC-box	DNA
defines	O
a	O
binding	O
site	O
for	O
three	O
(	O
A1	protein
,	O
A2	protein
,	O
B	protein
)	O
constitutive	protein
proteins	protein
.	O
We	O
report	O
here	O
that	O
three	O
copies	O
of	O
the	O
GC-box	DNA
can	O
functionally	O
compensate	O
for	O
the	O
GM-kappa	DNA
B/	DNA
GC-box	DNA
region	DNA
,	O
suggesting	O
that	O
the	O
GC-motif	DNA
can	O
function	O
independently	O
of	O
the	O
GM-kappa	DNA
B	DNA
motif	DNA
.	O
The	O
major	O
GC-box	DNA
binding	O
activity	O
A1	protein
was	O
purified	O
and	O
identified	O
as	O
the	O
transcription	protein
factor	protein
Sp1	protein
.	O
We	O
show	O
that	O
depletion	O
of	O
Sp1	protein
(	O
A1	protein
)	O
from	O
nuclear	O
extracts	O
specifically	O
decreases	O
in	O
vitro	O
transcription	O
activity	O
on	O
GM-CSF	protein
templates	O
.	O
Since	O
the	O
human	DNA
GM-CSF	DNA
promoter	DNA
has	O
a	O
base	O
difference	O
within	O
the	O
GC-box	DNA
,	O
we	O
speculate	O
that	O
this	O
may	O
explain	O
why	O
the	O
human	O
promoter	O
is	O
weak	O
and	O
that	O
an	O
upstream	DNA
enhancer	DNA
is	O
required	O
for	O
the	O
induction	O
of	O
the	O
human	DNA
GM-CSF	DNA
gene	DNA
.	O

A	O
factor	O
that	O
regulates	O
the	O
class	DNA
II	DNA
major	DNA
histocompatibility	DNA
complex	DNA
gene	DNA
DPA	DNA
is	O
a	O
member	O
of	O
a	O
subfamily	O
of	O
zinc	protein
finger	protein
proteins	protein
that	O
includes	O
a	O
Drosophila	protein
developmental	protein
control	protein
protein	protein
.	O
A	O
novel	O
DNA	DNA
sequence	DNA
element	DNA
termed	O
the	O
J	DNA
element	DNA
involved	O
in	O
the	O
regulated	O
expression	O
of	O
class	DNA
II	DNA
major	DNA
histocompatibility	DNA
complex	DNA
genes	DNA
was	O
recently	O
described.	O
To	O
study	O
this	O
element	O
and	O
its	O
role	O
in	O
class	DNA
II	DNA
gene	DNA
regulation	O
further,	O
a	O
cDNA	DNA
library	DNA
was	O
screened	O
with	O
oligonucleotide	O
probes	O
containing	O
both	O
the	O
S	DNA
element	DNA
and	O
the	O
nearby	O
J	DNA
element	DNA
of	O
the	O
human	DNA
DPA	DNA
gene	DNA
.	O
Several	O
DNA	DNA
clones	DNA
were	O
obtained	O
by	O
this	O
procedure,	O
one	O
of	O
which,	O
clone	DNA
18	DNA
,	O
is	O
reported	O
and	O
characterized	O
here.	O
It	O
encodes	O
a	O
protein	O
predicted	O
to	O
contain	O
688	O
amino	O
acid	O
residues	O
,	O
including	O
11	O
zinc	protein
finger	protein
motifs	protein
of	O
the	O
C2H2	protein
type	protein
in	O
the	O
C-terminal	protein
region	protein
,	O
that	O
are	O
Kruppel-like	O
in	O
the	O
conservation	O
of	O
the	O
H/C	protein
link	protein
sequence	protein
connecting	O
them.	O
The	O
160	protein
N-terminal	protein
amino	protein
acids	protein
in	O
the	O
nonfinger	protein
region	protein
of	O
clone	protein
18	protein
are	O
highly	O
homologous	O
with	O
similar	O
regions	O
of	O
several	O
other	O
human	O
,	O
mouse	O
,	O
and	O
Drosophila	O
sequences	O
,	O
defining	O
a	O
subfamily	O
of	O
Kruppel-like	O
zinc	protein
finger	protein
proteins	protein
termed	O
TAB	protein
(	O
tramtrack	protein
[ttk]-associated	protein
box	protein
)	O
here.	O
One	O
of	O
the	O
Drosophila	DNA
sequences	DNA
,	O
ttk	DNA
,	O
is	O
a	O
developmental	DNA
control	DNA
gene	DNA
,	O
while	O
a	O
second	O
does	O
not	O
contain	O
a	O
zinc	protein
finger	protein
region	protein
but	O
encodes	O
a	O
structure	O
important	O
in	O
oocyte	O
development	O
.	O
An	O
acidic	protein
activation	protein
domain	protein
is	O
located	O
between	O
the	O
N-terminal	protein
conserved	protein
region	protein
of	O
clone	protein
18	protein
and	O
its	O
zinc	protein
fingers	protein
.	O
This	O
protein	O
appears	O
to	O
require	O
both	O
the	O
S	O
and	O
J	O
elements	O
,	O
which	O
are	O
separated	O
by	O
10	O
bp	O
for	O
optimal	O
binding.	O
Antisense	O
cDNA	O
to	O
clone	protein
18	protein
inhibited	O
the	O
expression	O
of	O
a	O
reporter	O
construct	O
containing	O
the	O
DPA	DNA
promoter	DNA
,	O
indicating	O
its	O
functional	O
importance	O
in	O
the	O
expression	O
of	O
this	O
class	DNA
II	DNA
gene	DNA
.	O

Separation	O
of	O
oxidant-initiated	O
and	O
redox-regulated	O
steps	O
in	O
the	O
NF-kappa	protein
B	protein
signal	O
transduction	O
pathway	O
.	O
Studies	O
presented	O
here	O
show	O
that	O
overall	O
NF-kappa	protein
B	protein
signal	O
transduction	O
begins	O
with	O
a	O
parallel	O
series	O
of	O
stimuli-specific	O
pathways	O
through	O
which	O
cytokines	protein
(	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
),	O
oxidants	O
(	O
hydrogen	O
peroxide	O
and	O
mitomycin	O
C	O
),	O
and	O
phorbol	O
ester	O
(	O
phorbol	O
12-myristate	O
13-acetate	O
)	O
individually	O
initiate	O
signaling.	O
These	O
initial	O
pathways	O
culminate	O
in	O
a	O
common	O
pathway	O
through	O
which	O
all	O
of	O
the	O
stimulating	O
agents	O
ultimately	O
signal	O
NF-kappa	protein
B	protein
activation	O
.	O
We	O
distinguish	O
the	O
stimuli-specific	O
pathways	O
by	O
showing	O
that	O
the	O
oxidative	O
stimuli	O
trigger	O
NF-kappa	protein
B	protein
activation	O
in	O
only	O
one	O
of	O
two	O
human	cell_line
T-cell	cell_line
lines	cell_line
(	O
Wurzburg	cell_line
but	O
not	O
Jurkat	cell_line
),	O
whereas	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
and	O
phorbol	O
12-myristate	O
13-acetate	O
readily	O
stimulate	O
in	O
both	O
lines.	O
We	O
propose	O
the	O
common	O
pathway	O
as	O
the	O
simplest	O
way	O
of	O
accounting	O
for	O
the	O
common	O
requirements	O
and	O
properties	O
of	O
the	O
signaling	O
pathway.	O
We	O
include	O
a	O
redox-regulatory	O
mechanism	O
(s)	O
in	O
this	O
common	O
pathway	O
to	O
account	O
for	O
the	O
previously	O
demonstrated	O
redox	O
regulation	O
of	O
NF-kappa	protein
B	protein
activation	O
in	O
Jurkat	cell_line
cells	cell_line
(in	O
which	O
oxidants	O
don't	O
activate	O
NF-kappa	protein
B	protein
);	O
we	O
put	O
tyrosine	O
phosphorylation	O
in	O
the	O
common	O
pathway	O
by	O
showing	O
that	O
kinase	O
activity	O
(inhibitable	O
by	O
herbimycin	O
A	O
and	O
tyrphostin	O
47	O
)	O
is	O
required	O
for	O
NF-kappa	protein
B	protein
activation	O
by	O
all	O
stimuli	O
tested	O
in	O
both	O
cell	O
lines.	O
Since	O
internal	O
sites	O
of	O
oxidant	O
production	O
have	O
been	O
shown	O
to	O
play	O
a	O
key	O
role	O
in	O
the	O
cytokine	protein
-stimulated	O
activation	O
of	O
NF-kappa	protein
B	protein
,	O
and	O
since	O
tyrosine	O
kinase	O
and	O
phosphatase	O
activities	O
are	O
known	O
to	O
be	O
altered	O
by	O
oxidants,	O
these	O
findings	O
suggest	O
that	O
intracellular	O
redox	O
status	O
controls	O
NF-kappa	protein
B	protein
activation	O
by	O
regulating	O
tyrosine	O
phosphorylation	O
event(s)	O
within	O
the	O
common	O
step	O
of	O
the	O
NF-kappa	protein
B	protein
signal	O
transduction	O
pathway	O
.	O

Deleted	O
chromosome	DNA
20	DNA
from	O
a	O
patient	O
with	O
Alagille	O
syndrome	O
isolated	O
in	O
a	O
cell	O
hybrid	O
through	O
leucine	O
transport	O
selection	O
:	O
study	O
of	O
three	O
candidate	O
genes.	O
Alagille	O
syndrome	O
(	O
AGS	O
)	O
is	O
a	O
well-defined	O
genetic	O
entity	O
assigned	O
to	O
the	O
short	DNA
arm	DNA
of	O
Chromosome	DNA
(Chr)	DNA
20	DNA
by	O
a	O
series	O
of	O
observations	O
of	O
AGS	O
patients	O
associated	O
with	O
microdeletions	O
in	O
this	O
region.	O
By	O
fusing	O
lymphoblastoid	cell_type
cells	cell_type
of	O
an	O
AGS	O
patient	O
that	O
exhibited	O
a	O
microdeletion	O
in	O
the	O
short	DNA
arm	DNA
of	DNA
Chr	DNA
20	DNA
encompassing	O
bands	O
p11.23	DNA
to	DNA
p12.3	DNA
with	O
rodent	cell_line
thermosensitive	cell_line
mutant	cell_line
cells	cell_line
(	O
CHOtsH1-1	cell_line
)	O
deficient	O
in-leucyl-tRNA	protein
synthetase	protein
,	O
we	O
isolated	O
a	O
somatic	cell_line
cell	cell_line
hybrid	cell_line
segregating	O
the	O
deleted	O
human	O
Chr	DNA
20	DNA
.	O
This	O
hybrid	O
clone,	O
designated	O
NR2	cell_line
,	O
was	O
characterized	O
by	O
several	O
methods,	O
including	O
PCR	O
,	O
with	O
eight	O
pairs	O
of	O
oligonucleotides	O
mapped	O
to	O
Chr	DNA
20	DNA
:	O
D20S5	DNA
,	O
D20S41	DNA
,	O
D20S42	DNA
,	O
D20S56	DNA
,	O
D20S57	DNA
,	O
D20S58	DNA
,	O
adenosine	DNA
deaminase	DNA
(	O
ADA	protein
),	O
and	O
Prion	DNA
protein	DNA
(	O
PRIP	protein
);	O
Restriction	O
Fragment	O
Length	O
Polymorphism	O
(	O
RFLP	DNA
)	O
analyses	O
with	O
four	O
genomic	DNA
anonymous	DNA
probes	DNA
(	O
D20S5	DNA
,	O
cD3H12	DNA
,	O
D20S17	DNA
,	O
D20S18	DNA
);	O
and	O
fluorescent	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
with	O
total	DNA
human	DNA
DNA	DNA
and	O
D20Z1	DNA
,	O
a	O
sequence	O
specific	O
to	O
the	O
human	DNA
Chr	DNA
20	DNA
centromere	DNA
,	O
as	O
probes.	O
The	O
NR2	cell_line
hybrid	cell_line
allowed	O
us	O
to	O
exclude	O
three	O
candidate	DNA
genes	DNA
for	O
AGS	O
:	O
hepatic	DNA
nuclear	DNA
factor	DNA
3	DNA
beta	DNA
(	O
HNF3	DNA
beta	DNA
),	O
paired	DNA
box	DNA
1	DNA
(	O
PAX1	DNA
),	O
and	O
cystatin	DNA
C	DNA
(	O
CST3	DNA
)	O
as	O
shown	O
by	O
their	O
localization	O
outside	O
of	O
the	O
deletion.	O
The	O
NR2	cell_line
hybrid	cell_line
is	O
a	O
powerful	O
tool	O
for	O
the	O
mapping	O
of	O
new	O
probes	O
of	O
this	O
region,	O
as	O
well	O
as	O
for	O
obtaining	O
new	O
informative	O
probes	O
specific	O
for	O
the	O
deletion	O
by	O
subtractive	O
cloning	O
of	O
the	O
region.	O
Such	O
markers	O
will	O
be	O
useful	O
for	O
linkage	O
analysis	O
and	O
screening	O
of	O
cDNA	DNA
libraries	DNA
.	O

Positive	O
and	O
negative	O
regulation	O
of	O
the	O
composite	DNA
octamer	DNA
motif	DNA
of	O
the	O
interleukin	DNA
2	DNA
enhancer	DNA
by	O
AP-1	protein
,	O
Oct-2	protein
,	O
and	O
retinoic	protein
acid	protein
receptor	protein
.	O
The	O
differentiating	O
agent	O
retinoic	O
acid	O
(	O
RA	O
)	O
has	O
been	O
previously	O
reported	O
to	O
interfere	O
with	O
12-O-tetradecanoyl-phorbol-13-acetate	O
(	O
TPA	O
)/	O
Ca(2+)	O
-induced	O
signals	O
for	O
the	O
regulation	O
of	O
the	O
-96	DNA
to	DNA
-66-bp	DNA
octamer	DNA
motif	DNA
found	O
in	O
the	O
enhancer	O
for	O
the	O
interleukin	DNA
(IL)-2	DNA
gene	DNA
,	O
which	O
encodes	O
a	O
major	O
T	protein
lymphocyte	protein
growth	protein
factor	protein
.	O
The	O
IL-2	DNA
octamer	DNA
motif	DNA
is	O
a	O
composite	O
cis-element	DNA
which	O
binds	O
Oct-1	protein
and	O
Oct-2	protein
as	O
well	O
as	O
a	O
TPA	protein
/	protein
Ca(2+)	protein
-inducible	protein
nuclear	protein
factor	protein
,	O
previously	O
termed	O
octamer-associated	protein
protein	protein
(	O
OAP40	protein
).	O
We	O
show	O
here	O
that	O
Oct-2	protein
,	O
despite	O
the	O
presence	O
of	O
an	O
active	O
transcriptional	O
activation	O
domain,	O
requires	O
TPA/Ca(2+)-induced	O
signals	O
to	O
strongly	O
transactivate	O
the	O
IL-2	DNA
octamer	DNA
motif	DNA
in	O
Jurkat	O
T	O
cells.	O
This	O
Oct-2	protein
-dependent	O
transactivation	O
is	O
inhibited	O
by	O
RA	O
.	O
The	O
presence	O
of	O
an	O
intact	protein
COOH-terminal	protein
domain	protein
of	O
Oct-2	protein
contributes	O
to	O
both	O
TPA	O
/	O
Ca(2+)	O
-induced	O
transactivation	O
and	O
the	O
RA	O
-mediated	O
repression.	O
We	O
also	O
show	O
that	O
both	O
Fos	protein
and	O
Jun	protein
components	O
of	O
the	O
AP-1	protein
factors	O
participate	O
in	O
the	O
OAP40	protein
complex	protein
.	O
Furthermore,	O
transfected	O
c-jun	O
,	O
jun-B	O
,	O
jun-D	O
,	O
c-fos	O
,	O
or	O
Fos-B	O
expression	O
vectors	O
partially	O
substitute	O
for	O
TPA	O
and	O
Ca2+	O
and	O
cooperate	O
with	O
Oct-2	protein
for	O
the	O
transactivation	O
of	O
the	O
combined	O
OAP/octamer	DNA
cis-element	DNA
.	O
Mutations	O
of	O
the	O
genuine	DNA
octamer-binding	DNA
site	DNA
abrogate	O
both	O
the	O
binding	O
of	O
Oct-1	protein
and	O
Oct-2	protein
and	O
the	O
TPA	O
/	O
Ca(2+)	O
-induced	O
transactivation	O
of	O
the	O
OAP	DNA
/octamer	DNA
motif	DNA
.	O
OAP	protein
confers	O
to	O
Oct-2	protein
responsivity	O
to	O
both	O
TPA	O
/Ca2+	O
and	O
RA	O
,	O
since	O
specific	O
mutations	O
of	O
the	O
AP-1	DNA
/	DNA
OAP	DNA
-binding	DNA
site	DNA
significantly	O
reduce	O
the	O
transactivation	O
by	O
Oct-2	protein
in	O
response	O
to	O
TPA	O
and	O
Ca2+	O
and	O
abolish	O
the	O
inhibition	O
by	O
RA	O
.	O
Furthermore,	O
retinoic	protein
acid	protein
receptor	protein
(	O
RAR	protein
)	O
alpha	O
is	O
able	O
to	O
inhibit	O
in	O
vitro	O
the	O
formation	O
of	O
the	O
complex	O
between	O
the	O
nuclear	O
AP-1	protein
/OAP	protein
and	O
its	O
specific	O
binding	O
site,	O
resulting	O
in	O
the	O
interference	O
with	O
Oct-2	protein
-dependent	O
cis-regulatory	O
function	O
of	O
this	O
AP-1	protein
element.	O
Therefore,	O
we	O
propose	O
that	O
the	O
TPA	O
/	O
calcium	O
-activated	O
AP-1	protein
/OAP	protein
element	O
is	O
the	O
main	O
target	O
of	O
positive	O
or	O
negative	O
regulatory	O
signals	O
influencing	O
the	O
IL-2	DNA
octamer	DNA
motif	DNA
,	O
through	O
synergism	O
with	O
Oct-2	protein
and	O
antagonism	O
by	O
RAR	protein
.	O

Missense	O
mutation	O
in	O
exon	DNA
7	DNA
of	O
the	O
common	DNA
gamma	DNA
chain	DNA
gene	DNA
causes	O
a	O
moderate	O
form	O
of	O
X-linked	O
combined	O
immunodeficiency	O
.	O
Clinical	O
and	O
immunologic	O
features	O
of	O
a	O
recently	O
recognized	O
X-linked	O
combined	O
immunodeficiency	O
disease	O
(	O
XCID	O
)	O
suggested	O
that	O
XCID	O
and	O
X-linked	O
severe	O
combined	O
immunodeficiency	O
(	O
XSCID	O
)	O
might	O
arise	O
from	O
different	O
genetic	O
defects	O
.	O
The	O
recent	O
discovery	O
of	O
mutations	O
in	O
the	O
common	DNA
gamma	DNA
chain	DNA
(gamma	DNA
c)	DNA
gene	DNA
,	O
a	O
constituent	O
of	O
several	O
cytokine	protein
receptors	protein
,	O
in	O
XSCID	O
provided	O
an	O
opportunity	O
to	O
test	O
directly	O
whether	O
a	O
previously	O
unrecognized	O
mutation	O
in	O
this	O
same	O
gene	O
was	O
responsible	O
for	O
XCID	O
.	O
The	O
status	O
of	O
X	DNA
chromosome	DNA
inactivation	O
in	O
blood	O
leukocytes	O
from	O
obligate	O
carriers	O
of	O
XCID	O
was	O
determined	O
from	O
the	O
polymorphic,	O
short	DNA
tandem	DNA
repeats	DNA
(	O
CAG	O
),	O
in	O
the	O
androgen	DNA
receptor	DNA
gene	DNA
,	O
which	O
also	O
contains	O
a	O
methylation-sensitive	DNA
HpaII	DNA
site	DNA
.	O
As	O
in	O
XSCID,	O
X-chromosome	O
inactivation	O
in	O
obligate	O
carriers	O
of	O
XCID	O
was	O
nonrandom	O
in	O
T	O
and	O
B	O
lymphocytes	O
.	O
In	O
addition,	O
X	DNA
chromosome	DNA
inactivation	O
in	O
PMNs	O
was	O
variable.	O
Findings	O
from	O
this	O
analysis	O
prompted	O
sequencing	O
of	O
the	O
gamma	DNA
c	DNA
gene	DNA
in	O
this	O
pedigree.	O
A	O
missense	O
mutation	O
in	O
the	O
region	O
coding	O
for	O
the	O
cytoplasmic	O
portion	O
of	O
the	O
gamma	DNA
c	DNA
gene	DNA
was	O
found	O
in	O
three	O
affected	O
males	O
but	O
not	O
in	O
a	O
normal	O
brother.	O
Therefore,	O
this	O
point	O
mutation	O
in	O
the	O
gamma	DNA
c	DNA
gene	DNA
leads	O
to	O
a	O
less	O
severe	O
degree	O
of	O
deficiency	O
in	O
cellular	O
and	O
humoral	O
immunity	O
than	O
that	O
seen	O
in	O
XSCID	O
.	O

Posttranscriptional	O
regulation	O
of	O
macrophage	O
tissue	protein
factor	protein
expression	O
by	O
antioxidants	O
.	O
Tissue	protein
factor	protein
(	O
TF	protein
)	O
expression	O
by	O
cells	O
of	O
monocyte/macrophage	cell_type
lineage	cell_type
represents	O
an	O
important	O
mechanism	O
underlying	O
the	O
initiation	O
of	O
fibrin	protein
deposition	O
at	O
sites	O
of	O
extravascular	O
inflammation	O
.	O
Recent	O
evidence	O
suggests	O
a	O
role	O
for	O
oxidant	O
stress	O
in	O
the	O
signalling	O
pathway	O
of	O
various	O
cell	O
types	O
by	O
virtue	O
of	O
its	O
ability	O
to	O
induce	O
DNA	O
binding	O
of	O
various	O
transcription	protein
factors	protein
,	O
including	O
nuclear	protein
factor	protein
kappa	protein
B	protein
and	O
AP-1	protein
.	O
The	O
effect	O
of	O
antioxidant	O
treatment	O
on	O
lipopolysaccharide	O
(	O
LPS	O
)-induced	O
TF	protein
expression	O
was	O
examined	O
in	O
murine	cell_type
peritoneal	cell_type
macrophages	cell_type
and	O
human	cell_type
monocytes	cell_type
.	O
Both	O
pyrrolidine	O
dithiocarbamate	O
,	O
an	O
oxidant	O
scavenger	O
,	O
and	O
N-acetyl-cysteine	O
,	O
a	O
precursor	O
of	O
the	O
endogenous	O
antioxidant	O
glutathione	O
,	O
inhibited	O
stimulation	O
of	O
macrophage	O
procoagulant	O
activity	O
by	O
LPS	O
.	O
Northern	O
blot	O
analysis	O
showed	O
that	O
neither	O
of	O
these	O
agents	O
reduced	O
LPS	O
-stimulated	O
TF	protein
mRNA	O
accumulation	O
,	O
thereby	O
suggesting	O
a	O
posttranscriptional	O
mechanism	O
for	O
the	O
effect.	O
Immunofluorescence	O
studies	O
of	O
human	cell_type
monocytes	cell_type
using	O
polyclonal	O
anti-	protein
TF	protein
antibody	protein
showed	O
that	O
N-acetyl-cysteine	O
treatment	O
prevented	O
the	O
characteristic	O
plasmalemmal	O
localization	O
of	O
TF	protein
antigen	protein
that	O
occurs	O
in	O
response	O
to	O
LPS	O
.	O
Western	O
blot	O
analysis	O
showed	O
that	O
N-acetyl-cysteine	O
reduced	O
the	O
accumulation	O
of	O
the	O
47-kD	protein
mature	protein
glycoprotein	protein
in	O
LPS	cell_line
-treated	cell_line
cells	cell_line
,	O
a	O
finding	O
consistent	O
with	O
the	O
results	O
of	O
the	O
immunofluorescence	O
studies	O
.	O
Furthermore,	O
these	O
conditions	O
did	O
not	O
result	O
in	O
an	O
accumulation	O
of	O
the	O
less	O
mature	O
forms	O
of	O
TF	protein
.	O
When	O
considered	O
together,	O
these	O
data	O
suggest	O
that	O
antioxidants	O
exert	O
their	O
effects	O
by	O
impairing	O
translation	O
and/or	O
by	O
causing	O
degradation	O
of	O
newly	O
translated	protein
protein	protein
.	O
The	O
effect	O
of	O
antioxidants	O
on	O
tumor	protein
necrosis	protein
factor	protein
appeared	O
to	O
be	O
species	O
specific,	O
with	O
no	O
effect	O
on	O
LPS	O
-induced	O
tumor	O
necrosis	O
factor	O
in	O
murine	O
cells,	O
but	O
with	O
inhibition	O
in	O
human	cell_type
monocytes	cell_type
.	O
The	O
posttranscriptional	O
effect	O
of	O
antioxidants	O
on	O
TF	protein
expression	O
data	O
suggests	O
a	O
novel	O
mechanism	O
whereby	O
these	O
agents	O
might	O
modulate	O
monocyte	cell_type
/macrophage	cell_type
activation	O
.	O

Characterization	O
of	O
the	O
CD48	DNA
gene	DNA
demonstrates	O
a	O
positive	O
element	O
that	O
is	O
specific	O
to	O
Epstein-Barr	cell_type
virus	cell_type
-immortalized	cell_type
B-cell	cell_type
lines	cell_type
and	O
contains	O
an	O
essential	O
NF-kappa	DNA
B	DNA
site	DNA
.	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
infection	O
of	O
mature,	O
resting	cell_type
B	cell_type
cells	cell_type
drives	O
them	O
to	O
become	O
lymphoblasts	O
expressing	O
high	O
levels	O
of	O
cell	O
surface	O
molecules,	O
such	O
as	O
CD48	protein
,	O
characteristically	O
expressed	O
on	O
normal	cell_type
activated	cell_type
B	cell_type
cells	cell_type
.	O
Here,	O
we	O
report	O
on	O
the	O
identification	O
of	O
an	O
enhancer	DNA
element	DNA
in	O
the	O
CD48	DNA
gene	DNA
which	O
reproducibly	O
confers	O
strong	O
transcriptional	O
activity	O
only	O
in	O
EBV	cell_line
-positive	cell_line
B-lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
.	O
The	O
element	O
is	O
not	O
activated	O
upon	O
infection	O
of	O
established	O
EBV	cell_line
-negative	cell_line
B-cell	cell_line
lines	cell_line
,	O
indicating	O
that	O
EBV	O
fails	O
to	O
drive	O
these	O
cells	O
to	O
a	O
fully	O
lymphoblastoid	cell_type
phenotype	cell_type
.	O
An	O
NF-kappa	DNA
B	DNA
binding	DNA
site	DNA
is	O
an	O
essential	O
component	O
of	O
the	O
element	O
but	O
alone	O
is	O
not	O
sufficient	O
to	O
account	O
for	O
the	O
activity	O
or	O
the	O
specificity	O
of	O
the	O
element.	O
We	O
have	O
detected	O
a	O
specific	O
nuclear	protein
protein	protein
complex	protein
that	O
binds	O
to	O
the	O
element	O
and	O
show	O
that	O
NF-kappa	protein
B1	protein
(	O
p50	protein
)	O
is	O
a	O
part	O
of	O
this	O
complex.	O
The	O
EBV	protein
-encoded	protein
latent	protein
membrane	protein
protein	protein
1	protein
is	O
capable	O
of	O
transactivating	O
the	O
isolated	O
CD48	protein
NF-kappa	DNA
B	DNA
site	DNA
but	O
not	O
the	O
intact	DNA
element	DNA
,	O
suggesting	O
that	O
the	O
latent	protein
membrane	protein
protein	protein
1	protein
-driven	O
activation	O
of	O
NF-kappa	protein
B/Rel	protein
must	O
interact	O
with	O
other	O
regulatory	O
pathways	O
to	O
control	O
expression	O
of	O
cellular	O
genes	O
as	O
EBV	O
drives	O
resting	cell_type
B	cell_type
cells	cell_type
into	O
the	O
cell	O
cycle	O
.	O

Thapsigargin	O
induces	O
IL-2	protein
receptor	protein
alpha-chain	protein
in	O
human	cell_type
peripheral	cell_type
and	O
Jurkat	cell_line
T	cell_line
cells	cell_line
via	O
a	O
protein	protein
kinase	protein
C	protein
-independent	O
mechanism	O
.	O
Thapsigargin	O
(	O
TG	O
),	O
an	O
inhibitor	O
of	O
Ca(2+)-ATPase	protein
,	O
depletes	O
intracellular	O
Ca2+	O
stores	O
and	O
induces	O
a	O
sustained	O
Ca2+	O
influx	O
without	O
altering	O
phosphatidyl	O
inositol	O
levels	O
.	O
TG	O
plus	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
but	O
not	O
TG	O
alone	O
induced	O
IL-2	protein
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
,	O
suggesting	O
that	O
TG	O
had	O
no	O
effect	O
on	O
protein	protein
kinase	protein
C	protein
(	O
PKC	protein
).	O
However,	O
TG	O
induced	O
increases	O
in	O
IL-2R	protein
alpha	protein
protein	protein
as	O
well	O
as	O
IL-2R	RNA
alpha	RNA
mRNA	RNA
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
in	O
a	O
dose-dependent	O
manner.	O
A	O
similar	O
increase	O
in	O
IL-2R	protein
alpha	protein
by	O
TG	O
was	O
also	O
observed	O
in	O
human	cell_type
peripheral	cell_type
T	cell_type
cells	cell_type
.	O
Further,	O
like	O
PMA	O
,	O
TG	O
markedly	O
induced	O
NF	protein
kappa	protein
B	protein
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
However,	O
TG	O
and	O
PMA	O
exhibited	O
a	O
synergistic	O
action	O
on	O
IL-2R	protein
alpha	protein
expression,	O
suggesting	O
that	O
TG	O
and	O
PMA	O
induce	O
IL-2R	protein
alpha	protein
through	O
distinct	O
pathways.	O
PMA	O
-but	O
not	O
TG	O
-induced	O
IL-2R	O
alpha	O
is	O
inhibited	O
by	O
the	O
PKC	protein
inhibitor	O
H7	O
,	O
whereas	O
TG	O
-but	O
not	O
PMA	O
-induced	O
IL-2R	O
alpha	O
was	O
inhibited	O
by	O
cholera	O
toxin	O
,	O
forskolin	O
and	O
1,9-dideoxy	O
forskolin	O
.	O
In	O
toto,	O
these	O
results	O
suggest	O
that	O
TG	O
induces	O
IL-2R	protein
alpha	protein
in	O
human	cell_type
T	cell_type
cells	cell_type
through	O
a	O
PKC	protein
-independent	O
pathway	O
.	O

Physiological	O
concentration	O
of	O
estradiol	O
inhibits	O
polymorphonuclear	cell_type
leukocyte	cell_type
chemotaxis	O
via	O
a	O
receptor	O
mediated	O
system.	O
Estrogen	O
exhibits	O
a	O
variety	O
of	O
actions,	O
including	O
immuno-modulatory	O
effects	O
,	O
in	O
vivo	O
and	O
in	O
vitro.	O
The	O
mechanism	O
by	O
which	O
estrogen	O
exerts	O
its	O
anti-inflammatory	O
effect	O
is	O
not	O
yet	O
understood.	O
We	O
investigated	O
the	O
possible	O
mechanisms	O
of	O
estradiol	O
acting	O
via	O
the	O
polymorphonuclear	cell_type
leukocytes	cell_type
(	O
PMNs	cell_type
),	O
which	O
are	O
important	O
in	O
the	O
immune	O
response	O
.	O
The	O
agent,	O
17	O
beta-	O
estradiol	O
,	O
but	O
not	O
17	O
alpha-	O
estradiol	O
,	O
significantly	O
reduced	O
PMNs	cell_type
chemotaxis	O
to	O
FMLP	O
in	O
a	O
dose-dependent	O
manner	O
(control	O
vs	O
estrogen	O
10(-10)-(-6)	O
M,	O
P	O
&lt;	O
0.05).	O
Physiological	O
concentrations	O
of	O
estradiol	O
significantly	O
reduced	O
the	O
chemotaxis	O
of	O
PMNs	cell_type
(10(-10)	O
mol).	O
Pre-incubation	O
with	O
clomiphene	O
or	O
tamoxifen	O
which	O
are	O
estrogen	O
receptor	O
antagonists,	O
eliminated	O
the	O
inhibitory	O
effect	O
of	O
17	O
beta-	O
estradiol	O
on	O
the	O
chemotaxis	O
of	O
PMNs	cell_type
,	O
restoring	O
it	O
to	O
the	O
control	O
level.	O
These	O
observations	O
suggest	O
that	O
17	O
beta-	O
estradiol	O
suppressed	O
the	O
chemotaxis	O
of	O
PMNs	cell_type
by	O
a	O
receptor-dependent	O
mechanism	O
.	O
In	O
addition,	O
the	O
level	O
of	O
estradiol	O
in	O
human	cell_type
plasma	cell_type
,	O
which	O
PMNs	cell_type
were	O
drawn,	O
showed	O
a	O
close,	O
inverse	O
correlation	O
with	O
the	O
PMNs	cell_type
chemotaxis	O
to	O
FMLP	O
(r	O
=	O
-0.821	O
p	O
&lt;	O
0.001).	O
Estrogen	O
may	O
modify	O
the	O
activity	O
of	O
neutrophils	cell_type
during	O
the	O
normal	O
menstrual	O
cycle,	O
not	O
only	O
during	O
pregnancy,	O
and	O
influence	O
inflammation.	O

Identification	O
of	O
the	O
TCL1	DNA
gene	DNA
involved	O
in	O
T-cell	cell_type
malignancies	O
.	O
The	O
TCL1	DNA
locus	DNA
on	O
chromosome	DNA
14q32.1	DNA
is	O
frequently	O
involved	O
in	O
chromosomal	O
translocations	O
and	O
inversions	O
with	O
one	O
of	O
the	O
T-cell	DNA
receptor	DNA
loci	DNA
in	O
human	O
T-cell	O
leukemias	O
and	O
lymphomas	O
.	O
The	O
chromosome	DNA
14	DNA
region	DNA
translocated	O
or	O
rearranged	O
involves	O
approximately	O
350	O
kb	O
of	O
DNA	O
at	O
chromosome	DNA
band	DNA
14q32.1	DNA
.	O
Within	O
this	O
region	O
we	O
have	O
identified	O
a	O
gene	O
coding	O
for	O
a	O
1.3-kb	RNA
transcript	RNA
,	O
expressed	O
only	O
in	O
restricted	O
subsets	O
of	O
cells	O
within	O
the	O
lymphoid	cell_type
lineage	cell_type
and	O
expressed	O
at	O
high	O
levels	O
in	O
leukemic	cell_type
cells	cell_type
carrying	O
a	O
t(14;14)(q11;q32)	DNA
chromosome	DNA
translocation	DNA
or	O
a	O
inv(14)(q11;q32)	DNA
chromosome	DNA
inversion	DNA
.	O
The	O
cognate	DNA
cDNA	DNA
sequence	DNA
reveals	O
an	O
open	DNA
reading	DNA
frame	DNA
of	O
342	O
nt	O
encoding	O
a	O
protein	protein
of	protein
14	protein
kDa	protein
.	O
The	O
TCL1	DNA
gene	DNA
sequence,	O
which,	O
to	O
our	O
knowledge,	O
shows	O
no	O
sequence	O
homology	O
with	O
other	O
human	DNA
genes	DNA
,	O
is	O
preferentially	O
expressed	O
early	O
in	O
T-	O
and	O
B-	O
lymphocyte	O
differentiation.	O

Identification	O
of	O
a	O
region	O
which	O
directs	O
the	O
monocytic	O
activity	O
of	O
the	O
colony-stimulating	DNA
factor	DNA
1	DNA
(	DNA
macrophage	DNA
colony-stimulating	DNA
factor	DNA
)	DNA
receptor	DNA
promoter	DNA
and	O
binds	O
PEBP2/CBF	protein
(	O
AML1	protein
).	O
The	O
receptor	O
for	O
the	O
macrophage	protein
colony-stimulating	protein
factor	protein
(or	O
colony-stimulating	protein
factor	protein
1	protein
[	O
CSF-1	protein
])	O
is	O
expressed	O
from	O
different	O
promoters	O
in	O
monocytic	cell_type
cells	cell_type
and	O
placental	cell_type
trophoblasts	cell_type
.	O
We	O
have	O
demonstrated	O
that	O
the	O
monocyte-specific	O
expression	O
of	O
the	O
CSF-1	protein
receptor	protein
is	O
regulated	O
at	O
the	O
level	O
of	O
transcription	O
by	O
a	O
tissue-specific	DNA
promoter	DNA
whose	O
activity	O
is	O
stimulated	O
by	O
the	O
monocyte/B-cell-specific	protein
transcription	protein
factor	protein
PU.1	protein
(D.-E.Zhang,	O
C.J.Hetherington,	O
H.-M.Chen,	O
and	O
D.G.Tenen,	O
Mol.Cell.	O
Biol.14:373-381,	O
1994).	O
Here	O
we	O
report	O
that	O
the	O
tissue	O
specificity	O
of	O
this	O
promoter	DNA
is	O
also	O
mediated	O
by	O
sequences	O
in	O
a	O
region	DNA
II	DNA
(bp	O
-88	O
to	O
-	O
59),	O
which	O
lies	O
10	DNA
bp	DNA
upstream	DNA
from	O
the	O
PU.1	DNA
-binding	DNA
site	DNA
.	O
When	O
analyzed	O
by	O
DNase	protein
footprinting	O
,	O
region	DNA
II	DNA
was	O
protected	O
preferentially	O
in	O
monocytic	cell_type
cells	cell_type
.	O
Electrophoretic	O
mobility	O
shift	O
assays	O
confirmed	O
that	O
region	DNA
II	DNA
interacts	O
specifically	O
with	O
nuclear	protein
proteins	protein
from	O
monocytic	cell_type
cells	cell_type
.	O
Two	O
gel	protein
shift	protein
complexes	protein
(	O
Mono	protein
A	protein
and	O
Mono	protein
B	protein
)	O
were	O
formed	O
with	O
separate	O
sequence	O
elements	O
within	O
this	O
region.	O
Competition	O
and	O
supershift	O
experiments	O
indicate	O
that	O
Mono	protein
B	protein
contains	O
a	O
member	O
of	O
the	O
polyomavirus	protein
enhancer-binding	protein
protein	protein
2/core-binding	protein
factor	protein
(	protein
PEBP2/CBF	protein
)	protein
family,	protein
which	O
includes	O
the	O
AML1	O
gene	O
product,	O
while	O
Mono	protein
A	protein
is	O
a	O
distinct	O
complex	O
preferentially	O
expressed	O
in	O
monocytic	cell_type
cells	cell_type
.	O
Promoter	DNA
constructs	DNA
with	O
mutations	O
in	O
these	O
sequence	O
elements	O
were	O
no	O
longer	O
expressed	O
specifically	O
in	O
monocytes	cell_type
.	O
Furthermore,	O
multimerized	DNA
region	DNA
II	DNA
sequence	DNA
elements	DNA
enhanced	O
the	O
activity	O
of	O
a	O
heterologous	DNA
thymidine	DNA
kinase	DNA
promoter	DNA
in	O
monocytic	cell_type
cells	cell_type
but	O
not	O
other	O
cell	O
types	O
tested.	O
These	O
results	O
indicate	O
that	O
the	O
monocyte/B-cell-specific	protein
transcription	protein
factor	protein
PU.1	protein
and	O
the	O
Mono	O
A	O
and	O
Mono	O
B	O
protein	O
complexes	O
act	O
in	O
concert	O
to	O
regulate	O
monocyte-specific	O
transcription	O
of	O
the	O
CSF-1	protein
receptor	protein
.	O

Pyrrolidine	O
dithiocarbamate	O
,	O
a	O
potent	O
inhibitor	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
activation,	O
prevents	O
apoptosis	O
in	O
human	O
promyelocytic	cell_line
leukemia	cell_line
HL-60	cell_line
cells	cell_line
and	O
thymocytes	cell_type
.	O
We	O
examined	O
the	O
effect	O
of	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
),	O
which	O
potently	O
blocks	O
the	O
activation	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
),	O
on	O
the	O
induction	O
of	O
apoptosis	O
by	O
a	O
variety	O
of	O
agents.	O
Treatment	O
of	O
a	O
human	cell_line
promyelocytic	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
,	O
HL-60	cell_line
,	O
with	O
10	O
micrograms/mL	O
etoposide	O
or	O
2	O
microM	O
1-beta-D-arabinofuranosylcytosine	O
induced	O
NF-kappa	protein
B	protein
activation	O
within	O
1	O
hr	O
and	O
subsequently	O
caused	O
apoptosis	O
within	O
3-4	O
hr.	O
The	O
simultaneous	O
addition	O
of	O
50-500	O
microM	O
PDTC	O
with	O
these	O
agents	O
blocked	O
NF-kappa	protein
B	protein
activation	O
and	O
completely	O
abrogated	O
both	O
morphologically	O
apoptotic	O
changes	O
and	O
internucleosomal	O
DNA	O
fragmentation	O
for	O
up	O
to	O
6	O
hr.	O
However,	O
PDTC	O
failed	O
to	O
inhibit	O
the	O
endonuclease	protein
activity	O
contained	O
in	O
the	O
whole	O
cell	O
lysates.	O
The	O
inhibitory	O
effect	O
of	O
PDTC	O
was	O
also	O
observed	O
in	O
etoposide	O
-and	O
dexamethasone-induced	O
apoptosis	O
in	O
human	cell_type
thymocytes	cell_type
at	O
a	O
concentration	O
of	O
1-10	O
microM.	O
Since	O
PDTC	O
has	O
both	O
antioxidant	O
and	O
metal-ion	O
chelating	O
activities	O
,	O
we	O
tested	O
the	O
effects	O
of	O
N-acetyl-L-cysteine	O
(	O
NAC	O
)	O
(	O
antioxidant	O
)	O
or	O
o-phenanthroline	O
(	O
OP	O
)	O
(	O
metal-ion	O
chelator	O
)	O
on	O
the	O
induction	O
of	O
apoptosis	O
.	O
Pretreatment	O
of	O
HL-60	O
cells	O
or	O
thymocytes	cell_type
with	O
100-500	O
microM	O
OP	O
for	O
2	O
hr,	O
but	O
not	O
10-60	O
mM	O
NAC	O
,	O
suppressed	O
subsequent	O
occurrence	O
of	O
apoptosis	O
induced	O
by	O
etoposide	O
.	O
These	O
results	O
suggest	O
that	O
the	O
activation	O
of	O
NF-kappa	protein
B	protein
plays	O
an	O
important	O
role	O
in	O
the	O
apoptotic	O
process	O
of	O
human	cell_type
hematopoietic	cell_type
cells	cell_type
.	O

Overexpression	O
of	O
protein	protein
kinase	protein
C	protein
-zeta	protein
stimulates	O
leukemic	cell_type
cell	cell_type
differentiation	O
.	O
A	O
function	O
for	O
protein	protein
kinase	protein
C	protein
-zeta	protein
(	O
PKC	protein
-zeta	protein
),	O
a	O
member	O
of	O
the	O
phorbol	O
ester	O
nonresponsive	O
atypical	O
protein	protein
kinase	protein
C	protein
subfamily	protein
,	O
in	O
modulating	O
differentiation	O
was	O
examined	O
in	O
the	O
leukemic	cell_line
U937	cell_line
cell	cell_line
.	O
Transfected	O
U937	cell_line
cells	cell_line
stably	O
overexpressing	O
PKC-zeta	protein
displayed	O
a	O
longer	O
doubling	O
time,	O
lower	O
saturation	O
density	O
at	O
confluency,	O
and	O
an	O
increase	O
in	O
adherence	O
to	O
plastic	O
as	O
compared	O
to	O
control	cell_line
cells	cell_line
.	O
PKC-zeta	cell_line
cells	cell_line
expressed	O
a	O
more	O
differentiated	O
phenotype	O
as	O
assessed	O
by	O
changes	O
in	O
morphology,	O
surface	O
antigen	O
expression,	O
and	O
lysosomal	protein
enzyme	protein
activities	O
and	O
were	O
distinct	O
from	O
parental	cell_line
U937	cell_line
cells	cell_line
stimulated	O
to	O
differentiate	O
by	O
exposure	O
to	O
phorbol	O
esters	O
.	O
In	O
contrast	O
to	O
parental	O
U937	cell_line
cells	cell_line
,	O
PKC-zeta	cell_line
cells	cell_line
constitutively	O
expressed	O
mRNA	RNA
transcripts	RNA
for	O
c-jun	DNA
and	O
a	O
low	O
mobility	O
AP-1	protein
binding	O
activity	O
.	O
Thus,	O
PKC-zeta	protein
overexpression	O
stimulates	O
a	O
type	O
of	O
phenotypic	O
differentiation	O
that	O
differs	O
significantly	O
from	O
maturation	O
occurring	O
upon	O
activation	O
of	O
other	O
PKC	protein
subfamilies	protein
induced	O
by	O
phorbol	O
ester	O
treatment	O
.	O
Increased	O
expression	O
of	O
the	O
c-jun	DNA
protooncogene	O
and	O
an	O
increase	O
in	O
AP-1	protein
binding	O
activity	O
in	O
PKC-zeta	cell_line
cells	cell_line
provides	O
a	O
potential	O
mechanism	O
for	O
explaining	O
the	O
altered	O
differentiation	O
status	O
of	O
this	O
cell.	O

A	O
family	O
of	O
serine	protein
proteases	protein
expressed	O
exclusively	O
in	O
myelo-	O
monocytic	cell_type
cells	cell_type
specifically	O
processes	O
the	O
nuclear	protein
factor-kappa	protein
B	protein
subunit	protein
p65	protein
in	O
vitro	O
and	O
may	O
impair	O
human	O
immunodeficiency	O
virus	O
replication	O
in	O
these	O
cells.	O
Two	O
groups	O
of	O
U937	cell_line
promonocytic	cell_line
cells	cell_line
were	O
obtained	O
by	O
limiting	O
dilution	O
cloning	O
which	O
differed	O
strikingly	O
in	O
their	O
ability	O
to	O
support	O
human	O
immunodeficiency	O
virus	O
1	O
(	O
HIV-1	O
)	O
replication	O
.	O
"Plus"	cell_line
clones	cell_line
replicated	O
the	O
virus	O
efficiently,	O
whereas	O
"minus"	cell_line
clones	cell_line
did	O
not.	O
We	O
examined	O
these	O
clones	O
for	O
differences	O
in	O
nuclear	protein
factor	protein
(NF)-kappa	protein
B	protein
activity	O
which	O
might	O
account	O
for	O
the	O
observed	O
phenomenon.	O
Stimulation	O
of	O
plus	cell_line
clones	cell_line
liberated	O
the	O
classical	O
p50-p65	protein
complex	protein
from	O
cytoplasmic	O
pools,	O
whereas	O
minus	cell_line
clones	cell_line
produced	O
an	O
apparently	O
novel,	O
faster-migrating	protein
complex	protein
,	O
as	O
judged	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O
It	O
is	O
surprising	O
that	O
the	O
faster-migrating	protein
complex	protein
was	O
composed	O
also	O
of	O
p50	protein
and	O
p65	protein
.	O
However,	O
the	O
p65	protein
subunit	protein
was	O
COOH-terminally	O
truncated	O
,	O
as	O
shown	O
by	O
immunoprecipitation	O
.	O
The	O
truncation	O
resulted	O
from	O
limited	O
proteolysis	O
of	O
p65	protein
during	O
cellular	O
extraction	O
which	O
released	O
particular	O
lysosomal	protein
serine	protein
proteases	protein
,	O
such	O
as	O
elastase	protein
,	O
cathepsin	protein
G	protein
,	O
and	O
proteinase	protein
3	protein
.	O
These	O
specific	O
proteases	O
are	O
coordinately	O
expressed	O
and	O
were	O
present	O
exclusively	O
in	O
the	O
minus	cell_line
U937	cell_line
clones	cell_line
,	O
but	O
not	O
in	O
the	O
plus	cell_line
clones	cell_line
,	O
as	O
demonstrated	O
in	O
the	O
case	O
of	O
cathepsin	protein
G	protein
.	O
In	O
addition,	O
these	O
proteases	O
were	O
detected	O
in	O
certain	O
subclones	O
of	O
THP-1	cell_line
and	O
HL-60	cell_line
cells	cell_line
and	O
in	O
primary	O
monocytes	cell_type
,	O
in	O
each	O
case	O
correlating	O
with	O
the	O
truncated	O
from	O
of	O
p65	protein
.	O
We	O
demonstrate	O
in	O
vitro	O
cleavage	O
of	O
p65	protein
by	O
purified	O
elastase	protein
and	O
cathepsin	protein
G	protein
.	O
It	O
is	O
possible	O
that	O
particular	O
serine	protein
proteases	protein
may	O
have	O
inhibiting	O
effects	O
on	O
the	O
replication	O
of	O
HIV-1	O
in	O
myelo-	cell_line
monocytic	cell_line
cells	cell_line
.	O
The	O
data	O
also	O
demonstrate	O
that	O
special	O
precautions	O
must	O
be	O
taken	O
when	O
making	O
extracts	O
from	O
myelo-	cell_line
monocytic	cell_line
cells	cell_line
.	O

A	O
germline	DNA
TaqI	DNA
restriction	DNA
fragment	DNA
length	DNA
polymorphism	DNA
in	O
the	O
progesterone	DNA
receptor	DNA
gene	DNA
in	O
ovarian	O
carcinoma	O
[see	O
comments]	O
Clinical	O
outcome	O
in	O
ovarian	O
carcinoma	O
is	O
predicted	O
by	O
progesterone	protein
receptor	protein
status	O
,	O
indicating	O
an	O
endocrine	O
aspect	O
to	O
this	O
disease.	O
Peripheral	DNA
leucocyte	DNA
genomic	DNA
DNAs	DNA
were	O
obtained	O
from	O
41	O
patients	O
with	O
primary	O
ovarian	O
carcinoma	O
and	O
83	O
controls	O
from	O
Ireland,	O
as	O
well	O
as	O
from	O
26	O
primary	O
ovarian	O
carcinoma	O
patients	O
and	O
101	O
controls	O
in	O
Germany.	O
Southern	O
analysis	O
using	O
a	O
human	DNA
progesterone	DNA
receptor	DNA
(	DNA
hPR	DNA
)	DNA
cDNA	DNA
probe	DNA
identified	O
a	O
germline	DNA
TaqI	DNA
restriction	DNA
fragment	DNA
length	DNA
polymorphism	DNA
(	O
RFLP	DNA
)	O
defined	O
by	O
two	O
alleles	DNA
:	O
T1	DNA
,	O
represented	O
by	O
a	O
2.7	DNA
kb	DNA
fragment	DNA
;	O
and	O
T2	DNA
,	O
represented	O
by	O
a	O
1.9	DNA
kb	DNA
fragment	DNA
and	O
characterised	O
by	O
an	O
additional	O
TaqI	DNA
restriction	DNA
site	DNA
with	O
respect	O
to	O
T1	DNA
.	O
An	O
over-representation	O
of	O
T2	DNA
in	O
ovarian	O
cancer	O
patients	O
compared	O
with	O
controls	O
in	O
the	O
pooled	O
Irish/German	O
population	O
(P	O
&lt;	O
0.025)	O
was	O
observed.	O
A	O
difference	O
(P	O
&lt;	O
0.02)	O
in	O
the	O
distribution	O
of	O
the	O
RFLP	DNA
genotypes	O
between	O
Irish	O
and	O
German	O
control	O
populations	O
was	O
also	O
observed.	O
The	O
allele	O
distributions	O
could	O
not	O
be	O
shown	O
to	O
differ	O
significantly	O
from	O
Hardy-Weinberg	O
distribution	O
in	O
any	O
subgroup.	O
Using	O
hPR	DNA
cDNA	DNA
region-specific	DNA
probes	DNA
,	O
the	O
extra	O
TaqI	O
restriction	O
site	O
was	O
mapped	O
to	O
intron	DNA
G	DNA
of	O
the	O
hPR	DNA
gene	DNA
.	O

OBF-1	protein
,	O
a	O
novel	protein
B	protein
cell-specific	protein
coactivator	protein
that	O
stimulates	O
immunoglobulin	DNA
promoter	DNA
activity	O
through	O
association	O
with	O
octamer-binding	protein
proteins	protein
.	O
Recent	O
biochemical	O
and	O
genetic	O
studies	O
indicate	O
that	O
in	O
addition	O
to	O
the	O
octamer-binding	protein
proteins	protein
Oct-1	protein
and	O
Oct-2	protein
,	O
other	O
B	protein
cell	protein
components	protein
are	O
required	O
for	O
lymphoid-restricted,	O
octamer	O
site-mediated	O
immunoglobulin	DNA
gene	DNA
promoter	DNA
activity	O
.	O
Using	O
a	O
genetic	O
screen	O
in	O
yeast,	O
we	O
have	O
isolated	O
B	DNA
cell-derived	DNA
cDNAs	DNA
encoding	O
Oct-binding	protein
factor	protein
1	protein
(	O
OBF-1	protein
),	O
a	O
novel	O
protein	O
that	O
specifically	O
associates	O
with	O
Oct-1	protein
and	O
Oct-2	protein
.	O
Biochemical	O
studies	O
demonstrate	O
that	O
OBF-1	protein
has	O
no	O
intrinsic	O
DNA-binding	O
activity	O
and	O
recognizes	O
the	O
POU	protein
domains	protein
of	O
Oct-1	protein
and	O
Oct-2	protein
,	O
but	O
not	O
those	O
of	O
Oct-4	protein
and	O
Oct-6	protein
.	O
The	O
OBF-1	RNA
mRNA	RNA
is	O
expressed	O
in	O
a	O
highly	O
cell-specific	O
manner,	O
being	O
most	O
abundant	O
in	O
B	cell_type
cells	cell_type
and	O
essentially	O
absent	O
in	O
most	O
of	O
the	O
other	O
cells	O
or	O
tissues	O
tested.	O
Furthermore,	O
expression	O
of	O
OBF-1	protein
in	O
HeLa	cell_line
cells	cell_line
selectively	O
stimulates	O
the	O
activity	O
of	O
a	O
natural	O
immunoglobulin	DNA
promoter	DNA
in	O
an	O
octamer	DNA
site	DNA
-dependent	O
manner	O
.	O
Thus,	O
OBF-1	protein
has	O
all	O
the	O
properties	O
expected	O
for	O
a	O
B	protein
cell-specific	protein
transcriptional	protein
coactivator	protein
protein	protein
.	O

Modulation	O
of	O
transcription	protein
factor	protein
NF	protein
kappa	protein
B	protein
activity	O
by	O
intracellular	O
glutathione	O
levels	O
and	O
by	O
variations	O
of	O
the	O
extracellular	O
cysteine	O
supply	O
.	O
HIV	O
-infected	O
individuals	O
and	O
SIV	O
-infected	O
rhesus	O
macaques	O
have,	O
on	O
the	O
average,	O
decreased	O
plasma	O
cysteine	O
and	O
cystine	O
concentrations	O
and	O
decreased	O
intracellular	O
glutathione	O
levels	O
.	O
We	O
now	O
show	O
that	O
a	O
depletion	O
of	O
intracellular	O
glutathione	O
in	O
a	O
human	cell_line
T	cell_line
cell	cell_line
line	cell_line
(	O
Molt-4	cell_line
)	O
inhibits	O
the	O
activation	O
and	O
nuclear	O
translocation	O
of	O
the	O
transcription	protein
factor	protein
NF	protein
kappa	protein
B	protein
,	O
whereas	O
incubation	O
with	O
increasing	O
extracellular	O
concentrations	O
of	O
cysteine	O
inhibits	O
the	O
DNA-binding	O
and	O
transactivating	O
activity	O
of	O
NF	protein
kappa	protein
B	protein
.	O
Because	O
inhibition	O
of	O
DNA-binding	O
activity	O
is	O
associated	O
with	O
increasing	O
intracellular	O
glutathione	O
disulfide	O
levels	O
and	O
GSSG	protein
can	O
be	O
shown	O
to	O
inhibit	O
the	O
DNA-binding	O
activity	O
directly	O
in	O
cell-free	O
systems	O
,	O
our	O
studies	O
suggest	O
that	O
GSSG	protein
is	O
a	O
physiologically	O
relevant	O
inhibitor	O
in	O
intact	cell_type
cells	cell_type
also.	O
NF	protein
kappa	protein
B	protein
controls	O
many	O
immunologically	DNA
important	DNA
genes	DNA
,	O
so	O
our	O
studies	O
suggest	O
that	O
the	O
immune	O
system	O
may	O
be	O
sensitive	O
not	O
only	O
against	O
a	O
cysteine	O
and	O
glutathione	O
deficiency	O
but	O
also	O
against	O
an	O
excess	O
of	O
cysteine	O
.	O

Two	O
distinct	O
signalling	O
pathways	O
are	O
involved	O
in	O
the	O
control	O
of	O
the	O
biphasic	O
junB	DNA
transcription	O
induced	O
by	O
interleukin-6	protein
in	O
the	O
B	cell_line
cell	cell_line
hybridoma	cell_line
7TD1	cell_line
.	O
We	O
have	O
measured	O
the	O
level	O
of	O
junB	RNA
mRNA	RNA
in	O
the	O
B	cell_line
hybridoma	cell_line
cell	cell_line
line	cell_line
7TD1	cell_line
,	O
under	O
interleukin-6	protein
(	O
IL-6	protein
)	O
stimulation.	O
IL-6	protein
increases	O
junB	RNA
mRNA	RNA
in	O
a	O
biphasic	O
fashion.	O
The	O
first	O
early-induced	O
peak	O
was	O
transient	O
and	O
likely	O
corresponds	O
to	O
the	O
well	O
documented	O
typical	O
junB	RNA
mRNA	RNA
,	O
stimulated	O
in	O
response	O
to	O
numerous	O
growth	protein
factors	protein
,	O
including	O
IL-6	protein
.	O
At	O
variance,	O
the	O
second	O
peak	O
which	O
has	O
never	O
been	O
reported	O
previously,	O
lasted	O
several	O
hours.	O
As	O
a	O
consequence	O
of	O
its	O
effect	O
on	O
junB	RNA
mRNA	RNA
,	O
IL-6	protein
stimulated,	O
in	O
a	O
biphasic	O
fashion,	O
the	O
nuclear	O
accumulation	O
of	O
the	O
JunB	protein
protein	protein
.	O
In	O
this	O
study,	O
we	O
demonstrated	O
that	O
IL-6	protein
regulation	O
occurred	O
exclusively	O
at	O
the	O
transcriptional	O
level	O
and	O
that	O
the	O
bimodal	O
increase	O
of	O
junB	RNA
mRNA	RNA
and	O
JunB	protein
protein	protein
can	O
be	O
accounted	O
for	O
by	O
a	O
biphasic	O
stimulation	O
of	O
junB	DNA
transcription	O
.	O
Furthermore,	O
our	O
data	O
point	O
to	O
two	O
major	O
differences	O
between	O
the	O
mechanism	O
of	O
control	O
of	O
the	O
early	O
and	O
the	O
late	O
IL-6	protein
-induced	O
junB	DNA
transcription	O
waves	O
.	O
First,	O
cycloheximide	O
strongly	O
potentiated	O
the	O
transcription	O
of	O
the	O
second	O
wave,	O
whereas	O
it	O
failed	O
to	O
affect	O
the	O
early-induced	O
burst.	O
Second,	O
tyrphostin	O
,	O
a	O
tyrosine	O
kinase	O
inhibitor	O
,	O
impaired	O
the	O
expression	O
of	O
the	O
first	O
but	O
not	O
the	O
second	O
junB	RNA
mRNA	RNA
peak	O
.	O
Conversely,	O
genistein	O
,	O
another	O
tyrosine	O
kinase	O
inhibitor	O
,	O
totally	O
abolished	O
the	O
expression	O
of	O
the	O
second	O
peak	O
of	O
junB	RNA
mRNA	RNA
whereas	O
it	O
did	O
not	O
affect	O
the	O
expression	O
of	O
the	O
first	O
peak.	O
Altogether	O
these	O
data	O
indicate	O
that,	O
in	O
7TD1	cell_line
cells	cell_line
,	O
IL-6	protein
controls	O
junB	DNA
transcription	O
in	O
a	O
biphasic	O
fashion	O
by	O
means	O
of	O
two	O
separate	O
transduction	O
pathways	O
.	O

A	O
newly	O
established	O
megakaryoblastic/erythroid	cell_line
cell	cell_line
line	cell_line
that	O
differentiates	O
to	O
red	cell_type
cells	cell_type
in	O
the	O
presence	O
of	O
erythropoietin	protein
and	O
produces	O
platelet-like	cell_type
particles	cell_type
.	O
In	O
August,	O
1992,	O
we	O
established	O
a	O
leukemic	cell_line
cell	cell_line
line	cell_line
(	O
NS-Meg	cell_line
)	O
from	O
a	O
patient	O
in	O
megakaryoblastic	O
transformation	O
of	O
Philadelphia	O
chromosome-positive	O
chronic	O
myeloid	O
leukemia	O
.	O
The	O
NS-Meg	cell_line
cells	cell_line
were	O
positive	O
for	O
alpha-naphthyl	protein
acetate	protein
esterase	protein
and	O
periodic	O
acid-Schiff	O
(PAS)	O
staining	O
and	O
for	O
surface	O
CD4	protein
,	O
CD7	protein
,	O
CD13	protein
,	O
CD34	protein
,	O
CD41a	protein
,	O
and	O
glycophorin	protein
A	protein
antigens	protein
.	O
Ultrastructurally,	O
the	O
cells	O
had	O
alpha-granules	O
,	O
demarcation	O
membranes	O
,	O
and	O
platelet	protein
peroxidase	protein
activity	O
.	O
The	O
NS-Meg	cell_line
cells	cell_line
spontaneously	O
produced	O
platelet-like	cell_type
particles	cell_type
which	O
contained	O
alpha-granules	O
,	O
mitochondria	O
and	O
dense	O
bodies	O
,	O
strongly	O
suggesting	O
platelet	O
production	O
.	O
Erythropoietin	protein
(	O
Epo	protein
),	O
granulocyte/macrophage	protein
colony	protein
stimulating	protein
factor	protein
(	O
GM-CSF	protein
),	O
and	O
interleukin	protein
3	protein
(	O
IL-3	protein
)	O
promoted	O
the	O
growth	O
of	O
NS-Meg	cell_line
cells	cell_line
.	O
Phorbol-12-myristate-13-acetate	O
increased	O
the	O
expression	O
of	O
both	O
CD41a	protein
and	O
CD61	O
antigens.	O
Ten-day	O
exposure	O
to	O
Epo	protein
induced	O
mature	cell_type
erythroblasts	cell_type
and	O
red	cell_type
cells	cell_type
.	O
These	O
benzidine-positive	cell_line
cells	cell_line
were	O
positive	O
for	O
hemoglobin	protein
F	O
staining	O
.	O
Untreated	O
NS-Meg	cell_line
cells	cell_line
expressed	O
mRNA	RNA
for	O
the	O
Epo	protein
receptor	protein
(	O
EpoR	protein
),	O
for	O
GATA-1	protein
,	O
and	O
for	O
alpha	O
1	O
,	O
alpha	O
2	O
and	O
gamma	O
globin	O
genes	O
.	O
These	O
results	O
indicate	O
that	O
NS-Meg	cell_line
cells	cell_line
undergo	O
terminal	O
differentiation	O
of	O
both	O
megakaryocytic	O
and	O
erythroid	O
lineages	O
.	O
This	O
cell	cell_line
line	cell_line
should	O
be	O
a	O
very	O
useful	O
tool	O
for	O
the	O
investigation	O
of	O
both	O
megakaryocytic	O
and	O
erythroid	O
maturation	O
.	O

Differential	O
regulation	O
of	O
proto-oncogenes	DNA
c-jun	DNA
and	O
c-fos	DNA
in	O
T	cell_type
lymphocytes	cell_type
activated	O
through	O
CD28	protein
.	O
The	O
T	protein
cell	protein
surface	protein
molecule	protein
CD28	protein
binds	O
to	O
ligands	O
on	O
accessory	cell_type
cells	cell_type
and	O
APCs	cell_type
,	O
playing	O
an	O
important	O
costimulatory	O
role	O
in	O
the	O
response	O
of	O
T	cell_type
cells	cell_type
to	O
Ags	protein
.	O
Our	O
knowledge	O
of	O
the	O
intracellular	O
signaling	O
pathways	O
coupled	O
to	O
this	O
receptor	O
is	O
incomplete.	O
In	O
addition	O
to	O
activation	O
of	O
phospholipase	protein
C	protein
gamma	protein
1	protein
,	O
ligation	O
of	O
this	O
receptor	O
also	O
seems	O
to	O
activate	O
a	O
calcium	O
-independent	O
,	O
CD28	protein
-specific	O
pathway	O
.	O
In	O
this	O
paper,	O
we	O
report	O
that	O
cross-linking	O
of	O
CD28	protein
(but	O
not	O
CD2	protein
,	O
CD5	protein
,	O
LFA-1	protein
,	O
or	O
CD7	protein
)	O
leads	O
to	O
an	O
elevation	O
of	O
c-jun	RNA
mRNA	RNA
,	O
with	O
only	O
minimal	O
activation	O
of	O
c-fos	DNA
expression	O
.	O
CD28	protein
-dependent	O
induction	O
of	O
c-jun	DNA
expression	O
requires	O
protein	protein
tyrosine	protein
kinase	protein
activity	O
,	O
but	O
does	O
not	O
depend	O
on	O
activation	O
of	O
a	O
phorbol	protein
ester	protein
-responsive	protein
protein	protein
kinase	protein
C	protein
or	O
elevation	O
of	O
cytosolic	O
calcium	O
.	O
Furthermore,	O
CD28	protein
-dependent	O
elevation	O
of	O
c-jun	RNA
mRNA	RNA
does	O
not	O
appear	O
to	O
be	O
mediated	O
at	O
the	O
level	O
of	O
mRNA	O
stability	O
.	O
A	O
mechanism	O
is	O
suggested	O
whereby	O
expression	O
of	O
c-jun	DNA
and	O
junB	DNA
,	O
in	O
the	O
absence	O
of	O
members	O
of	O
the	O
fos	DNA
family	DNA
,	O
can	O
prevent	O
inappropriate	O
activation	O
of	O
T	cell_type
cells	cell_type
caused	O
by	O
ligation	O
of	O
CD28	protein
in	O
the	O
absence	O
of	O
a	O
specific	O
antigenic	O
stimulus	O
.	O

Enhanced	O
responsiveness	O
to	O
nuclear	protein
factor	protein
kappa	protein
B	protein
contributes	O
to	O
the	O
unique	O
phenotype	O
of	O
simian	O
immunodeficiency	O
virus	O
variant	O
SIVsmmPBj14	O
.	O
Infection	O
with	O
a	O
variant	O
of	O
simian	O
immunodeficiency	O
virus	O
,	O
SIVsmmPBj14	O
,	O
leads	O
to	O
severe	O
acute	O
disease	O
in	O
macaques	O
.	O
This	O
study	O
was	O
designed	O
to	O
investigate	O
the	O
functional	O
significance	O
of	O
previously	O
described	O
mutations	O
in	O
the	O
viral	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
and	O
to	O
elucidate	O
their	O
contribution	O
to	O
the	O
unique	O
phenotype	O
of	O
SIVsmmPBj14	O
.	O
LTR	DNA
-directed	O
transcription	O
was	O
measured	O
by	O
using	O
luciferase	DNA
reporter	DNA
constructs	DNA
that	O
were	O
transiently	O
transfected	O
into	O
cultured	cell_line
cells	cell_line
.	O
In	O
a	O
wide	O
range	O
of	O
cell	O
types,	O
the	O
basal	O
transcriptional	O
activity	O
of	O
the	O
LTR	DNA
from	O
SIVsmmPBj14	O
was	O
found	O
to	O
be	O
2-	O
to	O
4.5-fold	O
higher	O
than	O
that	O
of	O
an	O
LTR	DNA
from	O
a	O
non-acutely	O
pathogenic	O
strain.	O
These	O
LTRs	DNA
differ	O
by	O
five	O
point	O
mutations	O
and	O
a	O
22-bp	DNA
duplication	DNA
in	O
SIVsmmPBj14	O
,	O
which	O
includes	O
a	O
nuclear	DNA
factor	DNA
kappa	DNA
B	DNA
(	DNA
NF	DNA
kappa	DNA
B	DNA
)	DNA
site	DNA
.	O
Transcriptional	O
differences	O
between	O
these	O
LTRs	DNA
were	O
further	O
enhanced	O
by	O
two-	O
to	O
threefold	O
upon	O
treatment	O
of	O
cells	O
with	O
phorbol	O
ester	O
or	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
or	O
by	O
cotransfection	O
with	O
plasmids	DNA
expressing	O
NF	protein
kappa	protein
B	protein
subunits.	O
Mutagenesis	O
studies,	O
and	O
the	O
use	O
of	O
a	O
reporter	O
construct	O
containing	O
an	O
enhancerless	O
promoter,	O
indicate	O
that	O
these	O
transcriptional	O
effects	O
are	O
due	O
principally	O
to	O
the	O
22-bp	DNA
sequence	DNA
duplication	DNA
and	O
the	O
NF	DNA
kappa	DNA
B	DNA
site	DNA
contained	O
within	O
it.	O
Finally,	O
infectious	O
virus	O
stocks	O
that	O
were	O
isogenic	O
except	O
for	O
the	O
LTR	DNA
were	O
generated.	O
The	O
LTR	DNA
from	O
SIVsmmPBj14	O
was	O
found	O
to	O
confer	O
an	O
increase	O
in	O
the	O
kinetics	O
of	O
virus	O
replication	O
in	O
cultured	cell_line
cells	cell_line
.	O
Inclusion	O
of	O
this	O
LTR	DNA
in	O
recombinant	O
SIVs	O
also	O
resulted	O
in	O
a	O
two-	O
to	O
threefold	O
rise	O
in	O
the	O
extent	O
of	O
cellular	O
proliferation	O
that	O
was	O
induced	O
in	O
quiescent	cell_line
simian	cell_line
peripheral	cell_line
blood	cell_line
mononuclear	cell_line
cells	cell_line
.	O
These	O
studies	O
are	O
consistent	O
with	O
the	O
hypothesis	O
that	O
LTR	DNA
mutations	O
assist	O
SIVsmmPBj14	O
in	O
responding	O
efficiently	O
to	O
cellular	O
stimulation	O
and	O
allow	O
it	O
to	O
replicate	O
to	O
high	O
titers	O
during	O
the	O
acute	O
phase	O
of	O
viral	O
infection	O
.	O

Constitutive	O
nuclear	protein
NF-kappa	protein
B	protein
in	O
cells	O
of	O
the	O
monocyte	O
lineage.	O
In	O
monocytes	cell_type
,	O
the	O
nuclear	protein
factor	protein
NF-kappa	protein
B	protein
has	O
been	O
invoked	O
as	O
an	O
important	O
transcription	protein
factor	protein
in	O
the	O
expression	O
of	O
cytokine	DNA
genes	DNA
,	O
of	O
cell-surface	protein
receptors	protein
and	O
in	O
the	O
expression	O
of	O
human	O
immunodeficiency	O
virus	O
.	O
In	O
such	O
cells,	O
DNA	O
binding	O
activity	O
of	O
NF-kappa	protein
B	protein
can	O
be	O
detected	O
without	O
intentional	O
stimulation.	O
In	O
our	O
studies,	O
cells	O
of	O
the	O
human	cell_line
monocytic	cell_line
line	cell_line
Mono	cell_line
Mac	cell_line
6	cell_line
,	O
cultured	O
in	O
medium	O
containing	O
fetal-calf	O
serum	O
and	O
low	O
levels	O
of	O
lipopolysaccharide	O
(	O
LPS	O
),	O
also	O
exhibit	O
such	O
'constitutive'	O
NF-kappa	protein
B	protein
,	O
as	O
demonstrated	O
by	O
mobility-shift	O
analysis	O
of	O
nuclear	O
extracts	O
.	O
This	O
nuclear	protein
NF-kappa	protein
B	protein
was	O
still	O
present	O
when	O
contaminant	O
LPS	O
was	O
removed	O
by	O
ultrafiltration	O
and	O
when	O
serum	O
was	O
omitted.	O
Protein-DNA	O
complexes	O
of	O
constitutive	O
NF-kappa	protein
B	protein
are	O
similar	O
in	O
mobility	O
to	O
the	O
LPS	protein
-induced	protein
NF-kappa	protein
B	protein
and	O
both	O
are	O
recognized	O
by	O
an	O
antibody	O
specific	O
to	O
the	O
p50	protein
subunit	protein
of	O
NF-kappa	protein
B	protein
.	O
By	O
contrast,	O
treatment	O
of	O
cells	O
with	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
)	O
will	O
only	O
block	O
LPS	protein
-induced	protein
NF-kappa	protein
B	protein
,	O
but	O
not	O
the	O
constitutive	protein
binding	protein
protein	protein
.	O
Using	O
LPS-free	O
and	O
serum-free	O
conditions	O
,	O
constitutive	O
NF-kappa	protein
B	protein
can	O
be	O
detected	O
in	O
different	O
cell	cell_line
lines	cell_line
of	O
the	O
monocytic	cell_type
lineage	cell_type
(	O
HL60	cell_line
,	O
U937	cell_line
,	O
THP-1	cell_line
,	O
Mono	cell_line
Mac	cell_line
1	cell_line
and	O
Mono	cell_line
Mac	cell_line
6	cell_line
),	O
but	O
not	O
in	O
Molt	cell_line
4	cell_line
T	cell_line
cells	cell_line
or	O
K562	cell_line
stem	cell_line
cells	cell_line
.	O
When	O
ordered	O
according	O
to	O
stage	O
of	O
maturation,	O
the	O
amount	O
of	O
constitutive	O
NF-kappa	protein
B	protein
was	O
not	O
increased	O
in	O
more	O
mature	cell_line
cell	cell_line
lines	cell_line
.	O
Furthermore,	O
when	O
inducing	O
differentiation	O
in	O
Mono	cell_line
Mac	cell_line
6	cell_line
cells	cell_line
,	O
with	O
vitamin	O
D3	O
,	O
no	O
change	O
in	O
constitutive	O
or	O
inducible	O
NF-kappa	protein
B	protein
can	O
be	O
detected.	O
Analysis	O
of	O
primary	O
cells	O
revealed	O
substantial	O
constitutive	O
NF-kappa	protein
B	protein
-binding	O
activity	O
in	O
blood	cell_type
monocytes	cell_type
,	O
pleural	cell_type
macrophages	cell_type
and	O
alveolar	cell_type
macrophages	cell_type
.	O
The	O
constitutive	O
NF-kappa	protein
B	protein
appears	O
to	O
be	O
functionally	O
active,	O
since	O
a	O
low	O
level	O
of	O
tumour	RNA
necrosis	RNA
factor	RNA
(TNF)	RNA
transcript	RNA
is	O
detectable	O
in	O
monocytes	cell_type
,	O
and	O
this	O
level	O
can	O
be	O
increased	O
by	O
blocking	O
transcript	O
degradation	O
using	O
cycloheximide	O
.	O
The	O
level	O
of	O
constitutive	O
NF-kappa	protein
B	protein
in	O
these	O
cells	O
is	O
variable	O
and	O
is	O
frequently	O
found	O
to	O
be	O
lower	O
in	O
the	O
more	O
mature	cell_type
macrophages	cell_type
.	O
Constitutive	O
NF-kappa	protein
B	protein
was	O
not	O
maintained	O
by	O
autocrine	O
action	O
of	O
cytokines	protein
TNF	protein
,	O
interleukin	protein
6	protein
,	O
interleukin	protein
10,	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
or	O
macrophage	protein
colony-stimulating	protein
factor	protein
,	O
since	O
neutralizing	O
antibodies	O
did	O
not	O
reduce	O
constitutive	O
DNA-binding	O
activity	O
.	O
Furthermore,	O
blockade	O
of	O
prostaglandin	O
or	O
leukotriene	O
biosynthesis	O
did	O
not	O
affect	O
constitutive	O
NF-kappa	protein
B	protein
.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
400	O
WORDS)	O

Steel	protein
factor	protein
affects	O
SCL	protein
expression	O
during	O
normal	O
erythroid	O
differentiation	O
.	O
Steel	protein
factor	protein
is	O
one	O
of	O
the	O
growth	protein
factors	protein
that	O
controls	O
the	O
proliferation	O
and	O
differentiation	O
of	O
hematopoietic	cell_type
cells	cell_type
and	O
SCL	protein
,	O
also	O
known	O
as	O
Tcl-5	protein
or	O
Tal-1	protein
,	O
is	O
a	O
transcription	protein
factor	protein
involved	O
in	O
erythropoiesis.	O
In	O
this	O
report,	O
we	O
studied	O
the	O
role	O
of	O
SCL	O
in	O
the	O
proliferation	O
of	O
human	cell_type
peripheral	cell_type
blood	cell_type
burst-forming	cell_type
unit-erythroid	cell_type
(	O
BFU-E	cell_type
)	O
and	O
the	O
effects	O
of	O
Steel	protein
factor	protein
on	O
SCL	protein
expression	O
in	O
proliferating	cell_type
erythroid	cell_type
cells	cell_type
.	O
BFU-E	cell_line
-derived	cell_line
colonies	cell_line
increase	O
progressively	O
in	O
size,	O
as	O
determined	O
by	O
cell	O
number,	O
from	O
day	O
7	O
to	O
day	O
14	O
of	O
culture,	O
with	O
the	O
greatest	O
increase	O
in	O
colony	O
size	O
(10-fold	O
expansion)	O
occurring	O
between	O
day	O
7	O
and	O
day	O
10.	O
SCL	protein
protein	protein
levels	O
in	O
BFU-E	cell_line
-derived	cell_line
cells	cell_line
were	O
highest	O
in	O
day	O
7	O
cells	O
and	O
decreased	O
progressively	O
from	O
day	O
7	O
to	O
day	O
14	O
of	O
culture,	O
suggesting	O
an	O
association	O
of	O
SCL	protein
with	O
erythroid	O
proliferation	O
.	O
In	O
contrast,	O
SCL	RNA
mRNA	RNA
levels	O
did	O
not	O
decrease	O
significantly	O
between	O
day	O
7	O
and	O
day	O
14	O
cells,	O
suggesting	O
that	O
posttranscriptional	O
mechanisms	O
are	O
largely	O
responsible	O
for	O
the	O
decrease	O
in	O
SCL	protein
protein	protein
observed.	O
The	O
role	O
of	O
SCL	protein
in	O
Steel	protein
factor	protein
-induced	O
erythroid	O
proliferation	O
was	O
then	O
examined.	O
In	O
BFU-E	cell_line
-derived	cell_line
colonies	cell_line
cultured	O
with	O
Steel	protein
factor	protein
,	O
colony	O
size	O
was	O
significantly	O
increased	O
compared	O
to	O
control.	O
In	O
day	O
7	O
and	O
day	O
10	O
erythroid	cell_type
precursors	cell_type
cultured	O
with	O
Steel	protein
factor	protein
,	O
SCL	protein
protein	protein
was	O
increased	O
significantly	O
compared	O
to	O
control.	O
The	O
increase	O
in	O
SCL	protein
protein	O
levels	O
in	O
early	O
erythroid	cell_type
precursors	cell_type
stimulated	O
with	O
Steel	protein
factor	protein
suggests	O
one	O
mechanism	O
through	O
which	O
Steel	protein
factor	protein
may	O
enhance	O
normal	O
erythroid	O
proliferation	O
.	O
SCL	RNA
mRNA	RNA
levels	O
assessed	O
by	O
Northern	O
blot	O
in	O
day	O
7	O
cells	O
did	O
not	O
increase	O
significantly	O
in	O
response	O
to	O
Steel	protein
factor	protein
stimulation,	O
suggesting	O
that	O
posttranscriptional	O
mechanisms	O
may	O
also	O
be	O
important	O
in	O
the	O
increase	O
in	O
SCL	protein
protein	protein
observed	O
in	O
response	O
to	O
Steel	protein
.	O

C/EBP	protein
beta	protein
regulation	O
of	O
the	O
tumor	DNA
necrosis	DNA
factor	DNA
alpha	DNA
gene	DNA
.	O
Activated	cell_type
macrophages	cell_type
contribute	O
to	O
chronic	O
inflammation	O
by	O
the	O
secretion	O
of	O
cytokines	protein
and	O
proteinases	protein
.	O
Tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF	protein
alpha	protein
)	O
is	O
particularly	O
important	O
in	O
this	O
process	O
because	O
of	O
its	O
ability	O
to	O
regulate	O
other	O
inflammatory	O
mediators	O
in	O
an	O
autocrine	O
and	O
paracrine	O
fashion	O
.	O
The	O
mechanism(s)	O
responsible	O
for	O
the	O
cell	O
type-specific	O
regulation	O
of	O
TNF	protein
alpha	protein
is	O
not	O
known.	O
We	O
present	O
data	O
to	O
show	O
that	O
the	O
expression	O
of	O
TNF	protein
alpha	protein
is	O
regulated	O
by	O
the	O
transcription	protein
factor	protein
C/EBP	protein
beta	protein
(	O
NF-IL6	protein
).	O
C/EBP	protein
beta	protein
activated	O
the	O
TNF	DNA
alpha	DNA
gene	DNA
promoter	DNA
in	O
cotransfection	O
assays	O
and	O
bound	O
to	O
it	O
at	O
a	O
site	O
which	O
failed	O
to	O
bind	O
the	O
closely	O
related	O
protein	O
C/EBP	protein
alpha	protein
.	O
Finally,	O
a	O
dominant-negative	O
version	O
of	O
C/EBP	protein
beta	protein
blocked	O
TNF	DNA
alpha	DNA
promoter	DNA
activation	O
in	O
myeloid	cell_type
cells	cell_type
.	O
Our	O
results	O
implicate	O
C/EBP	protein
beta	protein
as	O
an	O
important	O
regulator	O
of	O
TNF	protein
alpha	protein
by	O
myelomonocytic	cell_type
cells	cell_type
.	O

Calcium/calmodulin-dependent	protein
protein	protein
kinase	protein
II	protein
downregulates	O
both	O
calcineurin	O
and	O
protein	O
kinase	O
C	O
-mediated	O
pathways	O
for	O
cytokine	DNA
gene	DNA
transcription	O
in	O
human	cell_type
T	cell_type
cells	cell_type
.	O
Engagement	O
of	O
the	O
T	protein
cell	protein
receptor	protein
for	O
antigen	O
activates	O
phospholipase	protein
C	protein
resulting	O
in	O
an	O
increase	O
in	O
intracellular	O
free	O
calcium	O
concentration	O
(	O
[	O
Ca2+	O
]i	O
)	O
and	O
activation	O
of	O
protein	protein
kinase	protein
C	protein
(	O
PKC	protein
).	O
Increased	O
[	O
Ca2+	O
]i	O
activates	O
Ca2+	protein
/calmodulin-dependent	protein
kinases	protein
including	O
the	O
multifunctional	O
Ca2+	protein
/calmodulin-dependent	protein
protein	protein
kinase	protein
II	protein
(	O
CaM-K	protein
II	protein
),	O
as	O
well	O
as	O
calcineurin	protein
,	O
a	O
type	protein
2B	protein
protein	protein
phosphatase	protein
.	O
Recent	O
studies	O
have	O
identified	O
calcineurin	protein
as	O
a	O
key	O
enzyme	O
for	O
interleukin	O
(IL)-2	O
and	O
IL-4	O
promoter	O
activation	O
.	O
However,	O
the	O
role	O
of	O
CaM-K	protein
II	protein
remains	O
unknown.	O
We	O
have	O
used	O
mutants	O
of	O
these	O
kinases	protein
and	O
phosphatases	protein
(	O
gamma	protein
B*CaM-K	protein
and	O
delta	protein
CaM-AI	protein
,	O
respectively)	O
to	O
explore	O
their	O
relative	O
role	O
in	O
cytokine	DNA
gene	DNA
transcription	O
and	O
their	O
interactions	O
with	O
PKC	protein
-dependent	O
signaling	O
systems	O
.	O
gamma	protein
B*CaM-K	protein
and	O
delta	protein
CaM-AI	protein
,	O
known	O
to	O
exhibit	O
constitutive	O
Ca(2+)-independent	O
activity	O
,	O
were	O
cotransfected	O
(alone	O
or	O
in	O
combination)	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
with	O
a	O
plasmid	O
containing	O
the	O
intact	O
IL-2	DNA
promoter	DNA
driving	O
the	O
expression	O
of	O
the	O
chloramphenicol	DNA
acetyltransferase	DNA
reporter	DNA
gene	DNA
.	O
Cotransfection	O
of	O
gamma	protein
B*CaM-K	protein
with	O
the	O
IL-2	DNA
promoter	DNA
construct	DNA
downregulated	O
its	O
transcription	O
in	O
response	O
to	O
stimulation	O
with	O
ionomycin	O
and	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
).	O
The	O
inhibitory	O
effect	O
of	O
CaM-K	protein
II	protein
on	O
IL-2	DNA
promoter	DNA
was	O
associated	O
with	O
decreased	O
transcription	O
of	O
its	O
AP-1	O
and	O
NF-AT	O
transactivating	O
pathways	O
.	O
Under	O
the	O
same	O
conditions,	O
delta	protein
CaM-AI	protein
superinduced	O
IL-2	DNA
promoter	DNA
activity	O
(approximately	O
twofold	O
increase).	O
When	O
both	O
mutants	O
were	O
used	O
in	O
combination,	O
gamma	protein
B*CaM-K	protein
inhibited	O
the	O
induction	O
of	O
the	O
IL-2	DNA
promoter	DNA
by	O
delta	protein
CaM-AI	protein
.	O
Similar	O
results	O
were	O
obtained	O
when	O
a	O
construct	O
containing	O
the	O
IL-4	DNA
promoter	DNA
also	O
was	O
used.	O
gamma	protein
B*CaM-K	protein
also	O
downregulated	O
the	O
activation	O
of	O
AP-1	protein
in	O
response	O
to	O
transfection	O
with	O
a	O
constitutively	O
active	O
mutant	O
of	O
PKC	protein
or	O
stimulation	O
with	O
PMA	O
.	O
These	O
results	O
suggest	O
that	O
CaM-K	protein
II	protein
may	O
exert	O
negative	O
influences	O
on	O
cytokine	DNA
gene	DNA
transcription	O
in	O
human	cell_type
T	cell_type
cells	cell_type
,	O
and	O
provide	O
preliminary	O
evidence	O
for	O
negative	O
cross-talk	O
with	O
the	O
calcineurin-	O
and	O
PKC-	O
dependent	O
signaling	O
systems	O
.	O

Induction	O
of	O
ICAM-1	protein
and	O
LFA-3	protein
by	O
Tax1	protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
and	O
mechanism	O
of	O
down-regulation	O
of	O
ICAM-1	protein
or	O
LFA-1	protein
in	O
adult-T-cell-leukemia	cell_line
cell	cell_line
lines	cell_line
.	O
The	O
present	O
study	O
was	O
undertaken	O
to	O
determine	O
the	O
role	O
of	O
HTLV-I	protein
TaxI	protein
in	O
the	O
up-regulation	O
of	O
ICAM-I	protein
and	O
LFA-3	protein
in	O
human	cell_type
T	cell_type
cells	cell_type
transformed	O
with	O
HTLV-I	O
and	O
the	O
mechanism	O
of	O
down-regulation	O
of	O
ICAM-I	protein
and	O
LFA-I	protein
in	O
ATL-derived	cell_line
cell	cell_line
lines	cell_line
.	O
Induction	O
of	O
TaxI	protein
in	O
a	O
human	cell_line
T-cell	cell_line
line	cell_line
Jurkat	cell_line
carrying	O
the	O
TaxI	DNA
gene	DNA
under	O
the	O
metallothionein	DNA
promoter	DNA
led	O
to	O
increases	O
in	O
mRNA	RNA
and	O
surface	O
expression	O
of	O
ICAM-I	protein
.	O
The	O
response	O
of	O
LFA-3	protein
to	O
TaxI	protein
induction	O
was,	O
on	O
the	O
other	O
hand,	O
relatively	O
slow	O
and	O
weak,	O
and	O
might	O
be	O
indirect.	O
Transactivation	O
of	O
the	O
ICAM-I	DNA
promoter	DNA
by	O
TaxI	protein
was	O
further	O
shown	O
by	O
co-transfection	O
of	O
a	O
CAT	DNA
reporter	DNA
construct	DNA
with	O
the	O
ICAM-I	DNA
promoter	DNA
and	O
a	O
plasmid	DNA
expressing	O
TaxI	protein
.	O
The	O
mechanism	O
of	O
down-regulation	O
of	O
ICAM-I	protein
or	O
LFA-I	protein
in	O
4	cell_line
ATL	cell_line
cell	cell_line
lines	cell_line
was	O
next	O
examined.	O
ICAM-I	RNA
mRNA	RNA
was	O
quite	O
low	O
in	O
MT-I	cell_line
,	O
but	O
no	O
genomic	O
changes	O
were	O
found.	O
The	O
CAT	DNA
reporter	DNA
with	O
the	O
ICAM-I	DNA
promoter	DNA
was	O
inactive	O
in	O
MT-I	cell_line
.	O
Finally,	O
combined	O
treatment	O
of	O
MT-I	cell_line
with	O
5-azacytidine	O
and	O
IFN-gamma	protein
induced	O
re-expression	O
of	O
ICAM-I	protein
.	O
Collectively,	O
(a)	O
transcriptional	protein
factor	protein
(s)	O
necessary	O
for	O
expression	O
of	O
ICAM-I	DNA
gene	DNA
may	O
be	O
repressed	O
in	O
MT-I	cell_line
through	O
DNA	O
methylation	O
.	O
Three	O
other	O
ATL	cell_line
cell	cell_line
lines	cell_line
(	O
TL-OmI	cell_line
,	O
H582	cell_line
,	O
HuT102	cell_line
)	O
were	O
found	O
to	O
have	O
little	O
mRNA	RNA
for	O
the	O
LFA-I	protein
beta	protein
chain	protein
(	O
CD18	protein
).	O
H582	cell_line
and	O
HuT102	cell_line
were	O
also	O
negative	O
for	O
the	O
LFA-I	RNA
alpha	RNA
chain	RNA
(CDIIa)	RNA
mRNA	RNA
.	O
No	O
genomic	O
changes	O
were	O
found,	O
and	O
a	O
CAT	DNA
reporter	DNA
gene	DNA
with	O
the	O
CD18	DNA
promoter	DNA
was	O
inactive	O
in	O
the	O
3	O
of	O
them,	O
again	O
suggesting	O
lack	O
of	O
(a)	O
transcriptional	protein
factor	protein
(s)	O
necessary	O
for	O
CD18	protein
expression	O
.	O

Infection	O
with	O
Theileria	O
annulata	O
induces	O
expression	O
of	O
matrix	protein
metalloproteinase	protein
9	protein
and	O
transcription	protein
factor	protein
AP-1	protein
in	O
bovine	cell_type
leucocytes	cell_type
.	O
Theileria	O
annulata	O
infects	O
bovine	cell_type
leucocytes	cell_type
and	O
results	O
in	O
their	O
reversible	O
transformation	O
such	O
that	O
they	O
become	O
immortalised	O
and	O
metastatic.	O
The	O
present	O
study	O
describes	O
parasite-induced	O
changes	O
in	O
host	DNA
cell	DNA
gene	DNA
expression	O
which	O
have	O
a	O
direct	O
bearing	O
on	O
this	O
transformation	O
process.	O
T.	cell_type
annulata	cell_type
-infected	cell_type
leucocytes	cell_type
produce	O
a	O
number	O
of	O
novel	O
metalloproteinase	protein
activities	O
.	O
One	O
of	O
these,	O
previously	O
called	O
B1	protein
,	O
is	O
a	O
97-kDa	protein
protein	protein
which	O
is	O
secreted	O
in	O
large	O
amounts	O
and	O
has	O
been	O
purified	O
from	O
protein-free,	O
conditioned	O
medium	O
.	O
An	O
antiserum	O
to	O
this	O
enzyme	O
was	O
used	O
to	O
isolate	O
a	O
cDNA	DNA
clone	DNA
.	O
The	O
predicted	O
protein	O
sequence	O
of	O
B1	protein
is	O
81%	O
identical	O
to	O
human	O
matrix	protein
metalloproteinase	protein
9	protein
(	O
MMP9	protein
),	O
demonstrating	O
that	O
it	O
is	O
the	O
bovine	O
homologue	O
of	O
this	O
enzyme.	O
RNAase	protein
protection	O
assays	O
demonstrated	O
that	O
the	O
MMP9	protein
activity,	O
unique	O
to	O
infected	cell_type
cells	cell_type
,	O
is	O
due	O
to	O
increased	O
MMP9	protein
mRNA	O
levels	O
.	O
We	O
also	O
assayed	O
the	O
levels	O
of	O
transcription	protein
factor	protein
AP-1	protein
and	O
demonstrated	O
that	O
it	O
was	O
constitutively	O
present	O
in	O
increased	O
amounts	O
in	O
Theileria-infected	cell_type
cells	cell_type
.	O
In	O
addition	O
we	O
assayed	O
the	O
level	O
of	O
mRNA	RNA
encoding	O
c-Fos	protein
,	O
a	O
common	O
component	O
of	O
AP-1	protein
and	O
observed	O
that	O
it	O
was	O
indeed	O
up-regulated	O
in	O
infected	cell_type
cells	cell_type
.	O
Since	O
AP-1	protein
is	O
implicated	O
in	O
the	O
control	O
of	O
the	O
cell	O
cycle,	O
and	O
MMP9	protein
can	O
confer	O
metastatic	O
properties,	O
these	O
results	O
are	O
of	O
considerable	O
significance	O
with	O
respect	O
to	O
the	O
transformed	O
phenotype	O
induced	O
by	O
Theileria	O
infection	O
.	O

B-cell	cell_type
proliferation	O
and	O
induction	O
of	O
early	O
G1-regulating	protein
proteins	protein
by	O
Epstein-Barr	O
virus	O
mutants	O
conditional	O
for	O
EBNA2	protein
.	O
Infection	O
of	O
primary	cell_type
B-lymphocytes	cell_type
by	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
leads	O
to	O
growth	O
transformation	O
of	O
these	O
B-cells	cell_type
in	O
vitro.	O
EBV	O
nuclear	O
antigen	O
2	O
(	O
EBNA2	protein
),	O
one	O
of	O
the	O
first	O
genes	O
expressed	O
after	O
EBV	O
infection	O
of	O
B-cells	cell_type
,	O
is	O
a	O
transcriptional	O
activator	O
of	O
viral	DNA
and	DNA
cellular	DNA
genes	DNA
and	O
is	O
essential	O
for	O
the	O
transforming	O
potential	O
of	O
the	O
virus	O
.	O
We	O
generated	O
conditional	O
EBV	O
mutants	O
by	O
expressing	O
EBNA2	protein
as	O
chimeric	protein
fusion	protein
protein	protein
with	O
the	O
hormone	O
binding	O
domain	O
of	O
the	O
estrogen	protein
receptor	protein
on	O
the	O
genetic	O
background	O
of	O
the	O
virus.	O
Growth	O
transformation	O
of	O
primary	cell_type
normal	cell_type
B-cells	cell_type
by	O
mutant	O
virus	O
resulted	O
in	O
estrogen	cell_line
-dependent	cell_line
lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
expressing	O
the	O
chimeric	O
EBNA2	protein
protein	protein
.	O
In	O
the	O
absence	O
of	O
estrogen	O
about	O
half	O
of	O
the	O
cells	O
enter	O
a	O
quiescent	O
non-proliferative	O
state	O
whereas	O
the	O
others	O
die	O
by	O
apoptosis	O
.	O
EBNA2	protein
is	O
thus	O
required	O
not	O
only	O
for	O
initiation	O
but	O
also	O
for	O
maintenance	O
of	O
transformation.	O
Growth	O
arrest	O
occurred	O
at	O
G1	O
and	O
G2	O
stages	O
of	O
the	O
cell	O
cycle	O
,	O
indicating	O
that	O
functional	O
EBNA2	protein
is	O
required	O
at	O
different	O
restriction	O
points	O
of	O
the	O
cell	O
cycle	O
.	O
Growth	O
arrest	O
is	O
reversible	O
for	O
G1/G0	cell_type
cells	cell_type
as	O
indicated	O
by	O
the	O
sequential	O
accumulation	O
and	O
modification	O
of	O
cell	protein
cycle	protein
regulating	protein
proteins	protein
.	O
EBV	O
induces	O
the	O
same	O
cell	O
cycle	O
regulating	O
proteins	O
as	O
polyclonal	O
stimuli	O
in	O
primary	O
B-cells	cell_type
.	O
These	O
data	O
suggest	O
that	O
EBV	O
is	O
using	O
a	O
common	O
pathway	O
for	O
B-cell	O
activation	O
bypassing	O
the	O
requirement	O
for	O
antigen,	O
T-cell	O
signals	O
and	O
growth	protein
factors	protein
.	O

IL-1	protein
receptor	protein
and	O
TCR	protein
signals	O
synergize	O
to	O
activate	O
NF-kappa	protein
B	protein
-mediated	O
gene	O
transcription	O
.	O
Previous	O
studies	O
have	O
demonstrated	O
that	O
IL-1	protein
receptor	protein
(	O
IL-1R	protein
)-	O
and	O
TCR	protein
-initiated	O
signals	O
can	O
interact	O
synergistically	O
to	O
increase	O
the	O
rate	O
of	O
transcription	O
of	O
several	O
lymphokine	O
and	O
lymphokine	O
receptor	O
genes	O
during	O
the	O
competence	O
phase	O
of	O
the	O
activation	O
program	O
in	O
T	cell_type
helper	cell_type
lymphocytes	cell_type
.	O
In	O
this	O
report	O
we	O
describe	O
how	O
signals	O
initiated	O
through	O
the	O
type	protein
I	protein
IL-1R	protein
interact	O
with	O
signals	O
from	O
the	O
antigen	O
receptor	O
to	O
synergistically	O
augment	O
the	O
transactivating	O
properties	O
of	O
NF-kappa	protein
B	protein
.	O
The	O
synergistic	O
antigen	protein
receptor	protein
initiated	O
signals	O
are	O
mediated	O
through	O
protein	protein
kinase	protein
C	protein
because	O
they	O
can	O
be	O
mimicked	O
by	O
the	O
phorbol	O
ester,	O
12-O-tetradecanoylphorbol-13-acetate	O
,	O
but	O
not	O
with	O
calcium	O
ionophores;	O
and	O
are	O
staurosporine	O
sensitive	O
but	O
cyclosporine	O
resistant	O
.	O
Gel	O
shift	O
analyses	O
demonstrate	O
that	O
NF-kappa	protein
B	protein
nuclear	O
translocation	O
is	O
stimulated	O
primarily	O
by	O
IL-1	protein
rather	O
than	O
by	O
antigen	protein
receptor	protein
signals	O
.	O
Western	O
blot	O
and	O
phosphorylation	O
analyses	O
demonstrate	O
that	O
the	O
synergistic	O
effect	O
on	O
NF-kappa	protein
B	protein
functional	O
activity	O
is	O
independent	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
(	O
MAD3	protein
)-	O
NF-kappa	protein
B	protein
dissociation	O
in	O
the	O
cytosol	O
and	O
is	O
not	O
associated	O
with	O
I	protein
kappa	protein
B	protein
nuclear	O
translocation	O
.	O
The	O
IL-1	protein
-induced	O
NF-kappa	protein
B	protein
DNA	O
nuclear	O
localization	O
is	O
transient	O
and	O
can	O
be	O
prolonged	O
either	O
by	O
an	O
antigen	O
receptor-initiated	O
signal	O
or	O
by	O
inhibiting	O
protein	O
synthesis	O
.	O
These	O
results	O
suggest	O
that	O
IL-1	protein
induces	O
both	O
NF-kappa	protein
B	protein
nuclear	O
translocation	O
and	O
the	O
synthesis	O
of	O
a	O
protein(s)	O
responsible	O
for	O
terminating	O
NF-kappa	protein
B	protein
-DNA	O
interaction	O
in	O
the	O
nucleus	O
.	O
Antigen	O
receptor	O
signals	O
prolong	O
NF-kappa	protein
B	protein
-DNA	O
interaction	O
,	O
probably	O
by	O
functionally	O
antagonizing	O
the	O
IL-1	protein
-induced	O
synthesis	O
of	O
a	O
protein(s)	O
responsible	O
for	O
the	O
transient	O
NF-kappa	protein
B	protein
-DNA	O
interaction	O
and	O
consequently	O
synergistically	O
enhance	O
IL-1	protein
-induced	O
NF-kappa	protein
B	protein
-dependent	O
gene	O
transcription	O
.	O

Identification	O
of	O
the	O
promoter	DNA
region	DNA
of	O
chicken	O
anemia	O
virus	O
(	O
CAV	O
)	O
containing	O
a	O
novel	O
enhancer-like	DNA
element	DNA
.	O
The	O
single	O
promoter	DNA
region	DNA
in	O
the	O
cloned	O
genome	O
[Noteborn	O
et	O
al.,	O
J.	O
Virol.	O
65	O
(1991)	O
3131-3139]	O
of	O
chicken	O
anemia	O
virus	O
(	O
CAV	O
)	O
in	O
chicken	cell_type
T-cells	cell_type
was	O
analysed	O
via	O
CAT	protein
assays	O
.	O
A	O
unique	O
region	O
containing	O
four	O
or	O
five	O
near-perfect	O
direct	DNA
repeats	DNA
(	O
DR	DNA
)	O
of	O
21	O
bp	O
with	O
one	O
12-bp	DNA
insert	DNA
was	O
proven	O
to	O
be	O
the	O
main	O
transcription-activation	DNA
element	DNA
,	O
with	O
enhancer-like	O
characteristics	O
.	O
PCR	O
studies	O
revealed	O
that	O
CAV	O
isolates	O
from	O
across	O
the	O
world	O
all	O
contained	O
this	O
promoter	DNA
sequence	DNA
.	O
Electrophoretic	O
mobility-shift	O
assays	O
(	O
EMSA	O
)	O
showed	O
that	O
individual	DNA
DR	DNA
units	DNA
,	O
as	O
well	O
as	O
the	O
12-bp	DNA
insert	DNA
,	O
can	O
bind	O
to	O
nuclear	protein
factors	protein
of	O
chicken	cell_type
T-cells	cell_type
.	O
Competition	O
assays	O
revealed	O
that	O
the	O
DR	DNA
units	DNA
bound	O
to	O
factors	O
other	O
than	O
the	O
12-bp	DNA
insert	DNA
.	O
A	O
synthetic	O
oligodeoxyribonucleotide	O
containing	O
an	O
SP1-box	DNA
(	O
5'-GGGCGG	O
)	O
could	O
compete	O
with	O
factors	O
binding	O
to	O
the	O
12-bp	DNA
insert	DNA
.	O
Purified	O
human	protein
SP1	protein
was	O
shown	O
to	O
have	O
very	O
strong	O
affinity	O
for	O
the	O
12-bp	DNA
insert	DNA
.	O

Functional	O
Myc-Max	protein
heterodimer	protein
is	O
required	O
for	O
activation-induced	O
apoptosis	O
in	O
T	cell_line
cell	cell_line
hybridomas	cell_line
.	O
T	cell_line
cell	cell_line
hybridomas	cell_line
respond	O
to	O
activation	O
signals	O
by	O
undergoing	O
apoptotic	O
cell	O
death	O
,	O
and	O
this	O
is	O
likely	O
to	O
represent	O
comparable	O
events	O
related	O
to	O
tolerance	O
induction	O
in	O
immature	O
and	O
mature	O
T	O
cells	O
in	O
vivo.	O
Previous	O
studies	O
using	O
antisense	O
oligonucleotides	O
implicated	O
the	O
c-Myc	protein
protein	protein
in	O
the	O
phenomenon	O
of	O
activation-induced	O
apoptosis	O
.	O
This	O
role	O
for	O
c-Myc	protein
in	O
apoptosis	O
is	O
now	O
confirmed	O
in	O
studies	O
using	O
a	O
dominant	O
negative	O
form	O
of	O
its	O
heterodimeric	O
binding	O
partner,	O
Max	protein
,	O
which	O
we	O
show	O
here	O
inhibits	O
activation-induced	O
apoptosis	O
.	O
Further,	O
coexpression	O
of	O
a	O
reciprocally	protein
mutant	protein
Myc	protein
protein	protein
capable	O
of	O
forming	O
functional	O
heterodimers	protein
with	O
the	O
mutant	O
Max	protein
can	O
compensate	O
for	O
the	O
dominant	O
negative	O
activity	O
and	O
restore	O
activation-induced	O
apoptosis	O
.	O
These	O
results	O
imply	O
that	O
Myc	protein
promotes	O
activation-induced	O
apoptosis	O
by	O
obligatory	O
heterodimerization	O
with	O
Max	protein
,	O
and	O
therefore,	O
by	O
regulating	O
gene	O
transcription	O
.	O

Epstein-Barr	protein
virus	protein
SM	protein
protein	protein
.	O
The	O
protein	O
products	O
of	O
the	O
Epstein-Barr	DNA
virus	DNA
(	DNA
EBV	DNA
)	DNA
BMLF1	DNA
open	DNA
reading	DNA
frame	DNA
have	O
been	O
characterized	O
in	O
the	O
early	O
productive	O
cycle	O
in	O
B95-8	cell_line
and	O
Akata	cell_line
cells	cell_line
.	O
The	O
SM	protein
protein	protein
derived	O
from	O
the	O
spliced	O
RNA	O
joining	O
BSLF2	protein
to	O
BMLF1	protein
is	O
much	O
the	O
most	O
abundant	O
protein.	O
SM	protein
is	O
a	O
phosphoprotein	protein
in	O
EBV	O
-infected	cell_type
cells	cell_type
and	O
can	O
be	O
phosphorylated	O
in	O
vitro	O
with	O
casein	protein
kinase	protein
II	protein
(	O
CKII	protein
).	O
Computer	O
analysis	O
of	O
the	O
SM	protein
protein	protein
sequence	protein
showed	O
a	O
C	protein
terminal	protein
section	protein
of	O
SM	protein
to	O
be	O
related	O
to	O
genome	protein
positional	protein
homologues	protein
of	O
four	O
other	O
herpesviruses	O
and	O
revealed	O
consensus	protein
CKII	protein
sites	protein
near	O
the	O
N	protein
termini	protein
of	O
the	O
EBV	protein
SM	protein
protein	protein
,	O
the	O
herpes	protein
simplex	protein
virus	protein
(	protein
HSV	protein
)	protein
ICP27	protein
protein	protein
and	O
the	O
herpesvirus	protein
saimiri	protein
(	protein
HVS	protein
)	protein
open	protein
reading	protein
frame	protein
57	protein
protein	protein
.	O
Site-directed	O
mutagenesis	O
of	O
the	O
consensus	DNA
CKII	DNA
site	DNA
in	O
EBV	O
SM	O
greatly	O
reduced	O
the	O
in	O
vitro	O
phosphorylation	O
of	O
SM	protein
by	O
CKII	protein
.	O
The	O
mechanism	O
of	O
transactivation	O
by	O
BMLF1	protein
proteins	protein
has	O
been	O
controversial	O
but	O
SM	protein
was	O
shown	O
to	O
transactivate	O
gene	O
expression	O
from	O
a	O
CAT	DNA
reporter	DNA
construct	DNA
by	O
increasing	O
the	O
amount	O
of	O
cytoplasmic	RNA
CAT	RNA
mRNA	RNA
.	O
Mutagenesis	O
of	O
the	O
CKII	protein
site	O
in	O
SM	protein
made	O
no	O
difference	O
to	O
the	O
transactivation	O
in	O
this	O
transient	O
transfection	O
assay	O
.	O

Inducible	O
binding	O
to	O
the	O
c-fos	O
serum	O
response	O
element	O
during	O
T	O
cell	O
activation	O
is	O
regulated	O
by	O
a	O
phosphotyrosine-containing	protein
protein	protein
.	O
The	O
proto-oncogene	DNA
c-fos	DNA
is	O
an	O
immediate-early	DNA
gene	DNA
,	O
and	O
one	O
of	O
the	O
first	O
genes	O
transcribed	O
after	O
stimulation	O
of	O
most	O
cells	O
with	O
a	O
variety	O
of	O
ligands.	O
Fos	O
expression	O
may	O
be	O
a	O
pivotal	O
event	O
in	O
converting	O
ligand-receptor	O
interactions	O
at	O
the	O
membrane	O
into	O
functional	O
modulation	O
of	O
cell	O
phenotype	O
.	O
The	O
serum	DNA
response	DNA
element	DNA
(	O
SRE	DNA
)	O
in	O
the	O
c-fos	DNA
regulatory	DNA
region	DNA
participates	O
in	O
induction	O
of	O
transcription	O
by	O
various	O
growth	protein
factors	protein
and	O
by	O
phorbol	O
esters	O
and	O
subsequent	O
squelching	O
of	O
transcription.	O
We	O
show	O
that	O
an	O
inducible	O
protein	protein
complex	protein
(	O
Band	protein
A	protein
)	O
binds	O
to	O
SRE	DNA
DNA	DNA
within	O
10	O
min	O
after	O
mitogenic	O
stimulation	O
of	O
human	cell_line
PBL-T	cell_line
,	O
and	O
becomes	O
nondetectable	O
by	O
60	O
min.	O
Band	protein
A	protein
contains	O
the	O
serum	protein
response	protein
factor	protein
plus	O
additional	O
factor(s).	O
A	O
protein	O
that	O
is	O
phosphorylated	O
on	O
a	O
tyrosine	O
residue	O
in	O
resting	cell_line
PBL-T	cell_line
suppresses	O
binding	O
of	O
a	O
component	O
of	O
Band	protein
A	protein
to	O
the	O
SRE	DNA
motif	DNA
.	O
Upon	O
stimulation	O
of	O
the	O
cells,	O
this	O
protein	O
no	O
longer	O
prevents	O
binding	O
of	O
DNA	O
by	O
Band	protein
A	protein
,	O
and	O
suppression	O
of	O
binding	O
is	O
restored	O
within	O
30	O
min.	O
The	O
phosphorylated	O
tyrosine	O
residue	O
itself	O
is	O
important	O
for	O
the	O
protein-protein	O
interaction	O
.	O

In	O
vivo	O
modification	O
of	O
major	DNA
histocompatibility	DNA
complex	DNA
class	DNA
II	DNA
DRA	DNA
promoter	DNA
occupancy	O
mediated	O
by	O
the	O
AIR-1	protein
trans-activator	protein
.	O
RJ	cell_line
2.2.5	cell_line
is	O
a	O
human	cell_line
B	cell_line
cell	cell_line
mutant	cell_line
derived	O
from	O
the	O
Burkitt	cell_line
lymphoma	cell_line
Raji	cell_line
cell	cell_line
which	O
is	O
defective	O
in	O
the	O
AIR-1	O
locus	O
function	O
.	O
This	O
locus	O
encodes	O
a	O
transcriptional	O
trans-activator	O
required	O
for	O
the	O
constitutive	O
expression	O
of	O
major	DNA
histocompatibility	DNA
complex	DNA
(MHC)	DNA
class	DNA
II	DNA
genes	DNA
.	O
Here	O
we	O
show,	O
by	O
in	O
vivo	O
DNase	protein
I	protein
footprinting	O
,	O
that	O
the	O
AIR-1	DNA
locus	DNA
defect	DNA
correlates	O
with	O
changes	O
in	O
the	O
DRA	DNA
promoter	DNA
occupancy	O
.	O
Interestingly,	O
reexpression	O
of	O
human	DNA
MHC	DNA
class	DNA
II	DNA
genes	DNA
in	O
RJ	cell_line
2.2.5	cell_line
x	cell_line
mouse	cell_line
spleen	cell_line
cell	cell_line
hybrids	cell_line
is	O
associated	O
with	O
partial	O
reversion	O
of	O
DRA	DNA
promoter	DNA
occupancy	O
to	O
the	O
Raji	O
pattern	O
.	O
DRA	DNA
promoter	DNA
occupancy	O
in	O
other	O
class	cell_line
II-negative	cell_line
B	cell_line
cell	cell_line
lines	cell_line
,	O
derived	O
from	O
patients	O
with	O
bare	O
lymphocyte	O
syndrome	O
,	O
is	O
drastically	O
different	O
from	O
the	O
one	O
observed	O
in	O
RJ	cell_line
2.2.5	cell_line
and	O
Raji	cell_line
cells	cell_line
.	O
Moreover,	O
the	O
use	O
of	O
the	O
DNase	protein
I	protein
as	O
an	O
in	O
vivo	O
footprinting	O
agent	O
reveals	O
that	O
the	O
patients	cell_line
'	cell_line
cell	cell_line
lines	cell_line
do	O
not	O
display	O
a	O
completely	O
"	O
bare	DNA
promoter	DNA
"	O
as	O
previously	O
reported	O
using	O
dimethyl	O
sulfate	O
as	O
the	O
footprinting	O
agent	O
.	O
Thus,	O
the	O
use	O
of	O
DNase	protein
I	protein
allowed	O
us,	O
for	O
the	O
first	O
time,	O
to	O
correlate	O
the	O
AIR-1	DNA
locus	DNA
defect	DNA
with	O
class	DNA
II	DNA
promoter	DNA
occupancy	O
alterations	O
and	O
distinguish	O
these	O
alterations	O
from	O
the	O
ones	O
observed	O
in	O
phenotypically	O
similar	O
but	O
genetically	O
distinct	O
MHC	cell_line
class	cell_line
II-negative	cell_line
cells	cell_line
.	O

Regulation	O
of	O
cell-type-specific	O
interleukin-2	protein
receptor	protein
alpha-chain	protein
gene	O
expression	O
:	O
potential	O
role	O
of	O
physical	O
interactions	O
between	O
Elf-1	protein
,	O
HMG-I(Y)	protein
,	O
and	O
NF-kappa	protein
B	protein
family	protein
proteins	protein
.	O
The	O
interleukin	DNA
2	DNA
receptor	DNA
alpha-chain	DNA
(	DNA
IL-2R	DNA
alpha	DNA
)	DNA
gene	DNA
is	O
rapidly	O
and	O
potently	O
induced	O
in	O
T	cell_type
cells	cell_type
in	O
response	O
to	O
mitogenic	O
stimuli.	O
Previously,	O
an	O
inducible	DNA
enhancer	DNA
between	O
nucleotides	DNA
-299	DNA
and	DNA
-228	DNA
that	O
contains	O
NF-kappa	O
B	O
and	O
CArG	O
motifs	O
was	O
identified.	O
We	O
now	O
report	O
the	O
characterization	O
of	O
a	O
second	O
essential	DNA
positive	DNA
regulatory	DNA
element	DNA
located	O
between	O
nucleotides	DNA
-137	DNA
and	DNA
-64	DNA
that	O
binds	O
Elf-1	protein
and	O
HMG-I(Y)	protein
.	O
This	O
element	O
had	O
maximal	O
activity	O
in	O
lymphoid	cell_type
cells	cell_type
,	O
paralleling	O
the	O
cell	O
type	O
specificity	O
of	O
Elf-1	protein
expression	O
.	O
Transcription	O
from	O
the	O
IL-2R	DNA
alpha	DNA
promoter	DNA
was	O
inhibited	O
when	O
either	O
the	O
Elf-1	protein
or	O
the	O
HMG-I(Y)	protein
binding	O
site	O
was	O
mutated.	O
Coexpression	O
of	O
both	O
proteins	O
activated	O
transcription	O
of	O
the	O
-137	DNA
to	DNA
-64	DNA
element	DNA
in	O
COS-7	cell_line
cells	cell_line
.	O
Elf-1	protein
physically	O
associated	O
with	O
HMG-I	protein
and	O
with	O
NF-kappa	protein
B	protein
p50	protein
and	O
c-Rel	protein
in	O
vitro,	O
suggesting	O
that	O
protein-protein	O
interactions	O
might	O
functionally	O
coordinate	O
the	O
actions	O
of	O
the	O
upstream	O
and	O
downstream	O
positive	O
regulatory	O
elements	O
.	O
This	O
is	O
the	O
first	O
report	O
of	O
a	O
physical	O
interaction	O
between	O
an	O
Ets	O
family	O
member	O
and	O
NF-kappa	protein
B	protein
family	protein
proteins	protein
.	O
These	O
findings	O
provide	O
significant	O
new	O
insights	O
into	O
the	O
protein-protein	O
and	O
protein-DNA	O
interactions	O
that	O
regulate	O
cell-type-specific	O
and	O
inducible	O
IL-2R	protein
alpha	protein
gene	O
expression	O
and	O
also	O
have	O
implications	O
for	O
other	O
genes	O
regulated	O
by	O
Elf-1	protein
and	O
NF-kappa	protein
B	protein
family	protein
proteins	protein
.	O

Isolation	O
of	O
cDNA	DNA
clones	DNA
for	O
42	O
different	O
Kruppel-related	protein
zinc	protein
finger	protein
proteins	protein
expressed	O
in	O
the	O
human	cell_line
monoblast	cell_line
cell	cell_line
line	cell_line
U-937	cell_line
.	O
To	O
study	O
the	O
complexity	O
and	O
structural	O
characteristics	O
of	O
zinc	protein
finger	protein
proteins	protein
expressed	O
during	O
human	O
hematopoiesis	O
and	O
to	O
isolate	O
novel	O
regulators	O
of	O
blood	O
cell	O
development	O
,	O
a	O
degenerate	O
oligonucleotide	O
probe	O
specific	O
for	O
a	O
consensus	protein
zinc	protein
finger	protein
peptide	protein
domain	protein
was	O
used	O
to	O
isolate	O
63	O
cDNA	DNA
clones	DNA
for	O
Kruppel-related	DNA
zinc	DNA
finger	DNA
genes	DNA
from	O
the	O
human	cell_line
monoblast	cell_line
cell	cell_line
line	cell_line
U-937	cell_line
.	O
By	O
extensive	O
nucleotide	O
sequence	O
and	O
Northern	O
blot	O
analysis	O
,	O
these	O
cDNA	DNA
clones	DNA
were	O
found	O
to	O
originate	O
from	O
approximately	O
42	O
different	O
genes	O
(	O
HZF	DNA
1-42	DNA
)	O
of	O
which	O
only	O
8	O
have	O
previously	O
been	O
described.	O
Northern	O
blot	O
analysis	O
showed	O
that	O
a	O
majority	O
of	O
these	O
genes	O
were	O
expressed	O
at	O
comparable	O
levels	O
in	O
U-937	cell_line
and	O
HeLa	cell_line
cells	cell_line
.	O
The	O
large	O
number	O
of	O
individual	O
genes	O
represented	O
among	O
the	O
63	O
clones	O
and	O
their	O
apparent	O
non-cell-type-specific	O
expression	O
suggest	O
that	O
the	O
majority	O
of	O
the	O
Kruppel-related	DNA
zinc	DNA
finger	DNA
genes	DNA
are	O
likely	O
to	O
be	O
expressed	O
in	O
most	O
human	O
tissues	O
.	O
In	O
contrast,	O
some	O
of	O
the	O
genes	O
displayed	O
a	O
restricted	O
expression	O
pattern,	O
indicating	O
that	O
they	O
represent	O
potential	O
regulators	O
of	O
monocyte	O
differentiation	O
or	O
proliferation	O
.	O
Detailed	O
structural	O
analysis	O
of	O
the	O
first	O
12	O
cDNAs	DNA
(	O
HZF	DNA
1-10	DNA
)	O
and	O
a	O
partial	O
characterization	O
of	O
HZF	DNA
11-42	DNA
revealed	O
that	O
a	O
common	O
feature	O
of	O
human	protein
Kruppel-related	protein
zinc	protein
finger	protein
proteins	protein
is	O
the	O
presence	O
of	O
tandem	O
arrays	O
of	O
zinc	protein
fingers	protein
ranging	O
in	O
number	O
from	O
3	O
to	O
over	O
20	O
that	O
are	O
preferentially	O
located	O
in	O
the	O
carboxy-terminal	protein
regions	protein
of	O
the	O
proteins.	O
In	O
addition,	O
several	O
novel	O
KRAB-containing	DNA
zinc	DNA
finger	DNA
genes	DNA
and	O
a	O
novel	O
conserved	DNA
sequence	DNA
element	DNA
were	O
identified.	O

CAG	DNA
repeat	DNA
length	DNA
variation	DNA
in	O
sperm	cell_type
from	O
a	O
patient	O
with	O
Kennedy's	O
disease	O
.	O
Using	O
a	O
modified	O
sperm	cell_type
typing	O
protocol	O
,	O
the	O
mutation	O
frequency	O
of	O
the	O
CAG	DNA
repeat	DNA
region	DNA
at	O
the	O
androgen	DNA
receptor	DNA
locus	DNA
has	O
been	O
measured	O
using	O
a	O
rare	O
semen	O
sample	O
from	O
an	O
individual	O
with	O
spinal	O
and	O
bulbar	O
muscular	O
atrophy	O
(	O
SBMA	O
).	O
Among	O
258	O
X	cell_type
chromosome-containing	cell_type
sperm	cell_type
,	O
19%	O
had	O
a	O
repeat	O
number	O
equal	O
to	O
the	O
donor's	DNA
somatic	DNA
DNA	DNA
(47	O
repeats),	O
66%	O
were	O
expansions	O
and	O
15%	O
were	O
contractions	O
.	O
The	O
average	O
expansion	O
was	O
2.7	O
repeats.	O
More	O
than	O
half	O
of	O
the	O
expansions	O
involved	O
one	O
or	O
two	O
repeats;	O
the	O
largest	O
was	O
11	O
repeats.	O
68%	O
of	O
the	O
contractions	O
were	O
also	O
one	O
or	O
two	O
repeats	O
but	O
six	O
(16%)	O
were	O
very	O
large	O
(12-25	O
repeats).	O
One	O
contraction	O
generated	O
an	O
allele	O
in	O
an	O
intermediate	O
size	O
range	O
(33-39	O
repeats).	O
Such	O
alleles	O
have	O
not	O
been	O
observed	O
among	O
more	O
than	O
900	O
normal	O
and	O
SBMA	DNA
X-chromosomes	DNA
that	O
have	O
been	O
examined.	O
Comparison	O
of	O
the	O
SBMA	O
sperm	cell_type
typing	O
results	O
with	O
mutation	O
frequency	O
data	O
on	O
normal	O
alleles	O
supports	O
the	O
hypothesis	O
that	O
trinucleotide	DNA
repeat	DNA
expansions	O
may	O
have	O
a	O
different	O
molecular	O
origin	O
than	O
contractions	O
.	O

Aspirin-like	O
drugs	O
can	O
protect	O
human	cell_type
T	cell_type
lymphocytes	cell_type
against	O
benzoquinone	O
cytotoxicity	O
:	O
evidence	O
for	O
a	O
NAD(P)H:quinone	protein
reductase	protein
-dependent	O
mechanism	O
.	O
Benzene	O
toxicity	O
towards	O
lymphocytes	cell_type
is	O
thought	O
to	O
be	O
mediated	O
by	O
metabolites	O
of	O
benzene	O
including	O
benzoquinone	O
(	O
BQ	O
).	O
NAD(P)H:quinone	protein
reductase	protein
(	O
QR	protein
)	O
is	O
known	O
to	O
protect	O
against	O
BQ	O
toxicity	O
.	O
The	O
expression	O
of	O
the	O
QR	DNA
gene	DNA
is	O
regulated	O
by	O
the	O
transcription	protein
factor	protein
AP-1	protein
.	O
We	O
had	O
previously	O
found	O
that	O
aspirin-like	O
drugs	O
(	O
ALD	O
)	O
induce	O
AP-1	protein
in	O
human	cell_type
T	cell_type
lymphocytes	cell_type
.	O
It	O
was	O
therefore	O
hypothesized	O
that	O
ALD	O
would	O
protect	O
lymphocytes	cell_type
against	O
BQ	O
toxicity	O
by	O
inducing	O
QR	protein
.	O
Molt-4	cell_line
cells	cell_line
(	O
M4	cell_line
),	O
a	O
human	cell_line
T	cell_line
lymphocyte	cell_line
cell	cell_line
line	cell_line
,	O
were	O
incubated	O
with	O
different	O
concentrations	O
of	O
two	O
ALD	O
,	O
flurbiprofen	O
and	O
sodium	O
diclofenac	O
,	O
and	O
then	O
exposed	O
to	O
BQ	O
.	O
Toxicity	O
was	O
measured	O
by	O
viability	O
(	O
trypan	O
blue	O
exclusion	O
).	O
Both	O
drugs	O
protected	O
the	O
cells	O
against	O
BQ	O
cytotoxicity	O
in	O
a	O
dose-dependent	O
manner	O
,	O
e.g.,	O
sodium	O
diclofenac	O
at	O
15	O
microM	O
reduced	O
the	O
fraction	O
of	O
BQ	O
-treated	O
dead	O
cells	O
by	O
70%.	O
ALDs	O
induced	O
QR	protein
activity	O
in	O
the	O
M4	O
cells	O
in	O
the	O
same	O
range	O
of	O
concentrations	O
that	O
protected	O
the	O
cells	O
against	O
BQ	O
toxicity.	O
The	O
protective	O
effect	O
of	O
ALD	O
was	O
significantly	O
reduced	O
by	O
dicoumarol	O
,	O
a	O
QR	protein
-specific	O
inhibitor	O
.	O
Since	O
human	cell_type
T	cell_type
cells	cell_type
and	O
T	cell_type
cell	cell_type
lines	cell_type
do	O
not	O
metabolize	O
arachidonic	O
acid,	O
our	O
data	O
suggest	O
that	O
ALD	O
can	O
protect	O
human	cell_type
T	cell_type
lymphocytes	cell_type
against	O
a	O
metabolite	O
of	O
benzene	O
by	O
induction	O
of	O
QR	protein
activity	O
.	O

Correlation	O
of	O
differentiation-inducing	O
activity	O
of	O
retinoids	O
on	O
human	cell_line
leukemia	cell_line
cell	cell_line
lines	cell_line
HL-60	cell_line
and	O
NB4	cell_line
.	O
Retinoids	O
,	O
including	O
all-trans-retinoic	O
acid	O
,	O
its	O
isomers,	O
and	O
fifty	O
synthetic	O
retinoids	O
(retinobenzoic	O
acids),	O
were	O
tested	O
for	O
differentiation-inducing	O
activity	O
on	O
human	cell_line
leukemia	cell_line
cell	cell_line
lines	cell_line
HL-60	cell_line
and	O
NB4	cell_line
.	O
A	O
good	O
linear	O
correlation,	O
with	O
an	O
r	O
value	O
of	O
0.91,	O
between	O
the	O
ED50	O
values	O
for	O
the	O
differentiation-inducing	O
activity	O
towards	O
HL-60	cell_line
cells	cell_line
and	O
that	O
towards	O
NB4	cell_line
cells	cell_line
was	O
found.	O

Platelet-activating	protein
factor	protein
(	O
PAF	protein
)	O
positively	O
auto-regulates	O
the	O
expression	O
of	O
human	protein
PAF	protein
receptor	protein
transcript	protein
1	protein
(	O
leukocyte-type	O
)	O
through	O
NF-kappa	protein
B	protein
.	O
The	O
human	DNA
platelet-activating	DNA
factor	DNA
receptor	DNA
(	DNA
PAFR	DNA
)	DNA
gene	DNA
is	O
transcribed	O
by	O
two	O
distinct	O
promoters	DNA
(	O
promoter	DNA
1	DNA
and	O
promoter	DNA
2	DNA
)	O
to	O
generate	O
two	O
transcripts	O
(designated	O
as	O
PAFR	RNA
transcript	RNA
1	RNA
and	O
PAFR	RNA
transcript	RNA
2	RNA
),	O
though	O
their	O
open	O
reading	O
frames	O
are	O
identical.	O
By	O
primer	O
extension	O
analysis	O
to	O
discriminate	O
two	O
transcripts,	O
we	O
found	O
that	O
the	O
levels	O
of	O
PAFR	RNA
transcript	RNA
1	RNA
(	O
leukocyte-type	O
),	O
but	O
not	O
PAFR	RNA
transcript	RNA
2	RNA
(	O
tissue-type	O
),	O
are	O
upregulated	O
by	O
PAF	protein
as	O
well	O
as	O
by	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
)	O
in	O
the	O
human	cell_line
stomach	cell_line
cancer	cell_line
cell	cell_line
line	cell_line
(	O
JR-St	cell_line
cells	cell_line
)	O
which	O
expresses	O
both	O
functional	O
PAFR	RNA
transcript	RNA
1	RNA
and	O
PAFR	RNA
transcript	RNA
2	RNA
endogenously.	O
Functional	O
analysis	O
of	O
the	O
promoter	DNA
1	DNA
with	O
a	O
transient	O
expression	O
assay	O
using	O
chloramphenicol	DNA
acetyltransferase	DNA
(CAT)	DNA
gene	DNA
as	O
a	O
reporter	O
showed	O
that	O
both	O
PAF	protein
and	O
TPA	O
activated	O
the	O
promoter	DNA
1	DNA
but	O
not	O
the	O
deleted	DNA
promoter	DNA
lacking	O
the	O
three	O
consensus	DNA
binding	DNA
sites	DNA
for	O
NF-kappa	protein
B	protein
located	O
from	O
-571	O
bp	O
to	O
-459	O
bp.	O
These	O
findings	O
suggest	O
a	O
molecular	O
mechanism	O
of	O
positive	O
regulation	O
of	O
PAFR	protein
gene	O
expression	O
by	O
PAF	protein
through	O
NF-kappa	protein
B	protein
,	O
possibly	O
by	O
a	O
phosphorylation	O
reaction	O
involving	O
protein	protein
kinase	protein
C	protein
by	O
PAF	protein
.	O

One	O
gene,	O
two	O
transcripts	RNA
:	O
isolation	O
of	O
an	O
alternative	O
transcript	O
encoding	O
for	O
the	O
autoantigen	protein
La/SS-B	protein
from	O
a	O
cDNA	DNA
library	DNA
of	O
a	O
patient	O
with	O
primary	O
Sjogrens'	O
syndrome	O
.	O
A	O
cDNA	DNA
library	DNA
was	O
prepared	O
from	O
peripheral	O
blood	O
lymphocytes	cell_type
of	O
an	O
autoimmune	O
patient	O
with	O
primary	O
Sjogrens'	O
syndrome	O
.	O
The	O
cDNA	DNA
library	DNA
was	O
screened	O
with	O
the	O
patients	O
own	O
autoimmune	O
serum	O
being	O
monospecific	O
for	O
the	O
nuclear	protein
autoantigen	protein
La/SS-B	protein
.	O
Thereby	O
an	O
alternative	O
type	O
of	O
La	RNA
mRNA	RNA
was	O
identified	O
that	O
differed	O
from	O
the	O
known	O
La	RNA
mRNA	RNA
due	O
to	O
an	O
exchange	O
of	O
the	O
exon	DNA
1	DNA
.	O
Sequencing	O
of	O
the	O
genomic	O
region	O
between	O
the	O
exons	O
1	O
and	O
2	O
showed	O
that	O
the	O
alternative	DNA
5'-end	DNA
is	O
a	O
part	O
of	O
the	O
intron	DNA
.	O
In	O
addition,	O
the	O
presence	O
of	O
an	O
alternative	DNA
promoter	DNA
site	DNA
,	O
which	O
exists	O
within	O
the	O
intron	DNA
downstream	O
of	O
the	O
exon	DNA
1	DNA
,	O
became	O
evident.	O
In	O
consequence,	O
the	O
alternative	RNA
La	RNA
mRNA	RNA
is	O
the	O
result	O
of	O
a	O
promoter	O
switching	O
combined	O
with	O
an	O
alternative	O
splicing	O
mechanism	O
.	O
In	O
the	O
intron,	O
further	O
transcription	protein
factor	protein
binding	O
sites,	O
including	O
a	O
NF-kappa	DNA
B	DNA
element	DNA
,	O
were	O
identified	O
leading	O
to	O
the	O
suggestion	O
that	O
the	O
expression	O
of	O
the	O
gene	O
encoding	O
for	O
the	O
nuclear	protein
autoantigen	protein
La/SS-B	protein
alters	O
in	O
dependence	O
on	O
disease	O
conditions.	O

Cross-linking	O
CD40	protein
on	O
B	cell_type
cells	cell_type
rapidly	O
activates	O
nuclear	protein
factor-kappa	protein
B	protein
.	O
The	O
B	protein
cell-associated	protein
surface	protein
molecule	protein
CD40	protein
functions	O
to	O
regulate	O
B	O
cell	O
responses.	O
Cross-linking	O
CD40	protein
on	O
B	cell_type
cells	cell_type
can	O
lead	O
to	O
homotypic	O
cell	O
adhesion,	O
IL-6	protein
production	O
,	O
and,	O
in	O
combination	O
with	O
cytokines	protein
,	O
to	O
Ig	O
isotype	O
switching	O
.	O
Tyrosine	O
kinase	O
activity	O
is	O
increased	O
shortly	O
after	O
engagement	O
of	O
this	O
receptor.	O
Little	O
is	O
known	O
about	O
how	O
the	O
very	O
early	O
events	O
induced	O
by	O
CD40	protein
cross-linking	O
link	O
to	O
cellular	O
responses.	O
In	O
this	O
study,	O
we	O
demonstrate	O
that	O
nuclear	protein
factor	protein
(NF)-kappa	protein
B	protein
and	O
NF-kappa	protein
B-like	protein
transcription	protein
factors	protein
are	O
activated	O
after	O
cross-linking	O
CD40	protein
on	O
resting	O
human	cell_type
tonsillar	cell_type
B	cell_type
cells	cell_type
and	O
on	O
B	cell_line
cell	cell_line
lines	cell_line
.	O
The	O
activation	O
is	O
rapid	O
and	O
is	O
mediated	O
through	O
a	O
tyrosine	O
kinase-dependent	O
pathway	O
.	O
The	O
complexes	O
detected	O
in	O
electrophoretic	O
mobility	O
shift	O
assays	O
contain	O
p50	protein
,	O
p65	protein
(	O
RelA	protein
),	O
c-Rel	protein
,	O
and	O
most	O
likely	O
other	O
components.	O
By	O
using	O
transient	O
transfection	O
assays	O
,	O
we	O
found	O
that	O
cross-linking	O
CD40	protein
supports	O
NF-kappa	protein
B	protein
-dependent	O
gene	O
expression	O
.	O
Our	O
results	O
define	O
the	O
NF-kappa	protein
B	protein
system	O
as	O
an	O
intermediate	O
event	O
in	O
CD40	protein
signaling	O
and	O
suggest	O
that	O
the	O
CD40	protein
pathway	O
can	O
influence	O
the	O
expression	O
of	O
B	DNA
cell-associated	DNA
genes	DNA
with	O
NF-kappa	DNA
B	DNA
consensus	DNA
sites	DNA
.	O

Protease	O
inhibitors	O
block	O
lipopolysaccharide	O
induction	O
of	O
tissue	O
factor	O
gene	O
expression	O
in	O
human	cell_type
monocytic	cell_type
cells	cell_type
by	O
preventing	O
activation	O
of	O
c-Rel/	protein
p65	protein
heterodimers	protein
.	O
Tissue	protein
factor	protein
(	O
TF	protein
)	O
is	O
expressed	O
rapidly	O
by	O
human	cell_type
monocytes	cell_type
exposed	O
to	O
bacterial	protein
endotoxin	protein
(	O
lipopolysaccharide	O
,	O
or	O
LPS	O
).	O
Transcriptional	O
regulation	O
is	O
mediated	O
by	O
binding	O
of	O
c-Rel	protein
/p65	protein
heterodimers	protein
to	O
a	O
kappa	DNA
B-like	DNA
site	DNA
in	O
the	O
TF	DNA
promoter	DNA
.	O
Nuclear	O
translocation	O
of	O
cytosolic	protein
c-Rel/	protein
p65	protein
heterodimers	protein
and	O
other	O
members	O
of	O
the	O
NF-kappa	protein
B	protein
/Rel	protein
family	protein
requires	O
dissociation	O
and	O
proteolytic	O
degradation	O
of	O
the	O
inhibitor	protein
protein	protein
,	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
The	O
protease	O
inhibitors	O
N	O
alpha-tosylphenylalanyl	O
chloromethyl	O
ketone	O
(	O
TPCK	O
)	O
and	O
N	O
alpha-tosyl-L-lysine	O
chloromethyl	O
ketone	O
(	O
TLCK	O
)	O
block	O
activation	O
of	O
NF-kappa	protein
B	protein
/Rel	protein
proteins	protein
by	O
preventing	O
degradation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
To	O
determine	O
if	O
TPCK	O
and	O
TLCK	O
inhibited	O
LPS	O
induction	O
of	O
TF	protein
expression	O
,	O
freshly	O
isolated	O
human	cell_type
monocytes	cell_type
and	O
monocytic	cell_line
THP-1	cell_line
cells	cell_line
were	O
pretreated	O
with	O
these	O
inhibitors	O
for	O
30	O
min	O
before	O
LPS	O
stimulation	O
.	O
Both	O
TPCK	O
and	O
TLCK	O
inhibited	O
LPS	O
induction	O
of	O
TF	protein
protein	protein
,	O
TF	RNA
mRNA	RNA
and	O
TF	protein
promoter	O
activity	O
in	O
a	O
dose-dependent	O
manner	O
.	O
These	O
inhibitors	O
specifically	O
prevented	O
degradation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
and	O
nuclear	O
translocation	O
of	O
c-Rel	protein
/p65	protein
heterodimers	protein
.	O
In	O
contrast,	O
TPCK	O
and	O
TLCK	O
did	O
not	O
block	O
induction	O
of	O
an	O
immediate-early	DNA
gene	DNA
encoding	O
the	O
transcription	protein
factor	protein
,	O
Egr-1	protein
.	O
Taken	O
together,	O
these	O
data	O
indicated	O
that	O
inhibiting	O
nuclear	O
translocation	O
of	O
c-Rel	protein
/p65	protein
heterodimers	protein
prevented	O
LPS	O
induction	O
of	O
TF	protein
gene	O
transcription	O
in	O
monocytic	cell_type
cells	cell_type
.	O

1,25-Dihydroxyvitamin	protein
D3	protein
receptors	protein
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
from	O
patients	O
with	O
primary	O
and	O
secondary	O
hyperparathyroidism	O
.	O
A	O
decreased	O
number	O
of	O
calcitriol	protein
(	protein
1,25(OH)2D3	protein
)	protein
receptors	protein
has	O
been	O
observed	O
in	O
parathyroid	O
glands	O
of	O
uremic	O
animals	O
.	O
In	O
humans	O
,	O
studies	O
carried	O
out	O
in	O
surgically	O
removed	O
parathyroid	O
glands	O
have	O
shown	O
that	O
calcitriol	O
binding	O
is	O
higher	O
in	O
primary	O
than	O
in	O
secondary	O
hyperparathyroidism	O
.	O
Since	O
specific	O
receptors	O
for	O
calcitriol	O
have	O
been	O
described	O
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
),	O
we	O
have	O
investigated	O
the	O
specific	O
uptake	O
of	O
3H-labelled	O
1,25(OH)2D3	O
in	O
PBMC	cell_type
of	O
12	O
women	O
with	O
primary	O
hyperparathyroidism	O
(	O
PHP	O
),	O
8	O
women	O
with	O
hyperparathyroidism	O
secondary	O
to	O
chronic	O
renal	O
failure	O
(	O
SH	O
),	O
9	O
women	O
with	O
renal	O
transplant	O
(	O
RT	O
),	O
and	O
23	O
healthy	O
women	O
.	O
The	O
median	O
dissociation	O
constant	O
(	O
Kd	O
)	O
was	O
similar	O
in	O
all	O
three	O
groups	O
of	O
patients	O
and	O
in	O
healthy	O
women	O
(mean	O
+/-	O
S.D.	O
(range):	O
PHP	O
,	O
1.2	O
+/-	O
1.0	O
(0.2-4)	O
x	O
10(-10)	O
M;	O
SH	O
,	O
0.6	O
+/-	O
0.4	O
(0.2-1.2)	O
x	O
10(-10)	O
M;	O
RT	O
,	O
1.1	O
+/-	O
0.5	O
(0.4-1.9)	O
x	O
10(-10)	O
M;	O
controls	O
,	O
1.0	O
+/-	O
0.6	O
(0.3-2.6)	O
x	O
10(-10)	O
M).	O
However,	O
the	O
maximal	O
binding	O
capacity	O
(	O
Nmax	O
)	O
was	O
significantly	O
enhanced	O
in	O
PHP	O
(3.9	O
+/-	O
1.9	O
(1.3-7.6)	O
fmol/10(7)	O
cells	O
vs.	O
2.3	O
+/-	O
0.9	O
(1.1-4.4)	O
fmol/10(7)	O
cells	O
in	O
controls	O
;	O
P	O
=	O
0.0006)	O
and	O
decreased	O
in	O
SH	O
(0.8	O
+/-	O
0.5	O
(0.2-1.6)	O
fmol/10(7)	O
cells	O
vs.	O
2.3	O
+/-	O
0.9	O
(1.1-4.4)	O
fmol/10(7)	O
cells	O
in	O
controls	O
;	O
P	O
=	O
0.0001),	O
whereas	O
no	O
changes	O
were	O
seen	O
in	O
RT	O
(2.3	O
+/-	O
0.7	O
(1.2-3.3)	O
fmol/10(7)	O
cells	O
vs.	O
2.3	O
+/-	O
0.9	O
(1.1-4.4)	O
fmol/10(7)	O
cells	O
in	O
controls	O
).	O
In	O
three	O
patients	O
with	O
PHP	O
who	O
were	O
subjected	O
to	O
parathyroidectomy,	O
the	O
calcitriol	O
number	O
came	O
down	O
to	O
normal.	O
Changes	O
of	O
calcitriol	protein
receptors	protein
in	O
primary	O
and	O
secondary	O
hyperparathyroidism	O
could	O
magnify	O
the	O
consequences	O
of	O
disturbances	O
in	O
serum	O
concentration	O
of	O
calcitriol	O
itself	O
and	O
might	O
play	O
an	O
important	O
role	O
in	O
the	O
development	O
of	O
secondary	O
hyperparathyroidism	O
in	O
uremia	O
.	O

The	O
severe	O
phenotype	O
of	O
females	O
with	O
tiny	DNA
ring	DNA
X	DNA
chromosomes	DNA
is	O
associated	O
with	O
inability	O
of	O
these	O
chromosomes	DNA
to	O
undergo	O
X	O
inactivation	O
.	O
Mental	O
retardation	O
and	O
a	O
constellation	O
of	O
congenital	O
malformations	O
not	O
usually	O
associated	O
with	O
Turner	O
syndrome	O
are	O
seen	O
in	O
some	O
females	O
with	O
a	O
mosaic	DNA
45,X/46,X,r(X)	DNA
karyotype	DNA
.	O
Studies	O
of	O
these	O
females	O
show	O
that	O
the	O
XIST	DNA
locus	DNA
on	O
their	O
tiny	DNA
ring	DNA
X	DNA
chromosomes	DNA
is	O
either	O
not	O
present	O
or	O
not	O
expressed.	O
As	O
XIST	DNA
transcription	O
is	O
well	O
correlated	O
with	O
inactivation	O
of	O
the	O
X	DNA
chromosome	DNA
in	O
female	cell_type
somatic	cell_type
cells	cell_type
and	O
spermatogonia	cell_type
,	O
nonexpression	O
of	O
the	O
locus	O
even	O
when	O
it	O
is	O
present	O
suggests	O
that	O
these	O
chromosomes	DNA
are	O
transcriptionally	O
active	O
.	O
We	O
examined	O
the	O
transcriptional	O
activity	O
of	O
ring	O
X	DNA
chromosomes	DNA
lacking	O
XIST	DNA
expression	O
(XISTE-),	O
from	O
three	O
females	O
with	O
severe	O
phenotypes.	O
The	O
two	O
tiny	O
ring	O
X	DNA
chromosomes	DNA
studied	O
with	O
an	O
antibody	protein
specific	O
for	O
the	O
acetylated	O
isoforms	O
of	O
histone	protein
H4	protein
marking	O
transcribed	DNA
chromatin	DNA
domains	DNA
were	O
labeled	O
at	O
a	O
level	O
consistent	O
with	O
their	O
being	O
active.	O
We	O
also	O
examined	O
tow	O
of	O
the	O
XISTE-	DNA
ring	DNA
chromosomes	DNA
to	O
determine	O
whether	O
genes	DNA
that	O
are	O
normally	O
silent	O
on	O
an	O
inactive	DNA
X	DNA
are	O
expressed	O
from	O
these	O
chromosomes	DNA
.	O
Analyses	O
of	O
hybrid	cell_line
cells	cell_line
show	O
that	O
TIMP	DNA
,	O
ZXDA	DNA
,	O
and	O
ZXDB	DNA
loci	DNA
on	O
the	O
proximal	DNA
short	DNA
arm	DNA
,	O
and	O
AR	DNA
and	O
PHKA1	DNA
loci	DNA
on	O
the	O
long	O
arm,	O
are	O
well	O
expressed	O
from	O
the	O
tiny	DNA
ring	DNA
X	DNA
chromosome	DNA
lacking	O
XIST	DNA
DNA	DNA
.	O
Studies	O
of	O
the	O
ring	DNA
chromosome	DNA
that	O
has	O
XIST	DNA
DNA	DNA
but	O
does	O
not	O
transcribe	O
it	O
show	O
that	O
its	O
AR	O
allele	O
is	O
transcribed	O
along	O
with	O
the	O
one	O
on	O
the	O
normal	O
X	O
allele	O
.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS)	O

Inhibition	O
of	O
activation	O
of	O
transcription	protein
factor	protein
AP-1	protein
by	O
CD28	protein
signalling	O
in	O
human	cell_type
T-cells	cell_type
.	O
Co-stimulation	O
of	O
T-lymphocytes	cell_type
by	O
T-cell	protein
receptor	protein
(	O
TcR	protein
)	O
occupancy	O
and	O
activation	O
of	O
the	O
CD28	protein
surface	protein
molecule	protein
results	O
in	O
enhanced	O
proliferation	O
and	O
interleukin	protein
2	protein
(	O
IL-2	protein
)	O
production	O
.	O
The	O
increase	O
in	O
IL-2	protein
gene	O
expression	O
triggered	O
by	O
CD28	protein
involves	O
a	O
kappa	DNA
B-like	DNA
sequence	DNA
in	O
the	O
5'-regulatory	DNA
region	DNA
of	O
the	O
IL-2	DNA
promoter	DNA
,	O
called	O
CD28	DNA
-responsive	DNA
element	DNA
.	O
Stimulation	O
of	O
T-cells	cell_type
by	O
agonistic	O
anti-	protein
CD28	protein
antibodies	protein
in	O
conjunction	O
with	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)-	O
or	O
TcR	protein
-derived	O
signals	O
induces	O
the	O
enhanced	O
activation	O
of	O
the	O
transcription	protein
factor	protein
NF-kappa	protein
B	protein
.	O
Here	O
we	O
report	O
that	O
CD28	protein
engagement,	O
however,	O
exerts	O
opposite	O
effects	O
on	O
the	O
transcription	protein
factor	protein
AP-1	protein
.	O
Whereas	O
anti-	protein
CD28	protein
together	O
with	O
PMA	O
increased	O
the	O
DNA	O
binding	O
and	O
trans-activation	O
activity	O
of	O
NF-kappa	protein
B	protein
,	O
PMA	O
-induced	O
activation	O
of	O
AP-1	protein
was	O
significantly	O
suppressed.	O
The	O
inhibitory	O
effect	O
exerted	O
by	O
anti-	protein
CD28	protein
was	O
observed	O
at	O
the	O
level	O
of	O
DNA	O
binding	O
as	O
well	O
as	O
in	O
functional	O
reporter-gene	O
assays	O
.	O
These	O
results	O
suggest	O
that	O
the	O
two	O
transcription	protein
factors	protein
are	O
independently	O
regulated	O
and	O
may	O
perform	O
different	O
functions	O
during	O
T-cell	O
activation	O
.	O

HIV-1	protein
Nef	protein
leads	O
to	O
inhibition	O
or	O
activation	O
of	O
T	cell_type
cells	cell_type
depending	O
on	O
its	O
intracellular	O
localization	O
.	O
Nef	protein
of	O
primate	O
lentiviruses	O
is	O
required	O
for	O
viremia	O
and	O
progression	O
to	O
AIDS	O
in	O
monkeys	O
.	O
Negative,	O
positive,	O
and	O
no	O
effects	O
of	O
Nef	protein
have	O
also	O
been	O
reported	O
on	O
viral	O
replication	O
in	O
cells.	O
To	O
reconcile	O
these	O
observations,	O
we	O
expressed	O
a	O
hybrid	protein
CD8-	protein
Nef	protein
protein	protein
in	O
Jurkat	cell_line
cells	cell_line
.	O
Two	O
opposite	O
phenotypes	O
were	O
found,	O
which	O
depended	O
on	O
the	O
intracellular	O
localization	O
of	O
Nef	protein
.	O
Expressed	O
in	O
the	O
cytoplasm	O
or	O
on	O
the	O
cell	O
surface	O
,	O
the	O
chimera	protein
inhibited	O
or	O
activated	O
early	O
signaling	O
events	O
from	O
the	O
T	protein
cell	protein
antigen	protein
receptor	protein
.	O
Activated	O
Jurkat	cell_line
cells	cell_line
died	O
by	O
apoptosis	O
,	O
and	O
only	O
cells	O
with	O
mutated	O
nef	DNA
genes	DNA
expressing	O
truncated	O
Nefs	protein
survived,	O
which	O
rendered	O
Nef	protein
nonfunctional.	O
These	O
mutations	O
paralleled	O
those	O
in	O
other	O
viral	O
strains	O
passaged	O
in	O
vitro.	O
Not	O
only	O
do	O
these	O
positional	O
effects	O
of	O
Nef	protein
reconcile	O
diverse	O
phenotypes	O
of	O
Nef	protein
and	O
suggest	O
a	O
role	O
for	O
its	O
N-terminal	O
myristylation	O
,	O
but	O
they	O
also	O
explain	O
effects	O
of	O
Nef	protein
in	O
HIV	O
infection	O
and	O
progression	O
to	O
AIDS	O
.	O

An	O
intricate	O
arrangement	O
of	O
binding	O
sites	O
for	O
the	O
Ets	protein
family	protein
of	O
transcription	protein
factors	protein
regulates	O
activity	O
of	O
the	O
alpha	DNA
4	DNA
integrin	DNA
gene	DNA
promoter	DNA
.	O
alpha	protein
4	protein
integrins	protein
mediate	O
cell-cell	O
and	O
cell-extracellular	O
matrix	O
interactions	O
that	O
are	O
critical	O
for	O
maturation	O
and	O
function	O
of	O
the	O
immune	O
system	O
as	O
well	O
as	O
differentiation	O
of	O
skeletal	O
muscle	O
.	O
Here	O
we	O
examine	O
molecular	O
mechanisms	O
controlling	O
the	O
pattern	O
of	O
alpha	protein
4	protein
expression	O
.	O
The	O
activity	O
of	O
constructs	O
containing	O
5'	DNA
deletion	DNA
mutants	DNA
of	O
the	O
alpha	DNA
4	DNA
gene	DNA
promoter	DNA
was	O
compared	O
in	O
transfection	O
assays	O
into	O
cell	cell_line
lines	cell_line
that	O
express	O
alpha	protein
4	protein
and	O
cell	cell_line
lines	cell_line
that	O
do	O
not.	O
The	O
sequence	O
between	O
position	O
-42	DNA
and	DNA
-76	DNA
base	DNA
pairs	DNA
(bp)	O
was	O
required	O
for	O
efficient	O
transcription	O
in	O
cells	O
that	O
express	O
alpha	protein
4	protein
,	O
but	O
it	O
showed	O
no	O
activity	O
in	O
HeLa	cell_line
cells	cell_line
,	O
which	O
do	O
not	O
express	O
alpha	protein
4	protein
.	O
Three	O
binding	DNA
sites	DNA
for	O
the	O
Ets	protein
family	protein
of	O
transcription	protein
factors	protein
are	O
found	O
in	O
this	O
region:	O
two	O
adjacent	O
sites	O
at	O
positions	O
-50	DNA
and	DNA
-54	DNA
bp	DNA
and	O
a	O
more	O
5'	DNA
site	DNA
at	O
position	O
-67	DNA
bp	DNA
.	O
Using	O
a	O
series	O
of	O
constructs	O
containing	O
deletions	O
and	O
mutations	O
in	O
this	O
region,	O
we	O
found	O
that	O
the	O
3'-most	DNA
site	DNA
alone	O
was	O
sufficient	O
for	O
binding	O
GA-binding	protein
protein	protein
alpha	protein
(	O
GABP	protein
alpha	protein
)/	protein
GABP	protein
beta	protein
and	O
for	O
a	O
low	O
level	O
of	O
transcriptional	O
activation	O
.	O
When	O
all	O
three	O
sites	O
were	O
present,	O
a	O
second	O
complex	O
"a"	O
was	O
detected,	O
which	O
contains	O
an	O
unknown	O
member	O
of	O
the	O
Ets	protein
family	protein
.	O
Formation	O
of	O
complex	O
a	O
was	O
cell-type	O
specific	O
and	O
correlated	O
with	O
a	O
high	O
level	O
of	O
transcription.	O
Deletion	O
of	O
the	O
5'-most	DNA
Ets	DNA
site	DNA
had	O
no	O
effect	O
on	O
binding	O
to	O
GABP	protein
alpha/GABP	protein
beta	protein
,	O
but	O
it	O
eliminated	O
a.	O
Concomitant	O
with	O
this	O
loss	O
of	O
a,	O
a	O
new	protein
Ets-1-containing	protein
complex	protein
"	O
c	protein
"	O
appeared.	O
Complex	O
c	O
substituted	O
efficiently	O
for	O
complex	O
a	O
in	O
transcriptional	O
activation	O
.	O
We	O
conclude	O
that	O
although	O
neither	O
of	O
the	O
two	O
5'-most	DNA
Ets	DNA
sites	DNA
alone	O
binds	O
nuclear	protein
protein	protein
,	O
they	O
appear	O
to	O
act	O
as	O
modulators	O
which	O
control	O
the	O
pattern	O
of	O
Ets	protein
proteins	protein
that	O
bind	O
the	O
alpha	DNA
4	DNA
gene	DNA
promoter	DNA
.	O
This	O
arrangement	O
of	O
Ets	DNA
sites	DNA
,	O
coupled	O
with	O
the	O
tissue-	O
and	O
developmental-specific	O
expression	O
of	O
Ets	protein
members	protein
,	O
likely	O
play	O
a	O
key	O
role	O
in	O
defining	O
the	O
pattern	O
of	O
alpha	protein
4	protein
integrin	protein
.	O

Mechanism	O
of	O
antiandrogen	O
action	O
:	O
conformational	O
changes	O
of	O
the	O
receptor.	O
Androgen	RNA
receptor	RNA
mRNA	RNA
was	O
translated	O
in	O
vitro,	O
and	O
androgen-	O
and	O
antiandrogen-	O
bound	O
receptor	O
complexes	O
were	O
studied	O
using	O
limited	O
proteolytic	O
digestion	O
by	O
trypsin	protein
.	O
Partial	O
proteolysis	O
of	O
androgen	protein
-bound	protein
receptor	protein
protein	protein
resulted	O
in	O
a	O
29-kDa	protein
proteolysis-resisting	protein
fragment	protein
,	O
whereas	O
antiandrogen	O
binding	O
stabilised	O
a	O
35-kDa	protein
fragment	protein
.	O
Both	O
fragments	O
contain	O
the	O
entire	O
ligand	protein
binding	protein
domain	protein
,	O
and	O
the	O
35-kDa	protein
fragment	protein
extended	O
into	O
the	O
hinge	protein
region	protein
of	O
the	O
receptor.	O
Several	O
antiandrogens	O
show	O
agonistic	O
properties	O
for	O
a	O
mutated	protein
androgen	protein
receptor	protein
(	O
LNCaP	cell_line
cell	cell_line
variant	cell_line
);	O
trypsin	protein
digestion	O
of	O
antiandrogen	protein
-bound	protein
mutated	protein
receptor	protein
also	O
resulted	O
in	O
a	O
29-kDa	protein
fragment	protein
.	O
Our	O
results	O
point	O
to	O
an	O
important	O
difference	O
between	O
antiandrogens	O
and	O
antagonists	O
of	O
other	O
steroid	protein
hormone	protein
receptors	protein
.	O
Antiandrogens	O
result	O
in	O
protection	O
of	O
both	O
the	O
hinge	protein
region	protein
and	O
C-terminus	protein
of	O
the	O
androgen	protein
receptor	protein
agonist	O
proteolytic	O
attack	O
,	O
whereas	O
other	O
studies	O
showed	O
that	O
antiestrogens	O
and	O
antiprogestagens	O
expose	O
the	O
C-terminal	protein
end	protein
of	O
the	O
ligand	protein
binding	protein
domain	protein
of	O
their	O
respective	O
receptors	O
to	O
protease	protein
.	O
Differences	O
in	O
conformation	O
of	O
the	O
hinge	protein
region	protein
distinguish	O
androgen	protein
-bound	protein
from	O
antiandrogen	protein
-bound	protein
receptor	protein
complexes	protein
,	O
which	O
represents	O
an	O
important	O
feature	O
of	O
antiandrogen	O
action	O
.	O

Activation	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
in	O
human	cell_line
neuroblastoma	cell_line
cell	cell_line
lines	cell_line
.	O
The	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
is	O
a	O
eukaryotic	O
transcription	protein
factor	protein
.	O
In	O
B	cell_type
cells	cell_type
and	O
macrophages	cell_type
it	O
is	O
constitutively	O
present	O
in	O
cell	O
nuclei,	O
whereas	O
in	O
many	O
other	O
cell	O
types,	O
NF-kappa	protein
B	protein
translocates	O
from	O
cytosol	O
to	O
nucleus	O
as	O
a	O
result	O
of	O
transduction	O
by	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF	protein
alpha	protein
),	O
phorbol	O
ester	O
,	O
and	O
other	O
polyclonal	O
signals	O
.	O
Using	O
neuroblastoma	cell_line
cell	cell_line
lines	cell_line
as	O
models,	O
we	O
have	O
shown	O
that	O
in	O
neural	cell_type
cells	cell_type
NF-kappa	protein
B	protein
was	O
present	O
in	O
the	O
cytosol	O
and	O
translocated	O
into	O
nuclei	O
as	O
a	O
result	O
of	O
TNF	protein
alpha	protein
treatment	O
.	O
The	O
TNF	protein
alpha	protein
-activated	O
NF-kappa	protein
B	protein
was	O
transcriptionally	O
functional.	O
NF-kappa	protein
B	protein
activation	O
by	O
TNF	protein
alpha	protein
was	O
not	O
correlated	O
with	O
cell	O
differentiation	O
or	O
proliferation	O
.	O
However,	O
reagents	O
such	O
as	O
nerve	protein
growth	protein
factor	protein
(	O
NGF	protein
)	O
and	O
the	O
phorbol	O
ester	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
),	O
which	O
induce	O
phenotypical	O
differentiation	O
of	O
the	O
SH-SY5Y	cell_line
neuroblastoma	cell_line
cell	cell_line
line	cell_line
,	O
activated	O
NF-kappa	protein
B	protein
,	O
but	O
only	O
in	O
that	O
particular	O
cell	cell_line
line	cell_line
.	O
In	O
a	O
NGF	cell_line
-responsive	cell_line
rat	cell_line
pheochromocytoma	cell_line
cell	cell_line
line	cell_line
,	O
PC12	cell_line
,	O
PMA	O
activated	O
NF-kappa	protein
B	protein
,	O
whereas	O
NGF	protein
did	O
not.	O
In	O
other	O
neuroblastoma	cell_line
cell	cell_line
lines	cell_line
,	O
such	O
as	O
SK-N-Be(2)	cell_line
,	O
the	O
lack	O
of	O
PMA	O
induction	O
of	O
differentiation	O
was	O
correlated	O
with	O
the	O
lack	O
of	O
NF-kappa	protein
B	protein
activation	O
.	O
We	O
found,	O
moreover,	O
that	O
in	O
SK-N-Be(2)	cell_line
cells	cell_line
protein	protein
kinase	protein
C	protein
(	O
PKC	protein
)	O
enzymatic	O
activity	O
was	O
much	O
lower	O
compared	O
with	O
that	O
in	O
a	O
control	cell_line
cell	cell_line
line	cell_line
and	O
that	O
the	O
low	O
PKC	protein
enzymatic	O
activity	O
was	O
due	O
to	O
low	O
PKC	protein
protein	O
expression	O
.	O
NF-kappa	protein
B	protein
was	O
not	O
activated	O
by	O
retinoic	O
acid	O
,	O
which	O
induced	O
morphological	O
differentiation	O
of	O
all	O
the	O
neuroblastoma	cell_line
cell	cell_line
lines	cell_line
used	O
in	O
the	O
present	O
study.	O
Thus,	O
NF-kappa	protein
B	protein
activation	O
was	O
not	O
required	O
for	O
neuroblastoma	cell_type
cell	O
differentiation	O
.	O
Furthermore,	O
the	O
results	O
obtained	O
with	O
TNF	protein
alpha	protein
proved	O
that	O
NF-kappa	protein
B	protein
activation	O
was	O
not	O
sufficient	O
for	O
induction	O
of	O
neuroblastoma	cell_type
differentiation	O
.	O

ERP	protein
,	O
a	O
new	O
member	O
of	O
the	O
ets	protein
transcription	protein
factor/oncoprotein	protein
family	protein
:	O
cloning	O
,	O
characterization	O
,	O
and	O
differential	O
expression	O
during	O
B-lymphocyte	O
development	O
.	O
The	O
ets	DNA
gene	DNA
family	DNA
encodes	O
a	O
group	O
of	O
proteins	O
which	O
function	O
as	O
transcription	protein
factors	protein
under	O
physiological	O
conditions	O
and,	O
if	O
aberrantly	O
expressed,	O
can	O
cause	O
cellular	O
transformation	O
.	O
We	O
have	O
recently	O
identified	O
two	O
regulatory	O
elements	O
in	O
the	O
murine	DNA
immunoglobulin	DNA
heavy-chain	DNA
(IgH)	DNA
enhancer	DNA
,	O
pi	DNA
and	O
microB	DNA
,	O
which	O
exhibit	O
striking	O
similarity	O
to	O
binding	DNA
sites	DNA
for	O
ets-related	DNA
proteins	DNA
.	O
To	O
identify	O
ets-related	protein
transcriptional	protein
regulators	protein
expressed	O
in	O
pre-B	cell_type
lymphocytes	cell_type
that	O
may	O
interact	O
with	O
either	O
the	O
pi	DNA
or	O
the	O
microB	DNA
site	DNA
,	O
we	O
have	O
used	O
a	O
PCR	O
approach	O
with	O
degenerate	O
oligonucleotides	O
encoding	O
conserved	O
sequences	O
in	O
all	O
members	O
of	O
the	O
ets	DNA
family	DNA
.	O
We	O
have	O
cloned	O
the	O
gene	O
for	O
a	O
new	O
ets-related	protein
transcription	protein
factor	protein
,	O
ERP	protein
(	O
ets-related	protein
protein	protein
),	O
from	O
the	O
murine	cell_line
pre-B	cell_line
cell	cell_line
line	cell_line
BASC	cell_line
6C2	cell_line
and	O
from	O
mouse	O
lung	O
tissue	O
.	O
The	O
ERP	protein
protein	O
contains	O
a	O
region	O
of	O
high	O
homology	O
with	O
the	O
ETS	O
DNA-binding	O
domain	O
common	O
to	O
all	O
members	O
of	O
the	O
ets	protein
transcription	protein
factor/oncoprotein	protein
family	protein
.	O
Three	O
additional	O
smaller	O
regions	O
show	O
homology	O
to	O
the	O
ELK-1	O
and	O
SAP-1	protein
genes,	O
a	O
subgroup	O
of	O
the	O
ets	DNA
gene	DNA
family	DNA
that	O
interacts	O
with	O
the	O
serum	protein
response	protein
factor	protein
.	O
Full-length	O
ERP	protein
expresses	O
only	O
negligible	O
DNA-binding	O
activity	O
by	O
itself.	O
Removal	O
of	O
the	O
carboxy	protein
terminus	protein
enables	O
ERP	protein
to	O
interact	O
with	O
a	O
variety	O
of	O
ets-binding	DNA
sites	DNA
including	O
the	O
E74	DNA
site	DNA
,	O
the	O
IgH	DNA
enhancer	DNA
pi	DNA
site	DNA
,	O
and	O
the	O
lck	DNA
promoter	DNA
ets	DNA
site	DNA
,	O
suggesting	O
a	O
carboxy-terminal	protein
negative	protein
regulatory	protein
domain	protein
.	O
At	O
least	O
three	O
ERP	protein
-related	protein
transcripts	protein
are	O
expressed	O
in	O
a	O
variety	O
of	O
tissues.	O
However,	O
within	O
the	O
B-cell	cell_type
lineage	cell_type
,	O
ERP	protein
is	O
highly	O
expressed	O
primarily	O
at	O
early	O
stages	O
of	O
B-lymphocyte	cell_type
development	O
,	O
and	O
expression	O
declines	O
drastically	O
upon	O
B-cell	O
maturation	O
,	O
correlating	O
with	O
the	O
enhancer	O
activity	O
of	O
the	O
IgH	DNA
pi	DNA
site	DNA
.	O
These	O
data	O
suggest	O
that	O
ERP	protein
might	O
play	O
a	O
role	O
in	O
B-cell	cell_type
development	O
and	O
in	O
IgH	DNA
gene	DNA
regulation	O
.	O

Gene	O
for	O
a	O
tissue-specific	protein
transcriptional	protein
activator	protein
(	O
EBF	protein
or	O
Olf-1	protein
),	O
expressed	O
in	O
early	cell_type
B	cell_type
lymphocytes	cell_type
,	O
adipocytes	cell_type
,	O
and	O
olfactory	cell_type
neurons	cell_type
,	O
is	O
located	O
on	O
human	DNA
chromosome	DNA
5	DNA
,	O
band	DNA
q34	DNA
,	O
and	O
proximal	DNA
mouse	DNA
chromosome	DNA
11	DNA
.	O
Murine	cell_type
B	cell_type
lymphocytes	cell_type
,	O
adipocytes	cell_type
,	O
and	O
olfactory	cell_type
neurons	cell_type
contain	O
a	O
DNA-binding	protein
protein	protein
that	O
participates	O
in	O
the	O
regulation	O
of	O
genes	DNA
encoding	O
tissue-specific	O
components	O
of	O
signal	O
transduction	O
.	O
Purification	O
and	O
cloning	O
of	O
this	O
protein,	O
termed	O
early	O
B-cell	protein
factor	protein
(	O
EBF	protein
),	O
from	O
murine	cell_type
B	cell_type
lymphocytes	cell_type
and	O
independent	O
cloning	O
of	O
a	O
protein,	O
termed	O
Olf-1	protein
,	O
from	O
olfactory	cell_type
neuronal	cell_type
cells	cell_type
revealed	O
virtual	O
complete	O
amino	protein
acid	protein
sequence	protein
identity	O
between	O
these	O
proteins.	O
As	O
a	O
first	O
step	O
towards	O
identifying	O
a	O
human	O
genetic	O
disorder	O
or	O
mouse	O
mutation	O
for	O
which	O
EBF	protein
could	O
be	O
a	O
candidate	O
gene,	O
we	O
have	O
chromosomally	O
mapped	O
the	O
corresponding	O
locus	O
in	O
both	O
species.	O
By	O
Southern	O
hybridization	O
analyses	O
of	O
somatic	O
cell	O
hybrid	O
panels	O
with	O
murine	DNA
cDNA	DNA
probe	DNA
,	O
fluorescence	O
chromosomal	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
of	O
human	DNA
genomic	DNA
clones	DNA
,	O
and	O
analysis	O
of	O
recombinant	cell_line
inbred	cell_line
mouse	cell_line
strains	cell_line
,	O
we	O
have	O
found	O
single	O
sites	O
for	O
EBF	DNA
homologous	DNA
sequences	DNA
on	O
human	O
Chromosome	O
(Chr)	O
5,	O
band	DNA
q34	DNA
,	O
and	O
on	O
proximal	DNA
mouse	DNA
Chr	DNA
11	DNA
,	O
in	O
an	O
evolutionarily	DNA
conserved	DNA
region	DNA
.	O

Calcineurin	protein
activates	O
transcription	O
from	O
the	O
GM-CSF	DNA
promoter	DNA
in	O
synergy	O
with	O
either	O
protein	protein
kinase	protein
C	protein
or	O
NF-kappa	protein
B	protein
/AP-1	protein
in	O
T	cell_type
cells	cell_type
.	O
Two	O
cis-acting	DNA
elements	DNA
GM-kappa	DNA
B/GC-box	DNA
and	O
CLE0	DNA
,	O
of	O
the	O
granulocyte-macrophage	DNA
colony-stimulating	DNA
factor	DNA
(	DNA
GM-CSF	DNA
)	DNA
gene	DNA
are	O
required	O
for	O
maximal	O
induction	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
by	O
costimulation	O
with	O
phorbol-12-myristate	O
acetate	O
(	O
PMA	O
)	O
and	O
Ca2+	O
ionophore	O
(	O
A23187	O
).	O
The	O
GM-kappa	DNA
B	DNA
sequence	DNA
is	O
recognized	O
by	O
NF-kappa	protein
B	protein
,	O
which	O
is	O
mainly	O
induced	O
by	O
PMA	O
.	O
The	O
CLE0	DNA
sequence	DNA
interacts	O
with	O
factors,	O
related	O
to	O
a	O
PMA	protein
-induced	protein
AP-1	protein
and	O
a	O
PMA	protein
/	protein
A23187	protein
-induced	protein
NF-AT	protein
.	O
We	O
examined	O
whether	O
signal	O
transducing	O
components	O
in	O
T	cell_type
cells	cell_type
can	O
activate	O
transcription	O
of	O
the	O
GM-CSF	DNA
gene	DNA
.	O
Cotransfection	O
of	O
NF-kappa	O
B	O
(p50/p65)-	O
or	O
AP-1	O
(c-Jun/c-Fos)-	O
expression	O
vectors	O
into	O
Jurkat	cell_line
cells	cell_line
with	O
a	O
luciferase	DNA
reporter	DNA
containing	O
the	O
GM-CSF	DNA
promoter	DNA
did	O
not	O
stimulate	O
transcription	O
from	O
the	O
GM-CSF	DNA
promoter	DNA
.	O
In	O
contrast,	O
cotransfection	O
with	O
a	O
combination	O
of	O
NF-kappa	protein
B	protein
and	O
AP-1	protein
significantly	O
augmented	O
transcription	O
from	O
the	O
GM-CSF	DNA
promoter	DNA
containing	O
the	O
GM-kappa	DNA
B/GC-box	DNA
and	O
the	O
CLE0	DNA
(	O
AP-1	protein
/NF-AT	protein
).	O
Expression	O
of	O
a	O
constitutively	O
active	O
calcineurin	protein
(	O
CN	protein
),	O
a	O
Ca2+	protein
/calmodulin-dependent	protein
protein	protein
phosphatase	protein
,	O
potentiated	O
by	O
two	O
fold	O
the	O
transcriptional	O
activation	O
by	O
NF-kappa	protein
B	protein
/AP-1	protein
.	O
Both	O
constitutively	O
active	O
forms	O
of	O
CN	protein
and	O
protein	protein
kinase	protein
C	protein
(	O
PKC	protein
)	O
synergistically	O
activated	O
transcription	O
from	O
the	O
GM-CSF	DNA
promoter	DNA
.	O
These	O
results	O
suggest	O
that	O
cooperation	O
among	O
NF-kappa	O
B-	O
,	O
AP-1-	O
and	O
NF-AT-	O
binding	O
sequences	O
is	O
required	O
for	O
induction	O
of	O
the	O
GM-CSF	DNA
gene	DNA
through	O
PKC-	O
and	O
Ca2+-	O
signaling	O
pathways	O
downstream	O
of	O
T	O
cell	O
activation.	O

Nonpituitary	DNA
human	DNA
prolactin	DNA
gene	DNA
transcription	O
is	O
independent	O
of	O
Pit-1	protein
and	O
differentially	O
controlled	O
in	O
lymphocytes	cell_type
and	O
in	O
endometrial	O
stroma	O
.	O
Expression	O
of	O
the	O
human	DNA
PRL	DNA
(hPRL)	DNA
gene	DNA
in	O
extrapituitary	O
sites	O
such	O
as	O
the	O
uterus	O
(decidualized	O
endometrial	O
stroma	O
and	O
myometrium	O
)	O
and	O
cells	O
of	O
the	O
hematopoietic	cell_type
lineage	cell_type
is	O
directed	O
by	O
an	O
alternative	DNA
promoter	DNA
which	O
is	O
located	O
approximately	O
6	DNA
kilobases	DNA
(kb)	DNA
upstream	DNA
of	O
the	O
pituitary-specific	DNA
start	DNA
site	DNA
.	O
In	O
order	O
to	O
delineate	O
the	O
tissue-specific	O
mechanisms	O
governing	O
the	O
control	O
of	O
nonpituitary	O
PRL	DNA
gene	DNA
expression	O
,	O
we	O
have	O
cloned	O
and	O
sequenced	O
3	DNA
kb	DNA
5'-flanking	DNA
DNA	DNA
of	O
the	O
upstream	O
decidual/lymphoid	DNA
(dPRL)	DNA
promoter	DNA
.	O
Based	O
on	O
sequence	O
homology	O
we	O
identified	O
two	O
binding	DNA
motifs	DNA
for	O
Pit-1	protein
and	O
seven	O
half-sites	DNA
for	O
glucocorticoid	protein
receptor/progesterone	protein
receptor	protein
(	O
PR	protein
)	O
binding	O
.	O
We	O
focused	O
our	O
studies	O
on	O
the	O
role	O
of	O
Pit-1	protein
and	O
of	O
PR	protein
as	O
potential	O
transcriptional	protein
regulators	protein
,	O
since	O
the	O
POU	protein
domain	protein
protein	protein
Pit-1	protein
is	O
essential	O
in	O
the	O
control	O
of	O
pituitary	O
PRL	protein
expression	O
,	O
and	O
progesterone	O
induces	O
decidual	O
transformation	O
of	O
the	O
endometrial	O
stroma	O
,	O
a	O
differentiation	O
process	O
during	O
which	O
the	O
decidual	O
PRL	DNA
gene	DNA
is	O
activated.	O
We	O
demonstrate	O
in	O
a	O
variety	O
of	O
cell	O
types,	O
including	O
lymphocytes	cell_type
and	O
endometrial	O
stroma	O
,	O
that	O
Pit-1	protein
is	O
not	O
involved	O
in	O
the	O
regulation	O
of	O
dPRL	DNA
promoter/reporter	DNA
gene	DNA
constructs	DNA
carrying	O
3	DNA
kb	DNA
5'-flanking	DNA
DNA	DNA
.	O
Our	O
experiments	O
also	O
show	O
that	O
activated	O
PR	protein
does	O
not	O
confer	O
direct	O
transcriptional	O
control	O
on	O
the	O
dPRL	DNA
promoter	DNA
.	O
When	O
we	O
compared	O
the	O
activity	O
of	O
the	O
transfected	O
dPRL	DNA
promoter	DNA
in	O
PRL-	O
secreting	O
and	O
nonsecreting	O
lymphoid	O
cells	O
,	O
we	O
found	O
that	O
the	O
3	DNA
kb	DNA
5'-flanking	DNA
region	DNA
of	O
the	O
dPRL	DNA
promoter	DNA
did	O
not	O
contain	O
elements	O
restricting	O
expression	O
to	O
only	O
those	O
lymphocytes	cell_type
that	O
produce	O
PRL	O
but	O
allowed	O
expression	O
of	O
fusion	O
reporter	O
genes	O
irrespective	O
of	O
the	O
status	O
of	O
the	O
endogenous	O
PRL	DNA
gene	DNA
.	O
This	O
was	O
in	O
sharp	O
contrast	O
to	O
endometrial	O
cells	O
where	O
3	O
kb	O
5'-flanking	O
DNA	O
conferred	O
strong	O
transcriptional	O
activation	O
on	O
the	O
dPRL	DNA
promoter	DNA
in	O
decidualized	O
endometrial	cell_type
stromal	cell_type
cells	cell_type
actively	O
secreting	O
PRL	protein
,	O
but	O
did	O
not	O
allow	O
transcription	O
in	O
undifferentiated	O
non-PRL-secreting	cell_type
endometrial	cell_type
stromal	cell_type
cells	cell_type
.	O
Activation	O
of	O
the	O
dPRL	DNA
promoter	DNA
construct	O
in	O
these	O
undifferentiated	O
cells	O
could	O
however	O
be	O
induced	O
by	O
the	O
addition	O
of	O
cAMP	O
,	O
in	O
the	O
absence	O
of	O
progesterone	O
,	O
suggesting	O
that	O
a	O
signal	O
transduced	O
through	O
the	O
cAMP	O
signaling	O
pathway	O
is	O
a	O
primary	O
inducer	O
of	O
decidual	O
PRL	DNA
gene	DNA
expression	O
.	O

Signals	O
and	O
nuclear	protein
factors	protein
that	O
regulate	O
the	O
expression	O
of	O
interleukin-4	O
and	O
interleukin-5	O
genes	O
in	O
helper	cell_type
T	cell_type
cells	cell_type
.	O
Mouse	cell_line
thymoma	cell_line
line	cell_line
EL-4	cell_line
cells	cell_line
produce	O
cytokines	protein
such	O
as	O
interleukin	protein
(IL)-2	protein
,	O
IL-3	protein
,	O
IL-4	protein
,	O
IL-10	protein
,	O
and	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
in	O
response	O
to	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
).	O
EL-4	cell_line
cells	cell_line
also	O
produce	O
low	O
levels	O
of	O
IL-5	protein
when	O
stimulated	O
by	O
PMA	O
alone;	O
however,	O
cAMP	O
greatly	O
augments	O
PMA	O
-dependent	O
IL-5	protein
production	O
.	O
A	O
transient	O
transfection	O
assay	O
revealed	O
that	O
two	O
signals,	O
PMA	O
and	O
cAMP	O
,	O
are	O
required	O
for	O
optimal	O
activation	O
of	O
the	O
IL-5	DNA
promoter	DNA
.	O
In	O
contrast,	O
cAMP	O
almost	O
completely	O
inhibited	O
the	O
PMA	O
-dependent	O
activation	O
of	O
the	O
endogenous	DNA
IL-2	DNA
gene	DNA
,	O
as	O
well	O
as	O
the	O
transfected	O
IL-2	DNA
promoter	DNA
.	O
These	O
results	O
indicate	O
that	O
the	O
IL-5	DNA
gene	DNA
is	O
positively	O
regulated	O
by	O
cAMP	O
in	O
a	O
manner	O
opposite	O
to	O
that	O
for	O
the	O
IL-2	DNA
gene	DNA
.	O
One	O
of	O
the	O
nuclear	protein
factors	protein
(	O
NFs	protein
)	O
that	O
regulates	O
the	O
response	O
of	O
the	O
IL-5	DNA
promoter	DNA
to	O
cAMP	O
and	O
PMA	O
has	O
properties	O
similar	O
to	O
NF	protein
for	O
activated	cell_type
t	cell_type
cell	cell_type
.	O
The	O
P	DNA
sequence	DNA
of	O
the	O
IL-4	DNA
gene	DNA
,	O
defined	O
as	O
a	O
responsive	DNA
element	DNA
for	O
PMA	O
and	O
calcium	O
ionophore	O
(	O
A23187	O
),	O
shares	O
sequence	O
similarity	O
with	O
the	O
NF	O
kappa	O
B	O
and	O
the	O
NF-activated	O
T	O
cell	O
binding	O
sites	O
.	O
We	O
attempted	O
to	O
determine	O
whether	O
NF(P)	protein
,	O
a	O
nuclear	O
factor	O
specific	O
for	O
the	O
P	DNA
sequence	DNA
,	O
is	O
related	O
to	O
NF-kappa	protein
B	protein
and	O
nuclear	protein
factor	protein
for	protein
activated	protein
T	protein
cell	protein
(	O
NF-AT	protein
).	O
In	O
electromobility	O
shift	O
assays	O
both	O
NF-kappa	protein
B	protein
(	O
P65	protein
or	O
P65/P50	protein
heterodimer	protein
)	O
and	O
NF-AT	protein
bound	O
to	O
the	O
P	DNA
sequence	DNA
.	O
However,	O
sequence	O
specificity	O
of	O
NF-AT	protein
was	O
more	O
similar	O
to	O
that	O
of	O
NF(P)	protein
,	O
and	O
only	O
a	O
small	O
amount	O
of	O
P65	protein
was	O
detected	O
in	O
NF(P)	protein
.	O
These	O
results	O
indicate	O
that	O
a	O
component	O
or	O
components	O
of	O
NF-AT	protein
have	O
the	O
potential	O
to	O
reconstitute	O
NF(P)	protein
,	O
whereas	O
NF-kappa	protein
B	protein
alone	O
does	O
not	O
account	O
for	O
NF(P)	protein
in	O
Jurkat	O
crude	O
extract	O
.	O
Taken	O
together,	O
these	O
results	O
suggest	O
that	O
NF-AT-like	protein
factors	protein
are	O
involved	O
in	O
the	O
regulation	O
of	O
IL-4	O
and	O
IL-5	O
genes	O
.	O

Solution	O
structure	O
of	O
a	O
POU-specific	protein
homeodomain	protein
:	O
3D-NMR	O
studies	O
of	O
human	O
B-cell	protein
transcription	protein
factor	protein
Oct-2	protein
.	O
The	O
POU	protein
DNA-binding	protein
motif	protein
defines	O
a	O
conserved	O
family	O
of	O
eukaryotic	protein
transcription	protein
factors	protein
involved	O
in	O
regulation	O
of	O
gene	O
expression	O
.	O
This	O
bipartite	protein
motif	protein
consists	O
of	O
an	O
N-terminal	protein
POU-specific	protein
domain	protein
(	O
POUs	protein
),	O
a	O
flexible	protein
linker	protein
,	O
and	O
a	O
C-terminal	protein
POU-specific	protein
homeodomain	protein
(	O
POUHD	protein
).	O
Here	O
we	O
describe	O
the	O
solution	O
structure	O
of	O
a	O
POU-specific	protein
homeodomain	protein
.	O
An	O
NMR	O
model	O
is	O
obtained	O
from	O
Oct-2	protein
,	O
a	O
human	protein
B-cell	protein
specific	protein
transcription	protein
factor	protein
which	O
participates	O
in	O
the	O
regulation	O
of	O
immunoglobulin	DNA
genes	DNA
.	O
A	O
fragment	O
of	O
Oct-2	protein
containing	O
POUHD	protein
and	O
an	O
adjoining	O
linker	O
was	O
expressed	O
in	O
Escherichia	O
coli	O
and	O
characterized	O
by	O
three-dimensional	O
nuclear	O
magnetic	O
resonance	O
(	O
3D-NMR	O
)	O
spectroscopy	O
.	O
Complete	O
1H	O
and	O
15N	O
resonance	O
assignment	O
of	O
the	O
POUHD	protein
moiety	protein
is	O
presented.	O
The	O
POUHD	protein
solution	O
structure	O
,	O
as	O
calculated	O
by	O
distance	O
geometry	O
and	O
simulated	O
annealing	O
(	O
DG/SA	O
),	O
is	O
similar	O
to	O
that	O
of	O
canonical	protein
homeodomains	protein
.	O
A	O
salient	O
difference	O
between	O
solution	O
and	O
crystal	O
structures	O
is	O
observed	O
in	O
the	O
C-terminal	protein
segment	protein
of	O
alpha-helix	protein
3	protein
(the	O
HTH	protein
recognition	protein
helix	protein
),	O
which	O
is	O
not	O
well	O
ordered	O
in	O
solution.	O
Because	O
this	O
segment	O
presumably	O
folds	O
upon	O
specific	O
DNA	O
binding,	O
its	O
flexibility	O
in	O
solution	O
may	O
reduce	O
the	O
intrinsic	O
DNA	O
affinity	O
of	O
POUHD	protein
in	O
the	O
absence	O
of	O
POUs	protein
.	O

NF-kappa	O
B	O
-dependent	O
and	O
-independent	O
pathways	O
of	O
HIV	O
activation	O
in	O
a	O
chronically	cell_line
infected	cell_line
T	cell_line
cell	cell_line
line	cell_line
.	O
J	cell_line
delta	cell_line
K	cell_line
cells	cell_line
were	O
isolated	O
as	O
a	O
chronically	cell_line
infected	cell_line
survivor	cell_line
cell	cell_line
line	cell_line
,	O
following	O
infection	O
of	O
Jurkat	cell_line
CD4+	cell_line
T	cell_line
cells	cell_line
with	O
dl-NF	O
,	O
a	O
mutated	O
strain	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
containing	O
a	O
deletion	O
of	O
the	O
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
NF-kappa	protein
B	protein
sites.	O
J	cell_line
delta	cell_line
K	cell_line
cells	cell_line
exhibited	O
very	O
low	O
levels	O
of	O
constitutive	O
HIV	O
production	O
.	O
HIV-1	O
expression	O
was	O
activated	O
from	O
J	cell_line
delta	cell_line
K	cell_line
cells	cell_line
by	O
treatment	O
with	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
),	O
sodium	O
butyrate	O
(	O
NaB	O
),	O
or	O
hexamethylene	O
bisacetamide	O
(	O
HMBA	O
),	O
but	O
not	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF-alpha	protein
),	O
confirming	O
the	O
role	O
of	O
NF-kappa	protein
B	protein
in	O
mediating	O
TNF-alpha	protein
induction	O
of	O
HIV	O
transcription	O
.	O
The	O
strong	O
induction	O
of	O
HIV	O
expression	O
by	O
NaB	O
or	O
HMBA	O
in	O
J	cell_line
delta	cell_line
K	cell_line
cells	cell_line
clearly	O
demonstrates	O
the	O
existence	O
of	O
NF-kappa	protein
B	protein
-independent	O
mechanisms	O
of	O
HIV	O
activation	O
in	O
chronically	cell_type
infected	cell_type
cells	cell_type
.	O
J	cell_line
delta	cell_line
K	cell_line
cells	cell_line
may	O
provide	O
a	O
useful	O
model	O
for	O
characterizing	O
NF-kappa	protein
B	protein
-independent	O
transcriptional	O
activation	O
of	O
the	O
HIV	DNA
LTR	DNA
.	O

JNK	protein
is	O
involved	O
in	O
signal	O
integration	O
during	O
costimulation	O
of	O
T	cell_type
lymphocytes	cell_type
.	O
T	cell_type
lymphocyte	cell_type
activation	O
and	O
interleukin-2	protein
(	O
IL-2	protein
)	O
production	O
require	O
at	O
least	O
two	O
signals,	O
generated	O
by	O
phorbol	O
ester	O
(	O
TPA	O
)	O
and	O
Ca2+	O
ionophore	O
or	O
costimulation	O
of	O
the	O
T	protein
cell	protein
receptor	protein
(	O
TCR	protein
)	O
and	O
the	O
CD28	protein
auxiliary	protein
receptor	protein
.	O
We	O
investigated	O
how	O
these	O
stimuli	O
affect	O
mitogen	protein
activated	protein
protein	protein
(MAP)	protein
kinases	protein
.	O
Full	O
activation	O
of	O
the	O
MAP	protein
kinases	protein
that	O
phosphorylate	O
the	O
Jun	protein
activation	protein
domain	protein
,	O
JNK1	protein
and	O
JNK2	protein
,	O
required	O
costimulation	O
of	O
T	cell_type
cells	cell_type
with	O
either	O
TPA	O
and	O
Ca2+	O
ionophore	O
or	O
antibodies	O
to	O
TCR	protein
and	O
CD28	protein
.	O
Alone,	O
each	O
stimulus	O
resulted	O
in	O
little	O
or	O
no	O
activation.	O
Similar	O
to	O
its	O
effect	O
on	O
IL-2	protein
induction	O
,	O
cyclosporin	O
A	O
(	O
CsA	O
)	O
inhibited	O
the	O
synergistic	O
activation	O
of	O
JNK	protein
,	O
and	O
a	O
competitive	O
inhibitor	O
of	O
Jun	protein
phosphorylation	O
by	O
JNK	protein
inhibited	O
IL-2	DNA
promoter	DNA
activation	O
.	O
By	O
contrast,	O
the	O
MAP	protein
kinases	protein
ERK1	protein
and	O
ERK2	protein
were	O
fully	O
activated	O
by	O
TPA	O
or	O
TCR	protein
stimulation	O
and	O
were	O
not	O
affected	O
by	O
Ca2+	O
,	O
CD28,	O
or	O
CsA	O
.	O
Hence,	O
integration	O
of	O
signals	O
that	O
lead	O
to	O
T	O
cell	O
activation	O
occurs	O
at	O
the	O
level	O
of	O
JNK	protein
activation.	O

Inhibition	O
of	O
rat	cell_type
splenocyte	cell_type
proliferation	O
with	O
methylprednisolone	O
:	O
in	O
vivo	O
effect	O
of	O
liposomal	O
formulation	O
.	O
The	O
effect	O
of	O
a	O
liposomal	O
formulation	O
of	O
methylprednisolone	O
(	O
MPL	O
)	O
on	O
the	O
inhibition	O
of	O
lymphocyte	O
proliferation	O
in	O
spleen	cell_type
cells	cell_type
was	O
investigated	O
following	O
IV	O
dosing	O
in	O
rats	O
.	O
Liposomes	O
do	O
not	O
alter	O
the	O
suppressive	O
action	O
of	O
MPL	O
when	O
placed	O
in	O
lymphocyte	cell_line
culture	cell_line
.	O
Rat	cell_type
splenocytes	cell_type
were	O
found	O
to	O
have	O
greater	O
sensitivity	O
to	O
MPL	O
(EC50	O
=	O
7.9	O
nM)	O
than	O
do	O
human	cell_type
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
(EC50	O
=	O
28	O
nM).	O
In	O
vivo	O
studies	O
in	O
rats	O
utilized	O
2	O
mg/kg	O
IV	O
bolus	O
doses	O
of	O
liposomal	O
MPL	O
compared	O
to	O
drug	O
in	O
solution.	O
Animals	O
were	O
sacrificed	O
at	O
various	O
times	O
post-dosing	O
until	O
120	O
h,	O
spleen	O
was	O
excised	O
and,	O
after	O
incubation	O
of	O
lymphocytes	cell_type
with	O
PHA	protein
,	O
splenocyte	O
blastogenic	O
responses	O
were	O
assessed	O
by	O
measuring	O
cellular	O
incorporation	O
of	O
3H-thymidine	O
.	O
The	O
suppressive	O
effect	O
of	O
liposomal	O
MPL	O
in	O
comparison	O
with	O
free	O
drug	O
was	O
significantly	O
prolonged	O
(&gt;	O
120	O
h	O
vs	O
&lt;	O
18	O
h).	O
Inhibition	O
effects	O
versus	O
time	O
were	O
described	O
by	O
a	O
pharmacodynamic	O
model	O
using	O
MPL	O
concentrations	O
in	O
plasma	cell_type
as	O
an	O
input	O
function.	O
A	O
nonlinear	O
relationship	O
was	O
found	O
between	O
suppression	O
of	O
splenocyte	cell_type
proliferation	O
and	O
the	O
concentration	O
of	O
bound	O
glucocorticoid	protein
receptors	protein
in	O
spleen	O
.	O
Only	O
partial	O
receptor	O
occupancy	O
accompanied	O
complete	O
lymphocyte	O
suppression	O
.	O
The	O
suppression	O
of	O
endogenous	O
corticosterone	O
in	O
plasma	cell_type
for	O
both	O
treatments	O
was	O
similar	O
with	O
values	O
from	O
L-	O
MPL	O
rats	O
returning	O
to	O
baseline	O
after	O
24	O
h.	O
These	O
results	O
demonstrate	O
enhanced	O
efficacy	O
of	O
local	O
immunosuppression	O
by	O
targeting	O
spleen	O
with	O
liposomal	O
MPL	O
.	O

Function	O
of	O
NF-kappa	DNA
B	DNA
/Rel	DNA
binding	DNA
sites	DNA
in	O
the	O
major	DNA
histocompatibility	DNA
complex	DNA
class	DNA
II	DNA
invariant	DNA
chain	DNA
promoter	DNA
is	O
dependent	O
on	O
cell-specific	O
binding	O
of	O
different	O
NF-kappa	protein
B	protein
/Rel	protein
subunits	protein
.	O
The	O
promoter	DNA
of	O
the	O
human	O
major	O
histocompatibility	DNA
complex	DNA
class	DNA
II-associated	DNA
invariant-chain	DNA
gene	DNA
(	O
Ii	DNA
)	O
contains	O
two	O
NF-kappa	DNA
B	DNA
/Rel	DNA
binding	DNA
sites	DNA
located	O
at	O
-109	DNA
to	DNA
-118	DNA
(	O
Ii	DNA
kappa	DNA
B-1	DNA
)	O
and	O
-163	DNA
to	DNA
-172	DNA
(	O
Ii	DNA
kappa	DNA
B-2	DNA
)	O
from	O
the	O
transcription	O
start	O
site.	O
We	O
report	O
here	O
that	O
the	O
differential	O
function	O
of	O
each	O
of	O
these	O
NF-kappa	DNA
B	DNA
/Rel	DNA
sites	DNA
in	O
several	O
distinct	O
cell	O
types	O
depends	O
on	O
cell-specific	O
binding	O
of	O
NF-kappa	protein
B	protein
/Rel	protein
transcription	protein
factors	protein
.	O
Ii	DNA
kappa	DNA
B-1	DNA
is	O
a	O
positive	DNA
regulatory	DNA
element	DNA
in	O
B-cell	cell_line
lines	cell_line
and	O
in	O
the	O
Ii-expressing	cell_line
T-cell	cell_line
line	cell_line
,	O
H9	cell_line
,	O
but	O
acts	O
as	O
a	O
negative	DNA
regulatory	DNA
element	DNA
in	O
myelomonocytic	O
and	O
glia	O
cell	O
lines	O
.	O
In	O
vivo	O
protein-DNA	O
contacts	O
are	O
detectable	O
at	O
Ii	DNA
kappa	DNA
B-1	DNA
in	O
cell	cell_line
lines	cell_line
in	O
which	O
this	O
site	O
is	O
functional	O
as	O
either	O
a	O
positive	O
or	O
negative	O
regulator	O
.	O
Electrophoretic	O
mobility	O
supershift	O
assays	O
determine	O
that	O
members	O
of	O
the	O
NF-kappa	protein
B	protein
/Rel	protein
family	protein
of	O
transcription	protein
factors	protein
can	O
bind	O
to	O
this	O
site	O
in	O
vitro	O
and	O
that	O
DNA-binding	protein
complexes	protein
that	O
contain	O
p50	protein
,	O
p52	protein
,	O
p65	protein
,	O
and	O
cRel	protein
correlate	O
with	O
positive	O
regulation	O
whereas	O
the	O
presence	O
of	O
p50	protein
correlates	O
with	O
negative	O
regulation	O
.	O
Ii	DNA
kappa	DNA
B-2	DNA
is	O
a	O
site	O
of	O
positive	O
regulation	O
in	O
B-cell	cell_line
lines	cell_line
and	O
a	O
site	O
of	O
negative	O
regulation	O
in	O
H9	cell_line
T	cell_line
cells	cell_line
,	O
myelomonocytic	O
,	O
and	O
glial	O
cell	O
lines	O
.	O
In	O
vivo	O
occupancy	O
of	O
this	O
site	O
is	O
observed	O
only	O
in	O
the	O
H9	cell_line
T-cell	cell_line
line	cell_line
.	O
Again,	O
in	O
vitro	O
supershift	O
studies	O
indicate	O
that	O
the	O
presence	O
of	O
p50	protein
,	O
p52	protein
,	O
p65	protein
,	O
and	O
cRel	protein
correlates	O
with	O
positive	O
function	O
whereas	O
the	O
presence	O
of	O
only	O
p50	protein
and	O
p52	protein
correlates	O
with	O
negative	O
function	O
.	O
This	O
differential	O
binding	O
of	O
specific	O
NF-kappa	protein
B	protein
/Rel	protein
subunits	protein
is	O
likely	O
to	O
mediate	O
the	O
disparate	O
functions	O
of	O
these	O
two	O
NF-kappa	DNA
B	DNA
/Rel	DNA
binding	DNA
sites	DNA
.	O

Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
replicative	O
gene	O
expression	O
in	O
tumour	cell_type
cells	cell_type
of	O
AIDS-related	O
non-Hodgkin's	O
lymphoma	O
in	O
relation	O
to	O
CD4	protein
cell	O
number	O
and	O
antibody	O
titres	O
to	O
EBV	O
.	O
OBJECTIVE:	O
To	O
determine	O
whether	O
activation	O
of	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
replication	O
in	O
tumour	cell_type
cells	cell_type
of	O
AIDS-related	O
non-Hodgkin's	O
lymphoma	O
(	O
ARNHL	O
)	O
is	O
correlated	O
with	O
CD4+	protein
cell	O
counts	O
and	O
influences	O
antibody	O
response	O
to	O
EBV	O
[	O
anti-Z	protein
Epstein-Barr	protein
replicative	protein
activator	protein
(	O
ZEBRA	protein
),	O
anti-early	protein
antigen	protein
(	O
EA	protein
),	O
anti-viral	protein
capsid	protein
antigen	protein
(	O
VCA	protein
)].	O
DESIGN:	O
Retrospective	O
study	O
based	O
on	O
immunohistochemistry	O
and	O
in	O
situ	O
hybridization	O
to	O
detect	O
EBV	O
replicative	O
gene	O
products	O
in	O
tissue	O
samples	O
from	O
patients	O
affected	O
by	O
ARNHL	O
and	O
correlation	O
with	O
CD4+	protein
cell	O
counts	O
and	O
results	O
of	O
EBV	O
serology	O
(including	O
anti-	O
ZEBRA	protein
activity	O
)	O
in	O
sera	O
from	O
the	O
same	O
patients	O
.	O
METHODS:	O
Seventeen	O
out	O
of	O
22	O
cases	O
of	O
ARNHL	O
were	O
selected	O
for	O
the	O
presence	O
of	O
EBV	O
[	O
Epstein-Barr	O
early	O
region	O
(EBER)	O
RNA-positive	O
].	O
Immunohistochemistry	O
was	O
performed	O
with	O
anti-	protein
ZEBRA	protein
,	O
anti-	protein
EA	protein
-restricted,	protein
anti-	protein
VCA	protein
antibodies	protein
and	O
in	O
situ	O
hybridization	O
with	O
BHLF1/NotI	O
oligoprobes	O
on	O
tumour	O
samples	O
.	O
Results	O
were	O
statistically	O
correlated	O
with	O
those	O
of	O
CD4+	protein
cell	O
counts	O
(17	O
out	O
of	O
17)	O
and	O
with	O
anti-	O
EBV	O
antibody	O
titres	O
(13	O
out	O
of	O
17)	O
assessed	O
using	O
standard	O
immunofluorescence	O
method	O
and	O
enzyme-linked	O
immunosorbent	O
assay	O
procedure	O
using	O
recombinant	protein
ZEBRA	protein
protein	protein
and	O
synthetic	O
peptides	O
as	O
antigens	protein
.	O
RESULTS:	O
BZLF1	protein
(	O
ZEBRA	protein
)	O
or	O
early	protein
gene	protein
products	protein
(	O
EA-R	protein
and	O
EA-D/BHLF1/NotI	protein
)	O
were	O
detected	O
in	O
a	O
small	O
proportion	O
(&lt;	O
0.01-5%)	O
of	O
tumour	cell_type
cells	cell_type
in	O
eight	O
of	O
these	O
17	O
cases	O
by	O
immunohistochemistry	O
and	O
in	O
situ	O
hybridization	O
.	O
Demonstration	O
of	O
replicative	O
gene	O
expression	O
did	O
not	O
correlate	O
with	O
either	O
low	O
CD4+	protein
cell	O
counts	O
(P	O
&gt;	O
0.05)	O
or	O
anti-	O
EBV	O
antibody	O
titres	O
(P	O
&gt;	O
0.05).	O
Anti-	O
ZEBRA	protein
activity	O
was	O
not	O
significantly	O
increased	O
in	O
patients	O
affected	O
with	O
ARNHL	O
,	O
the	O
cells	O
of	O
which	O
expressed	O
replicative	O
gene	O
products	O
(P	O
&gt;	O
0.05).	O
CONCLUSION:	O
The	O
degree	O
of	O
immunodeficiency	O
does	O
not	O
clearly	O
enhance	O
replicative	O
gene	O
expression	O
in	O
tumour	cell_type
cells	cell_type
of	O
ARNHL	O
.	O
EBV	O
serology	O
,	O
including	O
anti-	O
ZEBRA	protein
activity	O
,	O
is	O
not	O
a	O
reliable	O
tool	O
for	O
predicting	O
the	O
occurrence	O
of	O
such	O
proliferations.	O

Effects	O
of	O
prostaglandin	protein
E2	protein
on	O
Th0-type	cell_line
human	cell_line
T	cell_line
cell	cell_line
clones	cell_line
:	O
modulation	O
of	O
functions	O
of	O
nuclear	protein
proteins	protein
involved	O
in	O
cytokine	protein
production	O
.	O
The	O
effects	O
of	O
prostaglandin	protein
E2	protein
(	O
PGE2	protein
)	O
on	O
cytokine	protein
production	O
and	O
proliferation	O
of	O
the	O
CD4+	cell_line
human	cell_line
helper	cell_line
T	cell_line
cell	cell_line
clone	cell_line
SP-B21	cell_line
were	O
investigated.	O
In	O
cells	O
stimulated	O
with	O
anti-CD3	protein
mAb	protein
,	O
PGE2	protein
inhibited	O
cell	O
proliferation	O
and	O
the	O
production	O
of	O
all	O
the	O
cytokines	protein
examined.	O
Addition	O
of	O
rIL-2	protein
fully	O
restored	O
the	O
proliferative	O
response	O
and	O
partially	O
restored	O
the	O
production	O
of	O
IL-4	protein
and	O
IL-5	protein
,	O
but	O
not	O
that	O
of	O
other	O
cytokines	protein
.	O
In	O
contrast,	O
in	O
cells	O
stimulated	O
with	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)/	O
A23187	O
,	O
PGE2	protein
enhanced	O
the	O
production	O
of	O
IL-4	protein
and	O
IL-5	protein
,	O
and	O
only	O
partially	O
inhibited	O
the	O
production	O
of	O
other	O
cytokines	protein
.	O
Therefore,	O
the	O
effects	O
of	O
PGE2	protein
vary	O
depending	O
on	O
the	O
mode	O
of	O
T	O
cell	O
activation	O
,	O
and	O
the	O
IL-4	protein
and	O
IL-5	protein
are	O
regulated	O
differently	O
from	O
other	O
cytokines	protein
.	O
In	O
a	O
mobility	O
shift	O
assay	O
,	O
only	O
the	O
NF-kappa	protein
B	protein
(	protein
p50	protein
/p50	protein
)	protein
homodimer	protein
was	O
observed	O
in	O
a	O
complex	O
formed	O
with	O
the	O
kappa	DNA
B	DNA
sequence	DNA
in	O
unstimulated	O
SP-B21	O
cells.	O
When	O
cells	O
were	O
stimulated	O
with	O
anti-CD3	protein
mAb	protein
or	O
PMA	O
/A23187	O
,	O
a	O
complex	O
formation	O
of	O
NF-kappa	protein
B	protein
(	O
p50	protein
/p65	protein
)	O
heterodimer	O
with	O
the	O
kappa	DNA
B	DNA
sequence	DNA
was	O
induced.	O
Interestingly,	O
PGE2	protein
or	O
di-butyryl	O
(Bt2)	O
cAMP	O
abolished	O
the	O
binding	O
of	O
NF-kappa	protein
B	protein
(	protein
p50	protein
/p65	protein
)	protein
heterodimer	protein
to	O
the	O
kappa	DNA
B	DNA
sequence	DNA
in	O
cells	O
stimulated	O
with	O
anti-CD3	protein
mAb	protein
but	O
not	O
with	O
PMA	O
/A23187	O
.	O
Our	O
results	O
suggest	O
that	O
the	O
target	O
of	O
PGE2	protein
action	O
is	O
a	O
component	O
in	O
the	O
signal	O
transduction	O
pathway	O
leading	O
to	O
the	O
activation	O
of	O
protein	protein
kinase	protein
C	protein
.	O
However,	O
the	O
inhibition	O
of	O
the	O
T	O
cell	O
activation	O
signals	O
by	O
PGE2	protein
is	O
selective.	O
PGE2	protein
enhanced	O
the	O
complex	O
formation	O
with	O
NF-AT	O
,	O
AP-1	O
and	O
CLE0	O
sequences	O
when	O
the	O
cells	O
were	O
activated	O
by	O
either	O
anti-CD3	protein
mAb	protein
or	O
PMA	O
/A23187	O
stimulation	O
.	O
It	O
seems	O
therefore	O
that	O
PGE2	protein
,	O
by	O
elevating	O
cAMP	O
levels	O
,	O
interferes	O
with	O
the	O
activation	O
pathway	O
for	O
NF-kappa	protein
B	protein
but	O
not	O
for	O
NF-AT	protein
,	O
AP-1	protein
or	O
CLE0	protein
binding	protein
protein	protein
.	O

Characterization	O
of	O
NF(P)	protein
,	O
the	O
nuclear	protein
factor	protein
that	O
interacts	O
with	O
the	O
regulatory	O
P	DNA
sequence	DNA
(	O
5'-CGAAAATTTCC-3'	O
)	O
of	O
the	O
human	DNA
interleukin-4	DNA
gene	DNA
:	O
relationship	O
to	O
NF-kappa	protein
B	protein
and	O
NF-AT	protein
.	O
The	O
P	DNA
sequence	DNA
of	O
the	O
human	DNA
interleukin-4	DNA
(	DNA
IL-4	DNA
)	DNA
gene	DNA
,	O
which	O
was	O
defined	O
as	O
a	O
responsive	DNA
element	DNA
for	O
phorbol	O
12-myristate	O
13-acetate	O
and	O
calcium	O
ionophore	O
(	O
A23187	O
)	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
,	O
shares	O
sequence	O
similarity	O
with	O
the	O
NF-kappa	DNA
B	DNA
and	DNA
the	DNA
NF-AT	DNA
binding	DNA
sites	DNA
.	O
We	O
examined	O
whether	O
NF(P)	protein
,	O
a	O
nuclear	protein
factor	protein
specific	O
for	O
the	O
P	DNA
sequence	DNA
,	O
is	O
related	O
to	O
NF-kappa	protein
B	protein
and	O
NF-AT	protein
.	O
NF-kappa	protein
B	protein
(	O
P65	protein
or	O
P65/P50	protein
heterodimer	protein
)	O
bound	O
to	O
the	O
P	DNA
sequence	DNA
in	O
electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSA	O
)	O
and	O
activated	O
transcription	O
through	O
the	O
P	DNA
sequence	DNA
when	O
expression	DNA
plasmids	DNA
were	O
cotransfected	O
with	O
P	DNA
sequence	DNA
-driven	DNA
reporter	DNA
plasmids	DNA
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
In	O
EMSAs	O
,	O
NF(P)	protein
binding	O
was	O
inhibited	O
by	O
the	O
unlabeled	DNA
NF-AT	DNA
binding	DNA
site	DNA
but	O
not	O
by	O
the	O
unlabeled	DNA
AP1	DNA
binding	DNA
site	DNA
and	O
purified	protein
NF-AT	protein
contained	O
an	O
activity	O
that	O
bound	O
to	O
the	O
P	DNA
sequence	DNA
.	O
Both	O
mobility	O
shift	O
and	O
sequence	O
specificity	O
of	O
NF-AT	protein
were	O
similar	O
to	O
those	O
of	O
NF(P)	protein
and	O
only	O
a	O
small	O
amount	O
of	O
P65	protein
was	O
detected	O
in	O
NF(P)	protein
in	O
crude	O
nuclear	O
extracts	O
.	O
These	O
results	O
indicate	O
that	O
the	O
component(s)	O
of	O
NF-AT	protein
has	O
the	O
potential	O
to	O
reconstitute	O
NF(P)	protein
whereas	O
NF-kappa	protein
B	protein
alone	O
cannot	O
account	O
for	O
NF(P)	protein
in	O
crude	O
extracts	O
.	O
Unlike	O
NF-AT	protein
,	O
NF(P)	protein
does	O
not	O
contain	O
AP1	protein
as	O
its	O
DNA	protein
binding	protein
component	protein
.	O

Activation	O
of	O
early	DNA
growth	DNA
response	DNA
1	DNA
gene	DNA
transcription	O
and	O
pp90rsk	protein
during	O
induction	O
of	O
monocytic	O
differentiation	O
.	O
The	O
present	O
work	O
has	O
studied	O
mechanisms	O
responsible	O
for	O
induction	O
of	O
early	DNA
growth	DNA
response	DNA
1	DNA
(EGR-1)	DNA
gene	DNA
expression	O
during	O
monocytic	O
differentiation	O
of	O
U-937	cell_line
myeloid	cell_line
leukemia	cell_line
cells	cell_line
.	O
Differentiation	O
of	O
U-937	cell_line
cells	cell_line
with	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
),	O
an	O
activator	O
of	O
the	O
serine/threonine	protein
protein	protein
kinase	protein
C	protein
,	O
was	O
associated	O
with	O
transcriptional	O
activation	O
of	O
EGR-1	DNA
promoter-reporter	DNA
constructs	DNA
.	O
The	O
EGR-1	DNA
promoter	DNA
contains	O
six	O
CC(A/T)6GG	DNA
(CArG)	DNA
motifs	DNA
.	O
The	O
two	O
5'-most	DNA
distal	DNA
CArG	DNA
sequences	DNA
conferred	O
TPA	O
inducibility.	O
In	O
contrast,	O
there	O
was	O
little	O
effect	O
of	O
TPA	O
on	O
EGR-1	DNA
transcription	O
in	O
a	O
TPA	cell_line
-resistant	cell_line
U-937	cell_line
cell	cell_line
variant	cell_line
,	O
designated	O
TUR	cell_line
.	O
Treatment	O
of	O
both	O
U-937	cell_line
and	O
TUR	cell_line
cells	cell_line
with	O
okadaic	O
acid	O
,	O
an	O
inhibitor	O
of	O
serine/threonine	O
protein	O
phosphatases	O
1	O
and	O
2A	O
,	O
was	O
associated	O
with	O
induction	O
of	O
monocytic	O
differentiation	O
and	O
EGR-1	DNA
transcription	O
through	O
the	O
5'-most	DNA
CArG	DNA
element	DNA
.	O
Since	O
these	O
findings	O
supported	O
the	O
involvement	O
of	O
serine	O
/threonine	O
protein	O
phosphorylation	O
in	O
the	O
regulation	O
of	O
EGR-1	DNA
expression	O
,	O
we	O
studied	O
activation	O
of	O
the	O
40S	protein
ribosomal	protein
protein	protein
S6	protein
serine	protein
/threonine	protein
kinases	protein
,	O
pp70S6K	protein
and	O
pp90rsk	protein
.	O
Although	O
both	O
kinases	O
participate	O
in	O
regulating	O
cell	O
growth	O
,	O
there	O
was	O
no	O
detectable	O
activation	O
of	O
pp70S6K	protein
during	O
TPA-	O
or	O
okadaic	O
acid-	O
induced	O
monocytic	O
differentiation	O
.	O
Moreover,	O
rapamycin,	O
an	O
inhibitor	O
of	O
pp70S6K	protein
activation	O
,	O
had	O
no	O
effect	O
on	O
induction	O
of	O
EGR-1	DNA
expression	O
.	O
In	O
contrast,	O
analysis	O
of	O
pp90rsk	protein
activity	O
by	O
phosphorylation	O
of	O
a	O
peptide	O
derived	O
from	O
S6	protein
protein	protein
demonstrated	O
stimulation	O
of	O
this	O
kinase	protein
in	O
TPA-treated	O
U-937	O
,	O
and	O
not	O
TUR	O
,	O
cells	O
.	O
Okadaic	O
acid	O
treatment	O
of	O
both	O
cell	O
types	O
was	O
associated	O
with	O
activation	O
of	O
pp90rsk	protein
.	O

Antioxidants	O
inhibit	O
monocyte	cell_type
adhesion	O
by	O
suppressing	O
nuclear	protein
factor-kappa	protein
B	protein
mobilization	O
and	O
induction	O
of	O
vascular	protein
cell	protein
adhesion	protein
molecule-1	protein
in	O
endothelial	cell_type
cells	cell_type
stimulated	O
to	O
generate	O
radicals	O
.	O
Cell	O
adhesion	O
to	O
endothelial	cell_type
cells	cell_type
stimulated	protein
by	protein
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF	protein
)	O
is	O
due	O
to	O
induction	O
of	O
surface	protein
receptors	protein
,	O
such	O
as	O
vascular	protein
cell	protein
adhesion	protein
molecule-1	protein
(	O
VCAM-1	protein
).	O
The	O
antioxidant	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
)	O
specifically	O
inhibits	O
activation	O
of	O
nuclear	protein
factor-kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
).	O
Since	O
kappa	DNA
B	DNA
motifs	DNA
are	O
present	O
in	O
VCAM-1	DNA
and	DNA
intercellular	DNA
adhesion	DNA
molecule-1	DNA
(	DNA
ICAM-1	DNA
)	DNA
promoters	DNA
,	O
we	O
used	O
PDTC	O
to	O
study	O
the	O
regulatory	O
mechanisms	O
of	O
VCAM-1	protein
and	O
ICAM-1	protein
induction	O
and	O
subsequent	O
monocyte	cell_type
adhesion	O
in	O
TNF-treated	cell_line
human	cell_line
umbilical	cell_line
vein	cell_line
endothelial	cell_line
cells	cell_line
(	O
HUVECs	cell_line
).	O
PDTC	O
or	O
N-acetylcysteine	O
dose	O
dependently	O
reduced	O
TNF-induced	protein
VCAM-1	protein
but	O
not	O
ICAM-1	protein
surface	protein
protein	protein
(also	O
in	O
human	cell_type
umbilical	cell_type
arterial	cell_type
endothelial	cell_type
cells	cell_type
)	O
and	O
mRNA	O
expression	O
(by	O
70%	O
at	O
100	O
mumol/L	O
PDTC	O
)	O
in	O
HUVECs	cell_line
as	O
assessed	O
by	O
flow	O
cytometry	O
and	O
polymerase	O
chain	O
reaction	O
.	O
Gel-shift	O
analysis	O
in	O
HUVECs	cell_line
demonstrated	O
that	O
PDTC	O
prevented	O
NF-kappa	protein
B	protein
mobilization	O
by	O
TNF	protein
,	O
suggesting	O
that	O
only	O
VCAM-1	protein
induction	O
was	O
controlled	O
by	O
NF-kappa	protein
B	protein
.	O
Since	O
HUVECs	cell_line
released	O
superoxide	O
anions	O
in	O
response	O
to	O
TNF,	O
and	O
H2O2	O
induces	O
VCAM-1	protein
,	O
PDTC	O
may	O
act	O
as	O
a	O
radical	O
scavenger	O
.	O
Although	O
ICAM-1	protein
induction	O
was	O
unaffected,	O
inhibitors	O
of	O
NADPH	protein
oxidase	protein
(	O
apocynin	O
)	O
or	O
cytochrome	protein
P-450	protein
(	O
SKF525a	O
)	O
suppressed	O
VCAM-1	protein
induction	O
by	O
TNF,	O
revealing	O
that	O
several	O
radical-generating	O
systems	O
are	O
involved	O
in	O
its	O
regulation.	O
PDTC	O
,	O
apocynin	O
,	O
or	O
SKF525a	O
decreased	O
adhesion	O
of	O
monocytic	cell_line
U937	cell_line
cells	cell_line
to	O
TNF-treated	cell_line
HUVECs	cell_line
(by	O
75%	O
at	O
100	O
mumol/L	O
PDTC	O
).	O
Inhibition	O
by	O
anti-	protein
VCAM-1	protein
monoclonal	protein
antibody	protein
1G11	protein
indicated	O
that	O
U937	cell_line
adhesion	O
was	O
VCAM-1	protein
dependent	O
and	O
suppression	O
by	O
antioxidants	O
was	O
due	O
to	O
reduced	O
VCAM-1	protein
induction	O
.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS)	O

Displacement	O
of	O
an	O
E-box-binding	protein
repressor	protein
by	O
basic	protein
helix-loop-helix	protein
proteins	protein
:	O
implications	O
for	O
B-cell	O
specificity	O
of	O
the	O
immunoglobulin	DNA
heavy-chain	DNA
enhancer	DNA
.	O
The	O
activity	O
of	O
the	O
immunoglobulin	DNA
heavy-chain	DNA
(IgH)	DNA
enhancer	DNA
is	O
restricted	O
to	O
B	cell_type
cells	cell_type
,	O
although	O
it	O
binds	O
both	O
B-cell-restricted	O
and	O
ubiquitous	O
transcription	O
factors	O
.	O
Activation	O
of	O
the	O
enhancer	DNA
in	O
non-	cell_type
B	cell_type
cells	cell_type
upon	O
overexpression	O
of	O
the	O
basic	protein
helix-loop-helix	protein
(bHLH)	protein
protein	protein
E2A	protein
appears	O
to	O
be	O
mediated	O
not	O
only	O
by	O
the	O
binding	O
of	O
E2A	protein
to	O
its	O
cognate	O
E	DNA
box	DNA
but	O
also	O
by	O
the	O
resulting	O
displacement	O
of	O
a	O
repressor	protein
from	O
that	O
same	O
site.	O
We	O
have	O
identified	O
a	O
"two-handed"	protein
zinc	protein
finger	protein
protein	protein
,	O
denoted	O
ZEB	protein
,	O
the	O
DNA-binding	O
specificity	O
of	O
which	O
mimics	O
that	O
of	O
the	O
cellular	protein
repressor	protein
.	O
By	O
employing	O
a	O
derivative	O
E	DNA
box	DNA
that	O
binds	O
ZEB	protein
but	O
not	O
E2A	protein
,	O
we	O
have	O
shown	O
that	O
the	O
repressor	protein
is	O
active	O
in	O
B	cell_type
cells	cell_type
and	O
the	O
IgH	DNA
enhancer	DNA
is	O
silenced	O
in	O
the	O
absence	O
of	O
binding	O
competition	O
by	O
bHLH	protein
proteins	protein
.	O
Hence,	O
we	O
propose	O
that	O
a	O
necessary	O
prerequisite	O
of	O
enhancer	DNA
activity	O
is	O
the	O
B-cell-specific	O
displacement	O
of	O
a	O
ZEB	protein
-like	protein
repressor	protein
by	O
bHLH	protein
proteins	protein
.	O

Inhibition	O
of	O
NF-kappa	protein
B	protein
by	O
sodium	O
salicylate	O
and	O
aspirin	O
[see	O
comments]	O
The	O
transcription	protein
factor	protein
nuclear	protein
factor-kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
is	O
critical	O
for	O
the	O
inducible	O
expression	O
of	O
multiple	O
cellular	O
and	O
viral	O
genes	O
involved	O
in	O
inflammation	O
and	O
infection	O
including	O
interleukin-1	protein
(	O
IL-1	protein
),	O
IL-6	protein
,	O
and	O
adhesion	protein
molecules	protein
.	O
The	O
anti-inflammatory	O
drugs	O
sodium	O
salicylate	O
and	O
aspirin	O
inhibited	O
the	O
activation	O
of	O
NF-kappa	protein
B	protein
,	O
which	O
further	O
explains	O
the	O
mechanism	O
of	O
action	O
of	O
these	O
drugs.	O
This	O
inhibition	O
prevented	O
the	O
degradation	O
of	O
the	O
NF-kappa	protein
B	protein
inhibitor	protein
,	O
I	protein
kappa	protein
B	protein
,	O
and	O
therefore	O
NF-kappa	protein
B	protein
was	O
retained	O
in	O
the	O
cytosol	O
.	O
Sodium	O
salicylate	O
and	O
aspirin	O
also	O
inhibited	O
NF-kappa	protein
B	protein
-dependent	O
transcription	O
from	O
the	O
Ig	DNA
kappa	DNA
enhancer	DNA
and	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
(HIV)	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
in	O
transfected	cell_line
T	cell_line
cells	cell_line
.	O

Effects	O
of	O
the	O
antisense	O
myb	O
expression	O
on	O
hemin-	O
and	O
erythropoietin-	O
induced	O
erythroid	O
differentiation	O
of	O
K562	cell_line
cells	cell_line
.	O
In	O
order	O
to	O
elucidate	O
the	O
role	O
of	O
c-myb	DNA
gene	DNA
in	O
erythroid	O
differentiation	O
of	O
K562	cell_line
cell	cell_line
induced	O
by	O
hemin	protein
(	O
Hm	protein
)	O
and	O
erythropoietin	protein
(	O
Epo	protein
),	O
we	O
constructed	O
recombinant	DNA
plasmid	DNA
that	O
could	O
produce	O
antisense	RNA
myb	RNA
RNA	RNA
after	O
induction	O
with	O
dexamethasone	O
.	O
During	O
treatment	O
with	O
Hm	protein
,	O
K562	cell_line
cells	cell_line
constitutively	O
expressed	O
c-myb	RNA
mRNA	RNA
,	O
and	O
50%	O
of	O
them	O
began	O
to	O
synthesize	O
hemoglobin	protein
(	O
Hb	protein
).	O
Expression	O
of	O
antisense	RNA
myb	RNA
RNA	RNA
reduced	O
the	O
amount	O
of	O
c-myb	RNA
mRNA	RNA
,	O
and	O
the	O
percentage	O
of	O
Hb	cell_line
-synthesizing	cell_line
cells	cell_line
was	O
decreased	O
to	O
20%.	O
In	O
the	O
presence	O
of	O
Epo	protein
,	O
c-myb	RNA
mRNA	RNA
declined	O
and	O
20%	O
of	O
K562	cell_line
cells	cell_line
synthesized	O
Hb	protein
regardless	O
of	O
antisense	RNA
myb	RNA
RNA	RNA
expression.	O
It	O
is	O
suggested	O
that	O
constitutive	O
expression	O
of	O
c-myb	RNA
mRNA	RNA
is	O
necessary	O
for	O
Hm	protein
-induced	O
differentiation	O
,	O
and	O
that	O
a	O
decrease	O
in	O
the	O
amount	O
of	O
c-myb	RNA
mRNA	RNA
induced	O
by	O
antisense	RNA
myb	RNA
RNA	RNA
expression	O
suppresses	O
Hm	protein
-induced	O
differentiation	O
.	O
The	O
amount	O
of	O
c-myb	RNA
mRNA	RNA
in	O
K562	cell_line
cells	cell_line
was	O
reduced	O
during	O
the	O
differentiation	O
induced	O
by	O
Epo	protein
.	O
Expression	O
of	O
GATA-1	RNA
mRNA	RNA
was	O
almost	O
constant	O
during	O
Hm	protein
-induced	O
differentiation	O
,	O
but	O
increased	O
during	O
Epo	protein
treatment	O
.	O
It	O
is	O
supposed	O
that	O
the	O
mechanism	O
of	O
Hm	protein
-induced	O
differentiation	O
is	O
distinguished	O
from	O
that	O
of	O
Epo	protein
-induced	O
differentiation	O
in	O
K562	cell_line
cells	cell_line
.	O

Prenatal	O
immune	O
challenge	O
alters	O
the	O
hypothalamic-pituitary-adrenocortical	O
axis	O
in	O
adult	O
rats	O
.	O
We	O
investigated	O
whether	O
non-abortive	O
maternal	O
infections	O
would	O
compromise	O
fetal	O
brain	O
development	O
and	O
alter	O
hypothalamic-pituitary-adrenocortical	O
(HPA)	O
axis	O
functioning	O
when	O
adult.	O
To	O
study	O
putative	O
teratogenic	O
effects	O
of	O
a	O
T	O
cell-mediated	O
immune	O
response	O
versus	O
an	O
endotoxic	O
challenge	O
,	O
10-d-pregnant	O
rats	O
received	O
a	O
single	O
intraperitoneal	O
injection	O
of	O
5	O
x	O
10(8)	O
human	cell_type
red	cell_type
blood	cell_type
cells	cell_type
(	O
HRBC	cell_type
)	O
or	O
gram-negative	O
bacterial	O
endotoxin	O
(	O
Escherichia	O
coli	O
LPS	O
:	O
30	O
micrograms/kg).	O
The	O
adult	O
male	O
progeny	O
(3	O
mo	O
old)	O
of	O
both	O
experimental	O
groups	O
showed	O
increased	O
basal	O
plasma	O
corticosterone	O
levels	O
.	O
In	O
addition,	O
after	O
novelty	O
stress	O
the	O
HRBC	cell_type
group,	O
but	O
not	O
the	O
LPS	cell_line
group	cell_line
,	O
showed	O
increased	O
ACTH	O
and	O
corticosterone	O
levels	O
.	O
Both	O
groups	O
showed	O
substantial	O
decreases	O
in	O
mineralocorticoid	O
(MR)	O
and	O
glucocorticoid	O
receptor	O
(GR)	O
levels	O
in	O
the	O
hippocampus	O
,	O
a	O
limbic	O
brain	O
structure	O
critical	O
for	O
HPA	O
axis	O
regulation	O
,	O
whereas	O
GR	protein
concentrations	O
in	O
the	O
hypothalamus	O
were	O
unchanged	O
and	O
in	O
anterior	O
pituitary	O
were	O
slightly	O
increased.	O
HRBC	cell_type
and	O
LPS	O
indeed	O
stimulated	O
the	O
maternal	O
immune	O
system	O
as	O
revealed	O
by	O
specific	O
anti-	protein
HRBC	protein
antibody	protein
production	O
and	O
enhanced	O
IL-1	O
beta	O
mRNA	O
expression	O
in	O
splenocytes	cell_type
,	O
respectively.	O
This	O
study	O
demonstrates	O
that	O
a	O
T	O
cell-mediated	O
immune	O
response	O
as	O
well	O
as	O
an	O
endotoxic	O
challenge	O
during	O
pregnancy	O
can	O
induce	O
anomalies	O
in	O
HPA	O
axis	O
function	O
in	O
adulthood.	O
Clinically,	O
it	O
may	O
be	O
postulated	O
that	O
disturbed	O
fetal	O
brain	O
development	O
due	O
to	O
prenatal	O
immune	O
challenge	O
increases	O
the	O
vulnerability	O
to	O
develop	O
mental	O
illness	O
involving	O
inadequate	O
responses	O
to	O
stress	O
.	O

A	O
low	O
NM23.H1	DNA
gene	DNA
expression	O
identifying	O
high	O
malignancy	O
human	O
melanomas	O
.	O
The	O
NM23	DNA
gene	DNA
has	O
been	O
proposed	O
as	O
a	O
metastasis-suppressor	DNA
gene	DNA
,	O
and	O
its	O
use	O
has	O
been	O
suggested	O
as	O
prognostic	O
factor	O
.	O
NM23	protein
was	O
identified	O
in	O
a	O
system	O
of	O
murine	cell_line
melanoma	cell_line
cell	cell_line
lines	cell_line
,	O
in	O
which	O
an	O
inverse	O
relationship	O
was	O
found	O
between	O
NM23	protein
expression	O
and	O
metastatic	O
ability	O
.	O
In	O
a	O
human	O
malignant	O
melanoma	O
study	O
NM23	protein
expression	O
was	O
found	O
to	O
be	O
significantly	O
lower	O
in	O
metastases	O
that	O
developed	O
less	O
than	O
24	O
months	O
after	O
diagnosis	O
of	O
the	O
primary	O
tumours	O
.	O
The	O
present	O
paper	O
studies	O
the	O
expression	O
of	O
the	O
NM23	DNA
.H1	DNA
gene	DNA
in	O
cell	cell_line
lines	cell_line
which	O
derive	O
from	O
primary	O
or	O
metastatic	O
human	O
malignant	O
melanomas	O
in	O
relation	O
to	O
staging,	O
infiltration	O
degree,	O
lymphocytic	O
infiltration	O
,	O
cell	O
morphology	O
,	O
cell	O
pigmentation	O
,	O
karyotype	O
,	O
and	O
disease-free	O
survival	O
.	O
The	O
level	O
of	O
mRNA	O
expression	O
of	O
the	O
NM23	DNA
gene	DNA
is	O
significantly	O
lower	O
in	O
cell	cell_line
lines	cell_line
that	O
derive	O
from	O
more	O
infiltrating	O
primary	O
melanomas	O
than	O
in	O
cell	cell_line
lines	cell_line
obtained	O
from	O
less	O
infiltrating	O
tumours	O
.	O
Moreover,	O
cell	cell_line
lines	cell_line
derived	O
from	O
tumours	O
of	O
patients	O
with	O
a	O
disease-free	O
survival	O
of	O
more	O
than	O
24	O
months	O
(24-58	O
months)	O
express	O
the	O
NM23	DNA
gene	DNA
at	O
higher	O
levels	O
than	O
cell	cell_line
lines	cell_line
obtained	O
from	O
melanomas	O
of	O
patients	O
with	O
a	O
disease-free	O
survival	O
of	O
less	O
than	O
24	O
months	O
(6-15	O
months).	O

Activation	O
of	O
a	O
novel	O
serine	protein
/threonine	protein
kinase	protein
that	O
phosphorylates	O
c-Fos	protein
upon	O
stimulation	O
of	O
T	O
and	O
B	O
lymphocytes	O
via	O
antigen	O
and	O
cytokine	protein
receptors	protein
.	O
Ligation	O
of	O
Ag	protein
receptors	protein
in	O
T	O
and	O
B	O
lymphocytes	O
initiates	O
signal	O
transduction	O
cascades	O
which	O
alter	O
the	O
expression	O
of	O
genes	O
that	O
regulate	O
cellular	O
proliferation	O
and	O
differentiation	O
.	O
The	O
transmission	O
of	O
signals	O
from	O
the	O
membrane	O
to	O
the	O
nucleus	O
is	O
mediated	O
principally	O
through	O
the	O
action	O
of	O
protein	O
tyrosine	O
and	O
serine/threonine	O
kinases	O
.	O
We	O
have	O
identified	O
and	O
characterized	O
a	O
novel	O
serine	protein
/threonine	protein
kinase	protein
that	O
phosphorylated	O
the	O
proto-oncogene	protein
product	protein
,	O
c-Fos	protein
,	O
and	O
is	O
termed	O
Fos	protein
kinase	protein
.	O
Fos	protein
kinase	protein
was	O
rapidly	O
activated	O
after	O
ligation	O
of	O
the	O
CD3	O
and	O
CD2	O
receptors	O
in	O
Jurkat	cell_line
and	O
normal	cell_type
human	cell_type
T	cell_type
lymphocytes	cell_type
and	O
in	O
response	O
to	O
IL-6	protein
and	O
anti-IgM	protein
in	O
the	O
human	cell_line
B	cell_line
cell	cell_line
lines	cell_line
AF10	cell_line
and	O
Ramos	cell_line
,	O
respectively.	O
The	O
phorbol	O
ester	O
,	O
PMA	O
,	O
was	O
also	O
a	O
potent	O
inducer	O
of	O
Fos	protein
kinase	protein
activity	O
in	O
all	O
of	O
the	O
above	O
populations,	O
suggesting	O
that	O
PKC	protein
plays	O
a	O
role	O
in	O
the	O
regulation	O
of	O
this	O
enzyme	protein
.	O
Fos	protein
kinase	protein
phosphorylates	O
c-Fos	protein
at	O
a	O
site	O
near	O
the	O
C-terminus	protein
,	O
as	O
well	O
as	O
a	O
peptide	O
derived	O
from	O
this	O
region	O
(	O
residues	protein
359-370	protein
,	O
RKGSSSNEPSSD	protein
),	O
and	O
Fos	O
peptide	O
competitively	O
inhibited	O
c-Fos	protein
phosphorylation.	O
Fos	protein
kinase	protein
was	O
shown	O
to	O
be	O
distinct	O
from	O
other	O
identified	O
serine	protein
/threonine	protein
kinases	protein
,	O
including	O
protein	protein
kinase	protein
A	protein
,	O
protein	protein
kinase	protein
C	protein
,	O
casein	protein
kinase	protein
II	protein
,	O
MAP	protein
kinases	protein
,	O
p70S6K	protein
and	O
p90RSK	protein
.	O
Fos	protein
kinase	protein
was	O
purified	O
by	O
anion	O
exchange	O
chromatography	O
and	O
exhibited	O
an	O
apparent	O
M(r)	O
=	O
65,000	O
and	O
isoelectric	O
point	O
=	O
6.1.	O
Fos	protein
kinase	protein
may	O
play	O
a	O
role	O
in	O
transcriptional	O
regulation	O
through	O
its	O
capacity	O
to	O
phosphorylate	O
c-Fos	protein
at	O
a	O
site	O
required	O
for	O
expression	O
of	O
the	O
transcriptional	O
transrepressive	O
activity	O
of	O
this	O
molecule.	O
Moreover,	O
its	O
rapid	O
activation	O
suggests	O
it	O
may	O
have	O
a	O
wider	O
role	O
within	O
signal	O
transduction	O
cascades	O
in	O
lymphocytes	cell_type
.	O

Antigenic	O
specificities	O
of	O
human	cell_line
CD4+	cell_line
T-cell	cell_line
clones	cell_line
recovered	O
from	O
recurrent	O
genital	O
herpes	O
simplex	O
virus	O
type	O
2	O
lesions	O
.	O
Lesions	O
resulting	O
from	O
recurrent	O
genital	O
herpes	O
simplex	O
virus	O
(	O
HSV	O
)	O
infection	O
are	O
characterized	O
by	O
infiltration	O
of	O
CD4+	cell_type
lymphocytes	cell_type
.	O
We	O
have	O
investigated	O
the	O
antigenic	O
specificity	O
of	O
47	O
HSV-specific	cell_line
CD4+	cell_line
T-cell	cell_line
clones	cell_line
recovered	O
from	O
the	O
HSV-2	O
buttock	O
and	O
thigh	O
lesions	O
of	O
five	O
patients	O
.	O
Clones	O
with	O
proliferative	O
responses	O
to	O
recombinant	protein
truncated	protein
glycoprotein	protein
B	protein
(	O
gB	protein
)	O
or	O
gD	protein
of	O
HSV-2	O
or	O
purified	O
natural	O
gC	O
of	O
HSV-2	O
comprised	O
a	O
minority	O
of	O
the	O
total	O
number	O
of	O
HSV-specific	cell_line
clones	cell_line
isolated	O
from	O
lesions	O
.	O
The	O
gC2-	O
and	O
gD2-	O
specific	O
CD4+	O
clones	O
had	O
cytotoxic	O
activity	O
.	O
The	O
approximate	O
locations	O
of	O
the	O
HSV-2	O
genes	O
encoding	O
HSV-2	O
type-specific	O
CD4+	protein
antigens	protein
have	O
been	O
determined	O
by	O
using	O
HSV-1	O
x	O
HSV-2	O
intertypic	O
recombinant	O
virus	O
and	O
include	O
the	O
approximate	O
map	O
regions	O
0.30	O
to	O
0.46	O
,	O
0.59	O
to	O
0.67	O
,	O
0.67	O
to	O
0.73	O
,	O
and	O
0.82	O
to	O
1.0	O
units	O
.	O
The	O
antigenic	O
specificity	O
of	O
an	O
HLA	cell_line
DQ2-restricted,	cell_line
HSV-2	cell_line
type-specific	cell_line
T-cell	cell_line
clone	cell_line
was	O
mapped	O
to	O
amino	protein
acids	protein
425	protein
to	protein
444	protein
of	O
VP16	protein
of	O
HSV-2	O
by	O
sequential	O
use	O
of	O
an	O
intertypic	O
recombinant	O
virus	O
containing	O
VP16	protein
of	O
HSV-2	O
in	O
an	O
HSV-1	O
background	O
,	O
recombinant	protein
VP16	protein
fusion	protein
proteins	protein
,	O
and	O
synthetic	O
peptides	O
.	O
Each	O
of	O
the	O
remaining	O
four	O
patients	O
also	O
yielded	O
at	O
least	O
one	O
type-specific	cell_line
T-cell	cell_line
clone	cell_line
reactive	O
with	O
an	O
HSV-2	O
epitope	O
mapping	O
to	O
approximately	O
0.67	O
to	O
0.73	O
map	O
units	O
.	O
The	O
antigenic	O
specificities	O
of	O
lesion-derived	cell_line
CD4+	cell_line
T-cell	cell_line
clones	cell_line
are	O
quite	O
diverse	O
and	O
include	O
at	O
least	O
10	O
epitopes.	O
Human	cell_line
T-cell	cell_line
clones	cell_line
reactive	O
with	O
gC	protein
and	O
VP16	protein
are	O
reported	O
here	O
for	O
the	O
first	O
time.	O

Marked	O
basophilia	O
in	O
acute	O
promyelocytic	O
leukaemia	O
treated	O
with	O
all-trans	O
retinoic	O
acid	O
:	O
molecular	O
analysis	O
of	O
the	O
cell	O
origin	O
of	O
the	O
basophils	cell_type
.	O
We	O
report	O
a	O
patient	O
with	O
acute	O
promyelocytic	O
leukaemia	O
who	O
developed	O
marked	O
basophilia	O
during	O
all-trans	O
retinoic	O
acid	O
treatment	O
.	O
We	O
studied	O
genomic	DNA
DNA	DNA
and	O
RNA	RNA
extracted	O
from	O
the	O
patient's	O
peripheral	cell_type
leucocytes	cell_type
in	O
order	O
to	O
determine	O
the	O
origin	O
of	O
the	O
basophils	cell_type
.	O
The	O
RAR	protein
alpha	protein
rearranged	O
band	O
in	O
the	O
Southern	O
blot	O
analysis	O
and	O
a	O
chimaeric	protein
product	protein
of	O
PML-RAR	protein
alpha	protein
by	O
polymerase	O
chain	O
reaction	O
were	O
strongly	O
visible	O
before	O
ATRA	O
treatment	O
,	O
but	O
at	O
the	O
time	O
of	O
maximal	O
basophilia	O
both	O
of	O
them	O
were	O
markedly	O
diminished.	O
These	O
findings	O
suggest	O
that	O
the	O
basophils	cell_type
which	O
appeared	O
during	O
the	O
ATRA	O
treatment	O
are	O
reactive	O
in	O
nature	O
rather	O
than	O
a	O
leukaemic	cell_line
clone	cell_line
.	O

Activation	O
of	O
the	O
interleukin	DNA
6	DNA
gene	DNA
by	O
Mycobacterium	O
tuberculosis	O
or	O
lipopolysaccharide	O
is	O
mediated	O
by	O
nuclear	protein
factors	protein
NF-IL6	protein
and	O
NF-kappa	protein
B	protein
[published	O
erratum	O
appears	O
in	O
Proc	O
Natl	O
Acad	O
Sci	O
U	O
S	O
A	O
1995	O
Apr	O
11;92(8):3632]	O
The	O
host	O
response	O
to	O
Mycobacterium	O
tuberculosis	O
includes	O
granuloma	O
formation	O
at	O
sites	O
of	O
infection	O
and	O
systemic	O
symptoms	O
.	O
Cytokines	protein
have	O
been	O
identified	O
by	O
immunohistochemistry	O
in	O
granulomas	O
in	O
animal	O
models	O
of	O
bacillus	O
Calmette-Guerin	O
(BCG)	O
infection	O
and	O
are	O
released	O
by	O
mononuclear	cell_type
phagocytes	cell_type
upon	O
stimulation	O
by	O
mycobacterial	O
proteins.	O
In	O
this	O
regard,	O
the	O
cytokine	protein
interleukin	protein
6	protein
(	O
IL-6	protein
)	O
may	O
play	O
a	O
role	O
in	O
the	O
clinical	O
manifestations	O
and	O
pathological	O
events	O
of	O
tuberculosis	protein
infection	protein
.	O
We	O
have	O
demonstrated	O
that	O
lipoarabinomannan	protein
(	O
LAM	protein
)	O
from	O
the	O
mycobacterial	O
cell	O
wall,	O
which	O
was	O
virtually	O
devoid	O
of	O
lipopolysaccharide	O
(	O
LPS	O
),	O
stimulated	O
mononuclear	cell_type
phagocytes	cell_type
to	O
release	O
IL-6	protein
in	O
a	O
dose-response	O
manner	O
.	O
LAM	protein
and	O
LPS	O
were	O
potent	O
inducers	O
of	O
IL-6	DNA
gene	DNA
expression	O
in	O
peripheral	cell_type
blood	cell_type
monocytes	cell_type
.	O
Both	O
LAM	protein
-and	O
LPS	DNA
-inducible	DNA
IL-6	DNA
promoter	DNA
activity	O
was	O
localized	O
to	O
a	O
DNA	DNA
fragment	DNA
,	O
positions	O
-158	DNA
to	DNA
-49	DNA
,	O
by	O
deletion	O
analysis	O
and	O
chloramphenicol	protein
acetyltransferase	protein
assay	O
.	O
Two	O
nuclear	protein
factor	protein
NF-IL6	protein
(positions	O
-153	DNA
to	DNA
-145	DNA
and	O
-83	O
to	O
-75)	O
and	O
one	O
nuclear	DNA
factor	DNA
NF-kappa	DNA
B	DNA
(positions	DNA
-72	DNA
to	DNA
-63)	DNA
motifs	DNA
are	O
present	O
within	O
this	O
fragment.	O
Site-directed	O
mutagenesis	O
of	O
one	O
or	O
more	O
of	O
these	O
motifs	O
within	O
the	O
IL-6	protein
promoter	O
demonstrated	O
that	O
each	O
has	O
positive	O
regulatory	O
activity	O
and	O
that	O
they	O
could	O
act	O
in	O
a	O
function-	O
and	O
orientation-independent	O
manner	O
.	O
Deletion	O
of	O
all	O
three	O
elements	O
abolished	O
inducibility	O
of	O
IL-6	DNA
promoter	DNA
activity	O
by	O
both	O
LAM	protein
and	O
LPS	O
.	O
We	O
conclude	O
that	O
the	O
NF-IL6	O
and	O
NF-kappa	O
B	O
sites	O
mediate	O
IL-6	protein
induction	O
in	O
response	O
to	O
both	O
LPS	O
and	O
LAM	protein
,	O
acting	O
as	O
bacterial	O
or	O
mycobacterial	O
response	O
elements	O
.	O

Regulation	O
of	O
CD14	protein
expression	O
during	O
monocytic	O
differentiation	O
induced	O
with	O
1	O
alpha,25-dihydroxyvitamin	O
D3	O
.	O
CD14	protein
,	O
a	O
monocyte/macrophage	protein
receptor	protein
for	O
the	O
complex	O
of	O
LPS	O
and	O
LPS	protein
binding	protein
protein	protein
,	O
is	O
a	O
differentiation	O
marker	O
for	O
the	O
monocyte/macrophage	cell_type
lineage	cell_type
.	O
We	O
have	O
analyzed	O
the	O
regulation	O
of	O
CD14	protein
expression	O
during	O
1	O
alpha,25-dihydroxyvitamin	O
D3	O
(VitD3)-induced	O
monocytic	O
differentiation	O
.	O
Using	O
FACS	O
,	O
Northern	O
blotting	O
,	O
and	O
nuclear	O
run-on	O
analyses	O
,	O
we	O
demonstrate	O
that	O
the	O
up-regulation	O
of	O
CD14	protein
expression	O
during	O
monocytic	O
cell	O
maturation	O
is	O
regulated	O
mainly	O
at	O
the	O
level	O
of	O
gene	O
transcription	O
,	O
and	O
that	O
new	O
protein	O
synthesis	O
is	O
required	O
for	O
CD14	protein
induction	O
.	O
We	O
have	O
recently	O
cloned	O
the	O
CD14	DNA
5'	DNA
upstream	DNA
sequence	DNA
and	O
demonstrated	O
its	O
tissue-specific	DNA
promoter	DNA
activity	O
.	O
Using	O
stable	O
transfection	O
of	O
the	O
monocytoid	cell_line
U937	cell_line
cell	cell_line
line	cell_line
with	O
a	O
series	O
of	O
deletion	O
mutants	O
of	O
the	O
CD14	DNA
5'	DNA
upstream	DNA
sequence	DNA
coupled	O
to	O
a	O
reporter	O
gene	O
construct,	O
we	O
show	O
that	O
bp	DNA
-128	DNA
to	DNA
-70	DNA
is	O
the	O
critical	O
region	O
for	O
the	O
induction	O
of	O
CD14	protein
expression	O
.	O
This	O
region	O
contains	O
two	O
binding	DNA
sites	DNA
for	O
the	O
Sp1	protein
transcription	protein
factor	protein
.	O
A	O
3-bp	O
mutation	O
at	O
the	O
distal	O
Sp1-binding	DNA
site	DNA
not	O
only	O
eliminates	O
Sp1	protein
interaction	O
,	O
but	O
also	O
abolishes	O
most	O
of	O
the	O
VitD3	O
induction	O
of	O
CD14	protein
expression	O
.	O
Electrophoretic	O
mobility	O
shift	O
analysis	O
does	O
not	O
detect	O
a	O
direct	O
interaction	O
of	O
the	O
CD14	protein
distal	O
Sp1-binding	DNA
site	DNA
with	O
the	O
vitamin	protein
D3	protein
receptor	protein
and	O
its	O
partner,	O
the	O
retinoid	protein
X	protein
receptor	protein
.	O
These	O
data	O
demonstrate	O
that	O
VitD3	O
induces	O
CD14	protein
indirectly	O
through	O
some	O
intermediary	protein
factor	protein
,	O
and	O
suggest	O
a	O
critical	O
role	O
for	O
Sp1	protein
in	O
this	O
process.	O

DNA-binding	O
and	O
transcriptional	O
regulatory	O
properties	O
of	O
hepatic	protein
leukemia	protein
factor	protein
(	O
HLF	protein
)	O
and	O
the	O
t(17;19)	O
acute	protein
lymphoblastic	protein
leukemia	protein
chimera	protein
E2A-	protein
HLF	protein
.	O
The	O
t(17;19)	DNA
translocation	O
in	O
acute	O
lymphoblastic	O
leukemias	O
results	O
in	O
creation	O
of	O
E2A-	protein
hepatic	protein
leukemia	protein
factor	protein
(	O
HLF	protein
)	O
chimeric	protein
proteins	protein
that	O
contain	O
the	O
DNA-binding	protein
and	protein
protein	protein
dimerization	protein
domains	protein
of	O
the	O
basic	protein
leucine	protein
zipper	protein
(bZIP)	protein
protein	protein
HLF	protein
fused	O
to	O
a	O
portion	O
of	O
E2A	protein
proteins	protein
with	O
transcriptional	O
activation	O
properties	O
.	O
An	O
in	O
vitro	O
binding	O
site	O
selection	O
procedure	O
was	O
used	O
to	O
determine	O
DNA	O
sequences	O
preferentially	O
bound	O
by	O
wild-type	protein
HLF	protein
and	O
chimeric	protein
E2A-	protein
HLF	protein
proteins	O
isolated	O
from	O
various	O
t(17;19)-bearing	cell_line
leukemias	cell_line
.	O
All	O
were	O
found	O
to	O
selectively	O
bind	O
the	O
consensus	DNA
sequence	DNA
5'-GTTACGTAAT-3'	O
with	O
high	O
affinity.	O
Wild-type	O
and	O
chimeric	protein
HLF	protein
proteins	protein
also	O
bound	O
closely	O
related	O
sites	O
identified	O
previously	O
for	O
bZIP	protein
proteins	protein
of	O
both	O
the	O
proline	protein
-and	O
acidic	protein
amino	protein
acid-rich	protein
(	O
PAR	protein
)	O
and	O
C/EBP	protein
subfamilies	protein
;	O
however,	O
E2A-	protein
HLF	protein
proteins	O
were	O
significantly	O
less	O
tolerant	O
of	O
certain	O
deviations	O
from	O
the	O
HLF	DNA
consensus	DNA
binding	DNA
site	DNA
.	O
These	O
differences	O
were	O
directly	O
attributable	O
to	O
loss	O
of	O
an	O
HLF	DNA
ancillary	DNA
DNA-binding	DNA
domain	DNA
in	O
all	O
E2A-	protein
HLF	protein
chimeras	protein
and	O
were	O
further	O
exacerbated	O
by	O
a	O
zipper	O
mutation	O
in	O
one	O
isolate.	O
Both	O
wild-type	protein
and	O
chimeric	protein
HLF	protein
proteins	protein
displayed	O
transcriptional	protein
activator	protein
properties	O
in	O
lymphoid	O
and	O
nonlymphoid	O
cells	O
on	O
reporter	DNA
genes	DNA
containing	O
HLF	protein
or	O
C/EBP	protein
consensus	O
binding	O
sites	O
.	O
But	O
on	O
reporter	DNA
genes	DNA
with	O
nonoptimal	DNA
binding	DNA
sites	DNA
,	O
their	O
transcriptional	O
properties	O
diverged	O
and	O
E2A-	protein
HLF	protein
competitively	O
inhibited	O
activation	O
by	O
wild-type	protein
PAR	protein
proteins	protein
.	O
These	O
findings	O
establish	O
a	O
spectrum	O
of	O
binding	O
site-specific	O
transcriptional	O
properties	O
for	O
E2A-	protein
HLF	protein
which	O
may	O
preferentially	O
activate	O
expression	O
of	O
select	O
subordinate	O
genes	O
as	O
a	O
homodimer	O
and	O
potentially	O
antagonize	O
expression	O
of	O
others	O
through	O
heteromeric	O
interactions	O
.	O

ZAP-70	protein
tyrosine	protein
kinase	protein
,	O
CD45	protein
,	O
and	O
T	protein
cell	protein
receptor	protein
involvement	O
in	O
UV-	O
and	O
H2O2-	O
induced	O
T	O
cell	O
signal	O
transduction	O
.	O
Several	O
mammalian	O
responses	O
to	O
UV	O
irradiation	O
,	O
including	O
the	O
activation	O
of	O
NF-kappa	protein
B	protein
,	O
are	O
believed	O
to	O
involve	O
tyrosine	O
phosphorylation	O
.	O
UV	O
irradiation	O
and	O
H2O2	O
treatment	O
of	O
T	cell_type
lymphocytes	cell_type
induce	O
protein	O
tyrosine	O
phosphorylation	O
and	O
Ca2+	O
signals	O
similar	O
to	O
those	O
observed	O
following	O
biological	O
stimulation.	O
We	O
have	O
examined	O
the	O
role	O
of	O
cell	O
surface	O
molecules	O
in	O
these	O
responses.	O
Normal	O
T	cell_type
lymphocytes	cell_type
whose	O
surface	O
expression	O
of	O
CD3	protein
was	O
depleted	O
showed	O
impaired	O
UV-induced	O
tyrosine	O
phosphorylation	O
and	O
Ca2+	O
signals	O
.	O
Similarly,	O
Jurkat	cell_line
T	cell_line
cell	cell_line
lines	cell_line
deficient	O
in	O
CD3	O
or	O
CD45	O
expression	O
also	O
gave	O
impaired	O
UV	O
responses	O
.	O
However,	O
all	O
these	O
cell	O
types	O
still	O
gave	O
strong	O
Ca2+	O
and	O
tyrosine	O
phosphorylation	O
responses	O
to	O
H2O2	O
.	O
The	O
T	O
cell	O
tyrosine	O
kinase	protein
ZAP-70	protein
was	O
found	O
to	O
be	O
highly	O
responsive	O
to	O
UV	O
and	O
H2O2	O
treatment.	O
ZAP-70	protein
responsiveness	O
to	O
UV	O
required	O
expression	O
of	O
both	O
CD3	protein
and	O
CD45	protein
,	O
whereas	O
only	O
CD3	protein
was	O
required	O
for	O
the	O
response	O
to	O
H2O2	O
.	O
UV	O
-induced	O
activation	O
of	O
NF-kappa	protein
B	protein
was	O
blocked	O
by	O
CD3	protein
depletion,	O
indicating	O
the	O
importance	O
of	O
such	O
cell	protein
surface	protein
molecules	protein
in	O
biological	O
responses	O
to	O
UV	O
.	O
In	O
nonlymphoid	cell_type
cells	cell_type
,	O
the	O
epidermal	protein
growth	protein
factor	protein
receptor	protein
displayed	O
increased	O
tyrosine	O
phosphorylation	O
within	O
seconds	O
of	O
UV	O
irradiation	O
.	O
These	O
results	O
suggest	O
that	O
UV	O
-induced	O
signal	O
transduction	O
is	O
mediated	O
via	O
cell	protein
surface	protein
receptors	protein
that	O
normally	O
respond	O
to	O
biological	O
stimulation	O
,	O
whereas	O
H2O2	O
is	O
able	O
to	O
partially	O
bypass	O
this	O
requirement.	O

Inhibition	O
of	O
the	O
differentiation	O
of	O
human	cell_line
myeloid	cell_line
cell	cell_line
lines	cell_line
by	O
redox	O
changes	O
induced	O
through	O
glutathione	O
depletion	O
.	O
We	O
have	O
investigated	O
the	O
effect	O
of	O
redox	O
changes	O
in	O
vivo	O
on	O
the	O
differentiation	O
of	O
two	O
human	cell_line
myeloid	cell_line
cell	cell_line
lines	cell_line
,	O
HL-60	cell_line
and	O
KG-1	cell_line
.	O
The	O
glutathione	O
-depleting	O
agent	O
diethyl	O
maleate	O
(	O
DEM	O
)	O
prevented	O
the	O
development	O
of	O
differentiated	O
features	O
in	O
response	O
to	O
phorbol	O
esters	O
,	O
including	O
adherence	O
of	O
the	O
cells	O
to	O
plastic	O
surfaces	O
and	O
repression	O
of	O
the	O
myeloperoxidase	O
and	O
CD34	O
genes	O
.	O
Moreover,	O
DEM	O
abolished	O
phorbol	O
12-myristate	O
13-acetate	O
-induced	O
activation	O
of	O
the	O
transcription	protein
factors	protein
AP-1	protein
and	O
Egr-1	protein
,	O
suggesting	O
that	O
inhibition	O
of	O
differentiation	O
may	O
be	O
due,	O
at	O
least	O
in	O
part,	O
to	O
redox	O
modifications	O
of	O
these	O
proteins	protein
.	O

Lipopolysaccharide	O
induction	O
of	O
tissue	DNA
factor	DNA
gene	DNA
expression	O
in	O
monocytic	cell_type
cells	cell_type
is	O
mediated	O
by	O
binding	O
of	O
c-Rel/p65	protein
heterodimers	protein
to	O
a	O
kappa	DNA
B-like	DNA
site	DNA
.	O
Exposure	O
of	O
monocytic	cell_type
cells	cell_type
to	O
bacterial	O
lipopolysaccharide	O
(	O
LPS	O
)	O
activates	O
the	O
NF-kappa	protein
B	protein
/Rel	protein
family	protein
of	O
proteins	O
and	O
leads	O
to	O
the	O
rapid	O
induction	O
of	O
inflammatory	protein
gene	protein
products	protein
,	O
including	O
tissue	protein
factor	protein
(	O
TF	protein
).	O
TF	protein
is	O
the	O
primary	O
cellular	O
initiator	O
of	O
the	O
coagulation	protein
protease	protein
cascades	O
.	O
Here	O
we	O
report	O
the	O
characterization	O
of	O
a	O
nuclear	protein
complex	protein
from	O
human	O
monocytic	cell_type
cells	cell_type
that	O
bound	O
to	O
a	O
kappa	DNA
B-like	DNA
site	DNA
,	O
5'-CGGAGTTTCC-3'	DNA
,	O
in	O
the	O
5'-flanking	DNA
region	DNA
of	O
the	O
human	DNA
TF	DNA
gene	DNA
.	O
This	O
nuclear	protein
complex	protein
was	O
activated	O
by	O
LPS	O
with	O
kinetics	O
that	O
preceded	O
induction	O
of	O
the	O
TF	DNA
gene	DNA
.	O
In	O
vitro	O
binding	O
studies	O
demonstrated	O
that	O
the	O
TF	DNA
site	DNA
bound	O
translated	O
c-	O
Rel	protein
and	O
p65	O
homodimers	O
but	O
not	O
p50/p65	protein
heterodimers	protein
or	O
p50	protein
homodimers	protein
.	O
Base-pair	O
substitutions	O
in	O
the	O
TF	DNA
site	DNA
indicated	O
that	O
the	O
presence	O
of	O
a	O
cytosine	O
at	O
position	protein
1	protein
precluded	O
binding	O
of	O
NF-kappa	protein
B	protein
.	O
In	O
fact,	O
under	O
low-ionic-strength	O
conditions	O
,	O
the	O
TF	protein
complex	protein
did	O
not	O
migrate	O
with	O
translated	O
p50/p65	protein
dimers	protein
but	O
instead	O
comigrated	O
with	O
c-Rel	protein
/p65	protein
dimers	protein
.	O
Antibodies	O
against	O
the	O
NF-kappa	protein
B	protein
and	O
Rel	O
proteins	O
and	O
UV	O
cross-linking	O
studies	O
revealed	O
the	O
presence	O
of	O
c-Rel	protein
and	O
p65	protein
and	O
the	O
absence	O
of	O
p50	protein
in	O
the	O
TF	protein
complex	protein
and	O
further	O
showed	O
that	O
c-Rel/	protein
p65	protein
heterodimers	protein
selectively	O
bound	O
to	O
the	O
TF	DNA
kappa	DNA
B-like	DNA
site	DNA
.	O
Functional	O
studies	O
indicated	O
that	O
the	O
TF	DNA
site	DNA
conferred	O
LPS	O
inducibility	O
on	O
a	O
heterologous	DNA
promoter	DNA
and	O
was	O
transactivated	O
by	O
c-Rel	protein
or	O
p65	protein
.	O
Taken	O
together,	O
our	O
results	O
demonstrated	O
that	O
binding	O
of	O
c-Rel/	protein
p65	protein
heterodimers	protein
to	O
a	O
novel	O
kappa	DNA
B-like	DNA
site	DNA
mediated	O
LPS	O
induction	O
of	O
TF	protein
gene	O
expression	O
in	O
monocytic	cell_type
cells	cell_type
.	O

Inhibition	O
of	O
T	O
cell	O
activation	O
by	O
the	O
extracellular	protein
matrix	protein
protein	protein
tenascin	protein
.	O
Tenascin	protein
(	O
TN	protein
)	O
is	O
an	O
extracellular	protein
matrix	protein
protein	protein
that	O
is	O
expressed	O
widely	O
in	O
the	O
fetus	O
and	O
sparingly	O
in	O
the	O
adult	O
,	O
but	O
reappears	O
at	O
high	O
levels	O
in	O
certain	O
areas	O
of	O
tissue	O
insult	O
such	O
as	O
tumor	O
matrices	O
and	O
sites	O
of	O
wound	O
healing	O
.	O
We	O
show	O
here	O
that	O
soluble	O
TN	protein
inhibits	O
proliferation	O
of	O
human	cell_type
T	cell_type
cells	cell_type
in	O
response	O
to	O
alpha	protein
CD3	protein
Ab	protein
co-immobilized	O
with	O
the	O
extracellular	protein
matrix	protein
protein	protein
fibronectin	protein
(	O
FN	protein
).	O
TN	protein
also	O
inhibits	O
proliferation	O
driven	O
by	O
alpha	protein
CD3	protein
/IL-2	protein
or	O
by	O
phorbol	protein
ester/IL-2,	protein
and	O
it	O
prevents	O
high	O
level	O
induction	O
of	O
IL-2R	protein
.	O
The	O
presence	O
of	O
TN	protein
in	O
culture	O
medium	O
does	O
not	O
detectably	O
alter	O
the	O
pattern	O
of	O
tyrosine	O
phosphorylation	O
resulting	O
from	O
T	O
cell	O
triggering	O
with	O
alpha	protein
CD3	protein
,	O
but	O
at	O
later	O
time	O
points	O
prevents	O
the	O
appearance	O
of	O
functional	O
NF-AT1	protein
transcription	protein
factor	protein
complexes	protein
in	O
T	protein
cell	protein
nuclear	protein
extracts	protein
.	O
These	O
findings	O
are	O
consistent	O
with	O
the	O
postulated	O
role	O
for	O
TN	protein
as	O
a	O
natural	O
antagonist	O
to	O
FN	protein
action,	O
and	O
suggest	O
that	O
T	O
cell	O
responses	O
occurring	O
at	O
tissue	O
sites	O
in	O
which	O
TN	protein
is	O
expressed	O
could	O
be	O
influenced	O
by	O
its	O
presence.	O

Human	protein
immunodeficiency	protein
virus	protein
type	protein
1	protein
Nef	protein
protein	protein
down-regulates	O
transcription	protein
factors	protein
NF-kappa	protein
B	protein
and	O
AP-1	protein
in	O
human	cell_type
T	cell_type
cells	cell_type
in	O
vitro	O
after	O
T-cell	O
receptor	O
stimulation.	O
Human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
negative	protein
factor	protein
(	O
Nef	protein
)	O
has	O
been	O
shown	O
to	O
down-regulate	O
the	O
transcription	protein
factors	protein
NF-kappa	protein
B	protein
and	O
AP-1	protein
in	O
vitro.	O
To	O
define	O
the	O
mechanism	O
of	O
action	O
of	O
the	O
Nef	protein
protein,	O
the	O
signal	O
transduction	O
pathways	O
which	O
may	O
be	O
affected	O
in	O
T	cell_type
cells	cell_type
by	O
constitutive	O
expression	O
of	O
the	O
nef	O
gene	O
were	O
examined.	O
Stimulation	O
of	O
T	cell_type
cells	cell_type
with	O
tumor	O
necrosis	O
factor,	O
interleukin-1,	O
or	O
lipopolysaccharide	O
resulted	O
in	O
the	O
recruitment	O
of	O
transcriptional	O
factors	O
to	O
a	O
similar	O
level	O
whether	O
or	O
not	O
the	O
cells	O
expressed	O
the	O
nef	O
gene.	O
On	O
the	O
other	O
hand,	O
stimulation	O
of	O
T	cell_type
cells	cell_type
by	O
mitogens	O
or	O
antibodies	O
to	O
the	O
T-cell	O
receptor	O
(TCR)-	O
CD3	protein
complex	O
resulted	O
in	O
the	O
down-regulation	O
of	O
transcriptional	O
factors	O
NF-kappa	protein
B	protein
and	O
AP-1	protein
in	O
cells	O
expressing	O
the	O
nef	O
gene	O
compared	O
with	O
cells	O
not	O
expressing	O
the	O
nef	O
gene.	O
Because	O
the	O
Nef	protein
protein	O
does	O
not	O
affect	O
the	O
surface	O
expression	O
of	O
the	O
CD3	protein
-TCR	O
complex,	O
we	O
conclude	O
that	O
the	O
Nef	protein
protein	O
down-regulates	O
the	O
transcriptional	O
factors	O
NF-kappa	protein
B	protein
and	O
AP-1	protein
in	O
T	cell_type
cells	cell_type
in	O
vitro	O
through	O
an	O
effect	O
on	O
the	O
TCR-dependent	O
signal	O
transduction	O
pathway	O
.	O

Effects	O
of	O
alpha-lipoic	O
acid	O
and	O
dihydrolipoic	O
acid	O
on	O
expression	O
of	O
proto-oncogene	DNA
c-fos	DNA
.	O
The	O
transcription	protein
factor	protein
AP-1	protein
is	O
an	O
important	O
human	O
mediator	O
of	O
the	O
cellular	O
response	O
to	O
serum	O
,	O
growth	protein
factors	protein
,	O
and	O
phorbol	O
esters	O
such	O
as	O
12-O-tetradecanoyl-phorbol-13	O
acetate	O
(	O
TPA	O
).	O
The	O
AP-1	protein
complex	O
consists	O
of	O
distinct	O
protein	protein
heterodimers	protein
encoded	O
by	O
the	O
proto-oncogene	DNA
c-fos	DNA
and	O
c-jun	RNA
mRNA	RNA
whose	O
gene	O
expression	O
can	O
be	O
induced	O
by	O
TPA	O
,	O
cyclic	O
AMP	O
and	O
growth	protein
factors	protein
.	O
Recent	O
findings	O
suggest	O
an	O
involvement	O
of	O
reactive	O
oxygen	O
species	O
in	O
the	O
pathway	O
of	O
TPA	O
and	O
protein	protein
kinase	protein
C	protein
leading	O
to	O
expression	O
of	O
c-fos	O
and	O
c-jun	O
mRNA	O
.	O
To	O
investigate	O
the	O
role	O
of	O
reactive	O
oxygen	O
species	O
we	O
studied	O
the	O
effects	O
of	O
alpha-lipoic	O
acid	O
and	O
dihydrolipoic	O
acid	O
(	O
natural	O
thiol	O
antioxidants	O
)	O
on	O
the	O
expression	O
of	O
c-fos	RNA
mRNA	RNA
in	O
human	cell_line
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
When	O
cells	O
were	O
preincubated	O
with	O
dihydrolipoic	O
acid	O
(0.2	O
mM)	O
the	O
expression	O
of	O
c-fos	RNA
mRNA	RNA
was	O
suppressed	O
at	O
30	O
min	O
after	O
stimulation	O
of	O
TPA	O
(0.5	O
microM)	O
whereas	O
in	O
the	O
case	O
of	O
preincubation	O
of	O
alpha-lipoic	O
acid	O
(0.2	O
microM),	O
the	O
expression	O
was	O
enhanced	O
at	O
30	O
min.	O
These	O
studies	O
support	O
the	O
idea	O
that	O
superoxide	O
anion	O
radical	O
plays	O
a	O
role	O
in	O
the	O
expression	O
of	O
c-fos	RNA
mRNA	RNA
.	O

Appraisal	O
of	O
potential	O
therapeutic	O
index	O
of	O
antioxidants	O
on	O
the	O
basis	O
of	O
their	O
in	O
vitro	O
effects	O
on	O
HIV	O
replication	O
in	O
monocytes	cell_type
and	O
interleukin	protein
2	protein
-induced	O
lymphocyte	O
proliferation	O
.	O
Antioxidant	O
molecules	O
have	O
been	O
suggested	O
to	O
be	O
of	O
therapeutic	O
value	O
in	O
the	O
treatment	O
of	O
HIV	O
-infected	O
patients	O
.	O
To	O
evaluate	O
this	O
possibility,	O
we	O
examined	O
in	O
vitro	O
the	O
effects	O
of	O
two	O
types	O
of	O
antioxidant	O
molecules	O
in	O
terms	O
of	O
inhibition	O
of	O
HIV	O
replication	O
in	O
monocytes	cell_type
,	O
one	O
of	O
the	O
main	O
reservoirs	O
of	O
HIV	O
,	O
and	O
also	O
in	O
terms	O
of	O
modulation	O
of	O
the	O
immune	O
competence	O
as	O
measured	O
by	O
PBMC	cell_type
proliferation	O
.	O
We	O
tested	O
the	O
effects	O
of	O
BHA	O
,	O
a	O
phenolic,	O
lipid-soluble,	O
chain-breaking	O
antioxidant	O
,	O
and	O
NAC	O
,	O
a	O
known	O
glutathione	O
precursor	O
with	O
some	O
direct	O
free-radical	O
scavenging	O
properties	O
as	O
well,	O
on	O
the	O
regulation	O
of	O
HIV	O
-1	O
expression	O
in	O
latently	O
infected	O
U1	cell_line
cells	cell_line
and	O
in	O
productively	O
and	O
chronically	O
infected	O
U937	cell_line
cells	cell_line
.	O
Both	O
antioxidants	O
inhibited	O
TNF	protein
-or	O
PMA-	O
induced	O
NF-kappa	protein
B	protein
activity	O
in	O
U1	cell_line
cells	cell_line
,	O
as	O
well	O
as	O
the	O
sustained	O
NF-kappa	protein
B	protein
activity	O
permanently	O
induced	O
by	O
the	O
virus	O
itself	O
in	O
chronically	O
HIV	O
-infected	O
U937	cell_line
cells	cell_line
.	O
This	O
resulted	O
in	O
only	O
a	O
partial	O
inhibition	O
of	O
TNF	protein
-or	O
PMA-	O
induced	O
HIV	O
replication	O
in	O
U1	cell_line
cells	cell_line
,	O
and	O
no	O
detectable	O
effect	O
on	O
HIV	O
replication	O
in	O
chronically	cell_line
infected	cell_line
U937	cell_line
cells	cell_line
.	O
This	O
may	O
be	O
the	O
first	O
limitation	O
to	O
potential	O
antiviral	O
effects	O
of	O
antioxidant	O
therapies.	O
Another	O
limitation	O
is	O
that	O
antioxidant	O
concentrations	O
high	O
enough	O
to	O
block	O
NK-kappa	protein
B	protein
activation	O
were	O
shown	O
to	O
have	O
a	O
suppressive	O
effect	O
on	O
immune	O
functions	O
in	O
vitro	O
,	O
because	O
NAC	O
and	O
BHA	O
blocked	O
IL-2	cell_type
-induced	cell_type
PBMC	cell_type
proliferation	O
.	O
These	O
data	O
warrant	O
prudence	O
in	O
the	O
design	O
of	O
antioxidant-based	O
therapies	O
aimed	O
at	O
suppressing	O
HIV	O
replication	O
.	O

Isolation	O
and	O
characterization	O
of	O
gelatinase	O
granules	O
from	O
human	cell_type
neutrophils	cell_type
.	O
We	O
recently	O
confirmed	O
the	O
existence	O
of	O
gelatinase	O
granules	O
as	O
a	O
subpopulation	O
of	O
peroxidase-negative	O
granules	O
by	O
double-labeling	O
immunogold	O
electron	O
microscopy	O
on	O
intact	O
cells	O
and	O
by	O
subcellular	O
fractionation	O
.	O
Further	O
characterization	O
of	O
gelatinase	O
granules	O
has	O
been	O
hampered	O
by	O
poor	O
separation	O
of	O
specific	O
and	O
gelatinase	O
granules	O
on	O
both	O
two-layer	O
Percoll	O
gradients	O
and	O
sucrose	O
gradients	O
.	O
We	O
have	O
developed	O
a	O
three-layer	O
Percoll	O
density	O
gradient	O
that	O
allows	O
separation	O
of	O
the	O
different	O
granules	O
and	O
vesicles	O
from	O
human	cell_type
neutrophils	cell_type
;	O
in	O
particular,	O
it	O
allows	O
separation	O
of	O
specific	O
and	O
gelatinase	O
granules	O
.	O
This	O
allows	O
us	O
to	O
characterize	O
these	O
two	O
granule	O
populations	O
with	O
regard	O
to	O
their	O
content	O
of	O
membrane	protein
proteins	protein
,	O
which	O
become	O
incorporated	O
into	O
the	O
plasma	O
membrane	O
during	O
exocytosis	O
.	O
We	O
found	O
that	O
gelatinase	O
granules	O
,	O
defined	O
as	O
peroxidase-negative	O
granules	O
containing	O
gelatinase	protein
but	O
lacking	O
lactoferrin	protein
,	O
contain	O
50%	O
of	O
total	O
cell	O
gelatinase	protein
,	O
with	O
the	O
remaining	O
residing	O
in	O
specific	O
granules	O
.	O
Furthermore,	O
we	O
found	O
that	O
20%	O
to	O
25%	O
of	O
both	O
the	O
adhesion	protein
protein	protein
Mac-1	protein
and	O
the	O
NADPH-oxidase	protein
component	protein
cytochrome	protein
b558	protein
is	O
localized	O
in	O
gelatinase	protein
granules	O
.	O
Although	O
no	O
qualitative	O
difference	O
was	O
observed	O
between	O
specific	O
granules	O
and	O
gelatinase	protein
granules	O
with	O
respect	O
to	O
cytochrome	protein
b558	protein
and	O
Mac-1	protein
,	O
stimulation	O
of	O
the	O
neutrophil	cell_type
with	O
FMLP	protein
resulted	O
in	O
a	O
selective	O
mobilization	O
of	O
the	O
least	O
dense	O
peroxidase-negative	O
granules	O
,	O
ie,	O
gelatinase	protein
granules	O
,	O
which,	O
in	O
concert	O
with	O
secretory	O
vesicles	O
,	O
furnish	O
the	O
plasma	O
membrane	O
with	O
Mac-1	protein
and	O
cytochrome	protein
b558	protein
.	O
This	O
shows	O
that	O
gelatinase	protein
granules	O
are	O
functionally	O
important	O
relative	O
to	O
specific	O
granules	O
in	O
mediating	O
early	O
inflammatory	O
responses	O
.	O

Regulation	O
of	O
interleukin-2	protein
receptor	protein
alpha	protein
chain	protein
expression	O
and	O
nuclear	protein
factor.kappa	protein
B	protein
activation	O
by	O
protein	protein
kinase	protein
C	protein
in	O
T	cell_type
lymphocytes	cell_type
.	O
Autocrine	O
role	O
of	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
.	O
The	O
regulation	O
of	O
interleukin-2	protein
receptor	protein
alpha	protein
chain	protein
(	O
IL-2R	protein
alpha	protein
)	O
expression	O
and	O
nuclear	protein
factor	protein
(NF)	O
activation	O
by	O
protein	protein
kinase	protein
C	protein
(	O
PKC	protein
)	O
in	O
resting	cell_type
T	cell_type
cells	cell_type
,	O
has	O
been	O
studied.	O
Treatment	O
of	O
human	O
resting	cell_type
T	cell_type
cells	cell_type
with	O
phorbol	O
esters	O
strongly	O
induced	O
the	O
expression	O
of	O
IL-2R	protein
alpha	protein
and	O
the	O
activation	O
of	O
NF.kappa	protein
B	protein
.	O
This	O
activation	O
was	O
due	O
to	O
the	O
translocation	O
of	O
p65	protein
and	O
c-Rel	protein
NF.kappa	protein
B	protein
proteins	O
from	O
cytoplasmic	O
stores	O
to	O
the	O
nucleus,	O
where	O
they	O
bound	O
the	O
kappa	DNA
B	DNA
sequence	DNA
of	O
the	O
IL-2R	DNA
alpha	DNA
promoter	DNA
either	O
as	O
p50.p65	protein
or	O
as	O
p50.	protein
c-Rel	protein
heterodimers.	O
Interestingly,	O
all	O
of	O
those	O
events	O
were	O
largely	O
indirect	O
and	O
mediated	O
by	O
endogenously	O
secreted	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF	protein
alpha	protein
),	O
as	O
they	O
were	O
strongly	O
inhibited	O
by	O
a	O
neutralizing	protein
anti-	protein
TNF	protein
alpha	protein
monoclonal	protein
antibody	protein
.	O
Furthermore,	O
cyclosporin	O
A	O
,	O
which	O
blocked	O
TNF	protein
alpha	protein
production	O
induced	O
by	O
PKC	protein
,	O
strongly	O
inhibited	O
IL-2R	protein
alpha	protein
and	O
NF.kappa	protein
B	protein
activation	O
.	O
The	O
addition	O
of	O
either	O
TNF	protein
alpha	protein
or	O
IL-2	protein
partially	O
recovered	O
cyclosporin	O
A	O
-induced	O
IL-2R	protein
alpha	protein
inhibition,	O
but	O
only	O
TNF	protein
alpha	protein
completely	O
recovered	O
NF.kappa	protein
B	protein
activation.	O
Those	O
results	O
indicate	O
that,	O
in	O
resting	cell_type
T	cell_type
cells	cell_type
,	O
PKC	protein
activation	O
has	O
only	O
a	O
triggering	O
role,	O
whereas	O
the	O
endogenously	O
secreted	O
TNF	protein
alpha	protein
plays	O
an	O
essential	O
role	O
in	O
the	O
quantitative	O
control	O
of	O
the	O
expression	O
of	O
IL-2R	protein
alpha	protein
chain	O
or	O
NF.kappa	protein
B	protein
activation	O
.	O

Superantigens	protein
activate	O
HIV-1	O
gene	O
expression	O
in	O
monocytic	cell_type
cells	cell_type
.	O
Binding	O
of	O
superantigens	O
to	O
MHC	protein
class	protein
II	protein
molecules	protein
results	O
in	O
transduction	O
of	O
biochemical	O
signals	O
leading	O
to	O
cellular	O
activation	O
and	O
gene	O
expression	O
.	O
We	O
demonstrate	O
that	O
the	O
staphylococcal	protein
superantigens	protein
toxic	protein
shock	protein
syndrome	protein
toxin-1	protein
(	O
TSST-1	protein
)	O
and	O
staphylococcal	protein
enterotoxin	protein
A	protein
(	O
SEA	protein
)	O
activate	O
HIV-1	DNA
-LTR	DNA
-driven	O
transcription	O
of	O
chloramphenicol	protein
acetyl	protein
transferase	protein
in	O
the	O
human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
THP-1	cell_line
.	O
Induction	O
of	O
HIV-1	O
-	O
LTR	DNA
-driven	O
transcription	O
in	O
THP-1	cell_line
cells	cell_line
by	O
superantigens	protein
was	O
associated	O
with	O
the	O
induction	O
of	O
nuclear	protein
factor-kappa	protein
B	protein
DNA-binding	O
activity	O
.	O
Superantigens	protein
also	O
increased	O
viral	O
protein	O
secretion	O
from	O
the	O
granulocyte-macrophage	cell_line
colony-stimulating	cell_line
factor	cell_line
-pretreated	cell_line
chronically	cell_line
infected	cell_line
human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
U1	cell_line
.	O
Induction	O
of	O
HIV-1	O
gene	O
expression	O
in	O
monocytic	cell_type
cells	cell_type
by	O
superantigens	protein
occurred	O
via	O
tumor	O
necrosis	O
factor-alpha	O
-dependent	O
and	O
-independent	O
mechanisms	O
.	O
Our	O
results	O
suggest	O
that	O
superantigens	protein
and	O
other	O
MHC	protein
class	protein
II	protein
ligands	protein
may	O
activate	O
HIV-1	O
gene	O
expression	O
in	O
monocytes/macrophages	cell_type
.	O

Mitogen	O
activation	O
of	O
human	cell_type
peripheral	cell_type
T	cell_type
lymphocytes	cell_type
induces	O
the	O
formation	O
of	O
new	O
cyclic	protein
AMP	protein
response	protein
element-binding	protein
protein	protein
nuclear	protein
complexes	protein
.	O
A	O
large	O
body	O
of	O
evidence	O
indicates	O
that	O
experimental	O
agents	O
which	O
raise	O
cellular	O
cAMP	O
levels	O
inhibit	O
T	O
cell	O
growth	O
and	O
division.	O
By	O
contrast,	O
many	O
studies	O
have	O
reported	O
that	O
mitogen	protein
activation	O
of	O
T	cell_type
cells	cell_type
increases	O
cAMP	O
levels,	O
implying	O
a	O
positive	O
physiological	O
role	O
for	O
cAMP	O
in	O
the	O
activation	O
process.	O
In	O
the	O
present	O
study	O
we	O
demonstrate	O
that	O
mitogen	protein
activation	O
of	O
human	cell_type
peripheral	cell_type
T	cell_type
lymphocytes	cell_type
induces	O
nuclear	O
factors	O
that	O
form	O
complexes	O
with	O
cyclic	protein
AMP	protein
response	protein
element-binding	protein
protein	protein
(	O
CREB	protein
).	O
Four	O
complexes	O
are	O
identified	O
by	O
the	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
two	O
of	O
which	O
are	O
induced	O
by	O
mitogen	protein
activation	O
.	O
All	O
four	O
complexes	O
contain	O
CREB	protein
and	O
are	O
bound	O
to	O
the	O
cAMP	DNA
response	DNA
element	DNA
(	DNA
CRE	DNA
)	DNA
core	DNA
sequence	DNA
(	O
TGACGTCA	O
),	O
as	O
indicated	O
by	O
antibody	O
and	O
oligonucleotide	O
competition	O
experiments	O
.	O
Binding	O
of	O
the	O
four	O
complexes	O
to	O
CRE	DNA
is	O
prevented	O
by	O
dephosphorylation	O
of	O
nuclear	O
extracts	O
and	O
is	O
restored	O
by	O
rephosphorylation	O
with	O
cAMP	protein
-dependent	protein
protein	protein
kinase	protein
or	O
endogenous	protein
kinases	protein
.	O
Similar	O
complexes	O
are	O
detected	O
in	O
nuclear	O
extracts	O
of	O
Jurkat	cell_line
cells	cell_line
.	O
Mitogen	O
induction	O
of	O
the	O
electrophoretic	protein
mobility	protein
shift	protein
assay	protein
complexes	protein
is	O
not	O
accounted	O
for	O
by	O
protein	O
phosphorylation	O
or	O
by	O
induction	O
of	O
CREB	protein
.	O
Rather,	O
the	O
data	O
indicate	O
that	O
mitogen	O
increases	O
the	O
levels	O
of	O
a	O
nuclear	O
factor(s)	O
that	O
dimerizes	O
with	O
CREB	protein
.	O
Induction	O
of	O
new	O
CREB	protein
complexes	protein
implies	O
a	O
physiological	O
role	O
for	O
cAMP	O
in	O
mitogen	protein
activation	O
of	O
T	cell_type
lymphocytes	cell_type
.	O

Alpha-tocopherol	O
inhibits	O
agonist-induced	O
monocytic	O
cell	O
adhesion	O
to	O
cultured	cell_line
human	cell_line
endothelial	cell_line
cells	cell_line
.	O
Antioxidants	O
have	O
been	O
proposed	O
to	O
be	O
anti-atherosclerotic	O
agents	O
;	O
however,	O
the	O
mechanisms	O
underlying	O
their	O
beneficial	O
effects	O
are	O
poorly	O
understood.	O
We	O
have	O
examined	O
the	O
effect	O
of	O
alpha-tocopherol	O
(	O
alpha-tcp	O
)	O
on	O
one	O
cellular	O
event	O
in	O
atherosclerotic	O
plaque	O
development	O
,	O
monocyte	O
adhesion	O
to	O
stimulated	cell_type
endothelial	cell_type
cells	cell_type
(	O
ECs	cell_type
).	O
Human	O
umbilical	O
vein	O
ECs	cell_type
were	O
pretreated	O
with	O
alpha-tcp	O
before	O
stimulation	O
with	O
known	O
agonists	O
of	O
monocyte	O
adhesion	O
:	O
IL-1	protein
(10	O
ng/ml),	O
LPS	O
(10	O
ng/ml),	O
thrombin	protein
(30	O
U/ml),	O
or	O
PMA	O
(10	O
nM).	O
Agonist-induced	O
monocytic	O
cell	O
adhesion	O
,	O
but	O
not	O
basal	O
adhesion	O
,	O
was	O
inhibited	O
in	O
a	O
time-	O
and	O
concentration-dependent	O
manner	O
by	O
alpha-tcp	O
.	O
The	O
IC50	O
of	O
alpha-tcp	O
on	O
an	O
IL-1	protein
-induced	O
response	O
was	O
45	O
microM.	O
The	O
inhibition	O
correlated	O
with	O
a	O
decrease	O
in	O
steady	O
state	O
levels	O
of	O
E-selectin	RNA
mRNA	RNA
and	O
cell	O
surface	O
expression	O
of	O
E-selectin	protein
which	O
is	O
consistent	O
with	O
the	O
ability	O
of	O
a	O
monoclonal	protein
antibody	protein
to	O
E-selectin	protein
to	O
inhibit	O
monocytic	O
cell	O
adhesion	O
in	O
this	O
system.	O
Probucol	O
(50	O
microM)	O
and	O
N-acetylcysteine	O
(20	O
mM)	O
also	O
inhibited	O
agonist-induced	O
monocytic	O
cell	O
adhesion	O
;	O
whereas,	O
several	O
other	O
antioxidants	O
had	O
no	O
significant	O
effect.	O
Protein	protein
kinase	protein
C	protein
(	O
PKC	protein
)	O
does	O
not	O
appear	O
to	O
play	O
a	O
role	O
in	O
the	O
alpha-tcp	O
effect	O
since	O
no	O
suppression	O
of	O
phosphorylation	O
of	O
PKC	protein
substrates	O
was	O
observed.	O
Activation	O
of	O
the	O
transcription	protein
factor	protein
NF-kappa	protein
B	protein
is	O
reported	O
to	O
be	O
necessary	O
but	O
not	O
sufficient	O
for	O
E-selectin	protein
expression	O
in	O
EC	cell_line
.	O
Electrophoretic	O
mobility	O
shift	O
assays	O
failed	O
to	O
show	O
an	O
alpha-tcp	O
-induced	O
decrease	O
in	O
activation	O
of	O
this	O
transcription	protein
factor	protein
after	O
cytokine	protein
stimulation	O
.	O
It	O
has	O
been	O
hypothesized	O
that	O
alpha-tcp	O
acts	O
as	O
an	O
anti-atherosclerotic	O
molecule	O
by	O
inhibiting	O
generation	O
of	O
oxidized	O
LDL	O
--a	O
putative	O
triggering	O
molecule	O
in	O
the	O
atherosclerotic	O
process	O
.	O
Our	O
results	O
point	O
to	O
a	O
novel	O
alternative	O
mechanism	O
of	O
action	O
of	O
alpha-tcp	O
.	O

Central	cell_type
nervous	cell_type
system	cell_type
-derived	cell_type
cells	cell_type
express	O
a	O
kappa	O
B-binding	O
activity	O
that	O
enhances	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
transcription	O
in	O
vitro	O
and	O
facilitates	O
TAR	DNA
-independent	O
transactivation	O
by	O
Tat	protein
.	O
The	O
Tat	protein
protein	protein
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
is	O
a	O
potent	O
activator	O
of	O
long	DNA
terminal	DNA
repeat	DNA
-directed	O
transcription	O
.	O
While	O
in	O
most	O
cell	O
types,	O
activation	O
requires	O
interaction	O
of	O
Tat	O
with	O
the	O
unusual	O
transcription	DNA
element	DNA
TAR	DNA
,	O
astrocytic	cell_type
glial	cell_type
cells	cell_type
support	O
TAR	DNA
-independent	O
transactivation	O
of	O
HIV-1	O
transcription	O
by	O
Tat.	O
This	O
alternative	O
pathway	O
of	O
Tat	protein
activation	O
is	O
mediated	O
by	O
the	O
viral	DNA
enhancer	DNA
,	O
a	O
kappa	O
B	O
domain	O
capable	O
of	O
binding	O
the	O
prototypical	O
form	O
of	O
the	O
transcription	protein
factor	protein
nuclear	O
factor	O
kappa	O
B	O
(	O
NF-kappa	protein
B	protein
)	O
present	O
in	O
many	O
cell	O
types,	O
including	O
T	cell_type
lymphocytes	cell_type
.	O
Tat	protein
transactivation	O
mediated	O
by	O
the	O
kappa	DNA
B	DNA
domain	DNA
is	O
sufficient	O
to	O
allow	O
replication	O
of	O
TAR	DNA
-deleted	O
mutant	O
HIV-1	O
in	O
astrocytes	cell_type
.	O
The	O
present	O
study	O
demonstrates	O
the	O
existence	O
of	O
kappa	protein
B-specific	protein
binding	protein
factors	protein
present	O
in	O
human	cell_type
glial	cell_type
astrocytes	cell_type
that	O
differ	O
from	O
prototypical	O
NF-kappa	protein
B	protein
.	O
The	O
novel	O
astrocyte-derived	O
kappa	O
B-binding	O
activity	O
is	O
retained	O
on	O
an	O
HIV-1	O
Tat	protein
affinity	O
column	O
,	O
while	O
prototypical	O
NF-kappa	protein
B	protein
from	O
Jurkat	cell_line
T	cell_line
cells	cell_line
is	O
not.	O
In	O
vitro	O
transcription	O
studies	O
demonstrate	O
that	O
astrocyte-derived	protein
kappa	protein
B-binding	protein
factors	protein
activate	O
transcription	O
of	O
the	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
and	O
that	O
this	O
activation	O
is	O
dependent	O
on	O
the	O
kappa	DNA
B	DNA
domain	DNA
.	O
Moreover,	O
TAR	DNA
-independent	O
transactivation	O
of	O
HIV-1	O
transcription	O
is	O
reproduced	O
in	O
vitro	O
in	O
an	O
astrocyte	O
factor-dependent	O
manner	O
which	O
correlates	O
with	O
kappa	O
B-binding	O
activity	O
.	O
The	O
importance	O
of	O
the	O
central	protein
nervous	protein
system	protein
-enriched	protein
kappa	protein
B	protein
transcription	protein
factor	protein
in	O
the	O
regulation	O
of	O
HIV-1	O
expression	O
is	O
discussed.	O

Human	protein
interleukin-13	protein
activates	O
the	O
interleukin-4-dependent	protein
transcription	protein
factor	protein
NF-IL4	protein
sharing	O
a	O
DNA	protein
binding	protein
motif	protein
with	O
an	O
interferon-gamma-induced	protein
nuclear	protein
binding	protein
factor	protein
.	O
The	O
effects	O
of	O
interleukin-13	protein
(	O
IL-13	protein
)	O
and	O
interleukin-4	protein
(	O
IL-4	protein
)	O
on	O
cellular	O
functions	O
were	O
shown	O
to	O
be	O
quite	O
similar.	O
We	O
provide	O
evidence	O
that	O
in	O
monocytes	O
as	O
well	O
as	O
in	O
T	cell_type
lymphocytes	cell_type
both	O
IL-4	protein
and	O
IL-13	protein
activate	O
the	O
same	O
recently	O
identified	O
transcription	protein
factor	protein
NF-IL4	protein
which	O
binds	O
to	O
the	O
specific	DNA
responsive	DNA
element	DNA
IL-4RE	DNA
.	O
In	O
addition,	O
we	O
show	O
that	O
a	O
nuclear	protein
factor	protein
activated	O
by	O
interferon-gamma	O
also	O
interacts	O
with	O
the	O
IL-4RE	DNA
.	O
It	O
differs	O
from	O
NF-IL4	protein
in	O
the	O
electrophoretic	O
mobility	O
of	O
the	O
complex	O
with	O
DNA,	O
in	O
its	O
DNA-binding	O
specificity	O
and	O
in	O
the	O
proteins	O
interacting	O
with	O
the	O
DNA	DNA
sequence	DNA
.	O
Sensitivity	O
against	O
various	O
enzyme	O
inhibitors	O
suggests	O
that	O
components	O
of	O
the	O
signal	O
transduction	O
pathway	O
are	O
shared	O
by	O
all	O
three	O
cytokines	protein
.	O

Encephalomyocarditis	O
virus	O
internal	O
ribosomal	O
entry	O
site	O
RNA-protein	O
interactions	O
.	O
Translational	O
initiation	O
of	O
encephalomyocarditis	RNA
virus	RNA
(	RNA
EMCV	RNA
)	RNA
mRNA	RNA
occurs	O
by	O
ribosomal	O
entry	O
into	O
the	O
5'	DNA
nontranslated	DNA
region	DNA
of	O
the	O
EMCV	RNA
mRNA	RNA
,	O
rather	O
than	O
by	O
ribosomal	O
scanning	O
.	O
Internal	O
ribosomal	O
binding	O
requires	O
a	O
cis-acting	DNA
element	DNA
termed	O
the	O
internal	DNA
ribosomal	DNA
entry	DNA
site	DNA
(	O
IRES	DNA
).	O
IRES	DNA
elements	DNA
have	O
been	O
proposed	O
to	O
be	O
involved	O
in	O
the	O
translation	O
of	O
picornavirus	RNA
mRNAs	RNA
and	O
some	O
cellular	RNA
mRNAs	RNA
.	O
Internal	O
ribosome	O
binding	O
likely	O
requires	O
the	O
interaction	O
of	O
trans-acting	protein
factors	protein
that	O
recognize	O
both	O
the	O
mRNA	RNA
and	O
the	O
ribosomal	protein
complex	protein
.	O
Five	O
cellular	protein
proteins	protein
(	O
p52	protein
,	O
p57	protein
,	O
p70	protein
,	O
p72	protein
,	O
and	O
p100	protein
)	O
cross-link	O
the	O
EMCV	O
IRES	DNA
or	O
fragments	O
of	O
the	O
IRES	DNA
.	O
For	O
one	O
of	O
these	O
proteins,	O
p57	protein
,	O
binding	O
to	O
the	O
IRES	DNA
correlates	O
with	O
translation.	O
Recently,	O
p57	protein
was	O
identified	O
to	O
be	O
very	O
similar,	O
if	O
not	O
identical,	O
to	O
polypyrimidine	protein
tract-binding	protein
protein	protein
.	O
On	O
the	O
basis	O
of	O
cross-linking	O
results	O
with	O
21	O
different	O
EMCV	DNA
IRES	DNA
fragments	DNA
and	O
cytoplasmic	O
HeLa	O
extract	O
or	O
rabbit	O
reticulocyte	O
lysate	O
as	O
the	O
source	O
of	O
polypeptides	O
,	O
consensus	DNA
binding	DNA
sites	DNA
for	O
p52	protein
,	O
p57	protein
,	O
p70	protein
,	O
and	O
p100	protein
are	O
proposed.	O
It	O
is	O
suggested	O
that	O
each	O
of	O
these	O
proteins	O
recognizes	O
primarily	O
a	O
structural	O
feature	O
of	O
the	O
RNA	RNA
rather	O
than	O
a	O
specific	O
sequence.	O

A	O
novel	O
heterodimerization	protein
partner	protein
for	O
thyroid	protein
hormone	protein
receptor	protein
.	O
Peroxisome	protein
proliferator-activated	protein
receptor	protein
.	O
Retinoid-like	protein
receptors	protein
play	O
a	O
central	O
role	O
in	O
hormonal	O
responses	O
by	O
forming	O
heterodimers	protein
with	O
other	O
nuclear	protein
hormone	protein
receptors	protein
.	O
In	O
this	O
study	O
we	O
have	O
identified	O
the	O
peroxisome	protein
proliferator-activated	protein
receptor	protein
(	O
PPAR	protein
)	O
as	O
a	O
new	O
thyroid	protein
hormone	protein
receptor	protein
(	protein
THR	protein
)	protein
auxiliary	protein
nuclear	protein
protein	protein
,	O
heterodimerizing	O
with	O
THR	protein
in	O
solution.	O
Although	O
these	O
heterodimers	protein
do	O
not	O
recognize	O
a	O
classical	O
thyroid	DNA
hormone	DNA
response	DNA
element	DNA
(	O
TRE	DNA
)	O
characterized	O
by	O
direct	DNA
repeat	DNA
separated	O
by	O
four	O
nucleotides	O
(	O
DR+4	DNA
),	O
PPAR	protein
behaves	O
as	O
a	O
dominant	O
negative	O
regulator	O
of	O
thyroid	O
hormone	O
(	O
TH	O
)	O
action	O
.	O
However,	O
a	O
TH	O
-dependent	O
positive	O
effect	O
is	O
elicited	O
by	O
selective	O
interaction	O
of	O
the	O
THR	protein
beta-	protein
PPAR	protein
but	O
not	O
the	O
THR	protein
alpha-	protein
PPAR	protein
heterodimer	protein
with	O
a	O
novel	O
TRE	DNA
(	O
DR+2	DNA
).	O
The	O
critical	O
region	O
of	O
THR	protein
beta	O
was	O
mapped	O
to	O
3	O
amino	O
acids	O
in	O
the	O
distal	protein
box	protein
of	O
the	O
DNA	protein
binding	protein
domain	protein
.	O
Hence,	O
PPAR	protein
can	O
positively	O
or	O
negatively	O
influence	O
TH	O
action	O
depending	O
on	O
TRE	DNA
structure	O
and	O
THR	protein
isotype	protein
.	O

Comparison	O
of	O
retinoic	O
acid	O
and	O
phorbol	O
myristate	O
acetate	O
as	O
inducers	O
of	O
monocytic	O
differentiation	O
.	O
Several	O
human	cell_line
myeloid	cell_line
leukemia	cell_line
cell	cell_line
lines	cell_line
growing	O
in	O
vitro	O
can	O
be	O
induced	O
to	O
differentiate	O
to	O
more	O
mature	O
monocyte/macrophage-like	cell_type
cells	cell_type
by	O
treatment	O
with	O
protein	protein
kinase	protein
C	protein
-activating	O
phorbol	O
esters	O
,	O
such	O
as	O
PMA	O
.	O
In	O
addition	O
to	O
PMA	O
,	O
cells	O
of	O
the	O
THP-1	cell_line
myeloid	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
acquire	O
macrophage-like	O
characteristics	O
after	O
treatment	O
with	O
all-trans	O
retinoic	O
acid	O
(	O
RA	O
).	O
To	O
analyze	O
the	O
signal	O
transduction	O
mechanisms	O
induced	O
by	O
RA	O
,	O
we	O
first	O
compared	O
the	O
effects	O
of	O
PMA	O
and	O
RA	O
on	O
the	O
expression	O
of	O
genes	O
which	O
are	O
known	O
to	O
be	O
regulated	O
during	O
monocytic	O
differentiation	O
.	O
Both	O
RA	O
and	O
PMA	O
effectively	O
down-regulated	O
c-myc	DNA
expression	O
,	O
while	O
c-myb	DNA
expression	O
decreased	O
only	O
after	O
PMA	O
treatment	O
.	O
Expression	O
of	O
the	O
beta	DNA
2-integrin	DNA
genes	DNA
,	O
CD11a	DNA
and	O
CD11b	DNA
,	O
was	O
clearly	O
increased	O
after	O
both	O
of	O
these	O
treatments.	O
Their	O
effects	O
on	O
the	O
src-family	DNA
tyrosine	DNA
kinase	DNA
genes	DNA
were	O
different:	O
hck	DNA
expression	O
was	O
similarly	O
induced	O
by	O
these	O
agents	O
but	O
lyn	O
expression	O
was	O
stronger	O
and	O
more	O
rapid	O
after	O
RA	O
treatment	O
.	O
RA	O
also	O
enhanced	O
lyn	RNA
mRNA	RNA
production	O
rapidly	O
in	O
HL-60	cell_line
,	O
indicating	O
that	O
the	O
activation	O
of	O
lyn	DNA
gene	DNA
expression	O
is	O
common	O
in	O
monocytic	O
and	O
granulocytic	O
maturation	O
of	O
myeloid	cell_type
leukemia	cell_type
cells	cell_type
.	O
To	O
examine	O
whether	O
the	O
AP-1	DNA
enhancer	DNA
activity	O
is	O
involved	O
in	O
RA	O
-induced	O
monocytic	O
differentiation	O
,	O
THP-1	cell_line
cells	cell_line
were	O
transiently	O
transfected	O
with	O
a	O
chloramphenicol	DNA
acetyl	DNA
transferase	DNA
(	DNA
CAT	DNA
)-reporter	DNA
gene	DNA
containing	O
5	O
copies	O
of	O
the	O
AP-1	DNA
binding	DNA
sites	DNA
.	O
In	O
contrast	O
to	O
PMA	O
,	O
RA	O
did	O
not	O
induce	O
any	O
CAT	protein
activity	O
in	O
these	O
cells,	O
thus	O
suggesting	O
that	O
the	O
RA	O
-induced	O
changes	O
in	O
the	O
expression	O
of	O
those	O
genes	O
described	O
above	O
were	O
not	O
dependent	O
on	O
the	O
AP-1	DNA
enhancer	DNA
activity	O
.	O

An	O
active	O
v-abl	protein
protein	protein
tyrosine	protein
kinase	protein
blocks	O
immunoglobulin	DNA
light-chain	DNA
gene	DNA
rearrangement	O
.	O
Lymphoid	cell_type
cells	cell_type
transformed	O
by	O
Abelson	O
murine	O
leukemia	O
virus	O
have	O
provided	O
one	O
of	O
the	O
classic	O
models	O
for	O
study	O
of	O
early	O
B-cell	O
development	O
and	O
immunoglobulin	protein
rearrangement	O
.	O
Most	O
of	O
these	O
cells	O
have	O
rearranged	O
their	O
heavy-chain	DNA
locus	DNA
but	O
not	O
their	O
light	DNA
chain	DNA
genes	DNA
,	O
suggesting	O
that	O
an	O
active	O
v-abl	protein
protein	protein
interferes	O
with	O
this	O
differentiation	O
step.	O
To	O
test	O
this	O
hypothesis,	O
light-chain	DNA
gene	DNA
structure	DNA
was	O
examined	O
in	O
pre-B	cell_line
cells	cell_line
transformed	O
by	O
temperature-sensitive	O
mutants	O
of	O
the	O
Abelson	O
virus	O
and	O
in	O
derivatives	O
that	O
survive	O
at	O
the	O
nonpermissive	O
temperature	O
because	O
they	O
express	O
a	O
human	DNA
BCL-2	DNA
gene	DNA
.	O
Our	O
studies	O
reveal	O
that	O
inactivation	O
of	O
the	O
v-abl	protein
protein	protein
tyrosine	protein
kinase	protein
triggers	O
high-frequency	O
rearrangement	O
of	O
kappa	O
and	O
lambda	O
light-chain	O
genes	O
.	O
These	O
events	O
are	O
accompanied	O
by	O
marked	O
increases	O
in	O
the	O
expression	O
of	O
RAG-1	RNA
and	RNA
RAG-2	RNA
RNAs	RNA
.	O
These	O
increases	O
occur	O
in	O
the	O
absence	O
of	O
protein	O
synthesis	O
but	O
are	O
dependent	O
on	O
inactivation	O
of	O
the	O
v-abl	protein
protein	protein
tyrosine	protein
kinase	protein
.	O
As	O
documented	O
in	O
the	O
accompanying	O
paper	O
(Klug	O
et	O
al.,	O
this	O
issue),	O
an	O
active	O
v-abl	protein
protein	protein
also	O
suppresses	O
the	O
activity	O
of	O
NF-kappa	protein
B	protein
/rel	protein
and	O
expression	O
controlled	O
by	O
the	O
kappa	DNA
intron	DNA
enhancer	DNA
.	O
Together	O
these	O
data	O
demonstrate	O
that	O
the	O
v-abl	protein
protein	protein
specifically	O
interferes	O
with	O
light-chain	DNA
gene	DNA
rearrangement	O
by	O
suppressing	O
at	O
least	O
two	O
pathways	O
essential	O
for	O
this	O
stage	O
of	O
B-cell	cell_type
differentiation	O
and	O
suggest	O
that	O
tyrosine	O
phosphorylation	O
is	O
important	O
in	O
regulating	O
RAG	DNA
gene	DNA
expression	O
.	O

Calcium	O
signalling	O
in	O
T	cell_type
cells	cell_type
stimulated	O
by	O
a	O
cyclophilin	protein
B-binding	protein
protein	protein
.	O
The	O
immunosuppressant	O
drug	O
cyclosporin	O
A	O
blocks	O
a	O
calcium	O
-dependent	O
signal	O
from	O
the	O
T-cell	protein
receptor	protein
(	O
TCR	protein
)	O
that	O
normally	O
leads	O
to	O
T-cell	O
activation	O
.	O
When	O
bound	O
to	O
cyclophilin	protein
,	O
cyclosporin	O
A	O
binds	O
and	O
inactivates	O
the	O
key	O
signalling	O
intermediate	O
calcineurin	protein
.	O
To	O
identify	O
potential	O
cellular	O
homologues	O
of	O
cyclosporin	O
A	O
that	O
might	O
regulate	O
calcium	O
signalling	O
,	O
we	O
have	O
cloned	O
human	O
genes	O
encoding	O
cyclophilin	protein
B-binding-proteins	protein
using	O
the	O
yeast	O
two-hybrid	O
system	O
.	O
One	O
gene	O
product,	O
when	O
overexpressed	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
,	O
specifically	O
induced	O
transcription	O
from	O
the	O
interleukin-2	DNA
enhancer	DNA
,	O
by	O
activating	O
the	O
T-cell-specific	protein
transcription	protein
factors	protein
NF-AT	protein
and	O
NF-IL2A	protein
.	O
This	O
protein,	O
termed	O
calcium	protein
-signal	protein
modulating	protein
cyclophilin	protein
ligand	protein
(	O
CAML	protein
),	O
acts	O
downstream	O
of	O
the	O
TCR	protein
and	O
upstream	O
of	O
calcineurin	protein
by	O
causing	O
an	O
influx	O
of	O
calcium	O
.	O
CAML	protein
appears	O
to	O
be	O
a	O
new	O
participant	O
in	O
the	O
calcium	O
-signal	O
transduction	O
pathway	O
,	O
implicating	O
cyclophilin	protein
B	protein
in	O
calcium	O
signalling	O
,	O
even	O
in	O
the	O
absence	O
of	O
cyclosporin	O
.	O

Expression	O
and	O
genomic	O
configuration	O
of	O
GM-CSF	protein
,	O
IL-3	protein
,	O
M-CSF	protein
receptor	protein
(	O
C-FMS	protein
),	O
early	DNA
growth	DNA
response	DNA
gene-1	DNA
(	O
EGR-1	DNA
)	O
and	O
M-CSF	DNA
genes	DNA
in	O
primary	O
myelodysplastic	O
syndromes	O
.	O
Peripheral	O
blood	O
mononuclear	O
cells	O
from	O
seventeen	O
patients	O
with	O
primary	O
myelodysplastic	O
syndromes	O
(	O
MDS	O
)	O
in	O
advanced	O
stage	O
were	O
enriched	O
for	O
blasts	cell_type
and	O
tested	O
for	O
(1)	O
karyotype	O
,	O
(2)	O
genomic	O
configuration	O
and	O
(3)	O
expression	O
of	O
IL-3	O
,	O
GM-CSF	O
,	O
FMS	O
and	O
EGR-1	O
genes	O
which	O
are	O
all	O
located	O
on	O
the	O
long	DNA
arm	DNA
of	DNA
chromosome	DNA
5	DNA
.	O
The	O
expression	O
of	O
the	O
M-CSF	DNA
gene	DNA
,	O
that	O
has	O
been	O
recently	O
reassigned	O
to	O
the	O
short	DNA
arm	DNA
of	DNA
chromosome	DNA
1	DNA
(	O
lp	DNA
),	O
was	O
also	O
investigated.	O
Aims	O
of	O
the	O
study	O
were	O
to	O
(1)	O
assess	O
the	O
potential	O
role	O
of	O
the	O
expression	O
of	O
these	O
genes	O
in	O
the	O
maintenance	O
and	O
expansion	O
of	O
the	O
neoplastic	cell_line
clones	cell_line
and	O
(2)	O
search	O
for	O
constitutional	O
losses	O
or	O
rearrangements	O
of	O
one	O
allele	DNA
followed	O
by	O
a	O
deletion	O
of	O
the	O
second	O
allele	DNA
of	O
the	O
same	O
genes	O
in	O
the	O
leukemic	cell_type
cells	cell_type
.	O
The	O
latter	O
issue	O
was	O
investigated	O
by	O
comparing,	O
in	O
8	O
cases,	O
constitutive	DNA
DNA	DNA
from	O
skin	cell_type
fibroblasts	cell_type
with	O
leukemic	DNA
DNA	DNA
.	O
Eleven	O
of	O
the	O
17	O
patients	O
had	O
abnormal	O
karyotypes	O
.	O
The	O
M-CSF	DNA
gene	DNA
was	O
expressed	O
in	O
6	O
cases	O
and	O
the	O
FMS	DNA
and	O
the	O
EGR-1	DNA
genes	DNA
were	O
expressed	O
in	O
2	O
of	O
the	O
latter	O
cases.	O
An	O
autocrine	O
mechanism	O
of	O
growth	O
could	O
be	O
hypothesized	O
only	O
for	O
the	O
2	O
patients	O
whose	O
cells	O
expressed	O
both	O
the	O
M-CSF	O
and	O
FMS	O
genes	O
.	O
No	O
germline	O
changes	O
or	O
rearrangements	O
were	O
observed	O
in	O
any	O
of	O
the	O
genes	O
studied.	O
Thus,	O
deregulation	O
of	O
genes	O
encoding	O
for	O
certain	O
hemopoietic	protein
growth	protein
factors	protein
or	O
receptors	O
does	O
not	O
seem	O
to	O
represent	O
a	O
major	O
mechanism	O
of	O
MDS	O
progression	O
.	O

A	O
novel	O
human	DNA
homeobox	DNA
gene	DNA
distantly	O
related	O
to	O
proboscipedia	DNA
is	O
expressed	O
in	O
lymphoid	O
and	O
pancreatic	O
tissues	O
.	O
A	O
novel	O
human	DNA
homeobox	DNA
gene	DNA
,	O
HB9	DNA
,	O
was	O
isolated	O
from	O
a	O
cDNA	DNA
library	DNA
prepared	O
from	O
in	O
vitro	cell_type
stimulated	cell_type
human	cell_type
tonsil	cell_type
B	cell_type
lymphocytes	cell_type
and	O
from	O
a	O
human	DNA
genomic	DNA
library	DNA
.	O
The	O
HB9	DNA
gene	DNA
is	O
composed	O
of	O
3	O
exons	DNA
spread	O
over	O
6	O
kilobases	O
of	O
DNA.	O
An	O
open	DNA
reading	DNA
frame	DNA
of	O
1206	O
nucleotides	O
is	O
in	O
frame	O
with	O
a	O
diverged	DNA
homeodomain	DNA
.	O
The	O
predicted	O
HB9	protein
protein	protein
has	O
a	O
molecular	O
mass	O
of	O
41	O
kilodaltons	O
and	O
is	O
enriched	O
for	O
alanine	O
,	O
glycine	O
,	O
and	O
leucine	O
.	O
The	O
HB9	DNA
homeodomain	DNA
is	O
most	O
similar	O
to	O
that	O
of	O
the	O
Drosophila	DNA
melanogaster	DNA
homeobox	DNA
gene	DNA
proboscipedia	DNA
.	O
Northern	O
blot	O
analysis	O
of	O
poly(A)	RNA
RNA	RNA
purified	O
from	O
the	O
human	cell_line
B	cell_line
cell	cell_line
line	cell_line
RPMI	cell_line
8226	cell_line
and	O
from	O
activated	cell_type
T	cell_type
cells	cell_type
revealed	O
a	O
major	RNA
mRNA	RNA
transcript	RNA
of	O
2.2	O
kilobases	O
.	O
Similar	O
analysis	O
of	O
poly(A)	RNA
RNA	RNA
from	O
a	O
variety	O
of	O
adult	O
tissues	O
demonstrated	O
HB9	DNA
transcripts	O
in	O
pancreas	O
,	O
small	O
intestine	O
,	O
and	O
colon	O
.	O
Reverse	O
transcriptase-polymerase	O
chain	O
reaction	O
was	O
used	O
to	O
examine	O
HB9	RNA
RNA	RNA
transcripts	RNA
in	O
hematopoietic	cell_line
cell	cell_line
lines	cell_line
.	O
HB9	RNA
RNA	RNA
transcripts	RNA
were	O
most	O
prevalent	O
in	O
several	O
human	cell_line
B	cell_line
cell	cell_line
lines	cell_line
and	O
K562	cell_line
cells	cell_line
.	O
In	O
addition,	O
transcripts	O
were	O
detected	O
in	O
RNA	O
prepared	O
from	O
tonsil	cell_type
B	cell_type
cells	cell_type
and	O
in	O
situ	O
hybridization	O
studies	O
localized	O
them	O
in	O
the	O
germinal	O
center	O
region	O
of	O
adult	O
tonsil	O
.	O
These	O
findings	O
suggest	O
the	O
involvement	O
of	O
HB9	DNA
in	O
regulating	O
gene	O
transcription	O
in	O
lymphoid	O
and	O
pancreatic	O
tissues	O
.	O

Human	protein
immunodeficiency	protein
virus	protein
type	protein
1	protein
Tat	protein
upregulates	O
interleukin-2	protein
secretion	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
.	O
Dysregulation	O
of	O
cytokines	protein
secreted	O
by	O
T	cell_type
cells	cell_type
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
AIDS	O
.	O
To	O
investigate	O
the	O
effects	O
of	O
human	protein
immunodeficiency	protein
virus	protein
type	protein
1	protein
(	protein
HIV-1	protein
)	protein
Tat	protein
on	O
interleukin-2	protein
(	O
IL-2	protein
)	O
expression	O
,	O
we	O
used	O
IL-2	DNA
promoter	DNA
-chloramphenicol	DNA
acetyltransferase	DNA
constructs	DNA
and	O
IL-2	cell_line
-secreting	cell_line
Jurkat	cell_line
T	cell_line
cells	cell_line
as	O
a	O
model	O
system.	O
Transient	O
expression	O
of	O
HIV-1	protein
Tat	protein
induced	O
a	O
five-	O
to	O
eightfold	O
increase	O
in	O
IL-2	DNA
promoter	DNA
activity	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
stimulated	O
with	O
phytohemagglutinin	protein
and	O
phorbol	O
myristate	O
acetate	O
.	O
IL-2	protein
secretion	O
was	O
increased	O
more	O
than	O
twofold	O
in	O
both	O
Jurkat	cell_line
T	cell_line
cells	cell_line
and	O
primary	cell_line
T	cell_line
cells	cell_line
stimulated	O
by	O
extracellular	protein
HIV-1	protein
Tat	protein
protein	protein
.	O
Analysis	O
of	O
mRNA	RNA
suggested	O
that	O
Tat	O
exerts	O
its	O
effect	O
on	O
IL-2	protein
primarily	O
at	O
the	O
transcriptional	O
level	O
.	O
The	O
NF-kappa	DNA
B	DNA
site	DNA
at	O
positions	O
-206	DNA
to	DNA
-195	DNA
of	O
the	O
IL-2	DNA
promoter	DNA
was	O
required	O
but	O
not	O
sufficient	O
for	O
the	O
Tat	protein
effect	O
.	O
The	O
Tat	protein
-mediated	O
increase	O
in	O
IL-2	DNA
promoter	DNA
activity	O
could	O
selectively	O
be	O
blocked	O
by	O
antisense	O
tat	O
or-unlike	O
the	O
analogous	O
effect	O
of	O
human	protein
T-cell	protein
lymphotropic	protein
virus	protein
type	protein
1	protein
Tax	protein
-by	O
cyclosporin	O
A	O
.	O
The	O
observed	O
increase	O
in	O
IL-2	protein
levels	O
might	O
facilitate	O
virus	O
spread	O
from	O
or	O
to	O
T	cell_type
cells	cell_type
.	O
Furthermore,	O
it	O
might	O
contribute	O
to	O
the	O
hypergammaglobulinemia	O
or,	O
together	O
with	O
other	O
cytokines	protein
found	O
to	O
be	O
dysregulated,	O
the	O
T-helper	O
cell	O
dysfunctions	O
observed	O
in	O
AIDS	O
patients	O
.	O

Activation	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
in	O
human	cell_type
lymphoblastoid	cell_type
cells	cell_type
by	O
low-dose	O
ionizing	O
radiation	O
.	O
Nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
is	O
a	O
pleiotropic	protein
transcription	protein
factor	protein
which	O
is	O
involved	O
in	O
the	O
transcriptional	O
regulation	O
of	O
several	O
specific	O
genes.	O
Recent	O
reports	O
demonstrated	O
that	O
ionizing	O
radiation	O
in	O
the	O
dose	O
range	O
of	O
2-50	O
Gy	O
results	O
in	O
expression	O
of	O
NF-kappa	protein
B	protein
in	O
human	cell_line
KG-1	cell_line
myeloid	cell_line
leukemia	cell_line
cells	cell_line
and	O
human	cell_type
B-lymphocyte	cell_type
precursor	cell_type
cells	cell_type
;	O
the	O
precise	O
mechanism	O
involved	O
and	O
the	O
significance	O
are	O
not	O
yet	O
known.	O
The	O
present	O
report	O
demonstrates	O
that	O
even	O
lower	O
doses	O
of	O
ionizing	O
radiation	O
,	O
0.25-2.0	O
Gy	O
,	O
are	O
capable	O
of	O
inducing	O
expression	O
of	O
NF-kappa	protein
B	protein
in	O
EBV-transformed	cell_line
244B	cell_line
human	cell_line
lymphoblastoid	cell_line
cells	cell_line
.	O
These	O
results	O
are	O
in	O
a	O
dose	O
range	O
where	O
the	O
viability	O
of	O
the	O
cells	O
remains	O
very	O
high.	O
After	O
exposure	O
to	O
137Cs	O
gamma	O
rays	O
at	O
a	O
dose	O
rate	O
of	O
1.17	O
Gy/min	O
,	O
a	O
maximum	O
in	O
expression	O
of	O
NF-kappa	protein
B	protein
was	O
seen	O
at	O
8	O
h	O
after	O
a	O
0.5-Gy	O
exposure	O
.	O
Time-course	O
studies	O
revealed	O
a	O
biphasic	O
time-dependent	O
expression	O
after	O
0.5-,	O
1-	O
and	O
2-Gy	O
exposures	O
.	O
However,	O
for	O
each	O
time	O
examined,	O
the	O
expression	O
of	O
NF-kappa	protein
B	protein
was	O
maximum	O
after	O
the	O
0.5-Gy	O
exposure	O
.	O
The	O
expression	O
of	O
the	O
p50	O
and	O
p65	O
NF-kappa	O
B	O
subunits	O
was	O
also	O
shown	O
to	O
be	O
regulated	O
differentially	O
after	O
exposures	O
to	O
1.0	O
and	O
2.0	O
Gy	O
.	O

Alternative	O
splicing	O
of	O
RNA	RNA
transcripts	RNA
encoded	O
by	O
the	O
murine	DNA
p105	DNA
NF-kappa	DNA
B	DNA
gene	DNA
generates	O
I	protein
kappa	protein
B	protein
gamma	protein
isoforms	protein
with	O
different	O
inhibitory	O
activities	O
.	O
The	O
gene	O
encoding	O
the	O
105-kDa	protein
protein	protein
(	protein
p105	protein
)	protein
precursor	protein
of	O
the	O
p50	protein
subunit	O
of	O
transcription	O
factor	O
NF-kappa	protein
B	protein
also	O
encodes	O
a	O
p70	protein
I	protein
kappa	protein
B	protein
protein	protein
,	O
I	protein
kappa	protein
B	protein
gamma	protein
,	O
which	O
is	O
identical	O
to	O
the	O
C-terminal	protein
607	protein
amino	protein
acids	protein
of	O
p105	protein
.	O
Here	O
we	O
show	O
that	O
alternative	O
RNA	O
splicing	O
generates	O
I	protein
kappa	protein
B	protein
gamma	protein
isoforms	protein
with	O
properties	O
different	O
from	O
those	O
of	O
p70	protein
.	O
One	O
63-kDa	protein
isoform	protein
,	O
termed	O
I	protein
kappa	protein
B	protein
gamma-1	protein
,	O
which	O
lacks	O
59	O
amino	O
acids	O
C-terminal	O
to	O
ankyrin	protein
repeat	protein
7	protein
,	O
has	O
a	O
novel	O
35-amino	protein
acid	protein
C	protein
terminus	protein
encoded	O
by	O
an	O
alternative	DNA
reading	DNA
frame	DNA
of	O
the	O
p105	DNA
gene	DNA
.	O
A	O
55-kDa	protein
isoform	protein
,	O
I	protein
kappa	protein
B	protein
gamma-2	protein
,	O
lacks	O
the	O
190	protein
C-terminal	protein
amino	protein
acids	protein
of	O
p70	protein
I	protein
kappa	protein
B	protein
gamma	protein
.	O
In	O
contrast	O
to	O
p70	protein
I	protein
kappa	protein
B	protein
gamma	protein
,	O
which	O
is	O
a	O
cytoplasmic	protein
protein	protein
,	O
I	protein
kappa	protein
B	protein
gamma-1	protein
is	O
found	O
in	O
both	O
the	O
cytoplasm	O
and	O
nucleus,	O
whereas	O
I	protein
kappa	protein
B	protein
gamma-2	protein
is	O
predominantly	O
nuclear.	O
The	O
I	protein
kappa	protein
B	protein
gamma	protein
isoforms	protein
also	O
display	O
differences	O
in	O
specificity	O
and	O
affinity	O
for	O
Rel/	protein
NF-kappa	protein
B	protein
proteins	protein
.	O
While	O
p70	protein
I	protein
kappa	protein
B	protein
gamma	protein
inhibits	O
p50-	O
,	O
p65-	O
,	O
and	O
c-Rel-	O
mediated	O
transactivation	O
and/or	O
DNA	O
binding	O
,	O
both	O
I	protein
kappa	protein
B	protein
gamma-1	protein
and	O
I	protein
kappa	protein
B	protein
gamma-2	protein
are	O
specific	O
for	O
p50	protein
and	O
have	O
different	O
affinities	O
for	O
this	O
subunit.	O
The	O
absence	O
in	O
I	protein
kappa	protein
B	protein
gamma-1	protein
and	O
I	protein
kappa	protein
B	protein
gamma-2	protein
of	O
a	O
protein	DNA
kinase	DNA
A	DNA
site	DNA
whose	O
phosphorylation	O
modulates	O
p70	protein
I	protein
kappa	protein
B	protein
gamma	protein
inhibitory	O
activity	O
suggests	O
that	O
alternative	O
RNA	O
splicing	O
may	O
be	O
used	O
to	O
generate	O
I	protein
kappa	protein
B	protein
gamma	protein
isoforms	protein
that	O
respond	O
differently	O
to	O
intracellular	O
signals	O
.	O

Structure	O
and	O
expression	O
of	O
the	O
human	DNA
GATA3	DNA
gene	DNA
.	O
GATA3	protein
,	O
a	O
member	O
of	O
the	O
GATA	protein
family	protein
that	O
is	O
abundantly	O
expressed	O
in	O
the	O
T-lymphocyte	cell_type
lineage	cell_type
,	O
is	O
thought	O
to	O
participate	O
in	O
T-cell	protein
receptor	protein
gene	O
activation	O
through	O
binding	O
to	O
enhancers	DNA
.	O
To	O
understand	O
GATA3	DNA
gene	DNA
regulation	O
,	O
we	O
cloned	O
the	O
human	DNA
gene	DNA
and	O
the	O
5'	DNA
end	DNA
of	O
the	O
mouse	DNA
GATA3	DNA
gene	DNA
.	O
We	O
show	O
that	O
the	O
human	DNA
GATA3	DNA
gene	DNA
contains	O
six	O
exons	DNA
distributed	O
over	O
17	O
kb	O
of	O
DNA	O
.	O
The	O
two	O
human	protein
GATA3	protein
zinc	protein
fingers	protein
are	O
encoded	O
by	O
two	O
separate	O
exons	DNA
highly	O
conserved	O
with	O
those	O
of	O
GATA1	protein
,	O
but	O
no	O
other	O
structural	O
homologies	O
between	O
these	O
two	O
genes	O
can	O
be	O
found.	O
The	O
human	O
and	O
mouse	O
GATA3	O
transcription	O
units	O
start	O
at	O
a	O
major	DNA
initiation	DNA
site	DNA
.	O
The	O
promoter	O
sequence	O
analysis	O
of	O
these	O
two	O
genes	O
revealed	O
that	O
they	O
are	O
embedded	O
within	O
a	O
CpG	DNA
island	DNA
and	O
share	O
structural	O
features	O
often	O
found	O
in	O
the	O
promoters	DNA
of	O
housekeeping	DNA
genes	DNA
.	O
Finally,	O
we	O
show	O
that	O
a	O
DNA	DNA
fragment	DNA
containing	O
the	O
human	DNA
GATA3	DNA
transcription	DNA
unit	DNA
,	O
3	DNA
kb	DNA
upstream	DNA
from	O
the	O
initiation	DNA
site	DNA
and	O
4	DNA
kb	DNA
downstream	DNA
from	O
the	O
polyadenylation	DNA
site	DNA
,	O
displays	O
T-cell	O
specificity	O
.	O

Characterization	O
of	O
the	O
human	DNA
gene	DNA
encoding	O
LBR	protein
,	O
an	O
integral	protein
protein	protein
of	O
the	O
nuclear	O
envelope	O
inner	O
membrane	O
.	O
We	O
have	O
characterized	O
the	O
human	DNA
gene	DNA
encoding	O
LBR	protein
,	O
an	O
integral	protein
protein	protein
of	O
the	O
nuclear	O
envelope	O
inner	O
membrane	O
.	O
Restriction	O
mapping	O
shows	O
that	O
the	O
transcription	DNA
unit	DNA
spans	O
approximately	O
35	O
kilobases	O
.	O
A	O
transcription	O
start	O
site	O
is	O
located	O
approximately	O
4	O
kilobases	O
5'	O
to	O
the	O
translation	DNA
initiation	DNA
codon	DNA
,	O
and	O
an	O
RNA	O
splice	O
of	O
3863	O
bases	O
occurs	O
in	O
the	O
5'-untranslated	DNA
region	DNA
to	O
generate	O
mature	RNA
HeLa	RNA
cell	RNA
mRNA	RNA
.	O
5'	O
to	O
the	O
identified	O
transcription	DNA
start	DNA
site	DNA
are	O
two	O
CCAAT	DNA
sequences	DNA
and	O
potential	DNA
recognition	DNA
sites	DNA
for	O
several	O
transcription	protein
factors	protein
including	O
Sp1	protein
,	O
AP-1	protein
,	O
AP-2	protein
,	O
and	O
NF-kB	protein
.	O
There	O
are	O
13	O
protein	O
coding	O
exons	DNA
in	O
the	O
LBR	DNA
gene	DNA
.	O
LBR	protein
's	O
nucleoplasmic	protein
domain	protein
is	O
encoded	O
by	O
exons	DNA
1-4	DNA
,	O
and	O
its	O
hydrophobic	protein
domain	protein
,	O
with	O
eight	O
putative	O
transmembrane	protein
segments	protein
,	O
is	O
encoded	O
by	O
exons	DNA
5-13	DNA
.	O
The	O
hydrophobic	protein
domain	protein
is	O
homologous	O
to	O
three	O
yeast	O
polypeptides	O
,	O
suggesting	O
that	O
this	O
higher	DNA
eukaryotic	DNA
gene	DNA
could	O
have	O
evolved	O
from	O
recombination	O
between	O
a	O
gene	O
that	O
encoded	O
a	O
soluble	protein
nuclear	protein
protein	protein
and	O
a	O
membrane	DNA
protein	DNA
gene	DNA
similar	O
to	O
those	O
in	O
yeast	O
.	O
These	O
results	O
are	O
the	O
first	O
to	O
demonstrate	O
the	O
structural	O
organization	O
of	O
a	O
vertebrate	DNA
gene	DNA
encoding	O
an	O
integral	protein
membrane	protein
protein	protein
of	O
the	O
nuclear	O
envelope	O
that	O
may	O
be	O
a	O
member	O
of	O
a	O
family	O
of	O
polypeptides	O
conserved	O
in	O
evolution	O
.	O

Retinoic	O
acid-induced	O
expression	O
of	O
CD38	protein
antigen	protein
in	O
myeloid	cell_type
cells	cell_type
is	O
mediated	O
through	O
retinoic	protein
acid	protein
receptor-alpha	protein
.	O
CD38	protein
is	O
a	O
leukocyte	protein
differentiation	protein
antigen	protein
that	O
has	O
been	O
thought	O
to	O
be	O
a	O
phenotypic	O
marker	O
of	O
different	O
subpopulations	O
of	O
T-	O
and	O
B-	O
lymphocytes	O
.	O
In	O
myeloid	cell_type
cells	cell_type
,	O
CD38	protein
is	O
expressed	O
during	O
early	O
stages	O
of	O
differentiation	O
.	O
Virtually	O
no	O
information	O
is	O
available	O
on	O
regulation	O
and	O
functions	O
of	O
CD38	protein
.	O
Recently	O
we	O
reported	O
that	O
all-trans-retinoic	O
acid	O
(	O
ATRA	O
)	O
is	O
a	O
potent	O
and	O
highly	O
specific	O
inducer	O
of	O
CD38	protein
expression	O
in	O
human	cell_type
promyelocytic	cell_type
leukemia	cell_type
cells	cell_type
.	O
Here	O
we	O
report	O
that	O
ATRA	O
-induced	O
expression	O
of	O
CD38	protein
antigen	protein
in	O
myeloid	cell_type
cells	cell_type
is	O
mediated	O
through	O
retinoic	protein
acid-alpha	protein
receptor	protein
(	O
RAR	protein
alpha	protein
).	O
ATRA	O
failed	O
to	O
induce	O
CD38	protein
expression	O
in	O
a	O
mutant	cell_line
subclone	cell_line
of	O
the	O
HL-60	cell_line
myeloid	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
(designated	O
HL-60R	cell_line
)	O
that	O
is	O
relatively	O
resistant	O
to	O
ATRA	O
-induced	O
granulocytic	O
differentiation	O
.	O
Retroviral	O
vector-mediated	O
transduction	O
of	O
RA	protein
receptor	protein
(	O
RAR	protein
alpha	protein
)	O
into	O
this	O
HL-60R	cell_line
subclone	cell_line
completely	O
restored	O
the	O
sensitivity	O
of	O
these	O
cells	O
to	O
ATRA	O
in	O
terms	O
of	O
their	O
ability	O
to	O
express	O
CD38	protein
.	O
In	O
contrast,	O
CD38	protein
expression	O
was	O
not	O
inducible	O
by	O
ATRA	O
in	O
HL-60R	cell_line
cells	cell_line
,	O
transfected	O
with	O
a	O
functional	O
RAR	protein
beta	protein
,	O
RAR	protein
gamma	protein
,	O
or	O
RXR	protein
alpha	protein
receptor	protein
.	O
Induction	O
of	O
CD38	protein
in	O
acute	O
promyelocytic	O
and	O
acute	O
myeloblastic	O
leukemia	O
cells	O
was	O
independent	O
of	O
ATRA	O
-induced	O
cytodifferentiation	O
.	O
Following	O
culture	O
with	O
ATRA	O
,	O
increased	O
CD38	protein
protein	O
levels	O
were	O
also	O
observed	O
in	O
normal	cell_type
CD34+	cell_type
bone	cell_type
marrow	cell_type
cells	cell_type
,	O
but	O
not	O
on	O
normal	cell_type
circulating	cell_type
granulocytes	cell_type
.	O
From	O
these	O
results,	O
we	O
conclude	O
that	O
CD38	protein
is	O
ATRA	O
inducible	O
in	O
myeloid	cell_type
leukemia	cell_type
cells	cell_type
and	O
normal	cell_type
CD34+	cell_type
bone	cell_type
marrow	cell_type
cells	cell_type
.	O
This	O
effect	O
is	O
independent	O
of	O
differentiation	O
and	O
is	O
mediated	O
by	O
RAR	protein
alpha	protein
in	O
HL-60	cell_type
cells	cell_type
,	O
suggesting	O
a	O
similar	O
role	O
for	O
RAR	protein
alpha	protein
in	O
CD38	protein
expression	O
in	O
other	O
hematopoietic	cell_type
cells	cell_type
.	O

Some	O
antioxidants	O
inhibit,	O
in	O
a	O
co-ordinate	O
fashion,	O
the	O
production	O
of	O
tumor	protein
necrosis	protein
factor-alpha	protein
,	O
IL-beta	protein
,	O
and	O
IL-6	protein
by	O
human	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
.	O
Some	O
antioxidants	O
,	O
including	O
butylated	O
hydroxyanisole	O
(	O
BHA	O
),	O
tetrahydropapaveroline	O
(	O
THP	O
),	O
nordihydroguiauretic	O
acid	O
,	O
and	O
10,11-dihydroxyaporphine	O
(	O
DHA	O
),	O
were	O
found	O
to	O
be	O
potent	O
inhibitors	O
of	O
the	O
production	O
of	O
tumor	protein
necrosis	protein
factor	protein
(TNF)-alpha	protein
,	O
IL-1	protein
beta	protein
,	O
and	O
IL-6	protein
by	O
human	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
)	O
stimulated	O
by	O
lipopolysaccharide	O
(	O
LPS	O
)	O
(	O
IC50s	O
in	O
the	O
low	O
micromolar	O
range).	O
Inhibition	O
of	O
cytokine	protein
production	O
was	O
gene	O
selective	O
and	O
not	O
due	O
to	O
general	O
effects	O
on	O
protein	O
synthesis	O
.	O
Inhibition	O
of	O
cytokine	protein
production	O
by	O
PBMC	cell_type
was	O
observed	O
also	O
when	O
other	O
inducers	O
were	O
used	O
(	O
staphylococci	O
,	O
silica	O
,	O
zymosan	O
).	O
Much	O
higher	O
concentrations	O
of	O
other	O
antioxidants	O
--including	O
ascorbic	O
acid	O
,	O
trolox	O
,	O
alpha-tocopherol	O
,	O
butylated	O
hydroxytoluene	O
,	O
and	O
the	O
5-lipoxygenase	O
inhibitor	O
zileuton	O
--did	O
not	O
affect	O
the	O
production	O
of	O
these	O
cytokines	protein
.	O
The	O
active	O
compounds	O
did	O
not	O
inhibit	O
IL-1	protein
-induced	O
production	O
of	O
IL-6	protein
in	O
fibroblasts	cell_type
,	O
showing	O
the	O
cell	O
selectivity	O
of	O
the	O
effect.	O
Antioxidant-mediated	O
inhibition	O
of	O
cytokine	protein
production	O
was	O
correlated	O
with	O
low	O
levels	O
of	O
the	O
corresponding	O
messenger	RNA
RNAs	RNA
.	O
Nuclear	O
run-on	O
experiments	O
showed	O
that	O
THP	O
inhibited	O
transcription	O
of	O
the	O
IL-1	DNA
beta	DNA
gene	DNA
.	O
THP	O
decreased	O
the	O
concentration	O
of	O
the	O
transcription	protein
factors	protein
NF-kappa	protein
B	protein
and	O
AP-1	protein
detected	O
in	O
nuclear	O
extracts	O
of	O
PBMC	cell_type
cultured	O
in	O
the	O
presence	O
or	O
absence	O
of	O
LPS	O
.	O
THP	O
and	O
DHA	O
markedly	O
decreased	O
the	O
levels	O
of	O
TNF-alpha	protein
and	O
IL-1	protein
beta	protein
in	O
the	O
circulation	O
of	O
mice	O
following	O
LPS	O
injection.	O
Thus	O
antioxidants	O
vary	O
widely	O
in	O
potency	O
as	O
inhibitors	O
of	O
the	O
activation	O
of	O
transcription	protein
factors	protein
and	O
of	O
the	O
transcription	O
of	O
genes	DNA
for	O
pro-inflammatory	protein
cytokines	protein
.	O
Coordinate	O
inhibition	O
of	O
the	O
transcription	O
of	O
genes	O
for	O
inflammatory	O
cytokines	protein
could	O
provide	O
a	O
strategy	O
for	O
therapy	O
of	O
diseases	O
with	O
inflammatory	O
pathogenesis	O
and	O
for	O
septic	O
shock	O
.	O

An	O
interleukin-4-induced	protein
transcription	protein
factor	protein
:	O
IL-4	protein
Stat	protein
.	O
Interleukin-4	protein
(	O
IL-4	protein
)	O
is	O
an	O
immunomodulatory	O
cytokine	O
secreted	O
by	O
activated	O
T	cell_type
lymphocytes	cell_type
,	O
basophils	cell_type
,	O
and	O
mast	cell_type
cells	cell_type
.	O
It	O
plays	O
an	O
important	O
role	O
in	O
modulating	O
the	O
balance	O
of	O
T	cell_type
helper	cell_type
(Th)	cell_type
cell	cell_type
subsets	cell_type
,	O
favoring	O
expansion	O
of	O
the	O
Th2	cell_type
lineage	cell_type
relative	O
to	O
Th1	cell_type
.	O
Imbalance	O
of	O
these	O
T	cell_type
lymphocyte	cell_type
subsets	cell_type
has	O
been	O
implicated	O
in	O
immunological	O
diseases	O
including	O
allergy	O
,	O
inflammation	O
,	O
and	O
autoimmune	O
disease	O
.	O
IL-4	protein
may	O
mediate	O
its	O
biological	O
effects,	O
at	O
least	O
in	O
part,	O
by	O
activating	O
a	O
tyrosine-phosphorylated	protein
DNA	protein
binding	protein
protein	protein
.	O
This	O
protein	O
has	O
now	O
been	O
purified	O
and	O
its	O
encoding	O
gene	O
cloned.	O
Examination	O
of	O
the	O
primary	protein
amino	protein
acid	protein
sequence	protein
of	O
this	O
protein	O
indicates	O
that	O
it	O
is	O
a	O
member	O
of	O
the	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(Stat)	protein
family	protein
of	O
DNA	protein
binding	protein
proteins	protein
,	O
hereby	O
designated	O
IL-4	protein
Stat	protein
.	O
Study	O
of	O
the	O
inhibitory	O
activities	O
of	O
phosphotyrosine-containing	O
peptides	O
derived	O
from	O
the	O
intracellular	protein
domain	protein
of	protein
the	protein
IL-4	protein
receptor	protein
provided	O
evidence	O
for	O
direct	O
coupling	O
of	O
receptor	protein
and	O
transcription	protein
factor	protein
during	O
the	O
IL-4	protein
Stat	protein
activation	O
cycle	O
.	O
Such	O
observations	O
indicate	O
that	O
IL-4	protein
Stat	protein
has	O
the	O
same	O
functional	protein
domain	protein
for	O
both	O
receptor	O
coupling	O
and	O
dimerization	O
.	O

Evaluation	O
of	O
the	O
respiratory	O
epithelium	O
of	O
normals	O
and	O
individuals	O
with	O
cystic	O
fibrosis	O
for	O
the	O
presence	O
of	O
adenovirus	DNA
E1a	DNA
sequences	DNA
relevant	O
to	O
the	O
use	O
of	O
E1a-	O
adenovirus	O
vectors	O
for	O
gene	O
therapy	O
for	O
the	O
respiratory	O
manifestations	O
of	O
cystic	O
fibrosis	O
.	O
Lung	O
disease	O
associated	O
with	O
disorders	O
such	O
as	O
cystic	O
fibrosis	O
(CF)	O
may	O
be	O
amenable	O
to	O
somatic	O
gene	O
therapy	O
in	O
which	O
there	O
is	O
delivery	O
of	O
the	O
normal	DNA
gene	DNA
directly	O
to	O
the	O
respiratory	O
epithelium	O
using	O
E1a-	O
adenovirus	O
(Ad)	O
type	O
2-	O
or	O
5-based	O
vectors	O
.	O
For	O
safety	O
reasons,	O
the	O
Ad	O
vectors	O
are	O
rendered	O
replication	O
deficient	O
by	O
deletion	O
of	O
the	O
E1a	DNA
region	DNA
.	O
Because	O
there	O
is	O
the	O
theoretical	O
possibility	O
of	O
an	O
E1a-	O
replication-deficient	O
vector	O
replicating	O
as	O
a	O
result	O
of	O
recombination	O
or	O
complementation	O
with	O
Ad	DNA
2/5	DNA
E1a	DNA
sequences	DNA
present	O
in	O
the	O
target	O
cell,	O
this	O
study	O
is	O
directed	O
toward	O
evaluating	O
respiratory	O
epithelium	O
of	O
normals	O
and	O
individuals	O
with	O
CF	O
for	O
the	O
presence	O
of	O
E1a	O
sequences.	O
Using	O
Ad	DNA
2/5	DNA
E1a-specific	DNA
primers	DNA
and	O
the	O
polymerase	O
chain	O
reaction	O
to	O
evaluate	O
DNA	O
recovered	O
from	O
freshly	O
isolated	O
nasal	O
and	O
bronchial	O
epithelium	O
recovered	O
by	O
brushing,	O
E1a	DNA
sequences	DNA
were	O
detected	O
in	O
respiratory	O
epithelium	O
of	O
19	O
of	O
91	O
normals	O
(21%).	O
In	O
the	O
E1a-positive	O
samples	O
,	O
the	O
average	O
of	O
E1a	O
copy	O
number	O
was	O
55	O
+/-	O
18/10(3)	O
recovered	O
cells.	O
In	O
CF	O
individuals	O
,	O
7	O
of	O
52	O
(13%)	O
had	O
detectable	O
E1a	DNA
sequences	DNA
in	O
the	O
respiratory	O
epithelium	O
,	O
with	O
E1a	O
copy	O
number	O
in	O
the	O
positive	O
samples	O
of	O
80	O
+/-	O
21/10(3)	O
recovered	O
cells.	O
These	O
results	O
demonstrate	O
that	O
there	O
are	O
detectable	O
Ad	DNA
2/5	DNA
E1a	DNA
sequences	DNA
in	O
the	O
respiratory	O
epithelium	O
of	O
a	O
small	O
percentage	O
of	O
normals	O
and	O
individuals	O
with	O
CF	O
.	O
Because	O
of	O
the	O
theoretical	O
potential	O
of	O
such	O
sequences	O
supporting	O
replication	O
of	O
E1a-	O
Ad	O
vectors	O
,	O
human	O
gene	O
therapy	O
protocols	O
for	O
CF	O
utilizing	O
such	O
vectors	O
should	O
consider	O
evaluating	O
study	O
individuals	O
for	O
the	O
presence	O
of	O
Ad	DNA
2/5	DNA
E1a	DNA
sequences	DNA
in	O
the	O
respiratory	O
epithelium	O
.	O

Leiomyosarcoma	O
of	O
the	O
vulva	O
:	O
report	O
of	O
a	O
case.	O
A	O
52-year-old	O
female	O
presented	O
with	O
a	O
progressively	O
enlarging	O
vulvar	O
mass	O
.	O
Pathological	O
evaluation	O
revealed	O
a	O
high-grade	O
vulvar	O
leiomyosarcoma	O
.	O
Immunohistochemical	O
and	O
ultrastructural	O
studies	O
were	O
performed	O
to	O
support	O
the	O
diagnosis.	O
In	O
an	O
effort	O
to	O
better	O
understand	O
the	O
biology	O
of	O
this	O
tumor	O
additional	O
immunohistochemical	O
studies	O
for	O
the	O
protein	protein
product	protein
of	O
p53	DNA
tumor	DNA
suppressor	DNA
gene	DNA
and	O
estrogen	protein
receptor	protein
expression	O
by	O
tumor	cell_type
cells	cell_type
,	O
as	O
well	O
as	O
the	O
type	O
of	O
immune	cell_type
cells	cell_type
infiltrating	O
the	O
tumor	O
were	O
performed.	O
Tumor	cell_type
cells	cell_type
showed	O
an	O
overexpression	O
of	O
p53	protein
protein	protein
and	O
were	O
estrogen	protein
receptor	protein
-positive	O
.	O
Macrophages	cell_type
and	O
T	O
and	O
B	O
lymphocytes	O
infiltrated	O
the	O
tumor	O
in	O
moderate	O
numbers	O
with	O
occasional	O
lymphoid	O
aggregate	O
formation	O
.	O
This	O
study	O
is	O
the	O
first	O
attempt	O
to	O
better	O
understand	O
the	O
biology	O
of	O
these	O
tumors	O
.	O

Stimulation	O
of	O
HIV	O
replication	O
in	O
mononuclear	cell_type
phagocytes	cell_type
by	O
leukemia	protein
inhibitory	protein
factor	protein
.	O
This	O
study	O
examined	O
the	O
effects	O
of	O
leukemia	protein
inhibitory	protein
factor	protein
(	O
LIF	protein
)	O
on	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
replication	O
in	O
mononuclear	cell_type
phagocytes	cell_type
(	O
MNP	cell_type
).	O
LIF	protein
induced	O
a	O
dose-dependent	O
increase	O
in	O
p24	protein
antigen	protein
production	O
in	O
the	O
chronically	cell_line
infected	cell_line
promonocytic	cell_line
cell	cell_line
line	cell_line
U1	cell_line
.	O
The	O
magnitude	O
and	O
time	O
kinetics	O
of	O
the	O
LIF	protein
effects	O
were	O
similar	O
to	O
interleukin	protein
1	protein
(	O
IL-1	protein
),	O
IL-6	protein
,	O
and	O
tumor	protein
necrosis	protein
factor	protein
(	O
TNF	protein
),	O
other	O
cytokines	O
known	O
to	O
induce	O
HIV	O
replication	O
in	O
this	O
cell	O
line.	O
To	O
characterize	O
mechanisms	O
responsible	O
for	O
these	O
LIF	protein
effects	O
,	O
levels	O
of	O
HIV	RNA
mRNA	RNA
,	O
activation	O
of	O
the	O
DNA	protein
binding	protein
protein	protein
nuclear	protein
factor	protein
(NF)-kB	protein
,	O
signal	O
transduction	O
pathways	O
,	O
and	O
potential	O
interactions	O
with	O
other	O
cytokines	protein
were	O
analyzed.	O
LIF	protein
increased	O
steady-state	O
levels	O
of	O
HIV	RNA
mRNA	RNA
at	O
2.0,	O
4.3,	O
and	O
9.2	O
kB.	O
This	O
was	O
detectable	O
by	O
24	O
h	O
and	O
persisted	O
until	O
72	O
h.	O
The	O
DNA	protein
binding	protein
protein	protein
NF-kB	protein
is	O
a	O
central	O
mediator	O
in	O
cytokine	protein
activation	O
of	O
HIV	O
transcription	O
.	O
NF-kB	protein
levels	O
were	O
higher	O
in	O
unstimulated	cell_line
U1	cell_line
cells	cell_line
as	O
compared	O
to	O
the	O
parent	cell_line
cell	cell_line
line	cell_line
U937	cell_line
.	O
In	O
both	O
cell	O
lines	O
LIF	protein
increased	O
NF-kB	protein
activity	O
.	O
Induction	O
of	O
NF-kB	protein
and	O
HIV	O
replication	O
by	O
cytokines	protein
are	O
at	O
least	O
in	O
part	O
dependent	O
on	O
reactive	O
oxygen	O
intermediates	O
.	O
The	O
oxygen	O
radical	O
scavenger	O
N-acetyl-L-cysteine	O
,	O
but	O
not	O
an	O
inhibitor	O
of	O
nitric	protein
oxide	protein
synthase	protein
,	O
inhibited	O
LIF	protein
-induced	O
HIV	O
replication	O
.	O
LIF	protein
induces	O
the	O
production	O
of	O
other	O
cytokines	protein
in	O
monocytes	O
but	O
its	O
effects	O
on	O
HIV	O
replication	O
were	O
not	O
inhibited	O
by	O
antibodies	protein
to	O
IL-1	protein
,	O
TNF	protein
,	O
or	O
IL-6	protein
.	O
These	O
results	O
identify	O
LIF	protein
as	O
a	O
stimulus	O
of	O
HIV	O
replication	O
.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS)	O

Mechanisms	O
involved	O
in	O
the	O
inhibition	O
of	O
growth	O
of	O
a	O
human	cell_line
B	cell_line
lymphoma	cell_line
cell	cell_line
line	cell_line
,	O
B104	cell_line
,	O
by	O
anti-MHC	protein
class	protein
II	protein
antibodies	protein
.	O
The	O
mechanisms	O
involved	O
in	O
the	O
inhibition	O
of	O
growth	O
of	O
a	O
human	cell_line
B	cell_line
lymphoma	cell_line
cell	cell_line
line	cell_line
,	O
B104	cell_line
,	O
by	O
anti-MHC	protein
class	protein
II	protein
antibodies	protein
(	O
Ab	protein
)	O
were	O
compared	O
with	O
those	O
in	O
anti-IgM	protein
Ab	protein
-induced	O
B104	O
growth	O
inhibition	O
.	O
Two	O
anti-MHC	protein
class	protein
II	protein
Ab	protein
,	O
L227	protein
and	O
2.06	protein
,	O
inhibited	O
the	O
growth	O
of	O
B104	cell_line
cells	cell_line
,	O
although	O
2.06	protein
,	O
but	O
not	O
L227	protein
,	O
needed	O
to	O
be	O
further	O
cross-linked	O
with	O
a	O
goat	protein
anti-mouse	protein
IgG	protein
Ab	protein
(	O
GAM	protein
)	O
to	O
show	O
the	O
effect.	O
L227	protein
induced	O
an	O
increase	O
in	O
intracellular	O
free	O
Ca2+	O
concentration	O
(	O
[	O
Ca2+	O
]i	O
)	O
from	O
the	O
intracellular	O
pool	O
and	O
little	O
or	O
no	O
protein	O
tyrosine	O
phosphorylation	O
,	O
phosphatidyl	O
inositol	O
turnover	O
,	O
or	O
expression	O
of	O
Egr-1	RNA
mRNA	RNA
,	O
whereas	O
2.06	protein
plus	O
GAM	protein
induced	O
an	O
increase	O
in	O
[	O
Ca2+	O
]i	O
from	O
both	O
the	O
intracellular	O
and,	O
in	O
particular,	O
the	O
extracellular	O
pools	O
.	O
The	O
inhibition	O
of	O
B104	cell_line
cell	cell_line
growth	O
induced	O
by	O
anti-MHC	protein
class	protein
II	protein
Ab	protein
was	O
Ca(2+)	O
-independent	O
and	O
not	O
inhibited	O
by	O
actinomycin	O
D	O
or	O
cyclosporin	O
A	O
,	O
and	O
cell	O
cycle	O
arrest	O
at	O
the	O
G2/M	O
interphase	O
was	O
not	O
observed.	O
These	O
features	O
are	O
very	O
different	O
from	O
those	O
observed	O
in	O
B104	cell_line
cell	cell_line
death	O
induced	O
by	O
anti-IgM	protein
Ab	protein
.	O
Neither	O
DNA	O
fragmentation	O
nor	O
the	O
morphology	O
of	O
apoptosis	O
was	O
observed.	O
These	O
findings	O
demonstrate	O
that	O
cross-linking	O
of	O
MHC	protein
class	protein
II	protein
molecules	protein
transduced	O
the	O
negative	O
signals	O
through	O
intracellular	O
mechanisms	O
different	O
from	O
those	O
present	O
in	O
the	O
cross-linking	O
of	O
surface	O
IgM	protein
.	O

Functional	O
block	O
for	O
1	O
alpha,25-dihydroxyvitamin	O
D3	O
-mediated	O
gene	O
regulation	O
in	O
human	cell_type
B	cell_type
lymphocytes	cell_type
.	O
Elements	O
necessary	O
for	O
the	O
steroid	O
hormone	O
1	O
alpha,25-dihydroxyvitamin	O
D3	O
(	O
1	O
alpha,25-(OH)2D3	O
)	O
to	O
induce	O
a	O
biological	O
response	O
include	O
the	O
presence	O
of	O
specific	O
intracellular	protein
receptors	protein
(	O
vitamin	protein
D3	protein
receptors	protein
(	O
VDR	protein
))	O
and	O
modulation	O
of	O
gene	O
expression	O
via	O
hormone-activated	O
receptor	O
binding	O
to	O
regulatory	protein
regions	protein
of	O
target	DNA
genes	DNA
.	O
These	O
parameters	O
were	O
examined	O
in	O
normal	O
and	O
Epstein-Barr	cell_line
virus-immortalized	cell_line
human	cell_line
B	cell_line
cells	cell_line
and	O
compared	O
with	O
1	cell_line
alpha,25-(OH)2D3	cell_line
-responsive	cell_line
cells	cell_line
of	O
the	O
T	O
and	O
monocytic	O
lineages	O
.	O
Although	O
resting	O
tonsillar	O
B	O
cells	O
did	O
not	O
express	O
VDR	RNA
mRNA	RNA
,	O
activation	O
of	O
these	O
cells	O
with	O
interleukin-4	protein
induced	O
VDR	protein
in	O
the	O
absence	O
of	O
exogenously	O
supplemented	O
1	O
alpha,25-(OH)2D3	O
.	O
As	O
indicators	O
of	O
hormone-mediated	O
gene	O
regulation	O
we	O
analyzed	O
modulation	O
of	O
CD23	protein
,	O
a	O
common	protein
B	protein
cell/monocyte	protein
surface	protein
antigen	protein
,	O
and	O
24-hydroxylase	protein
.	O
1	O
alpha,25-(OH)2D3	O
inhibited	O
CD23	protein
expression	O
in	O
U937	cell_line
cells	cell_line
,	O
yet	O
failed	O
to	O
modulate	O
CD23	protein
expression	O
in	O
B	cell_type
cells	cell_type
.	O
Furthermore,	O
1	O
alpha,25-(OH)2D3	O
induced	O
24-hydroxylase	protein
mRNA	O
expression	O
and	O
metabolic	O
activity	O
in	O
both	O
U937	cell_line
cells	cell_line
and	O
lectin-activated	cell_type
T	cell_type
cells	cell_type
,	O
yet	O
failed	O
to	O
induce	O
24-hydroxylase	RNA
mRNA	RNA
or	O
its	O
metabolic	O
activity	O
in	O
B	cell_type
cells	cell_type
.	O
These	O
findings	O
suggest	O
that	O
although	O
human	cell_type
B	cell_type
lymphocytes	cell_type
can	O
express	O
VDR	RNA
mRNA	RNA
and	O
protein	protein
,	O
they	O
exhibit	O
a	O
functional	O
block	O
for	O
vitamin	O
D	O
-dependent	O
gene	O
regulation	O
.	O

Positive	O
and	O
negative	O
regulation	O
of	O
IL-2	protein
gene	O
expression	O
:	O
role	O
of	O
multiple	O
regulatory	O
sites.	O
Interleukin	protein
2	protein
(	O
IL-2	protein
)	O
is	O
an	O
important	O
lymphokine	protein
required	O
in	O
the	O
process	O
of	O
T	O
cell	O
activation	O
,	O
proliferation	O
,	O
clonal	O
expansion	O
and	O
differentiation	O
.	O
The	O
IL-2	DNA
gene	DNA
displays	O
both	O
T	O
cell	O
specific	O
and	O
inducible	O
expression:	O
it	O
is	O
only	O
expressed	O
in	O
CD4+	cell_type
T	cell_type
cells	cell_type
after	O
antigenic	O
or	O
mitogenic	O
stimulation	O
.	O
Several	O
cis-acting	DNA
regulatory	DNA
sites	DNA
are	O
required	O
for	O
induction	O
of	O
the	O
IL-2	DNA
gene	DNA
after	O
stimulation.	O
In	O
this	O
study,	O
we	O
have	O
analysed	O
the	O
function	O
of	O
these	O
cis-acting	DNA
regulatory	DNA
sites	DNA
in	O
the	O
context	O
of	O
the	O
native	O
IL-2	DNA
enhancer	DNA
and	O
promoter	DNA
sequence	DNA
.	O
The	O
results	O
of	O
this	O
study	O
suggest	O
that	O
the	O
NFAT	protein
(	O
-276	DNA
to	DNA
-261	DNA
),	O
the	O
distal	DNA
octamer	DNA
(	O
-256	DNA
to	DNA
-248	DNA
)	O
and	O
the	O
proximal	DNA
octamer	DNA
(	O
-75	DNA
to	DNA
-66	DNA
)	O
sites	O
not	O
only	O
act	O
as	O
enhancers	O
of	O
IL-2	DNA
gene	DNA
transcription	O
in	O
the	O
presence	O
of	O
cellular	O
stimulation	O
,	O
but	O
also	O
have	O
a	O
silencing	O
effect	O
on	O
IL-2	DNA
gene	DNA
expression	O
in	O
resting	O
cells.	O
Two	O
other	O
sites	O
display	O
disparate	O
effects	O
on	O
IL-2	DNA
gene	DNA
expression	O
in	O
different	O
T	cell_line
leukemia	cell_line
cell	cell_line
lines	cell_line
:	O
the	O
distal	DNA
purine	DNA
box	DNA
(	O
-291	DNA
to	DNA
-277	DNA
)	O
and	O
the	O
proximal	DNA
purine	DNA
box	DNA
sites	DNA
(	O
-145	DNA
to	DNA
-128	DNA
).	O
Finally,	O
the	O
AP-1	O
(-186	O
to	O
-176)	O
and	O
the	O
kappa	O
B	O
sites	O
(	O
-206	DNA
to	DNA
-195	DNA
)	O
respond	O
to	O
different	O
cellular	O
activation	O
in	O
EL4	cell_line
cells	cell_line
.	O
The	O
AP-1	DNA
site	DNA
mediated	O
the	O
response	O
to	O
PMA	O
stimulation	O
while	O
the	O
kappa	DNA
B	DNA
site	DNA
responded	O
to	O
IL-1	protein
stimulation	O
.	O
These	O
data	O
suggest	O
that	O
the	O
regulation	O
of	O
IL-2	DNA
gene	DNA
expression	O
is	O
a	O
complex	O
process	O
and	O
multiple	O
cis-acting	DNA
regulatory	DNA
sites	DNA
interact	O
to	O
exert	O
different	O
effects	O
in	O
T	cell_type
cells	cell_type
representative	O
of	O
alternative	O
stages	O
of	O
differentiation	O
.	O

Sp1	protein
is	O
a	O
critical	O
factor	O
for	O
the	O
monocytic	O
specific	O
expression	O
of	O
human	protein
CD14	protein
.	O
CD14	protein
is	O
a	O
membrane	protein
glycoprotein	protein
expressed	O
specifically	O
on	O
monocytes	cell_type
and	O
macrophages	cell_type
,	O
and	O
its	O
expression	O
is	O
markedly	O
increased	O
during	O
the	O
process	O
of	O
monocyte	cell_type
differentiation	O
.	O
In	O
order	O
to	O
study	O
CD14	DNA
gene	DNA
regulation	O
,	O
the	O
human	DNA
CD14	DNA
gene	DNA
was	O
cloned	O
from	O
a	O
partial	O
EcoRI	DNA
digested	DNA
chromosome	DNA
5	DNA
library	DNA
.	O
A	O
5.5-kilobase	DNA
genomic	DNA
clone	DNA
contained	O
the	O
full-length	O
CD14	DNA
coding	DNA
sequence	DNA
and	O
4.2	DNA
kilobases	DNA
of	DNA
5'-upstream	DNA
sequence	DNA
.	O
One	O
major	O
and	O
one	O
minor	O
transcription	O
start	O
site	O
were	O
identified	O
101	DNA
and	DNA
130	DNA
base	DNA
pairs	DNA
(bp)	DNA
upstream	DNA
,	O
respectively,	O
from	O
the	O
protein	DNA
translation	DNA
start	DNA
ATG	DNA
.	O
A	O
DNA	DNA
fragment	DNA
containing	O
128	DNA
bp	DNA
of	DNA
upstream	DNA
sequence	DNA
had	O
strong,	O
monocyte-specific	O
promoter	O
activity	O
in	O
the	O
CD14	cell_line
positive	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
Mono	cell_line
Mac	cell_line
6	cell_line
as	O
compared	O
to	O
the	O
nonmonocytic	cell_line
cell	cell_line
lines	cell_line
HeLa	cell_line
and	O
REX	cell_line
.	O
Four	O
regions	O
in	O
this	O
DNA	DNA
fragment	DNA
interact	O
with	O
nuclear	protein
proteins	protein
isolated	O
from	O
monocytic	cell_type
cells	cell_type
.	O
The	O
Sp1	protein
transcription	protein
factor	protein
bound	O
to	O
three	O
different	O
regions	O
in	O
the	O
CD14	DNA
promoter	DNA
.	O
Mutation	O
of	O
the	O
major	DNA
Sp1	DNA
binding	DNA
site	DNA
(	O
-110	DNA
bp	DNA
)	O
decreased	O
tissue-specific	O
promoter	O
activity,	O
and	O
these	O
results,	O
together	O
with	O
transactivation	O
experiments	O
,	O
demonstrate	O
that	O
Sp1	protein
plays	O
a	O
critical	O
role	O
in	O
the	O
tissue-specific	O
expression	O
of	O
CD14	protein
in	O
monocytic	cell_type
cells	cell_type
.	O
CD14	protein
Sp1	protein
site	O
oligonucleotides	O
bound	O
preferentially	O
to	O
a	O
105-kDa	protein
Sp1	protein
species	protein
,	O
which	O
is	O
present	O
in	O
higher	O
relative	O
levels	O
in	O
monocytic	cell_type
than	O
non-monocytic	cell_type
cells	cell_type
,	O
suggesting	O
that	O
modification	O
of	O
Sp1	protein
,	O
such	O
as	O
phosphorylation,	O
may	O
explain	O
how	O
the	O
Sp1	protein
site	O
mediates	O
monocytic	O
specific	O
promoter	O
activity	O
.	O

The	O
interleukin-8	O
AP-1	O
and	O
kappa	O
B-like	O
sites	O
are	O
genetic	O
end	O
targets	O
of	O
FK506-sensitive	O
pathway	O
accompanied	O
by	O
calcium	O
mobilization	O
.	O
FK506	O
,	O
an	O
immunosuppressant	O
,	O
inhibits	O
the	O
production	O
of	O
several	O
cytokines	protein
in	O
T	cell_type
lymphocytes	cell_type
.	O
We	O
observed	O
that	O
FK506	O
suppressed	O
the	O
transcription	O
of	O
a	O
chemotactic	protein
cytokine	protein
,	O
interleukin-8	protein
(	O
IL-8	protein
)	O
in	O
a	O
human	cell_line
T	cell_line
cell	cell_line
line	cell_line
,	O
Jurkat	cell_line
cells	cell_line
,	O
activated	O
by	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
and	O
calcium	O
(	O
Ca2+	O
)	O
ionophore	O
(	O
ionomycin	O
).	O
By	O
deleted	O
and	O
mutated	O
analysis	O
of	O
the	O
IL-8	DNA
promoters	DNA
,	O
the	O
AP-1	DNA
and	DNA
kappa	DNA
B-like	DNA
sites	DNA
were	O
identified	O
as	O
the	O
responsive	O
elements	O
for	O
PMA	O
and	O
ionomycin	O
.	O
FK506	O
suppressed	O
the	O
transcriptions	O
through	O
the	O
AP-1	DNA
or	O
kappa	DNA
B-like	DNA
sites	DNA
induced	O
by	O
PMA	O
plus	O
Ca(2+)-mobilizing	O
agents,	O
but	O
not	O
those	O
induced	O
by	O
Ca(2+)-independent	O
stimuli.	O
In	O
gel	O
retardation	O
analysis,	O
FK506	O
had	O
little	O
effect	O
on	O
the	O
binding	O
to	O
the	O
AP-1	DNA
site	DNA
of	O
PMA	O
/	O
ionomycin	O
-induced	O
nuclear	O
factors,	O
which	O
were	O
recognized	O
with	O
anti-JunD	protein
or	O
c-Fos	protein
antibody	protein
.	O
In	O
contrast,	O
FK506	O
or	O
EGTA	O
(	O
Ca2+	O
chelator	O
)	O
similarly	O
affected	O
the	O
formation	O
of	O
kappa	protein
B-like	protein
site	protein
binding	protein
complexes	protein
,	O
which	O
were	O
not	O
recognized	O
by	O
any	O
antibodies	protein
against	O
the	O
human	protein
Rel	protein
family	protein
proteins	protein
(	O
c-Rel	protein
,	O
p65	protein
,	O
p50	protein
,	O
and	O
p49	protein
).	O
Furthermore,	O
we	O
confirmed	O
the	O
previous	O
report	O
that	O
FK506	O
suppressed	O
the	O
PMA	O
/	O
ionomycin	O
-induced	O
activation	O
through	O
authentic	O
kappa	DNA
B	DNA
site	DNA
of	O
immunoglobulin	DNA
(Ig)	DNA
gene	DNA
,	O
to	O
which	O
NF-kappa	protein
B	protein
binding	O
was	O
also	O
decreased	O
by	O
FK506	O
,	O
indicating	O
that	O
both	O
IL-8	DNA
kappa	DNA
B-like	DNA
site	DNA
and	O
Ig	O
kappa	DNA
B	DNA
site	DNA
are	O
FK506	O
-sensitive	O
in	O
spite	O
of	O
the	O
difference	O
of	O
binding	protein
factors	protein
.	O
Our	O
results	O
indicate	O
that	O
not	O
only	O
the	O
reported	O
IL-2	O
NF-AT	O
and	O
NFIL-2A	O
sites	O
and	O
Ig	O
kappa	DNA
B	DNA
site	DNA
,	O
but	O
also	O
the	O
IL-8	protein
AP-1	DNA
and	O
kappa	DNA
B-like	DNA
sites	DNA
are	O
terminals	O
of	O
FK506	O
-sensitive	O
pathway	O
involving	O
Ca2+	O
mobilization	O
.	O

Androgen	protein
binding	protein
sites	protein
in	O
peripheral	cell_type
human	cell_type
mononuclear	cell_type
leukocytes	cell_type
of	O
healthy	O
males	O
and	O
females	O
.	O
Androgen	protein
binding	protein
sites	protein
have	O
been	O
identified	O
in	O
circulating	cell_type
human	cell_type
mononuclear	cell_type
leukocytes	cell_type
of	O
healthy	O
donors	O
of	O
both	O
sexes.	O
Cells	O
were	O
separated	O
from	O
blood	O
samples	O
on	O
a	O
Ficoll	O
gradient	O
and	O
incubated	O
with	O
different	O
concentrations	O
of	O
[3H]testosterone	O
in	O
the	O
presence	O
or	O
absence	O
of	O
a	O
400-fold	O
excess	O
of	O
unlabelled	O
testosterone	O
.	O
Binding	O
data	O
were	O
derived	O
from	O
Scatchard	O
analysis	O
.	O
The	O
binding	protein
sites	protein
fulfil	O
the	O
required	O
criteria	O
for	O
specific	O
steroid	protein
binding	protein
sites	protein
however	O
differ	O
somewhat	O
from	O
the	O
classic	O
androgen	protein
receptors	protein
from	O
genital	cell_type
skin	cell_type
fibroblast	cell_type
:	O
in	O
fertile	O
adult	O
males	O
(n	O
=	O
20)	O
the	O
binding	protein
sites	protein
showed	O
(1)	O
a	O
high	O
affinity	O
for	O
testosterone	O
(1.32	O
+/-	O
0.49	O
nM;	O
mean	O
+/-	O
SD),	O
(2)	O
a	O
saturable	O
capacity	O
(184	O
+/-	O
52	O
binding	protein
sites	protein
per	O
cell;	O
mean	O
+/-	O
SD),	O
and	O
(3)	O
a	O
characteristic	O
competitive	O
binding	O
profile	O
for	O
other	O
steroid	O
hormones	O
(relative	O
binding	O
affinities:	O
testosterone	O
=	O
dihydrotestosterone	O
&gt;	O
17	O
beta-estradiol	O
&gt;	O
progesterone	O
,	O
whereas	O
aldosterone,	O
17-hydroxy-progesterone	O
and	O
cortisol	O
did	O
not	O
compete	O
appreciably).	O
Furthermore	O
the	O
number	O
of	O
binding	protein
sites	protein
determined	O
using	O
[3H]dihydrotestosterone	O
,	O
[3H]RU-1881	O
,	O
or	O
[3H]	O
testosterone	O
were	O
comparable.	O
This	O
raises	O
the	O
possibility	O
that	O
androgen	protein
receptors	protein
in	O
peripheral	cell_type
mononuclear	cell_type
leukocytes	cell_type
differ	O
from	O
those	O
in	O
genital	cell_type
skin	cell_type
fibroblasts	cell_type
.	O
There	O
was	O
no	O
apparent	O
correlation	O
between	O
serum	O
testosterone	O
concentrations	O
and	O
androgen	protein
binding	protein
sites	protein
.	O
In	O
fertile	O
women	O
remarkable	O
changes	O
in	O
androgen	protein
binding	protein
sites	protein
were	O
seen	O
in	O
the	O
course	O
of	O
the	O
menstrual	O
cycle	O
,	O
with	O
a	O
significant	O
increase	O
in	O
the	O
immediate	O
preovulatory	O
period	O
.	O
The	O
presence	O
of	O
androgen	protein
receptors	protein
in	O
peripheral	cell_type
mononuclear	cell_type
leukocytes	cell_type
provides	O
for	O
the	O
first	O
time	O
the	O
experimental	O
basis	O
for	O
an	O
hypothesis	O
of	O
direct,	O
receptor-mediated	O
effects	O
of	O
androgens	O
on	O
mature	cell_type
immunocompetent	cell_type
cells	cell_type
.	O
The	O
immunological	O
implications	O
of	O
these	O
results	O
are	O
discussed.	O

Induction	O
of	O
IL-8	protein
expression	O
in	O
T	cell_type
cells	cell_type
uses	O
the	O
CD28	protein
costimulatory	O
pathway	O
.	O
IL-8	protein
,	O
a	O
potent	O
chemotactic	protein
factor	protein
for	O
neutrophil	cell_type
granulocytes	cell_type
and	O
lymphocytes	cell_type
,	O
is	O
a	O
proinflammatory	O
cytokine	O
secreted	O
by	O
a	O
variety	O
of	O
cell	O
types,	O
including	O
T	cell_type
cells	cell_type
.	O
Stimulation	O
of	O
the	O
CD28	protein
cell	protein
surface	protein
molecule	protein
delivers	O
costimulatory	O
signals	O
essential	O
for	O
lymphokine	protein
production	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
via	O
a	O
conserved	DNA
sequence	DNA
element	DNA
found	O
in	O
the	O
promoter	DNA
of	O
several	O
lymphokine	DNA
genes	DNA
.	O
Anti-	cell_line
CD28	cell_line
-stimulated	cell_line
T	cell_line
cells	cell_line
produced	O
significant	O
amounts	O
of	O
IL-8	protein
;	O
additionally,	O
costimulation	O
with	O
anti-CD3	protein
and	O
anti-	protein
CD28	protein
Abs	protein
resulted	O
in	O
a	O
synergistic	O
induction	O
of	O
IL-8	protein
secretion	O
.	O
Sequence	O
homology,	O
single	O
nucleotide	O
mutations	O
,	O
and	O
anti-	protein
CD28	protein
Ab	protein
stimulation	O
studies	O
established	O
that	O
the	O
NF-kappa	DNA
B	DNA
-like	DNA
sequence	DNA
in	O
the	O
promoter	DNA
of	O
the	O
IL-8	DNA
gene	DNA
functioned	O
as	O
a	O
CD28	DNA
response	DNA
element	DNA
.	O
Furthermore,	O
cyclosporin	O
A	O
,	O
but	O
not	O
rapamycin	O
,	O
blocked	O
the	O
synergistic	O
induction	O
of	O
IL-8	protein
expression	O
achieved	O
with	O
anti-CD3	protein
and	O
anti-	O
CD28	protein
costimulation	O
.	O
The	O
involvement	O
of	O
a	O
CD28	DNA
response	DNA
element	DNA
in	O
the	O
induction	O
of	O
IL-8	protein
expression	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
may	O
provide	O
new	O
insights	O
into	O
the	O
pathogenesis	O
and	O
persistence	O
of	O
immune	O
disorders	O
characterized	O
by	O
increased	O
levels	O
of	O
IL-8	protein
,	O
such	O
as	O
psoriasis	O
and	O
rheumatoid	O
arthritis	O
.	O

MHC	protein
class	protein
II	protein
signaling	O
in	O
B-cell	cell_type
activation	O
[see	O
comments]	O
The	O
cognate	O
interaction	O
between	O
T	cell_type
cells	cell_type
and	O
antigen-presenting	cell_type
cells	cell_type
(	O
APCs	cell_type
),	O
mediated	O
by	O
major	protein
histocompatibility	protein
complex	protein
(MHC)	protein
class	protein
II	protein
molecules	protein
,	O
results	O
in	O
the	O
delivery	O
of	O
activation	O
signals	O
to	O
the	O
APC	cell_type
.	O
These	O
signals	O
contribute	O
to	O
the	O
expression	O
of	O
co-stimulatory	O
activity	O
by	O
APCs	cell_type
and	O
have	O
important	O
consequences	O
for	O
cell	O
effector	O
function	O
.	O
MHC	protein
class	protein
II	protein
molecules	O
also	O
serve	O
as	O
receptors	O
for	O
B-cell	cell_type
stimulation	O
by	O
microbial	protein
superantigens	protein
.	O
In	O
this	O
review,	O
Paul	O
Scholl	O
and	O
Raif	O
Geha	O
discuss	O
recent	O
advances	O
in	O
our	O
understanding	O
of	O
mechanisms	O
of	O
MHC	protein
class	protein
II	protein
signaling	O
and	O
analyse	O
their	O
role	O
in	O
human	O
B-cell	cell_type
activation	O
.	O

Effects	O
of	O
glucocorticoids	O
in	O
rheumatoid	O
arthritis	O
.	O
Diminished	O
glucocorticoid	protein
receptors	protein
do	O
not	O
result	O
in	O
glucocorticoid	O
resistance	O
.	O
OBJECTIVE.	O
Lymphocytes	O
of	O
patients	O
with	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
have	O
diminished	O
receptor	O
density;	O
thus,	O
patients	O
with	O
RA	O
should	O
show	O
partial	O
resistance	O
to	O
glucocorticoids	O
.	O
We	O
investigated	O
the	O
glucocorticoid	O
sensitivity	O
of	O
lymphocytes	cell_type
in	O
RA	O
patients	O
compared	O
with	O
healthy	O
subjects	O
.	O
METHODS.	O
We	O
determined	O
the	O
effects	O
of	O
glucocorticoids	O
on	O
lymphocyte	cell_type
proliferation	O
and	O
cytokine	protein
release	O
.	O
RESULTS.	O
Proliferation	O
and	O
cytokine	protein
release	O
were	O
inhibited	O
in	O
RA	O
patients	O
to	O
the	O
same	O
extent	O
as	O
in	O
healthy	O
controls	O
.	O
CONCLUSION.	O
Diminished	O
receptor	O
density	O
in	O
RA	O
patients	O
does	O
not	O
result	O
in	O
glucocorticoid	O
resistance	O
.	O

Arrested	O
development	O
:	O
understanding	O
v-abl	DNA
.	O
The	O
protein	protein
tyrosine	protein
kinase	protein
activity	O
of	O
the	O
v-abl	DNA
oncogene	DNA
has	O
been	O
demonstrated	O
to	O
subvert	O
the	O
normal	O
second	O
messenger	O
systems	O
used	O
by	O
lymphoid	cell_type
cells	cell_type
for	O
growth	O
and	O
differentiation	O
.	O
Transformation	O
of	O
bone	O
marrow	O
with	O
the	O
Abelson	O
murine	O
leukemia	O
virus	O
results	O
in	O
the	O
appearance	O
of	O
B	cell_type
cell	cell_type
lineage	cell_type
cells	cell_type
arrested	O
at	O
the	O
pre-B	O
cell	O
stage	O
.	O
Recent	O
reports	O
have	O
characterized	O
these	O
cells	O
expressing	O
high	O
v-abl	DNA
kinase	O
activity	O
as	O
deficient	O
in	O
detectable	O
NF-kappaB	protein
DNA	O
binding	O
activity	O
and	O
low	O
level	O
RAG	DNA
gene	DNA
expression	O
.	O
These	O
observations	O
suggest	O
that	O
v-abl	DNA
may	O
be	O
inhibiting	O
the	O
differentiation	O
of	O
B	cell_type
cells	cell_type
by	O
blocking	O
these	O
two	O
crucial	O
elements	O
in	O
the	O
maturation	O
pathway	O
.	O

Corticosteroid	protein
receptors	protein
in	O
lymphocytes	cell_type
:	O
a	O
possible	O
marker	O
of	O
brain	O
involution	O
?	O
A	O
similarity	O
has	O
recently	O
been	O
found	O
between	O
the	O
regulation	O
of	O
corticosteroid	protein
receptors	protein
in	O
brain	O
and	O
in	O
lymphoid	O
tissue	O
.	O
We	O
have	O
studied	O
the	O
regulation	O
of	O
corticosteroid	protein
receptors	protein
in	O
human	cell_type
mononuclear	cell_type
leukocytes	cell_type
as	O
a	O
possible	O
marker	O
of	O
brain	O
involution	O
.	O
Type	protein
I	protein
corticosteroid	protein
receptors	protein
are	O
down	O
regulated	O
by	O
excess	O
of	O
mineralocorticoids	O
(primary	O
and	O
secondary	O
hyperaldosteronism	O
,	O
pseudohyperaldosteronism	O
)	O
and	O
of	O
glucocorticoids	O
(	O
Cushing's	O
syndrome	O
).	O
Type	protein
II	protein
corticosteroid	protein
receptors	protein
are	O
not	O
reduced	O
by	O
excess	O
of	O
endogenous	O
corticosteroids	O
(	O
Cushing's	O
syndrome	O
).	O
In	O
normal	O
adults	O
there	O
is	O
a	O
direct	O
significant	O
correlation	O
between	O
plasma	O
cortisol	O
and	O
Type	protein
I	protein
and	O
between	O
plasma	O
cortisol	O
and	O
Type	protein
II	protein
receptors	protein
in	O
mononuclear	cell_type
leukocytes	cell_type
,	O
while	O
in	O
Cushing's	O
syndrome	O
the	O
correlation	O
is	O
inverse	O
between	O
plasma	O
cortisol	O
at	O
8	O
a.m.	O
and	O
Type	protein
II	protein
receptors	protein
.	O
In	O
an	O
aged	O
population	O
the	O
mean	O
numbers	O
of	O
Type	protein
I	protein
and	O
of	O
Type	protein
II	protein
receptors	protein
are	O
lower	O
and	O
plasma	O
cortisol	O
is	O
higher	O
than	O
in	O
adult	O
controls	O
,	O
but	O
the	O
increase	O
of	O
plasma	O
cortisol	O
is	O
not	O
followed	O
by	O
a	O
clinical	O
picture	O
of	O
hypercorticism	O
.	O
Corticosteroid	O
Type	O
I	O
and	O
Type	O
II	O
receptors	O
are	O
inversely	O
correlated	O
with	O
age.	O
After	O
dexamethasone	O
suppression	O
(1	O
mg	O
at	O
11	O
p.m.)	O
Type	protein
I	protein
receptors	protein
always	O
decrease	O
in	O
controls	O
while	O
the	O
response	O
of	O
Type	protein
II	protein
is	O
not	O
homogeneous.	O
In	O
an	O
aged	O
group	O
of	O
patients	O
,	O
both	O
receptors	O
are	O
reduced	O
by	O
dexamethasone	O
.	O
We	O
conclude	O
that	O
the	O
decrease	O
with	O
age	O
of	O
corticosteroid	protein
receptors	protein
is	O
possibly	O
related	O
to	O
a	O
physiological	O
involution	O
of	O
corticosteroid	protein
receptors	protein
and	O
that	O
this	O
reduction	O
does	O
increase	O
plasma	O
cortisol	O
concentration,	O
without	O
affecting	O
the	O
glucocorticoid	O
effector	O
mechanism	O
.	O

All-trans	O
retinoic	O
acid	O
and	O
1	O
alpha,25-dihydroxyvitamin	O
D3	O
co-operate	O
to	O
promote	O
differentiation	O
of	O
the	O
human	cell_line
promyeloid	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
HL60	cell_line
to	O
monocytes	cell_type
.	O
A	O
basis	O
for	O
differentiation	O
therapy	O
of	O
leukemias	O
is	O
provided	O
by	O
knowledge	O
of	O
agents	O
which	O
induce	O
specific	O
lineage	O
maturation.	O
All-trans	O
retinoic	O
acid	O
(	O
RA	O
)	O
induces	O
differentiation	O
of	O
HL60	cell_line
cells	cell_line
to	O
neutrophils	cell_type
and	O
is	O
used	O
to	O
treat	O
acute	O
promyelocytic	O
leukemia	O
.	O
We	O
observed	O
that	O
RA	O
did	O
not	O
induced	O
neutrophil	O
differentiation	O
in	O
serum-free	cell_line
grown	cell_line
HL60	cell_line
cells	cell_line
whereas	O
50	O
nM	O
1	O
alpha,25-dihydroxyvitamin	O
D3	O
(	O
D3	O
)	O
induced	O
maximal	O
monocyte	O
differentiation	O
.	O
Increasing	O
RA	O
concentrations	O
reduced	O
the	O
D3	O
concentration	O
required	O
for	O
monocyte	O
differentiation	O
.	O
Cells	O
treated	O
with	O
5	O
nM	O
D3	O
showed	O
little	O
response,	O
but	O
differentiated	O
maximally	O
with	O
5	O
nM	O
D3	O
and	O
10	O
nM	O
RA	O
.	O
The	O
D3	O
analogs	O
MC903	O
,	O
EB1089	O
and	O
KH1060	O
were	O
more	O
potent	O
inducers	O
of	O
monocyte	O
differentiation	O
.	O
The	O
extent	O
to	O
which	O
analog	O
activity	O
was	O
increased	O
after	O
cotreatment	O
with	O
RA	O
was	O
inversely	O
related	O
to	O
potency.	O
Twenty-four	O
hour	O
treatment	O
with	O
10	O
nM	O
RA	cell_line
primed	cell_line
cells	cell_line
for	O
response	O
to	O
5	O
nM	O
D3	O
;	O
the	O
reverse	O
sequence	O
being	O
ineffective.	O
Priming	O
with	O
10	O
nM	O
RA	O
,	O
or	O
subsequent	O
treatment	O
with	O
D3	O
(5	O
nM),	O
did	O
not	O
alter	O
expression	O
of	O
mRNAs	RNA
encoding	O
receptors	protein
for	O
D3	O
(	O
VDR	protein
),	O
RA	O
(	O
RAR	protein
alpha	protein
)	O
or	O
9-CIS	O
RA	O
(	O
RXR	O
alpha	O
,	O
beta	O
,	O
gamma	O
).	O
That	O
RA	O
promotes	O
both	O
neutrophil	O
and	O
monocyte	O
differentiation	O
has	O
implications	O
for	O
the	O
use	O
of	O
RA	O
and	O
D3	O
in	O
treatment	O
of	O
leukemias	O
and	O
provides	O
insight	O
into	O
mechanisms	O
whereby	O
RAR,	O
VDR	protein
and	O
RXR	protein
facilitate	O
monocyte	O
differentiation	O
.	O

[An	O
overexpression	O
of	O
retinoic	protein
acid	protein
receptor	protein
alpha	protein
blocks	O
myeloid	cell_type
cell	cell_type
differentiation	O
at	O
the	O
promyelocyte	O
stage	O
]	O
Retinoic	O
acid	O
(	O
RA	O
),	O
a	O
vitamin	O
A	O
derivative	O
,	O
exerts	O
a	O
wide	O
range	O
of	O
biological	O
effects	O
related	O
to	O
cell	O
proliferation	O
and	O
differentiation	O
.	O
The	O
pleiotropic	O
effects	O
of	O
RA	O
are	O
thought	O
to	O
be	O
mediated	O
through	O
specific	O
nuclear	O
RA	protein
receptors	protein
(	O
RARs	protein
).	O
RARs	protein
are	O
members	O
of	O
the	O
steroid/thyroid	protein
hormone	protein
receptor	protein
superfamily	protein
and	O
exhibit	O
a	O
molecular	O
structure	O
that	O
possess	O
discrete	O
DNA-binding	O
and	O
RA	protein
(ligand)-binding	protein
domains	protein
.	O
In	O
hematopoietic	O
system,	O
RA	O
and	O
RARs	protein
,	O
predominantly	O
RAR	protein
alpha	protein
may	O
play	O
key	O
roles	O
for	O
the	O
proliferation	O
and	O
differentiation	O
of	O
hematopoietic	cell_type
progenitors	cell_type
.	O
However,	O
it	O
is	O
currently	O
unknown	O
how	O
RA	O
and	O
RARs	protein
are	O
involved	O
in	O
regulating	O
normal	O
hematopoietic	O
differentiation	O
.	O
To	O
make	O
clear	O
the	O
roles	O
of	O
RA	O
and	O
RAR	protein
alpha	protein
in	O
the	O
normal	O
hematopoiesis	O
,	O
I	O
have	O
introduced	O
the	O
construct	O
of	O
human	protein
RAR	protein
alpha	protein
(	O
hRAR	protein
alpha	protein
)	O
into	O
murine	cell_type
bone	cell_type
marrow	cell_type
cells	cell_type
with	O
retroviral	O
vector	O
,	O
and	O
selected	O
infected	O
cells	O
with	O
drug	DNA
resistant	DNA
marker	DNA
(	O
Neo(r)	DNA
)	O
cultured	O
on	O
the	O
stroma	cell_line
cell	cell_line
line	cell_line
(	O
PA6-neo	cell_line
),	O
and	O
analyzed	O
the	O
behavior	O
of	O
infected	cell_type
cells	cell_type
.	O
All	O
of	O
procedure	O
were	O
done	O
in	O
vitro.	O
Most	O
cells	O
infected	O
with	O
hRAR	protein
alpha	protein
exhibited	O
promyelocytic	cell_type
morphology	cell_type
and	O
were	O
thought	O
to	O
be	O
blocked	O
at	O
the	O
promyelocytic	O
stage	O
in	O
their	O
myeloid	O
differentiation	O
.	O
Furthermore,	O
these	O
immature	cell_type
cells	cell_type
differentiated	O
terminally	O
into	O
mature	O
granulocytes	O
by	O
adding	O
with	O
RA	O
(10(-6)	O
M).	O
RAR	protein
alpha	protein
infected	cell_type
cells	cell_type
were	O
also	O
able	O
to	O
differentiate	O
into	O
mature	cell_type
macrophages	cell_type
in	O
the	O
both	O
of	O
long	O
term	O
culture	O
and	O
IL3	cell_line
colony	cell_line
.	O
These	O
observations	O
suggest	O
that	O
an	O
overexpression	O
of	O
RAR	protein
alpha	protein
alone	O
is	O
effective	O
to	O
suppress	O
myeloid	cell_type
cell	cell_type
differentiation	O
and	O
RAR	protein
alpha	protein
plays	O
a	O
crucial	O
role	O
in	O
the	O
terminal	O
differentiation	O
of	O
myeloid	O
precursors.	O
The	O
system	O
described	O
here	O
may	O
serve	O
as	O
a	O
model	O
for	O
studying	O
the	O
the	O
essential	DNA
genes	DNA
for	O
differentiation	O
of	O
normal	cell_type
bone	cell_type
marrow	cell_type
cells	cell_type
.	O

Hypoxic	O
induction	O
of	O
interleukin-8	DNA
gene	DNA
expression	O
in	O
human	cell_type
endothelial	cell_type
cells	cell_type
.	O
Because	O
leukocyte-mediated	O
tissue	O
damage	O
is	O
an	O
important	O
component	O
of	O
the	O
pathologic	O
picture	O
in	O
ischemia/reperfusion	O
,	O
we	O
have	O
sought	O
mechanisms	O
by	O
which	O
PMNs	cell_type
are	O
directed	O
into	O
hypoxic	O
tissue	O
.	O
Incubation	O
of	O
human	cell_type
endothelial	cell_type
cells	cell_type
(	O
ECs	cell_type
)	O
in	O
hypoxia	O
,	O
PO2	O
approximately	O
14-18	O
Torr,	O
led	O
to	O
time-dependent	O
release	O
of	O
IL-8	protein
antigen	O
into	O
the	O
conditioned	O
medium;	O
this	O
was	O
accompanied	O
by	O
increased	O
chemotactic	O
activity	O
for	O
PMNs	cell_type
,	O
blocked	O
by	O
antibody	O
to	O
IL-8	protein
.	O
Production	O
of	O
IL-8	protein
by	O
hypoxic	O
ECs	cell_type
occurred	O
concomitantly	O
with	O
both	O
increased	O
levels	O
of	O
IL-8	RNA
mRNA	RNA
,	O
based	O
on	O
polymerase	O
chain	O
reaction	O
analysis	O
,	O
and	O
increased	O
IL-8	protein
transcription	O
,	O
based	O
on	O
nuclear	O
run-on	O
assays	O
.	O
Northern	O
analysis	O
of	O
mRNA	O
from	O
hypoxic	O
ECs	cell_type
also	O
demonstrated	O
increased	O
levels	O
of	O
mRNA	RNA
for	O
macrophage	protein
chemotactic	protein
protein-1	protein
,	O
another	O
member	O
of	O
the	O
chemokine	protein
superfamily	protein
of	O
proinflammatory	protein
cytokines	protein
.	O
IL-8	DNA
gene	DNA
induction	O
was	O
associated	O
with	O
the	O
presence	O
of	O
increased	O
binding	O
activity	O
in	O
nuclear	O
extracts	O
from	O
hypoxic	cell_type
ECs	cell_type
for	O
the	O
NF-kB	O
site.	O
Studies	O
with	O
human	O
umbilical	O
vein	O
segments	O
exposed	O
to	O
hypoxia	O
also	O
demonstrated	O
increased	O
elaboration	O
of	O
IL-8	protein
antigen	protein
compared	O
with	O
normoxic	O
controls.	O
In	O
mice	O
exposed	O
to	O
hypoxia	O
(PO2	O
approximately	O
30-40	O
Torr),	O
there	O
was	O
increased	O
pulmonary	O
leukostasis,	O
as	O
evidenced	O
by	O
increased	O
myeloperoxidase	protein
activity	O
in	O
tissue	O
homogenates	O
.	O
In	O
parallel,	O
increased	O
levels	O
of	O
transcripts	O
for	O
IP-10	protein
,	O
a	O
murine	O
homologue	O
in	O
the	O
chemokine	protein
family	protein
related	O
to	O
IL-8	protein
,	O
were	O
observed	O
in	O
hypoxic	O
lung	O
tissue	O
.	O
Taken	O
together,	O
these	O
data	O
suggest	O
that	O
hypoxia	O
constitutes	O
a	O
stimulus	O
for	O
leukocyte	O
chemotaxis	O
and	O
tissue	O
leukostasis	O
.	O

Thrombin	protein
and	O
thrombin	protein
receptor	protein
agonist	O
peptide	O
induce	O
early	O
events	O
of	O
T	O
cell	O
activation	O
and	O
synergize	O
with	O
TCR	protein
cross-linking	O
for	O
CD69	protein
expression	O
and	O
interleukin	O
2	O
production.	O
Thrombin	protein
stimulation	O
of	O
the	O
T	cell_line
leukemic	cell_line
cell	cell_line
line	cell_line
Jurkat	cell_line
induced	O
a	O
transient	O
increase	O
in	O
[	O
Ca2+	O
]i	O
.	O
Proteolytic	O
activity	O
of	O
the	O
enzyme	protein
was	O
required	O
for	O
this	O
effect	O
since	O
diisopropyl	protein
fluorophosphate-thrombin	protein
failed	O
to	O
increase	O
[	O
Ca2+	O
]i	O
.	O
Furthermore,	O
hirudin	O
and	O
anti-thrombin	protein
III	protein
inhibited	O
the	O
thrombin-induced	O
[	O
Ca2+	O
]i	O
rise	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
A	O
synthetic	O
thrombin	protein
receptor	protein
agonist	O
peptide	O
(	O
TRP	O
)	O
of	O
7	O
residues	O
(	O
SFLLRNP	O
)	O
was	O
found	O
to	O
be	O
as	O
effective	O
as	O
thrombin	protein
for	O
[	O
Ca2+	O
]i	O
mobilization,	O
and	O
both	O
agonists	O
induced	O
Ca2+	O
release	O
exclusively	O
from	O
internal	O
stores	O
.	O
Thrombin	protein
stimulated	O
tyrosine	O
phosphorylation	O
of	O
several	O
proteins	O
of	O
molecular	O
mass	O
40	O
,	O
42	O
,	O
70	O
,	O
120	O
,	O
and	O
130	O
kDa	O
.	O
There	O
was	O
a	O
good	O
correlation	O
between	O
thrombin	protein
-induced	O
tyrosine	O
phosphorylation	O
of	O
the	O
latter	O
three	O
proteins	O
and	O
Ca2+	O
mobilization	O
.	O
Thrombin	protein
and	O
TRP	O
also	O
caused	O
translocation	O
of	O
protein	protein
kinase	protein
C	protein
from	O
the	O
cytosol	O
to	O
the	O
plasma	O
membrane	O
.	O
As	O
a	O
likely	O
consequence	O
of	O
these	O
events,	O
thrombin	protein
activated	O
the	O
nuclear	protein
factor	protein
NF-kB	protein
.	O
Several	O
cell	O
lines	O
of	O
hematopoietic	O
origin	O
including	O
the	O
leukemic	cell_line
T	cell_line
cell	cell_line
line	cell_line
HPB.ALL	cell_line
and	O
the	O
erythroleukemic	cell_line
cell	cell_line
line	cell_line
K562	cell_line
were	O
responsive	O
to	O
thrombin	protein
,	O
whereas	O
others	O
such	O
as	O
THP1	cell_line
,	O
a	O
myelomonocytic	cell_line
cell	cell_line
line	cell_line
,	O
and	O
BL2,	cell_line
a	O
Burkitt	cell_line
lymphoma	cell_line
were	O
refractory	O
to	O
thrombin	protein
or	O
TRP	O
stimulation.	O
The	O
magnitude	O
of	O
the	O
thrombin	protein
response	O
in	O
the	O
different	O
cell	O
types	O
paralleled	O
the	O
expression	O
of	O
the	O
thrombin	RNA
receptor	RNA
mRNA	RNA
.	O
We	O
found	O
that	O
activation	O
of	O
Jurkat	cell_line
T	cell_line
cells	cell_line
by	O
a	O
combination	O
of	O
phytohemagglutinin	protein
and	O
phorbol	O
12-myristate	O
13-acetate	O
led	O
to	O
a	O
dramatic	O
inhibition	O
of	O
thrombin	RNA
receptor	RNA
mRNA	RNA
expression	O
and	O
to	O
a	O
concomitant	O
loss	O
of	O
the	O
thrombin	protein
response	O
.	O
Finally,	O
we	O
demonstrate	O
that	O
thrombin	protein
and	O
TRP	O
enhanced	O
CD69	protein
expression	O
and	O
interleukin	protein
2	protein
production	O
induced	O
by	O
T	protein
cell	protein
receptor	protein
cross-linking	O
in	O
both	O
Jurkat	cell_line
T	cell_line
cells	cell_line
and	O
peripheral	O
blood	O
lymphocytes	cell_type
.	O
These	O
findings	O
highlight	O
the	O
role	O
of	O
thrombin	protein
as	O
a	O
potential	O
regulator	O
of	O
T	cell_type
lymphocyte	cell_type
activation	O
.	O

Stress	O
response	O
of	O
senescent	cell_type
T	cell_type
lymphocytes	cell_type
:	O
reduced	O
hsp70	protein
is	O
independent	O
of	O
the	O
proliferative	O
block	O
.	O
Senescent	cell_line
human	cell_line
T	cell_line
lymphocyte	cell_line
cultures	cell_line
are	O
unable	O
to	O
undergo	O
proliferation,	O
but	O
show	O
no	O
difference	O
from	O
early	cell_line
passage	cell_line
cells	cell_line
in	O
cytotoxic	O
function	O
or	O
surface	O
antigenic	O
profile	O
.	O
A	O
second	O
feature	O
of	O
senescent	cell_line
T	cell_line
cells	cell_line
is	O
the	O
dramatic	O
reduction	O
in	O
hsp70	protein
production	O
in	O
response	O
to	O
heat	O
shock	O
.	O
This	O
decline	O
is	O
associated	O
with	O
a	O
decrease	O
in	O
binding	O
of	O
nuclear	O
extracts	O
to	O
the	O
consensus	DNA
heat	DNA
shock	DNA
element	DNA
.	O
Interestingly,	O
the	O
progressive	O
decline	O
in	O
the	O
heat	O
shock	O
response	O
of	O
cultured	cell_line
T	cell_line
cells	cell_line
correlates	O
with	O
the	O
percent	O
proliferative	O
life	O
span	O
completed	O
rather	O
than	O
with	O
the	O
actual	O
proliferative	O
activity	O
at	O
the	O
time	O
of	O
heat	O
shock	O
.	O
This	O
suggests	O
that	O
for	O
senescent	cell_type
T	cell_type
cells	cell_type
the	O
reduced	O
ability	O
to	O
respond	O
to	O
heat	O
shock	O
by	O
producing	O
hsp70	protein
,	O
although	O
possibly	O
lying	O
at	O
the	O
level	O
of	O
transcriptional	O
control	O
,	O
may	O
nevertheless	O
be	O
unrelated	O
to	O
the	O
reduced	O
DNA	DNA
synthesis	O
or	O
the	O
diminished	O
proliferative	O
activity	O
also	O
manifested	O
by	O
these	O
cells.	O

Involvement	O
of	O
phospholipase	protein
D	protein
in	O
the	O
activation	O
of	O
transcription	protein
factor	protein
AP-1	protein
in	O
human	cell_line
T	cell_line
lymphoid	cell_line
Jurkat	cell_line
cells	cell_line
.	O
The	O
induction	O
of	O
the	O
AP-1	protein
transcription	protein
factor	protein
has	O
been	O
ascribed	O
to	O
the	O
early	O
events	O
leading	O
to	O
T	O
lymphocyte	O
activation	O
.	O
We	O
have	O
examined	O
the	O
possibility	O
that	O
stimulation	O
of	O
phospholipase	protein
D	protein
(	O
PLD	protein
)	O
may	O
regulate	O
activation	O
of	O
transcription	protein
factor	protein
AP-1	protein
in	O
human	O
T	O
cells	O
by	O
transfecting	O
human	O
T	cell_line
lymphocyte	cell_line
Jurkat	cell_line
cells	cell_line
with	O
a	O
plasmid	O
containing	O
an	O
AP-1	DNA
enhancer	DNA
element	DNA
and	O
a	O
chloramphenicol	DNA
acetyltransferase	DNA
reporter	DNA
gene	DNA
.	O
We	O
have	O
detected	O
activatable	O
PLD	protein
in	O
Jurkat	cell_line
cells	cell_line
,	O
and	O
we	O
have	O
found	O
that	O
addition	O
of	O
phosphatidic	O
acid	O
(	O
PA	O
),	O
the	O
physiologic	O
product	O
of	O
PLD	protein
action	O
on	O
phospholipids	O
,	O
is	O
rapidly	O
incorporated	O
into	O
Jurkat	cell_line
cells	cell_line
and	O
leads	O
to	O
activation	O
of	O
transcription	protein
factor	protein
AP-1	protein
.	O
Treatment	O
of	O
Jurkat	cell_line
cells	cell_line
with	O
anti-CD3	protein
mAb	protein
activated	O
both	O
PLD	protein
and	O
transcription	protein
factor	protein
AP-1	protein
.	O
Wortmannin,	O
an	O
inhibitor	O
of	O
receptor-coupled	O
PLD	protein
activation,	O
blocked	O
the	O
anti-CD3	protein
-induced	O
increases	O
in	O
both	O
PLD	protein
activity	O
and	O
AP-1	DNA
enhancer	DNA
activity	O
.	O
We	O
found	O
a	O
good	O
correlation	O
in	O
the	O
transfected	cell_line
cells	cell_line
between	O
PLD	protein
activation	O
and	O
induction	O
of	O
AP-1	DNA
enhancer	DNA
activity	O
under	O
different	O
experimental	O
conditions.	O
Furthermore,	O
ethanol	O
,	O
an	O
inhibitor	O
of	O
the	O
PLD	protein
pathway,	O
blocked	O
the	O
anti-CD3-stimulated	O
AP-1	DNA
enhancer	DNA
activity	O
.	O
However,	O
this	O
anti-CD3	protein
-mediated	O
response	O
was	O
not	O
inhibited	O
by	O
neomycin	O
,	O
an	O
inhibitor	O
of	O
phosphoinositide	O
hydrolysis	O
.	O
The	O
increases	O
in	O
AP-1	DNA
enhancer	DNA
activity	O
induced	O
by	O
PA	O
or	O
anti-CD3	protein
mAb	protein
were	O
efficiently	O
abrogated	O
by	O
the	O
presence	O
of	O
propranolol	O
,	O
an	O
inhibitor	O
of	O
PA	O
phosphohydrolase	protein
and	O
protein	protein
kinase	protein
C	protein
(	O
PKC	protein
).	O
Furthermore,	O
the	O
PA	O
-and	O
the	O
anti-CD3	protein
-induced	O
increases	O
in	O
AP-1	DNA
enhancer	DNA
activity	O
were	O
blocked	O
by	O
the	O
presence	O
of	O
PKC	protein
inhibitors	O
or	O
by	O
PKC	protein
down-regulation	O
.	O
These	O
data	O
indicate	O
that	O
PLD	protein
stimulation	O
can	O
activate	O
the	O
transcription	protein
factor	protein
AP-1	protein
in	O
T	cell_type
lymphocytes	cell_type
,	O
and	O
suggest	O
that	O
the	O
induction	O
of	O
AP-1	DNA
enhancer	DNA
factor	O
activity	O
by	O
PA	O
is	O
mediated	O
via	O
PKC	protein
stimulation	O
,	O
either	O
through	O
a	O
direct	O
activating	O
effect	O
of	O
PA	O
or	O
through	O
PA	O
-derived	O
diacylglycerol	O
formation	O
.	O
These	O
data	O
also	O
provide	O
evidence	O
for	O
a	O
role	O
of	O
PLD	protein
-derived	O
lipids	O
in	O
the	O
induction	O
of	O
AP-1	DNA
enhancer	DNA
activity	O
resulting	O
from	O
stimulation	O
of	O
the	O
TCR/CD3	protein
complex	protein
,	O
suggesting	O
that	O
increased	O
PLD	protein
activity	O
can	O
play	O
an	O
important	O
role	O
in	O
T	cell_type
lymphocyte	cell_type
activation	O
.	O

Upregulation	O
of	O
bcl-2	DNA
by	O
the	O
Epstein-Barr	protein
virus	protein
latent	protein
membrane	protein
protein	protein
LMP1	protein
:	O
a	O
B-cell-specific	O
response	O
that	O
is	O
delayed	O
relative	O
to	O
NF-kappa	protein
B	protein
activation	O
and	O
to	O
induction	O
of	O
cell	protein
surface	protein
markers	protein
.	O
An	O
ability	O
of	O
the	O
Epstein-Barr	protein
virus	protein
latent	protein
membrane	protein
protein	protein
LMP1	protein
to	O
enhance	O
the	O
survival	O
of	O
infected	cell_type
B	cell_type
cells	cell_type
through	O
upregulation	O
of	O
the	O
bcl-2	DNA
oncogene	DNA
was	O
first	O
suggested	O
by	O
experiments	O
involving	O
gene	O
transfection	O
and	O
the	O
selection	O
of	O
stable	O
LMP1	cell_line
+	cell_line
clones	cell_line
(S.Henderson,	O
M.	O
Rowe,	O
C.Gregory,	O
F.Wang,	O
E.Kieff,	O
and	O
A.Rickinson,	O
Cell	O
65:1107-1115,	O
1991).	O
However,	O
it	O
was	O
not	O
possible	O
to	O
ascertain	O
whether	O
Bcl-2	protein
upregulation	O
was	O
a	O
specific	O
consequence	O
of	O
LMP1	protein
expression	O
or	O
an	O
artifact	O
of	O
the	O
selection	O
procedure	O
whereby	O
rare	O
Bcl-2	cell_line
+	cell_line
cells	cell_line
already	O
present	O
in	O
the	O
starting	O
population	O
might	O
best	O
be	O
able	O
to	O
tolerate	O
the	O
potentially	O
toxic	O
effects	O
of	O
LMP1	protein
.	O
We	O
therefore	O
reexamined	O
this	O
issue	O
by	O
using	O
two	O
different	O
experimental	O
approaches	O
that	O
allowed	O
LMP1	protein
-induced	O
effects	O
to	O
be	O
monitored	O
immediately	O
following	O
expression	O
of	O
the	O
viral	O
protein	O
and	O
in	O
the	O
absence	O
of	O
selective	O
pressures;	O
activation	O
of	O
the	O
NF-kappa	protein
B	protein
transcription	protein
factor	protein
and	O
upregulation	O
of	O
the	O
cell	protein
adhesion	protein
molecule	protein
ICAM-1	protein
were	O
used	O
as	O
early	O
indices	O
of	O
LMP1	protein
function.	O
In	O
the	O
first	O
approach,	O
stable	O
clones	O
of	O
two	O
B-cell	cell_line
lines	cell_line
carrying	O
an	O
LMP1	protein
gene	O
under	O
the	O
control	O
of	O
an	O
inducible	O
metallothionein	DNA
promoter	DNA
were	O
induced	O
to	O
express	O
LMP1	protein
in	O
all	O
cells.	O
Activation	O
of	O
NK-kappa	protein
B	protein
and	O
upregulation	O
of	O
ICAM-1	protein
occurred	O
within	O
24	O
h	O
and	O
were	O
followed	O
at	O
48	O
to	O
72	O
h	O
by	O
upregulation	O
of	O
Bcl-2	protein
.	O
In	O
the	O
second	O
approach,	O
we	O
tested	O
the	O
generality	O
of	O
this	O
phenomenon	O
by	O
transiently	O
expressing	O
LMP1	protein
from	O
a	O
strong	O
constitutively	O
active	O
promoter	O
in	O
a	O
range	O
of	O
different	O
cell	O
types.	O
All	O
six	O
B-cell	cell_line
lines	cell_line
tested	O
showed	O
NF-kappa	protein
B	protein
activation	O
in	O
response	O
to	O
LMP1	protein
expression	O
,	O
and	O
this	O
was	O
followed	O
in	O
five	O
of	O
six	O
lines	O
by	O
expression	O
of	O
ICAM-1	protein
and	O
Bcl-2	protein
.	O
In	O
the	O
same	O
experiments,	O
all	O
three	O
non-	O
B-cell	cell_line
lines	cell_line
showed	O
NF-kappa	protein
B	protein
activation	O
and	O
ICAM-1	protein
upregulation	O
but	O
never	O
any	O
effect	O
upon	O
Bcl-2	protein
.	O
We	O
therefore	O
conclude	O
that	O
Bcl-2	protein
upregulation	O
is	O
part	O
of	O
the	O
panoply	O
of	O
cellular	O
changes	O
induced	O
by	O
LMP1	protein
but	O
that	O
the	O
effect	O
is	O
cell	O
type	O
specific.	O
Our	O
data	O
also	O
suggest	O
that	O
whilst	O
NF-kappa	protein
B	protein
may	O
be	O
an	O
essential	O
component	O
of	O
LMP1	protein
signal	O
transduction	O
,	O
other	O
cell-specific	protein
factors	protein
may	O
be	O
required	O
to	O
effect	O
some	O
functions	O
of	O
the	O
viral	protein
protein	protein
.	O

Long-term	O
inositol	O
phosphate	O
release	O
,	O
but	O
not	O
tyrosine	protein
kinase	protein
activity	O
,	O
correlates	O
with	O
IL-2	protein
secretion	O
and	O
NF-AT	protein
induction	O
in	O
anti-CD3-activated	cell_line
peripheral	cell_line
human	cell_line
T	cell_line
lymphocytes	cell_line
.	O
The	O
cascade	O
of	O
events	O
within	O
the	O
first	O
few	O
minutes	O
of	O
T	cell_type
cell	cell_type
stimulation	O
has	O
been	O
well	O
characterized.	O
Although	O
many	O
second	O
messengers	O
have	O
been	O
shown	O
to	O
be	O
necessary	O
and	O
sufficient	O
for	O
T	cell_type
cell	cell_type
activation	O
in	O
a	O
number	O
of	O
model	O
systems,	O
the	O
rate-limiting	O
step	O
in	O
peripheral	cell_type
T	cell_type
cells	cell_type
has	O
not	O
been	O
demonstrated.	O
To	O
model	O
effective	O
versus	O
ineffective	O
CD3	protein
-mediated	O
stimulation	O
in	O
peripheral	cell_type
T	cell_type
cells	cell_type
,	O
we	O
used	O
two	O
anti-CD3	protein
mAbs	protein
that	O
differ	O
in	O
their	O
ability	O
to	O
stimulate	O
purified	cell_type
T	cell_type
cells	cell_type
:	O
OKT3	protein
,	O
which	O
causes	O
early	O
second	O
messenger	O
generation	O
but	O
is	O
unable	O
to	O
activate	O
T	cell_type
cells	cell_type
without	O
a	O
second	O
signal,	O
and	O
64.1	protein
,	O
which	O
stimulates	O
T	cell_type
cell	cell_type
proliferation	O
on	O
its	O
own.	O
We	O
found	O
that	O
tyrosine	protein
kinase	protein
activity	O
was	O
similar	O
for	O
both	O
mAbs	protein
over	O
a	O
period	O
of	O
hours.	O
However,	O
the	O
inositol	O
phosphate	O
response	O
was	O
stronger	O
for	O
64.1	protein
than	O
for	O
OKT3	protein
.	O
To	O
tie	O
these	O
events	O
to	O
gene	O
activation	O
,	O
we	O
measured	O
NF-kappa	protein
B	protein
and	O
NF-AT	protein
activity	O
in	O
the	O
nucleus	O
after	O
anti-CD3	protein
stimulation	O
.	O
Both	O
stimuli	O
induced	O
the	O
appearance	O
of	O
the	O
NF-kappa	protein
B	protein
components	protein
(	O
c-Rel	protein
,	O
p65	protein
(	O
RelA	protein
),	O
and	O
p50	protein
(	O
NF-kappa	protein
B1	protein
))	O
and	O
NF-kappa	protein
B	protein
DNA	O
binding	O
activity	O
in	O
the	O
nucleus.	O
However,	O
only	O
64.1	protein
induced	O
NF-AT	protein
in	O
the	O
nucleus,	O
correlating	O
with	O
its	O
ability	O
to	O
activate	O
T	cell_type
cells	cell_type
.	O
Thus,	O
NF-AT	protein
induction	O
and	O
IL-2	protein
secretion	O
were	O
correlated	O
with	O
the	O
levels	O
of	O
inositol	O
phosphate	O
release	O
but	O
not	O
with	O
gross	O
levels	O
of	O
tyrosine	protein
kinase	protein
activity	O
induced	O
late	O
following	O
the	O
response.	O
On	O
the	O
other	O
hand,	O
NF-kappa	protein
B	protein
induction	O
and	O
IL-2	protein
receptor	O
expression	O
occurred	O
even	O
with	O
the	O
smaller	O
second	O
messenger	O
response	O
generated	O
by	O
OKT3	protein
.	O

HLA-DR-	O
,	O
CD33+	O
,	O
CD56+	O
,	O
CD16-	O
myeloid/natural	O
killer	O
cell	O
acute	O
leukemia	O
:	O
a	O
previously	O
unrecognized	O
form	O
of	O
acute	O
leukemia	O
potentially	O
misdiagnosed	O
as	O
French-American-British	O
acute	O
myeloid	O
leukemia-M3	O
[see	O
comments]	O
We	O
have	O
identified	O
and	O
characterized	O
a	O
previously	O
unrecognized	O
form	O
of	O
acute	O
leukemia	O
that	O
shares	O
features	O
of	O
both	O
myeloid	O
and	O
natural	O
killer	O
(NK)	O
cells	O
.	O
From	O
a	O
consecutive	O
series	O
of	O
350	O
cases	O
of	O
adult	O
de	O
novo	O
acute	O
myeloid	O
leukemia	O
(	O
AML	O
),	O
we	O
identified	O
20	O
cases	O
(6%)	O
with	O
a	O
unique	O
immunophenotype:	O
CD33+,	O
CD56+,	O
CD11a+,	O
CD13lo,	O
CD15lo,	O
CD34+/-,	O
HLA-DR	protein
-,	O
CD16	protein
-.	O
Multicolor	O
flow	O
cytometric	O
assays	O
confirmed	O
the	O
coexpression	O
of	O
myeloid	O
(CD33,	O
CD13,	O
CD15)	O
and	O
NK	O
cell-associated	O
(CD56)	O
antigens	O
in	O
each	O
case,	O
whereas	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(RT-PCR)	O
assays	O
confirmed	O
the	O
identity	O
of	O
CD56	protein
(	O
neural	protein
cell	protein
adhesion	protein
molecule	protein
)	O
in	O
leukemic	cell_type
blasts	cell_type
.	O
Although	O
two	O
cases	O
expressed	O
CD4	protein
,	O
no	O
case	O
expressed	O
CD2	protein
,	O
CD3	protein
,	O
or	O
CD8	protein
and	O
no	O
case	O
showed	O
clonal	O
rearrangement	O
of	O
genes	O
encoding	O
the	O
T-cell	protein
receptor	protein
(	O
TCR	O
beta	O
,	O
gamma	O
,	O
delta	O
).	O
Leukemic	O
blasts	O
in	O
the	O
majority	O
of	O
cases	O
shared	O
unique	O
morphologic	O
features	O
(	O
deeply	O
invaginated	O
nuclear	O
membranes	O
,	O
scant	O
cytoplasm	O
with	O
fine	O
azurophilic	O
granularity	O
,	O
and	O
finely	O
granular	O
Sudan	O
black	O
B	O
and	O
myeloperoxidase	protein
cytochemical	O
reactivity	O
)	O
that	O
were	O
remarkably	O
similar	O
to	O
those	O
of	O
acute	O
promyelocytic	O
leukemia	O
(	O
APL	O
);	O
particularly	O
the	O
microgranular	protein
variant	protein
(	O
FAB	protein
AML	protein
-M3v	protein
).	O
However,	O
all	O
20	O
cases	O
lacked	O
the	O
t(15;17)	O
and	O
17	O
cases	O
tested	O
lacked	O
the	O
promyelocytic/retinoic	RNA
acid	RNA
receptor	RNA
alpha	RNA
(	RNA
RAR	RNA
alpha	RNA
)	RNA
fusion	RNA
transcript	RNA
in	O
RT-PCR	O
assays	O
;	O
12	O
cases	O
had	O
46,XX	O
or	O
46,XY	O
karyotypes	O
,	O
whereas	O
2	O
cases	O
had	O
abnormalities	O
of	O
chromosome	DNA
17q	DNA
:	O
1	O
with	O
del(17)(q25)	DNA
and	O
the	O
other	O
with	O
t(11;17)(q23;q21)	DNA
and	O
the	O
promyelocytic	RNA
leukemia	RNA
zinc	RNA
finger/	RNA
RAR	RNA
alpha	RNA
fusion	RNA
transcript	RNA
.	O
All	O
cases	O
tested	O
(6/20),	O
including	O
the	O
case	O
with	O
t(11;17)	DNA
,	O
failed	O
to	O
differentiate	O
in	O
vitro	O
in	O
response	O
to	O
all-trans	O
retinoic	O
acid	O
(	O
ATRA	O
),	O
suggesting	O
that	O
these	O
cases	O
may	O
account	O
for	O
some	O
APLs	O
that	O
have	O
not	O
shown	O
a	O
clinical	O
response	O
to	O
ATRA	O
.	O
Four	O
of	O
6	O
cases	O
tested	O
showed	O
functional	O
NK	O
cell-mediated	O
cytotoxicity	O
,	O
suggesting	O
a	O
relationship	O
between	O
these	O
unique	O
CD33+,	O
CD56+,	O
CD16	protein
-acute	O
leukemias	O
and	O
normal	cell_type
CD56+,	cell_type
CD16-	cell_type
NK	cell_type
precursor	cell_type
cells	cell_type
.	O
Using	O
a	O
combination	O
of	O
panning	O
and	O
multiparameter	O
flow	O
cytometric	O
sorting,	O
we	O
identified	O
a	O
normal	cell_type
CD56+,	cell_type
CD33+,	cell_type
CD16-	cell_type
counterpart	cell_type
cell	cell_type
at	O
a	O
frequency	O
of	O
1%	O
to	O
2%	O
in	O
the	O
peripheral	O
blood	O
of	O
healthy	O
individuals	O
.	O
Our	O
studies	O
suggest	O
that	O
this	O
form	O
of	O
acute	O
leukemia	O
may	O
arise	O
from	O
transformation	O
of	O
a	O
precursor	O
cell	O
common	O
to	O
both	O
the	O
myeloid	O
and	O
NK	O
cell	O
lineages	O
;	O
thus	O
we	O
propose	O
the	O
designation	O
myeloid/NK	O
acute	O
leukemia	O
.	O
Recognition	O
of	O
this	O
new	O
leukemic	O
entity	O
will	O
be	O
important	O
in	O
distinguishing	O
these	O
ATRA	O
-nonresponsive	O
cases	O
from	O
ATRA	O
-responsive	O
true	O
APL	O
.	O

IL-4	protein
down-regulates	O
IL-2	protein
-,	O
IL-3	protein
-,	O
and	O
GM-CSF	protein
-induced	O
cytokine	O
gene	O
expression	O
in	O
peripheral	O
blood	O
monocytes.	O
IL-4	protein
,	O
a	O
product	O
of	O
the	O
T-helper	O
0	O
(	O
Th0	cell_type
)	O
and	O
2	O
(	O
Th2	cell_type
)	O
subset	O
,	O
was	O
originally	O
described	O
as	O
a	O
B-cell	protein
stimulatory	protein
factor	protein
and	O
has	O
subsequently	O
been	O
found	O
to	O
suppress	O
IL-1	O
alpha	O
,	O
IL-1	O
beta	O
,	O
IL-6	O
,	O
IL-8	O
,	O
and	O
TNF-alpha	O
gene	O
expression	O
in	O
monocytes	cell_type
stimulated	O
with	O
LPS	O
,	O
and	O
to	O
upregulate	O
IL-1	DNA
receptor	DNA
antagonist	DNA
(IL1-RA)	DNA
gene	DNA
expression	O
.	O
In	O
this	O
study	O
we	O
investigated	O
the	O
effect	O
of	O
IL-4	protein
on	O
the	O
expression	O
of	O
cytokine	DNA
genes	DNA
in	O
monocytes	cell_type
evoked	O
by	O
other	O
T-helper	protein
cell	protein
cytokines	protein
:	O
IL-2	protein
,	O
IL-3	protein
,	O
and	O
GM-CSF	protein
.	O
IL-4	protein
down-regulated	O
mRNA	O
accumulation	O
of	O
the	O
proinflammatory	protein
cytokines	protein
IL-1	protein
beta	protein
,	O
IL-8	protein
,	O
and	O
TNF-alpha	protein
in	O
monocytes	cell_type
stimulated	O
with	O
IL-2	protein
,	O
IL-3	protein
,	O
and	O
GM-CSF	protein
.	O
IL-4	protein
also	O
suppressed	O
the	O
IL-2	protein
-induced	O
IL-6	protein
mRNA	O
expression	O
.	O
Temporal	O
analysis	O
of	O
the	O
IL-4	protein
down-regulatory	O
effect	O
on	O
the	O
IL-2-	O
,	O
IL-3-	O
,	O
or	O
GM-CSF-	O
induced	O
proinflammatory	O
cytokine	O
gene	O
expression	O
in	O
monocytes	cell_type
provided	O
evidence	O
that	O
IL-4	protein
acts	O
predominantly	O
on	O
the	O
post-transcriptional	O
level	O
.	O
This	O
was	O
supported	O
by	O
the	O
observation	O
that	O
the	O
down-regulatory	O
capacity	O
of	O
IL-4	protein
appeared	O
to	O
be	O
dependent	O
on	O
de	O
novo	O
protein	O
synthesis	O
.	O
IL-4	protein
did	O
not	O
exert	O
significant	O
influence	O
on	O
the	O
induction	O
of	O
expression	O
of	O
IL-1-RA	protein
or	O
various	O
CSFs	protein
by	O
IL-2	protein
,	O
IL-3	protein
,	O
and	O
GM-CSF	protein
.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS)	O

Induction	O
of	O
proto-oncogene	DNA
and	O
cytokine	protein
expression	O
in	O
human	O
peripheral	O
blood	O
monocytes	cell_type
and	O
the	O
monocytic	cell_line
cell	cell_line
line	cell_line
THP-1	cell_line
after	O
stimulation	O
with	O
mycoplasma-derived	O
material	O
MDHM	O
.	O
Mycoplasma	O
fermentans-derived	O
high-molecular-weight	O
material	O
(	O
MDHM	O
)	O
was	O
originally	O
described	O
to	O
induce	O
differentiation	O
of	O
murine	cell_type
thymocytes	cell_type
to	O
cytolytic	cell_type
effector	cell_type
T-cells	cell_type
by	O
stimulating	O
IL-6	protein
release	O
from	O
adherent	cell_type
cells	cell_type
.	O
This	O
study	O
shows	O
that	O
human	O
peripheral	O
blood	O
monocytes	cell_type
(	O
PBMo	cell_type
)	O
also	O
respond	O
to	O
MDHM	O
with	O
increases	O
in	O
IL-1	protein
beta	protein
,	O
IL-6	protein
and	O
TNF	protein
alpha	protein
expression	O
,	O
both	O
at	O
the	O
mRNA	O
and	O
protein	O
level.	O
The	O
induced	O
expression	O
of	O
IL-1	O
beta	O
and	O
TNF	O
alpha	O
mRNA	O
in	O
the	O
monocytic	O
THP-1	cell_line
cell	cell_line
line	cell_line
increased	O
as	O
quickly	O
as	O
in	O
primary	cell_type
cells	cell_type
.	O
In	O
contrast	O
to	O
PBMo	cell_type
,	O
THP-1	cell_line
and	O
14	O
other	O
monocytic/myeloid	cell_line
leukemia-derived	cell_line
cell	cell_line
lines	cell_line
did	O
not	O
secrete	O
measurable	O
amounts	O
of	O
the	O
cytokines	protein
upon	O
treatment	O
with	O
MDHM	O
.	O
IL-1	DNA
beta	DNA
and	DNA
IL-6	DNA
genes	DNA
contain	O
AP-1	DNA
binding	DNA
sites	DNA
as	O
regulatory	DNA
elements	DNA
,	O
the	O
AP-1	protein
protein	O
being	O
composed	O
of	O
c-jun	O
and	O
c-fos	O
gene	O
products	O
.	O
In	O
THP-1	cell_line
cells	cell_line
c-jun	RNA
mRNA	RNA
expression	O
increased	O
after	O
incubation	O
with	O
MDHM	O
while	O
positive	O
c-fos	DNA
expression	O
remained	O
unaffected.	O
Although	O
these	O
data	O
suggest	O
AP-1	protein
regulated	O
cytokine	protein
mRNA	O
expression,	O
results	O
from	O
PBMo	cell_type
are	O
not	O
in	O
accordance	O
with	O
this	O
notion.	O
In	O
the	O
primary	cell_type
cells	cell_type
MDHM	O
-induced	O
elevation	O
of	O
cytokine	RNA
mRNA	RNA
levels	O
was	O
preceded	O
by	O
a	O
downregulation	O
of	O
c-fos	DNA
expression	O
while	O
positive	O
c-jun	DNA
expression	O
was	O
not	O
modulated.	O
c-myc	RNA
mRNA	RNA
expression	O
,	O
constitutively	O
high	O
in	O
THP-1	cell_line
cells	cell_line
,	O
was	O
induced	O
in	O
MDHM	O
-stimulated	O
PBMo	cell_type
.	O
In	O
conclusion,	O
MDHM	O
-stimulated	O
induction	O
of	O
cytokine	RNA
mRNA	RNA
expression	O
was	O
accompanied	O
by	O
different	O
proto-oncogene	DNA
responses	O
in	O
PBMo	cell_type
and	O
THP-1	cell_line
cells	cell_line
.	O
These	O
differences	O
may	O
represent	O
different	O
regulatory	O
pathways	O
of	O
the	O
two	O
cell	O
systems.	O
Alternatively,	O
these	O
data	O
support	O
the	O
notion	O
that	O
neither	O
AP-1	protein
nor	O
the	O
c-myc	protein
protein	protein
are	O
involved	O
in	O
the	O
MDHM	O
-induced	O
increase	O
in	O
IL-1	O
beta	O
,	O
IL-6	O
or	O
TNF	O
alpha	O
mRNA	O
levels	O
.	O
Furthermore,	O
the	O
present	O
results	O
demonstrate	O
clearly	O
that	O
mycoplasma	protein
products	protein
can	O
have	O
a	O
profound	O
impact	O
on	O
the	O
activation	O
status	O
of	O
eukaryotic	cell_type
cells	cell_type
.	O

Novel	protein
membrane	protein
receptors	protein
for	O
aldosterone	O
in	O
human	cell_type
lymphocytes	cell_type
:	O
a	O
50	protein
kDa	protein
protein	protein
on	O
SDS-PAGE	O
.	O
Fast	O
in	O
vitro	O
effects	O
of	O
aldosterone	O
on	O
the	O
Na+/H(+)-exchanger	protein
,	O
inositoltrisphosphate	O
generation	O
and	O
corresponding	O
specific	O
binding	O
to	O
plasma	O
membranes	O
at	O
Kd-values	O
of	O
approximately	O
0.1	O
nM	O
have	O
been	O
found	O
in	O
human	cell_type
mononuclear	cell_type
leukocytes	cell_type
and	O
vascular	cell_type
smooth	cell_type
muscle	cell_type
cells	cell_type
.	O
The	O
novel	O
aldosterone	O
membrane	O
receptor	O
was	O
analyzed	O
on	O
SDS-PAGE	O
after	O
labeling	O
of	O
microsomal	O
membranes	O
from	O
human	cell_type
mononuclear	cell_type
leukocytes	cell_type
with	O
a	O
[125I]-	O
aldosterone	O
-derivative	O
by	O
use	O
of	O
BASED	O
as	O
a	O
photoactivatable	O
crosslinker	O
.	O
Binding	O
of	O
1	O
nM	O
[125I]-	O
aldosterone	O
was	O
found	O
at	O
a	O
molecular	O
weight	O
of	O
approximately	O
50	O
kDa	O
which	O
was	O
absent	O
with	O
1	O
microM	O
cold	O
aldosterone	O
,	O
but	O
not	O
cortisol	O
in	O
the	O
binding	O
media	O
.	O
This	O
aldosterone	O
-selectivity	O
is	O
typical	O
and	O
discriminatory	O
for	O
the	O
new	O
aldosterone	protein
membrane	protein
receptor	protein
.	O
Solubilization	O
of	O
the	O
receptor	protein
protein	protein
from	O
membranes	O
by	O
high	O
salt	O
concentrations	O
(1	O
M	O
NaCl	O
,	O
1	O
mM	O
EDTA	O
)	O
was	O
not	O
achieved.	O
It,	O
thus,	O
appears	O
as	O
an	O
integral	protein
membrane	protein
protein	protein
.	O
Dithiothreitol	O
,	O
a	O
sulfhydryl	O
agent	O
,	O
does	O
not	O
reduce	O
specific	O
aldosterone	O
binding	O
indicating	O
the	O
absence	O
of	O
SH-groups	protein
in	O
the	O
binding	protein
domain	protein
or	O
sensitive	O
structures	O
of	O
the	O
receptors.	O
The	O
results	O
are	O
the	O
first	O
to	O
characterize	O
the	O
novel	protein
membrane	protein
receptor	protein
for	O
aldosterone	O
with	O
regard	O
to	O
molecular	O
weight	O
and	O
basic	O
properties.	O
These	O
findings	O
and	O
other	O
related	O
results	O
are	O
reviewed	O
here.	O

A	O
transcriptional	DNA
regulatory	DNA
element	DNA
is	O
associated	O
with	O
a	O
nuclease-hypersensitive	DNA
site	DNA
in	O
the	O
pol	DNA
gene	DNA
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
.	O
Analysis	O
of	O
the	O
chromatin	O
organization	O
of	O
the	O
integrated	O
human	DNA
immunodeficiency	DNA
virus	DNA
type	DNA
1	DNA
(	DNA
HIV-1	DNA
)	DNA
genome	DNA
has	O
previously	O
revealed	O
a	O
major	DNA
constitutive	DNA
DNase	DNA
I-hypersensitive	DNA
site	DNA
associated	O
with	O
the	O
pol	DNA
gene	DNA
(E.	O
Verdin,	O
J.	O
Virol.	O
65:6790-6799,	O
1991).	O
In	O
the	O
present	O
report,	O
high-resolution	O
mapping	O
of	O
this	O
site	O
with	O
DNase	protein
I	protein
and	O
micrococcal	protein
nuclease	protein
identified	O
a	O
nucleosome-free	DNA
region	DNA
centered	O
around	O
nucleotides	DNA
(nt)	DNA
4490	DNA
to	DNA
4766	DNA
.	O
A	O
500-bp	DNA
fragment	DNA
encompassing	O
this	O
hypersensitive	DNA
site	DNA
(	O
nt	DNA
4481	DNA
to	DNA
4982	DNA
)	O
exhibited	O
transcription-enhancing	O
activity	O
(two-	O
to	O
threefold)	O
when	O
it	O
was	O
cloned	O
in	O
its	O
natural	O
position	O
with	O
respect	O
to	O
the	O
HIV-1	DNA
promoter	DNA
after	O
transient	O
transfection	O
in	O
U937	cell_line
and	O
CEM	cell_line
cells	cell_line
.	O
Using	O
in	O
vitro	O
footprinting	O
and	O
gel	O
shift	O
assays	O
,	O
we	O
have	O
identified	O
four	O
distinct	O
binding	DNA
sites	DNA
for	O
nuclear	protein
proteins	protein
within	O
this	O
positive	DNA
regulatory	DNA
element	DNA
.	O
Site	DNA
B	DNA
(	O
nt	DNA
4519	DNA
to	DNA
4545	DNA
)	O
specifically	O
bound	O
four	O
distinct	O
nuclear	protein
protein	protein
complexes	protein
:	O
a	O
ubiquitous	protein
factor	protein
,	O
a	O
T-cell-specific	protein
factor	protein
,	O
a	O
B-cell-specific	protein
factor	protein
,	O
and	O
the	O
monocyte/macrophage-	protein
and	protein
B-cell-specific	protein
transcription	protein
factor	protein
PU.1/Spi-1	protein
.	O
In	O
most	O
HIV-1	O
isolates	O
in	O
which	O
this	O
PU	DNA
box	DNA
was	O
not	O
conserved,	O
it	O
was	O
replaced	O
by	O
a	O
binding	DNA
site	DNA
for	O
the	O
related	O
factor	O
Ets1	protein
.	O
Factors	O
binding	O
to	O
site	DNA
C	DNA
(	O
nt	DNA
4681	DNA
to	DNA
4701	DNA
)	O
had	O
a	O
DNA-binding	O
specificity	O
similar	O
to	O
that	O
of	O
factors	O
binding	O
to	O
site	DNA
B	DNA
,	O
except	O
for	O
PU.1/Spi-1	protein
.	O
A	O
GC	DNA
box	DNA
containing	O
a	O
binding	DNA
site	DNA
for	O
Sp1	protein
was	O
identified	O
(	O
nt	DNA
4623	DNA
to	DNA
4631	DNA
).	O
Site	DNA
D	DNA
(	O
nt	DNA
4816	DNA
to	DNA
4851	DNA
)	O
specifically	O
bound	O
a	O
ubiquitously	protein
expressed	protein
factor	protein
.	O
These	O
results	O
identify	O
a	O
transcriptional	DNA
regulatory	DNA
element	DNA
associated	O
with	O
a	O
nuclease-	DNA
hypersensitive	DNA
site	DNA
in	O
the	O
pol	DNA
gene	DNA
of	O
HIV-1	O
and	O
suggest	O
that	O
its	O
activity	O
may	O
be	O
controlled	O
by	O
a	O
complex	O
interplay	O
of	O
cis-	O
regulatory	DNA
elements	DNA
.	O

Expression	O
of	O
v-src	DNA
in	O
T	cell_type
cells	cell_type
correlates	O
with	O
nuclear	O
expression	O
of	O
NF-kappa	protein
B	protein
.	O
NF-kappa	protein
B	protein
is	O
a	O
rapidly	O
inducible	O
transcriptional	DNA
activator	DNA
that	O
responds	O
to	O
a	O
variety	O
of	O
signals	O
and	O
influences	O
the	O
expression	O
of	O
many	O
genes	O
involved	O
in	O
the	O
immune	O
response	O
.	O
Protein	O
tyrosine	protein
kinases	protein
transmit	O
signals	O
from	O
cytokine	O
and	O
immune	O
receptors	O
.	O
Very	O
little	O
information	O
exists	O
linking	O
these	O
two	O
important	O
classes	O
of	O
signaling	protein
molecules	protein
.	O
We	O
now	O
demonstrate	O
that	O
v-src	DNA
expression	O
correlates	O
with	O
nuclear	O
expression	O
of	O
a	O
kappa	protein
B	protein
binding	protein
complex	protein
similar	O
to	O
that	O
induced	O
by	O
phorbol	O
ester	O
and	O
ionomycin	O
,	O
as	O
detected	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
using	O
a	O
variety	O
of	O
kappa	DNA
B	DNA
sites	DNA
.	O
This	O
complex	O
was	O
blocked	O
by	O
the	O
tyrosine	protein
kinase	protein
inhibitor,	O
herbimycin	O
A.	O
The	O
v-src	protein
-induced	protein
complex	protein
comprised	O
the	O
p50	protein
and	O
p65	protein
components	O
of	O
NF-kappa	protein
B	protein
,	O
as	O
determined	O
by	O
supershift	O
and	O
immunoblot	O
analysis	O
.	O
As	O
a	O
functional	O
correlate	O
of	O
this	O
finding,	O
transient	O
co-transfection	O
of	O
HIV-1	DNA
LTR	DNA
reporter	DNA
constructs	DNA
in	O
a	O
different	O
T	cell_line
cell	cell_line
line	cell_line
demonstrated	O
that	O
v-src	DNA
activated	O
this	O
promoter	protein
in	O
a	O
kappa	O
B-dependent	O
manner	O
.	O
We	O
found	O
that	O
transactivation	O
of	O
the	O
HIV-1	DNA
LTR	DNA
by	O
v-src	DNA
was	O
more	O
sensitive	O
to	O
mutations	O
of	O
the	O
proximal,	O
rather	O
than	O
the	O
distal,	O
kappa	DNA
B	DNA
element	DNA
.	O
The	O
implications	O
for	O
T	protein
cell	protein
receptor	protein
signaling	O
and	O
HIV-1	DNA
gene	DNA
expression	O
are	O
considered.	O

trans-activation	O
of	O
the	O
HIV	DNA
promoter	DNA
by	O
a	O
cDNA	O
and	O
its	O
genomic	O
clones	O
of	O
human	O
herpesvirus-6	O
.	O
Human	O
herpesvirus	O
6	O
(	O
HHV-6	O
)	O
is	O
a	O
lymphotropic	O
herpesvirus	O
,	O
and	O
in	O
vitro,	O
it	O
can	O
productively	O
infect	O
human	O
CD4+	cell_line
T	cell_line
cells	cell_line
as	O
HIV-1	O
.	O
Co-infection	O
of	O
T	cell_type
cells	cell_type
by	O
HIV-1	O
and	O
HHV-6	O
can	O
lead	O
to	O
both	O
activation	O
of	O
the	O
HIV-1	DNA
promoter	DNA
and	O
acceleration	O
of	O
the	O
cytopathic	O
effects.	O
An	O
HHV-6	DNA
(GS)	DNA
cDNA	DNA
clone	DNA
,	O
pCD41	DNA
,	O
encoding	O
for	O
a	O
41-kDa	protein
nuclear	protein
protein	protein
was	O
identified	O
and	O
characterized	O
previously	O
(Chang	O
and	O
Balachandran,	O
J.	O
Virol.	O
65,	O
2884-2894	O
and	O
7085,	O
1991).	O
Sequence	O
analyses	O
show	O
that	O
this	O
protein	O
has	O
significant	O
homology	O
with	O
the	O
human	DNA
cytomegalovirus	DNA
UL44	DNA
gene	DNA
coding	O
for	O
the	O
ICP36	protein
family	protein
of	O
early-late-class	protein
phosphoprotein	protein
.	O
Using	O
this	O
cDNA	DNA
as	O
the	O
probe,	O
a	O
3.8-kb	DNA
EcoRI	DNA
genomic	DNA
fragment	DNA
encoding	O
the	O
HHV-6	protein
(GS)P41	protein
was	O
cloned	O
and	O
designated	O
as	O
pGD41	DNA
.	O
When	O
cotransfected	O
with	O
the	O
HIV	DNA
LTR	DNA
CAT	DNA
into	O
CV-1	cell_line
cells	cell_line
,	O
both	O
the	O
pCD41	DNA
and	O
pGD41	DNA
clones	O
trans-activated	O
the	O
HIV	DNA
LTR	DNA
.	O
Sequence	O
analyses	O
of	O
pCD41	DNA
indicate	O
that	O
there	O
are	O
two	O
potential	O
open	DNA
reading	DNA
frames	DNA
(	O
ORFs	DNA
),	O
A	DNA
and	O
B	DNA
,	O
which	O
are	O
homologous	O
to	O
the	O
ORFs	DNA
found	O
in	O
the	O
genomic	O
clone	O
pGD41	DNA
.	O
Deletion	O
constructs	O
of	O
the	O
pCD41	DNA
clone	DNA
demonstrated	O
that	O
ORF-A	protein
was	O
critical	O
for	O
the	O
HIV	DNA
LTR	DNA
activation.	O
Deletion	O
analyses	O
of	O
the	O
pCD41	DNA
ORF-A	protein
and	O
the	O
use	O
of	O
promoter	DNA
constructs	DNA
further	O
mapped	O
an	O
internal	O
functional	O
promoter	O
within	O
the	O
pCD41	DNA
sequence	O
that	O
can	O
direct	O
the	O
synthesis	O
of	O
the	O
trans-activating	protein
protein	protein
.	O
By	O
using	O
HIV	DNA
LTR	DNA
deletion	DNA
mutants	DNA
,	O
the	O
NF-kappa	protein
B	protein
binding	DNA
sites	DNA
were	O
found	O
to	O
be	O
critical	O
for	O
response	O
to	O
the	O
pCD41	DNA
trans-activation	O
.	O

CD14	protein
-mediated	O
translocation	O
of	O
nuclear	protein
factor-kappa	protein
B	protein
induced	O
by	O
lipopolysaccharide	O
does	O
not	O
require	O
tyrosine	protein
kinase	protein
activity	O
.	O
During	O
the	O
course	O
of	O
serious	O
bacterial	O
infections	O
,	O
lipopolysaccharide	O
(	O
LPS	O
)	O
is	O
believed	O
to	O
interact	O
with	O
macrophage	protein
receptors	protein
,	O
resulting	O
in	O
the	O
generation	O
of	O
inflammatory	O
mediators	O
and	O
systemic	O
symptoms	O
including	O
hemodynamic	O
instability	O
and	O
shock	O
.	O
CD14	protein
,	O
a	O
glycosylphosphatidylinositol-linked	protein
antigen	protein
,	O
functions	O
as	O
an	O
LPS	protein
signaling	protein
receptor	protein
.	O
A	O
critical	O
issue	O
concerns	O
the	O
mechanism	O
by	O
which	O
CD14	protein
,	O
which	O
has	O
no	O
transmembrane	protein
domain	protein
,	O
transduces	O
its	O
signal	O
following	O
LPS	O
binding.	O
Recently,	O
investigators	O
have	O
hypothesized	O
that	O
CD14	protein
-mediated	O
signaling	O
is	O
effected	O
through	O
a	O
receptor-associated	O
tyrosine	protein
kinase	protein
(TK),	O
suggesting	O
a	O
multicomponent	O
receptor	O
model	O
of	O
LPS	O
signaling	O
.	O
Wild-type	O
Chinese	cell_line
hamster	cell_line
ovary	cell_line
(CHO)-K1	cell_line
cells	cell_line
can	O
be	O
activated	O
by	O
endotoxin	O
to	O
release	O
arachidonate	O
following	O
transfection	O
with	O
human	O
CD14	protein
(	O
CHO/	protein
CD14	protein
).	O
Nuclear	O
translocation	O
of	O
cytosolic	O
NF-kappa	O
B	O
is	O
correlated	O
with	O
a	O
number	O
of	O
LPS	O
-inducible	O
responses	O
.	O
We	O
sought	O
to	O
determine	O
if	O
this	O
pathway	O
were	O
present	O
in	O
CHO/	cell_line
CD14	cell_line
cells	cell_line
and	O
to	O
elucidate	O
the	O
relationship	O
of	O
NF-kappa	protein
B	protein
activation	O
to	O
the	O
CD14	protein
receptor	O
system	O
.	O
LPS	O
-stimulated	O
translocation	O
of	O
NF-kappa	protein
B	protein
in	O
CHO/	cell_line
CD14	cell_line
cells	cell_line
resembled	O
the	O
same	O
response	O
in	O
the	O
murine	cell_line
macrophage-like	cell_line
cell	cell_line
line	cell_line
RAW	cell_line
264.7	cell_line
.	O
Protein	O
synthesis	O
inhibitors	O
and	O
corticosteroids	O
,	O
which	O
suppress	O
arachidonate	O
release	O
and	O
the	O
synthesis	O
of	O
proinflammatory	protein
cytokines	protein
,	O
had	O
no	O
effect	O
on	O
translocation	O
of	O
NF-kappa	protein
B	protein
in	O
CHO/	O
CD14	protein
or	O
RAW	cell_line
264.7	cell_line
cells	cell_line
,	O
demonstrating	O
that	O
NF-kappa	protein
B	protein
translocation	O
is	O
an	O
early	O
event.	O
Although	O
TK	O
activity	O
was	O
consistently	O
observed	O
by	O
immunoblotting	O
extracts	O
from	O
activated	O
RAW	cell_line
264.7	cell_line
cells	cell_line
,	O
LPS-induced	O
phosphotyrosine	O
residues	O
were	O
not	O
observed	O
from	O
similarly	O
treated	O
CHO/CD14	cell_line
cells	cell_line
.	O
Furthermore,	O
the	O
TK	O
inhibitors	O
herbimycin	O
A	O
and	O
genistein	O
failed	O
to	O
inhibit	O
translocation	O
of	O
NF-kappa	protein
B	protein
in	O
CHO/CD14	cell_line
or	O
RAW	cell_line
264.7	cell_line
cells	cell_line
,	O
although	O
both	O
of	O
these	O
agents	O
inhibited	O
LPS	O
-induced	O
TK	O
activity	O
in	O
RAW	cell_line
264.7	cell_line
cells	cell_line
.	O
These	O
results	O
imply	O
that	O
TK	O
activity	O
is	O
not	O
obligatory	O
for	O
CD14	protein
-mediated	O
signal	O
transduction	O
to	O
occur	O
in	O
response	O
to	O
LPS	O
.	O

Signals	O
transduced	O
through	O
the	O
CD4	protein
molecule	protein
on	O
T	cell_type
lymphocytes	cell_type
activate	O
NF-kappa	protein
B	protein
.	O
We	O
have	O
demonstrated	O
that	O
native	protein
envelope	protein
glycoproteins	protein
of	O
HIV-1	O
,	O
gp160	O
can	O
induce	O
activation	O
of	O
the	O
transcription	protein
factor	protein
,	O
NF-kappa	protein
B	protein
.	O
The	O
stimulatory	O
effects	O
of	O
gp160	O
are	O
mediated	O
through	O
the	O
CD4	protein
molecule	protein
,	O
since	O
pretreatment	O
with	O
soluble	O
CD4	protein
abrogates	O
its	O
activity.	O
The	O
gp160	protein
-induced	protein
NF-kappa	protein
B	protein
complex	protein
consists	O
of	O
p65	protein
,	O
p50	protein
and	O
c-rel	protein
proteins	protein
.	O
The	O
stimulatory	O
effect	O
of	O
gp160	O
on	O
NF-kappa	protein
B	protein
activation	O
is	O
protein	O
synthesis	O
independent,	O
is	O
dependent	O
upon	O
protein	O
tyrosine	O
phosphorylation,	O
and	O
abrogated	O
by	O
inhibitors	O
of	O
protein	protein
kinase	protein
C	protein
.	O
The	O
gp160	O
-mediated	O
activation	O
of	O
NF-kappa	protein
B	protein
in	O
CD4	cell_type
positive	cell_type
T	cell_type
cells	cell_type
may	O
be	O
involved	O
in	O
biological	O
effects,	O
e.g.,	O
enhanced	O
HIV	O
replication	O
,	O
hypergammaglobulinemia	O
,	O
increased	O
cytokine	protein
secretion	O
,	O
hypercellularity	O
in	O
bone	O
marrow	O
and	O
apoptosis	O
.	O

No	O
evidence	O
for	O
the	O
expression	O
of	O
the	O
progesterone	protein
receptor	protein
on	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
during	O
pregnancy	O
[see	O
comments]	O
The	O
expression	O
of	O
the	O
progesterone	protein
receptor	protein
in	O
human	cell_type
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
was	O
analysed,	O
using	O
an	O
enzyme	O
linked	O
immunosorbent	O
assay	O
(	O
Abbott	O
PgR-EIA	O
monoclonal	O
),	O
in	O
order	O
to	O
evaluate	O
its	O
prognostic	O
character	O
in	O
the	O
context	O
of	O
spontaneous	O
abortion	O
.	O
Cytosols	O
were	O
prepared	O
from	O
lymphocytes	O
of	O
24	O
healthy	O
pregnant	O
women	O
(11	O
first,	O
10	O
second	O
and	O
three	O
third	O
trimester),	O
seven	O
healthy	O
non-pregnant	O
women	O
,	O
nine	O
women	O
with	O
recurrent	O
spontaneous	O
abortion	O
,	O
and	O
six	O
healthy	O
men	O
.	O
In	O
addition,	O
a	O
human	cell_line
breast	cell_line
carcinoma	cell_line
cell	cell_line
line	cell_line
(	O
ZR-75-1	cell_line
),	O
which	O
expresses	O
the	O
progesterone	protein
receptor	protein
,	O
was	O
analysed	O
throughout.	O
The	O
ZR-75-1	cell_line
cell	cell_line
line	cell_line
showed	O
an	O
expression	O
of	O
642	O
fmol/mg	O
whereas	O
lymphocytes	O
of	O
pregnant	O
women	O
showed	O
an	O
expression	O
&lt;	O
or	O
=	O
4	O
fmol/mg.	O
Lymphocytes	cell_type
of	O
non-pregnant	O
women	O
,	O
women	O
with	O
threatened	O
pre-term	O
delivery,	O
and	O
men	O
showed	O
equivalent	O
levels:	O
3	O
+/-	O
1,	O
3	O
+/-	O
2	O
and	O
5	O
+/-	O
4	O
fmol/mg	O
respectively.	O
These	O
results	O
show	O
that	O
there	O
is	O
no	O
evidence	O
of	O
specific	O
expression	O
of	O
the	O
progesterone	protein
receptor	protein
in	O
pregnancy	O
and	O
exclude	O
any	O
prognostic	O
character	O
in	O
spontaneous	O
abortion	O
.	O
A	O
role	O
for	O
the	O
progesterone	protein
receptor	protein
in	O
the	O
mechanism	O
of	O
the	O
known	O
effect	O
of	O
progesterone	O
on	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
is	O
also	O
excluded.	O

Tolerance	O
to	O
lipopolysaccharide	O
involves	O
mobilization	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
with	O
predominance	O
of	O
p50	protein
homodimers.	O
Stimulation	O
of	O
the	O
human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
Mono	cell_line
Mac	cell_line
6	cell_line
with	O
lipopolysaccharide	O
(	O
LPS	O
)	O
leads	O
to	O
rapid	O
and	O
transient	O
expression	O
of	O
cytokines	protein
like	O
tumor	protein
necrosis	protein
factor	protein
(	O
TNF	protein
).	O
When	O
such	O
cells	O
are	O
precultured	O
for	O
2	O
days	O
with	O
a	O
low	O
dose	O
of	O
LPS	O
(20	O
ng/ml)	O
followed	O
by	O
stimulation	O
with	O
a	O
high	O
dose	O
of	O
LPS	O
(1	O
microgram/ml),	O
expression	O
of	O
the	O
TNF	DNA
gene	DNA
is	O
minimal,	O
i.e.	O
the	O
cells	O
are	O
tolerant.	O
In	O
nuclear	O
run-on	O
analysis	O
,	O
such	O
tolerant	cell_type
cells	cell_type
show	O
only	O
a	O
low	O
degree	O
of	O
transcription,	O
indicating	O
that	O
tolerance	O
operates	O
at	O
or	O
upstream	O
of	O
the	O
transcription	O
level	O
.	O
The	O
CD14	protein
LPS	O
receptor	O
is,	O
however,	O
up-regulated	O
(not	O
down-regulated)	O
in	O
tolerant	cell_line
cells	cell_line
,	O
and	O
LPS	O
can,	O
in	O
fact,	O
still	O
lead	O
to	O
activation	O
of	O
tolerant	cell_line
cells	cell_line
as	O
evidenced	O
by	O
mobilization	O
of	O
the	O
transcription	protein
factor	protein
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
).	O
Resolution	O
of	O
the	O
NF-kappa	protein
B	protein
complex	protein
in	O
gel	O
shift	O
analysis	O
shows	O
that	O
the	O
binding	protein
protein	protein
,	O
mobilized	O
in	O
naive	cell_line
Mono	cell_line
Mac	cell_line
6	cell_line
cells	cell_line
,	O
consists	O
mainly	O
of	O
p50	protein
-p65	protein
heterodimers	protein
,	O
while	O
in	O
tolerant	cell_line
cells	cell_line
,	O
the	O
p50	protein
homodimer	protein
is	O
predominant.	O
This	O
increase	O
in	O
p50	protein
homodimers	protein
coincides	O
with	O
an	O
increase	O
in	O
p105	RNA
mRNA	RNA
,	O
suggestive	O
of	O
a	O
transcriptional	O
up-regulation	O
of	O
p50	protein
.	O
Reporter	O
gene	O
analysis	O
reveals	O
that	O
the	O
NF-kappa	protein
B	protein
complex	protein
mobilized	O
in	O
tolerant	cell_line
cells	cell_line
is	O
functionally	O
inactive	O
in	O
that	O
NF-kappa	DNA
B	DNA
-dependent	DNA
luciferase	DNA
constructs	DNA
containing	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
long	DNA
terminal	DNA
repeat	DNA
or	O
the	O
TNF	DNA
5'-region	DNA
show	O
only	O
minimal	O
transactivation	O
after	O
LPS	O
stimulation.	O
Similar	O
to	O
Mono	cell_line
Mac	cell_line
6	cell_line
cells	cell_line
,	O
primary	cell_type
blood	cell_type
monocytes	cell_type
,	O
when	O
precultured	O
with	O
a	O
low	O
dose	O
of	O
LPS	O
,	O
also	O
become	O
tolerant	O
and	O
produce	O
little	O
TNF	protein
after	O
LPS	O
stimulation	O
.	O
The	O
tolerant	cell_type
blood	cell_type
monocytes	cell_type
also	O
up-regulate	O
CD14	protein
,	O
and	O
they	O
mobilize	O
NF-kappa	protein
B	protein
with	O
a	O
predominance	O
of	O
p50	protein
homodimers	protein
.	O
Taken	O
together,	O
these	O
results	O
demonstrate	O
that	O
tolerance	O
to	O
LPS	O
is	O
determined	O
by	O
post-receptor	O
mechanisms	O
that	O
involve	O
an	O
altered	O
composition	O
of	O
the	O
NF-kappa	protein
B	protein
complex	protein
.	O

Analysis	O
of	O
Oct2-isoform	protein
expression	O
in	O
lipopolysaccharide	cell_line
-stimulated	cell_line
B	cell_line
lymphocytes	cell_line
.	O
Oct2-isoform	protein
expression	O
in	O
splenic	cell_type
B	cell_type
cells	cell_type
stimulated	O
with	O
lipopolysaccharide	O
or	O
lipopolysaccharide	O
plus	O
phorbol-di-butyrate	O
was	O
analysed	O
by	O
cDNA	O
cloning	O
.	O
The	O
frequency	O
of	O
Oct2-positive	cell_line
clones	cell_line
was	O
1/15,000	O
in	O
both	O
libraries.	O
Two	O
new	O
isoforms	O
were	O
found	O
that	O
generate	O
novel	O
amino-	O
or	O
carboxy-	O
terminal	O
sequences	O
.	O
An	O
isoform	O
lacking	O
exon	DNA
11	DNA
destroyed	O
the	O
carboxy-terminal	protein
leucin-zipper	protein
region	protein
and	O
introduced	O
a	O
frame	O
shift	O
creating	O
a	O
novel,	O
proline	protein
-rich	protein
carboxy	protein
terminus	protein
.	O
A	O
new	O
exon	DNA
containing	O
a	O
highly	O
basic	O
region	O
(4c)	O
was	O
characterized,	O
between	DNA
exons	DNA
4	DNA
and	DNA
5	DNA
.	O
This	O
exon	O
was	O
inserted	O
between	DNA
glutamine-rich	DNA
regions	DNA
2	DNA
and	DNA
3	DNA
,	O
carboxy	protein
terminal	protein
of	O
a	O
tentative	O
leucine-zipper	protein
structure	protein
.	O
In	O
addition,	O
a	O
new	O
combination	O
isoform	O
containing	O
Oct2a	protein
's	protein
amino	protein
terminal	protein
insert	protein
(	O
exon	DNA
7a	DNA
)	O
and	O
Oct2b	protein
's	protein
carboxy	protein
terminal	protein
insert	protein
(	O
exon	DNA
13	DNA
)	O
was	O
found	O
that	O
created	O
a	O
novel	O
large	O
isoform,	O
Oct2ab	protein
.	O
More	O
frequent	O
use	O
of	O
the	O
classical	O
Oct2a	protein
and	O
Oct2b	protein
isoforms	O
was	O
observed	O
in	O
the	O
lipopolysaccharide	cell_line
-stimulated	cell_line
B	cell_line
cells	cell_line
,	O
while	O
a	O
preference	O
for	O
the	O
Oct2ab	protein
and	O
Oct2ba	protein
isoforms	O
was	O
observed	O
in	O
lipopolysaccharide	cell_line
plus	cell_line
phorbol-di-butyrate	cell_line
-treated	cell_line
cells	cell_line
.	O

Positive	O
regulators	O
of	O
the	O
lineage-specific	O
transcription	protein
factor	protein
GATA-1	protein
in	O
differentiating	cell_type
erythroid	cell_type
cells	cell_type
.	O
The	O
zinc	protein
finger	protein
transcription	protein
factor	protein
GATA-1	protein
is	O
a	O
major	O
regulator	O
of	O
gene	O
expression	O
in	O
erythroid	O
,	O
megakaryocyte	O
,	O
and	O
mast	O
cell	O
lineages	O
.	O
GATA-1	protein
binds	O
to	O
WGATAR	DNA
consensus	DNA
motifs	DNA
in	O
the	O
regulatory	DNA
regions	DNA
of	O
virtually	O
all	O
erythroid	DNA
cell-specific	DNA
genes	DNA
.	O
Analyses	O
with	O
cultured	cell_line
cells	cell_line
and	O
cell-free	O
systems	O
have	O
provided	O
strong	O
evidence	O
that	O
GATA-1	protein
is	O
involved	O
in	O
control	O
of	O
globin	DNA
gene	DNA
expression	O
during	O
erythroid	O
differentiation	O
.	O
Targeted	O
mutagenesis	O
of	O
the	O
GATA-1	DNA
gene	DNA
in	O
embryonic	cell_type
stem	cell_type
cells	cell_type
has	O
demonstrated	O
its	O
requirement	O
in	O
normal	O
erythroid	O
development	O
.	O
Efficient	O
rescue	O
of	O
the	O
defect	O
requires	O
an	O
intact	O
GATA	DNA
element	DNA
in	O
the	O
distal	DNA
promoter	DNA
,	O
suggesting	O
autoregulatory	O
control	O
of	O
GATA-1	protein
transcription	O
.	O
To	O
examine	O
whether	O
GATA-1	protein
expression	O
involves	O
additional	O
regulatory	protein
factors	protein
or	O
is	O
maintained	O
entirely	O
by	O
an	O
autoregulatory	O
loop	O
,	O
we	O
have	O
used	O
a	O
transient	O
heterokaryon	O
system	O
to	O
test	O
the	O
ability	O
of	O
erythroid	protein
factors	protein
to	O
activate	O
the	O
GATA-1	DNA
gene	DNA
in	O
nonerythroid	O
nuclei	O
.	O
We	O
show	O
here	O
that	O
proerythroblasts	cell_type
and	O
mature	cell_type
erythroid	cell_type
cells	cell_type
contain	O
a	O
diffusible	O
activity	O
(	O
TAG	O
)	O
capable	O
of	O
transcriptional	O
activation	O
of	O
GATA-1	protein
and	O
that	O
this	O
activity	O
decreases	O
during	O
the	O
terminal	O
differentiation	O
of	O
erythroid	cell_type
cells	cell_type
.	O
Nuclei	O
from	O
GATA-1	cell_line
-mutant	cell_line
embryonic	cell_line
stem	cell_line
cells	cell_line
can	O
still	O
be	O
reprogrammed	O
to	O
express	O
their	O
globin	DNA
genes	DNA
in	O
erythroid	cell_type
heterokaryons	cell_type
,	O
indicating	O
that	O
de	O
novo	O
induction	O
of	O
GATA-1	protein
is	O
not	O
required	O
for	O
globin	DNA
gene	DNA
activation	O
following	O
cell	O
fusion	O
.	O

Role	O
of	O
HIV-1	protein
Nef	protein
expression	O
in	O
activation	O
pathways	O
in	O
CD4	protein
+	O
T	O
cells.	O
The	O
role	O
of	O
the	O
human	protein
immunodeficiency	protein
virus	protein
(	protein
HIV-1	protein
)	protein
Nef	protein
protein	protein
in	O
T	O
cell	O
activation	O
pathways	O
was	O
investigated	O
using	O
a	O
Jurkat	cell_line
CD4	cell_line
+	cell_line
cell	cell_line
line	cell_line
stably	O
transfected	O
with	O
a	O
Nef	O
expression	O
vector	O
.	O
Secretion	O
of	O
IL-2	protein
and	O
TNF-alpha	protein
,	O
surface	O
expression	O
of	O
IL-2R	protein
,	O
and	O
DNA-binding	O
activity	O
of	O
NF-kappa	protein
B	protein
and	O
AP-1	protein
(Fos/Jun)	protein
complex	protein
in	O
response	O
to	O
phorbol	O
myristate	O
acetate	O
,	O
TNF-alpha	protein
,	O
or	O
immobilized	O
antibodies	O
to	O
CD3	protein
were	O
monitored.	O
These	O
parameters	O
were	O
not	O
modified	O
by	O
Nef	protein
expression	O
in	O
Jurkat	cell_line
cells	cell_line
,	O
whereas	O
stimulation	O
with	O
the	O
same	O
stimuli	O
resulted	O
in	O
partial	O
inhibition	O
of	O
LTR	DNA
activation	O
in	O
Nef	cell_line
+	cell_line
Jurkat	cell_line
cells	cell_line
.	O
This	O
inhibition	O
was	O
not	O
mediated	O
through	O
Nef	protein
phosphorylation	O
on	O
Thr-15	O
or	O
GTP	O
-binding	O
activity	O
because	O
mutations	O
in	O
critical	O
sites	O
did	O
not	O
alter	O
this	O
inhibition.	O
Analysis	O
of	O
truncated	O
LTRs	DNA
confirmed	O
that	O
inhibition	O
of	O
LTR	DNA
activation	O
was	O
not	O
mediated	O
through	O
NF-kappa	protein
B	protein
-binding	O
activity	O
but	O
through	O
the	O
region	O
containing	O
the	O
negative	DNA
responding	DNA
elements	DNA
(	O
NREs	DNA
).	O
These	O
results	O
suggest	O
that	O
Nef	protein
downmodulates	O
LTR	DNA
activation	O
without	O
significantly	O
inhibiting	O
the	O
capacity	O
of	O
T	cell_type
cells	cell_type
to	O
respond	O
to	O
immunological	O
activations	O
.	O

Tat-binding	protein
protein	protein
7	protein
is	O
a	O
subunit	O
of	O
the	O
26S	protein
protease	protein
.	O
Subunit	protein
6	protein
(	O
S6	protein
),	O
an	O
integral	O
component	O
of	O
the	O
26S	protein
protease	protein
from	O
human	cell_type
erythrocytes	cell_type
,	O
has	O
been	O
studied	O
by	O
SDS-PAGE	O
,	O
peptide	O
mapping	O
and	O
sequence	O
analysis	O
.	O
S6	protein
was	O
cleaved	O
with	O
CNBr	protein
and	O
three	O
internal	O
peptides	O
were	O
sequenced.	O
A	O
comparison	O
with	O
known	O
proteins	O
in	O
Genbank	O
revealed	O
that	O
all	O
three	O
S6	protein
peptides	O
match	O
the	O
predicted	O
sequence	O
of	O
TBP7	protein
,	O
Tat-binding	protein
protein	protein
7	protein
.	O
Based	O
on	O
peptide	O
matches	O
covering	O
more	O
than	O
10%	O
of	O
the	O
TBP7	protein
sequence	protein
,	O
and	O
the	O
fact	O
that	O
the	O
migration	O
of	O
S6	protein
on	O
SDS-PAGE	O
is	O
consistent	O
with	O
the	O
estimated	O
molecular	O
mass	O
for	O
TBP7	protein
,	O
we	O
conclude	O
that	O
subunit	protein
6	protein
of	O
the	O
26S	protein
protease	protein
is	O
TBP7	protein
.	O

Hypoxia	O
causes	O
the	O
activation	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
through	O
the	O
phosphorylation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
on	O
tyrosine	O
residues	O
.	O
The	O
response	O
of	O
mammalian	cell_type
cells	cell_type
to	O
stress	O
is	O
controlled	O
by	O
transcriptional	protein
regulatory	protein
proteins	protein
such	O
as	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
to	O
induce	O
a	O
wide	O
variety	O
of	O
early	DNA
response	DNA
genes	DNA
.	O
In	O
this	O
report,	O
we	O
show	O
that	O
exposure	O
of	O
cells	O
to	O
hypoxia	O
(0.02%	O
O2)	O
results	O
in	O
I	protein
kappa	protein
B	protein
alpha	protein
degradation,	O
increased	O
NF-kappa	protein
B	protein
DNA	O
binding	O
activity	O
,	O
and	O
transactivation	O
of	O
a	O
reporter	DNA
gene	DNA
construct	DNA
containing	O
two	O
NF-kappa	DNA
B	DNA
DNA	DNA
binding	DNA
sites	DNA
.	O
Pretreatment	O
of	O
cells	O
with	O
protein	O
tyrosine	protein
kinase	protein
inhibitors	O
and	O
the	O
dominant	DNA
negative	DNA
allele	DNA
of	O
c-Raf-1	DNA
(	O
Raf	protein
301	protein
)	O
inhibited	O
I	protein
kappa	protein
B	protein
alpha	protein
degradation	O
,	O
NF-kappa	protein
B	protein
binding	O
,	O
and	O
transactivation	O
of	O
kappa	DNA
B	DNA
reporter	DNA
constructs	DNA
by	O
hypoxia	O
.	O
To	O
demonstrate	O
a	O
direct	O
link	O
between	O
changes	O
in	O
the	O
phosphorylation	O
pattern	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
with	O
NF-kappa	protein
B	protein
activation	O
,	O
we	O
immunoprecipitated	O
I	protein
kappa	protein
B	protein
alpha	protein
after	O
varying	O
times	O
of	O
hypoxic	O
exposure	O
and	O
found	O
that	O
its	O
tyrosine	O
phosphorylation	O
status	O
increased	O
during	O
hypoxic	O
exposure	O
.	O
Inhibition	O
of	O
the	O
transfer	O
of	O
tyrosine	O
phosphoryl	O
groups	O
onto	O
I	protein
kappa	protein
B	protein
alpha	protein
prevented	O
I	protein
kappa	protein
B	protein
alpha	protein
degradation	O
and	O
NF-kappa	protein
B	protein
binding	O
.	O
In	O
comparison	O
to	O
other	O
activators	O
of	O
NF-kappa	protein
B	protein
such	O
as	O
phorbol	O
myristate	O
acetate	O
or	O
tumor	protein
necrosis	protein
factor	protein
,	O
we	O
did	O
not	O
detect	O
changes	O
in	O
the	O
tyrosine	O
phosphorylation	O
status	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
following	O
treatment	O
with	O
either	O
of	O
these	O
agents.	O
These	O
results	O
suggest	O
that	O
tyrosine	O
phosphorylation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
during	O
hypoxia	O
is	O
an	O
important	O
proximal	O
step	O
which	O
precedes	O
its	O
dissociation	O
and	O
degradation	O
from	O
NF-kappa	protein
B	protein
.	O

Overproduction	O
of	O
NFKB2	protein
(	O
lyt-10	protein
)	O
and	O
c-Rel	protein
:	O
a	O
mechanism	O
for	O
HTLV-I	protein
Tax	protein
-mediated	O
trans-activation	O
via	O
the	O
NF-kappa	protein
B	protein
signalling	O
pathway	O
.	O
Molecular,	O
biochemical	O
and	O
epidemiological	O
evidence	O
implicate	O
HTLV-I	O
as	O
an	O
etiologic	O
agent	O
of	O
adult	O
T	O
cell	O
leukemia	O
(	O
ATL	O
).	O
The	O
Tax	protein
protein	protein
of	O
HTLV-I	O
,	O
a	O
positive	protein
transcriptional	protein
activator	protein
of	O
HTLV-I	O
gene	O
expression	O
,	O
is	O
a	O
viral	O
oncogene	O
that	O
also	O
increases	O
transcription	O
of	O
cellular	DNA
genes	DNA
including	O
GM-CSF	protein
,	O
IL-2R	protein
alpha	protein
and	O
IL-2	protein
.	O
One	O
of	O
the	O
cellular	O
targets	O
of	O
the	O
trans-activating	O
effects	O
of	O
Tax	O
is	O
the	O
NF-kappa	protein
B	protein
/Rel	protein
family	protein
of	O
transcription	protein
factors	protein
,	O
pleiotropic	protein
regulators	protein
of	O
immunoregulatory	O
,	O
cytokine	O
and	O
viral	O
gene	O
expression	O
.	O
In	O
this	O
report,	O
we	O
demonstrate	O
that	O
NFKB2	protein
(	O
lyt-10	protein
)	O
and	O
c-Rel	protein
are	O
overexpressed	O
in	O
HTLV-I	O
infected	O
and	O
Tax-expressing	cell_type
cells	cell_type
and,	O
together,	O
account	O
for	O
the	O
majority	O
of	O
the	O
constitutive	O
NF-kappa	protein
B	protein
binding	O
activity	O
in	O
these	O
cells	O
before	O
and	O
after	O
PMA	O
stimulation	O
.	O
Most	O
importantly,	O
we	O
show	O
a	O
Tax	protein
-dependent	O
correlation	O
between	O
expression	O
of	O
NFKB2	protein
(	O
p100	protein
)	O
and	O
processing	O
to	O
the	O
DNA	O
binding	O
NFKB2	protein
(	O
p52	protein
)	O
form,	O
induction	O
of	O
c-Rel	protein
,	O
and	O
trans-activation	O
of	O
NF-kappa	protein
B	protein
-mediated	O
gene	O
expression	O
.	O
Furthermore,	O
the	O
NFKB2	protein
precursor	O
is	O
physically	O
associated	O
with	O
c-Rel	protein
and	O
with	O
Tax	protein
in	O
HTLV-I	cell_type
infected	cell_type
cells	cell_type
.	O
We	O
propose	O
that	O
NFKB2	protein
synthesis	O
and	O
processing	O
allows	O
continuous	O
nuclear	O
expression	O
of	O
an	O
otherwise	O
cytoplasmic	protein
protein	protein
and,	O
in	O
conjunction	O
with	O
overexpression	O
of	O
c-Rel	protein
,	O
NFKB2	protein
alters	O
the	O
NF-kappa	protein
B	protein
signalling	O
pathway	O
and	O
contributes	O
to	O
leukemic	O
transformation	O
of	O
T	cell_type
cells	cell_type
by	O
HTLV-I	O
.	O

Induction	O
of	O
activator	protein
protein	protein
(AP)-1	protein
and	O
nuclear	protein
factor-kappaB	protein
by	O
CD28	protein
stimulation	O
involves	O
both	O
phosphatidylinositol	protein
3-kinase	protein
and	O
acidic	protein
sphingomyelinase	protein
signals	O
.	O
A	O
major	O
obstacle	O
in	O
understanding	O
the	O
signaling	O
events	O
that	O
follow	O
CD28	protein
receptor	O
ligation	O
arises	O
from	O
the	O
fact	O
that	O
CD28	protein
acts	O
as	O
a	O
costimulus	O
to	O
TCR	protein
engagement	O
,	O
making	O
it	O
difficult	O
to	O
assess	O
the	O
relative	O
contribution	O
of	O
CD28	protein
signals	O
as	O
distinct	O
from	O
those	O
of	O
the	O
TCR	protein
.	O
To	O
overcome	O
this	O
problem,	O
we	O
have	O
exploited	O
the	O
observation	O
that	O
activated	O
human	cell_type
T	cell_type
cell	cell_type
blasts	cell_type
can	O
be	O
stimulated	O
via	O
the	O
CD28	protein
surface	protein
molecule	protein
in	O
the	O
absence	O
of	O
antigenic	O
challenge	O
;	O
thus,	O
we	O
have	O
been	O
able	O
to	O
observe	O
the	O
response	O
of	O
normal	cell_type
T	cell_type
cells	cell_type
to	O
CD28	protein
activation	O
in	O
isolation.	O
Using	O
this	O
system,	O
we	O
observed	O
that	O
CD28	protein
stimulation	O
by	O
B7-transfected	cell_line
CHO	cell_line
cells	cell_line
induced	O
a	O
proliferative	O
response	O
in	O
T	cell_type
cells	cell_type
that	O
was	O
not	O
accompanied	O
by	O
measurable	O
IL-2	protein
production	O
.	O
However,	O
subsequent	O
analysis	O
of	O
transcription	protein
factor	protein
generation	O
revealed	O
that	O
B7	O
stimulation	O
induced	O
both	O
activator	protein
protein-1	protein
(	O
AP-1	protein
)	O
and	O
nuclear	protein
factor-kappaB	protein
(	protein
NF-kappaB	protein
)	protein
complexes	protein
,	O
but	O
not	O
NF-AT	protein
.	O
In	O
contrast,	O
engagement	O
of	O
the	O
TCR	protein
by	O
class	protein
II	protein
MHC/superantigen	protein
,	O
either	O
with	O
or	O
without	O
CD28	protein
ligation,	O
resulted	O
in	O
the	O
induction	O
of	O
NF-AT	protein
,	O
AP-1	protein
,	O
and	O
NF-kappaB	protein
as	O
well	O
as	O
IL-2	protein
production	O
.	O
Using	O
selective	O
inhibitors	O
,	O
we	O
investigated	O
the	O
signaling	O
pathways	O
involved	O
in	O
the	O
CD28	protein
-mediated	O
induction	O
of	O
AP-1	protein
and	O
NF-kappaB	protein
.	O
This	O
revealed	O
that	O
NF-kappaB	protein
generation	O
was	O
sensitive	O
to	O
chloroquine,	O
an	O
inhibitor	O
of	O
acidic	protein
sphingomyelinase	protein
,	O
but	O
not	O
to	O
the	O
phosphatidylinositol	protein
3-kinase	protein
inhibitor	O
,	O
wortmannin	O
.	O
In	O
contrast,	O
AP-1	protein
generation	O
was	O
inhibited	O
by	O
wortmannin	O
and	O
was	O
also	O
variably	O
sensitive	O
to	O
chloroquine	O
.	O
These	O
data	O
suggest	O
that	O
in	O
activated	O
normal	cell_type
T	cell_type
cells	cell_type
,	O
CD28	protein
-derived	O
signals	O
can	O
stimulate	O
proliferation	O
at	O
least	O
in	O
part	O
via	O
NF-kappaB	O
and	O
AP-1	O
generation	O
,	O
and	O
that	O
this	O
response	O
uses	O
both	O
acidic	protein
sphingomyelinase	protein
and	O
phosphatidylinositol	protein
3-kinase	protein
-linked	O
pathways	O
.	O

Presence	O
of	O
a	O
variant	O
form	O
of	O
the	O
estrogen	protein
receptor	protein
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
from	O
normal	O
individuals	O
and	O
lupus	O
patients	O
.	O
Estrogen	O
may	O
participate	O
in	O
the	O
pathogenesis	O
of	O
systemic	O
lupus	O
erythematosus	O
(	O
SLE	O
)	O
via	O
its	O
intracellular	protein
receptor	protein
.	O
To	O
investigate	O
the	O
presence	O
of	O
various	O
isoforms	O
of	O
the	O
estrogen	protein
receptor	protein
(	O
ER	protein
)	O
in	O
SLE	O
we	O
isolated	O
RNA	O
from	O
mononuclear	cell_type
cells	cell_type
of	O
lupus	O
patients	O
and	O
normal	O
controls	O
.	O
Using	O
RT-PCR	O
we	O
were	O
able	O
to	O
identify	O
both	O
the	O
full	protein
length	protein
wild-type	protein
form	protein
and	O
an	O
isoform	O
of	O
the	O
ER	protein
which	O
precisely	O
lacks	O
exon	DNA
V	DNA
in	O
both	O
patient	O
and	O
normal	O
individuals	O
.	O
Our	O
results,	O
although	O
limited,	O
suggest	O
that	O
normal	O
individuals	O
can	O
express	O
both	O
the	O
wild-type	O
and	O
truncated	O
version	O
at	O
the	O
same	O
time,	O
whereas	O
lupus	O
patients	O
only	O
express	O
either	O
the	O
wild-type	O
or	O
the	O
truncated	O
ER	O
.	O
This	O
finding	O
may	O
lead	O
to	O
a	O
better	O
understanding	O
of	O
the	O
reasons	O
for	O
the	O
prevalence	O
of	O
lupus	O
in	O
females	O
and	O
of	O
the	O
estrogenic	O
effects	O
on	O
SLE	O
disease	O
activity	O
.	O

Regulation	O
of	O
sialoadhesin	protein
expression	O
on	O
rat	cell_type
macrophages	cell_type
.	O
Induction	O
by	O
glucocorticoids	O
and	O
enhancement	O
by	O
IFN-beta	protein
,	O
IFN-gamma	protein
,	O
IL-4	protein
,	O
and	O
lipopolysaccharide	O
.	O
Sialoadhesin	protein
is	O
a	O
macrophage-restricted	protein
member	protein
of	O
the	O
Ig	protein
superfamily	protein
that	O
mediates	O
adhesion	O
with	O
lymphoid	O
and	O
myeloid	O
cells	O
.	O
It	O
is	O
expressed	O
on	O
a	O
subpopulation	O
of	O
macrophages	cell_type
in	O
lymphoid	O
tissues	O
and	O
in	O
chronic	O
inflammation	O
(e.g.,	O
during	O
autoimmune	O
diseases).	O
We	O
have	O
studied	O
the	O
regulation	O
of	O
sialoadhesin	protein
expression	O
in	O
vitro	O
and	O
show	O
that	O
glucocorticoids	O
(	O
GC	O
)	O
induce	O
sialoadhesin	protein
expression	O
on	O
freshly	O
isolated	O
rat	cell_type
macrophages	cell_type
and	O
the	O
rat	cell_line
macrophage	cell_line
cell	cell_line
line	cell_line
R2	cell_line
.	O
The	O
cytokines	protein
IFN-beta	protein
,	O
IFN-gamma	protein
,	O
IL-4	protein
,	O
and	O
LPS	O
,	O
although	O
unable	O
to	O
induce	O
sialoadhesin	protein
expression	O
by	O
themselves,	O
were	O
able	O
to	O
enhance	O
GC	O
-mediated	O
induction	O
of	O
sialoadhesin	protein
.	O
Sialoadhesin	protein
expression	O
was	O
functional	O
as	O
shown	O
by	O
cell	O
adhesion	O
assays	O
with	O
human	cell_type
RBCs	cell_type
.	O
Northern	O
blotting	O
experiments	O
indicated	O
that	O
regulation	O
predominantly	O
occurred	O
at	O
the	O
mRNA	O
level	O
.	O
Comparison	O
of	O
the	O
different	O
combinations	O
of	O
GC	O
and	O
cytokines	protein
/LPS	O
revealed	O
differences	O
in	O
the	O
level	O
of	O
GC	O
-dependent	O
enhancement	O
of	O
sialoadhesin	protein
expression	O
,	O
with	O
IFN-beta	protein
and	O
IL-4	protein
being	O
more	O
potent	O
than	O
IFN-gamma	protein
and	O
LPS	O
.	O
Moreover,	O
the	O
effects	O
of	O
IFN-gamma	protein
and	O
LPS	O
could	O
be	O
reproduced	O
by	O
priming,	O
whereas	O
IFN-beta	protein
and	O
IL-4	protein
were	O
required	O
simultaneously	O
with	O
GC	O
.	O
The	O
regulation	O
of	O
sialoadhesin	protein
expression	O
was	O
mediated	O
by	O
the	O
GC	protein
receptor	protein
,	O
and	O
not	O
by	O
mineralocorticoid	protein
receptor	protein
,	O
as	O
shown	O
by	O
inhibition	O
experiments	O
with	O
specific	O
antagonists	O
.	O
Finally,	O
it	O
is	O
demonstrated	O
that	O
macrophages	cell_type
in	O
the	O
adrenal	O
gland,	O
the	O
major	O
site	O
of	O
endogenous	O
GC	O
production	O
,	O
express	O
sialoadhesin	protein
.	O
This	O
study	O
demonstrates	O
that	O
GC	O
act	O
as	O
a	O
primary	O
inducer	O
of	O
sialoadhesin	protein
expression	O
on	O
rat	cell_type
macrophages	cell_type
,	O
and	O
that	O
the	O
response	O
can	O
be	O
enhanced	O
by	O
IFN-beta	protein
,	O
T	protein
cell-derived	protein
cytokines	protein
,	O
or	O
LPS	O
.	O

Apoptosis	O
mediated	O
by	O
HIV	protein
protease	protein
is	O
preceded	O
by	O
cleavage	O
of	O
Bcl-2	protein
.	O
Expression	O
of	O
the	O
human	protein
immunodeficiency	protein
virus	protein
type	protein
1	protein
(	protein
HIV	protein
)	protein
protease	protein
in	O
cultured	cell_line
cells	cell_line
leads	O
to	O
apoptosis	O
,	O
preceded	O
by	O
cleavage	O
of	O
bcl-2	protein
,	O
a	O
key	O
negative	O
regulator	O
of	O
cell	O
death.	O
In	O
contrast,	O
a	O
high	O
level	O
of	O
bcl-2	protein
protects	O
cells	O
in	O
vitro	O
and	O
in	O
vivo	O
from	O
the	O
viral	protein
protease	protein
and	O
prevents	O
cell	O
death	O
following	O
HIV	O
infection	O
of	O
human	cell_type
lymphocytes	cell_type
,	O
while	O
reducing	O
the	O
yields	O
of	O
viral	protein
structural	protein
proteins	protein
,	O
infectivity,	O
and	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
.	O
We	O
present	O
a	O
model	O
for	O
HIV	O
replication	O
in	O
which	O
the	O
viral	protein
protease	protein
depletes	O
the	O
infected	O
cells	O
of	O
bcl-2	protein
,	O
leading	O
to	O
oxidative	O
stress-dependent	O
activation	O
of	O
NF	protein
kappa	protein
B	protein
,	O
a	O
cellular	protein
factor	protein
required	O
for	O
HIV	O
transcription	O
,	O
and	O
ultimately	O
to	O
cell	O
death	O
.	O
Purified	O
bcl-2	protein
is	O
cleaved	O
by	O
HIV	protein
protease	protein
between	O
phenylalanine	O
112	O
and	O
alanine	O
113	O
.	O
The	O
results	O
suggest	O
a	O
new	O
option	O
for	O
HIV	O
gene	O
therapy	O
;	O
bcl-2	protein
muteins	protein
that	O
have	O
noncleavable	protein
alterations	protein
surrounding	O
the	O
HIV	protein
protease	protein
cleavage	protein
site	protein
.	O

Alpha	protein
4	protein
beta	protein
1	protein
(	protein
CD49d/CD29	protein
)	protein
integrin	protein
costimulation	O
of	O
human	cell_type
T	cell_type
cells	cell_type
enhances	O
transcription	protein
factor	protein
and	O
cytokine	O
induction	O
in	O
the	O
absence	O
of	O
altered	O
sensitivity	O
to	O
anti-CD3	protein
stimulation	O
.	O
The	O
integrin	protein
alpha	protein
4	protein
beta	protein
1	protein
can	O
provide	O
a	O
costimulus	O
to	O
induce	O
IL-2	protein
secretion	O
and	O
IL-2R	protein
expression	O
leading	O
to	O
enhanced	O
proliferation	O
of	O
purified,	O
peripheral	cell_type
blood	cell_type
T	cell_type
cells	cell_type
.	O
Similar	O
to	O
expression	O
of	O
IL-2	protein
,	O
we	O
demonstrated	O
that	O
recombinant	protein
vascular-cell	protein
adhesion	protein
molecule-1	protein
,	O
when	O
co-immobilized	O
with	O
anti-CD3	protein
mAb	protein
,	O
significantly	O
enhanced	O
the	O
induction	O
of	O
transcription	protein
factors	protein
NF-AT	protein
,	O
AP-1	protein
,	O
and	O
NF-kappa	protein
B	protein
as	O
determined	O
by	O
electromobility	O
shift	O
assays	O
.	O
alpha	protein
4	protein
beta	protein
1	protein
ligation	O
alone	O
had	O
no	O
effect	O
on	O
transcription	protein
factor	protein
binding	O
.	O
The	O
requirements	O
for	O
induction	O
of	O
transcription	protein
factors	protein
reflected	O
the	O
requirements	O
for	O
the	O
secretion	O
of	O
multiple	O
cytokines	protein
,	O
including	O
IL-2	protein
,	O
TNF-alpha	protein
,	O
IFN-gamma	protein
,	O
and	O
granulocyte	protein
macrophage-CSF	protein
.	O
In	O
contrast	O
to	O
freshly	cell_type
isolated	cell_type
T	cell_type
cells	cell_type
,	O
in	O
vitro-cultured	cell_line
T	cell_line
cells	cell_line
did	O
not	O
require	O
costimulation	O
for	O
cytokine	protein
secretion	O
in	O
response	O
to	O
anti-CD3	protein
alone.	O
Comparison	O
of	O
the	O
dose	O
response	O
to	O
anti-CD3	protein
stimulation	O
demonstrated	O
that	O
half-maximal	O
induction	O
of	O
IL-2	protein
was	O
achieved	O
using	O
the	O
same	O
dose	O
of	O
anti-CD3	protein
for	O
both	O
freshly	cell_type
isolated	cell_type
and	O
cultured	cell_line
T	cell_line
cells	cell_line
.	O
Furthermore,	O
the	O
dose	O
of	O
OKT3	protein
required	O
to	O
achieve	O
half-maximal	O
activation	O
was	O
the	O
same	O
using	O
PMA	O
or	O
different	O
concentrations	O
of	O
alpha	protein
4	protein
beta	protein
1	protein
ligands.	O
Therefore,	O
costimulation	O
by	O
alpha	protein
4	protein
beta	protein
1	protein
ligands	O
was	O
not	O
due	O
to	O
stabilization	O
of	O
the	O
interaction	O
of	O
the	O
cells	O
with	O
its	O
substrate.	O
We	O
conclude,	O
rather,	O
that	O
alpha	protein
4	protein
beta	protein
1	protein
in	O
freshly	cell_type
isolated	cell_type
T	cell_type
cells	cell_type
delivers	O
a	O
distinct	O
signal	O
that	O
synergizes	O
early	O
with	O
signals	O
initiated	O
by	O
TCR/CD3	protein
ligation	O
to	O
induce	O
DNA	O
binding	O
of	O
multiple	O
transcription	protein
factors	protein
required	O
for	O
cytokine	DNA
gene	DNA
induction	O
.	O

Inhibition	O
of	O
T	cell_type
lymphocyte	cell_type
activation	O
by	O
cAMP	O
is	O
associated	O
with	O
down-regulation	O
of	O
two	O
parallel	O
mitogen-activated	O
protein	protein
kinase	protein
pathways	O
,	O
the	O
extracellular	protein
signal-related	protein
kinase	protein
and	O
c-Jun	protein
N-terminal	protein
kinase	protein
.	O
The	O
induction	O
of	O
T	O
cell	O
proliferation	O
requires	O
signals	O
from	O
the	O
TCR	protein
and	O
a	O
co-receptor	protein
molecule	protein
,	O
such	O
as	O
CD28	protein
,	O
that	O
activate	O
parallel	O
and	O
partially	O
cross-reactive	O
signaling	O
pathways	O
.	O
These	O
pathways	O
are	O
disrupted	O
by	O
agonists	O
that	O
utilize	O
adenylate	protein
cyclase	protein
and	O
cAMP	protein
-dependent	protein
protein	protein
kinase	protein
A	protein
(	O
PKA	protein
).	O
We	O
found	O
that	O
the	O
adenylate	protein
cyclase	protein
activator,	O
forskolin,	O
inhibits	O
anti-CD3	protein
-induced	O
shift	O
in	O
Lck	protein
electrophoretic	O
mobility	O
,	O
suggesting	O
an	O
intervention	O
at	O
the	O
TCR	protein
-coupled	O
phosphoinositide	O
turnover	O
that	O
precedes	O
the	O
activation	O
of	O
PKC	protein
.	O
The	O
shift	O
of	O
Lck	protein
following	O
direct	O
PKC	protein
activation	O
by	O
12-O-tetradecanoyl	O
phorbol	O
13-acetate	O
,	O
which	O
bypasses	O
early	O
receptor-triggered	O
biochemical	O
events,	O
is	O
insensitive	O
to	O
forskolin	O
.	O
Nevertheless,	O
forskolin	O
also	O
inhibits	O
PKC	protein
downstream	O
events	O
,	O
such	O
as	O
c-jun	DNA
expression	O
,	O
which	O
is	O
critical	O
for	O
the	O
activation	O
process	O
of	O
T	cell_type
cells	cell_type
.	O
To	O
further	O
analyze	O
potential	O
cross	O
points	O
between	O
positively	O
and	O
negatively	O
regulating	O
signaling	O
pathways	O
in	O
T	cell_type
cells	cell_type
,	O
we	O
tested	O
the	O
effects	O
of	O
activators	O
of	O
the	O
adenylate	protein
cyclase	protein
or	O
PKA	protein
on	O
two	O
parallel	O
mitogen-activated	O
protein	O
kinase	O
signaling	O
pathways	O
mediated	O
by	O
extracellular	protein
signal-regulated	protein
kinase	protein
(	O
ERK	protein
)	O
and	O
c-Jun	protein
N-terminal	protein
kinase	protein
.	O
Using	O
a	O
PKC	protein
-specific	O
inhibitor	O
,	O
GF109203X	O
,	O
or	O
PKC	cell_line
-depleted	cell_line
T	cell_line
cells	cell_line
,	O
we	O
found	O
that	O
a	O
large	O
part	O
of	O
the	O
anti-CD3	protein
-induced	O
ERK	protein
activation	O
is	O
PKC	protein
dependent	O
.	O
Both	O
PKC-	O
dependent	O
and	O
-independent	O
activation	O
of	O
ERK	protein
were	O
sensitive	O
to	O
inhibition	O
by	O
forskolin	O
or	O
a	O
cell-permeable	O
cAMP	O
analogue	O
,	O
dbcAMP	O
.	O
Furthermore,	O
the	O
effect	O
of	O
12-O-tetradecanoyl	O
phorbol	O
13-acetate	O
and	O
ionomycin	O
,	O
which	O
synergized	O
to	O
fully	O
activate	O
c-Jun	protein
N-terminal	protein
kinase	protein
,	O
was	O
also	O
sensitive	O
to	O
inhibition	O
by	O
forskolin	O
.	O
Our	O
results	O
suggest	O
that	O
PKA	protein
inhibits	O
T	O
cell	O
activation	O
by	O
interfering	O
with	O
multiple	O
events	O
along	O
the	O
two	O
signaling	O
pathways	O
operating	O
downstream	O
of	O
the	O
TCR	protein
and	O
the	O
CD28	protein
co-receptor	protein
molecules	protein
.	O

Transcriptional	O
and	O
posttranscriptional	O
regulation	O
of	O
erythroid	DNA
gene	DNA
expression	O
in	O
anthracycline	O
-induced	O
differentiation	O
of	O
human	cell_type
erythroleukemic	cell_type
cells	cell_type
.	O
Aclacinomycin	O
(	O
ACLA	O
)	O
and	O
doxorubicin	O
(	O
DOX	O
)	O
were	O
used	O
at	O
subtoxic	O
concentrations	O
to	O
induce	O
erythroid	O
differentiation	O
in	O
the	O
human	cell_line
leukemic	cell_line
cell	cell_line
line	cell_line
K562	cell_line
.	O
Cell	O
hemoglobinization	O
was	O
accompanied	O
by	O
the	O
increased	O
expression	O
of	O
genes	DNA
encoding	O
gamma-globin	protein
and	protein
porphobilinogen	protein
deaminase	protein
(	O
PBGD	protein
),	O
an	O
enzyme	O
of	O
heme	O
synthesis	O
.	O
By	O
using	O
run-on	O
assays	O
,	O
ACLA	O
was	O
shown	O
to	O
induce	O
an	O
enhancement	O
of	O
the	O
transcription	O
of	O
erythroid	DNA
genes	DNA
,	O
including	O
gamma-globin	protein
,	O
PBGD	protein
,	O
erythropoietin	protein
receptor	protein
,	O
and	O
GATA-1	protein
transcription	protein
factor	protein
.	O
In	O
contrast,	O
in	O
DOX	cell_line
-treated	cell_line
cells	cell_line
,	O
the	O
transcription	O
rate	O
of	O
these	O
genes	DNA
was	O
unchanged	O
in	O
comparison	O
with	O
control	cell_type
cells	cell_type
.	O
In	O
addition,	O
inhibition	O
of	O
mRNA	RNA
synthesis	O
with	O
actinomycin	O
D	O
indicated	O
that	O
DOX	O
induced	O
an	O
increased	O
stability	O
of	O
PBGD	O
and	O
GATA-1	O
mRNAs	O
,	O
whereas	O
ACLA	O
did	O
not	O
affect	O
the	O
half-lives	O
of	O
these	O
mRNAs	RNA
.	O
Because	O
the	O
increase	O
in	O
erythroid	RNA
mRNA	RNA
steady-state	O
level	O
in	O
anthracycline	cell_type
-treated	cell_type
cells	cell_type
was	O
inhibited	O
by	O
cycloheximide	O
,	O
this	O
suggests	O
that	O
transcriptional	O
activation	O
in	O
ACLA	cell_line
-treated	cell_line
cells	cell_line
and	O
mRNA	O
stabilization	O
in	O
DOX	cell_type
-treated	cell_type
cells	cell_type
were	O
dependent	O
on	O
de	O
novo	O
protein	O
synthesis	O
.	O
Finally,	O
GATA-1	protein
protein	O
level	O
was	O
shown	O
to	O
be	O
increased	O
in	O
ACLA-treated	O
but	O
not	O
in	O
DOX-treated	O
cells	O
.	O
These	O
two	O
anthracyclines	O
,	O
although	O
closely	O
related	O
in	O
their	O
structures,	O
appeared	O
to	O
act	O
as	O
differentiation	O
inducers	O
by	O
distinct	O
mechanisms.	O
Indeed,	O
erythroid	DNA
gene	DNA
expression	O
was	O
demonstrated	O
to	O
be	O
regulated	O
transcriptionally	O
by	O
ACLA	O
and	O
mainly	O
posttranscriptionally	O
by	O
DOX	O
.	O

Interleukin-7	protein
signaling	O
in	O
human	cell_line
B	cell_line
cell	cell_line
precursor	cell_line
acute	cell_line
lymphoblastic	cell_line
leukemia	cell_line
cells	cell_line
and	O
murine	cell_line
BAF3	cell_line
cells	cell_line
involves	O
activation	O
of	O
STAT1	protein
and	O
STAT5	protein
mediated	O
via	O
the	O
interleukin-7	protein
receptor	protein
alpha	protein
chain	protein
.	O
Interleukin-7	protein
(	O
IL-7	protein
)	O
stimulates	O
the	O
proliferation	O
of	O
normal	O
and	O
leukemic	O
B	O
and	O
T	O
cell	O
precursors	O
and	O
T	O
lymphocytes	O
.	O
Activation	O
of	O
the	O
JAK	protein
/STAT	protein
pathway	O
has	O
been	O
implicated	O
in	O
IL-7R	protein
signaling	O
.	O
We	O
investigated	O
which	O
STAT	protein
complexes	protein
are	O
formed	O
upon	O
stimulation	O
of	O
B	cell_line
cell	cell_line
precursor	cell_line
acute	cell_line
lymphoblastic	cell_line
leukemia	cell_line
(BCP-ALL)	cell_line
cells	cell_line
with	O
IL-7	protein
.	O
Gel	O
retardation	O
assays	O
with	O
STAT-binding	O
oligonucleotides	O
showed	O
that	O
IL-7	protein
induces	O
the	O
formation	O
of	O
two	O
major	O
STAT	protein
complexes	protein
in	O
BCP-ALL	cell_line
cells	cell_line
.	O
Supershifts	O
with	O
anti-STAT	DNA
antibodies	DNA
identified	O
these	O
as	O
STAT1	protein
and	O
STAT5	protein
complexes	protein
.	O
This	O
pattern	O
of	O
STAT	protein
activation	O
was	O
seen	O
in	O
all	O
BCP-ALL	O
cases	O
that	O
respond	O
to	O
IL-7	protein
in	O
proliferation	O
assays	O
.	O
IL-7	protein
also	O
induced	O
STAT	protein
/DNA	O
binding	O
in	O
BCP-ALL	O
cases	O
that	O
failed	O
to	O
proliferate	O
in	O
response	O
to	O
IL-7	protein
,	O
suggesting	O
that	O
the	O
ability	O
of	O
IL-7R	protein
to	O
activate	O
the	O
JAK	protein
/STAT	protein
pathway	O
per	O
se	O
is	O
not	O
sufficient	O
for	O
proliferation	O
induction.	O
To	O
determine	O
the	O
contribution	O
of	O
the	O
cytoplasmic	protein
domain	protein
of	O
the	O
IL-7	protein
receptor	protein
alpha	protein
chain	protein
(	O
IL-7R	protein
alpha	protein
)	O
to	O
activation	O
of	O
STAT	protein
proteins	protein
,	O
transfectants	O
of	O
the	O
murine	cell_line
pro-B	cell_line
cell	cell_line
line	cell_line
BAF3	cell_line
were	O
made	O
that	O
express	O
chimeric	protein
receptors	protein
consisting	O
of	O
the	O
extracellular	protein
domain	protein
of	O
human	protein
granulocyte	protein
colony-stimulating	protein
factor	protein
receptor	protein
(	O
G-CSF-R	protein
)	O
and	O
the	O
transmembrane	O
and	O
intracellular	O
domains	O
of	O
human	protein
IL-7R	protein
alpha	protein
.	O
Activation	O
of	O
the	O
chimeric	protein
G-CSF-R	protein
/IL-7R	protein
alpha	protein
with	O
G-CSF	protein
resulted	O
in	O
a	O
full	O
proliferative	O
response	O
and	O
induced	O
the	O
phosphorylation	O
of	O
JAK1	protein
but	O
not	O
JAK2	protein
.	O
Major	O
STAT	protein
complexes	protein
activated	O
by	O
G-CSF-R	protein
/IL-7R	protein
alpha	protein
contained	O
STAT1	protein
or	O
STAT5	protein
,	O
while	O
some	O
formation	O
of	O
STAT3-containing	protein
complexes	protein
was	O
also	O
seen.	O
These	O
findings	O
establish	O
that	O
STAT1	protein
and	O
STAT5	protein
,	O
and	O
possibly	O
STAT3	protein
,	O
are	O
activated	O
upon	O
stimulation	O
of	O
precursor	cell_type
B	cell_type
cells	cell_type
with	O
IL-7	protein
.	O
The	O
data	O
further	O
indicate	O
that	O
the	O
IL-7R	protein
alpha	protein
chains	protein
are	O
directly	O
involved	O
in	O
the	O
activation	O
of	O
JAKs	protein
and	O
STATs	protein
and	O
have	O
a	O
major	O
role	O
in	O
proliferative	O
signaling	O
in	O
precursor	cell_type
B	cell_type
cells	cell_type
.	O

Stimulation	O
of	O
human	O
lymphocyte	O
proliferation	O
and	O
CD40	protein
antigen	O
expression	O
by	O
phosphorothioate	O
oligonucleotides	O
complementary	O
to	O
hepatitis	DNA
B	DNA
virus	DNA
genome	DNA
.	O
We	O
have	O
studied	O
the	O
proliferation	O
and	O
CD40	protein
antigen	O
expression	O
of	O
lymphocytes	cell_type
,	O
and	O
the	O
cytotoxicity	O
to	O
monocytes	cell_type
,	O
of	O
antisense	O
phosphorothioate	O
oligodeoxynucleotides	O
complementary	O
to	O
the	O
SP	DNA
II	DNA
promoter	DNA
of	O
HBV	RNA
mRNA	RNA
(	O
sequence	O
I	O
)	O
and	O
the	O
X	DNA
gene	DNA
(	O
sequence	O
II	O
)	O
in	O
patients	O
with	O
chronic	O
hepatitis	O
B	O
.	O
The	O
oligo	O
sequence	O
I	O
stimulated	O
proliferation	O
of	O
both	O
T	O
and,	O
to	O
a	O
lesser	O
extent,	O
B	O
cells	O
.	O
The	O
percentage	O
of	O
cells	O
expressing	O
CD40	protein
in	O
T	O
and	O
B	O
cell	O
co-cultures	O
increased	O
from	O
4.2%	O
to	O
13.8%	O
after	O
oligo	O
stimulation	O
in	O
patients	O
,	O
while	O
it	O
increased	O
form	O
4.7%	O
to	O
48.6%	O
in	O
healthy	O
controls	O
.	O
The	O
sense	O
sequence	O
(	O
sequence	O
III	O
)	O
of	O
the	O
X	DNA
gene	DNA
also	O
enhanced	O
the	O
expression	O
of	O
CD40	protein
antigen	protein
in	O
patients	O
with	O
hepatitis	O
B	O
.	O
The	O
proportion	O
of	O
CD40	cell_line
cells	cell_line
(26%)	O
in	O
a	O
resting	cell_line
B-cell	cell_line
preparation	cell_line
from	O
hepatitis	O
B	O
patients	O
decreased	O
to	O
zero	O
after	O
a	O
5-day	O
culture	O
with	O
sequence	O
I	O
,	O
but	O
IgG	O
levels	O
in	O
the	O
culture	O
supernatant	O
increased.	O
The	O
cytotoxic	O
properties	O
of	O
monocytes	cell_type
were	O
not	O
influenced	O
by	O
the	O
oligos.	O
These	O
findings	O
indicate	O
that	O
antisense	O
oligos	O
against	O
hepatitis	O
B	O
virus	O
(	O
HBV	O
)	O
have	O
mitogenic	O
effects	O
on	O
the	O
proliferation	O
of	O
human	cell_type
lymphocytes	cell_type
in	O
a	O
non-specific	O
manner	O
and	O
may	O
activate	O
T	cell_type
cells	cell_type
to	O
express	O
CD40	protein
antigen	protein
.	O

Activation	protein
protein	protein
1	protein
-dependent	O
transcriptional	O
activation	O
of	O
interleukin	DNA
2	DNA
gene	DNA
by	O
Ca2+	protein
/calmodulin	protein
kinase	protein
type	protein
IV/Gr	protein
.	O
The	O
Ca2+	protein
/calmodulin-dependent	protein
protein	protein
kinase	protein
(CaMK)	protein
type	protein
IV/Gr	protein
is	O
selectively	O
expressed	O
in	O
T	cell_type
lymphocytes	cell_type
and	O
is	O
activated	O
after	O
signaling	O
via	O
the	O
T	protein
cell	protein
antigen	protein
receptor	protein
(	O
TCR	protein
),	O
indicating	O
that	O
it	O
mediates	O
some	O
of	O
the	O
Ca(2+)-dependent	O
transcriptional	O
events	O
that	O
follow	O
TCR	protein
engagement	O
.	O
Here	O
we	O
show	O
that	O
CaMKIV/Gr	protein
induces	O
the	O
transcription	protein
factor	protein
activation	protein
protein	protein
1	protein
(	O
AP-1	protein
)	O
alone	O
or	O
in	O
synergy	O
with	O
T	protein
cell	protein
mitogens	protein
and	O
with	O
the	O
p21ras	protein
oncoprotein	protein
.	O
CaMKIV/	protein
Gr	protein
signaling	O
is	O
associated	O
with	O
transcriptional	O
activation	O
of	O
c-fos	DNA
but	O
is	O
independent	O
of	O
p21ras	DNA
or	O
calcineurin	protein
.	O
AP-1	protein
is	O
an	O
integral	O
component	O
of	O
the	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(NFAT)	protein
transcriptional	protein
complex	protein
,	O
which	O
is	O
required	O
for	O
interleukin	DNA
2	DNA
gene	DNA
expression	O
in	O
T	cell_type
cells	cell_type
.	O
We	O
demonstrate	O
that	O
CaMKIV/Gr	protein
reconstitutes	O
the	O
capacity	O
of	O
the	O
cytosolic	O
component	O
of	O
NFAT	protein
to	O
direct	O
transcription	O
from	O
NFAT	DNA
sites	DNA
in	O
non-	O
T	cell_type
cells	cell_type
.	O
These	O
results	O
reveal	O
a	O
central	O
role	O
for	O
CaMKIV/Gr	protein
as	O
a	O
Ca(2+)	O
-regulated	O
activator	O
of	O
gene	O
transcription	O
in	O
T	cell_type
lymphocytes	cell_type
.	O

Receptors	O
for	O
interleukin	O
(IL)-10	O
and	O
IL-6	O
-type	O
cytokines	O
use	O
similar	O
signaling	O
mechanisms	O
for	O
inducing	O
transcription	O
through	O
IL-6	DNA
response	DNA
elements	DNA
.	O
The	O
cytoplasmic	protein
domain	protein
of	O
the	O
receptor	O
for	O
interleukin	protein
10	protein
(	O
IL-10R	protein
)	O
contains	O
two	O
box	protein
3	protein
sequence	protein
motifs	protein
that	O
have	O
been	O
identified	O
in	O
the	O
signal-transducing	protein
receptor	protein
subunits	protein
for	O
IL-6-type	protein
cytokines	protein
and	O
noted	O
to	O
be	O
required	O
for	O
activating	O
STAT3	protein
and	O
inducing	O
transcription	O
through	O
IL-6-responsive	DNA
elements	DNA
.	O
To	O
determine	O
whether	O
the	O
IL-10R	protein
has	O
signaling	O
functions	O
similar	O
to	O
IL-6R	protein
in	O
cells	O
normally	O
expressing	O
these	O
receptors,	O
leukocytes	cell_type
of	O
the	O
B-	O
,	O
T-	O
,	O
and	O
NK-	O
cell	O
lineages	O
were	O
treated	O
with	O
either	O
cytokine.	O
Both	O
cytokines	protein
activated	O
factors	O
that	O
bound	O
to	O
the	O
sis-inducible	DNA
element	DNA
and	O
included	O
STAT1	protein
and	O
STAT3	protein
.	O
The	O
cell	O
response	O
to	O
IL-10	protein
characteristically	O
differed	O
from	O
that	O
to	O
IL-2/IL-15	protein
,	O
IL-4	protein
,	O
and	O
interferon	protein
gamma	protein
.	O
The	O
signaling	O
capabilities	O
of	O
the	O
IL-10R	protein
for	O
activating	O
specific	O
STAT	protein
proteins	protein
and	O
inducing	O
gene	O
transcription	O
were	O
defined	O
by	O
reconstitution	O
of	O
receptor	O
functions	O
in	O
transfected	cell_line
tissue	cell_line
culture	cell_line
cells	cell_line
.	O
COS-1	cell_line
cells	cell_line
,	O
co-expressing	O
the	O
human	O
IL-10R	protein
and	O
individual	O
STAT	protein
proteins	protein
,	O
confirmed	O
a	O
preference	O
of	O
the	O
IL-10R	protein
for	O
STAT3	protein
and	O
STAT1	protein
.	O
Unlike	O
many	O
hematopoietin	protein
receptors	protein
,	O
the	O
IL-10R	protein
did	O
not	O
detectably	O
activate	O
STAT5	protein
.	O
The	O
IL-10R	protein
,	O
together	O
with	O
reporter	O
gene	O
constructs	O
containing	O
different	O
IL-6-responsive	DNA
gene	DNA
elements	DNA
,	O
reconstituted	O
in	O
hepatoma	cell_type
cells	cell_type
an	O
induction	O
of	O
transcription	O
by	O
IL-10	protein
that	O
was	O
comparable	O
to	O
that	O
by	O
IL-6	protein
.	O
This	O
regulation	O
could	O
not	O
be	O
appreciably	O
modified	O
by	O
enhanced	O
expression	O
of	O
STAT	protein
proteins	protein
.	O
The	O
similar	O
actions	O
of	O
IL-10R	protein
and	O
IL-6R	protein
on	O
the	O
induction	O
of	O
endogenous	O
IL-6	DNA
-responsive	DNA
genes	DNA
were	O
demonstrated	O
in	O
hepatoma	cell_type
cells	cell_type
stably	O
expressing	O
the	O
IL-10R	protein
.	O
These	O
receptor	O
functions	O
required	O
the	O
presence	O
of	O
the	O
box	protein
3	protein
motifs	protein
,	O
as	O
shown	O
by	O
the	O
analysis	O
of	O
the	O
mouse	O
IL-10R	protein
constructs	O
containing	O
progressively	protein
truncated	protein
cytoplasmic	protein
domains	protein
.	O
The	O
data	O
demonstrate	O
that	O
the	O
IL-10R	protein
,	O
unlike	O
other	O
members	O
of	O
the	O
interferon	O
receptor	O
family,	O
is	O
highly	O
effective	O
in	O
recruiting	O
the	O
signaling	O
pathways	O
of	O
IL-6	protein
-type	protein
cytokine	protein
receptors	protein
.	O

Induction	O
of	O
CIITA	protein
and	O
modification	O
of	O
in	O
vivo	O
HLA-DR	DNA
promoter	DNA
occupancy	O
in	O
normal	cell_type
thymic	cell_type
epithelial	cell_type
cells	cell_type
treated	O
with	O
IFN-gamma	protein
:	O
similarities	O
and	O
distinctions	O
with	O
respect	O
to	O
HLA-DR-constitutive	cell_type
B	cell_type
cells	cell_type
.	O
In	O
this	O
study,	O
the	O
IFN-gamma	protein
induction	O
of	O
MHC	DNA
class	DNA
II	DNA
gene	DNA
expression	O
in	O
primary	O
cultures	O
of	O
thymic	cell_line
epithelial	cell_line
cells	cell_line
(	O
TEC	cell_line
)	O
was	O
analyzed.	O
This	O
cellular	O
system	O
offers	O
the	O
advantage	O
that	O
MHC	protein
class	protein
II	protein
induction	O
is	O
studied	O
in	O
a	O
"physiologic"	cell_type
cell	cell_type
lineage	cell_type
that,	O
as	O
a	O
result	O
of	O
this	O
expression	O
within	O
the	O
thymus	O
,	O
is	O
thought	O
to	O
participate	O
to	O
the	O
selection	O
and	O
maturation	O
of	O
the	O
T	cell_type
cells	cell_type
.	O
It	O
was	O
found	O
that	O
the	O
MHC	DNA
class	DNA
II	DNA
gene	DNA
expression	O
was	O
associated	O
with	O
the	O
de	O
novo	O
transcription	O
of	O
the	O
gene	O
encoding	O
the	O
CIITA	protein
trans-activator	protein
,	O
a	O
crucial	O
MHC	protein
class	protein
II	protein
gene	protein
regulatory	protein
factor	protein
.	O
Furthermore,	O
the	O
anatomy	O
of	O
interaction	O
between	O
the	O
MHC	DNA
class	DNA
II	DNA
DRA	DNA
promoter	DNA
and	O
corresponding	O
binding	protein
factors	protein
was	O
analyzed	O
by	O
in	O
vivo	O
DNAse	protein
I	protein
footprint	O
.	O
It	O
was	O
found	O
that	O
treatment	O
with	O
IFN-gamma	protein
induces	O
changes	O
in	O
the	O
occupancy	O
of	O
the	O
DRA	DNA
gene	DNA
regulatory	DNA
sequences	DNA
by	O
nuclear	protein
factors	protein
.	O
The	O
resulting	O
occupancy	O
displays	O
strong	O
similarities	O
with	O
the	O
one	O
observed	O
in	O
the	O
MHC	cell_type
class	cell_type
II-constitutive	cell_type
B	cell_type
cells	cell_type
,	O
represented	O
by	O
both	O
the	O
Burkitt	cell_line
lymphoma	cell_line
line	cell_line
Raji	cell_line
and	O
normal	cell_type
tonsil-	cell_type
derived	cell_type
B	cell_type
cells	cell_type
.	O
However,	O
some	O
peculiar	O
differences	O
were	O
observed	O
between	O
the	O
TEC	cell_line
,	O
either	O
IFN-gamma	protein
-induced	O
or	O
not,	O
and	O
the	O
constitutive	O
B	cell_line
cells	cell_line
.	O
These	O
results	O
suggest	O
that	O
both	O
common	O
mechanisms,	O
such	O
as	O
the	O
one	O
mediated	O
by	O
the	O
CIITA	protein
trans-activator	protein
,	O
and	O
distinct	O
tissue-specific	O
constraints	O
contribute	O
to	O
the	O
transcriptional	O
control	O
of	O
constitutive	O
and	O
IFN-gamma	protein
-induced	O
MHC	DNA
class	DNA
II	DNA
gene	DNA
expression	O
.	O

Inhibitory	O
effect	O
of	O
E3330	O
,	O
a	O
novel	O
quinone	O
derivative	O
able	O
to	O
suppress	O
tumor	protein
necrosis	protein
factor-alpha	protein
generation	O
,	O
on	O
activation	O
of	O
nuclear	protein
factor-kappa	protein
B	protein
.	O
(2E)-3-[5-(2,3-Dimethoxy-6-methyl-1,4-benzoquinoyl)]-2-nonyl-2-	O
propenoic	O
acid	O
(	O
E3330	O
),	O
is	O
a	O
novel	O
agent	O
with	O
hepatoprotective	O
activity	O
.	O
We	O
report	O
the	O
effect	O
of	O
E3330	O
on	O
transcriptional	O
activation	O
of	O
tumor	DNA
necrosis	DNA
factor	DNA
(TNF)-alpha	DNA
gene	DNA
and	O
on	O
nuclear	protein
factor	protein
(NF)-kappa	protein
B	protein
activation	O
.	O
Nuclear	O
run-on	O
experiments	O
showed	O
that	O
E3330	O
decreases	O
transcriptional	O
activation	O
of	O
TNF-alpha	DNA
gene	DNA
induced	O
by	O
lipopolysaccharide	O
(	O
LPS	O
)	O
stimulation	O
in	O
human	cell_type
peripheral	cell_type
monocytes	cell_type
.	O
To	O
investigate	O
the	O
inhibitory	O
mechanisms,	O
we	O
constructed	O
a	O
secreted-type	DNA
placental	DNA
alkaline	DNA
phosphatase	DNA
(	DNA
PLAP	DNA
)	DNA
reporter	DNA
gene	DNA
whose	O
transcription	O
is	O
controlled	O
by	O
a	O
1.4-kb	DNA
human	DNA
TNF-alpha	DNA
promoter	DNA
.	O
A	O
stable	O
transformant	O
of	O
the	O
PLAP	DNA
reporter	DNA
gene	DNA
derived	O
from	O
human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
showed	O
very	O
little	O
activity	O
on	O
the	O
promoter	O
before	O
stimulation,	O
whereas	O
LPS	O
stimulation	O
led	O
to	O
a	O
dramatic	O
increase	O
in	O
PLAP	protein
activity	O
.	O
E3330	O
inhibited	O
this	O
induced	O
promoter	O
activity	O
in	O
a	O
dose-dependent	O
manner.	O
There	O
are	O
four	O
putative	O
NF-kappa	DNA
B	DNA
binding	DNA
sites	DNA
(	O
kappa	DNA
B-1	DNA
,	O
kappa	DNA
B-2	DNA
,	O
kappa	DNA
B-3	DNA
,	O
kappa	DNA
B-4	DNA
)	O
in	O
human	DNA
TNF-alpha	DNA
promoter	DNA
.	O
By	O
using	O
mutated	DNA
promoter-	DNA
PLAP	DNA
plasmids	DNA
,	O
we	O
established	O
that	O
these	O
NF-kappa	DNA
B	DNA
sites	DNA
were	O
necessary	O
for	O
induction	O
of	O
TNF-alpha	protein
transcription	O
on	O
stimulation	O
with	O
LPS	O
.	O
A	O
gel	O
retardation	O
experiment	O
with	O
synthetic	O
double-stranded	O
oligonucleotides	O
showed	O
that	O
activated	O
NF-kappa	protein
B	protein
consisting	O
of	O
p50/p65	protein
heterodimer	protein
bound	O
to	O
all	O
four	O
putative	O
NF-kappa	DNA
B	DNA
DNA	DNA
probes	DNA
,	O
suggesting	O
that	O
all	O
four	O
putative	O
NF-kappa	DNA
B	DNA
recognition	DNA
sites	DNA
play	O
an	O
important	O
role	O
in	O
inducible	O
TNF-alpha	protein
expression	O
.	O
E3330	O
decreased	O
activated	O
NF-kappa	protein
B	protein
in	O
nuclei	O
,	O
suggesting	O
that	O
E3330	O
inhibits	O
NF-kappa	protein
B	protein
activation	O
and/or	O
translocation	O
of	O
the	O
nuclei	O
.	O
Western	O
blotting	O
analysis	O
with	O
anti-I	protein
kappa	protein
B-alpha	protein
antibody	protein
indicated	O
that	O
E3330	O
inhibited	O
degradation	O
of	O
I	protein
kappa	protein
B-alpha	protein
,	O
which	O
is	O
an	O
inhibitory	protein
protein	protein
of	O
NF-kappa	protein
B	protein
,	O
in	O
LPS	cell_line
-stimulated	cell_line
monocytes	cell_line
.	O
E3330	O
may	O
suppress	O
the	O
production	O
of	O
active	O
oxygen	O
species	O
serving	O
as	O
common	O
messengers	O
to	O
activate	O
NF-kappa	protein
B	protein
.	O

C-terminal	O
activating	O
and	O
inhibitory	O
domains	O
determine	O
the	O
transactivation	O
potential	O
of	O
BSAP	protein
(	O
Pax-5	DNA
),	O
Pax-2	DNA
and	O
Pax-8	DNA
.	O
Pax-5	DNA
encodes	O
the	O
transcription	protein
factor	protein
BSAP	protein
which	O
plays	O
an	O
essential	O
role	O
in	O
early	O
B	O
cell	O
development	O
and	O
midbrain	O
patterning	O
.	O
In	O
this	O
study	O
we	O
have	O
analysed	O
the	O
structural	O
requirements	O
for	O
transcriptional	O
activation	O
by	O
BSAP	protein
.	O
In	O
vitro	O
mutagenesis	O
and	O
transient	O
transfection	O
experiments	O
indicate	O
that	O
the	O
C-terminal	protein
serine	protein
/	protein
threonine	protein
/	protein
proline	protein
-rich	protein
region	protein
of	O
BSAP	protein
contains	O
a	O
potent	O
transactivation	protein
domain	protein
of	O
55	O
amino	O
acids	O
which	O
is	O
active	O
from	O
promoter	O
and	O
enhancer	O
positions	O
.	O
This	O
transactivation	protein
domain	protein
was	O
found	O
to	O
be	O
inactivated	O
by	O
a	O
naturally	O
occurring	O
frameshift	O
mutation	O
in	O
one	O
PAX-5	DNA
allele	DNA
of	O
the	O
acute	cell_line
lymphoblastic	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
REH	cell_line
.	O
The	O
function	O
of	O
the	O
transactivation	protein
domain	protein
is	O
negatively	O
regulated	O
by	O
adjacent	O
sequences	O
from	O
the	O
extreme	protein
C-terminus	protein
.	O
The	O
activating	O
and	O
inhibitory	O
domains	O
function	O
together	O
as	O
an	O
independent	O
regulatory	O
module	O
in	O
different	O
cell	O
types	O
as	O
shown	O
by	O
fusion	O
to	O
the	O
GAL4	protein
DNA	protein
binding	protein
domain	protein
.	O
The	O
same	O
arrangement	O
of	O
positively	O
and	O
negatively	O
acting	O
sequences	O
has	O
been	O
conserved	O
in	O
the	O
mammalian	DNA
Pax-2	DNA
and	O
Pax-8	DNA
,	O
the	O
zebrafish	DNA
Pax-b	DNA
as	O
well	O
as	O
the	O
sea	protein
urchin	protein
Pax-258	protein
proteins	protein
.	O
These	O
data	O
demonstrate	O
that	O
the	O
transcriptional	O
competence	O
of	O
a	O
subfamily	O
of	O
Pax	protein
proteins	protein
is	O
determined	O
by	O
a	O
C-terminal	protein
regulatory	protein
module	protein
composed	O
of	O
activating	O
and	O
inhibitory	O
sequences	O
.	O

Second	O
messenger	O
up-regulation	O
of	O
androgen	DNA
receptor	DNA
gene	DNA
transcription	O
is	O
absent	O
in	O
androgen	cell_line
insensitive	cell_line
human	cell_line
prostatic	cell_line
carcinoma	cell_line
cell	cell_line
lines	cell_line
,	O
PC-3	cell_line
and	O
DU-145	cell_line
.	O
A	O
theoretical	O
pathway	O
of	O
transcriptional	O
regulation	O
of	O
the	O
androgen	DNA
receptor	DNA
(AR)	DNA
gene	DNA
is	O
via	O
a	O
cAMP	DNA
response	DNA
element	DNA
(	O
CRE	DNA
)	O
present	O
in	O
its	O
promoter	DNA
region	DNA
(-508	O
to	O
-501).	O
After	O
20	O
h	O
of	O
stimulation	O
with	O
8-bromo-cAMP	O
,	O
AR	RNA
mRNA	RNA
was	O
upregulated	O
in	O
LNCaP	cell_line
but	O
not	O
in	O
either	O
PC-3	cell_line
or	O
DU-145	cell_line
cell	cell_line
lines	cell_line
.	O
We	O
have	O
demonstrated	O
that	O
the	O
level	O
of	O
CRE	protein
binding	protein
protein	protein
(	O
CREB	protein
)	O
was	O
the	O
same	O
in	O
all	O
cell	O
lines	O
and	O
that	O
the	O
putative	O
AR-CRE	protein
forms	O
specific	O
and	O
compatible	O
protein	O
interactions	O
with	O
CREB	protein
.	O
The	O
ability	O
to	O
regulate	O
AR	DNA
gene	DNA
transcription	O
via	O
the	O
second	O
messenger	O
pathway	O
is	O
lost	O
in	O
the	O
PC-3	O
and	O
DU-145	O
cell	O
lines	O
.	O
This	O
may	O
be	O
an	O
important	O
primary	O
mechanism	O
of	O
androgen	O
insensitivity	O
in	O
prostate	O
cancer	O
.	O

Structural	O
and	O
functional	O
characterization	O
of	O
the	O
human	DNA
CD36	DNA
gene	DNA
promoter	DNA
:	O
identification	O
of	O
a	O
proximal	O
PEBP2/CBF	DNA
site	DNA
.	O
CD36	protein
is	O
a	O
cell	O
surface	O
glycoprotein	protein
composed	O
of	O
a	O
single	O
polypeptide	O
chain	O
,	O
which	O
interacts	O
with	O
thrombospondin	protein
,	O
collagens	O
type	O
I	O
and	O
IV	O
,	O
oxidized	O
low	protein
density	protein
lipoprotein	protein
,	O
fatty	O
acids	O
,	O
anionic	O
phospholipids	O
,	O
and	O
erythrocytes	cell_type
parasitized	O
with	O
Plasmodium	O
falciparum	O
.	O
Its	O
expression	O
is	O
restricted	O
to	O
a	O
few	O
cell	O
types,	O
including	O
monocyte/macrophages	cell_type
.	O
In	O
these	O
cells,	O
CD36	protein
is	O
involved	O
in	O
phagocytosis	O
of	O
apoptotic	cell_type
cells	cell_type
,	O
and	O
foam	O
cell	O
formation	O
by	O
uptake	O
of	O
oxidized	protein
low	protein
density	protein
lipoprotein	protein
.	O
To	O
study	O
the	O
molecular	O
mechanisms	O
that	O
control	O
the	O
transcription	O
of	O
the	O
CD36	protein
gene	O
in	O
monocytic	O
cells	O
we	O
have	O
isolated	O
and	O
analyzed	O
the	O
CD36	DNA
promoter	DNA
.	O
Transient	O
expression	O
experiments	O
of	O
5'-deletion	DNA
fragments	DNA
of	O
the	O
CD36	DNA
promoter	DNA
coupled	O
to	O
luciferase	protein
demonstrated	O
that	O
as	O
few	O
as	O
158	DNA
base	DNA
pairs	DNA
upstream	DNA
from	O
the	O
transcription	DNA
initiation	DNA
site	DNA
were	O
sufficient	O
to	O
direct	O
the	O
monocyte-specific	O
transcription	O
of	O
the	O
reporter	DNA
gene	DNA
.	O
Within	O
the	O
above	O
region,	O
the	O
fragment	O
spanning	O
nucleotides	DNA
-158	DNA
to	DNA
-90	DNA
was	O
required	O
for	O
optimal	O
transcription	O
in	O
monocytic	cell_type
cells	cell_type
.	O
Biochemical	O
analysis	O
of	O
the	O
region	O
-158/-90	DNA
revealed	O
a	O
binding	O
site	O
for	O
transcription	protein
factors	protein
of	O
the	O
polyomavirus	protein
enhancer-binding	protein
protein	protein
2/core-binding	protein
factor	protein
(PEBP2/CBF)	protein
family	protein
at	O
position	DNA
-103	DNA
.	O
Disruption	O
of	O
the	O
PEBP2/CBF	DNA
site	DNA
markedly	O
diminished	O
the	O
role	O
of	O
the	O
PEBP2/CBF	protein
factors	protein
in	O
the	O
constitutive	O
transcription	O
of	O
the	O
CD36	DNA
gene	DNA
.	O
The	O
involvement	O
of	O
members	O
of	O
the	O
PEBP2/CBF	protein
family	protein
in	O
chromosome	O
translocations	O
associated	O
with	O
acute	O
myeloid	O
leukemia	O
,	O
and	O
in	O
the	O
transcriptional	O
regulation	O
of	O
the	O
myeloid-specific	DNA
genes	DNA
encoding	O
for	O
myeloperoxidase	protein
,	O
elastase	protein
,	O
and	O
the	O
colony-stimulating	protein
factor	protein
receptor	protein
,	O
highlights	O
the	O
relevance	O
of	O
the	O
regulation	O
of	O
the	O
CD36	DNA
gene	DNA
promoter	DNA
in	O
monocytic	cell_type
cells	cell_type
by	O
members	O
of	O
the	O
PEBP2/CBF	protein
family	protein
.	O

HLA-DQB1	DNA
codon	DNA
57	DNA
is	O
critical	O
for	O
peptide	O
binding	O
and	O
recognition	O
.	O
The	O
association	O
of	O
specific	O
HLA-DQ	DNA
alleles	DNA
with	O
autoimmunity	O
is	O
correlated	O
with	O
discrete	O
polymorphisms	O
in	O
the	O
HLA-DQ	DNA
sequence	DNA
that	O
are	O
localized	O
within	O
sites	O
suitable	O
for	O
peptide	O
recognition	O
.	O
The	O
polymorphism	O
at	O
residue	O
57	O
of	O
the	O
DQB1	O
polypeptide	O
is	O
of	O
particular	O
interest	O
since	O
it	O
may	O
play	O
a	O
major	O
structural	O
role	O
in	O
the	O
formation	O
of	O
a	O
salt	protein
bridge	protein
structure	protein
at	O
one	O
end	O
of	O
the	O
peptide-binding	protein
cleft	protein
of	O
the	O
DQ	O
molecules	O
.	O
This	O
polymorphism	O
at	O
residue	O
57	O
is	O
a	O
recurrent	O
feature	O
of	O
HLA-DQ	O
evolution	O
,	O
occurring	O
in	O
multiple	O
distinct	O
allelic	O
families	O
,	O
which	O
implies	O
a	O
functional	O
selection	O
for	O
maintaining	O
variation	O
at	O
this	O
position	O
in	O
the	O
class	protein
II	protein
molecule	protein
.	O
We	O
directly	O
tested	O
the	O
amino	O
acid	O
polymorphism	O
at	O
this	O
site	O
as	O
a	O
determinant	O
for	O
peptide	O
binding	O
and	O
for	O
antigen-specific	O
T	O
cell	O
stimulation	O
.	O
We	O
found	O
that	O
a	O
single	O
Ala	O
--&gt;	O
Asp	O
amino	O
acid	O
57	O
substitution	O
in	O
an	O
HLA-DQ3.2	O
molecule	O
regulated	O
binding	O
of	O
an	O
HSV-2	O
VP-16-derived	O
peptide	O
.	O
A	O
complementary	O
single-residue	O
substitution	O
in	O
the	O
peptide	O
abolished	O
its	O
binding	O
to	O
DQ3.2	O
and	O
converted	O
it	O
to	O
a	O
peptide	O
that	O
can	O
bind	O
to	O
DQ3.1	O
and	O
DQ3.3	protein
Asp	protein
-57-positive	protein
MHC	protein
molecules	protein
.	O
These	O
binding	O
studies	O
were	O
paralleled	O
by	O
specific	O
T	O
cell	O
recognition	O
of	O
the	O
class	protein
II-peptide	protein
complex	protein
,	O
in	O
which	O
the	O
substituted	O
peptide	O
abolished	O
T	O
cell	O
reactivity	O
,	O
which	O
was	O
directed	O
to	O
the	O
DQ3.2	protein
-peptide	protein
complex	protein
,	O
whereas	O
the	O
same	O
T	cell_line
cell	cell_line
clone	cell_line
recognized	O
the	O
substituted	O
peptide	O
presented	O
by	O
DQ3.3	O
,	O
a	O
class	O
II	O
restriction	O
element	O
differing	O
from	O
DQ3.2	O
only	O
at	O
residue	O
57	O
.	O
This	O
structural	O
and	O
functional	O
complementarity	O
for	O
residue	O
57	O
and	O
a	O
specific	O
peptide	O
residue	O
identifies	O
this	O
interaction	O
as	O
a	O
key	O
controlling	O
determinant	O
of	O
restricted	O
recognition	O
in	O
HLA-DQ	O
-specific	O
immune	O
response	O
.	O

Autocrine	O
activation	O
by	O
interferon-gamma	protein
of	O
STAT	protein
factors	protein
following	O
T	O
cell	O
activation	O
.	O
The	O
activation	O
of	O
T	cell_type
cells	cell_type
requires	O
engagement	O
of	O
the	O
T	protein
cell	protein
receptor/CD3	protein
complex	protein
and	O
co-stimulatory	protein
molecules	protein
,	O
and	O
results	O
in	O
the	O
triggering	O
of	O
several	O
signaling	O
pathways	O
which	O
lead	O
rapidly	O
to	O
the	O
nuclear	O
translocation	O
of	O
several	O
transcription	protein
factors	protein
,	O
such	O
as	O
nuclear	protein
factor	protein
(NF)-kappa	protein
B	protein
and	O
NF-AT	protein
.	O
A	O
result	O
of	O
this	O
activation	O
process	O
is	O
the	O
induction	O
of	O
a	O
number	O
of	O
genes,	O
including	O
those	O
encoding	O
cytokines	protein
such	O
as	O
interleukin-2	protein
,	O
tumor	protein
necrosis	protein
factor-alpha	protein
,	O
and	O
interferon	protein
(IFN)-gamma	protein
which	O
have	O
important	O
immunoregulatory	protein
effects	O
.	O
We	O
report	O
here	O
that	O
a	O
DNA-binding	protein
factor	protein
containing	O
STAT1	protein
also	O
becomes	O
activated	O
in	O
human	cell_type
peripheral	cell_type
blood	cell_type
T	cell_type
lymphocytes	cell_type
or	O
Jurkat	cell_line
cells	cell_line
,	O
although	O
not	O
until	O
1-2	O
h	O
after	O
stimulation.	O
Activation	O
is	O
delayed	O
a	O
further	O
1-2	O
hr	O
when	O
mononuclear	cell_line
cell	cell_line
cultures	cell_line
are	O
stimulated	O
by	O
an	O
antigen	O
which	O
requires	O
processing.	O
Appearance	O
of	O
the	O
STAT1	protein
factor	O
is	O
significantly	O
reduced	O
in	O
the	O
presence	O
of	O
cyclosporin	O
A	O
,	O
and	O
blocked	O
by	O
cycloheximide	O
,	O
indicating	O
that	O
its	O
activation	O
is	O
dependent	O
upon	O
a	O
protein(s)	O
synthesized	O
in	O
response	O
to	O
initial	O
signaling	O
events	O
.	O
Neutralizing	O
antiserum	O
against	O
IFN-gamma	protein
,	O
but	O
not	O
other	O
cytokines	protein
tested,	O
blocked	O
activation	O
of	O
the	O
factor	O
almost	O
completely,	O
and	O
IFN-gamma	protein
was	O
found	O
in	O
the	O
culture	O
supernatants	O
of	O
stimulated	cell_line
cells	cell_line
at	O
levels	O
at	O
which	O
recombinant	O
IFN-gamma	protein
could	O
activate	O
the	O
factor	O
in	O
naive	cell_type
cells	cell_type
.	O
Therefore,	O
a	O
STAT1	protein
transcription	protein
factor	protein
is	O
activated	O
by	O
IFN-gamma	protein
synthesized	O
and	O
released	O
upon	O
stimulation	O
of	O
T	cell_type
lymphocyte	cell_type
populations	cell_type
.	O
While	O
Jurkat	cell_line
cells	cell_line
both	O
secrete	O
and	O
respond	O
to	O
IFN-gamma	protein
in	O
an	O
autocrine	O
loop	O
,	O
it	O
seems	O
likely	O
that	O
the	O
responding	O
cells	O
may	O
differ	O
from	O
those	O
synthesizing	O
this	O
cytokine	protein
in	O
the	O
mononuclear	cell_line
cell	cell_line
cultures	cell_line
in	O
the	O
light	O
of	O
the	O
recent	O
report	O
that	O
Th1	cell_line
cells	cell_line
lack	O
the	O
IFN-gamma	protein
receptor	O
chain	O
necessary	O
for	O
activation	O
of	O
STAT1	protein
(Pernis,	O
A.,	O
Gupta,	O
S.,	O
Gollob,	O
K.J.,	O
Garfein,	O
E.,	O
Coffman,	O
R.L.,	O
Schindler,	O
C.,	O
and	O
Rothman,	O
P.,	O
Science	O
1995.	O
269:245).	O

Absence	O
of	O
T-cell-	O
and	O
B-cell-	O
specific	O
transcription	O
factors	O
TCF-1	protein
,	O
GATA-3	protein
,	O
and	O
BSAP	protein
in	O
Hodgkin's	cell_line
Reed-Sternberg	cell_line
cells	cell_line
.	O
Based	O
on	O
the	O
presence	O
of	O
T	DNA
cell	DNA
receptor-beta	DNA
(	DNA
TcR-beta	DNA
)	DNA
gene	DNA
rearrangements	DNA
in	O
L428	O
and	O
HDLM-1	O
cells	O
,	O
the	O
expression	O
of	O
CD2	protein
in	O
HDLM-1	cell_line
cells	cell_line
,	O
and	O
the	O
presence	O
of	O
immunoglobulin	DNA
heavy-chain	DNA
(	DNA
IgH	DNA
)	DNA
gene	DNA
rearrangement	DNA
in	O
KM-H2	cell_line
cells	cell_line
,	O
some	O
researchers	O
have	O
concluded	O
that	O
these	O
long-term	cell_line
cell	cell_line
lines	cell_line
derived	O
from	O
patients	O
with	O
Hodgkin's	O
disease	O
are	O
lymphoid	O
in	O
nature.	O
The	O
information	O
obtained	O
from	O
these	O
cell	cell_line
lines	cell_line
has	O
also	O
been	O
used	O
in	O
arguments	O
for	O
a	O
lymphoid	O
origin	O
of	O
H-RS	cell_line
cells	cell_line
in	O
tissue	O
despite	O
the	O
frequent	O
absence	O
of	O
lymphoid	protein
markers	protein
and	O
Ig/TcR	DNA
gene	DNA
rearrangements	DNA
in	O
these	O
cells.	O
We	O
questioned	O
whether	O
one	O
can	O
use	O
the	O
limited	O
expression	O
of	O
lymphoid	protein
markers	protein
or	O
the	O
limited	O
gene	O
rearrangement	O
to	O
conclude	O
that	O
H-RS	cell_line
cells	cell_line
have	O
a	O
lymphoid	O
origin	O
,	O
because	O
these	O
markers	O
may	O
be	O
aberrant	O
in	O
tumor	cell_type
cells	cell_type
.	O
In	O
this	O
study,	O
we	O
examined	O
the	O
expression	O
of	O
two	O
T-cell-specific	protein
transcription	protein
factors	protein
(	O
TCF-1	protein
and	O
GATA-3	protein
)	O
and	O
one	O
B-cell-specific	protein
transcription	protein
factor	protein
(	O
BSAP	protein
)	O
in	O
cultured	cell_line
H-RS	cell_line
cells	cell_line
by	O
using	O
a	O
gel	O
mobility	O
shift	O
assay	O
.	O
The	O
sensitivity	O
and	O
specificity	O
of	O
this	O
assay	O
for	O
determination	O
of	O
cell	cell_line
lineage	cell_line
have	O
been	O
established	O
in	O
a	O
large	O
number	O
of	O
cultured	O
human	O
and	O
murine	O
cell	O
lines	O
.	O
All	O
three	O
types	O
of	O
H-RS	cell_line
cell	cell_line
lines	cell_line
were	O
consistently	O
negative	O
for	O
BSAP	protein
,	O
TCF-1	protein
,	O
and	O
GATA-3	protein
.	O
The	O
absence	O
of	O
GATA-3	protein
was	O
confirmed	O
in	O
H-RS	cell_line
cells	cell_line
in	O
tissues	O
by	O
an	O
in	O
situ	O
hybridization	O
technique	O
.	O
Virtually	O
all	O
B-cell	cell_line
lines	cell_line
,	O
with	O
the	O
exception	O
of	O
some	O
myeloma	cell_line
cell	cell_line
lines	cell_line
,	O
are	O
positive	O
for	O
BSAP	protein
,	O
which	O
is	O
the	O
transcription	protein
factor	protein
for	O
promoters	DNA
for	O
several	O
B-cell	protein
markers	protein
,	O
including	O
VpreB1	protein
,	O
lambda	protein
5	protein
,	O
CD19	protein
,	O
and	O
CD20	protein
.	O
All	O
T-cell	cell_line
lines	cell_line
tested	O
were	O
positive	O
for	O
TCF-1	protein
and	O
GATA-3	protein
,	O
which	O
are	O
the	O
transcription	protein
factors	protein
for	O
promoters	O
for	O
several	O
T-cell-restricted	protein
markers	protein
,	O
including	O
CD2	protein
,	O
CD3	protein
,	O
TcR	protein
,	O
and	O
lck	protein
.	O
The	O
absence	O
of	O
BSAP	protein
,	O
TCF-1	protein
,	O
and	O
GATA-3	protein
clearly	O
indicates	O
an	O
underlying	O
difference	O
between	O
H-RS	cell_line
cells	cell_line
and	O
lymphoid	cell_type
cells	cell_type
.	O

MEK1	protein
and	O
the	O
extracellular	protein
signal-regulated	protein
kinases	protein
are	O
required	O
for	O
the	O
stimulation	O
of	O
IL-2	DNA
gene	DNA
transcription	O
in	O
T	cell_type
cells	cell_type
.	O
TCR	protein
engagement	O
stimulates	O
the	O
activation	O
of	O
the	O
protein	protein
kinase	protein
Raf-1	protein
.	O
Active	O
Raf-1	protein
phosphorylates	O
and	O
activates	O
the	O
mitogen-activated	protein
protein	protein
(MAP)	protein
kinase	protein
/extracellular	protein
signal-regulated	protein
kinase	protein
kinase	protein
1	protein
(	O
MEK1	protein
),	O
which	O
in	O
turn	O
phosphorylates	O
and	O
activates	O
the	O
MAP	protein
kinases/extracellular	protein
signal	protein
regulated	protein
kinases	protein
,	O
ERK1	protein
and	O
ERK2	protein
.	O
Raf-1	protein
activity	O
promotes	O
IL-2	O
production	O
in	O
activated	O
T	cell_type
lymphocytes	cell_type
.	O
Therefore,	O
we	O
sought	O
to	O
determine	O
whether	O
MEK1	protein
and	O
ERK	protein
activities	O
also	O
stimulate	O
IL-2	DNA
gene	DNA
transcription	O
.	O
Expression	O
of	O
constitutively	O
active	O
Raf-1	protein
or	O
MEK1	protein
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
enhanced	O
the	O
stimulation	O
of	O
IL-2	DNA
promoter	DNA
-driven	O
transcription	O
stimulated	O
by	O
a	O
calcium	O
ionophore	O
and	O
PMA	O
,	O
and	O
together	O
with	O
a	O
calcium	O
ionophore	O
the	O
expression	O
of	O
each	O
protein	O
was	O
sufficient	O
to	O
stimulate	O
NF-AT	protein
activity	O
.	O
Expression	O
of	O
MEK1	protein
-interfering	protein
mutants	protein
inhibited	O
the	O
stimulation	O
of	O
IL-2	DNA
promoter	DNA
-driven	O
transcription	O
and	O
blocked	O
the	O
ability	O
of	O
constitutively	O
active	O
Ras	protein
and	O
Raf-1	protein
to	O
costimulate	O
NF-AT	protein
activity	O
with	O
a	O
calcium	O
ionophore	O
.	O
Expression	O
of	O
the	O
MAP	protein
kinase-specific	protein
phosphatase	protein
,	O
MKP-1	protein
,	O
which	O
blocks	O
ERK	protein
activation	O
,	O
inhibited	O
IL-2	DNA
promoter	DNA
and	O
NF-AT	protein
-driven	O
transcription	O
stimulated	O
by	O
a	O
calcium	O
ionophore	O
and	O
PMA	O
,	O
and	O
in	O
addition,	O
MKP-1	protein
neutralized	O
the	O
transcriptional	O
enhancement	O
caused	O
by	O
active	O
Raf-1	O
and	O
MEK1	O
expression	O
.	O
We	O
conclude	O
that	O
the	O
MAP	protein
kinase	protein
signal	O
transduction	O
pathway	O
consisting	O
of	O
Raf-1	protein
,	O
MEK1	protein
,	O
and	O
ERK1	protein
and	O
ERK2	protein
functions	O
in	O
the	O
stimulation	O
IL-2	DNA
gene	DNA
transcription	O
in	O
activated	O
T	cell_type
lymphocytes	cell_type
.	O

Multiple	O
transcription	protein
factors	protein
are	O
required	O
for	O
activation	O
of	O
human	DNA
interleukin	DNA
9	DNA
gene	DNA
in	O
T	cell_type
cells	cell_type
.	O
The	O
genetic	O
elements	O
and	O
regulatory	O
mechanisms	O
responsible	O
for	O
human	DNA
interleukin	DNA
9	DNA
(	DNA
IL-9	DNA
)	DNA
gene	DNA
expression	O
in	O
a	O
human	cell_line
T	cell_line
cell	cell_line
leukemia	cell_line
virus	cell_line
type	cell_line
I-transformed	cell_line
human	cell_line
T	cell_line
cell	cell_line
line	cell_line
,	O
C5MJ2	cell_line
,	O
were	O
investigated.	O
We	O
demonstrated	O
that	O
IL-9	DNA
gene	DNA
expression	O
is	O
controlled,	O
at	O
least	O
in	O
part,	O
by	O
transcriptional	O
activation.	O
Transient	O
expression	O
of	O
the	O
luciferase	DNA
reporter	DNA
gene	DNA
linked	O
to	O
serially	O
deleted	O
sequences	O
of	O
the	O
5'-flanking	DNA
region	DNA
of	O
the	O
IL-9	DNA
gene	DNA
has	O
revealed	O
several	O
positive	O
and	O
negative	DNA
regulatory	DNA
elements	DNA
involved	O
in	O
the	O
basal	O
and	O
inducible	O
expression	O
of	O
the	O
IL-9	DNA
gene	DNA
in	O
C5MJ2	cell_line
cells	cell_line
.	O
An	O
AP-1	O
site	O
at	O
-146	O
to	O
-140	O
was	O
shown	O
to	O
be	O
involved	O
in	O
the	O
expression	O
of	O
the	O
IL-9	DNA
gene	DNA
.	O
A	O
proximal	DNA
region	DNA
between	O
-46	DNA
and	DNA
-80	DNA
was	O
identified	O
as	O
the	O
minimum	O
sequence	O
for	O
the	O
basal	O
and	O
inducible	O
expression	O
of	O
the	O
IL-9	DNA
gene	DNA
in	O
C5MJ2	cell_line
cells	cell_line
.	O
Within	O
this	O
region,	O
an	O
NF-kappaB	DNA
site	DNA
at	O
-59	DNA
to	DNA
-50	DNA
and	O
its	O
adjacent	O
20-base	DNA
pair	DNA
upstream	DNA
sequence	DNA
were	O
demonstrated	O
to	O
play	O
a	O
critical	O
role	O
for	O
the	O
IL-9	DNA
promoter	DNA
activity	O
.	O
DNA-protein	O
binding	O
studies	O
indicated	O
that	O
NF-kappaB	protein
,	O
c-Jun	protein
,	O
and	O
potentially	O
novel	protein
proteins	protein
(around	O
35	protein
kDa	protein
)	O
can	O
bind	O
to	O
this	O
important	O
sequence.	O
Mutations	O
at	O
different	O
sites	O
within	O
this	O
proximal	DNA
promoter	DNA
region	DNA
abolished	O
the	O
promoter	O
activity	O
as	O
well	O
as	O
the	O
DNA	O
binding.	O
Taken	O
together,	O
these	O
results	O
suggest	O
that	O
the	O
cooperation	O
of	O
different	O
transcription	protein
factors	protein
is	O
essential	O
for	O
IL-9	DNA
gene	DNA
expression	O
in	O
T	cell_type
cells	cell_type
.	O

DNA	O
triplex	O
formation	O
selectively	O
inhibits	O
granulocyte-macrophage	DNA
colony-stimulating	DNA
factor	DNA
gene	DNA
expression	O
in	O
human	O
T	O
cells.	O
Granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
(	O
GM-CSF	protein
)	O
is	O
a	O
hemopoietic	O
growth	O
factor	O
that	O
is	O
expressed	O
in	O
activated	O
T	O
cells,	O
fibroblasts,	O
macrophages,	O
and	O
endothelial	O
cells.	O
Although	O
GM-CSF	protein
does	O
not	O
appear	O
to	O
be	O
essential	O
for	O
normal	O
hemopoiesis,	O
overexpression	O
of	O
GM-CSF	O
has	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
some	O
diseases	O
such	O
as	O
myeloid	O
leukemia	O
and	O
chronic	O
inflammation.	O
An	O
NF-kappaB	protein
/Rel	O
binding	O
site	O
within	O
the	O
GM-CSF	DNA
promoter	DNA
,	O
termed	O
the	O
kappaB	O
element	O
appears	O
to	O
be	O
important	O
for	O
controlling	O
expression	O
in	O
reporter	DNA
gene	DNA
assays	O
in	O
response	O
to	O
a	O
number	O
of	O
stimuli	O
in	O
T	cell_type
cells	cell_type
.	O
We	O
investigated	O
oligonucleotide	O
-directed	O
triple	O
helix	O
formation	O
across	O
this	O
regulatory	DNA
sequence	DNA
as	O
a	O
potential	O
tool	O
to	O
inhibit	O
GM-CSF	protein
gene	O
transcription	O
.	O
A	O
15-base	O
oligonucleotide	O
,	O
GM3	O
,	O
was	O
targeted	O
to	O
a	O
purine-rich	DNA
region	DNA
in	O
the	O
GM-CSF	DNA
proximal	DNA
promoter	DNA
,	O
which	O
overlaps	O
the	O
kappaB	DNA
element	DNA
.	O
Gel	O
mobility	O
shift	O
assays	O
and	O
DNase	protein
I	protein
footprinting	O
demonstrated	O
that	O
GM3	O
formed	O
a	O
sequence-specific	DNA
collinear	DNA
triplex	DNA
with	O
its	O
double-stranded	DNA
DNA	DNA
target	DNA
.	O
Triplex	O
formation	O
by	O
GM3	O
blocked	O
recombinant	O
and	O
nuclear	O
NF-kappaB	O
proteins	O
binding	O
to	O
the	O
GM-CSF	DNA
element	DNA
.	O
GM3	O
also	O
caused	O
selective	O
inhibition	O
of	O
the	O
human	protein
T-cell	protein
lymphotrophic	protein
virus-1	protein
Tax	protein
transactivator-induced	O
luciferase	protein
activity	O
from	O
a	O
reporter	O
construct	O
driven	O
by	O
the	O
GM-CSF	DNA
promoter	DNA
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
Finally,	O
GM3	O
greatly	O
reduced	O
the	O
concentration	O
of	O
endogenous	O
GM-CSF	RNA
mRNA	RNA
induced	O
by	O
different	O
stimuli	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
but	O
did	O
not	O
affect	O
interleukin	RNA
3	RNA
mRNA	RNA
levels	O
in	O
the	O
same	O
cells.	O
We	O
conclude	O
that	O
the	O
kappaB	DNA
element	DNA
in	O
the	O
GM-CSF	DNA
promoter	DNA
plays	O
a	O
central	O
role	O
in	O
the	O
transcriptional	O
activation	O
of	O
the	O
endogenous	O
GM-CSF	DNA
gene	DNA
.	O
Colinear	O
triplex	O
formation	O
acts	O
as	O
a	O
selective	O
transcriptional	O
repressor	O
of	O
the	O
GM-CSF	DNA
gene	DNA
and	O
may	O
have	O
potential	O
therapeutic	O
application	O
in	O
cases	O
of	O
undesirable	O
overexpression	O
of	O
this	O
protein.	O

Reversible	O
differentiation	O
of	O
human	cell_line
monoblastic	cell_line
leukemia	cell_line
U937	cell_line
cells	cell_line
by	O
ML-9	O
,	O
an	O
inhibitor	O
of	O
myosin	protein
light	protein
chain	protein
kinase	protein
.	O
Human	cell_line
monoblastic	cell_line
leukemia	cell_line
U937	cell_line
cells	cell_line
are	O
induced	O
to	O
differentiate	O
into	O
monocytes	cell_type
and	O
macrophages	cell_type
by	O
various	O
agents.	O
We	O
have	O
shown	O
that	O
1-(5-chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine	O
hydrochloride	O
(	O
ML-9	O
),	O
an	O
inhibitor	O
of	O
myosin	protein
light	protein
chain	protein
kinase	protein
,	O
induces	O
differentiation	O
of	O
monocytoid	cell_line
leukemia	cell_line
cell	cell_line
lines	cell_line
U937	cell_line
and	O
THP-1	cell_line
but	O
not	O
of	O
myeloblastic	cell_line
leukemic	cell_line
ML-1	cell_line
cell	cell_line
or	O
erythroleukemia	cell_line
K562	cell_line
cells	cell_line
.	O
In	O
the	O
present	O
study,	O
we	O
further	O
analyzed	O
the	O
effect	O
of	O
ML-9	O
in	O
comparison	O
with	O
that	O
of	O
1	O
alpha,	O
25-dihydroxyvitamin	O
D3	O
(	O
VD3	O
)	O
a	O
typical	O
inducer	O
of	O
monocytic	O
differentiation	O
.	O
ML-9	O
induced	O
nitroblue	O
tetrazolium	O
(	O
NBT	O
)-reducing	O
activity	O
of	O
U937	cell_line
cell	cell_line
more	O
rapidly	O
than	O
VD3	O
:	O
This	O
differentiation	O
marker	O
was	O
induced	O
significantly	O
after	O
incubation	O
with	O
ML-9	O
and	O
VD3	O
for	O
4	O
hours	O
and	O
1	O
day,	O
respectively.	O
ML-9	O
also	O
induced	O
alpha-naphthyl	protein
acetate	protein
esterase	protein
(	O
ANAE	protein
)	O
activity	O
,	O
another	O
monocytic	O
differentiation	O
marker,	O
more	O
rapidly	O
than	O
VD3	O
.	O
The	O
maximum	O
levels	O
of	O
these	O
markers	O
induced	O
by	O
ML-9	O
were	O
comparable	O
to	O
those	O
induced	O
by	O
VD3	O
,	O
but	O
after	O
removal	O
of	O
ML-9	O
from	O
the	O
medium	O
by	O
washing	O
the	O
cells,	O
the	O
expressions	O
of	O
theses	O
markers	O
decreased	O
within	O
4	O
hours	O
and	O
reached	O
basal	O
levels	O
in	O
1	O
day,	O
indicating	O
that	O
ML-9	O
's	O
induction	O
of	O
expression	O
of	O
differentiation-associated	O
phenotypes	O
was	O
reversible.	O
The	O
growth	O
inhibition	O
of	O
U937	cell_line
cells	cell_line
by	O
ML-9	O
was	O
also	O
reversible.	O
Similar	O
effects	O
were	O
observed	O
in	O
another	O
line	O
of	O
human	cell_line
monoblastic	cell_line
cells	cell_line
,	O
THP-1	cell_line
.	O
ML-9	O
had	O
little	O
or	O
no	O
effect	O
on	O
the	O
morphology	O
of	O
U937	cell_line
cells	cell_line
but	O
increased	O
the	O
expression	O
of	O
monocyte-macrophage	protein
lineage-associated	protein
surface	protein
antigen	protein
,	O
CD14	protein
,	O
to	O
some	O
extent.	O
Irreversible	O
terminal	O
differentiation	O
induced	O
by	O
VD3	O
is	O
associated	O
with	O
down	O
regulation	O
of	O
the	O
expression	O
of	O
c-myc	O
and	O
upregulation	O
of	O
the	O
expression	O
of	O
c-fos	O
and	O
c-jun,	O
but	O
ML-9	O
did	O
not	O
affect	O
the	O
expression	O
of	O
these	O
oncogenes	O
appreciably.	O
ML-9	O
-induced	O
differentiation	O
was	O
also	O
reversible	O
when	O
the	O
cells	O
were	O
cultured	O
with	O
cultured	O
with	O
ML-9	O
plus	O
an	O
anti-cancer	O
drug	O
such	O
as	O
1-beta-D-arabino-furanosylcytosine	O
or	O
daunomycin	O
.	O
it	O
became	O
irreversible,	O
however,	O
upon	O
simultaneous	O
treatment	O
with	O
dexamethasone	O
and	O
transforming	protein
growth	protein
factor-beta	protein
1	protein
(	O
TGF-beta	protein
1	protein
),	O
which	O
did	O
not	O
induce	O
differentiation	O
of	O
U937	cell_line
cells	cell_line
but	O
caused	O
growth	O
arrest	O
of	O
the	O
cells	O
in	O
the	O
G0/G1	O
phase	O
of	O
the	O
cell	O
cycle	O
.	O
These	O
results	O
suggest	O
that	O
ML-9	O
should	O
be	O
useful	O
for	O
studying	O
the	O
mechanisms	O
of	O
monocytic	O
differentiation	O
.	O

Modulation	O
of	O
endogenous	O
IL-1	protein
beta	protein
and	O
IL-1	protein
receptor	protein
antagonist	O
results	O
in	O
opposing	O
effects	O
on	O
HIV	O
expression	O
in	O
chronically	cell_line
infected	cell_line
monocytic	cell_line
cells	cell_line
.	O
A	O
proportion	O
of	O
HIV	O
-infected	O
individuals	O
experience	O
episodes	O
of	O
localized	O
or	O
systemic	O
bacterial	O
infections	O
caused	O
by	O
Gram-negative	O
bacteria	O
.	O
Many	O
of	O
the	O
clinical	O
side	O
effects	O
of	O
these	O
infections	O
are	O
associated	O
with	O
the	O
production	O
of	O
proinflammatory	protein
cytokines	protein
,	O
which	O
are	O
induced	O
primarily	O
by	O
LPS	O
,	O
a	O
constituent	O
of	O
the	O
bacterial	O
cell	O
wall	O
of	O
Gram-negative	O
bacteria	O
.	O
The	O
present	O
study	O
examines	O
the	O
mechanisms	O
involved	O
in	O
LPS	O
-mediated	O
induction	O
of	O
HIV	O
expression	O
in	O
U1	cell_line
cells	cell_line
,	O
a	O
promonocytic	cell_line
cell	cell_line
line	cell_line
chronically	O
infected	O
with	O
HIV	O
.	O
Stimulation	O
of	O
U1	cell_line
cells	cell_line
by	O
LPS	O
alone	O
induced	O
minimal	O
levels	O
of	O
HIV	O
expression	O
,	O
which	O
was	O
significantly	O
enhanced	O
by	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
(	O
GM-CSF	protein
).	O
Costimulation	O
of	O
U1	cell_line
cells	cell_line
with	O
LPS	O
plus	O
GM-CSF	protein
resulted	O
in	O
the	O
accumulation	O
of	O
steady-state	O
levels	O
of	O
HIV	RNA
RNA	RNA
;	O
however,	O
only	O
a	O
weak	O
induction	O
of	O
HIV	DNA
long	DNA
terminal	DNA
repeat	DNA
-driven	O
transcription	O
,	O
which	O
was	O
not	O
associated	O
with	O
the	O
activation	O
of	O
the	O
cellular	protein
transcription	protein
factor	protein
nuclear	protein
factor-kappa	protein
B	protein
,	O
was	O
noted.	O
Costimulation	O
of	O
cells	O
with	O
LPS	O
plus	O
GM-CSF	protein
induced	O
the	O
production	O
of	O
proinflammatory	protein
cytokines	protein
,	O
IL-8	protein
,	O
IL-1	protein
beta	protein
and	O
IL-6	protein
,	O
but	O
not	O
TNF-alpha	protein
.	O
IL-1	protein
receptor	protein
antagonist	O
(ra)	O
inhibited	O
LPS	O
enhancement	O
of	O
HIV	O
expression	O
in	O
GM-CSF	cell_line
-stimulated	cell_line
cells	cell_line
,	O
suggesting	O
that	O
endogenous	protein
IL-1	protein
was	O
involved	O
in	O
LPS	O
-mediated	O
viral	O
production	O
.	O
In	O
this	O
regard,	O
anti-inflammatory	protein
cytokines	protein
inhibited	O
LPS	O
plus	O
GM-CSF	protein
-stimulated	O
HIV	O
expression	O
,	O
and	O
this	O
effect	O
closely	O
correlated	O
with	O
inhibition	O
of	O
IL-1	protein
beta	protein
release	O
and,	O
in	O
particular,	O
with	O
up-regulation	O
of	O
endogenous	O
IL-1ra	O
production	O
.	O
Thus,	O
the	O
balance	O
between	O
an	O
endogenously	protein
produced	protein
viral	protein
inducer	protein
(	O
IL-1	protein
beta	protein
)	O
and	O
an	O
inhibitor	O
(	O
IL-1ra	protein
)	O
may	O
represent	O
an	O
important	O
pathway	O
leading	O
to	O
modulation	O
of	O
HIV	O
expression	O
from	O
monocytic	cell_type
cells	cell_type
.	O

Herpesvirus	cell_line
saimiri	cell_line
immortalized	cell_line
gamma	cell_line
delta	cell_line
T	cell_line
cell	cell_line
line	cell_line
activated	O
by	O
IL-12	protein
.	O
IL-12	protein
is	O
a	O
novel	O
heterodimeric	protein
cytokine	protein
important	O
for	O
the	O
regulation	O
and	O
differentiation	O
of	O
lymphocytes	O
and	O
NK	O
cells	O
.	O
Like	O
other	O
cytokines,	O
IL-12	protein
mediates	O
its	O
biologic	O
activity	O
through	O
high-affinity	O
receptors	O
expressed	O
on	O
responsive	cell_type
cells	cell_type
.	O
To	O
date,	O
a	O
large	O
number	O
of	O
receptors	O
for	O
IL-12	protein
have	O
been	O
found	O
only	O
on	O
PBMC	cell_type
following	O
activation	O
with	O
PHA	protein
or	O
IL-2	protein
.	O
To	O
gain	O
further	O
knowledge	O
of	O
the	O
IL-12R	protein
complex	protein
and	O
the	O
IL-12	protein
signal	O
transduction	O
pathway	O
in	O
cytotoxic	cell_type
T	cell_type
cells	cell_type
,	O
we	O
studied	O
a	O
number	O
of	O
human	cell_line
T	cell_line
cell	cell_line
lines	cell_line
that	O
had	O
been	O
transformed	O
to	O
permanent	O
growth	O
with	O
Herpesvirus	O
saimiri	O
,	O
an	O
oncogenic	O
virus	O
of	O
nonhuman	O
primates	O
.	O
This	O
paper	O
reports	O
the	O
expression	O
of	O
IL-12R	protein
on	O
a	O
human	cell_line
gamma	cell_line
delta	cell_line
T	cell_line
cell	cell_line
line	cell_line
that	O
responds	O
to	O
IL-12	protein
with	O
enhanced	O
cytolytic	O
activity	O
and	O
increased	O
expression	O
of	O
cytolytic	protein
effector	protein
molecules	protein
granzyme	protein
B	protein
and	O
perforin	protein
.	O
Using	O
these	O
T	cell_type
cells	cell_type
as	O
a	O
model	O
of	O
IL-12	protein
signal	O
transduction	O
,	O
we	O
confirmed	O
that	O
these	O
events	O
involve	O
members	O
of	O
the	O
Janus	protein
kinase	protein
family	protein
of	O
nonreceptor	protein
tyrosine	protein
kinases	protein
JAK2	protein
,	O
TYK2	protein
,	O
and	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
4	protein
.	O

Regulation	O
of	O
gene	O
expression	O
at	O
early	O
stages	O
of	O
B-cell	O
and	O
T-cell	O
differentiation	O
.	O
The	O
expression	O
of	O
distinct	O
sets	O
of	O
genes	O
at	O
different	O
stages	O
of	O
B-lymphocyte	O
and	O
T-lymphocyte	O
differentiation	O
is	O
controlled	O
at	O
the	O
level	O
of	O
transcription.	O
A	O
number	O
of	O
recent	O
studies	O
have	O
described	O
interactions	O
between	O
transcription	protein
factors	protein
in	O
lymphocytes	O
that	O
provide	O
new	O
insights	O
into	O
mechanisms	O
regulating	O
gene	O
expression	O
.	O
These	O
mechanisms	O
include	O
the	O
assembly	O
of	O
higher	protein
order	protein
nucleoprotein	protein
complexes	protein
and	O
other	O
protein-protein	O
interactions	O
that	O
enhance	O
the	O
functional	O
specificity	O
of	O
transcriptional	protein
regulators	protein
in	O
lymphocytes	O
.	O

Identification	O
of	O
a	O
human	DNA
LIM-Hox	DNA
gene	DNA
,	O
hLH-2	DNA
,	O
aberrantly	O
expressed	O
in	O
chronic	O
myelogenous	O
leukaemia	O
and	O
located	O
on	O
9q33-34.1	DNA
.	O
We	O
describe	O
the	O
isolation	O
of	O
human	protein
LH-2	protein
,	O
a	O
putative	protein
transcription	protein
factor	protein
containing	O
two	O
cysteine	protein
-rich	protein
regions	protein
(	O
LIM	protein
domains	protein
)	O
and	O
a	O
homeobox	protein
(Hox)	protein
DNA-binding	protein
domain	protein
.	O
High	O
levels	O
of	O
hLH-2	DNA
expression	O
were	O
observed	O
in	O
all	O
cases	O
of	O
chronic	O
myelogenous	O
leukaemia	O
(	O
CML	O
)	O
tested,	O
regardless	O
of	O
disease	O
status.	O
hLH-2	DNA
was	O
mapped	O
to	O
chromosome	DNA
9Q33-34.1	DNA
,	O
in	O
the	O
same	O
region	O
as	O
the	O
reciprocal	O
translocation	O
that	O
creates	O
the	O
BCR-ABL	protein
chimera	protein
of	O
the	O
Philadelphia	O
chromosome	O
(	O
Ph'	O
),	O
the	O
hallmark	O
of	O
CML	O
;	O
hLH-2	DNA
was	O
retained	O
on	O
the	O
derivative	DNA
9	DNA
chromosome	DNA
and	O
is	O
therefore	O
centromeric	O
of	O
c-ABL	DNA
.	O
The	O
proximity	O
of	O
hLH-2	DNA
to	O
the	O
breakpoint	O
on	O
chromosome	DNA
9	DNA
raises	O
the	O
possibility	O
of	O
cis-activation	O
by	O
the	O
t(9;22)(q34;q11)	DNA
translocation	DNA
.	O
In	O
addition	O
to	O
finding	O
hLH-2	DNA
expression	O
in	O
all	O
cases	O
of	O
CML	O
,	O
expression	O
was	O
observed	O
in	O
lymphoid	O
malignancies	O
and	O
myeloid	cell_line
cell	cell_line
lines	cell_line
,	O
but	O
not	O
in	O
primary	O
cases	O
of	O
acute	O
myelogenous	O
leukaemia	O
.	O
The	O
role	O
of	O
hLH-2	DNA
in	O
the	O
development	O
or	O
progression	O
of	O
leukaemia	O
is	O
not	O
known.	O
However,	O
hLH-2	DNA
may	O
prove	O
useful	O
as	O
a	O
marker	O
of	O
CML	O
for	O
monitoring	O
residual	O
disease	O
.	O

Lymphoid	O
cell	O
resistance	O
to	O
glucocorticoids	O
in	O
HIV	O
infection.	O
In	O
humans	O
infected	O
with	O
the	O
HIV-1	O
virus	O
there	O
may	O
be	O
a	O
disproportionate	O
severity	O
of	O
signs	O
and	O
symptoms	O
of	O
illness	O
compared	O
to	O
the	O
fraction	O
of	O
CD4+	cell_line
infected	cell_line
T-lymphoid	cell_line
cells	cell_line
.	O
In	O
part,	O
this	O
may	O
be	O
due	O
to	O
altered	O
intercellular	O
signalling	O
systems	O
and	O
intracellular	O
signal	O
transduction	O
.	O
Glucocorticoids	O
are	O
well	O
known	O
for	O
their	O
effects	O
on	O
the	O
vitality	O
and	O
function	O
of	O
lymphoid	cell_type
cells	cell_type
.	O
Patients	O
with	O
HIV	O
infections	O
often	O
show	O
elevated	O
circulating	O
levels	O
of	O
cortisol	O
,	O
suggesting	O
some	O
misfunction	O
in	O
the	O
regulatory	O
systems	O
that	O
maintain	O
the	O
levels	O
of	O
this	O
critical	O
hormone.	O
At	O
the	O
cellular	O
level,	O
it	O
is	O
known	O
that	O
both	O
acute	O
HIV	O
infection	O
and	O
glucocorticoids	O
can	O
cause	O
apoptotic	O
cell	O
death	O
in	O
thymic	cell_type
lymphocytes	cell_type
.	O
However,	O
chronically	cell_type
HIV	cell_type
-infected	cell_type
cells	cell_type
appear	O
to	O
be	O
resistant	O
to	O
glucocorticoid-evoked	O
cell	O
death	O
.	O
Glucocorticoid	protein
receptor	protein
-ligand	O
binding	O
studies	O
on	O
patients'	O
cells	O
have	O
shown	O
reduced	O
affinity	O
between	O
the	O
receptor	protein
binding	protein
sites	protein
and	O
test	O
steroids	O
.	O
In	O
vitro,	O
chronically	cell_line
HIV	cell_line
-infected	cell_line
cells	cell_line
of	O
the	O
lymphoid	cell_line
CEM	cell_line
line	cell_line
displayed	O
resistance	O
to	O
glucocorticoid-induced	O
apoptosis	O
.	O
These	O
cells	O
showed	O
reduced	O
numbers	O
of	O
binding	protein
sites	protein
with	O
little	O
alteration	O
in	O
apparent	O
affinity	O
between	O
ligand	O
and	O
receptor.	O
Thus	O
it	O
appears	O
that	O
there	O
may	O
often	O
be	O
malfunction	O
of	O
the	O
normal	O
glucocorticoid	O
response	O
in	O
HIV	cell_type
-infected	cell_type
cells	cell_type
probably	O
due	O
to	O
altered	O
interactions	O
between	O
the	O
glucocorticoid	protein
receptor	protein
and	O
its	O
hormone.	O
Such	O
alterations	O
may	O
have	O
clinical	O
consequences	O
,	O
including	O
the	O
possibility	O
of	O
a	O
relatively	O
longer	O
life	O
span	O
of	O
infected	cell_type
CD4+	cell_type
T-lymphocytes	cell_type
,	O
as	O
well	O
as	O
systemic	O
effects	O
of	O
chronically	O
elevated	O
cortisol	O
level	O
.	O

Abundant	O
expression	O
of	O
erythroid	RNA
transcription	RNA
factor	RNA
P45	RNA
NF-E2	RNA
mRNA	RNA
in	O
human	cell_type
peripheral	cell_type
granurocytes	cell_type
.	O
Transcription	protein
factor	protein
NF-E2	protein
is	O
crucial	O
for	O
regulation	O
of	O
erythroid-specific	O
gene	O
expression	O
.	O
p45	protein
subunit	protein
of	O
NF-E2	protein
contains	O
a	O
basic-leucine	protein
zipper	protein
domain	protein
and	O
dimerizes	O
with	O
the	O
small	protein
Maf	protein
family	protein
protein	protein
to	O
form	O
functional	O
NF-E2	protein
complex	protein
.	O
While	O
p45	protein
expression	O
was	O
shown	O
to	O
be	O
restricted	O
to	O
erythroid	cell_type
cells	cell_type
,	O
megakaryocytes	cell_type
and	O
mast	cell_type
cells	cell_type
in	O
hematopoietic	O
lineage	O
,	O
we	O
found	O
in	O
this	O
study	O
that	O
p45	RNA
mRNA	RNA
is	O
abundantly	O
transcribed	O
in	O
the	O
granulocyte	cell_type
fraction	cell_type
of	O
human	cell_type
peripheral	cell_type
blood	cell_type
cells	cell_type
.	O
As	O
neutrophils	cell_type
occupy	O
approximately	O
92%	O
of	O
the	O
cells	O
in	O
granulocyte	cell_type
fraction	cell_type
of	O
human	cell_type
peripheral	cell_type
blood	cell_type
cells	cell_type
.	O
As	O
neutrophils	cell_type
occupy	O
approximately	O
92%	O
of	O
the	O
cells	O
in	O
this	O
fraction,	O
the	O
cells	O
expressing	O
p45	protein
is	O
most	O
likely	O
to	O
be	O
neutrophils	cell_type
.	O
p45	RNA
mRNA	RNA
is	O
also	O
expressed	O
in	O
HL-60	cell_line
promyelocytes	cell_line
,	O
albeit	O
the	O
expression	O
level	O
is	O
much	O
lower	O
than	O
that	O
of	O
the	O
granulocyte	cell_type
fraction	cell_type
.	O
HL-60	cell_line
cells	cell_line
were	O
found	O
to	O
express	O
mafK	RNA
mRNA	RNA
,	O
indicating	O
the	O
presence	O
of	O
genuine	O
NF-E2	protein
complex	protein
in	O
the	O
cells.	O
Although	O
p45	RNA
mRNA	RNA
is	O
transcribed	O
from	O
two	O
different	O
promoters,	O
aNF-E2	DNA
promoter	DNA
and	O
fNF-E2	DNA
promoter	DNA
,	O
in	O
erythroid	O
and	O
megakaryocytic	O
lineage	O
cells	O
,	O
p45	RNA
mRNA	RNA
is	O
transcribed	O
only	O
from	O
aNF-E2	DNA
promoter	DNA
.	O
The	O
expression	O
of	O
p45	protein
megakaryocytic	cell_type
lineage	cell_type
cells	cell_type
,	O
p45	RNA
mRNA	RNA
is	O
transcribed	O
only	O
from	O
aNF-E2	DNA
promoter	DNA
.	O
The	O
expression	O
of	O
p45	RNA
mRNA	RNA
in	O
the	O
neutrophils	cell_type
declined	O
rapidly	O
after	O
transfer	O
of	O
the	O
cells	O
to	O
in	O
vitro	O
culture	O
and	O
G-CSF	protein
could	O
not	O
sustain	O
the	O
expression	O
from	O
the	O
down-regulation,	O
suggesting	O
the	O
E2	protein
may	O
also	O
participate	O
in	O
the	O
regulation	O
of	O
neutrophil-specific	O
gene	O
expression	O
.	O

Expression	O
of	O
c-fos	protein
and	protein
c-jun	protein
proteins	protein
and	O
AP-1	protein
binding	O
activity	O
during	O
cell	O
cycle	O
progression	O
of	O
HL60	cell_line
cells	cell_line
and	O
phytohemagglutinin	cell_line
-stimulated	cell_line
lymphocytes	cell_line
.	O
The	O
protein	O
products	O
of	O
the	O
c-fos	DNA
(	O
p62c-fos	protein
)	O
and	O
c-jun	DNA
(	O
p39c-jun	protein
)	O
genes	O
are	O
members	O
of	O
the	O
AP-1	protein
transcription	protein
factor	protein
family	protein
and	O
are	O
thought	O
to	O
play	O
important	O
roles	O
in	O
the	O
regulation	O
of	O
gene	O
expression	O
during	O
the	O
cell	O
cycle	O
.	O
Most	O
studies	O
on	O
the	O
expression	O
of	O
these	O
proteins	O
in	O
relation	O
to	O
the	O
cell	O
cycle	O
have	O
been	O
performed	O
at	O
the	O
mRNA	O
level	O
,	O
and	O
therefore	O
do	O
not	O
give	O
direct	O
information	O
about	O
the	O
presence	O
of	O
the	O
proteins	O
during	O
the	O
cell	O
cycle	O
.	O
We	O
have	O
used	O
Western	O
blotting	O
to	O
investigate	O
the	O
presence	O
of	O
these	O
proteins	O
during	O
the	O
cell	O
cycles	O
of	O
two	O
different	O
cellular	cell_line
systems	cell_line
:	O
a	O
continuously	cell_line
growing	cell_line
myeloid	cell_line
leukemic	cell_line
cell	cell_line
line	cell_line
,	O
HL60	cell_line
,	O
and	O
normal	cell_type
cells	cell_type
stimulated	O
into	O
cycle,	O
phyto-	cell_line
hemagglutinin	cell_line
(	cell_line
PHA	cell_line
)-stimulated	cell_line
normal	cell_line
human	cell_line
peripheral	cell_line
blood	cell_line
lymphocytes	cell_line
(	O
PBL	cell_type
).	O
The	O
binding	O
activity	O
of	O
transcription	O
factor	O
AP-1	protein
,	O
which	O
consists	O
of	O
dimers	O
of	O
Fos	O
and	O
Jun	O
family	O
proteins	O
,	O
was	O
also	O
studied	O
using	O
a	O
gel	O
shift	O
assay	O
.	O
We	O
found	O
nuclear	O
p62c-fos	protein
,	O
p39c-jun	protein
,	O
and	O
AP-1	protein
binding	O
activity	O
throughout	O
the	O
cell	O
cycle	O
both	O
in	O
HL60	cell_line
cells	cell_line
and	O
in	O
PHA	cell_line
-stimulated	cell_line
PBL	cell_line
,	O
and	O
we	O
postulate	O
that	O
these	O
proteins	O
are	O
required	O
throughout	O
the	O
cell	O
cycle	O
and	O
not	O
transiently	O
in	O
the	O
G0	O
to	O
G1	O
transition	O
as	O
previous	O
mRNA	O
studies	O
have	O
indicated.	O
We	O
demonstrated	O
an	O
uncoupling	O
of	O
AP-1	protein
binding	O
activity	O
from	O
p62c-fos	protein
,	O
and	O
p39c-jun	protein
AP-1	protein
activity	O
was	O
expressed	O
more	O
strongly	O
in	O
the	O
G1-	O
and	O
G2/M-	O
phase	O
enriched	O
samples	O
than	O
in	O
the	O
S-phase	O
enriched	O
samples	O
of	O
HL60	cell_line
cells	cell_line
,	O
while	O
levels	O
of	O
nuclear	O
p62c-fos	O
and	O
p39c-jun	O
were	O
constant.	O
Nuclei	O
of	O
unstimulated	cell_type
PBL	cell_type
from	O
different	O
donors	O
expressed	O
p62c-fos	protein
and	O
p39c-jun	protein
,	O
but	O
AP-1	protein
was	O
not	O
detected	O
in	O
the	O
majority	O
of	O
samples.	O
Following	O
PHA	protein
stimulation	O
of	O
PBL	cell_type
,	O
the	O
increase	O
in	O
AP-1	protein
activity	O
was	O
delayed	O
with	O
respect	O
to	O
the	O
augmentation	O
of	O
p39c-jun	protein
expression	O
.	O
We	O
also	O
observed	O
that	O
cytoplasmic	O
p62c-fos	O
and	O
p39c-jun	O
were	O
present	O
in	O
HL60	cell_line
cells	cell_line
and	O
PHA	cell_line
-stimulated	cell_line
PBL	cell_line
.	O
However,	O
no	O
cytoplasmic	protein
p62c-fos	protein
was	O
detected	O
in	O
unstimulated	cell_type
PBL	cell_type
,	O
although	O
in	O
some	O
cases	O
cytoplasmic	protein
p39c-jun	protein
was	O
detected,	O
suggesting	O
that	O
subcellular	O
compartmentalization	O
of	O
these	O
proteins	protein
may	O
occur	O
under	O
certain	O
circumstances.	O

Octamer	protein
binding	protein
factors	protein
and	O
their	O
coactivator	protein
can	O
activate	O
the	O
murine	DNA
PU.1	DNA
(spi-1)	DNA
promoter	DNA
.	O
PU.1	protein
(	O
spi-1	protein
),	O
a	O
member	O
of	O
the	O
Ets	protein
transcription	protein
factor	protein
family	protein
,	O
is	O
predominantly	O
expressed	O
in	O
myeloid	O
and	O
B	O
cells	O
,	O
activates	O
many	O
B	O
cell	O
and	O
myeloid	O
genes	O
,	O
and	O
is	O
critical	O
for	O
development	O
of	O
both	O
of	O
these	O
lineages.	O
Our	O
previous	O
studies	O
(Chen,	O
H.M.,	O
Ray-Gallet,	O
D.,	O
Zhang,	O
P.,	O
Hetherington,	O
C.J.,	O
Gonzalez,	O
D.A.,	O
Zhang,	O
D.-E.,	O
Moreau-Gachelin,	O
F.,	O
and	O
Tenen,	O
D.G.(1995)	O
Oncogene	O
11,	O
1549-1560)	O
demonstrate	O
that	O
the	O
PU.1	DNA
promoter	DNA
directs	O
cell	DNA
type-specific	DNA
reporter	DNA
gene	DNA
expression	O
in	O
myeloid	O
cell	O
lines,	O
and	O
that	O
PU.1	protein
activates	O
its	O
own	O
promoter	O
in	O
an	O
autoregulatory	O
loop	O
.	O
Here	O
we	O
show	O
that	O
the	O
murine	DNA
PU.1	DNA
promoter	DNA
is	O
also	O
specifically	O
and	O
highly	O
functional	O
in	O
B	cell_line
cell	cell_line
lines	cell_line
as	O
well.	O
Oct-1	protein
and	O
Oct-2	protein
can	O
bind	O
specifically	O
to	O
a	O
site	O
at	O
base	O
pair	O
-55	O
in	O
vitro,	O
and	O
this	O
site	O
is	O
specifically	O
protected	O
in	O
B	cell_type
cells	cell_type
in	O
vivo.	O
We	O
also	O
demonstrate	O
that	O
two	O
other	O
sites	O
contribute	O
to	O
promoter	O
activity	O
in	O
B	cell_type
cells	cell_type
;	O
an	O
Sp1	DNA
binding	DNA
site	DNA
adjacent	O
to	O
the	O
octamer	DNA
site	DNA
,	O
and	O
the	O
PU.1	DNA
autoregulatory	DNA
site	DNA
.	O
Finally,	O
we	O
show	O
that	O
the	O
B	O
cell	O
coactivator	protein
OBF-1/Bob1/OCA-B	protein
is	O
only	O
expressed	O
in	O
B	cell_type
cells	cell_type
and	O
not	O
in	O
myeloid	cell_type
cells	cell_type
,	O
and	O
that	O
OBF-1/Bob1/OCA-B	protein
can	O
transactivate	O
the	O
PU.1	DNA
promoter	DNA
in	O
HeLa	cell_line
and	O
myeloid	cell_type
cells	cell_type
.	O
This	O
B	protein
cell	protein
restricted	protein
coactivator	protein
may	O
be	O
responsible	O
for	O
the	O
B	O
cell	O
specific	O
expression	O
of	O
PU.1	protein
mediated	O
by	O
the	O
octamer	DNA
site	DNA
.	O

Inhibition	O
of	O
p105	protein
processing	O
by	O
NF-kappaB	protein
proteins	protein
in	O
transiently	cell_line
transfected	cell_line
cells	cell_line
.	O
Regulation	O
of	O
the	O
transcription	O
factor	O
NF-kappaB	protein
involves	O
proteasome-mediated	O
processing	O
of	O
the	O
NF-kappaB1	protein
p105	protein
precursor	protein
protein	protein
,	O
which	O
generates	O
the	O
p50	protein
subunit	protein
of	O
NF-kappaB	protein
.	O
The	O
processing	O
of	O
p105	protein
occurs	O
constitutively	O
in	O
vivo	O
but	O
can	O
be	O
markedly	O
enhanced	O
by	O
various	O
cellular	O
activation	O
agents	O
,	O
although	O
the	O
underlying	O
regulatory	O
mechanism	O
is	O
not	O
yet	O
clear.	O
In	O
the	O
present	O
study,	O
we	O
demonstrate	O
that	O
signal-mediated	O
induction	O
of	O
p105	protein
processing	O
in	O
human	cell_type
T	cell_type
cells	cell_type
is	O
associated	O
with	O
de	O
novo	O
synthesis	O
of	O
this	O
precursor	protein
protein	protein
.	O
Transient	O
transfection	O
studies	O
performed	O
in	O
COS7	cell_line
cells	cell_line
revealed	O
that	O
the	O
newly	O
synthesized	O
p105	protein
protein	O
appears	O
to	O
be	O
more	O
rapidly	O
processed	O
compared	O
to	O
its	O
accumulated	O
form	O
that	O
is	O
already	O
associated	O
with	O
the	O
processed	O
product	O
p50	protein
.	O
Interestingly,	O
the	O
processing	O
rate	O
of	O
p105	protein
is	O
markedly	O
inhibited	O
in	O
cells	O
co-transfected	O
with	O
p50	protein
or	O
other	O
NF-kappaB	protein
subunits	protein
,	O
including	O
RelA	protein
and	O
c-Rel	protein
,	O
that	O
physically	O
interact	O
with	O
p105	protein
.	O
These	O
findings	O
suggest	O
that	O
the	O
processing	O
of	O
p105	protein
is	O
subject	O
to	O
negative	O
regulation	O
by	O
the	O
various	O
NF-kappaB	protein
subunits	protein
.	O
We	O
further	O
demonstrate	O
that	O
p105	protein
undergoes	O
degradation	O
in	O
lipopolysaccharide	cell_line
-stimulated	cell_line
human	cell_line
monocytic	cell_line
cells	cell_line
.	O
However,	O
the	O
inducible	O
degradation	O
of	O
p105	protein
is	O
not	O
coupled	O
with	O
the	O
generation	O
of	O
p50	protein
.	O
Together,	O
these	O
studies	O
demonstrate	O
that	O
the	O
processing	O
and	O
inducible	O
degradation	O
of	O
p105	protein
are	O
differentially	O
regulated.	O

Identification	O
of	O
an	O
inducible	protein
regulator	protein
of	O
c-myb	DNA
expression	O
during	O
T-cell	cell_type
activation	O
.	O
Resting	cell_type
T	cell_type
cells	cell_type
express	O
very	O
low	O
levels	O
of	O
c-Myb	protein
protein	protein
.	O
During	O
T-cell	O
activation	O
,	O
c-myb	DNA
expression	O
is	O
induced	O
and	O
much	O
of	O
the	O
increase	O
in	O
expression	O
occurs	O
at	O
the	O
transcriptional	O
level	O
.	O
We	O
identified	O
a	O
region	O
of	O
the	O
c-myb	DNA
5'	DNA
flanking	DNA
sequence	DNA
that	O
increased	O
c-myb	DNA
expression	O
during	O
T-cell	O
activation	O
.	O
In	O
vivo	O
footprinting	O
by	O
ligation-mediated	O
PCR	O
was	O
performed	O
to	O
correlate	O
in	O
vivo	O
protein	O
binding	O
with	O
functional	O
activity	O
.	O
A	O
protein	O
footprint	O
was	O
visible	O
over	O
this	O
region	O
of	O
the	O
c-myb	DNA
5'	DNA
flanking	DNA
sequence	DNA
in	O
activated	cell_type
T	cell_type
cells	cell_type
but	O
not	O
in	O
unactivated	cell_type
T	cell_type
cells	cell_type
.	O
An	O
electrophoretic	O
mobility	O
shift	O
assay	O
(	O
EMSA	O
)	O
with	O
nuclear	O
extract	O
from	O
activated	cell_type
T	cell_type
cells	cell_type
and	O
an	O
oligonucleotide	O
of	O
this	O
binding	O
site	O
demonstrated	O
a	O
new	O
protein-DNA	protein
complex	protein
,	O
referred	O
to	O
as	O
CMAT	protein
for	O
c-myb	protein
in	protein
activated	protein
T	protein
cells	protein
;	O
this	O
complex	O
was	O
not	O
present	O
in	O
unactivated	cell_type
T	cell_type
cells	cell_type
.	O
Because	O
the	O
binding	DNA
site	DNA
showed	O
some	O
sequence	O
similarity	O
with	O
the	O
nuclear	DNA
factor	DNA
of	DNA
activated	DNA
T	DNA
cells	DNA
(	DNA
NFAT	DNA
)	DNA
binding	DNA
site	DNA
,	O
we	O
compared	O
the	O
kinetics	O
of	O
induction	O
of	O
the	O
two	O
binding	O
complexes	O
and	O
the	O
molecular	O
masses	O
of	O
the	O
two	O
proteins.	O
Studies	O
of	O
the	O
kinetics	O
of	O
induction	O
showed	O
that	O
the	O
NFAT	protein
EMSA	protein
binding	protein
complex	protein
appeared	O
earlier	O
than	O
the	O
CMAT	protein
complex	protein
.	O
The	O
NFAT	protein
protein	O
migrated	O
more	O
slowly	O
in	O
a	O
sodium	O
dodecyl	O
sulfate-polyacrylamide	O
gel	O
than	O
the	O
CMAT	protein
protein	protein
did.	O
In	O
addition,	O
an	O
antibody	O
against	O
NFAT	protein
did	O
not	O
cross-react	O
with	O
the	O
CMAT	protein
protein	protein
.	O
The	O
appearance	O
of	O
the	O
CMAT	protein
binding	protein
complex	protein
was	O
inhibited	O
by	O
both	O
cyclosporin	O
A	O
and	O
rapamycin	O
.	O
The	O
CMAT	protein
protein	O
appears	O
to	O
be	O
a	O
novel	O
inducible	O
protein	O
involved	O
in	O
the	O
regulation	O
of	O
c-myb	DNA
expression	O
during	O
T-cell	O
activation	O
.	O

CNI-1493	O
inhibits	O
monocyte/macrophage	protein
tumor	protein
necrosis	protein
factor	protein
by	O
suppression	O
of	O
translation	O
efficiency	O
.	O
Tumor	protein
necrosis	protein
factor	protein
(	O
TNF	protein
)	O
mediates	O
a	O
wide	O
variety	O
of	O
disease	O
states	O
including	O
septic	O
shock	O
,	O
acute	O
and	O
chronic	O
inflammation	O
,	O
and	O
cachexia	O
.	O
Recently,	O
a	O
multivalent	O
guanylhydrazone	O
(	O
CNI-1493	O
)	O
developed	O
as	O
an	O
inhibitor	O
of	O
macrophage	O
activation	O
was	O
shown	O
to	O
suppress	O
TNF	protein
production	O
and	O
protect	O
against	O
tissue	O
inflammation	O
and	O
endotoxin	O
lethality	O
[Bianchi,	O
M.,	O
Ulrich,	O
P.,	O
Bloom,	O
O.,	O
Meistrell,	O
M.,	O
Zimmerman,	O
G.A.,	O
Schmidtmayerova,	O
H.,	O
Bukrinsky,	O
M.,	O
Donnelley,	O
T.,	O
Bucala,	O
R.,	O
Sherry,	O
B.,	O
Manogue,	O
K.R.,	O
Tortolani,	O
A.J.,	O
Cerami,	O
A.&amp;	O
Tracey,	O
K.J.(1995)	O
Mol.Med.1,	O
254-266,	O
and	O
Bianchi,	O
M.,	O
Bloom,	O
O.,	O
Raabe,	O
T.,	O
Cohen,	O
P.	O
S.,	O
Chesney,	O
J.,	O
Sherry,	O
B.,	O
Schmidtmayerova,	O
H.,	O
Zhang,	O
X.,	O
Bukrinsky,	O
M.,	O
Ulrich,	O
P.,	O
Cerami,	O
A.&amp;	O
Tracey,	O
J.(1996)	O
J.Exp.Med.,	O
in	O
press].	O
We	O
have	O
now	O
elucidated	O
the	O
mechanism	O
by	O
which	O
CNI-1493	O
inhibits	O
macrophage	O
TNF	protein
synthesis	O
and	O
show	O
here	O
that	O
it	O
acts	O
through	O
suppression	O
of	O
TNF	protein
translation	O
efficiency	O
.	O
CNI-1493	O
blocked	O
neither	O
the	O
lipopolysaccharide	O
(LPS)-induced	O
increases	O
in	O
the	O
expression	O
of	O
TNF	RNA
mRNA	RNA
nor	O
the	O
translocation	O
of	O
nuclear	protein
factor	protein
NF-kappa	protein
B	protein
to	O
the	O
nucleus	O
in	O
macrophages	cell_type
activated	O
by	O
15	O
min	O
of	O
LPS	O
stimulation	O
,	O
indicating	O
that	O
CNI-1493	O
does	O
not	O
interfere	O
with	O
early	O
NF-kappa	protein
B	protein
-mediated	O
transcriptional	O
regulation	O
of	O
TNF	protein
.	O
However,	O
synthesis	O
of	O
the	O
26-kDa	protein
membrane	protein
form	protein
of	O
TNF	protein
was	O
effectively	O
blocked	O
by	O
CNI-1493	O
.	O
Further	O
evidence	O
for	O
the	O
translational	O
suppression	O
of	O
TNF	protein
is	O
given	O
by	O
experiments	O
using	O
chloram-phenicol	DNA
acetyltransferase	DNA
(CAT)	DNA
constructs	DNA
containing	O
elements	O
of	O
the	O
TNF	DNA
gene	DNA
that	O
are	O
involved	O
in	O
TNF	protein
translational	O
regulation	O
.	O
Both	O
the	O
5'	O
and	O
3'	O
untranslated	O
regions	O
of	O
the	O
TNF	DNA
gene	DNA
were	O
required	O
to	O
elicit	O
maximal	O
translational	O
suppression	O
by	O
CNI-1493	O
.	O
Identification	O
of	O
the	O
molecular	O
target	O
through	O
which	O
CNI-	O
1493	O
inhibits	O
TNF	protein
translation	O
should	O
provide	O
insight	O
into	O
the	O
regulation	O
of	O
macrophage	O
activation	O
and	O
mechanisms	O
of	O
inflammation	O
.	O

Soluble	protein
tumor	protein
necrosis	protein
factor	protein
receptors	protein
inhibit	O
phorbol	O
myristate	O
acetate	O
and	O
cytokine-induced	O
HIV-1	O
expression	O
chronically	O
infected	cell_type
U1	cell_type
cells	cell_type
.	O
Recombinant	protein
human	protein
tumor	protein
necrosis	protein
factor	protein
(	protein
TNF	protein
)	protein
binding	protein
protein-1	protein
(	O
r-h	protein
TBP-1	protein
)	O
and	O
recombinant	protein
human	protein
soluble	protein
dimeric	protein
TNF	protein
receptor	protein
(	O
rhu	protein
TNFR:Fc	protein
)	O
were	O
used	O
to	O
determine	O
the	O
relative	O
contributions	O
of	O
TNF	protein
to	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
and	O
cytokine-induced	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
replication	O
in	O
chronically	O
infected	O
cell	O
lines.	O
Treatment	O
of	O
HIV-1	cell_type
-infected	cell_type
promonocytic	cell_type
U1	cell_type
cells	cell_type
with	O
r-h-TBP-1	protein
or	O
rhu	protein
TNFR:Fc	protein
reduced	O
PMA	O
-induced	O
HIV-1	protein
p24	protein
antigen	protein
production	O
in	O
a	O
concentration-dependent	O
manner,	O
with	O
a	O
maximal	O
inhibition	O
of	O
approximately	O
90%.	O
Maximal	O
inhibition	O
of	O
p24	protein
antigen	protein
production	O
in	O
T-lymphocytic	cell_line
ACH-2	cell_line
cells	cell_line
was	O
47%	O
with	O
r-hTBP-1	protein
and	O
42%	O
with	O
rhu	protein
TNFR:Fc	protein
.	O
r-hTBP-1	protein
and	O
rhu	protein
TNFR:Fc	protein
also	O
decreased	O
p24	protein
antigen	protein
synthesized	O
by	O
U1	cell_line
cells	cell_line
in	O
response	O
to	O
other	O
stimuli,	O
including	O
phytohemagglutinin	protein
(	protein
PHA	protein
)-induced	protein
supernatant	protein
,	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
,	O
interleukin-6	protein
,	O
and	O
TNF	protein
.	O
Addition	O
of	O
r-hTBP-1	protein
to	O
U1	cell_line
cells	cell_line
during	O
the	O
last	O
4	O
h	O
of	O
a	O
24	O
h	O
incubation	O
with	O
PMA	O
still	O
inhibited	O
p24	protein
antigen	protein
production	O
by	O
15%.	O
U1	cell_line
cells	cell_line
stimulated	O
with	O
10(-7)	O
M	O
PMA	O
released	O
approximately	O
1	O
ng/ml	O
endogenous	protein
TBP-1	protein
with	O
an	O
initial	O
peak	O
observed	O
at	O
1	O
h	O
and	O
a	O
second	O
peak	O
at	O
24	O
h	O
after	O
PMA	O
stimulation.	O
r-hTBP-1	protein
also	O
partially	O
reversed	O
inhibition	O
of	O
U1	O
cellular	O
proliferation	O
caused	O
by	O
PMA	O
.	O
Both	O
r-hTBP-1	protein
and	O
rhu	protein
TNFR:Fc	protein
blocked	O
PMA	O
induction	O
of	O
nuclear	protein
factor	protein
(NK)-	protein
kappa	protein
B	protein
DNA-binding	O
activity	O
in	O
U1	cell_line
cells	cell_line
in	O
association	O
with	O
decreases	O
in	O
HIV-1	O
replication	O
.	O
We	O
conclude	O
that	O
soluble	O
TNF	O
receptors	O
can	O
inhibit	O
stimuli-induced	O
HIV-1	O
expression	O
and	O
NK-	protein
kappa	protein
B	protein
DNA-binding	O
activity	O
in	O
chronically	O
infected	cell_type
U1	cell_type
cells	cell_type
.	O

Transcriptional	O
activation	O
of	O
RNA	DNA
polymerase	DNA
III-dependent	DNA
genes	DNA
by	O
the	O
human	protein
T-cell	protein
leukemia	protein
virus	protein
type	protein
1	protein
tax	protein
protein	protein
.	O
The	O
human	protein
T-cell	protein
leukemia	protein
virus	protein
-encoded	protein
tax	protein
protein	protein
is	O
a	O
potent	O
activator	O
of	O
many	O
viral	O
and	O
cellular	O
genes	O
transcribed	O
by	O
RNA	protein
polymerase	protein
II	protein
.	O
We	O
find	O
that	O
both	O
chromatin	DNA
and	O
cell	O
extracts	O
derived	O
from	O
human	cell_line
T-cell	cell_line
leukemia	cell_line
virus	cell_line
type	cell_line
1	cell_line
-infected	cell_line
human	cell_line
T	cell_line
lymphocytes	cell_line
support	O
higher	O
levels	O
of	O
5S	O
rRNA	O
and	O
tRNA	O
gene	O
transcription	O
than	O
chromatin	DNA
or	O
extracts	O
from	O
uninfected	cell_type
T	cell_type
lymphocytes	cell_type
.	O
The	O
viral	protein
protein	protein
Tax	protein
was	O
likely	O
responsible	O
for	O
this	O
higher	O
level	O
of	O
class	DNA
II	DNA
gene	DNA
transcription	O
,	O
as	O
purified	protein
Tax	protein
was	O
found	O
to	O
stimulate	O
both	O
genes	O
when	O
added	O
to	O
the	O
uninfected	O
cell	O
extract	O
or	O
in	O
reconstituted	O
systems	O
.	O
Both	O
limiting-component	O
transcription	O
assays	O
and	O
DNA	O
binding	O
assays	O
identified	O
the	O
class	protein
III	protein
gene	protein
transcription	protein
factor	protein
TFIIIB	protein
as	O
the	O
principle	O
target	O
of	O
Tax	protein
activity	O
.	O
Surprisingly,	O
we	O
find	O
that	O
Tax	protein
increases	O
the	O
effective	O
concentration	O
of	O
active	protein
TFIIIB	protein
molecules	protein
.	O
These	O
data	O
suggest	O
that	O
Tax	protein
stimulates	O
RNA	DNA
polymerase	DNA
III-dependent	DNA
gene	DNA
expression	O
by	O
accelerating	O
the	O
rate	O
and/or	O
extent	O
of	O
transcription	protein
initiation	protein
complex	protein
assembly	O
.	O

Expression	O
of	O
Retinoid	protein
X	protein
Receptor	protein
alpha	protein
is	O
increased	O
upon	O
monocytic	O
cell	O
differentiation	O
.	O
1	O
alpha,	O
25-Dihydroxyvitamin	O
D3	O
(	O
VD	O
)	O
is	O
a	O
potent	O
inducer	O
of	O
monocytic	O
differentiation	O
of	O
both	O
normal	O
and	O
leukemic	O
cells	O
.	O
Its	O
effects	O
are	O
mediated	O
by	O
its	O
nuclear	protein
receptor	protein
(	O
VDR	protein
).	O
Efficient	O
gene	O
activation	O
requires	O
the	O
heterodimerization	O
of	O
VDR	protein
with	O
Retinoid	protein
X	protein
Receptors	protein
(	O
RXR	protein
).	O
In	O
the	O
present	O
study	O
using	O
specific	protein
antibodies	protein
,	O
we	O
analyzed	O
the	O
expression	O
of	O
the	O
RXR	protein
alpha	protein
protein	protein
in	O
blood	cell_type
mononuclear	cell_type
cells	cell_type
from	O
acute	O
myeloid	O
patients	O
(	O
AML	O
)	O
(10	O
cases)	O
and	O
from	O
myelomonocytic	cell_line
cell	cell_line
lines	cell_line
arrested	O
at	O
different	O
stages	O
of	O
differentiation.	O
We	O
observed	O
that	O
the	O
RXR	protein
alpha	protein
expression	O
increased	O
during	O
myelomonocytic	O
differentiation	O
,	O
since	O
the	O
highest	O
levels	O
were	O
found	O
in	O
AML	O
samples	O
and	O
in	O
myelomonocytic	cell_line
cell	cell_line
lines	cell_line
having	O
the	O
highest	O
amounts	O
of	O
monocytic	cell_type
precursors	cell_type
.	O
We	O
also	O
demonstrated	O
that	O
fresh	O
leukemic	cell_type
cells	cell_type
,	O
whatever	O
their	O
stage	O
of	O
differentiation,	O
as	O
well	O
as	O
myelomonocytic	cell_line
cell	cell_line
lines	cell_line
,	O
respond	O
to	O
VD	O
by	O
an	O
increase	O
in	O
RXR	protein
alpha	protein
levels.	O
Combinations	O
of	O
all-trans	O
retinoic	O
acid	O
(	O
RA	O
)	O
and	O
VD	O
,	O
in	O
some	O
cases,	O
increased	O
this	O
effect.	O
This	O
response	O
suggests	O
the	O
involvement	O
of	O
RXR	protein
alpha	protein
in	O
monocytic	O
differentiation	O
upon	O
VD	O
treatment	O
.	O

Expression	O
of	O
p13MTCP1	protein
is	O
restricted	O
to	O
mature	O
T-cell	O
proliferations	O
with	O
t(X;14)	O
translocations	O
.	O
T-cell	O
prolymphocytic	O
leukemia	O
(	O
T-PLL	O
),	O
a	O
rare	O
form	O
of	O
mature	O
T-cell	O
leukemias	O
,	O
and	O
ataxia	O
telangiectasia	O
clonal	O
proliferation	O
,	O
a	O
related	O
condition	O
occurring	O
in	O
patients	O
suffering	O
from	O
ataxia	O
telangiectasia	O
,	O
have	O
been	O
associated	O
to	O
translocations	O
involving	O
the	O
14q32.1	DNA
or	O
Xq28	DNA
regions	DNA
,	O
where	O
are	O
located	O
the	O
TCL1	DNA
and	DNA
MTCP1	DNA
putative	DNA
oncogenes	DNA
,	O
respectively.	O
The	O
MTCP1	DNA
gene	DNA
is	O
involved	O
in	O
the	O
t(X;14)(q28;q11)	DNA
translocation	DNA
associated	O
with	O
these	O
T-cell	O
proliferations	O
.	O
Alternative	O
splicing	O
generates	O
type	O
A	O
and	O
B	O
transcripts	O
that	O
potentially	O
encode	O
two	O
entirely	O
distinct	O
proteins;	O
type	O
A	RNA
transcripts	RNA
code	O
for	O
a	O
small	O
mitochondrial	protein
protein	protein
,	O
p8MTCP1	protein
,	O
and	O
type	RNA
B	RNA
transcripts	RNA
,	O
containing	O
an	O
additional	O
open	DNA
reading	DNA
frame	DNA
,	O
may	O
code	O
for	O
107	protein
amino-acid	protein
protein	protein
,	O
p13MTCP1	protein
.	O
The	O
recently	O
cloned	O
TCL1	DNA
gene	DNA
,	O
also	O
involved	O
in	O
translocations	O
and	O
inversions	O
associated	O
with	O
T-cell	O
proliferations	O
,	O
codes	O
for	O
a	O
14-kD	protein
protein	protein
that	O
displays	O
significant	O
homology	O
with	O
p13MTCP1	protein
.	O
We	O
have	O
generated	O
rabbit	O
antisera	O
against	O
this	O
putative	O
p13MTCP1	protein
protein	protein
and	O
screened	O
for	O
expression	O
of	O
p13MTCP1	protein
normal	O
lymphoid	O
tissues	O
and	O
33	O
cases	O
of	O
immature	O
and	O
mature	O
lymphoid	O
T-cell	O
proliferations	O
using	O
a	O
sensitive	O
Western	O
blot	O
assay	O
.	O
We	O
also	O
investigated	O
the	O
MTCP1	DNA
locus	DNA
configuration	O
by	O
Southern	O
blot	O
analysis	O
.	O
The	O
p13MTCP1	protein
protein	protein
was	O
detected	O
in	O
the	O
three	O
T-cell	O
proliferations	O
with	O
MTCP1	DNA
rearrangements	DNA
because	O
of	O
t(X;14)	O
translocations	O
,	O
but	O
neither	O
in	O
normal	O
resting	O
and	O
activated	cell_type
lymphocytes	cell_type
nor	O
in	O
the	O
other	O
T-cell	cell_type
leukemias	O
.	O
Our	O
data	O
support	O
the	O
hypothesis	O
that	O
p13MTCP1	protein
and	O
p14TCL1	protein
form	O
a	O
new	O
protein	protein
family	protein
that	O
plays	O
a	O
key	O
role	O
in	O
the	O
pathogenesis	O
of	O
T-PLL	O
and	O
related	O
conditions.	O

Preassociation	O
of	O
STAT1	protein
with	O
STAT2	protein
and	O
STAT3	protein
in	O
separate	O
signalling	protein
complexes	protein
prior	O
to	O
cytokine	protein
stimulation	O
.	O
A	O
variety	O
of	O
cytokines	protein
and	O
growth	protein
factors	protein
act	O
through	O
an	O
induction	O
of	O
gene	O
expression	O
mediated	O
by	O
a	O
family	O
of	O
latent	protein
transcription	protein
factors	protein
called	O
STAT	protein
(signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription)	protein
proteins	protein
.	O
Ligand-induced	O
tyrosine	O
phosphorylation	O
of	O
the	O
STATs	protein
promotes	O
their	O
homodimer	O
and	O
heterodimer	O
formation	O
and	O
subsequent	O
nuclear	O
translocation	O
.	O
We	O
demonstrate	O
here	O
that	O
STAT	protein
protein	protein
heterocomplexes	protein
exist	O
prior	O
to	O
cytokine	protein
treatment	O
.	O
When	O
unstimulated	cell_line
HeLa	cell_line
cells	cell_line
are	O
ruptured	O
in	O
hypotonic	O
buffer	O
without	O
salt	O
or	O
detergent	O
,	O
immunoadsorption	O
of	O
either	O
STAT1	protein
or	O
STAT2	protein
from	O
the	O
resulting	O
cytosol	O
yields	O
coimmunoadsorption	O
of	O
the	O
other	O
STAT	protein
protein	protein
.	O
Similarly,	O
STAT1	protein
-STAT3	protein
heterocomplexes	O
are	O
coimmunoadsorbed	O
from	O
hypotonic	O
cytosol	O
.	O
STAT1	protein
and	O
STAT2	protein
or	O
STAT1	protein
and	O
STAT3	protein
translated	O
in	O
reticulocyte	O
lysate	O
spontaneously	O
form	O
heterocomplexes	O
when	O
the	O
translation	O
lysates	O
are	O
mixed	O
at	O
0	O
degrees	O
C.	O
Our	O
data	O
suggest	O
that	O
interferon-alpha	protein
/beta-induced	O
tyrosine	O
phosphorylation	O
increases	O
the	O
stability	O
of	O
a	O
preexisting,	O
latent,	O
STAT1	protein
-	O
STAT2	protein
signaling	protein
complex	protein
.	O
Newly	O
translated	O
STAT1	protein
binds	O
in	O
equilibrium	O
fashion	O
to	O
STAT2	protein
and	O
STAT3	protein
,	O
but	O
we	O
show	O
that	O
STAT2	protein
and	O
STAT3	protein
exist	O
in	O
separate	O
heterocomplexes	protein
with	O
STAT1	protein
,	O
consistent	O
with	O
a	O
model	O
in	O
which	O
STAT1	protein
contains	O
a	O
common	O
binding	O
site	O
for	O
other	O
STAT	protein
proteins	protein
.	O

Interferon-gamma	protein
modulates	O
the	O
lipopolysaccharide	O
-induced	O
expression	O
of	O
AP-1	protein
and	O
NF-kappa	protein
B	protein
at	O
the	O
mRNA	O
and	O
protein	O
level	O
in	O
human	cell_type
monocytes	cell_type
.	O
Interferon-gamma	protein
(	O
IFN-gamma	protein
)	O
modulates	O
the	O
expression	O
of	O
several	O
cytokines	protein
by	O
human	cell_type
monocytes	cell_type
at	O
the	O
transcriptional	O
level	O
.	O
In	O
view	O
of	O
these	O
findings,	O
we	O
analyzed	O
the	O
effects	O
of	O
IFN-gamma	protein
on	O
the	O
expression	O
of	O
different	O
transcription	protein
factors	protein
in	O
activated	O
human	cell_type
monocytes	cell_type
.	O
Priming	O
of	O
human	cell_type
monocytes	cell_type
with	O
IFN-gamma	protein
resulted	O
in	O
the	O
down	O
regulation	O
of	O
c-fos	O
and	O
c-jun	O
mRNA	O
in	O
response	O
to	O
stimulation	O
with	O
lipopolysaccharide	O
(	O
LPS	O
)	O
compared	O
to	O
the	O
effects	O
of	O
LPS	O
alone.	O
Not	O
only	O
was	O
this	O
effect	O
observed	O
at	O
the	O
mRNA	O
level	O
,	O
but	O
activator	protein
protein-1	protein
(	O
AP-1	protein
)	O
DNA	O
binding	O
capacity	O
was	O
affected	O
as	O
well,	O
A	O
strong	O
reduction	O
was	O
observed	O
in	O
the	O
LPS	O
-induced	O
DNA-binding	O
activity	O
of	O
AP-1	protein
in	O
the	O
presence	O
of	O
IFN-gamma	protein
.	O
LPS	cell_type
-stimulated	cell_type
monocytes	cell_type
showed	O
an	O
increased	O
expression	O
of	O
p105	RNA
mRNA	RNA
,	O
the	O
precursor	O
of	O
the	O
p50	protein
subunit	protein
of	O
the	O
transcription	protein
factor	protein
nuclear	protein
factor-kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
),	O
while	O
no	O
effect	O
was	O
noticed	O
on	O
the	O
expression	O
of	O
p65	RNA
mRNA	RNA
.	O
In	O
contrast,	O
IFN-gamma	protein
priming	O
did	O
not	O
affect	O
the	O
expression	O
of	O
p105	RNA
transcripts	RNA
but	O
enhanced	O
the	O
expression	O
of	O
p65	RNA
mRNA	RNA
(two-fold).	O
Priming	O
with	O
IFN-gamma	protein
followed	O
by	O
LPS	O
stimulation	O
resulted	O
in	O
a	O
further	O
increase	O
in	O
the	O
expression	O
of	O
p65	RNA
mRNA	RNA
.	O
This	O
was	O
due	O
to	O
an	O
increase	O
in	O
the	O
half-life	O
of	O
p65	RNA
mRNA	RNA
(75	O
vs	O
150	O
minutes).	O
Electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSAs	O
)	O
demonstrated	O
that	O
unstimulated	O
monocytes	O
predominantly	O
expressed	O
p50	protein
NF-kappa	protein
B	protein
.	O
Stimulation	O
with	O
LPS	O
or	O
IFN-gamma	protein
resulted	O
in	O
the	O
expression	O
of	O
p50	protein
and	O
p65	protein
subunits	protein
,	O
while	O
the	O
combination	O
of	O
IFN-gamma	protein
plus	O
LPS	O
caused	O
a	O
further	O
increase	O
in	O
the	O
expression	O
of	O
NF-kappa	protein
B	protein
.	O
With	O
Western	O
blotting	O
,	O
it	O
was	O
shown	O
that	O
nuclear	O
extracts	O
from	O
monocytes	cell_type
contained	O
p50	protein
and	O
p65	protein
protein	protein
in	O
response	O
to	O
LPS	O
and	O
IFN-gamma	protein
stimulation	O
.	O
However,	O
the	O
combined	O
stimulation	O
did	O
not	O
result	O
in	O
enhanced	O
p50	protein
and	O
p65	protein
protein	protein
expression.	O
The	O
effects	O
of	O
IFN-gamma	protein
on	O
the	O
transcription	protein
factors	protein
were	O
specific,	O
since	O
no	O
change	O
was	O
observed	O
in	O
the	O
expression	O
of	O
NF-IL-6	protein
or	O
I	protein
kappa	protein
B	protein
alpha	protein
,	O
the	O
inhibitor	O
of	O
NF-kappa	protein
B	protein
.	O
We	O
conclude	O
that	O
the	O
effects	O
of	O
IFN-gamma	protein
on	O
the	O
expression	O
of	O
the	O
transcription	protein
factors	protein
AP-1	protein
and	O
NF-kappa	protein
B	protein
may	O
be	O
important	O
for	O
the	O
modulatory	O
effects	O
of	O
IFN-gamma	protein
on	O
the	O
cytokine	protein
expression	O
in	O
activated	O
human	cell_type
monocytes	cell_type
.	O

HIV-1	protein
tat	protein
induces	O
the	O
expression	O
of	O
a	O
new	O
hematopoietic	protein
cell-specific	protein
transcription	protein
factor	protein
and	O
downregulates	O
MIP-1	DNA
alpha	DNA
gene	DNA
expression	O
in	O
activated	cell_type
T-cells	cell_type
.	O
MIP-1	protein
alpha	protein
is	O
a	O
secreted	O
chemokine	protein
which	O
can	O
inhibit	O
hematopoietic	cell_type
stem	cell_type
cells	cell_type
and	O
modulate	O
inflammatory	O
responses	O
.	O
It	O
is	O
also	O
an	O
inhibitor	O
of	O
HIV	O
replication	O
in	O
CD8+	cell_type
T-cells	cell_type
.	O
The	O
expression	O
of	O
MIP-1	protein
alpha	protein
is	O
induced	O
during	O
cellular	O
activation	O
of	O
CD4+	cell_type
T-cells	cell_type
and	O
monocytes	cell_type
.	O
It	O
is	O
also	O
expressed	O
in	O
transformed	cell_line
B-cells	cell_line
.	O
We	O
have	O
previously	O
identified	O
a	O
new	O
transcription	protein
factor	protein
family	protein
(the	O
MNP	protein
family	protein
)	O
whose	O
expression	O
is	O
crucial	O
for	O
the	O
induction	O
of	O
MIP-1	protein
alpha	protein
transcription	O
during	O
cellular	O
activation	O
and	O
in	O
transformed	cell_line
B	cell_line
cells	cell_line
.	O
Monocytes	O
and	O
transformed	cell_line
B-cells	cell_line
normally	O
express	O
MNP-1	protein
strongly	O
and	O
MNP-2	protein
weakly,	O
while	O
T-cells	O
strongly	O
express	O
only	O
MNP-2	protein
.	O
Recently,	O
we	O
reported	O
that	O
HIV-1	protein
tat	protein
downregulates	O
MIP-1	protein
alpha	protein
expression	O
in	O
Jurkat	cell_line
T-cells	cell_line
.	O
In	O
this	O
report	O
we	O
show	O
induction	O
of	O
MNP-1	protein
in	O
Jurkat	cell_line
T-cells	cell_line
expressing	O
HIV-1	protein
tat	protein
.	O
Expression	O
of	O
neither	O
HTLV-1	protein
tax	protein
in	O
Jurkat	cell_line
T-cells	cell_line
nor	O
EBV	O
in	O
B-cells	cell_type
had	O
any	O
effect	O
on	O
MNP-1	protein
or	O
MNP-2	protein
expression,	O
showing	O
that	O
the	O
effect	O
is	O
specific	O
for	O
HIV-1	protein
tat	protein
.	O
We	O
propose	O
that	O
HIV-1	protein
tat	protein
may	O
inhibit	O
MIP-1	protein
alpha	protein
expression	O
by	O
inducing	O
MNP-1	protein
expression	O
in	O
T-cells	cell_type
,	O
probably	O
by	O
either	O
competing	O
with	O
MNP-2	protein
for	O
binding	O
to	O
the	O
MIP-1	DNA
alpha	DNA
promoter	DNA
or	O
by	O
sequestering	O
it	O
into	O
inactive	O
forms.	O

Differentiation	O
of	O
T-helper	cell_type
lymphocytes	cell_type
:	O
selective	O
regulation	O
by	O
members	O
of	O
the	O
STAT	protein
family	protein
of	O
transcription	protein
factors	protein
.	O
Interleukin-4	protein
(	O
IL-4	protein
)	O
and	O
interleukin-12	protein
(	O
IL-12	protein
)	O
control	O
the	O
differentiation	O
of	O
T-helper	cell_type
cells	cell_type
.	O
Here	O
we	O
summarize	O
studies	O
which	O
investigate	O
the	O
mechanism	O
by	O
which	O
these	O
cytokines	protein
selectively	O
reprogramme	O
gene	O
expression	O
in	O
T-lymphocytes	cell_type
.	O
Cytokine	protein
stimulation	O
leads	O
to	O
the	O
phosphorylation	O
of	O
specific	O
tyrosine	O
residues	O
within	O
the	O
intracellular	protein
domain	protein
of	O
the	O
corresponding	O
cytokine	protein
receptor	protein
.	O
These	O
phosphotyrosines	O
serve	O
as	O
docking	protein
sites	protein
for	O
latent,	O
cytoplasmic	protein
transcription	protein
factors	protein
known	O
as	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(Stat)	protein
proteins	protein
.	O
Receptor/Stat	O
interaction	O
is	O
mediated	O
by	O
the	O
src	protein
homology	protein
2	protein
(SH2)	protein
domain	protein
of	O
the	O
corresponding	O
Stat	protein
protein	protein
.	O
Although	O
Stat	O
binding	O
to	O
the	O
intracellular	protein
domain	protein
of	O
the	O
cytokine	protein
receptor	protein
strongly	O
depends	O
on	O
the	O
phosphotyrosine	O
residue	O
,	O
the	O
recruitment	O
of	O
a	O
specific	O
Stat	protein
protein	protein
is	O
dictated	O
by	O
amino	O
acid	O
residues	O
C-terminal	O
to	O
the	O
phosphotyrosine	O
.	O
Specific	O
docking	protein
sites	protein
within	O
individual	O
cytokine	protein
receptors	protein
have	O
been	O
identified	O
for	O
almost	O
all	O
Stat	protein
proteins	protein
.	O
The	O
direct	O
coupling	O
between	O
cytokine	protein
receptor	protein
and	O
transcription	protein
factor	protein
helps	O
to	O
explain	O
how	O
different	O
cytokines	protein
elicit	O
distinct	O
patterns	O
of	O
gene	O
expression	O
.	O

Role	O
of	O
EGR1	protein
in	O
regulation	O
of	O
stimulus-dependent	O
CD44	protein
transcription	O
in	O
B	O
lymphocytes.	O
The	O
immediate-early	DNA
gene	DNA
egr-1	DNA
encodes	O
a	O
transcription	protein
factor	protein
(	O
EGR1	protein
)	O
that	O
links	O
B-cell	protein
antigen	protein
receptor	protein
(	O
BCR	protein
)	O
signals	O
to	O
downstream	O
activation	O
events	O
through	O
the	O
regulation	O
of	O
previously	O
unidentified	O
target	DNA
genes	DNA
.	O
Here	O
we	O
identify	O
the	O
gene	O
encoding	O
the	O
lymphocyte	protein
homing	protein
and	protein
migration	protein
protein	protein
CD44	protein
as	O
a	O
target	O
of	O
EGR1	protein
regulation	O
in	O
B	cell_type
cells	cell_type
.	O
BCR	protein
-induced	O
increases	O
in	O
CD44	RNA
mRNA	RNA
expression	O
and	O
transcription	O
levels	O
are	O
shown	O
to	O
occur	O
in	O
EGR1	protein
-expressing	O
but	O
not	O
in	O
nonexpressing	O
subclones	O
of	O
the	O
B-cell	cell_line
line	cell_line
WEHI-231	cell_line
.	O
Kinetics	O
of	O
egr-1	DNA
transcription	O
and	O
the	O
appearance	O
of	O
nuclear	O
EGR1	protein
protein	protein
precede	O
CD44	protein
induction	O
and	O
occur	O
within	O
30	O
min	O
after	O
stimulation	O
in	O
the	O
EGR1	cell_line
-expressing	cell_line
subclone	cell_line
.	O
A	O
single	O
EGR1	protein
binding	O
motif	O
is	O
demonstrated	O
at	O
bp	O
-301	O
of	O
the	O
human	DNA
CD44	DNA
promoter	DNA
.	O
Cotransfection	O
of	O
a	O
CD44	DNA
promoter-chloramphenicol	DNA
acetyltransferase	DNA
reporter	DNA
construct	DNA
with	O
an	O
egr-1	DNA
expression	DNA
vector	DNA
resulted	O
in	O
a	O
6.5-	O
to	O
8.5-fold	O
induction	O
of	O
transcriptional	O
activity	O
relative	O
to	O
an	O
empty	DNA
expression	DNA
vector	DNA
.	O
The	O
EGR1	DNA
binding	DNA
motif	DNA
was	O
shown	O
to	O
be	O
necessary	O
for	O
stimulus-induced	O
expression	O
of	O
a	O
CD44	protein
promoter-chloramphenicol	DNA
acetyltransferase	DNA
reporter	DNA
construct	DNA
in	O
nontransformed	cell_type
B	cell_type
lymphocytes	cell_type
and	O
was	O
required	O
for	O
transactivation	O
by	O
an	O
EGR1	DNA
expression	DNA
vector	DNA
in	O
a	O
B-cell	cell_line
line	cell_line
.	O
These	O
studies	O
identify	O
EGR1	protein
as	O
an	O
intermediary	O
linking	O
BCR	protein
-derived	O
signals	O
to	O
the	O
induction	O
of	O
CD44	protein
.	O
The	O
relevance	O
of	O
these	O
molecular	O
events	O
to	O
BCR	protein
signal	O
transduction	O
and	O
antigen-stimulated	O
B-cell-mediated	O
immune	O
responses	O
is	O
discussed.	O

Involvement	O
of	O
intracellular	O
Ca2+	O
in	O
oxidant-induced	O
NF-kappa	protein
B	protein
activation	O
.	O
In	O
human	cell_line
Jurkat	cell_line
T	cell_line
cells	cell_line
and	O
its	O
subclone	O
Wurzburg	cell_line
cells	cell_line
oxidant	O
challenge	O
elevated	O
[Ca2+]i	O
by	O
mobilizing	O
Ca2+	O
from	O
intracellular	O
stores.	O
In	O
Jurkat	cell_line
cells	cell_line
this	O
effect	O
was	O
rapid	O
and	O
transient,	O
but	O
in	O
Wurzburg	cell_line
cells	cell_line
the	O
response	O
was	O
slow	O
and	O
sustained.	O
H2O2	O
-induced	O
NF-kappaB	protein
activation	O
in	O
Wurzburg	cell_line
cells	cell_line
was	O
not	O
influenced	O
by	O
the	O
presence	O
of	O
extracellular	O
EGTA	O
but	O
was	O
totally	O
inhibited	O
in	O
cells	O
that	O
were	O
loaded	O
with	O
esterified	O
EGTA	O
.	O
In	O
Jurkat	cell_line
cells	cell_line
that	O
are	O
not	O
sensitive	O
to	O
H2O2	O
-induced	O
NF-kappaB	protein
activation	O
,	O
H2O2	O
potentiated	O
NF-kappaB	protein
activation	O
in	O
the	O
presence	O
of	O
sustained	O
high	O
[	O
Ca2+	O
]i	O
following	O
thapsigargin	O
treatment	O
.	O
NF-kappaB	protein
regulatory	O
effect	O
of	O
alpha-lipoate	O
and	O
N-acetylcysteine	O
appeared	O
to	O
be,	O
at	O
least	O
in	O
part,	O
due	O
to	O
their	O
ability	O
to	O
stabilize	O
elevation	O
of	O
[	O
Ca2+	O
]i	O
following	O
oxidant	O
challenge.	O
Results	O
of	O
this	O
study	O
indicate	O
that	O
a	O
sustained	O
elevated	O
[Ca2+]i	O
is	O
a	O
significant	O
factor	O
in	O
oxidant-induced	O
NF-kappaB	protein
activation	O
.	O

Transactivation	O
of	O
the	O
interleukin-1alpha	DNA
promoter	DNA
by	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
and	O
type	O
II	O
Tax	O
proteins	O
.	O
Human	cell_line
T-cell	cell_line
leukemia	cell_line
virus	cell_line
type	cell_line
I	cell_line
(	cell_line
HTLV-I	cell_line
)-infected	cell_line
T-cell	cell_line
lines	cell_line
constitutively	O
produce	O
high	O
levels	O
of	O
interleukin-1alpha	protein
(	O
IL-1alpha	protein
).	O
To	O
analyze	O
the	O
mechanisms	O
that	O
lead	O
to	O
the	O
expression	O
of	O
IL-1alpha	protein
in	O
HTLV-I	cell_line
-infected	cell_line
cell	cell_line
lines	cell_line
,	O
we	O
studied	O
regulatory	O
regions	O
of	O
the	O
human	O
IL-1alpha	DNA
promoter	DNA
involved	O
in	O
activation	O
of	O
the	O
IL-1alpha	DNA
gene	DNA
.	O
IL-1alpha	DNA
promoter	DNA
constructs	DNA
drive	O
transcription	O
of	O
the	O
chloramphenicol	DNA
acetyltransferase	DNA
(CAT)	DNA
reporter	DNA
gene	DNA
in	O
HTLV-I	cell_line
-positive	cell_line
MT-2	cell_line
cells	cell_line
,	O
which	O
constitutively	O
produce	O
IL-1alpha	protein
.	O
In	O
a	O
cotransfection	O
assay,	O
the	O
Tax	protein
protein	protein
of	O
both	O
HTLV-I	O
and	O
HTLV-II	O
specifically	O
activated	O
transcription	O
from	O
the	O
IL-1alpha	DNA
promoter	DNA
in	O
an	O
uninfected	cell_line
Jurkat	cell_line
cell	cell_line
line	cell_line
.	O
A	O
mutant	O
Tax	protein
protein	protein
deficient	O
in	O
transactivation	O
of	O
genes	O
by	O
the	O
nuclear	protein
factor	protein
(NF)-kappaB	protein
pathway	O
was	O
unable	O
to	O
induce	O
transcriptional	O
activity	O
of	O
IL-1alpha	DNA
promoter	DNA
-CAT	DNA
constructs	DNA
,	O
but	O
was	O
rescued	O
by	O
exogenous	O
provision	O
of	O
p65/p50	protein
NF-kappaB	protein
.	O
We	O
found	O
that	O
two	O
IL-1alpha	DNA
kappaB-like	DNA
sites	DNA
(positions	O
-1,065	DNA
to	DNA
-1,056	DNA
and	O
+646	DNA
to	DNA
+655	DNA
)	O
specifically	O
formed	O
a	O
complex	O
with	O
NF-kappaB	protein
-containing	O
nuclear	O
extract	O
from	O
MT-2	cell_line
cells	cell_line
and	O
that	O
NF-kappaB	protein
bound	O
with	O
higher	O
affinity	O
to	O
the	O
3'	DNA
NF-kappaB	DNA
binding	DNA
site	DNA
than	O
to	O
the	O
5'	DNA
NF-kappaB	DNA
site	DNA
.	O
Moreover,	O
deletion	O
of	O
either	O
5'	O
or	O
3'	O
NF-kappaB	O
sites	O
reduced	O
IL-1alpha	DNA
promoter	DNA
activity	O
in	O
MT-2	cell_line
cells	cell_line
and	O
transactivation	O
of	O
the	O
IL-1alpha	DNA
promoter	DNA
by	O
exogenous	O
NF-kappaB	protein
and	O
Tax	protein
in	O
Jurkat	cell_line
cells	cell_line
.	O
These	O
data	O
suggest	O
a	O
general	O
role	O
for	O
Tax	protein
induction	O
of	O
IL-1alpha	DNA
gene	DNA
transcription	O
by	O
the	O
NF-kappaB	protein
pathway	O
.	O
Expression	O
of	O
IL-1alpha	protein
by	O
HTLV-I	O
productively	O
infected	cell_type
cells	cell_type
may	O
be	O
important	O
in	O
the	O
hypercalcemia	O
,	O
osteolytic	O
bone	O
lesions	O
,	O
neutrophilia	O
,	O
elevation	O
of	O
C-reactive	protein
protein	protein
,	O
and	O
fever	O
frequently	O
seen	O
in	O
patients	O
with	O
HTLV-I	O
-induced	O
adult	O
T-cell	O
leukemia/lymphoma	O
.	O

The	O
myeloid-cell-specific	DNA
c-fes	DNA
promoter	DNA
is	O
regulated	O
by	O
Sp1	protein
,	O
PU.1	protein
,	O
and	O
a	O
novel	O
transcription	protein
factor	protein
.	O
The	O
protein	O
product	O
of	O
the	O
c-fps/fes	DNA
(c-fes)	DNA
proto-oncogene	DNA
has	O
been	O
implicated	O
in	O
the	O
normal	O
development	O
of	O
myeloid	cell_type
cells	cell_type
(	O
macrophages	cell_type
and	O
neutrophils	cell_type
).	O
mRNA	O
for	O
c-fes	O
has	O
been	O
detected	O
exclusively	O
in	O
myeloid	cell_type
cells	cell_type
and	O
vascular	cell_type
endothelial	cell_type
cells	cell_type
in	O
adult	O
mammals	O
.	O
Although	O
a	O
13-kilobase-pair	DNA
(kb)	DNA
human	DNA
c-fes	DNA
transgene	DNA
exhibits	O
high	O
levels	O
of	O
expression	O
in	O
mice	O
,	O
the	O
sequences	O
that	O
confer	O
myeloid-cell-specific	O
expression	O
of	O
the	O
human	DNA
c-fes	DNA
gene	DNA
have	O
not	O
been	O
defined.	O
Transient-transfection	O
experiments	O
demonstrated	O
that	O
plasmids	DNA
containing	O
446	O
bp	O
of	O
c-fes	DNA
5'-flanking	DNA
sequences	DNA
linked	O
to	O
a	O
luciferase	O
reporter	O
gene	O
were	O
active	O
exclusively	O
in	O
myeloid	cell_type
cells	cell_type
.	O
No	O
other	O
DNA	O
element	O
within	O
the	O
13-kb	DNA
human	DNA
c-fes	DNA
locus	DNA
contained	O
positive	DNA
cis-acting	DNA
elements	DNA
,	O
with	O
the	O
exception	O
of	O
a	O
weakly	O
active	O
region	O
within	O
the	O
3'-flanking	DNA
sequences	DNA
.	O
DNase	O
I	O
footprinting	O
assays	O
revealed	O
four	O
distinct	O
sites	O
that	O
bind	O
myeloid	protein
nuclear	protein
proteins	protein
(	O
-408	DNA
to	DNA
-386	DNA
,	O
-293	DNA
to	DNA
-254	DNA
,	O
-76	DNA
to	DNA
-65	DNA
,	O
and	O
-34	DNA
to	DNA
+3	DNA
).	O
However,	O
the	O
first	O
two	O
footprints	O
resided	O
in	O
sequences	O
that	O
were	O
largely	O
dispensable	O
for	O
transient	O
activity.	O
Plasmids	O
containing	O
151	DNA
bp	DNA
of	O
5'-flanking	DNA
sequences	DNA
confer	O
myeloid-cell-specific	O
gene	O
expression	O
.	O
Electrophoretic	O
mobility	O
shift	O
analyses	O
demonstrated	O
that	O
the	O
151-bp	DNA
region	DNA
contains	O
nuclear	DNA
protein	DNA
binding	DNA
sites	DNA
for	O
Sp1	protein
,	O
PU.1	protein
,	O
and/or	O
Elf-1	protein
,	O
and	O
a	O
novel	protein
factor	protein
.	O
This	O
unidentified	O
factor	O
binds	O
immediately	O
3'	O
of	O
the	O
PU.1	DNA
/Elf-1	DNA
sites	DNA
and	O
appears	O
to	O
be	O
myeloid	O
cell	O
specific	O
.	O
Mutation	O
of	O
the	O
PU.1	protein
/Elf-1	protein
site	O
or	O
the	O
3'	DNA
site	DNA
(	O
FP4-3'	DNA
)	O
within	O
the	O
context	O
of	O
the	O
c-fes	DNA
promoter	DNA
resulted	O
in	O
substantially	O
reduced	O
activity	O
in	O
transient	O
transfections	O
.	O
Furthermore,	O
transient-cotransfection	O
assay	O
demonstrated	O
that	O
PU.1	protein
(and	O
not	O
Elf-1	protein
)	O
can	O
transactivate	O
the	O
c-fes	DNA
promoter	DNA
in	O
nonmyeloid	cell_line
cell	cell_line
lines	cell_line
.	O
We	O
conclude	O
that	O
the	O
human	DNA
c-fes	DNA
gene	DNA
contains	O
a	O
strong	O
myeloid-cell-specific	DNA
promoter	DNA
that	O
is	O
regulated	O
by	O
Sp1	protein
,	O
PU.1	protein
,	O
and	O
a	O
novel	O
transcription	protein
factor	protein
.	O

IL-10	protein
inhibits	O
nuclear	protein
factor-kappa	protein
B/Rel	protein
nuclear	O
activity	O
in	O
CD3-stimulated	cell_line
human	cell_line
peripheral	cell_line
T	cell_line
lymphocytes	cell_line
.	O
IL-10	protein
markedly	O
reduces	O
nuclear	O
factor	O
(NF)-kappa	protein
B/Rel	protein
nuclear	O
activity	O
induced	O
in	O
PBMC	cell_type
by	O
stimulation	O
with	O
the	O
anti-CD3	protein
mAb	protein
OKT3	protein
.	O
The	O
inhibition	O
is	O
exerted	O
specifically	O
on	O
the	O
NF-kappa	protein
B/Rel	protein
activation	O
induced	O
by	O
mAb	protein
OKT3	protein
,	O
and	O
not	O
that	O
produced	O
by	O
PMA	O
.	O
As	O
judged	O
by	O
supershifting	O
the	O
DNA-protein	protein
complexes	protein
with	O
Abs	protein
recognizing	O
specific	O
components	O
of	O
the	O
NF-kappa	protein
B/Rel	protein
protein	protein
family	protein
,	O
the	O
p50/p65	protein
(	O
Rel	protein
A	protein
)	O
heterodimeric	O
form	O
of	O
NF-kappa	protein
B	protein
is	O
primarily	O
affected.	O
The	O
maximal	O
effect	O
is	O
observed	O
at	O
the	O
IL-10	protein
concentration	O
of	O
20	O
U/ml.	O
IL-10	protein
inhibitory	O
activity	O
is	O
exerted	O
on	O
T	cell_type
lymphocytes	cell_type
and	O
is	O
mediated	O
by	O
monocytes	cell_type
.	O
Indeed,	O
monocytes	cell_type
pretreated	O
with	O
IL-10	protein
are	O
able	O
so	O
inhibit	O
NF-kappa	protein
B	protein
nuclear	O
activity	O
in	O
purified	O
T	cell_type
lymphocytes	cell_type
stimulated	O
with	O
OKT3	protein
.	O
Soluble	O
factors	O
do	O
not	O
appear	O
to	O
be	O
involved	O
in	O
the	O
mechanism	O
of	O
inhibition.	O
On	O
the	O
other	O
hand,	O
the	O
up-regulation	O
of	O
CD80	protein
Ag	protein
,	O
found	O
on	O
monocytes	cell_type
obtained	O
from	O
PBMC	cell_type
incubated	O
with	O
OKT3	protein
,	O
is	O
not	O
detected	O
after	O
addition	O
of	O
IL-10	protein
,	O
and	O
the	O
anti-CD28	protein
mAb	protein
CLB-CD28/1	protein
restores	O
the	O
NF-kappa	protein
B/Rel	protein
nuclear	O
activity	O
in	O
IL-10	cell_line
-inhibited	cell_line
lymphocytes	cell_line
.	O
Therefore,	O
the	O
NF-kappa	protein
B/Rel	protein
inhibition	O
might	O
be	O
ascribed	O
to	O
a	O
lack	O
of	O
cooperation	O
between	O
accessory	O
cells	O
and	O
T	cell_type
lymphocytes	cell_type
,	O
resulting	O
from	O
down-regulation	O
of	O
a	O
costimulatory	O
molecule,	O
such	O
as	O
CD80	protein
,	O
produced	O
by	O
IL-10	protein
on	O
activated	O
monocytes	cell_type
.	O
Our	O
results	O
demonstrate	O
that	O
IL-10	protein
can	O
inhibit	O
the	O
induction	O
of	O
NF-kappa	protein
B/Rel	protein
nuclear	O
activity	O
in	O
CD3-stimulated	cell_line
T	cell_line
lymphocytes	cell_line
.	O
Since	O
inappropriate	O
activation	O
of	O
kappa	DNA
B-driven	DNA
genes	DNA
has	O
a	O
physiopathologic	O
role	O
in	O
a	O
number	O
of	O
diseases,	O
such	O
as	O
HIV	O
infection	O
,	O
our	O
findings	O
support	O
the	O
possibility	O
of	O
using	O
this	O
cytokine	O
to	O
suppress	O
an	O
undesirable	O
activation	O
of	O
these	O
transcription	protein
factors	protein
.	O

Expression	O
of	O
A-myb	DNA
,	O
but	O
not	O
c-myb	DNA
and	O
B-myb	DNA
,	O
is	O
restricted	O
to	O
Burkitt's	O
lymphoma	O
,	O
sIg+	O
B-acute	O
lymphoblastic	O
leukemia	O
,	O
and	O
a	O
subset	O
of	O
chronic	O
lymphocytic	O
leukemias	O
.	O
The	O
A-myb	DNA
gene	DNA
encodes	O
a	O
transcription	protein
factor	protein
that	O
is	O
related	O
both	O
functionally	O
and	O
structurally	O
to	O
the	O
v-myb	DNA
oncogene	DNA
.	O
Following	O
our	O
observations	O
that	O
A-myb	DNA
is	O
expressed	O
in	O
a	O
restricted	O
subset	O
of	O
normal	O
mature	cell_type
human	cell_type
B	cell_type
lymphocytes	cell_type
,	O
with	O
the	O
phenotype	O
CD38+,	O
CD39-,	O
slgM-	O
,	O
we	O
have	O
now	O
investigated	O
the	O
pattern	O
of	O
A-myb	DNA
expression	O
in	O
neoplastic	O
B	cell_type
cells	cell_type
representating	O
the	O
whole	O
spectrum	O
of	O
B-cell	O
differentiation	O
and	O
compared	O
it	O
to	O
that	O
of	O
c-myb	DNA
and	O
B-myb	DNA
.	O
In	O
a	O
panel	O
of	O
32	O
B-cell	cell_line
lines	cell_line
,	O
A-myb	DNA
was	O
very	O
strongly	O
expressed	O
in	O
most	O
Burkitt's	O
lymphoma	O
(	O
BL	O
)	O
cell	O
lines,	O
but	O
weak	O
or	O
negative	O
in	O
2	O
pre-B	O
acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
),	O
4	O
non-Hodgkin's	O
lymphoma	O
(	O
NHL	O
),	O
6	O
Epstein-Barr	cell_line
virus-immortalized	cell_line
lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
,	O
and	O
6	O
myeloma	cell_line
lines	cell_line
.	O
Protein	O
expression	O
paralleled	O
that	O
of	O
the	O
RNA.	O
We	O
have	O
also	O
investigated	O
A-myb	DNA
expression	O
in	O
49	O
fresh	O
cases	O
of	O
B	O
leukemias	O
.	O
Among	O
24	O
ALL	O
,	O
6	O
were	O
of	O
the	O
null	O
and	O
11	O
of	O
the	O
common	O
type	O
and	O
all	O
these	O
were	O
negative	O
for	O
A-myb	protein
expression	O
;	O
on	O
the	O
other	O
hand,	O
all	O
7	O
B-	O
ALL	O
cases	O
(	O
slg+	O
),	O
as	O
well	O
as	O
one	O
fresh	O
BL	O
case	O
with	O
bone	O
marrow	O
infiltration	O
,	O
expressed	O
A-myb	DNA
.	O
A-myb	DNA
was	O
undetectable	O
in	O
4	O
prolymphocytic	O
leukemias	O
(PLL)	O
but	O
was	O
strongly	O
expressed	O
in	O
5/20	O
(25%)	O
of	O
chronic	O
lymphocytic	O
leukemia	O
(CLL)	O
samples	O
.	O
In	O
the	O
latter	O
A-myb	DNA
did	O
not	O
correlate	O
with	O
phenotype	O
or	O
clinical	O
stage.	O
Finally,	O
we	O
have	O
studied	O
the	O
progression	O
of	O
one	O
case	O
of	O
CLL	O
into	O
Richter's	O
syndrome	O
and	O
have	O
found	O
that	O
the	O
Richter's	cell_line
cells	cell_line
expressed	O
about	O
25-fold	O
less	O
A-myb	RNA
RNA	RNA
than	O
the	O
CLL	cell_line
cells	cell_line
from	O
the	O
same	O
patient.	O
The	O
pattern	O
of	O
c-myb	DNA
and	O
B-myb	DNA
was	O
clearly	O
distinct	O
from	O
that	O
of	O
A-myb	DNA
.	O
C-myb	O
and	O
B-myb	DNA
were	O
expressed	O
in	O
all	O
neoplastic	O
groups,	O
except	O
in	O
CLL	cell_line
cells	cell_line
.	O
Thus,	O
A-myb	DNA
expression	O
,	O
unlike	O
that	O
of	O
c-myb	DNA
and	O
B-myb	DNA
,	O
is	O
restricted	O
to	O
a	O
subset	O
of	O
B-cell	O
neoplasias	O
(in	O
particular	O
BL	O
and	O
slg+B-	O
ALL	O
)	O
representative	O
of	O
a	O
specific	O
stage	O
of	O
B-cell	O
differentiation	O
.	O
This	O
expression	O
may	O
in	O
part	O
reflect	O
expression	O
of	O
A-myb	DNA
by	O
the	O
normal	O
germinal	O
center	O
B	cell_type
cells	cell_type
that	O
are	O
the	O
normal	O
counterpart	O
of	O
these	O
transformed	cell_line
B	cell_line
cells	cell_line
.	O
The	O
data	O
presented	O
strongly	O
support	O
a	O
role	O
for	O
this	O
transcription	protein
factor	protein
in	O
B-cell	O
differentiation	O
and	O
perhaps	O
in	O
B-cell	O
transformation	O
in	O
some	O
neoplasias	O
.	O

Granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
stimulates	O
JAK2	protein
signaling	O
pathway	O
and	O
rapidly	O
activates	O
p93fes	protein
,	O
STAT1	protein
p91	protein
,	O
and	O
STAT3	protein
p92	protein
in	O
polymorphonuclear	cell_type
leukocytes	cell_type
.	O
Granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
(	O
GM-CSF	protein
),	O
supports	O
proliferation	O
,	O
differentiation	O
,	O
and	O
functional	O
activation	O
of	O
hemopoietic	O
cells	O
by	O
its	O
interaction	O
with	O
a	O
heterodimeric	O
receptor.	O
Although	O
GM-CSF	protein
receptor	O
is	O
devoid	O
of	O
tyrosine	protein
kinase	protein
enzymatic	O
activity	O
,	O
GM-CSF	cell_line
-induced	cell_line
peripheral	cell_line
blood	cell_line
polymorphonuclear	cell_line
leukocytes	cell_line
(	O
PMN	cell_type
)	O
functional	O
activation	O
is	O
mediated	O
by	O
the	O
phosphorylation	O
of	O
a	O
large	O
number	O
of	O
intracellular	protein
signaling	protein
molecules	protein
.	O
We	O
have	O
previously	O
shown	O
that	O
JAK2	protein
becomes	O
tyrosine	O
-phosphorylated	O
in	O
response	O
to	O
GM-CSF	protein
in	O
PMN	cell_type
.	O
In	O
the	O
present	O
study	O
we	O
demonstrate	O
that	O
also	O
the	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(STAT)	protein
family	protein
members	protein
STAT1	protein
p91	protein
and	O
STAT3	protein
p92	protein
and	O
the	O
product	O
of	O
the	O
c-fps/fes	DNA
protooncogene	DNA
become	O
tyrosine	O
-phosphorylated	O
upon	O
GM-CSF	protein
stimulation	O
and	O
physically	O
associated	O
with	O
both	O
GM-CSF	protein
receptor	O
beta	O
common	O
subunit	O
and	O
JAK2	protein
.	O
Moreover	O
GM-CSF	protein
was	O
able	O
to	O
induce	O
JAK2	protein
and	O
p93fes	protein
catalytic	O
activity	O
.	O
We	O
also	O
demonstrate	O
that	O
the	O
association	O
of	O
the	O
GM-CSF	protein
receptor	protein
beta	protein
common	protein
subunit	protein
with	O
JAK2	protein
is	O
ligand-dependent.	O
Finally	O
we	O
demonstrate	O
that	O
GM-CSF	protein
induces	O
a	O
DNA-binding	protein
complex	protein
that	O
contains	O
both	O
p91	protein
and	O
p92	protein
.	O
These	O
results	O
identify	O
a	O
new	O
signal	O
transduction	O
pathway	O
activated	O
by	O
GM-CSF	protein
and	O
provide	O
a	O
mechanism	O
for	O
rapid	O
activation	O
of	O
gene	O
expression	O
in	O
GM-CSF	cell_type
-stimulated	cell_type
PMN	cell_type
.	O

Epstein-Barr	protein
virus	protein
nuclear	protein
antigen	protein
2	protein
(EBNA2)-oestrogen	protein
receptor	protein
fusion	protein
proteins	protein
complement	O
the	O
EBNA2-deficient	O
Epstein-Barr	O
virus	O
strain	O
P3HR1	O
in	O
transformation	O
of	O
primary	cell_type
B	cell_type
cells	cell_type
but	O
suppress	O
growth	O
of	O
human	cell_line
B	cell_line
cell	cell_line
lymphoma	cell_line
lines	cell_line
.	O
To	O
develop	O
a	O
transformation	O
system	O
with	O
a	O
conditional	O
Epstein-Barr	DNA
virus	DNA
nuclear	DNA
antigen	DNA
2	DNA
(	DNA
EBNA2	DNA
)	DNA
gene	DNA
,	O
we	O
fused	O
the	O
hormone	protein
binding	protein
domain	protein
of	O
the	O
oestrogen	O
receptor	O
to	O
the	O
N	O
or	O
C	O
terminus	O
of	O
EBNA2	protein
.	O
In	O
promoter	O
transactivation	O
as	O
well	O
as	O
primary	O
B	O
cell	O
transformation	O
assays	O
these	O
chimeric	O
EBNA2	protein
proteins	O
are	O
able	O
to	O
substitute	O
for	O
wild-type	protein
EBNA2	protein
in	O
the	O
presence	O
of	O
oestrogen	O
.	O
Here	O
we	O
provide	O
evidence	O
that	O
this	O
transformation	O
is	O
the	O
result	O
of	O
double	O
infection	O
of	O
a	O
cell	O
with	O
two	O
virions	O
,	O
the	O
P3HR1	DNA
virus	DNA
genome	DNA
and	O
a	O
mini-	DNA
EBV	DNA
plasmid	DNA
carrying	O
the	O
chimeric	O
EBNA2	DNA
gene	DNA
.	O
Unexpectedly,	O
expression	O
of	O
the	O
same	O
EBNA2	protein
-oestrogen	O
receptor	O
fusion	O
protein	O
in	O
established	cell_line
human	cell_line
B	cell_line
cell	cell_line
lymphoma	cell_line
lines	cell_line
resulted	O
in	O
growth	O
retardation	O
or	O
growth	O
arrest	O
upon	O
the	O
addition	O
of	O
oestrogen	O
.	O
By	O
titrating	O
the	O
oestrogen	O
concentration	O
in	O
these	O
stably	cell_line
transfected	cell_line
cells	cell_line
,	O
the	O
growth	O
retarding	O
and	O
the	O
transactivating	O
function	O
of	O
the	O
chimeric	protein
proteins	protein
could	O
not	O
be	O
dissociated.	O
We	O
propose	O
that	O
growth	O
inhibition	O
of	O
established	O
B	cell_line
cell	cell_line
lymphoma	cell_line
lines	cell_line
is	O
a	O
novel	O
function	O
of	O
EBNA2	protein
which	O
has	O
not	O
been	O
detected	O
in	O
the	O
absence	O
of	O
an	O
inducible	O
system	O
.	O
It	O
remains	O
open	O
whether	O
the	O
growth	O
retarding	O
property	O
of	O
the	O
EBNA2	protein
-oestrogen	protein
receptor	protein
fusion	protein
protein	protein
in	O
B	cell_line
cell	cell_line
lymphoma	cell_line
lines	cell_line
is	O
due	O
to	O
unphysiologically	O
high	O
expression	O
of	O
the	O
chimeric	protein
protein	protein
or	O
to	O
interference	O
with	O
a	O
cellular	O
programme	O
driving	O
proliferation	O
in	O
these	O
cell	cell_line
lines	cell_line
.	O

Tissue-specific	O
activity	O
of	O
the	O
gammac	DNA
chain	DNA
gene	DNA
promoter	DNA
depends	O
upon	O
an	O
Ets	DNA
binding	DNA
site	DNA
and	O
is	O
regulated	O
by	O
GA-binding	protein
protein	protein
.	O
The	O
gammac	protein
chain	protein
is	O
a	O
subunit	O
of	O
multiple	O
cytokine	protein
receptors	protein
(	O
interleukin	protein
(IL)-2	protein
,	O
IL-4	protein
,	O
IL-7	protein
,	O
IL-9	protein
,	O
and	O
IL-15	protein
),	O
the	O
expression	O
of	O
which	O
is	O
restricted	O
to	O
hematopoietic	cell_type
lineages	cell_type
.	O
A	O
defect	O
in	O
gammac	O
leads	O
to	O
the	O
X-linked	O
severe	O
combined	O
immunodeficiency	O
characterized	O
by	O
a	O
block	O
in	O
T	O
cell	O
differentiation	O
.	O
In	O
order	O
to	O
better	O
characterize	O
the	O
human	DNA
gammac	DNA
promoter	DNA
and	O
define	O
the	O
minimal	DNA
tissue-specific	DNA
promoter	DNA
region	DNA
,	O
progressive	O
5'-deletion	DNA
constructs	DNA
of	O
a	O
segment	O
extending	O
1053	DNA
base	DNA
pairs	DNA
upstream	DNA
of	O
the	O
major	DNA
transcription	DNA
start	DNA
site	DNA
were	O
generated	O
and	O
tested	O
for	O
promoter	O
activity	O
in	O
various	O
hematopoietic	O
and	O
nonhematopoietic	O
cell	O
types	O
.	O
The	O
-1053/+34	DNA
construct	DNA
allowed	O
promoter	O
activity	O
only	O
in	O
cells	O
of	O
hematopoietic	cell_type
origin	cell_type
,	O
and	O
tissue	O
specificity	O
was	O
conserved	O
in	O
all	O
other	O
constructs	O
tested.	O
The	O
region	O
downstream	O
of	O
-90	O
appeared	O
critical	O
for	O
basal	O
promoter	O
activity	O
.	O
It	O
contains	O
two	O
potential	O
Ets	DNA
binding	DNA
sites	DNA
conserved	O
in	O
the	O
murine	DNA
gammac	DNA
promoter	DNA
gene	DNA
,	O
one	O
of	O
which	O
was	O
found	O
essential	O
for	O
functional	O
promoter	O
activity	O
as	O
determined	O
by	O
mutational	O
analysis	O
.	O
The	O
functional	O
Ets	DNA
binding	DNA
site	DNA
was	O
found	O
to	O
bind	O
Ets	protein
family	protein
proteins	protein
,	O
principally	O
GA-binding	protein
protein	protein
and	O
Elf-1	protein
and	O
could	O
be	O
transactivated	O
by	O
GABPalpha	protein
and	O
-beta	protein
synergistically.	O
These	O
results	O
indicate	O
that,	O
as	O
already	O
reported	O
for	O
the	O
IL2Rbeta	DNA
promoter	DNA
,	O
GA-binding	protein
protein	protein
is	O
an	O
essential	O
component	O
of	O
gammac	O
basal	O
promoter	O
activity	O
.	O
Although	O
GABP	protein
expression	O
is	O
not	O
restricted	O
to	O
the	O
hematopoietic	cell_type
lineage	cell_type
,	O
its	O
interaction	O
with	O
other	O
specific	protein
factors	protein
may	O
contribute	O
to	O
the	O
tissue-specific	O
expression	O
of	O
the	O
gammac	DNA
gene	DNA
.	O

Detection	O
of	O
intracellular	protein
signal	protein
transduction	protein
molecules	protein
in	O
PBMC	cell_type
from	O
rhesus	O
macaques	O
and	O
sooty	O
mangabeys	O
.	O
One	O
of	O
the	O
manifestations	O
of	O
human	O
HIV-1	O
and	O
nonhuman	O
primate	O
SIV	O
infection	O
that	O
lead	O
to	O
disease	O
is	O
reasoned	O
to	O
be	O
secondary	O
to	O
generalized	O
T-cell	O
dysfunction	O
.	O
The	O
molecular	O
mechanisms	O
associated	O
with	O
the	O
T-cell	O
dysfunction	O
remain	O
to	O
be	O
elucidated.	O
To	O
address	O
this	O
issue,	O
we	O
sought	O
to	O
utilize	O
the	O
nonhuman	O
primate	O
model	O
to	O
study	O
intracellular	O
signaling	O
events	O
in	O
cells	O
from	O
disease-susceptible	O
rhesus	O
macaques	O
and	O
disease-resistant	O
sooty	O
mangabeys	O
.	O
Because	O
relatively	O
little	O
is	O
known	O
about	O
these	O
events	O
in	O
nonhuman	O
primates	O
,	O
our	O
laboratory	O
defined	O
optimal	O
conditions,	O
reagents,	O
and	O
assays	O
for	O
the	O
study	O
of	O
signal	O
transduction	O
events	O
in	O
cells	O
from	O
nonhuman	O
primates	O
.	O
The	O
protein	O
phosphorylation	O
patterns	O
in	O
the	O
two	O
monkeys	O
exhibited	O
quantitative,	O
qualitative,	O
and	O
kinetic	O
differences.	O
Antibodies	O
to	O
Stat6	protein
detected	O
a	O
unique	O
band	O
in	O
macaque	O
cell	O
lysates	O
.	O
This	O
band	O
is	O
markedly	O
decreased	O
human	O
cell	O
lysates	O
and	O
never	O
seen	O
in	O
mangabey	O
cell	O
lysates	O
.	O
Detection	O
of	O
various	O
other	O
intracellular	protein
signaling	protein
proteins	protein
is	O
also	O
described.	O

Genetic	O
characterization	O
of	O
transactivation	O
of	O
the	O
human	DNA
T-cell	DNA
leukemia	DNA
virus	DNA
type	DNA
1	DNA
promoter	DNA
:	O
Binding	O
of	O
Tax	protein
to	O
Tax	DNA
-responsive	DNA
element	DNA
1	DNA
is	O
mediated	O
by	O
the	O
cyclic	protein
AMP-responsive	protein
members	protein
of	O
the	O
CREB/ATF	protein
family	protein
of	O
transcription	O
factors.	O
To	O
achieve	O
a	O
better	O
understanding	O
of	O
the	O
mechanism	O
of	O
transactivation	O
by	O
Tax	protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
Tax	DNA
-responsive	DNA
element	DNA
1	DNA
(	O
TRE-1	DNA
),	O
we	O
developed	O
a	O
genetic	O
approach	O
with	O
Saccharomyces	O
cerevisiae	O
.	O
We	O
constructed	O
a	O
yeast	O
reporter	O
strain	O
containing	O
the	O
lacZ	DNA
gene	DNA
under	O
the	O
control	O
of	O
the	O
CYC1	DNA
promoter	DNA
associated	O
with	O
three	O
copies	O
of	O
TRE-1	DNA
.	O
Expression	O
of	O
either	O
the	O
cyclic	protein
AMP	protein
response	protein
element-binding	protein
protein	protein
(	O
CREB	protein
)	O
or	O
CREB	protein
fused	O
to	O
the	O
GAL4	protein
activation	protein
domain	protein
(	O
GAD	protein
)	O
in	O
this	O
strain	O
did	O
not	O
modify	O
the	O
expression	O
of	O
the	O
reporter	DNA
gene	DNA
.	O
Tax	protein
alone	O
was	O
also	O
inactive.	O
However,	O
expression	O
of	O
the	O
reporter	DNA
gene	DNA
was	O
induced	O
by	O
coexpression	O
of	O
Tax	protein
and	O
CREB	protein
.	O
This	O
effect	O
was	O
stronger	O
with	O
the	O
GAD-CREB	protein
fusion	protein
protein	protein
.	O
Analysis	O
of	O
different	O
CREB	protein
mutants	protein
with	O
this	O
genetic	O
system	O
indicated	O
that	O
the	O
C-terminal	protein
92	protein
amino	protein
acid	protein
residues	protein
,	O
which	O
include	O
the	O
basic	protein
domain	protein
and	O
the	O
leucine	protein
zipper	protein
,	O
are	O
necessary	O
and	O
sufficient	O
to	O
mediate	O
transactivation	O
by	O
Tax	protein
.	O
To	O
identify	O
cellular	protein
proteins	protein
binding	O
to	O
TRE-1	DNA
in	O
a	O
Tax	protein
-dependent	O
manner	O
,	O
this	O
strain	O
was	O
also	O
used	O
to	O
screen	O
a	O
library	O
of	O
human	DNA
cDNAs	DNA
fused	O
to	O
GAD	protein
.	O
Of	O
five	O
positive	O
clones	O
isolated	O
from	O
0.75	O
x	O
10(6)	O
yeast	O
colonies,	O
four	O
were	O
members	O
of	O
the	O
CREB/activating	protein
transcription	protein
factor	protein
(ATF)	protein
family	protein
:	O
CREB	protein
,	O
two	protein
isoforms	protein
of	protein
the	protein
cyclic	protein
AMP-responsive	protein
element	protein
modulator	protein
(	O
CREM	protein
),	O
and	O
ATF-1	protein
.	O
Interestingly,	O
these	O
three	O
proteins	O
can	O
be	O
phosphorylated	O
by	O
protein	protein
kinase	protein
A	protein
and	O
thus	O
form	O
a	O
particular	O
subgroup	O
within	O
the	O
CREB/ATF	protein
family	protein
.	O
Expression	O
of	O
ATF-2	protein
in	O
S.	O
cerevisiae	O
did	O
not	O
activate	O
TRE-1	DNA
in	O
the	O
presence	O
of	O
Tax	protein
.	O
This	O
shows	O
that	O
in	O
a	O
eukaryotic	O
nucleus	O
,	O
Tax	protein
specifically	O
interacts	O
with	O
the	O
basic	protein
domain	protein
-leucine	protein
zipper	protein
region	protein
of	O
ATF-1	protein
,	O
CREB	protein
,	O
and	O
CREM	protein
.	O
The	O
fifth	O
clone	O
identified	O
in	O
this	O
screening	O
corresponded	O
to	O
the	O
Ku	protein
autoantigen	protein
p70	protein
subunit	protein
.	O
When	O
fused	O
to	O
GAD	protein
,	O
the	O
C-terminal	protein
region	protein
of	O
Ku	protein
was	O
able	O
to	O
activate	O
transcription	O
via	O
TRE-1	DNA
but	O
this	O
activation	O
was	O
not	O
dependent	O
on	O
Tax	protein
.	O

A	O
mammalian	protein
histone	protein
deacetylase	protein
related	O
to	O
the	O
yeast	protein
transcriptional	protein
regulator	protein
Rpd3p	protein
[see	O
comments]	O
Trapoxin	O
is	O
a	O
microbially	O
derived	O
cyclotetrapeptide	O
that	O
inhibits	O
histone	protein
deacetylation	O
in	O
vivo	O
and	O
causes	O
mammalian	O
cells	O
to	O
arrest	O
in	O
the	O
cell	O
cycle.	O
A	O
trapoxin	O
affinity	O
matrix	O
was	O
used	O
to	O
isolate	O
two	O
nuclear	O
proteins	O
that	O
copurified	O
with	O
histone	protein
deacetylase	protein
activity	O
.	O
Both	O
proteins	O
were	O
identified	O
by	O
peptide	O
microsequencing	O
,	O
and	O
a	O
complementary	DNA
DNA	DNA
encoding	O
the	O
histone	protein
deacetylase	protein
catalytic	protein
subunit	protein
(	O
HD1	protein
)	O
was	O
cloned	O
from	O
a	O
human	O
Jurkat	O
T	O
cell	O
library	O
.	O
As	O
the	O
predicted	O
protein	O
is	O
very	O
similar	O
to	O
the	O
yeast	protein
transcriptional	protein
regulator	protein
Rpd3p	protein
,	O
these	O
results	O
support	O
a	O
role	O
for	O
histone	protein
deacetylase	protein
as	O
a	O
key	O
regulator	O
of	O
eukaryotic	O
transcription	O
.	O

Coexpression	O
of	O
the	O
interleukin-13	O
and	O
interleukin-4	O
genes	O
correlates	O
with	O
their	O
physical	O
linkage	O
in	O
the	O
cytokine	DNA
gene	DNA
cluster	DNA
on	O
human	DNA
chromosome	DNA
5q23-31	DNA
.	O
Interleukin-13	protein
(	O
IL-13	protein
)	O
and	O
IL-4	protein
are	O
cytokines	O
produced	O
by	O
T	O
cells	O
that	O
are	O
encoded	O
by	O
the	O
q23-31	O
region	O
of	O
human	O
chromosome	O
5.	O
To	O
investigate	O
the	O
regulation	O
of	O
IL-13	DNA
gene	DNA
expression	O
by	O
T	cell_type
cells	cell_type
,	O
we	O
isolated	O
and	O
sequenced	O
the	O
human	O
IL-13	DNA
gene	DNA
,	O
analyzed	O
its	O
5'-flanking	DNA
region	DNA
for	O
potential	O
transcriptional	DNA
activation	DNA
elements	DNA
,	O
and	O
examined	O
its	O
expression	O
in	O
nontransformed	cell_line
T-lineage	cell_line
cell	cell_line
populations	cell_line
.	O
The	O
human	DNA
IL-13	DNA
gene	DNA
was	O
located	O
12.5-kb	DNA
upstream	DNA
of	O
the	O
IL-4	DNA
gene	DNA
and	O
2-kb	DNA
downstream	DNA
of	O
a	O
CpG	DNA
island	DNA
.	O
The	O
IL-13	DNA
gene	DNA
5'	DNA
flank	DNA
region	DNA
included	O
a	O
segment	O
with	O
sequence	O
homology	O
to	O
P	DNA
elements	DNA
of	O
the	O
IL-4	DNA
promoter	DNA
involved	O
in	O
transcriptional	O
activation	O
in	O
T	cell_type
cells	cell_type
.	O
Mutation	O
of	O
the	O
IL-13	DNA
P	DNA
element	DNA
site	DNA
significantly	O
reduced	O
IL-13	protein
promoter	O
activity	O
in	O
response	O
to	O
T-cell	O
activation	O
.	O
Oligonucleotides	O
containing	O
the	O
IL-13	protein
or	O
IL-4	DNA
P	DNA
element	DNA
sites	DNA
specifically	O
bound	O
the	O
transcriptional	protein
activator	protein
protein	protein
,	O
nuclear	protein
factor-activated	protein
T	protein
cells	protein
,	O
preformed	O
(	O
NF-ATp	protein
),	O
when	O
incubated	O
with	O
nuclear	O
protein	O
extracts	O
from	O
activated	cell_type
T	cell_type
cells	cell_type
.	O
Similar	O
to	O
IL-4	protein
,	O
IL-13	RNA
mRNA	RNA
expression	O
was	O
highest	O
in	O
T-cell	cell_line
populations	cell_line
enriched	O
for	O
cells	O
that	O
had	O
previously	O
been	O
primed	O
in	O
vivo	O
or	O
in	O
vitro,	O
indicating	O
that	O
priming	O
increases	O
the	O
expression	O
of	O
the	O
IL-13	O
and	O
IL-4	O
genes	O
in	O
a	O
coordinate	O
manner.	O
Because	O
the	O
primed	cell_line
T	cell_line
cells	cell_line
contain	O
higher	O
levels	O
of	O
nuclear	protein
NF-ATp	protein
,	O
capable	O
of	O
binding	O
to	O
P	DNA
elements	DNA
of	O
the	O
IL-4	O
and	O
IL-13	O
promoters	O
,	O
than	O
do	O
freshly-isolated	cell_type
T	cell_type
cells	cell_type
,	O
the	O
NF-AT-binding	DNA
P	DNA
elements	DNA
are	O
attractive	O
candidates	O
to	O
mediate	O
the	O
coordinate	O
expression	O
of	O
these	O
two	O
cytokine	DNA
genes	DNA
.	O

Inhibition	O
of	O
alpha	protein
interferon	protein
but	O
not	O
gamma	protein
interferon	protein
signal	O
transduction	O
by	O
phorbol	O
esters	O
is	O
mediated	O
by	O
a	O
tyrosine	protein
phosphatase	protein
.	O
Previous	O
studies	O
have	O
indicated	O
that	O
the	O
expression	O
of	O
viral	O
oncoproteins,	O
cell	O
transformation,	O
or	O
phorbol	O
ester	O
treatment	O
of	O
cells	O
can	O
inhibit	O
alpha/beta	O
interferon	O
(IFN-alpha/beta)-induced	O
gene	O
expression.	O
The	O
mechanisms	O
by	O
which	O
these	O
promoters	O
of	O
cell	O
growth	O
exert	O
their	O
inhibitory	O
effects	O
vary,	O
but	O
in	O
most	O
instances	O
they	O
involve	O
a	O
disruption	O
of	O
the	O
IFN-alpha/beta-induced	O
transcription	O
complex	O
ISGF3	O
such	O
that	O
the	O
DNA-binding	O
component	O
of	O
this	O
complex	O
(the	O
48-kDa	O
ISGF3gamma	O
protein)	O
does	O
not	O
bind	O
to	O
the	O
interferon-stimulated	O
response	O
element	O
(ISRE).	O
In	O
this	O
report,	O
we	O
demonstrated	O
that	O
phorbol	O
ester	O
treatment	O
of	O
human	O
peripheral	O
blood	O
monocytes	O
dramatically	O
inhibits	O
activation	O
of	O
IFN-alpha/B-stimulated	O
early	O
response	O
genes	O
but	O
by	O
a	O
mechanism	O
which	O
does	O
not	O
involve	O
abrogation	O
of	O
the	O
ISRE	O
binding	O
of	O
ISGF3gamma.	O
Phorbol	O
ester	O
treatment	O
of	O
monocytes	O
inhibited	O
IFN	O
alpha-stimulated	O
tyrosine	O
phosphorylation	O
of	O
the	O
transcription	protein
factors	protein
Stat1alpha	protein
,	O
Stat2	protein
,	O
and	O
Stat3	protein
and	O
of	O
the	O
tyrosine	protein
kinase	protein
Tyk2	protein
but	O
had	O
no	O
effect	O
on	O
IFN-gamma	protein
activation	O
of	O
Stat1alpha	protein
.	O
IFNalpha-stimulated	O
tyrosine	O
phosphorylation	O
of	O
Jak1	protein
and	O
the	O
alpha	protein
subunit	protein
of	O
the	O
IFN-alpha	protein
receptor	protein
were	O
unaffected	O
by	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
).	O
Moreover,	O
PMA	O
caused	O
the	O
dephosphorylation	O
of	O
Tyk2	protein
but	O
not	O
of	O
Jak1	protein
,	O
which	O
was	O
activated	O
by	O
IFN	protein
.	O
Pretreatment	O
of	O
cells	O
with	O
vanadate	O
prevented	O
the	O
effects	O
of	O
PMA	O
with	O
regard	O
to	O
PMA	O
-induced	O
Tyk2	protein
dephosphorylation	O
.	O
These	O
observations	O
suggest	O
that	O
PMA	O
exerts	O
its	O
inhibitory	O
effects	O
by	O
activation	O
of	O
a	O
tyrosine	protein
phosphatase	protein
which	O
selectively	O
regulates	O
Tyk2	protein
but	O
not	O
Jak1	protein
activity	O
.	O

Transcriptional	O
regulation	O
of	O
the	O
interleukin-2	DNA
gene	DNA
in	O
normal	O
human	cell_type
peripheral	cell_type
blood	cell_type
T	cell_type
cells	cell_type
.	O
Convergence	O
of	O
costimulatory	O
signals	O
and	O
differences	O
from	O
transformed	cell_type
T	cell_type
cells	cell_type
.	O
To	O
study	O
transcriptional	O
regulation	O
in	O
normal	cell_type
human	cell_type
T	cell_type
cells	cell_type
,	O
we	O
have	O
optimized	O
conditions	O
for	O
transient	O
transfection	O
.	O
Interleukin-2	DNA
(	DNA
IL-2	DNA
)	DNA
promoter	DNA
-reporter	DNA
gene	DNA
behavior	O
closely	O
parallels	O
the	O
endogenous	DNA
gene	DNA
in	O
response	O
to	O
T	protein
cell	protein
receptor	protein
and	O
costimulatory	O
signals	O
.	O
As	O
assessed	O
with	O
mutagenized	DNA
promoters	DNA
,	O
the	O
most	O
important	O
IL-2	DNA
cis-regulatory	DNA
elements	DNA
in	O
normal	cell_type
T	cell_type
cells	cell_type
are	O
the	O
proximal	DNA
AP-1	DNA
site	DNA
and	O
the	O
NF-	DNA
kappaB	DNA
site	DNA
.	O
Both	O
primary	O
activation,	O
with	O
phytohemagglutinin	protein
or	O
antibodies	protein
to	protein
CD3	protein
,	O
and	O
costimulation	O
,	O
provided	O
by	O
pairs	O
of	O
CD2	protein
antibodies	protein
or	O
B7-positive	cell_type
(B	cell_type
cells)	cell_type
or	O
B7-negative	cell_type
(endothelial)	cell_type
accessory	cell_type
cells,	cell_type
are	O
mediated	O
through	O
the	O
same	O
cis-elements	DNA
.	O
Interestingly,	O
the	O
nuclear	DNA
factor	DNA
of	DNA
activated	DNA
T	DNA
cell	DNA
sites	DNA
are	O
much	O
less	O
important	O
in	O
normal	cell_type
T	cell_type
cells	cell_type
than	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
We	O
conclude	O
that	O
IL-2	protein
transcriptional	O
regulation	O
differs	O
in	O
tumor	cell_line
cell	cell_line
lines	cell_line
compared	O
with	O
normal	cell_type
T	cell_type
cells	cell_type
and	O
that	O
different	O
costimulatory	O
signals	O
converge	O
on	O
the	O
same	O
cis-elements	DNA
in	O
the	O
IL-2	DNA
promoter	DNA
.	O

The	O
RAR-RXR	protein
as	O
well	O
as	O
the	O
RXR-RXR	protein
pathway	O
is	O
involved	O
in	O
signaling	O
growth	O
inhibition	O
of	O
human	cell_line
CD34+	cell_line
erythroid	cell_line
progenitor	cell_line
cells	cell_line
.	O
Previous	O
studies	O
have	O
shown	O
that	O
retinoic	O
acid	O
(	O
RA	O
),	O
similar	O
to	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
),	O
can	O
act	O
as	O
a	O
bifunctional	O
regulator	O
of	O
the	O
growth	O
of	O
bone	cell_type
marrow	cell_type
progenitors	cell_type
,	O
in	O
that	O
it	O
can	O
stimulate	O
granulocyte-macrophage	O
colony-stimulating	O
factor	O
(GM-CSF)-	O
or	O
interleukin-3	O
(IL-3)-	O
induced	O
GM	O
colony	O
formation	O
,	O
but	O
potently	O
inhibit	O
G-CSF	protein
-induced	O
growth	O
.	O
The	O
present	O
study,	O
using	O
highly	O
enriched	O
human	protein
CD34+	protein
as	O
well	O
as	O
Lin-	cell_line
murine	cell_line
bone	cell_line
marrow	cell_line
progenitor	cell_line
cells	cell_line
,	O
demonstrates	O
a	O
potent	O
inhibitory	O
effect	O
of	O
9-cis-RA	O
on	O
burst-forming	O
unit-erythroid	O
(BFU-E)	O
colony	O
formation	O
regardless	O
of	O
the	O
cytokine	protein
stimulating	O
growth	O
.	O
Specifically,	O
9-cis-RA	O
potently	O
inhibited	O
the	O
growth	O
of	O
BFU-E	O
response	O
to	O
erythropoietin	protein
(	O
Epo	protein
)	O
(100%),	O
stem	protein
cell	protein
factor	protein
(	O
SCF	protein
)	O
+	O
Epo	protein
(92%),	O
IL-3	protein
+	O
Epo	protein
(97%),	O
IL-4	protein
+	O
Epo	protein
(88%),	O
and	O
IL-9	protein
+	O
Epo	protein
(100%).	O
Erythroid	O
colony	O
growth	O
was	O
also	O
inhibited	O
when	O
CD34+	cell_type
progenitors	cell_type
were	O
seeded	O
at	O
one	O
cell	O
per	O
well,	O
suggesting	O
a	O
direct	O
action	O
of	O
RA	O
.	O
Using	O
synthetic	O
ligands	O
to	O
retinoic	protein
acid	protein
receptors	protein
(	O
RARs	protein
)	O
and	O
retinoid	protein
X	protein
receptors	protein
(	O
RXRs	protein
)	O
that	O
selectively	O
bind	O
and	O
activate	O
RAR-RXR	protein
or	O
RXR-RXR	protein
dimers,	O
respectively,	O
we	O
dissected	O
the	O
involvement	O
of	O
the	O
two	O
retinoid	O
response	O
pathways	O
in	O
the	O
regulation	O
of	O
normal	O
myeloid	O
and	O
erythroid	O
progenitor	O
cell	O
growth	O
.	O
Transactivation	O
studies	O
showed	O
that	O
both	O
the	O
RAR	protein
(	O
Ro	O
13-7410	O
)	O
and	O
RXR	protein
(	O
Ro	O
25-6603	O
and	O
Ro	O
25-7386	O
)	O
ligands	O
were	O
highly	O
selective	O
at	O
100	O
nmol/L.	O
At	O
this	O
concentration,	O
Ro	O
13-7410	O
potently	O
inhibited	O
G-CSF	protein
-stimulated	O
myeloid	O
as	O
well	O
as	O
SCF	protein
+	O
Epo	protein
-induced	O
erythroid	O
colony	O
growth	O
.	O
At	O
the	O
same	O
concentration,	O
Ro	O
25-6603	O
and	O
Ro	O
25-7386	O
had	O
little	O
or	O
no	O
effect	O
on	O
G-CSF	protein
-induced	O
colony	O
formation	O
,	O
whereas	O
they	O
inhibited	O
75%	O
and	O
53%,	O
respectively,	O
of	O
SCF	protein
+	O
Epo	protein
-stimulated	O
BFU-E	O
colony	O
growth	O
.	O
Thus,	O
the	O
RAR-RXR	protein
response	O
pathway	O
can	O
signal	O
growth	O
inhibition	O
of	O
normal	O
bone	O
marrow	O
myeloid	O
and	O
erythroid	O
progenitor	O
cells	O
.	O
In	O
addition,	O
we	O
demonstrate	O
a	O
unique	O
involvement	O
of	O
the	O
RXR-RXR	protein
pathway	O
in	O
mediating	O
growth	O
inhibition	O
of	O
erythroid	cell_type
but	O
not	O
myeloid	cell_type
progenitor	cell_type
cells	cell_type
.	O

AM580	O
,	O
a	O
stable	O
benzoic	O
derivative	O
of	O
retinoic	O
acid	O
,	O
has	O
powerful	O
and	O
selective	O
cyto-differentiating	O
effects	O
on	O
acute	cell_line
promyelocytic	cell_line
leukemia	cell_line
cells	cell_line
.	O
All-trans	O
retinoic	O
acid	O
(	O
ATRA	O
)	O
is	O
successfully	O
used	O
in	O
the	O
cyto-differentiating	O
treatment	O
of	O
acute	O
promyelocytic	O
leukemia	O
(	O
APL	O
).	O
Paradoxically,	O
APL	cell_line
cells	cell_line
express	O
PML-RAR	protein
,	O
an	O
aberrant	O
form	O
of	O
the	O
retinoic	protein
acid	protein
receptor	protein
type	protein
alpha	protein
(	O
RAR	protein
alpha	protein
)	O
derived	O
from	O
the	O
leukemia-specific	DNA
t(15;17)	DNA
chromosomal	DNA
translocation	DNA
.	O
We	O
show	O
here	O
that	O
AM580	O
,	O
a	O
stable	O
retinobenzoic	O
derivative	O
originally	O
synthesized	O
as	O
a	O
RAR	protein
alpha	protein
agonist	O
,	O
is	O
a	O
powerful	O
inducer	O
of	O
granulocytic	O
maturation	O
in	O
NB4	cell_line
,	O
an	O
APL	cell_line
-derived	cell_line
cell	cell_line
line	cell_line
,	O
and	O
in	O
freshly	cell_type
isolated	cell_type
APL	cell_type
blasts	cell_type
.	O
After	O
treatment	O
of	O
APL	cell_line
cells	cell_line
with	O
AM580	O
either	O
alone	O
or	O
in	O
combination	O
with	O
granulocyte	protein
colony-stimulating	protein
factor	protein
(	O
G-CSF	protein
),	O
the	O
compound	O
induces	O
granulocytic	O
maturation	O
,	O
as	O
assessed	O
by	O
determination	O
of	O
the	O
levels	O
of	O
leukocyte	O
alkaline	O
phosphatase	O
,	O
CD11b	O
,	O
CD33	O
,	O
and	O
G-CSF	O
receptor	O
mRNA	O
,	O
at	O
concentrations	O
that	O
are	O
10-	O
to	O
100-fold	O
lower	O
than	O
those	O
of	O
ATRA	O
necessary	O
to	O
produce	O
similar	O
effects.	O
By	O
contrast,	O
AM580	O
is	O
not	O
effective	O
as	O
ATRA	O
in	O
modulating	O
the	O
expression	O
of	O
these	O
differentiation	protein
markers	protein
in	O
the	O
HL-60	cell_line
cell	cell_line
line	cell_line
and	O
in	O
freshly	cell_type
isolated	cell_type
granulocytes	cell_type
obtained	O
from	O
the	O
peripheral	O
blood	O
of	O
chronic	O
myelogenous	O
leukemia	O
patients	O
during	O
the	O
stable	O
phase	O
of	O
the	O
disease.	O
In	O
NB4	cell_line
cells	cell_line
,	O
two	O
other	O
synthetic	O
nonselective	O
RAR	O
ligands	O
are	O
capable	O
of	O
inducing	O
LAP	protein
as	O
much	O
as	O
AM580	O
,	O
whereas	O
RAR	O
beta-	O
or	O
RAR	O
gamma-specific	O
ligands	O
are	O
totally	O
ineffective.	O
These	O
results	O
show	O
that	O
AM580	O
is	O
more	O
powerful	O
than	O
ATRA	O
in	O
modulating	O
the	O
expression	O
of	O
differentiation	O
antigens	O
only	O
in	O
cells	O
in	O
which	O
PML-RAR	protein
is	O
present.	O
Binding	O
experiments,	O
using	O
COS-7	cell_line
cells	cell_line
transiently	O
transfected	O
with	O
PML-RAR	protein
and	O
the	O
normal	O
RAR	protein
alpha	protein
,	O
show	O
that	O
AM580	O
has	O
a	O
lower	O
affinity	O
than	O
ATRA	O
for	O
both	O
receptors.	O
However,	O
in	O
the	O
presence	O
of	O
PML-RAR	protein
,	O
the	O
synthetic	O
retinoid	O
is	O
a	O
much	O
better	O
transactivator	O
of	O
retinoic	DNA
acid	DNA
-responsive	DNA
element-containing	DNA
promoters	DNA
than	O
the	O
natural	O
retinoid	O
,	O
whereas,	O
in	O
the	O
presence	O
of	O
RAR	protein
alpha	protein
,	O
AM580	O
and	O
ATRA	O
have	O
similar	O
activity.	O
This	O
may	O
explain	O
the	O
strong	O
cyto-differentiating	O
potential	O
of	O
AM580	O
in	O
PML-RAR	cell_type
-containing	cell_type
leukemic	cell_type
cells	cell_type
.	O

Inhibition	O
of	O
vitamin	protein
D	protein
receptor	protein
-retinoid	protein
X	protein
receptor	protein
-vitamin	protein
D	protein
response	protein
element	protein
complex	protein
formation	O
by	O
nuclear	O
extracts	O
of	O
vitamin	cell_type
D-resistant	cell_type
New	cell_type
World	cell_type
primate	cell_type
cells	cell_type
.	O
Most	O
New	O
World	O
primate	O
(	O
NWP	O
)	O
genera	O
evolved	O
to	O
require	O
high	O
circulating	O
levels	O
of	O
steroid	O
hormones	O
and	O
vitamin	O
D	O
.	O
We	O
hypothesized	O
that	O
an	O
intracellular	protein
vitamin	protein
D	protein
binding	protein
protein	protein
(	O
IDBP	protein
),	O
present	O
in	O
both	O
nuclear	O
and	O
cytoplasmic	O
fractions	O
of	O
NWP	cell_line
cells	cell_line
,	O
or	O
another	O
protein(s)	O
may	O
cause	O
or	O
contribute	O
to	O
the	O
steroid	O
hormone-resistant	O
state	O
in	O
NWP	cell_line
by	O
disruption	O
of	O
the	O
receptor	O
dimerization	O
process	O
and/or	O
by	O
interference	O
of	O
receptor	protein
complex	protein
binding	O
to	O
the	O
consensus	DNA
response	DNA
elements	DNA
present	O
in	O
the	O
enhancer	DNA
regions	DNA
of	O
steroid-responsive	DNA
genes	DNA
.	O
We	O
employed	O
electromobility	O
shift	O
assay	O
(	O
EMSA	O
)	O
to	O
screen	O
for	O
the	O
presence	O
of	O
proteins	O
capable	O
of	O
binding	O
to	O
the	O
vitamin	DNA
D	DNA
response	DNA
element	DNA
(	O
VDRE	DNA
).	O
Nuclear	O
and	O
post-	O
nuclear	O
extracts	O
were	O
prepared	O
from	O
two	O
B-lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
known	O
to	O
be	O
representative	O
of	O
the	O
vitamin	cell_line
D	cell_line
-resistant	cell_line
and	O
wild	cell_line
type	cell_line
phenotypes	cell_line
,	O
respectively.	O
The	O
extracts	O
were	O
compared	O
for	O
their	O
ability	O
to	O
retard	O
the	O
migration	O
of	O
radiolabeled	O
double	O
stranded	O
oligomers	O
representative	O
of	O
the	O
VDREs	DNA
of	O
the	O
human	O
osteocalcin	O
and	O
the	O
mouse	O
osteopontin	O
gene	O
promoters	O
.	O
A	O
specific,	O
retarded	O
band	O
containing	O
VDR-RXR	protein
was	O
identified	O
when	O
wild	O
type	O
cell	O
but	O
not	O
when	O
vitamin	O
D	O
-resistant	O
cell	O
nuclear	O
extract	O
was	O
used	O
in	O
the	O
binding	O
reaction	O
with	O
either	O
probe.	O
In	O
addition,	O
vitamin	O
D	O
-resistant	O
cell	O
nuclear	O
extract	O
contained	O
a	O
protein(s)	O
which	O
was	O
bound	O
specifically	O
to	O
the	O
VDRE	DNA
and	O
was	O
capable	O
of	O
completely	O
inhibiting	O
VDR-RXR-	protein
VDRE	protein
complex	protein
formation	O
;	O
these	O
effects	O
were	O
not	O
demonstrated	O
with	O
nuclear	O
extract	O
from	O
the	O
wild	cell_line
type	cell_line
cell	cell_line
line	cell_line
or	O
with	O
the	O
post-nuclear	O
extract	O
of	O
the	O
vitamin	cell_line
D	cell_line
-resistant	cell_line
cell	cell_line
line	cell_line
.	O
We	O
conclude	O
that	O
a	O
VDRE	protein
-binding	protein
protein	protein
(s),	O
distinct	O
from	O
IDBP	protein
and	O
present	O
in	O
nuclear	O
extract	O
of	O
cells	O
from	O
a	O
prototypical	cell_line
vitamin	cell_line
D	cell_line
-resistant	cell_line
NWP	cell_line
,	O
is	O
capable	O
of	O
inhibiting	O
normal	O
VDR-RXR	protein
heterodimer	O
binding	O
to	O
the	O
VDRE	DNA
.	O

BCL-6	protein
expression	O
during	O
B-cell	O
activation.	O
Translocations	O
involving	O
the	O
BCL-6	DNA
gene	DNA
are	O
common	O
in	O
the	O
diffuse	O
large	O
cell	O
subtype	O
of	O
non-Hodgkin's	O
lymphoma	O
.	O
Invariably,	O
the	O
BCL-6	protein
coding	O
region	O
is	O
intact,	O
but	O
its	O
5'	DNA
untranslated	DNA
region	DNA
is	O
replaced	O
with	O
sequences	O
from	O
the	O
translocation	DNA
partner	DNA
.	O
The	O
present	O
study	O
shows	O
that	O
BCL-6	protein
expression	O
is	O
regulated	O
in	O
lymphocytes	cell_type
during	O
mitogenic	O
stimulation	O
.	O
Resting	O
B	O
and	O
T	O
lymphocytes	O
contain	O
high	O
levels	O
of	O
BCL-6	RNA
mRNA	RNA
.	O
Stimulation	O
of	O
mouse	cell_type
B	cell_type
cells	cell_type
with	O
anti-	O
IgM	O
or	O
IgD	O
antibodies	O
,	O
bacterial	O
lipopolysaccharide	O
,	O
phorbol	O
12-myristate	O
13-acetate	O
plus	O
ionomycin	O
,	O
or	O
CD40	protein
ligand	protein
led	O
to	O
a	O
five-fold	O
to	O
35-fold	O
decrease	O
in	O
BCL-6	RNA
mRNA	RNA
levels	O
.	O
Similar	O
downregulation	O
of	O
BCL-6	RNA
mRNA	RNA
was	O
seen	O
in	O
human	cell_type
B	cell_type
cells	cell_type
stimulated	O
with	O
Staphylococcus	O
aureus	O
plus	O
interleukin-2	protein
or	O
anti-IgM	protein
antibodies	protein
and	O
in	O
human	cell_type
T	cell_type
lymphocytes	cell_type
stimulated	O
with	O
phytohemagglutinin	protein
.	O
BCL-6	RNA
mRNA	RNA
levels	O
began	O
to	O
decrease	O
8	O
to	O
16	O
hours	O
after	O
stimulation,	O
before	O
cells	O
entered	O
S	O
phase	O
.	O
Although	O
polyclonal	O
activation	O
of	O
B	cell_type
cells	cell_type
in	O
vitro	O
invariably	O
decreased	O
BCL-6	protein
MRNA	O
expression,	O
activated	cell_type
B	cell_type
cells	cell_type
from	O
human	O
germinal	O
centers	O
expressed	O
BCL-6	O
mRNA	O
at	O
levels	O
comparable	O
to	O
the	O
levels	O
in	O
resting	O
B	O
cells.	O
Despite	O
these	O
similar	O
mRNA	O
levels,	O
BCL-6	protein
protein	O
expression	O
was	O
threefold	O
to	O
34-fold	O
higher	O
in	O
germinal	cell_type
center	cell_type
B	cell_type
cells	cell_type
than	O
in	O
resting	cell_type
B	cell_type
cells	cell_type
,	O
suggesting	O
that	O
BCL-6	protein
protein	O
levels	O
are	O
controlled	O
by	O
translational	O
or	O
posttranslational	O
mechanisms	O
.	O
These	O
observations	O
suggest	O
that	O
the	O
germinal	O
center	O
reaction	O
provides	O
unique	O
activation	O
signals	O
to	O
B	cell_type
cells	cell_type
that	O
allow	O
for	O
continued,	O
high-level	O
BCL-6	protein
expression	O
.	O

DNA-binding	protein
phosphoproteins	protein
induced	O
after	O
T	O
cell	O
activation	O
:	O
effects	O
of	O
cyclosporin	O
A	O
.	O
To	O
define	O
novel	protein
proteins	protein
involved	O
in	O
the	O
early	O
transcriptional	O
response	O
during	O
the	O
activation	O
of	O
human	cell_type
T	cell_type
lymphocytes	cell_type
,	O
we	O
used	O
a	O
high-resolution,	O
two-dimensional	O
gel	O
electrophoresis	O
system	O
to	O
identify	O
nuclear,	protein
deoxyribonucleic	protein
acid	protein
(DNA)	protein
binding	protein
proteins	protein
exhibiting	O
rapid	O
changes	O
in	O
phosphorylation	O
following	O
cell	O
stimulation.	O
We	O
identified	O
18	O
nuclear	protein
proteins	protein
whose	O
phosphorylation	O
level	O
changed	O
more	O
than	O
5-fold	O
upon	O
activation.	O
Of	O
these,	O
11	O
were	O
found	O
to	O
possess	O
DNA-binding	O
properties	O
.	O
The	O
11	O
phosphoproteins	protein
with	O
DNA-binding	O
activity	O
,	O
along	O
with	O
4	O
others,	O
were	O
analyzed	O
further.	O
Phosphoamino	O
acid	O
analysis	O
revealed	O
several	O
sets	O
of	O
proteins	O
with	O
different	O
phosphorylated	O
residues	O
Kinetic	O
analysis	O
of	O
the	O
phosphorylation	O
of	O
the	O
selected	O
proteins	O
was	O
performed	O
and	O
revealed	O
a	O
complex	O
group	O
of	O
transient	O
and	O
sustained	O
responses	O
to	O
cell	O
activation	O
.	O
Finally,	O
the	O
activation-induced	O
changes	O
in	O
one	O
set	O
of	O
phosphoproteins	protein
were	O
dramatically	O
inhibited	O
by	O
cyclosporin	O
A	O
.	O
We	O
suggest	O
that	O
these	O
phosphoproteins	protein
may	O
be	O
directly	O
involved	O
in	O
regulating	O
the	O
transcriptional	O
response	O
to	O
cellular	O
activation	O
by	O
external	O
stimuli.	O

Inactivation	O
of	O
IkappaBbeta	protein
by	O
the	O
tax	protein
protein	protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
:	O
a	O
potential	O
mechanism	O
for	O
constitutive	O
induction	O
of	O
NF-kappaB	protein
.	O
In	O
resting	cell_type
T	cell_type
lymphocytes	cell_type
,	O
the	O
transcription	protein
factor	protein
NF-kappaB	protein
is	O
sequestered	O
in	O
the	O
cytoplasm	O
via	O
interactions	O
with	O
members	O
of	O
the	O
I	protein
kappa	protein
B	protein
family	protein
of	O
inhibitors,	O
including	O
IkappaBalpha	protein
and	O
IkappaBbeta	protein
.	O
During	O
normal	O
T-cell	O
activation	O
,	O
IkappaBalpha	protein
is	O
rapidly	O
phosphorylated,	O
ubiquitinated,	O
and	O
degraded	O
by	O
the	O
26S	protein
proteasome	protein
,	O
thus	O
permitting	O
the	O
release	O
of	O
functional	O
NF-kappaB	protein
.	O
In	O
contrast	O
to	O
its	O
transient	O
pattern	O
of	O
nuclear	O
induction	O
during	O
an	O
immune	O
response,	O
NF-kappaB	protein
is	O
constitutively	O
activated	O
in	O
cells	O
expressing	O
the	O
Tax	protein
transforming	protein
protein	protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-1	O
).	O
Recent	O
studies	O
indicate	O
that	O
HTLV-1	O
Tax	protein
targets	O
IkappaBalpha	protein
to	O
the	O
ubiquitin-	O
proteasome	O
pathway	O
.	O
However,	O
it	O
remains	O
unclear	O
how	O
this	O
viral	protein
protein	protein
induces	O
a	O
persistent	O
rather	O
than	O
transient	O
NF-kappaB	protein
response	O
.	O
In	O
this	O
report,	O
we	O
provide	O
evidence	O
that	O
in	O
addition	O
to	O
acting	O
on	O
IkappaBalpha	protein
,	O
Tax	protein
stimulates	O
the	O
turnover	O
Of	O
IkappaBbeta	protein
via	O
a	O
related	O
targeting	O
mechanism.	O
Like	O
IkappaBalpha	protein
,	O
Tax	protein
-mediated	O
breakdown	O
of	O
IkappaBbeta	protein
in	O
transfected	cell_line
T	cell_line
lymphocytes	cell_line
is	O
blocked	O
either	O
by	O
cell-permeable	O
proteasome	O
inhibitors	O
or	O
by	O
mutation	O
Of	O
IkappaBbeta	protein
at	O
two	O
serine	O
residues	O
present	O
within	O
its	O
N-terminal	protein
region	protein
.	O
Despite	O
the	O
dual	O
specificity	O
of	O
HTLV-1	O
Tax	protein
for	O
IkappaBalpha	protein
and	O
IkappaBbeta	protein
at	O
the	O
protein	O
level,	O
Tax	protein
selectively	O
stimulates	O
NF-kappaB	protein
-directed	O
transcription	O
of	O
the	O
IkappaBalpha	DNA
gene	DNA
.	O
Consequently,	O
IkappaBbeta	protein
protein	O
expression	O
is	O
chronically	O
downregulated	O
in	O
HTLV-1	cell_type
-infected	cell_type
T	cell_type
lymphocytes	cell_type
.	O
These	O
findings	O
with	O
IkappaBbeta	protein
provide	O
a	O
potential	O
mechanism	O
for	O
the	O
constitutive	O
activation	O
of	O
NF-kappaB	protein
in	O
Tax	cell_line
-expressing	cell_line
cells	cell_line
.	O

The	O
role	O
of	O
p16	protein
in	O
the	O
E2F-dependent	protein
thymidine	protein
kinase	protein
regulation	O
.	O
The	O
role	O
of	O
alterations	O
of	O
the	O
MTS1	DNA
tumor	DNA
suppressor	DNA
gene	DNA
on	O
chromosome	DNA
9p21	DNA
,	O
which	O
encodes	O
p16	protein
,	O
the	O
inhibitor	O
of	O
cyclin-dependent-kinase-	O
4	O
and	O
6	O
,	O
in	O
tumorigenesis	O
is	O
not	O
yet	O
clear.	O
Phosphorylation	O
of	O
the	O
retinoblastoma	protein
protein	protein
by	O
cyclin-dependent	O
kinases	O
4	O
and	O
6	O
prevents	O
its	O
interaction	O
with	O
the	O
transcription	protein
factor	protein
E2F	protein
,	O
which	O
subsequently	O
promotes	O
the	O
expression	O
of	O
S	DNA
phase	DNA
regulated	DNA
genes	DNA
,	O
such	O
as	O
thymidine	protein
kinase	protein
.	O
Although	O
a	O
role	O
of	O
p16	protein
in	O
this	O
regulation	O
has	O
been	O
presumed,	O
there	O
is	O
no	O
proof	O
so	O
far	O
that	O
loss	O
of	O
this	O
tumor	DNA
suppressor	DNA
gene	DNA
really	O
affects	O
E2F	protein
-mediated	O
regulations.	O
We	O
investigated	O
the	O
regulation	O
of	O
thymidine	protein
kinase	protein
in	O
phytohemagglutinin	cell_line
-stimulated	cell_line
normal	cell_line
human	cell_line
lymphocytes	cell_line
and	O
in	O
the	O
p16	cell_line
-negative	cell_line
human	cell_line
acute	cell_line
lymphoblastic	cell_line
leukemia	cell_line
cell	cell_line
lines	cell_line
,	O
MOLT-4	cell_line
and	O
CEM	cell_line
.	O
Compared	O
to	O
normal	cell_type
lymphocytes	cell_type
,	O
MOLT-4	O
and	O
CEM	O
cells	O
exhibited	O
an	O
altered	O
cell	O
cycle	O
regulation	O
of	O
thymidine	protein
kinase	protein
,	O
a	O
much	O
higher	O
intracellular	O
activity	O
of	O
this	O
enzyme	protein
,	O
and	O
higher	O
thymidine	RNA
kinase	RNA
mRNA	RNA
expression	O
.	O
Transient	O
expression	O
of	O
p16	protein
in	O
normal	O
human	O
lymphocytes	O
caused	O
arrest	O
in	O
G1,	O
but	O
was	O
without	O
effect	O
on	O
the	O
cell	O
growth	O
of	O
MOLT-4	O
and	O
CEM	O
cells	O
,	O
although	O
all	O
of	O
them	O
express	O
functional	O
retinoblastoma	protein
protein	protein
.	O
Nevertheless,	O
in	O
the	O
two	O
leukemia	cell_line
cell	cell_line
lines	cell_line
transient	O
overexpression	O
of	O
p16	protein
reestablished	O
the	O
normal	O
regulation	O
of	O
thymidine	protein
kinase	protein
,	O
paralleled	O
by	O
an	O
increase	O
of	O
the	O
underphosphorylated	O
form	O
of	O
retinoblastoma	protein
protein	protein
and	O
decrease	O
of	O
free	O
E2F	protein
bound	O
to	O
its	O
motif	O
in	O
the	O
thymidine	DNA
kinase	DNA
promoter	DNA
.	O
We	O
demonstrate	O
that	O
loss	O
of	O
p16	protein
causes	O
upregulation	O
of	O
this	O
DNA	O
precursor	O
pathway	O
enzyme	protein
via	O
activation	O
of	O
E2F	protein
by	O
a	O
mechanism	O
involving	O
retinoblastoma	protein
protein	protein
.	O

Interactions	O
of	O
a	O
transcriptional	DNA
activator	DNA
in	O
the	O
env	DNA
gene	DNA
of	O
the	O
mouse	O
mammary	O
tumor	O
virus	O
with	O
activation-dependent,	protein
T	protein
cell-specific	protein
transacting	protein
factors	protein
.	O
The	O
mouse	O
mammary	O
tumor	O
virus	O
env	DNA
gene	DNA
contains	O
a	O
transcriptional	DNA
activator	DNA
(	O
META	DNA
)	O
that	O
can	O
control	O
transcription	O
of	O
the	O
adjacent	O
long	DNA
terminal	DNA
repeat	DNA
region	DNA
.	O
Transcriptional	O
control	O
by	O
META	DNA
parallels	O
that	O
of	O
several	O
lymphokine	DNA
genes	DNA
,	O
being	O
specific	O
to	O
T	cell_type
cells	cell_type
,	O
dependent	O
on	O
their	O
activation,	O
and	O
inhibited	O
by	O
the	O
immunosuppressive	O
drug	O
cyclosporine	O
(	O
CsA	O
).	O
DNase	protein
I	protein
footprinting	O
indicated	O
that	O
nuclear	protein
factors	protein
from	O
activated	cell_type
T	cell_type
lymphocytes	cell_type
bound	O
a	O
promoter-proximal	DNA
site	DNA
,	O
META(P)	DNA
,	O
and	O
a	O
promoter-distal	DNA
site	DNA
,	O
META(D+)	DNA
,	O
within	O
the	O
400-base	DNA
pair	DNA
META	DNA
region	DNA
.	O
Nuclear	protein
factors	protein
from	O
unstimulated,	O
but	O
not	O
from	O
activated	O
cells,	O
bound	O
a	O
site,	O
META(D-)	DNA
,	O
adjacent	O
to	O
META(D+)	DNA
.	O
META(D+)	DNA
directed	O
transcription	O
of	O
a	O
linked	O
luciferase	DNA
gene	DNA
,	O
and	O
gel	O
shift	O
analysis	O
revealed	O
binding	O
of	O
inducible,	O
CsA	protein
-sensitive	protein
T	protein
cell	protein
factors	protein
,	O
in	O
parallel	O
with	O
transfection	O
results	O
.	O
Authentic	O
NFAT	O
and	O
NF-kappaB	O
targets	O
did	O
not	O
compete	O
for	O
the	O
META(D+)	protein
binding	protein
factor	protein
(s).	O
The	O
SV40	DNA
core	DNA
sequence	DNA
competed	O
for	O
META(D+)	protein
binding	protein
factors	protein
,	O
but	O
META(D+)	DNA
failed	O
to	O
compete	O
for	O
the	O
complexes	O
obtained	O
with	O
the	O
SV40	O
probe	O
.	O
Our	O
results,	O
taken	O
together,	O
indicate	O
that	O
META(D+)	DNA
is	O
a	O
novel	O
transcriptional	DNA
enhancer	DNA
element	DNA
that	O
is	O
similar	O
in	O
its	O
cell-type	O
specificity,	O
activation	O
dependence,	O
and	O
CsA	O
sensitivity	O
to	O
the	O
NFAT	DNA
element	DNA
.	O
It	O
may	O
be	O
relevant	O
to	O
the	O
role	O
of	O
MMTV	O
in	O
expression	O
of	O
Mls	protein
antigens	protein
or	O
the	O
induction	O
of	O
T	O
cell	O
lymphomas	O
.	O

A	O
novel	O
interferon	protein
regulatory	protein
factor	protein
family	protein
transcription	protein
factor	protein
,	O
ICSAT/Pip/LSIRF	protein
,	O
that	O
negatively	O
regulates	O
the	O
activity	O
of	O
interferon-regulated	DNA
genes	DNA
.	O
We	O
have	O
isolated	O
a	O
novel	DNA
cDNA	DNA
clone	DNA
encoding	O
interferon	protein
(IFN)	protein
consensus	protein
sequence-binding	protein
protein	protein
in	O
adult	cell_line
T-cell	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
or	O
activated	O
T	cell_type
cells	cell_type
(	O
ICSAT	protein
);	O
this	O
protein	O
is	O
the	O
human	O
homolog	O
of	O
the	O
recently	O
cloned	O
Pip/LSIRF	protein
.	O
ICSAT	protein
is	O
structurally	O
most	O
closely	O
related	O
to	O
the	O
previously	O
cloned	O
ICSBP	protein
,	O
a	O
member	O
of	O
the	O
IFN	protein
regulatory	protein
factor	protein
(IRF)	protein
family	protein
of	O
proteins	O
that	O
binds	O
to	O
interferon	DNA
consensus	DNA
sequences	DNA
(	O
ICSs	DNA
)	O
found	O
in	O
many	O
promoters	O
of	O
the	O
IFN-regulated	DNA
genes	DNA
.	O
Among	O
T-cell	cell_line
lines	cell_line
investigated,	O
ICSAT	protein
was	O
abundantly	O
expressed	O
in	O
human	cell_line
T-cell	cell_line
leukemia	cell_line
virus	cell_line
type	cell_line
1	cell_line
(	cell_line
HTLV-1	cell_line
)-infected	cell_line
T	cell_line
cells	cell_line
.	O
When	O
the	O
HTLV-1	DNA
tax	DNA
gene	DNA
was	O
expressed	O
or	O
phorbol	O
myristake	O
acetate-A23187	O
stimulation	O
was	O
used,	O
ICSAT	protein
expression	O
was	O
induced	O
in	O
Jurkat	cell_line
cells	cell_line
which	O
otherwise	O
do	O
not	O
express	O
ICSAT	protein
.	O
When	O
the	O
binding	O
of	O
ICSAT	protein
to	O
four	O
different	O
ICSs	DNA
was	O
tested,	O
the	O
relative	O
differences	O
in	O
binding	O
affinities	O
for	O
those	O
ICSs	DNA
were	O
determined.	O
To	O
study	O
the	O
functional	O
role	O
of	O
ICSAT	protein
,	O
we	O
performed	O
cotransfection	O
experiments	O
with	O
the	O
human	cell_line
embryonal	cell_line
carcinoma	cell_line
cell	cell_line
line	cell_line
N-Tera2	cell_line
.	O
ICSAT	protein
was	O
demonstrated	O
to	O
possess	O
repressive	O
function	O
over	O
the	O
gene	O
activation	O
induced	O
by	O
IFN	protein
stimulation	O
or	O
by	O
IRF-1	protein
cotransfection	O
.	O
Such	O
repressive	O
function	O
is	O
similar	O
to	O
that	O
seen	O
in	O
IRF-2	protein
or	O
ICSBP	protein
.	O
However,	O
we	O
have	O
found	O
that	O
ICSAT	protein
has	O
a	O
different	O
repressive	O
effect	O
from	O
that	O
of	O
IRF-2	protein
or	O
ICSBP	protein
in	O
some	O
IFN-responsive	DNA
reporter	DNA
constructs	DNA
.	O
These	O
results	O
suggest	O
that	O
a	O
novel	O
mechanism	O
of	O
gene	O
regulation	O
by	O
"differential	O
repression"	O
is	O
used	O
by	O
multiple	O
members	O
of	O
repressor	protein
proteins	protein
with	O
different	O
repressive	O
effects	O
on	O
the	O
IFN-responsive	DNA
genes	DNA
.	O

Regulation	O
of	O
[	O
Ca2+	O
]i	O
rise	O
activated	O
by	O
doxepin-sensitive	protein
H1-histamine	protein
receptors	protein
in	O
Jurkat	cell_line
cells	cell_line
,	O
cloned	cell_line
human	cell_line
T	cell_line
lymphocytes	cell_line
.	O
To	O
clarify	O
the	O
presence	O
of	O
histamine	protein
receptor	protein
and	O
its	O
transmembrane	O
mechanism	O
in	O
human	cell_type
T	cell_type
lymphocytes	cell_type
,	O
we	O
investigated	O
the	O
effects	O
of	O
agonists	O
or	O
antagonists	O
of	O
histamine	protein
receptor	protein
subtypes	O
and	O
bacterial	O
toxins	O
on	O
intracellular	O
concentration	O
of	O
Ca2+	O
[	O
Ca2+	O
]i	O
),	O
[3H]pyrilamine	O
binding	O
and	O
c-fos	RNA
mRNA	RNA
expression	O
in	O
Jurkat	cell_line
cells	cell_line
,	O
cloned	O
human	cell_type
T	cell_type
lymphocytes	cell_type
.	O
H1-agonists	O
(	O
histamine	O
and	O
2-methylhistamine	O
)	O
caused	O
a	O
transient	O
rise	O
of	O
[	O
Ca2+	O
],	O
and	O
H1-antagonists	O
(	O
pyrilamine	O
and	O
doxepin	O
)	O
inhibited	O
the	O
histamine	O
-induced	O
[	O
Ca2+	O
]i	O
rise	O
more	O
potently	O
than	O
the	O
H2-antagonist	O
(	O
cimetidine	O
)	O
on	O
the	O
H3-antagonist	O
(	O
impromidine	O
).	O
Binding	O
parameters	O
of	O
[3H]	O
pyrilamine	O
binding	O
were	O
Kd	O
=	O
5.53	O
nM	O
and	O
Bmax	O
=	O
2,647	O
sites/cell.	O
Pretreatment	O
with	O
B.pertussis	O
,	O
V.cholera.	O
or	O
C.botulinum	O
toxin	O
did	O
not	O
influence	O
histamine	O
-induced	O
[	O
Ca2+	O
]i	O
rise	O
.	O
Western	O
Blot	O
analysis	O
using	O
antibodies	O
against	O
subunits	O
of	O
GTP-binding	protein
proteins	protein
indicated	O
that	O
Gq/G11	protein
richly	O
existed	O
in	O
Jurkat	cell_line
cells	cell_line
.	O
Histamine	O
induced	O
mRNA	RNA
expression	O
of	O
an	O
immediate	DNA
early	DNA
gene	DNA
c-fos	DNA
.	O
Pretreatment	O
with	O
a	O
protein	protein
kinase	protein
C	protein
activator	O
,	O
phorbol	O
12-myristate	O
13-acetate	O
,	O
caused	O
almost	O
complete	O
inhibition	O
of	O
histamine	O
-induced	O
[	O
Ca2+	O
]i	O
rise	O
,	O
but	O
did	O
not	O
do	O
so	O
by	O
activators	O
of	O
cAMP-	O
and	O
cGMP-	O
dependent	O
protein	O
kinases	O
.	O

STAT-related	O
transcription	protein
factors	protein
are	O
constitutively	O
activated	O
in	O
peripheral	cell_type
blood	cell_type
cells	cell_type
from	O
acute	O
leukemia	O
patients	O
.	O
A	O
signal	O
transduction	O
pathway	O
activated	O
by	O
many	O
cytokines	protein
has	O
recently	O
been	O
elaborated.	O
The	O
JAK	protein
kinases	protein
and	O
the	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(STAT)	protein
factors	protein
have	O
been	O
found	O
to	O
be	O
essential	O
components.	O
In	O
this	O
report,	O
we	O
describe	O
the	O
presence	O
of	O
constitutively	O
activated	O
STAT	protein
factors	protein
in	O
peripheral	cell_type
blood	cell_type
cells	cell_type
from	O
patients	O
with	O
acute	O
leukemia	O
.	O
We	O
used	O
oligonucleotide	O
probes	O
from	O
the	O
beta-casein	O
and	O
IRF-1	O
gene	O
promoters	O
and	O
the	O
ISRE	O
probe	O
to	O
detect	O
STAT	protein
proteins	protein
in	O
nuclear	O
extracts	O
from	O
acute	cell_type
leukemia	cell_type
cells	cell_type
in	O
bandshift	O
assays	O
.	O
Specific	O
DNA	O
protein	protein
complex	protein
formation	O
was	O
observed	O
with	O
the	O
probes	O
from	O
the	O
beta-casein	O
and	O
IRF-1	DNA
gene	DNA
promoters	DNA
,	O
but	O
not	O
with	O
the	O
ISRE	O
oligonucleotide	O
probe	O
,	O
when	O
cell	O
extracts	O
from	O
acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
)	O
and	O
acute	O
myeloid	O
leukemia	O
(	O
AML	O
)	O
were	O
investigated.	O
We	O
used	O
nonradioactive	O
oligonucleotides	O
as	O
competitors	O
to	O
show	O
the	O
specificity	O
of	O
the	O
complex	O
formation	O
.	O
Specific	O
antibodies	protein
directed	O
against	O
the	O
individual	O
STAT	protein
proteins	protein
were	O
used	O
in	O
supershift	O
experiments	O
.	O
STAT5-	O
and	O
STAT1-	O
related	O
factors	O
were	O
detected	O
in	O
ALL	O
and	O
STAT1-	O
,	O
STAT3-	O
,	O
and	O
STAT5-	O
related	O
proteins	O
were	O
present	O
in	O
nuclear	O
cell	O
extracts	O
from	O
AML	O
.	O
Since	O
the	O
cells	O
were	O
not	O
treated	O
with	O
cytokines	protein
before	O
the	O
nuclear	protein
proteins	protein
were	O
extracted,	O
we	O
conclude	O
that	O
these	O
factors	O
are	O
constitutively	O
activated	O
in	O
vivo	O
.	O
It	O
is	O
likely	O
that	O
the	O
constitutive	O
activation	O
of	O
STAT	protein
proteins	protein
is	O
a	O
part	O
of	O
the	O
events	O
of	O
leukemogenesis	O
.	O

An	O
element	DNA
upstream	O
from	O
the	O
human	DNA
delta-globin-encoding	DNA
gene	DNA
specifically	O
enhances	O
beta-globin	DNA
reporter	DNA
gene	DNA
expression	O
in	O
murine	cell_type
erythroleukemia	cell_type
cells	cell_type
.	O
We	O
have	O
previously	O
shown	O
that	O
a	O
DNA-binding	protein
factor	protein
specific	O
to	O
adult	cell_type
hematopoietic	cell_type
cells	cell_type
(	O
polypryrimidine-binding	protein
factor	protein
,	O
PYBF	protein
)	O
binds	O
to	O
a	O
pyrimidine-rich	DNA
region	DNA
1	DNA
kb	DNA
upstream	DNA
from	O
the	O
human	DNA
delta-globin-encoding	DNA
gene	DNA
(	O
HBD	DNA
).	O
The	O
developmental	O
stage-specificity	O
of	O
PYBF	protein
and	O
the	O
location	O
of	O
its	O
binding	O
site	O
between	O
the	O
fetal	DNA
and	DNA
adult	DNA
beta-globin	DNA
(HBB)-like	DNA
genes	DNA
suggest	O
that	O
PBYF	protein
and	O
its	O
binding	O
site	O
may	O
function	O
in	O
fetal-to-adult	O
globin	DNA
gene	DNA
switching	O
.	O
Here,	O
we	O
describe	O
the	O
effect	O
of	O
383-bp	O
(delta383)	O
and	O
99-bp	O
(delta99)	O
sequences	O
containing	O
the	O
PYBF	DNA
-binding	DNA
site	DNA
on	O
transcription	O
from	O
various	O
globin	O
and	O
non-globin	O
promoters,	O
using	O
a	O
transient	O
assay	O
with	O
the	O
cat	DNA
reporter	DNA
gene	DNA
in	O
murine	cell_line
erythroleukemia	cell_line
(MEL)	cell_line
cells	cell_line
,	O
a	O
cell	O
line	O
with	O
abundant	O
PYBF	protein
activity	O
.	O
We	O
show	O
that	O
both	O
delta383	DNA
and	O
delta99	DNA
specifically	O
enhance	O
expression	O
of	O
cat	protein
for	O
plasmids	DNA
containing	O
a	O
human	DNA
adult	DNA
globin	DNA
(HBB)	DNA
promoter	DNA
,	O
whereas	O
expression	O
of	O
similar	O
constructs	O
using	O
human	O
fetal	O
(A	O
gamma-)	O
globin	O
(HBG1)	O
or	O
simian	O
virus	O
40	O
(SV40)	O
promoters	O
is	O
not	O
enhanced.	O
The	O
results	O
suggest	O
that	O
PYBF	protein
and	O
the	O
pyrimidine-rich	DNA
region	DNA
upstream	O
from	O
HBD	DNA
can	O
specifically	O
enhance	O
HBB	DNA
transcription	O
in	O
adult	cell_type
erythroid	cell_type
cells	cell_type
.	O

Translocation	DNA
breakpoints	DNA
in	O
three	O
patients	O
with	O
campomelic	O
dysplasia	O
and	O
autosomal	O
sex	O
reversal	O
map	O
more	O
than	O
130	O
kb	O
from	O
SOX9	DNA
.	O
Campomelic	O
dysplasia	O
(	O
CMPD1	O
)	O
and	O
autosomal	O
XY	O
sex	O
reversal	O
(	O
SRA1	O
)	O
are	O
caused	O
by	O
mutations	O
in	O
the	O
SRY-related	DNA
gene	DNA
SOX9	DNA
on	O
17q	DNA
.	O
Unexpectedly,	O
the	O
17q	DNA
breakpoints	DNA
in	O
four	O
CMPD1	O
translocation	O
cases	O
previously	O
analyzed	O
by	O
us	O
and	O
others	O
map	O
50	O
kb	O
or	O
more	O
from	O
SOX9	DNA
.	O
Here,	O
we	O
present	O
clinical	O
,	O
cytogenetic	O
,	O
and	O
molecular	O
data	O
from	O
a	O
new	O
CMPD1	O
/SRA1	O
patient	O
with	O
t(6;17)(q14;q24)	DNA
.	O
Fluorescence	O
in	O
situ	O
hybridization	O
has	O
shown	O
that	O
the	O
17q	DNA
breakpoint	DNA
in	O
this	O
case	O
maps	O
to	O
the	O
same	O
region	O
as	O
the	O
breakpoints	O
in	O
the	O
other	O
translocation	O
cases	O
,	O
at	O
least	O
130	O
kb	O
from	O
SOX9	DNA
.	O
Likewise,	O
the	O
breakpoints	O
in	O
two	O
of	O
the	O
previously	O
described	O
cases	O
also	O
map	O
more	O
than	O
130	O
kb	O
and,	O
as	O
shown	O
by	O
pulsed	O
field	O
gel	O
electrophoresis	O
analysis	O
,	O
at	O
most	O
400	O
kb	O
or	O
690	O
kb	O
from	O
SOX9	DNA
.	O
By	O
using	O
a	O
SOX9	DNA
coding	DNA
sequence	DNA
polymorphism	DNA
,	O
expression	O
of	O
both	O
SOX9	DNA
alleles	O
has	O
been	O
demonstrated	O
by	O
the	O
reverse	protein
transcriptase	protein
polymerase	O
chain	O
reaction	O
in	O
lymphoblastoid	cell_type
cells	cell_type
from	O
one	O
of	O
the	O
translocation	O
cases	O
.	O

An	O
alternatively	O
spliced	O
isoform	O
of	O
the	O
Spi-B	protein
transcription	protein
factor	protein
.	O
Spi-B	protein
is	O
an	O
Ets	protein
transcription	protein
factor	protein
related	O
to	O
the	O
oncoprotein	protein
Spi-1/PU.1	protein
and	O
highly	O
expressed	O
in	O
B	cell_type
lymphoid	cell_type
cells	cell_type
.	O
The	O
Ets	protein
proteins	protein
share	O
a	O
conserved	O
Ets	protein
domain	protein
that	O
mediates	O
specific	O
DNA	O
binding	O
.	O
Spi-B	protein
binds	O
DNA	DNA
sequences	DNA
containing	O
a	O
core	O
5'-GGAA-3'	O
and	O
activates	O
transcription	O
through	O
this	O
motif.	O
Up	O
to	O
date,	O
the	O
biological	O
function	O
of	O
Spi-B	protein
remains	O
unknown.	O
Here,	O
we	O
describe	O
the	O
characterization	O
of	O
an	O
alternatively	O
spliced	O
variant	O
of	O
Spi-B	protein
,	O
named	O
deltaSpi-B	protein
,	O
which	O
has	O
lost	O
the	O
Ets	protein
domain	protein
.	O
In	O
B	cell_type
lymphoid	cell_type
cells	cell_type
,	O
deltaspi-B	O
and	O
spi-B	O
mRNAs	O
were	O
present	O
simultaneously	O
in	O
a	O
ratio	O
of	O
around	O
10%.	O
DeltaSpi-B	protein
product	O
was	O
not	O
able	O
to	O
bind	O
DNA	O
and	O
was	O
recovered	O
in	O
cytoplasmic	O
cellular	O
extracts	O
.	O
We	O
raise	O
the	O
hypothesis	O
that	O
delta	protein
Spi-B	protein
might	O
affect	O
Spi-B	protein
function	O
by	O
recruiting	O
factors	O
involved	O
in	O
Spi-B	protein
activity	O
.	O

Binding	O
and	O
cooperative	O
interactions	O
between	O
two	O
B	protein
cell-specific	protein
transcriptional	protein
coactivators	protein
.	O
The	O
class	protein
II	protein
transactivator	protein
(	O
CIITA	protein
)	O
and	O
B	protein
cell	protein
octamer-binding	protein
protein	protein
1/octamer-binding	protein
factor	protein
1/Oct	protein
coactivator	protein
from	O
B	cell_type
cells	cell_type
(	O
Bob1/OBF-1/OCA-B	protein
)	O
represent	O
two	O
B	protein
cell-specific	protein
transcriptional	protein
coactivators	protein
.	O
CIITA	protein
and	O
Bob1	protein
interact	O
with	O
proteins	O
that	O
bind	O
to	O
conserved	DNA
upstream	DNA
sequences	DNA
in	O
promoters	DNA
of	O
class	DNA
II	DNA
major	DNA
histocompatibility	DNA
genes	DNA
and	O
octamer-binding	protein
transcription	protein
factors	protein
Oct-1	protein
and	O
Oct-2	protein
,	O
respectively.	O
Both	O
CIITA	protein
and	O
Bob1	protein
increase	O
the	O
expression	O
from	O
the	O
DRA	DNA
promoter	DNA
,	O
which	O
is	O
a	O
prototypic	O
class	DNA
II	DNA
promoter	DNA
.	O
Moreover,	O
in	O
the	O
presence	O
of	O
CIITA	protein
,	O
interactions	O
between	O
class	DNA
II	DNA
promoters	DNA
and	O
Bob1	protein
are	O
independent	O
of	O
the	O
octamer-binding	RNA
site	RNA
.	O
Using	O
in	O
vivo	O
and	O
in	O
vitro	O
binding	O
assays	O
,	O
we	O
confirm	O
that	O
Bob1	protein
binds	O
to	O
CIITA	protein
.	O
Thus,	O
CIITA	protein
not	O
only	O
activates	O
the	O
expression	O
of	O
class	DNA
II	DNA
genes	DNA
but	O
recruits	O
another	O
B	O
cell-specific	O
coactivator	O
to	O
increase	O
transcriptional	O
activity	O
of	O
class	DNA
II	DNA
promoters	DNA
in	O
B	cell_type
cells	cell_type
.	O

Efficient	O
transcription	O
and	O
replication	O
of	O
simian	O
immunodeficiency	O
virus	O
in	O
the	O
absence	O
of	O
NF-kappaB	O
and	O
Sp1	O
binding	O
elements	O
.	O
Ten	O
mutants	O
of	O
the	O
simian	O
immunodeficiency	O
virus	O
(	O
SIV	O
)	O
SIVmac239	O
bearing	O
deletions	O
(delta)	O
or	O
substitutions	O
(subst)	O
in	O
the	O
NF-kappaB	DNA
and/or	O
Sp1	DNA
binding	DNA
elements	DNA
were	O
created,	O
and	O
the	O
replicative	O
capacities	O
of	O
the	O
mutants	O
were	O
analyzed.	O
All	O
mutants,	O
including	O
one	O
extensively	O
mutagenized	O
strain	O
entirely	O
missing	O
the	O
NF-kappaB	O
and	O
four	O
Spl	O
binding	O
elements	O
,	O
replicated	O
with	O
wild-type	O
kinetics	O
and	O
to	O
a	O
wild-type	O
level	O
in	O
peripheral	cell_line
blood	cell_line
mononuclear	cell_line
cell	cell_line
cultures	cell_line
in	O
50	O
to	O
100%	O
of	O
the	O
experiments.	O
One	O
group	O
of	O
mutants	O
replicated	O
very	O
similarly	O
to	O
SIVmac239	O
in	O
kinetics	O
and	O
yield	O
in	O
CEMxl74	cell_line
cells	cell_line
(2x	O
NFKappaB	protein
&gt;	O
or	O
=	O
SlVmac239	protein
approximately	O
deltaNFkappaB	protein
approximately	O
deltaSpl234	protein
approximately	O
substNFkappaB	protein
approximately	O
substSpl2	protein
approximately	O
substSp23	protein
),	O
while	O
a	O
second	O
group	O
replicated	O
with	O
delayed	O
or	O
slightly	O
delayed	O
kinetics	O
in	O
CEMxl74	cell_line
cells	cell_line
(	O
SIVmac239	O
&gt;	O
substSp34	protein
&gt;	O
deltaNFkappaBdeltaSpl234	protein
approximately	O
deltaNFkappaBdeltaSp1	protein
&gt;	O
substSpl234	protein
).	O
Reversions	O
or	O
additional	O
mutations	O
were	O
not	O
detected	O
in	O
the	O
U3	O
and	O
R	O
regions	O
of	O
proviral	DNA
DNA	DNA
from	O
CEMxl74	cell_line
cells	cell_line
infected	O
with	O
the	O
SIVmac239	O
mutants	O
.	O
Similar	O
results	O
were	O
obtained	O
when	O
mutants	O
of	O
SIVmacMER	O
(a	O
macrophage-competent	O
derivative	O
of	O
SIVmac239	O
)	O
were	O
tested	O
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cell	cell_type
and	O
CEMx174	cell_line
cultures	cell_line
.	O
However,	O
the	O
growth	O
of	O
most	O
mutated	O
viruses	O
was	O
suppressed	O
in	O
primary	cell_type
rhesus	cell_type
monkey	cell_type
alveolar	cell_type
macrophages	cell_type
(	O
SIVmacMER	O
approximately	O
2xNFkappaB	protein
approximately	O
substNFkappaB	protein
&gt;	O
deltaNFkappaB	protein
&gt;	O
deltaNFkappaB	protein
deltaSpl234	protein
approximately	O
deltaNFkappaBdeltaSpl	protein
&gt;	O
deltaSpl234	protein
approximately	O
substSpl2	protein
&gt;	O
substSp23	protein
approximately	O
substSp34	protein
approximately	O
substSpl234	protein
&gt;	O
or	O
=	O
SIVmac239	O
).	O
Thus,	O
changes	O
in	O
the	O
Sp1	DNA
binding	DNA
sites	DNA
had	O
the	O
most	O
dramatic	O
effects	O
on	O
SIVmac	O
replication	O
in	O
primary	cell_line
macrophage	cell_line
cultures	cell_line
.	O
Analysis	O
of	O
long	DNA
terminal	DNA
repeat	DNA
-driven	O
secreted	O
alkaline	protein
phosphatase	protein
activity	O
in	O
transient	O
assays	O
showed	O
that,	O
unlike	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
,	O
the	O
SIV	DNA
long	DNA
terminal	DNA
repeat	DNA
possesses	O
an	O
enhancer	DNA
region	DNA
just	O
upstream	O
of	O
the	O
NF-kappaB	DNA
element	DNA
which	O
maintains	O
significant	O
levels	O
of	O
basal	O
transcription	O
in	O
the	O
absence	O
of	O
NF-kappaB	O
and	O
Sp1	O
sites	O
.	O
This	O
region	O
is	O
responsive	O
to	O
transactivation	O
by	O
Tat	protein
.	O
In	O
addition,	O
the	O
SIV	DNA
TATA	DNA
box	DNA
was	O
shown	O
to	O
be	O
stronger	O
than	O
that	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
.	O
Therefore,	O
the	O
surprisingly	O
high	O
replicative	O
capacity	O
of	O
NF-kappaB	O
and	O
Sp1	O
binding	O
site	O
mutants	O
of	O
SIVmac	O
is	O
due	O
to	O
unique	O
features	O
or	O
the	O
enhancer/promoter	DNA
region	DNA
.	O

cAMP	O
inducibility	O
of	O
transcriptional	protein
repressor	protein
ICER	protein
in	O
developing	O
and	O
mature	cell_type
human	cell_type
T	cell_type
lymphocytes	cell_type
[published	O
erratum	O
appears	O
in	O
Proc	O
Natl	O
Acad	O
Sci	O
U	O
S	O
A	O
1996	O
Jul	O
23;93(15):8154]	O
Stimulation	O
of	O
the	O
cAMP	O
-dependent	O
signaling	O
pathway	O
exerts	O
an	O
inhibitory	O
effect	O
on	O
the	O
proliferation	O
and	O
effector	O
functions	O
of	O
T	cell_type
cells	cell_type
.	O
The	O
ability	O
of	O
T	cell_type
cells	cell_type
to	O
form	O
high	O
intracellular	O
levels	O
of	O
cAMP	O
is	O
acquired	O
during	O
development	O
in	O
the	O
human	O
thymus	O
and	O
is	O
retained	O
by	O
the	O
majority	O
of	O
mature	O
peripheral	cell_type
T	cell_type
lymphocytes	cell_type
.	O
Here	O
we	O
show	O
that	O
elevated	O
cAMP	O
levels	O
in	O
T	cell_type
cells	cell_type
correlate	O
with	O
the	O
expression	O
of	O
the	O
potent	protein
transcriptional	protein
repressor	protein
ICER	protein
(	O
inducible	protein
cAMP	protein
early	protein
repressor	protein
)	O
previously	O
described	O
in	O
the	O
hypothalamic-pituitary-gonadal	O
axis	O
.	O
Further,	O
in	O
transcriptional	O
assays	O
in	O
vivo,	O
ICER	protein
inhibits	O
calcineurin	protein
-mediated	O
expression	O
of	O
the	O
interleukin	DNA
2	DNA
promoter	DNA
as	O
well	O
as	O
Tax	protein
-mediated	O
transactivation	O
of	O
the	O
human	DNA
T-lymphotropic	DNA
virus	DNA
type	DNA
I	DNA
(	DNA
HTLV-I	DNA
)	DNA
promoter	DNA
.	O
Thus,	O
the	O
induction	O
of	O
ICER	protein
in	O
T	cell_type
cells	cell_type
may	O
play	O
an	O
important	O
role	O
in	O
the	O
cAMP	O
-induced	O
quiescence	O
and	O
the	O
persistent	O
latency	O
of	O
HTLV-I	O
.	O

A	O
hydrophobic	O
domain	O
of	O
Ca2+	protein
-modulating	protein
cyclophilin	protein
ligand	protein
modulates	O
calcium	O
influx	O
signaling	O
in	O
T	O
lymphocytes.	O
Ca2+	protein
-modulating	protein
cyclophilin	protein
ligand	protein
(	O
CAML	protein
)	O
was	O
originally	O
described	O
as	O
a	O
cyclophilin	protein
B-binding	protein
protein	protein
whose	O
overexpression	O
in	O
T	cell_type
cells	cell_type
causes	O
a	O
rise	O
in	O
intracellular	O
calcium	O
,	O
thus	O
activating	O
transcription	protein
factors	protein
responsible	O
for	O
the	O
early	O
immune	O
response	O
.	O
As	O
reported	O
here,	O
structure-function	O
analysis	O
of	O
the	O
CAML	DNA
gene	DNA
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
indicates	O
that	O
two	O
of	O
CAML	protein
's	O
putative	protein
membrane-spanning	protein
domains	protein
are	O
necessary	O
and	O
sufficient	O
for	O
the	O
modulation	O
of	O
intracellular	O
calcium	O
.	O
We	O
propose	O
that	O
the	O
hydrophobic	protein
C-terminal	protein
tail	protein
of	O
CAML	protein
forms	O
its	O
effector	O
domain,	O
thus	O
implicating	O
the	O
N-terminal	protein
hydrophilic	protein
domain	protein
in	O
a	O
regulatory	O
role.	O
These	O
findings	O
define	O
a	O
novel	protein
protein	protein
motif	protein
that	O
functions	O
in	O
intracellular	O
calcium	O
signaling	O
.	O

The	O
Epstein-Barr	protein
virus	protein
-encoded	protein
nuclear	protein
antigen	protein
EBNA-5	protein
accumulates	O
in	O
PML-containing	O
bodies	O
.	O
EBNA-5	protein
is	O
one	O
of	O
the	O
Epstein-Barr	protein
virus	protein
(	protein
EBV	protein
)-encoded	protein
nuclear	protein
proteins	protein
required	O
for	O
immortalization	O
of	O
human	cell_type
B	cell_type
lymphocytes	cell_type
.	O
In	O
the	O
nuclei	O
of	O
EBV-transformed	cell_line
lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
EBNA-5	protein
is	O
preferentially	O
targetted	O
to	O
distinct	O
nuclear	O
foci	O
.	O
Previously	O
we	O
have	O
shown	O
(W.Q.	O
Jiang,	O
L.Szekely,	O
V.Wendel-Hansen,	O
N.Ringertz,	O
G.Klein,	O
and	O
A.	O
Rosen,	O
Exp.Cell	O
Res.	O

A	O
new	O
variant	O
translocation	O
in	O
acute	O
promyelocytic	O
leukaemia	O
:	O
molecular	O
characterization	O
and	O
clinical	O
correlation.	O
Translocation	DNA
t(15;17)(q22;q21	DNA
)	O
is	O
an	O
acquired	O
clonal	O
cytogenetic	O
change	O
present	O
in	O
almost	O
all	O
cases	O
of	O
acute	O
promelocytic	O
leukemia	O
(	O
APL	O
).	O
The	O
molecular	O
genetic	O
basis	O
of	O
the	O
translocation	O
supports	O
its	O
integral	O
role	O
in	O
pathogenesis.	O
We	O
describe	O
a	O
patient	O
with	O
APL	O
in	O
whom	O
the	O
leukaemic	O
clone	O
was	O
characterized	O
by	O
a	O
true	O
variant	O
of	O
the	O
classical	DNA
t(15;17)	DNA
.	O
The	O
patient	O
whose	O
disease	O
had	O
numerous	O
atypical	O
clinical	O
features	O
,	O
had	O
t(11;17)(q13;121)	DNA
.	O
The	O
chromosome	DNA
17	DNA
breakpoint	DNA
was	O
localized	O
to	O
intron	DNA
2	DNA
of	O
RARA	DNA
by	O
Southern	O
blotting	O
,	O
and	O
there	O
was	O
no	O
evidence	O
at	O
the	O
molecular	O
level	O
for	O
rearrangement	O
at	O
PML	DNA
locus	DNA
.	O
These	O
data,	O
along	O
with	O
previous	O
reports	O
of	O
rare	O
variant	O
translocations	O
in	O
APL	O
,	O
indicate	O
that	O
while	O
dysregulation	O
of	O
RARA	DNA
by	O
gene	O
fusion	O
may	O
be	O
essential	O
for	O
the	O
APL	O
phenotype,	O
the	O
particular	O
fusion	O
partner	O
may	O
determine	O
clinicopathological	O
aspects	O
,	O
including	O
presentation,	O
response	O
to	O
treatment	O
with	O
all-trans	O
retinoic	O
acid	O
(	O
ATRA	O
),	O
and	O
prognosis.	O
This	O
heterogeneity	O
suggests	O
that	O
the	O
variant	O
fusion	protein
partners	protein
of	O
RARA	DNA
in	O
APL	O
encode	O
factors	protein
with	O
properties	O
both	O
common	O
to	O
and	O
distinct	O
from	O
those	O
of	O
PML	cell_type
.	O
Investigation	O
of	O
these	O
factors	O
promises	O
to	O
shed	O
light	O
on	O
the	O
complex	O
development	O
pathways	O
involved	O
in	O
the	O
regulation	O
of	O
haematopoiesis	O
.	O

A	O
model	O
of	O
latent	O
adenovirus	O
5	O
infection	O
in	O
the	O
guinea	O
pig	O
(Cavia	O
porcellus).	O
A	O
model	O
of	O
adenovirus	O
5	O
(	O
Ad5	O
)	O
infection	O
was	O
developed	O
in	O
guinea	O
pigs	O
to	O
begin	O
to	O
study	O
its	O
role	O
in	O
the	O
pathogenesis	O
of	O
peripheral	O
lung	O
inflammation	O
.	O
Forty	O
animals	O
were	O
inoculated	O
intranasally	O
with	O
10(7.0)	O
pfu	O
of	O
Ad5	O
/animal,	O
and	O
15	O
animals	O
inoculated	O
with	O
sterile	O
culture	O
media	O
served	O
as	O
controls.	O
Viral	O
titres	O
were	O
10(4.4),	O
10(6.1),	O
10(5.2),	O
and	O
10(2.9)	O
pfu/animal,	O
on	O
days	O
1,	O
3,	O
4,	O
and	O
7	O
after	O
infection,	O
respectively.	O
In	O
situ	O
hybridization	O
to	O
viral	DNA
DNA	DNA
and	O
immunocytochemistry	O
for	O
Ad5	O
E1A	protein
protein	protein
localized	O
the	O
virus	O
to	O
airway	O
and	O
alveolar	cell_type
epithelial	cell_type
cells	cell_type
.	O
Histologic	O
examination	O
showed	O
an	O
extensive	O
inflammatory	O
cell	O
infiltration	O
around	O
the	O
airways,	O
with	O
epithelial	O
necrosis	O
and	O
an	O
alveolar	O
exudate	O
that	O
caused	O
localized	O
alveolar	O
collapse	O
in	O
the	O
infected	O
areas	O
.	O
Immunocytochemistry	O
identified	O
the	O
cells	O
in	O
the	O
infiltrate	O
as	O
cytotoxic	cell_type
T	cell_type
cells	cell_type
.	O
Although	O
all	O
animals	O
20	O
and	O
47	O
days	O
after	O
infection	O
had	O
seroconverted	O
to	O
Ad5	O
,	O
virus	O
was	O
not	O
detected	O
in	O
these	O
groups	O
either	O
by	O
viral	O
plaque	O
assay	O
or	O
in	O
situ	O
hybridization	O
.	O
Ad5	DNA
E1A	DNA
DNA	DNA
was	O
detected	O
by	O
polymerase	O
chain	O
reaction	O
in	O
five	O
of	O
six	O
animals	O
20	O
days	O
after	O
infection	O
and	O
in	O
five	O
of	O
five	O
animals	O
47	O
days	O
after	O
infection.	O
In	O
these	O
same	O
animals	O
,	O
E1A	protein
protein	protein
was	O
detected	O
20	O
days	O
after	O
infection	O
in	O
two	O
and	O
47	O
days	O
after	O
infection	O
in	O
one	O
while	O
persistent	O
bronchiolitis	O
was	O
observed	O
in	O
four	O
and	O
three	O
animals	O
20	O
and	O
47	O
days	O
after	O
infection	O
,	O
respectively.	O
These	O
results	O
demonstrate	O
that	O
the	O
guinea	O
pig	O
provides	O
a	O
useful	O
model	O
to	O
study	O
the	O
role	O
of	O
Ad5	O
infection	O
in	O
chronic	O
airway	O
inflammation	O
.	O

Cyclic	O
AMP	O
-responsive	DNA
element	DNA
-dependent	O
activation	O
of	O
Epstein-Barr	O
virus	O
zebra	DNA
promoter	DNA
by	O
human	O
herpesvirus	O
6	O
.	O
We	O
have	O
recently	O
shown	O
that	O
infection	O
of	O
Epstein-Barr	cell_line
virus	cell_line
(	cell_line
EBV	cell_line
)	cell_line
genome-positive	cell_line
B	cell_line
cells	cell_line
by	O
human	O
herpesvirus	O
6	O
(	O
HHV-6	O
)	O
results	O
in	O
the	O
expression	O
of	O
the	O
immediate-early	DNA
EBV	DNA
Zebra	DNA
gene	DNA
,	O
followed	O
by	O
virus	O
replication	O
(L.Flamand,	O
I.Stefanescu,	O
D.V.Ablashi,	O
and	O
J.Menezes,	O
J.Virol.67:6768-6777,	O
1993).	O
Here	O
we	O
show	O
that	O
HHV-6	O
upregulates	O
Zebra	DNA
gene	DNA
transcription	O
through	O
a	O
cyclic	DNA
AMP	DNA
-responsive	DNA
element	DNA
(	O
CRE	DNA
)	O
located	O
within	O
the	O
Zebra	DNA
promoter	DNA
(	O
Zp	DNA
).	O
Using	O
human	O
B-	O
or	O
T-	O
cell	O
lines	O
transfected	O
with	O
ZpCat	DNA
reporter	DNA
gene	DNA
constructs	DNA
,	O
we	O
demonstrate	O
that	O
a	O
region	O
designated	O
the	O
ZII	DNA
domain	DNA
of	O
Zp	DNA
is	O
the	O
target	O
of	O
HHV-6	O
transactivation	O
.	O
Mutation	O
of	O
the	O
consensus	DNA
AP-1/	DNA
CRE	DNA
site	DNA
within	O
ZII	DNA
abolished	O
the	O
inducibility	O
of	O
Zp	DNA
by	O
HHV-6	O
,	O
whereas	O
positioning	O
of	O
the	O
ZII	DNA
domain	DNA
upstream	O
of	O
the	O
beta-globin	DNA
minimal	DNA
promoter	DNA
conferred	O
responsiveness	O
following	O
HHV-6	O
infection	O
.	O
Binding	O
of	O
these	O
factors	O
to	O
ZII	DNA
was	O
prevented	O
by	O
oligonucleotides	O
containing	O
CRE	DNA
but	O
not	O
by	O
AP-1	DNA
consensus	DNA
sequences	DNA
.	O
Antibodies	O
against	O
CRE	protein
-binding	protein
(CREB)	protein
protein	protein
but	O
not	O
against	O
c-Fos	protein
or	O
c-Jun	protein
were	O
able	O
to	O
supershift	O
the	O
DNA-protein	protein
complex	protein
,	O
identifying	O
the	O
nature	O
of	O
the	O
transcription	protein
factor	protein
which	O
binds	O
to	O
ZII	DNA
as	O
a	O
member	O
of	O
the	O
CREB	protein
family	protein
of	protein
proteins	protein
.	O
Finally,	O
transfection	O
of	O
CREB	protein
protein	protein
and	O
protein	DNA
kinase	DNA
A	DNA
expression	DNA
vectors	DNA
were	O
found	O
to	O
activate	O
Zp	DNA
in	O
Jurkat	cell_type
cells	cell_type
,	O
suggesting	O
that	O
phosphorylated	O
form	O
of	O
CREB	protein
protein	protein
can	O
play	O
a	O
determining	O
role	O
in	O
the	O
EBV	O
reactivation	O
process	O
.	O

Regulation	O
of	O
the	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
in	O
stably	O
transfected	O
Jurkat	cell_line
cell	cell_line
clones	cell_line
.	O
Two	O
Jurkat	cell_line
cell	cell_line
clones	cell_line
have	O
been	O
stably	O
transfected	O
with	O
a	O
reporter	DNA
vector	DNA
for	O
the	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NFAT	protein
).	O
Upon	O
stimulation,	O
they	O
express	O
high	O
levels	O
of	O
secreted	O
heat	O
stable	O
placental	protein
alkaline	protein
phosphatase	protein
.	O
With	O
these	O
clones,	O
we	O
demonstrated	O
that	O
NFAT	protein
activation	O
induced	O
by	O
phorbol	O
12-myristate	O
13-acetate	O
and	O
ionomycin	O
was	O
inhibited	O
by	O
both	O
cyclosporin	O
A	O
(	O
CsA	O
)	O
(IC50	O
=	O
8	O
nM)	O
and	O
FK506	O
(IC50	O
=	O
160	O
pM),	O
presumably	O
by	O
inhibition	O
of	O
calcineurin	protein
activity	O
.	O
Selective	O
phosphatase	O
inhibitors	O
for	O
protein	protein
phosphatase	protein
1	protein
(	O
PP1	protein
)	O
and	O
2A	protein
(	O
PP2A	protein
)	O
that	O
do	O
not	O
inhibit	O
calcineurin	protein
,	O
such	O
as	O
okadaic	O
acid	O
and	O
calyculin	O
A	O
,	O
also	O
inhibited	O
NFAT	protein
activation	O
with	O
IC50s	O
of	O
87	O
nM	O
and	O
4	O
nM,	O
respectively,	O
suggesting	O
that	O
okadaic	O
acid	O
and	O
related	O
inhibitors	O
may	O
block	O
NFAT	protein
activation	O
through	O
the	O
inhibition	O
of	O
PP1	protein
,	O
instead	O
of	O
PP2A	protein
.	O
NFAT	protein
activation	O
was	O
also	O
inhibited	O
by	O
agents	O
that	O
increase	O
cAMP	O
concentrations	O
such	O
as	O
dibutyryl	O
cAMP	O
,	O
forskolin	O
and	O
prostaglandin	O
E2	O
.	O
These	O
stable	O
Jurkat	cell_line
cell	cell_line
clones	cell_line
provide	O
a	O
convenient	O
and	O
sensitive	O
tool	O
to	O
study	O
NFAT	protein
regulation	O
.	O

Glucocorticoids	O
induced	O
down-regulation	O
of	O
glucocorticoid	protein
receptor	protein
mRNA	O
expression	O
in	O
asthma.	O
Although	O
their	O
precise	O
mechanism	O
of	O
action	O
remains	O
to	O
be	O
elucidated,	O
glucocorticoids	O
represent	O
the	O
most	O
effective	O
therapy	O
in	O
the	O
treatment	O
of	O
asthma	O
.	O
Interactions	O
between	O
the	O
glucocorticoid	protein
receptor	protein
and	O
the	O
AP-1	protein
complex	protein
have	O
been	O
shown	O
to	O
regulate	O
the	O
transcription	O
of	O
some	O
genes,	O
including	O
glucocorticoid	protein
receptor	protein
itself.	O
The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
compare	O
the	O
expression	O
of	O
mRNA	RNA
for	O
glucocorticoid	protein
receptor	protein
in	O
human	cell_type
blood	cell_type
monocytes	cell_type
obtained	O
from	O
seven	O
unstable	O
untreated	O
asthmatic	O
patients	O
who	O
were	O
subsequently	O
treated	O
with	O
high	O
doses	O
of	O
parenteral	O
corticosteroid	O
(	O
methyl	O
prednisolone	O
120	O
mg/day)	O
for	O
10	O
days.	O
mRNA	RNA
expression	O
was	O
identified	O
after	O
RNA	O
extraction	O
using	O
RNAzol	O
and	O
analysed	O
after	O
reverse	protein
transcriptase	protein
,	O
by	O
polymerase	O
chain	O
reaction	O
using	O
a	O
semiquantitative	O
competitive	O
hybridization	O
assay	O
.	O
All	O
asthmatic	O
patients	O
showed	O
an	O
improvement	O
in	O
their	O
FEV1	O
values	O
after	O
corticosteroid	O
treatment	O
(per	O
cent	O
of	O
predicted	O
value	O
68.28	O
+/-	O
4.93	O
versus	O
95.57	O
+/-	O
6.41,	O
P	O
&lt;	O
0.02),	O
and	O
a	O
significant	O
decrease	O
for	O
glucocorticoid	protein
receptor	protein
mRNA	RNA
expression	O
(P	O
&lt;	O
0.02)	O
was	O
observed	O
in	O
their	O
monocytes.	O
This	O
is	O
the	O
first	O
report	O
of	O
an	O
ex	O
vivo	O
down-regulation	O
for	O
the	O
glucocorticoid	protein
receptor	protein
mRNA	RNA
expression	O
,	O
following	O
corticosteroid	O
treatment	O
.	O

Mapping	O
of	O
the	O
transcriptional	protein
repression	protein
domain	protein
of	O
the	O
lymphoid-specific	protein
transcription	protein
factor	protein
oct-2A	protein
.	O
The	O
lymphoid-specific	protein
transcription	protein
factor	protein
Oct-2a	protein
is	O
implicated	O
in	O
B	O
cell-specific	O
transcriptional	O
activity	O
via	O
the	O
octamer	O
motif	O
.	O
Structure/function	O
analysis	O
of	O
various	O
Oct-2a	protein
effector	protein
regions	protein
in	O
the	O
context	O
of	O
the	O
GAL4	protein
DNA-binding	protein
domain	protein
revealed	O
that	O
Oct-2a	protein
contains	O
two	O
functionally	O
different	O
activation	protein
domains	protein
at	O
the	O
N	O
and	O
the	O
C	O
termini	O
.	O
The	O
transcriptional	O
activity	O
of	O
both	O
domains	O
is	O
strongly	O
potentiated	O
by	O
interactions	O
with	O
distinct	O
B	protein
cell-specific	protein
coactivators	protein
.	O
Recently,	O
we	O
have	O
identified	O
a	O
repression	protein
domain	protein
located	O
within	O
the	O
N	protein
terminus	protein
of	O
Oct-2a	protein
(	O
amino	protein
acids	protein
2-99	protein
).	O
When	O
this	O
domain	O
was	O
transferred	O
to	O
a	O
potent	O
activator,	O
transcription	O
was	O
strongly	O
inhibited.	O
In	O
this	O
study	O
we	O
present	O
a	O
deletion	O
analysis	O
of	O
the	O
N-terminal	protein
region	protein
of	O
Oct-2a	protein
to	O
determine	O
the	O
minimal	protein
repression	protein
domain	protein
.	O
We	O
identified	O
a	O
stretch	O
of	O
23	O
amino	O
acids	O
,	O
rich	O
in	O
serine	O
and	O
threonine	O
residues	O
,	O
which	O
was	O
responsible	O
for	O
most	O
of	O
the	O
repression	O
activity.	O
We	O
show	O
that	O
repression	O
is	O
strongly	O
dependent	O
on	O
the	O
type	O
of	O
enhancer	DNA
present	O
in	O
the	O
reporter	DNA
plasmid	DNA
as	O
well	O
as	O
on	O
the	O
cell	cell_line
line	cell_line
tested.	O
The	O
possibility	O
that	O
Oct-2a	protein
can	O
act	O
as	O
an	O
activator	O
and/or	O
a	O
repressor	O
may	O
have	O
important	O
consequences	O
for	O
the	O
function	O
of	O
Oct-2a	protein
in	O
B	O
cell	O
differentiation	O
and	O
other	O
developmental	O
processes.	O

Opposing	O
effects	O
of	O
glucocorticoids	O
on	O
the	O
rate	O
of	O
apoptosis	O
in	O
neutrophilic	O
and	O
eosinophilic	O
granulocytes	O
.	O
Eosinophils	cell_type
and	O
neutrophils	cell_type
are	O
closely	O
related,	O
terminally	cell_type
differentiated	cell_type
cells	cell_type
that	O
in	O
vitro	O
undergo	O
constitutive	O
cell	O
death	O
by	O
apoptosis	O
.	O
The	O
onset	O
of	O
apoptosis	O
in	O
both	O
cell	O
types	O
can	O
be	O
delayed	O
by	O
hemopoietins	protein
and	O
inflammatory	protein
mediators	protein
.	O
Although	O
there	O
have	O
been	O
a	O
number	O
of	O
reports	O
demonstrating	O
that	O
glucocorticoids	O
(in	O
particular	O
dexamethasone	O
)	O
antagonize	O
the	O
eosinophil	O
life-prolonging	O
effects	O
of	O
hemopoietins	protein
,	O
direct	O
effects	O
of	O
dexamethasone	O
on	O
eosinophil	O
apoptosis	O
have	O
not	O
been	O
documented.	O
In	O
this	O
study	O
we	O
examined	O
the	O
direct	O
effects	O
of	O
glucocorticoids	O
on	O
eosinophil	cell_type
and	O
neutrophil	cell_type
apoptosis	O
in	O
light	O
of	O
their	O
common	O
therapeutic	O
use	O
as	O
anti-inflammatory	O
and	O
anti-allergic	O
/hypereosinophilic	O
agents	O
.	O
We	O
found	O
that	O
treatment	O
with	O
dexamethasone	O
induced	O
eosinophil	cell_type
apoptosis	O
.	O
In	O
contrast,	O
dexamethasone	O
was	O
a	O
potent	O
inhibitor	O
of	O
neutrophil	cell_type
apoptosis	O
.	O
The	O
effect	O
of	O
dexamethasone	O
on	O
both	O
cell	O
types	O
was	O
mediated	O
through	O
the	O
glucocorticoid	protein
receptor	protein
,	O
i.e.,	O
it	O
was	O
abolished	O
by	O
the	O
glucocorticoid	protein
receptor	protein
antagonist	O
RU38486	O
.	O
This	O
is	O
the	O
first	O
description	O
of	O
an	O
agent	O
that	O
promotes	O
eosinophil	cell_type
apoptosis	O
while	O
inhibiting	O
neutrophil	cell_type
apoptosis	O
,	O
and	O
thus	O
presents	O
a	O
novel	O
approach	O
to	O
the	O
study	O
of	O
control	O
of	O
apoptosis	O
in	O
these	O
closely	O
related	O
cell	O
types	O
as	O
well	O
as	O
increases	O
our	O
understanding	O
of	O
the	O
clinical	O
action	O
of	O
glucocorticoids	O
in	O
inflammation	O
.	O

Permanent	O
occupancy	O
of	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
type	DNA
1	DNA
enhancer	DNA
by	O
NF-kappa	protein
B	protein
is	O
needed	O
for	O
persistent	O
viral	O
replication	O
in	O
monocytes	cell_type
.	O
This	O
work	O
aimed	O
to	O
ascertain	O
the	O
role	O
of	O
kappaB-responsive	DNA
elements	DNA
of	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
type	DNA
1	DNA
(	DNA
HIV-1	DNA
)	DNA
enhancer	DNA
not	O
only	O
in	O
early	O
initiation	O
but	O
also	O
in	O
long-term	O
maintenance	O
of	O
proviral	O
transcription	O
in	O
cells	O
of	O
the	O
monocytic	cell_type
lineage	cell_type
.	O
For	O
this	O
purpose,	O
we	O
used	O
three	O
main	O
approaches.	O
The	O
first	O
was	O
to	O
abruptly	O
terminate	O
tumor	O
necrosis	O
factor-induced	O
NF-kappaB	protein
binding	O
to	O
the	O
enhancer	O
sequences	O
in	O
U1	O
monocytic	O
cells,	O
using	O
a	O
short	O
pulse	O
of	O
exogenous	protein
tumor	protein
necrosis	protein
factor	protein
.	O
This	O
resulted	O
in	O
concomitant	O
decrease	O
in	O
nuclear	O
NF-kappaB	protein
DNA-binding	O
activity	O
and	O
endogenous	DNA
long	DNA
terminal	DNA
repeat	DNA
transcriptional	O
activity	O
.	O
The	O
second	O
was	O
to	O
suppress	O
the	O
permanent	O
NF-kappaB	protein
translocation	O
induced	O
by	O
HIV-1	O
replication	O
itself	O
in	O
chronically	cell_line
infected	cell_line
U937	cell_line
cells	cell_line
,	O
using	O
a	O
specific	O
proteasome	O
inhibitor	O
(	O
Z-LLL-H	O
).	O
As	O
early	O
as	O
2	O
h	O
after	O
addition	O
of	O
the	O
inhibitor	O
to	O
the	O
culture	O
medium	O
,	O
there	O
was	O
an	O
inhibition	O
of	O
both	O
constitutive	O
activation	O
of	O
NF-kappaB	protein
and	O
HIV-1	O
genome	O
expression	O
.	O
The	O
third	O
approach	O
was	O
to	O
monitor	O
the	O
replication	O
competence	O
in	O
U937	cell_line
cells	cell_line
of	O
an	O
infectious	O
HIV-1	O
provirus	O
carrying	O
point	O
mutations	O
in	O
the	O
kappaB-responsive	DNA
elements	DNA
of	O
both	O
long	DNA
terminal	DNA
repeats	DNA
.	O
Compared	O
with	O
its	O
wild-type	O
counterpart,	O
this	O
mutated	O
provirus	O
showed	O
a	O
profoundly	O
decreased,	O
Z-LLL-H	O
-insensitive	O
transcriptional	O
and	O
replicative	O
activity	O
in	O
U937	cell_line
monocytes	cell_line
.	O
Together,	O
our	O
results	O
indicate	O
that	O
occupancy	O
of	O
the	O
viral	DNA
enhancer	DNA
by	O
NF-kappaB	protein
(	protein
p50/p65	protein
)	protein
heterodimers	protein
is	O
required	O
for	O
ongoing	O
transcription	O
of	O
integrated	O
HIV	O
provirus	O
in	O
monocytes	cell_type
,	O
even	O
in	O
cells	O
chronically	O
infected	O
and	O
permanently	O
producing	O
functional	O
HIV	protein
Tat	protein
protein	protein
.	O
Thus,	O
the	O
ability	O
of	O
HIV-1	O
replication	O
to	O
activate	O
NF-kappaB	protein
is	O
crucial	O
to	O
the	O
intense	O
self-perpetuated	O
viral	O
transcription	O
observed	O
in	O
cells	O
of	O
the	O
monocytic	cell_type
lineage	cell_type
.	O

Rel-deficient	cell_type
T	cell_type
cells	cell_type
exhibit	O
defects	O
in	O
production	O
of	O
interleukin	protein
3	protein
and	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
.	O
The	O
c-rel	DNA
protooncogene	DNA
encodes	O
a	O
subunit	O
of	O
the	O
NF-kappa	protein
B	protein
-like	protein
family	protein
of	protein
transcription	protein
factors	protein
.	O
Mice	O
lacking	O
Rel	protein
are	O
defective	O
in	O
mitogenic	O
activation	O
of	O
B	O
and	O
T	O
lymphocytes	O
and	O
display	O
impaired	O
humoral	O
immunity	O
.	O
In	O
an	O
attempt	O
to	O
identify	O
changes	O
in	O
gene	O
expression	O
that	O
accompany	O
the	O
T-cell	O
stimulation	O
defects	O
associated	O
with	O
the	O
loss	O
of	O
Rel	protein
,	O
we	O
have	O
examined	O
the	O
expression	O
of	O
cell	protein
surface	protein
activation	protein
markers	protein
and	O
cytokine	O
production	O
in	O
mitogen-stimulated	O
Rel	cell_type
-/-	cell_type
T	cell_type
cells	cell_type
.	O
The	O
expression	O
of	O
cell	O
surface	O
markers	O
including	O
the	O
interleukin	protein
2	protein
receptor	protein
alpha	protein
(	protein
IL-2R	protein
alpha	protein
)	protein
chain	protein
(	O
CD25	protein
),	O
CD69	protein
and	O
L-selectin	protein
(	O
CD62	protein
)	O
is	O
normal	O
in	O
mitogen-activated	cell_line
Rel	cell_line
-/-	cell_line
T	cell_line
cells	cell_line
,	O
but	O
cytokine	protein
production	O
is	O
impaired.	O
In	O
Rel	cell_line
-/-	cell_line
splenic	cell_line
T	cell_line
cell	cell_line
cultures	cell_line
stimulated	O
with	O
phorbol	O
12-myristate	O
13-acetate	O
and	O
ionomycin	O
,	O
the	O
levels	O
of	O
IL-3,	O
IL-5,	O
granulocyte-	protein
macrophage	protein
colony-stimulating	protein
factor	protein
(	O
GM-CSF	protein
),	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF-alpha	protein
),	O
and	O
gamma	protein
interferon	protein
(	O
IFN-gamma	protein
)	O
were	O
only	O
2-	O
to	O
3-fold	O
lower	O
compared	O
with	O
normal	O
T	O
cells.	O
In	O
contrast,	O
anti-CD3	protein
and	O
anti-CD28	protein
stimulated	O
Rel	cell_line
-/-	cell_line
T	cell_line
cells	cell_line
,	O
which	O
fail	O
to	O
proliferate,	O
make	O
little	O
or	O
no	O
detectable	O
cytokines	protein
.	O
Exogenous	O
IL-2	protein
,	O
which	O
restitutes	O
the	O
proliferative	O
response	O
of	O
the	O
anti-CD3-	O
and	O
anti-CD28-	O
treated	O
Rel-/-	O
T	O
cells	O
,	O
restores	O
production	O
of	O
IL-5,	O
TNF-alpha	protein
,	O
and	O
IFN-gamma	protein
,	O
but	O
not	O
IL-3	protein
and	O
GM-CSF	protein
expression	O
to	O
approximately	O
normal	O
levels.	O
In	O
contrast	O
to	O
mitogen-activated	cell_line
Rel	cell_line
-/-	cell_line
T	cell_line
cells	cell_line
,	O
lipopolysaccharide-stimulated	O
Rel	cell_line
-/-	cell_line
macrophages	cell_line
produce	O
higher	O
than	O
normal	O
levels	O
of	O
GM-CSF	protein
.	O
These	O
findings	O
establish	O
that	O
Rel	protein
can	O
function	O
as	O
an	O
activator	O
or	O
repressor	O
of	O
gene	O
expression	O
and	O
is	O
required	O
by	O
T	cell_type
lymphocytes	cell_type
for	O
production	O
of	O
IL-3	protein
and	O
GM-CSF	protein
.	O

Nuclear	O
appearance	O
of	O
a	O
factor	O
that	O
binds	O
the	O
CD28	DNA
response	DNA
element	DNA
within	O
the	O
interleukin-2	DNA
enhancer	DNA
correlates	O
with	O
interleukin-2	protein
production	O
.	O
Activation	O
of	O
T	cell_type
lymphocytes	cell_type
requires	O
the	O
combined	O
signaling	O
of	O
the	O
T	protein
cell	protein
receptor	protein
and	O
costimulatory	protein
molecules	protein
such	O
as	O
CD28	protein
.	O
The	O
ability	O
of	O
T	cell_type
cells	cell_type
to	O
produce	O
interleukin-2	protein
(	O
IL-2	protein
)	O
is	O
a	O
critical	O
control	O
point	O
in	O
T	O
lymphocyte	O
activation	O
.	O
The	O
IL-2	protein
enhancer	O
contains	O
a	O
functional	O
motif	O
named	O
CD28	DNA
response	DNA
element	DNA
(	O
CD28RE	DNA
)	O
that	O
serves	O
a	O
role	O
as	O
a	O
target	O
for	O
mitogenic	O
T	O
cell	O
activation	O
signals	O
.	O
The	O
CD28RE	DNA
sequence	O
reveals	O
similarity	O
to	O
the	O
consensus	DNA
kappaB	DNA
binding	DNA
motif	DNA
.	O
Here	O
we	O
demonstrate	O
that	O
CD28RE	DNA
binds	O
an	O
inducible	O
protein	O
with	O
a	O
molecular	O
mass	O
of	O
approximately	O
35	O
kDa	O
called	O
nuclear	protein
factor	protein
of	protein
mitogenic-activated	protein
T	protein
cells	protein
(	O
NF-MATp35	protein
)	O
that	O
is	O
clearly	O
different	O
from	O
the	O
known	O
NF-	protein
kappaB/	protein
Rel	protein
family	protein
members	protein
.	O
Induction	O
of	O
NF-MATp35	protein
was	O
shown	O
to	O
depend	O
on	O
de	O
novo	O
protein	O
synthesis	O
and	O
was	O
restricted	O
to	O
T	cell_type
cells	cell_type
that	O
received	O
a	O
mitogenic	O
combination	O
of	O
T	O
cell	O
stimuli	O
,	O
not	O
necessarily	O
including	O
CD28	protein
signaling.	O
Nonmitogenic	O
T	O
cell	O
stimulation	O
did	O
not	O
result	O
in	O
appearance	O
of	O
NF-MATp35	protein
.	O
These	O
results	O
indicate	O
that	O
mitogenic	O
combinations	O
of	O
T	O
cell	O
activation	O
signals	O
are	O
integrated	O
at	O
the	O
level	O
of	O
NF-MATp35	protein
induction	O
.	O
Similar	O
to	O
its	O
effect	O
on	O
IL-2	protein
production	O
,	O
cyclosporin	O
A	O
inhibited	O
the	O
induction	O
of	O
NF-MATp35	protein
.	O
Taken	O
together,	O
these	O
data	O
demonstrate	O
that	O
the	O
nuclear	O
appearance	O
of	O
NF-MATp35	protein
shows	O
excellent	O
correlation	O
with	O
IL-2	protein
production,	O
which	O
is	O
a	O
unique	O
characteristic	O
among	O
nuclear	O
factors	O
implicated	O
in	O
the	O
control	O
of	O
IL-2	protein
gene	O
expression	O
.	O

Transcriptional	O
basis	O
for	O
hyporesponsiveness	O
of	O
the	O
human	DNA
inducible	DNA
nitric	DNA
oxide	DNA
synthase	DNA
gene	DNA
to	O
lipopolysaccharide/interferon-gamma.	O
The	O
work	O
reported	O
here	O
resolves,	O
at	O
the	O
level	O
of	O
gene	O
regulation,	O
the	O
controversy	O
as	O
to	O
whether	O
or	O
not	O
human	cell_type
monocytes	cell_type
/macrophages	cell_type
can	O
produce	O
nitric	O
oxide	O
(	O
NO	O
)	O
when	O
stimulated	O
with	O
lipopolysaccharide	O
(	O
LPS	O
),	O
with	O
or	O
without	O
co-stimulation	O
by	O
interferon-gamma	O
(	O
IFN-gamma	protein
).	O
Studies	O
included	O
structural	O
comparison	O
of	O
the	O
promoters	O
for	O
human	O
and	O
mouse	O
inducible	DNA
NO	DNA
synthase	DNA
(	DNA
iNOS	DNA
)	DNA
genes	DNA
,	O
transfection	O
and	O
assay	O
of	O
human	O
and	O
mouse	O
iNOS	DNA
promoter	DNA
regions	DNA
in	O
response	O
to	O
LPS	O
+/-	O
IFN-gamma	protein
,	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
of	O
kappa	DNA
B	DNA
response	DNA
elements	DNA
.	O
Two	O
explanations	O
for	O
hyporesponsiveness	O
of	O
the	O
human	DNA
iNOS	DNA
promoter	DNA
to	O
LPS	O
+/-	O
IFN-gamma	protein
were	O
found:	O
(1)	O
multiple	O
inactivating	O
nucleotide	O
substitutions	O
in	O
the	O
human	O
counterpart	O
of	O
the	O
enhancer	DNA
element	DNA
that	O
has	O
been	O
shown	O
to	O
regulate	O
LPS	O
/	O
IFN-gamma	protein
induced	O
expression	O
of	O
the	O
mouse	DNA
iNOS	DNA
gene	DNA
;	O
and	O
(2)	O
and	O
absence	O
of	O
one	O
or	O
more	O
nuclear	protein
factors	protein
in	O
human	cell_type
macrophages	cell_type
(e.g.,	O
an	O
LPS	protein
-inducible	protein
nuclear	protein
factor-kappa	protein
B/	protein
Rel	protein
complex	protein
),	O
that	O
is	O
(are)	O
required	O
for	O
maximal	O
expression	O
of	O
the	O
gene.	O
The	O
importance	O
of	O
resolution	O
of	O
this	O
controversy	O
is	O
that	O
future	O
research	O
in	O
this	O
area	O
should	O
be	O
directed	O
toward	O
the	O
understanding	O
of	O
alternative	O
mechanisms	O
that	O
can	O
result	O
in	O
the	O
successful	O
production	O
of	O
NO	O
.	O

X	O
inactivation	O
analysis	O
in	O
a	O
female	O
with	O
hypomelanosis	O
of	O
Ito	O
associated	O
with	O
a	O
balanced	DNA
X;17	DNA
translocation	DNA
:	O
evidence	O
for	O
functional	O
disomy	O
of	O
Xp.	O
X	O
inactivation	O
analysis	O
was	O
performed	O
on	O
normal	O
and	O
hypopigmented	O
skin	O
samples	O
obtained	O
from	O
a	O
female	O
with	O
hypomelanosis	O
of	O
Ito	O
associated	O
with	O
a	O
balanced	DNA
whole	DNA
arm	DNA
X;17	DNA
translocation	DNA
.	O
Severe	O
skewing	O
of	O
X	O
inactivation	O
resulting	O
in	O
inactivity	O
of	O
the	O
intact	O
X	DNA
was	O
found	O
in	O
blood	O
and	O
cultures	O
of	O
both	O
types	O
of	O
skin	O
,	O
but	O
analysis	O
of	O
DNA	O
prepared	O
directly	O
from	O
hypopigmented	O
skin	O
showed	O
significant	O
inactivation	O
of	O
the	O
translocated	O
X	DNA
,	O
inconsistent	O
with	O
the	O
usual	O
mechanism	O
of	O
phenotypic	O
expression	O
in	O
X	DNA
;autosome	DNA
translocations	DNA
.	O
In	O
addition,	O
dual	O
colour	O
FISH	O
analysis	O
using	O
centromere	O
specific	O
probes	O
for	O
chromosomes	O
X	DNA
and	O
17	DNA
showed	O
that	O
the	O
breakpoints	O
on	O
both	O
chromosomes	DNA
lie	O
within	O
the	O
alphoid	O
arrays	O
,	O
making	O
interruption	O
of	O
a	O
locus	O
on	O
either	O
chromosome	O
unlikely.	O
While	O
partial	O
variable	O
monosomy	O
of	O
loci	O
on	O
chromosome	DNA
17p	DNA
cannot	O
be	O
excluded	O
as	O
contributing	O
to	O
the	O
phenotype	O
in	O
this	O
patient,	O
it	O
is	O
argued	O
that	O
the	O
major	O
likely	O
factor	O
is	O
partial	O
functional	O
disomy	O
of	O
sequences	O
on	O
Xp	DNA
in	O
cell	O
lineages	O
that	O
have	O
failed	O
to	O
inactivate	O
the	O
intact	O
X	DNA
chromosome	DNA
.	O

Identification	O
of	O
a	O
herpesvirus	DNA
Saimiri	DNA
cis-acting	DNA
DNA	DNA
fragment	DNA
that	O
permits	O
stable	O
replication	O
of	O
episomes	O
in	O
transformed	O
T	cell_type
cells	cell_type
.	O
Herpesvirus	O
saimiri	O
is	O
a	O
lymphotropic	O
herpesvirus	O
capable	O
of	O
immortalizing	O
and	O
transforming	O
T	cell_type
cells	cell_type
both	O
in	O
vitro	O
and	O
in	O
vivo.	O
Immortalized	O
and	O
transformed	O
T	cell_type
cells	cell_type
harbor	O
several	O
copies	O
of	O
the	O
viral	DNA
genome	DNA
as	O
a	O
persisting	DNA
genome	DNA
.	O
The	O
mapping	O
of	O
the	O
cis-acting	DNA
genetic	DNA
cis-acting	DNA
segment	DNA
(	O
oriP	DNA
)	O
required	O
for	O
viral	O
episomal	O
maintenance	O
is	O
reported	O
here.	O
Viral	DNA
DNA	DNA
fragments	DNA
that	O
potentially	O
contain	O
oriP	DNA
were	O
cloned	O
into	O
a	O
plasmid	DNA
that	O
contains	O
the	O
hygromycin	DNA
resistance	DNA
gene	DNA
.	O
After	O
several	O
round	O
of	O
subcloning	O
followed	O
by	O
transfection,	O
oriP	DNA
was	O
mapped	O
to	O
a	O
1.955-kb	DNA
viral	DNA
segment	DNA
.	O
This	O
viral	O
fragment	O
permits	O
stable	O
plasmid	DNA
replication	O
without	O
deletion	O
or	O
rearrangement	O
as	O
well	O
as	O
episomal	O
maintenance	O
without	O
integration	O
or	O
recombination	O
.	O
The	O
function	O
of	O
oriP	DNA
depends	O
on	O
a	O
trans-acting	protein
factor	protein
(s)	O
encoded	O
by	O
the	O
viral	DNA
genome	DNA
.	O
The	O
1.955-kb	DNA
viral	DNA
segment	DNA
includes	O
a	O
dyad	DNA
symmetry	DNA
region	DNA
located	O
between	O
two	O
small	DNA
nuclear	DNA
RNA	DNA
genes	DNA
and	O
is	O
located	O
upstream	O
of	O
the	O
dihydrofolate	DNA
reductase	DNA
gene	DNA
homolog	DNA
.	O
Therefore,	O
this	O
oriP	DNA
contains	O
novel	O
elements	O
distinct	O
from	O
those	O
of	O
other	O
DNA	O
viruses.	O

In	O
vivo	O
anergized	cell_line
CD4+	cell_line
T	cell_line
cells	cell_line
express	O
perturbed	O
AP-1	O
and	O
NF-kappa	protein
B	protein
transcription	protein
factors	protein
.	O
Anergy	O
is	O
a	O
major	O
mechanism	O
to	O
ensure	O
antigen-specific	O
tolerance	O
in	O
T	cell_type
lymphocytes	cell_type
in	O
the	O
adult.	O
In	O
vivo,	O
anergy	O
has	O
mainly	O
been	O
studied	O
at	O
the	O
cellular	O
level.	O
In	O
this	O
study,	O
we	O
used	O
the	O
T-cell-activating	protein
superantigen	protein
staphylococcal	protein
enterotoxin	protein
A	protein
(	O
SEA	protein
)	O
to	O
investigate	O
molecular	O
mechanisms	O
of	O
T-lymphocyte	O
anergy	O
in	O
vivo.	O
Injection	O
of	O
SEA	protein
to	O
adult	O
mice	O
activates	O
CD4+	cell_type
T	cell_type
cells	cell_type
expressing	O
certain	O
T-cell	protein
receptor	protein
(TCR)	protein
variable	protein
region	protein
beta-chain	protein
families	protein
and	O
induces	O
strong	O
and	O
rapid	O
production	O
of	O
interleukin	O
2	O
(	O
IL-2	protein
).	O
In	O
contrast,	O
repeated	O
injections	O
of	O
SEA	protein
cause	O
CD4+	protein
T-cell	protein
deletion	protein
and	O
anergy	O
in	O
the	O
remaining	O
CD4+	O
T	cell_type
cells	cell_type
,	O
characterized	O
by	O
reduced	O
expression	O
of	O
IL-2	protein
at	O
mRNA	O
and	O
protein	O
levels	O
.	O
We	O
analyzed	O
expression	O
of	O
AP-1	protein
,	O
NF-kappa	protein
B	protein
,	O
NF-AT	protein
,	O
and	O
octamer	protein
binding	protein
transcription	protein
factors	protein
,	O
which	O
are	O
known	O
to	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
IL-2	protein
gene	O
promoter	O
activity	O
.	O
Large	O
amounts	O
of	O
AP-1	protein
and	O
NF-kappa	protein
B	protein
and	O
significant	O
quantities	O
of	O
NF-AT	protein
were	O
induced	O
in	O
SEA	cell_line
-activated	cell_line
CD4+	cell_line
spleen	cell_line
T	cell_line
cells	cell_line
,	O
whereas	O
Oct-1	O
and	O
Oct-2	O
DNA	O
binding	O
activity	O
was	O
similar	O
in	O
both	O
resting	O
and	O
activated	cell_type
T	cell_type
cells	cell_type
.	O
In	O
contrast,	O
anergic	cell_type
CD4+	cell_type
T	cell_type
cells	cell_type
contained	O
severely	O
reduced	O
levels	O
of	O
AP-1	protein
and	O
Fos/Jun-containing	protein
NF-AT	protein
complexes	protein
but	O
expressed	O
significant	O
amounts	O
of	O
NF-kappa	protein
B	protein
and	O
Oct	protein
binding	protein
proteins	protein
after	O
SEA	protein
stimulation	O
.	O
Resolution	O
of	O
the	O
NF-kappa	protein
B	protein
complex	protein
demonstrated	O
predominant	O
expression	O
of	O
p50-p65	protein
heterodimers	protein
in	O
activated	cell_type
CD4+	cell_type
T	cell_type
cells	cell_type
,	O
while	O
anergic	O
cells	O
mainly	O
expressed	O
the	O
transcriptionally	O
inactive	O
p50	protein
homodimer	protein
.	O
These	O
alterations	O
of	O
transcription	protein
factors	protein
are	O
likely	O
to	O
be	O
responsible	O
for	O
repression	O
of	O
IL-2	protein
in	O
anergic	cell_type
T	cell_type
cells	cell_type
.	O

Fas	protein
ligation	O
induces	O
apoptosis	O
and	O
Jun	protein
kinase	protein
activation	O
independently	O
of	O
CD45	protein
and	O
Lck	protein
in	O
human	cell_type
T	cell_type
cells	cell_type
.	O
Stimulation	O
through	O
the	O
Fas/APO-1	protein
receptor	protein
results	O
in	O
apoptosis	O
through	O
an	O
incompletely	O
characterized	O
signaling	O
pathway	O
.	O
More	O
is	O
known	O
regarding	O
signal	O
transduction	O
events	O
that	O
occur	O
after	O
ligation	O
of	O
the	O
T-cell	protein
antigen	protein
receptor	protein
(	O
TCR	protein
).	O
It	O
has	O
been	O
shown	O
that	O
TCR	protein
stimulation	O
requires	O
both	O
the	O
membrane	protein
tyrosine	protein
phosphatase	protein
,	O
CD45	protein
,	O
and	O
the	O
Src-family	protein
kinase	protein
,	O
Lck	protein
,	O
to	O
result	O
in	O
cellular	O
activation	O
.	O
Although	O
prior	O
studies	O
suggest	O
a	O
role	O
for	O
protein	protein
tyrosine	protein
kinases	protein
and	O
phosphatases	O
in	O
Fas	protein
signaling	O
,	O
we	O
report	O
here	O
that	O
Fas	O
ligation	O
induces	O
apoptosis	O
in	O
T	cell_type
cells	cell_type
deficient	O
in	O
either	O
CD45	protein
or	O
Lck	protein
.	O
Further,	O
in	O
normal	O
and	O
CD45-	O
or	O
Lck-	O
deficient	O
cell	O
lines	O
,	O
Fas	O
stimulation	O
results	O
in	O
activation	O
of	O
Jun	protein
kinase	protein
(	O
JNK	protein
),	O
a	O
proposed	O
mediator	O
of	O
stress	O
activation	O
pathways.	O
Previous	O
studies	O
have	O
also	O
demonstrated	O
a	O
role	O
for	O
endogenous	O
ceramide	O
release	O
in	O
Fas-mediated	O
apoptosis	O
.	O
We	O
show	O
that	O
stimulation	O
with	O
a	O
synthetic	O
ceramide	O
analog	O
results	O
in	O
JNK	protein
activation	O
as	O
well	O
as	O
apoptosis	O
,	O
suggesting	O
ceramide	O
release	O
occurs	O
proximal	O
to	O
JNK	protein
activation	O
in	O
Fas	protein
signaling	O
.	O
Our	O
data	O
suggest	O
that	O
although	O
CD45	protein
and	O
Lck	protein
are	O
not	O
required	O
for	O
Fas	protein
signaling	O
,	O
JNK	protein
activation	O
may	O
play	O
an	O
important	O
role	O
transducing	O
distal	O
signals	O
that	O
lead	O
to	O
apoptosis	O
after	O
Fas	protein
ligation	O
.	O

Globin	O
gene	O
switching.	O
In	O
vivo	O
protein-DNA	O
interactions	O
of	O
the	O
human	DNA
beta-globin	DNA
locus	DNA
in	O
erythroid	cell_type
cells	cell_type
expressing	O
the	O
fetal	O
or	O
the	O
adult	O
globin	DNA
gene	DNA
program	O
.	O
To	O
characterize	O
the	O
protein-DNA	O
interactions	O
important	O
for	O
the	O
developmental	O
control	O
of	O
the	O
human	DNA
beta-globin	DNA
locus	DNA
,	O
we	O
analyzed	O
by	O
in	O
vivo	O
dimethyl	O
sulfate	O
footprinting	O
erythroid	cell_type
cells	cell_type
expressing	O
either	O
the	O
fetal	O
or	O
the	O
adult	O
globin	O
developmental	O
program	O
.	O
In	O
the	O
locus	DNA
control	DNA
region	DNA
(	O
LCR	DNA
)	O
of	O
the	O
beta-globin	DNA
locus	DNA
,	O
in	O
vivo	O
footprints	O
on	O
NF-E2	protein
(or	O
AP-1	protein
)	O
and	O
GATA-1	DNA
motifs	DNA
remained	O
the	O
same	O
regardless	O
of	O
whether	O
the	O
fetal	O
or	O
the	O
adult	DNA
globin	DNA
genes	DNA
are	O
expressed.	O
In	O
contrast,	O
in	O
vivo	O
footprints	O
on	O
GT	DNA
(CACCC)	DNA
motifs	DNA
differed	O
between	O
the	O
cells	O
expressing	O
the	O
fetal	O
or	O
the	O
adult	O
globin	O
program	O
.	O
In	O
promoter	DNA
regions	DNA
,	O
the	O
actively	DNA
transcribed	DNA
genes	DNA
demonstrated	O
extensive	O
and	O
consistent	O
footprints	O
over	O
the	O
canonical	O
elements,	O
such	O
as	O
CACCC	O
and	O
CCAAT	O
motifs	O
.	O
The	O
adult	cell_type
globin	cell_type
expressing	cell_type
cells	cell_type
displayed	O
more	O
extensive	O
footprints	O
than	O
the	O
fetal	cell_type
globin	cell_type
expressing	cell_type
cells	cell_type
in	O
the	O
3'	DNA
regulatory	DNA
sequences	DNA
of	O
both	O
the	O
Agamma-	O
and	O
the	O
beta-	O
globin	O
genes	O
,	O
suggesting	O
a	O
role	O
of	O
these	O
3'	DNA
elements	DNA
in	O
beta-globin	DNA
gene	DNA
expression	O
.	O
Our	O
results	O
suggest	O
that	O
the	O
bulk	O
of	O
protein-DNA	O
interactions	O
that	O
underlies	O
the	O
developmental	O
control	O
of	O
globin	DNA
genes	DNA
takes	O
place	O
in	O
the	O
gamma-	O
and	O
beta-	O
globin	O
gene	O
promoters	O
,	O
and	O
that	O
GT	DNA
motifs	DNA
of	O
the	O
beta-globin	DNA
locus	DNA
LCR	DNA
may	O
play	O
a	O
role	O
in	O
the	O
developmental	O
regulation	O
of	O
human	O
beta-globin	DNA
gene	DNA
expression	O
,	O
perhaps	O
by	O
increasing	O
the	O
probability	O
of	O
interaction	O
of	O
the	O
LCR	protein
holocomplex	protein
with	O
the	O
fetal	O
or	O
the	O
adult	O
globin	O
gene	O
.	O

Antisense	O
inhibition	O
of	O
vitamin	protein
D	protein
receptor	protein
expression	O
induces	O
apoptosis	O
in	O
monoblastoid	cell_line
U937	cell_line
cells	cell_line
.	O
The	O
active	O
vitamin	O
D3	O
metabolite	O
1,25-dihydroxycholecalciferol	O
(	O
1,25(OH)2D3	O
)	O
acts	O
as	O
an	O
antiproliferative	O
and	O
differentiating	O
agent	O
for	O
the	O
monoblastoid	cell_line
cell	cell_line
line	cell_line
U937	cell_line
and	O
as	O
an	O
important	O
immunologic	O
mediator	O
implicated	O
particularly	O
in	O
the	O
function	O
of	O
cells	O
belonging	O
to	O
the	O
monocyte/macrophage	cell_type
lineage	cell_type
.	O
These	O
effects	O
are	O
controlled	O
by	O
the	O
vitamin	protein
D	protein
receptor	protein
(	O
VDR	protein
),	O
a	O
member	O
of	O
the	O
steroid	protein
hormone	protein
receptor	protein
family	protein
.	O
The	O
objective	O
of	O
this	O
study	O
was	O
to	O
develop	O
U937	cell_line
transfectants	O
expressing	O
antisense	O
VDR	RNA
mRNA	RNA
,	O
and	O
to	O
use	O
these	O
to	O
examine	O
the	O
role	O
of	O
1,25(OH)2D3	O
-VDR	protein
interaction	O
in	O
this	O
lineage.	O
A	O
2-kb	DNA
VDR	DNA
cDNA	DNA
insert	DNA
(including	O
the	O
complete	O
VDR	DNA
coding	DNA
region	DNA
)	O
was	O
cloned	O
in	O
an	O
antisense	O
orientation	O
into	O
the	O
EBV	O
episomal	O
vector	O
pMEP4	O
under	O
the	O
control	O
of	O
an	O
inducible	DNA
promoter	DNA
and	O
transfected	O
into	O
U937	cell_line
.	O
The	O
resultant	cell_line
cell	cell_line
line	cell_line
,	O
DH42	cell_line
,	O
was	O
hygromycin	O
resistant	O
,	O
contained	O
VDR	DNA
cDNA	DNA
,	O
expressed	O
fewer	O
VDRs	protein
than	O
controls,	O
and	O
showed	O
a	O
substantial	O
decrease	O
in	O
antiproliferative	O
response	O
to	O
1,25(OH)2D3	O
.	O
However,	O
1,25(OH)2D3	O
increased	O
the	O
number	O
of	O
cells	O
expressing	O
macrophage	protein
cell	protein
surface	protein
Ags	protein
,	O
including	O
CD14	protein
and	O
CD11b	protein
.	O
A	O
subpopulation	O
of	O
smaller	O
cells	O
did	O
not	O
express	O
the	O
differentiation	O
markers	O
after	O
cadmium	O
stimulation	O
.	O
Cell	O
cycle	O
analysis	O
showed	O
shifts	O
in	O
the	O
distribution	O
of	O
cells	O
from	O
G1	O
to	O
S	O
phase	O
,	O
which	O
were	O
more	O
pronounced	O
after	O
cadmium	O
treatment	O
.	O
A	O
considerable	O
proportion	O
of	O
cells	O
were	O
outside	O
the	O
cycle	O
and	O
DNA	O
fragmentation	O
confirmed	O
apoptosis	O
.	O
Thus,	O
the	O
functional	O
outcome	O
of	O
the	O
VDR	protein
antisense	O
transfection	O
suggests	O
that	O
in	O
the	O
myelomonocytic	cell_type
lineage	cell_type
,	O
VDR	protein
expression	O
may	O
act	O
as	O
a	O
protective	O
mechanism	O
against	O
programmed	O
cell	O
death	O
.	O

Human	O
T	O
lymphotropic	O
virus-I	O
infection	O
of	O
human	cell_type
T	cell_type
lymphocytes	cell_type
induces	O
expression	O
of	O
the	O
beta-galactoside-binding	protein
lectin	protein
,	O
galectin-3	protein
.	O
Animal	O
lectins	protein
play	O
important	O
roles	O
in	O
a	O
variety	O
of	O
biological	O
processes	O
via	O
their	O
recognition	O
of	O
glycoconjugates	O
.	O
Galectin-3	O
is	O
a	O
beta-galactoside-binding	protein
lectin	protein
previously	O
designated	O
as	O
epsilon	protein
BP	protein
(	O
IgE-binding	protein
protein	protein
),	O
CBP35	protein
,	O
Mac-2	protein
,	O
L-29	protein
,	O
and	O
L-34	protein
,	O
and	O
its	O
expression	O
has	O
been	O
associated	O
with	O
various	O
physiological	O
and	O
pathological	O
processes,	O
including	O
cell	O
growth	O
,	O
tumor	O
transformation	O
,	O
and	O
metastasis	O
.	O
Galectin-3	protein
is	O
widely	O
distributed	O
in	O
various	O
tissues	O
and	O
cell	O
types	O
and	O
is	O
expressed	O
in	O
many	O
leukocytes	cell_type
,	O
with	O
the	O
notable	O
exception	O
of	O
B	O
and	O
T	O
lymphocytes	O
.	O
We	O
now	O
report	O
that	O
galectin-3	protein
is	O
abundantly	O
expressed	O
in	O
a	O
number	O
of	O
human	cell_line
T	cell_line
lymphotropic	cell_line
virus	cell_line
(HTLV)-I	cell_line
-infected	cell_line
human	cell_line
T	cell_line
cell	cell_line
lines	cell_line
,	O
including	O
F6T	cell_line
,	O
HUT	cell_line
102	cell_line
,	O
K3T	cell_line
,	O
MT-2	cell_line
,	O
and	O
SLB-I	cell_line
,	O
but	O
is	O
not	O
expressed	O
in	O
non-	cell_line
HTLV-I	cell_line
-infected	cell_line
T	cell_line
cell	cell_line
lines	cell_line
such	O
as	O
Jurkat	cell_line
,	O
CEM	cell_line
,	O
and	O
MOLT-4	cell_line
.	O
In	O
addition,	O
the	O
galectin-3	protein
level	O
was	O
markedly	O
increased	O
in	O
human	cell_type
thymocytes	cell_type
after	O
infection	O
with	O
HTLV-I	O
as	O
compared	O
with	O
uninfected	cell_type
thymocytes	cell_type
.	O
The	O
up-regulation	O
of	O
galectin-3	protein
expression	O
appeared	O
to	O
correlate	O
well	O
with	O
HTLV-I	O
gene	O
expression	O
,	O
as	O
undetectable	O
or	O
very	O
low	O
levels	O
of	O
galectin-3	protein
were	O
found	O
in	O
the	O
S1T	O
and	O
ATL-1K	O
cell	O
lines	O
,	O
which	O
are	O
nonproductively	O
infected	O
with	O
HTLV-I	O
.	O
In	O
co-transfection	O
experiments	O
,	O
the	O
galectin-3	DNA
promoter	DNA
was	O
significantly	O
up-regulated	O
by	O
expression	DNA
vectors	DNA
encoding	O
the	O
40-kd	protein
Tax	protein
protein	protein
,	O
a	O
potent	O
transactivator	O
in	O
HTLV-I	O
.	O
Analysis	O
of	O
various	O
Tax	protein
mutants	protein
suggested	O
that	O
galectin-3	DNA
promoter	DNA
induction	O
is	O
dependent	O
on	O
activation	O
of	O
the	O
cyclic-AMP	protein
-responsive	protein
element	protein
binding	protein
protein/activation	protein
transcription	protein
factor	protein
family	protein
of	O
transcription	protein
factors	protein
and,	O
to	O
a	O
lesser	O
extent,	O
nuclear	protein
factor-kappa	protein
B/Rel	protein
induction	O
.	O
Transfection	O
of	O
human	cell_line
promonocytic	cell_line
U-937	cell_line
cells	cell_line
with	O
an	O
HTLV-I	O
Tax	O
expression	O
vector	O
induced	O
galectin-3	protein
expression	O
in	O
this	O
cell	O
line.	O
Functionally,	O
galectin-3	protein
was	O
shown	O
to	O
activate	O
interleukin-2	protein
production	O
in	O
Jurkat	cell_type
T	cell_type
cells	cell_type
.	O
Together,	O
these	O
findings	O
raise	O
the	O
possibility	O
that	O
HTLV-I	O
Tax	protein
production	O
induces	O
the	O
transcription	O
and	O
subsequent	O
synthesis	O
and	O
secretion	O
of	O
galectin-3	protein
,	O
which	O
in	O
turn	O
may	O
further	O
activate	O
these	O
T	cell_type
cells	cell_type
and	O
contribute	O
to	O
the	O
altered	O
properties	O
of	O
cell	O
growth	O
found	O
in	O
adult	O
T	O
cell	O
leukemia	O
induced	O
by	O
HTLV-I	O
.	O

Monocytic	O
cell	O
type-specific	O
transcriptional	O
induction	O
of	O
collagenase	protein
.	O
Interstitial	O
collagenase	protein
(	O
MMP-1	protein
),	O
a	O
metalloproteinase	protein
produced	O
by	O
resident	O
and	O
inflammatory	O
cells	O
during	O
connective	O
tissue	O
turnover,	O
cleaves	O
type	protein
I	protein
collagen	protein
fibrils	protein
.	O
This	O
catalytic	O
event	O
is	O
rate	O
limiting	O
in	O
remodeling	O
of	O
tissues	O
rich	O
in	O
fibrillar	protein
collagen	protein
such	O
as	O
the	O
skin	O
and	O
lungs	O
.	O
The	O
regulation	O
of	O
collagenase	protein
expression	O
is	O
cell-type	O
specific;	O
bacterial	O
LPS	O
and	O
zymosan	O
,	O
a	O
yeast	O
cell	O
wall	O
derivative	O
,	O
are	O
potent	O
inducers	O
of	O
collagenase	protein
expression	O
in	O
macrophages	cell_type
,	O
but	O
do	O
not	O
alter	O
fibroblast	cell_type
collagenase	protein
expression	O
.	O
Since	O
promoter	O
elements	O
controlling	O
collagenase	protein
transcription	O
in	O
monocytic	O
cells	O
have	O
not	O
been	O
previously	O
defined,	O
we	O
sought	O
to	O
delineate	O
responsive	O
cis-acting	DNA
elements	DNA
of	O
the	O
collagenase	DNA
promoter	DNA
in	O
transiently	O
transfected	O
human	O
(U937)	O
and	O
murine	O
(J774)	O
monocytic	O
cell	O
lines	O
.	O
Deletion	O
constructs	O
containing	O
as	O
little	O
as	O
72	O
bp	O
of	O
5'	DNA
-flanking	DNA
sequence	DNA
of	O
the	O
collagenase	DNA
promoter	DNA
were	O
sufficient	O
for	O
LPS-	O
or	O
zymosan-	O
mediated	O
transcriptional	O
induction	O
,	O
whereas	O
phorbol	O
inducibility	O
exhibited	O
an	O
absolute	O
requirement	O
for	O
upstream	O
elements	O
including	O
the	O
polyoma	DNA
enhancer	DNA
A-binding	DNA
protein-3	DNA
site	DNA
(	O
-83	DNA
to	DNA
-91	DNA
)	O
and	O
TTCA	DNA
sequence	DNA
(	O
-102	DNA
to	DNA
-105	DNA
)	O
in	O
both	O
monocytic	cell_type
cells	cell_type
and	O
fibroblasts	cell_type
.	O
Mutagenesis	O
of	O
the	O
activator	DNA
protein-1	DNA
[	DNA
AP-1	DNA
]	DNA
site	DNA
at	O
-72	DNA
abolished	O
basal	DNA
promoter	DNA
activity	O
and	O
LPS	O
/zymosan	O
inducibility	O
,	O
while	O
mutagenesis	O
of	O
an	O
NF-kappaB-like	DNA
site	DNA
at	O
-20	O
to	O
-10	O
had	O
no	O
effect.	O
Nuclear	O
extracts	O
from	O
LPS	O
-and	O
zymosan	cell_type
-treated	cell_type
cells	cell_type
showed	O
strong	O
AP-1	protein
activity	O
by	O
gel-shift	O
analysis	O
,	O
and	O
supershift	O
analysis	O
showed	O
the	O
AP-1	protein
complexes	protein
contained	O
specific	O
members	O
of	O
both	O
the	O
jun	O
and	O
fos	O
gene	O
families	O
.	O
These	O
data	O
indicate	O
that,	O
in	O
contrast	O
to	O
most	O
LPS	O
effects,	O
AP-1	protein
,	O
but	O
not	O
nuclear	protein
factor-kappaB	protein
,	O
mediates	O
LPS	O
induction	O
of	O
collagenase	protein
transcription	O
in	O
macrophagelike	cell_type
cells	cell_type
.	O
Furthermore,	O
as	O
compared	O
to	O
regulation	O
by	O
phorbol	O
ester	O
,	O
collagenase	protein
induction	O
in	O
monocytic	cell_type
cells	cell_type
by	O
cell	O
wall	O
derivatives	O
of	O
bacteria	O
or	O
yeast	O
is	O
largely	O
independent	O
of	O
upstream	DNA
promoter	DNA
sequences	DNA
.	O

Activation	O
of	O
c-Jun	protein
N-terminal	protein
kinase	protein
in	O
bacterial	cell_type
lipopolysaccharide	cell_type
-stimulated	cell_type
macrophages	cell_type
.	O
Activation	O
of	O
macrophages	cell_type
by	O
bacterial	O
lipopolysaccharide	O
(	O
LPS	O
)	O
induces	O
transcription	O
of	O
genes	O
that	O
encode	O
for	O
proinflammatory	protein
regulators	protein
of	O
the	O
immune	O
response	O
.	O
Previous	O
work	O
has	O
suggested	O
that	O
activation	O
of	O
the	O
transcription	protein
factor	protein
activator	protein
protein	protein
1	protein
(	O
AP-1	protein
)	O
is	O
one	O
LPS	O
-induced	O
event	O
that	O
mediates	O
this	O
response.	O
Consistent	O
with	O
this	O
notion,	O
we	O
found	O
that	O
LPS	O
stimulated	O
AP-1	protein
-mediated	O
transcription	O
of	O
a	O
transfected	DNA
reporter	DNA
gene	DNA
in	O
the	O
murine	cell_line
macrophage	cell_line
cell	cell_line
line	cell_line
RAW	cell_line
264.7	cell_line
.	O
As	O
AP-1	protein
activity	O
is	O
regulated	O
in	O
part	O
by	O
activation	O
of	O
the	O
c-Jun	protein
N-terminal	protein
kinase	protein
(	O
JNK	protein
),	O
which	O
phosphorylates	O
and	O
subsequently	O
increases	O
the	O
transcriptional	O
activity	O
of	O
c-Jun,	O
we	O
examined	O
whether	O
LPS	O
treatment	O
of	O
macrophages	cell_type
resulted	O
in	O
activation	O
of	O
this	O
kinase	protein
.	O
LPS	O
treatment	O
of	O
RAW	cell_line
264.7	cell_line
cells	cell_line
,	O
murine	cell_type
bone	cell_type
marrow-derived	cell_type
macrophages	cell_type
,	O
and	O
the	O
human	cell_line
monocyte	cell_line
cell	cell_line
line	cell_line
THP-1	cell_line
resulted	O
in	O
rapid	O
activation	O
of	O
the	O
p46	O
and	O
p54	O
isoforms	O
of	O
JNK	protein
.	O
Treatment	O
with	O
wild-type	O
and	O
rough	O
mutant	O
forms	O
of	O
LPS	O
and	O
synthetic	O
lipid	O
A	O
resulted	O
in	O
JNK	protein
activation	O
,	O
while	O
pretreatment	O
with	O
the	O
tyrosine	protein
kinase	protein
inhibitor	O
herbimycin	O
A	O
inhibited	O
this	O
response.	O
Binding	O
of	O
LPS	O
-	O
LPS	protein
binding	protein
protein	protein
(LBP)	protein
complexes	protein
to	O
CD14	protein
,	O
a	O
surface	protein
receptor	protein
that	O
mediates	O
many	O
LPS	O
responses	O
,	O
was	O
found	O
to	O
be	O
crucial,	O
as	O
pretreatment	O
of	O
THP-1	cell_line
cells	cell_line
with	O
the	O
monoclonal	protein
antibody	protein
60b	protein
,	O
which	O
blocks	O
this	O
binding,	O
inhibited	O
JNK	protein
activation.	O
These	O
results	O
suggest	O
that	O
LPS	O
activation	O
of	O
JNK	protein
in	O
monocyte/macrophage	cell_type
cells	cell_type
is	O
a	O
CD14-	O
and	O
protein	O
tyrosine	O
phosphorylation-	O
dependent	O
event	O
that	O
may	O
mediate	O
the	O
early	O
activation	O
of	O
AP-1	protein
in	O
regulating	O
LPS	O
-triggered	O
gene	O
induction	O
.	O

Surfactant	O
suppresses	O
NF-kappa	protein
B	protein
activation	O
in	O
human	O
monocytic	cell_type
cells	cell_type
.	O
In	O
addition	O
to	O
biophysical	O
properties,	O
pulmonary	O
surfactant	O
has	O
immunomodulatory	O
activity	O
.	O
We	O
previously	O
demonstrated	O
that	O
both	O
synthetic	O
(	O
Exosurf	O
)	O
and	O
modified	O
natural	O
surfactant	O
(	O
Survanta	O
)	O
downregulated	O
endotoxin-stimulated	O
inflammatory	RNA
c	RNA
ytokine	RNA
mRNA	RNA
levels	O
and	O
protein	protein
products	protein
(	O
tumor	protein
necrosis	protein
factor-alpha	protein
[TNF],	O
interleukin-1-beta	protein
[	O
IL-1	protein
],	O
interleukin-6	protein
[	O
IL-6	protein
])	O
in	O
human	cell_type
alveolar	cell_type
macrophages	cell_type
.	O
In	O
this	O
study,	O
we	O
report	O
that	O
both	O
Exosurf	O
and	O
Survanta	O
suppress	O
TNF	RNA
mRNA	RNA
and	O
secretion	O
(85	O
+/-	O
4%	O
mean	O
percent	O
inhibition	O
+/-	O
SEM	O
by	O
Exosurf	O
;	O
71	O
+/-	O
6%	O
by	O
Survanta	O
)	O
by	O
endotoxin-stimulated	cell_line
THP-1	cell_line
,	O
a	O
human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
.	O
Because	O
surfactant	O
downregulated	O
inflammatory	protein
cytokine	protein
production	O
similarly	O
in	O
both	O
normal	cell_type
human	cell_type
alveolar	cell_type
macrophages	cell_type
and	O
the	O
THP-1	cell_line
cell	cell_line
line	cell_line
,	O
we	O
used	O
this	O
cell	cell_line
line	cell_line
to	O
investigate	O
whether	O
surfactant	O
affected	O
transcriptional	O
mechanisms	O
.	O
Specifically,	O
we	O
examined	O
nuclear	protein
factor-kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
activation	O
because	O
it	O
is	O
crucial	O
in	O
transcriptional	O
regulation	O
of	O
many	O
inflammatory	DNA
cytokine	DNA
genes	DNA
including	O
TNF	DNA
,	O
IL-1	DNA
,	O
and	O
IL-6	DNA
.	O
Electrophoretic	O
mobility	O
shift	O
assays	O
showed	O
that	O
both	O
surfactants	O
decreased	O
activation	O
of	O
NF-kappa	protein
B	protein
.	O
The	O
presence	O
of	O
both	O
p65	protein
and	O
p50	protein
NF-kappa	protein
B	protein
components	protein
in	O
LPS	O
-activated	O
THP-1	cell_line
cells	cell_line
was	O
confirmed	O
by	O
specific	O
antibody	O
induction	O
of	O
supershifts	O
in	O
mobility	O
assays	O
.	O
These	O
results	O
are	O
the	O
first	O
to	O
suggest	O
that	O
surfactant's	O
suppressive	O
effects	O
on	O
inflammatory	protein
cytokine	protein
production	O
may	O
involve	O
transcriptional	O
regulation	O
through	O
inhibition	O
of	O
NF-kappa	protein
B	protein
activation	O
.	O

A	O
cell	DNA
type-specific	DNA
enhancer	DNA
in	O
the	O
human	DNA
B7.1	DNA
gene	DNA
regulated	O
by	O
NF-kappaB	protein
.	O
The	O
costimulatory	protein
molecule	protein
B7.1	protein
provides	O
a	O
second	O
signal	O
critical	O
for	O
T	O
cell	O
activation	O
.	O
The	O
distribution	O
of	O
this	O
integral	protein
membrane	protein
protein	protein
is	O
restricted	O
to	O
certain	O
tissues	O
where	O
its	O
level	O
of	O
expression	O
is	O
modulated	O
by	O
multiple	O
exogenous	O
stimuli	O
.	O
To	O
identify	O
the	O
molecular	O
basis	O
for	O
specificity	O
and	O
inducibility,	O
the	O
chromatin	DNA
configuration	O
of	O
the	O
human	DNA
B7.1	DNA
gene	DNA
was	O
examined	O
in	O
intact	O
nuclei	O
from	O
various	O
cell	O
types.	O
The	O
identification	O
of	O
a	O
tissue-specific	O
deoxyribonuclease	DNA
I	DNA
hypersensitive	DNA
site	DNA
approximately	O
3kb	DNA
upstream	DNA
of	O
the	O
transcription	DNA
start	DNA
site	DNA
led	O
to	O
the	O
characterization	O
of	O
a	O
cell	DNA
type-specific	DNA
enhancer	DNA
region	DNA
.	O
This	O
183-bp	DNA
region	DNA
was	O
both	O
cell	O
type	O
specific	O
and	O
responsive	O
to	O
two	O
distinct	O
stimuli,	O
lipopolysaccharide	O
and	O
dibutyryl	O
cAMP	O
,	O
known	O
to	O
regulate	O
B7.1	protein
expression	O
.	O
Deletional	O
and	O
site-directed	O
mutagenesis	O
revealed	O
the	O
presence	O
of	O
multiple	O
functionally	O
critical	O
cis	DNA
elements	DNA
within	O
this	O
region,	O
one	O
of	O
which	O
was	O
a	O
nuclear	DNA
factor	DNA
(NF)-kappaB	DNA
consensus	DNA
sequence	DNA
.	O
In	O
B7.1	cell_type
-positive	cell_type
B	cell_type
cells	cell_type
,	O
this	O
element	O
bound	O
several	O
members	O
of	O
the	O
NF-kappaB	protein
family	protein
,	O
transcription	protein
factors	protein
already	O
implicated	O
in	O
signal	O
transduction	O
pathways	O
relevant	O
to	O
B7.1	protein
expression	O
.	O
This	O
is	O
the	O
first	O
description,	O
to	O
our	O
knowledge,	O
of	O
regulatory	DNA
elements	DNA
that	O
control	O
expression	O
of	O
a	O
gene	O
encoding	O
a	O
B7	protein
costimulatory	protein
molecule	protein
.	O

Ubiquitinylation	O
of	O
transcription	protein
factors	protein
c-Jun	protein
and	O
c-Fos	protein
using	O
reconstituted	protein
ubiquitinylating	protein
enzymes	protein
.	O
Recombinant	O
c-Jun	protein
and	O
c-Fos	protein
were	O
ubiquitinylated	O
by	O
the	O
ubiquitin	protein
carrier	protein
enzymes	protein
E214K	protein
,	O
E220K	protein
,	O
or	O
E232K	protein
in	O
the	O
presence	O
of	O
the	O
ubiquitin-activating	protein
enzyme	protein
,	O
E1	protein
.	O
Addition	O
of	O
ubiquitin	protein
protein	protein
ligase	protein
E3	protein
substantially	O
enhanced	O
the	O
E214K	protein
-mediated	O
ubiquitinylation	O
of	O
c-Jun	protein
and	O
c-Fos	protein
.	O
Truncated	O
c-Jun	O
and	O
c-Fos	O
mutant	O
proteins	O
including	O
wbJun	protein
and	O
wbFos	protein
were	O
also	O
ubiquitinylated	O
under	O
the	O
same	O
conditions,	O
suggesting	O
the	O
sites	O
of	O
ubiquitinylation	O
are	O
located	O
within	O
the	O
dimerization	O
and	O
DNA	O
binding	O
domains	O
of	O
c-Jun	protein
and	O
c-Fos	protein
.	O
The	O
E3-dependent	O
ubiquitinylation	O
of	O
c-Jun	protein
was	O
inhibited	O
upon	O
the	O
heterodimerization	O
of	O
c-Jun	protein
with	O
c-Fos	protein
.	O
Further	O
addition	O
of	O
E220K	protein
significantly	O
enhanced	O
ubiquitinylation	O
of	O
c-Jun	protein
in	O
the	O
heterodimer	O
suggesting	O
a	O
regulatory	O
role	O
of	O
E220K	protein
.	O
Polyubiquitinylated	O
c-Jun	protein
,	O
wbFos	protein
,	O
and	O
wbJun	protein
,	O
but	O
not	O
E220K	protein
-ubiquitinylated	protein
c-Jun	protein
,	O
were	O
readily	O
degraded	O
by	O
the	O
ATP-dependent	protein
26	protein
S	protein
multicatalytic	protein
proteases	protein
.	O
These	O
results	O
suggest	O
that	O
the	O
temporal	O
control	O
of	O
c-Jun	protein
and	O
c-Fos	protein
may	O
be	O
regulated	O
through	O
the	O
ubiquitinylation	O
pathways	O
,	O
and	O
the	O
ubiquitinylation	O
of	O
c-Jun	protein
and	O
c-Fos	protein
may	O
in	O
turn	O
be	O
regulated	O
in	O
response	O
to	O
the	O
heterodimerization	O
between	O
them	O
and	O
the	O
cooperation	O
between	O
E220K	protein
and	O
E3	O
mediated	O
polyubiquitinylation	O
.	O

Cloning	O
and	O
characterization	O
of	O
the	O
murine	protein
B-cell	protein
specific	protein
transcriptional	protein
coactivator	protein
Bob1	protein
.	O
From	O
a	O
murine	DNA
B-cell	DNA
cDNA-library	DNA
we	O
have	O
cloned	O
a	O
cDNA	DNA
encoding	O
the	O
murine	protein
B-cell	protein
specific	protein
coactivator	protein
mBob1	protein
.	O
The	O
protein	O
is	O
the	O
murine	O
homologue	O
to	O
the	O
recently	O
described	O
human	protein
coactivator	protein
Bob1	protein
(	O
hBob1	protein
),	O
also	O
referred	O
to	O
as	O
OBF-1	protein
or	O
OCA-B	protein
.	O
We	O
have	O
also	O
characterized	O
the	O
genomic	protein
mBob1	protein
clone	protein
.	O
Analysis	O
of	O
its	O
intron-exon	O
structure	O
has	O
allowed	O
identification	O
of	O
a	O
C-terminal	protein
splice	protein
variant	protein
.	O
mBob1	protein
is	O
B-cell	O
restricted,	O
and	O
is	O
found	O
in	O
all	O
B-cell	cell_line
lines	cell_line
representing	O
different	O
stages	O
of	O
B-cell	O
differentiation	O
.	O
mBob1	protein
interacts	O
with	O
the	O
octamer	protein
transcription	protein
factors	protein
Oct-1	protein
and	O
Oct-2	protein
and	O
stimulates	O
transcription	O
mediated	O
by	O
these	O
factors.	O

HIV	protein
glycoprotein	protein
120	protein
enhances	O
intercellular	protein
adhesion	protein
molecule-1	protein
gene	O
expression	O
in	O
glial	cell_type
cells	cell_type
.	O
Involvement	O
of	O
Janus	protein
kinase	protein
/signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
and	O
protein	protein
kinase	protein
C	protein
signaling	O
pathways	O
.	O
It	O
is	O
well	O
established	O
that	O
the	O
two	O
major	O
glial	cell_type
cells	cell_type
in	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
),	O
astrocytes	cell_type
and	O
microglia	cell_type
,	O
are	O
key	O
participants	O
in	O
mediating	O
the	O
neurologic	O
dysfunction	O
associated	O
with	O
HIV	O
infection	O
of	O
the	O
CNS	O
.	O
In	O
this	O
study,	O
we	O
investigated	O
the	O
ability	O
of	O
the	O
major	protein
envelope	protein
glycoprotein	protein
of	O
HIV	O
,	O
glycoprotein	protein
120	protein
(	O
gp120	protein
),	O
to	O
regulate	O
intercellular	protein
adhesion	protein
molecule-1	protein
(	O
ICAM-1	protein
)	O
expression	O
in	O
glial	cell_type
cells	cell_type
,	O
because	O
ICAM-1	protein
is	O
important	O
in	O
mediating	O
immune	O
responsiveness	O
in	O
the	O
CNS	O
,	O
facilitating	O
entry	O
of	O
HIV	cell_type
-infected	cell_type
cells	cell_type
into	O
the	O
CNS	O
,	O
and	O
promoting	O
syncytia	O
formation.	O
Our	O
results	O
indicate	O
that	O
gp120	protein
enhances	O
ICAM-1	protein
gene	O
expression	O
in	O
primary	cell_type
rat	cell_type
astrocytes	cell_type
,	O
primary	cell_type
human	cell_type
astrocytes	cell_type
,	O
a	O
human	cell_line
astroglioma	cell_line
cell	cell_line
line	cell_line
CRT	cell_line
,	O
and	O
primary	cell_type
rat	cell_type
microglia	cell_type
.	O
The	O
signal	O
transduction	O
events	O
involved	O
in	O
gp120	protein
-mediated	O
enhancement	O
of	O
ICAM-1	protein
appear	O
to	O
involve	O
activation	O
of	O
both	O
protein	protein
kinase	protein
C	protein
and	O
tyrosine	protein
kinase	protein
,	O
because	O
inhibitors	O
of	O
protein	protein
kinase	protein
C	protein
and	O
tyrosine	protein
kinase	protein
abrogate	O
gp120	protein
-mediated	O
ICAM-1	protein
expression	O
in	O
both	O
astrocytes	cell_type
and	O
microglia	cell_type
.	O
Moreover,	O
gp120	protein
induces	O
tyrosine	O
phosphorylation	O
of	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
(	O
STAT-1	protein
alpha	protein
)	O
as	O
well	O
as	O
the	O
Janus	protein
kinase	protein
(	O
JAK2	protein
)	O
in	O
glial	cell_type
cells	cell_type
.	O
We	O
also	O
demonstrate	O
that	O
gp120	protein
-mediated	O
ICAM-1	protein
expression	O
has	O
functional	O
significance,	O
as	O
it	O
enhances	O
the	O
ability	O
of	O
monocytic	cell_type
cells	cell_type
to	O
bind	O
to	O
gp120	cell_type
-stimulated	cell_type
human	cell_type
astrocytes	cell_type
in	O
an	O
ICAM-1	protein
/beta	O
2	O
integrin	protein
-dependent	O
fashion	O
.	O
These	O
results	O
provide	O
new	O
insights	O
into	O
how	O
gp120	protein
can	O
influence	O
the	O
involvement	O
of	O
glial	cell_type
cells	cell_type
in	O
the	O
pathogenesis	O
of	O
AIDS	O
dementia	O
complex	O
.	O

IL-10	protein
cooperates	O
with	O
TNF-alpha	protein
to	O
activate	O
HIV-1	O
from	O
latently	O
and	O
acutely	O
infected	O
cells	O
of	O
monocyte/macrophage	cell_type
lineage	cell_type
.	O
IL-10	protein
is	O
elevated	O
in	O
HIV-1	O
-infected	O
individuals	O
and	O
has	O
been	O
implicated	O
in	O
disease	O
progression.	O
In	O
this	O
study,	O
we	O
investigated	O
the	O
effects	O
of	O
IL-10	protein
on	O
the	O
activation	O
of	O
HIV-1	O
from	O
infected	cell_type
monocytes	cell_type
and	O
macrophages	cell_type
.	O
Although	O
IL-10	protein
alone	O
did	O
not	O
induce	O
HIV-1	O
replication	O
,	O
in	O
the	O
presence	O
of	O
TNF-alpha	protein
,	O
IL-10	protein
markedly	O
enhanced	O
virion	O
production	O
from	O
a	O
chronically	O
infected	O
promonocytic	cell_line
cell	cell_line
line	cell_line
(	O
U1	cell_line
)	O
and	O
in	O
acutely	O
infected	O
monocyte-derived	cell_type
macrophages	cell_type
.	O
Neutralizing	O
mAbs	protein
to	O
IL-10	protein
and	O
TNF-alpha	protein
indicated	O
that	O
both	O
cytokines	protein
were	O
essential	O
for	O
the	O
induction	O
and	O
were	O
required	O
to	O
generate	O
a	O
synergistic	O
increase	O
in	O
virus	O
expression	O
.	O
The	O
effects	O
of	O
the	O
two	O
cytokines	protein
were	O
distinguishable	O
functionally	O
since	O
pretreatment	O
with	O
TNF-alpha	protein
attenuated	O
the	O
cytokine	protein
cooperativity	O
,	O
while	O
pretreatment	O
with	O
IL-10	protein
potentiated	O
their	O
cooperativity,	O
suggesting	O
that	O
IL-10	protein
and	O
TNF-alpha	protein
play	O
different	O
roles	O
in	O
the	O
activation	O
of	O
virus.	O
Northern	O
blot	O
analysis	O
as	O
well	O
as	O
Ab	O
blocking	O
and	O
cytokine	protein
secretion	O
studies	O
indicated	O
that	O
the	O
induction	O
of	O
either	O
endogenous	protein
TNF-alpha	protein
or	O
IL-10	protein
was	O
not	O
involved	O
in	O
the	O
cooperativity,	O
nor	O
was	O
an	O
up-regulation	O
of	O
TNF-alpha	protein
receptors	protein
.	O
In	O
combination	O
with	O
TNF-alpha	protein
,	O
IL-10	protein
stimulated	O
activating	protein
protein-1	protein
(	O
AP-1	protein
)	O
and	O
nuclear	protein
factor	protein
(NF)-kappa	protein
B	protein
binding	O
activities	O
and	O
cooperated	O
to	O
increase	O
HIV-1	O
steady-state	O
mRNA	O
levels	O
and	O
enhance	O
long	DNA
terminal	DNA
repeat	DNA
-directed	O
transcription	O
through	O
activation	O
of	O
the	O
NF-kappa	DNA
B	DNA
binding	DNA
sites	DNA
,	O
suggesting	O
the	O
IL-10	protein
effect	O
occurs	O
at	O
least	O
in	O
part	O
at	O
the	O
transcriptional	O
level	O
.	O
These	O
results	O
indicate	O
that	O
IL-10	protein
,	O
in	O
addition	O
to	O
down-regulating	O
the	O
cellular	O
immune	O
response	O
to	O
HIV-1	O
,	O
may	O
also	O
play	O
a	O
role	O
in	O
TNF-alpha	protein
-mediated	O
activation	O
of	O
HIV-1	O
replication	O
in	O
the	O
monocyte/macrophage	cell_type
lineage	cell_type
.	O

Interaction	O
of	O
HTLV-I	protein
Tax	protein
with	O
the	O
human	protein
proteasome	protein
:	O
implications	O
for	O
NF-kappa	protein
B	protein
induction.	O
The	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
has	O
been	O
etiologically	O
associated	O
with	O
the	O
development	O
of	O
the	O
adult	O
T-cell	O
leukemia	O
(	O
ATL	O
)	O
as	O
well	O
as	O
degenerative	O
neurologic	O
syndrome	O
termed	O
tropical	O
spastic	O
paraparesis	O
(	O
TSP	O
).	O
HTLV-I	O
encodes	O
a	O
potent	O
transactivator	protein
protein	O
termed	O
Tax	protein
that	O
appears	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
process	O
of	O
T-cell	O
immortalization	O
.	O
Even	O
though	O
the	O
mechanisms	O
by	O
which	O
Tax	protein
induces	O
transformation	O
are	O
still	O
unknown,	O
it	O
seems	O
likely	O
that	O
the	O
ability	O
of	O
Tax	protein
to	O
alter	O
the	O
expression	O
of	O
many	O
cellular	DNA
genes	DNA
plays	O
an	O
important	O
part	O
in	O
this	O
process.	O
Tax	protein
does	O
not	O
bind	O
directly	O
to	O
DNA	O
but	O
rather	O
deregulates	O
the	O
activity	O
of	O
cellular	protein
transcription	protein
factors	protein
.	O
One	O
family	O
of	O
host	protein
transcription	protein
factors	protein
whose	O
activity	O
is	O
altered	O
by	O
Tax	protein
includes	O
NF-kappa	protein
B/Rel	protein
.	O
These	O
transcription	protein
factors	protein
are	O
post-transcriptionally	O
regulated	O
by	O
their	O
assembly	O
with	O
a	O
second	O
family	O
of	O
inhibitory	protein
proteins	protein
termed	O
I	protein
kappa	protein
B	protein
that	O
serve	O
to	O
sequester	O
the	O
NF-kappa	protein
B/Rel	protein
complexes	protein
in	O
the	O
cytoplasm	O
.	O
Upon	O
cellular	O
activation,	O
I	protein
kappa	protein
B	protein
alpha	protein
is	O
phosphorylated,	O
polyubiquitinated,	O
and	O
degraded	O
in	O
the	O
proteasome	protein
.	O
This	O
proteolytic	O
event	O
liberates	O
NF-kappa	protein
B	protein
,	O
permitting	O
its	O
rapid	O
translocation	O
into	O
the	O
nucleus	O
where	O
it	O
binds	O
to	O
its	O
cognate	DNA
enhancer	DNA
elements	DNA
.	O
Similarly,	O
the	O
p105	protein
precursor	protein
of	O
the	O
NF-kappa	protein
B	protein
p50	protein
subunit	protein
is	O
also	O
post-translationally	O
processed	O
in	O
the	O
proteasome	protein
.	O
The	O
mechanisms	O
by	O
which	O
Tax	protein
activates	O
NF-kappa	protein
B	protein
remain	O
unclear,	O
and	O
findings	O
presented	O
in	O
the	O
literature	O
are	O
often	O
controversial.	O
We	O
identified	O
a	O
physical	O
interaction	O
between	O
Tax	protein
and	O
the	O
HsN3	protein
subunit	protein
of	O
the	O
human	protein
proteasome	protein
.	O
This	O
raises	O
the	O
intriguing	O
possibility	O
that	O
physical	O
association	O
of	O
the	O
HsN3	protein
proteasome	protein
subunit	protein
with	O
HTLV-I	protein
Tax	protein
coupled	O
with	O
the	O
independent	O
interaction	O
of	O
Tax	protein
with	O
either	O
p100	O
or	O
p65-	O
I	protein
kappa	protein
B	protein
alpha	protein
targets	O
these	O
cytoplasmic	protein
NF-kappa	protein
B/Rel	protein
complexes	protein
to	O
the	O
proteasome	protein
for	O
processing.	O

Immunophenotype	O
of	O
intraductal	O
carcinoma	O
.	O
OBJECTIVE--	O
Mammography	O
and	O
breast-conserving	O
therapy	O
have	O
focused	O
attention	O
on	O
the	O
classification	O
of	O
intraductal	O
carcinoma	O
(	O
IDC	O
)	O
and	O
emphasized	O
the	O
prognostic	O
importance	O
of	O
comedo	O
versus	O
noncomedo	O
variants.	O
We	O
used	O
histochemical	O
markers	O
to	O
define	O
the	O
immunophenotype	O
of	O
43	O
IDCs	O
with	O
respect	O
to	O
comedo	O
versus	O
noncomedo	O
status	O
and	O
patterns	O
of	O
angiogenesis	O
.	O
RESULTS--Reactions	O
in	O
comedo	O
carcinomas	O
were	O
significantly	O
negative	O
for	O
estrogen	protein
receptor	protein
and	O
progesterone	protein
receptor	protein
,	O
and	O
positive	O
for	O
p53	protein
and	O
HER-2/neu	protein
more	O
often	O
than	O
the	O
noncomedo	O
variant	O
.	O
All	O
seven	O
IDCs	O
associated	O
with	O
Paget's	O
disease	O
showed	O
positive	O
reactions	O
for	O
HER-2/neu	protein
.	O
Basement	O
membrane	O
immunoreactivity	O
for	O
type	protein
IV	protein
collagen	protein
and	O
laminin	protein
was	O
discontinuous	O
in	O
most	O
examples	O
of	O
IDC	O
regardless	O
of	O
type,	O
with	O
a	O
trend	O
toward	O
more	O
intense	O
staining	O
in	O
comedo	O
than	O
in	O
noncomedo	O
carcinomas	O
.	O
Periductal	O
angiogenesis	O
was	O
not	O
significantly	O
related	O
to	O
the	O
type	O
of	O
IDC	O
but	O
was	O
more	O
pronounced	O
with	O
comedo	O
carcinomas	O
.	O
CONCLUSIONS--These	O
observations	O
indicate	O
that	O
there	O
are	O
immunophenotypic	O
correlates	O
to	O
the	O
current	O
structural	O
classification	O
of	O
IDC	O
.	O
The	O
immunophenotype	O
of	O
IDC	O
is	O
helpful	O
in	O
subclassifying	O
an	O
IDC	O
and	O
could	O
prove	O
useful	O
as	O
a	O
prognostic	O
indicator	O
for	O
local	O
control	O
in	O
patients	O
treated	O
by	O
breast-conserving	O
therapy	O
.	O

Inhibition	O
of	O
protein	protein
phosphatase	protein
2A	protein
induces	O
serine	O
/threonine	O
phosphorylation	O
,	O
subcellular	O
redistribution,	O
and	O
functional	O
inhibition	O
of	O
STAT3	protein
.	O
Signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(	O
STATs	protein
)	O
are	O
rapidly	O
phosphorylated	O
on	O
tyrosine	O
residues	O
in	O
response	O
to	O
cytokine	protein
and	O
growth	protein
factor	protein
stimulation	O
of	O
cell	protein
surface	protein
receptors	protein
.	O
STATs	protein
hereafter	O
are	O
translocated	O
to	O
the	O
nucleus	O
where	O
they	O
act	O
as	O
transcription	protein
factors	protein
.	O
Recent	O
reports	O
suggest	O
that	O
serine	O
phosphorylation	O
of	O
STATs	protein
also	O
is	O
involved	O
in	O
the	O
regulation	O
of	O
STAT	protein
-mediated	O
gene	O
transcription	O
.	O
Here,	O
we	O
studied	O
the	O
role	O
of	O
serine	protein
/threonine	protein
phosphatases	protein
in	O
STAT3	protein
signaling	O
in	O
human	cell_line
antigen-specific	cell_line
CD4(+)	cell_line
T	cell_line
cell	cell_line
lines	cell_line
and	O
cutaneous	cell_line
T	cell_line
cell	cell_line
lymphoma	cell_line
lines	cell_line
,	O
expressing	O
a	O
constitutively	O
activated	O
STAT3	protein
.	O
We	O
show	O
that	O
an	O
inhibitor	O
of	O
protein	protein
phosphatases	protein
(	O
PPs	protein
)	O
PP1/PP2A	protein
,	O
calyculin	protein
A	protein
,	O
induces	O
(i)	O
phosphorylation	O
of	O
STAT3	protein
on	O
serine	O
and	O
threonine	O
residues,	O
(ii)	O
inhibition	O
of	O
STAT3	protein
tyrosine	O
phosphorylation	O
and	O
DNA	O
binding	O
activity,	O
and	O
(iii)	O
relocation	O
of	O
STAT3	protein
from	O
the	O
nucleus	O
to	O
the	O
cytoplasm	O
.	O
Similar	O
results	O
were	O
obtained	O
with	O
other	O
PP2A	O
inhibitors	O
(	O
okadaic	O
acid	O
,	O
endothall	O
thioanhydride	O
)	O
but	O
not	O
with	O
inhibitors	O
of	O
PP1	protein
(	O
tautomycin	O
)	O
or	O
PP2B	protein
(	O
cyclosporine	O
A	O
).	O
Pretreatment	O
with	O
the	O
broad	O
serine	O
/threonine	O
kinase	O
inhibitor	O
staurosporine	O
partly	O
blocked	O
the	O
calyculin	protein
A	protein
-induced	O
STAT3	protein
phosphorylation	O
,	O
whereas	O
inhibitors	O
of	O
serine	protein
/threonine	protein
kinases	protein
,	O
such	O
as	O
mitogen-activated	protein
protein	protein
kinase-1	protein
extracellular-regulated	protein
kinase-kinase	protein
,	O
mitogen-activated	protein
protein	protein
p38	protein
kinase	protein
,	O
and	O
phosphatidylinositol	protein
3-kinase	protein
,	O
did	O
not.	O
In	O
conclusion,	O
we	O
provide	O
evidence	O
that	O
PP2A	protein
plays	O
a	O
crucial	O
role	O
in	O
the	O
regulation	O
of	O
STAT3	protein
phosphorylation	O
and	O
subcellular	O
distribution	O
in	O
T	cell_type
cells	cell_type
.	O
Moreover,	O
our	O
findings	O
suggest	O
that	O
the	O
level	O
of	O
STAT3	protein
phosphorylation	O
is	O
balanced	O
between	O
a	O
staurosporine	protein
-sensitive	protein
kinase	protein
(s)	O
and	O
PP2A	protein
.	O

Polyamines	O
in	O
human	O
breast	O
cancer	O
and	O
its	O
relations	O
to	O
classical	O
prognostic	O
features:	O
clinical	O
implications.	O
Experimental	O
evidence	O
suggest	O
an	O
important	O
role	O
of	O
polyamines	O
in	O
breast	O
cancer	O
development.	O
Polyamines	O
have	O
been	O
determined	O
in	O
tissue	O
and	O
erythrocyte	O
samples	O
from	O
100	O
patients	O
with	O
primary	O
invasive	O
breast	O
cancer	O
and	O
30	O
patients	O
with	O
fibroadenomas	O
.	O
Statistical	O
analysis	O
was	O
performed	O
in	O
order	O
to	O
determine	O
the	O
prognostic	O
value	O
of	O
the	O
polyamine	O
patterns	O
of	O
tumor	O
tissues	O
and	O
erythrocytes	O
in	O
comparison	O
with	O
clinical	O
and	O
histological	O
prognostic	O
factors	O
.	O
In	O
malignant	O
tissues	O
,	O
polyamine	O
levels	O
were	O
significantly	O
higher	O
than	O
in	O
benign	O
tissues	O
.	O
They	O
correlated	O
with	O
markers	O
of	O
tumor	O
aggressivity	O
(axillary	O
node	O
involvement	O
and	O
especially	O
with	O
markers	O
of	O
high	O
mitotic	O
rate	O
as	O
Ki-67	O
staining	O
,	O
histological	O
grade).	O
No	O
correlation	O
was	O
found	O
between	O
estrogen	O
and	O
progesterone	O
status	O
,	O
tumor	O
size	O
and	O
polyamine	O
concentrations	O
.	O
Erythrocyte	O
polyamines	O
levels	O
were	O
identical	O
between	O
cancer	O
patients	O
and	O
controls	O
.	O
The	O
knowledge	O
of	O
the	O
polyamine	O
pattern	O
in	O
breast	O
cancer	O
could	O
become	O
useful	O
in	O
clinical	O
practice	O
particularly	O
if	O
polyamine	O
metabolism	O
is	O
targeted	O
as	O
a	O
therapeutic	O
approach	O
.	O

Signal	O
transduction	O
pathways	O
triggered	O
by	O
the	O
FcepsilonRIIb	protein
receptor	protein
(	O
CD23	protein
)	O
in	O
human	cell_type
monocytes	cell_type
lead	O
to	O
nuclear	protein
factor-kappaB	protein
activation	O
.	O
BACKGROUND:	O
Alveolar	cell_type
macrophages	cell_type
play	O
a	O
key	O
role	O
in	O
the	O
initiation	O
of	O
the	O
inflammatory	O
reaction	O
of	O
allergic	O
asthma	O
.	O
Alveolar	cell_type
macrophages	cell_type
and	O
peripheral	cell_type
blood	cell_type
monocytes	cell_type
are	O
activated	O
when	O
IgE/allergen	protein
immune	protein
complexes	protein
bind	O
to	O
the	O
CD23	protein
receptor	protein
,	O
which	O
leads	O
to	O
the	O
production	O
of	O
inflammatory	protein
cytokines	protein
.	O
OBJECTIVE:	O
We	O
sought	O
to	O
investigate	O
the	O
molecular	O
mechanisms	O
regulating	O
this	O
early	O
inflammatory	O
response	O
.	O
We	O
have	O
focused	O
on	O
the	O
study	O
of	O
the	O
signal	O
transduction	O
pathways	O
triggered	O
by	O
CD23	protein
in	O
human	cell_type
monocytes	cell_type
and	O
the	O
promonocytic	cell_line
cell	cell_line
line	cell_line
U937	cell_line
.	O
METHODS:	O
CD23	protein
was	O
cross-linked	O
in	O
human	cell_type
monocytes	cell_type
and	O
U937	cell_line
cells	cell_line
with	O
IgE	protein
immune	protein
complexes	protein
.	O
Surface	O
expression	O
of	O
CD23	protein
was	O
determined	O
by	O
FACS	O
analysis	O
.	O
Transcription	protein
factor	protein
activation	O
and	O
gene	O
transcription	O
were	O
studied	O
by	O
gel-shift	O
assays	O
and	O
Northern	O
blot	O
analysis	O
,	O
respectively.	O
IkappaBalpha	protein
phosphorylation	O
and	O
degradation	O
was	O
analyzed	O
by	O
Western	O
blot	O
.	O
RESULTS:	O
Nuclear	protein
factor	protein
(NF)-kappaB	protein
is	O
the	O
main	O
transcription	O
factor	O
involved	O
in	O
the	O
gene	O
activation	O
that	O
follows	O
CD23	protein
cross-linking	O
in	O
monocytes	cell_type
.	O
CD23	protein
-induced	protein
NF-kappaB	protein
is	O
a	O
heterodimer	O
composed	O
of	O
p65/p50	protein
subunits	protein
.	O
NF-kappaB	O
nuclear	O
translocation	O
is	O
secondary	O
to	O
the	O
phosphorylation	O
and	O
subsequent	O
degradation	O
of	O
the	O
NF-kappaB	protein
inhibitory	protein
molecule	protein
IkappaBalpha	protein
.	O
Tyrosine	protein
kinase	protein
-dependent	O
,	O
and	O
not	O
protein	protein
kinase	protein
C	protein
-dependent	O
,	O
pathways	O
mediate	O
CD23	protein
-triggered	O
NF-kappaB	protein
activation	O
but	O
do	O
not	O
participate	O
in	O
the	O
direct	O
phosphorylation	O
of	O
IkappaBalpha	protein
.	O
IkappaBalpha	protein
degradation	O
and	O
NF-kappaB	protein
nuclear	O
translocation	O
correlate	O
with	O
transcriptional	O
activation	O
of	O
the	O
inflammatory	protein
cytokines	protein
TNF-alpha	protein
and	O
IL-1beta.	O
CONCLUSIONS:	O
NF-kappaB	protein
is	O
the	O
main	O
transcription	O
factor	O
involved	O
in	O
the	O
signal	O
transduction	O
pathway	O
of	O
CD23	protein
in	O
monocytes	cell_type
.	O

Suppression	O
of	O
TNFalpha	protein
-mediated	O
NFkappaB	protein
activity	O
by	O
myricetin	O
and	O
other	O
flavonoids	O
through	O
downregulating	O
the	O
activity	O
of	O
IKK	protein
in	O
ECV304	cell_line
cells	cell_line
.	O
Flavonoids	O
are	O
a	O
group	O
of	O
naturally-occurring	O
phenolic	O
compounds	O
in	O
the	O
plant	O
kingdom,	O
and	O
many	O
flavonoids	O
are	O
found	O
with	O
vascular	O
protective	O
properties	O
.	O
Nevertheless	O
how	O
the	O
protective	O
response	O
is	O
exerted	O
by	O
flavonoids	O
is	O
not	O
well	O
characterized.	O
In	O
view	O
of	O
the	O
nuclear	protein
factor-kappaB	protein
(	O
NFkappaB	protein
)	O
may	O
play	O
a	O
central	O
role	O
in	O
the	O
initiation	O
of	O
atherosclerosis	O
,	O
prevention	O
of	O
the	O
activation	O
of	O
NFkappaB	protein
represents	O
an	O
important	O
role	O
in	O
protecting	O
vascular	O
injury	O
.	O
In	O
this	O
study,	O
the	O
effects	O
of	O
flavonoids	O
on	O
NFkappaB	protein
/inhibitor-kappaB	O
(	O
IkappaB	protein
)	O
system	O
in	O
ECV304	cell_line
cells	cell_line
activated	O
with	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNFalpha	protein
)	O
were	O
examined.	O
We	O
investigated	O
the	O
inhibitory	O
action	O
of	O
six	O
flavonoids	O
on	O
IkappaB	protein
kinase	protein
(	O
IKK	protein
)	O
activity,	O
an	O
enzyme	O
recently	O
found	O
to	O
phosphorylate	O
critical	O
serine	O
residues	O
of	O
IkappaB	O
for	O
degradation.	O
Of	O
six	O
flavonoids	O
tested,	O
myricetin	O
was	O
found	O
to	O
strongly	O
inhibit	O
IKK	protein
kinase	O
activity,	O
and	O
prevent	O
the	O
degradation	O
of	O
IkappaBalpha	protein
and	O
IkappaBbeta	protein
in	O
activated	O
endothelial	O
cells.	O
Furthermore,	O
myricetin	O
was	O
also	O
found	O
to	O
inhibit	O
NFkappaB	protein
activity	O
correlated	O
with	O
suppression	O
of	O
monocyte	O
adhesion	O
to	O
ECV304	cell_line
cells	cell_line
.	O
Therefore	O
we	O
conclude	O
that	O
flavonoids	O
may	O
be	O
of	O
therapeutic	O
value	O
for	O
vascular	O
disease	O
through	O
down	O
regulation	O
of	O
NFkappaB	protein
/IkappaB	protein
system	O
.	O
Copyright	O
1999	O
Wiley-Liss,	O
Inc.	O

Bcl-2	protein
-mediated	O
drug	O
resistance	O
:	O
inhibition	O
of	O
apoptosis	O
by	O
blocking	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
lymphocytes	protein
(	O
NFAT	protein
)-induced	O
Fas	protein
ligand	O
transcription	O
.	O
Bcl-2	protein
inhibits	O
apoptosis	O
induced	O
by	O
a	O
variety	O
of	O
stimuli,	O
including	O
chemotherapy	O
drugs	O
and	O
glucocorticoids	O
.	O
It	O
is	O
generally	O
accepted	O
that	O
Bcl-2	protein
exerts	O
its	O
antiapoptotic	O
effects	O
mainly	O
by	O
dimerizing	O
with	O
proapoptotic	O
members	O
of	O
the	O
Bcl-2	protein
family	protein
such	O
as	O
Bax	protein
and	O
Bad	protein
.	O
However,	O
the	O
mechanism	O
of	O
the	O
antiapoptotic	O
effects	O
is	O
unclear.	O
Paclitaxel	O
and	O
other	O
drugs	O
that	O
disturb	O
microtubule	protein
dynamics	O
kill	O
cells	O
in	O
a	O
Fas	protein
/Fas	protein
ligand	protein
(	O
FasL	protein
)-dependent	O
manner	O
;	O
antibody	O
to	O
FasL	protein
inhibits	O
paclitaxel-induced	O
apoptosis	O
.	O
We	O
have	O
found	O
that	O
Bcl-2	protein
overexpression	O
leads	O
to	O
the	O
prevention	O
of	O
chemotherapy	O
(	O
paclitaxel	O
)-induced	O
expression	O
of	O
FasL	protein
and	O
blocks	O
paclitaxel	O
-induced	O
apoptosis	O
.	O
The	O
mechanism	O
of	O
this	O
effect	O
is	O
that	O
Bcl-2	protein
prevents	O
the	O
nuclear	O
translocation	O
of	O
NFAT	protein
(	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
lymphocytes	protein
,	O
a	O
transcription	protein
factor	protein
activated	O
by	O
microtubule	protein
damage)	O
by	O
binding	O
and	O
sequestering	O
calcineurin,	O
a	O
calcium-dependent	O
phosphatase	O
that	O
must	O
dephosphorylate	O
NFAT	protein
to	O
move	O
to	O
the	O
nucleus	O
.	O
Without	O
NFAT	protein
nuclear	O
translocation	O
,	O
the	O
FasL	protein
gene	O
is	O
not	O
transcribed.	O
Thus,	O
it	O
appears	O
that	O
paclitaxel	O
and	O
other	O
drugs	O
that	O
disturb	O
microtubule	protein
function	O
kill	O
cells	O
at	O
least	O
in	O
part	O
through	O
the	O
induction	O
of	O
FasL	protein
.	O
Furthermore,	O
Bcl-2	protein
antagonizes	O
drug-induced	O
apoptosis	O
by	O
inhibiting	O
calcineurin	protein
activation	O
,	O
blocking	O
NFAT	protein
nuclear	O
translocation	O
,	O
and	O
preventing	O
FasL	protein
expression	O
.	O
The	O
effects	O
of	O
Bcl-2	protein
can	O
be	O
overcome,	O
at	O
least	O
partially,	O
through	O
phosphorylation	O
of	O
Bcl-2	protein
.	O
Phosphorylated	O
Bcl-2	protein
cannot	O
bind	O
calcineurin	protein
,	O
and	O
NFAT	protein
activation,	O
FasL	protein
expression,	O
and	O
apoptosis	O
can	O
occur	O
after	O
Bcl-2	protein
phosphorylation	O
.	O

MHC-peptide	O
ligand	O
interactions	O
establish	O
a	O
functional	O
threshold	O
for	O
antigen-specific	O
T	O
cell	O
recognition	O
.	O
Antigen-specific	O
T	O
cell	O
recognition	O
is	O
dependent	O
on	O
the	O
functional	O
density	O
of	O
the	O
TCR	protein
-ligand	O
,	O
which	O
consists	O
of	O
specific	O
MHC	protein
molecules	protein
and	O
a	O
specifically	O
bound	O
peptide	O
.	O
We	O
have	O
examined	O
the	O
influence	O
of	O
the	O
affinity	O
and	O
concentration	O
of	O
exogenous	O
peptide	O
and	O
the	O
density	O
of	O
specific	O
MHC	protein
molecules	protein
on	O
the	O
proliferation	O
of	O
a	O
CD4+,	cell_line
DQA1*0501/DQB1*0201	cell_line
(DQ2.1)-restricted,	cell_line
HSV-2	cell_line
-specific	cell_line
T	cell_line
cell	cell_line
clone	cell_line
.	O
Using	O
antigen	O
peptide	O
analogs	O
with	O
different	O
mutations	O
of	O
known	O
DQ2-anchor	O
residues	O
,	O
T	O
cell	O
response	O
was	O
reduced	O
in	O
an	O
peptide-affinity	O
and	O
-	O
concentration	O
specific	O
manner	O
.	O
The	O
decrease	O
using	O
weaker	O
binding	O
peptides	O
was	O
gradual	O
as	O
stimulation	O
with	O
a	O
peptide	O
with	O
intermediate	O
affinity	O
yielded	O
intermediate	O
T	cell_type
cell	cell_type
proliferation	O
and	O
the	O
poorest	O
binding	O
peptide	O
induced	O
an	O
even	O
weaker	O
T	cell_type
cell	cell_type
response	O
.	O
MHC	protein
class	protein
II	protein
density	O
on	O
the	O
APC	cell_type
was	O
modified	O
using	O
DQ2	O
homo	O
-and	O
hetero	O
zygous	O
B-LCLs	O
as	O
APCs	cell_type
,	O
however	O
this	O
variation	O
of	O
MHC	O
concentration	O
had	O
no	O
effect	O
on	O
T	cell_type
cell	cell_type
proliferation	O
.	O
We	O
interpret	O
this	O
as	O
a	O
reflection	O
of	O
a	O
low	O
threshold	O
for	O
activation	O
of	O
the	O
T	cell_line
cell	cell_line
clone	cell_line
,	O
in	O
which	O
peptide-	O
MHC	protein
avidity	O
is	O
the	O
over-riding	O
determinant	O
of	O
the	O
strength	O
of	O
ligand	O
signal	O
.	O

Regulatory	O
effects	O
of	O
interleukin-11	protein
during	O
acute	O
lung	O
inflammatory	O
injury	O
.	O
The	O
role	O
of	O
interleukin-11	protein
(	O
IL-11	protein
)	O
was	O
evaluated	O
in	O
the	O
IgG	protein
immune	protein
complex	protein
model	O
of	O
acute	O
lung	O
injury	O
in	O
rats	O
.	O
IL-11	RNA
mRNA	RNA
and	O
protein	O
were	O
both	O
up-regulated	O
during	O
the	O
course	O
of	O
this	O
inflammatory	O
response	O
.	O
Exogenously	O
administered	O
IL-11	protein
substantially	O
reduced,	O
in	O
a	O
dose-dependent	O
manner,	O
the	O
intrapulmonary	O
accumulation	O
of	O
neutrophils	cell_type
and	O
the	O
lung	O
vascular	O
leak	O
of	O
albumin	protein
.	O
These	O
in	O
vivo	O
anti-inflammatory	O
effects	O
of	O
IL-11	protein
were	O
associated	O
with	O
reduced	O
NF-kappaB	protein
activation	O
in	O
lung,	O
reduced	O
levels	O
of	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF-alpha	protein
)	O
in	O
bronchoalveolar	O
lavage	O
(BAL)	O
fluids	O
,	O
and	O
diminished	O
up-regulation	O
of	O
lung	protein
vascular	protein
ICAM-1	protein
.	O
It	O
is	O
interesting	O
that	O
IL-11	protein
did	O
not	O
affect	O
BAL	O
fluid	O
content	O
of	O
the	O
CXC	protein
chemokines	protein
,	O
macrophage	protein
inflammatory	protein
protein-2	protein
(	O
MIP-2	protein
)	O
and	O
cytokine	protein
-inducible	protein
neutrophil	protein
chemoattractant	protein
(	O
CINC	protein
);	O
the	O
presence	O
of	O
IL-11	protein
did	O
not	O
affect	O
these	O
chemokines	protein
.	O
However,	O
BAL	O
content	O
of	O
C5a	O
was	O
reduced	O
by	O
IL-11	protein
.	O
These	O
data	O
indicate	O
that	O
IL-11	protein
is	O
a	O
regulatory	protein
cytokine	protein
in	O
the	O
lung	O
and	O
that,	O
like	O
other	O
members	O
of	O
this	O
family,	O
its	O
anti-inflammatory	O
properties	O
appear	O
to	O
be	O
linked	O
to	O
its	O
suppression	O
of	O
NF-kappaB	protein
activation	O
,	O
diminished	O
production	O
of	O
TNF-alpha	protein
,	O
and	O
reduced	O
up-regulation	O
of	O
lung	protein
vascular	protein
ICAM-1	protein
.	O

Thrombopoietin	protein
induces	O
tyrosine	O
phosphorylation	O
of	O
Stat3	protein
and	O
Stat5	protein
in	O
human	cell_type
blood	cell_type
platelets	cell_type
.	O
Thrombopoietin	protein
is	O
known	O
to	O
be	O
essential	O
for	O
megakaryocytopoiesis	O
and	O
thrombopoiesis	O
.	O
Recently,	O
we	O
and	O
others	O
have	O
shown	O
that	O
thrombopoietin	protein
induces	O
rapid	O
tyrosine	O
phosphorylation	O
of	O
Jak2	protein
and	O
other	O
proteins	O
in	O
human	cell_type
platelets	cell_type
and	O
BaF3	cell_line
cells	cell_line
,	O
genetically	O
engineered	O
to	O
express	O
c-Mpl	protein
,	O
a	O
receptor	O
for	O
thrombopoietin	protein
.	O
The	O
Jak	O
family	O
of	O
tyrosine	protein
kinases	protein
are	O
known	O
to	O
mediate	O
some	O
of	O
the	O
effects	O
of	O
cytokines	protein
or	O
hematopoietic	protein
growth	protein
factors	protein
by	O
recruitment	O
and	O
tyrosine	O
phosphorylation	O
of	O
a	O
variety	O
of	O
Stat	protein
(	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
)	O
proteins.	O
Hence,	O
we	O
have	O
investigated	O
whether	O
Stat	protein
proteins	protein
are	O
present	O
in	O
platelets	cell_type
and,	O
if	O
so,	O
whether	O
they	O
become	O
tyrosine	O
phosphorylated	O
in	O
response	O
to	O
thrombopoietin	protein
.	O
We	O
immunologically	O
identified	O
Stat1	protein
,	O
Stat2	protein
,	O
Stat3	protein
,	O
and	O
Stat5	protein
in	O
human	O
platelet	O
lysates	O
.	O
Thrombopoietin	protein
induced	O
tyrosine	O
phosphorylation	O
of	O
Stat3	protein
and	O
Stat5	protein
in	O
these	O
cells.	O
Thrombopoietin	protein
also	O
induced	O
tyrosine	O
phosphorylation	O
of	O
Stat3	protein
and	O
Stat5	protein
in	O
FDCP-2	cell_line
cells	cell_line
genetically	O
engineered	O
to	O
constitutively	O
express	O
human	protein
c-Mpl	protein
.	O
Thus,	O
our	O
data	O
indicate	O
that	O
Stat3	protein
and	O
Stat5	protein
may	O
be	O
involved	O
in	O
signal	O
transduction	O
after	O
ligand	O
binding	O
to	O
c-Mpl	protein
and	O
that	O
this	O
event	O
may	O
have	O
a	O
role	O
in	O
megakaryopoiesis/	O
thrombopoiesis	O
or	O
possibly	O
a	O
mature	O
platelet	O
function	O
such	O
as	O
aggregation	O
.	O

Mechanisms	O
that	O
contribute	O
to	O
the	O
development	O
of	O
lymphoid	O
malignancies	O
:	O
roles	O
for	O
genetic	O
alterations	O
and	O
cytokine	protein
production	O
.	O
Recent	O
studies	O
have	O
defined	O
genetic	O
alterations	O
commonly	O
associated	O
with	O
transformed	cell_line
lymphocytes	cell_line
.	O
This	O
review	O
suggests	O
roles	O
for	O
these	O
alterations	O
in	O
the	O
development	O
of	O
lymphoid	O
neoplasms	O
.	O
Damage	O
to	O
the	O
genes	O
encoding	O
proteins	O
that	O
function	O
in	O
intracellular	O
signaling	O
,	O
transcription,	O
or	O
regulation	O
of	O
the	O
cell	O
cycle	O
has	O
been	O
identified	O
and	O
linked	O
at	O
varying	O
degrees	O
to	O
the	O
progression	O
of	O
certain	O
lymphoid	O
malignancies	O
.	O
An	O
understanding	O
of	O
the	O
mechanistic	O
consequences	O
following	O
such	O
genetic	O
alterations	O
is	O
essential	O
to	O
an	O
understanding	O
of	O
the	O
development	O
of	O
these	O
lymphoid	O
neoplasms	O
.	O
In	O
contrast,	O
it	O
is	O
also	O
becoming	O
clear	O
that	O
the	O
dysregulated	O
expression	O
of	O
proteins	O
that	O
are	O
not	O
genetically	O
altered	O
can	O
also	O
contribute	O
to	O
the	O
progression	O
of	O
lymphoid	O
malignancies	O
.	O
One	O
such	O
example	O
is	O
the	O
excessive	O
expression	O
of	O
"normal"	protein
lymphokines	protein
of	O
cytokines	protein
which	O
accompanies	O
many	O
lymphoproliferative	O
diseases	O
.	O
The	O
dysregulated	O
expression	O
of	O
cytokines	protein
during	O
malignancy	O
can	O
result	O
in	O
the	O
augmentation	O
of	O
growth	O
of	O
transformed	cell_line
lymphocytes	cell_line
,	O
as	O
well	O
as	O
an	O
alteration	O
of	O
the	O
anti-tumor	O
immune	O
response	O
.	O
The	O
latter	O
mechanism	O
is	O
especially	O
important	O
because	O
evasion	O
of	O
the	O
impending	O
immune	O
response	O
is	O
a	O
prerequisite	O
for	O
the	O
progression	O
of	O
lymphoproliferative	O
diseases	O
.	O
Taken	O
together,	O
this	O
review	O
supports	O
the	O
notion	O
that	O
the	O
development	O
of	O
lymphoid	O
malignancies	O
is	O
multifactorial,	O
involving	O
genetic	O
alterations	O
as	O
well	O
as	O
dysregulated	O
cytokine	protein
expression	O
.	O

Dehydroepiandrosterone	O
modulation	O
of	O
lipopolysaccharide	O
-stimulated	O
monocyte	O
cytotoxicity	O
.	O
Dehydroepiandrosterone	O
(	O
DHEA	O
),	O
the	O
predominant	O
androgen	O
secreted	O
by	O
the	O
adrenal	O
cortex	O
,	O
can	O
be	O
converted	O
to	O
both	O
potent	O
androgens	O
and	O
estrogens	O
.	O
In	O
addition	O
to	O
its	O
role	O
as	O
a	O
precursor	O
for	O
other	O
steroid	O
hormones	O
,	O
DHEA	O
has	O
been	O
proposed	O
to	O
play	O
an	O
important	O
role	O
in	O
immunity.	O
This	O
study	O
has	O
investigated	O
DHEA	O
modulation	O
of	O
LPS	O
-induced	O
monocyte	O
cytotoxicity	O
.	O
Cytotoxicity	protein
markers	protein
assessed	O
include	O
tumor	O
cell	O
killing	O
,	O
IL-1	protein
secretion	O
,	O
reactive	O
oxygen	O
intermediate	O
release	O
,	O
nitric	protein
oxide	protein
synthetase	protein
activity	O
as	O
measured	O
by	O
the	O
release	O
of	O
reactive	O
nitrogen	O
intermediates	O
,	O
complement	protein
receptor-1	protein
cell	protein
surface	protein
protein	protein
,	O
and	O
TNF-alpha	protein
protein	protein
presence	O
.	O
Monocytes	cell_type
stimulated	O
with	O
LPS	O
concentrations	O
of	O
1.0	O
micrograms/ml	O
displayed	O
the	O
above	O
cytotoxic	O
markers,	O
whereas	O
monocytes	cell_type
stimulated	O
with	O
DHEA	O
alone	O
or	O
with	O
LPS	O
at	O
a	O
lower	O
concentration	O
of	O
0.2	O
ng/ml	O
did	O
not.	O
However,	O
when	O
used	O
simultaneously,	O
DHEA	O
and	O
LPS	O
0.2	O
ng/ml	O
displayed	O
a	O
synergistic	O
effect	O
on	O
monocyte	O
cytotoxicity	O
against	O
cancerous	cell_line
cell	cell_line
lines	cell_line
,	O
IL-1	protein
secretion	O
,	O
reactive	O
nitrogen	O
intermediate	O
release	O
,	O
complement	protein
receptor-1	protein
cell-surface	protein
protein	protein
,	O
and	O
TNF-alpha	protein
protein	protein
to	O
levels	O
comparable	O
with	O
levels	O
obtained	O
using	O
LPS	O
1.0	O
microgram/ml.	O
Finally,	O
Scatchard	O
plot	O
analysis	O
demonstrated	O
the	O
presence	O
of	O
a	O
DHEA	O
receptor	O
in	O
monocytes	cell_type
,	O
suggesting	O
that	O
DHEA	O
effects	O
on	O
LPS	cell_line
-stimulated	cell_line
monocytes	cell_line
are	O
mediated	O
through	O
a	O
receptor-dependent	O
process	O
.	O

Interferons	O
inhibit	O
activation	O
of	O
STAT6	protein
by	O
interleukin	protein
4	protein
in	O
human	cell_type
monocytes	cell_type
by	O
inducing	O
SOCS-1	DNA
gene	DNA
expression	O
.	O
Interferons	protein
(	O
IFNs	protein
)	O
inhibit	O
induction	O
by	O
IL-4	protein
of	O
multiple	O
genes	O
in	O
human	cell_type
monocytes	cell_type
.	O
However,	O
the	O
mechanism	O
by	O
which	O
IFNs	protein
mediate	O
this	O
inhibition	O
has	O
not	O
been	O
defined.	O
IL-4	protein
activates	O
gene	O
expression	O
by	O
inducing	O
tyrosine	O
phosphorylation	O
,	O
homodimerization	O
,	O
and	O
nuclear	O
translocation	O
of	O
the	O
latent	protein
transcription	protein
factor	protein
,	O
STAT6	protein
(	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription-6	protein
).	O
STAT6	protein
-responsive	O
elements	O
are	O
characteristically	O
present	O
in	O
the	O
promoters	DNA
of	O
IL-4	DNA
-inducible	DNA
genes	DNA
.	O
Because	O
STAT6	protein
activation	O
is	O
essential	O
for	O
IL-4	protein
-induced	O
gene	O
expression	O
,	O
we	O
examined	O
the	O
ability	O
of	O
type	O
I	O
and	O
type	O
II	O
IFNs	protein
to	O
regulate	O
activation	O
of	O
STAT6	protein
by	O
IL-4	protein
in	O
primary	cell_type
human	cell_type
monocytes	cell_type
.	O
Pretreatment	O
of	O
monocytes	cell_type
with	O
IFN-beta	protein
or	O
IFN-gamma	protein
,	O
but	O
not	O
IL-1	protein
,	O
IL-2	protein
,	O
macrophage	protein
colony-stimulating	protein
factor	protein
,	O
granulocyte/macrophage	protein
colony-stimulating	protein
factor	protein
,	O
IL-6	protein
,	O
or	O
transforming	O
growth	O
factor	O
beta	O
suppressed	O
activation	O
of	O
STAT6	protein
by	O
IL-4	protein
.	O
This	O
inhibition	O
was	O
associated	O
with	O
decreased	O
tyrosine	O
phosphorylation	O
and	O
nuclear	O
translocation	O
of	O
STAT6	protein
and	O
was	O
not	O
evident	O
unless	O
the	O
cells	O
were	O
preincubated	O
with	O
IFN	protein
for	O
at	O
least	O
1	O
hr	O
before	O
IL-4	protein
stimulation	O
.	O
Furthermore,	O
inhibition	O
by	O
IFN	protein
could	O
be	O
blocked	O
by	O
cotreatment	O
with	O
actinomycin	O
D	O
and	O
correlated	O
temporally	O
with	O
induction	O
of	O
the	O
JAK/STAT	DNA
inhibitory	DNA
gene	DNA
,	O
SOCS-1	DNA
.	O
Forced	O
expression	O
of	O
SOCS-1	DNA
in	O
a	O
macrophage	cell_line
cell	cell_line
line	cell_line
,	O
RAW264	cell_line
,	O
markedly	O
suppressed	O
trans-activation	O
of	O
an	O
IL-4	DNA
-inducible	DNA
reporter	DNA
as	O
well	O
as	O
IL-6-	O
and	O
IFN-gamma-	O
induced	O
reporter	O
gene	O
activity	O
.	O
These	O
findings	O
demonstrate	O
that	O
IFNs	protein
inhibit	O
IL-4	protein
-induced	O
activation	O
of	O
STAT6	protein
and	O
STAT6	protein
-dependent	O
gene	O
expression	O
,	O
at	O
least	O
in	O
part,	O
by	O
inducing	O
expression	O
of	O
SOCS-1	DNA
.	O

An	O
activation-responsive	O
element	O
in	O
single	O
C	DNA
motif-1/lymphotactin	DNA
promoter	DNA
is	O
a	O
site	O
of	O
constitutive	O
and	O
inducible	O
DNA-protein	O
interactions	O
involving	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cell	protein
.	O
Single	protein
C	protein
motif-1	protein
(SCM-1)/lymphotactin	protein
is	O
a	O
C-type	protein
chemokine	protein
whose	O
expression	O
is	O
activation	O
dependent	O
,	O
cyclosporin	O
A	O
sensitive	O
and	O
restricted	O
to	O
CD8+	cell_type
T	cell_type
cells	cell_type
,	O
double-negative	cell_type
thymocytes	cell_type
,	O
gammadelta-type	cell_type
T	cell_type
cells	cell_type
,	O
and	O
NK	cell_type
cells	cell_type
.	O
In	O
humans,	O
there	O
are	O
two	O
highly	O
homologous	DNA
genes	DNA
encoding	O
SCM-1alpha	protein
and	O
SCM-1beta	protein
.	O
Here	O
we	O
examined	O
the	O
regulatory	O
mechanism	O
of	O
the	O
SCM-1	DNA
genes	DNA
.	O
The	O
luciferase	DNA
reporter	DNA
gene	DNA
under	O
the	O
control	O
of	O
the	O
5'	DNA
flanking	DNA
region	DNA
of	O
0.7	O
kb	O
was	O
strongly	O
induced	O
upon	O
activation	O
with	O
anti-CD3	protein
or	O
PHA	protein
plus	O
PMA	O
only	O
in	O
SCM-1-producer	cell_line
T	cell_line
cell	cell_line
lines	cell_line
through	O
a	O
cyclosporin	O
A-sensitive	O
mechanism	O
.	O
An	O
element	O
termed	O
E1	DNA
located	O
at	O
-108	DNA
to	DNA
-95	DNA
nt	DNA
relative	O
to	O
the	O
major	O
transcription	O
start	O
site	O
was	O
found	O
to	O
be	O
critical	O
for	O
the	O
promoter	O
activity	O
.	O
In	O
electrophoretic	O
mobility	O
shift	O
assays	O
using	O
the	O
E1	DNA
oligonucleotide	O
as	O
probe,	O
nuclear	O
extracts	O
from	O
unstimulated	O
T	O
and	O
B	cell_line
cell	cell_line
lines	cell_line
formed	O
a	O
constitutive	protein
complex	protein
termed	O
complex	protein
I	protein
,	O
while	O
nuclear	O
extracts	O
from	O
stimulated	O
SCM-1-producer	cell_line
T	cell_line
cell	cell_line
lines	cell_line
formed	O
a	O
higher	protein
mobility	protein
complex	protein
termed	O
complex	protein
II	protein
with	O
a	O
concomitant	O
decrease	O
in	O
complex	protein
I	protein
.	O
The	O
shift	O
from	O
complex	protein
I	protein
to	O
complex	protein
II	protein
seen	O
only	O
in	O
SCM-1-producer	cell_line
T	cell_line
cell	cell_line
lines	cell_line
upon	O
activation	O
was	O
completely	O
suppressed	O
by	O
cyclosporin	O
A	O
.	O
Both	O
complexes	O
were	O
critically	O
dependent	O
on	O
the	O
NF-AT	DNA
core	DNA
sequence	DNA
TTTCC	O
in	O
the	O
E1	DNA
element	DNA
and	O
were	O
partially	O
supershifted	O
by	O
anti-NF-ATp	protein
.	O
One-hybrid	O
assays	O
in	O
yeast	protein
isolated	protein
NF-ATp	protein
as	O
an	O
E1	protein
binding	protein
protein	protein
,	O
and	O
transfection	O
of	O
NF-ATp	protein
into	O
T	O
and	O
B	O
cell	O
lines	O
strongly	O
enhanced	O
the	O
activation-dependent	protein
SCM-1	protein
promoter	O
activity	O
.	O
Collectively,	O
a	O
unique	O
mechanism	O
involving	O
NF-ATp	protein
appears	O
to	O
regulate	O
the	O
cell	O
type-specific	O
and	O
activation-dependent	O
expression	O
of	O
the	O
SCM-1	DNA
genes	DNA
.	O

Dopamine	O
stimulates	O
expression	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
via	O
NF-kappaB	protein
in	O
cells	O
of	O
the	O
immune	O
system	O
.	O
Recent	O
studies	O
have	O
reported	O
that	O
lymphocytes	cell_type
produce,	O
transport	O
and	O
bind	O
dopamine	O
present	O
in	O
plasma	O
.	O
However,	O
the	O
action	O
of	O
dopamine	O
on	O
HIV-1	O
gene	O
expression	O
in	O
cells	O
of	O
the	O
immune	O
system	O
has	O
not	O
yet	O
been	O
examined.	O
Here,	O
we	O
have	O
investigated	O
the	O
regulation	O
of	O
HIV-1	O
expression	O
by	O
dopamine	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
and	O
in	O
primary	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
).	O
HIV-1	O
replication	O
was	O
increased	O
by	O
dopamine	O
,	O
which	O
correlated	O
with	O
the	O
increased	O
levels	O
of	O
HIV-1	O
transactivation	O
.	O
Our	O
transient	O
expression	O
data	O
revealed	O
that	O
dopamine	O
stimulated	O
transcription	O
through	O
the	O
NF-kappaB	DNA
element	DNA
present	O
in	O
the	O
long	DNA
terminal	DNA
repeat	DNA
.	O
The	O
importance	O
of	O
NF-kappaB	DNA
sites	DNA
was	O
confirmed	O
by	O
using	O
vectors	O
containing	O
wild-type	O
or	O
mutant	O
kappaB	O
sites	O
in	O
a	O
heterologous	DNA
promoter	DNA
.	O
Consistent	O
with	O
the	O
role	O
of	O
NF-kappaB	protein
in	O
mediating	O
dopamine	O
responsiveness	O
,	O
the	O
proteasome	O
inhibitor	O
MG132	O
abolished	O
dopamine	O
-induced	O
transcriptional	O
activation	O
.	O
We	O
further	O
explored	O
the	O
effect	O
of	O
dopamine	O
in	O
the	O
presence	O
of	O
phorbol	O
esters	O
or	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
)	O
known	O
to	O
activate	O
NF-kappaB	protein
.	O
The	O
combination	O
of	O
dopamine	O
and	O
TNF-alpha	protein
led	O
to	O
a	O
stimulation	O
of	O
HIV-1	O
transcription	O
and	O
replication.	O
However,	O
in	O
contrast	O
with	O
TNF-alpha	protein
,	O
dopamine	O
treatment	O
did	O
not	O
affect	O
NF-kappaB	protein
DNA	O
binding	O
activity	O
nor	O
the	O
concentrations	O
of	O
p50	protein
,	O
p65	protein
and	O
IkappaB-alpha	protein
proteins	protein
,	O
which	O
suggests	O
a	O
distinct	O
NF-kappaB	protein
activation	O
mechanism	O
.	O
These	O
results	O
reveal	O
a	O
new	O
link	O
between	O
the	O
dopamine	O
system	O
,	O
cytokine	protein
signaling	O
pathway	O
and	O
regulation	O
of	O
gene	O
expression	O
via	O
the	O
involvement	O
of	O
NF-kappaB	protein
in	O
T	cell_type
cells	cell_type
and	O
PBMC	cell_type
.	O

[	O
Hormonal	O
metabolic	O
status	O
in	O
breast	O
cancer	O
patients	O
after	O
conservative	O
surgery	O
:	O
comparison	O
with	O
known	O
prognostic	O
criteria]	O
Body	O
weight	O
,	O
body	O
mass	O
index	O
,	O
body	O
fat	O
,	O
lean	O
body	O
mass	O
,	O
blood-glucose	O
,	O
cholesterol	O
,	O
HDL-cholesterol	protein
,	O
triglyceride	O
,	O
beta-lipoproteins	protein
,	O
insulin	O
,	O
gonadotropin	O
,	O
estradiol	O
,	O
testosterone	O
,	O
SHBG	protein
,	O
T3	protein
,	O
T4	protein
and	O
TSH	O
levels	O
as	O
well	O
as	O
estradiol	O
and	O
progesterone	O
receptor	O
levels	O
in	O
excised	O
tumor	O
were	O
studied	O
in	O
40	O
patients	O
with	O
breast	O
cancer	O
prior	O
to	O
conservative	O
treatment	O
.	O
Said	O
anthropometric,	O
metabolic	O
and	O
hormonal	O
parameters	O
were	O
compared	O
with	O
the	O
index	O
of	O
lymphocytic	O
infiltration	O
of	O
tumor	O
selected	O
as	O
a	O
prognostic	O
factor	O
.	O
A	O
significant	O
correlation	O
between	O
high	O
lymphocytic	O
infiltration	O
(2.5	O
points),	O
low	O
body	O
mass	O
and	O
fat	O
was	O
identified.	O
Also,	O
smoking	O
contributed	O
to	O
loss	O
of	O
body	O
mass	O
and	O
fat	O
;	O
however,	O
it	O
caused	O
lymphocytic	O
infiltration	O
to	O
rise.	O
Moderate	O
body	O
mass	O
,	O
relatively	O
low	O
fat	O
level	O
and	O
positive	O
receptor	O
status	O
are	O
among	O
factors	O
of	O
good	O
prognosis	O
in	O
breast	O
cancer	O
of	O
early	O
stages	O
.	O

Selective	O
DNA-binding	O
activity	O
of	O
interleukin-10	protein
-stimulated	protein
STAT	protein
molecules	protein
in	O
human	cell_type
monocytes	cell_type
.	O
It	O
has	O
been	O
demonstrated	O
that	O
interferon-gamma	protein
(	O
IFN-gamma	protein
)	O
and	O
interleukin-10	protein
(	O
IL-10	protein
)	O
have	O
various	O
reverse	O
effects	O
on	O
macrophages	cell_type
;	O
however,	O
the	O
molecular	O
mechanism	O
of	O
this	O
difference	O
has	O
not	O
been	O
fully	O
understood.	O
In	O
this	O
study,	O
we	O
analyzed	O
the	O
binding	O
activity	O
of	O
IL-10-	O
and	O
IFN-gamma-	O
activated	O
STAT	O
molecules	O
to	O
two	O
kinds	O
of	O
GAS	DNA
-motif	O
sequences	O
.	O
IL-10	protein
-activated	protein
STAT1	protein
could	O
bind	O
to	O
the	O
GAS-motif	DNA
sequence	DNA
in	O
the	O
promoter	O
region	O
of	O
the	O
Fcgamma	protein
receptor	protein
,	O
but	O
not	O
to	O
that	O
in	O
the	O
promoter	DNA
region	DNA
of	O
the	O
COX-2	DNA
gene	DNA
,	O
whereas	O
IFN-gamma	protein
-activated	protein
STAT1	protein
and	O
STAT5	protein
could	O
bind	O
to	O
both	O
sequences.	O
IL-10	protein
inhibited	O
IFN-gamma	protein
-induced	O
STAT	protein
activation	O
without	O
newly	protein
synthesized	protein
protein	protein
.	O
We	O
further	O
demonstrated	O
that	O
aspirin	O
,	O
but	O
not	O
dexamethasone	O
,	O
suppressed	O
IFN-gamma	protein
-induced	O
STAT	protein
activation	O
.	O
Taken	O
together,	O
these	O
results	O
suggest	O
that	O
IL-10-activated	protein
STAT1	protein
has	O
a	O
specificity	O
in	O
binding	O
to	O
the	O
GAS-motif	DNA
sequences	DNA
,	O
whereas	O
IFN-gamma	protein
-activated	protein
STAT1	protein
and	O
STAT5	protein
have	O
a	O
broader	O
spectrum	O
in	O
binding	O
to	O
the	O
GAS-motif	DNA
sequences	DNA
.	O
This	O
may	O
explain	O
the	O
difference	O
between	O
IL-10	protein
and	O
IFN-gamma	protein
in	O
biological	O
activity	O
,	O
and	O
the	O
inhibitory	O
effect	O
of	O
IL-10	protein
on	O
IFN-gamma	protein
activities	O
.	O

Peptide	O
binding	O
affinity	O
and	O
pH	O
variation	O
establish	O
functional	O
thresholds	O
for	O
activation	O
of	O
HLA-DQ	DNA
-restricted	O
T	O
cell	O
recognition	O
.	O
Peptides	O
derived	O
from	O
the	O
HSV-2	protein
VP16	protein
protein	protein
were	O
utilized	O
for	O
studies	O
of	O
peptide	O
binding	O
to	O
DQ0302	O
molecules	O
and	O
T	O
cell	O
activation	O
at	O
both	O
neutral	O
and	O
acidic	O
pH	O
.	O
The	O
native	O
peptide	O
VP16	O
430-444	O
contains	O
an	O
Asp	O
at	O
position	protein
442	protein
,	O
binds	O
to	O
DQ0302	O
strongly,	O
with	O
a	O
Kd	O
value	O
of	O
50nM	O
at	O
acidic	O
pH	O
and	O
very	O
weakly,	O
with	O
a	O
Kd	O
value	O
of	O
greater	O
than	O
10	O
microM	O
at	O
neutral	O
pH	O
.	O
A	O
truncated	O
version	O
of	O
430-444	O
,	O
i.e.,	O
VP16	O
433-442	O
,	O
binds	O
with	O
an	O
affinity	O
10-fold	O
lower	O
compared	O
to	O
430-444	O
at	O
acidic	O
pH,	O
and	O
binding	O
at	O
neutral	O
pH	O
was	O
barely	O
detectable.	O
The	O
homologous	O
peptide	O
430-444,442A	O
has	O
an	O
Asp	O
to	O
Ala	O
substitution	O
at	O
position	O
442	O
and	O
binds	O
to	O
DQ0302	O
with	O
a	O
Kd	O
similar	O
to	O
433-442	O
.	O
The	O
short	O
truncated	O
analog	O
433-442A	O
binds	O
very	O
poorly	O
at	O
both	O
acidic	O
and	O
neutral	O
pH	O
.	O
Both	O
the	O
wild	O
type	O
430-444	O
and	O
433-442	O
peptides	O
stimulated	O
a	O
HSV-specific	O
T	O
cell	O
clone	O
after	O
a	O
brief	O
incubation	O
with	O
antigen	cell_type
presenting	cell_type
cells	cell_type
(	O
APC	cell_type
)	O
expressing	O
DQ0302	O
at	O
acidic	O
pH	O
.	O
Much	O
higher	O
concentrations	O
of	O
wild	O
type	O
peptides	O
were	O
needed	O
to	O
activate	O
T	cell_type
cells	cell_type
at	O
neutral	O
pH	O
.	O
In	O
contrast,	O
APC	cell_type
pulsed	O
with	O
Ala	O
-substituted	O
peptides	O
430-444	O
,	O
442A	O
or	O
433-442A	O
at	O
neutral	O
pH	O
failed	O
to	O
stimulate	O
the	O
T	cell_line
cell	cell_line
clone	cell_line
,	O
while	O
APC	cell_type
pulsed	O
at	O
acidic	O
pH	O
and	O
subsequently	O
washed	O
led	O
to	O
successful	O
T	O
cell	O
activation	O
.	O
The	O
Ala	O
-substituted	O
peptide	O
was	O
recognized	O
by	O
the	O
T	cell_line
cell	cell_line
clone	cell_line
at	O
neutral	O
pH	O
only	O
when	O
it	O
was	O
present	O
in	O
the	O
APC	cell_line
culture	cell_line
throughout	O
the	O
stimulation	O
process.	O
While	O
the	O
MHC-peptide	protein
complexes	protein
formed	O
with	O
the	O
native	O
peptide	O
are	O
stable,	O
complexes	O
formed	O
with	O
the	O
Ala	O
-substituted	O
peptide	O
had	O
a	O
functional	O
t1/2	O
of	O
less	O
than	O
4	O
hr	O
at	O
neutral	O
pH	O
.	O

ETS	protein
transcription	protein
factors	protein
regulate	O
an	O
enhancer	O
activity	O
in	O
the	O
third	DNA
intron	DNA
of	O
TNF-alpha	protein
.	O
We	O
describe	O
an	O
enhancer	O
site	O
in	O
the	O
third	DNA
intron	DNA
of	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF-alpha	protein
).	O
A	O
reporter	DNA
construct	DNA
containing	O
the	O
5'-flanking	DNA
region	DNA
of	O
the	O
mouse	O
TNF-alpha	DNA
gene	DNA
displayed	O
weak	O
activity	O
when	O
transfected	O
into	O
RAW264.7	cell_line
macrophage-like	cell_line
cells	cell_line
.	O
The	O
addition	O
of	O
the	O
third	DNA
intron	DNA
of	O
TNF-alpha	protein
to	O
this	O
construct	O
resulted	O
in	O
an	O
enhancement	O
of	O
CAT	protein
protein	protein
.	O
This	O
enhancement	O
was	O
eliminated	O
if	O
a	O
conserved	DNA
20-bp	DNA
sequence	DNA
was	O
removed	O
from	O
the	O
intron	DNA
or	O
if	O
a	O
dominant-negative	protein
ets-binding	protein
factor	protein
was	O
co-transfected	O
with	O
the	O
reporter	DNA
gene	DNA
.	O
Mutations	O
of	O
this	O
site	O
that	O
destroyed	O
potential	O
ets	DNA
transcription	DNA
factor	DNA
binding	DNA
sites	DNA
had	O
reduced	O
transcriptional	O
activity	O
.	O
The	O
major	O
transcription	O
factor	O
that	O
bound	O
to	O
the	O
oligonucleotide	O
was	O
confirmed	O
to	O
be	O
GABP	protein
by	O
supershift	O
and	O
competition	O
analysis	O
.	O
In	O
RAW264.7	cell_line
cells	cell_line
,	O
the	O
binding	O
was	O
constitutive,	O
however,	O
in	O
bone	cell_line
marrow-derived	cell_line
macrophages	cell_line
binding	O
activity	O
was	O
shown	O
to	O
be	O
interferon-gamma	protein
inducible	O
.	O
This	O
may	O
imply	O
a	O
role	O
for	O
ets	protein
transcription	protein
factors	protein
in	O
the	O
production	O
of	O
TNF-alpha	protein
.	O

E2F-1	protein
blocks	O
terminal	O
differentiation	O
and	O
causes	O
proliferation	O
in	O
transgenic	cell_type
megakaryocytes	cell_type
.	O
The	O
transcription	protein
factor	protein
E2F-1	protein
plays	O
a	O
central	O
role	O
in	O
the	O
cell	O
cycle	O
through	O
its	O
ability	O
to	O
activate	DNA
genes	DNA
involved	O
in	O
cell	O
division	O
.	O
E2F-1	protein
activity	O
is	O
regulated	O
by	O
a	O
number	O
of	O
proteins,	O
including	O
the	O
retinoblastoma	O
susceptibility	DNA
gene	DNA
product	O
,	O
cyclin-dependent	protein
kinases	protein
,	O
and	O
their	O
inhibitors	O
,	O
proteins	O
that	O
have	O
been	O
implicated	O
in	O
the	O
control	O
of	O
certain	O
developmental	O
processes	O
.	O
To	O
investigate	O
a	O
potential	O
role	O
of	O
E2F-1	protein
in	O
differentiation	O
,	O
we	O
assayed	O
the	O
ability	O
of	O
megakaryocytes	cell_type
to	O
form	O
platelets	cell_type
in	O
an	O
in	O
vivo	O
transgenic	O
model	O
.	O
E2F-1	protein
expression	O
in	O
megakaryocytes	cell_type
blocked	O
differentiation	O
during	O
maturation,	O
resulting	O
in	O
severe	O
thrombocytopenia	O
.	O
Ultrastructural	O
analysis	O
of	O
megakaryocytes	cell_type
revealed	O
abnormal	O
development	O
characterized	O
by	O
hyperdemarcation	O
of	O
cytoplasmic	O
membranes	O
and	O
reduced	O
numbers	O
of	O
alpha	O
granules	O
.	O
Administration	O
of	O
megakaryocyte	protein
growth	protein
and	protein
development	protein
factor	protein
or	O
interleukin	protein
6	protein
could	O
not	O
overcome	O
the	O
differentiation	O
block	O
.	O
Additionally,	O
E2F-1	protein
caused	O
massive	O
megakaryocyte	cell_type
accumulation	O
in	O
both	O
normal	O
and	O
ectopic	O
sites,	O
first	O
evident	O
in	O
E15	O
embryonic	O
liver	O
.	O
Furthermore,	O
significant	O
apoptosis	O
was	O
observed	O
in	O
transgenic	cell_type
megakaryocytes	cell_type
.	O
These	O
data	O
indicate	O
that	O
E2F-1	protein
can	O
prevent	O
terminal	O
differentiation	O
,	O
probably	O
through	O
its	O
cell	O
cycle	O
-stimulatory	O
activity	O
.	O

Polymorphic	O
nucleotides	O
within	O
the	O
human	DNA
IL-4	DNA
promoter	DNA
that	O
mediate	O
overexpression	O
of	O
the	O
gene.	O
Atopy	O
,	O
which	O
predisposes	O
individuals	O
to	O
develop	O
asthma	O
,	O
severe	O
systemic	O
anaphylaxis	O
,	O
and	O
atopic	O
dermatitis	O
,	O
is	O
usually	O
associated	O
with	O
dramatically	O
elevated	O
total	O
serum	O
IgE	protein
levels	O
and	O
is	O
thought	O
to	O
be	O
controlled	O
by	O
a	O
major	O
susceptibility	DNA
gene	DNA
and	O
multiple	O
minor	O
susceptibility	DNA
genes	DNA
.	O
A	O
recent	O
sib-pair	O
analysis	O
revealed	O
a	O
tight	O
linkage	O
between	O
markers	O
on	O
5q31.1	DNA
and	O
a	O
major	DNA
susceptibility	DNA
gene	DNA
controlling	O
total	O
serum	O
IgE	protein
levels	O
.	O
Due	O
to	O
its	O
location	O
within	O
this	O
cluster	O
and	O
its	O
biologic	O
role	O
in	O
Ig	O
class	O
switching	O
and	O
Th2	cell_line
cell	cell_line
differentiation	O
,	O
the	O
IL-4	DNA
gene	DNA
has	O
emerged	O
as	O
one	O
major	O
candidate	O
for	O
the	O
atopy	DNA
gene	DNA
.	O
In	O
one	O
model,	O
polymorphisms	O
within	O
IL-4	DNA
regulatory	DNA
elements	DNA
might	O
result	O
in	O
overexpression	O
of	O
the	O
gene,	O
amplifying	O
Th2	cell_line
cell	cell_line
differentiation	O
and	O
class	O
switching	O
to	O
IgE	protein
.	O
In	O
support	O
of	O
this	O
model,	O
we	O
report	O
that	O
the	O
human	DNA
IL-4	DNA
promoter	DNA
exists	O
in	O
multiple	O
allelic	O
forms	O
that	O
exhibit	O
distinct	O
transcriptional	O
activities	O
in	O
IL-4	cell_type
-positive	cell_type
T	cell_type
cells	cell_type
.	O
A	O
particular	O
allele	O
has	O
an	O
unusually	O
high	O
transcriptional	O
activity	O
.	O
A	O
nucleotide	O
substitution	O
within	O
a	O
recently	O
described	O
OAP40	DNA
element	DNA
located	O
just	O
upstream	O
of	O
an	O
NF-AT	DNA
site	DNA
(	O
P	DNA
sequence	DNA
)	O
appears	O
to	O
be	O
largely	O
responsible	O
for	O
the	O
increased	O
promotor	O
strength	O
of	O
this	O
particular	O
allelic	O
form	O
of	O
the	O
IL-4	DNA
promoter	DNA
.	O
In	O
EMSAs	O
,	O
this	O
substitution	O
results	O
in	O
a	O
markedly	O
enhanced	O
affinity	O
for	O
sequence-specific	O
complexes	O
exhibiting	O
an	O
AP-1	protein
specificity	O
.	O
The	O
identification	O
of	O
allelic	O
nucleotides	O
,	O
which	O
results	O
in	O
overexpression	O
of	O
the	O
IL-4	DNA
gene	DNA
,	O
provides	O
specific	O
targets	O
for	O
a	O
comprehensive	O
screening	O
of	O
atopic	O
and	O
nonatopic	O
individuals	O
and	O
may	O
provide	O
a	O
clue	O
for	O
genetic	O
predisposition	O
for	O
atopy	O
.	O

Evidence	O
for	O
lowered	O
induction	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
in	O
activated	cell_type
human	cell_type
T	cell_type
lymphocytes	cell_type
during	O
aging.	O
Transcription	O
factor	O
NF	protein
kappa	protein
B	protein
(	O
nuclear	protein
factor	protein
kappa	protein
B	protein
)	O
is	O
induced	O
in	O
T	cell_type
lymphocytes	cell_type
from	O
young	O
individuals	O
following	O
activation	O
with	O
a	O
variety	O
of	O
stimuli	O
including	O
anti-CD3	protein
,	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
),	O
and	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
).	O
In	O
contrast,	O
activated	O
T	cell_type
lymphocytes	cell_type
from	O
older	O
individuals	O
show	O
a	O
significant	O
reduction	O
in	O
the	O
induction	O
of	O
NF	protein
kappa	protein
B	protein
in	O
response	O
to	O
the	O
same	O
stimuli.	O
The	O
age-related	O
decline	O
in	O
induction	O
of	O
NF	protein
kappa	protein
B	protein
could	O
not	O
be	O
attributed	O
to	O
alteration	O
in	O
the	O
composition	O
of	O
subunits,	O
p50	protein
and	O
p65	protein
were	O
found	O
to	O
be	O
the	O
predominant	O
subunits	O
of	O
induced	O
NF	protein
kappa	protein
B	protein
in	O
T	cell_type
cells	cell_type
from	O
young	O
as	O
well	O
as	O
elderly	O
donors.	O
Furthermore,	O
similar	O
levels	O
of	O
NF	protein
kappa	protein
B	protein
were	O
found	O
in	O
the	O
cytosols	O
of	O
unactivated	O
T	cell_type
cells	cell_type
from	O
both	O
young	O
and	O
elderly	O
donors	O
suggesting	O
that	O
precursor	O
levels	O
of	O
NF	protein
kappa	protein
B	protein
remain	O
unaltered	O
during	O
aging.	O
These	O
results	O
suggest	O
that	O
an	O
age-associated	O
decline	O
in	O
the	O
induction	O
of	O
NF	protein
kappa	protein
B	protein
in	O
activated	O
T	cell_type
cells	cell_type
from	O
elderly	O
individuals	O
may	O
be	O
attributable	O
to	O
altered	O
regulation	O
of	O
the	O
inhibitor,	O
I	protein
kappa	protein
B	protein
,	O
and	O
may	O
play	O
an	O
important	O
role	O
in	O
immune	O
dysregulation	O
accompanying	O
aging	O
.	O

Inhibition	O
of	O
lipopolysaccharide	O
-induced	O
monocyte	protein
interleukin-1	protein
receptor	protein
antagonist	O
synthesis	O
by	O
cortisol	O
:	O
involvement	O
of	O
the	O
mineralocorticoid	protein
receptor	protein
.	O
Glucocorticoids	O
,	O
as	O
a	O
part	O
of	O
their	O
physiological	O
role	O
in	O
the	O
control	O
of	O
inflammatory	O
and	O
immune	O
processes	O
,	O
suppress	O
the	O
expression	O
of	O
interleukin-1	protein
(	O
IL-1	protein
)	O
and	O
other	O
cytokines	protein
.	O
Human	RNA
monocyte	RNA
IL-1	RNA
receptor	RNA
antagonist	RNA
(IL-1ra)	RNA
messenger	RNA
ribonucleic	RNA
acid	RNA
(mRNA)	O
expression	O
and	O
protein	O
secretion	O
are	O
inhibited	O
by	O
dexamethasone	O
.	O
We	O
have	O
now	O
further	O
studied	O
the	O
regulation	O
of	O
IL-1ra	protein
by	O
the	O
major	O
physiological	O
human	O
glucocorticoid	O
,	O
cortisol	O
.	O
We	O
found	O
that	O
cortisol	O
incubation	O
induced	O
a	O
decrease	O
in	O
IL-1ra	RNA
mRNA	RNA
expression	O
and	O
a	O
significant	O
inhibition	O
of	O
IL-1ra	protein
protein	protein
secretion	O
in	O
cell	O
cultures	O
of	O
human	cell_type
peripheral	cell_type
monocytes	cell_type
stimulated	O
with	O
the	O
bacterial	O
endotoxin	O
lipopolysaccharide	O
(	O
LPS	O
).	O
Oral	O
administration	O
of	O
276	O
mumol	O
cortisol	O
to	O
normal	O
subjects	O
also	O
decreased	O
LPS	O
-induced	O
IL-1ra	protein
synthesis	O
in	O
cultured	cell_line
monocytes	cell_line
.	O
By	O
coincubating	O
the	O
monocytes	cell_type
with	O
either	O
the	O
mineralocorticoid	O
antagonist	O
spironolactone	O
or	O
the	O
glucocorticoid	protein
receptor	protein
antagonist	O
RU	O
38486	O
,	O
the	O
in	O
vitro	O
cortisol	O
-induced	O
inhibition	O
of	O
LPS	O
-stimulated	O
IL-1ra	protein
secretion	O
was	O
partially	O
reversed.	O
The	O
mineralocorticoid	O
aldosterone	O
exerted	O
a	O
significant	O
decrease	O
in	O
LPS	O
-induced	O
monocyte	O
IL-1ra	protein
secretion	O
in	O
vitro,	O
which	O
was	O
blocked	O
by	O
coincubation	O
with	O
spironolactone	O
.	O
In	O
addition,	O
the	O
expression	O
of	O
mineralocorticoid	RNA
receptor	RNA
mRNA	RNA
in	O
human	O
monocytes	cell_type
was	O
observed	O
by	O
PCR	O
of	O
reversed	RNA
transcribed	RNA
RNA	RNA
.	O
Our	O
results	O
further	O
indicate	O
that	O
corticosteroids	O
physiologically	O
control	O
the	O
IL-1/	O
IL-1ra	protein
system	O
during	O
inflammatory	O
or	O
immune	O
processes	O
.	O
Moreover,	O
we	O
provide	O
evidence	O
that,	O
in	O
addition	O
to	O
a	O
glucocorticoid	protein
receptor	protein
-mediated	O
effect	O
,	O
the	O
mineralocorticoid	protein
receptor	protein
is	O
involved	O
in	O
the	O
inhibition	O
of	O
monocyte	O
IL-1ra	protein
secretion	O
by	O
cortisol	O
.	O

Target	O
structures	O
of	O
the	O
CD8(+)-T-cell	O
response	O
to	O
human	O
cytomegalovirus	O
:	O
the	O
72-kilodalton	protein
major	protein
immediate-early	protein
protein	protein
revisited.	O
Cell-mediated	O
immunity	O
plays	O
an	O
essential	O
role	O
in	O
the	O
control	O
of	O
infection	O
with	O
the	O
human	O
cytomegalovirus	O
(	O
HCMV	O
).	O
However,	O
only	O
a	O
few	O
CD8(+)-T-cell	protein
epitopes	protein
are	O
known,	O
with	O
the	O
majority	O
being	O
contained	O
in	O
the	O
pp65	protein
phosphoprotein	protein
,	O
which	O
is	O
believed	O
to	O
dominate	O
the	O
CD8(+)-T-cell	O
response	O
to	O
HCMV	O
.	O
Here,	O
we	O
have	O
readdressed	O
the	O
issue	O
of	O
CD8(+)	cell_type
T	cell_type
cells	cell_type
specific	O
for	O
the	O
72-kDa	protein
major	protein
immediate-early	protein
protein	protein
(	O
IE-1	protein
),	O
which	O
is	O
nonstructural	O
but	O
is	O
found	O
very	O
early	O
and	O
throughout	O
the	O
replicative	O
cycle.	O
Using	O
a	O
novel	O
flow-cytometric	O
assay	O
,	O
we	O
were	O
able	O
to	O
identify	O
CD8(+)-T-cell	protein
epitopes	protein
(by	O
IE-1	protein
peptide-specific	O
induction	O
of	O
cytokine	protein
synthesis	O
)	O
and	O
simultaneously	O
measure	O
the	O
frequency	O
of	O
cells	O
directed	O
against	O
them.	O
For	O
this	O
purpose,	O
81	O
pentadecamer	O
peptides	O
covering	O
the	O
complete	O
491-amino-acid	protein
sequence	protein
of	O
IE-1	protein
were	O
tested	O
on	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
of	O
anti-	O
HCMV	O
immunoglobulin	O
G-seropositive	O
donors	O
.	O
At	O
least	O
10	O
new	O
epitopes	protein
were	O
identified,	O
and	O
the	O
fine	O
specificity	O
and	O
presenting	O
HLA	protein
molecule	protein
of	O
the	O
first	O
of	O
them	O
was	O
determined.	O
The	O
frequencies	O
of	O
CD8(+)	cell_type
T	cell_type
cells	cell_type
directed	O
against	O
IE-1	protein
were	O
similar	O
to	O
those	O
directed	O
against	O
pp65	protein
in	O
donors	O
tested	O
with	O
known	O
pp65	protein
-derived	O
peptides	O
.	O
Importantly,	O
additional	O
testing	O
of	O
a	O
corresponding	O
set	O
of	O
peptides	O
covering	O
the	O
complete	O
sequence	O
of	O
pp65	protein
on	O
10	O
of	O
these	O
donors	O
identified	O
individuals	O
whose	O
CD8(+)	cell_type
T	cell_type
cells	cell_type
recognized	O
IE-1	protein
but	O
not	O
pp65	protein
and	O
vice	O
versa,	O
clearly	O
illustrating	O
that	O
either	O
protein	O
may	O
be	O
a	O
major	O
target.	O
In	O
summary,	O
our	O
results	O
suggest	O
that	O
IE-1	protein
is	O
far	O
more	O
important	O
as	O
a	O
CD8(+)-T-cell	O
target	O
than	O
current	O
opinion	O
suggests.	O

E1A	DNA
oncogene	DNA
induction	O
of	O
cellular	O
susceptibility	O
to	O
killing	O
by	O
cytolytic	cell_type
lymphocytes	cell_type
through	O
target	O
cell	O
sensitization	O
to	O
apoptotic	O
injury	O
.	O
E1A	DNA
oncogene	DNA
expression	O
increases	O
mammalian	O
cell	O
susceptibility	O
to	O
lysis	O
by	O
cytolytic	cell_type
lymphocytes	cell_type
(	O
CLs	cell_type
)	O
at	O
a	O
stage	O
in	O
this	O
intercellular	O
interaction	O
that	O
is	O
independent	O
of	O
cell	O
surface	O
recognition	O
events	O
.	O
Since	O
CLs	cell_type
can	O
induce	O
either	O
apoptotic	O
or	O
necrotic	O
cell	O
death	O
,	O
we	O
asked	O
whether	O
E1A	protein
sensitization	O
to	O
injury-induced	O
apoptosis	O
is	O
sufficient	O
to	O
explain	O
E1A	protein
-induced	O
cytolytic	O
susceptibility	O
.	O
Mouse	O
,	O
rat	O
,	O
hamster	O
,	O
and	O
human	O
cells	O
that	O
were	O
rendered	O
cytolytic	O
susceptible	O
by	O
E1A	protein
were	O
also	O
sensitized	O
to	O
CL-induced	O
and	O
chemically	O
induced	O
apoptosis	O
.	O
In	O
contrast,	O
E1A	cell_type
-positive	cell_type
cells	cell_type
were	O
no	O
more	O
susceptible	O
to	O
injury-induced	O
necrosis	O
than	O
E1A	cell_type
-negative	cell_type
cells	cell_type
.	O
Similar	O
to	O
induction	O
of	O
cytolytic	O
susceptibility	O
and	O
in	O
contrast	O
to	O
other	O
E1A	protein
activities,	O
cellular	O
sensitization	O
to	O
chemically	O
induced	O
apoptosis	O
depended	O
on	O
high-level	O
E1A	protein
oncoprotein	protein
expression	O
.	O
Loss	O
of	O
both	O
cytolytic	O
susceptibility	O
and	O
sensitization	O
to	O
chemically	O
induced	O
apoptosis	O
was	O
coselected	O
during	O
in	O
vivo	O
selection	O
of	O
E1A	cell_type
-positive	cell_type
sarcoma	cell_type
cells	cell_type
for	O
increased	O
tumorigenicity	O
.	O
Furthermore,	O
E1A	protein
mutant	protein
proteins	protein
that	O
cannot	O
bind	O
the	O
cellular	protein
transcriptional	protein
coactivator	protein
,	O
p300	protein
,	O
and	O
that	O
fail	O
to	O
induce	O
cytolytic	O
susceptibility	O
also	O
failed	O
to	O
sensitize	O
cells	O
to	O
injury-induced	O
apoptosis	O
.	O
These	O
data	O
indicate	O
that	O
E1A	protein
induces	O
susceptibility	O
to	O
killer	O
cell-induced	O
lysis	O
through	O
sensitization	O
of	O
cells	O
to	O
injury-induced	O
apoptosis	O
.	O
Copyright	O
1999	O
Academic	O
Press.	O

TCL1	DNA
oncogene	DNA
expression	O
in	O
AIDS-related	O
lymphomas	O
and	O
lymphoid	O
tissues	O
.	O
AIDS-related	O
non-Hodgkin's	O
lymphoma	O
(	O
AIDS	O
NHL	O
)	O
comprises	O
a	O
diverse	O
and	O
heterogeneous	O
group	O
of	O
high-grade	O
B	O
cell	O
tumors	O
.	O
Certain	O
classes	O
of	O
AIDS	O
NHL	O
are	O
associated	O
with	O
alterations	O
in	O
oncogenes	DNA
or	O
tumor-suppressor	DNA
genes	DNA
or	O
infections	O
by	O
oncogenic	O
herpesviruses	O
.	O
However,	O
the	O
clinically	O
significant	O
class	O
of	O
AIDS	O
NHL	O
designated	O
immunoblastic	O
lymphoma	O
plasmacytoid	O
(	O
AIDS	O
IBLP	O
)	O
lacks	O
any	O
consistent	O
genetic	O
alterations.	O
We	O
identified	O
the	O
TCL1	DNA
oncogene	DNA
from	O
a	O
set	O
of	O
AIDS	DNA
IBLP	DNA
-associated	DNA
cDNA	DNA
fragments	DNA
generated	O
by	O
subtractive	O
hybridization	O
with	O
non-	O
AIDS	O
IBLP	O
.	O
Aberrant	O
TCL1	protein
expression	O
has	O
been	O
implicated	O
in	O
T	O
cell	O
leukemia/lymphoma	O
development	O
,	O
and	O
its	O
expression	O
also	O
has	O
been	O
seen	O
in	O
many	O
established	O
B	cell_line
cell	cell_line
tumor	cell_line
lines	cell_line
.	O
However,	O
TCL1	protein
expression	O
has	O
not	O
been	O
reported	O
in	O
AIDS	O
NHL	O
.	O
We	O
find	O
that	O
TCL1	protein
is	O
expressed	O
in	O
the	O
majority	O
of	O
AIDS	O
IBLP	O
tumors	O
examined.	O
TCL1	protein
protein	O
expression	O
is	O
restricted	O
to	O
tumor	O
cells	O
in	O
AIDS	O
IBLP	O
tissue	O
samples	O
analyzed	O
with	O
immunohistochemical	O
staining	O
.	O
Hyperplastic	O
lymph	O
node	O
and	O
tonsil	O
also	O
exhibit	O
strong	O
TCL1	protein
protein	O
expression	O
in	O
mantle	cell_type
zone	cell_type
B	cell_type
cells	cell_type
and	O
in	O
rare	O
interfollicular	cell_type
zone	cell_type
cells	cell_type
,	O
whereas	O
follicle-center	cell_type
B	cell_type
cells	cell_type
(	O
centroblasts	cell_type
and	O
centrocytes	cell_type
)	O
show	O
weaker	O
expression.	O
These	O
results	O
establish	O
TCL1	protein
as	O
the	O
most	O
prevalent	O
of	O
all	O
of	O
the	O
surveyed	O
oncogenes	DNA
associated	O
with	O
AIDS	O
IBLP	O
.	O
They	O
also	O
indicate	O
that	O
abundant	O
TCL1	protein
expression	O
in	O
quiescent	cell_type
mantle	cell_type
zone	cell_type
B	cell_type
cells	cell_type
is	O
down-regulated	O
in	O
activated	O
germinal	cell_type
center	cell_type
follicular	cell_type
B	cell_type
cells	cell_type
in	O
parallel	O
to	O
the	O
known	O
expression	O
pattern	O
of	O
BCL-2	protein
.	O
High-level	O
expression	O
in	O
nonproliferating	cell_type
B	cell_type
cells	cell_type
suggests	O
that	O
TCL1	protein
may	O
function	O
in	O
protecting	O
naive	cell_type
preactivated	cell_type
B	cell_type
cells	cell_type
from	O
apoptosis	O
.	O

IL-2	protein
-independent	O
activation	O
and	O
proliferation	O
in	O
human	cell_type
T	cell_type
cells	cell_type
induced	O
by	O
CD28	protein
.	O
Although	O
the	O
role	O
of	O
CD28	protein
in	O
T	O
cell	O
costimulation	O
is	O
firmly	O
established,	O
the	O
mechanisms	O
by	O
which	O
it	O
exerts	O
its	O
costimulatory	O
actions	O
are	O
less	O
clear.	O
In	O
many	O
circumstances	O
it	O
is	O
difficult	O
to	O
distinguish	O
the	O
effects	O
of	O
CD28	protein
from	O
subsequent	O
actions	O
of	O
cytokines	protein
,	O
such	O
as	O
IL-2	protein
,	O
on	O
T	O
cell	O
proliferation	O
.	O
Here,	O
we	O
report	O
a	O
model	O
of	O
CD28	protein
costimulation	O
using	O
PMA	O
plus	O
the	O
natural	protein
ligand	protein
CD80	protein
that	O
resulted	O
in	O
very	O
limited	O
stimulation	O
of	O
IL-2	protein
,	O
as	O
evidenced	O
by	O
both	O
cytokine	protein
production	O
and	O
IL-2	DNA
promoter	DNA
stimulation	O
.	O
Promoter	O
assays	O
revealed	O
CD28	protein
-dependent	O
effects	O
on	O
both	O
NF-kappaB	protein
and	O
AP-1	protein
,	O
but	O
not	O
on	O
NF-AT	protein
or	O
the	O
intact	O
IL-2	DNA
promoter	DNA
.	O
In	O
addition,	O
T	O
cell	O
proliferation	O
was	O
completely	O
resistant	O
to	O
the	O
actions	O
of	O
the	O
immunosuppressant	O
cyclosporin	O
A	O
(	O
CsA	O
).	O
Moreover	O
T	O
cell	O
proliferation	O
was	O
unaffected	O
by	O
the	O
addition	O
of	O
blocking	O
Abs	protein
to	O
both	O
IL-2	protein
and	O
the	O
IL-2	protein
receptor	protein
,	O
demonstrating	O
that	O
this	O
form	O
of	O
costimulation	O
by	O
CD28	protein
was	O
independent	O
of	O
IL-2	protein
.	O
We	O
also	O
investigated	O
the	O
effects	O
of	O
stimulating	O
T	cell_type
cell	cell_type
blasts	cell_type
with	O
CD80	protein
alone	O
and	O
found	O
that	O
there	O
was	O
a	O
limited	O
requirement	O
for	O
IL-2	protein
in	O
this	O
system.	O
We	O
conclude	O
that	O
CD28	protein
costimulation	O
can	O
cause	O
substantial	O
T	O
cell	O
proliferation	O
in	O
the	O
absence	O
of	O
IL-2	protein
,	O
which	O
is	O
driven	O
by	O
a	O
soluble	protein
factor	protein
independent	O
of	O
NF-AT	protein
transactivation	O
.	O

The	O
Epstein-Barr	DNA
virus	DNA
latency	DNA
BamHI-Q	DNA
promoter	DNA
is	O
positively	O
regulated	O
by	O
STATs	protein
and	O
Zta	protein
interference	O
with	O
JAK	protein
/STAT	protein
activation	O
leads	O
to	O
loss	O
of	O
BamHI-Q	DNA
promoter	DNA
activity	O
.	O
In	O
Epstein-Barr	O
virus	O
(EBV)-associated	O
tumors	O
in	O
nonimmunocompromised	O
patients	O
,	O
EBV	O
gene	O
expression	O
is	O
highly	O
restricted.	O
EBV-encoded	protein
nuclear	protein
antigen	protein
(	protein
EBNA	protein
)-1	protein
is	O
expressed,	O
whereas	O
the	O
immunogenic	O
and	O
proliferative	O
EBNAs	protein
are	O
not.	O
This	O
pattern	O
of	O
EBNA	protein
expression	O
is	O
generated	O
by	O
usage	O
of	O
the	O
BamHI-Q	DNA
promoter	DNA
(	O
Qp	DNA
).	O
We	O
have	O
determined	O
that	O
the	O
JAK	protein
/STAT	protein
pathway	O
positively	O
regulates	O
Qp	DNA
activity	O
.	O
In	O
transient-transfection	O
assays	O
,	O
a	O
Qp	DNA
-CAT	DNA
reporter	DNA
was	O
activated	O
by	O
cotransfected	O
JAK-1	protein
and	O
by	O
treatment	O
of	O
cells	O
with	O
the	O
cytokine	protein
IL-6	protein
.	O
The	O
ability	O
of	O
Qp	DNA
to	O
bind	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
(STAT)	protein
proteins	protein
was	O
directly	O
demonstrated	O
by	O
electrophoretic	O
mobility-shift	O
assay	O
,	O
and	O
mutation	O
of	O
potential	O
STAT-binding	DNA
sites	DNA
reduced	O
Qp	DNA
responsiveness	O
to	O
Janus	protein
kinase	protein
(JAK)-1	protein
.	O
Consistent	O
with	O
a	O
role	O
for	O
STATs	protein
in	O
Qp	DNA
function,	O
Qp	DNA
using	O
Burkitt's	cell_line
lymphoma	cell_line
Rael	cell_line
cells	cell_line
and	O
cultured	cell_type
nasopharyngeal	cell_type
carcinoma	cell_type
(NPC)	cell_type
cells	cell_type
contained	O
nuclear	O
STAT	protein
protein	protein
.	O
We	O
investigated	O
whether	O
the	O
inability	O
to	O
maintain	O
EBV-positive	cell_line
NPC	cell_line
cell	cell_line
lines	cell_line
in	O
culture	O
was	O
related	O
to	O
Qp	DNA
activity	O
.	O
Passaging	O
of	O
the	O
NPC	cell_line
cell	cell_line
line	cell_line
HK666	cell_line
led	O
to	O
activation	O
of	O
expression	O
of	O
BZLF1	DNA
,	O
which	O
encodes	O
Zta	protein
and	O
loss	O
of	O
Qp	DNA
function	O
.	O
Transient	O
expression	O
assays	O
linked	O
Zta	protein
expression	O
to	O
the	O
down-regulation	O
of	O
Qp	DNA
.	O
Cotransfection	O
of	O
Zta	protein
reduced	O
Qp	DNA
activity	O
in	O
reporter	O
assays	O
.	O
This	O
negative	O
regulation	O
required	O
Zta	protein
DNA-binding	O
activity	O
.	O
We	O
provide	O
evidence	O
that	O
Zta	protein
up-regulation	O
of	O
p53	protein
leads	O
to	O
p53	protein
-mediated	O
interference	O
with	O
JAK	protein
/STAT	protein
activation	O
of	O
Qp	DNA
.	O
The	O
data	O
imply	O
that	O
JAK	protein
/STAT	protein
signaling	O
has	O
a	O
role	O
in	O
EBV-associated	O
malignancies	O
.	O

Reactive	O
oxygen	O
intermediate	O
-release	O
of	O
fibre	cell_line
-exposed	cell_line
monocytes	cell_line
increases	O
inflammatory	O
cytokine	RNA
-mRNA	RNA
level	O
,	O
protein	protein
tyrosine	protein
kinase	protein
and	O
NF-kappaB	protein
activity	O
in	O
co-cultured	cell_line
bronchial	cell_line
epithelial	cell_line
cells	cell_line
(	O
BEAS-2B	cell_line
).	O
Some	O
pulmonary	O
diseases	O
like	O
bronchitis	O
or	O
asthma	O
bronchiale	O
are	O
mediated	O
by	O
inflammatory	O
mechanisms	O
in	O
bronchial	cell_type
epithelial	cell_type
cells	cell_type
.	O
Alveolar	cell_type
macrophages	cell_type
are	O
located	O
directly	O
in	O
the	O
surrounding	O
of	O
these	O
cells,	O
so	O
that	O
we	O
suppose	O
an	O
interaction	O
between	O
epithelial	cell_type
cells	cell_type
and	O
macrophages	cell_type
regarding	O
to	O
the	O
release	O
of	O
inflammatory	protein
mediators	protein
.	O
For	O
measuring	O
the	O
contribution	O
of	O
macrophages	cell_type
to	O
the	O
release	O
of	O
inflammatory	protein
mediators	protein
by	O
bronchial	cell_type
epithelial	cell_type
cells	cell_type
,	O
we	O
established	O
an	O
in	O
vitro	O
model	O
of	O
co-cultured	cell_type
blood	cell_type
monocytes	cell_type
(	O
BM	cell_type
)	O
and	O
BEAS-2B	cell_line
cells	cell_line
in	O
a	O
transwell	O
system	O
(Costar).	O
BM	cell_type
were	O
exposed	O
to	O
Chrysotile	O
B	O
and	O
soot	O
particle	O
FR	O
101	O
in	O
a	O
concentration	O
of	O
100	O
microg/10(6)	O
cells.	O
After	O
up	O
to	O
90	O
min	O
exposure	O
time	O
ELISA	O
,	O
EMSA	O
(	O
electromobility	O
shift	O
assay	O
)	O
and	O
RT-	O
PCR	O
were	O
used	O
to	O
measure	O
protein	protein
tyrosine	protein
kinase	protein
activity	O
,	O
protein	O
activity	O
of	O
NF-kappaB	protein
and	O
cytokine	protein
(	O
IL-1beta	protein
,	O
IL-6	protein
,	O
TNF-alpha	protein
)	O
specific	O
mRNA	RNA
levels	O
in	O
BEAS-2B	cell_type
cells	cell_type
.	O
We	O
observed	O
an	O
increase	O
in	O
protein	protein
tyrosine	protein
kinase	protein
activity	O
(up	O
to	O
1.8	O
+/-	O
0.5-fold)	O
and	O
NF-kappaB	protein
protein	O
activity	O
in	O
BEAS-2B	cell_type
cells	cell_type
after	O
particle	O
or	O
fibre	O
exposure	O
of	O
co-cultured	cell_line
BM	cell_line
.	O
Consecutive	O
IL-1beta-	O
,	O
IL-6-	O
and	O
TNF-alpha-	O
mRNA	O
were	O
elevated	O
(up	O
to	O
1.9	O
+/-	O
0.58-fold).	O
Protein	protein
tyrosine	protein
kinase	protein
activity	O
,	O
NF-kappaB	protein
activity	O
,	O
and	O
the	O
synthesis	O
of	O
cytokine	RNA
-specific	RNA
mRNA	RNA
were	O
inhibited	O
by	O
antioxidants	O
.	O
These	O
data	O
suggest	O
a	O
ROI-dependent	O
NF-kappaB	protein
mediated	O
transcription	O
of	O
inflammatory	protein
cytokines	protein
in	O
bronchial	cell_type
epithelial	cell_type
cells	cell_type
.	O

Suppression	O
of	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
long	DNA
terminal	DNA
repeat	DNA
by	O
CD8+	cell_type
T	cell_type
cells	cell_type
is	O
dependent	O
on	O
the	O
NFAT-1	DNA
element	DNA
.	O
CD8+	cell_type
T	cell_type
lymphocytes	cell_type
of	O
HIV-1	O
infected	O
individuals	O
produce	O
a	O
soluble	protein
factor	protein
that	O
efficiently	O
suppresses	O
HIV-1	O
replication	O
at	O
the	O
transcriptional	O
level	O
.	O
We	O
show	O
here	O
that	O
the	O
response	O
of	O
the	O
HIV-1	O
long	O
terminal	O
repeat	O
(	O
LTR	DNA
)	O
to	O
mitogenic	O
or	O
Tat	protein
-mediated	O
activation	O
is	O
sensitive	O
to	O
the	O
suppressive	O
action	O
of	O
a	O
Herpesvirus	cell_line
saimiri	cell_line
(	cell_line
HVS	cell_line
)-transformed	cell_line
CD8+	cell_line
T	cell_line
cell	cell_line
clone	cell_line
from	O
an	O
HIV-infected	O
individual	O
and	O
supernatants	O
from	O
CD8+	cell_type
T	cell_type
cells	cell_type
of	O
HIV-1	O
-infected	O
asymptomatic	O
subjects	O
(	O
CD4+	protein
&gt;	O
350/microliters).	O
Mutagenesis	O
of	O
NF	O
kappa	O
B	O
or	O
Sp-1	O
elements	O
within	O
the	O
LTR	DNA
resulted	O
in	O
no	O
change	O
in	O
the	O
ability	O
of	O
CD8+	cell_type
T	cell_type
cell	cell_type
supernatants	O
to	O
inhibit	O
Tat-	O
or	O
mitogen-	O
mediated	O
LTR	O
transcription	O
.	O
However,	O
the	O
response	O
to	O
HIV-1	protein
Tat	protein
by	O
a	O
LTR	DNA
in	O
which	O
the	O
interleukin	DNA
(IL)-2	DNA
homology	DNA
NFAT-1	DNA
region	DNA
was	O
mutated	O
resulted	O
in	O
almost	O
complete	O
elimination	O
of	O
suppression	O
by	O
CD8+	cell_type
T	cell_type
cells	cell_type
.	O
This	O
was	O
not	O
observed	O
when	O
the	O
NFAT-1	DNA
mutant	DNA
LTR	DNA
was	O
activated	O
by	O
mitogen	protein
.	O
We	O
have	O
previously	O
shown	O
that	O
gene	O
expression	O
directed	O
by	O
the	O
HIV-1	O
NF	DNA
kappa	DNA
B	DNA
elements	DNA
is	O
inhibited	O
by	O
CD8	protein
+	O
cell-derived	O
supernatants	O
(Copeland	O
et	O
al.,	O
AIDS	O
Res	O
Hum	O
Retroviruses,	O
1995;11:1321-1326).	O
Taken	O
together,	O
these	O
observations	O
suggest	O
that	O
mitogenic	O
activation	O
,	O
mediated	O
primarily	O
through	O
the	O
NF	DNA
kappa	DNA
B	DNA
enhancer	DNA
,	O
is	O
susceptible	O
to	O
CD8	protein
-mediated	O
inhibition	O
,	O
however,	O
inhibition	O
of	O
Tat	protein
-mediated	O
activation	O
may	O
rely	O
upon	O
a	O
different	O
pathway	O
that	O
is	O
NFAT-1	protein
dependent	O
.	O

Inhibition	O
of	O
NF-kappa	protein
B	protein
activation	O
in	O
human	cell_line
T-cell	cell_line
lines	cell_line
by	O
anetholdithiolthione	O
.	O
Nuclear	protein
factor	protein
(NF)-kappa	protein
B	protein
is	O
a	O
redox	protein
sensitive	protein
cytosolic	protein
transcription	protein
factor	protein
.	O
Redox	O
regulation	O
of	O
NF-kappa	protein
B	protein
has	O
been	O
implicated	O
in	O
the	O
activation	O
of	O
the	O
human	O
immuno-deficiency	O
virus	O
(	O
HIV	O
).	O
Therefore,	O
inhibition	O
of	O
NF-kappa	protein
B	protein
activation	O
may	O
be	O
an	O
effective	O
strategy	O
for	O
acquired	O
immunodeficiency	O
syndrome	O
therapy	O
.	O
Anetholdithiolthione	O
(	O
ADT	O
,	O
5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione	O
)	O
is	O
an	O
antioxidant	O
which	O
has	O
been	O
used	O
to	O
protect	O
against	O
acetaminophen-	O
and	O
CCl4-	O
induced	O
hepatotoxicity	O
,	O
lipid	O
peroxidation	O
,	O
radiation	O
injury	O
,	O
and	O
also	O
has	O
been	O
used	O
clinically	O
as	O
an	O
anti-choleretic	O
agent	O
.	O
The	O
present	O
study	O
examined	O
the	O
effect	O
of	O
ADT	O
pretreatment	O
on	O
NF-kappa	protein
B	protein
activation	O
in	O
response	O
to	O
a	O
variety	O
of	O
stimuli	O
such	O
as	O
H2O2	O
,	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
or	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF	protein
alpha	protein
).	O
PMA	O
and	O
TNF	protein
alpha	protein
induced	O
activation	O
of	O
(NF)-kappa	protein
B	protein
in	O
human	O
Jurkat	cell_line
T-cells	cell_line
was	O
partially	O
inhibited	O
by	O
ADT	O
(0.1	O
mM)	O
pretreatment.	O
ADT	O
(0.1	O
mM)	O
also	O
inhibited	O
H2O2	O
induced	O
activation	O
of	O
the	O
transcription	protein
factor	protein
in	O
the	O
peroxide	cell_line
sensitive	cell_line
human	cell_line
Wurzburg	cell_line
T-cells	cell_line
.	O
Furthermore,	O
ADT	O
treated	O
Wurzburg	cell_line
cells	cell_line
had	O
significantly	O
higher	O
glutathione	O
levels	O
as	O
compared	O
with	O
untreated	cell_type
cells	cell_type
.	O
H2O2	O
induced	O
lipid	O
peroxidation	O
in	O
Wurzburg	cell_line
cells	cell_line
was	O
remarkably	O
inhibited	O
by	O
ADT	O
pretreatment	O
.	O
ADT	O
,	O
a	O
pro-	O
glutathione	O
antioxidant	O
,	O
was	O
observed	O
to	O
be	O
capable	O
of	O
modulating	O
NF-kappa	protein
B	protein
activation	O
.	O

Involvement	O
of	O
tyrosine	O
phosphorylation	O
in	O
endothelial	protein
adhesion	protein
molecule	protein
induction	O
.	O
Induction	O
of	O
endothelial	protein
adhesion	protein
molecules	protein
by	O
the	O
cytokine	protein
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF	protein
)	O
can	O
occur	O
independently	O
of	O
protein	protein
kinase	protein
C	protein
and	O
activation	O
of	O
a	O
protein	protein
tyrosine	protein
kinase	protein
(	O
PTK	protein
)	O
has	O
recently	O
been	O
implicated	O
in	O
the	O
upregulation	O
of	O
vascular	protein
cell	protein
adhesion	protein
molecule	protein
1	protein
(	O
VCAM-1	protein
)	O
by	O
interleukin-4	protein
(	O
IL-4	protein
)	O
on	O
endothelial	cell_type
cells	cell_type
.	O
We	O
demonstrate	O
that	O
the	O
PTK	protein
inhibitors	O
herbimycin	O
A	O
or	O
genistein	O
suppress	O
induction	O
of	O
endothelial	O
VCAM-1	protein
and	O
E-selectin	protein
,	O
as	O
well	O
as	O
subsequent	O
monocytic	O
cell	O
adhesion	O
to	O
endothelial	cell_type
cells	cell_type
stimulated	O
by	O
TNF	protein
.	O
Inhibition	O
studies	O
indicate	O
that	O
specific	O
tyrosine	O
phosphorylation	O
following	O
PTK	protein
activation	O
is	O
involved	O
in	O
the	O
mobilization	O
of	O
the	O
transcription	protein
factor	protein
,	O
nuclear	protein
factor	protein
kappa	protein
B	protein
,	O
and	O
VCAM-1	RNA
mRNA	RNA
expression	O
.	O
This	O
may	O
have	O
implications	O
for	O
pathophysiological	O
conditions	O
that	O
involve	O
the	O
upregulation	O
of	O
these	O
molecules	O
(e.g.	O
inflammation	O
and	O
atherosclerosis	O
).	O

Protein	protein
kinase	protein
C-zeta	protein
mediates	O
NF-kappa	protein
B	protein
activation	O
in	O
human	cell_type
immunodeficiency	cell_type
virus	cell_type
-infected	cell_type
monocytes	cell_type
.	O
The	O
molecular	O
mechanisms	O
regulating	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
persistence	O
in	O
a	O
major	O
cell	O
reservoir	O
such	O
as	O
the	O
macrophage	cell_type
remain	O
unknown.	O
NF-kappa	protein
B	protein
is	O
a	O
transcription	protein
factor	protein
involved	O
in	O
the	O
regulation	O
of	O
the	O
HIV	DNA
long	DNA
terminal	DNA
repeat	DNA
and	O
is	O
selectively	O
activated	O
following	O
HIV	O
infection	O
of	O
human	cell_type
macrophages	cell_type
.	O
Although	O
little	O
information	O
as	O
to	O
what	O
signal	O
transduction	O
pathways	O
mediate	O
NF-kappa	protein
B	protein
activation	O
in	O
monocytes-macrophages	cell_type
is	O
available,	O
our	O
previous	O
work	O
indicated	O
that	O
classical	O
protein	protein
kinase	protein
C	protein
(	protein
PKC	protein
)	protein
isoenzymes	protein
were	O
not	O
involved	O
in	O
the	O
HIV	O
-mediated	O
NF-kappa	protein
B	protein
activation	O
.	O
In	O
this	O
study,	O
we	O
have	O
focused	O
on	O
atypical	O
PKC	protein
isoenzymes	protein
.	O
PKC-zeta	protein
belongs	O
to	O
this	O
family	O
and	O
is	O
known	O
to	O
be	O
an	O
important	O
step	O
in	O
NF-kappa	protein
B	protein
activation	O
in	O
other	O
cell	O
systems.	O
Immunoblotting	O
experiments	O
with	O
U937	cell_line
cells	cell_line
demonstrate	O
that	O
PKC-zeta	protein
is	O
present	O
in	O
these	O
cells,	O
and	O
its	O
expression	O
can	O
be	O
downmodulated	O
by	O
antisense	O
oligonucleotides	O
(	O
AO	O
).	O
The	O
HIV	O
-mediated	O
NF-kappa	protein
B	protein
activation	O
is	O
selectively	O
reduced	O
by	O
AO	O
to	O
PKC-zeta	protein
.	O
In	O
addition,	O
cotransfection	O
of	O
a	O
negative	O
dominant	O
molecule	O
of	O
PKC-zeta	protein
(	O
PKC-zeta	protein
mut	protein
)	O
with	O
NF-kappa	protein
B	protein
-dependent	O
reporter	O
genes	O
selectively	O
inhibits	O
the	O
HIV	O
-but	O
not	O
phorbol	O
myristate	O
acetate-	O
or	O
lipopolysaccharide-	O
mediated	O
activation	O
of	O
NF-kappa	protein
B	protein
.	O
That	O
PKC-zeta	protein
is	O
specific	O
in	O
regulating	O
NF-kappa	protein
B	protein
is	O
concluded	O
from	O
the	O
inability	O
of	O
PKC-zeta	protein
(mut)	protein
to	O
interfere	O
with	O
the	O
basal	O
or	O
phorbol	O
myristate	O
acetate	O
-inducible	O
CREB	protein
-or	O
AP1	protein
-dependent	O
transcriptional	O
activity	O
.	O
Lastly,	O
we	O
demonstrate	O
a	O
selective	O
inhibition	O
of	O
p24	protein
production	O
by	O
HIV	cell_type
-infected	cell_type
human	cell_type
macrophages	cell_type
when	O
treated	O
with	O
AO	O
to	O
PKC-zeta	protein
.	O
Altogether,	O
these	O
results	O
suggest	O
that	O
atypical	protein
PKC	protein
isoenzymes	protein
,	O
including	O
PKC-zeta	protein
,	O
participate	O
in	O
the	O
signal	O
transduction	O
pathways	O
by	O
which	O
HIV	O
infection	O
results	O
in	O
the	O
activation	O
of	O
NF-kappa	protein
B	protein
in	O
human	cell_type
monocytic	cell_type
cells	cell_type
and	O
macrophages	cell_type
.	O

Induction	O
of	O
Bcl-x(L)	protein
expression	O
by	O
human	protein
T-cell	protein
leukemia	protein
virus	protein
type	protein
1	protein
Tax	protein
through	O
NF-kappaB	protein
in	O
apoptosis-resistant	cell_line
T-cell	cell_line
transfectants	cell_line
with	O
Tax	protein
.	O
Human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
Tax	protein
is	O
thought	O
to	O
play	O
a	O
pivotal	O
role	O
in	O
immortalization	O
of	O
T	cell_type
cells	cell_type
.	O
We	O
have	O
recently	O
shown	O
that	O
the	O
expression	O
of	O
Tax	protein
protected	O
the	O
mouse	cell_line
T-cell	cell_line
line	cell_line
CTLL-2	cell_line
against	O
apoptosis	O
induced	O
by	O
interleukin-2	protein
(	O
IL-2	protein
)	O
deprivation	O
and	O
converted	O
its	O
growth	O
from	O
being	O
IL-2	protein
dependent	O
to	O
being	O
IL-2	protein
independent	O
.	O
In	O
this	O
study,	O
we	O
demonstrate	O
that	O
constitutive	O
expression	O
of	O
bcl-xl	protein
but	O
not	O
bcl-2	protein
,	O
bcl-xs	protein
,	O
bak	protein
,	O
bad	protein
,	O
or	O
bax	protein
was	O
associated	O
with	O
apoptosis	O
resistance	O
after	O
IL-2	protein
deprivation	O
in	O
CTLL-2	cell_line
cells	cell_line
that	O
expressed	O
Tax	protein
.	O
Transient-transfection	O
assays	O
showed	O
that	O
bcl-x	DNA
promoter	DNA
was	O
transactivated	O
by	O
wild-type	protein
Tax	protein
.	O
Similar	O
effects	O
were	O
observed	O
in	O
mutant	O
Tax	protein
retaining	O
transactivating	O
ability	O
through	O
NF-kappaB	protein
.	O
Deletion	O
or	O
substitution	O
of	O
a	O
putative	protein
NF-kappaB	protein
binding	protein
site	protein
identified	O
in	O
the	O
bcl-x	DNA
promoter	DNA
significantly	O
decreased	O
Tax	protein
-induced	O
transactivation	O
.	O
This	O
NF-kappaB	DNA
-like	DNA
element	DNA
was	O
able	O
to	O
form	O
a	O
complex	O
with	O
NF-kappaB	protein
family	protein
proteins	protein
in	O
vitro.	O
Furthermore,	O
Tax	protein
-induced	O
transactivation	O
of	O
the	O
bcl-x	DNA
promoter	DNA
was	O
also	O
diminished	O
by	O
the	O
mutant	protein
IkappaBalpha	protein
,	O
which	O
specifically	O
inhibits	O
NF-kappaB	protein
activity.	O
Our	O
findings	O
suggest	O
that	O
constitutive	O
expression	O
of	O
Bcl-x(L)	protein
induced	O
by	O
Tax	protein
through	O
the	O
NF-kappaB	protein
pathway	O
contributes	O
to	O
the	O
inhibition	O
of	O
apoptosis	O
in	O
CTLL-2	cell_line
cells	cell_line
after	O
IL-2	protein
deprivation	O
.	O

The	O
beta-globin	DNA
promoter	DNA
is	O
important	O
for	O
recruitment	O
of	O
erythroid	protein
Kruppel-like	protein
factor	protein
to	O
the	O
locus	DNA
control	DNA
region	DNA
in	O
erythroid	cell_type
cells	cell_type
.	O
Erythroid	protein
Kruppel-like	protein
factor	protein
(	O
EKLF	protein
),	O
which	O
binds	O
to	O
the	O
CACCC	O
box	O
in	O
the	O
beta-globin	DNA
promoter	DNA
,	O
is	O
required	O
for	O
the	O
expression	O
of	O
the	O
beta-globin	DNA
gene	DNA
in	O
adult	cell_type
erythroid	cell_type
cells	cell_type
.	O
It	O
was	O
recently	O
demonstrated	O
that	O
EKLF	protein
is	O
also	O
required	O
for	O
the	O
activity	O
of	O
the	O
beta-globin	DNA
locus	DNA
control	DNA
region	DNA
(	O
LCR	DNA
)	O
5'HS3	DNA
.	O
Some	O
evidence	O
suggests	O
that	O
the	O
LCR	DNA
and	O
the	O
beta-globin	DNA
promoter	DNA
interact	O
in	O
adult	cell_type
erythroid	cell_type
cells	cell_type
,	O
and	O
the	O
network	O
of	O
protein-protein	O
interactions	O
that	O
exists	O
between	O
these	O
two	O
elements	O
may	O
regulate	O
how	O
EKLF	protein
is	O
recruited	O
to	O
the	O
LCR	DNA
.	O
In	O
this	O
report,	O
we	O
use	O
the	O
PIN*POINT	O
assay	O
to	O
study	O
the	O
role	O
of	O
the	O
promoter	O
on	O
the	O
recruitment	O
of	O
EKLF	protein
to	O
5'HS2	DNA
and	O
5'HS3	DNA
of	O
the	O
LCR	DNA
.	O
We	O
find	O
that	O
recruitment	O
of	O
EKLF	protein
to	O
5'HS2	DNA
requires	O
the	O
TATA	DNA
box	DNA
,	O
but	O
recruitment	O
to	O
5'HS3	DNA
depends	O
on	O
the	O
CACCC	O
and	O
TATA	DNA
boxes	DNA
of	O
the	O
beta-globin	DNA
promoter	DNA
.	O
Furthermore,	O
recruitment	O
of	O
EKLF	protein
to	O
5'HS3	DNA
only	O
occurred	O
in	O
beta-globin-expressing	cell_type
murine	cell_type
erythroid	cell_type
leukemia	cell_type
cells	cell_type
,	O
whereas	O
recruitment	O
of	O
EKLF	protein
to	O
5'HS2	DNA
occurred	O
in	O
both	O
gamma-globin-expressing	cell_line
K562	cell_line
cells	cell_line
and	O
murine	cell_type
erythroid	cell_type
leukemia	cell_type
cells	cell_type
.	O
Unlike	O
EKLF	protein
,	O
Sp1	protein
,	O
which	O
also	O
binds	O
to	O
CACCC	O
boxes,	O
is	O
not	O
recruited	O
to	O
5'HS3	DNA
.	O
We	O
have	O
also	O
examined	O
how	O
one	O
5'HS	DNA
affects	O
the	O
recruitment	O
of	O
EKLF	protein
to	O
another	O
5'HS	DNA
.	O
We	O
have	O
found	O
that	O
the	O
recruitment	O
of	O
EKLF	protein
to	O
5'HS3	DNA
depends	O
on	O
the	O
presence	O
of	O
5'HS2	DNA
in	O
cis,	O
but	O
the	O
recruitment	O
to	O
5'HS2	DNA
does	O
not	O
depend	O
on	O
5'HS3	DNA
.	O
Based	O
on	O
these	O
results,	O
we	O
present	O
a	O
model	O
that	O
illustrates	O
how	O
EKLF	protein
may	O
be	O
recruited	O
to	O
the	O
beta-globin	DNA
locus	DNA
.	O

Estrogen	O
decreases	O
TNF	protein
gene	O
expression	O
by	O
blocking	O
JNK	protein
activity	O
and	O
the	O
resulting	O
production	O
of	O
c-Jun	protein
and	O
JunD	protein
.	O
Central	O
to	O
the	O
bone-sparing	O
effect	O
of	O
estrogen	O
(	O
E(2)	O
)	O
is	O
its	O
ability	O
to	O
block	O
the	O
monocytic	O
production	O
of	O
the	O
osteoclastogenic	protein
cytokine	protein
TNF-alpha	protein
(	O
TNF	protein
).	O
However,	O
the	O
mechanism	O
by	O
which	O
E(2)	O
downregulates	O
TNF	protein
production	O
is	O
presently	O
unknown.	O
Transient	O
transfection	O
studies	O
in	O
HeLa	cell_line
cells	cell_line
,	O
an	O
E(2)	O
receptor-negative	O
line,	O
suggest	O
that	O
E(2)	O
inhibits	O
TNF	protein
gene	O
expression	O
through	O
an	O
effect	O
mediated	O
by	O
estrogen	protein
receptor	protein
beta	protein
(	O
ERbeta	protein
).	O
We	O
also	O
report	O
that	O
in	O
RAW	cell_line
264.7	cell_line
cells	cell_line
,	O
an	O
E(2)	O
receptor-positive	O
murine	O
monocytic	O
line,	O
E(2)	O
downregulates	O
cytokine-induced	O
TNF	protein
gene	O
expression	O
by	O
decreasing	O
the	O
activity	O
of	O
the	O
Jun	protein
NH(2)-terminal	protein
kinase	protein
(	O
JNK	protein
).	O
The	O
resulting	O
diminished	O
phosphorylation	O
of	O
c-Jun	protein
and	O
JunD	protein
at	O
their	O
NH(2)-termini	protein
decreases	O
the	O
ability	O
of	O
these	O
nuclear	O
proteins	O
to	O
autostimulate	O
the	O
expression	O
of	O
the	O
c-Jun	O
and	O
JunD	O
genes	O
,	O
thus	O
leading	O
to	O
lower	O
production	O
of	O
c-Jun	protein
and	O
JunD	protein
.	O
The	O
consequent	O
decrease	O
in	O
the	O
nuclear	O
levels	O
of	O
c-Jun	protein
and	O
JunD	protein
leads	O
to	O
diminished	O
binding	O
of	O
c-Jun	protein
/c-Fos	protein
and	O
JunD	protein
/c-Fos	protein
heterodimers	protein
to	O
the	O
AP-1	DNA
consensus	DNA
sequence	DNA
in	O
the	O
TNF	DNA
promoter	DNA
and,	O
thus,	O
to	O
decreased	O
transactivation	O
of	O
the	O
TNF	DNA
gene	DNA
.	O

Cutting	O
edge:	O
TCR	protein
stimulation	O
by	O
antibody	O
and	O
bacterial	O
superantigen	O
induces	O
Stat3	protein
activation	O
in	O
human	cell_type
T	cell_type
cells	cell_type
.	O
Recent	O
data	O
show	O
that	O
TCR/CD3	protein
stimulation	O
induces	O
activation	O
of	O
Stat5	protein
in	O
murine	cell_type
T	cell_type
cells	cell_type
.	O
Here,	O
we	O
show	O
that	O
CD3	O
ligation	O
by	O
mAb	O
and	O
Staphylococcal	O
enterotoxin	O
(SE)	O
induce	O
a	O
rapid,	O
gradually	O
accumulating,	O
long-lasting	O
tyrosine	O
,	O
and	O
serine	O
phosphorylation	O
of	O
Stat3	protein
(but	O
not	O
Stat5	protein
)	O
in	O
allogen-specific	cell_line
human	cell_line
CD4+	cell_line
T	cell_line
cell	cell_line
lines	cell_line
.	O
In	O
contrast,	O
IL-2	protein
induces	O
a	O
rapid	O
and	O
transient	O
tyrosine	O
and	O
serine	O
phosphorylation	O
of	O
Stat3	protein
.	O
Compared	O
with	O
IL-2	protein
,	O
CD3	protein
ligation	O
induces	O
a	O
delayed	O
Stat3	protein
binding	O
to	O
oligonucleotide	O
probes	O
from	O
the	O
ICAM-1	protein
and	O
IL-2R	DNA
alpha	DNA
promoter	DNA
.	O
CD3	protein
-mediated	O
activation	O
of	O
Stat3	protein
is	O
almost	O
completely	O
inhibited	O
by	O
a	O
Src	protein
kinase	protein
inhibitor	protein
(	O
PP1	protein
),	O
whereas	O
IL-2	protein
-induced	O
Stat3	protein
activation	O
is	O
unaffected.	O
In	O
conclusion,	O
we	O
show	O
that	O
CD3	protein
ligation	O
by	O
mAb	protein
and	O
SE	O
triggers	O
a	O
rapid,	O
PP1	protein
-sensitive	O
tyrosine	O
and	O
serine	O
phosphorylation	O
of	O
Stat3	protein
in	O
human	cell_type
CD4+	cell_type
T	cell_type
cells	cell_type
.	O
Moreover,	O
we	O
provide	O
evidence	O
that	O
TCR/	protein
CD3	protein
and	O
IL-2	protein
induce	O
Stat3	protein
activation	O
via	O
distinct	O
signaling	O
pathways	O
.	O

Distinctive	O
gene	O
expression	O
patterns	O
in	O
human	cell_type
mammary	cell_type
epithelial	cell_type
cells	cell_type
and	O
breast	O
cancers	O
.	O
cDNA	DNA
microarrays	DNA
and	O
a	O
clustering	O
algorithm	O
were	O
used	O
to	O
identify	O
patterns	O
of	O
gene	O
expression	O
in	O
human	cell_type
mammary	cell_type
epithelial	cell_type
cells	cell_type
growing	O
in	O
culture	O
and	O
in	O
primary	O
human	O
breast	O
tumors	O
.	O
Clusters	O
of	O
coexpressed	DNA
genes	DNA
identified	O
through	O
manipulations	O
of	O
mammary	cell_type
epithelial	cell_type
cells	cell_type
in	O
vitro	O
also	O
showed	O
consistent	O
patterns	O
of	O
variation	O
in	O
expression	O
among	O
breast	O
tumor	O
samples	O
.	O
By	O
using	O
immunohistochemistry	O
with	O
antibodies	O
against	O
proteins	O
encoded	O
by	O
a	O
particular	O
gene	O
in	O
a	O
cluster,	O
the	O
identity	O
of	O
the	O
cell	O
type	O
within	O
the	O
tumor	O
specimen	O
that	O
contributed	O
the	O
observed	O
gene	O
expression	O
pattern	O
could	O
be	O
determined.	O
Clusters	O
of	O
genes	DNA
with	O
coherent	O
expression	O
patterns	O
in	O
cultured	cell_type
cells	cell_type
and	O
in	O
the	O
breast	O
tumors	O
samples	O
could	O
be	O
related	O
to	O
specific	O
features	O
of	O
biological	O
variation	O
among	O
the	O
samples.	O
Two	O
such	O
clusters	O
were	O
found	O
to	O
have	O
patterns	O
that	O
correlated	O
with	O
variation	O
in	O
cell	O
proliferation	O
rates	O
and	O
with	O
activation	O
of	O
the	O
IFN	protein
-regulated	O
signal	O
transduction	O
pathway	O
,	O
respectively.	O
Clusters	O
of	O
genes	DNA
expressed	O
by	O
stromal	cell_type
cells	cell_type
and	O
lymphocytes	cell_type
in	O
the	O
breast	O
tumors	O
also	O
were	O
identified	O
in	O
this	O
analysis.	O
These	O
results	O
support	O
the	O
feasibility	O
and	O
usefulness	O
of	O
this	O
systematic	O
approach	O
to	O
studying	O
variation	O
in	O
gene	O
expression	O
patterns	O
in	O
human	O
cancers	O
as	O
a	O
means	O
to	O
dissect	O
and	O
classify	O
solid	O
tumors	O
.	O

PPARgamma	protein
activation	O
induces	O
the	O
expression	O
of	O
the	O
adipocyte	DNA
fatty	DNA
acid	DNA
binding	DNA
protein	DNA
gene	DNA
in	O
human	cell_type
monocytes	cell_type
.	O
The	O
peroxisome-proliferator	protein
activated	protein
receptor	protein
gamma	protein
(	O
PPARgamma	protein
),	O
a	O
member	O
of	O
the	O
nuclear	protein
receptor	protein
superfamily	protein
of	O
ligand	protein
activated	protein
transcription	protein
factors	protein
,	O
plays	O
a	O
key	O
role	O
in	O
the	O
anti-diabetic	O
actions	O
of	O
the	O
thiazolidinediones	O
(	O
TZDs	O
).	O
PPARgamma	protein
induces	O
the	O
expression	O
of	O
many	O
genes	DNA
involved	O
in	O
lipid	O
anabolism	O
,	O
including	O
the	O
adipocyte	protein
fatty	protein
acid	protein
binding	protein
protein	protein
(	O
aP2	protein
),	O
and	O
is	O
a	O
key	O
regulator	O
of	O
adipocyte	cell_type
differentiation	O
.	O
PPARgamma	protein
is	O
also	O
expressed	O
in	O
hematopoietic	cell_type
cells	cell_type
and	O
is	O
up-regulated	O
in	O
activated	O
monocytes/	cell_type
macrophages	cell_type
.	O
Activation	O
of	O
PPARgamma	protein
may	O
play	O
a	O
role	O
in	O
the	O
induction	O
of	O
differentiation	O
of	O
macrophages	cell_type
to	O
foam	cell_type
cells	cell_type
that	O
are	O
associated	O
with	O
atherosclerotic	O
lesions	O
.	O
We	O
report	O
that	O
both	O
natural	O
and	O
synthetic	O
PPARgamma	O
agonists	O
induce	O
time-	O
and	O
dose-dependent	O
increases	O
in	O
aP2	RNA
mRNA	RNA
in	O
both	O
primary	cell_type
human	cell_type
monocytes	cell_type
and	O
the	O
monocytic	cell_line
cell	cell_line
line	cell_line
,	O
THP-1	cell_line
.	O
These	O
data	O
suggest	O
that	O
PPARgamma	protein
activation	O
may	O
play	O
a	O
role	O
in	O
monocyte	cell_type
differentiation	O
and	O
function	O
analogous	O
to	O
its	O
well-characterized	O
role	O
in	O
adipocytes.	cell_type

Identification	O
of	O
a	O
physical	O
interaction	O
between	O
calcineurin	protein
and	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NFATp	protein
).	O
In	O
T	cell_type
lymphocytes	cell_type
,	O
the	O
calcium/calmodulin-dependent	protein
serine/threonine	protein
phosphatase	protein
,	O
calcineurin	protein
,	O
plays	O
a	O
pivotal	O
role	O
in	O
transducing	O
membrane-associated	O
signals	O
to	O
the	O
nucleus	O
.	O
One	O
of	O
the	O
putative	O
targets	O
of	O
calcineurin	protein
is	O
the	O
pre-existing,	O
cytosolic	protein
component	protein
of	O
the	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NFATp	protein
;	O
also	O
referred	O
to	O
as	O
NFAT1	protein
),	O
which	O
is	O
one	O
of	O
several	O
transcription	protein
factors	protein
required	O
for	O
the	O
expression	O
of	O
interleukin	protein
2	protein
.	O
Inhibition	O
of	O
calcineurin	protein
by	O
the	O
immunosuppressive	O
drugs	O
cyclosporin	O
A	O
and	O
FK506	O
prevents	O
dephosphorylation	O
of	O
NFATp	protein
and	O
its	O
translocation	O
to	O
the	O
nucleus	O
.	O
However,	O
a	O
physical	O
interaction	O
between	O
calcineurin	protein
and	O
NFATp	protein
has	O
not	O
been	O
demonstrated.	O
Here	O
we	O
demonstrate	O
the	O
binding	O
of	O
NFATp	protein
from	O
lysates	O
of	O
T	cell_type
cells	cell_type
to	O
immobilized	O
calcineurin	protein
.	O
Stimulation	O
of	O
T	cell_type
cells	cell_type
with	O
calcium	O
ionophore	O
induced	O
a	O
shift	O
in	O
the	O
molecular	O
weight	O
of	O
NFATp	protein
that	O
is	O
due	O
to	O
its	O
dephosphorylation	O
.	O
This	O
dephosphorylation	O
was	O
inhibited	O
by	O
treatment	O
of	O
T	cell_type
cells	cell_type
with	O
cyclosporin	O
A	O
or	O
FK506	O
prior	O
to	O
stimulation.	O
Of	O
note,	O
both	O
the	O
phosphorylated	O
and	O
the	O
dephosphorylated	O
form	O
of	O
NFATp	protein
bound	O
to	O
calcineurin	protein
.	O
Furthermore,	O
the	O
binding	O
of	O
both	O
forms	O
of	O
NFATp	protein
to	O
calcineurin	protein
was	O
inhibited	O
by	O
pretreatment	O
of	O
calcineurin	protein
with	O
a	O
complex	O
of	O
FK506	O
and	O
its	O
ligand	O
FKBP12	O
.	O
Taken	O
together	O
these	O
data	O
strongly	O
suggest	O
a	O
direct	O
interaction	O
of	O
calcineurin	protein
with	O
NFATp	protein
and	O
that	O
this	O
interaction	O
does	O
not	O
depend	O
upon	O
the	O
phosphorylation	DNA
sites	DNA
of	O
NFATp	protein
affected	O
by	O
activation.	O

Cross-linking	O
CD40	protein
on	O
B	cell_type
cells	cell_type
preferentially	O
induces	O
stress-activated	protein
protein	protein
kinases	protein
rather	O
than	O
mitogen-activated	protein
protein	protein
kinases	protein
.	O
The	O
B	protein
cell-associated	protein
surface	protein
molecule	protein
CD40	protein
plays	O
a	O
key	O
role	O
in	O
T	O
cell-dependent	O
B	O
cell	O
maturation	O
,	O
as	O
individuals	O
with	O
defects	O
in	O
either	O
CD40	protein
or	O
its	O
ligand	O
are	O
impaired	O
in	O
immunoglobulin	protein
isotype	O
class	O
switching	O
and	O
germinal	O
center	O
formation	O
.	O
CD40	protein
signaling	O
activates	O
downstream	protein
effectors	protein
,	O
including	O
the	O
tyrosine	protein
protein	protein
kinase	protein
,	O
Lyn	protein
,	O
the	O
phosphatidylinositol-3-kinase	protein
(	O
PI-3	protein
kinase	protein
),	O
and	O
the	O
transcription	O
factor,	O
NF-kappa	protein
B	protein
.	O
In	O
this	O
study,	O
we	O
demonstrate	O
that	O
stress-activated	protein
protein	protein
kinases	protein
(	O
SAPK	protein
)	O
are	O
activated	O
after	O
CD40	protein
cross-linking	O
on	O
various	O
B	cell_line
cell	cell_line
lines	cell_line
or	O
human	cell_type
tonsillar	cell_type
B	cell_type
cells	cell_type
.	O
The	O
activation	O
is	O
rapid	O
and	O
transient	O
and	O
is	O
mediated	O
through	O
a	O
cyclosporin	O
A	O
-insensitive	O
pathway	O
.	O
Furthermore,	O
this	O
signaling	O
pathway	O
appears	O
not	O
to	O
rely	O
on	O
protein	protein
kinase	protein
C	protein
.	O
While	O
CD40	protein
ligation	O
strongly	O
activates	O
the	O
SAPKs	protein
(up	O
to	O
25-fold),	O
it	O
does	O
not	O
affect	O
members	O
of	O
the	O
mitogen-activated	protein
protein	protein
kinase	protein
family	protein
(	O
MAPK	protein
;	O
ERK1	protein
and	O
ERK2	protein
).	O
Consistent	O
with	O
these	O
data,	O
CD40	protein
signals	O
up-regulate	O
c-jun	O
but	O
not	O
c-fos	O
mRNA	O
and	O
alter	O
the	O
transcription	protein
factor	protein
ATF2	protein
but	O
not	O
the	O
Raf-1	protein
protein	protein
.	O
In	O
summary,	O
CD40	protein
signaling	O
preferentially	O
induces	O
SAPK	protein
but	O
not	O
MAPK	protein
.	O

Stimulation	O
of	O
the	O
T-cell	protein
antigen	protein
receptor-CD3	protein
complex	protein
signaling	O
pathway	O
by	O
the	O
tyrosine	protein
phosphatase	protein
inhibitor	O
pervanadate	O
is	O
mediated	O
by	O
inhibition	O
of	O
CD45	protein
:	O
evidence	O
for	O
two	O
interconnected	O
Lck/Fyn-	O
or	O
zap-70-	O
dependent	O
signaling	O
pathways	O
.	O
The	O
tyrosine	protein
phosphatase	protein
specific	O
inhibitor	O
pervanadate	O
is	O
a	O
potent	O
activator	O
of	O
T	cell_type
lymphocytes	cell_type
through	O
induction	O
of	O
tyrosine	protein
phosphorylation	protein
and	O
downstream	O
events	O
of	O
the	O
activation	O
cascade	O
.	O
Using	O
CD45-	O
or	O
CD3-	O
negative	O
variants	O
of	O
the	O
Jurkat	cell_line
leukemic	cell_line
T-cell	cell_line
line	cell_line
we	O
show	O
that	O
the	O
different	O
biochemical	O
events	O
induced	O
by	O
pervanadate	O
appeared	O
to	O
be	O
dependent	O
on	O
the	O
presence	O
at	O
the	O
cell	O
surface	O
of	O
either	O
CD45	protein
or	O
CD3	protein
.	O
CD45	protein
-dependent	O
events	O
such	O
as	O
tyrosine	protein
phosphorylation	protein
of	O
Shc	protein
,	O
activation	O
of	O
nuclear	protein
factor-kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
),	O
activator	protein
protein-1	protein
(	O
AP-1	protein
),	O
transcription	protein
factors	protein
,	O
and	O
stimulation	O
of	O
interleukin-2	DNA
(	DNA
IL-2	DNA
)	DNA
promoter	DNA
and	O
of	O
CD69	protein
and	O
CD25	protein
surface	O
expression	O
paralleled	O
activation	O
of	O
the	O
tyrosine	protein
kinases	protein
lck	protein
and	O
fyn	protein
.	O
By	O
contrast,	O
stimulation	O
of	O
calcium	O
influx	O
,	O
a	O
CD3	protein
-dependent	O
event	O
,	O
paralleled	O
zap-70	protein
activation	O
.	O
The	O
data	O
demonstrate	O
that	O
the	O
T-cell	O
antigen	O
receptor	O
-CD3	protein
(TcR-	protein
CD3	protein
)	protein
complex	protein
is	O
functionally	O
linked	O
to	O
two	O
different	O
protein	protein
tyrosine	protein
kinase	protein
(	O
PTK	protein
)	O
modules	O
with	O
separate	O
specific	O
functions	O
and	O
that	O
CD45	protein
may	O
be	O
an	O
important	O
regulator	O
of	O
this	O
coupling.	O

Vitamin	O
D	O
analogs	O
,	O
20-Epi-22-oxa-24a,26a,27a,-trihomo-1alpha,25(OH)2-vitamin	O
D3	O
,	O
1,24(OH)2-22-ene-24-cyclopropyl-vitamin	O
D3	O
and	O
1alpha,25(OH)2-lumisterol3	O
prime	O
NB4	cell_line
leukemia	cell_line
cells	cell_line
for	O
monocytic	O
differentiation	O
via	O
nongenomic	O
signaling	O
pathways	O
,	O
involving	O
calcium	O
and	O
calpain	O
.	O
Side-chain	O
modified	O
vitamin	O
D	O
analogs	O
including	O
20-Epi-22-oxa-24a,26a,27a-trihomo-1alpha,2	O
5-dihydroxyvitamin	O
D3	O
(	O
KH1060	O
),	O
and	O
1,24-dihydroxy-22-ene-24-cyclopropyl-vitamin	O
D3	O
(	O
MC903	O
)	O
were	O
originally	O
designed	O
to	O
aid	O
in	O
the	O
treatment	O
of	O
hyperproliferative	O
disorders	O
including	O
psoriasis	O
and	O
cancer	O
.	O
Here	O
we	O
demonstrate	O
that	O
these	O
analogs,	O
as	O
well	O
as	O
the	O
6-cis-locked	O
conformer	O
,	O
1alpha,25-dihydroxy-lumisterol3	cell_line
(JN)	cell_line
prime	cell_line
NB4	cell_line
cells	cell_line
for	O
monocytic	O
differentiation	O
.	O
Previously,	O
the	O
action	O
of	O
MC903	O
and	O
KH1060	O
was	O
presumed	O
to	O
be	O
mediated	O
by	O
the	O
nuclear	protein
vitamin	protein
D	protein
receptor	protein
(	O
VDRnuc	protein
).	O
Differentiation	O
in	O
response	O
to	O
all	O
analogs	O
was	O
shown	O
to	O
be	O
inhibited	O
by	O
1beta,25-dihydroxyvitamin	O
D3	O
(	O
HL	O
),	O
the	O
antagonist	O
to	O
the	O
nongenomic	O
activities	O
of	O
1,25D3	O
.	O
These	O
data	O
suggest	O
that	O
although	O
MC903	O
and	O
KH1060	O
may	O
bind	O
the	O
VDRnuc	protein
,	O
that	O
the	O
differentiative	O
activities	O
of	O
these	O
agents	O
requires	O
nongenomic	O
signaling	O
pathways	O
.	O
Here	O
we	O
show	O
that	O
1alpha,25(OH)2-d5-previtamin	O
D3	O
(	O
HF	O
),	O
JN	O
,	O
KH1060	O
,	O
and	O
MC903	O
induce	O
expression	O
of	O
PKC	protein
alpha	protein
and	O
PKC	protein
delta	protein
and	O
translocation	O
of	O
both	O
isoforms	O
to	O
the	O
particulate	O
fraction	O
,	O
and	O
PKC	protein
alpha	protein
to	O
the	O
nuclear	O
fraction	O
.	O
The	O
full	O
differentiation	O
response	O
with	O
combinations	O
of	O
analogs	O
and	O
TPA	O
was	O
inhibited	O
50%	O
by	O
the	O
membrane	O
permeable	O
Ca2+	O
chelator	O
,	O
1,2-bis(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic	O
acid	O
(	O
BAPTA-AM	O
)	O
or	O
calpain	protein
inhibitor	O
I	O
.	O
These	O
data	O
demonstrate	O
that	O
intracellular	O
free	O
calcium	O
and	O
the	O
calcium	protein
-dependent	protein
protease	protein
,	O
calpain	protein
play	O
critical	O
roles	O
in	O
monocytic	O
differentiation	O
.	O
Intracellular	O
calcium	O
appears	O
to	O
be	O
most	O
critical	O
in	O
the	O
1,25D3	O
-priming	O
stage	O
of	O
differentiation,	O
while	O
calpain	protein
is	O
essential	O
in	O
the	O
TPA	O
maturation	O
response	O
.	O

Neutrophil	cell_type
maturation	O
and	O
the	O
role	O
of	O
retinoic	O
acid.	O
Neutrophil	cell_type
maturation	O
occurs	O
in	O
well	O
defined	O
morphological	O
stages	O
that	O
correlate	O
with	O
the	O
acquisition	O
of	O
molecular	protein
markers	protein
associated	O
with	O
neutrophil	O
function	O
.	O
A	O
variety	O
of	O
factors	O
are	O
known	O
to	O
play	O
a	O
role	O
in	O
terminal	O
neutrophil	cell_type
maturation	O
,	O
including	O
the	O
vitamin	O
A	O
derivative,	O
retinoic	O
acid	O
.	O
Retinoic	O
acid	O
can	O
directly	O
modulate	O
gene	O
expression	O
via	O
binding	O
to	O
its	O
nuclear	protein
receptors	protein
,	O
which	O
can,	O
in	O
turn,	O
activate	O
transcription	O
of	O
target	DNA
genes	DNA
.	O
A	O
role	O
for	O
retinoic	O
acid	O
during	O
neutrophil	cell_type
maturation	O
has	O
been	O
suggested	O
from	O
a	O
variety	O
of	O
sources.	O
Here	O
we	O
present	O
a	O
review	O
of	O
the	O
mechanism	O
of	O
retinoic	protein
acid	protein
receptor	protein
action	O
and	O
the	O
major	O
evidence	O
showing	O
that	O
normal	O
retinoid	O
signaling	O
is	O
required	O
for	O
neutrophil	cell_type
maturation	O
.	O

Human	DNA
T-cell	DNA
lymphotrophic	DNA
virus	DNA
type-I	DNA
tax	DNA
gene	DNA
induces	O
secretion	O
of	O
human	protein
macrophage	protein
inflammatory	protein
protein-1alpha	protein
.	O
Human	O
T-cell	O
lymphotropic	O
virus	O
I	O
(	O
HTLV-I	O
)	O
encodes	O
for	O
a	O
40-kDa	protein
protein	protein
,	O
Tax	protein
,	O
which	O
is	O
important	O
for	O
the	O
immortalization	O
of	O
T	cell_type
cells	cell_type
.	O
Tax	protein
has	O
been	O
shown	O
to	O
transactivate	O
several	O
cellular	DNA
genes	DNA
.	O
In	O
this	O
study,	O
we	O
show	O
that	O
MIP-1alpha	protein
is	O
selectively	O
expressed	O
and	O
secreted	O
in	O
the	O
tax	cell_line
transfected	cell_line
Jurkat	cell_line
cell	cell_line
line	cell_line
upon	O
mitogen	protein
stimulation	O
.	O
Expression	O
of	O
MIP-1alpha-R	RNA
mRNA	RNA
in	O
these	O
cells	O
suggests	O
an	O
autocrine	O
role	O
for	O
this	O
chemokine	protein
in	O
HTLV-I	cell_type
infected	cell_type
T-cells	cell_type
.	O
Induced	O
MIP-1alpha	protein
expression	O
and	O
secretion	O
in	O
PMA/PHA	cell_line
stimulated	cell_line
tax	cell_line
transfected	cell_line
cells	cell_line
correlate	O
with	O
the	O
noninduction	O
of	O
MNP-1	protein
transcription	protein
factor	protein
,	O
which	O
is	O
intimately	O
involved	O
in	O
downmodulating	O
the	O
MIP-1alpha	DNA
gene	DNA
.	O
Copyright	O
1999	O
Academic	O
Press.	O

Dendritic	cell_type
cells	cell_type
and	O
the	O
pathogenesis	O
of	O
rheumatoid	O
arthritis.	O
Rheumatoid	O
arthritis	O
(	O
RA	O
)	O
is	O
a	O
chronic	O
autoimmune	O
inflammatory	O
disease	O
in	O
which	O
unknown	O
arthrogenic	protein
autoantigen	protein
is	O
presented	O
to	O
CD4	cell_type
+	cell_type
T	cell_type
cells	cell_type
.	O
The	O
strong	O
association	O
of	O
the	O
disease	O
with	O
an	O
epitope	protein
within	O
the	O
HLA-DR	protein
chain	protein
shared	O
between	O
various	O
alleles	O
of	O
HLA-DR4	protein
and	O
DR1	protein
emphasizes	O
the	O
importance	O
of	O
antigen	O
presentation	O
.	O
This	O
immune	O
response	O
predominantly	O
occurs	O
in	O
the	O
synovial	O
tissue	O
and	O
fluid	O
of	O
the	O
joints	O
and	O
autoreactive	cell_type
T	cell_type
cells	cell_type
are	O
readily	O
demonstrable	O
in	O
both	O
the	O
synovial	O
compartment	O
and	O
blood	O
.	O
Circulating	cell_type
dendritic	cell_type
cells	cell_type
(	O
DC	cell_type
)	O
are	O
phenotypically	O
and	O
functionally	O
identical	O
with	O
normal	cell_type
peripheral	cell_type
blood	cell_type
(	cell_type
PB	cell_type
)	cell_type
DC	cell_type
.	O
In	O
the	O
synovial	O
tissue	O
,	O
fully	O
differentiated	O
perivascular	cell_type
DC	cell_type
are	O
found	O
in	O
close	O
association	O
with	O
T	cell_type
cells	cell_type
and	O
with	O
B	cell_type
cell	cell_type
follicles	cell_type
,	O
sometimes	O
containing	O
follicular	cell_type
DC	cell_type
.	O
These	O
perivascular	cell_type
DC	cell_type
migrate	O
across	O
the	O
activated	O
endothelium	O
from	O
blood	O
and	O
receive	O
differentiative	O
signals	O
within	O
the	O
joint	O
from	O
monocyte-derived	protein
cytokines	protein
and	O
CD40	cell_type
-ligand+	cell_type
T	cell_type
cells	cell_type
.	O
In	O
the	O
SF,	O
DC	cell_type
manifest	O
an	O
intermediate	O
phenotype,	O
similar	O
to	O
that	O
of	O
monocyte-derived	cell_type
DC	cell_type
in	O
vitro.	O
Like	O
a	O
delayed-type	O
hypersensitivity	O
response	O
,	O
the	O
rheumatoid	O
synovium	O
represents	O
an	O
effector	O
site.	O
DC	O
at	O
many	O
effector	O
sites	O
have	O
a	O
characteristic	O
pattern	O
of	O
infiltration	O
and	O
differentiation	O
.	O
It	O
is	O
important	O
to	O
note	O
that	O
the	O
effector	O
response	O
is	O
not	O
self-limiting	O
in	O
RA	O
autoimmune	O
inflammation	O
.	O
In	O
this	O
article,	O
we	O
argue	O
that	O
the	O
presentation	O
of	O
self-antigen	protein
by	O
DC	cell_type
and	O
by	O
autoantibody-producing	cell_type
B	cell_type
cells	cell_type
is	O
critical	O
for	O
the	O
perpetuation	O
of	O
the	O
autoimmune	O
response	O
.	O
Permanently	O
arresting	O
this	O
ongoing	O
immune	O
response	O
with	O
either	O
pharmaceutical	O
agents	O
or	O
immunotherapy	O
is	O
a	O
major	O
challenge	O
for	O
immunology	O
.	O

Thymocyte-thymic	O
epithelial	cell_type
cell	cell_type
interaction	O
leads	O
to	O
high-level	O
replication	O
of	O
human	O
immunodeficiency	O
virus	O
exclusively	O
in	O
mature	cell_type
CD4	cell_type
(+)	cell_type
CD8(-)	cell_type
CD3	cell_type
(+)	cell_type
thymocytes	cell_type
:	O
a	O
critical	O
role	O
for	O
tumor	protein
necrosis	protein
factor	protein
and	O
interleukin-7	protein
.	O
This	O
work	O
aims	O
at	O
identifying	O
the	O
thymocyte	O
subpopulation	O
able	O
to	O
support	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
replication	O
under	O
the	O
biological	O
stimuli	O
of	O
the	O
thymic	O
microenvironment	O
.	O
In	O
this	O
report	O
we	O
demonstrate	O
that	O
interaction	O
with	O
thymic	cell_type
epithelial	cell_type
cells	cell_type
(	O
TEC	cell_type
)	O
induces	O
a	O
high-level	O
replication	O
of	O
the	O
T-tropic	protein
primary	protein
isolate	protein
HIV-1	protein
(	O
B-LAIp	protein
)	O
exclusively	O
in	O
the	O
mature	O
CD4	cell_type
(+)	cell_type
CD8(-)	cell_type
CD3	cell_type
(+)	cell_type
thymocytes	cell_type
.	O
Tumor	protein
necrosis	protein
factor	protein
(	O
TNF	protein
)	O
and	O
interleukin-7	protein
(	O
IL-7	protein
),	O
secreted	O
during	O
this	O
interaction,	O
are	O
critical	O
cytokines	O
for	O
HIV	DNA
long	DNA
terminal	DNA
repeat	DNA
transactivation	O
through	O
NF-kappaB	protein
-dependent	O
activation	O
.	O
TNF	protein
is	O
the	O
major	O
inducer	O
of	O
NF-kappaB	protein
and	O
particularly	O
of	O
the	O
p50-p65	protein
complex	protein
,	O
whereas	O
IL-7	protein
acts	O
as	O
a	O
cofactor	O
by	O
sustaining	O
the	O
expression	O
of	O
the	O
p75	protein
TNF	protein
receptor	protein
.	O
The	O
requirement	O
for	O
TNF	protein
is	O
further	O
confirmed	O
by	O
the	O
observation	O
that	O
the	O
inability	O
of	O
the	O
intermediate	cell_type
CD4	cell_type
(+)	cell_type
CD8(-)	cell_type
CD3	cell_type
(-)	cell_type
thymocytes	cell_type
to	O
replicate	O
the	O
virus	O
is	O
associated	O
with	O
a	O
defect	O
in	O
TNF	protein
production	O
during	O
their	O
interaction	O
with	O
TEC	cell_type
and	O
correlates	O
with	O
the	O
absence	O
of	O
nuclear	O
NF-kappaB	protein
activity	O
in	O
these	O
freshly	cell_type
isolated	cell_type
thymocytes	cell_type
.	O
Addition	O
of	O
exogenous	O
TNF	protein
to	O
the	O
intermediate	cell_line
thymocyte	cell_line
cultures	cell_line
induces	O
NF-kappaB	protein
activity	O
and	O
is	O
sufficient	O
to	O
promote	O
HIV	O
replication	O
in	O
the	O
cocultures	O
with	O
TEC	cell_type
.	O
The	O
other	O
major	O
subpopulation	O
expressing	O
the	O
CD4	protein
receptor	protein
,	O
namely,	O
the	O
double-positive	cell_type
(DP)	cell_type
CD4	cell_type
(+)	cell_type
CD8(+)	cell_type
CD3	cell_type
(+/-)	cell_type
thymocytes	cell_type
,	O
despite	O
the	O
entry	O
of	O
the	O
virus,	O
do	O
not	O
produce	O
a	O
significant	O
level	O
of	O
virus,	O
presumably	O
because	O
they	O
are	O
unresponsive	O
to	O
TNF	protein
and	O
IL-7	protein
.	O
Together,	O
these	O
data	O
suggest	O
that	O
in	O
vivo,	O
despite	O
an	O
efficient	O
entry	O
of	O
the	O
virus	O
in	O
all	O
the	O
CD4	cell_type
(+)	cell_type
subpopulations	cell_type
,	O
a	O
high	O
viral	O
load	O
may	O
be	O
generated	O
exclusively	O
within	O
the	O
mature	cell_type
CD4	cell_type
(+)	cell_type
CD8(-)	cell_type
CD3	cell_type
(+)	cell_type
subset	cell_type
of	cell_type
thymocytes	cell_type
.	O
However,	O
under	O
conditions	O
of	O
inflammatory	O
response	O
after	O
infection,	O
TNF	protein
might	O
also	O
be	O
present	O
in	O
the	O
intermediate	cell_type
thymocyte	cell_type
compartment	cell_type
,	O
leading	O
to	O
efficient	O
HIV	O
replication	O
in	O
these	O
cells.	O

NF-kappaB	cell_type
-mediated	cell_type
up-regulation	cell_type
of	O
Bcl-x	protein
and	O
Bfl-1/A1	protein
is	O
required	O
for	O
CD40	protein
survival	O
signaling	O
in	O
B	cell_type
lymphocytes	cell_type
.	O
Activation	O
of	O
CD40	protein
is	O
essential	O
for	O
thymus-dependent	O
humoral	O
immune	O
responses	O
and	O
rescuing	O
B	cell_type
cells	cell_type
from	O
apoptosis	O
.	O
Many	O
of	O
the	O
effects	O
of	O
CD40	protein
are	O
believed	O
to	O
be	O
achieved	O
through	O
altered	O
gene	O
expression	O
.	O
In	O
addition	O
to	O
Bcl-x	protein
,	O
a	O
known	O
CD40	protein
-regulated	protein
antiapoptotic	protein
molecule	protein
,	O
we	O
identified	O
a	O
related	O
antiapoptotic	protein
molecule	protein
,	O
A1/Bfl-1	protein
,	O
as	O
a	O
CD40	DNA
-inducible	DNA
gene	DNA
.	O
Inhibition	O
of	O
the	O
NF-kappaB	protein
pathway	O
by	O
overexpression	O
of	O
a	O
dominant-active	O
inhibitor	O
of	O
NF-kappaB	protein
abolished	O
CD40	protein
-induced	O
up-regulation	O
of	O
both	O
the	O
Bfl-1	protein
and	O
Bcl-x	protein
genes	O
and	O
also	O
eliminated	O
the	O
ability	O
of	O
CD40	protein
to	O
rescue	O
Fas	protein
-induced	O
cell	O
death	O
.	O
Within	O
the	O
upstream	DNA
promoter	DNA
region	DNA
of	O
Bcl-x	protein
,	O
a	O
potential	O
NF-kappaB	DNA
-binding	DNA
sequence	DNA
was	O
found	O
to	O
support	O
NF-kappaB	protein
-dependent	O
transcriptional	O
activation	O
.	O
Furthermore,	O
expression	O
of	O
physiological	O
levels	O
of	O
Bcl-x	cell_type
protected	cell_type
B	cell_type
cells	cell_type
from	O
Fas-mediated	O
apoptosis	O
in	O
the	O
absence	O
of	O
NF-kappaB	protein
signaling	O
.	O
Thus,	O
our	O
results	O
suggest	O
that	O
CD40	protein
-mediated	O
cell	O
survival	O
proceeds	O
through	O
NF-kappaB	protein
-dependent	O
up-regulation	O
of	O
Bcl-2	protein
family	protein
members	protein
.	O

Stimulation	O
of	O
neutrophil	cell_type
interleukin-8	protein
production	O
by	O
eosinophil	protein
granule	protein
major	protein
basic	protein
protein	protein
.	O
We	O
evaluated	O
the	O
ability	O
of	O
eosinophil	protein
granule	protein
major	protein
basic	protein
protein	protein
(	O
MBP	protein
)	O
to	O
stimulate	O
interleukin	protein
(IL)-8	protein
production	O
by	O
neutrophils	cell_type
.	O
MBP	protein
over	O
the	O
concentration	O
range	O
of	O
0.1	O
to	O
10	O
microM	O
stimulated	O
the	O
release	O
of	O
up	O
to	O
approximately	O
8	O
ng/ml	O
IL-8	protein
.	O
Incubation	O
with	O
2	O
microM	O
MBP	protein
showed	O
that,	O
after	O
a	O
1	O
h	O
lag,	O
the	O
level	O
of	O
IL-8	protein
release	O
increased	O
with	O
time	O
for	O
approximately	O
10	O
h.	O
At	O
the	O
2	O
microM	O
concentration,	O
eosinophil	protein
cationic	protein
protein	protein
,	O
eosinophil-derived	O
neurotoxin	O
,	O
and	O
eosinophil	protein
peroxidase	protein
did	O
not	O
stimulate	O
significant	O
levels	O
of	O
IL-8	protein
production	O
.	O
MBP	protein
stimulated	O
2-fold	O
increases	O
in	O
IL-8	RNA
messenger	RNA
RNA	RNA
(	O
mRNA	RNA
)	O
after	O
1	O
and	O
3	O
h	O
of	O
incubation,	O
which	O
were	O
blocked	O
by	O
pretreatment	O
with	O
actinomycin	O
D	O
.	O
However,	O
stimulation	O
with	O
MBP	protein
did	O
not	O
produce	O
an	O
increase	O
in	O
the	O
binding	O
activity	O
of	O
nuclear	protein
factor	protein
(NF)-kappaB	protein
or	O
activator	protein
protein-1	protein
.	O
No	O
NF-IL-6	protein
binding	O
activity	O
was	O
detected	O
in	O
the	O
same	O
nuclear	O
extracts	O
.	O
In	O
addition,	O
stimulation	O
with	O
MBP	protein
prolonged	O
the	O
stability	O
of	O
IL-8	RNA
mRNA	RNA
.	O
MBP	protein
also	O
induced	O
transient	O
increases	O
in	O
mRNA	RNA
for	O
macrophage	protein
inflammatory	protein
protein	protein
(MIP)-1alpha	protein
and	O
MIP-1beta	protein
,	O
but	O
did	O
not	O
stimulate	O
the	O
release	O
of	O
either	O
chemokine	protein
.	O
These	O
findings	O
indicate	O
that	O
MBP	protein
is	O
selective	O
among	O
the	O
eosinophil	protein
granule	protein
proteins	protein
as	O
a	O
stimulus	O
for	O
neutrophil	cell_type
IL-8	protein
release	O
and,	O
further,	O
that	O
stimulation	O
of	O
neutrophil	cell_type
IL-8	protein
release	O
by	O
MBP	protein
involves	O
both	O
transcriptional	O
and	O
posttranscriptional	O
regulation	O
.	O
We	O
postulate	O
that	O
MBP	protein
-induced	O
release	O
of	O
IL-8	protein
by	O
neutrophils	cell_type
may	O
contribute	O
to	O
the	O
pathophysiology	O
of	O
acute	O
asthma	O
and	O
other	O
inflammatory	O
lung	O
diseases	O
.	O

Expression	O
of	O
either	O
the	O
TCL1	DNA
oncogene	DNA
,	O
or	O
transcripts	O
from	O
its	O
homologue	O
MTCP1/c6.1B	DNA
,	O
in	O
leukaemic	O
and	O
non-leukaemic	cell_type
T	cell_type
cells	cell_type
from	O
ataxia	O
telangiectasia	O
patients	O
.	O
Patients	O
with	O
the	O
recessively	O
inherited	O
disorder	O
ataxia	O
telangiectasia	O
(	O
A-T	O
)	O
have	O
a	O
high	O
level	O
of	O
specific	O
chromosome	DNA
translocations	DNA
which	O
can	O
be	O
easily	O
observed	O
in	O
peripheral	cell_type
T	cell_type
cells	cell_type
and	O
show	O
a	O
greatly	O
increased	O
predisposition	O
to	O
leukaemia/lymphoma	O
,	O
mainly	O
of	O
T	cell_type
cell	cell_type
origin	O
.	O
Some	O
translocation	cell_type
cells	cell_type
proliferate	O
into	O
a	O
large	O
clone	O
and	O
may	O
develop	O
into	O
T	O
cell	O
prolymphocytic	O
leukaemia	O
(	O
T-PLL	O
).	O
By	O
the	O
time	O
of	O
diagnosis	O
of	O
T-PLL	O
,	O
the	O
clone	O
contains	O
many	O
more	O
genetic	O
changes	O
in	O
the	O
form	O
of	O
additional	O
translocations.	O
T-PLL	O
is	O
also	O
seen	O
in	O
non-	O
A-T	O
individuals	O
where	O
expression	O
of	O
either	O
TCL1	protein
(at	O
14q32	DNA
)	O
or	O
the	O
c6.1B/MTCP1	protein
A1	protein
transcript	protein
(	O
at-Xq28	DNA
)	O
has	O
been	O
demonstrated	O
in	O
just	O
a	O
few	O
instances.	O
We	O
show	O
here,	O
that	O
expression	O
of	O
TCL1	protein
occurs	O
in	O
leukaemic	cell_type
T	cell_type
cells	cell_type
from	O
A-T	O
patients	O
with	O
chromosome	DNA
14	DNA
rearrangements	O
.	O
Expression	O
of	O
TCL1	protein
also	O
occurs	O
in	O
the	O
preleukaemic	cell_type
clone	cell_type
cells	cell_type
of	O
A-T	O
patients	O
containing	O
the	O
primary	O
translocation	O
alone.	O
Some	O
expression	O
of	O
TCL1	protein
could	O
also	O
be	O
detected	O
in	O
randomly	O
selected	O
A-T	O
patients	O
without	O
large	O
cytogenetic	O
clones	O
and	O
without	O
any	O
evidence	O
of	O
leukaemic	O
change.	O
We	O
also	O
show	O
that	O
expression	O
of	O
the	O
B1	RNA
transcript	RNA
from	O
a	O
second	O
gene,	O
MTCP1	DNA
,	O
occurred	O
at	O
a	O
relatively	O
high	O
level	O
only	O
in	O
two	O
T-PLL	O
tumours	O
from	O
A-T	O
patients	O
with	O
t(X;14)	O
translocations	O
whereas	O
the	O
MTCP1	RNA
/A1	RNA
transcript	RNA
is	O
much	O
more	O
widely	O
expressed	O
in	O
both	O
tumour	O
and	O
non	O
tumour	O
cells	O
of	O
A-T	O
and	O
non-	O
A-T	O
individuals	O
.	O

[Correlation	O
of	O
lymphocytic	O
infiltration	O
of	O
tumor	O
tissue	O
with	O
the	O
hormonal	O
and	O
metabolic	O
state	O
in	O
patients	O
with	O
breast	O
cancer	O
]	O
Lymphocyte	O
infiltration	O
of	O
tumor	O
was	O
studied	O
vis-a-vis	O
hormone	O
metabolic	O
status	O
,	O
tumor	O
tissue	O
hormone	O
sensitivity	O
and	O
tobacco	O
smoking	O
,	O
in	O
113	O
breast	O
cancer	O
patients	O
,	O
aged	O
25-77.	O
On	O
the	O
average,	O
no	O
correlation	O
was	O
established	O
between	O
degree	O
of	O
lymphocyte	O
infiltration	O
in	O
breast	O
tumor	O
and	O
age	O
and	O
menopause	O
onset.	O
In	O
smoking	O
menopausal	O
patients	O
,	O
lymphocyte	O
infiltration	O
was	O
found	O
to	O
be	O
higher	O
than	O
in	O
non-smokers	O
(p	O
&lt;	O
0.05).	O
There	O
was	O
a	O
direct	O
correlation	O
between	O
the	O
rate	O
of	O
lymphocyte	O
infiltration	O
and	O
the	O
level	O
of	O
progesterone	protein
receptors	protein
in	O
tumor.	O
Some	O
subgroups	O
displayed	O
a	O
direct	O
correlation	O
between	O
infiltration	O
and	O
sex-binding	protein
globulin	protein
,	O
cholesterol	O
,	O
luteinizing	O
hormone	O
in	O
blood	O
,	O
and	O
lean	O
body	O
mass	O
.	O
It	O
was	O
matched	O
by	O
an	O
inverse	O
correlation	O
between	O
lymphocyte	O
infiltration	O
and	O
blood-thyroid	O
hormone	O
concentration	O
,	O
urine	O
catecholamines	O
and	O
free	O
cortisol	O
excretion	O
and	O
fat/lean	O
body	O
mass	O
ratio	O
.	O
Considering	O
the	O
abovesaid	O
as	O
well	O
as	O
the	O
lymphocyte	O
ability	O
to	O
perform	O
the	O
dual	O
function	O
of	O
immunocytes	cell_type
and	O
hormonocytes	cell_type
,	O
it	O
is	O
suggested	O
that	O
the	O
results	O
may	O
be	O
used	O
in	O
both	O
the	O
study	O
of	O
lymphocyte	O
infiltration	O
and	O
research	O
in	O
means	O
of	O
its	O
control.	O

Gene	O
transcription	O
through	O
activation	O
of	O
G-protein-coupled	protein
chemoattractant	protein
receptors	protein
.	O
Receptors	O
for	O
leukocyte	protein
chemoattractants	protein
,	O
including	O
chemokines	protein
,	O
are	O
traditionally	O
considered	O
to	O
be	O
responsible	O
for	O
the	O
activation	O
of	O
special	O
leukocyte	O
functions	O
such	O
as	O
chemotaxis	O
,	O
degranulation	O
,	O
and	O
the	O
release	O
of	O
superoxide	O
anions	O
.	O
Recently,	O
these	O
G-protein-coupled	protein
serpentine	protein
receptors	protein
have	O
been	O
found	O
to	O
transduce	O
signals	O
leading	O
to	O
gene	O
transcription	O
and	O
translation	O
in	O
leukocytes	cell_type
.	O
Transcription	protein
factors	protein
,	O
such	O
as	O
NF	protein
kappa	protein
B	protein
and	O
AP-1	protein
,	O
are	O
activated	O
upon	O
stimulation	O
of	O
the	O
cells	O
with	O
several	O
chemoattractants	O
at	O
physiologically	O
relevant	O
concentrations.	O
Activation	O
of	O
transcription	O
factors	O
through	O
these	O
receptors	O
involves	O
G-protein	protein
coupling	O
and	O
the	O
activation	O
of	O
protein	protein
kinases	protein
.	O
The	O
underlying	O
signaling	O
pathways	O
appear	O
to	O
be	O
different	O
from	O
those	O
utilized	O
by	O
TNF-alpha	protein
,	O
a	O
better	O
characterized	O
cytokine	O
that	O
induces	O
the	O
transcription	O
of	O
immediate-early	DNA
genes	DNA
.	O
Chemoattractants	O
stimulate	O
the	O
expression	O
of	O
several	O
inflammatory	protein
cytokines	protein
and	O
chemokines	protein
,	O
which	O
in	O
turn	O
may	O
activate	O
their	O
respective	O
receptors	O
and	O
initiate	O
an	O
autocrine	O
regulatory	O
mechanism	O
for	O
persistent	O
cytokine	protein
and	O
chemokine	protein
gene	O
expression	O
.	O

Affinity-driven	O
peptide	O
selection	O
of	O
an	O
NFAT	O
inhibitor	O
more	O
selective	O
than	O
cyclosporin	O
A	O
[see	O
comments]	O
The	O
flow	O
of	O
information	O
from	O
calcium-mobilizing	protein
receptors	protein
to	O
nuclear	DNA
factor	DNA
of	DNA
activated	DNA
T	DNA
cells	DNA
(	DNA
NFAT	DNA
)-dependent	DNA
genes	DNA
is	O
critically	O
dependent	O
on	O
interaction	O
between	O
the	O
phosphatase	protein
calcineurin	protein
and	O
the	O
transcription	protein
factor	protein
NFAT	protein
.	O
A	O
high-affinity	O
calcineurin	protein
-binding	O
peptide	O
was	O
selected	O
from	O
combinatorial	O
peptide	O
libraries	O
based	O
on	O
the	O
calcineurin	protein
docking	protein
motif	protein
of	O
NFAT	protein
.	O
This	O
peptide	O
potently	O
inhibited	O
NFAT	protein
activation	O
and	O
NFAT	protein
-dependent	O
expression	O
of	O
endogenous	DNA
cytokine	DNA
genes	DNA
in	O
T	cell_type
cells	cell_type
,	O
without	O
affecting	O
the	O
expression	O
of	O
other	O
cytokines	protein
that	O
require	O
calcineurin	protein
but	O
not	O
NFAT	protein
.	O
Substitution	O
of	O
the	O
optimized	O
peptide	O
sequence	O
into	O
the	O
natural	O
calcineurin	protein
docking	protein
site	protein
increased	O
the	O
calcineurin	protein
responsiveness	O
of	O
NFAT	protein
.	O
Compounds	O
that	O
interfere	O
selectively	O
with	O
the	O
calcineurin	protein
-NFAT	protein
interaction	O
without	O
affecting	O
calcineurin	protein
phosphatase	protein
activity	O
may	O
be	O
useful	O
as	O
therapeutic	O
agents	O
that	O
are	O
less	O
toxic	O
than	O
current	O
drugs.	O

9-cis	O
retinoic	O
acid	O
induces	O
monocyte	protein
chemoattractant	protein
protein-1	protein
secretion	O
in	O
human	cell_type
monocytic	cell_type
THP-1	cell_type
cells	cell_type
.	O
Monocyte	O
migration	O
and	O
activation	O
are	O
regulated	O
by	O
monocyte	protein
chemoattractant	protein
protein-1	protein
(	O
MCP-1	protein
).	O
Prior	O
studies	O
have	O
shown	O
MCP-1	protein
expression	O
is	O
modulated	O
by	O
a	O
variety	O
of	O
ligands	O
that	O
act	O
through	O
extracellular	protein
receptors	protein
.	O
In	O
the	O
current	O
study,	O
we	O
show	O
9-cis	O
retinoic	O
acid	O
(	O
RA	O
),	O
a	O
ligand	O
for	O
the	O
nuclear	protein
hormone	protein
receptor	protein
retinoid	protein
X	protein
receptor	protein
(	O
RXR	protein
)	O
and	O
retinoic	protein
acid	protein
receptor	protein
(	O
RAR	protein
),	O
markedly	O
induces	O
the	O
expression	O
of	O
MCP-1	protein
.	O
In	O
human	cell_line
THP-1	cell_line
monocytic	cell_line
leukemia	cell_line
cells	cell_line
cultured	O
with	O
RA	O
(0.05	O
to	O
500	O
nmol/L),	O
MCP-1	protein
expression	O
was	O
induced	O
rapidly,	O
significantly,	O
and	O
dose-dependently	O
by	O
as	O
much	O
as	O
165-fold.	O
MCP-1	RNA
RNA	RNA
level	O
was	O
also	O
increased	O
in	O
RA	O
-treated	O
cells.	O
Expression	O
of	O
PPARgamma	protein
,	O
a	O
heterodimer	O
partner	O
of	O
RXR	protein
,	O
is	O
also	O
markedly	O
induced	O
by	O
RA	O
in	O
THP-1	cell_type
cells	cell_type
.	O
However,	O
BRL49653	O
,	O
a	O
PPARgamma	protein
ligand	O
,	O
failed	O
to	O
induce	O
MCP-1	protein
secretion	O
either	O
alone	O
or	O
to	O
modify	O
the	O
expression	O
level	O
induced	O
by	O
RA	O
.	O
In	O
contrast,	O
BRL49653	O
significantly	O
increased	O
MCP-1	protein
(	O
biotinylated	protein
MCP-1	protein
)	O
binding	O
to	O
THP-1	cell_type
cells	cell_type
,	O
whereas	O
RA	O
had	O
no	O
effect.	O
Other	O
peroxisome	protein
proliferator	protein
activated	protein
receptor	protein
(	O
PPAR	protein
)	O
ligands	O
,	O
15d-PGJ(2)	O
and	O
troglitazone	O
(	O
PPARgamma	protein
)	O
,	O
Wy14,643	O
(	O
PPARalpha	protein
),	O
and	O
PD195599	O
(	O
PPARbeta	protein
)	O
inhibited	O
the	O
induction	O
of	O
MCP-1	protein
by	O
RA	O
.	O
RA	O
's	O
effect	O
on	O
MCP-1	protein
expression	O
in	O
human	O
elutriated	O
monocytes	O
were	O
similar	O
to	O
that	O
observed	O
in	O
the	O
THP-1	cell_line
cells	cell_line
.	O
These	O
studies	O
identify	O
RA	O
as	O
a	O
nuclear	O
signal	O
for	O
MCP-1	protein
induction	O
in	O
undifferentiated	cell_type
human	cell_type
monocytic	cell_type
cells	cell_type
.	O
These	O
studies	O
also	O
suggest	O
monocyte	O
MCP-1	protein
expression	O
induced	O
through	O
RA	O
may	O
modulate	O
cell	O
migration.	O

Classification	O
of	O
IVS1-10T--&gt;C	O
as	O
a	O
polymorphism	O
of	O
BRCA1	DNA
.	O
Mutations	O
inactivating	O
the	O
tumor	DNA
suppressor	DNA
gene	DNA
BRCA1	DNA
may	O
be	O
responsible	O
for	O
disease	O
for	O
up	O
to	O
80%	O
of	O
familial	O
ovarian	O
cancer	O
cases	O
.	O
In	O
this	O
syndrome,	O
tumorigenesis	O
classically	O
initiates	O
from	O
an	O
inherited	O
mutation	O
in	O
one	O
allele	DNA
followed	O
by	O
somatic	O
deletion	O
of	O
the	O
normal	DNA
allele	DNA
.	O
Sequencing	O
of	O
BRCA1	DNA
amplified	O
from	O
genomic	DNA
DNA	DNA
of	O
lymphocytes	cell_type
and	O
microdissected	cell_type
ovarian	cell_type
tumor	cell_type
cells	cell_type
of	O
a	O
familial	O
ovarian	O
cancer	O
patient	O
revealed	O
three,	O
rare	O
heterozygous	O
DNA	O
variations	O
(	O
2418delA	O
,	O
233G--&gt;A	O
,	O
and	O
IVS1-10T--&gt;C	O
)	O
in	O
both	O
tumor	O
and	O
constitutional	O
(lymphocyte)	O
DNA	O
.	O
Thus,	O
both	O
copies	O
of	O
BRCA1	DNA
were	O
retained	O
in	O
tumor.	O
Haplotype	O
analysis	O
of	O
the	O
patient	O
and	O
four	O
siblings	O
assigned	O
2418delA	O
to	O
one	O
copy	O
of	O
BRCA1	DNA
and	O
233G--&gt;A	O
and	O
IVS1-10T--&gt;C	O
to	O
the	O
other.	O
The	O
DNA	O
change	O
,	O
2418delA	O
,	O
is	O
considered	O
a	O
mutation	O
that	O
inactivated	O
one	O
BRCA1	DNA
allele	O
because	O
it	O
caused	O
a	O
frameshift	O
and	O
generation	O
of	O
a	O
premature	DNA
stop	DNA
codon	DNA
,	O
resulting	O
in	O
synthesis	O
of	O
a	O
truncated	O
peptide	O
as	O
evidenced	O
by	O
an	O
in	O
vitro	O
protein	O
truncation	O
test.	O
The	O
DNA	O
variation	O
,	O
233G--&gt;A	O
,	O
does	O
not	O
result	O
in	O
an	O
amino	O
acid	O
change	O
,	O
and	O
is	O
considered	O
a	O
benign	O
polymorphism	O
.	O
IVS1-10T--&gt;C	O
is	O
a	O
unique	O
BRCA1	DNA
change	O
that	O
occurs	O
in	O
the	O
last	O
nucleotide	O
of	O
a	O
consensus	DNA
sequence	DNA
for	O
a	O
branch	DNA
site	DNA
critical	O
for	O
RNA	O
splicing	O
.	O
Therefore,	O
we	O
investigated	O
whether	O
IVS1-10T--&gt;C	O
deleteriously	O
affected	O
BRCA1	DNA
splicing	O
or	O
expression,	O
and	O
thereby	O
inactivated	O
the	O
other	O
BRCA1	DNA
allele	DNA
.	O
Using	O
the	O
technique	O
of	O
reverse	O
transcription-polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
with	O
RNA	O
isolated	O
from	O
lymphoid	cell_line
cell	cell_line
lines	cell_line
of	O
the	O
patient	O
and	O
of	O
controls,	O
no	O
evidence	O
was	O
found	O
that	O
IVS1-10TC	O
abnormally	O
disrupted	O
mRNA	RNA
splicing	O
or	O
caused	O
the	O
absence	O
of	O
BRCA1	RNA
mRNA	RNA
.	O
Thus,	O
IVS1-10T--&gt;C	O
is	O
not	O
harmful	O
to	O
BRCA1	DNA
function,	O
and	O
is	O
classified	O
a	O
benign	O
polymorphism	O
.	O
Retention	O
of	O
the	O
normal	O
BRCA1	DNA
allele	DNA
in	O
the	O
tumor	O
with	O
the	O
heterozygous	O
germline	O
BRCA1	DNA
mutation	O
,	O
2418delA	O
,	O
indicated	O
that	O
mutational	O
inactivation	O
of	O
both	O
BRCA1	DNA
alleles	DNA
was	O
not	O
required	O
for	O
tumorigenesis	O
.	O
It	O
is	O
possible	O
that	O
the	O
normal	DNA
allele	DNA
may	O
be	O
functionally	O
inactivated	O
by	O
a	O
nonmutational	O
mechanism	O
.	O

Myb-transformed	cell_type
hematopoietic	cell_type
cells	cell_type
as	O
a	O
model	O
for	O
monocyte	O
differentiation	O
into	O
dendritic	cell_type
cells	cell_type
and	O
macrophages	cell_type
.	O
Immune	O
induction	O
is	O
effected	O
through	O
the	O
interaction	O
of	O
antigen-presenting	cell_type
cells	cell_type
with	O
specific	O
receptors	protein
on	O
the	O
surface	O
of	O
thymus-derived	cell_type
lymphocytes	cell_type
.	O
Cells	O
most	O
able	O
to	O
ingest,	O
process,	O
and	O
present	O
antigen	O
appear	O
to	O
be	O
related	O
to	O
the	O
mononuclear	cell_type
phagocyte/neutrophil	cell_type
series	cell_type
.	O
For	O
example	O
dendritic	cell_type
cells	cell_type
(	O
DC	cell_type
)	O
can	O
be	O
found	O
in	O
colonies	O
of	O
GM-CSF-responsive	cell_type
bone	cell_type
marrow	cell_type
cells	cell_type
,	O
and	O
under	O
experimental	O
conditions	O
are	O
routinely	O
expanded	O
as	O
a	O
population	O
in	O
vitro	O
from	O
GM-CSF-responsive	cell_type
progenitor	cell_type
cells	cell_type
.	O
To	O
address	O
the	O
question	O
of	O
DC	cell_type
lineage	cell_type
and	O
to	O
determine	O
what	O
genes	O
are	O
involved	O
in	O
lineage	O
commitment,	O
we	O
have	O
generated	O
a	O
series	O
of	O
GM-CSF-responsive	cell_line
cell	cell_line
lines	cell_line
that	O
can	O
be	O
induced	O
to	O
differentiate	O
in	O
a	O
homogeneous	O
manner	O
in	O
vitro.	O
The	O
cloned	cell_line
cell	cell_line
lines	cell_line
are	O
derived	O
from	O
12-day	O
fetal	O
liver	O
and	O
are	O
transformed	O
with	O
a	O
truncated	O
form	O
of	O
c-myb	DNA
,	O
which	O
lacks	O
the	O
normal	O
autoregulatory	DNA
sequences	DNA
.	O
As	O
far	O
as	O
we	O
know,	O
these	O
myb-transformed	cell_line
hemopoi-etic	cell_line
cells	cell_line
(	O
MTHC	cell_line
)	O
differ	O
from	O
normal	O
only	O
in	O
the	O
unregulated	O
expression	O
of	O
myb,	O
a	O
gene	O
whose	O
expression	O
is	O
obligatory	O
for	O
proliferation	O
of	O
hemopoietic	O
cells.	O
MTHC	cell_line
in	O
the	O
presence	O
of	O
TNF-alpha	protein
and	O
IL-4	protein
will	O
differentiate	O
into	O
cells	O
that	O
have	O
many	O
of	O
the	O
properties	O
of	O
macrophages	cell_type
.	O
When	O
the	O
same	O
MTHC	cell_line
lines	cell_line
are	O
exposed	O
to	O
TNF-alpha	protein
in	O
combination	O
with	O
IFN-gamma	protein
,	O
the	O
cells	O
instead	O
become	O
DC	cell_type
.	O
The	O
differentiated	O
DC	cell_type
are	O
potent	O
presenters	O
of	O
antigen	O
in	O
mixed	O
lymphocyte	O
reactions	O
and	O
of	O
soluble	O
antigen	O
to	O
specific	O
T	cell_line
cell	cell_line
lines	cell_line
.	O
Thus,	O
cells	O
with	O
the	O
properties	O
of	O
both	O
macrophages	cell_type
and	O
DC	cell_type
can	O
be	O
derived	O
from	O
a	O
single	O
type	O
of	O
GM-CSF-responsive	cell_type
progenitor	cell_type
cell	cell_type
.	O
We	O
have	O
used	O
this	O
MTHC	cell_line
system	cell_line
to	O
analyze	O
differences	O
in	O
gene	O
expression	O
as	O
the	O
cells	O
mature	O
along	O
the	O
DC	cell_type
and	O
macrophage	cell_type
pathways	cell_type
.	O
A	O
distinctive	O
pattern	O
of	O
differentially	O
expressed	O
cDNAs	DNA
is	O
evident	O
where	O
macrophage-specific	DNA
cDNAs	DNA
are	O
homologous	O
to	O
genes	O
encoding	O
cytoskeletal	O
and	O
cell-surface	O
proteins	O
,	O
whereas	O
the	O
DC	cell_type
-specific	O
cDNAs	DNA
are	O
homologous	O
to	O
signaling	O
,	O
chemokine	O
,	O
and	O
IFN-gamma-inducible	O
genes	O
.	O
We	O
discuss	O
the	O
utility	O
of	O
MTHC	cell_line
in	O
analyzing	O
the	O
relationships	O
between	O
DC	cell_type
and	O
macrophages	cell_type
,	O
and	O
suggest	O
that	O
DC	cell_type
and	O
macrophages	cell_type
represent	O
extreme	O
phenotypes	O
in	O
a	O
spectrum	O
of	O
antigen	cell_type
handling	cell_type
cells	cell_type
that	O
are	O
somewhat	O
interchangeable,	O
depending	O
on	O
their	O
immediate	O
environment.	O

The	O
Legionella	O
pneumophila	O
rpoS	DNA
gene	DNA
is	O
required	O
for	O
growth	O
within	O
Acanthamoeba	O
castellanii	O
.	O
To	O
investigate	O
regulatory	O
networks	O
in	O
Legionella	O
pneumophila	O
,	O
the	O
gene	O
encoding	O
the	O
homolog	O
of	O
the	O
Escherichia	protein
coli	protein
stress	protein
and	protein
stationary-phase	protein
sigma	protein
factor	protein
RpoS	protein
was	O
identified	O
by	O
complementation	O
of	O
an	O
E.	O
coli	O
rpoS	DNA
mutation	O
.	O
An	O
open	DNA
reading	DNA
frame	DNA
that	O
is	O
approximately	O
60%	O
identical	O
to	O
the	O
E.	DNA
coli	DNA
rpoS	DNA
gene	DNA
was	O
identified.	O
Western	O
blot	O
analysis	O
showed	O
that	O
the	O
level	O
of	O
L.	O
pneumophila	O
RpoS	protein
increased	O
in	O
stationary	O
phase.	O
An	O
insertion	O
mutation	O
was	O
constructed	O
in	O
the	O
rpoS	DNA
gene	DNA
on	O
the	O
chromosome	O
of	O
L.	O
pneumophila	O
,	O
and	O
the	O
ability	O
of	O
this	O
mutant	O
strain	O
to	O
survive	O
various	O
stress	O
conditions	O
was	O
assayed	O
and	O
compared	O
with	O
results	O
for	O
the	O
wild-type	O
strain	O
.	O
Both	O
the	O
mutant	O
and	O
wild-type	O
strains	O
were	O
more	O
resistant	O
to	O
stress	O
when	O
in	O
stationary	O
phase	O
than	O
when	O
in	O
the	O
logarithmic	O
phase	O
of	O
growth	O
.	O
This	O
finding	O
indicates	O
that	O
L.	O
pneumophila	O
RpoS	protein
is	O
not	O
required	O
for	O
a	O
stationary-phase-dependent	O
resistance	O
to	O
stress.	O
Although	O
the	O
mutant	O
strain	O
was	O
able	O
to	O
kill	O
HL-60-	O
and	O
THP-1-	O
derived	O
macrophages	O
,	O
it	O
could	O
not	O
replicate	O
within	O
a	O
protozoan	O
host	O
,	O
Acanthamoeba	O
castellanii	O
.	O
These	O
data	O
suggest	O
that	O
L.	O
pneumophila	O
possesses	O
a	O
growth	O
phase-dependent	O
resistance	O
to	O
stress	O
that	O
is	O
independent	O
of	O
RpoS	protein
control	O
and	O
that	O
RpoS	protein
likely	O
regulates	O
genes	O
that	O
enable	O
it	O
to	O
survive	O
in	O
the	O
environment	O
within	O
protozoa	O
.	O
Our	O
data	O
indicate	O
that	O
the	O
role	O
of	O
rpoS	DNA
in	O
L.	O
pneumophila	O
is	O
very	O
different	O
from	O
what	O
has	O
previously	O
been	O
reported	O
for	O
E.	O
coli	O
rpoS	DNA
.	O

Monoallelic	O
expression	O
of	O
Pax5	protein
:	O
a	O
paradigm	O
for	O
the	O
haploinsufficiency	O
of	O
mammalian	DNA
Pax	DNA
genes	DNA
?	O
It	O
is	O
generally	O
assumed	O
that	O
most	O
mammalian	DNA
genes	DNA
are	O
transcribed	O
from	O
both	O
alleles	DNA
.	O
Hence,	O
the	O
diploid	O
state	O
of	O
the	O
genome	O
offers	O
the	O
advantage	O
that	O
a	O
loss-of-function	O
mutation	O
in	O
one	O
allele	DNA
can	O
be	O
compensated	O
for	O
by	O
the	O
remaining	O
wild-type	DNA
allele	DNA
of	O
the	O
same	O
gene.	O
Indeed,	O
the	O
vast	O
majority	O
of	O
human	O
disease	O
syndromes	O
and	O
engineered	O
mutations	O
in	O
the	O
mouse	DNA
genome	DNA
are	O
recessive,	O
indicating	O
that	O
recessiveness	O
is	O
the	O
'default'	O
state.	O
However,	O
a	O
minority	O
of	O
genes	O
are	O
semi-dominant	O
,	O
as	O
heterozygous	O
loss-of-function	O
mutation	O
in	O
these	O
genes	O
leads	O
to	O
phenotypic	O
abnormalities	O
.	O
This	O
condition,	O
known	O
as	O
haploinsufficiency,	O
has	O
been	O
described	O
for	O
five	O
of	O
the	O
nine	O
mammalian	DNA
Pax	DNA
genes	DNA
,	O
which	O
are	O
associated	O
with	O
mouse	O
developmental	O
mutants	O
and	O
human	O
disease	O
syndromes	O
.	O
Recently	O
we	O
have	O
reported	O
that	O
the	O
Pax5	DNA
gene	DNA
is	O
subject	O
to	O
allele	DNA
-specific	O
regulation	O
during	O
B	O
cell	O
development	O
.	O
Pax5	protein
is	O
predominantly	O
transcribed	O
from	O
only	O
one	O
of	O
its	O
two	O
alleles	DNA
in	O
early	cell_type
B-lymphoid	cell_type
progenitors	cell_type
and	O
mature	cell_type
B	cell_type
cells	cell_type
,	O
while	O
it	O
transiently	O
switches	O
to	O
a	O
biallelic	O
mode	O
of	O
transcription	O
in	O
pre-B	O
and	O
immature	O
B	O
cells	O
.	O
As	O
a	O
consequence,	O
B-lymphoid	O
tissues	O
are	O
mosaic	O
with	O
regard	O
to	O
the	O
transcribed	O
allele	DNA
,	O
and	O
heterozygous	O
mutation	O
of	O
Pax5	protein
therefore	O
results	O
in	O
deletion	O
of	O
B	cell_type
lymphocytes	cell_type
expressing	O
only	O
the	O
mutant	DNA
allele	DNA
.	O
The	O
allele	DNA
-specific	O
regulation	O
of	O
Pax5	protein
raises	O
the	O
intriguing	O
possibility	O
that	O
monoallelic	O
expression	O
may	O
also	O
be	O
the	O
mechanism	O
causing	O
the	O
haploinsufficiency	O
of	O
other	O
Pax	DNA
genes	DNA
.	O
In	O
this	O
review,	O
we	O
discuss	O
different	O
models	O
accounting	O
for	O
the	O
haploinsufficiency	O
of	O
mammalian	DNA
Pax	DNA
genes	DNA
,	O
provide	O
further	O
evidence	O
in	O
support	O
of	O
the	O
allele	DNA
-specific	O
regulation	O
of	O
Pax5	protein
and	O
discuss	O
the	O
implication	O
of	O
these	O
findings	O
in	O
the	O
context	O
of	O
the	O
recent	O
literature	O
describing	O
the	O
stochastic	O
and	O
monoallelic	O
activation	O
of	O
other	O
hematopoietic	DNA
genes	DNA
.	O

Activation	O
of	O
STAT5	protein
by	O
IL-4	protein
relies	O
on	O
Janus	protein
kinase	protein
function	O
but	O
not	O
on	O
receptor	O
tyrosine	O
phosphorylation	O
,	O
and	O
can	O
contribute	O
to	O
both	O
cell	O
proliferation	O
and	O
gene	O
regulation	O
.	O
We	O
have	O
investigated	O
mechanisms	O
and	O
consequences	O
of	O
STAT5	protein
activation	O
through	O
the	O
human	protein
IL-4	protein
receptor	protein
(	O
IL-4R	protein
).	O
By	O
functionally	O
expressing	O
receptor	protein
mutants	protein
in	O
the	O
murine	cell_line
pro-B	cell_line
cell	cell_line
line	cell_line
Ba/F3	cell_line
,	O
we	O
could	O
show	O
that	O
phosphorylated	O
tyrosine	O
residues	O
within	O
the	O
IL-4R	protein
alpha	protein
chain	protein
are	O
dispensable	O
for	O
IL-4	protein
-induced	O
STAT5	protein
activity	O
.	O
However,	O
disruption	O
of	O
a	O
membrane-proximal	protein
proline-rich	protein
sequence	protein
motif	protein
('	O
box1	protein
')	O
in	O
either	O
subunit	O
of	O
the	O
bipartite	protein
IL-4R	protein
abolished	O
not	O
only	O
ligand-induced	O
tyrosine	O
phosphorylation	O
of	O
Janus	protein
kinases	protein
JAK1	protein
and	O
JAK3	protein
,	O
but	O
also	O
IL-4	protein
-triggered	O
activation	O
of	O
STAT5	protein
and	O
concomitant	O
cell	O
proliferation	O
.	O
A	O
dominant-negative	protein
version	protein
of	O
STAT5b	protein
,	O
but	O
not	O
of	O
STAT5a	protein
,	O
interfered	O
with	O
IL-4	protein
-induced	O
DNA	O
synthesis	O
in	O
Ba/F3	cell_line
cells	cell_line
,	O
suggesting	O
an	O
involvement	O
of	O
STAT5b	protein
in	O
the	O
control	O
of	O
cell	O
proliferation	O
through	O
IL-4R	protein
.	O
Reporter	O
gene	O
experiments	O
finally	O
showed	O
that	O
transcription	O
from	O
promoters	O
of	O
STAT5	protein
target	O
genes	O
can	O
be	O
specifically	O
induced	O
by	O
challenging	O
cells	O
with	O
IL-4	protein
,	O
and	O
that	O
both	O
STAT5a	protein
and	O
STAT5b	protein
can	O
contribute	O
to	O
IL-4	protein
-triggered	O
transcriptional	O
control	O
.	O

Inhibition	O
of	O
NF-AT	protein
signal	O
transduction	O
events	O
by	O
a	O
dominant-negative	O
form	O
of	O
calcineurin	protein
.	O
An	O
inhibitory,	O
"dominant-negative,"	O
form	O
of	O
the	O
calcineurin	protein
catalytic	protein
(A)	protein
subunit	protein
was	O
prepared,	O
which	O
lacks	O
the	O
calmodulin	protein
-binding	protein
domain	protein
,	O
autoinhibitory	protein
domain	protein
and	O
most	O
of	O
its	O
catalytic	O
core	O
but	O
possesses	O
the	O
regulatory	protein
(B)	protein
subunit	protein
binding	O
domain.	O
When	O
tested	O
for	O
its	O
ability	O
to	O
block	O
calcineurin	protein
-dependent	O
signaling	O
in	O
Jurkat	O
cells,	O
expression	O
of	O
this	O
"B-subunit	DNA
knock-out"	DNA
(BKO)	DNA
construct	DNA
suppressed	O
reporter	DNA
gene	DNA
activity	O
driven	O
by	O
NF-AT	protein
,	O
the	O
pivotal	O
promoter	DNA
element	DNA
for	O
interleukin	DNA
(IL)-2	DNA
gene	DNA
induction	O
.	O
Immunoprecipitation	O
of	O
epitope-labeled	protein
BKO	protein
demonstrated	O
for	O
the	O
formation	O
of	O
a	O
tight	O
complex	O
with	O
endogenous	protein
B	protein
subunit	protein
in	O
Jurkat	cell_line
cells	cell_line
,	O
consistent	O
with	O
an	O
inhibitory	O
mechanism	O
that	O
involves	O
the	O
sequestration	O
of	O
the	O
B	protein
subunit	protein
.	O
Furthermore,	O
the	O
sharply	O
reduced	O
NF-AT	protein
activity	O
produced	O
by	O
co-transfecting	DNA
BKO	DNA
could	O
be	O
"rescued"	O
by	O
overexpression	O
of	O
transfected	O
B	protein
subunit	protein
,	O
suggesting	O
that	O
depletion	O
of	O
this	O
subunit	O
was	O
responsible	O
for	O
the	O
inhibition.	O
These	O
data	O
suggest	O
the	O
potential	O
utility	O
of	O
agents	O
that	O
disrupt	O
calcineurin	protein
-mediated	O
signal	O
transduction	O
pathways	O
by	O
blocking	O
formation	O
of	O
the	O
catalytically	protein
active	protein
dimer	protein
of	O
calcineurin	O
A	O
and	O
B	O
subunits	O
.	O

Evaluation	O
of	O
monoclonal	O
anti-D	O
reagents	O
using	O
D	cell_line
variant	cell_line
cells	cell_line
.	O
Monoclonal	protein
anti-D	protein
antibodies	protein
submitted	O
to	O
the	O
Third	O
Monoclonal	O
International	O
Workshop	O
were	O
evaluated	O
against	O
a	O
number	O
of	O
D	cell_line
variant	cell_line
cells	cell_line
using	O
standard	O
serological	O
techniques	O
.	O
The	O
monoclonal	protein
antibodies	protein
were	O
able	O
to	O
discriminate	O
between	O
the	O
cells	O
of	O
Categories	O
Va	O
,	O
VI	O
and	O
DFR	O
but	O
not	O
Category	O
III	O
cells	O
.	O
Cells	O
within	O
each	O
category	O
did	O
not	O
give	O
any	O
aberrant	O
results.	O
The	O
Rh:33	cell_line
cells	cell_line
behaved	O
as	O
normal	cell_type
Rh(D)	cell_type
positive	cell_type
cells	cell_type
.	O

Interleukin	protein
10	protein
induced	O
c-fos	DNA
expression	O
in	O
human	cell_type
B	cell_type
cells	cell_type
by	O
activation	O
of	O
divergent	protein
protein	protein
kinases	protein
.	O
IL-10	protein
is	O
a	O
potent	O
mediator	O
of	O
human	cell_type
B	cell_type
cell	cell_type
growth	O
and	O
plasma	O
cell	O
formation	O
.	O
However,	O
signal	O
transduction	O
of	O
IL-10	protein
in	O
B	cell_type
cells	cell_type
is	O
poorly	O
understood.	O
In	O
this	O
study	O
the	O
effect	O
of	O
IL-10	protein
on	O
the	O
expression	O
of	O
the	O
protooncogene	DNA
c-fos	DNA
was	O
investigated,	O
because	O
Fos	O
plays	O
a	O
potential	O
role	O
in	O
the	O
regulation	O
of	O
B	O
cell	O
proliferation	O
and	O
differentiation	O
.	O
B	cell_type
cells	cell_type
were	O
purified	O
from	O
buffy	O
coat	O
preparations	O
of	O
healthy	O
blood	O
donors	O
by	O
positive	O
selection	O
using	O
an	O
anti	protein
CD20	protein
monoclonal	protein
antibody	protein
and	O
a	O
MiniMACS	O
separation	O
unit	O
.	O
B	cell_type
cells	cell_type
were	O
prestimulated	O
with	O
SAC	O
for	O
48	O
hrs.	O
Then,	O
cells	O
were	O
incubated	O
with	O
medium	O
or	O
IL-10	protein
(100	O
ng/ml)	O
for	O
10	O
to	O
120	O
min.	O
RNA	RNA
was	O
extracted	O
by	O
phenol/chloroform	O
and	O
c-fos	DNA
expression	O
was	O
analyzed	O
by	O
PCR	O
assisted	O
mRNA	O
assay	O
.	O
A	O
significant	O
2-4	O
fold	O
increase	O
of	O
c-fos	DNA
expression	O
was	O
observed	O
within	O
30	O
min	O
of	O
stimulation	O
with	O
IL-10	protein
(p	O
&lt;	O
0.01).	O
After	O
2	O
hrs	O
c-fos	DNA
expression	O
declined	O
to	O
basal	O
levels.	O
The	O
effect	O
of	O
IL-10	protein
was	O
dose-dependent	O
with	O
a	O
maximum	O
stimulation	O
using	O
100	O
ng/ml	O
of	O
IL-10	protein
.	O
The	O
IL-10	protein
effect	O
on	O
c-fos	DNA
expression	O
was	O
not	O
blocked	O
by	O
polymyxin	O
B	O
.	O
Using	O
the	O
tyrosine	O
kinase	O
inhibitor	O
genistein	O
(10	O
microM)	O
a	O
complete	O
inhibition	O
of	O
IL-10	protein
induced	O
c-fos	DNA
expression	O
was	O
observed.	O
In	O
addition,	O
H-7	O
(10	O
microM),	O
a	O
specific	O
inhibitor	O
of	O
serine	protein
/threonine	protein
kinases	protein
,	O
significantly	O
blocked	O
IL-10	protein
mediated	O
c-fos	DNA
expression	O
(p	O
&lt;	O
0.05).	O
In	O
conclusion,	O
these	O
data	O
show	O
that	O
IL-10	protein
induces	O
c-fos	DNA
expression	O
in	O
human	cell_type
B-cells	cell_type
by	O
activation	O
of	O
tyrosine	O
and	O
serine	protein
/threonine	protein
kinases	protein
.	O
Since	O
this	O
is	O
the	O
first	O
report	O
on	O
IL-10	protein
induced	O
signal	O
transduction	O
,	O
these	O
data	O
may	O
help	O
to	O
identify	O
the	O
intracellular	O
mechanisms	O
by	O
which	O
IL-10	protein
stimulates	O
human	cell_type
B-cells	cell_type
.	O

Immunocytochemical	O
analysis	O
of	O
MNDA	protein
in	O
tissue	O
sections	O
and	O
sorted	O
normal	O
bone	O
marrow	O
cells	O
documents	O
expression	O
only	O
in	O
maturing	O
normal	O
and	O
neoplastic	O
myelomonocytic	O
cells	O
and	O
a	O
subset	O
of	O
normal	O
and	O
neoplastic	O
B	O
lymphocytes.	O
The	O
human	O
myeloid	O
cell	O
nuclear	O
differentiation	O
antigen	O
(	O
MNDA	protein
)	O
is	O
a	O
nuclear	O
antigen	O
known	O
to	O
be	O
expressed	O
in	O
mature	O
myelomonocytic	O
cell	O
lines.	O
An	O
extensive	O
immunocytochemical	O
evaluation	O
of	O
fixed	O
tissues	O
confirmed	O
MNDA	protein
expression	O
in	O
normal	cell_type
maturing	cell_type
granulocytes	cell_type
and	O
monocytes	cell_type
and	O
in	O
acute	O
nonlymphocytic	O
leukemias	O
and	O
chronic	O
myelogenous	O
leukemia	O
.	O
MNDA	protein
was	O
not	O
detected	O
in	O
normal	O
tissue	O
histiocytes	O
but	O
was	O
found	O
in	O
activated	cell_type
macrophages	cell_type
and	O
foreign	cell_type
body	cell_type
giant	cell_type
cells	cell_type
associated	O
with	O
inflammation	O
.	O
Flow	O
cytometric	O
cell	O
sorting	O
of	O
normal	O
bone	O
marrow	O
established	O
that	O
MNDA	protein
is	O
initially	O
expressed	O
in	O
myeloid	cell_type
blast	cell_type
cells	cell_type
.	O
Examination	O
of	O
lymphoid	O
tissues	O
showed	O
a	O
low	O
level	O
of	O
expression	O
in	O
a	O
population	O
of	O
normal	O
mande	cell_line
B	cell_line
lymphocytes	cell_line
but	O
not	O
in	O
germinal	cell_type
center	cell_type
cells	cell_type
or	O
plasma	cell_type
cells	cell_type
.	O
A	O
subset	O
of	O
B	cell_type
cell	cell_type
neoplasms	cell_type
expressing	O
MNDA	protein
included	O
hairy	O
cell	O
leukemia	O
,	O
parafollicular	O
(monocytoid)	O
B	O
cell	O
lymphoma	O
,	O
mantle	O
cell	O
lymphoma	O
,	O
and	O
small	O
lymphocytic	O
lymphoma	O
.	O
Cell	O
sorting	O
of	O
normal	O
bone	O
marrow	O
showed	O
MNDA	protein
expression	O
in	O
CD20	protein
+/CD10-/CD5-	O
B	cell_type
cells	cell_type
.	O
MNDA	protein
was	O
not	O
detected	O
in	O
other	O
normal	O
bone	O
marrow	O
or	O
all	O
other	O
nonhematopoietic	cell_type
cells	cell_type
.	O
The	O
hematopoietic	O
cell-specific	O
pattern	O
of	O
MNDA	protein
expression	O
was	O
elucidated	O
through	O
a	O
comprehensive	O
analysis	O
of	O
normal	O
and	O
neoplastic	O
tissues,	O
and	O
the	O
results	O
provide	O
further	O
evidence	O
of	O
the	O
coexpression	O
of	O
B-	O
and	O
myeloid	O
cell	O
markers	O
in	O
neoplastic	cell_type
B	cell_type
cells	cell_type
and	O
identify	O
a	O
normal	cell_type
B	cell_type
cell	cell_type
population	cell_type
that	O
might	O
be	O
related	O
to	O
the	O
cell	O
of	O
origin	O
of	O
a	O
subset	O
of	O
B	cell_type
cell	cell_type
neoplasms	cell_type
.	O

Peroxisome	protein
proliferator-activated	protein
receptor	protein
activators	protein
target	O
human	cell_type
endothelial	cell_type
cells	cell_type
to	O
inhibit	O
leukocyte	cell_type
-endothelial	cell_type
cell	cell_type
interaction	O
.	O
An	O
early	O
event	O
in	O
acute	O
and	O
chronic	O
inflammation	O
and	O
associated	O
diseases	O
such	O
as	O
atherosclerosis	O
and	O
rheumatoid	O
arthritis	O
is	O
the	O
induced	O
expression	O
of	O
specific	O
adhesion	protein
molecules	protein
on	O
the	O
surface	O
of	O
endothelial	cell_type
cells	cell_type
(	O
ECs	cell_type
),	O
which	O
subsequently	O
bind	O
leukocytes	cell_type
.	O
Peroxisome	protein
proliferator-activated	protein
receptors	protein
(	O
PPARs	protein
),	O
members	O
of	O
the	O
nuclear	protein
receptor	protein
superfamily	protein
of	O
transcription	protein
factors	protein
,	O
are	O
activated	O
by	O
fatty	O
acid	O
metabolites	O
,	O
peroxisome	O
proliferators	O
,	O
and	O
thiazolidinediones	O
and	O
are	O
now	O
recognized	O
as	O
important	O
mediators	O
in	O
the	O
inflammatory	O
response	O
.	O
Whether	O
PPAR	O
activators	O
influence	O
the	O
inflammatory	O
responses	O
of	O
ECs	cell_type
is	O
unknown.	O
We	O
show	O
that	O
the	O
PPAR	O
activators	O
15-deoxy-Delta(12,14)-prostaglandin	O
J(2)	O
(	O
15d-PGJ(2)	O
),	O
Wyeth	O
14643	O
,	O
ciglitazone	O
,	O
and	O
troglitazone	O
,	O
but	O
not	O
BRL	O
49653	O
,	O
partially	O
inhibit	O
the	O
induced	O
expression	O
of	O
vascular	protein
cell	protein
adhesion	protein
molecule-1	protein
(	O
VCAM-1	protein
),	O
as	O
measured	O
by	O
ELISA	O
,	O
and	O
monocyte	O
binding	O
to	O
human	cell_type
aortic	cell_type
endothelial	cell_type
cells	cell_type
(	O
HAECs	cell_type
)	O
activated	O
by	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
or	O
lipopolysaccharide	O
.	O
The	O
"natural"	O
PPAR	O
activator	O
15d-PGJ(2)	O
had	O
the	O
greatest	O
potency	O
and	O
was	O
the	O
only	O
tested	O
molecule	O
capable	O
of	O
partially	O
inhibiting	O
the	O
induced	O
expression	O
of	O
E-selectin	protein
and	O
neutrophil-like	O
HL60	cell_line
cell	cell_line
binding	O
to	O
PMA	O
-activated	O
HAECs	cell_type
.	O
Intracellular	protein
adhesion	protein
molecule-1	protein
induction	O
by	O
PMA	O
was	O
unaffected	O
by	O
any	O
of	O
the	O
molecules	O
tested.	O
Both	O
PPAR-alpha	RNA
and	RNA
PPAR-gamma	RNA
mRNAs	RNA
were	O
detected	O
in	O
HAECs	cell_type
by	O
using	O
reverse	O
transcription-polymerase	O
chain	O
reaction	O
and	O
a	O
ribonuclease	protein
protection	O
assay	O
;	O
however,	O
we	O
have	O
yet	O
to	O
determine	O
which,	O
if	O
any,	O
of	O
the	O
PPARs	protein
are	O
mediating	O
this	O
process.	O
These	O
results	O
suggest	O
that	O
certain	O
PPAR	O
activators	O
may	O
help	O
limit	O
chronic	O
inflammation	O
mediated	O
by	O
VCAM-1	protein
and	O
monocytes	cell_type
without	O
affecting	O
acute	O
inflammation	O
mediated	O
by	O
E-selectin	protein
and	O
neutrophil	cell_type
binding	O
.	O

Dephosphorylation	O
of	O
ZAP-70	protein
and	O
inhibition	O
of	O
T	O
cell	O
activation	O
by	O
activated	protein
SHP1	protein
.	O
Studies	O
with	O
motheaten	O
mice	O
,	O
which	O
lack	O
the	O
SHP1	protein
protein	protein
tyrosine	protein
phosphatase	protein
,	O
indicate	O
that	O
this	O
enzyme	O
plays	O
an	O
important	O
negative	O
role	O
in	O
T	protein
cell	protein
antigen	protein
receptor	protein
(	O
TCR	protein
)	O
signaling	O
.	O
The	O
physiological	O
substrates	O
for	O
SHP1	protein
in	O
T	cell_type
lymphocytes	cell_type
,	O
however,	O
have	O
remained	O
unclear	O
or	O
controversial.	O
To	O
define	O
these	O
targets	O
for	O
SHP1	protein
we	O
have	O
compared	O
the	O
effects	O
of	O
constitutively	O
active	O
and	O
inactive	O
mutants	O
of	O
SHP1	protein
on	O
TCR	protein
signaling	O
.	O
Expression	O
of	O
wild-type	protein
SHP1	protein
had	O
a	O
very	O
small	O
effect	O
on	O
the	O
TCR-induced	O
tyrosine	O
phosphorylation	O
of	O
ZAP-70	protein
and	O
Syk	protein
,	O
even	O
when	O
SHP1	protein
was	O
overexpressed	O
20	O
-	O
100-fold	O
over	O
endogenous	protein
SHP1	protein
.	O
Inactive	protein
SHP1	protein
-D421A	protein
and	O
wild-type	protein
SHP2	protein
were	O
without	O
effects.	O
Constitutively	protein
active	protein
SHP1	protein
-DeltaSH2	protein
had	O
a	O
more	O
pronounced	O
effect	O
on	O
ZAP-70	protein
and	O
Syk	protein
,	O
even	O
when	O
expressed	O
at	O
near	O
physiological	O
levels	O
.	O
SHP1	protein
-DeltaSH2	protein
also	O
inhibited	O
events	O
downstream	O
of	O
ZAP-70	protein
and	O
Syk	protein
,	O
such	O
as	O
activation	O
of	O
the	O
mitogen-activated	protein
protein	protein
kinase	protein
Erk2	protein
and	O
the	O
transcriptional	O
activation	O
of	O
the	O
interleukin-2	DNA
gene	DNA
.	O
In	O
contrast,	O
a	O
constitutively	O
active	O
SHP2-DeltaSH2	protein
had	O
no	O
statistically	O
significant	O
effect	O
(although	O
it	O
caused	O
a	O
slight	O
augmentation	O
in	O
some	O
individual	O
experiments).	O
None	O
of	O
the	O
constructs	O
influenced	O
the	O
anti-CD3-induced	O
tyrosine	O
phosphorylation	O
of	O
the	O
TCR	protein
zeta-chain	protein
or	O
phospholipase	protein
Cgamma1	protein
,	O
indicating	O
that	O
Src	protein
family	protein
kinase	protein
function	O
was	O
intact.	O
Taken	O
together,	O
our	O
findings	O
support	O
the	O
notion	O
that	O
ZAP-70	protein
and	O
Syk	protein
can	O
be	O
direct	O
substrates	O
for	O
SHP1	protein
in	O
intact	O
cells.	O
However,	O
the	O
two	O
SH2	protein
domains	protein
of	O
SHP1	protein
did	O
not	O
facilitate	O
its	O
recognition	O
of	O
ZAP-70	protein
and	O
Syk	protein
as	O
substrates	O
in	O
intact	O
cells.	O
Therefore,	O
we	O
suggest	O
that	O
SHP1	protein
is	O
not	O
actively	O
recruited	O
to	O
inhibit	O
TCR	protein
signaling	O
induced	O
by	O
ligation	O
of	O
this	O
receptor	O
alone.	O
Instead,	O
we	O
propose	O
that	O
ligation	O
of	O
a	O
distinct	O
inhibitory	protein
receptor	protein
leads	O
to	O
the	O
recruitment	O
of	O
SHP1	protein
via	O
its	O
SH2	protein
domains	protein
,	O
activation	O
of	O
SHP1	protein
and	O
subsequently	O
inhibition	O
of	O
TCR	protein
signals	O
if	O
the	O
inhibitory	protein
receptor	protein
is	O
juxtaposed	O
to	O
the	O
TCR	protein
.	O

Immune	O
responses	O
to	O
adenoviruses	O
:	O
viral	O
evasion	O
mechanisms	O
and	O
their	O
implications	O
for	O
the	O
clinic.	O
Adenoviruses	O
encode	O
proteins	O
that	O
block	O
responses	O
to	O
interferons	protein
,	O
intrinsic	O
cellular	O
apoptosis	O
,	O
killing	O
by	O
CD8(+)	cell_type
cytotoxic	cell_type
T	cell_type
lymphocytes	cell_type
and	O
killing	O
by	O
the	O
death	protein
ligands	protein
TNF	protein
,	O
Fas	protein
ligand	protein
and	O
TRAIL	protein
.	O
The	O
viral	protein
proteins	protein
are	O
believed	O
to	O
prolong	O
acute	O
and	O
persistent	O
adenovirus	O
infections	O
.	O
The	O
proteins	O
may	O
prove	O
useful	O
in	O
protecting	O
adenovirus	DNA
gene	DNA
therapy	DNA
vectors	DNA
and	O
transplanted	cell_line
cells	cell_line
from	O
the	O
immune	O
system	O
.	O

C/EBPbeta	protein
and	O
GATA-1	protein
synergistically	O
regulate	O
activity	O
of	O
the	O
eosinophil	DNA
granule	DNA
major	DNA
basic	DNA
protein	DNA
promoter	DNA
:	O
implication	O
for	O
C/EBPbeta	protein
activity	O
in	O
eosinophil	O
gene	O
expression	O
.	O
Eosinophil	protein
granule	protein
major	protein
basic	protein
protein	protein
(	O
MBP	protein
)	O
is	O
expressed	O
exclusively	O
in	O
eosinophils	cell_type
and	O
basophils	cell_type
in	O
hematopoietic	cell_type
cells	cell_type
.	O
In	O
our	O
previous	O
study,	O
we	O
demonstrated	O
a	O
major	O
positive	O
regulatory	O
role	O
for	O
GATA-1	protein
and	O
a	O
negative	O
regulatory	O
role	O
for	O
GATA-2	protein
in	O
MBP	protein
gene	O
transcription	O
.	O
Further	O
analysis	O
of	O
the	O
MBP	DNA
promoter	DNA
region	DNA
identified	O
a	O
C/EBP	DNA
(	DNA
CCAAT/enhancer-binding	DNA
protein	DNA
)	DNA
consensus	DNA
binding	DNA
site	DNA
6	O
bp	O
upstream	O
of	O
the	O
functional	O
GATA-binding	DNA
site	DNA
in	O
the	O
MBP	DNA
gene	DNA
.	O
In	O
the	O
cell	cell_line
line	cell_line
HT93A	cell_line
,	O
which	O
is	O
capable	O
of	O
differentiating	O
towards	O
both	O
the	O
eosinophil	cell_type
and	O
neutrophil	O
lineages	O
in	O
response	O
to	O
retinoic	O
acid	O
(	O
RA	O
),	O
C/EBPalpha	RNA
mRNA	RNA
expression	O
decreased	O
significantly	O
concomitant	O
with	O
eosinophilic	O
and	O
neutrophilic	O
differentiation	O
,	O
whereas	O
C/EBPbeta	protein
expression	O
was	O
markedly	O
increased.	O
Electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSAs	O
)	O
showed	O
that	O
recombinant	O
C/EBPbeta	protein
protein	O
could	O
bind	O
to	O
the	O
potential	O
C/EBP-binding	DNA
site	DNA
(	O
bp	DNA
-90	DNA
to	DNA
-82	DNA
)	O
in	O
the	O
MBP	protein
promoter.	O
Furthermore,	O
we	O
have	O
demonstrated	O
that	O
both	O
C/EBPbeta	protein
and	O
GATA-1	protein
can	O
bind	O
simultaneously	O
to	O
the	O
C/EBP-	O
and	O
GATA-binding	DNA
sites	DNA
in	O
the	O
MBP	DNA
promoter	DNA
.	O
To	O
determine	O
the	O
functionality	O
of	O
both	O
the	O
C/EBP-	O
and	O
GATA-	O
binding	O
sites	O
,	O
we	O
analyzed	O
whether	O
C/EBPbeta	protein
and	O
GATA-1	protein
can	O
stimulate	O
the	O
MBP	DNA
promoter	DNA
in	O
the	O
C/EBPbeta	cell_line
and	cell_line
GATA-1	cell_line
negative	cell_line
Jurkat	cell_line
T-cell	cell_line
line	cell_line
.	O
Cotransfection	O
with	O
C/EBPbeta	O
and	O
GATA-1	O
expression	O
vectors	O
produced	O
a	O
5-fold	O
increase	O
compared	O
with	O
cotransfection	O
with	O
the	O
C/EBPbeta	protein
or	O
GATA-1	DNA
expression	DNA
vectors	DNA
individually.	O
In	O
addition,	O
GST	protein
pull-down	O
experiments	O
demonstrated	O
a	O
physical	O
interaction	O
between	O
human	O
GATA-1	protein
and	O
C/EBPbeta	protein
.	O
Expression	O
of	O
FOG	protein
(	O
riend	protein
ATA	protein
),	O
which	O
binds	O
to	O
GATA-1	protein
and	O
acts	O
as	O
a	O
cofactor	O
for	O
GATA-binding	protein
proteins	protein
,	O
decreased	O
transactivation	O
activity	O
of	O
GATA-1	protein
for	O
the	O
MBP	DNA
promoter	DNA
in	O
a	O
dose-dependent	O
manner.	O
Our	O
results	O
provide	O
the	O
first	O
evidence	O
that	O
both	O
GATA-1	protein
and	O
C/EBPbeta	protein
synergistically	O
transactivate	O
the	O
promoter	DNA
of	O
an	O
eosinophil-specific	DNA
granule	DNA
protein	DNA
gene	DNA
and	O
that	O
FOG	protein
may	O
act	O
as	O
a	O
negative	O
cofactor	O
for	O
the	O
eosinophil	cell_type
lineage	cell_type
,	O
unlike	O
its	O
positively	O
regulatory	O
function	O
for	O
the	O
erythroid	O
and	O
megakaryocyte	O
lineages	O
.	O

Tissue-specific	O
regulation	O
of	O
the	O
ecto-5'-nucleotidase	DNA
promoter	DNA
.	O
Role	O
of	O
the	O
camp	DNA
response	DNA
element	DNA
site	DNA
in	O
mediating	O
repression	O
by	O
the	O
upstream	DNA
regulatory	DNA
region	DNA
.	O
We	O
have	O
isolated	O
the	O
5'	DNA
region	DNA
of	O
the	O
ecto-5'-nucleotidase	DNA
(low	DNA
K(m)	DNA
5'-NT)	DNA
gene	DNA
and	O
established	O
that	O
a	O
969-base	DNA
pair	DNA
(bp)	DNA
fragment	DNA
confers	O
cell-specific	O
expression	O
of	O
a	O
CAT	DNA
reporter	DNA
gene	DNA
that	O
correlates	O
with	O
the	O
expression	O
of	O
endogenous	RNA
ecto-5'-NT	RNA
mRNA	RNA
and	O
enzymatic	O
activity	O
.	O
A	O
768-bp	DNA
upstream	DNA
negative	DNA
regulatory	DNA
region	DNA
has	O
been	O
identified	O
that	O
conferred	O
lymphocyte-specific	O
negative	O
regulation	O
in	O
a	O
heterologous	O
system	O
with	O
a	O
244-bp	DNA
deoxycytidine	DNA
kinase	DNA
core	DNA
promoter	DNA
.	O
DNase	protein
I	protein
footprinting	O
identified	O
several	O
protected	O
areas	O
including	O
Sp1	O
,	O
Sp1/AP-2	O
,	O
and	O
cAMP	O
response	O
element	O
(CRE)	O
binding	O
sites	O
within	O
the	O
201-bp	O
core	O
promoter	O
region	O
and	O
Sp1	O
,	O
NRE-2a	O
,	O
TCF-1/LEF-1	O
,	O
and	O
Sp1/NF-AT	O
binding	O
sites	O
in	O
the	O
upstream	DNA
regulatory	DNA
region	DNA
.	O
Whereas	O
the	O
CRE	DNA
site	DNA
was	O
essential	O
in	O
mediating	O
the	O
negative	O
activity	O
of	O
the	O
upstream	DNA
regulatory	DNA
region	DNA
in	O
Jurkat	cell_line
but	O
not	O
in	O
HeLa	cell_line
cells	cell_line
,	O
mutation	O
of	O
the	O
Sp1/AP-2	DNA
site	DNA
decreased	O
promoter	O
activity	O
in	O
both	O
cell	O
lines.	O
Electrophoretic	O
mobility	O
shift	O
assay	O
analysis	O
of	O
proteins	O
binding	O
to	O
the	O
CRE	DNA
site	DNA
identified	O
both	O
ATF-1	protein
and	O
ATF-2	protein
in	O
Jurkat	cell_line
cells	cell_line
.	O
Finally,	O
phorbol	O
12-myristate	O
13-acetate	O
increased	O
the	O
activity	O
of	O
both	O
the	O
core	O
and	O
the	O
969-bp	DNA
promoter	DNA
fragments	DNA
,	O
and	O
this	O
increase	O
was	O
abrogated	O
by	O
mutations	O
at	O
the	O
CRE	DNA
site	DNA
.	O
In	O
summary,	O
we	O
have	O
identified	O
a	O
tissue-specific	DNA
regulatory	DNA
region	DNA
5'	O
of	O
the	O
ecto-5'-NT	DNA
core	DNA
promoter	DNA
that	O
requires	O
the	O
presence	O
of	O
a	O
functional	O
CRE	DNA
site	DNA
within	O
the	O
basal	DNA
promoter	DNA
for	O
its	O
suppressive	O
activity	O
.	O

Extracellular	O
signal-regulated	O
protein	O
kinase	O
(ERK)-dependent	O
and	O
ERK-independent	O
pathways	O
target	O
STAT3	protein
on	O
serine-727	O
in	O
human	O
neutrophils	O
stimulated	O
by	O
chemotactic	protein
factors	protein
and	O
cytokines	protein
.	O
STAT3	protein
(	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
3	protein
)	O
is	O
a	O
latent	O
transcription	O
factor	O
that	O
is	O
activated	O
by	O
tyrosine	O
phosphorylation	O
(	O
Tyr-705	O
)	O
in	O
cells	O
stimulated	O
with	O
cytokines	protein
or	O
growth	protein
factors	protein
.	O
Recent	O
studies	O
suggest	O
that	O
one	O
or	O
more	O
cytoplasmic	protein
serine	protein
kinases	protein
also	O
phosphorylate	O
STAT3	protein
and	O
are	O
necessary	O
for	O
maximal	O
gene	O
activation	O
.	O
Here	O
we	O
demonstrate,	O
with	O
a	O
site-specific	O
antibody,	O
that	O
STAT3	protein
is	O
phosphorylated	O
on	O
Ser-727	O
in	O
human	cell_type
neutrophils	cell_type
stimulated	O
with	O
chemotactic	protein
factors	protein
(	O
N-formyl-methionyl-leucyl-phenylalanine	O
and	O
complement	O
C5a	O
),	O
cytokines	protein
[	O
granulocyte/macrophage	protein
colony-stimulating	protein
factor	protein
(	O
GM-CSF	protein
)	O
and	O
granulocyte	protein
colony-stimulating	protein
factor	protein
(	O
G-CSF	protein
)],	O
or	O
a	O
protein	protein
kinase	protein
C	protein
activator	O
(	O
PMA	O
).	O
(2-Amino-3'-methoxyphenyl)oxanaphthalen-4-one	O
(	O
PD	O
98059	O
),	O
an	O
inhibitor	O
of	O
extracellular	O
signal-regulated	protein
protein	protein
kinase	protein
(	O
ERK	protein
)	O
activation	O
,	O
blocked	O
the	O
serine	O
phosphorylation	O
of	O
STAT3	protein
induced	O
by	O
chemotactic	protein
factors	protein
or	O
PMA	O
.	O
The	O
drug	O
was	O
less	O
effective	O
on	O
cytokines	protein
:	O
it	O
virtually	O
abolished	O
the	O
response	O
to	O
GM-CSF	protein
that	O
occurred	O
5	O
min	O
after	O
stimulation	O
but	O
only	O
partly	O
decreased	O
those	O
at	O
15-30	O
min	O
and	O
did	O
not	O
appreciably	O
alter	O
responses	O
to	O
G-CSF	protein
regardless	O
of	O
incubation	O
time.	O
1-(5-Isoquinolinylsulphonyl)-2-methylpiperazine	O
dihydrochloride	O
(	O
H7	O
),	O
an	O
inhibitor	O
of	O
a	O
putative	O
STAT3	protein
serine	protein
kinase	protein
,	O
and	O
4-(4-fluorophenyl)-2-(4-methylsulphinylphenyl)-5-(4-pyridyl)	O
1H-imidazole	O
(	O
SB	O
203580	O
),	O
an	O
inhibitor	O
of	O
p38	protein
mitogen-activated	protein
protein	protein
(MAP)	protein
kinase	protein
,	O
did	O
not	O
dampen	O
any	O
of	O
these	O
serine	O
phosphorylation	O
responses	O
.	O
We	O
propose	O
that	O
neutrophils	cell_type
use	O
both	O
ERK-dependent	O
and	O
ERK-independent	O
pathways	O
to	O
phosphorylate	O
Ser-727	O
on	O
STAT3	protein
.	O
The	O
former	O
pathway	O
is	O
recruited	O
by	O
all	O
ERK	protein
-activating	O
stimuli	O
,	O
whereas	O
the	O
latter	O
pathway	O
uses	O
an	O
undefined	O
serine	protein
kinase	protein
and	O
is	O
recruited	O
selectively	O
by	O
cytokines	protein
.	O

GATA	protein
transcription	protein
factors	protein
associate	O
with	O
a	O
novel	O
class	O
of	O
nuclear	O
bodies	O
in	O
erythroblasts	cell_type
and	O
megakaryocytes	cell_type
.	O
The	O
nuclear	O
distribution	O
of	O
GATA	protein
transcription	protein
factors	protein
in	O
murine	cell_type
haemopoietic	cell_type
cells	cell_type
was	O
examined	O
by	O
indirect	O
immunofluorescence	O
.	O
Specific	O
bright	O
foci	O
of	O
GATA-1	protein
fluorescence	O
were	O
observed	O
in	O
erythroleukaemia	cell_type
cells	cell_type
and	O
primary	cell_type
murine	cell_type
erythroblasts	cell_type
and	O
megakaryocytes	cell_type
,	O
in	O
addition	O
to	O
diffuse	O
nucleoplasmic	O
localization	O
.	O
These	O
foci,	O
which	O
were	O
preferentially	O
found	O
adjacent	O
to	O
nucleoli	O
or	O
at	O
the	O
nuclear	O
periphery,	O
did	O
not	O
represent	O
sites	O
of	O
active	O
transcription	O
or	O
binding	O
of	O
GATA-1	protein
to	O
consensus	DNA
sites	DNA
in	O
the	O
beta-globin	DNA
loci	DNA
.	O
Immunoelectron	O
microscopy	O
demonstrated	O
the	O
presence	O
of	O
intensely	O
labelled	O
structures	O
likely	O
to	O
represent	O
the	O
GATA-1	protein
foci	O
seen	O
by	O
immunofluorescence	O
.	O
The	O
GATA-1	protein
nuclear	O
bodies	O
differed	O
from	O
previously	O
described	O
nuclear	O
structures	O
and	O
there	O
was	O
no	O
co-localization	O
with	O
nuclear	protein
antigens	protein
involved	O
in	O
RNA	O
processing	O
or	O
other	O
ubiquitous	protein
(	protein
Spl	protein
,	protein
c-Jun	protein
and	protein
TBP	protein
)	protein
or	protein
haemopoietic	protein
(NF-E2)	protein
transcription	protein
factors	protein
.	O
Interestingly,	O
GATA-2	protein
and	O
GATA-3	protein
proteins	protein
also	O
localized	O
to	O
the	O
same	O
nuclear	O
bodies	O
in	O
cell	O
lines	O
co-expressing	O
GATA	O
-1	O
and	O
-2	O
or	O
GATA	O
-1	O
and	O
-3	O
gene	O
products	O
.	O
This	O
pattern	O
of	O
distribution	O
is,	O
thus	O
far,	O
unique	O
to	O
the	O
GATA	protein
transcription	protein
factors	protein
and	O
suggests	O
a	O
protein-protein	O
interaction	O
with	O
other	O
components	O
of	O
the	O
nuclear	O
bodies	O
via	O
the	O
GATA	protein
zinc	protein
finger	protein
domain	protein
.	O

Energy	O
substrates,	O
hormone	O
responses	O
and	O
glucocorticoid	O
binding	O
in	O
lymphocytes	cell_type
during	O
intense	O
physical	O
exercise	O
in	O
humans	O
following	O
phosphocreatine	O
administration	O
.	O
Eight	O
healthy	O
untrained	O
male	O
volunteers	O
pedalled	O
a	O
cycle	O
ergometer	O
according	O
to	O
two	O
exercise	O
protocols:	O
the	O
first	O
involved	O
step-wise	O
increasing	O
physical	O
exercise	O
to	O
maximal	O
(	O
MPE	O
);	O
the	O
second	O
involved	O
prolonged	O
(35	O
min)	O
submaximal	O
physical	O
exercise	O
(	O
PPE	O
)	O
at	O
70%	O
of	O
the	O
individual's	O
maximal	O
oxygen	O
uptake	O
.	O
Each	O
volunteer	O
performed	O
these	O
exercise	O
twice,	O
following	O
either	O
an	O
intravenous	O
injection	O
of	O
phosphocreatine	O
(	O
PCr	O
)	O
or	O
a	O
placebo	O
of	O
an	O
isotonic	O
NaCl	O
solution	O
.	O
Anaerobic	O
threshold	O
(	O
AT	O
)	O
was	O
determined	O
from	O
the	O
point	O
of	O
departure	O
of	O
the	O
ventilatory	O
response	O
from	O
linearity	O
and	O
from	O
the	O
sudden	O
increase	O
in	O
venous	O
blood	O
lactate	O
concentrations	O
during	O
MPE	O
.	O
After	O
exercise	O
following	O
placebo	O
administration	O
we	O
observed	O
increases	O
in	O
concentrations	O
of	O
blood	O
substrates	O
,	O
plasma	protein
adrenocorticotropin	protein
(	O
ACTH	protein
),	O
growth	O
hormone	O
and	O
cortisol	O
and	O
in	O
the	O
number	O
of	O
glucocorticoid	protein
receptors	protein
in	O
lymphocytes	cell_type
without	O
changes	O
in	O
the	O
dissociation	O
constant.	O
Intravenous	O
administration	O
of	O
PCr	O
(starting	O
1	O
day	O
before	O
exercise)	O
led	O
to	O
an	O
increase	O
in	O
the	O
total	O
workload	O
(on	O
average	O
by	O
5.8%)	O
and	O
in	O
AT	O
(on	O
average	O
by	O
6.8%)	O
during	O
MPE	O
and	O
to	O
a	O
better	O
tolerance	O
of	O
exercise	O
during	O
PPE	O
.	O
Following	O
PCr	O
administration	O
we	O
observed	O
lower	O
blood	O
lactate	O
concentrations	O
and	O
different	O
patterns	O
of	O
some	O
enzyme	O
activities,	O
less	O
pronounced	O
changes	O
in	O
plasma	protein
ACTH	protein
and	O
cortisol	O
concentrations	O
and	O
in	O
glucocorticoid	O
binding	O
in	O
lymphocytes	cell_type
,	O
but	O
no	O
changes	O
in	O
plasma	O
growth	O
hormone	O
concentrations	O
compared	O
to	O
the	O
placebo	O
.	O
The	O
results	O
showed	O
that	O
intense	O
physical	O
exercise	O
led	O
not	O
only	O
to	O
increases	O
in	O
blood	O
hormone	O
concentrations	O
but	O
also	O
to	O
an	O
increase	O
in	O
the	O
density	O
of	O
glucocorticoid	protein
receptors	protein
in	O
lymphocytes	cell_type
.	O
Intravenous	O
PCr	O
injection	O
led	O
to	O
smaller	O
changes	O
in	O
ACTH	protein
and	O
cortisol	O
concentrations	O
as	O
well	O
as	O
to	O
a	O
lower	O
activation	O
of	O
glucocorticoid	O
binding	O
in	O
lymphocytes	cell_type
.	O

Putative	protein
steroid	protein
binding	protein
domain	protein
of	O
the	O
human	protein
mineralocorticoid	protein
receptor	protein
,	O
expressed	O
in	O
E.	O
coli	O
in	O
the	O
presence	O
of	O
heat	protein
shock	protein
proteins	protein
shows	O
typical	O
native	O
receptor	O
characteristics.	O
Domain	protein
E	protein
,	O
considered	O
as	O
the	O
putative	protein
hormone	protein
binding	protein
domain	protein
(	O
HBD	protein
)	O
of	O
the	O
human	protein
mineralocorticoid	protein
receptor	protein
(	O
hMR	protein
)	O
was	O
expressed	O
in	O
Escherichia	O
coli	O
as	O
a	O
fusion	O
protein	O
with	O
either	O
maltose	protein
binding	protein
protein	protein
(	O
MBP	protein
)	O
or	O
glutathione	protein
S-transferase	protein
(	O
GST	protein
).	O
These	O
bacterially-produced	DNA
MR	DNA
constructs	DNA
had	O
no	O
steroid	O
binding	O
activity	O
per	O
se.	O
In	O
fact,	O
heat	protein
shock	protein
protein	protein
association	O
(	O
hsp	protein
)	O
is	O
required	O
for	O
high	O
affinity	O
ligand-binding	O
of	O
the	O
MR	protein
.	O
After	O
incubation	O
of	O
purified	O
MBP-	O
or	O
GST-	O
HBD	O
with	O
rabbit	O
reticulocyte	O
lysate	O
,	O
known	O
to	O
be	O
rich	O
in	O
heat	protein
shock	protein
proteins	protein
,	O
we	O
obtained	O
saturable	O
binding	O
of	O
[3H]aldosterone	O
.	O
The	O
Kd	O
value	O
for	O
aldosterone	O
was	O
0.3	O
nM	O
and	O
the	O
Bmax	O
=	O
32	O
pmol/mg.	O
Hormone	O
binding	O
specificity	O
was	O
assessed	O
by	O
competition	O
studies	O
with	O
various	O
steroid	O
ligands.	O
Sucrose	O
gradient	O
assays	O
performed	O
with	O
[3H]aldosterone	protein
-MBP-HBD	protein
revealed	O
complex	O
sedimenting	O
at	O
8.3S	O
and	O
4.9S	O
with	O
[3H]progesterone-MBP-HBD	protein
.	O
Western-blot	O
analysis	O
of	O
the	O
sedimentation	O
peak	O
showed	O
the	O
concomitant	O
presence	O
of	O
MBP-HBD	protein
by	O
a	O
monoclonal	protein
anti-MBP	protein
antibody	protein
,	O
and	O
hsp90	protein
by	O
a	O
monoclonal	protein
anti-hsp	protein
antibody	protein
.	O
Moreover,	O
following	O
incubation	O
with	O
the	O
anti-rabbit	protein
hsp90	protein
monoclonal	protein
antibody	protein
the	O
sedimenting	O
gradient	O
showed	O
a	O
10.4S	protein
sedimenting	protein
complex	protein
.	O
These	O
analyses	O
demonstrated	O
that	O
the	O
[3H]aldosterone	O
-	O
MBP-HBD	protein
complex	protein
is	O
at	O
least	O
associated	O
with	O
hsp90	protein
in	O
reticulocyte	O
lysate	O
and	O
that	O
the	O
HBD	protein
of	O
hMR	protein
is	O
sufficient	O
to	O
bind	O
hsp90	protein
.	O
Deletions	O
of	O
a	O
relatively	O
short	O
amino-	O
(729-766)	O
or	O
carboxy-	O
terminal	O
(940-984)	O
region	O
of	O
the	O
HBD	protein
fragment	protein
eliminated	O
all	O
steroid-binding	O
properties	O
.	O
Overall,	O
these	O
results	O
indicate	O
that	O
the	O
integrity	O
of	O
domain	protein
E	protein
is	O
necessary	O
and	O
sufficient	O
to	O
bind	O
steroid	O
ligands,	O
agonists	O
or	O
antagonists,	O
with	O
characteristics	O
similar	O
to	O
the	O
entire	O
native	O
MR	protein
.	O

Renal	O
cell	O
carcinoma-derived	O
gangliosides	O
suppress	O
nuclear	protein
factor-kappaB	protein
activation	O
in	O
T	cell_type
cells	cell_type
.	O
Activation	O
of	O
the	O
transcription	protein
factor	protein
nuclear	protein
factor-kappaB	protein
(	O
NFkappaB	protein
)	O
is	O
impaired	O
in	O
T	cell_type
cells	cell_type
from	O
patients	O
with	O
renal	O
cell	O
carcinomas	O
(	O
RCCs	O
).	O
In	O
circulating	O
T	cell_type
cells	cell_type
from	O
a	O
subset	O
of	O
patients	O
with	O
RCCs	O
,	O
the	O
suppression	O
of	O
NFkappaB	protein
binding	O
activity	O
is	O
downstream	O
from	O
the	O
stimulus-induced	O
degradation	O
of	O
the	O
cytoplasmic	protein
factor	protein
IkappaBalpha	protein
.	O
Tumor-derived	protein
soluble	protein
products	protein
from	O
cultured	O
RCC	O
explants	O
inhibit	O
NFkappaB	protein
activity	O
in	O
T	cell_type
cells	cell_type
from	O
healthy	O
volunteers	O
,	O
despite	O
a	O
normal	O
level	O
of	O
stimulus-induced	O
IkappaBalpha	protein
degradation	O
in	O
these	O
cells.	O
The	O
inhibitory	O
agent	O
has	O
several	O
features	O
characteristic	O
of	O
a	O
ganglioside	O
,	O
including	O
sensitivity	O
to	O
neuraminidase	protein
but	O
not	O
protease	protein
treatment	O
;	O
hydrophobicity	O
;	O
and	O
molecular	O
weight	O
less	O
than	O
3	O
kDa.	O
Indeed,	O
we	O
detected	O
gangliosides	O
in	O
supernatants	O
from	O
RCC	cell_type
explants	cell_type
and	O
not	O
from	O
adjacent	O
normal	O
kidney	O
tissue	O
.	O
Gangliosides	O
prepared	O
from	O
RCC	O
supernatants	O
,	O
as	O
well	O
as	O
the	O
purified	O
bovine	O
gangliosides	O
G(m1)	O
and	O
G(d1a),	O
suppressed	O
NFkappaB	protein
binding	O
activity	O
in	O
T	cell_type
cells	cell_type
and	O
reduced	O
expression	O
of	O
the	O
cytokines	protein
IL-2	protein
and	O
IFN-gamma	protein
.	O
Taken	O
together,	O
our	O
findings	O
suggest	O
that	O
tumor-derived	O
gangliosides	O
may	O
blunt	O
antitumor	O
immune	O
responses	O
in	O
patients	O
with	O
RCCs	O
.	O

Nuclear	protein
factor-kappaB	protein
-dependent	O
induction	O
of	O
interleukin-8	protein
gene	O
expression	O
by	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
:	O
evidence	O
for	O
an	O
antioxidant	O
sensitive	O
activating	O
pathway	O
distinct	O
from	O
nuclear	O
translocation	O
.	O
Tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNFalpha	protein
)	O
is	O
a	O
pluripotent	O
activator	O
of	O
inflammation	O
by	O
inducing	O
a	O
proinflammatory	protein
cytokine	protein
cascade	O
.	O
This	O
phenomenon	O
is	O
mediated,	O
in	O
part,	O
through	O
inducible	O
expression	O
of	O
the	O
CXC	protein
chemokine	protein
,	O
interleukin-8	protein
(IL-8).	O
In	O
this	O
study,	O
we	O
investigate	O
the	O
role	O
of	O
TNFalpha	protein
-inducible	O
reactive	O
oxygen	O
species	O
(ROS)	O
in	O
IL-8	protein
expression	O
by	O
"monocyte-like"	O
U937	cell_line
histiocytic	cell_line
lymphoma	cell_line
cells	cell_line
.	O
TNFalpha	protein
is	O
a	O
rapid	O
activator	O
of	O
IL-8	DNA
gene	DNA
expression	O
by	O
U937	cell_line
,	O
producing	O
a	O
50-fold	O
induction	O
of	O
mRNA	RNA
within	O
1	O
hour	O
of	O
treatment.	O
In	O
gene	O
transfection	O
assays,	O
the	O
effect	O
of	O
TNFalpha	protein
requires	O
the	O
presence	O
of	O
an	O
inducible	DNA
nuclear	DNA
factor-kappaB	DNA
(	DNA
NF-kappaB	DNA
)	DNA
(	DNA
Rel	DNA
A	DNA
)	DNA
binding	DNA
site	DNA
in	O
the	O
IL-8	DNA
promoter	DNA
.	O
TNFalpha	protein
treatment	O
induces	O
a	O
rapid	O
translocation	O
of	O
the	O
65	protein
kD	protein
transcriptional	protein
activator	protein
NF-kappaB	protein
subunit	protein
,	O
Rel	protein
A	protein
,	O
whose	O
binding	O
in	O
the	O
nucleus	O
occurs	O
before	O
changes	O
in	O
intracellular	O
ROS	O
.	O
Pretreatment	O
(or	O
up	O
to	O
15	O
minutes	O
posttreatment)	O
relative	O
to	O
TNFalpha	protein
with	O
the	O
antioxidant	O
dimethyl	O
sulfoxide	O
(	O
DMSO	O
)	O
(2%	O
[vol/vol])	O
blocks	O
80%	O
of	O
NF-kappaB	protein
-dependent	O
transcription	O
.	O
Surprisingly,	O
however,	O
DMSO	O
has	O
no	O
effect	O
on	O
inducible	O
Rel	protein
A	protein
binding.	O
Similar	O
selective	O
effects	O
on	O
NF-kappaB	protein
transcription	O
are	O
seen	O
with	O
the	O
unrelated	O
antioxidants,	O
N-acetylcysteine	O
(	O
NAC	O
)	O
and	O
vitamin	O
C	O
.	O
These	O
data	O
indicate	O
that	O
TNFalpha	protein
induces	O
a	O
delayed	O
ROS-dependent	O
signalling	O
pathway	O
that	O
is	O
required	O
for	O
NF-kappaB	protein
transcriptional	O
activation	O
and	O
is	O
separable	O
from	O
that	O
required	O
for	O
its	O
nuclear	O
translocation	O
.	O
Further	O
definition	O
of	O
this	O
pathway	O
will	O
yield	O
new	O
insights	O
into	O
inflammation	O
initiated	O
by	O
TNFalpha	protein
signalling	O
.	O

Gender	O
and	O
vascular	O
reactivity	O
.	O
Estrogen	protein
receptors	protein
are	O
found	O
on	O
vascular	O
endothelial	O
and	O
smooth	O
muscle	O
cells	O
;	O
their	O
expression	O
is	O
influenced	O
by	O
exposure	O
to	O
the	O
hormone.	O
Estrogen	protein
receptors	protein
influence	O
non-genomic	O
events	O
,	O
which	O
are	O
rapid	O
in	O
onset	O
and	O
genomic	O
events	O
,	O
which	O
are	O
longer	O
acting	O
responses.	O
Estrogens	O
affect	O
vascular	O
tone	O
indirectly	O
by	O
modulating	O
release	O
of	O
endothelium-derived	protein
vasoactive	protein
factors	protein
and	O
directly	O
by	O
modulating	O
intracellular	O
calcium	O
in	O
vascular	cell_type
smooth	cell_type
muscle	cell_type
cells	cell_type
.	O
Estrogens	O
indirectly	O
affect	O
thrombotic	O
events	O
and	O
inflammation	O
by	O
altering	O
platelet	cell_type
aggregation	O
and	O
leukocyte	cell_type
adherence	O
and	O
migration	O
,	O
respectively.	O
Estrogens	O
also	O
influence	O
production	O
of	O
mitogens	O
which,	O
when	O
released	O
at	O
sites	O
of	O
vascular	O
injury	O
,	O
affect	O
vascular	O
remodeling	O
.	O
Although	O
estrogens	O
initiate	O
vascular	O
responses	O
,	O
genomic	O
sex	O
may	O
influence	O
and/or	O
limit	O
expression	O
of	O
estrogen	O
receptors	O
and	O
therefore	O
actions	O
of	O
sex	O
steroid	O
hormones	O
throughout	O
the	O
vasculature	O
.	O

Induction	O
of	O
a	O
functional	O
vitamin	protein
D	protein
receptor	protein
in	O
all-trans-retinoic	O
acid	O
-induced	O
monocytic	O
differentiation	O
of	O
M2-type	cell_line
leukemic	cell_line
blast	cell_line
cells	cell_line
.	O
Different	O
types	O
of	O
acute	cell_type
myeloid	cell_type
leukemia	cell_type
blast	cell_type
cells	cell_type
were	O
induced	O
to	O
differentiate	O
in	O
vitro	O
with	O
all-trans-retinoic	O
acid	O
(	O
ATRA	O
)	O
and	O
vitamin	O
D3	O
(	O
VD	O
).	O
M0/M1	cell_line
leukemic	cell_line
cells	cell_line
are	O
not	O
sensitive	O
to	O
differentiating	O
agents	O
,	O
whereas	O
M3	cell_line
leukemic	cell_line
cells	cell_line
are	O
induced	O
to	O
undergo	O
granulocytic	O
differentiation	O
after	O
ATRA	O
treatment	O
but	O
are	O
not	O
sensitive	O
to	O
VD	O
.	O
M2	cell_line
leukemic	cell_line
blast	cell_line
cells	cell_line
behave	O
differently	O
because	O
they	O
undergo	O
monocytic	O
differentiation	O
with	O
both	O
the	O
differentiation	O
inducers.	O
To	O
gain	O
some	O
insight	O
into	O
the	O
maturation	O
of	O
M2-type	cell_type
leukemic	cell_type
cells	cell_type
,	O
we	O
studied	O
the	O
molecular	O
mechanisms	O
underlying	O
monocytic	O
differentiation	O
induced	O
by	O
ATRA	O
and	O
VD	O
in	O
spontaneous	O
M2	cell_line
blast	cell_line
cells	cell_line
as	O
well	O
as	O
in	O
Kasumi-1	cell_line
cells	cell_line
(an	O
acute	cell_line
myeloid	cell_line
leukemia	cell_line
M2-type	cell_line
cell	cell_line
line	cell_line
).	O
Our	O
results	O
indicate	O
that	O
ATRA	O
as	O
well	O
as	O
VD	O
efficiently	O
increases	O
the	O
nuclear	O
abundance	O
of	O
VD	protein
receptor	protein
(	O
VDR	protein
)	O
and	O
promotes	O
monocytic	O
differentiation.	O
VDR	protein
is	O
functionally	O
active	O
in	O
ATRA	O
-treated	O
Kasumi-1	cell_line
cells	cell_line
because	O
it	O
efficiently	O
heterodimerizes	O
with	O
retinoid	protein
X	protein
receptor	protein
,	O
binds	O
to	O
a	O
DR3-type	DNA
vitamin	DNA
D-responsive	DNA
element	DNA
,	O
and	O
activates	O
the	O
transcription	O
of	O
a	O
vitamin	DNA
D-responsive	DNA
element-regulated	DNA
reporter	DNA
gene	DNA
.	O
Consistent	O
with	O
these	O
findings,	O
VD	DNA
-responsive	DNA
genes	DNA
are	O
induced	O
by	O
ATRA	O
treatment	O
of	O
Kasumi-1	cell_line
cells	cell_line
,	O
suggesting	O
that	O
the	O
genetic	O
program	O
underlying	O
monocytic	O
differentiation	O
is	O
activated.	O
The	O
molecular	O
mechanism	O
by	O
which	O
ATRA	O
increases	O
the	O
nuclear	O
abundance	O
of	O
a	O
functional	O
VDR	protein
is	O
still	O
unknown,	O
but	O
our	O
data	O
clearly	O
indicate	O
that	O
the	O
M2	cell_line
leukemic	cell_line
cell	cell_line
context	O
is	O
only	O
permissive	O
of	O
monocytic	O
differentiation	O
.	O

Protein	protein
kinase	protein
C	protein
and	O
calcineurin	protein
synergize	O
to	O
activate	O
IkappaB	protein
kinase	protein
and	O
NF-kappaB	protein
in	O
T	cell_type
lymphocytes	cell_type
.	O
The	O
nuclear	O
factor	O
of	O
kappaB	O
(	O
NF-kappaB	protein
)	O
is	O
a	O
ubiquitous	protein
transcription	protein
factor	protein
that	O
is	O
key	O
in	O
the	O
regulation	O
of	O
the	O
immune	O
response	O
and	O
inflammation	O
.	O
T	protein
cell	protein
receptor	protein
(	O
TCR	protein
)	O
cross-linking	O
is	O
in	O
part	O
required	O
for	O
activation	O
of	O
NF-kappaB	protein
,	O
which	O
is	O
dependent	O
on	O
the	O
phosphorylation	O
and	O
degradation	O
of	O
IkappaBalpha	protein
.	O
By	O
using	O
Jurkat	cell_line
and	O
primary	cell_type
human	cell_type
T	cell_type
lymphocytes	cell_type
,	O
we	O
demonstrate	O
that	O
the	O
simultaneous	O
activation	O
of	O
two	O
second	O
messengers	O
of	O
the	O
TCR	protein
-initiated	O
signal	O
transduction	O
,	O
protein	protein
kinase	protein
C	protein
(	O
PKC	protein
)	O
and	O
calcineurin	protein
,	O
results	O
in	O
the	O
synergistic	O
activation	O
of	O
the	O
IkappaBalpha	protein
kinase	protein
(IKK)	protein
complex	protein
but	O
not	O
of	O
another	O
putative	protein
IkappaBalpha	protein
kinase	protein
,	O
p90(rsk)	protein
.	O
We	O
also	O
demonstrate	O
that	O
the	O
IKK	protein
complex	protein
,	O
but	O
not	O
p90(rsk)	protein
,	O
is	O
responsible	O
for	O
the	O
in	O
vivo	O
phosphorylation	O
of	O
IkappaBalpha	protein
mediated	O
by	O
the	O
co-activation	O
of	O
PKC	protein
and	O
calcineurin	protein
.	O
Each	O
second	O
messenger	O
is	O
necessary,	O
as	O
inhibition	O
of	O
either	O
one	O
reverses	O
the	O
activation	O
of	O
the	O
IKK	protein
complex	protein
and	O
IkappaBalpha	protein
phosphorylation	O
in	O
vivo.	O
Overexpression	O
of	O
dominant	O
negative	O
forms	O
of	O
IKK	O
alpha	O
and	O
-beta	O
demonstrates	O
that	O
only	O
IKKbeta	protein
is	O
the	O
target	O
for	O
PKC	protein
and	O
calcineurin	protein
.	O
These	O
results	O
indicate	O
that	O
within	O
the	O
TCR	protein
/CD3	protein
signal	O
transduction	O
pathway	O
both	O
PKC	protein
and	O
calcineurin	protein
are	O
required	O
for	O
the	O
effective	O
activation	O
of	O
the	O
IKK	protein
complex	protein
and	O
NF-kappaB	protein
in	O
T	cell_type
lymphocytes	cell_type
.	O

Diminished	O
responses	O
to	O
IL-13	protein
by	O
human	O
monocytes	O
differentiated	O
in	O
vitro:	O
role	O
of	O
the	O
IL-13Ralpha1	protein
chain	protein
and	O
STAT6	protein
.	O
The	O
primary	O
IL-13	protein
receptor	protein
complex	protein
on	O
human	cell_type
monocytes	cell_type
is	O
believed	O
to	O
be	O
a	O
heterodimer	O
comprised	O
of	O
the	O
IL-4R	protein
alpha	protein
chain	protein
and	O
the	O
IL-2R	protein
gamma	protein
chain	protein
(gamma(c))-like	protein
molecule	protein
,	O
IL-13R	protein
alpha1	protein
.	O
mRNA	RNA
levels	O
for	O
IL-13R	protein
alpha1	protein
,	O
but	O
not	O
IL-4R	protein
alpha	protein
,	O
were	O
markedly	O
decreased	O
in	O
in	cell_line
vitro	cell_line
monocyte-derived	cell_line
macrophages	cell_line
(	O
MDMac	cell_line
),	O
and	O
with	O
increasing	O
time	O
of	O
monocytes	cell_type
in	O
culture	O
correlated	O
with	O
the	O
loss	O
of	O
IL-13	protein
regulation	O
of	O
lipopolysaccharide	O
-induced	O
TNF-alpha	protein
production	O
.	O
Analysis	O
of	O
cell	cell_line
lines	cell_line
Daudi	cell_line
and	O
THP-1	cell_line
that	O
differentially	O
express	O
gamma(c)	protein
and	O
IL-13R	protein
alpha1	protein
showed	O
that	O
IL-13	protein
can	O
activate	O
STAT6	protein
in	O
IL-13R	cell_line
alpha1	cell_line
-positive	cell_line
THP-1	cell_line
cells	cell_line
but	O
not	O
in	O
gamma(c)-positive,	cell_line
IL-13R	cell_line
alpha1	cell_line
-negative	cell_line
Daudi	cell_line
cells	cell_line
.	O
IL-13	protein
activation	O
of	O
STAT6	protein
was	O
reduced	O
in	O
MDMac	cell_line
which	O
was	O
associated	O
with	O
diminished	O
IL-13	protein
-induced	O
expression	O
of	O
CD23	protein
and	O
MHC	protein
class	protein
II	protein
.	O
However,	O
with	O
reduced	O
IL-13R	protein
alpha1	protein
expression	O
and	O
low	O
nuclear	O
STAT6	protein
activity	O
,	O
some	O
IL-13	protein
-induced	O
responses	O
were	O
unaltered	O
in	O
magnitude	O
in	O
MDMac	cell_line
.	O
In	O
the	O
absence	O
of	O
functional	O
IL-13R	protein
alpha1	protein
and	O
gamma(c)	protein
,	O
IL-13	protein
must	O
signal	O
through	O
an	O
alternative	O
receptor	protein
complex	protein
on	O
MDMac	cell_line
.	O
Experiments	O
with	O
a	O
blocking	O
antibody	O
to	O
IL-4R	protein
alpha	protein
showed	O
that	O
this	O
chain	O
remains	O
an	O
essential	O
component	O
of	O
the	O
IL-13	protein
receptor	protein
complex	protein
on	O
MDMac	cell_line
.	O

The	O
p53	protein
paradox	O
in	O
the	O
pathogenesis	O
of	O
tumor	O
progression	O
.	O
Recent	O
evidence	O
suggests	O
that	O
the	O
p53	protein
molecule	protein
appears	O
in	O
two	O
different	O
forms:	O
the	O
mutant	protein
p53	protein
that	O
stimulates	O
tumor	O
progression	O
,	O
and	O
wild	protein
type	protein
p53	protein
that	O
inhibits	O
tumor	O
progression	O
.	O
In	O
addition,	O
it	O
has	O
been	O
established	O
that	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
)	O
can	O
activate	O
the	O
expression	O
of	O
wild	protein
type	protein
p53	protein
in	O
concert	O
with	O
the	O
nuclear	protein
transcription	protein
factor	protein
,	O
NF-kappa	protein
B	protein
.	O
Both	O
TNF-alpha	protein
and	O
NF-kappa	protein
B	protein
are	O
also	O
involved	O
in	O
the	O
stimulation	O
of	O
the	O
pathway	O
that	O
leads	O
to	O
the	O
expression	O
of	O
major	protein
histocompatibility	protein
complex	protein
(MHC)	protein
class	protein
I	protein
molecules	protein
and,	O
hence,	O
antigen	O
presentation	O
to	O
the	O
T	cell_type
cells	cell_type
.	O
In	O
this	O
paper	O
we	O
shall	O
advance	O
the	O
hypothesis	O
that:	O
(i)	O
TNF-alpha	protein
indirectly	O
controls	O
immune	O
surveillance	O
;	O
and	O
(ii)	O
TNF-alpha	protein
controls	O
DNA	O
repair	O
and	O
tumor	O
suppression	O
through	O
the	O
regulation	O
of	O
wild	protein
type	protein
p53	protein
.	O
Thus,	O
it	O
is	O
hypothesized	O
that	O
elevated	O
TNF-alpha	protein
is	O
primarily	O
responsible	O
for	O
promoting	O
tumor	O
progression	O
.	O

The	O
promoter	DNA
and	O
5'	DNA
flanking	DNA
sequences	DNA
controlling	O
human	O
B29	DNA
gene	DNA
expression	O
.	O
The	O
product	O
of	O
the	O
B-cell-specific	DNA
B29	DNA
gene	DNA
(	O
B29	protein
,	O
Ig	protein
beta	protein
,	O
CD79b	protein
)	O
is	O
essential	O
for	O
Ig-mediated	O
B-cell	O
activation	O
via	O
the	O
B-cell	protein
antigen	protein
receptor	protein
complex	protein
(	O
BCR	protein
)	O
on	O
human	O
and	O
murine	O
B	O
lymphocytes	O
.	O
To	O
better	O
understand	O
the	O
regulation	O
of	O
this	O
pivotal	O
gene,	O
we	O
have	O
analyzed	O
the	O
human	DNA
genomic	DNA
DNA	DNA
sequence	DNA
upstream	O
of	O
the	O
B29	protein
ATG	DNA
start	DNA
codon	DNA
for	O
transcriptional	O
control	O
activity	O
.	O
The	O
human	O
B29	DNA
gene	DNA
lacks	O
either	O
a	O
TATA	O
or	O
a	O
CAAT	O
box	O
and	O
transcription	O
is	O
initiated	O
at	O
multiple	DNA
sites	DNA
.	O
The	O
minimal	O
promoter	O
of	O
the	O
human	DNA
B29	DNA
gene	DNA
is	O
contained	O
within	O
a	O
193-bp	DNA
region	DNA
5'	O
of	O
these	O
multiple	DNA
start	DNA
sites	DNA
.	O
This	O
minimal	DNA
promoter	DNA
exhibits	O
B-cell-specific	O
activity	O
and	O
contains	O
SP1	O
,	O
ETS	O
,	O
OCT	O
,	O
and	O
IKAROS/LYF-1	O
transcription	O
factor	O
motifs	O
.	O
All	O
these	O
motifs	O
are	O
strikingly	O
conserved	O
in	O
sequence	O
and	O
placement	O
relative	O
to	O
the	O
previously	O
characterized	O
murine	DNA
B29	DNA
promoter	DNA
.	O
Additional	O
upstream	O
gene	O
segments	O
dramatically	O
affected	O
B29	protein
minimal	DNA
promoter	DNA
activity	O
.	O
A	O
newly	O
identified	O
motif	O
called	O
the	O
B29	DNA
conserved	DNA
sequence	DNA
(	O
BCS	DNA
),	O
found	O
upstream	O
of	O
both	O
human	DNA
and	DNA
murine	DNA
B29	DNA
promoters	DNA
,	O
appears	O
to	O
stimulate	O
B29	protein
transcription	O
through	O
a	O
novel	O
mechanism.	O
A	O
single	O
BCS	DNA
had	O
little	O
effect	O
either	O
on	O
the	O
minimal	O
B29	DNA
promoter	DNA
or	O
on	O
a	O
heterologous	O
promoter.	O
Instead,	O
the	O
BCS	DNA
stimulated	O
transcription	O
by	O
counteracting	O
5'	DNA
negative	DNA
regulatory	DNA
DNA	DNA
sequences	DNA
that	O
block	O
the	O
activity	O
of	O
the	O
B29	protein
minimal	DNA
promoter	DNA
in	O
its	O
absence.	O
These	O
findings	O
indicate	O
that	O
B29	DNA
gene	DNA
expression	O
is	O
controlled	O
by	O
the	O
complex	O
interplay	O
of	O
positive	O
and	O
negative	DNA
regulatory	DNA
elements	DNA
.	O

A	O
novel	O
immunosuppressive	protein
factor	protein
in	O
bovine	O
colostrum	O
blocks	O
activation	O
of	O
the	O
interleukin	DNA
2	DNA
gene	DNA
enhancer	DNA
at	O
the	O
NFAT	DNA
site	DNA
.	O
A	O
factor	O
in	O
bovine	O
colostrum	O
(	O
colostrum	protein
inhibitory	protein
factor	protein
,	O
CIF	protein
)	O
inhibits	O
interleukin	protein
2	protein
(	O
IL2	protein
)	O
production	O
in	O
activated	O
T	cell_type
helper	cell_type
cells	cell_type
by	O
blocking	O
the	O
accumulation	O
of	O
IL2	RNA
mRNA	RNA
.	O
To	O
determine	O
whether	O
CIF	protein
blocks	O
at	O
the	O
level	O
of	O
IL2	protein
transcription	O
,	O
we	O
introduced	O
reporter	O
plasmids	O
into	O
the	O
human	cell_line
T	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
Jurkat	cell_line
by	O
transient	O
transfection	O
.	O
These	O
contained	O
the	O
luciferase	DNA
gene	DNA
under	O
the	O
control	O
of	O
either	O
the	O
human	DNA
IL2	DNA
upstream	DNA
enhancer	DNA
region	O
(segments	O
-326	O
to	O
+45)	O
or	O
three	O
repeats	O
of	O
the	O
NFAT	DNA
element	DNA
contained	O
within	O
it	O
(segments	O
-255	O
to	O
-285).	O
Expression	O
of	O
luciferase	protein
in	O
these	O
cells	O
was	O
induced	O
by	O
phorbol	O
myristate	O
acetate	O
plus	O
a	O
calcium	O
ionophore	O
.	O
CIF	protein
inhibited	O
induction	O
of	O
either	O
construct	O
as	O
did	O
cyclosporine	O
,	O
which	O
is	O
known	O
to	O
block	O
activation	O
of	O
the	O
NFAT	protein
element	protein
.	O
CIF	protein
failed	O
to	O
inhibit	O
several	O
other	O
enhancer	DNA
elements	DNA
.	O
The	O
NFAT-controlled	DNA
luciferase	DNA
gene	DNA
system	DNA
distinguishes	O
CIF	protein
from	O
other	O
T	O
cell	O
inhibitory	O
activities	O
present	O
in	O
colostrum	O
,	O
in	O
particular,	O
TGF	protein
beta	protein
1	protein
and	O
TGF	protein
beta	protein
2	protein
and	O
the	O
glucocorticoids	O
.	O
Stably	O
transfected	O
Jurkat	O
cells	O
behaved	O
similarly	O
to	O
the	O
transiently	O
transfected	O
ones	O
with	O
respect	O
to	O
inhibition	O
by	O
CIF	protein
and	O
cyclosporine	O
.	O
The	O
NFAT	protein
-luc	O
assay	O
is	O
a	O
useful	O
technique	O
for	O
the	O
rapid,	O
sensitive	O
measurement	O
of	O
CIF	protein
or	O
other	O
immunosuppressants	O
with	O
a	O
similar	O
mode	O
of	O
action.	O

Heat	O
shock	O
induces	O
HIV-1	O
replication	O
in	O
chronically	O
infected	O
promyelocyte	cell_line
cell	cell_line
line	cell_line
OM10.1	cell_line
.	O
A	O
long	O
period	O
of	O
clinical	O
latency	O
before	O
development	O
of	O
symptoms	O
is	O
characteristic	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
infection	O
.	O
OM10.1	cell_line
,	O
a	O
promyelocyte	cell_line
cell	cell_line
line	cell_line
latently	O
infected	O
with	O
HIV-1	O
,	O
has	O
been	O
developed	O
as	O
a	O
model	O
for	O
studying	O
the	O
mechanism	O
of	O
viral	O
latency	O
and	O
the	O
activation	O
of	O
virus	O
expression	O
.	O
We	O
found	O
that	O
this	O
latently	O
infected	O
cell	O
line	O
with	O
heat	O
shock	O
at	O
42	O
degrees	O
C	O
for	O
2	O
h	O
resulted	O
in	O
a	O
high	O
level	O
of	O
HIV-1	O
production	O
without	O
addition	O
of	O
any	O
cytokines	protein
.	O
The	O
mechanism	O
of	O
activation	O
was	O
analyzed	O
by	O
using	O
anti-TNF-alpha	protein
antibody	protein
and	O
various	O
inhibitors.	O
Although	O
the	O
TNF-alpha	protein
level	O
in	O
culture	O
supernatants	O
was	O
below	O
the	O
sensitivity	O
of	O
an	O
ELISA	O
assay	O
system	O
,	O
addition	O
of	O
anti-	O
TNF-alpha	protein
antibody	O
in	O
culture	O
medium	O
could	O
partially	O
suppress	O
the	O
heat	O
shock	O
induced	O
HIV-1	O
production	O
.	O
Staurosporine	O
(	O
PKC	O
inhibitor	O
),	O
pentoxifylline	O
(	O
NF-kappa	O
B	O
inhibitor	O
),	O
and	O
Ro5-3335	O
(	O
HIV-1	O
Tat	protein
inhibitor	O
)	O
also	O
inhibited	O
significantly	O
the	O
heat	O
shock	O
induced	O
virus	O
activation	O
.	O
In	O
particular,	O
staurosporine	O
achieved	O
approximately	O
90%	O
inhibition	O
of	O
the	O
HIV-1	O
antigen	O
expression	O
in	O
heat	cell_line
shock	cell_line
-treated	cell_line
OM10.1	cell_line
at	O
a	O
non-toxic	O
concentration	O
.	O
Although	O
the	O
mechanism	O
of	O
HIV-1	O
activation	O
with	O
heat	O
shock	O
has	O
not	O
been	O
fully	O
elucidated	O
yet,	O
it	O
is	O
presumed	O
PKC	protein
plays	O
an	O
important	O
role	O
in	O
HIV-1	O
activation	O
.	O
Thus,	O
the	O
present	O
observations	O
will	O
provide	O
a	O
further	O
insight	O
into	O
the	O
pathogenesis	O
of	O
HIV-1	O
infections	O
.	O

Activation	O
of	O
the	O
CDC42	protein
effector	protein
N-WASP	protein
by	O
the	O
Shigella	protein
flexneri	protein
IcsA	protein
protein	protein
promotes	O
actin	protein
nucleation	O
by	O
Arp2/3	protein
complex	protein
and	O
bacterial	O
actin	protein
-based	O
motility	O
.	O
To	O
propel	O
itself	O
in	O
infected	cell_type
cells	cell_type
,	O
the	O
pathogen	O
Shigella	O
flexneri	O
subverts	O
the	O
Cdc42	protein
-controlled	O
machinery	O
responsible	O
for	O
actin	protein
assembly	O
during	O
filopodia	O
formation	O
.	O
Using	O
a	O
combination	O
of	O
bacterial	O
motility	O
assays	O
in	O
platelet	O
extracts	O
with	O
Escherichia	O
coli	O
expressing	O
the	O
Shigella	protein
IcsA	protein
protein	protein
and	O
in	O
vitro	O
analysis	O
of	O
reconstituted	O
systems	O
from	O
purified	protein
proteins	protein
,	O
we	O
show	O
here	O
that	O
the	O
bacterial	protein
protein	protein
IcsA	protein
binds	O
N-WASP	protein
and	O
activates	O
it	O
in	O
a	O
Cdc42	protein
-like	O
fashion	O
.	O
Dramatic	O
stimulation	O
of	O
actin	protein
assembly	O
is	O
linked	O
to	O
the	O
formation	O
of	O
a	O
ternary	O
IcsA-	protein
N-WASP	protein
-	protein
Arp2/3	protein
complex	protein
,	O
which	O
nucleates	O
actin	protein
polymerization	O
.	O
The	O
Arp2/3	protein
complex	protein
is	O
essential	O
in	O
initiation	O
of	O
actin	protein
assembly	O
and	O
Shigella	O
movement,	O
as	O
previously	O
observed	O
for	O
Listeria	O
monocytogenes	O
.	O
Activation	O
of	O
N-WASP	protein
by	O
IcsA	protein
unmasks	O
two	O
domains	O
acting	O
together	O
in	O
insertional	O
actin	protein
polymerization	O
.	O
The	O
isolated	O
COOH-terminal	protein
domain	protein
of	O
N-WASP	protein
containing	O
a	O
verprolin-homology	protein
region	protein
,	O
a	O
cofilin-homology	O
sequence	O
,	O
and	O
an	O
acidic	protein
terminal	protein
segment	protein
(	O
VCA	protein
)	O
interacts	O
with	O
G-actin	protein
in	O
a	O
unique	O
profilin-like	O
functional	O
fashion.	O
Hence,	O
when	O
N-WASP	protein
is	O
activated,	O
its	O
COOH-terminal	protein
domain	protein
feeds	O
barbed	O
end	O
growth	O
of	O
filaments	O
and	O
lowers	O
the	O
critical	O
concentration	O
at	O
the	O
bacterial	O
surface	O
.	O
On	O
the	O
other	O
hand,	O
the	O
NH(2)-terminal	protein
domain	protein
of	O
N-WASP	protein
interacts	O
with	O
F-actin	protein
,	O
mediating	O
the	O
attachment	O
of	O
the	O
actin	protein
tail	protein
to	O
the	O
bacterium	O
surface	O
.	O
VASP	O
is	O
not	O
involved	O
in	O
Shigella	O
movement	O
,	O
and	O
the	O
function	O
of	O
profilin	protein
does	O
not	O
require	O
its	O
binding	O
to	O
proline	protein
-rich	protein
regions	protein
.	O

c-Maf	protein
induces	O
monocytic	O
differentiation	O
and	O
apoptosis	O
in	O
bipotent	cell_type
myeloid	cell_type
progenitors	cell_type
.	O
The	O
transcriptional	O
mechanisms	O
that	O
drive	O
colony-forming	cell_line
unit	cell_line
granulocyte-macrophage	cell_line
(CFU-GM)	cell_line
myeloid	cell_line
progenitors	cell_line
to	O
differentiate	O
into	O
cells	O
of	O
either	O
the	O
granulocytic	O
or	O
monocytic	O
lineage	O
are	O
not	O
fully	O
understood.	O
We	O
have	O
shown	O
that	O
the	O
c-Maf	protein
and	O
c-Myb	protein
transcription	protein
factors	protein
physically	O
interact	O
in	O
myeloid	O
cells	O
to	O
form	O
inhibitory	O
complexes	O
that	O
hinder	O
transactivation	O
of	O
c-Myb	DNA
target	DNA
genes	DNA
through	O
direct	O
binding	O
to	O
Myb	DNA
consensus	DNA
sites	DNA
.	O
These	O
complexes	O
arise	O
in	O
a	O
developmentally	O
regulated	O
pattern,	O
peaking	O
at	O
the	O
promyelocyte	cell_type
stage	cell_type
,	O
or	O
in	O
cell	cell_line
model	cell_line
systems	cell_line
,	O
appearing	O
soon	O
after	O
the	O
induction	O
of	O
monocytic	O
differentiation	O
.	O
We	O
wished	O
to	O
determine	O
if	O
this	O
developmentally	O
related	O
interaction	O
is	O
a	O
consequence	O
of	O
myeloid	O
differentiation	O
or	O
an	O
intrinsic	O
differentiating	O
stimulus	O
.	O
Because	O
the	O
elevated	O
Myb:Maf	protein
status	O
seen	O
in	O
differentiating	cell_type
cells	cell_type
can	O
be	O
recapitulated	O
by	O
overexpression	O
of	O
c-Maf	protein
in	O
myeloid	O
cell	O
lines,	O
we	O
inducibly	O
expressed	O
the	O
c-Maf	DNA
cDNA	DNA
in	O
2	O
bipotent	O
human	cell_type
myeloid	cell_type
progenitor	cell_type
cells	cell_type
.	O
Elevated	O
levels	O
of	O
c-Maf	protein
protein	protein
led	O
to	O
marked	O
increases	O
in	O
Myb:Maf	protein
complexes	protein
and	O
the	O
accumulation	O
of	O
monocyte/macrophage	cell_type
cells	cell_type
,	O
followed	O
by	O
eventual	O
programmed	O
cell	O
death	O
.	O
Analysis	O
of	O
targets	O
that	O
could	O
mediate	O
these	O
phenotypic	O
changes	O
indicated	O
that	O
c-Maf	protein
likely	O
plays	O
a	O
key	O
role	O
in	O
myeloid	O
cell	O
development	O
through	O
dual	O
mechanisms;	O
inhibition	O
of	O
a	O
select	O
set	O
of	O
c-Myb	protein
regulated	O
targets,	O
such	O
as	O
Bcl-2	protein
and	O
CD13/APN	protein
,	O
coupled	O
with	O
the	O
activation	O
of	O
as	O
yet	O
undefined	O
differentiation-promoting	DNA
genes	DNA
.	O

AML1	protein
(	protein
CBFalpha2	protein
)	protein
cooperates	O
with	O
B	protein
cell-specific	protein
activating	protein
protein	protein
(	protein
BSAP/PAX5	protein
)	protein
in	O
activation	O
of	O
the	O
B	DNA
cell-specific	DNA
BLK	DNA
gene	DNA
promoter	DNA
.	O
AML1	protein
plays	O
a	O
critical	O
role	O
during	O
hematopoiesis	O
and	O
chromosomal	O
translocations	O
involving	O
AML1	protein
are	O
commonly	O
associated	O
with	O
different	O
forms	O
of	O
leukemia	O
,	O
including	O
pre-B	O
acute	O
lymphoblastic	O
leukemia	O
.	O
To	O
understand	O
the	O
function	O
of	O
AML1	protein
during	O
B	cell_type
cell	cell_type
differentiation	O
,	O
we	O
analyzed	O
regulatory	DNA
regions	DNA
of	O
B	DNA
cell-specific	DNA
genes	DNA
for	O
potential	O
AML1	DNA
-binding	DNA
sites	DNA
and	O
have	O
identified	O
a	O
putative	O
AML1	DNA
-binding	DNA
site	DNA
in	O
the	O
promoter	O
of	O
the	O
B	DNA
cell-specific	DNA
tyrosine	DNA
kinase	DNA
gene,	DNA
blk	DNA
.	O
Gel	O
mobility	O
shift	O
assays	O
and	O
transient	O
transfection	O
assays	O
demonstrate	O
that	O
AML1	protein
binds	O
specifically	O
to	O
this	O
site	O
in	O
the	O
blk	DNA
promoter	DNA
and	O
this	O
binding	O
site	O
is	O
important	O
for	O
blk	DNA
promoter	O
activity	O
.	O
Furthermore,	O
in	O
vitro	O
binding	O
analysis	O
revealed	O
that	O
the	O
AML1	DNA
runt	DNA
DNA-binding	DNA
domain	DNA
physically	O
interacts	O
with	O
the	O
paired	DNA
DNA-binding	DNA
domain	DNA
of	O
BSAP	protein
,	O
a	O
B	protein
cell	protein
-specific	protein
transcription	protein
factor	protein
.	O
BSAP	protein
has	O
been	O
shown	O
previously	O
to	O
be	O
important	O
for	O
B	O
cell-specific	O
regulation	O
of	O
the	O
blk	DNA
gene.	O
Physical	O
interaction	O
of	O
AML1	protein
with	O
BSAP	protein
correlates	O
with	O
functional	O
cooperativity	O
in	O
transfection	O
studies	O
where	O
AML1	protein
and	O
BSAP	protein
synergistically	O
activate	O
blk	DNA
promoter	O
transcription	O
by	O
more	O
than	O
50-fold.	O
These	O
results	O
demonstrate	O
physical	O
and	O
functional	O
interactions	O
between	O
AML1	protein
and	O
BSAP	protein
and	O
suggest	O
that	O
AML1	protein
is	O
an	O
important	O
factor	O
for	O
regulating	O
a	O
critical	O
B	DNA
cell-specific	DNA
gene	DNA
,	O
blk	DNA
.	O

Transcriptional	O
inhibition	O
by	O
interleukin-6	protein
of	O
the	O
class	protein
A	protein
macrophage	protein
scavenger	protein
receptor	protein
in	O
macrophages	cell_type
derived	O
from	O
human	cell_type
peripheral	cell_type
monocytes	cell_type
and	O
the	O
THP-1	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
.	O
Expression	O
of	O
the	O
class	protein
A	protein
macrophage	protein
scavenger	protein
receptor	protein
(	protein
MSR	protein
)	protein
contributes	O
to	O
the	O
uptake	O
of	O
modified	protein
low	protein
density	protein
lipoproteins	protein
(	protein
LDL	protein
)	protein
by	O
macrophages	cell_type
and	O
transformation	O
of	O
these	O
cells	O
into	O
lipid-laden	cell_type
foam	cell_type
cells	cell_type
,	O
which	O
characterize	O
atherosclerosis	O
.	O
Many	O
environmental	O
factors,	O
in	O
particular,	O
proinflammatory	protein
cytokines	protein
and	O
growth	protein
factors	protein
,	O
can	O
exert	O
regulatory	O
effects	O
on	O
MSR	protein
expression	O
,	O
whereas	O
intracellular	O
accumulation	O
of	O
cholesterol	O
itself	O
does	O
not	O
influence	O
MSR	protein
levels	O
to	O
any	O
considerable	O
extent.	O
In	O
the	O
present	O
study,	O
by	O
using	O
an	O
in	O
vitro	O
model,	O
we	O
examined	O
whether	O
stimulation	O
with	O
interleukin-6	protein
(IL-6)	protein
,	O
an	O
immunoregulatory	protein
,	O
multipotential	protein
cytokine	protein
,	O
modulates	O
the	O
expression	O
and	O
activities	O
of	O
the	O
MSR	protein
in	O
macrophages	cell_type
.	O
When	O
treated	O
with	O
IL-6	protein
,	O
macrophages	cell_type
derived	O
from	O
peripheral	cell_type
monocytes	cell_type
and	O
phorbol	cell_line
12-myristate	cell_line
13-acetate	cell_line
(PMA)-differentiated	cell_line
THP-1	cell_line
monocytic	cell_line
cells	cell_line
showed	O
significantly	O
reduced	O
uptake	O
and/or	O
binding	O
of	O
the	O
MSR	protein
ligand,	O
acetylated	protein
LDL	protein
.	O
This	O
effect	O
was	O
paralleled	O
by	O
a	O
reduction	O
in	O
the	O
expression	O
of	O
MSR	protein
protein	O
and	O
mRNA	RNA
.	O
Analysis	O
of	O
MSR	DNA
promoter	DNA
activity	O
in	O
THP-1	cell_line
cells	cell_line
transfected	O
with	O
an	O
MSR	DNA
promoter-reporter	DNA
gene	DNA
construct	DNA
demonstrated	O
decreased	O
activity	O
of	O
the	O
MSR	DNA
promoter	DNA
in	O
IL-6	protein
-treated	O
THP-1	cell_line
macrophages	cell_type
.	O
Electrophoretic	O
mobility	O
gel	O
shift	O
assay	O
also	O
showed	O
a	O
reduction	O
in	O
the	O
binding	O
of	O
a	O
transcription	protein
factor	protein
to	O
the	O
MSR	DNA
promoter	DNA
AP-1/ets	DNA
elements	DNA
in	O
IL-6	protein
-treated	O
cells.	O
Thus,	O
exposure	O
to	O
IL-6	protein
may	O
inhibit	O
expression	O
of	O
the	O
class	protein
A	protein
MSR	protein
in	O
differentiated	O
macrophages	cell_type
at	O
transcriptional	O
levels.	O
This	O
result	O
suggests	O
that	O
this	O
cytokine	protein
may	O
modulate	O
foam	O
cell	O
formation	O
during	O
atherogenesis	O
.	O

Retinoblastoma	protein
protein	protein
expression	O
leads	O
to	O
reduced	O
Oct-1	protein
DNA	O
binding	O
activity	O
and	O
enhances	O
interleukin-8	protein
expression.	O
Tumor	O
cell	O
lines	O
with	O
a	O
defective	O
retinoblastoma	DNA
gene	DNA
are	O
unable	O
to	O
transcribe	O
the	O
HLA	DNA
class	DNA
II	DNA
genes	DNA
in	O
response	O
to	O
IFN-gamma	protein
treatment	O
,	O
and	O
reconstitution	O
of	O
functional	O
Rb	protein
rescues	O
IFN-gamma-induced	O
class	DNA
II	DNA
gene	DNA
expression	O
.	O
However,	O
the	O
molecular	O
mechanism	O
of	O
Rb	protein
rescue	O
of	O
the	O
class	DNA
II	DNA
genes	DNA
is	O
unknown.	O
We	O
have	O
examined	O
the	O
effect	O
of	O
Rb	protein
expression	O
on	O
the	O
activation	O
of	O
the	O
promoter	O
for	O
HLA-DRA	DNA
,	O
the	O
prototype	DNA
class	DNA
II	DNA
gene	DNA
.	O
Oct-1	protein
,	O
a	O
POU	protein
domain	protein
transcription	protein
factor	protein
,	O
was	O
identified	O
as	O
a	O
repressor	O
of	O
HLA-DRA	DNA
promoter	O
activity	O
in	O
the	O
Rb-defective	cell_type
cells	cell_type
.	O
Rb	protein
expression	O
led	O
to	O
phosphorylation	O
of	O
Oct-1	protein
,	O
thus	O
relieving	O
its	O
repressive	O
effect.	O
Oct-1	protein
has	O
also	O
been	O
shown	O
to	O
repress	O
interleukin	protein
8	protein
promoter	O
activity	O
.	O
Consistent	O
with	O
reduced	O
levels	O
of	O
Oct-1	protein
DNA	O
binding	O
activity	O
in	O
the	O
Rb-transformed	cell_line
cell	cell_line
lines	cell_line
,	O
interleukin	protein
8	protein
expression	O
is	O
higher	O
in	O
these	O
cell	O
lines.	O

Cell	O
activation	O
and	O
apoptosis	O
by	O
bacterial	protein
lipoproteins	protein
through	O
toll-like	protein
receptor-2	protein
.	O
Apoptosis	O
is	O
implicated	O
in	O
the	O
generation	O
and	O
resolution	O
of	O
inflammation	O
in	O
response	O
to	O
bacterial	O
pathogens	O
.	O
All	O
bacterial	O
pathogens	O
produce	O
lipoproteins	protein
(	protein
BLPs	protein
)	protein
,	O
which	O
trigger	O
the	O
innate	O
immune	O
response	O
.	O
BLPs	protein
were	O
found	O
to	O
induce	O
apoptosis	O
in	O
THP-1	cell_line
monocytic	cell_line
cells	cell_line
through	O
human	protein
Toll-like	protein
receptor-2	protein
(	protein
hTLR2	protein
)	protein
.	O
BLPs	protein
also	O
initiated	O
apoptosis	O
in	O
an	O
epithelial	cell_line
cell	cell_line
line	cell_line
transfected	O
with	O
hTLR2	protein
.	O
In	O
addition,	O
BLPs	protein
stimulated	O
nuclear	protein
factor-kappaB	protein
,	O
a	O
transcriptional	protein
activator	protein
of	O
multiple	DNA
host	DNA
defense	DNA
genes	DNA
,	O
and	O
activated	O
the	O
respiratory	O
burst	O
through	O
hTLR2	protein
.	O
Thus,	O
hTLR2	protein
is	O
a	O
molecular	O
link	O
between	O
microbial	O
products	O
,	O
apoptosis	O
,	O
and	O
host	O
defense	O
mechanisms	O
.	O

Possible	O
differences	O
in	O
the	O
mechanism(s)	O
of	O
action	O
of	O
different	O
glucocorticoid	O
hormone	O
compounds	O
.	O
Different	O
glucocorticoid	O
hormones	O
(	O
GCH	O
)	O
show	O
differences	O
in	O
the	O
intensity	O
and	O
in	O
the	O
kinetics	O
of	O
their	O
immunomodulating	O
activity	O
.	O
The	O
mechanism(s)	O
of	O
action	O
of	O
GCH	O
is	O
under	O
investigation,	O
but	O
is	O
has	O
been	O
noted	O
that	O
they	O
exert	O
immune	O
activity	O
via	O
the	O
genomic	O
pathway	O
.	O
We	O
have	O
studied	O
the	O
effects	O
of	O
prednisone	O
(	O
PDN	O
)	O
,	O
deflazacort	O
(	O
DFC	O
)	O
,	O
and	O
dexamethasone	O
(	O
DXM	O
)	O
on	O
the	O
production	O
of	O
cytokines	protein
(	O
IL-2	protein
,	O
IL-6	protein
,	O
TNF-alpha	protein
,	O
IL-10	protein
)	O
by	O
peripheral	cell_type
T	cell_type
lymphocytes	cell_type
,	O
and	O
the	O
effects	O
on	O
the	O
inhibition	O
of	O
NF-kB	protein
DNA	O
binding	O
activity	O
by	O
activated	cell_line
Jurkat	cell_line
cell	cell_line
line	cell_line
.	O
The	O
data	O
obtained	O
show	O
that	O
the	O
three	O
GCH	O
molecules	O
exert	O
an	O
immunosuppression	O
on	O
cytokine	protein
production	O
by	O
T	cell_type
lymphocytes	cell_type
and	O
a	O
strong	O
decrease	O
in	O
the	O
nuclear	O
translocation	O
of	O
NF-kB	protein
in	O
Jurkat	cell_line
cells	cell_line
;	O
moreover,	O
(a)	O
not	O
all	O
the	O
cytokines	protein
investigated	O
were	O
affected,	O
and	O
not	O
with	O
the	O
same	O
intensity,	O
by	O
the	O
three	O
GCH	O
and	O
(b)	O
DXM	O
inhibited	O
the	O
binding	O
activity	O
of	O
NF-kB	protein
less	O
than	O
that	O
of	O
DFC	O
and	O
PDN	O
.	O
These	O
data	O
are	O
in	O
agreement	O
with	O
the	O
concept	O
that	O
different	O
GCH	O
compounds	O
might	O
differ	O
in	O
their	O
binding	O
and	O
affinity	O
properties	O
,	O
tissue-specific	O
metabolism	O
,	O
and	O
interaction	O
with	O
transcription	protein
factor	protein
.	O

Distinctive	O
expression	O
pattern	O
of	O
the	O
BCL-6	protein
protein	protein
in	O
nodular	O
lymphocyte	O
predominance	O
Hodgkin's	O
disease	O
.	O
The	O
BCL-6	RNA
gene	RNA
encoding	O
a	O
nuclear-located	protein
Kruppel-type	protein
zinc	protein
finger	protein
protein	protein
is	O
rearranged	O
in	O
about	O
30%	O
diffuse	O
large	O
B-cell	cell_type
lymphomas	cell_type
and	O
is	O
expressed	O
predominantly	O
in	O
normal	O
germinal	cell_type
center	cell_type
B	cell_type
cells	cell_type
and	O
related	O
lymphomas	O
.	O
These	O
findings	O
suggest	O
that	O
BCL-6	protein
may	O
play	O
a	O
role	O
in	O
regulating	O
differentiation	O
of	O
normal	O
germinal	cell_type
center	cell_type
B	cell_type
cells	cell_type
and	O
that	O
its	O
deregulated	O
expression	O
caused	O
by	O
rearrangements	O
may	O
contribute	O
to	O
lymphomagenesis	O
.	O
This	O
prompted	O
us	O
to	O
investigate	O
the	O
expression	O
of	O
the	O
BCL-6	protein
protein	protein
in	O
Hodgkin's	O
disease	O
(	O
HD	O
),	O
focusing	O
on	O
the	O
nodular	O
lymphocyte	O
predominance	O
subtype	O
(	O
NLPHD	O
),	O
which	O
differs	O
from	O
classical	O
HD	O
by	O
virtue	O
of	O
the	O
B-cell	O
nature	O
of	O
the	O
malignant	cell_type
cell	cell_type
population	cell_type
(so-called	O
L&amp;H	cell_type
cells	cell_type
)	O
and	O
its	O
relationship	O
with	O
germinal	O
centers.	O
Forty-one	O
HD	O
samples	O
(19	O
NLPHD	O
,	O
12	O
nodular	O
sclerosis	O
,	O
and	O
10	O
mixed	O
cellularity)	O
were	O
immunostained	O
with	O
the	O
monoclonal	protein
antibodies	protein
PG-B6	protein
and	O
PG-B6p	protein
that	O
react	O
with	O
a	O
fixative-sensitive	O
and	O
a	O
formalin-resistant	protein
epitope	protein
on	O
the	O
aminoterminal	protein
region	protein
of	O
the	O
BCL-6	protein
gene	protein
product	protein
,	O
respectively.	O
Strong	O
nuclear	O
positivity	O
for	O
the	O
BCL-6	protein
protein	protein
was	O
detected	O
in	O
tumor	cell_type
(L&amp;H)	cell_type
cells	cell_type
in	O
all	O
cases	O
of	O
NLPHD	O
.	O
In	O
contrast,	O
BCL-6	protein
was	O
expressed	O
only	O
in	O
a	O
small	O
percentage	O
of	O
Hodgkin	cell_line
and	cell_line
Reed-Sternberg	cell_line
cells	cell_line
in	O
about	O
30%	O
of	O
classical	O
HD	O
cases	O
.	O
Notably,	O
the	O
nuclei	O
of	O
reactive	cell_type
CD3+/CD4+	cell_type
T	cell_type
cells	cell_type
nearby	O
to	O
and	O
rosetting	O
around	O
L&amp;H	cell_type
cells	cell_type
in	O
NLPHD	O
were	O
also	O
strongly	O
BCL-6	protein
+,	O
but	O
lacked	O
CD40	protein
ligand	protein
(	O
CD40L	protein
)	O
expression	O
.	O
This	O
staining	O
pattern	O
clearly	O
differed	O
from	O
that	O
of	O
classical	O
HD	O
,	O
whose	O
cellular	O
background	O
was	O
made	O
up	O
of	O
CD3+/CD4+	cell_type
T	cell_type
cells	cell_type
showing	O
the	O
BCL-6	protein
-/	O
CD40L	protein
+	O
phenotype.	O
These	O
results	O
further	O
support	O
the	O
concept	O
that	O
NLPHD	O
is	O
an	O
histogenetically	O
distinct,	O
B-cell-derived	O
subtype	O
of	O
HD	O
and	O
suggest	O
a	O
role	O
for	O
BCL-6	protein
in	O
its	O
development.	O

Selenium	O
-mediated	O
inhibition	O
of	O
transcription	protein
factor	protein
NF-kappa	protein
B	protein
and	O
HIV-1	DNA
LTR	DNA
promoter	DNA
activity	O
.	O
The	O
eukaryotic	protein
transcription	protein
factor	protein
NF-kappa	protein
B	protein
is	O
involved	O
in	O
the	O
inducible	O
expression	O
of	O
various	O
inflammatory	DNA
genes	DNA
as	O
well	O
as	O
in	O
HIV-1	O
replication	O
.	O
Activation	O
of	O
NF-kappa	protein
B	protein
is	O
induced	O
by	O
prooxidants	O
and	O
several	O
stimuli	O
eliciting	O
oxidative	O
stress	O
,	O
such	O
as	O
cytokines	protein
,	O
lipopolysaccharide	O
,	O
UV	O
irradiation	O
and	O
other	O
mediators.	O
Various	O
antioxidants	O
inhibit	O
NF-kappa	protein
B	protein
activation	O
in	O
response	O
to	O
these	O
stimuli.	O
In	O
this	O
study,	O
we	O
have	O
investigated	O
the	O
effects	O
of	O
selenium	O
,	O
an	O
integral	O
component	O
of	O
glutathione	protein
peroxidase	protein
(	O
GPX	protein
),	O
on	O
NF-kappa	protein
B	protein
activation	O
.	O
In	O
selenium	cell_line
-deprived	cell_line
Jurkat	cell_line
and	O
ESb-L	cell_line
T	cell_line
lymphocytes	cell_line
,	O
supplementation	O
of	O
selenium	O
led	O
to	O
a	O
substantial	O
increase	O
of	O
GPX	protein
activity	O
.	O
Analysis	O
of	O
DNA	O
binding	O
revealed	O
that	O
NF-kappa	protein
B	protein
activation	O
in	O
response	O
to	O
TNF	protein
was	O
significantly	O
inhibited	O
under	O
these	O
conditions.	O
Likewise,	O
reporter	O
gene	O
assays	O
using	O
luciferase	O
constructs	O
driven	O
by	O
the	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
showed	O
a	O
dose-dependent	O
inhibition	O
of	O
NF-kappa	protein
B	protein
controlled	O
gene	O
expression	O
by	O
selenium	O
.	O
The	O
effects	O
of	O
selenium	O
were	O
specific	O
for	O
NF-kappa	protein
B	protein
,	O
since	O
the	O
activity	O
of	O
the	O
transcription	O
factor	O
AP-1	protein
was	O
not	O
suppressed.	O
These	O
data	O
suggest	O
that	O
selenium	O
supplementation	O
may	O
be	O
used	O
to	O
modulate	O
the	O
expression	O
of	O
NF-kappa	DNA
B	DNA
target	DNA
genes	DNA
and	O
HIV-1	O
.	O

The	O
involvement	O
of	O
p23	protein
,	O
hsp90	protein
,	O
and	O
immunophilins	protein
in	O
the	O
assembly	O
of	O
progesterone	protein
receptor	protein
complexes	protein
.	O
To	O
better	O
understand	O
the	O
assembly	O
mechanism	O
for	O
the	O
progesterone	protein
receptor	protein
(	O
PR	protein
),	O
we	O
have	O
developed	O
cell-free	O
systems	O
for	O
studying	O
interactions	O
of	O
PR	protein
,	O
hsp90	protein
,	O
and	O
other	O
associated	protein
proteins	protein
.	O
When	O
PR	protein
is	O
incubated	O
in	O
rabbit	O
reticulocyte	O
lysate	O
,	O
its	O
association	O
with	O
hsp90	protein
,	O
hsp70	protein
,	O
the	O
three	O
immunophilins	protein
FKBP54	protein
,	O
FKBP52	protein
and	O
CyP-40	protein
,	O
and	O
with	O
p23	protein
is	O
observed.	O
These	O
interactions	O
require	O
ATP/Mg2+	O
and	O
when	O
ATP	O
is	O
limiting	O
the	O
PR	protein
complex	O
is	O
altered	O
to	O
one	O
containing	O
the	O
proteins	O
p60	protein
and	O
p48	protein
,	O
but	O
lacking	O
immunophilins	protein
and	O
p23	protein
.	O
We	O
have	O
studied	O
two	O
pre-formed	protein
hsp90	protein
complexes	protein
that	O
may	O
participate	O
in	O
the	O
assembly	O
of	O
PR	protein
complexes	protein
.	O
One	O
contains	O
hsp90	protein
bound	O
to	O
hsp70	protein
and	O
p60	protein
and	O
this	O
complex	O
forms	O
spontaneously	O
in	O
the	O
absence	O
of	O
ATP	O
.	O
A	O
second	O
complex	O
contains	O
hsp90	protein
bound	O
to	O
p23	protein
plus	O
the	O
three	O
immunophilins	protein
and	O
some	O
hsp70	protein
.	O
The	O
formation	O
of	O
this	O
complex	O
requires	O
ATP	O
.	O
In	O
further	O
studies	O
we	O
have	O
shown	O
that	O
purified	O
hsp90	protein
can	O
bind	O
to	O
purified	O
p23	protein
and	O
this	O
interaction	O
requires	O
both	O
ATP	O
and	O
molybdate	O
.	O
This	O
explains,	O
in	O
part,	O
the	O
known	O
effects	O
of	O
ATP	O
and	O
molybdate	O
on	O
assembly	O
of	O
PR	protein
complexes	protein
.	O

Increased	O
IkappaB	protein
expression	O
and	O
diminished	O
nuclear	protein
NF-kappaB	protein
in	O
human	cell_type
mononuclear	cell_type
cells	cell_type
following	O
hydrocortisone	O
injection	O
.	O
We	O
have	O
recently	O
demonstrated	O
that	O
hydrocortisone	O
and	O
other	O
glucocorticoids	O
inhibit	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
generation	O
by	O
mononuclear	O
(MNC)	O
and	O
polymorphonuclear	O
leucocytes	O
(	O
PMNL	cell_type
).	O
Since	O
NF-kappaB/	O
IkappaB	protein
system	O
regulates	O
the	O
transcription	O
of	O
proinflammatory	protein
genes	protein
,	O
including	O
those	O
responsible	O
for	O
ROS	O
generation	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
hydrocortisone	O
may	O
stimulate	O
IkappaB	protein
production	O
thus	O
inhibiting	O
NF-kappaB	protein
translocation	O
from	O
the	O
cytosol	O
into	O
the	O
nucleus	O
in	O
MNC	cell_type
,	O
in	O
vivo.	O
One	O
hundred	O
milligram	O
of	O
hydrocortisone	O
was	O
injected	O
intravenously	O
into	O
4	O
normal	O
subjects	O
.	O
Blood	O
samples	O
were	O
obtained	O
prior	O
to	O
the	O
injection	O
and	O
at	O
1,	O
2,	O
4,	O
8	O
and	O
24	O
hr	O
after	O
the	O
injection.	O
Nuclear	O
extracts	O
and	O
total	O
cell	O
lysates	O
were	O
prepared	O
from	O
MNC	cell_type
by	O
standard	O
techniques.	O
IkappaB	protein
levels	O
in	O
MNC	cell_type
homogenates	O
increased	O
at	O
1	O
hr,	O
peaked	O
at	O
2-4	O
hr,	O
started	O
to	O
decrease	O
at	O
8	O
hr,	O
and	O
returned	O
to	O
baseline	O
levels	O
at	O
24	O
hr.	O
NF-kappaB	protein
in	O
MNC	cell_type
nuclear	O
extracts	O
decreased	O
at	O
1	O
hr,	O
reached	O
a	O
nadir	O
at	O
4	O
hr,	O
gradually	O
increased	O
at	O
8	O
hr	O
and	O
returned	O
back	O
to	O
baseline	O
levels	O
at	O
24	O
hr.	O
The	O
total	O
protein	O
content	O
of	O
NF-kappaB	protein
subunit	protein
(	O
P65	protein
)	O
in	O
MNC	cell_type
lysates	O
also	O
showed	O
a	O
decrease	O
following	O
hydrocortisone	O
injection	O
.	O
This	O
decrease	O
was	O
observed	O
at	O
2	O
hr,	O
reached	O
a	O
nadir	O
at	O
4	O
hr,	O
and	O
returned	O
to	O
baseline	O
levels	O
at	O
24	O
hr.	O
ROS	O
generation	O
inhibition	O
paralleled	O
NF-kappaB	protein
levels	O
in	O
the	O
nucleus	O
.	O
It	O
was	O
inhibited	O
at	O
1	O
hr,	O
reached	O
a	O
nadir	O
at	O
2-4	O
hr,	O
started	O
to	O
increase	O
at	O
8	O
hr,	O
and	O
returned	O
to	O
basal	O
levels	O
at	O
24	O
hr.	O
Our	O
data	O
demonstrate	O
that	O
hydrocortisone	O
induces	O
IkappaB	protein
and	O
suppresses	O
NF-kappaB	protein
expression	O
in	O
MNC	cell_type
in	O
parallel.	O
IkappaB	protein
further	O
reduces	O
the	O
translocation	O
of	O
NF-kappaB	protein
into	O
the	O
nucleus	O
thus	O
preventing	O
the	O
expression	O
of	O
proinflammatory	DNA
genes	DNA
.	O

Glucocorticoids	O
induce	O
apoptosis	O
in	O
human	cell_type
monocytes	cell_type
:	O
potential	O
role	O
of	O
IL-1	protein
beta	protein
.	O
Glucocorticoids	O
(	O
GC	O
)	O
are	O
potent	O
anti-inflammatory	O
and	O
immunosuppressive	O
agents	O
that	O
act	O
on	O
a	O
variety	O
of	O
immune	cell_type
cells	cell_type
,	O
including	O
monocytes	cell_type
and	O
macrophages	cell_type
.	O
However,	O
the	O
exact	O
cellular	O
mechanisms	O
underlying	O
this	O
anti-inflammatory	O
capacity	O
are	O
still	O
unknown.	O
In	O
our	O
study,	O
we	O
determined	O
the	O
induction	O
of	O
apoptosis	O
by	O
GC	O
in	O
human	cell_type
monocytes	cell_type
.	O
Peripheral	cell_type
blood	cell_type
monocytes	cell_type
were	O
isolated	O
by	O
density	O
centrifugation	O
methods	O
with	O
a	O
purity	O
of	O
&gt;90%	O
and	O
were	O
cultured	O
in	O
RPMI	O
1640	O
medium.	O
Monocyte	O
apoptosis	O
was	O
determined	O
by	O
four	O
independent	O
methods,	O
including	O
annexin-V	O
staining	O
,	O
TUNEL	O
,	O
DNA-laddering	O
,	O
and	O
typical	O
morphology	O
by	O
means	O
of	O
transmission	O
electron	O
microscopy	O
.	O
TNF-alpha	protein
and	O
IL-1beta	protein
were	O
measured	O
by	O
ELISA	O
.	O
GC	protein
receptor	protein
was	O
blocked	O
with	O
mifepristone	O
.	O
Caspase	O
3	O
was	O
inhibited	O
with	O
caspase-3	O
inhibitor	O
(	O
DEVD-CHO	O
).	O
Stimulation	O
with	O
different	O
GC	O
at	O
therapeutic	O
concentrations	O
resulted	O
in	O
monocyte	O
apoptosis	O
in	O
a	O
time-	O
and	O
dose-	O
dependent	O
manner	O
.	O
Necrosis	O
was	O
excluded	O
by	O
propidium	O
iodide	O
staining	O
.	O
Proinflammatory	protein
cytokines	protein
such	O
as	O
IL-1beta	protein
and	O
TNF-alpha	protein
were	O
down-regulated	O
by	O
GC	O
treatment	O
.	O
Continuous	O
treatment	O
of	O
monocytes	cell_type
with	O
IL-1beta	protein
,	O
but	O
not	O
with	O
TNF-alpha	protein
,	O
could	O
almost	O
completely	O
prevent	O
GC	O
-induced	O
cell	O
death.	O
The	O
addition	O
of	O
mifepristone	O
or	O
caspase-3	O
inhibitor	O
could	O
partially	O
abrogate	O
GC	O
-induced	O
apoptosis	O
as	O
well	O
as	O
GC	O
-induced	O
inhibition	O
of	O
IL-1beta	protein
.	O
This	O
is	O
the	O
first	O
study	O
to	O
demonstrate	O
induction	O
of	O
apoptosis	O
by	O
GC	O
in	O
human	cell_type
monocytes	cell_type
.	O
GC	O
-induced	O
monocyte	O
apoptosis	O
may	O
be	O
partially	O
mediated	O
through	O
effects	O
on	O
IL-1beta	protein
production	O
.	O
It	O
is	O
conceivable	O
that	O
GC	O
exert	O
their	O
anti-inflammatory	O
capacity	O
in	O
various	O
diseases,	O
at	O
least	O
in	O
part,	O
by	O
the	O
induction	O
of	O
apoptosis	O
in	O
monocytes	cell_type
.	O

Differential	O
effects	O
of	O
lipopolysaccharide	O
and	O
tumor	protein
necrosis	protein
factor	protein
on	O
monocytic	protein
IkappaB	protein
kinase	protein
signalsome	O
activation	O
and	O
IkappaB	protein
proteolysis	O
.	O
The	O
inflammatory	O
mediators	O
lipopolysaccharide	O
(	O
LPS	O
)	O
and	O
tumor	protein
necrosis	protein
factor	protein
(	O
TNF	protein
)	O
are	O
potent	O
activators	O
of	O
NF-kappaB	protein
.	O
This	O
study	O
compared	O
the	O
effect	O
of	O
these	O
stimuli	O
on	O
endogenous	O
IkappaB	protein
kinase	protein
(	O
IKK	protein
)	O
signalsome	O
activation	O
and	O
IkappaB	protein
phosphorylation/proteolysis	O
in	O
human	cell_type
monocytic	cell_type
cells	cell_type
and	O
investigated	O
the	O
role	O
of	O
the	O
signalsome	protein
proteins	protein
IKK-alpha	protein
,	O
IKK-beta	protein
,	O
NF-kappaB	protein
-inducing	protein
kinase	protein
(	O
NIK	protein
),	O
IKK-gamma	protein
(	O
NF-kappaB	protein
essential	O
modulator),	O
and	O
IKK	protein
complex	protein
-associated	protein
protein	protein
.	O
Kinase	O
assays	O
showed	O
that	O
TNF	protein
elicited	O
a	O
rapid	O
but	O
short-lived	O
induction	O
of	O
IKK	protein
activity	O
with	O
a	O
3-fold	O
greater	O
effect	O
on	O
IKK	protein
-alpha	protein
than	O
on	O
IKK-beta	protein
,	O
peaking	O
at	O
5	O
min.	O
In	O
contrast,	O
LPS	O
predominantly	O
stimulated	O
IKK-beta	protein
activity	O
,	O
which	O
slowly	O
increased,	O
peaking	O
at	O
30	O
min.	O
A	O
second	O
peak	O
was	O
observed	O
at	O
a	O
later	O
time	O
point	O
following	O
LPS	O
stimulation	O
,	O
which	O
consisted	O
of	O
both	O
IKK	O
-alpha	O
and	O
-beta	O
activity	O
.	O
The	O
endogenous	O
levels	O
of	O
the	O
signalsome	O
components	O
were	O
unaffected	O
by	O
stimulation.	O
Furthermore,	O
our	O
studies	O
showed	O
association	O
of	O
the	O
IKK-alpha	protein
/beta	protein
heterodimer	protein
with	O
NIK	protein
,	O
IkappaB	protein
-alpha	protein
and	O
-epsilon	protein
in	O
unstimulated	cell_type
cells	cell_type
.	O
Exposure	O
to	O
LPS	O
or	O
TNF	protein
led	O
to	O
differential	O
patterns	O
of	O
IkappaB	protein
-alpha	protein
and	O
IkappaB	protein
-epsilon	protein
disappearance	O
from	O
and	O
reassembly	O
with	O
the	O
signalsome,	O
whereas	O
IKK-alpha	protein
,	O
IKK-beta	protein
,	O
and	O
NIK	protein
remained	O
complex-associated.	O
NIK	protein
cannot	O
phosphorylate	O
IkappaB	protein
-alpha	protein
directly,	O
but	O
it	O
appears	O
to	O
be	O
a	O
functionally	O
important	O
subunit,	O
because	O
mutated	O
NIK	protein
inhibited	O
stimulus-induced	O
kappaB	protein
-dependent	O
transcription	O
more	O
effectively	O
than	O
mutated	O
IKK-alpha	protein
or	O
-beta	protein
.	O
Overexpression	O
of	O
IKK	protein
complex	protein
-associated	protein
protein	protein
inhibited	O
stimulus-mediated	O
transcription,	O
whereas	O
NF-kappaB	protein
essential	O
modulator	O
enhanced	O
it.	O
The	O
understanding	O
of	O
LPS-	O
and	O
TNF-	O
induced	O
signaling	O
may	O
allow	O
the	O
development	O
of	O
specific	O
strategies	O
to	O
treat	O
sepsis-associated	O
disease	O
.	O

Tumor	protein
necrosis	protein
factor	protein
alpha	protein
decreases,	O
and	O
interleukin-10	protein
increases,	O
the	O
sensitivity	O
of	O
human	cell_type
monocytes	cell_type
to	O
dexamethasone:	O
potential	O
regulation	O
of	O
the	O
glucocorticoid	protein
receptor	protein
.	O
Resistance	O
to	O
glucocorticoid	O
therapy	O
has	O
been	O
observed	O
in	O
patients	O
with	O
autoimmune/inflammatory	O
diseases	O
and	O
may	O
be	O
related	O
to	O
the	O
inflammatory	O
process	O
itself.	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
ability	O
of	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNFalpha	protein
,	O
a	O
proinflammatory	protein
cytokine	protein
)	O
and	O
interleukin	protein
(IL)-10	protein
(an	O
anti-inflammatory	protein
cytokine	protein
)	O
to	O
differentially	O
regulate	O
the	O
sensitivity	O
of	O
human	cell_type
monocytes	cell_type
/macrophages	cell_type
to	O
glucocorticoids	O
.	O
To	O
accomplish	O
this,	O
we	O
first	O
analyzed	O
the	O
pattern	O
of	O
TNFalpha	protein
and	O
IL-10	O
inhibition	O
by	O
dexamethasone	O
in	O
LPS	cell_line
-stimulated	cell_line
whole-blood	cell_line
cell	cell_line
cultures	cell_line
.	O
Second,	O
we	O
studied	O
the	O
modulation	O
of	O
the	O
sensitivity	O
of	O
these	O
cells	O
to	O
dexamethasone	O
by	O
preincubation	O
with	O
TNFalpha	protein
or	O
IL-10	protein
and	O
measurement	O
of	O
LPS	O
-stimulated	O
IL-6	protein
secretion	O
.	O
In	O
addition,	O
we	O
evaluated	O
the	O
effect	O
of	O
dexamethasone	O
on	O
phorbolmyristate-acetate	O
-stimulated	O
IL-1	protein
receptor	protein
antagonist	O
secretion	O
by	O
the	O
human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
U937	cell_line
.	O
Finally,	O
we	O
investigated	O
whether	O
the	O
modulation	O
of	O
corticosensitivity	O
in	O
TNFalpha-	O
and	O
IL-10-	O
pretreated	O
U937	O
cells	O
was	O
related	O
to	O
a	O
change	O
of	O
the	O
glucocorticoid	protein
receptor	protein
concentration	O
and	O
affinity.	O
Dexamethasone	O
had	O
different	O
effects	O
on	O
LPS	O
-induced	O
TNFalpha	protein
and	O
IL-10	protein
secretion	O
;	O
whereas	O
it	O
suppressed	O
TNFalpha	protein
in	O
a	O
dose-dependent	O
fashion,	O
its	O
effect	O
on	O
IL-10	protein
secretion	O
was	O
biphasic,	O
producing	O
stimulation	O
at	O
lower,	O
and	O
inhibition	O
at	O
higher	O
doses.	O
The	O
concentration	O
of	O
LPS	O
employed	O
influenced	O
the	O
effect	O
of	O
dexamethasone	O
on	O
IL-10	protein
secretion	O
(P	O
&lt;	O
0.001).	O
Pretreatment	O
with	O
TNFalpha	protein
diminished,	O
and	O
with	O
IL-10	protein
improved,	O
the	O
ability	O
of	O
dexamethasone	O
to	O
suppress	O
IL-6	protein
secretion	O
in	O
whole-blood	cell_type
cell	cell_type
cultures	cell_type
(P	O
&lt;	O
0.01	O
for	O
both)	O
and	O
to	O
enhance	O
IL-1	protein
receptor	O
antagonist	O
secretion	O
by	O
U937	O
cells	O
(P	O
&lt;	O
0.05	O
for	O
both).	O
TNFalpha	protein
decreased	O
(P	O
&lt;	O
0.001),	O
while	O
IL-10	protein
increased	O
(P	O
&lt;	O
0.001),	O
the	O
concentration	O
of	O
dexamethasone	O
binding	O
sites	O
in	O
these	O
cells,	O
with	O
no	O
discernible	O
effect	O
on	O
their	O
binding	O
affinity.	O
We	O
conclude	O
that	O
glucocorticoids	O
differentially	O
modulate	O
TNFalpha	protein
and	O
IL-10	protein
secretion	O
by	O
human	cell_type
monocytes	cell_type
in	O
a	O
LPS	O
dose-dependent	O
fashion	O
and	O
that	O
the	O
sensitivity	O
of	O
these	O
cells	O
to	O
glucocorticoids	O
is	O
altered	O
by	O
TNFalpha	protein
or	O
IL-10	protein
pretreatment	O
;	O
TNFalpha	protein
blocks	O
their	O
effects,	O
whereas	O
IL-10	protein
acts	O
synergistically	O
with	O
glucocorticoids	O
.	O
This	O
is	O
accompanied	O
by	O
opposite	O
glucocorticoid	protein
receptor	protein
changes,	O
respectively	O
opposing	O
and	O
favoring	O
glucocorticoid	O
actions	O
.	O
This	O
study	O
suggests	O
that	O
the	O
pattern	O
of	O
pro-/antiinflammatory	O
cytokine	protein
secretion	O
may	O
alter	O
the	O
response	O
of	O
patients	O
to	O
glucocorticoid	O
therapy	O
.	O

Block	O
of	O
granulocytic	O
differentiation	O
of	O
32Dcl3	cell_line
cells	cell_line
by	O
AML1/ETO(MTG8)	DNA
but	O
not	O
by	O
highly	O
expressed	O
Bcl-2	protein
.	O
The	O
chimeric	DNA
gene,	DNA
AML1/ETO	DNA
(MTG8)	DNA
,	O
generated	O
in	O
t(8;21)	DNA
acute	O
myeloid	O
leukemia	O
enhances	O
the	O
expression	O
of	O
Bcl-2	protein
.	O
To	O
evaluate	O
whether	O
this	O
enhancement	O
is	O
the	O
primary	O
role	O
of	O
AML1/ETO	DNA
in	O
leukemogenesis	O
,	O
effects	O
of	O
over-expression	O
of	O
Bcl-2	protein
in	O
the	O
murine	cell_line
myeloid	cell_line
precursor	cell_line
cell	cell_line
line	cell_line
,	O
32Dcl3	cell_line
,	O
were	O
examined.	O
When	O
32Dcl3	cell_line
cells	cell_line
expressing	O
exogenous	O
Bcl-2	protein
were	O
induced	O
to	O
differentiate,	O
the	O
onset	O
of	O
morphological	O
differentiation	O
was	O
delayed.	O
However,	O
even	O
the	O
cells	O
expressing	O
very	O
high	O
levels	O
of	O
exogenous	O
Bcl-2	protein
eventually	O
underwent	O
differentiation	O
without	O
a	O
significant	O
decrease	O
in	O
the	O
synthesis	O
of	O
Bcl-2	protein
.	O
On	O
the	O
contrary,	O
32Dcl3	cell_line
cells	cell_line
stably	O
expressing	O
AML1/ETO	DNA
were	O
completely	O
resistant	O
to	O
differentiation	O
and	O
continued	O
to	O
grow	O
in	O
the	O
presence	O
of	O
G-CSF	protein
.	O
These	O
results	O
are	O
consistent	O
with	O
the	O
interpretation	O
that	O
stimulation	O
of	O
Bcl-2	protein
expression	O
is	O
not	O
the	O
primary	O
target	O
of	O
AML1/ETO	DNA
.	O

Host	O
defense	O
mechanisms	O
triggered	O
by	O
microbial	protein
lipoproteins	protein
through	O
toll-like	protein
receptors	protein
.	O
The	O
generation	O
of	O
cell-mediated	O
immunity	O
against	O
many	O
infectious	O
pathogens	O
involves	O
the	O
production	O
of	O
interleukin-12	protein
(	O
IL-12	protein
),	O
a	O
key	O
signal	O
of	O
the	O
innate	O
immune	O
system	O
.	O
Yet,	O
for	O
many	O
pathogens,	O
the	O
molecules	O
that	O
induce	O
IL-12	protein
production	O
by	O
macrophages	cell_type
and	O
the	O
mechanisms	O
by	O
which	O
they	O
do	O
so	O
remain	O
undefined.	O
Here	O
it	O
is	O
shown	O
that	O
microbial	protein
lipoproteins	protein
are	O
potent	O
stimulators	O
of	O
IL-12	protein
production	O
by	O
human	O
macrophages	cell_type
,	O
and	O
that	O
induction	O
is	O
mediated	O
by	O
Toll-like	protein
receptors	protein
(	O
TLRs	protein
).	O
Several	O
lipoproteins	O
stimulated	O
TLR-dependent	O
transcription	O
of	O
inducible	O
nitric	protein
oxide	protein
synthase	protein
and	O
the	O
production	O
of	O
nitric	O
oxide	O
,	O
a	O
powerful	O
microbicidal	O
pathway	O
.	O
Activation	O
of	O
TLRs	protein
by	O
microbial	protein
lipoproteins	protein
may	O
initiate	O
innate	O
defense	O
mechanisms	O
against	O
infectious	O
pathogens	O
.	O

Abnormal	O
NF-kappa	protein
B	protein
activity	O
in	O
T	cell_type
lymphocytes	cell_type
from	O
patients	O
with	O
systemic	O
lupus	O
erythematosus	O
is	O
associated	O
with	O
decreased	O
p65-RelA	protein
protein	O
expression	O
.	O
Numerous	O
cellular	O
and	O
biochemical	O
abnormalities	O
in	O
immune	O
regulation	O
have	O
been	O
described	O
in	O
patients	O
with	O
systemic	O
lupus	O
erythematosus	O
(	O
SLE	O
),	O
including	O
surface	O
Ag	protein
receptor	protein
-initiated	O
signaling	O
events	O
and	O
lymphokine	protein
production	O
.	O
Because	O
NF-kappa	protein
B	protein
contributes	O
to	O
the	O
transcription	O
of	O
numerous	O
inflammatory	DNA
genes	DNA
and	O
has	O
been	O
shown	O
to	O
be	O
a	O
molecular	O
target	O
of	O
antiinflammatory	O
drugs	O
,	O
we	O
sought	O
to	O
characterize	O
the	O
functional	O
role	O
of	O
the	O
NF-kappa	protein
B	protein
protein	protein
complex	protein
in	O
lupus	cell_type
T	cell_type
cells	cell_type
.	O
Freshly	O
isolated	O
T	cell_type
cells	cell_type
from	O
lupus	O
patients	O
,	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
patients	O
,	O
and	O
normal	O
individuals	O
were	O
activated	O
physiologically	O
via	O
the	O
TCR	protein
with	O
anti-CD3	protein
and	O
anti-CD28	protein
Abs	protein
to	O
assess	O
proximal	O
membrane	O
signaling,	O
and	O
with	O
PMA	O
and	O
a	O
calcium	O
ionophore	O
(	O
A23187	O
)	O
to	O
bypass	O
membrane-mediated	O
signaling	O
events	O
.	O
We	O
measured	O
the	O
NF-kappa	protein
B	protein
binding	O
activity	O
in	O
nuclear	O
extracts	O
by	O
gel	O
shift	O
analysis	O
.	O
When	O
compared	O
with	O
normal	cell_type
cells	cell_type
,	O
the	O
activation	O
of	O
NF-kappa	protein
B	protein
activity	O
in	O
SLE	O
patients	O
was	O
significantly	O
decreased	O
in	O
SLE	O
,	O
but	O
not	O
in	O
RA	O
,	O
patients	O
.	O
NF-kappa	protein
B	protein
binding	O
activity	O
was	O
absent	O
in	O
several	O
SLE	O
patients	O
who	O
were	O
not	O
receiving	O
any	O
medication,	O
including	O
corticosteroids	O
.	O
Also,	O
NF-kappa	protein
B	protein
activity	O
remained	O
absent	O
in	O
follow-up	O
studies.	O
In	O
supershift	O
experiments	O
using	O
specific	O
Abs	protein
,	O
we	O
showed	O
that,	O
in	O
the	O
group	O
of	O
SLE	O
patients	O
who	O
displayed	O
undetectable	O
NF-kappa	protein
B	protein
activity,	O
p65	protein
complexes	protein
were	O
not	O
formed.	O
Finally,	O
immunoblot	O
analysis	O
of	O
nuclear	O
extracts	O
showed	O
decreased	O
or	O
absent	O
p65	protein
protein	protein
levels	O
.	O
As	O
p65	protein
complexes	protein
are	O
transcriptionally	O
active	O
in	O
comparison	O
to	O
the	O
p50	O
homodimer,	O
this	O
novel	O
finding	O
may	O
provide	O
insight	O
on	O
the	O
origin	O
of	O
abnormal	protein
cytokine	protein
or	O
other	O
gene	O
transcription	O
in	O
SLE	O
patients	O
.	O

Signaling	O
events	O
induced	O
by	O
lipopolysaccharide-activated	protein
toll-like	protein
receptor	protein
2	protein
.	O
Human	protein
Toll-like	protein
receptor	protein
2	protein
(	protein
TLR2	protein
)	protein
is	O
a	O
signaling	protein
receptor	protein
that	O
responds	O
to	O
LPS	O
and	O
activates	O
NF-kappaB	protein
.	O
Here,	O
we	O
investigate	O
further	O
the	O
events	O
triggered	O
by	O
TLR2	protein
in	O
response	O
to	O
LPS	O
.	O
We	O
show	O
that	O
TLR2	protein
associates	O
with	O
the	O
high-affinity	protein
LPS	protein
binding	protein
protein	protein
membrane	O
CD14	protein
to	O
serve	O
as	O
an	O
LPS	protein
receptor	protein
complex	protein
,	O
and	O
that	O
LPS	O
treatment	O
enhances	O
the	O
oligomerization	O
of	O
TLR2	protein
.	O
Concomitant	O
with	O
receptor	O
oligomerization	O
,	O
the	O
IL-1R-associated	protein
kinase	protein
(	protein
IRAK	protein
)	protein
is	O
recruited	O
to	O
the	O
TLR2	protein
complex.	O
Intracellular	O
deletion	O
variants	O
of	O
TLR2	protein
lacking	O
C-terminal	O
13	O
or	O
141	O
aa	O
fail	O
to	O
recruit	O
IRAK	protein
,	O
which	O
is	O
consistent	O
with	O
the	O
inability	O
of	O
these	O
mutants	O
to	O
transmit	O
LPS	O
cellular	O
signaling	O
.	O
Moreover,	O
both	O
deletion	O
mutants	O
could	O
still	O
form	O
complexes	O
with	O
wild-type	protein
TLR2	protein
and	O
act	O
in	O
a	O
dominant-negative	O
(	O
DN	O
)	O
fashion	O
to	O
block	O
TLR2	protein
-mediated	O
signal	O
transduction	O
.	O
DN	O
constructs	O
of	O
myeloid	protein
differentiation	protein
protein	protein
,	O
IRAK	protein
,	O
TNF	protein
receptor-associated	protein
factor	protein
6	protein
,	O
and	O
NF-kappaB	protein
-inducing	protein
kinase	protein
,	O
when	O
coexpressed	O
with	O
TLR2	protein
,	O
abrogate	O
TLR2	protein
-mediated	O
NF-kappaB	protein
activation	O
.	O
These	O
results	O
reveal	O
a	O
conserved	O
signaling	O
pathway	O
for	O
TLR2	protein
and	O
IL-1Rs	protein
and	O
suggest	O
a	O
molecular	O
mechanism	O
for	O
the	O
inhibition	O
of	O
TLR2	protein
by	O
DN	O
variants.	O

Tyrphostin	O
AG-490	O
inhibits	O
cytokine-mediated	O
JAK3	protein
/STAT5a/b	protein
signal	O
transduction	O
and	O
cellular	O
proliferation	O
of	O
antigen-activated	O
human	O
T	cell_type
cells	cell_type
.	O
Janus	protein
kinase	protein
3	protein
(	protein
JAK3	protein
)	protein
is	O
a	O
cytoplasmic	protein
tyrosine	protein
kinase	protein
required	O
for	O
T	cell_type
cell	cell_type
development	O
and	O
activated	O
by	O
cytokines	protein
that	O
utilize	O
the	O
interleukin-2	protein
(IL-2)	protein
receptor	protein
common	protein
gamma	protein
chain	protein
(	protein
gamma(c)	protein
)	protein
.	O
Genetic	O
inactivation	O
of	O
JAK3	protein
is	O
manifested	O
as	O
severe	O
combined	O
immunodeficiency	O
disease	O
(SCID)	O
in	O
humans	O
and	O
mice	O
.	O
These	O
findings	O
have	O
suggested	O
that	O
JAK3	protein
represents	O
a	O
pharmacological	O
target	O
to	O
control	O
certain	O
lymphoid-derived	O
diseases	O
.	O
Here	O
we	O
provide	O
novel	O
evidence	O
that	O
AG-490	O
potently	O
inhibits	O
the	O
autokinase	O
activity	O
of	O
JAK3	protein
and	O
tyrosine	O
phosphorylation	O
and	O
DNA	O
binding	O
of	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
5a	protein
and	protein
5b	protein
(	protein
STAT5a/b	protein
)	protein
.	O
Similar	O
inhibitory	O
effects	O
were	O
observed	O
with	O
other	O
cytokines	protein
that	O
use	O
gamma(c)	protein
.	O
AG-490	O
also	O
inhibited	O
IL-2	protein
-mediated	O
proliferative	O
growth	O
in	O
human	O
T	cell_type
cells	cell_type
with	O
an	O
IC50)	O
=	O
25	O
microM	O
that	O
was	O
partially	O
recoverable.	O
Moreover,	O
we	O
demonstrate	O
that	O
this	O
inhibitor	O
prevented	O
tetanus	O
toxoid	O
antigen-specific	O
T	O
cell	O
proliferation	O
and	O
expansion	O
but	O
failed	O
to	O
block	O
activation	O
of	O
Zap70	protein
or	O
p56Lck	protein
after	O
anti-CD3	protein
stimulation	O
of	O
human	O
T	cell_type
cells	cell_type
.	O
Taken	O
together,	O
these	O
findings	O
suggest	O
that	O
AG-490	O
inhibits	O
the	O
JAK3	protein
-mediated	O
Type	O
II	O
signaling	O
pathway	O
but	O
not	O
the	O
T	cell_type
cell	cell_type
receptor-derived	O
Type	O
I	O
pathway	O
and	O
possesses	O
therapeutic	O
potential	O
for	O
T	cell_type
cell	cell_type
-derived	O
pathologies	O
such	O
as	O
graft-versus-host	O
disease	O
,	O
allergy	O
,	O
and	O
autoimmune	O
disorders	O
.	O

C/EBP	protein
beta	protein
in	O
rheumatoid	O
arthritis	O
:	O
correlation	O
with	O
inflammation	O
,	O
not	O
disease	O
specificity.	O
Rheumatoid	O
arthritis	O
synovial	O
tissue	O
was	O
examined	O
and	O
compared	O
with	O
osteoarthritis	O
tissue	O
for	O
the	O
presence	O
of	O
the	O
nuclear	protein
transcription	protein
factor	protein
C/EBP	protein
beta	protein
(	protein
NF-IL-6	protein
)	protein
.	O
The	O
region	O
(lining	O
or	O
sublining),	O
cell	O
type,	O
and	O
subcellular	O
distribution	O
(cytoplasmic	O
or	O
nuclear)	O
of	O
the	O
expression	O
of	O
C/EBP	protein
beta	protein
was	O
characterized.	O
Rheumatoid	O
arthritis	O
synovial	O
fluid	O
and	O
blood	O
and	O
normal	O
peripheral	O
blood	O
were	O
also	O
examined.	O
C/EBP	protein
beta	protein
was	O
detected	O
in	O
the	O
synovial	O
lining	O
and	O
in	O
sublining	cell_type
cells	cell_type
of	cell_type
synovial	cell_type
tissue	cell_type
from	O
patients	O
with	O
both	O
rheumatoid	O
and	O
osteoarthritis	O
.	O
A	O
significant	O
(P	O
&lt;	O
0.001	O
and	O
&lt;	O
0.05,	O
respectively)	O
increase	O
in	O
the	O
percentage	O
of	O
cells	O
with	O
nuclear	O
staining	O
was	O
seen	O
in	O
the	O
lining	O
layer,	O
compared	O
to	O
cells	O
in	O
the	O
sublining	O
region,	O
in	O
rheumatoid	O
and	O
osteoarthritis	O
.	O
In	O
both	O
diseases	O
a	O
strong	O
correlation	O
(r	O
=	O
0.79,	O
P	O
&lt;	O
0.001)	O
was	O
observed	O
between	O
the	O
percentage	O
of	O
cells	O
in	O
the	O
synovial	O
lining	O
that	O
were	O
positive	O
for	O
nuclear	protein
C/EBP	protein
beta	protein
and	O
lining	O
cell	O
depth.	O
Two-color	O
immunohistochemistry	O
demonstrated	O
that	O
both	O
macrophages	cell_type
and	O
fibroblast-like	cell_type
synoviocytes	cell_type
were	O
positive	O
for	O
nuclear	O
C/EBP	protein
beta	protein
.	O
The	O
presence	O
of	O
C/EBP	protein
beta	protein
was	O
confirmed	O
by	O
immunohistochemistry	O
and	O
Western	O
blot	O
analysis	O
with	O
isolated	O
synovial	cell_type
fibroblasts	cell_type
.	O
Nuclear	O
C/EBP	protein
beta	protein
was	O
also	O
detected	O
in	O
rheumatoid	O
synovial	O
fluid	O
monocytes	O
/macrophages	O
,	O
but	O
not	O
in	O
lymphocytes	O
or	O
neutrophils	O
.	O
Western	O
blot	O
analysis	O
confirmed	O
the	O
presence	O
of	O
C/EBP	protein
beta	protein
in	O
these	O
cells.	O
The	O
intensity	O
of	O
C/EBP	protein
beta	protein
staining	O
was	O
greater	O
(P	O
&lt;	O
0.001)	O
in	O
synovial	cell_type
fluid	cell_type
monocytes	cell_type
than	O
in	O
those	O
from	O
normal	O
or	O
rheumatoid	O
peripheral	O
blood	O
.	O
In	O
conclusion,	O
the	O
enhanced	O
nuclear	O
staining	O
for	O
C/EBP	protein
beta	protein
in	O
the	O
synovial	O
lining	O
,	O
compared	O
to	O
the	O
sublining,	O
suggesting	O
activation	O
in	O
the	O
lining,	O
and	O
the	O
positive	O
correlation	O
of	O
lining	O
layer	O
depth	O
with	O
the	O
percentage	O
of	O
cells	O
in	O
the	O
lining	O
positive	O
for	O
nuclear	O
C/EBP	protein
beta	protein
,	O
suggest	O
a	O
potential	O
role	O
for	O
C/EBP	protein
beta	protein
in	O
chronic	O
inflammation	O
.	O
The	O
regulation	O
of	O
the	O
production	O
or	O
activity	O
of	O
C/EBP	protein
beta	protein
,	O
to	O
inhibit	O
inflammatory	O
mediator	O
expression	O
by	O
synovial	cell_type
macrophages	cell_type
and	O
fibroblasts	cell_type
,	O
offers	O
a	O
novel	O
approach	O
to	O
therapeutic	O
intervention.	O

Direct	O
interaction	O
of	O
hematopoietic	O
transcription	O
factors	O
PU.1	O
and	O
GATA-1	O
:	O
functional	O
antagonism	O
in	O
erythroid	cell_type
cells	cell_type
.	O
Malignant	O
transformation	O
usually	O
inhibits	O
terminal	O
cell	O
differentiation	O
but	O
the	O
precise	O
mechanisms	O
involved	O
are	O
not	O
understood.	O
PU.1	protein
is	O
a	O
hematopoietic-specific	protein
Ets	protein
family	protein
transcription	protein
factor	protein
that	O
is	O
required	O
for	O
development	O
of	O
some	O
lymphoid	O
and	O
myeloid	O
lineages	O
.	O
PU.1	protein
can	O
also	O
act	O
as	O
an	O
oncoprotein	protein
as	O
activation	O
of	O
its	O
expression	O
in	O
erythroid	O
precursors	O
by	O
proviral	O
insertion	O
or	O
transgenesis	O
causes	O
erythroleukemias	O
in	O
mice	O
.	O
Restoration	O
of	O
terminal	O
differentiation	O
in	O
the	O
mouse	cell_line
erythroleukemia	cell_line
(	cell_line
MEL	cell_line
)	cell_line
cells	cell_line
requires	O
a	O
decline	O
in	O
the	O
level	O
of	O
PU.1	protein
,	O
indicating	O
that	O
PU.1	protein
can	O
block	O
erythroid	O
differentiation	O
.	O
Here	O
we	O
investigate	O
the	O
mechanism	O
by	O
which	O
PU.1	protein
interferes	O
with	O
erythroid	O
differentiation	O
.	O
We	O
find	O
that	O
PU.1	protein
interacts	O
directly	O
with	O
GATA-1	protein
,	O
a	O
zinc	protein
finger	protein
transcription	protein
factor	protein
required	O
for	O
erythroid	O
differentiation	O
.	O
Interaction	O
between	O
PU.1	protein
and	O
GATA-1	protein
requires	O
intact	O
DNA-binding	protein
domains	protein
in	O
both	O
proteins.	O
PU.1	protein
represses	O
GATA-1	protein
-mediated	O
transcriptional	O
activation	O
.	O
Both	O
the	O
DNA	protein
binding	protein
and	O
transactivation	protein
domains	protein
of	O
PU.1	protein
are	O
required	O
for	O
repression	O
and	O
both	O
domains	O
are	O
also	O
needed	O
to	O
block	O
terminal	O
differentiation	O
in	O
MEL	cell_line
cells	cell_line
.	O
We	O
also	O
show	O
that	O
ectopic	O
expression	O
of	O
PU.1	protein
in	O
Xenopus	O
embryos	O
is	O
sufficient	O
to	O
block	O
erythropoiesis	O
during	O
normal	O
development.	O
Furthermore,	O
introduction	O
of	O
exogenous	O
GATA-1	protein
in	O
both	O
MEL	cell_line
cells	cell_line
and	O
Xenopus	O
embryos	O
and	O
explants	O
relieves	O
the	O
block	O
to	O
erythroid	O
differentiation	O
imposed	O
by	O
PU.1	protein
.	O
Our	O
results	O
indicate	O
that	O
the	O
stoichiometry	O
of	O
directly	O
interacting	O
but	O
opposing	O
transcription	protein
factors	protein
may	O
be	O
a	O
crucial	O
determinant	O
governing	O
processes	O
of	O
normal	O
differentiation	O
and	O
malignant	O
transformation.	O

IL-12	protein
induces	O
IFN	protein
regulating	protein
factor-1	protein
(	protein
IRF-1	protein
)	protein
gene	O
expression	O
in	O
human	O
NK	cell_type
and	O
T	cell_type
cells	cell_type
.	O
IL-12	protein
is	O
a	O
critical	protein
immunoregulatory	protein
cytokine	protein
that	O
promotes	O
cell-mediated	O
immune	O
responses	O
and	O
the	O
differentiation	O
of	O
naive	O
CD4+	cell_type
cells	cell_type
to	O
Th1	cell_type
cells	cell_type
;	O
however,	O
relatively	O
few	O
IL-12	protein
target	O
genes	O
have	O
been	O
identified.	O
To	O
better	O
clarify	O
the	O
molecular	O
basis	O
of	O
IL-12	protein
action,	O
we	O
set	O
out	O
to	O
characterize	O
genes	O
up-regulated	O
by	O
IL-12	protein
,	O
first	O
by	O
contrasting	O
IL-12	DNA
-and	O
IFN	DNA
-alpha-inducible	DNA
genes	DNA
.	O
We	O
identified	O
several	O
genes	O
up-regulated	O
by	O
IL-12	protein
,	O
namely,	O
MIP-1alpha	protein
,	O
MIP-1beta	protein
,	O
IL-1RA	protein
,	O
and	O
IFN	protein
regulatory	protein
factor-1	protein
(	protein
IRF-1	protein
)	protein
.	O
IRF-1	protein
is	O
a	O
transcription	protein
factor	protein
regulated	O
by	O
IFNs	protein
that	O
is	O
also	O
essential	O
for	O
Th1	cell_type
responses	O
.	O
We	O
demonstrated	O
that	O
IL-12	protein
directly	O
up-regulates	O
IRF-1	protein
to	O
the	O
same	O
extent	O
as	O
IFN-alpha	protein
in	O
normal	O
human	O
T	cell_type
cells	cell_type
and	O
in	O
NK	cell_type
cells	cell_type
.	O
We	O
showed	O
that	O
IL-12	protein
had	O
a	O
direct	O
effect	O
on	O
IRF-1	protein
,	O
an	O
effect	O
not	O
mediated	O
indirectly	O
by	O
the	O
induction	O
of	O
IFN-gamma	protein
production	O
.	O
Furthermore,	O
IL-2	protein
and	O
IL-12	protein
synergistically	O
induced	O
IRF-1	protein
,	O
whereas	O
IFN-alpha	protein
and	O
IL-12	protein
did	O
not.	O
The	O
participation	O
of	O
STAT4	protein
in	O
the	O
regulation	O
of	O
IRF-1	protein
was	O
demonstrated	O
in	O
two	O
ways.	O
First,	O
STAT4	protein
was	O
required	O
for	O
the	O
IL-12	protein
-dependent	O
transactivation	O
of	O
an	O
IRF-1	DNA
reporter	DNA
construct	DNA
,	O
and	O
second,	O
STAT4	protein
binding	O
to	O
the	O
IRF-1	DNA
promoter	DNA
was	O
shown	O
using	O
EMSA	O
.	O
In	O
contrast	O
to	O
IL-12	protein
,	O
no	O
up-regulation	O
of	O
IRF-1	protein
was	O
found	O
in	O
IL-4	cell_line
-stimulated	cell_line
cells	cell_line
,	O
and	O
IL-4	protein
did	O
not	O
block	O
IL-12	protein
-dependent	O
up-regulation	O
of	O
IRF-1	protein
.	O
Therefore,	O
IRF-1	protein
may	O
be	O
an	O
important	O
contributor	O
to	O
IL-12	protein
signaling	O
,	O
and	O
we	O
speculate	O
that	O
the	O
defective	O
IL-12	protein
responses	O
seen	O
in	O
IRF	protein
-1-/-	O
mice	O
might	O
be	O
attributable,	O
in	O
part,	O
to	O
the	O
absence	O
of	O
this	O
transcription	protein
factor	protein
.	O

Targeted	O
remodeling	O
of	O
human	DNA
beta-globin	DNA
promoter	DNA
chromatin	DNA
structure	DNA
produces	O
increased	O
expression	O
and	O
decreased	O
silencing.	O
The	O
chromatin	DNA
structure	DNA
of	O
the	O
human	DNA
beta-globin	DNA
gene	DNA
locus	DNA
assumes	O
a	O
transcriptionally-active	O
conformation	O
in	O
erythroid	cell_type
cells	cell_type
.	O
One	O
feature	O
of	O
this	O
chromatin	O
reorganization	O
is	O
the	O
formation	O
of	O
DNase	DNA
1	DNA
hypersensitive	DNA
sites	DNA
in	O
the	O
regions	O
of	O
active	DNA
globin	DNA
gene	DNA
promoters	DNA
.	O
This	O
reorganization	O
requires	O
the	O
globin	DNA
locus	DNA
control	DNA
region	DNA
and	O
is	O
associated	O
with	O
normal	O
expression	O
of	O
the	O
beta-like	DNA
globin	DNA
genes	DNA
.	O
To	O
determine	O
whether	O
it	O
is	O
possible	O
to	O
artificially	O
enhance	O
the	O
opening	O
of	O
the	O
chromatin	O
structure	O
of	O
a	O
minimal	DNA
beta-globin	DNA
promoter	DNA
,	O
we	O
placed	O
a	O
101bp,	O
erythroid-specific	DNA
DNase	DNA
1	DNA
hypersensitive	DNA
site-forming	DNA
element	DNA
(	O
HSFE	DNA
)	O
immediately	O
upstream	O
of	O
the	O
beta-globin	O
promoter	O
and	O
gene	O
.	O
This	O
element	O
includes	O
binding	O
sites	O
for	O
NF-E2	protein
,	O
AP-1	protein
,	O
GATA-1	protein
and	O
Sp-1	protein
.	O
Constructs	O
were	O
stably	O
transfected	O
into	O
murine	cell_type
erythroleukemia	cell_type
cells	cell_type
and	O
promoter	DNA
chromatin	DNA
structure	DNA
and	O
gene	O
expression	O
were	O
analyzed.	O
The	O
HSFE	DNA
induced	O
an	O
area	O
of	O
enhanced	O
DNase	protein
1	protein
hypersensitivity	O
extending	O
from	O
the	O
transcriptional	O
start	O
site	O
to	O
-300bp	O
of	O
the	O
artificial	DNA
promoter	DNA
and	O
significantly	O
increased	O
the	O
proportion	O
of	O
beta-globin	DNA
promoters	DNA
in	O
an	O
open	DNA
chromatin	DNA
configuration	DNA
.	O
This	O
remodeling	O
of	O
promoter	DNA
chromatin	DNA
structure	DNA
resulted	O
in	O
3-fold	O
increases	O
in	O
beta-globin	DNA
gene	DNA
transcription	O
and	O
induction,	O
and	O
inhibited	O
long-term	O
beta-globin	DNA
gene	DNA
silencing	O
.	O
These	O
results	O
indicate	O
that	O
a	O
relatively	O
small	O
cis-acting	DNA
element	DNA
is	O
able	O
to	O
enhance	O
remodeling	O
of	O
promoter	DNA
chromatin	DNA
structure	DNA
resulting	O
in	O
increased	O
beta-globin	DNA
gene	DNA
expression	O
.	O

Regulation	O
of	O
low	O
shear	O
flow-induced	O
HAEC	cell_line
VCAM-1	protein
expression	O
and	O
monocyte	O
adhesion.	O
We	O
recently	O
reported	O
that	O
prolonged	O
exposure	O
of	O
human	cell_type
aortic	cell_type
endothelial	cell_type
cells	cell_type
(	O
HAEC	cell_line
)	O
to	O
low	O
shear	O
stress	O
flow	O
patterns	O
is	O
associated	O
with	O
a	O
sustained	O
increase	O
in	O
the	O
activated	O
form	O
of	O
the	O
transcriptional	O
regulator	O
nuclear	protein
factor-kappaB	protein
(	O
NF-kappaB	protein
).	O
Here	O
we	O
investigate	O
the	O
hypothesis	O
that	O
low	O
shear-induced	O
activation	O
of	O
NF-kappaB	protein
is	O
responsible	O
for	O
enhanced	O
expression	O
of	O
vascular	protein
cell	protein
adhesion	protein
molecule	protein
(	O
VCAM-1	protein
)	O
resulting	O
in	O
augmented	O
endothelial	O
cell-monocyte	O
(EC-Mn)	O
adhesion	O
and	O
that	O
this	O
activation	O
is	O
dependent	O
on	O
intracellular	O
oxidant	O
activity.	O
Before	O
exposure	O
to	O
low	O
shear	O
(2	O
dyn/cm2)	O
for	O
6	O
h,	O
HAEC	cell_line
were	O
preincubated	O
with	O
or	O
without	O
the	O
antioxidants	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
)	O
or	O
N-acetyl-L-cysteine	O
(	O
NAC	O
).	O
PDTC	O
strongly	O
inhibited	O
low	O
shear-induced	O
activation	O
of	O
NF-kappaB	protein
,	O
expression	O
of	O
VCAM-1	protein
,	O
and	O
EC-Mn	O
adhesion	O
.	O
Paradoxically,	O
NAC	O
exerted	O
a	O
positive	O
effect	O
on	O
low	O
shear-induced	O
VCAM-1	protein
expression	O
and	O
EC-Mn	O
adhesion	O
and	O
only	O
slightly	O
downregulated	O
NF-kappaB	protein
activation.	O
However,	O
cytokine-induced	O
NF-kappaB	protein
activation	O
and	O
VCAM-1	protein
expression	O
are	O
blocked	O
by	O
both	O
PDTC	O
and	O
NAC	O
.	O
These	O
data	O
suggest	O
that	O
NF-kappaB	protein
plays	O
a	O
key	O
role	O
in	O
low	O
shear-induced	O
VCAM-1	protein
expression	O
and	O
that	O
pathways	O
mediating	O
low	O
shear-	O
and	O
cytokine-induced	O
EC-Mn	O
adhesion	O
may	O
be	O
differentially	O
regulated.	O

Nuclear	protein
factor-90	protein
of	O
activated	cell_type
T-cells	cell_type
:	O
A	O
double-stranded	RNA
RNA	RNA
-binding	O
protein	O
and	O
substrate	O
for	O
the	O
double-stranded	protein
RNA-dependent	protein
protein	protein
kinase	protein
,	O
PKR	protein
.	O
NFAT	O
transcription	O
factors	O
play	O
a	O
central	O
role	O
in	O
initiating	O
T-cell	O
activation	O
through	O
the	O
induction	O
of	O
immediate-early	O
T-cell	O
specific	O
genes	O
including	O
interleukin-2	O
(	O
IL-2	protein
).	O
NFAT	O
transcription	O
factors	O
bind	O
to	O
a	O
sequence	O
in	O
the	O
IL-2	DNA
enhancer	DNA
known	O
as	O
the	O
antigen	DNA
receptor	DNA
response	DNA
element	DNA
2	DNA
(	O
ARRE-2	DNA
).	O
Multiple	O
proteins	O
exhibiting	O
ARRE-2	DNA
binding	O
activity	O
have	O
been	O
isolated,	O
including	O
a	O
heterodimer	protein
from	O
stimulated	O
T-cell	O
nuclear	O
extracts	O
consisting	O
of	O
Mr	O
=	O
90	O
000	O
(	O
NF90	protein
)	O
and	O
Mr	O
=	O
45	O
000	O
(	O
NF45	protein
)	O
subunits.	O
The	O
subunits	O
of	O
this	O
heterodimer	protein
have	O
been	O
cloned,	O
and	O
NF90	protein
was	O
found	O
to	O
encode	O
a	O
protein	O
containing	O
two	O
domains	O
that	O
are	O
predicted	O
to	O
form	O
motifs	O
capable	O
of	O
binding	O
to	O
double-stranded	RNA
RNA	RNA
.	O
Using	O
in	O
vitro	O
translated	O
polypeptides	O
,	O
we	O
have	O
demonstrated	O
that	O
NF90	protein
specifically	O
binds	O
to	O
double-stranded	RNA
RNA	RNA
.	O
Furthermore,	O
NF90	protein
was	O
phosphorylated	O
in	O
a	O
double-stranded	RNA
RNA	RNA
-dependent	O
manner	O
likely	O
by	O
the	O
interferon-induced,	O
double-stranded	protein
RNA	protein
-dependent	protein
protein	protein
kinase	protein
,	O
PKR	protein
.	O
The	O
NF90	protein
protein	O
was	O
found	O
to	O
be	O
expressed	O
not	O
only	O
in	O
T-cells	cell_type
,	O
but	O
also	O
in	O
nonimmune	cell_line
HeLa	cell_line
cells	cell_line
.	O
In	O
HeLa	cell_line
cells	cell_line
,	O
the	O
protein	O
was	O
almost	O
exclusively	O
localized	O
to	O
the	O
ribosome	O
salt	O
wash	O
fraction	O
of	O
cell	O
lysates	O
.	O

NF-kappaB	protein
activation	O
is	O
required	O
for	O
C5a	DNA
-induced	DNA
interleukin-8	DNA
gene	DNA
expression	O
in	O
mononuclear	cell_type
cells	cell_type
.	O
C5a	O
,	O
a	O
potent	O
peptide	O
chemoattractant	O
,	O
stimulates	O
interleukin-8	protein
(	O
IL-8	protein
)	O
secretion	O
from	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
).	O
Experiments	O
were	O
conducted	O
to	O
understand	O
the	O
mechanisms	O
for	O
C5a	O
-induced	O
IL-8	protein
production	O
,	O
which	O
was	O
14-fold	O
greater	O
than	O
that	O
in	O
unstimulated	cell_type
cells	cell_type
by	O
2	O
hours.	O
IL-8	protein
secretion	O
was	O
accompanied	O
by	O
accumulation	O
of	O
IL-8	RNA
mRNA	RNA
in	O
the	O
cytosol	O
and	O
by	O
nuclear	O
expression	O
of	O
a	O
kappaB	protein
DNA	O
binding	O
activity	O
within	O
30	O
minutes.	O
AP-1	protein
but	O
not	O
NF-IL-6	protein
DNA	O
binding	O
activity	O
was	O
also	O
detected	O
in	O
C5a	cell_line
-stimulated	cell_line
PBMC	cell_line
;	O
however,	O
its	O
delayed	O
expression	O
(maximal	O
at	O
4	O
hours)	O
suggested	O
a	O
less	O
important	O
role	O
in	O
the	O
rapid	O
production	O
of	O
IL-8	protein
.	O
The	O
correlation	O
between	O
C5a	O
-induced	O
kappaB	protein
binding	O
activity	O
and	O
IL-8	protein
gene	O
expression	O
was	O
examined	O
in	O
the	O
RAW264.7	cell_line
macrophage	cell_line
cells	cell_line
using	O
reporter	O
genes	O
directed	O
by	O
the	O
kappaB	DNA
sequence	DNA
from	O
IkappaBalpha	protein
and	O
IL-8	DNA
promoter	DNA
regions	DNA
.	O
C5a	O
-induced	O
reporter	DNA
gene	DNA
expression	O
was	O
abolished	O
by	O
introducing	O
mutations	O
into	O
the	O
kappaB	DNA
sites	DNA
and	O
by	O
coexpression	O
of	O
a	O
dominant	DNA
negative	DNA
IkappaBalpha	DNA
construct	DNA
resistant	O
to	O
agonist-induced	O
phosphorylation	O
.	O
Pertussis	O
toxin	O
,	O
which	O
ADP	O
-ribosylates	O
the	O
Gi	protein
proteins	protein
known	O
to	O
couple	O
to	O
the	O
C5a	protein
receptor	protein
,	O
produced	O
minimal	O
inhibition	O
of	O
C5a	O
-induced	O
IL-8	protein
expression	O
and	O
had	O
little	O
effect	O
on	O
C5a	O
-induced	O
calcium	O
mobilization	O
in	O
RAW264.7	cell_line
cells	cell_line
.	O
These	O
results	O
suggest	O
that	O
NF-kappaB	protein
activation	O
is	O
required	O
for	O
C5a	O
-induced	O
IL-8	protein
gene	O
expression	O
and	O
that	O
this	O
response	O
is	O
mediated	O
primarily	O
through	O
a	O
pertussis	O
toxin	O
-insensitive	O
pathway	O
.	O

Increased	O
glucocorticoid	protein
receptor	protein
beta	protein
in	O
airway	cell_type
cells	cell_type
of	O
glucocorticoid	O
-insensitive	O
asthma	O
.	O
Glucocorticoid	O
(	O
GC	O
)-insensitive	O
asthma	O
is	O
a	O
challenging	O
clinical	O
problem	O
that	O
can	O
be	O
associated	O
with	O
life-threatening	O
disease	O
progression	O
.	O
The	O
molecular	O
basis	O
of	O
GC	O
insensitivity	O
is	O
unknown.	O
Alternative	O
splicing	O
of	O
the	O
GC	RNA
receptor	RNA
(	RNA
GCR	RNA
)	RNA
pre-mRNA	RNA
generates	O
a	O
second	O
GCR	protein
,	O
termed	O
GCRbeta	protein
,	O
which	O
does	O
not	O
bind	O
GC	O
but	O
antagonizes	O
the	O
transactivating	O
activity	O
of	O
the	O
classic	O
GCR	protein
.	O
Thus	O
increased	O
expression	O
of	O
GCRbeta	protein
could	O
account	O
for	O
glucocorticoid	O
insensitivity	O
.	O
Bronchoalveolar	cell_type
lavage	cell_type
(BAL)	cell_type
cells	cell_type
and	O
peripheral	O
blood	O
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
)	O
were	O
examined	O
for	O
GCRbeta	protein
immunoreactivity	O
using	O
a	O
GCRbeta	protein
-specific	protein
antibody	protein
by	O
immunohistochemical	O
staining	O
.	O
Cell	O
localization	O
of	O
GCRbeta	protein
expression	O
was	O
performed	O
using	O
a	O
double	O
immunostaining	O
technique	O
.	O
Patients	O
with	O
GC	O
-insensitive	O
asthma	O
expressed	O
a	O
significantly	O
higher	O
number	O
of	O
GCRbeta	cell_type
-immunoreactive	cell_type
cells	cell_type
in	O
their	O
BAL	O
and	O
peripheral	O
blood	O
than	O
GC	O
-sensitive	O
asthmatics	O
or	O
normal	O
control	O
subjects	O
.	O
Furthermore,	O
GCRbeta	protein
expression	O
in	O
GC-insensitive	O
asthma	O
was	O
particularly	O
high	O
in	O
airway	O
T	cell_type
cells	cell_type
,	O
which	O
are	O
thought	O
to	O
play	O
a	O
major	O
role	O
in	O
the	O
pathogenesis	O
of	O
asthma	O
.	O
We	O
also	O
examined	O
the	O
expression	O
of	O
GCRbeta	protein
in	O
specimens	O
from	O
the	O
airways	O
of	O
patients	O
with	O
chronic	O
bronchitis	O
.	O
In	O
chronic	O
bronchitis	O
,	O
few	O
cells	O
were	O
GCRbeta	cell_type
-positive	cell_type
and	O
their	O
numbers	O
did	O
not	O
differ	O
significantly	O
from	O
normal	O
control	O
subjects	O
.	O
We	O
conclude	O
that	O
GC	O
-insensitive	O
asthma	O
is	O
associated	O
with	O
increased	O
expression	O
of	O
GCRbeta	protein
in	O
airway	O
T	cell_type
cells	cell_type
.	O

Activation	O
of	O
the	O
Janus	protein
kinase	protein
3	protein
-STAT5a	protein
pathway	O
after	O
CD40	protein
triggering	O
of	O
human	cell_type
monocytes	cell_type
but	O
not	O
of	O
resting	cell_type
B	cell_type
cells	cell_type
.	O
CD40	protein
/CD40	protein
ligand	O
interactions	O
play	O
a	O
key	O
role	O
in	O
the	O
immune	O
responses	O
of	O
B	cell_type
lymphocytes	cell_type
,	O
monocytes	cell_type
,	O
and	O
dendritic	cell_type
cells	cell_type
.	O
The	O
signal	O
transduction	O
events	O
triggered	O
by	O
cross-linking	O
of	O
the	O
CD40	protein
receptor	protein
have	O
been	O
widely	O
studied	O
in	O
B	cell_line
cell	cell_line
lines	cell_line
,	O
but	O
little	O
is	O
known	O
about	O
signaling	O
following	O
CD40	protein
stimulation	O
of	O
monocytes	cell_type
and	O
resting	cell_line
tonsillar	cell_line
B	cell_line
cells	cell_line
.	O
Therefore,	O
we	O
studied	O
the	O
CD40	protein
pathway	O
in	O
highly	O
purified	O
human	cell_type
monocytes	cell_type
and	O
resting	cell_type
B	cell_type
cells	cell_type
.	O
After	O
CD40	protein
triggering	O
,	O
a	O
similar	O
activation	O
of	O
the	O
NF-kappaB	protein
(but	O
not	O
of	O
the	O
AP-1	protein
)	O
transcription	protein
factor	protein
complex	protein
occurred	O
in	O
both	O
cell	O
preparations.	O
However,	O
the	O
components	O
of	O
the	O
NF-kappaB	protein
complexes	protein
were	O
different	O
in	O
monocytes	cell_type
and	O
B	O
cells,	O
because	O
p50	protein
is	O
part	O
of	O
the	O
NF-kappaB	protein
complex	protein
induced	O
by	O
CD40	protein
triggering	O
in	O
both	O
monocytes	cell_type
and	O
B	cell_type
cells	cell_type
,	O
whereas	O
p65	protein
was	O
only	O
induced	O
in	O
B	cell_type
cells	cell_type
.	O
In	O
contrast,	O
although	O
the	O
Janus	protein
kinase	protein
3	protein
tyrosine	protein
kinase	protein
was	O
associated	O
with	O
CD40	protein
molecules	O
in	O
both	O
monocytes	cell_type
and	O
resting	cell_type
B	cell_type
cells	cell_type
,	O
Janus	protein
kinase	protein
3	protein
phosphorylation	O
induction	O
was	O
observed	O
only	O
in	O
CD40	cell_line
-activated	cell_line
monocytes	cell_line
,	O
with	O
subsequent	O
induction	O
of	O
STAT5a	protein
DNA	O
binding	O
activity	O
in	O
the	O
nucleus	O
.	O
These	O
results	O
suggest	O
that	O
the	O
activation	O
signals	O
in	O
human	cell_type
B	cell_type
cells	cell_type
and	O
monocytes	cell_type
differ	O
following	O
CD40	protein
stimulation	O
.	O
This	O
observation	O
is	O
consistent	O
with	O
the	O
detection	O
of	O
normal	O
CD40	protein
-induced	O
monocyte	O
activation	O
in	O
patients	O
with	O
CD40	protein
ligand+	O
hyper	O
IgM	protein
syndrome	O
in	O
whom	O
a	O
defect	O
in	O
CD40	protein
-induced	O
B	O
cell	O
activation	O
has	O
been	O
reported.	O

Genetic	O
evidence	O
for	O
an	O
additional	O
factor	O
required	O
for	O
erythropoietin	protein
-induced	O
signal	O
transduction	O
.	O
Erythropoietin	protein
(	O
EPO	protein
)	O
and	O
its	O
receptor	O
(	O
EPOR	protein
)	O
are	O
required	O
for	O
the	O
development	O
of	O
mature	O
erythrocytes.	O
After	O
binding	O
of	O
ligand,	O
the	O
EPOR	protein
activates	O
a	O
variety	O
of	O
signaling	O
pathways	O
that	O
ultimately	O
control	O
cellular	O
proliferation	O
,	O
survival,	O
and	O
specific	O
gene	O
expression.	O
Although	O
erythroid	cell_type
progenitors	cell_type
appear	O
to	O
be	O
the	O
principal	O
EPO	cell_type
-responsive	cell_type
cell	cell_type
type	cell_type
in	O
vivo	O
due	O
to	O
the	O
restricted	O
expression	O
of	O
the	O
EPOR	protein
,	O
many	O
growth	cell_line
factor-dependent	cell_line
cell	cell_line
lines	cell_line
expressing	O
the	O
EPOR	protein
can	O
respond	O
to	O
EPO	protein
by	O
activating	O
many	O
or	O
all	O
of	O
these	O
pathways.	O
In	O
the	O
present	O
study,	O
we	O
have	O
identified	O
a	O
cellular	O
context	O
(the	O
interleukin-2	cell_line
[IL-2]-dependent	cell_line
HT-2	cell_line
line	cell_line
)	O
in	O
which	O
the	O
EPO	protein
stimulation	O
of	O
the	O
EPOR	protein
fails	O
to	O
support	O
cellular	O
proliferation,	O
STAT-5	protein
induction	O
,	O
or	O
MAPK	protein
activation	O
,	O
despite	O
efficient	O
phosphorylation	O
of	O
the	O
EPOR	protein
and	O
JAK2	protein
and	O
inhibition	O
of	O
apoptosis	O
after	O
withdrawal	O
of	O
IL-2	protein
.	O
Interestingly,	O
when	O
we	O
fused	O
HT-2	cell_line
cells	cell_line
expressing	O
the	O
EPOR	protein
with	O
Ba/F3	cell_line
cells	cell_line
in	O
a	O
complementation	O
assay	O
,	O
the	O
resulting	O
hybridomas	cell_line
proliferated	O
and	O
potently	O
activated	O
STAT-5	protein
and	O
MAPK	protein
in	O
response	O
to	O
EPO	protein
.	O
These	O
data	O
indicate	O
that	O
an	O
unidentified	protein
cellular	protein
factor	protein
is	O
needed	O
to	O
mediate	O
signaling	O
by	O
the	O
EPOR	protein
.	O
Moreover,	O
Ba/F3	cell_line
cells	cell_line
apparently	O
express	O
this	O
factor(s)	O
and	O
somatic	O
fusions	O
can,	O
therefore,	O
confer	O
EPO	protein
-responsiveness	O
to	O
HT-2	cell_line
cells	cell_line
that	O
lack	O
this	O
factor.	O

Novel	O
therapies	O
for	O
inflammatory	O
bowel	O
disease	O
.	O
Looking	O
back	O
at	O
successes	O
and	O
failures	O
in	O
newer	O
approaches	O
to	O
treating	O
IBD	O
,	O
it	O
is	O
tempting--although	O
still	O
difficult--to	O
draw	O
conclusions	O
about	O
pathogenesis	O
.	O
When	O
a	O
therapy	O
proves	O
effective,	O
do	O
clinicians	O
truly	O
know	O
how	O
it	O
works?	O
Even	O
with	O
a	O
therapy	O
as	O
specific	O
as	O
anti-TNF	protein
antibody	protein
,	O
it	O
is	O
not	O
clear	O
if	O
the	O
benefit	O
is	O
attributable	O
to	O
simple	O
binding	O
and	O
clearance	O
of	O
TNF-alpha	protein
or	O
to	O
binding	O
on	O
the	O
cell	O
surface	O
and	O
subsequent	O
deletion	O
of	O
the	O
activated	cell_type
macrophage	cell_type
.	O
When	O
a	O
drug	O
appears	O
to	O
be	O
less	O
effective	O
than	O
preclinical	O
models	O
suggest,	O
can	O
failures	O
in	O
effectiveness	O
from	O
delivery	O
or	O
dosing	O
be	O
differentiated?	O
The	O
disappointing	O
results	O
of	O
clinical	O
trials	O
with	O
IL-10	protein
--so	O
at	O
odds	O
with	O
the	O
prediction	O
of	O
benefit	O
from	O
animal	O
models	O
--bring	O
into	O
question	O
the	O
validity	O
of	O
those	O
models	O
as	O
well	O
as	O
the	O
soundness	O
of	O
design	O
of	O
the	O
clinical	O
trials	O
on	O
which	O
efficacy	O
of	O
IL-10	protein
is	O
judged.	O
The	O
variability	O
of	O
response	O
even	O
to	O
the	O
most	O
narrowly	O
targeted	O
agents	O
suggests	O
that	O
these	O
diseases	O
are	O
far	O
more	O
heterogeneous	O
in	O
humans	O
than	O
in	O
their	O
murine	O
counterparts	O
.	O
Clinicians	O
are	O
only	O
just	O
beginning	O
to	O
recognize	O
subclinical	O
markers	O
of	O
response,	O
and	O
it	O
may	O
soon	O
be	O
possible	O
to	O
predict	O
response	O
on	O
the	O
basis	O
of	O
genetic	O
composition	O
.	O
For	O
the	O
moment,	O
however,	O
the	O
field	O
of	O
pharmacogenetics	O
is	O
embryonic.	O
Challenges	O
in	O
developing	O
new	O
therapeutic	O
strategies	O
include	O
not	O
only	O
identifying	O
novel	O
agents,	O
but	O
also	O
improving	O
the	O
definitions	O
of	O
clinical	O
endpoints	O
and	O
defining	O
efficacy	O
at	O
the	O
biologic	O
level.	O
Only	O
through	O
considered	O
evaluation	O
of	O
clinical	O
evidence	O
may	O
clinicians	O
determine	O
which	O
therapies	O
should	O
remain	O
novelties	O
and	O
which	O
should	O
become	O
an	O
accepted	O
part	O
of	O
the	O
armamentarium	O
.	O

Potent	O
and	O
stable	O
attenuation	O
of	O
live-HIV-1	O
by	O
gain	O
of	O
a	O
proteolysis-resistant	protein
inhibitor	protein
of	O
NF-kappaB	protein
(	O
IkappaB-alphaS32/36A	protein
)	O
and	O
the	O
implications	O
for	O
vaccine	O
development	O
.	O
Live-attenuated	O
human	O
immunodeficiency	O
viruses	O
(	O
HIVs	O
)	O
are	O
candidates	O
for	O
Acquired	O
Immunodeficiency	O
Syndrome	O
(AIDS)	O
vaccine	O
.	O
Based	O
on	O
the	O
simian	O
immunodeficiency	O
virus	O
(SIV)	O
model	O
for	O
AIDS	O
,	O
loss-of-function	O
(e.g.	O
deletion	O
of	O
accessory	O
genes	O
such	O
as	O
nef	DNA
)	O
has	O
been	O
forwarded	O
as	O
a	O
primary	O
approach	O
for	O
creating	O
enfeebled,	O
but	O
replication-competent,	O
HIV-1/SIV	O
.	O
Regrettably,	O
recent	O
evidence	O
suggests	O
that	O
loss-of-function	O
alone	O
is	O
not	O
always	O
sufficient	O
to	O
prevent	O
the	O
emergence	O
of	O
virulent	O
mutants	O
.	O
New	O
strategies	O
that	O
attenuate	O
via	O
mechanisms	O
distinct	O
from	O
loss-of-function	O
are	O
needed	O
for	O
enhancing	O
the	O
safety	O
phenotype	O
of	O
viral	DNA
genome	DNA
.	O
Here,	O
we	O
propose	O
gain-of-function	O
to	O
be	O
used	O
simultaneously	O
with	O
loss-of-function	O
as	O
a	O
novel	O
approach	O
for	O
attenuating	O
HIV-1	O
.	O
We	O
have	O
constructed	O
an	O
HIV-1	DNA
genome	DNA
carrying	O
the	O
cDNA	DNA
of	O
a	O
proteolysis-resistant	protein
nuclear	protein
factor-kappaB	protein
inhibitor	protein
(	O
IkappaB-alphaS32/36A	protein
)	O
in	O
the	O
nef	DNA
region	DNA
.	O
HIV-1	O
expressing	O
IkappaB-alphaS32/36A	protein
down-regulates	O
viral	O
expression	O
and	O
is	O
highly	O
attenuated	O
in	O
both	O
Jurkat	cell_line
and	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
.	O
We	O
provide	O
formal	O
proof	O
that	O
the	O
phenotypic	O
and	O
attenuating	O
characteristics	O
of	O
IkappaB-alphaS32/36A	protein
permit	O
its	O
stable	O
maintenance	O
in	O
a	O
live,	O
replicating	O
HIV-1	O
despite	O
180	O
days	O
of	O
forced	O
ex	O
vivo	O
passaging	O
in	O
tissue	O
culture	O
.	O
As	O
compared	O
with	O
other	O
open-reading	DNA
frames	DNA
embedded	O
into	O
HIV/SIV	DNA
genome	DNA
,	O
this	O
degree	O
of	O
stability	O
is	O
unprecedented.	O
Thus,	O
IkappaB-alphaS32/36A	protein
offers	O
proof-of-principle	O
that	O
artifactually	O
gained	O
functions,	O
when	O
used	O
to	O
attenuate	O
the	O
replication	O
of	O
live	O
HIV-1	O
,	O
can	O
be	O
stable.	O
These	O
findings	O
illustrate	O
gain-of-function	O
as	O
a	O
feasible	O
strategy	O
for	O
developing	O
safer	O
live-attenuated	O
HIVs	O
to	O
be	O
tested	O
as	O
candidates	O
for	O
AIDS	O
vaccine	O
.	O

Multiple	O
NF-ATc	protein
isoforms	protein
with	O
individual	O
transcriptional	O
properties	O
are	O
synthesized	O
in	O
T	cell_type
lymphocytes	cell_type
.	O
The	O
transcription	protein
factor	protein
NF-ATc	protein
that	O
controls	O
gene	O
expression	O
in	O
T	cell_type
lymphocytes	cell_type
and	O
embryonic	cell_type
cardiac	cell_type
cells	cell_type
is	O
expressed	O
in	O
three	O
prominent	O
isoforms.	O
This	O
is	O
due	O
to	O
alternative	O
splice/polyadenylation	O
events	O
that	O
lead	O
to	O
the	O
predominant	O
synthesis	O
of	O
two	O
long	O
isoforms	O
in	O
naive	cell_type
T	cell_type
cells	cell_type
and	O
a	O
shorter	O
NF-ATc	protein
isoform	protein
in	O
effector	cell_type
T	cell_type
cells	cell_type
.	O
Whereas	O
the	O
previously	O
described	O
isoform	protein
NF-ATc	protein
/A	protein
contains	O
a	O
relatively	O
short	O
C	protein
terminus	protein
,	O
the	O
longer	O
isoforms,	O
B	protein
and	O
C	protein
,	O
span	O
extra	O
C-terminal	O
peptides	O
of	O
128	O
and	O
246	O
aa	O
,	O
respectively.	O
We	O
show	O
here	O
that	O
in	O
addition	O
to	O
the	O
strong	protein
N-terminal	protein
trans-activation	protein
domain	protein
,	O
TAD-A	protein
,	O
which	O
is	O
common	O
to	O
all	O
three	O
NF-ATc	protein
isoforms	protein
,	O
NF-ATc	protein
/C	protein
contains	O
a	O
second	O
trans-activation	protein
domain	protein
,	O
TAD-B	protein
,	O
in	O
its	O
C-terminal	O
peptide	O
.	O
Various	O
stimuli	O
of	O
T	cell_type
cells	cell_type
that	O
induce	O
the	O
activity	O
of	O
TAD-A	protein
also	O
enhance	O
the	O
activity	O
of	O
TAD-B	protein
,	O
but,	O
unlike	O
TAD-A	protein
,	O
TAD-B	protein
remains	O
unphosphorylated	O
by	O
protein	O
from	O
12-O-tetradecanoyl	cell_line
12-phorbol	cell_line
13-acetate	cell_line
-stimulated	cell_line
T	cell_line
cells	cell_line
.	O
The	O
shorter	O
C-terminal	O
peptide	O
of	O
isoform	O
NF-ATc	protein
/B	protein
exerts	O
a	O
suppressive	O
transcriptional	O
effect	O
.	O
These	O
properties	O
of	O
NF-ATc	O
/	O
B	O
and	O
-	O
C	O
might	O
be	O
of	O
importance	O
for	O
gene	O
regulation	O
in	O
naive	cell_type
T	cell_type
lymphocytes	cell_type
in	O
which	O
NF-ATc	O
/	O
B	O
and	O
-C	O
are	O
predominantly	O
synthesized.	O

Selection	O
and	O
long-term	O
persistence	O
of	O
reactive	O
CTL	cell_line
clones	cell_line
during	O
an	O
EBV	O
chronic	O
response	O
are	O
determined	O
by	O
avidity,	O
CD8	protein
variable	O
contribution	O
compensating	O
for	O
differences	O
in	O
TCR	protein
affinities	O
.	O
Recent	O
studies	O
have	O
suggested	O
that	O
the	O
diversity	O
of	O
TCR	protein
repertoire	O
after	O
primary	O
immunization	O
is	O
conserved	O
in	O
memory	cell_type
T	cell_type
cells	cell_type
and	O
that	O
a	O
progressive	O
narrowing	O
of	O
this	O
repertoire	O
may	O
take	O
place	O
during	O
recall	O
infections	O
.	O
It	O
now	O
remains	O
to	O
be	O
investigated	O
which	O
parameters	O
determine	O
the	O
repertoire	O
of	O
the	O
memory	O
response	O
and	O
possibly	O
restrict	O
its	O
diversity	O
after	O
subsequent	O
antigenic	O
challenges	O
.	O
To	O
address	O
this	O
question,	O
we	O
took	O
advantage	O
of	O
a	O
panel	O
of	O
CD8+	cell_line
T	cell_line
cell	cell_line
clones	cell_line
from	O
the	O
joint	O
of	O
a	O
rheumatoid	O
arthritis	O
patient	O
and	O
selected	O
for	O
their	O
reactivity	O
against	O
a	O
single	protein
MHC/peptide	protein
complex	protein
.	O
Characterization	O
of	O
both	O
TCR	protein
chains	protein
documented	O
a	O
great	O
diversity	O
among	O
those	O
clones	O
and	O
the	O
persistence	O
of	O
clonotypes	O
over	O
a	O
2-yr	O
period.	O
Strikingly,	O
despite	O
the	O
observed	O
repertoire	O
heterogeneity,	O
all	O
clones	O
displayed	O
a	O
narrow	O
range	O
of	O
MHC	protein
/peptide	O
density	O
requirements	O
in	O
cytotoxicity	O
assays	O
(	O
ED50	O
between	O
9	O
and	O
36	O
nM).	O
TCR	protein
affinities	O
were	O
then	O
indirectly	O
estimated	O
by	O
blocking	O
CD8	protein
interaction	O
with	O
an	O
anti-CD8	protein
mAb	protein
.	O
We	O
found	O
a	O
wide	O
range	O
of	O
TCR	protein
affinities	O
among	O
the	O
different	O
clonotypes	O
that	O
segregated	O
with	O
Vbeta	O
usage.	O
We	O
thus	O
propose	O
that	O
during	O
an	O
in	O
vivo	O
chronic	O
response,	O
a	O
narrow	O
range	O
of	O
avidity	O
of	O
the	O
TCR	protein
-CD8	protein
complex	protein
conditions	O
long-term	O
clonotype	O
persistence,	O
and	O
that	O
the	O
level	O
of	O
CD8	protein
contribution	O
is	O
adjusted	O
to	O
keep	O
clonotypes	O
with	O
variable	O
TCR	protein
affinities	O
within	O
this	O
avidity	O
window	O
.	O

Nuclear	O
localization	O
and	O
formation	O
of	O
beta-catenin	protein
-lymphoid	protein
enhancer	protein
factor	protein
1	protein
complexes	protein
are	O
not	O
sufficient	O
for	O
activation	O
of	O
gene	O
expression	O
.	O
In	O
response	O
to	O
activation	O
of	O
the	O
Wnt	O
signaling	O
pathway	O
,	O
beta-catenin	protein
accumulates	O
in	O
the	O
nucleus	O
,	O
where	O
it	O
cooperates	O
with	O
LEF/TCF	protein
(for	O
lymphoid	protein
enhancer	protein
factor	protein
and	protein
T-cell	protein
factor	protein
)	O
transcription	protein
factors	protein
to	O
activate	O
gene	O
expression	O
.	O
The	O
mechanisms	O
by	O
which	O
beta-catenin	protein
undergoes	O
this	O
shift	O
in	O
location	O
and	O
participates	O
in	O
activation	O
of	O
gene	O
transcription	O
are	O
unknown.	O
We	O
demonstrate	O
here	O
that	O
beta-catenin	protein
can	O
be	O
imported	O
into	O
the	O
nucleus	O
independently	O
of	O
LEF/TCF	protein
binding	O
,	O
and	O
it	O
may	O
also	O
be	O
exported	O
from	O
nuclei	O
.	O
We	O
have	O
introduced	O
a	O
small	O
deletion	O
within	O
beta-catenin	protein
(	O
Delta19	DNA
)	O
that	O
disrupts	O
binding	O
to	O
LEF-1	protein
,	O
E-cadherin	protein
,	O
and	O
APC	protein
but	O
not	O
axin	protein
.	O
This	O
Delta19	protein
beta-catenin	protein
mutant	protein
localizes	O
to	O
the	O
nucleus	O
because	O
it	O
may	O
not	O
be	O
efficiently	O
sequestered	O
in	O
the	O
cytoplasm	O
.	O
The	O
nuclear	O
localization	O
of	O
Delta19	DNA
definitively	O
demonstrates	O
that	O
the	O
mechanisms	O
by	O
which	O
beta-catenin	protein
localizes	O
in	O
the	O
nucleus	O
are	O
completely	O
independent	O
of	O
LEF/TCF	protein
factors	protein
.	O
beta-Catenin	protein
and	O
LEF-1	protein
complexes	protein
can	O
activate	O
reporter	O
gene	O
expression	O
in	O
a	O
transformed	cell_line
T-lymphocyte	cell_line
cell	cell_line
line	cell_line
(	O
Jurkat	cell_line
)	O
but	O
not	O
in	O
normal	cell_type
T	cell_type
lymphocytes	cell_type
,	O
even	O
though	O
both	O
factors	O
are	O
nuclear.	O
Thus,	O
localization	O
of	O
both	O
factors	O
to	O
the	O
nucleus	O
is	O
not	O
sufficient	O
for	O
activation	O
of	O
gene	O
expression	O
.	O
Excess	O
beta-catenin	protein
can	O
squelch	O
reporter	O
gene	O
activation	O
by	O
LEF-1	protein
-beta-catenin	protein
complexes	protein
but	O
not	O
activation	O
by	O
the	O
transcription	protein
factor	protein
VP16	protein
.	O
Taken	O
together,	O
these	O
data	O
suggest	O
that	O
a	O
third	O
component	O
is	O
necessary	O
for	O
gene	O
activation	O
and	O
that	O
this	O
third	O
component	O
may	O
vary	O
with	O
cell	O
type.	O

Control	O
of	O
lymphocyte	O
development	O
by	O
the	O
Ikaros	DNA
gene	DNA
family	DNA
.	O
Lymphoid	O
cell	O
differentiation	O
relies	O
on	O
precisely	O
orchestrated	O
gene	O
activation	O
and	O
repression	O
events	O
.	O
Gene	O
targeting	O
studies	O
have	O
demonstrated	O
crucial	O
roles	O
for	O
the	O
transcription	protein
factors	protein
Ikaros	protein
and	O
Aiolos	protein
in	O
regulating	O
multiple	O
stages	O
of	O
B	O
and	O
T	O
cell	O
development	O
.	O
Recent	O
experiments	O
suggest	O
that	O
Ikaros	protein
and	O
Aiolos	protein
set	O
B	O
cell	O
antigen-receptor	O
(BCR)-	O
and	O
TCR-	O
mediated	O
signaling	O
thresholds	O
and	O
that	O
the	O
molecules	O
exist	O
within	O
T	cell_type
cells	cell_type
in	O
nuclear	protein
complexes	protein
that	O
contain	O
nucleosome	O
remodeling	O
and	O
histone	protein
deacetylase	protein
activities	O
.	O

Transcriptional	O
targeting	O
of	O
retroviral	O
vectors	O
to	O
the	O
erythroblastic	cell_type
progeny	cell_type
of	O
transduced	cell_line
hematopoietic	cell_line
stem	cell_line
cells	cell_line
.	O
Targeted	O
expression	O
to	O
specific	O
tissues	O
or	O
cell	O
lineages	O
is	O
a	O
necessary	O
feature	O
of	O
a	O
gene	O
therapy	O
vector	O
for	O
many	O
clinical	O
applications	O
,	O
such	O
as	O
correction	O
of	O
hemoglobinopathies	O
or	O
thalassemias	O
by	O
transplantation	O
of	O
genetically	cell_type
modified	cell_type
hematopoietic	cell_type
stem	cell_type
cells	cell_type
.	O
We	O
developed	O
retroviral	O
vectors	O
in	O
which	O
the	O
constitutive	DNA
viral	DNA
enhancer	DNA
in	O
the	O
U3	DNA
region	DNA
of	O
the	O
3'	DNA
LTR	DNA
is	O
replaced	O
by	O
an	O
autoregulatory	DNA
enhancer	DNA
of	O
the	O
erythroid-specific	DNA
GATA-1	DNA
transcription	DNA
factor	DNA
gene	DNA
.	O
The	O
replaced	DNA
enhancer	DNA
is	O
propagated	O
to	O
the	O
5'	DNA
LTR	DNA
upon	O
integration	O
into	O
the	O
target	DNA
cell	DNA
genome	DNA
.	O
The	O
modified	O
vectors	O
were	O
used	O
to	O
transduce	O
human	cell_line
hematopoietic	cell_line
cell	cell_line
lines	cell_line
,	O
cord	cell_type
blood-derived	cell_type
CD34(+)	cell_type
stem/progenitor	cell_type
cells	cell_type
,	O
and	O
murine	cell_line
bone	cell_line
marrow	cell_line
repopulating	cell_line
stem	cell_line
cells	cell_line
.	O
The	O
expression	O
of	O
appropriate	O
reporter	DNA
genes	DNA
(	O
triangle	DNA
upLNGFR	DNA
,	O
EGFP	DNA
)	O
was	O
analyzed	O
in	O
the	O
differentiated	O
progeny	O
of	O
transduced	cell_line
stem	cell_line
cells	cell_line
in	O
vitro,	O
in	O
liquid	O
culture	O
as	O
well	O
as	O
in	O
clonogenic	O
assay	O
,	O
and	O
in	O
vivo,	O
after	O
bone	O
marrow	O
transplantation	O
in	O
lethally	O
irradiated	O
mice	O
.	O
The	O
GATA-1	DNA
autoregulatory	DNA
enhancer	DNA
effectively	O
restricts	O
the	O
expression	O
of	O
the	O
LTR-driven	DNA
proviral	DNA
transcription	DNA
unit	DNA
to	O
the	O
erythroblastic	cell_type
progeny	cell_type
of	O
both	O
human	cell_type
progenitors	cell_type
and	O
mouse-repopulating	cell_line
stem	cell_line
cells	cell_line
.	O
Packaging	O
of	O
viral	O
particles,	O
integration	O
into	O
the	O
target	O
genome,	O
and	O
stability	O
of	O
the	O
integrated	O
provirus	O
are	O
not	O
affected	O
by	O
the	O
LTR	DNA
modification	O
.	O
Enhancer	O
replacement	O
is	O
therefore	O
an	O
effective	O
strategy	O
to	O
target	O
expression	O
of	O
a	O
retroviral	DNA
transgene	DNA
to	O
a	O
specific	O
progeny	O
of	O
transduced	cell_line
hematopoietic	cell_line
stem	cell_line
cells	cell_line
.	O

Regulation	O
of	O
Fas	protein
ligand	protein
expression	O
and	O
cell	O
death	O
by	O
apoptosis-linked	DNA
gene	DNA
4	DNA
.	O
Programmed	O
cell	O
death	O
is	O
a	O
process	O
required	O
for	O
the	O
normal	O
development	O
of	O
an	O
organism.	O
One	O
of	O
the	O
best	O
understood	O
apoptotic	O
pathways	O
occurs	O
in	O
T	cell_type
lymphocytes	cell_type
and	O
is	O
mediated	O
by	O
Fas	protein
/Fas	protein
ligand	protein
(	O
FasL	protein
)	O
interaction	O
.	O
During	O
studies	O
of	O
apoptosis	O
induced	O
by	O
T	O
cell-receptor	O
engagement	O
,	O
we	O
identified	O
ALG-4F	protein
,	O
a	O
truncated	protein
transcript	protein
that	O
prevents	O
T	O
cell-receptor-induced	O
FasL	protein
upregulation	O
and	O
cell	O
death	O
.	O
Overexpression	O
of	O
full-length	protein
ALG-4	protein
induced	O
transcription	O
of	O
FasL	protein
and,	O
consequently,	O
apoptosis	O
.	O
These	O
results	O
indicate	O
that	O
ALG-4	protein
is	O
necessary	O
and	O
sufficient	O
for	O
FasL	protein
expression	O
.	O
Fas/	O
FasL	protein
interaction	O
initiates	O
cell	O
death	O
in	O
many	O
other	O
systems,	O
and	O
its	O
dysregulation	O
is	O
a	O
mechanism	O
by	O
which	O
several	O
pathologic	O
conditions	O
arise.	O
Understanding	O
the	O
molecular	O
mechanisms	O
of	O
FasL	protein
regulation	O
could	O
be	O
very	O
useful	O
in	O
elucidating	O
how	O
these	O
diseases	O
develop	O
and	O
in	O
identifying	O
potential	O
therapeutic	O
targets	O
.	O

The	O
Epstein-Barr	protein
virus	protein
oncoprotein	protein
latent	protein
membrane	protein
protein	protein
1	protein
engages	O
the	O
tumor	protein
necrosis	protein
factor	protein
receptor-associated	protein
proteins	protein
TRADD	protein
and	O
receptor-interacting	protein
protein	protein
(	O
RIP	protein
)	O
but	O
does	O
not	O
induce	O
apoptosis	O
or	O
require	O
RIP	protein
for	O
NF-kappaB	protein
activation	O
.	O
A	O
site	O
in	O
the	O
Epstein-Barr	protein
virus	protein
(	protein
EBV	protein
)	protein
transforming	protein
protein	protein
LMP1	protein
that	O
constitutively	O
associates	O
with	O
the	O
tumor	protein
necrosis	protein
factor	protein
receptor	protein
1	protein
(	protein
TNFR1	protein
)-associated	protein
death	protein
domain	protein
protein	protein
TRADD	protein
to	O
mediate	O
NF-kappaB	protein
and	O
c-Jun	protein
N-terminal	protein
kinase	protein
activation	O
is	O
critical	O
for	O
long-term	O
lymphoblastoid	O
cell	O
proliferation	O
.	O
We	O
now	O
find	O
that	O
LMP1	protein
signaling	O
through	O
TRADD	protein
differs	O
from	O
TNFR1	protein
signaling	O
through	O
TRADD	protein
.	O
LMP1	protein
needs	O
only	O
11	O
amino	O
acids	O
to	O
activate	O
NF-kappaB	protein
or	O
synergize	O
with	O
TRADD	protein
in	O
NF-kappaB	protein
activation	O
,	O
while	O
TNFR1	protein
requires	O
approximately	O
70	O
residues	O
.	O
Further,	O
LMP1	protein
does	O
not	O
require	O
TRADD	protein
residues	O
294	O
to	O
312	O
for	O
NF-kappaB	protein
activation	O
,	O
while	O
TNFR1	protein
requires	O
TRADD	protein
residues	O
296	O
to	O
302.	O
LMP1	protein
is	O
partially	O
blocked	O
for	O
NF-kappaB	protein
activation	O
by	O
a	O
TRADD	protein
mutant	O
consisting	O
of	O
residues	protein
122	protein
to	protein
293	protein
.	O
Unlike	O
TNFR1	protein
,	O
LMP1	protein
can	O
interact	O
directly	O
with	O
receptor-interacting	protein
protein	protein
(	O
RIP	protein
)	O
and	O
stably	O
associates	O
with	O
RIP	protein
in	O
EBV	cell_line
-transformed	cell_line
lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
.	O
Surprisingly,	O
LMP1	protein
does	O
not	O
require	O
RIP	protein
for	O
NF-kappaB	protein
activation	O
.	O
Despite	O
constitutive	O
association	O
with	O
TRADD	protein
or	O
RIP	protein
,	O
LMP1	protein
does	O
not	O
induce	O
apoptosis	O
in	O
EBV-negative	O
Burkitt	O
lymphoma	O
or	O
human	O
embryonic	O
kidney	O
293	O
cells	O
.	O
These	O
results	O
add	O
a	O
different	O
perspective	O
to	O
the	O
molecular	O
interactions	O
through	O
which	O
LMP1	protein
,	O
TRADD	protein
,	O
and	O
RIP	protein
participate	O
in	O
B-lymphocyte	O
activation	O
and	O
growth	O
.	O

Inhibition	O
of	O
NF-kappa	protein
B	protein
activity	O
in	O
human	O
T	O
lymphocytes	O
induces	O
caspase-dependent	O
apoptosis	O
without	O
detectable	O
activation	O
of	O
caspase	O
-1	O
and	O
-3	O
.	O
NF-kappa	protein
B	protein
is	O
involved	O
in	O
the	O
transcriptional	O
control	O
of	O
various	DNA
genes	DNA
that	O
act	O
as	O
extrinsic	O
and	O
intrinsic	O
survival	O
factors	O
for	O
T	cell_type
cells	cell_type
.	O
Our	O
findings	O
show	O
that	O
suppression	O
of	O
NF-kappa	protein
B	protein
activity	O
with	O
cell-permeable	O
SN50	O
peptide	O
,	O
which	O
masks	O
the	O
nuclear	O
localization	O
sequence	O
of	O
NF-kappa	protein
B1	protein
dimers	protein
and	O
prevents	O
their	O
nuclear	O
localization	O
,	O
induces	O
apoptosis	O
in	O
resting	cell_type
normal	cell_type
human	cell_type
PBL	cell_type
.	O
Inhibition	O
of	O
NF-kappa	protein
B	protein
resulted	O
in	O
the	O
externalization	O
of	O
phosphatidylserine	O
,	O
induction	O
of	O
DNA	O
breaks,	O
and	O
morphological	O
changes	O
consistent	O
with	O
apoptosis	O
.	O
DNA	O
fragmentation	O
was	O
efficiently	O
blocked	O
by	O
the	O
caspase	protein
inhibitor	protein
Z-VAD-fmk	protein
and	O
partially	O
blocked	O
by	O
Ac-DEVD-fmk	protein
,	O
suggesting	O
that	O
SN50	O
-mediated	O
apoptosis	O
is	O
caspase	protein
-dependent	O
.	O
Interestingly,	O
apoptosis	O
induced	O
by	O
NF-kappa	protein
B	protein
suppression	O
,	O
in	O
contrast	O
to	O
that	O
induced	O
by	O
TPEN	O
(	O
N,N,N',N'-tetrakis	O
[2-pyridylmethyl]ethylenediamine	O
)	O
or	O
soluble	protein
Fas	protein
ligand	protein
(	O
CD95	protein
),	O
was	O
observed	O
in	O
the	O
absence	O
of	O
active	protein
death	protein
effector	protein
proteases	protein
caspase-1	protein
-like	O
(	O
IL-1	protein
converting	protein
enzyme	protein
),	O
caspase-3	protein
-like	O
(	O
CPP32/Yama/apopain	protein
),	O
and	O
caspase-6	protein
-like	O
and	O
without	O
cleavage	O
of	O
caspase-3	protein
substrates	protein
poly(	protein
ADP	protein
-ribose)	protein
polymerase	protein
and	O
DNA	protein
fragmentation	protein
factor-45	protein
.	O
These	O
findings	O
suggest	O
either	O
low	O
level	O
of	O
activation	O
is	O
required	O
or	O
that	O
different	O
caspases	protein
are	O
involved.	O
Preactivation	O
of	O
T	cell_type
cells	cell_type
resulting	O
in	O
NF-kappa	protein
B	protein
nuclear	O
translocation	O
protected	O
cells	O
from	O
SN50	O
-induced	O
apoptosis	O
.	O
Our	O
findings	O
demonstrate	O
an	O
essential	O
role	O
of	O
NF-kappa	protein
B	protein
in	O
survival	O
of	O
naive	cell_type
PBL	cell_type
.	O

Signal	O
transduction	O
pathways	O
in	O
normal	cell_type
human	cell_type
monocytes	cell_type
stimulated	O
by	O
cytokines	protein
and	O
mediators:	O
comparative	O
study	O
with	O
normal	cell_type
human	cell_type
neutrophils	cell_type
or	O
transformed	cell_line
cells	cell_line
and	O
the	O
putative	O
roles	O
in	O
functionality	O
and	O
cell	O
biology	O
.	O
Granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
(	O
GM-CSF	protein
)	O
and	O
interleukin	protein
(IL)	protein
-3	protein
induced	O
tyrosine	O
phosphorylation	O
of	O
92-kDa	protein
protein	protein
in	O
normal	cell_type
human	cell_type
monocytes	cell_type
.	O
We	O
identified	O
this	O
92-kDa	protein
protein	protein
as	O
STAT5	protein
,	O
but	O
not	O
as	O
STATs	O
1	O
,	O
3	O
,	O
and	O
6	O
nor	O
c-fes	protein
and	O
vav	protein
protooncogene	protein
products	protein
,	O
and	O
demonstrated	O
its	O
translocation	O
to	O
the	O
nucleus	O
,	O
enhancement	O
of	O
specific	O
DNA	O
binding	O
capacity	O
,	O
and	O
potentiation	O
of	O
trancriptional	O
activity	O
by	O
GM-CSF	protein
.	O
N-formyl-methionyl-leucyl-phenylalanine	O
(	O
FMLP	O
)	O
and	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
induced	O
tyrosine	O
phosphorylation	O
of	O
42-	O
and	O
44-	O
kDa	O
proteins	O
,	O
which	O
were	O
identified	O
as	O
extracellular	protein
signal-regulated	protein
kinase	protein
(	O
ERK	protein
),	O
in	O
human	cell_type
monocytes	cell_type
.	O
In	O
marked	O
contrast	O
to	O
neutrophils	cell_type
and	O
MO7e	cell_type
cells	cell_type
,	O
GM-CSF	protein
did	O
not	O
induce	O
tyrosine	O
phosphorylation	O
and	O
activation	O
of	O
ERK	protein
in	O
monocytes	cell_type
.	O
Among	O
upstream	protein
signaling	protein
molecules	protein
of	O
ERK	protein
,	O
Shc	protein
was	O
constitutively	O
associated	O
with	O
Grb2	O
and	O
was	O
not	O
tyrosine	O
-phosphorylated	O
by	O
GM-CSF	protein
and	O
FMLP	O
,	O
and	O
Sos1	protein
and	O
c-Raf-1	protein
were	O
not	O
phosphorylated	O
by	O
GM-CSF	protein
,	O
IL-3,	O
TNF,	O
and	O
FMLP	O
in	O
monocytes	cell_type
,	O
whereas	O
all	O
these	O
signaling	O
molecules	O
were	O
affected	O
and/or	O
utilized	O
by	O
GM-CSF	protein
in	O
MO7e	cell_type
cells	cell_type
.	O
In	O
contrast	O
to	O
neutrophils	cell_type
,	O
p38	protein
was	O
constitutively	O
phosphorylated	O
and	O
agonist-dependent	O
phosphorylation	O
and	O
activation	O
was	O
not	O
detected	O
in	O
human	cell_type
monocytes	cell_type
.	O
Superoxide	O
release	O
stimulated	O
by	O
FMLP	O
was	O
inhibited	O
partially	O
by	O
PD98059	O
or	O
SB203580	O
,	O
a	O
specific	O
inhibitor	O
of	O
ERK	O
or	O
p38	O
pathway	O
,	O
and	O
was	O
almost	O
completely	O
inhibited	O
by	O
the	O
combination	O
of	O
both	O
inhibitors,	O
whereas	O
PMA	O
-induced	O
superoxide	O
release	O
was	O
resistant	O
to	O
these	O
two	O
inhibitors	O
in	O
monocytes	cell_type
.	O
PD98059	O
inhibited	O
GM-CSF	protein
-dependent	O
proliferation	O
of	O
MO7e	cell_type
cells	cell_type
.	O
Present	O
results	O
indicate	O
trancriptional	O
roles	O
of	O
STAT5	protein
and	O
functional	O
roles	O
of	O
ERK	protein
and/or	O
p38	protein
in	O
normal	cell_type
human	cell_type
monocytes	cell_type
stimulated	O
by	O
physiological	O
receptor-mediated	O
agonists	O
GM-CSF	protein
and	O
FMLP	O
.	O
Possible	O
roles	O
of	O
ERK	protein
in	O
proliferation	O
of	O
transformed	cell_line
cells	cell_line
were	O
also	O
suggested.	O

Aiolos	protein
transcription	protein
factor	protein
controls	O
cell	O
death	O
in	O
T	cell_type
cells	cell_type
by	O
regulating	O
Bcl-2	protein
expression	O
and	O
its	O
cellular	O
localization.	O
We	O
searched	O
for	O
proteins	O
that	O
interact	O
with	O
Ras	protein
in	O
interleukin	O
(IL)-2-stimulated	O
or	O
IL-2-deprived	O
cells	O
,	O
and	O
found	O
that	O
the	O
transcription	protein
factor	protein
Aiolos	protein
interacts	O
with	O
Ras	protein
.	O
The	O
Ras	protein
-Aiolos	protein
interaction	O
was	O
confirmed	O
in	O
vitro	O
and	O
in	O
vivo	O
by	O
co-immunoprecipitation	O
.	O
Indirect	O
immunofluorescence	O
shows	O
that	O
IL-2	protein
controls	O
the	O
cellular	O
distribution	O
of	O
Aiolos	protein
and	O
induces	O
its	O
tyrosine	O
phosphorylation	O
,	O
required	O
for	O
dissociation	O
from	O
Ras	protein
.	O
We	O
also	O
identified	O
functional	O
Aiolos	DNA
-binding	DNA
sites	DNA
in	O
the	O
Bcl-2	DNA
promoter	DNA
,	O
which	O
are	O
able	O
to	O
activate	O
the	O
luciferase	DNA
reporter	DNA
gene	DNA
.	O
Mutation	O
of	O
Aiolos	DNA
-binding	DNA
sites	DNA
within	O
the	O
Bcl-2	DNA
promoter	DNA
inhibits	O
transactivation	O
of	O
the	O
reporter	DNA
gene	DNA
luciferase	DNA
,	O
suggesting	O
direct	O
control	O
of	O
Bcl-2	protein
expression	O
by	O
Aiolos	protein
.	O
Co-transfection	O
experiments	O
confirm	O
that	O
Aiolos	protein
induces	O
Bcl-2	protein
expression	O
and	O
prevents	O
apoptosis	O
in	O
IL-2	cell_line
-deprived	cell_line
cells	cell_line
.	O
We	O
propose	O
a	O
model	O
for	O
the	O
regulation	O
of	O
Bcl-2	protein
expression	O
via	O
Aiolos	protein
.	O

Binding	O
of	O
YY1	protein
and	O
Oct1	protein
to	O
a	O
novel	O
element	O
that	O
downregulates	O
expression	O
of	O
IL-5	protein
in	O
human	O
T	cell_type
cells	cell_type
.	O
BACKGROUND:	O
IL-5	protein
controls	O
development	O
of	O
eosinophilia	O
and	O
has	O
been	O
shown	O
to	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
allergic	O
diseases	O
.	O
In	O
both	O
atopic	O
and	O
nonatopic	O
asthma	O
,	O
elevated	O
IL-5	protein
has	O
been	O
detected	O
in	O
peripheral	O
blood	O
and	O
the	O
airways	O
.	O
IL-5	protein
is	O
produced	O
mainly	O
by	O
activated	O
T	cell_type
cells	cell_type
,	O
and	O
its	O
expression	O
is	O
regulated	O
at	O
the	O
transcriptional	O
level	O
.	O
OBJECTIVE:	O
This	O
study	O
focuses	O
on	O
the	O
functional	O
analysis	O
of	O
the	O
human	DNA
IL-5	DNA
(hIL-5)	DNA
promoter	DNA
and	O
characterization	O
of	O
cis	O
-regulatory	O
elements	O
and	O
transcription	O
factors	O
involved	O
in	O
the	O
suppression	O
of	O
IL-5	protein
transcription	O
in	O
T	cell_type
cells	cell_type
.	O
METHODS:	O
Methods	O
used	O
in	O
this	O
study	O
include	O
DNase	protein
I	protein
footprint	O
assays	O
,	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
and	O
functional	O
analysis	O
by	O
mammalian	O
cell	O
transfection	O
involving	O
deletion	O
analysis	O
and	O
site-directed	O
mutagenesis	O
.	O
RESULTS:	O
We	O
identified	O
5	O
protein	DNA
binding	DNA
regions	DNA
(	O
BRs	DNA
)	O
located	O
within	O
the	O
proximal	DNA
hIL-5	DNA
promoter	DNA
.	O
Functional	O
analysis	O
indicates	O
that	O
the	O
BRs	DNA
are	O
involved	O
in	O
control	O
of	O
hIL-5	DNA
promoter	DNA
activity	O
.	O
Two	O
of	O
these	O
regions,	O
BR3	DNA
and	O
BR4	DNA
located	O
at	O
positions	O
-102	O
to	O
-73,	O
have	O
not	O
previously	O
been	O
described	O
as	O
regulators	O
of	O
IL-5	protein
expression	O
in	O
T	cell_type
cells	cell_type
.	O
We	O
show	O
that	O
the	O
BR3	DNA
sequence	O
contains	O
a	O
novel	O
negative	DNA
regulatory	DNA
element	DNA
located	O
at	O
positions	O
-90	O
to	O
-79	O
of	O
the	O
hIL-5	DNA
promoter	DNA
,	O
which	O
binds	O
Oct1	protein
,	O
octamer-like	protein
,	O
and	O
YY1	protein
nuclear	protein
factors	protein
.	O
Substitution	O
mutations,	O
which	O
abolished	O
binding	O
of	O
these	O
proteins	O
to	O
the	O
BR3	DNA
sequence	DNA
,	O
significantly	O
increased	O
hIL-5	DNA
promoter	DNA
activity	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
.	O
CONCLUSION:	O
We	O
suggest	O
that	O
Oct1	protein
,	O
YY1	protein
,	O
and	O
octamer-like	protein
factors	protein
binding	O
to	O
the	O
-90/-79	DNA
sequence	DNA
within	O
the	O
proximal	DNA
IL-5	DNA
promoter	DNA
are	O
involved	O
in	O
suppression	O
of	O
IL-5	protein
transcription	O
in	O
T	cell_type
cells	cell_type
.	O

New	O
immunosuppressive	O
drug	O
PNU156804	O
blocks	O
IL-2	protein
-dependent	O
proliferation	O
and	O
NF-kappa	O
B	O
and	O
AP-1	O
activation	O
.	O
We	O
had	O
previously	O
shown	O
that	O
the	O
drug	O
undecylprodigiosin	O
(	O
UP	O
)	O
blocks	O
human	cell_type
lymphocyte	cell_type
proliferation	O
in	O
vitro.	O
We	O
have	O
now	O
investigated	O
the	O
mechanism	O
of	O
action	O
of	O
a	O
new	O
analogue	O
of	O
UP	O
,	O
PNU156804	O
,	O
which	O
shows	O
a	O
more	O
favorable	O
activity	O
profile	O
than	O
UP	O
in	O
mice	O
.	O
We	O
demonstrate	O
here	O
that	O
the	O
biological	O
effect	O
of	O
PNU156804	O
in	O
vitro	O
is	O
indistinguishable	O
from	O
UP	O
:	O
PNU156804	O
blocks	O
human	cell_type
T	cell_type
cell	cell_type
proliferation	O
in	O
mid-late	O
G1	O
,	O
as	O
determined	O
by	O
cell	O
cycle	O
analysis	O
,	O
expression	O
of	O
cyclins	protein
,	O
and	O
cyclin-dependent	protein
kinases	protein
and	O
retinoblastoma	O
phosphorylation	O
.	O
In	O
addition,	O
we	O
show	O
that	O
PNU156804	O
does	O
not	O
block	O
significantly	O
the	O
induction	O
of	O
either	O
IL-2	protein
or	O
IL-2R	O
alpha-	O
and	O
gamma-	O
chains	O
but	O
inhibits	O
IL-2	protein
-dependent	O
T	O
cell	O
proliferation	O
.	O
We	O
have	O
investigated	O
several	O
molecular	O
pathways	O
that	O
are	O
known	O
to	O
be	O
activated	O
by	O
IL-2	protein
in	O
T	cell_type
cells	cell_type
.	O
We	O
show	O
that	O
PNU156804	O
does	O
not	O
inhibit	O
c-myc	O
and	O
bcl-2	O
mRNA	O
induction	O
.	O
On	O
the	O
other	O
hand,	O
PNU156804	O
efficiently	O
inhibits	O
the	O
activation	O
of	O
the	O
NF-kappa	protein
B	protein
and	O
AP-1	protein
transcription	O
factors.	O
PNU156804	O
inhibition	O
of	O
NF-kappa	protein
B	protein
activation	O
is	O
due	O
to	O
the	O
inhibition	O
of	O
the	O
degradation	O
of	O
I	protein
kappa	protein
B-alpha	protein
and	O
I	protein
kappa	protein
B-beta	protein
.	O
PNU156804	O
action	O
is	O
restricted	O
to	O
some	O
signaling	O
pathways	O
;	O
it	O
does	O
not	O
affect	O
NF-kappa	protein
B	protein
activation	O
by	O
PMA	O
in	O
T	cell_type
cells	cell_type
but	O
blocks	O
that	O
induced	O
by	O
CD40	protein
cross-linking	O
in	O
B	cell_type
lymphocytes	cell_type
.	O
We	O
conclude	O
that	O
the	O
prodigiosin	O
family	O
of	O
immunosuppressants	O
is	O
a	O
new	O
family	O
of	O
molecules	O
that	O
show	O
a	O
novel	O
target	O
specificity	O
clearly	O
distinct	O
from	O
that	O
of	O
other	O
immunosuppressive	O
drugs	O
such	O
as	O
cyclosporin	O
A	O
,	O
FK506	O
,	O
and	O
rapamycin	O
.	O

Human	protein
T-cell	protein
leukemia	protein
virus	protein
type	protein
1	protein
Tax	protein
protein	protein
induces	O
the	O
expression	O
of	O
STAT1	O
and	O
STAT5	O
genes	O
in	O
T-cells	cell_type
.	O
Human	protein
T-cell	protein
leukemia	protein
virus	protein
type	protein
1	protein
(	protein
HTLV-1	protein
)	protein
Tax	protein
transforms	O
normal	O
T-cells	cell_type
in	O
the	O
presence	O
of	O
interleukin	protein
(IL)-2	protein
in	O
vitro.	O
STAT	protein
is	O
a	O
family	O
of	O
transcription	protein
factors	protein
that	O
play	O
a	O
pivotal	O
role	O
in	O
cytokine-induced	O
functions	O
of	O
a	O
various	O
type	O
of	O
cells.	O
We	O
investigated	O
the	O
involvement	O
of	O
STATs	protein
in	O
the	O
transformation	O
of	O
T-cells	cell_type
by	O
HTLV-1	O
.	O
HTLV-1	cell_line
-transformed	cell_line
T-cell	cell_line
lines	cell_line
expressed	O
higher	O
amounts	O
of	O
STAT1	O
,	O
STAT3	O
and	O
STAT5	O
RNA	O
and	O
proteins	O
than	O
virus-negative	cell_type
T	cell_type
cells	cell_type
.	O
The	O
expression	O
of	O
STAT1	protein
and	O
STAT5	protein
in	O
a	O
human	cell_line
T-cell	cell_line
line	cell_line
was	O
induced	O
by	O
Tax	protein
.	O
IL-2	protein
induced	O
the	O
DNA	O
binding	O
activity	O
of	O
STAT3	protein
and	O
STAT5	protein
of	O
a	O
HTLV-1	O
-transformed	O
cell	O
line	O
and	O
then	O
stimulated	O
its	O
proliferation.	O
In	O
contrast,	O
IL-2	protein
did	O
neither	O
in	O
a	O
cell	O
line	O
lacking	O
STAT3	protein
and	O
STAT5	protein
.	O
The	O
expression	O
of	O
STAT1	O
,	O
STAT3	O
and	O
STAT5	O
mRNAs	O
were	O
also	O
induced	O
by	O
a	O
T-cell	protein
mitogen	protein
in	O
normal	O
human	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
.	O
Our	O
results	O
suggest	O
that	O
the	O
induction	O
of	O
STAT1	protein
and	O
STAT5	protein
by	O
Tax	protein
enhances	O
cytokine	protein
-induced	O
functions	O
of	O
virus-infected	O
T-cells	cell_type
,	O
hence	O
the	O
induction	O
may	O
play	O
a	O
role	O
in	O
IL-2	protein
-dependent	O
transformation	O
steps	O
of	O
T-cells	cell_type
by	O
HTLV-1	O
.	O

Transcriptional	O
control	O
of	O
the	O
IL-5	protein
gene	O
by	O
human	cell_type
helper	cell_type
T	cell_type
cells	cell_type
:	O
IL-5	protein
synthesis	O
is	O
regulated	O
independently	O
from	O
IL-2	protein
or	O
IL-4	protein
synthesis	O
.	O
BACKGROUND:	O
IL-5	protein
is	O
fundamentally	O
involved	O
in	O
eosinophilic	O
inflammation	O
.	O
Control	O
of	O
IL-5	protein
production	O
may	O
be	O
effective	O
for	O
the	O
management	O
of	O
allergic	O
diseases	O
.	O
OBJECTIVE:	O
We	O
aimed	O
to	O
find	O
the	O
transcriptional	O
mechanisms	O
that	O
regulate	O
the	O
IL-5	protein
gene	O
to	O
selectively	O
control	O
IL-5	protein
synthesis	O
.	O
METHODS:	O
Allergen-specific	cell_line
T-cell	cell_line
clones	cell_line
and	O
T-cell	cell_line
hybridomas	cell_line
were	O
established	O
from	O
the	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
of	O
patients	O
with	O
asthma	O
,	O
and	O
the	O
transcriptional	O
regulation	O
of	O
the	O
IL-5	DNA
gene	DNA
was	O
investigated	O
with	O
transient	O
transfection	O
and	O
electrophoretic	O
mobility	O
shift	O
analysis	O
.	O
RESULTS:	O
A	O
human	O
IL-5	DNA
promoter/enhancer-	DNA
luciferase	DNA
gene	DNA
construct	DNA
,	O
pIL-5(-511)Luc	DNA
,	O
was	O
transcribed	O
on	O
activation	O
of	O
IL-5	cell_line
-producing	cell_line
T-cell	cell_line
clones	cell_line
,	O
but	O
not	O
IL-5	cell_line
-nonproducing	cell_line
clones	cell_line
.	O
pIL-5(-511)Luc	DNA
was	O
transcribed	O
by	O
T-cell	cell_line
hybridomas	cell_line
derived	O
from	O
fusion	O
between	O
IL-5	cell_line
-producing	cell_line
T-cell	cell_line
clones	cell_line
and	O
an	O
IL-5	cell_line
gene-nonexpressing	cell_line
T-cell	cell_line
line	cell_line
,	O
but	O
not	O
by	O
hybridomas	cell_line
derived	O
from	O
IL-5	cell_line
-nonproducing	cell_line
T-cell	cell_line
clones	cell_line
.	O
IL-5	protein
synthesis	O
was	O
not	O
only	O
induced	O
by	O
T-cell	O
receptor	O
stimulation	O
but	O
also	O
by	O
IL-2	protein
receptor	O
stimulation	O
.	O
Binding	O
of	O
NF-AT	protein
,	O
NF-kappaB	protein
,	O
and	O
AP-1	protein
was	O
induced	O
by	O
T-cell	protein
receptor	protein
(	O
TcR	protein
)	O
stimulation	O
,	O
although	O
there	O
was	O
no	O
significant	O
upregulation	O
of	O
binding	O
by	O
IL-2	protein
stimulation	O
.	O
CONCLUSION:	O
IL-5	protein
synthesis	O
by	O
human	cell_type
helper	cell_type
T	cell_type
cells	cell_type
is	O
regulated	O
at	O
the	O
transcriptional	O
level	O
.	O
A	O
unique	O
transcriptional	O
mechanism	O
distinct	O
from	O
those	O
regulating	O
the	O
IL-2	O
or	O
IL-4	O
genes	O
seems	O
to	O
control	O
the	O
IL-5	DNA
gene	DNA
.	O
Selective	O
regulation	O
of	O
IL-5	protein
gene	O
transcription	O
may	O
be	O
useful	O
for	O
treating	O
eosinophlic	O
inflammation	O
.	O

Defining	O
therapeutic	O
targets	O
by	O
using	O
adenovirus	O
:	O
blocking	O
NF-kappaB	protein
inhibits	O
both	O
inflammatory	O
and	O
destructive	O
mechanisms	O
in	O
rheumatoid	O
synovium	O
but	O
spares	O
anti-inflammatory	protein
mediators	protein
.	O
The	O
role	O
of	O
the	O
transcription	protein
factor	protein
NF-kappaB	protein
in	O
the	O
pathogenesis	O
of	O
rheumatoid	O
arthritis	O
has	O
long	O
been	O
a	O
subject	O
of	O
controversy.	O
We	O
used	O
an	O
adenoviral	O
technique	O
of	O
blocking	O
NF-kappaB	protein
through	O
overexpression	O
of	O
the	O
inhibitory	protein
subunit	protein
IkappaBalpha	protein
,	O
which	O
has	O
the	O
advantage	O
that	O
it	O
can	O
be	O
used	O
in	O
the	O
diseased	O
tissue	O
itself,	O
with	O
&gt;90%	O
of	O
the	O
synovial	cell_type
macrophages	cell_type
,	O
fibroblasts	cell_type
,	O
and	O
T	cell_type
cells	cell_type
infected.	O
We	O
found	O
that	O
the	O
spontaneous	O
production	O
of	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
and	O
other	O
pro-inflammatory	protein
cytokines	protein
is	O
NF-kappaB	protein
-dependent	O
in	O
rheumatoid	O
synovial	O
tissue	O
,	O
in	O
contrast	O
to	O
the	O
main	O
anti-inflammatory	protein
mediators	protein
,	O
like	O
IL	O
-10	O
and	O
-11	O
,	O
and	O
the	O
IL-1	protein
receptor	protein
antagonist	protein
.	O
Of	O
even	O
more	O
interest,	O
IkappaBalpha	protein
overexpression	O
inhibited	O
the	O
production	O
of	O
matrix	O
metalloproteinases	O
1	O
and	O
3	O
while	O
not	O
affecting	O
their	O
tissue	O
inhibitor	O
.	O
Blocking	O
NF-kappaB	protein
in	O
the	O
rheumatoid	O
joint	O
thus	O
has	O
a	O
very	O
beneficial	O
profile,	O
reducing	O
both	O
the	O
inflammatory	O
response	O
and	O
the	O
tissue	O
destruction	O
.	O
The	O
adenoviral	O
technique	O
described	O
here	O
has	O
widespread	O
applicability,	O
allowing	O
rapid	O
testing	O
of	O
the	O
effects	O
of	O
blocking	O
a	O
potential	O
therapeutic	O
target	O
in	O
either	O
cultures	O
of	O
normal	cell_type
cells	cell_type
or	O
in	O
the	O
diseased	O
tissue	O
itself.	O

Resistance	O
to	O
tumor	protein
necrosis	protein
factor	protein
induced	O
apoptosis	O
in	O
vitro	O
correlates	O
with	O
high	O
metastatic	O
capacity	O
of	O
cells	O
in	O
vivo.	O
TNF	protein
is	O
one	O
of	O
the	O
cytokines	protein
secreted	O
by	O
the	O
cells	O
of	O
the	O
immune	O
system	O
.	O
Our	O
data	O
demonstrate	O
that	O
those	O
cell	cell_line
lines	cell_line
lacking	O
capability	O
to	O
form	O
metastatic	O
tumors	O
in	O
vivo	O
are	O
susceptible	O
to	O
TNF	protein
induced	O
apoptosis	O
in	O
vitro.	O
However,	O
cell	cell_line
lines	cell_line
with	O
high	O
metastatic	O
potential	O
are	O
resistant	O
to	O
TNF	protein
in	O
vitro.	O
Furthermore,	O
the	O
same	O
cell	cell_line
lines	cell_line
were	O
resistant	O
to	O
cytolytic	O
action	O
of	O
other	O
cytotoxic	protein
proteins	protein
secreted	O
by	O
LAK	cell_line
cells	cell_line
.	O
Our	O
data	O
showed	O
that	O
TNF	protein
resistance	O
in	O
vitro	O
correlates	O
with	O
the	O
increased	O
level	O
of	O
transcription	protein
factor	protein
NF-kappaB	protein
.	O
This	O
finding	O
may	O
provide	O
a	O
tool	O
to	O
improve	O
current	O
protocols	O
of	O
immunotherapy	O
and	O
insights	O
to	O
how	O
tumor	cell_type
cells	cell_type
are	O
or	O
are	O
not	O
killed	O
by	O
LAK	cell_line
cells	cell_line
.	O

Clonality	O
analysis	O
of	O
granulocytes	cell_type
and	O
T	cell_type
lymphocytes	cell_type
in	O
healthy	O
females	O
by	O
the	O
PCR-based	O
HUMARA	DNA
method	O
.	O
Clonality	O
analysis	O
utilizing	O
X-chromosome	DNA
inactivation	O
has	O
been	O
used	O
in	O
the	O
study	O
of	O
various	O
diseases,	O
including	O
hematological	O
malignancies	O
.	O
The	O
human	DNA
androgen	DNA
receptor	DNA
gene	DNA
(	O
HUMARA	DNA
)	O
assay	O
is	O
the	O
newest	O
of	O
such	O
methods,	O
and	O
the	O
majority	O
of	O
the	O
female	O
population	O
can	O
be	O
assessed	O
by	O
this	O
relatively	O
simple	O
procedure.	O
One	O
problem	O
in	O
using	O
these	O
clonality	O
analysis	O
methods	O
,	O
however,	O
is	O
that	O
there	O
may	O
be	O
significant	O
variation	O
in	O
Lyonization	O
in	O
blood	cell_type
cells	cell_type
in	O
normal	O
individuals	O
.	O
To	O
determine	O
the	O
diversity	O
in	O
X-chromosome	DNA
methylation	O
patterns	O
,	O
which	O
reflect	O
Lyonization	O
,	O
assessed	O
by	O
the	O
HUMARA	DNA
assay	O
in	O
the	O
supposedly	O
normal	O
population,	O
we	O
analyzed	O
granulocytes	cell_type
and	O
T	cell_line
cells	cell_line
from	O
97	O
relatively	O
young	O
(18-	O
to	O
35-year-old)	O
healthy	O
female	O
volunteers	O
.	O
We	O
found	O
that	O
the	O
methylation	O
patterns	O
in	O
the	O
two	O
HUMARA	DNA
alleles	DNA
were	O
distributed	O
even	O
more	O
widely,	O
both	O
in	O
granuloctyes	cell_type
and	O
in	O
T	cell_line
cells	cell_line
,	O
than	O
previously	O
reported	O
with	O
other	O
methods.	O
We	O
also	O
found	O
that	O
the	O
deviation	O
of	O
methylation	O
in	O
granulocytes	cell_type
and	O
T	cell_line
cells	cell_line
was	O
well	O
correlated.	O
Thus,	O
we	O
conclude	O
that	O
appropriate	O
controls	O
from	O
the	O
same	O
individuals,	O
such	O
as	O
T	cell_line
cells	cell_line
in	O
the	O
case	O
of	O
stem	O
cell	O
disorders	O
,	O
should	O
always	O
be	O
employed	O
to	O
conclusively	O
determine	O
whether	O
certain	O
cells	O
of	O
hematopoietic	O
origin	O
are	O
clonal.	O

Functional	O
B-cell	O
response	O
in	O
intrahepatic	O
lymphoid	O
follicles	O
in	O
chronic	O
hepatitis	O
C	O
.	O
Intrahepatic	O
lymphoid	O
follicle	O
(	O
ILF	O
)	O
formation	O
is	O
one	O
of	O
the	O
most	O
characteristic	O
and	O
commonly	O
observed	O
histological	O
features	O
in	O
patients	O
with	O
chronic	O
hepatitis	O
C	O
.	O
However,	O
little	O
is	O
known	O
regarding	O
whether	O
follicles	O
in	O
the	O
liver	O
belong	O
to	O
functional	O
lymphoid	O
tissues,	O
where	O
B	O
cells	O
are	O
activated,	O
differentiated,	O
and	O
proliferated,	O
or	O
if	O
the	O
lymphocytes	O
are	O
merely	O
infiltrated	O
after	O
recruitment	O
from	O
the	O
secondary	O
lymphoid	O
organs.	O
To	O
ascertain	O
this	O
possibility,	O
we	O
examined	O
the	O
expression	O
of	O
markers	O
for	O
B-cell	O
activation,	O
differentiation,	O
and	O
proliferation	O
in	O
ILFs	O
in	O
patients	O
with	O
chronic	O
hepatitis	O
C	O
using	O
surgically	O
resected	O
specimens,	O
and	O
compared	O
them	O
with	O
specimens	O
of	O
perihepatic	O
lymph	O
nodes	O
by	O
an	O
immunohistochemical	O
technique	O
.	O
Germinal	O
center	O
(	O
GC	O
)	O
formation	O
in	O
the	O
ILFs	O
was	O
frequently	O
found	O
in	O
HCV-positive	O
cases.	O
The	O
distribution	O
of	O
immunoglobulin	O
M	O
(IgM)-,	O
IgD-,	O
and	O
IgG-positive	O
cells	O
and	O
the	O
expression	O
patterns	O
of	O
Ki-67,	O
CD23,	O
or	O
bcl-2	O
and	O
bcl-6	O
gene	O
products	O
in	O
the	O
follicles	O
with	O
GC	O
formation	O
in	O
the	O
liver	O
of	O
patients	O
with	O
chronic	O
hepatitis	O
C	O
were	O
similar	O
to	O
those	O
of	O
lymph	O
nodes	O
,	O
indicating	O
that	O
B	cell_type
cells	cell_type
are	O
activated,	O
proliferated,	O
and	O
differentiated	O
in	O
the	O
ILFs	O
with	O
GC	O
formation	O
in	O
patients	O
with	O
chronic	O
hepatitis	O
C	O
.	O
Oligoclonal	O
expansion	O
of	O
B	cell_type
cells	cell_type
in	O
the	O
livers	O
with	O
ILFs	O
was	O
confirmed	O
by	O
an	O
analysis	O
of	O
immunoglobulin	DNA
heavy	DNA
chain	DNA
(	DNA
IgH	DNA
)	DNA
gene	DNA
rearrangement	O
determined	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
).	O
These	O
data	O
strongly	O
suggest	O
that	O
ILFs	O
with	O
GC	O
formation	O
,	O
which	O
are	O
frequently	O
found	O
in	O
patients	O
with	O
chronic	O
hepatitis	O
C	O
,	O
may	O
functionally	O
be	O
the	O
same	O
as	O
those	O
found	O
in	O
lymph	O
nodes	O
with	O
respect	O
to	O
B-cell	O
expansion	O
and	O
maturation	O
.	O

Downregulation	O
of	O
Wilms'	DNA
tumor	DNA
gene	DNA
(	O
WT1	DNA
)	O
is	O
not	O
a	O
prerequisite	O
for	O
erythroid	O
or	O
megakaryocytic	O
differentiation	O
of	O
the	O
leukemic	cell_line
cell	cell_line
line	cell_line
K562	cell_line
.	O
The	O
Wilms'	DNA
tumor	DNA
gene	DNA
(	O
WT1	DNA
)	O
encodes	O
a	O
transcription	protein
factor	protein
of	O
the	O
zinc	protein
finger	protein
type	protein
.	O
A	O
high	O
expression	O
of	O
WT1	DNA
has	O
been	O
detected	O
in	O
a	O
range	O
of	O
acute	O
leukemias	O
,	O
and	O
WT1	DNA
is	O
downregulated	O
during	O
induced	O
differentiation	O
of	O
some	O
leukemic	cell_line
cell	cell_line
lines	cell_line
.	O
Overexpression	O
of	O
WT1	DNA
in	O
some	O
myeloid	cell_line
cell	cell_line
lines	cell_line
confers	O
resistance	O
to	O
differentiation	O
induction	O
.	O
These	O
observations	O
suggest	O
that	O
a	O
high	O
WT1	DNA
expression	O
in	O
hematopoietic	cell_type
cells	cell_type
is	O
incompatible	O
with	O
differentiation.	O
In	O
this	O
study,	O
each	O
of	O
the	O
four	O
different	O
isoforms	O
of	O
WT1	DNA
was	O
constitutively	O
overexpressed	O
in	O
the	O
leukemic	cell_line
cell	cell_line
line	cell_line
K562	cell_line
.	O
K562	cell_line
cells	cell_line
express	O
endogenous	O
WT1	DNA
,	O
which	O
is	O
downregulated	O
as	O
a	O
response	O
to	O
induced	O
differentiation	O
along	O
the	O
erythroid	O
and	O
megakaryocytic	O
pathways	O
.	O
We	O
now	O
demonstrate	O
that	O
a	O
forced	O
exogenous	O
expression	O
of	O
the	O
four	O
different	O
isoforms	O
of	O
WT1	DNA
in	O
K562	cell_line
does	O
not	O
affect	O
the	O
differentiation	O
response	O
,	O
as	O
judged	O
by	O
accumulation	O
of	O
hemoglobin	protein
in	O
response	O
to	O
hemin	protein
or	O
the	O
expression	O
of	O
megakaryocytic	protein
cell	protein
surface	protein
markers	protein
in	O
response	O
to	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
).	O
We	O
conclude	O
that	O
downregulation	O
of	O
WT1	DNA
during	O
induced	O
differentiation	O
of	O
K562	cell_line
cells	cell_line
is	O
not	O
a	O
prerequisite	O
for	O
erythroid	O
or	O
megakaryocytic	O
differentiation	O
of	O
these	O
cells.	O

Association	O
of	O
the	O
interleukin-4	protein
receptor	protein
alpha	protein
chain	protein
with	O
p47phox	O
,	O
an	O
activator	O
of	O
the	O
phagocyte	protein
NADPH	protein
oxidase	protein
in	O
B	cell_type
cells	cell_type
.	O
Interleukin	protein
(IL)-4	protein
plays	O
an	O
important	O
role	O
in	O
IgE	protein
synthesis	O
in	O
B	cell_type
cells	cell_type
and	O
in	O
Th2	O
differentiation	O
in	O
T	cell_line
cells	cell_line
.	O
IL-4	protein
conducts	O
its	O
biological	O
activities	O
through	O
binding	O
to	O
the	O
IL-4	protein
receptor	protein
(	O
IL-4R	protein
)	O
on	O
the	O
surface	O
of	O
target	cell_type
cells	cell_type
.	O
IL-4R	protein
are	O
thought	O
to	O
be	O
composed	O
of	O
the	O
IL-4R	protein
alpha	protein
chain	protein
(	O
IL-4R	protein
alpha	protein
)	O
and	O
either	O
the	O
IL-2R	protein
gamma	protein
chain	protein
or	O
the	O
IL-13R	protein
alpha	protein
chain	protein
.	O
We	O
have	O
previously	O
shown	O
that	O
the	O
membrane-proximal	protein
portion	protein
in	O
the	O
cytoplasmic	protein
domain	protein
of	O
the	O
human	protein
IL-4R	protein
alpha	protein
(	O
hIL-4R	protein
alpha	protein
)	O
is	O
critical	O
for	O
proliferation,	O
generation	O
of	O
germline	O
epsilon	O
transcript,	O
and	O
activation	O
of	O
STAT6	protein
,	O
based	O
on	O
analyses	O
of	O
truncated	protein
hIL-4R	protein
alphas	protein
.	O
In	O
this	O
study,	O
we	O
found	O
that	O
p47phox	O
,	O
an	O
activator	O
of	O
the	O
phagocyte	protein
NADPH	protein
oxidase	protein
,	O
binds	O
to	O
this	O
portion	O
by	O
the	O
two-hybrid	O
system	O
.	O
Furthermore,	O
we	O
observed	O
the	O
association	O
of	O
p47phox	O
with	O
the	O
hIL-4R	protein
alpha	protein
in	O
B	cell_type
cells	cell_type
derived	O
from	O
a	O
normal	O
donor	O
.	O
These	O
results	O
suggest	O
that	O
p47phox	O
is	O
involved	O
in	O
the	O
signal	O
transduction	O
of	O
IL-4	protein
in	O
B	cell_type
cells	cell_type
.	O
However,	O
activation	O
of	O
STAT6	protein
,	O
CD23	protein
expression	O
,	O
and	O
IgE	protein
synthesis	O
induced	O
by	O
IL-4	protein
were	O
not	O
affected	O
in	O
p47phox	O
-deficient	O
patients	O
,	O
which	O
raises	O
the	O
possibility	O
that	O
p47phox	O
may	O
be	O
important	O
in	O
other	O
signaling	O
activities	O
as	O
well	O
in	O
B	cell_type
cells	cell_type
.	O

Effects	O
of	O
diesel	O
organic	O
extracts	O
on	O
chemokine	protein
production	O
by	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
.	O
BACKGROUND:	O
Polyaromatic	O
hydrocarbons	O
(	O
PAHs	O
)	O
associated	O
with	O
diesel	O
exhaust	O
particles	O
(	O
DEPs	O
)	O
are	O
found	O
in	O
the	O
atmospheric	O
urban	O
pollution	O
.	O
Such	O
compounds	O
have	O
been	O
shown	O
to	O
favor	O
IgE	protein
production	O
,	O
bronchial	O
hyperresponsiveness	O
,	O
and	O
airway	O
inflammation	O
.	O
Chemokines	O
are	O
a	O
group	O
of	O
chemotactic	protein
cytokines	protein
involved	O
in	O
the	O
recruitment	O
of	O
inflammatory	cell_type
cells	cell_type
.	O
OBJECTIVE:	O
We	O
investigated	O
the	O
effect	O
of	O
DEP-	O
PAHs	O
on	O
the	O
release	O
and	O
mRNA	RNA
expression	O
of	O
IL-8	protein
,	O
MCP-1	protein
,	O
and	O
RANTES	protein
by	O
PBMCs	cell_type
obtained	O
from	O
healthy	O
subjects	O
.	O
METHODS:	O
Protein	O
production	O
in	O
supernatants	O
was	O
assessed	O
by	O
ELISA	O
,	O
and	O
mRNA	RNA
expression	O
was	O
evaluated	O
by	O
semiquantitative	O
RT-	O
PCR	O
.	O
RESULTS:	O
Secretion	O
of	O
IL-8	protein
and	O
RANTES	protein
increased	O
in	O
a	O
dose-dependent	O
manner	O
with	O
increasing	O
concentrations	O
of	O
DEP-	O
PAHs	O
(range,	O
0.5	O
ng	O
to	O
50	O
ng/mL).	O
On	O
the	O
contrary,	O
the	O
release	O
of	O
MCP-1	protein
was	O
significantly	O
inhibited,	O
also	O
in	O
a	O
dose-dependent	O
manner	O
.	O
Messenger	RNA
RNA	RNA
production	O
coding	O
for	O
IL-8	protein
,	O
RANTES	protein
,	O
and	O
MCP-1	protein
showed	O
parallel	O
variations	O
to	O
the	O
production	O
of	O
the	O
correspondent	protein
proteins	protein
.	O
Effects	O
of	O
DEP-	O
PAHs	O
became	O
significant	O
at	O
7	O
hours	O
and	O
up	O
to	O
48	O
hours	O
time	O
culture	O
for	O
MCP-1	protein
,	O
and	O
up	O
to	O
24	O
hours	O
time	O
culture	O
for	O
IL-8	protein
and	O
RANTES	protein
.	O
Moreover,	O
supernatants	O
from	O
DEP-PAH-activated	cell_type
cells	cell_type
,	O
compared	O
with	O
those	O
of	O
controls,	O
exhibited	O
a	O
significantly	O
enhanced	O
chemotactic	O
activity	O
for	O
neutrophils	cell_type
and	O
eosinophils	cell_type
,	O
which	O
was	O
significantly	O
inhibited	O
by	O
pretreatment	O
with	O
anti-	protein
IL-8	protein
and	O
anti-	protein
RANTES	protein
neutralizing	O
antibodies,	O
respectively.	O
CONCLUSION:	O
These	O
findings	O
suggest	O
that	O
the	O
chemokine	protein
pathways	O
are	O
modulated	O
by	O
DEP-	O
PAHs	O
at	O
the	O
transcriptional	O
level	O
,	O
reinforcing	O
the	O
idea	O
that	O
the	O
development	O
of	O
inflammatory	O
reactions	O
might	O
be	O
affected	O
by	O
diesel	O
exhaust	O
emission	O
.	O

20-Epi	O
analogues	O
of	O
1,25-dihydroxyvitamin	O
D3	O
are	O
highly	O
potent	O
inducers	O
of	O
DRIP	protein
coactivator	protein
complex	protein
binding	O
to	O
the	O
vitamin	protein
D3	protein
receptor	protein
.	O
1,25-Dihydroxyvitamin	O
D3	O
(	O
1,25(OH)2D3	O
)	O
plays	O
a	O
major	O
role	O
in	O
the	O
stimulation	O
of	O
bone	O
growth	O
,	O
mineralization	O
,	O
and	O
intestinal	O
calcium	O
and	O
phosphate	O
absorption	O
;	O
it	O
also	O
acts	O
as	O
a	O
general	O
inhibitor	O
of	O
cellular	O
proliferation	O
.	O
Several	O
new,	O
clinically	O
relevant	O
compounds	O
dissociate	O
antiproliferative	O
and	O
calcemic	O
activities	O
of	O
1,25(OH)2D3	O
,	O
but	O
the	O
molecular	O
basis	O
for	O
this	O
has	O
not	O
been	O
clearly	O
elucidated.	O
Here,	O
we	O
tested	O
whether	O
the	O
potency	O
of	O
one	O
class	O
of	O
compounds,	O
20-epi	O
analogues	O
,	O
to	O
induce	O
myeloid	O
cell	O
differentiation,	O
is	O
because	O
of	O
direct	O
molecular	O
effects	O
on	O
vitamin	protein
D	protein
receptor	protein
(	O
VDR	protein
).	O
We	O
report	O
that	O
two	O
20-epi	O
analogues	O
,	O
MC1627	O
and	O
MC1288	O
,	O
induced	O
differentiation	O
and	O
transcription	O
of	O
p21	DNA
(	O
Waf1	DNA
,	O
Cip1	DNA
),	O
a	O
key	O
VDR	DNA
target	DNA
gene	DNA
involved	O
in	O
growth	O
inhibition,	O
at	O
a	O
concentration	O
100-fold	O
lower	O
than	O
that	O
of	O
1,25(OH)2D3	O
.	O
We	O
compared	O
this	O
sensitivity	O
to	O
analogue	O
effects	O
on	O
VDR	protein
interacting	O
proteins:	O
RXR	protein
,	O
GRIP-1	protein
,	O
and	O
DRIP205	protein
,	O
a	O
subunit	O
of	O
the	O
DRIP	protein
coactivator	protein
complex	protein
.	O
Compared	O
with	O
the	O
interaction	O
of	O
VDR	protein
with	O
RXR	protein
or	O
GRIP-1	protein
,	O
the	O
differentiation	O
dose-response	O
most	O
closely	O
correlated	O
to	O
the	O
ligand-dependent	O
recruitment	O
of	O
the	O
DRIP	protein
coactivator	protein
complex	protein
to	O
VDR	protein
and	O
to	O
the	O
ability	O
of	O
the	O
receptor	O
to	O
activate	O
transcription	O
in	O
a	O
cell-free	O
system	O
.	O
These	O
results	O
provide	O
compelling	O
links	O
between	O
the	O
efficiency	O
of	O
the	O
20-epi	O
analogue	O
in	O
inducing	O
VDR	protein
/DRIP	O
interactions	O
,	O
transactivation	O
in	O
vitro,	O
and	O
its	O
enhanced	O
ability	O
to	O
induce	O
cellular	O
differentiation	O
.	O

SLP-76	protein
and	O
Vav	protein
function	O
in	O
separate,	O
but	O
overlapping	O
pathways	O
to	O
augment	O
interleukin-2	DNA
promoter	DNA
activity	O
.	O
SLP-76	protein
and	O
Vav	protein
,	O
two	O
hematopoietic	protein
cell	protein
specific	protein
molecules	protein
,	O
are	O
critical	O
for	O
T	O
cell	O
development	O
and	O
activation.	O
Following	O
T	protein
cell	protein
antigen	protein
receptor	protein
stimulation	O
,	O
SLP-76	protein
and	O
Vav	protein
both	O
undergo	O
tyrosine	O
phosphorylation	O
and	O
associate	O
with	O
each	O
other	O
via	O
the	O
SH2	O
domain	O
of	O
Vav	protein
and	O
phosphorylated	O
tyrosines	O
of	O
SLP-76	protein
.	O
Furthermore,	O
SLP-76	protein
and	O
Vav	protein
have	O
a	O
synergistic	O
effect	O
on	O
interleukin	DNA
(IL)-2	DNA
promoter	DNA
activity	O
in	O
T	cell_line
cells	cell_line
.	O
In	O
this	O
report,	O
we	O
show	O
that	O
two	O
tyrosines	O
,	O
Tyr-113	O
and	O
Tyr-128	O
,	O
of	O
SLP-76	protein
are	O
required	O
for	O
its	O
binding	O
to	O
Vav	protein
,	O
both	O
in	O
vitro	O
and	O
in	O
intact	cell_type
cells	cell_type
.	O
Surprisingly,	O
we	O
find	O
also	O
that	O
the	O
interaction	O
between	O
SLP-76	protein
and	O
Vav	protein
is	O
not	O
required	O
for	O
their	O
cooperation	O
in	O
augmenting	O
IL-2	DNA
promoter	DNA
activity	O
,	O
as	O
the	O
two	O
molecules	O
appear	O
to	O
function	O
in	O
different	O
signaling	O
pathways	O
upstream	O
of	O
IL-2	DNA
gene	DNA
expression	O
.	O
Overexpression	O
of	O
SLP-76	protein
in	O
the	O
Jurkat	cell_line
T	cell_line
cell	cell_line
line	cell_line
potentiates	O
the	O
activities	O
of	O
both	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
and	O
AP-1	protein
transcription	protein
factors	protein
.	O
In	O
contrast,	O
overexpression	O
of	O
Vav	protein
leads	O
to	O
enhanced	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
activity	O
without	O
affecting	O
AP-1	protein
.	O
Additionally,	O
overexpression	O
of	O
Vav	protein
,	O
but	O
not	O
SLP-76	protein
,	O
augments	O
CD28-induced	O
IL-2	DNA
promoter	DNA
activity	O
.	O
These	O
findings	O
suggest	O
that	O
the	O
synergy	O
between	O
SLP-76	protein
and	O
Vav	protein
in	O
regulating	O
IL-2	DNA
gene	DNA
expression	O
reflects	O
the	O
cooperation	O
between	O
different	O
signaling	O
pathways	O
.	O

Rel/NF-kappaB	protein
can	O
trigger	O
the	O
Notch	O
signaling	O
pathway	O
by	O
inducing	O
the	O
expression	O
of	O
Jagged1	protein
,	O
a	O
ligand	O
for	O
Notch	protein
receptors	protein
.	O
Jagged1	protein
belongs	O
to	O
the	O
DSL	protein
family	protein
of	protein
ligands	protein
for	O
Notch	protein
receptors	protein
that	O
control	O
the	O
proliferation	O
and	O
differentiation	O
of	O
various	O
cell	cell_type
lineages	cell_type
.	O
However,	O
little	O
is	O
known	O
about	O
the	O
transcription	protein
factors	protein
that	O
regulate	O
its	O
expression.	O
Here,	O
we	O
show	O
that	O
Jagged1	protein
is	O
a	O
Rel/NF-kappaB	DNA
-responsive	DNA
gene	DNA
.	O
Both	O
c-Rel	protein
and	O
RelA	protein
induced	O
jagged1	O
gene	O
expression	O
,	O
whereas	O
a	O
mutant	O
defective	O
for	O
transactivation	O
did	O
not.	O
Importantly,	O
jagged1	protein
transcripts	protein
were	O
also	O
upregulated	O
by	O
endogenous	O
NF-kappaB	protein
activation	O
and	O
this	O
effect	O
was	O
inhibited	O
by	O
a	O
dominant	O
mutant	O
of	O
IkappaBalpha	protein
,	O
a	O
physiological	O
inhibitor	O
of	O
NF-kappaB	protein
.	O
Cell	O
surface	O
expression	O
of	O
Jagged1	protein
in	O
c-Rel	cell_line
-expressing	cell_line
cell	cell_line
monolayers	cell_line
led	O
to	O
a	O
functional	O
interaction	O
with	O
lymphocytes	cell_type
expressing	O
the	O
Notch1/TAN-1	protein
receptor	protein
.	O
This	O
correlated	O
with	O
the	O
initiation	O
of	O
signaling	O
downstream	O
of	O
Notch,	O
as	O
evidenced	O
by	O
increased	O
levels	O
of	O
HES-1	RNA
transcripts	RNA
in	O
co-cultivated	cell_line
T	cell_line
cells	cell_line
and	O
of	O
CD23	RNA
transcripts	RNA
in	O
co-cultivated	O
B	cell_type
cells	cell_type
.	O
Consistent	O
with	O
its	O
Rel/NF-kappaB	protein
-dependent	O
induction	O
,	O
Jagged1	protein
was	O
found	O
to	O
be	O
highly	O
expressed	O
in	O
splenic	cell_type
B	cell_type
cells	cell_type
where	O
c-Rel	protein
is	O
expressed	O
constitutively.	O
These	O
results	O
demonstrate	O
that	O
c-Rel	protein
can	O
trigger	O
the	O
Notch	O
signaling	O
pathway	O
in	O
neighboring	O
cells	O
by	O
inducing	O
jagged1	O
gene	O
expression	O
,	O
and	O
suggest	O
a	O
role	O
for	O
Jagged1	protein
in	O
B-cell	O
activation	O
,	O
differentiation	O
or	O
function	O
.	O
These	O
findings	O
also	O
highlight	O
the	O
potential	O
for	O
an	O
interplay	O
between	O
the	O
Notch	O
and	O
NF-kappaB	O
signaling	O
pathways	O
in	O
the	O
immune	O
system	O
.	O

Bacterial	O
peptidoglycan	O
induces	O
CD14	protein
-dependent	O
activation	O
of	O
transcription	protein
factors	protein
CREB/ATF	protein
and	O
AP-1	protein
.	O
Peptidoglycan	O
(	O
PGN	O
),	O
the	O
major	O
cell	O
wall	O
component	O
of	O
Gram-positive	O
bacteria	O
,	O
induces	O
secretion	O
of	O
cytokines	protein
in	O
macrophages	cell_type
through	O
CD14	protein
,	O
the	O
pattern	O
recognition	O
receptor	O
that	O
binds	O
lipopolysaccharide	O
and	O
other	O
microbial	O
products	O
.	O
To	O
begin	O
to	O
elucidate	O
the	O
mechanisms	O
that	O
regulate	O
the	O
transcription	O
of	O
cytokine	DNA
genes	DNA
,	O
we	O
wanted	O
to	O
determine	O
which	O
transcription	protein
factors	protein
are	O
activated	O
by	O
PGN	O
in	O
mouse	cell_line
RAW264.7	cell_line
and	O
human	cell_line
THP-1	cell_line
macrophage	cell_line
cells	cell_line
.	O
Our	O
results	O
demonstrated	O
that:	O
(i)	O
PGN	O
induced	O
phosphorylation	O
of	O
the	O
transcription	protein
factors	protein
ATF-1	protein
and	O
CREB	protein
;	O
(ii)	O
ATF-1	protein
and	O
CREB	protein
bound	O
DNA	DNA
as	O
a	O
dimer	O
and	O
induced	O
transcriptional	O
activation	O
of	O
a	O
CRE	DNA
reporter	DNA
plasmid	DNA
,	O
which	O
was	O
inhibited	O
by	O
dominant	O
negative	O
CREB	protein
and	O
ATF-1	protein
;	O
(iii)	O
PGN	O
induced	O
phosphorylation	O
of	O
c-Jun	protein
,	O
protein	O
synthesis	O
of	O
JunB	protein
and	O
c-Fos	protein
,	O
and	O
transcriptional	O
activation	O
of	O
the	O
AP-1	DNA
reporter	DNA
plasmid	DNA
,	O
which	O
was	O
inhibited	O
by	O
dominant	O
negative	O
c-Fos	protein
;	O
and	O
(iv)	O
PGN	O
-induced	O
activation	O
of	O
CREB	protein
/ATF	protein
and	O
AP-1	protein
was	O
mediated	O
through	O
CD14	protein
.	O
This	O
is	O
the	O
first	O
study	O
to	O
demonstrate	O
activation	O
of	O
CREB	protein
/ATF	protein
and	O
AP-1	protein
transcription	protein
factors	protein
by	O
PGN	O
or	O
by	O
any	O
other	O
component	O
of	O
Gram-positive	O
bacteria	O
.	O

Glucocorticoid	protein
receptors	protein
are	O
down-regulated	O
in	O
inflamed	O
colonic	O
mucosa	O
but	O
not	O
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
from	O
patients	O
with	O
inflammatory	O
bowel	O
disease	O
[see	O
comments]	O
BACKGROUND:	O
Growing	O
evidence	O
indicates	O
that	O
the	O
immune	O
system	O
and	O
the	O
hypothalamic-pituitary-adrenal	O
system	O
are	O
linked	O
by	O
several	O
mechanisms,	O
for	O
example	O
intracellular	O
glucocorticoid	protein
receptors	protein
(	O
hGR	protein
).	O
Glucocorticoids	O
are	O
the	O
standard	O
treatment	O
of	O
acute	O
attacks	O
of	O
inflammatory	O
bowel	O
disease	O
(	O
IBD	O
).	O
Binding	O
of	O
glucocorticoids	O
to	O
hGR	protein
down-regulates	O
the	O
transcription	O
of	O
inflammatory	DNA
genes	DNA
that	O
can	O
propagate	O
IBD	O
.	O
PATIENTS	O
AND	O
METHODS:	O
IBD	O
patients	O
were	O
either	O
treated	O
with	O
5-60	O
mg	O
of	O
prednisolone	O
for	O
more	O
than	O
1	O
week	O
or	O
were	O
without	O
glucocorticoid	O
treatment	O
for	O
more	O
than	O
4	O
weeks.	O
hGR	protein
levels	O
were	O
determined	O
from	O
isolated	O
cytosol	O
of	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMCs	cell_type
)	O
or	O
mucosal	O
biopsies	O
using	O
a	O
radioassay	O
with	O
[3H]-dexamethasone	O
.	O
Interleukin	O
(IL)	O
6	O
levels	O
were	O
determined	O
by	O
enzyme-linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
).	O
RESULTS:	O
The	O
systemic	O
(PBMC)	O
hGR	protein
levels	O
of	O
corticosteroid-treated	O
IBD	O
patients	O
were	O
significantly	O
lower	O
than	O
those	O
of	O
control	O
subjects	O
(59.6	O
+/-	O
57.1	O
dpm	O
mg-1	O
cytosol	protein
protein	protein
vs.	O
227.0	O
+/-	O
90.8	O
dpm	O
mg-1	O
cytosol	protein
protein	protein
,	O
P	O
=	O
0.007)	O
and	O
IBD	O
patients	O
not	O
receiving	O
glucocorticoid	O
treatment	O
(179.7	O
+/-	O
171.3	O
dpm	O
mg-1	O
cytosol	protein
protein	protein
,	O
P	O
=	O
0.002).	O
Systemic	O
hGR	protein
levels	O
in	O
untreated	O
IBD	O
patients	O
did	O
not	O
differ	O
significantly	O
from	O
those	O
in	O
control	O
subjects	O
.	O
In	O
patients	O
with	O
connective	O
tissue	O
diseases,	O
systemic	O
hGR	protein
levels	O
were	O
also	O
found	O
to	O
be	O
decreased	O
in	O
the	O
absence	O
of	O
glucocorticoid	O
treatment	O
.	O
Systemic	O
hGR	protein
levels	O
in	O
patients	O
with	O
Crohn's	O
disease	O
(CD)	O
treated	O
with	O
steroids	O
(66.6	O
+/-	O
61.0	O
dpm	O
mg-1	O
cytosol	protein
protein	protein
)	O
were	O
not	O
different	O
from	O
those	O
in	O
patients	O
with	O
ulcerative	O
colitis	O
(UC)	O
(56.1	O
+/-	O
51.6	O
dpm	O
mg-1	O
cytosol	protein
protein	protein
).	O
In	O
contrast	O
to	O
these	O
findings,	O
mucosal	O
hGR	protein
levels	O
were	O
significantly	O
decreased	O
in	O
both	O
steroid-treated	O
(18.0	O
+/-	O
15.5)	O
and	O
not	O
steroid-treated	O
(37.8	O
+/-	O
30.5)	O
patients	O
compared	O
with	O
control	O
subjects	O
(	O
125.6	O
+/-	O
97.1;	O
P	O
=	O
0.00009	O
and	O
P	O
=	O
0.0008	O
respectively	O
).	O
IL-6	O
levels	O
in	O
all	O
IBD	O
groups	O
with	O
and	O
without	O
steroids	O
were	O
significantly	O
different	O
from	O
those	O
in	O
control	O
subjects	O
.	O
CONCLUSION:	O
In	O
IBD	O
there	O
is	O
no	O
difference	O
in	O
systemic	O
hGR	protein
levels	O
between	O
not	O
steroid-treated	O
patients	O
and	O
control	O
subjects	O
,	O
in	O
spite	O
of	O
inflammatory	O
activity	O
(	O
IL-6	protein
).	O
Mucosal	O
hGR	protein
levels	O
were	O
decreased	O
independently	O
of	O
treatment,	O
probably	O
leading	O
to	O
a	O
decreased	O
protection	O
against	O
NF-kappaB	protein
action	O
in	O
the	O
intestinal	O
mucosa	O
.	O

ICSAT	protein
overexpression	O
is	O
not	O
sufficient	O
to	O
cause	O
adult	O
T-cell	O
leukemia	O
or	O
multiple	O
myeloma	O
.	O
ICSAT	protein
(	O
Interferon	protein
Consensus	protein
Sequence	protein
binding	protein
protein	protein
for	protein
Activated	protein
T	protein
cells	protein
)	O
is	O
a	O
lymphocyte-specific	O
member	O
of	O
the	O
interferon	protein
regulatory	protein
factor	protein
(IRF)	protein
family	protein
of	O
transcription	O
factors,	O
originally	O
identified	O
through	O
Southwestern	O
screening	O
of	O
the	O
ATL	DNA
(	DNA
Adult	DNA
T-cell	DNA
leukemia	DNA
)-16T	DNA
expression	DNA
library	DNA
.	O
In	O
this	O
study,	O
we	O
created	O
transgenic	O
mice	O
overexpressing	O
ICSAT	protein
in	O
lymphocytes	cell_type
.	O
Although	O
spontaneous	O
tumorigenesis	O
was	O
not	O
observed,	O
IL-2	protein
production	O
with	O
Concanavalin	O
A	O
stimulation	O
was	O
significantly	O
increased	O
in	O
transgenic	O
mice	O
overexpressing	O
ICSAT	protein
.	O
ICSAT	protein
overexpression	O
in	O
lymphocytes	cell_type
seems	O
insufficient	O
for	O
the	O
leukemogenesis	O
of	O
ATL	O
or	O
multiple	O
myeloma	O
(	O
MM	O
),	O
however,	O
it	O
may	O
regulate	O
T	O
cell	O
activation	O
and	O
its	O
overexpression	O
may	O
lead	O
to	O
leukemogenesis	O
via	O
controlling	O
IL-2	protein
production	O
.	O
Copyright	O
1999	O
Academic	O
Press.	O

Altered	O
memory	cell_type
T	cell_type
cell	cell_type
differentiation	O
in	O
patients	O
with	O
early	O
rheumatoid	O
arthritis	O
.	O
The	O
chronic	O
immune	O
response	O
in	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
might	O
be	O
driven	O
by	O
activated	O
Th1	O
cells	O
without	O
sufficient	O
Th2	O
cell	O
differentiation	O
to	O
down-modulate	O
inflammation.	O
To	O
test	O
whether	O
disordered	O
memory	cell_type
T	cell_type
cell	cell_type
differentiation	O
contributes	O
to	O
the	O
typical	O
Th1-dominated	O
chronic	O
inflammation	O
in	O
RA	O
we	O
investigated	O
differentiation	O
of	O
resting	cell_type
CD4+	cell_type
memory	cell_type
T	cell_type
cells	cell_type
in	O
patients	O
with	O
early	O
(6	O
wk	O
to	O
12	O
mo)	O
untreated	O
RA	O
and	O
in	O
age-	O
and	O
sex-matched	O
healthy	O
controls	O
in	O
vitro.	O
No	O
difference	O
in	O
cytokine	protein
secretion	O
profiles	O
of	O
freshly	cell_type
isolated	cell_type
memory	cell_type
T	cell_type
cells	cell_type
was	O
detected	O
between	O
patients	O
and	O
controls.	O
A	O
cell	cell_line
culture	cell_line
system	cell_line
was	O
then	O
employed	O
that	O
permitted	O
the	O
differentiation	O
of	O
Th	protein
effectors	protein
from	O
resting	cell_type
memory	cell_type
T	cell_type
cells	cell_type
by	O
short	O
term	O
priming.	O
Marked	O
differences	O
were	O
found	O
in	O
response	O
to	O
priming.	O
Th2	cell_line
cells	cell_line
could	O
be	O
induced	O
in	O
all	O
healthy	O
controls	O
by	O
priming	O
with	O
anti-CD28	protein
in	O
the	O
absence	O
of	O
TCR	protein
ligation	O
.	O
By	O
contrast,	O
priming	O
under	O
those	O
conditions	O
resulted	O
in	O
Th2	O
differentiation	O
in	O
only	O
9	O
of	O
24	O
RA	O
patients	O
.	O
Exogenous	O
IL-4	protein
could	O
overcome	O
the	O
apparent	O
Th2	O
differentiation	O
defect	O
in	O
seven	O
patients	O
but	O
was	O
without	O
effect	O
in	O
the	O
remaining	O
eight	O
patients	O
.	O
In	O
all	O
patients	O
a	O
marked	O
decrease	O
in	O
IL-2	cell_type
-producing	cell_type
cells	cell_type
and	O
a	O
significant	O
increase	O
in	O
well-differentiated	O
Th1	cell_type
cells	cell_type
that	O
produced	O
IFN-gamma	protein
but	O
not	O
IL-2	protein
were	O
evident	O
after	O
priming	O
with	O
anti-CD3	protein
and	O
anti-CD28	protein
.	O
The	O
data	O
suggest	O
that	O
CD4+	cell_type
memory	cell_type
T	cell_type
cells	cell_type
from	O
patients	O
with	O
early	O
untreated	O
RA	O
manifest	O
an	O
intrinsic	O
abnormality	O
in	O
their	O
ability	O
to	O
differentiate	O
into	O
specific	O
cytokine-producing	cell_type
effector	cell_type
cells	cell_type
that	O
might	O
contribute	O
to	O
the	O
characteristic	O
Th1-dominated	O
chronic	O
(auto)immune	O
inflammation	O
in	O
RA	O
.	O

The	O
intracellular	O
parasite	O
Theileria	O
parva	O
protects	O
infected	cell_type
T	cell_type
cells	cell_type
from	O
apoptosis	O
.	O
Parasites	O
have	O
evolved	O
a	O
plethora	O
of	O
strategies	O
to	O
ensure	O
their	O
survival.	O
The	O
intracellular	O
parasite	O
Theileria	O
parva	O
secures	O
its	O
propagation	O
and	O
spreads	O
through	O
the	O
infected	O
animal	O
by	O
infecting	O
and	O
transforming	O
T	cell_type
cells	cell_type
,	O
inducing	O
their	O
continuous	O
proliferation	O
and	O
rendering	O
them	O
metastatic.	O
In	O
previous	O
work,	O
we	O
have	O
shown	O
that	O
the	O
parasite	O
induces	O
constitutive	O
activation	O
of	O
the	O
transcription	protein
factor	protein
NF-kappaB	protein
,	O
by	O
inducing	O
the	O
constitutive	O
degradation	O
of	O
its	O
cytoplasmic	protein
inhibitors	protein
.	O
The	O
biological	O
significance	O
of	O
NF-kappaB	protein
activation	O
in	O
T.	cell_type
parva-infected	cell_type
cells	cell_type
,	O
however,	O
has	O
not	O
yet	O
been	O
defined.	O
Cells	O
that	O
have	O
been	O
transformed	O
by	O
viruses	O
or	O
oncogenes	DNA
can	O
persist	O
only	O
if	O
they	O
manage	O
to	O
avoid	O
destruction	O
by	O
the	O
apoptotic	O
mechanisms	O
that	O
are	O
activated	O
on	O
transformation	O
and	O
that	O
contribute	O
to	O
maintain	O
cellular	O
homeostasis	O
.	O
We	O
now	O
demonstrate	O
that	O
parasite-induced	O
NF-kappaB	protein
activation	O
plays	O
a	O
crucial	O
role	O
in	O
the	O
survival	O
of	O
T.	cell_type
parva-transformed	cell_type
T	cell_type
cells	cell_type
by	O
conveying	O
protection	O
against	O
an	O
apoptotic	O
signal	O
that	O
accompanies	O
parasite-mediated	O
transformation	O
.	O
Consequently,	O
inhibition	O
of	O
NF-kappaB	protein
nuclear	O
translocation	O
and	O
the	O
expression	O
of	O
dominant	protein
negative	protein
mutant	protein
forms	O
of	O
components	O
of	O
the	O
NF-kappaB	protein
activation	O
pathway	O
,	O
such	O
as	O
IkappaBalpha	protein
or	O
p65	protein
,	O
prompt	O
rapid	O
apoptosis	O
of	O
T.	cell_type
parva-transformed	cell_type
T	cell_type
cells	cell_type
.	O
Our	O
findings	O
offer	O
important	O
insights	O
into	O
parasite	O
survival	O
strategies	O
and	O
demonstrate	O
that	O
parasite-induced	O
constitutive	O
NF-kappaB	protein
activation	O
is	O
an	O
essential	O
step	O
in	O
maintaining	O
the	O
transformed	O
phenotype	O
of	O
the	O
infected	cell_type
cells	cell_type
.	O

A	O
polymorphism	O
that	O
affects	O
OCT-1	protein
binding	O
to	O
the	O
TNF	DNA
promoter	DNA
region	DNA
is	O
associated	O
with	O
severe	O
malaria	O
[see	O
comments]	O
Genetic	O
variation	O
in	O
cytokine	DNA
promoter	DNA
regions	DNA
is	O
postulated	O
to	O
influence	O
susceptibility	O
to	O
infection,	O
but	O
the	O
molecular	O
mechanisms	O
by	O
which	O
such	O
polymorphisms	O
might	O
affect	O
gene	O
regulation	O
are	O
unknown.	O
Through	O
systematic	O
DNA	O
footprinting	O
of	O
the	O
TNF	O
(encoding	O
tumour	O
necrosis	O
factor,	O
TNF)	O
promoter	O
region,	O
we	O
have	O
identified	O
a	O
single	O
nucleotide	O
polymorphism	O
(SNP)	O
that	O
causes	O
the	O
helix-turn-helix	O
transcription	protein
factor	protein
OCT-1	O
to	O
bind	O
to	O
a	O
novel	O
region	O
of	O
complex	O
protein-DNA	O
interactions	O
and	O
alters	O
gene	O
expression	O
in	O
human	cell_type
monocytes	cell_type
.	O
The	O
OCT-1-binding	O
genotype	O
,	O
found	O
in	O
approximately	O
5%	O
of	O
Africans	O
,	O
is	O
associated	O
with	O
fourfold	O
increased	O
susceptibility	O
to	O
cerebral	O
malaria	O
in	O
large	O
case-control	O
studies	O
of	O
West	O
African	O
and	O
East	O
African	O
populations	O
,	O
after	O
correction	O
for	O
other	O
known	O
TNF	O
polymorphisms	O
and	O
linked	O
HLA	DNA
alleles	DNA
.	O

UV-induced	O
CYP1A1	protein
gene	O
expression	O
in	O
human	O
cells	O
is	O
mediated	O
by	O
tryptophan	O
.	O
Induction	O
of	O
cytochrome	protein
P-4501A1	protein
(	O
CYP1A1	protein
)	O
activity	O
by	O
UV	O
has	O
been	O
observed	O
earlier	O
in	O
animal	O
studies	O
via	O
a	O
mechanism	O
that	O
has	O
not	O
yet	O
been	O
resolved.	O
Our	O
previous	O
data	O
have	O
indicated	O
that	O
formylated	O
indolocarbazoles	O
which	O
are	O
formed	O
by	O
UV	O
irradiation	O
of	O
tryptophan	O
solutions	O
are	O
very	O
potent	O
Ah-receptor	O
agonists	O
.	O
To	O
evaluate	O
the	O
effect	O
of	O
UV	O
light	O
on	O
cytochrome	protein
P4501A1	protein
gene	O
expression	O
,	O
we	O
studied	O
the	O
induction	O
of	O
CYP1A1	RNA
mRNA	RNA
by	O
UV	O
irradiation	O
of	O
cultured	cell_line
human	cell_line
keratinocytes	cell_line
(	O
HaCaT	cell_line
cell	cell_line
line	cell_line
),	O
primary	cell_type
human	cell_type
blood	cell_type
lymphocytes	cell_type
and	O
mouse	cell_line
Hepa-1	cell_line
cells	cell_line
.	O
The	O
cells	O
were	O
exposed	O
to	O
UV	O
light	O
delivered	O
by	O
a	O
bank	O
of	O
6	O
Philips	O
TL20/12RS	O
sun	O
lamps	O
emitting	O
primarily	O
in	O
the	O
UVB	O
range	O
in	O
the	O
absence	O
and	O
presence	O
of	O
tryptophan	O
.	O
A	O
semiquantitative	O
reverse	protein
transcriptase	protein
-linked	O
polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
)	O
was	O
used	O
for	O
analysis	O
of	O
gene	O
expression	O
in	O
the	O
treated	cell_type
cells	cell_type
.	O
The	O
results	O
show	O
that	O
the	O
CYP1A1	RNA
mRNA	RNA
level	O
induced	O
by	O
UV	O
in	O
the	O
presence	O
of	O
tryptophan	O
was	O
higher	O
than	O
that	O
induced	O
by	O
UV	O
alone	O
in	O
both	O
HaCaT	cell_line
cells	cell_line
and	O
lymphocytes	cell_type
after	O
3	O
h	O
of	O
incubation	O
post-	O
UV	O
irradiation.	O
To	O
find	O
out	O
if	O
the	O
induction	O
by	O
UV	O
light	O
is	O
caused	O
by	O
the	O
formation	O
of	O
an	O
Ah	O
receptor	O
ligand,	O
Hepa-1	O
wild-type	O
and	O
Ah	O
receptor	O
deficient	O
c12	O
cell	O
lines	O
were	O
applied.	O
Wild-type	cell_line
(wt)	cell_line
cells	cell_line
were	O
inducible	O
either	O
by	O
the	O
tryptophan	O
photoproduct	O
6-formylindolo[3,2-b]carbazole	O
(	O
FICZ	O
)	O
or	O
by	O
UV	O
-irradiation	O
but	O
very	O
low	O
or	O
undetectable	O
levels	O
were	O
observed	O
in	O
the	O
c12	cell_type
cells	cell_type
.	O
This	O
shows	O
that	O
the	O
induction	O
of	O
gene	O
expression	O
by	O
FICZ	O
and	O
UV	O
is	O
Ah	protein
receptor	protein
dependent.	O
Together,	O
these	O
results	O
indicate	O
that	O
UV	O
-induced	O
CYP1A1	protein
gene	O
expression	O
in	O
mammalian	cell_type
cells	cell_type
is	O
mediated	O
by	O
an	O
Ah	protein
receptor	protein
ligand	O
formed	O
from	O
tryptophan	O
.	O
Thus,	O
the	O
photoproducts	O
of	O
tryptophan	O
are	O
suggested	O
to	O
be	O
mediators	O
of	O
light	O
via	O
binding	O
to	O
the	O
Ah	protein
receptor	protein
and	O
as	O
such	O
also	O
could	O
have	O
a	O
role	O
in	O
light-regulated	O
biological	O
rhythms	O
.	O

Repression	O
by	O
Ikaros	protein
and	O
Aiolos	protein
is	O
mediated	O
through	O
histone	protein
deacetylase	protein
complexes	protein
.	O
Here	O
we	O
show	O
that	O
the	O
lymphoid	protein
lineage-determining	protein
factors	protein
Ikaros	protein
and	O
Aiolos	protein
can	O
function	O
as	O
strong	protein
transcriptional	protein
repressors	protein
.	O
This	O
function	O
is	O
mediated	O
through	O
two	O
repression	protein
domains	protein
and	O
is	O
dependent	O
upon	O
the	O
promoter	O
context	O
and	O
cell	O
type	O
.	O
Repression	O
by	O
Ikaros	protein
proteins	protein
correlates	O
with	O
hypo-acetylation	O
of	O
core	protein
histones	protein
at	O
promoter	DNA
sites	DNA
and	O
is	O
relieved	O
by	O
histone	protein
deacetylase	protein
inhibitors	O
.	O
Consistent	O
with	O
these	O
findings,	O
Ikaros	protein
and	O
its	O
repression	protein
domains	protein
can	O
interact	O
in	O
vivo	O
and	O
in	O
vitro	O
with	O
the	O
mSin3	protein
family	protein
of	O
co-repressors	O
which	O
bind	O
to	O
histone	protein
deacetylases	protein
.	O
Based	O
on	O
these	O
and	O
our	O
recent	O
findings	O
of	O
associations	O
between	O
Ikaros	protein
and	O
Mi-2-HDAC	protein
,	O
we	O
propose	O
that	O
Ikaros	protein
family	protein
members	protein
modulate	O
gene	O
expression	O
during	O
lymphocyte	O
development	O
by	O
recruiting	O
distinct	O
histone	protein
deacetylase	protein
complexes	protein
to	O
specific	DNA
promoters	DNA
.	O

Protein	protein
kinase	protein
B	protein
(	O
c-Akt	protein
),	O
phosphatidylinositol	protein
3-kinase	protein
,	O
and	O
STAT5	protein
are	O
activated	O
by	O
erythropoietin	protein
(	O
EPO	protein
)	O
in	O
HCD57	cell_line
erythroid	cell_line
cells	cell_line
but	O
are	O
constitutively	O
active	O
in	O
an	O
EPO	cell_line
-independent,	cell_line
apoptosis	cell_line
-resistant	cell_line
subclone	cell_line
(	O
HCD57-SREI	cell_line
cells	cell_line
).	O
We	O
found	O
that	O
erythropoietin	protein
(	O
EPO	protein
)	O
and	O
stem	protein
cell	protein
factor	protein
(	O
SCF	protein
)	O
activated	protein
protein	protein
kinase	protein
B	protein
(	O
PKB/Akt	protein
)	O
in	O
EPO	cell_line
-dependent	cell_line
HCD57	cell_line
erythroid	cell_line
cells	cell_line
.	O
To	O
better	O
understand	O
signals	O
controlling	O
proliferation	O
and	O
viability,	O
erythroid	O
cells	O
that	O
resist	O
apoptosis	O
in	O
the	O
absence	O
of	O
EPO	protein
were	O
subcloned	O
and	O
characterized	O
(	O
HCD57-SREI	cell_line
cells	cell_line
).	O
Constitutive	O
activations	O
of	O
PKB/Akt	protein
,	O
STAT5a	protein
,	O
and	O
STAT5b	protein
were	O
noted	O
in	O
these	O
EPO	cell_line
-independent	cell_line
cells	cell_line
.	O
PI3-kinase	protein
activity	O
was	O
an	O
upstream	O
activator	O
of	O
PKB/Akt	protein
because	O
the	O
PI3-kinase	protein
inhibitor	O
LY294002	O
blocked	O
both	O
constitutive	O
PKB/Akt	protein
and	O
factor-dependent	O
PKB/Akt	protein
activity	O
.	O
The	O
LY294002	O
study	O
showed	O
that	O
proliferation	O
and	O
viability	O
of	O
both	O
HCD57-SREI	cell_line
and	O
HCD57	cell_line
cells	cell_line
correlated	O
with	O
the	O
activity	O
of	O
PKB/Akt	protein
;	O
however,	O
PKB/Akt	protein
activity	O
alone	O
did	O
not	O
protect	O
these	O
cells	O
from	O
apoptosis	O
.	O
Treatment	O
of	O
HCD57	cell_line
cells	cell_line
with	O
SCF	protein
also	O
activated	O
PKB/Akt	protein
,	O
but	O
did	O
not	O
protect	O
from	O
apoptosis	O
.	O
This	O
result	O
suggested	O
that	O
PKB/PI3-kinase	protein
activity	O
is	O
necessary	O
but	O
not	O
sufficient	O
to	O
promote	O
viability	O
and/or	O
proliferation.	O
Constitutive	O
STAT5	protein
activity	O
,	O
activated	O
through	O
an	O
unknown	O
pathway	O
not	O
including	O
JAK2	protein
or	O
EPOR	protein
,	O
may	O
act	O
in	O
concert	O
with	O
the	O
constitutive	O
PI3-kinase	protein
/PKB/Akt	protein
pathway	O
to	O
protect	O
the	O
EPO	cell_line
-independent	cell_line
HCD57-SREI	cell_line
cells	cell_line
from	O
apoptosis	O
and	O
promote	O
limited	O
proliferation	O
.	O

Disruption	O
of	O
alpha	O
beta	O
but	O
not	O
of	O
gamma	O
delta	O
T	O
cell	O
development	O
by	O
overexpression	O
of	O
the	O
helix-loop-helix	protein
protein	protein
Id3	protein
in	O
committed	cell_type
T	cell_type
cell	cell_type
progenitors	cell_type
.	O
Enforced	O
expression	O
of	O
Id3	protein
,	O
which	O
has	O
the	O
capacity	O
to	O
inhibit	O
many	O
basic	protein
helix-loop-helix	protein
(bHLH)	protein
transcription	protein
factors	protein
,	O
in	O
human	cell_type
CD34(+)	cell_type
hematopoietic	cell_type
progenitor	cell_type
cells	cell_type
that	O
have	O
not	O
undergone	O
T	DNA
cell	DNA
receptor	DNA
(	DNA
TCR	DNA
)	DNA
gene	DNA
rearrangements	DNA
inhibits	O
development	O
of	O
the	O
transduced	cell_type
cells	cell_type
into	O
TCR	O
alpha	O
beta	O
and	O
gamma	O
delta	O
cells	O
in	O
a	O
fetal	cell_line
thymic	cell_line
organ	cell_line
culture	cell_line
(	O
FTOC	cell_line
).	O
Here	O
we	O
document	O
that	O
overexpression	O
of	O
Id3	protein
,	O
in	O
progenitors	cell_type
that	O
have	O
initiated	O
TCR	DNA
gene	DNA
rearrangements	DNA
(	O
pre-T	cell_type
cells	cell_type
),	O
inhibits	O
development	O
into	O
TCRalpha	cell_line
beta	cell_line
but	O
not	O
into	O
TCRgamma	cell_line
delta	cell_line
T	cell_line
cells	cell_line
.	O
Furthermore,	O
Id3	protein
impedes	O
expression	O
of	O
recombination	O
activating	O
genes	O
and	O
downregulates	O
pre-Talpha	RNA
mRNA	RNA
.	O
These	O
observations	O
suggest	O
possible	O
mechanisms	O
by	O
which	O
Id3	protein
overexpression	O
can	O
differentially	O
affect	O
development	O
of	O
pre-T	cell_type
cells	cell_type
into	O
TCR	O
alpha	O
beta	O
and	O
gamma	O
delta	O
cells	O
.	O
We	O
also	O
observed	O
that	O
cell	cell_type
surface	cell_type
CD4(-)CD8(-)CD3(-)	cell_type
cells	cell_type
with	O
rearranged	DNA
TCR	DNA
genes	DNA
developed	O
from	O
Id3	cell_line
-transduced	cell_line
but	O
not	O
from	O
control-transduced	cell_line
pre-T	cell_line
cells	cell_line
in	O
an	O
FTOC	cell_line
.	O
These	O
cells	O
had	O
properties	O
of	O
both	O
natural	cell_type
killer	cell_type
(	O
NK	cell_type
)	O
and	O
pre-T	cell_type
cells	cell_type
.	O
These	O
findings	O
suggest	O
that	O
bHLH	protein
factors	protein
are	O
required	O
to	O
control	O
T	O
cell	O
development	O
after	O
the	O
T/NK	O
developmental	O
checkpoint	O
.	O

HIV-1	O
reactivation	O
in	O
resting	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
of	O
infected	O
adults	O
upon	O
in	O
vitro	O
CD4	protein
cross-linking	O
by	O
ligands	O
of	O
the	O
CDR2-loop	protein
in	O
extracellular	protein
domain	protein
1	protein
.	O
HIV-1	O
infects	O
resting	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMCs	cell_type
)	O
but	O
remains	O
inactive	O
state	O
until	O
subsequent	O
cell	O
activation	O
.	O
We	O
have	O
demonstrated	O
that	O
the	O
cross-linking	O
of	O
cell	protein
surface	protein
CD4	protein
by	O
gp120-anti-gp120	protein
immune	protein
complexes	protein
or	O
heat-inactivated	O
HIV-1	O
(	O
iHIV-1	O
)	O
is	O
sufficient	O
to	O
trigger	O
activation	O
signals	O
leading	O
to	O
virus	O
reactivation	O
(9).	O
In	O
this	O
study,	O
we	O
demonstrate	O
that	O
NF-kappaB	protein
nuclear	O
translocation	O
and	O
stimulation	O
of	O
virus	O
production	O
by	O
iHIV-1	O
were	O
strictly	O
linked	O
to	O
the	O
concentrations	O
of	O
viral	protein
proteins	protein
used	O
as	O
exogenous	O
stimuli.	O
Moreover,	O
we	O
further	O
investigated	O
the	O
physiologic	O
relevance	O
of	O
these	O
observations.	O
When	O
submitted	O
to	O
an	O
in	O
vitro	O
CD4	protein
cross-linking	O
by	O
iHIV-1	O
,	O
PBMCs	cell_type
from	O
HIV-1	O
-infected	O
patients	O
were	O
found	O
to	O
produce	O
virus.	O
This	O
viral	O
reactivation	O
was	O
associated	O
with	O
increased	O
NF-kappaB	protein
nuclear	O
translocation	O
in	O
patients	O
'	O
PBMCs	cell_type
.	O
Additionally,	O
virus	O
reactivation	O
in	O
resting	cell_type
PBMCs	cell_type
infected	O
in	O
vitro	O
with	O
HIV-1	O
was	O
found	O
to	O
be	O
specifically	O
induced	O
by	O
ligands	O
of	O
the	O
CDR2-loop	protein
in	O
domain	protein
1	protein
(	O
D1	protein
)	O
of	O
CD4	protein
(	O
virus	protein
envelope	protein
and	protein
anti-	protein
CD4	protein
monoclonal	protein
antibodies	protein
).	O
In	O
contrast,	O
virus	O
reactivation	O
was	O
not	O
observed	O
following	O
CD4	protein
oligomerization	O
by	O
antibodies	protein
that	O
bind	O
other	O
epitopes	O
in	O
D1	protein
,	O
including	O
the	O
D1/CDR3-loop	protein
.	O
Finally,	O
soluble	protein
CD4	protein
(	O
sCD4	protein
)	O
prevented	O
virus	O
reactivation	O
by	O
D1/CDR2-loop	protein
ligands	protein
.	O
Our	O
results	O
indicate	O
that	O
the	O
signaling	O
events	O
initiated	O
in	O
PBMCs	cell_type
by	O
oligomerization	O
of	O
CD4	protein
at	O
the	O
D1/	protein
CDR2-loop	protein
can	O
trigger	O
HIV-1	O
upregulation	O
in	O
infected	O
individuals	O
.	O

Signaling	O
through	O
the	O
lymphotoxin-beta	protein
receptor	protein
stimulates	O
HIV-1	O
replication	O
alone	O
and	O
in	O
cooperation	O
with	O
soluble	O
or	O
membrane-bound	protein
TNF-alpha	protein
.	O
The	O
level	O
of	O
ongoing	O
HIV-1	O
replication	O
within	O
an	O
individual	O
is	O
critical	O
to	O
HIV-1	O
pathogenesis	O
.	O
Among	O
host	O
immune	O
factors,	O
the	O
cytokine	protein
TNF-alpha	protein
has	O
previously	O
been	O
shown	O
to	O
increase	O
HIV-1	O
replication	O
in	O
various	O
monocyte	O
and	O
T	O
cell	O
model	O
systems	O
.	O
Here,	O
we	O
demonstrate	O
that	O
signaling	O
through	O
the	O
TNF	protein
receptor	O
family	O
member	O
,	O
the	O
lymphotoxin-beta	protein
(LT-beta)	protein
receptor	protein
(	O
LT-betaR	protein
),	O
also	O
regulates	O
HIV-1	O
replication	O
.	O
Furthermore,	O
HIV-1	O
replication	O
is	O
cooperatively	O
stimulated	O
when	O
the	O
distinct	O
LT-betaR	protein
and	O
TNF	protein
receptor	protein
systems	protein
are	O
simultaneously	O
engaged	O
by	O
their	O
specific	O
ligands.	O
Moreover,	O
in	O
a	O
physiological	O
coculture	O
cellular	O
assay	O
system	O
,	O
we	O
show	O
that	O
membrane-bound	protein
TNF-alpha	protein
and	O
LT-alpha1beta2	protein
act	O
virtually	O
identically	O
to	O
their	O
soluble	O
forms	O
in	O
the	O
regulation	O
of	O
HIV-1	O
replication	O
.	O
Thus,	O
cosignaling	O
via	O
the	O
LT-beta	O
and	O
TNF-alpha	O
receptors	O
is	O
probably	O
involved	O
in	O
the	O
modulation	O
of	O
HIV-1	O
replication	O
and	O
the	O
subsequent	O
determination	O
of	O
HIV-1	O
viral	O
burden	O
in	O
monocytes	cell_type
.	O
Intriguingly,	O
surface	O
expression	O
of	O
LT-alpha1beta2	protein
is	O
up-regulated	O
on	O
a	O
T	cell_line
cell	cell_line
line	cell_line
acutely	O
infected	O
with	O
HIV-1	O
,	O
suggesting	O
a	O
positive	O
feedback	O
loop	O
between	O
HIV-1	O
infection	O
,	O
LT-alpha1beta2	protein
expression	O
,	O
and	O
HIV-1	O
replication	O
.	O
Given	O
the	O
critical	O
role	O
that	O
LT-alpha1beta2	protein
plays	O
in	O
lymphoid	O
architecture,	O
we	O
speculate	O
that	O
LT-alpha1beta2	protein
may	O
be	O
involved	O
in	O
HIV	O
-associated	O
abnormalities	O
of	O
the	O
lymphoid	O
organs	O
.	O

Monoclonal	protein
anti-endothelial	protein
cell	protein
antibodies	protein
from	O
a	O
patient	O
with	O
Takayasu	O
arteritis	O
activate	O
endothelial	O
cells	O
from	O
large	O
vessels	O
.	O
OBJECTIVE:	O
To	O
create	O
monoclonal	protein
anti-endothelial	protein
cell	protein
antibodies	protein
(	O
mAECA	protein
)	O
from	O
a	O
patient	O
with	O
Takayasu	O
arteritis	O
to	O
evaluate	O
their	O
ability	O
to	O
activate	O
human	cell_line
umbilical	cell_line
vein	cell_line
endothelial	cell_line
cells	cell_line
(	O
HUVEC	cell_line
),	O
and	O
to	O
characterize	O
the	O
mechanism	O
of	O
EC	O
activation	O
.	O
METHODS:	O
A	O
panel	O
of	O
mAECA	protein
was	O
generated	O
from	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
of	O
a	O
patient	O
with	O
Takayasu	O
arteritis	O
,	O
using	O
Epstein-Barr	O
virus	O
transformation	O
.	O
Activity	O
against	O
macrovascular	cell_line
EC	cell_line
(	O
HUVEC	cell_line
)	O
and	O
microvascular	cell_line
EC	cell_line
(	O
human	cell_line
bone	cell_line
marrow	cell_line
EC	cell_line
immortalized	cell_line
by	cell_line
SV40	cell_line
)	O
antigens	O
was	O
detected	O
by	O
enzyme-linked	O
immunosorbent	O
assay	O
.	O
Inhibition	O
studies	O
were	O
used	O
to	O
select	O
the	O
monoclonal	protein
antibodies	protein
(	O
mAECA	protein
)	O
which	O
share	O
the	O
same	O
EC	O
epitope	O
binding	O
specificity	O
as	O
the	O
total	protein
IgG-AECA	protein
from	O
the	O
Takayasu	O
arteritis	O
patient	O
.	O
The	O
binding	O
of	O
the	O
mAECA	protein
to	O
human	cell_type
aortic	cell_type
EC	cell_type
was	O
studied	O
by	O
immunohistochemistry	O
.	O
The	O
secretion	O
levels	O
of	O
interleukin-6	protein
(	O
IL-6	protein
)	O
and	O
von	O
Willebrand	O
factor	O
(	O
vWF	O
)	O
were	O
determined,	O
to	O
serve	O
as	O
markers	O
for	O
EC	O
activation	O
.	O
The	O
activated	cell_line
EC	cell_line
were	O
examined	O
for	O
the	O
adherence	O
of	O
a	O
monocytic	cell_line
cell	cell_line
line	cell_line
(	O
U937	cell_line
),	O
as	O
well	O
as	O
for	O
expression	O
of	O
vascular	protein
cell	protein
adhesion	protein
molecule	protein
1	protein
,	O
intercellular	protein
adhesion	protein
molecule	protein
1	protein
,	O
and	O
E-selectin	protein
.	O
In	O
addition,	O
nuclear	O
extracts	O
of	O
the	O
mAECA	cell_line
-treated	cell_line
EC	cell_line
were	O
analyzed	O
for	O
the	O
induction	O
of	O
translocation	O
of	O
nuclear	protein
factor	protein
kappaB	protein
(	O
NF-kappaB	protein
),	O
using	O
a	O
specific	O
NF-kappaB	protein
oligoprobe	O
in	O
an	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O
RESULTS:	O
Six	O
mAECA	protein
were	O
selected,	O
the	O
mixture	O
of	O
which	O
produced	O
100%	O
inhibition	O
of	O
binding	O
of	O
the	O
original	O
IgG	protein
(from	O
the	O
patient	O
with	O
Takayasu	O
arteritis	O
)	O
to	O
HUVEC	cell_line
.	O
All	O
mAECA	protein
possessed	O
high	O
activity	O
against	O
macrovascular	cell_line
EC	cell_line
,	O
but	O
none	O
had	O
significant	O
antimicrovascular	O
EC	O
activity	O
.	O
The	O
mAECA	protein
,	O
but	O
not	O
normal	protein
human	protein
IgG	protein
,	O
had	O
anti-human	O
aortic	O
EC	O
activity	O
.	O
Four	O
of	O
the	O
6	O
mAECA	protein
activated	cell_line
EC	cell_line
,	O
manifested	O
by	O
increased	O
IL-6	protein
and	O
vWF	O
secretion	O
.	O
The	O
4	O
mAECA	protein
induced	O
EC	O
expression	O
of	O
adhesion	protein
molecules	protein
and	O
increased	O
adhesion	O
of	O
U937	cell_type
monocytic	cell_type
cells	cell_type
to	O
EC	cell_type
.	O
In	O
addition,	O
these	O
mAECA	protein
stimulated	O
the	O
nuclear	O
translocation	O
of	O
the	O
NF-kappaB	protein
transcription	protein
factor	protein
.	O
CONCLUSION:	O
Our	O
findings	O
suggest	O
that	O
AECA	protein
may	O
directly	O
stimulate	O
EC	cell_type
in	O
Takayasu	O
arteritis	O
through	O
elevation	O
of	O
adhesion	protein
molecule	protein
expression	O
associated	O
with	O
NF-kappaB	protein
activation	O
and	O
adhesion	O
of	O
monocytes	cell_type
,	O
and	O
may	O
therefore	O
play	O
a	O
pathogenic	O
role	O
in	O
the	O
development	O
of	O
the	O
vasculopathy	O
in	O
Takayasu	O
arteritis	O
.	O

Cutting	O
edge:	O
expression	O
of	O
the	O
NF	protein
of	protein
activated	protein
T	protein
cells	protein
in	O
eosinophils	cell_type
:	O
regulation	O
by	O
IL-4	protein
and	O
IL-5	protein
.	O
We	O
report	O
that	O
NF-AT1	protein
and	O
NF-AT4	protein
are	O
expressed	O
cytoplasmically	O
in	O
resting	cell_type
eosinophils	cell_type
,	O
whereas	O
NF-AT2	protein
and	O
NF-AT3	protein
have	O
not	O
been	O
seen.	O
Likewise,	O
NF-AT1	RNA
mRNA	RNA
and	O
NF-AT4	RNA
mRNA	RNA
have	O
been	O
detected	O
in	O
resting	cell_type
eosinophils	cell_type
,	O
and	O
their	O
levels	O
can	O
be	O
significantly	O
up-regulated	O
by	O
the	O
Th2-associated	protein
cytokines	protein
IL-4	protein
and	O
IL-5	protein
.	O
There	O
is	O
no	O
detectable	O
NF-AT	protein
protein	O
expression	O
in	O
the	O
nuclei	O
of	O
resting	cell_type
eosinophils	cell_type
.	O
However	O
NF-ATs	protein
appear	O
in	O
the	O
nuclei	O
of	O
IL-4-	O
,	O
IL-5-	O
,	O
or	O
ionomycin-	O
stimulated	O
eosinophils	O
.	O
Only	O
NF-AT1	protein
and	O
NF-AT4	protein
,	O
but	O
not	O
NF-AT2	protein
and	O
NF-AT3	protein
,	O
have	O
translocated	O
into	O
the	O
nuclei	O
in	O
IL-4-	O
or	O
IL-5-	O
stimulated	O
eosinophils	O
.	O
These	O
findings	O
delineate	O
a	O
novel	O
pathway	O
in	O
the	O
cytokine	O
network	O
in	O
which	O
Th2	cell_line
lymphocytes	cell_line
"control"	O
eosinophils	cell_type
via	O
the	O
release	O
of	O
IL-4	protein
and	O
IL-5	protein
,	O
and	O
activation	O
of	O
NF-AT	protein
in	O
eosinophils	cell_type
.	O
The	O
findings	O
also	O
suggest	O
that	O
a	O
later	O
feedback	O
"talking"	O
may	O
exist	O
between	O
eosinophils	cell_type
and	O
Th2	cell_line
lymphocytes	cell_line
.	O

PPARalpha	O
activators	O
inhibit	O
cytokine-induced	O
vascular	protein
cell	protein
adhesion	protein
molecule-1	protein
expression	O
in	O
human	cell_type
endothelial	cell_type
cells	cell_type
.	O
BACKGROUND:	O
Adhesion	O
molecule	O
expression	O
on	O
the	O
endothelial	O
cell	O
(EC)	O
surface	O
is	O
critical	O
for	O
leukocyte	O
recruitment	O
to	O
atherosclerotic	O
lesions	O
.	O
Better	O
understanding	O
of	O
transcriptional	O
regulation	O
of	O
adhesion	protein
molecules	protein
in	O
ECs	cell_type
may	O
provide	O
important	O
insight	O
into	O
plaque	O
formation	O
.	O
Peroxisome	protein
proliferator-activated	protein
receptor-alpha	protein
(	O
PPARalpha	protein
),	O
a	O
member	O
of	O
the	O
nuclear	protein
receptor	protein
family	protein
,	O
regulates	O
gene	O
expression	O
in	O
response	O
to	O
certain	O
fatty	O
acids	O
and	O
fibric	O
acid	O
derivatives.	O
The	O
present	O
study	O
investigated	O
PPARalpha	protein
expression	O
in	O
human	cell_type
ECs	cell_type
and	O
their	O
regulation	O
of	O
vascular	protein
cell	protein
adhesion	protein
molecule-1	protein
(	O
VCAM-1	protein
).	O
METHODS	O
AND	O
RESULTS:	O
Immunohistochemistry	O
revealed	O
that	O
human	cell_type
carotid	cell_type
artery	cell_type
ECs	cell_type
express	O
PPARalpha	protein
.	O
Pretreatment	O
of	O
cultured	cell_type
human	cell_type
ECs	cell_type
with	O
the	O
PPARalpha	protein
activators	O
fenofibrate	O
or	O
WY14643	O
inhibited	O
TNF-alpha-induced	protein
VCAM-1	protein
in	O
a	O
time-	O
and	O
concentration-dependent	O
manner,	O
an	O
effect	O
not	O
seen	O
with	O
PPARgamma	protein
activators	O
.	O
Both	O
PPARalpha	protein
activators	O
decreased	O
cytokine-induced	O
VCAM-1	protein
mRNA	O
expression	O
without	O
altering	O
its	O
mRNA	O
half-life	O
.	O
Transient	O
transfection	O
of	O
deletional	O
VCAM-1	DNA
promoter	DNA
constructs	DNA
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
suggest	O
that	O
fenofibrate	O
inhibits	O
VCAM-1	protein
transcription	O
in	O
part	O
by	O
inhibiting	O
NF-kappaB	protein
.	O
Finally,	O
PPARalpha	protein
activators	O
significantly	O
reduced	O
adhesion	O
of	O
U937	cell_line
cells	cell_line
to	O
cultured	cell_type
human	cell_type
ECs	cell_type
.	O
CONCLUSIONS:	O
Human	cell_type
ECs	cell_type
express	O
PPARalpha	protein
,	O
a	O
potentially	O
important	O
regulator	O
of	O
atherogenesis	O
through	O
its	O
transcriptional	O
control	O
of	O
VCAM-1	protein
gene	O
expression	O
.	O
Such	O
findings	O
also	O
have	O
implications	O
regarding	O
the	O
clinical	O
use	O
of	O
lipid-lowering	O
agents	O
,	O
like	O
fibric	O
acids	O
,	O
which	O
can	O
activate	O
PPARalpha	protein
.	O

CBP/p300	protein
integrates	O
Raf	protein
/	O
Rac	protein
-signaling	O
pathways	O
in	O
the	O
transcriptional	O
induction	O
of	O
NF-ATc	protein
during	O
T	O
cell	O
activation	O
.	O
NF-ATc	protein
,	O
an	O
inducibly	O
expressed	O
transcription	protein
factor	protein
,	O
controls	O
gene	O
expression	O
in	O
T	cell_type
lymphocytes	cell_type
and	O
cardiomyocytes	cell_type
.	O
We	O
show	O
here	O
that	O
the	O
transcriptional	protein
co-activators	protein
CBP/p300	protein
bind	O
to	O
and	O
control	O
the	O
activity	O
of	O
the	O
inducible	protein
N-terminal	protein
transactivation	protein
domain	protein
of	O
NF-ATc	protein
,	O
TAD-A	protein
.	O
Similar	O
to	O
the	O
N	protein
terminal	protein
transactivation	protein
domain	protein
of	O
c-Jun	protein
,	O
TAD-A	protein
is	O
inducibly	O
phosphorylated,	O
but	O
this	O
phosphorylation	O
is	O
dispensable	O
for	O
the	O
interaction	O
with	O
CBP/p300	protein
.	O
Constitutive	O
active	O
versions	O
of	O
c-Raf	protein
and	O
Rac	protein
synergistically	O
enhance	O
the	O
CBP/p300	protein
-mediated	O
increase	O
of	O
TAD-A	protein
activity,	O
indicating	O
the	O
important	O
role	O
CBP/p300	protein
plays	O
in	O
the	O
integration	O
of	O
T	O
cell	O
activation	O
signals.	O
Since	O
a	O
mutation	O
of	O
CBP	protein
abolishing	O
HAT	O
activity	O
is	O
almost	O
as	O
active	O
as	O
wild-type	protein
CBP	protein
in	O
T	cell_type
cells	cell_type
,	O
functions	O
of	O
CBP/p300	protein
other	O
than	O
histone	O
acetylation	O
appear	O
to	O
control	O
the	O
NF-AT	protein
-dependent	O
transcription	O
in	O
T	cell_type
cells	cell_type
.	O

Immune	O
functions	O
,	O
clinical	O
parameters	O
and	O
hormone	O
receptor	O
status	O
in	O
breast	O
cancer	O
patients	O
.	O
We	O
have	O
carried	O
out	O
a	O
detailed	O
analysis	O
of	O
the	O
cellular	O
immune	O
functions	O
of	O
breast	O
cancer	O
patients	O
in	O
comparison	O
with	O
healthy	O
controls	O
.	O
A	O
possible	O
correlation	O
between	O
immune	O
and	O
clinical	O
parameters	O
was	O
analysed	O
in	O
50	O
breast	O
cancer	O
patients	O
.	O
Immune	O
parameters	O
,	O
natural	cell_type
killer	cell_type
cell	cell_type
and	O
T	O
lymphocyte	O
functions	O
and	O
the	O
numbers	O
of	O
circulating	cell_type
T	cell_type
lymphocytes	cell_type
were	O
analysed	O
against	O
the	O
clinical	O
parameters	O
comprising	O
the	O
tumour	O
burden,	O
the	O
stage	O
of	O
the	O
disease	O
and	O
the	O
expression	O
of	O
hormone	protein
receptors	protein
on	O
the	O
tumour.	O
In	O
order	O
to	O
analyse	O
the	O
immune	O
function	O
data	O
effectively,	O
low	O
responders	O
were	O
identified	O
with	O
stringent	O
cut-off	O
values.	O
Considerably	O
higher	O
proportions	O
of	O
low	O
responders	O
were	O
found	O
among	O
the	O
patient	O
population	O
.	O
Elevated	O
numbers	O
of	O
circulating	cell_type
T	cell_type
lymphocytes	cell_type
and	O
CD3	protein
-directed	O
cytolysis	O
correlated	O
with	O
the	O
expression	O
of	O
oestrogen	protein
receptors	protein
independently	O
of	O
the	O
clinical/histological	O
parameters	O
.	O

Latent	protein
membrane	protein
protein	protein
1	protein
of	O
Epstein-Barr	O
virus	O
interacts	O
with	O
JAK3	protein
and	O
activates	O
STAT	protein
proteins	protein
.	O
Latent	protein
membrane	protein
protein	protein
1	protein
(	O
LMP1	protein
)	O
acts	O
like	O
a	O
permanently	protein
activated	protein
receptor	protein
of	O
the	O
tumor	protein
necrosis	protein
factor	protein
(TNF)-receptor	protein
superfamily	protein
and	O
is	O
absolutely	O
required	O
for	O
B	O
cell	O
immortalization	O
by	O
Epstein-Barr	O
virus	O
.	O
Molecular	O
and	O
biochemical	O
approaches	O
demonstrated	O
that	O
LMP1	protein
usurps	O
cellular	O
signaling	O
pathways	O
resulting	O
in	O
the	O
induction	O
of	O
NF-kappaB	protein
and	O
AP-1	protein
via	O
two	O
C-terminal	protein
activating	protein
regions	protein
.	O
We	O
demonstrate	O
here	O
that	O
a	O
third	O
region	O
encompassing	O
a	O
proline	protein
rich	protein
sequence	protein
within	O
the	O
33	O
bp	O
repetitive	O
stretch	O
of	O
LMP1	protein
's	O
C-terminus	protein
is	O
required	O
for	O
the	O
activation	O
of	O
Janus	protein
kinase	protein
3	protein
(	O
JAK3	protein
).	O
The	O
interaction	O
of	O
LMP1	protein
and	O
JAK3	protein
leads	O
to	O
the	O
enhanced	O
tyrosine	O
auto/transphosphorylation	O
of	O
JAK3	protein
within	O
minutes	O
after	O
crosslinking	O
of	O
a	O
conditional	O
NGF-R	protein
:	protein
LMP1	protein
chimera	protein
and	O
is	O
a	O
prerequisite	O
for	O
the	O
activation	O
of	O
STAT	protein
transcription	protein
factors	protein
.	O
These	O
results	O
reveal	O
a	O
novel	O
activating	O
region	O
in	O
the	O
LMP1	protein
C-terminus	protein
and	O
identify	O
the	O
JAK	protein
/STAT	protein
pathway	O
as	O
a	O
target	O
of	O
this	O
viral	protein
integral	protein
membrane	protein
protein	protein
in	O
B	cell_type
cells	cell_type
.	O

Monocyte	O
arrest	O
and	O
transmigration	O
on	O
inflamed	O
endothelium	O
in	O
shear	O
flow	O
is	O
inhibited	O
by	O
adenovirus-mediated	O
gene	O
transfer	O
of	O
IkappaB-alpha	protein
.	O
Mobilization	O
of	O
nuclear	protein
factor-kappaB	protein
(	O
NF-kappaB	protein
)	O
activates	O
transcription	O
of	O
genes	O
encoding	O
endothelial	protein
adhesion	protein
molecules	protein
and	O
chemokines	O
that	O
contribute	O
to	O
monocyte	O
infiltration	O
critical	O
in	O
atherogenesis	O
.	O
Inhibition	O
of	O
NF-kappaB	protein
has	O
been	O
achieved	O
by	O
pharmacological	O
and	O
genetic	O
approaches;	O
however,	O
monocyte	O
interactions	O
with	O
activated	O
endothelium	O
in	O
shear	O
flow	O
following	O
gene	O
transfer	O
of	O
the	O
NF-kappaB	protein
inhibitor	O
IkappaB-alpha	protein
have	O
not	O
been	O
studied.	O
We	O
found	O
that	O
overexpression	O
of	O
IkappaB-alpha	protein
in	O
endothelial	cell_type
cells	cell_type
using	O
a	O
recombinant	O
adenovirus	O
prevented	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
)-induced	O
degradation	O
of	O
IkappaB-alpha	protein
and	O
suppressed	O
the	O
upregulation	O
of	O
vascular	protein
cell	protein
adhesion	protein
molecule-1	protein
(	O
VCAM-1	protein
),	O
intercellular	protein
adhesion	protein
molecule-1	protein
(	O
ICAM-1	protein
),	O
and	O
E-selectin	RNA
mRNA	RNA
and	O
surface	O
protein	O
expression	O
and	O
the	O
upregulation	O
of	O
transcripts	O
for	O
the	O
chemokines	protein
monocyte	protein
chemoattractant	protein
protein	protein
1	protein
(	O
MCP-1	protein
)	O
and	O
growth-related	protein
activity-alpha	protein
(	O
GRO-alpha	protein
)	O
by	O
TNF-alpha	protein
.	O
This	O
was	O
associated	O
with	O
a	O
reduction	O
in	O
endothelial	O
MCP-1	protein
secretion	O
and	O
GRO-alpha	protein
immobilization	O
.	O
Adhesion	O
assays	O
under	O
physiological	O
shear	O
flow	O
conditions	O
showed	O
that	O
firm	O
arrest,	O
spreading,	O
and	O
transmigration	O
of	O
monocytes	cell_type
on	O
TNF-alpha	protein
-activated	O
endothelium	O
was	O
markedly	O
inhibited	O
by	O
IkappaB-alpha	protein
overexpression.	O
Inhibition	O
with	O
monoclonal	protein
antibodies	protein
and	O
peptide	O
antagonists	O
inferred	O
that	O
this	O
was	O
due	O
to	O
reduced	O
expression	O
of	O
Ig	O
integrin	O
ligand	O
as	O
well	O
as	O
of	O
chemokines	protein
specifically	O
involved	O
in	O
these	O
events.	O
In	O
contrast,	O
rolling	O
of	O
monocytes	cell_type
was	O
increased	O
by	O
IkappaB-alpha	protein
transfer	O
and	O
was	O
partly	O
mediated	O
by	O
P-selectin	protein
;	O
however,	O
it	O
appeared	O
to	O
be	O
unaffected	O
by	O
the	O
inhibition	O
of	O
E-selectin	protein
induction.	O
Thus,	O
our	O
data	O
provide	O
novel	O
evidence	O
that	O
selective	O
modulation	O
of	O
NF-kappaB	protein
by	O
adenoviral	O
transfer	O
of	O
IkappaB-alpha	protein
impairs	O
the	O
expression	O
of	O
multiple	O
endothelial	protein
gene	protein
products	protein
required	O
for	O
subsequent	O
monocyte	O
arrest	O
and	O
emigration	O
in	O
shear	O
flow	O
and	O
thus	O
for	O
monocyte	O
infiltration	O
in	O
atherosclerotic	O
plaques	O
.	O

Recognition	O
of	O
NFATp/AP-1	DNA
composite	DNA
elements	DNA
within	O
genes	O
induced	O
upon	O
the	O
activation	O
of	O
immune	cell_type
cells	cell_type
.	O
Composite	DNA
elements	DNA
are	O
regulatory	DNA
modules	DNA
of	O
promoters	DNA
or	O
enhancers	DNA
that	O
consist	O
of	O
binding	O
sites	O
of	O
two	O
different	O
but	O
synergizing	O
transcription	protein
factors	protein
.	O
A	O
well-studied	O
example	O
is	O
nuclear	DNA
factors	DNA
of	DNA
activated	DNA
T-cell	DNA
(NFAT)	DNA
sites	DNA
which	O
are	O
composite	O
elements	O
of	O
a	O
NFATp/c	O
and	O
an	O
activating	O
protein	O
1	O
(AP-1)	O
binding	O
site	O
.	O
We	O
have	O
developed	O
a	O
computational	O
approach	O
to	O
identify	O
potential	O
NFAT	DNA
target	DNA
genes	DNA
which	O
(a)	O
comprises	O
an	O
improved	O
method	O
to	O
scan	O
for	O
individual	O
NFAT	DNA
composite	DNA
elements	DNA
;	O
(b)	O
considers	O
positional	O
effects	O
relative	O
to	O
transcription	DNA
start	DNA
sites	DNA
;	O
and	O
(c)	O
involves	O
cluster	O
analysis	O
of	O
potential	O
NFAT	DNA
composite	DNA
elements	DNA
.	O
All	O
three	O
steps	O
progressively	O
helpX?ed	O
to	O
discriminate	O
T-cell-specific	DNA
promoter	DNA
sequences	DNA
against	O
other	O
functional	DNA
regions	DNA
(	O
coding	O
and	O
intronic	O
sequences	O
)	O
of	O
the	O
same	O
genes,	O
against	O
promoters	DNA
of	O
muscle-specific	DNA
genes	DNA
or	O
against	O
random	DNA
sequences	DNA
.	O
Using	O
this	O
approach,	O
we	O
identified	O
potential	O
NFAT	DNA
composite	DNA
elements	DNA
in	O
promoters	DNA
of	O
cytokine	DNA
genes	DNA
and	O
their	O
receptors	O
as	O
well	O
as	O
in	O
promoters	DNA
of	O
genes	O
for	O
AP-1	protein
family	protein
members	protein
,	O
Ca2+-binding	protein
proteins	protein
and	O
some	O
other	O
components	O
of	O
the	O
regulatory	O
network	O
operating	O
in	O
activated	cell_type
T-cells	cell_type
and	O
other	O
immune	cell_type
cells	cell_type
.	O
The	O
method	O
developed	O
can	O
be	O
adapted	O
to	O
characterize	O
and	O
identify	O
other	O
composite	DNA
elements	DNA
as	O
well.	O
The	O
program	O
for	O
recognition	O
NFAT	DNA
composite	DNA
elements	DNA
is	O
available	O
through	O
the	O
World	O
Wide	O
Web	O
(http://compel.bionet.nsc.ru/FunSite/CompelScan.html	O
and	O
http://transfac.gbf.de/dbsearch/funsitep/s_comp.html).	O
Copyright	O
1999	O
Academic	O
Press.	O

The	O
oestrogen	protein
receptor	protein
codon	DNA
10	DNA
polymorphism	O
detected	O
in	O
breast	O
cancer	O
is	O
also	O
present	O
in	O
non-malignant	cell_type
cells	cell_type
.	O
The	O
effect	O
of	O
oestrogens	O
on	O
oestrogen	O
-receptive	O
organs	O
and	O
cells	O
is	O
mediated	O
via	O
intracellular	protein
receptors	protein
(	O
ERalpha	protein
and	O
ERbeta	protein
).	O
Oestrogen	protein
receptor	protein
gene	O
polymorphisms	O
in	O
the	O
region	O
encoding	O
the	O
N-terminal	protein
portion	protein
of	O
the	O
protein	O
are	O
reportedly	O
associated	O
with	O
pathological	O
conditions	O
including	O
breast	O
cancer	O
,	O
hypertension	O
,	O
spontaneous	O
abortion	O
and	O
coronary	O
heart	O
disease	O
.	O
A	O
silent	O
mutation	O
in	O
codon	DNA
10	DNA
of	O
exon	DNA
1	DNA
,	O
detected	O
in	O
ER-negative	O
and	O
ER-positive	O
human	O
breast	O
cancer	O
cell	O
lines	O
,	O
in	O
breast	O
tumors	O
and	O
blood	DNA
DNA	DNA
from	O
breast	O
cancer	O
patients	O
,	O
has	O
been	O
recognized	O
as	O
a	O
polymorphic	DNA
site	DNA
.	O
In	O
this	O
study	O
we	O
examined,	O
by	O
denaturing	O
gradient-gel	O
electrophoresis	O
and	O
DNA	DNA
sequence	DNA
analysis	O
,	O
the	O
possible	O
presence	O
of	O
a	O
codon	DNA
10	DNA
polymorphic	DNA
site	DNA
in	O
normal	O
oestrogen	O
target	O
organs	O
and	O
cells	O
such	O
as	O
the	O
uterus	O
(	O
myometrium	O
and	O
endometrium	O
),	O
in	O
the	O
placenta	O
and	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
and	O
in	O
a	O
benign	O
uterus	O
tumour	O
(	O
leiomyoma	O
).	O
We	O
have	O
detected	O
ER	DNA
codon	DNA
10	DNA
polymorphism	O
in	O
these	O
samples	O
and	O
have	O
compared	O
them	O
to	O
those	O
observed	O
in	O
breast	O
cancer	O
samples	O
.	O
All	O
tissues	O
and	O
cells	O
studied	O
were	O
homozygous	O
for	O
the	O
wild-type	DNA
gene	DNA
,	O
and	O
were	O
heterozygous	O
as	O
well	O
as	O
homozygous	O
for	O
the	O
codon-10-variant	DNA
type	DNA
.	O
These	O
results	O
indicate	O
that	O
the	O
presence	O
of	O
the	O
codon-10-variant	DNA
type	DNA
is	O
not	O
a	O
characteristic	O
of	O
breast	O
cancer	O
.	O
Out	O
current	O
findings	O
suggest	O
that	O
further	O
investigations	O
are	O
warranted	O
to	O
elucidate	O
the	O
possible	O
linkage	O
of	O
ER	DNA
codon	DNA
10	DNA
polymorphism	O
to	O
physiological	O
and	O
pathological	O
conditions	O
.	O

USF/c-Myc	protein
enhances,	O
while	O
Yin-Yang	protein
1	protein
suppresses,	O
the	O
promoter	O
activity	O
of	O
CXCR4	protein
,	O
a	O
coreceptor	protein
for	O
HIV-1	O
entry	O
.	O
Transcription	protein
factors	protein
USF1	protein
and	O
USF2	protein
up-regulate	O
gene	O
expression	O
(i.e.,	O
HIV-1	DNA
long	DNA
terminal	DNA
repeats	DNA
)	O
via	O
interaction	O
with	O
an	O
E	DNA
box	DNA
on	O
their	O
target	O
promoters,	O
which	O
is	O
also	O
a	O
binding	DNA
site	DNA
for	O
c-Myc	protein
.	O
The	O
c-Myc	protein
oncoprotein	protein
is	O
important	O
in	O
control	O
of	O
cellular	O
proliferation	O
and	O
differentiation	O
,	O
while	O
Yin-Yang	protein
1	protein
(	O
YY1	protein
)	O
has	O
been	O
shown	O
to	O
control	O
the	O
expression	O
of	O
a	O
number	O
of	O
cellular	O
and	O
viral	O
genes	O
.	O
These	O
two	O
proteins	O
physically	O
interact	O
with	O
each	O
other	O
and	O
mutually	O
inhibit	O
their	O
respective	O
biological	O
functions	O
.	O
In	O
this	O
study,	O
we	O
show	O
that	O
USF/	protein
c-Myc	protein
up-regulates,	O
while	O
YY1	protein
down-regulates	O
the	O
promoter	O
activity	O
of	O
CXCR4	protein
,	O
a	O
coreceptor	O
for	O
T	O
cell-tropic	O
HIV-1	O
entry	O
.	O
We	O
have	O
identified	O
an	O
E	DNA
box	DNA
around	O
-260	DNA
and	O
a	O
YY1	DNA
binding	DNA
site	DNA
around	O
-300	DNA
relative	O
to	O
the	O
transcription	DNA
start	DNA
site	DNA
.	O
Mutation	O
of	O
the	O
E	DNA
box	DNA
abolished	O
USF/c-Myc	protein
-mediated	O
up-regulation	O
of	O
CXCR4	protein
promoter	O
activity	O
,	O
and	O
mutation	O
of	O
the	O
YY1	DNA
binding	DNA
site	DNA
was	O
associated	O
with	O
unresponsiveness	O
to	O
YY1	protein
-mediated	O
inhibition	O
.	O
These	O
data	O
suggest	O
that	O
USF/c-Myc	protein
and	O
YY1	protein
may	O
play	O
an	O
important	O
role	O
in	O
the	O
HIV-1	O
-replicative	O
cycle	O
,	O
by	O
modulating	O
both	O
the	O
viral	O
fusion/entry	O
process	O
and	O
viral	O
expression	O
.	O

Suppression	O
of	O
NF-kappaB	protein
activation	O
in	O
normal	cell_type
T	cell_type
cells	cell_type
by	O
supernatant	O
fluid	O
from	O
human	O
renal	O
cell	O
carcinomas	O
.	O
T	cell_type
lymphocytes	cell_type
from	O
patients	O
with	O
renal	O
cell	O
carcinoma	O
(	O
RCC	O
)	O
show	O
reduced	O
immune	O
function	O
and	O
impaired	O
activation	O
of	O
the	O
transcription	protein
factor	protein
,	O
NF-kappaB	protein
.	O
We	O
determined	O
the	O
mechanism	O
of	O
NF-kappaB	protein
suppression	O
in	O
T	cell_type
cells	cell_type
of	O
RCC	O
patient	O
and	O
determined	O
whether	O
supernatant	O
fluid	O
from	O
RCC	O
explants	O
(	O
RCC	O
-S)	O
induced	O
the	O
same	O
phenotype	O
of	O
NF-kappaB	protein
suppression	O
in	O
normal	cell_type
T	cell_type
cells	cell_type
that	O
is	O
observed	O
in	O
patient	O
T	cell_type
cells	cell_type
.	O
The	O
pattern	O
of	O
kappaB	protein
-binding	O
activity	O
in	O
T	cell_type
cells	cell_type
of	O
RCC	O
patient	O
was	O
altered	O
as	O
compared	O
to	O
that	O
seen	O
in	O
T	cell_type
cells	cell_type
obtained	O
from	O
normal	O
volunteers.	O
In	O
some	O
patients,	O
no	O
activation	O
of	O
RelA/NFkappaB1	protein
-binding	O
activity	O
was	O
detectable,	O
while	O
in	O
others	O
kappaB	protein
-binding	O
activity	O
was	O
modestly	O
induced	O
but	O
the	O
duration	O
was	O
reduced.	O
IkappaBalpha	protein
was	O
degraded	O
normally	O
following	O
stimulation	O
in	O
both	O
normal	O
controls	O
and	O
T	cell_type
cells	cell_type
from	O
RCC	O
patients	O
.	O
RCC	O
-S	O
did	O
not	O
alter	O
the	O
cytoplasmic	O
levels	O
of	O
RelA	protein
and	O
NF-kappaB1	protein
but	O
did	O
suppress	O
their	O
nuclear	O
localization	O
and	O
inhibited	O
the	O
activation	O
of	O
RelA	protein
/NF-kappaB1	protein
binding	protein
complexes	protein
.	O
These	O
results	O
show	O
that	O
RCC	O
-S	O
can	O
induce	O
in	O
normal	cell_type
T	cell_type
cells	cell_type
the	O
same	O
phenotype	O
of	O
impaired	O
NF-kappaB	protein
activation	O
that	O
is	O
detected	O
in	O
T	cell_type
cells	cell_type
of	O
RCC	O
patient.	O
It	O
also	O
appears	O
that	O
NF-kappaB	protein
suppression	O
by	O
RCC	O
-S	O
may	O
contribute	O
to	O
the	O
immunosuppression	O
of	O
host	O
immunity	O
.	O

STAT1	protein
activation	O
during	O
monocyte	O
to	O
macrophage	O
maturation	O
:	O
role	O
of	O
adhesion	protein
molecules	protein
.	O
Human	cell_type
monocytes	cell_type
isolated	O
from	O
peripheral	O
blood	O
of	O
healthy	O
donors	O
show	O
a	O
time-dependent	O
differentiation	O
into	O
macrophages	cell_type
upon	O
in	O
vitro	O
cultivation,	O
closely	O
mimicking	O
their	O
in	O
vivo	O
migration	O
and	O
maturation	O
into	O
extravascular	O
tissues	O
.	O
The	O
mediator(s)	O
of	O
this	O
maturation	O
process	O
has	O
not	O
been	O
yet	O
defined.	O
We	O
investigated	O
the	O
involvement	O
of	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(STAT)	protein
factors	protein
in	O
this	O
phenomenon	O
and	O
reported	O
the	O
specific,	O
time-dependent,	O
activation	O
of	O
STAT1	protein
protein	O
starting	O
at	O
day	O
0/1	O
of	O
cultivation	O
and	O
maximally	O
expressed	O
at	O
day	O
5.	O
STAT1	protein
activity	O
was	O
evident	O
on	O
the	O
STAT	DNA
binding	DNA
sequences	DNA
(	O
SBE	DNA
)	O
present	O
in	O
the	O
promoters	DNA
of	O
genes	O
which	O
are	O
up-regulated	O
during	O
monocyte	O
to	O
macrophage	O
maturation	O
such	O
as	O
FcgammaRI	DNA
and	O
ICAM-1	DNA
,	O
and	O
in	O
the	O
promoter	O
of	O
the	O
transcription	DNA
factor	DNA
IFN	DNA
regulatory	DNA
factor-1	DNA
.	O
Moreover,	O
the	O
effect	O
of	O
cell	O
adhesion	O
to	O
fibronectin	O
or	O
laminin	O
was	O
studied	O
to	O
investigate	O
mechanisms	O
involved	O
in	O
STAT1	protein
activation	O
.	O
Compared	O
with	O
monocytes	cell_type
adherent	O
on	O
plastic	O
surfaces	O
,	O
freshly	O
isolated	O
cells	O
allowed	O
to	O
adhere	O
either	O
to	O
fibronectin-	O
or	O
laminin-	O
coated	O
flasks	O
exhibited	O
an	O
increased	O
STAT1	protein
binding	O
activity	O
both	O
in	O
control	O
and	O
in	O
IFN-gamma-treated	cell_line
cells	cell_line
.	O
The	O
molecular	O
events	O
leading	O
to	O
enhanced	O
STAT1	protein
activation	O
and	O
cytokine	protein
responsiveness	O
concerned	O
both	O
Y701	protein
and	O
S727	protein
STAT1	protein
phosphorylation	O
.	O
Exogenous	O
addition	O
of	O
transforming	protein
growth	protein
factor-beta	protein
,	O
which	O
exerts	O
an	O
inhibitory	O
effect	O
on	O
some	O
monocytic	protein
differentiation	protein
markers	protein
,	O
inhibited	O
macrophage	O
maturation,	O
integrin	O
expression	O
and	O
STAT1	protein
binding	O
activity	O
.	O
Taken	O
together	O
these	O
results	O
indicate	O
that	O
STAT1	protein
plays	O
a	O
pivotal	O
role	O
in	O
the	O
differentiation/maturation	O
process	O
of	O
monocytes	cell_type
as	O
an	O
early	O
transcription	protein
factor	protein
initially	O
activated	O
by	O
adherence	O
and	O
then	O
able	O
to	O
modulate	O
the	O
expression	O
of	O
functional	DNA
genes	DNA
,	O
such	O
as	O
ICAM-1	protein
and	O
FcgammaRI	protein
.	O

Expression	O
and	O
role	O
of	O
PML	DNA
gene	DNA
in	O
normal	O
adult	O
hematopoiesis	O
:	O
functional	O
interaction	O
between	O
PML	O
and	O
Rb	O
proteins	O
in	O
erythropoiesis	O
.	O
The	O
expression	O
of	O
the	O
PML	DNA
gene	DNA
was	O
investigated	O
in	O
purified	O
early	O
hematopoietic	cell_type
progenitor	cell_type
cells	cell_type
(	O
HPCs	cell_type
)	O
induced	O
to	O
unilineage	O
erythroid	O
or	O
granulocytic	O
differentiation	O
.	O
PML	RNA
mRNA	RNA
and	O
protein	protein
,	O
while	O
barely	O
detectable	O
in	O
quiescent	O
HPCs	cell_type
,	O
are	O
consistently	O
induced	O
by	O
growth	protein
factor	protein
stimulation	O
through	O
the	O
erythroid	O
or	O
granulocytic	O
lineage	O
.	O
Thereafter,	O
PML	protein
is	O
downmodulated	O
in	O
late	O
granulocytic	O
maturation	O
,	O
whereas	O
it	O
is	O
sustainably	O
expressed	O
through	O
the	O
erythroid	O
pathway	O
.	O
In	O
functional	O
studies,	O
PML	protein
expression	O
was	O
inhibited	O
by	O
addition	O
of	O
antisense	O
oligomers	O
targeting	O
PML	RNA
mRNA	RNA
(	O
alpha-PML	protein
).	O
Interestingly,	O
early	O
treatment	O
(day	O
0	O
HPCs	cell_type
)	O
with	O
alpha-PML	protein
reduced	O
the	O
number	O
of	O
both	O
erythroid	O
and	O
granulocytic	O
colonies	O
,	O
whereas	O
late	O
treatment	O
(day	O
5	O
culture)	O
reduced	O
erythroid,	O
but	O
not	O
granulocytic,	O
clonogenesis	O
.	O
These	O
findings	O
suggest	O
that	O
PML	protein
is	O
required	O
for	O
early	O
hematopoiesis	O
and	O
erythroid,	O
but	O
not	O
granulocytic	O
maturation	O
.	O
The	O
pattern	O
of	O
PML	protein
expression	O
in	O
normal	O
hematopoiesis	O
mimics	O
that	O
of	O
retinoblastoma	cell_type
pRb	protein
105	protein
.	O
Combined	O
treatment	O
of	O
HPCs	cell_type
with	O
alpha-PML	protein
and	O
alpha-Rb	O
oligomers	O
inhibited	O
both	O
PML	O
and	O
Rb	O
protein	O
expression	O
and	O
completely	O
blocked	O
erythroid	O
colony	O
development	O
.	O
Furthermore,	O
PML	protein
and	O
pRb	protein
105	protein
were	O
co-immunoprecipitated	O
in	O
cellular	O
lysates	O
derived	O
from	O
erythroid	cell_type
precursors	cell_type
indicating	O
that	O
this	O
functional	O
interaction	O
may	O
have	O
a	O
biochemical	O
basis.	O
These	O
results	O
suggest	O
a	O
key	O
functional	O
role	O
of	O
PML	protein
in	O
early	O
hematopoiesis	O
and	O
late	O
erythropoiesis	O
:	O
the	O
latter	O
phenomenon	O
may	O
be	O
related	O
to	O
the	O
molecular	O
and	O
functional	O
interaction	O
of	O
PML	protein
with	O
pRb	protein
105	protein
.	O

Binding	O
characteristics	O
of	O
the	O
glucocorticoid	protein
receptor	protein
in	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
in	O
multiple	O
sclerosis	O
.	O
Although	O
the	O
exact	O
etiology	O
of	O
multiple	O
sclerosis	O
(	O
MS	O
)	O
remains	O
unresolved,	O
immune	O
reactions	O
are	O
believed	O
to	O
be	O
the	O
central	O
pathogenic	O
mechanisms	O
.	O
Endogenous	O
and	O
therapeutic	O
steroid	O
hormones	O
affect	O
the	O
immune	O
system	O
,	O
and	O
inflammatory	O
diseases	O
are	O
associated	O
with	O
activation	O
of	O
the	O
hypothalamic-pituitary-adrenal	O
axis	O
,	O
providing	O
evidence	O
of	O
an	O
immune-endocrine	O
interplay	O
.	O
Function	O
tests	O
in	O
MS	O
have	O
revealed	O
dysregulation	O
of	O
the	O
hypothalamic-pituitary-adrenal	O
system	O
in	O
a	O
substantial	O
proportion	O
of	O
patients	O
.	O
We	O
characterized	O
glucocorticoid	protein
receptor	protein
(	O
GR	protein
)	O
binding	O
in	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
from	O
39	O
MS	O
patients	O
and	O
14	O
age-	O
and	O
sex-matched	O
controls	O
with	O
respect	O
to	O
dissociation	O
constant	O
and	O
binding	O
capacity,	O
using	O
a	O
whole-cell	O
binding	O
assay	O
with	O
[3H]dexamethasone	O
as	O
the	O
ligand.	O
GR	protein
binding	O
parameters	O
did	O
not	O
differ	O
significantly	O
between	O
patients	O
(Kd	O
8.98	O
+/-	O
1.07	O
nM,	O
Bmax	O
183	O
+/-	O
29.8	O
fmol/mg)	O
and	O
controls	O
(Kd	O
9.36	O
+/-	O
1.17	O
nM,	O
Bmax	O
158	O
+/-	O
16	O
fmol/mg).	O
No	O
effect	O
of	O
age,	O
sex,	O
course,	O
duration	O
or	O
severity	O
of	O
disease,	O
or	O
prior	O
steroid	O
treatments	O
was	O
detected.	O
GR	protein
binding	O
parameters	O
were	O
analyzed	O
in	O
relation	O
to	O
the	O
results	O
of	O
the	O
combined	O
dexamethasone	O
-CRH	protein
test	O
,	O
which	O
reflects	O
corticosteroid	O
receptor	O
function	O
at	O
the	O
hypothalamus	O
,	O
in	O
30	O
patients	O
and	O
9	O
controls.	O
While	O
controls	O
showed	O
a	O
moderate	O
correlation	O
between	O
binding	O
affinity	O
of	O
the	O
GR	protein
in	O
lymphocytes	O
and	O
regulatory	O
function	O
at	O
the	O
hypothalamic	O
level,	O
the	O
patients	O
did	O
not.	O
These	O
data	O
suggest	O
that	O
the	O
physiological	O
relationship	O
between	O
binding	O
and	O
function	O
of	O
the	O
glucocorticoid	protein
receptor	protein
is	O
disturbed	O
in	O
MS	O
.	O

Phorbol	O
ester	O
-induced	O
mononuclear	O
cell	O
differentiation	O
is	O
blocked	O
by	O
the	O
mitogen-activated	protein
protein	protein
kinase	protein
kinase	protein
(	O
MEK	protein
)	O
inhibitor	O
PD98059	O
.	O
The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
whether	O
the	O
mitogen-activated	protein
protein	protein
kinase	protein
(	O
MAPK	protein
)	O
signaling	O
pathway	O
contributes	O
to	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
)-induced	O
mononuclear	O
differentiation	O
in	O
the	O
human	cell_line
myeloblastic	cell_line
leukemia	cell_line
ML-1	cell_line
cells	cell_line
.	O
Upon	O
TPA	O
treatment	O
,	O
the	O
activity	O
of	O
ERK1	protein
and	O
ERK2	protein
rapidly	O
increased,	O
with	O
maximal	O
induction	O
between	O
1	O
and	O
3	O
h,	O
while	O
ERK2	protein
protein	O
levels	O
remained	O
constant.	O
The	O
activity	O
of	O
JNK1	protein
was	O
also	O
significantly	O
induced,	O
with	O
JNK1	protein
protein	O
levels	O
increasing	O
moderately	O
during	O
exposure	O
to	O
TPA	O
.	O
Treatment	O
of	O
cells	O
with	O
PD98059	O
,	O
a	O
specific	O
inhibitor	O
of	O
mitogen-activated	protein
protein	protein
kinase	protein
kinase	protein
(	O
MEK	protein
),	O
inhibited	O
TPA	O
-induced	O
ERK2	protein
activity.	O
Furthermore,	O
PD98059	O
completely	O
blocked	O
the	O
TPA	O
-induced	O
differentiation	O
of	O
ML-1	cell_line
cells	cell_line
,	O
as	O
assessed	O
by	O
a	O
number	O
of	O
features	O
associated	O
with	O
mononuclear	O
differentiation	O
including	O
changes	O
in	O
morphology	O
,	O
nonspecific	O
esterase	protein
activity	O
,	O
phagocytic	O
ability	O
,	O
NADPH	protein
oxidase	protein
activity	O
,	O
mitochondrial	O
respiration	O
,	O
and	O
c-jun	RNA
mRNA	RNA
inducibility	O
.	O
We	O
conclude	O
that	O
activation	O
of	O
the	O
MEK	protein
/ERK	O
signaling	O
pathway	O
is	O
necessary	O
for	O
TPA	O
-induced	O
mononuclear	O
cell	O
differentiation	O
.	O

Glucocorticoid	protein
receptors	protein
in	O
anorexia	O
nervosa	O
and	O
Cushing's	O
disease.	O
BACKGROUND:	O
Patients	O
with	O
anorexia	O
nervosa	O
do	O
not	O
display	O
cushingoid	O
features	O
in	O
spite	O
of	O
elevated	O
cortisol	O
plasma	O
levels	O
.	O
Whether	O
a	O
cortisol	O
resistance	O
or	O
a	O
reduced	O
availability	O
of	O
the	O
metabolic	O
substrates	O
necessary	O
to	O
develop	O
the	O
effect	O
of	O
glucocorticoids	O
is	O
responsible	O
for	O
this	O
has	O
not	O
been	O
established.	O
METHODS:	O
Twenty-two	O
patients	O
with	O
severe	O
restrictive	O
anorexia	O
nervosa	O
,	O
10	O
patients	O
with	O
active	O
Cushing's	O
disease	O
,	O
and	O
24	O
healthy	O
volunteers	O
without	O
psychiatric	O
disorders	O
or	O
mood	O
alterations	O
were	O
investigated.	O
Glucocorticoid	O
receptor	O
characteristics	O
were	O
examined	O
on	O
mononuclear	cell_type
leukocytes	cell_type
by	O
measuring	O
[3H]dexamethasone	O
binding	O
and	O
the	O
effect	O
of	O
dexamethasone	O
on	O
[3H]thymidine	O
incorporation	O
,	O
which	O
represents	O
an	O
index	O
of	O
DNA	O
synthesis.	O
RESULTS:	O
The	O
number	O
of	O
glucocorticoid	protein
receptors	protein
on	O
mononuclear	cell_type
leukocytes	cell_type
(	O
MNL	cell_type
)	O
was	O
comparable	O
in	O
patients	O
with	O
anorexia	O
nervosa	O
,	O
patients	O
with	O
active	O
Cushing's	O
disease	O
,	O
and	O
normal	O
subjects	O
(binding	O
capacity	O
3.3	O
+/-	O
0.23	O
vs.	O
3.7	O
+/-	O
0.30	O
and	O
3.5	O
+/-	O
0.20	O
fmol/10(6)	O
cells).	O
Conversely,	O
glucocorticoid	protein
receptor	protein
affinity	O
was	O
significantly	O
decreased	O
in	O
anorexia	O
nervosa	O
as	O
well	O
as	O
in	O
Cushing's	O
patients	O
compared	O
to	O
control	O
subjects	O
(dissociation	O
constant	O
4.0	O
+/-	O
0.31	O
and	O
4.1	O
+/-	O
0.34	O
vs.	O
2.9	O
+/-	O
0.29	O
nmol/L,	O
p	O
&lt;	O
.001)	O
and	O
inversely	O
correlated	O
with	O
the	O
levels	O
of	O
urinary	O
free	O
cortisol	O
in	O
both	O
groups	O
of	O
patients	O
.	O
Basal	O
[3H]thymidine	O
incorporation	O
in	O
MNL	cell_type
was	O
significantly	O
reduced	O
in	O
anorexia	O
nervosa	O
as	O
well	O
as	O
in	O
Cushing's	O
patients	O
compared	O
to	O
control	O
subjects	O
(p	O
&lt;	O
.001)	O
and	O
was	O
diminished	O
by	O
dexamethasone	O
to	O
an	O
extent	O
similar	O
to	O
control	O
subjects	O
in	O
patients	O
with	O
anorexia	O
nervosa	O
,	O
but	O
significantly	O
(p	O
&lt;	O
.001)	O
less	O
in	O
those	O
with	O
Cushing's	O
disease	O
.	O
In	O
patients	O
with	O
anorexia	O
nervosa	O
,	O
the	O
incorporation	O
of	O
[3H]thymidine	O
into	O
the	O
MNL	cell_type
was	O
inversely	O
correlated	O
with	O
urinary	O
free	O
cortisol	O
levels.	O
CONCLUSIONS:	O
These	O
data	O
indicate	O
that	O
the	O
lack	O
of	O
cushingoid	O
features	O
in	O
patients	O
with	O
anorexia	O
nervosa	O
is	O
not	O
ascribable	O
to	O
a	O
reduced	O
sensitivity	O
to	O
glucocorticoids	O
but	O
is	O
more	O
likely	O
due	O
to	O
the	O
paucity	O
of	O
metabolic	O
substrates	O
.	O

Different	O
sequence	O
requirements	O
for	O
expression	O
in	O
erythroid	O
and	O
megakaryocytic	O
cells	O
within	O
a	O
regulatory	DNA
element	DNA
upstream	O
of	O
the	O
GATA-1	DNA
gene	DNA
.	O
The	O
lineage-restricted	protein
transcription	protein
factor	protein
GATA-1	protein
is	O
required	O
for	O
differentiation	O
of	O
erythroid	O
and	O
megakaryocytic	O
cells	O
.	O
We	O
have	O
localized	O
a	O
317	O
base	O
pair	O
cis-acting	DNA
regulatory	DNA
element	DNA
,	O
HS	DNA
I	DNA
,	O
associated	O
with	O
a	O
hematopoietic-specific	DNA
DNase	DNA
I	DNA
hypersensitive	DNA
site	DNA
,	O
which	O
lies	O
approx.	O
3.7	O
kilobases	O
upstream	O
of	O
the	O
murine	DNA
hematopoietic-specific	DNA
GATA-1	DNA
IE	DNA
promoter	DNA
.	O
HS	DNA
I	DNA
directs	O
high-level	O
expression	O
of	O
reporter	O
GATA-1/lacZ	DNA
genes	DNA
to	O
primitive	O
and	O
definitive	O
erythroid	O
cells	O
and	O
megakaryocytes	cell_type
in	O
transgenic	O
mice	O
.	O
Comparative	O
sequence	O
analysis	O
of	O
HS	DNA
I	DNA
between	O
human	O
and	O
mouse	O
shows	O
approx.	O
63%	O
nucleotide	O
identity	O
with	O
a	O
more	O
conserved	O
core	O
of	O
169	DNA
base	DNA
pairs	DNA
(86%	O
identity).	O
This	O
core	O
contains	O
a	O
GATA	DNA
site	DNA
separated	O
by	O
10	O
base	O
pairs	O
from	O
an	O
E-box	DNA
motif	DNA
.	O
The	O
composite	DNA
motif	DNA
binds	O
a	O
multi-protein	protein
hematopoietic-specific	protein
transcription	protein
factor	protein
complex	protein
which	O
includes	O
GATA-1	protein
,	O
SCL/tal-1,	protein
E2A	protein
,	O
Lmo2	protein
and	O
Ldb-1	protein
.	O
Point	O
mutations	O
of	O
the	O
GATA	DNA
site	DNA
abolishes	O
HS	DNA
I	DNA
function,	O
whereas	O
mutation	O
of	O
the	O
E-box	DNA
motif	DNA
still	O
allows	O
reporter	O
gene	O
expression	O
in	O
both	O
lineages.	O
Strict	O
dependence	O
of	O
HS	DNA
I	DNA
activity	O
on	O
a	O
GATA	DNA
site	DNA
implies	O
that	O
assembly	O
of	O
a	O
protein	O
complex	O
containing	O
a	O
GATA-factor	protein
,	O
presumably	O
GATA-1	protein
or	O
GATA-2	protein
,	O
is	O
critical	O
to	O
activating	O
or	O
maintaining	O
its	O
function.	O
Further	O
dissection	O
of	O
the	O
317	DNA
base	DNA
pair	DNA
region	DNA
demonstrates	O
that,	O
whereas	O
all	O
317	DNA
base	DNA
pairs	DNA
are	O
required	O
for	O
expression	O
in	O
megakaryocytes	cell_type
,	O
only	O
the	O
5'	DNA
62	DNA
base	DNA
pairs	DNA
are	O
needed	O
for	O
erythroid-specific	O
reporter	O
expression	O
.	O
These	O
findings	O
demonstrate	O
differential	O
lineage	O
requirements	O
for	O
expression	O
within	O
the	O
HS	DNA
I	DNA
element	DNA
.	O

Non-steroidal	O
anti-inflammatory	O
drugs	O
inhibit	O
the	O
expression	O
of	O
cytokines	protein
and	O
induce	O
HSP70	protein
in	O
human	cell_type
monocytes	cell_type
.	O
Recent	O
studies	O
have	O
shown	O
that	O
the	O
non-steroidal	O
anti-inflammatory	O
drugs	O
(	O
NSAIDs	O
)	O
activate	O
heat	protein
shock	protein
transcription	protein
factor	protein
(	O
HSF1	protein
)	O
from	O
a	O
latent	protein
cytoplasmic	protein
form	protein
to	O
a	O
nuclear,	protein
DNA	protein
binding	protein
state	protein
.	O
As	O
HSF1	protein
can	O
function	O
as	O
both	O
an	O
activator	O
of	O
heat	DNA
shock	DNA
genes	DNA
and	O
a	O
repressor	O
of	O
non-heat	DNA
shock	DNA
genes	DNA
such	O
as	O
IL1B	O
and	O
c-	O
fos,	O
we	O
have	O
examined	O
the	O
potential	O
role	O
of	O
HSF1	protein
in	O
the	O
effects	O
of	O
NSAIDs	O
on	O
gene	O
expression	O
in	O
a	O
human	O
monocytic	cell_line
cell	cell_line
line	cell_line
THP-1	cell_line
.	O
We	O
found	O
that	O
two	O
members	O
of	O
the	O
NSAIDs	O
,	O
sodium	O
salicylate	O
and	O
sulindac	O
repress	O
the	O
IL1B	DNA
promoter	DNA
to	O
similar	O
degree	O
to	O
heat	O
shock	O
or	O
HSF1	protein
overexpression	O
.	O
In	O
addition,	O
sodium	O
salicylate	O
and	O
additional	O
NSAIDs	O
used	O
at	O
concentrations	O
that	O
activate	O
HSF1	protein
also	O
inhibited	O
the	O
expression	O
of	O
other	O
monocytic	DNA
genes	DNA
(	O
TNF-alpha	DNA
,	O
IL-1beta	DNA
,	O
IL-6	DNA
,	O
IL-8	DNA
,	O
IL-10	DNA
,	O
ICAM-1	DNA
)	O
activated	O
by	O
exposure	O
to	O
a	O
pro-inflammatory	O
stimulus	O
(	O
lipopolysaccharide	O
,	O
LPS	O
).	O
At	O
least	O
in	O
the	O
case	O
of	O
the	O
IL1B	DNA
promoter	DNA
,	O
repression	O
did	O
not	O
seem	O
to	O
involve	O
another	O
factor	O
whose	O
activity	O
is	O
affected	O
by	O
the	O
NSAIDs	O
,	O
NFkappaB	protein
as	O
the	O
IL1B	DNA
promoter	DNA
fragment	DNA
used	O
in	O
our	O
studies	O
is	O
not	O
NFkappaB	protein
responsive	O
and	O
binds	O
specifically	O
to	O
HSF1	protein
.	O
Exposure	O
to	O
NSAIDs	O
had	O
a	O
complex	O
effect	O
on	O
HSP	O
gene	O
expression	O
and	O
while	O
sulindac	O
activated	O
the	O
stress	O
responsive	O
HSP70B	DNA
promoter	DNA
,	O
sodium	O
salicylate	O
did	O
not.	O
In	O
addition,	O
only	O
a	O
subset	O
of	O
the	O
NSAIDs	O
induced	O
HSP70	RNA
mRNA	RNA
species	RNA
.	O
These	O
findings	O
reflect	O
the	O
properties	O
of	O
HSF1	protein
which	O
can	O
be	O
activated	O
to	O
at	O
least	O
two	O
DNA	protein
binding	protein
forms	protein
only	O
one	O
of	O
which	O
activates	O
heat	DNA
shock	DNA
promoters	DNA
and	O
suggest	O
that	O
individual	O
NSAID	O
family	O
members	O
may	O
differentially	O
induce	O
one	O
or	O
other	O
of	O
these	O
forms.	O
Overall	O
therefore,	O
exposure	O
to	O
NSAIDs	O
leads	O
to	O
a	O
profound	O
switch	O
in	O
gene	O
expression	O
in	O
monocytic	cell_type
cells	cell_type
,	O
with	O
suppression	O
of	O
genes	O
involved	O
in	O
macrophage	O
activation	O
and	O
induction	O
of	O
stress	DNA
genes	DNA
and	O
HSF1	protein
appears	O
to	O
play	O
a	O
regulatory	O
role	O
in	O
these	O
effects.	O
Copyright	O
1999	O
Academic	O
Press.	O

Immortalization	O
of	O
CD4(+)	O
and	O
CD8(+)	O
T	O
lymphocytes	O
by	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
Tax	protein
mutants	protein
expressed	O
in	O
a	O
functional	cell_line
molecular	cell_line
clone	cell_line
.	O
The	O
human	protein
T-cell	protein
leukemia	protein
virus	protein
type	protein
1	protein
(	protein
HTLV-1	protein
)	protein
transcriptional	protein
trans-activator	protein
Tax	protein
has	O
been	O
demonstrated	O
to	O
have	O
transforming	O
activity	O
in	O
multiple	cell_line
cell	cell_line
culture	cell_line
and	O
transgenic-mouse	O
models	O
.	O
In	O
addition	O
to	O
activating	O
transcription	O
from	O
the	O
viral	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
through	O
the	O
cyclic	protein
AMP	protein
response	protein
element	protein
binding	protein
protein/activating	protein
transcription	protein
factor	protein
(CREB/ATF)	protein
family	protein
of	O
transcription	protein
factors	protein
,	O
Tax	protein
activates	O
the	O
expression	O
of	O
multiple	DNA
cellular	DNA
promoters	DNA
through	O
the	O
NF-kappaB	protein
pathway	O
of	O
transcriptional	O
activation	O
.	O
The	O
Tax	protein
mutants	protein
M22	protein
and	O
M47	protein
have	O
previously	O
been	O
demonstrated	O
to	O
selectively	O
abrogate	O
the	O
ability	O
of	O
Tax	protein
to	O
activate	O
transcription	O
through	O
the	O
NF-kappaB	O
or	O
CREB/ATF	O
pathway	O
,	O
respectively.	O
These	O
mutations	O
were	O
introduced	O
in	O
the	O
tax	DNA
gene	DNA
of	O
the	O
ACH	DNA
functional	DNA
molecular	DNA
clone	DNA
of	O
HTLV-1	O
,	O
and	O
virus	O
produced	O
from	O
the	O
mutant	DNA
ACH	DNA
clones	DNA
was	O
examined	O
for	O
the	O
ability	O
to	O
replicate	O
and	O
immortalize	O
primary	cell_type
human	cell_type
lymphocytes	cell_type
.	O
While	O
virus	O
derived	O
from	O
the	O
clone	O
containing	O
the	O
M47	protein
mutation	O
retained	O
the	O
ability	O
to	O
immortalize	O
T	cell_type
lymphocytes	cell_type
,	O
the	O
M22	protein
mutant	O
lost	O
the	O
ability	O
to	O
immortalize	O
infected	cell_type
cells	cell_type
.	O
These	O
results	O
indicate	O
that	O
activation	O
of	O
the	O
CREB/ATF	protein
pathway	O
by	O
Tax	protein
is	O
dispensable	O
for	O
the	O
immortalization	O
of	O
T	cell_type
cells	cell_type
by	O
HTLV-1	O
,	O
whereas	O
activation	O
of	O
the	O
NF-kappaB	protein
pathway	O
may	O
be	O
critical.	O

Fibroblast	protein
growth	protein
factor-1	protein
(	O
FGF-1	protein
)	O
enhances	O
IL-2	protein
production	O
and	O
nuclear	O
translocation	O
of	O
NF-kappaB	protein
in	O
FGF	cell_line
receptor	cell_line
-bearing	cell_line
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
Fibroblast	protein
growth	protein
factors	protein
(	O
FGFs	protein
)	O
are	O
heparin-binding	protein
proteins	protein
crucial	O
to	O
embryogenesis	O
,	O
angiogenesis	O
,	O
and	O
wound	O
healing	O
.	O
FGF-1	protein
is	O
abundantly	O
expressed	O
in	O
the	O
synovium	O
in	O
rheumatoid	O
arthritis	O
and	O
in	O
rejecting	O
allografts	O
,	O
sites	O
of	O
chronic	O
immune-mediated	O
inflammation	O
.	O
The	O
frequency	O
of	O
FGF-1	protein
-responsive	O
T	cell_type
cells	cell_type
is	O
increased	O
in	O
the	O
peripheral	O
blood	O
of	O
these	O
disorders,	O
and	O
a	O
high	O
percentage	O
of	O
infiltrating	cell_type
T	cell_type
cells	cell_type
in	O
rheumatoid	O
arthritis	O
synovium	O
express	O
receptors	O
for	O
FGF-1	protein
.	O
To	O
understand	O
the	O
action	O
of	O
FGF-1	protein
in	O
T	cell_type
cells	cell_type
,	O
studies	O
were	O
initiated	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
that	O
express	O
the	O
signaling	O
isoform	O
of	O
FGF	protein
receptor-1	protein
.	O
These	O
experiments	O
show	O
that	O
FGF-1	protein
stimulation	O
of	O
Jurkat	cell_line
T	cell_line
cells	cell_line
provides	O
a	O
second	O
signal	O
that	O
augments	O
TCR-mediated	O
IL-2	protein
production	O
.	O
Analogous	O
to	O
costimulation	O
via	O
CD28	protein
,	O
this	O
activity	O
is	O
mediated	O
through	O
activation	O
of	O
Rel/kappaB	protein
,	O
a	O
family	O
of	O
transcription	protein
factors	protein
known	O
to	O
regulate	O
IL-2	protein
and	O
other	O
activation-inducible	protein
proteins	protein
.	O
FGF-1	protein
alone	O
induces	O
modest	O
nuclear	O
translocation	O
of	O
kappaB-binding	protein
proteins	protein
,	O
and	O
this	O
translocation	O
is	O
enhanced	O
by	O
the	O
combination	O
of	O
anti-CD3	protein
and	O
FGF-1	protein
.	O
This	O
NF-kappaB	protein
binding	protein
complex	protein
is	O
composed	O
of	O
transcriptionally	protein
active	protein
p65(	protein
RelA	protein
)/p50	protein
heterodimers	protein
and	O
results	O
primarily	O
from	O
the	O
targeted	O
degradation	O
of	O
IkappaB-alpha	protein
,	O
an	O
inhibitor	O
that	O
sequesters	O
Rel/kappaB	protein
in	O
the	O
cytoplasm	O
.	O
These	O
data	O
are	O
the	O
first	O
to	O
show	O
a	O
connection	O
between	O
FGF-1	protein
signaling	O
and	O
NF-kappaB	protein
activation	O
outside	O
of	O
embryonic	O
development	O
.	O
The	O
signaling	O
events	O
that	O
link	O
FGF	protein
receptor-1	protein
engagement	O
and	O
NF-kappaB	protein
activation	O
in	O
Jurkat	cell_line
are	O
probably	O
distinct	O
from	O
the	O
CD28	protein
costimulation	O
pathway	O
,	O
since	O
FGF-1	protein
-induced	O
Rel/kappaB	protein
binding	protein
proteins	protein
do	O
not	O
contain	O
significant	O
levels	O
of	O
c-Rel	protein
and	O
are	O
not	O
identical	O
with	O
the	O
CD28	protein
response	protein
complex	protein
.	O

Escape	O
of	O
human	O
cytomegalovirus	O
from	O
HLA-DR	protein
-restricted	O
CD4(+)	O
T-cell	O
response	O
is	O
mediated	O
by	O
repression	O
of	O
gamma	protein
interferon	protein
-induced	O
class	protein
II	protein
transactivator	protein
expression	O
.	O
Human	O
cytomegalovirus	O
(	O
HCMV	O
),	O
a	O
betaherpesvirus	O
,	O
is	O
a	O
pathogen	O
which	O
escapes	O
immune	O
recognition	O
through	O
various	O
mechanisms.	O
In	O
this	O
paper,	O
we	O
show	O
that	O
HCMV	O
down	O
regulates	O
gamma	O
interferon	O
(	O
IFN-gamma	protein
)-induced	O
HLA-DR	protein
expression	O
in	O
U373	cell_line
MG	cell_line
astrocytoma	cell_line
cells	cell_line
due	O
to	O
a	O
defect	O
downstream	O
of	O
STAT1	protein
phosphorylation	O
and	O
nuclear	O
translocation.	O
Repression	O
of	O
class	O
II	O
transactivator	O
(	O
CIITA	DNA
)	O
mRNA	O
expression	O
is	O
detected	O
within	O
the	O
first	O
hours	O
of	O
IFN-gamma	protein
-HCMV	O
coincubation	O
and	O
results	O
in	O
the	O
absence	O
of	O
HLA-DR	protein
synthesis	O
.	O
This	O
defect	O
leads	O
to	O
the	O
absence	O
of	O
presentation	O
of	O
the	O
major	protein
immediate-early	protein
protein	protein
IE1	protein
to	O
specific	O
CD4(+)	cell_line
T-cell	cell_line
clones	cell_line
when	O
U373	cell_line
MG	cell_line
cells	cell_line
,	O
used	O
as	O
antigen-presenting	cell_type
cells	cell_type
,	O
are	O
treated	O
with	O
IFN-gamma	protein
plus	O
HCMV	O
.	O
However,	O
presentation	O
of	O
endogenously	O
synthesized	O
IE1	protein
can	O
be	O
restored	O
when	O
U373	cell_line
MG	cell_line
cells	cell_line
are	O
transfected	O
with	O
CIITA	DNA
prior	O
to	O
infection	O
with	O
HCMV	O
.	O
Altogether,	O
the	O
data	O
indicate	O
that	O
the	O
defect	O
induced	O
by	O
HCMV	O
resides	O
in	O
the	O
activation	O
of	O
the	O
IFN-gamma	DNA
-responsive	DNA
promoter	DNA
of	O
CIITA	DNA
.	O
This	O
is	O
the	O
first	O
demonstration	O
of	O
a	O
viral	O
inhibition	O
of	O
CIITA	DNA
expression	O
.	O

3-deazaadenosine	O
,	O
a	O
S-adenosylhomocysteine	protein
hydrolase	protein
inhibitor	O
,	O
has	O
dual	O
effects	O
on	O
NF-kappaB	protein
regulation	O
.	O
Inhibition	O
of	O
NF-kappaB	protein
transcriptional	O
activity	O
and	O
promotion	O
of	O
IkappaBalpha	protein
degradation	O
.	O
Previously	O
we	O
reported	O
that	O
3-deazaadenosine	O
(DZA),	O
a	O
potent	O
inhibitor	O
and	O
substrate	O
for	O
S-adenosylhomocysteine	protein
hydrolase	protein
inhibits	O
bacterial	O
lipopolysaccharide-induced	O
transcription	O
of	O
tumor	protein
necrosis	protein
factor-alpha	protein
and	O
interleukin-1beta	protein
in	O
mouse	cell_line
macrophage	cell_line
RAW	cell_line
264.7	cell_line
cells	cell_line
.	O
In	O
this	O
study,	O
we	O
demonstrate	O
the	O
effects	O
of	O
DZA	O
on	O
nuclear	protein
factor-kappaB	protein
(	O
NF-kappaB	protein
)	O
regulation	O
.	O
DZA	O
inhibits	O
the	O
transcriptional	O
activity	O
of	O
NF-kappaB	protein
through	O
the	O
hindrance	O
of	O
p65	protein
(	O
Rel-A	protein
)	O
phosphorylation	O
without	O
reduction	O
of	O
its	O
nuclear	O
translocation	O
and	O
DNA	O
binding	O
activity	O
.	O
The	O
inhibitory	O
effect	O
of	O
DZA	O
on	O
NF-kappaB	protein
transcriptional	O
activity	O
is	O
potentiated	O
by	O
the	O
addition	O
of	O
homocysteine	O
.	O
Taken	O
together,	O
DZA	O
promotes	O
the	O
proteolytic	O
degradation	O
of	O
IkappaBalpha	protein
,	O
but	O
not	O
IkappaBbeta	protein
,	O
resulting	O
in	O
an	O
increase	O
of	O
DNA	O
binding	O
activity	O
of	O
NF-kappaB	protein
in	O
the	O
nucleus	O
in	O
the	O
absence	O
of	O
its	O
transcriptional	O
activity	O
in	O
RAW	cell_line
264.7	cell_line
cells	cell_line
.	O
The	O
reduction	O
of	O
IkappaBalpha	protein
by	O
DZA	O
is	O
neither	O
involved	O
in	O
IkappaB	protein
kinase	protein
complex	protein
activation	O
nor	O
modulated	O
by	O
the	O
addition	O
of	O
homocysteine	O
.	O
This	O
study	O
strongly	O
suggests	O
that	O
DZA	O
may	O
be	O
a	O
potent	O
drug	O
for	O
the	O
treatment	O
of	O
diseases	O
in	O
which	O
NF-kappaB	protein
plays	O
a	O
central	O
pathogenic	O
role,	O
as	O
well	O
as	O
a	O
useful	O
tool	O
for	O
studying	O
the	O
regulation	O
and	O
physiological	O
functions	O
of	O
NF-kappaB	protein
.	O

The	O
role	O
of	O
gamma/delta	cell_type
T	cell_type
cell	cell_type
receptor	cell_type
positive	cell_type
cells	cell_type
in	O
pregnancy.	O
PROBLEM:	O
Due	O
to	O
the	O
lack	O
of	O
classical	protein
HLA	protein
antigens	protein
on	O
the	O
trophoblast,	O
fetal	protein
antigens	protein
are	O
possibly	O
presented	O
in	O
a	O
non	O
major	protein
histocompatibility	protein
complex	protein
(	O
MHC	protein
)	O
restricted	O
way	O
.	O
Decidual	cell_type
gammadelta	cell_type
T	cell_type
cells	cell_type
,	O
which	O
significantly	O
increase	O
in	O
number	O
during	O
pregnancy,	O
might	O
play	O
a	O
role	O
in	O
recognition	O
of	O
fetal	protein
antigens	protein
and	O
also	O
in	O
determining	O
the	O
quality	O
of	O
the	O
response	O
to	O
these	O
antigens	protein
.	O
Our	O
study	O
was	O
aimed	O
at	O
investigating	O
the	O
role	O
of	O
this	O
cell	O
population	O
in	O
progesterone	O
-dependent	O
immunomodulation	O
.	O
METHOD	O
OF	O
STUDY:	O
Peripheral	cell_type
lymphocytes	cell_type
from	O
healthy	O
pregnant	O
women	O
and	O
from	O
habitual	O
aborters	O
were	O
tested	O
by	O
immunocytochemistry	O
for	O
the	O
presence	O
of	O
gamma/delta	O
T	O
cell	O
receptor	O
(TCR)	O
and	O
progesterone	O
receptor.	O
To	O
investigate	O
the	O
effect	O
of	O
treatment	O
with	O
a	O
pan	O
anti	protein
gamma/delta	protein
antibody	protein
,	O
lymphocytes	cell_type
were	O
incubated	O
for	O
3	O
hr	O
with	O
the	O
antibody,	O
and	O
then	O
interleukin	protein
(IL)-10	protein
,	O
IL-12	protein
and	O
progesterone	protein
-induced	protein
blocking	protein
factor	protein
(	O
PIBF	protein
)	O
expression	O
(by	O
immuno-cytochemistry	O
)	O
as	O
well	O
as	O
natural	cell_type
killer	cell_type
(NK)	cell_type
cell	cell_type
activity	O
were	O
determined.	O
RESULTS:	O
In	O
peripheral	O
blood	O
of	O
healthy	O
pregnant	O
women	O
the	O
percentage	O
of	O
gamma/delta	cell_type
TCR+	cell_type
cells	cell_type
was	O
significantly	O
higher	O
(P	O
&lt;	O
0.001)	O
than	O
in	O
that	O
of	O
recurrent	O
aborters	O
or	O
of	O
non-pregnant	O
individuals	O
.	O
Ninety-seven	O
percent	O
of	O
gamma/delta	cell_type
TCR+	cell_type
pregnancy	cell_type
lymphocytes	cell_type
expressed	O
progesterone	protein
receptor	protein
.	O
Binding	O
of	O
a	O
specific	O
antibody	O
to	O
the	O
gamma/delta	O
TCR	O
inhibited	O
PIBF	O
-as	O
well	O
as	O
IL-10	O
production	O
,	O
whereas	O
it	O
increased	O
NK	O
activity	O
and	O
IL-12	protein
expression	O
.	O
CONCLUSIONS:	O
These	O
data	O
suggest	O
the	O
role	O
of	O
gamma/delta	cell_type
TCR	cell_type
-bearing	cell_type
lymphocytes	cell_type
in	O
progesterone	O
-dependent	O
immunomodulation	O
.	O

Monocyte	O
adhesion	O
and	O
spreading	O
on	O
human	cell_type
endothelial	cell_type
cells	cell_type
is	O
dependent	O
on	O
Rho	protein
-regulated	O
receptor	O
clustering	O
.	O
The	O
GTPase	protein
Rho	protein
is	O
known	O
to	O
mediate	O
the	O
assembly	O
of	O
integrin-containing	O
focal	O
adhesions	O
and	O
actin	O
stress	O
fibers	O
.	O
Here,	O
we	O
investigate	O
the	O
role	O
of	O
Rho	protein
in	O
regulating	O
the	O
distribution	O
of	O
the	O
monocyte-binding	protein
receptors	protein
E-selectin	protein
,	O
ICAM-1	protein
,	O
and	O
VCAM-1	protein
in	O
human	cell_type
endothelial	cell_type
cells	cell_type
.	O
Inhibition	O
of	O
Rho	protein
activity	O
with	O
C3	protein
transferase	protein
or	O
N19RhoA	protein
,	O
a	O
dominant	O
negative	O
RhoA	protein
mutant	protein
,	O
reduced	O
the	O
adhesion	O
of	O
monocytes	cell_type
to	O
activated	O
endothelial	cell_type
cells	cell_type
and	O
inhibited	O
their	O
spreading.	O
Similar	O
effects	O
were	O
observed	O
after	O
pretreatment	O
of	O
endothelial	cell_type
cells	cell_type
with	O
cytochalasin	O
D	O
.	O
In	O
contrast,	O
dominant	O
negative	O
Rac	O
and	O
Cdc42	O
proteins	O
did	O
not	O
affect	O
monocyte	O
adhesion	O
or	O
spreading.	O
C3	O
transferase	O
and	O
cytochalasin	O
D	O
did	O
not	O
alter	O
the	O
expression	O
levels	O
of	O
monocyte-binding	protein
receptors	protein
on	O
endothelial	cell_type
cells	cell_type
,	O
but	O
did	O
inhibit	O
clustering	O
of	O
E-selectin	protein
,	O
ICAM-1	protein
,	O
and	O
VCAM-1	protein
on	O
the	O
cell	O
surface	O
induced	O
by	O
monocyte	O
adhesion	O
or	O
cross-linking	protein
antibodies	protein
.	O
Similarly,	O
N19RhoA	protein
inhibited	O
receptor	O
clustering.	O
Monocyte	O
adhesion	O
and	O
receptor	O
cross-linking	O
induced	O
stress	O
fiber	O
assembly	O
,	O
and	O
inhibitors	O
of	O
myosin	protein
light	protein
chain	protein
kinase	protein
prevented	O
this	O
response	O
but	O
did	O
not	O
affect	O
receptor	O
clustering	O
.	O
Finally,	O
receptor	O
clusters	O
colocalized	O
with	O
ezrin	O
/	O
moesin	O
/	O
radixin	O
proteins	O
.	O
These	O
results	O
suggest	O
that	O
Rho	protein
is	O
required	O
in	O
endothelial	cell_type
cells	cell_type
for	O
the	O
assembly	O
of	O
stable	O
adhesions	O
with	O
monocytes	cell_type
via	O
the	O
clustering	O
of	O
monocyte-binding	protein
receptors	protein
and	O
their	O
association	O
with	O
the	O
actin	O
cytoskeleton	O
,	O
independent	O
of	O
stress	O
fiber	O
formation	O
.	O

Selection	O
of	O
the	O
T	O
cell	O
repertoire	O
.	O
Advances	O
in	O
gene	O
technology	O
have	O
allowed	O
the	O
manipulation	O
of	O
molecular	O
interactions	O
that	O
shape	O
the	O
T	O
cell	O
repertoire	O
.	O
Although	O
recognized	O
as	O
fundamental	O
aspects	O
of	O
T	cell_type
lymphocyte	cell_type
development,	O
only	O
recently	O
have	O
the	O
mechanisms	O
governing	O
positive	O
and	O
negative	O
selection	O
been	O
examined	O
at	O
a	O
molecular	O
level.	O
Positive	O
selection	O
refers	O
to	O
the	O
active	O
process	O
of	O
rescuing	O
MHC	cell_type
-restricted	cell_type
thymocytes	cell_type
from	O
programmed	O
cell	O
death	O
.	O
Negative	O
selection	O
refers	O
to	O
the	O
deletion	O
or	O
inactivation	O
of	O
potentially	O
autoreactive	cell_type
thymocytes	cell_type
.	O
This	O
review	O
focuses	O
on	O
interactions	O
during	O
thymocyte	cell_type
maturation	O
that	O
define	O
the	O
T	O
cell	O
repertoire	O
,	O
with	O
an	O
emphasis	O
placed	O
on	O
current	O
literature	O
within	O
this	O
field.	O

CD28	protein
costimulation	O
augments	O
IL-2	protein
secretion	O
of	O
activated	O
lamina	O
propria	O
T	O
cells	O
by	O
increasing	O
mRNA	O
stability	O
without	O
enhancing	O
IL-2	protein
gene	O
transactivation.	O
The	O
pathways	O
leading	O
to	O
activation	O
in	O
lamina	cell_type
propria	cell_type
(LP)	cell_type
T	cell_type
cells	cell_type
are	O
different	O
from	O
peripheral	cell_type
T	cell_type
cells	cell_type
.	O
LP	cell_type
T	cell_type
cells	cell_type
exhibit	O
enhanced	O
IL-2	protein
secretion	O
when	O
activated	O
through	O
the	O
CD2	protein
pathway	O
.	O
Coligation	O
of	O
CD28	protein
leads	O
to	O
synergistic	O
enhancement	O
of	O
IL-2	protein
secretion	O
.	O
Previous	O
studies	O
have	O
characterized	O
the	O
CD28	protein
augmentation	O
of	O
TCR	protein
-mediated	O
signaling	O
in	O
peripheral	cell_type
blood	cell_type
T	cell_type
cells	cell_type
through	O
transcriptional	O
activation	O
of	O
an	O
IL-2	protein
promoter	O
CD28	DNA
response	DNA
element	DNA
(	O
CD28RE	DNA
),	O
along	O
with	O
enhanced	O
mRNA	O
stability.	O
This	O
study	O
characterized	O
molecular	O
events	O
involved	O
in	O
CD28	protein
costimulation	O
of	O
IL-2	protein
production	O
in	O
LP	cell_type
mononuclear	cell_type
cells	cell_type
(	cell_type
LPMC	cell_type
)	cell_type
.	O
LPMC	cell_type
exhibited	O
increased	O
IL-2	protein
production	O
in	O
response	O
to	O
CD28	protein
costimulation,	O
compared	O
with	O
cells	O
activated	O
through	O
CD2	protein
alone.	O
IL-2	protein
secretion	O
was	O
paralleled	O
by	O
increased	O
expression	O
of	O
IL-2	RNA
mRNA	RNA
,	O
resulting	O
from	O
enhanced	O
IL-2	RNA
mRNA	RNA
stability.	O
In	O
contrast	O
to	O
transcriptional	O
activation	O
in	O
PBMC	cell_type
,	O
EMSA	O
revealed	O
that	O
CD28	protein
coligation	O
of	O
CD2	cell_type
-activated	cell_type
LPMC	cell_type
does	O
not	O
result	O
in	O
increased	O
binding	O
of	O
trans-factors	O
to	O
the	O
CD28RE	DNA
,	O
nor	O
did	O
Western	O
blots	O
detect	O
changes	O
in	O
I-kappaBalpha	protein
or	O
I-kappaBbeta	protein
levels	O
following	O
CD28	protein
coligation.	O
Furthermore,	O
CD28	protein
coligation	O
fails	O
to	O
enhance	O
IL-2	DNA
promoter-reporter	DNA
or	O
RE/AP	protein
construct	O
expression	O
in	O
CD2	cell_type
-activated	cell_type
LPMC	cell_type
.	O
The	O
results	O
reported	O
herein	O
indicate	O
that	O
the	O
molecular	O
mechanisms	O
involved	O
in	O
CD28	protein
cosignaling	O
and	O
regulation	O
of	O
IL-2	protein
secretion	O
in	O
LP	cell_type
T	cell_type
cells	cell_type
are	O
unique	O
to	O
that	O
compartment	O
and	O
differ	O
from	O
those	O
seen	O
in	O
peripheral	cell_type
blood	cell_type
T	cell_type
cells	cell_type
.	O
These	O
observations	O
suggest	O
a	O
biological	O
significance	O
for	O
different	O
mechanisms	O
of	O
IL-2	protein
activation	O
in	O
initiation	O
and	O
maintenance	O
of	O
the	O
cytokine	protein
repertoire	protein
found	O
in	O
the	O
mucosa	O
.	O

Expression	O
of	O
Th1	O
and	O
Th2	O
type	O
cytokines	O
responding	O
to	O
HBsAg	protein
and	O
HBxAg	protein
in	O
chronic	O
hepatitis	O
B	O
patients	O
.	O
The	O
cytokine	protein
pattern	protein
on	O
viral	O
antigen	O
recognition	O
is	O
believed	O
to	O
exert	O
a	O
profound	O
influence	O
on	O
the	O
resolution	O
of	O
viral	O
infections	O
and	O
viral	O
clearance	O
.	O
This	O
study	O
was	O
initiated	O
to	O
investigate	O
whether	O
a	O
cytokine	protein
imbalance	O
oriented	O
toward	O
Th2	O
type	O
response	O
plays	O
a	O
role	O
in	O
chronic	O
hepatitis	O
B	O
.	O
Cytokine	protein
profiles	protein
of	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
associated	O
with	O
chronic	O
hepatitis	O
B	O
were	O
analysed	O
by	O
RT-PCR	O
.	O
Upon	O
HBsAg	protein
stimulation,	O
expression	O
of	O
IFN-gamma	protein
,	O
IL-2	protein
,	O
IL-4	protein
,	O
and	O
IL-10	protein
was	O
detected	O
in	O
41%,	O
8%,	O
41%,	O
and	O
50%	O
of	O
the	O
patients	O
,	O
respectively.	O
Among	O
these	O
cytokines	protein
,	O
the	O
expression	O
of	O
IFN-gamma	protein
was	O
associated	O
with	O
high	O
levels	O
of	O
serum	protein
AST/ALT	protein
.	O
However,	O
we	O
could	O
not	O
prove	O
that	O
Th2	protein
type	protein
cytokines	protein
had	O
a	O
protective	O
effect	O
on	O
hepatocytes	cell_type
.	O
Upon	O
HBxAg	protein
stimulation	O
,	O
there	O
was	O
no	O
recognizable	O
association	O
of	O
cytokine	protein
patterns	protein
with	O
AST/ALT	O
levels	O
.	O
In	O
conclusion,	O
production	O
of	O
a	O
Th1	protein
cytokine	protein
,	O
IFN-gamma	protein
,	O
by	O
HBsAg	protein
-reactive	O
cells	O
was	O
associated	O
with	O
hepatocyte	O
damage	O
in	O
chronic	O
hepatitis	O
B	O
,	O
while	O
no	O
counteracting	O
effect	O
of	O
Th2	protein
cytokines	protein
produced	O
by	O
those	O
cells	O
was	O
observed.	O

Apoptosis	O
and	O
growth	O
inhibition	O
in	O
malignant	cell_type
lymphocytes	cell_type
after	O
treatment	O
with	O
arsenic	O
trioxide	O
at	O
clinically	O
achievable	O
concentrations	O
[see	O
comments]	O
BACKGROUND:	O
Arsenic	O
trioxide	O
(	O
As2O3	O
)	O
can	O
induce	O
clinical	O
remission	O
in	O
patients	O
with	O
acute	O
promyelocytic	O
leukemia	O
via	O
induction	O
of	O
differentiation	O
and	O
programmed	O
cell	O
death	O
(	O
apoptosis	O
).	O
We	O
investigated	O
the	O
effects	O
of	O
As2O3	O
on	O
a	O
panel	O
of	O
malignant	cell_type
lymphocytes	cell_type
to	O
determine	O
whether	O
growth-inhibitory	O
and	O
apoptotic	O
effects	O
of	O
As2O3	O
can	O
be	O
observed	O
in	O
these	O
cells	O
at	O
clinically	O
achievable	O
concentrations.	O
METHODS:	O
Eight	O
malignant	cell_line
lymphocytic	cell_line
cell	cell_line
lines	cell_line
and	O
primary	cell_line
cultures	cell_line
of	O
lymphocytic	O
leukemia	O
and	O
lymphoma	O
cells	O
were	O
treated	O
with	O
As2O3	O
,	O
with	O
or	O
without	O
dithiothreitol	O
(	O
DTT	O
)	O
or	O
buthionine	O
sulfoximine	O
(	O
BSO	O
)	O
(an	O
inhibitor	O
of	O
glutathione	O
synthesis	O
).	O
Apoptosis	O
was	O
assessed	O
by	O
cell	O
morphology	O
,	O
flow	O
cytometry	O
,	O
annexin	O
V	O
protein	O
level	O
,	O
and	O
terminal	protein
deoxynucleotidyl	protein
transferase	protein
labeling	O
of	O
DNA	DNA
fragments	DNA
.	O
Cellular	O
proliferation	O
was	O
determined	O
by	O
5-bromo-2'-deoxyuridine	O
incorporation	O
into	O
DNA	O
and	O
flow	O
cytometry	O
and	O
by	O
use	O
of	O
a	O
mitotic	O
arrest	O
assay	O
.	O
Mitochondrial	O
transmembrane	O
potential	O
(	O
delta	O
psi(m)	O
)	O
was	O
measured	O
by	O
means	O
of	O
rhodamine	O
123	O
staining	O
and	O
flow	O
cytometry	O
.	O
Protein	O
expression	O
was	O
assessed	O
by	O
western	O
blot	O
analysis	O
or	O
immunofluorescence	O
.	O
RESULTS:	O
Therapeutic	O
concentrations	O
of	O
As2O3	O
(1-2	O
microM)	O
had	O
dual	O
effects	O
on	O
malignant	cell_type
lymphocytes	cell_type
:	O
1)	O
inhibition	O
of	O
growth	O
through	O
adenosine	O
triphosphate	O
(	O
ATP	O
)	O
depletion	O
and	O
prolongation	O
of	O
cell	O
cycle	O
time	O
and	O
2)	O
induction	O
of	O
apoptosis	O
.	O
As2O3	O
-induced	O
apoptosis	O
was	O
preceded	O
by	O
delta	O
psi(m)	O
collapse	O
.	O
DTT	O
antagonized	O
and	O
BSO	O
enhanced	O
As2O3	O
-induced	O
ATP	O
depletion	O
,	O
delta	O
psi(m)	O
collapse	O
,	O
and	O
apoptosis	O
.	O
Caspase-3	protein
activation	O
,	O
usually	O
resulting	O
from	O
delta	O
psi(m)	O
collapse	O
,	O
was	O
not	O
always	O
associated	O
with	O
As2O3	O
-induced	O
apoptosis	O
.	O
As2O3	O
induced	O
PML	O
(	O
promyelocytic	O
leukemia	O
)	O
protein	O
degradation	O
but	O
did	O
not	O
modulate	O
expression	O
of	O
cell	protein
cycle-related	protein
proteins	protein
,	O
including	O
c-myc	protein
,	O
retinoblastoma	protein
protein	protein
,	O
cyclin-dependent	protein
kinase	protein
4	protein
,	O
cyclin	protein
D1	protein
,	O
and	O
p53	protein
,	O
or	O
expression	O
of	O
differentiation-related	protein
antigens	protein
.	O
CONCLUSIONS:	O
Substantial	O
growth	O
inhibition	O
and	O
apoptosis	O
without	O
evidence	O
of	O
differentiation	O
were	O
induced	O
in	O
most	O
malignant	cell_type
lymphocytic	cell_type
cells	cell_type
treated	O
with	O
1-2	O
microM	O
As2O3	O
.	O
As2O3	O
may	O
prove	O
useful	O
in	O
the	O
treatment	O
of	O
malignant	O
lymphoproliferative	O
disorders	O
.	O

Control	O
of	O
cell	O
cycle	O
entry	O
and	O
apoptosis	O
in	O
B	cell_type
lymphocytes	cell_type
infected	O
by	O
Epstein-Barr	O
virus	O
.	O
Infection	O
of	O
human	cell_type
B	cell_type
cells	cell_type
with	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
results	O
in	O
activation	O
of	O
the	O
cell	O
cycle	O
and	O
cell	O
growth	O
.	O
To	O
interpret	O
the	O
mechanisms	O
by	O
which	O
EBV	O
activates	O
the	O
cell,	O
we	O
have	O
assayed	O
many	O
proteins	O
involved	O
in	O
control	O
of	O
the	O
G0	O
and	O
G1	O
phases	O
of	O
the	O
cell	O
cycle	O
and	O
regulation	O
of	O
apoptosis	O
.	O
In	O
EBV	O
infection	O
most	O
of	O
the	O
changes,	O
including	O
the	O
early	O
induction	O
of	O
cyclin	protein
D2	protein
,	O
are	O
dependent	O
on	O
expression	O
of	O
EBV	DNA
genes	DNA
,	O
but	O
an	O
alteration	O
in	O
the	O
E2F-4	protein
profile	O
was	O
partly	O
independent	O
of	O
viral	O
gene	O
expression	O
,	O
presumably	O
occurring	O
in	O
response	O
to	O
signal	O
transduction	O
activated	O
when	O
the	O
virus	O
binds	O
to	O
its	O
receptor,	O
CD21	protein
.	O
By	O
comparing	O
the	O
expression	O
of	O
genes	O
controlling	O
apoptosis	O
,	O
including	O
those	O
encoding	O
several	O
members	O
of	O
the	O
BCL-2	protein
family	protein
of	O
proteins,	O
the	O
known	O
relative	O
resistance	O
of	O
EBV	cell_line
-immortalized	cell_line
B-cell	cell_line
lines	cell_line
to	O
apoptosis	O
induced	O
by	O
low	O
serum	O
was	O
found	O
to	O
correlate	O
with	O
expression	O
of	O
both	O
BCL-2	protein
and	O
A20	protein
.	O
A20	O
can	O
be	O
regulated	O
by	O
the	O
NF-kappaB	protein
transcription	protein
factor	protein
,	O
which	O
is	O
known	O
to	O
be	O
activated	O
by	O
the	O
EBV	protein
LMP-1	protein
protein	protein
.	O
Quantitative	O
assays	O
demonstrated	O
a	O
direct	O
temporal	O
relationship	O
between	O
LMP-1	protein
protein	protein
levels	O
and	O
active	O
NF-kappaB	protein
during	O
the	O
time	O
course	O
of	O
infection.	O

CTLA-4	protein
-Mediated	O
inhibition	O
of	O
early	O
events	O
of	O
T	O
cell	O
proliferation	O
.	O
CTLA-4	protein
engagement	O
by	O
mAbs	protein
inhibits,	O
while	O
CD28	protein
enhances,	O
IL-2	protein
production	O
and	O
proliferation	O
upon	O
T	O
cell	O
activation	O
.	O
Here,	O
we	O
have	O
analyzed	O
the	O
mechanisms	O
involved	O
in	O
CTLA-4	protein
-mediated	O
inhibition	O
of	O
T	O
cell	O
activation	O
of	O
naive	O
CD4+	cell_type
T	cell_type
cells	cell_type
using	O
Ab	O
cross-linking	O
.	O
CTLA-4	protein
ligation	O
inhibited	O
CD3/	O
CD28	protein
-induced	O
IL-2	RNA
mRNA	RNA
accumulation	O
by	O
inhibiting	O
IL-2	protein
transcription	O
,	O
which	O
appears	O
to	O
be	O
mediated	O
in	O
part	O
through	O
decreasing	O
NF-AT	protein
accumulation	O
in	O
the	O
nuclei	O
.	O
However,	O
CTLA-4	protein
ligation	O
did	O
not	O
appear	O
to	O
affect	O
the	O
CD28	protein
-mediated	O
stabilization	O
of	O
IL-2	RNA
mRNA	RNA
.	O
Further,	O
CTLA-4	protein
engagement	O
inhibited	O
progression	O
through	O
the	O
cell	O
cycle	O
by	O
inhibiting	O
the	O
production	O
of	O
cyclin	protein
D3	protein
,	O
cyclin-dependent	protein
kinase	protein
(cdk)4	protein
,	O
and	O
cdk6	protein
when	O
the	O
T	cell_type
cells	cell_type
were	O
stimulated	O
with	O
anti-CD3/	protein
CD28	protein
and	O
with	O
anti-CD3	protein
alone.	O
These	O
results	O
indicate	O
that	O
CTLA-4	protein
signaling	O
inhibits	O
events	O
early	O
in	O
T	O
cell	O
activation	O
both	O
at	O
IL-2	protein
transcription	O
and	O
at	O
the	O
level	O
of	O
IL-2	protein
-independent	O
events	O
of	O
the	O
cell	O
cycle	O
,	O
and	O
does	O
not	O
simply	O
oppose	O
CD28	protein
-mediated	O
costimulation	O
.	O

The	O
glucocorticoid	protein
receptor	protein
cooperates	O
with	O
the	O
erythropoietin	protein
receptor	protein
and	O
c-Kit	protein
to	O
enhance	O
and	O
sustain	O
proliferation	O
of	O
erythroid	cell_type
progenitors	cell_type
in	O
vitro.	O
Although	O
erythropoietin	protein
(	O
Epo	protein
)	O
is	O
essential	O
for	O
the	O
production	O
of	O
mature	cell_type
red	cell_type
blood	cell_type
cells	cell_type
,	O
the	O
cooperation	O
with	O
other	O
factors	O
is	O
required	O
for	O
a	O
proper	O
balance	O
between	O
progenitor	O
proliferation	O
and	O
differentiation	O
.	O
In	O
avian	O
erythroid	cell_type
progenitors	cell_type
,	O
steroid	O
hormones	O
cooperate	O
with	O
tyrosine	protein
kinase	protein
receptors	protein
to	O
induce	O
renewal	O
of	O
erythroid	cell_type
progenitors	cell_type
.	O
We	O
examined	O
the	O
role	O
of	O
corticosteroids	O
in	O
the	O
in	O
vitro	O
expansion	O
of	O
primary	cell_type
human	cell_type
erythroid	cell_type
cells	cell_type
in	O
liquid	O
cultures	O
and	O
colony	O
assays.	O
Dexamethasone	O
(	O
Dex	O
),	O
a	O
synthetic	O
glucocorticoid	O
hormone	O
,	O
cooperated	O
with	O
Epo	protein
and	O
stem	protein
cell	protein
factor	protein
to	O
induce	O
erythroid	cell_type
progenitors	cell_type
to	O
undergo	O
15	O
to	O
22	O
cell	O
divisions,	O
corresponding	O
to	O
a	O
10(5)-	O
to	O
10(6)-fold	O
amplification	O
of	O
erythroid	cell_type
cells	cell_type
.	O
Dex	O
acted	O
directly	O
on	O
erythroid	cell_type
progenitors	cell_type
and	O
maintained	O
the	O
colony-forming	O
capacity	O
of	O
the	O
progenitor	cell_type
cells	cell_type
expanded	O
in	O
liquid	cell_line
cultures	cell_line
.	O
The	O
hormone	O
delayed	O
terminal	O
differentiation	O
into	O
erythrocytes	cell_type
,	O
which	O
was	O
assayed	O
by	O
morphology,	O
hemoglobin	protein
accumulation	O
,	O
and	O
the	O
expression	O
of	O
genes	O
characteristic	O
for	O
immature	cell_type
cells	cell_type
.	O
Sustained	O
proliferation	O
of	O
erythroid	cell_type
progenitors	cell_type
could	O
be	O
induced	O
equally	O
well	O
from	O
purified	cell_line
erythroid	cell_line
burst-forming	cell_line
units	cell_line
(	O
BFU-E	cell_line
),	O
from	O
CD34(+)	cell_type
blast	cell_type
cells	cell_type
,	O
and	O
from	O
bone	O
marrow	O
depleted	O
from	O
CD34(+)	cell_type
cells	cell_type
.	O

NF-kappaB	protein
functions	O
as	O
both	O
a	O
proapoptotic	O
and	O
antiapoptotic	O
regulatory	O
factor	O
within	O
a	O
single	O
cell	O
type.	O
Recently	O
NF-kappaB	protein
has	O
been	O
shown	O
to	O
have	O
both	O
proapoptotic	O
and	O
antiapoptotic	O
functions	O
.	O
In	O
T	cell_line
cell	cell_line
hybridomas	cell_line
,	O
both	O
T	O
cell	O
activators	O
and	O
glucocorticoids	O
induce	O
apoptosis	O
.	O
Here	O
we	O
show	O
that	O
blockade	O
of	O
NF-kappaB	protein
activity	O
,	O
using	O
a	O
dominant	protein
negative	protein
IkappaBalpha	protein
,	O
has	O
opposite	O
effects	O
on	O
these	O
two	O
apoptotic	O
signals	O
.	O
Treatment	O
with	O
PMA	O
plus	O
ionomycin	O
(	O
P/I	O
)	O
results	O
in	O
the	O
upregulation	O
of	O
Fas	protein
Ligand	protein
(	O
FasL	protein
)	O
and	O
induction	O
of	O
apoptosis	O
.	O
Inhibition	O
of	O
NF-kappaB	protein
activity	O
inhibits	O
the	O
P/I	O
mediated	O
induction	O
of	O
FasL	RNA
mRNA	RNA
and	O
decreases	O
the	O
level	O
of	O
apoptosis	O
in	O
these	O
cultures,	O
thus	O
establishing	O
NF-kappaB	protein
as	O
a	O
proapoptotic	protein
factor	protein
in	O
this	O
context.	O
Conversely,	O
inhibition	O
of	O
NF-kappaB	protein
confers	O
a	O
tenfold	O
increase	O
in	O
glucocorticoid	O
mediated	O
apoptosis	O
,	O
establishing	O
that	O
NF-kappaB	protein
also	O
functions	O
as	O
an	O
antiapoptotic	O
factor	O
.	O
We	O
conclude	O
that	O
NF-kappaB	protein
is	O
a	O
context-dependent	O
apoptosis	O
regulator	O
.	O
Our	O
data	O
suggests	O
that	O
NF-kappaB	protein
may	O
function	O
as	O
an	O
antiapoptotic	O
factor	O
in	O
thymocytes	cell_type
while	O
functioning	O
as	O
a	O
proapoptotic	O
factor	O
in	O
mature	cell_type
peripheral	cell_type
T	cell_type
cells	cell_type
.	O

SOCS-3	protein
is	O
tyrosine	O
phosphorylated	O
in	O
response	O
to	O
interleukin-2	protein
and	O
suppresses	O
STAT5	protein
phosphorylation	O
and	O
lymphocyte	O
proliferation	O
.	O
Members	O
of	O
the	O
recently	O
discovered	O
SOCS/CIS/SSI	protein
family	protein
have	O
been	O
proposed	O
as	O
regulators	O
of	O
cytokine	protein
signaling	O
,	O
and	O
while	O
targets	O
and	O
mechanisms	O
have	O
been	O
suggested	O
for	O
some	O
family	O
members,	O
the	O
precise	O
role	O
of	O
these	O
proteins	O
remains	O
to	O
be	O
defined.	O
To	O
date	O
no	O
SOCS	protein
proteins	protein
have	O
been	O
specifically	O
implicated	O
in	O
interleukin-2	protein
(	O
IL-2	protein
)	O
signaling	O
in	O
T	cell_type
cells	cell_type
.	O
Here	O
we	O
report	O
SOCS-3	protein
expression	O
in	O
response	O
to	O
IL-2	protein
in	O
both	O
T-cell	cell_line
lines	cell_line
and	O
human	cell_type
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
.	O
SOCS-3	protein
protein	O
was	O
detectable	O
as	O
early	O
as	O
30	O
min	O
following	O
IL-2	protein
stimulation	O
,	O
while	O
CIS	protein
was	O
seen	O
only	O
at	O
low	O
levels	O
after	O
2	O
h.	O
Unlike	O
CIS	protein
,	O
SOCS-3	protein
was	O
rapidly	O
tyrosine	O
phosphorylated	O
in	O
response	O
to	O
IL-2	protein
.	O
Tyrosine	O
phosphorylation	O
of	O
SOCS-3	protein
was	O
observed	O
upon	O
coexpression	O
with	O
Jak1	protein
and	O
Jak2	protein
but	O
only	O
weakly	O
with	O
Jak3	protein
.	O
In	O
these	O
experiments,	O
SOCS-3	protein
associated	O
with	O
Jak1	protein
and	O
inhibited	O
Jak1	protein
phosphorylation	O
,	O
and	O
this	O
inhibition	O
was	O
markedly	O
enhanced	O
by	O
the	O
presence	O
of	O
IL-2	protein
receptor	protein
beta	protein
chain	protein
(	O
IL-2Rbeta	protein
).	O
Moreover,	O
following	O
IL-2	protein
stimulation	O
of	O
T	cell_type
cells	cell_type
,	O
SOCS-3	protein
was	O
able	O
to	O
interact	O
with	O
the	O
IL-2	protein
receptor	protein
complex	protein
,	O
and	O
in	O
particular	O
tyrosine	protein
phosphorylated	protein
Jak1	protein
and	O
IL-2Rbeta	protein
.	O
Additionally,	O
in	O
lymphocytes	cell_type
expressing	O
SOCS-3	protein
but	O
not	O
CIS	protein
,	O
IL-2	protein
-induced	O
tyrosine	O
phosphorylation	O
of	O
STAT5b	protein
was	O
markedly	O
reduced,	O
while	O
there	O
was	O
only	O
a	O
weak	O
effect	O
on	O
IL-3-mediated	protein
STAT5b	protein
tyrosine	O
phosphorylation.	O
Finally,	O
proliferation	O
induced	O
by	O
both	O
IL-2	protein
-and	O
IL-3	protein
was	O
significantly	O
inhibited	O
in	O
the	O
presence	O
of	O
SOCS-3	protein
.	O
The	O
findings	O
suggest	O
that	O
when	O
SOCS-3	protein
is	O
rapidly	O
induced	O
by	O
IL-2	protein
in	O
T	cell_type
cells	cell_type
,	O
it	O
acts	O
to	O
inhibit	O
IL-2	protein
responses	O
in	O
a	O
classical	O
negative	O
feedback	O
loop	O
.	O

Human	cell_type
alveolar	cell_type
macrophages	cell_type
are	O
markedly	O
deficient	O
in	O
REF-1	protein
and	O
AP-1	protein
DNA	O
binding	O
activity	O
.	O
Although	O
many	O
functions	O
of	O
human	cell_type
alveolar	cell_type
macrophages	cell_type
are	O
altered	O
compared	O
with	O
their	O
precursor	cell_type
cell	cell_type
,	O
the	O
blood	cell_type
monocyte	cell_type
(	O
monocyte	cell_type
),	O
the	O
reason(s)	O
for	O
these	O
functional	O
changes	O
have	O
not	O
been	O
determined.	O
We	O
recently	O
reported	O
that	O
human	cell_type
alveolar	cell_type
macrophages	cell_type
do	O
not	O
express	O
AP-1	protein
DNA	O
binding	O
activity	O
(Monick,	O
M.	O
M.,	O
Carter,	O
A.	O
B.,	O
Gudmundsson,	O
G.,	O
Geist,	O
L.	O
J.,	O
and	O
Hunninghake,	O
G.	O
W.	O
(1998)	O
Am.	O
J.	O
Physiol.	O
275,	O
L389-L397).	O
To	O
determine	O
why	O
alveolar	cell_type
macrophages	cell_type
do	O
not	O
express	O
AP-1	protein
DNA	O
binding	O
activity	O
,	O
we	O
first	O
showed	O
that	O
there	O
was	O
not	O
a	O
decrease	O
in	O
expression	O
of	O
the	O
FOS	O
and	O
JUN	O
proteins	O
that	O
make	O
up	O
the	O
AP-1	protein
complex.	O
There	O
was,	O
however,	O
a	O
significant	O
difference	O
in	O
the	O
amounts	O
of	O
the	O
nuclear	protein
protein	protein
,	O
REF-1	protein
(which	O
regulates	O
AP-1	protein
DNA	O
binding	O
by	O
altering	O
the	O
redox	O
status	O
of	O
FOS	protein
and	O
JUN	protein
proteins	protein
),	O
in	O
alveolar	cell_type
macrophages	cell_type
compared	O
with	O
monocytes	cell_type
.	O
In	O
addition,	O
in	O
vitro	O
differentiation	O
of	O
monocytes	cell_type
to	O
a	O
macrophage-like	cell_type
cell	cell_type
resulted	O
in	O
decreased	O
amounts	O
of	O
REF-1	protein
.	O
Finally,	O
addition	O
of	O
REF-1	protein
from	O
activated	cell_type
monocytes	cell_type
to	O
alveolar	O
macrophage	O
nuclear	O
proteins	O
resulted	O
in	O
a	O
marked	O
increase	O
in	O
AP-1	protein
DNA	O
binding	O
.	O
These	O
studies	O
strongly	O
suggest	O
that	O
the	O
process	O
of	O
differentiation	O
of	O
monocytes	cell_type
into	O
alveolar	cell_type
macrophages	cell_type
is	O
associated	O
with	O
a	O
loss	O
of	O
REF-1	protein
and	O
AP-1	protein
activity.	O
This	O
observation	O
may	O
explain,	O
in	O
part,	O
some	O
of	O
the	O
functional	O
differences	O
observed	O
for	O
alveolar	cell_type
macrophages	cell_type
compared	O
with	O
monocytes	cell_type
.	O

Development	O
and	O
maturation	O
of	O
secondary	O
lymphoid	O
tissues	O
.	O
The	O
secondary	O
lymphoid	O
tissues	O
are	O
located	O
at	O
strategic	O
sites	O
where	O
foreign	protein
antigens	protein
can	O
be	O
efficiently	O
brought	O
together	O
with	O
immune	O
system	O
regulatory	O
and	O
effector	O
cells	O
.	O
The	O
organized	O
structure	O
of	O
the	O
secondary	O
lymphoid	O
tissues	O
is	O
thought	O
to	O
enhance	O
the	O
sensitivity	O
of	O
antigen	O
recognition	O
and	O
to	O
support	O
proper	O
regulation	O
of	O
the	O
activation	O
and	O
maturation	O
of	O
the	O
antigen-responsive	cell_type
lymphoid	cell_type
cells	cell_type
.	O
Although	O
a	O
substantial	O
amount	O
is	O
known	O
about	O
the	O
cellular	DNA
elements	DNA
that	O
compose	O
the	O
lymphoid	O
and	O
nonlymphoid	O
components	O
of	O
the	O
secondary	O
lymphoid	O
tissues	O
,	O
information	O
concerning	O
the	O
signals	O
that	O
control	O
the	O
development	O
of	O
the	O
tissues	O
and	O
that	O
maintain	O
the	O
organized	O
tissue	O
microenvironment	O
remain	O
undefined.	O
Studies	O
over	O
the	O
past	O
few	O
years	O
have	O
identified	O
lymphotoxin	O
as	O
a	O
critical	O
signaling	O
molecule	O
not	O
only	O
for	O
the	O
organogenesis	O
of	O
secondary	O
lymphoid	O
tissues	O
but	O
for	O
the	O
maintenance	O
of	O
aspects	O
of	O
their	O
microarchitecture	O
as	O
well.	O
Additional	O
signaling	O
molecules	O
that	O
contribute	O
to	O
the	O
formation	O
of	O
normal	O
lymphoid	O
tissue	O
structure	O
are	O
being	O
identified	O
at	O
an	O
accelerating	O
pace.	O
Analyses	O
of	O
mouse	O
strains	O
with	O
congenital	O
defects	O
in	O
different	O
aspects	O
of	O
secondary	O
lymphoid	O
tissue	O
development	O
are	O
beginning	O
to	O
clarify	O
the	O
role	O
of	O
these	O
tissues	O
in	O
immune	O
responses	O
and	O
host	O
defense.	O
This	O
review	O
focuses	O
on	O
studies	O
defining	O
recently	O
identified	O
crucial	O
signals	O
for	O
the	O
biogenesis	O
of	O
secondary	O
lymphoid	O
organs	O
and	O
for	O
the	O
maintenance	O
of	O
their	O
proper	O
microarchitecture	O
.	O
It	O
also	O
discusses	O
new	O
insights	O
into	O
how	O
the	O
structure	O
of	O
these	O
tissues	O
supports	O
effective	O
immune	O
responses	O
.	O

Modulation	O
of	O
CD28	protein
expression	O
:	O
distinct	O
regulatory	O
pathways	O
during	O
activation	O
and	O
replicative	O
senescence.	O
The	O
costimulatory	protein
molecule	protein
CD28	protein
has	O
a	O
restricted	O
tissue	O
distribution	O
and	O
is	O
expressed	O
on	O
T	cell_type
cells	cell_type
and	O
some	O
plasmacytoma	cell_type
cells	cell_type
.	O
Although	O
CD28	protein
is	O
constitutively	O
expressed,	O
its	O
expression	O
is	O
transiently	O
down-regulated	O
following	O
T	O
cell	O
activation	O
and	O
declines	O
progressively	O
with	O
in	O
vitro	O
senescence.	O
In	O
vivo,	O
CD8+	cell_type
T	cell_type
cells	cell_type
and,	O
less	O
frequently,	O
CD4+	cell_type
T	cell_type
cells	cell_type
may	O
completely	O
lose	O
CD28	protein
surface	O
expression	O
during	O
chronic	O
infections	O
and	O
with	O
aging.	O
This	O
correlates	O
with	O
changes	O
of	O
nuclear	O
protein-binding	O
activities	O
to	O
two	O
motifs,	O
site	O
alpha	O
and	O
beta	O
,	O
within	O
the	O
CD28	DNA
minimal	DNA
promoter	DNA
.	O
Both	O
alpha-	O
and	O
beta-bound	O
complexes	O
are	O
found	O
only	O
in	O
lymphoid	O
tissues	O
,	O
in	O
CD28+	cell_type
T	cell_type
cells	cell_type
,	O
and	O
in	O
some	O
transformed	cell_line
B	cell_line
cells	cell_line
.	O
These	O
complexes	O
are	O
coordinately	O
expressed	O
except	O
during	O
replicative	O
senescence	O
,	O
which	O
is	O
characterized	O
by	O
the	O
down-modulation	O
of	O
site	protein
beta	protein
-but	O
not	O
site	protein
alpha	protein
-binding	O
activities	O
.	O
In	O
contrast,	O
T	O
cell	O
activation	O
induces	O
a	O
parallel	O
decline	O
in	O
both	O
site	O
alpha-	O
and	O
beta-	O
binding	O
activities	O
.	O
CD4+	O
and	O
CD8+	cell_type
T	cell_type
cells	cell_type
differ	O
in	O
their	O
beta-binding	O
profiles	O
,	O
which	O
may	O
explain	O
the	O
more	O
pronounced	O
down-regulation	O
of	O
CD28	protein
in	O
senescent	O
CD8+	cell_type
T	cell_type
cells	cell_type
.	O
In	O
vivo	O
expanded	O
CD4+CD28null	O
and	O
CD8+CD28null	O
T	O
cells	O
uniformly	O
lack	O
alpha-	O
and	O
beta-	O
bound	O
complexes	O
,	O
resembling	O
the	O
pattern	O
seen	O
in	O
chronically	cell_type
activated	cell_type
cells	cell_type
and	O
not	O
of	O
senescent	cell_type
cells	cell_type
.	O

A	O
role	O
for	O
RanBP1	protein
in	O
the	O
release	O
of	O
CRM1	protein
from	O
the	O
nuclear	protein
pore	protein
complex	protein
in	O
a	O
terminal	O
step	O
of	O
nuclear	O
export	O
.	O
We	O
recently	O
developed	O
an	O
assay	O
in	O
which	O
nuclear	O
export	O
of	O
the	O
shuttling	O
transcription	protein
factor	protein
NFAT	protein
(	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
)	O
can	O
be	O
reconstituted	O
in	O
permeabilized	O
cells	O
with	O
the	O
GTPase	protein
Ran	protein
and	O
the	O
nuclear	O
export	O
receptor	O
CRM1	protein
.	O
We	O
have	O
now	O
used	O
this	O
assay	O
to	O
identify	O
another	O
export	O
factor.	O
After	O
preincubation	O
of	O
permeabilized	cell_line
cells	cell_line
with	O
a	O
Ran	protein
mutant	protein
that	O
cannot	O
hydrolyze	O
GTP	O
(	O
RanQ69L	protein
),	O
cytosol	O
supports	O
NFAT	protein
export	O
,	O
but	O
CRM1	protein
and	O
Ran	protein
alone	O
do	O
not.	O
The	O
RanQ69L	protein
preincubation	O
leads	O
to	O
accumulation	O
of	O
CRM1	protein
at	O
the	O
cytoplasmic	O
periphery	O
of	O
the	O
nuclear	protein
pore	protein
complex	protein
(	O
NPC	protein
)	O
in	O
association	O
with	O
the	O
p62	protein
complex	protein
and	O
Can/Nup214.	O
Ran	protein
GTP	O
-dependent	O
association	O
of	O
CRM1	protein
with	O
these	O
nucleoporins	protein
was	O
reconstituted	O
in	O
vitro.	O
By	O
biochemical	O
fractionation	O
and	O
reconstitution	O
,	O
we	O
showed	O
that	O
RanBP1	protein
restores	O
nuclear	O
export	O
after	O
the	O
RanQ69L	protein
preincubation	O
.	O
It	O
also	O
stimulates	O
nuclear	O
export	O
in	O
cells	O
that	O
have	O
not	O
been	O
preincubated	O
with	O
RanQ69L	protein
.	O
RanBP1	protein
as	O
well	O
as	O
Ran	protein
-binding	protein
domains	protein
of	O
the	O
cytoplasmic	protein
nucleoporin	protein
RanBP2	protein
promote	O
the	O
release	O
of	O
CRM1	protein
from	O
the	O
NPC	protein
.	O
Taken	O
together,	O
our	O
results	O
indicate	O
that	O
Ran	protein
GTP	O
is	O
important	O
for	O
the	O
targeting	O
of	O
export	O
complexes	O
to	O
the	O
cytoplasmic	O
side	O
of	O
the	O
NPC	protein
and	O
that	O
RanBP1	protein
and	O
probably	O
RanBP2	protein
are	O
involved	O
in	O
the	O
dissociation	O
of	O
nuclear	protein
export	protein
complexes	protein
from	O
the	O
NPC	protein
in	O
a	O
terminal	O
step	O
of	O
transport	O
.	O

c-Myc	protein
and	O
E1A	protein
induced	O
cellular	O
sensitivity	O
to	O
activated	cell_type
NK	cell_type
cells	cell_type
involves	O
cytotoxic	O
granules	O
as	O
death	O
effectors	O
.	O
The	O
contact	O
of	O
natural	cell_type
killer	cell_type
(NK)	cell_type
cells	cell_type
with	O
foreign	cell_type
cells	cell_type
and	O
with	O
certain	O
virus-infected	O
or	O
tumor	O
cells	O
triggers	O
the	O
cytolytic	O
machinery	O
of	O
NK	cell_type
cells	cell_type
.	O
This	O
triggering	O
leads	O
to	O
exocytosis	O
of	O
the	O
cytotoxic	cell_type
NK	cell_type
cell	cell_type
granules	cell_type
.	O
The	O
oncoproteins	protein
c-Myc	protein
and	O
E1A	protein
render	O
cells	O
vulnerable	O
to	O
NK	O
cell	O
mediated	O
cytolysis	O
yet	O
the	O
mechanisms	O
of	O
sensitization	O
are	O
not	O
well	O
understood.	O
In	O
a	O
model	O
where	O
foreign	cell_type
cells	cell_type
(	O
rat	cell_type
fibroblasts	cell_type
)	O
were	O
cocultured	O
with	O
human	cell_type
IL-2	cell_type
activated	cell_type
NK	cell_type
cells	cell_type
,	O
we	O
observed	O
that	O
NK	cell_type
cells	cell_type
were	O
capable	O
of	O
efficiently	O
killing	O
their	O
targets	O
only	O
if	O
the	O
cells	O
overexpressed	O
the	O
oncogene	O
c-Myc	protein
or	O
E1A	protein
.	O
Both	O
the	O
parental	O
and	O
the	O
oncogene	cell_type
expressing	cell_type
fibroblasts	cell_type
similarly	O
triggered	O
phosphoinositide	O
hydrolysis	O
in	O
the	O
bound	O
NK	cell_type
cells	cell_type
,	O
demonstrating	O
that	O
NK	cell_type
cells	cell_type
were	O
cytolytically	O
activated	O
in	O
contact	O
with	O
both	O
resistant	O
parental	O
and	O
oncogene	cell_type
expressing	cell_type
sensitive	cell_type
target	cell_type
fibroblasts	cell_type
.	O
The	O
cell	O
death	O
was	O
independent	O
of	O
wild-type	protein
p53	protein
and	O
was	O
not	O
inhibited	O
by	O
an	O
anti-apoptotic	protein
protein	protein
EIB19K	protein
.	O
These	O
results	O
provided	O
evidence	O
that	O
c-Myc	protein
and	O
E1A	protein
activated	O
the	O
NK	O
cell	O
induced	O
cytolysis	O
at	O
a	O
post-triggering	O
stage	O
of	O
NK	O
cell-target	O
cell	O
interaction	O
.	O
In	O
consistence,	O
the	O
c-Myc	protein
and	O
E1A	protein
overexpressing	O
fibroblasts	cell_type
were	O
more	O
sensitive	O
to	O
the	O
cytolytic	O
effects	O
of	O
isolated	O
NK	O
cell-derived	O
granules	O
than	O
parental	cell_type
cells	cell_type
.	O
The	O
data	O
indicate	O
that	O
oncogenes	DNA
activate	O
the	O
cytotoxicity	O
of	O
NK	O
cell	O
granules	O
.	O
This	O
mechanism	O
can	O
have	O
a	O
role	O
in	O
directing	O
the	O
cytolytic	O
action	O
of	O
NK	cell_type
cells	cell_type
towards	O
the	O
virus-infected	cell_type
and	cell_type
cancer	cell_type
cells	cell_type
.	O

Unicellular-unilineage	cell_line
erythropoietic	cell_line
cultures	cell_line
:	O
molecular	O
analysis	O
of	O
regulatory	O
gene	O
expression	O
at	O
sibling	O
cell	O
level	O
.	O
In	O
vitro	O
studies	O
on	O
hematopoietic	O
control	O
mechanisms	O
have	O
been	O
hampered	O
by	O
the	O
heterogeneity	O
of	O
the	O
analyzed	O
cell	O
populations,	O
ie,	O
lack	O
of	O
lineage	O
specificity	O
and	O
developmental	O
stage	O
homogeneity	O
of	O
progenitor/precursor	cell_type
cells	cell_type
growing	O
in	O
culture.	O
We	O
developed	O
unicellular	O
culture	O
systems	O
for	O
unilineage	O
differentiation	O
of	O
purified	cell_type
hematopoietic	cell_type
progenitor	cell_type
cells	cell_type
followed	O
by	O
daughter	O
cell	O
analysis	O
at	O
cellular	O
and	O
molecular	O
level.	O
In	O
the	O
culture	O
system	O
reported	O
here,	O
(1)	O
the	O
growth	protein
factor	protein
(	O
GF	protein
)	O
stimulus	O
induces	O
cord	cell_type
blood	cell_type
(CB)	cell_type
progenitor	cell_type
cells	cell_type
to	O
proliferate	O
and	O
differentiate/mature	O
exclusively	O
along	O
the	O
erythroid	cell_type
lineage	cell_type
;	O
(2)	O
this	O
erythropoietic	O
wave	O
is	O
characterized	O
by	O
less	O
than	O
4%	O
apoptotic	O
cells;	O
(3)	O
asymmetric	O
divisions	O
are	O
virtually	O
absent,	O
ie,	O
nonresponsive	O
hematopoietic	cell_type
progenitors	cell_type
with	O
no	O
erythropoietic	O
potential	O
are	O
forced	O
into	O
apoptosis	O
;	O
(4)	O
the	O
system	O
is	O
cell	O
division	O
controlled	O
(cdc),	O
ie,	O
the	O
number	O
of	O
divisions	O
performed	O
by	O
each	O
cell	O
is	O
monitored.	O
Single-cell	O
reverse	protein
transcriptase	protein
-polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
)	O
analysis	O
was	O
applied	O
to	O
this	O
culture	O
system	O
to	O
investigate	O
gene	O
expression	O
of	O
diverse	O
receptors	protein
,	O
markers	protein
of	protein
differentiation	protein
,	O
and	O
transcription	protein
factors	protein
(	O
EKLF	protein
,	O
GATA-1	protein
,	O
GATA-2	protein
,	O
p45	protein
NF-E2	protein
,	O
PU.1	protein
,	O
and	O
SCL/Tal1	protein
)	O
at	O
discrete	O
stages	O
of	O
erythropoietic	O
development	O
.	O
Freshly	O
isolated	O
CD34(+)	cell_type
cells	cell_type
expressed	O
CD34	protein
,	O
c-kit	protein
,	O
PU.1	protein
,	O
and	O
GATA-2	protein
but	O
did	O
not	O
express	O
CD36	protein
,	O
erythropoietin	protein
receptor	protein
(	O
EpoR	protein
),	O
SCL/Tal1	protein
,	O
EKLF	protein
,	O
NF-E2,	O
GATA-1	protein
,	O
or	O
glyocophorin	protein
A	protein
(	O
GPA	protein
).	O
In	O
early	O
to	O
intermediate	O
stages	O
of	O
erythroid	O
differentiation	O
we	O
monitored	O
the	O
induction	O
of	O
CD36	protein
,	O
Tal1	protein
,	O
EKLF	protein
,	O
NF-E2	protein
,	O
and	O
GATA-1	protein
that	O
preceeded	O
expression	O
of	O
EpoR	protein
.	O
In	O
late	O
stages	O
of	O
erythroid	O
maturation,	O
GPA	protein
was	O
upregulated,	O
whereas	O
CD34	protein
,	O
c-kit	protein
,	O
PU.1	protein
,	O
and	O
GATA-2	protein
were	O
barely	O
or	O
not	O
detected.	O
In	O
addition,	O
competitive	O
single-cell	O
RT-PCR	O
was	O
used	O
to	O
assay	O
CD34	RNA
mRNA	RNA
transcripts	RNA
in	O
sibling	cell_line
CD34	cell_line
(+)	cell_line
CD38(-)	cell_line
cells	cell_line
differentiating	O
in	O
unilineage	cell_line
erythroid	cell_line
cultures	cell_line
:	O
this	O
analysis	O
allowed	O
us	O
to	O
semiquantitate	O
the	O
gradual	O
downmodulation	O
of	O
CD34	RNA
mRNA	RNA
from	O
progenitor	cell_type
cells	cell_type
through	O
their	O
differentiating	cell_line
erythroid	cell_line
progeny	cell_line
.	O
It	O
is	O
concluded	O
that	O
this	O
novel	O
culture	O
system,	O
coupled	O
with	O
single-cell	O
RT-PCR	O
analysis,	O
may	O
eliminate	O
the	O
ambiguities	O
intrinsic	O
to	O
molecular	O
studies	O
on	O
heterogeneous	O
populations	O
of	O
hematopoietic	cell_type
progenitors	cell_type
/precursors	cell_type
growing	O
in	O
culture,	O
particularly	O
in	O
the	O
initial	O
stages	O
of	O
development.	O

Differences	O
in	O
phosphorylation	O
of	O
the	O
IL-2R	protein
associated	protein
JAK/STAT	protein
proteins	protein
between	O
HTLV-I(+)	O
,	O
IL-2-independent	O
and	O
IL-2-dependent	O
cell	O
lines	O
and	O
uncultured	cell_type
leukemic	cell_type
cells	cell_type
from	O
patients	O
with	O
adult	O
T-cell	O
lymphoma/leukemia	O
.	O
To	O
determine	O
activation	O
status	O
of	O
the	O
IL-2R	protein
-associated	O
(	O
Jak/STAT	protein
)	O
pathway	O
in	O
the	O
HTLV-I	cell_line
infected	cell_line
cells	cell_line
,	O
we	O
examined	O
tyrosine	O
phosphorylation	O
of	O
Jak3	protein
,	O
STAT3	protein
,	O
and	O
STAT5	protein
in	O
several	O
HTLV-I(+)	cell_line
T-cell	cell_line
lines	cell_line
and	O
in	O
uncultured	cell_type
leukemic	cell_type
T	cell_type
cells	cell_type
isolated	O
from	O
patients	O
with	O
adult	O
T-cell	O
lymphoma/leukemia	O
(	O
ATLL	O
).	O
Constitutive	O
basal	O
phosphorylation	O
of	O
Jak3	protein
and,	O
usually,	O
STAT3	protein
and	O
STAT5	protein
was	O
detected	O
in	O
all	O
four	O
IL-2	cell_line
-independent	cell_line
cell	cell_line
lines	cell_line
tested,	O
but	O
in	O
none	O
of	O
the	O
three	O
IL-2	cell_line
-dependent	cell_line
cell	cell_line
lines	cell_line
.	O
Similarly,	O
there	O
was	O
no	O
detectable	O
basal	O
phosphorylation	O
of	O
Jak3	protein
and	O
STAT5	protein
in	O
the	O
leukemic	cell_type
cells	cell_type
from	O
ATLL	O
patients	O
(0/8	O
and	O
0/3,	O
respectively).	O
However,	O
stimulation	O
with	O
IL-2	protein
resulted	O
in	O
Jak3	protein
and	O
STAT5	protein
phosphorylation	O
in	O
both	O
leukemic	cell_type
ATLL	cell_type
cells	cell_type
and	O
IL-2	cell_line
-dependent	cell_line
lines	cell_line
.	O
Furthermore,	O
expression	O
of	O
SHP-1	protein
phosphatase	protein
which	O
is	O
a	O
negative	O
regulator	O
of	O
cytokine	protein
receptor	protein
signaling	O
,	O
was	O
lost	O
in	O
most	O
IL-2	cell_line
independent	cell_line
cell	cell_line
lines	cell_line
(3/4)	O
but	O
not	O
in	O
the	O
leukemic	O
ATLL	cell_type
cells	cell_type
(0/3).	O
Finally,	O
the	O
HTLV-I(+)	cell_line
T-cell	cell_line
lines	cell_line
(313)	O
but	O
not	O
the	O
control,	O
HTLV-I(-)	cell_line
T-cell	cell_line
lines	cell_line
were	O
resistant	O
to	O
rapamycin	O
and	O
its	O
novel	O
analog	O
RAD	O
.	O
We	O
conclude	O
that	O
(1)	O
HTLV-I	O
infection	O
per	O
se	O
does	O
not	O
result	O
in	O
a	O
constitutive	O
phosphorylation	O
of	O
the	O
Jak3	protein
,	O
STAT3	protein
,	O
and	O
STAT5	protein
proteins;	O
(2)	O
malignant	O
transformation	O
in	O
at	O
least	O
some	O
cases	O
of	O
ATLL	O
does	O
not	O
require	O
the	O
constitutive,	O
but	O
may	O
require	O
IL-2	protein
-induced,	O
activation	O
of	O
the	O
IL-2R	protein
Jak/STAT	protein
pathway	O
;	O
and	O
(3)	O
there	O
are	O
major	O
differences	O
in	O
T-cell	O
immortalization	O
mechanism	O
(s)	O
which	O
appear	O
to	O
involve	O
SHP-1	protein
and	O
target	O
molecules	O
for	O
rapamycin	O
and	O
RAD	O
.	O

Clonality	O
analysis	O
using	O
X-chromosome	DNA
inactivation	O
at	O
the	O
human	DNA
androgen	DNA
receptor	DNA
gene	DNA
(	O
Humara	DNA
).	O
Evaluation	O
of	O
large	O
cohorts	O
of	O
patients	O
with	O
chronic	O
myeloproliferative	O
diseases	O
,	O
secondary	O
neutrophilia	O
,	O
and	O
reactive	O
thrombocytosis	O
.	O
Chronic	O
myeloproliferative	O
diseases	O
(	O
MPDs	O
)	O
are	O
not	O
associated	O
with	O
consistent	O
cytogenetic	O
or	O
molecular	O
abnormalities	O
.	O
Demonstration	O
of	O
clonal	O
cell	O
growth	O
by	O
analysis	O
of	O
X-chromosome	DNA
inactivation	O
(XCI)	O
patterns	O
in	O
females	O
provides	O
a	O
promising	O
tool	O
for	O
diagnosis.	O
However,	O
this	O
technique	O
can	O
be	O
complicated	O
by	O
excessive	O
lyonization	O
of	O
normal	O
cells	O
mimicking	O
clonal	O
cell	O
growth	O
:	O
We	O
analyzed	O
XCI	O
patterns	O
at	O
the	O
human	DNA
androgen	DNA
receptor	DNA
(HUMARA)	DNA
locus	DNA
in	O
146	O
healthy	O
females	O
,	O
65	O
women	O
with	O
secondary	O
neutrophilia	O
,	O
31	O
women	O
with	O
reactive	O
thrombocytosis	O
,	O
and	O
86	O
women	O
with	O
chronic	O
MPDs	O
.	O
A	O
skewed	O
XCI	O
pattern	O
with	O
greater	O
than	O
75%	O
amplification	O
of	O
1	O
allele	DNA
(	O
allele	DNA
ratio	O
&gt;	O
3:1)	O
was	O
found	O
in	O
22	O
(9.1%)	O
of	O
242	O
control	O
subjects	O
.	O
The	O
incidence	O
of	O
skewing	O
was	O
statistically	O
significantly	O
lower	O
in	O
women	O
younger	O
than	O
30	O
years	O
(2/73)	O
compared	O
with	O
women	O
older	O
than	O
60	O
years	O
(10/53).	O
Of	O
86	O
patients	O
with	O
a	O
chronic	O
MPD	O
,	O
71	O
(82%)	O
exhibited	O
an	O
allele	DNA
ratio	O
greater	O
than	O
3:1,	O
whereas	O
only	O
10	O
(12%)	O
of	O
86	O
age-matched	O
control	O
subjects	O
showed	O
a	O
skewed	O
XCI	O
pattern	O
.	O
Although	O
statistical	O
evaluation	O
of	O
the	O
data	O
showed	O
a	O
significant	O
difference	O
between	O
patients	O
with	O
a	O
chronic	O
MPD	O
and	O
control	O
subjects	O
,	O
proof	O
of	O
clonality	O
in	O
individual,	O
especially	O
elderly,	O
patients	O
is	O
difficult.	O

GATA-1	protein
and	O
erythropoietin	protein
cooperate	O
to	O
promote	O
erythroid	O
cell	O
survival	O
by	O
regulating	O
bcl-xL	protein
expression	O
.	O
The	O
transcription	protein
factor	protein
GATA-1	protein
is	O
essential	O
for	O
normal	O
erythropoiesis.	O
By	O
examining	O
in	O
vitro-differentiated	cell_line
embryonic	cell_line
stem	cell_line
cells	cell_line
,	O
we	O
showed	O
previously	O
that	O
in	O
the	O
absence	O
of	O
GATA-1	protein
,	O
committed	cell_line
erythroid	cell_line
precursors	cell_line
fail	O
to	O
complete	O
maturation	O
and	O
instead	O
undergo	O
apoptosis	O
.	O
The	O
mechanisms	O
by	O
which	O
GATA-1	protein
controls	O
cell	O
survival	O
are	O
unknown.	O
Here	O
we	O
report	O
that	O
in	O
erythroid	cell_type
cells	cell_type
,	O
GATA-1	protein
strongly	O
induces	O
the	O
expression	O
of	O
the	O
anti-apoptotic	protein
protein	protein
bcl-xL	protein
,	O
but	O
not	O
the	O
related	O
proteins	O
bcl-2	protein
and	O
mcl-1	protein
.	O
Consistent	O
with	O
a	O
role	O
for	O
bcl-xL	protein
in	O
mediating	O
GATA-1	protein
-induced	O
erythroid	O
cell	O
survival	O
,	O
in	O
vitro-differentiated	cell_line
bcl-xL	cell_line
-/-	cell_line
embryonic	cell_line
stem	cell_line
cells	cell_line
fail	O
to	O
generate	O
viable	O
mature	O
definitive	O
erythroid	cell_type
cells	cell_type
,	O
a	O
phenotype	O
resembling	O
that	O
of	O
GATA-1	DNA
gene	DNA
disruption	O
.	O
In	O
addition,	O
we	O
show	O
that	O
erythropoietin	protein
,	O
which	O
is	O
also	O
required	O
for	O
erythroid	O
cell	O
survival	O
,	O
cooperates	O
with	O
GATA-1	protein
to	O
stimulate	O
bcl-xL	protein
gene	O
expression	O
and	O
to	O
maintain	O
erythroid	O
cell	O
viability	O
during	O
terminal	O
maturation	O
.	O
Together,	O
our	O
data	O
show	O
that	O
bcl-xL	protein
is	O
essential	O
for	O
normal	O
erythroid	O
development	O
and	O
suggest	O
a	O
regulatory	O
hierarchy	O
in	O
which	O
bcl-xL	protein
is	O
a	O
critical	O
downstream	O
effector	O
of	O
GATA-1	protein
and	O
erythropoietin	protein
-mediated	O
signals	O
.	O

p70(s6k)	protein
integrates	O
phosphatidylinositol	protein
3-kinase	protein
and	O
rapamycin-regulated	O
signals	O
for	O
E2F	protein
regulation	O
in	O
T	cell_type
lymphocytes	cell_type
.	O
In	O
T	cell_type
lymphocytes	cell_type
,	O
the	O
hematopoietic	protein
cytokine	protein
interleukin-2	protein
(	O
IL-2	protein
)	O
uses	O
phosphatidylinositol	protein
3-kinase	protein
(	O
PI	protein
3-kinase	protein
)-induced	O
signaling	O
pathways	O
to	O
regulate	O
E2F	protein
transcriptional	O
activity	O
,	O
a	O
critical	O
cell	O
cycle	O
checkpoint	O
.	O
PI	protein
3-kinase	protein
also	O
regulates	O
the	O
activity	O
of	O
p70(s6k)	protein
,	O
the	O
40S	protein
ribosomal	protein
protein	protein
S6	protein
kinase	protein
,	O
a	O
response	O
that	O
is	O
abrogated	O
by	O
the	O
macrolide	O
rapamycin	O
.	O
This	O
immunosuppressive	O
drug	O
is	O
known	O
to	O
prevent	O
T-cell	O
proliferation	O
,	O
but	O
the	O
precise	O
point	O
at	O
which	O
rapamycin	O
regulates	O
T-cell	O
cycle	O
progression	O
has	O
yet	O
to	O
be	O
elucidated.	O
Moreover,	O
the	O
effects	O
of	O
rapamycin	O
on,	O
and	O
the	O
role	O
of	O
p70(s6k)	protein
in,	O
IL-2	protein
and	O
PI	protein
3-kinase	protein
activation	O
of	O
E2Fs	protein
have	O
not	O
been	O
characterized.	O
Our	O
present	O
results	O
show	O
that	O
IL-2	protein
-and	O
PI	protein
3-kinase	protein
-induced	O
pathways	O
for	O
the	O
regulation	O
of	O
E2F	protein
transcriptional	O
activity	O
include	O
both	O
rapamycin-resistant	O
and	O
rapamycin-sensitive	O
components	O
.	O
Expression	O
of	O
a	O
rapamycin	protein
-resistant	protein
mutant	protein
of	O
p70(s6k)	protein
in	O
T	cell_type
cells	cell_type
could	O
restore	O
rapamycin	O
-suppressed	O
E2F	protein
responses	O
.	O
Thus,	O
the	O
rapamycin	O
-controlled	O
processes	O
involved	O
in	O
E2F	protein
regulation	O
appear	O
to	O
be	O
mediated	O
by	O
p70(s6k)	protein
.	O
However,	O
the	O
rapamycin	protein
-resistant	protein
p70(s6k)	protein
could	O
not	O
rescue	O
rapamycin	O
inhibition	O
of	O
T-cell	O
cycle	O
entry,	O
consistent	O
with	O
the	O
involvement	O
of	O
additional,	O
rapamycin	O
-sensitive	O
pathways	O
in	O
the	O
control	O
of	O
T-cell	O
cycle	O
progression	O
.	O
The	O
present	O
results	O
thus	O
show	O
that	O
p70(s6k)	protein
is	O
able	O
to	O
regulate	O
E2F	protein
transcriptional	O
activity	O
and	O
provide	O
direct	O
evidence	O
for	O
the	O
first	O
time	O
for	O
a	O
link	O
between	O
IL-2	protein
receptors,	O
PI	protein
3-kinase	protein
,	O
and	O
p70(s6k)	protein
that	O
regulates	O
a	O
crucial	O
G1	O
checkpoint	O
in	O
T	cell_type
lymphocytes	cell_type
.	O

Oxidative	O
stress	O
triggers	O
STAT3	protein
tyrosine	O
phosphorylation	O
and	O
nuclear	O
translocation	O
in	O
human	cell_type
lymphocytes	cell_type
.	O
Oxidizing	O
agents	O
are	O
powerful	O
activators	O
of	O
factors	O
responsible	O
for	O
the	O
transcriptional	O
activation	O
of	O
cytokine-encoding	DNA
genes	DNA
involved	O
in	O
tissue	O
injury	O
.	O
In	O
this	O
study	O
we	O
show	O
evidence	O
that	O
STAT3	protein
is	O
a	O
transcription	protein
factor	protein
whose	O
activity	O
is	O
modulated	O
by	O
H2O2	O
in	O
human	cell_type
lymphocytes	cell_type
,	O
in	O
which	O
endogenous	O
catalase	protein
had	O
previously	O
been	O
inhibited.	O
H2O2	O
-induced	O
nuclear	O
translocation	O
of	O
STAT3	protein
to	O
form	O
sequence-specific	protein
DNA-bound	protein
complexes	protein
was	O
evidenced	O
by	O
immunoblotting	O
of	O
nuclear	O
fractions	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
and	O
vanadate	O
was	O
found	O
to	O
strongly	O
synergize	O
with	O
H2O2	O
.	O
Moreover,	O
anti-	O
STAT3	protein
antibodies	protein
specifically	O
precipitated	O
a	O
protein	O
of	O
92	protein
kDa	protein
that	O
becomes	O
phosphorylated	O
on	O
tyrosine	O
upon	O
lymphocyte	O
treatment	O
with	O
H2O2	O
.	O
Phenylarsine	O
oxide	O
,	O
a	O
tyrosine	O
phosphatase	O
inhibitor	O
,	O
and	O
genistein	O
,	O
a	O
tyrosine	O
kinase	O
inhibitor	O
,	O
cooperated	O
and	O
cancelled,	O
respectively,	O
the	O
H2O2	O
-promoted	O
STAT3	protein
nuclear	O
translocation	O
.	O
Evidence	O
is	O
also	O
presented,	O
using	O
Fe2+	O
/Cu2+	O
ions	O
,	O
that.	O
OH	O
generated	O
from	O
H2O2	O
through	O
Fenton	O
reactions	O
could	O
be	O
a	O
candidate	O
oxygen	O
reactive	O
species	O
to	O
directly	O
activate	O
STAT3	protein
.	O
Present	O
data	O
suggest	O
that	O
H2O2	O
and	O
vanadate	O
are	O
likely	O
to	O
inhibit	O
the	O
activity	O
of	O
intracellular	protein
tyrosine	protein
phosphatase	protein
(s),	O
leading	O
to	O
enhanced	O
STAT3	protein
tyrosine	O
phosphorylation	O
and	O
hence	O
its	O
translocation	O
to	O
the	O
nucleus.	O
These	O
results	O
demonstrate	O
that	O
the	O
DNA	O
binding	O
activity	O
of	O
STAT3	protein
can	O
be	O
modulated	O
by	O
oxidizing	O
agents	O
and	O
provide	O
a	O
framework	O
to	O
understand	O
the	O
effects	O
of	O
oxidative	O
stress	O
on	O
the	O
JAK	protein
-STAT	protein
signaling	O
pathway	O
.	O

Transcriptional	O
regulation	O
of	O
T	O
lymphocyte	O
development	O
and	O
function.	O
The	O
development	O
and	O
function	O
of	O
T	cell_type
lymphocytes	cell_type
are	O
regulated	O
tightly	O
by	O
signal	O
transduction	O
pathways	O
that	O
include	O
specific	O
cell-surface	protein
receptors	protein
,	O
intracellular	protein
signaling	protein
molecules	protein
,	O
and	O
nuclear	protein
transcription	protein
factors	protein
.	O
Since	O
1988,	O
several	O
families	O
of	O
functionally	O
important	O
T	protein
cell	protein
transcription	protein
factors	protein
have	O
been	O
identified.	O
These	O
include	O
the	O
Ikaros	protein
,	O
LKLF	protein
,	O
and	O
GATA3	protein
zinc-finger	protein
proteins	protein
;	O
the	O
Ets	protein
,	O
CREB/ATF	protein
,	O
and	O
NF-kappa	protein
B/Rel/NFAT	protein
transcription	protein
factors	protein
;	O
the	O
Stat	protein
proteins	protein
;	O
and	O
HMG	protein
box	protein
transcription	protein
factors	protein
such	O
as	O
LEF1	protein
,	O
TCF1	protein
,	O
and	O
Sox4	protein
.	O
In	O
this	O
review,	O
we	O
summarize	O
our	O
current	O
understanding	O
of	O
the	O
transcriptional	O
regulation	O
of	O
T	O
cell	O
development	O
and	O
function	O
with	O
particular	O
emphasis	O
on	O
the	O
results	O
of	O
recent	O
gene	O
targeting	O
and	O
transgenic	O
experiments	O
.	O
In	O
addition	O
to	O
increasing	O
our	O
understanding	O
of	O
the	O
molecular	O
pathways	O
that	O
regulate	O
T	O
cell	O
development	O
and	O
function	O
,	O
these	O
results	O
have	O
suggested	O
novel	O
targets	O
for	O
genetic	O
and	O
pharmacological	O
manipulation	O
of	O
T	O
cell	O
immunity	O
.	O

In	O
vivo	O
inhibition	O
of	O
NF-kappa	protein
B	protein
in	O
T-lineage	cell_type
cells	cell_type
leads	O
to	O
a	O
dramatic	O
decrease	O
in	O
cell	O
proliferation	O
and	O
cytokine	protein
production	O
and	O
to	O
increased	O
cell	O
apoptosis	O
in	O
response	O
to	O
mitogenic	O
stimuli	O
,	O
but	O
not	O
to	O
abnormal	O
thymopoiesis	O
.	O
To	O
understand	O
the	O
role	O
of	O
NF-kappa	protein
B	protein
complexes	O
in	O
T	O
cell	O
development	O
and	O
activation	O
,	O
we	O
have	O
generated	O
transgenic	O
mice	O
in	O
which	O
RelA	protein
and	O
c-Rel	protein
complexes	protein
were	O
selectively	O
inhibited	O
in	O
the	O
T-lineage	cell_type
cells	cell_type
by	O
specific	O
expression	O
of	O
a	O
trans-dominant	O
form	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
Transgene	O
expression	O
did	O
not	O
affect	O
the	O
thymic	O
development	O
,	O
but	O
led	O
to	O
lowered	O
numbers	O
of	O
splenic	O
T	cell_type
cells	cell_type
and	O
to	O
a	O
dramatic	O
decrease	O
in	O
the	O
ex	O
vivo	O
proliferative	O
response	O
of	O
splenic	cell_type
T	cell_type
lymphocytes	cell_type
.	O
Analysis	O
of	O
IL-2	protein
and	O
IL-2R	protein
alpha	protein
expression	O
demonstrated	O
that	O
the	O
perturbation	O
of	O
the	O
proliferation	O
response	O
was	O
not	O
attributable	O
to	O
an	O
abnormal	O
expression	O
of	O
these	O
genes.	O
In	O
contrast,	O
expression	O
of	O
IL-4	protein
,	O
IL-10	protein
,	O
and	O
IFN-gamma	protein
was	O
strongly	O
inhibited	O
in	O
the	O
transgenic	cell_type
T	cell_type
cells	cell_type
.	O
The	O
proliferative	O
deficiency	O
of	O
the	O
transgenic	cell_type
T	cell_type
cells	cell_type
was	O
associated	O
with	O
an	O
increased	O
apoptosis	O
.	O
These	O
results	O
point	O
out	O
the	O
involvement	O
of	O
NF-kappa	protein
B	protein
/Rel	protein
family	protein
proteins	protein
in	O
growth	O
signaling	O
pathways	O
by	O
either	O
regulating	protein
proteins	protein
involved	O
in	O
the	O
IL-2	protein
signaling	O
or	O
by	O
functionally	O
interfering	O
with	O
the	O
cell	O
cycle	O
progression	O
.	O

Paradoxical	O
priming	O
effects	O
of	O
IL-10	protein
on	O
cytokine	protein
production	O
.	O
IL-10	protein
is	O
a	O
well-known	O
immunosuppressive	O
and/or	O
anti-inflammatory	O
cytokine	O
.	O
However,	O
we	O
report	O
in	O
vitro	O
experimental	O
studies	O
in	O
which	O
IL-10	cell_line
primed	cell_line
leukocytes	cell_line
and	O
led	O
to	O
an	O
enhanced	O
production	O
of	O
tumor	protein
necrosis	protein
factor	protein
(	O
TNF	protein
)	O
upon	O
further	O
stimulation	O
by	O
lipopolysaccharide	O
(	O
LPS	O
).	O
Monocytes	cell_type
and	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
)	O
prepared	O
from	O
whole	O
blood	O
maintained	O
for	O
20	O
h	O
at	O
37	O
degrees	O
C	O
in	O
the	O
presence	O
of	O
recombinant	protein
human	protein
IL-10	protein
had	O
an	O
enhanced	O
capacity	O
to	O
produce	O
TNF	protein
in	O
response	O
to	O
LPS	O
.	O
In	O
addition	O
to	O
TNF	protein
,	O
LPS-induced	O
IL-6	O
and	O
spontaneous	O
IL-1ra	O
production	O
were	O
also	O
enhanced.	O
When	O
isolated	O
PBMC	cell_type
were	O
first	O
cultured	O
for	O
20	O
h	O
in	O
the	O
presence	O
of	O
IL-10	protein
on	O
Teflon	O
to	O
prevent	O
adherence,	O
washed	O
to	O
remove	O
IL-10	protein
and	O
then	O
further	O
cultured	O
in	O
plastic	O
dishes	O
for	O
an	O
additional	O
20	O
h	O
in	O
the	O
presence	O
of	O
LPS	O
or	O
IL-1beta	protein
,	O
an	O
enhanced	O
release	O
of	O
TNF	protein
was	O
observed.	O
This	O
was	O
not	O
the	O
case	O
when	O
PBMC	cell_type
were	O
pre-cultured	O
in	O
plastic	O
multidishes	O
in	O
the	O
presence	O
of	O
IL-10	protein
.	O
TNF	RNA
mRNA	RNA
expression	O
induced	O
by	O
LPS	O
was	O
decreased	O
when	O
the	O
pre-treatment	O
of	O
PBMC	cell_type
with	O
IL-10	protein
was	O
performed	O
on	O
plastic,	O
whereas	O
this	O
was	O
not	O
the	O
case	O
when	O
cells	O
were	O
pre-cultured	O
with	O
IL-10	protein
on	O
Teflon	O
.	O
Furthermore,	O
NFkappaB	O
translocation	O
following	O
LPS	O
activation	O
was	O
higher	O
after	O
IL-10	protein
pre-treatment	O
on	O
Teflon	O
than	O
on	O
plastic.	O
Interestingly,	O
an	O
enhanced	O
frequency	O
of	O
CD16	protein
and	O
CD68(+)	O
cells	O
among	O
the	O
CD14(+)	O
cells	O
was	O
observed	O
in	O
the	O
presence	O
of	O
IL-10	protein
,	O
independently	O
of	O
the	O
pre-culture	O
conditions	O
of	O
the	O
PBMC	cell_type
.	O
Altogether,	O
these	O
results	O
indicate	O
that	O
the	O
IL-10	protein
-induced	O
up-regulation	O
of	O
cytokine	protein
production	O
depends	O
on	O
the	O
prevention	O
of	O
monocyte	O
adherence	O
by	O
red	cell_type
cells	cell_type
in	O
the	O
whole	O
blood	O
assays	O
or	O
by	O
cultures	O
of	O
PBMC	cell_type
on	O
Teflon	O
.	O
In	O
contrast,	O
the	O
adherence	O
parameter	O
has	O
no	O
effect	O
on	O
the	O
IL-10	protein
-induced	O
modulation	O
of	O
some	O
monocyte	protein
surface	protein
markers	protein
.	O

Cell	O
growth-regulated	O
expression	O
of	O
mammalian	O
MCM5	O
and	O
MCM6	O
genes	O
mediated	O
by	O
the	O
transcription	protein
factor	protein
E2F	protein
.	O
Initiation	O
of	O
DNA	O
replication	O
requires	O
the	O
function	O
of	O
MCM	protein
gene	protein
products	protein
,	O
which	O
participate	O
in	O
ensuring	O
that	O
DNA	O
replication	O
occurs	O
only	O
once	O
in	O
the	O
cell	O
cycle	O
.	O
Expression	O
of	O
all	O
mammalian	DNA
genes	DNA
of	O
the	O
MCM	DNA
family	DNA
is	O
induced	O
by	O
growth	O
stimulation	O
,	O
unlike	O
yeast	O
,	O
and	O
the	O
mRNA	O
levels	O
peak	O
at	O
G1/S	O
boundary	O
.	O
In	O
this	O
study,	O
we	O
examined	O
the	O
transcriptional	O
activities	O
of	O
isolated	DNA
human	DNA
MCM	DNA
gene	DNA
promoters	DNA
.	O
Human	O
MCM5	O
and	O
MCM6	O
promoters	O
with	O
mutation	O
in	O
the	O
E2F	DNA
sites	DNA
failed	O
in	O
promoter	O
regulation	O
following	O
serum	O
stimulation	O
and	O
exogenous	O
E2F	protein
expression	O
.	O
In	O
addition,	O
we	O
identified	O
a	O
novel	O
E2F	DNA
-like	DNA
sequence	DNA
in	O
human	DNA
MCM6	DNA
promoter	DNA
which	O
cooperates	O
with	O
the	O
authentic	O
E2F	DNA
sites	DNA
in	O
E2F	protein
-dependent	O
regulation	O
.	O
Forced	O
expression	O
of	O
E2F1	protein
could	O
induce	O
expression	O
of	O
all	O
members	O
of	O
the	O
endogenous	DNA
MCM	DNA
genes	DNA
in	O
rat	cell_line
embryonal	cell_line
fibroblast	cell_line
REF52	cell_line
cells	cell_line
.	O
Our	O
results	O
demonstrated	O
that	O
the	O
growth-regulated	O
expression	O
of	O
mammalian	O
MCM5	O
and	O
MCM6	O
genes	O
,	O
and	O
presumably	O
other	O
MCM	O
members,	O
is	O
primarily	O
regulated	O
by	O
E2F	protein
through	O
binding	O
to	O
multiple	DNA
E2F	DNA
sites	DNA
in	O
the	O
promoters	DNA
.	O

An	O
essential	O
role	O
for	O
NF-kappaB	protein
in	O
human	cell_type
CD34(+)	cell_type
bone	cell_type
marrow	cell_type
cell	cell_type
survival	O
.	O
The	O
transcription	protein
factor	protein
,	O
NF-kappaB	protein
,	O
is	O
important	O
for	O
T-cell	O
activation	O
,	O
B-cell	O
maturation	O
,	O
and	O
human	O
immunodeficiency	O
virus	O
transcription	O
and	O
plays	O
a	O
role	O
in	O
alternatively	O
mediating	O
and	O
protecting	O
against	O
apoptosis	O
in	O
a	O
variety	O
of	O
cell	O
types.	O
However,	O
a	O
role	O
for	O
NF-kappaB	protein
in	O
human	cell_type
CD34(+)	cell_type
bone	cell_type
marrow	cell_type
cells	cell_type
has	O
not	O
been	O
described.	O
We	O
provide	O
evidence	O
here	O
that	O
virtually	O
all	O
human	cell_type
CD34(+)	cell_type
bone	cell_type
marrow	cell_type
cells	cell_type
express	O
NF-kappaB	protein
that	O
can	O
be	O
activated	O
by	O
exposure	O
to	O
phorbol	O
12-myristate	O
13-acetate	O
and	O
a	O
variety	O
of	O
cytokines	protein
,	O
eg,	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
,	O
interleukin-3	protein
,	O
and	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
.	O
In	O
addition,	O
we	O
demonstrate	O
that	O
NF-kappaB	protein
may	O
be	O
required	O
for	O
human	O
CD34(+)	cell_type
bone	cell_type
marrow	cell_type
cell	cell_type
clonogenic	O
function	O
and	O
survival.	O
These	O
results	O
offer	O
insight	O
into	O
a	O
new	O
role	O
for	O
NF-kappaB	protein
in	O
maintaining	O
survival	O
and	O
function	O
in	O
hematopoietic	O
stem	O
and	O
progenitor	O
cells	O
and	O
suggest	O
that	O
proposed	O
strategies	O
involving	O
inhibition	O
of	O
NF-kappaB	protein
activation	O
as	O
an	O
adjunct	O
to	O
cancer	O
chemotherapy	O
should	O
be	O
approached	O
with	O
caution.	O

High	O
molecular	O
weight	O
dextran	O
sulfate	O
increases	O
the	O
activity	O
of	O
NF-kappaB	DNA
-regulated	DNA
promoter	DNA
in	O
monocyte-derived	cell_type
macrophages	cell_type
.	O
It	O
is	O
known	O
that	O
sulfated	O
polysaccharides	O
can	O
mimic	O
the	O
action	O
of	O
common	protein
T-cell	protein
mitogens	protein
.	O
To	O
investigate	O
the	O
molecular	O
basis	O
of	O
the	O
mitogenic	O
effect	O
of	O
high	O
molecular	O
weight	O
dextran	O
sulfate	O
(	O
HMDS	O
),	O
monocyte-derived	cell_type
macrophages	cell_type
were	O
transfected	O
with	O
recombinant	DNA
plasmid	DNA
containing	O
chloramphenicol	DNA
acetyl	DNA
transferase	DNA
(CAT)	DNA
reporter	DNA
gene	DNA
under	O
the	O
control	O
of	O
the	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
(LTR)	DNA
promoter	DNA
,	O
which	O
is	O
regulated	O
by	O
transcription	protein
factor	protein
NF-kappaB	protein
.	O
We	O
observed	O
that	O
HMDS	O
,	O
similar	O
to	O
bacterial	O
lipopolysaccharide	O
(	O
LPS	O
),	O
increases	O
the	O
expression	O
of	O
CAT	DNA
reporter	DNA
gene	DNA
suggesting	O
increased	O
activity	O
of	O
NF-kappaB	protein
.	O
The	O
activation	O
of	O
NF-kappaB	protein
correlated	O
with	O
the	O
increased	O
expression	O
of	O
B7.1	protein
molecules	protein
.	O
It	O
was	O
postulated	O
that	O
this	O
NF-kappaB	DNA
-regulated	DNA
promoter	DNA
might	O
play	O
a	O
role	O
in	O
the	O
activation	O
of	O
the	O
accessory	O
cells	O
as	O
well	O
as	O
the	O
rate	O
of	O
replication	O
of	O
HIV-1	O
in	O
monocyte-derived	cell_type
macrophages	cell_type
.	O

Transcription	protein
factors	protein
Sp1	protein
and	O
AP-2	protein
mediate	O
induction	O
of	O
acid	protein
sphingomyelinase	protein
during	O
monocytic	O
differentiation	O
.	O
Cells	O
from	O
the	O
human	cell_line
monocytic	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
THP-1	cell_line
differentiate	O
towards	O
a	O
macrophage-like	O
phenotype	O
when	O
stimulated	O
with	O
phorbol	O
12-myristate	O
-13-	O
acetate	O
(	O
PMA	O
),	O
1,25-dihydroxy-vitamin	O
D3	O
,	O
and	O
various	O
other	O
agents.	O
We	O
demonstrate	O
here	O
that	O
the	O
expression	O
of	O
the	O
lysosomal	protein
enzyme	protein
acid	protein
sphingomyelinase	protein
(ASM;	O
E.C.3.1.4.12)	O
is	O
induced	O
during	O
this	O
process	O
and	O
is	O
strongly	O
elevated	O
in	O
differentiated	O
THP-1	cell_line
cells	cell_line
,	O
as	O
well	O
as	O
in	O
differentiated	O
human	cell_type
mononuclear	cell_type
phagocytes	cell_type
.	O
Using	O
Northern	O
blotting	O
,	O
RNase	protein
protection	O
assay	O
,	O
and	O
nuclear	O
run-on	O
analyses	O
,	O
we	O
show	O
that	O
the	O
up-regulation	O
of	O
ASM	O
expression	O
is	O
regulated	O
mainly	O
at	O
the	O
level	O
of	O
transcription	O
and	O
that	O
new	O
protein	O
synthesis	O
is	O
required	O
for	O
enhanced	O
ASM	O
activity	O
.	O
This	O
cell-type	O
specific	O
induction	O
by	O
PMA	O
treatment	O
was	O
further	O
investigated	O
with	O
respect	O
to	O
transcriptional	O
control	O
.	O
A	O
series	O
of	O
5'	DNA
deletion	DNA
derivatives	DNA
of	O
the	O
upstream	DNA
regulatory	DNA
region	DNA
were	O
used	O
in	O
transient	O
transfection	O
assays	O
to	O
identify	O
promoter	DNA
elements	DNA
required	O
for	O
basal	O
and	O
inducible	O
gene	O
expression	O
.	O
A	O
PMA	DNA
responsive	DNA
element	DNA
was	O
localized	O
to	O
a	O
region	O
between	O
-319	DNA
and	DNA
-219	DNA
bp	DNA
upstream	DNA
of	O
the	O
initiation	O
codon	O
and	O
co-transfections	O
with	O
transcription	DNA
factor	DNA
expression	DNA
plasmids	DNA
for	O
AP-2	protein
and	O
Sp1	protein
resulted	O
in	O
augmented	O
ASM	O
promoter	O
activity	O
,	O
which	O
was	O
abolished	O
when	O
the	O
binding	DNA
sites	DNA
for	O
these	O
two	O
factors	O
were	O
deleted.	O
Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
and	O
supershift	O
assays	O
we	O
demonstrate	O
that	O
this	O
region	O
is	O
specifically	O
bound	O
by	O
Sp1	protein
and	O
AP-2	protein
.	O
These	O
factors	O
are	O
present	O
in	O
nuclear	O
extracts	O
prepared	O
from	O
both	O
induced	O
and	O
uninduced	O
THP-1	cell_line
cells	cell_line
.	O
However,	O
the	O
intensity	O
of	O
the	O
complex	O
formed	O
appeared	O
to	O
increase	O
when	O
nuclear	O
extracts	O
from	O
PMA	cell_line
-treated	cell_line
cells	cell_line
were	O
used.	O
From	O
these	O
studies,	O
we	O
conclude	O
that	O
a	O
concerted	O
action	O
of	O
the	O
transcription	protein
factors	protein
AP-2	protein
and	O
Sp1	protein
is	O
essential	O
for	O
the	O
up	O
-regulation	O
of	O
ASM	O
expression	O
during	O
the	O
process	O
of	O
macrophage	O
differentiation	O
.	O

LPS	O
-Induced	O
NF-kappaB	protein
activation	O
and	O
TNF-alpha	protein
release	O
in	O
human	cell_type
monocytes	cell_type
are	O
protein	protein
tyrosine	protein
kinase	protein
dependent	O
and	O
protein	protein
kinase	protein
C	protein
independent	O
.	O
BACKGROUND:	O
Tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF-alpha	protein
)	O
is	O
an	O
important	O
mediator	O
of	O
septic	O
shock	O
.	O
Endotoxin	O
(	O
LPS	O
)	O
signal	O
transduction	O
in	O
human	cell_type
monocytes	cell_type
leads	O
to	O
activation	O
of	O
nuclear	protein
factor-kappa	protein
B	protein
(	O
NF-kappaB	protein
)	O
and	O
TNF-alpha	protein
release	O
.	O
Previous	O
studies	O
have	O
implicated	O
activation	O
of	O
both	O
protein	protein
kinase	protein
C	protein
(	O
PKC	protein
)	O
and	O
protein	protein
tyrosine	protein
kinases	protein
(	O
PTK	protein
)	O
in	O
LPS	O
-induced	O
NF-kappaB	protein
activation	O
and	O
TNF-alpha	protein
production	O
.	O
We	O
hypothesized	O
that	O
inhibition	O
of	O
either	O
PKC	protein
or	O
PTK	protein
would	O
decrease	O
LPS	O
-induced	O
NF-kappaB	protein
DNA	O
binding	O
and	O
TNF-alpha	protein
release	O
in	O
human	cell_type
monocytes	cell_type
.	O
MATERIALS	O
AND	O
METHODS:	O
Human	cell_type
monocytes	cell_type
were	O
stimulated	O
with	O
PMA	O
(50	O
ng/ml)	O
alone	O
or	O
LPS	O
(100	O
ng/ml)	O
with	O
and	O
without	O
a	O
nonspecific	O
serine	protein
/threonine	protein
protein	protein
kinase	protein
inhibitor	O
staurosporine	O
(Stauro),	O
a	O
specific	O
pan-	O
PKC	protein
inhibitor	O
bisindolylmaleimide	O
(	O
Bis	O
),	O
or	O
an	O
inhibitor	O
of	O
PTK	protein
genistein	O
(	O
Gen	O
).	O
TNF-alpha	protein
release	O
in	O
culture	O
supernatants	O
was	O
measured	O
by	O
an	O
ELISA	O
.	O
NF-kappaB	protein
DNA	O
binding	O
was	O
evaluated	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O
RESULTS:	O
LPS	O
increased	O
NF-kappaB	protein
DNA	O
binding	O
and	O
TNF-alpha	protein
release	O
in	O
human	cell_type
monocytes	cell_type
.	O
Nonspecific	O
protein	protein
kinase	protein
inhibition	O
inhibited	O
NF-kappaB	protein
activation	O
and	O
TNF-alpha	protein
release	O
,	O
while	O
specific	O
PKC	protein
inhibition	O
with	O
Bis	O
had	O
no	O
effect	O
on	O
LPS	O
-induced	O
NF-kappaB	protein
DNA	O
binding	O
or	O
TNF-alpha	protein
release	O
.	O
PTK	protein
inhibition	O
with	O
Gen	O
attenuated	O
both	O
LPS	O
-induced	O
NF-kappaB	protein
DNA	O
binding	O
and	O
TNF-alpha	protein
production	O
in	O
human	cell_type
monocytes	cell_type
.	O
Direct	O
activation	O
of	O
PKC	protein
with	O
PMA	O
induced	O
both	O
NF-kappaB	protein
activation	O
and	O
TNF-alpha	protein
production	O
by	O
human	cell_type
monocytes	cell_type
.	O
CONCLUSIONS:	O
These	O
results	O
suggest	O
that	O
LPS	O
-induced	O
NF-kappaB	protein
activation	O
and	O
TNF-alpha	protein
release	O
in	O
human	cell_type
monocytes	cell_type
are	O
independent	O
of	O
PKC	protein
activity	O
.	O
Furthermore,	O
our	O
results	O
provide	O
evidence	O
that	O
PTK	protein
plays	O
a	O
role	O
in	O
LPS	O
-induced	O
NF-kappaB	protein
activation	O
and	O
TNF-alpha	protein
release	O
in	O
human	cell_type
monocytes	cell_type
and	O
thus	O
could	O
be	O
a	O
potential	O
therapeutic	O
target	O
in	O
inflammatory	O
states	O
.	O
Copyright	O
1999	O
Academic	O
Press.	O

Amelioration	O
of	O
rat	O
cerulein	O
pancreatitis	O
by	O
guamerin-derived	O
peptide	O
,	O
a	O
novel	O
elastase	protein
inhibitor	O
.	O
Increased	O
activity	O
of	O
various	O
proteases	protein
is	O
observed	O
in	O
both	O
human	O
and	O
experimental	O
pancreatitis	O
;	O
however,	O
the	O
information	O
on	O
the	O
effects	O
of	O
specific	O
protease	O
inhibitors	O
on	O
the	O
disease	O
is	O
limited.	O
In	O
this	O
study	O
we	O
show	O
that	O
a	O
novel	O
elastase	O
inhibitor	O
,	O
guamerin-derived	O
synthetic	O
peptide	O
(	O
GDSP	O
),	O
improves	O
the	O
parameters	O
of	O
cerulein-induced	O
acute	O
pancreatitis	O
in	O
the	O
rat	O
.	O
The	O
effects	O
of	O
GDSP	O
on	O
pancreatic	O
weight	O
,	O
serum	O
amylase	O
and	O
lipase	O
,	O
morphologic	O
changes	O
in	O
the	O
pancreas	O
,	O
neutrophil	O
infiltration	O
,	O
and	O
nuclear	protein
factor	protein
KB	protein
(	O
NF-KB	protein
)	O
activation	O
were	O
measured	O
in	O
rats	O
infused	O
with	O
supramaximal	O
dose	O
of	O
cerulein	O
(5	O
(g/kg/h)	O
for	O
6	O
h.	O
The	O
effects	O
of	O
GDSP	O
were	O
also	O
measured	O
on	O
superoxide	O
formation	O
by	O
activated	cell_type
human	cell_type
neutrophils	cell_type
.	O
The	O
effects	O
of	O
GDSP	O
were	O
compared	O
with	O
those	O
of	O
another	O
elastase	O
inhibitor	O
,	O
elastatinal	O
.	O
GDSP	O
significantly	O
inhibited	O
edema	O
formation	O
,	O
neutrophil	O
infiltration	O
,	O
acinar	O
cell	O
damage	O
,	O
and	O
plasma	protein
lipase	protein
and	O
amylase	protein
increases	O
caused	O
by	O
cerulein	O
.	O
GDSP	O
also	O
completely	O
inhibited	O
superoxide	O
formation	O
in	O
the	O
human	cell_type
neutrophils	cell_type
stimulated	O
by	O
N-formyl-methionine-leucine-phenyl-alanine	O
(	O
fMLP	O
)	O
or	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
).	O
Elastatinal	O
had	O
some	O
of	O
the	O
same	O
effects	O
as	O
GDSP	O
but	O
was	O
less	O
potent	O
and	O
effective.	O
These	O
results	O
demonstrate	O
a	O
beneficial	O
effect	O
of	O
GDSP	O
,	O
a	O
novel	O
specific	O
elastase	O
inhibitor	O
,	O
on	O
the	O
development	O
of	O
rat	O
cerulein	O
pancreatitis	O
.	O

A	O
novel	O
lipopolysaccharide-induced	protein
transcription	protein
factor	protein
regulating	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
gene	O
expression	O
:	O
molecular	O
cloning	O
,	O
sequencing	O
,	O
characterization	O
,	O
and	O
chromosomal	O
assignment	O
.	O
Lipopolysaccharide	O
(	O
LPS	O
)	O
is	O
a	O
potent	O
stimulator	O
of	O
monocytes	cell_type
and	O
macrophages	cell_type
,	O
causing	O
secretion	O
of	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF-alpha	protein
)	O
and	O
other	O
inflammatory	O
mediators	O
.	O
Given	O
the	O
deleterious	O
effects	O
to	O
the	O
host	O
of	O
TNF-alpha	protein
,	O
it	O
has	O
been	O
postulated	O
that	O
TNF-alpha	protein
gene	O
expression	O
must	O
be	O
tightly	O
regulated.	O
The	O
nature	O
of	O
the	O
nuclear	protein
factor	protein
(s)	O
that	O
control	O
TNF-alpha	protein
gene	O
transcription	O
in	O
humans	O
remains	O
obscure,	O
although	O
NF-kappaB	protein
has	O
been	O
suggested.	O
Our	O
previous	O
studies	O
pertaining	O
to	O
macrophage	O
response	O
to	O
LPS	O
identified	O
a	O
novel	O
DNA-binding	protein
domain	protein
located	O
from	O
-550	O
to	O
-487	O
in	O
the	O
human	DNA
TNF-alpha	DNA
promoter	DNA
that	O
contains	O
transcriptional	O
activity	O
,	O
but	O
lacks	O
any	O
known	O
NF-kappaB	protein
-binding	DNA
sites	DNA
.	O
We	O
have	O
used	O
this	O
DNA	O
fragment	O
to	O
isolate	O
and	O
purify	O
a	O
60-kDa	protein
protein	protein
binding	O
to	O
this	O
fragment	O
and	O
obtained	O
its	O
amino-terminal	protein
sequence	protein
,	O
which	O
was	O
used	O
to	O
design	O
degenerate	DNA
probes	DNA
to	O
screen	O
a	O
cDNA	O
library	O
from	O
THP-1	cell_line
cells	cell_line
.	O
A	O
novel	O
cDNA	DNA
clone	DNA
(1.8	O
kb)	O
was	O
isolated	O
and	O
fully	O
sequenced.	O
Characterization	O
of	O
this	O
cDNA	DNA
clone	DNA
revealed	O
that	O
its	O
induction	O
was	O
dependent	O
on	O
LPS	O
activation	O
of	O
THP-1	cell_line
cells	cell_line
;	O
hence,	O
the	O
name	O
LPS	protein
-induced	protein
TNF-alpha	protein
factor	protein
(	O
LITAF	protein
).	O
Inhibition	O
of	O
LITAF	RNA
mRNA	RNA
expression	O
in	O
THP-1	cell_line
cells	cell_line
resulted	O
in	O
a	O
reduction	O
of	O
TNF-alpha	protein
transcripts.	O
In	O
addition,	O
high	O
level	O
of	O
expression	O
of	O
LITAF	RNA
mRNA	RNA
was	O
observed	O
predominantly	O
in	O
the	O
placenta	O
,	O
peripheral	cell_type
blood	cell_type
leukocytes	cell_type
,	O
lymph	O
nodes	O
,	O
and	O
the	O
spleen	O
.	O
Finally,	O
chromosomal	O
localization	O
using	O
fluorescence	O
in	O
situ	O
hybridization	O
revealed	O
that	O
LITAF	protein
mapped	O
to	O
chromosome	DNA
16p12-16p13.3	DNA
.	O
Together,	O
these	O
findings	O
suggest	O
that	O
LITAF	protein
plays	O
an	O
important	O
role	O
in	O
the	O
activation	O
of	O
the	O
human	DNA
TNF-alpha	DNA
gene	DNA
and	O
proposes	O
a	O
new	O
mechanism	O
to	O
control	O
TNF-alpha	protein
gene	O
expression	O
.	O

A	O
human	DNA
IFNGR1	DNA
small	DNA
deletion	DNA
hotspot	DNA
associated	O
with	O
dominant	O
susceptibility	O
to	O
mycobacterial	O
infection	O
[see	O
comments]	O
The	O
immunogenetic	O
basis	O
of	O
severe	O
infections	O
caused	O
by	O
bacille	O
Calmette-Guerin	O
vaccine	O
and	O
environmental	O
mycobacteria	O
in	O
humans	O
remains	O
largely	O
unknown.	O
We	O
describe	O
18	O
patients	O
from	O
several	O
generations	O
of	O
12	O
unrelated	O
families	O
who	O
were	O
heterozygous	O
for	O
1	O
to	O
5	O
overlapping	DNA
IFNGR1	DNA
frameshift	DNA
small	DNA
deletions	DNA
and	O
a	O
wild-type	DNA
IFNGR1	DNA
allele	DNA
.	O
There	O
were	O
12	O
independent	O
mutation	O
events	O
at	O
a	O
single	DNA
mutation	DNA
site	DNA
,	O
defining	O
a	O
small	DNA
deletion	DNA
hotspot	DNA
.	O
Neighbouring	O
sequence	O
analysis	O
favours	O
a	O
small	O
deletion	O
model	O
of	O
slipped	O
mispairing	O
events	O
during	O
replication	O
.	O
The	O
mutant	O
alleles	O
encode	O
cell-surface	protein
IFNgamma	protein
receptors	protein
that	O
lack	O
the	O
intra-cytoplasmic	protein
domain	protein
,	O
which,	O
through	O
a	O
combination	O
of	O
impaired	O
recycling	O
,	O
abrogated	O
signalling	O
and	O
normal	O
binding	O
to	O
IFNgamma	protein
exert	O
a	O
dominant-negative	O
effect	O
.	O
We	O
thus	O
report	O
a	O
hotspot	O
for	O
human	DNA
IFNGR1	DNA
small	DNA
deletions	DNA
that	O
confer	O
dominant	O
susceptibility	O
to	O
infections	O
caused	O
by	O
poorly	O
virulent	O
mycobacteria	O
.	O

Characterization	O
of	O
expression	O
of	O
the	O
gene	O
for	O
human	protein
pterin	protein
carbinolamine	protein
dehydratase/dimerization	protein
cofactor	protein
of	O
HNF1	protein
.	O
Pterin	protein
carbinolamine	protein
dehydratase/dimerization	protein
cofactor	protein
of	O
HNF1	protein
(	O
PCD/DCoH	protein
)	O
is	O
a	O
dual-function	protein
protein	protein
.	O
In	O
the	O
cytoplasm	O
it	O
acts	O
as	O
a	O
dehydratase	protein
in	O
the	O
regeneration	O
of	O
tetrahydrobiopterin	protein
,	O
the	O
cofactor	O
for	O
aromatic	protein
amino	protein
acid	protein
hydroxylases	protein
.	O
In	O
the	O
nucleus,	O
it	O
functions	O
as	O
a	O
dimerization	protein
cofactor	protein
of	O
HNF1	protein
and	O
increases	O
the	O
transcriptional	O
activity	O
of	O
HNF1	protein
.	O
To	O
deepen	O
our	O
understanding	O
of	O
this	O
protein,	O
we	O
characterized	O
its	O
expression	O
in	O
human	O
tissues	O
and	O
cells.	O
Human	O
PCD/DCoH	protein
was	O
present	O
predominantly	O
in	O
liver	O
and	O
kidney	O
,	O
with	O
significant	O
amounts	O
in	O
testis	O
and	O
ovary	O
,	O
trace	O
amounts	O
in	O
lung	O
,	O
and	O
undetectable	O
levels	O
in	O
whole	O
brain	O
,	O
heart	O
,	O
and	O
spleen	O
.	O
It	O
was	O
expressed	O
in	O
all	O
of	O
the	O
cells	O
that	O
were	O
examined.	O
Importantly,	O
it	O
was	O
also	O
present	O
in	O
the	O
nucleus	O
of	O
HeLa	cell_line
cells	cell_line
,	O
which	O
lack	O
HNF1	protein
,	O
and	O
in	O
the	O
cytoplasm	O
of	O
fibroblasts	cell_type
that	O
have	O
little	O
or	O
no	O
tetrahydrobiopterin	protein
.	O
The	O
expression	O
of	O
human	protein
PCD/DCoH	protein
in	O
the	O
liver	O
and	O
nonhepatic	cell_type
cells	cell_type
was	O
compared	O
at	O
both	O
the	O
mRNA	O
and	O
protein	O
levels	O
.	O
Although	O
the	O
mRNA	O
level	O
in	O
liver	O
was	O
only	O
fourfold	O
higher	O
than	O
that	O
in	O
keratinocytes	cell_type
and	O
fibroblasts	cell_type
,	O
the	O
hepatic	protein
PCD/DCoH	protein
protein	protein
level	O
was	O
20-fold	O
higher	O
than	O
that	O
in	O
normal	cell_type
human	cell_type
epidermal	cell_type
keratinocytes	cell_type
and	O
dermal	cell_type
fibroblasts	cell_type
.	O
Cloning	O
of	O
the	O
5'	DNA
and	DNA
3'	DNA
untranslated	DNA
region	DNA
(	O
UTR	DNA
)	O
of	O
human	protein
keratinocyte	protein
PCD/DCoH	protein
revealed	O
that	O
it	O
has	O
53	O
bp	O
more	O
of	O
GC-rich	DNA
5'	DNA
untranslated	DNA
sequence	DNA
than	O
the	O
published	O
liver	protein
PCD/DCoH	protein
.	O
In	O
vitro	O
transcription	O
and	O
translation	O
analysis	O
showed	O
that	O
the	O
longer	O
5'	DNA
UTR	DNA
resulted	O
in	O
about	O
a	O
35%	O
decrease	O
in	O
translation	O
efficiency.	O
These	O
data	O
show	O
that	O
human	protein
PCD/DCoH	protein
is	O
not	O
only	O
present	O
in	O
cells	O
where	O
tetrahydrobiopterin	protein
is	O
synthesized	O
or	O
HNF1	protein
is	O
present	O
but	O
is	O
a	O
widely	O
distributed	O
protein.	O
Its	O
differential	O
expression	O
in	O
different	O
tissues	O
and	O
cells	O
is	O
regulated	O
not	O
only	O
at	O
the	O
transcriptional	O
level	O
but	O
also	O
at	O
the	O
translational	O
level	O
.	O

NF-kappaB	protein
regulates	O
Fas/APO-1/CD95-	O
and	O
TCR-	O
mediated	O
apoptosis	O
of	O
T	cell_type
lymphocytes	cell_type
.	O
The	O
maintenance	O
of	O
lymphocyte	O
homeostasis	O
by	O
apoptosis	O
is	O
a	O
critical	O
regulatory	O
mechanism	O
in	O
the	O
normal	O
immune	O
system	O
.	O
The	O
transcription	protein
factor	protein
NF-kappaB	protein
has	O
been	O
shown	O
to	O
play	O
a	O
role	O
in	O
protecting	O
cells	O
against	O
death	O
mediated	O
by	O
TNF	protein
We	O
show	O
here	O
that	O
NF-kappaB	protein
also	O
has	O
a	O
role	O
in	O
regulating	O
Fas	protein
/	O
APO-1	protein
/	O
CD95	protein
-mediated	O
death	O
,	O
a	O
major	O
pathway	O
of	O
peripheral	cell_type
T	cell_type
cell	cell_type
death	O
.	O
Transfection	O
of	O
Jurkat	cell_line
cells	cell_line
with	O
the	O
NF-kappaB	protein
subunits	protein
p50	protein
and	O
p65	protein
confers	O
resistance	O
against	O
Fas-mediated	O
apoptosis	O
.	O
Reciprocally,	O
inhibition	O
of	O
NF-kappaB	protein
activation	O
by	O
a	O
soluble	O
peptide	O
inhibitor	O
or	O
a	O
dominant	O
form	O
of	O
the	O
NF-kappaB	protein
inhibitor	O
,	O
IkappaB	protein
,	O
makes	O
the	O
cells	O
more	O
susceptible	O
to	O
Fas-mediated	O
apoptosis	O
.	O
Furthermore,	O
inhibition	O
of	O
NF-kappaB	protein
activation	O
by	O
a	O
soluble	O
peptide	O
inhibitor	O
rendered	O
a	O
T	cell_line
cell	cell_line
hybridoma	cell_line
more	O
susceptible	O
to	O
TCR-mediated	O
apoptosis	O
.	O
Correspondingly,	O
transfection	O
of	O
p50	protein
and	O
p65	protein
provided	O
considerable	O
protection	O
from	O
TCR-mediated	O
apoptosis	O
.	O
These	O
observations	O
were	O
corroborated	O
by	O
studies	O
on	O
Fas	protein
-mediated	O
death	O
in	O
primary	cell_type
T	cell_type
cells	cell_type
.	O
Concanavalin	O
A	O
-activated	O
cycling	cell_line
T	cell_line
cell	cell_line
blasts	cell_line
from	O
mice	O
that	O
are	O
transgenic	O
for	O
the	O
dominant	protein
IkappaB	protein
molecule	protein
have	O
increased	O
sensitivity	O
to	O
Fas-mediated	O
apoptosis	O
,	O
associated	O
with	O
a	O
down-regulation	O
of	O
NF-kappaB	protein
complexes	protein
in	O
the	O
nucleus.	O
In	O
addition,	O
blocking	O
TNF	protein
,	O
itself	O
a	O
positive	O
regulator	O
of	O
NF-kappaB	protein
,	O
with	O
neutralizing	protein
antibodies	protein
renders	O
the	O
cells	O
more	O
susceptible	O
to	O
anti-Fas-mediated	O
apoptosis	O
.	O
In	O
summary,	O
our	O
results	O
provide	O
compelling	O
evidence	O
that	O
NF-kappaB	protein
protects	O
against	O
Fas	protein
-mediated	O
death	O
and	O
is	O
likely	O
to	O
be	O
an	O
important	O
regulator	O
of	O
T	O
cell	O
homeostasis	O
and	O
tolerance	O
.	O

T	O
helper	O
differentiation	O
proceeds	O
through	O
Stat1-dependent	O
,	O
Stat4-dependent	O
and	O
Stat4-independent	O
phases	O
.	O
Much	O
of	O
our	O
focus	O
in	O
understanding	O
Th1/Th2	O
development	O
has	O
been	O
on	O
the	O
signals	O
delivered	O
by	O
IL-12	protein
and	O
IL-4	protein
as	O
final	O
determinants	O
of	O
terminal	O
T	O
cell	O
differentiation	O
.	O
Because	O
extinction	O
of	O
IL-12	protein
signaling	O
in	O
early	O
Th2	O
development	O
could	O
potentially	O
be	O
important	O
in	O
imprinting	O
a	O
more	O
permanent	O
Th2	O
phenotype	O
on	O
a	O
population	O
of	O
T	cell_type
cells	cell_type
,	O
we	O
have	O
also	O
examined	O
various	O
parameters	O
regulating	O
the	O
IL-12	protein
signaling	O
pathway	O
.	O
Whereas	O
IL-4	protein
appears	O
to	O
repress	O
functional	O
IL-12	protein
signaling	O
through	O
inhibition	O
of	O
IL-12R	protein
beta	protein
2	protein
expression	O
,	O
IFN-gamma	protein
in	O
the	O
mouse,	O
and	O
IFN-alpha	protein
in	O
the	O
human	O
appear	O
to	O
induce	O
IL-12R	protein
beta	protein
2	protein
expression	O
and	O
promote	O
IL-12	protein
responsiveness	O
.	O
We	O
propose	O
that	O
Th1	O
development	O
can	O
be	O
considered	O
in	O
two	O
stages,	O
capacitance	O
and	O
development.	O
Capacitance	O
would	O
simply	O
involve	O
expression	O
of	O
IL-12R	O
beta	O
1	O
and	O
beta	O
2	O
subunits	O
,	O
regulated	O
by	O
TCR,	O
IL-4	protein
and	O
IFNs	protein
.	O
The	O
second	O
stage,	O
development,	O
we	O
propose	O
is	O
the	O
true	O
IL-12	protein
induced	O
developmental	O
stage	O
,	O
involving	O
expression	O
of	O
Stat4	protein
inducible	protein
proteins	protein
.	O
In	O
the	O
human,	O
this	O
may	O
also	O
occur	O
via	O
IFN-alpha	protein
,	O
which	O
is	O
able	O
to	O
activate	O
Stat4	protein
.	O
It	O
is	O
perhaps	O
possible	O
that	O
all	O
of	O
Stat4	protein
actions	O
on	O
Th1	O
development	O
may	O
be	O
exert	O
directly	O
by	O
Stat4	protein
at	O
the	O
IFN-gamma	DNA
gene	DNA
,	O
however	O
we	O
suggest	O
that,	O
more	O
likely,	O
Stat4	protein
may	O
act	O
to	O
induce	O
Th1	O
development	O
through	O
the	O
induction	O
of	O
other	O
non-cytokine	DNA
genes	DNA
,	O
whose	O
stable	O
expression	O
maintains	O
the	O
transcriptional	O
state	O
of	O
a	O
Th1	cell_type
cell	cell_type
.	O

Lineage-specific	O
activation	O
of	O
STAT3	protein
by	O
interferon-gamma	protein
in	O
human	cell_type
neutrophils	cell_type
.	O
Binding	O
of	O
interferon-gamma	protein
(	O
IFN-gamma	protein
)	O
to	O
its	O
heterodimeric	O
receptor	O
induces	O
activation	O
of	O
the	O
tyrosine	protein
kinases	protein
JAK1	protein
and	O
JAK2	protein
followed	O
by	O
tyrosine	O
phosphorylation	O
of	O
STAT1alpha	protein
.	O
Selective	O
activation	O
of	O
STAT1alpha	protein
at	O
the	O
IFN-gamma	protein
receptor	protein
is	O
achieved	O
by	O
specific	O
interaction	O
between	O
a	O
cytosolic	protein
tyrosine	protein
motif	protein
including	O
Y440	protein
in	O
the	O
IFN-gamma	protein
receptor	protein
alpha-chain	protein
and	O
the	O
SH2	protein
domain	protein
of	O
STAT1alpha	protein
.	O
We	O
demonstrate	O
that,	O
in	O
addition	O
to	O
STAT1alpha	protein
,	O
STAT3	protein
is	O
also	O
activated	O
by	O
IFN-gamma	protein
in	O
human	cell_type
neutrophils	cell_type
.	O
The	O
activation	O
of	O
STAT3	protein
was	O
not	O
found	O
in	O
human	cell_type
eosinophils	cell_type
,	O
monocytes	cell_type
,	O
and	O
HL-60	cell_line
cells	cell_line
,	O
although	O
the	O
STAT3	protein
protein	protein
was	O
expressed	O
in	O
these	O
cells.	O
The	O
cell	O
type-specific	O
activation	O
of	O
STAT3	protein
by	O
IFN-gamma	protein
was	O
also	O
observed	O
in	O
neutrophils	cell_type
that	O
are	O
differentiated	O
in	O
vitro	O
from	O
human	cell_type
CD34+	cell_type
hematopoietic	cell_type
stem	cell_type
cells	cell_type
.	O
These	O
results	O
indicate	O
that	O
a	O
single	O
cytokine	protein
receptor	protein
can	O
activate	O
different	O
STAT	protein
family	protein
members	protein
in	O
a	O
cell-specific	O
manner	O
,	O
which	O
might	O
result	O
in	O
cell-specific	O
gene	O
transcription	O
.	O

Alternative	O
polyadenylation	O
events	O
contribute	O
to	O
the	O
induction	O
of	O
NF-ATc	protein
in	O
effector	cell_type
T	cell_type
cells	cell_type
.	O
The	O
transcription	protein
factor	protein
NF-ATc	protein
is	O
synthesized	O
in	O
three	O
prominent	O
isoforms	protein
.	O
These	O
differ	O
in	O
the	O
length	O
of	O
their	O
C	O
terminal	O
peptides	O
and	O
mode	O
of	O
synthesis.	O
Due	O
to	O
a	O
switch	O
from	O
the	O
use	O
of	O
a	O
3'	DNA
polyA	DNA
site	DNA
to	O
a	O
more	O
proximal	DNA
polyA	DNA
site	DNA
,	O
NF-ATc	protein
expression	O
switches	O
from	O
the	O
synthesis	O
of	O
the	O
two	O
longer	O
isoforms	O
in	O
naive	cell_type
T	cell_type
cells	cell_type
to	O
that	O
of	O
short	O
isoform	protein
A	protein
in	O
T	cell_type
effector	cell_type
cells	cell_type
.	O
The	O
relative	O
low	O
binding	O
affinity	O
of	O
cleavage	protein
stimulation	protein
factor	protein
CstF-64	protein
to	O
the	O
proximal	DNA
polyA	DNA
site	DNA
seems	O
to	O
contribute	O
to	O
its	O
neglect	O
in	O
naive	cell_type
T	cell_type
cells	cell_type
.	O
These	O
alternative	O
polyadenylation	O
events	O
ensure	O
the	O
rapid	O
accumulation	O
of	O
high	O
concentrations	O
of	O
NF-ATc	protein
necessary	O
to	O
exceed	O
critical	O
threshold	O
levels	O
of	O
NF-ATc	protein
for	O
gene	O
induction	O
in	O
effector	cell_type
T	cell_type
cells	cell_type
.	O

Estrogen	O
and	O
progesterone	O
induction	O
of	O
survival	O
of	O
monoblastoid	cell_type
cells	cell_type
undergoing	O
TNF-alpha	protein
-induced	O
apoptosis	O
.	O
Induction	O
of	O
apoptosis	O
of	O
mononucleated	cell_type
cells	cell_type
is	O
a	O
physiological	O
process	O
for	O
regulating	O
the	O
intensity	O
of	O
the	O
immune	O
response	O
.	O
The	O
female	O
steroid	O
hormones	O
estrogen	O
(	O
E2	O
)	O
and	O
progesterone	O
(	O
Prog	O
)	O
are	O
known	O
to	O
modulate	O
the	O
reactivity	O
of	O
the	O
immune	O
system	O
;	O
recently	O
it	O
has	O
been	O
demonstrated	O
that	O
they	O
can	O
regulate	O
induction	O
of	O
apoptosis	O
of	O
endothelial	cell_type
cells	cell_type
and	O
osteoblasts	cell_type
.	O
TNF-alpha	protein
-mediated	O
induction	O
of	O
apoptosis	O
has	O
been	O
well	O
characterized	O
in	O
myeloid	cell_type
cells	cell_type
.	O
We	O
investigated	O
whether	O
E2	O
and	O
Prog	O
could	O
interfere	O
with	O
TNF-alpha	protein
-induced	O
apoptosis	O
of	O
the	O
monoblastoid	cell_line
U937	cell_line
cell	cell_line
line	cell_line
.	O
Treatment	O
with	O
E2	O
or	O
Prog	O
increased	O
survival	O
and	O
prevented	O
apoptosis	O
induced	O
by	O
TNF-alpha	protein
in	O
both	O
undifferentiated	O
and	O
macrophage-like	O
PMA-differentiated	cell_line
U937	cell_line
cells	cell_line
,	O
as	O
assessed	O
by	O
trypan	O
blue	O
exclusion	O
cell	O
counting	O
,	O
thymidine	O
incorporation	O
,	O
AnnexinV	O
labeling	O
,	O
followed	O
by	O
flow	O
cytometry	O
and	O
DNA	O
fragmentation	O
studies	O
.	O
This	O
effect	O
can	O
be	O
associated	O
with	O
the	O
activation	O
of	O
specific	O
hormone	O
receptors,	O
since	O
we	O
observed	O
the	O
expression	O
of	O
the	O
estrogen	O
receptor	O
alpha	O
(ER-alpha)	O
,	O
ER-beta	O
,	O
and	O
progesterone	O
receptor	O
(PR)	O
mRNAs	O
;	O
the	O
ER-alpha	protein
protein	O
expression	O
was	O
confirmed	O
by	O
immunocytochemical	O
analysis	O
.	O
In	O
addition,	O
hormone-mediated	O
survival	O
against	O
apoptosis	O
was	O
concentration	O
dependent,	O
reaching	O
the	O
half-maximal	O
effect	O
at	O
10	O
nM	O
and	O
blocked	O
by	O
the	O
ER	O
antagonist	O
ICI	O
182,780	O
in	O
undifferentiated	cell_type
cells	cell_type
,	O
further	O
supporting	O
a	O
receptor-mediated	O
mechanism	O
of	O
cell	O
survival.	O
Other	O
steroid	O
receptor	O
drugs	O
such	O
as	O
Raloxifene	O
,	O
RU486	O
,	O
or	O
the	O
ICI	O
182,780	O
in	O
PMA-differentiated	cell_line
cells	cell_line
displayed	O
agonist	O
activity	O
by	O
preventing	O
TNF-alpha	protein
-induced	O
apoptosis	O
as	O
efficiently	O
as	O
the	O
hormones	O
alone,	O
providing	O
further	O
evidence	O
to	O
the	O
notion	O
that	O
steroid	O
receptor	O
drugs	O
may	O
manifest	O
agonist	O
or	O
antagonist	O
activities	O
depending	O
on	O
the	O
cellular	O
context	O
in	O
which	O
they	O
are	O
studied.	O
Treatment	O
with	O
E2	O
was	O
also	O
associated	O
with	O
a	O
time-dependent	O
decrease	O
in	O
the	O
mRNA	O
level	O
of	O
the	O
proapoptotic	protein
Nip-2	protein
protein	protein
,	O
supporting	O
the	O
hypothesis	O
that	O
hormone	O
responsiveness	O
of	O
U937	cell_line
cells	cell_line
is	O
mediated	O
by	O
target	O
gene	O
transcription.	O
Together,	O
these	O
results	O
demonstrate	O
that	O
ER	protein
and	O
PR	protein
can	O
be	O
activated	O
by	O
endogenous	O
or	O
exogenous	O
ligands	O
to	O
induce	O
a	O
genetic	O
response	O
that	O
impairs	O
TNF-alpha	protein
-induced	O
apoptosis	O
in	O
U937	cell_line
cells	cell_line
.	O
The	O
data	O
presented	O
here	O
suggest	O
that	O
the	O
female	protein
steroid	protein
receptors	protein
play	O
a	O
role	O
in	O
regulation	O
of	O
the	O
immune	O
response	O
by	O
preventing	O
apoptosis	O
of	O
monoblastoid	cell_type
cells	cell_type
;	O
this	O
effect	O
might	O
have	O
important	O
consequences	O
in	O
the	O
clinical	O
use	O
of	O
steroid	O
receptor	O
drugs	O
.	O
--Vegeto,	O
E.,	O
Pollio,	O
G.,	O
Pellicciari,	O
C.,	O
Maggi,	O
A.	O
Estrogen	O
and	O
progesterone	O
induction	O
of	O
survival	O
of	O
monoblastoid	cell_type
cells	cell_type
undergoing	O
TNF-alpha	protein
-inuced	O
apoptosis	O
.	O

Dicarba-closo-dodecaboranes	O
as	O
a	O
pharmacophore	O
.	O
Retinoidal	O
antagonists	O
and	O
potential	O
agonists	O
.	O
Synthesis	O
and	O
biological	O
evaluation	O
of	O
the	O
first	O
dicarba-closo-dodecaborane	O
(	O
carborane	O
)	O
derivatives	O
of	O
retinoids	O
are	O
described.	O
Their	O
retinoidal	O
activity	O
were	O
examined	O
in	O
terms	O
of	O
the	O
differentiation-inducing	O
ability	O
toward	O
human	cell_line
promyelocytic	cell_line
leukemia	cell_line
HL-60	cell_line
cells	cell_line
.	O
High	O
retinoidal	O
activity	O
(agonist	O
or	O
antagonist	O
for	O
retinoic	protein
acid	protein
receptor	protein
(	O
RAR	protein
)	O
requires	O
a	O
carboxylic	O
acid	O
moiety	O
and	O
an	O
appropriate	O
hydrophobic	O
group	O
located	O
at	O
a	O
suitable	O
position	O
on	O
the	O
molecule.	O
The	O
4-carboranyl-substituted	O
compounds	O
(	O
7	O
,	O
11	O
)	O
showed	O
antagonistic	O
activity	O
but	O
no	O
agonistic	O
activity	O
even	O
in	O
the	O
presence	O
of	O
the	O
potent	O
synergist	O
HX630	O
.	O
On	O
the	O
other	O
hand,	O
the	O
3-carboranyl-substituted	O
compounds	O
(	O
8	O
,	O
12	O
)	O
showed	O
potential	O
agonistic	O
activity	O
,	O
but	O
no	O
antagonistic	O
activity	O
.	O
The	O
results	O
indicates	O
that	O
carboranes	O
are	O
applicable	O
as	O
the	O
hydrophobic	O
moiety	O
of	O
biologically	O
active	O
molecules.	O

Inhibition	O
of	O
T	O
cell	O
signaling	O
by	O
mitogen-activated	protein
protein	protein
kinase	protein
-targeted	protein
hematopoietic	protein
tyrosine	protein
phosphatase	protein
(	O
HePTP	protein
).	O
Activation	O
of	O
T	cell_type
lymphocytes	cell_type
to	O
produce	O
cytokines	protein
is	O
regulated	O
by	O
the	O
counterbalance	O
of	O
protein-	protein
tyrosine	protein
kinases	protein
and	O
protein-	O
tyrosine	O
phosphatases,	O
many	O
of	O
which	O
have	O
a	O
high	O
degree	O
of	O
substrate	O
specificity	O
because	O
of	O
physical	O
association	O
with	O
their	O
targets.	O
Overexpression	O
of	O
hematopoietic	protein
protein-	protein
tyrosine	protein
phosphatase	protein
(	O
HePTP	protein
)	O
results	O
in	O
suppression	O
of	O
T	O
lymphocyte	O
activation	O
as	O
measured	O
by	O
T	protein
cell	protein
antigen	protein
receptor	protein
-induced	O
activation	O
of	O
transcription	protein
factors	protein
binding	O
to	O
the	O
5'	DNA
promoter	DNA
of	O
the	O
interleukin-2	DNA
gene	DNA
.	O
Efforts	O
to	O
pinpoint	O
the	O
exact	O
site	O
of	O
action	O
and	O
specificity	O
of	O
HePTP	protein
in	O
the	O
signaling	O
cascade	O
revealed	O
that	O
HePTP	protein
acts	O
directly	O
on	O
the	O
mitogen-activated	protein
protein	protein
(MAP)	protein
kinases	protein
Erk	O
1	O
and	O
2	O
and	O
consequently	O
reduces	O
the	O
magnitude	O
and	O
duration	O
of	O
their	O
catalytic	O
activation	O
in	O
intact	cell_type
T	cell_type
cells	cell_type
.	O
In	O
contrast,	O
HePTP	protein
had	O
no	O
effects	O
on	O
N-terminal	protein
c-Jun	protein
kinase	protein
or	O
on	O
events	O
upstream	O
of	O
the	O
MAP	O
kinases.	O
The	O
specificity	O
of	O
HePTP	protein
correlated	O
with	O
its	O
physical	O
association	O
through	O
its	O
noncatalytic	O
N	protein
terminus	protein
with	O
Erk	protein
and	O
another	O
MAP	protein
kinase	protein
,	O
p38	protein
,	O
but	O
not	O
Jnk	protein
or	O
other	O
proteins.	O
We	O
propose	O
that	O
HePTP	protein
plays	O
a	O
negative	O
role	O
in	O
antigen	O
receptor	O
signaling	O
by	O
specifically	O
regulating	O
MAP	protein
kinases	protein
in	O
the	O
cytosol	O
and	O
at	O
early	O
time	O
points	O
of	O
T	O
cell	O
activation	O
before	O
the	O
activation-induced	O
expression	O
of	O
nuclear	protein
dual-specific	protein
MAP	protein
kinase	protein
phosphatases	protein
.	O

p38	protein
mitogen-activated	protein
protein	protein
kinase	protein
mediates	O
signal	O
integration	O
of	O
TCR	protein
/CD28	protein
costimulation	O
in	O
primary	cell_type
murine	cell_type
T	cell_type
cells	cell_type
.	O
Optimal	O
T	O
cell	O
activation	O
requires	O
two	O
signals,	O
one	O
generated	O
by	O
TCR	protein
and	O
another	O
by	O
the	O
CD28	protein
costimulatory	protein
receptor	protein
.	O
In	O
this	O
study,	O
we	O
investigated	O
the	O
regulation	O
of	O
costimulation-induced	O
mitogen-activated	protein
protein	protein
kinase	protein
(	O
MAPK	protein
)	O
activation	O
in	O
primary	cell_type
mouse	cell_type
T	cell_type
cells	cell_type
.	O
In	O
contrast	O
to	O
that	O
reported	O
for	O
human	cell_type
Jurkat	cell_type
T	cell_type
cells	cell_type
,	O
we	O
found	O
that	O
p38	protein
MAPK	protein
,	O
but	O
not	O
Jun	protein
NH2-terminal	protein
kinase	protein
(	O
JNK	protein
),	O
is	O
weakly	O
activated	O
upon	O
stimulation	O
with	O
either	O
anti-CD3	protein
or	O
anti-CD28	protein
in	O
murine	cell_type
thymocytes	cell_type
and	O
splenic	cell_type
T	cell_type
cells	cell_type
.	O
However,	O
p38	protein
MAPK	protein
is	O
activated	O
strongly	O
and	O
synergistically	O
by	O
either	O
CD3/CD28	protein
coligation	O
or	O
PMA/Ca2+	O
ionophore	O
stimulation	O
,	O
which	O
mimics	O
TCR	protein
-	O
CD3/CD28	protein
-mediated	O
signaling	O
.	O
Activation	O
of	O
p38	protein
MAPK	protein
correlates	O
closely	O
with	O
the	O
stimulation	O
of	O
T	O
cell	O
proliferation	O
.	O
In	O
contrast,	O
PMA-induced	O
JNK	protein
activation	O
is	O
inhibited	O
by	O
Ca2+	O
ionophore	O
.	O
T	O
cell	O
proliferation	O
and	O
production	O
of	O
IL-2	protein
,	O
IL-4	protein
,	O
and	O
IFN-gamma	protein
induced	O
by	O
both	O
CD3	protein
and	O
CD3	protein
/CD28	protein
ligation	O
and	O
the	O
nuclear	O
expression	O
of	O
the	O
c-Jun	O
and	O
ATF-2	O
proteins	O
are	O
each	O
blocked	O
by	O
the	O
p38	protein
MAPK	protein
inhibitor	O
SB203580	O
.	O
Our	O
findings	O
demonstrate	O
that	O
p38	protein
MAPK	protein
1)	O
plays	O
an	O
important	O
role	O
in	O
signal	O
integration	O
during	O
costimulation	O
of	O
primary	cell_type
mouse	cell_type
T	cell_type
cells	cell_type
,	O
2)	O
may	O
be	O
involved	O
in	O
the	O
induction	O
of	O
c-Jun	protein
activation	O
and	O
augmentation	O
of	O
AP-1	protein
transcriptional	O
activity	O
,	O
and	O
3)	O
regulates	O
whether	O
T	cell_type
cells	cell_type
enter	O
a	O
state	O
of	O
functional	O
unresponsiveness	O
.	O

Erythroid	O
gene	O
expression	O
is	O
differentially	O
regulated	O
by	O
erythropoietin	protein
,	O
haemin	O
and	O
delta-aminolaevulinic	O
acid	O
in	O
UT-7	cell_line
cells	cell_line
.	O
Erythropoietin	O
(Epo)	O
is	O
essential	O
for	O
the	O
later	O
stages	O
of	O
erythropoiesis	O
,	O
acting	O
to	O
promote	O
cell	O
survival	O
and	O
proliferation,	O
but	O
its	O
role	O
in	O
differentiation	O
remains	O
to	O
be	O
defined.	O
The	O
UT-7	cell_line
cell	cell_line
line	cell_line
exhibits	O
both	O
erythroid	O
and	O
megakaryocytic	O
characteristics	O
and	O
can	O
be	O
induced	O
to	O
differentiate	O
along	O
the	O
erythroid	O
pathway	O
by	O
Epo	protein
or	O
the	O
megakaryocytic	O
pathway	O
by	O
phorbol	O
myristic	O
acetate	O
.	O
We	O
have	O
compared	O
the	O
effects	O
of	O
Epo	protein
and	O
the	O
chemical	O
inducers,	O
delta-aminolaevulinic	O
acid	O
(delta-ALA)	O
and	O
haemin	O
on	O
the	O
differentiation	O
capacity	O
of	O
UT-7	cell_line
cells	cell_line
.	O
Epo	protein
alone	O
promoted	O
relatively	O
early	O
events	O
in	O
erythroid	O
maturation	O
,	O
without	O
significant	O
changes	O
in	O
haemoglobin	O
production	O
or	O
morphology.	O
GATA-2	protein
and	O
c-myb	protein
were	O
down-regulated	O
by	O
Epo	protein
,	O
and	O
GATA-2	protein
was	O
further	O
down-modulated	O
by	O
the	O
inducers.	O
Conversely,	O
SCL	protein
expression	O
was	O
up-regulated	O
by	O
Epo	protein
and	O
further	O
increased	O
by	O
haemin	O
and	O
delta-ALA	O
.	O
Epo	protein
caused	O
an	O
increase	O
in	O
the	O
proportion	O
of	O
cells	O
expressing	O
cell	O
surface	O
glycophorin	protein
A	protein
(	O
GPA	protein
)	O
and	O
up-regulated	O
beta-	O
and	O
gamma-	O
globin	O
by	O
several	O
fold.	O
Both	O
haemin	O
and	O
delta-ALA	O
caused	O
a	O
de	O
novo	O
increase	O
in	O
alpha-globin	protein
expression	O
as	O
well	O
as	O
enhancing	O
Epo	protein
-induced	O
beta-globin	protein
expression	O
,	O
leading	O
to	O
a	O
marked	O
increase	O
in	O
haemoglobin	O
production	O
.	O
These	O
results	O
suggest	O
that	O
haemoglobin	O
production	O
in	O
UT-7	cell_line
cells	cell_line
is	O
limited	O
by	O
a	O
deficiency	O
of	O
erythroid-specific	protein
aminolaevulinic	protein
acid	protein
synthase	protein
(	protein
ALAS-E	protein
)	protein
activity	protein
or	O
globin	O
synthesis	O
as	O
a	O
consequence	O
of	O
their	O
immaturity	O
as	O
a	O
multipotential	cell_line
cell	cell_line
line	cell_line
.	O

Essential	O
role	O
of	O
alveolar	cell_type
macrophages	cell_type
in	O
intrapulmonary	O
activation	O
of	O
NF-kappaB	protein
.	O
Acute	O
inflammatory	O
injury	O
in	O
rat	O
lung	O
induced	O
by	O
deposition	O
of	O
immunoglobulin	protein
G	protein
immune	protein
complexes	protein
requires	O
expression	O
of	O
cytokines	protein
and	O
chemokines	protein
as	O
well	O
as	O
activation	O
of	O
the	O
transcription	protein
factor	protein
nuclear	protein
factor	protein
(NF)-kappaB	protein
.	O
There	O
is	O
little	O
direct	O
evidence	O
regarding	O
the	O
role	O
of	O
alveolar	cell_type
macrophages	cell_type
in	O
these	O
activation	O
events.	O
In	O
the	O
present	O
studies,	O
rat	O
lungs	O
were	O
depleted	O
of	O
alveolar	cell_type
macrophages	cell_type
by	O
airway	O
instillation	O
of	O
liposome-encapsulated	O
dichloromethylene	O
diphosphonate	O
.	O
These	O
procedures,	O
which	O
greatly	O
reduced	O
the	O
number	O
of	O
retrievable	O
alveolar	cell_type
macrophages	cell_type
,	O
suppressed	O
activation	O
of	O
lung	protein
NF-kappaB	protein
in	O
the	O
inflammatory	O
model.	O
In	O
addition,	O
bronchoalveolar	O
lavage	O
levels	O
of	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
)	O
and	O
the	O
CXC	protein
chemokine	protein
,	O
macrophage	protein
inflammatory	protein
protein-2	protein
,	O
were	O
substantially	O
reduced.	O
In	O
parallel,	O
upregulation	O
of	O
the	O
lung	protein
vascular	protein
adhesion	protein
molecule	protein
,	O
intercellular	protein
adhesion	protein
molecule-1	protein
,	O
was	O
greatly	O
reduced	O
by	O
intrapulmonary	O
instillation	O
of	O
phosphonate-containing	O
liposomes	O
.	O
Neutrophil	O
accumulation	O
and	O
development	O
of	O
lung	O
injury	O
were	O
also	O
substantially	O
diminished.	O
Lung	O
instillation	O
of	O
TNF-alpha	protein
in	O
alveolar	O
macrophage-depleted	O
rats	O
restored	O
the	O
NF-kappaB	protein
activation	O
response	O
in	O
whole	O
lung	O
.	O
These	O
data	O
suggest	O
that,	O
in	O
this	O
inflammatory	O
model	O
,	O
initial	O
activation	O
of	O
NF-kappaB	protein
occurs	O
in	O
alveolar	cell_type
macrophages	cell_type
and	O
the	O
ensuing	O
production	O
of	O
TNF-alpha	protein
may	O
propagate	O
NF-kappaB	protein
activation	O
to	O
other	O
cell	O
types	O
in	O
the	O
lung	O
.	O

Interferon-beta	protein
mediates	O
stromal	O
cell	O
rescue	O
of	O
T	cell_type
cells	cell_type
from	O
apoptosis	O
.	O
The	O
resolution	O
of	O
immune	O
responses	O
is	O
characterized	O
by	O
extensive	O
apoptosis	O
of	O
activated	O
T	cell_type
cells	cell_type
.	O
However,	O
to	O
generate	O
and	O
maintain	O
immunological	O
memory	O
,	O
some	O
antigen-specific	cell_type
T	cell_type
cells	cell_type
must	O
survive	O
and	O
revert	O
to	O
a	O
resting	O
G0/G1	O
state	O
.	O
Cytokines	protein
that	O
bind	O
to	O
the	O
common	O
gamma	protein
chain	protein
of	O
the	O
IL-2	protein
receptor	O
promote	O
the	O
survival	O
of	O
T	cell_type
cell	cell_type
blasts	cell_type
,	O
but	O
also	O
induce	O
proliferation.	O
In	O
contrast,	O
soluble	protein
factors	protein
secreted	O
by	O
stromal	cell_type
cells	cell_type
induce	O
Tcell	O
survival	O
in	O
a	O
resting	O
G0/G1	O
state	O
.	O
We	O
now	O
report	O
that	O
interferon-beta	O
is	O
the	O
principal	O
mediator	O
of	O
stromal	O
cell-mediated	O
Tcell	O
rescue	O
from	O
apoptosis	O
.	O
Interferon	O
-alpha	O
and	O
-beta	O
promote	O
the	O
reversion	O
of	O
blast	cell_type
Tcells	cell_type
to	O
a	O
resting	O
G0/G1	O
configuration	O
with	O
all	O
the	O
characteristic	O
features	O
of	O
stromal	O
cell	O
rescue	O
;	O
such	O
as	O
high	O
Bcl-XL	protein
expression	O
and	O
low	O
Bcl-2	protein
.	O
Type	protein
I	protein
interferons	protein
and	O
stromal	cell_type
cells	cell_type
stimulate	O
apparently	O
identical	O
signaling	O
pathways,	O
leading	O
to	O
STAT-1	protein
activation	O
.	O
We	O
also	O
show	O
that	O
this	O
mechanism	O
may	O
play	O
a	O
fundamental	O
role	O
in	O
the	O
persistence	O
of	O
T	cell_type
cells	cell_type
at	O
sites	O
of	O
chronic	O
inflammation	O
;	O
suggesting	O
that	O
chronic	O
inflammation	O
is	O
an	O
aberrant	O
consequence	O
of	O
immunological	O
memory	O
.	O

Reduction	O
of	O
tumour	protein
necrosis	protein
factor	protein
alpha	protein
expression	O
and	O
signalling	O
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
from	O
patients	O
with	O
thalassaemia	O
or	O
sickle	O
cell	O
anaemia	O
upon	O
treatment	O
with	O
desferrioxamine	O
.	O
Recent	O
evidence	O
indicates	O
that	O
the	O
rate	O
of	O
progression	O
of	O
the	O
HIV-1	O
disease	O
is	O
significantly	O
reduced	O
in	O
thalassaemia	O
major	O
patients	O
upon	O
treatment	O
with	O
high	O
doses	O
of	O
desferrioxamine	O
(DFX).	O
The	O
authors	O
have	O
previously	O
demonstrated	O
that	O
in	O
vitro	O
exposure	O
of	O
mononuclear	cell_type
cells	cell_type
to	O
DFX	O
decreases	O
the	O
bioavailability	O
of	O
tumour	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF-alpha	protein
)	O
which	O
has	O
a	O
stimulatory	O
effect	O
on	O
HIV-1	O
replication	O
.	O
In	O
this	O
study,	O
therefore,	O
TNF-alpha	protein
bioavailability	O
from	O
mononuclear	cell_type
cells	cell_type
isolated	O
from	O
10	O
patients	O
with	O
thalassaemia	O
or	O
sickle	O
cell	O
anaemia	O
given	O
DFX	O
as	O
compared	O
to	O
10	O
untreated	O
subjects	O
has	O
been	O
evaluated.	O
Evidence	O
is	O
presented	O
showing	O
that	O
DFX	O
treatment	O
reduces	O
TNF-alpha	protein
bioavailability	O
(P&lt;0.05)	O
by	O
inhibiting	O
its	O
steady	O
state	O
(P&lt;0.05)	O
and	O
by	O
enhancing	O
its	O
inactivation	O
through	O
binding	O
to	O
soluble	O
TNF-alpha	protein
receptor	O
type	O
II	O
(P&lt;0.05).	O
We	O
also	O
show	O
that	O
DFX	O
treatment	O
limits	O
the	O
in	O
vivo	O
activation	O
of	O
NF-kappaB	protein
,	O
a	O
transcription	protein
factor	protein
involved	O
in	O
both	O
TNF-alpha	protein
gene	O
transcription	O
and	O
TNF-alpha	protein
signalling	O
(P&lt;0.005).	O
We	O
conclude	O
that	O
TNF-alpha	protein
bioavailability	O
and	O
signalling	O
are	O
impaired	O
in	O
patients	O
upon	O
DFX	O
treatment.	O
This	O
mechanism	O
may	O
contribute	O
to	O
delayed	O
progression	O
of	O
the	O
HIV-1	O
infection	O
in	O
vivo.	O
Copyright	O
1999	O
Academic	O
Press.	O

Involvement	O
of	O
NF-kappaB	protein
p50/p65	protein
heterodimer	protein
in	O
activation	O
of	O
the	O
human	DNA
pro-interleukin-1beta	DNA
gene	DNA
at	O
two	O
subregions	O
of	O
the	O
upstream	DNA
enhancer	DNA
element	DNA
.	O
A	O
region	O
between-3134	O
and	O
-2729	O
bp	O
upstream	O
from	O
the	O
transcription	DNA
site	DNA
of	O
the	O
human	DNA
pro-interleukin	DNA
1beta	DNA
(	DNA
proIL-1beta	DNA
)	DNA
gene	DNA
was	O
identified	O
as	O
an	O
LPS-responsive	DNA
enhancer	DNA
element	DNA
.	O
In	O
this	O
study,	O
the	O
influence	O
of	O
the	O
sequences	O
located	O
between	DNA
-3134	DNA
and	DNA
-2987	DNA
on	O
the	O
transcriptional	O
activity	O
of	O
the	O
proIL-1beta	DNA
gene	DNA
in	O
LPS-stimulated	cell_line
Raw	cell_line
264.7	cell_line
cells	cell_line
was	O
examined	O
in	O
detail.	O
The	O
results	O
obtained	O
by	O
transient	O
transfection	O
of	O
fos	O
-CAT	DNA
constructs	DNA
that	O
contained	O
serial	DNA
5'-deletion	DNA
mutations	DNA
showed	O
that	O
the	O
region	O
between	O
-3134	O
and	O
-3059	O
appears	O
to	O
be	O
required	O
for	O
the	O
induction	O
of	O
transcription	O
by	O
LPS	O
.	O
Gel	O
shift	O
assay	O
studies	O
with	O
synthetic	DNA
oligonucleotides	DNA
corresponding	O
to	O
partial	O
sequences	O
of	O
the	O
latter	O
region	O
and	O
nuclear	O
extracts	O
from	O
stimulated	O
cells	O
revealed	O
specific	O
protein	DNA
binding	DNA
sites	DNA
between	O
-3110	O
and	O
-3090	O
and	O
between	O
-3079	O
and	O
-3059.	O
These	O
specific	O
bindings	O
were	O
time	O
and	O
LPS	O
dose	O
dependent.	O
The	O
results	O
of	O
supershift	O
analysis	O
using	O
specific	O
antibodies	O
against	O
transcription	protein
factors	protein
suggested	O
that	O
both	O
binding	O
complexes	O
contained	O
the	O
NF-kappaB	protein
components	protein
p50	protein
and	O
p65	protein
,	O
and	O
did	O
not	O
contain	O
other	O
NF-kappaB	protein
proteins	protein
(	O
p52	protein
,	O
c-Rel	protein
,	O
Rel	protein
B	protein
),	O
AP-1	protein
proteins	protein
(	O
c-Fos	protein
,	O
C-Jun	protein
),	O
CREB	protein
or	O
C/EBPbeta	protein
(	O
NF-IL6	protein
).	O
Mutation	O
of	O
either	O
of	O
the	O
putative	O
NF-kappaB-binding	DNA
sites	DNA
in	O
the	O
enhancer	O
element	O
decreased	O
the	O
LPS	O
-stimulated	O
transcriptional	O
activity	O
.	O
These	O
data	O
indicated	O
that	O
two	O
NF-kappaB-binding	DNA
sites	DNA
,	O
which	O
are	O
located	O
between	O
-3134	DNA
and	DNA
-3059	DNA
,	O
are	O
critical	O
for	O
the	O
activation	O
of	O
proIL-1beta	DNA
gene	DNA
transcription	O
.	O
Copyright	O
1999	O
Academic	O
Press.	O

N-acetyl-L-cysteine	O
inhibits	O
primary	O
human	O
T	O
cell	O
responses	O
at	O
the	O
dendritic	O
cell	O
level:	O
association	O
with	O
NF-kappaB	protein
inhibition	O
.	O
N-acetyl-L-cysteine	O
(	O
NAC	O
)	O
is	O
an	O
antioxidant	O
molecule	O
endowed	O
with	O
immunomodulatory	O
properties.	O
To	O
investigate	O
the	O
effect	O
of	O
NAC	O
on	O
the	O
induction	O
phase	O
of	O
T	O
cell	O
responses,	O
we	O
analyzed	O
its	O
action	O
on	O
human	O
dendritic	O
cells	O
(DC)	O
derived	O
from	O
adherent	O
PBMC	O
cultured	O
with	O
IL-4	protein
and	O
granulocyte-macrophage	protein
CSF	protein
.	O
We	O
first	O
found	O
that	O
NAC	O
inhibited	O
the	O
constitutive	O
as	O
well	O
as	O
the	O
LPS	O
-induced	O
activity	O
of	O
the	O
transcription	protein
factor	protein
NF-kappaB	protein
.	O
In	O
parallel,	O
NAC	O
was	O
shown	O
to	O
down-regulate	O
the	O
production	O
of	O
cytokines	protein
by	O
DC	cell_type
as	O
well	O
as	O
their	O
surface	O
expression	O
of	O
HLA-DR	protein
,	O
CD86	protein
(	O
B7-2	protein
),	O
and	O
CD40	protein
molecules	protein
both	O
at	O
the	O
basal	O
state	O
and	O
upon	O
LPS	O
activation.	O
NAC	O
also	O
inhibited	O
DC	O
responses	O
induced	O
by	O
CD40	protein
engagement	O
.	O
The	O
inhibitory	O
effects	O
of	O
NAC	O
were	O
not	O
due	O
to	O
nonspecific	O
toxicity	O
as	O
neither	O
the	O
viability	O
of	O
DC	cell_type
nor	O
their	O
mannose	O
receptor-mediated	O
endocytosis	O
were	O
modified	O
by	O
NAC	O
.	O
Finally,	O
we	O
found	O
that	O
the	O
addition	O
of	O
NAC	O
to	O
MLR	O
between	O
naive	cell_type
T	cell_type
cells	cell_type
and	O
allogeneic	O
DC	cell_type
resulted	O
in	O
a	O
profound	O
inhibition	O
of	O
alloreactive	O
responses	O
,	O
which	O
could	O
be	O
attributed	O
to	O
a	O
defect	O
of	O
DC	cell_type
as	O
APC-independent	O
T	O
cell	O
responses	O
were	O
not	O
inhibited	O
by	O
NAC	O
.	O
Altogether,	O
our	O
results	O
suggest	O
that	O
NAC	O
might	O
impair	O
the	O
generation	O
of	O
primary	O
immune	O
responses	O
in	O
humans	O
through	O
its	O
inhibitory	O
action	O
on	O
DC	cell_type
.	O

Thrombin	protein
-induced	protein
p65	protein
homodimer	protein
binding	O
to	O
downstream	O
NF-kappa	DNA
B	DNA
site	DNA
of	O
the	O
promoter	O
mediates	O
endothelial	O
ICAM-1	protein
expression	O
and	O
neutrophil	cell_type
adhesion	O
.	O
We	O
investigated	O
the	O
mechanisms	O
by	O
which	O
proinflammatory	protein
mediator	protein
,	O
thrombin	protein
,	O
released	O
during	O
intravascular	O
coagulation	O
and	O
tissue	O
injury	O
,	O
induces	O
ICAM-1	protein
(	O
CD54	protein
)	O
expression	O
in	O
endothelial	cell_type
cells	cell_type
.	O
Stimulation	O
of	O
HUVEC	cell_line
with	O
thrombin	protein
resulted	O
in	O
dose-	O
and	O
time-dependent	O
increases	O
in	O
ICAM-1	RNA
mRNA	RNA
and	O
cell	O
surface	O
expression	O
and	O
in	O
ICAM-1	protein
-dependent	O
endothelial	O
adhesivity	O
toward	O
polymorphonuclear	cell_type
leukocytes	cell_type
.	O
Transient	O
transfection	O
of	O
endothelial	cell_type
cells	cell_type
with	O
ICAM-1	DNA
promoter	DNA
luciferase	DNA
reporter	DNA
gene	DNA
(ICAM-1LUC)	DNA
constructs	DNA
indicated	O
that	O
deletion	O
of	O
upstream	O
NF-kappa	DNA
B	DNA
site	DNA
(	O
-533	DNA
bases	DNA
from	O
translation	DNA
start	DNA
site	DNA
)	O
had	O
no	O
effect	O
on	O
thrombin	protein
responsiveness	O
,	O
whereas	O
mutation/deletion	O
of	O
downstream	O
NF-kappa	DNA
B	DNA
site	DNA
(	O
-223	DNA
bases	DNA
from	O
the	O
translation	DNA
start	DNA
site	DNA
)	O
prevented	O
the	O
activation	O
of	O
ICAM-1	DNA
promoter	DNA
,	O
indicating	O
that	O
the	O
downstream	O
NF-kappa	DNA
B	DNA
site	DNA
is	O
critical	O
for	O
thrombin	protein
inducibility	O
.	O
NF-kappa	protein
B	protein
-directed	O
luciferase	protein
activity	O
increased	O
approximately	O
3-fold	O
when	O
cells	O
transfected	O
with	O
the	O
plasmid	DNA
pNF-kappa	DNA
BLUC	DNA
containing	O
five	O
copies	O
of	O
consensus	DNA
NF-kappa	DNA
B	DNA
site	DNA
linked	O
to	O
a	O
minimal	O
adenovirus	DNA
E1B	DNA
promoter-luciferase	DNA
gene	DNA
were	O
exposed	O
to	O
thrombin	protein
,	O
indicating	O
that	O
activation	O
of	O
NF-kappa	protein
B	protein
was	O
essential	O
for	O
thrombin	protein
response	O
.	O
Gel	O
supershift	O
assays	O
demonstrated	O
that	O
thrombin	protein
induced	O
binding	O
of	O
NF-kappa	protein
Bp65	protein
(	O
Rel	protein
A	protein
)	O
to	O
downstream	O
NF-kappa	DNA
B	DNA
site	DNA
of	O
the	O
ICAM-1	DNA
promoter	DNA
.	O
Thrombin	protein
receptor	O
activation	O
peptide	O
,	O
a	O
14-amino-acid	O
peptide	O
representing	O
the	O
new	O
NH2	protein
terminus	protein
of	O
proteolytically	O
activated	O
receptor-1	protein
,	O
mimicked	O
thrombin	protein
's	O
action	O
in	O
inducing	O
ICAM-1	protein
expression.	O
These	O
data	O
indicate	O
that	O
thrombin	protein
activates	O
endothelial	O
ICAM-1	protein
expression	O
and	O
polymorphonuclear	cell_type
leukocyte	cell_type
adhesion	O
by	O
NF-kappa	protein
Bp65	protein
binding	O
to	O
the	O
downstream	O
NF-kappa	DNA
B	DNA
site	DNA
of	O
ICAM-1	DNA
promoter	DNA
after	O
proteolytically	O
activated	O
receptor-1	O
activation	O
.	O

Differential	O
inhibition	O
of	O
Smad6	protein
and	O
Smad7	protein
on	O
bone	O
morphogenetic	O
protein-	O
and	O
activin-	O
mediated	O
growth	O
arrest	O
and	O
apoptosis	O
in	O
B	cell_type
cells	cell_type
.	O
Smad6	protein
and	O
Smad7	protein
prevent	O
ligand-induced	O
activation	O
of	O
signal-transducing	protein
Smad	protein
proteins	protein
in	O
the	O
transforming	protein
growth	protein
factor-beta	protein
family	protein
.	O
Here	O
we	O
demonstrate	O
that	O
both	O
Smad6	protein
and	O
Smad7	protein
are	O
human	protein
bone	protein
morphogenetic	protein
protein-2	protein
(	O
hBMP-2	protein
)-inducible	O
antagonists	O
of	O
hBMP-2	protein
-induced	O
growth	O
arrest	O
and	O
apoptosis	O
in	O
mouse	cell_line
B	cell_line
cell	cell_line
hybridoma	cell_line
HS-72	cell_line
cells	cell_line
.	O
Moreover,	O
we	O
confirmed	O
that	O
the	O
ectopic	O
expressions	O
of	O
Smad6	protein
and	O
Smad7	protein
inhibited	O
the	O
hBMP-2	protein
-induced	O
Smad1/Smad5	protein
phosphorylation	O
.	O
We	O
previously	O
reported	O
that	O
Smad7	protein
is	O
an	O
activin	O
A-inducible	O
antagonist	O
of	O
activin	O
A-induced	O
growth	O
arrest	O
and	O
apoptosis	O
in	O
HS-72	cell_line
cells	cell_line
.	O
Interestingly,	O
although	O
mRNA	O
expression	O
of	O
Smad6	protein
was	O
induced	O
by	O
activin	O
A	O
in	O
HS-72	cell_line
cells	cell_line
,	O
Smad6	protein
showed	O
no	O
antagonistic	O
effect	O
on	O
activin	O
A	O
-induced	O
growth	O
arrest	O
and	O
apoptosis	O
.	O
Moreover,	O
we	O
found	O
that	O
the	O
ectopic	O
expression	O
of	O
Smad7	protein
,	O
but	O
not	O
Smad6	protein
,	O
inhibited	O
the	O
activin	O
A	O
-induced	O
Smad2	O
phosphorylation	O
in	O
HS-72	cell_line
cells	cell_line
.	O
Thus,	O
Smad6	protein
and	O
Smad7	protein
exhibit	O
differential	O
inhibitory	O
effects	O
in	O
bone	O
morphogenetic	O
protein-2-	O
and	O
activin	O
A-	O
mediated	O
signaling	O
in	O
B	cell_type
lineage	cell_type
cells	cell_type
.	O

Retinoic	O
acid	O
induces	O
apoptosis	O
of	O
human	cell_type
CD34+	cell_type
hematopoietic	cell_type
progenitor	cell_type
cells	cell_type
:	O
involvement	O
of	O
retinoic	protein
acid	protein
receptors	protein
and	O
retinoid	protein
X	protein
receptors	protein
depends	O
on	O
lineage	O
commitment	O
of	O
the	O
hematopoietic	cell_type
progenitor	cell_type
cells	cell_type
.	O
Retinoids	O
are	O
bifunctional	O
regulators	O
of	O
growth	O
and	O
differentiation	O
of	O
hematopoietic	cell_type
cells	cell_type
.	O
In	O
this	O
study	O
we	O
explored	O
the	O
effects	O
of	O
retinoic	O
acid	O
(	O
RA	O
)	O
on	O
apoptosis	O
of	O
human	cell_type
CD34+	cell_type
hematopoietic	cell_type
progenitor	cell_type
cells	cell_type
isolated	O
from	O
normal	O
bone	O
marrow.	O
RA	O
(100	O
nM)	O
induced	O
an	O
increase	O
in	O
the	O
percentage	O
of	O
dead	cell_type
cells	cell_type
from	O
24%	O
to	O
44%	O
at	O
day	O
6	O
(p	O
&lt;	O
0.05,	O
n	O
=	O
6)	O
as	O
compared	O
to	O
control	cell_type
cells	cell_type
cultured	O
in	O
medium	O
alone.	O
The	O
effect	O
was	O
dose	O
dependent	O
and	O
appeared	O
relatively	O
late.	O
Significant	O
differences	O
were	O
observed	O
from	O
day	O
4	O
onward.	O
Apoptosis	O
,	O
or	O
programmed	O
cell	O
death	O
,	O
was	O
demonstrated	O
as	O
the	O
mode	O
of	O
cell	O
death	O
by	O
using	O
the	O
TUNEL	O
assay	O
,	O
which	O
detects	O
single	O
strand	O
nicks	O
in	O
DNA,	O
or	O
by	O
the	O
Nicoletti	O
technique	O
demonstrating	O
a	O
subdiploid	O
population	O
by	O
DNA	O
staining	O
.	O
RA	O
previously	O
was	O
found	O
to	O
inhibit	O
granulocyte	protein
colony-stimulating	protein
factor	protein
--and	O
not	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
--stimulated	O
proliferation	O
of	O
CD34+	cell_type
cells	cell_type
.	O
However,	O
we	O
found	O
that	O
RA	O
opposed	O
anti-apoptotic	O
effects	O
of	O
G-CSF	protein
and	O
GM-CSF	protein
on	O
CD34+	cell_type
cells	cell_type
(	O
G-CSF	protein
:	O
8%	O
dead	cell_type
cells	cell_type
at	O
day	O
6;	O
G-CSF	protein
+	O
RA	O
:	O
20%;	O
GM-CSF	protein
:	O
12%;	O
GM-CSF	protein
+	O
RA	O
:	O
27%).	O
Moreover,	O
RA	O
induced	O
apoptosis	O
of	O
CD34+	cell_type
cells	cell_type
and	O
CD34+CD71+	cell_type
cells	cell_type
stimulated	O
with	O
erythropoietin	protein
.	O
To	O
explore	O
the	O
receptor	O
signaling	O
pathways	O
involved	O
in	O
RA	O
-induced	O
apoptosis	O
,	O
we	O
used	O
selective	O
ligands	O
for	O
retinoic	protein
acid	protein
receptors	protein
(	O
RARs	O
;	O
RO13-7410)	O
and	O
retinoid	protein
X	protein
receptors	protein
(	O
RXRs	protein
;	O
RO	O
25-6603).	O
We	O
found	O
that	O
RARs	protein
were	O
involved	O
in	O
RA	O
-mediated	O
apoptosis	O
of	O
myeloid	O
progenitor	O
cells,	O
whereas	O
RARs	protein
as	O
well	O
as	O
RXRs	protein
were	O
involved	O
in	O
RA	O
-mediated	O
apoptosis	O
of	O
erythroid	cell_type
progenitor	cell_type
cells	cell_type
.	O

Suppressive	O
effects	O
of	O
anti-inflammatory	O
agents	O
on	O
human	cell_type
endothelial	cell_type
cell	cell_type
activation	O
and	O
induction	O
of	O
heat	protein
shock	protein
proteins	protein
.	O
BACKGROUND:	O
Studies	O
from	O
our	O
laboratory	O
have	O
shown	O
that	O
the	O
earliest	O
stages	O
of	O
atherosclerosis	O
may	O
be	O
mediated	O
by	O
an	O
autoimmune	O
reaction	O
against	O
heat	protein
shock	protein
protein	protein
60	protein
(	O
Hsp60	protein
).	O
The	O
interactions	O
of	O
Hsp60	cell_line
-specific	cell_line
T	cell_line
cells	cell_line
with	O
arterial	O
endothelial	cell_type
cells	cell_type
(	O
EC	cell_type
)	O
require	O
expression	O
of	O
both	O
Hsp60	protein
and	O
certain	O
adhesion	protein
molecules	protein
shown	O
to	O
be	O
induced	O
simultaneously	O
in	O
EC	cell_type
by	O
mechanical	O
and	O
other	O
types	O
of	O
stress.	O
Recently,	O
it	O
was	O
shown	O
that	O
suppression	O
of	O
T	O
cell-mediated	O
immune	O
responses	O
by	O
cyclosporin	O
A	O
(	O
CyA	O
)	O
enhanced	O
atherosclerotic	O
lesion	O
formation	O
in	O
mice	O
.	O
In	O
contrast,	O
aspirin	O
was	O
found	O
to	O
lower	O
the	O
risk	O
of	O
myocardial	O
infarction	O
in	O
men	O
.	O
These	O
conflicting	O
observations	O
may	O
be	O
due	O
to	O
different	O
effects	O
of	O
anti-inflammatory	O
agents	O
on	O
adhesion	O
molecule	O
and	O
Hsp	O
expression	O
in	O
EC	cell_type
,	O
respectively.	O
MATERIAL	O
AND	O
METHODS:	O
In	O
the	O
present	O
study,	O
we	O
analyzed	O
the	O
effects	O
of	O
CyA	O
,	O
aspirin	O
,	O
and	O
indomethacin	O
on	O
T	O
cell	O
proliferation	O
using	O
a	O
proliferation	O
assay.	O
To	O
explore	O
the	O
expression	O
of	O
adhesion	protein
molecules	protein
,	O
monocyte	protein
chemoattractant	protein
protein-1	protein
(	O
MCP-1	protein
),	O
and	O
Hsp60	protein
in	O
human	cell_type
umbilical	cell_type
vein	cell_type
endothelial	cell_type
cells	cell_type
(	O
HUVECs	cell_type
),	O
Northern	O
blot	O
analyses	O
were	O
used.	O
To	O
examine	O
the	O
activation	O
status	O
of	O
the	O
transcription	protein
factors	protein
nuclear	protein
factor	protein
kappaB	protein
(	O
NF-kappaB	protein
)	O
and	O
heat	protein
shock	protein
factor-1	protein
(	O
HSF-1	protein
),	O
electrophoretic	O
mobility	O
shift	O
assays	O
were	O
performed.	O
RESULTS:	O
With	O
the	O
exception	O
of	O
indomethacin	O
,	O
the	O
used	O
immunosuppressive	O
and	O
anti-inflammatory	O
agents	O
significantly	O
inhibited	O
T	O
cell	O
proliferation	O
in	O
response	O
to	O
influenza	protein
virus	protein
antigen	protein
in	O
a	O
dose-dependent	O
manner	O
.	O
Interestingly,	O
CyA	O
and	O
indomethacin	O
did	O
not	O
suppress	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
)-induced	O
adhesion	O
molecule	O
expression	O
on	O
HUVECs	cell_type
,	O
whereas	O
aspirin	O
had	O
an	O
inhibitory	O
effect	O
.	O
These	O
observations	O
correlated	O
with	O
the	O
modulation	O
of	O
NF-kappaB	protein
activity	O
in	O
EC	cell_type
.	O
All	O
agents	O
tested	O
induced	O
expression	O
of	O
Hsp60	protein
6	O
hr	O
after	O
application.	O
In	O
addition,	O
aspirin	O
and	O
indomethacin	O
,	O
but	O
not	O
CyA	O
,	O
induced	O
Hsp70	protein
expression	O
in	O
HUVECs	cell_type
that	O
correlated	O
with	O
induction	O
of	O
HSF-1	protein
activity	O
.	O
CONCLUSION:	O
Our	O
results	O
show	O
that	O
the	O
tested	O
agents	O
(except	O
indomethacin	O
)	O
are	O
inhibitors	O
of	O
the	O
T	O
cell-mediated	O
immune	O
response	O
,	O
as	O
expected,	O
that	O
aspirin	O
is	O
an	O
effective	O
suppressor	O
of	O
adhesion	protein
molecule	protein
expression	O
,	O
and	O
that	O
all	O
three	O
agents	O
can	O
induce	O
Hsp60	protein
in	O
HUVECs	cell_type
.	O
These	O
data	O
provide	O
the	O
molecular	O
basis	O
for	O
the	O
notion	O
that	O
(1)	O
part	O
of	O
the	O
anti-atherogenic	O
effect	O
of	O
aspirin	O
may	O
be	O
due	O
to	O
the	O
prevention	O
of	O
the	O
adhesion	O
of	O
sensitized	cell_type
T	cell_type
cells	cell_type
to	O
stressed	O
EC	cell_type
;	O
(2)	O
that	O
part	O
of	O
the	O
atherosclerosis-promoting	O
effect	O
of	O
CyA	O
may	O
be	O
due	O
to	O
its	O
potential	O
as	O
an	O
inducer	O
of	O
Hsp60	protein
expression	O
and	O
its	O
inability	O
to	O
down-regulate	O
adhesion	protein
molecule	protein
expression	O
on	O
EC	cell_type
;	O
and	O
(3)	O
that	O
down-regulation	O
of	O
MCP-1	protein
expression	O
by	O
aspirin	O
may	O
result	O
in	O
decreased	O
recruitment	O
of	O
monocytes	cell_type
into	O
the	O
arterial	O
intima	O
beneath	O
stressed	O
EC	cell_type
.	O

In	O
vivo	O
modulation	O
of	O
glucocorticoid	RNA
receptor	RNA
mRNA	RNA
by	O
inhaled	O
fluticasone	O
propionate	O
in	O
bronchial	O
mucosa	O
and	O
blood	cell_type
lymphocytes	cell_type
in	O
subjects	O
with	O
mild	O
asthma	O
.	O
BACKGROUND:	O
In	O
vivo	O
regulation	O
of	O
the	O
glucocorticoid	protein
receptor	protein
(	O
GR	protein
)	O
by	O
glucocorticoids	O
provides	O
a	O
means	O
of	O
modulating	O
sensitivity	O
of	O
targeted	O
cells.	O
OBJECTIVE:	O
We	O
sought	O
to	O
determine	O
the	O
in	O
vivo	O
modulation	O
of	O
GR	RNA
mRNA	RNA
expression	O
by	O
fluticasone	O
propionate	O
(	O
FP	O
)	O
in	O
subjects	O
with	O
mild	O
asthma	O
.	O
METHODS:	O
Ten	O
atopic	O
asthmatic	O
subjects	O
were	O
treated	O
with	O
FP	O
250	O
microg	O
twice	O
daily	O
for	O
4	O
weeks.	O
Before	O
and	O
after	O
treatment,	O
the	O
patients	O
underwent	O
fiberoptic	O
bronchoscopy	O
with	O
endobronchial	O
biopsy	O
and	O
sampling	O
of	O
venous	O
blood	O
for	O
measurements	O
of	O
GR	RNA
mRNA	RNA
levels.	O
A	O
solution	O
hybridization	O
assay	O
was	O
used	O
for	O
quantitative	O
analysis	O
of	O
GR	RNA
mRNA	RNA
.	O
In	O
addition,	O
a	O
24-hour	O
urinary	O
cortisol	O
excretion	O
and	O
an	O
adrenocorticotropic	O
hormone	O
test	O
before	O
and	O
after	O
treatment	O
with	O
FP	O
were	O
performed.	O
RESULTS:	O
A	O
high	O
interindividual	O
variation	O
in	O
GR	RNA
mRNA	RNA
expression	O
was	O
seen.	O
However,	O
we	O
detected	O
a	O
significant	O
reduction	O
of	O
the	O
GR	RNA
mRNA	RNA
levels	O
in	O
the	O
endobronchial	O
biopsy	O
specimens	O
after	O
FP	O
treatment	O
(36.6	O
+/-	O
23.1	O
and	O
25.0	O
+/-	O
10.9	O
amol	O
GR	RNA
mRNA	RNA
/microg	O
RNA	O
,	O
respectively;	O
P	O
&lt;.01).	O
In	O
the	O
peripheral	O
blood	cell_type
lymphocytes	cell_type
an	O
even	O
more	O
striking	O
downregulation	O
of	O
the	O
GR	O
by	O
its	O
cognate	O
ligand	O
was	O
documented	O
(30.3	O
+/-	O
26.5	O
and	O
8.8	O
+/-	O
5	O
amol	O
GR	RNA
mRNA	RNA
/microg	O
RNA,	O
respectively;	O
P	O
&lt;.001),	O
possibly	O
reflecting	O
differences	O
in	O
glucocorticoid	O
sensitivity	O
between	O
tissues.	O
A	O
small	O
but	O
significant	O
reduction	O
of	O
the	O
24-hour	O
urinary	O
cortisol	O
excretion	O
was	O
observed	O
(233	O
+/-	O
109	O
and	O
157	O
+/-	O
66	O
nmol/L,	O
respectively;	O
P	O
&lt;.01),	O
whereas	O
the	O
feedback	O
regulation	O
of	O
glucocorticoid	O
synthesis	O
by	O
means	O
of	O
the	O
hypothalamic-pituitary-adrenal	O
axis	O
as	O
assessed	O
by	O
the	O
adrenocorticotropic	O
hormone	O
test	O
remained	O
normal	O
after	O
treatment	O
with	O
FP	O
.	O
CONCLUSION:	O
The	O
results	O
in	O
this	O
study	O
confirm	O
the	O
potency	O
of	O
the	O
inhaled	O
corticosteroid	O
FP	O
and	O
provide	O
evidence	O
for	O
a	O
considerable	O
tissue-specific	O
interindividual	O
variation	O
in	O
the	O
expression	O
of	O
the	O
GR	protein
.	O

[Corticoids	O
and	O
allergy]	O
Inflammation	O
is	O
constantly	O
observed	O
in	O
allergic	O
reactions	O
.	O
Corticosteroids	O
are	O
most	O
effective	O
in	O
preventing	O
the	O
late	O
phase	O
of	O
allergic	O
reaction	O
.	O
The	O
action	O
of	O
glucocorticosteroids	O
is	O
mediated	O
through	O
glucocorticoid	protein
receptors	protein
present	O
in	O
the	O
cellular	O
cytoplasm	O
.	O
When	O
activated,	O
glucocorticoid	protein
receptors	protein
form	O
a	O
dimer	protein
and	O
bind	O
to	O
DNA	O
after	O
migration	O
into	O
the	O
nucleus	O
.	O
Interaction	O
to	O
DNA	O
induces	O
changes	O
in	O
the	O
transcription	O
rate	O
,	O
leading	O
to	O
either	O
gene	O
induction	O
or	O
gene	O
repression	O
.	O
Glucocorticoid	O
receptors	O
are	O
also	O
able	O
to	O
interact	O
with	O
transcriptional	O
factors	O
such	O
as	O
AP-1	protein
(	O
activator	protein
protein-1	protein
)	O
of	O
NF-kappa	protein
B	protein
(	O
nuclear	protein
factor-kappa	protein
B	protein
).	O
Through	O
these	O
actions	O
glucocorticosteroids	O
are	O
susceptible	O
to	O
modify	O
functions	O
of	O
cells	O
involved	O
in	O
the	O
allergic	O
inflammatory	O
response	O
.	O
They	O
are	O
in	O
particular	O
able	O
to	O
inhibit	O
most	O
of	O
the	O
pro-inflammatory	O
functions	O
of	O
the	O
eosinophils	cell_type
.	O

Jeg-3	O
human	O
choriocarcinoma-induced	O
immunosuppression	O
:	O
downregulation	O
of	O
interleukin-2	protein
,	O
interleukin-2	protein
receptor	protein
alpha-chain	protein
,	O
and	O
its	O
Jak/Stat	protein
signaling	O
pathway	O
.	O
PROBLEM:	O
The	O
mechanisms	O
of	O
the	O
immunosuppressive	O
and	O
immunosuppression-inducing	O
capacities	O
of	O
Jeg-3	cell_line
human	cell_line
choriocarcinoma	cell_line
cell	cell_line
line	cell_line
supernatants	O
(	O
HCSs	O
)	O
are	O
not	O
yet	O
completely	O
understood.	O
The	O
influence	O
on	O
interleukin	protein
(IL)-2	protein
,	O
IL-4	protein
and	O
interferon	protein
(IFN)-gamma	protein
production	O
;	O
IL-2	protein
receptor	protein
(IL-2R)	protein
alpha	protein
-,	O
beta	protein
-,	O
and	O
gamma-chain	protein
;	O
and	O
the	O
signaling	protein
pathway	protein
molecules	protein
Janus	protein
kinase	protein
(Jak)1	protein
,	O
Jak3	protein
,	O
signal	O
transducers	O
and	O
activators	protein
of	protein
transcription	protein
(Stat)1	protein
,	O
Stat3	protein
,	O
and	O
Stat5	protein
should	O
be	O
investigated.	O
METHOD	O
OF	O
STUDY:	O
For	O
assessment	O
of	O
IL	O
production	O
,	O
whole	O
peripheral	O
venous	O
blood	O
from	O
healthy	O
donors	O
was	O
stimulated	O
with	O
phorbol-myristate-acetate	O
and	O
ionomycine	O
.	O
Secretion	O
of	O
ILs	protein
was	O
blocked	O
with	O
monensine	O
.	O
Intracellular	O
ILs	protein
were	O
analyzed	O
by	O
flow	O
cytometry	O
.	O
For	O
IL-2R	protein
and	O
signaling	O
pathway	O
molecule	O
analysis	O
,	O
peripheral	O
blood	cell_type
lymphocytes	cell_type
were	O
stimulated	O
with	O
phytohemagglutinin	protein
(	O
PHA	protein
).	O
IL-2R	O
chains	O
were	O
measured	O
by	O
flow	O
cytometry	O
,	O
and	O
Jaks/Stats	protein
by	O
sodium	O
dodecyl	O
sulfate	O
polyacrylamide	O
gel	O
electrophoresis	O
(	O
SDS-PAGE	O
)	O
and	O
Western	O
blot	O
.	O
RESULTS:	O
Phorbol-myristate-acetate	O
and	O
ionomycine	O
strongly	O
increase	O
the	O
percent-age	O
of	O
IL-2+	cell_line
cells	cell_line
;	O
an	O
additional	O
50%	O
HCSs	O
significantly	O
suppresses	O
the	O
percentage	O
to,	O
or	O
below	O
the	O
level	O
of	O
unstimulated	cell_type
cells	cell_type
.	O
IFN-gamma	O
production	O
is	O
strongly	O
decreased	O
by	O
HCSs	O
in	O
some	O
cases,	O
but	O
not	O
in	O
others.	O
PHA	protein
stimulates	O
IL-2R	O
alpha-	O
,	O
beta-	O
,	O
and	O
gamma-	O
chain	O
expression	O
and	O
their	O
signaling	protein
pathway	protein
molecules	protein
Jak1	protein
,	O
Jak3	protein
,	O
Stat1,	O
Stat3	protein
,	O
and	O
Stat5	protein
.	O
50%	O
HCS	O
downregulates	O
the	O
alpha-chain	protein
and	O
slightly	O
upregulates	O
the	O
beta-chain	protein
.	O
Jak1	O
,	O
Jak3	O
,	O
Stat1	O
,	O
Stat3	O
,	O
and	O
Stat5	O
expression	O
is	O
suppressed	O
approximately	O
to,	O
or	O
below	O
the	O
level	O
of	O
unstimulated	cell_type
cells	cell_type
.	O
CONCLUSIONS:	O
HCS	O
forcefully	O
blocks	O
the	O
production	O
of	O
IL-2	protein
;	O
the	O
IL-2R	protein
alpha-chain	protein
;	O
and	O
Jak1	O
,	O
Jak3	O
,	O
Stat1	O
,	O
Stat3	O
,	O
and	O
Stat5	O
expression	O
.	O
The	O
observed	O
phenomena	O
might	O
be	O
caused	O
by	O
downregulation	O
of	O
an	O
IL-2R	DNA
regulation	DNA
gene	DNA
,	O
and	O
might	O
play	O
a	O
key	O
role	O
in	O
the	O
expansion	O
of	O
choriocarcinoma	O
,	O
and	O
possibly	O
in	O
the	O
survival	O
of	O
the	O
fetal	O
allograft	O
.	O

Apoptosis	cell_line
-resistant	cell_line
T	cell_line
cells	cell_line
have	O
a	O
deficiency	O
in	O
NF-kappaB	protein
-mediated	O
induction	O
of	O
Fas	protein
ligand	protein
transcription	O
.	O
Apoptosis	O
induced	O
through	O
the	O
TCR	protein
in	O
CD4+	cell_type
T	cell_type
cells	cell_type
is	O
mostly	O
mediated	O
by	O
the	O
inducible	O
expression	O
of	O
Fas	protein
ligand	protein
(	O
FasL	protein
)	O
as	O
a	O
primary	O
event	O
leading	O
to	O
the	O
commitment	O
to	O
death.	O
To	O
gain	O
a	O
better	O
understanding	O
of	O
the	O
transcriptional	O
events	O
that	O
regulate	O
this	O
expression,	O
we	O
took	O
advantage	O
of	O
our	O
previously	O
described	O
mutant	cell_line
Jurkat	cell_line
cells	cell_line
.	O
These	O
cells	O
are	O
deficient	O
in	O
FasL	protein
expression	O
and	O
apoptosis	O
induced	O
upon	O
TCR	protein
triggering,	O
although	O
their	O
cytokine	O
(	O
IL-2	protein
and	O
IFN-gamma	protein
)	O
production	O
is	O
normal.	O
Here	O
we	O
show	O
that	O
both	O
a	O
FasL-	O
and	O
a	O
consensus	O
NF-kappaB-	O
reporter	O
construct	O
are	O
inefficiently	O
induced	O
in	O
these	O
cells	O
compared	O
to	O
wild-type	cell_type
cells	cell_type
.	O
In	O
addition,	O
we	O
demonstrate	O
that	O
the	O
inducible	O
transcriptional	O
activity	O
of	O
the	O
FasL	DNA
reporter	DNA
is	O
abolished	O
by	O
specific	O
inhibitors	O
of	O
NF-kappaB	protein
activation	O
.	O
Thus,	O
we	O
could	O
trace	O
the	O
deficit	O
of	O
the	O
mutant	cell_type
cells	cell_type
to	O
an	O
inefficient	O
NF-kappaB	protein
activation	O
,	O
evidencing	O
a	O
relevant	O
role	O
for	O
NF-kappaB	protein
in	O
the	O
regulation	O
of	O
FasL	protein
expression	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
.	O
Furthermore,	O
our	O
results	O
suggest	O
that	O
the	O
induction	O
of	O
FasL	protein
versus	O
cytokine	DNA
gene	DNA
expression	O
is	O
differentially	O
sensitive	O
to	O
NF-kappaB	protein
deprivation	O
.	O

Decreased	O
proteasome	protein
-mediated	O
degradation	O
in	O
T	cell_type
cells	cell_type
from	O
the	O
elderly	O
:	O
A	O
role	O
in	O
immune	O
senescence	O
.	O
Induction	O
of	O
NFkappaB	protein
is	O
a	O
highly	O
regulated	O
process	O
requiring	O
phosphorylation	O
,	O
ubiquitination	O
,	O
and	O
proteasome	protein
-mediated	O
degradation	O
of	O
the	O
cytosolic	protein
inhibitor	protein
IkappaBalpha	protein
.	O
Analyses	O
of	O
the	O
regulation	O
of	O
IkappaBalpha	protein
in	O
TNF-alpha	cell_type
-treated	cell_type
T	cell_type
lymphocytes	cell_type
from	O
young	O
and	O
elderly	O
donors	O
revealed	O
severely	O
compromised	O
degradation	O
of	O
IkappaBalpha	protein
in	O
T	cell_type
cells	cell_type
from	O
the	O
elderly	O
.	O
Examination	O
of	O
activation-induced	O
phosphorylation	O
and	O
ubiquitination	O
of	O
IkappaBalpha	protein
did	O
not	O
demonstrate	O
any	O
significant	O
age-related	O
alterations	O
.	O
However,	O
examination	O
of	O
proteasome	protein
activity	O
in	O
these	O
T	cell_type
cells	cell_type
using	O
fluorogenic	O
peptide	O
assays	O
revealed	O
a	O
significant	O
age-related	O
decline	O
in	O
chymotryptic	O
activity	O
.	O
These	O
results	O
suggest	O
that	O
a	O
decline	O
in	O
proteasome	protein
activity	O
results	O
in	O
a	O
failure	O
to	O
fully	O
degrade	O
IkappaBalpha	protein
in	O
the	O
elderly	O
.	O
This	O
failure	O
to	O
degrade	O
IkappaBalpha	protein
may	O
underlie	O
both	O
the	O
observed	O
decrease	O
in	O
NFkappaB	protein
induction	O
and	O
the	O
IL-2	protein
receptor	O
expression	O
in	O
TNF-treated	cell_line
T	cell_line
cells	cell_line
during	O
aging.	O
Thus,	O
decreased	O
proteasome	protein
-mediated	O
degradation	O
may	O
be	O
central	O
to	O
immune	O
dysfunction	O
that	O
accompanies	O
aging.	O
Copyright	O
1999	O
Academic	O
Press.	O

Inhibition	O
of	O
IL-4	protein
-inducible	O
gene	O
expression	O
in	O
human	cell_type
monocytes	cell_type
by	O
type	O
I	O
and	O
type	O
II	O
interferons	O
.	O
The	O
Th2-type	protein
cytokines	protein
,	O
interleukin-4	protein
(	O
IL-4	protein
)	O
and	O
interleukin-13	protein
(	O
IL-13	protein
),	O
induce	O
expression	O
of	O
a	O
distinct	O
subset	O
of	O
genes	O
in	O
human	cell_type
monocytes	cell_type
,	O
including	O
FcepsilonRIIb	protein
(	O
CD23	protein
),	O
15-lipoxygenase	protein
,	O
IL-1	protein
receptor	protein
antagonist	protein
(	O
IL-1ra	protein
),	O
and	O
type	O
I	O
and	O
type	O
II	O
IL-1	O
receptors	O
(	O
IL-1R	protein
).	O
Type	protein
I	protein
interferons	protein
(	O
IFN-alpha	protein
and	O
IFN-beta	protein
)	O
and	O
type	protein
II	protein
interferon	protein
(	O
IFN-gamma	protein
)	O
inhibit	O
induction	O
of	O
these	O
genes	O
by	O
IL-4	protein
and	O
IL-13	protein
.	O
However,	O
the	O
mechanism	O
by	O
which	O
IFNs	protein
mediate	O
this	O
inhibition	O
has	O
not	O
been	O
defined.	O
In	O
this	O
overview,	O
we	O
discuss	O
the	O
role	O
of	O
the	O
transcription	protein
factor	protein
,	O
STAT6	protein
(	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription-6	protein
)	O
in	O
mediating	O
IL-4-	O
and	O
IL-13-	O
induced	O
gene	O
expression	O
in	O
monocytes	cell_type
.	O
We	O
also	O
discuss	O
our	O
recent	O
findings	O
that	O
type	O
I	O
and	O
type	O
II	O
IFNs	O
suppress	O
IL-4	protein
/	O
IL-13	protein
-inducible	O
gene	O
expression	O
by	O
inhibiting	O
tyrosine	O
phosphorylation	O
and	O
nuclear	O
translocation	O
of	O
STAT6	protein
.	O
The	O
ability	O
of	O
type	O
I	O
and	O
type	O
II	O
IFNs	O
to	O
inhibit	O
IL-4	protein
/	O
IL-13	protein
-induced	O
STAT6	protein
activity	O
is	O
dose-	O
and	O
time-dependent,	O
and	O
is	O
not	O
unique	O
to	O
monocytes	cell_type
because	O
IFNs	protein
induce	O
the	O
same	O
effects	O
in	O
fibroblasts	cell_type
.	O
Inhibition	O
of	O
STAT6	protein
activity	O
is	O
not	O
evident	O
unless	O
cells	O
are	O
preincubated	O
with	O
IFN	protein
for	O
at	O
least	O
1	O
h	O
before	O
IL-4	protein
stimulation	O
.	O
Furthermore,	O
inhibition	O
can	O
be	O
blocked	O
by	O
actinomycin	O
D	O
,	O
indicating	O
a	O
requirement	O
for	O
de	O
novo	O
transcription	O
.	O
We	O
propose	O
a	O
model	O
in	O
which	O
stimulation	O
of	O
monocytes	cell_type
by	O
IFN	protein
activates	O
de	O
novo	O
synthesis	O
of	O
an	O
inhibitory	protein
factor	protein
,	O
possibly	O
one	O
or	O
more	O
members	O
of	O
the	O
SOCS/	protein
SSI/CIS	protein
gene	protein
family	protein
,	O
capable	O
of	O
suppressing	O
activation	O
of	O
STAT6	protein
by	O
IL-4	protein
and	O
IL-13	protein
.	O
Because	O
STAT6	protein
activation	O
plays	O
an	O
essential	O
role	O
in	O
IL-4	protein
/	O
IL-13	protein
-induced	O
gene	O
expression	O
,	O
the	O
ability	O
of	O
IFN-beta	protein
and	O
IFN-gamma	protein
to	O
inhibit	O
STAT6	protein
activity	O
provides	O
an	O
explanation	O
for	O
how	O
IFNs	protein
can	O
suppress	O
IL-4	protein
/	O
IL-13	protein
-inducible	O
gene	O
expression	O
.	O

HLA	protein
class	protein
I	protein
-mediated	O
induction	O
of	O
cell	O
proliferation	O
involves	O
cyclin	DNA
E	DNA
-mediated	O
inactivation	O
of	O
Rb	O
function	O
and	O
induction	O
of	O
E2F	protein
activity	O
.	O
Chronic	O
rejection	O
of	O
transplanted	O
organs	O
is	O
manifested	O
as	O
atherosclerosis	O
of	O
the	O
blood	O
vessels	O
of	O
the	O
allograft	O
.	O
HLA	protein
class	protein
I	protein
Ags	protein
have	O
been	O
implicated	O
to	O
play	O
a	O
major	O
role	O
in	O
this	O
process,	O
since	O
signaling	O
via	O
HLA	protein
class	protein
I	protein
molecules	protein
can	O
induce	O
the	O
proliferation	O
of	O
aortic	cell_type
endothelial	cell_type
as	O
well	O
as	O
smooth	cell_type
muscle	cell_type
cells	cell_type
.	O
In	O
this	O
study,	O
we	O
show	O
that	O
HLA	protein
class	protein
I	protein
-mediated	O
induction	O
of	O
cell	O
proliferation	O
correlates	O
with	O
inactivation	O
of	O
the	O
Rb	protein
protein	protein
in	O
the	O
T	cell_line
cell	cell_line
line	cell_line
Jurkat	cell_line
as	O
well	O
as	O
human	cell_type
aortic	cell_type
endothelial	cell_type
cells	cell_type
.	O
HLA	protein
class	protein
I	protein
-mediated	O
inactivation	O
of	O
Rb	protein
can	O
be	O
inhibited	O
specifically	O
by	O
neutralizing	protein
Abs	protein
to	O
basic	protein
fibroblast	protein
growth	protein
factor	protein
(	O
bFGF	protein
),	O
suggesting	O
a	O
role	O
for	O
FGF	protein
receptors	protein
in	O
the	O
signaling	O
process.	O
Signaling	O
through	O
HLA	protein
class	protein
I	protein
molecules	protein
induced	O
cyclin	DNA
E	DNA
-associated	O
kinase	O
activity	O
within	O
4	O
h	O
in	O
quiescent	cell_type
endothelial	cell_type
cells	cell_type
,	O
and	O
appeared	O
to	O
mediate	O
the	O
inactivation	O
of	O
Rb	protein
.	O
A	O
cdk2	O
inhibitor	O
,	O
Olomoucine	O
,	O
as	O
well	O
as	O
a	O
dominant-negative	DNA
cdk2	DNA
construct	DNA
prevented	O
HLA	protein
class	protein
I	protein
-mediated	O
inactivation	O
of	O
Rb	protein
;	O
in	O
contrast,	O
dominant-negative	O
cdk4	O
and	O
cdk6	O
constructs	O
had	O
no	O
effect.	O
Furthermore,	O
there	O
was	O
no	O
increase	O
in	O
cyclin	protein
D-associated	protein
kinase	protein
activity	O
upon	O
HLA	protein
class	protein
I	protein
ligation	O
,	O
suggesting	O
that	O
cyclin	protein
E-dependent	protein
kinase	protein
activity	O
mediates	O
Rb	protein
inactivation,	O
leading	O
to	O
E2F	protein
activation	O
and	O
cell	O
proliferation	O
.	O

Immunosuppressant	O
PG490	O
(	O
triptolide	O
)	O
inhibits	O
T-cell	protein
interleukin-2	protein
expression	O
at	O
the	O
level	O
of	O
purine-box/nuclear	protein
factor	protein
of	O
activated	cell_type
T-cells	cell_type
and	O
NF-kappaB	protein
transcriptional	O
activation	O
.	O
PG490	O
(	O
triptolide	O
)	O
is	O
a	O
diterpene	O
triepoxide	O
with	O
potent	O
immunosuppressive	O
and	O
antiinflammatory	O
properties	O
.	O
PG490	O
inhibits	O
interleukin(IL)-2	protein
expression	O
by	O
normal	cell_type
human	cell_type
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
stimulated	O
with	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
and	O
antibody	O
to	O
CD3	protein
(IC50	O
of	O
10	O
ng/ml),	O
and	O
with	O
PMA	O
and	O
ionomycin	O
(Iono,	O
IC50	O
of	O
40	O
ng/ml).	O
In	O
Jurkat	cell_line
T-cells	cell_line
,	O
PG490	O
inhibits	O
PMA	O
/Iono-stimulated	O
IL-2	protein
transcription	O
.	O
PG490	O
inhibits	O
the	O
induction	O
of	O
DNA	O
binding	O
activity	O
at	O
the	O
purine-box/antigen	DNA
receptor	DNA
response	DNA
element	DNA
(ARRE)/nuclear	DNA
factor	DNA
of	DNA
activated	DNA
T-cells	DNA
(NF-AT)	DNA
target	DNA
sequence	DNA
but	O
not	O
at	O
the	O
NF-kappaB	DNA
site	DNA
.	O
PG490	O
can	O
completely	O
inhibit	O
transcriptional	O
activation	O
at	O
the	O
purine-box/ARRE/NF-AT	O
and	O
NF-kappaB	O
target	O
DNA	O
sequences	O
triggered	O
by	O
all	O
stimuli	O
examined	O
(	O
PMA	O
,	O
PMA	O
/Iono	O
,	O
tumor	protein
necrosis	protein
factor-alpha	protein
).	O
PG490	O
also	O
inhibits	O
PMA	O
-stimulated	O
activation	O
of	O
a	O
chimeric	protein
transcription	protein
factor	protein
in	O
which	O
the	O
C-terminal	protein
TA1	protein
transactivation	protein
domain	protein
of	O
NF-kappaB	protein
p65	protein
is	O
fused	O
to	O
the	O
DNA	protein
binding	protein
domain	protein
of	O
GAL4	protein
.	O
In	O
16HBE	cell_type
human	cell_type
bronchial	cell_type
epithelial	cell_type
cells	cell_type
,	O
IL-8	protein
expression	O
is	O
regulated	O
predominantly	O
by	O
NF-kappaB	protein
,	O
and	O
PG490	O
but	O
not	O
cyclosporin	O
A	O
can	O
completely	O
inhibit	O
expression	O
of	O
IL-8	protein
.	O
The	O
mechanism	O
of	O
PG490	O
inhibition	O
of	O
cytokine	DNA
gene	DNA
expression	O
differs	O
from	O
cyclosporin	O
A	O
and	O
involves	O
nuclear	O
inhibition	O
of	O
transcriptional	O
activation	O
of	O
NF-kappaB	protein
and	O
the	O
purine-box	DNA
regulator	DNA
operating	O
at	O
the	O
ARRE/NF-AT	DNA
site	DNA
at	O
a	O
step	O
after	O
specific	O
DNA	O
binding	O
.	O

Unexpected	O
and	O
coordinated	O
expression	O
of	O
Spi-1	protein
,	O
Fli-1	protein
,	O
and	O
megakaryocytic	DNA
genes	DNA
in	O
four	O
Epo-dependent	cell_line
cell	cell_line
lines	cell_line
established	O
from	O
transgenic	O
mice	O
displaying	O
erythroid-specific	O
expression	O
of	O
a	O
thermosensitive	protein
SV40	protein
T	protein
antigen	protein
.	O
Most	O
erythroleukemic	cell_line
cell	cell_line
lines	cell_line
established	O
in	O
vitro	O
coexpress	O
erythrocytic	O
and	O
megakaryocytic	O
markers	O
that	O
often	O
are	O
associated	O
with	O
expression	O
of	O
Spi-1	protein
and/or	O
Fli-1	protein
transcription	protein
factors	protein
known	O
as	O
transactivators	protein
of	protein
megakaryocyte-specific	protein
promoters	protein
.	O
In	O
the	O
present	O
study,	O
we	O
examined	O
the	O
possibility	O
of	O
establishing	O
new	cell_line
cell	cell_line
lines	cell_line
keeping	O
strictly	O
erythroid-specific	O
properties	O
in	O
vitro	O
through	O
the	O
targeted	O
and	O
conditional	O
immortalization	O
of	O
erythrocytic	cell_type
progenitors	cell_type
.	O
For	O
that	O
purpose,	O
we	O
established	O
several	O
lines	O
of	O
transgenic	O
mice	O
displaying	O
erythroid-specific	O
expression	O
of	O
a	O
thermosensitive	protein
SV40	protein
T	protein
antigen	protein
.	O
As	O
expected,	O
these	O
transgenic	O
mice	O
developed	O
splenomegaly	O
due	O
to	O
the	O
massive	O
amplification	O
of	O
Ter	cell_line
119	cell_line
positive	cell_line
erythroid	cell_line
nucleated	cell_line
cells	cell_line
expressing	O
T	protein
antigen	protein
.	O
Despite	O
this	O
drastic	O
effect	O
in	O
vivo,	O
the	O
in	O
vitro	O
immortalization	O
of	O
erythropoietin-dependent	cell_type
erythroid	cell_type
progenitors	cell_type
unexpectedly	O
occurred	O
at	O
low	O
frequency,	O
and	O
all	O
four	O
cell	cell_line
lines	cell_line
established	O
expressed	O
both	O
erythrocytic	O
(globins)	O
and	O
megakaryocytic	O
markers	O
(	O
glycoprotein	protein
IIb	protein
,	O
platelet	protein
factor	protein
4	protein
)	O
as	O
well	O
as	O
Spi-1	protein
and	O
Fli-1	protein
transcripts	protein
at	O
permissive	O
temperature	O
.	O
Switching	O
the	O
cells	O
to	O
the	O
nonpermissive	O
temperature	O
led	O
to	O
a	O
marked	O
increase	O
in	O
globin	DNA
gene	DNA
expression	O
and	O
concomitant	O
decrease	O
in	O
expression	O
of	O
Spi-1	protein
,	O
Fli-1	protein
,	O
and	O
megakaryocytic	DNA
genes	DNA
in	O
an	O
erythropoietin	protein
-dependent	O
manner	O
.	O
Interestingly,	O
enhanced	O
expression	O
of	O
Spi-1	O
and	O
Fli-1	O
genes	O
already	O
was	O
detected	O
in	O
the	O
Ter	cell_line
119	cell_line
positive	cell_line
cell	cell_line
population	cell_line
of	O
transgenic	O
mice	O
spleen	O
in	O
vivo.	O
However,	O
like	O
normal	cell_line
Ter	cell_line
119	cell_line
erythroid	cell_line
cells	cell_line
,	O
these	O
Ter	cell_line
119	cell_line
positive	cell_line
cells	cell_line
from	O
transgenic	O
mice	O
still	O
expressed	O
high	O
levels	O
of	O
beta-globin	protein
and	O
very	O
low	O
or	O
undetectable	O
glycoprotein	protein
IIb	protein
and	O
platelet	protein
factor	protein
4	protein
megakaryocytic	protein
transcripts	protein
.	O
Taken	O
together,	O
these	O
data	O
indicate	O
that	O
the	O
unexpected	O
expression	O
of	O
megakaryocytic	DNA
genes	DNA
is	O
a	O
specific	O
property	O
of	O
immortalized	cell_line
cells	cell_line
that	O
cannot	O
be	O
explained	O
only	O
by	O
enhanced	O
expression	O
of	O
Spi-1	O
and/or	O
Fli-1	O
genes	O
.	O

Fludarabine	O
-induced	O
immunosuppression	O
is	O
associated	O
with	O
inhibition	O
of	O
STAT1	protein
signaling	O
.	O
Fludarabine	O
is	O
a	O
nucleoside	O
analog	O
used	O
in	O
the	O
treatment	O
of	O
hematologic	O
malignancies	O
that	O
can	O
induce	O
severe	O
and	O
prolonged	O
immunosuppression	O
.	O
Although	O
it	O
can	O
be	O
incorporated	O
into	O
the	O
DNA	O
of	O
dividing	O
cells,	O
fludarabine	O
is	O
also	O
a	O
potent	O
inhibitor	O
of	O
cells	O
with	O
a	O
low	O
growth	O
fraction	O
,	O
thus	O
it	O
must	O
have	O
other	O
mechanisms	O
of	O
action.	O
STAT1	protein
,	O
which	O
is	O
activated	O
in	O
response	O
to	O
many	O
lymphocyte-activating	protein
cytokines	protein
including	O
the	O
interferons	protein
,	O
is	O
essential	O
for	O
cell-mediated	O
immunity	O
,	O
as	O
the	O
absence	O
of	O
this	O
protein	O
is	O
associated	O
with	O
prominent	O
defects	O
in	O
the	O
ability	O
to	O
control	O
viral	O
infections	O
.	O
Here	O
we	O
show	O
that	O
fludarabine	O
,	O
but	O
not	O
the	O
immunosuppressant	O
cyclosporine	O
A	O
,	O
inhibits	O
the	O
cytokine	protein
-induced	O
activation	O
of	O
STAT1	protein
and	O
STAT1	protein
-dependent	O
gene	O
transcription	O
in	O
normal	O
resting	O
or	O
activated	O
lymphocytes	O
.	O
Fludarabine	O
caused	O
a	O
specific	O
depletion	O
of	O
STAT1	protein
protein	protein
(and	O
mRNA)	O
but	O
not	O
of	O
other	O
STATs	protein
.	O
This	O
loss	O
of	O
STAT1	protein
was	O
also	O
seen	O
in	O
cells	O
from	O
patients	O
treated	O
with	O
fludarabine	O
in	O
vivo.	O
Brief	O
exposure	O
to	O
fludarabine	O
led	O
to	O
a	O
sustained	O
loss	O
of	O
STAT1	protein
,	O
analogous	O
to	O
the	O
prolonged	O
period	O
of	O
immunosuppression	O
induced	O
by	O
exposure	O
to	O
the	O
drug	O
in	O
vivo.	O
Thus,	O
STAT1	protein
may	O
be	O
a	O
useful	O
target	O
in	O
the	O
development	O
of	O
new	O
immunosuppressive	O
and	O
antineoplastic	O
agents	O
.	O

Studies	O
into	O
the	O
effect	O
of	O
tyrosine	protein
phosphatase	protein
inhibitor	O
phenylarsine	O
oxide	O
on	O
NFkappaB	protein
activation	O
in	O
T	cell_type
lymphocytes	cell_type
during	O
aging:	O
evidence	O
for	O
altered	O
IkappaB-alpha	protein
phosphorylation	O
and	O
degradation.	O
Nuclear	protein
Factor	protein
kappa	protein
B	protein
(	O
NFkappaB	protein
)	O
is	O
a	O
critical	O
regulator	O
of	O
several	O
genes	O
involved	O
in	O
immune	O
and	O
inflammatory	O
responses	O
.	O
Treatment	O
of	O
T	cell_type
cells	cell_type
with	O
a	O
variety	O
of	O
stimuli,	O
including	O
TNF-alpha	protein
,	O
leads	O
to	O
the	O
translocation	O
of	O
the	O
active	O
p65-50	protein
heterodimer	protein
to	O
the	O
nucleus	O
,	O
albeit	O
at	O
a	O
lower	O
level	O
in	O
T	cell_type
cells	cell_type
from	O
the	O
elderly.	O
We	O
demonstrate	O
here	O
that	O
pretreatment	O
with	O
PAO	O
results	O
in	O
the	O
inhibition	O
of	O
NFkappaB	protein
induction	O
in	O
TNF-alpha	protein
treated	O
T	cell_type
cells	cell_type
,	O
suggesting	O
a	O
role	O
for	O
PAO	protein
-sensitive	protein
phosphatase	protein
in	O
the	O
activation	O
of	O
the	O
NFkappaB	protein
via	O
this	O
pathway	O
in	O
human	cell_type
T	cell_type
cells	cell_type
.	O
Furthermore,	O
it	O
demonstrates	O
that	O
aging	O
does	O
not	O
influence	O
the	O
sensitivity	O
of	O
this	O
phosphatase	protein
.	O
Treatment	O
with	O
DMP	O
prior	O
to	O
treatment	O
with	O
PAO	O
and	O
TNF	protein
abolishes	O
the	O
inhibition	O
induced	O
by	O
PAO	O
,	O
in	O
T	cell_type
cells	cell_type
from	O
both	O
young	O
and	O
old	O
donors	O
,	O
alike.	O
Finally,	O
we	O
demonstrate	O
that	O
a	O
failure	O
to	O
degrade	O
IkappaB-alpha	protein
in	O
cytosols	O
of	O
TNF	cell_type
-treated	cell_type
T	cell_type
cells	cell_type
pretreated	O
with	O
PAO	O
is	O
due	O
to	O
its	O
interference	O
with	O
the	O
phosphorylation	O
of	O
IkappaB-alpha	protein
and	O
not	O
due	O
to	O
its	O
inhibitory	O
effect	O
on	O
proteasomal	O
degradation	O
.	O
These	O
data	O
collectively	O
suggest	O
that	O
PAO	O
interferes	O
with	O
the	O
phosphorylation	O
and	O
the	O
regulated	O
degradation	O
of	O
IkappaB-alpha	protein
,	O
induced	O
by	O
TNF	protein
,	O
without	O
affecting	O
the	O
chymotryptic	O
activity	O
of	O
the	O
proteasome	protein
,	O
independent	O
of	O
age.	O

Spi-C	protein
,	O
a	O
novel	O
Ets	protein
protein	protein
that	O
is	O
temporally	O
regulated	O
during	O
B	O
lymphocyte	O
development	O
.	O
A	O
novel	O
Ets	protein
protein	protein
was	O
isolated	O
by	O
yeast	O
one-hybrid	O
screening	O
of	O
a	O
cDNA	DNA
library	DNA
made	O
from	O
lipopolysaccharide-stimulated	cell_line
mouse	cell_line
splenic	cell_line
B	cell_line
cells	cell_line
,	O
using	O
the	O
SP6	DNA
kappa	DNA
promoter	DNA
kappaY	DNA
element	DNA
as	O
a	O
bait.	O
The	O
novel	O
Ets	protein
protein	protein
was	O
most	O
closely	O
related	O
to	O
PU.1	protein
and	O
Spi-B	protein
within	O
the	O
DNA	DNA
binding	DNA
Ets	DNA
domain	DNA
and	O
was	O
therefore	O
named	O
Spi-C	protein
.	O
However,	O
Spi-C	protein
may	O
represent	O
a	O
novel	O
subgroup	O
within	O
the	O
Ets	protein
protein	protein
family	protein
,	O
as	O
it	O
differed	O
significantly	O
from	O
Spi-B	protein
and	O
PU.1	protein
within	O
helix	protein
1	protein
of	O
the	O
Ets	protein
domain	protein
.	O
Spi-C	protein
was	O
encoded	O
by	O
a	O
single-copy	DNA
gene	DNA
that	O
was	O
mapped	O
to	O
chromosome	DNA
10	DNA
,	O
region	DNA
C	DNA
.	O
Spi-C	protein
interacted	O
with	O
DNA	O
similarly	O
to	O
PU.1	protein
as	O
judged	O
by	O
methylation	O
interference	O
,	O
band-shift	O
and	O
site	O
selection	O
analysis	O
,	O
and	O
activated	O
transcription	O
of	O
a	O
kappaY	DNA
element	DNA
reporter	DNA
gene	DNA
upon	O
co-transfection	O
of	O
HeLa	cell_line
cells	cell_line
.	O
Spi-C	RNA
RNA	RNA
was	O
expressed	O
in	O
mature	cell_type
B	cell_type
lymphocytes	cell_type
and	O
at	O
lower	O
levels	O
in	O
macrophages	cell_type
.	O
Furthermore,	O
pre-B	O
cell	O
and	O
plasma	O
cell	O
lines	O
were	O
Spi-C	protein
-negative	O
,	O
suggesting	O
that	O
Spi-C	protein
might	O
be	O
a	O
regulatory	protein
molecule	protein
during	O
a	O
specific	O
phase	O
of	O
B	O
lymphoid	O
development	O
.	O

Glucocorticoid	O
-induced	O
cell	O
death	O
requires	O
autoinduction	O
of	O
glucocorticoid	protein
receptor	protein
expression	O
in	O
human	cell_type
leukemic	cell_type
T	cell_type
cells	cell_type
.	O
In	O
contrast	O
to	O
the	O
negative	O
autoregulation	O
of	O
glucocorticoid	protein
receptor	protein
(	O
GR	protein
)	O
expression	O
seen	O
in	O
most	O
cells	O
and	O
tissues,	O
GR	protein
expression	O
is	O
positively	O
autoregulated	O
in	O
human	cell_type
leukemic	cell_type
T	cell_type
cells	cell_type
and	O
in	O
other	O
cells	O
sensitive	O
to	O
glucocorticoid-induced	O
cell	O
death	O
.	O
To	O
determine	O
whether	O
positive	O
autoregulation	O
is	O
a	O
necessary	O
component	O
of	O
glucocorticoid-induced	O
cell	O
death	O
,	O
a	O
wild-type	DNA
GR	DNA
gene	DNA
under	O
the	O
control	O
of	O
a	O
tetracycline	DNA
-regulated	DNA
promoter	DNA
was	O
stably	O
transfected	O
into	O
glucocorticoid-resistant	cell_line
cells	cell_line
lacking	O
endogenous	O
functional	O
receptor.	O
Transfectants	cell_line
grown	O
in	O
the	O
presence	O
of	O
tetracycline	O
contained	O
about	O
15,000	O
receptors/cell,	O
a	O
value	O
approximately	O
equal	O
to	O
basal	O
level	O
GR	protein
expression	O
in	O
glucocorticoid-sensitive	cell_line
6TG1.1	cell_line
cells	cell_line
before	O
steroid	O
treatment	O
.	O
Under	O
these	O
conditions,	O
dexamethasone	O
had	O
a	O
minimal	O
effect	O
on	O
cell	O
growth,	O
elicited	O
little	O
internucleosomal	O
DNA	O
fragmentation	O
,	O
and	O
induced	O
no	O
cell	O
cycle	O
perturbation	O
.	O
In	O
the	O
absence	O
of	O
tetracycline	O
,	O
GR	RNA
mRNA	RNA
and	O
protein	O
expression	O
increased	O
2-3-fold,	O
and	O
cells	O
expressed	O
48,000	O
receptors,	O
a	O
level	O
nearly	O
equivalent	O
to	O
that	O
present	O
in	O
6TG1.1	cell_line
cells	cell_line
after	O
18	O
h	O
of	O
autoinduction.	O
Under	O
these	O
conditions,	O
dexamethasone	O
markedly	O
inhibited	O
cell	O
growth	O
,	O
caused	O
G1	O
arrest,	O
and	O
induced	O
significant	O
internucleosomal	O
DNA	O
fragmentation	O
.	O
These	O
studies	O
therefore	O
suggest	O
that	O
basal	O
level	O
GR	protein
expression	O
is	O
inadequate	O
to	O
mediate	O
glucocorticoid-induced	O
apoptosis	O
in	O
glucocorticoid-sensitive	cell_line
T	cell_line
cells	cell_line
and	O
that	O
positive	O
autoregulation	O
is	O
a	O
necessary	O
component	O
of	O
this	O
process.	O

Constitutive	O
activation	O
of	O
NF-kappaB	protein
in	O
primary	cell_type
adult	cell_type
T-cell	cell_type
leukemia	cell_type
cells	cell_type
.	O
Human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
is	O
an	O
etiologic	O
agent	O
of	O
adult	O
T-cell	O
leukemia	O
(	O
ATL	O
).	O
The	O
viral	protein
protein	protein
Tax	protein
induces	O
the	O
activation	O
and	O
nuclear	O
translocalization	O
of	O
transcription	protein
factor	protein
NF-kappaB	protein
,	O
which	O
is	O
proposed	O
to	O
play	O
a	O
crucial	O
role	O
in	O
the	O
transformation	O
of	O
T	cell_type
cells	cell_type
by	O
HTLV-I	O
.	O
However,	O
the	O
HTLV-I	DNA
genes	DNA
including	O
Tax	protein
are	O
not	O
expressed	O
significantly	O
in	O
primary	cell_type
leukemic	cell_type
cells	cell_type
from	O
ATL	O
patients	O
.	O
In	O
this	O
study,	O
we	O
examined	O
the	O
basis	O
for	O
NF-kappaB	protein
activation	O
in	O
freshly	cell_type
isolated	cell_type
leukemic	cell_type
cells	cell_type
from	O
ATL	O
patients	O
.	O
We	O
found	O
that	O
leukemic	cell_type
cells	cell_type
from	O
ATL	O
patients	O
,	O
like	O
HTLV-I	cell_line
-infected	cell_line
T-cell	cell_line
lines	cell_line
,	O
display	O
constitutive	O
NF-kappaB	protein
DNA	O
binding	O
activity	O
and	O
increased	O
degradation	O
of	O
IkappaBalpha	protein
(an	O
inhibitor	O
of	O
NF-kappaB	protein
).	O
Whereas	O
the	O
NF-kappaB	protein
binding	O
activity	O
in	O
Tax	cell_line
-expressing	cell_line
T-cell	cell_line
lines	cell_line
consisted	O
mostly	O
of	O
p50/c-Rel	protein
,	O
fresh	O
ATL	O
samples	O
contained	O
p50/p50	O
and	O
p50/p65	O
heterodimers	O
.	O
One	O
T-cell	cell_line
line	cell_line
derived	O
from	O
ATL	O
leukemic	cell_type
cells	cell_type
,	O
TL-Om1,	O
displayed	O
constitutive	O
NF-kappaB	protein
activity	O
,	O
as	O
well	O
as	O
enhanced	O
degradation	O
of	O
IkappaBalpha	protein
,	O
despite	O
the	O
lack	O
of	O
detectable	O
Tax	protein
expression	O
.	O
Interestingly,	O
the	O
NF-kappaB	protein
in	O
TL-Om1	O
consists	O
of	O
p50/p50	protein
and	O
p50/p65	protein
like	O
that	O
in	O
fresh	O
primary	cell_type
leukemic	cell_type
cells	cell_type
.	O
Our	O
results	O
suggest	O
that	O
activation	O
of	O
NF-kappaB	protein
occurs	O
through	O
a	O
Tax	protein
-independent	O
mechanism	O
in	O
leukemic	cell_type
cells	cell_type
of	O
ATL	O
patients	O
,	O
possibly	O
due	O
to	O
differential	O
NF-kappaB	protein
subunit	O
activation	O
.	O

Interferon-alpha	protein
induction	O
of	O
STATs	O
1	O
,	O
-3	O
DNA	O
binding	O
and	O
growth	O
arrest	O
is	O
independent	O
of	O
Lck	protein
and	O
active	O
mitogen-activated	protein
kinase	protein
in	O
T	cell_type
cells	cell_type
.	O
Type	O
I	O
interferons	protein
(	O
IFNs	protein
)	O
are	O
a	O
family	O
of	O
cytokines	protein
that	O
have	O
antiviral	O
and	O
antiproliferative	O
effects	O
.	O
Data	O
regarding	O
the	O
processes	O
by	O
which	O
these	O
cytokines	protein
transduce	O
signals	O
from	O
the	O
cell	O
membrane	O
to	O
the	O
nucleus	O
are	O
becoming	O
increasingly	O
complex.	O
The	O
most	O
characterized	O
pathway	O
is	O
via	O
JAK	protein
-STAT	protein
signaling	O
.	O
Previous	O
studies	O
established	O
a	O
potential	O
role	O
for	O
the	O
Src-family	protein
kinase	protein
Lck	protein
in	O
JAK	protein
-STAT	protein
signaling	O
.	O
Therefore,	O
this	O
study	O
was	O
designed	O
to	O
analyze	O
the	O
role	O
of	O
Lck	protein
in	O
IFN-alpha	protein
signaling	O
by	O
using	O
the	O
Jurkat,	O
JCam	O
(an	O
Lck	cell_line
-defective	cell_line
cell	cell_line
line	cell_line
derived	O
from	O
Jurkat	cell_line
),	O
and	O
JCam/	cell_line
Lck	cell_line
(	O
JCam	cell_line
cells	cell_line
with	O
Lck	protein
restored).	O
The	O
results	O
show	O
that	O
IFN-alpha	protein
can	O
induce	O
MAPK	protein
activity	O
,	O
but	O
only	O
in	O
cells	O
containing	O
Lck	protein
.	O
Furthermore,	O
STATs	O
1	O
and	O
-3	O
are	O
effectively	O
phosphorylated	O
and	O
activated	O
to	O
bind	O
DNA	O
in	O
the	O
absence	O
of	O
Lck	protein
expression	O
in	O
IFN-alpha	cell_line
-treated	cell_line
cells	cell_line
.	O
Finally,	O
the	O
results	O
demonstrate	O
that	O
IFN-alpha	protein
exerts	O
an	O
antiproliferative	O
effect	O
in	O
all	O
three	O
cell	O
lines.	O
These	O
data	O
indicate	O
that	O
Lck	protein
and	O
active	O
MAPK	protein
do	O
not	O
affect	O
IFN-alpha	protein
-induced	O
growth	O
arrest	O
or	O
induction	O
of	O
STAT1s1	O
and	O
-3	O
DNA	O
binding	O
ability	O
.	O
Copyright	O
1999	O
Academic	O
Press.	O

Selective	O
activation	O
and	O
functional	O
significance	O
of	O
p38alpha	protein
mitogen-activated	protein
protein	protein
kinase	protein
in	O
lipopolysaccharide	cell_line
-stimulated	cell_line
neutrophils	cell_line
.	O
Activation	O
of	O
leukocytes	cell_type
by	O
proinflammatory	O
stimuli	O
selectively	O
initiates	O
intracellular	O
signal	O
transduction	O
via	O
sequential	O
phosphorylation	O
of	O
kinases	protein
.	O
Lipopolysaccharide	O
(	O
LPS	O
)	O
stimulation	O
of	O
human	cell_type
neutrophils	cell_type
is	O
known	O
to	O
result	O
in	O
activation	O
of	O
p38	protein
mitogen-activated	protein
protein	protein
kinase	protein
(	O
MAPk	protein
);	O
however,	O
the	O
upstream	protein
activator	protein
(s)	O
of	O
p38	protein
MAPk	protein
is	O
unknown,	O
and	O
consequences	O
of	O
p38	protein
MAPk	protein
activation	O
remain	O
largely	O
undefined.	O
We	O
investigated	O
the	O
MAPk	protein
kinase	protein
(	O
MKK	protein
)	O
that	O
activates	O
p38	protein
MAPk	protein
in	O
response	O
to	O
LPS	O
,	O
the	O
p38	protein
MAPk	protein
isoforms	protein
that	O
are	O
activated	O
as	O
part	O
of	O
this	O
pathway,	O
and	O
the	O
functional	O
responses	O
affected	O
by	O
p38	protein
MAPk	protein
activation	O
.	O
Although	O
MKK3	protein
,	O
MKK4	protein
,	O
and	O
MKK6	protein
all	O
activated	O
p38	protein
MAPk	protein
in	O
experimental	O
models	O
,	O
only	O
MKK3	protein
was	O
found	O
to	O
activate	O
recombinant	O
p38	protein
MAPk	protein
in	O
LPS	O
-treated	O
neutrophils.	O
Of	O
p38	protein
MAPk	protein
isoforms	protein
studied,	O
only	O
p38alpha	protein
and	O
p38delta	protein
were	O
detected	O
in	O
neutrophils	cell_type
.	O
LPS	O
stimulation	O
selectively	O
activated	O
p38alpha	protein
.	O
Specific	O
inhibitors	O
of	O
p38alpha	protein
MAPk	protein
blocked	O
LPS	O
-induced	O
adhesion	O
,	O
nuclear	O
factor-kappa	O
B	O
(	O
NF-kappaB	protein
)	O
activation	O
,	O
and	O
synthesis	O
of	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
).	O
Inhibition	O
of	O
p38alpha	protein
MAPk	protein
resulted	O
in	O
a	O
transient	O
decrease	O
in	O
TNF-alpha	RNA
mRNA	RNA
accumulation	O
but	O
persistent	O
loss	O
of	O
TNF-alpha	protein
synthesis	O
.	O
These	O
findings	O
support	O
a	O
pathway	O
by	O
which	O
LPS	O
stimulation	O
of	O
neutrophils	cell_type
results	O
in	O
activation	O
of	O
MKK3	protein
,	O
which	O
in	O
turn	O
activates	O
p38alpha	protein
MAPk	protein
,	O
ultimately	O
regulating	O
adhesion,	O
NF-kappaB	protein
activation	O
,	O
enhanced	O
gene	O
expression	O
of	O
TNF-alpha	protein
,	O
and	O
regulation	O
of	O
TNF-alpha	protein
synthesis	O
.	O

The	O
evolutionarily	DNA
conserved	DNA
sequence	DNA
upstream	O
of	O
the	O
human	protein
Ig	protein
heavy	protein
chain	protein
S	protein
gamma	protein
3	protein
region	protein
is	O
an	O
inducible	DNA
promoter	DNA
:	O
synergistic	O
activation	O
by	O
CD40	protein
ligand	protein
and	O
IL-4	protein
via	O
cooperative	O
NF-kappa	O
B	O
and	O
STAT-6	O
binding	O
sites	O
.	O
Germline	O
C	O
gamma	O
gene	O
transcription	O
is	O
a	O
crucial	O
event	O
in	O
the	O
process	O
that	O
leads	O
to	O
switch	O
DNA	O
recombination	O
to	O
IgG	protein
,	O
but	O
its	O
regulation	O
in	O
the	O
human	O
is	O
poorly	O
understood.	O
We	O
took	O
advantage	O
of	O
our	O
monoclonal	O
model	O
of	O
germinal	cell_type
center	cell_type
B	cell_type
cell	cell_type
differentiation	O
,	O
IgM+	cell_line
IgD+	cell_line
CL-01	cell_line
cells	cell_line
,	O
to	O
define	O
the	O
role	O
of	O
the	O
I	protein
gamma	protein
3	protein
evolutionarily	DNA
conserved	DNA
sequence	DNA
(	O
ECS	DNA
)	O
in	O
the	O
germline	DNA
transcriptional	O
activation	O
of	O
the	O
human	DNA
C	DNA
gamma	DNA
3	DNA
gene	DNA
.	O
The	O
I	protein
gamma	protein
3	protein
ECS	DNA
lies	O
upstream	O
of	O
the	O
major	DNA
I	DNA
gamma	DNA
3	DNA
transcription	DNA
initiation	DNA
site	DNA
and	O
displays	O
more	O
than	O
90%	O
identity	O
with	O
the	O
corresponding	O
human	DNA
I	DNA
gamma	DNA
1	DNA
,	O
I	DNA
gamma	DNA
2	DNA
,	O
and	O
I	DNA
gamma	DNA
4	DNA
regions.	O
Reporter	DNA
luciferase	DNA
gene	DNA
vectors	DNA
containing	O
the	O
human	DNA
gamma	DNA
3	DNA
ECS	DNA
were	O
used	O
to	O
transfect	O
CL-01	cell_line
cells	cell_line
,	O
which	O
have	O
been	O
shown	O
to	O
undergo	O
Smu--&gt;S	O
gamma	O
3	O
DNA	O
recombination	O
,	O
upon	O
engagement	O
of	O
CD40	protein
by	O
CD40	protein
ligand	protein
(	O
CD40L	protein
)	O
and	O
exposure	O
to	O
IL-4	protein
.	O
In	O
these	O
transfected	O
CL-01	cell_line
cells	cell_line
,	O
CD40:	O
CD40L	protein
engagement	O
and	O
exposure	O
to	O
IL-4	protein
synergistically	O
induced	O
gamma	O
3	O
ECS-dependent	O
luciferase	DNA
reporter	DNA
gene	DNA
activation	O
.	O
Targeted	O
mutational	O
analysis	O
demonstrated	O
that	O
a	O
tandem	O
NF-kappa	DNA
B	DNA
/Rel	DNA
binding	DNA
motif	DNA
is	O
critical	O
for	O
the	O
gamma	DNA
3	DNA
ECS	DNA
responsiveness	O
to	O
both	O
CD40L	protein
and	O
IL-4	protein
,	O
while	O
a	O
STAT-6-binding	DNA
site	DNA
is	O
additionally	O
required	O
for	O
IL-4	protein
inducibility	O
.	O
Electrophoretic	O
mobility	O
shift	O
assays	O
showed	O
that	O
p50/p65/c-Rel	protein
and	O
STAT-6	protein
are	O
effectively	O
induced	O
by	O
CD40L	protein
and	O
IL-4	protein
,	O
respectively,	O
and	O
bind	O
to	O
specific	O
DNA	DNA
motifs	DNA
within	O
the	O
ECS	DNA
.	O
These	O
partially	O
overlapping	O
CD40L	O
and	O
IL-4	O
responsive	O
elements	O
are	O
functionally	O
cooperative	O
as	O
the	O
disruption	O
of	O
one	O
of	O
them	O
prevents	O
synergistic	O
promoter	O
activation	O
.	O
Thus,	O
the	O
gamma	DNA
3	DNA
ECS	DNA
is	O
an	O
inducible	O
promoter	O
containing	O
cis	DNA
elements	DNA
that	O
critically	O
mediate	O
CD40L	protein
and	O
IL-4	protein
-triggered	O
transcriptional	O
activation	O
of	O
the	O
human	DNA
C	DNA
gamma	DNA
3	DNA
gene	DNA
.	O

CIITA	protein
-induced	O
occupation	O
of	O
MHC	DNA
class	DNA
II	DNA
promoters	DNA
is	O
independent	O
of	O
the	O
cooperative	O
stabilization	O
of	O
the	O
promoter-bound	protein
multi-protein	protein
complexes	protein
.	O
Precise	O
regulation	O
of	O
MHC	cell_type
class	cell_type
II	cell_type
expression	O
plays	O
a	O
crucial	O
role	O
in	O
the	O
control	O
of	O
the	O
immune	O
response	O
.	O
The	O
transactivator	protein
CIITA	protein
behaves	O
as	O
a	O
master	O
controller	O
of	O
constitutive	O
and	O
inducible	O
MHC	DNA
class	DNA
II	DNA
gene	DNA
activation	O
,	O
but	O
its	O
exact	O
mechanism	O
of	O
action	O
is	O
not	O
known.	O
Activation	O
of	O
MHC	DNA
class	DNA
II	DNA
promoters	DNA
requires	O
binding	O
of	O
at	O
least	O
three	O
distinct	O
multi-protein	protein
complexes	protein
(	O
RFX	protein
,	O
X2BP	protein
and	O
NF-Y	protein
).	O
It	O
is	O
known	O
that	O
the	O
stability	O
of	O
this	O
binding	O
results	O
from	O
cooperative	O
interactions	O
between	O
these	O
proteins.	O
We	O
show	O
here	O
that	O
expression	O
of	O
CIITA	protein
in	O
MHC	cell_line
class	cell_line
II	cell_line
-cells	cell_line
triggers	O
occupation	O
of	O
the	O
promoters	O
by	O
these	O
complexes.	O
This	O
observation	O
raised	O
the	O
possibility	O
that	O
the	O
effect	O
of	O
CIITA	protein
on	O
promoter	O
occupation	O
is	O
mediated	O
by	O
an	O
effect	O
on	O
the	O
cooperative	O
stabilization	O
of	O
the	O
DNA-bound	protein
multi-protein	protein
complexes	protein
.	O
We	O
show,	O
however,	O
that	O
the	O
presence	O
of	O
CIITA	protein
does	O
not	O
affect	O
the	O
stability	O
of	O
the	O
higher-order	O
protein	O
complex	O
formed	O
on	O
DNA	O
by	O
RFX	protein
,	O
X2BP	protein
and	O
NF-Y	protein
.	O
This	O
suggests	O
other	O
mechanisms	O
for	O
CIITA	protein
-induced	O
promoter	O
occupancy	O
,	O
such	O
as	O
an	O
effect	O
on	O
chromatin	DNA
structure	O
leading	O
to	O
increased	O
accessibility	O
of	O
MHC	DNA
class	DNA
II	DNA
promoters	DNA
.	O
This	O
ability	O
of	O
CIITA	protein
to	O
facilitate	O
promoter	O
occupation	O
is	O
undissociable	O
from	O
its	O
transactivation	O
potential.	O
Finally,	O
we	O
conclude	O
that	O
this	O
effect	O
of	O
CIITA	protein
is	O
cell-type	O
specific,	O
since	O
expression	O
of	O
CIITA	protein
is	O
not	O
required	O
for	O
normal	O
occupation	O
of	O
MHC	DNA
class	DNA
II	DNA
promoters	DNA
in	O
B	cell_type
lymphocytes	cell_type
.	O

GrpL	protein
,	O
a	O
Grb2	protein
-related	O
adaptor	protein
protein	protein
,	O
interacts	O
with	O
SLP-76	protein
to	O
regulate	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cell	protein
activation.	O
Propagation	O
of	O
signals	O
from	O
the	O
T	protein
cell	protein
antigen	protein
receptor	protein
(	O
TCR	protein
)	O
involves	O
a	O
number	O
of	O
adaptor	O
molecules.	O
SH2	protein
domain-containing	protein
protein	protein
76	protein
(	O
SLP-76	protein
)	O
interacts	O
with	O
the	O
guanine	protein
nucleotide	protein
exchange	protein
factor	protein
Vav	protein
to	O
activate	O
the	O
nuclear	protein
factor	protein
of	protein
activated	protein
cells	protein
(	O
NF-AT	protein
),	O
and	O
its	O
expression	O
is	O
required	O
for	O
normal	O
T	cell_type
cell	cell_type
development	O
.	O
We	O
report	O
the	O
cloning	O
and	O
characterization	O
of	O
a	O
novel	O
Grb2-like	protein
adaptor	protein
molecule	protein
designated	O
as	O
Grb2-related	protein
protein	protein
of	protein
the	protein
lymphoid	protein
system	protein
(	O
GrpL	protein
).	O
Expression	O
of	O
GrpL	protein
is	O
restricted	O
to	O
hematopoietic	O
tissues	O
,	O
and	O
it	O
is	O
distinguished	O
from	O
Grb2	protein
by	O
having	O
a	O
proline	protein
-rich	protein
region	protein
.	O
GrpL	protein
can	O
be	O
coimmunoprecipitated	O
with	O
SLP-76	protein
but	O
not	O
with	O
Sos1	protein
or	O
Sos2	protein
from	O
Jurkat	cell_line
cell	cell_line
lysates.	O
In	O
contrast,	O
Grb2	protein
can	O
be	O
coimmunoprecipitated	O
with	O
Sos1	protein
and	O
Sos2	protein
but	O
not	O
with	O
SLP-76	protein
.	O
Moreover,	O
tyrosine	protein
-phosphorylated	protein
LAT	protein
/	protein
pp36	protein
/	protein
38	protein
in	O
detergent	O
lysates	O
prepared	O
from	O
anti-CD3	cell_type
stimulated	cell_type
T	cell_type
cells	cell_type
associated	O
with	O
Grb2	protein
but	O
not	O
GrpL	protein
.	O
These	O
data	O
reveal	O
the	O
presence	O
of	O
distinct	O
complexes	O
involving	O
GrpL	protein
and	O
Grb2	protein
in	O
T	cell_type
cells	cell_type
.	O
A	O
functional	O
role	O
of	O
the	O
GrpL	protein
-SLP-76	protein
complex	protein
is	O
suggested	O
by	O
the	O
ability	O
of	O
GrpL	protein
to	O
act	O
alone	O
or	O
in	O
concert	O
with	O
SLP-76	protein
to	O
augment	O
NF-AT	protein
activation	O
in	O
Jurkat	cell_line
T	cell_type
cells	cell_type
.	O

Differential	O
induction	O
of	O
interferon	protein
(IFN)-inducible	protein
protein	protein
10	protein
following	O
differentiation	O
of	O
a	O
monocyte	cell_type
,	O
macrophage	cell_type
cell	cell_type
lineage	O
is	O
related	O
to	O
the	O
changes	O
of	O
nuclear	protein
proteins	protein
bound	O
to	O
IFN	DNA
stimulus	DNA
response	DNA
element	DNA
and	O
kappaB	DNA
sites	DNA
.	O
We	O
examined	O
chemokine	protein
gene	O
expression	O
following	O
the	O
differentiation	O
of	O
a	O
monocyte	cell_type
,	O
macrophage	cell_line
cell	cell_line
lineage	cell_line
.	O
The	O
human	cell_line
monoblastic	cell_line
cell	cell_line
line	cell_line
,	O
U937	cell_line
was	O
differentiated	O
to	O
macrophages	cell_type
by	O
the	O
treatment	O
with	O
either	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
,	O
retinoic	O
acid	O
(	O
RA	O
)	O
,	O
or	O
vitamin	O
D3	O
(	O
VitD3	O
)	O
.	O
The	O
gene	O
expression	O
of	O
interferon	protein
(IFN)-inducible	protein
protein	protein
10	protein
(	O
IP-10	protein
)	O
(a	O
CXC	protein
chemokine	protein
)	O
was	O
markedly	O
augmented	O
by	O
the	O
IFNgamma	protein
treatment	O
in	O
PMA	O
-or	O
RA	O
-differentiated	O
U937	cell_line
cells	cell_line
,	O
but	O
only	O
marginally	O
in	O
undifferentiated	O
or	O
VitD3	cell_line
-treated	cell_line
cells	cell_line
.	O
In	O
contrast,	O
another	O
inducible	O
gene	O
expression	O
of	O
monocyte	protein
chemotactic	protein
protein-1	protein
(a	O
CC	protein
chemokine	protein
)	O
and	O
the	O
activation	O
of	O
the	O
transcriptional	protein
factor	protein
(	O
FcRFgamma	protein
)	O
bound	O
to	O
the	O
gamma	DNA
response	DNA
region	DNA
were	O
similarly	O
or	O
less	O
abundantly	O
induced	O
by	O
IFNgamma	protein
treatment	O
in	O
PMA	O
-or	O
RA	O
-differentiated	O
U937	cell_line
cells	cell_line
,	O
indicating	O
that	O
increased	O
IP-10	RNA
mRNA	RNA
induction	O
was	O
not	O
due	O
to	O
the	O
augmented	O
ability	O
of	O
the	O
cells	O
to	O
respond	O
to	O
the	O
presence	O
of	O
IFNgamma	protein
.	O
Increased	O
expression	O
of	O
IFNgamma	protein
-induced	O
IP-10	RNA
mRNA	RNA
following	O
the	O
differentiation	O
of	O
U937	cell_line
cells	cell_line
was	O
mediated	O
largely	O
by	O
augmented	O
transcriptional	O
activity	O
of	O
the	O
gene	O
and	O
was	O
related	O
to	O
differentiation-dependent	O
changes	O
of	O
the	O
proteins	O
bound	O
to	O
IFN	DNA
stimulus	DNA
response	DNA
element	DNA
(	DNA
ISRE	DNA
)	DNA
and	O
kB	DNA
sites	DNA
,	O
suggesting	O
that	O
these	O
nuclear	protein
proteins	protein
may	O
determine	O
the	O
IP-10	RNA
mRNA	RNA
inducibility	O
by	O
IFNgamma	protein
.	O

Role	O
of	O
cellular	protein
tumor	protein
necrosis	protein
factor	protein
receptor-associated	protein
factors	protein
in	O
NF-kappaB	protein
activation	O
and	O
lymphocyte	cell_type
transformation	O
by	O
herpesvirus	O
Saimiri	O
STP	protein
.	O
The	O
STP	protein
oncoproteins	protein
of	O
the	O
herpesvirus	O
saimiri	O
(	O
HVS	O
)	O
subgroup	O
A	O
strain	O
11	O
and	O
subgroup	O
C	O
strain	O
488	O
are	O
now	O
found	O
to	O
be	O
stably	O
associated	O
with	O
tumor	protein
necrosis	protein
factor	protein
receptor-associated	protein
factor	protein
(	O
TRAF	protein
)	O
1	O
,	O
2	O
,	O
or	O
3	O
.	O
Mutational	O
analyses	O
identified	O
residues	O
of	O
PXQXT/S	protein
in	O
STP-A11	protein
as	O
critical	O
for	O
TRAF	protein
association.	O
In	O
addition,	O
a	O
somewhat	O
divergent	O
region	O
of	O
STP-C488	protein
is	O
critical	O
for	O
TRAF	protein
association	O
.	O
Mutational	O
analysis	O
also	O
revealed	O
that	O
STP-C488	protein
induced	O
NF-kappaB	protein
activation	O
that	O
was	O
correlated	O
with	O
its	O
ability	O
to	O
associate	O
with	O
TRAFs	protein
.	O
The	O
HVS	O
STP-C488	protein
P10--&gt;R	O
mutant	O
was	O
deficient	O
in	O
human	O
T-lymphocyte	O
transformation	O
to	O
interleukin-2-independent	O
growth	O
but	O
showed	O
wild-type	O
phenotype	O
for	O
marmoset	O
T-lymphocyte	O
transformation	O
in	O
vitro	O
and	O
in	O
vivo.	O
The	O
STP-C488	protein
P10--&gt;R	protein
mutant	protein
was	O
also	O
defective	O
in	O
Rat-1	O
fibroblast	O
transformation,	O
and	O
fibroblast	O
cell	O
transformation	O
was	O
blocked	O
by	O
a	O
TRAF2	protein
dominant-negative	O
mutant.	O
These	O
data	O
implicate	O
TRAFs	protein
in	O
STP-C488	protein
-mediated	O
transformation	O
of	O
human	cell_type
lymphocytes	cell_type
and	O
rodent	O
fibroblasts	cell_type
.	O
Other	O
factors	O
are	O
implicated	O
in	O
immortalization	O
of	O
common	cell_type
marmoset	cell_type
T	cell_type
lymphocytes	cell_type
and	O
may	O
also	O
be	O
critical	O
in	O
the	O
transformation	O
of	O
human	cell_type
lymphocytes	cell_type
and	O
rodent	cell_type
fibroblasts	cell_type
.	O

Cleavage	O
of	O
transcription	protein
factor	protein
SP1	protein
by	O
caspases	protein
during	O
anti-IgM-induced	O
B-cell	cell_type
apoptosis	O
.	O
Apoptosis	O
is	O
instrumental	O
in	O
the	O
processes	O
generating	O
the	O
diversity	O
of	O
the	O
B-cell	O
repertoire	O
.	O
Autoreactive	cell_type
B-cells	cell_type
are	O
eliminated	O
by	O
anti-IgM	protein
crosslinking	O
after	O
encountering	O
self-antigens	protein
,	O
but	O
precise	O
mechanisms	O
leading	O
to	O
B-cell	cell_type
apoptosis	O
are	O
still	O
not	O
well	O
understood.	O
We	O
report	O
here	O
the	O
cleavage	O
of	O
the	O
transcription	protein
factor	protein
SP1	protein
in	O
the	O
human	cell_line
Burkitt	cell_line
lymphoma	cell_line
cell	cell_line
line	cell_line
BL60	cell_line
during	O
anti-IgM	protein
-induced	O
apoptosis	O
.	O
Western	O
blot	O
analysis	O
revealed	O
two	O
cleavage	O
products	O
of	O
approximately	O
68	protein
kDa	protein
and	O
45	protein
kDa	protein
after	O
induction	O
of	O
apoptosis	O
.	O
Cleavage	O
could	O
be	O
completely	O
inhibited	O
by	O
zDEVD-fmk	O
,	O
an	O
inhibitor	O
specific	O
for	O
caspase	protein
3-like	protein
proteases	protein
.	O
In-vitro	O
cleavage	O
of	O
recombinant	protein
SP1	protein
by	O
recombinant	protein
caspase	protein
3	protein
(	O
CPP32	protein
)	O
or	O
caspase	protein
7	protein
(	O
Mch	protein
3	protein
)	O
results	O
in	O
similar	O
cleavage	O
products	O
as	O
those	O
observed	O
in	O
vivo.	O
Recombinant	protein
caspase	protein
6	protein
(	O
Mch	protein
2	protein
)	O
primarily	O
generates	O
a	O
68-kDa	O
cleavage	O
product,	O
as	O
observed	O
after	O
calcium	O
ionophore	O
(CaI)	O
induced	O
B-cell	cell_type
apoptosis	O
.	O
In	O
contrast,	O
caspase	O
1	O
(ICE)	O
did	O
not	O
cleave	O
SP1	protein
in	O
vitro.	O
The	O
time	O
course	O
of	O
SP1	protein
cleavage	O
during	O
anti-IgM-induced	O
apoptosis	O
is	O
paralleled	O
by	O
an	O
increase	O
of	O
caspase	O
activity	O
measured	O
by	O
DEVD-p-nitroanilide	O
(DEVD-pNA)	O
cleavage.	O
DNA	O
band-shift	O
assays	O
revealed	O
a	O
decrease	O
in	O
the	O
intensity	O
of	O
the	O
full	O
length	O
SP1	protein
/DNA	O
complex	O
and	O
an	O
increase	O
in	O
the	O
intensity	O
of	O
a	O
smaller	O
complex	O
due	O
to	O
the	O
binding	O
of	O
one	O
SP1	protein
cleavage	O
product.	O
By	O
Edman	O
sequencing	O
we	O
could	O
identify	O
a	O
caspase	O
3	O
cleavage	O
site	O
after	O
Asp584	O
(D584AQPQAGR),	O
generating	O
a	O
22-kDa	O
C-terminal	O
SP1	protein
protein	O
fragment	O
which	O
still	O
contains	O
the	O
DNA	O
binding	O
site.	O
Our	O
results	O
show	O
the	O
cleavage	O
of	O
the	O
human	O
transcription	protein
factor	protein
SP1	protein
in	O
vivo	O
and	O
in	O
vitro,	O
underlining	O
the	O
central	O
role	O
of	O
caspase	protein
3-like	protein
proteases	protein
during	O
the	O
process	O
of	O
anti-IgM-induced	O
apoptosis	O
.	O

Stimulation	O
of	O
CD40	protein
on	O
immunogenic	O
human	O
malignant	O
melanomas	O
augments	O
their	O
cytotoxic	cell_type
T	cell_type
lymphocyte	cell_type
-mediated	O
lysis	O
and	O
induces	O
apoptosis	O
.	O
Here,	O
we	O
report	O
the	O
functional	O
expression	O
of	O
CD40	protein
on	O
human	O
malignant	O
melanomas	O
(	O
MMs	O
).	O
Comparison	O
of	O
tumor	O
specimen	O
from	O
MM	O
precursor	O
lesions	O
,	O
primary	O
tumors	O
,	O
and	O
metastases	O
revealed	O
that	O
CD40	protein
surface	O
expression	O
is	O
down-regulated	O
during	O
tumor	O
progression	O
.	O
CD40	protein
expression	O
was	O
confirmed	O
in	O
7	O
human	cell_line
MM	cell_line
cell	cell_line
lines	cell_line
established	O
from	O
immunogenic	O
primary	O
tumors	O
or	O
metastases	O
,	O
whereas	O
11	O
cell	cell_line
lines	cell_line
established	O
from	O
advanced	O
stages	O
were	O
CD40	protein
negative	O
.	O
CD40	protein
expression	O
could	O
be	O
enhanced	O
in	O
CD40	protein
-positive	O
MM	O
by	O
stimulation	O
with	O
IFN-gamma	protein
and	O
tumor	protein
necrosis	protein
factor-alpha	protein
but	O
not	O
by	O
interleukin	protein
(IL)-1beta	protein
or	O
CD40	protein
triggering	O
.	O
CD40	protein
ligation	O
on	O
MM	O
by	O
CD40L	cell_line
-transfected	cell_line
murine	cell_line
L-cells	cell_line
or	O
by	O
a	O
soluble	O
CD40L	protein
fusion	protein
protein	protein
up-regulated	O
their	O
expression	O
of	O
intercellular	protein
adhesion	protein
molecule-1	protein
and	O
MHC	O
class	O
I	O
and	O
class	O
II	O
molecules	O
and	O
their	O
secretion	O
of	O
IL-6	protein
,	O
IL-8	protein
,	O
tumor	protein
necrosis	protein
factor-a	protein
,	O
and	O
granulocyte	protein
macrophage	protein
colony-stimulating	protein
factor	protein
and	O
also	O
induced	O
a	O
rapid	O
activation	O
of	O
the	O
transcription	protein
factor	protein
nuclear	protein
factor	protein
kappaB	protein
.	O
Furthermore,	O
CD40	protein
ligation	O
of	O
a	O
HLA-A2+,	cell_line
MelanA/MART1+	cell_line
MM	cell_line
cell	cell_line
line	cell_line
enhanced	O
its	O
susceptibility	O
to	O
specific	O
lysis	O
by	O
a	O
HLA-A2-restricted,	cell_line
MelanA/MART-1-specific	cell_line
CTL	cell_line
clone	cell_line
.	O
Finally,	O
CD40	protein
ligation	O
induced	O
growth	O
inhibition	O
and	O
apoptosis	O
in	O
MM	O
.	O
These	O
results	O
indicate	O
that	O
CD40	protein
-CD40L	protein
interactions	O
may	O
play	O
an	O
important	O
role	O
in	O
augmenting	O
antitumor	O
immunity	O
and	O
inducing	O
apoptosis	O
in	O
some	O
CD40	protein
-positive	O
immunogenic	O
human	O
MMs	O
.	O

Human	O
immunodeficiency	O
virus	O
-associated	O
Hodgkin's	O
disease	O
derives	O
from	O
post-germinal	cell_type
center	cell_type
B	cell_type
cells	cell_type
.	O
Human	O
immunodeficiency	O
virus	O
-associated	O
Hodgkin's	O
disease	O
(	O
HIV-HD	O
)	O
displays	O
several	O
peculiarities	O
when	O
compared	O
with	O
HD	O
of	O
the	O
general	O
population.	O
These	O
include	O
overrepresentation	O
of	O
clinically	O
aggressive	O
histologic	O
types	O
and	O
frequent	O
infection	O
of	O
Reed-Sternberg	cell_line
(RS)	cell_line
cells	cell_line
by	O
Epstein-Barr	O
virus	O
(	O
EBV	O
).	O
Recently,	O
we	O
have	O
reported	O
that	O
the	O
histogenesis	O
of	O
HD	O
of	O
the	O
general	O
population	O
may	O
be	O
assessed	O
by	O
monitoring	O
the	O
expression	O
pattern	O
of	O
BCL-6	protein
,	O
a	O
transcription	protein
factor	protein
expressed	O
in	O
germinal	cell_line
center	cell_line
(GC)	cell_line
B	cell_line
cells	cell_line
,	O
and	O
of	O
CD138/syndecan-1	protein
(	O
syn-1	protein
),	O
a	O
proteoglycan	O
associated	O
with	O
post-GC,	O
terminal	O
B-cell	cell_type
differentiation	O
.	O
In	O
this	O
study,	O
we	O
have	O
applied	O
these	O
two	O
markers	O
to	O
the	O
study	O
of	O
HIV-	O
HD	O
histogenesis	O
and	O
correlated	O
their	O
expression	O
status	O
to	O
the	O
virologic	O
features	O
of	O
this	O
disease.	O
We	O
have	O
found	O
that	O
RS	cell_line
cells	cell_line
of	O
all	O
histologic	O
categories	O
of	O
HIV-	O
HD	O
consistently	O
display	O
the	O
BCL-6	protein
(-)/syn-1(+)	O
phenotype	O
and	O
thus	O
reflect	O
post-GC	cell_line
B	cell_line
cells	cell_line
.	O
Although	O
BCL-6	protein
(-)/syn-1(+)	O
RS	cell_line
cells	cell_line
of	O
HIV-HD	O
express	O
CD40	protein
,	O
they	O
are	O
not	O
surrounded	O
by	O
CD40	cell_type
ligand	cell_type
-positive	cell_type
(	cell_type
CD40L	cell_type
+)	cell_type
reactive	cell_type
T	cell_type
lymphocytes	cell_type
,	O
which,	O
in	O
HD	O
of	O
the	O
general	O
population,	O
are	O
thought	O
to	O
regulate	O
the	O
disease	O
phenotype	O
through	O
CD40	protein
/CD40L	protein
interactions.	O
Conversely,	O
RS	cell_line
cells	cell_line
of	O
virtually	O
all	O
HIV-	O
HD	O
express	O
the	O
EBV	protein
-encoded	protein
latent	protein
membrane	protein
protein	protein
1	protein
(	O
LMP1	protein
),	O
which,	O
being	O
functionally	O
homologous	O
to	O
CD40	protein
,	O
may	O
contribute,	O
at	O
least	O
in	O
part,	O
to	O
the	O
modulation	O
of	O
the	O
HIV-	O
HD	O
phenotype	O
.	O

MDS1/EVI1	DNA
enhances	O
TGF-beta1	protein
signaling	O
and	O
strengthens	O
its	O
growth-inhibitory	O
effect	O
but	O
the	O
leukemia-associated	protein
fusion	protein
protein	protein
AML1/MDS1/EVI1	protein
,	O
product	O
of	O
the	O
t(3;21),	O
abrogates	O
growth-inhibition	O
in	O
response	O
to	O
TGF-beta1	protein
.	O
MDS1/EVI1	DNA
,	O
located	O
on	O
chromosome	DNA
3	DNA
band	DNA
q26	DNA
,	O
encodes	O
a	O
zinc-finger	protein
DNA-binding	protein
transcription	protein
activator	protein
not	O
detected	O
in	O
normal	cell_type
hematopoietic	cell_type
cells	cell_type
but	O
expressed	O
in	O
several	O
normal	O
tissues	O
.	O
MDS1/EVI1	DNA
is	O
inappropriately	O
activated	O
in	O
myeloid	cell_type
leukemias	cell_type
following	O
chromosomal	O
rearrangements	O
involving	O
band	protein
3q26	protein
.	O
The	O
rearrangements	O
lead	O
either	O
to	O
gene	O
truncation,	O
and	O
to	O
expression	O
of	O
the	O
transcription	protein
repressor	protein
EVI1	protein
,	O
as	O
seen	O
in	O
the	O
t(3;3)(q21;q26)	DNA
and	O
inv(3)(q21q26)	DNA
,	O
or	O
to	O
gene	O
fusion	O
,	O
as	O
seen	O
in	O
the	O
t(3;21)(q26;q22)	DNA
which	O
results	O
in	O
the	O
fusion	O
protein	O
AML1/MDS1/EVI1	protein
.	O
This	O
fusion	O
protein	O
contains	O
the	O
DNA-binding	protein
domain	protein
of	O
the	O
transcription	protein
factor	protein
AML1	protein
fused	O
in-frame	O
to	O
the	O
entire	O
MDS1/EVI1	DNA
with	O
the	O
exclusion	O
of	O
its	O
first	O
12	O
amino	O
acids	O
.	O
In	O
this	O
report,	O
we	O
have	O
analyzed	O
the	O
response	O
of	O
the	O
hematopoietic	cell_line
precursor	cell_line
cell	cell_line
line	cell_line
32Dcl3	cell_line
,	O
expressing	O
either	O
the	O
normal	protein
protein	protein
MDS1/EVI1	protein
or	O
the	O
fusion	protein
protein	protein
AML1/MDS1/EVI1	protein
,	O
to	O
factors	O
that	O
control	O
cell	O
differentiation	O
or	O
cell	O
replication	O
.	O
The	O
32Dcl3	cell_line
cells	cell_line
are	O
IL-3	protein
-dependent	O
for	O
growth	O
and	O
they	O
differentiate	O
into	O
granulocytes	O
when	O
exposed	O
to	O
G-CSF	protein
.	O
They	O
are	O
growth-inhibited	O
by	O
TGF-beta1	protein
.	O
We	O
show	O
that	O
whereas	O
the	O
expression	O
of	O
MDS1/EVI1	DNA
has	O
no	O
effect	O
on	O
granulocytic	O
differentiation	O
induced	O
by	O
G-CSF	protein
,	O
expression	O
of	O
AML1/MDS1/EVI1	protein
blocks	O
differentiation	O
resulting	O
in	O
cell	O
death	O
.	O
This	O
effect	O
is	O
similar	O
to	O
that	O
previously	O
described	O
by	O
others	O
for	O
32Dcl3	cell_line
cells	cell_line
that	O
express	O
transgenic	protein
Evil	protein
.	O
Furthermore,	O
we	O
show	O
that	O
whereas	O
the	O
expression	O
of	O
the	O
fusion	O
protein	O
AML1/MDS1/EVI1	protein
completely	O
abrogates	O
the	O
growth-inhibitory	O
effect	O
of	O
TGF-beta1	protein
and	O
allows	O
32Dcl3	cell_line
cells	cell_line
to	O
proliferate,	O
expression	O
of	O
the	O
normal	O
protein	O
MDS1/EVI1	DNA
has	O
the	O
opposite	O
effect,	O
and	O
it	O
strengthens	O
the	O
response	O
of	O
cells	O
to	O
the	O
growth-inhibitory	O
effect	O
of	O
TGF-beta1	protein
.	O
By	O
using	O
the	O
yeast	O
two-hybrid	O
system,	O
we	O
also	O
show	O
that	O
EVI1	protein
(contained	O
in	O
its	O
entirety	O
in	O
MDS1/EVI1	DNA
and	O
AML1/MDS1/EVI1	protein
)	O
physically	O
interacts	O
with	O
SMAD3	protein
,	O
which	O
is	O
an	O
intracellular	O
mediator	O
of	O
TGF-beta1	protein
signaling	O
.	O
Finally,	O
we	O
have	O
correlated	O
the	O
response	O
of	O
the	O
cells	O
to	O
G-CSF	protein
or	O
TGF-beta1	protein
with	O
the	O
ability	O
of	O
the	O
normal	O
and	O
fusion	protein
proteins	protein
to	O
activate	O
or	O
repress	O
promoters	O
which	O
they	O
can	O
directly	O
regulate	O
by	O
binding	O
to	O
the	O
promoter	DNA
site	DNA
.	O
We	O
propose	O
that	O
mutations	O
of	O
MDS1/EVI1	DNA
either	O
by	O
gene	O
truncation	O
resulting	O
in	O
the	O
transcription	protein
repressor	protein
EVI1	protein
or	O
by	O
gene	O
fusion	O
to	O
AML1	protein
lead	O
to	O
an	O
altered	O
cellular	O
response	O
to	O
growth	O
and	O
differentiation	protein
factors	protein
that	O
could	O
result	O
in	O
leukemic	O
transformation.	O
The	O
different	O
response	O
of	O
myeloid	O
cells	O
ectopically	O
expressing	O
the	O
normal	O
or	O
the	O
fusion	protein
protein	protein
to	O
G-CSF	protein
and	O
TGF-beta1	protein
could	O
depend	O
on	O
the	O
different	O
transactivation	O
properties	O
of	O
these	O
proteins	O
resulting	O
in	O
divergent	O
expression	O
of	O
downstream	DNA
genes	DNA
regulated	O
by	O
the	O
two	O
proteins.	O

Abnormalities	O
of	O
cyclic	O
adenosine	O
monophosphate	O
signaling	O
in	O
platelets	cell_type
from	O
untreated	O
patients	O
with	O
bipolar	O
disorder	O
.	O
BACKGROUND:	O
Abnormalities	O
in	O
the	O
cyclic	O
adenosine	O
monophosphate	O
(cAMP)-dependent	O
phosphorylation	O
system	O
have	O
been	O
recently	O
reported	O
in	O
patients	O
with	O
bipolar	O
disorder	O
.	O
We	O
evaluated	O
the	O
immunoreactivity	O
of	O
the	O
regulatory	O
and	O
catalytic	O
subunits	O
of	O
cAMP-dependent	protein
protein	protein
kinase	protein
(	O
protein	protein
kinase	protein
A	protein
)	O
and	O
1	O
of	O
its	O
substrates,	O
Rap1	protein
,	O
in	O
platelets	cell_type
from	O
untreated	O
euthymic	O
,	O
manic	O
,	O
and	O
depressed	O
patients	O
with	O
bipolar	O
disorder	O
and	O
healthy	O
subjects	O
.	O
METHODS:	O
Platelets	cell_type
were	O
collected	O
from	O
112	O
drug-free	O
patients	O
with	O
bipolar	O
disorder	O
(52	O
euthymic,	O
29	O
depressed,	O
and	O
31	O
manic)	O
and	O
62	O
healthy	O
subjects	O
.	O
The	O
levels	O
of	O
cAMP-dependent	protein
protein	protein
kinase	protein
and	O
Rap1	protein
were	O
assessed	O
by	O
Western	O
blot	O
analysis,	O
immunostaining,	O
and	O
computer-assisted	O
imaging	O
.	O
RESULTS:	O
The	O
immunolabeling	O
of	O
the	O
catalytic	protein
subunit	protein
of	O
cAMP-dependent	protein
protein	protein
kinase	protein
was	O
significantly	O
different	O
among	O
groups	O
(P&lt;.001),	O
with	O
higher	O
values	O
in	O
untreated	O
depressed	O
and	O
manic	O
patients	O
with	O
bipolar	O
disorder	O
compared	O
with	O
untreated	O
euthymic	O
patients	O
with	O
bipolar	O
disorder	O
and	O
healthy	O
subjects	O
.	O
No	O
significant	O
differences	O
were	O
found	O
in	O
the	O
immunolabeling	O
of	O
the	O
regulatory	protein
subunits	protein
(type	O
I	O
and	O
type	O
II)	O
of	O
cAMP-dependent	protein
protein	protein
kinase	protein
.	O
The	O
immunolabeling	O
of	O
Rap1	protein
was	O
significantly	O
higher	O
(P&lt;.001)	O
in	O
untreated	O
euthymic	O
,	O
depressed	O
,	O
and	O
manic	O
patients	O
than	O
in	O
healthy	O
persons	O
.	O
CONCLUSIONS:	O
Levels	O
of	O
Rap1	protein
and	O
the	O
catalytic	protein
subunit	protein
of	O
cAMP-dependent	protein
protein	protein
kinase	protein
are	O
altered	O
in	O
the	O
platelets	cell_type
of	O
bipolar	O
patients	O
.	O
These	O
findings	O
may	O
provide	O
clues	O
toward	O
understanding	O
the	O
involvement	O
of	O
cAMP	O
signaling	O
in	O
the	O
pathogenesis	O
of	O
bipolar	O
disorder	O
.	O

Molecular	O
regulation	O
of	O
cytokine	DNA
gene	DNA
expression	O
during	O
the	O
immune	O
response	O
.	O
Cytokine	protein
expression	O
by	O
immune	O
system	O
cells	O
plays	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
the	O
immune	O
response	O
.	O
On	O
first	O
encounter	O
with	O
antigen,	O
naive	cell_type
CD4+	cell_type
T	cell_type
helper	cell_type
(Th)	cell_type
cells	cell_type
differentiate	O
into	O
cytokine	cell_line
-producing	cell_line
effector	cell_line
cells	cell_line
.	O
Two	O
types	O
of	O
effector	O
cells	O
characterized	O
by	O
their	O
distinct	O
expression	O
of	O
cytokine	protein
profiles	O
have	O
been	O
described.	O
Th1	O
cells	O
produce	O
IL-2	protein
and	O
IFN-gamma	protein
,	O
whereas	O
Th2	cell_line
cells	cell_line
produce	O
IL-4	protein
,	O
IL-5	protein
,	O
IL-6	protein
,	O
IL-10	protein
,	O
and	O
IL-13	protein
.	O
In	O
many	O
pathological	O
situations,	O
the	O
balance	O
between	O
Th1	O
and	O
Th2	O
immune	O
responses	O
determines	O
the	O
outcome	O
of	O
diverse	O
immunologically	O
mediated	O
clinical	O
syndromes	O
including	O
infectious	O
,	O
autoimmune	O
,	O
and	O
allergic	O
diseases	O
.	O
However,	O
the	O
molecular	O
basis	O
for	O
the	O
tissue-specific	O
expression	O
of	O
Th1/Th2-like	protein
cytokines	protein
has	O
remained	O
elusive.	O
In	O
this	O
review	O
we	O
evaluate	O
the	O
possible	O
in	O
vivo	O
role	O
of	O
different	O
transcription	O
factors	O
and	O
transcriptional	O
mechanisms	O
in	O
T	O
cell	O
differentiation	O
and	O
the	O
immune	O
response	O
.	O

Tcf-1	protein
-mediated	O
transcription	O
in	O
T	cell_type
lymphocytes	cell_type
:	O
differential	O
role	O
for	O
glycogen	protein
synthase	protein
kinase-3	protein
in	O
fibroblasts	cell_type
and	O
T	cell_type
cells	cell_type
.	O
Beta-catenin	O
is	O
the	O
vertebrate	O
homolog	O
of	O
the	O
Drosophila	DNA
segment	DNA
polarity	DNA
gene	DNA
Armadillo	DNA
and	O
plays	O
roles	O
in	O
both	O
cell-cell	O
adhesion	O
and	O
transduction	O
of	O
the	O
Wnt	O
signaling	O
cascade	O
.	O
Recently,	O
members	O
of	O
the	O
Lef/Tcf	protein
transcription	protein
factor	protein
family	protein
have	O
been	O
identified	O
as	O
protein	O
partners	O
of	O
beta-catenin	protein
,	O
explaining	O
how	O
beta-catenin	protein
alters	O
gene	O
expression	O
.	O
Here	O
we	O
report	O
that	O
in	O
T	cell_type
cells	cell_type
,	O
Tcf-1	protein
also	O
becomes	O
transcriptionally	O
active	O
through	O
interaction	O
with	O
beta-catenin	protein
,	O
suggesting	O
that	O
the	O
Wnt	O
signal	O
transduction	O
pathway	O
is	O
operational	O
in	O
T	cell_type
lymphocytes	cell_type
as	O
well.	O
However,	O
although	O
Wnt	O
signals	O
are	O
known	O
to	O
inhibit	O
the	O
activity	O
of	O
the	O
negative	protein
regulatory	protein
protein	protein
kinase	protein
glycogen	protein
synthase	protein
kinase-3beta	protein
(	O
GSK-3beta	protein
),	O
resulting	O
in	O
increased	O
levels	O
of	O
beta-catenin	protein
,	O
we	O
find	O
no	O
evidence	O
for	O
involvement	O
of	O
GSK-3beta	protein
in	O
Tcf-mediated	O
transcription	O
in	O
T	cell_type
cells	cell_type
.	O
That	O
is,	O
a	O
dominant	protein
negative	protein
GSK-3beta	protein
does	O
not	O
specifically	O
activate	O
Tcf	O
transcription	O
and	O
stimuli	O
(	O
lithium	O
or	O
phytohemagglutinin	protein
)	O
that	O
inhibit	O
GSK-3beta	protein
activity	O
also	O
do	O
not	O
activate	O
Tcf	DNA
reporter	DNA
genes	DNA
.	O
Thus,	O
inhibition	O
of	O
GSK-3beta	protein
is	O
insufficient	O
to	O
activate	O
Tcf-dependent	O
transcription	O
in	O
T	cell_type
lymphocytes	cell_type
.	O
In	O
contrast,	O
in	O
C57MG	cell_line
fibroblast	cell_line
cells	cell_line
,	O
lithium	O
inactivates	O
GSK-3beta	protein
and	O
induces	O
Tcf-controlled	O
transcription	O
.	O
This	O
is	O
the	O
first	O
demonstration	O
that	O
lithium	O
can	O
alter	O
gene	O
expression	O
of	O
Tcf-responsive	DNA
genes	DNA
,	O
and	O
points	O
to	O
a	O
difference	O
in	O
regulation	O
of	O
Wnt	O
signaling	O
between	O
fibroblasts	cell_type
and	O
lymphocytes	cell_type
.	O

SHP2-interacting	protein
transmembrane	protein
adaptor	protein
protein	protein
(	O
SIT	protein
),	O
a	O
novel	O
disulfide-linked	protein
dimer	protein
regulating	O
human	O
T	O
cell	O
activation	O
.	O
T	cell_type
lymphocytes	cell_type
express	O
several	O
low	protein
molecular	protein
weight	protein
transmembrane	protein
adaptor	protein
proteins	protein
that	O
recruit	O
src	protein
homology	protein
(SH)2	protein
domain	protein
-containing	protein
intracellular	protein
molecules	protein
to	O
the	O
cell	O
membrane	O
via	O
tyrosine-based	O
signaling	O
motifs.	O
We	O
describe	O
here	O
a	O
novel	O
molecule	O
of	O
this	O
group	O
termed	O
SIT	protein
(	O
SHP2	protein
interacting	protein
transmembrane	protein
adaptor	protein
protein	protein
).	O
SIT	protein
is	O
a	O
disulfide-linked	protein
homodimeric	protein
glycoprotein	protein
that	O
is	O
expressed	O
in	O
lymphocytes	cell_type
.	O
After	O
tyrosine	O
phosphorylation	O
by	O
src	protein
and	O
possibly	O
syk	protein
protein	protein
tyrosine	protein
kinases	protein
SIT	protein
recruits	O
the	O
SH2	protein
domain	protein
-containing	protein
tyrosine	protein
phosphatase	protein
SHP2	protein
via	O
an	O
immunoreceptor	O
tyrosine-based	O
inhibition	O
motif.	O
Overexpression	O
of	O
SIT	protein
in	O
Jurkat	cell_line
cells	cell_line
downmodulates	O
T	O
cell	O
receptor-	O
and	O
phytohemagglutinin-	O
mediated	O
activation	O
of	O
the	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NF-AT	protein
)	O
by	O
interfering	O
with	O
signaling	O
processes	O
that	O
are	O
probably	O
located	O
upstream	O
of	O
activation	O
of	O
phospholipase	protein
C	protein
.	O
However,	O
binding	O
of	O
SHP2	protein
to	O
SIT	protein
is	O
not	O
required	O
for	O
inhibition	O
of	O
NF-AT	protein
induction	O
,	O
suggesting	O
that	O
SIT	protein
not	O
only	O
regulates	O
NF-AT	protein
activity	O
but	O
also	O
controls	O
NF-AT	protein
unrelated	O
pathways	O
of	O
T	O
cell	O
activation	O
involving	O
SHP2	protein
.	O

Extracellular-regulated	protein
kinase	protein
1/2	protein
,	O
Jun	protein
N-terminal	protein
kinase	protein
,	O
and	O
c-Jun	protein
are	O
involved	O
in	O
NF-kappa	protein
B	protein
-dependent	O
IL-6	protein
expression	O
in	O
human	O
monocytes.	O
In	O
the	O
present	O
study	O
we	O
investigated	O
the	O
possible	O
involvement	O
of	O
the	O
mitogen-activated	protein
protein	protein
kinase	protein
family	protein
members	O
extracellular-regulated	protein
kinase	protein
1/2	protein
(	O
ERK1/2	protein
)	O
and	O
c-	O
Jun	protein
N-terminal	protein
kinase	protein
(	O
JNK	protein
)	O
in	O
mediating	O
IL-6	protein
gene	O
expression	O
in	O
human	cell_type
monocytes	cell_type
,	O
in	O
particular	O
their	O
role	O
in	O
enhancing	O
NF-kappa	protein
B	protein
activity	O
.	O
Freshly	O
isolated	O
monocytes	O
treated	O
with	O
the	O
protein	O
phosphatase	O
inhibitor	O
okadaic	O
acid	O
secreted	O
high	O
levels	O
of	O
IL-6	protein
protein	protein
,	O
which	O
coincided	O
with	O
enhanced	O
binding	O
activity	O
of	O
NF-kappa	protein
B	protein
as	O
well	O
as	O
with	O
phosphorylation	O
and	O
activation	O
of	O
the	O
ERK1/2	O
and	O
JNK	O
proteins	O
.	O
The	O
ERK	O
pathway-specific	O
inhibitor	O
PD98059	O
inhibited	O
IL-6	protein
secretion	O
from	O
monocytes	cell_type
.	O
Transient	O
overexpression	O
of	O
inactive	O
mutants	O
of	O
either	O
Raf-1	protein
or	O
JNK1	protein
showed	O
that	O
both	O
pathways	O
were	O
involved	O
in	O
kappa	O
B-dependent	O
IL-6	protein
promoter	O
activity	O
.	O
By	O
using	O
PD98059	O
,	O
we	O
demonstrated	O
that	O
the	O
Raf1/MEK1/	O
ERK1/2	protein
pathway	O
did	O
not	O
affect	O
the	O
DNA	O
binding	O
of	O
NF-kappa	protein
B	protein
but,	O
rather,	O
acted	O
at	O
the	O
level	O
of	O
transcriptional	O
activity	O
of	O
NF-kappa	protein
B	protein
.	O
Interestingly,	O
it	O
was	O
shown	O
that	O
NF-kappa	protein
B	protein
-mediated	O
gene	O
transcription	O
,	O
both	O
in	O
the	O
context	O
of	O
the	O
IL-6	DNA
promoter	DNA
as	O
well	O
as	O
on	O
its	O
own,	O
was	O
dependent	O
on	O
both	O
serine	O
kinase	O
activity	O
and	O
interaction	O
with	O
c-Jun	protein
protein	protein
.	O
We	O
conclude	O
that	O
okadaic	O
acid	O
-induced	O
IL-6	protein
gene	O
expression	O
is	O
at	O
least	O
partly	O
mediated	O
through	O
the	O
ERK1/2	protein
and	O
JNK	protein
pathway-dependent	O
activation	O
of	O
NF-kappa	protein
B	protein
transcriptional	O
capacity	O
.	O
Our	O
results	O
suggest	O
that	O
the	O
JNK	protein
pathway	O
may	O
regulate	O
NF-kappa	protein
B	protein
-mediated	O
gene	O
transcription	O
through	O
its	O
phosphorylation	O
and	O
activation	O
of	O
c-Jun	protein
.	O

The	O
Epstein-Barr	protein
virus	protein
nuclear	protein
antigen	protein
2	protein
(	O
EBNA2	protein
),	O
a	O
protein	O
required	O
for	O
B	cell_type
lymphocyte	cell_type
immortalization	O
,	O
induces	O
the	O
synthesis	O
of	O
type	protein
I	protein
interferon	protein
in	O
Burkitt's	cell_line
lymphoma	cell_line
cell	cell_line
lines	cell_line
.	O
Epstein-Barr	protein
virus	protein
nuclear	protein
antigen	protein
2	protein
(	O
EBNA2	protein
),	O
a	O
protein	O
involved	O
in	O
cell	O
transformation,	O
interferes	O
with	O
the	O
cellular	O
response	O
to	O
type	protein
I	protein
interferons	protein
(	O
IFN-alpha/beta	protein
).	O
We	O
investigated	O
the	O
function	O
of	O
conditionally	O
expressed	O
EBNA2	protein
in	O
the	O
context	O
of	O
the	O
IFN	protein
response	O
in	O
Burkitt's	cell_line
lymphoma	cell_line
cell	cell_line
lines	cell_line
.	O
Expression	O
of	O
EBNA2	protein
led	O
to	O
the	O
transcriptional	O
activation	O
of	O
both	O
endogenous	O
or	O
transfected	O
IFN-stimulated	DNA
genes	DNA
(	O
ISGs	DNA
),	O
genes	O
which	O
contain	O
within	O
their	O
promoters	DNA
either	O
the	O
interferon-stimulated	DNA
response	DNA
element	DNA
(	O
ISRE	DNA
)	O
or	O
the	O
gamma	DNA
interferon	DNA
activation	DNA
site	DNA
(	O
GAS	DNA
).	O
In	O
search	O
of	O
a	O
molecular	O
mechanism	O
for	O
the	O
transcriptional	O
induction	O
of	O
ISGs	DNA
,	O
we	O
observed	O
an	O
EBNA2	protein
-dependent	O
synthesis	O
of	O
IFN-beta	O
mRNA	O
at	O
low	O
levels	O
and	O
the	O
secretion	O
of	O
low	O
amounts	O
of	O
IFN.	O
A	O
transfected	O
IFN-beta	O
promoter	O
responded	O
to	O
EBNA2	protein
activation,	O
and	O
a	O
sequence	O
closely	O
resembling	O
a	O
RBP-Jkappa	DNA
binding	DNA
site	DNA
was	O
pinpointed	O
as	O
a	O
potential	O
target	O
of	O
EBNA2	protein
activity	O
.	O
EBNA2	protein
-dependent	O
transcriptional	O
induction	O
of	O
the	O
IFN-beta	DNA
promoter	DNA
occurred	O
in	O
EBV-negative	cell_line
Burkitt's	cell_line
lymphoma	cell_line
cells	cell_line
,	O
indicating	O
that	O
other	O
EBV	DNA
genes	DNA
were	O
not	O
required	O
for	O
the	O
induction	O
of	O
IFN-beta	protein
synthesis	O
.	O

PGG-glucan,	O
a	O
soluble	O
beta-(1,3)-glucan	O
,	O
enhances	O
the	O
oxidative	O
burst	O
response	O
,	O
microbicidal	O
activity	O
,	O
and	O
activates	O
an	O
NF-kappa	protein
B	protein
-like	protein
factor	protein
in	O
human	cell_type
PMN	cell_type
:	O
evidence	O
for	O
a	O
glycosphingolipid	protein
beta-(1,3)-glucan	protein
receptor	protein
.	O
PGG-Glucan	O
,	O
a	O
soluble	O
beta-(1,6)-branched	O
beta-(1,3)-linked	O
glucose	O
homopolymer	O
derived	O
from	O
the	O
cell	O
wall	O
of	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
,	O
is	O
an	O
immunomodulator	O
which	O
enhances	O
leukocyte	O
anti-infective	O
activity	O
and	O
enhances	O
myeloid	O
and	O
megakaryocyte	O
progenitor	O
proliferation	O
.	O
Incubation	O
of	O
human	O
whole	O
blood	O
with	O
PGG-Glucan	O
significantly	O
enhanced	O
the	O
oxidative	O
burst	O
response	O
of	O
subsequently	cell_type
isolated	cell_type
blood	cell_type
leukocytes	cell_type
to	O
both	O
soluble	O
and	O
particulate	O
activators	O
in	O
a	O
dose-dependent	O
manner	O
,	O
and	O
increased	O
leukocyte	O
microbicidal	O
activity	O
.	O
No	O
evidence	O
for	O
inflammatory	O
cytokine	protein
production	O
was	O
obtained	O
under	O
these	O
conditions.	O
Electrophoretic	O
mobility	O
shift	O
assays	O
demonstrated	O
that	O
PGG-Glucan	O
induced	O
the	O
activation	O
of	O
an	O
NF-kappaB	protein
-like	protein
nuclear	protein
transcription	protein
factor	protein
in	O
purified	cell_type
human	cell_type
neutrophils	cell_type
.	O
The	O
binding	O
of	O
3	O
H-	O
PGG-Glucan	O
to	O
human	O
leukocyte	O
membranes	O
was	O
specific,	O
concentration-dependent,	O
saturable,	O
and	O
high	O
affinity	O
(Kd	O
approximately	O
6	O
nM).	O
A	O
monoclonal	protein
antibody	protein
specific	O
to	O
the	O
glycosphingolipid	O
lactosylceramide	O
was	O
able	O
to	O
inhibit	O
activation	O
of	O
the	O
NF-kappaB	protein
-like	protein
factor	protein
by	O
PGG-Glucan	O
,	O
and	O
ligand	O
binding	O
data,	O
including	O
polysaccharide	O
specificity	O
,	O
suggested	O
that	O
the	O
PGG-Glucan	O
binding	O
moiety	O
was	O
lactosylceramide	O
.	O
These	O
results	O
indicate	O
that	O
PGG-Glucan	O
enhances	O
neutrophil	O
anti-microbial	O
functions	O
and	O
that	O
interaction	O
between	O
this	O
beta-glucan	O
and	O
human	cell_type
neutrophils	cell_type
is	O
mediated	O
by	O
the	O
glycosphingolipid	O
lactosylceramide	O
present	O
at	O
the	O
cell	O
surface	O
.	O

Glucocorticoids	O
promote	O
nonphlogistic	O
phagocytosis	O
of	O
apoptotic	cell_type
leukocytes	cell_type
.	O
Phagocyte	O
recognition	O
,	O
uptake,	O
and	O
nonphlogistic	O
degradation	O
of	O
neutrophils	cell_type
and	O
other	O
leukocytes	cell_type
undergoing	O
apoptosis	O
promote	O
the	O
resolution	O
of	O
inflammation	O
.	O
This	O
study	O
assessed	O
the	O
effects	O
of	O
anti-inflammatory	O
glucocorticoids	O
on	O
this	O
leukocyte	O
clearance	O
mechanism	O
.	O
Pretreatment	O
of	O
"semimature"	O
5-day	O
human	cell_type
monocyte-derived	cell_type
macrophages	cell_type
(M	O
phi)	O
for	O
24	O
h	O
with	O
methylprednisolone	O
,	O
dexamethasone	O
,	O
and	O
hydrocortisone	O
,	O
but	O
not	O
the	O
nonglucocorticoid	O
steroids	O
aldosterone	O
,	O
estradiol	O
,	O
and	O
progesterone	O
,	O
potentiated	O
phagocytosis	O
of	O
apoptotic	cell_type
neutrophils	cell_type
.	O
These	O
effects	O
were	O
specific	O
in	O
that	O
the	O
potentiated	O
phagocytosis	O
of	O
apoptotic	cell_type
neutrophils	cell_type
was	O
completely	O
blocked	O
by	O
the	O
glucocorticoid	protein
receptor	protein
antagonist	O
RU38486	O
,	O
and	O
glucocorticoids	O
did	O
not	O
promote	O
5-day	O
M	O
phi	O
ingestion	O
of	O
opsonized	cell_type
erythrocytes	cell_type
.	O
Similar	O
glucocorticoid-mediated	O
potentiation	O
was	O
observed	O
with	O
5-day	O
M	O
phi	O
uptake	O
of	O
alternative	O
apoptotic	O
"targets"	O
(	O
eosinophils	cell_type
and	O
Jurkat	cell_line
T	cell_line
cells	cell_line
)	O
and	O
in	O
uptake	O
of	O
apoptotic	cell_type
neutrophils	cell_type
by	O
alternative	O
phagocytes	cell_type
(	O
human	cell_type
glomerular	cell_type
mesangial	cell_type
cells	cell_type
and	O
murine	cell_line
M	cell_line
phi	cell_line
elicited	O
into	O
the	O
peritoneum	O
or	O
derived	O
from	O
bone	O
marrow	O
).	O
Importantly,	O
methylprednisolone	O
-mediated	O
enhancement	O
of	O
the	O
uptake	O
of	O
apoptotic	cell_type
neutrophils	cell_type
did	O
not	O
trigger	O
the	O
release	O
of	O
the	O
chemokines	protein
IL-8	protein
and	O
monocyte	protein
chemoattractant	protein
protein-1	protein
.	O
Furthermore,	O
longer-term	O
potentiation	O
by	O
methylprednisolone	O
was	O
observed	O
in	O
maturing	cell_line
human	cell_line
monocyte-derived	cell_line
M	cell_line
phi	cell_line
,	O
with	O
greater	O
increases	O
in	O
5-day	O
M	cell_line
phi	cell_line
uptake	O
of	O
apoptotic	cell_type
cells	cell_type
being	O
observed	O
the	O
earlier	O
glucocorticoids	O
were	O
added	O
during	O
monocyte	O
maturation	O
into	O
M	cell_line
phi	cell_line
.	O
We	O
conclude	O
that	O
potentiation	O
of	O
nonphlogistic	O
clearance	O
of	O
apoptotic	cell_type
leukocytes	cell_type
by	O
phagocytes	cell_type
is	O
a	O
hitherto	O
unrecognized	O
property	O
of	O
glucocorticoids	O
that	O
has	O
potential	O
implications	O
for	O
therapies	O
aimed	O
at	O
promoting	O
the	O
resolution	O
of	O
inflammatory	O
diseases	O
.	O

1,25-Dihydroxyvitamin	O
D3	O
induces	O
differentiation	O
of	O
a	O
retinoic	cell_line
acid	cell_line
-resistant	cell_line
acute	cell_line
promyelocytic	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
(	O
UF-1	cell_line
)	O
associated	O
with	O
expression	O
of	O
p21(WAF1/CIP1)	protein
and	O
p27(KIP1)	protein
.	O
Retinoic	O
acid	O
(RA)	O
resistance	O
is	O
a	O
serious	O
problem	O
for	O
patients	O
with	O
acute	O
promyelocytic	O
leukemia	O
(	O
APL	O
)	O
who	O
are	O
receiving	O
all-trans	O
RA	O
.	O
However,	O
the	O
mechanisms	O
and	O
strategies	O
to	O
overcome	O
RA	O
resistance	O
by	O
APL	cell_type
cells	cell_type
are	O
still	O
unclear.	O
The	O
biologic	O
effects	O
of	O
RA	O
are	O
mediated	O
by	O
two	O
distinct	O
families	O
of	O
transcriptional	protein
factors	protein
:	O
RA	protein
receptors	protein
(	O
RARs	protein
)	O
and	O
retinoid	protein
X	protein
receptors	protein
(	O
RXRs	protein
).	O
RXRs	protein
heterodimerize	O
with	O
1,	protein
25-dihydroxyvitamin	protein
D3	protein
[	protein
1,25(OH)2D3	protein
]	protein
receptor	protein
(	O
VDR	protein
),	O
enabling	O
their	O
efficient	O
transcriptional	O
activation	O
.	O
The	O
cyclin-dependent	protein
kinase	protein
(	protein
cdk	protein
)	protein
inhibitor	protein
p21(WAF1/CIP1)	protein
has	O
a	O
vitamin	DNA
D3-responsive	DNA
element	DNA
(	O
VDRE	DNA
)	O
in	O
its	O
promoter	DNA
,	O
and	O
1,25(OH)2D3	O
enhances	O
the	O
expression	O
of	O
p21(WAF1/CIP1)	protein
and	O
induces	O
differentiation	O
of	O
selected	O
myeloid	cell_line
leukemic	cell_line
cell	cell_line
lines	cell_line
.	O
We	O
have	O
recently	O
established	O
a	O
novel	O
APL	cell_line
cell	cell_line
line	cell_line
(	O
UF-1	cell_line
)	O
with	O
features	O
of	O
RA	O
resistance	O
.	O
1,25(OH)2D3	O
can	O
induce	O
growth	O
inhibition	O
and	O
G1	O
arrest	O
of	O
UF-1	cell_line
cells	cell_line
,	O
resulting	O
in	O
differentiation	O
of	O
these	O
cells	O
toward	O
granulocytes	cell_type
.	O
This	O
1,	O
25(OH)2D3	O
-induced	O
G1	O
arrest	O
is	O
enhanced	O
by	O
all-trans	O
RA	O
.	O
Also,	O
1,	O
25(OH)2D3	O
(10(-10)	O
to	O
10(-7)	O
mol/L)	O
in	O
combination	O
with	O
RA	O
markedly	O
inhibits	O
cellular	O
proliferation	O
in	O
a	O
dose-	O
and	O
time-dependent	O
manner.	O
Associated	O
with	O
these	O
findings,	O
the	O
levels	O
of	O
p21(WAF1/CIP1)	protein
and	O
p27(KIP1)	RNA
mRNA	RNA
and	O
protein	O
increased	O
in	O
these	O
cells.	O
Northern	O
blot	O
analysis	O
showed	O
that	O
p21(WAF1/CIP1	O
)	O
and	O
p27(KIP1)	O
mRNA	O
and	O
protein	O
increased	O
in	O
these	O
cells.	O
Northern	O
blot	O
analysis	O
showed	O
that	O
p21(WAF1/CIP1)	protein
and	O
p27(KIP1)	protein
transcripts	O
were	O
induced	O
after	O
6	O
hours'	O
exposure	O
to	O
1,25(OH)2D3	O
and	O
then	O
decreased	O
to	O
basal	O
levels	O
over	O
48	O
hours.	O
Western	O
blot	O
experiments	O
showed	O
that	O
p21(WAF1/CIP1)	protein
protein	O
levels	O
increased	O
and	O
became	O
detectable	O
after	O
12	O
hours	O
of	O
1,25(OH)2D3	O
treatment	O
and	O
induction	O
of	O
p27(KIP1)	protein
protein	O
was	O
much	O
more	O
gradual	O
and	O
sustained	O
in	O
UF-1	cell_line
cells	cell_line
.	O
Interestingly,	O
the	O
combination	O
of	O
1,	O
25(OH)2D3	O
and	O
RA	O
markedly	O
enhanced	O
the	O
levels	O
of	O
p27(KIP1)	protein
transcript	O
and	O
protein	O
as	O
compared	O
with	O
levels	O
induced	O
by	O
1,	O
25(OH)2D3	O
alone.	O
In	O
addition,	O
exogenous	O
p27(KIP1)	protein
expression	O
can	O
enhance	O
the	O
level	O
of	O
CD11b	protein
antigen	protein
in	O
myeloid	cell_type
leukemic	cell_type
cells	cell_type
.	O
In	O
contrast,	O
RA	O
alone	O
can	O
induce	O
G1	O
arrest	O
of	O
UF-1	cell_line
cells	cell_line
;	O
however,	O
it	O
did	O
not	O
result	O
in	O
an	O
increase	O
of	O
p21(WAF1/CIP1)	protein
and	O
p27(KIP1)	protein
transcript	O
and	O
protein	O
expression	O
in	O
RA	O
-resistant	O
cells.	O
Taken	O
together,	O
we	O
conclude	O
that	O
1,25(OH)2D3	O
induces	O
increased	O
expression	O
of	O
cdk	protein
inhibitors	protein
,	O
which	O
mediates	O
a	O
G1	O
arrest	O
,	O
and	O
this	O
may	O
be	O
associated	O
with	O
differentiation	O
of	O
RA	O
-resistant	O
UF-1	cell_line
cells	cell_line
toward	O
mature	O
granulocytes	cell_type
.	O

Molecular	O
mechanisms	O
of	O
neutrophil-endothelial	O
cell	O
adhesion	O
induced	O
by	O
redox	O
imbalance	O
.	O
Previous	O
studies	O
have	O
implicated	O
a	O
role	O
for	O
intracellular	O
thiols	O
in	O
the	O
activation	O
of	O
nuclear	protein
factor-kappaB	protein
and	O
transcriptional	O
regulation	O
of	O
endothelial	protein
cell	protein
adhesion	protein
molecules	protein
.	O
This	O
study	O
was	O
designed	O
to	O
determine	O
whether	O
changes	O
in	O
endothelial	O
cell	O
glutathione	O
(	O
GSH	O
)	O
or	O
oxidized	O
glutathione	O
(	O
GSSG	O
)	O
can	O
alter	O
neutrophil	O
adhesivity	O
and	O
to	O
define	O
the	O
molecular	O
mechanism	O
that	O
underlies	O
this	O
GSSG	O
/	O
GSH	O
-induced	O
adhesion	O
response	O
.	O
Treatment	O
of	O
human	cell_line
umbilical	cell_line
vein	cell_line
endothelial	cell_line
cell	cell_line
(	cell_line
HUVEC	cell_line
)	cell_line
monolayers	cell_line
for	O
6	O
hours	O
with	O
0.2	O
mmol/L	O
diamide	O
and	O
1	O
mmol/L	O
buthionine	O
sulfoximine	O
(	O
BSO	O
)	O
decreased	O
GSH	O
levels	O
and	O
increased	O
the	O
ratio	O
of	O
GSSG	O
to	O
GSH	O
without	O
cell	O
toxicity	O
.	O
These	O
redox	O
changes	O
are	O
similar	O
to	O
those	O
observed	O
with	O
anoxia/reoxygenation	O
.	O
Diamide	O
plus	O
BSO	O
-induced	O
thiol/disulfide	O
imbalance	O
was	O
associated	O
with	O
a	O
biphasic	O
increase	O
in	O
neutrophil	cell_type
adhesion	O
to	O
HUVECs	cell_line
with	O
peak	O
responses	O
observed	O
at	O
15	O
minutes	O
(phase	O
1)	O
and	O
240	O
minutes	O
(phase	O
2).	O
N-Acetylcysteine	O
treatment	O
attenuated	O
neutrophil	cell_type
adhesion	O
in	O
both	O
phases,	O
which	O
indicated	O
a	O
role	O
for	O
GSH	O
in	O
the	O
adhesion	O
responses	O
.	O
Interestingly,	O
phase	O
1	O
adhesion	O
was	O
inversely	O
correlated	O
with	O
GSH	O
levels	O
but	O
not	O
with	O
the	O
GSSG	O
/	O
GSH	O
ratio	O
,	O
whereas	O
phase	O
2	O
neutrophil	cell_type
adhesion	O
was	O
positively	O
correlated	O
with	O
GSSG	O
/GSH	O
ratio	O
but	O
not	O
with	O
GSH	O
levels	O
.	O
Intercellular	protein
adhesion	protein
molecule-1	protein
and	O
P-selectin-specific	protein
monoclonal	protein
antibodies	protein
attenuated	O
the	O
increased	O
neutrophil	cell_type
adhesion	O
during	O
both	O
phases,	O
whereas	O
an	O
anti-E-selectin	protein
monoclonal	protein
antibody	protein
also	O
attenuated	O
the	O
phase	O
2	O
response.	O
Pretreatment	O
with	O
actinomycin	O
D	O
and	O
cycloheximide	O
or	O
with	O
competing	O
ds-oligonucleotides	O
that	O
contained	O
nuclear	protein
factor-kappaB	protein
or	O
activator	protein
protein-1	protein
cognate	O
DNA	O
sequences	O
significantly	O
attenuated	O
the	O
phase	O
2	O
response	O
,	O
which	O
implicated	O
a	O
role	O
for	O
de	O
novo	O
protein	O
synthesis	O
.	O
Surface	O
expression	O
of	O
intercellular	protein
adhesion	protein
molecule-1	protein
,	O
P-selectin	protein
,	O
and	O
E-selectin	protein
on	O
HUVECs	cell_line
correlated	O
with	O
the	O
phase	O
1	O
and	O
2	O
neutrophil	cell_type
adhesion	O
responses	O
.	O
This	O
study	O
demonstrates	O
that	O
changes	O
in	O
endothelial	O
cell	O
GSSG	O
/GSH	O
cause	O
transcription-independent	O
and	O
transcription-dependent	O
surface	O
expression	O
of	O
different	O
endothelial	protein
cell	protein
adhesion	protein
molecules	protein
,	O
which	O
leads	O
to	O
a	O
2-phase	O
neutrophil	cell_type
-endothelial	O
adhesion	O
response	O
.	O

Glucocorticoid	O
hormone	O
suppression	O
of	O
human	O
neutrophil	cell_type
-mediated	O
tumor	O
cell	O
cytostasis	O
.	O
In	O
the	O
present	O
study,	O
we	O
have	O
investigated	O
the	O
effect	O
of	O
glucocorticoid	O
hormones	O
on	O
neutrophil	cell_type
-mediated	O
tumor	O
cell	O
cytostasis	O
and	O
found	O
that	O
hydrocortisone	O
and	O
a	O
synthetic	O
hormone	O
,	O
dexamethasone	O
(	O
Dex	O
),	O
inhibited	O
cytostasis	O
in	O
the	O
presence	O
or	O
absence	O
of	O
tumor	protein
necrosis	protein
factor-alpha	protein
.	O
The	O
effect	O
of	O
Dex	O
was	O
completely	O
reversed	O
by	O
a	O
glucocorticoid	protein
receptor	protein
antagonist	O
,	O
RU38486	O
.	O
To	O
clarify	O
the	O
underlying	O
mechanisms	O
,	O
we	O
examined	O
effects	O
of	O
Dex	O
on	O
the	O
binding	O
avidity	O
of	O
beta2	protein
integrin	protein
on	O
the	O
neutrophil	cell_type
surface	O
and	O
how	O
these	O
might	O
in	O
turn	O
affect	O
neutrophil	cell_type
-to-tumor	O
cell	O
binding	O
.	O
Dex	O
was	O
found	O
to	O
inhibit	O
these	O
neutrophil	cell_type
properties	O
,	O
and	O
RU38486	O
completely	O
suppressed	O
both	O
forms	O
of	O
Dex	O
inhibition	O
.	O
Taken	O
together,	O
our	O
findings	O
suggest	O
that	O
glucocorticoid	O
hormone	O
inhibition	O
of	O
neutrophil	cell_type
-mediated	O
tumor	O
cell	O
cytostasis	O
is	O
at	O
least	O
partially	O
due	O
to	O
a	O
lowering	O
of	O
the	O
ligand	O
binding	O
avidity	O
of	O
beta2	protein
integrin	protein
on	O
the	O
neutrophil	cell_type
surface	O
.	O

Constitutive	O
activation	O
of	O
an	O
epithelial	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
(	O
STAT	protein
)	O
pathway	O
in	O
asthma	O
.	O
Cytokine	protein
effects	O
on	O
immunity	O
and	O
inflammation	O
often	O
depend	O
on	O
the	O
transcription	protein
factors	protein
termed	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(	O
STATs	protein
),	O
so	O
STAT	protein
signaling	O
pathways	O
are	O
candidates	O
for	O
influencing	O
inflammatory	O
disease	O
.	O
We	O
reasoned	O
that	O
selective	O
IFN	protein
responsiveness	O
of	O
the	O
first	O
STAT	protein
family	protein
member	protein
(	O
Stat1	protein
)	O
and	O
Stat1	DNA
-dependent	DNA
immune-response	DNA
genes	DNA
such	O
as	O
intercellular	protein
adhesion	protein
molecule-1	protein
(	O
ICAM-1	protein
),	O
IFN	protein
regulatory	protein
factor-1	protein
(	O
IRF-1	protein
),	O
and	O
Stat1	protein
itself	O
in	O
airway	cell_type
epithelial	cell_type
cells	cell_type
provides	O
a	O
basis	O
for	O
detecting	O
cytokine	protein
signaling	O
abnormalities	O
in	O
inflammatory	O
airway	O
disease	O
.	O
On	O
the	O
basis	O
of	O
nuclear	O
localization	O
and	O
phosphorylation	O
,	O
we	O
found	O
that	O
epithelial	protein
Stat1	protein
(but	O
not	O
other	O
control	O
transcription	protein
factors	protein
)	O
was	O
invariably	O
activated	O
in	O
asthmatic	O
compared	O
with	O
normal	O
control	O
or	O
chronic	O
bronchitis	O
subjects	O
.	O
Furthermore,	O
epithelial	O
levels	O
of	O
activated	O
Stat1	protein
correlated	O
with	O
levels	O
of	O
expression	O
for	O
epithelial	protein
ICAM-1	protein
,	O
IRF-1	protein
,	O
and	O
Stat1	protein
,	O
and	O
in	O
turn,	O
ICAM-1	protein
levels	O
correlated	O
with	O
T-cell	O
accumulation	O
in	O
tissue.	O
However,	O
only	O
low	O
levels	O
of	O
IFN-gamma	protein
or	O
IFN-gamma	cell_type
-producing	cell_type
cells	cell_type
were	O
detected	O
in	O
airway	O
tissue	O
in	O
all	O
subjects.	O
The	O
results	O
therefore	O
provide	O
initial	O
evidence	O
linking	O
abnormal	O
behavior	O
of	O
STAT	protein
pathways	O
for	O
cytokine	protein
signaling	O
to	O
the	O
development	O
of	O
an	O
inflammatory	O
disease	O
.	O
In	O
that	O
context,	O
the	O
results	O
also	O
change	O
the	O
current	O
scheme	O
for	O
asthma	O
pathogenesis	O
to	O
one	O
that	O
must	O
include	O
a	O
localized	O
gain	O
in	O
transcriptional	O
signal	O
ordinarily	O
used	O
for	O
a	O
T	protein
helper	protein
1-type	protein
cytokine	protein
(	O
IFN-gamma	protein
)	O
in	O
combination	O
with	O
allergy-driven	O
overproduction	O
of	O
T	protein
helper	protein
2-type	protein
cytokines	protein
.	O

Leukocyte	cell_type
populations	cell_type
,	O
hormone	protein
receptors	protein
and	O
apoptosis	O
in	O
eutopic	O
and	O
ectopic	O
first	O
trimester	O
human	O
pregnancies	O
.	O
The	O
implantation	O
of	O
trophoblast	cell_type
cells	cell_type
at	O
extrauterine	O
sites	O
still	O
results	O
in	O
decidualization	O
.	O
The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
compare	O
decidualization	O
at	O
eutopic	O
and	O
ectopic	O
implantation	O
sites	O
.	O
Tissues	O
from	O
women	O
undergoing	O
elective	O
termination	O
of	O
uterine	O
pregnancy	O
and	O
from	O
women	O
with	O
ectopic	O
pregnancy	O
were	O
used	O
to	O
detect	O
the	O
presence	O
of	O
cells	O
important	O
for	O
the	O
maintenance	O
of	O
pregnancy,	O
such	O
as	O
BCL-2+	O
,	O
CD56+	O
,	O
CD3+	O
,	O
CD8+	O
and	O
CD68+	O
cells	O
,	O
and	O
the	O
presence	O
of	O
oestrogen	protein
(	protein
ER	protein
)	protein
and	protein
progesterone	protein
receptors	protein
(	O
PR	protein
)	O
by	O
immunohistochemistry	O
.	O
In-situ	O
detection	O
of	O
fragmented	O
DNA	O
was	O
performed	O
to	O
identify	O
apoptotic	cell_type
cells	cell_type
.	O
The	O
percentage	O
of	O
CD3+	cell_type
cells	cell_type
among	O
all	O
immunocompetent	cell_type
cells	cell_type
in	O
the	O
tubal	O
epithelium	O
was	O
46.6%	O
(39.9%	O
of	O
CD3+	cell_type
were	O
also	O
CD8+	cell_type
);	O
the	O
other	O
53.4%	O
were	O
CD68+	cell_type
cells	cell_type
.	O
CD56+	cell_type
cells	cell_type
were	O
undetectable	O
in	O
ectopic	O
decidua	O
at	O
the	O
feto-maternal	O
interface	O
in	O
ectopic	O
tissue	O
.	O
In	O
uterine	O
decidua	O
,	O
we	O
found	O
29.9%	O
CD3+	cell_type
cells	cell_type
(2.2%	O
of	O
CD3+	O
were	O
CD8+),	O
51.6%	O
CD56+	cell_type
cells	cell_type
and	O
18.5%	O
CD68+	cell_type
cells	cell_type
.	O
The	O
ratio	O
of	O
BCL2+	cell_type
to	O
CD3+	cell_type
cells	cell_type
in	O
ectopic	O
pregnancy	O
was	O
0.41.	O
In	O
uterine	O
pregnancy	O
,	O
the	O
ratio	O
of	O
BCL-2	protein
to	O
CD3	O
was	O
0.44	O
and	O
0.39	O
for	O
CD56.	O
Tissues	O
from	O
both	O
ectopic	O
and	O
uterine	O
pregnancies	O
were	O
positive	O
for	O
PR	protein
.	O
Fewer	O
apoptotic	cell_type
cell	cell_type
bodies	cell_type
were	O
present	O
in	O
ectopic	O
pregnancy	O
.	O
The	O
use	O
of	O
tissue	O
obtained	O
from	O
ectopic	O
pregnancy	O
may	O
become	O
an	O
excellent	O
model	O
to	O
identify	O
the	O
mechanism	O
of	O
trophoblast	O
invasion	O
in	O
eutopic	O
pregnancies	O
.	O

Angiotensin	protein
II	protein
activates	O
the	O
proinflammatory	protein
transcription	protein
factor	protein
nuclear	protein
factor-kappaB	protein
in	O
human	cell_type
monocytes	cell_type
.	O
The	O
renin	protein
-angiotensin	O
system	O
may	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
atherosclerosis	O
.	O
A	O
common	O
feature	O
of	O
all	O
stages	O
of	O
atherosclerosis	O
is	O
inflammation	O
of	O
the	O
vessel	O
wall	O
.	O
The	O
transcription	O
factor	O
nuclear	protein
factor-kappaB	protein
(	O
NF-kappaB	protein
)	O
participates	O
in	O
most	O
signaling	O
pathways	O
involved	O
in	O
inflammation	O
.	O
This	O
study	O
therefore	O
examined	O
the	O
effect	O
of	O
angiotensin	protein
(ANG)	protein
II	protein
on	O
NF-kappaB	protein
activation	O
in	O
monocytic	cell_type
cells	cell_type
,	O
a	O
major	O
cellular	O
component	O
of	O
human	O
atheroma	O
,	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O
ANG	protein
II	protein
,	O
like	O
TNFalpha	protein
,	O
caused	O
rapid	O
activation	O
of	O
NF-kappaB	protein
in	O
human	cell_type
mononuclear	cell_type
cells	cell_type
isolated	O
from	O
peripheral	O
blood	O
by	O
Ficoll	O
density	O
gradient	O
.	O
This	O
ANG	protein
II	protein
effect	O
was	O
blocked	O
by	O
the	O
angiotensin	O
AT1	O
receptor	O
antagonist	O
losartan	O
.	O
Specificity	O
of	O
ANG	protein
II	protein
-induced	O
NF-kappaB	protein
activation	O
was	O
ascertained	O
by	O
supershift	O
and	O
competition	O
experiments	O
.	O
Moreover,	O
ANG	protein
II	protein
stimulated	O
NF-kappaB	protein
activation	O
in	O
human	cell_type
monocytes	cell_type
,	O
but	O
not	O
in	O
lymphocytes	cell_type
from	O
the	O
same	O
preparation.	O
Together,	O
the	O
data	O
demonstrate	O
the	O
ability	O
of	O
the	O
vasoactive	O
peptide	O
ANG	protein
II	protein
to	O
activate	O
inflammatory	O
pathways	O
in	O
human	cell_type
monocytes	cell_type
.	O
Copyright	O
1999	O
Academic	O
Press.	O

Signal	O
transduction	O
pathways	O
activated	O
in	O
endothelial	cell_type
cells	cell_type
following	O
infection	O
with	O
Chlamydia	O
pneumoniae	O
.	O
Chlamydia	O
pneumoniae	O
is	O
an	O
important	O
respiratory	O
pathogen	O
.	O
Recently,	O
its	O
presence	O
has	O
been	O
demonstrated	O
in	O
atherosclerotic	O
lesions	O
.	O
In	O
this	O
study,	O
we	O
characterized	O
C.	O
pneumoniae-mediated	O
activation	O
of	O
endothelial	cell_type
cells	cell_type
and	O
demonstrated	O
an	O
enhanced	O
expression	O
of	O
endothelial	protein
adhesion	protein
molecules	protein
followed	O
by	O
subsequent	O
rolling,	O
adhesion,	O
and	O
transmigration	O
of	O
leukocytes	cell_type
(	O
monocytes	cell_type
,	O
granulocytes	cell_type
).	O
These	O
effects	O
were	O
blocked	O
by	O
mAbs	protein
against	O
endothelial	O
and/or	O
leukocyte	O
adhesion	O
molecules	O
(	O
beta1	O
and	O
beta2	O
integrins	O
).	O
Additionally,	O
activation	O
of	O
different	O
signal	O
transduction	O
pathways	O
in	O
C.	cell_type
pneumoniae	cell_type
-infected	cell_type
endothelial	cell_type
cells	cell_type
was	O
shown:	O
protein	O
tyrosine	O
phosphorylation	O
,	O
up-regulation	O
of	O
phosphorylated	O
p42/p44	protein
mitogen-activated	protein
protein	protein
kinase	protein
,	O
and	O
NF-kappaB	protein
activation/translocation	O
occurred	O
within	O
10-15	O
min.	O
Increased	O
mRNA	RNA
and	O
surface	O
expression	O
of	O
E-selectin	protein
,	O
ICAM-1	protein
,	O
and	O
VCAM-1	protein
were	O
noted	O
within	O
hours.	O
Thus,	O
C.	O
pneumoniae	O
triggers	O
a	O
cascade	O
of	O
events	O
that	O
could	O
lead	O
to	O
endothelial	O
activation,	O
inflammation	O
,	O
and	O
thrombosis	O
,	O
which	O
in	O
turn	O
may	O
result	O
in	O
or	O
may	O
promote	O
atherosclerosis	O
.	O

Transient	O
pseudo-hypoaldosteronism	O
following	O
resection	O
of	O
the	O
ileum	O
:	O
normal	O
level	O
of	O
lymphocytic	protein
aldosterone	protein
receptors	protein
outside	O
the	O
acute	O
phase	O
.	O
Pseudo-hypoaldosteronism	O
(	O
PHA	O
)	O
is	O
due	O
to	O
mineralocorticoid	O
resistance	O
and	O
manifests	O
as	O
hyponatremia	O
and	O
hyperkalemia	O
with	O
increased	O
plasma	O
aldosterone	O
levels	O
.	O
It	O
may	O
be	O
familial	O
or	O
secondary	O
to	O
abnormal	O
renal	O
sodium	O
handling	O
.	O
We	O
report	O
the	O
case	O
of	O
a	O
54-year-old	O
woman	O
with	O
multifocal	O
cancer	O
of	O
the	O
colon,	O
who	O
developed	O
PHA	O
after	O
subtotal	O
colectomy	O
,	O
ileal	O
resection	O
and	O
jejunostomy	O
.	O
She	O
was	O
treated	O
with	O
6	O
g	O
of	O
salt	O
daily	O
to	O
prevent	O
dehydration	O
,	O
which	O
she	O
stopped	O
herself	O
because	O
of	O
reduced	O
fecal	O
losses	O
.	O
One	O
month	O
later	O
she	O
was	O
admitted	O
with	O
signs	O
of	O
acute	O
adrenal	O
failure	O
,	O
i.e.	O
fatigue	O
,	O
severe	O
nausea	O
,	O
blood	O
pressure	O
of	O
80/60	O
mmHg,	O
extracellular	O
dehydration	O
,	O
hyponatremia	O
(118	O
mmol/l);	O
hyperkalemia	O
(7.6	O
mmol/l),	O
increased	O
blood	O
urea	O
nitrogen	O
(	O
BUN	O
)	O
(200	O
mg/dl)	O
and	O
creatininemia	O
(2.5	O
mg/dl),	O
and	O
decreased	O
plasma	O
bicarbonates	O
level	O
(HCO3-:	O
16	O
mmol/l;	O
N:	O
27-30).	O
However,	O
the	O
plasma	O
cortisol	O
was	O
high	O
(66	O
microg/100	O
ml	O
at	O
10:00	O
h;	O
N:	O
8-15)	O
and	O
the	O
ACTH	O
was	O
normal	O
(13	O
pg/ml,	O
N:	O
10-60);	O
there	O
was	O
a	O
marked	O
increase	O
in	O
plasma	O
renin	O
activity	O
(&gt;37	O
ng/ml/h;	O
N	O
supine	O
&lt;3),	O
active	O
renin	O
(869	O
pg/ml;	O
N	O
supine:	O
1.120),	O
aldosterone	O
(&gt;2000	O
pg/ml;	O
N	O
supine	O
&lt;150)	O
and	O
plasma	O
AVP	O
(20	O
pmol/l;	O
N:	O
0.5-2.5).	O
The	O
plasma	O
ANH	O
level	O
was	O
38	O
pmol/l	O
(N	O
supine:	O
5-25).	O
A	O
urinary	O
steroidogram	O
resulted	O
in	O
highly	O
elevated	O
tetrahydrocortisol	O
(THF:	O
13.3	O
mg/24h;	O
N:	O
1.4+/-0.8)	O
with	O
no	O
increase	O
in	O
tetrahydrocortisone	O
(THE:	O
3.16	O
mg/24h;	O
N:	O
2.7+/-2.0)	O
excretion,	O
and	O
with	O
low	O
THE/THF	O
(0.24;	O
N:	O
1.87+/-0.36)	O
and	O
alpha	O
THF/THF	O
(0.35;	O
N:	O
0.92+/-0.42)	O
ratios.	O
The	O
number	O
of	O
mineralocorticoid	protein
receptors	protein
in	O
mononuclear	cell_type
leukocytes	cell_type
was	O
in	O
the	O
lower	O
normal	O
range	O
for	O
age,	O
while	O
the	O
number	O
of	O
glucocorticoid	protein
receptors	protein
was	O
reduced.	O
Small-bowel	O
resection	O
in	O
ileostomized	O
patients	O
causes	O
excessive	O
fecal	O
sodium	O
losses	O
and	O
results	O
in	O
chronic	O
sodium	O
depletion	O
with	O
contraction	O
of	O
the	O
plasma	O
volume	O
and	O
severe	O
secondary	O
hyperaldosteronism	O
.	O
Nevertheless,	O
this	O
hyperaldosteronism	O
may	O
be	O
associated	O
with	O
hyponatremia	O
and	O
hyperkalemia	O
suggesting	O
PHA	O
related	O
to	O
the	O
major	O
importance	O
of	O
the	O
colon	O
for	O
the	O
absorption	O
of	O
sodium	O
.	O
In	O
conclusion,	O
this	O
case	O
report	O
emphasizes	O
1)	O
the	O
possibility	O
of	O
a	O
syndrome	O
of	O
acquired	O
PHA	O
with	O
severe	O
hyperkalemia	O
after	O
resection	O
of	O
the	O
ileum	O
and	O
colon	O
responding	O
to	O
oral	O
salt	O
supplementation	O
;	O
2)	O
the	O
major	O
increase	O
in	O
AVP	O
and	O
the	O
small	O
increase	O
in	O
ANH	O
;	O
3)	O
the	O
strong	O
increase	O
in	O
urinary	O
THF	O
with	O
low	O
THE/THF	O
and	O
alpha	O
THF/THF	O
ratios	O
;	O
4)	O
the	O
normal	O
number	O
of	O
lymphocytic	protein
mineralocorticoid	protein
receptors	protein
outside	O
the	O
acute	O
episode	O
.	O

Modulation	O
of	O
the	O
immune	O
response	O
by	O
progesterone-induced	protein
lymphocyte	protein
factors	protein
.	O
Rat	O
spleen	O
and	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
express	O
progesterone	protein
receptors	protein
whose	O
concentration	O
is	O
increased	O
greatly	O
during	O
the	O
early	O
phase	O
of	O
pregnancy	O
.	O
After	O
stimulation	O
of	O
progesterone	O
the	O
expression	O
of	O
receptors	O
was	O
augmented	O
2-3	O
times.	O
When	O
cells	O
were	O
cultured	O
in	O
the	O
presence	O
of	O
progesterone	O
they	O
released	O
a	O
soluble	protein
factor	protein
that	O
inhibited	O
cellular	O
immunoreactions	O
(	O
MLR	O
,	O
CRC	O
)	O
and	O
cellular	O
proliferation	O
as	O
measured	O
by	O
thymidine	O
incorporation	O
by	O
spleen-cell	cell_line
culture	cell_line
.	O
This	O
factor	O
also	O
inhibited	O
the	O
synthesis	O
of	O
anti-DNP	protein
antibodies	protein
by	O
a	O
mouse	cell_line
hybridoma	cell_line
and	O
diminished	O
the	O
proportion	O
of	O
cells	O
in	O
phase	O
S	O
.	O
However,	O
the	O
percentage	O
of	O
asymmetric	protein
molecules	protein
produced	O
by	O
the	O
hybridoma	cell_line
remained	O
unaltered.	O
These	O
results	O
support	O
the	O
hypothesis	O
that	O
soluble	protein
factors	protein
released	O
by	O
rat	cell_type
lymphocytes	cell_type
modulate	O
the	O
immune	O
response	O
of	O
the	O
mother	O
and	O
participate	O
in	O
the	O
mechanism	O
that	O
protects	O
the	O
fetus	O
against	O
antipaternal	protein
antibodies	protein
.	O

Differential	O
regulation	O
of	O
4E-BP1	protein
and	O
4E-BP2	protein
,	O
two	O
repressors	O
of	O
translation	O
initiation	O
,	O
during	O
human	cell_type
myeloid	cell_type
cell	cell_type
differentiation	O
.	O
Human	O
myeloid	O
differentiation	O
is	O
accompanied	O
by	O
a	O
decrease	O
in	O
cell	O
proliferation	O
.	O
Because	O
the	O
translation	O
rate	O
is	O
an	O
important	O
determinant	O
of	O
cell	O
proliferation	O
,	O
we	O
have	O
investigated	O
translation	O
initiation	O
during	O
human	cell_type
myeloid	cell_type
cell	cell_type
differentiation	O
using	O
the	O
HL-60	cell_line
promyelocytic	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
and	O
the	O
U-937	cell_line
monoblastic	cell_line
cell	cell_line
line	cell_line
.	O
A	O
decrease	O
in	O
the	O
translation	O
rate	O
is	O
observed	O
when	O
the	O
cells	O
are	O
induced	O
to	O
differentiate	O
along	O
the	O
monocytic/macrophage	O
pathway	O
or	O
along	O
the	O
granulocytic	O
pathway	O
.	O
The	O
inhibition	O
in	O
protein	O
synthesis	O
correlates	O
with	O
specific	O
regulation	O
of	O
two	O
repressors	O
of	O
translation	O
initiation	O
,	O
4E-BP1	protein
and	O
4E-BP2	protein
.	O
Induction	O
of	O
HL-60	cell_line
and	O
U-937	cell_line
cell	O
differentiation	O
into	O
monocytes	cell_type
/macrophages	cell_type
by	O
IFN-gamma	protein
or	O
PMA	O
results	O
in	O
a	O
dephosphorylation	O
and	O
consequent	O
activation	O
of	O
4E-BP1	protein
.	O
Dephosphorylation	O
of	O
4E-BP1	protein
was	O
also	O
observed	O
when	O
U-937	cell_line
cells	cell_line
were	O
induced	O
to	O
differentiate	O
into	O
monocytes	cell_type
/macrophages	cell_type
following	O
treatment	O
with	O
retinoic	O
acid	O
or	O
DMSO	O
.	O
In	O
contrast,	O
treatment	O
of	O
HL-60	cell_line
cells	cell_line
with	O
retinoic	O
acid	O
or	O
DMSO	O
,	O
which	O
results	O
in	O
a	O
granulocytic	O
differentiation	O
of	O
these	O
cells,	O
decreases	O
4E-BP1	protein
amount	O
without	O
affecting	O
its	O
phosphorylation	O
and	O
strongly	O
increases	O
4E-BP2	protein
amount	O
.	O
Taken	O
together,	O
these	O
data	O
provide	O
evidence	O
for	O
differential	O
regulation	O
of	O
the	O
translational	O
machinery	O
during	O
human	O
myeloid	O
differentiation	O
,	O
specific	O
to	O
the	O
monocytic/macrophage	O
pathway	O
or	O
to	O
the	O
granulocytic	O
pathway	O
.	O

Nonimmunoglobulin	O
gene	O
hypermutation	O
in	O
germinal	cell_type
center	cell_type
B	cell_type
cells	cell_type
.	O
Somatic	O
hypermutation	O
is	O
the	O
most	O
critical	O
mechanism	O
underlying	O
the	O
diversification	O
of	O
Ig	DNA
genes	DNA
.	O
Although	O
mutation	O
occurs	O
specifically	O
in	O
B	cell_type
cells	cell_type
during	O
the	O
germinal	O
center	O
reaction,	O
it	O
remains	O
a	O
matter	O
of	O
debate	O
whether	O
the	O
mutation	O
machinery	O
also	O
targets	O
non-	DNA
Ig	DNA
genes	DNA
.	O
We	O
have	O
studied	O
mutations	O
in	O
the	O
5'	DNA
noncoding	DNA
region	DNA
of	O
the	O
Bcl6	DNA
gene	DNA
in	O
different	O
subtypes	O
of	O
lymphomas	O
.	O
We	O
found	O
frequent	O
hypermutation	O
in	O
follicular	O
lymphoma	O
(25	O
of	O
59	O
=	O
42%)	O
(	O
germinal	O
center	O
cell	O
origin	O
)	O
and	O
mucosa-associated	O
lymphoid	O
tissue	O
(	O
MALT	O
)	O
lymphoma	O
(19	O
of	O
45	O
=	O
42%)	O
(	O
postgerminal	O
center	O
),	O
but	O
only	O
occasionally	O
in	O
mantle	O
cell	O
lymphoma	O
(1	O
of	O
21	O
=	O
4.8%)	O
(	O
pregerminal	O
center	O
).	O
Most	O
mutations	O
were	O
outside	O
the	O
motifs	O
potentially	O
important	O
for	O
transcription,	O
suggesting	O
they	O
were	O
not	O
important	O
in	O
lymphomagenesis	O
but	O
may,	O
like	O
Ig	O
mutation,	O
represent	O
an	O
inherent	O
feature	O
of	O
the	O
lymphoma	cell_type
precursor	cell_type
cells	cell_type
.	O
Therefore,	O
we	O
investigated	O
their	O
normal	O
cell	O
counterparts	O
microdissected	O
from	O
a	O
reactive	O
tonsil	O
.	O
Bcl6	O
mutation	O
was	O
found	O
in	O
13	O
of	O
24	O
(54%)	O
clones	O
from	O
the	O
germinal	O
centre	O
but	O
only	O
in	O
1	O
of	O
24	O
(4%)	O
clones	O
from	O
the	O
naive	cell_type
B	cell_type
cells	cell_type
of	O
the	O
mantle	O
zone	O
.	O
The	O
frequency,	O
distribution,	O
and	O
nature	O
of	O
these	O
mutations	O
were	O
similar	O
to	O
those	O
resulting	O
from	O
the	O
Ig	O
hypermutation	O
process	O
.	O
The	O
results	O
show	O
unequivocal	O
evidence	O
of	O
non-	O
Ig	DNA
gene	DNA
hypermutation	O
in	O
germinal	cell_type
center	cell_type
B	cell_type
cells	cell_type
and	O
provide	O
fresh	O
insights	O
into	O
the	O
process	O
of	O
hypermutation	O
and	O
lymphomagenesis	O
.	O

Impaired	O
binding	O
of	O
a	O
DQ2	protein
and	O
DQ8	protein
-binding	O
HSV	O
VP16	O
peptide	O
to	O
a	O
DQA1*0501/DQB1*0302	protein
trans	protein
class	protein
II	protein
heterodimer	protein
.	O
DQalpha	protein
and	protein
DQbeta	protein
trans	protein
heterodimeric	protein
HLA-DQ	protein
molecules	protein
form	O
in	O
individuals	O
heterozygous	O
for	O
the	O
DQ2	protein
and	O
DQ8	protein
specificities.	O
Unique	O
functions	O
and	O
disease	O
associations	O
have	O
been	O
postulated	O
for	O
such	O
trans-dimers	protein
,	O
which	O
may	O
be	O
different	O
from	O
cis-encoded	protein
DQ	protein
molecules	protein
encoded	O
by	O
the	O
corresponding	O
haplotypes	O
.	O
We	O
analyzed	O
the	O
ability	O
of	O
the	O
trans-dimer	O
encoded	O
by	O
HLA-DQA1*0501/DQB1*0302	protein
to	O
bind	O
a	O
peptide	O
antigen	O
which	O
interacts	O
with	O
DQ	protein
molecules	protein
encoded	O
by	O
both	O
parental	O
haplotypes	O
.	O
Markedly	O
impaired	O
binding	O
was	O
observed,	O
consistent	O
with	O
both	O
the	O
use	O
of	O
different	O
anchor	O
residues	O
and	O
with	O
changes	O
in	O
levels	O
of	O
DQ	O
cis-	O
dimer	protein
availability	O
for	O
peptide	O
binding	O
interactions	O
.	O

Detection	O
of	O
intracellular	protein
phosphorylated	protein
STAT-1	protein
by	O
flow	O
cytometry	O
.	O
We	O
have	O
applied	O
flow	O
cytometry	O
to	O
the	O
investigation	O
of	O
interferon-gamma	protein
activation	O
of	O
human	cell_type
monocytes	cell_type
.	O
This	O
approach	O
uses	O
monoclonal	protein
antibodies	protein
that	O
distinguish	O
between	O
the	O
native	O
and	O
phosphorylated	O
forms	O
of	O
STAT-1	protein
.	O
It	O
enables	O
rapid	O
and	O
quantitative	O
assessment	O
of	O
STAT-1	protein
phosphorylation	O
on	O
a	O
discrete	O
cell	O
basis	O
and	O
is	O
both	O
more	O
sensitive	O
and	O
less	O
time	O
consuming	O
than	O
immunoblotting	O
.	O
Furthermore,	O
it	O
allows	O
for	O
discrimination	O
between	O
a	O
mixture	O
of	O
cells	O
that	O
differ	O
in	O
their	O
response	O
to	O
interferon-gamma	protein
.	O
This	O
approach	O
should	O
allow	O
for	O
the	O
evaluation	O
of	O
different	O
intracellular	O
signaling	O
pathways	O
using	O
a	O
combination	O
of	O
monoclonal	O
reagents	O
that	O
are	O
specific	O
for	O
native	O
and	O
activation	protein
modified	protein
proteins	protein
.	O
Application	O
of	O
this	O
form	O
of	O
testing	O
should	O
prove	O
valuable	O
in	O
screening	O
for	O
signaling	O
defects	O
in	O
selected	O
patients	O
with	O
recurrent	O
infections.	O
In	O
addition,	O
this	O
technique	O
should	O
permit	O
dissection	O
of	O
a	O
full	O
range	O
of	O
cellular	O
signaling	O
pathways	O
at	O
the	O
protein	O
level	O
.	O

Activation	O
of	O
nuclear	protein
factor-kappaB	protein
by	O
lipopolysaccharide	O
in	O
mononuclear	cell_type
leukocytes	cell_type
is	O
prevented	O
by	O
inhibitors	O
of	O
cytosolic	protein
phospholipase	protein
A2	protein
.	O
In	O
monocytes	cell_type
,	O
lipopolysaccharide	O
induces	O
synthesis	O
and	O
activity	O
of	O
the	O
85-kDa	O
cytosolic	protein
phospholipase	protein
A2	protein
.	O
This	O
enzyme	O
releases	O
arachidonic	O
acid	O
and	O
lyso-phospholipids	O
from	O
membranes	O
which	O
are	O
metabolized	O
to	O
eicosanoids	O
and	O
platelet-activating-factor	O
.	O
These	O
lipid	O
mediators	O
increase	O
activity	O
of	O
transcription	protein
factors	protein
and	O
expression	O
of	O
cytokine	DNA
genes	DNA
indicating	O
a	O
function	O
for	O
cytosolic	protein
phospholipase	protein
A2	protein
in	O
signal	O
transduction	O
and	O
inflammation	O
.	O
We	O
have	O
shown	O
previously	O
that	O
trifluoromethylketone	O
inhibitors	O
of	O
cytosolic	protein
phospholipase	protein
A2	protein
suppressed	O
interleukin-1beta	protein
protein	protein
and	O
steady-state	O
mRNA	O
levels	O
in	O
human	O
lipopolysaccharide	cell_type
-stimulated	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
leukocytes	cell_type
.	O
In	O
this	O
study,	O
the	O
subcellular	O
mechanisms	O
were	O
analyzed	O
by	O
which	O
trifluoromethylketones	O
interfere	O
with	O
gene	O
expression	O
.	O
We	O
found	O
that	O
they	O
reduced	O
the	O
initial	O
interleukin-1beta	RNA
mRNA	RNA
transcription	O
rate	O
through	O
prevention	O
of	O
degradation	O
of	O
inhibitor-kappaB	protein
alpha	protein
.	O
Consequently,	O
cytosolic	O
activation	O
,	O
nuclear	O
translocation	O
and	O
DNA-binding	O
of	O
nuclear	protein
factor-kappaB	protein
were	O
decreased.	O
Trifluoromethylketones	O
ameliorate	O
chronic	O
inflammation	O
in	O
vivo.	O
Thus,	O
this	O
therapeutic	O
potency	O
may	O
reside	O
in	O
retention	O
of	O
inactive	O
nuclear	protein
factor-kappaB	protein
in	O
the	O
cytosol	cell_type
thereby	O
abrogating	O
interleukin-1beta	protein
gene	O
transcription	O
.	O

Cellular	O
disposition	O
of	O
sulphamethoxazole	O
and	O
its	O
metabolites	O
:	O
implications	O
for	O
hypersensitivity	O
.	O
1.	O
Bioactivation	O
of	O
sulphamethoxazole	O
(	O
SMX	O
)	O
to	O
chemically-reactive	O
metabolites	O
and	O
subsequent	O
protein	O
conjugation	O
is	O
thought	O
to	O
be	O
involved	O
in	O
SMX	O
hypersensitivity	O
.	O
We	O
have	O
therefore	O
examined	O
the	O
cellular	O
metabolism,	O
disposition	O
and	O
conjugation	O
of	O
SMX	O
and	O
its	O
metabolites	O
in	O
vitro.	O
2.	O
Flow	O
cytometry	O
revealed	O
binding	O
of	O
N-hydroxy	O
(SMX-NHOH)	O
and	O
nitroso	O
(SMX-NO)	O
metabolites	O
of	O
SMX	O
,	O
but	O
not	O
of	O
SMX	O
itself,	O
to	O
the	O
surface	O
of	O
viable	O
white	cell_type
blood	cell_type
cells	cell_type
.	O
Cellular	O
haptenation	O
by	O
SMX	O
-NO	O
was	O
reduced	O
by	O
exogenous	O
glutathione	O
(	O
GSH	O
).	O
3.	O
SMX	O
-NHOH	O
and	O
SMX	O
-NO	O
were	O
rapidly	O
reduced	O
back	O
to	O
the	O
parent	O
compound	O
by	O
cysteine	O
(	O
CYS	O
),	O
GSH	O
,	O
human	cell_type
peripheral	cell_type
blood	cell_type
cells	cell_type
and	O
plasma,	O
suggesting	O
that	O
this	O
is	O
an	O
important	O
and	O
ubiquitous	protein
bioinactivation	O
mechanism	O
.	O
4.	O
Fluorescence	O
HPLC	O
showed	O
that	O
SMX	O
-NHOH	O
and	O
SMX	O
-NO	O
depleted	O
CYS	O
and	O
GSH	O
in	O
buffer,	O
and	O
to	O
a	O
lesser	O
extent,	O
in	O
cells	O
and	O
plasma	O
.	O
5.	O
Neutrophil	O
apoptosis	O
and	O
inhibition	O
of	O
neutrophil	O
function	O
were	O
induced	O
at	O
lower	O
concentrations	O
of	O
SMX	O
-NHOH	O
and	O
SMX	O
-NO	O
than	O
those	O
inducing	O
loss	O
of	O
membrane	O
viability,	O
with	O
SMX	O
having	O
no	O
effect.	O
Lymphocytes	cell_type
were	O
significantly	O
(P&lt;0.05)	O
more	O
sensitive	O
to	O
the	O
direct	O
cytotoxic	O
effects	O
of	O
SMX	O
-NO	O
than	O
neutrophils	cell_type
.	O
6.	O
Partitioning	O
of	O
SMX	O
-NHOH	O
into	O
red	cell_type
blood	cell_type
cells	cell_type
was	O
significantly	O
(P&lt;0.05)	O
lower	O
than	O
with	O
the	O
hydroxylamine	O
of	O
dapsone	O
.	O
7.	O
Our	O
results	O
suggest	O
that	O
the	O
balance	O
between	O
oxidation	O
of	O
SMX	O
to	O
its	O
toxic	O
metabolites	O
and	O
their	O
reduction	O
is	O
an	O
important	O
protective	O
cellular	O
mechanism.	O
If	O
an	O
imbalance	O
exists,	O
haptenation	O
of	O
the	O
toxic	O
metabolites	O
to	O
bodily	O
proteins	O
including	O
the	O
surface	O
of	O
viable	O
cells	O
can	O
occur,	O
and	O
may	O
result	O
in	O
drug	O
hypersensitivity	O
.	O

Bcl-6	protein
expression	O
in	O
reactive	O
follicular	O
hyperplasia	O
,	O
follicular	O
lymphoma	O
,	O
and	O
angioimmunoblastic	O
T-cell	O
lymphoma	O
with	O
hyperplastic	O
germinal	O
centers	O
:	O
heterogeneity	O
of	O
intrafollicular	cell_type
T-cells	cell_type
and	O
their	O
altered	O
distribution	O
in	O
the	O
pathogenesis	O
of	O
angioimmunoblastic	O
T-cell	O
lymphoma	O
.	O
BACKGROUND:	O
The	O
Bcl-6	protein
gene	protein
product	protein
,	O
a	O
nuclear	protein
phosphoprotein	protein
,	O
is	O
expressed	O
independently	O
of	O
Bcl-6	protein
gene	O
rearrangement	O
.	O
In	O
lymph	O
nodes	O
,	O
expression	O
of	O
Bcl-6	protein
protein	O
is	O
restricted	O
to	O
germinal	cell_type
center	cell_type
(GC)	cell_type
B-cells	cell_type
and	O
10%	O
to	O
15%	O
of	O
CD3/CD4+	cell_type
intrafollicular	cell_type
T	cell_type
cells	cell_type
.	O
Interfollicular	O
cells	O
are	O
negative	O
for	O
Bcl-6	protein
protein	protein
,	O
except	O
for	O
rare	O
CD3+/CD4+	cell_type
T	cell_type
cells	cell_type
.	O
Recently,	O
we	O
reported	O
cases	O
of	O
angioimmunoblastic	O
T-cell	O
lymphoma	O
(	O
AITL	O
)	O
with	O
hyperplastic	O
GCs	O
(	O
AITL/GC	O
),	O
and	O
observed	O
that	O
borders	O
of	O
enlarged	O
GCs	O
were	O
ill	O
defined,	O
with	O
features	O
suggestive	O
of	O
an	O
outward	O
migration	O
of	O
GC	cell_type
cells	cell_type
to	O
surrounding	O
interfollicular	O
zones	O
.	O
This	O
prompted	O
a	O
study	O
of	O
follicular	O
borders	O
with	O
Bcl-6	protein
staining	O
in	O
reactive	O
follicular	O
hyperplasias	O
and	O
follicular	O
lymphomas	O
to	O
compare	O
with	O
AITL	O
/GC.	O
MATERIALS	O
AND	O
METHODS:	O
Formalin-fixed	O
paraffin	O
sections	O
were	O
used	O
for	O
immunostaining	O
of	O
Bcl-6	protein
.	O
Six	O
cases	O
of	O
AITL/GC	O
,	O
12	O
nonspecific	O
reactive	O
follicular	O
hyperplasia	O
(	O
FH	O
),	O
7	O
HIV	O
adenopathy	O
,	O
10	O
follicular	O
lymphoma	O
(FL),	O
and	O
8	O
typical	O
AITL	O
(ie,	O
AITL	O
without	O
GC	O
)	O
were	O
studied.	O
Double	O
staining	O
for	O
Bcl-6	protein
/CD20	protein
,	O
Bcl-6	protein
/CD3	protein
,	O
and	O
Bcl-6	protein
/CD57	protein
was	O
performed	O
in	O
selected	O
cases.	O
RESULTS:	O
In	O
FH	O
and	O
HIV	O
adenopathy	O
,	O
staining	O
for	O
Bcl-6	protein
revealed	O
densely	O
populated	O
GCs	O
with	O
well-defined	O
and	O
regular	O
GC	O
borders	O
,	O
whereas	O
Bcl-6	cell_type
+	cell_type
cells	cell_type
were	O
rare	O
in	O
the	O
interfollicular	O
areas	O
.	O
An	O
occasional	O
GC	O
with	O
an	O
ill-defined	O
border	O
was	O
invariably	O
surrounded	O
by	O
a	O
broad	O
mantle	O
zone;	O
those	O
with	O
indistinct	O
mantle	O
zones	O
had	O
well-defined,	O
regular	O
borders.	O
In	O
FL,	O
follicles	O
were	O
densely	O
populated,	O
and	O
their	O
borders	O
were	O
irregular,	O
with	O
some	O
Bcl-6	cell_type
+	cell_type
cells	cell_type
in	O
the	O
interfollicular	O
zones	O
.	O
In	O
AITL	O
/GC,	O
GCs	O
were	O
less	O
dense,	O
GC	O
borders	O
were	O
ill	O
defined	O
and	O
irregular,	O
and	O
the	O
number	O
of	O
interfollicular	cell_type
Bcl-6	cell_type
+	cell_type
cells	cell_type
was	O
markedly	O
increased.	O
Double	O
staining	O
revealed	O
that	O
these	O
interfollicular	cell_type
Bcl-6	cell_type
+	cell_type
cells	cell_type
in	O
AITL	O
/GC	O
were	O
Bcl6+/CD3+/CD20-/CD57-	cell_type
T	cell_type
cells	cell_type
.	O
Moreover,	O
CD3+	cell_type
intrafollicular	cell_type
T	cell_type
cells	cell_type
were	O
depleted	O
in	O
AITL	O
/GC	O
,	O
whereas	O
they	O
were	O
abundant	O
in	O
FH	O
.	O
Intrafollicular	O
CD57+	cell_type
cells	cell_type
did	O
not	O
stain	O
for	O
Bcl-6	protein
,	O
and	O
were	O
also	O
depleted	O
in	O
AITL	O
/GC.	O
In	O
typical	O
AITL	O
,	O
some	O
neoplastic	O
cells	O
were	O
positive	O
for	O
Bcl-6	protein
,	O
showing	O
variable	O
degrees	O
of	O
staining.	O
CONCLUSIONS:	O
(1)	O
GCs	O
of	O
AITL/GC	O
differed	O
from	O
those	O
of	O
other	O
reactive	O
follicular	O
hyperplasias	O
and	O
follicular	O
lymphomas	O
,	O
and	O
staining	O
for	O
Bcl-6	protein
was	O
useful	O
to	O
discern	O
them.	O
(2)	O
Intrafollicular	cell_type
CD3+	cell_type
T	cell_type
cells	cell_type
,	O
many	O
of	O
which	O
were	O
also	O
positive	O
for	O
Bcl-6	protein
,	O
were	O
markedly	O
depleted	O
in	O
AITL	O
/GC,	O
with	O
increased	O
interfollicular	O
Bcl-6	cell_type
+/CD3+	cell_type
cells	cell_type
,	O
suggesting	O
an	O
outward	O
migration	O
of	O
intrafollicular	cell_type
T	cell_type
cells	cell_type
in	O
this	O
condition.	O
(3)	O
Interfollicular	cell_type
Bcl-6	cell_type
+/CD3+	cell_type
cells	cell_type
in	O
AITL/GC	O
were	O
too	O
numerous	O
to	O
be	O
accounted	O
for	O
by	O
migration	O
alone,	O
suggesting	O
local	O
proliferation.	O
(4)	O
Intrafollicular	cell_type
CD57+	cell_type
cells	cell_type
were	O
negative	O
for	O
Bcl-6	protein
,	O
indicating	O
heterogeneity	O
of	O
the	O
intrafollicular	cell_type
T-cell	cell_type
population	cell_type
.	O
(5)	O
Some	O
neoplastic	O
cells	O
in	O
AITL	O
stained	O
for	O
Bcl-6	protein
,	O
suggesting	O
up-regulation	O
of	O
Bcl-6	protein
expression	O
in	O
this	O
tumor	O
.	O

Human	O
cytomegalovirus	O
binding	O
to	O
human	cell_type
monocytes	cell_type
induces	O
immunoregulatory	O
gene	O
expression	O
.	O
To	O
continue	O
our	O
investigation	O
of	O
the	O
cellular	O
events	O
that	O
occur	O
following	O
human	O
CMV	O
(	O
HCMV	O
)	O
infection	O
,	O
we	O
focused	O
on	O
the	O
regulation	O
of	O
cellular	O
activation	O
following	O
viral	O
binding	O
to	O
human	cell_type
monocytes	cell_type
.	O
First,	O
we	O
showed	O
that	O
viral	O
binding	O
induced	O
a	O
number	O
of	O
immunoregulatory	cell_type
genes	cell_type
(	O
IL-1beta	protein
,	O
A20	protein
,	O
NF-kappaB-p105/p50	protein
,	O
and	O
IkappaBalpha	protein
)	O
in	O
unactivated	O
monocytes	cell_type
and	O
that	O
neutralizing	protein
Abs	protein
to	O
the	O
major	O
HCMV	protein
glycoproteins	protein
,	O
gB	protein
(	O
UL55	protein
)	O
and	O
gH	protein
(	O
UL75	protein
),	O
inhibited	O
the	O
induction	O
of	O
these	O
genes.	O
Next,	O
we	O
demonstrated	O
that	O
these	O
viral	O
ligands	O
directly	O
up-regulated	O
monocyte	O
gene	O
expression	O
upon	O
their	O
binding	O
to	O
their	O
appropriate	O
cellular	O
receptors.	O
We	O
then	O
investigated	O
if	O
HCMV	O
binding	O
also	O
resulted	O
in	O
the	O
translation	O
and	O
secretion	O
of	O
cytokines	protein
.	O
Our	O
results	O
showed	O
that	O
HCMV	O
binding	O
to	O
monocytes	cell_type
resulted	O
in	O
the	O
production	O
and	O
release	O
of	O
IL-1beta	protein
protein	protein
.	O
Because	O
these	O
induced	O
gene	O
products	O
have	O
NF-kappaB	DNA
sites	DNA
in	O
their	O
promoter	DNA
regions	DNA
,	O
we	O
next	O
examined	O
whether	O
there	O
was	O
an	O
up-regulation	O
of	O
nuclear	O
NF-kappaB	protein
levels	O
.	O
These	O
experiments	O
showed	O
that,	O
in	O
fact,	O
NF-kappaB	protein
was	O
translocated	O
to	O
the	O
nucleus	O
following	O
viral	O
binding	O
or	O
purified	O
viral	O
ligand	O
binding	O
.	O
Changes	O
in	O
IkappaBalpha	protein
levels	O
correlated	O
with	O
the	O
changes	O
in	O
NF-kappaB	protein
translocation	O
.	O
Lastly,	O
we	O
demonstrated	O
that	O
p38	protein
kinase	O
activity	O
played	O
a	O
central	O
role	O
in	O
IL-1beta	protein
production	O
and	O
that	O
it	O
was	O
rapidly	O
up-regulated	O
following	O
infection.	O
These	O
results	O
support	O
our	O
hypothesis	O
that	O
HCMV	O
initiates	O
a	O
signal	O
transduction	O
pathway	O
that	O
leads	O
to	O
monocyte	O
activation	O
and	O
pinpoints	O
a	O
potential	O
mechanism	O
whereby	O
HCMV	O
infection	O
of	O
monocytes	cell_type
can	O
result	O
in	O
profound	O
pathogenesis	O
,	O
especially	O
in	O
chronic	O
inflammatory-type	O
conditions	O
.	O

Regulation	O
of	O
the	O
megakaryocytic	DNA
glycoprotein	DNA
IX	DNA
promoter	DNA
by	O
the	O
oncogenic	protein
Ets	protein
transcription	protein
factor	protein
Fli-1	protein
.	O
Glycoprotein	protein
(GP)	protein
IX	protein
is	O
a	O
subunit	O
of	O
the	O
von	protein
Willebrand	protein
receptor	protein
,	O
GPIb-V-IX	protein
,	O
which	O
mediates	O
adhesion	O
of	O
platelets	cell_type
to	O
the	O
subendothelium	O
of	O
damaged	O
blood	O
vessels	O
.	O
Previous	O
characterization	O
of	O
the	O
GPIX	DNA
promoter	DNA
identified	O
a	O
functional	O
Ets	O
site	O
that,	O
when	O
disrupted,	O
reduced	O
promoter	O
activity	O
.	O
However,	O
the	O
Ets	protein
protein	protein
(s)	O
that	O
regulated	O
GPIX	DNA
promoter	DNA
expression	O
was	O
unknown.	O
In	O
this	O
study,	O
transient	O
cotransfection	O
of	O
several	O
GPIX	DNA
promoter	DNA
/reporter	DNA
constructs	DNA
into	O
293T	cell_line
kidney	cell_line
fibroblasts	cell_line
with	O
a	O
Fli-1	DNA
expression	DNA
vector	DNA
shows	O
that	O
the	O
oncogenic	O
protein	O
Fli-1	protein
can	O
transactivate	O
the	O
GPIX	DNA
promoter	DNA
when	O
an	O
intact	O
GPIX	DNA
Ets	DNA
site	DNA
is	O
present.	O
In	O
addition,	O
Fli-1	protein
binding	O
of	O
the	O
GPIX	DNA
Ets	DNA
site	DNA
was	O
identified	O
in	O
antibody	O
supershift	O
experiments	O
in	O
nuclear	O
extracts	O
derived	O
from	O
hematopoietic	cell_type
human	cell_type
erythroleukemia	cell_type
cells	cell_type
.	O
Comparative	O
studies	O
showed	O
that	O
Fli-1	protein
was	O
also	O
able	O
to	O
transactivate	O
the	O
GPIbalpha	DNA
and,	O
to	O
a	O
lesser	O
extent,	O
the	O
GPIIb	DNA
promoter	DNA
.	O
Immunoblot	O
analysis	O
identified	O
Fli-1	protein
protein	protein
in	O
lysates	O
derived	O
from	O
platelets	cell_type
.	O
In	O
addition,	O
expression	O
of	O
Fli-1	protein
was	O
identified	O
immunohistochemically	O
in	O
megakaryocytes	cell_type
derived	O
from	O
CD34(+)	cell_type
cells	cell_type
treated	O
with	O
the	O
megakaryocyte	protein
differentiation	protein
and	protein
proliferation	protein
factor	protein
,	O
thrombopoietin	protein
.	O
These	O
results	O
suggest	O
that	O
Fli-1	protein
is	O
likely	O
to	O
regulate	O
lineage-specific	DNA
genes	DNA
during	O
megakaryocytopoiesis	O
.	O

Expression	O
of	O
IkappaBalpha	protein
in	O
the	O
nucleus	O
of	O
human	cell_type
peripheral	cell_type
blood	cell_type
T	cell_type
lymphocytes	cell_type
.	O
According	O
to	O
current	O
models	O
the	O
inhibitory	O
capacity	O
of	O
I(kappa)B(alpha)	protein
would	O
be	O
mediated	O
through	O
the	O
retention	O
of	O
Rel/NF-kappaB	protein
proteins	protein
in	O
the	O
cytosol	cell_type
.	O
However,	O
I(kappa)B(alpha)	protein
has	O
also	O
been	O
detected	O
in	O
the	O
nucleus	O
of	O
cell	O
lines	O
and	O
when	O
overexpressed	O
by	O
transient	O
transfection.	O
To	O
gain	O
better	O
insight	O
into	O
the	O
potential	O
role	O
of	O
nuclear	protein
I(kappa)B(alpha)	protein
in	O
a	O
physiological	O
context	O
we	O
have	O
analysed	O
its	O
presence	O
in	O
the	O
nucleus	O
of	O
human	cell_type
peripheral	cell_type
blood	cell_type
T	cell_type
lymphocytes	cell_type
(	O
PBL	cell_type
).	O
We	O
demonstrate	O
the	O
nuclear	O
localization	O
of	O
I(kappa)B(alpha)	protein
in	O
PBL	cell_type
by	O
different	O
techniques:	O
Western	O
blot	O
,	O
indirect	O
immunofluorescence	O
and	O
electron	O
microscopy	O
.	O
Low	O
levels	O
of	O
nuclear	O
I(kappa)B(alpha)	protein
were	O
detected	O
in	O
resting	O
cells	O
whereas	O
a	O
superinduction	O
was	O
obtained	O
after	O
PMA	O
activation	O
.	O
The	O
nuclear	O
pool	O
of	O
I(kappa)B(alpha)	protein
showed	O
a	O
higher	O
stability	O
than	O
cytosolic	O
I(kappa)B(alpha)	protein
and	O
was	O
partially	O
independent	O
of	O
the	O
resynthesis	O
of	O
the	O
protein.	O
Unexpectedly,	O
the	O
presence	O
of	O
nuclear	protein
I(kappa)B(alpha)	protein
did	O
not	O
inhibit	O
NF-kappaB	protein
binding	O
to	O
DNA	O
and	O
this	O
phenomenon	O
was	O
not	O
due	O
to	O
the	O
presence	O
of	O
IkappaBbeta	protein
at	O
the	O
nuclear	O
level.	O
Immunoprecipitation	O
experiments	O
failed	O
to	O
demonstrate	O
an	O
association	O
between	O
nuclear	O
I(kappa)B(alpha)	protein
and	O
NF-kappaB	protein
proteins.	O
Our	O
results	O
demonstrate	O
that	O
in	O
resting	O
and	O
PMA-activated	cell_type
human	cell_type
PBL	cell_type
,	O
I(kappa)B(alpha)	protein
is	O
present	O
in	O
the	O
nucleus	O
in	O
an	O
apparently	O
inactive	O
form	O
unable	O
to	O
disrupt	O
NF-kappaB	protein
binding	O
from	O
DNA	DNA
.	O

Impaired	O
fetal	cell_type
thymocyte	cell_type
development	O
after	O
efficient	O
adenovirus	O
-mediated	O
inhibition	O
of	O
NF-kappa	protein
B	protein
activation	O
.	O
We	O
introduce	O
a	O
new	O
experimental	O
system	O
combining	O
adenovirus	O
-mediated	O
gene	O
transfer	O
and	O
fetal	O
thymic	O
organ	O
culture	O
(	O
FTOC	O
).	O
This	O
system	O
allowed	O
us	O
to	O
efficiently	O
express	O
in	O
developing	O
thymocytes	O
a	O
mutant	O
form	O
of	O
the	O
NF-kappa	protein
B	protein
inhibitor	O
I	protein
kappa	protein
B	protein
alpha	protein
(	O
mut-I	protein
kappa	protein
B	protein
)	O
and	O
to	O
study	O
the	O
maturation	O
defects	O
occurring	O
when	O
NF-kappa	protein
B	protein
activation	O
is	O
inhibited	O
during	O
fetal	O
development.	O
Fetal	cell_type
thymocytes	cell_type
infected	O
with	O
adenovirus	O
containing	O
mut-I	protein
kappa	protein
B	protein
were	O
found	O
to	O
develop	O
normally	O
until	O
the	O
CD44	protein
-CD25+,	O
CD4	protein
-	O
CD8	protein
-	O
double-negative	O
stage	O
,	O
while	O
production	O
of	O
more	O
mature	O
double-positive	O
and	O
single-positive	O
populations	O
was	O
strongly	O
decreased.	O
Proliferation,	O
as	O
measured	O
by	O
the	O
percentage	O
of	O
cells	O
in	O
cycle	O
appeared	O
normal,	O
as	O
did	O
rearrangement	O
and	O
expression	O
of	O
the	O
TCR	protein
beta-chain	protein
.	O
However,	O
apoptosis	O
was	O
much	O
higher	O
in	O
FTOC	O
infected	O
with	O
adenovirus	O
containing	O
mut-I	protein
kappa	protein
B	protein
than	O
in	O
FTOC	O
infected	O
with	O
a	O
control	O
virus	O
.	O
Taken	O
together,	O
these	O
results	O
suggest	O
that	O
NF-kappa	protein
B	protein
plays	O
a	O
crucial	O
role	O
in	O
ensuring	O
the	O
differentiation	O
and	O
survival	O
of	O
thymocytes	cell_type
in	O
the	O
early	O
stages	O
of	O
their	O
development.	O

The	O
relationship	O
between	O
Ca2+-ATPase	protein
and	O
freely	O
exchangeable	O
Ca2+	O
in	O
the	O
dense	O
tubules:	O
a	O
study	O
in	O
platelets	cell_type
from	O
women	O
.	O
The	O
main	O
aims	O
of	O
this	O
work	O
were	O
to	O
examine	O
in	O
women	O
:	O
the	O
relationship	O
between	O
the	O
freely	O
exchangeable	O
Ca2+	O
(	O
FECa2+	O
)	O
in	O
the	O
dense	O
tubules	O
and	O
the	O
activity	O
of	O
the	O
sarco(endo)plasmic	protein
reticulum	protein
(	protein
SER	protein
)	protein
Ca2+-ATPase	protein
(	protein
SERCA	protein
)	protein
in	O
platelets	cell_type
,	O
and	O
the	O
relationship	O
of	O
these	O
parameters	O
with	O
blood	O
pressure	O
and	O
serum	protein
lipoproteins	protein
.	O
Platelets	O
from	O
14	O
white	O
and	O
13	O
black	O
women	O
in	O
good	O
health	O
were	O
studied.	O
The	O
FECa2+	O
was	O
measured	O
as	O
the	O
ionomycin-evoked	O
Ca2+	O
release	O
(in	O
the	O
presence	O
of	O
thapsigargin)	O
in	O
Ca2+	O
-free	O
medium	O
.	O
SERCA	protein
activity	O
was	O
measured	O
as	O
the	O
thapsigargin	O
sensitive,	O
Ca2+	O
dependent	O
and	O
ouabain	O
resistant,	O
ATP	O
hydrolyses	O
in	O
platelet	O
membranes	O
.	O
Relative	O
expressions	O
of	O
SERCA	protein
2	O
and	O
3	O
isoforms	O
and	O
Ras-related	protein
protein	protein
(Rap)	protein
1	protein
in	O
platelet	O
membranes	O
were	O
determined	O
by	O
Western	O
immunoblots	O
.	O
Highly	O
significant	O
correlations	O
were	O
observed	O
for	O
FECa2+	O
in	O
the	O
dense	O
tubules	O
with:	O
1)	O
the	O
maximal	O
reaction	O
velocity	O
(Vmax)	O
of	O
the	O
SERCA	protein
(r	O
=	O
0.592,	O
P	O
=	O
.0014),	O
and	O
2)	O
Rapl	protein
(r	O
=	O
0.551,	O
P	O
=	O
.0035).	O
In	O
addition,	O
negative	O
correlations	O
were	O
observed	O
between	O
FECa2+	O
in	O
the	O
dense	O
tubules	O
and	O
age.	O
No	O
correlations	O
were	O
observed	O
for	O
these	O
variables	O
with	O
blood	O
pressure	O
or	O
serum	protein
lipoproteins	protein
.	O
We	O
conclude	O
the	O
FECa2+	O
and	O
the	O
Vmax	O
of	O
the	O
SERCA	protein
are	O
reliable	O
indicators	O
of	O
Ca2+	O
load	O
in	O
platelets	cell_type
from	O
women	O
.	O
However,	O
in	O
women	O
,	O
unlike	O
previous	O
observations	O
in	O
men	O
,	O
these	O
platelet	O
parameters	O
are	O
not	O
correlated	O
with	O
blood	O
pressure	O
and	O
serum	protein
lipoproteins	protein
.	O

Cobalt	O
chloride	O
-induced	O
signaling	O
in	O
endothelium	O
leading	O
to	O
the	O
augmented	O
adherence	O
of	O
sickle	cell_type
red	cell_type
blood	cell_type
cells	cell_type
and	O
transendothelial	O
migration	O
of	O
monocyte-like	cell_line
HL-60	cell_line
cells	cell_line
is	O
blocked	O
by	O
PAF-receptor	O
antagonist	O
.	O
In	O
response	O
to	O
hypoxia,	O
sickle	cell_type
red	cell_type
blood	cell_type
cells	cell_type
(	O
SS	cell_type
RBC	cell_type
)	O
and	O
leukocytes	cell_type
exhibit	O
increased	O
adherence	O
to	O
the	O
vascular	O
endothelium,	O
while	O
diapedesis	O
of	O
leukocytes	cell_type
through	O
the	O
blood	O
vessel	O
increases	O
.	O
However,	O
the	O
cellular	O
signaling	O
pathway	O
(s)	O
caused	O
by	O
hypoxia	O
is	O
poorly	O
understood.	O
We	O
utilized	O
CoCl2	O
as	O
a	O
mimetic	O
molecule	O
for	O
hypoxia	O
to	O
study	O
cellular	O
signaling	O
pathways	O
.	O
We	O
found	O
that	O
in	O
human	cell_type
umbilical	cell_type
vein	cell_type
endothelial	cell_type
cells	cell_type
(	O
HUVEC	cell_type
),	O
CoCl2	O
at	O
2	O
mM	O
concentration	O
induced	O
the	O
surface	O
expression	O
of	O
a	O
subset	O
of	O
CAMs	protein
(	O
VCAM-1	protein
)	O
and	O
activation	O
of	O
transcription	protein
factor	protein
NF-kappaB	protein
in	O
the	O
nuclear	O
extracts	O
of	O
HUVEC	cell_type
.	O
Furthermore,	O
CoCl2	O
also	O
caused	O
time-dependent	O
tyrosine	O
phosphorylation	O
of	O
mitogen-activated	protein
protein	protein
(MAP)	protein
kinase	protein
isoform	O
ERK2	protein
without	O
significantly	O
affecting	O
ERK1	protein
,	O
indicating	O
ERK2	protein
is	O
the	O
preferred	O
substrate	O
for	O
upstream	protein
kinase	protein
of	O
the	O
MAPK	protein
pathway	O
.	O
Inhibitors	O
of	O
MAP	protein
kinase	protein
(	O
PD98059	O
)	O
or	O
platelet-activating	O
factor	O
(PAF)-	O
receptor	O
antagonist	O
(	O
CV3988	O
)	O
inhibited	O
the	O
CoCl2	O
-induced	O
NF-kappaB	protein
activation	O
and	O
VCAM-1	protein
expression	O
.	O
Augmented	O
expression	O
of	O
VCAM-1	protein
led	O
to	O
increased	O
SS	cell_type
RBC	cell_type
adhesion	O
,	O
inhibitable	O
by	O
a	O
VCAM-1	protein
antibody	protein
.	O
Additionally,	O
CoCl2	O
caused	O
a	O
two-	O
to	O
threefold	O
increase	O
in	O
the	O
rate	O
of	O
transendothelial	O
migration	O
of	O
monocyte-like	cell_line
HL-60	cell_line
cells	cell_line
and	O
a	O
twentyfold	O
increase	O
in	O
phosphorylation	O
of	O
platelet	protein
endothelial	protein
cell	protein
adhesion	protein
molecules	protein
(	O
PECAM-1	protein
).	O
The	O
transendothelial	O
migration	O
of	O
monocytes	cell_type
was	O
inhibited	O
by	O
an	O
antibody	O
to	O
PECAM-1	protein
.	O
Both	O
phosphorylation	O
of	O
PECAM-1	protein
and	O
transendothelial	O
migration	O
of	O
monocytes	cell_type
in	O
response	O
to	O
CoCl2	O
were	O
inhibited	O
by	O
protein	O
kinase	O
inhibitor	O
(	O
GF109203X	O
)	O
and	O
augmented	O
by	O
protein	O
phosphatase	O
inhibitor	O
(	O
Calyculin	O
A	O
).	O
Our	O
data	O
suggests	O
that	O
CoCl2	O
-induced	O
cellular	O
signals	O
directing	O
increased	O
expression	O
of	O
VCAM-1	protein
in	O
HUVEC	cell_type
involve	O
downstream	O
activation	O
of	O
MAP	protein
kinase	protein
and	O
NF-kappaB	protein
,	O
while	O
the	O
phosphorylation	O
of	O
PECAM-1	protein
occurs	O
as	O
a	O
result	O
of	O
activation	O
of	O
PKC	protein
.	O
We	O
conclude	O
that	O
PAF-receptor	O
antagonist	O
inhibits	O
the	O
CoCl2	O
-or	O
hypoxia	O
-induced	O
increase	O
in	O
the	O
adhesion	O
of	O
SS	cell_type
RBC	cell_type
,	O
PECAM-1	protein
phosphorylation,	O
and	O
the	O
concomitant	O
transendothelial	O
migration	O
of	O
monocytes	cell_type
.	O

Bacterial	O
lipopolysaccharide	O
activates	O
nuclear	protein
factor-kappaB	protein
through	O
interleukin-1	protein
signaling	protein
mediators	protein
in	O
cultured	cell_line
human	cell_line
dermal	cell_line
endothelial	cell_line
cells	cell_line
and	O
mononuclear	cell_type
phagocytes	cell_type
.	O
Bacterial	O
lipopolysaccharide	O
(LPS)-mediated	O
immune	O
responses	O
,	O
including	O
activation	O
of	O
monocytes	cell_type
,	O
macrophages	cell_type
,	O
and	O
endothelial	cell_type
cells	cell_type
,	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
Gram-negative	O
bacteria	O
-induced	O
sepsis	O
syndrome	O
.	O
Activation	O
of	O
NF-kappaB	protein
is	O
thought	O
to	O
be	O
required	O
for	O
cytokine	O
release	O
from	O
LPS-responsive	cell_type
cells	cell_type
,	O
a	O
critical	O
step	O
for	O
endotoxic	O
effects	O
.	O
Here	O
we	O
investigated	O
the	O
role	O
and	O
involvement	O
of	O
interleukin-1	protein
(	O
IL-1	protein
)	O
and	O
tumor	protein
necrosis	protein
factor	protein
(	O
TNF-alpha	protein
)	O
signal	protein
transducer	protein
molecules	protein
in	O
LPS	O
signaling	O
in	O
human	cell_type
dermal	cell_type
microvessel	cell_type
endothelial	cell_type
cells	cell_type
(	O
HDMEC	cell_type
)	O
and	O
THP-1	cell_line
monocytic	cell_line
cells	cell_line
.	O
LPS	O
stimulation	O
of	O
HDMEC	cell_type
and	O
THP-1	cell_line
cells	cell_line
initiated	O
an	O
IL-1	protein
receptor	protein
-like	O
NF-kappaB	protein
signaling	O
cascade	O
.	O
In	O
transient	O
cotransfection	O
experiments	O
,	O
dominant	O
negative	O
mutants	O
of	O
the	O
IL-1	protein
signaling	O
pathway	O
,	O
including	O
MyD88	protein
,	O
IRAK	protein
,	O
IRAK2	protein
,	O
and	O
TRAF6	protein
inhibited	O
both	O
IL-1	protein
-and	O
LPS	O
-induced	O
NF-kappaB	protein
-luciferase	protein
activity	O
.	O
LPS	O
-induced	O
NF-kappaB	protein
activation	O
was	O
not	O
inhibited	O
by	O
a	O
dominant	O
negative	O
mutant	O
of	O
TRAF2	protein
that	O
is	O
involved	O
in	O
TNF	protein
signaling	O
.	O
LPS	O
-induced	O
activation	O
of	O
NF-kappaB	DNA
-responsive	DNA
reporter	DNA
gene	DNA
was	O
not	O
inhibited	O
by	O
IL-1	protein
receptor	O
antagonist	O
.	O
TLR2	protein
and	O
TLR4	protein
were	O
expressed	O
on	O
the	O
cell	O
surface	O
of	O
HDMEC	cell_type
and	O
THP-1	cell_line
cells	cell_line
.	O
These	O
findings	O
suggest	O
that	O
a	O
signal	protein
transduction	protein
molecule	protein
in	O
the	O
LPS	O
receptor	O
complex	O
may	O
belong	O
to	O
the	O
IL-1	protein
receptor/toll-like	O
receptor	O
(TLR)	O
super	O
family,	O
and	O
the	O
LPS	O
signaling	O
cascade	O
uses	O
an	O
analogous	O
molecular	O
framework	O
for	O
signaling	O
as	O
IL-1	protein
in	O
mononuclear	cell_type
phagocytes	cell_type
and	O
endothelial	cell_type
cells	cell_type
.	O

Signal	O
transduction	O
through	O
interferon-gamma	protein
receptor	protein
on	O
human	cell_type
eosinophils	cell_type
.	O
BACKGROUND:	O
We	O
reported	O
on	O
the	O
constitutive	O
interferon-gamma	protein
receptor	protein
(	O
IFN-gammaR	protein
)	O
expression	O
on	O
eosinophils	cell_type
.	O
But	O
signal	O
transduction	O
through	O
IFN-gammaR	protein
on	O
eosinophils	cell_type
remains	O
to	O
be	O
elucidated.	O
In	O
this	O
study,	O
we	O
examined	O
the	O
involvement	O
of	O
the	O
Jak/Stat	protein
pathway	O
in	O
the	O
signaling	O
of	O
eosinophils	cell_type
after	O
IFN-gammaR	protein
conjugation	O
by	O
the	O
ligand	O
binding.	O
METHODS:	O
Purified	cell_type
peripheral	cell_type
eosinophils	cell_type
were	O
stimulated	O
with	O
IFN-gamma	protein
at	O
37	O
degrees	O
C	O
for	O
1-60	O
min.	O
Tyrosine	O
phosphorylation	O
of	O
IFN-gammaR	protein
,	O
Jak1	protein
,	O
Jak2	protein
,	O
and	O
Stat1alpha	protein
was	O
examined	O
by	O
immunoblotting	O
.	O
Gel-shift	O
assay	O
was	O
also	O
examined	O
to	O
show	O
the	O
formation	O
of	O
Stat1alpha	protein
-DNA	protein
complexes	protein
.	O
RESULTS:	O
We	O
show	O
that	O
binding	O
of	O
IFN-gamma	protein
to	O
human	cell_type
eosinophils	cell_type
initiated	O
a	O
series	O
of	O
events	O
that	O
resulted	O
in	O
the	O
rapid	O
tyrosine	O
phosphorylation	O
of	O
not	O
only	O
the	O
IFN-gammaRalpha	protein
chain	protein
but	O
also	O
Jak1	protein
,	O
Jak2	protein
,	O
and	O
Stat1alpha	protein
.	O
In	O
addition,	O
IFN-gamma	protein
enhanced	O
the	O
DNA-binding	O
activity	O
of	O
Stat1alpha	protein
.	O
CONCLUSION:	O
These	O
data	O
indicate	O
that	O
IFN-gamma	protein
affects	O
eosinophils	cell_type
through	O
its	O
specific	O
receptor	O
and	O
utilizes	O
the	O
Jak/Stat	protein
pathway	O
as	O
its	O
mode	O
of	O
signaling.	O

Expression	O
of	O
E2A-HLF	protein
chimeric	protein
protein	protein
induced	O
T-cell	O
apoptosis	O
,	O
B-cell	O
maturation	O
arrest	O
,	O
and	O
development	O
of	O
acute	O
lymphoblastic	O
leukemia	O
.	O
The	O
E2A-HLF	DNA
fusion	DNA
gene	DNA
,	O
generated	O
by	O
t(17;19)(q22;p13)	DNA
in	O
acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
),	O
encodes	O
a	O
chimeric	protein
transcription	protein
factor	protein
in	O
which	O
the	O
trans-activating	protein
domains	protein
of	O
E2A	protein
are	O
fused	O
to	O
the	O
DNA-	O
binding	O
and	O
dimerization	O
domains	O
of	O
hepatic	protein
leukemic	protein
factor	protein
(	O
HLF	protein
).	O
To	O
investigate	O
its	O
biological	O
role,	O
we	O
generated	O
transgenic	O
mice	O
expressing	O
E2A-HLF	protein
using	O
Ig	O
enhancer	O
and	O
promoter	O
,	O
which	O
direct	O
transgene	O
expression	O
in	O
cells	O
committed	O
to	O
the	O
lymphoid	O
lineage.	O
The	O
transgenic	O
mice	O
exhibited	O
abnormal	O
development	O
in	O
the	O
thymus	O
and	O
spleen	O
and	O
were	O
susceptible	O
to	O
infection	O
.	O
The	O
thymus	O
contained	O
small	O
numbers	O
of	O
thymocytes	cell_type
,	O
and	O
TUNEL	O
staining	O
showed	O
that	O
higher	O
population	O
of	O
thymocytes	cell_type
were	O
undergoing	O
apoptosis	O
.	O
The	O
spleen	O
exhibited	O
a	O
marked	O
reduction	O
in	O
splenic	cell_type
lymphocytes	cell_type
and	O
the	O
flow	O
cytometric	O
analyses	O
and	O
the	O
in	O
vitro	O
colony	O
formation	O
assays	O
showed	O
that	O
the	O
B-cell	O
maturation	O
was	O
blocked	O
at	O
a	O
very	O
early	O
developmental	O
stage	O
.	O
These	O
findings	O
indicated	O
that	O
the	O
expression	O
of	O
E2A-HLF	protein
induced	O
T-cell	O
apoptosis	O
and	O
B-cell	O
maturation	O
arrest	O
in	O
vivo	O
and	O
that	O
the	O
susceptibility	O
of	O
the	O
transgenic	O
mice	O
to	O
infection	O
was	O
due	O
to	O
immunodeficiency	O
.	O
Moreover,	O
several	O
transgenic	O
mice	O
developed	O
acute	O
leukemia	O
,	O
classified	O
as	O
T-	O
ALL	O
based	O
on	O
the	O
surface	O
marker	O
analysis	O
and	O
DNA	O
rearrangements	O
,	O
suggesting	O
that	O
an	O
additional	O
event	O
is	O
required	O
for	O
malignant	O
transformation	O
of	O
lymphoid	cell_type
cells	cell_type
expressing	O
E2A-HLF	protein
.	O
Our	O
findings	O
provide	O
insight	O
into	O
the	O
biological	O
function	O
of	O
E2A-HLF	protein
in	O
lymphoid	O
development	O
and	O
also	O
its	O
role	O
in	O
leukemogenesis	O
.	O

Retinoid	protein
X	protein
receptor	protein
(	O
RXR	protein
)	O
agonist-induced	O
activation	O
of	O
dominant-negative	O
RXR	protein
-retinoic	O
acid	O
receptor	O
alpha403	O
heterodimers	O
is	O
developmentally	O
regulated	O
during	O
myeloid	O
differentiation	O
.	O
The	O
multiple	O
biologic	O
activities	O
of	O
retinoic	O
acid	O
(	O
RA	O
)	O
are	O
mediated	O
through	O
RAR	protein
and	O
retinoid	protein
X	protein
receptor	protein
(	protein
RXR	protein
)	protein
nuclear	protein
receptors	protein
that	O
interact	O
with	O
specific	O
DNA	DNA
target	DNA
sequences	DNA
as	O
heterodimers	protein
(	O
RXR-RAR	protein
)	O
or	O
homodimers	protein
(	O
RXR-RXR	protein
).	O
RA	O
receptor	O
activation	O
appears	O
critical	O
to	O
regulating	O
important	O
aspects	O
of	O
hematopoiesis	O
,	O
since	O
transducing	O
a	O
COOH-terminally	protein
truncated	protein
RARalpha	protein
exhibiting	O
dominant-negative	O
activity	O
(	O
RARalpha403	protein
)	O
into	O
normal	O
mouse	O
bone	O
marrow	O
generates	O
hematopoietic	cell_line
growth	cell_line
factor-dependent	cell_line
cell	cell_line
lines	cell_line
frozen	O
at	O
the	O
multipotent	O
progenitor	O
(EML)	O
or	O
committed	O
promyelocyte	O
(MPRO)	O
stages	O
.	O
Nevertheless,	O
relatively	O
high,	O
pharmacological	O
concentrations	O
of	O
RA	O
(1	O
to	O
10	O
&amp;mgr;M)	O
overcome	O
these	O
differentiation	O
blocks	O
and	O
induce	O
terminal	O
granulocytic	O
differentiation	O
of	O
the	O
MPRO	cell_type
promyelocytes	cell_type
while	O
potentiating	O
interleukin-3	protein
(	O
IL-3	protein
)-induced	O
commitment	O
of	O
EML	cell_type
cells	cell_type
to	O
the	O
granulocyte/monocyte	O
lineage.	O
In	O
the	O
present	O
study,	O
we	O
utilized	O
RXR	protein
-and	O
RAR	protein
-specific	O
agonists	O
and	O
antagonists	O
to	O
determine	O
how	O
RA	O
overcomes	O
the	O
dominant-negative	O
activity	O
of	O
the	O
truncated	protein
RARalpha	protein
in	O
these	O
different	O
myeloid	O
developmental	O
stages	O
.	O
Unexpectedly,	O
we	O
observed	O
that	O
an	O
RXR	protein
-specific	O
,	O
rather	O
than	O
an	O
RAR	protein
-specific	O
,	O
agonist	O
induces	O
terminal	O
granulocytic	O
differentiation	O
of	O
MPRO	cell_type
promyelocytes	cell_type
,	O
and	O
this	O
differentiation	O
is	O
associated	O
with	O
activation	O
of	O
DNA	DNA
response	DNA
elements	DNA
corresponding	O
to	O
RAR-RXR	protein
heterodimers	protein
rather	O
than	O
RXR-RXR	protein
homodimers	protein
.	O
This	O
RXR	protein
agonist	O
activity	O
is	O
blocked	O
by	O
RAR	protein
-specific	O
antagonists	O
,	O
suggesting	O
extensive	O
cross-talk	O
between	O
the	O
partners	O
of	O
the	O
RXR	protein
-RARalpha403	protein
heterodimer	protein
.	O
In	O
contrast,	O
in	O
the	O
more	O
immature,	O
multipotent	O
EML	cell_type
cells	cell_type
we	O
observed	O
that	O
this	O
RXR	protein
-specific	O
agonist	O
is	O
inactive	O
either	O
in	O
potentiating	O
IL-3	protein
-mediated	O
commitment	O
of	O
EML	cell_type
cells	cell_type
to	O
the	O
granulocyte	cell_type
lineage	cell_type
or	O
in	O
transactivating	O
RAR-RXR	DNA
response	DNA
elements	DNA
.	O
RA	O
-triggered	O
GALdbd-	O
RARalpha	protein
hybrid	O
activity	O
in	O
these	O
cells	O
indicates	O
that	O
the	O
multipotent	O
EML	cell_type
cells	cell_type
harbor	O
substantial	O
nuclear	O
hormone	O
receptor	O
coactivator	protein
activity	O
.	O
However,	O
the	O
histone	protein
deacetylase	protein
(HDAC)	protein
inhibitor	protein
trichostatin	O
A	O
readily	O
activates	O
an	O
RXR-RAR	DNA
reporter	DNA
construct	DNA
in	O
the	O
multipotent	O
EML	cell_type
cells	cell_type
but	O
not	O
in	O
the	O
committed	O
MPRO	cell_type
promyelocytes	cell_type
,	O
indicating	O
that	O
differences	O
in	O
HDAC-containing	protein
repressor	protein
complexes	protein
in	O
these	O
two	O
closely	O
related	O
but	O
distinct	O
hematopoietic	cell_type
lineages	cell_type
might	O
account	O
for	O
the	O
differential	O
activation	O
of	O
the	O
RXR-RARalpha403	protein
heterodimers	protein
that	O
we	O
observed	O
at	O
these	O
different	O
stages	O
of	O
myeloid	O
development	O
.	O

The	O
functional	O
synergy	O
between	O
IL-12	protein
and	O
IL-2	protein
involves	O
p38	protein
mitogen-activated	protein
protein	protein
kinase	protein
and	O
is	O
associated	O
with	O
the	O
augmentation	O
of	O
STAT	O
serine	O
phosphorylation	O
.	O
IL-12	protein
and	O
IL-2	protein
can	O
stimulate	O
mitogen-	O
or	O
CD3-	O
activated	O
T	O
cells	O
to	O
proliferate,	O
produce	O
IFN-gamma	protein
,	O
and	O
kill	O
tumor	cell_type
cells	cell_type
.	O
The	O
magnitude	O
of	O
these	O
functional	O
responses	O
is	O
greatly	O
augmented	O
when	O
T	cell_type
cells	cell_type
are	O
activated	O
by	O
the	O
combination	O
of	O
IL-12	protein
and	O
IL-2	protein
.	O
Although	O
peripheral	O
blood	O
T	cell_type
cells	cell_type
are	O
largely	O
unresponsive	O
to	O
these	O
cytokines	protein
without	O
prior	O
activation,	O
a	O
small	O
subset	O
of	O
CD8+	cell_type
T	cell_type
cells	cell_type
(	O
CD8+CD18bright	cell_type
)	O
is	O
strongly	O
activated	O
by	O
the	O
combination	O
of	O
IL-12	protein
and	O
IL-2	protein
.	O
In	O
this	O
report	O
we	O
show	O
that	O
the	O
functional	O
synergy	O
between	O
IL-12	protein
and	O
IL-2	protein
in	O
CD8+CD18bright	cell_type
T	cell_type
cells	cell_type
correlates	O
with	O
the	O
activation	O
of	O
the	O
stress	protein
kinases	protein
,	O
p38	protein
mitogen-activated	protein
protein	protein
(MAP)	protein
kinase	protein
and	O
stress-activated	protein
protein	protein
kinase	protein
(SAPK)/Jun	protein
N-terminal	protein
kinase	protein
,	O
but	O
not	O
with	O
the	O
activation	O
of	O
the	O
extracellular	protein
signal-regulated	protein
kinases	protein
.	O
The	O
functional	O
synergy	O
between	O
IL-2	protein
and	O
IL-12	protein
is	O
also	O
associated	O
with	O
a	O
prominent	O
increase	O
in	O
STAT1	protein
and	O
STAT3	protein
serine	O
phosphorylation	O
over	O
that	O
observed	O
with	O
IL-12	protein
or	O
IL-2	protein
alone.	O
By	O
contrast,	O
STAT	protein
tyrosine	O
phosphorylation	O
is	O
not	O
augmented	O
over	O
that	O
seen	O
with	O
either	O
cytokine	O
alone.	O
A	O
specific	O
inhibitor	O
of	O
p38	O
MAP	O
kinase	O
completely	O
inhibits	O
the	O
serine	O
phosphorylation	O
of	O
STAT1	protein
and	O
STAT3	protein
induced	O
by	O
IL-12	protein
and	O
IL-2	protein
and	O
abrogates	O
the	O
functional	O
synergy	O
between	O
IL-12	protein
and	O
IL-2	protein
without	O
affecting	O
STAT	O
tyrosine	O
phosphorylation	O
.	O
This	O
suggests	O
that	O
p38	O
MAP	O
kinase	O
may	O
play	O
an	O
important	O
role	O
in	O
regulating	O
STAT	O
serine	O
phosphorylation	O
in	O
response	O
to	O
the	O
combination	O
of	O
IL-12	protein
and	O
IL-2	protein
.	O
Furthermore,	O
these	O
findings	O
indicate	O
that	O
the	O
optimal	O
activation	O
of	O
T	cell_type
cells	cell_type
by	O
IL-12	protein
and	O
IL-2	protein
may	O
depend	O
on	O
an	O
interaction	O
between	O
the	O
p38	protein
MAP	protein
kinase	protein
and	O
Janus	protein
kinase/STAT	protein
signaling	O
pathways	O
.	O

Activation	O
of	O
NF-kappaB	protein
in	O
Mycobacterium	O
tuberculosis	O
-induced	O
interleukin-2	protein
receptor	protein
expression	O
in	O
mononuclear	cell_type
phagocytes	cell_type
.	O
Soluble	O
interleukin-2	protein
receptor	protein
-alpha	protein
(	O
IL-2Ralpha	protein
)	O
has	O
been	O
reported	O
to	O
be	O
increased	O
in	O
the	O
sera	O
of	O
patients	O
with	O
advanced	O
tuberculosis,	O
and	O
levels	O
decline	O
after	O
therapy	O
in	O
accordance	O
with	O
improvement	O
of	O
radiologic	O
findings	O
.	O
We	O
investigated	O
expression	O
of	O
the	O
IL-2Ralpha	protein
in	O
bronchoalveolar	cell_type
lavage	cell_type
(BAL)	cell_type
cells	cell_type
in	O
active	O
pulmonary	O
tuberculosis	O
,	O
and	O
evaluated	O
the	O
mechanism	O
Mycobacterium	O
tuberculosis	O
induces	O
in	O
the	O
IL-2Ralpha	protein
using	O
the	O
THP-1	cell_line
mononuclear	cell_line
phagocyte	cell_line
cell	cell_line
line	cell_line
.	O
We	O
found	O
IL-2Ralpha	protein
expression	O
to	O
be	O
increased	O
in	O
BAL	O
cells	O
from	O
involved	O
sites	O
of	O
active	O
pulmonary	O
tuberculosis	O
.	O
Expression	O
of	O
the	O
alpha-chain	protein
of	O
IL-2Ralpha	protein
on	O
peripheral	cell_type
blood	cell_type
monocytes	cell_type
(	O
PBM	cell_type
)	O
was	O
induced	O
by	O
M.	O
tuberculosis	O
by	O
flow	O
cytometry	O
evaluation.	O
Northern	O
analysis	O
demonstrated	O
increased	O
IL-2Ralpha	protein
gene	O
expression	O
after	O
stimulation	O
with	O
M.	O
tuberculosis	O
which	O
was	O
further	O
induced	O
by	O
interferon-gamma	protein
(	O
IFN-gamma	protein
).	O
The	O
IL-2Ralpha	DNA
promoter	DNA
containing	O
the	O
nuclear	DNA
factor	DNA
kappa	DNA
B	DNA
(	DNA
NF-kappaB	DNA
)	DNA
site	DNA
was	O
transcriptionally	O
induced	O
by	O
M.	O
tuberculosis	O
and	O
this	O
NF-kappaB	protein
site	O
could	O
confer	O
inducibility	O
to	O
a	O
heterologous	DNA
herpes	DNA
thymidine	DNA
kinase	DNA
(TK)	DNA
promoter	DNA
by	O
M.	O
tuberculosis	O
.	O
Electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSAs	O
)	O
revealed	O
specific	O
binding	O
of	O
nuclear	O
protein	O
to	O
the	O
NF-kappaB	DNA
site	DNA
upon	O
induction	O
with	O
M.	O
tuberculosis	O
.	O
Using	O
antibodies	O
against	O
the	O
p50	protein
and	O
p65	protein
subunits	protein
of	O
NF-kappaB	protein
in	O
EMSAs	O
,	O
the	O
involvement	O
of	O
both	O
p50	protein
and	O
p65	protein
proteins	protein
was	O
further	O
demonstrated.	O
Functional	O
expression	O
of	O
the	O
IL-2Ralpha	protein
on	O
mononuclear	cell_type
phagocytes	cell_type
in	O
M.	O
tuberculosis	O
infection	O
may	O
play	O
an	O
important	O
immunomodulatory	O
role	O
in	O
the	O
host	O
response	O
.	O

Vitamin	protein
D	protein
receptor	protein
3'-untranslated	DNA
region	DNA
polymorphisms	O
:	O
lack	O
of	O
effect	O
on	O
mRNA	O
stability	O
.	O
Allelic	O
variation	O
at	O
the	O
3'-end	O
of	O
the	O
vitamin	DNA
D	DNA
receptor	DNA
(VDR)	DNA
gene	DNA
has	O
been	O
associated	O
with	O
a	O
3-5-fold	O
increased	O
risk	O
of	O
developing	O
prostate	O
cancer	O
and	O
with	O
differences	O
in	O
bone	O
mineralization	O
.	O
This	O
genetic	O
diversity	O
does	O
not	O
alter	O
the	O
VDR	protein
protein	protein
structurally,	O
but	O
instead	O
may	O
be	O
a	O
marker(s)	O
of	O
other,	O
nearby	O
polymorphisms	O
that	O
influence	O
message	O
stability	O
or	O
translation.	O
The	O
work	O
reported	O
here	O
was	O
instigated	O
to	O
identify	O
additional	O
VDR	protein
3'-UTR	DNA
polymorphisms	O
that	O
may	O
have	O
functional	O
significance	O
and	O
to	O
then	O
test	O
whether	O
these	O
genetic	O
variants	O
alter	O
message	O
stability	O
.	O
Initially,	O
four	O
novel,	O
frequently	O
occurring	O
sequence	DNA
variants	DNA
were	O
identified	O
that	O
associated	O
with	O
two	O
common	O
haplotypes	O
that	O
were	O
described	O
previously.	O
These	O
common	O
sequence	O
variants	O
were	O
not	O
found	O
within	O
three	O
message-destabilizing	DNA
elements	DNA
that	O
we	O
mapped	O
within	O
the	O
3'-UTR	DNA
of	O
the	O
vitamin	RNA
D	RNA
receptor	RNA
mRNA	RNA
.	O
Furthermore,	O
the	O
two	O
VDR	DNA
3'-UTR	DNA
haplotypes	O
conferred	O
an	O
identical	O
half-life	O
on	O
a	O
heterologous	DNA
beta-globin	DNA
reporter	DNA
gene	DNA
,	O
in	O
an	O
in	O
vitro	O
assay	O
.	O
We	O
therefore	O
conclude	O
that	O
common	O
polymorphisms	O
within	O
the	O
VDR	DNA
3'-UTR	DNA
do	O
not	O
influence	O
message	O
stability	O
.	O

IL-2	protein
-mediated	O
cell	O
cycle	O
progression	O
and	O
inhibition	O
of	O
apoptosis	O
does	O
not	O
require	O
NF-kappa	protein
B	protein
or	O
activating	O
protein-1	O
activation	O
in	O
primary	O
human	O
T	O
cells.	O
The	O
IL-2	protein
growth	O
hormone	O
is	O
the	O
major	O
growth	O
factor	O
of	O
activated	O
T	cell_type
lymphocytes	cell_type
during	O
a	O
developing	O
immune	O
response	O
.	O
IL-2	protein
is	O
required	O
not	O
only	O
for	O
cell	O
cycle	O
progression	O
but	O
also	O
to	O
protect	O
Ag-activated	cell_type
T	cell_type
cells	cell_type
from	O
programmed	O
cell	O
death	O
.	O
In	O
several	O
cell	O
types,	O
activation	O
of	O
NF-kappa	protein
B	protein
and/or	O
activating	protein
protein-1	protein
(	O
AP-1	protein
)	O
has	O
been	O
demonstrated	O
to	O
be	O
extremely	O
important	O
in	O
blocking	O
apoptosis	O
.	O
To	O
determine	O
whether	O
either	O
or	O
both	O
of	O
these	O
transcription	protein
factors	protein
are	O
involved	O
in	O
cell	O
survival	O
or	O
cell	O
cycle	O
progression	O
in	O
response	O
to	O
IL-2	protein
,	O
primary	cell_type
human	cell_type
T	cell_type
cells	cell_type
responsive	O
to	O
the	O
growth	O
factor	O
were	O
analyzed	O
for	O
NF-kappa	O
B	O
and	O
AP-1	O
activation	O
.	O
The	O
current	O
study	O
clearly	O
demonstrates	O
that	O
IL-2	protein
does	O
not	O
induce	O
I	protein
kappa	protein
B	protein
alpha	O
degradation	O
or	O
NF-kappa	protein
B	protein
activation	O
in	O
primary	cell_type
human	cell_type
T	cell_type
cells	cell_type
that	O
respond	O
to	O
IL-2	protein
by	O
entering	O
the	O
cell	O
cycle	O
and	O
avoiding	O
apoptosis	O
.	O
Similarly,	O
IL-2	protein
neither	O
activates	O
JNK	protein
nor	O
increases	O
AP-1	protein
binding	O
activity	O
to	O
a	O
consensus	O
o-tetradecanoylphorbol	DNA
13-acetate	DNA
(	DNA
TPA	DNA
)	DNA
response	DNA
element	DNA
.	O
On	O
the	O
other	O
hand,	O
the	O
growth	protein
factor	protein
does	O
induce	O
the	O
activation	O
of	O
STAT3	protein
and	O
STAT5	protein
in	O
these	O
cells,	O
as	O
has	O
been	O
previously	O
demonstrated	O
.	O
These	O
data	O
show	O
that	O
neither	O
NF-kappa	protein
B	protein
nor	O
AP-1	protein
activation	O
is	O
required	O
for	O
IL-2	protein
-mediated	O
survival	O
or	O
cell	O
cycle	O
progression	O
in	O
activated	O
primary	cell_type
human	cell_type
T	cell_type
cells	cell_type
.	O

Estrone	O
potentiates	O
myeloid	O
cell	O
differentiation	O
:	O
a	O
role	O
for	O
17	protein
beta-hydroxysteroid	protein
dehydrogenase	protein
in	O
modulating	O
hemopoiesis.	O
Hormones	O
such	O
as	O
1	O
alpha,	O
25-dihydroxy	O
vitamin	O
D3	O
(	O
D3	O
),	O
all-trans	O
retinoic	O
acid	O
,	O
and	O
9-cis	O
retinoic	O
acid	O
stimulate	O
differentiation	O
of	O
myeloid	cell_type
progenitor	cell_type
cells	cell_type
via	O
their	O
interaction	O
with	O
specific	O
hormone	protein
receptors	protein
.	O
However,	O
the	O
sensitivity	O
of	O
cells	O
to	O
these	O
agents	O
is	O
not	O
merely	O
governed	O
by	O
the	O
expression	O
of	O
their	O
receptors	O
and	O
the	O
availability	O
of	O
ligand	O
to	O
bind	O
them.	O
Recent	O
studies	O
from	O
our	O
group	O
suggested	O
that	O
the	O
actions	O
of	O
D3	O
and	O
retinoids	O
on	O
myelopoiesis	O
also	O
are	O
influenced	O
by	O
endogenous	O
mechanisms	O
involving	O
other	O
steroid	O
hormones	O
.	O
In	O
this	O
study	O
we	O
examined	O
the	O
influence	O
of	O
local	O
estrogen	O
metabolism	O
on	O
the	O
differentiation	O
of	O
HL60	cell_line
cells	cell_line
and	O
normal	O
primitive	O
myeloid	cell_type
progenitor	cell_type
cells	cell_type
.	O
Quantitative	O
thin-layer	O
chromatography	O
(	O
TLC	O
)	O
analyses	O
showed	O
that	O
HL60	cell_line
and	O
normal	cell_type
cells	cell_type
are	O
able	O
to	O
generate	O
estrone	O
(	O
E1	O
)	O
from	O
estradiol	O
(	O
E2	O
).	O
Neither	O
cell	O
population	O
generated	O
significant	O
amounts	O
of	O
E2	O
from	O
E1	O
.	O
Reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
and	O
Northern	O
analyses	O
confirmed	O
that	O
normal	O
and	O
leukemic	O
myeloid	cell_type
progenitor	cell_type
cells	cell_type
expressed	O
mRNA	RNA
for	O
the	O
type	O
I	O
and	O
IV	O
isoforms	O
of	O
17	protein
beta-hydroxysteroid	protein
dehydrogenase	protein
.	O
Conversion	O
of	O
E2	O
to	O
E1	O
was	O
upregulated	O
within	O
24	O
hours	O
when	O
HL60	cell_line
cells	cell_line
were	O
treated	O
with	O
either	O
all-trans	O
retinoic	O
acid	O
or	O
D3	O
at	O
doses	O
that	O
induce	O
their	O
differentiation	O
toward	O
neutrophils	cell_type
or	O
monocytes	cell_type
,	O
respectively.	O
Similarly,	O
D3	O
-induced	O
monocyte	O
differentiation	O
of	O
normal	O
myeloid	cell_type
progenitor	cell_type
cells	cell_type
was	O
associated	O
with	O
increased	O
capacity	O
to	O
generate	O
E1	O
from	O
E2	O
.	O
When	O
HL60	cell_line
cells	cell_line
or	O
normal	O
myeloid	cell_type
progenitor	cell_type
cells	cell_type
were	O
exposed	O
to	O
exogenous	O
E1	O
they	O
became	O
more	O
sensitive	O
to	O
the	O
differentiation-inducing	O
effects	O
of	O
D3	O
.	O
Data	O
presented	O
provide	O
further	O
evidence	O
for	O
the	O
local	O
modulation	O
of	O
myelopoiesis	O
by	O
intracrine	O
mechanisms	O
.	O
In	O
particular,	O
our	O
findings	O
suggest	O
that	O
local	O
metabolism	O
of	O
steroids	O
by	O
normal	O
as	O
well	O
as	O
leukemic	cell_type
myeloid	cell_type
cells	cell_type
influences	O
their	O
responsiveness	O
to	O
D3	O
and	O
retinoids	O
.	O

Phosphorylation	O
of	O
TRAF2	protein
inhibits	O
binding	O
to	O
the	O
CD40	protein
cytoplasmic	protein
domain	protein
.	O
TRAF2	protein
is	O
a	O
signal	protein
transducing	protein
adaptor	protein
molecule	protein
which	O
binds	O
to	O
the	O
CD40	protein
cytoplasmic	protein
domain	protein
.	O
We	O
have	O
found	O
that	O
it	O
is	O
phosphorylated,	O
predominantly	O
on	O
serine	O
residues	O
,	O
when	O
transiently	O
overexpressed	O
in	O
293	cell_line
cells	cell_line
.	O
The	O
phosphorylation	O
appears	O
to	O
be	O
related	O
to	O
the	O
signaling	O
events	O
that	O
are	O
activated	O
by	O
TRAF2	protein
under	O
these	O
circumstances,	O
since	O
two	O
nonfunctional	O
mutants	O
were	O
found	O
to	O
be	O
phosphorylated	O
significantly	O
less	O
than	O
the	O
wild-type	protein
protein	protein
.	O
Furthermore,	O
the	O
phosphorylation	O
status	O
of	O
TRAF2	protein
had	O
significant	O
effects	O
on	O
the	O
ability	O
of	O
the	O
protein	O
to	O
bind	O
to	O
CD40	protein
,	O
as	O
evidenced	O
by	O
our	O
observations	O
that	O
the	O
CD40	protein
cytoplasmic	protein
domain	protein
interacted	O
preferentially	O
with	O
underphosphorylated	O
TRAF2	protein
and	O
that	O
phosphatase	protein
treatment	O
significantly	O
enhanced	O
the	O
binding	O
of	O
TRAF2	protein
to	O
CD40	protein
.	O
We	O
conclude	O
from	O
these	O
studies	O
that	O
the	O
phosphorylation	O
of	O
TRAF2	protein
is	O
likely	O
to	O
play	O
an	O
important	O
role	O
in	O
regulating	O
signaling	O
by	O
virtue	O
of	O
its	O
ability	O
to	O
influence	O
the	O
CD40	protein
-TRAF2	protein
interaction	O
.	O
Copyright	O
1999	O
Academic	O
Press.	O

A	O
direct	O
interaction	O
between	O
the	O
adaptor	protein
protein	protein
Cbl-b	protein
and	O
the	O
kinase	protein
zap-70	protein
induces	O
a	O
positive	O
signal	O
in	O
T	cell_type
cells	cell_type
.	O
Engagement	O
of	O
the	O
T-cell	protein
receptor	protein
(	protein
TCR	protein
)-CD3	protein
complex	protein
induces	O
a	O
rapid	O
increase	O
in	O
the	O
activities	O
of	O
Src-family	protein
and	O
Syk/Zap-70-family	protein
kinases	protein
[1]	O
[2].	O
These	O
activated	protein
kinases	protein
then	O
induce	O
the	O
tyrosine	O
phosphorylation	O
of	O
multiple	protein
intracellular	protein
proteins	protein
,	O
eventually	O
leading	O
to	O
T-cell	O
activation	O
.	O
One	O
of	O
the	O
prominent	O
substrates	O
for	O
these	O
kinases	protein
is	O
the	O
adaptor	protein
protein	protein
Cbl	O
[3]	O
and	O
recent	O
studies	O
suggest	O
that	O
Cbl	protein
negatively	O
regulates	O
upstream	protein
kinases	protein
such	O
as	O
Syk	protein
and	O
Zap-70	protein
[4]	O
[5].	O
Cbl-b	protein
,	O
a	O
homologue	O
of	O
Cbl	protein
,	O
is	O
widely	O
expressed	O
in	O
many	O
tissues	O
and	O
cells	O
including	O
hematopoietic	cell_type
cells	cell_type
[6]	O
[7].	O
Cbl-b	protein
undergoes	O
rapid	O
tyrosine	O
phosphorylation	O
upon	O
stimulation	O
of	O
the	O
TCR	protein
and	O
cytokine	O
receptors	O
[8]	O
[9].	O
The	O
role	O
of	O
Cbl-b	protein
is	O
unclear,	O
however.	O
Here,	O
we	O
show	O
that	O
overexpression	O
of	O
Cbl-b	protein
in	O
T	cell_type
cells	cell_type
induced	O
the	O
constitutive	O
activation	O
of	O
the	O
transcription	protein
factor	protein
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NFAT	protein
).	O
A	O
loss-of-function	O
mutation	O
in	O
Cbl-b	protein
disrupted	O
the	O
interaction	O
between	O
Cbl-b	protein
and	O
Zap-70	protein
and	O
nearly	O
completely	O
abrogated	O
the	O
Cbl-b	protein
-mediated	O
activation	O
of	O
NFAT	protein
.	O
Unlike	O
the	O
proposed	O
role	O
of	O
Cbl	protein
as	O
a	O
negative	O
regulator,	O
our	O
results	O
suggest	O
that	O
the	O
Cbl	protein
homologue	O
Cbl	protein
-b	protein
has	O
a	O
positive	O
role	O
in	O
T-cell	O
signaling	O
,	O
most	O
likely	O
via	O
a	O
direct	O
interaction	O
with	O
the	O
upstream	protein
kinase	protein
Zap-70	protein
.	O

Grf40	protein
,	O
A	O
novel	O
Grb2	protein
family	protein
member	protein
,	O
is	O
involved	O
in	O
T	O
cell	O
signaling	O
through	O
interaction	O
with	O
SLP-76	protein
and	O
LAT	protein
.	O
We	O
molecularly	O
cloned	O
a	O
new	O
Grb2	protein
family	protein
member	protein
,	O
named	O
Grf40	protein
,	O
containing	O
the	O
common	O
SH3-SH2-SH3	protein
motif	protein
.	O
Expression	O
of	O
Grf40	protein
is	O
predominant	O
in	O
hematopoietic	cell_type
cells	cell_type
,	O
particularly	O
T	cell_type
cells	cell_type
.	O
Grf40	protein
binds	O
to	O
the	O
SH2	protein
domain	protein
-containing	protein
leukocyte	protein
protein	protein
of	O
76	O
kD	O
(	O
SLP-76	protein
)	O
via	O
its	O
SH3	O
domain	O
more	O
tightly	O
than	O
Grb2	protein
.	O
Incidentally,	O
Grf40	protein
binds	O
to	O
linker	protein
for	protein
activation	protein
of	protein
T	protein
cells	protein
(	O
LAT	protein
)	O
possibly	O
via	O
its	O
SH2	protein
domain	protein
.	O
Overexpression	O
of	O
wild-type	protein
Grf40	protein
in	O
Jurkat	cell_line
cells	cell_line
induced	O
a	O
significant	O
increase	O
of	O
SLP-76	DNA
-dependent	DNA
interleukin	DNA
(IL)-2	DNA
promoter	DNA
and	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cell	protein
(	O
NF-AT	protein
)	O
activation	O
upon	O
T	protein
cell	protein
receptor	protein
(	O
TCR	protein
)	O
stimulation	O
,	O
whereas	O
the	O
COOH-terminal	protein
SH3-deleted	protein
Grf40	protein
mutant	protein
lacked	O
any	O
recognizable	O
increase	O
in	O
IL-2	DNA
promoter	DNA
activity	O
.	O
Furthermore,	O
the	O
SH2-deleted	protein
Grf40	protein
mutant	protein
led	O
to	O
a	O
marked	O
inhibition	O
of	O
these	O
regulatory	O
activities,	O
the	O
effect	O
of	O
which	O
is	O
apparently	O
stronger	O
than	O
that	O
of	O
the	O
SH2-deleted	protein
Grb2	protein
mutant	protein
.	O
Our	O
data	O
suggest	O
that	O
Grf40	protein
is	O
an	O
adaptor	protein
molecule	protein
involved	O
in	O
TCR	protein
-mediated	O
signaling	O
through	O
a	O
more	O
efficient	O
interaction	O
than	O
Grb2	protein
with	O
SLP-76	protein
and	O
LAT	protein
.	O

Modulation	O
of	O
the	O
immune	O
response	O
and	O
tumor	O
growth	O
by	O
activated	O
Ras	protein
.	O
As	O
a	O
result	O
of	O
its	O
transforming	O
abilities	O
,	O
activated	protein
Ras	protein
is	O
expressed	O
in	O
a	O
great	O
number	O
of	O
cancers	O
.	O
The	O
ras	O
mutation	O
frequency	O
varies	O
between	O
95%	O
in	O
pancreatic	O
cancer	O
and	O
5%	O
in	O
breast	O
cancer	O
.	O
In	O
leukemia	O
,	O
the	O
highest	O
frequency	O
(30%)	O
is	O
found	O
in	O
acute	O
myeloid	O
leukemia	O
.	O
The	O
presence	O
of	O
ras	O
mutations	O
has	O
been	O
correlated	O
with	O
a	O
poor	O
prognosis	O
and	O
negative	O
clinical	O
outcome.	O
This	O
suggests	O
that	O
mutated	protein
Ras	protein
activates	O
mechanisms,	O
which	O
favor	O
tumor	O
growth	O
,	O
enhance	O
the	O
metastatic	O
capacity	O
of	O
tumors	O
or	O
modulate	O
tumor-specific	O
immune	O
responses	O
.	O
Several	O
new	O
functions	O
of	O
Ras	protein
,	O
such	O
as	O
downregulation	O
of	O
major	protein
histocompatibility	protein
complex	protein
molecules	protein
,	O
upregulation	O
of	O
certain	O
cytokines	protein
,	O
growth	protein
factors	protein
and	O
degradative	protein
enzymes	protein
have	O
been	O
uncovered	O
in	O
the	O
last	O
decade.	O
Additionally,	O
mutated	protein
Ras	protein
can	O
also	O
serve	O
as	O
a	O
primary	O
target	O
for	O
the	O
development	O
of	O
immunotherapy	O
or	O
drug	O
therapy	O
.	O
This	O
review	O
will	O
discuss	O
the	O
mechanisms	O
by	O
which	O
Ras	protein
expressing	O
tumors	O
are	O
able	O
to	O
evade	O
destruction	O
by	O
the	O
immune	O
system	O
and	O
enhance	O
their	O
growth	O
and	O
metastatic	O
potential	O
.	O
It	O
will	O
further	O
elaborate	O
on	O
the	O
attempts	O
to	O
develop	O
successful	O
immunotherapy	O
and	O
drug	O
therapy	O
targeting	O
Ras	protein
expressing	O
tumors	O
.	O

Modulation	O
of	O
E2F	protein
complexes	protein
during	O
G0	O
to	O
S	O
phase	O
transition	O
in	O
human	cell_type
primary	cell_type
B-lymphocytes	cell_type
.	O
The	O
pocket	protein
protein-	protein
E2F	protein
complexes	protein
are	O
convergence	O
points	O
for	O
cell	O
cycle	O
signaling	O
.	O
In	O
the	O
present	O
report,	O
we	O
identified	O
and	O
monitored	O
the	O
pocket	protein
protein-	protein
E2F	protein
complexes	protein
in	O
human	cell_type
primary	cell_type
B-lymphocytes	cell_type
after	O
activation	O
by	O
phorbol	O
12-myristate	O
13-acetate	O
.	O
Consistent	O
with	O
previous	O
data	O
from	O
human	O
and	O
mouse	O
fibroblasts	O
and	O
T-lymphocytes	cell_type
,	O
E2F4	protein
and	O
DP1	protein
form	O
the	O
predominant	O
E2F	protein
heterodimers	protein
both	O
in	O
G0	O
and	O
G1	O
phases	O
of	O
the	O
human	O
B-lymphocyte	O
cell	O
cycle	O
,	O
whereas	O
E2F	O
1	O
and	O
-3	O
are	O
first	O
detected	O
in	O
late	O
G1	O
,	O
and	O
their	O
expression	O
levels	O
increase	O
towards	O
S	O
phase	O
.	O
Intriguingly,	O
the	O
major	protein
E2F	protein
complex	protein
that	O
we	O
detected	O
in	O
quiescent	cell_type
human	cell_type
B-lymphocytes	cell_type
is	O
consisted	O
of	O
pRB	protein
,	O
E2F4	protein
,	O
and	O
DP1	protein
.	O
Though	O
the	O
levels	O
of	O
DP	O
1	O
and	O
-2	O
increase	O
when	O
cells	O
progress	O
from	O
G0	O
to	O
S	O
,	O
the	O
proportion	O
of	O
DP1	protein
to	O
DP2	protein
remains	O
relatively	O
constant	O
during	O
the	O
cell	O
cycle.	O
We	O
also	O
observed	O
an	O
increase	O
in	O
electrophoretic	O
mobility	O
of	O
the	O
predominant	O
E2F	protein
components	protein
,	O
DP1	protein
and	O
E2F4	protein
,	O
as	O
B-lymphocytes	cell_type
progressed	O
from	O
G0	O
into	O
early	O
G1	O
.	O
This	O
increase	O
in	O
mobility	O
was	O
attributable	O
to	O
dephosphorylation	O
,	O
as	O
lambda	O
phosphatase	O
treatment	O
could	O
convert	O
the	O
slower	protein
migrating	protein
forms	protein
into	O
the	O
corresponding	protein
faster	protein
mobility	protein
forms	protein
.	O
We	O
further	O
demonstrated	O
that	O
this	O
change	O
in	O
phosphorylation	O
status	O
correlates	O
with	O
a	O
decrease	O
in	O
DNA	O
binding	O
activity.	O
This	O
modulation	O
of	O
DNA	O
binding	O
activity	O
mediated	O
through	O
the	O
dephosphorylation	O
of	O
DP1	protein
and	O
E2F4	protein
could	O
help	O
to	O
explain	O
the	O
lack	O
of	O
in	O
vivo	O
DNA	O
footprinting	O
in	O
late	O
G1	O
and	O
S	O
phases	O
of	O
gene	DNA
promoters	DNA
negatively	O
regulated	O
through	O
E2F	DNA
sites	DNA
and	O
suggests	O
a	O
novel	O
mechanism	O
for	O
controlling	O
E2F	protein
transcriptional	O
activity	O
during	O
the	O
transition	O
from	O
quiescence	O
to	O
proliferation	O
.	O

Engagement	O
of	O
natural	O
cytotoxicity	O
programs	O
regulates	O
AP-1	protein
expression	O
in	O
the	O
NKL	cell_line
human	cell_line
NK	cell_line
cell	cell_line
line	cell_line
.	O
NK	O
cell	O
cytotoxicity	O
is	O
a	O
fast	O
and	O
efficient	O
mechanism	O
of	O
target	O
cell	O
lysis	O
.	O
Using	O
transcription	O
analysis	O
,	O
such	O
as	O
multiplex	O
messenger	O
assays	O
,	O
we	O
show	O
here	O
that	O
natural	O
cytotoxicity	O
exerted	O
by	O
the	O
human	cell_line
NKL	cell_line
cell	cell_line
line	cell_line
correlates	O
with	O
mRNA	O
accumulation	O
of	O
very	protein
early	protein
activator	protein
protein	protein
(AP)-1	protein
transcription	DNA
factor	DNA
genes	DNA
such	O
as	O
JunB	DNA
,	O
FosB	DNA
and	O
c-Fos	DNA
.	O
In	O
addition,	O
DNA-binding	O
activities	O
of	O
Jun-Fos	protein
heterodimers	protein
were	O
observed	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
during	O
the	O
course	O
of	O
natural	O
cytotoxicity	O
.	O
Interaction	O
between	O
immunoglobulin-like	protein
transcript-2/leukocyte	protein
Ig-like	protein
receptor	protein
1	protein
on	O
NKL	cell_type
cells	cell_type
and	O
HLA-B27	protein
on	O
target	cell_type
cells	cell_type
leads	O
to	O
an	O
impairment	O
of	O
NKL	O
natural	O
cytotoxicity	O
,	O
which	O
correlates	O
with	O
an	O
absence	O
of	O
JunB	O
,	O
FosB	O
,	O
and	O
c-Fos	O
transcription	O
,	O
as	O
well	O
as	O
an	O
absence	O
of	O
their	O
DNA-binding	protein
activity	protein
.	O
Our	O
studies	O
thus	O
indicate	O
that,	O
despite	O
the	O
rapidity	O
of	O
NK	O
cell-mediated	O
lysis	O
,	O
AP-1	protein
transcription	protein
factor	protein
is	O
activated	O
during	O
the	O
early	O
stage	O
of	O
NK	O
cell	O
cytolytic	O
programs	O
and	O
that	O
engagement	O
of	O
NK	protein
cell	protein
inhibitory	protein
receptors	protein
for	O
MHC	protein
class	protein
I	protein
molecules	protein
impairs	O
the	O
very	O
early	O
activation	O
of	O
AP-1	protein
.	O

Evidence	O
for	O
a	O
polyclonal	O
etiology	O
of	O
palmar	O
fibromatosis	O
.	O
X	DNA
chromosome	DNA
inactivation	O
patterns	O
at	O
the	O
androgen	O
receptor	O
locus	O
were	O
evaluated	O
to	O
determine	O
clonality	O
in	O
microdissected	O
lesional	O
tissue	O
and	O
in	O
leukocytes	cell_type
from	O
2	O
women	O
with	O
Dupuytren's	O
disease	O
.	O
The	O
tissue	O
from	O
both	O
patients	O
generated	O
a	O
polyclonal	O
pattern	O
of	O
X	DNA
chromosome	DNA
inactivation	O
of	O
the	O
human	DNA
androgen	DNA
receptor	DNA
gene	DNA
.	O
This	O
finding	O
supports	O
a	O
polyclonal	O
reactive	O
process	O
as	O
the	O
underlying	O
etiology	O
for	O
palmar	O
fibromatosis	O
.	O

Inhibition	O
of	O
cyclooxygenase-2	protein
expression	O
by	O
4-trifluoromethyl	O
derivatives	O
of	O
salicylate	O
,	O
triflusal	O
,	O
and	O
its	O
deacetylated	O
metabolite	O
,	O
2-hydroxy-4-trifluoromethylbenzoic	O
acid	O
.	O
The	O
therapeutic	O
potential	O
of	O
drugs	O
that	O
block	O
the	O
induction	O
of	O
cyclooxygenase-2	protein
has	O
been	O
emphasized.	O
When	O
two	O
4-trifluoromethyl	O
salicylate	O
derivatives	O
[	O
2-acetoxy-4-trifluoromethyl-benzoic	O
acid	O
(	O
triflusal	O
)	O
and	O
its	O
deacetylated	O
metabolite	O
2-hydroxy-4-trifluoromethylbenzoic	O
acid	O
(	O
HTB	O
)]	O
were	O
compared	O
with	O
aspirin	O
and	O
sodium	O
salicylate	O
as	O
cyclooxygenase-2	protein
(COX-2)	O
inhibitors,	O
we	O
observed	O
that	O
in	O
bacterial	O
lipopolysaccharide-activated	O
human	O
blood	O
,	O
triflusal	O
,	O
aspirin	O
,	O
and	O
HTB	O
,	O
but	O
not	O
sodium	O
salicylate	O
,	O
inhibited	O
COX-2-mediated	O
prostaglandin	O
E2	O
(	O
PGE2	O
)	O
production	O
(IC50	O
=	O
0.16,	O
0.18,	O
0.39,	O
and	O
&gt;10	O
mM,	O
respectively).	O
However,	O
only	O
triflusal	O
and	O
aspirin	O
inhibited	O
purified	protein
COX-2	protein
enzyme	protein
.	O
To	O
test	O
this	O
apparent	O
discrepancy,	O
we	O
realized	O
that	O
HTB	O
and	O
triflusal	O
(but	O
neither	O
aspirin	O
nor	O
salicylate	O
)	O
produced	O
a	O
concentration-dependent	O
inhibition	O
of	O
COX-2	protein
protein	O
expression	O
in	O
peripheral	cell_type
human	cell_type
mononuclear	cell_type
cells	cell_type
.	O
This	O
observation	O
was	O
further	O
confirmed	O
in	O
a	O
rat	O
air	O
pouch	O
model	O
in	O
vivo,	O
in	O
which	O
both	O
aspirin	O
and	O
triflusal	O
inhibited	O
PGE2	O
production	O
(ID50	O
=	O
18.9	O
and	O
11.4	O
mg/kg	O
p.o.,	O
respectively)	O
but	O
only	O
triflusal	O
-treated	O
animals	O
showed	O
a	O
decrease	O
in	O
COX-2	protein
expression	O
.	O
This	O
different	O
behavior	O
may	O
be,	O
at	O
least	O
in	O
part,	O
due	O
to	O
the	O
ability	O
of	O
HTB	O
and	O
triflusal	O
to	O
block	O
the	O
activation	O
of	O
the	O
transcription	O
factor	O
nuclear	protein
factor-kappaB	protein
to	O
a	O
higher	O
extent	O
than	O
aspirin	O
and	O
sodium	O
salicylate	O
.	O
Thus,	O
in	O
addition	O
to	O
inhibiting	O
the	O
COX-2	O
activity	O
at	O
therapeutic	O
concentrations,	O
triflusal	O
is	O
able	O
to	O
block	O
through	O
its	O
metabolite	O
HTB	O
the	O
expression	O
of	O
new	O
enzyme,	O
and	O
hence	O
the	O
resumption	O
of	O
PGE2	O
synthesis	O
.	O
Triflusal	O
and	O
HTB	O
may	O
exert	O
beneficial	O
effects	O
in	O
processes	O
in	O
which	O
de	O
novo	O
COX-2	protein
expression	O
is	O
involved	O
and,	O
in	O
a	O
broader	O
sense,	O
in	O
pathological	O
situations	O
in	O
which	O
genes	O
under	O
nuclear	protein
factor-kappaB	protein
control	O
are	O
up-regulated.	O

Evidence	O
for	O
distinct	O
intracellular	O
signaling	O
pathways	O
in	O
CD34+	cell_type
progenitor	cell_type
to	O
dendritic	O
cell	O
differentiation	O
from	O
a	O
human	O
cell	O
line	O
model	O
.	O
Intracellular	O
signals	O
that	O
mediate	O
differentiation	O
of	O
pluripotent	cell_type
hemopoietic	cell_type
progenitors	cell_type
to	O
dendritic	cell_type
cells	cell_type
(	O
DC	cell_type
)	O
are	O
largely	O
undefined.	O
We	O
have	O
previously	O
shown	O
that	O
protein	protein
kinase	protein
C	protein
(	O
PKC	protein
)	O
activation	O
(with	O
phorbol	O
ester	O
(	O
PMA	O
)	O
alone)	O
specifically	O
induces	O
differentiation	O
of	O
primary	cell_line
human	cell_line
CD34+	cell_line
hemopoietic	cell_line
progenitor	cell_line
cells	cell_line
(	O
HPC	cell_line
)	O
to	O
mature	cell_type
DC	cell_type
.	O
We	O
now	O
find	O
that	O
cytokine-driven	O
(granulocyte-macrophage	O
CSF	O
and	O
TNF-alpha)	O
CD34+	O
HPC	cell_line
--&gt;DC	O
differentiation	O
is	O
preferentially	O
blocked	O
by	O
inhibitors	O
of	O
PKC	protein
activation	O
.	O
To	O
further	O
identify	O
intracellular	O
signals	O
and	O
downstream	O
events	O
important	O
in	O
CD34+	cell_line
HPC	cell_line
--&gt;	O
DC	cell_type
differentiation	O
we	O
have	O
characterized	O
a	O
human	O
leukemic	O
cell	O
line	O
model	O
of	O
this	O
process.	O
The	O
CD34+	cell_line
myelomonocytic	cell_line
cell	cell_line
line	cell_line
KG1	cell_line
differentiates	O
into	O
dendritic-like	O
cells	O
in	O
response	O
to	O
granulocyte-macrophage	protein
CSF	protein
plus	O
TNF-alpha	protein
,	O
or	O
PMA	O
(with	O
or	O
without	O
the	O
calcium	O
ionophore	O
ionomycin	O
,	O
or	O
TNF-alpha	protein
),	O
with	O
different	O
stimuli	O
mediating	O
different	O
aspects	O
of	O
the	O
process.	O
Phenotypic	O
DC	cell_type
characteristics	O
of	O
KG1	cell_line
dendritic-like	cell_line
cells	cell_line
include	O
morphology	O
(	O
loosely	cell_type
adherent	cell_type
cells	cell_type
with	O
long	O
neurite	O
processes	O
),	O
MHC	protein
I+/	O
MHC	protein
IIbright/CD83+/CD86+/	O
CD14	protein
-	O
surface	O
Ag	O
expression	O
,	O
and	O
RelB	protein
and	O
DC	cell_type
-CK1	O
gene	O
expression.	O
Functional	O
DC	cell_type
characteristics	O
include	O
fluid	O
phase	O
macromolecule	O
uptake	O
(	O
FITC-dextran	O
)	O
and	O
activation	O
of	O
resting	cell_type
T	cell_type
cells	cell_type
.	O
Comparison	O
of	O
KG1	cell_line
to	O
the	O
PMA	cell_line
-unresponsive	cell_line
subline	cell_line
KG1a	cell_line
reveals	O
differences	O
in	O
expression	O
of	O
TNF	O
receptors	O
1	O
and	O
2	O
;	O
PKC	O
isoforms	O
alpha	O
,	O
beta	O
I	O
,	O
beta	O
II	O
,	O
and	O
mu	O
;	O
and	O
RelB	protein
,	O
suggesting	O
that	O
these	O
components/pathways	O
are	O
important	O
for	O
DC	cell_type
differentiation	O
.	O
Together,	O
these	O
findings	O
demonstrate	O
that	O
cytokine	O
or	O
phorbol	O
ester	O
stimulation	O
of	O
KG1	cell_line
is	O
a	O
model	O
of	O
human	cell_line
CD34+	cell_line
HPC	cell_line
to	O
DC	cell_type
differentiation	O
and	O
suggest	O
that	O
specific	O
intracellular	O
signaling	O
pathways	O
mediate	O
specific	O
events	O
in	O
DC	cell_type
lineage	O
commitment	O
.	O

Involvement	O
of	O
adenylate	protein
cyclase	protein
and	O
p70(S6)-kinase	protein
activation	O
in	O
IL-10	protein
up-regulation	O
in	O
human	cell_type
monocytes	cell_type
by	O
gp41	protein
envelope	protein
protein	protein
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
.	O
Our	O
previous	O
results	O
show	O
that	O
recombinant	protein
gp41	protein
(	O
aa565-647	protein
),	O
the	O
extracellular	protein
domain	protein
of	O
HIV-1	protein
transmembrane	protein
glycoprotein	protein
,	O
stimulates	O
interleukin-10	protein
(	O
IL-10	protein
)	O
production	O
in	O
human	cell_type
monocytes	cell_type
.	O
The	O
signal	O
cascade	O
transducing	O
this	O
effect	O
is	O
not	O
yet	O
clear.	O
In	O
this	O
study,	O
we	O
examined	O
whether	O
gp41	protein
-induced	O
IL-10	protein
up-regulation	O
is	O
mediated	O
by	O
the	O
previously	O
described	O
synergistic	O
activation	O
of	O
cAMP	O
and	O
NF-kappaB	protein
pathways	O
.	O
gp41	protein
induced	O
cAMP	O
accumulation	O
in	O
monocytes	cell_type
in	O
a	O
time-	O
and	O
concentration-dependent	O
manner	O
and	O
the	O
adenylate	protein
cyclase	protein
inhibitor	O
SQ	O
22536	O
suppressed	O
gp41	protein
-induced	O
IL-10	protein
production	O
in	O
monocytes	cell_type
.	O
In	O
contrast,	O
gp41	protein
failed	O
to	O
stimulate	O
NF-kappaB	protein
binding	O
activity	O
in	O
as	O
much	O
as	O
no	O
NF-kappaB	protein
bound	O
to	O
the	O
main	DNA
NF-kappaB	DNA
-binding	DNA
site	DNA
2	O
of	O
the	O
IL-10	DNA
promoter	DNA
after	O
addition	O
of	O
gp41	protein
.	O
We	O
also	O
examined	O
the	O
involvement	O
of	O
other	O
signal	O
transduction	O
pathways	O
.	O
Specific	O
inhibitors	O
of	O
p70(S6)-kinase	protein
(	O
rapamycin	O
),	O
and	O
Gi	protein
protein	protein
(	O
pertussis	protein
toxin	protein
),	O
prevented	O
induction	O
of	O
IL-10	protein
production	O
by	O
gp41	protein
in	O
monocytes	cell_type
,	O
while	O
inhibitors	O
of	O
the	O
phosphatidylinositol	protein
3-kinase	protein
(	O
PI	protein
3-kinase	protein
)	O
(	O
wortmannin	O
)	O
and	O
mitogen-activated	O
protein	O
kinase	O
(	O
MAPK	protein
)	O
pathway	O
(	O
PD	O
98059	O
)	O
did	O
not.	O
Thus	O
HIV-1	O
gp41	protein
-induced	O
IL-10	protein
up-regulation	O
in	O
monocytes	cell_type
may	O
not	O
involve	O
NF-kappaB	protein
,	O
MAPK	protein
,	O
or	O
PI	protein
3-kinase	protein
activation	O
,	O
but	O
rather	O
may	O
operate	O
through	O
activation	O
of	O
adenylate	protein
cyclase	protein
and	O
pertussis-toxin-sensitive	protein
Gi/Go	protein
protein	protein
to	O
effect	O
p70(S6)-kinase	protein
activation	O
.	O

Analysis	O
of	O
the	O
modulation	O
of	O
transcriptional	O
activity	O
in	O
myelopoiesis	O
and	O
leukemogenesis	O
.	O
Acute	O
myeloid	O
leukemia	O
(	O
AML	O
)	O
is	O
still	O
associated	O
with	O
a	O
mortality	O
of	O
60	O
to	O
80%.	O
AML	O
is	O
characterized	O
by	O
a	O
block	O
in	O
myeloid	O
differentiation	O
.	O
The	O
transcription	protein
factors	protein
PU.1	protein
and	O
C/EBPalpha	protein
are	O
responsible	O
for	O
normal	O
myeloid	O
differentiation	O
from	O
stem	cell_type
cells	cell_type
to	O
monocytes	cell_type
or	O
granulocytes.	O
In	O
particular,	O
PU.1	protein
induces	O
expression	O
of	O
the	O
macrophage	protein
colony-stimulating	protein
factor	protein
(M-CSF)	protein
receptor	protein
and	O
the	O
development	O
of	O
monocytes	cell_type
,	O
whereas	O
C/EBPalpha	protein
increases	O
the	O
expression	O
of	O
the	O
granulocyte	protein
colony-stimulating	protein
factor	protein
(G-CSF)	protein
receptor	protein
and	O
leads	O
to	O
mature	O
granulocytes	cell_type
.	O
In	O
AML	O
,	O
chromosomal	O
aberrations	O
result	O
in	O
oncoproteins	protein
such	O
as	O
AML1/ETO	protein
,	O
PML/RARalpha	protein
,	O
or	O
activated	protein
Ras	protein
,	O
which	O
can	O
deregulate	O
genes	O
important	O
for	O
normal	O
myelopoiesis	O
.	O
Thus,	O
AML1/ETO	protein
can	O
bind	O
to	O
the	O
transcription	protein
factor	protein
C/EBPalpha	protein
,	O
inhibit	O
C/EBPalpha	protein
-dependent	O
transcription,	O
and	O
block	O
granulocytic	O
differentiation.	O
However,	O
AML1/ETO	protein
can	O
also	O
synergize	O
with	O
the	O
transcription	protein
factor	protein
AML1	protein
to	O
enhance	O
the	O
activity	O
of	O
the	O
M-CSF	DNA
receptor	DNA
promoter	DNA
.	O
On	O
the	O
other	O
hand,	O
the	O
PML/RARalpha	protein
fusion	protein
protein	protein
causes	O
transcriptional	O
repression	O
by	O
recruiting	O
the	O
nuclear	protein
corepressor	protein
(N-CoR)	protein
histone	protein
deacetylase	protein
complex	protein
to	O
the	O
DNA,	O
which	O
results	O
in	O
decreased	O
histone	protein
acetylation	O
and	O
a	O
repressive	O
chromatin	DNA
organization	O
.	O
Here	O
we	O
describe	O
methods	O
to	O
investigate	O
whether	O
and	O
how	O
signaling	O
agonists	O
induce	O
myeloid	O
differentiation	O
and	O
how	O
oncoproteins	protein
might	O
cause	O
AML	O
by	O
modulating	O
the	O
activity	O
of	O
transcription	protein
factors	protein
that	O
are	O
pivotal	O
for	O
normal	O
myeloid	O
development	O
.	O
Copyright	O
1999	O
Academic	O
Press.	O

NF-ATc	protein
isoforms	protein
are	O
differentially	O
expressed	O
and	O
regulated	O
in	O
murine	O
T	O
and	O
mast	O
cells	O
.	O
NF	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NF-AT	protein
)	O
denotes	O
a	O
family	O
of	O
transcription	protein
factors	protein
that	O
regulate	O
the	O
activation-dependent	O
expression	O
of	O
many	O
immunologically	protein
important	protein
proteins	protein
.	O
At	O
least	O
four	O
distinct	O
genes	O
encode	O
the	O
various	O
family	O
members,	O
and	O
several	O
isoforms	O
of	O
these	O
have	O
been	O
identified	O
as	O
well.	O
The	O
overlapping	O
expression	O
patterns	O
and	O
similar	O
in	O
vitro	O
binding	O
and	O
trans-activation	O
activities	O
on	O
various	O
promoter	DNA
elements	DNA
of	O
NF-AT	DNA
-regulated	DNA
genes	DNA
suggest	O
some	O
redundancy	O
in	O
the	O
function	O
of	O
these	O
proteins.	O
However,	O
the	O
phenotypic	O
analysis	O
of	O
NF-AT	protein
-deficient	O
mice	O
supports	O
the	O
idea	O
that	O
there	O
are	O
tissue-	O
and	O
gene-	O
specific	O
functions	O
as	O
well.	O
In	O
this	O
study	O
we	O
have	O
characterized	O
the	O
expression	O
of	O
NF-AT	DNA
cDNAs	DNA
in	O
murine	O
mast	cell_type
cells	cell_type
.	O
The	O
majority	O
of	O
clones	O
identified	O
correspond	O
to	O
two	O
NF-ATc	protein
isoforms	protein
that	O
differ	O
only	O
in	O
their	O
amino-terminal	protein
sequence	protein
.	O
Despite	O
minimal	O
discrepancies	O
in	O
the	O
coding	DNA
region	DNA
,	O
there	O
are	O
striking	O
tissue-	O
and	O
cell	O
type-specific	O
differences	O
in	O
isoform	O
expression	O
patterns	O
.	O
Detection	O
of	O
NF-ATc.alpha	RNA
mRNA	RNA
is	O
strictly	O
dependent	O
on	O
cell	O
activation	O
signals	O
in	O
both	O
T	O
and	O
mast	O
cell	O
lines	O
.	O
In	O
contrast,	O
the	O
beta	protein
isoform	protein
is	O
expressed	O
at	O
very	O
low	O
constitutive	O
levels	O
in	O
both	O
cell	O
types	O
but	O
is	O
only	O
up-regulated	O
in	O
response	O
to	O
mast	O
cell	O
activation	O
signals	O
delivered	O
through	O
the	O
FcepsilonRI	protein
or	O
via	O
calcium	O
ionophores	O
.	O
These	O
results	O
demonstrate	O
another	O
level	O
of	O
regulation	O
within	O
the	O
NF-AT	protein
family	protein
that	O
can	O
contribute	O
to	O
cell	O
type-specific	O
gene	O
expression	O
.	O

Crossreactive	O
recognition	O
of	O
viral,	O
self,	O
and	O
bacterial	O
peptide	O
ligands	O
by	O
human	cell_type
class	cell_type
I-restricted	cell_type
cytotoxic	cell_type
T	cell_type
lymphocyte	cell_type
clonotypes:	cell_type
implications	O
for	O
molecular	O
mimicry	O
in	O
autoimmune	O
disease	O
.	O
The	O
immunodominant,	O
CD8(+)	cell_type
cytotoxic	cell_type
T	cell_type
lymphocyte	cell_type
(CTL)	O
response	O
to	O
the	O
HLA-B8-restricted	O
peptide	O
,	O
RAKFKQLL	O
,	O
located	O
in	O
the	O
Epstein-Barr	protein
virus	protein
immediate-early	protein
antigen	protein
,	O
BZLF1	protein
,	O
is	O
characterized	O
by	O
a	O
diverse	O
T	protein
cell	protein
receptor	protein
(TCR)	protein
repertoire	protein
.	O
Here,	O
we	O
show	O
that	O
this	O
diversity	O
can	O
be	O
partitioned	O
on	O
the	O
basis	O
of	O
crossreactive	O
cytotoxicity	O
patterns	O
involving	O
the	O
recognition	O
of	O
a	O
self	O
peptide	O
-	O
RSKFRQIV	O
-located	O
in	O
a	O
serine	protein
/threonine	protein
kinase	protein
and	O
a	O
bacterial	O
peptide	O
-	O
RRKYKQII	O
-located	O
in	O
Staphylococcus	protein
aureus	protein
replication	protein
initiation	protein
protein	protein
.	O
Thus	O
CTL	cell_line
clones	cell_line
that	O
recognized	O
the	O
viral	O
,	O
self	O
,	O
and	O
bacterial	O
peptides	O
expressed	O
a	O
highly	O
restricted	O
alphabeta	O
TCR	protein
phenotype	O
.	O
The	O
CTL	cell_line
clones	cell_line
that	O
recognized	O
viral	O
and	O
self	O
peptides	O
were	O
more	O
oligoclonal,	O
whereas	O
clones	O
that	O
strictly	O
recognized	O
the	O
viral	O
peptide	O
displayed	O
a	O
diverse	O
TCR	protein
profile	O
.	O
Interestingly,	O
the	O
self	O
and	O
bacterial	O
peptides	O
equally	O
were	O
substantially	O
less	O
effective	O
than	O
the	O
cognate	O
viral	O
peptide	O
in	O
sensitizing	O
target	O
cell	O
lysis,	O
and	O
also	O
resulted	O
only	O
in	O
a	O
weak	O
reactivation	O
of	O
memory	cell_type
CTLs	cell_type
in	O
limiting	O
dilution	O
assays	O
,	O
whereas	O
the	O
cognate	O
peptide	O
was	O
highly	O
immunogenic.	O
The	O
described	O
crossreactions	O
show	O
that	O
human	O
antiviral,	O
CD8(+)	O
CTL	O
responses	O
can	O
be	O
shaped	O
by	O
peptide	O
ligands	O
derived	O
from	O
autoantigens	O
and	O
environmental	O
bacterial	O
antigens	O
,	O
thereby	O
providing	O
a	O
firm	O
structural	O
basis	O
for	O
molecular	O
mimicry	O
involving	O
class	O
I-restricted	cell_line
CTLs	cell_line
in	O
the	O
pathogenesis	O
of	O
autoimmune	O
disease	O
.	O

RFLAT-1	protein
:	O
a	O
new	O
zinc	protein
finger	protein
transcription	protein
factor	protein
that	O
activates	O
RANTES	DNA
gene	DNA
expression	O
in	O
T	cell_type
lymphocytes	cell_type
.	O
RANTES	protein
(	O
Regulated	protein
upon	protein
Activation,	protein
Normal	protein
T	protein
cell	protein
Expressed	protein
and	protein
Secreted	protein
)	O
is	O
a	O
chemoattractant	protein
cytokine	protein
(	O
chemokine	protein
)	O
important	O
in	O
the	O
generation	O
of	O
inflammatory	O
infiltrate	O
and	O
human	O
immunodeficiency	O
virus	O
entry	O
into	O
immune	cell_type
cells	cell_type
.	O
RANTES	protein
is	O
expressed	O
late	O
(3-5	O
days)	O
after	O
activation	O
in	O
T	cell_type
lymphocytes	cell_type
.	O
Using	O
expression	O
cloning,	O
we	O
identified	O
the	O
first	O
"late"	O
T	protein
lymphocyte	protein
associated	protein
transcription	protein
factor	protein
and	O
named	O
it	O
"	O
RANTES	protein
Factor	protein
of	protein
Late	protein
Activated	protein
T	protein
Lymphocytes-1	protein
"	O
(	O
RFLAT-1	protein
).	O
RFLAT-1	protein
is	O
a	O
novel,	O
phosphorylated,	O
zinc	protein
finger	protein
transcription	protein
factor	protein
that	O
is	O
expressed	O
in	O
T	cell_type
cells	cell_type
3	O
days	O
after	O
activation,	O
coincident	O
with	O
RANTES	protein
expression	O
.	O
While	O
Rel	protein
proteins	protein
play	O
the	O
dominant	O
role	O
in	O
RANTES	DNA
gene	DNA
expression	O
in	O
fibroblasts,	O
RFLAT-1	protein
is	O
a	O
strong	O
transactivator	O
for	O
RANTES	protein
in	O
T	cell_type
cells	cell_type
.	O

Fas	protein
ligand	protein
induction	O
in	O
human	cell_type
NK	cell_type
cells	cell_type
is	O
regulated	O
by	O
redox	O
through	O
a	O
calcineurin-nuclear	protein
factors	protein
of	O
activated	O
T	O
cell-dependent	O
pathway	O
.	O
Fas	protein
ligand	protein
(	O
FasL	protein
)	O
on	O
cytotoxic	O
lymphocytes	O
is	O
important	O
for	O
mediating	O
apoptosis	O
of	O
activated	O
lymphocytes	O
and	O
other	O
target	O
cells.	O
We	O
have	O
reported	O
that	O
NK	O
cell	O
functions,	O
such	O
as	O
proliferation,	O
cell	O
death,	O
and	O
killing	O
activity,	O
are	O
subject	O
to	O
regulation	O
by	O
cellular	O
redox	O
status.	O
Here,	O
we	O
report	O
that	O
expression	O
of	O
FasL	protein
protein	protein
and	O
mRNA	RNA
in	O
activated	cell_type
NK	cell_type
cells	cell_type
is	O
also	O
regulated	O
by	O
redox.	O
Ligation	O
of	O
CD16	protein
on	O
IL-2-	cell_type
preactivated	cell_type
NK	cell_type
cells	cell_type
resulted	O
in	O
reduction	O
of	O
intracellular	O
peroxide	O
level	O
as	O
well	O
as	O
induction	O
of	O
FasL	protein
expression	O
.	O
This	O
CD16	protein
-induced	O
FasL	protein
expression	O
was	O
suppressed	O
by	O
oxidative	O
stress	O
,	O
including	O
thiol	O
deprivation	O
or	O
treatment	O
with	O
hydrogen	O
peroxide	O
(	O
H2O2	O
).	O
Addition	O
of	O
thiol-reducing	O
compounds,	O
such	O
as	O
L-cystine	O
,	O
2-ME	O
,	O
or	O
N-acetyl	O
cysteine	O
,	O
restored	O
FasL	protein
expression	O
.	O
These	O
data	O
suggest	O
that	O
CD16	protein
stimulation	O
requires	O
cellular	O
reducing	O
status	O
for	O
FasL	protein
induction	O
in	O
NK	cell_type
cells	cell_type
.	O
Because	O
FasL	O
gene	O
activation	O
following	O
CD16	protein
cross-linking	O
is	O
regulated	O
by	O
the	O
NF	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NFAT	protein
),	O
we	O
examined	O
the	O
effect	O
of	O
oxidative	O
stresses	O
on	O
NFAT	protein
activation	O
.	O
Electrophoretic	O
mobility	O
shift	O
assays	O
revealed	O
that	O
both	O
thiol	O
insufficiency	O
and	O
H2O2	O
treatment	O
suppressed	O
DNA-binding	O
activity	O
of	O
NFAT	protein
and	O
that	O
addition	O
of	O
thiol-reducing	O
compounds	O
reversed	O
or	O
even	O
enhanced	O
it.	O
Furthermore,	O
these	O
oxidative	O
stresses	O
inhibited	O
activity	O
of	O
calcineurin,	O
a	O
serine	O
/	O
threonine	protein
phosphatase	protein
that	O
regulates	O
NFAT	protein
activation	O
.	O
These	O
results	O
suggest	O
that	O
suppression	O
of	O
calcineurin	protein
and	O
NFAT	protein
activation	O
is	O
a	O
mechanism	O
by	O
which	O
oxidative	O
stress	O
inhibits	O
FasL	protein
induction	O
in	O
activated	cell_type
NK	cell_type
cells	cell_type
and	O
further	O
support	O
the	O
hypothesis	O
that	O
thiol-reducing	O
compounds	O
might	O
be	O
required	O
for	O
maintenance	O
of	O
optimal	O
NK	O
functions	O
under	O
physiologic	O
oxidative	O
conditions	O
.	O

Heterogeneity	O
of	O
clonal	O
development	O
in	O
chronic	DNA
myeloproliferative	DNA
disorders	DNA
.	O
Recent	O
reports	O
have	O
suggested	O
a	O
previously	O
unexpected	O
variability	O
in	O
the	O
expression	O
of	O
the	O
dominant	cell_line
neoplastic	cell_line
clone	cell_line
in	O
myeloproliferative	O
disorders	O
(	O
MPD	O
).	O
We	O
evaluated	O
49	O
female	O
patients	O
with	O
MPD	O
and	O
informative	O
at	O
the	O
X-linked	DNA
androgen	DNA
receptor	DNA
(AR)	DNA
locus	DNA
to	O
establish	O
the	O
X	DNA
chromosome	DNA
inactivation	O
pattern	O
of	O
hemopoietic	cell_type
cells	cell_type
.	O
Whereas	O
in	O
chronic	O
myelogenous	O
leukemia	O
(	O
CML	O
)	O
the	O
granulocytes	cell_type
(	O
PMN	cell_type
)	O
were	O
uniformly	O
of	O
monoclonal	O
origin,	O
a	O
striking	O
heterogeneity	O
of	O
clonal	O
development	O
was	O
found	O
in	O
PMN	cell_type
from	O
patients	O
with	O
other	O
MPD	O
,	O
with	O
up	O
to	O
50%	O
of	O
them	O
expressing	O
a	O
polyclonal	O
pattern	O
of	O
X	O
inactivation	O
.	O

CD80	protein
and	O
CD86	protein
are	O
not	O
equivalent	O
in	O
their	O
ability	O
to	O
induce	O
the	O
tyrosine	O
phosphorylation	O
of	O
CD28	protein
.	O
Ligation	O
of	O
either	O
CD80	protein
(	O
B7-1	protein
)	O
or	O
CD86	protein
(	O
B7-2	protein
),	O
two	O
principal	O
ligands	O
for	O
CD28	protein
,	O
is	O
thought	O
to	O
skew	O
the	O
immune	O
response	O
toward	O
Th1	O
or	O
Th2	O
differentiation	O
.	O
We	O
have	O
examined	O
early	O
signal	O
transduction	O
pathways	O
recruited	O
following	O
T	O
cell	O
stimulation	O
with	O
either	O
CD80	protein
or	O
CD86	protein
.	O
Purified	cell_line
human	cell_line
peripheral	cell_line
T	cell_line
cells	cell_line
or	O
Jurkat	cell_line
T	cell_line
cells	cell_line
were	O
stimulated	O
with	O
Chinese	O
hamster	O
ovary	O
(CHO)	O
cells	O
expressing	O
either	O
human	protein
CD80	protein
(	O
CHO-CD80	protein
)	O
or	O
human	protein
CD86	protein
(	O
CHO-CD86	protein
)	O
or	O
with	O
anti-	protein
CD28	protein
monoclonal	protein
antibody	protein
(mAb).	O
In	O
the	O
presence	O
of	O
phorbol	O
12-myristate	O
13-acetate	O
,	O
both	O
CHO-CD80	protein
and	O
CHO-CD86	protein
,	O
like	O
anti-CD28	protein
mAb	protein
,	O
were	O
capable	O
of	O
stimulating	O
cytokine	protein
production	O
from	O
both	O
human	cell_type
peripheral	cell_type
T	cell_type
cells	cell_type
and	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
Both	O
CHO-CD80	protein
and	O
CHO-CD86	protein
,	O
in	O
the	O
presence	O
of	O
anti-CD3	protein
mAb	protein
,	O
costimulated	O
NFAT	protein
-dependent	O
transcriptional	O
activation	O
.	O
Several	O
intracellular	O
signaling	protein
proteins	protein
,	O
such	O
as	O
CBL	protein
and	O
VAV	protein
,	O
were	O
phosphorylated	O
on	O
tyrosine	O
in	O
response	O
to	O
CD80	protein
,	O
CD86	protein
,	O
and	O
anti-CD28	protein
mAb	protein
.	O
Surprisingly,	O
although	O
stimulation	O
of	O
Jurkat	cell_line
T	cell_line
cells	cell_line
with	O
either	O
CHO-CD80	protein
or	O
anti-CD28	protein
mAb	protein
resulted	O
in	O
robust	O
tyrosine	O
phosphorylation	O
of	O
CD28	protein
itself,	O
ligation	O
with	O
CHO-CD86	protein
was	O
unable	O
to	O
induce	O
detectable	O
CD28	protein
tyrosyl	O
phosphorylation	O
over	O
a	O
range	O
of	O
stimulation	O
conditions.	O
In	O
addition,	O
the	O
association	O
of	O
phosphoinositide	protein
3-kinase	protein
with	O
CD28	protein
and	O
enhanced	O
tyrosine	O
phosphorylation	O
of	O
phospholipase	O
Cgamma	O
were	O
seen	O
after	O
anti-CD28	O
mAb	O
and	O
CHO-CD80	O
stimulation	O
but	O
to	O
a	O
much	O
lesser	O
extent	O
after	O
CHO-CD86	protein
stimulation.	O
Thus,	O
ligation	O
of	O
CD28	protein
with	O
either	O
CD80	protein
or	O
CD86	protein
leads	O
to	O
shared	O
early	O
signal	O
transduction	O
events	O
such	O
as	O
the	O
tyrosine	O
phosphorylation	O
of	O
CBL	protein
and	O
VAV	protein
,	O
to	O
NFAT	protein
-mediated	O
transcriptional	O
activation,	O
and	O
to	O
the	O
costimulation	O
of	O
interleukin-2	protein
and	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
production	O
.	O
However,	O
CD80	protein
and	O
CD86	protein
also	O
induce	O
distinct	O
signal	O
transduction	O
pathways	O
including	O
the	O
tyrosine	O
phosphorylation	O
of	O
CD28	protein
and	O
phospholipase	protein
Cgamma1	protein
and	O
the	O
SH2	protein
-dependent	O
association	O
of	O
phosphoinositide	protein
3-kinase	protein
with	O
CD28	protein
.	O
These	O
quantitative,	O
if	O
not	O
qualitative,	O
differences	O
between	O
signaling	O
initiated	O
by	O
these	O
two	O
ligands	O
for	O
CD28	protein
may	O
contribute	O
to	O
functional	O
differences	O
(e.g.	O
Th1	O
or	O
Th2	O
differentiation	O
)	O
in	O
T	O
cell	O
responses	O
.	O

Binding	O
of	O
HMG-I(Y)	protein
elicits	O
structural	O
changes	O
in	O
a	O
silencer	O
of	O
the	O
human	DNA
beta-globin	DNA
gene	DNA
.	O
Proteins	O
involved	O
in	O
repression	O
of	O
the	O
human	DNA
beta-globin	DNA
gene	DNA
may	O
be	O
useful	O
in	O
the	O
treatment	O
of	O
sickle	O
cell	O
anemia	O
,	O
in	O
conjunction	O
with	O
therapy	O
to	O
reactivate	O
fetal	DNA
globin	DNA
genes	DNA
.	O
If	O
there	O
is	O
a	O
reciprocal	O
elevation	O
of	O
gamma-globin	protein
expression	O
upon	O
repression,	O
this	O
approach	O
could	O
be	O
useful	O
in	O
additional	O
hemoglobinopathies	O
.	O
We	O
previously	O
showed	O
that	O
repression	O
of	O
the	O
beta-globin	O
gene	O
appears	O
to	O
be	O
mediated	O
through	O
two	O
DNA	DNA
sequences	DNA
,	O
silencers	O
I	O
and	O
II	O
,	O
and	O
identified	O
a	O
protein	O
termed	O
BP1	protein
which	O
binds	O
to	O
both	O
silencer	O
sequences.	O
In	O
this	O
study,	O
we	O
cloned	O
two	O
cDNAs	DNA
encoding	O
proteins	O
which	O
bind	O
to	O
an	O
oligonucleotide	O
in	O
silencer	DNA
I	DNA
containing	O
a	O
BP1	protein
binding	O
site.	O
These	O
cDNAs	DNA
correspond	O
to	O
HMG-I	protein
and	O
HMG-Y	protein
,	O
isoforms	O
regarded	O
as	O
architectural	protein
proteins	protein
.	O
We	O
demonstrate	O
that	O
binding	O
of	O
HMG-I(Y)	protein
to	O
this	O
oligonucleotide	O
causes	O
bending/flexure	O
of	O
the	O
DNA.	O
HMG-I(Y)	protein
also	O
binds	O
to	O
a	O
second	O
oligonucleotide	O
containing	O
a	O
BP1	DNA
binding	DNA
site	DNA
located	O
in	O
a	O
negative	DNA
control	DNA
region	DNA
upstream	O
of	O
the	O
delta-globin	DNA
gene	DNA
,	O
suggesting	O
a	O
role	O
for	O
HMG-I(Y)	protein
in	O
repression	O
of	O
adult	O
globin	O
genes.	O
Expression	O
studies	O
revealed	O
that	O
HMG-I(Y)	protein
is	O
ubiquitously	O
expressed	O
in	O
human	O
tissues	O
that	O
do	O
not	O
express	O
beta-globin	protein
,	O
being	O
present	O
in	O
48	O
of	O
50	O
tissues	O
and	O
six	O
hematopoietic	cell_line
cell	cell_line
lines	cell_line
examined.	O
Furthermore,	O
HMG-I(Y)	protein
expression	O
is	O
down-regulated	O
during	O
differentiation	O
of	O
primary	cell_type
erythroid	cell_type
cells	cell_type
.	O
We	O
present	O
a	O
model	O
in	O
which	O
HMG-I(Y)	protein
alters	O
DNA	O
conformation	O
to	O
allow	O
binding	O
of	O
repressor	protein
proteins	protein
,	O
and	O
in	O
which	O
the	O
relative	O
amount	O
of	O
HMG-I(Y)	O
helps	O
to	O
determine	O
the	O
repressive	O
state	O
of	O
the	O
beta-globin	DNA
gene	DNA
.	O

Interactions	O
between	O
the	O
class	protein
II	protein
transactivator	protein
and	O
CREB	protein
binding	protein
protein	protein
increase	O
transcription	O
of	O
major	DNA
histocompatibility	DNA
complex	DNA
class	DNA
II	DNA
genes	DNA
.	O
Class	DNA
II	DNA
major	DNA
histocompatibility	DNA
(class	DNA
II)	DNA
genes	DNA
are	O
regulated	O
in	O
a	O
B-cell-specific	O
and	O
gamma	O
interferon-inducible	O
fashion	O
.	O
The	O
master	O
switch	O
for	O
the	O
expression	O
of	O
these	O
genes	O
is	O
the	O
class	protein
II	protein
transactivator	protein
(	O
CIITA	protein
).	O
In	O
this	O
report,	O
we	O
demonstrate	O
that	O
one	O
of	O
the	O
functions	O
of	O
CIITA	protein
is	O
to	O
recruit	O
the	O
CREB	protein
binding	protein
protein	protein
(	O
CBP	protein
)	O
to	O
class	DNA
II	DNA
promoters	DNA
.	O
Not	O
only	O
functional	O
but	O
also	O
specific	O
binding	O
interactions	O
between	O
CIITA	protein
and	O
CBP	protein
were	O
demonstrated.	O
Moreover,	O
a	O
dominant	O
negative	O
form	O
of	O
CBP	protein
decreased	O
the	O
activity	O
of	O
class	DNA
II	DNA
promoters	DNA
and	O
levels	O
of	O
class	protein
II	protein
determinants	protein
on	O
the	O
surface	O
of	O
cells	O
.	O
Finally,	O
the	O
inhibition	O
of	O
class	DNA
II	DNA
gene	DNA
expression	O
by	O
the	O
glucocorticoid	O
hormone	O
could	O
be	O
attributed	O
to	O
the	O
squelching	O
of	O
CBP	protein
by	O
the	O
glucocorticoid	protein
receptor	protein
.	O
We	O
conclude	O
that	O
CBP	protein
,	O
a	O
histone	protein
acetyltransferase	protein
,	O
plays	O
an	O
important	O
role	O
in	O
the	O
transcription	O
of	O
class	DNA
II	DNA
genes	DNA
.	O

Role	O
of	O
cyclic	protein
AMP	protein
response	protein
element-binding	protein
protein	protein
in	O
cyclic	O
AMP	O
inhibition	O
of	O
NF-kappaB	protein
-mediated	O
transcription	O
.	O
The	O
NF-kappaB	protein
family	O
of	O
transcription	O
factors	O
regulates	O
the	O
inducible	O
expression	O
of	O
a	O
variety	O
of	O
genes.	O
Recently,	O
we	O
showed	O
that	O
elevation	O
of	O
intracellular	O
cyclic	O
AMP	O
inhibits	O
NF-kappaB	protein
-mediated	O
transcription	O
in	O
human	cell_type
monocytes	cell_type
and	O
endothelial	cell_type
cells	cell_type
without	O
preventing	O
nuclear	O
translocation	O
of	O
NF-kappaB	protein
complexes	protein
.	O
The	O
present	O
study	O
examined	O
the	O
molecular	O
mechanism	O
of	O
this	O
inhibition.	O
We	O
hypothesized	O
that	O
activation	O
of	O
the	O
protein	protein
kinase	protein
A	protein
signaling	O
pathway	O
may	O
inhibit	O
NF-kappaB	protein
-mediated	O
transcription	O
by	O
phosphorylating	O
proteins,	O
such	O
as	O
cAMP	protein
response	protein
element-binding	protein
protein	protein
(	O
CREB	protein
),	O
which	O
compete	O
for	O
limiting	O
amounts	O
of	O
the	O
coactivator	O
CBP	protein
.	O
Here,	O
we	O
show	O
that	O
the	O
amino-terminal	protein
region	protein
(	O
amino	protein
acids	protein
1-450	protein
)	O
of	O
CBP	protein
specifically	O
interacts	O
with	O
the	O
carboxyl-terminal	protein
region	protein
(	O
amino	protein
acids	protein
286-551	protein
)	O
of	O
NF-kappaB	protein
p65	protein
(	O
RelA	protein
)	O
both	O
in	O
vitro	O
and	O
in	O
vivo.	O
Functional	O
studies	O
using	O
human	O
endothelial	cell_type
cells	cell_type
demonstrated	O
that	O
overexpression	O
of	O
CBP	protein
rescued	O
cAMP	O
inhibition	O
of	O
NF-kappaB	protein
-mediated	O
transcription	O
and	O
transcription	O
mediated	O
by	O
a	O
chimeric	protein
protein	protein
,	O
GAL4-p65(286-551)	protein
,	O
which	O
contained	O
the	O
GAL4	protein
DNA	protein
binding	protein
domain	protein
fused	O
to	O
the	O
carboxyl-terminal	protein
region	protein
of	O
p65	protein
(	O
amino	protein
acids	protein
286-551	protein
).	O
In	O
contrast,	O
overexpression	O
of	O
CREB	protein
inhibited	O
GAL4	protein
-p65(286-551)-mediated	O
transcription	O
.	O
These	O
results	O
suggest	O
that	O
activation	O
of	O
the	O
protein	protein
kinase	protein
A	protein
pathway	O
inhibits	O
NF-kappaB	protein
transcription	O
by	O
phosphorylating	O
CREB	protein
,	O
which	O
competes	O
with	O
p65	protein
for	O
limiting	O
amounts	O
of	O
CBP	protein
.	O

Glucocorticoid	protein
receptors	protein
in	O
cord	cell_type
blood	cell_type
lymphocytes	cell_type
of	O
healthy	O
neonates	O
and	O
of	O
preterms	O
suffering	O
from	O
respiratory	O
distress	O
syndrome	O
.	O
We	O
measured	O
the	O
number	O
of	O
glucocorticoid	protein
receptors	protein
(	O
GR	protein
)	O
in	O
cord	cell_type
blood	cell_type
lymphocytes	cell_type
and	O
the	O
binding	O
affinity	O
(Kd)	O
in	O
15	O
term	O
and	O
in	O
20	O
preterm	O
babies	O
.	O
Thirteen	O
preterms	O
of	O
the	O
latter	O
group	O
received	O
prenatal	O
steroid	O
treatment	O
.	O
Seven	O
preterms	O
developed	O
neonatal	O
respiratory	O
distress	O
syndrome	O
(	O
NRDS	O
).	O
The	O
number	O
of	O
GR	protein
and	O
the	O
Kd	O
were	O
similar	O
in	O
the	O
term	O
and	O
preterm	O
(with	O
and	O
without	O
NRDS	O
)	O
babies	O
.	O
The	O
maximum	O
(3H)-thymidine	O
incorporation	O
into	O
DNA	O
of	O
cord	cell_type
blood	cell_type
lymphocytes	cell_type
from	O
all	O
preterms	O
,	O
with	O
or	O
without	O
NRDS	O
was	O
suppressed	O
when	O
compared	O
to	O
that	O
from	O
term	O
babies	O
or	O
adults.	O
This	O
could	O
partly	O
be	O
explained	O
by	O
the	O
antenatal	O
steroid	O
treatment	O
.	O
Sensitivity	O
(ID50)	O
of	O
the	O
lymphocytes	cell_type
for	O
the	O
inhibitory	O
effect	O
of	O
dexamethasone	O
was	O
the	O
same	O
in	O
all	O
groups.	O
In	O
this	O
study	O
on	O
the	O
number	O
and	O
function	O
of	O
GR	protein
in	O
lymphocytes	cell_type
,	O
we	O
were	O
unable	O
to	O
find	O
a	O
relation	O
between	O
the	O
functionality	O
of	O
the	O
GR	protein
and	O
the	O
development	O
of	O
NRDS	O
.	O

Inefficient	O
termination	O
of	O
antigen	O
responses	O
in	O
NF-ATp	protein
-deficient	O
mice	O
.	O
In	O
order	O
to	O
elucidate	O
the	O
role	O
of	O
NF-ATp	protein
,	O
one	O
of	O
the	O
most	O
prominent	O
members	O
of	O
family	O
of	O
NF-AT	protein
transcription	protein
factors	protein
in	O
peripheral	cell_type
T	cell_type
lymphocytes	cell_type
,	O
in	O
T	O
cell	O
activation	O
and	O
differentiation	O
we	O
created	O
NF-ATp	protein
-deficient	O
mice	O
by	O
gene	O
targeting	O
.	O
Such	O
NF-ATp	protein
-/-	O
mice	O
are	O
born	O
and	O
appear	O
to	O
develop	O
a	O
normal	O
immune	O
system	O
.	O
Apart	O
from	O
clear-cut	O
defects	O
in	O
the	O
synthesis	O
of	O
mRNAs	RNA
for	O
Th2-type	protein
lymphokines	protein
,	O
such	O
as	O
IL-4	protein
,	O
IL-5	protein
,	O
IL-10	protein
and	O
IL-13	protein
,	O
in	O
primary	O
and	O
secondary	O
stimulations	O
of	O
spleen	cell_type
cells	cell_type
in	O
vitro,	O
of	O
a	O
distinct	O
impaired	O
deletion	O
of	O
V	cell_line
beta	cell_line
11+/CD4+	cell_line
T	cell_line
lymphocytes	cell_line
from	O
these	O
mice	O
was	O
detected	O
after	O
superantigen	O
injection.	O
Moreover,	O
NF-ATp	protein
-/-	O
mice	O
older	O
than	O
6	O
weeks	O
show	O
an	O
2-5	O
fold	O
increase	O
in	O
number	O
of	O
lymphocytes	cell_type
.	O
This	O
is	O
correlated	O
with	O
an	O
increased	O
expression	O
of	O
activation	protein
markers	protein
CD44	protein
and	O
CD69	protein
and	O
decreased	O
expression	O
of	O
CD62	protein
.	O

AML	O
and	O
Ets	O
proteins	O
regulate	O
the	O
I	DNA
alpha1	DNA
germ-line	DNA
promoter	DNA
.	O
The	O
immunoglobulin	protein
heavy	protein
chain	protein
(	O
IgH	protein
)	O
class	O
switch	O
recombination	O
of	O
B	cell_type
lymphocytes	cell_type
preferentially	O
targets	O
unrearranged	O
IgH	DNA
genes	DNA
that	O
have	O
already	O
been	O
rendered	O
transcriptionally	O
active	O
.	O
Transcription	O
of	O
the	O
germ-line	DNA
IgH	DNA
genes	DNA
is	O
controlled	O
by	O
intervening	DNA
(I)	DNA
regions	DNA
upstream	O
of	O
their	O
switch	O
regions.	O
The	O
I	O
alpha1	O
promoter	O
activates	O
transcription	O
of	O
the	O
human	DNA
germ-line	DNA
C	DNA
alpha1	DNA
gene	DNA
for	O
IgA1	protein
and	O
mediates	O
the	O
transforming	protein
growth	protein
factor	protein
(TGF)-beta1	protein
responsiveness	O
of	O
this	O
locus.	O
Here	O
we	O
show	O
that	O
the	O
I	O
alpha1	O
promoter	O
contains	O
several	O
binding	O
sites	O
for	O
the	O
AML	protein
/PEBP2/CBF	protein
family	protein
of	protein
transcription	protein
factors	protein
and	O
that	O
AML	O
and	O
Ets	O
proteins	O
are	O
major	O
regulators	O
of	O
the	O
basal	O
and	O
TGF-beta-inducible	O
promoter	O
activity	O
.	O
Our	O
data	O
constitute	O
a	O
starting	O
point	O
for	O
studies	O
to	O
elucidate	O
the	O
molecular	O
mechanism	O
by	O
which	O
TGF-beta	protein
regulates	O
IgA	protein
production	O
.	O

Daidzein	O
and	O
genistein	O
glucuronides	O
in	O
vitro	O
are	O
weakly	O
estrogenic	O
and	O
activate	O
human	cell_type
natural	cell_type
killer	cell_type
cells	cell_type
at	O
nutritionally	O
relevant	O
concentrations.	O
Daidzein	O
and	O
genistein	O
glucuronides	O
(	O
DG	O
and	O
GG	O
),	O
major	O
isoflavone	O
metabolites	O
,	O
may	O
be	O
partly	O
responsible	O
for	O
biological	O
effects	O
of	O
isoflavones	O
,	O
such	O
as	O
estrogen	O
receptor	O
binding	O
and	O
natural	cell_type
killer	cell_type
cell	cell_type
(NK)	O
activation	O
or	O
inhibition	O
.	O
DG	O
and	O
GG	O
were	O
synthesized	O
using	O
3-methylcholanthrene	O
-induced	O
rat	O
liver	O
microsomes	O
.	O
The	O
Km	O
and	O
Vmax	O
for	O
daidzein	O
and	O
genistein	O
were	O
9.0	O
and	O
7.7	O
micromol/L,	O
and	O
0.7	O
and	O
1.6	O
micromol/(mg	O
protein.	O
min),	O
respectively.	O
The	O
absence	O
of	O
ultraviolet	O
absorbance	O
maxima	O
shifts	O
in	O
the	O
presence	O
of	O
sodium	O
acetate	O
confirmed	O
that	O
the	O
synthesized	O
products	O
were	O
7-O-	O
glucuronides	O
.	O
DG	O
and	O
GG	O
were	O
further	O
purified	O
by	O
a	O
Sephadex	O
LH-20	O
column	O
.	O
DG	O
and	O
GG	O
competed	O
with	O
the	O
binding	O
of	O
17beta-(3H)	O
estradiol	O
to	O
estrogen	protein
receptors	protein
of	O
B6D2F1	O
mouse	O
uterine	O
cytosol	O
.	O
The	O
concentrations	O
required	O
for	O
50%	O
displacement	O
of	O
17beta-(3H)	O
estradiol	O
(CB50)	O
were:	O
17beta-estradiol	O
,	O
1.34	O
nmol/L;	O
diethylstilbestrol	O
,	O
1.46	O
nmol/L;	O
daidzein	O
,	O
1.6	O
micromol/L;	O
DG	O
,	O
14.7	O
micromol/L;	O
genistein	O
,	O
0.154	O
micromol/L;	O
GG	O
,	O
7.27	O
micromol/L.	O
In	O
human	cell_type
peripheral	cell_type
blood	cell_type
NK	cell_type
cells	cell_type
,	O
genistein	O
at	O
&lt;0.5	O
micromol/L	O
and	O
DG	O
and	O
GG	O
at	O
0.1-10	O
micromol/L	O
enhanced	O
NK	O
cell-mediated	O
K562	cell_line
cancer	cell_line
cell	cell_line
killing	O
significantly	O
(P	O
&lt;	O
0.05).	O
At	O
&gt;	O
0.5	O
micromol/L,	O
genistein	O
inhibited	O
NK	O
cytotoxicity	O
significantly	O
(P	O
&lt;	O
0.05).	O
The	O
glucuronides	O
only	O
inhibited	O
NK	O
cytotoxicity	O
at	O
50	O
micromol/L.	O
Isoflavones,	O
and	O
especially	O
the	O
isoflavone	O
glucuronides	O
,	O
enhanced	O
activation	O
of	O
NK	cell_type
cells	cell_type
by	O
interleukin-2	protein
(	O
IL-2	protein
),	O
additively.	O
At	O
physiological	O
concentrations,	O
DG	O
and	O
GG	O
were	O
weakly	O
estrogenic,	O
and	O
they	O
activated	O
human	cell_type
NK	cell_type
cells	cell_type
in	O
nutritionally	O
relevant	O
concentrations	O
in	O
vitro,	O
probably	O
at	O
a	O
site	O
different	O
from	O
IL-2	protein
action	O
.	O

Cross-linking	O
of	O
CD44	protein
on	O
rheumatoid	cell_type
synovial	cell_type
cells	cell_type
up-regulates	O
VCAM-1	protein
.	O
CD44	O
is	O
a	O
ubiquitous	O
molecule	O
also	O
known	O
as	O
hyaluronic	O
acid	O
or	O
homing	O
receptor	O
.	O
However,	O
the	O
cellular	O
functions	O
and	O
its	O
role	O
in	O
inflammation,	O
for	O
example,	O
rheumatoid	O
synovitis,	O
are	O
currently	O
unknown.	O
In	O
this	O
study,	O
we	O
propose	O
a	O
novel	O
function	O
for	O
CD44	O
.	O
Using	O
synovial	O
cells	O
from	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
patients	O
,	O
we	O
demonstrated	O
that	O
CD44	O
cross-linking	O
and	O
binding	O
to	O
hyaluronan	O
augmented	O
VCAM-1	protein
expression	O
and	O
subsequently	O
VCAM-1	protein
-mediated	O
cell	O
adhesion	O
.	O
Briefly,	O
we	O
found	O
that	O
1)	O
rheumatoid	cell_type
synovial	cell_type
cells	cell_type
highly	O
expressed	O
CD44	protein
;	O
2)	O
cross-linking	O
of	O
CD44	protein
markedly	O
but	O
transiently	O
augmented	O
VCAM-1	protein
expression	O
and	O
its	O
mRNA	O
transcription	O
much	O
more	O
than	O
did	O
IL-1beta	protein
and	O
TNF-alpha;	O
3)	O
hyaluronan	O
,	O
especially	O
when	O
fragmented,	O
also	O
up-regulated	O
VCAM-1	protein
;	O
4)	O
CD44	protein
activated	O
the	O
transcription	O
factor	O
AP-1;	O
and	O
5)	O
the	O
integrin	protein
-dependent	O
adhesive	O
function	O
of	O
RA	cell_type
synovial	cell_type
cells	cell_type
to	O
T	cell_type
cells	cell_type
was	O
also	O
amplified	O
by	O
CD44	protein
cross-linking	O
.	O
These	O
results	O
indicate	O
that	O
the	O
adhesion	O
of	O
RA	cell_type
synovial	cell_type
cells	cell_type
to	O
matrices	O
such	O
as	O
hyaluronic	O
acid	O
through	O
CD44	protein
could	O
up-regulate	O
VCAM-1	protein
expression	O
and	O
VCAM-1	protein
-mediated	O
adhesion	O
to	O
T	cell_type
cells	cell_type
,	O
which	O
might	O
in	O
turn	O
cause	O
activation	O
of	O
T	cell_type
cells	cell_type
and	O
synovial	cell_type
cells	cell_type
in	O
RA	O
synovitis	O
.	O
We	O
therefore	O
propose	O
that	O
such	O
cross-talking	O
among	O
distinct	O
adhesion	O
molecules	O
may	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
inflammation	O
,	O
including	O
RA	O
synovitis	O
.	O

NF-kappaB	protein
activation	O
is	O
a	O
critical	O
regulator	O
of	O
human	O
granulocyte	O
apoptosis	O
in	O
vitro.	O
During	O
beneficial	O
inflammation	O
,	O
potentially	O
tissue-damaging	cell_type
granulocytes	cell_type
undergo	O
apoptosis	O
before	O
being	O
cleared	O
by	O
phagocytes	O
in	O
a	O
non-phlogistic	O
manner	O
.	O
Here	O
we	O
show	O
that	O
the	O
rate	O
of	O
constitutive	O
apoptosis	O
in	O
human	cell_type
neutrophils	cell_type
and	O
eosinophils	cell_type
is	O
greatly	O
accelerated	O
in	O
both	O
a	O
rapid	O
and	O
concentration-dependent	O
manner	O
by	O
the	O
fungal	O
metabolite	O
gliotoxin	O
,	O
but	O
not	O
by	O
its	O
inactive	O
analog	O
methylthiogliotoxin	O
.	O
This	O
induction	O
of	O
apoptosis	O
was	O
abolished	O
by	O
the	O
caspase	O
inhibitor	O
zVAD-fmk	O
,	O
correlated	O
with	O
the	O
inhibition	O
of	O
nuclear	protein
factor-kappa	protein
B	protein
(	O
NF-kappaB	protein
),	O
and	O
was	O
mimicked	O
by	O
a	O
cell	O
permeable	O
inhibitory	O
peptide	O
of	O
NF-kappaB	protein
,	O
SN-50	O
;	O
other	O
NF-kappaB	protein
inhibitors	O
,	O
curcumin	O
and	O
pyrrolidine	O
dithiocarbamate	O
;	O
and	O
the	O
proteasome	O
inhibitor	O
,	O
MG-132	O
.	O
Gliotoxin	O
also	O
augmented	O
dramatically	O
the	O
early	O
(2-6	O
h)	O
pro-apoptotic	O
effects	O
of	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
)	O
in	O
neutrophils	cell_type
and	O
unmasked	O
the	O
ability	O
of	O
TNF-alpha	protein
to	O
induce	O
eosinophil	cell_type
apoptosis	O
.	O
In	O
neutrophils	cell_type
,	O
TNF-alpha	protein
caused	O
a	O
gliotoxin	O
-inhibitable	O
activation	O
of	O
an	O
inducible	O
form	O
of	O
NF-kappaB	protein
,	O
a	O
response	O
that	O
may	O
underlie	O
the	O
ability	O
of	O
TNF-alpha	protein
to	O
delay	O
apoptosis	O
at	O
later	O
times	O
(12-24	O
h)	O
and	O
limit	O
its	O
early	O
killing	O
effect	O
.	O
Furthermore,	O
cycloheximide	O
displayed	O
a	O
similar	O
capacity	O
to	O
enhance	O
TNF-alpha	protein
induced	O
neutrophil	O
apoptosis	O
even	O
at	O
time	O
points	O
when	O
cycloheximide	O
alone	O
had	O
no	O
pro-apoptotic	O
effect,	O
suggesting	O
that	O
NF-kappaB	protein
may	O
regulate	O
the	O
production	O
of	O
protein(s)	O
which	O
protect	O
neutrophils	cell_type
from	O
the	O
cytotoxic	O
effects	O
of	O
TNF-alpha	protein
.	O
These	O
data	O
shed	O
light	O
on	O
the	O
biochemical	O
and	O
molecular	O
mechanisms	O
regulating	O
human	O
granulocyte	O
apoptosis	O
and,	O
in	O
particular,	O
indicate	O
that	O
the	O
transcription	protein
factor	protein
NF-kappaB	protein
plays	O
a	O
crucial	O
role	O
in	O
regulating	O
the	O
physiological	O
cell	O
death	O
pathway	O
in	O
granulocytes	cell_type
.	O

Role	O
of	O
Egr-2	protein
in	O
up-regulation	O
of	O
Fas	protein
ligand	protein
in	O
normal	O
T	cell_type
cells	cell_type
and	O
aberrant	O
double-negative	O
lpr	O
and	O
gld	O
T	O
cells	O
.	O
We	O
previously	O
identified	O
a	O
Fas	DNA
ligand	DNA
regulatory	DNA
element	DNA
(	O
FLRE	DNA
)	O
in	O
the	O
Fas	DNA
ligand	DNA
(fasL)	DNA
promoter	DNA
that	O
binds	O
Egr	protein
family	protein
proteins	protein
and	O
demonstrated	O
that	O
Egr-3	protein
(	O
PILOT	protein
)	O
but	O
not	O
Egr-1	protein
(	O
NGFI-A	protein
,	O
Krox-24	protein
,	O
Tis-8	protein
,	O
and	O
Zif-268	protein
)	O
induces	O
transcription	O
of	O
fasL	protein
.	O
The	O
aberrant	cell_type
CD4(-)CD8(-)	cell_type
T	cell_type
cells	cell_type
from	O
lpr/lpr	O
and	O
gld/gld	O
mice	O
,	O
which	O
have	O
mutations	O
in	O
the	O
genes	O
encoding	O
Fas	protein
and	O
FasL	protein
,	O
respectively,	O
have	O
an	O
activated	O
phenotype	O
and	O
constitutively	O
express	O
high	O
levels	O
of	O
fasL	RNA
mRNA	RNA
,	O
prompting	O
us	O
to	O
ask	O
what	O
role	O
if	O
any	O
the	O
FLRE	DNA
and	O
Egr	protein
family	protein
proteins	protein
have	O
in	O
this	O
aberrant	O
expression	O
of	O
fasL	protein
.	O
Unstimulated	O
MRL-lpr/lpr	O
and	O
C3H-gld/gld	O
CD4(-)CD8(-)	O
T	O
cells	O
constitutively	O
contained	O
high	O
levels	O
of	O
two	O
proteins	O
that	O
bound	O
to	O
the	O
FLRE	DNA
.	O
Supershift	O
analysis	O
revealed	O
these	O
proteins	O
to	O
be	O
Egr-1	protein
and	O
Egr-2	protein
(Krox-20);	O
Egr-3	protein
was	O
not	O
detected.	O
Activation	O
of	O
normal	cell_type
lymph	cell_type
node	cell_type
cells	cell_type
resulted	O
in	O
increased	O
expression	O
of	O
Egr	O
-1	O
,	O
-2	O
,	O
and	O
-3	O
.	O
As	O
with	O
egr-3	DNA
,	O
expression	O
of	O
egr-2	DNA
was	O
blocked	O
by	O
cyclosporin	O
A	O
.	O
Although	O
overexpressed	O
Egr-1	protein
was	O
ineffective,	O
overexpressed	O
Egr-2	protein
was	O
as	O
potent	O
as	O
Egr-3	protein
in	O
inducing	O
fasL	DNA
promoter-dependent	DNA
reporter	DNA
constructs	DNA
in	O
T	O
cell	O
hybridomas	O
and	O
HeLa	O
cells,	O
and	O
both	O
up-regulated	O
endogenous	O
fasL	RNA
mRNA	RNA
in	O
HeLa	cell_line
cells	cell_line
.	O
FasL	DNA
-dependent	DNA
reporter	DNA
constructs	DNA
in	O
MRL-lpr/lpr	O
and	O
C3H-gld/gld	O
CD4(-)CD8(-)	O
T	O
cells	O
were	O
constitutively	O
active,	O
and	O
this	O
activity	O
was	O
largely	O
prevented	O
by	O
mutation	O
of	O
the	O
critical	O
Egr	DNA
family	DNA
binding	DNA
element	DNA
.	O
Thus,	O
Egr-2	protein
,	O
in	O
addition	O
to	O
Egr-3	protein
,	O
regulates	O
FasL	protein
expression	O
in	O
activated	O
normal	O
T	cell_type
cells	cell_type
,	O
and	O
Egr-2	protein
is	O
likely	O
to	O
play	O
a	O
direct	O
role	O
in	O
aberrant	O
fasL	protein
up-regulation	O
in	O
lpr/lpr	O
and	O
gld/gld	O
CD4(-)CD8(-)	O
T	O
cells	O
.	O

The	O
activity	O
of	O
the	O
CCAAT-box	protein
binding	protein
factor	protein
NF-Y	protein
is	O
modulated	O
through	O
the	O
regulated	O
expression	O
of	O
its	O
A	protein
subunit	protein
during	O
monocyte	O
to	O
macrophage	O
differentiation	O
:	O
regulation	O
of	O
tissue-specific	DNA
genes	DNA
through	O
a	O
ubiquitous	O
transcription	protein
factor	protein
.	O
In	O
this	O
study,	O
we	O
analyzed	O
the	O
regulation	O
of	O
NF-Y	protein
expression	O
during	O
human	O
monocyte	O
to	O
macrophage	O
maturation	O
.	O
NF-Y	protein
is	O
a	O
ubiquitous	O
and	O
evolutionarily	O
conserved	O
transcription	protein
factor	protein
that	O
binds	O
specifically	O
to	O
the	O
CCAAT	DNA
motif	DNA
present	O
in	O
the	O
5'	DNA
promoter	DNA
region	DNA
of	O
a	O
wide	O
variety	O
of	O
genes.	O
We	O
show	O
here	O
that	O
in	O
circulating	cell_type
monocytes	cell_type
,	O
NF-Y	protein
binding	O
activity	O
is	O
not	O
detected	O
on	O
the	O
CCAAT	DNA
motif	DNA
present	O
in	O
the	O
promoters	DNA
of	DNA
genes	DNA
such	O
as	O
major	DNA
histocompatibility	DNA
complex	DNA
(MHC)	DNA
class	DNA
II	DNA
,	O
gp91-phox	DNA
,	O
mig	DNA
,	O
and	O
fibronectin,	O
whereas	O
during	O
macrophage	O
differentiation	O
,	O
a	O
progressive	O
increase	O
in	O
NF-Y	protein
binding	O
activity	O
is	O
observed	O
on	O
these	O
promoters.	O
Analysis	O
of	O
NF-Y	protein
subunit	O
expression	O
indicates	O
that	O
the	O
absence	O
of	O
NF-Y	protein
activity	O
in	O
circulating	cell_type
monocytes	cell_type
is	O
caused	O
by	O
a	O
lack	O
of	O
the	O
A	protein
subunit	protein
.	O
Furthermore,	O
addition	O
of	O
the	O
recombinant	O
NF-Y	protein
A	protein
subunit	protein
restores	O
NF-Y	protein
binding	O
.	O
We	O
show	O
that	O
the	O
lack	O
of	O
NF-YA	protein
protein	protein
is	O
due	O
to	O
posttranscriptional	O
regulation	O
and	O
not	O
to	O
a	O
specific	O
proteolytic	O
activity.	O
In	O
fact,	O
NF-YA	RNA
mRNA	RNA
is	O
present	O
at	O
the	O
same	O
level	O
at	O
all	O
days	O
of	O
monocyte	O
cultivation	O
,	O
whereas	O
the	O
protein	O
is	O
absent	O
in	O
freshly	cell_type
isolated	cell_type
monocytes	cell_type
but	O
is	O
progressively	O
synthesized	O
during	O
the	O
maturation	O
process	O
.	O
We	O
thus	O
conclude	O
that	O
the	O
NF-Y	protein
A	protein
subunit	protein
plays	O
a	O
relevant	O
role	O
in	O
activating	O
transcription	O
of	O
genes	O
highly	O
expressed	O
in	O
mature	cell_type
monocytes	cell_type
.	O
In	O
line	O
with	O
this	O
conclusion,	O
we	O
show	O
that	O
the	O
cut/CDP	protein
protein	protein
,	O
a	O
transcriptional	O
repressor	O
that	O
inhibits	O
gpc91-phox	DNA
gene	DNA
expression	O
by	O
preventing	O
NF-Y	protein
binding	O
to	O
the	O
CAAT	DNA
box	DNA
,	O
is	O
absent	O
in	O
monocytes	cell_type
.	O

Interdomain	protein
B	protein
in	O
ZAP-70	protein
regulates	O
but	O
is	O
not	O
required	O
for	O
ZAP-70	protein
signaling	O
function	O
in	O
lymphocytes	cell_type
.	O
The	O
protein	O
tyrosine	O
kinase	O
ZAP-70	protein
plays	O
an	O
important	O
role	O
in	O
T-cell	O
activation	O
and	O
development	O
.	O
After	O
T-cell	protein
receptor	protein
stimulation	O
,	O
ZAP-70	protein
associates	O
with	O
the	O
receptor	O
and	O
is	O
phosphorylated	O
on	O
many	O
tyrosines	O
,	O
including	O
Y292	O
,	O
Y315	O
,	O
and	O
Y319	O
within	O
interdomain	O
B.	O
Previously,	O
we	O
demonstrated	O
that	O
Y292	O
negatively	O
regulates	O
ZAP-70	protein
function	O
and	O
that	O
Y315	O
positively	O
regulates	O
ZAP-70	protein
function	O
by	O
interacting	O
with	O
Vav	protein
.	O
Recent	O
studies	O
have	O
suggested	O
that	O
Y319	O
also	O
positively	O
regulate	O
ZAP-70	protein
function	O
.	O
Paradoxically,	O
removal	O
of	O
interdomain	protein
B	protein
(to	O
create	O
the	O
construct	O
designated	O
Delta	protein
),	O
containing	O
the	O
Y292	O
,	O
Y315	O
,	O
and	O
Y319	O
sites,	O
did	O
not	O
eliminate	O
the	O
ability	O
of	O
ZAP-70	protein
to	O
induce	O
multiple	DNA
gene	DNA
reporters	DNA
in	O
Syk-deficient	cell_line
DT-40	cell_line
B	cell_line
cells	cell_line
and	O
ZAP-70	cell_line
/Syk-deficient	cell_line
Jurkat	cell_line
cells	cell_line
.	O
Here	O
we	O
show	O
that	O
Delta	protein
still	O
utilizes	O
the	O
same	O
pathways	O
as	O
wild-type	O
ZAP-70	protein
to	O
mediate	O
NF-AT	protein
induction	O
.	O
This	O
is	O
manifested	O
by	O
the	O
ability	O
of	O
Delta	protein
to	O
restore	O
induction	O
of	O
calcium	O
fluxes	O
and	O
mitogen-activated	protein
protein	protein
kinase	protein
activation	O
and	O
by	O
the	O
ability	O
of	O
dominant	O
negative	O
Ras	protein
and	O
FK506	protein
to	O
block	O
the	O
induction	O
of	O
NF-AT	protein
activity	O
mediated	O
by	O
Delta	protein
.	O
Biochemically	O
we	O
show	O
that	O
the	O
stimulated	O
tyrosine	O
phosphorylation	O
of	O
Vav	protein
,	O
Shc	protein
,	O
and	O
ZAP-70	protein
itself	O
is	O
diminished,	O
whereas	O
that	O
of	O
Slp-76	protein
is	O
increased	O
in	O
cells	O
reconstituted	O
with	O
Delta	protein
.	O
Deletion	O
of	O
interdomain	protein
B	protein
did	O
not	O
affect	O
the	O
ability	O
of	O
ZAP-70	protein
to	O
bind	O
to	O
the	O
receptor.	O
The	O
in	O
vitro	O
kinase	O
activity	O
of	O
ZAP-70	protein
lacking	O
interdomain	protein
B	protein
was	O
markedly	O
reduced,	O
but	O
the	O
kinase	O
activity	O
was	O
still	O
required	O
for	O
the	O
protein's	O
in	O
vivo	O
activity.	O
Based	O
on	O
these	O
data,	O
we	O
concluded	O
that	O
interdomain	protein
B	protein
regulates	O
but	O
is	O
not	O
required	O
for	O
ZAP-70	protein
signaling	O
function	O
leading	O
to	O
cellular	O
responses	O
.	O

Differential	O
induction	O
of	O
DNA-binding	protein
activities	protein
following	O
CD19	protein
cross-linking	O
in	O
human	cell_type
B	cell_type
lineage	cell_type
cells	cell_type
.	O
The	O
B	protein
cell-specific	protein
cell	protein
surface	protein
molecule	protein
CD19	protein
is	O
expressed	O
at	O
all	O
stages	O
of	O
B	O
cell	O
development	O
,	O
including	O
normal	O
plasma	O
cells,	O
and	O
mediates	O
signal	O
transduction	O
via	O
interaction	O
with	O
cytoplasmic	protein
effector	protein
proteins	protein
.	O
Cross-linking	O
CD19	protein
on	O
early	O
human	cell_type
B	cell_type
lineage	cell_type
cells	cell_type
induces	O
the	O
formation	O
of	O
a	O
CD19	protein
/Vav/phosphatidylinositol-3	protein
kinase	protein
complex	protein
,	O
tyrosine	O
phosphorylation	O
of	O
CD19	protein
and	O
Vav	protein
,	O
and	O
activation	O
of	O
the	O
Ras	protein
pathway	O
.	O
To	O
further	O
explore	O
the	O
ramifications	O
of	O
CD19	protein
signaling,	O
the	O
current	O
study	O
examined	O
whether	O
phosphorylation	O
of	O
Elk-1	protein
,	O
activation	O
of	O
activator	protein
protein-1	protein
(	O
AP-1	protein
),	O
or	O
activation	O
of	O
nuclear	O
factor-kappaB	O
(	O
NF-kappaB	protein
)	O
transcription	protein
factors	protein
occurred	O
following	O
CD19	protein
cross-linking	O
.	O
The	O
cells	O
used	O
were	O
the	O
BLIN-1	cell_line
pre-B	cell_line
cell	cell_line
line	cell_line
expressing	O
low	O
levels	O
of	O
cell	protein
surface	protein
mu	protein
heavy	protein
chain	protein
associated	O
with	O
surrogate	protein
light	protein
chain	protein
and	O
the	O
1E8	O
immature	O
B	O
cell	O
line	O
expressing	O
cell	protein
surface	protein
mu/kappa	protein
.	O
Lysates	O
from	O
CD19	protein
cross-linked	O
1E8	cell_line
cells	cell_line
induced	O
robust	O
phosphorylation	O
of	O
an	O
Elk-1	protein
fusion	protein
protein	protein
in	O
vitro,	O
whereas	O
no	O
phosphorylation	O
of	O
Elk-1	protein
fusion	protein
protein	protein
occurred	O
using	O
lysates	O
from	O
CD19	cell_line
cross-linked	cell_line
BLIN-1	cell_line
cells	cell_line
.	O
An	O
electrophoretic	O
mobility	O
shift	O
assay	O
employing	O
AP-1	protein
and	O
NF-kappaB	protein
consensus	O
oligonucleotides	O
was	O
used	O
to	O
demonstrate	O
that	O
AP-1	protein
-binding	O
activity	O
increased,	O
while	O
constitutive	O
NF-kappaB	protein
-binding	O
activity	O
was	O
not	O
enhanced,	O
following	O
2	O
h	O
of	O
CD19	protein
cross-linking	O
in	O
1E8	cell_line
cells	cell_line
.	O
Supershift	O
experiments	O
revealed	O
that	O
JunD	protein
and	O
c-Fos	protein
proteins	protein
mediated	O
anti-	O
CD19	protein
induced	O
AP-1	protein
-binding	O
activity	O
in	O
1E8	cell_line
cells	cell_line
.	O
In	O
contrast,	O
CD19	protein
cross-linking	O
in	O
BLIN-1	cell_line
cells	cell_line
resulted	O
in	O
the	O
induction	O
of	O
NF-kappaB	protein
,	O
but	O
had	O
no	O
apparent	O
effect	O
on	O
AP-1	protein
-binding	O
activity	O
.	O
These	O
data	O
suggest	O
that	O
CD19	protein
-mediated	O
signal	O
transduction	O
activates	O
different	O
transcription	protein
factors	protein
at	O
juxtaposed	O
stages	O
of	O
B	O
cell	O
development	O
that	O
may	O
culminate	O
in	O
the	O
activation	O
or	O
suppression	O
of	O
distinct	O
sets	O
of	O
genes	DNA
.	O

Oxidants,	O
transcription	protein
factors	protein
,	O
and	O
intestinal	O
inflammation	O
.	O
It	O
is	O
now	O
well	O
appreciated	O
that	O
chronic	O
gut	O
inflammation	O
is	O
characterized	O
by	O
enhanced	O
production	O
of	O
reactive	O
metabolites	O
of	O
oxygen	O
and	O
nitrogen	O
.	O
Some	O
of	O
these	O
oxidants	O
are	O
known	O
to	O
modulate	O
the	O
expression	O
of	O
a	O
variety	O
of	O
genes	O
that	O
are	O
involved	O
in	O
the	O
immune	O
and	O
inflammatory	O
responses	O
.	O
For	O
example,	O
certain	O
oxidants	O
are	O
known	O
to	O
activate	O
the	O
nuclear	protein
transcription	protein
factor	protein
kappa	protein
B	protein
,	O
which	O
regulates	O
the	O
expression	O
of	O
a	O
variety	O
of	O
different	O
adhesion	protein
molecules	protein
,	O
cytokines	protein
,	O
and	O
enzymes	protein
.	O
Oxidants	O
are	O
also	O
known	O
to	O
activate	O
another	O
transcription	protein
factor	protein
,	O
activator	protein
protein-1	protein
.	O
This	O
transcription	protein
factor	protein
is	O
composed	O
of	O
products	O
from	O
the	O
fos	protein
and	protein
jun	protein
proto-oncogene	protein
family	protein
and	O
is	O
believed	O
to	O
be	O
important	O
in	O
regulating	O
cell	O
growth	O
and	O
proliferation	O
.	O
Finally,	O
oxidants	O
are	O
believed	O
to	O
promote	O
intestinal	cell_type
epithelial	cell_type
cell	cell_type
apoptosis	O
,	O
and	O
the	O
B-cell	protein
lymphoma/leukemia-2	protein
gene	protein
product	protein
is	O
believed	O
to	O
inhibit	O
this	O
phenomenon	O
in	O
an	O
antioxidant-dependent	O
manner	O
.	O
Taken	O
together,	O
these	O
observations	O
suggest	O
that	O
nontoxic	O
concentrations	O
of	O
reactive	O
metabolites	O
of	O
oxygen	O
and	O
nitrogen	O
play	O
an	O
important	O
role	O
in	O
regulating	O
the	O
expression	O
of	O
genes	O
involved	O
in	O
the	O
inflammatory	O
response	O
and	O
in	O
modulating	O
apoptosis	O
.	O

Identification	O
of	O
target	DNA
genes	DNA
of	O
the	O
lymphoid-specific	protein
transcription	protein
factor	protein
Oct2	protein
.	O
The	O
Oct2	protein
transcription	protein
factor	protein
is	O
expressed	O
predominantly	O
in	O
B	cell_type
lymphocytes	cell_type
and	O
plays	O
an	O
essential	O
role	O
during	O
the	O
terminal	O
phase	O
of	O
B	O
cell	O
differentiation	O
.	O
The	O
regulatory	DNA
regions	DNA
of	O
several	O
genes	O
specifically	O
expressed	O
in	O
B	cell_type
cells	cell_type
contain	O
functional	DNA
binding	DNA
sites	DNA
for	O
Oct2	protein
.	O
Nevertheless,	O
none	O
of	O
the	O
genes	O
originally	O
thought	O
to	O
be	O
regulated	O
by	O
Oct2	protein
were	O
affected	O
in	O
their	O
expression	O
in	O
Oct2	cell_line
-deficient	cell_line
B	cell_line
cells	cell_line
.	O
In	O
an	O
attempt	O
to	O
find	O
such	O
elusive	O
Oct2	protein
target	DNA
genes	DNA
and	O
to	O
understand	O
the	O
molecular	O
function	O
of	O
Oct2	protein
in	O
B	O
cell	O
development	O
,	O
we	O
isolated	O
cDNAs	DNA
for	O
Oct2	protein
target	DNA
genes	DNA
.	O
So	O
far,	O
we	O
have	O
identified	O
five	O
potential	O
targets	O
for	O
Oct2	protein
:	O
the	O
membrane	protein
glycoprotein	protein
CD36	protein
,	O
the	O
cysteine-rich	protein
secreted	protein
protein	protein
3	protein
(	O
CRISP-3	protein
),	O
a	O
mouse	O
homolog	O
of	O
the	O
human	protein
monocyte/neutrophil	protein
elastase	protein
inhibitor	protein
(	O
mEI	protein
)	O
and	O
two	O
unknown	O
cDNA	DNA
sequences	DNA
Nov1	DNA
and	O
Nov2	DNA
.	O
These	O
target	DNA
genes	DNA
show	O
quite	O
distinct	O
expression	O
patterns	O
demonstrating	O
that	O
transcription	protein
factors	protein
in	O
addition	O
to	O
Oct2	protein
are	O
involved	O
in	O
their	O
regulation.	O
Whereas	O
CD36	protein
and	O
mEI	protein
were	O
expressed	O
in	O
all	O
hematopoetic	cell_line
cell	cell_line
lines	cell_line
containing	O
Oct2	protein
,.	O
CRISP-3	protein
is	O
pre-B	O
cell-specific	O
,	O
Nov1	DNA
is	O
plasma	O
B	O
cell-specific	O
and	O
Nov2	DNA
is	O
B	O
cell-specifically	O
expressed	O
.	O

RFX-B	DNA
is	O
the	O
gene	O
responsible	O
for	O
the	O
most	O
common	O
cause	O
of	O
the	O
bare	O
lymphocyte	O
syndrome	O
,	O
an	O
MHC	protein
class	protein
II	protein
immunodeficiency	O
[published	O
erratum	O
appears	O
in	O
Immunity	O
1999	O
Mar;10(3):399]	O
The	O
bare	O
lymphocyte	O
syndrome	O
(	O
BLS	O
)	O
is	O
characterized	O
by	O
the	O
absence	O
of	O
MHC	protein
class	protein
II	protein
transcription	O
and	O
humoral-	O
and	O
cellular-	O
mediated	O
immune	O
responses	O
to	O
foreign	O
antigens.	O
Three	O
of	O
the	O
four	O
BLS	O
genetic	O
complementation	O
groups	O
have	O
defects	O
in	O
the	O
activity	O
of	O
the	O
MHC	protein
class	protein
II	protein
transcription	protein
factor	protein
RFX	protein
.	O
We	O
have	O
purified	O
the	O
RFX	protein
complex	protein
and	O
sequenced	O
its	O
three	O
subunits.	O
The	O
sequence	O
of	O
the	O
smallest	O
subunit	O
describes	O
a	O
novel	O
gene,	O
termed	O
RFX-B	DNA
.	O
RFX-B	DNA
complements	O
the	O
predominant	O
BLS	protein
complementation	protein
group	protein
(	O
group	protein
B	protein
)	O
and	O
was	O
found	O
to	O
be	O
mutant	O
in	O
cell	cell_line
lines	cell_line
from	O
this	O
BLS	O
group	O
.	O
The	O
protein	O
has	O
no	O
known	O
DNA-binding	protein
domain	protein
but	O
does	O
contain	O
three	O
ankyrin	O
repeats	O
that	O
are	O
likely	O
to	O
be	O
important	O
in	O
protein-protein	O
interactions	O
.	O

Binding	O
of	O
c-Rel	protein
to	O
STAT5	DNA
target	DNA
sequences	DNA
in	O
HTLV-I-transformed	cell_type
T	cell_type
cells	cell_type
.	O
The	O
type	O
I	O
human	O
T-cell	O
leukemia	O
virus	O
(	O
HTLV-I	O
)	O
induces	O
abnormal	O
growth	O
and	O
subsequent	O
transformation	O
of	O
T	cell_type
cells	cell_type
,	O
which	O
is	O
associated	O
with	O
the	O
development	O
of	O
an	O
acute	O
T-cell	O
malignancy	O
termed	O
adult	O
T-cell	O
leukemia	O
.	O
A	O
characteristic	O
of	O
HTLV-I	cell_type
-transformed	cell_type
T	cell_type
cells	cell_type
is	O
the	O
constitutive	O
nuclear	O
expression	O
of	O
NF-kappaB/Rel	protein
family	protein
of	O
transcription	O
factors,	O
which	O
appears	O
to	O
be	O
essential	O
for	O
the	O
growth	O
of	O
these	O
transformed	cell_type
cells	cell_type
.	O
Although	O
NF-kappaB/Rel	protein
factors	protein
are	O
known	O
to	O
induce	O
the	O
expression	O
of	O
T-cell	protein
growth	protein
factor	protein
interleukin	protein
(IL)-2	protein
,	O
it	O
is	O
unclear	O
how	O
they	O
participate	O
in	O
the	O
IL-2	protein
-independent	O
growth	O
of	O
HTLV-I	cell_line
-transformed	cell_line
cells	cell_line
.	O
In	O
this	O
study,	O
we	O
show	O
that	O
certain	O
NF-kappaB/Rel	protein
members	protein
,	O
predominantly	O
c-Rel	protein
,	O
interact	O
with	O
enhancer	O
sequences	O
for	O
STAT5	protein
,	O
a	O
key	O
transcription	O
factor	O
mediating	O
IL-2	protein
-induced	O
T-cell	O
proliferation	O
.	O
Reporter	O
gene	O
assays	O
reveal	O
that	O
the	O
binding	O
of	O
c-Rel	protein
to	O
the	O
STAT5	protein
site	O
present	O
in	O
the	O
Fc	DNA
gammaR1	DNA
gene	DNA
leads	O
to	O
potent	O
transactivation	O
of	O
this	O
enhancer.	O
Binding	O
of	O
c-Rel	protein
to	O
the	O
Fc	DNA
gammaR1	DNA
STAT	DNA
site	DNA
also	O
occurs	O
in	O
human	O
peripheral	cell_type
blood	cell_type
T	cell_type
cells	cell_type
immortalized	O
with	O
HTLV-I	O
in	O
vitro	O
and	O
is	O
correlated	O
with	O
enhanced	O
levels	O
of	O
proliferation	O
of	O
these	O
cells.	O
These	O
results	O
raise	O
the	O
possibility	O
that	O
NF-kappaB/Rel	protein
may	O
participate	O
in	O
the	O
growth	O
control	O
of	O
HTLV-I	cell_line
-transformed	cell_line
T	cell_line
cells	cell_line
by	O
regulating	O
genes	O
driven	O
by	O
both	O
kappaB	DNA
and	O
certain	O
STAT	DNA
enhancers	DNA
.	O

Activation-dependent	O
transcriptional	O
regulation	O
of	O
the	O
human	DNA
Fas	DNA
promoter	DNA
requires	O
NF-kappaB	protein
p50-p65	protein
recruitment	O
.	O
Fas	protein
(	O
CD95	protein
)	O
and	O
Fas	protein
ligand	protein
(	O
CD95L	protein
)	O
are	O
an	O
interacting	O
receptor-ligand	protein
pair	protein
required	O
for	O
immune	O
homeostasis	O
.	O
Lymphocyte	O
activation	O
results	O
in	O
the	O
upregulation	O
of	O
Fas	protein
expression	O
and	O
the	O
acquisition	O
of	O
sensitivity	O
to	O
FasL	protein
-mediated	O
apoptosis	O
.	O
Although	O
Fas	O
upregulation	O
is	O
central	O
to	O
the	O
preservation	O
of	O
immunologic	O
tolerance,	O
little	O
is	O
known	O
about	O
the	O
molecular	O
machinery	O
underlying	O
this	O
process.	O
To	O
investigate	O
the	O
events	O
involved	O
in	O
activation-induced	O
Fas	protein
upregulation	O
,	O
we	O
have	O
examined	O
mRNA	O
accumulation	O
,	O
fas	O
promoter	O
activity	O
,	O
and	O
protein	O
expression	O
in	O
the	O
Jurkat	cell_line
T-cell	cell_line
line	cell_line
treated	O
with	O
phorbol	O
myristate	O
acetate	O
and	O
ionomycin	O
(	O
P/I	O
),	O
pharmacological	O
mimics	O
of	O
T-cell	protein
receptor	protein
activation	O
.	O
Although	O
resting	cell_line
Jurkat	cell_line
cells	cell_line
express	O
Fas	protein
,	O
Fas	RNA
mRNA	RNA
was	O
induced	O
approximately	O
10-fold	O
in	O
2	O
h	O
upon	O
P/I	O
stimulation.	O
Using	O
sequential	DNA
deletion	DNA
mutants	DNA
of	O
the	O
human	DNA
fas	DNA
promoter	DNA
in	O
transient	O
transfection	O
assays,	O
we	O
identified	O
a	O
47-bp	DNA
sequence	DNA
(	O
positions	DNA
-306	DNA
to	DNA
-260	DNA
relative	O
to	O
the	O
ATG	O
)	O
required	O
for	O
activation-driven	O
fas	O
upregulation	O
.	O
Sequence	O
analysis	O
revealed	O
the	O
presence	O
of	O
a	O
previously	O
unrecognized	DNA
composite	DNA
binding	DNA
site	DNA
for	O
both	O
the	O
Sp1	protein
and	O
NF-kappaB	protein
transcription	protein
factors	protein
at	O
positions	DNA
-295	DNA
to	DNA
-286	DNA
.	O
Electrophoretic	O
mobility	O
shift	O
assay	O
(	O
EMSA	O
)	O
and	O
supershift	O
analyses	O
of	O
this	O
region	O
documented	O
constitutive	O
binding	O
of	O
Sp1	protein
in	O
unactivated	O
nuclear	O
extracts	O
and	O
inducible	O
binding	O
of	O
p50-p65	protein
NF-kappaB	protein
heterodimers	protein
after	O
P/I	O
activation.	O
Sp1	protein
and	O
NF-kappaB	protein
transcription	O
factor	O
binding	O
was	O
shown	O
to	O
be	O
mutually	O
exclusive	O
by	O
EMSA	O
displacement	O
studies	O
with	O
purified	O
recombinant	O
Sp1	protein
and	O
recombinant	O
p50	protein
.	O
The	O
functional	O
contribution	O
of	O
the	O
kappaB-	DNA
Sp1	DNA
composite	DNA
site	DNA
in	O
P/I	DNA
-inducible	DNA
fas	DNA
promoter	DNA
activation	O
was	O
verified	O
by	O
using	O
kappaB-	O
Sp1	protein
concatamers	O
(	O
-295	DNA
to	DNA
-286	DNA
)	O
in	O
a	O
thymidine	DNA
kinase	DNA
promoter-driven	DNA
reporter	DNA
construct	DNA
and	O
native	DNA
promoter	DNA
constructs	DNA
in	O
Jurkat	cell_line
cells	cell_line
overexpressing	O
IkappaB-alpha	protein
.	O
Site-directed	O
mutagenesis	O
of	O
the	O
critical	O
guanine	O
nucleotides	O
in	O
the	O
kappaB-	DNA
Sp1	DNA
element	DNA
documented	O
the	O
essential	O
role	O
of	O
this	O
site	O
in	O
activation-dependent	O
fas	O
promoter	O
induction	O
.	O

Evidence	O
for	O
repression	O
of	O
IL-2	DNA
gene	DNA
activation	O
in	O
anergic	cell_type
T	cell_type
cells	cell_type
.	O
The	O
induction	O
of	O
clonal	O
anergy	O
in	O
a	O
T	O
cell	O
inhibits	O
IL-2	protein
secretion	O
because	O
of	O
the	O
development	O
of	O
a	O
proximal	O
signal	O
transduction	O
defect	O
.	O
Fusion	O
of	O
anergic	cell_type
murine	cell_type
T	cell_type
cells	cell_type
to	O
human	cell_type
Jurkat	cell_type
T	cell_type
leukemia	cell_type
cells	cell_type
and	O
formation	O
of	O
heterokaryons	cell_line
failed	O
to	O
result	O
in	O
a	O
complementation	O
of	O
this	O
signaling	O
defect	O
and	O
restoration	O
of	O
murine	RNA
IL-2	RNA
mRNA	RNA
inducibility.	O
Instead,	O
signal	O
transduction	O
to	O
the	O
human	O
IL-2	DNA
gene	DNA
became	O
disrupted.	O
Heterokaryons	cell_line
formed	O
by	O
the	O
fusion	O
of	O
anergic	cell_type
murine	cell_type
T	cell_type
cells	cell_type
to	O
normal	cell_type
murine	cell_type
T	cell_type
cells	cell_type
also	O
failed	O
to	O
accumulate	O
intracellular	protein
IL-2	protein
protein	protein
in	O
response	O
to	O
stimulation	O
either	O
with	O
the	O
combination	O
of	O
CD3	protein
and	O
CD28	protein
mAbs	protein
or	O
with	O
ionomycin	O
plus	O
a	O
protein	protein
kinase	protein
C	protein
-activating	O
phorbol	O
ester	O
.	O
The	O
results	O
argue	O
against	O
a	O
loss-of-function	O
signaling	O
defect	O
as	O
the	O
sole	O
basis	O
for	O
clonal	O
anergy	O
induction	O
and	O
document	O
the	O
presence	O
of	O
a	O
dominant-acting	protein
repressor	protein
molecule	protein
that	O
inhibits	O
signal	O
transduction	O
to	O
the	O
IL-2	DNA
gene	DNA
within	O
viable	O
anergic	cell_type
T	cell_type
cells	cell_type
.	O

Comparison	O
of	O
HTLV-I	O
basal	O
transcription	O
and	O
expression	O
of	O
CREB/ATF-1/CREM	protein
family	protein
members	protein
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
and	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
HTLV-I	O
is	O
the	O
etiologic	O
agent	O
of	O
adult	O
T-cell	O
leukemia	O
/lymphoma	O
and	O
is	O
associated	O
with	O
tropical	O
spastic	O
paraparesis/	O
HTLV-I	O
-associated	O
myelopathy	O
.	O
Following	O
integration	O
into	O
the	O
host	O
cell	O
genome	O
,	O
HTLV-I	O
replication	O
is	O
regulated	O
by	O
both	O
host	O
and	O
viral	O
mechanisms	O
that	O
control	O
transcription.	O
Low	O
levels	O
of	O
viral	O
transcription	O
(	O
basal	O
transcription	O
)	O
occur	O
before	O
expression	O
of	O
the	O
virally	protein
encoded	protein
Tax	protein
protein	protein
(	O
Tax	protein
-mediated	O
transcription	O
).	O
Members	O
of	O
the	O
cyclic	protein
adenosine	protein
monophosphate	protein
(	protein
cAMP	protein
)	protein
response	protein
element	protein
binding	protein
(CREB)/activating	protein
transcription	protein
factor	protein
1	protein
(	protein
ATF-1	protein
)	protein
family	protein
of	O
transcription	protein
factors	protein
bind	O
three	O
21-bp	DNA
repeats	DNA
(	O
Tax-responsive	DNA
element-1	DNA
,	O
or	O
TRE-1	DNA
)	O
within	O
the	O
viral	DNA
promoter	DNA
and	O
are	O
important	O
for	O
basal	O
and	O
Tax-mediated	O
transcription	O
.	O
Using	O
mitogen	O
stimulated	O
and	O
quiescent	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
)	O
and	O
Jurkat	cell_line
cells	cell_line
,	O
we	O
compared	O
differences	O
in	O
basal	O
transcription	O
and	O
amounts	O
and	O
binding	O
of	O
transcription	protein
factors	protein
with	O
TRE-1	DNA
.	O
We	O
demonstrate	O
that	O
amounts	O
of	O
transcriptionally	O
active	O
phosphorylated	protein
CREB	protein
protein	protein
(	O
P-CREB	protein
)	O
differ	O
between	O
activated	O
PBMC	cell_type
and	O
Jurkat	cell_line
cells	cell_line
.	O
Following	O
stimulation,	O
P-CREB	protein
levels	O
remain	O
elevated	O
in	O
PBMC	cell_type
for	O
up	O
to	O
24	O
hours	O
whereas	O
CREB	O
is	O
dephosphorylated	O
in	O
Jurkat	cell_line
cells	cell_line
within	O
4	O
hours	O
following	O
stimulation.	O
The	O
differences	O
in	O
P-CREB	protein
levels	O
between	O
PBMC	cell_type
and	O
Jurkat	cell_line
cells	cell_line
were	O
directly	O
correlated	O
with	O
basal	O
transcription	O
of	O
HTLV-I	O
in	O
the	O
two	O
cell	O
types.	O
Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
we	O
determined	O
that	O
the	O
pattern	O
of	O
band	O
migration	O
differed	O
between	O
the	O
two	O
cell	O
types.	O
These	O
data	O
demonstrate	O
that	O
PBMC	cell_type
differentially	O
regulate	O
basal	O
HTLV-I	O
transcription	O
compared	O
with	O
Jurkat	cell_line
T	cell_line
cells	cell_line
,	O
and	O
this	O
differential	O
regulation	O
is	O
due,	O
in	O
part	O
to	O
differential	O
phosphorylation	O
and	O
binding	O
of	O
CREB/ATF-1	protein
to	O
TRE-1	DNA
in	O
the	O
HTLV-I	O
promoter.	O
We	O
demonstrate	O
the	O
utility	O
of	O
using	O
primary	O
lymphocyte	O
models	O
to	O
study	O
HTLV-I	O
transcription	O
in	O
the	O
context	O
of	O
cell	O
signaling	O
and	O
suggest	O
that	O
activated	O
PBMC	cell_type
maintain	O
elevated	O
levels	O
of	O
P-CREB	protein
,	O
which	O
promote	O
basal	O
HTLV-I	O
transcription	O
and	O
enhance	O
viral	O
persistence	O
in	O
vivo.	O

Anoxia/reoxygenation-induced	O
tolerance	O
with	O
respect	O
to	O
polymorphonuclear	O
leukocyte	O
adhesion	O
to	O
cultured	cell_line
endothelial	cell_line
cells	cell_line
.	O
A	O
nuclear	protein
factor-kappaB	protein
-mediated	O
phenomenon	O
.	O
Exposing	O
human	cell_line
umbilical	cell_line
vein	cell_line
endothelial	cell_line
cells	cell_line
(	O
HUVECs	cell_line
)	O
to	O
anoxia/reoxygenation	O
(	O
A/R	O
)	O
results	O
in	O
an	O
increase	O
in	O
polymorphonuclear	O
leukocyte	O
(	O
PMN	cell_type
)	O
adhesion	O
to	O
HUVECs	cell_line
.	O
This	O
A/R	O
-induced	O
hyperadhesion	O
is	O
completely	O
prevented	O
by	O
a	O
previous	O
(24	O
hours	O
earlier)	O
exposure	O
of	O
HUVECs	cell_line
to	O
A/R	O
.	O
This	O
phenomenon	O
has	O
been	O
termed	O
"	O
A/R	O
tolerance	O
."	O
Exposing	O
HUVECs	cell_line
to	O
A/R	O
induces	O
an	O
increase	O
in	O
nuclear	protein
factor	protein
kappaB	protein
(	O
NF-kappaB	protein
)	O
in	O
HUVEC	O
nuclei	O
within	O
4	O
hours.	O
Interfering	O
with	O
either	O
NF-kappaB	protein
activation	O
(	O
proteasome	protein
inhibitor	O
)	O
or	O
translocation	O
(	O
double-stranded	O
oligonucleotides	O
containing	O
NF-kappaB	DNA
binding	DNA
sequence	DNA
)	O
prevents	O
the	O
development	O
of	O
A/R	O
tolerance	O
(ie,	O
the	O
increase	O
in	O
A/R	O
-induced	O
PMN	O
adhesion	O
to	O
HUVECs	cell_line
is	O
the	O
same	O
after	O
the	O
first	O
and	O
second	O
A/R	O
challenges	O
).	O
NO	O
production	O
by	O
HUVECs	cell_line
is	O
increased	O
after	O
the	O
second	O
A/R	O
challenge,	O
but	O
not	O
after	O
the	O
first	O
A/R	O
challenge	O
.	O
Inhibition	O
of	O
NO	protein
synthase	protein
(	O
NOS	protein
)	O
during	O
the	O
second	O
A/R	O
challenge	O
prevents	O
the	O
development	O
of	O
A/R	O
tolerance	O
with	O
respect	O
to	O
PMN	O
adhesion	O
.	O
However,	O
while	O
HUVECs	cell_line
contained	O
endothelial	O
NOS	protein
protein	protein
,	O
no	O
inducible	O
NOS	protein
was	O
detected	O
in	O
either	O
tolerant	O
or	O
nontolerant	cell_type
cells	cell_type
.	O
Further	O
studies	O
indicated	O
that	O
inhibition	O
of	O
GTP-cyclohydrolase	protein
I	protein
(an	O
enzyme	O
involved	O
in	O
de	O
novo	O
synthesis	O
of	O
an	O
important	O
cofactor	O
for	O
NOS	protein
activity	O
,	O
tetrahydrobiopterin)	O
prevented	O
the	O
generation	O
of	O
NO	O
in	O
A/R	cell_line
-tolerant	cell_line
cells	cell_line
.	O
Extracellular	O
generation	O
of	O
NO	O
(	O
NO	O
donor)	O
did	O
not	O
effect	O
the	O
hyperadhesion	O
response	O
induced	O
by	O
the	O
initial	O
A/R	O
challenge	O
.	O
A/R	O
also	O
induced	O
an	O
oxidant	O
stress	O
in	O
naive	O
HUVECs	cell_line
,	O
but	O
not	O
in	O
A/R	cell_line
-tolerant	cell_line
HUVECs	cell_line
.	O
Inhibition	O
of	O
NOS	protein
during	O
the	O
second	O
A/R	O
insult	O
results	O
in	O
the	O
generation	O
of	O
an	O
oxidant	O
stress	O
similar	O
to	O
that	O
observed	O
after	O
the	O
first	O
A/R	O
challenge	O
.	O
Taken	O
together,	O
the	O
findings	O
of	O
the	O
present	O
study	O
are	O
consistent	O
with	O
a	O
role	O
for	O
NF-kappaB	protein
in	O
the	O
development	O
of	O
A/R	O
tolerance	O
(with	O
respect	O
to	O
PMN	cell_type
adhesion	O
),	O
perhaps	O
by	O
transcriptional	O
regulation	O
of	O
GTP	protein
-cyclohydrolase	protein
.	O
The	O
increased	O
NO	O
production	O
during	O
the	O
second	O
A/R	O
insult	O
reduces	O
PMN	O
adhesion	O
most	O
likely	O
by	O
reducing	O
the	O
intracellular	O
oxidant	O
stress	O
induced	O
by	O
A/R	O
.	O

Mildly	O
oxidized	O
low-density	protein
lipoproteins	protein
decrease	O
early	O
production	O
of	O
interleukin	protein
2	protein
and	O
nuclear	protein
factor	protein
kappaB	protein
binding	O
to	O
DNA	O
in	O
activated	cell_type
T-lymphocytes	cell_type
.	O
Activated	O
T-lymphocytes	O
are	O
found	O
early	O
in	O
atherosclerosis	O
lesions	O
,	O
but	O
little	O
is	O
known	O
about	O
their	O
role.	O
Oxidized	O
low-density	protein
lipoproteins	protein
(	O
oxLDLs	protein
)	O
are	O
considered	O
to	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
the	O
lesions,	O
and	O
we	O
have	O
previously	O
demonstrated	O
that	O
oxLDLs	protein
inhibit	O
not	O
only	O
interleukin	protein
(IL)-2-receptor	protein
expression	O
on	O
the	O
surface	O
of	O
in	O
vitro-activated	O
T-lymphocytes	O
but	O
also	O
their	O
proliferation.	O
We	O
have	O
now	O
investigated	O
the	O
effect	O
of	O
oxLDLs	protein
on	O
blast	O
differentiation	O
,	O
on	O
IL-2	protein
synthesis	O
and	O
on	O
the	O
activation	O
of	O
the	O
nuclear	protein
factor	protein
kappaB	protein
(	O
NF-kappaB	protein
)	O
system	O
in	O
activated	O
lymphocytes.	O
Mildly	O
oxLDLs	protein
(50	O
and	O
100	O
microgram/ml)	O
decreased	O
the	O
number	O
of	O
lymphoblasts	cell_type
and	O
the	O
level	O
of	O
IL-2	O
concentration	O
in	O
the	O
culture	O
supernatants	O
after	O
activation	O
of	O
lymphocytes	cell_type
by	O
phytohaemagglutinin	protein
and	O
PMA+	O
ionomycin	O
.	O
The	O
inhibition	O
of	O
IL-2	protein
production	O
was	O
observed	O
in	O
the	O
CD3	protein
(+)	O
T-lymphocyte	O
cytoplasm	O
as	O
early	O
as	O
4	O
h	O
after	O
activation	O
by	O
PMA+	O
ionomycin	O
.	O
The	O
study	O
of	O
NF-kappaB	protein
showed	O
that	O
oxLDLs	protein
led	O
to	O
a	O
decrease	O
of	O
activation-induced	protein
p65/	protein
p50	protein
NF-kappaB	protein
heterodimer	O
binding	O
to	O
DNA,	O
whereas	O
the	O
presence	O
of	O
the	O
constitutive	O
nuclear	O
form	O
of	O
p50	protein
dimer	protein
was	O
unchanged.	O
This	O
was	O
correlated	O
with	O
an	O
unchanged	O
level	O
of	O
the	O
active	O
form	O
of	O
the	O
cytosolic	protein
inhibitor	protein
protein	protein
IkappaB-alpha	protein
.	O
Taken	O
together,	O
these	O
observations	O
suggest	O
that	O
the	O
immunosuppressive	O
effect	O
of	O
oxLDLs	protein
might	O
operate	O
via	O
a	O
dysregulation	O
of	O
the	O
T-lymphocyte	cell_type
activation	O
mechanisms	O
.	O

The	O
B29	DNA
(	DNA
immunoglobulin	DNA
beta-chain	DNA
)	DNA
gene	DNA
is	O
a	O
genetic	O
target	O
for	O
early	protein
B-cell	protein
factor	protein
.	O
Early	protein
B-cell	protein
factor	protein
(	O
EBF	protein
)	O
is	O
a	O
transcription	protein
factor	protein
suggested	O
as	O
essential	O
for	O
early	O
B-lymphocyte	cell_type
development	O
by	O
findings	O
in	O
mice	O
where	O
the	O
coding	O
gene	O
has	O
been	O
inactivated	O
by	O
homologous	O
disruption	O
.	O
This	O
makes	O
the	O
identification	O
of	O
genetic	O
targets	O
for	O
this	O
transcription	protein
factor	protein
pertinent	O
for	O
the	O
understanding	O
of	O
early	O
B-cell	O
development	O
.	O
The	O
lack	O
of	O
B29	RNA
transcripts	RNA
,	O
coding	O
for	O
the	O
beta	protein
subunit	protein
of	O
the	O
B-cell	O
receptor	O
complex,	O
in	O
pro-B	cell_type
cells	cell_type
from	O
EBF	protein
-deficient	O
mice	O
suggested	O
that	O
B29	O
might	O
be	O
a	O
genetic	O
target	O
for	O
EBF	protein
.	O
We	O
here	O
present	O
data	O
suggesting	O
that	O
EBF	protein
interacts	O
with	O
three	O
independent	O
sites	O
within	O
the	O
mouse	DNA
B29	DNA
promoter	DNA
.	O
Furthermore,	O
ectopic	O
expression	O
of	O
EBF	protein
in	O
HeLa	cell_line
cells	cell_line
activated	O
a	O
B29	DNA
promoter	DNA
-controlled	DNA
reporter	DNA
construct	DNA
13-fold	O
and	O
induced	O
a	O
low	O
level	O
of	O
expression	O
from	O
the	O
endogenous	DNA
B29	DNA
gene	DNA
.	O
Finally,	O
mutations	O
in	O
the	O
EBF	protein
binding	O
sites	O
diminished	O
B29	DNA
promoter	DNA
activity	O
in	O
pre-B	cell_type
cells	cell_type
while	O
the	O
same	O
mutations	O
did	O
not	O
have	O
as	O
striking	O
an	O
effect	O
on	O
the	O
promoter	O
function	O
in	O
B-cell	cell_line
lines	cell_line
of	O
later	O
differentiation	O
stages.	O
These	O
data	O
suggest	O
that	O
the	O
B29	DNA
gene	DNA
is	O
a	O
genetic	O
target	O
for	O
EBF	protein
in	O
early	O
B-cell	O
development	O
.	O

Delta-opioid	O
receptors	O
expressed	O
by	O
Jurkat	cell_line
T	cell_line
cells	cell_line
enhance	O
IL-2	protein
secretion	O
by	O
increasing	O
AP-1	protein
complexes	protein
and	O
activity	O
of	O
the	O
NF-AT/AP-1-binding	DNA
promoter	DNA
element	DNA
.	O
Recent	O
molecular	O
evidence	O
points	O
to	O
transient	O
and/or	O
stage-specific	O
expression	O
of	O
delta-	O
and	O
kappa-	O
opioid	O
receptors	O
by	O
thymic	O
and	O
peripheral	O
T	O
lymphocytes	O
.	O
Since	O
medical	O
treatments	O
or	O
stress	O
commonly	O
increase	O
opioid	O
levels	O
,	O
it	O
is	O
important	O
to	O
understand	O
the	O
mechanisms	O
by	O
which	O
opioids	O
affect	O
T	O
lymphocyte	O
functions	O
.	O
We	O
therefore	O
created	O
and	O
studied	O
a	O
T	cell_line
cell	cell_line
line	cell_line
expressing	O
the	O
cloned	protein
delta-opioid	protein
receptor	protein
(	O
DOR1	protein
).	O
DOR1	protein
ligation	O
by	O
a	O
specific	O
DOR1	protein
agonist	O
,	O
deltorphin	O
,	O
augmented	O
IL-2	protein
secretion	O
by	O
synergizing	O
with	O
signals	O
from	O
TCR-	protein
CD3	protein
and	O
CD28	protein
.	O
Reporter	O
gene	O
constructs	O
were	O
used	O
to	O
map	O
this	O
effect	O
of	O
deltorphin	O
to	O
the	O
AP-1-	O
and	O
NF-AT/AP-1-	O
binding	O
sites	O
of	O
the	O
IL-2	DNA
promoter	DNA
.	O
Although	O
DOR1	protein
signaling	O
increased	O
[	O
Ca2+	O
]i	O
,	O
deltorphin	O
enhanced	O
transcriptional	O
activity	O
of	O
the	O
NF-AT/AP-1-binding	DNA
site	DNA
via	O
a	O
mechanism	O
independent	O
of	O
calcineurin	protein
and	O
distinct	O
from	O
the	O
effects	O
of	O
elevated	O
[	O
Ca2+	O
]i	O
.	O
Deltorphin	O
also	O
increased	O
accumulation	O
of	O
AP-1	protein
transcription	protein
factor	protein
complexes	protein
,	O
suggesting	O
that	O
DOR1	protein
augments	O
IL-2	protein
secretion	O
by	O
increasing	O
the	O
AP-1	protein
component	protein
of	O
the	O
NF-AT/AP-1	protein
transcription	protein
factor	protein
.	O
These	O
results	O
advance	O
the	O
molecular	O
understanding	O
of	O
opioid	O
effects	O
on	O
lymphocytes	cell_type
,	O
and	O
in	O
addition,	O
demonstrate	O
regulation	O
of	O
IL-2	protein
synthesis	O
and	O
secretion	O
by	O
the	O
novel	O
mechanism	O
of	O
receptor-mediated	O
AP-1	protein
induction	O
.	O

Induction	O
of	O
interleukin-12	protein
p40	RNA
transcript	RNA
by	O
CD40	protein
ligation	O
via	O
activation	O
of	O
nuclear	protein
factor-kappaB	protein
.	O
Interleukin-12	protein
is	O
produced	O
in	O
response	O
to	O
infection	O
with	O
bacteria	O
or	O
parasites	O
or	O
to	O
bacterial	O
constituents	O
such	O
as	O
LPS	O
in	O
monocytes/macrophages	cell_type
and	O
dendritic	cell_type
cells	cell_type
,	O
and	O
also	O
generated	O
by	O
the	O
interaction	O
between	O
activated	cell_type
T	cell_type
cells	cell_type
and	O
antigen-presenting	cell_type
cells	cell_type
via	O
CD40	protein
-CD40	protein
ligand	protein
(	O
CD40L	protein
).	O
So	O
far,	O
transcriptional	O
analyses	O
of	O
p40	protein
have	O
been	O
carried	O
out	O
only	O
using	O
bacterial	O
constituents	O
such	O
as	O
LPS	O
as	O
stimuli.	O
In	O
the	O
present	O
study,	O
we	O
have	O
characterized	O
the	O
transcriptional	O
induction	O
of	O
p40	protein
by	O
CD40	protein
ligation	O
in	O
a	O
human	cell_line
B	cell_line
lymphoblastoid	cell_line
cell	cell_line
line	cell_line
,	O
Daudi	cell_line
,	O
and	O
a	O
human	cell_line
acute	cell_line
monocytic	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
,	O
THP-1	cell_line
.	O
These	O
cells,	O
stimulated	O
by	O
an	O
agonistic	O
monoclonal	O
antibody	O
against	O
CD40	protein
or	O
by	O
transfection	O
with	O
a	O
CD40L	DNA
expression	DNA
vector	DNA
,	O
secreted	O
p40	protein
and	O
showed	O
enhanced	O
p40	RNA
mRNA	RNA
expression	O
.	O
Sequence	O
analysis	O
of	O
the	O
p40	DNA
promoter	DNA
region	DNA
identified	O
two	O
potential	DNA
nuclear	DNA
factor	DNA
(NF)-kappaB	DNA
binding	DNA
sites	DNA
conserved	O
between	O
mouse	O
and	O
human.	O
Electrophoretic	O
mobility	O
shift	O
assay	O
revealed	O
that	O
the	O
potential	O
NF-kappaB	DNA
binding	DNA
sequence	DNA
which	O
is	O
located	O
around	O
120	DNA
bp	DNA
upstream	DNA
of	O
the	O
transcription	DNA
initiation	DNA
site	DNA
in	O
murine	O
and	O
human	O
p40	O
genes	O
formed	O
an	O
NF-kappaB	protein
complex	protein
with	O
nuclear	O
extract	O
from	O
Daudi	cell_line
cells	cell_line
stimulated	O
by	O
CD40	protein
ligation	O
.	O
Moreover,	O
transfection	O
of	O
Daudi	cell_line
cells	cell_line
with	O
the	O
polymerized	O
NF-kappaB	DNA
binding	DNA
sequence	DNA
ligated	O
to	O
a	O
thymidine	DNA
kinase	DNA
/chloramphenicol	DNA
acetyltransferase	DNA
(	DNA
CAT	DNA
)	DNA
reporter	DNA
plasmid	DNA
greatly	O
induced	O
CAT	protein
activity	O
,	O
but	O
transfection	O
with	O
the	O
polymerized	DNA
mutated	DNA
NF-kappaB	DNA
binding	DNA
sequence	DNA
did	O
not.	O
These	O
results	O
suggest	O
that	O
the	O
NF-kappaB	DNA
binding	DNA
site	DNA
located	O
around	O
120	O
bp	O
upstream	O
of	O
the	O
transcription	DNA
initiation	DNA
site	DNA
in	O
murine	O
and	O
human	O
p40	O
promoter	O
regions	O
could	O
be	O
important	O
for	O
the	O
p40	protein
induction	O
by	O
CD40	protein
ligation	O
via	O
activation	O
of	O
NF-kappaB	protein
.	O

High	O
frequency	O
of	O
germ-line	O
BRCA2	DNA
mutations	O
among	O
Hungarian	O
male	O
breast	O
cancer	O
patients	O
without	O
family	O
history.	O
To	O
determine	O
the	O
contribution	O
of	O
BRCA1	DNA
and	O
BRCA2	DNA
mutations	O
to	O
the	O
pathogenesis	O
of	O
male	O
breast	O
cancer	O
in	O
Hungary,	O
the	O
country	O
with	O
the	O
highest	O
male	O
breast	O
cancer	O
mortality	O
rates	O
in	O
continental	O
Europe,	O
a	O
series	O
of	O
18	O
male	O
breast	O
cancer	O
patients	O
and	O
three	O
patients	O
with	O
gynecomastia	O
was	O
analyzed	O
for	O
germ-line	O
mutations	O
in	O
both	O
BRCA1	DNA
and	O
BRCA2	DNA
.	O
Although	O
no	O
germ-line	O
BRCA1	DNA
mutation	O
was	O
observed,	O
6	O
of	O
the	O
18	O
male	O
breast	O
cancer	O
cases	O
(33%)	O
carried	O
truncating	O
mutations	O
in	O
the	O
BRCA2	DNA
gene.	O
Unexpectedly,	O
none	O
of	O
them	O
reported	O
a	O
family	O
history	O
for	O
breast/ovarian	O
cancer	O
.	O
Four	O
of	O
six	O
truncating	O
mutations	O
were	O
novel,	O
and	O
two	O
mutations	O
were	O
recurrent.	O
Four	O
patients	O
(22%)	O
had	O
a	O
family	O
history	O
of	O
breast/ovarian	O
cancer	O
in	O
at	O
least	O
one	O
first-	O
or	O
second-degree	O
relative;	O
however,	O
no	O
BRCA2	DNA
mutation	O
was	O
identified	O
among	O
them.	O
No	O
mutation	O
was	O
identified	O
in	O
either	O
of	O
the	O
genes	O
in	O
the	O
gynecomastias	O
.	O
These	O
results	O
provide	O
evidence	O
for	O
a	O
strong	O
genetic	O
component	O
of	O
male	O
breast	O
cancer	O
in	O
Hungary.	O

T-cell	O
expression	O
of	O
the	O
human	DNA
GATA-3	DNA
gene	DNA
is	O
regulated	O
by	O
a	O
non-lineage-specific	DNA
silencer	DNA
.	O
The	O
GATA-3	protein
transcription	protein
factor	protein
is	O
required	O
for	O
development	O
of	O
the	O
T-cell	cell_line
lineage	cell_line
and	O
Th2	DNA
cytokine	DNA
gene	DNA
expression	O
in	O
CD4	cell_type
T-cells	cell_type
.	O
We	O
have	O
mapped	O
the	O
DNase-I-hypersensitive	DNA
(HS)	DNA
regions	DNA
of	O
the	O
human	DNA
GATA-3	DNA
gene	DNA
in	O
T-cells	cell_type
and	O
non-T-cells	cell_type
and	O
studied	O
their	O
transcriptional	O
activities	O
.	O
HS	DNA
I-III	DNA
,	O
located	O
5'	O
from	O
the	O
transcriptional	DNA
initiation	DNA
site	DNA
,	O
were	O
found	O
in	O
hematopoietic	O
and	O
non-hematopoietic	O
cells	O
,	O
whereas	O
HS	DNA
IV-VII	DNA
,	O
located	O
3'	O
from	O
the	O
transcriptional	DNA
start	DNA
site	DNA
,	O
were	O
exclusively	O
observed	O
in	O
T-cells	cell_type
.	O
Among	O
these	O
hypersensitive	DNA
sites	DNA
,	O
two	O
transcriptional	DNA
control	DNA
elements	DNA
were	O
found,	O
one	O
in	O
the	O
first	DNA
intron	DNA
of	O
the	O
GATA-3	DNA
gene	DNA
and	O
the	O
other	O
between	DNA
8.3	DNA
and	DNA
5.9	DNA
kilobases	DNA
5'	O
from	O
the	O
GATA-3	DNA
transcriptional	DNA
initiation	DNA
site	DNA
.	O
The	O
first	DNA
intron	DNA
acted	O
as	O
a	O
strong	O
transcriptional	O
activator	O
in	O
a	O
position-dependent	O
manner	O
and	O
with	O
no	O
cell-type	O
specificity	O
.	O
The	O
upstream	DNA
regulatory	DNA
element	DNA
could	O
confer	O
T-cell	O
specificity	O
to	O
the	O
GATA-3	DNA
promoter	DNA
activity	O
,	O
and	O
analysis	O
of	O
this	O
region	O
revealed	O
a	O
707-base	DNA
pair	DNA
silencer	DNA
that	O
drastically	O
inhibited	O
GATA-3	DNA
promoter	DNA
activity	O
in	O
non-	cell_type
T-cells	cell_type
.	O
Two	O
CAGGTG	DNA
E-boxes	DNA
,	O
located	O
at	O
the	O
5'-	O
and	O
3'-	O
ends	O
of	O
the	O
silencer,	O
were	O
necessary	O
for	O
this	O
silencer	O
activity	O
.	O
The	O
3'-CAGGTG	DNA
E-box	DNA
could	O
bind	O
USF	protein
proteins	protein
,	O
the	O
ubiquitous	protein
repressor	protein
ZEB	protein
,	O
or	O
the	O
basic	protein
helix-loop-helix	protein
proteins	protein
E2A	protein
and	O
HEB	protein
,	O
and	O
we	O
showed	O
that	O
a	O
competition	O
between	O
ZEB	protein
and	O
E2A	protein
/HEB	protein
proteins	protein
is	O
involved	O
in	O
the	O
silencer	O
activity	O
.	O

Reactive	O
oxygen	O
intermediate-dependent	O
NF-kappaB	protein
activation	O
by	O
interleukin-1beta	protein
requires	O
5-lipoxygenase	protein
or	O
NADPH	O
oxidase	O
activity	O
.	O
We	O
previously	O
reported	O
that	O
the	O
role	O
of	O
reactive	O
oxygen	O
intermediates	O
(	O
ROIs	O
)	O
in	O
NF-kappaB	protein
activation	O
by	O
proinflammatory	protein
cytokines	protein
was	O
cell	O
specific.	O
However,	O
the	O
sources	O
for	O
ROIs	O
in	O
various	O
cell	O
types	O
are	O
yet	O
to	O
be	O
determined	O
and	O
might	O
include	O
5-lipoxygenase	protein
(	O
5-LOX	protein
)	O
and	O
NADPH	O
oxidase.	O
5-LOX	protein
and	O
5-LOX	protein
activating	protein
protein	protein
(	O
FLAP	protein
)	O
are	O
coexpressed	O
in	O
lymphoid	cell_type
cells	cell_type
but	O
not	O
in	O
monocytic	O
or	O
epithelial	O
cells	O
.	O
Stimulation	O
of	O
lymphoid	cell_type
cells	cell_type
with	O
interleukin-1beta	protein
(	O
IL-1beta	protein
)	O
led	O
to	O
ROI	O
production	O
and	O
NF-kappaB	protein
activation	O
,	O
which	O
could	O
both	O
be	O
blocked	O
by	O
antioxidants	O
or	O
FLAP	protein
inhibitors,	O
confirming	O
that	O
5-LOX	protein
was	O
the	O
source	O
of	O
ROIs	O
and	O
was	O
required	O
for	O
NF-kappaB	protein
activation	O
in	O
these	O
cells.	O
IL-1beta	protein
stimulation	O
of	O
epithelial	cell_type
cells	cell_type
did	O
not	O
generate	O
any	O
ROIs	O
and	O
NF-kappaB	protein
induction	O
was	O
not	O
influenced	O
by	O
5-LOX	protein
inhibitors.	O
However,	O
reintroduction	O
of	O
a	O
functional	O
5-LOX	protein
system	O
in	O
these	O
cells	O
allowed	O
ROI	O
production	O
and	O
5-LOX	protein
-dependent	O
NF-kappaB	protein
activation	O
.	O
In	O
monocytic	cell_type
cells	cell_type
,	O
IL-1beta	protein
treatment	O
led	O
to	O
a	O
production	O
of	O
ROIs	O
which	O
is	O
independent	O
of	O
the	O
5-LOX	protein
enzyme	protein
but	O
requires	O
the	O
NADPH	O
oxidase	O
activity	O
.	O
This	O
pathway	O
involves	O
the	O
Rac1	protein
and	O
Cdc42	protein
GTPases	protein
,	O
two	O
enzymes	O
which	O
are	O
not	O
required	O
for	O
NF-kappaB	protein
activation	O
by	O
IL-1beta	protein
in	O
epithelial	cell_type
cells	cell_type
.	O
In	O
conclusion,	O
three	O
different	O
cell-specific	O
pathways	O
lead	O
to	O
NF-kappaB	protein
activation	O
by	O
IL-1beta	protein
:	O
a	O
pathway	O
dependent	O
on	O
ROI	O
production	O
by	O
5-LOX	protein
in	O
lymphoid	cell_type
cells	cell_type
,	O
an	O
ROI-	O
and	O
5-LOX	protein
-independent	O
pathway	O
in	O
epithelial	cell_type
cells	cell_type
,	O
and	O
a	O
pathway	O
requiring	O
ROI	O
production	O
by	O
NADPH	protein
oxidase	protein
in	O
monocytic	cell_type
cells	cell_type
.	O

Cutting	O
edge:	O
dominant	O
effect	O
of	O
Ile50Val	protein
variant	protein
of	O
the	O
human	protein
IL-4	protein
receptor	protein
alpha-chain	protein
in	O
IgE	protein
synthesis	O
.	O
Two	O
variants	O
of	O
the	O
IL-4R	DNA
alpha-chain	DNA
(	DNA
IL-4Ralpha	DNA
)	DNA
gene	DNA
have	O
been	O
recently	O
identified	O
in	O
association	O
with	O
different	O
atopic	O
disorders	O
.	O
To	O
clarify	O
the	O
etiological	O
relationship	O
between	O
the	O
two	O
variants,	O
we	O
analyzed	O
responsiveness	O
to	O
IL-4	protein
of	O
transfectants	O
with	O
four	O
kinds	O
of	O
IL-4Ralpha	protein
carrying	O
either	O
Val	O
or	O
Ile	O
at	O
50	protein
and	O
either	O
Gln	O
or	O
Arg	O
at	O
551	protein
.	O
The	O
substitution	O
of	O
Ile	O
for	O
Val	O
augmented	O
STAT6	protein
activation	O
,	O
proliferation,	O
and	O
transcription	O
activity	O
of	O
the	O
Iepsilon	DNA
promoter	DNA
by	O
IL-4	protein
,	O
whereas	O
that	O
of	O
Arg	O
for	O
Gln	O
did	O
not	O
change	O
these	O
IL-4	protein
signals	O
.	O
Arg551	O
was	O
not	O
associated	O
with	O
atopic	O
asthma	O
in	O
the	O
Japanese	O
population	O
.	O
CD23	protein
expression	O
and	O
IgE	protein
synthesis	O
by	O
IL-4	protein
were	O
augmented	O
in	O
Ile50	cell_line
-bearing	cell_line
PBMC	cell_line
,	O
compared	O
with	O
those	O
bearing	O
Val50	O
.	O
Taken	O
together,	O
substitution	O
of	O
Arg551	O
does	O
not	O
enhance	O
the	O
IL-4	protein
signal	O
for	O
generation	O
of	O
germline	O
epsilon	O
transcript,	O
whereas	O
the	O
substitution	O
of	O
Ile50	O
contributes	O
to	O
enhancement	O
of	O
IgE	protein
synthesis	O
.	O

A	O
novel	O
growth-factor-dependent	cell_line
myeloid	cell_line
cell	cell_line
line	cell_line
derived	O
from	O
mouse	cell_type
bone	cell_type
marrow	cell_type
cells	cell_type
contains	O
progenitors	O
endowed	O
with	O
high	O
proliferative	O
potential	O
.	O
Constitutive	O
expression	O
of	O
human	protein
colony-stimulating	protein
factor-1	protein
receptor	protein
(	O
CSF-1R	protein
)	O
confers	O
long-lasting	O
CSF-1	protein
-dependent	O
proliferation	O
to	O
mouse	cell_line
myeloid	cell_line
cell	cell_line
lines	cell_line
.	O
We	O
developed	O
mice	O
transgenic	O
for	O
human	O
CSF-1R	protein
because	O
mouse	O
CSF-1	protein
cannot	O
activate	O
human	O
CSF-1R	protein
.	O
Then	O
bone	cell_type
marrow	cell_type
cells	cell_type
from	O
transgenic	O
mice	O
were	O
plated	O
onto	O
MS-5	O
stromal	O
cells	O
expressing	O
the	O
membrane	protein
form	protein
of	O
human	protein
CSF-1	protein
(	O
2M-1	cell_line
cells	cell_line
)	O
in	O
order	O
to	O
combine	O
the	O
hematopoietic	O
supporting	O
properties	O
of	O
stromal	cell_type
cells	cell_type
and	O
the	O
proliferative	O
effects	O
of	O
CSF-1	protein
.	O
Thus,	O
we	O
were	O
able	O
to	O
derive	O
a	O
hematopoietic	cell_line
cell	cell_line
line	cell_line
,	O
called	O
47.10	cell_line
,	O
that	O
grew	O
indefinitely	O
under	O
these	O
conditions,	O
whereas	O
no	O
cell	O
line	O
could	O
be	O
developed	O
from	O
nontransgenic	O
mice	O
.	O
Proliferation	O
of	O
47.10	cell_line
cells	cell_line
is	O
severely	O
affected	O
by	O
neutralizing	O
anti-	protein
CSF-1R	protein
monoclonal	protein
antibodies	protein
.	O
Morphologic	O
and	O
cytofluorometry	O
analysis	O
established	O
that	O
most	O
47.10	cell_line
cells	cell_line
are	O
immature	cell_type
myelomonocytic	cell_type
cells	cell_type
.	O
Consistent	O
with	O
this	O
phenotype,	O
the	O
myeloid	protein
transcription	protein
factor	protein
PU.1	protein
,	O
but	O
not	O
the	O
erythroid	protein
transcription	protein
factor	protein
GATA-1	protein
,	O
is	O
expressed	O
in	O
47.10	cell_line
cells	cell_line
.	O
A	O
few	O
47.10	cell_line
cells	cell_line
(3-5%)	O
do	O
not	O
express	O
lineage	O
specific	O
markers;	O
they	O
differentiate	O
spontaneously	O
to	O
lineage-positive	cell_line
cells	cell_line
after	O
replating	O
on	O
2M-1	cell_line
cells	cell_line
.	O
In	O
agar	O
cultures,	O
47.10	cell_line
cells	cell_line
form	O
7-	O
and	O
14-day	O
colonies	O
in	O
response	O
to	O
a	O
cocktail	O
of	O
granulocyte/macrophage	protein
colony-stimulating	protein
factor	protein
(2.5	O
ng/mL),	O
interleukin-3	protein
(1	O
ng/mL),	O
and	O
mouse	O
CSF-1	protein
(10	O
ng/mL).	O
Under	O
these	O
conditions,	O
about	O
0.5%	O
of	O
47.10	cell_line
cells	cell_line
formed	O
large	O
14-day	O
colonies	O
(&gt;1	O
mm)	O
composed	O
of	O
mature	cell_type
monocytes	cell_type
and	O
granulocytes	cell_type
,	O
reflecting	O
the	O
presence	O
of	O
progenitors	O
endowed	O
with	O
high	O
proliferative	O
potential	O
(	O
HPP-	cell_line
47.10	cell_line
cells	cell_line
).	O
In	O
conclusion,	O
we	O
have	O
characterized	O
a	O
novel	O
continuous	cell_line
myeloid	cell_line
cell	cell_line
line	cell_line
presenting	O
a	O
hierarchical	O
structure	O
similar	O
to	O
that	O
of	O
the	O
bone	cell_line
marrow	cell_line
progenitor	cell_line
cell	cell_line
compartment	cell_line
.	O

Regulation	O
of	O
IL-4	protein
expression	O
by	O
the	O
transcription	protein
factor	protein
JunB	protein
during	O
T	O
helper	O
cell	O
differentiation	O
.	O
The	O
molecular	O
basis	O
for	O
restricted	O
cytokine	protein
expression	O
by	O
T	O
helper	O
1	O
(Th1)	O
and	O
T	O
helper	O
2	O
(Th2)	O
cells	O
is	O
unclear.	O
Previous	O
studies	O
found	O
that	O
P1	DNA
,	O
an	O
element	O
of	O
the	O
interleukin	DNA
4	DNA
(	DNA
IL-4	DNA
)	DNA
promoter	DNA
that	O
binds	O
AP-1,	O
is	O
important	O
for	O
Th2-restricted	O
IL-4	protein
expression	O
.	O
Here	O
we	O
show	O
that	O
JunB	protein
,	O
but	O
not	O
the	O
other	O
Jun	protein
family	protein
members	protein
,	O
was	O
selectively	O
induced	O
in	O
Th2	cell_type
cells	cell_type
and	O
not	O
in	O
Th1	cell_type
cells	cell_type
during	O
differentiation.	O
JunB	protein
has	O
previously	O
been	O
considered	O
to	O
be	O
a	O
negative	O
regulator	O
of	O
transcription.	O
However,	O
we	O
show	O
that	O
JunB	protein
binds	O
directly	O
to	O
the	O
P1	DNA
site	DNA
and	O
synergizes	O
with	O
c-Maf	protein
to	O
activate	O
an	O
IL-4	DNA
luciferase	DNA
reporter	DNA
gene	DNA
.	O
JunB	protein
-control	O
of	O
IL-4	protein
expression	O
is	O
mediated	O
by	O
the	O
phosphorylation	O
of	O
JunB	protein
at	O
Thr	O
102	O
and-	O
104	O
by	O
JNK	protein
MAP	protein
kinase	protein
.	O
The	O
synergy	O
between	O
c-Maf	protein
and	O
JunB	protein
can	O
be	O
attributed	O
to	O
cooperative	O
DNA	O
binding,	O
which	O
is	O
facilitated	O
by	O
JunB	protein
phosphorylation	O
.	O
In	O
transgenic	O
mice	O
,	O
elevated	O
JunB	protein
levels	O
caused	O
increased	O
expression	O
of	O
several	O
Th2	protein
cytokines	protein
in	O
developing	O
Th1	cell_type
cells	cell_type
.	O
JunB	protein
also	O
upregulated	O
IL-4	protein
expression	O
in	O
response	O
to	O
immunization	O
.	O
Thus,	O
the	O
early	O
increase	O
of	O
JunB	protein
protein	O
in	O
Th2	cell_type
cells	cell_type
can	O
provide	O
the	O
specificity	O
for	O
c-Maf	protein
in	O
IL-4	protein
expression	O
during	O
T	O
cell	O
development	O
and	O
directs	O
thereby	O
Th2	O
differentiation	O
.	O

Human	protein
T-cell	protein
leukemia	protein
virus	protein
type	protein
1	protein
tax	protein
protein	protein
abrogates	O
interleukin-2	protein
dependence	O
in	O
a	O
mouse	cell_line
T-cell	cell_line
line	cell_line
.	O
Human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
is	O
the	O
etiologic	O
agent	O
of	O
adult	O
T-cell	O
leukemia	O
.	O
Tax	protein
,	O
the	O
viral	protein
protein	protein
,	O
is	O
thought	O
to	O
be	O
crucial	O
in	O
the	O
development	O
of	O
the	O
disease,	O
since	O
it	O
transforms	O
healthy	cell_type
T	cell_type
cells	cell_type
in	O
vitro	O
and	O
induces	O
tumors	O
in	O
transgenic	O
animals	O
.	O
We	O
examined	O
the	O
effect	O
of	O
Tax	protein
activity	O
on	O
the	O
growth	O
of	O
the	O
interleukin-2	cell_line
(IL-2)-dependent	cell_line
T-cell	cell_line
line	cell_line
CTLL-2	cell_line
.	O
Stable	O
expression	O
of	O
Tax	protein
in	O
CTLL-2	cell_line
transformed	O
cell	O
growth	O
from	O
being	O
IL-2	protein
dependent	O
to	O
IL-2	protein
independent	O
.	O
Tax	protein
stimulated	O
transcription	O
through	O
NF-kappaB	protein
and	O
the	O
cyclic	DNA
AMP	DNA
-responsive	DNA
element-like	DNA
sequence	DNA
in	O
the	O
HTLV-1	O
promoter.	O
The	O
finding	O
of	O
Tax	protein
mutants	O
segregating	O
these	O
two	O
pathways	O
suggested	O
that	O
the	O
NF-kappaB	protein
pathway	O
was	O
essential	O
for	O
IL-2	protein
-independent	O
growth	O
of	O
CTLL-2	cell_type
cells	cell_type
while	O
the	O
CRE	DNA
pathway	O
was	O
unnecessary.	O
However,	O
both	O
pathways	O
were	O
necessary	O
for	O
another	O
transformation-related	O
activity	O
(colony	O
formation	O
in	O
soft	O
agar)	O
of	O
CTLL-2/	protein
Tax	protein
.	O
Our	O
results	O
show	O
that	O
Tax	protein
has	O
at	O
least	O
two	O
distinct	O
activities	O
on	O
T	cell_type
cells	cell_type
,	O
and	O
suggest	O
that	O
Tax	protein
plays	O
a	O
crucial	O
role	O
in	O
IL-2	protein
-independent	O
T-cell	O
transformation	O
induced	O
by	O
HTLV-1	O
,	O
in	O
addition	O
to	O
its	O
well-known	O
IL-2	protein
-dependent	O
cell	O
transformation	O
.	O

Accessing	O
Epstein-Barr	O
virus	O
-specific	O
T-cell	O
memory	O
with	O
peptide-loaded	cell_line
dendritic	cell_line
cells	cell_line
.	O
The	O
conventional	O
means	O
of	O
studying	O
Epstein-Barr	O
virus	O
(EBV)-induced	O
cytotoxic	cell_type
T-lymphocyte	cell_type
(CTL)	O
memory	O
,	O
by	O
in	O
vitro	O
stimulation	O
with	O
the	O
latently	O
infected	O
autologous	O
lymphoblastoid	cell_line
cell	cell_line
line	cell_line
(	O
LCL	cell_line
),	O
has	O
important	O
limitations.	O
First,	O
it	O
gives	O
no	O
information	O
on	O
memory	O
to	O
lytic	protein
cycle	protein
antigens	protein
;	O
second,	O
it	O
preferentially	O
amplifies	O
the	O
dominant	O
components	O
of	O
latent	O
antigen-specific	O
memory	O
at	O
the	O
expense	O
of	O
key	O
subdominant	O
reactivities.	O
Here	O
we	O
describe	O
an	O
alternative	O
approach,	O
based	O
on	O
in	O
vitro	O
stimulation	O
with	O
epitope	cell_line
peptide-loaded	cell_line
dendritic	cell_line
cells	cell_line
(	O
DCs	cell_line
),	O
which	O
allows	O
one	O
to	O
probe	O
the	O
CTL	O
repertoire	O
for	O
any	O
individual	O
reactivity	O
of	O
choice;	O
this	O
method	O
proved	O
significantly	O
more	O
efficient	O
than	O
stimulation	O
with	O
peptide	O
alone.	O
Using	O
this	O
approach	O
we	O
first	O
show	O
that	O
reactivities	O
to	O
the	O
immunodominant	O
and	O
subdominant	O
lytic	protein
cycle	protein
epitopes	protein
identified	O
by	O
T	cell_type
cells	cell_type
during	O
primary	O
EBV	O
infection	O
are	O
regularly	O
detectable	O
in	O
the	O
CTL	O
memory	O
of	O
virus	O
carriers	O
;	O
this	O
implies	O
that	O
in	O
such	O
carriers	O
chronic	O
virus	O
replication	O
remains	O
under	O
direct	O
T-cell	O
control.	O
We	O
further	O
show	O
that	O
subdominant	O
latent	O
cycle	O
reactivities	O
to	O
epitopes	O
in	O
the	O
latent	protein
membrane	protein
protein	protein
LMP2	protein
,	O
though	O
rarely	O
undetectable	O
in	O
LCL	cell_line
-stimulated	O
populations	O
,	O
can	O
be	O
reactivated	O
by	O
DC	O
stimulation	O
and	O
selectively	O
expanded	O
as	O
polyclonal	O
CTL	cell_line
lines	cell_line
;	O
the	O
adoptive	O
transfer	O
of	O
such	O
preparations	O
may	O
be	O
of	O
value	O
in	O
targeting	O
certain	O
EBV-positive	O
malignancies	O
.	O

Regulation	O
of	O
the	O
human	DNA
interleukin-2	DNA
gene	DNA
by	O
the	O
alpha	protein
and	protein
beta	protein
isoforms	protein
of	O
the	O
glucocorticoid	protein
receptor	protein
.	O
The	O
immunosuppressive	O
effects	O
of	O
glucocorticoids	O
are	O
largely	O
due	O
to	O
transcriptional	O
inhibition	O
of	O
immunologically	DNA
relevant	DNA
genes	DNA
,	O
such	O
as	O
the	O
interleukin-2	DNA
(	DNA
IL-2	DNA
)	DNA
gene	DNA
.	O
These	O
effects	O
are	O
mediated	O
by	O
the	O
intracellular	O
glucocorticoid	protein
receptor	protein
(	O
GR	protein
).	O
In	O
humans,	O
alternative	O
splicing	O
of	O
the	O
GR	RNA
precursor	RNA
mRNA	RNA
gives	O
rise	O
to	O
two	O
receptor	O
isoforms,	O
termed	O
GRalpha	protein
and	O
GRbeta	protein
.	O
We	O
previously	O
demonstrated	O
that	O
GRbeta	protein
could	O
antagonize	O
GRalpha	protein
-mediated	O
transactivation	O
of	O
a	O
glucocorticoid-responsive	DNA
element	DNA
(GRE)-driven	DNA
reporter	DNA
gene	DNA
in	O
COS-7	cell_line
cells	cell_line
.	O
The	O
present	O
study	O
was	O
designed	O
to	O
analyze	O
the	O
roles	O
of	O
the	O
two	O
GR	protein
isoforms	protein
on	O
glucocorticoid-mediated	O
transrepression	O
of	O
the	O
IL-2	DNA
gene	DNA
.	O
Using	O
a	O
recently	O
developed	O
transfection	O
technique,	O
we	O
demonstrate	O
that	O
in	O
primary	cell_type
human	cell_type
lymphocytes	cell_type
,	O
stimulation	O
of	O
a	O
548	DNA
bp	DNA
IL-2	DNA
promoter	DNA
-luciferase	DNA
reporter	DNA
construct	DNA
by	O
phorbol	O
ester	O
and	O
calcium	O
ionophore	O
is	O
reversed	O
by	O
dexamethasone	O
to	O
a	O
similar	O
extent	O
as	O
in	O
Jurkat	O
T	O
lymphoma	O
cells	O
transfected	O
with	O
a	O
GRalpha	protein
expression	O
vector	O
.	O
Transfection	O
of	O
a	O
GRbeta	protein
expression	O
vector	O
alone	O
did	O
not	O
result	O
in	O
IL-2	DNA
promoter	DNA
repression	O
in	O
response	O
to	O
glucocorticoids	O
.	O
Furthermore,	O
GRbeta	protein
did	O
not	O
antagonize	O
the	O
repressive	O
effects	O
of	O
GRalpha	protein
on	O
IL-2	DNA
promoter	DNA
activity	O
.	O
Surprisingly,	O
overexpression	O
of	O
GRbeta	protein
in	O
Jurkat	cell_line
cells	cell_line
did	O
not	O
cause	O
significant	O
inhibition	O
of	O
GRalpha	protein
-induced	O
transactivation	O
of	O
a	O
GRE-dependent	DNA
luciferase	DNA
reporter	DNA
gene	DNA
either.	O
We	O
conclude	O
that	O
the	O
transrepressive	O
effect	O
of	O
glucocorticoids	O
on	O
IL-2	DNA
gene	DNA
transcription	O
is	O
exclusively	O
mediated	O
by	O
GRalpha	protein
.	O
GRbeta	protein
can	O
neither	O
antagonize	O
GRalpha	protein
-mediated	O
transactivation	O
nor	O
transrepression	O
in	O
Jurkat	cell_line
cells	cell_line
,	O
indicating	O
a	O
cell	O
type-specific	O
pattern	O
of	O
GRbeta	protein
-mediated	O
antiglucocorticoid	O
activity	O
.	O

Extinction	O
of	O
immunoglobulin	DNA
gene	DNA
expression	O
in	O
B	cell_type
cells	cell_type
upon	O
fusion	O
with	O
HeLa	cell_line
cells	cell_line
is	O
preceded	O
by	O
rapid	O
nuclear	O
depletion	O
of	O
essential	protein
transcription	protein
factors	protein
and	O
is	O
accompanied	O
by	O
widespread	O
inactivation	O
of	O
genes	O
expressed	O
in	O
a	O
B	O
cell-specific	O
manner	O
.	O
When	O
immunoglobulin	cell_type
(	cell_type
Ig	cell_type
)	cell_type
expressing	cell_type
B	cell_type
cells	cell_type
are	O
fused	O
with	O
non-B	cell_type
cells	cell_type
,	O
Ig	O
expression	O
is	O
rapidly	O
suppressed	O
at	O
the	O
level	O
of	O
transcription,	O
a	O
phenomenon	O
termed	O
extinction	O
.	O
Here	O
we	O
demonstrate	O
that	O
fusion	O
of	O
HeLa	cell_line
cells	cell_line
with	O
either	O
diploid	O
or	O
tetraploid	O
B	O
cells	O
(	O
Daudi	cell_line
)	O
results	O
in	O
widespread	O
extinction	O
of	O
several	O
other	O
B	DNA
cell-encoded	DNA
genes	DNA
that	O
are	O
expressed	O
in	O
a	O
B	O
cell-specific	O
manner	O
.	O
In	O
contrast,	O
expression	O
of	O
B	DNA
cell-expressed	DNA
genes	DNA
that	O
are	O
not	O
dependent	O
on	O
cell-specific	O
controls	O
is	O
unaffected.	O
We	O
show	O
that	O
the	O
molecular	O
mechanism	O
(s)	O
underlying	O
Ig	DNA
gene	DNA
extinction	O
can	O
be	O
explained,	O
at	O
least	O
in	O
part,	O
by	O
a	O
lack	O
of	O
transcription	protein
factors	protein
that	O
are	O
essential	O
for	O
Ig	DNA
gene	DNA
transcription	O
.	O
These	O
transcription	protein
factors	protein
are	O
either	O
not	O
produced	O
due	O
to	O
block	O
of	O
transcription	O
of	O
their	O
respective	O
genes	O
(	O
Oct-2	DNA
,	O
OBF-1	DNA
,	O
PU.1	protein
),	O
or	O
are	O
rendered	O
inactive	O
posttranslationally	O
(	O
NF-kappa	protein
B	protein
,	O
E47	DNA
).	O
By	O
isolating	O
Daudi	cell_line
x	cell_line
HeLa	cell_line
heterokaryons	cell_line
a	O
few	O
hours	O
after	O
fusion,	O
we	O
have	O
studied	O
the	O
initial	O
fate	O
of	O
two	O
B	protein
cell-specific	protein
transcription	protein
factors	protein
involved	O
in	O
Ig	DNA
gene	DNA
transcription	O
,	O
Oct-2	DNA
and	O
NF-kappa	protein
B	protein
.	O
This	O
report	O
provides	O
the	O
first	O
demonstration	O
that	O
upon	O
fusion	O
with	O
HeLa	cell_line
cells	cell_line
,	O
the	O
nuclear	O
contents	O
of	O
B	protein
cell-expressed	protein
transcription	protein
factors	protein
are	O
depleted	O
within	O
a	O
few	O
hours	O
with	O
kinetics	O
that	O
are	O
as	O
fast	O
or	O
faster	O
than	O
that	O
of	O
Ig	DNA
gene	DNA
extinction	O
.	O
Thus,	O
the	O
extinguishing	O
mechanism	O
is	O
effective	O
very	O
early	O
after	O
fusion.	O
We	O
suggest	O
that	O
extinction	O
of	O
Ig	DNA
genes	DNA
is	O
part	O
of	O
a	O
global	O
mechanism	O
that	O
suppresses	O
the	O
differentiation	O
program	O
foreign	O
to	O
the	O
HeLa	cell_line
phenotype	cell_line
.	O

Evidence	O
for	O
suppressed	O
activity	O
of	O
the	O
transcription	protein
factor	protein
NFAT1	protein
at	O
its	O
proximal	DNA
binding	DNA
element	DNA
P0	DNA
in	O
the	O
IL-4	DNA
promoter	DNA
associated	O
with	O
enhanced	O
IL-4	DNA
gene	DNA
transcription	O
in	O
T	cell_type
cells	cell_type
of	O
atopic	O
patients	O
.	O
Allergen-specific	O
T	cell_type
cells	cell_type
in	O
atopic	O
patients	O
are	O
polarized	O
IL-4-producing	cell_line
Th2	cell_line
cells	cell_line
,	O
promoting	O
IgE	protein
synthesis	O
by	O
B	cell_type
cells	cell_type
.	O
The	O
molecular	O
basis	O
for	O
increased	O
IL-4	DNA
gene	DNA
expression	O
in	O
atopy	O
is	O
not	O
fully	O
understood.	O
IL-4	DNA
gene	DNA
regulation	O
in	O
general	O
involves	O
the	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	protein
NFAT	protein
)	protein
family	protein
of	O
transcription	protein
factors	protein
,	O
of	O
which	O
NFAT1	protein
and	O
NFAT2	protein
are	O
most	O
prominent	O
in	O
peripheral	cell_type
T	cell_type
cells	cell_type
.	O
Recently,	O
a	O
unique	O
inhibitory	O
role	O
of	O
NFAT1	protein
in	O
IL-4	DNA
gene	DNA
control	O
was	O
shown	O
in	O
the	O
mouse	O
.	O
In	O
a	O
series	O
of	O
electrophoretic	O
mobility	O
shift	O
assays	O
with	O
protein	O
extracts	O
of	O
highly	cell_line
polarized	cell_line
Th2	cell_line
clones	cell_line
from	O
atopics	O
and	O
Th1	cell_line
clones	cell_line
from	O
controls	O
we	O
compared	O
DNA-binding	O
activities	O
at	O
the	O
two	O
NFAT-binding	DNA
elements	DNA
P0	DNA
and	O
P1	DNA
of	O
the	O
crucial	O
proximal	O
human	O
IL-4	DNA
promoter	DNA
.	O
At	O
the	O
most	O
proximal	O
P0	DNA
site,	O
NFAT-containing	O
complexes	O
devoid	O
of	O
NFAT2	protein
were	O
readily	O
inducible	O
in	O
the	O
Th1	cell_line
clones	cell_line
,	O
but	O
hardly	O
or	O
not	O
in	O
the	O
Th2	cell_line
clones	cell_line
.	O
In	O
contrast,	O
both	O
in	O
Th1	O
and	O
Th2	O
clones	O
NFAT-containing	O
complexes	O
were	O
strongly	O
inducible	O
at	O
the	O
P1	DNA
site	DNA
,	O
consisting	O
of	O
NFAT2	protein
and	O
a	O
P0	DNA
-compatible	O
NFAT	protein
activity	O
,	O
without	O
apparent	O
differences	O
between	O
Th1	O
and	O
Th2	O
clones	O
.	O
Like	O
in	O
Th2	cell_line
clones	cell_line
,	O
suppressed	O
NFAT-	O
P0	DNA
complex	O
formation	O
was	O
observed	O
also	O
at	O
the	O
polyclonal	O
level	O
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
)	O
of	O
three	O
of	O
five	O
severe	O
atopic	O
dermatitis	O
patients	O
with	O
strongly	O
elevated	O
serum	O
IgE	protein
levels	O
,	O
but	O
not	O
in	O
control	O
PBMC	cell_type
.	O
These	O
findings	O
suggest	O
that	O
high-level	O
IL-4	protein
production	O
in	O
atopic	cell_type
Th2	cell_type
cells	cell_type
is	O
associated	O
with	O
selective	O
reduction	O
of	O
suppressive	O
NFAT1	protein
activity	O
at	O
the	O
IL-4	DNA
P0	DNA
element	DNA
and	O
that	O
some	O
patients	O
with	O
this	O
multifactorial	O
disease	O
may	O
have	O
a	O
putative	O
systemic	O
disorder	O
at	O
this	O
level.	O

Differential	O
expression	O
and	O
phosphorylation	O
of	O
CTCF	protein
,	O
a	O
c-myc	O
transcriptional	O
regulator,	O
during	O
differentiation	O
of	O
human	O
myeloid	O
cells.	O
CTCF	protein
is	O
a	O
transcriptional	O
repressor	O
of	O
the	O
c-myc	O
gene.	O
Although	O
CTCF	protein
has	O
been	O
characterized	O
in	O
some	O
detail,	O
there	O
is	O
very	O
little	O
information	O
about	O
the	O
regulation	O
of	O
CTCF	protein
activity	O
.	O
Therefore	O
we	O
investigated	O
CTCF	protein
expression	O
and	O
phosphorylation	O
during	O
induced	O
differentiation	O
of	O
human	cell_type
myeloid	cell_type
leukemia	cell_type
cells	cell_type
.	O
We	O
found	O
that:	O
(i)	O
both	O
CTCF	RNA
mRNA	RNA
and	O
protein	O
are	O
down-regulated	O
during	O
terminal	O
differentiation	O
in	O
most	O
cell	O
lines	O
tested;	O
(ii)	O
CTCF	protein
down-regulation	O
is	O
retarded	O
and	O
less	O
pronounced	O
than	O
that	O
of	O
c-myc	DNA
;	O
(iii)	O
CTCF	protein
protein	protein
is	O
differentially	O
phosphorylated	O
and	O
the	O
phosphorylation	O
profiles	O
depend	O
on	O
the	O
differentiation	O
pathway	O
.	O
We	O
concluded	O
that	O
CTCF	protein
expression	O
and	O
activity	O
is	O
controlled	O
at	O
transcriptional	O
and	O
post-transcriptional	O
levels	O
.	O

Glucocorticoid	O
resistance	O
in	O
the	O
squirrel	O
monkey	O
is	O
associated	O
with	O
overexpression	O
of	O
the	O
immunophilin	protein
FKBP51	protein
.	O
Squirrel	O
monkeys	O
are	O
neotropical	O
primates	O
that	O
have	O
high	O
circulating	O
cortisol	O
to	O
compensate	O
for	O
expression	O
of	O
glucocorticoid	protein
receptors	protein
(	O
GRs	protein
)	O
with	O
reduced	O
affinity.	O
The	O
low	O
binding	O
affinity	O
of	O
squirrel	O
monkey	O
GR	protein
does	O
not	O
result	O
from	O
substitutions	O
in	O
the	O
receptor,	O
because	O
squirrel	protein
monkey	protein
GR	protein
expressed	O
in	O
vitro	O
exhibits	O
high	O
affinity.	O
Rather,	O
squirrel	O
monkeys	O
express	O
a	O
soluble	O
factor	O
that,	O
in	O
mixing	O
studies	O
of	O
cytosol	O
from	O
squirrel	cell_type
monkey	cell_type
lymphocytes	cell_type
(	O
SML	cell_type
)	O
and	O
mouse	O
L929	O
cells,	O
reduced	O
GR	O
binding	O
affinity	O
by	O
11-fold.	O
In	O
an	O
effort	O
to	O
identify	O
this	O
factor,	O
the	O
cellular	O
levels	O
of	O
components	O
of	O
the	O
GR	protein
heterocomplex	protein
in	O
SML	cell_type
and	O
human	cell_type
lymphocytes	cell_type
(	O
HL	cell_type
)	O
were	O
compared.	O
The	O
immunophilin	protein
FKBP51	protein
was	O
13-fold	O
higher	O
in	O
SML	cell_type
than	O
in	O
HL	O
cytosol	O
;	O
FKBP52	protein
in	O
SML	cell_type
was	O
42%	O
of	O
that	O
in	O
HL	O
cytosol	O
.	O
A	O
role	O
for	O
changes	O
in	O
immunophilins	protein
,	O
causing	O
glucocorticoid	O
resistance	O
in	O
neotropical	O
primates	O
,	O
is	O
supported	O
by	O
the	O
following:	O
the	O
changes	O
in	O
FKBP51	protein
and	O
FKBP52	protein
were	O
observed	O
in	O
cells	O
from	O
other	O
neotropical	O
primates	O
with	O
glucocorticoid	O
resistance	O
;	O
the	O
elevated	O
level	O
of	O
FKBP51	protein
was	O
reflected	O
in	O
an	O
abundance	O
of	O
FKBP51	protein
in	O
heat	protein
shock	protein
protein	protein
90	protein
complexes	protein
in	O
SML	cell_type
;	O
when	O
cytosols	O
of	O
SML	cell_type
and	O
L929	cell_line
cells	cell_line
were	O
mixed,	O
the	O
decrease	O
in	O
GR	O
binding	O
was	O
associated	O
with	O
incorporation	O
of	O
FKBP51	protein
into	O
GR	protein
heterocomplexes	protein
;	O
the	O
effect	O
of	O
SML	cell_type
cytosol	O
on	O
GR	O
binding	O
was	O
reproduced	O
with	O
cytosol	O
from	O
COS	cell_line
cells	cell_line
expressing	O
squirrel	O
monkey	O
FKBP51	protein
;	O
and	O
both	O
the	O
effect	O
of	O
SML	cell_type
cytosol	O
on	O
GR	O
binding	O
and	O
the	O
incorporation	O
of	O
FKBP51	protein
into	O
GR	protein
heterocomplexes	protein
were	O
blocked	O
by	O
FK506.	O
Regulation	O
of	O
GR	O
binding	O
by	O
FKBP51	protein
represents	O
a	O
previously	O
unrecognized	O
mechanism	O
for	O
regulating	O
glucocorticoid	O
sensitivity	O
.	O

High-level	O
replication	O
of	O
human	O
immunodeficiency	O
virus	O
in	O
thymocytes	cell_type
requires	O
NF-kappaB	protein
activation	O
through	O
interaction	O
with	O
thymic	cell_type
epithelial	cell_type
cells	cell_type
.	O
We	O
have	O
previously	O
demonstrated	O
that	O
interaction	O
of	O
infected	O
thymocytes	cell_type
with	O
autologous	O
thymic	cell_type
epithelial	cell_type
cells	cell_type
(	O
TEC	cell_type
)	O
is	O
a	O
prerequisite	O
for	O
a	O
high	O
level	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(HIV-1)	O
replication	O
in	O
thymocytes	cell_type
(M.Rothe,	O
L.Chene,	O
M.Nugeyre,	O
F.Barre-Sinoussi,	O
and	O
N.Israel,	O
J.Virol.72:5852-5861,	O
1998).	O
We	O
report	O
here	O
that	O
this	O
activation	O
of	O
HIV	O
replication	O
takes	O
place	O
at	O
the	O
transcriptional	O
level	O
through	O
activation	O
of	O
the	O
Rel/	protein
NF-kappaB	protein
transcription	protein
factors	protein
.	O
We	O
first	O
demonstrate	O
that	O
an	O
HIV-1	O
provirus	O
(	O
SF-2	O
strain	O
)	O
very	O
effectively	O
replicates	O
in	O
thymocytes	cell_type
cocultured	O
with	O
TEC	cell_type
whereas	O
this	O
provirus	O
,	O
with	O
kappaB	DNA
sites	DNA
deleted,	O
fails	O
to	O
replicate.	O
We	O
provide	O
evidence	O
that	O
several	O
NF-kappaB	protein
complexes	protein
are	O
constitutively	O
found	O
in	O
the	O
nuclei	O
of	O
thymocytes	cell_type
either	O
freshly	O
isolated	O
from	O
the	O
thymus	O
or	O
maintained	O
in	O
coculture	O
with	O
autologous	O
or	O
heterologous	O
TEC	cell_type
.	O
The	O
prevalent	O
complex	O
is	O
the	O
heterodimer	protein
p50-p65	protein
.	O
NF-kappaB	protein
activity	O
is	O
tightly	O
correlated	O
with	O
the	O
transcriptional	O
activity	O
of	O
a	O
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
of	O
HIV-1	O
transfected	O
in	O
thymocytes	cell_type
.	O
The	O
cotransfection	O
of	O
this	O
LTR	DNA
with	O
a	O
mutated	O
IkappaBalpha	protein
molecule	protein
formally	O
demonstrates	O
that	O
LTR	DNA
transactivation	O
is	O
regulated	O
by	O
members	O
of	O
the	O
Rel/	protein
NF-kappaB	protein
family	protein
in	O
thymocytes	cell_type
.	O
We	O
also	O
showed	O
that	O
tumor	protein
necrosis	protein
factor	protein
(	O
TNF	protein
)	O
and	O
to	O
a	O
lesser	O
extent	O
interleukin-1	protein
(	O
IL-1	protein
),	O
secreted	O
within	O
the	O
coculture,	O
induce	O
NF-kappaB	protein
activity	O
and	O
a	O
correlative	O
LTR	DNA
transactivation	O
.	O
However	O
IL-7	protein
,	O
a	O
crucial	O
factor	O
for	O
thymopoiesis	O
that	O
is	O
secreted	O
mainly	O
by	O
TEC	cell_type
,	O
is	O
a	O
necessary	O
cofactor	O
for	O
NF-kappaB	protein
activation	O
elicited	O
by	O
TNF	protein
or	O
IL-1	protein
.	O
Together,	O
these	O
data	O
indicate	O
that	O
NF-kappaB	protein
activation	O
,	O
required	O
for	O
a	O
high	O
level	O
of	O
HIV	O
replication	O
in	O
thymocytes	cell_type
,	O
is	O
regulated	O
in	O
a	O
specific	O
manner	O
in	O
the	O
thymic	O
microenvironment	O
which	O
provides	O
the	O
necessary	O
cytokines:	O
TNF	protein
,	O
IL-1	protein
,	O
and	O
IL-7	protein
.	O

Imbalanced	O
expression	O
of	O
the	O
glucocorticoid	protein
receptor	protein
isoforms	protein
in	O
cultured	cell_type
lymphocytes	cell_type
from	O
a	O
patient	O
with	O
systemic	O
glucocorticoid	O
resistance	O
and	O
chronic	O
lymphocytic	O
leukemia	O
.	O
The	O
human	protein
glucocorticoid	protein
receptor	protein
(	O
GR	protein
)	O
is	O
expressed	O
as	O
two	O
alternatively	O
spliced	O
isoforms,	O
GRalpha	protein
and	O
GRbeta	protein
.	O
Whereas	O
GRalpha	protein
is	O
a	O
hormone-activated	O
transcription	protein
factor	protein
,	O
GRbeta	protein
does	O
not	O
bind	O
glucocorticoids	O
(	O
GCs	O
),	O
is	O
transcriptionally	O
inactive	O
,	O
and	O
is	O
a	O
potential	O
inhibitor	O
of	O
activated	O
GRalpha	protein
.	O
Differential	O
expression	O
of	O
GR	protein
isoforms	protein
may	O
play	O
a	O
role	O
in	O
generalized	O
or	O
tissue-specific	O
GC	O
resistance	O
.	O
GCs	O
induce	O
apoptosis	O
in	O
neoplastic	cell_type
lymphoid	cell_type
cells	cell_type
;	O
and,	O
defective	O
apoptosis	O
is	O
implicated	O
in	O
the	O
genesis	O
of	O
chronic	O
lymphocytic	O
leukemia	O
(	O
CLL	O
).	O
We	O
studied	O
a	O
patient	O
with	O
generalized	O
GC	O
resistance	O
and	O
CLL	O
.	O
GR	O
number	O
in	O
the	O
patient's	O
transformed	cell_line
lymphocytes	cell_line
was	O
approximately	O
one	O
half	O
that	O
of	O
control	O
cells	O
with	O
a	O
approximately	O
10-fold	O
reduction	O
in	O
binding	O
affinity	O
for	O
dexamethasone	O
.	O
In	O
vitro	O
apoptosis	O
induction	O
in	O
CLL	cell_line
cells	cell_line
was	O
delayed	O
in	O
response	O
to	O
GCs	O
,	O
but	O
not	O
to	O
other	O
apoptosis	O
inducers.	O
Sequencing	O
of	O
the	O
GR	DNA
cDNA	DNA
and	O
gene	O
including	O
the	O
2.3-kb	O
coding	O
region,	O
the	O
intron/exon	O
junctions,	O
the	O
known	O
5'-regulatory	DNA
region	DNA
,	O
and	O
approximately	O
300	O
bp	O
of	O
the	O
3'-region	DNA
revealed	O
no	O
alterations.	O
Western	O
blot	O
with	O
an	O
N-terminal	O
antibody	O
showed	O
normal	O
levels	O
of	O
immunoreactive	protein
GR	protein
,	O
but	O
quantitative	O
analysis	O
with	O
isoform-specific	O
C-terminal	protein
antibodies	protein
revealed	O
a	O
markedly	O
reduced	O
GRalpha	protein
expression	O
,	O
and	O
high	O
GRbeta	protein
expression	O
.	O
These	O
findings	O
indicate	O
that	O
imbalanced	O
expression	O
of	O
the	O
GR	protein
isoforms	protein
may	O
be	O
a	O
mechanism	O
of	O
GC	O
resistance	O
,	O
and	O
may	O
have	O
implications	O
for	O
tumorigenesis	O
by	O
enhancing	O
cell	O
survival.	O
Copyright	O
1999	O
Academic	O
Press.	O

Intranuclear	O
targeted	O
delivery	O
of	O
functional	O
NF-kappaB	protein
by	O
70	protein
kDa	protein
heat	protein
shock	protein
protein	protein
.	O
The	O
70	protein
kDa	protein
heat	protein
shock	protein
protein	protein
(	O
Hsp70	protein
)	O
is	O
a	O
highly	O
conserved,	O
ubiquitous	protein
protein	protein
involved	O
in	O
chaperoning	protein
proteins	protein
to	O
various	O
cellular	O
organelles	O
.	O
Here	O
we	O
show	O
that	O
when	O
added	O
exogenously	O
to	O
cells,	O
Hsp70	protein
is	O
readily	O
imported	O
into	O
both	O
cytoplasmic	O
and	O
nuclear	O
compartments	O
in	O
a	O
cell-type-specific	O
fashion	O
.	O
We	O
exploited	O
this	O
ability	O
of	O
Hsp70	protein
to	O
deliver	O
NF-kappaB	protein
,	O
a	O
key	O
transcriptional	O
regulator	O
of	O
inflammatory	O
responses	O
.	O
We	O
demonstrate	O
that	O
a	O
fusion	O
protein	O
composed	O
of	O
a	O
C-terminal	O
Hsp70	protein
peptide	O
and	O
the	O
p50	protein
subunit	protein
of	O
NF-kappaB	protein
was	O
directed	O
into	O
the	O
nucleus	O
of	O
cells,	O
could	O
bind	O
DNA	O
specifically,	O
and	O
activated	O
Igkappa	protein
expression	O
and	O
TNFalpha	protein
production	O
.	O
We	O
therefore	O
propose	O
that	O
Hsp70	protein
can	O
be	O
used	O
as	O
a	O
vehicle	O
for	O
intracytoplasmic	O
and	O
intranuclear	O
delivery	O
of	O
proteins	O
or	O
DNA	O
to	O
modulate	O
gene	O
expression	O
and	O
thereby	O
control	O
immune	O
responses	O
.	O

Characterization	O
of	O
the	O
human	DNA
elk-1	DNA
promoter	DNA
.	O
Potential	O
role	O
of	O
a	O
downstream	DNA
intronic	DNA
sequence	DNA
for	O
elk-1	DNA
gene	DNA
expression	O
in	O
monocytes	cell_type
.	O
To	O
characterize	O
the	O
human	DNA
elk-1	DNA
promoter	DNA
,	O
we	O
mapped	O
the	O
transcriptional	DNA
start	DNA
site	DNA
and	O
isolated	O
elk-1	cell_line
-specific	cell_line
genomic	cell_line
phage	cell_line
clones	cell_line
that	O
contained	O
extensive	O
upstream	O
and	O
downstream	O
sequences	O
.	O
A	O
TATA-like	DNA
motif	DNA
was	O
identified	O
immediately	O
upstream	O
of	O
the	O
transcriptional	DNA
start	DNA
site	DNA
.	O
Functional	O
analyses	O
of	O
DNA	DNA
fragments	DNA
containing	O
the	O
TATA	DNA
element	DNA
and	O
the	O
identification	O
of	O
a	O
DNase	DNA
I-hypersensitive	DNA
chromatin	DNA
site	DNA
(	O
HS	DNA
1	DNA
)	O
in	O
close	O
proximity	O
to	O
the	O
TATA	DNA
box	DNA
suggest	O
that	O
the	O
identified	O
TATA	DNA
motif	DNA
is	O
important	O
for	O
elk-1	DNA
transcription	O
in	O
vivo.	O
Sequences	O
upstream	O
and	O
downstream	O
from	O
the	O
TATA	DNA
box	DNA
were	O
found	O
to	O
contribute	O
to	O
elk-1	DNA
promoter	O
activity.	O
A	O
second	O
hypersensitive	O
site	O
(HS	O
2)	O
was	O
identified	O
within	O
the	O
first	O
intron	O
in	O
pre-monocytic	O
cells,	O
which	O
express	O
Elk-1	O
only	O
when	O
differentiating	O
to	O
monocytes	cell_type
.	O
In	O
a	O
variety	O
of	O
other	O
cell	O
types,	O
which	O
display	O
a	O
constitutive	O
Elk-1	protein
expression	O
,	O
HS	O
2	O
did	O
not	O
exist,	O
suggesting	O
that	O
inducibility	O
of	O
elk-1	DNA
expression	O
is	O
associated	O
with	O
the	O
presence	O
of	O
HS	O
2.	O
Egr-1	O
and	O
the	O
serum	O
response	O
factor	O
were	O
found	O
to	O
interact	O
specifically	O
with	O
the	O
intronic	DNA
sequence	DNA
at	O
+265	O
and	O
+448,	O
respectively.	O
Because	O
Egr-1	RNA
mRNA	RNA
and	O
protein	O
levels	O
were	O
observed	O
to	O
increase	O
significantly	O
before	O
induction	O
of	O
elk-1	DNA
expression	O
,	O
we	O
propose	O
that	O
Egr-1	protein
is	O
important	O
for	O
the	O
regulation	O
of	O
elk-1	DNA
transcription	O
in	O
differentiating	O
monocytes	cell_type
.	O

Immunohistochemical	O
study	O
of	O
c-fos-positive	protein
lymphocytes	protein
infiltrated	O
into	O
human	O
squamous	O
cell	O
carcinomas	O
of	O
the	O
head	O
and	O
neck	O
during	O
radiation	O
therapy	O
and	O
its	O
clinical	O
significance.	O
C-fos	DNA
has	O
been	O
reported	O
to	O
be	O
one	O
of	O
the	O
immediate	DNA
early	DNA
genes	DNA
in	O
signal	O
transduction	O
systems	O
after	O
many	O
kinds	O
of	O
stresses,	O
including	O
ionizing	O
radiation.	O
Changes	O
in	O
c-fos	DNA
expression	O
induced	O
by	O
radiation	O
therapy	O
in	O
tumor	O
tissues	O
have	O
not	O
yet	O
been	O
reported.	O
In	O
this	O
study,	O
we	O
have	O
attempted	O
to	O
determine	O
whether	O
c-fos	DNA
expression	O
is	O
induced	O
by	O
radiotherapy	O
in	O
human	O
squamous	O
cell	O
carcinomas	O
of	O
the	O
head	O
and	O
neck	O
and	O
to	O
establish	O
a	O
possible	O
correlation	O
between	O
c-fos	DNA
expression	O
and	O
the	O
therapeutic	O
effects	O
of	O
radiation	O
therapy	O
.	O
Twenty-seven	O
patients	O
with	O
tumors	O
of	O
the	O
oral	O
cavity	O
,	O
oropharynx	O
,	O
and	O
maxillary	O
sinus	O
were	O
examined,	O
all	O
of	O
which	O
were	O
confirmed	O
as	O
squamous	O
cell	O
carcinomas	O
.	O
After	O
obtaining	O
the	O
patients	O
'	O
informed	O
consent,	O
biopsies	O
were	O
performed	O
before	O
treatment	O
and	O
at	O
doses	O
of	O
4,	O
10,	O
and	O
20	O
Gy	O
of	O
radiotherapy	O
,	O
and	O
the	O
specimens	O
were	O
preserved	O
in	O
liquid	O
nitrogen	O
for	O
further	O
examination.	O
Serial	O
sectioning	O
of	O
6	O
micrometer	O
was	O
performed	O
using	O
a	O
cryostat,	O
and	O
samples	O
were	O
immunohistochemically	O
stained	O
using	O
the	O
streptoavidin	protein
-biotin	protein
peroxidase	protein
method	O
and	O
a	O
monoclonal	O
antibody	O
against	O
c-fos.	O
Three	O
of	O
the	O
27	O
patients	O
with	O
squamous	O
cell	O
carcinoma	O
showed	O
slight	O
expression	O
of	O
c-fos	O
in	O
their	O
tumor	O
cells	O
before	O
and/or	O
at	O
4	O
or	O
10	O
Gy	O
of	O
radiotherapy	O
.	O
The	O
tumors	O
showed	O
high	O
radiosensitivity.	O
Concerning	O
tumor-infiltrating	cell_type
lymphocytes	cell_type
,	O
the	O
rate	O
of	O
moderate	O
or	O
remarkable	O
grades	O
of	O
c-fos-positive	protein
lymphocytes	protein
before	O
radiotherapy	O
and	O
at	O
radiation	O
doses	O
of	O
4,	O
10,	O
and	O
20	O
Gy	O
was	O
8.0,	O
29.2,	O
4.8,	O
and	O
0%,	O
respectively.	O
The	O
relationship	O
between	O
the	O
immunohistochemical	O
findings	O
and	O
the	O
antitumor	O
effect	O
at	O
a	O
radiation	O
dose	O
of	O
20	O
Gy	O
was	O
examined	O
on	O
the	O
corresponding	O
H&amp;E-stained	O
sections	O
.	O
In	O
patients	O
whose	O
infiltration	O
of	O
c-fos-positive	protein
lymphocytes	protein
into	O
tumor	O
tissues	O
were	O
moderate	O
or	O
remarkable	O
at	O
4	O
Gy	O
of	O
radiotherapy	O
,	O
the	O
tumors	O
responded	O
significantly	O
well	O
to	O
radiation	O
therapy	O
(P	O
&lt;	O
0.025,	O
chi2	O
test),	O
and	O
the	O
patients	O
took	O
a	O
significantly	O
favorable	O
clinical	O
course	O
(P	O
&lt;	O
0.05,	O
chi2	O
test).	O
In	O
a	O
sample	O
from	O
one	O
of	O
the	O
patients	O
,	O
c-fos-positive	protein
lymphocytes	protein
were	O
identified	O
as	O
CD4	O
positive	O
and	O
CD8	O
negative.	O
Therefore,	O
the	O
high	O
radiosensitivity	O
of	O
squamous	O
cell	O
carcinomas	O
in	O
our	O
samples	O
could	O
be	O
explained	O
by	O
an	O
overexpression	O
of	O
c-fos	protein
in	O
the	O
tumor-infiltrating	cell_type
lymphocytes	cell_type
induced	O
by	O
small	O
doses	O
of	O
radiation	O
therapy	O
,	O
and	O
these	O
activated	cell_type
lymphocytes	cell_type
exerted	O
a	O
cytotoxic	O
effect	O
against	O
the	O
cancer	cell_type
cells	cell_type
.	O

Paternal	O
expression	O
of	O
WT1	protein
in	O
human	cell_type
fibroblasts	cell_type
and	O
lymphocytes	cell_type
.	O
The	O
Wilms'	DNA
tumor	DNA
suppressor	DNA
gene	DNA
(	O
WT1	protein
)	O
was	O
previously	O
identified	O
as	O
being	O
imprinted,	O
with	O
frequent	O
maternal	O
expression	O
in	O
human	O
placentae	O
and	O
fetal	O
brains	O
.	O
We	O
examined	O
the	O
allele-specific	O
expression	O
of	O
WT1	protein
in	O
cultured	O
human	cell_type
fibroblasts	cell_type
from	O
15	O
individuals	O
.	O
Seven	O
of	O
15	O
fibroblast	cell_line
lines	cell_line
were	O
heterozygous	O
for	O
polymorphic	DNA
alleles	DNA
,	O
and	O
the	O
expression	O
patterns	O
were	O
variable,	O
i.e.,	O
equal,	O
unequal	O
or	O
monoallelic	O
paternal	O
expression	O
in	O
three,	O
two	O
and	O
two	O
cases,	O
respectively.	O
Exclusive	O
paternal	O
expression	O
of	O
WT1	protein
was	O
also	O
shown	O
in	O
non-cultured	cell_type
peripheral	cell_type
lymphocytes	cell_type
from	O
the	O
latter	O
two	O
individuals.	O
The	O
allele-specific	O
expression	O
profiles	O
of	O
other	O
imprinted	DNA
genes	DNA
,	O
IGF2	DNA
and	O
H19	DNA
,	O
on	O
human	DNA
chromosome	DNA
11	DNA
were	O
constant	O
and	O
consistent	O
with	O
those	O
in	O
other	O
tissues.	O
Our	O
unexpected	O
observations	O
of	O
paternal	O
or	O
biallelic	O
expression	O
of	O
WT1	protein
in	O
fibroblasts	cell_type
and	O
lymphocytes	cell_type
,	O
together	O
with	O
the	O
previous	O
findings	O
of	O
maternal	O
or	O
biallelic	O
expression	O
in	O
placentae	O
and	O
brains	O
,	O
suggest	O
that	O
the	O
allele-specific	O
regulatory	O
system	O
of	O
WT1	protein
is	O
unique	O
and	O
may	O
be	O
controlled	O
by	O
a	O
putative	O
tissue-	O
and	O
individual-specific	O
modifier	O
.	O

T	O
cell	O
reactivity	O
to	O
Sjogren's	O
syndrome	O
related	O
antigen	O
La(SSB)	protein
.	O
OBJECTIVE.	O
Many	O
patients	O
with	O
primary	O
Sjogren's	O
syndrome	O
(SS)	O
make	O
high	O
titer	O
IgG	protein
autoantibodies	protein
to	O
the	O
La(SSB)	protein
antigen,	O
suggesting	O
antigen	O
specific	O
T	O
cell-B	O
cell	O
interactions	O
.	O
T	O
cell	O
responses	O
to	O
some	O
nuclear	O
antigens,	O
particularly	O
U1RNP	protein
,	O
have	O
been	O
detected	O
in	O
patients	O
with	O
systemic	O
lupus	O
erythematosus	O
(	O
SLE	O
)	O
and	O
in	O
healthy	O
subjects	O
.	O
We	O
investigated	O
T	O
cell	O
reactivity	O
to	O
the	O
autoantigen	protein
SSB	protein
in	O
patients	O
with	O
SS	O
and	O
healthy	O
controls	O
.	O
METHODS.	O
Using	O
the	O
[3H]thymidine	O
proliferation	O
assay	O
,	O
we	O
determined	O
reactivity	O
to	O
purified	protein
recombinant	protein
SSB	protein
(	O
rSSB	protein
)	O
in	O
20	O
patients	O
with	O
SS	O
and	O
19	O
controls	O
.	O
Specificity	O
was	O
determined	O
using	O
tetanus	O
toxoid	O
,	O
endotoxin	O
,	O
and	O
3	O
other	O
autoantigens	protein
(	O
PBC.M2	protein
,	O
Sc170	protein
,	O
and	O
GAD	protein
).	O
Precursor	O
frequency	O
was	O
calculated	O
by	O
limiting	O
dilution	O
analysis	O
.	O
HLA	O
Class	O
II	O
dependency	O
was	O
investigated	O
using	O
anti-Class	protein
II	protein
monoclonal	protein
antibodies	protein
.	O
HLA-DR	O
typing	O
was	O
by	O
polymerase	O
chain	O
reaction	O
and	O
sequence	O
specific	O
oligonucleotide	O
typing	O
.	O
RESULTS.	O
Six	O
of	O
20	O
patients	O
with	O
SS	O
and	O
10/19	O
controls	O
proliferated	O
to	O
La(	O
rSSB	protein
).	O
Precursor	O
frequency	O
of	O
anti-SSB	cell_line
T	cell_line
cells	cell_line
was	O
1:77,040	O
and	O
1:115,000	O
in	O
2	O
healthy	O
subjects	O
and	O
1:230,250	O
and	O
1:103,034	O
in	O
two	O
patients	O
with	O
SS	O
.	O
Anti-	O
HLA-DR	protein
abrogated	O
proliferation	O
to	O
SSB	protein
and	O
tetanus	O
toxoid	O
.	O
Thirteen	O
of	O
15	O
patients	O
with	O
SS	O
and	O
4/17	O
controls	O
were	O
HLA-DR3	protein
positive	O
,	O
with	O
no	O
apparent	O
association	O
of	O
HLA-DR3	protein
with	O
SSB	protein
reactivity	O
in	O
controls	O
.	O
CONCLUSION.	O
Anti-	cell_line
La(SSB)	cell_line
specific	cell_line
T	cell_line
cells	cell_line
occur	O
in	O
a	O
significant	O
proportion	O
of	O
controls	O
and	O
in	O
some	O
patients	O
with	O
SS	O
.	O
The	O
function	O
of	O
SSB	cell_line
T	cell_line
cells	cell_line
in	O
controls	O
remains	O
to	O
be	O
defined.	O
They	O
may	O
represent	O
immunoregulatory	cell_type
cells	cell_type
,	O
and	O
further	O
analysis	O
of	O
these	O
cells,	O
and	O
a	O
comparison	O
to	O
those	O
found	O
in	O
patients	O
with	O
SS	O
,	O
may	O
elucidate	O
normal	O
immunoregulation	O
and	O
the	O
derangements	O
that	O
lead	O
to	O
Sjogren's	O
syndrome	O
.	O

Anti-rheumatic	O
compound	O
aurothioglucose	O
inhibits	O
tumor	protein
necrosis	protein
factor-alpha	protein
-induced	O
HIV-1	O
replication	O
in	O
latently	O
infected	O
OM10.1	O
and	O
Ach2	O
cells	O
.	O
NF-kappaB	protein
is	O
a	O
potent	O
cellular	O
activator	O
of	O
HIV-1	O
gene	O
expression.	O
Down-regulation	O
of	O
NF-kappaB	protein
activation	O
is	O
known	O
to	O
inhibit	O
HIV	O
replication	O
from	O
the	O
latently	cell_type
infected	cell_type
cells	cell_type
.	O
Gold	O
compounds	O
have	O
been	O
effectively	O
used	O
for	O
many	O
decades	O
in	O
the	O
treatment	O
of	O
rheumatoid	O
arthritis	O
.	O
We	O
previously	O
reported	O
that	O
gold	O
compounds	O
,	O
especially	O
aurothioglucose	O
(	O
AuTG	O
)	O
containing	O
monovalent	O
gold	O
ion	O
,	O
inhibited	O
the	O
DNA-binding	O
of	O
NF-kappaB	protein
in	O
vitro.	O
In	O
this	O
report	O
we	O
have	O
examined	O
the	O
efficacy	O
of	O
the	O
gold	O
compound	O
AuTG	O
as	O
an	O
inhibitor	O
of	O
HIV	O
replication	O
in	O
latently	O
infected	O
OM10.1	O
and	O
Ach2	O
cells	O
.	O
Tumor	protein
necrosis	protein
factor	protein
(TNF)-alpha	protein
-induced	O
HIV-1	O
replication	O
in	O
OM10.1	cell_line
or	O
Ach2	cell_line
cells	cell_line
was	O
significantly	O
inhibited	O
by	O
non-cytotoxic	O
doses	O
of	O
AuTG	O
(&gt;10	O
microM	O
in	O
OM10.1	O
cells	O
and	O
&gt;25	O
F.M	O
in	O
Ach2	cell_line
cells	cell_line
),	O
while	O
25	O
microM	O
of	O
the	O
counter-anion	protein
thioglucose	protein
(	O
TG	protein
)	O
or	O
gold	O
compound	O
containing	O
divalent	O
gold	O
ion	O
,	O
HAuCl3	O
,	O
had	O
no	O
effect.	O
The	O
effect	O
of	O
AuTG	O
on	O
NF-kappaB	protein
-dependent	O
gene	O
expression	O
was	O
confirmed	O
by	O
a	O
transient	O
CAT	protein
assay	O
.	O
Specific	O
staining	O
as	O
well	O
as	O
electron	O
microscopic	O
examinations	O
revealed	O
the	O
accumulation	O
of	O
metal	O
gold	O
in	O
the	O
cells,	O
supporting	O
our	O
previous	O
hypothesis	O
that	O
gold	O
ions	O
could	O
block	O
NF-kappaB	protein
-DNA	O
binding	O
by	O
a	O
redox	O
mechanism	O
.	O
These	O
observations	O
indicate	O
that	O
the	O
monovalent	O
gold	O
compound	O
AuTG	O
is	O
a	O
potentially	O
useful	O
drug	O
for	O
the	O
treatment	O
of	O
patients	O
infected	O
with	O
HIV	O
.	O

Clonality	O
of	O
isolated	cell_type
eosinophils	cell_type
in	O
the	O
hypereosinophilic	O
syndrome	O
.	O
The	O
idiopathic	O
hypereosinophilic	O
syndrome	O
(	O
IHES	O
)	O
is	O
a	O
rare	O
disorder	O
characterized	O
by	O
unexplained,	O
persistent	O
eosinophilia	O
associated	O
with	O
multiple	O
organ	O
dysfunction	O
due	O
to	O
eosinophilic	O
tissue	O
infiltration	O
.	O
In	O
the	O
absence	O
of	O
karyotypic	O
abnormalities	O
,	O
there	O
is	O
no	O
specific	O
test	O
to	O
detect	O
clonal	O
eosinophilia	O
in	O
IHES	O
.	O
Analysis	O
of	O
X-chromosome	DNA
inactivation	O
patterns	O
can	O
be	O
used	O
to	O
determine	O
whether	O
proliferative	O
disorders	O
are	O
clonal	O
in	O
origin.	O
Methylation	O
of	O
HpaII	O
and	O
Hha	O
I	O
sites	O
near	O
the	O
polymorphic	DNA
trinucleotide	DNA
repeat	DNA
of	O
the	O
human	DNA
androgen	DNA
receptor	DNA
gene	DNA
(	O
HUMARA	DNA
)	O
has	O
been	O
shown	O
to	O
correlate	O
with	O
X-inactivation	O
.	O
In	O
this	O
study,	O
we	O
have	O
used	O
the	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
with	O
nested	O
primers	O
to	O
analyze	O
X-inactivation	O
patterns	O
of	O
the	O
HUMARA	DNA
loci	DNA
in	O
purified	cell_type
eosinophils	cell_type
from	O
female	O
patients	O
with	O
eosinophilia	O
.	O
Peripheral	cell_type
blood	cell_type
eosinophils	cell_type
were	O
isolated	O
by	O
their	O
autofluoresence	O
using	O
flow	O
cytometric	O
sorting.	O
Eosinophils	cell_type
purified	O
from	O
a	O
female	O
patient	O
presenting	O
with	O
IHES	O
were	O
found	O
to	O
show	O
a	O
clonal	O
pattern	O
of	O
X-inactivation	O
.	O
Eosinophil-depleted	cell_type
leukocytes	cell_type
from	O
this	O
patient	O
were	O
polyclonal	O
by	O
HUMARA	DNA
analysis	O
,	O
thus	O
excluding	O
skewedness	O
of	O
random	O
X-inactivation	O
.	O
After	O
corticosteroid	O
suppression	O
of	O
her	O
blood	O
eosinophilia	O
,	O
a	O
clonal	O
population	O
of	O
eosinophils	cell_type
could	O
no	O
longer	O
be	O
detected	O
in	O
purified	cell_type
eosinophils	cell_type
.	O
In	O
contrast,	O
eosinophils	cell_type
purified	O
from	O
a	O
patient	O
with	O
Churg-Strauss	O
syndrome	O
and	O
from	O
six	O
patients	O
with	O
reactive	O
eosinophilias	O
attributed	O
to	O
allergy,	O
parasitic	O
infection	O
,	O
or	O
drug	O
reaction	O
showed	O
a	O
polyclonal	O
pattern	O
of	O
X-inactivation	O
by	O
HUMARA	DNA
analysis	O
.	O
The	O
finding	O
of	O
clonal	O
eosinophilia	O
in	O
a	O
patient	O
presenting	O
with	O
IHES	O
indicates	O
that	O
such	O
patients	O
may	O
have,	O
in	O
reality,	O
a	O
low-grade	O
clonal	O
disorder	O
that	O
can	O
be	O
distinguished	O
from	O
reactive	O
eosinophilias	O
by	O
HUMARA	DNA
analysis	O
.	O
Further,	O
the	O
method	O
described	O
can	O
be	O
used	O
to	O
monitor	O
disease	O
progression	O
.	O

GA-binding	protein
protein	protein
factors	protein
,	O
in	O
concert	O
with	O
the	O
coactivator	protein
CREB	protein
binding	protein
protein/p300	protein
,	O
control	O
the	O
induction	O
of	O
the	O
interleukin	DNA
16	DNA
promoter	DNA
in	O
T	cell_type
lymphocytes	cell_type
.	O
Interleukin	protein
16	protein
(	O
IL-16	protein
)	O
is	O
a	O
chemotactic	protein
cytokine	protein
that	O
binds	O
to	O
the	O
CD4	protein
receptor	protein
and	O
affects	O
the	O
activation	O
of	O
T	cell_type
cells	cell_type
and	O
replication	O
of	O
HIV	O
.	O
It	O
is	O
expressed	O
as	O
a	O
large	O
67-kDa	protein
precursor	protein
protein	protein
(	O
pro-IL-16	protein
)	O
in	O
lymphocytes	cell_type
,	O
macrophages	cell_type
,	O
and	O
mast	cell_type
cells	cell_type
,	O
as	O
well	O
as	O
in	O
airway	cell_type
epithelial	cell_type
cells	cell_type
from	O
asthmatics	O
after	O
challenge	O
with	O
allergen.	O
This	O
pro-IL-16	protein
is	O
subsequently	O
processed	O
to	O
the	O
mature	O
cytokine	O
of	O
13	protein
kDa	protein
.	O
To	O
study	O
the	O
expression	O
of	O
IL-16	protein
at	O
the	O
transcriptional	O
level,	O
we	O
cloned	O
the	O
human	DNA
chromosomal	DNA
IL-16	DNA
gene	DNA
and	O
analyzed	O
its	O
promoter.	O
The	O
human	DNA
IL-16	DNA
gene	DNA
consists	O
of	O
seven	O
exons	DNA
and	O
six	O
introns	DNA
.	O
The	O
5'	DNA
sequences	DNA
up	O
to	O
nucleotide	O
-120	O
of	O
the	O
human	O
and	O
murine	O
IL-16	protein
genes	O
share	O
&gt;84%	O
sequence	O
homology	O
and	O
harbor	DNA
promoter	DNA
elements	DNA
for	O
constitutive	O
and	O
inducible	O
transcription	O
in	O
T	cell_type
cells	cell_type
.	O
Although	O
both	O
promoters	O
lack	O
any	O
TATA	DNA
box	DNA
,	O
they	O
contain	O
two	O
CAAT	DNA
box-like	DNA
motifs	DNA
and	O
three	O
binding	DNA
sites	DNA
of	O
GA-binding	protein
protein	protein
(GABP)	protein
transcription	protein
factors	protein
.	O
Two	O
of	O
these	O
motifs	O
are	O
part	O
of	O
a	O
highly	O
conserved	O
and	O
inducible	O
dyad	DNA
symmetry	DNA
element	DNA
shown	O
previously	O
to	O
control	O
a	O
remote	O
IL-2	DNA
enhancer	DNA
and	O
the	O
CD18	DNA
promoter	DNA
.	O
In	O
concert	O
with	O
the	O
coactivator	protein
CREB	protein
binding	protein
protein/p300	protein
,	O
which	O
interacts	O
with	O
GABPalpha	protein
,	O
the	O
binding	O
of	O
GABPalpha	protein
and	O
-beta	protein
to	O
the	O
dyad	DNA
symmetry	DNA
element	DNA
controls	O
the	O
induction	O
of	O
IL-16	DNA
promoter	DNA
in	O
T	cell_type
cells	cell_type
.	O
Supplementing	O
the	O
data	O
on	O
the	O
processing	O
of	O
pro-IL-16	protein
,	O
our	O
results	O
indicate	O
the	O
complexity	O
of	O
IL-16	protein
expression	O
,	O
which	O
is	O
tightly	O
controlled	O
at	O
the	O
transcriptional	O
and	O
posttranslational	O
levels	O
in	O
T	cell_type
lymphocytes	cell_type
.	O

Tuberculosis	O
and	O
chronic	O
hepatitis	O
B	O
virus	O
infection	O
in	O
Africans	O
and	O
variation	O
in	O
the	O
vitamin	DNA
D	DNA
receptor	DNA
gene	DNA
.	O
The	O
active	O
metabolite	O
of	O
vitamin	O
D,	O
1,25	O
dihydroxyvitamin	O
D3,	O
is	O
an	O
important	O
immunoregulatory	O
hormone	O
[1].	O
Its	O
effects	O
are	O
exerted	O
by	O
interaction	O
with	O
the	O
vitamin	protein
D	protein
receptor	protein
,	O
which	O
is	O
present	O
on	O
human	cell_type
monocytes	cell_type
and	O
activated	O
T	O
and	O
B	O
lymphocytes	O
.	O
Variation	O
in	O
the	O
vitamin	DNA
D	DNA
receptor	DNA
gene	DNA
was	O
typed	O
in	O
2015	O
subjects	O
from	O
large	O
case-control	O
studies	O
of	O
three	O
major	O
infectious	O
diseases	O
:	O
tuberculosis	O
,	O
malaria	O
,	O
and	O
hepatitis	O
B	O
virus	O
.	O
Homozygotes	O
for	O
a	O
polymorphism	O
at	O
codon	DNA
352	DNA
(	O
genotype	O
tt	O
)	O
were	O
significantly	O
underrepresented	O
among	O
those	O
with	O
tuberculosis	O
(chi2=6.22,	O
1	O
df,	O
P=.01)	O
and	O
persistent	O
hepatitis	O
B	O
infection	O
(chi2=6.25,	O
1	O
df,	O
P=.01)	O
but	O
not	O
in	O
subjects	O
with	O
clinical	O
malaria	O
compared	O
with	O
the	O
other	O
genotypes	O
.	O
Therefore,	O
this	O
genetic	O
variant,	O
which	O
predisposes	O
to	O
low	O
bone	O
mineral	O
density	O
in	O
many	O
populations,	O
may	O
confer	O
resistance	O
to	O
certain	O
infectious	O
diseases	O
.	O

Inhibition	O
of	O
NF-kappa	protein
B	protein
activation	O
in	O
vitro	O
and	O
in	O
vivo:	O
role	O
of	O
26S	protein
proteasome	protein
.	O
It	O
is	O
becoming	O
increasingly	O
apparent	O
that	O
NF-kappa	protein
B	protein
plays	O
a	O
critical	O
role	O
in	O
regulating	O
the	O
inflammatory	O
response	O
.	O
Data	O
obtained	O
from	O
studies	O
in	O
our	O
laboratories	O
demonstrate	O
that	O
the	O
proteasome	O
plays	O
an	O
important	O
role	O
in	O
the	O
inflammatory	O
cascade	O
by	O
regulating	O
the	O
activation	O
of	O
NF-kappa	protein
B	protein
.	O
Indeed,	O
the	O
availability	O
of	O
selective	O
and	O
orally	O
active	O
proteasome	O
inhibitors	O
should	O
prove	O
useful	O
in	O
delineating	O
the	O
roles	O
of	O
the	O
proteasome	O
and	O
NF-kappa	protein
B	protein
in	O
other	O
pathophysiological	O
conditions	O
such	O
as	O
cancer	O
and	O
heart	O
disease	O
.	O

Tissue	O
factor	O
expression	O
of	O
human	cell_type
monocytes	cell_type
is	O
suppressed	O
by	O
lysophosphatidylcholine	O
.	O
The	O
expression	O
of	O
tissue	protein
factor	protein
(	O
TF	protein
),	O
the	O
principal	O
initiator	O
of	O
coagulation	O
,	O
is	O
increased	O
during	O
inflammation	O
and	O
atherosclerosis	O
.	O
Both	O
conditions	O
are	O
promoted	O
by	O
lysophosphatidylcholine	O
(	O
lysoPC	O
).	O
We	O
observed	O
in	O
the	O
present	O
study	O
that	O
lysoPC	O
(1	O
to	O
10	O
micromol/L)	O
dose-dependently	O
reduced	O
TF	protein
activity	O
in	O
human	cell_type
monocytes	cell_type
,	O
as	O
elicited	O
by	O
lipopolysaccharide	O
(	O
LPS	O
).	O
Lysophosphatidylethanolamine	O
(	O
lysoPE	O
)	O
and	O
other	O
lysophospholipids	O
did	O
not	O
affect	O
LPS	O
-induced	O
TF	O
activity	O
of	O
human	cell_type
monocytes	cell_type
.	O
TF	O
antigen	O
expression	O
as	O
elicited	O
by	O
LPS	O
was	O
also	O
lowered	O
by	O
lysoPC	O
.	O
Phospholipid	O
analyses	O
indicated	O
a	O
selective	O
increase	O
in	O
the	O
lysoPC	O
content	O
of	O
the	O
monocytes	cell_type
after	O
preincubation	O
with	O
the	O
lysophospholipid.	O
LysoPC	O
inhibited	O
the	O
TF	O
activity	O
of	O
Mono	cell_line
Mac-6	cell_line
cells	cell_line
to	O
a	O
similar	O
extent	O
as	O
in	O
the	O
monocytes	cell_type
.	O
LPS	O
binding	O
to	O
plasma	O
membrane	O
receptors	O
and	O
internalization	O
of	O
LPS	O
into	O
monocytes	cell_type
were	O
not	O
affected	O
by	O
lysoPC	O
.	O
In	O
contrast,	O
LPS	O
-mediated	O
nuclear	O
binding	O
of	O
nuclear	protein
factor-kappaB/Rel	protein
to	O
a	O
TF-specific	DNA
kappaB	DNA
site	DNA
was	O
inhibited	O
by	O
lysoPC	O
.	O
Induction	O
of	O
TF	RNA
mRNA	RNA
expression	O
by	O
LPS	O
tended	O
to	O
be	O
partially	O
reduced	O
by	O
the	O
lysophospholipid	O
.	O
Preincubation	O
with	O
lysoPC	O
increased	O
monocytic	O
cAMP	O
levels	O
.	O
Inhibition	O
of	O
adenylyl	protein
cyclase	protein
by	O
pretreatment	O
with	O
2'-deoxy-3'-adenosine	protein
monophosphate	protein
partially	O
reversed	O
the	O
inhibition	O
of	O
TF	O
activity	O
promoted	O
by	O
lysoPC	O
.	O
In	O
conclusion,	O
lysoPC	O
markedly	O
decreases	O
LPS	O
-mediated	O
TF	O
expression	O
of	O
human	cell_type
monocytes	cell_type
,	O
the	O
effect	O
probably	O
being	O
mediated	O
by	O
both	O
transcriptional	O
and	O
posttranscriptional	O
mechanisms.	O
LysoPC	O
may	O
thus	O
attenuate	O
activation	O
of	O
coagulation	O
during	O
inflammation	O
and	O
atherosclerosis	O
.	O

Regulation	O
of	O
fas-ligand	O
expression	O
during	O
activation-induced	O
cell	O
death	O
in	O
T	cell_type
lymphocytes	cell_type
via	O
nuclear	protein
factor	protein
kappaB	protein
.	O
T	O
cell	O
receptor	O
engagement	O
activates	O
transcription	protein
factors	protein
important	O
for	O
cytokine	DNA
gene	DNA
regulation	O
.	O
Additionally,	O
this	O
signaling	O
pathway	O
also	O
leads	O
to	O
activation-induced	O
apoptosis	O
in	O
T	cell_type
lymphocytes	cell_type
that	O
is	O
dependent	O
on	O
FasL	O
transcription	O
and	O
expression	O
.	O
Here	O
we	O
demonstrate	O
that	O
nuclear	protein
factor	protein
kappaB	protein
(	O
NF-kappaB	protein
),	O
which	O
is	O
involved	O
in	O
the	O
transcriptional	O
regulation	O
of	O
many	O
cytokine	DNA
genes	DNA
expressed	O
in	O
activated	cell_type
lymphocytes	cell_type
,	O
also	O
plays	O
a	O
role	O
in	O
T	O
cell	O
activation-induced	O
FasL	protein
expression	O
.	O
Inhibition	O
of	O
NF-kappaB	protein
activity	O
in	O
a	O
T	cell_line
cell	cell_line
hybridoma	cell_line
leads	O
to	O
decreased	O
FasL	protein
expression	O
and	O
apoptosis	O
upon	O
T	protein
cell	protein
receptor	protein
stimulation	O
.	O
We	O
identified	O
the	O
NF-kappaB	DNA
site	DNA
in	O
the	O
FasL	DNA
promoter	DNA
that	O
contributes	O
to	O
such	O
regulation.	O
Co-expression	O
of	O
p65	protein
(Rel	protein
A)	protein
with	O
the	O
FasL	DNA
promoter	DNA
enhanced	O
its	O
activity,	O
and	O
co-expression	O
of	O
IkappaB	protein
dramatically	O
inhibited	O
the	O
inducible	DNA
promoter	DNA
activity	O
.	O
In	O
contrast,	O
the	O
transcription	protein
factor	protein
AP-1	protein
is	O
not	O
required	O
for	O
activation-induced	O
FasL	protein
promoter	O
activity	O
.	O
These	O
results	O
define	O
a	O
role	O
for	O
NF-kappaB	protein
in	O
mediating	O
FasL	protein
expression	O
during	O
T	O
cell	O
activation	O
.	O

Promoter	DNA
sequence	DNA
,	O
exon:intron	DNA
structure	DNA
,	O
and	O
synteny	O
of	O
genetic	O
location	O
show	O
that	O
a	O
chicken	protein
cytokine	protein
with	O
T-cell	O
proliferative	O
activity	O
is	O
IL2	protein
and	O
not	O
IL15	protein
.	O
The	O
gene	O
encoding	O
a	O
chicken	protein
cytokine	protein
with	O
T-cell	O
proliferative	O
activity	O
was	O
cloned,	O
sequenced,	O
and	O
mapped.	O
The	O
results	O
show	O
that	O
this	O
cytokine	protein
is	O
chicken	O
IL2	protein
and	O
not	O
IL15	protein
.	O
The	O
exon:intron	DNA
structure	DNA
of	O
chicken	protein
IL2	protein
corresponds	O
almost	O
exactly	O
to	O
those	O
of	O
mammalian	O
IL2s	protein
with	O
the	O
exceptions	O
of	O
exon	DNA
2	DNA
and	O
introns	DNA
2	O
and	O
3	O
which	O
are	O
shorter.	O
Chicken	O
IL2	protein
contains	O
five	O
repeats	O
of	O
the	O
"instability"	O
motif	O
ATTTA	O
in	O
the	O
3'untranslated	DNA
region	DNA
in	O
exon	DNA
4	DNA
.	O
It	O
is	O
a	O
single-copy	DNA
gene	DNA
,	O
with	O
neither	O
structural	O
(amino	O
acid)	O
nor	O
promoter	O
sequence	O
polymorphisms	O
identified.	O
Analysis	O
of	O
the	O
predicted	protein
amino	protein
acid	protein
sequence	protein
suggests	O
that	O
overall	O
protein	protein
structure	protein
is	O
conserved,	O
but	O
the	O
receptor	O
binding	O
sites	O
are	O
not.	O
A	O
number	O
of	O
potential	DNA
regulatory	DNA
sequences	DNA
similar	O
to	O
those	O
found	O
in	O
mammals	O
have	O
been	O
identified	O
in	O
the	O
promoter	DNA
.	O
These	O
include	O
(5'-3')	O
a	O
composite	O
NF-AT/	DNA
"AP-1"	DNA
element	DNA
,	O
a	O
CD28	DNA
response	DNA
element	DNA
,	O
an	O
AP-1	DNA
element	DNA
,	O
an	O
NF-AT	DNA
element	DNA
,	O
and	O
the	O
AP-1	DNA
part	DNA
of	DNA
an	DNA
AP-1/octamer	DNA
composite	DNA
element	DNA
.	O
The	O
mammalian	protein
NF-kappaB	protein
and	O
octamer	DNA
binding	DNA
sites	DNA
seem	O
to	O
be	O
absent,	O
although	O
there	O
are	O
alternative	O
potential	O
NF-kappaB	protein
and	O
octamer-binding	DNA
elements	DNA
in	O
the	O
chicken	DNA
IL2	DNA
promoter	DNA
,	O
in	O
close	O
proximity	O
to	O
their	O
mammalian	DNA
homologues	DNA
.	O
Sequence	O
comparisons	O
also	O
predict	O
other	O
potential	O
transcription	O
factor	O
binding	O
sites	O
as	O
yet	O
undescribed	O
in	O
mammalian	DNA
IL2	DNA
promoters	DNA
.	O
A	O
Taq	DNA
I	DNA
polymorphism	DNA
was	O
identified	O
which	O
enabled	O
chicken	O
IL2	protein
to	O
be	O
mapped	O
to	O
chromosome	DNA
4	DNA
,	O
linked	O
to	O
ANX5	DNA
,	O
with	O
synteny	O
with	O
mouse	DNA
chromosome	DNA
3	DNA
and	O
human	DNA
chromosome	DNA
4	DNA
.	O
This	O
is	O
the	O
first	O
non-mammalian	DNA
cytokine	DNA
gene	DNA
to	O
be	O
mapped.	O

Endothelial	O
production	O
of	O
MCP-1	protein
:	O
modulation	O
by	O
heparin	O
and	O
consequences	O
for	O
mononuclear	O
cell	O
activation	O
.	O
Heparin	O
is	O
a	O
polyanionic	O
glycosaminoglycan	O
(	O
GAG	O
)	O
that	O
can	O
bind	O
with	O
high	O
affinity	O
to	O
a	O
range	O
of	O
cytokines	protein
including	O
interferon-gamma	protein
(	O
IFN-gamma	protein
)	O
and	O
members	O
of	O
the	O
chemokine	protein
superfamily	protein
.	O
This	O
GAG	O
also	O
possesses	O
immunomodulatory	O
activity	O
in	O
vivo	O
and	O
can	O
antagonize	O
the	O
capacity	O
of	O
IFN-gamma	protein
to	O
induce	O
class	protein
II	protein
MHC	protein
antigen	protein
expression	O
,	O
and	O
to	O
up-regulate	O
intercellular	protein
adhesion	protein
molecule-1	protein
,	O
by	O
cultured	cell_line
endothelial	cell_line
cells	cell_line
.	O
Previous	O
studies	O
have	O
shown	O
that	O
binding	O
to	O
cell-surface	O
heparan	O
sulphate	O
is	O
essential	O
for	O
optimal	O
activity	O
of	O
IFN-gamma	protein
and	O
that	O
free	O
heparin	O
competitively	O
inhibits	O
this	O
sequestration	O
process	O
.	O
The	O
present	O
study	O
was	O
performed	O
to	O
increase	O
our	O
understanding	O
of	O
the	O
immunosuppressive	O
activity	O
of	O
heparin	O
by	O
investigation	O
of	O
potential	O
antagonism	O
of	O
the	O
production	O
and	O
function	O
of	O
monocyte	protein
chemotactic	protein
peptide-1	protein
(	O
MCP-1	protein
),	O
a	O
chemokine	protein
important	O
for	O
mononuclear	O
leucocyte	O
recruitment	O
across	O
vascular	O
endothelium	O
.	O
It	O
was	O
found	O
that	O
mixture	O
of	O
heparin	O
with	O
IFN-gamma	protein
inhibited	O
up-regulation	O
of	O
the	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
protein,	O
STAT-1	protein
produced	O
normally	O
by	O
treatment	O
of	O
endothelial	cell_type
cells	cell_type
with	O
IFN-gamma	protein
.	O
An	O
inhibition	O
of	O
MCP-1	protein
production	O
was	O
observed	O
that	O
was	O
specifically	O
caused	O
by	O
mixture	O
of	O
IFN-gamma	protein
with	O
heparin-like	O
,	O
and	O
therefore	O
cytokine-binding	O
,	O
GAGs	O
.	O
It	O
was	O
also	O
shown	O
that	O
mixture	O
of	O
heparin	O
-like	O
GAGs	O
with	O
MCP-1	protein
inhibited	O
the	O
rapid	O
tyrosine	O
phosphorylation	O
of	O
phosphatidylinositol	protein
3-kinase	protein
which	O
is	O
normally	O
produced	O
by	O
treatment	O
of	O
mononuclear	cell_type
leucocytes	cell_type
with	O
this	O
chemokine	protein
.	O
Blockade	O
of	O
this	O
intracellular	O
signalling	O
event	O
was	O
associated	O
with	O
a	O
reduction	O
in	O
the	O
normal	O
transendothelial	O
migration	O
response	O
towards	O
MCP-1	protein
.	O
Results	O
from	O
this	O
study	O
indicate	O
that	O
soluble,	O
heparin	O
-like	O
GAGs	O
can	O
block	O
IFN-gamma	protein
-dependent	O
up-regulation	O
of	O
MCP-1	protein
production	O
by	O
cultured	cell_line
endothelial	cell_line
cells	cell_line
,	O
and	O
can	O
also	O
antagonize	O
the	O
leucocyte-activating	O
and	O
migration-promoting	O
properties	O
of	O
pre-existing	O
MCP-1	protein
.	O
These	O
activities	O
may	O
contribute	O
to	O
the	O
immunomodulatory	O
properties	O
of	O
heparin	O
.	O

[	O
Molecular-biologic	O
aspects	O
of	O
interaction	O
between	O
nervous	O
and	O
immune	O
systems	O
]	O
The	O
problem	O
of	O
the	O
neuro-immuno	O
interactions	O
on	O
the	O
level	O
of	O
the	O
protein	protein
trans-factors	protein
,	O
stimulating	O
interleukin-2	DNA
(	DNA
IL-2	DNA
)	DNA
gene	DNA
expression	O
was	O
discussed.	O
The	O
physico-chemical	O
and	O
functional	O
parameters	O
of	O
the	O
low	protein
molecular	protein
nuclear	protein
proteins	protein
(	O
SP	protein
and	O
BP-	O
14	O
,	O
18	O
,	O
19	O
kDs	O
)	O
isolated	O
from	O
splenic	O
and	O
brain	O
cells	O
of	O
immunized	O
rats	O
were	O
studied.	O
The	O
binding	O
of	O
these	O
proteins	O
to	O
the	O
regulatory	O
region	O
of	O
IL-2	DNA
gene	DNA
in	O
vitro	O
and	O
stimulation	O
of	O
the	O
IL-2mRNA	RNA
synthesis	O
in	O
splenic	cell_line
T-lymphocytes	cell_line
culture	cell_line
in	O
normal	O
conditions	O
were	O
shown.	O
The	O
protective	O
effect	O
of	O
SP	protein
and	O
BP	protein
on	O
the	O
IL-2mRNA	RNA
synthesis	O
in	O
stressful	O
conditions	O
and	O
by	O
the	O
T-cells	cell_type
treatment	O
with	O
the	O
CsA	O
was	O
demonstrated.	O

Interferon-alpha	protein
activates	O
multiple	O
STAT	protein
proteins	protein
and	O
upregulates	O
proliferation-associated	O
IL-2Ralpha	protein
,	O
c-myc	DNA
,	DNA
and	DNA
pim-1	DNA
genes	DNA
in	O
human	cell_type
T	cell_type
cells	cell_type
.	O
Interferon-alpha	protein
(	O
IFN-alpha	protein
)	O
is	O
a	O
pleiotropic	protein
cytokine	protein
that	O
has	O
antiviral,	O
antiproliferative,	O
and	O
immunoregulatory	protein
functions	O
.	O
There	O
is	O
increasing	O
evidence	O
that	O
IFN-alpha	protein
has	O
an	O
important	O
role	O
in	O
T-cell	O
biology	O
.	O
We	O
have	O
analyzed	O
the	O
expression	O
of	O
IL-2Ralpha	protein
,	O
c-myc	DNA
,	O
and	O
pim-1	DNA
genes	DNA
in	O
anti-CD3-activated	cell_type
human	cell_type
T	cell_type
lymphocytes	cell_type
.	O
The	O
induction	O
of	O
these	O
genes	O
is	O
associated	O
with	O
interleukin-2	protein
(	O
IL-2	protein
)-induced	O
T-cell	O
proliferation	O
.	O
Treatment	O
of	O
T	cell_type
lymphocytes	cell_type
with	O
IFN-alpha	protein
,	O
IL-2	protein
,	O
IL-12	protein
,	O
and	O
IL-15	protein
upregulated	O
IL-2Ralpha	protein
,	O
c-myc	DNA
,	O
and	O
pim-1	DNA
gene	DNA
expression	O
.	O
IFN-alpha	protein
also	O
sensitized	cell_line
T	cell_line
cells	cell_line
to	O
IL-2	protein
-induced	O
proliferation	O
,	O
further	O
suggesting	O
that	O
IFN-alpha	protein
may	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
T-cell	O
mitogenesis	O
.	O
When	O
we	O
analyzed	O
the	O
nature	O
of	O
STAT	protein
proteins	protein
capable	O
of	O
binding	O
to	O
IL-2Ralpha	protein
,	O
pim-1	O
,	O
and	O
IRF-1	O
GAS	O
elements	O
after	O
cytokine	protein
stimulation	O
,	O
we	O
observed	O
IFN-alpha	protein
-induced	O
binding	O
of	O
STAT1	protein
,	O
STAT3	protein
,	O
and	O
STAT4	protein
,	O
but	O
not	O
STAT5	protein
to	O
all	O
of	O
these	O
elements.	O
Yet,	O
IFN-alpha	protein
was	O
able	O
to	O
activate	O
binding	O
of	O
STAT5	protein
to	O
the	O
high-affinity	O
IFP53	O
GAS	O
site.	O
IFN-alpha	protein
enhanced	O
tyrosine	O
phosphorylation	O
of	O
STAT1,	O
STAT3	protein
,	O
STAT4	protein
,	O
STAT5a	protein
,	O
and	O
STAT5b	protein
.	O
IL-12	protein
induced	O
STAT4	protein
and	O
IL-2	protein
and	O
IL-15	protein
induced	O
STAT5	protein
binding	O
to	O
the	O
GAS	DNA
elements	DNA
.	O
Taken	O
together,	O
our	O
results	O
suggest	O
that	O
IFN-alpha	protein
,	O
IL-2	protein
,	O
IL-12	protein
,	O
and	O
IL-15	protein
have	O
overlapping	O
activities	O
on	O
human	cell_type
T	cell_type
cells	cell_type
.	O
These	O
findings	O
thus	O
emphasize	O
the	O
importance	O
of	O
IFN-alpha	protein
as	O
a	O
T-cell	protein
regulatory	protein
cytokine	protein
.	O

The	O
Megakaryocyte/Platelet-specific	DNA
enhancer	DNA
of	O
the	O
alpha2beta1	DNA
integrin	DNA
gene	DNA
:	O
two	O
tandem	O
AP1	DNA
sites	DNA
and	O
the	O
mitogen-activated	protein
protein	protein
kinase	protein
signaling	O
cascade	O
.	O
The	O
alpha2beta1	protein
integrin	protein
,	O
a	O
collagen	O
receptor	O
on	O
platelets	cell_type
and	O
megakaryocytes	cell_type
,	O
is	O
required	O
for	O
normal	O
platelet	O
function	O
.	O
Transcriptional	O
regulation	O
of	O
the	O
alpha2	DNA
integrin	DNA
gene	DNA
in	O
cells	O
undergoing	O
megakaryocytic	O
differentiation	O
requires	O
a	O
core	DNA
promoter	DNA
between	O
bp	O
-30	O
and	O
-92,	O
a	O
silencer	DNA
between	O
bp	O
-92	O
and	O
-351,	O
and	O
megakaryocytic	DNA
enhancers	DNA
in	O
the	O
distal	DNA
5'	DNA
flank	DNA
.	O
We	O
have	O
now	O
identified	O
a	O
229-bp	DNA
region	DNA
of	O
the	O
distal	DNA
5'	DNA
flank	DNA
of	O
the	O
alpha2	DNA
integrin	DNA
gene	DNA
required	O
for	O
high-level	cell_type
enhancer	cell_type
activity	cell_type
in	cell_type
cells	cell_type
with	O
megakaryocytic	O
features	O
.	O
Two	O
tandem	O
AP1	DNA
binding	DNA
sites	DNA
with	O
dyad	O
symmetry	O
are	O
required	O
for	O
enhancer	O
activity	O
and	O
for	O
DNA-protein	protein
complex	protein
formation	O
with	O
members	O
of	O
the	O
c-fos/c-jun	protein
family	protein
.	O
The	O
requirement	O
for	O
AP1	protein
activation	O
suggested	O
a	O
role	O
for	O
the	O
mitogen-activated	protein
protein	protein
kinase	protein
(	O
MAPK	protein
)	O
signaling	O
pathway	O
in	O
regulating	O
alpha2	DNA
integrin	DNA
gene	DNA
expression	O
.	O
Inhibition	O
of	O
the	O
MAP	protein
kinase	protein
cascade	O
with	O
PD98059	O
,	O
a	O
specific	O
inhibitor	O
of	O
MAPK	protein
kinase	protein
1	protein
,	O
prevented	O
the	O
expression	O
of	O
the	O
alpha2	protein
integrin	protein
subunit	protein
in	O
cells	O
induced	O
to	O
become	O
megakaryocytic.	O
We	O
provide	O
a	O
model	O
of	O
megakaryocytic	O
differentiation	O
in	O
which	O
expression	O
of	O
the	O
alpha2	DNA
integrin	DNA
gene	DNA
requires	O
signaling	O
via	O
the	O
MAP	protein
kinase	protein
pathway	O
to	O
activate	O
two	O
tandem	O
AP1	DNA
binding	DNA
sites	DNA
in	O
the	O
alpha2	DNA
integrin	DNA
enhancer	DNA
.	O

Functional	O
association	O
of	O
Nmi	protein
with	O
Stat5	protein
and	O
Stat1	protein
in	O
IL-2	protein
-and	O
IFNgamma	protein
-mediated	O
signaling	O
.	O
Using	O
the	O
coiled-coil	O
region	O
of	O
Stat5b	protein
as	O
the	O
bait	O
in	O
a	O
yeast	O
two-hybrid	O
screen	O
,	O
we	O
identified	O
the	O
association	O
of	O
Nmi	protein
,	O
a	O
protein	O
of	O
unknown	O
function	O
previously	O
reported	O
as	O
an	O
N-Myc	protein
interactor	O
.	O
We	O
further	O
show	O
that	O
Nmi	protein
interacts	O
with	O
all	O
STATs	protein
except	O
Stat2	protein
.	O
We	O
evaluated	O
two	O
cytokine	O
systems,	O
IL-2	protein
and	O
IFNgamma	protein
,	O
and	O
demonstrate	O
that	O
Nmi	protein
augments	O
STAT	protein
-mediated	O
transcription	O
in	O
response	O
to	O
these	O
cytokines	protein
.	O
Interestingly,	O
Nmi	protein
lacks	O
an	O
intrinsic	O
transcriptional	protein
activation	protein
domain	protein
;	O
instead,	O
Nmi	protein
enhances	O
the	O
association	O
of	O
CBP/p300	protein
coactivator	protein
proteins	protein
with	O
Stat1	protein
and	O
Stat5	protein
,	O
and	O
together	O
with	O
CBP/p300	protein
can	O
augment	O
IL-2-	O
and	O
IFNgamma-	O
dependent	O
transcription	O
.	O
Therefore,	O
our	O
data	O
not	O
only	O
reveal	O
that	O
Nmi	protein
can	O
potentiate	O
STAT	protein
-dependent	O
transcription	O
,	O
but	O
also	O
suggest	O
that	O
it	O
can	O
augment	O
coactivator	O
protein	O
recruitment	O
to	O
at	O
least	O
some	O
members	O
of	O
a	O
group	O
of	O
sequence-specific	protein
transcription	protein
factors	protein
.	O

Lactobacilli	O
and	O
vaginal	O
host	O
defense:	O
activation	O
of	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
type	DNA
1	DNA
long	DNA
terminal	DNA
repeat	DNA
,	O
cytokine	protein
production	O
,	O
and	O
NF-kappaB	protein
.	O
Lactobacilli,	O
a	O
component	O
of	O
the	O
normal	O
vaginal	O
flora,	O
can	O
activate	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
(HIV)-1	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
in	O
the	O
Jurkat	cell_line
T	cell_line
lymphocyte	cell_line
and	O
THP-1	cell_line
macrophage	cell_line
cell	cell_line
lines	cell_line
.	O
Activation	O
of	O
the	O
LTR	DNA
in	O
Jurkat	cell_line
cells	cell_line
was	O
strongly	O
enhanced	O
by	O
vanadate	O
and	O
inhibited	O
by	O
catalase	protein
,	O
implicating	O
H2O2	O
.	O
In	O
contrast,	O
activation	O
in	O
THP-1	protein
cells	protein
occurred	O
in	O
the	O
absence	O
of	O
vanadate	O
and	O
was	O
unaffected	O
by	O
catalase	protein
.	O
The	O
active	O
material	O
partitioned	O
into	O
the	O
phenol	O
layer	O
on	O
hot	O
aqueous	O
phenol	O
extraction	O
.	O
Lactobacilli	O
also	O
increased	O
tumor	protein
necrosis	protein
factor	protein
-alphaand	O
interleukin	protein
-1betaproduction	O
and	O
activated	O
NF-kappaB	protein
in	O
THP-1	protein
cells	protein
and	O
increased	O
tumor	protein
necrosis	protein
factor	protein
-alphaproduction	O
by	O
human	cell_type
monocytes	cell_type
.	O
Human	O
vaginal	O
fluid	O
specimens	O
had	O
comparable	O
properties	O
,	O
which	O
correlated	O
with	O
their	O
bacterial	O
content	O
.	O
These	O
findings	O
suggest	O
the	O
presence	O
in	O
vaginal	O
fluid	O
of	O
agent(s)	O
derived	O
from	O
indigenous	O
bacteria	O
that	O
can	O
activate	O
the	O
HIV-1	DNA
LTR	DNA
,	O
cytokine	protein
production	O
,	O
and	O
NF-kappaB	protein
in	O
cells	O
of	O
macrophage	cell_type
lineage	cell_type
,	O
with	O
possible	O
influence	O
on	O
vaginal	O
physiology	O
and	O
host	O
defense	O
.	O

T	O
cell	O
priming	O
enhances	O
IL-4	DNA
gene	DNA
expression	O
by	O
increasing	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
.	O
The	O
repetitive	O
activation	O
of	O
T	cell_type
cells	cell_type
(priming)	O
enhances	O
the	O
expression	O
of	O
many	O
cytokines	protein
,	O
such	O
as	O
IL-4,	O
but	O
not	O
others,	O
such	O
as	O
IL-2	protein
.	O
Molecular	O
mechanisms	O
underlying	O
selective	O
expression	O
of	O
cytokines	protein
by	O
T	cell_type
cells	cell_type
remain	O
poorly	O
understood.	O
Here	O
we	O
show	O
that	O
priming	O
of	O
CD4	cell_type
T	cell_type
cells	cell_type
selectively	O
enhances	O
IL-4	protein
expression	O
relative	O
to	O
IL-2	protein
expression	O
by	O
a	O
transcriptional	O
mechanism	O
involving	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(NFAT)	protein
proteins	protein
.	O
As	O
detected	O
by	O
in	O
vivo	O
footprinting	O
,	O
priming	O
markedly	O
increases	O
the	O
activation-dependent	O
engagement	O
of	O
the	O
P0	DNA
and	O
P1	DNA
NFAT-binding	DNA
elements	DNA
of	O
the	O
IL-4	DNA
promoter	DNA
.	O
Moreover,	O
each	O
proximal	DNA
P	DNA
element	DNA
is	O
essential	O
for	O
optimal	O
IL-4	DNA
promoter	DNA
activity	O
.	O
Activated	O
primed	O
CD4	cell_type
T	cell_type
cells	cell_type
contain	O
more	O
NFAT1	protein
and	O
support	O
greater	O
NFAT	protein
-directed	O
transcription	O
than	O
unprimed	O
CD4	cell_type
T	cell_type
cells	cell_type
,	O
while	O
activator	protein
protein	protein
1	protein
binding	O
and	O
activator	protein
protein	protein
1	protein
-mediated	O
transcription	O
by	O
both	O
cell	O
types	O
is	O
similar.	O
Increased	O
expression	O
of	O
wild-type	O
NFAT1	protein
substantially	O
increases	O
IL-4	DNA
promoter	DNA
activity	O
in	O
unprimed	O
CD4	cell_type
T	cell_type
cells	cell_type
,	O
suggesting	O
NFAT1	protein
may	O
be	O
limiting	O
for	O
IL-4	protein
gene	O
expression	O
in	O
this	O
cell	O
type.	O
Furthermore,	O
a	O
truncated	O
form	O
of	O
NFAT1	protein
acts	O
as	O
a	O
dominant-negative,	O
reducing	O
IL-4	DNA
promoter	DNA
activity	O
in	O
primed	O
CD4	cell_type
T	cell_type
cells	cell_type
and	O
confirming	O
the	O
importance	O
of	O
endogenous	protein
NFAT	protein
to	O
increased	O
IL-4	protein
gene	O
expression	O
by	O
effector	O
T	O
cells.	O
NFAT1	protein
appears	O
to	O
be	O
the	O
major	O
NFAT	protein
family	protein
member	protein
responsible	O
for	O
the	O
initial	O
increased	O
expression	O
of	O
IL-4	protein
by	O
primed	O
CD4	cell_type
T	cell_type
cells	cell_type
.	O

Differential	O
monocyte	O
adhesion	O
and	O
adhesion	protein
molecule	protein
expression	O
in	O
venous	O
and	O
arterial	O
endothelial	O
cells.	O
We	O
compared	O
U-937	cell_line
cell	cell_line
adhesion	O
and	O
adhesion	protein
molecule	protein
expression	O
in	O
human	cell_type
umbilical	cell_type
venous	cell_type
(	O
HUVECs	cell_type
)	O
and	O
arterial	cell_type
(HUAECs)	cell_type
endothelial	cell_type
cells	cell_type
exposed	O
to	O
tumor	protein
necrosis	protein
factor	protein
(	O
TNF	protein
),	O
interleukin-1	protein
,	O
and	O
lipopolysaccharide	O
(	O
LPS	O
).	O
TNF	protein
and	O
LPS	O
stimulated	O
vascular	protein
cell	protein
adhesion	protein
molecule	protein
(	O
VCAM	protein
)-1	O
surface	O
expression	O
and	O
adhesion	O
of	O
U-937	cell_line
monocyte-like	cell_line
cells	cell_line
to	O
HUVECs	cell_type
but	O
not	O
to	O
HUAECs	cell_type
.	O
Antibody	O
studies	O
demonstrated	O
that	O
in	O
HUVECs	cell_type
at	O
least	O
75%	O
of	O
the	O
adhesion	O
response	O
is	O
VCAM-1	protein
mediated	O
.	O
Interleukin-1	protein
stimulated	O
U-937	cell_line
cell	cell_line
adhesion	O
to	O
and	O
VCAM-1	protein
surface	O
expression	O
in	O
both	O
HUVECs	cell_type
and	O
HUAECs	cell_type
.	O
Pyrrolidinedithiocarbamate	O
and	O
the	O
proteasome	O
inhibitor	O
MG-132	O
blocked	O
TNF	protein
-and	O
LPS	O
-stimulated	O
U-937	cell_line
cell	cell_line
adhesion	O
to	O
HUVECs	cell_type
.	O
These	O
agents	O
also	O
significantly	O
decreased	O
TNF	protein
-and	O
LPS	O
-stimulated	O
increases	O
in	O
HUVEC	protein
surface	protein
VCAM-1	protein
.	O
TNF	protein
increased	O
VCAM-1	protein
protein	O
and	O
mRNA	RNA
in	O
HUVECs	cell_type
that	O
was	O
blocked	O
by	O
pyrrolidinedithiocarbamate	O
.	O
However,	O
neither	O
TNF	protein
or	O
LPS	O
stimulated	O
VCAM-1	protein
expression	O
in	O
HUAECs	cell_type
.	O
TNF	protein
stimulated	O
expression	O
of	O
both	O
intercellular	protein
adhesion	protein
molecule-1	protein
and	O
E-selectin	protein
in	O
HUVECs	cell_type
,	O
but	O
in	O
HUAECs	cell_type
,	O
only	O
intercellular	protein
adhesion	protein
molecule-1	protein
was	O
increased.	O
Electrophoretic	O
mobility	O
shift	O
assays	O
demonstrated	O
no	O
difference	O
in	O
the	O
pattern	O
of	O
TNF	protein
-stimulated	O
nuclear	protein
factor-kappaB	protein
activation	O
between	O
HUVECs	cell_type
and	O
HUAECs	cell_type
.	O
These	O
studies	O
demonstrate	O
a	O
novel	O
and	O
striking	O
insensitivity	O
of	O
arterial	O
endothelium	O
to	O
the	O
effects	O
of	O
TNF	protein
and	O
LPS	O
and	O
indicate	O
a	O
dissociation	O
between	O
the	O
ability	O
of	O
HUAECs	cell_type
to	O
upregulate	O
nuclear	protein
factor-kappaB	protein
and	O
VCAM-1	protein
.	O

Functional	O
testosterone	protein
receptors	protein
in	O
plasma	O
membranes	O
of	O
T	cell_type
cells	cell_type
.	O
T	cell_type
cells	cell_type
are	O
considered	O
to	O
be	O
unresponsive	O
to	O
testosterone	O
due	O
to	O
the	O
absence	O
of	O
androgen	protein
receptors	protein
(	O
AR	protein
).	O
Here,	O
we	O
demonstrate	O
the	O
testosterone	O
responsiveness	O
of	O
murine	cell_type
splenic	cell_type
T	cell_type
cells	cell_type
in	O
vitro	O
as	O
well	O
as	O
the	O
presence	O
of	O
unconventional	protein
cell	protein
surface	protein
receptors	protein
for	O
testosterone	O
and	O
classical	protein
intracellular	protein
AR	protein
.	O
Binding	O
sites	O
for	O
testosterone	O
on	O
the	O
surface	O
of	O
both	O
CD4(+)	O
and	O
CD8(+)	O
subsets	O
of	O
T	cell_type
cells	cell_type
are	O
directly	O
revealed	O
with	O
the	O
impeded	O
ligand	O
testosterone	O
-BSA-FITC	O
by	O
confocal	O
laser	O
scanning	O
microscopy	O
(	O
CLSM	O
)	O
and	O
flow	O
cytometry	O
,	O
respectively.	O
Binding	O
of	O
the	O
plasma	O
membrane	O
impermeable	O
testosterone	protein
-BSA	protein
conjugate	protein
induces	O
a	O
rapid	O
rise	O
(&lt;5	O
s)	O
in	O
[Ca2+]i	O
of	O
Fura-2-loaded	cell_type
T	cell_type
cells	cell_type
.	O
This	O
rise	O
reflects	O
influx	O
of	O
extracellular	O
Ca2+	O
through	O
non-voltage-gated	O
and	O
Ni2+-blockable	protein
Ca2+	protein
channels	protein
of	O
the	O
plasma	O
membrane	O
.	O
The	O
testosterone	O
-BSA-induced	O
Ca2+	O
import	O
is	O
not	O
affected	O
by	O
cyproterone,	O
a	O
blocker	O
of	O
the	O
AR	protein
.	O
In	O
addition,	O
AR	protein
are	O
not	O
detectable	O
on	O
the	O
surface	O
of	O
intact	cell_type
T	cell_type
cells	cell_type
when	O
using	O
anti-	protein
AR	protein
antibodies	protein
directed	O
against	O
the	O
amino	protein
and	protein
carboxy	protein
terminus	protein
of	O
the	O
AR	protein
,	O
although	O
T	cell_type
cells	cell_type
contain	O
AR	protein
,	O
as	O
revealed	O
by	O
reverse	O
transcription-polymerase	O
chain	O
reactions	O
and	O
Western	O
blotting	O
.	O
AR	protein
can	O
be	O
visualized	O
with	O
the	O
anti-	protein
AR	protein
antibodies	protein
in	O
the	O
cytoplasm	O
of	O
permeabilized	cell_type
T	cell_type
cells	cell_type
by	O
using	O
CLSM	O
,	O
though	O
AR	protein
are	O
not	O
detectable	O
in	O
cytosol	O
fractions	O
when	O
using	O
the	O
charcoal	O
binding	O
assay	O
with	O
3H-R1881	O
as	O
ligand.	O
Cytoplasmic	protein
AR	protein
do	O
not	O
translocate	O
to	O
the	O
nucleus	O
of	O
T	cell_type
cells	cell_type
in	O
the	O
presence	O
of	O
testosterone	O
,	O
in	O
contrast	O
to	O
cytoplasmic	protein
AR	protein
in	O
human	cell_line
cancer	cell_line
LNCaP	cell_line
cells	cell_line
.	O
These	O
findings	O
suggest	O
that	O
the	O
classical	protein
AR	protein
present	O
in	O
splenic	cell_type
T	cell_type
cells	cell_type
are	O
not	O
active	O
in	O
the	O
genomic	O
pathway	O
.	O
By	O
contrast,	O
the	O
cell	protein
surface	protein
receptors	protein
for	O
testosterone	O
are	O
in	O
a	O
functionally	O
active	O
state	O
,	O
enabling	O
T	cell_type
cells	cell_type
a	O
nongenomic	O
response	O
to	O
testosterone	O
.	O

Limited	O
proteolysis	O
for	O
assaying	O
ligand	O
binding	O
affinities	O
of	O
nuclear	protein
receptors	protein
.	O
The	O
binding	O
of	O
natural	O
or	O
synthetic	O
ligands	O
to	O
nuclear	protein
receptors	protein
is	O
the	O
triggering	O
event	O
leading	O
to	O
gene	O
transcription	O
activation	O
or	O
repression	O
.	O
Ligand	O
binding	O
to	O
the	O
ligand	protein
binding	protein
domain	protein
of	O
these	O
receptors	protein
induces	O
conformational	O
changes	O
that	O
are	O
evidenced	O
by	O
an	O
increased	O
resistance	O
of	O
this	O
domain	O
to	O
proteases	protein
.	O
In	protein
vitro	protein
labeled	protein
receptors	protein
were	O
incubated	O
with	O
various	O
synthetic	O
or	O
natural	O
agonists	O
or	O
antagonists	O
and	O
submitted	O
to	O
trypsin	protein
digestion	O
.	O
Proteolysis	O
products	O
were	O
separated	O
by	O
SDS-PAGE	O
and	O
quantified.	O
The	O
amount	O
of	O
trypsin	protein
-resistant	O
fragments	O
was	O
proportional	O
to	O
receptor	O
occupancy	O
by	O
the	O
ligand,	O
and	O
allowed	O
the	O
determination	O
of	O
dissociation	O
constants	O
(	O
kDa	O
).	O
Using	O
the	O
wild-type	O
or	O
mutated	O
human	O
retinoic	O
acid	O
receptor	O
alpha	O
as	O
a	O
model,	O
kDa	O
values	O
determined	O
by	O
classical	O
competition	O
binding	O
assays	O
using	O
tritiated	O
ligands	O
are	O
in	O
agreement	O
with	O
those	O
measured	O
by	O
the	O
proteolytic	O
assay	O
.	O
This	O
method	O
was	O
successfully	O
extended	O
to	O
human	protein
retinoic	protein
X	protein
receptor	protein
alpha	protein
,	O
glucocorticoid	protein
receptor	protein
,	O
and	O
progesterone	protein
receptor	protein
,	O
thus	O
providing	O
a	O
basis	O
for	O
a	O
new,	O
faster	O
assay	O
to	O
determine	O
simultaneously	O
the	O
affinity	O
and	O
conformation	O
of	O
receptors	O
when	O
bound	O
to	O
a	O
given	O
ligand.	O

Genes	O
that	O
regulate	O
interleukin-4	protein
expression	O
in	O
T	cell_type
cells	cell_type
.	O
Interleukin-4	protein
is	O
an	O
immunomodulatory	protein
cytokine	protein
which	O
plays	O
a	O
central	O
role	O
in	O
the	O
regulation	O
of	O
allergic	O
and	O
atopic	O
immune	O
responses	O
.	O
Significant	O
progress	O
has	O
been	O
made	O
in	O
gaining	O
a	O
detailed	O
understanding	O
of	O
the	O
transcriptional	O
regulation	O
of	O
the	O
interleukin-4	DNA
gene	DNA
.	O
The	O
recent	O
identification	O
and	O
characterization	O
of	O
several	O
key	O
transcription	protein
factors	protein
has	O
helped	O
to	O
elucidate	O
the	O
molecular	O
mechanisms	O
of	O
T	DNA
helper	DNA
cell	DNA
cytokine	DNA
gene	DNA
expression	O
.	O

B	cell_type
lymphocytes	cell_type
from	O
patients	O
with	O
chronic	O
lymphocytic	O
leukemia	O
contain	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
(STAT)	protein
1	protein
and	O
STAT3	protein
constitutively	O
phosphorylated	O
on	O
serine	O
residues	O
.	O
To	O
explore	O
the	O
pathogenesis	O
of	O
chronic	O
lymphocytic	O
leukemia	O
(	O
CLL	O
),	O
we	O
examined	O
whether	O
phosphorylation	O
of	O
one	O
or	O
more	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
(STAT)	protein
factors	protein
was	O
abnormal	O
in	O
cells	O
from	O
CLL	O
patients	O
.	O
No	O
constitutive	O
tyrosine	O
phosphorylation	O
was	O
detected	O
on	O
any	O
STAT	protein
in	O
CLL	cell_line
cells	cell_line
.	O
To	O
assess	O
the	O
phosphorylation	O
of	O
serine	O
residues	O
of	O
STAT1	protein
and	O
STAT3	protein
in	O
CLL	cell_line
cells	cell_line
,	O
we	O
raised	O
antibodies	O
that	O
specifically	O
recognize	O
the	O
form	O
of	O
STAT1	protein
phosphorylated	O
on	O
ser-727	O
and	O
the	O
form	O
of	O
STAT3	protein
phosphorylated	O
on	O
ser-727	O
.	O
We	O
found	O
that	O
in	O
100%	O
of	O
patients	O
with	O
CLL	O
(n	O
=	O
32),	O
STAT1	protein
and	O
STAT3	protein
were	O
constitutively	O
phosphorylated	O
on	O
serine	O
.	O
This	O
was	O
in	O
contrast	O
to	O
normal	O
peripheral	O
blood	O
B	cell_type
lymphocytes	cell_type
or	O
CD5+)	cell_type
B	cell_type
cells	cell_type
isolated	O
from	O
tonsils	O
,	O
in	O
which	O
this	O
phosphorylation	O
was	O
absent.	O
Serine	O
phosphorylation	O
of	O
STAT1	protein
and	O
STAT3	protein
was	O
seen	O
occasionally	O
in	O
other	O
leukemias	O
,	O
but	O
it	O
was	O
a	O
universal	O
finding	O
only	O
in	O
CLL	O
.	O
The	O
serine	O
phosphorylation	O
of	O
these	O
STATs	protein
was	O
a	O
continuous	O
process,	O
as	O
incubation	O
of	O
CLL	cell_line
cells	cell_line
with	O
the	O
kinase	protein
inhibitor	protein
H7	protein
led	O
to	O
the	O
dephosphorylation	O
of	O
these	O
serine	O
residues	O
.	O
The	O
STAT	O
serine	O
kinase	O
in	O
CLL	O
cells	O
has	O
not	O
been	O
identified,	O
and	O
appears	O
to	O
be	O
neither	O
mitogen-activated	protein
protein	protein
kinase	protein
nor	O
pp70(s6k)	protein
.	O
In	O
summary,	O
the	O
constitutive	O
serine	O
phosphorylation	O
of	O
STAT1	protein
and	O
STAT3	protein
is	O
present	O
in	O
all	O
CLL	O
samples	O
tested	O
to	O
date,	O
although	O
the	O
physiologic	O
significance	O
of	O
this	O
modification	O
remains	O
to	O
be	O
determined.	O

Activation	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
expression	O
by	O
Gardnerella	O
vaginalis	O
.	O
Bacterial	O
vaginosis	O
(	O
BV	O
)	O
is	O
associated	O
with	O
an	O
increased	O
rate	O
of	O
sexual	O
transmission	O
of	O
human	O
immunodeficiency	O
virus	O
(HIV)	O
type	O
1	O
,	O
and	O
Gardnerella	O
vaginalis	O
is	O
frequently	O
isolated	O
from	O
the	O
genital	O
tracts	O
of	O
women	O
with	O
BV	O
.	O
G.	O
vaginalis	O
lysates	O
were	O
found	O
to	O
significantly	O
stimulate	O
HIV	O
expression	O
in	O
monocytoid	cell_type
cells	cell_type
.	O
Stimulation	O
was	O
significantly	O
higher	O
when	O
lysates	O
were	O
heated	O
at	O
100	O
degrees	O
C	O
for	O
5	O
min	O
but	O
was	O
reduced	O
by	O
treatment	O
with	O
lysozyme	protein
or	O
protease	protein
.	O
G.	O
vaginalis	O
lysates	O
also	O
activated	O
HIV	O
expression	O
in	O
certain	O
T	cell_line
cell	cell_line
lines	cell_line
.	O
G.	O
vaginalis	O
lysates	O
activated	O
HIV	O
long-terminal	O
repeat	O
transcription	O
in	O
HIV	cell_type
-infected	cell_type
cells	cell_type
and	O
increased	O
NF-kappaB	protein
binding	O
activity	O
,	O
indicating	O
an	O
effect	O
by	O
G.	O
vaginalis	O
on	O
HIV	O
transcription.	O
The	O
activation	O
of	O
HIV	O
production	O
by	O
G.	O
vaginalis	O
suggests	O
that	O
genital	O
tract	O
infection	O
with	O
G.	O
vaginalis	O
increases	O
the	O
risk	O
of	O
HIV	O
transmission	O
by	O
increasing	O
HIV	O
expression	O
in	O
the	O
genital	O
tract	O
.	O
This	O
may	O
explain,	O
at	O
least	O
in	O
part,	O
the	O
increased	O
rate	O
of	O
HIV	O
transmission	O
in	O
women	O
with	O
BV	O
.	O

Interleukin-10	protein
inhibits	O
expression	O
of	O
both	O
interferon	O
alpha-	O
and	O
interferon	O
gamma-	O
induced	O
genes	O
by	O
suppressing	O
tyrosine	O
phosphorylation	O
of	O
STAT1	protein
.	O
Interleukin-10	protein
(	O
IL-10	protein
)	O
helps	O
maintain	O
polarized	cell_type
T-helper	cell_type
cells	cell_type
in	O
a	O
T-helper	cell_type
lymphocyte	cell_type
2	cell_type
(Th2)	cell_type
phenotype	cell_type
.	O
Part	O
of	O
this	O
process	O
involves	O
the	O
prevention	O
of	O
the	O
development	O
of	O
Th1	cell_type
cells	cell_type
,	O
which	O
are	O
a	O
primary	O
source	O
of	O
interferon	protein
gamma	protein
(	O
IFNgamma	protein
),	O
a	O
potent	O
activator	O
of	O
monocytes	cell_type
and	O
an	O
inhibitor	O
of	O
Th2	O
proliferation	O
.	O
Because	O
monocytes	cell_type
and	O
macrophages	O
are	O
important	O
mediators	O
of	O
Th1-type	O
responses	O
,	O
such	O
as	O
delayed-type	O
hypersensitivity	O
,	O
we	O
sought	O
to	O
determine	O
if	O
IL-10	protein
could	O
directly	O
mediate	O
inhibition	O
of	O
IFNgamma-	O
and	O
IFNalpha-	O
induced	O
gene	O
expression	O
in	O
these	O
cells.	O
Highly	O
purified	O
monocytes	cell_type
were	O
incubated	O
with	O
IL-10	protein
for	O
60	O
to	O
90	O
minutes	O
before	O
the	O
addition	O
of	O
IFNgamma	protein
or	O
IFNalpha	protein
.	O
IL-10	protein
preincubation	O
resulted	O
in	O
the	O
inhibition	O
of	O
gene	O
expression	O
for	O
several	O
IFN-induced	DNA
genes	DNA
,	O
such	O
as	O
IP-10	protein
,	O
ISG54	protein
,	O
and	O
intercellular	protein
adhesion	protein
molecule-1	protein
.	O
The	O
reduction	O
in	O
gene	O
expression	O
resulted	O
from	O
the	O
ability	O
of	O
IL-10	protein
to	O
suppress	O
IFN	protein
-induced	O
assembly	O
of	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
(STAT)	protein
factors	protein
to	O
specific	DNA
promoter	DNA
motifs	DNA
on	O
IFNalpha-	O
and	O
IFNgamma-	O
inducible	O
genes	O
.	O
This	O
was	O
accomplished	O
by	O
preventing	O
the	O
IFN-induced	O
tyrosine	O
phosphorylation	O
of	O
STAT1	protein
,	O
a	O
component	O
of	O
both	O
IFNalpha-	O
and	O
IFNgamma-	O
induced	O
DNA	O
binding	O
complexes	O
.	O
Therefore,	O
IL-10	protein
can	O
directly	O
inhibit	O
STAT-dependent	DNA
early	DNA
response	DNA
gene	DNA
expression	O
induced	O
by	O
both	O
IFNalpha	protein
and	O
IFNgamma	protein
in	O
monocytes	cell_type
by	O
suppressing	O
the	O
tyrosine	O
phosphorylation	O
of	O
STAT1	protein
.	O
This	O
may	O
occur	O
through	O
the	O
ability	O
of	O
IL-10	protein
to	O
induce	O
expression	O
of	O
the	O
gene,	O
suppressor	O
of	O
cytokine	protein
signaling	protein
3	protein
(	O
SOCS3	protein
).	O

Clonality	O
analysis	O
of	O
refractory	O
anemia	O
with	O
ring	cell_type
sideroblasts	cell_type
:	O
simultaneous	O
study	O
of	O
clonality	O
and	O
cytochemistry	O
of	O
bone	cell_type
marrow	cell_type
progenitors	cell_type
.	O
X	O
chromosome	O
inactivation	O
and	O
polymorphism	O
of	O
the	O
human	DNA
androgen	DNA
receptor	DNA
(	DNA
HUMARA	DNA
)	DNA
gene	DNA
has	O
been	O
applied	O
for	O
analyzing	O
the	O
clonality	O
of	O
blood	cell_type
cells	cell_type
.	O
In	O
the	O
present	O
study,	O
the	O
clonal	O
relationship	O
was	O
investigated	O
between	O
peripheral	cell_type
blood	cell_type
polymorphonuclear	cell_type
cells	cell_type
(	O
PMNCs	cell_type
)	O
and	O
marrow	cell_type
progenitor	cell_type
cells	cell_type
and	O
the	O
origin	O
of	O
ringed	cell_type
sideroblasts	cell_type
in	O
patients	O
with	O
refractory	O
anemia	O
with	O
ring	cell_type
sideroblasts	cell_type
(	O
RARS	cell_type
)	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
of	O
HUMARA	DNA
gene	DNA
.	O
The	O
X-inactivation	O
patterns	O
of	O
circulating	O
PMNCs	cell_type
and	O
T	cell_type
lymphocytes	cell_type
as	O
well	O
as	O
individual	O
granulocyte	cell_line
colonies	cell_line
grown	O
in	O
vitro	O
from	O
bone	O
marrow	O
cells	O
were	O
analyzed.	O
The	O
development	O
of	O
ringed	cell_type
sideroblasts	cell_type
in	O
erythroid	cell_line
colonies	cell_line
by	O
iron	O
staining	O
and	O
their	O
X-inactivation	O
pattern	O
were	O
also	O
examined.	O
All	O
three	O
RARS	cell_type
patients	O
showed	O
monoclonal	O
PMNCs	cell_type
.	O
In	O
granulocyte	cell_line
colonies	cell_line
,	O
however,	O
two	O
different	O
X-inactivation	O
patterns	O
were	O
observed	O
in	O
all	O
patients	O
,	O
indicating	O
that	O
non-clonal	cell_type
progenitor	cell_type
cells	cell_type
remained	O
in	O
the	O
bone	O
marrow	O
.	O
All	O
erythroid	cell_line
colonies	cell_line
consisted	O
of	O
ringed	cell_type
sideroblasts	cell_type
exclusively	O
showed	O
one	O
pattern	O
dominant	O
in	O
those	O
of	O
PMNCs	cell_type
.	O
Our	O
findings	O
suggest	O
that	O
non-clonal	cell_type
progenitor	cell_type
cells	cell_type
persist	O
in	O
some	O
RARS	cell_type
cases,	O
that	O
erythroid	cell_type
progenitors	cell_type
show	O
mosaicism,	O
and	O
that	O
ringed	cell_type
sideroblasts	cell_type
may	O
be	O
derived	O
from	O
an	O
abnormal	O
clone	O
involved	O
in	O
the	O
pathogenesis	O
of	O
this	O
disease.	O

Granulosa	O
cell	O
tumor	O
of	O
the	O
ovary	O
.	O
Immunohistochemical	O
evidence	O
of	O
low	O
proliferative	O
activity	O
and	O
virtual	O
absence	O
of	O
mutation	O
of	O
the	O
p53	DNA
tumor-suppressor	DNA
gene	DNA
.	O
BACKGROUND	O
AND	O
METHODS:	O
Because	O
the	O
use	O
of	O
immunohistochemistry	O
in	O
the	O
diagnosis	O
of	O
granulosa	O
cell	O
tumor	O
(	O
GCT	O
)	O
has	O
not	O
been	O
fully	O
explored,	O
routinely	O
processed	O
(formalin-fixed,	O
paraffin-embedded)	O
tissue	O
from	O
11	O
GCT	O
,	O
adult	O
type,	O
was	O
investigated	O
immunohistochemically	O
(	O
ABC	O
method	O
)	O
with	O
a	O
broad	O
spectrum	O
of	O
antibodies	O
against	O
various	O
markers,	O
including	O
p53	protein
and	O
Ki-67	protein
.	O
All	O
of	O
the	O
tumors	O
exhibited	O
typical	O
morphology,	O
were	O
limited	O
to	O
the	O
ovary	O
(stage	O
I),	O
and	O
7	O
cases	O
followed	O
a	O
benign	O
clinical	O
course	O
.	O
RESULTS:	O
All	O
the	O
tumors	O
exhibited	O
strong	O
expression	O
of	O
vimentin	protein
,	O
but	O
most	O
other	O
antigens	O
(including	O
smooth	protein
muscle	protein
actin	protein
)	O
were	O
expressed	O
infrequently	O
by	O
a	O
minority	O
of	O
tumor	cell_type
cells	cell_type
or	O
not	O
at	O
all.	O
Tumor	O
cells	O
in	O
9	O
GCT	O
expressed	O
inhibin	O
A.	O
All	O
the	O
tumors	O
exhibited	O
very	O
low	O
proliferative	O
activity,	O
fewer	O
than	O
10%	O
of	O
the	O
tumor	O
cell	O
nuclei	O
being	O
stained	O
by	O
the	O
antibody	protein
MIB-1	protein
(	O
Ki-67	protein
antigen	protein
).	O
The	O
antibody	protein
D07	protein
revealed	O
marked	O
overexpression	O
of	O
p53	protein
protein	protein
in	O
only	O
one	O
tumor.	O
Clinical	O
outcome	O
was	O
not	O
found	O
to	O
be	O
related	O
to	O
immunophenotypic	O
differences.	O
CONCLUSIONS:	O
The	O
diagnosis	O
of	O
GCT	O
should	O
be	O
based	O
primarily	O
on	O
the	O
typical	O
morphology	O
revealed	O
by	O
conventional	O
stains,	O
but	O
additional	O
immunohistochemical	O
staining	O
with	O
a	O
small	O
panel	O
of	O
selected	O
antibodies	O
(for	O
example,	O
against	O
keratin	protein
,	O
vimentin	protein
,	O
and	O
inhibin	protein
A	protein
)	O
may	O
be	O
helpful	O
in	O
a	O
few	O
cases.	O
The	O
very	O
low	O
proliferative	O
activity	O
and	O
the	O
lack	O
of	O
overexpression	O
of	O
p53	protein
protein	protein
are	O
consistent	O
with	O
the	O
benign	O
clinical	O
behavior	O
of	O
the	O
majority	O
of	O
GCT	O
.	O

Protective	O
effects	O
of	O
notch-1	protein
on	O
TCR	protein
-induced	O
apoptosis	O
.	O
The	O
Notch	protein
receptor	protein
protein	protein
was	O
originally	O
identified	O
in	O
Drosophila	O
and	O
is	O
known	O
to	O
mediate	O
cell	O
to	O
cell	O
communication	O
and	O
influence	O
cell	O
fate	O
decisions	O
.	O
Members	O
of	O
this	O
family	O
have	O
been	O
isolated	O
from	O
invertebrates	O
as	O
well	O
as	O
vertebrates	O
.	O
We	O
isolated	O
mouse	protein
Notch-1	protein
in	O
a	O
yeast	O
two-hybrid	O
screen	O
with	O
Nur77	protein
,	O
which	O
is	O
a	O
protein	O
that	O
has	O
been	O
shown	O
previously	O
to	O
be	O
required	O
for	O
apoptosis	O
in	O
T	cell_line
cell	cell_line
lines	cell_line
.	O
The	O
data	O
presented	O
below	O
indicate	O
that	O
Notch-1	protein
expression	O
provides	O
significant	O
protection	O
to	O
T	cell_line
cell	cell_line
lines	cell_line
from	O
TCR	protein
-mediated	O
apoptosis	O
.	O
These	O
data	O
demonstrate	O
a	O
new	O
antiapoptotic	O
role	O
for	O
Notch-1	protein
,	O
providing	O
evidence	O
that,	O
in	O
addition	O
to	O
regulating	O
cell	O
fate	O
decisions	O
,	O
Notch-1	protein
can	O
play	O
a	O
critical	O
role	O
in	O
controlling	O
levels	O
of	O
cell	O
death	O
in	O
T	cell_type
cells	cell_type
.	O

Comparison	O
of	O
primary	O
sensitization	O
of	O
naive	cell_type
human	cell_type
T	cell_type
cells	cell_type
to	O
varicella-zoster	O
virus	O
peptides	O
by	O
dendritic	cell_type
cells	cell_type
in	O
vitro	O
with	O
responses	O
elicited	O
in	O
vivo	O
by	O
varicella	O
vaccination	O
.	O
Dendritic	cell_type
cells	cell_type
(	O
DC	cell_type
)	O
are	O
potent	O
APC	cell_type
during	O
primary	O
and	O
secondary	O
immune	O
responses	O
.	O
The	O
first	O
objective	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
human	cell_type
DC	cell_type
mediate	O
in	O
vitro	O
sensitization	O
of	O
naive	cell_type
CD4+	cell_type
T	cell_type
cells	cell_type
to	O
epitopes	protein
of	O
the	O
immediate	protein
early	protein
62	protein
(IE62)	protein
protein	protein
of	O
varicella	O
zoster	O
virus	O
(	O
VZV	O
).	O
The	O
induction	O
of	O
CD4+	protein
T	O
cell	O
proliferative	O
responses	O
to	O
eight	O
synthetic	O
peptides	O
representing	O
amino	protein
acid	protein
sequences	protein
of	O
the	O
VZV	protein
IE62	protein
protein	protein
was	O
assessed	O
using	O
T	cell_type
cells	cell_type
and	O
DC	cell_type
from	O
VZV	O
-susceptible	O
donors	O
.	O
The	O
second	O
objective	O
was	O
to	O
compare	O
in	O
vitro	O
responses	O
of	O
naive	cell_type
T	cell_type
cells	cell_type
with	O
responses	O
to	O
VZV	O
peptides	O
induced	O
in	O
vivo	O
after	O
immunization	O
with	O
varicella	O
vaccine	O
.	O
T	O
cell	O
proliferation	O
was	O
induced	O
by	O
three	O
peptides	O
,	O
P1	O
,	O
P4	O
,	O
and	O
P7	O
,	O
in	O
71-100%	O
of	O
the	O
donors	O
tested	O
before	O
and	O
after	O
vaccination	O
using	O
DC	cell_type
as	O
APC	cell_type
.	O
Monocytes	cell_type
were	O
effective	O
APC	cell_type
for	O
VZV	O
peptides	O
only	O
after	O
immunization.	O
Two	O
peptides	O
,	O
P2	O
and	O
P8	O
,	O
induced	O
naive	O
T	O
cell	O
proliferation	O
less	O
effectively	O
and	O
were	O
also	O
less	O
immunogenic	O
for	O
T	cell_type
cells	cell_type
from	O
vaccinated	O
or	O
naturally	O
immune	O
donors	O
.	O
T	O
cell	O
recognition	O
of	O
specific	O
peptides	O
was	O
concordant	O
between	O
naive,	O
DC	cell_type
-mediated	O
responses	O
,	O
and	O
postvaccine	O
responses	O
using	O
monocytes	cell_type
as	O
APC	cell_type
in	O
69%	O
of	O
comparisons	O
(p	O
=	O
0.05;	O
chi2);	O
the	O
predictive	O
value	O
of	O
a	O
positive	O
response	O
to	O
an	O
IE62	O
peptide	O
before	O
immunization	O
for	O
T	O
cell	O
sensitization	O
in	O
vivo	O
was	O
82%.	O
These	O
observations	O
indicate	O
that	O
primary	O
T	O
cell	O
responses	O
detected	O
in	O
vitro	O
using	O
DC	cell_type
as	O
APC	cell_type
may	O
be	O
useful	O
to	O
characterize	O
the	O
potential	O
immunogenicity	O
of	O
viral	O
protein	O
epitopes	O
in	O
vivo.	O

Mechanism	O
of	O
interleukin-10	protein
inhibition	O
of	O
T-helper	O
cell	O
activation	O
by	O
superantigen	protein
at	O
the	O
level	O
of	O
the	O
cell	O
cycle.	O
We	O
have	O
analyzed	O
the	O
effects	O
of	O
interleukin-10	protein
(	O
IL-10	protein
)	O
on	O
the	O
entry	O
of	O
quiescent	O
CD4(+)	cell_type
T	cell_type
cells	cell_type
into	O
the	O
cell	O
cycle	O
upon	O
stimulation	O
with	O
the	O
superantigen	protein
staphylococcal	protein
enterotoxin	protein
B	protein
(	O
SEB	protein
).	O
IL-10	protein
arrested	O
cells	O
at	O
G0/G1	O
.	O
IL-10	protein
treatment	O
prevented	O
the	O
downregulation	O
of	O
p27(Kip1	protein
),	O
an	O
inhibitory	protein
protein	protein
that	O
controls	O
progression	O
out	O
of	O
the	O
G0	O
phase	O
of	O
the	O
cell	O
cycle	O
.	O
IL-10	protein
also	O
prevented	O
the	O
upregulation	O
of	O
the	O
G1	protein
cyclins	protein
D2	protein
and	O
D3	protein
,	O
proteins	O
necessary	O
for	O
entry	O
and	O
progression	O
through	O
the	O
G1	O
phase	O
of	O
the	O
cell	O
cycle	O
.	O
Associated	O
with	O
the	O
inhibition	O
of	O
the	O
cell	O
cycle	O
,	O
IL-10	protein
suppressed	O
SEB	protein
induction	O
of	O
interleukin-2	protein
(	O
IL-2	protein
).	O
Addition	O
of	O
exogenous	O
IL-2	protein
to	O
IL-10	cell_line
-treated	cell_line
cells	cell_line
significantly	O
reversed	O
the	O
antiproliferative	O
effects	O
of	O
IL-10	protein
.	O
Moreover,	O
IL-10	protein
effects	O
on	O
the	O
early	protein
G1	protein
proteins	protein
p27(Kip1)	protein
and	O
cyclin	protein
D2	protein
were	O
similarly	O
reversed	O
by	O
exogenous	O
IL-2	protein
.	O
Although	O
this	O
reversal	O
by	O
IL-2	protein
was	O
pronounced,	O
it	O
was	O
not	O
complete,	O
suggesting	O
that	O
IL-10	protein
may	O
have	O
some	O
effects	O
not	O
directly	O
related	O
to	O
the	O
suppression	O
of	O
IL-2	protein
production	O
.	O
Cell	O
separation	O
experiments	O
suggest	O
that	O
IL-10	protein
can	O
effect	O
purified	O
CD4(+)	cell_type
T	cell_type
cells	cell_type
directly,	O
providing	O
functional	O
evidence	O
for	O
the	O
presence	O
of	O
IL-10	protein
receptors	O
on	O
CD4(+)	cell_type
T	cell_type
cells	cell_type
.	O
IL-10	protein
also	O
inhibited	O
expression	O
of	O
IL-2	protein
transcriptional	protein
regulators	protein
c-fos	protein
and	O
c-jun	protein
,	O
which	O
also	O
inhibit	O
other	O
cell	O
functions.	O
Our	O
studies	O
show	O
that	O
the	O
mechanism	O
of	O
IL-10	protein
regulation	O
of	O
quiescent	O
CD4(+)	O
T-cell	O
activation	O
is	O
mainly	O
by	O
blocking	O
induction	O
of	O
IL-2	protein
that	O
is	O
critical	O
to	O
downregulation	O
of	O
p27(Kip1)	protein
and	O
upregulation	O
of	O
D	protein
cyclins	protein
in	O
T-cell	O
activation	O
and	O
entry	O
into	O
the	O
cell	O
cycle	O
.	O

IFN-gamma	protein
and	O
IL-10	protein
inhibit	O
induction	O
of	O
IL-1	O
receptor	O
type	O
I	O
and	O
type	O
II	O
gene	O
expression	O
by	O
IL-4	protein
and	O
IL-13	protein
in	O
human	O
monocytes	cell_type
.	O
The	O
Th2-type	protein
cytokines	protein
IL-4	protein
and	O
IL-13	protein
induce	O
expression	O
of	O
a	O
distinct	O
subset	O
of	O
genes	O
in	O
human	cell_type
monocytes	cell_type
.	O
These	O
include	O
Fc	protein
epsilonRII	protein
(	O
CD23	protein
),	O
15-lipoxygenase	protein
,	O
IL-1	protein
receptor	protein
antagonist	protein
(	O
IL-1ra	protein
),	O
and	O
type	O
I	O
and	O
type	O
II	O
IL-1	O
receptors	O
(	O
IL-1R	protein
).	O
IFN-gamma	protein
has	O
been	O
shown	O
to	O
inhibit	O
induction	O
of	O
CD23	protein
and	O
15-lipoxygenase	protein
in	O
monocytes	cell_type
;	O
however,	O
the	O
effects	O
of	O
IFN-gamma	protein
on	O
type	O
I	O
and	O
type	O
II	O
IL-1R	O
gene	O
expression	O
have	O
not	O
been	O
defined.	O
We	O
examined	O
the	O
effects	O
of	O
IFN-gamma	protein
on	O
both	O
basal	O
and	O
IL-4	protein
/	O
IL-13	protein
-induced	O
IL-1R	DNA
gene	DNA
expression	O
in	O
primary	cell_type
monocytes	cell_type
.	O
IL-4	protein
and	O
IL-13	protein
induced	O
dose-	O
and	O
time-dependent	O
increases	O
in	O
IL-1RI	O
and	O
IL-1RII	O
mRNA	O
levels	O
.	O
IFN-gamma	protein
decreased	O
basal	O
expression	O
as	O
well	O
as	O
the	O
induction	O
of	O
these	O
genes	O
by	O
IL-4	protein
and	O
IL-13	protein
.	O
Inhibition	O
of	O
IL-1RI	protein
and	O
IL-1RII	O
mRNA	O
levels	O
by	O
IFN-gamma	protein
was	O
transcriptionally	O
mediated,	O
and	O
correlated	O
directly	O
with	O
decreased	O
production	O
of	O
soluble	O
IL-1RII	protein
.	O
Furthermore,	O
the	O
ability	O
to	O
suppress	O
IL-1RI	O
and	O
IL-1RII	protein
mRNA	O
levels	O
was	O
not	O
unique	O
to	O
IFN-gamma	protein
because	O
IL-10	protein
also	O
inhibited	O
expression	O
of	O
these	O
genes	O
in	O
IL-4	cell_line
/	cell_line
IL-13	cell_line
-stimulated	cell_line
monocytes	cell_line
.	O
Inhibition	O
of	O
IL-1R	DNA
gene	DNA
expression	O
by	O
IFN-gamma	protein
and	O
IL-10	protein
was	O
not	O
due	O
to	O
down-regulation	O
of	O
surface	protein
IL-4R	protein
because	O
pretreatment	O
with	O
these	O
cytokines	O
did	O
not	O
decrease	O
the	O
number	O
of	O
IL-4	protein
binding	O
sites	O
per	O
cell.	O
However,	O
suppression	O
of	O
IL-1R	DNA
gene	DNA
expression	O
by	O
IFN-gamma	protein
and	O
IL-10	protein
was	O
associated	O
with	O
decreased	O
tyrosine	O
phosphorylation	O
and	O
nuclear	O
translocation	O
of	O
the	O
IL-4	protein
/	protein
IL-13	protein
-inducible	protein
transcription	protein
factor	protein
,	O
Stat6	protein
,	O
suggesting	O
a	O
potential	O
mechanism	O
by	O
which	O
IFN-gamma	protein
and	O
IL-10	protein
may	O
mediate	O
their	O
suppressive	O
effects.	O
These	O
findings	O
demonstrate	O
that	O
certain	O
cytokines,	O
including	O
IFN-gamma	protein
and	O
IL-10	protein
,	O
antagonize	O
the	O
ability	O
of	O
IL-4	protein
and	O
IL-13	protein
to	O
induce	O
increased	O
expression	O
of	O
the	O
IL-1RI	O
and	O
IL-1RII	DNA
genes	DNA
in	O
monocytes	cell_type
.	O

Cytokine	protein
rescue	O
from	O
glucocorticoid	O
induced	O
apoptosis	O
in	O
T	cell_type
cells	cell_type
is	O
mediated	O
through	O
inhibition	O
of	O
IkappaBalpha	protein
.	O
We	O
previously	O
reported	O
that	O
dexamethasone	O
(	O
DEX	O
),	O
a	O
synthetic	O
glucocorticoid	O
,	O
causes	O
apoptosis	O
in	O
mature	cell_line
Th	cell_line
cell	cell_line
lines	cell_line
,	O
and	O
that	O
this	O
induction	O
of	O
cell	O
death	O
is	O
prevented	O
by	O
specific	O
cytokines	protein
,	O
namely,	O
by	O
IL-2	protein
in	O
Th1	cell_type
cells	cell_type
and	O
by	O
IL-4	protein
in	O
Th2	cell_type
cells	cell_type
.	O
We	O
now	O
show	O
that	O
this	O
differential	O
rescue	O
by	O
specific	O
cytokines	protein
in	O
Th	cell_type
cells	cell_type
correlates	O
with	O
the	O
level	O
of	O
IkappaBalpha	protein
that	O
is	O
regulated	O
by	O
DEX	O
and	O
cytokines	protein
.	O
In	O
both	O
cell	O
types	O
the	O
cellular	O
levels	O
of	O
IkappaBalpha	RNA
mRNA	RNA
and	O
protein	O
were	O
evaluated	O
by	O
DEX	O
treatment.	O
Interestingly,	O
the	O
DEX	O
-mediated	O
IkappaBalpha	protein
induction	O
was	O
completely	O
inhibited	O
by	O
IL-2	protein
,	O
but	O
not	O
IL-4	protein
,	O
in	O
Th1	cell_type
cells	cell_type
,	O
while	O
the	O
reverse	O
profile	O
was	O
seen	O
in	O
Th2	cell_type
cells	cell_type
.	O
In	O
both	O
cell	O
types,	O
the	O
cytokine	protein
that	O
inhibits	O
the	O
induction	O
of	O
IkappaBalpha	protein
by	O
DEX	O
,	O
also	O
rescues	O
these	O
cells	O
from	O
DEX	O
-induced	O
apoptosis	O
,	O
although	O
the	O
rescue	O
cytokine	O
is	O
different	O
in	O
Th1	O
and	O
Th2	O
cells	O
.	O
Our	O
results	O
imply	O
that	O
T	cell_type
cells	cell_type
need	O
to	O
maintain	O
a	O
certain	O
level	O
of	O
NF-kappaB	protein
transcriptional	O
activity	O
in	O
order	O
to	O
survive;	O
up-	O
or	O
down-regulation	O
of	O
nuclear	protein
NF	protein
kappaB	protein
through	O
modulation	O
of	O
IkappaBalpha	protein
expression	O
by	O
cytokines	protein
or	O
DEX	O
may	O
lead	O
to	O
cell	O
survival	O
or	O
cell	O
death	O
,	O
respectively.	O

Expression	O
of	O
transcription	DNA
factor	DNA
genes	DNA
after	O
influenza	O
A	O
virus	O
infection	O
.	O
Infection	O
of	O
human	O
monocytes	cell_type
with	O
influenza	O
A	O
virus	O
induces	O
a	O
broad	O
range	O
of	O
proinflammatory	protein
cytokines	protein
and	O
mononuclear	O
cell	O
attracting	O
chemokines	protein
before	O
the	O
infected	cell_type
cells	cell_type
undergo	O
apoptosis	O
.	O
The	O
underlying	O
mechanisms	O
by	O
which	O
the	O
corresponding	O
genes	O
are	O
transcriptionally	O
initiated	O
after	O
virus	O
infection	O
are	O
still	O
poorly	O
understood.	O
Activation	O
of	O
NF-kappa	protein
B	protein
seems	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
many	O
proinflammatory	DNA
cytokine	DNA
genes	DNA
,	O
but	O
cannot	O
be	O
the	O
only	O
mechanism,	O
since	O
several	O
cytokine	DNA
genes	DNA
lack	O
respective	O
binding	DNA
sites	DNA
in	O
their	O
promoter	DNA
regions	DNA
.	O
Therefore,	O
we	O
additionally	O
investigated	O
other	O
transcription	protein
factors	protein
of	O
possible	O
importance	O
such	O
as	O
CREB	protein
,	O
CTF	protein
,	O
OTF-1	protein
,	O
and	O
OTF-2	protein
.	O
To	O
explore	O
long-term	O
regulatory	O
mechanisms	O
,	O
we	O
investigated	O
the	O
induction	O
of	O
transcription	protein
factors	protein
on	O
the	O
gene	O
expression	O
level	O
which	O
may	O
be	O
important	O
to	O
substitute	O
for	O
metabolized	protein
transcription	protein
factor	protein
proteins	protein
after	O
their	O
activation.	O
We	O
identified	O
a	O
cell-type-specific	O
differential	O
response	O
:	O
CREB	O
,	O
CTF	O
,	O
OTF-1	O
,	O
OFT-2	O
,	O
and	O
NF-kappa	O
B	O
genes	O
were	O
strongly	O
induced	O
1	O
to	O
4	O
hours	O
after	O
influenza	O
A	O
virus	O
infection	O
in	O
the	O
monocytic	cell_line
cell	cell_line
line	cell_line
Mono	cell_line
Mac	cell_line
6	cell_line
,	O
while	O
in	O
freshly	O
prepared	O
human	O
monocytes	cell_type
no	O
significant	O
changes	O
were	O
detected.	O
In	O
infected	O
monocytes	cell_type
,	O
which	O
die	O
by	O
apoptosis,	O
the	O
expression	O
of	O
CREB	protein
,	O
CTF	protein
,	O
and	O
OTF-2	protein
was	O
rather	O
suppressed	O
8	O
hours	O
after	O
infection.	O
In	O
conclusion,	O
the	O
long-term	O
regulation	O
of	O
transcription	protein
factor	protein
gene	O
expression	O
in	O
non-proliferating	cell_type
cells	cell_type
seems	O
to	O
be	O
of	O
minor	O
importance	O
after	O
influenza	O
infection	O
since	O
in	O
apoptosisprone	cell_type
cells	cell_type
an	O
immediate	O
availability	O
of	O
transcription	protein
factor	protein
proteins	protein
is	O
required.	O

Peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
isolated	O
from	O
patients	O
with	O
diabetic	O
nephropathy	O
show	O
increased	O
activation	O
of	O
the	O
oxidative-stress	protein
sensitive	protein
transcription	protein
factor	protein
NF-kappaB	protein
.	O
Increased	O
oxidative	O
stress	O
and	O
subsequent	O
activation	O
of	O
the	O
transcription	O
factor	O
NF-kappaB	protein
has	O
been	O
linked	O
to	O
the	O
development	O
of	O
late	O
diabetic	O
complications	O
.	O
To	O
determine	O
whether	O
oxidative	O
stress	O
dependent	O
NF-kappaB	protein
activation	O
is	O
evident	O
in	O
patients	O
with	O
diabetic	O
nephropathy	O
we	O
used	O
an	O
Electrophoretic	O
Mobility	O
Shift	O
Assay	O
based	O
semiquantitative	O
detection	O
system	O
which	O
enabled	O
us	O
to	O
determine	O
NF-kappaB	protein
activation	O
in	O
ex	O
vivo	O
isolated	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
.	O
We	O
examined	O
33	O
patients	O
with	O
diabetes	O
mellitus	O
(Type	O
I	O
and	O
Type	O
II).	O
Patients	O
with	O
diabetic	O
nephropathy	O
showed	O
higher	O
NF-kappaB	protein
binding	O
activity	O
in	O
Electrophoretic	O
Mobility	O
Shift	O
Assays	O
and	O
stronger	O
immunohistological	O
staining	O
for	O
activated	O
NF-kappaBp65	protein
than	O
patients	O
without	O
renal	O
complications	O
.	O
NF-kappaB	protein
binding	O
activity	O
correlated	O
with	O
the	O
degree	O
of	O
albuminuria	O
(r	O
=	O
0.316)	O
and	O
with	O
thrombomodulin	protein
plasma	O
concentrations	O
(r	O
=	O
0.33),	O
indicative	O
for	O
albuminuria	O
associated	O
endothelial	O
dysfunction.	O
In	O
a	O
3	O
day	O
intervention	O
study	O
in	O
which	O
600	O
mg	O
of	O
the	O
antioxidant	O
thioctic	O
acid	O
(	O
alpha-lipoic	O
acid	O
)	O
per	O
day	O
were	O
given	O
to	O
nine	O
patients	O
with	O
diabetic	O
nephropathy	O
oxidative	O
stress	O
in	O
plasma	O
samples	O
was	O
decreased	O
by	O
48%	O
and	O
NF-kappaB	protein
binding	O
activity	O
in	O
ex	O
vivo	O
isolated	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
by	O
38%.	O
In	O
conclusion,	O
activation	O
of	O
the	O
transcription	protein
factor	protein
NF-kappaB	protein
in	O
ex	O
vivo	O
isolated	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
of	O
patients	O
with	O
diabetes	O
mellitus	O
correlates	O
with	O
the	O
degree	O
of	O
diabetic	O
nephropathy	O
.	O
NF-kappaB	protein
activation	O
is	O
at	O
least	O
in	O
part	O
dependent	O
on	O
oxidative	O
stress	O
since	O
thioctic	O
acid	O
(	O
alpha-lipoic	O
acid	O
)	O
reduced	O
NF-kappaB	protein
binding	O
activity	O
.	O

Osteoclast	protein
markers	protein
accumulate	O
on	O
cells	O
developing	O
from	O
human	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
precursors	cell_type
.	O
Recent	O
studies	O
show	O
that	O
human	cell_type
osteoclasts	cell_type
develop	O
in	O
vitro	O
from	O
hematopoietic	cell_type
cells	cell_type
;	O
however,	O
special	O
cultures	O
conditions	O
and/or	O
cytokine	O
mobilized	O
peripheral	O
blood	O
are	O
apparently	O
required.	O
Here,	O
we	O
report	O
that	O
cells	O
expressing	O
osteoclast	protein
markers	protein
differentiate	O
from	O
precursors	O
present	O
in	O
nonmobilized	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
),	O
without	O
the	O
addition	O
of	O
stromal	cell_type
cells	cell_type
,	O
growth	protein
factors	protein
,	O
cytokines	O
or	O
steroids	O
;	O
and	O
characterize	O
their	O
phenotype.	O
Three	O
days	O
after	O
establishing	O
high-density	O
PBMC	cell_type
cultures	O
(1.5	O
x	O
10(6)	O
cells/cm2),	O
in	O
serum-containing	O
medium,	O
small	O
adherent	cell_line
colonies	cell_line
of	O
tartrate	cell_line
resistant	cell_line
acid	cell_line
phosphatase	cell_line
positive	cell_line
(TRAP+)	cell_line
cells	cell_line
emerge,	O
amidst	O
massive	O
monocyte	O
cell	O
death	O
.	O
These	O
adherent	cell_type
cells	cell_type
have	O
an	O
eccentrically	O
placed,	O
round	O
nucleus	O
,	O
and	O
express	O
low	O
levels	O
of	O
TRAP	protein
and	O
sodium	protein
fluoride-resistant-	protein
alpha-naphthyl-acetate-esterase	protein
(	O
NaF-R-NSE	protein
).	O
Over	O
the	O
next	O
week,	O
this	O
cell	O
population	O
accumulates	O
phenotypic	O
markers	O
of	O
osteoclasts	cell_type
(	O
vitronectin	protein
receptor	protein
[	O
VR	protein
],	O
calcitonin	protein
receptor	protein
,	O
TRAP	protein
,	O
cathepsin	protein
K	protein
protein	protein
,	O
and	O
mRNA	RNA
)	O
with	O
increased	O
nuclearity,	O
covering	O
the	O
entire	O
surface	O
by	O
15	O
days.	O
When	O
cultured	O
on	O
bone	O
,	O
VR	cell_line
+,	cell_line
TRAP	cell_line
+	cell_line
cells	cell_line
of	O
low	O
multinuclearity	O
appear	O
and	O
cover	O
up	O
to	O
50%	O
of	O
the	O
surface.	O
Resorption	O
lacunae	O
can	O
be	O
observed	O
by	O
day	O
22.	O
Although	O
these	O
pits	O
are	O
not	O
nearly	O
as	O
numerous	O
as	O
the	O
cells	O
of	O
preosteoclast	cell_type
phenotype	cell_type
,	O
they	O
do	O
represent	O
the	O
activity	O
of	O
a	O
subset	O
of	O
osteoclast	cell_type
-like	cell_type
cells	cell_type
that	O
has	O
achieved	O
osteoclastic	O
maturity	O
under	O
these	O
culture	O
conditions.	O
Transcripts	O
for	O
osteoprotegerin	protein
ligand	protein
(	O
OPGL	protein
),	O
an	O
osteoclast	protein
differentiation	protein
factor	protein
(also	O
known	O
as	O
RANKL	protein
and	O
TRANCE	protein
)	O
are	O
expressed,	O
likely	O
by	O
adherent	cell_type
cells	cell_type
.	O
Thus,	O
an	O
adherent	O
population	O
of	O
cells,	O
with	O
preosteoclast/	O
osteoclast	cell_type
phenotypic	O
properties	O
,	O
arises	O
selectively	O
under	O
simple	O
culture	O
conditions	O
from	O
normal	O
PBMC	cell_type
.	O
Further	O
characterization	O
of	O
these	O
cells	O
should	O
identify	O
factors	O
involved	O
in	O
the	O
growth,	O
terminal	O
differentiation	O
and	O
activation	O
of	O
osteoclasts	cell_type
.	O

Oleic	O
acid	O
inhibits	O
endothelial	O
activation	O
:	O
A	O
direct	O
vascular	O
antiatherogenic	O
mechanism	O
of	O
a	O
nutritional	O
component	O
in	O
the	O
mediterranean	O
diet	O
.	O
Because	O
oleic	O
acid	O
is	O
implicated	O
in	O
the	O
antiatherogenic	O
effects	O
attributed	O
to	O
the	O
Mediterranean	O
diet	O
,	O
we	O
investigated	O
whether	O
this	O
fatty	O
acid	O
can	O
modulate	O
endothelial	O
activation	O
,	O
ie,	O
the	O
concerted	O
expression	O
of	O
gene	protein
products	protein
involved	O
in	O
leukocyte	O
recruitment	O
and	O
early	O
atherogenesis	O
.	O
We	O
incubated	O
sodium	O
oleate	O
with	O
human	cell_type
umbilical	cell_type
vein	cell_type
endothelial	cell_type
cells	cell_type
for	O
0	O
to	O
72	O
hours,	O
followed	O
by	O
coincubation	O
of	O
oleate	O
with	O
human	protein
recombinant	protein
tumor	protein
necrosis	protein
factor	protein
,	O
interleukin	protein
(IL)-1alpha	protein
,	O
IL-1beta	protein
,	O
IL-4	protein
,	O
Escherichia	O
coli	O
lipopolysaccharide	O
(	O
LPS	O
),	O
or	O
phorbol	O
12-myristate	O
13-acetate	O
for	O
a	O
further	O
6	O
to	O
24	O
hours.	O
The	O
endothelial	O
expression	O
of	O
vascular	protein
cell	protein
adhesion	protein
molecule-1	protein
(	O
VCAM-1	protein
),	O
E-selectin	protein
,	O
and	O
intercellular	protein
adhesion	protein
molecule-1	protein
was	O
monitored	O
by	O
cell	O
surface	O
enzyme	O
immunoassays	O
or	O
flow	O
cytometry	O
,	O
and	O
steady-state	O
levels	O
of	O
VCAM-1	RNA
mRNA	RNA
were	O
assessed	O
by	O
Northern	O
blot	O
analysis	O
.	O
At	O
10	O
to	O
100	O
micromol/L	O
for	O
&gt;24	O
hours,	O
oleate	O
inhibited	O
the	O
expression	O
of	O
all	O
adhesion	protein
molecules	protein
tested.	O
After	O
a	O
72-hour	O
incubation	O
with	O
oleate	O
and	O
a	O
further	O
16-hour	O
incubation	O
with	O
oleate	O
plus	O
1	O
microg/mL	O
LPS	O
,	O
VCAM-1	protein
expression	O
was	O
reduced	O
by	O
&gt;40%	O
compared	O
with	O
control.	O
Adhesion	O
of	O
monocytoid	cell_line
U937	cell_line
cells	cell_line
to	O
LPS	O
-treated	O
endothelial	O
cells	O
was	O
reduced	O
concomitantly.	O
Oleate	O
also	O
produced	O
a	O
quantitatively	O
similar	O
reduction	O
of	O
VCAM-1	RNA
mRNA	RNA
levels	O
on	O
Northern	O
blot	O
analysis	O
and	O
inhibited	O
nuclear	protein
factor-kappaB	protein
activation	O
on	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O
Incubation	O
of	O
endothelial	cell_type
cells	cell_type
with	O
oleate	O
for	O
72	O
hours	O
decreased	O
the	O
relative	O
proportions	O
of	O
saturated	O
(palmitic	O
and	O
stearic)	O
acids	O
in	O
total	O
cell	O
lipids	O
and	O
increased	O
the	O
proportions	O
of	O
oleate	O
in	O
total	O
cell	O
lipids	O
without	O
significantly	O
changing	O
the	O
relative	O
proportions	O
of	O
polyunsaturated	O
fatty	O
acids	O
.	O
Although	O
less	O
potent	O
than	O
polyunsaturated	O
fatty	O
acids	O
in	O
inhibiting	O
endothelial	O
activation	O
,	O
oleic	O
acid	O
may	O
contribute	O
to	O
the	O
prevention	O
of	O
atherogenesis	O
through	O
selective	O
displacement	O
of	O
saturated	O
fatty	O
acids	O
in	O
cell	O
membrane	O
phospholipids	O
and	O
a	O
consequent	O
modulation	O
of	O
gene	O
expression	O
for	O
molecules	O
involved	O
in	O
monocyte	O
recruitment	O
.	O

Both	O
Stat3	protein
-activation	O
and	O
Stat3	protein
-independent	O
BCL2	protein
downregulation	O
are	O
important	O
for	O
interleukin-6	protein
-induced	O
apoptosis	O
of	O
1A9-M	cell_line
cells	cell_line
.	O
A	O
unique	O
subclone	O
of	O
a	O
bone	cell_line
marrow-derived	cell_line
stromal	cell_line
cell	cell_line
line	cell_line
,	O
BMS2.4	cell_line
,	O
produces	O
soluble	protein
factors	protein
that	O
inhibit	O
proliferation	O
of	O
several	O
types	O
of	O
hematopoietic	cell_line
cell	cell_line
lines	cell_line
.	O
An	O
understanding	O
of	O
these	O
molecules	O
may	O
be	O
informative	O
about	O
negative	O
regulatory	O
circuits	O
that	O
can	O
potentially	O
limit	O
blood	O
cell	O
formation.	O
We	O
used	O
expression	O
cloning	O
to	O
identify	O
interleukin-6	protein
(	O
IL-6	protein
)	O
as	O
one	O
factor	O
that	O
suppressed	O
growth	O
of	O
a	O
pre-B-cell	cell_line
variant	cell_line
line	cell_line
,	O
1A9-M	cell_line
.	O
Moreover,	O
IL-6	protein
induced	O
macrophage-differentiation	O
and	O
apoptosis	O
of	O
1A9-M	cell_line
cells	cell_line
.	O
During	O
this	O
process,	O
IL-6	protein
downregulated	O
expression	O
of	O
BCL2	protein
in	O
1A9-M	cell_line
cells	cell_line
and	O
stimulated	O
BCL-XL	O
expression	O
,	O
but	O
had	O
no	O
effect	O
on	O
p53	O
,	O
Bax	O
,	O
or	O
Bak	O
gene	O
expression	O
.	O
Mechanisms	O
for	O
transduction	O
of	O
IL-6	protein
-induced	O
signals	O
were	O
then	O
evaluated	O
in	O
IL-6	cell_line
-stimulated	cell_line
1A9-M	cell_line
cells	cell_line
.	O
Whereas	O
the	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
3	protein
(	O
Stat3	protein
)	O
was	O
phosphorylated	O
and	O
activated,	O
there	O
was	O
no	O
effect	O
on	O
either	O
Stat1	protein
or	O
Stat5	protein
.	O
The	O
importance	O
of	O
BCL2	protein
and	O
Stat3	protein
on	O
IL-6	protein
-induced	O
macrophage-differentiation	O
and	O
apoptosis	O
was	O
studied	O
with	O
1A9-M	cell_line
cells	cell_line
expressing	O
human	protein
BCL2	protein
or	O
a	O
dominant-negative	O
form	O
of	O
Stat3	protein
,	O
respectively.	O
IL-6	protein
-induced	O
apoptosis	O
,	O
but	O
not	O
macrophage-differentiation	O
,	O
was	O
blocked	O
by	O
continuously	O
expressed	O
BCL2	protein
.	O
A	O
dominant-negative	protein
form	protein
of	protein
Stat3	protein
inhibited	O
both	O
macrophage-differentiation	O
and	O
apoptosis	O
induced	O
by	O
IL-6	protein
.	O
However,	O
diminished	O
Stat3	protein
activity	O
did	O
not	O
prevent	O
IL-6	protein
-induced	O
downregulation	O
of	O
the	O
BCL2	DNA
gene	DNA
.	O
Therefore,	O
activation	O
of	O
Stat3	protein
is	O
essential	O
for	O
IL-6	protein
-induced	O
macrophage-differentiation	O
and	O
programmed	O
cell	O
death	O
in	O
this	O
model.	O
Whereas	O
overexpression	O
of	O
BCL2	protein
abrogates	O
the	O
apoptotic	O
response	O
,	O
Stat3	protein
-independent	O
signals	O
appear	O
to	O
downregulate	O
expression	O
of	O
the	O
BCL2	DNA
gene	DNA
.	O

Involvement	O
of	O
mitogen-activated	protein
protein	protein
kinase	protein
pathways	O
in	O
interleukin-8	protein
production	O
by	O
human	cell_type
monocytes	cell_type
and	O
polymorphonuclear	cell_type
cells	cell_type
stimulated	O
with	O
lipopolysaccharide	O
or	O
Mycoplasma	protein
fermentans	protein
membrane	protein
lipoproteins	protein
.	O
Interleukin-8	protein
(	O
IL-8	protein
)	O
is	O
a	O
chemokine	protein
that	O
belongs	O
to	O
the	O
alpha-chemokine	protein
or	O
CXC	protein
subfamily	protein
and	O
is	O
produced	O
by	O
a	O
wide	O
variety	O
of	O
human	O
cells,	O
including	O
monocytes	cell_type
and	O
polymorphonuclear	cell_type
cells	cell_type
(	O
PMN	cell_type
).	O
IL-8	protein
is	O
secreted	O
in	O
response	O
to	O
inflammatory	O
stimuli	O
,	O
notably	O
bacterial	O
products	O
such	O
as	O
lipopolysaccharide	O
(	O
LPS	O
),	O
but	O
little	O
is	O
known	O
about	O
the	O
mechanisms	O
by	O
which	O
these	O
agents	O
mediate	O
IL-8	protein
induction	O
.	O
In	O
this	O
report,	O
we	O
show	O
that	O
Mycoplasma	protein
fermentans	protein
lipid-associated	protein
membrane	protein
proteins	protein
(	O
LAMPf	protein
)	O
induce	O
the	O
production	O
of	O
high	O
levels	O
of	O
IL-8	protein
by	O
THP-1	cell_line
(human	cell_line
monocyte)	cell_line
cells	cell_line
and	O
PMN	cell_type
at	O
the	O
same	O
extent	O
as	O
LPS	O
.	O
It	O
was	O
previously	O
demonstrated	O
that	O
stimulation	O
of	O
monocytic	O
cells	O
with	O
either	O
LPS	O
or	O
LAMPf	protein
led	O
to	O
a	O
series	O
of	O
common	O
downstream	O
signaling	O
events	O
,	O
including	O
the	O
activation	O
of	O
protein	protein
tyrosine	protein
kinase	protein
and	O
of	O
mitogen-activated	protein
protein	protein
kinase	protein
cascades	O
.	O
By	O
using	O
PD-98059	O
and	O
SB203580	O
,	O
two	O
potent	O
and	O
selective	O
inhibitors	O
of	O
MEK1	protein
(a	O
kinase	protein
upstream	O
of	O
ERK1/2	protein
)	O
and	O
p38	protein
,	O
respectively,	O
we	O
have	O
demonstrated	O
that	O
both	O
ERK1/2	O
and	O
p38	O
cascades	O
play	O
a	O
key	O
role	O
in	O
the	O
production	O
of	O
IL-8	protein
by	O
monocytes	cell_type
and	O
PMN	cell_type
stimulated	O
with	O
bacterial	O
fractions	O
.	O

Regulation	O
of	O
IL-6	protein
synthesis	O
in	O
human	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
by	O
C3a	protein
and	O
C3a(desArg)	protein
.	O
The	O
anaphylatoxin	protein
C3a	protein
has	O
been	O
reported	O
to	O
have	O
immunomodulatory	O
effects	O
on	O
a	O
number	O
of	O
different	O
cell	O
types.	O
In	O
this	O
study	O
we	O
investigated	O
the	O
effects	O
of	O
C3a	protein
and	O
C3a(desArg)	protein
on	O
gene	O
expression	O
and	O
protein	O
secretion	O
of	O
IL-6	protein
in	O
human	O
PBMCs	cell_type
,	O
either	O
alone	O
or	O
in	O
combination	O
with	O
LPS	O
or	O
IL-1beta	protein
.	O
C3a	protein
or	O
C3a(desArg)	protein
alone	O
exhibited	O
no	O
effect	O
on	O
the	O
expression	O
or	O
secretion	O
of	O
IL-6	protein
.	O
However,	O
when	O
PBMC	cell_type
were	O
stimulated	O
with	O
LPS	O
or	O
IL-1beta	protein
,	O
both	O
C3a	protein
and	O
C3a(desArg)	protein
were	O
found	O
to	O
enhance	O
IL-6	protein
release	O
by	O
PBMC	cell_type
in	O
a	O
dose-dependent	O
manner	O
.	O
Since	O
C3a	protein
has	O
been	O
shown	O
to	O
induce	O
PGE2	O
production	O
by	O
monocytes	cell_type
,	O
and	O
PGE2	O
has	O
been	O
shown	O
to	O
influence	O
cytokine	O
production,	O
we	O
investigated	O
the	O
potential	O
role	O
of	O
PGE2	O
in	O
C3a	protein
-mediated	O
enhancement	O
of	O
LPS-	O
and	O
IL-1beta-	O
induced	O
IL-6	O
production	O
.	O
Indomethacin	O
blocked	O
PGE2	O
release,	O
but	O
had	O
no	O
influence	O
on	O
the	O
observed	O
effects	O
of	O
C3a	protein
,	O
suggesting	O
that	O
the	O
effects	O
of	O
C3a	protein
on	O
IL-6	protein
production	O
are	O
independent	O
of	O
PGE2	O
formation	O
by	O
monocytes	cell_type
.	O
Northern	O
blot	O
analysis	O
showed	O
that	O
C3a	protein
as	O
well	O
as	O
C3a(desArg)	protein
enhanced	O
LPS	O
-induced	RNA
mRNA	RNA
levels	O
for	O
IL-6	protein
.	O
Pretreatment	O
of	O
PBMCs	cell_type
with	O
pertussis	protein
toxin	protein
blocked	O
the	O
functions	O
of	O
C3a	protein
and	O
C3a(desArg)	protein
,	O
indicating	O
that	O
the	O
actions	O
of	O
these	O
two	O
molecules	O
are	O
mediated	O
by	O
a	O
G	protein
protein	protein
-coupled	O
pathway	O
.	O
Furthermore,	O
we	O
investigated	O
the	O
effects	O
of	O
C3a	protein
and	O
C3a(desArg)	protein
on	O
induction	O
of	O
NF-kappaB	protein
and	O
activating	protein
protein-1	protein
binding	O
.	O
Both	O
molecules	O
enhanced	O
LPS	O
-induced	O
NF-kappaB	protein
and	O
activating	protein
protein-1	protein
binding	O
activity	O
.	O
These	O
results	O
demonstrate	O
the	O
capacity	O
of	O
intact	O
C3a	protein
and	O
its	O
circulating	O
des-Arg	protein
form	protein
to	O
exert	O
immunmodulatory	O
effects	O
in	O
vitro.	O

Phenylarsine	O
oxide	O
inhibits	O
ex	O
vivo	O
HIV-1	O
expression	O
.	O
Phenylarsine	O
oxide	O
(	O
PAO	O
),	O
which	O
is	O
described	O
as	O
an	O
inhibitor	O
of	O
tyrosine	protein
phosphatase	protein
activity	O
,	O
inhibits	O
H2O2	O
release	O
from	O
human	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMCs	cell_type
)	O
as	O
measured	O
by	O
electrochemistry	O
.	O
Since	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
replication	O
is	O
known	O
to	O
be	O
favored	O
under	O
oxidative	O
stress	O
conditions,	O
ex	O
vivo	O
experiments	O
using	O
uninfected	O
PBMCs	cell_type
,	O
primary	cell_type
monocytes	cell_type
or	O
a	O
latently	O
infected	O
promonocytic	cell_line
U1	cell_line
cell	cell_line
line	cell_line
show	O
that	O
HIV-1	O
replication	O
and	O
reactivation,	O
monitored	O
by	O
p24	protein
antigen	protein
measurement	O
,	O
are	O
inhibited	O
by	O
PAO	O
in	O
a	O
time-	O
and	O
concentration-dependent	O
manner	O
.	O
These	O
observations	O
can	O
be	O
linked	O
with	O
the	O
inhibition	O
of	O
NF-kappa	protein
B	protein
activation	O
when	O
uninfected	O
monocytes	O
are	O
induced	O
by	O
either	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF-alpha	protein
)	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
or	O
lipopolysaccharide	O
(	O
LPS	O
).	O

Pharmacological	O
control	O
of	O
antigen	O
responsiveness	O
in	O
genetically	cell_line
modified	cell_line
T	cell_line
lymphocytes	cell_line
.	O
A	O
chimeric	DNA
TCR	DNA
gene	DNA
,	O
comprising	O
an	O
anti-hapten	protein
single-chain	protein
Ab	protein
variable	protein
fragment	protein
fused	O
to	O
the	O
transmembrane	protein
and	protein
cytoplasmic	protein
regions	protein
of	O
the	O
human	protein
TCR	protein
zeta-chain	protein
,	O
was	O
used	O
to	O
determine	O
whether	O
the	O
tetracycline-regulatable	O
system	O
could	O
be	O
used	O
to	O
regulate	O
gene	O
expression	O
in	O
T	cell_type
cells	cell_type
.	O
Jurkat	cell_line
T	cell_line
cells	cell_line
were	O
stably	O
transfected	O
with	O
a	O
single	O
vector	O
encoding	O
the	O
tetracycline	protein
trans-activator	protein
protein	protein
,	O
controlled	O
by	O
a	O
constitutive	DNA
promoter	DNA
,	O
and	O
the	O
chimeric	protein
TCR	protein
,	O
under	O
the	O
control	O
of	O
a	O
trans-activator	DNA
protein-responsive	DNA
promoter	DNA
.	O
In	O
the	O
absence	O
of	O
tetracyclines	O
,	O
the	O
transfected	O
T	cell_type
cells	cell_type
were	O
shown	O
to	O
express	O
the	O
chimeric	protein
receptor	protein
on	O
the	O
cell	O
surface	O
and	O
could	O
be	O
activated	O
by	O
its	O
cognate	protein
Ag	protein
,	O
leading	O
to	O
the	O
secretion	O
of	O
IL-2	protein
.	O
When	O
the	O
cells	O
were	O
exposed	O
to	O
increasing	O
concentrations	O
of	O
tetracyclines	O
,	O
surface	O
expression	O
of	O
the	O
chimeric	protein
receptor	protein
was	O
suppressed	O
in	O
a	O
dose-dependent	O
manner	O
,	O
and	O
this	O
suppression	O
was	O
sufficient	O
to	O
result	O
in	O
complete	O
loss	O
of	O
responsiveness	O
to	O
the	O
targeted	protein
Ag	protein
.	O
Prolonged	O
suppression	O
of	O
trans-	O
gene	O
expression	O
for	O
up	O
to	O
7	O
days	O
was	O
observed	O
after	O
doxycycline	O
was	O
removed	O
from	O
the	O
cultures,	O
but	O
eventual	O
recovery	O
of	O
surface	O
expression	O
was	O
complete,	O
and	O
the	O
absolute	O
time	O
to	O
recovery	O
was	O
directly	O
proportional	O
to	O
the	O
initial	O
concentration	O
of	O
the	O
drug.	O
Pharmacologic	O
control	O
of	O
trans-gene	O
expression	O
in	O
gene-modified	cell_line
T	cell_line
cells	cell_line
will	O
not	O
only	O
facilitate	O
new	O
approaches	O
to	O
the	O
study	O
of	O
different	O
aspects	O
of	O
T	O
cell	O
biology	O
,	O
but	O
will	O
also	O
provide	O
the	O
basis	O
for	O
new	O
gene	O
therapy	O
strategies	O
.	O

Glucocorticoid	protein
receptors	protein
,	O
fibromyalgia	O
and	O
low	O
back	O
pain	O
.	O
Recently,	O
fibromyalgia	O
(	O
FMS	O
)	O
was	O
shown	O
to	O
be	O
a	O
disorder	O
associated	O
with	O
an	O
altered	O
functioning	O
of	O
the	O
stress	O
response	O
system	O
.	O
FMS	O
patients	O
display	O
a	O
hyperreactive	O
pituitary	O
adrenocorticotropic	O
hormone	O
(	O
ACTH	O
)	O
release	O
in	O
response	O
to	O
corticotropin-releasing	O
hormone	O
(	O
CRH	O
)	O
and	O
to	O
insulin-induced	O
hypoglycemia	O
.	O
We	O
suggested	O
that	O
negative	O
feedback	O
of	O
cortisol	O
could	O
be	O
deranged.	O
Therefore	O
we	O
investigated	O
the	O
properties	O
and	O
function	O
of	O
the	O
glucocorticoid	protein
receptors	protein
(	O
GR	protein
)	O
in	O
FMS	O
patients	O
and	O
compared	O
the	O
results	O
with	O
those	O
of	O
healthy	O
persons	O
and	O
patients	O
with	O
chronic	O
low	O
back	O
pain	O
(	O
LBP	O
a	O
localized	O
pain	O
condition).	O
Forty	O
primary	O
FMS	O
patients	O
(F:M	O
=	O
36:4),	O
28	O
LBP	O
patients	O
(25:3)	O
and	O
14	O
(12:2)	O
healthy,	O
sedentary	O
control	O
persons	O
were	O
recruited	O
for	O
the	O
study.	O
Urinary	O
free	O
cortisol	O
excretion	O
in	O
FMS	O
and	O
LBP	O
patients	O
was	O
lower	O
compared	O
to	O
controls.	O
Only	O
FMS	O
patients	O
displayed	O
lower	O
CBG	O
and	O
basal	O
serum	O
cortisol	O
concentrations	O
when	O
compared	O
to	O
controls.	O
However,	O
plasma	O
free	O
cortisol	O
concentrations	O
were	O
similar	O
in	O
the	O
three	O
groups.	O
There	O
was	O
no	O
difference	O
in	O
the	O
number	O
of	O
GR	protein
per	O
cell	O
among	O
the	O
three	O
groups	O
(	O
FMS	O
:	O
6498	O
+/-	O
252,	O
LBP	O
:	O
6625	O
+/-	O
284,	O
controls	O
:	O
6576	O
+/-	O
304),	O
but	O
the	O
dissociation	O
constant	O
(Kd)	O
of	O
the	O
FMS	O
(14.5	O
+/-	O
0.9	O
nmol/l)	O
and	O
LBP	O
(14.7	O
+/-	O
1.3	O
nmol/l)	O
subjects	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
controls	O
(10.9	O
+/-	O
0.8	O
nmol/l)	O
(p	O
&lt;	O
.05).	O
The	O
maximal	O
stimulation	O
of	O
the	O
lymphocytes	cell_type
,	O
as	O
measured	O
by	O
the	O
maximal	O
thymidine	O
incorporation	O
(in	O
the	O
absence	O
of	O
cortisol	O
)	O
in	O
the	O
FMS	O
group	O
was	O
approximately	O
1.5	O
times	O
higher	O
(p	O
&lt;	O
.05)	O
than	O
in	O
the	O
control	O
or	O
LBP	O
group	O
.	O
The	O
ED50	O
(the	O
cortisol	O
concentration	O
giving	O
50%	O
inhibition	O
of	O
the	O
thymidine	O
incorporation	O
),	O
however,	O
was	O
identical	O
in	O
all	O
three	O
groups.	O
We	O
conclude	O
that	O
FMS	O
patients	O
have	O
a	O
mild	O
hypocortisolemia	O
,	O
increased	O
cortisol	O
feedback	O
resistance	O
in	O
combination	O
probably	O
with	O
a	O
reduced	O
CRH	O
synthesis	O
or	O
release	O
in	O
the	O
hypothalamus.	O
The	O
role	O
of	O
the	O
GR	protein
and	O
mineralocorticoid	protein
receptor	protein
(	O
MR	protein
)	O
in	O
the	O
CRH	O
regulation	O
in	O
the	O
FMS	O
patients	O
remains	O
to	O
be	O
solved.	O

Temporal	O
control	O
of	O
IgH	DNA
gene	DNA
expression	O
in	O
developing	cell_type
B	cell_type
cells	cell_type
by	O
the	O
3'	DNA
locus	DNA
control	DNA
region	DNA
.	O
The	O
suggested	O
roles	O
of	O
the	O
downstream	DNA
3'	DNA
regions	DNA
acting	O
as	O
a	O
Locus	DNA
Control	DNA
Region	DNA
(	O
LCR	DNA
),	O
have	O
allowed	O
comparisons	O
to	O
be	O
made	O
between	O
the	O
regulation	O
of	O
the	O
IgH	DNA
locus	DNA
with	O
other	O
model	O
systems	O
whose	O
gene	O
expression	O
is	O
governed	O
by	O
LCR	DNA
activity	O
.	O
Here	O
we	O
summarize	O
the	O
importance	O
of	O
the	O
IgH	DNA
3'	DNA
LCR	DNA
and	O
its	O
putative	O
functional	O
role	O
in	O
IgH	DNA
gene	DNA
expression	O
and	O
compare	O
it	O
with	O
the	O
5'	DNA
LCR	DNA
regulatory	DNA
region	DNA
of	O
the	O
human	DNA
beta-globin	DNA
locus	DNA
.	O

HLA	O
binding	O
characteristics	O
and	O
generation	O
of	O
cytotoxic	cell_type
lymphocytes	cell_type
against	O
peptides	O
derived	O
from	O
oncogenic	protein
proteins	protein
.	O
AIMS	O
AND	O
BACKGROUND:	O
Structurally	O
altered	O
proteins	O
(derived	O
from	O
chromosomal	O
translocations	O
or	O
gene	O
mutations	O
)	O
can	O
be	O
considered	O
tumor	O
specific	O
antigens	O
and	O
represent	O
an	O
attractive	O
target	O
for	O
a	O
T-cell	O
mediated	O
response	O
.	O
T	O
lymphocytes	O
recognize	O
antigens	O
in	O
the	O
form	O
of	O
peptides	O
bound	O
to	O
HLA-molecules	protein
.	O
MATERIALS	O
AND	O
METHODS:	O
Peptides	O
derived	O
from	O
oncogenic	protein
proteins	protein
were	O
screened	O
for	O
the	O
presence	O
of	O
HLA	protein
binding	protein
motifs	protein
;	O
actual	O
binding	O
were	O
evaluated	O
by	O
HLA	O
stabilization	O
experiments	O
using	O
transfectants	O
and	O
specific	O
anti-HLA	protein
antibodies	protein
.	O
Specific	O
lymphocytes	cell_type
were	O
induced	O
by	O
in	O
vitro	O
peptide	O
sensitization	O
and	O
screened	O
by	O
thymidine	O
uptake	O
or	O
cellular	O
cytotoxic	O
assays	O
.	O
RESULTS:	O
We	O
identified	O
peptides	O
derived	O
from	O
EWS/FLI-1	protein
fusion	protein
protein	protein
and	O
from	O
mutated	protein
K-RAS	protein
protein	protein
(encompassing	O
respectively	O
the	O
fusion	protein
point	protein
and	O
the	O
mutation	O
at	O
position	protein
12	protein
)	O
that	O
showed	O
binding	protein
motif	protein
for	O
HLA-Cw*0702	protein
and	O
HLA-A3	protein
respectively.	O
The	O
actual	O
binding	O
of	O
these	O
peptides	O
was	O
analysed	O
in	O
a	O
stabilization	O
assay	O
.	O
We	O
detected	O
binding	O
for	O
the	O
EWS/FLI-1	O
peptide	O
and	O
for	O
5	O
RAS	O
peptides	O
(1	O
wild	O
type	O
and	O
4	O
mutated).	O
The	O
effect	O
of	O
temperature,	O
beta	protein
2-microglobulin	protein
(	O
beta	protein
2-m	protein
)	O
and	O
fetal	O
calf	O
serum	O
(	O
FCS	O
)	O
on	O
the	O
binding	O
and	O
the	O
stability	O
of	O
the	O
HLA/peptide	protein
complex	protein
was	O
studied.	O
A	O
low	O
temperature	O
(26	O
degrees	O
C)	O
increased	O
the	O
binding	O
both	O
in	O
HLA-A3	protein
and	O
HLA-Cw*0702	protein
,	O
while	O
FCS	O
reduced	O
it.	O
beta	protein
2-m	protein
increased	O
the	O
binding	O
to	O
the	O
HLA-A3	protein
molecule	protein
but	O
did	O
not	O
influence	O
the	O
binding	O
to	O
the	O
HLA-Cw*0702	protein
.	O
The	O
stability	O
of	O
already	O
formed	O
complexed	O
was	O
somewhat	O
different	O
in	O
the	O
HLA-A3	protein
and	O
HLA-Cw*0702	protein
system	O
:	O
both	O
were	O
more	O
stable	O
at	O
26	O
degrees	O
C	O
than	O
at	O
37	O
degrees	O
C	O
but	O
while	O
the	O
beta	protein
2-m	protein
and	O
FCS	O
did	O
not	O
influence	O
the	O
stability	O
of	O
the	O
HLA-A3	protein
/peptide	protein
complex	protein
,	O
they	O
seemed	O
to	O
cause	O
opposite	O
effects	O
in	O
the	O
HLA-Cw*0702	protein
system	O
(	O
beta	protein
2-m	protein
stabilized	O
and	O
FCS	O
destabilized	O
the	O
complex).	O
Finally,	O
we	O
were	O
able	O
to	O
generate	O
a	O
specific	O
CD8+	cell_line
CTL	cell_line
line	cell_line
against	O
a	O
K-RAS	O
mutated	O
peptide	O
.	O
CONCLUSIONS:	O
Although	O
binding	protein
motifs	protein
and	O
actual	O
HLA	O
binding	O
can	O
be	O
detected	O
in	O
several	O
cases,	O
the	O
generation	O
of	O
a	O
cellular	O
response	O
is	O
infrequent,	O
confirming	O
that	O
HLA	O
binding	O
is	O
necessary	O
but	O
not	O
sufficient	O
to	O
obtain	O
an	O
in	O
vitro	O
response	O
.	O
Further	O
optimization	O
of	O
culture	O
conditions,	O
type	O
of	O
Antigen	cell_type
Presenting	cell_type
Cells	cell_type
(	O
APC	cell_type
),	O
peptides	O
,	O
use	O
of	O
stabilizers	O
like	O
beta	protein
2-m	protein
are	O
still	O
needed.	O

OCA-B	protein
is	O
a	O
functional	O
analog	O
of	O
VP16	protein
but	O
targets	O
a	O
separate	O
surface	O
of	O
the	O
Oct-1	protein
POU	protein
domain	protein
[published	O
erratum	O
appears	O
in	O
Mol	O
Cell	O
Biol	O
1998	O
Apr;18(4):2430]	O
OCA-B	protein
is	O
a	O
B-cell-specific	protein
coregulator	protein
of	O
the	O
broadly	O
expressed	O
POU	protein
domain	protein
transcription	protein
factor	protein
Oct-1	protein
.	O
OCA-B	protein
associates	O
with	O
the	O
Oct-1	protein
POU	protein
domain	protein
,	O
a	O
bipartite	O
DNA-binding	O
structure	O
containing	O
a	O
POU-specific	protein
(POU[S])	protein
domain	protein
joined	O
by	O
a	O
flexible	O
linker	O
to	O
a	O
POU	protein
homeodomain	protein
(	O
POU[H]	protein
).	O
Here,	O
we	O
show	O
that	O
OCA-B	protein
alters	O
the	O
activity	O
of	O
Oct-1	protein
in	O
two	O
ways.	O
It	O
provides	O
a	O
transcriptional	O
activation	O
domain	O
which,	O
unlike	O
Oct-1	protein
,	O
activates	O
an	O
mRNA-type	DNA
promoter	DNA
effectively,	O
and	O
it	O
stabilizes	O
Oct-1	protein
on	O
the	O
Oct-1	DNA
-responsive	DNA
octamer	DNA
sequence	DNA
ATGCAAAT	O
.	O
These	O
properties	O
of	O
OCA-B	protein
parallel	O
those	O
displayed	O
by	O
the	O
herpes	protein
simplex	protein
virus	protein
Oct-1	protein
coregulator	protein
VP16	protein
.	O
OCA-B	protein
,	O
however,	O
interacts	O
with	O
a	O
different	O
surface	O
of	O
the	O
DNA-bound	O
Oct-1	protein
POU	protein
domain	protein
,	O
interacting	O
with	O
both	O
the	O
POU(S)	protein
and	protein
POU(H)	protein
domains	protein
and	O
the	O
center	O
of	O
the	O
ATGCAAAT	DNA
octamer	DNA
sequence	DNA
.	O
The	O
OCA-B	O
and	O
VP16	protein
interactions	O
with	O
the	O
Oct-1	protein
POU	protein
domain	protein
are	O
sufficiently	O
different	O
to	O
permit	O
OCA-B	protein
and	O
VP16	protein
to	O
bind	O
the	O
Oct-1	protein
POU	protein
domain	protein
simultaneously.	O
These	O
results	O
emphasize	O
the	O
structural	O
versatility	O
of	O
the	O
Oct-1	protein
POU	protein
domain	protein
in	O
its	O
interaction	O
with	O
coregulators.	O

Phosphatidylinositol	protein
3-kinase	protein
couples	O
the	O
interleukin-2	protein
receptor	protein
to	O
the	O
cell	protein
cycle	protein
regulator	protein
E2F	protein
.	O
Cell	O
cycle	O
progression	O
initiated	O
by	O
interleukin-2	protein
(	O
IL-2	protein
)	O
in	O
T	cell_type
cells	cell_type
is	O
critical	O
for	O
lymphoproliferation	O
and	O
an	O
immune	O
response	O
.	O
Phosphatidyl	protein
inositol	protein
3-kinase	protein
(	O
PI3K	protein
)	O
is	O
activated	O
by	O
IL-2	protein
.	O
However,	O
nuclear	O
targets	O
for	O
PI3K	protein
are	O
not	O
known.	O
Here	O
we	O
identify	O
the	O
cell	protein
cycle	protein
regulator	protein
E2F	protein
as	O
an	O
IL-2	protein
target	O
in	O
T	O
lymphocytes	cell_type
and	O
PI3K	protein
as	O
the	O
critical	O
signaling	O
pathway	O
.	O
We	O
eliminate	O
both	O
Stat5	protein
and	O
Raf	protein
/MEK	protein
pathways	O
from	O
E2F	protein
regulation	O
.	O
Protein	protein
kinase	protein
B	protein
(	O
PKB	protein
)	O
is	O
activated	O
by	O
IL-2	protein
via	O
PI3K	protein
.	O
The	O
expression	O
of	O
an	O
active	O
PKB	protein
is	O
sufficient	O
to	O
induce	O
E2F	protein
activity	O
.	O
Inhibition	O
of	O
PI3K	protein
inhibits	O
phosphorylation	O
of	O
Rb	protein
,	O
induction	O
of	O
cyclin	protein
D3	protein
,	O
and	O
degradation	O
of	O
p27kip1	protein
.	O
These	O
results	O
establish	O
a	O
crucial	O
PI3K	protein
/	O
PKB	protein
-mediated	O
link	O
between	O
the	O
IL-2	protein
teceptor	protein
and	O
the	O
cell	O
cycle	O
machinery	O
.	O

The	O
Epstein-Barr	protein
virus	protein
oncogene	protein
product	protein
latent	protein
membrane	protein
protein	protein
1	protein
engages	O
the	O
tumor	O
necrosis	O
factor	O
receptor-associated	O
death	O
domain	O
protein	O
to	O
mediate	O
B	O
lymphocyte	O
growth	O
transformation	O
and	O
activate	O
NF-kappaB.	O
The	O
Epstein-Barr	O
virus	O
latent	protein
membrane	protein
protein	protein
1	protein
(	O
LMP1	protein
)	O
is	O
essential	O
for	O
the	O
transformation	O
of	O
B	cell_type
lymphocytes	cell_type
into	O
lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
.	O
Previous	O
data	O
are	O
consistent	O
with	O
a	O
model	O
that	O
LMP1	protein
is	O
a	O
constitutively	protein
activated	protein
receptor	protein
that	O
transduces	O
signals	O
for	O
transformation	O
through	O
its	O
carboxyl-terminal	protein
cytoplasmic	protein
tail	protein
.	O
One	O
transformation	protein
effector	protein
site	protein
(	O
TES1	protein
),	O
located	O
within	O
the	O
membrane	protein
proximal	protein
45	protein
residues	protein
of	O
the	O
cytoplasmic	O
tail,	O
constitutively	O
engages	O
tumor	protein
necrosis	protein
factor	protein
receptor-associated	protein
factors	protein
.	O
Signals	O
from	O
TES1	protein
are	O
sufficient	O
to	O
drive	O
initial	O
proliferation	O
of	O
infected	O
resting	O
B	O
lymphocytes	cell_type
,	O
but	O
most	O
lymphoblastoid	cell_type
cells	cell_type
infected	O
with	O
a	O
virus	O
that	O
does	O
not	O
express	O
the	O
155	protein
residues	protein
beyond	O
TES1	protein
fail	O
to	O
grow	O
as	O
long-term	cell_line
cell	cell_line
lines	cell_line
.	O
We	O
now	O
find	O
that	O
mutating	O
two	O
tyrosines	O
to	O
an	O
isoleucine	O
at	O
the	O
carboxyl	protein
end	protein
of	O
the	O
cytoplasmic	protein
tail	protein
cripples	O
the	O
ability	O
of	O
EBV	O
to	O
cause	O
lymphoblastoid	O
cell	O
outgrowth	O
,	O
thereby	O
marking	O
a	O
second	O
transformation	protein
effector	protein
site	protein
,	O
TES2	protein
.	O
A	O
yeast	O
two-hybrid	O
screen	O
identified	O
TES2	protein
interacting	protein
proteins	protein
,	O
including	O
the	O
tumor	protein
necrosis	protein
factor	protein
receptor-associated	protein
death	protein
domain	protein
protein	protein
(	O
TRADD	protein
).	O
TRADD	protein
was	O
the	O
only	O
protein	O
that	O
interacted	O
with	O
wild-type	protein
TES2	protein
and	O
not	O
with	O
isoleucine	protein
-mutated	protein
TES2	protein
.	O
TRADD	protein
associated	O
with	O
wild-type	protein
LMP1	protein
but	O
not	O
with	O
isoleucine	O
-mutated	O
LMP1	protein
in	O
mammalian	O
cells,	O
and	O
TRADD	protein
constitutively	O
associated	O
with	O
LMP1	protein
in	O
EBV	cell_line
-transformed	cell_line
cells	cell_line
.	O
In	O
transfection	O
assays,	O
TRADD	protein
and	O
TES2	protein
synergistically	O
mediated	O
high-level	O
NF-kappaB	protein
activation	O
.	O
These	O
results	O
indicate	O
that	O
LMP1	protein
appropriates	O
TRADD	protein
to	O
enable	O
efficient	O
long-term	O
lymphoblastoid	O
cell	O
outgrowth	O
.	O
High-level	O
NF-kappaB	protein
activation	O
also	O
appears	O
to	O
be	O
a	O
critical	O
component	O
of	O
long-term	O
outgrowth	O
.	O

Inhibition	O
of	O
T	cell_type
cell	cell_type
and	O
promotion	O
of	O
natural	O
killer	O
cell	O
development	O
by	O
the	O
dominant	protein
negative	protein
helix	protein
loop	protein
helix	protein
factor	protein
Id3	protein
.	O
Bipotential	cell_type
T/natural	cell_type
killer	cell_type
(NK)	cell_type
progenitor	cell_type
cells	cell_type
are	O
present	O
in	O
the	O
human	O
thymus	O
.	O
Despite	O
their	O
bipotential	O
capacity,	O
these	O
progenitors	O
develop	O
predominantly	O
to	O
T	cell_type
cells	cell_type
in	O
the	O
thymus	O
.	O
The	O
mechanisms	O
controlling	O
this	O
developmental	O
choice	O
are	O
unknown.	O
Here	O
we	O
present	O
evidence	O
that	O
a	O
member(s)	O
of	O
the	O
family	O
of	O
basic	protein
helix	protein
loop	protein
helix	protein
(bHLH)	protein
transcription	protein
factors	protein
determines	O
lineage	O
specification	O
of	O
NK/T	cell_type
cell	cell_type
progenitors	cell_type
.	O
The	O
natural	O
dominant	protein
negative	protein
HLH	protein
factor	protein
Id3	protein
,	O
which	O
blocks	O
transcriptional	O
activity	O
of	O
a	O
number	O
of	O
known	O
bHLH	protein
factors	protein
,	O
was	O
expressed	O
in	O
CD34+	cell_type
progenitor	cell_type
cells	cell_type
by	O
retrovirus-mediated	O
gene	O
transfer.	O
Constitutive	O
expression	O
of	O
Id3	protein
completely	O
blocks	O
development	O
of	O
CD34+	cell_type
cells	cell_type
into	O
T	cell_type
cells	cell_type
in	O
a	O
fetal	O
thymic	O
organ	O
culture	O
(	O
FTOC	O
).	O
In	O
contrast,	O
development	O
into	O
NK	cell_type
cells	cell_type
in	O
an	O
FTOC	O
is	O
enhanced.	O
Thus,	O
the	O
activity	O
of	O
a	O
bHLH	protein
transcription	protein
factor	protein
is	O
necessary	O
for	O
T	O
lineage	O
differentiation	O
of	O
bipotential	cell_type
precursors	cell_type
,	O
in	O
the	O
absence	O
of	O
which	O
a	O
default	O
pathway	O
leading	O
to	O
NK	O
cell	O
development	O
is	O
chosen.	O
Our	O
results	O
identify	O
a	O
molecular	O
switch	O
for	O
lineage	O
specification	O
in	O
early	cell_type
lymphoid	cell_type
precursors	cell_type
of	O
humans	O
.	O

Late	O
gene	O
expression	O
from	O
the	O
Epstein-Barr	O
virus	O
BcLF1	O
and	O
BFRF3	O
promoters	O
does	O
not	O
require	O
DNA	O
replication	O
in	O
cis.	O
Late	O
gene	O
expression	O
follows	O
and	O
is	O
dependent	O
upon	O
lytic	O
replication	O
of	O
the	O
viral	DNA
genome	DNA
.	O
Although	O
experimental	O
evidence	O
is	O
lacking,	O
lytic	O
viral	O
DNA	O
replication	O
is	O
believed	O
to	O
remove	O
modifications	O
or	O
binding	protein
factors	protein
from	O
the	O
genome	O
which	O
serve	O
to	O
repress	O
late	O
gene	O
expression	O
during	O
latency	O
or	O
the	O
early	O
lytic	O
cycle	O
.	O
We	O
have	O
developed	O
a	O
reporter	O
assay	O
to	O
begin	O
characterizing	O
the	O
mechanisms	O
that	O
regulate	O
late	O
gene	O
expression	O
in	O
Epstein-Barr	O
virus	O
(	O
EBV	O
).	O
In	O
this	O
model	O
system,	O
the	O
activities	O
of	O
late	DNA
promoter-reporter	DNA
fusions	DNA
are	O
measured	O
following	O
transient	O
transfection	O
into	O
tissue	cell_line
culture	cell_line
cells	cell_line
expressing	O
EBV	O
during	O
different	O
stages	O
of	O
the	O
lytic	O
cycle	O
.	O
This	O
system	O
faithfully	O
recapitulates	O
late	O
expression	O
patterns	O
from	O
the	O
endogenous	O
virus,	O
implicating	O
specific	O
cis-active	DNA
sequences	DNA
in	O
the	O
control	O
of	O
late	O
gene	O
expression	O
.	O
In	O
addition,	O
these	O
promoters	O
respond	O
only	O
indirectly	O
to	O
the	O
viral	DNA
immediate-early	DNA
transactivator	DNA
,	O
ZEBRA	DNA
.	O
This	O
indirect	O
response	O
is	O
mediated	O
by	O
other	O
viral	O
or	O
virally	O
induced	O
activities	O
downstream	O
of	O
ZEBRA	DNA
in	O
the	O
lytic	O
cascade	O
.	O
In	O
this	O
system,	O
late	O
gene	O
expression	O
is	O
sensitive	O
to	O
inhibitors	O
of	O
the	O
viral	protein
DNA	protein
polymerase	protein
such	O
as	O
phosphonoacetic	O
acid	O
,	O
although	O
the	O
reporters	O
lack	O
a	O
eukaryotic	O
origin	O
of	O
replication	O
and	O
are	O
not	O
replicated	O
under	O
the	O
assay	O
conditions	O
.	O
Thus,	O
replication	O
of	O
the	O
transcriptional	DNA
template	DNA
is	O
not	O
a	O
prerequisite	O
for	O
expression	O
with	O
late	O
kinetics	O
,	O
a	O
finding	O
inconsistent	O
with	O
the	O
current	O
models	O
which	O
posit	O
a	O
cis-active	O
relationship	O
between	O
lytic	O
EBV	O
DNA	O
replication	O
and	O
late	O
gene	O
expression	O
.	O
Rather,	O
analysis	O
of	O
this	O
system	O
has	O
revealed	O
a	O
trans	O
relationship	O
between	O
late	O
gene	O
expression	O
and	O
viral	O
DNA	O
replication	O
and	O
highlights	O
the	O
indirect	O
and	O
complex	O
link	O
between	O
these	O
two	O
events.	O

Modulation	O
of	O
mRNA	O
expression	O
of	O
a	O
novel	DNA
human	DNA
myeloid-selective	DNA
CCAAT/enhancer	DNA
binding	DNA
protein	DNA
gene	DNA
(	O
C/EBP	DNA
epsilon	DNA
).	O
Human	O
C/EBP	DNA
epsilon	DNA
is	O
a	O
newly	O
cloned	O
gene	O
coding	O
for	O
a	O
CCAAT/enhancer	protein
binding	protein
protein	protein
that	O
may	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
myeloid	O
differentiation	O
.	O
Our	O
studies	O
showed	O
that	O
levels	O
of	O
C/EBP	RNA
epsilon	RNA
mRNA	RNA
were	O
markedly	O
increased	O
in	O
NB4	cell_line
cells	cell_line
(	O
promyelocytic	cell_line
leukemia	cell_line
line	cell_line
),	O
because	O
they	O
were	O
induced	O
by	O
9-cis	O
retinoic	O
acid	O
(	O
9-cis	O
RA	O
)	O
to	O
differentiate	O
towards	O
granulocytes	cell_type
.	O
Accumulation	O
of	O
C/EBP	RNA
epsilon	RNA
mRNA	RNA
occurred	O
as	O
early	O
as	O
1	O
hour	O
after	O
exposure	O
of	O
NB4	cell_line
cells	cell_line
to	O
9-cis	O
RA	O
(5	O
x	O
10(-7)	O
mol/L);	O
and	O
at	O
48	O
hours,	O
levels	O
were	O
increased	O
by	O
5.1-fold.	O
Dose-response	O
studies	O
showed	O
that	O
10(-7)	O
to	O
10(-6)	O
mol/L	O
9-cis	O
RA	O
(12	O
hours)	O
resulted	O
in	O
peak	O
levels	O
of	O
C/EBP	RNA
epsilon	RNA
mRNA	RNA
;	O
but	O
even	O
10(-10)	O
mol/L	O
9-cis	O
RA	O
increased	O
levels	O
of	O
these	O
transcripts.	O
NB4	cell_line
cells	cell_line
pulse-exposed	O
(30	O
minutes)	O
to	O
all-trans	O
retinoic	O
acid	O
(	O
ATRA	O
),	O
washed,	O
and	O
cultured	O
(3	O
days)	O
with	O
either	O
dimethylsulfoxide	O
(	O
DMSO	O
)	O
or	O
hexamethylene	O
bisacetamide	O
(	O
HMBA	O
)	O
had	O
a	O
prominent	O
increase	O
in	O
levels	O
of	O
C/EBP	RNA
epsilon	RNA
mRNA	RNA
and	O
an	O
increase	O
in	O
granulocytic	O
differentiation	O
,	O
but	O
exposure	O
to	O
either	O
DMSO	O
or	O
HMBA	O
alone	O
had	O
no	O
effect	O
on	O
base	O
levels	O
of	O
C/EBP	O
epsilon	O
and	O
did	O
not	O
induce	O
differentiation.	O
Macrophage-differentiation	O
of	O
NB4	cell_line
reduced	O
levels	O
of	O
C/EBP	RNA
epsilon	RNA
mRNA	RNA
.	O
Nuclear	O
run-off	O
assays	O
and	O
half-life	O
studies	O
showed	O
that	O
accumulation	O
of	O
C/EBP	RNA
epsilon	RNA
mRNA	RNA
by	O
9-cis	O
RA	O
was	O
due	O
to	O
enhanced	O
transcription.	O
Furthermore,	O
this	O
C/EBP	RNA
epsilon	RNA
mRNA	RNA
accumulation	O
did	O
not	O
require	O
synthesis	O
of	O
new	O
protein	protein
factors	protein
because	O
9-cis	O
RA	O
induced	O
C/EBP	RNA
epsilon	RNA
mRNA	RNA
accumulation	O
in	O
the	O
absence	O
of	O
new	O
protein	O
synthesis	O
.	O
ATRA	O
also	O
induced	O
expression	O
of	O
C/EBP	protein
epsilon	protein
protein	protein
in	O
NB4	cell_line
cells	cell_line
,	O
as	O
shown	O
by	O
Western	O
blotting	O
.	O
In	O
contrast	O
to	O
the	O
increase	O
of	O
C/EBP	O
epsilon	O
in	O
9-cis	O
RA	O
-mediated	O
granulocytic	O
differentiation	O
,	O
the	O
DMSO	O
-induced	O
differentiation	O
of	O
HL-60	cell_line
cells	cell_line
down	O
the	O
granulocytic	O
pathway	O
was	O
associated	O
with	O
an	O
initial	O
reduction	O
of	O
C/EBP	RNA
epsilon	RNA
mRNA	RNA
levels.	O
In	O
summary,	O
we	O
have	O
discovered	O
that	O
expression	O
of	O
C/EBP	RNA
epsilon	RNA
mRNA	RNA
is	O
markedly	O
enhanced	O
as	O
the	O
NB4	cell_line
promyelocytes	cell_line
are	O
induced	O
by	O
retinoids	O
to	O
differentiate	O
towards	O
granulocytes	cell_type
.	O
This	O
induction	O
of	O
C/EBP	RNA
epsilon	RNA
mRNA	RNA
expression	O
is	O
transcriptionally	O
mediated	O
and	O
occurs	O
in	O
the	O
absence	O
of	O
synthesis	O
of	O
additional	O
protein	protein
factors	protein
.	O
We	O
suspect	O
that	O
the	O
C/EBP	DNA
epsilon	DNA
promoter/enhancer	DNA
contains	O
a	O
retinoic	DNA
acid-response	DNA
element	DNA
that	O
is	O
directly	O
stimulated	O
by	O
retinoids	O
.	O

Dual	O
effects	O
of	O
LPS	protein
antibodies	protein
on	O
cellular	O
uptake	O
of	O
LPS	O
and	O
LPS	O
-induced	O
proinflammatory	O
functions	O
.	O
Human	cell_type
phagocytes	cell_type
recognize	O
bacterial	O
LPS	O
(endotoxin)	O
through	O
membrane	protein
CD14	protein
(	O
mCD14	protein
),	O
a	O
proinflammatory	protein
LPS	protein
receptor	protein
.	O
This	O
study	O
tested	O
the	O
hypothesis	O
that	O
anti-	protein
LPS	protein
Abs	protein
neutralize	O
endotoxin	O
by	O
blocking	O
cellular	O
uptake	O
through	O
mCD14	protein
.	O
Ab-associated	O
changes	O
in	O
the	O
uptake	O
and	O
cellular	O
distribution	O
of	O
FITC-	O
LPS	O
were	O
assessed	O
by	O
flow	O
cytometry	O
and	O
laser	O
scanning	O
confocal	O
microscopy	O
in	O
human	cell_line
CD14-transfected	cell_line
Chinese	cell_line
hamster	cell_line
ovary	cell_line
fibroblasts	cell_line
(	O
CHO-CD14	cell_line
cells	cell_line
)	O
and	O
human	cell_type
peripheral	cell_type
blood	cell_type
monocytes	cell_type
.	O
LPS	O
core-	O
and	O
O-side	O
chain-	O
specific	O
mAbs	O
inhibited	O
mCD14	protein
-mediated	O
LPS	O
uptake	O
by	O
both	O
cell	O
types	O
in	O
the	O
presence	O
of	O
serum.	O
O-side	protein
chain-specific	protein
mAb	protein
concurrently	O
enhanced	O
complement-dependent	O
LPS	O
uptake	O
by	O
monocytes	O
through	O
complement	protein
receptor-1	protein
(	O
CR1	protein
)	O
and	O
uptake	O
by	O
CHO-CD14	cell_line
cells	cell_line
involving	O
another	O
heat-labile	protein
serum	protein
factor	protein
(s)	O
and	O
cell-associated	protein
recognition	protein
molecule	protein
(s).	O
Core-specific	protein
mAb	protein
inhibited	O
mCD14	protein
-mediated	O
uptake	O
of	O
homologous	O
and	O
heterologous	O
LPS	O
,	O
while	O
producing	O
less	O
concurrent	O
enhancement	O
of	O
non-	O
mCD14	protein
-mediated	O
LPS	O
uptake	O
.	O
The	O
modulation	O
by	O
anti-	protein
LPS	protein
mAbs	protein
of	O
mCD14	protein
-mediated	O
LPS	O
uptake	O
was	O
associated	O
with	O
inhibition	O
of	O
LPS	protein
-induced	protein
nuclear	protein
factor-kappaB	protein
(	O
NF-kappaB	protein
)	O
translocation	O
and	O
TNF-alpha	protein
secretion	O
in	O
CHO-CD14	cell_line
cells	cell_line
and	O
monocytes,	O
respectively,	O
while	O
mAb	O
enhancement	O
of	O
non-	O
mCD14	protein
-mediated	O
LPS	O
uptake	O
stimulated	O
these	O
activities.	O
LPS	protein
-specific	protein
Abs	protein
thus	O
mediate	O
anti-inflammatory	O
and	O
proinflammatory	O
functions	O
,	O
respectively,	O
by	O
preventing	O
target	O
cell	O
uptake	O
of	O
LPS	O
through	O
mCD14	protein
and	O
augmenting	O
uptake	O
through	O
CR1	protein
or	O
other	O
cell	protein
receptors	protein
.	O

Four	O
P-like	DNA
elements	DNA
are	O
required	O
for	O
optimal	O
transcription	O
of	O
the	O
mouse	DNA
IL-4	DNA
gene	DNA
:	O
involvement	O
of	O
a	O
distinct	O
set	O
of	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
and	O
activator	protein
protein-1	protein
family	protein
proteins	protein
.	O
We	O
previously	O
identified	O
the	O
P	DNA
sequence	DNA
as	O
a	O
critical	O
regulatory	DNA
element	DNA
of	O
the	O
human	DNA
IL-4	DNA
promoter	DNA
.	O
In	O
the	O
mouse	DNA
IL-4	DNA
promoter	DNA
,	O
there	O
are	O
five	O
elements	O
homologous	O
to	O
the	O
human	O
P	DNA
sequence	DNA
designated	O
conserved	DNA
lymphokine	DNA
element	DNA
0	DNA
(	O
CLE0	DNA
),	O
P	DNA
,	O
P2	DNA
,	O
P3	DNA
and	O
P4	DNA
.	O
To	O
characterize	O
the	O
role	O
of	O
these	O
P	DNA
-like	DNA
elements	DNA
and	O
their	O
binding	protein
factors	protein
in	O
the	O
native	DNA
promoter	DNA
,	O
we	O
did	O
transient	O
transfection	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSA	O
).	O
Transfection	O
of	O
EL-4	cell_line
cells	cell_line
with	O
the	O
IL-4	DNA
promoter-reporter	DNA
constructs	DNA
carrying	O
mutated	DNA
P	DNA
-like	DNA
elements	DNA
showed	O
that	O
four	O
P-like	DNA
elements	DNA
,	O
CLE0	DNA
,	O
P	DNA
,	O
P2	DNA
and	O
P4	DNA
,	O
but	O
not	O
P3	DNA
,	O
were	O
required	O
for	O
optimal	O
activation	O
of	O
the	O
IL-4	DNA
promoter	DNA
.	O
EMSA	O
showed	O
that	O
both	O
constitutive	O
and	O
inducible	O
complexes	O
bound	O
to	O
CLE0	DNA
,	O
P	DNA
,	O
P2	DNA
and	O
P4	DNA
,	O
whereas	O
only	O
a	O
constitutive	O
complex	O
bound	O
to	O
P3	DNA
.	O
In	O
competition	O
and	O
antibody	O
supershift	O
assays	O
in	O
EMSA	O
,	O
complexes	O
formed	O
with	O
P	DNA
or	O
P2	DNA
proved	O
to	O
contain	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(NFAT)	protein
family	protein
proteins	protein
as	O
major	O
components.	O
Activator	protein
protein	protein
(AP)-1	protein
family	protein
proteins	protein
interacted	O
with	O
CLE0	DNA
,	O
P,	O
P2	DNA
and	O
P4	DNA
.	O
NFAT/AP-1	protein
complex	protein
formed	O
only	O
with	O
P	DNA
and	O
P2	DNA
.	O
Cross-competition	O
assays	O
among	O
the	O
P-like	DNA
elements	DNA
revealed	O
element-specific	O
and	O
common	O
complexes	O
.	O
Six	O
tandem	O
repeats	O
of	O
the	O
P	DNA
element	DNA
linked	O
to	O
the	O
SV40	DNA
promoter	DNA
responded	O
to	O
phorbol	O
12-myristate	O
13-acetate	O
,	O
while	O
that	O
of	O
other	O
elements	O
did	O
not.	O
It	O
would	O
thus	O
appear	O
that	O
components	O
of	O
each	O
P-like	protein
element-binding	protein
complexes	protein
are	O
not	O
identical	O
and	O
may	O
coordinately	O
contribute	O
to	O
transcriptional	O
activity	O
.	O

Constitutive	O
expression	O
c-fos	O
,	O
c-jun	O
,	O
and	O
NF	O
kappa	O
B	O
mRNA	O
is	O
in	O
nucleated	cell_type
fetal	cell_type
blood	cell_type
cells	cell_type
and	O
up-regulation	O
of	O
c-fos	protein
and	O
c-jun	protein
with	O
anti-CD3	protein
stimulation	O
.	O
Fetal	O
and	O
neonatal	O
lymphocytes	O
are	O
relatively	O
resistant	O
to	O
activation	O
and	O
cytokine	protein
production	O
when	O
stimulated	O
either	O
via	O
their	O
T-cell	protein
antigen	protein
receptors	protein
or	O
lectins	protein
.	O
The	O
molecular	protein
mechanism	protein
(s)	O
responsible	O
for	O
this	O
phenomenon	O
have	O
not	O
been	O
clearly	O
elucidated.	O
We	O
have	O
hypothesized	O
that	O
such	O
defects	O
in	O
fetal/neonatal	O
T-cell	O
activation	O
may	O
be	O
due	O
to	O
lack	O
of	O
expression	O
of	O
the	O
transcriptional	protein
regulatory	protein
elements	protein
required	O
for	O
T-cell	O
activation	O
.	O
We	O
used	O
reverse	protein
transcriptase	protein
-polymerase	O
chain	O
reaction	O
to	O
examine	O
both	O
fetal	O
and	O
term	O
neonatal	O
cord	O
bloods	O
for	O
mRNA	O
expression	O
of	O
three	O
transcription	protein
factors	protein
implicated	O
in	O
T-cell	O
activation	O
:	O
c-jun	protein
,	O
c-fos	protein
,	O
and	O
NF	protein
kappa	protein
B	protein
(	O
p50	protein
subunit	protein
).	O
We	O
demonstrate	O
that	O
mRNAs	RNA
for	O
all	O
three	O
of	O
these	O
regulatory	O
factors	O
are	O
expressed	O
in	O
fetal	cell_type
blood	cell_type
cells	cell_type
by	O
the	O
27th	O
week	O
of	O
gestation	O
and	O
in	O
term	O
cord	O
bloods	O
.	O
Activation	O
of	O
term	cell_type
infant	cell_type
cord	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
with	O
anti-CD3	protein
monoclonal	protein
antibodies	protein
resulted	O
in	O
up-regulation	O
of	O
both	O
c-jun	protein
and	O
c-fos	O
mRNAs	RNA
within	O
15	O
min	O
of	O
stimulation.	O
However,	O
secretion	O
of	O
IL-2	protein
by	O
anti-CD3-stimulated	cell_line
cord	cell_line
blood	cell_line
mononuclear	cell_line
cells	cell_line
was	O
still	O
blunted	O
compared	O
with	O
control	cell_type
cells	cell_type
from	O
adults.	O
We	O
conclude	O
that	O
fetal	cell_type
nucleated	cell_type
blood	cell_type
cells	cell_type
constitutively	O
express	O
important	O
genes	O
for	O
cytokine	protein
regulation	O
and	O
are	O
able	O
to	O
increase	O
intracellular	O
accumulation	O
of	O
the	O
mRNAs	RNA
for	O
these	O
factors	O
in	O
response	O
to	O
anti-CD3	protein
stimulation	O
.	O
Thus,	O
qualitative	O
differences	O
in	O
the	O
capacity	O
to	O
regulate	O
these	O
factors	O
could	O
not	O
be	O
shown	O
in	O
fetal	cell_type
blood	cell_type
cells	cell_type
.	O
Quantitative	O
experiments	O
comparing	O
binding	O
of	O
these	O
transcription	protein
factors	protein
to	O
the	O
IL-2	DNA
promoter	DNA
are	O
currently	O
under	O
investigation.	O

Nuclear	O
accumulation	O
of	O
NFAT4	protein
opposed	O
by	O
the	O
JNK	protein
signal	O
transduction	O
pathway	O
.	O
The	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(NFAT)	protein
group	protein
of	O
transcription	protein
factors	protein
is	O
retained	O
in	O
the	O
cytoplasm	O
of	O
quiescent	cell_type
cells	cell_type
.	O
NFAT	protein
activation	O
is	O
mediated	O
in	O
part	O
by	O
induced	O
nuclear	O
import	O
.	O
This	O
process	O
requires	O
calcium	O
-dependent	O
dephosphorylation	O
of	O
NFAT	protein
caused	O
by	O
the	O
phosphatase	protein
calcineurin	protein
.	O
The	O
c-Jun	protein
amino-terminal	protein
kinase	protein
(	O
JNK	protein
)	O
phosphorylates	O
NFAT4	protein
on	O
two	O
sites.	O
Mutational	O
removal	O
of	O
the	O
JNK	protein
phosphorylation	protein
sites	protein
caused	O
constitutive	O
nuclear	O
localization	O
of	O
NFAT4	protein
.	O
In	O
contrast,	O
JNK	protein
activation	O
in	O
calcineurin	cell_line
-stimulated	cell_line
cells	cell_line
caused	O
nuclear	O
exclusion	O
of	O
NFAT4	protein
.	O
These	O
findings	O
show	O
that	O
the	O
nuclear	O
accumulation	O
of	O
NFAT4	protein
promoted	O
by	O
calcineurin	protein
is	O
opposed	O
by	O
the	O
JNK	protein
signal	O
transduction	O
pathway	O
.	O

Thiol	O
modulation	O
inhibits	O
the	O
interleukin	protein
(IL)-1	protein
-mediated	O
activation	O
of	O
an	O
IL-1	protein
receptor-associated	protein
protein	protein
kinase	protein
and	O
NF-kappa	protein
B	protein
.	O
The	O
interleukin-1	protein
receptor	protein
type	protein
I	protein
(	O
IL-1RI	protein
)	O
is	O
associated	O
with	O
other	O
proteins	O
thus	O
forming	O
a	O
complex	protein
system	protein
by	O
which	O
IL-1	protein
exerts	O
its	O
various	O
signals.	O
The	O
initiating	O
event	O
is	O
still	O
uncertain,	O
but	O
activation	O
of	O
a	O
recently	O
described	O
receptor-associated	protein
protein	protein
kinase	protein
is	O
one	O
of	O
the	O
earliest	O
events	O
detectable	O
(Martin	O
et	O
al.,	O
Eur.J.Immunol.1994.24:	O
1566).	O
IL-1	protein
signaling	O
is	O
commonly	O
accompanied	O
by	O
oxidative	O
processes	O
and	O
is	O
thought	O
to	O
be	O
subject	O
to	O
redox	O
regulation.	O
We	O
therefore	O
investigated	O
whether	O
the	O
activation	O
of	O
the	O
IL-1RI	protein
-associated	protein
protein	protein
kinase	protein
could	O
be	O
a	O
target	O
for	O
redox	O
regulation	O
and	O
whether	O
an	O
altered	O
activity	O
of	O
the	O
kinase	O
could	O
influence	O
IL-1	protein
-mediated	O
NF-kappa	protein
B	protein
activation	O
.	O
A	O
murine	cell_line
T	cell_line
cell	cell_line
line	cell_line
,	O
EL4	cell_line
,	O
was	O
stimulated	O
with	O
IL-1	protein
with	O
and	O
without	O
pretreatment	O
with	O
different	O
compounds	O
known	O
to	O
influence	O
the	O
cellular	O
redox	O
status	O
.	O
Thiol	O
modifying	O
agents	O
like	O
diamide	O
,	O
menadione	O
,	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
),	O
diethyl	O
dithiocarbamate	O
or	O
phenylarsine	O
oxide	O
inhibited	O
the	O
IL-1	protein
-induced	O
activation	O
of	O
the	O
IL-1RI-associated	protein
protein	protein
kinase	protein
.	O
N-Acetylcysteine	O
,	O
alpha,alpha'-dipyridyl	O
,	O
aminotriazole	O
or	O
nitrofurantoin	O
did	O
not	O
show	O
any	O
effect.	O
The	O
inhibition	O
by	O
PDTC	O
was	O
reversible	O
unless	O
glutathione	O
synthesis	O
was	O
blocked	O
by	O
buthionine	O
sulfoximine	O
.	O
The	O
described	O
conditions	O
which	O
inhibited	O
or	O
prevented	O
the	O
activation	O
of	O
the	O
IL-1RI	protein
-associated	protein
kinase	protein
similarly	O
impaired	O
the	O
activation	O
of	O
NF-kappa	protein
B	protein
in	O
EL4	cell_line
cells	cell_line
.	O
From	O
these	O
observations	O
we	O
conclude	O
that	O
free	O
thiols	O
in	O
the	O
IL-1RI	protein
complex	protein
are	O
essential	O
for	O
the	O
activation	O
of	O
the	O
IL-1RI	protein
-associated	protein
protein	protein
kinase	protein
and	O
that	O
this	O
process	O
is	O
mandatory	O
for	O
IL-1	protein
signaling	O
leading	O
to	O
NF-kappa	protein
B	protein
activation	O
.	O

Switching	O
gears	O
during	O
T-cell	O
maturation	O
:	O
RANTES	protein
and	O
late	O
transcription	O
.	O
Although	O
much	O
is	O
understood	O
about	O
the	O
induction	O
of	O
genes	DNA
expressed	O
early	O
(within	O
24	O
h)	O
after	O
T-cell	O
activation	O
,	O
little	O
is	O
known	O
about	O
the	O
regulation	O
of	O
expression	O
of	O
genes	DNA
expressed	O
'late'	O
(three	O
or	O
more	O
days)	O
post-stimulation	O
.	O
A	O
better	O
understanding	O
of	O
transcriptional	O
regulation	O
at	O
this	O
important	O
stage	O
of	O
T-cell	O
maturation	O
may	O
yield	O
new	O
insights	O
into	O
T-cell	O
development	O
and	O
new	O
immunotherapeutic	O
targets	O
.	O

Involvement	O
of	O
different	O
transduction	O
pathways	O
in	O
NF-kappa	protein
B	protein
activation	O
by	O
several	O
inducers	DNA
.	O
Double-stimulation	O
was	O
used	O
to	O
demonstrate	O
that,	O
in	O
a	O
T	cell_line
lymphocytic	cell_line
cell	cell_line
line	cell_line
(	O
CEM	cell_line
),	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
rapidly	O
induced	O
NF-kappa	protein
B	protein
through	O
a	O
signaling	O
pathway	O
which	O
did	O
not	O
involve	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
and	O
was	O
different	O
from	O
the	O
activation	O
triggered	O
by	O
either	O
H2O2	O
or	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
).	O
Since	O
these	O
latter	O
compounds	O
were	O
known	O
to	O
activate	O
NF-kappa	protein
B	protein
translocation	O
in	O
a	O
redox-sensitive	O
way,	O
we	O
have	O
demonstrated	O
that	O
NF-kappa	protein
B	protein
activation	O
by	O
PMA	O
was	O
resistant	O
to	O
antioxidant	O
N-acetyl-L-cysteine	O
(	O
NAC	O
)	O
and	O
sensitive	O
to	O
kinase	O
inhibitors	O
staurosporine	O
and	O
H7	O
while	O
activation	O
by	O
H2O2	O
or	O
TNF-alpha	protein
were	O
not.	O

Blockade	O
of	O
T-cell	O
activation	O
by	O
dithiocarbamates	O
involves	O
novel	O
mechanisms	O
of	O
inhibition	O
of	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
.	O
Dithiocarbamates	O
(	O
DTCs	O
)	O
have	O
recently	O
been	O
reported	O
as	O
powerful	O
inhibitors	O
of	O
NF-kappaB	protein
activation	O
in	O
a	O
number	O
of	O
cell	O
types.	O
Given	O
the	O
role	O
of	O
this	O
transcription	O
factor	O
in	O
the	O
regulation	O
of	O
gene	O
expression	O
in	O
the	O
inflammatory	O
response	O
,	O
NF-kappaB	protein
inhibitors	O
have	O
been	O
suggested	O
as	O
potential	O
therapeutic	O
drugs	O
for	O
inflammatory	O
diseases	O
.	O
We	O
show	O
here	O
that	O
DTCs	O
inhibited	O
both	O
interleukin	protein
2	protein
(	O
IL-2	protein
)	O
synthesis	O
and	O
membrane	O
expression	O
of	O
antigens	protein
which	O
are	O
induced	O
during	O
T-cell	O
activation	O
.	O
This	O
inhibition,	O
which	O
occurred	O
with	O
a	O
parallel	O
activation	O
of	O
c-Jun	protein
transactivating	O
functions	O
and	O
expression,	O
was	O
reflected	O
by	O
transfection	O
experiments	O
at	O
the	O
IL-2	DNA
promoter	DNA
level	O
,	O
and	O
involved	O
not	O
only	O
the	O
inhibition	O
of	O
NF-kappaB	protein
-driven	O
reporter	O
activation	O
but	O
also	O
that	O
of	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NFAT	protein
).	O
Accordingly,	O
electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSAs	O
)	O
indicated	O
that	O
pyrrolidine	O
DTC	O
(	O
PDTC	O
)	O
prevented	O
NF-kappaB	protein
,	O
and	O
NFAT	protein
DNA-binding	O
activity	O
in	O
T	cell_type
cells	cell_type
stimulated	O
with	O
either	O
phorbol	O
myristate	O
acetate	O
plus	O
ionophore	O
or	O
antibodies	O
against	O
the	O
CD3-T-cell	protein
receptor	protein
complex	protein
and	O
simultaneously	O
activated	O
the	O
binding	O
of	O
AP-1	protein
.	O
Furthermore,	O
PDTC	O
differentially	O
targeted	O
both	O
NFATp	O
and	O
NFATc	O
family	O
members	O
,	O
inhibiting	O
the	O
transactivation	O
functions	O
of	O
NFATp	protein
and	O
mRNA	O
induction	O
of	O
NFATc	protein
.	O
Strikingly,	O
Western	O
blotting	O
and	O
immunocytochemical	O
experiments	O
indicated	O
that	O
PDTC	O
promoted	O
a	O
transient	O
and	O
rapid	O
shuttling	O
of	O
NFATp	protein
and	O
NFATc	protein
,	O
leading	O
to	O
their	O
accelerated	O
export	O
from	O
the	O
nucleus	O
of	O
activated	cell_type
T	cell_type
cells	cell_type
.	O
We	O
propose	O
that	O
the	O
activation	O
of	O
an	O
NFAT	O
kinase	O
by	O
PDTC	O
could	O
be	O
responsible	O
for	O
the	O
rapid	O
shuttling	O
of	O
the	O
NFAT	protein
,	O
therefore	O
transiently	O
converting	O
the	O
sustained	O
transactivation	O
of	O
this	O
transcription	protein
factor	protein
that	O
occurs	O
during	O
lymphocyte	O
activation	O
,	O
and	O
show	O
that	O
c-Jun	protein
NH2-terminal	protein
kinase	protein
(	O
JNK	protein
)	O
can	O
act	O
by	O
directly	O
phosphorylating	O
NFATp	protein
.	O
In	O
addition,	O
the	O
combined	O
inhibitory	O
effects	O
on	O
NFAT	protein
and	O
NF-KB	protein
support	O
a	O
potential	O
use	O
of	O
DTCs	O
as	O
immunosuppressants.	O

Activation	O
of	O
a	O
novel	DNA
gene	DNA
in	O
3q21	DNA
and	O
identification	O
of	O
intergenic	O
fusion	O
transcripts	O
with	O
ecotropic	DNA
viral	DNA
insertion	DNA
site	DNA
I	DNA
in	O
leukemia	O
.	O
We	O
have	O
identified	O
a	O
novel	DNA
gene	DNA
,	O
GR6	DNA
,	O
located	O
within	O
the	O
leukemia	O
breakpoint	O
region	O
of	O
3q21	DNA
,	O
that	O
is	O
normally	O
expressed	O
in	O
early	O
fetal	O
development	O
but	O
not	O
in	O
adult	O
peripheral	O
blood	O
.	O
GR6	DNA
is	O
activated	O
in	O
the	O
UCSD-AML1	cell_line
cell	cell_line
line	cell_line
and	O
in	O
a	O
leukemic	cell_line
sample	cell_line
,	O
both	O
of	O
which	O
carry	O
a	O
t(3;3)(q21;q26)	DNA
.	O
In	O
UCSD-AML1	cell_line
,	O
we	O
have	O
also	O
identified	O
fusion	RNA
transcripts	RNA
between	O
the	O
ecotropic	DNA
viral	DNA
insertion	DNA
site	DNA
I	DNA
(EVI1)	DNA
gene	DNA
in	O
3q26	DNA
and	O
GR6	DNA
and	O
between	O
EVI1	DNA
and	O
Ribophorin	DNA
I	DNA
that	O
maps	O
30	O
kb	O
telomeric	O
to	O
GR6	DNA
in	O
3q21	DNA
.	O
All	O
fusions	O
splice	O
the	O
5'	DNA
ends	DNA
of	O
the	O
3q21	DNA
genes	DNA
into	O
exon	DNA
2	DNA
of	O
the	O
EVI1	DNA
gene,	O
an	O
event	O
that	O
is	O
similar	O
to	O
the	O
normal	O
intergenic	O
splicing	O
of	O
MDS1-	DNA
EVI1	DNA
and	O
to	O
those	O
previously	O
documented	O
in	O
leukemias	O
with	O
t(3;21)	DNA
and	O
t(3;12)	DNA
,	O
in	O
which	O
acute	O
myelogenous	DNA
leukemia	DNA
1-	DNA
EVI1	DNA
fusions	DNA
and	O
ETV6-	DNA
EVI1	DNA
fusions	DNA
,	O
respectively,	O
occur.	O
The	O
Ribophorin	DNA
I	DNA
-EVI1	DNA
fusion	DNA
in	O
particular	O
may	O
be	O
a	O
common	O
occurrence	O
in	O
t(3;3)	DNA
.	O

The	O
A-myb	protein
transcription	protein
factor	protein
in	O
neoplastic	O
and	O
normal	O
B	O
cells	O
.	O
The	O
myb	protein
family	protein
of	O
transcription	protein
factors	protein
has	O
been	O
strongly	O
implicated	O
in	O
the	O
regulation	O
of	O
cell	O
growth	O
and	O
differentiation	O
in	O
the	O
haematopoietic	O
system	O
.	O
The	O
v-myb	DNA
oncogene	DNA
,	O
carried	O
by	O
avian	O
defective	O
retroviruses	O
,	O
causes	O
leukaemias	O
in	O
the	O
chicken	O
and	O
transforms	O
haematopoietic	cell_type
cells	cell_type
in	O
vitro.	O
Its	O
normal	O
cellular	O
equivalent	O
c-myb	DNA
,	O
has	O
been	O
shown	O
to	O
promote	O
the	O
proliferation	O
and	O
block	O
the	O
differentiation	O
of	O
haematopoietic	cell_type
cells	cell_type
in	O
several	O
experimental	O
models	O
and	O
is	O
required	O
for	O
fetal	O
haematopoiesis	O
.	O
Two	O
other	O
members	O
of	O
the	O
family	O
have	O
been	O
cloned	O
more	O
recently,	O
A-myb	protein
and	O
B-myb	protein
,	O
which	O
show	O
sequence	O
homology	O
with	O
c-myb	DNA
in	O
several	O
domains,	O
of	O
which	O
the	O
DNA	protein
binding	protein
domain	protein
as	O
well	O
as	O
other	O
regulatory	protein
domains	protein
.	O
Both	O
have	O
been	O
shown	O
to	O
be	O
transcription	protein
factors	protein
.	O
B-myb	protein
is	O
also	O
involved	O
in	O
the	O
control	O
of	O
proliferation	O
and	O
differentiation	O
,	O
but,	O
unlike	O
c-myb	DNA
,	O
it	O
is	O
expressed	O
in	O
many	O
cell	O
types.	O
The	O
third	O
member	O
of	O
the	O
family	protein
,	O
A-myb	protein
,	O
shows	O
the	O
most	O
restricted	O
pattern	O
of	O
expression,	O
suggesting	O
a	O
very	O
specific	O
role	O
for	O
this	O
transcription	protein
factor	protein
.	O
A-myb	protein
is	O
expressed	O
in	O
a	O
subpopulation	O
of	O
normal	cell_type
B	cell_type
lymphocytes	cell_type
activated	O
in	O
vivo	O
and	O
localised	O
in	O
the	O
germinal	O
center	O
of	O
peripheral	O
lymphoid	O
organs	O
and	O
is	O
not	O
detected	O
at	O
significant	O
levels	O
in	O
all	O
other	O
mature	O
or	O
immature	cell_type
haematopoietic	cell_type
populations	cell_type
studied,	O
including	O
bone	cell_type
marrow	cell_type
cells	cell_type
,	O
T	cell_type
lymphocytes	cell_type
,	O
granulocytes	cell_type
,	O
monocytes	cell_type
,	O
either	O
at	O
rest	O
or	O
after	O
in	O
vitro	O
activation	O
.	O
These	O
studies	O
indicate	O
that	O
A-myb	protein
plays	O
a	O
role	O
during	O
a	O
narrow	O
window	O
of	O
normal	cell_type
B	cell_type
cell	cell_type
differentiation	O
.	O
A-myb	protein
expression	O
has	O
also	O
been	O
studied	O
in	O
a	O
wide	O
range	O
of	O
neoplastic	cell_type
B	cell_type
cells	cell_type
,	O
representing	O
the	O
whole	O
spectrum	O
of	O
B	O
cell	O
differentiation	O
.	O
A-myb	protein
is	O
strongly	O
expressed	O
in	O
Burkitt's	O
lymphomas	O
(	O
BL	O
)	O
and	O
slg+	O
B-acute	O
lymphoblastic	O
leukaemias	O
(	O
B-ALL	O
)	O
and	O
not	O
in	O
all	O
other	O
leukaemias	O
/lymphomas	O
tested,	O
with	O
the	O
exception	O
of	O
a	O
subset	O
of	O
CLL	O
(about	O
25%	O
of	O
cases).	O
It	O
is	O
intriguing	O
that	O
the	O
A-myb	DNA
genome	DNA
has	O
been	O
localised	O
relatively	O
close	O
to	O
the	O
c-myc	DNA
gene	DNA
on	O
chromosome	DNA
8	DNA
,	O
suggesting	O
that	O
the	O
c-myc	O
translocation	O
in	O
BL	O
and	O
B-ALL	O
may	O
affect	O
A-myb	protein
transcription	O
.	O
Studies	O
are	O
in	O
progress	O
to	O
investigate	O
the	O
functional	O
relationship	O
between	O
A-myb	protein
and	O
c-myc	DNA
,	O
particularly	O
in	O
the	O
context	O
of	O
BL	cell_type
cells	cell_type
and	O
to	O
determine	O
whether	O
A-myb	protein
is	O
deregulated	O
in	O
these	O
cells.	O

Expression	O
of	O
bcl-6	protein
protein	protein
in	O
normal	O
skin	O
and	O
epidermal	O
neoplasms	O
.	O
Bcl-6	protein
protein	protein
is	O
a	O
recently	O
identified	O
novel	O
transcription	protein
factor	protein
whose	O
deregulated	O
expression	O
is	O
associated	O
with	O
diffuse	O
large	O
B	O
cell	O
lymphomas	O
.	O
It	O
was	O
recently	O
shown	O
by	O
us	O
that	O
the	O
protein	O
is	O
located	O
in	O
germinal	cell_type
center	cell_type
B	cell_type
cells	cell_type
and	O
their	O
neoplastic	cell_type
counterparts	cell_type
.	O
In	O
the	O
present	O
study,	O
the	O
expression	O
of	O
bcl-6	protein
protein	protein
on	O
normal	O
epidermis	O
,	O
benign	O
,	O
and	O
malignant	O
tumors	O
originating	O
from	O
epidermal	cell_type
cells	cell_type
,	O
and	O
squamous	cell_line
cell	cell_line
carcinoma	cell_line
(SCC)	cell_line
cell	cell_line
lines	cell_line
are	O
investigated.	O
With	O
the	O
use	O
of	O
immunohistochemistry	O
,	O
bcl-6	protein
protein	protein
was	O
shown	O
to	O
stain	O
intensely	O
on	O
normal	cell_line
prickle	cell_line
cells	cell_line
,	O
but	O
none	O
to	O
only	O
slightly	O
on	O
epidermal	cell_type
basal	cell_type
cells	cell_type
.	O
Papillomas	O
and	O
keratoacanthomas	O
copied	O
their	O
normal	O
counterparts	O
in	O
the	O
mode	O
of	O
expression.	O
Various	O
levels	O
of	O
expression	O
were	O
found	O
on	O
seborrheic	O
keratoses,	O
while	O
the	O
expression	O
level	O
on	O
basal	O
cell	O
epitheliomas	O
was	O
low.	O
Peculiarly,	O
eccrine	O
poromas	O
and	O
undifferentiated	O
spindle-shaped	O
basal	O
cell	O
epitheliomas	O
were	O
totally	O
unstained.	O
Squamous	O
cell	O
carcinomas	O
showed	O
a	O
variety	O
of	O
expression	O
levels	O
,	O
while	O
two	O
undifferentiated	O
spindle-shaped	O
carcinomas	O
and	O
one	O
undifferentiated	O
SCC	cell_line
cell	cell_line
line	cell_line
remained	O
unstained.	O
These	O
results	O
suggest	O
that	O
the	O
expression	O
of	O
bcl-6	protein
protein	protein
may	O
be	O
associated	O
with	O
morphological	O
differentiation	O
in	O
normal	O
and	O
neoplastic	cell_type
epidermal	cell_type
cells	cell_type
.	O

Sp3	protein
mediates	O
transcriptional	O
activation	O
of	O
the	O
leukocyte	DNA
integrin	DNA
genes	DNA
CD11C	DNA
and	O
CD11B	DNA
and	O
cooperates	O
with	O
c-Jun	O
to	O
activate	O
CD11C	DNA
.	O
The	O
leukocyte	DNA
integrin	DNA
genes	DNA
CD11c	DNA
and	O
CD11b	DNA
are	O
expressed	O
predominately	O
in	O
myelomonocytic	O
cells.	O
In	O
previous	O
experiments,	O
the	O
-70	O
to	O
-65	O
and	O
-121	O
to	O
-103	O
regions	O
of	O
the	O
CD11c	DNA
promoter	DNA
and	O
the	O
-66	DNA
to	DNA
-59	DNA
region	DNA
of	O
the	O
CD11b	DNA
promoter	DNA
were	O
shown	O
to	O
be	O
essential	O
for	O
Sp1-	protein
mediated	O
activation	O
of	O
these	O
genes.	O
In	O
vivo	O
genomic	O
footprinting	O
had	O
also	O
revealed	O
cell-specific	O
binding	O
of	O
protein,	O
presumably	O
Sp1	protein
,	O
to	O
these	O
regions.	O
In	O
this	O
study,	O
electrophoretic	O
mobility	O
shift	O
analysis	O
showed	O
that	O
the	O
Sp1	protein
-related	protein
factor	protein
,	O
Sp3	protein
,	O
also	O
binds	O
at	O
or	O
near	O
these	O
same	O
regions.	O
Cotransfection	O
of	O
Sp3	protein
along	O
with	O
CD11c	DNA
promoter	DNA
-luciferase	DNA
constructs	DNA
into	O
Sp-deficient	cell_line
Drosophila	cell_line
Schneider	cell_line
2	cell_line
cells	cell_line
showed	O
that	O
Sp3	protein
could	O
activate	O
the	O
CD11c	DNA
promoter	DNA
.	O
Deletion	O
of	O
both	O
the	O
-70	O
to	O
-65	O
and	O
-121	O
to	O
-103	O
regions	O
of	O
the	O
CD11c	DNA
promoter	DNA
resulted	O
in	O
the	O
loss	O
of	O
activation	O
by	O
Sp3	protein
.	O
Both	O
sites	O
showed	O
activation	O
by	O
Sp3	protein
;	O
however,	O
the	O
-70	DNA
to	DNA
-65	DNA
region	DNA
was	O
more	O
responsive	O
to	O
Sp3	protein
than	O
to	O
Sp1	protein
.	O
Similar	O
transfection	O
analysis	O
of	O
the	O
-66	DNA
to	DNA
-59	DNA
region	DNA
of	O
the	O
CD11b	DNA
promoter	DNA
showed	O
Sp3	protein
-dependent	O
expression	O
.	O
Further,	O
cotransfection	O
analysis	O
in	O
Drosophila	cell_line
cells	cell_line
showed	O
that	O
Sp3	protein
,	O
as	O
was	O
previously	O
shown	O
for	O
Sp1	protein
,	O
also	O
synergizes	O
with	O
c-Jun	protein
to	O
activate	O
CD11c	DNA
.	O
Antisense	O
experiments	O
that	O
knocked	O
out	O
endogenous	O
Sp3	protein
expression	O
in	O
the	O
myelomocytic	cell_line
cell	cell_line
line	cell_line
,	O
HL60	cell_line
,	O
revealed	O
that	O
Sp3	protein
participates	O
in	O
activation	O
of	O
the	O
CD11c	O
and	O
CD11b	O
promoters	O
in	O
vivo.	O

The	O
winged-helix	protein
transcription	protein
factor	protein
Trident	protein
is	O
expressed	O
in	O
actively	O
dividing	cell_type
lymphocytes	cell_type
.	O
We	O
recently	O
identified	O
the	O
winged-helix	protein
transcription	protein
factor	protein
Trident	protein
and	O
described	O
its	O
expression	O
pattern	O
in	O
synchronized	cell_type
fibroblasts	cell_type
.	O
We	O
have	O
now	O
studied	O
Trident	protein
expression	O
in	O
cell	cell_line
lines	cell_line
,	O
differentiating	cell_type
thymocytes	cell_type
and	O
in	O
lymphocytes	O
derived	O
from	O
peripheral	O
blood	O
.	O
During	O
T	O
cell	O
differentiation	O
,	O
expression	O
peaked	O
in	O
the	O
actively	cell_type
dividing	cell_type
immature	cell_type
single	cell_type
positive	cell_type
cells	cell_type
.	O
In	O
peripheral	O
blood	O
lymphocytes,	O
expression	O
of	O
Trident	RNA
mRNA	RNA
was	O
absent,	O
but	O
could	O
be	O
induced	O
upon	O
stimulation	O
with	O
mitogens	O
in	O
vitro.	O
These	O
observations	O
imply	O
a	O
function	O
for	O
Trident	protein
in	O
dividing	cell_type
lymphocytes	cell_type
.	O

Estrogen	protein
receptor	protein
diminishes	O
DNA-binding	O
activities	O
of	O
chicken	protein
GATA-1	protein
and	O
CACCC-binding	protein
proteins	protein
.	O
The	O
estrogen	protein
receptor	protein
(	O
ER	protein
)	O
repressed	O
erythroid	O
differentiation	O
and	O
erythroid-specific	DNA
gene	DNA
expression	O
.	O
In	O
this	O
study,	O
we	O
investigated	O
the	O
effect	O
of	O
ER	protein
alpha	protein
(referred	O
to	O
throughout	O
as	O
ER	protein
)	O
on	O
DNA-binding	O
activities	O
of	O
transcription	protein
factors	protein
involved	O
in	O
regulating	O
the	O
expression	O
of	O
erythroid-specific	DNA
genes	DNA
,	O
and,	O
in	O
particular,	O
the	O
histone	DNA
H5	DNA
gene	DNA
.	O
Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
we	O
found	O
that	O
in	O
the	O
presence	O
of	O
rabbit	O
reticulocyte	O
lysate	O
,	O
human	protein
ER	protein
reduced	O
the	O
binding	O
activities	O
of	O
chicken	protein
immature	protein
erythrocyte	protein
nuclear	protein
extracted	protein
proteins	protein
to	O
GATA	O
and	O
CACCC	O
sites	O
in	O
the	O
H5	O
promoter	O
and	O
enhancer	O
.	O
In	O
contrast,	O
the	O
binding	O
activities	O
of	O
NF1	protein
and	O
Sp1	protein
were	O
not	O
affected	O
by	O
ER	protein
.	O
Binding	O
of	O
ER	protein
to	O
an	O
estrogen	DNA
response	DNA
element	DNA
was	O
enhanced	O
by	O
addition	O
of	O
rabbit	O
reticulocyte	O
lysate	O
.	O
This	O
lysate	O
was	O
also	O
necessary	O
for	O
ER	protein
to	O
diminish	O
the	O
DNA-binding	O
activity	O
of	O
GATA-1	protein
.	O
These	O
results	O
suggest	O
that	O
additional	O
factor(s)	O
are	O
necessary	O
for	O
full	O
ER	protein
function.	O
Both	O
GATA-1	protein
and	O
CACCC-binding	protein
proteins	protein
are	O
critical	O
for	O
the	O
developmentally	O
regulated	O
expression	O
of	O
erythroid-specific	DNA
genes	DNA
.	O
We	O
hypothesize	O
that	O
interference	O
in	O
DNA-binding	O
activities	O
of	O
GATA-1	protein
and	O
CACCC-binding	protein
proteins	protein
is	O
the	O
mechanism	O
by	O
which	O
the	O
ER	protein
inhibits	O
regulation	O
of	O
these	O
genes.	O

Regulation	O
of	O
Id3	protein
cell	O
cycle	O
function	O
by	O
Cdk-2-dependent	O
phosphorylation	O
.	O
The	O
functions	O
of	O
basic	protein
helix-loop-helix	protein
(bHLH)	protein
transcription	protein
factors	protein
in	O
activating	O
differentiation-linked	O
gene	O
expression	O
and	O
in	O
inducing	O
G1	O
cell	O
cycle	O
arrest	O
are	O
negatively	O
regulated	O
by	O
members	O
of	O
the	O
Id	protein
family	protein
of	protein
HLH	protein
proteins	protein
.	O
These	O
bHLH	protein
antagonists	protein
are	O
induced	O
during	O
a	O
mitogenic	O
signalling	O
response	O
,	O
and	O
they	O
function	O
by	O
sequestering	O
their	O
bHLH	protein
targets	protein
in	O
inactive	protein
heterodimers	protein
that	O
are	O
unable	O
to	O
bind	O
to	O
specific	O
gene	DNA
regulatory	DNA
(E	DNA
box)	DNA
sequences	DNA
.	O
Recently,	O
cyclin	O
E-Cdk2-	O
and	O
cyclin	O
A-Cdk2-	O
dependent	O
phosphorylation	O
of	O
a	O
single	O
conserved	O
serine	O
residue	O
(	O
Ser5	O
)	O
in	O
Id2	protein
has	O
been	O
shown	O
to	O
occur	O
during	O
late	O
G1-to-S	O
phase	O
transition	O
of	O
the	O
cell	O
cycle,	O
and	O
this	O
neutralizes	O
the	O
function	O
of	O
Id2	protein
in	O
abrogating	O
E-box-dependent	protein
bHLH	protein
homo	O
-or	O
hetero	O
dimer	O
complex	O
formation	O
in	O
vitro	O
(E.Hara,	O
M.Hall,	O
and	O
G.Peters,	O
EMBO	O
J.16:332-342,	O
1997).	O
We	O
now	O
show	O
that	O
an	O
analogous	O
cell-cycle-regulated	O
phosphorylation	O
of	O
Id3	protein
alters	O
the	O
specificity	O
of	O
Id3	protein
for	O
abrogating	O
both	O
E-box-dependent	protein
bHLH	protein
homo-	O
or	O
heterodimer	O
complex	O
formation	O
in	O
vitro	O
and	O
E-box-dependent	O
reporter	DNA
gene	DNA
function	O
in	O
vivo.	O
Furthermore,	O
compared	O
with	O
wild-type	protein
Id3	protein
,	O
an	O
Id3	protein
Asp5	protein
mutant	protein
(mimicking	O
phosphorylation)	O
is	O
unable	O
to	O
promote	O
cell	O
cycle	O
S	O
phase	O
entry	O
in	O
transfected	cell_line
fibroblasts	cell_line
,	O
whereas	O
an	O
Id3	protein
Ala5	protein
mutant	protein
(ablating	O
phosphorylation)	O
displays	O
an	O
activity	O
significantly	O
greater	O
than	O
that	O
of	O
wild-type	protein
Id3	protein
protein	protein
.	O
Cdk2-dependent	O
phosphorylation	O
therefore	O
provides	O
a	O
switch	O
during	O
late	O
G1-to-S	O
phase	O
that	O
both	O
nullifies	O
an	O
early	O
G1	O
cell	O
cycle	O
regulatory	O
function	O
of	O
Id3	protein
and	O
modulates	O
its	O
target	O
bHLH	protein
specificity	O
.	O
These	O
data	O
also	O
demonstrate	O
that	O
the	O
ability	O
of	O
Id3	protein
to	O
promote	O
cell	O
cycle	O
S	O
phase	O
entry	O
is	O
not	O
simply	O
a	O
function	O
of	O
its	O
ability	O
to	O
modulate	O
bHLH	protein
heterodimer-dependent	O
gene	O
expression	O
and	O
establish	O
a	O
biologically	O
important	O
mechanism	O
through	O
which	O
Cdk2	O
and	O
Id-bHLH	O
functions	O
are	O
integrated	O
in	O
the	O
coordination	O
of	O
cell	O
proliferation	O
and	O
differentiation	O
.	O

Molecular	O
cloning	O
and	O
functional	O
characterization	O
of	O
murine	protein
cDNA	protein
encoding	protein
transcription	protein
factor	protein
NFATc	protein
.	O
Transcription	protein
factors	protein
of	O
the	O
NFAT	protein
(	protein
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
)	protein
family	protein
play	O
important	O
roles	O
in	O
immune	O
and	O
inflammatory	O
responses	O
by	O
regulating	O
the	O
expression	O
of	O
genes	O
encoding	O
cytokines	protein
and	O
immunoregulatory	protein
proteins	protein
.	O
Here	O
we	O
describe	O
cloning	O
and	O
characterization	O
of	O
full-length	O
cDNA	protein
encoding	protein
murine	protein
(m)	protein
NFATc	protein
which	O
predicts	O
that	O
the	O
protein	O
has	O
all	O
the	O
conserved	protein
structural	protein
motifs	protein
of	O
NFAT	protein
family	protein
members	protein
,	O
including	O
the	O
rel	O
homology	O
domain,	O
the	O
NFAT	protein
homology	protein
domain	protein
and	O
the	O
nuclear	O
translocation	O
signals	O
.	O
mNFATc	protein
complexed	O
with	O
AP-1	protein
bound	O
specifically	O
to	O
the	O
murine	protein
IL-2	protein
NFAT	protein
recognition	protein
sequence	protein
and	O
activated	O
transcription	O
from	O
the	O
co-transfected	DNA
IL-2	DNA
promoter	DNA
in	O
COS-7	cell_line
cells	cell_line
.	O
Northern	O
blot	O
analysis	O
showed	O
that	O
the	O
cDNA	DNA
probe	DNA
hybridized	O
with	O
a	O
4.5	O
kb	O
transcript	O
which	O
is	O
highly	O
inducible	O
in	O
murine	cell_type
T	cell_type
cells	cell_type
.	O
By	O
Northern	O
and	O
in	O
situ	O
hybridization	O
,	O
mNFATc	RNA
transcript	RNA
was	O
detected	O
from	O
the	O
early	O
stage	O
of	O
development.	O
In	O
the	O
mouse	O
embryo	O
,	O
mNFATc	RNA
transcript	RNA
was	O
strongly	O
expressed	O
in	O
thymus	O
,	O
lung	O
and	O
submandibular	O
gland	O
and	O
weakly	O
in	O
skeletal	O
muscle	O
and	O
heart	O
suggesting	O
that	O
mNFATc	protein
may	O
have	O
a	O
role	O
both	O
in	O
embryogenesis	O
and	O
in	O
mature	cell_type
T	cell_type
cells	cell_type
.	O

TNFalpha	protein
cooperates	O
with	O
the	O
protein	protein
kinase	protein
A	protein
pathway	O
to	O
synergistically	O
increase	O
HIV-1	DNA
LTR	DNA
transcription	O
via	O
downstream	O
TRE-like	DNA
cAMP	DNA
response	DNA
elements	DNA
.	O
Activating	protein
protein-1	protein
(	O
AP-1	protein
)	O
binding	O
TPA	DNA
responsive	DNA
elements	DNA
(	O
TRE	DNA
)	O
are	O
located	O
downstream	O
of	O
the	O
transcription	DNA
initiation	DNA
site	DNA
in	O
the	O
U5	DNA
region	DNA
of	O
the	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
).	O
These	O
downstream	DNA
sequence	DNA
elements	DNA
,	O
termed	O
DSE	DNA
,	O
can	O
bind	O
both	O
AP-1	protein
and	O
CREB/ATF	protein
transcription	protein
factors	protein
.	O
Recently,	O
we	O
demonstrated	O
that	O
the	O
DSE	DNA
are	O
also	O
cAMP-responsive	DNA
elements	DNA
(	O
CRE	DNA
),	O
since	O
they	O
mediated	O
activation	O
signals	O
elicited	O
by	O
cholera	protein
toxin	protein
(	O
Ctx	protein
),	O
a	O
potent	O
activator	O
of	O
the	O
cAMP-dependent	O
protein	protein
kinase	protein
A	protein
(	O
PKA	protein
)	O
signal	O
transduction	O
pathway	O
.	O
In	O
the	O
present	O
study,	O
we	O
demonstrate	O
that	O
the	O
HIV-1	DNA
DSE	DNA
can	O
mediate	O
the	O
transcriptional	O
synergy	O
elicited	O
by	O
the	O
combination	O
of	O
Ctx	protein
and	O
TNFalpha	protein
.	O
Ctx	protein
combined	O
with	O
TNFalpha	protein
or	O
IL-1beta	protein
to	O
produce	O
a	O
synergistic	O
increase	O
in	O
p24	protein
antigen	protein
production	O
in	O
U1	cell_line
promonocytic	cell_line
cells	cell_line
.	O
Transfection	O
studies	O
of	O
LTR	DNA
reporter	DNA
constructs	DNA
indicated	O
that	O
mutation	O
of	O
the	O
DSE	DNA
sites	DNA
abrogated	O
the	O
LTR	DNA
-mediated	O
synergy	O
induced	O
by	O
Ctx	protein
and	O
TNFalpha	protein
,	O
whereas	O
the	O
synergy	O
induced	O
by	O
Ctx	protein
and	O
IL-1beta	protein
was	O
unaffected,	O
suggesting	O
TNFalpha	protein
and	O
IL-1beta	protein
cooperate	O
differently	O
with	O
the	O
cAMP	O
/PKA	protein
activation	O
pathway	O
to	O
induce	O
HIV-1	O
expression	O
in	O
U1	cell_line
cells	cell_line
.	O
Because	O
the	O
DSE	DNA
are	O
also	O
TRE	DNA
sites,	O
we	O
assessed	O
the	O
effect	O
of	O
the	O
agonist	O
combinations	O
on	O
AP-1	protein
-dependent	O
transcription	O
.	O
TNFalpha	protein
as	O
well	O
as	O
IL-1beta	protein
cooperated	O
with	O
Ctx	protein
to	O
produce	O
a	O
synergistic	O
activation	O
of	O
AP-1	protein
-mediated	O
transcription	O
.	O
These	O
data	O
indicate	O
that	O
the	O
TRE	DNA
-like	DNA
cAMP-responsive	DNA
DSE	DNA
sites	DNA
within	O
the	O
5'-untranslated	DNA
leader	DNA
can	O
mediate	O
the	O
transcriptional	O
cooperativity	O
between	O
TNFalpha	protein
and	O
the	O
cAMP	O
/PKA	protein
pathway	O
.	O
Since	O
the	O
DSE	DNA
and	O
TRE	DNA
sites	O
cannot	O
bind	O
CREB/ATF	protein
homodimers	protein
,	O
we	O
propose	O
a	O
mechanism	O
in	O
which	O
the	O
HIV-1	O
DSE	DNA
bind	O
heterodimers	protein
composed	O
of	O
both	O
AP-1	O
and	O
CREB/ATF	O
proteins	O
.	O
Copyright	O
1997	O
Academic	O
Press.	O

Association	O
of	O
glucocorticoid	O
insensitivity	O
with	O
increased	O
expression	O
of	O
glucocorticoid	protein
receptor	protein
beta	protein
.	O
In	O
many	O
chronic	O
inflammatory	O
disorders	O
,	O
glucocorticoid	O
(	O
GC	O
)	O
insensitivity	O
is	O
a	O
challenging	O
clinical	O
problem	O
associated	O
with	O
life-threatening	O
disease	O
progression.	O
The	O
molecular	O
basis	O
of	O
GC	O
insensitivity	O
,	O
however,	O
is	O
unknown.	O
Alternative	O
splicing	O
of	O
the	O
GC	RNA
receptor	RNA
(R)	RNA
pre-messenger	RNA
RNA	RNA
generates	O
a	O
second	O
GCR	protein
,	O
termed	O
GCR-beta	protein
,	O
which	O
does	O
not	O
bind	O
GCs	O
but	O
antagonizes	O
the	O
transactivating	O
activity	O
of	O
the	O
classic	O
GCR	protein
,	O
termed	O
GCR-alpha	protein
.	O
In	O
the	O
current	O
study,	O
we	O
demonstrate	O
that	O
GC-insensitive	O
asthma	O
is	O
associated	O
with	O
a	O
significantly	O
higher	O
number	O
of	O
GCR-beta	cell_type
-immunoreactive	cell_type
cells	cell_type
in	O
peripheral	O
blood	O
than	O
GC-sensitive	O
asthmatics	O
or	O
normal	O
controls	O
.	O
Furthermore,	O
we	O
show	O
that	O
patients	O
with	O
GC-insensitive	O
asthma	O
have	O
cytokine-induced	O
abnormalities	O
in	O
the	O
DNA	O
binding	O
capability	O
of	O
the	O
GCR	protein
.	O
These	O
abnormalities	O
can	O
be	O
reproduced	O
by	O
transfection	O
of	O
cell	cell_line
lines	cell_line
with	O
the	O
GCR-beta	protein
gene	O
resulting	O
in	O
significant	O
reduction	O
of	O
their	O
GCR-alpha	protein
DNA	O
binding	O
capacity	O
.	O
We	O
conclude	O
that	O
increased	O
expression	O
of	O
GCR-beta	protein
is	O
cytokine	protein
inducible	O
and	O
may	O
account	O
for	O
GC	O
insensitivity	O
in	O
this	O
common	O
inflammatory	O
condition	O
.	O

Epstein-Barr	O
virus	O
EBNA3C	protein
represses	O
Cp	DNA
,	O
the	O
major	O
promoter	O
for	O
EBNA	protein
expression	O
,	O
but	O
has	O
no	O
effect	O
on	O
the	O
promoter	O
of	O
the	O
cell	DNA
gene	DNA
CD21	DNA
.	O
EBNA3C	protein
is	O
a	O
potent	O
repressor	O
of	O
transcription	O
when	O
bound	O
to	O
DNA	O
as	O
a	O
fusion	O
with	O
the	O
DNA	protein
binding	protein
domain	protein
(	O
DBD	protein
)	O
of	O
GALA.	O
A	O
survey	O
of	O
promoters	O
has	O
revealed	O
that	O
the	O
wild-type,	protein
unfused	protein
EBNA3C	protein
can	O
specifically	O
repress	O
expression	O
from	O
reporter	DNA
plasmids	DNA
containing	O
the	O
Epstein-Barr	O
virus	O
Cp	DNA
latency-associated	DNA
promoter	DNA
.	O
Repression	O
of	O
Cp	DNA
activity	O
required	O
amino	protein
acids	protein
207	protein
to	protein
368	protein
,	O
which	O
encompasses	O
a	O
region	O
resembling	O
a	O
basic	protein
DBD	protein
adjacent	O
to	O
a	O
leucine	protein
zipper	protein
DNA	protein
binding	protein
motif	protein
and	O
a	O
site	O
which	O
binds	O
to	O
the	O
cellular	protein
factor	protein
CBF1/RBP-Jkappa	protein
.	O
However,	O
amino	O
acids	O
207	O
to	O
368	O
are	O
dispensable	O
when	O
the	O
protein	O
is	O
bound	O
to	O
DNA	O
as	O
a	O
fusion	O
with	O
the	O
GAL4	O
DBD	protein
,	O
thus	O
implicating	O
this	O
region	O
in	O
DNA	O
binding.	O
Mutation	O
of	O
the	O
CBF1/RBP-Jkappa	protein
binding	protein
site	protein
in	O
EBNA3C	protein
abrogated	O
repression,	O
strongly	O
suggesting	O
that	O
CBF1/RBP-Jkappa	protein
is	O
necessary	O
for	O
targeting	O
the	O
viral	O
protein	O
to	O
Cp	DNA
.	O
Consistent	O
with	O
this	O
result,	O
mutation	O
of	O
the	O
EBNA2	DNA
response	DNA
element	DNA
(a	O
CBF1/RBP-Jkappa	DNA
binding	DNA
site	DNA
)	O
in	O
Cp	DNA
also	O
prevented	O
significant	O
repression.	O
In	O
addition,	O
amino	protein
acids	protein
346	protein
to	protein
543	protein
,	O
which	O
were	O
previously	O
defined	O
as	O
important	O
for	O
the	O
repressor	O
activity	O
of	O
the	O
GAL4-EBNA3C	protein
fusion	protein
proteins	protein
,	O
also	O
appear	O
to	O
be	O
necessary	O
for	O
the	O
repression	O
of	O
Cp	DNA
.	O
Since	O
repression	O
by	O
these	O
fusions	O
was	O
not	O
observed	O
in	O
all	O
cell	O
types,	O
it	O
seems	O
likely	O
that	O
EBNA3C	protein
either	O
depends	O
on	O
a	O
corepressor	protein
which	O
may	O
interact	O
with	O
amino	protein
acids	protein
346	protein
to	protein
543	protein
or	O
is	O
modified	O
in	O
a	O
cell-specific	O
manner	O
in	O
order	O
to	O
repress.	O
These	O
data	O
are	O
consistent	O
with	O
EBNA3C	protein
contributing	O
to	O
the	O
regulation	O
of	O
EBNA	protein
expression	O
in	O
latently	cell_type
infected	cell_type
B	cell_type
cells	cell_type
through	O
CBF1/RBP-Jkappa	protein
and	O
another	O
factor,	O
but	O
this	O
need	O
not	O
directly	O
involve	O
EBNA2	protein
.	O
Finally,	O
although	O
it	O
has	O
been	O
reported	O
that	O
EBNA3C	protein
can	O
upregulate	O
CD21	protein
in	O
some	O
B	cell_type
cells	cell_type
,	O
we	O
were	O
unable	O
to	O
demonstrate	O
any	O
effect	O
of	O
EBNA3C	protein
on	O
reporter	DNA
plasmids	DNA
which	O
contain	O
the	O
CD21	DNA
promoter	DNA
.	O

Relationship	O
between	O
glucocorticoid	protein
receptor	protein
and	O
response	O
to	O
glucocorticoid	O
therapy	O
in	O
ulcerative	O
colitis	O
.	O
PURPOSE:	O
To	O
clarify	O
the	O
relationship	O
between	O
the	O
glucocorticoid	protein
receptor	protein
and	O
the	O
effectiveness	O
of	O
glucocorticoid	O
therapy	O
in	O
patients	O
with	O
ulcerative	O
colitis	O
,	O
we	O
investigated	O
the	O
number	O
and	O
apparent	O
dissociation	O
constant	O
of	O
glucocorticoid	protein
receptor	protein
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
leukocytes	cell_type
of	O
patients	O
with	O
ulcerative	O
colitis	O
.	O
MATERIALS	O
AND	O
METHODS:	O
Eleven	O
patients	O
with	O
ulcerative	O
colitis	O
(5	O
who	O
responded	O
to	O
intravenous	O
glucocorticoids	O
and	O
6	O
who	O
did	O
not)	O
and	O
ten	O
control	O
subjects	O
were	O
studied.	O
The	O
number	O
and	O
apparent	O
dissociation	O
constant	O
of	O
glucocorticoid	protein
receptor	protein
were	O
measured	O
using	O
a	O
whole-cell	O
binding	O
assay	O
.	O
Results	O
were	O
expressed	O
as	O
a	O
median	O
(interquartile	O
range).	O
RESULTS:	O
The	O
number	O
of	O
glucocorticoid	protein
receptors	protein
from	O
the	O
six	O
nonresponders	O
,	O
five	O
responders	O
,	O
and	O
ten	O
healthy	O
controls	O
were	O
4922	O
(range,	O
4484-5643),	O
3413	O
(range,	O
3183-4450),	O
and	O
3610	O
(range,	O
2594-3979)	O
binding	O
sites/cell,	O
respectively.	O
The	O
apparent	O
dissociation	O
constant	O
of	O
the	O
glucocorticoid	protein
receptors	protein
from	O
the	O
nonresponders	O
,	O
responders	O
,	O
and	O
healthy	O
controls	O
were	O
7.03	O
(range,	O
5.66-10),	O
4.27	O
(range,	O
4-5.13),	O
and	O
6.18	O
(range,	O
5.86-6.74)	O
nM,	O
respectively.	O
Nonresponders	O
had	O
a	O
significant	O
increase	O
both	O
in	O
the	O
number	O
of	O
binding	protein
sites	protein
and	O
in	O
the	O
apparent	O
dissociation	O
constant	O
compared	O
with	O
responders	O
(P	O
=	O
0.045;	O
P	O
=	O
0.029).	O
CONCLUSIONS:	O
The	O
increased	O
number	O
and	O
apparent	O
dissociation	O
constant	O
of	O
glucocorticoid	protein
receptor	protein
are	O
closely	O
associated	O
with	O
the	O
effectiveness	O
of	O
glucocorticoid	O
therapy	O
.	O
The	O
measurement	O
of	O
the	O
number	O
and	O
apparent	O
dissociation	O
constant	O
of	O
glucocorticoid	protein
receptor	protein
may	O
be	O
useful	O
in	O
predicting	O
response	O
to	O
glucocorticoids	O
.	O

Cooperation	O
of	O
binding	protein
sites	protein
for	O
STAT6	protein
and	O
NF	protein
kappa	protein
B/rel	protein
in	O
the	O
IL-4	protein
-induced	O
up-regulation	O
of	O
the	O
human	DNA
IgE	DNA
germline	DNA
promoter	DNA
.	O
Ig	protein
heavy	protein
chain	protein
class	O
switching	O
is	O
directed	O
by	O
cytokines	protein
inducing	O
transcription	O
from	O
unrearranged	O
CH	DNA
genes	DNA
.	O
Subsequently,	O
such	O
primed	cell_type
cells	cell_type
can	O
undergo	O
switch	O
recombination	O
to	O
express	O
the	O
selected	O
new	O
isotype.	O
In	O
the	O
case	O
of	O
IgE	protein
class	O
switching	O
,	O
IL-4	protein
activates	O
the	O
IgE	DNA
germline	DNA
promoter	DNA
by	O
inducing	O
the	O
interaction	O
of	O
the	O
transcription	protein
factor	protein
STAT6	protein
(	O
IL-4STAT	protein
)	O
with	O
a	O
responsive	DNA
DNA	DNA
element	DNA
in	O
the	O
proximal	DNA
region	DNA
of	O
the	O
promoter	DNA
.	O
This	O
study	O
describes	O
the	O
characterization	O
of	O
two	O
additional	O
cis-acting	DNA
elements	DNA
that	O
interact	O
with	O
members	O
of	O
the	O
NF	protein
kappa	protein
B/rel	protein
transcription	protein
factor	protein
family	protein
in	O
an	O
IL-4	protein
-independent	O
fashion	O
.	O
Electrophoretic	O
mobility	O
shift	O
assays	O
show	O
that	O
the	O
nucleoprotein	protein
complex	protein
formed	O
on	O
the	O
upstream	DNA
site	DNA
(	O
NF	protein
kappa	protein
B1	protein
)	O
contains	O
the	O
classical	protein
p50/p65	protein
heterodimer	protein
.	O
The	O
complex	O
on	O
the	O
proximal	DNA
site	DNA
(	O
NF	protein
kappa	protein
B2	protein
)	O
appears	O
to	O
be	O
composed	O
of	O
p50	protein
and	O
relB	protein
.	O
IgE	DNA
germline	DNA
promoter	DNA
reporter	DNA
gene	DNA
constructs	DNA
carrying	O
point	O
mutations	O
in	O
the	O
NF	protein
kappa	protein
B2	protein
site	O
were	O
largely	O
unresponsive	O
to	O
IL-4	protein
stimulation	O
in	O
transient	O
transfection	O
experiments,	O
while	O
plasmids	O
with	O
similar	O
mutations	O
in	O
the	O
NF	protein
kappa	protein
B1	protein
site	O
responded	O
to	O
cytokine	protein
stimulation	O
better	O
than	O
the	O
wild-type	DNA
promoter	DNA
.	O
The	O
NF	protein
kappa	protein
B2	protein
effect	O
was	O
dependent	O
on	O
the	O
presence	O
of	O
the	O
STAT6	DNA
binding	DNA
site	DNA
,	O
demonstrating	O
that	O
the	O
NF	protein
kappa	protein
B2	protein
motif	protein
is	O
necessary	O
but	O
not	O
sufficient	O
for	O
mediating	O
cytokine	protein
up-regulation	O
.	O
In	O
addition,	O
the	O
combination	O
of	O
a	O
NF	DNA
kappa	DNA
B/rel	DNA
binding	DNA
site	DNA
and	O
the	O
STAT6	DNA
response	DNA
element	DNA
conferred	O
IL-4	protein
inducibility	O
to	O
a	O
heterologous	DNA
minimal	DNA
promoter	DNA
,	O
while	O
the	O
individual	O
sites	O
had	O
no	O
effect.	O
The	O
available	O
data	O
suggest	O
that	O
the	O
NF	protein
kappa	protein
B2	protein
nucleoprotein	protein
complex	protein
may	O
cooperate	O
with	O
DNA-bound	protein
STAT6	protein
to	O
achieve	O
IL-4	protein
-dependent	O
activation	O
of	O
the	O
human	DNA
IgE	DNA
germline	DNA
gene	DNA
.	O

Alcohol-induced	O
regulation	O
of	O
nuclear	protein
regulatory	protein
factor-kappa	protein
beta	protein
in	O
human	cell_type
monocytes	cell_type
.	O
Acute	O
ethanol	O
exposure	O
has	O
the	O
capacity	O
to	O
modulate	O
immune	O
functions	O
,	O
particularly,	O
to	O
down	O
regulate	O
monocyte	O
production	O
of	O
inflammatory	protein
cytokines	protein
.	O
However,	O
the	O
intracellular	O
mechanisms	O
for	O
these	O
effects	O
of	O
ethanol	O
are	O
yet	O
to	O
be	O
understood.	O
Considering	O
that	O
nuclear	protein
regulatory	protein
factor-kappa	protein
beta	protein
(NF-kappa	protein
B)/Rel	protein
is	O
a	O
common	O
regulatory	protein
element	protein
of	O
the	O
promoter	DNA
region	DNA
of	O
the	O
inflammatory	DNA
cytokine	DNA
genes	DNA
,	O
herein,	O
we	O
tested	O
the	O
hypothesis	O
that	O
acute	O
ethanol	O
affects	O
NF-kappa	protein
B	protein
activation	O
in	O
human	cell_type
monocytes	cell_type
.	O
Adherence-isolated	cell_line
monocytes	cell_line
showed	O
constitutive	O
DNA	O
binding	O
activity	O
of	O
NF-kappa	protein
B	protein
.	O
A	O
clinically	O
relevant	O
dose	O
(25	O
mM)	O
of	O
acute	O
ethanol	O
treatment	O
in	O
vitro	O
increased	O
NF-kappa	protein
B	protein
binding	O
activity	O
in	O
monocytes	cell_type
with	O
a	O
preferential	O
induction	O
of	O
the	O
inhibitory,	O
p50	protein
/p50	protein
,	O
NF-kappa	protein
B	protein
/Rel	protein
homodimer	protein
,	O
and	O
resulted	O
in	O
no	O
induction	O
of	O
the	O
p65	protein
/p50	protein
heterodimer	protein
.	O
In	O
contrast,	O
lipopolysaccharide	O
stimulation	O
primarily	O
induced	O
the	O
p65	protein
/p50	protein
heterodimer	protein
that	O
has	O
been	O
shown	O
to	O
result	O
in	O
gene	O
activation	O
.	O
Thus,	O
such	O
unique	O
activation	O
of	O
the	O
inhibitory	protein
p50	protein
/p50	protein
homodimer	protein
by	O
acute	O
ethanol	O
treatment	O
may	O
result	O
in	O
inhibition	O
rather	O
than	O
activation	O
of	O
NF-kappa	DNA
B	DNA
-regulated	DNA
inflammatory	DNA
cytokine	DNA
genes	DNA
.	O
Consequently,	O
these	O
results	O
suggest	O
that	O
physiologically	O
relevant	O
concentrations	O
of	O
ethanol	O
may	O
affect	O
production	O
of	O
inflammatory	protein
cytokines	protein
,	O
such	O
as	O
tumor	protein
necrosis	protein
factor-alpha	protein
,	O
interleukin-1	protein
beta	protein
,	O
and	O
interleukin-6	protein
by	O
disrupting	O
NF-kappa	protein
B	protein
signaling	O
in	O
monocytes	cell_type
.	O

LPS	O
tolerance	O
in	O
monocytes/macrophages	cell_type
:	O
three	O
3'	O
cytosins	O
are	O
required	O
in	O
the	O
DNA	DNA
binding	DNA
motif	DNA
for	O
detection	O
of	O
upregulated	O
NF-kappa	protein
B	protein
p50	protein
homodimers	protein
.	O
When	O
monocytes	cell_type
are	O
stimulated	O
with	O
LPS	O
(	O
lipopolysaccharide	O
)	O
repeatedly	O
then	O
the	O
initially	O
high	O
expression	O
of	O
the	O
TNF	DNA
(	DNA
tumor	DNA
necrosis	DNA
factor	DNA
)	DNA
gene	DNA
is	O
only	O
very	O
low,	O
i.e.	O
the	O
cells	O
are	O
tolerant	O
to	O
LPS	O
.	O
Tolerant	O
cells	O
still	O
express	O
the	O
CD14	protein
receptor	protein
and	O
they	O
can	O
still	O
be	O
activated	O
to	O
mobilize	O
NF-kappa	protein
B	protein
into	O
nucleus	O
.	O
Analysis	O
of	O
the	O
binding	O
proteins	O
employing	O
the	O
-605	O
motif	O
of	O
the	O
human	DNA
TNF	DNA
promoter	DNA
(	O
GGGGCTGTCCC	O
)	O
revealed	O
that	O
in	O
tolerant	O
cells	O
of	O
the	O
human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
Mono	cell_line
Mac	cell_line
6	cell_line
there	O
is	O
a	O
predominance	O
of	O
p50p50	protein
of	O
NF-kappa	protein
B	protein
.	O
We	O
now	O
show	O
that	O
a	O
mutant	DNA
motif	DNA
that	O
exchanges	O
the	O
terminal	O
3'	O
C	O
for	O
a	O
G	O
fails	O
to	O
bind	O
the	O
p50	protein
homodimer	protein
that	O
is	O
upregulated	O
in	O
LPS	O
toler	O
ant	O
human	cell_line
Mono	cell_line
Mac	cell_line
6	cell_line
cells	cell_line
.	O
The	O
same	O
is	O
true	O
for	O
nuclear	O
extracts	O
taken	O
from	O
the	O
murine	cell_line
P388D1	cell_line
macrophage	cell_line
cell	cell_line
line	cell_line
when	O
tested	O
with	O
the	O
-516	DNA
motif	DNA
of	O
the	O
murine	DNA
TNF	DNA
promoter	DNA
(	O
GGGGGCTTTCCC	O
).	O
Here	O
the	O
wild	DNA
type	DNA
motif	DNA
gives	O
efficient	O
binding	O
of	O
p50p50	protein
that	O
again	O
is	O
upregulated	O
in	O
tolerant	cell_type
cells	cell_type
whereas	O
a	O
mutant	O
with	O
a	O
3'	O
G	O
shows	O
hardly	O
any	O
binding	O
of	O
p50p50	protein
.	O
Conversely,	O
the	O
murine	DNA
kappa	DNA
light	DNA
chain	DNA
enhancer	DNA
motif	DNA
(	O
GGGGACTTTCCG	O
)	O
does	O
not	O
efficiently	O
bind	O
the	O
nuclear	O
p50p50	protein
from	O
tolerant	cell_line
murine	cell_line
P388	cell_line
macrophages	cell_line
.	O
Binding	O
is,	O
however,	O
readily	O
detected	O
when	O
the	O
3'	O
G	O
is	O
replaced	O
by	O
a	O
C	O
.	O
These	O
data	O
show	O
that	O
the	O
detection	O
of	O
upregulated	O
p50	protein
homodimers	protein
in	O
LPS	O
tolerant	cell_type
cells	cell_type
is	O
dependent	O
on	O
subtle	O
differences	O
in	O
the	O
sequence	O
of	O
the	O
DNA	DNA
binding	DNA
motif	DNA
.	O

Cyclosporin	O
A	O
inhibits	O
early	O
mRNA	O
expression	O
of	O
G0/G1	DNA
switch	DNA
gene	DNA
2	DNA
(	O
G0S2	DNA
)	O
in	O
cultured	cell_line
human	cell_line
blood	cell_line
mononuclear	cell_line
cells	cell_line
.	O
Cyclosporin	O
A	O
(	O
CsA	O
)	O
may	O
achieve	O
its	O
immunosuppressive	O
effects	O
by	O
inhibiting	O
the	O
calcium-	protein
and	protein
calmodulin-dependent	protein
phosphatase	protein
calcineurin	protein
which	O
is	O
required	O
for	O
activation	O
of	O
target	DNA
genes	DNA
by	O
members	O
of	O
the	O
NFAT	protein
(	protein
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
)	protein
transcription	protein
factor	protein
family	protein
.	O
Among	O
these	O
target	DNA
genes	DNA
is	O
the	O
gene	O
encoding	O
interleukin-2	protein
(	O
IL2	protein
),	O
a	O
cytokine	protein
facilitating	O
progression	O
through	O
the	O
G1	O
phase	O
of	O
the	O
cell	O
cycle	O
.	O
However,	O
IL2	protein
does	O
not	O
reverse	O
CsA	O
inhibition,	O
suggesting	O
that	O
at	O
least	O
one	O
other	O
NFAT-sensitive	DNA
gene	DNA
may	O
be	O
involved.	O
The	O
human	DNA
G0/G1	DNA
switch	DNA
gene	DNA
,	O
G0S2	DNA
,	O
has	O
potential	O
NFAT-binding	DNA
sites	DNA
in	O
the	O
5'	DNA
flank	DNA
and	O
encodes	O
a	O
small	protein
basic	protein
potential	protein
phosphoprotein	protein
of	O
unknown	O
function.	O
Using	O
a	O
sensitive,	O
reverse	O
transcription-polymerase	O
chain	O
reaction	O
(RT-PCR)	O
assay	O
,	O
G0S2	DNA
mRNA	O
levels	O
were	O
assayed	O
in	O
cultured	cell_line
blood	cell_line
mononuclear	cell_line
cells	cell_line
.	O
Freshly	O
isolated	O
cells	O
contain	O
high	O
levels	O
of	O
G0S2	RNA
mRNA	RNA
which	O
rapidly	O
decline.	O
This	O
"spontaneous	O
stimulation"	O
is	O
also	O
noted	O
with	O
some	O
other	O
G0S	DNA
genes	DNA
and	O
has	O
been	O
attributed	O
to	O
some	O
aspect	O
of	O
the	O
isolation	O
procedure.	O
In	O
cells	O
that	O
have	O
been	O
preincubated	O
to	O
lower	O
mRNA	O
levels	O
,	O
there	O
is	O
a	O
transient	O
increase	O
in	O
G0S2	RNA
mRNA	RNA
,	O
peaking	O
between	O
1-2	O
h,	O
in	O
response	O
to	O
Concanavalin-A	O
(	O
ConA	O
),	O
or	O
to	O
the	O
combination	O
of	O
phorbol	O
ester	O
(	O
TPA	O
),	O
and	O
the	O
calcium	O
ionophore,	O
ionomycin.	O
Both	O
these	O
responses	O
are	O
inhibited	O
by	O
CsA	O
.	O
Our	O
results	O
suggest	O
that	O
G0S2	DNA
expression	O
is	O
required	O
to	O
commit	O
cells	O
to	O
enter	O
the	O
G1	O
phase	O
of	O
the	O
cell	O
cycle	O
,	O
and	O
that,	O
while	O
not	O
excluding	O
other	O
possible	O
targets,	O
early	O
inhibition	O
of	O
G0S2	DNA
expression	O
by	O
CsA	O
may	O
be	O
important	O
in	O
achieving	O
immunosuppression.	O
G0S2	DNA
may	O
be	O
of	O
value	O
as	O
a	O
reporter	O
gene	O
for	O
analyzing	O
the	O
mechanism	O
of	O
action	O
of	O
CsA	O
and	O
its	O
influence	O
on	O
the	O
positive	O
and	O
negative	O
selection	O
of	O
lymphocytes	cell_type
in	O
response	O
to	O
self	O
and	O
not-self	O
antigens.	O

c-Rel	O
and	O
p65	O
subunits	O
bind	O
to	O
an	O
upstream	DNA
NF-kappaB	DNA
site	DNA
in	O
human	DNA
granulocyte	DNA
macrophage-colony	DNA
stimulating	DNA
factor	DNA
promoter	DNA
involved	O
in	O
phorbol	O
ester	O
response	O
in	O
5637	cell_line
cells	cell_line
.	O
To	O
further	O
clarify	O
the	O
complex	O
transcriptional	O
regulation	O
of	O
the	O
human	DNA
GM-CSF	DNA
gene	DNA
,	O
which	O
was	O
extensively	O
investigated	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
,	O
we	O
have	O
studied	O
the	O
role	O
of	O
an	O
upstream	O
NF-kappaB	DNA
like	DNA
site	DNA
in	O
the	O
5637	cell_line
non-lymphoid	cell_line
cell	cell_line
line	cell_line
,	O
which	O
derives	O
from	O
a	O
bladder	O
carcinoma	O
and	O
constitutively	O
produces	O
GM-CSF	protein
.	O
This	O
sequence,	O
named	O
the	O
A	O
element,	O
has	O
an	O
active	O
role	O
on	O
GM-CSF	protein
transcription	O
and	O
is	O
responsive	O
to	O
the	O
tumor	DNA
promoter	DNA
PMA	DNA
in	O
transient	O
transfection	O
experiments	O
.	O
We	O
describe	O
here	O
a	O
heterodimeric	protein
binding	protein
complex	protein
of	O
NF-kappaB	protein
subunits	protein
(	O
c-Rel	protein
and	O
p65	protein
)	O
which	O
is	O
identical	O
to	O
the	O
one	O
obtained	O
using	O
the	O
HIV-LTR-kappaB	DNA
site	DNA
as	O
recognition	O
sequence	O
and	O
different	O
from	O
the	O
one	O
(	O
c-Rel	protein
and	O
p50	protein
)	O
observed	O
with	O
nuclear	O
extracts	O
from	O
Mo	cell_line
T-lymphoid	cell_line
HTLV-II	cell_line
infected	cell_line
cells	cell_line
.	O

Repression	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
through	O
the	O
novel	O
cooperation	O
of	O
human	protein
factors	protein
YY1	protein
and	O
LSF	protein
[published	O
erratum	O
appears	O
in	O
J	O
Virol	O
1998	O
Feb;72(2):1709]	O
A	O
subpopulation	O
of	O
stably	cell_type
infected	cell_type
CD4+	cell_type
cells	cell_type
capable	O
of	O
producing	O
virus	O
upon	O
stimulation	O
has	O
been	O
identified	O
in	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)-positive	O
individuals	O
(T.-W.Chun,	O
D.Finzi,	O
J.Margolick,	O
K.Chadwick,	O
D.Schwartz,	O
and	O
R.F.Siliciano,	O
Nat.Med.1:1284-1290,	O
1995).	O
Few	O
host	O
factors	O
that	O
directly	O
limit	O
HIV-1	O
transcription	O
and	O
could	O
support	O
this	O
state	O
of	O
nonproductive	O
HIV-1	O
infection	O
have	O
been	O
described.	O
YY1	protein
,	O
a	O
widely	O
distributed	O
human	protein
transcription	protein
factor	protein
,	O
is	O
known	O
to	O
inhibit	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
transcription	O
and	O
virus	O
production	O
.	O
LSF	protein
(also	O
known	O
as	O
LBP-1	protein
,	O
UBP	protein
,	O
and	O
CP-2	protein
)	O
has	O
been	O
shown	O
to	O
repress	O
LTR	O
transcription	O
in	O
vitro,	O
but	O
transient	O
expression	O
of	O
LSF	protein
has	O
no	O
effect	O
on	O
LTR	DNA
activity	O
in	O
vivo.	O
We	O
report	O
that	O
both	O
YY1	protein
and	O
LSF	protein
participate	O
in	O
the	O
formation	O
of	O
a	O
complex	O
that	O
recognizes	O
the	O
initiation	O
region	O
of	O
the	O
HIV-1	DNA
LTR	DNA
.	O
Further,	O
we	O
have	O
found	O
that	O
these	O
factors	O
cooperate	O
in	O
the	O
repression	O
of	O
LTR	DNA
expression	O
and	O
viral	O
replication	O
.	O
This	O
cooperative	O
function	O
may	O
account	O
for	O
the	O
divergent	O
effects	O
of	O
LSF	protein
previously	O
observed	O
in	O
vitro	O
and	O
in	O
vivo.	O
Thus,	O
the	O
cooperation	O
of	O
two	O
general	O
cellular	O
transcription	O
factors	O
may	O
allow	O
for	O
the	O
selective	O
downregulation	O
of	O
HIV	O
transcription	O
.	O
Through	O
this	O
mechanism	O
of	O
gene	O
regulation	O
,	O
YY1	protein
and	O
LSF	protein
could	O
contribute	O
to	O
the	O
establishment	O
and	O
maintenance	O
of	O
a	O
population	O
of	O
cells	O
stably	O
but	O
nonproductively	O
infected	O
with	O
HIV-1	O
.	O

Analysis	O
of	O
interactions	O
between	O
huGATA-3	protein
transcription	O
factor	O
and	O
three	O
GATA	DNA
regulatory	DNA
elements	DNA
of	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
,	O
by	O
surface	O
plasmon	O
resonance	O
.	O
Relative	O
affinities	O
of	O
transcriptional	DNA
regulatory	DNA
elements	DNA
for	O
their	O
respective	O
factor	O
have	O
been	O
essentially	O
studied	O
by	O
bandshift	O
analysis	O
.	O
Here	O
we	O
report	O
a	O
real-time	O
study	O
of	O
factor/DNA	O
interactions	O
using	O
a	O
surface	O
plasmon	O
resonance	O
approach	O
and	O
further	O
characterization	O
of	O
recovered	protein
proteins	protein
involved	O
in	O
this	O
interaction.	O
For	O
this	O
purpose,	O
human	protein
GATA-3	protein
,	O
either	O
recombinant	O
or	O
in	O
nuclear	O
extracts	O
,	O
and	O
three	O
natural	DNA
GATA	DNA
elements	DNA
of	O
the	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
sites	O
1	O
,	O
2	O
,	O
and	O
3	O
)	O
were	O
chosen,	O
in	O
which	O
only	O
site	DNA
2	DNA
is	O
a	O
noncanonical	O
GATA	DNA
site	DNA
.	O
Direct	O
analysis	O
of	O
sensorgrams	O
,	O
with	O
recombinant	protein
huGATA-3	protein
,	O
allowed	O
the	O
comparison	O
of	O
association	O
and	O
dissociation	O
profiles	O
of	O
the	O
three	O
DNA	DNA
regions	DNA
and	O
their	O
ranking	O
according	O
to	O
their	O
relative	O
affinities.	O
This	O
result,	O
confirmed	O
by	O
competitions	O
with	O
each	O
GATA	DNA
site	DNA
,	O
demonstrated	O
the	O
higher	O
relative	O
affinity	O
(at	O
least	O
sevenfold)	O
of	O
site	O
3.	O
Interactions	O
between	O
the	O
canonical	O
and	O
unique	O
GATA	DNA
site	DNA
3	DNA
and	O
nuclear	O
extracts	O
were	O
also	O
studied	O
in	O
real	O
time	O
and	O
provided	O
information	O
on	O
its	O
association	O
and	O
dissociation	O
rates	O
for	O
native	O
huGATA-3	protein
.	O
Finally,	O
recovered	O
protein	O
was	O
identified	O
as	O
genuine	O
huGATA-3	protein
by	O
SDS-PAGE	O
,	O
Western	O
blotting	O
,	O
and	O
bandshift	O
assays	O
.	O
Copyright	O
1997	O
Academic	O
Press.	O

Stable	O
transfection	O
of	O
U937	cell_line
cells	cell_line
with	O
sense	O
or	O
antisense	DNA
RXR-alpha	DNA
cDNA	DNA
suggests	O
a	O
role	O
for	O
RXR-alpha	protein
in	O
the	O
control	O
of	O
monoblastic	O
differentiation	O
induced	O
by	O
retinoic	O
acid	O
and	O
vitamin	O
D	O
.	O
Although	O
retinoic	O
acid	O
(	O
RA	O
)	O
has	O
been	O
known	O
for	O
many	O
years	O
to	O
be	O
a	O
modulating	O
agent	O
that	O
plays	O
a	O
role	O
in	O
generating	O
both	O
granulocytes	cell_type
and	O
monocytes	cell_type
,	O
the	O
molecular	O
mechanism	O
underlying	O
this	O
role	O
has	O
not	O
been	O
defined	O
in	O
the	O
monoblast	cell_type
lineage	cell_type
.	O
In	O
particular,	O
the	O
part	O
played	O
by	O
the	O
retinoid	protein
X	protein
receptors	protein
(	O
RXRs	protein
),	O
which	O
are	O
members	O
of	O
the	O
steroid/thyroid	protein
hormone	protein
nuclear	protein
receptor	protein
family	protein
,	O
has	O
not	O
been	O
explored.	O
In	O
this	O
study,	O
therefore,	O
the	O
human	cell_line
monoblastic	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
U937	cell_line
has	O
been	O
used	O
as	O
a	O
model	O
system	O
to	O
investigate	O
the	O
role	O
of	O
one	O
of	O
the	O
RXRs	protein
,	O
RXR-alpha	protein
,	O
in	O
monoblast	O
differentiation	O
.	O
RXR-alpha	RNA
mRNA	RNA
was	O
present	O
in	O
untreated	O
U937	cell_line
cells	cell_line
,	O
and	O
levels	O
increased	O
after	O
induction	O
of	O
differentiation	O
with	O
phorbol	O
ester	O
.	O
The	O
same	O
was	O
found	O
for	O
RXR-beta	RNA
mRNA	RNA
.	O
Using	O
plasmids	O
containing	O
sense	O
or	O
antisense	DNA
RXR-alpha	DNA
sequences	DNA
under	O
the	O
control	O
of	O
an	O
inducible	O
promoter,	O
we	O
generated	O
stably	O
transfected	O
cell	O
lines	O
which	O
expressed	O
either	O
increased	O
or	O
decreased	O
levels	O
of	O
RXR-alpha	protein
,	O
respectively.	O
The	O
sense	cell_line
cell	cell_line
lines	cell_line
(	O
U	cell_line
alpha	cell_line
S	cell_line
and	O
its	O
clonal	O
derivative	O
alpha	O
G2S	cell_line
)	O
showed	O
increased	O
sensitivity	O
to	O
RA	O
,	O
while	O
the	O
antisense	cell_line
cell	cell_line
lines	cell_line
(	O
U	cell_line
alpha	cell_line
A	cell_line
and	O
its	O
clonal	O
derivative	O
alpha	O
B5A	cell_line
)	O
showed	O
decreased	O
sensitivity	O
to	O
RA	O
,	O
as	O
demonstrated	O
by	O
growth	O
inhibition	O
and	O
by	O
regulation	O
of	O
an	O
RA	DNA
-responsive	DNA
reporter	DNA
gene	DNA
.	O
Both	O
U	cell_line
alpha	cell_line
A	cell_line
and	O
alpha	O
B5A	cell_line
also	O
failed	O
to	O
respond	O
to	O
another	O
modulating	O
agent,	O
1	O
alpha,25-dihydroxycholecalciferol	O
(	O
DHCC	O
),	O
but	O
only	O
U	cell_line
alpha	cell_line
S	cell_line
and	O
not	O
alpha	protein
G2S	protein
showed	O
an	O
enhanced	O
response	O
to	O
DHCC	O
.	O
The	O
combination	O
of	O
RA	O
and	O
DHCC	O
together	O
inhibited	O
growth	O
of	O
both	O
sense	O
and	O
antisense	cell_line
cell	cell_line
lines	cell_line
.	O
In	O
addition,	O
alpha	protein
G2S	protein
exhibited	O
increased	O
expression	O
of	O
CD11b	protein
and	O
CD54	protein
,	O
while	O
alpha	cell_line
B5A	cell_line
cells	cell_line
showed	O
increased	O
expression	O
of	O
CD102	protein
,	O
suggesting	O
that	O
RXR-alpha	protein
has	O
a	O
role	O
in	O
regulating	O
expression	O
of	O
cell	protein
adhesion	protein
molecules	protein
in	O
U937	cell_line
cells	cell_line
.	O
These	O
results	O
demonstrate	O
that	O
RXR-alpha	protein
has	O
a	O
role	O
in	O
mediating	O
growth	O
inhibition	O
and	O
cell	O
adhesion	O
during	O
myelomonocytic	O
differentiation	O
,	O
and	O
suggest	O
that	O
different	O
species	O
of	O
heterodimers	protein
involving	O
RXR-alpha	protein
may	O
control	O
the	O
acquisition	O
of	O
different	O
features	O
of	O
mature	O
monocyte/macrophage	O
function	O
.	O

Transcriptional	O
activation	O
of	O
the	O
vascular	DNA
cell	DNA
adhesion	DNA
molecule-1	DNA
gene	DNA
in	O
T	cell_type
lymphocytes	cell_type
expressing	O
human	protein
T-cell	protein
leukemia	protein
virus	protein
type	protein
1	protein
Tax	protein
protein	protein
.	O
Recruitment	O
and	O
extravasation	O
of	O
T	cell_type
cells	cell_type
through	O
the	O
blood-brain	O
barrier	O
are	O
favored	O
by	O
adhesion	protein
molecule	protein
-mediated	O
interactions	O
of	O
circulating	cell_type
T	cell_type
cells	cell_type
with	O
endothelial	cell_type
cells	cell_type
.	O
Since	O
a	O
common	O
pathological	O
finding	O
in	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
(HTLV-1)-associated	O
diseases	O
is	O
the	O
infiltration	O
of	O
HTLV-1-infected	cell_type
T	cell_type
lymphocytes	cell_type
into	O
various	O
organs,	O
we	O
have	O
looked	O
for	O
the	O
profile	O
of	O
adhesion	protein
molecules	protein
expressed	O
by	O
HTLV-1-transformed	cell_type
T	cell_type
cells	cell_type
.	O
Flow	O
cytometry	O
analysis	O
indicated	O
that	O
these	O
cells	O
were	O
expressing	O
high	O
levels	O
of	O
vascular	protein
cell	protein
adhesion	protein
molecule	protein
1	protein
(	O
VCAM-1	protein
[	O
CD106	protein
]),	O
a	O
110-kDa	O
member	O
of	O
the	O
immunoglobulin	protein
gene	protein
superfamily	protein
,	O
first	O
identified	O
on	O
endothelial	cell_type
cells	cell_type
stimulated	O
with	O
inflammatory	protein
cytokines	protein
.	O
This	O
adhesion	O
molecule	O
was	O
also	O
expressed	O
by	O
T	cell_type
cells	cell_type
obtained	O
from	O
one	O
patient	O
with	O
HTLV-1	O
-associated	O
myelopathy/tropical	O
spastic	O
paraparesis	O
but	O
not	O
by	O
activated	cell_type
T	cell_type
cells	cell_type
isolated	O
from	O
one	O
normal	O
blood	O
donor	O
.	O
The	O
role	O
of	O
the	O
viral	protein
trans-activator	protein
Tax	protein
protein	protein
in	O
the	O
induction	O
of	O
VCAM-1	protein
was	O
first	O
indicated	O
by	O
the	O
detection	O
of	O
this	O
adhesion	protein
molecule	protein
on	O
Jurkat	cell_line
T-cell	cell_line
clones	cell_line
stably	O
expressing	O
the	O
tax	O
gene.	O
The	O
effect	O
of	O
Tax	protein
on	O
VCAM-1	protein
gene	O
transcription	O
was	O
next	O
confirmed	O
in	O
JPX-9	cell_line
cells	cell_line
,	O
a	O
subclone	O
of	O
Jurkat	cell_line
cells	cell_line
,	O
carrying	O
the	O
tax	DNA
sequences	DNA
under	O
the	O
control	O
of	O
an	O
inducible	DNA
promoter	DNA
.	O
Furthermore,	O
deletion	O
and	O
mutation	O
analyses	O
of	O
the	O
VCAM-1	DNA
promoter	DNA
performed	O
with	O
chloramphenicol	DNA
acetyltransferase	DNA
constructs	DNA
revealed	O
that	O
Tax	protein
was	O
trans	O
activating	O
the	O
VCAM-1	DNA
promoter	DNA
via	O
two	O
NF-kappaB	DNA
sites	DNA
present	O
at	O
bp	O
-72	O
and	O
-57	O
in	O
the	O
VCAM-1	DNA
gene	DNA
promoter	DNA
,	O
with	O
both	O
of	O
them	O
being	O
required	O
for	O
the	O
Tax	protein
-induced	O
expression	O
of	O
this	O
adhesion	protein
molecule	protein
.	O
Finally,	O
gel	O
mobility	O
shift	O
assays	O
demonstrated	O
the	O
nuclear	O
translocation	O
of	O
proteins	O
specifically	O
bound	O
to	O
these	O
two	O
NF-kappaB	DNA
motifs	DNA
,	O
confirming	O
that	O
VCAM-1	protein
was	O
induced	O
on	O
Tax	cell_line
-expressing	cell_line
cells	cell_line
in	O
a	O
kappaB	protein
-dependent	O
manner	O
.	O
Collectively,	O
these	O
results	O
therefore	O
suggest	O
that	O
the	O
exclusive	O
Tax	protein
-induced	O
expression	O
of	O
VCAM-1	protein
on	O
T	cell_type
cells	cell_type
may	O
represent	O
a	O
pivotal	O
event	O
in	O
the	O
progression	O
of	O
HTLV-1	O
-associated	O
diseases	O
.	O

HIV-1	protein
Vpr	protein
suppresses	O
immune	O
activation	O
and	O
apoptosis	O
through	O
regulation	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
[see	O
comments]	O
The	O
HIV-1	protein
accessory	protein
gene	protein
product	protein
Vpr	protein
can	O
influence	O
viral	O
pathogenesis	O
by	O
affecting	O
viral	O
replication	O
as	O
well	O
as	O
host	O
cell	O
transcription	O
and	O
proliferation	O
.	O
We	O
have	O
investigated	O
the	O
effects	O
of	O
Vpr	protein
on	O
host	O
cell	O
activation	O
and	O
confirm	O
that	O
it	O
influences	O
cellular	O
proliferation	O
.	O
However,	O
we	O
have	O
also	O
found	O
that	O
Vpr	protein
modulates	O
T-cell	O
receptor	O
(	O
TCR	protein
)-triggered	O
apoptosis	O
in	O
a	O
manner	O
similar	O
to	O
that	O
of	O
glucocorticoids	O
.	O
In	O
the	O
absence	O
of	O
TCR	protein
-mediated	O
activation	O
,	O
Vpr	protein
induces	O
apoptosis	O
whereas	O
in	O
its	O
presence,	O
Vpr	protein
interrupts	O
the	O
expected	O
induction	O
of	O
apoptosis	O
.	O
This	O
regulation	O
of	O
apoptosis	O
is	O
linked	O
to	O
Vpr	protein
suppression	O
of	O
NF-kappa	protein
B	protein
activity	O
via	O
the	O
induction	O
of	O
I	protein
kappa	protein
B	protein
,	O
an	O
inhibitor	O
of	O
NF-kappa	protein
B	protein
.	O
Further,	O
Vpr	protein
suppresses	O
expression	O
of	O
IL-2	protein
,	O
IL-10	protein
,	O
IL-12	protein
,	O
TNF	protein
alpha	protein
and	O
IL-4	protein
,	O
all	O
of	O
which	O
are	O
NF-kappa	protein
B	protein
-dependent	O
.	O
The	O
effects	O
of	O
Vpr	protein
could	O
be	O
reversed	O
by	O
RU486	O
.	O
Our	O
finding	O
that	O
Vpr	protein
can	O
regulate	O
NF-kappa	protein
B	protein
supports	O
the	O
hypothesis	O
that	O
some	O
aspects	O
of	O
viral	O
pathogenesis	O
are	O
the	O
consequence	O
of	O
cell	O
dysregulation	O
by	O
Vpr	protein
.	O

Tissue	O
transglutaminase-dependent	O
posttranslational	O
modification	O
of	O
the	O
retinoblastoma	protein
gene	protein
product	protein
in	O
promonocytic	cell_line
cells	cell_line
undergoing	O
apoptosis	O
.	O
The	O
retinoblastoma	protein
gene	protein
product	protein
(	O
pRB	protein
)	O
plays	O
an	O
important	O
role	O
in	O
controlling	O
both	O
cell	O
release	O
from	O
the	O
G1	O
phase	O
and	O
apoptosis	O
.	O
We	O
show	O
here	O
that	O
in	O
the	O
early	O
phases	O
of	O
apoptosis	O
,	O
pRB	protein
is	O
posttranslationally	O
modified	O
by	O
a	O
tissue	O
transglutaminase	O
(	O
tTG	protein
)-catalyzed	O
reaction	O
.	O
In	O
fact,	O
by	O
employing	O
a	O
novel	O
haptenized	O
lysis	O
synthetic	O
substrate	O
which	O
allows	O
the	O
isolation	O
of	O
glutaminyl-tTG	O
substrates	O
in	O
vivo,	O
we	O
identified	O
pRB	protein
as	O
a	O
potential	O
tTG	O
substrate	O
in	O
U937	cell_line
cells	cell_line
undergoing	O
apoptosis	O
.	O
In	O
keeping	O
with	O
this	O
finding,	O
we	O
showed	O
that	O
apoptosis	O
of	O
U937	cell_line
cells	cell_line
is	O
characterized	O
by	O
the	O
rapid	O
disappearance	O
of	O
the	O
105,000-	O
to	O
110,000-molecular-weight	O
pRB	protein
forms	O
concomitantly	O
with	O
the	O
appearance	O
of	O
a	O
smear	O
of	O
immunoreactive	O
products	O
with	O
a	O
molecular	O
weight	O
of	O
greater	O
than	O
250,000.	O
The	O
shift	O
in	O
pRB	protein
molecular	O
weight	O
was	O
reproduced	O
by	O
adding	O
exogenous	O
purified	O
tTG	O
to	O
extracts	O
obtained	O
from	O
viable	O
U937	cell_line
cells	cell_line
and	O
was	O
prevented	O
by	O
dansylcadaverine	O
,	O
a	O
potent	O
enzyme	O
inhibitor	O
.	O
The	O
effect	O
of	O
the	O
pRB	protein
posttranslational	O
modification	O
during	O
apoptosis	O
was	O
investigated	O
by	O
determining	O
the	O
E2F-1	protein
levels	O
and	O
by	O
isolating	O
and	O
characterizing	O
pRB	cell_line
-null	cell_line
clones	cell_line
from	O
U937	cell_line
cells	cell_line
.	O
Notably,	O
the	O
lack	O
of	O
pRB	protein
in	O
these	O
U937-derived	cell_line
clones	cell_line
renders	O
these	O
p53-null	cell_line
cells	cell_line
highly	O
resistant	O
to	O
apoptosis	O
induced	O
by	O
serum	O
withdrawal	O
,	O
calphostin	O
C	O
,	O
and	O
ceramide	O
.	O
Taken	O
together,	O
these	O
data	O
suggest	O
that	O
tTG	protein
,	O
acting	O
on	O
the	O
pRB	protein
protein	protein
,	O
might	O
play	O
an	O
important	O
role	O
in	O
the	O
cell	O
progression	O
through	O
the	O
death	O
program.	O

STAT3	protein
is	O
a	O
serine	protein
kinase	protein
target	protein
in	O
T	cell_type
lymphocytes	cell_type
.	O
Interleukin	protein
2	protein
and	O
T	protein
cell	protein
antigen	protein
receptor	protein
signals	O
converge	O
upon	O
serine	O
727	O
.	O
Interleukin	protein
2	protein
(	O
IL-2	protein
)	O
induces	O
tyrosine	O
phosphorylation	O
of	O
STATs	O
3	O
and	O
5	O
(signal	O
transducer	O
and	O
activator	O
of	O
transcription).	O
We	O
now	O
show	O
that	O
IL-2	protein
regulation	O
of	O
STAT3	protein
proteins	protein
in	O
T	cell_type
cells	cell_type
is	O
a	O
complex	O
response	O
involving	O
activation	O
of	O
two	O
forms	O
of	O
STAT3	protein
:	O
90-kDa	O
STAT3alpha	protein
and	O
an	O
83-kDa	protein
carboxyl-terminal	protein
truncated	protein
STAT3beta	protein
.	O
The	O
phosphorylation	O
of	O
STAT	protein
proteins	protein
on	O
serine	O
residues	O
is	O
also	O
required	O
for	O
competent	O
STAT	protein
transcription	O
.	O
A	O
critical	O
serine	protein
phosphorylation	protein
site	protein
in	O
STAT3alpha	protein
is	O
at	O
position	O
727	O
.	O
In	O
this	O
study	O
we	O
have	O
produced	O
an	O
antisera	O
specific	O
for	O
STAT3alpha	protein
proteins	protein
phosphorylated	O
on	O
serine	O
727	O
and	O
used	O
this	O
to	O
monitor	O
the	O
phosphorylation	O
of	O
this	O
residue	O
during	O
T	O
lymphocyte	O
activation	O
.	O
Our	O
results	O
show	O
that	O
phosphorylation	O
of	O
STAT3alpha	protein
on	O
serine	O
727	O
is	O
not	O
constitutive	O
in	O
quiescent	cell_type
T	cell_type
cells	cell_type
but	O
can	O
be	O
induced	O
by	O
the	O
cytokine	protein
IL-2	protein
.	O
Interestingly,	O
triggering	O
of	O
the	O
T	protein
cell	protein
antigen	protein
receptor	protein
complex	protein
or	O
activation	O
of	O
protein	protein
kinase	protein
C	protein
with	O
phorbol	O
esters	O
also	O
induces	O
phosphorylation	O
of	O
serine	O
727	O
but	O
without	O
simultaneously	O
inducing	O
STAT3	protein
tyrosine	O
phosphorylation	O
or	O
DNA	O
binding.	O
Hence,	O
the	O
present	O
results	O
show	O
that	O
STAT3	protein
serine	O
phosphorylation	O
can	O
be	O
regulated	O
independently	O
of	O
the	O
tyrosine	O
phosphorylation	O
of	O
this	O
molecule.	O
IL-2	protein
and	O
T	protein
cell	protein
antigen	protein
receptor	protein
complex	protein
induction	O
of	O
STAT3alpha	protein
serine	O
727	O
phosphorylation	O
is	O
dependent	O
on	O
the	O
activity	O
of	O
the	O
MEK	protein
/ERK	protein
pathway	O
.	O
Previous	O
studies	O
have	O
identified	O
H-7-sensitive	O
kinase	O
pathways	O
that	O
regulate	O
STAT3	protein
DNA	O
binding	O
.	O
We	O
show	O
that	O
H-7-sensitive	O
pathways	O
regulate	O
STAT3	protein
DNA	O
binding	O
in	O
T	cell_type
cells	cell_type
.	O
Nevertheless,	O
we	O
show	O
that	O
H-7-sensitive	protein
kinases	protein
do	O
not	O
regulate	O
STAT3	protein
tyrosine	O
phosphorylation	O
or	O
phosphorylation	O
of	O
serine	O
727	O
.	O
These	O
results	O
thus	O
show	O
that	O
STAT3	protein
proteins	protein
are	O
targets	O
for	O
multiple	O
kinase	O
pathways	O
in	O
T	cell_type
cells	cell_type
and	O
can	O
integrate	O
signals	O
from	O
both	O
cytokine	protein
receptors	protein
and	O
antigen	protein
receptors	protein
.	O

NF-kappa	protein
B/Rel	protein
family	protein
members	protein
regulating	O
the	O
ICAM-1	DNA
promoter	DNA
in	O
monocytic	cell_line
THP-1	cell_line
cells	cell_line
.	O
A	O
kappa	DNA
B-site	DNA
was	O
identified	O
in	O
the	O
promoter	O
of	O
the	O
intercellular	DNA
adhesion	DNA
molecule-1	DNA
(	DNA
ICAM-1	DNA
)	DNA
gene	DNA
,	O
which	O
is	O
involved	O
in	O
regulation	O
of	O
ICAM-1	protein
expression	O
by	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF-alpha	protein
)	O
and	O
glucocorticoids	O
.	O
We	O
now	O
report	O
on	O
the	O
transcription	protein
factors	protein
which	O
bind	O
and	O
transactivate	O
this	O
enhancer	DNA
sequence	DNA
.	O
In	O
vitro,	O
the	O
ICAM-1	DNA
kappa	DNA
B	DNA
site	DNA
appeared	O
to	O
bind	O
RelA	protein
and	O
c-Rel	protein
homodimers	protein
as	O
well	O
as	O
heterodimers	O
with	O
NF-kappa	protein
B1	protein
,	O
but	O
weakly	O
NF-kappa	protein
B1	protein
homodimers	protein
.	O
In	O
addition,	O
both	O
RelA	protein
and	O
c-Rel	protein
,	O
but	O
not	O
NF-kappa	protein
B1	protein
,	O
were	O
shown	O
to	O
transactivate	O
an	O
ICAM-1	DNA
kappa	DNA
B-reporter	DNA
construct	DNA
.	O
In	O
monocytic	cell_line
THP-1	cell_line
cells	cell_line
TNF-alpha	protein
induced	O
two	O
nuclear	protein
complexes	protein
which	O
in	O
vitro	O
bound	O
to	O
the	O
ICAM-1	DNA
kappa	DNA
B	DNA
site	DNA
.	O
Using	O
antibodies	O
in	O
an	O
electrophoretic	O
mobility	O
supershift	O
assay	O
,	O
one	O
of	O
these	O
complexes	O
was	O
shown	O
to	O
contain	O
NF-kappa	protein
B1	protein
and	O
RelA	protein
,	O
and	O
to	O
bind	O
with	O
higher	O
affinity	O
to	O
the	O
consensus	DNA
kappa	DNA
B	DNA
site	DNA
in	O
the	O
HIV	DNA
long	DNA
terminal	DNA
repeat	DNA
.	O
The	O
second	O
complex	O
contained	O
RelA	protein
,	O
and	O
exhibited	O
higher	O
affinity	O
towards	O
the	O
ICAM-1	DNA
kappa	DNA
B	DNA
than	O
to	O
the	O
HIV	DNA
kappa	DNA
B	DNA
site	DNA
.	O
The	O
glucocorticoid	protein
receptor	protein
was	O
shown	O
to	O
repress	O
activity	O
of	O
both	O
the	O
RelA	protein
homodimer	protein
and	O
the	O
NF-kappa	protein
B1	protein
/RelA	protein
heterodimer	protein
.	O
We	O
argue	O
that	O
in	O
vivo	O
RelA	protein
homodimers	protein
are	O
likely	O
to	O
play	O
a	O
dominant	O
role	O
in	O
TNF-alpha	protein
-induced	O
ICAM-1	protein
transcription	O
in	O
monocytic	cell_type
cells	cell_type
.	O

Competent	O
transcription	O
initiation	O
by	O
RNA	protein
polymerase	protein
II	protein
in	O
cell-free	cell_type
extracts	cell_type
from	O
xeroderma	O
pigmentosum	O
groups	O
B	O
and	O
D	O
in	O
an	O
optimized	O
RNA	O
transcription	O
assay.	O
The	O
human	O
autosomal	O
recessive	O
disease	O
,	O
xeroderma	O
pigmentosum	O
(	O
XP	O
),	O
can	O
result	O
from	O
mutations	O
in	O
any	O
one	O
of	O
seven	O
genes,	O
designated	O
XPA	DNA
through	O
XPG	DNA
.	O
Of	O
these,	O
the	O
XPB	O
and	O
XPD	O
genes	O
encode	O
proteins	O
that	O
are	O
subunits	O
of	O
a	O
general	protein
transcription	protein
factor	protein
,	O
TFIIH	protein
,	O
involved	O
in	O
both	O
nucleotide	O
excision	O
repair	O
(	O
NER	O
)	O
and	O
initiation	O
of	O
mRNA	O
transcription	O
by	O
RNA	protein
polymerase	protein
II	protein
.	O
In	O
humans	O
,	O
mutation	O
of	O
the	O
XPB	O
or	O
XPD	O
gene	O
impairs	O
NER	O
,	O
resulting	O
in	O
hyper-sensitivity	O
to	O
sunlight	O
and	O
greatly	O
increased	O
skin	O
tumor	O
formation.	O
However,	O
no	O
transcription	O
deficiency	O
has	O
been	O
demonstrated	O
in	O
either	O
XP-B	O
or	O
XP-D	O
.	O
We	O
have	O
employed	O
an	O
optimized	O
cell-free	O
RNA	O
transcription	O
assay	O
to	O
analyze	O
transcription	O
activity	O
of	O
XP-B	O
and	O
XP-D	O
.	O
Although	O
the	O
growth	O
rate	O
was	O
normal,	O
the	O
XP-B	O
and	O
XP-D	O
cells	O
contained	O
reduced	O
amounts	O
of	O
TFIIH	protein
.	O
Extracts	O
prepared	O
from	O
XP-B	O
and	O
XP-D	O
lymphoblastoid	O
cells	O
exhibited	O
similar	O
transcription	O
activity	O
from	O
the	O
adenovirus	DNA
major	DNA
late	DNA
promoter	DNA
when	O
compared	O
to	O
that	O
in	O
extracts	O
from	O
normal	O
cells.	O
Thus,	O
we	O
conclude	O
that	O
the	O
XP-B	O
and	O
XP-D	O
lymphoblastoid	O
cells	O
do	O
not	O
have	O
impaired	O
RNA	O
transcription	O
activity	O
.	O
We	O
consider	O
the	O
possible	O
consequences	O
of	O
the	O
reduced	O
cellular	O
content	O
of	O
TFIIH	protein
for	O
the	O
clinical	O
symptoms	O
in	O
XP-B	O
or	O
XP-D	O
patients	O
,	O
and	O
discuss	O
a	O
'conditional	O
phenotype'	O
that	O
may	O
involve	O
an	O
impairment	O
of	O
cellular	O
function	O
only	O
under	O
certain	O
growth	O
conditions	O
.	O

A	O
novel	O
form	O
of	O
the	O
myeloid-specific	protein
zinc	protein
finger	protein
protein	protein
(	O
MZF-2	protein
).	O
BACKGROUND:	O
Myeloid	O
cell	O
development	O
is	O
controlled	O
by	O
tissue-specific	O
transcription	protein
factors	protein
.	O
Human	protein
myeloid	protein
zinc	protein
finger	protein
protein	protein
(	O
MZF-1	protein
)	O
is	O
a	O
putative	O
transcription	O
factor	O
containing	O
13	protein
zinc	protein
fingers	protein
,	O
and	O
has	O
been	O
suggested	O
that	O
it	O
regulates	O
the	O
development	O
of	O
neutrophilic	cell_type
granulocytes	cell_type
.	O
RESULTS:	O
Here,	O
we	O
have	O
isolated	O
the	O
murine	O
and	O
human	O
cDNAs	O
which	O
encode	O
a	O
novel	O
form	O
of	O
MZF	protein
protein	protein
(	O
MZF-2	protein
).	O
Murine	O
and	O
human	O
MZF-2	O
proteins	O
consisted	O
of	O
814	O
and	O
775	O
amino	O
acids,	O
respectively,	O
and	O
have	O
identity	O
of	O
75.3%	O
between	O
them.	O
The	O
C-terminal	protein
half	protein
of	O
human	protein
MZF-2	protein
,	O
carrying	O
the	O
zinc	protein
finger	protein
domains	protein
,	O
was	O
completely	O
identical	O
with	O
that	O
of	O
human	protein
MZF-1	protein
,	O
whereas	O
the	O
N-terminal	protein
half	protein
of	O
MZF-2	protein
was	O
different	O
from	O
the	O
corresponding	O
region	O
of	O
human	O
MZF-1	protein
,	O
and	O
was	O
coded	O
by	O
distinct	O
exons	DNA
.	O
MZF-2	RNA
mRNA	RNA
was	O
expressed	O
in	O
myeloid	O
cells,	O
particularly	O
in	O
the	O
cells	O
committed	O
to	O
the	O
neutrophilic	cell_type
lineage	cell_type
,	O
and	O
down-regulated	O
by	O
G-CSF	protein
.	O
CONCLUSIONS:	O
MZF-1	O
and	O
MZF-2	O
mRNAs	O
seem	O
to	O
be	O
produced	O
by	O
the	O
alternative	O
use	O
of	O
two	O
different	O
transcription	DNA
initiation	DNA
sites	DNA
.	O
The	O
distinct	O
N-terminal	protein
half	protein
of	O
MZF-2	protein
carries	O
two	O
characteristic	O
domains,	O
a	O
leucine-rich	protein
domain	protein
called	O
LeR	protein
and	O
an	O
acidic	protein
domain	protein
,	O
which	O
suggests	O
a	O
unique	O
function	O
of	O
MZF-2	protein
in	O
neutrophil	O
development	O
.	O

Impaired	O
cortisol	O
binding	O
to	O
glucocorticoid	protein
receptors	protein
in	O
hypertensive	O
patients	O
.	O
We	O
compared	O
glucocorticoid	O
receptor	O
binding	O
characteristics	O
and	O
glucocorticoid	O
responsiveness	O
of	O
human	cell_type
mononuclear	cell_type
leukocytes	cell_type
(	O
HML	cell_type
)	O
from	O
hypertensive	O
patients	O
and	O
matched	O
normotensive	O
volunteers	O
.	O
We	O
also	O
considered	O
associations	O
of	O
these	O
variables	O
with	O
plasma	O
renin	protein
activity	O
,	O
aldosterone	O
,	O
cortisol	O
,	O
corticotropin	O
,	O
and	O
electrolyte	O
concentrations	O
.	O
We	O
calculated	O
binding	O
affinity	O
(Kd;	O
nmol/L)	O
and	O
capacity	O
(Bmax;	O
sites/cell)	O
for	O
dexamethasone	O
and	O
cortisol	O
from	O
homologous	O
and	O
heterologous	O
competition	O
curves	O
for	O
specific	O
[3H]dexamethasone	O
binding	O
sites	O
on	O
HML	cell_type
isolated	O
from	O
the	O
blood	O
of	O
normotensive	O
volunteers	O
and	O
subjects	O
with	O
essential	O
hypertension.	O
Glucocorticoid	O
responsiveness	O
of	O
HML	cell_type
was	O
evaluated	O
as	O
IC50	O
values	O
(nmol/L)	O
for	O
dexamethasone	O
and	O
cortisol	O
for	O
the	O
inhibition	O
of	O
lysozyme	protein
release	O
.	O
We	O
measured	O
plasma	O
hormones	O
by	O
radioimmunoassay	O
.	O
Kd	O
values	O
(mean+/-SE)	O
for	O
cortisol	O
in	O
HML	cell_type
of	O
hypertensive	O
patients	O
were	O
higher	O
than	O
in	O
control	O
subjects	O
(24.6+/-2.4	O
versus	O
17.5+/-1.7	O
nmol/L,	O
P&lt;.04).	O
Binding	O
capacity	O
(4978+/-391	O
versus	O
4131+/-321	O
sites/cell),	O
Kd	O
values	O
for	O
dexamethasone	O
(6.7+/-0.5	O
versus	O
5.7+/-0.3	O
nmol/L),	O
and	O
IC50	O
values	O
for	O
dexamethasone	O
(3.4+/-0.3	O
versus	O
3.1+/-0.2	O
nmol/L)	O
and	O
cortisol	O
(12.2+/-1.6	O
versus	O
9.5+/-0.3	O
nmol/L)	O
were	O
not	O
significantly	O
different.	O
Patients	O
with	O
renin	protein
values	O
less	O
than	O
0.13	O
ng	O
angiotensin	O
I/L	O
per	O
second	O
were	O
markedly	O
less	O
sensitive	O
to	O
cortisol	O
than	O
those	O
with	O
higher	O
values.	O
Both	O
Kd	O
(30.3+/-2.5	O
versus	O
19.2+/-2.4	O
nmol/L)	O
and	O
IC50	O
values	O
(15.5+/-1.8	O
versus	O
8.9+/-1.2	O
nmol/L)	O
for	O
cortisol	O
were	O
significantly	O
higher	O
in	O
patients	O
with	O
lower	O
renin	protein
values	O
(P&lt;.03).	O
Other	O
variables,	O
including	O
plasma	O
hormone	O
and	O
electrolyte	O
values	O
and	O
binding	O
characteristics	O
for	O
dexamethasone	O
,	O
were	O
not	O
different.	O
These	O
data	O
suggest	O
that	O
cortisol	O
binding	O
to	O
glucocorticoid	protein
receptor	protein
is	O
slightly	O
impaired	O
in	O
patients	O
with	O
essential	O
hypertension.	O
In	O
vivo,	O
this	O
could	O
lead	O
to	O
inappropriate	O
binding	O
of	O
cortisol	O
to	O
mineralocorticoid	O
receptors.	O
Hence,	O
decreased	O
sensitivity	O
to	O
cortisol	O
is	O
associated	O
with	O
renin	protein
suppression	O
.	O
This	O
hypothesis	O
is	O
supported	O
by	O
evidence	O
of	O
hypertension	O
and	O
low	O
renin	protein
activity,	O
which	O
others	O
have	O
described	O
in	O
patients	O
with	O
primary	O
glucocorticoid	O
resistance	O
due	O
to	O
mutations	O
of	O
the	O
glucocorticoid	protein
receptor	protein
.	O

PU.1/Pip	protein
and	O
basic	protein
helix	protein
loop	protein
helix	protein
zipper	protein
transcription	protein
factors	protein
interact	O
with	O
binding	DNA
sites	DNA
in	O
the	O
CD20	DNA
promoter	DNA
to	O
help	O
confer	O
lineage-	O
and	O
stage-specific	O
expression	O
of	O
CD20	protein
in	O
B	cell_type
lymphocytes	cell_type
.	O
CD20	protein
is	O
a	O
B-lineage-specific	DNA
gene	DNA
expressed	O
at	O
the	O
pre-B-cell	O
stage	O
of	O
B-cell	O
development	O
that	O
disappears	O
on	O
differentiation	O
to	O
plasma	cell_type
cells	cell_type
.	O
As	O
such,	O
it	O
serves	O
as	O
an	O
excellent	O
paradigm	O
for	O
the	O
study	O
of	O
lineage	O
and	O
developmental	O
stage-specific	O
gene	O
expression	O
.	O
Using	O
in	O
vivo	O
footprinting	O
we	O
identified	O
two	O
sites	O
in	O
the	O
promoter	O
at	O
-45	DNA
and	DNA
-160	DNA
that	O
were	O
occupied	O
only	O
in	O
CD20	protein
+	O
B	O
cells.	O
The	O
-45	DNA
site	DNA
is	O
an	O
E	DNA
box	DNA
that	O
binds	O
basic	protein
helix-loop-helix-zipper	protein
proteins	protein
whereas	O
the	O
-160	DNA
site	DNA
is	O
a	O
composite	DNA
PU.1	DNA
and	DNA
Pip	DNA
binding	DNA
site	DNA
.	O
Transfection	O
studies	O
with	O
reporter	DNA
constructs	DNA
and	O
various	O
expression	O
vectors	O
verified	O
the	O
importance	O
of	O
these	O
sites.	O
The	O
composite	DNA
PU.1	DNA
and	DNA
Pip	DNA
site	DNA
likely	O
accounts	O
for	O
both	O
lineage	O
and	O
stage	O
-specific	O
expression	O
of	O
CD20	protein
whereas	O
the	O
CD20	protein
E	protein
box	protein
binding	protein
proteins	protein
enhance	O
overall	O
promoter	O
activity	O
and	O
may	O
link	O
the	O
promoter	O
to	O
a	O
distant	DNA
enhancer	DNA
.	O

Glucocorticoids	O
and	O
the	O
immune	O
function	O
in	O
the	O
human	O
immunodeficiency	O
virus	O
infection	O
:	O
a	O
study	O
in	O
hypercortisolemic	O
and	O
cortisol-resistant	O
patients	O
.	O
Immunological	O
studies	O
in	O
human	O
immunodeficiency	O
virus	O
(HIV)-positive	O
patients	O
suggest	O
that	O
the	O
disease	O
progression	O
is	O
accompanied	O
by	O
a	O
defective	O
production	O
of	O
type	O
1	protein
cytokines	protein
(	O
interleukin-2	protein
(	O
IL-2	protein
)	O
and	O
IL-12	protein
],	O
an	O
increased	O
production	O
of	O
type	protein
2	protein
cytokines	protein
(	O
IL-4	protein
,	O
IL-6	protein
,	O
and	O
IL-10	protein
),	O
and	O
an	O
increased	O
production	O
of	O
IgE	protein
.	O
HIV	O
infection	O
is	O
also	O
associated	O
with	O
activation	O
of	O
the	O
hypothalamo-pituitary-adrenal	O
axis	O
function	O
and	O
increased	O
plasma	O
and	O
urinary	O
cortisol	O
concentrations	O
.	O
As	O
cortisol	O
is	O
involved	O
in	O
the	O
physiological	O
regulation	O
of	O
cytokines	protein
,	O
a	O
study	O
was	O
conducted	O
to	O
examine	O
cytokine	protein
patterns	O
in	O
two	O
groups	O
of	O
hypercortisolemic	O
patients	O
,	O
one	O
with	O
normal	O
sensitivity	O
to	O
glucocorticoids	O
and	O
the	O
other	O
with	O
glucocorticoid	O
resistance	O
.	O
Ten	O
HIV-infected	O
patients	O
with	O
normal	O
receptor	O
affinity	O
to	O
glucocorticoids	O
(	O
AIDS-C	O
),	O
10	O
HIV-infected	O
patients	O
with	O
low	O
receptor	O
affinity	O
to	O
glucocorticoids	O
(	O
AIDS-GR	O
),	O
and	O
20	O
healthy	O
subjects	O
were	O
studied.	O
Receptor	O
characteristics	O
of	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
were	O
evaluated	O
by	O
[3H]dexamethasone	O
binding	O
.	O
Serum	O
cortisol	O
and	O
urinary	O
free	O
cortisol	O
were	O
measured	O
by	O
RIA	O
.	O
Serum	O
ACTH	O
and	O
IgE	protein
were	O
measured	O
by	O
immunoradiometric	O
assay	O
,	O
and	O
IL-2	protein
,	O
IL-4	protein
,	O
and	O
IL-10	protein
cytokines	protein
and	O
interferon-gamma	protein
were	O
measured	O
by	O
enzyme-linked	O
immunosorbent	O
assay	O
.	O
AIDS-C	O
patients	O
showed	O
low	O
IL-2	protein
and	O
high	O
IL-4	protein
,	O
IL-10	protein
,	O
and	O
IgE	protein
concentratios	O
;	O
conversely,	O
AIDS-GR	O
patients	O
showed	O
high	O
IL-2	protein
and	O
low	O
IL-4	protein
and	O
IgE	protein
concentrations	O
.	O
Thus,	O
in	O
HIV	O
infection	O
,	O
elevated	O
cortisol	O
levels	O
suppress	O
cell-mediated	O
immunity	O
and	O
stimulate	O
humoral	O
immunity	O
,	O
whereas	O
this	O
response	O
is	O
not	O
detected	O
in	O
cortisol	O
-resistant	O
patients	O
.	O
These	O
findings	O
indicate	O
that	O
cortisol	O
and	O
its	O
receptors	O
are	O
critically	O
involved	O
in	O
the	O
regulation	O
of	O
immune	O
function	O
in	O
HIV	O
infection	O
.	O

Monocytic	O
differentiation	O
of	O
HL-60	cell_line
promyelocytic	cell_line
leukemia	cell_line
cells	cell_line
correlates	O
with	O
the	O
induction	O
of	O
Bcl-xL	protein
.	O
Treatment	O
of	O
human	cell_line
promyelocytic	cell_line
leukemia	cell_line
HL-60	cell_line
cells	cell_line
with	O
phorbol	O
esters	O
ultimately	O
induces	O
the	O
differentiation	O
of	O
these	O
cells	O
along	O
the	O
monocyte/macrophage	cell_type
lineage	cell_type
,	O
whereas	O
treatment	O
with	O
retinoic	O
acid	O
or	O
DMSO	O
induces	O
granulocytic/neutrophillic	O
differentiation	O
.	O
In	O
this	O
study,	O
we	O
demonstrate	O
the	O
disparate	O
fates	O
of	O
HL-60	cell_line
cells	cell_line
treated	O
with	O
the	O
phorbol	O
ester	O
12,13-phorbol	O
dibutyric	O
acid	O
(	O
PDBu	O
)	O
or	O
DMSO	O
.	O
After	O
DMSO	O
treatment,	O
HL-60	cell_line
cells	cell_line
eventually	O
died	O
via	O
apoptosis	O
,	O
whereas	O
the	O
viability	O
of	O
PDBu	cell_line
-treated	cell_line
cells	cell_line
was	O
not	O
affected	O
during	O
the	O
same	O
interval.	O
The	O
levels	O
of	O
the	O
apoptosis	O
effector	O
proteins	O
Bak	protein
and	O
Bad	protein
were	O
enhanced,	O
whereas	O
there	O
was	O
a	O
slight	O
down-regulation	O
of	O
the	O
apoptosis	protein
suppressor	protein
protein	protein
Bcl-2	protein
after	O
treatment	O
of	O
the	O
cells	O
with	O
PDBu	O
and	O
DMSO	O
.	O
Treatment	O
with	O
DMSO	O
resulted	O
in	O
the	O
elevation	O
of	O
the	O
apoptosis	protein
effector	protein
Bax	protein
,	O
whereas	O
treatment	O
with	O
PDBu	O
did	O
not	O
significantly	O
alter	O
the	O
levels	O
of	O
this	O
protein.	O
However,	O
treatment	O
of	O
HL-60	cell_line
cells	cell_line
with	O
PDBu	O
induced	O
the	O
rapid	O
expression	O
of	O
the	O
apoptosis	protein
suppressor	protein
protein	protein
Bcl-xL	protein
,	O
whereas	O
the	O
expression	O
of	O
this	O
protein	O
remained	O
unaltered	O
in	O
DMSO	O
-treated	O
cells.	O
The	O
generality	O
of	O
this	O
finding	O
was	O
confirmed	O
by	O
the	O
induction	O
of	O
Bcl-xL	protein
in	O
human	cell_line
myeloid	cell_line
U-937	cell_line
cells	cell_line
,	O
human	cell_type
peripheral	cell_type
blood	cell_type
monocytes	cell_type
exposed	O
to	O
phorbol	O
ester	O
,	O
and	O
mouse	cell_line
thioglycollate-activated	cell_line
and	cell_line
resident	cell_line
peritoneal	cell_line
macrophages	cell_line
.	O
PDBu	cell_line
-treated	cell_line
HL-60	cell_line
cells	cell_line
remained	O
viable	O
for	O
7	O
days	O
and	O
thereafter	O
began	O
to	O
die	O
via	O
apoptosis	O
,	O
with	O
a	O
concomitant	O
down-regulation	O
of	O
Bcl-xL	protein
.	O
In	O
conclusion,	O
we	O
propose	O
that	O
Bcl-xL	protein
expression	O
is	O
associated	O
with	O
differentiation	O
and	O
survival	O
of	O
hematopoietic	cell_type
cells	cell_type
along	O
the	O
monocyte/macrophage	cell_type
lineage	cell_type
.	O

Monochloramine	O
inhibits	O
phorbol	O
ester	O
-inducible	O
neutrophil	O
respiratory	O
burst	O
activation	O
and	O
T	O
cell	O
interleukin-2	protein
receptor	O
expression	O
by	O
inhibiting	O
inducible	O
protein	protein
kinase	protein
C	protein
activity	O
.	O
Monochloramine	O
derivatives	O
are	O
long	O
lived	O
physiological	O
oxidants	O
produced	O
by	O
neutrophils	cell_type
during	O
the	O
respiratory	O
burst	O
.	O
The	O
effects	O
of	O
chemically	O
prepared	O
monochloramine	O
(	O
NH2Cl	O
)	O
on	O
protein	protein
kinase	protein
C	protein
(	O
PKC	protein
)	O
and	O
PKC	protein
-mediated	O
cellular	O
responses	O
were	O
studied	O
in	O
elicited	cell_type
rat	cell_type
peritoneal	cell_type
neutrophils	cell_type
and	O
human	cell_line
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
Neutrophils	O
pretreated	O
with	O
NH2Cl	O
(30-50	O
microM)	O
showed	O
a	O
marked	O
decrease	O
in	O
the	O
respiratory	O
burst	O
activity	O
induced	O
by	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
),	O
which	O
is	O
a	O
potent	O
PKC	protein
activator	O
.	O
These	O
cells,	O
however,	O
were	O
viable	O
and	O
showed	O
a	O
complete	O
respiratory	O
burst	O
upon	O
arachidonic	O
acid	O
stimulation	O
,	O
which	O
induces	O
the	O
respiratory	O
burst	O
by	O
a	O
PKC	protein
-independent	O
mechanism	O
.	O
The	O
NH2Cl	cell_line
-treated	cell_line
neutrophils	cell_line
showed	O
a	O
decrease	O
in	O
both	O
PKC	protein
activity	O
and	O
PMA	O
-induced	O
phosphorylation	O
of	O
a	O
47-kDa	protein
protein	protein
,	O
which	O
corresponds	O
to	O
the	O
cytosolic	protein
factor	protein
of	O
NADPH	protein
oxidase	protein
,	O
p47(phox)	protein
.	O
Jurkat	cell_line
T	cell_line
cells	cell_line
pretreated	O
with	O
NH2Cl	O
(20-70	O
microM)	O
showed	O
a	O
decrease	O
in	O
the	O
expression	O
of	O
the	O
interleukin-2	protein
receptor	protein
alpha	protein
chain	protein
following	O
PMA	O
stimulation.	O
This	O
was	O
also	O
accompanied	O
by	O
a	O
decrease	O
in	O
both	O
PKC	protein
activity	O
and	O
nuclear	O
transcription	O
factor-	O
kappaB	protein
activation	O
,	O
also	O
without	O
loss	O
of	O
cell	O
viability.	O
These	O
results	O
show	O
that	O
NH2Cl	O
inhibits	O
PKC	protein
-mediated	O
cellular	O
responses	O
through	O
inhibition	O
of	O
the	O
inducible	O
PKC	protein
activity	O
.	O

Evidence	O
that	O
calcineurin	O
is	O
rate-limiting	O
for	O
primary	O
human	O
lymphocyte	O
activation	O
.	O
Cyclosporine	O
(	O
CsA	O
)	O
is	O
both	O
a	O
clinical	O
immunosuppressive	O
drug	O
and	O
a	O
probe	O
to	O
dissect	O
intracellular	O
signaling	O
pathways	O
.	O
In	O
vitro,	O
CsA	O
inhibits	O
lymphocyte	DNA
gene	DNA
activation	O
by	O
inhibiting	O
the	O
phosphatase	protein
activity	O
of	O
calcineurin	protein
(	O
CN	protein
).	O
In	O
clinical	O
use,	O
CsA	O
treatment	O
inhibits	O
50-75%	O
of	O
CN	protein
activity	O
in	O
circulating	cell_type
leukocytes	cell_type
.	O
We	O
modeled	O
this	O
degree	O
of	O
CN	protein
inhibition	O
in	O
primary	cell_type
human	cell_type
leukocytes	cell_type
in	O
vitro	O
in	O
order	O
to	O
study	O
the	O
effect	O
of	O
partial	O
CN	protein
inhibition	O
on	O
the	O
downstream	O
signaling	O
events	O
that	O
lead	O
to	O
gene	O
activation	O
.	O
In	O
CsA	cell_line
-treated	cell_line
leukocytes	cell_line
stimulated	O
by	O
calcium	O
ionophore	O
,	O
the	O
degree	O
of	O
reduction	O
in	O
CN	protein
activity	O
was	O
accompanied	O
by	O
a	O
similar	O
degree	O
of	O
inhibition	O
of	O
each	O
event	O
tested:	O
dephosphorylation	O
of	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cell	protein
proteins	protein
,	O
nuclear	O
DNA	O
binding	O
,	O
activation	O
of	O
a	O
transfected	DNA
reporter	DNA
gene	DNA
construct	DNA
,	O
IFN-gamma	O
and	O
IL-2	O
mRNA	O
accumulation	O
,	O
and	O
IFN-gamma	protein
production	O
.	O
Furthermore,	O
the	O
degree	O
of	O
CN	protein
inhibition	O
was	O
reflected	O
by	O
a	O
similar	O
degree	O
of	O
reduction	O
in	O
lymphocyte	O
proliferation	O
and	O
IFN-gamma	protein
production	O
in	O
the	O
allogeneic	cell_line
mixed	cell_line
lymphocyte	cell_line
cultures	cell_line
.	O
These	O
data	O
support	O
the	O
conclusion	O
that	O
CN	protein
activity	O
is	O
rate-limiting	O
for	O
the	O
activation	O
of	O
primary	cell_type
human	cell_type
T	cell_type
lymphocytes	cell_type
.	O
Thus,	O
the	O
reduction	O
of	O
CN	protein
activity	O
observed	O
in	O
CsA	O
-treated	O
patients	O
is	O
accompanied	O
by	O
a	O
similar	O
degree	O
of	O
reduction	O
in	O
lymphocyte	DNA
gene	DNA
activation	O
,	O
and	O
accounts	O
for	O
the	O
immunosuppression	O
observed.	O

Selection	O
of	O
down-regulated	DNA
sequences	DNA
along	O
the	O
monocytic	O
differentiation	O
of	O
leukemic	cell_line
HL60	cell_line
cells	cell_line
.	O
In	O
order	O
to	O
dissect	O
the	O
molecular	O
mechanisms	O
of	O
monocytic	O
differentiation	O
we	O
have	O
developed	O
a	O
subtractive	O
hybridisation	O
method	O
based	O
on	O
a	O
simplified	O
'	O
representational	O
difference	O
analysis	O
'.	O
We	O
have	O
selected	O
16	DNA
sequences	DNA
and	O
confirmed	O
their	O
down-regulation	O
along	O
the	O
TPA	O
-induced	O
monocytic	O
differentiation	O
of	O
HL60	cell_line
cells	cell_line
.	O
Among	O
these	O
sequences	O
we	O
have	O
identified	O
the	O
alpha-tubulin	protein
,	O
the	O
TaxREB	protein
protein	protein
and	O
two	O
ribosomal	DNA
protein	DNA
sequences	DNA
which	O
had	O
not	O
been	O
previously	O
described	O
as	O
differentially	O
expressed.	O
These	O
results	O
add	O
to	O
our	O
knowledge	O
about	O
the	O
molecules	O
implicated	O
along	O
the	O
monocytic	O
differentiation	O
and	O
growth	O
arrest	O
of	O
leukemic	cell_type
cells	cell_type
and	O
provide	O
a	O
first	O
step	O
in	O
the	O
study	O
of	O
their	O
respective	O
roles.	O

Control	O
of	O
NF-kappa	protein
B	protein
activity	O
by	O
the	O
I	protein
kappa	protein
B	protein
beta	protein
inhibitor	protein
.	O
The	O
transcription	protein
factor	protein
NF-kappa	protein
B	protein
is	O
maintained	O
in	O
an	O
inactive	O
cytoplasmic	O
state	O
by	O
I	protein
kappa	protein
B	protein
inhibitors	protein
.	O
In	O
mammalian	cell_type
cells	cell_type
,	O
I	protein
kappa	protein
B	protein
alpha	protein
and	O
I	protein
kappa	protein
B	protein
beta	protein
proteins	protein
have	O
been	O
purified	O
and	O
shown	O
to	O
be	O
the	O
inhibitors	O
of	O
NF-kappa	protein
B	protein
through	O
their	O
association	O
with	O
the	O
p65	O
or	O
c-Rel	O
subunits	O
.	O
In	O
addition,	O
we	O
have	O
isolated	O
a	O
third	O
NF-kappa	protein
B	protein
inhibitor	protein
,	O
I	protein
kappa	protein
B	protein
epsilon	protein
(1).	O
Upon	O
treatment	O
with	O
a	O
large	O
variety	O
of	O
inducers,	O
I	protein
kappa	protein
B	protein
alpha	protein
,	O
I	protein
kappa	protein
B	protein
beta	protein
are	O
proteolytically	O
degraded,	O
resulting	O
in	O
NF-kappa	protein
B	protein
translocation	O
into	O
the	O
nucleus	O
.	O
Here	O
we	O
show	O
that	O
in	O
E29.1	cell_line
T	cell_line
cell	cell_line
hybridoma	cell_line
I	protein
kappa	protein
B	protein
alpha	protein
and	O
I	protein
kappa	protein
B	protein
beta	protein
are	O
equally	O
associated	O
with	O
p65	protein
and	O
that	O
I	protein
kappa	protein
B	protein
beta	protein
is	O
degraded	O
in	O
response	O
to	O
TNF	protein
alpha	protein
in	O
contrast	O
to	O
what	O
has	O
been	O
originally	O
published.	O
Our	O
data	O
also	O
suggest	O
that,	O
unlike	O
I	protein
kappa	protein
B	protein
alpha	protein
,	O
I	protein
kappa	protein
B	protein
beta	protein
is	O
constitutively	O
phosphorylated	O
and	O
resynthesized	O
as	O
a	O
hypophosphorylated	protein
form	protein
.	O
The	O
absence	O
of	O
slow	O
migrating	O
forms	O
of	O
I	protein
kappa	protein
B	protein
beta	protein
following	O
stimulation	O
suggests	O
that	O
the	O
phosphorylation	O
does	O
not	O
necessarily	O
constitute	O
the	O
signal-induced	O
event	O
which	O
targets	O
the	O
molecule	O
for	O
proteolysis	O
.	O

Agonistic	O
activity	O
of	O
a	O
CD40-specific	protein
single-chain	protein
Fv	protein
constructed	O
from	O
the	O
variable	protein
regions	protein
of	O
mAb	protein
G28-5	protein
.	O
A	O
single-chain	protein
Fv	protein
(	O
sFv	protein
)	O
was	O
expressed	O
from	O
the	O
variable	protein
regions	protein
of	O
the	O
CD40-specific	O
mAb	protein
G28-5	protein
.	O
The	O
molecule	O
bound	O
CD40	protein
with	O
a	O
high	O
affinity	O
(2.2	O
nM)	O
and	O
was	O
a	O
monomer	O
in	O
solution.	O
Surprisingly,	O
G28-5	protein
sFv	protein
was	O
a	O
potent	O
CD40	protein
agonist	protein
that	O
rapidly	O
crosslinked	O
CD40	protein
on	O
the	O
cell	O
surface	O
but	O
did	O
not	O
crosslink	O
CD40	protein
-Ig	protein
in	O
solution.	O
G28-5	protein
sFv	protein
was	O
a	O
more	O
potent	O
agonist	O
than	O
G28-5	protein
IgG	protein
and	O
was	O
able	O
to	O
stimulate	O
CD40	protein
responses	O
by	O
B	cell_type
cells	cell_type
and	O
monocytes.	O
G28-5	protein
IgG	protein
partially	O
blocked,	O
whereas	O
G28-5	protein
sFv	protein
augmented	O
CD40	protein
responses	O
during	O
stimulation	O
with	O
natural	protein
ligand	protein
(	O
gp39-CD8	protein
fusion	protein
protein	protein
).	O
These	O
results	O
indicate	O
that	O
the	O
functional	O
activity	O
of	O
ligands	O
built	O
from	O
the	O
binding	protein
site	protein
of	O
G28-5	protein
is	O
highly	O
dependent	O
upon	O
the	O
size	O
and	O
physical	O
properties	O
of	O
the	O
molecule	O
both	O
in	O
solution	O
and	O
on	O
the	O
cell	O
surfaces	O
.	O

C/EBP	protein
activates	O
the	O
human	DNA
corticotropin-releasing	DNA
hormone	DNA
gene	DNA
promoter	DNA
.	O
The	O
purpose	O
of	O
these	O
studies	O
was	O
to	O
identify	O
whether	O
transcription	O
factors,	O
associated	O
with	O
cytokine	O
signalling,	O
affected	O
promoter	O
activity	O
of	O
the	O
corticotropin	DNA
releasing	DNA
hormone	DNA
(	DNA
CRH	DNA
)	DNA
gene	DNA
.	O
Fragments	O
of	O
a	O
3.6	O
kb	O
sequence	O
of	O
the	O
human	DNA
CRH	DNA
gene	DNA
promoter	DNA
were	O
amplified	O
by	O
PCR	O
and	O
ligated	O
upstream	O
of	O
a	O
CAT	DNA
reporter	DNA
.	O
These	O
constructs	O
were	O
transfected	O
into	O
a	O
variety	O
of	O
cell	O
lines,	O
either	O
alone	O
or	O
together,	O
with	O
transcription	protein
factor	protein
expression	O
vectors	O
.	O
Basal	O
activity	O
of	O
a	O
3070	DNA
bp	DNA
CRH	DNA
promoter	DNA
fragment	DNA
was	O
only	O
seen	O
in	O
neuronal	O
and	O
lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
.	O
Promoter	O
activity	O
was	O
increased	O
by	O
the	O
transcription	protein
factors	protein
C/EBPbeta	protein
(	O
NF-IL6	protein
)	O
and	O
more	O
strongly,	O
by	O
C/EBPdelta	protein
(	O
NF-IL6beta	protein
).	O
Increased	O
CRH	protein
promoter	O
activity	O
following	O
phorbol	O
ester	O
treatment	O
was	O
inhibited	O
by	O
a	O
dominant	O
negative	O
NF-IL6	protein
mutant	protein
,	O
showing	O
that	O
the	O
effects	O
of	O
phorbol	O
ester	O
were	O
principally	O
mediated	O
by	O
C/EBP	protein
.	O
Moreover,	O
the	O
inverse	O
changes	O
in	O
the	O
expression	O
of	O
CRH	protein
in	O
the	O
hypothalamus	O
and	O
spleens	O
of	O
arthritic	O
rats	O
were	O
paralleled	O
by	O
similar	O
inverse	O
changes	O
in	O
NF-IL6beta	protein
expression	O
in	O
these	O
organs.	O
These	O
data	O
show	O
that	O
some	O
transcription	protein
factors	protein
associated	O
with	O
cytokine	protein
signalling	O
can	O
also	O
activate	O
the	O
CRH	DNA
promoter	DNA
.	O

Aberrant	O
splicing	O
of	O
the	O
TSG101	O
and	O
FHIT	O
genes	O
occurs	O
frequently	O
in	O
multiple	O
malignancies	O
and	O
in	O
normal	O
tissues	O
and	O
mimics	O
alterations	O
previously	O
described	O
in	O
tumours	O
.	O
Intragenic	O
deletions	O
of	O
TSG101	DNA
,	O
the	O
human	O
homolog	O
of	O
a	O
mouse	DNA
gene	DNA
(	O
tsg101	DNA
)	O
that	O
acts	O
to	O
suppress	O
malignant	O
cell	O
growth,	O
were	O
reported	O
in	O
human	cell_type
breast	cell_type
tumours	cell_type
.	O
We	O
screened	O
TSG101	DNA
for	O
somatic	O
mutations	O
in	O
DNA	O
and	O
RNA	O
samples	O
isolated	O
from	O
a	O
variety	O
of	O
common	O
human	O
malignancies	O
,	O
EBV-immortalised	cell_type
B-cells	cell_type
,	O
and	O
normal	O
lung	O
parenchyma	O
.	O
Intragenic	O
TSG101	DNA
deletions	O
in	O
RNA	RNA
transcripts	RNA
were	O
frequently	O
found	O
in	O
all	O
types	O
of	O
samples.	O
Analysis	O
of	O
DNA	O
failed	O
to	O
show	O
genomic	O
rearrangements	O
corresponding	O
to	O
transcripts	O
containing	O
deletions	O
in	O
the	O
same	O
samples.	O
The	O
breakpoints	O
of	O
most	O
transcript	O
deletions	O
coincide	O
with	O
genuine	O
or	O
cryptic	O
splice	DNA
site	DNA
sequences	DNA
,	O
suggesting	O
that	O
they	O
result	O
from	O
alternative	O
or	O
aberrant	O
splicing.	O
A	O
similar	O
spectrum	O
of	O
transcript	O
deletions	O
has	O
previously	O
been	O
described	O
in	O
the	O
putative	DNA
tumour	DNA
suppressor	DNA
gene	DNA
FHIT	DNA
.	O
We	O
analysed	O
FHIT	DNA
in	O
the	O
same	O
series	O
of	O
RNA	RNA
samples	RNA
and	O
detected	O
truncated	O
FHIT	RNA
transcripts	RNA
frequently	O
in	O
both	O
tumour	O
and	O
normal	O
tissues	O
.	O
In	O
addition,	O
transcripts	O
from	O
TSG101	DNA
,	O
FHIT	DNA
and	O
seven	O
other	O
genes	O
were	O
analysed	O
in	O
RNA	O
isolated	O
from	O
normal	cell_type
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
.	O
Large	O
TSG101	DNA
and	O
FHIT	DNA
intragenic	O
transcript	O
deletions	O
were	O
detected	O
and	O
these	O
appeared	O
to	O
be	O
the	O
predominant	O
transcript	O
in	O
'aged'	cell_type
lymphocytes	cell_type
.	O
Similar	O
alterations	O
were	O
not	O
detected	O
in	O
transcripts	O
of	O
the	O
other	O
genes	O
which	O
were	O
analysed.	O
Our	O
findings	O
demonstrate	O
that	O
truncated	O
TSG101	O
and	O
FHIT	O
transcripts	O
are	O
commonly	O
detected	O
in	O
both	O
normal	O
and	O
malignant	O
tissues	O
and	O
that	O
a	O
significant	O
fraction	O
of	O
these	O
are	O
likely	O
to	O
be	O
the	O
result	O
of	O
aberrant	O
splicing.	O
While	O
we	O
cannot	O
exclude	O
that	O
alterations	O
in	O
TSG101	DNA
and	O
FHIT	DNA
occur	O
during	O
cancer	O
development	O
,	O
our	O
data	O
indicate	O
that	O
in	O
this	O
context	O
the	O
commonly	O
observed	O
transcript	O
abnormalities	O
are	O
misleading.	O

Inhibition	O
of	O
proliferation	O
and	O
apoptosis	O
of	O
human	O
and	O
rat	O
T	O
lymphocytes	O
by	O
curcumin	O
,	O
a	O
curry	O
pigment	O
.	O
Curcumin	O
(	O
diferuoylmethane	O
),	O
the	O
yellow	O
pigment	O
in	O
the	O
rhizome	O
of	O
tumeric	O
(	O
Curcuma	O
longa	O
),	O
an	O
ingredient	O
of	O
curry	O
spice	O
,	O
is	O
known	O
to	O
exhibit	O
a	O
variety	O
of	O
pharmacological	O
effects	O
including	O
antitumor	O
,	O
antiinflammatory	O
,	O
and	O
antiinfectious	O
activities	O
.	O
Although	O
its	O
precise	O
mode	O
of	O
action	O
remains	O
elusive,	O
curcumin	O
has	O
been	O
shown	O
to	O
suppress	O
the	O
activity	O
of	O
the	O
AP-1	protein
transcription	protein
factor	protein
in	O
cells	O
stimulated	O
to	O
proliferate.	O
In	O
this	O
study,	O
we	O
observed	O
that	O
curcumin	O
(50	O
microM)	O
inhibited	O
proliferation	O
of	O
rat	cell_type
thymocytes	cell_type
stimulated	O
with	O
concanavalin	O
A	O
(	O
Con	O
A	O
)	O
as	O
well	O
as	O
that	O
of	O
human	cell_type
Jurkat	cell_type
lymphoblastoid	cell_type
cells	cell_type
in	O
the	O
logarithmic	O
growth	O
phase	O
.	O
The	O
pigment	O
also	O
inhibited	O
apoptosis	O
in	O
dexamethasone-treated	cell_line
rat	cell_line
thymocytes	cell_line
and	O
in	O
UV-irradiated	cell_line
Jurkat	cell_line
cells	cell_line
as	O
judged	O
by	O
DNA	O
ladder	O
formation	O
,	O
cellular	O
morphological	O
changes	O
,	O
and	O
flow	O
cytometry	O
analysis	O
.	O
The	O
inhibition	O
of	O
apoptosis	O
by	O
curcumin	O
in	O
rat	cell_type
thymocytes	cell_type
was	O
accompanied	O
by	O
partial	O
suppression	O
of	O
AP-1	protein
activity	O
.	O
Complete	O
suppression	O
of	O
AP-1	protein
activity	O
was	O
observed	O
in	O
Con	cell_line
A	cell_line
-treated,	cell_line
proliferating	cell_line
thymocytes	cell_line
.	O
The	O
capacity	O
of	O
curcumin	O
to	O
inhibit	O
both	O
cell	O
growth	O
and	O
death	O
strongly	O
implies	O
that	O
these	O
two	O
biological	O
processes	O
share	O
a	O
common	O
pathway	O
at	O
some	O
point	O
and	O
that	O
curcumin	O
affects	O
a	O
common	O
step,	O
presumably	O
involving	O
a	O
modulation	O
of	O
the	O
AP-1	protein
transcription	protein
factor	protein
.	O

Interleukin-7	protein
upregulates	O
the	O
interleukin-2-gene	DNA
expression	O
in	O
activated	cell_type
human	cell_type
T	cell_type
lymphocytes	cell_type
at	O
the	O
transcriptional	O
level	O
by	O
enhancing	O
the	O
DNA	O
binding	O
activities	O
of	O
both	O
nuclear	O
factor	O
of	O
activated	cell_type
T	cell_type
cells	cell_type
and	O
activator	protein
protein-1	protein
.	O
In	O
the	O
present	O
report,	O
we	O
studied	O
the	O
role	O
of	O
the	O
stromal-derived	protein
cytokine	protein
interleukin-7	protein
(	O
IL-7	protein
)	O
in	O
the	O
IL-2-gene	DNA
regulation	O
in	O
activated	cell_type
T	cell_type
lymphocytes	cell_type
.	O
Production	O
of	O
IL-2	protein
requires	O
the	O
formation	O
of	O
transcription	protein
factors	protein
involved	O
in	O
the	O
IL-2	DNA
-gene	DNA
regulation	O
.	O
T-cell	protein
receptor	protein
(TCR)/CD3	protein
engagement	O
results	O
in	O
the	O
activation	O
of	O
nuclear	O
factor	O
of	O
activated	cell_type
T	cell_type
cells	cell_type
(	O
NFAT	protein
),	O
activator	protein
protein-1	protein
(	O
AP-1	protein
),	O
and	O
nuclear	protein
factor	protein
kappaB	protein
(	O
NFkappaB	protein
),	O
whereas	O
the	O
CD28	protein
responsive	protein
complex	protein
(	O
CD28RC	protein
)	O
is	O
activated	O
in	O
response	O
to	O
the	O
CD28	protein
signal	O
.	O
Costimulation	O
of	O
phytohemagglutinin	cell_line
/anti-CD28	cell_line
activated	cell_line
T	cell_line
lymphocytes	cell_line
with	O
IL-7	protein
induces	O
a	O
fivefold	O
enhanced	O
IL-2	protein
-mRNA	O
accumulation	O
and	O
a	O
2.5-fold	O
enhanced	O
protein	O
secretion	O
.	O
The	O
IL-2	DNA
-gene	DNA
transcription	O
rate	O
is	O
increased	O
3.4-fold,	O
indicating	O
that	O
the	O
effect	O
of	O
IL-7	protein
is	O
in	O
part	O
mediated	O
at	O
the	O
transcriptional	O
level.	O
The	O
molecular	O
mechanisms	O
underlying	O
the	O
IL-7	protein
effect	O
involve	O
the	O
upregulation	O
of	O
the	O
DNA	O
binding	O
activity	O
of	O
NFAT	protein
(60%)	O
and	O
AP-1	protein
(120%),	O
without	O
affecting	O
the	O
activities	O
of	O
NFkappaB	protein
and	O
CD28RC	protein
,	O
which	O
was	O
confirmed	O
by	O
transfection	O
assays	O
.	O
We	O
also	O
show	O
that	O
the	O
IL-7	protein
-induced	O
enhancement	O
of	O
the	O
AP-1	protein
-DNA	O
binding	O
activity	O
is	O
not	O
cyclosporin	O
A-sensitive	O
.	O
Since	O
AP-1	protein
is	O
part	O
of	O
the	O
NFAT	protein
complex	protein
,	O
we	O
conclude	O
that	O
the	O
IL-7	protein
-signaling	O
pathway	O
is	O
involved	O
in	O
the	O
activation	O
of	O
the	O
fos	O
and	O
jun	O
proteins	O
of	O
which	O
AP-1	protein
consists.	O

The	O
spatial	O
distribution	O
of	O
human	DNA
immunoglobulin	DNA
genes	DNA
within	O
the	O
nucleus	O
:	O
evidence	O
for	O
gene	O
topography	O
independent	O
of	O
cell	O
type	O
and	O
transcriptional	O
activity	O
.	O
The	O
three-dimensional	O
positioning	O
of	O
immunoglobulin	DNA
(Ig)	DNA
genes	DNA
within	O
the	O
nucleus	O
of	O
human	cell_type
cells	cell_type
was	O
investigated	O
using	O
in	O
situ	O
hybridization	O
and	O
confocal	O
microscopy	O
.	O
The	O
visualization	O
of	O
heavy	O
and	O
light	O
chain	O
genes	O
in	O
B-lymphoid	cell_type
cells	cell_type
showed	O
that	O
the	O
three	O
Ig	DNA
genes	DNA
are	O
differentially	O
and	O
nonrandomly	O
distributed	O
in	O
different	O
nuclear	O
subvolumes:	O
the	O
kappa	DNA
genes	DNA
were	O
found	O
to	O
be	O
preferentially	O
confined	O
to	O
an	O
outer	O
nuclear	O
volume,	O
whereas	O
the	O
gamma	O
and	O
lambda	O
genes	O
consistently	O
occupied	O
more	O
central	O
positions	O
within	O
the	O
nucleus	O
,	O
the	O
lambda	DNA
genes	DNA
being	O
more	O
interior	O
when	O
compared	O
with	O
the	O
gamma	DNA
genes	DNA
.	O
The	O
data	O
further	O
show	O
that	O
these	O
overall	O
topographical	O
distributions	O
are	O
independent	O
of	O
gene	O
transcriptional	O
activity	O
and	O
are	O
conserved	O
in	O
different	cell_type
cell	cell_type
types	cell_type
.	O
Although	O
subtle	O
gene	O
movements	O
within	O
those	O
defined	O
topographical	O
regions	O
cannot	O
be	O
excluded	O
by	O
this	O
study,	O
the	O
results	O
indicate	O
that	O
tissue	O
specificity	O
of	O
gene	O
expression	O
is	O
not	O
accompanied	O
by	O
drastic	O
changes	O
in	O
gene	O
nuclear	O
topography	O
,	O
rather	O
suggesting	O
that	O
gene	O
organization	O
within	O
the	O
nucleus	O
may	O
be	O
primarily	O
dependent	O
on	O
structural	O
constraints	O
imposed	O
on	O
the	O
respective	O
chromosomes	DNA
.	O

Dominant	O
cytotoxic	cell_type
T	cell_type
lymphocyte	cell_type
response	O
to	O
the	O
immediate-early	protein
trans-activator	protein
protein	protein
,	O
BZLF1	protein
,	O
in	O
persistent	O
type	O
A	O
or	O
B	O
Epstein-Barr	O
virus	O
infection	O
.	O
Five	O
healthy	O
human	O
leukocyte	O
antigen-B8	O
(HLA-B8)-positive	O
virus	O
carriers	O
were	O
studied	O
to	O
investigate	O
the	O
CD8+	cell_type
cytotoxic	cell_type
T	cell_type
lymphocyte	cell_type
(CTL)	O
response	O
to	O
an	O
HLA-B8-restricted	O
peptide	O
,	O
RAKFKQLLQ	O
,	O
located	O
in	O
the	O
Epstein-Barr	protein
virus	protein
(	protein
EBV	protein
)	protein
immediate-early	protein
trans-activator	protein
protein	protein
,	O
BZLF1	protein
.	O
Of	O
the	O
5	O
virus	O
carriers	O
,	O
4	O
were	O
infected	O
with	O
type	O
A	O
and	O
1	O
with	O
type	O
B	O
EBV	O
.	O
Using	O
limiting-dilution	O
analysis	O
of	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
,	O
a	O
high	O
RAKFKQLLQ	O
-specific	O
CTL	O
precursor	O
frequency	O
was	O
demonstrated	O
after	O
specific	O
peptide	O
or	O
autologous	O
lymphoblastoid	O
cell	O
line	O
stimulation	O
in	O
both	O
type	O
A	O
and	O
type	O
B	O
EBV	O
carriers	O
.	O
The	O
RAKFKQLLQ	O
-specific	O
CTL	O
precursor	O
frequencies	O
in	O
all	O
5	O
persons	O
were	O
at	O
least	O
as	O
dominant	O
as	O
those	O
observed	O
with	O
two	O
other	O
EBV-associated,	protein
HLA-B8-restricted	protein
latent	protein
epitopes	protein
,	O
FLRGRAYGL	O
and	O
QAKWRLQTL	O
.	O
These	O
findings	O
show	O
that	O
healthy	O
virus	O
carriers	O
maintain	O
a	O
high	O
frequency	O
of	O
BZLF1	cell_type
-specific	cell_type
memory	cell_type
T	cell_type
cells	cell_type
,	O
potentially	O
to	O
control	O
virus	O
spread	O
from	O
lytically	cell_type
infected	cell_type
cells	cell_type
.	O

The	O
DNA	protein
binding	protein
domain	protein
of	O
the	O
A-MYB	protein
transcription	protein
factor	protein
is	O
responsible	O
for	O
its	O
B	O
cell-specific	O
activity	O
and	O
binds	O
to	O
a	O
B	protein
cell	protein
110-kDa	protein
nuclear	protein
protein	protein
.	O
Expression	O
studies	O
as	O
well	O
as	O
the	O
use	O
of	O
transgenic	O
animals	O
have	O
demonstrated	O
that	O
the	O
A-MYB	protein
transcription	protein
factor	protein
plays	O
central	O
and	O
specific	O
role	O
in	O
the	O
regulation	O
of	O
mature	cell_type
B	cell_type
cell	cell_type
proliferation	O
and/or	O
differentiation	O
.	O
Furthermore,	O
it	O
is	O
highly	O
expressed	O
in	O
Burkitt's	cell_line
lymphoma	cell_line
cells	cell_line
and	O
may	O
participate	O
in	O
the	O
pathogenesis	O
of	O
this	O
disease.	O
We	O
have	O
therefore	O
investigated	O
the	O
transcriptional	O
activity	O
of	O
A-MYB	protein
and	O
its	O
regulation	O
in	O
several	O
human	cell_line
lymphoid	cell_line
cell	cell_line
lines	cell_line
using	O
co-transfection	O
assays	O
and	O
show	O
that	O
A-MYB	protein
is	O
transcriptionally	O
active	O
in	O
all	O
the	O
B	cell_line
cell	cell_line
lines	cell_line
studied,	O
but	O
not	O
in	O
T	cell_type
cells	cell_type
.	O
In	O
particular	O
the	O
best	O
responder	cell_line
cell	cell_line
line	cell_line
was	O
the	O
Burkitt's	cell_line
cell	cell_line
line	cell_line
Namalwa	cell_line
.	O
The	O
activity	O
of	O
A-MYB	protein
in	O
B	O
and	O
not	O
T	O
cells	O
was	O
observed	O
when	O
either	O
an	O
artificial	O
construct	O
or	O
the	O
c-MYC	DNA
promoter	DNA
was	O
used	O
as	O
a	O
reporter.	O
Furthermore,	O
the	O
functional	protein
domains	protein
responsible	O
for	O
DNA	O
binding	O
,	O
transactivation	O
,	O
and	O
negative	O
regulation	O
,	O
previously	O
characterized	O
in	O
a	O
fibroblast	O
context	O
,	O
were	O
found	O
to	O
have	O
similar	O
activity	O
in	O
B	cell_type
cells	cell_type
.	O
The	O
region	O
of	O
A-MYB	protein
responsible	O
for	O
the	O
B	O
cell	O
specific	O
activity	O
was	O
defined	O
to	O
be	O
the	O
N-terminal	protein
218	protein
amino	protein
acids	protein
containing	O
the	O
DNA	protein
binding	protein
domain	protein
.	O
Finally,	O
a	O
110-kDa	protein
protein	protein
has	O
been	O
identified	O
in	O
the	O
nuclei	O
of	O
all	O
the	O
B	O
,	O
but	O
not	O
T	O
,	O
cell	O
lines	O
that	O
specifically	O
binds	O
to	O
this	O
A-MYB	protein
N-terminal	protein
domain	protein
.	O
We	O
hypothesize	O
that	O
this	O
110-kDa	protein
protein	protein
may	O
be	O
a	O
functionally	O
important	O
B	protein
cell-specific	protein
co-activator	protein
of	O
A-MYB	protein
.	O

Transcription	O
factor	O
Egr-1	protein
activity	O
down-regulates	O
Fas	O
and	O
CD23	O
expression	O
in	O
B	cell_type
cells	cell_type
.	O
Activation	O
of	O
mature	O
B	cell_type
cells	cell_type
via	O
Ag	protein
receptor	protein
cross-linking	O
induces	O
transient	O
expression	O
of	O
the	O
transcription	protein
factor	protein
Egr-1	protein
.	O
Although	O
the	O
activating	O
signals	O
leading	O
to	O
Egr-1	protein
induction	O
have	O
been	O
studied	O
extensively,	O
little	O
is	O
known	O
about	O
the	O
genes	O
that	O
are	O
placed	O
further	O
downstream	O
within	O
this	O
activation	O
cascade	O
and	O
that	O
are	O
transcriptionally	O
regulated	O
by	O
Egr-1	protein
.	O
To	O
identify	O
such	O
target	DNA
genes	DNA
,	O
we	O
established	O
Egr-1	cell_line
-overexpressing	cell_line
transfectants	cell_line
from	O
the	O
murine	cell_line
B	cell_line
cell	cell_line
line	cell_line
K46	cell_line
and	O
from	O
human	cell_line
Ramos	cell_line
B	cell_line
cells	cell_line
.	O
All	O
clones	O
derived	O
from	O
K46	cell_line
B	cell_line
cells	cell_line
showed	O
increased	O
expression	O
of	O
CD44	protein
.	O
Most	O
interestingly,	O
expression	O
of	O
CD95	protein
(	O
Fas	protein
/Apo-1	protein
)	O
and	O
of	O
CD23	protein
was	O
down-regulated	O
in	O
all	O
K46	cell_line
transfectants	cell_line
.	O
As	O
a	O
consequence,	O
they	O
became	O
resistant	O
to	O
apoptosis	O
induced	O
by	O
anti-CD95	protein
Ab	protein
treatment	O
.	O
Similarly,	O
the	O
Egr-1	cell_line
-expressing	cell_line
Ramos	cell_line
cells	cell_line
showed	O
reduced	O
levels	O
of	O
CD95	protein
expression	O
.	O
Thus,	O
Egr-1	protein
seems	O
to	O
control	O
the	O
expression	O
of	O
downstream	DNA
target	DNA
genes	DNA
not	O
only	O
as	O
a	O
transcriptional	O
activator,	O
but	O
also	O
as	O
a	O
repressor	protein
molecule	protein
.	O
In	O
B	cell_type
cells	cell_type
,	O
Egr-1	protein
therefore	O
plays	O
a	O
critical	O
role	O
in	O
integrating	O
the	O
short-lived	O
signal	O
delivered	O
by	O
triggering	O
of	O
the	O
Ag	protein
receptor	protein
into	O
phenotypic	O
changes,	O
including	O
repression	O
of	O
CD95	protein
and	O
CD23	protein
transcription	O
.	O

Regulation	O
of	O
NF-kappa	protein
B	protein
activity	O
by	O
I	O
kappa	O
B	O
alpha	O
and	O
I	O
kappa	O
B	O
beta	O
stability	O
.	O
Transcription	protein
factor	protein
NF-kappa	protein
B	protein
must	O
be	O
released	O
from	O
cytoplasmic	protein
inhibitory	protein
molecules	protein
(	O
I	protein
kappa	protein
Bs	protein
)	O
in	O
order	O
to	O
move	O
to	O
the	O
nucleus	O
and	O
to	O
activate	O
its	O
target	DNA
genes	DNA
.	O
Little	O
is	O
known	O
about	O
the	O
mechanisms	O
regulating	O
the	O
maintenance	O
of	O
constitutive	protein
nuclear	protein
NF-kappa	protein
B	protein
in	O
some	O
cell-types	O
and	O
of	O
sustained	O
nuclear	O
NF-kappa	protein
B	protein
activity	O
after	O
stimulation.	O
Increased	O
turnover	O
has	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
constitutive	O
NF-kappa	protein
B	protein
activity	O
in	O
mature	cell_type
B	cell_type
cells	cell_type
.	O
We	O
therefore	O
compared	O
the	O
turnover	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
and	O
I	protein
kappa	protein
B	protein
beta	protein
in	O
mature	cell_type
B	cell_type
cells	cell_type
and	O
HeLa	cell_line
cells	cell_line
.	O
Both	O
proteins	O
display	O
a	O
high	O
turnover	O
in	O
B	cell_type
cells	cell_type
although	O
I	protein
kappa	protein
B	protein
beta	protein
is	O
considerably	O
more	O
stable	O
than	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
The	O
half-life	O
of	O
both	O
inhibitors	O
is	O
increased	O
in	O
HeLa	cell_line
cells	cell_line
.	O
In	O
contrast,	O
all	O
other	O
NF-kappa	protein
B	protein
/I	O
kappa	O
B	O
molecules	O
tested	O
are	O
relatively	O
stable	O
in	O
both	O
cell-types.	O
The	O
elevated	O
turnover	O
of	O
endogenous	O
I	protein
kappa	protein
B	protein
alpha	protein
in	O
Namalwa	cell_type
cells	cell_type
is	O
inhibited	O
by	O
a	O
proteasome	O
inhibitor	O
and	O
thus	O
seems	O
to	O
be	O
driven	O
by	O
the	O
same	O
degradation	O
machinery	O
as	O
the	O
slower	O
turnover	O
in	O
non-B	cell_type
cells	cell_type
.	O
Furthermore,	O
we	O
investigated	O
the	O
processes	O
involved	O
in	O
persistent	O
activation	O
of	O
NF-kappa	protein
B	protein
.	O
TNF-alpha	O
signaling	O
leads	O
to	O
a	O
rapid	O
depletion	O
of	O
cellular	O
I	protein
kappa	protein
B	protein
beta	protein
pools	O
.	O
I	protein
kappa	protein
B	protein
alpha	protein
is	O
efficiently	O
resynthesized	O
whereas	O
I	protein
kappa	protein
B	protein
beta	protein
levels	O
stay	O
low	O
for	O
a	O
prolonged	O
time.	O
NF-kappa	protein
B	protein
binding	O
activity	O
can	O
be	O
detected	O
for	O
several	O
hours	O
after	O
stimulation.	O
We	O
found	O
that	O
removal	O
of	O
the	O
TNF-alpha	protein
containing	O
medium	O
causes	O
a	O
rapid	O
decrease	O
in	O
nuclear	protein
NF-kappa	protein
B	protein
.	O
A	O
phosphoform	O
of	O
newly	O
synthesized	O
I	protein
kappa	protein
B	protein
alpha	protein
is	O
visible	O
when	O
degradation	O
by	O
the	O
proteasome	protein
is	O
inhibited	O
and	O
new	O
I	protein
kappa	protein
B	protein
alpha	protein
displays	O
the	O
same	O
properties	O
regarding	O
phosphorylation	O
and	O
degradation	O
in	O
response	O
to	O
a	O
second	O
inducer.	O
There	O
is	O
no	O
significant	O
difference	O
in	O
the	O
turnover	O
of	O
pre-	O
and	O
post-inductive	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
These	O
observations	O
suggest	O
that	O
resynthesis	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
and	O
removal	O
of	O
the	O
stimulus	O
are	O
obligatory	O
steps	O
for	O
the	O
inactivation	O
of	O
nuclear	protein
NF	protein
kappa	protein
B	protein
.	O

Selection	O
of	O
a	O
diverse	O
TCR	protein
repertoire	protein
in	O
response	O
to	O
an	O
Epstein-Barr	protein
virus	protein
-encoded	protein
transactivator	protein
protein	protein
BZLF1	protein
by	O
CD8+	cell_type
cytotoxic	cell_type
T	cell_type
lymphocytes	cell_type
during	O
primary	O
and	O
persistent	O
infection.	O
We	O
investigated	O
the	O
CD8+	protein
cytotoxic	protein
T	protein
lymphocyte	protein
(CTL)	protein
repertoire	protein
to	O
an	O
HLA	O
B8-restricted	O
peptide	O
,	O
RAKFKQLLQ	O
,	O
located	O
in	O
the	O
Epstein-Barr	protein
virus	protein
(EBV)	protein
immediate-early	protein
protein	protein
,	O
BZLF1	protein
.	O
Repertoire	O
selection	O
was	O
monitored	O
by	O
determining	O
the	O
TCR	protein
beta	protein
chain	protein
sequences	protein
of	O
RAKFKQLLQ	cell_line
-specific	cell_line
CTL	cell_line
established	O
from	O
primary	O
infected	O
and	O
healthy	O
virus	O
carriers	O
.	O
PCR	O
analysis	O
of	O
spontaneous	cell_line
EBV	cell_line
-transformed	cell_line
lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
(	O
LCL	cell_line
)	O
from	O
three	O
individuals	O
with	O
primary	O
infection	O
showed	O
that	O
two	O
were	O
infected	O
with	O
type	O
A	O
and	O
one	O
with	O
type	O
B	O
EBV	O
.	O
Polyclonal	O
and	O
clonal	O
CTL	O
that	O
were	O
generated	O
by	O
stimulating	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
with	O
an	O
HLA	cell_line
B8+	cell_line
homozygous	cell_line
LCL	cell_line
lysed	cell_line
T	cell_line
cell	cell_line
blasts	cell_line
pulsed	O
with	O
the	O
peptide	O
,	O
RAKFKQLLQ	O
;	O
lysis	O
of	O
certain	O
HLA	O
B8+	O
LCL	O
targets	O
was	O
associated	O
with	O
the	O
abundance	O
of	O
BZLF1	RNA
transcripts	RNA
.	O
TCR	DNA
beta	DNA
analysis	O
showed	O
that	O
while	O
there	O
was	O
loop	O
length	O
restriction	O
in	O
the	O
putative	O
peptide	O
contact	O
site	O
of	O
all	O
responding	O
beta	protein
chains	protein
,	O
diverse	O
and	O
unique	cell_line
(non-recurrent)	cell_line
TCR	cell_line
beta	cell_line
clonotypes	cell_line
were	O
selected	O
in	O
individuals	O
during	O
primary	O
infection	O
and	O
continued	O
to	O
emerge	O
after	O
long-term	O
virus	O
exposure	O
.	O
TCR	protein
-contact	O
site	O
heterogeneity	O
was	O
excluded	O
as	O
the	O
selective	O
force	O
in	O
diversity	O
generation	O
since	O
the	O
epitope-encoded	O
sequences	O
were	O
found	O
to	O
be	O
identical	O
within	O
endogenous	O
virus	O
isolates	O
.	O
In	O
this	O
first	O
study	O
of	O
TCR	protein
repertoire	protein
selection	O
for	O
an	O
EBV	protein
lytic	protein
antigen	protein
,	O
a	O
BZLF1	protein
-reactive	O
component	O
of	O
diverse	O
clonotypes	O
was	O
identified	O
in	O
primary	O
type	O
A	O
or	O
type	O
B	O
EBV	O
infection	O
which	O
was	O
sustained	O
in	O
the	O
EBV	O
-specific	O
memory	O
response	O
throughout	O
life-long	O
infection	O
.	O
This	O
diversity	O
selection	O
is	O
likely	O
to	O
play	O
a	O
critical	O
role	O
in	O
maintaining	O
a	O
balanced	O
viral	O
load	O
throughout	O
EBV	O
persistence	O
.	O

Molecular	O
mechanisms	O
of	O
anoxia/reoxygenation-induced	O
neutrophil	O
adherence	O
to	O
cultured	cell_line
endothelial	cell_line
cells	cell_line
.	O
The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
(1)	O
determine	O
the	O
time	O
course	O
of	O
neutrophil	O
adhesion	O
to	O
monolayers	O
of	O
human	cell_line
umbilical	cell_line
vein	cell_line
endothelial	cell_line
cells	cell_line
(	O
HUVECs	cell_line
)	O
that	O
were	O
exposed	O
to	O
60	O
minutes	O
of	O
anoxia	O
followed	O
by	O
30	O
to	O
600	O
minutes	O
of	O
reoxygenation	O
and	O
(2)	O
define	O
the	O
mechanisms	O
responsible	O
for	O
both	O
the	O
early	O
(minutes)	O
and	O
late	O
(hours)	O
hyperadhesivity	O
of	O
postanoxic	cell_line
HUVECs	cell_line
to	O
human	cell_type
neutrophils	cell_type
.	O
The	O
results	O
clearly	O
demonstrate	O
that	O
anoxia	O
/reoxygenation	O
(	O
A/R	O
)	O
leads	O
to	O
a	O
biphasic	O
increase	O
in	O
neutrophil	O
adhesion	O
to	O
HUVECs	cell_line
,	O
with	O
peak	O
responses	O
occurring	O
at	O
30	O
minutes	O
(phase	O
1)	O
and	O
240	O
minutes	O
(phase	O
2)	O
after	O
reoxygenation	O
.	O
Oxypurinol	O
and	O
catalase	protein
inhibited	O
phase-1	O
adhesion	O
,	O
suggesting	O
a	O
role	O
for	O
xanthine	protein
oxidase	protein
and	O
H2O2	O
.	O
In	O
comparison,	O
platelet	protein
activating	protein
factor	protein
(	O
PAF	protein
)	O
contributed	O
to	O
both	O
phases	O
of	O
neutrophil	O
adhesion	O
.	O
Anti-intercellular	protein
adhesion	protein
molecule-1	protein
(	O
ICAM-1	protein
)	O
and	O
anti-P-selectin	protein
antibodies	protein
(	O
monoclonal	protein
antibodies	protein
[	O
mAbs	protein
])	O
attenuated	O
phase-1	O
neutrophil	O
adhesion	O
,	O
consistent	O
with	O
roles	O
for	O
constitutively	O
expressed	O
ICAM-1	protein
and	O
enhanced	O
surface	O
expression	O
of	O
preformed	O
P-selectin	protein
.	O
Phase-2	O
neutrophil	O
adhesion	O
was	O
attenuated	O
by	O
an	O
anti-E-selectin	protein
mAb	protein
,	O
indicating	O
a	O
dominant	O
role	O
of	O
this	O
adhesion	O
molecule	O
in	O
the	O
late	O
phase	O
response	O
.	O
Pretreatment	O
with	O
actinomycin	O
D	O
and	O
cycloheximide	O
or	O
with	O
competing	O
ds-oligonucleotides	O
containing	O
the	O
nuclear	protein
factor-kappa	protein
B	protein
or	O
activator	protein
protein-1	protein
cognate	DNA
DNA	DNA
sequences	DNA
significantly	O
attenuated	O
phase-2	O
response	O
,	O
suggesting	O
a	O
role	O
for	O
de	O
novo	O
macromolecule	O
synthesis	O
.	O
Surface	O
expression	O
of	O
ICAM-1	protein
,	O
P-selectin	protein
,	O
and	O
E-selectin	protein
on	O
HUVECs	cell_line
correlated	O
with	O
the	O
phase	O
-1	O
and	O
-2	O
neutrophil	O
adhesion	O
responses	O
.	O
Collectively,	O
these	O
findings	O
indicate	O
that	O
A/R	O
elicits	O
a	O
two-phase	O
neutrophil-endothelial	O
cell	O
adhesion	O
response	O
that	O
involves	O
transcription-independent	O
and	O
transcription-dependent	O
surface	O
expression	O
of	O
different	O
endothelial	protein
cell	protein
adhesion	protein
molecules	protein
.	O

Characterization	O
of	O
CD40	protein
signaling	O
determinants	O
regulating	O
nuclear	protein
factor-kappa	protein
B	protein
activation	O
in	O
B	cell_type
lymphocytes	cell_type
.	O
CD40	protein
signaling	O
to	O
B	cell_type
cells	cell_type
is	O
important	O
for	O
generating	O
an	O
effective	O
humoral	O
immune	O
response	O
.	O
CD40	protein
ligation	O
leads	O
to	O
B	O
cell	O
activation	O
events	O
such	O
as	O
proliferation	O
,	O
Ig	O
secretion	O
,	O
isotype	O
switching	O
,	O
and	O
up-regulation	O
of	O
cell	protein
surface	protein
molecules	protein
,	O
as	O
well	O
as	O
the	O
generation	O
of	O
memory	cell_type
B	cell_type
cells	cell_type
.	O
Many	O
of	O
these	O
events	O
are	O
dependent	O
upon	O
the	O
ability	O
of	O
CD40	protein
to	O
activate	O
the	O
transcription	O
factor	O
NF-kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
).	O
To	O
define	O
the	O
CD40	protein
signaling	O
components	O
upstream	O
of	O
NF-kappa	protein
B	protein
activation	O
and	O
the	O
functional	O
consequences	O
downstream	O
of	O
NF-kappa	protein
B	protein
activation	O
,	O
we	O
examined	O
mouse	cell_line
B	cell_line
cell	cell_line
transfectants	cell_line
expressing	O
wild-type	O
or	O
mutant	O
human	O
CD40	O
.	O
Analysis	O
of	O
CD40	protein
cytoplasmic	protein
domain	protein
truncation	O
and	O
point	O
mutants	O
defined	O
a	O
10-amino	protein
acid	protein
CD40	protein
cytoplasmic	protein
signaling	protein
determinant	protein
required	O
for	O
NF-kappa	protein
B	protein
activation	O
.	O
A	O
threonine	O
residue	O
at	O
position	protein
234	protein
,	O
previously	O
shown	O
to	O
be	O
important	O
for	O
CD40	protein
association	O
with	O
TNF	protein
receptor-associated	protein
factor	protein
2	protein
(	O
TRAF2	protein
),	O
TRAF3	protein
,	O
and	O
TRAF5	protein
,	O
was	O
not	O
required	O
for	O
NF-kappa	protein
B	protein
activation.	O
This	O
suggests	O
that	O
in	O
B	cell_type
cells	cell_type
,	O
CD40	protein
-induced	O
NF-kappa	protein
B	protein
activation	O
can	O
occur	O
independently	O
of	O
TRAF2	protein
and	O
TRAF5	protein
association.	O
NF-kappa	protein
B	protein
activation	O
was	O
independent	O
of	O
the	O
transmembrane	protein
domain	protein
of	O
CD40	protein
,	O
suggesting	O
that	O
it	O
is	O
independent	O
of	O
p23	protein
,	O
a	O
molecule	O
that	O
associates	O
with	O
CD40	protein
in	O
a	O
region	O
other	O
than	O
the	O
cytoplasmic	protein
domain	protein
.	O
Proteasome-dependent	O
inhibitory	O
kappa	O
B	O
alpha	O
(	O
I	protein
kappa	protein
B	protein
alpha	protein
)	O
and	O
I	protein
kappa	protein
B	protein
beta	protein
degradation	O
occurred	O
downstream	O
of	O
CD40	protein
ligation	O
and	O
preceded	O
CD40	protein
-mediated	O
NF-kappa	protein
B	protein
nuclear	O
translocation	O
.	O
CD40-	O
or	O
pervanadate-	O
mediated	O
I	O
kappa	O
B	O
tyrosine	O
phosphorylation	O
was	O
not	O
detected.	O
NF-kappa	protein
B	protein
activation	O
correlated	O
with	O
the	O
ability	O
of	O
CD40	protein
to	O
induce	O
Ab	O
secretion	O
and	O
the	O
up-regulation	O
of	O
ICAM-1	protein
and	O
LFA-1	protein
.	O
However,	O
NF-kappa	protein
B	protein
activation	O
was	O
insufficient	O
for	O
CD40	protein
-mediated	O
up-regulation	O
of	O
B7-1	protein
,	O
Fas	protein
,	O
and	O
CD23	protein
.	O

CD30	protein
-dependent	O
degradation	O
of	O
TRAF2	protein
:	O
implications	O
for	O
negative	O
regulation	O
of	O
TRAF	protein
signaling	O
and	O
the	O
control	O
of	O
cell	O
survival.	O
CD30	protein
is	O
a	O
cell-surface	protein
receptor	protein
that	O
can	O
augment	O
lymphocyte	O
activation	O
and	O
survival	O
through	O
its	O
ability	O
to	O
induce	O
the	O
transcription	protein
factor	protein
NF-kappaB	protein
.	O
CD30	protein
,	O
however,	O
has	O
also	O
been	O
implicated	O
in	O
the	O
induction	O
of	O
apoptotic	O
cell	O
death	O
of	O
lymphocytes	cell_type
.	O
Here	O
we	O
show	O
that	O
one	O
of	O
the	O
effects	O
of	O
CD30	protein
signal	O
transduction	O
is	O
to	O
render	O
cells	O
sensitive	O
to	O
apoptosis	O
induced	O
by	O
the	O
type	protein
1	protein
tumor	protein
necrosis	protein
factor	protein
receptor	protein
(	O
TNFR1	protein
).	O
This	O
sensitization	O
is	O
dependent	O
on	O
the	O
TRAF-binding	protein
sites	protein
within	O
the	O
CD30	protein
cytoplasmic	protein
domain	protein
.	O
One	O
of	O
the	O
proteins	O
that	O
binds	O
to	O
these	O
sites	O
is	O
TRAF2	protein
,	O
a	O
signal	protein
transduction	protein
molecule	protein
that	O
is	O
also	O
utilized	O
by	O
TNFR1	protein
to	O
mediate	O
the	O
activation	O
of	O
several	O
downstream	O
kinases	protein
and	O
transcription	protein
factors	protein
.	O
During	O
CD30	protein
signal	O
transduction	O
,	O
we	O
found	O
that	O
binding	O
of	O
TRAF2	protein
to	O
the	O
cytoplasmic	protein
domain	protein
of	O
CD30	protein
results	O
in	O
the	O
rapid	O
depletion	O
of	O
TRAF2	protein
and	O
the	O
associated	O
protein	O
TRAF1	protein
by	O
proteolysis.	O
These	O
data	O
suggest	O
a	O
model	O
in	O
which	O
CD30	protein
limits	O
its	O
own	O
ability	O
to	O
transduce	O
cell	O
survival	O
signals	O
through	O
signal-coupled	O
depletion	O
of	O
TRAF2	protein
.	O
Depletion	O
of	O
intracellular	O
TRAF2	protein
and	O
its	O
coassociated	protein
proteins	protein
also	O
increased	O
the	O
sensitivity	O
of	O
the	O
cell	O
to	O
undergoing	O
apoptosis	O
during	O
activation	O
of	O
death-inducing	protein
receptors	protein
such	O
as	O
TNFR1	protein
.	O
Consistent	O
with	O
this	O
hypothesis,	O
expression	O
of	O
a	O
dominant-negative	protein
form	protein
of	O
TRAF2	protein
was	O
found	O
to	O
potentiate	O
TNFR1	protein
-mediated	O
death	O
.	O
These	O
studies	O
provide	O
a	O
potential	O
mechanism	O
through	O
which	O
CD30	protein
,	O
as	O
well	O
as	O
other	O
TRAF-binding	protein
members	protein
of	O
the	O
TNFR	protein
superfamily	protein
,	O
can	O
negatively	O
regulate	O
cell	O
survival.	O

Analysis	O
of	O
myeloid-associated	DNA
genes	DNA
in	O
human	cell_type
hematopoietic	cell_type
progenitor	cell_type
cells	cell_type
.	O
The	O
distribution	O
of	O
myeloid	protein
lineage-associated	protein
cytokine	protein
receptors	protein
and	O
lysosomal	protein
proteins	protein
was	O
analyzed	O
in	O
human	cell_line
CD34+	cell_line
cord	cell_line
blood	cell_line
cell	cell_line
(CB)	cell_line
subsets	cell_line
at	O
different	O
stages	O
of	O
myeloid	O
commitment	O
by	O
reverse-transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
).	O
The	O
highly	O
specific	O
granulomonocyte-associated	protein
lysosomal	protein
proteins	protein
myeloperoxidase	protein
(	O
MPO	protein
)	O
and	O
lysozyme	protein
(	O
LZ	protein
),	O
as	O
well	O
as	O
the	O
transcription	protein
factor	protein
PU.1	protein
,	O
were	O
already	O
detectable	O
in	O
the	O
most	O
immature	O
CD34+Thy-1+	cell_line
subset	cell_line
.	O
Messenger	RNA
RNA	RNA
(	O
mRNA	RNA
)	O
levels	O
for	O
the	O
granulocyte-colony	protein
stimulating	protein
factor	protein
(	protein
G-CSF	protein
)	protein
receptor	protein
,	O
granulocyte-macrophage	protein
(GM)-CSF	protein
receptor	protein
alpha	protein
subunit	protein
and	O
tumor	O
necrosis	O
factor	O
(TNF)	O
receptors	O
I	O
(p55)	O
and	O
II	O
(p75)	O
were	O
also	O
detected	O
in	O
this	O
subset	O
in	O
addition	O
to	O
c-kit	protein
and	O
flt-3	protein
,	O
receptors	O
known	O
to	O
be	O
expressed	O
on	O
progenitor	cell_type
cells	cell_type
.	O
By	O
contrast,	O
the	O
monocyte-macrophage	protein
colony	protein
stimulating	protein
factor	protein
(M-CSF)	protein
receptor	protein
was	O
largely	O
absent	O
at	O
this	O
stage	O
and	O
in	O
the	O
CD34+Thy-1-CD45RA-	cell_line
subsets	cell_line
.	O
The	O
M-CSF	protein
receptor	protein
was	O
first	O
detectable	O
in	O
the	O
myeloid-committed	cell_line
CD34+Thy-l-CD45RA+	cell_line
subset	cell_line
.	O
All	O
other	O
molecules	O
studied	O
were	O
found	O
to	O
be	O
expressed	O
at	O
this	O
stage	O
of	O
differentiation.	O
Different	O
cocktails	O
of	O
the	O
identified	O
ligands	O
were	O
added	O
to	O
sorted	cell_line
CD34+Thy-1+	cell_line
single	cell_line
cells	cell_line
.	O
Low	O
proliferative	O
capacity	O
was	O
observed	O
after	O
1	O
week	O
in	O
culture	O
in	O
the	O
presence	O
of	O
stem	protein
cell	protein
factor	protein
(	O
SCF	protein
)	O
+	O
Flt-3	protein
ligand	protein
(	O
FL	protein
)	O
+	O
G-CSF	protein
.	O
Addition	O
of	O
GM-CSF	protein
to	O
this	O
basic	O
cocktail	O
consistently	O
increased	O
the	O
clonogenic	O
capacity	O
of	O
single	cell_line
CD34+Thy-1+	cell_line
cells	cell_line
,	O
and	O
this	O
effect	O
was	O
further	O
enhanced	O
(up	O
to	O
72.3	O
+/-	O
4.3%	O
on	O
day	O
7)	O
by	O
the	O
inclusion	O
of	O
TNF-alpha	protein
.	O
In	O
conclusion,	O
the	O
presence	O
of	O
myeloid-associated	RNA
growth	RNA
factor	RNA
receptor	RNA
transcripts	RNA
in	O
CD34+	cell_line
CB	cell_line
subsets	cell_line
does	O
not	O
discriminate	O
the	O
various	O
stages	O
of	O
differentiation	O
,	O
with	O
the	O
exception	O
of	O
the	O
M-CSF	protein
receptor	protein
.	O
In	O
addition,	O
we	O
show	O
that	O
TNF-alpha	protein
is	O
a	O
potent	O
costimulatory	O
factor	O
of	O
the	O
very	O
immature	cell_line
CD34+Thy-1+	cell_line
CB	cell_line
subset	cell_line
.	O

Induction	O
of	O
endothelial	protein
cell	protein
surface	protein
adhesion	protein
molecules	protein
by	O
tumor	protein
necrosis	protein
factor	protein
is	O
blocked	O
by	O
protein	O
tyrosine	O
phosphatase	O
inhibitors	O
:	O
role	O
of	O
the	O
nuclear	protein
transcription	protein
factor	protein
NF-kappa	protein
B	protein
.	O
Recent	O
studies	O
from	O
our	O
laboratory	O
have	O
indicated	O
that	O
protein	protein
tyrosine	protein
phosphatase	protein
(	O
PTPase	protein
)	O
inhibitors	O
can	O
down-modulate	O
the	O
tumor	protein
necrosis	protein
factor	protein
(	O
TNF	protein
)-mediated	O
activation	O
of	O
the	O
nuclear	protein
transcription	protein
factor	protein
NF-kappa	protein
B	protein
in	O
ML-1a	cell_line
,	O
a	O
monocytic	cell_line
cell	cell_line
line	cell_line
(Singh	O
and	O
Aggarwal,	O
J.	O
Biol.	O
Chem.	O
1995:	O
270:	O
10631).	O
Since	O
TNF	protein
is	O
one	O
of	O
the	O
major	O
inducers	O
of	O
various	O
adhesion	protein
molecules	protein
in	O
human	O
endothelial	O
cells	O
and	O
their	O
expression	O
is	O
known	O
to	O
require	O
the	O
activation	O
of	O
NF-kappa	protein
B	protein
,	O
we	O
examined	O
the	O
effect	O
of	O
PTPase	protein
inhibitors	O
on	O
the	O
TNF	protein
-mediated	O
induction	O
of	O
intracellular	protein
adhesion	protein
molecule	protein
(ICAM)-1	protein
,	O
vascular	protein
cell	protein
adhesion	protein
molecule	protein
(VCAM)-1	protein
and	O
endothelial	protein
leukocyte	protein
adhesion	protein
molecule	protein
(ELAM)-1	protein
.	O
Like	O
ML-1a	cell_line
,	O
human	cell_line
dermal	cell_line
microvessel	cell_line
endothelial	cell_line
cells	cell_line
(	O
MVEC	cell_line
)	O
treated	O
with	O
TNF	protein
rapidly	O
activated	O
(within	O
30	O
min)	O
NF-kappa	protein
B	protein
;	O
this	O
effect	O
was	O
completely	O
abolished	O
by	O
co-treatment	O
with	O
phenylarsine	O
oxide	O
(	O
PAO	O
),	O
a	O
specific	O
inhibitor	O
of	O
PTPase	protein
.	O
The	O
induction	O
of	O
ICAM-1	protein
,	O
VCAM-1	protein
,	O
and	O
ELAM-1	protein
by	O
TNF	protein
in	O
MVEC	cell_line
occurred	O
within	O
6	O
h	O
and	O
was	O
also	O
completely	O
down-regulated	O
by	O
PAO	O
in	O
a	O
dose-dependent	O
manner.	O
PAO	O
was	O
found	O
to	O
be	O
effective	O
even	O
when	O
added	O
3	O
h	O
after	O
TNF	protein
,	O
suggesting	O
a	O
rapid	O
mode	O
of	O
action	O
of	O
this	O
inhibitor.	O
Besides	O
PAO	O
,	O
other	O
inhibitors	O
of	O
PTPase	protein
,	O
including	O
pervanadate	O
and	O
diamide,	O
also	O
blocked	O
TNF	protein
-dependent	O
NF-kappa	protein
B	protein
activation	O
and	O
induction	O
of	O
all	O
the	O
three	O
adhesion	protein
proteins	protein
.	O
Consistent	O
with	O
these	O
results,	O
the	O
attachment	O
of	O
monocytes	O
to	O
MVEC	cell_line
was	O
also	O
blocked	O
by	O
the	O
PTPase	protein
inhibitors	O
.	O
Thus,	O
overall,	O
our	O
results	O
demonstrate	O
that	O
a	O
PTPase	protein
is	O
involved	O
either	O
directly	O
or	O
indirectly	O
in	O
the	O
pathway	O
leading	O
to	O
the	O
induction	O
of	O
endothelial	protein
cell	protein
adhesion	protein
molecules	protein
by	O
TNF	protein
.	O
Because	O
of	O
their	O
role	O
in	O
cell	O
adhesion	O
,	O
PTPase	protein
may	O
provide	O
a	O
novel	O
target	O
of	O
drug	O
development	O
for	O
treatment	O
of	O
inflammation	O
,	O
atherogenesis	O
,	O
and	O
tumor	O
metastasis	O
.	O

Regulation	O
of	O
nuclear	protein
factor-kappa	protein
B	protein
and	O
its	O
inhibitor	O
I	protein
kappa	protein
B-alpha/MAD-3	protein
in	O
monocytes	cell_type
by	O
Mycobacterium	O
tuberculosis	O
and	O
during	O
human	O
tuberculosis	O
.	O
Blood	cell_type
monocytes	cell_type
from	O
patients	O
with	O
active	O
tuberculosis	O
are	O
activated	O
in	O
vivo,	O
as	O
evidenced	O
by	O
an	O
increase	O
in	O
the	O
stimulated	O
release	O
of	O
proinflammatory	protein
cytokines	protein
,	O
such	O
as	O
TNF	protein
-alpha	protein
,	O
and	O
the	O
spontaneous	O
expression	O
of	O
IL-2R	protein
.	O
Further,	O
monocytes	cell_type
from	O
patients	O
demonstrate	O
an	O
augmented	O
susceptibility	O
to	O
a	O
productive	O
infection	O
with	O
HIV-1	O
in	O
vitro.	O
Mycobacterium	O
tuberculosis	O
and	O
its	O
components	O
are	O
strong	O
signals	O
to	O
activate	O
monocytes	cell_type
to	O
production	O
of	O
cytokines	protein
.	O
In	O
this	O
study	O
we	O
examined	O
the	O
basis	O
of	O
activation	O
of	O
monocytes	cell_type
during	O
active	O
tuberculosis	O
and	O
by	O
M.	O
tuberculosis	O
.	O
We	O
found	O
a	O
constitutive	O
degradation	O
of	O
I	protein
kappa	protein
B-alpha	protein
,	O
the	O
major	O
cytoplasmic	protein
inhibitor	protein
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
),	O
in	O
freshly	O
isolated	O
PBMC	cell_type
and	O
monocytes	cell_type
from	O
patients	O
with	O
tuberculosis.	O
In	O
contrast,	O
I	protein
kappa	protein
B-alpha	protein
levels	O
in	O
PBMC	cell_type
and	O
monocytes	cell_type
from	O
healthy	O
subjects	O
or	O
from	O
patients	O
with	O
nontuberculous	O
pulmonary	O
conditions	O
were	O
intact.	O
Further,	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
NF-kappa	protein
B	protein
was	O
activated	O
in	O
monocytes	cell_type
from	O
tuberculous	O
patients	O
.	O
The	O
expression	O
of	O
I	protein
kappa	protein
B-alpha	protein
gene,	O
which	O
is	O
responsive	O
to	O
activation	O
by	O
NF-kappa	protein
B	protein
,	O
was	O
up-regulated	O
in	O
PBMC	cell_type
and	O
monocytes	cell_type
from	O
patients	O
,	O
but	O
not	O
in	O
mononuclear	cell_type
cells	cell_type
from	O
healthy	O
subjects	O
or	O
those	O
with	O
nontuberculous	O
lung	O
diseases	O
.	O
By	O
contrast,	O
the	O
expression	O
of	O
other	O
adherence-associated	DNA
early	DNA
genes	DNA
,	O
such	O
as	O
IL-8	protein
and	O
IL-1	protein
beta	protein
,	O
was	O
not	O
up-regulated	O
in	O
PBMC	cell_type
of	O
tuberculous	O
patients	O
.	O
Further,	O
M.	O
tuberculosis	O
and	O
its	O
tuberculin	protein
,	O
purified	protein
protein	protein
derivative	protein
,	O
induced	O
the	O
degradation	O
of	O
I	protein
kappa	protein
B-alpha	protein
and	O
the	O
expression	O
of	O
I	RNA
kappa	RNA
B-alpha	RNA
mRNA	RNA
,	O
and	O
purified	O
protein	O
derivative	O
induced	O
the	O
activation	O
of	O
NF-kappa	protein
B	protein
in	O
monocytes	cell_type
.	O

Cooperation	O
of	O
Spi-1/	protein
PU.1	protein
with	O
an	O
activated	protein
erythropoietin	protein
receptor	protein
inhibits	O
apoptosis	O
and	O
Epo	protein
-dependent	O
differentiation	O
in	O
primary	cell_type
erythroblasts	cell_type
and	O
induces	O
their	O
Kit	O
ligand-dependent	O
proliferation	O
.	O
Spi-1/	protein
PU.1	protein
is	O
a	O
myeloid-	protein
and	protein
B-cell	protein
specific	protein
transcription	protein
factor	protein
which	O
is	O
also	O
involved	O
in	O
Friend	O
virus	O
-induced	O
murine	O
erythroleukemia	O
.	O
The	O
pre-leukemic	O
phase	O
of	O
Friend	O
erythroleukemia	O
results	O
from	O
activation	O
of	O
the	O
erythropoietin	protein
receptor	protein
(	O
EpoR	protein
)	O
by	O
the	O
spleen	protein
focus	protein
forming	protein
virus	protein
(SFFV)	protein
envelope	protein
glycoprotein	protein
,	O
followed	O
by	O
the	O
emergence	O
of	O
leukemic	O
clones	O
characterized	O
by	O
overexpression	O
of	O
Spi-1	protein
and	O
mutation	O
of	O
the	O
p53	DNA
tumor	DNA
suppressor	DNA
gene	DNA
.	O
We	O
developed	O
a	O
heterologous	O
system	O
to	O
analyze	O
the	O
contribution	O
of	O
these	O
alterations	O
to	O
the	O
induction	O
of	O
primary	O
erythroblast	O
transformation	O
.	O
Avian	cell_type
erythroblasts	cell_type
expressing	O
the	O
activated	protein
mouse	protein
EpoR	protein
(R129C)	protein
differentiated	O
into	O
erythrocytes	cell_type
in	O
response	O
to	O
hEpo	protein
.	O
Expression	O
of	O
Spi-1	protein
in	O
these	O
cells	O
inhibited	O
this	O
ability	O
to	O
differentiate	O
and	O
rescued	O
the	O
cells	O
from	O
the	O
apoptotic	O
cell	O
death	O
program	O
normally	O
induced	O
upon	O
hEpo	protein
withdrawal.	O
Although	O
devoid	O
of	O
any	O
effect	O
by	O
itself,	O
a	O
mutant	protein
p53	protein
cooperated	O
with	O
Spi-1	protein
and	O
EpoR	protein
(R129C)	protein
to	O
reinforce	O
both	O
phenotypes.	O
Analysis	O
of	O
erythroblasts	O
co-expressing	O
Spi-1	protein
and	O
the	O
wild-type	protein
mouse	protein
EpoR	protein
showed	O
that	O
differentiation	O
arrest	O
and	O
inhibition	O
of	O
apoptosis	O
depended	O
on	O
specific	O
cooperation	O
between	O
Spi-1	protein
and	O
EpoR	protein
(R129C)	protein
.	O
This	O
cooperation	O
was	O
also	O
required	O
to	O
induce	O
the	O
sustained	O
proliferation	O
of	O
differentiation-blocked	cell_line
erythroblasts	cell_line
in	O
response	O
to	O
ligand	O
activation	O
of	O
the	O
endogenous	protein
tyrosine	protein
kinase	protein
receptor	protein
c-Kit	protein
.	O
These	O
results	O
show	O
that	O
Spi-1/	O
PU.1	protein
requires	O
signals	O
emanating	O
from	O
specific	O
cytokine	O
and	O
growth	O
factor	O
receptors	O
to	O
affect	O
the	O
survival,	O
proliferation	O
and	O
differentiation	O
control	O
of	O
primary	cell_type
erythroblasts	cell_type
.	O
They	O
also	O
suggest	O
that	O
the	O
function	O
of	O
Spi-1	protein
/PU.1	protein
in	O
the	O
late	O
phase	O
of	O
Friend	O
leukemia	O
requires	O
specific	O
signaling	O
from	O
the	O
gp55	protein
-modified	protein
EpoR	protein
generated	O
during	O
the	O
early	O
phase	O
of	O
the	O
disease.	O

The	O
role	O
of	O
Rel/	protein
NF-kappa	protein
B	protein
proteins	protein
in	O
viral	O
oncogenesis	O
and	O
the	O
regulation	O
of	O
viral	O
transcription	O
.	O
Rel	protein
/NF-kappa	protein
B	protein
is	O
a	O
ubiquitous	protein
transcription	protein
factor	protein
that	O
consists	O
of	O
multiple	protein
polypeptide	protein
subunits	protein
,	O
and	O
is	O
subject	O
to	O
complex	O
regulatory	O
mechanisms	O
that	O
involve	O
protein-protein	O
interactions	O
,	O
phosphorylation	O
,	O
ubiquitination	O
,	O
proteolytic	O
degradation	O
,	O
and	O
nucleocytoplasmic	O
translocation	O
.	O
The	O
sophisticated	O
control	O
of	O
Rel	protein
/NF-kappa	protein
B	protein
activity	O
is	O
not	O
surprising	O
since	O
this	O
transcription	protein
factor	protein
is	O
involved	O
in	O
a	O
wide	O
array	O
of	O
cellular	O
responses	O
to	O
extracellular	O
cues,	O
associated	O
with	O
growth,	O
development,	O
apoptosis	O
,	O
and	O
pathogen	O
invasion	O
.	O
Thus,	O
it	O
is	O
not	O
unexpected	O
that	O
this	O
versatile	O
cellular	O
homeostatic	O
switch	O
would	O
be	O
affected	O
by	O
a	O
variety	O
of	O
viral	O
pathogens,	O
which	O
have	O
evolved	O
mechanisms	O
to	O
utilize	O
various	O
aspects	O
of	O
Rel	protein
/NF-kappa	protein
B	protein
activity	O
to	O
facilitate	O
their	O
replication,	O
cell	O
survival	O
and	O
possibly	O
evasion	O
of	O
immune	O
responses	O
.	O
This	O
review	O
will	O
cover	O
the	O
molecular	O
mechanisms	O
that	O
are	O
utilized	O
by	O
mammalian	O
oncogenic	O
viruses	O
to	O
affect	O
the	O
activity	O
of	O
Rel/	protein
NF-kappa	protein
B	protein
transcription	protein
factors	protein
and	O
the	O
role	O
of	O
Rel	protein
/NF-kappa	protein
B	protein
in	O
the	O
regulation	O
of	O
viral	O
gene	O
expression	O
and	O
replication	O
.	O

Cellular	O
and	O
molecular	O
mechanisms	O
of	O
IL-5	protein
synthesis	O
in	O
atopic	O
diseases	O
:	O
a	O
study	O
with	O
allergen-specific	cell_line
human	cell_line
helper	cell_line
T	cell_line
cells	cell_line
.	O
BACKGROUND:	O
Cytokines	protein
produced	O
by	O
helper	cell_type
T	cell_type
cells	cell_type
are	O
intimately	O
involved	O
in	O
chronic	O
allergic	O
diseases	O
associated	O
with	O
eosinophilic	O
inflammation	O
.	O
OBJECTIVE:	O
We	O
investigated	O
the	O
production	O
of	O
IL-5	protein
,	O
a	O
potent	O
growth	O
factor	O
and	O
chemotactic	O
factor	O
for	O
eosinophils	cell_type
,	O
by	O
CD4+	cell_type
T	cell_type
lymphocytes	cell_type
in	O
patients	O
with	O
asthma	O
.	O
METHODS:	O
Allergen-specific	cell_line
T	cell_line
cell	cell_line
clones	cell_line
and	O
T	cell_line
cell	cell_line
hybridomas	cell_line
were	O
established	O
from	O
the	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
of	O
patients	O
with	O
asthma	O
,	O
and	O
the	O
responses	O
to	O
various	O
stimuli	O
were	O
determined.	O
RESULTS:	O
After	O
nonspecific	O
stimulation,	O
IL-5	protein
production	O
by	O
CD4+	cell_type
T	cell_type
cells	cell_type
from	O
both	O
atopic	O
and	O
nonatopic	O
subjects	O
with	O
asthma	O
was	O
significantly	O
enhanced	O
compared	O
with	O
that	O
by	O
cells	O
from	O
healthy	O
controls	O
.	O
Peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
from	O
atopic	O
asthma	O
patients	O
both	O
proliferated	O
and	O
produced	O
IL-5	protein
after	O
incubation	O
with	O
mite	O
allergen,	O
suggesting	O
that	O
mite-specific	cell_type
helper	cell_type
T	cell_type
cells	cell_type
were	O
involved	O
in	O
the	O
eosinophilic	O
inflammation	O
of	O
atopic	O
asthma	O
.	O
A	O
human	O
IL-5	DNA
promoter/enhancer	DNA
luciferase	DNA
gene	DNA
construct	DNA
transfected	O
into	O
IL-5	cell_line
-producing	cell_line
T	cell_line
cell	cell_line
clones	cell_line
was	O
clearly	O
transcribed	O
after	O
stimulation,	O
indicating	O
that	O
the	O
515	O
base	O
pair	O
IL-5	DNA
gene	DNA
segment	DNA
upstream	O
of	O
the	O
coding	O
region	O
was	O
sufficient	O
to	O
respond	O
to	O
activating	O
signals	O
in	O
human	O
helper	cell_type
T	cell_type
cells	cell_type
.	O
The	O
same	O
gene	O
segment	O
was	O
not	O
transcribed	O
in	O
IL-5	cell_line
-nonproducing	cell_line
T	cell_line
cell	cell_line
clones	cell_line
,	O
suggesting	O
that	O
human	O
T	O
cell	O
IL-5	protein
synthesis	O
is	O
regulated	O
at	O
the	O
transcriptional	O
level	O
.	O
Experiments	O
with	O
T	cell_line
cell	cell_line
hybridomas	cell_line
confirmed	O
these	O
findings	O
and	O
suggested	O
that	O
a	O
unique	protein
transcription	protein
factor	protein
may	O
be	O
essential	O
for	O
human	O
IL-5	protein
gene	O
transcription	O
.	O
CONCLUSION:	O
Enhanced	O
IL-5	protein
production	O
by	O
helper	cell_type
T	cell_type
cells	cell_type
seems	O
to	O
cause	O
the	O
eosinophilic	O
inflammation	O
of	O
both	O
atopic	O
and	O
nonatopic	O
asthma	O
.	O
Elucidation	O
of	O
IL-5	protein
-specific	O
regulatory	O
mechanisms	O
may	O
facilitate	O
the	O
development	O
of	O
novel	O
treatments	O
for	O
allergic	O
diseases	O
associated	O
with	O
eosinophilic	O
inflammation	O
.	O

Cyclosporin	O
A	O
inhibits	O
monocyte	O
tissue	protein
factor	protein
activation	O
in	O
cardiac	O
transplant	O
recipients	O
.	O
BACKGROUND:	O
Fibrin	O
deposition	O
and	O
thrombosis	O
have	O
been	O
implicated	O
in	O
both	O
allograft	O
rejection	O
and	O
vasculopathy	O
after	O
cardiac	O
transplantation	O
.	O
Because	O
monocytes	cell_type
play	O
a	O
pivotal	O
role	O
in	O
the	O
pathophysiology	O
of	O
intravascular	O
coagulation	O
activation	O
through	O
their	O
ability	O
to	O
synthesize	O
tissue	protein
factor	protein
(	O
TF	protein
),	O
we	O
asked	O
(1)	O
whether	O
monocyte	O
TF	protein
activation	O
occurs	O
in	O
cardiac	O
transplant	O
recipients	O
and	O
(2)	O
whether	O
monocyte	O
TF	protein
expression	O
is	O
affected	O
by	O
treatment	O
with	O
cyclosporin	O
A	O
(	O
CsA	O
).	O
METHODS	O
AND	O
RESULTS:	O
We	O
measured	O
levels	O
of	O
TF	protein
activity	O
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
and	O
highly	cell_type
purified	cell_type
monocytes	cell_type
/macrophages	cell_type
from	O
10	O
consecutive	O
cardiac	O
transplant	O
recipients	O
and	O
10	O
healthy	O
control	O
subjects	O
.	O
TF	protein
activity	O
generated	O
by	O
both	O
unstimulated	cell_line
and	O
endotoxin-stimulated	cell_line
cells	cell_line
was	O
significantly	O
higher	O
in	O
transplant	O
recipients	O
than	O
in	O
control	O
subjects	O
(P&lt;.05).	O
Increased	O
monocyte	O
TF	protein
expression	O
in	O
transplant	O
recipients	O
was	O
shown	O
to	O
be	O
adversely	O
affected	O
by	O
treatment	O
with	O
CsA	O
:	O
TF	protein
induction	O
was	O
markedly	O
reduced	O
by	O
CsA	O
serum	O
concentrations	O
reaching	O
peak	O
CsA	O
drug	O
levels	O
.	O
Inhibition	O
of	O
TF	protein
induction	O
in	O
the	O
presence	O
of	O
high	O
CsA	O
blood	O
concentrations	O
was	O
also	O
observed	O
when	O
stimulation	O
of	O
cells	O
was	O
performed	O
with	O
interferon-gamma	protein
or	O
interleukin-1beta	protein
.	O
As	O
shown	O
by	O
reverse	O
transcription-polymerase	O
chain	O
reaction	O
and	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
respectively,	O
treatment	O
with	O
CsA	O
leads	O
to	O
decreased	O
TF	RNA
mRNA	RNA
expression	O
and	O
reduced	O
activation	O
of	O
the	O
NF-kappaB	protein
transcription	protein
factor	protein
,	O
which	O
is	O
known	O
to	O
contribute	O
to	O
the	O
induction	O
of	O
the	O
TF	DNA
promotor	DNA
in	O
human	cell_type
monocytes	cell_type
.	O
CONCLUSIONS:	O
This	O
study	O
demonstrates	O
that	O
TF	protein
activation	O
,	O
occurring	O
in	O
mononuclear	cell_type
cells	cell_type
of	O
cardiac	O
transplant	O
recipients	O
,	O
is	O
inhibited	O
by	O
treatment	O
with	O
CsA	O
.	O
Inhibition	O
of	O
monocyte	O
TF	protein
induction	O
by	O
CsA	O
may	O
contribute	O
to	O
its	O
successful	O
use	O
in	O
cardiac	O
transplant	O
medicine	O
and	O
might	O
be	O
useful	O
in	O
managing	O
further	O
settings	O
of	O
vascular	O
pathology	O
also	O
known	O
to	O
involve	O
TF	protein
expression	O
and	O
NF-kappaB	protein
activation	O
.	O

IL-2	protein
and	O
IL-7	protein
induce	O
heterodimerization	O
of	O
STAT5	protein
isoforms	protein
in	O
human	cell_type
peripheral	cell_type
blood	cell_type
T	cell_type
lymphoblasts	cell_type
.	O
Despite	O
differences	O
in	O
T	O
cell	O
responses	O
induced	O
by	O
interleukin	protein
(IL)-2	protein
and	O
IL-7	protein
,	O
both	O
cytokines	protein
modulate	O
T	O
cell	O
functions	O
by	O
activation	O
of	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(STAT)	protein
proteins	protein
.	O
We	O
examined	O
the	O
contribution	O
of	O
the	O
two	O
isoforms	O
of	O
STAT5	protein
,	O
STAT5A	protein
and	O
STAT5B	protein
,	O
to	O
IL-2-	O
and	O
IL-7-	O
induced	O
activation	O
of	O
human	cell_type
peripheral	cell_type
blood	cell_type
T	cell_type
lymphoblasts	cell_type
.	O
Both	O
cytokines	protein
induced	O
assembly	O
of	O
STAT5A	protein
and	O
STAT5B	protein
containing	O
complexes	O
capable	O
of	O
binding	O
to	O
the	O
interferon-gamma	DNA
activation	DNA
sequence	DNA
(	O
GAS	DNA
),	O
and	O
these	O
complexes	O
rapidly	O
translocated	O
(within	O
1	O
min)	O
into	O
the	O
nucleus	O
of	O
IL-2-	O
or	O
IL-7-	O
treated	O
cells	O
.	O
The	O
kinetics	O
of	O
this	O
translocation	O
were	O
delayed	O
in	O
IL-7	cell_line
-treated	cell_line
as	O
compared	O
to	O
IL-2	cell_line
-treated	cell_line
cells	cell_line
.	O
IL-2	protein
and	O
IL-7	protein
were	O
equivalent	O
in	O
their	O
ability	O
to	O
induce	O
tyrosine	O
phosphorylation	O
of	O
STAT5A	protein
and	O
STAT5B	protein
and	O
to	O
facilitate	O
binding	O
of	O
these	O
STATs	protein
to	O
an	O
immobilized	DNA
GAS	DNA
element	DNA
.	O
Both	O
IL-2	protein
and	O
IL-7	protein
induced	O
substantial	O
amounts	O
of	O
STAT5A	protein
/STAT5B	protein
heterodimerization	O
.	O
Moreover,	O
we	O
observed	O
constitutive	O
association	O
of	O
STAT3	protein
with	O
each	O
STAT5	protein
isomer	protein
.	O
These	O
data	O
suggest	O
that	O
IL-2	protein
and	O
IL-7	protein
induce	O
assembly	O
of	O
STAT	protein
heterodimers	protein
in	O
a	O
similar	O
manner	O
and	O
that	O
subsequent	O
cellular	O
responses	O
may	O
be	O
driven	O
by	O
induction	O
of	O
similar	O
sets	O
of	O
genes	DNA
.	O

Transcription	protein
factor	protein
NF-kappaB	protein
regulates	O
inducible	O
Oct-2	DNA
gene	DNA
expression	O
in	O
precursor	cell_type
B	cell_type
lymphocytes	cell_type
.	O
The	O
POU	protein
transcription	protein
factors	protein
Oct-1	protein
and	O
Oct-2	protein
regulate	O
the	O
activity	O
of	O
octamer-dependent	DNA
promoters	DNA
,	O
including	O
those	O
that	O
direct	O
transcription	O
from	O
rearranged	O
immunoglobulin	protein
genes	protein
.	O
Unlike	O
Oct-1	protein
,	O
which	O
is	O
constitutively	O
expressed	O
in	O
many	O
cell	O
types,	O
Oct-2	protein
expression	O
is	O
restricted	O
primarily	O
to	O
B	cell_type
lymphocytes	cell_type
and	O
can	O
be	O
induced	O
in	O
precursor	cell_type
B	cell_type
cells	cell_type
by	O
stimulation	O
with	O
bacterial	O
lipopolysaccharide	O
(	O
LPS	O
).	O
However,	O
the	O
precise	O
factors	O
that	O
mediate	O
this	O
induction	O
mechanism	O
remain	O
unknown.	O
In	O
the	O
present	O
study,	O
we	O
monitored	O
Oct-2	protein
expression	O
in	O
cells	O
arrested	O
for	O
the	O
activation	O
of	O
NF-kappaB	protein
,	O
an	O
LPS	protein
-responsive	protein
member	protein
of	O
the	O
Rel	protein
transcription	protein
factor	protein
family	protein
.	O
Despite	O
stimulation	O
with	O
LPS	O
,	O
disruption	O
of	O
the	O
NF-kappaB	protein
signaling	O
pathway	O
in	O
precursor	cell_type
B	cell_type
cells	cell_type
led	O
to	O
the	O
loss	O
of	O
inducible	O
Oct-2	protein
DNA	O
binding	O
activity	O
in	O
vitro	O
and	O
the	O
suppression	O
of	O
Oct-2	protein
-directed	O
transcription	O
in	O
vivo.	O
This	O
biochemical	O
defect	O
correlated	O
with	O
a	O
specific	O
block	O
to	O
Oct-2	DNA
gene	DNA
expression	O
at	O
the	O
level	O
of	O
transcription,	O
whereas	O
the	O
expression	O
of	O
Oct-1	protein
was	O
unaffected.	O
The	O
finding	O
that	O
Oct-2	protein
is	O
under	O
NF-kappaB	protein
control	O
highlights	O
an	O
important	O
cross-talk	O
mechanism	O
involving	O
two	O
distinct	O
transcription	protein
factor	protein
families	protein
that	O
regulate	O
B	cell_type
lymphocyte	cell_type
function	O
.	O

Suppression	O
of	O
MHC	protein
class	protein
II	protein
expression	O
by	O
human	DNA
class	DNA
II	DNA
trans-activator	DNA
constructs	DNA
lacking	O
the	O
N-terminal	protein
domain	protein
.	O
The	O
class	protein
II	protein
trans-activator	protein
(	O
CIITA	protein
)	O
is	O
a	O
bi-	protein
or	protein
multi-functional	protein
domain	protein
protein	protein
which	O
plays	O
a	O
critical	O
role	O
in	O
the	O
expression	O
of	O
MHC	DNA
class	DNA
II	DNA
genes	DNA
.	O
We	O
report	O
that	O
removal	O
of	O
the	O
N-terminal	protein
151	protein
amino	protein
acids	protein
,	O
encompassing	O
all	O
of	O
the	O
acidic	protein
domain	protein
but	O
leaving	O
intact	O
the	O
proline	protein
/	protein
serine	protein
/	protein
threonine	protein
-rich	protein
domain	protein
,	O
results	O
in	O
a	O
mutant	O
protein	O
with	O
potent	O
suppressive	O
properties	O
for	O
MHC	protein
class	protein
II	protein
expression	O
.	O
HeLa	cell_line
cells	cell_line
stably	O
or	O
transiently	O
transfected	O
with	O
mutant	DNA
CIITA	DNA
constructs	DNA
showed	O
up	O
to	O
99%	O
suppression	O
of	O
MHC	protein
class	protein
II	protein
antigen	O
induction	O
by	O
IFN-gamma	protein
and	O
marked	O
suppression	O
of	O
HLA-DRA	RNA
mRNA	RNA
expression	O
.	O
Transient	O
transfection	O
of	O
a	O
B	O
lymphoma	O
line	O
resulted	O
in	O
up	O
to	O
89%	O
reduction	O
of	O
constitutive	O
MHC	protein
class	protein
II	protein
expression	O
within	O
5	O
days	O
and	O
suppression	O
of	O
HLA-DRA	RNA
mRNA	RNA
synthesis	O
.	O

Helenalin	O
,	O
an	O
anti-inflammatory	O
sesquiterpene	O
lactone	O
from	O
Arnica	O
,	O
selectively	O
inhibits	O
transcription	protein
factor	protein
NF-kappaB	protein
[see	O
comments]	O
Alcoholic	O
extracts	O
prepared	O
form	O
Arnicae	O
flos	O
,	O
the	O
collective	O
name	O
for	O
flowerheads	O
from	O
Arnica	O
montana	O
and	O
A.	O
chamissonis	O
ssp.	O
foliosa,	O
are	O
used	O
therapeutically	O
as	O
anti-inflammatory	O
remedies	O
.	O
The	O
active	O
ingredients	O
mediating	O
the	O
pharmacological	O
effect	O
are	O
mainly	O
sesquiterpene	O
lactones	O
,	O
such	O
as	O
helenalin	O
,	O
11alpha,13-dihydrohelenalin	O
,	O
chamissonolid	O
and	O
their	O
ester	O
derivatives	O
.	O
While	O
these	O
compounds	O
affect	O
various	O
cellular	O
processes	O
,	O
current	O
data	O
do	O
not	O
fully	O
explain	O
how	O
sesquiterpene	O
lactones	O
exert	O
their	O
anti-inflammatory	O
effect	O
.	O
We	O
show	O
here	O
that	O
helenalin	O
,	O
and,	O
to	O
a	O
much	O
lesser	O
degree,	O
11alpha,13-dihydrohelenalin	O
and	O
chamissonolid	O
,	O
inhibit	O
activation	O
of	O
transcription	protein
factor	protein
NF-kappaB	protein
.	O
This	O
difference	O
in	O
efficacy,	O
which	O
correlates	O
with	O
the	O
compounds'	O
anti-inflammatory	O
potency	O
in	O
vivo,	O
may	O
be	O
explained	O
by	O
differences	O
in	O
structure	O
and	O
conformation.	O
NF-kappaB	protein
,	O
which	O
resides	O
in	O
an	O
inactive,	O
cytoplasmic	protein
complex	protein
in	O
unstimulated	cell_line
cells	cell_line
,	O
is	O
activated	O
by	O
phosphorylation	O
and	O
degradation	O
of	O
its	O
inhibitory	protein
subunit	protein
,	O
IkappaB	protein
.	O
Helenalin	O
inhibits	O
NF-kappaB	protein
activation	O
in	O
response	O
to	O
four	O
different	O
stimuli	O
in	O
T-cells	cell_type
,	O
B-cells	cell_type
and	O
epithelial	cell_type
cells	cell_type
and	O
abrogates	O
kappaB	protein
-driven	O
gene	O
expression	O
.	O
This	O
inhibition	O
is	O
selective,	O
as	O
the	O
activity	O
of	O
four	O
other	O
transcription	protein
factors	protein
,	O
Oct-1	protein
,	O
TBP	protein
,	O
Sp1	protein
and	O
STAT	protein
5	protein
was	O
not	O
affected.	O
We	O
show	O
that	O
inhibition	O
is	O
not	O
due	O
to	O
a	O
direct	O
modification	O
of	O
the	O
active	O
NF-kappaB	protein
heterodimer	protein
.	O
Rather,	O
helenalin	O
modifies	O
the	O
NF-kappaB/	protein
IkappaB	protein
complex	protein
,	O
preventing	O
the	O
release	O
of	O
IkappaB	protein
.	O
These	O
data	O
suggest	O
a	O
molecular	O
mechanism	O
for	O
the	O
anti-inflammatory	O
effect	O
of	O
sesquiterpene	O
lactones	O
,	O
which	O
differs	O
from	O
that	O
of	O
other	O
nonsteroidal	O
anti-inflammatory	O
drugs	O
(	O
NSAIDs	O
),	O
indomethacin	O
and	O
acetyl	O
salicylic	O
acid	O
.	O

The	O
tax	protein
protein	protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
mediates	O
the	O
transactivation	O
of	O
the	O
c-sis/platelet-derived	DNA
growth	DNA
factor-B	DNA
promoter	DNA
through	O
interactions	O
with	O
the	O
zinc	protein
finger	protein
transcription	protein
factors	protein
Sp1	protein
and	O
NGFI-A/Egr-1	protein
.	O
Transcriptional	O
up-regulation	O
of	O
the	O
c-sis/platelet-derived	DNA
growth	DNA
factor-B	DNA
(	DNA
PDGF-B	DNA
)	DNA
proto-oncogene	DNA
by	O
the	O
Tax	protein
protein	protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
has	O
been	O
implicated	O
as	O
one	O
possible	O
mechanism	O
of	O
cellular	O
transformation	O
by	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
.	O
In	O
previous	O
work,	O
we	O
identified	O
an	O
essential	O
site	O
in	O
the	O
c-sis/PDGF-B	DNA
promoter	DNA
,	O
Tax-responsive	DNA
element	DNA
1	DNA
(	O
TRE1	DNA
),	O
necessary	O
for	O
transactivation	O
by	O
Tax	protein
.	O
We	O
also	O
identified	O
Sp1	protein
,	O
Sp3,	O
and	O
NGFI-A/Egr-1	protein
as	O
the	O
primary	protein
nuclear	protein
transcription	protein
factors	protein
binding	O
to	O
TRE1	DNA
which	O
mediate	O
Tax	protein
responsiveness	O
.	O
In	O
the	O
present	O
work,	O
we	O
have	O
investigated	O
the	O
mechanism(s)	O
whereby	O
Tax	protein
transactivates	O
the	O
c-sis/PDGF-B	DNA
proto-oncogene	DNA
.	O
In	O
vitro	O
transcription	O
assays	O
showed	O
that	O
Tax	protein
was	O
able	O
to	O
significantly	O
increase	O
the	O
transcriptional	O
activity	O
of	O
a	O
template	O
containing	O
the	O
-257	DNA
to	DNA
+74	DNA
region	DNA
of	O
the	O
c-sis/PDGF-B	DNA
promoter	DNA
.	O
Electrophoretic	O
mobility	O
shift	O
assay	O
analysis	O
showed	O
that	O
Tax	protein
increased	O
the	O
DNA	O
binding	O
activity	O
of	O
both	O
Sp1	protein
and	O
NGFI-A/Egr-1	protein
using	O
a	O
TRE1	DNA
probe	DNA
.	O
Analysis	O
of	O
Tax	protein
mutants	protein
showed	O
that	O
two	O
mutants,	O
IEXC29S	protein
and	O
IEXL320G	protein
,	O
were	O
unable	O
to	O
significantly	O
transactivate	O
the	O
c-sis/PDGF-B	DNA
promoter	DNA
.	O
Finally,	O
co-immunoprecipitation	O
analysis	O
revealed	O
that	O
Tax	protein
is	O
able	O
to	O
stably	O
bind	O
to	O
both	O
Sp1	protein
and	O
NGFI-A/Egr-1	protein
.	O
Interestingly,	O
co-immunoprecipitation	O
analysis	O
also	O
revealed	O
that	O
Tax	protein
mutant	O
IEXC29S	protein
is	O
unable	O
to	O
interact	O
with	O
NGFI-A/Egr-1	protein
,	O
whereas	O
Tax	protein
mutant	O
IEXL320G	protein
is	O
able	O
to	O
interact	O
with	O
NGFI-A/Egr-1	protein
.	O

Nuclear	O
localization	O
of	O
RelB	protein
is	O
associated	O
with	O
effective	O
antigen-presenting	O
cell	O
function	O
.	O
Dendritic	cell_type
cells	cell_type
(	O
DC	cell_type
)	O
are	O
potent	O
APCs	cell_type
that	O
enter	O
resting	O
tissues	O
as	O
precursors	O
and,	O
after	O
Ag	O
exposure	O
,	O
differentiate	O
and	O
migrate	O
to	O
draining	O
lymph	O
nodes	O
.	O
The	O
phenotype	O
of	O
RelB	protein
knockout	O
mice	O
implicates	O
this	O
member	O
of	O
the	O
NF	protein
kappa	protein
B/Rel	protein
family	protein
in	O
DC	cell_type
differentiation	O
.	O
To	O
further	O
elucidate	O
the	O
role	O
of	O
RelB	protein
in	O
DC	cell_type
differentiation	O
,	O
mRNA	RNA
,	O
intracellular	O
protein	O
expression	O
,	O
and	O
DNA	O
binding	O
activity	O
of	O
RelB	protein
were	O
examined	O
in	O
immature	O
and	O
differentiated	O
human	cell_type
DC	cell_type
,	O
as	O
well	O
as	O
other	O
PB	cell_type
mononuclear	cell_type
cell	cell_type
populations	cell_type
.	O
RelB	protein
protein	O
and	O
mRNA	RNA
were	O
detected	O
constitutively	O
in	O
lymphocytes	cell_type
and	O
in	O
activated	cell_type
monocytes	cell_type
,	O
differentiated	cell_type
DC	cell_type
,	O
and	O
monocyte-derived	cell_line
DC	cell_line
.	O
Immunohistochemical	O
staining	O
demonstrated	O
RelB	protein
within	O
the	O
differentiated	cell_type
lymph	cell_type
node	cell_type
interdigitating	cell_type
DC	cell_type
and	O
follicular	cell_type
DC	cell_type
,	O
but	O
not	O
undifferentiated	cell_type
DC	cell_type
in	O
normal	O
skin	O
.	O
Active	O
nuclear	O
RelB	protein
was	O
detected	O
by	O
supershift	O
assay	O
only	O
in	O
differentiated	O
DC	cell_type
derived	O
from	O
either	O
PB	cell_type
precursors	cell_type
or	O
monocytes	cell_type
and	O
in	O
activated	cell_type
B	cell_type
cells	cell_type
.	O
These	O
RelB	cell_type
+	cell_type
APC	cell_type
were	O
potent	O
stimulators	O
of	O
the	O
MLR	protein
.	O
The	O
data	O
indicate	O
that	O
RelB	protein
expression	O
is	O
regulated	O
both	O
transcriptionally	O
and	O
post-translationally	O
in	O
myeloid	cell_type
cells	cell_type
.	O
Within	O
the	O
nucleus,	O
RelB	protein
may	O
specifically	O
transactivate	O
genes	O
that	O
are	O
critical	O
for	O
APC	cell_type
function	O
.	O

NF-AT	protein
activation	O
induced	O
by	O
a	O
CAML	protein
-interacting	O
member	O
of	O
the	O
tumor	protein
necrosis	protein
factor	protein
receptor	protein
superfamily	protein
.	O
Activation	O
of	O
the	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
transcription	protein
factor	protein
(	O
NF-AT	protein
)	O
is	O
a	O
key	O
event	O
underlying	O
lymphocyte	O
action	O
.	O
The	O
CAML	protein
(calcium-modulator	protein
and	protein
cyclophilin	protein
ligand)	protein
protein	protein
is	O
a	O
coinducer	O
of	O
NF-AT	protein
activation	O
when	O
overexpressed	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
A	O
member	O
of	O
the	O
tumor	protein
necrosis	protein
factor	protein
receptor	protein
superfamily	protein
was	O
isolated	O
by	O
virtue	O
of	O
its	O
affinity	O
for	O
CAML	protein
.	O
Cross-linking	O
of	O
this	O
lymphocyte-specific	protein
protein	protein
,	O
designated	O
TACI	protein
(	O
transmembrane	protein
activator	protein
and	protein
CAML	protein
-interactor	protein
),	O
on	O
the	O
surface	O
of	O
transfected	cell_line
Jurkat	cell_line
cells	cell_line
with	O
TACI	protein
-specific	protein
antibodies	protein
led	O
to	O
activation	O
of	O
the	O
transcription	protein
factors	protein
NF-AT	protein
,	O
AP-1	protein
,	O
and	O
NFkappaB	protein
.	O
TACI	protein
-induced	O
activation	O
of	O
NF-AT	protein
was	O
specifically	O
blocked	O
by	O
a	O
dominant-negative	protein
CAML	protein
mutant	protein
,	O
thus	O
implicating	O
CAML	protein
as	O
a	O
signaling	O
intermediate	O
.	O

Rel/NF-kappa	protein
B	protein
transcription	protein
factors	protein
and	O
the	O
control	O
of	O
apoptosis	O
.	O
The	O
process	O
of	O
apoptosis	O
is	O
used	O
to	O
eliminate	O
unwanted	cell_type
cells	cell_type
from	O
a	O
wide	O
variety	O
of	O
organisms.	O
Various	O
extracellular	O
signals	O
,	O
often	O
converging	O
in	O
common	O
intracellular	O
pathways	O
,	O
can	O
induce	O
apoptosis	O
in	O
a	O
cell-type-specific	O
fashion	O
.	O
Recent	O
work	O
from	O
several	O
laboratories	O
has	O
demonstrated	O
that	O
Rel/NF-kappa	protein
B	protein
transcription	protein
factors	protein
regulate	O
apoptosis	O
in	O
many	O
cell	O
types.	O
In	O
most	O
cells,	O
Rel/NF-kappa	protein
B	protein
transcription	protein
factors	protein
appear	O
to	O
mediate	O
survival	O
signals	O
that	O
protect	O
cells	O
from	O
apoptosis	O
;	O
however,	O
under	O
some	O
circumstances,	O
activation	O
of	O
these	O
factors	O
may	O
also	O
promote	O
apoptosis	O
.	O

A	O
thiol	O
antioxidant	O
regulates	O
IgE	protein
isotype	protein
switching	O
by	O
inhibiting	O
activation	O
of	O
nuclear	protein
factor-kappaB	protein
.	O
The	O
binding	DNA
site	DNA
for	O
nuclear	protein
factor-kappaB	protein
(	O
NF-kappaB	protein
)	O
is	O
present	O
at	O
the	O
promoter	DNA
region	DNA
of	O
the	O
germline	DNA
Cepsilon	DNA
gene	DNA
,	O
but	O
there	O
is	O
little	O
information	O
on	O
whether	O
this	O
factor	O
is	O
involved	O
in	O
regulating	O
IgE	protein
synthesis	O
by	O
human	cell_type
B	cell_type
cells	cell_type
.	O
Accordingly,	O
we	O
studied	O
the	O
role	O
of	O
NF-kappaB	protein
in	O
germline	DNA
Cepsilon	O
transcription	O
by	O
using	O
two	O
human	cell_line
Burkitt's	cell_line
lymphoma	cell_line
B	cell_line
cell	cell_line
lines	cell_line
,	O
DND39	cell_line
and	O
DG75	cell_line
.	O
In	O
both	O
cell	cell_line
lines	cell_line
,	O
n-acetyl-L-cysteine	O
(	O
NAC	O
),	O
a	O
potent	O
thiol	O
antioxidant	O
,	O
inhibited	O
the	O
triggering	O
of	O
the	O
nuclear	O
expression	O
of	O
NF-kappaB	protein
by	O
IL-4	protein
and	O
by	O
anti-CD40	protein
monoclonal	protein
antibody	protein
.	O
Although	O
IL-4	protein
activated	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(STAT)	protein
6	protein
in	O
addition	O
to	O
NF-kappaB	protein
,	O
NAC	O
treatment	O
or	O
the	O
transfection	O
of	O
decoy	O
oligodeoxynucleotides	O
for	O
NF-kappaB	protein
or	O
STAT6	protein
only	O
partly	O
blocked	O
IL-4	protein
-induced	O
germline	DNA
Cepsilon	O
transcription	O
.	O
However,	O
these	O
two	O
decoy	O
oligodeoxynucleotides	O
together	O
almost	O
completely	O
abrogated	O
IL-4	protein
-induced	O
germline	DNA
Cepsilon	O
transcription	O
.	O
Of	O
note,	O
CD40	protein
-mediated	O
enhancement	O
of	O
IL-4	protein
-driven	O
germline	DNA
Cepsilon	O
transcription	O
was	O
markedly	O
decreased	O
by	O
NAC	O
or	O
by	O
a	O
decoy	O
oligodeoxynucleotide	O
for	O
NF-kappaB	protein
.	O
The	O
effect	O
of	O
NAC	O
was	O
also	O
examined	O
on	O
deletional	O
switch	O
recombination	O
underlying	O
the	O
isotype	O
switch	O
to	O
IgE	protein
.	O
NAC	O
inhibited	O
the	O
generation	O
of	O
Smu/Sepsilon	protein
switch	protein
fragments	protein
in	O
normal	O
human	cell_type
B	cell_type
cells	cell_type
costimulated	O
with	O
IL-4	protein
and	O
anti-CD40	protein
monoclonal	protein
antibody	protein
.	O
It	O
also	O
abolished	O
IL-4	protein
-induced	O
upregulation	O
of	O
CD40	protein
but	O
promoted	O
upregulation	O
of	O
CD23.	O
These	O
results	O
suggest	O
that	O
coordination	O
of	O
NF-kappaB	protein
and	O
STAT6	protein
may	O
be	O
required	O
for	O
induction	O
of	O
germline	DNA
Cepsilon	O
transcription	O
by	O
IL-4	protein
,	O
and	O
that	O
CD40	protein
-mediated	O
NF-kappaB	protein
activation	O
may	O
be	O
important	O
in	O
regulating	O
both	O
enhancement	O
of	O
germline	DNA
Cepsilon	O
transcription	O
and	O
class	O
switching	O
to	O
IgE	protein
.	O

Pathogenesis.	O
There	O
are	O
many	O
hypotheses	O
concerning	O
the	O
pathogenesis	O
of	O
endometriosis	O
,	O
though	O
no	O
single	O
theory	O
can	O
explain	O
all	O
cases.	O
It	O
is	O
likely	O
that	O
several	O
mechanisms	O
are	O
involved.	O
Early	O
studies	O
concentrated	O
on	O
the	O
histogenesis	O
of	O
the	O
endometriotic	O
lesion	O
.	O
Recent	O
evidence	O
has	O
implicated	O
components	O
of	O
the	O
immune	O
system	O
in	O
the	O
pathogenesis	O
of	O
endometriosis	O
.	O
This	O
review	O
considers	O
the	O
evidence	O
for	O
different	O
theories	O
of	O
the	O
histogenesis	O
of	O
endometriosis	O
and	O
discusses	O
possible	O
immune	O
factors	O
that	O
may	O
be	O
involved	O
in	O
the	O
pathophysiology	O
of	O
the	O
disease	O
.	O

ATF1	protein
and	O
CREB	protein
trans-activate	O
a	O
cell	DNA
cycle	DNA
regulated	DNA
histone	DNA
H4	DNA
gene	DNA
at	O
a	O
distal	DNA
nuclear	DNA
matrix	DNA
associated	DNA
promoter	DNA
element	DNA
.	O
Proteins	O
of	O
the	O
ATF/	O
CREB	protein
class	O
of	O
transcription	protein
factors	protein
stimulate	O
gene	O
expression	O
of	O
several	O
cell	DNA
growth-related	DNA
genes	DNA
through	O
protein	DNA
kinase	DNA
A-related	DNA
cAMP	DNA
response	DNA
elements	DNA
.	O
The	O
promoter	O
activity	O
of	O
cell	DNA
cycle	DNA
regulated	DNA
histone	DNA
H4	DNA
genes	DNA
is	O
regulated	O
by	O
at	O
least	O
four	O
principal	DNA
cis-acting	DNA
elements	DNA
which	O
mediate	O
G1/S	O
phase	O
control	O
and/or	O
enhancement	O
of	O
transcription	O
during	O
the	O
cell	O
cycle	O
.	O
Using	O
protein-DNA	O
interaction	O
assays	O
we	O
show	O
that	O
the	O
H4	DNA
promoter	DNA
contains	O
two	O
ATF/	O
CREB	protein
recognition	O
motifs	O
which	O
interact	O
with	O
CREB	protein
,	O
ATF1	protein
,	O
and	O
ATF2	protein
but	O
not	O
with	O
ATF4/CREB2	protein
.	O
One	O
ATF/CRE	DNA
motif	DNA
is	O
located	O
in	O
the	O
distal	DNA
promoter	DNA
at	O
the	O
nuclear	DNA
matrix-associated	DNA
Site	DNA
IV	DNA
,	O
and	O
the	O
second	O
motif	O
is	O
present	O
in	O
the	O
proximal	DNA
promoter	DNA
at	O
Site	DNA
I	DNA
.	O
Both	O
ATF/CRE	DNA
motifs	DNA
overlap	O
binding	DNA
sequences	DNA
for	O
the	O
multifunctional	protein
YY1	protein
transcription	protein
factor	protein
,	O
which	O
has	O
previously	O
been	O
shown	O
to	O
be	O
nuclear	O
matrix	O
associated.	O
Subnuclear	O
fractionation	O
reveals	O
that	O
there	O
are	O
two	O
ATF1	protein
isoforms	protein
which	O
appear	O
to	O
differ	O
with	O
respect	O
to	O
DNA	O
binding	O
activity	O
and	O
partition	O
selectively	O
between	O
nuclear	O
matrix	O
and	O
nonmatrix	O
compartments	O
,	O
consistent	O
with	O
the	O
role	O
of	O
the	O
nuclear	O
matrix	O
in	O
regulating	O
gene	O
expression	O
.	O
Site-directed	O
mutational	O
studies	O
demonstrate	O
that	O
Site	DNA
I	DNA
and	O
Site	DNA
IV	DNA
together	O
support	O
ATF1-	O
and	O
CREB-	O
induced	O
trans-activation	O
of	O
the	O
H4	DNA
promoter	DNA
.	O
Thus,	O
our	O
data	O
establish	O
that	O
ATF/CREB	protein
factors	protein
functionally	O
modulate	O
histone	DNA
H4	DNA
gene	DNA
transcription	O
at	O
distal	O
and	O
proximal	O
promoter	O
elements	O
.	O

Is	O
celiac	O
disease	O
due	O
to	O
molecular	O
mimicry	O
between	O
gliadin	O
peptide	O
-HLA	protein
class	protein
II	protein
molecule	protein
-T	O
cell	O
interactions	O
and	O
those	O
of	O
some	O
unidentified	protein
superantigen	protein
?	O
This	O
paper	O
presents	O
a	O
new	O
hypothesis	O
for	O
the	O
etiology	O
and	O
pathogenesis	O
of	O
celiac	O
disease	O
(	O
CD	O
).	O
It	O
is	O
our	O
contention	O
that	O
CD	O
is	O
triggered	O
by	O
the	O
binding	O
of	O
one	O
or	O
more	O
gliadin	O
peptides	O
to	O
CD	protein
-associated	protein
HLA	protein
class	protein
II	protein
molecules	protein
.	O
Furthermore,	O
we	O
propose	O
that	O
these	O
putative	O
CD	O
peptides	O
bind	O
to	O
oligosaccharide	O
residues	O
on	O
HLA	protein
class	protein
II	protein
molecules	protein
distal	O
to	O
the	O
peptide-binding	protein
groove	protein
invoking	O
recognition	O
and	O
binding	O
by	O
specialized	O
subsets	O
of	O
gamma	cell_type
delta	cell_type
T	cell_type
cell	cell_type
receptor-bearing	cell_type
lymphocytes	cell_type
.	O
The	O
binding	O
of	O
these	O
gamma	cell_type
delta	cell_type
T	cell_type
cells	cell_type
serves	O
as	O
a	O
signal	O
for	O
abrogation	O
of	O
oral	O
tolerance	O
to	O
ingested	protein
proteins	protein
setting	O
in	O
motion	O
a	O
series	O
of	O
immune	O
responses	O
directed	O
against	O
the	O
small	O
intestinal	O
epithelium	O
of	O
CD	O
patients	O
.	O
CD	O
patients	O
are	O
victimized	O
by	O
this	O
self-distructed	O
immune	O
response	O
because	O
of	O
inheritance	O
of	O
certain	O
combinations	O
of	O
HLA-DQ	O
and	O
DR	O
haplotypes	O
.	O
Dimers	O
encoded	O
by	O
HLA-DR	protein
haplotypes	O
may	O
be	O
the	O
primary	DNA
restriction	DNA
elements	DNA
for	O
lectin-like,	O
gliadin	O
peptides	O
while	O
the	O
degree	O
of	O
immune	O
suppression	O
(or	O
lack	O
thereof)	O
to	O
ingested	O
gliadins	O
is	O
governed	O
by	O
inherited	O
HLA-DQ	DNA
haplotypes	O
.	O
Finally,	O
we	O
speculate	O
that	O
molecular	O
mimicry	O
between	O
one	O
or	O
more	O
gliadin	O
peptides	O
and	O
some,	O
as	O
yet	O
unidentified,	O
bacterial	O
or	O
viral	O
superantigen	O
plays	O
a	O
role	O
in	O
disease	O
pathogenesis	O
.	O

Epstein-Barr	O
virus	O
latent	protein
membrane	protein
protein-1	protein
triggers	O
AP-1	protein
activity	O
via	O
the	O
c-Jun	protein
N-terminal	O
kinase	O
cascade	O
.	O
The	O
Epstein-Barr	O
virus	O
latent	protein
membrane	protein
protein-1	protein
(	O
LMP-1	protein
)	O
is	O
an	O
integral	protein
membrane	protein
protein	protein
which	O
transforms	O
fibroblasts	cell_type
and	O
is	O
essential	O
for	O
EBV-mediated	O
B-cell	O
immortalization	O
.	O
LMP-1	protein
has	O
been	O
shown	O
to	O
trigger	O
cellular	O
NF-kappa	protein
B	protein
activity	O
which,	O
however,	O
cannot	O
fully	O
explain	O
the	O
oncogenic	O
potential	O
of	O
LMP-1	protein
.	O
Here	O
we	O
show	O
that	O
LMP-1	protein
induces	O
the	O
activity	O
of	O
the	O
AP-1	protein
transcription	protein
factor	protein
,	O
a	O
dimer	O
of	O
Jun/Jun	protein
or	protein
Jun/Fos	protein
proteins	protein
.	O
LMP-1	protein
effects	O
on	O
AP-1	protein
are	O
mediated	O
through	O
activation	O
of	O
the	O
c-Jun	protein
N-terminal	O
kinase	O
(	O
JNK	protein
)	O
cascade	O
,	O
but	O
not	O
the	O
extracellular	protein
signal-regulated	protein
kinase	protein
(	O
Erk	protein
)	O
pathway	O
.	O
Consequently,	O
LMP-1	protein
triggers	O
the	O
activity	O
of	O
the	O
c-Jun	protein
N-terminal	protein
transactivation	protein
domain	protein
which	O
is	O
known	O
to	O
be	O
activated	O
upon	O
JNK	protein
-mediated	O
phosphorylation	O
.	O
Deletion	O
analysis	O
indicates	O
that	O
the	O
55	O
C-terminal	protein
amino	protein
acids	protein
of	O
the	O
LMP-1	protein
molecule	protein
,	O
but	O
not	O
its	O
TRAF	protein
interaction	protein
domain	protein
,	O
are	O
essential	O
for	O
AP-1	protein
activation	O
.	O
JNK	protein
-mediated	O
transcriptional	O
activation	O
of	O
AP-1	protein
is	O
the	O
direct	O
output	O
of	O
LMP	protein
-1-triggered	O
signaling	O
,	O
as	O
shown	O
by	O
an	O
inducible	O
LMP-1	protein
mutant	protein
.	O
Using	O
a	O
tetracycline-regulated	DNA
LMP-1	DNA
allele	DNA
,	O
we	O
demonstrate	O
that	O
JNK	protein
is	O
also	O
an	O
effector	O
of	O
non-cytotoxic	O
LMP-1	protein
signaling	O
in	O
B	cell_type
cells	cell_type
,	O
the	O
physiological	O
target	O
cells	O
of	O
EBV	O
.	O
In	O
summary,	O
our	O
data	O
reveal	O
a	O
novel	O
effector	O
of	O
LMP-1	protein
,	O
the	O
SEK/	O
JNK	protein
/	O
c-Jun	protein
/	O
AP-1	protein
pathway	O
,	O
which	O
contributes	O
to	O
our	O
understanding	O
of	O
the	O
immortalizing	O
and	O
transforming	O
potential	O
of	O
LMP-1	protein
.	O

Abnormal	O
apoptosis	O
and	O
cell	O
cycle	O
progression	O
in	O
humans	O
exposed	O
to	O
methyl	O
tertiary-butyl	O
ether	O
and	O
benzene	O
contaminating	O
water	O
.	O
1.	O
In	O
this	O
study	O
we	O
hypothesized	O
that	O
in	O
individuals	O
with	O
certain	O
genetic	O
makeup,	O
MTBE	O
,	O
benzene	O
or	O
their	O
metabolites	O
act	O
as	O
adducts	O
and	O
may	O
induce	O
programmed	O
cell	O
death	O
.	O
2.	O
Our	O
study	O
involved	O
a	O
group	O
of	O
60	O
male	O
and	O
female	O
subjects	O
who	O
were	O
exposed	O
to	O
MTBE	O
and	O
benzene	O
-contaminated	O
water	O
concentrations	O
up	O
to	O
76	O
PPB	O
for	O
MTBE	O
and	O
14	O
PPB	O
for	O
benzene	O
,	O
for	O
a	O
period	O
of	O
5	O
to	O
8	O
years.	O
For	O
comparison,	O
we	O
recruited	O
a	O
control	O
group	O
consisting	O
of	O
32	O
healthy	O
males	O
and	O
females	O
with	O
similar	O
age	O
distribution	O
and	O
without	O
a	O
history	O
of	O
exposure	O
to	O
MTBE	O
or	O
benzene	O
.	O
3.	O
Peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
(	O
PBL	cell_type
)	O
of	O
both	O
groups	O
were	O
tested	O
for	O
the	O
percentage	O
of	O
apoptotic	cell_type
cells	cell_type
and	O
cell	O
cycle	O
progression	O
using	O
flow	O
cytometry	O
.	O
4.	O
When	O
apoptotic	cell_type
lymphocytes	cell_type
from	O
exposed	O
individuals	O
were	O
compared	O
to	O
apoptotic	cell_type
lymphocytes	cell_type
from	O
the	O
control	O
group,	O
statistically-significant	O
differences	O
between	O
each	O
mean	O
group	O
were	O
detected	O
(26.4	O
+/-	O
1.8	O
and	O
12.1	O
+/-	O
1.3,	O
respectively),	O
indicating	O
an	O
increased	O
rate	O
of	O
apoptosis	O
in	O
80.5%	O
of	O
exposed	O
individuals	O
(P	O
&lt;	O
0.0001,	O
Mann-Whitney	O
U-Test).	O
MTBE	O
and	O
benzene	O
-induced	O
apoptosis	O
is	O
attributed	O
to	O
a	O
discrete	O
block	O
within	O
the	O
cell	O
cycle	O
progression	O
.	O
Because	O
cell	O
cycle	O
analysis	O
showed	O
that	O
in	O
PBL	cell_type
from	O
chemically-	O
exposed	O
individuals	O
,	O
between	O
20-50%	O
of	O
cells	O
were	O
accumulated	O
at	O
the	O
S-G2/M	O
boundaries.	O
5.	O
One	O
of	O
the	O
signaling	protein
molecules	protein
which	O
mediates	O
programmed	O
cell	O
death	O
is	O
nuclear	protein
factor	protein
Kappa-B	protein
(	O
NF-kappa	protein
B	protein
).	O
NF-kappa	protein
B	protein
was	O
examined	O
as	O
one	O
of	O
the	O
many	O
molecular	O
mechanisms	O
for	O
mediating	O
cell	O
death	O
by	O
MTBE	O
and	O
benzene	O
.	O
Indeed,	O
addition	O
of	O
inhibitors	O
of	O
NF-kappa	protein
B	protein
activation	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
),	O
to	O
the	O
lymphocytes	cell_type
of	O
the	O
chemically-exposed	O
group	O
was	O
capable	O
of	O
inhibiting	O
programmed	O
cell	O
death	O
by	O
40%.	O
This	O
reversal	O
of	O
apoptosis	O
almost	O
to	O
the	O
control	O
level	O
by	O
inhibitor	O
of	O
NF-kappa	protein
B	protein
activation	O
may	O
indicate	O
involvement	O
of	O
this	O
signaling	protein
molecule	protein
in	O
MTBE	O
and	O
benzene	O
induction	O
of	O
programmed	O
cell	O
death	O
.	O

Purification	O
and	O
characterization	O
of	O
the	O
human	protein
SR	protein
31747A-binding	protein
protein	protein
.	O
A	O
nuclear	protein
membrane	protein
protein	protein
related	O
to	O
yeast	protein
sterol	protein
isomerase	protein
.	O
SR	O
31747A	O
,	O
defined	O
as	O
a	O
sigma	O
ligand,	O
is	O
a	O
novel	O
immunosuppressive	O
agent	O
that	O
blocks	O
proliferation	O
of	O
human	O
and	O
mouse	O
lymphocytes	O
.	O
Using	O
a	O
radiolabeled	O
chemical	O
probe	O
,	O
we	O
here	O
purified	O
a	O
target	O
of	O
SR	O
31747A	O
and	O
called	O
it	O
SR	protein
31747A	protein
-binding	protein
protein	protein
(	O
SR-BP	protein
).	O
Purified	protein
SR-BP	protein
retained	O
its	O
binding	O
properties	O
and	O
migrated	O
on	O
SDS-polyacrylamide	O
gel	O
as	O
a	O
Mr	protein
28,000	protein
protein	protein
.	O
Cloning	O
of	O
the	O
cDNA	DNA
encoding	O
human	protein
SR-BP	protein
shows	O
an	O
open	DNA
reading	DNA
frame	DNA
for	O
a	O
223-amino	protein
acid	protein
protein	protein
,	O
which	O
is	O
homologous	O
to	O
the	O
recently	O
cloned	O
sigma	protein
1	protein
receptor	protein
.	O
Interestingly,	O
the	O
deduced	O
amino	protein
acid	protein
sequence	protein
was	O
found	O
to	O
be	O
related	O
to	O
fungal	protein
C8-C7	protein
sterol	protein
isomerase	protein
,	O
encoded	O
by	O
the	O
ERG2	DNA
gene	DNA
.	O
The	O
ERG2	protein
gene	protein
product	protein
has	O
been	O
identified	O
recently	O
as	O
the	O
molecular	O
target	O
of	O
SR	O
31747A	O
that	O
mediates	O
antiproliferative	O
effects	O
of	O
the	O
drug	O
in	O
yeast	O
.	O
Northern	O
blot	O
analysis	O
of	O
SR-BP	protein
gene	O
expression	O
revealed	O
a	O
single	O
transcript	O
of	O
2	RNA
kilobases	RNA
which	O
was	O
widely	O
expressed	O
among	O
organs	O
,	O
with	O
the	O
highest	O
abundance	O
in	O
liver	O
and	O
the	O
lowest	O
abundance	O
in	O
brain	O
.	O
Subcellular	O
localization	O
analysis	O
in	O
various	O
cells,	O
using	O
a	O
specific	protein
monoclonal	protein
antibody	protein
raised	O
against	O
SR-BP	protein
,	O
demonstrated	O
that	O
this	O
protein	O
was	O
associated	O
with	O
the	O
nuclear	O
envelope	O
.	O
When	O
studying	O
the	O
binding	O
of	O
SR	O
31747A	O
on	O
membranes	O
from	O
yeast	O
expressing	O
SR-BP	protein
,	O
we	O
found	O
a	O
pharmacological	O
profile	O
of	O
sigma	protein
1	protein
receptors	protein
;	O
binding	O
was	O
displaced	O
by	O
(+)-pentazocine	O
,	O
haloperidol	O
,	O
and	O
(+)-SKF	O
10,047	O
,	O
with	O
(+)-SKF	O
10,	O
047	O
being	O
a	O
more	O
potent	O
competitor	O
than	O
(-)-SKF	O
10,047	O
.	O
Scatchard	O
plot	O
analysis	O
revealed	O
Kd	O
values	O
of	O
7.1	O
nM	O
and	O
0.15	O
nM	O
for	O
(+)-pentazocine	O
and	O
SR	O
31747A	O
,	O
respectively,	O
indicating	O
an	O
affinity	O
of	O
SR-BP	protein
50-fold	O
higher	O
for	O
SR	O
31747A	O
than	O
for	O
pentazocine	O
.	O
Additionally,	O
we	O
showed	O
that	O
pentazocine	O
,	O
a	O
competitive	O
inhibitor	O
of	O
SR	O
31747A	O
binding	O
,	O
also	O
prevents	O
the	O
immunosuppressive	O
effect	O
of	O
SR	O
31747A	O
.	O
Taken	O
together,	O
these	O
findings	O
strongly	O
suggest	O
that	O
SR-BP	protein
represents	O
the	O
molecular	O
target	O
for	O
SR	O
31747A	O
in	O
mammalian	O
tissues	O
,	O
which	O
could	O
be	O
critical	O
for	O
T	O
cell	O
proliferation	O
.	O

Phospholipase	protein
C	protein
gamma	protein
1	protein
overexpression	O
and	O
activation	O
induced	O
by	O
interferon	protein
beta	protein
in	O
human	cell_type
T	cell_type
lymphocytes	cell_type
:	O
an	O
ISGF3	protein
-independent	O
response	O
.	O
Interferons	protein
exert	O
their	O
antiviral,	O
antiproliferative	O
and	O
immunoregulatory	protein
activities	O
by	O
stimulating	O
the	O
expression	O
of	O
several	O
genes.	O
Such	O
genes	O
disclose	O
a	O
common	O
element	O
within	O
their	O
promoters	DNA
,	O
defined	O
Interferon	DNA
Stimulated	DNA
Response	DNA
Element	DNA
(	O
ISRE	DNA
),	O
which	O
binds	O
a	O
nuclear	protein
factor	protein
(s)	O
translocated	O
from	O
the	O
cytoplasm	O
to	O
the	O
nucleus	O
(	O
ISGF3	protein
)	O
after	O
the	O
binding	O
of	O
interferon	protein
(	O
IFN	protein
)	O
to	O
the	O
specific	O
receptor.	O
Here	O
we	O
report	O
the	O
induction	O
of	O
the	O
synthesis	O
and	O
of	O
the	O
hydrolytic	O
activity	O
of	O
phospholipase	protein
C	protein
gamma	protein
1	protein
(	O
PLC	protein
gamma	protein
1	protein
)	O
in	O
human	cell_type
T	cell_type
lymphocytes	cell_type
by	O
IFN-beta	protein
.	O
The	O
increased	O
level	O
of	O
PLC	protein
gamma	protein
1	protein
becomes	O
evident	O
after	O
90	O
min	O
of	O
IFN-beta	protein
treatment	O
and	O
is	O
still	O
detectable	O
after	O
24	O
h.	O
Neither	O
the	O
PLC	protein
gamma	protein
1	protein
overexpression	O
induced	O
by	O
IFN	protein
nor	O
the	O
increased	O
hydrolytic	O
activity	O
of	O
the	O
enzyme	protein
appear	O
to	O
be	O
affected	O
by	O
pretreatment	O
of	O
the	O
cells	O
with	O
the	O
protein	O
tyrosine	protein
kinase	protein
inhibitor	O
genistein	O
,	O
which	O
is	O
known	O
to	O
prevent	O
the	O
association	O
of	O
ISGF3	protein
components.	O
These	O
results	O
suggest	O
that	O
in	O
human	cell_type
T	cell_type
lymphocytes	cell_type
IFN-beta	protein
can	O
activate	O
other	O
transcription	protein
factor	protein
(s)	O
distinct	O
from	O
ISGF3	protein
to	O
regulate	O
PLC	protein
gamma	protein
1	protein
expression	O
.	O
In	O
addition,	O
the	O
ability	O
of	O
this	O
enzyme	protein
to	O
hydrolyse	O
PIP2	O
,	O
also	O
in	O
the	O
presence	O
of	O
genistein	O
,	O
implies	O
the	O
possibility	O
that	O
this	O
enzyme	O
can	O
exert	O
its	O
hydrolytic	O
activity	O
independently	O
of	O
protein	protein
tyrosine	protein
kinase	protein
activation	O
.	O

Negative	O
regulation	O
by	O
HLA-DO	protein
of	O
MHC	protein
class	protein
II	protein
-restricted	O
antigen	O
processing	O
.	O
HLA-DM	protein
is	O
a	O
major	protein
histocompatibility	protein
complex	protein
(MHC)	protein
class	protein
II-like	protein
molecule	protein
that	O
facilitates	O
antigen	O
processing	O
by	O
catalyzing	O
the	O
exchange	O
of	O
invariant	O
chain-derived	O
peptides	O
(	O
CLIP	O
)	O
from	O
class	protein
II	protein
molecules	protein
for	O
antigenic	O
peptides	O
.	O
HLA-DO	protein
is	O
a	O
second	O
class	protein
II-like	protein
molecule	protein
that	O
physically	O
associates	O
with	O
HLA-DM	protein
in	O
B	cell_type
cells	cell_type
.	O
HLA-DO	protein
was	O
shown	O
to	O
block	O
HLA-DM	protein
function	O
.	O
Purified	O
HLA-DM	protein
-DO	protein
complexes	protein
could	O
not	O
promote	O
peptide	O
exchange	O
in	O
vitro.	O
Expression	O
of	O
HLA-DO	protein
in	O
a	O
class	cell_line
II+	cell_line
and	cell_line
DM+,	cell_line
DO-	cell_line
human	cell_line
T	cell_line
cell	cell_line
line	cell_line
caused	O
the	O
accumulation	O
of	O
class	protein
II-	protein
CLIP	protein
complexes	protein
,	O
indicating	O
that	O
HLA-DO	protein
blocked	O
DM	O
function	O
in	O
vivo	O
and	O
suggesting	O
that	O
HLA-DO	protein
is	O
an	O
important	O
modulator	O
of	O
class	O
II-restricted	O
antigen	O
processing	O
.	O

Vitamin	protein
D	protein
receptor	protein
:	O
no	O
evidence	O
for	O
allele-specific	O
mRNA	O
stability	O
in	O
cells	O
which	O
are	O
heterozygous	O
for	O
the	O
Taq	protein
I	protein
restriction	protein
enzyme	protein
polymorphism	O
.	O
Allelic	O
variations	O
of	O
the	O
vitamin	DNA
D	DNA
receptor	DNA
(	DNA
VDR	DNA
)	DNA
gene	DNA
have	O
been	O
associated	O
with	O
the	O
risk	O
of	O
developing	O
prostate	O
cancer	O
in	O
men	O
and	O
osteoporosis	O
in	O
postmenopausal	O
women	O
.	O
Three	O
RFLPs	DNA
(	O
TaqI	DNA
,	O
ApaI	DNA
,	O
BsmI	DNA
)	O
define	O
two	O
common	O
haplotypes	O
:	O
BAt	O
and	O
baT	O
.	O
None	O
of	O
these	O
polymorphisms	DNA
change	O
the	O
translated	protein
protein	protein
.	O
Since	O
sequence	DNA
variations	DNA
in	O
the	O
3'	DNA
UTR	DNA
of	O
VDR	protein
have	O
been	O
linked	O
to	O
the	O
different	O
haplotypes	O
,	O
investigators	O
have	O
proposed	O
that	O
the	O
stability	O
of	O
VDR	RNA
mRNA	RNA
is	O
influenced	O
by	O
allelic	O
variations.	O
Indirect	O
evidence	O
suggested	O
that	O
allele	DNA
T	DNA
is	O
less	O
stable	O
than	O
allele	DNA
t	DNA
.	O
In	O
this	O
study,	O
we	O
used	O
a	O
RT-PCR	O
based	O
approach	O
to	O
compare	O
the	O
stability	O
of	O
the	O
big	O
T	O
and	O
small	O
t	O
allele	O
in	O
normal	cell_type
heterozygous	cell_type
lymphocytes	cell_type
and	O
the	O
heterozygous	cell_line
cell	cell_line
lines	cell_line
NB4	cell_line
(	O
myeloid	O
leukemia	O
)	O
and	O
PC-3	cell_line
and	O
DU	cell_line
145	cell_line
(	O
prostate	O
cancers	O
).	O
In	O
all	O
three	O
cases,	O
we	O
did	O
not	O
find	O
a	O
significant	O
difference	O
in	O
stability.	O
Interestingly,	O
we	O
consistently	O
observed	O
30%	O
less	O
RT-PCR	DNA
product	DNA
derived	O
from	O
the	O
small	RNA
t	RNA
allele	RNA
mRNA	RNA
in	O
steady	O
state,	O
a	O
finding	O
which	O
also	O
speaks	O
against	O
a	O
higher	O
stability	O
of	O
the	O
small	RNA
t	RNA
allele	RNA
mRNA	RNA
.	O
These	O
results	O
indicate	O
a	O
variation	O
in	O
transcriptional	O
regulation	O
rather	O
than	O
mRNA	O
stability	O
between	O
the	O
alleles	DNA
.	O
We	O
hypothesize	O
that	O
an	O
unknown	O
gene	O
or	O
genes	O
in	O
linkage	O
with	O
the	O
polymorphisms	DNA
is	O
(are)	O
responsible	O
for	O
the	O
relationship	O
between	O
risk	O
of	O
prostate	O
cancer	O
and	O
VDR	protein
polymorphisms	DNA
.	O

Replication	O
of	O
human	O
immunodeficiency	O
virus-1	O
in	O
primary	cell_type
human	cell_type
T	cell_type
cells	cell_type
is	O
dependent	O
on	O
the	O
autocrine	O
secretion	O
of	O
tumor	protein
necrosis	protein
factor	protein
through	O
the	O
control	O
of	O
nuclear	protein
factor-kappa	protein
B	protein
activation	O
.	O
Tumor	protein
necrosis	protein
factor	protein
(TNF)-alpha	protein
controls	O
T-cell	O
activation	O
and	O
is	O
a	O
major	O
inducer	O
of	O
human	O
immunodeficiency	O
virus	O
(HIV)-1	O
replication	O
in	O
chronically	cell_type
infected	cell_type
cells	cell_type
.	O
Therefore,	O
we	O
have	O
investigated	O
its	O
role	O
in	O
primary	O
cultures	O
of	O
HIV-infected	cell_type
human	cell_type
T	cell_type
lymphocytes	cell_type
by	O
using	O
neutralizing	O
anti-TNF-alpha	protein
antibodies	protein
or	O
TNF-alpha	protein
.	O
Primary	O
resting	O
T	O
lymphocytes	O
produced	O
TNF-alpha	protein
and	O
supported	O
HIV	O
replication	O
after	O
T-cell	O
receptor	O
activation	O
.	O
Addition	O
of	O
neutralizing	O
anti-	protein
TNF-alpha	protein
antibodies	protein
drastically	O
reduced	O
p24	protein
antigen	protein
release	O
and	O
prevented	O
CD4+	protein
cell	O
depletion	O
associated	O
with	O
infection.	O
Anti-	protein
TNF-alpha	protein
also	O
prevented	O
nuclear	protein
factor-kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
activation	O
,	O
and	O
a	O
good	O
correlation	O
between	O
this	O
inhibition	O
and	O
inhibition	O
of	O
HIV	O
replication	O
was	O
observed.	O
Moreover,	O
supplementing	O
the	O
cultures	O
with	O
high	O
doses	O
of	O
IL-2	O
reverted	O
anti-	O
TNF-alpha	protein
inhibition	O
of	O
cell	O
proliferation	O
but	O
did	O
not	O
affect	O
the	O
inhibition	O
of	O
HIV	O
p24	protein
antigen	protein
release	O
or	O
NF-kappa	protein
B	protein
activation	O
in	O
the	O
same	O
cultures.	O
Moreover,	O
anti-	protein
TNF-alpha	protein
inhibited	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)-driven	O
transcription	O
of	O
a	O
reporter	DNA
gene	DNA
in	O
primary	cell_type
T	cell_type
cells	cell_type
in	O
response	O
to	O
activation,	O
either	O
in	O
the	O
presence	O
or	O
the	O
absence	O
of	O
HIV-1	protein
Tat	protein
.	O
Our	O
results	O
support	O
an	O
important	O
role	O
for	O
autocrine	O
TNF-alpha	protein
secretion	O
in	O
controlling	O
HIV	O
replication	O
in	O
primary	cell_type
T	cell_type
cells	cell_type
because	O
of	O
its	O
ability	O
to	O
maintain	O
NF-kappa	protein
B	protein
elevated	O
in	O
the	O
nucleus	O
of	O
T	cell_type
cells	cell_type
.	O

Hypoxia	O
enhances	O
induction	O
of	O
endothelial	protein
ICAM-1	protein
:	O
role	O
for	O
metabolic	O
acidosis	O
and	O
proteasomes	protein
.	O
Intercellular	protein
adhesion	protein
molecule	protein
1	protein
(	O
ICAM-1	protein
)	O
is	O
an	O
important	O
molecule	O
in	O
promotion	O
of	O
polymorphonuclear	O
neutrophil	O
transendothelial	O
migration	O
during	O
inflammation	O
.	O
Coincident	O
with	O
many	O
inflammatory	O
diseases	O
is	O
tissue	O
hypoxia	O
.	O
Thus	O
we	O
hypothesized	O
that	O
combinations	O
of	O
hypoxia	O
and	O
inflammatory	O
stimuli	O
may	O
differentially	O
regulate	O
expression	O
of	O
endothelial	protein
ICAM-1	protein
.	O
Human	cell_type
endothelial	cell_type
cells	cell_type
were	O
exposed	O
to	O
hypoxia	O
in	O
the	O
presence	O
or	O
absence	O
of	O
added	O
lipopolysaccharide	O
(	O
LPS	O
)	O
and	O
examined	O
for	O
expression	O
of	O
functional	O
ICAM-1	protein
.	O
Although	O
hypoxia	O
alone	O
did	O
not	O
induce	O
ICAM-1	protein
,	O
the	O
combination	O
of	O
LPS	O
and	O
hypoxia	O
enhanced	O
(3	O
+/-	O
0.4-fold	O
over	O
normoxia)	O
ICAM-1	protein
expression	O
.	O
Combinations	O
of	O
hypoxia	O
and	O
LPS	O
significantly	O
increased	O
lymphocyte	O
binding,	O
and	O
such	O
increases	O
were	O
inhibited	O
by	O
addition	O
of	O
anti-	protein
ICAM-1	protein
antibodies	protein
or	O
antisense	O
oligonucleotides	O
.	O
Hypoxic	O
endothelia	O
showed	O
a	O
&gt;	O
10-fold	O
increase	O
in	O
sensitivity	O
to	O
inhibitors	O
of	O
proteasome	protein
activation	O
,	O
and	O
combinations	O
of	O
hypoxia	O
and	O
LPS	O
enhanced	O
proteasome	protein
-dependent	O
cytoplasmic-to-nuclear	O
localization	O
of	O
the	O
nuclear	protein
transcription	protein
factor-kappa	protein
B	protein
p65	protein
(Rel	protein
A)	protein
subunit	protein
.	O
Such	O
proteasome	protein
activation	O
correlated	O
with	O
hypoxia	O
-evoked	O
decreases	O
in	O
both	O
extracellular	O
and	O
intracellular	O
pH	O
.	O
We	O
conclude	O
from	O
these	O
studies	O
that	O
endothelial	O
hypoxia	O
provides	O
a	O
novel,	O
proteasome	protein
-dependent	O
stimulus	O
for	O
ICAM-1	protein
induction	O
.	O

Differanisole	O
A	O
,	O
a	O
novel	O
antitumor	O
antibiotic	O
,	O
enhances	O
growth	O
inhibition	O
and	O
differentiation	O
of	O
human	cell_type
myeloid	cell_type
leukemia	cell_type
cells	cell_type
induced	O
by	O
9-cis	O
retinoic	O
acid	O
.	O
Differanisole	O
A	O
,	O
3,5-dichloro-2-hydroxy-4-methoxy-6-n-propylbenzoic	O
acid	O
,	O
inhibited	O
growth	O
of	O
human	cell_type
myeloid	cell_type
leukemia	cell_type
cells	cell_type
.	O
The	O
compound	O
induced	O
G1	O
arrest	O
and	O
granulocytic	O
differentiation	O
of	O
HL-60	cell_line
cells	cell_line
,	O
although	O
the	O
differentiation-inducing	O
effect	O
was	O
modest.	O
Differanisole	O
A	O
and	O
9-cis	O
retinoic	O
acid	O
(	O
9cisRA	O
)	O
synergistically	O
inhibited	O
the	O
growth	O
and	O
induced	O
functional	O
and	O
morphologic	O
differentiation	O
of	O
HL-60	O
and	O
NB4	O
cells	O
,	O
whereas	O
the	O
combined	O
treatment	O
with	O
differanisole	O
A	O
and	O
all-trans	O
retinoic	O
acid	O
or	O
1alpha,25-dihydroxyvitamin	O
D3	O
was	O
less	O
effective.	O
Similar	O
results	O
were	O
obtained	O
in	O
primary	O
culture	O
of	O
leukemia	cell_type
cells	cell_type
from	O
a	O
patient	O
with	O
acute	O
promyelocytic	O
leukemia	O
.	O
The	O
synergistic	O
effect	O
on	O
growth	O
inhibition	O
and	O
induction	O
of	O
differentiation	O
required	O
simultaneous	O
treatment	O
with	O
differanisole	O
A	O
and	O
9cisRA	O
.	O
Differanisole	O
A	O
and	O
an	O
RXR-specific	O
ligand	O
(	O
Ro47-5944	O
)	O
cooperatively	O
inhibited	O
the	O
cell	O
growth,	O
while	O
the	O
combined	O
effect	O
of	O
differanisole	O
A	O
and	O
an	O
RAR-specific	O
ligand	O
Am80	O
was	O
just	O
additive.	O
Differanisole	O
A	O
in	O
combination	O
with	O
9cisRA	O
may	O
have	O
implications	O
for	O
therapy	O
of	O
acute	O
promyelocytic	O
leukemia	O
patients	O
.	O

The	O
activation	O
of	O
the	O
JAK2	protein
/STAT5	protein
pathway	O
is	O
commonly	O
involved	O
in	O
signaling	O
through	O
the	O
human	protein
IL-5	protein
receptor	protein
.	O
The	O
JAK	protein
(	protein
Janus	protein
kinase	protein
)	protein
family	protein
of	O
protein	protein
tyrosine	protein
kinases	protein
and	O
the	O
STATs	protein
(	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
)	O
have	O
been	O
shown	O
to	O
be	O
activated	O
in	O
response	O
to	O
a	O
number	O
of	O
cytokines	protein
and	O
growth	protein
factors	protein
.	O
In	O
this	O
study,	O
we	O
evaluated	O
the	O
activation	O
of	O
JAK	protein
/STAT	protein
pathway	O
upon	O
human	protein
interleukin-5	protein
(	O
hIL-5	protein
)	O
stimulation	O
of	O
two	O
different	O
hIL-5	cell_line
-responsive	cell_line
cell	cell_line
lines	cell_line
,	O
hIL-5	cell_line
receptor	cell_line
alpha-subunit	cell_line
(	cell_line
hIL-5R	cell_line
alpha	cell_line
)	cell_line
cDNA-transfected	cell_line
TF-1	cell_line
(	O
TF-h5R	cell_line
alpha	cell_line
)	O
and	O
butyric-acid	cell_line
-treated	cell_line
YY-1	cell_line
(	O
YY-Bu	cell_line
),	O
and	O
peripheral	cell_line
eosinophils	cell_line
.	O
Immunoprecipitation	O
and	O
electrophoretic	O
mobility	O
shift	O
analysis	O
revealed	O
that	O
tyrosine	O
phosphorylation	O
of	O
JAK2	protein
and	O
activation	O
of	O
STAT5	protein
were	O
induced	O
upon	O
stimulation	O
with	O
hIL-5	protein
in	O
all	O
three	O
cell	O
types,	O
while	O
STAT1	protein
activation	O
was	O
only	O
observed	O
in	O
eosinophils	cell_type
.	O
These	O
results	O
indicate	O
that	O
JAK2	protein
/STAT5	protein
activation	O
is	O
a	O
common	O
JAK	protein
/STAT	protein
pathway	O
for	O
hIL-5	protein
-mediated	O
signal	O
in	O
these	O
cells.	O

Dysregulation	O
of	O
monocytic	protein
nuclear	protein
factor-kappa	protein
B	protein
by	O
oxidized	O
low-density	protein
lipoprotein	protein
.	O
Nuclear	protein
factor-kappa	protein
B	protein
(	protein
NF-kappa	protein
B	protein
)/Rel	protein
transcription	protein
factors	protein
may	O
be	O
involved	O
in	O
atherosclerosis	O
,	O
as	O
is	O
suggested	O
by	O
the	O
presence	O
of	O
activated	O
NF-kappa	protein
B	protein
in	O
human	O
atherosclerotic	O
lesions	O
.	O
The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
effects	O
of	O
oxidized	protein
LDL	protein
(	O
oxLDL	protein
)	O
on	O
the	O
NF-kappa	protein
B	protein
system	O
in	O
human	O
THP-1	cell_line
monocytic	cell_line
cells	cell_line
as	O
well	O
as	O
adherent	cell_type
monocytes	cell_type
.	O
Our	O
results	O
demonstrate	O
that	O
short-term	O
incubation	O
of	O
these	O
cells	O
with	O
oxLDL	protein
activated	protein
p50/p65	protein
containing	O
NF-kappa	protein
B	protein
dimers	protein
and	O
induced	O
the	O
expression	O
of	O
the	O
target	DNA
gene	DNA
IL-8	DNA
.	O
This	O
activation	O
of	O
NF-kappa	protein
B	protein
was	O
inhibited	O
by	O
the	O
antioxidant	O
and	O
H2O2	O
scavenger	O
pyrrolidine	O
dithiocarbamate	O
and	O
the	O
proteasome	protein
inhibitor	O
PSI	O
.	O
The	O
oxLDL	protein
-induced	O
NF-kappa	protein
B	protein
activation	O
was	O
accompanied	O
by	O
an	O
initial	O
depletion	O
of	O
I	protein
kappa	protein
B-alpha	protein
followed	O
by	O
a	O
slight	O
transient	O
increase	O
in	O
the	O
level	O
of	O
this	O
inhibitor	O
protein.	O
In	O
contrast,	O
long-term	O
treatment	O
with	O
oxLDL	protein
prevented	O
the	O
lipopolysaccharide	O
-induced	O
depletion	O
of	O
I	protein
kappa	protein
B-alpha	protein
,	O
accompanied	O
by	O
an	O
inhibition	O
of	O
both	O
NF-kappa	protein
B	protein
activation	O
and	O
the	O
expression	O
of	O
tumor	O
necrosis	O
factor-alpha	O
and	O
interleukin-1	O
beta	O
genes	O
.	O
These	O
observations	O
provide	O
additional	O
evidence	O
that	O
oxLDL	protein
is	O
a	O
potent	O
modulator	O
of	O
gene	O
expression	O
and	O
suggest	O
that	O
(dys)regulation	O
of	O
NF-kappa	protein
B	protein
/Rel	protein
is	O
likely	O
to	O
play	O
an	O
important	O
role	O
in	O
atherogenesis	O
.	O

Suppression	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
and	O
CD18	protein
-mediated	O
leukocyte	O
adhesion	O
to	O
the	O
corneal	O
endothelium	O
by	O
dexamethasone	O
.	O
PURPOSE:	O
To	O
demonstrate	O
that	O
leukocyte	O
adhesion	O
to	O
cultured	cell_line
corneal	cell_line
endothelial	cell_line
cells	cell_line
is	O
mediated	O
by	O
the	O
CD18	protein
antigen	protein
,	O
and	O
to	O
determine	O
whether	O
dexamethasone	O
directly	O
suppresses	O
adhesion	O
by	O
inhibiting	O
activation	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NFkappaB	protein
).	O
METHODS:	O
Cultured	O
bovine	O
corneal	O
endothelium	O
was	O
stimulated	O
for	O
6	O
hours	O
by	O
40	O
micron/ml	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNFalpha	protein
).	O
Dexamethasone	O
was	O
added	O
1	O
hour	O
before	O
TNFalpha	protein
stimulation	O
in	O
the	O
dexamethasone	O
group	O
.	O
After	O
stimulation,	O
neutrophils	O
separated	O
from	O
a	O
healthy	O
human	O
volunteer	O
were	O
added	O
with	O
or	O
without	O
anti-	protein
CD18	protein
antibody	protein
.	O
The	O
culture	O
plate	O
was	O
settled	O
for	O
15	O
minutes	O
at	O
37	O
degrees	O
C,	O
and	O
then	O
neutrophils	cell_type
were	O
activated	O
by	O
N-formyl-methionyl-leucyl-phenylalanine	O
for	O
5	O
minutes.	O
Nonadherent	O
neutrophils	cell_type
were	O
removed	O
by	O
sealing	O
and	O
inverting	O
the	O
culture	O
well.	O
The	O
intracellular	O
localization	O
of	O
NFkappaB	protein
after	O
TNFalpha	protein
simulation	O
was	O
determined	O
by	O
confocal	O
immunocytochemistry	O
using	O
an	O
anti-p65	protein
antibody	protein
.	O
RESULTS:	O
Neutrophil	O
adhesion	O
to	O
cultured	cell_line
corneal	cell_line
endothelial	cell_line
cells	cell_line
increased	O
significantly	O
on	O
exposure	O
to	O
TNFalpha	protein
(451.4+/-45.4	O
cells/mm2,	O
n	O
=	O
16)	O
compared	O
to	O
control	O
(156.7+/-27.3	O
cells/mm2,	O
n	O
=	O
16,	O
P	O
&lt;	O
0.01).	O
This	O
increased	O
adhesion	O
was	O
suppressed	O
by	O
the	O
addition	O
of	O
anti-	protein
CD18	protein
antibody	protein
(157.6+/-25.1	O
cells/mm2,	O
n	O
=	O
8,	O
P	O
&lt;	O
0.01)	O
and	O
by	O
pretreatment	O
with	O
10(-7)	O
M	O
dexamethasone	O
(207.9+/-31.5	O
cells/mm2,	O
n	O
=	O
10,	O
P	O
&lt;	O
0.01).	O
Immunocytochemistry	O
60	O
minutes	O
after	O
stimulation	O
revealed	O
that	O
NFkappaB	protein
was	O
located	O
in	O
the	O
cytoplasm	O
in	O
unstimulated	cell_type
cells	cell_type
;	O
however,	O
the	O
addition	O
of	O
TNFalpha	protein
caused	O
NFkappaB	protein
to	O
translocate	O
into	O
the	O
nucleus	O
.	O
Pretreatment	O
with	O
dexamethasone	O
tapered	O
NFkappaB	protein
translocation	O
into	O
the	O
nucleus	O
.	O
CONCLUSIONS:	O
Leukocyte	O
adhesion	O
to	O
the	O
corneal	O
endothelium	O
was	O
shown	O
to	O
be	O
mediated	O
by	O
CD18	protein
expressed	O
on	O
activated	cell_type
leukocytes	cell_type
.	O
Pretreatment	O
of	O
the	O
endothelium	O
with	O
dexamethasone	O
inhibited	O
leukocyte	O
adhesion	O
;	O
this	O
may	O
be	O
due	O
in	O
part	O
to	O
the	O
suppression	O
of	O
NFkappaB	protein
entry	O
into	O
the	O
nucleus	O
.	O

Molecular	O
characterization	O
and	O
pattern	O
of	O
tissue	O
expression	O
of	O
the	O
gene	O
for	O
neutrophil	protein
gelatinase-associated	protein
lipocalin	protein
from	O
humans	O
.	O
Neutrophil	protein
gelatinase-associated	protein
lipocalin	protein
(	O
NGAL	protein
)	O
is	O
a	O
25-kDa	protein
lipocalin	protein
first	O
identified	O
as	O
a	O
protein	O
stored	O
in	O
specific	O
granules	O
of	O
the	O
human	cell_type
neutrophil	cell_type
.	O
The	O
protein	O
is	O
believed	O
to	O
bind	O
small	O
lipophilic	O
substances	O
such	O
as	O
bacterial	O
derived	O
formylpeptides	O
and	O
lipopolysaccharides	O
(	O
LPS	O
)	O
and	O
might	O
function	O
as	O
a	O
modulator	O
of	O
inflammation	O
.	O
To	O
characterize	O
the	O
regulation	O
of	O
NGAL	protein
further,	O
we	O
have	O
cloned	O
and	O
sequenced	O
a	O
5869-bp	DNA
region	DNA
of	O
the	O
NGAL	DNA
gene	DNA
including	O
1695	O
bp	O
of	O
the	O
5'	DNA
nontranscribed	DNA
region	DNA
and	O
a	O
3696-bp	DNA
coding	DNA
region	DNA
encompassing	O
seven	DNA
exons	DNA
and	DNA
six	DNA
introns	DNA
.	O
The	O
transcriptional	DNA
start	DNA
sites	DNA
were	O
identified	O
by	O
an	O
RNase	protein
protection	O
assay	O
.	O
The	O
NGAL	protein
gene	O
is	O
highly	O
homologous	O
to	O
the	O
mouse	DNA
gene	DNA
24p3	DNA
.	O
NGAL	protein
was	O
expressed	O
in	O
bone	O
marrow	O
and	O
in	O
tissues	O
that	O
are	O
prone	O
to	O
exposure	O
to	O
microorganisms	O
.	O
Potential	O
cis-acting	DNA
elements	DNA
were	O
identified	O
in	O
the	O
promoter	DNA
region	DNA
of	O
the	O
NGAL	DNA
gene	DNA
by	O
computer	O
analysis	O
and	O
include	O
binding	DNA
sites	DNA
for	O
CTF/CBP	protein
,	O
the	O
hematopoietic	protein
transcription	protein
factors	protein
GATA-1	protein
and	O
PU.1	protein
,	O
and	O
the	O
LPS	protein
-inducible	protein
factor	protein
NF-kappa	protein
B	protein
.	O

Human	cell_type
neutrophils	cell_type
express	O
GH-N	RNA
gene	RNA
transcripts	RNA
and	O
the	O
pituitary	protein
transcription	protein
factor	protein
Pit-1b	protein
.	O
Since	O
GH	protein
stimulates	O
the	O
development	O
and	O
function	O
of	O
granulocytes	cell_type
,	O
we	O
investigated	O
the	O
expression	O
of	O
GH	protein
in	O
granulocyte	cell_type
subsets	cell_type
.	O
By	O
immunocytochemistry	O
,	O
25	O
+/-	O
7%	O
of	O
the	O
human	cell_type
neutrophils	cell_type
were	O
shown	O
to	O
express	O
immunoreactive	protein
GH	protein
,	O
whereas	O
eosinophils	cell_type
were	O
negative.	O
Reversed	O
transcription	O
(RT)-PCR	O
analysis	O
demonstrated	O
GH	RNA
mRNA	RNA
in	O
neutrophils	cell_type
.	O
Restriction	O
analysis	O
revealed	O
that	O
neutrophils	cell_type
express	O
the	O
GH-N	DNA
gene	DNA
but	O
not	O
the	O
GH-V	DNA
gene	DNA
.	O
Furthermore,	O
we	O
demonstrated	O
by	O
western	O
blot	O
analysis	O
that	O
neutrophils	cell_type
express	O
an	O
alternatively	O
spliced	O
variant	O
of	O
the	O
pituitary	protein
transcription	protein
factor	protein
Pit-1	protein
,	O
designated	O
Pit-1b	protein
.	O

The	O
ability	O
of	O
BHRF1	protein
to	O
inhibit	O
apoptosis	O
is	O
dependent	O
on	O
stimulus	O
and	O
cell	O
type.	O
The	O
development	O
of	O
resistance	O
to	O
host	O
defense	O
mechanisms	O
such	O
as	O
tumor	O
necrosis	O
factor	O
(TNF)-	O
and	O
Fas-	O
mediated	O
apoptosis	O
of	O
transformed	cell_type
or	O
virus-infected	cell_type
cells	cell_type
may	O
be	O
a	O
critical	O
component	O
in	O
the	O
development	O
of	O
disease.	O
To	O
find	O
genes	O
that	O
protect	O
cells	O
from	O
apoptosis	O
,	O
we	O
used	O
an	O
expression	O
cloning	O
strategy	O
and	O
identified	O
BHRF1	protein
,	O
an	O
Epstein-Barr	protein
virus	protein
(	protein
EBV	protein
)	protein
early-lytic-cycle	protein
protein	protein
with	O
distant	O
homology	O
to	O
Bcl-2	protein
,	O
as	O
an	O
anti-	protein
apoptosis	protein
protein	protein
.	O
Expression	O
of	O
BHRF1	protein
in	O
MCF-Fas	cell_line
cells	cell_line
conferred	O
nearly	O
complete	O
resistance	O
against	O
both	O
anti-Fas	protein
antibody	protein
and	O
TNF-mediated	O
apoptosis	O
.	O
In	O
addition,	O
BHRF1	protein
protected	O
these	O
cells	O
from	O
monocyte-mediated	O
killing	O
but	O
failed	O
to	O
protect	O
them	O
from	O
killing	O
mediated	O
by	O
lymphokine-activated	cell_type
killer	cell_type
cells	cell_type
.	O
The	O
ability	O
of	O
BHRF1	protein
to	O
protect	O
MCF-Fas	cell_line
cells	cell_line
from	O
apoptosis	O
induced	O
by	O
various	O
stimuli	O
was	O
identical	O
to	O
that	O
of	O
Bcl-2	protein
and	O
Bcl-xL	protein
.	O
Moreover,	O
the	O
mechanism	O
of	O
action	O
of	O
BHRF1	protein
resembled	O
that	O
of	O
Bcl-2	protein
and	O
Bcl-xL	protein
as	O
it	O
inhibited	O
TNF-	O
and	O
anti-Fas-	O
induced	O
activation	O
of	O
two	O
enzymes	O
participating	O
in	O
the	O
apoptosis	O
pathway	O
,	O
cytosolic	protein
phospholipase	protein
A2	protein
and	O
caspase-3/CPP32	protein
,	O
but	O
did	O
not	O
interfere	O
with	O
the	O
activation	O
of	O
NF-kappaB	protein
-like	protein
transcription	protein
factors	protein
.	O
A	O
putative	O
function	O
of	O
BHRF1	protein
in	O
EBV	cell_type
-infected	cell_type
epithelial	cell_type
cells	cell_type
may	O
be	O
to	O
protect	O
virus-infected	O
cells	O
from	O
TNF-	O
and/or	O
anti-Fas-	O
induced	O
cell	O
death	O
in	O
order	O
to	O
maximize	O
virus	O
production.	O
Surprisingly,	O
expression	O
of	O
neither	O
BHRF1	protein
nor	O
Bcl-2	protein
in	O
a	O
B-cell	cell_line
line	cell_line
,	O
BJAB	cell_line
,	O
protected	O
the	O
cells	O
from	O
anti-Fas-mediated	O
apoptosis	O
even	O
though	O
they	O
increased	O
the	O
survival	O
of	O
serum-starved	cell_type
cells	cell_type
.	O
Thus,	O
the	O
protective	O
role	O
of	O
BHRF1	protein
against	O
apoptosis	O
resembles	O
that	O
of	O
Bcl-2	protein
in	O
being	O
cell	O
type	O
specific	O
and	O
dependent	O
on	O
the	O
apoptotic	O
stimulus	O
.	O

Genomic	O
organization	O
,	O
sequence	O
,	O
and	O
transcriptional	O
regulation	O
of	O
the	O
human	DNA
eotaxin	DNA
gene	DNA
.	O
Eotaxin	protein
is	O
an	O
eosinophil	protein
specific	protein
beta-chemokine	protein
assumed	O
to	O
be	O
involved	O
in	O
eosinophilic	O
inflammatory	O
diseases	O
such	O
as	O
atopic	O
dermatitis	O
,	O
allergic	O
rhinitis	O
,	O
asthma	O
and	O
parasitic	O
infections	O
.	O
Its	O
expression	O
is	O
stimulus-	O
and	O
cell-specific.	O
We	O
here	O
describe	O
the	O
genomic	O
organisation	O
(3	O
exons	DNA
of	O
132,	O
112	O
and	O
542	O
bp	O
and	O
2	O
introns	DNA
of	O
1211	O
and	O
378	O
bp)	O
and	O
sequence	O
including	O
3	O
kb	O
of	O
DNA	O
from	O
the	O
immediate	O
5'	DNA
upstream	DNA
region	DNA
of	O
the	O
human	DNA
eotaxin	DNA
gene	DNA
.	O
Among	O
the	O
regulatory	DNA
promoter	DNA
elements	DNA
potentially	O
regulating	O
eotaxin	DNA
gene	DNA
expression	O
and/or	O
mediating	O
the	O
effects	O
of	O
anti-inflammatory	O
drugs	O
we	O
identified	O
consensus	DNA
sequences	DNA
known	O
to	O
interact	O
with	O
nuclear	protein
factors	protein
like	O
NF-IL6	protein
,	O
AP-1	protein
,	O
a	O
NF-kappa-B	DNA
like	DNA
consensus	DNA
sequence	DNA
and	O
gamma-interferon-	O
as	O
well	O
as	O
glucocorticoid	O
response	O
elements	O
.	O

Differential	O
interaction	O
of	O
nuclear	protein
factors	protein
with	O
the	O
leukocyte-specific	DNA
pp52	DNA
promoter	DNA
in	O
B	O
and	O
T	O
cells	O
.	O
The	O
leukocyte-specific,	O
cytoskeleton-binding	O
pp52	O
(LSP-1,	O
WP-34)	O
protein	O
is	O
widely	O
expressed	O
in	O
multiple	O
leukocyte	O
lineages,	O
including	O
B	O
and	O
T	O
lymphocytes	O
,	O
granulocytes	cell_type
,	O
and	O
macrophages	cell_type
.	O
We	O
previously	O
detected	O
a	O
tissue-specific	DNA
promoter	DNA
preceding	O
the	O
exon	O
encoding	O
the	O
N	protein
terminus	protein
of	O
the	O
pp52	protein
leukocyte	protein
protein	protein
.	O
Here	O
we	O
describe	O
the	O
functional	O
characterization	O
of	O
this	O
promoter	O
and	O
identification	O
of	O
the	O
factors	O
in	O
B	O
and	O
T	O
cells	O
that	O
regulate	O
its	O
activity.	O
The	O
pp52	DNA
promoter	DNA
contains	O
an	O
initiator	O
specifying	O
the	O
unique	O
5'	DNA
terminus	DNA
of	O
pp52	RNA
mRNA	RNA
,	O
tandem	O
pairs	O
of	O
Ets	O
and	O
SP1	O
motifs	O
,	O
and	O
a	O
lone	DNA
C/EBP	DNA
motif	DNA
.	O
All	O
these	O
motifs	O
are	O
essential	O
and	O
collectively	O
control	O
transcriptional	O
activity	O
.	O
DNA	O
binding	O
studies	O
and	O
Ab	O
supershift	O
assays	O
revealed	O
that	O
different	O
combinations	O
of	O
factors	O
interact	O
with	O
these	O
motifs	O
in	O
B	cell_type
cells	cell_type
vs	O
T	cell_type
cells	cell_type
.	O
The	O
Ets	DNA
motifs	DNA
are	O
preferentially	O
bound	O
by	O
PU-1	protein
in	O
B	O
cell	O
extracts	O
from	O
all	O
stages	O
of	O
development,	O
whereas	O
a	O
different	O
Ets	protein
family	protein
member	protein
reacts	O
with	O
these	O
motifs	O
in	O
T	O
cell	O
extracts	O
.	O
The	O
C/EBP	DNA
motif	DNA
is	O
bound	O
by	O
Ig/EBP-1	protein
in	O
pre-B	O
cell	O
and	O
T	O
cell	O
extracts	O
,	O
but	O
is	O
replaced	O
by	O
nuclear	protein
factor-IL-6beta	protein
or	O
a	O
nuclear	protein
factor-IL-6beta	protein
-Ig/EBP-1	protein
heterodimer	protein
in	O
plasmacytoma	O
cell	O
extracts.	O
Despite	O
its	O
reported	O
role	O
as	O
a	O
negative	O
regulator	O
of	O
transcription,	O
Ig/EBP-1	protein
appears	O
to	O
exert	O
a	O
stimulatory	O
effect	O
on	O
this	O
promoter	DNA
.	O
These	O
findings	O
reveal	O
the	O
features	O
controlling	O
the	O
pp52	DNA
promoter	DNA
in	O
B	O
and	O
T	O
cells	O
and	O
provide	O
the	O
foundation	O
for	O
determining	O
the	O
regulation	O
of	O
this	O
promoter	DNA
in	O
other	O
leukocyte	cell_type
lineages	cell_type
.	O

Regulation	O
of	O
B-cell	O
commitment	O
to	O
plasma	cell_type
cells	cell_type
or	O
to	O
memory	cell_type
B	cell_type
cells	cell_type
.	O
During	O
humoral	O
immune	O
responses	O
,	O
B-lymphocyte	O
activation	O
is	O
followed	O
by	O
differentiation	O
along	O
either	O
the	O
plasma	O
cell	O
pathway	O
or	O
the	O
memory	O
B-cell	O
pathway	O
.	O
Recent	O
studies	O
suggest	O
that	O
CD40-CD40	protein
ligand	protein
,	O
OX-OX40	protein
ligand	protein
,	O
a	O
group	O
of	O
cytokines	protein
and	O
intracellular	O
transcriptional	O
factors	O
may	O
all	O
contribute	O
to	O
B-lymphocyte	O
differentiation	O
control	O
.	O

Transcription	protein
factor	protein
binding	O
sites	O
downstream	O
of	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
type	DNA
1	DNA
transcription	DNA
start	DNA
site	DNA
are	O
important	O
for	O
virus	O
infectivity	O
.	O
When	O
transcriptionally	O
active,	O
the	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
promoter	DNA
contains	O
a	O
nucleosome-free	O
region	O
encompassing	O
both	O
the	O
promoter	DNA
/enhancer	DNA
region	DNA
and	O
a	O
large	O
region	O
(	O
255	DNA
nucleotides	DNA
[nt])	O
downstream	O
of	O
the	O
transcription	DNA
start	DNA
site	DNA
.	O
We	O
have	O
previously	O
identified	O
new	O
binding	O
sites	O
for	O
transcription	protein
factors	protein
downstream	O
of	O
the	O
transcription	DNA
start	DNA
site	DNA
(	O
nt	DNA
465	DNA
to	DNA
720	DNA
):	O
three	O
AP-1	DNA
sites	DNA
(I,	O
II,	O
and	O
III),	O
an	O
AP3-like	DNA
motif	DNA
(	O
AP3-L	DNA
),	O
a	O
downstream	DNA
binding	DNA
factor	DNA
(DBF)	DNA
site	DNA
,	O
and	O
juxtaposed	DNA
Sp1	DNA
sites	DNA
.	O
Here,	O
we	O
show	O
that	O
the	O
DBF	DNA
site	DNA
is	O
an	O
interferon-responsive	DNA
factor	DNA
(IRF)	DNA
binding	DNA
site	DNA
and	O
that	O
the	O
AP3-L	DNA
motif	DNA
binds	O
the	O
T-cell-specific	protein
factor	protein
NF-AT	protein
.	O
Mutations	O
that	O
abolish	O
the	O
binding	O
of	O
each	O
factor	O
to	O
its	O
cognate	O
site	O
are	O
introduced	O
in	O
an	O
infectious	O
HIV-1	O
molecular	O
clone	O
to	O
study	O
their	O
effect	O
on	O
HIV-1	O
transcription	O
and	O
replication.	O
Individual	O
mutation	O
of	O
the	O
DBF	O
or	O
AP3-L	DNA
site	O
as	O
well	O
as	O
the	O
double	O
mutation	DNA
AP-1(III)/	DNA
AP3-L	DNA
did	O
not	O
affect	O
HIV-1	O
replication	O
compared	O
to	O
that	O
of	O
the	O
wild-type	O
virus	O
.	O
In	O
contrast,	O
proviruses	O
carrying	O
mutations	O
in	O
the	O
Sp1	DNA
sites	DNA
were	O
totally	O
defective	O
in	O
terms	O
of	O
replication.	O
Virus	O
production	O
occurred	O
with	O
slightly	O
delayed	O
kinetics	O
for	O
viruses	O
containing	O
combined	O
mutations	O
in	O
the	O
AP-1(III)	DNA
,	O
AP3-L	DNA
,	O
and	O
DBF	DNA
sites	DNA
and	O
in	O
the	O
AP3-L	DNA
and	O
DBF-sites	DNA
,	O
whereas	O
viruses	O
mutated	O
in	O
the	O
AP-1(I,II,III)	DNA
and	O
AP3-L	DNA
sites	DNA
and	O
in	O
the	O
AP-1(I,II,III),	O
AP3-L	DNA
,	O
and	O
DBF	DNA
sites	DNA
exhibited	O
a	O
severely	O
defective	O
replicative	O
phenotype.	O
No	O
RNA-packaging	O
defect	O
could	O
be	O
measured	O
for	O
any	O
of	O
the	O
mutant	O
viruses	O
as	O
determined	O
by	O
quantification	O
of	O
their	O
HIV	RNA
genomic	RNA
RNA	RNA
.	O
Measurement	O
of	O
the	O
transcriptional	O
activity	O
of	O
the	O
HIV-1	DNA
promoter	DNA
after	O
transient	O
transfection	O
of	O
the	O
HIV-1	DNA
provirus	DNA
DNA	DNA
or	O
of	O
long	DNA
terminal	DNA
repeat-luciferase	DNA
constructs	DNA
showed	O
a	O
positive	O
correlation	O
between	O
the	O
transcriptional	O
and	O
the	O
replication	O
defects	O
for	O
most	O
mutants.	O

Glucocorticoid	protein
receptor	protein
regulates	O
expression	O
of	O
L-selectin	protein
and	O
CD11/CD18	protein
on	O
human	cell_type
neutrophils	cell_type
[see	O
comments]	O
BACKGROUND:	O
Recent	O
studies	O
have	O
raised	O
the	O
hypothesis	O
that	O
glucocorticoids	O
could	O
diminish	O
the	O
ability	O
of	O
endothelial	cell_type
cells	cell_type
to	O
direct	O
leukocyte	O
traffic	O
into	O
inflamed	O
tissues	O
by	O
inhibiting	O
expression	O
of	O
the	O
adhesion	protein
molecules	protein
endothelial-leukocyte	protein
adhesion	protein
molecule-1	protein
and	O
intercellular	protein
adhesion	protein
molecule-1	protein
.	O
The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
whether	O
glucocorticoids	O
also	O
regulate	O
the	O
expression	O
of	O
L-selectin	protein
and	O
CD11/CD18	protein
integrins	protein
on	O
human	cell_type
neutrophil	cell_type
granulocytes	cell_type
.	O
METHODS	O
AND	O
RESULTS:	O
Incubation	O
of	O
human	O
whole	O
blood	O
with	O
platelet-activating	protein
factor	protein
(	O
PAF	protein
,	O
1	O
mumol/L)	O
evoked	O
downregulation	O
of	O
L-selectin	protein
and	O
upregulation	O
of	O
CD11/CD18	protein
adhesion	protein
receptors	protein
on	O
neutrophils	O
as	O
measured	O
by	O
flow	O
cytometry	O
.	O
While	O
dexamethasone	O
(0.1	O
nmol/L	O
to	O
100	O
mumol/L)	O
did	O
not	O
affect	O
expression	O
of	O
adhesion	protein
molecules	protein
on	O
resting	cell_type
neutrophils	cell_type
,	O
it	O
attenuated	O
the	O
PAF	protein
-induced	O
changes	O
in	O
L-selectin	protein
and	O
CD18	protein
expression	O
in	O
a	O
time-	O
and	O
concentration-dependent	O
fashion	O
with	O
IC50	O
values	O
of	O
31	O
and	O
13	O
nmol/L,	O
respectively.	O
These	O
effects	O
of	O
dexamethasone	O
were	O
completely	O
aborted	O
by	O
RU-486	O
(10	O
mumol/L),	O
which	O
blocks	O
transcriptional	O
activation	O
of	O
the	O
glucocorticoid	protein
receptor	protein
,	O
and	O
by	O
the	O
protein	O
synthesis	O
inhibitor	O
cycloheximide	O
(35.5	O
mumol/L).	O
Dexamethasone	O
,	O
up	O
to	O
a	O
concentration	O
of	O
1	O
mumol/L,	O
neither	O
affected	O
significantly	O
the	O
release	O
of	O
granule	protein
enzymes	protein
nor	O
interfered	O
with	O
PAF	protein
binding	O
to	O
its	O
membrane	protein
receptors	protein
.	O
CONCLUSIONS:	O
Our	O
results	O
show	O
that	O
glucocorticoids	O
at	O
clinically	O
relevant	O
concentrations	O
exert	O
specific	O
actions	O
on	O
expression	O
of	O
adhesion	protein
molecules	protein
on	O
activated	cell_type
neutrophils	cell_type
,	O
which	O
are	O
mediated	O
through	O
ligation	O
of	O
glucocorticoid	protein
receptors	protein
and	O
induction	O
of	O
protein	O
synthesis,	O
and	O
suggest	O
a	O
novel	O
mechanism	O
by	O
which	O
anti-inflammatory	O
corticosteroids	O
may	O
inhibit	O
leukocyte	O
accumulation	O
.	O

The	O
immediate-early	O
gene	O
product	O
Egr-1	protein
regulates	O
the	O
human	DNA
interleukin-2	DNA
receptor	DNA
beta-chain	DNA
promoter	DNA
through	O
noncanonical	O
Egr	O
and	O
Sp1	O
binding	O
sites	O
.	O
The	O
interleukin-2	protein
IL-2	protein
receptor	protein
beta-chain	protein
(	O
IL-2Rbeta	protein
)	O
is	O
an	O
essential	O
component	O
of	O
the	O
receptors	O
for	O
IL-2	protein
and	O
IL-15	protein
.	O
Although	O
IL-2Rbeta	protein
is	O
constitutively	O
expressed	O
by	O
lymphocytes,	O
its	O
expression	O
can	O
be	O
further	O
induced	O
by	O
a	O
number	O
of	O
stimuli,	O
including	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
).	O
We	O
have	O
now	O
characterized	O
factors	O
that	O
bind	O
to	O
an	O
enhancer	O
region	O
located	O
between	O
nucleotides	DNA
-170	DNA
and	DNA
-139	DNA
of	O
the	O
human	O
IL-2Rbeta	DNA
promoter	DNA
.	O
Both	O
Sp1	protein
and	O
Sp3	protein
bound	O
to	O
the	O
5'	DNA
portion	DNA
of	O
this	O
region,	O
whereas	O
a	O
PMA	protein
-inducible	protein
factor	protein
(	O
PIF	protein
)	O
mainly	O
bound	O
to	O
its	O
3'	DNA
portion	DNA
and	O
bound	O
to	O
the	O
Sp	DNA
binding	DNA
motifs	DNA
as	O
well.	O
In	O
Jurkat	cell_line
T	cell_line
cells	cell_line
,	O
induction	O
of	O
PIF	protein
DNA	O
binding	O
activity	O
was	O
rapidly	O
induced,	O
required	O
de	O
novo	O
protein	O
synthesis,	O
and	O
was	O
sustained	O
at	O
a	O
high	O
level	O
for	O
at	O
least	O
23	O
h.	O
Interestingly,	O
PIF	protein
was	O
constitutively	O
activated	O
in	O
human	cell_line
T-cell	cell_line
leukemia	cell_line
virus	cell_line
type	cell_line
1	cell_line
-transformed	cell_line
MT-2	cell_line
cells	cell_line
.	O
In	O
this	O
paper,	O
we	O
demonstrate	O
that	O
PIF	protein
is	O
Egr-1	protein
based	O
on	O
its	O
recognition	O
by	O
anti-	O
Egr-1	protein
antisera	O
in	O
gel	O
mobility	O
shift	O
assays	O
,	O
even	O
though	O
the	O
IL-2Rbeta	DNA
DNA	DNA
binding	DNA
motif	DNA
differed	O
substantially	O
from	O
the	O
canonical	O
Egr-1	DNA
binding	DNA
site	DNA
.	O
In	O
addition,	O
Egr-1	protein
bound	O
to	O
the	O
Sp	DNA
binding	DNA
site	DNA
.	O
In	O
Jurkat	cell_line
cells	cell_line
,	O
both	O
sites	O
were	O
required	O
for	O
maximal	O
IL-2Rbeta	protein
promoter	O
activity	O
,	O
and	O
in	O
HeLaS3	O
cells,	O
transfection	O
of	O
Egr-1	protein
could	O
drive	O
activity	O
of	O
a	O
reporter	O
construct	O
containing	O
both	O
sites.	O
Moreover,	O
Sp1	protein
and	O
Egr-1	protein
could	O
form	O
a	O
complex	O
with	O
kinetics	O
that	O
correlated	O
with	O
the	O
production	O
of	O
Egr-1	protein
in	O
Jurkat	cell_line
cells	cell_line
upon	O
PMA	O
stimulation.	O
Thus,	O
Sp1	protein
and	O
Egr-1	protein
physically	O
and	O
functionally	O
cooperate	O
to	O
mediate	O
maximal	O
IL-2Rbeta	DNA
promoter	DNA
activity	O
.	O

Overexpression	O
of	O
HSF2-beta	protein
inhibits	O
hemin	protein
-induced	O
heat	O
shock	O
gene	O
expression	O
and	O
erythroid	O
differentiation	O
in	O
K562	cell_line
cells	cell_line
.	O
Acquisition	O
of	O
heat	O
shock	O
factor	O
2	O
(HSF2)	O
DNA	O
binding	O
activity	O
is	O
accompanied	O
by	O
induced	O
transcription	O
of	O
heat	DNA
shock	DNA
genes	DNA
in	O
hemin-treated	O
K562	cell_line
cells	cell_line
undergoing	O
erythroid	O
differentiation	O
.	O
Previous	O
studies	O
revealed	O
that	O
HSF2	protein
consists	O
of	O
two	O
alternatively	O
spliced	O
isoforms,	O
HSF2-alpha	protein
and	O
HSF2-beta	protein
,	O
whose	O
relative	O
abundance	O
is	O
developmentally	O
regulated	O
and	O
varies	O
between	O
different	O
tissues.	O
To	O
investigate	O
whether	O
the	O
molar	O
ratio	O
of	O
HSF2-alpha	protein
and	O
HSF2-beta	protein
isoforms	O
is	O
crucial	O
for	O
the	O
activation	O
of	O
HSF2	protein
and	O
whether	O
the	O
HSF2	protein
isoforms	O
play	O
functionally	O
distinct	O
roles	O
during	O
the	O
hemin-mediated	O
erythroid	O
differentiation	O
,	O
we	O
generated	O
cell	O
clones	O
expressing	O
different	O
levels	O
of	O
HSF2-alpha	protein
and	O
HSF2-beta	protein
.	O
We	O
show	O
that	O
in	O
parental	O
K562	cell_line
cells	cell_line
,	O
the	O
HSF2-alpha	protein
isoform	protein
is	O
predominantly	O
expressed	O
and	O
HSF2	protein
can	O
be	O
activated	O
upon	O
hemin	O
treatment.	O
In	O
contrast,	O
when	O
HSF2-beta	protein
is	O
expressed	O
at	O
levels	O
exceeding	O
those	O
of	O
endogenous	protein
HSF2-alpha	protein
,	O
the	O
hemin-induced	O
DNA	O
binding	O
activity	O
and	O
transcription	O
of	O
heat	DNA
shock	DNA
genes	DNA
are	O
repressed,	O
whereas	O
overexpression	O
of	O
HSF2-alpha	protein
results	O
in	O
an	O
enhanced	O
hemin	protein
response	O
.	O
Furthermore,	O
the	O
hemin	protein
-induced	O
accumulation	O
of	O
globin	protein
,	O
known	O
as	O
a	O
marker	O
of	O
erythroid	O
differentiation	O
,	O
is	O
decreased	O
in	O
cells	O
overexpressing	O
HSF2-beta	protein
.	O
We	O
suggest	O
that	O
HSF2-beta	protein
acts	O
as	O
a	O
negative	O
regulator	O
of	O
HSF2	protein
activity	O
during	O
hemin-mediated	O
erythroid	O
differentiation	O
of	O
K562	cell_line
cells	cell_line
.	O

Sequential	O
development	O
of	O
structural	O
and	O
functional	O
alterations	O
in	O
T	cell_type
cells	cell_type
from	O
tumor-bearing	O
mice	O
.	O
The	O
TCR	O
alpha	O
beta	O
or	O
-gamma	O
delta	O
chains	O
bind	O
the	O
peptide	O
ligand	O
,	O
whereas	O
the	O
associated	O
CD3	protein
delta	protein
epsilon	protein
gamma	protein
and	O
TCR	protein
zeta	protein
subunits	protein
couple	O
the	O
TCR	protein
to	O
intracellular	O
signal	O
transduction	O
components.	O
Recently,	O
several	O
groups	O
have	O
described	O
marked	O
alterations	O
in	O
signal	O
transduction	O
elements	O
in	O
T	cell_type
cells	cell_type
from	O
cancer	O
patients	O
or	O
in	O
mice	O
bearing	O
tumor	O
for	O
a	O
few	O
weeks	O
(&gt;26	O
days).	O
The	O
sequence	O
in	O
which	O
these	O
alterations	O
develop	O
is	O
unknown.	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
explore	O
the	O
kinetics	O
of	O
the	O
development	O
of	O
alterations	O
in	O
signal	O
transduction	O
molecules	O
(	O
TCR	protein
zeta	protein
chain	protein
,	O
NF	protein
kappaB	protein
family	protein
proteins	protein
,	O
and	O
tyrosine	protein
kinase	protein
p56(lck)	protein
)	O
in	O
mice	O
bearing	O
MC38	O
colon	O
adenocarcinoma	O
.	O
The	O
results	O
demonstrate	O
that	O
alterations	O
in	O
NF	protein
kappaB	protein
family	protein
proteins	protein
,	O
specifically	O
the	O
failure	O
of	O
p65	protein
translocation	O
to	O
the	O
nucleus,	O
occur	O
earlier	O
and	O
more	O
frequently	O
than	O
the	O
decrease	O
in	O
zeta-chain	protein
.	O
These	O
defects	O
are	O
paralleled	O
by	O
an	O
impaired	O
ability	O
to	O
produce	O
Th1	protein
cytokines	protein
(	O
IL-2	protein
and	O
IFN-gamma	protein
).	O
These	O
initial	O
changes	O
are	O
followed	O
by	O
the	O
eventual	O
loss	O
of	O
TCR	protein
zeta	protein
chain	protein
and	O
p56(lck)	protein
and	O
a	O
marked	O
decrease	O
in	O
cytotoxic	O
function	O
.	O
An	O
increased	O
rate	O
of	O
lysosomal	O
degradation	O
is	O
one	O
of	O
the	O
mechanisms	O
responsible	O
for	O
the	O
loss	O
of	O
zeta-chain	protein
.	O

HLA-DMA	O
and	O
HLA-DMB	O
gene	O
expression	O
functions	O
through	O
the	O
conserved	O
S-X-Y	DNA
region	DNA
.	O
The	O
MHC	protein
class	protein
II	protein
homologous	protein
proteins	protein
HLA-DMA	protein
and	O
HLA-DMB	protein
function	O
in	O
the	O
loading	O
of	O
peptides	O
onto	O
class	protein
II	protein
molecules	protein
.	O
Like	O
the	O
class	DNA
II	DNA
genes	DNA
,	O
the	O
HLA-DM	DNA
genes	DNA
contain	O
upstream	O
regulatory	O
sequences	O
similar	O
to	O
the	O
S-X-Y	DNA
regulatory	DNA
region	DNA
as	O
well	O
as	O
additional	O
putative	O
regulatory	O
sites.	O
To	O
determine	O
whether	O
the	O
DM	DNA
genes	DNA
are	O
regulated	O
in	O
a	O
similar	O
manner	O
as	O
class	DNA
II	DNA
genes	DNA
,	O
a	O
series	O
of	O
in	O
vivo	O
and	O
in	O
vitro	O
analyses	O
was	O
performed.	O
Deletion	O
analysis	O
showed	O
that	O
expression	O
from	O
the	O
DM	DNA
promoters	DNA
is	O
dependent	O
on	O
the	O
conserved	O
S-X-Y	DNA
region	DNA
.	O
The	O
class	protein
II-specific	protein
transcription	protein
factors	protein
RFX	protein
and	O
CIITA	protein
are	O
also	O
required	O
for	O
expression,	O
as	O
cell	O
lines	O
deficient	O
in	O
these	O
factors	O
failed	O
to	O
allow	O
transcription	O
from	O
the	O
DM	DNA
promoters	DNA
.	O
In	O
addition,	O
in	O
vivo	O
footprint	O
analysis	O
showed	O
the	O
putative	O
X	O
and	O
Y	O
boxes	O
to	O
be	O
occupied	O
by	O
transcription	protein
factors	protein
in	O
wild-type	cell_type
B	cell_type
cells	cell_type
,	O
but	O
not	O
in	O
RFX	cell_line
-deficient	cell_line
B	cell_line
cells	cell_line
.	O
In	O
astrocytes	cell_type
,	O
IFN-gamma	protein
treatment	O
induced	O
increased	O
occupancy	O
of	O
these	O
sites.	O
None	O
of	O
the	O
other	O
putative	O
regulatory	O
sites	O
was	O
occupied	O
in	O
vivo,	O
indicating	O
that	O
they	O
may	O
not	O
be	O
functional.	O
Finally,	O
gel	O
shift	O
analysis	O
showed	O
synergistic	O
complex	O
formation	O
between	O
proteins	O
that	O
bind	O
to	O
the	O
putative	O
X	DNA
boxes	DNA
of	O
the	O
DM	O
genes,	O
as	O
is	O
found	O
for	O
the	O
DRA	DNA
gene	DNA
.	O
Therefore,	O
the	O
DM	DNA
genes	DNA
share	O
a	O
common	O
mechanism	O
of	O
regulation	O
with	O
the	O
class	DNA
II	DNA
genes	DNA
.	O

Effect	O
of	O
adenovirus	O
2	O
on	O
cellular	O
gene	O
activation	O
in	O
blood-derived	cell_type
monocytes	cell_type
and	O
macrophages	cell_type
.	O
We	O
have	O
investigated	O
the	O
effect	O
of	O
adenovirus	O
2	O
(	O
Ad2	O
)	O
infection	O
on	O
human	cell_type
monocytes	cell_type
and	O
monocyte-derived	cell_type
macrophages	cell_type
with	O
regard	O
to	O
expression	O
of	O
TNF-alpha	protein
and	O
IL-1	protein
beta	protein
.	O
In	O
monocytes,	O
the	O
virus	O
was	O
bound	O
to	O
the	O
surface	O
without	O
being	O
internalized.	O
On	O
the	O
other	O
hand,	O
Ad2	O
was	O
internalized	O
by	O
macrophages	cell_type
.	O
No	O
virus	O
replication	O
and	O
no	O
transcription	O
of	O
the	O
Ad2	DNA
early	DNA
genes	DNA
was	O
observed	O
in	O
either	O
of	O
the	O
cells.	O
Ad2	O
infection	O
induced	O
transient	O
increase	O
in	O
the	O
mRNA	RNA
levels	O
for	O
TNF-alpha	protein
and	O
IL-1	protein
beta	protein
in	O
both	O
monocytes	cell_type
and	O
in	O
macrophages	cell_type
,	O
although	O
the	O
kinetics	O
of	O
the	O
transcription	O
was	O
slightly	O
different.	O
The	O
production	O
of	O
both	O
cytokines	protein
,	O
measured	O
by	O
ELISA	O
tests	O
,	O
was	O
enhanced	O
in	O
monocytes	cell_type
.	O
In	O
macrophages	cell_type
,	O
a	O
slight	O
enhancement	O
of	O
TNF-alpha	protein
production	O
was	O
seen,	O
whereas	O
IL-1	protein
beta	protein
was	O
not	O
detected.	O
The	O
data	O
indicate	O
that	O
cellular	DNA
genes	DNA
might	O
be	O
activated	O
by	O
Ad2	O
virus	O
infection	O
in	O
nonpermissive	O
cells	O
where	O
no	O
viral	protein
gene	protein
products	protein
could	O
be	O
detected.	O

Structure	O
and	O
function	O
analysis	O
of	O
the	O
human	DNA
myeloid	DNA
cell	DNA
nuclear	DNA
differentiation	DNA
antigen	DNA
promoter	DNA
:	O
evidence	O
for	O
the	O
role	O
of	O
Sp1	protein
and	O
not	O
of	O
c-Myb	protein
or	O
PU.1	protein
in	O
myelomonocytic	O
lineage-specific	O
expression	O
.	O
The	O
human	protein
myeloid	protein
nuclear	protein
differentiation	protein
antigen	protein
(	O
MNDA	protein
)	O
is	O
expressed	O
specifically	O
in	O
maturing	cell_type
cells	cell_type
of	O
the	O
myelomonocytic	O
lineage	O
and	O
in	O
monocytes	cell_type
and	O
granulocytes	cell_type
.	O
Epitope	O
enhancement	O
was	O
used	O
to	O
confirm	O
the	O
strict	O
lineage-	O
and	O
stage-specific	O
expression	O
of	O
MNDA	protein
in	O
bone	O
marrow	O
as	O
well	O
as	O
in	O
other	O
paraffin-embedded	O
fixed	O
tissues	O
.	O
A	O
1-kb	DNA
region	DNA
of	O
the	O
gene	O
that	O
includes	O
5'	DNA
flanking	DNA
sequence	DNA
was	O
reported	O
earlier	O
to	O
contain	O
functional	O
promoter	O
activity	O
and	O
was	O
specifically	O
demethylated	O
in	O
expressing	cell_type
cells	cell_type
in	O
contrast	O
to	O
null	cell_type
cells	cell_type
.	O
Further	O
analysis	O
has	O
revealed	O
that	O
this	O
1-kb	DNA
fragment	DNA
promotes	O
higher	O
reporter	O
gene	O
activity	O
in	O
MNDA	protein
-expressing	cell_type
cells	cell_type
than	O
non-expressing	cell_type
cells	cell_type
,	O
indicating	O
cell-specific	O
differences	O
in	O
transactivation	O
.	O
This	O
sequence	O
contains	O
consensus	DNA
elements	DNA
consistent	O
with	O
myeloid-specific	O
gene	O
expression	O
,	O
including	O
a	O
PU.1	DNA
consensus	DNA
site	DNA
near	O
the	O
major	O
transcription	DNA
start	DNA
site	DNA
and	O
a	O
cluster	O
of	O
c-Myb	DNA
sites	DNA
located	O
several	O
hundred	O
bases	O
upstream	O
of	O
this	O
region.	O
However,	O
analysis	O
of	O
deletion	DNA
mutants	DNA
localized	O
nearly	O
all	O
of	O
the	O
promoter	O
activity	O
to	O
a	O
short	O
region	O
(	O
-73	DNA
to	DNA
-16	DNA
)	O
that	O
did	O
not	O
include	O
the	O
cluster	O
of	O
c-Myb	DNA
sites	DNA
.	O
A	O
4-bp	O
mutation	O
of	O
the	O
core	DNA
Sp1	DNA
consensus	DNA
element	DNA
(	O
GC	DNA
box	DNA
)	O
(-20)	O
reduced	O
overall	O
promoter	O
activity	O
of	O
the	O
1-kb	DNA
fragment	DNA
.	O
Mutation	O
of	O
the	O
PU.1	DNA
site	DNA
did	O
not	O
significantly	O
affect	O
promoter	O
activity	O
.	O
Only	O
a	O
small	O
region	O
(-35	O
to	O
+22)	O
including	O
the	O
Sp1	DNA
element	DNA
and	O
transcription	DNA
start	DNA
site	DNA
,	O
but	O
not	O
the	O
PU.1	DNA
site	DNA
was	O
footprinted.	O
The	O
4-bp	O
mutation	O
of	O
the	O
core	O
Sp1	DNA
consensus	DNA
element	DNA
abolished	O
footprinting	O
at	O
the	O
site	O
and	O
an	O
antibody	O
super-shift	O
reaction	O
showed	O
that	O
Sp1	protein
is	O
one	O
of	O
the	O
factors	O
binding	O
the	O
consensus	DNA
site	DNA
.	O
The	O
Sp1	DNA
site	DNA
also	O
co-localizes	O
with	O
a	O
DNase	DNA
I	DNA
hypersensitive	DNA
site	DNA
.	O
The	O
results	O
indicate	O
that	O
DNA	O
methylation	O
,	O
chromatin	DNA
structure	O
,	O
and	O
transactivation	O
at	O
an	O
Sp1	DNA
site	DNA
contribute	O
to	O
the	O
highly	O
restricted	O
expression	O
of	O
this	O
myelomonocytic	DNA
lineage	DNA
specific	DNA
gene	DNA
.	O

Critical	O
cytoplasmic	protein
domains	protein
of	O
human	protein
interleukin-9	protein
receptor	protein
alpha	protein
chain	protein
in	O
interleukin	protein
-9-mediated	O
cell	O
proliferation	O
and	O
signal	O
transduction.	O
Interleukin-9	protein
receptor	protein
(IL-9R)	protein
complex	protein
consists	O
of	O
a	O
ligand-specific	protein
alpha	protein
chain	protein
and	O
IL-2R	protein
gamma	protein
chain	protein
.	O
In	O
this	O
study,	O
two	O
regions	O
in	O
the	O
cytoplasmic	protein
domain	protein
of	O
human	protein
IL-9Ralpha	protein
were	O
found	O
to	O
be	O
important	O
for	O
IL-9	protein
-mediated	O
cell	O
growth	O
.	O
A	O
membrane-proximal	protein
region	protein
that	O
contains	O
the	O
BOX1	protein
consensus	protein
sequence	protein
is	O
required	O
for	O
IL-9	protein
-induced	O
cell	O
proliferation	O
and	O
tyrosine	O
phosphorylation	O
of	O
Janus	protein
kinases	protein
(	O
JAKs	protein
).	O
Deletion	O
of	O
this	O
region	O
or	O
internal	O
deletion	O
of	O
the	O
BOX1	protein
motif	protein
abrogated	O
IL-9	protein
-induced	O
cell	O
proliferation	O
and	O
signal	O
transduction.	O
However,	O
substitution	O
of	O
the	O
Pro-X-Pro	protein
in	O
the	O
BOX1	protein
motif	protein
with	O
Ala-X-Ala	protein
failed	O
to	O
abolish	O
IL-9	protein
-induced	O
cell	O
proliferation	O
but	O
decreased	O
IL-9	protein
-mediated	O
tyrosine	O
phosphorylation	O
of	O
JAK	protein
kinases	protein
,	O
insulin	protein
receptor	protein
substrate-2	protein
,	O
and	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
3	protein
(	O
STAT3	protein
)	O
and	O
expression	O
of	O
c-myc	DNA
and	O
junB	DNA
.	O
Another	O
important	O
region	O
is	O
downstream	O
of	O
the	O
BOX1	protein
motif	protein
and	O
contains	O
a	O
STAT3	DNA
binding	DNA
motif	DNA
YLPQ	DNA
.	O
Deletion	O
of	O
this	O
region	O
significantly	O
impaired	O
IL-9	protein
-induced	O
cell	O
growth	O
,	O
activation	O
of	O
JAK	protein
kinases	protein
,	O
insulin	protein
receptor	protein
substrate-2	protein
,	O
and	O
STAT3	protein
and	O
expression	O
of	O
early	DNA
response	DNA
genes	DNA
.	O
A	O
point	O
mutation	O
changing	O
YLPQ	DNA
into	O
YLPA	DNA
greatly	O
reduced	O
IL-9	protein
-induced	O
activation	O
of	O
STAT3	protein
and	O
expression	O
of	O
c-myc	DNA
but	O
did	O
not	O
affect	O
cell	O
proliferation	O
.	O
These	O
results	O
suggest	O
that	O
cooperation	O
or	O
cross-talk	O
of	O
signaling	O
molecules	O
associated	O
with	O
different	O
domains	O
of	O
IL-9Ralpha	protein
other	O
than	O
STAT3	protein
is	O
essential	O
for	O
IL-9	protein
-mediated	O
cell	O
growth	O
.	O

Bcl-2	protein
protein	protein
inhibits	O
bufalin	O
-induced	O
apoptosis	O
through	O
inhibition	O
of	O
mitogen-activated	protein
protein	protein
kinase	protein
activation	O
in	O
human	cell_line
leukemia	cell_line
U937	cell_line
cells	cell_line
.	O
In	O
a	O
previous	O
study,	O
we	O
demonstrated	O
that	O
bufalin	O
,	O
which	O
is	O
an	O
active	O
principle	O
of	O
Chinese	O
medicine	O
,	O
chan'su	O
,	O
caused	O
apoptosis	O
in	O
human	cell_line
leukemia	cell_line
U937	cell_line
cells	cell_line
by	O
anomalous	O
activation	O
of	O
mitogen-activated	protein
protein	protein
kinase	protein
(	O
MAPK	protein
)	O
via	O
the	O
signaling	O
pathway	O
of	O
Ras	protein
,	O
Raf-1	protein
,	O
and	O
MAPK	protein
kinase-1	protein
.	O
Here,	O
we	O
report	O
the	O
effect	O
of	O
overexpression	O
of	O
bcl-2	protein
in	O
U937	cell_line
cells	cell_line
on	O
the	O
signaling	O
pathway	O
of	O
apoptosis	O
that	O
is	O
induced	O
by	O
bufalin	O
.	O
The	O
results	O
indicated	O
that	O
the	O
apoptosis	O
induced	O
by	O
bufalin	O
in	O
U937	cell_line
cells	cell_line
was	O
significantly	O
inhibited	O
by	O
overexpression	O
of	O
the	O
Bcl-2	protein
protein	protein
.	O
No	O
significant	O
difference	O
was	O
detected	O
in	O
the	O
activation	O
of	O
MAPK	protein
kinase-1	protein
that	O
is	O
induced	O
by	O
bufalin	O
in	O
wild-type	O
or	O
Bcl-2-overexpressed	cell_type
U937	cell_type
cells	cell_type
;	O
however,	O
the	O
activation	O
of	O
MAPK	protein
by	O
bufalin	O
was	O
significantly	O
attenuated	O
in	O
the	O
cells	O
overexpressing	O
Bcl-2	protein
.	O
Bufalin	O
treatment	O
activated	protein
activator	protein
protein-1	protein
transcriptional	O
activity	O
;	O
however,	O
this	O
activation	O
was	O
decreased	O
to	O
40%	O
in	O
bcl-2	protein
-overexpressed	O
U937	cell_line
cells	cell_line
.	O
These	O
results	O
indicate	O
that	O
Bcl-2	protein
acts	O
downstream	O
of	O
MAPK	protein
kinase-1	protein
but	O
upstream	O
of	O
MAPK	protein
and	O
suggest	O
that,	O
in	O
the	O
signaling	O
pathway	O
of	O
the	O
apoptotic	O
process	O
induced	O
by	O
bufalin	O
,	O
the	O
transcriptional	O
activity	O
of	O
activator	protein
protein-1	protein
may	O
be	O
down-regulated	O
through	O
the	O
inhibition	O
of	O
MAPK	protein
activity	O
by	O
Bcl-2	protein
.	O

Pancreatic	O
islet	O
expression	O
studies	O
and	O
polymorphic	O
DNA	O
markers	O
in	O
the	O
genes	O
encoding	O
hepatocyte	O
nuclear	O
factor	O
-3alpha	O
,	O
-3beta	O
,	O
-3gamma	O
,	O
-4gamma	O
,	O
and	O
-6	O
.	O
The	O
genes	O
encoding	O
the	O
functionally	O
related	O
hepatocyte	protein
nuclear	protein
factors	protein
HNF-1alpha	protein
and	O
HNF-4alpha	protein
play	O
a	O
critical	O
role	O
in	O
normal	O
pancreatic	O
beta-cell	O
function	O
.	O
Mutations	O
in	O
these	O
liver	protein
-enriched	protein
transcription	protein
factors	protein
result	O
in	O
two	O
forms	O
of	O
early-onset	O
type	O
2	O
diabetes	O
(	O
maturity-onset	O
diabetes	O
of	O
the	O
young	O
[	O
MODY	O
]),	O
MODY3	O
and	O
MODY1	O
,	O
which	O
are	O
characterized	O
by	O
impaired	O
glucose-stimulated	O
insulin	O
secretion	O
,	O
early	O
disease	O
onset,	O
and	O
autosomal	O
dominant	O
inheritance	O
.	O
The	O
transcriptional	O
hierarchy	O
of	O
HNFs	O
suggests	O
that	O
other	O
proteins	O
of	O
the	O
regulatory	O
cascade	O
might	O
be	O
responsible	O
for	O
other	O
forms	O
of	O
MODY	O
and/or	O
late-onset	O
type	O
2	O
diabetes	O
.	O
In	O
this	O
study,	O
we	O
show	O
that	O
HNF	O
-3alpha	O
,	O
-3beta	O
,	O
-3gamma	O
,	O
-4gamma	O
,	O
and	O
-6	O
are	O
expressed	O
in	O
pancreatic	cell_type
beta-cells	cell_type
.	O
We	O
report	O
the	O
identification	O
and	O
characterization	O
of	O
simple	DNA
tandem	DNA
repeat	DNA
DNA	DNA
polymorphisms	DNA
in	O
the	O
genes	O
encoding	O
HNF-3alpha	protein
,	O
-3beta	protein
,	O
-3gamma	protein
,	O
-4gamma	protein
,	O
and	O
-6	protein
and	O
the	O
mapping	O
of	O
HNF-6	protein
to	O
chromosome	DNA
bands	DNA
15q21.1-21.2	DNA
by	O
fluorescence	O
in	O
situ	O
hybridization	O
.	O
These	O
markers	O
will	O
be	O
useful	O
to	O
study	O
the	O
role	O
of	O
genetic	O
variation	O
in	O
these	O
genes	O
in	O
the	O
pathogenesis	O
of	O
type	O
2	O
diabetes	O
.	O

Induction	O
of	O
nuclear	protein
factor	protein
kappa	protein
B/Rel	protein
nuclear	O
activity	O
in	O
human	cell_type
peripheral	cell_type
blood	cell_type
T	cell_type
lymphocytes	cell_type
by	O
anti-HLA	protein
class	protein
I	protein
monoclonal	protein
antibodies	protein
.	O
Monoclonal	O
antibodies	O
against	O
either	O
monomorphic	O
or	O
polymorphic	O
determinants	O
of	O
class	protein
I	protein
antigen	protein
induced	O
in	O
PBMC	cell_type
and	O
highly	O
purified	cell_type
T	cell_type
lymphocytes	cell_type
the	O
nuclear	O
activity	O
of	O
NF-kappa	protein
B/Rel	protein
complexes	protein
.	O
These	O
included	O
both	O
p50/p50	protein
and	O
p50/p65	protein
dimers	protein
,	O
recognized	O
by	O
specific	protein
antibodies	protein
in	O
EMSA	O
.	O
The	O
induced	O
complexes	protein
were	O
detectable	O
in	O
extracts	O
of	O
cells	O
incubated	O
with	O
anti-class	protein
I	protein
monoclonal	protein
antibody	protein
(	O
mAb	protein
)	O
for	O
1.5	O
h;	O
the	O
induction	O
was	O
maximal	O
at	O
5	O
h,	O
persistent	O
at	O
16	O
h	O
and	O
no	O
longer	O
observed	O
at	O
40	O
h.	O
The	O
mAb	protein
failed	O
to	O
induce	O
NF-kappa	protein
B/Rel	protein
nuclear	O
activity	O
in	O
cells	O
incubated	O
in	O
the	O
presence	O
of	O
3,4-dichloroisocoumarin	O
,	O
an	O
inhibitor	O
of	O
I	protein
kappa	protein
B-alpha	protein
degradation	O
.	O
Together,	O
these	O
results	O
suggest	O
that	O
class	O
I	O
triggering	O
can	O
induce	O
the	O
activity	O
of	O
NF-kappa	protein
B/Rel	protein
nuclear	O
activity	O
in	O
peripheral	cell_type
blood	cell_type
T	cell_type
lymphocytes	cell_type
,	O
thereby	O
modulating	O
the	O
expression	O
of	O
genes	O
regulated	O
by	O
these	O
transcription	protein
factors	protein
.	O

Anti-Ehrlichia	protein
chaffeensis	protein
antibody	protein
complexed	O
with	O
E.	O
chaffeensis	O
induces	O
potent	O
proinflammatory	RNA
cytokine	RNA
mRNA	RNA
expression	O
in	O
human	cell_type
monocytes	cell_type
through	O
sustained	O
reduction	O
of	O
IkappaB-alpha	protein
and	O
activation	O
of	O
NF-kappaB	protein
.	O
Ehrlichia	O
chaffeensis	O
is	O
an	O
obligatory	O
intracellular	O
bacterium	O
that	O
infects	O
monocytes	cell_type
and	O
macrophages	cell_type
and	O
is	O
the	O
etiologic	O
agent	O
of	O
human	O
ehrlichiosis	O
in	O
the	O
United	O
States	O
.	O
Our	O
previous	O
studies	O
showed	O
that	O
the	O
exposure	O
of	O
human	cell_type
monocytes	cell_type
to	O
E.	O
chaffeensis	O
induces	O
the	O
expression	O
of	O
interleukin-1beta	protein
(	O
IL-1beta	protein
),	O
IL-8	protein
,	O
and	O
IL-10	DNA
genes	DNA
in	O
vitro	O
but	O
not	O
the	O
expression	O
of	O
tumor	O
necrosis	O
factor	O
alpha	O
(TNF-alpha)	O
and	O
IL-6	O
mRNAs	O
.	O
In	O
this	O
study,	O
the	O
effect	O
of	O
anti-	protein
E.	protein
chaffeensis	protein
antibody	protein
complexed	O
with	O
E.	O
chaffeensis	O
on	O
the	O
expression	O
of	O
major	protein
proinflammatory	protein
cytokines	protein
in	O
human	cell_type
monocytes	cell_type
was	O
examined.	O
Human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
THP-1	cell_line
was	O
treated	O
with	O
E.	O
chaffeensis	O
which	O
had	O
been	O
preincubated	O
with	O
human	O
anti-	O
E.	O
chaffeensis	O
serum	O
for	O
2	O
h,	O
and	O
the	O
levels	O
of	O
cytokine	RNA
mRNAs	RNA
were	O
evaluated	O
by	O
competitive	O
reverse	O
transcription-PCR	O
.	O
Anti-	protein
E.	protein
chaffeensis	protein
antibody	protein
complexed	O
with	O
E.	O
chaffeensis	O
significantly	O
enhanced	O
mRNA	O
expression	O
of	O
IL-1beta	protein
in	O
THP-1	cell_line
cells	cell_line
.	O
The	O
expression	O
of	O
TNF-alpha	O
and	O
IL-6	O
mRNAs	O
was	O
also	O
induced.	O
The	O
levels	O
of	O
secreted	O
IL-1beta	protein
,	O
TNF-alpha	protein
,	O
and	O
IL-6	protein
during	O
24	O
h	O
of	O
stimulation	O
were	O
comparable	O
to	O
those	O
induced	O
by	O
Escherichia	O
coli	O
lipopolysaccharide	O
at	O
1	O
microg/ml.	O
Fab	O
fragment	O
of	O
anti-	protein
E.	protein
chaffeensis	protein
immunoglobulin	protein
G	protein
complexed	O
with	O
E.	O
chaffeensis	O
did	O
not	O
induce	O
any	O
of	O
these	O
three	O
cytokines,	O
indicating	O
that	O
ehrlichial	O
binding	O
is	O
required	O
for	O
IL-1beta	RNA
mRNA	RNA
expression	O
and	O
that	O
binding	O
of	O
the	O
immune	protein
complex	protein
to	O
the	O
Fc	protein
gamma	protein
receptor	protein
is	O
required	O
for	O
TNF-alpha	protein
and	O
IL-6	RNA
mRNA	RNA
expression	O
and	O
enhanced	O
IL-1beta	RNA
mRNA	RNA
expression	O
.	O
Furthermore,	O
prolonged	O
degradation	O
of	O
IkappaB-alpha	protein
and	O
activation	O
of	O
NF-kappaB	protein
were	O
demonstrated	O
in	O
THP-1	cell_line
cells	cell_line
exposed	O
to	O
anti-	O
E.	O
chaffeensis	O
serum	O
and	O
E.	O
chaffeensis	O
.	O
This	O
result	O
implies	O
that	O
development	O
of	O
anti-	protein
E.	protein
chaffeensis	protein
antibody	protein
in	O
patients	O
can	O
result	O
in	O
the	O
production	O
of	O
major	protein
proinflammatory	protein
cytokines	protein
,	O
which	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathophysiology	O
of	O
ehrlichiosis	O
and	O
immune	O
responses	O
to	O
it.	O

The	O
class	protein
II	protein
trans-activator	protein
CIITA	protein
interacts	O
with	O
the	O
TBP-associated	protein
factor	protein
TAFII32	protein
.	O
The	O
class	protein
II	protein
trans-	protein
activator	protein
(	O
CIITA	protein
)	O
is	O
the	O
main	O
transcriptional	O
co-activator	O
for	O
the	O
expression	O
of	O
MHC	protein
class	protein
II	protein
proteins	protein
.	O
Its	O
N-terminal	protein
125	protein
amino	protein
acids	protein
function	O
as	O
an	O
independent	protein
transcriptional	protein
activation	protein
domain	protein
.	O
Analyses	O
of	O
the	O
primary	protein
amino	protein
acid	protein
sequence	protein
of	O
the	O
activation	protein
domain	protein
predict	O
the	O
presence	O
of	O
three	O
alpha-helices	protein
,	O
each	O
with	O
a	O
high	O
proportion	O
of	O
acidic	O
residues	O
.	O
Using	O
site-directed	O
mutagenesis,	O
we	O
found	O
that	O
two	O
of	O
these	O
predicted	O
alpha-helices	protein
are	O
required	O
for	O
full	O
transcriptional	O
activation	O
by	O
CIITA	protein
.	O
Moreover,	O
a	O
CIITA	protein
protein	protein
in	O
which	O
both	O
functional	O
alpha-helices	protein
have	O
been	O
deleted	O
displays	O
a	O
dominant	O
negative	O
phenotype	O
.	O
This	O
activation	protein
domain	protein
of	O
CIITA	protein
interacts	O
with	O
the	O
32	protein
kDa	protein
subunit	protein
of	O
the	O
general	protein
transcription	protein
complex	protein
TFIID	protein
,	O
TAFII32	protein
.	O
Decreased	O
transcriptional	O
activation	O
by	O
N-terminal	protein
deletions	protein
of	O
CIITA	protein
is	O
correlated	O
directly	O
with	O
their	O
reduced	O
binding	O
to	O
TAFII32	protein
.	O
We	O
conclude	O
that	O
interactions	O
between	O
TAFII32	protein
and	O
CIITA	protein
are	O
responsible	O
for	O
activation	O
of	O
class	DNA
II	DNA
genes	DNA
.	O

Characterization	O
of	O
interleukin-10	protein
receptor	protein
expression	O
on	O
B-cell	cell_line
chronic	cell_line
lymphocytic	cell_line
leukemia	cell_line
cells	cell_line
.	O
B-cell	cell_line
chronic	cell_line
lymphocytic	cell_line
leukemia	cell_line
(B-CLL)	cell_line
cells	cell_line
accumulate	O
in	O
vivo	O
in	O
the	O
G0/G1	O
phase	O
of	O
the	O
cell	O
cycle	O
,	O
suggesting	O
that	O
their	O
malignant	O
expansion	O
is	O
due,	O
at	O
least	O
in	O
part,	O
to	O
a	O
delay	O
in	O
cell	O
death	O
.	O
However,	O
the	O
cellular	O
or	O
molecular	protein
factors	protein
responsible	O
for	O
a	O
delay	O
in	O
B-CLL	O
cell	O
death	O
are	O
unknown.	O
B-CLL	O
cells	O
do	O
express	O
receptors	O
for	O
interferon-alpha	protein
(	O
IFN-alpha	protein
)	O
and	O
IFN-gamma	protein
,	O
and	O
activation	O
of	O
both	O
has	O
been	O
shown	O
to	O
promote	O
B-CLL	O
survival	O
in	O
vitro	O
by	O
preventing	O
apoptosis	O
.	O
The	O
interleukin-10	protein
(IL-10)	protein
receptor	protein
is	O
another	O
member	O
of	O
the	O
IFN	protein
receptor	protein
family	protein
,	O
but	O
its	O
ligand,	O
IL-10	protein
,	O
has	O
been	O
reported	O
to	O
induce	O
apoptosis	O
in	O
B-CLL	cell_line
cells	cell_line
.	O
In	O
the	O
current	O
study,	O
we	O
undertook	O
a	O
biochemical	O
analysis	O
of	O
IL-10	protein
receptor	protein
expression	O
on	O
freshly	O
isolated	O
B-CLL	cell_line
cells	cell_line
and	O
characterized	O
the	O
functional	O
responsiveness	O
of	O
IL-10	protein
binding	O
to	O
its	O
constitutively	protein
expressed	protein
receptor	protein
.	O
We	O
show	O
that	O
B-CLL	cell_line
cells	cell_line
bind	O
IL-10	protein
with	O
significant	O
specificity	O
and	O
express	O
between	O
47	O
and	O
127	O
IL-10	protein
receptor	protein
sites	O
per	O
cell,	O
with	O
a	O
dissociation	O
constant	O
in	O
the	O
range	O
of	O
168	O
to	O
426	O
x	O
10(-12)	O
mol/L.	O
Ligand	O
binding	O
and	O
activation	O
of	O
the	O
IL-10	protein
receptor	protein
expressed	O
on	O
B-CLL	cell_line
cells	cell_line
results	O
in	O
the	O
phosphorylation	O
of	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
1	protein
(	O
STAT1	protein
)	O
and	O
STAT3	protein
proteins.	O
This	O
pattern	O
of	O
STAT	protein
protein	protein
phosphorylation	O
is	O
identical	O
to	O
IL-10	protein
receptor	protein
activation	O
on	O
normal	cell_type
cells	cell_type
and	O
similar	O
to	O
IFN-alpha	protein
(	O
STAT1	protein
and	O
STAT3	protein
)	O
and	O
IFN-gamma	protein
(	O
STAT1	protein
)	O
receptor	O
activation	O
in	O
CLL	cell_line
.	O
Further,	O
in	O
consecutive	O
samples	O
of	O
fresh	O
blood	O
obtained	O
from	O
patients	O
with	O
B-CLL	cell_line
cells	cell_line
,	O
the	O
addition	O
of	O
IL-10	protein
inhibited	O
B-CLL	cell_line
proliferation	O
,	O
enhanced	O
B-CLL	cell_line
differentiation	O
,	O
but	O
did	O
not	O
induce	O
apoptosis	O
.	O
Indeed,	O
IL-10	protein
,	O
like	O
IFN-gamma	protein
,	O
was	O
able	O
to	O
significantly	O
reduce	O
the	O
amount	O
of	O
B-CLL	O
cell	O
death	O
caused	O
by	O
hydrocortisone-induced	O
apoptosis	O
.	O
We	O
conclude	O
that	O
cytokines	protein
,	O
which	O
signal	O
through	O
the	O
interferon	protein
family	protein
of	O
receptors,	O
have	O
comparable	O
functional	O
effects	O
on	O
B-CLL	cell_line
cells	cell_line
.	O

Involvement	O
of	O
the	O
N-terminal	protein
region	protein
of	O
the	O
human	protein
mineralocorticoid	protein
receptor	protein
hormone-binding	protein
domain	protein
in	O
agonist	O
and	O
antagonist	O
binding	O
as	O
revealed	O
by	O
a	O
new	protein
monoclonal	protein
antibody	protein
.	O
To	O
gain	O
a	O
better	O
understanding	O
of	O
the	O
mechanism	O
of	O
binding	O
to	O
the	O
human	protein
mineralocorticoid	protein
receptor	protein
(	O
hMR	protein
),	O
we	O
developed	O
a	O
new	O
monoclonal	protein
antibody	protein
(	O
mAb	protein
)	O
raised	O
against	O
the	O
hormone-binding	protein
domain	protein
(	O
HBD	protein
).	O
For	O
this	O
purpose,	O
mice	O
were	O
immunized	O
with	O
a	O
fusion	protein
protein	protein
including	O
the	O
sequence	O
Thr729-Lys984	protein
of	O
hMR	protein
.	O
After	O
ELISA	O
screening	O
,	O
mAb	protein
18C7	protein
was	O
selected	O
for	O
its	O
specificity	O
towards	O
the	O
HBD	protein
.	O
This	O
antibody	O
recognized	O
both	O
the	O
denatured	O
and	O
native	protein
MR	protein
forms	protein
,	O
as	O
well	O
as	O
the	O
hetero-oligomeric	protein
MR	protein
form	protein
and	O
the	O
transformed	protein
MR	protein
state	protein
.	O
By	O
using	O
several	O
HBD	protein
subfragments	protein
,	O
the	O
mAb	protein
18C7	protein
epitope	protein
was	O
located	O
in	O
the	O
N-terminal	protein
region	protein
of	O
the	O
HBD	protein
from	O
Thr729	protein
to	protein
Leu765	protein
.	O
We	O
then	O
studied	O
the	O
effect	O
of	O
the	O
antibody	O
on	O
aldosterone	O
and	O
progesterone	O
binding	O
to	O
the	O
hMR	protein
.	O
When	O
18C7	protein
was	O
incubated	O
with	O
liganded	protein
MR	protein
,	O
it	O
was	O
able	O
to	O
partly	O
displace	O
(20%)	O
the	O
hormone	O
from	O
its	O
binding	O
site.	O
When	O
18C7	protein
was	O
incubated	O
with	O
MR	protein
before	O
aldosterone	O
or	O
progesterone	O
,	O
the	O
antibody	O
inhibited	O
75-80%	O
of	O
the	O
binding.	O
The	O
effect	O
of	O
18C7	protein
on	O
the	O
binding	O
was	O
similar	O
with	O
both	O
hormones.	O
A	O
sucrose	O
gradient	O
analysis	O
indicated	O
the	O
simultaneous	O
presence	O
of	O
two	O
kinds	O
of	O
receptor	O
complexes:	O
the	O
steroid-MR	protein
complex	protein
and	O
the	O
antibody-MR	protein
complex	protein
.	O
After	O
its	O
associated	O
proteins,	O
especially	O
the	O
heat-shock	protein
protein	protein
hsp90	protein
,	O
had	O
been	O
cross-linked	O
with	O
the	O
hMR	protein
by	O
dimethylpimelimidate	O
,	O
18C7	protein
was	O
still	O
able	O
to	O
react	O
with	O
the	O
receptor.	O
Our	O
results	O
indicated	O
that	O
the	O
epitope	protein
recognized	O
by	O
18C7	protein
was	O
directly	O
implicated	O
in	O
hormone	O
binding.	O
The	O
lack	O
of	O
steroid	O
binding	O
of	O
HBD	protein
mutants	O
with	O
the	O
Thr729-Leu765	protein
sequence	protein
deleted	O
[Jalaguier,	O
Mesnier,	O
Leger	O
and	O
Auzou	O
(1996)	O
J.Steroid	O
Biochem.Mol.Biol.57,	O
43-50]	O
supports	O
this	O
hypothesis.	O
Because	O
of	O
the	O
similar	O
behaviours	O
of	O
aldosterone	O
and	O
progesterone	O
,	O
we	O
conclude	O
that	O
the	O
N-terminal	protein
Thr729-Leu765	protein
region	protein
of	O
the	O
HBD	protein
is	O
similarly	O
involved	O
in	O
the	O
binding	O
of	O
both	O
hormones.	O

Molecular	O
cloning	O
of	O
SLAP-130	protein
,	O
an	O
SLP-76-associated	protein
substrate	protein
of	O
the	O
T	protein
cell	protein
antigen	protein
receptor-stimulated	protein
protein	protein
tyrosine	protein
kinases	protein
.	O
Previous	O
work	O
has	O
demonstrated	O
that	O
SLP-76	protein
,	O
a	O
Grb2-associated	protein
tyrosine	protein
-phosphorylated	protein
protein	protein
,	O
augments	O
Interleukin-2	DNA
promoter	DNA
activity	O
when	O
overexpressed	O
in	O
the	O
Jurkat	cell_line
T	cell_line
cell	cell_line
line	cell_line
.	O
This	O
activity	O
requires	O
regions	O
of	O
SLP-76	protein
that	O
mediate	O
protein-protein	O
interactions	O
with	O
other	O
molecules	O
in	O
T	cell_type
cells	cell_type
,	O
suggesting	O
that	O
SLP-76	protein
-associated	O
proteins	O
also	O
function	O
to	O
regulate	O
signal	O
transduction.	O
Here	O
we	O
describe	O
the	O
molecular	O
cloning	O
of	O
SLAP-130	protein
,	O
a	O
SLP-76	protein
-associated	protein
phosphoprotein	protein
of	O
130	O
kDa.	O
We	O
demonstrate	O
that	O
SLAP-130	protein
is	O
hematopoietic	O
cell-specific	O
and	O
associates	O
with	O
the	O
SH2	protein
domain	protein
of	O
SLP-76	protein
.	O
Additionally,	O
we	O
show	O
that	O
SLAP-130	protein
is	O
a	O
substrate	O
of	O
the	O
T	protein
cell	protein
antigen	protein
receptor-induced	protein
protein	protein
tyrosine	protein
kinases	protein
.	O
Interestingly,	O
we	O
find	O
that	O
in	O
contrast	O
to	O
SLP-76	protein
,	O
overexpression	O
of	O
SLAP-130	protein
diminishes	O
T	protein
cell	protein
antigen	protein
receptor	protein
-induced	O
activation	O
of	O
the	O
interleukin-2	DNA
promoter	DNA
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
and	O
interferes	O
with	O
the	O
augmentation	O
of	O
interleukin-2	DNA
promoter	DNA
activity	O
seen	O
when	O
SLP-76	protein
is	O
overexpressed	O
in	O
these	O
cells.	O
These	O
data	O
suggest	O
that	O
SLP-76	protein
recruits	O
a	O
negative	O
regulator,	O
SLAP-130	protein
,	O
as	O
well	O
as	O
positive	O
regulators	O
of	O
signal	O
transduction	O
in	O
T	cell_type
cells	cell_type
.	O

Molecular	O
actions	O
of	O
prolactin	O
in	O
the	O
immune	O
system	O
.	O
The	O
immunoregulatory	protein
properties	O
of	O
prolactin	O
,	O
a	O
pituitary	O
peptide	O
hormone	O
,	O
have	O
received	O
renewed	O
attention.	O
The	O
prolactin	protein
receptor	protein
,	O
a	O
member	O
of	O
the	O
hematopoietin/cytokine	protein
receptor	protein
superfamily	protein
,	O
is	O
ubiquitously	O
expressed	O
by	O
cells	O
in	O
the	O
immune	O
system	O
.	O
Certain	O
subpopulations	O
of	O
lymphocytes	cell_type
synthesize	O
and	O
secrete	O
biologically	O
active	O
prolactin	O
,	O
which	O
suggests	O
that	O
prolactin	O
can	O
act	O
as	O
an	O
autocrine	O
and/or	O
paracrine	O
factor	O
to	O
modulate	O
the	O
activities	O
of	O
cells	O
of	O
the	O
immune	O
system	O
.	O
This	O
review	O
focuses	O
on	O
the	O
molecular	O
actions	O
of	O
prolactin	O
in	O
the	O
immune	O
system	O
.	O
Emphasis	O
is	O
given	O
to	O
recent	O
information	O
about	O
the	O
molecular	O
mechanisms	O
of	O
prolactin	O
receptor	O
signal	O
transduction	O
,	O
and	O
the	O
signaling	protein
molecules	protein
and	O
prolactin	DNA
-inducible	DNA
target	DNA
genes	DNA
that	O
participate	O
in	O
these	O
responses.	O
In	O
particular,	O
the	O
prolactin	DNA
-inducible	DNA
interferon	DNA
regulatory	DNA
factor-1	DNA
gene	DNA
and	O
its	O
roles	O
in	O
mediating	O
diverse	O
immune	O
responses	O
.	O

Transcriptional	O
regulation	O
during	O
myelopoiesis	O
.	O
The	O
coordinated	O
production	O
of	O
all	O
blood	cell_type
cells	cell_type
from	O
a	O
common	cell_type
stem	cell_type
cell	cell_type
is	O
a	O
highly	O
regulated	O
process	O
involving	O
successive	O
stages	O
of	O
commitment	O
and	O
differentiation.	O
From	O
analyses	O
of	O
mice	O
deficient	O
in	O
transcription	DNA
factor	DNA
genes	DNA
and	O
from	O
the	O
characterizations	O
of	O
chromosome	DNA
breakpoints	DNA
in	O
human	O
leukemias	O
,	O
it	O
has	O
become	O
evident	O
that	O
transcription	protein
factors	protein
are	O
important	O
regulators	O
of	O
hematopoiesis	O
.	O
During	O
myelopoiesis,	O
which	O
includes	O
the	O
development	O
of	O
granulocytic	O
and	O
monocytic	O
lineages	O
,	O
transcription	protein
factors	protein
from	O
several	O
families	O
are	O
active,	O
including	O
AML1/CBF	DNA
beta	DNA
,	O
C/EBP	DNA
,	O
Ets	DNA
,	O
c-Myb	DNA
,	O
HOX	DNA
,	O
and	O
MZF-1	DNA
.	O
Few	O
of	O
these	O
factors	O
are	O
expressed	O
exclusively	O
in	O
myeloid	cell_type
cells	cell_type
;	O
instead	O
it	O
appears	O
that	O
they	O
cooperatively	O
regulate	O
transcription	O
of	O
myeloid-specific	DNA
genes	DNA
.	O
Here	O
we	O
discuss	O
recent	O
advances	O
in	O
transcriptional	O
regulation	O
during	O
myelopoiesis	O
.	O

Activation	O
of	O
transcription	O
factor	O
NF-kappa	protein
B	protein
by	O
phagocytic	O
stimuli	O
in	O
human	O
neutrophils.	O
Phagocytosis	O
represents	O
an	O
important	O
physiological	O
trigger	O
for	O
the	O
inducible	O
expression	O
of	O
several	O
genes	O
in	O
human	cell_type
neutrophils	cell_type
.	O
Here,	O
we	O
report	O
that	O
a	O
DNA-binding	O
activity	O
primarily	O
consisting	O
of	O
the	O
classical	O
NF-kappa	protein
B	protein
heterodimer	protein
,	O
p50/RelA	protein
,	O
is	O
induced	O
in	O
phagocytosing	cell_type
neutrophils	cell_type
.	O
Under	O
these	O
conditions,	O
NF-kappa	protein
B	protein
activation	O
was	O
found	O
to	O
be	O
a	O
rapid	O
and	O
transient	O
response,	O
reaching	O
a	O
maximum	O
by	O
10-15	O
min,	O
and	O
returning	O
to	O
near-basal	O
levels	O
by	O
30	O
min.	O
In	O
neutrophils	O
undergoing	O
the	O
phagocytosis	O
of	O
opsonized	O
yeasts	O
,	O
the	O
onset	O
of	O
NF-kappa	protein
B	protein
activation	O
was	O
paralleled	O
by	O
a	O
decline	O
in	O
immunoreactive	O
I	protein
kappa	protein
B-alpha	protein
protein	O
levels	O
,	O
and	O
the	O
cellular	O
I	protein
kappa	protein
B	protein
-alpha	O
pool	O
was	O
replenished	O
by	O
30	O
min,	O
in	O
agreement	O
with	O
our	O
gel	O
shift	O
data.	O
We	O
conclude	O
that	O
NF-kappa	protein
B	protein
activation	O
could	O
constitute	O
one	O
of	O
the	O
mechanisms	O
whereby	O
the	O
expression	O
of	O
kappa	DNA
B-responsive	DNA
genes	DNA
is	O
enhanced	O
in	O
phagocytosing	cell_type
neutrophils	cell_type
.	O
To	O
our	O
knowledge,	O
this	O
represents	O
the	O
first	O
demonstration	O
that	O
phagocytic	O
stimuli	O
can	O
induce	O
NF-kappa	protein
B	protein
activation	O
in	O
human	cell_type
neutrophils	cell_type
.	O

Induction	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
expression	O
in	O
monocytic	cell_type
cells	cell_type
by	O
Cryptococcus	O
neoformans	O
and	O
Candida	O
albicans	O
.	O
Because	O
candidiasis	O
and	O
cryptococcosis	O
are	O
common	O
in	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)-infected	O
persons	O
,	O
the	O
effect	O
of	O
Cryptococcus	O
neoformans	O
and	O
Candida	O
albicans	O
on	O
HIV	O
expression	O
in	O
monocytic	cell_type
cells	cell_type
was	O
examined.	O
Stimulation	O
of	O
the	O
latently	O
HIV-infected	cell_line
myelomonocytic	cell_line
cell	cell_line
line	cell_line
OM-10.1	O
with	O
C.	O
neoformans	O
and	O
C.	O
albicans	O
in	O
the	O
presence	O
of	O
pooled	O
human	O
serum	O
caused	O
a	O
ratio-dependent	O
increase	O
in	O
HIV	O
production	O
.	O
Induction	O
of	O
HIV	O
by	O
C.	O
neoformans	O
was	O
enhanced	O
by	O
anti-capsular	protein
antibody	protein
,	O
while	O
induction	O
by	O
both	O
organisms	O
was	O
inhibited	O
by	O
anti-TNF-alpha	protein
antibody	protein
.	O
In	O
THP-1	O
cells	O
transfected	O
with	O
HIV	DNA
plasmid	DNA
constructs	DNA
,	O
both	O
organisms	O
induced	O
transcription	O
from	O
the	O
HIV	DNA
long	DNA
terminal	DNA
repeat	DNA
that	O
was	O
dependent	O
on	O
intact	O
NF-kappaB	DNA
binding	DNA
sequences	DNA
.	O
Thus,	O
C.	O
neoformans	O
and	O
C.	O
albicans	O
enhance	O
HIV	O
expression	O
in	O
monocytic	cell_type
cells	cell_type
through	O
a	O
TNF-alpha-	O
and	O
NF-kappaB-	O
dependent	O
mechanism	O
.	O
In	O
HIV	O
-infected	O
patients	O
,	O
such	O
enhancement	O
may	O
further	O
impair	O
host	O
immunity	O
and	O
could	O
accelerate	O
the	O
course	O
of	O
HIV	O
disease	O
.	O

Nuclear	O
levels	O
of	O
NF-kappaB	protein
correlate	O
with	O
syncytium-forming	O
capacity	O
of	O
8e51	cell_line
cells	cell_line
,	O
expressing	O
a	O
defective	O
HIV	O
virus	O
.	O
The	O
double	DNA
NF-kappaB	DNA
site	DNA
identified	O
in	O
the	O
LTR	DNA
of	O
the	O
human	O
immunodeficiency	O
virus-1	O
(	O
HIV-1	O
)	O
has	O
been	O
demonstrated	O
to	O
be	O
necessary	O
for	O
efficient	O
viral	O
transcription	O
.	O
In	O
this	O
report	O
we	O
present	O
the	O
characterisation	O
of	O
NF-kappaB	protein
subunits	protein
engaged	O
in	O
complexes	O
binding	O
to	O
the	O
HIV-1	DNA
NF-kappaB	DNA
site	DNA
in	O
human	cell_line
8e51	cell_line
T-cells	cell_line
,	O
that	O
harbour	O
a	O
defective	O
HIV-1	O
.	O
At	O
least	O
four	O
different	O
specific	O
NF-kappaB	protein
complexes	protein
are	O
present	O
in	O
the	O
nucleus	O
of	O
these	O
cells.	O
With	O
the	O
use	O
of	O
specific	protein
antibodies	protein
we	O
have	O
determined	O
the	O
composition	O
of	O
each	O
complex	O
using	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O
The	O
results	O
show	O
the	O
presence	O
of	O
several	O
NF-kappaB	protein
family	protein
members,	protein
with	O
the	O
transactivating	O
RelA	protein
being	O
engaged	O
in	O
multiple	O
complexes.	O
The	O
importance	O
of	O
NF-kappaB	protein
complexes	protein
in	O
viral	O
functions	O
has	O
been	O
established	O
comparing	O
the	O
level	O
of	O
NF-kappaB	O
DNA-binding	O
complexes	O
with	O
syncytia-forming	O
activity	O
of	O
8e51	cell_line
cells	cell_line
.	O
In	O
fact,	O
8e51	cell_line
cells	cell_line
that	O
had	O
almost	O
lost	O
their	O
syncytia-forming	O
capacity	O
were	O
found	O
to	O
contain	O
at	O
least	O
10	O
times	O
less	O
active	O
NF-kappaB	protein
DNA-binding	protein
complex	protein
than	O
the	O
actively	cell_type
fusing	cell_type
cells	cell_type
.	O
The	O
correlation	O
is	O
specific	O
as	O
the	O
level	O
of	O
at	O
least	O
three	O
other	O
transcription	protein
factors	protein
did	O
not	O
change.	O

c-Myb	DNA
and	O
Ets	protein
proteins	protein
synergize	O
to	O
overcome	O
transcriptional	O
repression	O
by	O
ZEB	protein
.	O
The	O
Zfh	protein
family	protein
of	O
zinc	protein
finger/homeodomain	protein
proteins	protein
was	O
first	O
identified	O
in	O
Drosophila	O
where	O
it	O
is	O
required	O
for	O
differentiation	O
of	O
tissues	O
such	O
as	O
the	O
central	O
nervous	O
system	O
and	O
muscle	O
.	O
ZEB	protein
,	O
a	O
vertebrate	O
homolog	O
of	O
Zfh-1	protein
,	O
binds	O
a	O
subset	O
of	O
E	DNA
boxes	DNA
and	O
blocks	O
myogenesis	O
through	O
transcriptional	O
repression	O
of	O
muscle	DNA
genes	DNA
.	O
We	O
present	O
evidence	O
here	O
that	O
ZEB	protein
also	O
has	O
an	O
important	O
role	O
in	O
controlling	O
hematopoietic	DNA
gene	DNA
transcription	O
.	O
Two	O
families	O
of	O
transcription	protein
factors	protein
that	O
are	O
required	O
for	O
normal	O
hematopoiesis	O
are	O
c-Myb	protein
and	O
Ets	protein
.	O
These	O
factors	O
act	O
synergistically	O
to	O
activate	O
transcription,	O
and	O
this	O
synergy	O
is	O
required	O
for	O
transcription	O
of	O
at	O
least	O
several	O
important	O
hematopoietic	DNA
genes	DNA
.	O
ZEB	protein
blocks	O
the	O
activity	O
of	O
c-Myb	protein
and	O
Ets	protein
individually,	O
but	O
together	O
the	O
factors	O
synergize	O
to	O
resist	O
this	O
repression.	O
Such	O
repression	O
imposes	O
a	O
requirement	O
for	O
both	O
c-Myb	protein
and	O
Ets	protein
for	O
transcriptional	O
activity,	O
providing	O
one	O
explanation	O
for	O
why	O
synergy	O
between	O
these	O
factors	O
is	O
important.	O
The	O
balance	O
between	O
repression	O
by	O
ZEB	protein
and	O
transcriptional	O
activation	O
by	O
c-Myb	protein
/Ets	protein
provides	O
a	O
flexible	O
regulatory	O
mechanism	O
for	O
controlling	O
gene	O
expression	O
in	O
hematopoietic	cell_type
cells	cell_type
.	O
We	O
demonstrate	O
that	O
one	O
target	O
of	O
this	O
positive/negative	O
regulation	O
in	O
vivo	O
is	O
the	O
alpha4	protein
integrin	protein
,	O
which	O
play	O
a	O
key	O
role	O
in	O
normal	O
hematopoiesis	O
and	O
function	O
of	O
mature	cell_type
leukocytes	cell_type
.	O

Comparison	O
of	O
the	O
transactivation	protein
domains	protein
of	O
Stat5	protein
and	O
Stat6	protein
in	O
lymphoid	cell_type
cells	cell_type
and	O
mammary	cell_type
epithelial	cell_type
cells	cell_type
.	O
Stat	protein
(	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
)	O
and	O
Jak	protein
(	O
Janus	protein
kinases	protein
)	O
proteins	O
are	O
central	O
components	O
in	O
the	O
signal	O
transduction	O
events	O
in	O
hematopoietic	O
and	O
epithelial	O
cells	O
.	O
They	O
are	O
rapidly	O
activated	O
by	O
various	O
cytokines	protein
,	O
hormones	O
,	O
and	O
growth	O
factors.	O
Upon	O
ligand	O
binding	O
and	O
cytokine	protein
receptor	protein
dimerization	O
,	O
Stat	protein
proteins	protein
are	O
phosphorylated	O
on	O
tyrosine	O
residues	O
by	O
Jak	protein
kinases	protein
.	O
Activated	O
Stat	protein
proteins	protein
form	O
homo-	O
or	O
heterodimers,	O
translocate	O
to	O
the	O
nucleus	O
,	O
and	O
induce	O
transcription	O
from	O
responsive	O
genes.	O
Stat5	protein
and	O
Stat6	protein
are	O
transcription	protein
factors	protein
active	O
in	O
mammary	cell_type
epithelial	cell_type
cells	cell_type
and	O
immune	O
cells.	O
Prolactin	O
activates	O
Stat5	protein
,	O
and	O
interleukin-4	protein
(	O
IL-4	protein
)	O
activates	O
Stat6	protein
.	O
Both	O
cytokines	protein
are	O
able	O
to	O
stimulate	O
cell	O
proliferation,	O
differentiation,	O
and	O
survival.	O
We	O
investigated	O
the	O
transactivation	O
potential	O
of	O
Stat6	protein
and	O
found	O
that	O
it	O
is	O
not	O
restricted	O
to	O
lymphocytes.	O
IL-4	protein
-dependent	O
activation	O
of	O
Stat6	protein
was	O
also	O
observed	O
in	O
HC11	cell_line
mammary	cell_line
epithelial	cell_line
cells	cell_line
.	O
In	O
these	O
cells,	O
Stat6	protein
activation	O
led	O
to	O
the	O
induction	O
of	O
the	O
beta-casein	DNA
gene	DNA
promoter	DNA
.	O
The	O
induction	O
of	O
this	O
promoter	O
was	O
confirmed	O
in	O
COS7	cell_line
cells	cell_line
.	O
The	O
glucocorticoid	protein
receptor	protein
was	O
able	O
to	O
further	O
enhance	O
IL-4	protein
-induced	O
gene	O
transcription	O
through	O
the	O
action	O
of	O
Stat6	protein
.	O
Deletion	O
analysis	O
of	O
the	O
carboxyl-terminal	protein
region	protein
of	O
Stat6	protein
and	O
recombination	O
of	O
this	O
region	O
with	O
a	O
heterologous	protein
DNA	protein
binding	protein
domain	protein
allowed	O
the	O
delimitation	O
and	O
characterization	O
of	O
the	O
transactivation	O
domain	O
of	O
Stat6	protein
.	O
The	O
potencies	O
of	O
the	O
transactivation	protein
domains	protein
of	O
Stat5	protein
,	O
Stat6	protein
,	O
and	O
viral	protein
protein	protein
VP16	protein
were	O
compared.	O
Stat6	protein
had	O
a	O
transactivation	O
domain	O
which	O
was	O
about	O
10-fold	O
stronger	O
than	O
that	O
of	O
Stat5	protein
.	O
In	O
pre-B	cell_type
cells	cell_type
(Ba/F3),	O
the	O
transactivation	O
domain	O
of	O
Stat6	protein
was	O
IL-4	protein
regulated,	O
independently	O
from	O
its	O
DNA	O
binding	O
function	O
.	O

ETS1	protein
,	O
NFkappaB	protein
and	O
AP1	protein
synergistically	O
transactivate	O
the	O
human	DNA
GM-CSF	DNA
promoter	DNA
.	O
Activation	O
of	O
helper	cell_type
T	cell_type
cells	cell_type
results	O
in	O
coordinate	O
expression	O
of	O
a	O
number	O
of	O
cytokines	protein
involved	O
in	O
differentiation,	O
proliferation	O
and	O
activation	O
of	O
the	O
haematopoietic	O
system	O
.	O
Granulocyte-macrophage	protein
colony	protein
stimulating	protein
factor	protein
(	O
GM-CSF	protein
)	O
is	O
one	O
such	O
cytokine	protein
,	O
whose	O
increased	O
expression	O
results	O
mostly	O
from	O
increases	O
in	O
transcription.	O
Cis-acting	DNA
elements	DNA
with	O
NFkappaB	O
,	O
AP1	O
and	O
ETS	O
-like	O
binding	O
motifs	O
have	O
been	O
identified	O
in	O
the	O
promoter	O
region	O
of	O
the	O
GM-CSF	DNA
gene	DNA
,	O
and	O
are	O
important	O
or	O
essential	O
for	O
transcriptional	O
activity	O
following	O
T	O
cell	O
activation	O
.	O
ETS1	protein
is	O
a	O
transcription	protein
factor	protein
of	O
the	O
ETS	protein
family	protein
that	O
is	O
expressed	O
in	O
T	cell_type
cells	cell_type
.	O
We	O
have	O
previously	O
shown	O
that	O
ETS1	protein
can	O
transactivate	O
GM-CSF	protein
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
,	O
but	O
only	O
after	O
the	O
cells	O
have	O
been	O
stimulated	O
by	O
treatment	O
with	O
PMA	O
and	O
ionomycin,	O
agents	O
that	O
mimic	O
T	O
cell	O
activation	O
.	O
Thus	O
we	O
proposed	O
that	O
ETS1	protein
,	O
which	O
is	O
expressed	O
constitutively	O
in	O
Jurkat	cell_line
cells	cell_line
,	O
may	O
act	O
in	O
concert	O
with	O
PMA/ionomycin	protein
inducible	protein
factors	protein
.	O
Here	O
we	O
show	O
that	O
ETS1	protein
can	O
transactivate	O
a	O
GM-CSF	DNA
reporter	DNA
construct	DNA
in	O
unstimulated	O
Jurkat	cell_line
cells	cell_line
,	O
providing	O
that	O
either	O
NFkappaB	protein
or	O
AP1	protein
transcription	protein
factors	protein
are	O
supplied	O
by	O
co-transfection.	O
We	O
confirm	O
that	O
binding	O
of	O
endogenous	O
NFkappaB	protein
and	O
AP1	protein
is	O
induced	O
following	O
PMA	O
/ionomycin	O
treatment	O
of	O
T	cell_type
cells	cell_type
.	O
Transactivation	O
by	O
ETS1	protein
,	O
NFkappaB	protein
and	O
AP1	protein
is	O
synergistic,	O
and	O
mutation	O
of	O
the	O
individual	O
binding	O
sites	O
reveals	O
that	O
the	O
transcriptional	O
activities	O
of	O
these	O
factors	O
are	O
interdependent.	O
Our	O
results	O
suggest	O
that	O
constitutive	O
ETS1	protein
,	O
and	O
inducible	O
NFkappaB	protein
and	O
AP1	protein
,	O
cooperate	O
as	O
part	O
of	O
a	O
higher	O
order	O
transcriptional	protein
complex	protein
in	O
activated	O
T	cell_type
cells	cell_type
.	O

Abnormal	O
T	cell_type
lymphocyte	cell_type
development	O
induced	O
by	O
targeted	O
overexpression	O
of	O
IkappaB	protein
alpha	protein
.	O
A	O
role	O
in	O
thymic	O
maturation	O
for	O
factors	O
of	O
the	O
NF-kappaB	protein
family	protein
has	O
long	O
been	O
suspected,	O
but	O
not	O
yet	O
proven.	O
Transgenic	O
mice	O
with	O
a	O
lymphocyte-specific	O
defect	O
in	O
NF-kappaB	protein
activation	O
were	O
produced	O
by	O
targeted	O
expression	O
of	O
human	O
IkappaB	protein
alpha	protein
.	O
The	O
thymic	O
cellularity	O
of	O
these	O
mice	O
was	O
significantly	O
decreased.	O
The	O
proportion	O
of	O
mature,	O
TCRhigh	cell_type
thymocytes	cell_type
of	O
the	O
alphabeta	cell_type
lineage	cell_type
was	O
reduced,	O
and	O
the	O
remaining	O
TCRhigh	cell_type
population	cell_type
contained	O
an	O
unusually	O
high	O
proportion	O
of	O
double-positive	cell_line
cells	cell_line
.	O
This	O
defect	O
in	O
maturation	O
resulted	O
in	O
a	O
transgene	O
dose-dependent	O
reduction	O
in	O
peripheral	cell_type
T	cell_type
lymphocytes	cell_type
,	O
with	O
the	O
CD8	cell_type
lineage	cell_type
being	O
more	O
severely	O
affected.	O
These	O
data	O
provide	O
direct	O
evidence	O
for	O
the	O
involvement	O
of	O
NF-kappaB	protein
/Rel	protein
family	protein
proteins	protein
in	O
late	O
stages	O
of	O
T	cell_type
lymphocyte	cell_type
development	O
,	O
coincident	O
with	O
positive	O
and	O
negative	O
selection.	O

CD40	protein
is	O
a	O
functional	O
activation	protein
antigen	protein
and	O
B7-independent	protein
T	protein
cell	protein
costimulatory	protein
molecule	protein
on	O
normal	O
human	cell_type
lung	cell_type
fibroblasts	cell_type
.	O
CD40	protein
is	O
an	O
important	O
signaling	O
and	O
activation	O
Ag	O
found	O
on	O
certain	O
bone	cell_type
marrow-derived	cell_type
cells	cell_type
.	O
Recently,	O
CD40	protein
also	O
has	O
been	O
shown	O
to	O
be	O
expressed	O
by	O
mesenchymal	cell_type
cells	cell_type
,	O
including	O
human	cell_type
fibroblasts	cell_type
.	O
Little	O
is	O
known	O
about	O
the	O
role	O
of	O
CD40	protein
in	O
fibroblasts	cell_type
.	O
The	O
current	O
study	O
investigates	O
the	O
hypothesis	O
that	O
CD40	protein
expressed	O
on	O
lung	cell_type
fibroblasts	cell_type
is	O
an	O
activation	O
structure	O
and	O
mechanism	O
for	O
interaction	O
with	O
hemopoietic	cell_type
cells	cell_type
.	O
Communication	O
between	O
resident	O
tissue	O
fibroblasts	cell_type
and	O
T	cell_type
cells	cell_type
is	O
necessary	O
for	O
normal	O
wound	O
healing,	O
and	O
can	O
be	O
pathologic,	O
resulting	O
in	O
tissue	O
fibrosis	O
.	O
Signaling	O
through	O
CD40	protein
with	O
soluble	O
CD40	protein
ligand	O
stimulated	O
fibroblast	O
activation	O
,	O
as	O
evidenced	O
by	O
mobilization	O
of	O
nuclear	O
factor-kappaB	O
and	O
by	O
induction	O
of	O
the	O
proinflammatory	O
and	O
chemoattractant	O
cytokines	protein
IL-6	protein
and	O
IL-8	protein
.	O
IFN-gamma-primed	cell_line
lung	cell_line
fibroblasts	cell_line
costimulate	O
T	O
lymphocyte	O
proliferation	O
utilizing	O
CD40	protein
,	O
but	O
not	O
the	O
well-studied	O
costimulatory	protein
molecules	protein
B7-1	protein
and	O
B7-2	protein
.	O
Data	O
reported	O
herein	O
support	O
the	O
hypothesis	O
that	O
cognate	O
interactions	O
between	O
tissue	cell_type
fibroblasts	cell_type
and	O
infiltrating	O
T	O
lymphocytes,	O
via	O
the	O
CD40	protein
/CD40L	protein
pathway	O
,	O
augment	O
inflammation	O
and	O
may	O
promote	O
fibrogenesis	O
by	O
activating	O
both	O
cell	O
types.	O

Biphasic	O
control	O
of	O
NF-kappa	protein
B	protein
activation	O
induced	O
by	O
the	O
triggering	O
of	O
HLA-DR	protein
antigens	protein
expressed	O
on	O
B	cell_type
cells	cell_type
.	O
The	O
regulation	O
of	O
NF-kappa	protein
B	protein
activation	O
following	O
the	O
triggering	O
of	O
HLA-DR	protein
antigens	protein
by	O
mAb	protein
L243	protein
has	O
been	O
studied	O
at	O
various	O
times	O
in	O
Raji	cell_line
cells	cell_line
.	O
Electrophoretic	O
mobility	O
shift	O
assays	O
demonstrated	O
a	O
strong	O
increase	O
of	O
NF-kappa	protein
B	protein
DNA	O
binding	O
after	O
triggering	O
of	O
HLA-DR	protein
antigens	protein
.	O
Using	O
TNF-alpha-activity	protein
neutralizing	protein
antibodies	protein
,	O
the	O
authors	O
demonstrated	O
that	O
the	O
upregulation	O
of	O
NF-kappa	protein
B	protein
was	O
found	O
to	O
depend,	O
at	O
later	O
time	O
point,	O
on	O
an	O
autocrine	O
effect	O
of	O
TNF-alpha	protein
secreted	O
following	O
triggering	O
of	O
HLA-DR	protein
antigens	protein
.	O
In	O
contrast,	O
it	O
was	O
found	O
to	O
be	O
TNF-alpha	protein
independent	O
in	O
the	O
early	O
time	O
point.	O
Moreover,	O
the	O
upregulation	O
of	O
NF-kappa	protein
B	protein
binding	O
activity	O
is	O
regulated	O
by	O
the	O
triggering	O
of	O
selected	O
epitopes	protein
of	O
HLA-DR	protein
antigens	protein
.	O
In	O
fact,	O
mAb	protein
L243	protein
but	O
not	O
the	O
staphylococcal	protein
superantigens	protein
,	O
staphylococcal	protein
exotoxin	protein
toxic	protein
shock	protein
syndrome	protein
toxin-I	protein
or	O
staphylococcal	protein
enterotoxin	protein
B	protein
,	O
regulate	O
the	O
NF-kappa	protein
B	protein
binding	O
activity	O
.	O

Regulation	O
of	O
inosine-5'-monophosphate	protein
dehydrogenase	protein
type	protein
II	protein
gene	O
expression	O
in	O
human	cell_type
T	cell_type
cells	cell_type
.	O
Role	O
for	O
a	O
novel	O
5'	DNA
palindromic	DNA
octamer	DNA
sequence	DNA
.	O
Expression	O
of	O
the	O
gene	O
encoding	O
human	protein
inosine-	protein
5'-monophosphate	protein
dehydrogenase	protein
(IMPDH)	protein
type	protein
II	protein
,	O
an	O
enzyme	protein
catalyzing	O
the	O
rate-limiting	O
step	O
in	O
the	O
generation	O
of	O
guanine	O
nucleotides	O
,	O
is	O
increased	O
more	O
than	O
10-fold	O
in	O
activated	cell_type
peripheral	cell_type
blood	cell_type
T	cell_type
lymphocytes	cell_type
and	O
is	O
required	O
for	O
T	O
cell	O
activation	O
.	O
We	O
have	O
examined	O
the	O
5'-regulatory	DNA
sequences	DNA
that	O
are	O
important	O
for	O
the	O
transcriptional	O
regulation	O
of	O
this	O
gene	O
in	O
T	cell_type
cells	cell_type
.	O
DNase	protein
I	protein
mapping	O
of	O
genomic	DNA
DNA	DNA
identified	O
a	O
hypersensitive	DNA
element	DNA
near	O
the	O
transcription	DNA
initiation	DNA
site	DNA
.	O
Fine	O
mapping	O
by	O
in	O
vivo	O
footprinting	O
demonstrated	O
five	O
transcription	O
factor	O
binding	O
sites	O
that	O
are	O
occupied	O
in	O
both	O
resting	O
and	O
activated	cell_type
peripheral	cell_type
blood	cell_type
T	cell_type
lymphocytes	cell_type
;	O
these	O
are	O
tandem	DNA
CRE	DNA
motifs	DNA
,	O
a	O
Sp1	DNA
site	DNA
,	O
an	O
overlapping	O
Egr-1/	DNA
Sp1	DNA
site	DNA
,	O
and	O
a	O
novel	O
palindromic	DNA
octamer	DNA
sequence	DNA
(	O
POS	DNA
).	O
The	O
tandem	O
CRE	O
and	O
POS	O
sites	O
are	O
of	O
major	O
functional	O
importance	O
as	O
judged	O
by	O
mutational	O
and	O
electrophoretic	O
mobility	O
shift	O
analyses	O
.	O
These	O
data	O
provide	O
evidence	O
that	O
expression	O
of	O
the	O
human	DNA
IMPDH	DNA
type	DNA
II	DNA
gene	DNA
is	O
predominantly	O
regulated	O
by	O
the	O
nuclear	protein
factors	protein
ATF-2	protein
and	O
an	O
as	O
yet	O
unidentified	O
POS	protein
-binding	protein
protein	protein
.	O
Additional	O
major	O
protein-DNA	O
interactions	O
do	O
not	O
occur	O
within	O
the	O
promoter	O
region	O
after	O
T	O
lymphocyte	O
activation	O
,	O
indicating	O
a	O
requirement	O
for	O
additional	O
protein-protein	O
interactions	O
and/or	O
post-translational	O
modifications	O
of	O
pre-bound	protein
transcription	protein
factors	protein
to	O
account	O
for	O
the	O
observed	O
increase	O
in	O
IMPDH	O
type	O
II	O
gene	O
expression	O
.	O

Distinct	O
mechanisms	O
for	O
N-acetylcysteine	O
inhibition	O
of	O
cytokine-induced	protein
E-selectin	protein
and	O
VCAM-1	protein
expression	O
.	O
We	O
have	O
examined	O
the	O
effects	O
of	O
N-acetyl-L-cysteine	O
(	O
NAC	O
),	O
a	O
well-characterized,	O
thiol-containing	O
antioxidant	O
,	O
on	O
agonist-induced	O
monocytic	O
cell	O
adhesion	O
to	O
endothelial	cell_type
cells	cell_type
(	O
EC	cell_type
).	O
NAC	O
inhibited	O
interleukin-1	protein
(	O
IL-1	protein
beta	protein
)-induced,	O
but	O
not	O
basal,	O
adhesion	O
with	O
50%	O
inhibition	O
at	O
approximately	O
20	O
mM.	O
Monocytic	O
cell	O
adhesion	O
to	O
EC	cell_type
in	O
response	O
to	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
),	O
lipopolysaccharide	O
(	O
LPS	O
),	O
alpha-thrombin	protein
,	O
or	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
was	O
similarly	O
inhibited	O
by	O
NAC	O
.	O
Unlike	O
published	O
studies	O
with	O
pyrrolidinedithiocarbamate	O
,	O
which	O
specifically	O
inhibited	O
vascular	protein
cell	protein
adhesion	protein
molecule	protein
1	protein
(	O
VCAM-1	protein
),	O
NAC	O
inhibited	O
IL-1	RNA
beta	RNA
-induced	RNA
mRNA	RNA
and	O
cell	O
surface	O
expression	O
of	O
both	O
E-selectin	protein
and	O
VCAM-1	protein
.	O
NAC	O
had	O
no	O
effect	O
on	O
the	O
half-life	O
of	O
E-selectin	O
or	O
VCAM-1	O
mRNA	O
.	O
Although	O
NAC	O
reduced	O
nuclear	protein
factor-kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
activation	O
in	O
EC	cell_type
as	O
measured	O
by	O
gel-shift	O
assays	O
using	O
an	O
oligonucleotide	DNA
probe	DNA
corresponding	O
to	O
the	O
consensus	O
NF-kappa	DNA
B	DNA
binding	DNA
sites	DNA
of	O
the	O
VCAM-1	DNA
gene	DNA
(	O
VCAM-	protein
NF-kappa	protein
B	protein
),	O
the	O
antioxidant	O
had	O
no	O
appreciable	O
effect	O
when	O
an	O
oligomer	O
corresponding	O
to	O
the	O
consensus	DNA
NF-kappa	DNA
B	DNA
binding	DNA
site	DNA
of	O
the	O
E-selectin	DNA
gene	DNA
(	O
E-selectin	protein
-NF-kappa	protein
B	protein
)	O
was	O
used.	O
Because	O
NF-kappa	protein
B	protein
has	O
been	O
reported	O
to	O
be	O
redox	O
sensitive,	O
we	O
studied	O
the	O
effects	O
of	O
NAC	O
on	O
the	O
EC	cell_type
redox	O
environment	O
.	O
NAC	O
caused	O
an	O
expected	O
dramatic	O
increase	O
in	O
the	O
reduced	O
glutathione	O
(	O
GSH	O
)	O
levels	O
in	O
EC	cell_type
.	O
In	O
vitro	O
studies	O
demonstrated	O
that	O
whereas	O
the	O
binding	O
affinity	O
of	O
NF-kappa	protein
B	protein
to	O
the	O
VCAM-	DNA
NF-kappa	DNA
B	DNA
oligomer	DNA
peaked	O
at	O
a	O
GSH	O
-to-oxidized	O
glutathione	O
(	O
GSSG	O
)	O
ratio	O
of	O
approximately	O
200	O
and	O
decreased	O
at	O
higher	O
ratios,	O
the	O
binding	O
to	O
the	O
E-selectin	DNA
-NF-kappa	DNA
B	DNA
oligomer	DNA
appeared	O
relatively	O
unaffected	O
even	O
at	O
ratios	O
&gt;	O
400,	O
i.e.,	O
those	O
achieved	O
in	O
EC	cell_type
treated	O
with	O
40	O
mM	O
NAC	O
.	O
These	O
results	O
suggest	O
that	O
NF-kappa	protein
B	protein
binding	O
to	O
its	O
consensus	O
sequences	O
in	O
the	O
VCAM-1	protein
and	O
E-selectin	DNA
gene	DNA
exhibits	O
marked	O
differences	O
in	O
redox	O
sensitivity,	O
allowing	O
for	O
differential	O
gene	O
expression	O
regulated	O
by	O
the	O
same	O
transcription	O
factor.	O
Our	O
data	O
also	O
demonstrate	O
that	O
NAC	O
increases	O
the	O
GSH	O
-to-	O
GSSG	O
ratio	O
within	O
the	O
EC	cell_type
suggesting	O
one	O
possible	O
mechanism	O
through	O
which	O
this	O
antioxidant	O
inhibits	O
agonist-induced	O
monocyte	O
adhesion	O
to	O
EC	cell_type
.	O

Opposite	O
effects	O
of	O
the	O
acute	protein
promyelocytic	protein
leukemia	protein
PML-retinoic	protein
acid	protein
receptor	protein
alpha	protein
(	O
RAR	protein
alpha	protein
)	O
and	O
PLZF-RAR	protein
alpha	protein
fusion	protein
proteins	protein
on	O
retinoic	O
acid	O
signalling	O
.	O
Fusion	O
proteins	O
involving	O
the	O
retinoic	O
acid	O
receptor	protein
alpha	protein
(	O
RAR	protein
alpha	protein
)	O
and	O
the	O
PML	protein
or	O
PLZF	protein
nuclear	protein
protein	protein
are	O
the	O
genetic	O
markers	O
of	O
acute	O
promyelocytic	O
leukemias	O
(	O
APLs	O
).	O
APLs	O
with	O
the	O
PML-RAR	protein
alpha	protein
or	O
the	O
PLZF-RAR	protein
alpha	protein
fusion	protein
protein	protein
are	O
phenotypically	O
indistinguishable	O
except	O
that	O
they	O
differ	O
in	O
their	O
sensitivity	O
to	O
retinoic	O
acid	O
(RA)-induced	O
differentiation	O
:	O
PML-RAR	protein
alpha	protein
blasts	O
are	O
sensitive	O
to	O
RA	O
and	O
patients	O
enter	O
disease	O
remission	O
after	O
RA	O
treatment	O
,	O
while	O
patients	O
with	O
PLZF-RAR	protein
alpha	protein
do	O
not.	O
We	O
here	O
report	O
that	O
(i)	O
like	O
PML-RAR	protein
alpha	protein
expression	O
,	O
PLZF-RAR	protein
alpha	protein
expression	O
blocks	O
terminal	O
differentiation	O
of	O
hematopoietic	O
precursor	O
cell	O
lines	O
(	O
U937	cell_line
and	O
HL-60	cell_line
)	O
in	O
response	O
to	O
different	O
stimuli	O
(	O
vitamin	O
D3	O
,	O
transforming	O
growth	O
factor	O
beta1	O
,	O
and	O
dimethyl	O
sulfoxide	O
);	O
(ii)	O
PML-RAR	protein
alpha	protein
,	O
but	O
not	O
PLZF-RAR	protein
alpha	protein
,	O
increases	O
RA	O
sensitivity	O
of	O
hematopoietic	cell_type
precursor	cell_type
cells	cell_type
and	O
restores	O
RA	O
sensitivity	O
of	O
RA-resistant	cell_type
hematopoietic	cell_type
cells	cell_type
;	O
(iii)	O
PML-RAR	protein
alpha	protein
and	O
PLZF-RAR	protein
alpha	protein
have	O
similar	O
RA	O
binding	O
affinities;	O
and	O
(iv)	O
PML-RAR	protein
alpha	protein
enhances	O
the	O
RA	O
response	O
of	O
RA	DNA
target	DNA
genes	DNA
(those	O
for	O
RAR	protein
beta	protein
,	O
RAR	protein
gamma	protein
,	O
and	O
transglutaminase	protein
type	protein
II	protein
[	O
TGase	protein
])	O
in	O
vivo,	O
while	O
PLZF-RAR	protein
alpha	protein
expression	O
has	O
either	O
no	O
effect	O
(	O
RAR	protein
beta	protein
)	O
or	O
an	O
inhibitory	O
activity	O
(	O
RAR	protein
gamma	protein
and	O
type	protein
II	protein
TGase	protein
).	O
These	O
data	O
demonstrate	O
that	O
PML-RAR	protein
alpha	protein
and	O
PLZF-RAR	protein
alpha	protein
have	O
similar	O
(inhibitory)	O
effects	O
on	O
RA-independent	O
differentiation	O
and	O
opposite	O
(stimulatory	O
or	O
inhibitory)	O
effects	O
on	O
RA	O
-dependent	O
differentiation	O
and	O
that	O
they	O
behave	O
in	O
vivo	O
as	O
RA	DNA
-dependent	DNA
enhancers	DNA
or	O
inhibitors	O
of	O
RA	DNA
-responsive	DNA
genes	DNA
,	O
respectively.	O
Their	O
different	O
activities	O
on	O
the	O
RA	O
signalling	O
pathway	O
might	O
underlie	O
the	O
different	O
responses	O
of	O
PML-RAR	protein
alpha	protein
and	O
PLZF-RAR	protein
alpha	protein
APLs	O
to	O
RA	O
treatment	O
.	O
The	O
PLZF-RAR	protein
alpha	protein
fusion	protein
protein	protein
contains	O
an	O
approximately	O
120-amino-acid	protein
N-terminal	protein
motif	protein
(called	O
the	O
POZ	protein
domain	protein
),	O
which	O
is	O
also	O
found	O
in	O
a	O
variety	O
of	O
zinc	O
finger	O
proteins	O
and	O
a	O
group	O
of	O
poxvirus	protein
proteins	protein
and	O
which	O
mediates	O
protein-protein	O
interactions	O
.	O
Deletion	O
of	O
the	O
PLZF	protein
POZ	protein
domain	protein
partially	O
abrogated	O
the	O
inhibitory	O
effect	O
of	O
PLZF-RAR	protein
alpha	protein
on	O
RA-induced	O
differentiation	O
and	O
on	O
RA-mediated	O
type	protein
II	protein
TGase	protein
up-regulation	O
,	O
suggesting	O
that	O
POZ-mediated	O
protein	O
interactions	O
might	O
be	O
responsible	O
for	O
the	O
inhibitory	O
transcriptional	O
activities	O
of	O
PLZF-RAR	protein
alpha	protein
.	O

A	O
human	O
homologue	O
of	O
the	O
Drosophila	protein
Toll	protein
protein	protein
signals	O
activation	O
of	O
adaptive	O
immunity	O
[see	O
comments]	O
Induction	O
of	O
the	O
adaptive	O
immune	O
response	O
depends	O
on	O
the	O
expression	O
of	O
co-stimulatory	protein
molecules	protein
and	O
cytokines	protein
by	O
antigen-presenting	cell_type
cells	cell_type
.	O
The	O
mechanisms	O
that	O
control	O
the	O
initial	O
induction	O
of	O
these	O
signals	O
upon	O
infection	O
are	O
poorly	O
understood.	O
It	O
has	O
been	O
proposed	O
that	O
their	O
expression	O
is	O
controlled	O
by	O
the	O
non-clonal,	O
or	O
innate,	O
component	O
of	O
immunity	O
that	O
preceded	O
in	O
evolution	O
the	O
development	O
of	O
an	O
adaptive	O
immune	O
system	O
in	O
vertebrates	O
.	O
We	O
report	O
here	O
the	O
cloning	O
and	O
characterization	O
of	O
a	O
human	protein
homologue	protein
of	O
the	O
Drosophila	protein
toll	protein
protein	protein
(	O
Toll	protein
)	O
which	O
has	O
been	O
shown	O
to	O
induce	O
the	O
innate	O
immune	O
response	O
in	O
adult	O
Drosophila	O
.	O
Like	O
Drosophila	O
Toll	protein
,	O
human	protein
Toll	protein
is	O
a	O
type	O
I	O
transmembrane	O
protein	O
with	O
an	O
extracellular	O
domain	O
consisting	O
of	O
a	O
leucine-rich	protein
repeat	protein
(	protein
LRR	protein
)	protein
domain	protein
,	O
and	O
a	O
cytoplasmic	O
domain	O
homologous	O
to	O
the	O
cytoplasmic	protein
domain	protein
of	O
the	O
human	protein
interleukin	protein
(IL)-1	protein
receptor	protein
.	O
Both	O
Drosophila	O
Toll	protein
and	O
the	O
IL-1	O
receptor	O
are	O
known	O
to	O
signal	O
through	O
the	O
NF-kappaB	protein
pathway	O
.	O
We	O
show	O
that	O
a	O
constitutively	O
active	O
mutant	O
of	O
human	protein
Toll	protein
transfected	O
into	O
human	O
cell	O
lines	O
can	O
induce	O
the	O
activation	O
of	O
NF-kappaB	protein
and	O
the	O
expression	O
of	O
NF-kappaB	DNA
-controlled	DNA
genes	DNA
for	O
the	O
inflammatory	protein
cytokines	protein
IL-1	protein
,	O
IL-6	protein
and	O
IL-8	protein
,	O
as	O
well	O
as	O
the	O
expression	O
of	O
the	O
co-stimulatory	protein
molecule	protein
B7.1	protein
,	O
which	O
is	O
required	O
for	O
the	O
activation	O
of	O
naive	cell_type
T	cell_type
cells	cell_type
.	O

Role	O
of	O
ascorbate	O
in	O
the	O
activation	O
of	O
NF-kappaB	protein
by	O
tumour	protein
necrosis	protein
factor-alpha	protein
in	O
T-cells	cell_type
.	O
The	O
first	O
product	O
of	O
ascorbate	O
oxidation,	O
the	O
ascorbate	O
free	O
radical	O
(	O
AFR	O
),	O
acts	O
in	O
biological	O
systems	O
mainly	O
as	O
an	O
oxidant,	O
and	O
through	O
its	O
role	O
in	O
the	O
plasma	O
membrane	O
redox	O
system	O
exerts	O
different	O
effects	O
on	O
the	O
cell.	O
We	O
have	O
investigated	O
the	O
role	O
of	O
ascorbate	O
,	O
AFR	O
and	O
dehydroascorbate	O
(	O
DHA	O
)	O
in	O
the	O
activation	O
of	O
the	O
NF-kappaB	protein
transcription	protein
factor	protein
in	O
Jurkat	cell_line
T-cells	cell_line
stimulated	O
by	O
tumour	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
).	O
Here	O
we	O
show,	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
that	O
ascorbate	O
increases	O
the	O
binding	O
of	O
NF-kappaB	protein
to	O
DNA	O
in	O
TNF-alpha	cell_line
-stimulated	cell_line
Jurkat	cell_line
cells	cell_line
.	O
The	O
ability	O
of	O
ascorbate	O
to	O
enhance	O
cytoplasmic	O
inhibitory	O
IkBalpha	protein
protein	protein
degradation	O
correlates	O
completely	O
with	O
its	O
capacity	O
to	O
induce	O
NF-kappaB	protein
binding	O
to	O
DNA	O
and	O
to	O
potentiate	O
NF-kappaB	protein
-mediated	O
transactivation	O
of	O
the	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
promoter	DNA
in	O
TNF-alpha	cell_line
-stimulated	cell_line
Jurkat	cell_line
cells	cell_line
but	O
not	O
in	O
cells	O
stimulated	O
with	O
PMA	O
plus	O
ionomycin	O
.	O
AFR	O
behaves	O
like	O
ascorbate	O
,	O
while	O
DHA	O
and	O
ascorbate	O
phosphate	O
do	O
not	O
affect	O
TNF-alpha	protein
-mediated	O
NF-kappaB	protein
activation	O
.	O
These	O
results	O
provide	O
new	O
evidence	O
for	O
a	O
possible	O
relationship	O
between	O
the	O
activation	O
of	O
the	O
electron-transport	O
system	O
at	O
the	O
plasma	O
membrane	O
by	O
ascorbate	O
or	O
its	O
free	O
radical	O
and	O
redox-dependent	O
gene	O
transcription	O
in	O
T-cells	cell_type
.	O

Human	O
cytomegalovirus	O
induces	O
interleukin-8	protein
production	O
by	O
a	O
human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
,	O
THP-1	cell_line
,	O
through	O
acting	O
concurrently	O
on	O
AP-1-	O
and	O
NF-kappaB-	O
binding	O
sites	O
of	O
the	O
interleukin-8	DNA
gene	DNA
.	O
Cytomegalovirus	O
(CMV)	O
infection	O
induced	O
interleukin-8	protein
(	O
IL-8	protein
)	O
gene	O
transcription	O
in	O
a	O
human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
,	O
THP-1	cell_line
cells	cell_line
,	O
leading	O
to	O
IL-8	protein
secretion	O
.	O
The	O
functional	O
analysis	O
of	O
the	O
IL-8	DNA
gene	DNA
revealed	O
that	O
both	O
AP-1-	O
and	O
NF-kappaB	O
factor-	O
binding	O
elements	O
were	O
involved	O
in	O
conferring	O
the	O
responsiveness	O
to	O
CMV	O
.	O
Moreover,	O
electrophoretic	O
mobility	O
shift	O
assays	O
demonstrated	O
that	O
CMV	O
induced	O
the	O
formation	O
of	O
NF-kappaB	protein
and	O
AP-1	protein
complexes	protein
.	O
These	O
results	O
suggest	O
that	O
CMV	O
activates	O
these	O
transcriptional	protein
factors	protein
,	O
resulting	O
in	O
IL-8	protein
gene	O
expression	O
.	O

Construction	O
and	O
biological	O
characterization	O
of	O
an	O
interleukin-12	protein
fusion	protein
protein	protein
(	O
Flexi-12	protein
):	O
delivery	O
to	O
acute	cell_type
myeloid	cell_type
leukemic	cell_type
blasts	cell_type
using	O
adeno-associated	O
virus	O
.	O
Interleukin-12	protein
(	O
IL-12	protein
)	O
is	O
a	O
cytokine	protein
that	O
exhibits	O
pleiotropic	O
effects	O
on	O
lymphocytes	cell_type
and	O
natural	cell_type
killer	cell_type
cells	cell_type
and	O
has	O
been	O
shown	O
to	O
have	O
promise	O
for	O
the	O
immunotherapy	O
of	O
cancer.	O
The	O
combination	O
of	O
the	O
immune	protein
costimulatory	protein
molecule	protein
B7.1	protein
and	O
IL-12	protein
has	O
been	O
shown	O
to	O
be	O
synergistic	O
for	O
T	O
cell	O
activation	O
.	O
By	O
transfecting	O
tumor	O
cells	O
with	O
both	O
IL-12	O
and	O
B7.1	O
cDNAs	O
,	O
it	O
may	O
be	O
possible	O
to	O
use	O
these	O
modified	O
targets	O
as	O
vaccines	O
.	O
A	O
major	O
obstacle	O
in	O
designing	O
a	O
vector	O
to	O
deliver	O
these	O
genes	O
results	O
from	O
the	O
structure	O
of	O
IL-12	protein
.	O
Functional	O
IL-12	protein
is	O
a	O
heterodimer	protein
composed	O
of	O
two	O
distinct	O
subunits	O
that	O
are	O
encoded	O
by	O
separate	O
genes	O
on	O
different	O
chromosomes.	O
Production	O
of	O
functional	protein
IL-12	protein
requires	O
the	O
coordinated	O
expression	O
of	O
both	O
genes.	O
This	O
presents	O
several	O
problems	O
in	O
vectors,	O
particularly	O
those	O
in	O
which	O
additional	O
genes,	O
either	O
a	O
co-stimulatory	DNA
gene	DNA
or	O
a	O
selectable	O
marker,	O
are	O
inserted.	O
Therefore,	O
we	O
have	O
constructed	O
a	O
single	O
cDNA	DNA
that	O
encodes	O
a	O
single-chain	protein
protein	protein
,	O
called	O
Flexi-12	protein
,	O
which	O
retains	O
all	O
of	O
the	O
biological	O
characteristics	O
of	O
recombinant	O
IL-12	protein
(	O
rIL-12	protein
).	O
The	O
monomeric	O
polypeptide	O
Flexi-12	protein
is	O
able	O
to	O
induce	O
the	O
proliferation	O
of	O
phytohemagglutinin	cell_line
(	cell_line
PHA	cell_line
)	cell_line
blasts	cell_line
,	O
induce	O
PHA	cell_line
blasts	cell_line
to	O
secrete	O
interferon-gamma	protein
(	O
IFN-gamma	protein
)	O
and	O
additionally,	O
by	O
preincubation,	O
enhance	O
the	O
killing	O
of	O
K562	O
targets	O
by	O
PBLs	cell_type
.	O
These	O
phenomena	O
are	O
in	O
a	O
dose-dependent	O
manner	O
comparable	O
to	O
that	O
seen	O
with	O
rIL-12	protein
.	O
We	O
have	O
also	O
shown	O
that	O
tyrosine	O
phosphorylation	O
of	O
the	O
STAT	protein
4	protein
transcription	protein
factor	protein
,	O
which	O
has	O
been	O
shown	O
to	O
be	O
unique	O
to	O
the	O
IL-12	protein
signaling	O
pathway,	O
occurs	O
with	O
Flexi-12	protein
at	O
levels	O
similar	O
to	O
those	O
seen	O
with	O
rIL-12	protein
.	O
We	O
have	O
packaged	O
Flexi-12	protein
into	O
a	O
recombinant	O
adeno-associated	O
virus	O
(	O
AAV	O
)	O
and	O
used	O
this	O
vector	O
to	O
infect	O
acute	cell_type
myeloid	cell_type
leukemic	cell_type
(AML)	cell_type
blasts	cell_type
.	O
Infected	O
AML	cell_type
blasts	cell_type
produced	O
between	O
2	O
and	O
6	O
ng	O
of	O
IL-12/10(6)	O
cells	O
per	O
ml	O
per	O
48	O
hr.	O
These	O
studies	O
also	O
confirm	O
that	O
AAV	O
is	O
an	O
efficient	O
delivery	O
vehicle	O
for	O
cytokines	protein
to	O
leukemic	O
cells.	O
Direct	O
analysis	O
of	O
these	O
modified	O
cells	O
acting	O
as	O
tumor	O
vaccines	O
is	O
underway.	O

Plasma	O
sialyltransferase	protein
levels	O
in	O
psychiatric	O
disorders	O
as	O
a	O
possible	O
indicator	O
of	O
HPA	O
axis	O
function	O
.	O
A	O
dysfunction	O
in	O
the	O
regulation	O
of	O
the	O
hypothalamic-pituitary-adrenal	O
(HPA)	O
axis	O
,	O
possibly	O
attributed	O
to	O
a	O
change	O
in	O
glucocorticoid	protein
receptor	protein
(	O
GR	protein
)	O
functionality	O
,	O
has	O
been	O
implicated	O
in	O
depression.	O
We	O
have	O
measured	O
both	O
lymphocyte	protein
GR	protein
receptor	O
binding	O
parameters	O
and	O
plasma	O
sialyltransferase	protein
activity	O
,	O
as	O
a	O
biochemical	O
marker	O
of	O
GR	protein
function	O
,	O
in	O
two	O
groups	O
of	O
patients	O
suffering	O
from	O
depression	O
or	O
schizophrenia	O
and	O
in	O
a	O
group	O
of	O
age-	O
and	O
sex-matched	O
controls.	O
While	O
there	O
was	O
a	O
significant	O
increase	O
in	O
plasma	O
cortisol	O
levels	O
in	O
the	O
depressed	O
group,	O
there	O
were	O
no	O
changes	O
in	O
the	O
lymphocyte	O
GR	protein
binding	O
parameters	O
(K(m)	O
and	O
Bmax).	O
There	O
was,	O
however,	O
a	O
significant	O
decrease	O
in	O
the	O
plasma	protein
sialyltransferase	protein
:	protein
cortisol	O
ratio	O
in	O
the	O
depressed	O
group	O
suggesting	O
an	O
inability	O
of	O
the	O
raised	O
cortisol	O
levels	O
to	O
induce	O
enzyme	O
expression	O
and	O
this	O
ratio	O
may	O
provide	O
a	O
useful	O
biochemical	O
marker	O
of	O
cortisol	O
receptor	O
function.	O
Although	O
there	O
was	O
an	O
increase	O
in	O
the	O
plasma	O
activity	O
of	O
the	O
alpha	protein
2,6	protein
sialyltransferase	protein
isozyme	protein
in	O
the	O
schizophrenic	O
group	O
,	O
no	O
other	O
changes	O
were	O
determined.	O
Therefore,	O
while	O
the	O
total	O
plasma	protein
sialyltransferase	protein
:	O
cortisol	O
ratio	O
reflects	O
HPA	O
axis	O
function	O
,	O
alterations	O
in	O
specific	O
isozyme	O
activity	O
may	O
also	O
be	O
associated	O
with	O
other	O
CNS	O
disease	O
states	O
.	O

Regulation	O
of	O
CD95	protein
(Fas)	protein
ligand	protein
expression	O
by	O
TCR	protein
-mediated	O
signaling	O
events	O
.	O
Stimulation	O
of	O
mature	cell_type
peripheral	cell_type
T	cell_type
cells	cell_type
by	O
TCR	protein
engagement	O
results	O
in	O
activation	O
of	O
signals	O
that	O
drive	O
induction	O
of	O
cytokine	protein
gene	O
expression	O
and	O
clonal	O
expansion	O
.	O
However,	O
under	O
some	O
conditions,	O
engagement	O
of	O
the	O
TCR	protein
leads	O
instead	O
to	O
apoptosis.	O
Recent	O
studies	O
demonstrate	O
that	O
TCR	protein
-stimulated	O
apoptosis	O
requires	O
expression	O
of	O
CD95	protein
ligand	protein
on	O
activated	cell_type
T	cell_type
cells	cell_type
followed	O
by	O
an	O
interaction	O
between	O
CD95	protein
ligand	protein
and	O
the	O
CD95	protein
receptor	protein
also	O
expressed	O
on	O
this	O
population.	O
The	O
experiments	O
reported	O
in	O
this	O
study	O
were	O
designed	O
to	O
address	O
the	O
signaling	O
events	O
triggered	O
by	O
TCR	protein
engagement	O
that	O
are	O
important	O
for	O
regulating	O
CD95	protein
ligand	protein
gene	O
expression	O
.	O
To	O
approach	O
this,	O
we	O
generated	O
a	O
luciferase	DNA
reporter	DNA
construct	DNA
containing	O
elements	O
of	O
the	O
CD95	protein
ligand	protein
promoter.	O
Using	O
a	O
previously	O
described	O
mutant	O
of	O
the	O
Jurkat	cell_line
T	cell_line
cell	cell_line
line	cell_line
,	O
we	O
show	O
that	O
proximal	O
signaling	O
events	O
dependent	O
on	O
the	O
presence	O
of	O
the	O
CD45	protein
tyrosine	protein
phosphatase	protein
are	O
required	O
for	O
TCR	protein
-stimulated	O
CD95	protein
ligand	protein
expression	O
.	O
Transient	O
transfection	O
studies	O
demonstrate	O
further	O
that	O
TCR	protein
-stimulated	O
activation	O
of	O
the	O
Ras	protein
signaling	O
pathway	O
is	O
required	O
for	O
optimal	O
activation	O
of	O
CD95	protein
ligand	protein
.	O
Next,	O
in	O
an	O
effort	O
to	O
determine	O
critical	O
transcription	protein
factors	protein
that	O
regulate	O
CD95	protein
ligand	protein
expression,	O
we	O
demonstrate	O
a	O
cyclosporin	DNA
A-sensitive	DNA
nuclear	DNA
factor-AT	DNA
response	DNA
element	DNA
in	O
the	O
promoter	DNA
region	DNA
of	O
this	O
gene	O
that	O
is	O
critical	O
for	O
optimal	O
CD95	protein
ligand	protein
reporter	O
activity	O
in	O
stimulated	cell_type
T	cell_type
cells	cell_type
.	O
Together,	O
these	O
studies	O
begin	O
a	O
dissection	O
of	O
the	O
biochemical	O
events	O
that	O
lead	O
to	O
expression	O
of	O
CD95	protein
ligand	protein
,	O
a	O
required	O
step	O
for	O
TCR	protein
-induced	O
apoptosis	O
.	O

Reactive	O
oxygen	O
species	O
and	O
antioxidants	O
in	O
inflammatory	O
diseases	O
.	O
This	O
paper	O
aims	O
to	O
review	O
the	O
role	O
of	O
free	O
radical-induced	O
tissue	O
damage	O
and	O
antioxidant	O
defence	O
mechanisms	O
in	O
inflammatory	O
diseases	O
that	O
involve	O
pathogenic	O
processes	O
similar	O
to	O
the	O
periodontal	O
diseases	O
.	O
There	O
is	O
a	O
clearly	O
defined	O
and	O
substantial	O
role	O
for	O
free	O
radicals	O
or	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
in	O
periodontitis	O
,	O
but	O
little	O
research	O
has	O
been	O
performed	O
in	O
this	O
area.	O
This	O
paper	O
reviews	O
the	O
considerable	O
data	O
available	O
relating	O
ROS	O
activity	O
and	O
antioxidant	O
defence	O
to	O
inflammatory	O
diseases	O
and	O
attempts	O
to	O
draw	O
parallels	O
with	O
periodontitis	O
,	O
in	O
an	O
effort	O
to	O
stimulate	O
more	O
periodontal	O
research	O
in	O
this	O
important	O
area.	O
The	O
recent	O
discovery	O
of	O
the	O
transcription	protein
factor	protein
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
is	O
reviewed	O
and	O
several	O
potential	O
pathways	O
for	O
cytokine	protein
-induced	O
periodontal	O
tissue	O
damage	O
,	O
mediated	O
by	O
NF-kappa	protein
B1	protein
are	O
discussed.	O
Emphasis	O
is	O
placed	O
on	O
cytokines	protein
that	O
have	O
been	O
studied	O
in	O
periodontitis	O
,	O
principally	O
TNF-alpha	protein
,	O
IL-1	protein
,	O
IL-6	protein
,	O
IL-8	protein
and	O
beta-interferon	protein
.	O
The	O
link	O
between	O
cellular	O
production	O
of	O
such	O
important	O
mediators	O
of	O
inflammation	O
and	O
the	O
antioxidant	O
(AO)	O
thiols	O
,	O
cysteine	O
and	O
reduced	O
glutathione	O
(	O
GSH	O
),	O
is	O
discussed	O
and	O
it	O
is	O
hypothesised	O
that	O
NF-kappa	protein
B	protein
antagonists	O
may	O
offer	O
important	O
therapeutic	O
benefits	O
.	O

Mutations	O
in	O
the	O
TSC2	DNA
gene	DNA
:	O
analysis	O
of	O
the	O
complete	O
coding	O
sequence	O
using	O
the	O
protein	O
truncation	O
test	O
(	O
PTT	O
).	O
Mutations	O
in	O
the	O
TSC2	DNA
gene	DNA
on	O
chromosome	DNA
16p13.3	DNA
are	O
responsible	O
for	O
approximately	O
50%	O
of	O
familial	O
tuberous	O
sclerosis	O
(	O
TSC	O
).	O
The	O
gene	O
has	O
41	DNA
small	DNA
exons	DNA
spanning	O
45	DNA
kb	DNA
of	O
genomic	DNA
DNA	DNA
and	O
encoding	O
a	O
5.5	RNA
kb	RNA
mRNA	RNA
.	O
Large	O
germline	O
deletions	O
of	O
TSC2	DNA
occur	O
in	O
&lt;5%	O
of	O
cases,	O
and	O
a	O
number	O
of	O
small	O
intragenic	O
mutations	O
have	O
been	O
described.	O
We	O
analysed	O
mRNA	O
from	O
18	O
unrelated	O
cases	O
of	O
TSC	O
for	O
TSC2	DNA
mutations	DNA
using	O
the	O
protein	O
truncation	O
test	O
(	O
PTT	O
).	O
Three	O
cases	O
were	O
predicted	O
to	O
be	O
TSC2	DNA
mutations	DNA
on	O
the	O
basis	O
of	O
linkage	O
analysis	O
or	O
because	O
a	O
hamartoma	O
from	O
the	O
patient	O
showed	O
loss	O
of	O
heterozygosity	O
for	O
16p13.3	DNA
markers	DNA
.	O
Three	O
overlapping	O
PCR	DNA
products	DNA
,	O
covering	O
the	O
complete	O
coding	O
sequence	O
of	O
mRNA	RNA
,	O
were	O
generated	O
from	O
lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
,	O
translated	O
into	O
35S-methionine	protein
labelled	protein
protein	protein
,	O
and	O
analysed	O
by	O
SDS-PAGE	O
.	O
PCR	DNA
products	DNA
showing	O
PTT	O
shifts	O
were	O
directly	O
sequenced,	O
and	O
mutations	O
confirmed	O
by	O
restriction	O
enzyme	O
digestion	O
where	O
possible.	O
Six	O
PTT	O
shifts	O
were	O
identified.	O
Five	O
of	O
these	O
were	O
caused	O
by	O
mutations	O
predicted	O
to	O
produce	O
a	O
truncated	protein
protein	protein
:	O
(i)	O
a	O
sporadic	O
case	O
showed	O
a	O
32	DNA
bp	DNA
deletion	DNA
in	O
exon	RNA
11	RNA
,	O
and	O
a	O
mutant	RNA
mRNA	RNA
without	O
exon	RNA
11	RNA
was	O
produced;	O
the	O
normal	O
exon	O
10	O
was	O
also	O
spliced	O
out;	O
(ii)	O
a	O
sporadic	O
case	O
had	O
a	O
1	DNA
bp	DNA
deletion	DNA
in	O
exon	RNA
12	RNA
(	O
1634delT	RNA
);	O
(iii)	O
a	O
TSC2	RNA
-linked	RNA
mother	RNA
and	RNA
daughter	RNA
pair	RNA
had	O
a	O
G--&gt;T	O
transversion	O
in	O
exon	RNA
23	RNA
(	O
G2715T	RNA
)	O
introducing	O
a	O
cryptic	O
splice	O
site	O
causing	O
a	O
29	O
bp	O
truncation	O
of	O
mRNA	O
from	O
exon	RNA
23	RNA
;	O
(iv)	O
a	O
sporadic	O
case	O
showed	O
a	O
2	DNA
bp	DNA
deletion	DNA
in	O
exon	RNA
36	RNA
;	O
(v)	O
a	O
sporadic	O
case	O
showed	O
a	O
1	DNA
bp	DNA
insertion	DNA
disrupting	O
the	O
donor	O
splice	O
site	O
of	O
exon	RNA
37	RNA
(	O
5007+2insA	RNA
),	O
resulting	O
in	O
the	O
use	O
of	O
an	O
upstream	RNA
exonic	RNA
cryptic	RNA
splice	RNA
site	RNA
to	O
cause	O
a	O
29	RNA
bp	RNA
truncation	RNA
of	O
mRNA	RNA
from	O
exon	RNA
37	RNA
.	O
In	O
one	O
case,	O
the	O
PTT	O
shift	O
was	O
explained	O
by	O
in-frame	O
splicing	O
out	O
of	O
exon	RNA
10	RNA
,	O
in	O
the	O
presence	O
of	O
a	O
normal	DNA
exon	DNA
10	DNA
genomic	DNA
sequence	DNA
.	O
Alternative	O
splicing	O
of	O
exon	RNA
10	RNA
of	O
the	O
TSC2	DNA
gene	DNA
may	O
be	O
a	O
normal	O
variant.	O
Three	O
3rd	O
base	O
substitution	O
polymorphisms	O
were	O
also	O
detected	O
during	O
direct	O
sequencing	O
of	O
PCR	DNA
products	DNA
.	O
Confirmed	O
mutations	O
were	O
identified	O
in	O
28%	O
of	O
the	O
families	O
studied	O
and	O
on	O
the	O
assumption	O
that	O
half	O
of	O
the	O
sporadic	O
cases	O
should	O
have	O
TSC2	DNA
mutations	DNA
,	O
a	O
crude	O
estimate	O
of	O
the	O
detection	O
rate	O
would	O
be	O
60%.	O
This	O
compares	O
favourably	O
with	O
other	O
screening	O
methods	O
used	O
for	O
TSC2	DNA
,	O
notably	O
SSCP	O
,	O
and	O
since	O
PTT	O
involves	O
much	O
less	O
work	O
it	O
may	O
be	O
the	O
method	O
of	O
choice.	O

alpha-Tocopheryl	O
succinate	O
inhibits	O
monocytic	O
cell	O
adhesion	O
to	O
endothelial	cell_type
cells	cell_type
by	O
suppressing	O
NF-kappa	protein
B	protein
mobilization	O
.	O
The	O
adherence	O
of	O
monocytes	cell_type
to	O
activated	O
endothelium	O
is	O
an	O
early	O
event	O
in	O
atherogenesis	O
.	O
Because	O
antioxidants	O
have	O
been	O
considered	O
to	O
be	O
of	O
antiatherosclerotic	O
potential	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
alpha-tocopherol	O
(	O
TCP	O
)	O
and	O
its	O
acetate	O
and	O
succinate	O
esters	O
on	O
monocyte	O
adhesion	O
to	O
cytokine-stimulated	cell_line
human	cell_line
umbilical	cell_line
vein	cell_line
endothelial	cell_line
cells	cell_line
(	O
HUVEC	cell_line
).	O
Endothelial	cell_type
cells	cell_type
were	O
treated	O
with	O
TCP	O
,	O
alpha-tocopherol	O
acetate	O
(	O
TCP	O
acetate	O
),	O
or	O
alpha-tocopheryl	O
succinate	O
(	O
TCP	O
succinate	O
)	O
before	O
stimulation	O
with	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
;	O
10	O
U/ml,	O
6	O
h)	O
or	O
interleukin-1	protein
beta	protein
(	O
IL-1	protein
beta	protein
;	O
10	O
U/ml,	O
6	O
h).	O
Cytokine-stimulated	O
cell	O
surface	O
expression	O
of	O
vascular	protein
cell	protein
adhesion	protein
molecule-1	protein
(	O
VCAM-1	protein
,	O
CD106	protein
)	O
and	O
E-selectin	protein
(	O
ELAM-1	protein
,	O
CD62E	protein
),	O
but	O
not	O
of	O
intercellular	protein
adhesion	protein
molecule-1	protein
(	O
ICAM-1	protein
,	O
CD54	protein
),	O
was	O
time-	O
and	O
dose-dependently	O
inhibited	O
by	O
TCP	O
succinate	O
but	O
not	O
by	O
TCP	O
or	O
TCP	O
acetate	O
.	O
TCP	O
succinate	O
(200	O
microM,	O
24	O
h)	O
reduced	O
TNF-induced	protein
VCAM-1	protein
and	O
E-selectin	protein
expression	O
from	O
a	O
specific	O
mean	O
fluorescence	O
intensity	O
of	O
151	O
+/-	O
28	O
to	O
12	O
+/-	O
4	O
channels	O
and	O
from	O
225	O
+/-	O
38	O
to	O
79	O
+/-	O
21	O
channels,	O
respectively.	O
Succinate	O
alone	O
had	O
no	O
effect.	O
Decreased	O
adhesion	protein
molecule	protein
expression	O
was	O
associated	O
with	O
a	O
reduction	O
of	O
monocytic	O
cell	O
adhesion	O
.	O
TCP	O
succinate	O
(20	O
microM,	O
72	O
h),	O
but	O
not	O
TCP	O
(200	O
microM,	O
72	O
h),	O
reduced	O
U-937	cell_line
cell	cell_line
adhesion	O
to	O
TNF-alpha	cell_line
-stimulated	cell_line
(10	cell_line
U/ml,	cell_line
6	cell_line
h)	cell_line
HUVEC	cell_line
by	O
30%	O
(P	O
&lt;	O
0.025)	O
and	O
to	O
IL-1	cell_line
beta	cell_line
-stimulated	cell_line
HUVEC	cell_line
by	O
56%	O
(P	O
&lt;	O
0.010).	O
Electrophoretic	O
mobility-shift	O
assays	O
of	O
HUVEC	cell_line
nuclear	protein
proteins	protein
revealed	O
a	O
decrease	O
in	O
TNF-alpha	protein
-stimulated	protein
nuclear	protein
factor-kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
activation	O
after	O
pretreatment	O
of	O
HUVEC	cell_line
with	O
TCP	O
succinate	O
but	O
not	O
with	O
TCP	O
,	O
TCP	O
acetate	O
,	O
or	O
succinate	O
alone.	O
In	O
conclusion,	O
we	O
demonstrate	O
that	O
the	O
vitamin	O
E	O
derivative	O
TCP	O
succinate	O
prevents	O
monocytic	O
cell	O
adhesion	O
to	O
cytokine-stimulated	O
endothelial	cell_type
cells	cell_type
by	O
inhibiting	O
the	O
activation	O
of	O
NF-kappa	protein
B	protein
,	O
further	O
emphasizing	O
the	O
antiatherosclerotic	O
potential	O
of	O
lipid	O
soluble	O
antioxidants	O
.	O

The	O
product	O
of	O
the	O
murine	DNA
homolog	DNA
of	O
the	O
Drosophila	DNA
extra	DNA
sex	DNA
combs	DNA
gene	DNA
displays	O
transcriptional	protein
repressor	protein
activity	O
.	O
The	O
heterogeneous	protein
nuclear	protein
ribonucleoprotein	protein
K	protein
protein	protein
represents	O
a	O
novel	O
class	O
of	O
proteins	O
that	O
may	O
act	O
as	O
docking	O
platforms	O
that	O
orchestrate	O
cross-talk	O
among	O
molecules	O
involved	O
in	O
signal	O
transduction	O
and	O
gene	O
expression	O
.	O
Using	O
a	O
fragment	O
of	O
K	protein
protein	protein
as	O
bait	O
in	O
the	O
yeast	O
two-hybrid	O
screen	O
,	O
we	O
isolated	O
a	O
cDNA	DNA
that	O
encodes	O
a	O
protein	O
whose	O
primary	O
structure	O
has	O
extensive	O
similarity	O
to	O
the	O
Drosophila	protein
melanogaster	protein
extra	protein
sex	protein
combs	protein
(esc)	protein
gene	protein
product	protein
,	O
Esc	protein
,	O
a	O
putative	O
silencer	O
of	O
homeotic	DNA
genes	DNA
.	O
The	O
cDNA	DNA
that	O
we	O
isolated	O
is	O
identical	O
to	O
the	O
cDNA	DNA
of	O
the	O
recently	O
positionally	O
cloned	O
mouse	DNA
embryonic	DNA
ectoderm	DNA
development	DNA
gene	DNA
,	O
eed.	O
Like	O
Esc	protein
,	O
Eed	protein
contains	O
six	O
WD-40	protein
repeats	protein
in	O
the	O
C-terminal	protein
half	protein
of	O
the	O
protein	O
and	O
is	O
thought	O
to	O
repress	O
homeotic	O
gene	O
expression	O
during	O
mouse	O
embryogenesis	O
.	O
Eed	protein
binds	O
to	O
K	protein
protein	protein
through	O
a	O
domain	O
in	O
its	O
N	protein
terminus	protein
,	O
but	O
interestingly,	O
this	O
domain	O
is	O
not	O
found	O
in	O
the	O
Drosophila	O
Esc	protein
.	O
Gal4-	protein
Eed	protein
fusion	protein
protein	protein
represses	O
transcription	O
of	O
a	O
reporter	O
gene	O
driven	O
by	O
a	O
promoter	O
that	O
contains	O
Gal4-binding	DNA
DNA	DNA
elements	DNA
.	O
Eed	protein
also	O
represses	O
transcription	O
when	O
recruited	O
to	O
a	O
target	O
promoter	O
by	O
Gal4-	protein
K	protein
protein	protein
.	O
Point	O
mutations	O
within	O
the	O
eed	O
gene	O
that	O
are	O
responsible	O
for	O
severe	O
embryonic	O
development	O
abnormalities	O
abolished	O
the	O
transcriptional	protein
repressor	protein
activity	O
of	O
Eed	protein
.	O
Results	O
of	O
this	O
study	O
suggest	O
that	O
Eed	protein
-restricted	O
homeotic	O
gene	O
expression	O
during	O
embryogenesis	O
reflects	O
the	O
action	O
of	O
Eed	protein
as	O
a	O
transcriptional	protein
repressor	protein
.	O
The	O
Eed	protein
-mediated	O
transcriptional	O
effects	O
are	O
likely	O
to	O
reflect	O
the	O
interaction	O
of	O
Eed	protein
with	O
multiple	O
molecular	O
partners,	O
including	O
K	protein
protein	protein
.	O

Interferons	protein
up-regulate	O
STAT1	protein
,	O
STAT2	protein
,	O
and	O
IRF	protein
family	O
transcription	O
factor	O
gene	O
expression	O
in	O
human	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
and	O
macrophages	cell_type
.	O
IFN	protein
signaling	O
is	O
mediated	O
by	O
binding	O
of	O
IFNs	protein
to	O
their	O
receptors	O
and	O
subsequent	O
activation	O
of	O
Janus	O
tyrosine	O
kinase	O
(	O
JAK	protein
)-	O
STAT	protein
signaling	O
pathway	O
.	O
Stimulation	O
of	O
cells	O
with	O
IFN-alpha	protein
leads	O
to	O
the	O
assembly	O
of	O
IFN-stimulated	protein
gene	protein
factor	protein
3	protein
transcription	protein
factor	protein
complex	protein
formed	O
by	O
STAT1	protein
,	O
STAT2	protein
,	O
and	O
p48	protein
protein	protein
.	O
IFN-gamma	protein
signaling	O
is	O
mediated	O
by	O
homodimeric	protein
STAT1	protein
protein	protein
.	O
Although	O
these	O
signaling	O
molecules	O
are	O
expressed	O
constitutively,	O
there	O
is	O
also	O
evidence	O
of	O
transcriptional	O
regulation	O
by	O
IFNs	protein
.	O
We	O
have	O
characterized	O
the	O
expression	O
of	O
STAT	protein
and	protein
IFN	protein
regulatory	protein
factor	protein
(IRF)	protein
family	protein
transcription	protein
factors	protein
in	O
primary	cell_type
human	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
and	O
macrophages	cell_type
in	O
response	O
to	O
IFN-alpha	O
and	O
IFN-gamma	O
stimulation	O
.	O
We	O
show	O
that	O
IFN-alpha	protein
and	O
IFN-gamma	protein
rapidly	O
and	O
efficiently	O
enhanced	O
STAT1	protein
,	O
STAT2	protein
,	O
p48	protein
,	O
and	O
IRF-1	DNA
gene	DNA
expression	O
.	O
IFN-gamma	protein
induced	O
IRF-1	DNA
gene	DNA
expression	O
more	O
strongly	O
than	O
IFN-alpha	protein
.	O
Stimulation	O
experiments	O
in	O
the	O
presence	O
of	O
protein	O
synthesis	O
inhibitor,	O
cycloheximide	O
,	O
suggested	O
that	O
these	O
genes	O
were	O
activated	O
directly	O
by	O
IFNs	protein
.	O
IRF-2	DNA
gene	DNA
was	O
apparently	O
only	O
weakly	O
responsive	O
to	O
IFNs	protein
in	O
these	O
cells.	O
When	O
macrophages	cell_type
were	O
pretreated	O
with	O
low	O
doses	O
of	O
IFN-gamma	protein
and	O
then	O
stimulated	O
with	O
IFN-alpha	protein
,	O
clearly	O
enhanced	O
formation	O
of	O
specific	O
transcription	protein
factor	protein
complexes	O
was	O
detected.	O
This	O
suggests	O
that	O
higher	O
intracellular	O
levels	O
of	O
STAT1	protein
,	O
STAT2	protein
,	O
and	O
p48	protein
protein	protein
may	O
result	O
in	O
enhanced	O
signal	O
transduction	O
for	O
cytokines	protein
utilizing	O
these	O
transcription	protein
factors	protein
.	O

The	O
role	O
of	O
nuclear	protein
factor-kappa	protein
B	protein
in	O
cytokine	DNA
gene	DNA
regulation	O
.	O
Transcription	protein
factors	protein
are	O
DNA-binding	protein
proteins	protein
that	O
regulate	O
gene	O
expression	O
.	O
Nuclear	protein
factor-kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
is	O
a	O
critical	O
transcription	protein
factor	protein
for	O
maximal	O
expression	O
of	O
many	O
cytokines	protein
that	O
are	O
involved	O
in	O
the	O
pathogenesis	O
of	O
inflammatory	O
diseases	O
,	O
such	O
as	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
sepsis	O
syndrome	O
.	O
Activation	O
and	O
regulation	O
of	O
NF-kappa	protein
B	protein
are	O
tightly	O
controlled	O
by	O
a	O
group	O
of	O
inhibitory	protein
proteins	protein
(	O
I	protein
kappa	protein
B	protein
)	O
that	O
sequester	O
NF-kappa	protein
B	protein
in	O
the	O
cytoplasm	O
of	O
immune/inflammatory	cell_type
effector	cell_type
cells	cell_type
.	O
NF-kappa	protein
B	protein
activation	O
involves	O
signaled	O
phosphorylation	O
,	O
ubiquitination	O
,	O
and	O
proteolysis	O
of	O
I	protein
kappa	protein
B	protein
.	O
Liberated	O
NF-kappa	protein
B	protein
migrates	O
to	O
the	O
nucleus	O
,	O
where	O
it	O
binds	O
to	O
specific	DNA
promoter	DNA
sites	DNA
and	O
activates	O
gene	O
transcription	O
.	O
The	O
activation	O
of	O
NF-kappa	protein
B	protein
initiates	O
both	O
extracellular	O
and	O
intracellular	O
regulatory	O
events	O
that	O
result	O
in	O
autoregulation	O
of	O
the	O
inflammatory	O
cascade	O
through	O
modulation	O
of	O
NF-kappa	protein
B	protein
activation	O
.	O
Recently,	O
activation	O
of	O
NF-kappa	protein
B	protein
has	O
been	O
linked	O
to	O
ARDS	O
and	O
has	O
been	O
shown	O
to	O
be	O
a	O
critical	O
proximal	O
step	O
in	O
the	O
initiation	O
of	O
neutrophilic	O
inflammation	O
in	O
animal	O
models	O
.	O
Activation	O
of	O
NF-kappa	protein
B	protein
can	O
be	O
inhibited	O
in	O
vivo	O
by	O
treatment	O
with	O
antioxidants	O
,	O
corticosteroids	O
,	O
and	O
the	O
induction	O
of	O
endotoxin	protein
tolerance	O
.	O
Identification	O
of	O
more	O
specific	O
and	O
efficacious	O
inhibitors	O
of	O
NF-kappa	protein
B	protein
activation	O
might	O
prove	O
beneficial	O
for	O
the	O
treatment	O
of	O
cytokine-mediated	O
inflammatory	O
diseases	O
.	O

Chimeric	protein
oncoprotein	protein
E2a-Pbx1	protein
induces	O
apoptosis	O
of	O
hematopoietic	cell_type
cells	cell_type
by	O
a	O
p53	protein
-independent	O
mechanism	O
that	O
is	O
suppressed	O
by	O
Bcl-2	protein
.	O
The	O
chimeric	protein
oncoprotein	protein
E2a-Pbx1	protein
results	O
from	O
fusion	O
of	O
the	O
E2A	O
and	O
PBX1	O
genes	O
following	O
t(1;19)	DNA
chromosomal	DNA
translocations	DNA
in	O
B	O
cell	O
precursor	O
acute	O
leukemias	O
.	O
Experimentally	O
B	cell_type
cell	cell_type
progenitors	cell_type
do	O
not	O
tolerate	O
constitutive	O
expression	O
of	O
E2a-Pbx1	protein
which	O
contrasts	O
with	O
transformation	O
of	O
several	O
other	O
cell	O
types	O
following	O
its	O
stable	O
expression	O
both	O
in	O
vitro	O
and	O
in	O
vivo.	O
To	O
further	O
investigate	O
the	O
effects	O
of	O
E2a-Pbx1	protein
on	O
the	O
B	cell_type
cell	cell_type
progenitors	cell_type
,	O
we	O
conditionally	O
expressed	O
E2a-Pbx1	protein
under	O
control	O
of	O
a	O
metal	O
response	O
element	O
in	O
hematopoietic	cell_line
precursor	cell_line
cell	cell_line
lines	cell_line
in	O
vitro.	O
Inducible	O
expression	O
of	O
E2a-Pbx1	protein
resulted	O
in	O
cell	O
death	O
with	O
the	O
morphologic	O
and	O
molecular	O
features	O
of	O
apoptosis	O
.	O
A	O
structure-function	O
analysis	O
demonstrated	O
that	O
induction	O
of	O
apoptosis	O
was	O
not	O
a	O
dominant-negative	O
effect	O
of	O
the	O
E2a	protein
moiety	protein
but,	O
rather,	O
required	O
the	O
DNA-binding	protein
homeodomain	protein
of	O
Pbx1	protein
.	O
E2a-	O
Pbx1	protein
-induced	O
apoptosis	O
proceeded	O
through	O
a	O
BCL2	protein
-responsive	O
checkpoint	O
eventuating	O
in	O
PARP	protein
inactivation	O
but	O
did	O
require	O
p53	protein
.	O
Constitutive	O
expression	O
of	O
E2a-	protein
Pbx1	protein
did	O
not	O
induce	O
apoptosis	O
or	O
continued	O
cycling	O
of	O
Rat-1	cell_line
fibroblasts	cell_line
in	O
low	O
serum	O
conditions	O
.	O
These	O
studies	O
demonstrate	O
that	O
E2a-	protein
Pbx1	protein
initiates	O
programmed	O
cell	O
death	O
of	O
hematopoietic	cell_type
precursers	cell_type
by	O
a	O
mechanism	O
that	O
requires	O
its	O
chimeric	O
transcriptional	O
properties,	O
but,	O
unlike	O
other	O
nuclear	protein
oncoproteins	protein
,	O
is	O
independent	O
of	O
p53	protein
.	O

CCAAT/enhancer	protein
binding	protein
protein	protein
epsilon	protein
is	O
preferentially	O
up-regulated	O
during	O
granulocytic	O
differentiation	O
and	O
its	O
functional	O
versatility	O
is	O
determined	O
by	O
alternative	O
use	O
of	O
promoters	DNA
and	O
differential	O
splicing	O
.	O
CCAAT/enhancer	protein
binding	protein
protein	protein
(C/EBP)	protein
epsilon	protein
is	O
a	O
recently	O
cloned	O
member	O
of	O
the	O
C/EBP	protein
family	protein
of	O
transcription	protein
factors	protein
and	O
is	O
expressed	O
exclusively	O
in	O
cells	O
of	O
hematopoietic	O
origin.	O
The	O
human	DNA
C/EBPepsilon	DNA
gene	DNA
is	O
transcribed	O
by	O
two	O
alternative	O
promoters	DNA
,	O
Palpha	DNA
and	O
Pbeta	DNA
.	O
A	O
combination	O
of	O
differential	O
splicing	O
and	O
alternative	O
use	O
of	O
promoters	DNA
generates	O
four	O
mRNA	RNA
isoforms	RNA
,	O
of	O
2.6	O
kb	O
and	O
1.3-1.5	O
kb	O
in	O
size.	O
These	O
transcripts	O
can	O
encode	O
three	O
proteins	O
of	O
calculated	O
molecular	O
mass	O
32.2	RNA
kDa	RNA
,	O
27.8	RNA
kDa	RNA
,	O
and	O
14.3	RNA
kDa	RNA
.	O
Accordingly,	O
Western	O
blots	O
with	O
antibodies	protein
specific	O
for	O
the	O
DNA-binding	O
domain	O
,	O
that	O
is	O
common	O
to	O
all	O
forms,	O
identify	O
multiple	O
proteins.	O
C/EBPepsilon	RNA
mRNA	RNA
was	O
greatly	O
induced	O
during	O
in	O
vitro	O
granulocytic	O
differentiation	O
of	O
human	cell_type
primary	cell_type
CD34(+)	cell_type
cells	cell_type
.	O
Retinoic	O
acid	O
treatment	O
of	O
HL60	cell_line
promyelocytic	cell_line
leukemia	cell_line
cells	cell_line
for	O
24	O
hr	O
induced	O
C/EBPepsilon	RNA
mRNA	RNA
levels	O
by	O
4-fold,	O
while	O
prolonged	O
treatment	O
gradually	O
reduced	O
mRNA	O
expression	O
to	O
pretreatment	O
levels.	O
Transient	O
transfection	O
experiments	O
with	O
expression	O
vectors	O
for	O
two	O
of	O
the	O
isoforms	O
demonstrated	O
that	O
the	O
32.2-kDa	protein
protein	protein
is	O
an	O
activator	O
of	O
transcription	O
of	O
granulocyte	DNA
colony-stimulating	DNA
factor	DNA
receptor	DNA
promoter	DNA
,	O
while	O
the	O
14.3-kDa	protein
protein	protein
is	O
not.	O
Thus,	O
C/EBPepsilon	protein
is	O
regulated	O
in	O
a	O
complex	O
fashion	O
and	O
may	O
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
genes	O
involved	O
in	O
myeloid	O
differentiation	O
.	O

Effects	O
of	O
TPA	protein
,	O
bryostatin	protein
1	protein
,	O
and	O
retinoic	O
acid	O
on	O
PO-B	protein
,	O
AP-1	protein
,	O
and	O
AP-2	protein
DNA	O
binding	O
during	O
HL-60	O
differentiation	O
.	O
PO-B	protein
was	O
originally	O
characterized	O
as	O
a	O
transcriptional	protein
regulatory	protein
factor	protein
of	O
the	O
pro-opiomelanocortin	DNA
(POMC)	DNA
gene	DNA
;	O
however,	O
it	O
has	O
become	O
increasingly	O
clear	O
that	O
this	O
protein	O
may	O
be	O
active	O
in	O
tissues	O
outside	O
the	O
pituitary	O
,	O
since	O
it	O
is	O
present	O
in	O
diverse	O
cell	O
types,	O
including	O
differentiated	O
HL-60	cell_type
promyelocytic	cell_type
leukemia	cell_type
cells	cell_type
.	O
We	O
previously	O
showed	O
that	O
PO-B	protein
DNA-binding	O
is	O
progressively	O
induced	O
during	O
differentiation	O
of	O
promyelomonocytic	cell_line
leukemic	cell_line
HL-60	cell_line
cells	cell_line
to	O
the	O
macrophage-like	cell_type
lineage	cell_type
(with	O
phorbol	O
esters	O
).	O
We	O
now	O
report	O
that	O
PO-B	protein
DNA-binding	O
in	O
HL-60	cell_line
cells	cell_line
is	O
similarly	O
induced	O
during	O
differentiation	O
to	O
the	O
granulocytic	cell_type
lineage	cell_type
(with	O
either	O
retinoic	O
acid	O
or	O
dimethylsulfoxide	O
).	O
Either	O
a	O
genetic	O
or	O
pharmacologic	O
blockade	O
of	O
HL-60	O
differentiation	O
prohibited	O
these	O
inductive	O
effects.	O
These	O
studies	O
have	O
prompted	O
our	O
interest	O
in	O
the	O
dynamics	O
of	O
other	O
transcription	protein
factor	protein
changes	O
during	O
HL-60	O
differentiation	O
.	O
Of	O
these,	O
we	O
observed	O
that	O
another	O
transcription	protein
factor	protein
(	O
AP-1	protein
)	O
is	O
also	O
robustly	O
induced	O
at	O
the	O
DNA-binding	O
level	O
during	O
macrophage-like	O
HL-60	O
differentiation	O
,	O
but	O
not	O
during	O
granulocytic	O
differentiation	O
.	O
Conversely,	O
the	O
DNA-binding	O
of	O
the	O
transcription	protein
factor	protein
AP-2	protein
was	O
slightly	O
reduced	O
by	O
TPA	protein
-induced	O
HL-60	O
differentiation	O
but	O
unchanged	O
during	O
granulocyte	O
differentiation	O
.	O
From	O
these	O
data,	O
we	O
conclude	O
that	O
the	O
induction	O
of	O
PO-B	protein
DNA	O
binding	O
is	O
a	O
general	O
marker	O
of	O
HL-60	O
myelomonocytic	O
differentiation	O
,	O
but	O
that	O
qualitative	O
aspects	O
of	O
the	O
induction	O
of	O
additional	O
distinct	O
transcription	protein
factors	protein
,	O
such	O
as	O
AP-1	protein
,	O
may	O
contribute	O
to	O
lineage-specific	O
determinants	O
of	O
cell	O
fate.	O

A	O
novel	O
genetic	O
system	O
to	O
isolate	O
a	O
dominant	protein
negative	protein
effector	protein
on	O
DNA-binding	O
activity	O
of	O
Oct-2	protein
.	O
Recent	O
studies	O
have	O
revealed	O
that	O
interactions	O
between	O
transcription	protein
factors	protein
play	O
an	O
important	O
role	O
in	O
regulation	O
of	O
gene	O
expression	O
in	O
eukaryotic	cell_type
cells	cell_type
.	O
To	O
isolate	O
cDNA	O
clones	O
that	O
dominantly	O
inhibit	O
the	O
DNA-binding	O
activity	O
of	O
Oct-2	protein
,	O
chosen	O
as	O
a	O
representative	O
factor	O
,	O
we	O
have	O
developed	O
a	O
novel	O
screening	O
system	O
.	O
This	O
employs	O
an	O
Escherichia	O
coli	O
tester	O
strain	O
carrying	O
a	O
modified	DNA
lac	DNA
operon	DNA
as	O
a	O
reporter	DNA
gene	DNA
,	O
with	O
the	O
lac	O
operator	O
sequence	O
replaced	O
by	O
an	O
octamer	DNA
sequence	DNA
.	O
Oct-2	protein
expressed	O
in	O
this	O
tester	O
strain	O
represses	O
the	O
expression	O
of	O
the	O
reporter	O
gene	O
and	O
changes	O
the	O
phenotype	O
of	O
the	O
cell	O
from	O
Lac+to	O
Lac-.	O
Introduction	O
of	O
a	O
cDNA	O
expression	O
library	O
prepared	O
from	O
a	O
human	cell_line
T-cell	cell_line
line	cell_line
into	O
the	O
Oct-2	protein
-harboring	O
tester	O
strain	O
allowed	O
selection	O
of	O
three	O
Lac+clones	O
out	O
of	O
1	O
x	O
10(5)	O
transformants	O
.	O
One	O
of	O
them,	O
hT86	O
,	O
encoding	O
a	O
putative	protein
zinc	protein
finger	protein
protein	protein
was	O
found	O
to	O
derepress	O
beta-galactosidase	protein
activity	O
in	O
the	O
Oct-2	protein
-harboring	O
tester	O
strain	O
at	O
the	O
transcriptional	O
level.	O
In	O
gel	O
mobility	O
shift	O
assays	O
,	O
hT86	O
attenuated	O
the	O
intensity	O
of	O
the	O
retarded	O
band	O
composed	O
of	O
the	O
octamer	DNA
probe	DNA
and	O
Oct-2	protein
,	O
suggesting	O
a	O
dominant	O
negative	O
effect	O
on	O
the	O
DNA-binding	O
activity	O
of	O
Oct-2	protein
.	O
The	O
strategy	O
described	O
here	O
provides	O
a	O
new	O
approach	O
for	O
studying	O
protein-protein	O
interactions	O
that	O
govern	O
the	O
complex	O
regulation	O
of	O
gene	O
expression	O
.	O

Tap	protein
:	O
a	O
novel	O
cellular	protein
protein	protein
that	O
interacts	O
with	O
tip	O
of	O
herpesvirus	O
saimiri	O
and	O
induces	O
lymphocyte	cell_type
aggregation	O
.	O
Tip	O
of	O
herpesvirus	O
saimiri	O
associates	O
with	O
Lck	protein
and	O
down-regulates	O
Lck	protein
-mediated	O
activation	O
.	O
We	O
identified	O
a	O
novel	O
cellular	O
Tip-associated	protein
protein	protein
(	O
Tap	protein
)	O
by	O
a	O
yeast	O
two-hybrid	O
screen	O
.	O
Tap	protein
associated	O
with	O
Tip	protein
following	O
transient	O
expression	O
in	O
COS-1	cell_line
cells	cell_line
and	O
stable	O
expression	O
in	O
human	cell_line
Jurkat-T	cell_line
cells	cell_line
.	O
Expression	O
of	O
Tip	protein
and	O
Tap	protein
in	O
Jurkat-T	cell_line
cells	cell_line
induced	O
dramatic	O
cell	O
aggregation.	O
Aggregation	O
was	O
likely	O
caused	O
by	O
the	O
up-regulated	O
surface	O
expression	O
of	O
adhesion	protein
molecules	protein
including	O
integrin	protein
alpha	protein
,	O
L-selectin	protein
,	O
ICAM-3	protein
,	O
and	O
H-CAM	protein
.	O
Furthermore,	O
NF-kappaB	protein
transcriptional	protein
factor	protein
of	O
aggregated	O
cells	O
had	O
approximately	O
40-fold	O
higher	O
activity	O
than	O
that	O
of	O
parental	cell_type
cells	cell_type
.	O
Thus,	O
Tap	protein
is	O
likely	O
to	O
be	O
an	O
important	O
cellular	O
mediator	O
of	O
Tip	protein
function	O
in	O
T	O
cell	O
transformation	O
by	O
herpesvirus	O
saimiri	O
.	O

Human	cell_type
monocyte	cell_type
binding	O
to	O
fibronectin	protein
enhances	O
IFN-gamma	protein
-induced	O
early	O
signaling	O
events	O
.	O
Leukocyte	protein
integrins	protein
are	O
fundamentally	O
important	O
in	O
modulating	O
adhesion	O
to	O
extracellular	O
matrix	O
components	O
and	O
to	O
other	O
cells.	O
This	O
integrin-mediated	O
adhesion	O
controls	O
leukocyte	O
arrest	O
and	O
extravasation	O
during	O
the	O
onset	O
of	O
inflammatory	O
responses	O
.	O
Moreover,	O
integrin	protein
-ligand	O
interactions	O
trigger	O
signaling	O
pathways	O
that	O
may	O
influence	O
leukocyte	O
phenotype	O
and	O
function	O
at	O
sites	O
of	O
inflammation	O
.	O
In	O
the	O
current	O
studies,	O
we	O
evaluated	O
the	O
combinatorial	O
effects	O
of	O
monocyte	O
adhesion	O
and	O
IFN-gamma	protein
on	O
intracellular	O
signaling	O
pathways	O
.	O
IFN-gamma	protein
triggers	O
a	O
well-defined	O
signal	O
transduction	O
pathway,	O
which	O
although	O
not	O
directly	O
stimulated	O
by	O
monocyte	O
adherence	O
to	O
fibronectin	protein
or	O
arginine-glycine-aspartate	protein
(RGD)-coated	protein
substrata	protein
,	O
was	O
enhanced	O
significantly	O
in	O
these	O
matrix-adherent	cell_type
cells	cell_type
.	O
Compared	O
with	O
monocytes	O
in	O
suspension	O
or	O
adherent	O
on	O
plastic	O
surfaces	O
,	O
monocytes	O
adherent	O
to	O
fibronectin	protein
or	O
RGD	O
exhibited	O
a	O
greater	O
than	O
threefold	O
increase	O
in	O
steady	O
state	O
levels	O
of	O
IFN-gamma	RNA
-induced	RNA
mRNA	RNA
for	O
the	O
high	protein
affinity	protein
Fc	protein
gammaRI	protein
receptor	protein
.	O
By	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
this	O
increase	O
in	O
mRNA	RNA
was	O
associated	O
with	O
a	O
5-	O
to	O
10-fold	O
increase	O
in	O
the	O
STAT1-containing	protein
DNA-binding	protein
complex	protein
that	O
binds	O
to	O
Fc	DNA
gammaRI	DNA
promoter	DNA
elements	DNA
.	O
Furthermore,	O
the	O
tyrosine	O
phosphorylation	O
of	O
STAT1	protein
and	O
the	O
tyrosine	protein
kinases	protein
JAK1	protein
and	O
JAK2	protein
was	O
enhanced	O
significantly	O
in	O
RGD	cell_type
-adherent	cell_type
monocytes	cell_type
compared	O
with	O
control	cell_type
cells	cell_type
.	O
These	O
results	O
suggest	O
a	O
novel	O
mechanism	O
by	O
which	O
integrin	protein
-mediated	O
cell	O
adhesion	O
can	O
modulate	O
the	O
magnitude	O
of	O
cytokine	protein
-induced	O
signal	O
transduction	O
pathways	O
,	O
thereby	O
amplifying	O
cellular	O
events	O
leading	O
to	O
monocyte	O
activation	O
and	O
inflammation	O
.	O

Surfactant	protein
protein	protein
A	protein
activates	O
NF-kappa	protein
B	protein
in	O
the	O
THP-1	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
.	O
The	O
expression	O
of	O
many	O
genes	O
for	O
which	O
products	O
are	O
involved	O
in	O
inflammation	O
is	O
controlled	O
by	O
the	O
transcriptional	protein
regulator	protein
nuclear	protein
factor	protein
(NF)-kappa	protein
B	protein
.	O
Because	O
surfactant	protein
protein	protein
(SP)	protein
A	protein
is	O
involved	O
in	O
local	O
host	O
defense	O
in	O
the	O
lung	O
and	O
alters	O
immune	O
cell	O
function	O
by	O
modulating	O
the	O
expression	O
of	O
proinflammatory	protein
cytokines	protein
as	O
well	O
as	O
surface	protein
proteins	protein
involved	O
in	O
inflammation	O
,	O
we	O
hypothesized	O
that	O
SP-A	protein
exerts	O
its	O
action,	O
at	O
least	O
in	O
part,	O
via	O
activation	O
of	O
NF-kappa	protein
B	protein
.	O
We	O
used	O
gel	O
shift	O
assays	O
to	O
determine	O
whether	O
SP-A	protein
activated	O
NF-kappa	protein
B	protein
in	O
the	O
THP-1	cell_line
cell	cell_line
line	cell_line
,	O
a	O
human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
.	O
Activation	O
of	O
NF-kappa	protein
B	protein
in	O
THP-1	cell_line
cells	cell_line
by	O
SP-A	protein
doses	O
as	O
low	O
as	O
1	O
microgram/ml	O
occurred	O
within	O
30	O
min	O
of	O
SP-A	protein
treatment	O
,	O
peaked	O
at	O
60	O
min,	O
and	O
then	O
declined.	O
This	O
activation	O
is	O
inhibited	O
by	O
known	O
inhibitors	O
of	O
NF-kappa	protein
B	protein
or	O
by	O
simultaneous	O
treatment	O
of	O
the	O
cells	O
with	O
surfactant	O
lipids	O
.	O
Moreover,	O
the	O
NF-kappa	protein
B	protein
inhibitors	protein
blocked	O
SP-A	protein
-dependent	O
increases	O
in	O
tumor	RNA
necrosis	RNA
factor-alpha	RNA
mRNA	RNA
levels	O
.	O
These	O
observations	O
suggest	O
a	O
mechanism	O
by	O
which	O
SP-A	protein
plays	O
a	O
role	O
in	O
the	O
pathogenesis	O
of	O
some	O
lung	O
conditions	O
and	O
point	O
to	O
potential	O
therapeutic	O
measures	O
that	O
could	O
be	O
used	O
to	O
prevent	O
SP-A	protein
induced	O
inflammation	O
in	O
the	O
lung	O
.	O

GABP	protein
factors	protein
bind	O
to	O
a	O
distal	DNA
interleukin	DNA
2	DNA
(IL-2)	DNA
enhancer	DNA
and	O
contribute	O
to	O
c-Raf	protein
-mediated	O
increase	O
in	O
IL-2	protein
induction	O
.	O
Triggering	O
of	O
the	O
T-cell	protein
receptor-CD3	protein
complex	protein
activates	O
two	O
major	O
signal	O
cascades	O
in	O
T	cell_type
lymphocytes	cell_type
,	O
(i)	O
Ca2+-dependent	O
signal	O
cascades	O
and	O
(ii)	O
protein	protein
kinase	protein
cascades	O
.	O
Both	O
signal	O
cascades	O
contribute	O
to	O
the	O
induction	O
of	O
the	O
interleukin	DNA
2	DNA
(	DNA
IL-2	DNA
)	DNA
gene	DNA
during	O
T-cell	O
activation	O
.	O
Prominent	O
protein	protein
kinase	protein
cascades	O
are	O
those	O
that	O
activate	O
mitogen-activated	protein
protein	protein
(MAP)	protein
kinases	protein
.	O
We	O
show	O
here	O
that	O
c-Raf	protein
,	O
which	O
is	O
at	O
the	O
helm	O
of	O
the	O
classic	O
MAP-	O
Erk	protein
cascade	O
,	O
contributes	O
to	O
IL-2	protein
induction	O
through	O
a	O
distal	DNA
enhancer	DNA
element	DNA
spanning	O
the	O
nucleotides	O
from	O
positions	O
-502	O
to	O
-413	O
in	O
front	O
of	O
the	O
transcriptional	O
start	O
site	O
of	O
the	O
IL-2	DNA
gene	DNA
.	O
Induction	O
of	O
this	O
distal	DNA
IL-2	DNA
enhancer	DNA
differs	O
from	O
induction	O
of	O
the	O
proximal	DNA
IL-2	DNA
promoter-enhancer	DNA
,	O
since	O
it	O
is	O
induced	O
by	O
phorbol	O
esters	O
alone	O
and	O
independent	O
from	O
Ca2+	O
signals	O
.	O
In	O
DNA-protein	O
binding	O
studies	O
,	O
we	O
detected	O
the	O
binding	O
of	O
transcription	protein
factors	protein
GABP	O
alpha	O
and	O
-beta	O
to	O
a	O
dyad	DNA
symmetry	DNA
element	DNA
(	O
DSE	DNA
)	O
of	O
the	O
distal	DNA
enhancer	DNA
,	O
which	O
is	O
formed	O
by	O
palindromic	DNA
binding	DNA
sites	DNA
of	O
Ets-like	protein
factors	protein
.	O
Introduction	O
of	O
point	O
mutations	O
suppressing	O
GABP	O
binding	O
to	O
the	O
DSE	DNA
interfered	O
with	O
the	O
induction	O
of	O
the	O
distal	DNA
enhancer	DNA
and	O
the	O
entire	O
IL-2	DNA
promoter-enhancer	DNA
,	O
while	O
overexpression	O
of	O
both	O
GABP	protein
factors	protein
enhanced	O
the	O
IL-2	DNA
promoter-enhancer	DNA
induction	O
.	O
Overexpression	O
of	O
BXB	protein
,	O
a	O
constitutive	O
active	O
version	O
of	O
c-Raf	protein
,	O
and	O
of	O
further	O
members	O
of	O
the	O
Ras	protein
-	O
Raf	protein
-	O
Erk	protein
signal	O
cascade	O
exerted	O
an	O
increase	O
of	O
GABP	protein
-mediated	O
promoter-enhancer	O
induction	O
.	O
In	O
conjunction	O
with	O
previously	O
published	O
data	O
on	O
c-Raf	protein
-induced	O
phosphorylation	O
of	O
GABP	protein
factors	protein
(E.Flory,	O
A.	O
Hoffmeyer,	O
U.Smola,	O
U.R.Rapp,	O
and	O
J.T.Bruder,	O
J.Virol.70:2260-	O
2268,	O
1996),	O
these	O
results	O
indicate	O
a	O
contribution	O
of	O
GABP	protein
factors	protein
to	O
the	O
Raf	protein
-mediated	O
enhancement	O
of	O
IL-2	protein
induction	O
during	O
T-cell	O
activation	O
.	O

Lipopolysaccharide	O
induction	O
of	O
the	O
tumor	DNA
necrosis	DNA
factor-alpha	DNA
promoter	DNA
in	O
human	cell_type
monocytic	cell_type
cells	cell_type
.	O
Regulation	O
by	O
Egr-1	protein
,	O
c-Jun	protein
,	O
and	O
NF-kappaB	protein
transcription	protein
factors	protein
.	O
Biosynthesis	O
of	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
)	O
is	O
predominantly	O
by	O
cells	O
of	O
the	O
monocytic	cell_type
lineage	cell_type
.	O
This	O
study	O
examined	O
the	O
role	O
of	O
various	O
cis-acting	DNA
regulatory	DNA
elements	DNA
in	O
the	O
lipopolysaccharide	O
(	O
LPS	O
)	O
induction	O
of	O
the	O
human	DNA
TNF-alpha	DNA
promoter	DNA
in	O
cells	O
of	O
monocytic	cell_type
lineage	cell_type
.	O
Functional	O
analysis	O
of	O
monocytic	cell_line
THP-1	cell_line
cells	cell_line
transfected	O
with	O
plasmids	DNA
containing	O
various	O
lengths	O
of	O
TNF-alpha	DNA
promoter	DNA
localized	O
enhancer	DNA
elements	DNA
in	O
a	O
region	O
(	O
-182	DNA
to	DNA
-37	DNA
base	DNA
pairs	DNA
(bp))	O
that	O
were	O
required	O
for	O
optimal	O
transcription	O
of	O
the	O
TNF-alpha	DNA
gene	DNA
in	O
response	O
to	O
LPS	O
.	O
Two	O
regions	O
were	O
identified:	O
region	DNA
I	DNA
(	O
-182	DNA
to	DNA
-162	DNA
bp	DNA
)	O
contained	O
an	O
overlapping	O
Sp1/	DNA
Egr-1	DNA
site	DNA
,	O
and	O
region	DNA
II	DNA
(	O
-119	DNA
to	DNA
-88	DNA
)	O
contained	O
CRE	DNA
and	O
NF-kappaB	DNA
(designated	DNA
kappaB3)	DNA
sites	DNA
.	O
In	O
unstimulated	O
THP-1	cell_line
,	O
CRE	protein
-binding	protein
protein	protein
and,	O
to	O
a	O
lesser	O
extent,	O
c-Jun	protein
complexes	protein
were	O
found	O
to	O
bind	O
to	O
the	O
CRE	DNA
site	DNA
.	O
LPS	O
stimulation	O
increased	O
the	O
binding	O
of	O
c-Jun	protein
-containing	protein
complexes	protein
.	O
In	O
addition,	O
LPS	O
stimulation	O
induced	O
the	O
binding	O
of	O
cognate	O
nuclear	protein
factors	protein
to	O
the	O
Egr-1	O
and	O
kappaB3	O
sites	O
,	O
which	O
were	O
identified	O
as	O
Egr-1	protein
and	O
p50/p65	protein
,	O
respectively.	O
The	O
CRE	O
and	O
kappaB3	O
sites	O
in	O
region	DNA
II	DNA
together	O
conferred	O
strong	O
LPS	O
responsiveness	O
to	O
a	O
heterologous	DNA
promoter	DNA
,	O
whereas	O
individually	O
they	O
failed	O
to	O
provide	O
transcriptional	O
activation	O
.	O
Furthermore,	O
increasing	O
the	O
spacing	O
between	O
the	O
CRE	DNA
and	DNA
the	DNA
kappaB3	DNA
sites	DNA
completely	O
abolished	O
LPS	O
induction	O
,	O
suggesting	O
a	O
cooperative	O
interaction	O
between	O
c-Jun	protein
complexes	protein
and	O
p50/p65	protein
.	O
These	O
studies	O
indicate	O
that	O
maximal	O
LPS	O
induction	O
of	O
the	O
TNF-alpha	DNA
promoter	DNA
is	O
mediated	O
by	O
concerted	O
participation	O
of	O
at	O
least	O
two	O
separate	O
cis-acting	DNA
regulatory	DNA
elements	DNA
.	O

Rescue	O
by	O
cytokines	protein
of	O
apoptotic	O
cell	O
death	O
induced	O
by	O
IL-2	protein
deprivation	O
of	O
human	cell_line
antigen-specific	cell_line
T	cell_line
cell	cell_line
clones	cell_line
.	O
The	O
control	O
of	O
cell	O
survival	O
and	O
cell	O
death	O
is	O
of	O
central	O
importance	O
in	O
tissues	O
with	O
high	O
cell	O
turnover	O
such	O
as	O
the	O
lymphoid	O
system	O
.	O
We	O
have	O
examined	O
the	O
effect	O
of	O
cytokines	protein
on	O
IL-2	protein
deprivation-induced	O
apoptosis	O
of	O
human	cell_line
antigen-specific	cell_line
T	cell_line
helper	cell_line
clones	cell_line
with	O
different	O
cytokine	protein
production	O
profiles	O
.	O
We	O
found	O
that	O
IL-2	protein
,	O
interferon-alpha	protein
(	O
IFN-alpha	protein
),	O
and	O
IFN-beta	protein
inhibited	O
IL-2	protein
deprivation	O
apoptosis	O
in	O
Th0	O
,	O
Th1	O
,	O
and	O
Th2	O
clones	O
.	O
We	O
also	O
found	O
that	O
IL-2	protein
protects	O
T	cell_line
cell	cell_line
clones	cell_line
from	O
IL-2	protein
deprivation	O
apoptosis	O
accompanying	O
active	O
proliferation	O
and	O
enhanced	O
expression	O
of	O
P53	protein
,	O
Rb	protein
and	O
Bcl-xL	protein
proteins	protein
.	O
In	O
contrast,	O
IFN-alpha	protein
/beta	protein
rescued	O
T	cell_line
cell	cell_line
clones	cell_line
from	O
apoptosis	O
without	O
active	O
proliferation,	O
and	O
expression	O
of	O
apoptosis	protein
-associated	protein
proteins	protein
tested	O
so	O
far	O
was	O
unaffected.	O
This	O
may	O
be	O
due	O
to	O
the	O
fact	O
that	O
T	cell_type
cells	cell_type
treated	O
with	O
IL-2	protein
contained	O
those	O
located	O
in	O
S	O
+	O
G2/M	O
phases	O
of	O
the	O
cell	O
cycle,	O
whereas	O
the	O
vast	O
majority	O
of	O
T	cell_type
cells	cell_type
treated	O
with	O
IFN-alpha	protein
/beta	protein
were	O
located	O
in	O
G0/G1	O
phase	O
.	O
IFN-alpha	protein
/beta	protein
specifically	O
induced	O
tyrosine	O
phosphorylation	O
and	O
translocation	O
into	O
nucleus	O
of	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(STAT)	protein
2	protein
protein	protein
in	O
the	O
T	cell_line
cell	cell_line
clones	cell_line
.	O
In	O
addition,	O
over-expression	O
of	O
STAT2	protein
by	O
transfection	O
of	O
the	O
cDNA	O
prevented	O
apoptosis	O
of	O
the	O
T	cell_line
cell	cell_line
clones	cell_line
.	O
Our	O
present	O
study	O
shows	O
that	O
IFN	O
-alpha	O
and	O
-beta	O
mediate	O
anti-apoptotic	O
effect	O
through	O
other	O
pathways	O
than	O
that	O
of	O
IL-2	protein
in	O
growth	O
factor	O
deprivation	O
apoptosis	O
.	O

Interleukin-10	protein
inhibits	O
interferon-gamma-induced	O
intercellular	DNA
adhesion	DNA
molecule-1	DNA
gene	DNA
transcription	O
in	O
human	cell_type
monocytes	cell_type
.	O
Interleukin-10	protein
(	O
IL-10	protein
)	O
is	O
a	O
potent	O
monocyte	protein
regulatory	protein
cytokine	protein
that	O
inhibits	O
gene	O
expression	O
of	O
proinflammatory	protein
mediators	protein
.	O
In	O
this	O
study,	O
we	O
investigated	O
the	O
mechanism	O
by	O
which	O
IL-10	protein
downregulates	O
expression	O
of	O
intercellular	protein
adhesion	protein
molecule-1	protein
(	O
ICAM-1	protein
)	O
on	O
the	O
cell	O
surface	O
of	O
normal	cell_type
human	cell_type
monocytes	cell_type
activated	O
with	O
interferon-gamma	protein
(	O
IFN-gamma	protein
).	O
IL-10	protein
inhibition	O
of	O
IFN-gamma	protein
-induced	O
ICAM-1	protein
expression	O
was	O
apparent	O
as	O
early	O
as	O
3	O
hours	O
and	O
was	O
blocked	O
by	O
an	O
anti-	protein
IL-10	protein
antibody	protein
but	O
not	O
by	O
an	O
isotype-matched	protein
control	protein
antibody	protein
.	O
Northern	O
blot	O
analysis	O
showed	O
that	O
IL-10	protein
reduced	O
the	O
accumulation	O
of	O
ICAM-1	RNA
mRNA	RNA
in	O
IFN-gamma	cell_line
-stimulated	cell_line
monocytes	cell_line
.	O
IL-10	protein
inhibition	O
of	O
ICAM-1	RNA
steady-state	RNA
mRNA	RNA
was	O
detected	O
at	O
3	O
hours	O
and	O
remained	O
at	O
24	O
hours.	O
Nuclear	O
run-on	O
transcription	O
assays	O
showed	O
that	O
IL-10	protein
inhibited	O
the	O
rate	O
of	O
IFN-gamma	protein
-induced	O
transcription	O
of	O
the	O
ICAM-1	DNA
gene	DNA
,	O
and	O
mRNA	O
stability	O
studies	O
showed	O
that	O
IL-10	protein
did	O
not	O
alter	O
the	O
half-life	O
of	O
IFN-gamma	RNA
-induced	RNA
ICAM-1	RNA
message	RNA
.	O
Thus,	O
IL-10	protein
inhibits	O
IFN-gamma	protein
-induced	O
ICAM-1	protein
expression	O
in	O
monocytes	cell_type
primarily	O
at	O
the	O
level	O
of	O
gene	O
transcription	O
.	O
Activation	O
of	O
IFN-gamma	DNA
-responsive	DNA
genes	DNA
requires	O
tyrosine	O
phosphorylation	O
of	O
the	O
transcriptional	O
factor	O
STAT-1alpha	protein
(	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription-1alpha	protein
).	O
However,	O
IL-10	protein
did	O
not	O
affect	O
IFN-gamma	protein
-induced	O
tyrosine	O
phosphorylation	O
of	O
STAT-1alpha	protein
or	O
alter	O
STAT-1alpha	protein
binding	O
to	O
the	O
IFN-gamma	DNA
response	DNA
element	DNA
(	O
IRE	DNA
)	O
in	O
the	O
ICAM-1	DNA
promoter	DNA
.	O
Instead,	O
IL-10	protein
prevented	O
IFN-gamma	protein
-induced	O
binding	O
activity	O
at	O
the	O
NF-kappaB	protein
site	O
of	O
the	O
tumor	DNA
necrosis	DNA
factor	DNA
alpha	DNA
(	DNA
TNF-alpha	DNA
)-responsive	DNA
NF-kappaB	DNA
/C-EBP	DNA
composite	DNA
element	DNA
in	O
the	O
ICAM-1	DNA
promoter	DNA
.	O
These	O
data	O
indicate	O
that	O
IL-10	protein
inhibits	O
IFN-gamma	protein
-induced	O
transcription	O
of	O
the	O
ICAM-1	DNA
gene	DNA
by	O
a	O
regulatory	O
mechanism	O
that	O
may	O
involve	O
NF-kappaB	protein
.	O

Specific	O
complex	O
formation	O
between	O
the	O
type	protein
II	protein
bare	protein
lymphocyte	protein
syndrome-associated	protein
transactivators	protein
CIITA	protein
and	O
RFX5	protein
.	O
Two	O
of	O
the	O
genes	O
defective	O
in	O
the	O
five	O
complementation	O
groups	O
identified	O
in	O
the	O
class	O
II-negative	O
bare	O
lymphocyte	O
syndrome	O
or	O
corresponding	O
laboratory	O
mutants	O
have	O
been	O
cloned.	O
One	O
gene	O
encodes	O
a	O
protein,	O
RFX5	protein
,	O
that	O
is	O
a	O
member	O
of	O
the	O
RFX	protein
family	protein
of	protein
DNA	protein
binding	protein
proteins	protein
.	O
The	O
other,	O
CIITA	protein
,	O
encodes	O
a	O
large	O
protein	O
with	O
a	O
defined	O
acidic	protein
transcriptional	protein
activation	protein
domain	protein
;	O
this	O
protein	O
does	O
not	O
interact	O
with	O
DNA.	O
Expression	DNA
plasmids	DNA
encoding	O
regions	O
of	O
RFX5	protein
fused	O
to	O
the	O
GAL4	protein
DNA	protein
binding	protein
domain	protein
activated	O
transcription	O
from	O
a	O
reporter	O
construct	O
containing	O
GAL4	DNA
sites	DNA
in	O
a	O
cotransfection	O
assay	O
in	O
the	O
Raji	cell_line
human	cell_line
B	cell_line
cell	cell_line
line	cell_line
.	O
However,	O
these	O
plasmids	DNA
produced	O
transcriptional	O
activity	O
in	O
HeLa	cell_line
cells	cell_line
only	O
in	O
conjunction	O
with	O
interferon	protein
gamma	protein
stimulation	O
,	O
a	O
condition	O
in	O
which	O
expression	O
of	O
both	O
CIITA	protein
and	O
class	protein
II	protein
major	protein
histocompatibility	protein
complex	protein
surface	protein
proteins	protein
are	O
induced.	O
Furthermore,	O
these	O
plasmids	DNA
were	O
not	O
active	O
in	O
RJ2.2.5	cell_line
,	O
an	O
in	O
vitro	O
mutagenized	O
derivative	O
of	O
Raji	cell_line
in	O
which	O
both	O
copies	O
of	O
CIITA	protein
are	O
defective.	O
Transcriptional	O
activation	O
by	O
the	O
RFX5	protein
fusion	protein
protein	protein
could	O
be	O
restored	O
in	O
RJ2.2.5	cell_line
by	O
cotransfection	O
with	O
a	O
CIITA	DNA
expression	DNA
plasmid	DNA
.	O
Finally,	O
a	O
direct	O
interaction	O
between	O
RFX5	protein
and	O
CIITA	protein
was	O
detected	O
with	O
the	O
yeast	O
two-hybrid	O
and	O
far-Western	O
blot	O
assays	O
.	O
Thus,	O
RFX5	protein
can	O
activate	O
transcription	O
only	O
in	O
cooperation	O
with	O
CIITA	protein
.	O
RFX5	protein
and	O
CIITA	protein
associate	O
to	O
form	O
a	O
complex	O
capable	O
of	O
activating	O
transcription	O
from	O
class	DNA
II	DNA
major	DNA
histocompatibility	DNA
complex	DNA
promoters	DNA
.	O
In	O
this	O
complex,	O
promoter	O
specificity	O
is	O
determined	O
by	O
the	O
DNA	O
binding	O
domain	O
of	O
RFX5	protein
and	O
the	O
general	O
transcription	O
apparatus	O
is	O
recruited	O
by	O
the	O
acidic	protein
activation	protein
domain	protein
of	O
CIITA	protein
.	O

Involvement	O
of	O
phosphatidylinositol	protein
3-kinase	protein
in	O
NFAT	protein
activation	O
in	O
T	cell_type
cells	cell_type
.	O
Phosphatidylinositol	protein
3-kinase	protein
(	O
PI3-K	protein
)	O
has	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
cell	O
proliferation	O
in	O
many	O
cell	O
types.	O
We	O
have	O
previously	O
shown	O
that	O
in	O
T	cell_type
cells	cell_type
the	O
PI3-K	protein
inhibitor	O
,	O
wortmannin	O
,	O
interferes	O
with	O
activation	O
of	O
the	O
mitogen-activated	protein
kinase	protein
,	O
Erk2	protein
,	O
after	O
T	protein
cell	protein
receptor	protein
(	O
TcR	protein
)	O
stimulation	O
.	O
To	O
further	O
explore	O
the	O
involvement	O
of	O
PI3-K	protein
in	O
T	O
cell	O
activation	O
,	O
we	O
created	O
a	O
set	O
of	O
potentially	O
dominant	DNA
negative	DNA
PI3-K	DNA
constructs	DNA
comprising	O
individual	O
or	O
tandem	DNA
domains	DNA
of	O
the	O
regulatory	protein
p85	protein
subunit	protein
and	O
tested	O
their	O
effect	O
on	O
downstream	O
signaling	O
events	O
like	O
Erk2	protein
activation	O
and	O
transcription	O
from	O
an	O
NFAT	DNA
(	DNA
nuclear	DNA
factor	DNA
of	DNA
activated	DNA
T	DNA
cells	DNA
)	DNA
element	DNA
taken	O
from	O
the	O
interleukin-2	DNA
promoter	DNA
.	O
Following	O
TcR	protein
stimulation	O
,	O
activation	O
of	O
Erk2	protein
was	O
only	O
inhibited	O
by	O
a	O
previously	O
described	O
truncated	protein
form	protein
of	protein
p85	protein
that	O
cannot	O
bind	O
the	O
catalytic	protein
subunit	protein
,	O
but	O
not	O
by	O
other	O
constructs	O
of	O
p85	protein
.	O
In	O
contrast,	O
several	O
mutant	O
p85	protein
alleles	O
had	O
dramatic	O
effects	O
on	O
NFAT	protein
activation	O
.	O
Most	O
interestingly,	O
the	O
N-terminal	protein
SH2	protein
domain	protein
had	O
an	O
inhibitory	O
effect,	O
whereas	O
a	O
mutant	protein
p85	protein
containing	O
only	O
the	O
two	protein
SH2	protein
domains	protein
enhanced	O
basal	O
NFAT	protein
activity	O
in	O
a	O
Ras	protein
-dependent	O
manner	O
.	O
Ionomycin	O
induced	O
synergistic	O
activation	O
of	O
NFAT	protein
in	O
cells	O
expressing	O
p85	protein
mutants	protein
that	O
contained	O
the	O
C-terminal	protein
SH2	protein
domain	protein
.	O
Analysis	O
of	O
phosphotyrosine	protein
-containing	protein
proteins	protein
bound	O
to	O
truncated	O
p85	protein
constructs	protein
revealed	O
cooperative	O
binding	O
of	O
the	O
two	protein
SH2	protein
domains	protein
but	O
no	O
apparent	O
differences	O
between	O
the	O
N-	O
and	O
C-	O
terminal	O
SH2	O
domains	O
.	O
Wortmannin	O
did	O
not	O
interfere	O
with	O
NFAT	protein
activation	O
,	O
although	O
it	O
inhibited	O
PI3-K	protein
and	O
Erk2	protein
activation	O
in	O
the	O
same	O
experiment.	O
These	O
results	O
suggest	O
that	O
PI3-K	protein
is	O
involved	O
in	O
NFAT	protein
activation	O
through	O
a	O
complex	O
adaptor	O
function	O
of	O
its	O
regulatory	protein
subunit	protein
and	O
that	O
its	O
lipid	protein
kinase	protein
activity	O
is	O
dispensable	O
for	O
this	O
effect.	O

Acute	O
leukemia	O
with	O
promyelocytic	O
features	O
in	O
PML/RARalpha	O
transgenic	O
mice	O
.	O
Acute	O
promyelocytic	O
leukemia	O
(	O
APL	O
)	O
is	O
associated	O
with	O
reciprocal	O
chromosomal	O
translocations	O
involving	O
the	O
retinoic	DNA
acid	DNA
receptor	DNA
alpha	DNA
(	DNA
RARalpha	DNA
)	DNA
locus	DNA
on	O
chromosome	DNA
17	DNA
.	O
In	O
the	O
majority	O
of	O
cases,	O
RARalpha	protein
translocates	O
and	O
fuses	O
with	O
the	O
promyelocytic	DNA
leukemia	DNA
(PML)	DNA
gene	DNA
located	O
on	O
chromosome	DNA
15	DNA
.	O
The	O
resulting	O
fusion	DNA
genes	DNA
encode	O
the	O
two	O
structurally	O
unique	O
PML/	protein
RARalpha	protein
and	O
RARalpha	protein
/PML	protein
fusion	protein
proteins	protein
as	O
well	O
as	O
aberrant	protein
PML	protein
gene	protein
products	protein
,	O
the	O
respective	O
pathogenetic	O
roles	O
of	O
which	O
have	O
not	O
been	O
elucidated.	O
We	O
have	O
generated	O
transgenic	O
mice	O
in	O
which	O
the	O
PML/	protein
RARalpha	protein
fusion	protein
protein	protein
is	O
specifically	O
expressed	O
in	O
the	O
myeloid-promyelocytic	cell_type
lineage	cell_type
.	O
During	O
their	O
first	O
year	O
of	O
life,	O
all	O
the	O
PML/	O
RARalpha	protein
transgenic	O
mice	O
have	O
an	O
abnormal	O
hematopoiesis	O
that	O
can	O
best	O
be	O
described	O
as	O
a	O
myeloproliferative	O
disorder	O
.	O
Between	O
12	O
and	O
14	O
months	O
of	O
age,	O
10%	O
of	O
them	O
develop	O
a	O
form	O
of	O
acute	O
leukemia	O
with	O
a	O
differentiation	O
block	O
at	O
the	O
promyelocytic	O
stage	O
that	O
closely	O
mimics	O
human	O
APL	O
even	O
in	O
its	O
response	O
to	O
retinoic	O
acid	O
.	O
Our	O
results	O
are	O
conclusive	O
in	O
vivo	O
evidence	O
that	O
PML/	protein
RARalpha	protein
plays	O
a	O
crucial	O
role	O
in	O
the	O
pathogenesis	O
of	O
APL	O
.	O

Constitutive	O
and	O
inducible	O
protein/DNA	O
interactions	O
of	O
the	O
interferon-gamma	DNA
promoter	DNA
in	O
vivo	O
in	O
[corrected]	O
CD45RA	O
and	O
CD45R0	O
T	O
helper	O
subsets	O
[published	O
erratum	O
appears	O
in	O
Eur	O
J	O
Immunol	O
1997	O
Jul;27(7):1830]	O
Interferon-gamma	O
(	O
IFN-gamma	protein
)	O
is	O
a	O
key	O
cytokine	O
of	O
T	cell_type
lymphocytes	cell_type
with	O
major	O
regulatory	O
functions	O
in	O
the	O
immune	O
system	O
.	O
To	O
determine	O
and	O
compare	O
protein/DNA	O
interactions	O
at	O
the	O
native	O
IFN-gamma	protein
locus	O
in	O
T	cell_type
cells	cell_type
,	O
we	O
analyzed	O
the	O
human	DNA
IFN-gamma	DNA
promoter	DNA
by	O
ligation-mediated	O
polymerase	O
chain	O
reaction	O
(LM-PCR)	O
techniques	O
.	O
Accordingly,	O
Jurkat	cell_line
T	cell_line
cells	cell_line
and	O
primary	O
CD45RA	O
and	O
CD45R0	O
CD4+	O
T	O
cell	O
subsets	O
isolated	O
from	O
peripheral	O
blood	O
using	O
immunomagnetic	O
beads	O
were	O
cultured	O
and	O
analyzed	O
by	O
LM-PCR	O
.	O
Constitutive	O
and	O
inducible	O
protein/DNA	O
interactions	O
of	O
the	O
IFN-gamma	DNA
promoter	DNA
in	O
vivo	O
were	O
detected	O
in	O
all	O
T	cell_type
cells	cell_type
tested.	O
Interestingly,	O
an	O
inducible	O
footprint	O
between	O
-183	DNA
and	DNA
-196	DNA
was	O
consistently	O
observed	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
and	O
CD45RA	O
and	O
CD45R0	O
T	O
helper	O
subsets	O
upon	O
stimulation	O
with	O
phorbol	O
12-myristate	O
13-acetate	O
+	O
phytohemagglutinin	protein
(	O
PMA	O
+	O
PHA	protein
)	O
that	O
was	O
highly	O
sensitive	O
to	O
treatment	O
with	O
corticosteroids	O
.	O
This	O
novel	DNA
target	DNA
site	DNA
,	O
denoted	O
the	O
C-site	DNA
,	O
was	O
shown	O
by	O
several	O
criteria,	O
including	O
cell	O
distribution	O
studies,	O
stimulation	O
experiments	O
,	O
supershift	O
assays	O
,	O
and	O
cross-competition	O
electrophoretic	O
mobility	O
shift	O
assays	O
to	O
bind	O
the	O
transcription	protein
factor	protein
AP-1	protein
.	O
Mutation	O
of	O
the	O
C-site	DNA
that	O
prevented	O
AP-1	protein
binding	O
to	O
this	O
site	O
was	O
sufficient	O
strikingly	O
to	O
reduce	O
inducible	O
promoter	O
activity	O
in	O
primary	cell_type
CD45R0	cell_type
T	cell_type
cells	cell_type
.	O
In	O
summary,	O
the	O
data	O
demonstrate	O
that	O
IFN-gamma	protein
gene	O
transcription	O
in	O
primary	cell_type
T	cell_type
cells	cell_type
is	O
regulated	O
in	O
vivo	O
at	O
the	O
level	O
of	O
constitutive	O
and	O
inducible	O
protein/DNA	O
interactions	O
.	O
We	O
propose	O
a	O
model	O
where	O
basal	O
transcription	O
is	O
maintained	O
by	O
binding	O
of	O
various	O
transcription	protein
factors	protein
to	O
the	O
IFN-gamma	DNA
promoter	DNA
,	O
whereas	O
PMA	O
+	O
PHA	protein
-inducible	O
IFN-gamma	protein
transcription	O
in	O
CD45R0	cell_type
T	cell_type
cells	cell_type
is	O
associated	O
with	O
binding	O
of	O
AP-1	protein
to	O
the	O
C-site	DNA
.	O

Activation	O
domain	O
requirements	O
for	O
disruption	O
of	O
Epstein-Barr	O
virus	O
latency	O
by	O
ZEBRA	protein
.	O
Latent	O
infection	O
of	O
B	cell_type
lymphocytes	cell_type
by	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
can	O
be	O
disrupted	O
by	O
expression	O
of	O
the	O
EBV	protein
ZEBRA	protein
protein	protein
.	O
ZEBRA	protein
,	O
a	O
transcriptional	O
activator,	O
initiates	O
the	O
EBV	O
lytic	O
cascade	O
by	O
activating	O
viral	O
gene	O
expression	O
.	O
ZEBRA	protein
is	O
also	O
indispensable	O
for	O
viral	O
replication	O
and	O
binds	O
directly	O
to	O
the	O
EBV	O
lytic	O
origin	O
of	O
replication.	O
The	O
studies	O
described	O
herein	O
demonstrate	O
that	O
the	O
activation	O
domain.	O
ZEBRA	protein
activation	O
can	O
be	O
replaced	O
by	O
a	O
heterologous	O
acidic	O
,	O
proline-rich	O
,	O
or	O
glutamine-rich	O
activation	O
domain	O
.	O
ZEBRA	protein
activation	O
domain	O
swap	O
constructs	O
retain	O
ZEBRA	protein
's	O
native	O
abilities	O
to	O
activate	O
specific	O
EBV	DNA
promoters	DNA
,	O
to	O
disrupt	O
EBV	O
latency	O
,	O
and	O
to	O
stimulate	O
replication	O
at	O
the	O
EBV	DNA
lytic	DNA
origin	DNA
.	O
Additional	O
work,	O
employing	O
sequential	O
and	O
internal	O
deletions	O
of	O
ZEBRA	protein
's	O
N-terminal	protein
activation	protein
domain	protein
,	O
indicates	O
that	O
its	O
separate	O
activities	O
are	O
not	O
attributable	O
to	O
specific	O
subdomains	protein
but	O
are	O
spread	O
throughout	O
its	O
N	protein
terminus	protein
and	O
therefore	O
cannot	O
be	O
inactivated	O
by	O
deleting	O
localized	O
regions.	O

CholecystokininB	protein
receptor	protein
from	O
human	cell_line
Jurkat	cell_line
lymphoblastic	cell_line
T	cell_line
cells	cell_line
is	O
involved	O
in	O
activator	protein
protein-1	protein
-responsive	O
gene	O
activation	O
.	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	O
the	O
role	O
of	O
cholecystokinin	protein
(CCK(B))	protein
receptor	protein
in	O
human	cell_line
lymphoblastic	cell_line
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
We	O
investigated	O
the	O
trophic	O
effect	O
resulting	O
from	O
activation	O
of	O
such	O
a	O
receptor	O
by	O
using	O
the	O
reporter	DNA
gene	DNA
strategy	O
.	O
For	O
this	O
purpose,	O
we	O
transiently	O
transfected	O
Jurkat	cell_line
T	cell_line
cells	cell_line
with	O
the	O
reporter	DNA
plasmid	DNA
p[(TRE)3-tk-Luc]	DNA
and	O
found	O
that	O
CCK-8	O
was	O
able	O
to	O
dose-dependently	O
induce	O
luciferase	protein
expression	O
related	O
to	O
activator	protein
protein-1	protein
(	O
AP-1	protein
)	O
activation	O
with	O
a	O
maximal	O
response	O
identical	O
to	O
that	O
obtained	O
with	O
compounds	O
known	O
to	O
activate	O
AP-1	protein
complex	protein
(quantitatively,	O
the	O
same	O
level	O
of	O
induction	O
was	O
obtained	O
with	O
1	O
nM	O
12-O-tetradecanoylphorbol-13-acetate	O
,	O
100	O
microM	O
diacylglycerol	O
,	O
or	O
4	O
nM	O
epidermal	O
growth	O
factor	O
).	O
The	O
involvement	O
of	O
the	O
CCK(B)	protein
receptor	protein
in	O
such	O
a	O
stimulation	O
was	O
demonstrated	O
by	O
the	O
inhibiting	O
effect	O
of	O
the	O
selective	O
CCK(B)	protein
receptor	protein
antagonist	O
PD-135,158	O
.	O
This	O
effect	O
was	O
confirmed	O
in	O
COS-7	O
cells	O
transfected	O
with	O
the	O
cDNA	O
of	O
CCK(B)	protein
receptor	protein
cloned	O
from	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
To	O
better	O
understand	O
the	O
AP-1	protein
-dependent	O
luciferase	protein
expression	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
,	O
we	O
tested	O
two	O
specific	O
inhibitors	O
of	O
serine/threonine	O
phosphatases	O
-1	O
and	O
-2A	O
:	O
okadaic	O
acid	O
and	O
calyculin	O
A	O
.	O
These	O
compounds	O
strongly	O
increased	O
the	O
phorbol-12-myristate-13-acetate	O
response	O
,	O
whereas	O
we	O
have	O
not	O
observed	O
a	O
contribution	O
of	O
phosphatase	O
inhibitors	O
on	O
a	O
CCK-8	O
-induced	O
luciferase	protein
activity	O
.	O
To	O
confirm	O
that	O
CCK(B)	protein
receptors	protein
are	O
involved	O
in	O
AP-1	protein
response	O
,	O
we	O
investigated	O
the	O
CCK-8	O
effect	O
on	O
interleukin-2	protein
expression	O
,	O
a	O
natural	O
endogenous	DNA
gene	DNA
regulated	O
by	O
several	O
factors,	O
including	O
AP-1	protein
.	O
In	O
Jurkat	cell_line
T	cell_line
cells	cell_line
activated	O
by	O
phorbol-12-myristate-13-acetate	O
and	O
phytohemagglutinin	protein
,	O
CCK-8	O
induced	O
IL-2	O
expression.	O
This	O
induction	O
was	O
abolished	O
by	O
PD-135,158	O
.	O
Our	O
results	O
indicate	O
that	O
CCK-8	O
exerts	O
a	O
trophic	O
effect	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
through	O
stimulation	O
of	O
CCK(B)	protein
receptors	protein
by	O
modulation	O
of	O
expression	O
of	O
AP-1	DNA
-regulated	DNA
genes	DNA
.	O

A	O
conserved	O
tissue-specific	O
structure	O
at	O
a	O
human	DNA
T-cell	DNA
receptor	DNA
beta-chain	DNA
core	DNA
promoter	DNA
.	O
The	O
T-cell	DNA
receptor	DNA
(TCR)	DNA
beta-chain	DNA
promoters	DNA
have	O
been	O
characterized	O
as	O
nonstructured	DNA
basal	DNA
promoters	DNA
that	O
carry	O
a	O
single	O
conserved	O
ubiquitous	DNA
cyclic	DNA
AMP-responsive	DNA
element	DNA
.	O
Our	O
investigation	O
of	O
the	O
human	DNA
TCR	DNA
beta	DNA
gene	DNA
uncovers	O
a	O
surprisingly	O
complex	O
and	O
tissue-specific	O
structure	O
at	O
the	O
TCR	DNA
Vbeta	DNA
8.1	DNA
promoter	DNA
.	O
The	O
core	O
of	O
the	O
promoter	DNA
(	O
positions	DNA
-42	DNA
to	DNA
+11	DNA
)	O
is	O
recognized	O
by	O
the	O
lymphoid	protein
cell	protein
-specific	protein
transcription	protein
factors	protein
Ets-1	protein
,	O
LEF1	protein
,	O
and	O
AML1	protein
as	O
well	O
as	O
by	O
CREB/ATF-1	protein
,	O
as	O
is	O
demonstrated	O
in	O
gel	O
shift	O
and	O
footprinting	O
experiments	O
.	O
With	O
the	O
exception	O
of	O
LEF1	protein
,	O
these	O
factors	O
activate	O
transcription	O
in	O
T	cell_type
cells	cell_type
.	O
Binding	DNA
sites	DNA
at	O
the	O
core	O
region	O
show	O
little	O
conservation	O
with	O
consensus	DNA
sites	DNA
.	O
Nonetheless,	O
CREB	protein
,	O
Ets-1	protein
,	O
and	O
AML1	protein
bind	O
and	O
activate	O
cooperatively	O
and	O
very	O
efficiently	O
through	O
the	O
nonconsensus	DNA
binding	DNA
sites	DNA
at	O
the	O
core	DNA
promoter	DNA
region	DNA
.	O
Moderate	O
ubiquitous	O
activation	O
is	O
further	O
induced	O
by	O
CREB/ATF	O
and	O
Sp1	O
factors	O
through	O
proximal	DNA
upstream	DNA
elements	DNA
.	O
The	O
tissue-specific	DNA
core	DNA
promoter	DNA
structure	DNA
is	O
apparently	O
conserved	O
in	O
other	O
T-cell-specifically	DNA
expressed	DNA
genes	DNA
such	O
as	O
the	O
CD4	DNA
gene	DNA
.	O
Our	O
observations	O
suggest	O
that	O
both	O
the	O
enhancer	DNA
and	O
the	O
promoter	DNA
have	O
a	O
complex	DNA
tissue-specific	DNA
structure	DNA
whose	O
functional	O
interplay	O
potentiates	O
T-cell-specific	O
transcription	O
.	O

The	O
cytoplasmic	protein
domain	protein
of	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
(	protein
GM-CSF	protein
)	protein
receptor	protein
alpha	protein
subunit	protein
is	O
essential	O
for	O
both	O
GM-CSF	protein
-mediated	O
growth	O
and	O
differentiation.	O
Granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
(	O
GM-CSF	protein
)	O
regulates	O
differentiation,	O
survival,	O
and	O
proliferation	O
of	O
colony-forming	cell_line
unit-granulocyte-macrophage	cell_line
progenitor	cell_line
cells	cell_line
.	O
The	O
biologic	O
actions	O
of	O
GM-CSF	protein
are	O
mediated	O
by	O
binding	O
to	O
a	O
specific	O
receptor	O
consisting	O
of	O
two	O
chains	O
designated	O
as	O
alpha	O
and	O
beta	O
subunits	O
.	O
We	O
have	O
demonstrated	O
that	O
the	O
murine	cell_line
FDC-P1-derived	cell_line
cell	cell_line
line	cell_line
WT-19	cell_line
transfected	O
with	O
the	O
human	O
GM-CSF	O
receptor	O
alpha	O
and	O
beta	O
subunits	O
(	O
GM-CSFR	O
alpha	O
and	O
beta	O
)	O
can	O
be	O
induced	O
to	O
differentiate	O
by	O
the	O
addition	O
of	O
human	protein
GM-CSF	protein
(	O
hGM-CSF	protein
).	O
By	O
expressing	O
a	O
series	O
of	O
GM-CSFRalpha	protein
mutants	protein
in	O
WT19	cell_line
cells	cell_line
,	O
we	O
have	O
determined	O
the	O
amino	protein
acid	protein
domains	protein
of	O
the	O
GM-CSFRalpha	protein
cytoplasmic	protein
domain	protein
that	O
regulate	O
cell	O
differentiation,	O
proliferation,	O
and	O
survival.	O
We	O
found	O
that	O
the	O
membrane	protein
proximal	protein
proline-rich	protein
domain	protein
and	O
adjacent	protein
16	protein
residues	protein
are	O
essential	O
for	O
both	O
hGM-CSF	protein
-dependent	O
cell	O
proliferation	O
and	O
differentiation	O
.	O
In	O
contrast,	O
the	O
C-terminal	protein
region	protein
of	O
the	O
GM-CSFRalpha	protein
cytoplasmic	protein
domain	protein
was	O
not	O
necessary	O
for	O
cell	O
differentiation	O
mediated	O
by	O
hGM-CSF	protein
,	O
but	O
the	O
removal	O
of	O
this	O
region	O
severely	O
impaired	O
the	O
ability	O
of	O
hGM-CSF	protein
to	O
support	O
cell	O
survival	O
.	O
While	O
the	O
activation	O
of	O
JAK2	protein
,	O
Shc	protein
,	O
Erk	protein
,	O
and	O
STAT5	protein
proteins	protein
correlated	O
with	O
hGM-CSF	protein
-mediated	O
cell	O
growth	O
,	O
cellular	O
differentiation	O
occurred	O
in	O
the	O
absence	O
of	O
activation	O
of	O
these	O
signal	O
transduction	O
pathways	O
.	O

gamma-Interferon	protein
-induced	O
resistance	O
to	O
1,25-(OH)2	O
D3	O
in	O
human	cell_type
monocytes	cell_type
and	O
macrophages	cell_type
:	O
a	O
mechanism	O
for	O
the	O
hypercalcemia	O
of	O
various	O
granulomatoses	O
.	O
The	O
hypercalcemia	O
of	O
various	O
granulomatoses	O
is	O
caused	O
by	O
endogenous	O
1,25-dihydroxyvitamin	O
D	O
[	O
1,25-(OH)2D3	O
]	O
overproduction	O
by	O
disease-activated	O
macrophages	cell_type
.	O
The	O
inability	O
of	O
1,25(OH)2D3	O
to	O
suppress	O
its	O
synthesis	O
in	O
macrophages	cell_type
contrasts	O
with	O
the	O
tight	O
control	O
of	O
its	O
production	O
in	O
macrophage	O
precursors,	O
peripheral	cell_type
blood	cell_type
monocytes	cell_type
(	O
PBM	cell_type
).	O
We	O
examined	O
whether	O
1,25(OH)2D3	O
resistance	O
develops	O
as	O
PBM	cell_type
differentiate	O
to	O
macrophages	cell_type
or	O
with	O
macrophage	O
activation	O
.	O
Normal	O
human	cell_type
pulmonary	cell_type
alveolar	cell_type
macrophages	cell_type
(	O
PAM	cell_type
)	O
are	O
less	O
sensitive	O
to	O
1,25(OH)2D3	O
than	O
PBM	cell_type
,	O
despite	O
similar	O
vitamin	protein
D	protein
receptor	protein
content	O
;	O
however,	O
both	O
PBM	cell_type
and	O
PAM	cell_type
respond	O
to	O
exogenous	O
1,25-(OH)2D3	O
by	O
inhibiting	O
1,25(OH)2D3	O
synthesis	O
and	O
inducing	O
1,25(OH)2D3	O
degradation	O
through	O
enhancement	O
of	O
24-hydroxylase	protein
mRNA	O
levels	O
and	O
activity.	O
The	O
human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
THP-1	cell_line
mimics	O
PAM	cell_type
in	O
1,25(OH)2D3	O
synthesis	O
and	O
sensitivity	O
to	O
exogenous	O
1,25(OH)2D3	O
.	O
We	O
utilized	O
THP-1	cell_line
cells	cell_line
to	O
examine	O
the	O
response	O
to	O
1,25(OH)2D3	O
with	O
macrophage	O
activation	O
.	O
Activation	O
of	O
THP-1	cell_line
cells	cell_line
with	O
gamma-interferon	protein
(	O
gamma-IFN	protein
)	O
enhances	O
1,25(OH)2D3	O
synthesis	O
30-fold,	O
blocks	O
1,25-(OH)2D3	O
suppression	O
of	O
its	O
synthesis,	O
and	O
reduces	O
by	O
42.2%	O
1,25-(OH)2D3	O
induction	O
of	O
its	O
degradation.	O
The	O
antagonistic	O
effects	O
of	O
gamma-IFN	protein
are	O
not	O
merely	O
restricted	O
to	O
enzymatic	O
activities	O
.	O
In	O
THP-1	cell_line
cells	cell_line
and	O
in	O
normal	O
PBM	cell_type
,	O
gamma-IFN	protein
inhibits	O
1,25-(OH)2D3	O
induction	O
of	O
24-hydroxylase	protein
mRNA	O
levels	O
without	O
reducing	O
mRNA	O
stability,	O
suggesting	O
gamma-IFN	protein
inhibition	O
of	O
1,25(OH)2D3	O
transactivating	O
function.	O
These	O
results	O
explain	O
1,25(OH)2D3	O
overproduction	O
in	O
granulomatoses	O
and	O
demonstrate	O
potent	O
inhibition	O
by	O
gamma-IFN	protein
of	O
1,25(OH)2D3	O
action	O
in	O
immune	cell_type
cells	cell_type
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
cDNA	DNA
,	O
CHEMR1	DNA
,	O
encoding	O
a	O
chemokine	protein
receptor	protein
with	O
a	O
homology	O
to	O
the	O
human	protein
C-C	protein
chemokine	protein
receptor	protein
,	O
CCR-4	protein
.	O
Chemokines	protein
refer	O
to	O
a	O
rapidly	O
expanding	O
family	O
of	O
small	O
cytokines	protein
whose	O
primary	O
function	O
is	O
recruitment	O
of	O
leukocytes	O
to	O
inflammatory	O
sites.	O
These	O
are	O
known	O
to	O
bind	O
to	O
seven-transmembrane-domain	protein
containing	protein
receptors	protein
.	O
A	O
cDNA	DNA
clone	DNA
,	O
CHEMR1	DNA
,	O
resembling	O
the	O
typical	O
G	protein
protein-coupled	protein
receptor	protein
,	O
was	O
isolated	O
from	O
a	O
mouse	DNA
cytotoxic	DNA
T-lymphocyte	DNA
(CTL)	DNA
library	DNA
.	O
Northern	O
blot	O
analysis	O
in	O
mouse	O
cell	O
lines	O
suggests	O
that	O
its	O
expression	O
is	O
found	O
in	O
a	O
variety	O
of	O
cells,	O
including	O
T	cell_type
cells	cell_type
,	O
B	cell_type
cells	cell_type
,	O
and	O
macrophages	cell_type
.	O
The	O
CHEMR1	DNA
gene	DNA
Scya3r2	DNA
is	O
a	O
single-copy	DNA
gene	DNA
whose	O
open	O
reading	O
frame	O
may	O
be	O
in	O
a	O
single	O
exon	O
and	O
maps	O
to	O
the	O
distal	O
region	O
of	O
mouse	DNA
Chr	DNA
9	DNA
where	O
the	O
mouse	DNA
macrophage	DNA
inflammatory	DNA
protein-1alpha	DNA
(	DNA
MIP-1alpha	DNA
)	DNA
receptor	DNA
gene	DNA
Scya3r	DNA
and	O
two	O
related	O
C-C	DNA
chemokine	DNA
receptor-like	DNA
genes	DNA
reside.	O
Amino	O
acid	O
sequence	O
comparison	O
shows	O
that	O
CHEMR1	DNA
is	O
84%	O
identical	O
to	O
human	protein
CCR-4	protein
,	O
indicating	O
that	O
CHEMR1	DNA
is	O
likely	O
to	O
be	O
a	O
mouse	protein
CCR-4	protein
.	O
Binding	O
assays	O
using	O
125I-labeled	protein
C-C	protein
chemokines	protein
in	O
mammalian	cell_type
cells	cell_type
indicated	O
that	O
CHEMR1	DNA
did	O
not	O
bind	O
MIP-1alpha,	O
RANTES,	O
or	O
MIP-1beta,	O
whereas	O
CCR-1	protein
binds	O
MIP-1alpha	protein
and	O
RANTES	protein
.	O
Our	O
result	O
is	O
different	O
from	O
the	O
reported	O
properties	O
of	O
human	protein
CCR-4	protein
.	O
This	O
suggests	O
that	O
CHEMR1	DNA
may	O
be	O
a	O
receptor	O
for	O
unidentified	O
C-C	protein
chemokine	protein
or	O
a	O
low-affinity	O
receptor	O
for	O
MIP-1alpha	protein
.	O

Transactivation	O
by	O
CIITA	protein
,	O
the	O
type	protein
II	protein
bare	protein
lymphocyte	protein
syndrome-associated	protein
factor	protein
,	O
requires	O
participation	O
of	O
multiple	O
regions	O
of	O
the	O
TATA	protein
box	protein
binding	protein
protein	protein
.	O
CIITA	protein
is	O
a	O
positive	O
regulator	O
of	O
class	DNA
II	DNA
major	DNA
histocompatibility	DNA
complex	DNA
gene	DNA
transcription	O
that	O
has	O
been	O
found	O
to	O
be	O
defective	O
in	O
one	O
of	O
the	O
five	O
complementation	O
groups	O
of	O
class	cell_line
II	cell_line
major	cell_line
histocompatibility	cell_line
complex	cell_line
-negative	cell_line
cell	cell_line
lines	cell_line
.	O
Its	O
N-terminal	protein
region	protein
is	O
capable	O
of	O
activating	O
transcription	O
from	O
a	O
reporter	O
gene	O
when	O
fused	O
to	O
a	O
DNA	protein
binding	protein
domain	protein
.	O
We	O
have	O
investigated	O
the	O
mechanism	O
of	O
transactivation	O
mediated	O
by	O
the	O
CIITA	protein
activation	protein
domain	protein
by	O
studying	O
its	O
role	O
in	O
the	O
process	O
of	O
transcription	O
initiation	O
and	O
elongation.	O
Specifically	O
the	O
altered	O
specificity	O
TBP	O
(	O
TATA	protein
box	protein
binding	protein
protein	protein
)	O
assay	O
has	O
been	O
used	O
to	O
analyze	O
the	O
response	O
of	O
the	O
CIITA	protein
activation	protein
domain	protein
to	O
mutations	O
in	O
TBP	protein
known	O
to	O
disrupt	O
its	O
interaction	O
with	O
its	O
associated	protein
general	protein
factors	protein
.	O
Transactivation	O
by	O
CIITA	protein
was	O
extremely	O
sensitive	O
to	O
a	O
mutation	O
in	O
TBP	protein
that	O
in	O
yeast	O
is	O
known	O
to	O
abolish	O
VP16	protein
-mediated	O
transcription	O
but	O
leaves	O
basal	O
transcription	O
unaffected.	O
A	O
TBP	O
mutant	O
defective	O
in	O
interaction	O
with	O
TBP	protein
-associated	protein
factor	protein
TAFII250	protein
also	O
failed	O
to	O
mediate	O
transactivation	O
through	O
the	O
CIITA	protein
activation	protein
domain	protein
.	O
Certain	O
interactions	O
between	O
TBP	protein
and	O
general	protein
factors	protein
that	O
are	O
specifically	O
required	O
for	O
acidic	protein
activation	protein
domains	protein
were	O
also	O
required	O
for	O
CIITA	protein
-mediated	O
transactivation	O
to	O
reach	O
its	O
full	O
potential.	O
Finally,	O
like	O
VP16,	O
CIITA	protein
was	O
able	O
to	O
stimulate	O
elongation	O
of	O
transcription.	O
Overall	O
the	O
mechanism	O
of	O
transactivation	O
by	O
the	O
human	protein
B-cell-specific	protein
CIITA	protein
is	O
very	O
similar	O
to	O
that	O
mediated	O
by	O
the	O
herpes	protein
virus	protein
transactivator	protein
VP16	protein
in	O
the	O
ways	O
that	O
have	O
been	O
tested.	O

Relief	O
of	O
cyclin	protein
A	protein
gene	O
transcriptional	O
inhibition	O
during	O
activation	O
of	O
human	cell_type
primary	cell_type
T	cell_type
lymphocytes	cell_type
via	O
CD2	protein
and	O
CD28	protein
adhesion	protein
molecules	protein
.	O
Cyclin	protein
A	protein
transcription	O
is	O
cell	O
cycle	O
regulated	O
and	O
induced	O
by	O
cell	O
proliferative	O
signals	O
.	O
To	O
understand	O
the	O
mechanisms	O
underlined	O
in	O
this	O
regulation	O
in	O
normal	O
human	O
cells,	O
we	O
have	O
analysed	O
in	O
vivo	O
protein-DNA	O
interactions	O
at	O
the	O
Cyclin	protein
A	protein
locus	O
in	O
primary	cell_type
T	cell_type
lymphocytes	cell_type
.	O
Stimulation	O
of	O
purified	O
T	O
lymphocytes	O
by	O
a	O
combination	O
of	O
monoclonal	protein
antibodies	protein
directed	O
at	O
CD2	protein
and	O
CD28	protein
adhesion	protein
molecules	protein
gives	O
rise	O
to	O
a	O
long	O
lasting	O
proliferation	O
in	O
the	O
absence	O
of	O
accessory	cell_type
cells	cell_type
.	O
Cyclin	protein
A	protein
was	O
observed	O
after	O
4	O
days	O
of	O
costimulation	O
with	O
anti	protein
CD2	protein
+	O
CD28	protein
whereas	O
stimulation	O
by	O
anti	protein
CD2	protein
or	O
anti	protein
CD28	protein
alone	O
was	O
not	O
effective.	O
In	O
vivo	O
genomic	O
DMS	O
footprinting	O
revealed	O
upstream	O
of	O
the	O
major	O
transcription	DNA
initiation	DNA
sites	DNA
,	O
the	O
presence	O
of	O
at	O
least	O
three	O
protein	DNA
binding	DNA
sites	DNA
,	O
two	O
of	O
which	O
were	O
constitutively	O
occupied.	O
They	O
bind	O
in	O
vitro	O
respectively	O
ATF-1	protein
and	O
NF-Y	protein
proteins	protein
.	O
The	O
third	O
site	O
was	O
occupied	O
in	O
quiescent	O
cells	O
or	O
in	O
cells	O
stimulated	O
by	O
anti	protein
CD2	protein
or	O
anti	protein
CD28	protein
alone.	O
The	O
mitogenic	O
combination	O
of	O
anti	protein
CD2	protein
+	O
anti	protein
CD28	protein
released	O
the	O
footprint	O
as	O
cells	O
were	O
committed	O
to	O
proliferation.	O
Consistent	O
with	O
theses	O
results,	O
nuclear	O
extracts	O
prepared	O
from	O
quiescent	O
cells	O
formed	O
a	O
specific	O
complex	O
with	O
this	O
element,	O
whereas	O
extracts	O
prepared	O
from	O
cells	O
treated	O
with	O
anti	protein
CD2	protein
+	O
anti	protein
CD28	protein
failed	O
to	O
do	O
so	O
after	O
cells	O
entered	O
a	O
proliferative	O
state	O
.	O

An	O
enhancer-blocking	DNA
element	DNA
between	O
alpha	O
and	O
delta	O
gene	O
segments	O
within	O
the	O
human	DNA
T	DNA
cell	DNA
receptor	DNA
alpha/delta	DNA
locus	DNA
.	O
T	protein
cell	protein
receptor	protein
(TCR)	protein
alpha	protein
and	O
delta	O
gene	O
segments	O
are	O
organized	O
within	O
a	O
single	O
genetic	O
locus	O
but	O
are	O
differentially	O
regulated	O
during	O
T	O
cell	O
development	O
.	O
An	O
enhancer-blocking	DNA
element	DNA
(	O
BEAD-1	DNA
,	O
for	O
blocking	O
element	DNA
alpha/delta	DNA
1	DNA
)	O
was	O
localized	O
to	O
a	O
2.0-kb	DNA
region	DNA
3'	O
of	O
TCR	DNA
delta	DNA
gene	DNA
segments	DNA
and	O
5'	O
of	O
TCR	DNA
alpha	DNA
joining	DNA
gene	DNA
segments	DNA
within	O
this	O
locus.	O
BEAD-1	DNA
blocked	O
the	O
ability	O
of	O
the	O
TCR	DNA
delta	DNA
enhancer	DNA
(	O
Edelta	DNA
)	O
to	O
activate	O
a	O
promoter	O
when	O
located	O
between	O
the	O
two	O
in	O
a	O
chromatin-integrated	DNA
construct	DNA
.	O
We	O
propose	O
that	O
BEAD-1	DNA
functions	O
as	O
a	O
boundary	O
that	O
separates	O
the	O
TCR	DNA
alpha/delta	DNA
locus	DNA
into	O
distinct	O
regulatory	DNA
domains	DNA
controlled	O
by	O
Edelta	DNA
and	O
the	O
TCR	DNA
alpha	DNA
enhancer	DNA
,	O
and	O
that	O
it	O
prevents	O
Edelta	DNA
from	O
opening	O
the	O
chromatin	DNA
of	O
the	O
TCR	DNA
alpha	DNA
joining	O
gene	O
segments	O
for	O
VDJ	O
recombination	O
at	O
an	O
early	O
stage	O
of	O
T	O
cell	O
development	O
.	O

Uncoupling	O
of	O
cell	O
cycle	O
arrest	O
from	O
the	O
expression	O
of	O
monocytic	O
differentiation	O
markers	O
in	O
HL60	cell_line
cell	cell_line
variants	cell_line
.	O
Differentiation	O
generally	O
leads	O
to	O
cell	O
cycle	O
arrest	O
.	O
Human	cell_line
leukemia	cell_line
HL60	cell_line
cells	cell_line
respond	O
to	O
the	O
presence	O
of	O
1,25-dihydroxyvitamin	O
D3	O
(	O
1,25D3	O
)	O
by	O
expressing	O
a	O
number	O
of	O
markers	O
of	O
the	O
monocyte/macrophage	O
phenotype	O
and	O
become	O
arrested	O
predominantly	O
in	O
the	O
G1	O
phase	O
of	O
the	O
cell	O
cycle.	O
We	O
have	O
recently	O
reported	O
a	O
series	O
(A)	O
of	O
1,25D3	O
-resistant	O
variants	O
of	O
HL60	cell_line
cells	cell_line
which	O
proliferate	O
in	O
the	O
presence	O
of	O
1,25D3	O
and	O
do	O
not	O
express	O
differentiation	O
markers	O
(Exp.	O
Cell	O
Res.	O
224,	O
312,	O
1996).	O
We	O
now	O
describe	O
another	O
series	O
(B)	O
of	O
such	O
variants,	O
which	O
differ	O
from	O
A	O
series	O
cells	O
grown	O
in	O
similar	O
concentrations	O
of	O
1,25D3	O
in	O
that	O
they	O
express	O
the	O
CD14	protein
antigen	protein
and	O
nonspecific	O
esterase	protein
,	O
characteristic	O
of	O
the	O
monocyte,	O
while	O
continuing	O
to	O
proliferate	O
and	O
they	O
develop	O
hypotetraploid	O
DNA	O
(4C)	O
content	O
at	O
higher	O
concentrations	O
of	O
ambient	O
1,25D3	O
than	O
the	O
A	O
series	O
cells.	O
Cells	O
in	O
the	O
B	O
series	O
with	O
4C	O
DNA	O
content	O
(100B	O
and	O
200B)	O
also	O
differed	O
from	O
the	O
A	cell_line
series	cell_line
4C	cell_line
cells	cell_line
by	O
the	O
absence	O
of	O
DNA	O
binding	O
by	O
the	O
full-length	O
Sp1	protein
transcription	protein
factor	protein
.	O
However,	O
B	O
series	O
cells	O
resembled	O
the	O
A	O
series	O
cells	O
in	O
exhibiting	O
faster	O
growth	O
rates	O
than	O
the	O
parental	O
HL60	cell_line
cells	cell_line
and	O
showed	O
high	O
levels	O
of	O
vitamin	protein
D	protein
receptor	protein
and	O
retinoid	protein
receptor	protein
X	protein
proteins	protein
.	O
These	O
results	O
show	O
that	O
the	O
initial	O
steps	O
in	O
the	O
1,25D3	O
signaling	O
pathway	O
are	O
intact	O
in	O
B	O
series	O
resistant	O
cells	O
and	O
lead	O
to	O
the	O
appearance	O
of	O
early	O
markers	O
of	O
monocytic	O
differentiation	O
.	O
However,	O
the	O
progression	O
to	O
subsequent	O
events	O
which	O
comprise	O
terminal	O
differentiation	O
and	O
cell	O
cycle	O
arrest	O
is	O
halted	O
during	O
the	O
adaptation	O
to	O
the	O
presence	O
of	O
1,25D3	O
in	O
these	O
cells.	O
Thus,	O
the	O
availability	O
of	O
these	O
variant	O
cells	O
should	O
provide	O
a	O
system	O
for	O
studying	O
the	O
link	O
between	O
differentiation	O
and	O
cell	O
cycle	O
arrest	O
.	O

Inhibition	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
replication	O
in	O
vitro	O
by	O
a	O
novel	O
combination	O
of	O
anti-Tat	protein
single-chain	protein
intrabodies	protein
and	O
NF-kappa	O
B	O
antagonists	O
.	O
Human	protein
immunodeficiency	protein
virus	protein
type	protein
1	protein
(HIV-1)	protein
Tat	protein
,	O
an	O
early	O
regulatory	protein
protein	protein
that	O
is	O
critical	O
for	O
viral	O
gene	O
expression	O
and	O
replication	O
,	O
transactivates	O
the	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
via	O
its	O
binding	O
to	O
the	O
transactivation	DNA
response	DNA
element	DNA
(	O
TAR	DNA
)	O
and,	O
along	O
with	O
other	O
cellular	O
factors,	O
increases	O
viral	O
transcription	O
initiation	O
and	O
elongation	O
.	O
Tat	O
also	O
superactivates	O
the	O
HIV-1	DNA
promoter	DNA
through	O
a	O
TAR	DNA
-independent	O
mechanism	O
,	O
including	O
tumor	O
necrosis	O
factor	O
alpha-induced	O
and	O
protein	O
kinase	O
C	O
(	O
PKC	protein
)-dependent	O
activation	O
of	O
NF-kappa	protein
B	protein
,	O
and	O
inhibitors	O
of	O
Tat	protein
and	O
NF-kappa	protein
B	protein
cooperatively	O
down-regulate	O
this	O
Tat	protein
-mediated	O
LTR	DNA
superactivation	O
.	O
In	O
this	O
study,	O
a	O
combined	O
pharmacologic	O
and	O
genetic	O
strategy	O
using	O
two	O
PKC	protein
(	O
NF-kappa	protein
B	protein
)	O
inhibitors,	O
pentoxifylline	O
(	O
PTX	O
)	O
and	O
Go-6976	O
,	O
and	O
a	O
stably	O
expressed	O
anti-	protein
Tat	protein
single-chain	protein
intracellular	protein
antibody	protein
(	O
sFv	protein
intrabody	protein
)	O
was	O
employed	O
to	O
obtain	O
cooperative	O
inhibition	O
of	O
both	O
HIV-1	O
LTR	DNA
-driven	O
gene	O
expression	O
and	O
HIV-1	O
replication	O
.	O
Treatment	O
of	O
cells	O
with	O
PTX	O
and	O
Go-6976	O
resulted	O
in	O
cooperative	O
inhibition	O
of	O
both	O
HIV-1	DNA
LTR	DNA
-driven	O
gene	O
expression	O
and	O
HIV-1	O
replication	O
.	O
In	O
addition,	O
the	O
combined	O
use	O
of	O
anti-	protein
Tat	protein
sFv	protein
intrabodies	protein
and	O
the	O
two	O
NF-kappa	protein
B	protein
inhibitors	O
retained	O
the	O
virus	O
in	O
the	O
latent	O
state	O
for	O
as	O
long	O
as	O
45	O
days.	O
The	O
combined	O
treatment	O
resulted	O
in	O
more	O
durable	O
inhibition	O
of	O
HIV-1	O
replication	O
than	O
was	O
seen	O
with	O
the	O
NF-kappa	protein
B	protein
inhibitors	O
alone	O
or	O
the	O
anti-	O
Tat	protein
sFv	protein
intrabodies	protein
alone.	O
Together,	O
these	O
results	O
suggest	O
that	O
in	O
future	O
clinical	O
gene	O
therapy	O
trials,	O
a	O
combined	O
pharmacologic	O
and	O
genetic	O
strategy	O
like	O
the	O
one	O
reported	O
here	O
may	O
improve	O
the	O
survival	O
of	O
transduced	cell_line
cells	cell_line
and	O
prolong	O
clinical	O
benefit.	O

Transcription	protein
factors	protein
in	O
immune-mediated	O
disease	O
.	O
A	O
large	O
amount	O
of	O
detailed	O
information	O
about	O
the	O
intracellular	protein
proteins	protein
regulating	O
NF-kappa	protein
B	protein
activation	O
and	O
the	O
cellular	O
response	O
to	O
NF-kappa	protein
B	protein
activation	O
has	O
emerged	O
recently.	O
Several	O
small	O
molecules,	O
an	O
antisense	DNA
oligonucleotide	DNA
,	O
and	O
gene	O
therapeutic	O
agents	O
that	O
inhibit	O
NF-kappa	protein
b	protein
activation	O
have	O
been	O
described.	O
Despite	O
this,	O
there	O
are	O
still	O
significant	O
gaps	O
in	O
our	O
understanding	O
of	O
this	O
process	O
and	O
its	O
consequences.	O
In	O
contrast,	O
the	O
characterization	O
of	O
transcription	protein
factors	protein
selectively	O
regulating	O
cytokine	O
production	O
by	O
CD4+	cell_type
T	cell_type
cell	cell_type
subsets	cell_type
is	O
at	O
a	O
very	O
early	O
stage.	O
Three	O
interacting	protein
proteins	protein
have	O
recently	O
been	O
shown	O
to	O
contribute	O
to	O
subset-restricted	O
expression	O
of	O
the	O
IL-4	DNA
gene	DNA
.	O
There	O
are	O
other	O
elements	O
regulating	O
IL-4	DNA
gene	DNA
expression	O
,	O
however,	O
and	O
the	O
relative	O
importance	O
of	O
these	O
recently	O
identified	O
proteins	O
has	O
yet	O
to	O
be	O
determined.	O

Involvement	O
of	O
Rel	O
,	O
Fos	O
,	O
and	O
Jun	O
proteins	O
in	O
binding	O
activity	O
to	O
the	O
IL-2	DNA
promoter	DNA
CD28	DNA
response	DNA
element/	DNA
AP-1	DNA
sequence	DNA
in	O
human	cell_type
T	cell_type
cells	cell_type
.	O
CD28	protein
is	O
an	O
important	O
costimulatory	protein
molecule	protein
in	O
the	O
activation	O
of	O
human	cell_type
T	cell_type
cells	cell_type
.	O
Costimulation	O
of	O
T	cell_type
cells	cell_type
through	O
both	O
the	O
Ag	O
receptor	O
and	O
CD28	protein
leads	O
to	O
high	O
level	O
IL-2	protein
production	O
,	O
which	O
is	O
vital	O
to	O
the	O
development	O
of	O
an	O
immune	O
response	O
in	O
vivo.	O
Previous	O
reports	O
have	O
suggested	O
the	O
CD28	protein
stimulation	O
contributes	O
to	O
the	O
activation	O
of	O
the	O
IL-2	DNA
promoter	DNA
by	O
up-regulating	O
the	O
activity	O
of	O
several	O
transcription	protein
factors	protein
,	O
including	O
AP-1	protein
and	O
nuclear	protein
factor-kappaB	protein
(	protein
NF-kappaB	protein
)/	protein
Rel	protein
family	protein
members	protein
as	O
well	O
as	O
an	O
uncharacterized	protein
transcription	protein
factor	protein
called	O
CD28	protein
response	O
complex.	O
While	O
several	O
lines	O
of	O
investigation	O
have	O
suggested	O
that	O
NF-kappaB/Rel	protein
family	protein
members	protein
make	O
up	O
the	O
CD28	protein
response	O
complex	O
transcription	protein
factor	protein
,	O
other	O
work	O
has	O
not	O
supported	O
this	O
conclusion.	O
Recent	O
studies	O
suggest	O
that	O
the	O
CD28	DNA
response	DNA
element	DNA
(	O
CD28RE	DNA
)	O
does	O
not	O
function	O
independently	O
but	O
works	O
instead	O
in	O
conjunction	O
with	O
the	O
adjacent	DNA
promoter	DNA
proximal	DNA
AP-1	DNA
-binding	DNA
site	DNA
and	O
this	O
hypothesis	O
is	O
confirmed	O
here.	O
Also	O
in	O
the	O
current	O
study,	O
binding	O
activity	O
to	O
the	O
CD28RE	DNA
/AP-1	DNA
sequence	DNA
of	O
the	O
IL-2	DNA
promoter	DNA
is	O
evaluated.	O
Although	O
four	O
specific	O
complexes	O
can	O
be	O
detected	O
binding	O
to	O
this	O
sequence,	O
only	O
one	O
of	O
these	O
complexes	O
is	O
specific	O
for	O
both	O
the	O
CD28RE	DNA
and	O
the	O
adjacent	DNA
AP-1	DNA
site	DNA
.	O
Of	O
the	O
NF-kappaB/Rel	protein
family	protein
members	protein
tested,	O
this	O
CD28RE	protein
/AP-1-specific	protein
complex	protein
contains	O
predominantly	O
c-Rel	protein
,	O
despite	O
the	O
fact	O
that	O
both	O
p50	protein
and	O
RelA	protein
can	O
efficiently	O
bind	O
to	O
the	O
CD28RE	DNA
.	O
c-Fos	protein
and	O
c-Jun	protein
are	O
also	O
found	O
in	O
this	O
CD28RE	protein
/AP-1-specific	protein
complex	protein
.	O
These	O
data	O
indicate	O
that	O
functional	O
complexes	O
encompassing	O
both	O
the	O
CD28RE	DNA
and	O
the	O
AP-1-binding	DNA
sites	DNA
influence	O
IL-2	DNA
promoter	DNA
activity	O
in	O
CD28	protein
-costimulated	O
T	cell_type
cells	cell_type
.	O

Inducible	O
expression	O
and	O
phosphorylation	O
of	O
coactivator	protein
BOB.1/OBF.1	protein
in	O
T	cell_type
cells	cell_type
[see	O
comments]	O
BOB.1/OBF.1	protein
is	O
a	O
transcriptional	protein
coactivator	protein
that	O
is	O
constitutively	O
expressed	O
in	O
B	cell_type
cells	cell_type
and	O
interacts	O
with	O
the	O
Oct1	O
and	O
Oct2	O
transcription	protein
factors	protein
.	O
Upon	O
activation	O
of	O
Jurkat	cell_line
T	cell_line
cells	cell_line
and	O
primary	cell_type
murine	cell_type
thymocytes	cell_type
with	O
phorbol	O
esters	O
and	O
ionomycin	O
,	O
BOB.1/OBF.1	protein
expression	O
and	O
transactivation	O
function	O
were	O
induced.	O
BOB.1/OBF.1	protein
was	O
phosphorylated	O
at	O
Ser184	O
both	O
in	O
vivo	O
and	O
in	O
vitro,	O
and	O
this	O
modification	O
was	O
required	O
for	O
inducible	O
activation.	O
Mutation	O
of	O
Ser184	O
also	O
diminished	O
transactivation	O
function	O
in	O
B	cell_type
cells	cell_type
,	O
suggesting	O
that	O
the	O
activating	O
phosphorylation	O
that	O
is	O
inducible	O
in	O
T	cell_type
cells	cell_type
is	O
constitutively	O
present	O
in	O
B	cell_type
cells	cell_type
.	O
Thus,	O
BOB.1/OBF.1	protein
is	O
a	O
transcriptional	protein
coactivator	protein
that	O
is	O
critically	O
regulated	O
by	O
posttranslational	O
modifications	O
to	O
mediate	O
cell	O
type-specific	O
gene	O
expression	O
.	O

Increased	O
expression	O
of	O
Gs(alpha)	protein
enhances	O
activation	O
of	O
the	O
adenylyl	protein
cyclase	protein
signal	O
transduction	O
cascade	O
.	O
Expression	O
of	O
the	O
stimulatory	O
G	protein
protein	protein
,	O
G(S)alpha	protein
,	O
can	O
vary	O
over	O
a	O
3-fold	O
range	O
in	O
human	O
tissues	O
and	O
in	O
rodent	O
central	O
nervous	O
system	O
.	O
In	O
fact,	O
the	O
offspring	O
of	O
alcoholics	O
have	O
higher	O
levels	O
of	O
G(S)alpha	protein
expression	O
in	O
certain	O
tissues	O
compared	O
with	O
the	O
offspring	O
of	O
nonalcoholics	O
.	O
The	O
aim	O
of	O
this	O
research	O
was	O
to	O
test	O
the	O
hypothesis	O
that	O
a	O
causal	O
relationship	O
exists	O
between	O
the	O
level	O
of	O
expression	O
of	O
G(S)alpha	protein
and	O
induction	O
of	O
the	O
adenylyl	protein
cyclase	protein
(AC)	O
cascade	O
.	O
The	O
methodology	O
employed	O
transient	O
transfection	O
of	O
HEK	cell_line
293	cell_line
cells	cell_line
with	O
a	O
cDNA	O
for	O
the	O
52-kDa	O
form	O
of	O
G(S)alpha	protein
under	O
regulation	O
by	O
inducible	DNA
metallothionein	DNA
promoters	DNA
.	O
Transfectants	O
were	O
exposed	O
to	O
varying	O
concentrations	O
(0-125	O
microM)	O
of	O
zinc	O
sulfate	O
that	O
produced	O
a	O
3-fold	O
range	O
of	O
membrane	O
G(S)alpha	protein
expression	O
.	O
The	O
range	O
of	O
G(S)alpha	protein
expression	O
produced	O
was	O
found	O
to	O
mimic	O
a	O
physiologically	O
relevant	O
spectrum	O
of	O
G(S)alpha	protein
expression	O
in	O
membranes	O
derived	O
from	O
human	O
tissues	O
and	O
rat	O
brain	O
.	O
It	O
was	O
observed	O
that	O
induction	O
of	O
G(S)alpha	protein
expression	O
increased	O
constitutive	O
as	O
well	O
as	O
stimulated	O
cAMP	O
accumulation	O
.	O
Moreover,	O
induction	O
of	O
G(S)alpha	protein
expression	O
increased	O
events	O
distal	O
to	O
the	O
accumulation	O
of	O
cAMP	O
including	O
the	O
phosphorylation	O
of	O
the	O
transcription	O
factor,	O
cAMP	protein
response	protein
element	protein
binding	protein
protein	protein
and	O
transcriptional	O
activation	O
of	O
cAMP-dependent	DNA
reporter	DNA
genes	DNA
.	O
In	O
summary,	O
these	O
studies	O
show	O
that	O
the	O
amount	O
of	O
G(S)alpha	protein
expression	O
has	O
a	O
marked	O
impact	O
on	O
the	O
level	O
of	O
activity	O
of	O
the	O
AC	O
cascade	O
from	O
the	O
membrane	O
through	O
to	O
the	O
nucleus	O
.	O
It	O
is	O
hypothesized	O
that	O
individuals	O
who	O
differ	O
in	O
G(S)alpha	protein
expression	O
may	O
also	O
differ	O
in	O
the	O
expression	O
of	O
certain	O
cAMP	DNA
-dependent	DNA
genes	DNA
.	O

Thrombin	protein
generation	O
by	O
apoptotic	cell_type
vascular	cell_type
smooth	cell_type
muscle	cell_type
cells	cell_type
.	O
Thrombin	protein
activation	O
requires	O
assembly	O
of	O
a	O
prothrombinase	protein
complex	protein
of	O
activated	O
coagulation	protein
factors	protein
on	O
an	O
anionic	O
phospholipid	O
surface	O
,	O
classically	O
provided	O
by	O
activated	cell_type
platelets	cell_type
.	O
We	O
have	O
previously	O
shown	O
that	O
anionic	O
phosphatidylserine	O
is	O
exposed	O
by	O
rat	cell_type
vascular	cell_type
smooth	cell_type
muscle	cell_type
cells	cell_type
(	O
VSMCs	cell_type
)	O
undergoing	O
apoptosis	O
after	O
serum	O
withdrawal	O
.	O
In	O
this	O
study,	O
using	O
a	O
chromogenic	O
assay	O
,	O
we	O
have	O
shown	O
thrombin	protein
generation	O
by	O
apoptotic	cell_type
VSMCs	cell_type
expressing	O
c-myc	protein
(	O
VSMC-myc	cell_line
)	O
with	O
an	O
area	O
under	O
the	O
thrombin	protein
-generation	O
curve	O
(AUC)	O
of	O
305	O
+/-	O
17	O
nmol	O
x	O
min/L	O
and	O
a	O
peak	O
thrombin	protein
(PT)	O
of	O
154	O
+/-	O
9	O
nmol/L.	O
The	O
thrombin	protein
-generating	O
potential	O
of	O
the	O
apoptotic	cell_line
VSMC-myc	cell_line
cells	cell_line
was	O
greater	O
than	O
that	O
of	O
unactivated	cell_type
platelets	cell_type
(P	O
=	O
.003	O
for	O
AUC;	O
P	O
=	O
.0002	O
for	O
PT)	O
and	O
similar	O
to	O
calcium-ionophore	O
activated	cell_type
platelets	cell_type
(AUC	O
of	O
332	O
+/-	O
15	O
nmol	O
x	O
min/L,	O
P	O
=	O
.3;	O
PT	O
of	O
172	O
+/-	O
8	O
nmol/L,	O
P	O
=	O
.2).	O
Thrombin	protein
activation	O
was	O
also	O
seen	O
with	O
apoptotic	cell_type
human	cell_type
VSMCs	cell_type
(AUC	O
of	O
211	O
+/-	O
8	O
nmol	O
x	O
min/L;	O
PT	O
of	O
103	O
+/-	O
4	O
nmol/L)	O
and	O
was	O
inhibited	O
by	O
annexin	O
V	O
(P	O
&lt;	O
.0001	O
for	O
AUC	O
and	O
PT).	O
VSMC-myc	cell_line
cells	cell_line
maintained	O
in	O
serum	O
generated	O
less	O
thrombin	protein
than	O
after	O
serum	O
withdrawal	O
(P	O
=	O
.0002	O
for	O
AUC	O
and	O
PT).	O
VSMCs	cell_type
derived	O
from	O
human	O
coronary	O
atherosclerotic	O
plaques	O
that	O
apoptose	O
even	O
in	O
serum	O
also	O
generated	O
thrombin	protein
(AUC	O
of	O
260	O
+/-	O
2	O
nmol	O
x	O
min/L;	O
PT	O
of	O
128	O
+/-	O
4	O
nmol/L).	O
We	O
conclude	O
that	O
apoptotic	cell_type
VSMCs	cell_type
possess	O
a	O
significant	O
thrombin	protein
-generating	O
capacity	O
secondary	O
to	O
phosphatidylserine	O
exposure	O
.	O
Apoptotic	O
cells	O
within	O
atherosclerotic	O
plaques	O
may	O
allow	O
local	O
thrombin	protein
activation	O
,	O
thereby	O
contributing	O
to	O
disease	O
progression	O
.	O

An	O
isotype-specific	O
activator	O
of	O
major	DNA
histocompatibility	DNA
complex	DNA
(MHC)	DNA
class	DNA
II	DNA
genes	DNA
that	O
is	O
independent	O
of	O
class	protein
II	protein
transactivator	protein
.	O
Patients	O
with	O
one	O
type	O
of	O
major	protein
histocompatibility	protein
complex	protein
class	protein
II	protein
combined	O
immunodeficiency	O
have	O
mutations	O
in	O
a	O
gene	O
termed	O
class	protein
II	protein
transactivator	protein
(	O
CIITA	protein
),	O
which	O
coordinately	O
controls	O
the	O
transcription	O
of	O
the	O
three	O
major	O
human	DNA
class	DNA
II	DNA
genes	DNA
,	O
HLA	O
-DR	O
,	O
-DQ	O
,	O
and	O
-DP	O
.	O
However,	O
the	O
experimentally	O
derived	O
B-lymphoblastoid	cell_line
cell	cell_line
line	cell_line
,	O
clone	cell_line
13	cell_line
,	O
expresses	O
high	O
levels	O
of	O
HLADQ	protein
in	O
the	O
absence	O
of	O
HLA-DR	DNA
and	O
HLA-DP	DNA
,	O
despite	O
its	O
mapping	O
by	O
complementation	O
analysis	O
to	O
this	O
group.	O
It	O
was	O
possible	O
that	O
one	O
of	O
the	O
clone	DNA
13	DNA
CIITA	DNA
alleles	DNA
bore	O
a	O
mutation	O
that	O
allowed	O
HLA-DQ	DNA
,	O
but	O
not	O
HLA	O
-DR	O
or	O
-DP	O
transcription	O
.	O
Alternatively,	O
another	O
factor,	O
distinct	O
from	O
CIITA	protein
,	O
might	O
control	O
HLA-DQ	DNA
expression	O
.	O
We	O
report	O
here	O
that	O
ectopic	O
expression	O
of	O
CIITA	DNA
cDNAs	DNA
derived	O
by	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
from	O
clone	cell_line
13	cell_line
do	O
not	O
restore	O
expression	O
of	O
HLA-DQ	DNA
in	O
another	O
CIITA	cell_line
-deficient	cell_line
cell	cell_line
line	cell_line
,	O
RJ2.2.5	cell_line
.	O
In	O
addition,	O
no	O
CIITA	protein
protein	O
is	O
detectable	O
in	O
clone	cell_line
13	cell_line
nuclear	O
extracts	O
.	O
In	O
contrast,	O
somatic	O
cell	O
fusion	O
between	O
clone	cell_line
13	cell_line
and	O
RJ2.2.5	cell_line
restored	O
expression	O
of	O
the	O
HLA-DQ	DNA
haplotype	O
encoded	O
by	O
the	O
RJ2.2.5	DNA
DQB	DNA
gene	DNA
.	O
Taken	O
together,	O
these	O
data	O
demonstrate	O
the	O
existence	O
of	O
an	O
HLA-DQ	protein
isotype-specific	protein
trans-acting	protein
factor	protein
,	O
which	O
functions	O
independently	O
of	O
CIITA	protein
.	O

Homodimerization	O
of	O
the	O
human	protein
interleukin	protein
4	protein
receptor	protein
alpha	protein
chain	protein
induces	O
Cepsilon	RNA
germline	RNA
transcripts	RNA
in	O
B	cell_type
cells	cell_type
in	O
the	O
absence	O
of	O
the	O
interleukin	protein
2	protein
receptor	protein
gamma	protein
chain	protein
.	O
The	O
cytokines	protein
interleukin	protein
(IL)-4	protein
and	O
IL-13	protein
play	O
a	O
critical	O
role	O
in	O
inducing	O
Cepsilon	RNA
germline	RNA
transcripts	RNA
and	O
IgE	protein
isotype	protein
switching	O
in	O
human	cell_type
B	cell_type
cells	cell_type
.	O
The	O
IL-4	protein
receptor	protein
(	O
IL-4R	protein
)	O
in	O
B	cell_type
cells	cell_type
is	O
composed	O
of	O
two	O
chains,	O
the	O
IL-4-binding	protein
IL-4Ralpha	protein
chain	protein
,	O
which	O
is	O
shared	O
with	O
the	O
IL-13R	protein
,	O
and	O
the	O
IL-2Rgamma	protein
(gammac)	protein
chain	protein
,	O
which	O
is	O
shared	O
with	O
IL-7R	protein
,	O
IL-9R	protein
,	O
and	O
IL-15R	protein
.	O
IL-4	protein
induces	O
Cepsilon	RNA
germline	RNA
transcripts	RNA
and	O
IgE	protein
isotype	protein
switching	O
in	O
B	cell_type
cells	cell_type
from	O
patients	O
with	O
gammac	protein
chain	protein
deficiency	O
.	O
Induction	O
of	O
Cepsilon	RNA
germline	RNA
transcripts	RNA
by	O
IL-4	protein
in	O
B	cell_type
cells	cell_type
that	O
lack	O
the	O
gammac	protein
chain	protein
may	O
involve	O
signaling	O
via	O
the	O
IL-13R	protein
.	O
Alternatively,	O
the	O
IL-4Ralpha	protein
chain	protein
may	O
transduce	O
intracellular	O
signals	O
that	O
lead	O
to	O
Cepsilon	DNA
gene	DNA
transcription	O
independently	O
of	O
its	O
association	O
with	O
other	O
chains.	O
We	O
show	O
that	O
ligand-induced	O
homodimerization	O
of	O
chimeric	protein
surface	protein
receptors	protein
consisting	O
of	O
the	O
extracellular	O
and	O
transmembrane	O
domains	O
of	O
the	O
erythropoietin	protein
receptor	protein
and	O
of	O
the	O
intracellular	protein
domain	protein
of	O
IL-4Ralpha	protein
induces	O
Janus	protein
kinase	protein
1	protein
(	O
Jak1	protein
)	O
activation	O
,	O
STAT6	protein
activation	O
,	O
and	O
Cepsilon	RNA
germline	RNA
transcripts	RNA
in	O
human	cell_line
B	cell_line
cell	cell_line
line	cell_line
BJAB	cell_line
.	O
Disruption	O
of	O
the	O
Jak1	protein
-binding	protein
proline-rich	protein
Box1	protein
region	protein
of	O
IL-4Ralpha	protein
abolished	O
signaling	O
by	O
this	O
chimeric	protein
receptor	protein
.	O
Furthermore,	O
B	cell_type
cells	cell_type
transfected	O
with	O
a	O
chimeric	protein
CD8alpha/IL-4Ralpha	protein
receptor	protein
,	O
which	O
is	O
expressed	O
on	O
the	O
cell	O
surface	O
as	O
a	O
homodimer	protein
,	O
constitutively	O
expressed	O
Cepsilon	RNA
germline	RNA
transcripts	RNA
.	O
These	O
results	O
suggest	O
that	O
homodimerization	O
of	O
the	O
IL-4Ralpha	protein
chain	protein
is	O
sufficient	O
to	O
transduce	O
Jak1	protein
-dependent	O
intracellular	O
signals	O
that	O
lead	O
to	O
IgE	protein
isotype	protein
switching	O
.	O

Transcriptional	O
activity	O
and	O
constitutive	O
nuclear	O
localization	O
of	O
the	O
ETS	protein
protein	protein
Elf-1	protein
.	O
Elf-1	protein
is	O
a	O
lymphoid-specific	protein
transcription	protein
factor	protein
that	O
belongs	O
to	O
the	O
ETS	protein
protein	protein
family	protein
.	O
It	O
can	O
bind	O
to	O
DNA	O
target	O
sequences	O
within	O
a	O
variety	O
of	O
cytokine	DNA
genes	DNA
.	O
We	O
demonstrate	O
that	O
Elf-1	protein
is	O
constitutively	O
localized	O
in	O
the	O
nucleus	O
which	O
is	O
dependent	O
on	O
the	O
presence	O
of	O
amino	protein
acids	protein
86-265	protein
.	O
Analysis	O
of	O
Gal4-Elf-1	protein
fusion	protein
proteins	protein
revealed	O
that	O
the	O
N-terminal	O
86	O
amino	O
acids	O
of	O
Elf-1	protein
contain	O
a	O
transcriptional	protein
activation	protein
domain	protein
,	O
the	O
activity	O
of	O
which	O
is	O
attenuated	O
by	O
an	O
internal	protein
repression	protein
domain	protein
.	O
Furthermore,	O
Elf-1	protein
interacts	O
specifically	O
with	O
the	O
E74	DNA
target	DNA
sequence	DNA
and	O
can	O
stimulate	O
transcription	O
driven	O
by	O
the	O
E74	DNA
site	DNA
independent	O
of	O
mitogenic	O
signaling	O
.	O
Thus,	O
Elf-1	protein
is	O
able	O
to	O
stimulate	O
gene	O
transcription	O
which	O
may	O
be	O
required	O
for	O
the	O
development	O
and	O
activity	O
of	O
lymphocytes	cell_type
.	O

Characterization	O
of	O
peripheral	cell_type
blood	cell_type
T-lymphocytes	cell_type
transduced	O
with	O
HTLV-I	protein
Tax	protein
mutants	protein
with	O
different	O
trans-activating	O
phenotypes	O
.	O
Tax1	protein
,	O
a	O
transcriptional	protein
trans-activator	protein
of	O
the	O
Human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
),	O
induces	O
the	O
expression	O
of	O
many	O
cellular	O
genes	O
through	O
interaction	O
with	O
at	O
least	O
three	O
distinct	O
cellular	protein
transcription	protein
factors	protein
;	O
CREB/ATF	protein
,	O
NF-kappaB	protein
,	O
and	O
SRF	protein
.	O
This	O
Tax1	protein
-induced	O
activation	O
of	O
cellular	DNA
genes	DNA
is	O
considered	O
to	O
be	O
a	O
critical	O
event	O
in	O
T-cell	O
transformation	O
by	O
HTLV-I	O
.	O
To	O
elucidate	O
the	O
role	O
of	O
each	O
Tax1	protein
-inducible	O
transcriptional	O
pathway	O
in	O
T-cell	O
transformation	O
,	O
we	O
introduced	O
Tax1	protein
mutants	protein
with	O
different	O
trans-activating	O
phenotypes	O
into	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
(	O
PBL	cell_type
)	O
by	O
retroviral	O
vectors.	O
Analysis	O
of	O
these	O
PBLs	cell_type
revealed	O
that	O
activation	O
of	O
the	O
NF-kappaB	protein
pathway	O
is	O
sufficient	O
to	O
promote	O
the	O
growth	O
response	O
to	O
IL-2	protein
.	O
However,	O
for	O
the	O
clonal	O
expansion	O
of	O
CD4+	cell_type
T-cells	cell_type
,	O
which	O
is	O
a	O
characteristic	O
result	O
of	O
HTLV-I	O
infection	O
,	O
activation	O
of	O
the	O
CREB/ATF	O
and	O
SRF	O
pathways	O
is	O
also	O
required.	O

Epstein-Barr	O
virus	O
binding	O
to	O
CD21	protein
activates	O
the	O
initial	O
viral	DNA
promoter	DNA
via	O
NF-kappaB	protein
induction	O
.	O
Epstein-Barr	O
virus	O
(	O
EBV	O
),	O
an	O
oncogenic	O
human	O
herpesvirus	O
,	O
binds	O
to	O
and	O
infects	O
normal	cell_type
human	cell_type
B	cell_type
lymphocytes	cell_type
via	O
CD21	protein
,	O
the	O
CR2	protein
complement	protein
receptor	protein
.	O
Studies	O
of	O
the	O
mechanisms	O
that	O
enable	O
EBV	O
to	O
infect	O
nonactivated,	O
noncycling	cell_type
B	cell_type
cells	cell_type
provide	O
compelling	O
evidence	O
for	O
a	O
sequence	O
of	O
events	O
in	O
which	O
EBV	O
binding	O
to	O
CD21	protein
on	O
purified	O
resting	cell_type
human	cell_type
B	cell_type
cells	cell_type
rapidly	O
activates	O
the	O
NF-kappaB	protein
transcription	protein
factor	protein
,	O
which,	O
in	O
turn,	O
binds	O
to	O
and	O
mediates	O
transcriptional	O
activation	O
of	O
Wp,	O
the	O
initial	O
viral	DNA
latent	DNA
gene	DNA
promoter	DNA
.	O
Thus,	O
EBV	O
binding	O
to	O
its	O
cellular	O
receptor	O
on	O
resting	O
B	O
cells	O
triggers	O
an	O
NF-kappaB	protein
-dependent	O
intracellular	O
signaling	O
pathway	O
which	O
is	O
required	O
for	O
infection.	O

Synthetic	O
glucocorticoids	O
that	O
dissociate	O
transactivation	O
and	O
AP-1	protein
transrepression	O
exhibit	O
antiinflammatory	O
activity	O
in	O
vivo.	O
Some	O
of	O
the	O
most	O
potent	O
antiinflammatory	O
and	O
immunosuppressive	O
agents	O
are	O
synthetic	O
glucocorticoids	O
.	O
However,	O
major	O
side	O
effects	O
severely	O
limit	O
their	O
therapeutic	O
use.	O
The	O
development	O
of	O
improved	O
glucocorticoid-based	O
drugs	O
will	O
require	O
the	O
separation	O
of	O
beneficial	O
from	O
deleterious	O
effects.	O
One	O
possibility	O
toward	O
this	O
goal	O
is	O
to	O
try	O
to	O
dissociate	O
two	O
main	O
activities	O
of	O
glucocorticoids	O
,	O
i.e.	O
transactivation	O
and	O
transrepression.	O
Screening	O
of	O
a	O
library	O
of	O
compounds	O
using	O
transactivation	O
and	O
AP-1	protein
transrepression	O
models	O
in	O
transiently	O
transfected	O
cells	O
identified	O
dissociated	O
glucocorticoids	O
,	O
which	O
exert	O
strong	O
AP-1	protein
inhibition	O
but	O
little	O
or	O
no	O
transactivation	O
.	O
Importantly,	O
despite	O
high	O
ligand	O
binding	O
affinity	O
,	O
the	O
prototypic	O
dissociated	O
compound,	O
RU24858	O
,	O
acted	O
as	O
a	O
weak	O
agonist	O
and	O
did	O
not	O
efficiently	O
antagonize	O
dexamethasone-induced	O
transcription	O
in	O
transfected	cell_type
cells	cell_type
.	O
Similar	O
results	O
were	O
obtained	O
in	O
hepatic	cell_line
HTC	cell_line
cells	cell_line
for	O
the	O
transactivation	O
of	O
the	O
endogenous	DNA
tyrosine	DNA
amino	DNA
transferase	DNA
gene	DNA
(	O
TAT	DNA
),	O
which	O
encodes	O
one	O
of	O
the	O
enzymes	O
involved	O
in	O
the	O
glucocorticoid-dependent	O
stimulation	O
of	O
neoglucogenesis	O
.	O
To	O
investigate	O
whether	O
dissociated	O
glucocorticoids	O
retained	O
the	O
antiinflammatory	O
and	O
immunosuppressive	O
potential	O
of	O
classic	O
glucocorticoids	O
,	O
several	O
in	O
vitro	O
and	O
in	O
vivo	O
models	O
were	O
used.	O
Indeed,	O
secretion	O
of	O
the	O
proinflammatory	protein
lymphokine	protein
interleukin-1beta	protein
was	O
severely	O
inhibited	O
by	O
dissociated	O
glucocorticoids	O
in	O
human	cell_line
monocytic	cell_line
THP	cell_line
1	cell_line
cells	cell_line
.	O
Moreover,	O
in	O
two	O
in	O
vivo	O
models,	O
these	O
compounds	O
exerted	O
an	O
antiinflammatory	O
and	O
immunosuppressive	O
activity	O
as	O
potent	O
as	O
that	O
of	O
the	O
classic	O
glucocorticoid	O
prednisolone	O
.	O
These	O
results	O
may	O
lead	O
to	O
an	O
improvement	O
of	O
antiinflammatory	O
and	O
immunosuppressive	O
therapies	O
and	O
provide	O
a	O
novel	O
concept	O
for	O
drug	O
discovery	O
.	O

In	O
vivo	O
footprinting	O
and	O
mutational	O
analysis	O
of	O
the	O
proximal	DNA
CD19	DNA
promoter	DNA
reveal	O
important	O
roles	O
for	O
an	O
SP1/Egr-1	DNA
binding	DNA
site	DNA
and	O
a	O
novel	O
site	O
termed	O
the	O
PyG	DNA
box	DNA
.	O
CD19	protein
expression	O
begins	O
at	O
the	O
pro-B	O
cell	O
stage	O
of	O
B	O
cell	O
development	O
.	O
As	O
such	O
it	O
serves	O
as	O
a	O
good	O
prototype	O
for	O
B	DNA
cell-specific	DNA
genes	DNA
whose	O
expression	O
begins	O
shortly	O
after	O
lineage	O
commitment	O
.	O
To	O
understand	O
the	O
molecular	O
mechanisms	O
controlling	O
CD19	protein
gene	O
expression	O
,	O
we	O
isolated	O
and	O
functionally	O
characterized	O
the	O
CD19	DNA
promoter	DNA
using	O
in	O
vivo	O
footprinting	O
,	O
gel	O
shift	O
assays	O
,	O
and	O
transfection	O
studies	O
.	O
Reporter	O
constructs	O
spanning	O
portions	O
of	O
the	O
promoter	O
identified	O
a	O
region	DNA
between	DNA
-85	DNA
and	DNA
-200	DNA
that	O
produced	O
high	O
levels	O
of	O
reporter	O
gene	O
activity	O
in	O
lymphoid	cell_type
cells	cell_type
.	O
In	O
vivo	O
footprinting	O
identified	O
protected	O
regions	O
over	O
the	O
known	O
high	O
affinity	O
B	DNA
cell	DNA
lineage-specific	DNA
activator	DNA
protein	DNA
(BSAP)	DNA
site	DNA
,	O
the	O
low	DNA
affinity	DNA
BSAP	DNA
site	DNA
,	O
a	O
SP1/Egr-1	DNA
site	DNA
termed	O
the	O
CD19	DNA
GC	DNA
box	DNA
,	O
and	O
two	O
novel	O
sites	O
named	O
the	O
AT	DNA
box	DNA
and	O
PyG	DNA
box	DNA
.	O
Phorbol	O
ester	O
treatment	O
of	O
a	O
pre-B	cell_line
cell	cell_line
line	cell_line
up-regulated	O
CD19	protein
expression	O
,	O
induced	O
Egr-1	protein
,	O
and	O
enhanced	O
the	O
footprint	O
over	O
the	O
GC	O
box.	O
Gel	O
shift	O
assays	O
demonstrated	O
SP1	O
and	O
Egr-1	protein
binding	O
to	O
the	O
CD19	DNA
GC	DNA
box	DNA
,	O
while	O
unknown	O
nuclear	O
proteins	O
bound	O
the	O
PyG	O
and	O
AT	O
boxes	O
.	O
Mutations	O
in	O
the	O
AT	DNA
box	DNA
or	O
in	O
the	O
BSAP	DNA
sites	DNA
did	O
not	O
affect	O
CD19	protein
reporter	DNA
construct	DNA
activity	O
,	O
while	O
a	O
mutation	O
of	O
the	O
GC	DNA
box	DNA
reduced	O
it	O
modestly,	O
and	O
a	O
PyG	DNA
box	DNA
mutation	O
reduced	O
it	O
dramatically.	O
BSAP	protein
failed	O
to	O
trans-activate	O
CD19	DNA
promoter	DNA
constructs	DNA
in	O
B	cell_type
cells	cell_type
or	O
non-B	cell_type
cells	cell_type
,	O
suggesting	O
that	O
cis	O
elements	O
such	O
as	O
the	O
PyG	O
and	O
GC	O
boxes	O
are	O
also	O
necessary	O
for	O
high	O
level	O
CD19	DNA
promoter	DNA
expression	O
.	O

EBF	protein
and	O
E47	protein
collaborate	O
to	O
induce	O
expression	O
of	O
the	O
endogenous	DNA
immunoglobulin	DNA
surrogate	DNA
light	DNA
chain	DNA
genes	DNA
.	O
Early	protein
B	protein
cell	protein
factor	protein
(	O
EBF	protein
)	O
and	O
E47	protein
participate	O
in	O
the	O
transcriptional	O
control	O
of	O
early	O
B	O
lymphocyte	O
differentiation	O
.	O
With	O
the	O
aim	O
of	O
identifying	O
genetic	O
targets	O
for	O
these	O
transcription	O
factors,	O
we	O
stably	O
transfected	DNA
cDNAs	DNA
encoding	O
EBF	protein
or	O
a	O
covalent	O
homodimer	O
of	O
E47	protein
,	O
individually	O
or	O
together,	O
into	O
immature	cell_line
hematopoietic	cell_line
Ba/F3	cell_line
cells	cell_line
,	O
which	O
lack	O
both	O
factors.	O
In	O
combination,	O
EBF	protein
and	O
E47	protein
induce	O
efficient	O
expression	O
of	O
the	O
endogenous	DNA
immunoglobulin	DNA
surrogate	DNA
light	DNA
chain	DNA
genes	DNA
,	O
lambda5	DNA
and	O
VpreB	DNA
,	O
whereas	O
other	O
pre-B	DNA
cell-specific	DNA
genes	DNA
remain	O
silent.	O
Multiple	O
functionally	O
important	O
EBF	O
and	O
E47	O
binding	O
sites	O
were	O
identified	O
in	O
the	O
lambda5	DNA
promoter/enhancer	DNA
region	DNA
,	O
indicating	O
that	O
lambda5	DNA
is	O
a	O
direct	O
genetic	O
target	O
for	O
these	O
transcription	protein
factors	protein
.	O
Taken	O
together,	O
these	O
data	O
suggest	O
that	O
EBF	protein
and	O
E47	protein
synergize	O
to	O
activate	O
expression	O
of	O
a	O
subset	O
of	O
genes	O
that	O
define	O
an	O
early	O
stage	O
of	O
the	O
B	cell_type
cell	cell_type
lineage	cell_type
.	O

Cytokines	protein
:	O
shared	O
receptors	protein
,	O
distinct	O
functions	O
.	O
That	O
the	O
signal	O
transduction	O
pathways	O
used	O
by	O
the	O
cytokines	protein
IL-2	protein
and	O
IL-15	protein
are	O
identical	O
would	O
suggest	O
that	O
these	O
cytokines	protein
have	O
redundant	O
roles	O
in	O
lymphoid	O
development	O
;	O
instead,	O
IL-2	protein
is	O
the	O
guardian	O
of	O
thymus-derived	O
T-cell	O
homeostasis	O
,	O
while	O
interleukin-15	protein
promotes	O
extrathymic	O
development	O
of	O
T	O
and	O
NK	O
cells	O
.	O

The	O
IL-4	protein
receptor	protein
alpha-chain	protein
cytoplasmic	protein
domain	protein
is	O
sufficient	O
for	O
activation	O
of	O
JAK-1	protein
and	O
STAT6	protein
and	O
the	O
induction	O
of	O
IL-4	protein
-specific	O
gene	O
expression	O
.	O
The	O
common	protein
gamma-chain	protein
(	O
gamma(c)	protein
)	O
is	O
a	O
functional	O
component	O
of	O
the	O
IL-4R	protein
,	O
yet	O
cells	O
lacking	O
gamma(c)	protein
are	O
able	O
to	O
respond	O
to	O
IL-4	protein
.	O
This	O
has	O
led	O
to	O
the	O
suggestion	O
that	O
a	O
surrogate	protein
gamma'-chain	protein
,	O
which	O
can	O
interact	O
with	O
the	O
IL-4R	protein
alpha	protein
chain	protein
to	O
mediate	O
signaling,	O
is	O
expressed	O
on	O
cells	O
lacking	O
gamma(c)	protein
.	O
An	O
alternative	O
possibility	O
is	O
that	O
in	O
the	O
absence	O
of	O
gamma(c)	protein
,	O
the	O
IL-4R	protein
alpha	protein
chain	protein
is	O
able	O
to	O
transduce	O
signals	O
by	O
homodimerization	O
.	O
To	O
test	O
this	O
latter	O
possibility,	O
a	O
chimeric	protein
receptor	protein
containing	O
the	O
extracellular	protein
domain	protein
of	O
c-kit	protein
(the	O
stem	protein
cell	protein
factor	protein
(SCF)	protein
receptor	protein
)	O
and	O
the	O
cytoplasmic	O
and	O
transmembrane	O
domains	O
of	O
the	O
IL-4R	protein
alpha	protein
chain	protein
was	O
generated.	O
Treatment	O
of	O
cells	O
expressing	O
the	O
chimeric	protein
receptor	protein
kit/IL-4R	protein
alpha	protein
with	O
SCF	protein
induces	O
activation	O
of	O
the	O
IL-4R	protein
alpha-associated	protein
kinase	protein
JAK-1	protein
and	O
the	O
transcription	protein
factor	protein
STAT6	protein
.	O
However,	O
tyrosine	O
phosphorylation	O
of	O
JAK-3	protein
,	O
which	O
associates	O
with	O
gamma(c)	protein
,	O
is	O
not	O
induced	O
by	O
SCF	protein
in	O
these	O
cells.	O
SCF	protein
-mediated	O
ligation	O
of	O
kit/IL-4R	protein
alpha	protein
is	O
sufficient	O
to	O
elicit	O
IL-4	protein
-specific	O
gene	O
expression	O
,	O
including	O
up-regulation	O
of	O
CD23	protein
and	O
synthesis	O
of	O
germ-line	RNA
epsilon	RNA
transcripts	RNA
.	O
In	O
the	O
T	cell_line
cell	cell_line
line	cell_line
CTLL2	cell_line
,	O
ligation	O
of	O
kit/IL-4R	protein
alpha	protein
induces	O
cellular	O
proliferation	O
.	O
Finally,	O
in	O
JAK-1	cell_line
-deficient	cell_line
HeLa	cell_line
cells	cell_line
,	O
STAT6	protein
activation	O
by	O
IL-4	protein
is	O
completely	O
abolished.	O
Together,	O
these	O
data	O
demonstrate	O
that	O
the	O
IL-4R	protein
alpha	protein
cytoplasmic	protein
domain	protein
is	O
sufficient	O
to	O
activate	O
JAK-1	protein
and	O
STAT6	protein
and	O
to	O
induce	O
expression	O
of	O
IL-4	DNA
target	DNA
genes	DNA
,	O
thus	O
identifying	O
a	O
mechanism	O
by	O
which	O
IL-4	protein
signaling	O
can	O
proceed	O
in	O
the	O
absence	O
of	O
JAK-3	protein
and	O
gamma(c)	protein
.	O

Histamine	O
modulates	O
the	O
expression	O
of	O
c-fos	DNA
through	O
cyclic	O
AMP	O
production	O
via	O
the	O
H2	protein
receptor	protein
in	O
the	O
human	cell_line
promonocytic	cell_line
cell	cell_line
line	cell_line
U937	cell_line
.	O
We	O
examined	O
the	O
effects	O
of	O
histamine	O
and	O
its	O
agonists	O
on	O
the	O
expression	O
of	O
the	O
c-fos	O
and	O
c-myc	O
proto-oncogenes	O
at	O
the	O
transcriptional	O
and	O
translational	O
levels	O
in	O
the	O
human	cell_line
promonocytic	cell_line
U937	cell_line
cell	cell_line
line	cell_line
.	O
Histamine	O
transiently	O
increased	O
cAMP	O
and	O
c-fos	DNA
expression	O
through	O
H2	protein
receptors	protein
.	O
Dibutyryl	O
cAMP	O
also	O
increased	O
c-fos	RNA
mRNA	RNA
and	O
protein	protein
,	O
and	O
levels	O
remained	O
elevated	O
even	O
after	O
12	O
hr	O
of	O
treatment.	O
Dose-dependence	O
studies	O
using	O
histamine	O
and	O
dimaprit	O
showed	O
that	O
the	O
EC50	O
values	O
for	O
cAMP	O
production	O
and	O
c-fos	DNA
increase	O
were	O
similar,	O
suggesting	O
that	O
cAMP	O
might	O
be	O
involved	O
in	O
c-fos	DNA
induction	O
via	O
H2	protein
receptors	protein
.	O
Furthermore,	O
studies	O
carried	O
out	O
using	O
H7	protein
,	O
a	O
protein	protein
kinase	protein
A	protein
/protein	protein
kinase	protein
C	protein
inhibitor	protein
,	O
blocked	O
c-fos	DNA
induction,	O
whereas	O
no	O
effect	O
was	O
observed	O
with	O
bisindolylmaleimide	O
,	O
a	O
specific	O
protein	protein
kinase	protein
C	protein
inhibitor	O
.	O
No	O
modification	O
of	O
c-myc	DNA
expression	O
could	O
be	O
detected	O
on	O
treatment	O
with	O
histamine	O
or	O
its	O
analogues.	O
Nevertheless,	O
dibutyryl	O
cAMP	O
induced	O
a	O
down-regulation	O
of	O
the	O
levels	O
of	O
this	O
proto-oncogene	DNA
.	O
In	O
addition,	O
dibutyryl	O
cAMP	O
inhibited	O
cell	O
growth	O
in	O
a	O
dose-dependent	O
manner,	O
whereas	O
histamine	O
failed	O
to	O
affect	O
proliferation	O
and	O
differentiation	O
of	O
U937	cell_line
cells	cell_line
.	O
Cells	O
pretreated	O
with	O
dimaprit	O
showed	O
a	O
decrease	O
in	O
the	O
cAMP	O
response	O
to	O
subsequent	O
addition	O
of	O
H2	O
agonists	O
,	O
whereas	O
the	O
cAMP	O
response	O
to	O
prostaglandin	O
E2	O
remained	O
unaltered.	O
This	O
homologous	O
mechanism	O
of	O
H2	protein
receptor	protein
desensitization	O
was	O
time	O
dependent.	O
These	O
results	O
indicate	O
that	O
histamine	O
activates	O
several	O
mechanisms	O
involved	O
in	O
the	O
induction	O
of	O
differentiation,	O
such	O
as	O
cAMP	O
and	O
c-fos	DNA
production	O
,	O
but	O
fails	O
to	O
promote	O
differentiation	O
of	O
U937	cell_line
cells	cell_line
,	O
apparently	O
due	O
to	O
the	O
rapid	O
desensitization	O
of	O
H2	protein
receptors	protein
.	O

Induction	O
of	O
cytokine	protein
expression	O
in	O
leukocytes	cell_type
by	O
binding	O
of	O
thrombin-stimulated	cell_type
platelets	cell_type
.	O
BACKGROUND:	O
Activated	cell_type
platelets	cell_type
tether	O
and	O
activate	O
myeloid	cell_type
leukocytes	cell_type
.	O
To	O
investigate	O
the	O
potential	O
relevance	O
of	O
this	O
mechanism	O
in	O
acute	O
myocardial	O
infarction	O
(	O
AMI	O
),	O
we	O
examined	O
cytokine	protein
induction	O
by	O
leukocyte-platelet	O
adhesion	O
and	O
the	O
occurrence	O
of	O
leukocyte-platelet	O
conjugates	O
in	O
patients	O
with	O
AMI	O
.	O
METHODS	O
AND	O
RESULTS:	O
We	O
obtained	O
peripheral	O
venous	O
blood	O
samples	O
in	O
20	O
patients	O
with	O
AMI	O
before	O
and	O
daily	O
for	O
5	O
days	O
after	O
direct	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
(	O
PTCA	O
)	O
and	O
in	O
20	O
patients	O
undergoing	O
elective	O
PTCA	O
.	O
Throughout	O
the	O
study	O
period,	O
CD41	O
immunofluorescence	O
of	O
leukocytes	cell_type
(	O
flow	O
cytometry	O
)	O
revealed	O
increased	O
leukocyte-platelet	O
adhesion	O
in	O
patients	O
with	O
AMI	O
compared	O
with	O
control	O
patients	O
(mean	O
+/-	O
SE	O
of	O
fluorescence	O
[channels]	O
before	O
PTCA	O
:	O
77	O
+/-	O
16	O
versus	O
35	O
+/-	O
9;	O
P	O
=	O
.003).	O
In	O
vitro,	O
thrombin-stimulated	cell_type
fixed	cell_type
platelets	cell_type
bound	O
to	O
neutrophils	cell_type
and	O
monocytes	cell_type
.	O
Within	O
2	O
hours,	O
this	O
resulted	O
in	O
increased	O
mRNA	O
for	O
interleukin	protein
(IL),1	protein
beta	protein
,	O
IL-8	protein
,	O
and	O
monocyte	protein
chemoattractant	protein
protein	protein
(MCP)-1	protein
in	O
unfractionated	O
leukocytes	cell_type
.	O
After	O
4	O
hours,	O
IL-1	protein
beta	protein
and	O
IL-8	protein
concentration	O
of	O
the	O
cell-free	O
supernatant	O
had	O
increased	O
by	O
268	O
+/-	O
36%	O
and	O
210	O
+/-	O
7%,	O
respectively,	O
and	O
cellular	O
MCP-1	protein
content	O
had	O
increased	O
by	O
170	O
+/-	O
8%.	O
Addition	O
of	O
activated	cell_type
platelets	cell_type
to	O
adherent	O
monocytes	cell_type
had	O
a	O
similar	O
effect	O
and	O
was	O
associated	O
with	O
nuclear	protein
factor-kappa	protein
B	protein
activation	O
.	O
Inhibition	O
of	O
binding	O
by	O
anti-P	protein
selectin	protein
antibodies	protein
reduced	O
the	O
effect	O
of	O
activated	cell_type
platelets	cell_type
on	O
cytokine	protein
production	O
.	O
CONCLUSIONS:	O
In	O
patients	O
with	O
AMI	O
,	O
leukocyte-platelet	O
adhesion	O
is	O
increased.	O
Binding	O
of	O
activated	cell_type
platelets	cell_type
induces	O
IL-1	protein
beta	protein
,	O
IL-8	protein
,	O
and	O
MCP-1	protein
in	O
leukocytes	cell_type
.	O
Our	O
findings	O
suggest	O
that	O
leukocyte-platelet	O
adhesion	O
contributes	O
to	O
the	O
regulation	O
of	O
inflammatory	O
responses	O
in	O
AMI	O
.	O

Immediate	O
early	O
and	O
early	protein
lytic	protein
cycle	protein
proteins	protein
are	O
frequent	O
targets	O
of	O
the	O
Epstein-Barr	O
virus	O
-induced	O
cytotoxic	O
T	O
cell	O
response	O
.	O
Epstein-Barr	O
virus	O
(	O
EBV	O
),	O
a	O
human	O
gamma-herpesvirus	O
,	O
can	O
establish	O
both	O
nonproductive	O
(latent)	O
and	O
productive	O
(lytic)	O
infections	O
.	O
Although	O
the	O
CD8+	O
cytotoxic	O
T	O
lymphocyte	O
(CTL)	O
response	O
to	O
latently	cell_type
infected	cell_type
cells	cell_type
is	O
well	O
characterized,	O
very	O
little	O
is	O
known	O
about	O
T	O
cell	O
controls	O
over	O
lytic	O
infection	O
;	O
this	O
imbalance	O
in	O
our	O
understanding	O
belies	O
the	O
importance	O
of	O
virus-replicative	O
lesions	O
in	O
several	O
aspects	O
of	O
EBV	O
disease	O
pathogenesis	O
.	O
The	O
present	O
work	O
shows	O
that	O
the	O
primary	O
CD8+	O
CTL	O
response	O
to	O
EBV	O
in	O
infectious	O
mononucleosis	O
patients	O
contains	O
multiple	O
lytic	O
antigen-specific	O
reactivities	O
at	O
levels	O
at	O
least	O
as	O
high	O
as	O
those	O
seen	O
against	O
latent	protein
antigens	protein
;	O
similar	O
reactivities	O
are	O
also	O
detectable	O
in	O
CTL	O
memory	O
.	O
Clonal	O
analysis	O
revealed	O
individual	O
responses	O
to	O
the	O
two	O
immediate	protein
early	protein
proteins	protein
BZLF1	protein
and	O
BRLF1	protein
,	O
and	O
to	O
three	O
(	O
BMLF1	protein
,	O
BMRF1	protein
,	O
and	O
BALF2	protein
)	O
of	O
the	O
six	O
early	protein
proteins	protein
tested.	O
In	O
several	O
cases,	O
the	O
peptide	O
epitope	O
and	O
HLA-restricting	O
determinant	O
recognized	O
by	O
these	O
CTLs	cell_type
has	O
been	O
defined,	O
one	O
unusual	O
feature	O
being	O
the	O
number	O
of	O
responses	O
restricted	O
through	O
HLA-C	DNA
alleles	DNA
.	O
The	O
work	O
strongly	O
suggests	O
that	O
EBV	O
-replicative	O
lesions	O
are	O
subject	O
to	O
direct	O
CTL	O
control	O
in	O
vivo	O
and	O
that	O
immediate	O
early	O
and	O
early	O
proteins	O
are	O
frequently	O
the	O
immunodominant	O
targets	O
.	O
This	O
contrasts	O
with	O
findings	O
in	O
alpha-	O
and	O
beta-	O
herpesvirus	O
systems	O
(	O
herpes	O
simplex	O
,	O
cytomegalovirus	O
)	O
where	O
viral	O
interference	O
with	O
the	O
antigen-processing	O
pathway	O
during	O
lytic	O
infection	O
renders	O
immediate	O
early	O
and	O
early	O
proteins	O
much	O
less	O
immunogenic.	O
The	O
unique	O
capacity	O
of	O
gamma-herpesvirus	O
to	O
amplify	O
the	O
viral	O
load	O
in	O
vivo	O
through	O
a	O
latent	O
growth-transforming	O
infection	O
may	O
have	O
rendered	O
these	O
agents	O
less	O
dependent	O
upon	O
viral	O
replication	O
as	O
a	O
means	O
of	O
successfully	O
colonizing	O
their	O
hosts.	O

Triggering	O
of	O
HLA-DR	protein
antigens	protein
differentially	O
modulates	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
release	O
by	O
B	cell_type
cells	cell_type
at	O
distinct	O
stage	O
of	O
maturation.	O
Triggering	O
of	O
HLA	protein
class	protein
II	protein
antigens	protein
by	O
the	O
anti-HLA-DR	protein
monoclonal	protein
antibody	protein
(	protein
mAb	protein
)	protein
L243	protein
significantly	O
(P	O
&lt;	O
0.05)	O
and	O
differentially	O
enhanced	O
the	O
release	O
of	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF-alpha	protein
)	O
by	O
the	O
non-Hodgkin's	cell_type
lymphoma	cell_type
cells	cell_type
Ri-I	cell_line
,	O
Ci-I	cell_line
,	O
and	O
Sc-I	cell_line
,	O
which	O
are	O
at	O
a	O
distinct	O
stage	O
of	O
B-cell	O
differentiation	O
,	O
and	O
by	O
the	O
more	O
mature	O
Burkitt	cell_line
lymphoma	cell_line
cell	cell_line
Raji	cell_line
;	O
in	O
contrast,	O
it	O
did	O
not	O
induce	O
TNF-alpha	protein
release	O
by	O
the	O
pre-B	cell_type
leukemia	cell_type
cells	cell_type
Nalm-6	cell_line
and	O
BV173	cell_line
.	O
TNF-alpha	protein
release	O
peaked	O
at	O
24	O
h	O
and	O
decreased	O
thereafter,	O
and	O
it	O
was	O
dose	O
dependent	O
and	O
preceded	O
by	O
an	O
increase	O
of	O
TNF-alpha	RNA
mRNA	RNA
detectable	O
after	O
3	O
h	O
of	O
stimulation	O
with	O
mAb	protein
L243	protein
.	O
Secreted	O
TNF-alpha	protein
mediated	O
the	O
enhancement	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
and	O
activator	O
protein-1	O
(	O
AP-1	protein
)	O
binding	O
activity;	O
in	O
fact,	O
the	O
triggering	O
of	O
HLA-DR	protein
antigens	protein
in	O
the	O
presence	O
of	O
antihuman	protein
TNF-alpha	protein
-neutralizing	protein
antibodies	protein
did	O
not	O
upregulate	O
NF-kappa	protein
B	protein
and	O
AP-1	protein
.	O
In	O
contrast,	O
released	O
TNF-alpha	protein
was	O
not	O
responsible	O
for	O
the	O
homotypic	O
aggregation	O
of	O
Ri-I	cell_line
,	O
Ci-I	cell_line
,	O
Sc-I	cell_line
,	O
and	O
Raji	cell_line
cells	cell_line
induced	O
by	O
mAb	protein
L243	protein
,	O
and	O
it	O
did	O
not	O
affect	O
the	O
proliferation	O
of	O
B	cell_type
cells	cell_type
investigated.	O
Altogether,	O
our	O
data	O
demonstrate	O
that:	O
(a)	O
the	O
ability	O
of	O
B	cell_type
cells	cell_type
to	O
release	O
TNF-alpha	protein
after	O
triggering	O
of	O
HLA-DR	protein
antigens	protein
depends	O
on	O
their	O
stage	O
of	O
differentiation;	O
(b)	O
levels	O
of	O
released	O
TNF-alpha	protein
seem	O
to	O
correlate	O
with	O
the	O
stage	O
of	O
B-cell	O
maturation	O
but	O
do	O
not	O
correlate	O
with	O
the	O
amounts	O
of	O
cell	protein
surface	protein
HLA-DR	protein
antigens	protein
;	O
(c)	O
secreted	O
TNF-alpha	protein
regulates	O
the	O
levels	O
of	O
expression	O
of	O
NF-kappa	protein
B	protein
and	O
AP-1	protein
by	O
an	O
autocrine	O
loop	O
;	O
and	O
(d)	O
intracellular	O
signals	O
mediating	O
TNF-alpha	protein
release	O
by	O
B	cell_type
cells	cell_type
are	O
distinct	O
from	O
those	O
regulating	O
homotypic	O
aggregation	O
and	O
proliferation	O
.	O

Transcription	protein
factor	protein
GATA-3	protein
is	O
differentially	O
expressed	O
in	O
murine	O
Th1	O
and	O
Th2	O
cells	O
and	O
controls	O
Th2-specific	O
expression	O
of	O
the	O
interleukin-5	DNA
gene	DNA
.	O
Interleukin-5	protein
(	O
IL-5	protein
),	O
which	O
is	O
produced	O
by	O
CD4(+)	cell_type
T	cell_type
helper	cell_type
2	cell_type
(Th2)	cell_type
cells	cell_type
,	O
but	O
not	O
by	O
Th1	cell_type
cells	cell_type
,	O
plays	O
a	O
key	O
role	O
in	O
the	O
development	O
of	O
eosinophilia	O
in	O
asthma	O
.	O
Despite	O
increasing	O
evidence	O
that	O
the	O
outcome	O
of	O
many	O
diseases	O
is	O
determined	O
by	O
the	O
ratio	O
of	O
the	O
two	O
subsets	O
of	O
CD4(+)	cell_type
T	cell_type
helper	cell_type
cells	cell_type
,	O
Th1	cell_type
and	O
Th2	cell_type
,	O
the	O
molecular	O
basis	O
for	O
Th1-	O
and	O
Th2-	O
specific	O
gene	O
expression	O
remains	O
to	O
be	O
elucidated.	O
We	O
previously	O
established	O
a	O
critical	O
role	O
for	O
the	O
transcription	protein
factor	protein
GATA-3	protein
in	O
IL-5	DNA
promoter	DNA
activation	O
in	O
EL-4	cell_line
cells	cell_line
,	O
which	O
express	O
both	O
Th1-	O
and	O
Th2-	O
type	O
cytokines	O
.	O
Our	O
studies	O
reported	O
here	O
demonstrate	O
that	O
GATA-3	protein
is	O
critical	O
for	O
expression	O
of	O
the	O
IL-5	protein
gene	O
in	O
bona	cell_type
fide	cell_type
Th2	cell_type
cells	cell_type
.	O
Whereas	O
mutations	O
in	O
the	O
GATA-3	protein
site	O
abolished	O
antigen-	O
or	O
cAMP-	O
stimulated	O
IL-5	O
promoter	O
activation	O
in	O
Th2	O
cells,	O
ectopic	O
expression	O
of	O
GATA-3	protein
in	O
Th1	cell_type
cells	cell_type
or	O
in	O
a	O
non-lymphoid,	cell_line
non-	cell_line
IL-5	cell_line
-producing	cell_line
cell	cell_line
line	cell_line
activated	O
the	O
IL-5	DNA
promoter	DNA
.	O
During	O
the	O
differentiation	O
of	O
naive	cell_type
CD4(+)	cell_type
T	cell_type
cells	cell_type
isolated	O
from	O
T	O
cell	O
receptor	O
transgenic	O
mice	O
,	O
GATA-3	protein
gene	O
expression	O
was	O
up-regulated	O
in	O
developing	O
Th2	cell_type
cells	cell_type
,	O
but	O
was	O
down-regulated	O
in	O
Th1	cell_type
cells	cell_type
,	O
and	O
antigen-	cell_type
or	cell_type
cAMP-activated	cell_type
Th2	cell_type
cells	cell_type
(but	O
not	O
Th1	cell_type
cells	cell_type
)	O
expressed	O
the	O
GATA-3	protein
protein	protein
.	O
Thus,	O
GATA-3	protein
may	O
play	O
an	O
important	O
role	O
in	O
the	O
balance	O
between	O
Th1	cell_type
and	O
Th2	cell_type
subsets	cell_type
in	O
immune	O
responses	O
.	O
Inhibition	O
of	O
GATA-3	protein
activity	O
has	O
therapeutic	O
potential	O
in	O
the	O
treatment	O
of	O
asthma	O
and	O
other	O
hypereosinophilic	O
diseases	O
.	O

A	O
shortened	O
life	O
span	O
of	O
EKLF-/-	cell_type
adult	cell_type
erythrocytes	cell_type
,	O
due	O
to	O
a	O
deficiency	O
of	O
beta-globin	protein
chains	protein
,	O
is	O
ameliorated	O
by	O
human	protein
gamma-globin	protein
chains	protein
.	O
Using	O
homologous	O
recombination,	O
both	O
EKLF	DNA
alleles	DNA
in	O
murine	cell_line
embryonic	cell_line
stem	cell_line
(ES)	cell_line
cells	cell_line
were	O
inactivated.	O
These	O
EKLF-/-	cell_line
ES	cell_line
cells	cell_line
were	O
capable	O
of	O
undergoing	O
in	O
vitro	O
differentiation	O
to	O
form	O
definitive	O
erythroid	O
colonies	O
that	O
were	O
similar	O
in	O
size	O
and	O
number	O
to	O
those	O
formed	O
by	O
wild-type	cell_type
ES	cell_type
cells	cell_type
.	O
However,	O
the	O
EKLF-/-	cell_line
colonies	cell_line
were	O
poorly	O
hemoglobinized	O
and	O
enucleated	cell_type
erythrocytes	cell_type
in	O
these	O
colonies	O
contained	O
numerous	O
Heinz	O
bodies	O
.	O
Reverse	O
transcriptase-polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
)	O
analyses	O
revealed	O
that	O
adult	O
and	O
embryonic	DNA
globin	DNA
genes	DNA
were	O
appropriately	O
regulated,	O
with	O
the	O
exception	O
of	O
beta	protein
h1-globin	protein
,	O
which	O
continued	O
to	O
be	O
expressed	O
at	O
a	O
very	O
low	O
level.	O
The	O
ratio	O
of	O
adult	RNA
beta-globin/alpha-globin	RNA
mRNA	RNA
in	O
the	O
mutant	cell_line
ES	cell_line
cells	cell_line
was	O
1/15	O
of	O
that	O
in	O
wild-type	cell_type
ES	cell_type
cells	cell_type
.	O
When	O
the	O
EKLF-/-	cell_line
cells	cell_line
were	O
injected	O
into	O
blastocysts,	O
they	O
did	O
not	O
contribute	O
at	O
a	O
detectable	O
level	O
to	O
the	O
mature	O
erythrocyte	O
compartment	O
of	O
the	O
chimeric	O
animals	O
,	O
based	O
on	O
analysis	O
of	O
glucose	protein
phosphate	protein
isomerase-1	protein
(GPI-1)	protein
isozymes	protein
and	O
hemoglobins	O
that	O
distinguish	O
ES	cell_type
cell-derived	cell_type
erythrocytes	cell_type
from	O
host	O
blastocyst-derived	cell_type
erythrocytes	cell_type
.	O
In	O
contrast,	O
semiquantitative	O
RT-PCR	O
analysis	O
of	O
RNA	O
from	O
reticulocytes	cell_type
of	O
the	O
same	O
chimeric	O
animals	O
suggested	O
that	O
the	O
ES	cell_type
cell-derived	cell_type
reticulocytes	cell_type
were	O
present	O
at	O
a	O
level	O
of	O
6%	O
to	O
8%.	O
This	O
indicated	O
that	O
the	O
EKLF-/-	cell_line
erythrocytes	cell_line
in	O
adult	O
animals	O
must	O
be	O
short-lived,	O
apparently	O
due	O
to	O
the	O
imbalance	O
of	O
beta-	O
versus	O
alpha-	O
globin	O
chains	O
,	O
leading	O
to	O
the	O
precipitation	O
of	O
excess	O
alpha-globin	protein
chains	protein
to	O
form	O
Heinz	O
bodies	O
.	O
Consistent	O
with	O
this	O
hypothesis,	O
the	O
short	O
life	O
span	O
was	O
ameliorated	O
by	O
introduction	O
into	O
the	O
EKLF-/-	cell_line
ES	cell_line
cells	cell_line
of	O
a	O
human	DNA
LCR/gamma-globin	DNA
gene	DNA
,	O
as	O
evidenced	O
by	O
the	O
presence	O
of	O
ES	cell_type
cell-derived	cell_type
reticulocytes	cell_type
as	O
well	O
as	O
mature	cell_type
erythrocytes	cell_type
in	O
the	O
blood	O
of	O
the	O
chimeric	O
animals	O
.	O

RP1	DNA
,	O
a	O
new	O
member	O
of	O
the	O
adenomatous	DNA
polyposis	DNA
coli-binding	DNA
EB1-like	DNA
gene	DNA
family	DNA
,	O
is	O
differentially	O
expressed	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
.	O
Cross-linking	O
of	O
the	O
CD3	O
and	O
CD28	O
molecules	O
on	O
T	cell_type
lymphocytes	cell_type
represents	O
one	O
of	O
the	O
most	O
effective	O
signals	O
for	O
T	cell_type
lymphocyte	cell_type
activation	O
and	O
triggering	O
of	O
their	O
cytotoxic	O
effector	O
function	O
.	O
To	O
identify	O
genes	O
that	O
are	O
expressed	O
in	O
T	cell_type
cells	cell_type
after	O
stimulation,	O
mRNA	O
from	O
T	cell_type
lymphocytes	cell_type
that	O
had	O
been	O
activated	O
by	O
the	O
simultaneous	O
stimulation	O
of	O
the	O
CD3	protein
and	O
CD28	protein
trigger	O
molecules	O
was	O
transcribed	O
for	O
a	O
differential	O
mRNA	O
display	O
analysis	O
into	O
cDNA	O
and	O
was	O
compared	O
with	O
cDNA	O
from	O
CD28	protein
-or	O
CD3	protein
-activated	O
or	O
resting	O
lymphocytes	cell_type
.	O
Differential	O
expression	O
was	O
confirmed	O
subsequently	O
by	O
Northern	O
blot	O
analysis	O
.	O
One	O
of	O
the	O
cDNA	DNA
fragments	DNA
expressed	O
specifically	O
in	O
CD3	protein
-and	O
CD28	protein
-activated	cell_type
T	cell_type
cells	cell_type
was	O
designated	O
RP1	DNA
.	O
The	O
predictive	DNA
protein-coding	DNA
region	DNA
of	O
RP1	DNA
had	O
a	O
significant	O
homology	O
to	O
members	O
of	O
the	O
recently	O
found	O
adenomatous	DNA
polyposis	DNA
coli	DNA
(APC)	DNA
protein	DNA
-binding	DNA
EB1	DNA
gene	DNA
family	DNA
,	O
which	O
codes	O
for	O
yet	O
unknown	O
protein(s).	O
Bacterially	O
expressed	O
RP1	protein
protein	protein
revealed	O
specific	O
binding	O
to	O
wild-type	protein
but	O
not	O
to	O
mutated	protein
APC	protein
protein	protein
.	O
The	O
rapid	O
up-regulation	O
of	O
RP1	RNA
mRNA	RNA
in	O
properly	O
activated	cell_type
T	cell_type
cells	cell_type
suggests	O
that	O
this	O
gene	O
might	O
belong	O
to	O
the	O
immediate/early	DNA
gene	DNA
family	DNA
,	O
which	O
controls	O
the	O
signal	O
transduction	O
cascade	O
downstream	O
of	O
the	O
TCR	protein
.	O
As	O
the	O
expression	O
level	O
of	O
the	O
RP1	DNA
gene	DNA
in	O
activated	cell_type
T	cell_type
cells	cell_type
and	O
a	O
spectrum	O
of	O
tumor-derived	cell_line
cell	cell_line
lines	cell_line
correlates	O
with	O
the	O
proliferative	O
status	O
of	O
the	O
cells,	O
members	O
of	O
the	O
EB1-like	DNA
gene	DNA
family	DNA
may	O
not	O
only	O
be	O
involved	O
in	O
the	O
tumorigenesis	O
of	O
colorectal	O
cancers	O
but	O
may	O
also	O
play	O
a	O
role	O
in	O
the	O
proliferative	O
control	O
of	O
normal	cell_type
cells	cell_type
.	O

Cyclosporin	O
A	O
interferes	O
with	O
the	O
inducible	O
degradation	O
of	O
NF-kappa	protein
B	protein
inhibitors	O
,	O
but	O
not	O
with	O
the	O
processing	O
of	O
p105/	O
NF-kappa	protein
B1	protein
in	O
T	cell_type
cells	cell_type
.	O
The	O
transcription	protein
factor	protein
NF-kappa	protein
B	protein
controls	O
the	O
induction	O
of	O
numerous	O
cytokine	DNA
promoters	DNA
during	O
the	O
activation	O
of	O
T	cell_type
lymphocytes	cell_type
.	O
Inhibition	O
of	O
T	O
cell	O
activation	O
by	O
the	O
immunosuppressants	O
cyclosporin	O
A	O
(	O
CsA	O
)	O
and	O
FK506	O
exerts	O
a	O
suppressive	O
effect	O
on	O
the	O
induction	O
of	O
these	O
NF-kappa	DNA
B	DNA
-controlled	DNA
cytokine	DNA
promoters	DNA
.	O
We	O
show	O
for	O
human	cell_line
Jurkat	cell_line
T	cell_line
leukemia	cell_line
cells	cell_line
,	O
as	O
well	O
as	O
human	O
and	O
mouse	O
primary	O
T	O
lymphocytes	O
,	O
that	O
this	O
inhibitory	O
effect	O
is	O
accompanied	O
by	O
an	O
impaired	O
nuclear	O
translocation	O
of	O
the	O
Rel	protein
proteins	protein
c-Rel	protein
,	O
RelA/p65	protein
and	O
NF-kappa	protein
B1/p50	protein
,	O
whereas	O
the	O
nuclear	O
appearance	O
of	O
RelB	protein
remains	O
unaffected.	O
CsA	O
does	O
not	O
interfere	O
with	O
the	O
synthesis	O
of	O
Rel	protein
proteins	protein
,	O
but	O
prevents	O
the	O
inducible	O
degradation	O
of	O
cytosolic	protein
NF-kappa	protein
B	protein
inhibitors	protein
I	protein
kappa	protein
B	protein
alpha	protein
and	O
I	protein
kappa	protein
B	protein
beta	protein
upon	O
T	O
cell	O
activation	O
.	O
CsA	O
neither	O
inhibits	O
the	O
processing	O
of	O
the	O
NF-kappa	protein
B1	protein
precursor	protein
p105	protein
to	O
p50	protein
,	O
nor	O
does	O
it	O
"stabilize"	O
the	O
C-terminal	O
portion	O
of	O
p105	protein
,	O
I	protein
kappa	protein
B	protein
gamma	protein
,	O
which	O
is	O
degraded	O
during	O
p105	protein
processing	O
to	O
mature	protein
p50	protein
.	O
These	O
results	O
indicate	O
that	O
CsA	O
interferes	O
with	O
a	O
specific	O
event	O
in	O
the	O
signal-induced	O
degradation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
and	O
I	protein
kappa	protein
B	protein
beta	protein
,	O
but	O
does	O
not	O
affect	O
the	O
processing	O
of	O
NF-kappa	protein
B1/	protein
p105	protein
to	O
p50	protein
.	O

Activation	O
of	O
nuclear	protein
factor-kappa	protein
B	protein
by	O
beta-amyloid	O
peptides	O
and	O
interferon-gamma	protein
in	O
murine	O
microglia	O
.	O
An	O
increasing	O
body	O
of	O
evidence	O
suggests	O
that	O
amyloid-beta	O
(A	O
beta)	O
peptides	O
and	O
microglia	cell_type
are	O
crucially	O
involved	O
in	O
the	O
pathogenesis	O
of	O
Alzheimer's	O
disease	O
.	O
In	O
an	O
effort	O
to	O
further	O
elucidate	O
the	O
biological	O
effects	O
of	O
A	O
beta	O
towards	O
microglia	cell_type
,	O
we	O
investigated	O
the	O
ability	O
of	O
A	O
beta	O
peptides	O
to	O
activate	O
nuclear	protein
factor	protein
(NF)-kappa	protein
B	protein
in	O
the	O
N9	cell_line
murine	cell_line
microglial	cell_line
cell	cell_line
line	cell_line
.	O
Co-stimulation	O
of	O
microglia	cell_type
with	O
suboptimal	O
concentrations	O
of	O
A	O
beta	O
(25-35)	O
and	O
100	O
U/ml	O
IFN	protein
gamma	protein
resulted	O
in	O
the	O
detection	O
of	O
a	O
specific	O
NF-kappa	protein
B	protein
DNA-binding	O
activity	O
in	O
nuclear	O
extracts	O
,	O
as	O
determined	O
in	O
gel	O
mobility	O
shift	O
assays	O
.	O
This	O
response	O
required	O
at	O
least	O
120	O
min	O
to	O
be	O
evident	O
and	O
supershift	O
experiments	O
revealed	O
that	O
the	O
NF-kappa	protein
B	protein
complex	protein
contains	O
both	O
RelA	protein
and	O
p50	protein
.	O
Accordingly,	O
immunoblot	O
experiments	O
showed	O
that	O
amongst	O
NF-kappa	protein
B	protein
/Rel	protein
proteins	protein
,	O
RelA	protein
and	O
p50	protein
are	O
mobilized	O
to	O
the	O
nucleus	O
following	O
microglial	O
cell	O
stimulation	O
with	O
A	O
beta	O
(25-35)	O
plus	O
IFN	protein
gamma	protein
.	O
Higher	O
concentrations	O
of	O
A	O
beta	O
(25-35)	O
were	O
effective	O
by	O
themselves	O
in	O
inducing	O
NF-kappa	protein
B	protein
activation	O
,	O
both	O
in	O
the	O
N9	cell_line
microglial	cell_line
cell	cell_line
line	cell_line
and	O
in	O
rat	cell_line
primary	cell_line
microglia	cell_line
,	O
as	O
well	O
as	O
in	O
human	cell_type
monocytes	cell_type
.	O
For	O
purposes	O
of	O
comparison,	O
microglia	cell_type
were	O
also	O
stimulated	O
with	O
bacterial	O
LPS	O
,	O
a	O
known	O
NF-kappa	protein
B	protein
inducer	O
.	O
As	O
expected,	O
LPS	O
strongly	O
induced	O
the	O
formation	O
of	O
two	O
NF-kappa	protein
B	protein
DNA-binding	O
activities	O
,	O
one	O
of	O
which	O
was	O
identified	O
as	O
RelA	protein
/p50	protein
.	O
The	O
LPS	O
response	O
was	O
also	O
more	O
rapid,	O
as	O
it	O
was	O
already	O
evident	O
by	O
40	O
min	O
and	O
remained	O
sustained	O
for	O
up	O
to	O
3	O
h.	O
Collectively,	O
these	O
findings	O
indicate	O
that	O
NF-kappa	protein
B	protein
activation	O
might	O
constitute	O
one	O
of	O
the	O
mechanisms	O
underlying	O
the	O
inducible	O
expression	O
of	O
kappa	DNA
B-dependent	DNA
genes	DNA
in	O
microglia	cell_type
stimulated	O
by	O
A	O
beta	O
peptides	O
and	O
IFN	protein
gamma	protein
,	O
or	O
by	O
LPS	O
.	O

Glucocorticoid	O
-mediated	O
repression	O
of	O
cytokine	DNA
gene	DNA
transcription	O
in	O
human	O
arteritis-SCID	protein
chimeras	protein
.	O
Giant	O
cell	O
arteritis	O
(	O
GCA	O
)	O
is	O
a	O
vasculitic	O
syndrome	O
that	O
preferentially	O
affects	O
medium	O
and	O
large	O
-sized	O
arteries	O
.	O
Glucocorticoid	O
therapy	O
resolves	O
clinical	O
symptoms	O
within	O
hours	O
to	O
days,	O
but	O
therapy	O
has	O
to	O
be	O
continued	O
over	O
several	O
years	O
to	O
prevent	O
disease	O
relapses.	O
It	O
is	O
not	O
known	O
whether	O
and	O
how	O
glucocorticoids	O
affect	O
the	O
function	O
of	O
the	O
inflammatory	O
infiltrate	O
or	O
why	O
the	O
disease	O
persists	O
subclinically	O
despite	O
chronic	O
treatment	O
.	O
GCA	O
is	O
self-sustained	O
in	O
temporal	O
arteries	O
engrafted	O
into	O
SCID	O
mice	O
,	O
providing	O
a	O
model	O
in	O
which	O
the	O
mechanisms	O
of	O
action	O
and	O
limitations	O
of	O
glucocorticoid	O
therapy	O
can	O
be	O
examined	O
in	O
vivo.	O
Administration	O
of	O
dexamethasone	O
to	O
temporal	cell_line
artery-SCID	cell_line
chimeras	cell_line
for	O
1	O
wk	O
induced	O
a	O
partial	O
suppression	O
of	O
T	O
cell	O
and	O
macrophage	O
function	O
as	O
indicated	O
by	O
the	O
reduced	O
tissue	O
concentrations	O
of	O
IL-2	O
,	O
IL-1beta	O
,	O
and	O
IL-6	O
mRNA	O
,	O
and	O
by	O
the	O
diminished	O
expression	O
of	O
inducible	O
NO	protein
synthase	protein
.	O
In	O
contrast,	O
synthesis	O
of	O
IFN-gamma	RNA
mRNA	RNA
was	O
only	O
slightly	O
decreased,	O
and	O
expression	O
of	O
TGF-beta1	protein
was	O
unaffected.	O
These	O
findings	O
correlated	O
with	O
activation	O
of	O
the	O
IkappaBalpha	DNA
gene	DNA
and	O
blockade	O
of	O
the	O
nuclear	O
translocation	O
of	O
NFkappaB	protein
in	O
the	O
xenotransplanted	O
tissue	O
.	O
Dose-response	O
experiments	O
suggested	O
that	O
steroid	O
doses	O
currently	O
used	O
in	O
clinical	O
medicine	O
are	O
suboptimal	O
in	O
repressing	O
NFkappaB	protein
-mediated	O
cytokine	protein
production	O
in	O
the	O
inflammatory	O
lesions	O
.	O
Chronic	O
steroid	O
therapy	O
was	O
able	O
to	O
deplete	O
the	O
T	protein
cell	protein
products	protein
IL-2	protein
and	O
IFN-gamma	protein
,	O
whereas	O
the	O
activation	O
of	O
tissue-infiltrating	cell_type
macrophages	cell_type
was	O
only	O
partially	O
affected.	O
IL-1beta	protein
transcription	O
was	O
abrogated;	O
in	O
contrast,	O
TGF-beta1	RNA
mRNA	RNA
synthesis	O
was	O
steroid	O
resistant	O
.	O
The	O
persistence	O
of	O
TGF-beta1-transcribing	cell_type
macrophages	cell_type
,	O
despite	O
paralysis	O
of	O
T	O
cell	O
function	O
,	O
may	O
provide	O
an	O
explanation	O
for	O
the	O
chronicity	O
of	O
the	O
disease,	O
and	O
may	O
identify	O
a	O
novel	O
therapeutic	O
target	O
in	O
this	O
inflammatory	O
vasculopathy	O
.	O

Defective	O
survival	O
and	O
activation	O
of	O
thymocytes	cell_type
in	O
transgenic	O
mice	O
expressing	O
a	O
catalytically	protein
inactive	protein
form	protein
of	O
Ca2+/calmodulin-dependent	protein
protein	protein
kinase	protein
IV	protein
.	O
We	O
have	O
generated	O
transgenic	O
mice	O
that	O
express	O
a	O
catalytically	protein
inactive	protein
form	protein
of	O
Ca2+/calmodulin-dependent	protein
protein	protein
kinase	protein
IV	protein
(	O
CaMKIV	protein
)	O
specifically	O
in	O
thymic	cell_type
T	cell_type
cells	cell_type
.	O
The	O
presence	O
of	O
this	O
protein	O
results	O
in	O
a	O
markedly	O
reduced	O
thymic	O
cellularity	O
,	O
although	O
the	O
distribution	O
of	O
the	O
remaining	O
cells	O
is	O
normal	O
based	O
on	O
evaluation	O
of	O
the	O
CD4	protein
and	O
CD8	protein
cell	protein
surface	protein
antigens	protein
that	O
are	O
used	O
to	O
gauge	O
T	O
cell	O
development	O
.	O
Isolated	O
thymic	cell_type
T	cell_type
cells	cell_type
from	O
the	O
transgenic	O
mice	O
also	O
show	O
a	O
dramatically	O
decreased	O
survival	O
rate	O
when	O
evaluated	O
in	O
culture	O
under	O
conditions	O
that	O
do	O
not	O
favor	O
activation.	O
When	O
challenged	O
with	O
an	O
activating	O
stimulus	O
such	O
as	O
alpha-	protein
CD3	protein
or	O
a	O
combination	O
of	O
phorbol	O
ester	O
plus	O
ionophore	O
,	O
the	O
cells	O
are	O
severely	O
compromised	O
in	O
their	O
ability	O
to	O
produce	O
the	O
cytokine	protein
interleukin-2	protein
(	O
IL-2	protein
).	O
Reduction	O
of	O
IL-2	protein
production	O
is	O
secondary	O
to	O
the	O
inability	O
to	O
phosphorylate	O
the	O
cAMP	protein
response	protein
element	protein
binding	protein
protein	protein
,	O
CREB	protein
,	O
and	O
induce	O
expression	O
of	O
the	O
immediate	DNA
early	DNA
genes	DNA
such	O
as	O
Fos	DNA
B	DNA
that	O
are	O
required	O
to	O
transactivate	O
the	O
IL-2	DNA
promoter	DNA
.	O
Because	O
transgene	O
expression	O
was	O
regulated	O
by	O
the	O
proximal	DNA
promoter	DNA
of	O
the	O
murine	DNA
lck	DNA
gene	DNA
and	O
this	O
promoter	O
is	O
inactivated	O
in	O
T	cell_type
cells	cell_type
that	O
exit	O
the	O
thymus	O
,	O
the	O
mutant	protein
hCaMKIV	protein
is	O
not	O
present	O
in	O
peripheral	cell_type
T	cell_type
cells	cell_type
.	O
Consequently,	O
T	cell_type
lymphocytes	cell_type
present	O
in	O
the	O
spleen	O
can	O
be	O
activated	O
normally	O
in	O
response	O
to	O
either	O
stimulus	O
mentioned	O
above,	O
demonstrating	O
that	O
the	O
effects	O
of	O
the	O
inactive	protein
CaMKIV	protein
on	O
activation	O
are	O
reversible.	O
Our	O
results	O
suggest	O
that	O
CaMKIV	protein
may	O
represent	O
a	O
physiologically	O
relevant	O
CREB	protein
kinase	protein
in	O
T	cell_type
cells	cell_type
and	O
that	O
the	O
enzyme	O
is	O
also	O
required	O
to	O
ensure	O
normal	O
expansion	O
of	O
T	cell_type
cells	cell_type
in	O
the	O
thymus	O
.	O
Whereas	O
the	O
pathway	O
responsible	O
for	O
this	O
latter	O
role	O
is	O
yet	O
to	O
be	O
elucidated,	O
it	O
is	O
unlikely	O
to	O
include	O
CREB	protein
phosphorylation	O
.	O

A	O
new	O
mouse	DNA
gene	DNA
,	O
SRG3	DNA
,	O
related	O
to	O
the	O
SWI3	DNA
of	O
Saccharomyces	O
cerevisiae	O
,	O
is	O
required	O
for	O
apoptosis	O
induced	O
by	O
glucocorticoids	O
in	O
a	O
thymoma	cell_line
cell	cell_line
line	cell_line
.	O
We	O
isolated	O
a	O
new	O
mouse	DNA
gene	DNA
that	O
is	O
highly	O
expressed	O
in	O
thymocytes	cell_type
,	O
testis	O
,	O
and	O
brain	O
.	O
This	O
gene,	O
SRG3	DNA
,	O
showed	O
a	O
significant	O
sequence	O
homology	O
to	O
SWI3	DNA
,	O
a	O
yeast	DNA
transcriptional	DNA
activator	DNA
,	O
and	O
its	O
human	DNA
homolog	DNA
BAF155	DNA
.	O
SRG3	DNA
encodes	O
1,100	O
amino	O
acids	O
and	O
has	O
33-47%	O
identity	O
with	O
SWI3	protein
protein	protein
over	O
three	O
regions.	O
The	O
SRG3	protein
protein	protein
contains	O
an	O
acidic	protein
NH2	protein
terminus	protein
,	O
a	O
myb-like	protein
DNA	protein
binding	protein
domain	protein
,	O
a	O
leucine-zipper	protein
motif	protein
,	O
and	O
a	O
proline-	protein
and	protein
glutamine-rich	protein
region	protein
at	O
its	O
COOH	protein
terminus	protein
.	O
Rabbit	O
antiserum	O
raised	O
against	O
a	O
COOH-terminal	O
polypeptide	O
of	O
the	O
SRG3	DNA
recognized	O
a	O
protein	O
with	O
an	O
apparent	O
molecular	O
mass	O
of	O
155	O
kD.	O
The	O
serum	O
also	O
detected	O
a	O
170-kD	protein
protein	protein
that	O
seems	O
to	O
be	O
a	O
mouse	O
homologue	O
of	O
human	protein
BAF170	protein
.	O
Immunoprecipitation	O
of	O
cell	O
extract	O
with	O
the	O
antiserum	O
against	O
the	O
mouse	protein
SRG3	protein
also	O
brought	O
down	O
a	O
195-kD	protein
protein	protein
that	O
could	O
be	O
recognized	O
by	O
an	O
antiserum	O
raised	O
against	O
human	protein
SWI2	protein
protein	protein
.	O
The	O
results	O
suggest	O
that	O
the	O
SRG3	protein
protein	protein
associates	O
with	O
a	O
mouse	protein
SWI2	protein
.	O
The	O
SRG3	protein
protein	protein
is	O
expressed	O
about	O
three	O
times	O
higher	O
in	O
thymocytes	cell_type
than	O
in	O
peripheral	cell_type
lymphocytes	cell_type
.	O
The	O
expression	O
of	O
anti-sense	protein
RNA	protein
to	O
SRG3	RNA
mRNA	RNA
in	O
a	O
thymoma	cell_line
cell	cell_line
line	cell_line
,	O
S49.1	cell_line
,	O
reduced	O
the	O
expression	O
level	O
of	O
the	O
SRG3	protein
protein	protein
,	O
and	O
decreased	O
the	O
apoptotic	O
cell	O
death	O
induced	O
by	O
glucocorticoids	O
.	O
These	O
results	O
suggest	O
that	O
the	O
SRG3	protein
protein	protein
is	O
involved	O
in	O
the	O
glucocorticoid-induced	O
apoptosis	O
in	O
the	O
thymoma	cell_line
cell	cell_line
line	cell_line
.	O
This	O
implicates	O
that	O
the	O
SRG3	DNA
may	O
play	O
an	O
important	O
regulatory	O
role	O
during	O
T	O
cell	O
development	O
in	O
thymus	O
.	O

Transcriptional	O
induction	O
of	O
collagenase-1	protein
in	O
differentiated	cell_line
monocyte-like	cell_line
(U937)	cell_line
cells	cell_line
is	O
regulated	O
by	O
AP-1	protein
and	O
an	O
upstream	DNA
C/EBP-beta	DNA
site	DNA
.	O
In	O
this	O
report,	O
we	O
demonstrate	O
that	O
the	O
AP-1	protein
site	O
and	O
a	O
distal	DNA
promoter	DNA
element	DNA
regulate	O
transcriptional	O
induction	O
of	O
collagenase-1	protein
during	O
monocytic	O
differentiation	O
.	O
Chloramphenicol	DNA
acetyltransferase	DNA
expression	DNA
constructs	DNA
containing	O
regions	O
of	O
the	O
human	DNA
collagenase-1	DNA
promoter	DNA
were	O
stably	O
or	O
transiently	O
transfected	O
into	O
U937	cell_line
cells	cell_line
,	O
and	O
reporter	O
activity	O
was	O
assessed	O
at	O
various	O
times	O
after	O
the	O
onset	O
of	O
phorbol	O
12-myristate	O
13-acetate	O
(PMA)-mediated	O
differentiation	O
.	O
Rapid	O
and	O
strong	O
induction	O
of	O
promoter	O
activity	O
was	O
lost	O
in	O
constructs	O
with	O
a	O
mutant	DNA
AP-1	DNA
element	DNA
;	O
however,	O
at	O
16-96	O
h	O
post-PMA	O
,	O
the	O
mutant	DNA
collagenase-1	DNA
promoter	DNA
displayed	O
AP-1	protein
independent	O
PMA-mediated	O
transactivation	O
.	O
The	O
AP-1	DNA
mutant	DNA
constructs	DNA
also	O
showed	O
delayed	O
transcriptional	O
activation	O
in	O
PMA-treated	cell_line
fibroblasts	cell_line
.	O
Western	O
and	O
supershift	O
analyses	O
indicated	O
that	O
functional	O
Jun	O
and	O
Fos	O
proteins	O
were	O
present	O
in	O
nuclear	O
extracts	O
of	O
PMA-differentiated	cell_line
U937	cell_line
cells	cell_line
.	O
Promoter	O
deletion	O
constructs	O
demonstrated	O
the	O
potential	O
role	O
of	O
distal	DNA
promoter	DNA
sequences	DNA
in	O
regulating	O
collagenase-1	protein
transcription	O
.	O
In	O
particular,	O
Western	O
,	O
supershift	O
,	O
and	O
promoter	O
deletion	O
analyses	O
suggested	O
a	O
role	O
for	O
CCAAT/enhancer-binding	DNA
protein-beta	DNA
(	DNA
C/EBP-beta	DNA
)	DNA
binding	DNA
site	DNA
between	O
-2010	DNA
and	DNA
-1954	DNA
in	O
regulating	O
transcription	O
of	O
collagenase-1	protein
in	O
monocytic	cell_type
cells	cell_type
.	O
Our	O
findings	O
suggest	O
that	O
distinct	O
regulatory	DNA
elements	DNA
,	O
acting	O
somewhat	O
independently	O
of	O
each	O
other,	O
control	O
expression	O
of	O
collagenase-1	protein
.	O
In	O
addition,	O
our	O
data	O
suggests	O
that	O
the	O
rapid	O
PMA-mediated	O
induction	O
of	O
collagenase-1	protein
transcription	O
is	O
controlled	O
by	O
a	O
mechanism	O
distinct	O
from	O
that	O
regulating	O
the	O
sustained	O
expression	O
of	O
this	O
proteinase	protein
in	O
activated	cell_type
macrophages	cell_type
.	O

Quantification	O
of	O
vitamin	RNA
D	RNA
receptor	RNA
mRNA	RNA
by	O
competitive	O
polymerase	O
chain	O
reaction	O
in	O
PBMC	cell_type
:	O
lack	O
of	O
correspondence	O
with	O
common	DNA
allelic	DNA
variants	DNA
.	O
It	O
has	O
been	O
recently	O
claimed	O
that	O
polymorphism	O
for	O
the	O
vitamin	protein
D	protein
receptor	protein
(	O
VDR	protein
)	O
influences	O
several	O
aspects	O
of	O
calcium	O
and	O
bone	O
metabolism	O
.	O
To	O
evaluate	O
the	O
physiologic	O
plausibility	O
of	O
these	O
claims,	O
we	O
compared	O
the	O
abundance	O
of	O
the	O
VDR	RNA
mRNA	RNA
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMCs	cell_type
)	O
between	O
different	O
VDR	protein
genotypes	protein
using	O
a	O
quantitative	O
reverse	O
transcribed	O
polymerase	O
chain	O
reaction-based	O
method	O
.	O
The	O
method	O
is	O
based	O
on	O
the	O
coamplification	O
of	O
VDR	DNA
cDNA	DNA
and	O
an	O
internal	O
standard	O
consisting	O
of	O
known	O
concentrations	O
of	O
a	O
human	DNA
VDR	DNA
CDNA	DNA
mutated	O
at	O
a	O
BglII	DNA
restriction	DNA
site	DNA
;	O
the	O
interassay	O
coefficient	O
of	O
variation	O
is	O
11%.	O
To	O
validate	O
the	O
method,	O
we	O
made	O
use	O
of	O
earlier	O
receptor	O
binding	O
studies	O
indicating	O
that	O
normal	cell_type
human	cell_type
monocytes	cell_type
and	O
activated,	O
but	O
not	O
resting,	O
lymphocytes	cell_type
expressed	O
the	O
VDR	protein
.	O
The	O
concentration	O
of	O
the	O
VDR	RNA
mRNA	RNA
was	O
10(-8)	O
to	O
10(-7)	O
g/g	O
of	O
total	O
RNA	RNA
in	O
cell-sorted	cell_type
monocytes	cell_type
and	O
in	O
in	cell_type
vitro	cell_type
activated	cell_type
lymphocytes	cell_type
,	O
but	O
only	O
10(-12)	O
g/g	O
of	O
total	RNA
mRNA	RNA
in	O
resting	O
lymphocytes	cell_type
,	O
establishing	O
that	O
the	O
VDR	RNA
mRNA	RNA
determined	O
by	O
our	O
method	O
in	O
PBMCs	cell_type
is	O
due	O
to	O
constitutive	O
expression	O
in	O
monocytes	cell_type
.	O
Following	O
an	O
initial	O
genotype	O
screening	O
of	O
85	O
normal	O
volunteers	O
by	O
polymerase	O
chain	O
reaction	O
or	O
restriction	DNA
fragment	DNA
length	DNA
polymorphism	DNA
analysis	O
,	O
14	O
individuals	O
with	O
the	O
Bb	O
genotype	O
,	O
12	O
with	O
the	O
bb	O
genotype	O
,	O
and	O
12	O
with	O
the	O
BB	O
genotype	O
were	O
selected.	O
The	O
concentration	O
of	O
the	O
VDR	RNA
mRNA	RNA
,	O
corrected	O
for	O
the	O
number	O
of	O
monocytes	cell_type
,	O
was	O
similar	O
among	O
the	O
three	O
genotype	O
groups,	O
as	O
were	O
the	O
other	O
variables	O
examined:	O
serum	protein
calcitriol	protein
,	O
serum	protein
osteocalcin	protein
,	O
and	O
vertebral	O
and	O
hip	O
bone	O
density	O
.	O
We	O
conclude	O
that	O
VDR	protein
polymorphism	O
does	O
not	O
affect	O
the	O
abundance	O
of	O
the	O
VDR	RNA
mRNA	RNA
.	O

Oncogenic	O
forms	O
of	O
NOTCH1	protein
lacking	O
either	O
the	O
primary	DNA
binding	DNA
site	DNA
for	O
RBP-Jkappa	protein
or	O
nuclear	protein
localization	protein
sequences	protein
retain	O
the	O
ability	O
to	O
associate	O
with	O
RBP-Jkappa	protein
and	O
activate	O
transcription.	O
Truncated	O
forms	O
of	O
the	O
NOTCH1	protein
transmembrane	protein
receptor	protein
engineered	O
to	O
resemble	O
mutant	O
forms	O
of	O
NOTCH1	protein
found	O
in	O
certain	O
cases	O
of	O
human	O
T	O
cell	O
leukemia/lymphoma	O
(	O
T-ALL	O
)	O
efficiently	O
induce	O
T-ALL	O
when	O
expressed	O
in	O
the	O
bone	O
marrow	O
of	O
mice	O
.	O
Unlike	O
full-sized	O
NOTCH1	protein
,	O
two	O
such	O
truncated	O
forms	O
of	O
the	O
protein	O
either	O
lacking	O
a	O
major	O
portion	O
of	O
the	O
extracellular	protein
domain	protein
(	O
DeltaE	protein
)	O
or	O
consisting	O
only	O
of	O
the	O
intracellular	protein
domain	protein
(	O
ICN	protein
)	O
were	O
found	O
to	O
activate	O
transcription	O
in	O
cultured	O
cells,	O
presumably	O
through	O
RBP-Jkappa	protein
response	O
elements	O
within	O
DNA.	O
Both	O
truncated	O
forms	O
also	O
bound	O
to	O
the	O
transcription	protein
factor	protein
RBP-Jkappa	protein
in	O
extracts	O
prepared	O
from	O
human	O
and	O
murine	O
T-ALL	O
cell	O
lines	O
.	O
Transcriptional	O
activation	O
required	O
the	O
presence	O
of	O
a	O
weak	O
RBP-Jkappa	protein
-binding	protein
site	protein
within	O
the	O
NOTCH1	protein
ankyrin	protein
repeat	protein
region	protein
of	O
the	O
intracellular	protein
domain	protein
.	O
Unexpectedly,	O
a	O
second,	O
stronger	O
RBP-Jkappa	protein
-binding	protein
site	protein
,	O
which	O
lies	O
within	O
the	O
intracellular	protein
domain	protein
close	O
to	O
the	O
transmembrane	O
region	O
and	O
significantly	O
augments	O
association	O
with	O
RBP-Jkappa	protein
,	O
was	O
not	O
needed	O
for	O
oncogenesis	O
or	O
for	O
transcriptional	O
activation	O
.	O
While	O
ICN	protein
appeared	O
primarily	O
in	O
the	O
nucleus	O
,	O
DeltaE	protein
localized	O
to	O
cytoplasmic	O
and	O
nuclear	O
membranes	O
,	O
suggesting	O
that	O
intranuclear	O
localization	O
is	O
not	O
essential	O
for	O
oncogenesis	O
or	O
transcriptional	O
activation	O
.	O
In	O
support	O
of	O
this	O
interpretation,	O
mutation	O
of	O
putative	O
nuclear	protein
localization	protein
sequences	protein
decreased	O
nuclear	O
localization	O
and	O
increased	O
transcriptional	O
activation	O
by	O
membrane-bound	protein
DeltaE	protein
.	O
Transcriptional	O
activation	O
by	O
this	O
mutant	O
form	O
of	O
membrane-bound	protein
DeltaE	protein
was	O
approximately	O
equivalent	O
to	O
that	O
produced	O
by	O
intranuclear	protein
ICN	protein
.	O
These	O
data	O
are	O
most	O
consistent	O
with	O
NOTCH1	protein
oncogenesis	O
and	O
transcriptional	O
activation	O
being	O
independent	O
of	O
association	O
with	O
RBP-Jkappa	protein
at	O
promoter	DNA
sites	DNA
.	O

Sp	protein
family	protein
members	protein
preferentially	O
interact	O
with	O
the	O
promoter	DNA
proximal	DNA
repeat	DNA
within	O
the	O
HTLV-I	DNA
enhancer	DNA
.	O
Human	O
T	O
cell	O
lymphotropic	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
encodes	O
the	O
transactivator	protein
protein	protein
,	O
Tax	protein
,	O
which	O
facilitates	O
viral	O
transcription	O
from	O
three	O
21	DNA
bp	DNA
repeated	DNA
elements	DNA
within	O
the	O
U3	DNA
region	DNA
of	O
the	O
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
).	O
Examination	O
of	O
the	O
basal	protein
factors	protein
interacting	O
with	O
the	O
21	DNA
bp	DNA
repeat	DNA
elements	DNA
through	O
electrophoretic	O
mobility	O
shift	O
(EMS)	O
analyses	O
has	O
demonstrated	O
the	O
formation	O
of	O
DNA-protein	protein
complexes	protein
common	O
to	O
each	O
of	O
the	O
21	DNA
bp	DNA
repeats	DNA
(	O
C1-C3	DNA
)	O
as	O
well	O
as	O
three	O
DNA-protein	protein
complexes	protein
specific	O
to	O
the	O
promoter	DNA
proximal	DNA
(pp)	DNA
repeat	DNA
(	O
U1	DNA
(	O
U1A/U1B	DNA
)	O
and	O
U2	DNA
;	O
1-4).	O
These	O
studies	O
have	O
indicated	O
that	O
the	O
individual	O
repeats	O
are	O
not	O
identical	O
with	O
respect	O
to	O
the	O
cellular	protein
factors	protein
with	O
which	O
they	O
interact.	O
EMS	O
analyses	O
utilizing	O
a	O
series	O
of	O
mutated	DNA
pp	DNA
repeat	DNA
elements	DNA
demonstrate	O
that	O
the	O
nucleotide	O
sequence	O
requirements	O
for	O
U1	DNA
(	O
U1A/U1B	DNA
)	O
and	O
U2	DNA
formation	O
are	O
separable	O
from	O
those	O
required	O
for	O
C1-C3	DNA
formation	O
.	O
Competition	O
EMS	O
analyses	O
utilizing	O
Sp1	O
and	O
CREB	O
binding	O
site	O
oligonucleotides	O
demonstrate	O
that	O
Sp	protein
family	protein
members	protein
are	O
critical	O
components	O
of	O
U1	DNA
(	O
U1A/U1B	DNA
)	O
and	O
U2	DNA
and	O
that	O
ATF/CREB	protein
family	protein
members	protein
are	O
critical	O
components	O
of	O
C1-C3	DNA
.	O
EMS	O
supershift	O
analyses	O
have	O
demonstrated	O
that	O
Sp1	protein
is	O
involved	O
in	O
U1A	O
formation	O
while	O
Sp3	protein
is	O
involved	O
in	O
U1B	O
and	O
U2	O
formation	O
.	O
EMS	O
analyses	O
performed	O
with	O
nuclear	O
extracts	O
from	O
Tax	cell_line
-expressing	cell_line
Jurkat	cell_line
cells	cell_line
and	O
HTLV-I	cell_type
-transformed	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
demonstrate	O
that	O
Tax	protein
prevents	O
the	O
formation	O
of	O
U1	DNA
(	O
U1A/U1B	DNA
)	O
and	O
U2	DNA
DNA-protein	protein
complexes	protein
.	O
Therefore,	O
Tax	protein
appears	O
to	O
inhibit	O
the	O
interaction	O
of	O
Sp	protein
family	protein
members	protein
with	O
the	O
pp	DNA
repeat	DNA
.	O
Based	O
on	O
these	O
observations,	O
it	O
is	O
possible	O
that	O
the	O
interaction	O
of	O
Sp	protein
and	O
ATF/CREB	protein
family	protein
members	protein
with	O
the	O
pp	DNA
repeat	DNA
during	O
basal	O
and	O
Tax	protein
-mediated	O
transcription	O
may	O
play	O
a	O
critical	O
role	O
in	O
viral	O
gene	O
expression	O
during	O
the	O
initial	O
stages	O
of	O
virus	O
infection	O
or	O
during	O
activation	O
of	O
a	O
latent	O
infection	O
.	O

Lineage-	O
and	O
stage-	O
specific	O
expression	O
of	O
runt	protein
box	protein
polypeptides	protein
in	O
primitive	O
and	O
definitive	O
hematopoiesis	O
.	O
Translocations	O
involving	O
the	O
human	DNA
CBFA2	DNA
locus	DNA
have	O
been	O
associated	O
with	O
leukemia	O
.	O
This	O
gene,	O
originally	O
named	O
AML1	DNA
,	O
is	O
a	O
human	O
homologue	O
of	O
the	O
Drosophila	DNA
gene	DNA
runt	DNA
that	O
controls	O
early	O
events	O
in	O
fly	O
embryogenesis	O
.	O
To	O
clarify	O
the	O
role	O
of	O
mammalian	protein
runt	protein
products	protein
in	O
normal	O
and	O
leukemic	O
hematopoiesis	O
,	O
we	O
have	O
studied	O
their	O
pattern	O
of	O
expression	O
in	O
mouse	O
hematopoietic	O
tissues	O
in	O
the	O
adult	O
and	O
during	O
ontogeny	O
using	O
an	O
anti-runt	O
box	O
antiserum	O
.	O
In	O
the	O
adult	O
bone	O
marrow	O
,	O
we	O
found	O
expression	O
of	O
runt	O
polypeptides	O
in	O
differentiating	cell_type
myeloid	cell_type
cells	cell_type
and	O
in	O
B	cell_type
lymphocytes	cell_type
.	O
Within	O
the	O
erythroid	cell_type
lineage	cell_type
,	O
runt	O
expression	O
is	O
biphasic,	O
clearly	O
present	O
in	O
the	O
erythroblasts	cell_type
of	O
early	O
blood	O
islands	O
and	O
of	O
the	O
fetal	O
liver	O
,	O
but	O
absent	O
in	O
the	O
adult.	O
Biochemical	O
analysis	O
by	O
Western	O
blotting	O
of	O
fetal	O
and	O
adult	O
hematopoietic	O
populations	O
shows	O
several	O
runt	protein
isoforms	protein
.	O
At	O
least	O
one	O
of	O
them	O
appears	O
to	O
be	O
myeloid	O
specific.	O

Signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription-3	protein
(	O
STAT3	protein
)	O
is	O
constitutively	O
activated	O
in	O
normal,	O
self-renewing	cell_type
B-1	cell_type
cells	cell_type
but	O
only	O
inducibly	O
expressed	O
in	O
conventional	O
B	cell_type
lymphocytes	cell_type
[see	O
comments]	O
Cytokine	protein
and	O
growth	protein
factor	protein
receptor	protein
engagement	O
leads	O
to	O
the	O
rapid	O
phosphorylation	O
and	O
activation	O
of	O
latent,	O
cytosolic	protein
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(STAT)	protein
proteins	protein
,	O
which	O
then	O
translocate	O
to	O
the	O
nucleus	O
where	O
they	O
regulate	O
transcriptional	O
events	O
from	O
specific	DNA
promoter	DNA
sequences	DNA
.	O
STAT3	protein
expression	O
in	O
particular	O
has	O
been	O
associated	O
with	O
Abl	protein
,	O
Src	protein
,	O
and	O
HTLV-1	O
transformation	O
of	O
normal	cell_type
cells	cell_type
.	O
B-1	cell_type
lymphocytes	cell_type
are	O
self-renewing,	O
CD5+	cell_type
B	cell_type
cells	cell_type
that	O
display	O
a	O
propensity	O
for	O
malignant	O
transformation	O
and	O
are	O
the	O
normal	O
counterpart	O
to	O
human	O
chronic	O
lymphocytic	O
leukemias	O
.	O
Further,	O
B-1	cell_type
cells	cell_type
are	O
characterized	O
by	O
aberrant	O
intracellular	O
signaling	O
,	O
including	O
hyperresponsiveness	O
to	O
phorbol	O
ester	O
PKC	O
agonists	O
.	O
Here	O
we	O
demonstrate	O
that	O
B-1	cell_type
lymphocytes	cell_type
constitutively	O
express	O
nuclear	protein
activated	protein
STAT3	protein
,	O
which	O
is	O
not	O
expressed	O
by	O
unmanipulated	cell_type
conventional	cell_type
(B-2)	cell_type
lymphocytes	cell_type
.	O
In	O
contrast,	O
STAT3	protein
activation	O
is	O
induced	O
in	O
B-2	cell_type
cells	cell_type
after	O
antigen	O
receptor	O
engagement	O
in	O
a	O
delayed	O
fashion	O
(after	O
3	O
h).	O
Induction	O
of	O
STAT3	protein
is	O
inhibited	O
by	O
both	O
the	O
serine/threonine	O
protein	O
kinase	O
inhibitor	O
H-7	O
and	O
the	O
immunosuppressive	O
drug	O
rapamycin	O
and	O
requires	O
de	O
novo	O
protein	O
synthesis,	O
demonstrating	O
novel	O
coupling	O
between	O
sIg	protein
and	O
STAT	protein
proteins	protein
that	O
differs	O
from	O
the	O
classical	O
paradigm	O
for	O
STAT	protein
induction	O
by	O
cytokine	protein
receptors	protein
.	O
The	O
inability	O
of	O
prolonged	O
stimulation	O
of	O
conventional	O
B-2	cell_type
cells	cell_type
with	O
anti-Ig	protein
,	O
a	O
treatment	O
sufficient	O
to	O
induce	O
CD5	protein
expression	O
,	O
to	O
result	O
in	O
sustained	O
STAT3	protein
activation	O
suggests	O
that	O
STAT3	protein
is	O
a	O
specific	O
nuclear	O
marker	O
for	O
B-1	cell_type
cells	cell_type
.	O
Thus,	O
STAT3	protein
may	O
play	O
a	O
role	O
in	O
B	O
cell	O
antigen-specific	O
signaling	O
responses	O
,	O
and	O
its	O
constitutive	O
activation	O
is	O
associated	O
with	O
a	O
normal	O
cell	O
population	O
exhibiting	O
intrinsic	O
proliferative	O
behavior	O
.	O

Significance	O
of	O
quantitative	O
analysis	O
of	O
AML1	RNA
/ETO	RNA
transcripts	RNA
in	O
peripheral	cell_type
blood	cell_type
stem	cell_type
cells	cell_type
from	O
t(8;21)	O
acute	O
myelogenous	O
leukemia	O
.	O
Autologous	O
peripheral	cell_type
blood	cell_type
stem	cell_type
cell	cell_type
transplantation	O
(	O
PBSCT	O
)	O
is	O
replacing	O
autologous	O
bone	O
marrow	O
transplantation	O
(	O
BMT	O
)	O
in	O
the	O
treatment	O
of	O
leukemia	O
.	O
One	O
of	O
the	O
potential	O
advantages	O
of	O
autologous	O
PBSCT	O
is	O
the	O
possibility	O
that	O
peripheral	cell_type
blood	cell_type
stem	cell_type
cells	cell_type
(	O
PBSC	cell_type
)	O
are	O
less	O
likely	O
to	O
be	O
contaminated	O
by	O
leukemic	cell_type
cells	cell_type
than	O
bone	O
marrow	O
grafts	O
.	O
However,	O
the	O
major	O
problem	O
still	O
remains	O
the	O
high	O
incidence	O
of	O
leukemic	O
relapse	O
following	O
autologous	O
PBSCT	O
,	O
which	O
may	O
be	O
caused	O
by	O
the	O
reinfusion	O
of	O
PBSC	cell_type
contaminated	O
by	O
leukemic	cell_type
cells	cell_type
.	O
Recently,	O
we	O
have	O
developed	O
a	O
quantitative	O
assay	O
using	O
competitive	O
reverse	protein
transcriptase	protein
polymerase	protein
chain	O
reaction	O
that	O
estimates	O
the	O
number	O
of	O
AML1	RNA
/ETO	RNA
transcripts	RNA
in	O
t(8;21)	O
acute	O
myelogenous	O
leukemia	O
(	O
AML	O
),	O
in	O
order	O
to	O
determine	O
the	O
degree	O
of	O
leukemic	O
cell	O
contamination	O
in	O
PBSC	cell_type
harvests	O
,	O
and	O
to	O
monitor	O
minimal	O
residual	O
disease	O
(	O
MRD	O
)	O
quantitatively	O
in	O
patients	O
with	O
t(8;21)	O
AML	O
.	O
Our	O
data	O
indicate	O
that	O
although	O
PBSC	cell_type
harvests	O
collected	O
after	O
consolidation	O
chemotherapy	O
are	O
contaminated	O
by	O
leukemic	cell_type
cells	cell_type
,	O
the	O
degree	O
of	O
leukemic	O
cell	O
contamination	O
decreases	O
with	O
repeated	O
cycles	O
of	O
chemotherapy.	O
Furthermore,	O
the	O
MRD	O
in	O
PBSC	cell_type
harvests	O
is	O
less	O
than	O
in	O
the	O
corresponding	O
bone	O
marrow	O
obtained	O
on	O
the	O
day	O
of	O
the	O
PBSC	cell_type
collection	O
.	O
There	O
appears	O
to	O
be	O
no	O
relationship	O
between	O
the	O
number	O
of	O
AML1	RNA
/ETO	RNA
transcripts	RNA
found	O
in	O
the	O
infused	O
PBSC	cell_type
harvests	O
and	O
the	O
incidence	O
of	O
leukemic	O
relapse	O
following	O
autologous	O
PBSCT	O
in	O
our	O
study.	O
However,	O
a	O
substantial	O
decrease	O
of	O
AML1	RNA
/ETO	RNA
transcripts	RNA
was	O
seen	O
following	O
autologous	O
PBSCT	O
.	O
Thus,	O
the	O
quantitative	O
analysis	O
of	O
AML1	RNA
/ETO	RNA
transcripts	RNA
may	O
be	O
clinically	O
useful	O
in	O
patients	O
with	O
t(8;21)	O
AML	O
.	O

Upregulation	O
of	O
c-Fos	protein
in	O
activated	O
T	O
lymphoid	O
and	O
monocytic	O
cells	O
by	O
human	protein
immunodeficiency	protein
virus-1	protein
Tat	protein
protein	protein
.	O
The	O
regulatory	protein
Tat	protein
protein	protein
of	O
the	O
human	O
immunodeficiency	O
virus	O
type-1	O
(	O
HIV-1	O
)	O
is	O
essential	O
for	O
viral	O
replication	O
and	O
also	O
shows	O
pleiotropic	O
activities	O
on	O
various	O
cell	O
functions	O
.	O
To	O
get	O
further	O
insights	O
into	O
the	O
molecular	O
mechanisms	O
underlying	O
the	O
biological	O
activity	O
of	O
Tat	protein
,	O
we	O
investigated	O
the	O
effect	O
of	O
endogenous	O
and	O
exogenous	O
Tat	protein
protein	protein
on	O
c-fos	O
gene	O
expression	O
in	O
T	O
lymphoblastoid	O
(Jurkat)	O
and	O
monocytic	O
(U937)	O
cell	O
lines	O
,	O
as	O
well	O
as	O
in	O
primary	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
).	O
Transient	O
cotransfection	O
of	O
tat	DNA
cDNA	DNA
in	O
sense	O
orientation	O
(	O
tat/S	DNA
),	O
together	O
with	O
a	O
plasmid	DNA
containing	O
the	O
c-fos	DNA
promoter	DNA
(	O
FC3	DNA
,	O
from-	O
711	DNA
to	DNA
+42	DNA
)	O
in	O
front	O
of	O
the	O
bacterial	DNA
chloramphenicol	DNA
acetyltransferase	DNA
(CAT)	DNA
gene	DNA
significantly	O
enhanced	O
CAT	protein
activity	O
in	O
Jurkat	cell_line
cells	cell_line
activated	O
by	O
the	O
addition	O
of	O
15%	O
fetal	O
calf	O
serum	O
(	O
FCS	O
)	O
or	O
5	O
micrograms/mL	O
phytohemagglutinin	protein
plus	O
10(-7)	O
mol/L	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
and	O
U937	cell_line
cells	cell_line
activated	O
by	O
15%	O
FCS	O
or	O
10(-7)	O
mol/L	O
PMA	O
.	O
This	O
effect	O
was	O
specifically	O
due	O
to	O
Tat	protein
,	O
since	O
Jurkat	cell_line
and	O
U937	cell_line
cells	cell_line
cotransfected	O
either	O
with	O
tat	DNA
cDNA	DNA
in	O
antisense	O
orientation	O
(	O
tat/AS	DNA
),	O
tat	DNA
carrying	O
a	O
mutation	O
in	O
the	O
aminoacid	protein
cys22-gly22	protein
(	O
tat	DNA
22/S	DNA
)	O
or	O
with	O
the	O
backbone	DNA
vector	DNA
alone	DNA
(	O
pRPneo-SL3	DNA
)	O
did	O
not	O
show	O
any	O
significant	O
difference	O
in	O
c-fos	DNA
promoter	DNA
activity	O
as	O
compared	O
to	O
cells	O
transfected	O
with	O
FC3	DNA
plasmid	DNA
alone.	O
By	O
using	O
deletion	O
mutants	O
of	O
the	O
c-fos	DNA
promoter	DNA
,	O
we	O
found	O
that	O
the	O
minimal	DNA
DNA	DNA
sequence	DNA
required	O
for	O
Tat	protein
activity	O
was	O
located	O
between	O
nucleotides	DNA
-404/-220	DNA
and	O
that	O
the	O
serum	DNA
responsive	DNA
element	DNA
(	O
SRE	DNA
,	O
-317/-288	DNA
),	O
present	O
within	O
this	O
region,	O
was	O
still	O
responsive	O
to	O
Tat	protein
.	O
A	O
single	DNA
point	DNA
mutation	DNA
in	O
the	O
SRE	DNA
completely	O
abrogated	O
the	O
responsiveness	O
to	O
tat/S	DNA
.	O
Exogenous	O
recombinant	protein
Tat	protein
protein	protein
was	O
also	O
able	O
to	O
upregulate	O
c-fos	DNA
promoter	DNA
activity	O
in	O
serum-activated	O
Jurkat	O
and	O
U937	cell_line
cells	cell_line
,	O
as	O
well	O
as	O
endogenous	O
c-fos	RNA
mRNA	RNA
expression	O
and	O
c-Fos	protein
protein	O
synthesis	O
in	O
both	O
serum-activated	cell_line
cell	cell_line
lines	cell_line
and	O
primary	cell_type
PBMC	cell_type
.	O
c-Fos	protein
protein	O
was	O
shown	O
essential	O
for	O
an	O
optimal	O
transactivation	O
of	O
the	O
HIV-1	O
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
by	O
Tat	protein
:	O
incubation	O
of	O
Jurkat	cell_line
cells	cell_line
with	O
antisense,	O
but	O
not	O
sense,	O
c-fos	O
oligonucleotides	O
significantly	O
reduced	O
either	O
the	O
Tat	protein
-enhanced	O
expression	O
of	O
an	O
LTR-CAT	DNA
reporter	DNA
construct	DNA
or	O
the	O
levels	O
of	O
gag	protein
p24	protein
in	O
the	O
culture	O
supernatants	O
of	O
Jurkat	cell_line
cells	cell_line
and	O
PBMC	cell_type
acutely	O
infected	O
with	O
HIV-1	O
.	O
Our	O
data	O
suggest	O
that	O
the	O
c-fos	DNA
upregulation	O
mediated	O
by	O
Tat	protein
might	O
play	O
a	O
significant	O
role	O
in	O
the	O
control	O
of	O
viral	O
gene	O
transactivation	O
.	O

Cytokine	protein
signal	protein
networks	protein
and	O
a	O
new	O
era	O
in	O
biomedical	O
research	O
.	O
Elucidation	O
of	O
the	O
biochemical	O
nature	O
of	O
the	O
signal	O
transduction	O
pathway	O
that	O
regulate	O
transcription	O
and	O
replication	O
is	O
the	O
focus	O
of	O
attention	O
in	O
molecular	O
biology	O
.	O
This	O
research	O
may	O
make	O
feasible	O
manipulation	O
of	O
growth	O
and	O
differentiation	O
of	O
mammalian	cell_type
cells	cell_type
,	O
which	O
in	O
turn	O
would	O
have	O
profound	O
implication	O
in	O
biomedical	O
research	O
on	O
cell	O
and	O
gene	O
therapy,	O
and	O
development	O
of	O
pharmaceutical	O
products	O
.	O
Cytokines	protein
control	O
growth,	O
differentiation,	O
death,	O
and	O
function	O
of	O
cells	O
of	O
lymphocytic	O
,	O
hemopoietic	O
systems	O
,	O
and	O
together	O
with	O
nerve	cell_type
cells	cell_type
provide	O
a	O
pertinent	O
model	O
to	O
study	O
intercellular	O
communications	O
and	O
intercellular	O
signal	O
networks	O
.	O
This	O
review	O
outlines	O
general	O
features	O
of	O
signal	O
transduction	O
and	O
several	O
aspects	O
of	O
cytokine	protein
networks	protein
are	O
discussed	O
with	O
emphasis	O
on:	O
transcriptional	O
regulation	O
of	O
Th1	O
and	O
Th2-specific	O
cytokine	DNA
genes	DNA
in	O
T	cell_type
cells	cell_type
,	O
the	O
roles	O
of	O
cytokines	protein
and	O
their	O
receptors	O
in	O
growth	O
and	O
differentiation	O
of	O
hemopoietic	cell_type
cells	cell_type
,	O
and	O
the	O
manipulation	O
of	O
cytokine	protein
networks	protein
.	O

Regulation	O
of	O
the	O
tissue	DNA
factor	DNA
gene	DNA
in	O
human	cell_type
monocytic	cell_type
cells	cell_type
.	O
Role	O
of	O
AP-1	protein
,	O
NF-kappa	protein
B/Rel	protein
,	O
and	O
Sp1	protein
proteins	O
in	O
uninduced	O
and	O
lipopolysaccharide	O
-induced	O
expression	O
.	O
Tissue	protein
factor	protein
(TF)	O
expression	O
by	O
peripheral	cell_type
blood	cell_type
monocytes	cell_type
during	O
sepsis	O
initiates	O
intravascular	O
thrombosis	O
.	O
Bacterial	O
lipopolysaccharide	O
(	O
LPS	O
)	O
rapidly	O
induces	O
TF	DNA
gene	DNA
transcription	O
in	O
monocytes	cell_type
.	O
The	O
human	DNA
TF	DNA
promoter	DNA
contains	O
binding	O
sites	O
for	O
the	O
transcription	O
factors	O
AP-1	protein
,	O
c-Rel/p65	protein
,	O
Egr-1	protein
,	O
and	O
Sp1	protein
.	O
NF-kappa	protein
B/Rel	protein
proteins	protein
have	O
been	O
shown	O
to	O
physically	O
interact	O
with	O
both	O
AP-1	O
and	O
Sp1	O
proteins	O
.	O
In	O
this	O
study,	O
we	O
investigated	O
the	O
role	O
of	O
these	O
transcription	protein
factors	protein
in	O
uninduced	O
and	O
LPS	O
-induced	O
TF	DNA
gene	DNA
expression	O
in	O
human	cell_type
monocytic	cell_type
THP-1	cell_type
cells	cell_type
.	O
Deletional	O
analysis	O
indicated	O
that	O
five	O
Sp1	DNA
sites	DNA
mediated	O
basal	O
expression	O
in	O
uninduced	cell_type
cells	cell_type
.	O
The	O
two	O
AP-1	DNA
sites	DNA
bound	O
c-Fos	protein
/c-Jun	protein
heterodimers	protein
in	O
both	O
unstimulated	O
and	O
LPS-stimulated	O
cells	O
.	O
Maximal	O
LPS	O
induction	O
of	O
the	O
TF	DNA
promoter	DNA
required	O
the	O
two	O
AP-1	protein
sites	O
and	O
the	O
kappa	DNA
B	DNA
site	DNA
within	O
the	O
LPS	DNA
response	DNA
element	DNA
.	O
Disruption	O
of	O
the	O
conserved	O
spacing	O
between	O
the	O
proximal	DNA
AP-1	DNA
site	DNA
and	O
the	O
kappa	DNA
B	DNA
site	DNA
abolished	O
LPS	O
induction	O
.	O
Replacement	O
of	O
the	O
two	O
AP-1	DNA
sites	DNA
with	O
intrinsically	O
bent	O
DNA	O
partially	O
restored	O
LPS	O
induction	O
,	O
suggesting	O
an	O
additional	O
structural	O
role	O
for	O
the	O
AP-1	DNA
sites	DNA
.	O
Synergistic	O
transactivation	O
of	O
the	O
LPS	DNA
response	DNA
element	DNA
in	O
Drosophila	cell_line
Schneider	cell_line
cells	cell_line
by	O
coexpression	O
of	O
c-Fos	protein
,	O
c-Jun	protein
,	O
c-Rel	protein
,	O
and	O
p65	protein
or	O
c-Jun	protein
and	O
p65	protein
required	O
the	O
transactivation	protein
domains	protein
of	O
c-Jun	protein
and	O
p65	protein
.	O
These	O
data	O
indicated	O
that	O
c-Fos	protein
/c-Jun	protein
,	O
c-Rel	protein
/p65	protein
,	O
and	O
Sp1	protein
regulate	O
TF	DNA
gene	DNA
expression	O
in	O
human	cell_type
monocytic	cell_type
cells	cell_type
.	O

Inhibitory	O
effect	O
of	O
growth	O
hormone	O
on	O
TNF-alpha	protein
secretion	O
and	O
nuclear	protein
factor-kappaB	protein
translocation	O
in	O
lipopolysaccharide	cell_type
-stimulated	cell_type
human	cell_type
monocytes	cell_type
.	O
Several	O
studies	O
have	O
pointed	O
to	O
a	O
link	O
between	O
immune	O
and	O
endocrine	O
systems	O
,	O
including	O
a	O
regulatory	O
function	O
of	O
GH	O
on	O
monocyte	O
activation.	O
The	O
present	O
study	O
demonstrates	O
that	O
human	O
THP-1	cell_line
promonocytic	cell_line
cells	cell_line
,	O
engineered	O
by	O
gene	O
transfer	O
to	O
constitutively	O
produce	O
human	O
growth	O
hormone	O
(	O
hGH	O
),	O
secreted	O
depressed	O
amounts	O
of	O
TNF-alpha	protein
in	O
response	O
to	O
challenge	O
by	O
LPS	O
.	O
The	O
effect	O
of	O
GH	O
appears	O
to	O
occur	O
in	O
an	O
autocrine	O
fashion,	O
since	O
the	O
inhibitory	O
effect	O
on	O
TNF-alpha	protein
secretion	O
by	O
constitutive	O
GH	O
production	O
could	O
be	O
abolished	O
in	O
the	O
presence	O
of	O
anti-hGH	protein
mAb	protein
.	O
The	O
GH	O
-induced	O
inhibitory	O
effect	O
was	O
also	O
observed	O
using	O
normal	cell_type
human	cell_type
monocytes	cell_type
and	O
monocyte-derived	cell_type
macrophages	cell_type
.	O
Inhibition	O
of	O
TNF-alpha	protein
production	O
by	O
THP-1-hGH-transfected	cell_line
cells	cell_line
cultured	O
in	O
the	O
presence	O
of	O
LPS	O
is	O
dependent	O
on	O
a	O
selective	O
pathway,	O
since	O
no	O
inhibition	O
of	O
TNF-alpha	protein
production	O
was	O
observed	O
when	O
cells	O
were	O
cultured	O
in	O
the	O
presence	O
of	O
PMA	O
.	O
Inhibition	O
of	O
TNF-alpha	protein
secretion	O
by	O
LPS	cell_line
-stimulated	cell_line
THP-1-hGH	cell_line
cells	cell_line
was	O
associated	O
with	O
a	O
decrease	O
in	O
nuclear	O
translocation	O
of	O
nuclear	protein
factor-kappaB	protein
.	O
The	O
capacity	O
of	O
GH	O
to	O
inhibit	O
LPS	O
-induced	O
TNF-alpha	protein
production	O
by	O
monocytes	cell_type
without	O
altering	O
other	O
pathways	O
leading	O
to	O
TNF-alpha	protein
production	O
may	O
be	O
of	O
potential	O
relevance	O
in	O
septic	O
shock	O
,	O
since	O
GH	O
is	O
available	O
for	O
clinical	O
use.	O

Nuclear	protein
factor-kappaB	protein
activation	O
in	O
human	cell_type
monocytes	cell_type
stimulated	O
with	O
lipopolysaccharide	O
is	O
inhibited	O
by	O
fibroblast	O
conditioned	O
medium	O
and	O
exogenous	O
PGE2	O
.	O
The	O
nuclear	protein
factor	protein
kappaB	protein
(	O
NF-kappaB	protein
)	O
is	O
thought	O
to	O
be	O
crucially	O
involved	O
in	O
the	O
gene	O
activation	O
of	O
several	O
cytokines	protein
,	O
including	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF	protein
).	O
Previously,	O
we	O
showed	O
that	O
fibroblast	O
conditioned	O
medium	O
(	O
FCM	O
)	O
is	O
able	O
to	O
inhibit	O
both	O
TNF	RNA
mRNA	RNA
accumulation	O
and	O
protein	O
release	O
in	O
peripheral	cell_line
blood-derived	cell_line
human	cell_line
monocytes	cell_line
(	O
PBM	cell_line
)	O
stimulated	O
with	O
lipopolysaccharide	O
(	O
LPS	O
).	O
In	O
this	O
study	O
we	O
have	O
investigated	O
the	O
effect	O
of	O
FCM	O
on	O
the	O
LPS	O
-induced	O
DNA-binding	O
activity	O
of	O
NF-kappaB	protein
,	O
by	O
means	O
of	O
electrophoretic	O
shift	O
assay	O
(	O
EMSA	O
).	O
We	O
provide	O
evidence	O
that	O
FCM	O
strongly	O
inhibits	O
the	O
LPS	O
-induced	O
NF-kappaB	protein
activation	O
in	O
PBM	cell_line
.	O
Furthermore,	O
we	O
show	O
that	O
exogenous	O
PGE2	O
mimics	O
the	O
NF-kappaB	protein
inhibitory	O
effect	O
of	O
FCM	O
.	O
On	O
the	O
other	O
hand,	O
FCM	O
produced	O
in	O
the	O
presence	O
of	O
indomethacin	O
does	O
not	O
inhibit	O
NF-kappaB	protein
activation	O
by	O
LPS	O
.	O
Our	O
results	O
lend	O
further	O
support	O
to	O
the	O
hypothesis	O
that	O
inflammatory	O
and	O
immune	O
responses	O
of	O
monocytes/macrophages	cell_type
may	O
be	O
modulated	O
at	O
the	O
molecular	O
level	O
by	O
signals	O
originating	O
from	O
tissue	cell_type
structural	cell_type
cells	cell_type
such	O
as	O
fibroblasts	cell_type
.	O

Human	protein
neutrophil	protein
elastase	protein
proteolytically	O
activates	O
the	O
platelet	protein
integrin	protein
alphaIIbbeta3	protein
through	O
cleavage	O
of	O
the	O
carboxyl	protein
terminus	protein
of	O
the	O
alphaIIb	protein
subunit	protein
heavy	protein
chain	protein
.	O
Involvement	O
in	O
the	O
potentiation	O
of	O
platelet	O
aggregation	O
.	O
Neutrophil	protein
elastase	protein
(	O
NE	protein
)	O
and	O
cathepsin	protein
G	protein
are	O
two	O
serine	protein
proteinases	protein
released	O
concomitantly	O
by	O
stimulated	O
polymorphonuclear	cell_type
neutrophils	cell_type
.	O
We	O
previously	O
demonstrated	O
that	O
while	O
NE	protein
by	O
itself	O
does	O
not	O
activate	O
human	cell_type
platelets	cell_type
,	O
it	O
strongly	O
enhances	O
the	O
weak	O
aggregation	O
induced	O
by	O
a	O
threshold	O
concentration	O
of	O
cathepsin	protein
G	protein
(threshold	O
of	O
cathepsin	protein
G	protein
)	O
(Renesto,	O
P.,	O
and	O
Chignard,	O
M.	O
(1993)	O
Blood	O
82,	O
139-144).	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
delineate	O
the	O
molecular	O
mechanisms	O
involved	O
in	O
this	O
potentiation	O
process.	O
Two	O
main	O
pieces	O
of	O
data	O
prompted	O
us	O
to	O
focus	O
on	O
the	O
activation	O
of	O
the	O
platelet	protein
fibrinogen	protein
receptor	protein
,	O
the	O
alphaIIbbeta3	protein
integrin	protein
.	O
First,	O
previous	O
studies	O
have	O
shown	O
this	O
integrin	protein
to	O
be	O
particularly	O
prone	O
to	O
proteolytic	O
regulation	O
of	O
its	O
function.	O
Second,	O
we	O
found	O
that	O
the	O
potentiating	O
activity	O
of	O
NE	protein
on	O
the	O
threshold	O
of	O
cathepsin	protein
G	protein
-induced	O
platelet	O
aggregation	O
was	O
strictly	O
dependent	O
on	O
the	O
presence	O
of	O
exogenous	protein
fibrinogen	protein
.	O
Using	O
flow	O
cytometry	O
analysis,	O
NE	protein
was	O
shown	O
to	O
trigger	O
a	O
time-dependent	O
binding	O
of	O
PAC-1	protein
and	O
AP-5	protein
,	O
two	O
monoclonal	protein
antibodies	protein
specific	O
for	O
the	O
activated	O
and	O
ligand-occupied	O
conformers	O
of	O
alphaIIbbeta3	protein
.	O
Furthermore,	O
the	O
potentiated	O
aggregation	O
was	O
shown	O
to	O
result	O
from	O
an	O
increased	O
capacity	O
of	O
platelets	O
to	O
bind	O
fibrinogen.	O
Indeed,	O
the	O
combination	O
of	O
NE	protein
and	O
threshold	O
of	O
cathepsin	protein
G	protein
increased	O
the	O
binding	O
of	O
PAC-1	protein
approximately	O
5.5-fold	O
over	O
basal	O
values	O
measured	O
on	O
nontreated	cell_type
platelets	cell_type
,	O
whereas	O
this	O
binding	O
raised	O
only	O
by	O
approximately	O
3-fold	O
in	O
threshold	O
of	O
cathepsin	cell_type
G	cell_type
-stimulated	cell_type
platelets	cell_type
(p	O
&lt;	O
0.05).	O
By	O
contrast,	O
phosphatidic	O
acid	O
accumulation	O
,	O
pleckstrin	O
phosphorylation	O
,	O
and	O
calcium	O
mobilization	O
produced	O
by	O
the	O
combination	O
of	O
NE	protein
and	O
threshold	O
of	O
cathepsin	protein
G	protein
were	O
not	O
significantly	O
different	O
from	O
those	O
measured	O
with	O
threshold	O
of	O
cathepsin	protein
G	protein
alone	O
(p	O
&gt;	O
0.05),	O
indicating	O
that	O
the	O
phospholipase	protein
C	protein
/protein	protein
kinase	protein
C	protein
pathway	O
is	O
not	O
involved	O
in	O
the	O
potentiation	O
of	O
aggregation.	O
The	O
foregoing	O
data,	O
as	O
well	O
as	O
the	O
requirement	O
of	O
catalytically	O
active	O
NE	protein
to	O
trigger	O
alphaIIbbeta3	protein
activation	O
and	O
potentiate	O
threshold	O
of	O
cathepsin	protein
G	protein
-initiated	O
platelet	O
aggregation	O
,	O
led	O
us	O
to	O
examine	O
whether	O
the	O
structure	O
of	O
this	O
integrin	protein
was	O
affected	O
by	O
NE	protein
.	O
Immunoblot	O
and	O
flow	O
cytometry	O
analysis	O
revealed	O
a	O
limited	O
proteolysis	O
of	O
the	O
carboxyl	protein
terminus	protein
of	O
the	O
alphaIIb	protein
subunit	protein
heavy	protein
chain	protein
(	O
alphaIIbH	protein
),	O
as	O
judged	O
by	O
the	O
disappearance	O
of	O
the	O
epitope	O
for	O
the	O
monoclonal	protein
antibody	protein
PMI-1	protein
.	O
Mass	O
spectrometry	O
studies	O
performed	O
on	O
a	O
synthetic	O
peptide	O
mapping	O
over	O
the	O
cleavage	protein
domain	protein
of	O
alphaIIbH	protein
predicted	O
the	O
site	O
of	O
proteolysis	O
as	O
located	O
between	O
Val837	O
and	O
Asp838	O
.	O
Treatment	O
by	O
NE	protein
of	O
ATP-depleted	cell_type
platelets	cell_type
or	O
Chinese	cell_line
hamster	cell_line
ovary	cell_line
cells	cell_line
expressing	O
human	protein
recombinant	protein
alphaIIbbeta3	protein
clearly	O
established	O
that	O
activation	O
of	O
the	O
integrin	protein
was	O
independent	O
of	O
signal	O
transduction	O
events	O
and	O
was	O
concomitant	O
with	O
the	O
proteolysis	O
of	O
alphaIIbH	protein
.	O

AP-1	protein
derived	O
from	O
mature	cell_type
monocytes	cell_type
and	O
astrocytes	cell_type
preferentially	O
interacts	O
with	O
the	O
HTLV-I	DNA
promoter	DNA
central	O
21	DNA
bp	DNA
repeat	DNA
.	O
Characterization	O
of	O
the	O
cellular	O
transcription	protein
factors	protein
interacting	O
with	O
the	O
human	DNA
T	DNA
cell	DNA
lymphotropic	DNA
virus	DNA
type	DNA
I	DNA
(	DNA
HTLV-I	DNA
)	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
is	O
essential	O
to	O
dissecting	O
the	O
mechanisms	O
involved	O
in	O
viral	O
transcription	O
that	O
may	O
be	O
pertinent	O
to	O
the	O
oncogenic	O
and	O
neuropathogenic	O
processes	O
associated	O
with	O
HTLV-I	O
infection	O
in	O
both	O
the	O
immune	O
and	O
nervous	O
systems	O
.	O
Electrophoretic	O
mobility	O
shift	O
(	O
EMS	O
)	O
analyses	O
utilizing	O
oligonucleotides	O
homologous	O
to	O
each	O
of	O
the	O
21	DNA
bp	DNA
repeat	DNA
elements	DNA
reacted	O
with	O
nuclear	O
extracts	O
derived	O
from	O
cell	cell_line
lines	cell_line
of	O
lymphocytic	O
,	O
monocytic	O
,	O
neuronal	O
,	O
and	O
glial	O
cell	O
origin	O
have	O
demonstrated	O
differential	O
binding	O
of	O
cellular	protein
factors	protein
to	O
the	O
three	O
21	DNA
bp	DNA
repeats	DNA
(1-4).	O
ATF/CREB	protein
and	O
Sp	protein
family	protein
members	protein
interacted	O
with	O
the	O
21	DNA
bp	DNA
repeats	DNA
to	O
form	O
DNA-protein	protein
complexes	protein
common	O
to	O
all	O
cell	O
types	O
examined.	O
However,	O
a	O
unique	O
DNA-protein	protein
complex	protein
was	O
detected	O
when	O
the	O
promoter	O
central	O
21	DNA
bp	DNA
repeat	DNA
was	O
reacted	O
with	O
nuclear	O
extracts	O
derived	O
from	O
either	O
the	O
U-373	cell_line
MG	cell_line
glioblastoma	cell_line
cell	cell_line
line	cell_line
or	O
the	O
THP-1	cell_line
mature	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
.	O
Based	O
on	O
nucleotide	O
sequence	O
requirements	O
and	O
immunoreactivity,	O
we	O
demonstrate	O
that	O
this	O
DNA-protein	protein
complex	protein
is	O
comprised	O
of	O
the	O
AP-1	protein
components,	O
Fos	protein
and	O
Jun	protein
.	O

HIV	O
does	O
not	O
replicate	O
in	O
naive	cell_type
CD4	cell_type
T	cell_type
cells	cell_type
stimulated	O
with	O
CD3/CD28	protein
.	O
In	O
this	O
report,	O
we	O
demonstrate	O
that	O
the	O
T	O
cell	O
tropic	O
strain	O
of	O
HIV	O
,	O
LAI	O
,	O
does	O
not	O
replicate	O
in	O
naive	cell_type
CD4	cell_type
T	cell_type
cells	cell_type
stimulated	O
by	O
cross-linking	O
CD3	protein
and	O
CD28	protein
.	O
In	O
contrast,	O
LAI	O
replicates	O
well	O
in	O
memory	cell_type
CD4	cell_type
T	cell_type
cells	cell_type
stimulated	O
in	O
the	O
same	O
way.	O
Unlike	O
this	O
physiologically	O
relevant	O
stimulation,	O
PHA	protein
stimulates	O
productive	O
LAI	O
replication	O
in	O
both	O
naive	O
and	O
memory	O
T	O
cells	O
.	O
These	O
studies	O
were	O
conducted	O
with	O
highly	O
purified	O
(FACS-isolated)	O
subsets	O
of	O
CD4	cell_type
T	cell_type
cells	cell_type
identified	O
by	O
expression	O
of	O
both	O
CD45RA	protein
and	O
CD62L	protein
.	O
Remixing	O
of	O
purified	cell_type
T	cell_type
cells	cell_type
showed	O
that	O
naive	cell_type
T	cell_type
cells	cell_type
do	O
not	O
suppress	O
LAI	O
replication	O
in	O
memory	cell_type
T	cell_type
cells	cell_type
and	O
that	O
memory	cell_type
T	cell_type
cells	cell_type
do	O
not	O
restore	O
LAI	O
expression	O
in	O
naive	cell_type
T	cell_type
cells	cell_type
.	O
The	O
suppression	O
of	O
productive	O
LAI	O
replication	O
in	O
naive	cell_type
T	cell_type
cells	cell_type
is	O
not	O
due	O
to	O
differential	O
expression	O
of	O
viral	protein
coreceptors	protein
,	O
nor	O
is	O
it	O
due	O
to	O
inhibition	O
of	O
activation	O
of	O
the	O
important	O
HIV	O
transcription	protein
factors	protein
,	O
nuclear	protein
factor-kappaB	protein
and	O
activator	protein
protein-1	protein
.	O
The	O
inherent	O
resistance	O
of	O
naive	cell_type
T	cell_type
cells	cell_type
to	O
productive	O
HIV	O
infection,	O
coupled	O
with	O
their	O
proliferative	O
advantage	O
as	O
demonstrated	O
here,	O
provides	O
a	O
sound	O
basis	O
for	O
proposed	O
clinical	O
therapies	O
using	O
ex	O
vivo	O
expansion	O
and	O
reinfusion	O
of	O
CD4	cell_type
T	cell_type
cells	cell_type
from	O
HIV	O
-infected	O
adults	O
.	O

A	O
PMLRARalpha	DNA
transgene	DNA
initiates	O
murine	O
acute	O
promyelocytic	O
leukemia	O
.	O
The	O
malignant	cell_type
cells	cell_type
of	O
acute	O
promyelocytic	O
leukemia	O
(	O
APL	O
)	O
contain	O
a	O
reciprocal	O
chromosomal	O
translocation	O
that	O
fuses	O
the	O
promyelocytic	DNA
leukemia	DNA
gene	DNA
(	O
PML	O
)	O
with	O
the	O
retinoic	DNA
acid	DNA
receptor	DNA
alpha	DNA
gene	DNA
(	O
RAR	protein
alpha	protein
).	O
To	O
test	O
the	O
hypothesis	O
that	O
the	O
chimera	protein
PMLRAR	protein
alpha	protein
plays	O
a	O
role	O
in	O
leukemogenesis	O
,	O
we	O
expressed	O
a	O
PMLRAR	DNA
alpha	DNA
cDNA	DNA
in	O
myeloid	cell_type
cells	cell_type
of	O
transgenic	O
mice	O
.	O
PMLRAR	O
alpha	O
transgenic	O
mice	O
exhibited	O
impaired	O
neutrophil	O
maturation	O
early	O
in	O
life,	O
which	O
progressed	O
at	O
a	O
low	O
frequency	O
over	O
the	O
course	O
of	O
several	O
months	O
to	O
overt	O
APL	O
.	O
Both	O
the	O
preleukemic	O
state	O
and	O
the	O
leukemia	O
could	O
be	O
transplanted	O
to	O
nontransgenic	O
mice	O
,	O
and	O
the	O
transplanted	O
preleukemia	O
could	O
progress	O
to	O
APL	O
.	O
The	O
APL	O
recapitulated	O
features	O
of	O
the	O
human	O
disease	O
,	O
including	O
a	O
response	O
to	O
retinoic	O
acid	O
.	O
Retinoic	O
acid	O
caused	O
the	O
leukemic	cell_type
cells	cell_type
to	O
differentiate	O
in	O
vitro	O
and	O
in	O
vivo,	O
eliciting	O
remissions	O
of	O
both	O
the	O
preleukemic	O
state	O
and	O
APL	O
in	O
mice	O
.	O
Our	O
results	O
demonstrate	O
that	O
PMLRAR	protein
alpha	protein
impairs	O
neutrophil	O
differentiation	O
and	O
initiates	O
the	O
development	O
of	O
APL	O
.	O
The	O
transgenic	O
mice	O
described	O
here	O
provide	O
an	O
apparently	O
accurate	O
model	O
for	O
human	O
APL	O
that	O
includes	O
clear	O
evidence	O
of	O
tumor	O
progression	O
.	O
The	O
model	O
should	O
be	O
useful	O
for	O
exploring	O
the	O
molecular	O
pathogenesis	O
of	O
APL	O
and	O
the	O
mechanisms	O
of	O
the	O
therapeutic	O
response	O
to	O
retinoic	O
acid	O
,	O
as	O
well	O
as	O
for	O
preclinical	O
studies	O
of	O
therapeutic	O
regimens	O
.	O

DNA	O
methylation	O
changes	O
in	O
hematologic	O
malignancies	O
:	O
biologic	O
and	O
clinical	O
implications.	O
DNA	O
methylation	O
changes	O
are	O
among	O
the	O
most	O
common	O
detectable	O
abnormalities	O
in	O
human	O
neoplasia	O
.	O
Hypermethylation	O
within	O
the	O
promoters	DNA
of	O
selected	O
genes	O
appears	O
to	O
be	O
especially	O
common	O
in	O
all	O
types	O
of	O
human	cell_type
hematopoietic	cell_type
neoplasms	cell_type
,	O
and	O
is	O
usually	O
associated	O
with	O
inactivation	O
of	O
the	O
involved	O
gene(s).	O
Such	O
hypermethylation-associated	O
silencing	O
of	O
gene	O
expression	O
has	O
been	O
shown	O
for	O
several	O
genes	O
regulating	O
the	O
growth	O
and	O
differentiation	O
of	O
hematopoietic	cell_type
cells	cell_type
,	O
including	O
the	O
estrogen	DNA
receptor	DNA
(ER)	DNA
gene	DNA
,	O
P15,	O
P16	O
and	O
others.	O
Hypermethylation	O
within	O
the	O
promoters	DNA
of	O
some	O
genes	O
appear	O
to	O
be	O
an	O
early	O
event	O
in	O
the	O
pathogenesis	O
of	O
neoplasia	O
(	O
ER	DNA
,	O
P15	DNA
),	O
while	O
other	O
genes	O
seem	O
to	O
become	O
methylated	O
during	O
the	O
progression	O
of	O
leukemias	O
(HIC1,	O
c-abl).	O
The	O
high	O
prevalence	O
of	O
promoter	O
methylation	O
suggests	O
that	O
this	O
molecular	O
abnormality	O
can	O
be	O
used	O
to	O
monitor	O
disease	O
activity	O
during	O
therapy.	O
In	O
addition,	O
new	O
technology	O
allows	O
the	O
sensitive	O
identification	O
of	O
gene	O
hypermethylation	O
in	O
a	O
background	O
of	O
normal	cell_type
cells	cell_type
,	O
suggesting	O
possible	O
new	O
strategies	O
for	O
the	O
detection	O
of	O
minimal	O
residual	O
disease.	O
Finally,	O
reactivation	O
of	O
tumor-suppressor	O
gene	O
expression	O
through	O
pharmacologic	O
inhibition	O
of	O
DNA	protein
methyltransferase	protein
and	O
resultant	O
DNA	O
demethylation	O
appears	O
to	O
be	O
a	O
promising	O
new	O
avenue	O
of	O
therapy	O
in	O
acute	O
leukemia	O
.	O

Redox	O
regulation	O
of	O
the	O
mitogen-activated	protein
protein	protein
kinase	protein
pathway	O
during	O
lymphocyte	O
activation	O
.	O
We	O
have	O
previously	O
demonstrated	O
an	O
obligatory	O
requirement	O
for	O
intracellular	O
reactive	O
oxygen	O
species	O
generation	O
during	O
T	O
lymphocyte	O
activation	O
,	O
and	O
have	O
proposed	O
that	O
intracellular	O
reactive	O
oxygen	O
species	O
may	O
act	O
as	O
signalling	O
agents	O
in	O
the	O
regulation	O
of	O
certain	O
cellular	O
processes,	O
for	O
example,	O
during	O
cell	O
cycle	O
entry	O
.	O
To	O
test	O
this	O
hypothesis,	O
we	O
have	O
been	O
interested	O
to	O
determine	O
which,	O
if	O
any,	O
cell	O
cycle	O
entry	O
events	O
are	O
affected	O
by	O
oxidative	O
signalling.	O
In	O
earlier	O
studies,	O
we	O
have	O
identified	O
the	O
transcription	protein
factors	protein
NF-kappa	protein
B	protein
and	O
AP-1	protein
as	O
molecular	O
targets	O
for	O
oxidative	O
signalling	O
processes	O
during	O
cell	O
cycle	O
entry	O
,	O
and	O
have	O
shown	O
that	O
oxidative	O
signalling	O
is	O
involved	O
in	O
the	O
regulation	O
of	O
early	O
changes	O
in	O
gene	O
expression	O
during	O
the	O
G0	O
to	O
G1	O
phase	O
transition	O
.	O
To	O
extend	O
these	O
initial	O
observations,	O
we	O
have	O
examined	O
the	O
effect	O
of	O
antioxidant	O
treatment	O
on	O
the	O
activity	O
of	O
the	O
mitogen-activated	protein
protein	protein
kinases	protein
erk1	protein
and	O
erk2	protein
,	O
as	O
members	O
of	O
a	O
signal	O
transduction	O
pathway	O
known	O
to	O
directly	O
regulate	O
transcription	O
factor	O
function	O
.	O
Using	O
as	O
a	O
probe	O
cysteamine	O
,	O
an	O
aminothiol	O
compound	O
with	O
both	O
antioxidant	O
and	O
antiproliferative	O
activity	O
,	O
we	O
have	O
identified	O
erk2	protein
,	O
a	O
key	O
element	O
of	O
the	O
MAP	O
kinase	O
pathway,	O
as	O
being	O
responsive	O
to	O
oxidative	O
signalling	O
during	O
lymphocyte	O
activation	O
.	O
These	O
observations	O
provide	O
further	O
evidence	O
to	O
suggest	O
a	O
role	O
for	O
intracellular	O
oxidant	O
generation	O
as	O
a	O
regulatory	O
mechanism	O
during	O
cell	O
cycle	O
entry	O
,	O
and	O
establish	O
a	O
link	O
between	O
oxidative	O
signalling	O
and	O
other	O
aspects	O
of	O
the	O
intracellular	O
signalling	O
network	O
that	O
is	O
activated	O
in	O
response	O
to	O
mitogenic	O
stimulation	O
.	O

Physical	O
and	O
functional	O
interaction	O
between	O
the	O
human	protein
T-cell	protein
lymphotropic	protein
virus	protein
type	protein
1	protein
Tax1	protein
protein	protein
and	O
the	O
CCAAT	protein
binding	protein
protein	protein
NF-Y	protein
.	O
Tax1	protein
,	O
a	O
potent	O
activator	O
of	O
human	O
T-cell	O
lymphotropic	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
transcription	O
,	O
has	O
been	O
shown	O
to	O
modulate	O
expression	O
of	O
many	O
cellular	DNA
genes	DNA
.	O
Tax1	protein
does	O
not	O
bind	O
DNA	O
directly	O
but	O
regulates	O
transcription	O
through	O
protein-protein	O
interactions	O
with	O
sequence-specific	protein
transcription	protein
factors	protein
.	O
Using	O
the	O
yeast	O
two-hybrid	O
system	O
to	O
screen	O
for	O
proteins	O
which	O
interact	O
with	O
Tax1	protein
,	O
we	O
isolated	O
the	O
B	protein
subunit	protein
of	O
the	O
CCAAT	protein
binding	protein
protein	protein
NF-Y	protein
from	O
a	O
HeLa	DNA
cDNA	DNA
library	DNA
.	O
The	O
interaction	O
of	O
Tax1	protein
with	O
NF-YB	protein
was	O
specific	O
in	O
that	O
NF-YB	protein
did	O
not	O
interact	O
with	O
a	O
variety	O
of	O
other	O
transcription	protein
factors	protein
,	O
including	O
human	protein
immunodeficiency	protein
virus	protein
Tat	protein
,	O
human	protein
papillomavirus	protein
E6	protein
,	O
and	O
Bicoid	protein
,	O
or	O
with	O
the	O
M7	protein
(amino	protein
acids	protein
29CP-AS)	protein
Tax1	protein
mutant	protein
.	O
However,	O
NF-YB	protein
did	O
interact	O
with	O
the	O
C-terminal	protein
Tax1	protein
mutants	protein
M22	protein
(	O
130TL-AS	protein
)	O
and	O
M47	protein
(	O
319LL-RS	protein
).	O
We	O
also	O
show	O
that	O
in	O
vitro-translated	O
NF-YB	protein
specifically	O
bound	O
to	O
a	O
glutathione	protein
S-transferase-	protein
Tax1	protein
fusion	protein
protein	protein
.	O
Further,	O
Tax1	protein
coimmunoprecipitated	O
with	O
NF-Y	protein
from	O
nuclear	O
extracts	O
of	O
HTLV-1-transformed	cell_type
cells	cell_type
,	O
providing	O
evidence	O
for	O
in	O
vivo	O
interaction	O
of	O
Tax1	protein
and	O
NF-YB	protein
.	O
We	O
further	O
demonstrate	O
that	O
Tax1	protein
specifically	O
activated	O
the	O
NF-Y	DNA
-responsive	DNA
DQbeta	DNA
promoter	DNA
,	O
as	O
well	O
as	O
a	O
minimal	DNA
promoter	DNA
which	O
contains	O
only	O
the	O
Y-box	DNA
element	DNA
.	O
In	O
addition,	O
mutation	O
of	O
the	O
Y-box	DNA
element	DNA
alone	O
abrogated	O
Tax1	protein
-mediated	O
activation	O
.	O
Taken	O
together,	O
these	O
data	O
indicate	O
that	O
Tax1	protein
interacts	O
with	O
NF-Y	protein
through	O
the	O
B	protein
subunit	protein
and	O
that	O
this	O
interaction	O
results	O
in	O
activation	O
of	O
the	O
major	DNA
histocompatibility	DNA
complex	DNA
class	DNA
II	DNA
promoter	DNA
.	O
Through	O
activation	O
of	O
this	O
and	O
other	O
NF-Y	protein
driven	O
promoters	DNA
,	O
the	O
Tax1	protein
-NF-Y	protein
interaction	O
may	O
play	O
a	O
critical	O
role	O
in	O
causing	O
cellular	O
transformation	O
and	O
HTLV-1	O
pathogenesis	O
.	O

High	O
levels	O
of	O
the	O
DNA-binding	O
activity	O
of	O
E2F	protein
in	O
adult	O
T-cell	O
leukemia	O
and	O
human	cell_type
T-cell	cell_type
leukemia	cell_type
virus	cell_type
type	cell_type
I	cell_type
-infected	cell_type
cells	cell_type
:	O
possible	O
enhancement	O
of	O
DNA-binding	O
of	O
E2F	protein
by	O
the	O
human	protein
T-cell	protein
leukemia	protein
virus	protein
I	protein
transactivating	protein
protein	protein
,	O
Tax	protein
.	O
Transcription	protein
factor	protein
E2F	protein
binds	O
to	O
cellular	DNA
promoters	DNA
of	O
certain	O
growth-	O
and	O
cell	O
cycle-	O
controlling	O
genes	O
and	O
forms	O
distinct	O
heteromeric	protein
complexes	protein
with	O
other	O
nuclear	protein
proteins	protein
.	O
It	O
has	O
therefore	O
been	O
proposed	O
that	O
E2F	protein
is	O
involved	O
in	O
cellular	O
proliferation	O
control	O
.	O
Human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
is	O
an	O
etiological	O
agent	O
of	O
adult	O
T-cell	O
leukemia	O
(	O
ATL	O
).	O
We	O
show	O
here	O
by	O
mobility-shift	O
assay	O
that	O
E2F	protein
-containing	protein
DNA-binding	protein
complexes	protein
were	O
detected	O
in	O
HTLV-I	cell_line
-infected	cell_line
T-cell	cell_line
lines	cell_line
and	O
leukemic	cell_type
cells	cell_type
obtained	O
from	O
ATL	O
patients	O
but	O
not	O
in	O
an	O
uninfected	cell_line
T-cell	cell_line
line	cell_line
,	O
Jurkat	cell_line
,	O
and	O
normal	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
.	O
The	O
Tax	protein
protein	protein
,	O
encoded	O
by	O
HTLV-I	O
,	O
is	O
a	O
potent	O
transcription	O
activator	O
of	O
viral	O
and	O
several	O
cellular	DNA
genes	DNA
.	O
We	O
demonstrate	O
that	O
expression	O
of	O
Tax	protein
can	O
induce	O
the	O
E2F	protein
-containing	protein
DNA-binding	protein
complexes	protein
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
Thus,	O
Tax	protein
,	O
through	O
enhancement	O
of	O
the	O
DNA-binding	O
activity	O
of	O
E2F	protein
,	O
may	O
be	O
capable	O
of	O
regulating	O
cellular	O
gene	O
expression	O
implicated	O
in	O
the	O
proliferation	O
and	O
transformation	O
of	O
T	cell_type
cells	cell_type
in	O
ATL	O
.	O
This	O
activity	O
may	O
be	O
relevant	O
to	O
the	O
mechanisms	O
whereby	O
HTLV-I	O
which	O
does	O
not	O
contain	O
oncogenes	DNA
induces	O
neoplasia	O
.	O

Dissociation	O
of	O
the	O
Jak	protein
kinase	protein
pathway	O
from	O
G-CSF	protein
receptor	protein
signaling	O
in	O
neutrophils.	O
Activation	O
of	O
the	O
granulocyte	protein
colony-stimulating	protein
factor	protein
receptor	protein
(	O
G-CSFR	protein
)	O
induces	O
rapid	O
tyrosine	O
phosphorylation	O
of	O
multiple	O
intracellular	protein
substrates	protein
in	O
proliferating	cell_type
cells	cell_type
and	O
nonproliferating,	cell_type
terminally	cell_type
differentiated	cell_type
neutrophils	cell_type
.	O
The	O
kinases	O
that	O
couple	O
ligand	O
binding	O
to	O
tyrosine	O
phosphorylation	O
of	O
cellular	protein
substrates	protein
by	O
the	O
G-CSFR	O
with	O
activation	O
of	O
specific	O
functional	O
programs	O
are	O
largely	O
unknown.	O
In	O
this	O
study,	O
we	O
examined	O
early	O
signaling	O
events	O
in	O
proliferating	cell_type
and	O
terminally	cell_type
differentiated	cell_type
cells	cell_type
following	O
G-CSF	protein
stimulation	O
to	O
determine	O
whether	O
identical	O
signaling	O
cascades	O
are	O
activated.	O
In	O
murine	cell_line
Ba/F3	cell_line
cells	cell_line
transfected	O
with	O
the	O
human	protein
G-CSFR	protein
and	O
NFS-60	cell_line
cells	cell_line
constitutively	O
expressing	O
the	O
murine	protein
G-CSFR	protein
,	O
G-CSF	protein
induced	O
tyrosine	O
phosphorylation	O
and	O
activation	O
of	O
Jak1	protein
,	O
Jak2	protein
,	O
and	O
Tyk2	protein
.	O
Tyrosine	O
phosphorylation	O
of	O
Stat3	protein
and,	O
to	O
a	O
lesser	O
extent,	O
Stat1	protein
was	O
also	O
detected	O
following	O
G-CSF	protein
stimulation	O
.	O
Using	O
a	O
mitogenically	protein
incompetent	protein
human	protein
G-CSFR	protein
mutant	protein
in	O
which	O
Pro639	O
and	O
Pro641	O
were	O
substituted	O
by	O
alanine	O
,	O
the	O
box	protein
1	protein
PDP	protein
motif	protein
was	O
found	O
to	O
be	O
required	O
for	O
activation	O
of	O
Jak	protein
kinases	protein
,	O
tyrosine	O
phosphorylation	O
of	O
the	O
G-CSFR	protein
,	O
and	O
recruitment	O
of	O
Stat	protein
proteins	protein
.	O
Notably,	O
no	O
activation	O
of	O
Jak1	protein
,	O
Jak2	protein
,	O
Tyk2	protein
,	O
Stat1	protein
,	O
or	O
Stat3	protein
was	O
observed	O
in	O
neutrophils	cell_type
following	O
G-CSF	protein
stimulation	O
.	O
In	O
addition,	O
there	O
was	O
no	O
detectable	O
activation	O
in	O
neutrophils	cell_type
of	O
the	O
recently	O
cloned	O
Jak3	protein
kinase	protein
,	O
which	O
has	O
been	O
reported	O
to	O
be	O
expressed	O
at	O
high	O
levels	O
as	O
myeloid	cell_type
cells	cell_type
undergo	O
terminal	O
neutrophilic	O
maturation	O
.	O
These	O
results	O
indicate	O
a	O
lack	O
of	O
involvement	O
of	O
Jak	protein
kinases	protein
in	O
signaling	O
by	O
the	O
G-CSFR	protein
in	O
neutrophils	cell_type
,	O
and	O
suggest	O
utilization	O
of	O
alternative	O
signal	O
transduction	O
pathways	O
distinct	O
from	O
those	O
in	O
proliferating	cell_type
cells	cell_type
.	O
Activation	O
of	O
the	O
Jak	protein
-Stat	protein
pathway	O
correlates	O
with	O
proliferative	O
signaling	O
by	O
the	O
G-CSFR	protein
and	O
requires	O
the	O
membrane-proximal	protein
box	protein
1	protein
PXP	protein
motif	protein
,	O
which	O
is	O
conserved	O
in	O
members	O
of	O
the	O
cytokine	protein
receptor	protein
superfamily	protein
.	O

Impaired	O
induction	O
of	O
c-fos/c-jun	DNA
genes	DNA
and	O
of	O
transcriptional	protein
regulatory	protein
proteins	protein
binding	O
distinct	O
c-fos/c-jun	DNA
promoter	DNA
elements	DNA
in	O
activated	cell_type
human	cell_type
T	cell_type
cells	cell_type
during	O
aging	O
.	O
The	O
activation	O
of	O
transcriptional	protein
factor	protein
c-Fos/c-Jun	O
AP-1	protein
is	O
essential	O
for	O
normal	O
T	cell_type
cell	cell_type
responsiveness	O
and	O
is	O
often	O
impaired	O
in	O
T	cell_type
cells	cell_type
during	O
aging	O
.	O
In	O
the	O
present	O
study,	O
we	O
investigated	O
whether	O
aberrancies	O
in	O
the	O
regulation	O
of	O
c-fos/c-jun	DNA
at	O
the	O
mRNA	O
or	O
protein	O
level	O
might	O
underlie	O
the	O
age-associated	O
impairments	O
of	O
AP-1	protein
in	O
human	cell_type
T	cell_type
cells	cell_type
.	O
Whereas	O
T	cell_type
cells	cell_type
from	O
young	O
subjects	O
stimulated	O
with	O
cross-linked	protein
anti-CD3epsilon	protein
mAb	protein
OKT3	protein
plus	O
PMA	O
or	O
with	O
the	O
lectin	protein
PHA	protein
plus	O
PMA	O
demonstrated	O
considerable	O
increases	O
in	O
c-Fos	protein
protein	O
expression	O
,	O
the	O
expression	O
of	O
c-Fos	protein
but	O
not	O
c-Jun	protein
was	O
markedly	O
reduced	O
in	O
stimulated	O
T	cell_type
cells	cell_type
from	O
certain	O
elderly	O
subjects	O
.	O
In	O
addition,	O
RNase	protein
protection	O
assays	O
revealed	O
that	O
anti-CD3/	O
PMA	cell_type
-stimulated	cell_type
T	cell_type
cells	cell_type
from	O
a	O
substantial	O
proportion	O
of	O
elderly	O
subjects	O
exhibited	O
decreased	O
levels	O
of	O
c-fos	O
and/or	O
c-jun	O
mRNA	O
compared	O
to	O
T	cell_type
cells	cell_type
from	O
young	O
subjects	O
.	O
Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
the	O
levels	O
of	O
nuclear	protein
regulatory	protein
proteins	protein
recognizing	O
the	O
AP-1	DNA
consensus	DNA
TRE	DNA
motif	DNA
,	O
the	O
proximal	DNA
c-jun	DNA
TRE-like	DNA
promoter	DNA
element	DNA
,	O
and	O
the	O
c-fos	DNA
serum	DNA
response	DNA
element	DNA
(	O
SRE	DNA
)	O
were	O
determined	O
in	O
resting	O
and	O
stimulated	O
T	O
cells	O
.	O
Although	O
the	O
stimulation	O
of	O
T	cell_type
cells	cell_type
from	O
young	O
subjects	O
resulted	O
in	O
coordinated	O
increases	O
of	O
nuclear	protein
protein	protein
complexes	protein
binding	O
the	O
AP-1	DNA
TRE	DNA
,	O
c-jun	DNA
TRE	DNA
,	O
and	O
c-fos	DNA
SRE	DNA
DNA	DNA
sequence	DNA
motifs	DNA
,	O
age-related	O
reductions	O
in	O
the	O
activation	O
of	O
AP-1	protein
were	O
accompanied	O
by	O
decreased	O
levels	O
of	O
c-jun	O
TRE	O
and	O
c-fos	O
SRE	O
binding	O
complexes	O
.	O
Furthermore,	O
the	O
nuclear	protein
protein	protein
complexes	protein
binding	O
the	O
SRE	DNA
motif	DNA
induced	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
of	O
young	O
and	O
elderly	O
subjects	O
contained	O
serum	protein
response	protein
factor	protein
and	O
Elk-1	protein
pointing	O
toward	O
age-related	O
defects	O
in	O
the	O
activation	O
of	O
transcriptional	protein
regulatory	protein
proteins	protein
distinct	O
from	O
c-jun/	protein
AP-1	protein
.	O
These	O
results	O
suggest	O
that	O
underlying	O
aberrancies	O
in	O
the	O
induction	O
of	O
c-fos/c-jun	DNA
as	O
well	O
as	O
their	O
nuclear	protein
regulatory	protein
proteins	protein
may	O
contribute	O
to	O
the	O
age-related	O
impairments	O
of	O
AP-1	protein
activation	O
in	O
human	cell_type
T	cell_type
cells	cell_type
.	O

Retinoic	O
acid	O
-induced	O
modulation	O
of	O
IL-2	RNA
mRNA	RNA
production	O
and	O
IL-2	protein
receptor	O
expression	O
on	O
T	cell_type
cells	cell_type
.	O
BACKGROUND:	O
Retinoic	O
acid	O
(	O
RA	O
)	O
has	O
important	O
immune-modulating	O
effects	O
on	O
both	O
T	O
and	O
B	O
cell	O
function	O
.	O
Our	O
laboratory	O
has	O
shown	O
that	O
RA	O
can	O
enhance	O
in	O
vitro	O
polyclonal	O
B	O
cell	O
immunoglobulin	protein
(Ig)	O
response	O
.	O
Investigating	O
cytokines	protein
known	O
to	O
affect	O
B	O
cell	O
differentiation	O
,	O
we	O
have	O
recently	O
shown	O
that	O
IL-6	protein
production	O
is	O
augmented	O
by	O
RA	O
.	O
In	O
the	O
present	O
study	O
we	O
have	O
examined	O
the	O
immune	O
modulating	O
effects	O
of	O
RA	O
on	O
IL-2	RNA
mRNA	RNA
,	O
another	O
important	O
cytokine	protein
for	O
B	O
cell	O
immunoglobulin	protein
production	O
,	O
the	O
expression	O
of	O
IL-2	protein
receptors	protein
on	O
T	cell_type
cells	cell_type
,	O
and	O
the	O
RA	protein
nuclear	protein
receptors	protein
.	O
METHODS:	O
Purified	O
T	cell_type
cells	cell_type
were	O
obtained	O
from	O
adenoidal	O
tissues	O
,	O
and	O
incubated	O
with	O
RA	O
(10(-7)	O
M)	O
or	O
DMSO	O
solvent/media	O
control	O
for	O
0,	O
6-8,	O
and	O
24	O
h.	O
Total	O
mRNA	RNA
was	O
extracted	O
from	O
T	cell_type
cells	cell_type
,	O
and	O
using	O
RT-PCR	O
,	O
changes	O
in	O
the	O
production	O
of	O
IL-2	protein
and	O
RA	protein
receptors	protein
(	O
RAR	protein
)-	O
alpha	RNA
,	O
beta	RNA
,	O
gamma	RNA
mRNA	RNA
were	O
determined.	O
The	O
effects	O
of	O
RA	O
on	O
IL-2-alpha	O
receptor	O
expression	O
was	O
determined	O
by	O
flow	O
cytometry	O
on	O
T	cell_type
cells	cell_type
.	O
CONCLUSION:	O
These	O
studies	O
suggest	O
that	O
RA	O
can	O
augment	O
IL-2	RNA
mRNA	RNA
production	O
by	O
T	cell_type
cells	cell_type
with	O
a	O
possible	O
paracrine	O
effect	O
on	O
IL-2R-alpha	protein
expression	O
.	O
These	O
changes	O
appear	O
to	O
be	O
mediated	O
by	O
RAR-alpha	protein
.	O
Thus,	O
IL-2	protein
may	O
be	O
another	O
important	O
cytokine	protein
modulated	O
by	O
RA	O
in	O
the	O
immune	O
response	O
.	O

Involvement	O
of	O
an	O
SAF-like	protein
transcription	protein
factor	protein
in	O
the	O
activation	O
of	O
serum	DNA
amyloid	DNA
A	DNA
gene	DNA
in	O
monocyte/macrophage	cell_type
cells	cell_type
by	O
lipopolysaccharide	O
.	O
Serum	protein
amyloid	protein
A	protein
(	O
SAA	protein
)	O
has	O
been	O
linked	O
to	O
atherosclerosis	O
because	O
of	O
its	O
ability	O
to	O
remodel	O
high-density	O
lipoprotein	O
by	O
the	O
depletion	O
of	O
apolipoprotein	O
A1,	O
its	O
ability	O
to	O
bind	O
cholesterol	O
,	O
and	O
its	O
presence	O
in	O
the	O
atherosclerotic	O
plaques	O
of	O
coronary	O
and	O
carotid	O
arteries	O
.	O
In	O
the	O
present	O
study,	O
we	O
investigated	O
the	O
induction	O
mechanism	O
of	O
SAA	DNA
gene	DNA
in	O
THP-1	cell_line
monocyte/macrophage	cell_line
cells	cell_line
which	O
play	O
a	O
critical	O
role	O
in	O
the	O
development	O
of	O
atherosclerotic	O
fatty	O
streak	O
and	O
plaque	O
formation	O
.	O
We	O
and	O
others	O
have	O
shown	O
that	O
SAA	protein
gene	O
is	O
induced	O
in	O
monocyte/macrophage	cell_type
cells	cell_type
by	O
lipopolysaccharide	O
(	O
LPS	O
).	O
By	O
promoter	O
function	O
analysis,	O
we	O
show	O
that	O
the	O
SAA	DNA
promoter	DNA
sequence	DNA
between	O
-280	O
and	O
-226	O
can	O
confer	O
LPS	O
responsiveness	O
.	O
Gel	O
electrophoretic	O
mobility	O
shift	O
assay	O
detected	O
an	O
induced	O
DNA-binding	O
activity	O
in	O
these	O
cells	O
in	O
response	O
to	O
LPS	O
.	O
Characterization	O
of	O
the	O
DNA-binding	protein
protein	protein
by	O
UV	O
cross-linking	O
,	O
Southwestern	O
blot	O
,	O
and	O
antibody	O
ablation/supershift	O
assays	O
revealed	O
that	O
it	O
is	O
similar	O
to	O
a	O
recently	O
reported	O
nuclear	protein
factor	protein
designated	O
SAF	protein
.	O
These	O
results	O
demonstrated	O
that	O
LPS	O
-mediated	O
SAA	protein
gene	O
induction	O
in	O
monocyte/macrophage	cell_type
cells	cell_type
is	O
primarily	O
due	O
to	O
the	O
induction	O
of	O
SAF	protein
activity.	O

Cytomegalovirus	DNA
immediate	DNA
early	DNA
genes	DNA
upregulate	O
interleukin-6	protein
gene	O
expression	O
.	O
BACKGROUND:	O
The	O
immediate	DNA
early	DNA
genes	DNA
(	O
IE	DNA
)	O
of	O
human	O
cytomegalovirus	O
(	O
CMV	O
)	O
can	O
be	O
expressed	O
in	O
monocytic	cell_type
cells	cell_type
and	O
are	O
known	O
to	O
regulate	O
viral	O
and	O
cellular	O
genes	O
.	O
Interleukin-6	protein
(	O
IL-6	protein
)	O
plays	O
a	O
central	O
role	O
in	O
numerous	O
inflammatory	O
and	O
immune	O
processes	O
.	O
Interleukin-6	protein
levels	O
are	O
increased	O
in	O
lung	O
transplant	O
patients	O
clinically	O
diagnosed	O
with	O
CMV	O
pneumonitis	O
.	O
The	O
regulation	O
of	O
IL-6	protein
is	O
dependent	O
on	O
various	O
stimuli	O
that	O
include	O
lipopolysaccharide	O
(	O
LPS	O
),	O
viruses,	O
and	O
other	O
cytokines	protein
.	O
These	O
studies	O
examined	O
the	O
ability	O
of	O
CMV	O
IE	O
gene	O
products	O
to	O
modulate	O
IL-6	protein
production	O
.	O
METHODS:	O
THP-1	cell_line
cells	cell_line
,	O
a	O
monocytic	cell_line
cell	cell_line
line	cell_line
,	O
were	O
transfected	O
with	O
the	O
CMV	DNA
IE	DNA
genes	DNA
.	O
Interleukin-6	protein
protein	O
and	O
IL-6	RNA
mRNA	RNA
were	O
measured	O
in	O
control	O
and	O
CMV	cell_type
immediate	cell_type
early	cell_type
transfected	cell_type
cells	cell_type
.	O
Cotransfection	O
of	O
CMV	DNA
IE	DNA
genes	DNA
and	O
IL-6	O
chloramphenicol	O
acetyl	O
transferase	O
(CAT)	O
or	O
IL-6	O
luciferase	O
constructs	O
were	O
used	O
to	O
study	O
IL-6	protein
promoter	O
activity	O
.	O
RESULTS:	O
Interleukin-6	protein
protein	protein
and	O
mRNA	O
production	O
were	O
significantly	O
increased	O
in	O
cells	O
transfected	O
with	O
the	O
CMV	DNA
IE	DNA
genes	DNA
and	O
stimulated	O
with	O
LPS	O
compared	O
to	O
LPS	cell_line
-stimulated	cell_line
control	cell_line
cells	cell_line
.	O
Cytomegalovirus	protein
IE	protein
gene	protein
products	protein
significantly	O
enhanced	O
LPS	O
stimulation	O
of	O
IL-6	DNA
promoter	DNA
activity	O
in	O
both	O
IL-6	protein
CAT	O
and	O
IL-6	O
luciferase	O
assays	O
.	O
A	O
deletion	O
construct	O
that	O
contains	O
a	O
NF-kappa	DNA
B	DNA
site	DNA
but	O
is	O
missing	O
the	O
multiple	O
response	O
region	O
demonstrated	O
a	O
continued	O
increase	O
in	O
IL-6	protein
luciferase	protein
activity	O
in	O
LPS	cell_line
-stimulated	cell_line
CMV	cell_line
transfected	cell_line
cells	cell_line
.	O
CONCLUSION:	O
Cytomegalovirus	protein
immediate	protein
early	protein
gene	protein
products	protein
significantly	O
enhanced	O
expression	O
of	O
IL-6	protein
in	O
LPS	O
-stimulated	O
cells.	O
The	O
increase	O
in	O
IL-6	protein
luciferase	protein
activity	O
occurs	O
in	O
the	O
absence	O
of	O
the	O
multiple	O
response	O
region,	O
the	O
area	O
of	O
the	O
IL-6	DNA
promoter	DNA
responsive	O
to	O
IL-1	protein
,	O
TNF	protein
alpha	protein
,	O
cyclic	O
amp	O
,	O
and	O
phorbol	O
12-myristate	O
13-acetate	O
.	O
The	O
ability	O
of	O
CMV	protein
IE	protein
gene	protein
products	protein
to	O
enhance	O
IL-6	protein
production	O
may	O
play	O
an	O
important	O
role	O
in	O
immune	O
inflammatory	O
states	O
associated	O
with	O
CMV	O
infection	O
.	O

Induction	O
of	O
relA(p65)	protein
and	O
I	protein
kappa	protein
B	protein
alpha	protein
subunit	protein
expression	O
during	O
differentiation	O
of	O
human	cell_type
peripheral	cell_type
blood	cell_type
monocytes	cell_type
to	O
macrophages	cell_type
.	O
We	O
evaluated	O
the	O
expression	O
and	O
DNA	O
binding	O
activity	O
of	O
nuclear	protein
factor	protein
(NF)-kappa	protein
B	protein
subunits	protein
in	O
human	cell_type
peripheral	cell_type
blood	cell_type
monocytes	cell_type
and	O
in	O
monocyte-derived	cell_type
macrophages	cell_type
(	O
MDMs	cell_type
).	O
Constitutive	O
DNA	O
binding	O
activity	O
consisting	O
of	O
p50	protein
homodimers	protein
was	O
detected	O
in	O
nuclear	O
extracts	O
from	O
both	O
cell	O
types.	O
An	O
additional	O
complex	O
composed	O
of	O
p50/RelA(p65)	protein
heterodimers	protein
appeared	O
only	O
in	O
nuclear	O
extracts	O
from	O
7-day	O
MDMs	cell_type
.	O
Immunoblot	O
analysis	O
showed	O
that	O
the	O
p50	O
subunit	O
was	O
constitutively	O
expressed	O
in	O
monocytes	cell_type
and	O
MDMs	cell_type
.	O
In	O
contrast,	O
the	O
RelA(p65)	protein
subunit	protein
was	O
barely	O
detectable	O
in	O
monocytes	cell_type
,	O
but	O
its	O
level	O
increased	O
markedly	O
in	O
MDMs	cell_type
.	O
Analysis	O
of	O
RelA(p65)	RNA
mRNA	RNA
revealed	O
that	O
the	O
stability	O
of	O
RelA(p65)	RNA
mRNA	RNA
was	O
significantly	O
higher	O
in	O
MDMs	cell_type
,	O
compared	O
with	O
monocytes	cell_type
.	O
In	O
MDMs	cell_type
,	O
an	O
upregulation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
synthesis	O
as	O
well	O
as	O
the	O
appearance	O
of	O
a	O
novel	O
M(r)	O
40,000	O
form	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
were	O
also	O
observed.	O
These	O
results	O
suggest	O
that	O
macrophage	O
differentiation	O
results	O
in	O
the	O
expression	O
of	O
active	O
p50/RelA(p65)	protein
heterodimers	protein
with	O
the	O
capacity	O
to	O
activate	O
target	O
gene	O
expression.	O
The	O
parallel	O
induction	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
synthesis	O
may	O
allow	O
for	O
the	O
continuous	O
presence	O
of	O
a	O
cytoplasmic	O
reservoir	O
of	O
p50/RelA(p65)	protein
complexes	protein
that	O
are	O
readily	O
available	O
for	O
inducer-mediated	O
stimulation	O
.	O

Nuclear	O
Rel-A	O
and	O
c-Rel	O
protein	O
complexes	O
are	O
differentially	O
distributed	O
within	O
human	cell_type
thymocytes	cell_type
.	O
Nuclear	protein
factor-kappa	protein
B	protein
(	protein
NF-kappa	protein
B	protein
)/Rel	protein
proteins	protein
are	O
inducible	O
transcriptional	protein
regulators	protein
of	O
numerous	O
cellular	DNA
genes	DNA
.	O
They	O
are	O
particularly	O
abundant	O
in	O
lymphoid	O
tissues	O
and	O
are	O
thought	O
to	O
be	O
critical	O
for	O
the	O
transcription	O
of	O
genes	O
involved	O
in	O
immune	O
and	O
inflammatory	O
responses	O
.	O
We	O
have	O
reported	O
previously	O
that	O
a	O
nuclear	O
NF-kappa	protein
B	protein
activity	O
was	O
present	O
in	O
freshly	O
extracted	O
human	cell_type
thymocytes	cell_type
in	O
the	O
absence	O
of	O
in	O
vitro	O
treatment	O
of	O
these	O
cells.	O
In	O
the	O
present	O
report,	O
we	O
identified	O
NF-kappa	protein
B	protein
proteins	protein
extracted	O
from	O
human	O
thymocyte	O
nuclei	O
as	O
being	O
p50/p65	O
and	O
p50/c-Rel	O
complexes	O
.	O
Immunochemical	O
and	O
immunofluorescent	O
staining	O
of	O
thymus	O
sections	O
using	O
specific	protein
Abs	protein
allowed	O
visualization	O
of	O
nuclear	protein
NF-kappa	protein
B	protein
proteins	protein
in	O
both	O
thymocytes	cell_type
and	O
nonthymocyte	cell_type
cells	cell_type
.	O
This	O
detection	O
suggested	O
a	O
preferential	O
activation	O
of	O
p50/c-Rel	protein
in	O
medullary	cell_type
thymocytes	cell_type
,	O
whereas	O
p50/p65	protein
was	O
present	O
in	O
both	O
cortical	O
and	O
medullary	O
regions	O
of	O
human	O
thymus	O
lobules	O
.	O
However,	O
the	O
intensity	O
of	O
p65	protein
labeling	O
was	O
much	O
higher	O
in	O
several	O
thymocytes	cell_type
from	O
the	O
medulla	O
.	O
p65	O
,	O
p50	O
,	O
and	O
c-Rel	O
activities	O
were	O
found	O
in	O
both	O
CD4-	O
and	O
CD8-	O
positive	O
thymocytes	O
.	O
These	O
observations	O
suggest	O
that	O
p65	O
and	O
c-Rel	O
complexes	O
play	O
distinct	O
roles	O
in	O
gene	O
expression	O
and	O
that	O
both	O
forms	O
of	O
NF-kappa	protein
B	protein
play	O
critical	O
roles	O
during	O
late	O
stages	O
of	O
the	O
intrathymic	O
maturation	O
of	O
T	cell_type
cells	cell_type
.	O

ALY	protein
,	O
a	O
context-dependent	protein
coactivator	protein
of	O
LEF-1	protein
and	O
AML-1	protein
,	O
is	O
required	O
for	O
TCRalpha	DNA
enhancer	DNA
function	O
.	O
LEF-1	protein
is	O
a	O
transcription	O
factor	O
that	O
participates	O
in	O
the	O
regulation	O
of	O
the	O
T-cell	DNA
receptor	DNA
alpha	DNA
(TCR	DNA
alpha)	DNA
enhancer	DNA
by	O
facilitating	O
the	O
assembly	O
of	O
multiple	protein
proteins	protein
into	O
a	O
higher	O
order	O
nucleoprotein	protein
complex	protein
.	O
The	O
function	O
of	O
LEF-1	protein
is	O
dependent,	O
in	O
part,	O
on	O
the	O
HMG	protein
domain	protein
that	O
induces	O
a	O
sharp	O
bend	O
in	O
the	O
DNA	O
helix,	O
and	O
on	O
an	O
activation	protein
domain	protein
that	O
stimulates	O
transcription	O
only	O
in	O
a	O
specific	O
context	O
of	O
other	O
enhancer-binding	protein
proteins	protein
.	O
With	O
the	O
aim	O
of	O
gaining	O
insight	O
into	O
the	O
function	O
of	O
context-dependent	protein
activation	protein
domains	protein
,	O
we	O
cloned	O
ALY	protein
,	O
a	O
novel	O
LEF-1	protein
-interacting	protein
protein	protein
.	O
ALY	protein
is	O
a	O
ubiquitously	O
expressed,	O
nuclear	O
protein	O
that	O
specifically	O
associates	O
with	O
the	O
activation	protein
domains	protein
of	O
LEF-1	protein
and	O
AML-1	protein
(	O
CBF	protein
alpha2	protein
,	O
PEBP2	protein
alpha	protein
(B),	O
which	O
is	O
another	O
protein	O
component	O
of	O
the	O
TCR	protein
alpha	protein
enhancer	protein
complex	protein
.	O
In	O
addition,	O
ALY	protein
can	O
increase	O
DNA	O
binding	O
by	O
both	O
LEF-1	protein
and	O
AML	protein
proteins	protein
.	O
Overexpression	O
of	O
ALY	protein
stimulates	O
the	O
activity	O
of	O
the	O
TCR	protein
alpha	protein
enhancer	protein
complex	protein
reconstituted	O
in	O
transfected	cell_line
nonlymphoid	cell_line
HeLa	cell_line
cells	cell_line
,	O
whereas	O
down-regulation	O
of	O
ALY	protein
by	O
anti-sense	O
oligonucleotides	O
virtually	O
eliminates	O
TCR	DNA
alpha	DNA
enhancer	DNA
activity	O
in	O
T	cell_type
cells	cell_type
.	O
Similar	O
to	O
LEF-1	protein
,	O
ALY	protein
can	O
stimulate	O
transcription	O
in	O
the	O
context	O
of	O
the	O
TCR	DNA
alpha	DNA
enhancer	DNA
but	O
apparently	O
not	O
when	O
tethered	O
to	O
DNA	O
through	O
an	O
heterologous	protein
DNA-binding	protein
domain	protein
.	O
We	O
propose	O
that	O
ALY	protein
mediates	O
context-dependent	O
transcriptional	O
activation	O
by	O
facilitating	O
the	O
functional	O
collaboration	O
of	O
multiple	protein
proteins	protein
in	O
the	O
TCR	protein
alpha	protein
enhancer	protein
complex	protein
.	O

AML1a	protein
but	O
not	O
AML1b	protein
inhibits	O
erythroid	O
differentiation	O
induced	O
by	O
sodium	O
butyrate	O
and	O
enhances	O
the	O
megakaryocytic	O
differentiation	O
of	O
K562	cell_type
leukemia	cell_type
cells	cell_type
.	O
AML1	protein
may	O
play	O
a	O
role	O
in	O
growth	O
and	O
differentiation	O
of	O
cells	O
along	O
erythroid	O
and/or	O
megakaryocytic	O
lineages	O
,	O
because	O
a	O
significant	O
level	O
of	O
the	O
AML1	protein
gene	O
is	O
expressed	O
in	O
these	O
cells.	O
We	O
overexpressed	O
AML1a	protein
(without	O
the	O
transcription-activating	protein
domain	protein
)	O
and	O
AML1b	protein
(with	O
the	O
domain)	O
proteins	O
in	O
K562	cell_type
leukemia	cell_type
cells	cell_type
,	O
which	O
can	O
be	O
induced	O
to	O
differentiate	O
into	O
hemoglobin-producing	cell_type
cells	cell_type
and	O
megakaryocytes	cell_type
.	O
The	O
AML1a	cell_line
-transfected	cell_line
K562	cell_line
cells	cell_line
had	O
a	O
reduced	O
capacity	O
to	O
differentiate	O
in	O
the	O
presence	O
of	O
sodium	O
n-butyrate	O
but	O
not	O
in	O
the	O
presence	O
of	O
other	O
inducers,	O
such	O
as	O
hemin	O
,	O
1-beta-D-arabinofuranosylcytosine	O
,	O
and	O
herbimycin	O
A	O
.	O
The	O
AML1	protein
antisense	O
oligodeoxynucleotide	O
but	O
not	O
the	O
sense	O
oligomer	O
recovered	O
its	O
differentiation-inducing	O
capacity	O
in	O
the	O
presence	O
of	O
butyrate	O
.	O
On	O
the	O
other	O
hand,	O
AML1b	protein
conferred	O
a	O
similar	O
differentiation-inducing	O
capacity	O
upon	O
K562	cell_line
cells	cell_line
transfected	O
with	O
vector	O
alone.	O
AML1a	protein
expression	O
was	O
associated	O
with	O
enhanced	O
sensitivity	O
to	O
megakaryocytic	O
differentiation	O
induced	O
by	O
phorbol	O
ester	O
.	O
These	O
results	O
provide	O
evidence	O
that	O
AML1	protein
proteins	O
play	O
a	O
role	O
in	O
erythroid	O
and	O
megakaryocytic	O
differentiation	O
.	O

Identification	O
of	O
sequence	O
alterations	O
in	O
the	O
upstream	DNA
regulatory	DNA
region	DNA
of	O
the	O
estrogen	DNA
receptor	DNA
gene	DNA
in	O
an	O
ER-negative	cell_line
breast	cell_line
cancer	cell_line
cell	cell_line
line	cell_line
.	O
Given	O
the	O
important	O
role	O
of	O
the	O
estrogen	protein
receptor	protein
(	O
ER	protein
)	O
in	O
the	O
development	O
and	O
physiology	O
of	O
the	O
breast	O
,	O
it	O
is	O
essential	O
to	O
delineate	O
the	O
mechanisms	O
responsible	O
for	O
its	O
failed	O
expression	O
in	O
some	O
breast	O
tumors	O
.	O
We	O
have	O
cloned	O
and	O
sequenced	O
a	O
portion	O
of	O
the	O
ER	protein
upstream	DNA
regulatory	DNA
region	DNA
from	O
the	O
ER	cell_line
-positive	cell_line
MCF-7	cell_line
and	O
the	O
ER	cell_line
-negative	cell_line
MDA-MB-231	cell_line
breast	cell_line
cancer	cell_line
cell	cell_line
lines	cell_line
to	O
determine	O
if	O
sequence	O
alterations	O
in	O
this	O
region	O
account	O
for	O
the	O
ER	protein
-negative	O
phenotype	O
of	O
some	O
tumors	O
.	O
From	O
this,	O
we	O
identified	O
a	O
number	O
of	O
variations	O
between	O
the	O
sequences,	O
two	O
of	O
which	O
were	O
determined	O
to	O
be	O
associated	O
with	O
a	O
50%	O
decrease	O
in	O
CAT	protein
activity	O
.	O

Suppression	O
by	O
azelastine	O
hydrochloride	O
of	O
NF-kappa	protein
B	protein
activation	O
involved	O
in	O
generation	O
of	O
cytokines	protein
and	O
nitric	O
oxide	O
.	O
The	O
influence	O
of	O
the	O
anti-allergy	O
agent	O
azelastine	O
hydrochloride	O
(	O
Azeptin	O
)	O
on	O
NF-kappa	protein
B	protein
activation	O
associated	O
with	O
the	O
generation	O
of	O
cytokines	protein
and	O
nitric	O
oxide	O
(	O
NO	O
)	O
was	O
investigated	O
in	O
various	O
kinds	O
of	O
human	O
and	O
mouse	O
cells	O
.	O
Azeptin	O
dose-dependently	O
suppressed	O
both	O
DNA	O
and	O
protein	O
synthesis	O
in	O
human	cell_type
gingival	cell_type
fibroblasts	cell_type
(	O
HF	cell_type
)	O
and	O
also	O
suppressed	O
blastogenesis	O
of	O
human	cell_type
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
(	O
PBL	cell_type
).	O
Generation	O
of	O
tumor	protein
necrosis	protein
factor-alpha	protein
,	O
interleukin	protein
1-beta	protein
,	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
and	O
interleukin-6	protein
from	O
10(-5)	O
M	O
Azeptin	O
-treated	O
PBL	cell_type
and	O
human	cell_type
monocytes	cell_type
(	O
HM	cell_type
)	O
was	O
decreased	O
to	O
approximately	O
1/3	O
to	O
2/3	O
of	O
the	O
control	O
levels.	O
In	O
parallel	O
with	O
the	O
decreased	O
cytokine	protein
generation	O
,	O
each	O
cytokine	RNA
mRNA	RNA
was	O
less	O
expressed	O
in	O
the	O
presence	O
of	O
10(-5)	O
M	O
Azeptin	O
.	O
In	O
addition,	O
both	O
inducible	O
nitric	protein
oxide	protein
synthase	protein
-mRNA	O
level	O
and	O
NO	O
generation	O
in	O
mouse	cell_type
peritoneal	cell_type
macrophages	cell_type
were	O
suppressed	O
by	O
10(-5)	O
M	O
Azeptin	O
.	O
Being	O
compatible	O
with	O
those	O
results,	O
Azeptin	O
(10(-5)	O
M)	O
suppressed	O
activation	O
of	O
NF-kappa	protein
B	protein
in	O
PBL	cell_type
,	O
HM	O
and	O
HF	cell_type
.	O
These	O
results	O
appear	O
to	O
indicate	O
that	O
suppression	O
of	O
cytokine	protein
and	O
NO	O
generation	O
by	O
Azeptin	O
results	O
at	O
least	O
partially	O
from	O
the	O
inhibition	O
of	O
NF-kappa	protein
B	protein
activation	O
.	O

Differential	O
interaction	O
of	O
nuclear	O
factors	O
with	O
the	O
PRE-I	DNA
enhancer	DNA
element	DNA
of	O
the	O
human	DNA
IL-4	DNA
promoter	DNA
in	O
different	O
T	cell_type
cell	cell_type
subsets	cell_type
.	O
The	O
immunomodulatory	O
cytokine	protein
IL-4	protein
affects	O
cells	O
of	O
most	O
hemopoietic	cell_type
lineages	cell_type
.	O
IL-4	protein
is	O
secreted	O
by	O
activated	O
Th2	cell_type
but	O
not	O
Th1	cell_type
cells	cell_type
and	O
plays	O
a	O
major	O
role	O
in	O
the	O
immune	O
response	O
by	O
modulating	O
the	O
differentiation	O
of	O
naive	cell_type
Th	cell_type
cells	cell_type
toward	O
the	O
Th2	cell_type
phenotype	cell_type
.	O
We	O
have	O
previously	O
identified	O
an	O
enhancer	DNA
element	DNA
,	O
PRE-I	DNA
,	O
that	O
is	O
essential	O
for	O
the	O
function	O
of	O
the	O
human	DNA
IL-4	DNA
promoter	DNA
.	O
To	O
investigate	O
the	O
mechanisms	O
responsible	O
for	O
tissue-specific	O
expression	O
of	O
the	O
IL-4	protein
gene,	O
we	O
analyzed	O
nuclear	protein
factors	protein
binding	O
to	O
the	O
PRE-I	DNA
site	DNA
and	O
compared	O
the	O
binding	O
activities	O
of	O
these	O
factors	O
to	O
the	O
IL-4	protein
promoter	O
of	O
Th1	O
and	O
Th2	O
cells	O
.	O
We	O
show	O
that	O
PRE-I	DNA
interacts	O
with	O
PMA	O
-and	O
PMA	O
/	O
ionomycin	O
-inducible,	O
cyclosporin	O
A	O
-sensitive	O
nuclear	protein
factors	protein
.	O
Using	O
anti-C/EBPbeta	protein
(	O
NF-IL6	protein
),	O
anti-C/EBPdelta	protein
(	O
NF-IL6beta	protein
),	O
anti-NF-ATc	protein
,	O
anti-NF-ATp	protein
,	O
anti-Fos	protein
,	O
and	O
anti-Jun	protein
Abs	protein
we	O
demonstrate	O
that	O
the	O
previously	O
identified	O
PRE-I	protein
binding	protein
factor	protein
POS-1	protein
is	O
composed	O
of	O
different	O
transcription	protein
factors	protein
in	O
different	O
Th	O
cell	O
subsets.	O
In	O
the	O
IL-4	cell_line
-producing	cell_line
Th0-like	cell_line
human	cell_line
Jurkat	cell_line
and	O
mouse	cell_line
EL-4	cell_line
cells	cell_line
,	O
POS-1	protein
(designated	O
POS-1a	protein
)	O
contains	O
NF-IL6beta	protein
and	O
Jun	protein
.	O
In	O
the	O
mouse	cell_line
Th2	cell_line
D10	cell_line
cells	cell_line
and	O
in	O
the	O
human	cell_line
Th2	cell_line
clones	cell_line
,	O
POS-1	protein
(designated	O
POS-1b	protein
)	O
contains	O
NF-IL6beta	protein
,	O
Jun	protein
,	O
and	O
NF-ATc/p	protein
.	O
In	O
contrast,	O
POS-1	protein
was	O
not	O
found	O
in	O
nuclear	O
extracts	O
of	O
human	cell_line
Th1	cell_line
clones	cell_line
.	O
These	O
findings	O
suggest	O
that	O
PRE-I	DNA
may	O
play	O
a	O
role	O
in	O
the	O
differential	O
regulation	O
of	O
IL-4	DNA
gene	DNA
expression	O
levels	O
.	O

Regulation	O
of	O
human	O
epsilon	O
germline	DNA
transcription	O
:	O
role	O
of	O
B-cell-specific	protein
activator	protein
protein	protein
.	O
Germline	protein
transcripts	protein
initiate	O
from	O
promoters	DNA
upstream	O
of	O
the	O
immunoglobulin	DNA
switch	DNA
region	DNA
,	O
and	O
are	O
necessary	O
to	O
target	O
the	O
appropriate	O
switch	O
region	O
for	O
recombination	O
and	O
switching.	O
Different	O
cytokines	protein
activate	O
transcription	O
at	O
the	O
appropriate	O
germline	DNA
promoter	DNA
.	O
Because	O
binding	DNA
sites	DNA
for	O
B-cell-specific	protein
activator	protein
protein	protein
(	O
BSAP	protein
)	O
are	O
located	O
upstream	O
of	O
several	O
switch	O
regions	O
in	O
the	O
immunoglobulin	DNA
heavy	DNA
chain	DNA
gene	DNA
cluster	DNA
,	O
BSAP	protein
might	O
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
germline	DNA
transcription	O
and	O
isotype	O
switching	O
.	O
We	O
investigated	O
whether	O
BSAP	protein
plays	O
a	O
role	O
in	O
the	O
transcriptional	O
regulation	O
of	O
the	O
epsilon	O
germline	DNA
promoter	DNA
in	O
human	cell_type
B	cell_type
cells	cell_type
.	O
Our	O
results	O
showed	O
that	O
BSAP	protein
plays	O
a	O
role	O
in	O
both	O
IL-4	protein
-dependent	O
induction	O
and	O
CD40	protein
-mediated	O
upregulation	O
of	O
human	O
epsilon	O
germline	DNA
transcription	O
.	O
BSAP	protein
is	O
unique	O
among	O
the	O
transcription	protein
factors	protein
that	O
regulate	O
epsilon	O
germline	DNA
expression	O
,	O
because	O
it	O
is	O
B	O
cell	O
specific,	O
and	O
is	O
at	O
the	O
merging	O
point	O
of	O
two	O
signalling	O
pathways	O
that	O
are	O
critical	O
for	O
IgE	protein
switching	O
.	O

Experimental	O
expression	O
in	O
mice	O
and	O
spontaneous	O
expression	O
in	O
human	O
SLE	O
of	O
polyomavirus	protein
T-antigen	protein
.	O
A	O
molecular	O
basis	O
for	O
induction	O
of	O
antibodies	protein
to	O
DNA	O
and	O
eukaryotic	protein
transcription	protein
factors	protein
.	O
We	O
have	O
previously	O
demonstrated	O
that	O
experimental	O
expression	O
of	O
the	O
polyomavirus	protein
transcription	protein
factor	protein
T-antigen	protein
has	O
the	O
potential	O
to	O
induce	O
anti-DNA	protein
antibodies	protein
in	O
mice	O
.	O
Two	O
sets	O
of	O
independent	O
evidences	O
are	O
presented	O
here	O
that	O
demonstrate	O
a	O
biological	O
relevance	O
for	O
this	O
model.	O
First,	O
we	O
describe	O
results	O
demonstrating	O
that	O
mice	O
inoculated	O
with	O
T-antigen-expressing	DNA
plasmids	DNA
produced	O
antibodies	protein
,	O
not	O
only	O
to	O
T-antigen	protein
and	O
DNA,	O
but	O
also	O
to	O
the	O
DNA-binding	protein
eukaryotic	protein
transcription	protein
factors	protein
TATA-binding	protein
protein	protein
(	O
TBP	protein
),	O
and	O
to	O
the	O
cAMP-response-element-binding	protein
protein	protein
(	O
CREB	protein
).	O
Secondly,	O
we	O
investigated	O
whether	O
polyomavirus	O
reactivation	O
occurs	O
in	O
SLE	O
patients	O
,	O
and	O
whether	O
antibodies	protein
to	O
T-antigen	protein
,	O
DNA	DNA
,	O
and	O
to	O
TBP	protein
and	O
CREB	protein
are	O
linked	O
to	O
such	O
events.	O
Both	O
within	O
and	O
among	O
these	O
SLE	O
patients	O
,	O
frequent	O
polyomavirus	O
reactivations	O
were	O
observed	O
that	O
could	O
not	O
be	O
explained	O
by	O
certain	O
rearrangements	O
of	O
the	O
noncoding	O
control	O
regions,	O
nor	O
by	O
corticosteroid	O
treatment	O
.	O
Linked	O
to	O
these	O
events,	O
antibodies	protein
to	O
T-antigen	protein
,	O
DNA	DNA
,	O
TBP	protein
,	O
and	O
CREB	protein
were	O
detected,	O
identical	O
to	O
what	O
we	O
observed	O
in	O
mice	O
.	O
Antibodies	O
recognizing	O
double-stranded	O
DNA	O
were	O
confined	O
to	O
patients	O
with	O
frequent	O
polyomavirus	O
reactivations.	O
The	O
results	O
described	O
here	O
indicate	O
that	O
cognate	O
interaction	O
of	O
B	O
cells	O
recognizing	O
DNA	O
or	O
DNA-associated	protein
proteins	protein
and	O
T	cell_type
cells	cell_type
recognizing	O
T	protein
antigen	protein
had	O
taken	O
place	O
as	O
a	O
consequence	O
of	O
complex	O
formation	O
between	O
T	protein
ag	protein
and	O
DNA	DNA
in	O
vivo	O
in	O
the	O
context	O
of	O
polyomavirus	O
reactivations	O
.	O

Jak3	protein
is	O
associated	O
with	O
CD40	protein
and	O
is	O
critical	O
for	O
CD40	protein
induction	O
of	O
gene	O
expression	O
in	O
B	cell_type
cells	cell_type
.	O
CD40	protein
is	O
a	O
receptor	O
that	O
is	O
critical	O
for	O
the	O
survival,	O
growth,	O
differentiation,	O
and	O
isotype	O
switching	O
of	O
B	cell_type
lymphocytes	cell_type
.	O
Although	O
CD40	protein
lacks	O
intrinsic	O
tyrosine	O
kinase	O
activity,	O
its	O
ligation	O
induces	O
protein	O
tyrosine	O
phosphorylation	O
,	O
which	O
is	O
necessary	O
for	O
several	O
CD40	protein
-mediated	O
events	O
.	O
We	O
show	O
that	O
engagement	O
of	O
CD40	protein
induces	O
tyrosine	O
phosphorylation	O
and	O
activation	O
of	O
Jak3	protein
as	O
well	O
as	O
of	O
STAT3	protein
.	O
Jak3	protein
is	O
constitutively	O
associated	O
with	O
CD40	protein
,	O
and	O
this	O
interaction	O
requires	O
a	O
proline-rich	protein
sequence	protein
in	O
the	O
membrane-proximal	protein
region	protein
of	O
CD40	protein
.	O
Deletion	O
of	O
this	O
sequence	O
abolishes	O
the	O
capacity	O
of	O
CD40	protein
to	O
induce	O
expression	O
of	O
CD23	protein
,	O
ICAM-1	protein
,	O
and	O
lymphotoxin-alpha	DNA
genes	DNA
in	O
B	cell_type
cells	cell_type
.	O
These	O
results	O
indicate	O
that	O
signaling	O
through	O
Jak3	protein
is	O
activated	O
by	O
CD40	protein
and	O
plays	O
an	O
important	O
role	O
in	O
CD40	protein
-mediated	O
functions	O
.	O

Transcription	protein
factors	protein
required	O
for	O
lymphoid	O
lineage	O
commitment	O
.	O
Intimate	O
interactions	O
between	O
multipotential	O
hemopoietic	cell_type
stem	cell_type
cells	cell_type
and	O
their	O
microenvironment	O
work	O
towards	O
redefining	O
the	O
identity	O
and	O
the	O
differentiative	O
fate	O
of	O
these	O
primitive	cell_type
cells	cell_type
.	O
Molecular	O
cues	O
delivered	O
by	O
the	O
microenvironment	O
frequently	O
act	O
in	O
an	O
instructive	O
fashion	O
by	O
initiating	O
intracellular	O
signaling	O
pathways	O
that	O
ultimately	O
target	O
a	O
select	O
group	O
of	O
transcription	protein
factors	protein
.	O
These	O
transcriptional	O
regulators	O
in	O
turn	O
trigger	O
a	O
cascade	O
of	O
genetic	O
changes	O
that	O
ultimately	O
determine	O
the	O
course	O
of	O
the	O
cells	O
during	O
differentiation.	O
Gene	O
inactivation	O
studies	O
on	O
the	O
PU.1	O
,	O
Ikaros	O
and	O
GATA-3	O
genes	O
have	O
revealed	O
that	O
their	O
encoded	O
factors	O
are	O
essential	O
for	O
the	O
earliest	O
commitment	O
step	O
into	O
the	O
B	O
and	O
T	O
lymphoid	O
lineages	O
.	O

Interleukin-4	protein
signaling	O
in	O
B	cell_type
lymphocytes	cell_type
from	O
patients	O
with	O
X-linked	O
severe	O
combined	O
immunodeficiency	O
.	O
Interleukin-4	protein
(	O
IL-4	protein
)	O
is	O
an	O
important	O
cytokine	O
for	O
B	O
and	O
T	O
lymphocyte	O
function	O
and	O
mediates	O
its	O
effects	O
via	O
a	O
receptor	O
that	O
contains	O
gammac	protein
.	O
B	cell_type
cells	cell_type
derived	O
from	O
patients	O
with	O
X-linked	O
severe	O
combined	O
immunodeficiency	O
(	O
X-SCID	O
)	O
are	O
deficient	O
in	O
gammac	O
and	O
provide	O
a	O
useful	O
model	O
in	O
which	O
to	O
dissect	O
the	O
role	O
of	O
this	O
subunit	O
in	O
IL-4	protein
-mediated	O
signaling.	O
We	O
found	O
that	O
although	O
IL-4	protein
stimulation	O
of	O
X-SCID	cell_type
B	cell_type
cells	cell_type
did	O
not	O
result	O
in	O
Janus	protein
tyrosine	protein
kinase-3	protein
(	O
JAK3	protein
)	O
phosphorylation	O
,	O
other	O
IL-4	protein
substrates	protein
including	O
JAK1	protein
and	O
IRS-1	protein
were	O
phosphorylated.	O
Additionally,	O
we	O
detected	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
6	protein
(	O
STAT6	protein
)	O
tyrosine	O
phosphorylation	O
and	O
DNA	O
binding	O
activity	O
in	O
X-SCID	cell_type
B	cell_type
cells	cell_type
with	O
a	O
wide	O
range	O
of	O
gammac	protein
mutations	O
.	O
However,	O
reconstitution	O
of	O
these	O
X-SCID	cell_type
B	cell_type
cells	cell_type
with	O
gammac	protein
enhanced	O
IL-4	protein
-mediated	O
responses	O
including	O
STAT6	protein
phosphorylation	O
and	O
DNA	O
binding	O
activity	O
and	O
resulted	O
in	O
increased	O
CD23	protein
expression	O
.	O
Thus,	O
gammac	protein
is	O
not	O
necessary	O
to	O
trigger	O
IL-4	protein
-mediated	O
responses	O
in	O
B	cell_type
cells	cell_type
,	O
but	O
its	O
presence	O
is	O
important	O
for	O
optimal	O
IL-4	protein
-signaling	O
.	O
These	O
results	O
suggest	O
that	O
two	O
distinct	O
IL-4	protein
signaling	O
pathways	O
exist.	O

Cell-to-cell	O
contact	O
activates	O
the	O
long	DNA
terminal	DNA
repeat	DNA
of	O
human	O
immunodeficiency	O
virus	O
1	O
through	O
its	O
kappaB	DNA
motif	DNA
.	O
Cell-to-cell	O
contact	O
between	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
and	O
transfected	cell_line
human	cell_line
colonic	cell_line
carcinoma	cell_line
cell	cell_line
line	cell_line
HT29	cell_line
activates	O
transcription	O
of	O
the	O
long	DNA
terminal	DNA
repeats	DNA
(	O
LTR	DNA
)	O
of	O
human	O
immunodeficiency	O
virus	O
.	O
HIV-1	DNA
LTR	DNA
transcription	O
is	O
controlled	O
by	O
a	O
complex	O
array	O
of	O
virus-encoded	O
and	O
cellular	O
proteins	O
.	O
Using	O
various	O
constructs	O
expressing	O
a	O
lacZ	DNA
reporter	DNA
gene	DNA
under	O
the	O
control	O
of	O
the	O
intact	O
or	O
three	O
deleted	O
forms	O
of	O
HIV-1	DNA
LTR	DNA
,	O
we	O
obtained	O
evidence	O
that	O
the	O
kappaB	DNA
regulatory	DNA
elements	DNA
located	O
in	O
the	O
U3	DNA
region	DNA
are	O
involved	O
in	O
cell-to-cell	O
activation	O
of	O
HIV-1	DNA
LTR	DNA
.	O
Cell-to-cell	O
contact	O
activates	O
in	O
vitro	O
binding	O
of	O
the	O
nuclear	protein
factor	protein
kappaB	protein
(	protein
NF-kappaB	protein
)	protein
p50/p65	protein
heterodimer	protein
to	O
an	O
HIV-1	O
kappaB	O
oligonucleotide	O
.	O
Cell-to-cell	O
contact	O
activation	O
of	O
NF-kappaB	protein
was	O
only	O
partially	O
inhibited	O
by	O
100	O
microM	O
pyrrolidine	O
dithiocarbamate	O
and	O
was	O
not	O
correlated	O
with	O
a	O
significant	O
decrease	O
of	O
cellular	protein
inhibitor	protein
kappaB	protein
alpha	protein
.	O
NF-kappaB	protein
nuclear	O
activation	O
was	O
not	O
detectable	O
before	O
1	O
h	O
after	O
cell	O
contact	O
and	O
was	O
dependent	O
on	O
protein	O
synthesis	O
.	O

Identification	O
of	O
nucleotide	DNA
sequences	DNA
that	O
regulate	O
transcription	O
of	O
the	O
MCF13	O
murine	O
leukemia	O
virus	O
long	DNA
terminal	DNA
repeat	DNA
in	O
activated	O
T	cell_type
cells	cell_type
.	O
The	O
region	O
downstream	O
of	O
the	O
enhancer	DNA
(	O
DEN	DNA
)	O
of	O
the	O
long	DNA
terminal	DNA
repeat	DNA
of	O
the	O
mink	O
cell	O
focus-forming	O
murine	O
leukemia	O
virus	O
is	O
important	O
for	O
viral	O
pathogenicity	O
.	O
Another	O
important	O
activity	O
of	O
DEN	DNA
is	O
its	O
control	O
of	O
transcription	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
,	O
and	O
we	O
have	O
determined	O
that	O
an	O
NF-kappaB	protein
site	O
is	O
critical	O
for	O
this	O
activity.	O

Possible	O
role	O
of	O
nuclear	protein
factor-kappa	protein
B	protein
activity	O
in	O
germline	DNA
C	O
epsilon	O
transcription	O
in	O
a	O
human	cell_line
Burkitt	cell_line
lymphoma	cell_line
B	cell_line
cell	cell_line
line	cell_line
.	O
Nuclear	protein
factor-kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
plays	O
a	O
broad	O
role	O
in	O
gene	O
regulation,	O
but	O
it	O
is	O
not	O
evident	O
whether	O
NF-kappa	protein
B	protein
acts	O
as	O
a	O
messenger	O
system	O
for	O
germline	DNA
C	O
epsilon	O
transcription	O
.	O
We	O
report	O
here	O
that	O
the	O
signaling	O
cascade	O
triggered	O
by	O
interleukin-4	protein
(	O
IL-4	protein
)	O
or	O
anti-	protein
CD40	protein
monoclonal	protein
antibody	protein
(	O
mAb	protein
)	O
participates	O
in	O
NF-kappa	protein
B	protein
activation	O
responsible	O
for	O
germline	DNA
C	O
epsilon	O
transcription	O
in	O
a	O
human	cell_line
Burkitt	cell_line
lymphoma	cell_line
B	cell_line
cell	cell_line
line	cell_line
,	O
DND39	cell_line
.	O
Both	O
IL-4	protein
and	O
anti-	O
CD40	protein
mAb	protein
induced	O
activation	O
of	O
phosphatidylinositol	protein
3-kinase	protein
(	O
PI3-kinase	protein
),	O
translocation	O
of	O
a	O
zeta	O
isoform	O
of	O
protein	protein
kinase	protein
C	protein
,	O
and	O
nuclear	O
expression	O
of	O
NF-kappa	protein
B	protein
.	O
All	O
such	O
events	O
were	O
abrogated	O
by	O
treatment	O
with	O
LY294002	O
,	O
a	O
specific	O
inhibitor	O
of	O
PI3-kinase	protein
.	O
In	O
addition,	O
N-acetyl-L-cysteine	O
(	O
NAC	O
),	O
a	O
potent	O
antioxidant,	O
decreased	O
NF-kappa	protein
B	protein
activation	O
caused	O
by	O
IL-4	protein
,	O
anti-	protein
CD40	protein
mAb	protein
,	O
or	O
their	O
combination.	O
NAC	O
was	O
also	O
effective	O
in	O
diminishing	O
germline	DNA
C	O
epsilon	O
transcription	O
,	O
and	O
its	O
potency	O
was	O
higher	O
in	O
cultures	O
costimulated	O
with	O
IL-4	protein
and	O
anti-	protein
CD40	protein
mAb	protein
than	O
in	O
those	O
stimulated	O
with	O
IL-4	protein
alone.	O
These	O
results	O
indicate	O
that	O
IL-4	protein
and	O
ligation	O
of	O
CD40	protein
induce	O
NF-kappa	protein
B	protein
expression	O
via	O
at	O
least	O
a	O
mechanism	O
dependent	O
on	O
the	O
PI3-kinase	protein
pathway	O
and	O
suggest	O
that	O
NF-kappa	protein
B	protein
sensitive	O
to	O
NAC	O
may	O
play	O
a	O
role	O
in	O
regulating	O
germline	DNA
C	O
epsilon	O
transcription	O
.	O

Differentiation	O
of	O
U-937	cell_line
promonocytic	cell_line
cells	cell_line
by	O
etoposide	O
and	O
ICRF-193	O
,	O
two	O
antitumour	O
DNA	protein
topoisomerase	protein
II	protein
inhibitors	O
with	O
different	O
mechanisms	O
of	O
action.	O
We	O
have	O
compared	O
the	O
action	O
on	O
U-937	cell_line
human	cell_line
promonocytic	cell_line
leukemia	cell_line
cells	cell_line
of	O
two	O
DNA	protein
topoisomerase	protein
II	protein
inhibitors	O
,	O
namely	O
the	O
epipodophyllotoxin	O
etoposide	O
and	O
the	O
bisdioxopiperazine	O
ICRF-193	O
.	O
One	O
hour	O
pulse-treatment	O
with	O
3	O
microM	O
etoposide	O
caused	O
topoisomerase	protein
associated,	O
primary	O
DNA	O
breakage	O
,	O
which	O
was	O
rapidly	O
followed	O
by	O
apoptosis	O
.	O
By	O
contrast,	O
these	O
effects	O
were	O
not	O
observed	O
upon	O
pulse-treatment	O
with	O
6	O
microM	O
ICRF-193	O
.	O
However,	O
continuous	O
treatments	O
with	O
subcytotoxic	O
concentrations	O
of	O
etoposide	O
(0.15	O
microM)	O
and	O
ICRF-193	O
(0.3	O
microM)	O
produced	O
several	O
similar	O
effects,	O
namely	O
decreased	O
cell	O
proliferation	O
,	O
accumulation	O
of	O
cells	O
at	O
G2,	O
increase	O
in	O
cell	O
mass,	O
and	O
induction	O
of	O
differentiation.	O
Under	O
these	O
conditions,	O
etoposide	O
produced	O
a	O
biphasic	O
activation	O
of	O
protein	protein
kinase	protein
C	protein
,	O
which	O
consisted	O
in	O
an	O
early	O
transient	O
activation	O
(from	O
hours	O
1	O
to	O
6)	O
of	O
the	O
membrane-bound	protein
enzyme	protein
followed	O
by	O
a	O
later	O
activation	O
(hour	O
48)	O
of	O
the	O
total,	O
membrane-bound	O
and	O
cytosolic	O
enzyme	O
.	O
By	O
contrast,	O
ICRF-193	O
only	O
provoked	O
a	O
late	O
activation	O
(from	O
hours	O
72	O
to	O
96)	O
of	O
the	O
total	O
enzyme.	O
When	O
used	O
at	O
differentiation-inducing	O
concentrations,	O
both	O
topoisomerase	protein
inhibitors	O
caused	O
a	O
great	O
stimulation	O
of	O
AP-1	protein
binding	O
activity	O
,	O
with	O
maximum	O
value	O
at	O
hour	O
12	O
in	O
etoposide	O
-treated	O
cells	O
and	O
at	O
hour	O
48	O
in	O
ICRF-193	cell_type
-treated	cell_type
cells	cell_type
.	O
By	O
contrast,	O
the	O
binding	O
activity	O
of	O
the	O
NF-kappa(B)	protein
and	O
EGR-1	protein
transcription	protein
factors	protein
was	O
little	O
affected.	O
It	O
is	O
concluded	O
that	O
topoisomerase	O
II	O
inhibitors	O
may	O
induce	O
the	O
differentiation	O
of	O
promonocytic	O
cells,	O
independently	O
of	O
their	O
capacity	O
to	O
cause	O
DNA	O
strand	O
breaks	O
.	O
However,	O
there	O
are	O
other	O
effects,	O
such	O
as	O
the	O
early	O
activation	O
of	O
protein	protein
kinase	protein
C	protein
,	O
which	O
are	O
probably	O
derived	O
from	O
the	O
production	O
of	O
primary	O
DNA	O
breakage	O
by	O
some	O
anti-	O
topoisomerase	protein
drugs	O
.	O

GATA-1	protein
DNA	O
binding	O
activity	O
is	O
down-regulated	O
in	O
late	O
S	O
phase	O
in	O
erythroid	cell_type
cells	cell_type
.	O
We	O
have	O
set	O
out	O
to	O
test	O
a	O
model	O
for	O
tissue-specific	O
gene	O
expression	O
that	O
relies	O
on	O
the	O
early	O
replication	O
of	O
expressed	O
genes	O
to	O
sequester	O
limiting	O
activating	O
transcription	protein
factors	protein
.	O
Using	O
an	O
erythroid	cell_line
cell	cell_line
line	cell_line
,	O
we	O
have	O
tested	O
the	O
changes	O
in	O
the	O
DNA	O
binding	O
activity	O
of	O
the	O
lineage-restricted	protein
transcription	protein
factor	protein
GATA-1	protein
through	O
the	O
cell	O
cycle	O
.	O
We	O
find	O
that	O
GATA-1	protein
activity	O
is	O
low	O
in	O
G1	O
,	O
peaks	O
in	O
mid-S	O
phase	O
,	O
and	O
then	O
decreases	O
in	O
G2/M	O
.	O
In	O
contrast,	O
the	O
binding	O
activities	O
of	O
two	O
ubiquitous	O
transcription	protein
factors	protein
,	O
Oct1	protein
and	O
Sp1	protein
,	O
remain	O
high	O
in	O
G2/M	O
.	O
GATA-1	protein
protein	O
and	O
mRNA	RNA
vary	O
in	O
a	O
similar	O
manner	O
through	O
the	O
cell	O
cycle	O
,	O
suggesting	O
that	O
the	O
expression	O
of	O
the	O
gene	O
or	O
the	O
stability	O
of	O
its	O
message	O
is	O
regulated.	O
Although	O
a	O
number	O
of	O
transcription	protein
factors	protein
involved	O
in	O
the	O
control	O
of	O
the	O
cell	O
cycle	O
or	O
DNA	O
replication	O
have	O
been	O
shown	O
to	O
peak	O
in	O
S	O
phase	O
,	O
this	O
is	O
the	O
first	O
example	O
of	O
a	O
lineage-restricted	protein
transcription	protein
factor	protein
displaying	O
S	O
phase	O
-specific	O
DNA	O
binding	O
activity	O
.	O
One	O
interpretation	O
of	O
these	O
data	O
leads	O
to	O
a	O
model	O
in	O
which	O
the	O
peak	O
in	O
GATA-1	protein
DNA	O
binding	O
amplifies	O
the	O
effect	O
of	O
early	O
replication	O
on	O
the	O
activation	O
of	O
erythroid-specific	DNA
genes	DNA
at	O
the	O
same	O
time	O
as	O
preventing	O
activation	O
of	O
non-erythroid	DNA
genes	DNA
containing	O
GATA-responsive	DNA
elements	DNA
.	O
These	O
results	O
may	O
also	O
relate	O
to	O
recent	O
data	O
implicating	O
GATA-1	protein
function	O
in	O
apoptosis	O
and	O
cell	O
cycle	O
progression	O

Activation	O
of	O
the	O
NF-kappaB	protein
pathway	O
by	O
inflammatory	O
stimuli	O
in	O
human	cell_type
neutrophils	cell_type
.	O
Activated	cell_type
neutrophils	cell_type
have	O
the	O
ability	O
to	O
upregulate	O
the	O
expression	O
of	O
many	O
genes,	O
in	O
particular	O
those	O
encoding	O
cytokines	protein
and	O
chemokines	protein
,	O
and	O
to	O
subsequently	O
release	O
the	O
corresponding	O
proteins.	O
Although	O
little	O
is	O
known	O
to	O
date	O
concerning	O
the	O
regulation	O
of	O
gene	O
transcription	O
in	O
neutrophils	cell_type
,	O
it	O
is	O
noteworthy	O
that	O
many	O
of	O
these	O
genes	O
depend	O
on	O
the	O
activation	O
of	O
transcription	protein
factors	protein
,	O
such	O
as	O
NF-kappaB	protein
,	O
for	O
inducible	O
expression.	O
We	O
therefore	O
investigated	O
whether	O
NF-kappaB	protein
/Rel	protein
proteins	protein
are	O
expressed	O
in	O
human	cell_type
neutrophils	cell_type
,	O
as	O
well	O
as	O
their	O
fate	O
on	O
cell	O
activation.	O
We	O
now	O
report	O
that	O
dimers	O
consisting	O
of	O
p50	protein
NFkappaB1	protein
,	O
p65	protein
RelA	protein
,	O
and/or	O
c-Rel	protein
are	O
present	O
in	O
neutrophils	cell_type
and	O
that	O
the	O
greater	O
part	O
of	O
these	O
protein	protein
complexes	protein
is	O
physically	O
associated	O
with	O
cytoplasmic	protein
IkappaB-alpha	protein
in	O
resting	O
cells.	O
Following	O
neutrophil	O
stimulation	O
with	O
proinflammatory	O
agonists	O
(such	O
as	O
lipopolysaccharide	O
[	O
LPS	O
],	O
tumor	protein
necrosis	protein
factor-alpha	protein
[	O
TNF-alpha	protein
],	O
and	O
fMet-Leu-Phe	O
)	O
that	O
induce	O
the	O
production	O
of	O
cytokines	protein
and	O
chemokines	protein
in	O
these	O
cells,	O
NF-kappaB	protein
/Rel	protein
proteins	protein
translocated	O
to	O
nuclear	O
fractions	O
,	O
resulting	O
in	O
a	O
transient	O
induction	O
of	O
NF-kappaB	protein
DNA	O
binding	O
activity	O
,	O
as	O
determined	O
in	O
gel	O
mobility	O
shift	O
assays	O
.	O
The	O
onset	O
of	O
both	O
processes	O
was	O
found	O
to	O
be	O
closely	O
paralleled	O
by,	O
and	O
dependent	O
on,	O
IkappaB-alpha	protein
degradation	O
.	O
Proinflammatory	cell_type
neutrophil	cell_type
stimuli	O
also	O
promoted	O
the	O
accumulation	O
of	O
IkappaB-alpha	RNA
mRNA	RNA
transcripts	RNA
,	O
resulting	O
in	O
the	O
reexpression	O
of	O
the	O
IkappaB-alpha	protein
protein	protein
.	O
To	O
our	O
knowledge,	O
this	O
constitutes	O
the	O
first	O
indication	O
that	O
NF-kappaB	protein
activation	O
may	O
underlie	O
the	O
action	O
of	O
proinflammatory	O
stimuli	O
towards	O
human	O
neutrophil	O
gene	O
expression	O
and,	O
as	O
such,	O
adds	O
a	O
new	O
facet	O
to	O
our	O
understanding	O
of	O
neutrophil	cell_type
biology	cell_type
.	O

Two	O
distinct	O
pathways	O
of	O
interleukin-5	protein
synthesis	O
in	O
allergen-specific	cell_line
human	cell_line
T-cell	cell_line
clones	cell_line
are	O
suppressed	O
by	O
glucocorticoids	O
.	O
Glucocorticoids	O
(	O
GC	O
)	O
have	O
long	O
been	O
used	O
as	O
the	O
most	O
effective	O
agents	O
for	O
the	O
treatment	O
of	O
allergic	O
diseases	O
accompanied	O
by	O
eosinophilia	O
such	O
as	O
chronic	O
asthma	O
and	O
atopic	O
dermatitis	O
.	O
The	O
development	O
of	O
chronic	O
eosinophilic	O
inflammation	O
is	O
dependent	O
on	O
interleukin-5	protein
(	O
IL-5	protein
),	O
a	O
selective	protein
eosinophil-activating	protein
factor	protein
,	O
produced	O
by	O
helper	cell_type
T	cell_type
cells	cell_type
.	O
To	O
delineate	O
the	O
regulatory	O
mechanisms	O
of	O
human	O
IL-5	protein
synthesis	O
,	O
we	O
established	O
allergen-specific	cell_line
CD4+	cell_line
T-cell	cell_line
clones	cell_line
from	O
asthmatic	O
patients	O
.	O
GC	O
efficiently	O
suppressed	O
IL-5	protein
synthesis	O
of	O
T-cell	O
clones	O
activated	O
via	O
either	O
T-cell	protein
receptor	protein
(	O
TCR	protein
)	O
or	O
IL-2	protein
receptor	protein
(	O
IL-2R	protein
).	O
Induction	O
of	O
IL-5	RNA
mRNA	RNA
upon	O
TCR	protein
and	O
IL-2R	protein
stimulation	O
was	O
totally	O
inhibited	O
by	O
dexamethasone	O
.	O
Human	O
IL-5	protein
promoter/enhancer-luciferase	O
gene	O
construct	O
transfected	O
to	O
T-cell	cell_line
clones	cell_line
was	O
transcribed	O
on	O
either	O
TCR	protein
or	O
IL-2R	protein
stimulation	O
and	O
was	O
clearly	O
downregulated	O
by	O
dexamethasone	O
,	O
indicating	O
that	O
the	O
approximately	O
500-bp	DNA
human	DNA
IL-5	DNA
gene	DNA
segment	DNA
located	O
5'	DNA
upstream	DNA
of	O
the	O
coding	O
region	O
contains	O
activation-inducible	DNA
enhancer	DNA
elements	DNA
responsible	O
for	O
the	O
regulation	O
by	O
GC	O
.	O
Electrophoretic	O
mobility	O
shift	O
assay	O
analysis	O
suggested	O
that	O
AP-1	protein
and	O
NF-kappaB	protein
are	O
among	O
the	O
possible	O
targets	O
of	O
GC	O
actions	O
on	O
TCR	cell_type
-stimulated	cell_type
T	cell_type
cells	cell_type
.	O
NF-AT	protein
and	O
NF-kappaB	protein
were	O
not	O
significantly	O
induced	O
by	O
IL-2	protein
stimulation	O
.	O
Our	O
results	O
showing	O
that	O
GC	O
suppressed	O
IL-5	protein
production	O
by	O
human	cell_type
CD4+	cell_type
T	cell_type
cells	cell_type
activated	O
by	O
two	O
distinct	O
stimuli,	O
TCR	protein
and	O
IL-2R	protein
stimulation	O
,	O
underscore	O
the	O
efficacy	O
of	O
GC	O
in	O
the	O
treatment	O
of	O
allergic	O
diseases	O
via	O
suppression	O
of	O
T-cell	O
IL-5	protein
synthesis	O
.	O

Itk	protein
,	O
a	O
T	protein
cell-specific	protein
tyrosine	protein
kinase	protein
,	O
is	O
required	O
for	O
CD2-mediated	DNA
interleukin-2	DNA
promoter	DNA
activation	O
in	O
the	O
human	cell_line
T	cell_line
cell	cell_line
line	cell_line
Jurkat	cell_line
.	O
We	O
investigated	O
the	O
functional	O
role	O
of	O
Itk	protein
,	O
a	O
member	O
of	O
the	O
cytoplasmic	protein
tyrosine	protein
kinase	protein
Tec	protein
family	protein
,	O
in	O
T	O
cell	O
activation	O
.	O
Stimulation	O
of	O
either	O
CD2	protein
or	O
T	O
cell	O
receptor	O
(	O
TCR	protein
)/CD3	O
on	O
Tcells	O
by	O
monoclonal	O
antibody-mediated	O
cross-linking	O
induced	O
tyrosine	O
phosphorylation	O
of	O
Itk	protein
,	O
which	O
was	O
maximal	O
as	O
early	O
as	O
1	O
min	O
after	O
stimulation.	O
The	O
tyrosine	O
kinase	O
activity	O
in	O
the	O
anti-	O
Itk	protein
immunoprecipitate	O
was	O
significantly	O
activated	O
upon	O
these	O
stimulations.	O
Interleukin-2	O
(	O
IL-2	protein
)	O
promoter	O
activity	O
stimulated	O
by	O
cross-linking	O
of	O
CD2	protein
,	O
TCR	protein
/CD3,	O
and	O
CD28	protein
with	O
antibodies	protein
was	O
significantly	O
reduced	O
by	O
transient	O
expression	O
of	O
an	O
Itk	protein
mutant	protein
lacking	O
the	O
kinase	O
activity	O
.	O
The	O
reduction	O
paralleled	O
a	O
decrease	O
in	O
tyrosine	O
phosphorylation	O
of	O
endogenous	protein
wild-type	protein
Itk	protein
.	O
Stimulation	O
of	O
CD2	protein
or	O
TCR/CD3	protein
induced	O
activation	O
of	O
the	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NFAT	protein
),	O
the	O
binding	DNA
site	DNA
of	O
which	O
is	O
included	O
in	O
the	O
IL-2	DNA
gene	DNA
promoter	DNA
.	O
The	O
activation	O
of	O
NFAT	protein
was	O
also	O
impaired	O
by	O
expression	O
of	O
the	O
Itk	protein
mutant	protein
.	O
These	O
results	O
demonstrate	O
that	O
Itk	protein
plays	O
a	O
role	O
in	O
IL-2	protein
production	O
,	O
indicating	O
a	O
critical	O
involvement	O
of	O
Itk	protein
in	O
the	O
initial	O
stage	O
of	O
T	O
cell	O
activation	O
by	O
mediating	O
signals	O
from	O
the	O
TCR/CD3	protein
complex	protein
,	O
CD2	protein
,	O
and	O
CD28	protein
.	O

Expression	O
of	O
LAZ3/BCL6	protein
in	O
follicular	O
center	O
(FC)	O
B	O
cells	O
of	O
reactive	O
lymph	O
nodes	O
and	O
FC-derived	O
non-Hodgkin	O
lymphomas	O
.	O
Chromosomal	O
translocation	O
resulting	O
in	O
abnormal	O
expression	O
of	O
the	O
LAZ3/BCL6	DNA
gene	DNA
in	O
B	cell_type
cells	cell_type
has	O
been	O
implicated	O
in	O
the	O
tumorigenesis	O
of	O
non-Hodgkin	O
lymphoma	O
(	O
NHL	O
).	O
Therefore	O
we	O
studied	O
the	O
expression	O
pattern	O
of	O
LAZ3/BCL6	protein
by	O
in	O
situ	O
hybridization	O
with	O
synthetic	O
oligonucleotide	O
probes	O
in	O
frozen	O
tissue	O
sections	O
from	O
five	O
reactive	O
lymph	O
nodes	O
and	O
38	O
B	O
cell	O
and	O
non-B	O
NHL	O
.	O
In	O
addition,	O
we	O
investigated	O
the	O
expression	O
of	O
LAZ3/BCL6	protein
by	O
Northern	O
blot	O
analysis	O
on	O
multiple	O
human	O
tissues	O
.	O
The	O
LAZ3/BCL6	RNA
transcript	RNA
was	O
found	O
in	O
a	O
variety	O
of	O
tissues,	O
including	O
skeletal	O
muscle	O
,	O
peripheral	cell_type
blood	cell_type
leukocytes	cell_type
,	O
and	O
weakly	O
in	O
normal	O
lymph	O
nodes	O
.	O
In	O
the	O
tumor	O
samples	O
,	O
expression	O
of	O
LAZ3/BCL6	protein
was	O
observed	O
in	O
68%	O
of	O
all	O
B	O
cell	O
NHL	O
and	O
none	O
of	O
the	O
non-B	O
lymphomas	O
.	O
All	O
cases	O
of	O
follicular	O
,	O
mixed	O
small	O
and	O
large	O
cell	O
lymphomas	O
showed	O
LAZ3/BCL6	protein
expression	O
confined	O
to	O
the	O
neoplastic	O
follicles	O
.	O
A	O
follicular	O
expression	O
pattern	O
was	O
also	O
found	O
in	O
all	O
non-malignant	O
reactive	O
lymph	O
nodes	O
.	O
Hence,	O
the	O
expression	O
of	O
LAZ3/BCL6	protein
does	O
not	O
correlate	O
to	O
malignancy,	O
but	O
reflects	O
the	O
origin	O
of	O
B	cell_type
cells	cell_type
from	O
the	O
germinal	O
centers	O
.	O

Jak1	protein
expression	O
is	O
required	O
for	O
mediating	O
interleukin-4-induced	O
tyrosine	O
phosphorylation	O
of	O
insulin	O
receptor	O
substrate	O
and	O
Stat6	protein
signaling	protein
molecules	protein
.	O
The	O
Jak1	O
,	O
Jak2	O
,	O
Jak3	O
,	O
and	O
Fes	O
tyrosine	O
kinases	O
have	O
been	O
demonstrated	O
to	O
undergo	O
tyrosine	O
phosphorylation	O
in	O
response	O
to	O
interleukin	protein
(IL)-4	protein
stimulation	O
in	O
different	O
cell	O
systems.	O
However,	O
it	O
is	O
not	O
clear	O
which,	O
if	O
any,	O
of	O
these	O
kinases	O
are	O
responsible	O
for	O
initiating	O
IL-4-induced	O
tyrosine	O
phosphorylation	O
of	O
intracellular	protein
substrates	protein
in	O
vivo.	O
In	O
the	O
present	O
study,	O
we	O
have	O
utilized	O
a	O
mutant	cell_line
Jak1	cell_line
-deficient	cell_line
HeLa	cell_line
cell	cell_line
line	cell_line
,	O
E1C3	cell_line
,	O
and	O
its	O
parental	cell_line
Jak1	cell_line
-expressing	cell_line
counterpart	cell_line
,	O
1D4	cell_line
,	O
to	O
analyze	O
the	O
role	O
of	O
Jak1	protein
in	O
mediating	O
IL-4-induced	O
tyrosine	O
phosphorylation	O
events.	O
IL-4	O
treatment	O
rapidly	O
induced	O
tyrosine	O
phosphorylation	O
of	O
insulin	protein
receptor	protein
substrate	protein
(IRS)-1	protein
and	O
IRS-2	protein
in	O
1D4	cell_line
but	O
not	O
in	O
E1C3	cell_line
cells	cell_line
.	O
IL-4	protein
-mediated	O
tyrosine	O
phosphorylation	O
of	O
Stat6	protein
was	O
pronounced	O
in	O
1D4	cell_line
cells	cell_line
,	O
while	O
no	O
IL-4	protein
-induced	O
Stat6	protein
phosphorylation	O
was	O
detected	O
in	O
E1C3	cell_line
cells	cell_line
.	O
IL-4	protein
also	O
induced	O
Stat6	protein
DNA	O
binding	O
activity	O
from	O
lysates	O
of	O
1D4	cell_line
but	O
not	O
E1C3	cell_line
cells	cell_line
utilizing	O
a	O
radiolabeled	DNA
immunoglobulin	DNA
heavy	DNA
chain	DNA
germline	DNA
epsilon	DNA
promotor	DNA
sequence	DNA
(	O
Iepsilon	DNA
)	O
in	O
an	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O
Reconstitution	O
of	O
Jak1	protein
expression	O
in	O
E1C3	cell_line
cells	cell_line
restored	O
the	O
ability	O
of	O
IL-4	protein
to	O
induce	O
IRS	DNA
and	O
Stat6	protein
tyrosine	O
phosphorylation	O
.	O
These	O
results	O
provide	O
evidence	O
that	O
Jak1	protein
expression	O
is	O
required	O
for	O
mediating	O
tyrosine	O
phosphorylation	O
and	O
activation	O
of	O
crucial	O
molecules	O
involved	O
in	O
IL-4	protein
signal	O
transduction	O
.	O

Oxidant-regulation	O
of	O
gene	O
expression	O
in	O
the	O
chronically	O
inflamed	O
intestine	O
.	O
It	O
is	O
becoming	O
increasingly	O
apparent	O
that	O
the	O
chronic	O
gut	O
inflammation	O
observed	O
in	O
the	O
idiopathic	O
inflammatory	O
bowel	O
diseases	O
(e.g.	O
ulcerative	O
colitis	O
,	O
Crohn's	O
disease	O
)	O
is	O
associated	O
with	O
enhanced	O
production	O
of	O
leukocyte-derived	O
oxidants	O
.	O
Oxidants	O
such	O
as	O
hydrogen	O
peroxide	O
are	O
known	O
to	O
activate	O
certain	O
transcription	protein
factors	protein
such	O
as	O
nuclear	protein
transcription	protein
factor	protein
kappa	protein
beta	protein
.	O
Nuclear	protein
transcription	protein
factor	protein
kB	protein
(	O
NF-kappa	protein
B	protein
)	O
is	O
a	O
ubiquitous	protein
transcription	protein
factor	protein
and	O
pleiotropic	protein
regulator	protein
of	O
numerous	O
genes	O
involved	O
in	O
the	O
immune	O
and	O
inflammatory	O
responses	O
.	O
This	O
transcription	protein
factor	protein
is	O
activated	O
via	O
the	O
selective	O
phosphorylation	O
,	O
ubiquination	O
and	O
degradation	O
of	O
its	O
inhibitor	protein
protein	protein
I-kB	protein
thereby	O
allowing	O
translocation	O
of	O
NF-kappa	protein
B	protein
into	O
the	O
nucleus	O
where	O
it	O
upregulates	O
the	O
transcription	O
of	O
a	O
variety	O
of	O
adhesion	protein
molecules	protein
(e.g.	O
ICAM-1	protein
,	O
VCAM-1	protein
),	O
cytokines	protein
(	O
TNF	protein
,	O
IL-1	protein
,	O
IL-6	protein
)	O
and	O
enzymes	protein
(	O
iNOS	protein
).	O
The	O
proteolytic	O
degradation	O
of	O
the	O
post-translationally	O
modified	O
I-kappa	protein
B	protein
is	O
known	O
to	O
be	O
mediated	O
by	O
the	O
26S	protein
proteasome	protein
complex	protein
.	O
Based	O
upon	O
work	O
from	O
our	O
laboratory,	O
we	O
propose	O
that	O
inhibition	O
of	O
NF-kappa	protein
B	protein
activation	O
produces	O
significant	O
anti	O
inflammatory	O
activity	O
which	O
may	O
be	O
mediated	O
by	O
the	O
inhibition	O
of	O
transcription	O
of	O
certain	O
pro-inflammatory	protein
mediators	protein
and	O
adhesion	protein
molecules	protein
.	O

Generation	O
of	O
cytotoxic	cell_type
T	cell_type
lymphocytes	cell_type
against	O
immunorecessive	protein
epitopes	protein
after	O
multiple	O
immunizations	O
with	O
adenovirus	O
vectors	O
is	O
dependent	O
on	O
haplotype	O
.	O
Currently,	O
adenovirus	O
(	O
Ad	O
)	O
is	O
being	O
considered	O
as	O
a	O
vector	O
for	O
the	O
treatment	O
of	O
cystic	O
fibrosis	O
as	O
well	O
as	O
other	O
diseases.	O
However,	O
the	O
cytotoxic	cell_type
T	cell_type
lymphocyte	cell_type
(	O
CTL	cell_type
)	O
response	O
to	O
Ad	O
could	O
limit	O
the	O
effectiveness	O
of	O
such	O
approaches.	O
Since	O
the	O
CTL	cell_type
response	O
to	O
virus	O
infection	O
is	O
often	O
focused	O
on	O
one	O
or	O
a	O
few	O
immunodominant	protein
epitopes	protein
,	O
one	O
approach	O
to	O
circumvent	O
this	O
response	O
is	O
to	O
create	O
vectors	O
that	O
lack	O
these	O
immunodominant	protein
epitopes	protein
.	O
The	O
effectiveness	O
of	O
this	O
approach	O
was	O
tested	O
by	O
immunizing	O
mice	O
with	O
human	O
group	O
C	O
adenoviruses	O
.	O
Three	O
mouse	O
strains	O
(	O
C57BL/10SnJ	O
[H-2b]	O
,	O
C3HeB/FeJ	O
[H-2k]	O
,	O
and	O
BALB/cByJ	O
[H-2d]	O
)	O
were	O
immunized	O
with	O
wild-type	O
Ad	O
or	O
Ad	O
vectors	O
lacking	O
the	O
immunodominant	protein
antigen	protein
(s),	O
and	O
the	O
CTL	cell_type
responses	O
were	O
measured.	O
In	O
C57BL/10	O
(B10)	O
mice	O
,	O
a	O
single	O
inoculation	O
intraperitoneally	O
(i.p.)	O
led	O
to	O
the	O
recognition	O
of	O
an	O
immunodominant	protein
antigen	protein
in	O
E1A	DNA
.	O
When	O
B10	O
mice	O
were	O
inoculated	O
multiple	O
times	O
either	O
i.p.	O
or	O
intranasally	O
with	O
wild-type	O
Ad	O
or	O
an	O
Ad	O
vector	O
lacking	O
most	O
of	O
the	O
E1	DNA
region	DNA
,	O
subdominant	O
epitopes	O
outside	O
this	O
region	O
were	O
recognized.	O
In	O
contrast,	O
C3H	O
mice	O
inoculated	O
with	O
wild-type	O
Ad	O
recognized	O
an	O
epitope	O
mapping	O
within	O
E1B	DNA
.	O
When	O
inoculated	O
twice	O
with	O
Ad	O
vectors	O
lacking	O
both	O
E1A	DNA
and	O
E1B	DNA
,	O
no	O
immunorecessive	protein
epitopes	protein
were	O
recognized.	O
The	O
immune	O
response	O
to	O
Ad	O
in	O
BALB/c	O
mice	O
was	O
more	O
complex.	O
CTLs	cell_type
from	O
BALB/c	O
mice	O
inoculated	O
i.p.	O
with	O
wild-type	O
Ad	O
recognized	O
E1B	DNA
in	O
the	O
context	O
of	O
the	O
major	DNA
histocompatibility	DNA
complex	DNA
(	DNA
MHC	DNA
)	DNA
class	DNA
I	DNA
Dd	DNA
allele	DNA
and	O
a	O
region	O
outside	O
E1	DNA
associated	O
with	O
the	O
Kd	DNA
allele	DNA
.	O
When	O
BALB/c	O
mice	O
were	O
inoculated	O
with	O
E1	DNA
-deleted	O
Ad	O
vectors	O
,	O
only	O
the	O
immunodominant	protein
Kd-restricted	protein
epitope	protein
was	O
recognized,	O
and	O
Dd-restricted	O
CTLs	cell_type
did	O
not	O
develop.	O
This	O
report	O
indicates	O
that	O
the	O
emergence	O
of	O
CTLs	cell_type
against	O
immunorecessive	protein
epitopes	protein
following	O
multiple	O
administrations	O
of	O
Ad	O
vectors	O
lacking	O
immunodominant	O
antigens	O
is	O
dependent	O
on	O
haplotype	O
and	O
could	O
present	O
an	O
obstacle	O
to	O
gene	O
therapy	O
in	O
an	O
MHC	protein
-diverse	O
human	O
population	O
.	O

Characterization	O
of	O
the	O
human	DNA
platelet/endothelial	DNA
cell	DNA
adhesion	DNA
molecule-1	DNA
promoter	DNA
:	O
identification	O
of	O
a	O
GATA-2	DNA
binding	DNA
element	DNA
required	O
for	O
optimal	O
transcriptional	O
activity	O
.	O
Platelet/endothelial	protein
cell	protein
adhesion	protein
molecule-1	protein
(	O
PECAM-1	protein
)	O
is	O
a	O
130-kD	protein
member	protein
of	O
the	O
Ig	DNA
gene	DNA
superfamily	DNA
that	O
is	O
expressed	O
on	O
platelets	cell_type
,	O
endothelial	cell_type
cells	cell_type
,	O
and	O
certain	O
leukocyte	cell_type
subsets	cell_type
.	O
To	O
examine	O
the	O
factors	O
controlling	O
vascular-specific	O
expression	O
of	O
PECAM-1	protein
,	O
we	O
cloned	O
the	O
5'-flanking	DNA
region	DNA
of	O
the	O
PECAM-1	DNA
gene	DNA
and	O
analyzed	O
its	O
transcriptional	O
activity	O
.	O
5'-Rapid	O
amplification	O
of	O
cDNA	DNA
ends	DNA
(	O
5'-RACE	DNA
)	O
analysis	O
showed	O
that	O
transcription	O
initiation	O
occurred	O
at	O
several	O
closely	O
spaced	O
nearby	O
sites	O
originating	O
approximately	O
204	DNA
bp	DNA
upstream	DNA
from	O
the	O
translation	DNA
start	DNA
site	DNA
.	O
Analysis	O
of	O
the	O
sequence	O
immediately	O
upstream	O
from	O
the	O
transcription	DNA
initiation	DNA
site	DNA
(	O
TIS	DNA
)	O
showed	O
no	O
canonical	O
TATA	DNA
or	O
CAAT	DNA
elements	DNA
,	O
however	O
an	O
initiator	O
element	O
commonly	O
found	O
in	O
TATA	DNA
-less	DNA
promoters	DNA
encompassed	O
the	O
TIS	DNA
.	O
5'-serially	DNA
truncated	DNA
PECAM-1	DNA
promoter	DNA
segments	DNA
cloned	O
in	O
front	O
of	O
a	O
luciferase	DNA
reporter	DNA
drove	O
transcription	O
in	O
both	O
a	O
lineage-	O
and	O
orientation-specific	O
manner.	O
Putative	O
cis-acting	DNA
control	DNA
elements	DNA
present	O
within	O
a	O
300-bp	DNA
core	DNA
promoter	DNA
included	O
two	O
ets	DNA
sites	DNA
,	O
an	O
Sp1	DNA
site	DNA
,	O
tandem	O
E-box	DNA
domains	DNA
,	O
two	O
GATA-associated	DNA
sites	DNA
(	O
CACCC	O
),	O
an	O
AP-2	DNA
binding	DNA
site	DNA
,	O
and	O
a	O
GATA	DNA
element	DNA
at	O
-24	DNA
.	O
Mutational	O
analysis	O
showed	O
that	O
optimal	O
transcriptional	O
activity	O
required	O
the	O
GATA	DNA
sequence	DNA
at	O
position	O
-24	DNA
,	O
and	O
gel-shift	O
assays	O
further	O
showed	O
that	O
the	O
GATA-2	protein
transcription	protein
factor	protein
,	O
but	O
not	O
GATA-1	protein
,	O
bound	O
to	O
this	O
region	O
of	O
the	O
PECAM-1	DNA
promoter	DNA
.	O
Understanding	O
the	O
cis-	O
and	O
trans	O
acting	O
factors	O
that	O
regulate	O
the	O
tissue-specific	O
expression	O
of	O
PECAM-1	protein
should	O
increase	O
our	O
understanding	O
of	O
the	O
mechanisms	O
by	O
which	O
vascular-specific	O
gene	O
expression	O
is	O
achieved.	O

A	O
negative	O
regulatory	O
region	O
containing	O
a	O
glucocorticosteroid	DNA
response	DNA
element	DNA
(	O
nGRE	DNA
)	O
in	O
the	O
human	DNA
interleukin-1beta	DNA
gene	DNA
.	O
Interleukin-1	protein
beta	protein
(	O
IL-1beta	protein
)	O
is	O
one	O
of	O
the	O
most	O
important	O
inflammatory	protein
mediators	protein
in	O
human	O
inflammatory	O
and	O
immunological	O
diseases	O
.	O
The	O
regulation	O
of	O
human	protein
IL-1beta	protein
gene	O
expression	O
has	O
been	O
studied	O
for	O
several	O
years,	O
and	O
a	O
few	O
regulatory	DNA
elements	DNA
have	O
been	O
discovered	O
in	O
the	O
promoter	DNA
region	DNA
.	O
However,	O
little	O
is	O
known	O
about	O
negative	O
regulation	O
of	O
IL-1beta	protein
expression	O
at	O
the	O
transcriptional	O
level	O
,	O
which	O
may	O
play	O
an	O
important	O
role	O
in	O
anti-inflammatory	O
and	O
immunosuppressive	O
effects	O
.	O
We	O
have	O
identified	O
a	O
negative	DNA
regulatory	DNA
element	DNA
located	O
in	O
the	O
region	O
between	O
-685	DNA
and	DNA
-395	DNA
.	O
Within	O
this	O
region,	O
a	O
19-bp	DNA
nuclear	DNA
factor	DNA
binding	DNA
site	DNA
(	O
-570	DNA
to	DNA
-552	DNA
)	O
was	O
characterized	O
by	O
DNase	protein
I	protein
footprinting	O
and	O
electromobility	O
shift	O
assay	O
.	O
A	O
consensus	DNA
sequence	DNA
for	O
a	O
negative	DNA
glucocorticoid	DNA
response	DNA
element	DNA
(	O
nGRE	DNA
)	O
and	O
a	O
transcription	DNA
activator	DNA
protein-2	DNA
binding	DNA
site	DNA
were	O
noted	O
within	O
this	O
footprint.	O
Functional	O
studies	O
showed	O
a	O
2.5-fold	O
increase	O
in	O
promoter	O
activity	O
when	O
this	O
19-bp	DNA
binding	DNA
site	DNA
was	O
deleted	O
in	O
the	O
reporter	DNA
constructs	DNA
IL-1beta	protein
/CAT	protein
and	O
IL-1beta	protein
/SV40	DNA
promoter	DNA
/CAT	protein
.	O
Dexamethasone	O
(10(-8)	O
M)	O
repressed	O
chloramphenicol	protein
acetyltransferase	protein
(	O
CAT	protein
)	O
production	O
by	O
75%	O
in	O
the	O
wild-type	DNA
fragment	DNA
but	O
not	O
in	O
a	O
deletion	DNA
mutant	DNA
lacking	O
the	O
19-bp	DNA
site	DNA
.	O
A	O
protein	O
of	O
about	O
150	protein
kD	protein
that	O
bound	O
to	O
this	O
negative	DNA
regulatory	DNA
sequence	DNA
was	O
identified	O
by	O
UV	O
cross-linking	O
.	O
This	O
is	O
the	O
first	O
description	O
of	O
a	O
negative	DNA
regulatory	DNA
region	DNA
responsive	O
to	O
glucocorticoids	O
in	O
a	O
cytokine	DNA
gene	DNA
.	O

Interaction	O
of	O
transcription	protein
factors	protein
RFX1	protein
and	O
MIBP1	protein
with	O
the	O
gamma	DNA
motif	DNA
of	O
the	O
negative	DNA
regulatory	DNA
element	DNA
of	O
the	O
hepatitis	DNA
B	DNA
virus	DNA
core	DNA
promoter	DNA
.	O
The	O
negative	DNA
regulatory	DNA
element	DNA
(	O
NRE	DNA
)	O
of	O
the	O
hepatitis	DNA
B	DNA
virus	DNA
(	DNA
HBV	DNA
)	DNA
core	DNA
promoter	DNA
contains	O
three	O
subregions	O
which	O
act	O
synergistically	O
to	O
suppress	O
core	O
promoter	O
activity	O
.	O
One	O
of	O
these	O
subregions,	O
NRE	DNA
gamma	DNA
,	O
is	O
active	O
in	O
both	O
HeLa	cell_line
cervical	cell_line
carcinoma	cell_line
cells	cell_line
and	O
Huh7	cell_line
hepatoma	cell_line
cells	cell_line
and	O
was	O
found	O
to	O
be	O
bound	O
by	O
a	O
protein	O
factor	O
present	O
in	O
both	O
cell	O
types.	O
Here	O
we	O
show	O
that	O
the	O
transcription	protein
factor	protein
RFX1	protein
can	O
bind	O
to	O
NRE	DNA
gamma	DNA
and	O
transactivate	O
the	O
core	DNA
promoter	DNA
through	O
this	O
site.	O
Mutations	O
which	O
abrogated	O
the	O
gene-suppressive	O
activity	O
of	O
NRE	DNA
gamma	DNA
prevented	O
RFX1	protein
from	O
binding	O
to	O
NRE	DNA
gamma	DNA
.	O
In	O
addition,	O
RFX1	protein
can	O
bind	O
simultaneously,	O
most	O
likely	O
as	O
a	O
heterodimer	protein
,	O
with	O
the	O
transcription	protein
factor	protein
MIBP1	protein
to	O
NRE	DNA
gamma	DNA
.	O
In	O
the	O
absence	O
of	O
a	O
cloned	O
MIBP1	DNA
gene	DNA
for	O
further	O
studies,	O
we	O
hypothesize	O
that	O
RFX1	protein
acts	O
with	O
MIBP1	protein
to	O
negatively	O
regulate	O
the	O
core	O
promoter	O
activity	O
through	O
the	O
NRE	DNA
gamma	DNA
site	DNA
.	O
The	O
ability	O
of	O
RFX1	protein
to	O
transactivate	O
the	O
core	DNA
promoter	DNA
raises	O
the	O
possibility	O
that	O
RFX1	protein
may	O
play	O
a	O
dual	O
role	O
in	O
regulating	O
HBV	O
gene	O
expression	O

Use	O
of	O
arsenic	O
trioxide	O
(	O
As2O3	O
)	O
in	O
the	O
treatment	O
of	O
acute	O
promyelocytic	O
leukemia	O
(APL):	O
II	O
.	O
Clinical	O
efficacy	O
and	O
pharmacokinetics	O
in	O
relapsed	O
patients	O
.	O
The	O
therapeutic	O
effect	O
of	O
arsenic	O
trioxide	O
(	O
As2O3	O
)	O
in	O
the	O
treatment	O
of	O
acute	O
promyelocytic	O
leukemia	O
(	O
APL	O
)	O
was	O
evaluated	O
among	O
15	O
APL	O
patients	O
at	O
relapse	O
after	O
all-trans	O
retinoic	O
acid	O
(	O
ATRA	O
)	O
induced	O
and	O
chemotherapy	O
maintained	O
complete	O
remission	O
(	O
CR	O
).	O
As2O3	O
was	O
administered	O
intravenously	O
at	O
the	O
dose	O
of	O
10	O
mg/d.	O
Clinical	O
CR	O
was	O
achieved	O
in	O
nine	O
of	O
10	O
(90%)	O
patients	O
treated	O
with	O
As2O3	O
alone	O
and	O
in	O
the	O
remaining	O
five	O
patients	O
treated	O
by	O
the	O
combination	O
of	O
As2O3	O
and	O
low-dose	O
chemotherapeutic	O
drugs	O
or	O
ATRA	O
.	O
During	O
the	O
treatment	O
with	O
As2O3	O
,	O
there	O
was	O
no	O
bone	O
marrow	O
depression	O
and	O
only	O
limited	O
side	O
effects	O
were	O
encountered.	O
Pharmacokinetic	O
studies	O
,	O
which	O
were	O
performed	O
in	O
eight	O
patients	O
,	O
showed	O
that	O
after	O
a	O
peak	O
level	O
of	O
5.54	O
micromol/L	O
to	O
7.30	O
micromol/L,	O
plasma	O
arsenic	O
was	O
rapidly	O
eliminated,	O
and	O
the	O
continuous	O
administration	O
of	O
As2O3	O
did	O
not	O
alter	O
its	O
pharmacokinetic	O
behaviors	O
.	O
In	O
addition,	O
increased	O
amounts	O
of	O
arsenic	O
appeared	O
in	O
the	O
urine	O
,	O
with	O
a	O
daily	O
excretion	O
accounting	O
for	O
approximately	O
1%	O
to	O
8%	O
of	O
the	O
total	O
daily	O
dose	O
administered.	O
Arsenic	O
contents	O
in	O
hair	O
and	O
nail	O
were	O
increased,	O
and	O
the	O
peak	O
content	O
of	O
arsenic	O
could	O
reach	O
2.5	O
to	O
2.7	O
microg/g	O
tissue	O
at	O
CR	O
.	O
On	O
the	O
other	O
hand,	O
a	O
decline	O
of	O
the	O
arsenic	O
content	O
in	O
hair	O
and	O
nail	O
was	O
observed	O
after	O
withdrawal	O
of	O
the	O
drug.	O
We	O
conclude	O
that	O
As2O3	O
treatment	O
is	O
an	O
effective	O
and	O
relatively	O
safe	O
drug	O
in	O
APL	O
patients	O
refractory	O
to	O
ATRA	O
and	O
conventional	O
chemotherapy	O
.	O

Nucleolin	protein
is	O
one	O
component	O
of	O
the	O
B	protein
cell-specific	protein
transcription	protein
factor	protein
and	O
switch	protein
region	protein
binding	protein
protein	protein
,	O
LR1	protein
.	O
LR1	protein
is	O
a	O
B	O
cell-specific,	O
sequence-specific	O
DNA	O
binding	O
activity	O
that	O
regulates	O
transcription	O
in	O
activated	cell_type
B	cell_type
cells	cell_type
.	O
LR1	protein
also	O
binds	O
Ig	protein
heavy	protein
chain	protein
switch	O
region	O
sequences	O
and	O
may	O
function	O
in	O
class	O
switch	O
recombination.	O
LR1	protein
contains	O
two	O
polypeptides	O
,	O
of	O
106	O
kDa	O
and	O
45	O
kDa	O
,	O
and	O
here	O
we	O
report	O
that	O
the	O
106-kDa	protein
component	protein
of	O
LR1	protein
is	O
nucleolin	protein
.	O
This	O
identification,	O
initially	O
made	O
by	O
microsequence	O
analysis	O
,	O
was	O
verified	O
by	O
showing	O
that	O
(i)	O
LR1	protein
-DNA	O
binding	O
activity	O
increased	O
in	O
B	cell_type
cells	cell_type
transfected	O
with	O
a	O
nucleolin	DNA
cDNA	DNA
expression	DNA
construct	DNA
;	O
(ii)	O
LR1	protein
-DNA	O
binding	O
activity	O
was	O
recognized	O
by	O
antibodies	O
raised	O
against	O
recombinant	protein
human	protein
nucleolin	protein
;	O
and	O
(iii)	O
in	O
B	cell_type
cells	cell_type
transfected	O
with	O
epitope-tagged	DNA
nucleolin	DNA
expression	DNA
constructs	DNA
,	O
the	O
LR1	protein
-DNA	protein
complex	protein
was	O
recognized	O
by	O
the	O
anti-tag	protein
antibody	protein
.	O
Nucleolin	protein
is	O
an	O
abundant	protein
nucleolar	protein
protein	protein
which	O
is	O
believed	O
to	O
play	O
a	O
role	O
in	O
rDNA	DNA
transcription	O
or	O
organization,	O
or	O
rRNA	RNA
processing	O
.	O
Homology	O
between	O
nucleolin	protein
and	O
histone	protein
H1	protein
suggests	O
that	O
nucleolin	protein
may	O
alter	O
DNA	O
organization	O
in	O
response	O
to	O
cell	O
cycle	O
controls	O
,	O
and	O
the	O
nucleolin	protein
component	O
of	O
LR1	protein
may	O
therefore	O
function	O
to	O
organize	O
switch	DNA
regions	DNA
before,	O
during,	O
or	O
after	O
switch	O
recombination.	O
The	O
demonstration	O
that	O
nucleolin	protein
is	O
a	O
component	O
of	O
a	O
B	protein
cell-specific	protein
complex	protein
that	O
binds	O
switch	O
region	O
sequences	O
suggests	O
that	O
the	O
G-rich	DNA
switch	DNA
regions	DNA
may	O
have	O
evolved	O
from	O
rDNA	DNA
.	O

Glucocorticoid	O
-resistance	O
in	O
peripheral-blood	cell_type
lymphocytes	cell_type
does	O
not	O
correlate	O
with	O
number	O
of	O
affinity	O
of	O
glucocorticoid-receptors	protein
in	O
chronic	O
renal	O
failure	O
patients	O
.	O
Glucocorticoid	O
(	O
GC	O
)	O
resistance	O
in	O
patients	O
with	O
chronic	O
renal	O
failure	O
(	O
CRF	O
)	O
seriously	O
impairs	O
successive	O
GC	O
therapy	O
after	O
renal	O
transplantation	O
.	O
We	O
examined	O
the	O
relationship	O
between	O
GC	O
-receptor	O
(GC-R)	O
parameters	O
in	O
peripheral-blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
)	O
and	O
PBMC	cell_type
resistance	O
to	O
GC	O
in	O
21	O
CRF	O
patients	O
and	O
18	O
healthy	O
subjects	O
.	O
Each	O
subject	O
group	O
was	O
divided	O
into	O
two	O
subgroups	O
according	O
to	O
PBMC	cell_type
sensitivity	O
to	O
prednisolone	O
in	O
a	O
mitogen	O
assay	O
procedure;	O
i.e.,	O
sensitive	O
(IC50	O
&lt;	O
381	O
ng/mL)	O
and	O
resistant	O
(IC50	O
&gt;	O
381	O
ng/mL)	O
groups.	O
In	O
healthy	O
subjects	O
,	O
the	O
mean	O
GC-R	protein
Bmax	O
and	O
Kd	O
in	O
quiescent	O
PBMC	cell_type
of	O
the	O
GC	O
-sensitive	O
group	O
were	O
2.89	O
+/-	O
1.23	O
fmol/10(6)	O
cells	O
and	O
4.00	O
+/-	O
2.24	O
nM,	O
respectively.	O
The	O
Bmax	O
in	O
these	O
subjects	O
significantly	O
increased	O
to	O
6.61	O
+/-	O
2.02	O
(257.7	O
+/-	O
107.8%)	O
after	O
24	O
h	O
stimulation	O
with	O
concanavalin	O
A	O
(p	O
&lt;	O
0.01),	O
while	O
the	O
Kd	O
change	O
was	O
not	O
significant.	O
The	O
GC-R	protein
Bmax	O
and	O
Kd	O
in	O
quiescent	O
PBMC	cell_type
of	O
the	O
GC	O
-resistant	O
group	O
were	O
5.33	O
+/-	O
1.37	O
fmol/10(6)	O
cells	O
and	O
3.20	O
+/-	O
1.39	O
nM,	O
respectively.	O
Both	O
of	O
these	O
parameters,	O
however,	O
did	O
not	O
change	O
significantly	O
after	O
mitogen	protein
stimulation	O
.	O
There	O
was	O
a	O
significant	O
negative	O
correlation	O
between	O
IC50S	O
of	O
prednisolone	O
and	O
increase-ratios	O
(post/pre	O
ratio)	O
of	O
Bmax	O
after	O
mitogen	protein
stimulation	O
(p	O
&lt;	O
0.05).	O
In	O
CRF	O
patients	O
,	O
Bmax	O
and	O
Kd	O
in	O
quiescent	O
PBMC	cell_type
of	O
the	O
GC	O
-sensitive	O
group	O
were	O
6.04	O
+/-	O
2.35	O
fmol/10(6)	O
cells	O
and	O
3.49	O
+/-	O
1.72	O
nM,	O
respectively,	O
while	O
those	O
in	O
PBMC	cell_type
of	O
the	O
GC	O
-resistant	O
group	O
were	O
5.13	O
+/-	O
2.31	O
fmol/10(6)	O
cells	O
and	O
4.04	O
+/-	O
1.62	O
nM,	O
respectively.	O
The	O
Bmax	O
and	O
Kd	O
were	O
not	O
significantly	O
changed	O
after	O
mitogen	protein
stimulation	O
in	O
both	O
subgroups	O
of	O
CRF	O
.	O
Moreover,	O
in	O
contrast	O
to	O
healthy	O
subjects	O
,	O
there	O
was	O
no	O
correlation	O
between	O
IC50	O
and	O
GC-R	protein
parameters	O
in	O
CRF	O
.	O
We	O
concluded	O
that,	O
in	O
healthy	O
subjects	O
,	O
decreased	O
PBMC	cell_type
capacity	O
to	O
amplify	O
GC-R	protein
numbers	O
in	O
response	O
to	O
mitogen	protein
is	O
correlated	O
with	O
GC	O
resistance,	O
whereas	O
in	O
CRF	O
patients	O
the	O
resistant	O
mechanism	O
is	O
not	O
correlated	O
with	O
GC-R	protein
parameters	O
.	O
An	O
unknown	O
event	O
might	O
be	O
involved	O
in	O
GC	O
-resistance	O
of	O
CRF	O
.	O

Alteration	O
of	O
a	O
single	O
serine	O
in	O
the	O
basic	protein
domain	protein
of	O
the	O
Epstein-Barr	protein
virus	protein
ZEBRA	protein
protein	protein
separates	O
its	O
functions	O
of	O
transcriptional	O
activation	O
and	O
disruption	O
of	O
latency.	O
The	O
ZEBRA	protein
protein	protein
from	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
activates	O
a	O
switch	O
from	O
the	O
latent	O
to	O
the	O
lytic	O
expression	O
program	O
of	O
the	O
virus	O
.	O
ZEBRA	protein
,	O
a	O
member	O
of	O
the	O
bZIP	protein
family	protein
of	O
DNA-binding	protein
proteins	protein
,	O
is	O
a	O
transcriptional	O
activator	O
capable	O
of	O
inducing	O
expression	O
from	O
viral	DNA
lytic	DNA
cycle	DNA
promoters	DNA
.	O
It	O
had	O
previously	O
been	O
thought	O
that	O
ZEBRA	protein
's	O
capacity	O
to	O
disrupt	O
EBV	O
latency	O
resided	O
primarily	O
in	O
its	O
ability	O
to	O
activate	O
transcription	O
of	O
genes	O
that	O
encode	O
products	O
required	O
for	O
lytic	O
replication	O
.	O
We	O
generated	O
a	O
point	O
mutant	O
of	O
ZEBRA	protein
,	O
Z(S186A)	protein
,	O
that	O
was	O
not	O
impaired	O
in	O
its	O
ability	O
to	O
activate	O
transcription	O
;	O
however,	O
this	O
mutation	O
abolished	O
its	O
ability	O
to	O
initiate	O
the	O
viral	O
lytic	O
cascade	O
.	O
The	O
mutant,	O
containing	O
a	O
serine	O
-to-	O
alanine	O
substitution	O
in	O
the	O
DNA-binding	protein
domain	protein
of	O
the	O
protein,	O
bound	O
to	O
several	O
known	O
ZEBRA	DNA
-binding	DNA
sites	DNA
and	O
activated	O
transcription	O
from	O
reporters	O
bearing	O
known	O
ZEBRA	DNA
-responsive	DNA
promoters	DNA
but	O
did	O
not	O
disrupt	O
latency	O
in	O
EBV	cell_line
-infected	cell_line
cell	cell_line
lines	cell_line
.	O
Therefore,	O
initiation	O
of	O
the	O
EBV	O
lytic	O
cycle	O
by	O
the	O
ZEBRA	protein
protein	protein
requires	O
a	O
function	O
in	O
addition	O
to	O
transcriptional	O
activation	O
;	O
a	O
change	O
of	O
serine	O
186	O
to	O
alanine	O
in	O
the	O
DNA-binding	protein
domain	protein
of	O
ZEBRA	protein
abolished	O
this	O
additional	O
function	O
and	O
uncovered	O
a	O
new	O
role	O
for	O
the	O
ZEBRA	protein
protein	protein
in	O
disruption	O
of	O
EBV	O
latency.	O
The	O
additional	O
function	O
that	O
is	O
required	O
for	O
initiation	O
of	O
the	O
lytic	O
viral	O
life	O
cycle	O
is	O
likely	O
to	O
require	O
phosphorylation	O
of	O
serine	O
186	O
of	O
the	O
ZEBRA	protein
protein	protein
,	O
which	O
may	O
influence	O
either	O
DNA	O
recognition	O
or	O
transcriptional	O
activation	O
of	O
lytic	DNA
viral	DNA
promoters	DNA
in	O
a	O
chromatinized	DNA
viral	DNA
episome	DNA
.	O

Immune	O
hyperactivation	O
of	O
HIV-1	cell_type
-infected	cell_type
T	cell_type
cells	cell_type
mediated	O
by	O
Tat	protein
and	O
the	O
CD28	protein
pathway	O
.	O
Human	O
immunodeficiency	O
virus-type	O
1	O
(	O
HIV-1	O
)	O
infection	O
is	O
characterized	O
by	O
a	O
chronic	O
state	O
of	O
immune	O
hyperactivation	O
in	O
patients	O
.	O
Infection	O
of	O
human	cell_type
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
with	O
HIV-1	O
in	O
vitro	O
resulted	O
in	O
increased	O
interleukin-2	O
(IL-2)	O
secretion	O
in	O
response	O
to	O
T	O
cell	O
activation	O
via	O
the	O
CD3	O
and	O
CD28	O
receptors	O
.	O
Expression	O
of	O
the	O
HIV-1	protein
transactivator	protein
Tat	protein
recapitulated	O
this	O
phenotype	O
and	O
was	O
associated	O
with	O
increased	O
IL-2	protein
secretion	O
in	O
response	O
to	O
costimulation	O
with	O
CD3	protein
plus	O
CD28	protein
.	O
IL-2	protein
superinduction	O
by	O
Tat	protein
occurred	O
at	O
the	O
transcriptional	O
level	O
,	O
was	O
mediated	O
by	O
the	O
CD28	DNA
-responsive	DNA
element	DNA
in	O
the	O
IL-2	DNA
promoter	DNA
,	O
and	O
was	O
exclusively	O
dependent	O
on	O
the	O
29	protein
amino	protein
acids	protein
encoded	O
by	O
the	O
second	DNA
exon	DNA
of	DNA
Tat	DNA
.	O

Response	O
to	O
intranasal	O
fluticasone	O
propionate	O
in	O
perennial	O
allergic	O
rhinitis	O
not	O
associated	O
with	O
glucocorticoid	protein
receptor	protein
characteristics	O
.	O
BACKGROUND:	O
The	O
reduction	O
of	O
symptoms	O
due	O
to	O
treatment	O
with	O
corticosteroids	O
varies	O
among	O
patients	O
with	O
perennial	O
rhinitis.	O
Most	O
patients	O
will	O
respond	O
but	O
a	O
few	O
patients	O
respond	O
less	O
to	O
these	O
drugs.	O
OBJECTIVE:	O
To	O
investigate	O
the	O
association	O
in	O
reduction	O
of	O
symptoms	O
due	O
to	O
glucocorticoids	O
and	O
glucocorticoid	protein
receptor	protein
characteristics	O
in	O
patients	O
with	O
perennial	O
allergic	O
rhinitis	O
,	O
in	O
vitro	O
glucocorticoid	protein
receptor	protein
binding	O
studies	O
were	O
performed	O
with	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
using	O
dexamethasone	O
and	O
in	O
vitro	O
production	O
of	O
mediators	protein
were	O
measured.	O
METHODS:	O
During	O
a	O
double-blind	O
placebo-controlled	O
crossover	O
study	O
,	O
200	O
micrograms	O
fluticasone	O
propionate	O
aqueous	O
nasal	O
spray	O
(in	O
the	O
active	O
treatment	O
period	O
)	O
and	O
placebo	O
(in	O
the	O
placebo	O
treatment	O
period	O
)	O
were	O
administered	O
twice	O
daily	O
for	O
2	O
weeks	O
to	O
22	O
patients	O
allergic	O
to	O
house	O
dust	O
mite	O
.	O
At	O
the	O
end	O
of	O
both	O
treatment	O
periods	O
symptoms	O
were	O
scored	O
after	O
allergen	O
provocation	O
(100,	O
1000,	O
10000	O
BU/mL)	O
and	O
during	O
the	O
9.5	O
hours	O
after	O
this	O
challenge.	O
Receptor	O
binding	O
studies	O
with	O
dexamethasone	O
were	O
performed	O
with	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
.	O
Leukotriene	O
B4	O
produced	O
by	O
monocytes	cell_type
in	O
vitro	O
and	O
soluble	O
interleukin-2	protein
receptor	protein
released	O
by	O
lymphocytes	cell_type
in	O
vitro	O
and	O
cortisol	O
levels	O
in	O
plasma	O
were	O
determined.	O
RESULTS:	O
No	O
significant	O
partial	O
correlations	O
of	O
the	O
number	O
of	O
the	O
peripheral	protein
blood	protein
mononuclear	protein
cell	protein
glucocorticoid	protein
receptors	protein
(6821	O
+/-	O
5669	O
binding	O
sites	O
per	O
cell)	O
and	O
the	O
affinity	O
(	O
Kd	O
:	O
16.5	O
+/-	O
13.51	O
nmol/L)	O
for	O
the	O
glucocorticoid	protein
receptors	protein
with	O
the	O
symptom	O
score	O
(placebo:	O
4.3	O
+/-	O
2.45	O
pts;	O
fluticasone:	O
2.4	O
+/-	O
1.55	O
pts)	O
after	O
active	O
treatment	O
were	O
found.	O
Also	O
no	O
significant	O
partial	O
correlations	O
of	O
the	O
levels	O
of	O
leukotriene	O
B4	O
(45.6	O
+/-	O
105.3	O
ng/10(6)	O
cells)	O
produced	O
by	O
monocytes	cell_type
in	O
vitro,	O
soluble	O
interleukin-2	protein
receptor	protein
(734	O
+/-	O
237	O
ng/10(6)	O
cells)	O
released	O
by	O
lymphocytes	cell_type
in	O
vitro	O
and	O
cortisol	O
levels	O
(571	O
+/-	O
236	O
ng/mL)	O
in	O
plasma	O
with	O
the	O
symptom	O
score	O
after	O
active	O
treatment	O
were	O
found.	O
CONCLUSIONS:	O
The	O
reduction	O
of	O
symptoms	O
due	O
to	O
topical	O
fluticasone	O
propionate	O
in	O
patients	O
with	O
rhinitis	O
and	O
allergy	O
to	O
house	O
dust	O
mite	O
is	O
not	O
correlated	O
with	O
the	O
characteristics	O
of	O
the	O
glucocorticoid	protein
receptor	protein
.	O

Constitutive	O
expression	O
of	O
p50	protein
homodimer	protein
in	O
freshly	cell_type
isolated	cell_type
human	cell_type
monocytes	cell_type
decreases	O
with	O
in	O
vitro	O
and	O
in	O
vivo	O
differentiation:	O
a	O
possible	O
mechanism	O
influencing	O
human	O
immunodeficiency	O
virus	O
replication	O
in	O
monocytes	cell_type
and	O
mature	O
macrophages.	O
Human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
replicates	O
more	O
efficiently	O
in	O
vitro	O
in	O
differentiated	cell_type
macrophages	cell_type
than	O
in	O
freshly	cell_type
isolated	cell_type
monocytes	cell_type
.	O
We	O
investigated	O
whether	O
this	O
may	O
be	O
partly	O
explained	O
by	O
changes	O
in	O
expression	O
of	O
NF-kappaB	protein
with	O
monocyte	O
differentiation	O
.	O
We	O
demonstrated	O
that	O
constitutive	O
expression	O
of	O
NF-kappaB	protein
in	O
primary	cell_type
human	cell_type
monocytes	cell_type
changed	O
significantly	O
with	O
differentiation	O
in	O
vitro	O
to	O
monocyte-derived	cell_type
macrophages	cell_type
(	O
MDMs	cell_type
)	O
and	O
differentiation	O
in	O
vivo	O
to	O
alveolar	cell_type
macrophages	cell_type
(	O
AMs	cell_type
).	O
Freshly	O
isolated	O
monocytes	O
constitutively	O
expressed	O
high	O
levels	O
of	O
transcriptionally	protein
inactive	protein
p50	protein
homodimer	protein
which	O
decreased	O
with	O
time	O
in	O
culture	O
in	O
favor	O
of	O
the	O
transcriptionally	O
active	O
p50/p65	O
and	O
p50/RelB	O
heterodimers	O
.	O
As	O
in	O
MDMs	cell_type
,	O
AMs	cell_type
constitutively	O
expressed	O
p50/p65	protein
and	O
p50/RelB	protein
although	O
at	O
lower	O
levels.	O
HIV	O
infection	O
of	O
fresh	O
monocytes	cell_type
failed	O
to	O
induce	O
p50/p65	protein
as	O
seen	O
in	O
MDMs	cell_type
.	O
The	O
replacement	O
of	O
p50	protein
homodimers	protein
with	O
transcriptionally	O
active	O
heterodimers	O
following	O
time	O
in	O
culture	O
may	O
partially	O
explain	O
the	O
progressive	O
increase	O
in	O
susceptibility	O
of	O
monocytes	cell_type
to	O
HIV	O
infection	O
during	O
in	O
vitro	O
culture	O
.	O
The	O
change	O
in	O
NF-kappaB	protein
components	protein
with	O
monocyte	O
differentiation	O
in	O
vivo	O
may	O
also	O
explain	O
the	O
different	O
transcriptional	O
activities	O
of	O
these	O
cell	O
populations	O
in	O
HIV	O
-infected	O
individuals	O
.	O

NF-kappa	protein
B	protein
-independent	O
suppression	O
of	O
HIV	O
expression	O
by	O
ascorbic	O
acid	O
.	O
Ascorbic	O
acid	O
(	O
ascorbate	O
or	O
vitamin	O
C	O
)	O
has	O
been	O
shown	O
to	O
suppress	O
the	O
induction	O
of	O
HIV	O
in	O
latently	cell_type
infected	cell_type
T	cell_type
lymphocytic	cell_type
cells	cell_type
following	O
stimulation	O
with	O
a	O
tumor	O
promoter	O
(	O
PMA	O
)	O
and	O
inflammatory	protein
cytokine	protein
(	O
TNF-alpha	protein
).	O
To	O
assess	O
whether	O
this	O
inhibition	O
was	O
mediated	O
via	O
modulation	O
of	O
the	O
cellular	protein
transcription	protein
factor	protein
,	O
NF-kappa	protein
B	protein
,	O
we	O
carried	O
out	O
gel	O
shift	O
analysis	O
on	O
nuclear	O
extracts	O
prepared	O
under	O
different	O
conditions	O
of	O
cell	O
stimulation	O
in	O
the	O
presence	O
or	O
absence	O
of	O
ascorbate	O
,	O
N-acetylcysteine	O
(	O
NAC	O
),	O
or	O
zidovudine	O
(	O
AZT	O
).	O
Pretreatment	O
of	O
ACH-2	cell_line
T	cell_line
cells	cell_line
by	O
NAC	O
followed	O
by	O
stimulation	O
with	O
PMA	O
,	O
TNF-alpha	protein
,	O
or	O
hydrogen	O
peroxide	O
(	O
H2O2	O
)	O
resulted	O
in	O
strong	O
suppression	O
of	O
NF-kappa	protein
B	protein
activation	O
.	O
In	O
contrast,	O
neither	O
ascorbate	O
nor	O
AZT	O
affected	O
NF-kappa	protein
B	protein
activity	O
under	O
all	O
three	O
induction	O
conditions	O
in	O
the	O
ACH-2	cell_line
cell	cell_line
line	cell_line
.	O
Ascorbate	O
and	O
AZT	O
also	O
had	O
no	O
effect	O
on	O
NF-kappa	protein
B	protein
activation	O
following	O
TNF-alpha-	O
or	O
PMA-	O
induced	O
stimulation	O
of	O
U1	O
promonocytic	O
cells.	O
These	O
results	O
suggest	O
that	O
the	O
molecular	O
mechanism	O
of	O
HIV	O
inhibition	O
by	O
ascorbate	O
is	O
not	O
mediated	O
via	O
NF-kappa	protein
B	protein
inhibition	O
,	O
unlike	O
that	O
seen	O
with	O
other	O
antioxidants	O
.	O

A	O
T	DNA
cell-specific	DNA
enhancer	DNA
in	O
the	O
interleukin-3	DNA
locus	DNA
is	O
activated	O
cooperatively	O
by	O
Oct	O
and	O
NFAT	O
elements	O
within	O
a	O
DNase	DNA
I-hypersensitive	DNA
site	DNA
.	O
Interleukin-3	protein
(	O
IL-3	protein
)	O
is	O
a	O
cytokine	protein
that	O
is	O
expressed	O
primarily	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
.	O
Here	O
we	O
identified	O
an	O
inducible	O
T	DNA
cell-specific	DNA
enhancer	DNA
14	O
kb	O
upstream	O
of	O
the	O
IL-3	DNA
gene	DNA
that	O
responded	O
to	O
activation	O
of	O
T	protein
cell	protein
receptor	protein
signaling	O
pathways	O
.	O
The	O
IL-3	protein
enhancer	O
spanned	O
an	O
inducible	O
cyclosporin	DNA
A	DNA
-sensitive	DNA
DNase	DNA
I-hypersensitive	DNA
site	DNA
found	O
only	O
in	O
T	cell_type
cells	cell_type
.	O
Four	O
NFAT-like	DNA
elements	DNA
exist	O
within	O
the	O
enhancer.	O
The	O
two	O
most	O
active	O
NFAT-like	DNA
elements	DNA
were	O
located	O
at	O
the	O
center	O
of	O
the	O
DNase	DNA
I-hypersensitive	DNA
site	DNA
.	O
One	O
of	O
these	O
NFAT-like	DNA
elements	DNA
encompassed	O
overlapping	O
Oct-	O
and	O
NFATp/c-	O
binding	O
sites	O
,	O
which	O
functioned	O
in	O
a	O
highly	O
synergistic	O
manner.	O
We	O
suggest	O
that	O
the	O
T	O
cell-specific	O
expression	O
of	O
the	O
IL-3	DNA
gene	DNA
is	O
partly	O
controlled	O
through	O
the	O
enhancer	O
by	O
cooperation	O
between	O
Oct	O
and	O
NFAT	O
family	O
proteins	O
.	O

Adenovirus	protein
E1B	protein
19K	protein
protein	protein
is	O
required	O
for	O
efficient	O
DNA	O
replication	O
in	O
U937	cell_line
cells	cell_line
.	O
The	O
adenovirus	DNA
E1B	DNA
19K	DNA
gene	DNA
plays	O
an	O
essential	O
role	O
in	O
transformation	O
of	O
primary	cell_type
rodent	cell_type
cells	cell_type
in	O
cooperation	O
with	O
E1A	protein
and	O
in	O
the	O
inhibition	O
of	O
apoptosis	O
during	O
lytic	O
infection	O
.	O
It	O
has	O
been	O
shown	O
that	O
this	O
E1B	protein
19K	protein
protein	protein
is	O
not	O
necessary	O
for	O
viral	O
DNA	O
replication	O
in	O
human	cell_line
cell	cell_line
lines	cell_line
,	O
such	O
as	O
HeLa	cell_line
and	O
KB	cell_line
.	O
We	O
reported	O
here	O
that	O
the	O
E1B	protein
19K	protein
mutant	O
viruses	O
were	O
unable	O
to	O
replicate	O
efficiently	O
in	O
a	O
monocyte	cell_line
cell	cell_line
line	cell_line
,	O
U937	cell_line
.	O
Viral	O
DNA	O
synthesis	O
and	O
late	O
gene	O
expression	O
were	O
found	O
to	O
be	O
defective	O
in	O
U937	cell_line
cells	cell_line
infected	O
with	O
E1B	protein
19K	protein
mutants	O
compared	O
with	O
wild-type	O
virus	O
.	O
Early	O
viral	O
RNA	O
splicing	O
patterns	O
also	O
differ	O
between	O
wild-type	O
and	O
dl337-infected	O
cells	O
.	O
Furthermore,	O
the	O
defect	O
in	O
viral	O
replication	O
could	O
be	O
complemented	O
by	O
dl312	O
virus	O
defective	O
in	O
E1A	protein
expression	O
4	O
days	O
after	O
infection	O
with	O
E1B	O
mutants	O
,	O
suggesting	O
persistence	O
of	O
the	O
E1B	DNA
mutant	DNA
genome	DNA
in	O
the	O
infected	O
cells	O
despite	O
defective	O
onset	O
of	O
the	O
late	O
phase	O
of	O
replication.	O
These	O
results	O
imply	O
that	O
E1B	protein
19K	protein
is	O
required	O
for	O
efficient	O
viral	O
DNA	O
replication	O
in	O
U937	cell_line
cells	cell_line
.	O
Inefficient	O
DNA	O
replication	O
is	O
also	O
found	O
in	O
another	O
monocyte	cell_line
cell	cell_line
line	cell_line
,	O
THP-1	cell_line

Activation	O
of	O
Ras	O
and	O
mitogen-activated	protein
protein	protein
kinase	protein
pathway	O
by	O
terminal	protein
complement	protein
complexes	protein
is	O
G	protein
protein	protein
dependent	O
.	O
Assembly	O
of	O
terminal	protein
complement	protein
complexes	protein
(	O
TCC	protein
)	O
C5b-7	protein
,	O
C5b-8	protein
,	O
and	O
C5b-9	protein
on	O
target	O
cells	O
during	O
acute	O
and	O
chronic	O
inflammation	O
induces	O
hydrolysis	O
of	O
plasma	O
membrane	O
phospholipids	O
and	O
heterotrimeric	O
G	protein
protein	protein
activation	O
.	O
TCC	protein
also	O
stimulate	O
a	O
variety	O
of	O
cellular	O
activities,	O
which	O
include	O
cytokine	protein
synthesis	O
,	O
proto-oncogene	DNA
activation	O
,	O
and	O
mitotic	O
signaling	O
.	O
Now	O
we	O
report	O
that	O
sublytic	O
TCC	protein
induced	O
Ras	protein
,	O
Raf-1	protein
,	O
and	O
extracellular	protein
signal-regulated	protein
kinase	protein
(ERK)	protein
1	protein
activation	O
in	O
JY25	O
B	O
cell	O
line.	O
When	O
cells	O
were	O
exposed	O
to	O
C5b-9	protein
,	O
GTP-bound	protein
Ras	protein
in	O
anti-	protein
C5b-9	protein
immunoprecipitates	protein
was	O
increased	O
3.2-fold	O
at	O
2	O
min,	O
while	O
GTP-bound	protein
Ras	protein
in	O
anti-	protein
Ras	protein
immunoprecipitates	protein
was	O
increased	O
2-fold	O
at	O
10	O
min.	O
Both	O
C5b-9	protein
and	O
C5b-7	protein
,	O
but	O
not	O
C5b6	protein
,	O
increased	O
Raf-1	protein
kinase	O
activity	O
maximum	O
3.3-fold	O
at	O
2	O
min	O
and	O
2.8-fold	O
at	O
5	O
min,	O
respectively.	O
ERK1	protein
activity	O
was	O
2-fold	O
increased	O
by	O
C5b-9	protein
at	O
2	O
min	O
and	O
by	O
C5b-7	protein
at	O
10	O
min,	O
over	O
the	O
C5b6	protein
level.	O
The	O
role	O
of	O
mitogen-activated	protein
protein	protein
kinase	protein
(	O
MAPK	protein
)	O
pathway	O
on	O
TCC	protein
-inducible	O
mitotic	O
signaling	O
was	O
evaluated	O
by	O
assessing	O
DNA	O
synthesis	O
and	O
activator	protein
protein	protein
1	protein
(	O
AP-1	protein
)	O
DNA-binding	O
activity	O
.	O
The	O
MAPK/ERK-specific	O
inhibitor	O
PD	O
098,059	O
abolished	O
the	O
C5b-9	protein
-induced	O
DNA	O
synthesis	O
.	O
Involvement	O
of	O
G	protein
protein	protein
in	O
the	O
activation	O
of	O
MAPK	protein
pathway	O
by	O
TCC	protein
was	O
indicated	O
by	O
inhibition	O
of	O
Raf-1	protein
and	O
ERK1	protein
kinase	O
activity,	O
as	O
well	O
as	O
the	O
DNA	O
synthesis	O
by	O
pretreatment	O
of	O
cells	O
with	O
pertussis	protein
toxin	protein
.	O
Overexpression	O
of	O
beta-adrenergic	O
receptor	O
kinase	O
1	O
carboxyl-terminal	O
peptide	O
in	O
JY25	cell_line
cells	cell_line
also	O
inhibited	O
Raf-1	protein
and	O
ERK1	protein
activity	O
,	O
indicating	O
a	O
direct	O
involvement	O
of	O
G	O
betagamma	O
subunits	O
in	O
the	O
signal	O
transduction	O
generated	O
through	O
activation	O
of	O
MAPK	protein
pathway	O
by	O
TCC	protein
assembly	O
in	O
the	O
plasma	O
membrane	O
.	O

Spontaneous	O
occurrence	O
of	O
early	O
region	O
1A	O
reiteration	O
mutants	O
of	O
type	O
5	O
adenovirus	O
in	O
persistently	cell_type
infected	cell_type
human	cell_type
T-lymphocytes	cell_type
.	O
Mutants	O
of	O
type	O
5	O
adenovirus	O
(	O
Ad5	O
)	O
with	O
reiterated	DNA
DNA	DNA
sequences	DNA
in	O
the	O
E1a	DNA
region	DNA
appeared	O
in	O
a	O
human	cell_line
T-lymphocyte	cell_line
cell	cell_line
line	cell_line
,	O
Molt-4	cell_line
,	O
persistently	O
infected	O
with	O
H5sub304	O
,	O
a	O
deletion/substitution	O
mutant	O
that	O
has	O
a	O
wild-type	O
phenotype	O
in	O
viral	O
replication	O
.	O
Endonuclease	protein
analyses	O
and	O
DNA	O
sequencing	O
revealed	O
DNA	O
reiteration	O
in	O
each	O
mutant.	O
In	O
the	O
four	O
representative	O
mutants	O
investigated,	O
the	O
DNA	DNA
reiterations	DNA
all	O
started	O
within	O
a	O
six-base-pair	DNA
consensus	DNA
sequence	DNA
,	O
G(or	O
C)CTGTG	O
,	O
located	O
in	O
the	O
second	O
exon	DNA
of	O
the	O
E1a	DNA
region	DNA
(at	O
nt	O
1333	O
,	O
1367	O
,	O
or	O
1419	O
).	O
There	O
was	O
not	O
any	O
DNA	O
homology	O
between	O
the	O
breakpoints	O
in	O
the	O
second	O
exon	DNA
and	O
the	O
inserting	DNA
sequences	DNA
(starting	O
at	O
nt	O
532,	O
710,	O
or	O
792).	O
Northern	O
analyses	O
suggested	O
that	O
the	O
reiterated	DNA
splicing	DNA
sites	DNA
of	O
the	O
representative	O
mutants	O
were	O
all	O
used	O
in	O
RNA	O
splicing,	O
and	O
the	O
closest	O
donor	O
and	O
recipient	O
joints	O
were	O
used	O
most	O
frequently.	O
These	O
observations	O
imply	O
that	O
during	O
persistent	O
infection	O
Ad5	O
underwent	O
spontaneous	O
mutations	O
by	O
sequence-specific	O
breakage	O
and	O
nonhomologous	O
end-end	O
joining	O
recombination	O
events	O
.	O
These	O
E1a	O
reiteration	O
mutants	O
could	O
be	O
propagated	O
in	O
HeLa	cell_line
,	O
A549	cell_line
,	O
and	O
KB	cell_line
cells	cell_line
;	O
they	O
were	O
genetically	O
stable;	O
and	O
they	O
killed	O
CREF	cell_line
cells	cell_line
at	O
a	O
strikingly	O
high	O
frequency.	O
Preliminary	O
observations	O
tend	O
to	O
correlate	O
this	O
CREF	O
cell	O
killing	O
with	O
the	O
accumulation	O
of	O
the	O
early	protein
viral	protein
proteins	protein
and/or	O
viral	DNA
DNA	DNA
in	O
the	O
infected	cell_type
cells	cell_type
.	O
This	O
degree	O
of	O
cell	O
damage	O
was	O
not	O
observed	O
in	O
Ad5wt	O
or	O
H5sub304	O
infection	O
of	O
CREF	cell_line
cells	cell_line
.	O
The	O
observed	O
E1a	DNA
reiterations	DNA
provide	O
a	O
model	O
to	O
gain	O
insight	O
into	O
understanding	O
the	O
evolutionary	O
events	O
of	O
some,	O
if	O
not	O
all,	O
adenovirus	O
types	O
during	O
many	O
years	O
of	O
symbiotic,	O
persistent	O
relationship	O
in	O
human	O
tonsils	O
and	O
adenoids	O
and	O
possibly	O
other	O
lymphoid	O
organs	O
.	O

Preferential	O
presentation	O
of	O
herpes	protein
simplex	protein
virus	protein
T-cell	protein
antigen	protein
by	O
HLA	protein
DQA1*0501/DQB1*0201	protein
in	O
comparison	O
to	O
HLA	protein
DQA1*0201/DQB1*0201	protein
.	O
The	O
HLA	DNA
DQA1	DNA
locus	DNA
is	O
polymorphic.	O
Haplotypes	O
containing	O
HLA	DNA
DQA1*0501	DNA
,	O
but	O
not	O
HLA	DNA
DQA1*0201	DNA
,	O
together	O
with	O
HLA	DNA
DQB1*0201	DNA
are	O
associated	O
with	O
Grave's	O
disease	O
and	O
celiac	O
sprue	O
.	O
In	O
this	O
report,	O
we	O
demonstrate	O
a	O
functional	O
correlate	O
of	O
DQA1	O
polymorphism	O
.	O
T	cell_type
cells	cell_type
infiltrating	O
a	O
herpes	O
simplex	O
virus	O
(	O
HSV	O
)	O
lesion	O
from	O
a	O
HLA	O
DQ	O
2,7	O
individual	O
yielded	O
a	O
virus-specific	cell_line
CD4+	cell_line
clone	cell_line
restricted	O
by	O
DQ2	protein
.	O
Presentation	O
of	O
viral	O
peptide	O
and	O
protein	O
segregated	O
with	O
DQA1	DNA
allele	DNA
,	O
because	O
cell	O
lines	O
bearing	O
DQA1*0501/DQB1*0201	protein
heterodimers	protein
presented	O
antigen	O
in	O
proliferation	O
and	O
cytotoxicity	O
assays	O
much	O
more	O
efficiently	O
than	O
cell	cell_line
lines	cell_line
bearing	O
DQA1*0201/DQB1*0201	protein
.	O
Binding	O
of	O
viral	O
peptide	O
to	O
cell	O
lines	O
bearing	O
DQA1*0201	protein
,	O
in	O
comparison	O
to	O
DQA1*0501	protein
,	O
was	O
only	O
moderately	O
reduced	O
and	O
may	O
not	O
explain	O
this	O
effect.	O
Truncation	O
and	O
substitution	O
analyses	O
of	O
peptide	O
binding	O
and	O
T-cell	O
activation	O
were	O
performed	O
to	O
determine	O
which	O
viral	O
peptide	O
residues	O
contacting	O
TCR	protein
might	O
therefore	O
be	O
presented	O
in	O
an	O
altered	O
conformation	O
by	O
DQA1*0201/DQB1*0201	protein
.	O
Residues	O
432	O
,	O
435	O
,	O
437	O
,	O
438	O
,	O
and	O
440	O
(	O
position	O
P1	O
,	O
P4	O
,	O
P6	O
,	O
P7	O
,	O
and	O
P9	O
)	O
contributed	O
to	O
DQ2	protein
binding	O
,	O
whereas	O
residues	O
431	O
,	O
433	O
,	O
434	O
,	O
and	O
436	O
(	O
positions	O
P	O
1	O
,	O
P2	O
,	O
P3	O
,	O
and	O
P5	O
)	O
contributed	O
to	O
TCR	protein
contact.	O
Differential	O
presentation	O
of	O
peptide	O
by	O
HLA	protein
DQ2	protein
heterodimers	protein
varying	O
at	O
the	O
DQA1	DNA
locus	DNA
may	O
have	O
relevance	O
to	O
host	O
defense	O
and	O
the	O
pathogenesis	O
of	O
HLA	O
DQ2	protein
-associated	O
autoimmune	O
diseases	O
.	O

Inhibitor	O
(IK)	O
of	O
IFN-gamma	protein
induced	O
HLA	protein
class	protein
II	protein
antigens	protein
expression	O
also	O
inhibits	O
HLA	protein
class	protein
II	protein
constitutive	O
expression	O
in	O
the	O
human	cell_line
Raji	cell_line
B	cell_line
cell	cell_line
line	cell_line
.	O
The	O
expression	O
of	O
major	protein
histocompatibility	protein
complex	protein
(MHC)	protein
class	protein
II	protein
antigens	protein
is	O
constitutive	O
in	O
professional	cell_type
antigen	cell_type
presenting	cell_type
cells	cell_type
(	O
APCs	cell_type
)	O
but	O
can	O
also	O
be	O
induced	O
by	O
interferon-gamma	protein
(	O
IFN-gamma	protein
)	O
on	O
the	O
majority	O
of	O
the	O
non	O
professional	cell_type
APCs	cell_type
(e.g.	O
fibroblasts	cell_type
).	O
We	O
have	O
recently	O
characterised	O
a	O
new	O
factor	O
called	O
IK	protein
which	O
is	O
an	O
efficient	O
inhibitor	O
of	O
IFN-gamma	protein
induction	O
of	O
MHC	protein
class	protein
II	protein
antigens	protein
expression	O
.	O
Here,	O
we	O
demonstrate	O
a	O
novel	O
role	O
for	O
IK	protein
in	O
MHC	protein
class	protein
II	protein
expression	O
since	O
over-expression	O
of	O
this	O
protein	O
by	O
stable	O
transfection	O
into	O
human	O
B	O
cells	O
led	O
to	O
a	O
total	O
disappearance	O
of	O
constitutive	O
MHC	RNA
class	RNA
II	RNA
mRNA	RNA
expression	O
.	O
The	O
class	DNA
II	DNA
transactivator	DNA
(	O
CIITA	DNA
)	O
is	O
necessary	O
for	O
both	O
constitutive	O
and	O
IFN-gamma	protein
induced	O
MHC	protein
class	protein
II	protein
expressions	O
.	O
Examination	O
of	O
CIITA	RNA
mRNA	RNA
in	O
IK	protein
stably	O
transfected	O
clones	O
revealed	O
a	O
marked	O
reduction	O
of	O
CIITA	RNA
mRNA	RNA
transcription	O
.	O
Taken	O
together	O
these	O
results	O
demonstrate	O
that	O
the	O
IK	protein
protein	protein
plays	O
a	O
key	O
role	O
in	O
the	O
constitutive	O
expression	O
of	O
MHC	protein
class	protein
II	protein
antigens	protein
and	O
that	O
inhibition	O
induced	O
by	O
IK	protein
is	O
upstream	O
of	O
CIITA	DNA
in	O
this	O
regulatory	O
pathway	O
.	O

Selective	O
expression	O
of	O
an	O
interleukin-12	protein
receptor	protein
component	protein
by	O
human	cell_type
T	cell_type
helper	cell_type
1	cell_type
cells	cell_type
.	O
Interleukin-12	protein
(	O
IL-12	protein
),	O
a	O
heterodimeric	protein
cytokine	protein
produced	O
by	O
activated	O
monocytes	O
and	O
dendritic	O
cells,	O
plays	O
a	O
crucial	O
role	O
in	O
regulating	O
interferon	protein
(IFN)-gamma	protein
production	O
and	O
in	O
the	O
generation	O
of	O
IFN-gamma	cell_type
-producing	cell_type
T	cell_type
helper	cell_type
1	cell_type
(Th1)	cell_type
cells	cell_type
.	O
Here	O
we	O
show	O
that	O
the	O
IL-12	protein
receptor	protein
(	protein
IL-12R	protein
)	protein
beta	protein
2	protein
subunit	protein
,	O
a	O
recently	O
cloned	O
binding	O
and	O
signal	O
transducing	O
component	O
of	O
the	O
IL-12R	protein
,	O
is	O
expressed	O
on	O
human	O
Th1	O
but	O
not	O
Th2	O
clones	O
and	O
is	O
induced	O
during	O
differentiation	O
of	O
human	cell_type
naive	cell_type
cells	cell_type
along	O
the	O
Th1	O
but	O
not	O
the	O
Th2	O
pathway	O
.	O
IL-12	protein
and	O
type	O
I	O
but	O
not	O
type	O
II	O
interferons	O
induce	O
expression	O
of	O
the	O
IL-12R	protein
beta	protein
2	protein
chain	protein
during	O
in	O
vitro	O
T	O
cell	O
differentiation	O
after	O
antigen	O
receptor	O
triggering.	O
The	O
selective	O
expression	O
and	O
regulation	O
of	O
the	O
IL-12R	protein
beta	protein
2	protein
subunit	protein
may	O
help	O
to	O
understand	O
the	O
basis	O
of	O
Th1/Th2	O
differentiation	O
and	O
may	O
provide	O
therapeutic	O
options	O
for	O
altering	O
the	O
Th1/Th2	O
balance	O
in	O
several	O
immuno-pathological	O
conditions	O
such	O
as	O
autoimmune	O
diseases	O
and	O
allergies	O
.	O

The	O
T	protein
cell	protein
activation	protein
factor	protein
NF-ATc	protein
positively	O
regulates	O
HIV-1	O
replication	O
and	O
gene	O
expression	O
in	O
T	cell_type
cells	cell_type
.	O
Clinical	O
deterioration	O
in	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
infection	O
is	O
associated	O
with	O
increased	O
levels	O
of	O
viral	O
replication	O
and	O
burden	O
in	O
the	O
peripheral	O
blood	O
and	O
lymphoid	O
organs	O
.	O
T	O
cell	O
activation	O
and	O
ensuing	O
cellular	O
gene	O
activation	O
can	O
be	O
critical	O
for	O
HIV-1	O
replication	O
.	O
The	O
hypothesis	O
that	O
the	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NF-AT	protein
)	O
may	O
influence	O
HIV-1	O
replication	O
is	O
therefore	O
compelling	O
given	O
the	O
tight	O
correlation	O
of	O
HIV-1	O
transcriptional	O
induction	O
to	O
T	O
cell	O
activation	O
.	O
We	O
report	O
that	O
certain	O
NF-AT(Rel)	protein
family	protein
members	protein
productively	O
bind	O
the	O
kappaB	DNA
regulatory	DNA
elements	DNA
,	O
synergize	O
with	O
NF-kappaB	protein
and	O
Tat	protein
in	O
transcriptional	O
activation	O
of	O
HIV-1	O
,	O
and	O
enhance	O
HIV-1	O
replication	O
in	O
T	cell_type
cells	cell_type
.	O
These	O
results	O
link	O
regulatory	protein
factors	protein
critical	O
to	O
T	O
cell	O
commitment	O
directly	O
to	O
HIV-1	O
replication	O
.	O

Transcription	O
mediated	O
by	O
NFAT	protein
is	O
highly	O
inducible	O
in	O
effector	O
CD4+	cell_type
T	cell_type
helper	cell_type
2	cell_type
(Th2)	cell_type
cells	cell_type
but	O
not	O
in	O
Th1	cell_type
cells	cell_type
.	O
Transcriptional	protein
factors	protein
of	O
the	O
NFAT	protein
family	protein
play	O
an	O
important	O
role	O
in	O
regulating	O
the	O
expression	O
of	O
several	O
cytokine	DNA
genes	DNA
during	O
the	O
immune	O
response	O
,	O
such	O
as	O
the	O
genes	O
for	O
interleukin	protein
2	protein
(	O
IL-2	protein
)	O
and	O
IL-4	protein
,	O
among	O
others.	O
Upon	O
antigen	O
stimulation,	O
precursor	O
CD4+	cell_type
T	cell_type
helper	cell_type
(pTh)	cell_type
cells	cell_type
proliferate	O
and	O
differentiate	O
into	O
two	O
populations	O
of	O
effector	cell_type
cells	cell_type
(	O
eTh1	cell_type
and	O
eTh2	cell_type
),	O
each	O
one	O
expressing	O
a	O
specific	O
pattern	O
of	O
cytokines	protein
that	O
distinguishes	O
them	O
from	O
their	O
precursors.	O
eTh2	cell_type
cells	cell_type
are	O
the	O
major	O
source	O
of	O
IL-4	protein
,	O
while	O
gamma	protein
interferon	protein
is	O
produced	O
by	O
eTh1	cell_type
cells	cell_type
.	O
Here	O
we	O
have	O
used	O
reporter	O
transgenic	O
mice	O
to	O
show	O
that	O
DNA	O
binding	O
and	O
transcriptional	O
activities	O
of	O
NFAT	protein
are	O
transiently	O
induced	O
during	O
the	O
differentiation	O
of	O
pTh	cell_type
cells	cell_type
into	O
either	O
eTh1	cell_type
or	O
eTh2	cell_type
cells	cell_type
to	O
mediate	O
the	O
expression	O
of	O
IL-2	protein
as	O
a	O
common	O
growth	O
factor	O
in	O
both	O
pathways.	O
However,	O
although	O
NFAT	protein
DNA	O
binding	O
is	O
similarly	O
induced	O
in	O
both	O
eTh1	cell_type
and	O
eTh2	cell_type
cells	cell_type
upon	O
antigen	O
stimulation	O
,	O
only	O
the	O
NFAT	protein
complexes	protein
present	O
in	O
eTh2	cell_type
cells	cell_type
are	O
able	O
to	O
mediate	O
high-level	O
transcription	O
,	O
and	O
relatively	O
little	O
NFAT	protein
transcriptional	O
activity	O
was	O
induced	O
in	O
eTh1	cell_type
cells	cell_type
.	O
In	O
contrast	O
to	O
activated	O
pTh	cell_type
cells	cell_type
,	O
neither	O
eTh1	cell_type
nor	O
eTh2	cell_type
cells	cell_type
produced	O
significant	O
IL-2	protein
upon	O
stimulation,	O
but	O
the	O
high	O
levels	O
of	O
NFAT	protein
transcriptional	O
activities	O
directly	O
correlate	O
with	O
the	O
IL-4	protein
production	O
induced	O
in	O
response	O
to	O
antigen	O
stimulation	O
in	O
eTh2	cell_type
cells	cell_type
.	O
These	O
data	O
suggest	O
that	O
activated	O
NFAT	protein
is	O
involved	O
in	O
the	O
effector	O
function	O
of	O
eTh2	cell_type
cells	cell_type
and	O
that	O
the	O
failure	O
of	O
eTh1	cell_type
cells	cell_type
to	O
produce	O
IL-4	protein
in	O
response	O
to	O
an	O
antigen	O
is	O
due,	O
at	O
least	O
partially,	O
to	O
a	O
failure	O
to	O
induce	O
high-level	O
transcription	O
of	O
the	O
IL-4	DNA
gene	DNA
by	O
NFAT	protein
.	O
Regulation	O
of	O
NFAT	protein
could	O
be	O
therefore	O
a	O
critical	O
element	O
in	O
the	O
polarization	O
to	O
eTh1	cell_type
or	O
eTh2	cell_type
.	O

Activation	O
of	O
the	O
transcription	protein
factor	protein
NF-kappaB	protein
in	O
lipopolysaccharide	cell_line
-stimulated	cell_line
U937	cell_line
cells	cell_line
.	O
During	O
the	O
course	O
of	O
serious	O
bacterial	O
infections	O
,	O
lipopolysaccharide	O
(	O
LPS	O
)	O
interacts	O
with	O
monocyte/macrophage	protein
receptors	protein
,	O
resulting	O
in	O
the	O
generation	O
of	O
inflammatory	protein
cytokines	protein
.	O
Transcription	protein
factor	protein
NF-kappaB	protein
is	O
crucial	O
in	O
activating	O
the	O
transcription	O
of	O
genes	O
encoding	O
proinflammatory	protein
cytokines	protein
.	O
In	O
this	O
paper,	O
we	O
demonstrate	O
that	O
the	O
activation	O
of	O
NF-kappaB	protein
by	O
LPS	O
in	O
a	O
promonocytic	cell_line
cell	cell_line
line	cell_line
(	O
U937	cell_line
)	O
followed	O
a	O
rather	O
slow	O
kinetics,	O
depending	O
on	O
the	O
rate	O
of	O
IkappaB-alpha	protein
inhibitor	O
hydrolysis	O
.	O
No	O
degradation	O
of	O
p105	O
and	O
p100	O
inhibitors	O
was	O
observed	O
under	O
these	O
conditions.	O
The	O
transduction	O
pathway	O
leading	O
to	O
NF-kappaB	protein
activation	O
in	O
U937	cell_line
cells	cell_line
involved	O
the	O
intracellular	O
generation	O
of	O
reactive	O
oxygen	O
species	O
(	O
ROS)	O
,	O
as	O
demonstrated	O
by	O
the	O
concomitant	O
inhibitory	O
effects	O
of	O
antioxidants	O
on	O
NF-kappaB	protein
activation	O
and	O
the	O
emission	O
of	O
a	O
fluorescent	O
probe	O
reacting	O
intracellularly	O
with	O
hydrogen	O
peroxide	O
.	O
This	O
ROS	O
pathway	O
was	O
also	O
characterized	O
by	O
the	O
use	O
of	O
other	O
inhibitors.	O
This	O
finding	O
indicates	O
that	O
phospholipase	protein
A2	protein
and	O
5-lipoxygenase	protein
are	O
also	O
involved.	O
However,	O
the	O
NF-kappaB	protein
activation	O
pathway	O
involving	O
the	O
acidic	protein
sphingomyelinase	protein
of	O
the	O
endolysosomial	O
membrane	O
did	O
not	O
seem	O
to	O
participate	O
in	O
the	O
LPS	O
-induced	O
NF-kappaB	protein
activation	O
in	O
U937	cell_line
cells	cell_line
.	O

c-Rel	protein
is	O
a	O
target	O
of	O
pentoxifylline	O
-mediated	O
inhibition	O
of	O
T	O
lymphocyte	O
activation.	O
The	O
possible	O
clinical	O
use	O
of	O
the	O
methyl	O
xanthine	O
derivative	O
,	O
pentoxifylline	O
(	O
PF	O
),	O
for	O
the	O
treatment	O
of	O
T	O
cell-dependent	O
diseases	O
is	O
being	O
noted	O
with	O
increasing	O
interest.	O
In	O
this	O
paper,	O
we	O
studied	O
the	O
molecular	O
consequences	O
of	O
PF	O
treatment	O
during	O
lymphocyte	O
activation	O
.	O
We	O
found	O
that	O
in	O
T	cell_type
cells	cell_type
,	O
anti-CD3-induced	O
c-Rel	protein
expression	O
was	O
blocked	O
by	O
PF	O
,	O
whereas	O
the	O
induction	O
of	O
other	O
NF-kappaB	protein
family	protein
members	protein
was	O
not	O
significantly	O
affected.	O
However,	O
induction	O
of	O
NF-AT	protein
,	O
which	O
has	O
the	O
same	O
signaling	O
requirements	O
as	O
c-Rel	protein
induction	O
,	O
was	O
not	O
inhibited	O
by	O
PF	O
.	O
Among	O
genes	O
that	O
respond	O
to	O
these	O
transcription	protein
factors	protein
,	O
IL-2	RNA
mRNA	RNA
induction	O
was	O
suppressed	O
by	O
PF	O
,	O
whereas	O
IL-2R(alpha)	RNA
chain	RNA
mRNA	RNA
induction	O
was	O
not	O
affected.	O
These	O
observations	O
implicated	O
c-Rel	protein
as	O
an	O
IL-2	protein
promoter	protein
factor	protein
,	O
for	O
which	O
experimental	O
support	O
was	O
obtained	O
from	O
transient	O
transfection	O
experiments	O
.	O
In	O
contrast	O
with	O
the	O
observation	O
in	O
T	cell_type
cells	cell_type
,	O
c-Rel	protein
induction	O
was	O
not	O
blocked	O
by	O
PF	O
in	O
B	cell_type
cells	cell_type
.	O
The	O
greater	O
selectivity	O
of	O
PF	O
,	O
compared	O
with	O
FK506	O
,	O
at	O
both	O
the	O
molecular	O
and	O
cellular	O
levels	O
may	O
prove	O
advantageous	O
in	O
manipulating	O
T	O
cell	O
responses	O
in	O
vivo.	O

V3	protein
loop	protein
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
suppresses	O
interleukin	protein
2	protein
-induced	O
T	O
cell	O
growth	O
[published	O
erratum	O
appears	O
in	O
AIDS	O
Res	O
Hum	O
Retroviruses	O
1997	O
May	O
1;13(7):633]	O
We	O
tested	O
the	O
effect	O
of	O
three	O
linear	O
or	O
two	O
loop	O
peptides	O
derived	O
from	O
the	O
V3	protein
region	protein
of	O
the	O
HTLV-III	O
BH10	O
clone	O
or	O
the	O
SF2	O
strain	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
on	O
IL-2	protein
-driven	O
T	O
cell	O
proliferation	O
.	O
V3-BH10	protein
,	O
which	O
consists	O
of	O
42	protein
amino	protein
acids	protein
and	O
has	O
a	O
loop	protein
structure	protein
,	O
suppressed	O
IL-2	protein
-driven	O
proliferation	O
of	O
all	O
IL-2	cell_line
-dependent	cell_line
cells	cell_line
[	O
Kit225	cell_line
,	O
ED-40515(+)	cell_line
,	O
KT-3	cell_line
,	O
7-day	cell_line
PHA-blasts	cell_line
,	O
and	O
fresh	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
]	O
tested,	O
whereas	O
it	O
did	O
not	O
suppress	O
the	O
cell	O
growth	O
of	O
IL-2	cell_line
-independent	cell_line
cell	cell_line
lines	cell_line
(	O
Hut102	cell_line
,	O
Molt-4	cell_line
,	O
and	O
Jurkat	cell_line
).	O
This	O
suppressive	O
effect	O
was	O
also	O
seen	O
in	O
IL-2	protein
-driven	O
cell	O
growth	O
of	O
CD8-positive	cell_type
lymphocytes	cell_type
purified	O
from	O
7-day	cell_type
PHA-blasts	cell_type
,	O
indicating	O
that	O
CD4	protein
molecules	protein
were	O
not	O
required	O
for	O
the	O
suppression.	O
The	O
treatment	O
with	O
anti-	protein
V3	protein
loop	protein
monoclonal	protein
antibody	protein
(	O
902	protein
antibody	protein
)	O
completely	O
abolished	O
the	O
suppressive	O
effect	O
of	O
V3-BH10	protein
.	O
In	O
addition,	O
V3-BH10	protein
generated	O
the	O
arrest	O
of	O
Kit225	cell_line
cells	cell_line
and	O
also	O
purified	cell_line
CD8-positive	cell_line
lymphocytes	cell_line
in	O
G1	O
phase	O
in	O
the	O
presence	O
of	O
IL-2	protein
.	O
Neither	O
chromatin	DNA
condensation	O
nor	O
DNA	O
fragmentation	O
was	O
detected	O
in	O
Kit225	cell_line
cells	cell_line
cultured	O
with	O
V3-BH10	protein
and	O
IL-2	protein
.	O
V3-BH10	protein
neither	O
blocked	O
radiolabeled	O
IL-2	protein
binding	O
to	O
IL-2	protein
receptors	protein
nor	O
affected	O
tyrosyl	O
phosphorylation	O
of	O
several	O
cellular	protein
proteins	protein
(	O
p120	protein
,	O
p98	protein
,	O
p96	protein
,	O
p54	protein
,	O
and	O
p38	protein
),	O
which	O
is	O
immediately	O
induced	O
by	O
IL-2	protein
stimulation	O
.	O
However,	O
V3-BH10	protein
enhanced	O
IL-2	protein
-induced	RNA
mRNA	RNA
expression	O
of	O
c-fos	DNA
but	O
not	O
c-myc	DNA
or	O
junB	DNA
.	O
Thus,	O
the	O
binding	O
of	O
V3	protein
loop	protein
of	O
gp120	protein
to	O
the	O
cell	O
surface	O
molecule(s)	O
appears	O
to	O
affect	O
intracellular	O
IL-2	protein
signaling	O
,	O
which	O
leads	O
to	O
the	O
suppression	O
of	O
IL-2	protein
-induced	O
T	O
cell	O
growth	O

A	O
negative	O
role	O
for	O
phosphoinositide	protein
3-kinase	protein
in	O
T-cell	protein
antigen	protein
receptor	protein
function	O
.	O
BACKGROUND:	O
A	O
delicate	O
balance	O
between	O
positive	O
and	O
negative	O
regulatory	O
mechanisms	O
during	O
T-cell	O
activation	O
determines	O
the	O
specificity	O
and	O
magnitude	O
of	O
an	O
immune	O
response	O
.	O
Phosphoinositide	protein
3-kinase	protein
(	O
PI	protein
3-kinase	protein
)	O
is	O
activated	O
by	O
a	O
diverse	O
set	O
of	O
receptors	O
that	O
determine	O
T-cell	O
function	O
,	O
including	O
the	O
T-cell	protein
antigen	protein
receptor	protein
(	O
TCR	protein
),	O
the	O
costimulatory	protein
receptor	protein
CD28	protein
,	O
and	O
negative	protein
regulators	protein
of	O
T-cell	O
activation	O
such	O
as	O
CTLA-4	protein
.	O
PI	protein
3-kinase	protein
is	O
also	O
regulated	O
by	O
the	O
haematopoietic	O
cytokines	O
that	O
determine	O
T-cell	O
differentiation	O
and	O
lymphocyte	cell_type
proliferation	O
.	O
PI	protein
3-kinase	protein
can	O
thus	O
dynamically	O
influence	O
the	O
outcome	O
of	O
the	O
immune	O
reactions	O
at	O
various	O
stages.	O
In	O
this	O
study,	O
we	O
investigated	O
the	O
importance	O
of	O
PI	protein
3-kinase	protein
in	O
TCR	protein
-directed	O
T-cell	O
activation	O
using	O
activated	O
or	O
inhibitory	O
versions	O
of	O
PI	protein
3-kinase	protein
.	O
RESULTS:	O
Certain	O
aspects	O
of	O
TCR	protein
responses	O
such	O
as	O
the	O
induction	O
of	O
transcriptional	O
activity	O
of	O
AP1	protein
and	O
serum	protein
response	protein
factor	protein
were	O
not	O
affected	O
by	O
expression	O
of	O
the	O
mutant	O
forms	O
of	O
PI	protein
3-kinase	protein
.	O
We	O
found,	O
however,	O
that	O
PI	protein
3-kinase	protein
profoundly	O
influenced	O
the	O
transactivation	O
capacity	O
of	O
'	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
'	O
(	O
NF-AT	protein
)	O
elicited	O
by	O
the	O
TCR	protein
:	O
expression	O
of	O
an	O
activated	O
form	O
of	O
PI	protein
3-kinase	protein
inhibited	O
TCR	protein
-mediated	O
NF-AT	protein
responses	O
,	O
whereas	O
expression	O
of	O
a	O
dominant	O
negative	O
mutant	O
of	O
PI	protein
3-kinase	protein
potently	O
enhanced	O
TCR	protein
-controlled	O
NF-AT	protein
induction	O
.	O
These	O
effects	O
of	O
PI	protein
3-kinase	protein
were	O
not	O
mediated	O
by	O
previously	O
identified	O
PI	protein
3-kinase	protein
effectors	protein
,	O
such	O
as	O
protein	protein
kinase	protein
B	protein
,	O
a	O
positive	protein
regulator	protein
of	O
PI	protein
3-kinase	protein
,	O
or	O
the	O
GTPase	protein
Rac	protein
,	O
and	O
are	O
therefore	O
likely	O
to	O
involve	O
a	O
novel,	O
as	O
yet	O
unknown,	O
effector	protein
molecule	protein
.	O
CONCLUSIONS:	O
Our	O
results	O
establish	O
that	O
PI	protein
3-kinase	protein
can	O
both	O
positively	O
and	O
negatively	O
regulate	O
T-cell	O
function	O
,	O
and	O
uncover	O
a	O
previously	O
unrecognized	O
function	O
for	O
PI	protein
3-kinase	protein
in	O
T	cell_type
cells	cell_type
as	O
a	O
selective	O
negative	O
regulator	O
of	O
TCR	protein
-signalling	O
events	O
and	O
therefore	O
as	O
a	O
determinant	O
of	O
T-cell	O
homeostasis	O
.	O

The	O
Pax-5	DNA
gene	DNA
is	O
alternatively	O
spliced	O
during	O
B-cell	O
development	O
.	O
The	O
transcription	protein
factor	protein
Pax-5	protein
is	O
expressed	O
during	O
the	O
early	O
stages	O
of	O
B-cell	O
differentiation	O
and	O
influences	O
the	O
expression	O
of	O
several	O
B-cell-specific	DNA
genes	DNA
.	O
In	O
addition	O
to	O
the	O
existing	O
isoform	O
(	O
Pax-5	protein
,	O
which	O
we	O
have	O
named	O
Pax-5a	protein
),	O
we	O
have	O
isolated	O
three	O
new	O
isoforms,	O
Pax-5b	protein
,	O
Pax-5d	protein
,	O
and	O
Pax-5e	protein
,	O
from	O
murine	O
spleen	O
and	O
B-lymphoid	cell_line
cell	cell_line
lines	cell_line
using	O
library	O
screenings	O
and	O
polymerase	O
chain	O
reaction	O
amplification	O
.	O
Isoforms	O
Pax-5b	protein
and	O
Pax-5e	protein
have	O
spliced	O
out	O
their	O
second	O
exon,	O
resulting	O
in	O
proteins	O
with	O
only	O
a	O
partial	O
DNA-binding	protein
domain	protein
.	O
Isoforms	O
Pax-5d	O
and	O
Pax-5e	protein
have	O
deleted	O
the	O
3'-region	protein
,	O
which	O
encodes	O
the	O
transactivating	O
domain,	O
and	O
replaced	O
it	O
with	O
a	O
novel	O
sequence.	O
The	O
existence	O
of	O
alternative	O
Pax-5	RNA
transcripts	RNA
was	O
confirmed	O
using	O
RNase	protein
protection	O
assays	O
.	O
Furthermore,	O
Pax-5a	protein
and	O
Pax-5b	protein
proteins	protein
were	O
detected	O
using	O
Western	O
blot	O
analysis	O
.	O
Pax-5a	protein
was	O
detectable	O
in	O
pro-	O
,	O
pre-	O
,	O
and	O
mature	O
B-cell	O
lines	O
,	O
but	O
not	O
in	O
two	O
plasmacytomas	O
;	O
Pax-5b	protein
was	O
shown	O
to	O
be	O
present	O
at	O
low	O
levels	O
in	O
mature	cell_line
B-cell	cell_line
lines	cell_line
and,	O
unexpectedly,	O
in	O
one	O
plasma	O
cell	O
line,	O
but	O
not	O
in	O
pro-B-cell	O
or	O
T-cell	O
lines	O
.	O
Mobility	O
shift	O
assays	O
showed	O
that	O
in	O
vitro	O
translated	O
Pax-5a	protein
and	O
Pax-5d	protein
,	O
but	O
not	O
Pax-5b	protein
or	O
Pax-5e	protein
,	O
could	O
interact	O
with	O
a	O
B-cell-specific	DNA
activator	DNA
protein-binding	DNA
site	DNA
on	O
the	O
blk	DNA
promoter	DNA
.	O
Using	O
this	O
assay,	O
we	O
also	O
showed	O
that	O
Pax-5d	protein
was	O
present	O
in	O
nuclear	O
extracts	O
of	O
some	O
(but	O
not	O
all)	O
B-lymphoid	cell_line
lines	cell_line
and	O
interacts	O
with	O
the	O
B-cell-specific	DNA
activator	DNA
protein-binding	DNA
site	DNA
.	O
The	O
pattern	O
of	O
differential	O
expression	O
of	O
alternatively	protein
spliced	protein
Pax-5	protein
isoforms	protein
suggests	O
that	O
they	O
may	O
be	O
important	O
regulators	protein
of	protein
transcription	protein
during	O
B-cell	O
maturation	O
.	O

Reconstitution	O
of	O
T	O
cell	O
antigen	O
receptor-induced	O
Erk2	protein
kinase	protein
activation	O
in	O
Lck-negative	cell_line
JCaM1	cell_line
cells	cell_line
by	O
Syk	protein
.	O
The	O
two	O
related	O
protein-	protein
tyrosine	protein
kinases	protein
Syk	protein
and	O
Zap	protein
are	O
rapidly	O
phosphorylated	O
on	O
tyrosine	O
residues	O
and	O
enzymatically	O
activated	O
upon	O
crosslinking	O
of	O
the	O
T	protein
cell	protein
antigen	protein
receptor	protein
.	O
We	O
have	O
previously	O
reported	O
that	O
the	O
activation	O
of	O
Syk	protein
is	O
less	O
dependent	O
on	O
the	O
Src	protein
family	protein
kinase	protein
Lck	protein
than	O
the	O
activation	O
of	O
Zap	protein
.	O
Here	O
we	O
report	O
that	O
overexpression	O
of	O
Syk	protein
in	O
the	O
Lck	cell_line
-negative	cell_line
JCaM1	cell_line
cells	cell_line
enabled	O
the	O
T	protein
cell	protein
antigen	protein
receptor	protein
/CD3	protein
complex	protein
to	O
induce	O
a	O
normal	O
activation	O
of	O
the	O
mitogen-activated	protein
protein	protein
kinase	protein
(	O
MAPK	protein
)	O
pathway	O
and	O
expression	O
of	O
a	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
reporter	O
construct.	O
In	O
contrast,	O
Zap	protein
and	O
other	O
protein-	protein
tyrosine	protein
kinases	protein
were	O
unable	O
to	O
reconstitute	O
these	O
signaling	O
pathways	O
when	O
expressed	O
at	O
the	O
same	O
levels.	O
In	O
parallel,	O
Syk	protein
was	O
phosphorylated	O
on	O
tyrosine	O
,	O
while	O
Zap	protein
was	O
not.	O
The	O
Syk	protein
-mediated	O
T	protein
cell	protein
antigen	protein
receptor	protein
-induced	O
MAPK	protein
activation	O
was	O
detectable	O
within	O
1	O
min	O
of	O
receptor	O
stimulation	O
and	O
peaked	O
at	O
3-5	O
min.	O
The	O
capacity	O
of	O
Syk	protein
to	O
reconstitute	O
the	O
MAPK	protein
response	O
required	O
the	O
catalytic	O
activity	O
of	O
Syk	protein
,	O
an	O
intact	O
autophosphorylation	protein
site	protein
(	O
Y518	O
and	O
Y519	O
),	O
both	O
Src	protein
homology	protein
2	protein
domains	protein
and	O
it	O
was	O
blocked	O
by	O
the	O
inhibitory	protein
N17-mutated	protein
dominant-negative	protein
Ras	protein
construct	protein
.	O
A	O
Y341	O
--&gt;	O
F	protein
mutant	protein
of	O
Syk	protein
,	O
which	O
is	O
deficient	O
in	O
its	O
interaction	O
with	O
phospholipase	protein
Cy1	protein
and	O
Vav	protein
,	O
was	O
less	O
efficient	O
than	O
wild-type	protein
Syk	protein
.	O
Our	O
results	O
suggest	O
that	O
Syk	protein
,	O
in	O
contrast	O
to	O
Zap	protein
,	O
can	O
transduce	O
signals	O
from	O
the	O
T	protein
cell	protein
antigen	protein
receptor	protein
independently	O
of	O
Lck	protein
.	O

Activation	O
of	O
the	O
transcription	protein
factor	protein
MEF2C	protein
by	O
the	O
MAP	protein
kinase	protein
p38	protein
in	O
inflammation	O
.	O
For	O
cells	O
of	O
the	O
innate	O
immune	O
system	O
to	O
mount	O
a	O
host	O
defence	O
response	O
to	O
infection,	O
they	O
must	O
recognize	O
products	O
of	O
microbial	O
pathogens	O
such	O
as	O
lipopolysaccharide	O
(	O
LPS	O
),	O
the	O
endotoxin	O
secreted	O
by	O
Gram-negative	O
bacteria	O
.	O
These	O
cellular	O
responses	O
require	O
intracellular	O
signalling	O
pathways	O
,	O
such	O
as	O
the	O
four	O
MAP	protein
kinase	protein
(	O
MAPK	protein
)	O
pathways	O
.	O
In	O
mammalian	O
cells	O
the	O
MAPK	protein
p38	protein
is	O
thought	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
cellular	O
responses	O
during	O
infection	O
through	O
its	O
effects	O
on	O
the	O
expression	O
of	O
proinflammatory	protein
molecules	protein
.	O
One	O
means	O
of	O
understanding	O
the	O
role	O
of	O
p38	protein
in	O
these	O
responses	O
is	O
to	O
identify	O
proteins	O
with	O
functions	O
regulated	O
by	O
p38	protein
-catalysed	O
phosphorylation	O
.	O
Here	O
we	O
demonstrate	O
a	O
link	O
between	O
the	O
p38	protein
pathway	O
and	O
a	O
member	O
of	O
the	O
myocyte-enhancer	protein
factor	protein
2	protein
(MEF2)	protein
group	protein
of	O
transcription	protein
factors	protein
.	O
We	O
found	O
that	O
in	O
monocytic	cell_type
cells	cell_type
,	O
LPS	O
increases	O
the	O
transactivation	O
activity	O
of	O
MEF2C	protein
through	O
p38	protein
-catalysed	O
phosphorylation.	O
One	O
consequence	O
of	O
MEF2C	protein
activation	O
is	O
increased	O
c-jun	DNA
gene	DNA
transcription	O
.	O
Our	O
results	O
show	O
that	O
p38	protein
may	O
influence	O
host	O
defence	O
and	O
inflammation	O
by	O
maintaining	O
the	O
balance	O
of	O
c-Jun	protein
protein	protein
consumed	O
during	O
infection	O
.	O

Cellular	O
redox	O
status	O
influences	O
both	O
cytotoxic	O
and	O
NF-kappa	O
B	O
activation	O
in	O
natural	cell_type
killer	cell_type
cells	cell_type
.	O
The	O
role	O
of	O
cellular	O
redox	O
status	O
in	O
both	O
cytotoxic	O
activity	O
and	O
NF-kappa	protein
B	protein
activation	O
in	O
natural	cell_type
killer	cell_type
(NK)	cell_type
cells	cell_type
was	O
investigated.	O
The	O
results	O
indicate	O
that	O
stimulation	O
of	O
NK	cell_type
cells	cell_type
,	O
either	O
freshly	O
isolated	O
from	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
(	O
PBL	cell_type
)	O
or	O
long-term	cell_line
cultured	cell_line
NK	cell_line
clones	cell_line
,	O
with	O
specific	O
cell	O
targets	O
results	O
in	O
an	O
increased	O
binding	O
activity	O
of	O
NF-kappa	protein
B	protein
and	O
AP-1	protein
transcription	protein
factors	protein
measured	O
by	O
gel	O
retardation	O
.	O
Pretreatment	O
of	O
NK	cell_type
cells	cell_type
with	O
the	O
antioxidant	O
pyrrolidine	O
dithiocarbarmate	O
(	O
PDTC	O
)	O
leads	O
to	O
the	O
inhibition	O
of	O
NF-kappa	protein
B	protein
activation	O
but	O
the	O
AP-1	protein
binding	O
to	O
DNA	O
was	O
superinduced.	O
The	O
inhibition	O
of	O
NF-kappa	protein
B	protein
by	O
PDTC	O
paralleled	O
with	O
an	O
inhibition	O
of	O
spontaneous	O
cytotoxicity	O
mediated	O
by	O
NK	cell_type
cells	cell_type
.	O
Moreover,	O
the	O
inhibitors	O
of	O
serine	protein
proteases	protein
,	O
N-alpha-tosyl-L-lysine	O
chloromethyl	O
ketone	O
and	O
N-alpha-tosyl-L-phenylalanine	O
chloromethyl	O
ketone	O
,	O
also	O
blocked	O
the	O
cytolytic	O
activity	O
of	O
NK	cell_type
cells	cell_type
against	O
the	O
sensitive	O
target	O
K562	cell_line
.	O
In	O
contrast,	O
NK	O
activity	O
was	O
not	O
affected	O
by	O
pretreatment	O
of	O
the	O
effector	O
cells	O
with	O
the	O
proteasome	protein
inhibitor	O
N-acetyl-leu-leu-norleucinal	O
which	O
selectively	O
inhibits	O
NF-kappa	protein
B	protein
activation	O
.	O
Altogether,	O
these	O
results	O
support	O
the	O
hypothesis	O
that	O
the	O
activation	O
of	O
NK	cell_type
cells	cell_type
involved	O
transcriptional	O
and	O
post-transcriptional	O
events	O
,	O
and	O
that	O
reactive	O
intermediates	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
molecular	O
processes	O
related	O
with	O
the	O
generation	O
of	O
a	O
cytotoxic	O
response	O
by	O
NK	cell_type
cells	cell_type
.	O

The	O
predominant	O
E2F	protein
complex	protein
in	O
human	cell_type
primary	cell_type
haemopoietic	cell_type
cells	cell_type
and	O
in	O
AML	cell_type
blasts	cell_type
contains	O
E2F-4	protein
,	O
DP-1	protein
and	O
p130	protein
.	O
The	O
E2F	protein
family	protein
of	O
transcription	protein
factors	protein
are	O
thought	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
control	O
of	O
cell	O
cycle	O
progression	O
.	O
There	O
is	O
now	O
also	O
increasing	O
evidence	O
that	O
some	O
family	O
members	O
may	O
act	O
as	O
oncogenes	DNA
or	O
tumour	DNA
suppressor	DNA
genes	DNA
.	O
The	O
characterization	O
of	O
these	O
proteins	O
in	O
human	cell_type
primary	cell_type
haemopoietic	cell_type
cells	cell_type
and	O
acute	cell_type
myeloid	cell_type
leukaemia	cell_type
(AML)	cell_type
blasts	cell_type
may	O
thus	O
give	O
an	O
insight	O
to	O
the	O
molecular	O
mechanisms	O
governing	O
proliferation	O
and	O
leukaemogenesis	O
in	O
these	O
cells.	O
Therefore	O
we	O
analysed	O
the	O
expression	O
of	O
E2F	protein
-DNA	O
binding	O
activity	O
and	O
the	O
constituent	O
proteins	O
found	O
in	O
the	O
complexes	O
in	O
human	cell_type
primary	cell_type
haemopoietic	cell_type
cells	cell_type
of	O
various	O
lineages.	O
We	O
also	O
studied	O
blasts	O
from	O
18	O
patients	O
with	O
acute	O
myeloid	O
leukaemia	O
(	O
AML	O
).	O
On	O
electromobility	O
shift	O
assays	O
(	O
EMSA	O
)	O
a	O
single	O
E2F-DNA	protein
binding	protein
complex	protein
was	O
detected	O
in	O
T	cell_type
cells	cell_type
,	O
B	cell_type
cells	cell_type
and	O
monocytes	cell_type
which	O
was	O
shown	O
to	O
contain	O
E2F-4	protein
,	O
DP-1	protein
and	O
p130	protein
,	O
indicating	O
that	O
all	O
quiescent	cell_type
haemopoietic	cell_type
cells	cell_type
have	O
the	O
same	O
complex.	O
Examination	O
of	O
18	O
AML	O
samples	O
by	O
EMSA	O
revealed	O
the	O
presence	O
of	O
E2F	protein
binding	O
and	O
no	O
gross	O
abnormalities	O
were	O
detected.	O
An	O
E2F-4	protein
/p130	protein
complex	protein
was	O
detected	O
in	O
representative	O
samples	O
of	O
all	O
FAB	protein
types	O
analysed.	O
Thus	O
abnormalities	O
of	O
E2F	protein
function	O
are	O
unlikely	O
to	O
play	O
a	O
primary	O
pathogenic	O
role	O
in	O
AML	O
.	O

Characterization	O
of	O
a	O
mutant	cell_line
cell	cell_line
line	cell_line
that	O
does	O
not	O
activate	O
NF-kappaB	protein
in	O
response	O
to	O
multiple	O
stimuli.	O
Numerous	O
genes	O
required	O
during	O
the	O
immune	O
or	O
inflammation	O
response	O
as	O
well	O
as	O
the	O
adhesion	O
process	O
are	O
regulated	O
by	O
nuclear	protein
factor	protein
kappaB	protein
(	O
NF-kappaB	protein
).	O
Associated	O
with	O
its	O
inhibitor,	O
I	protein
kappaB	protein
,	O
NF-kappaB	protein
resides	O
as	O
an	O
inactive	O
form	O
in	O
the	O
cytoplasm	O
.	O
Upon	O
stimulation	O
by	O
various	O
agents,	O
I	protein
kappaB	protein
is	O
proteolyzed	O
and	O
NF-kappaB	protein
translocates	O
to	O
the	O
nucleus,	O
where	O
it	O
activates	O
its	O
target	O
genes.	O
The	O
transduction	O
pathways	O
that	O
lead	O
to	O
I	protein
kappaB	protein
inactivation	O
remain	O
poorly	O
understood.	O
In	O
this	O
study,	O
we	O
have	O
characterized	O
a	O
cellular	O
mutant,	O
the	O
70/Z3-derived	cell_line
1.3E2	cell_line
murine	cell_line
pre-B	cell_line
cell	cell_line
line	cell_line
,	O
that	O
does	O
not	O
activate	O
NF-kappaB	protein
in	O
response	O
to	O
several	O
stimuli.	O
We	O
demonstrate	O
that	O
upon	O
stimulation	O
by	O
lipopolysaccharide	O
,	O
Taxol	O
,	O
phorbol	O
myristate	O
acetate	O
,	O
interleukin-1	protein
,	O
or	O
double-stranded	RNA
RNA	RNA
,	O
I	protein
kappaB	protein
alpha	protein
is	O
not	O
degraded,	O
as	O
a	O
result	O
of	O
an	O
absence	O
of	O
induced	O
phosphorylation	O
on	O
serines	O
32	O
and	O
36	O
.	O
Neither	O
a	O
mutation	O
in	O
I	protein
kappaB	protein
alpha	protein
nor	O
a	O
mutation	O
in	O
p50	protein
or	O
relA	protein
,	O
the	O
two	O
major	O
subunits	O
of	O
NF-kappaB	protein
in	O
this	O
cell	O
line,	O
accounts	O
for	O
this	O
phosphorylation	O
defect	O
.	O
As	O
well	O
as	O
culminating	O
in	O
the	O
inducible	O
phosphorylation	O
of	O
I	protein
kappaB	protein
alpha	O
on	O
serines	O
32	O
and	O
36	O
,	O
all	O
the	O
stimuli	O
that	O
are	O
inactive	O
on	O
1.3E2	cell_line
cells	cell_line
exhibit	O
a	O
sensitivity	O
to	O
the	O
antioxidant	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
).	O
In	O
contrast,	O
stimuli	O
such	O
as	O
hyperosmotic	O
shock	O
or	O
phosphatase	O
inhibitors	O
,	O
which	O
use	O
PDTC	O
-insensitive	O
pathways	O
,	O
induce	O
I	protein
kappaB	protein
alpha	O
degradation	O
in	O
1.3E2	cell_line
.	O
Analysis	O
of	O
the	O
redox	O
status	O
of	O
1.3E2	cell_line
does	O
not	O
reveal	O
any	O
difference	O
from	O
wild-type	cell_line
70Z/3	cell_line
.	O
We	O
also	O
report	O
that	O
the	O
human	protein
T-cell	protein
leukemia	protein
virus	protein
type	protein
1	protein
(	protein
HTLV-1	protein
)-derived	protein
Tax	protein
trans-activator	protein
induces	O
NF-kappaB	protein
activity	O
in	O
1.3E2	cell_line
,	O
suggesting	O
that	O
this	O
viral	O
protein	O
does	O
not	O
operate	O
via	O
the	O
defective	O
pathway	O
.	O
Finally,	O
we	O
show	O
that	O
two	O
other	O
I	protein
kappaB	protein
molecules	protein
,	O
I	protein
kappaB	protein
beta	protein
and	O
the	O
recently	O
identified	O
I	protein
kappaB	protein
epsilon	protein
,	O
are	O
not	O
degraded	O
in	O
the	O
1.3E2	cell_line
cell	O
line	O
following	O
stimulation.	O
Our	O
results	O
demonstrate	O
that	O
1.3E2	cell_line
is	O
a	O
cellular	protein
transduction	protein
mutant	protein
exhibiting	O
a	O
defect	O
in	O
a	O
step	O
that	O
is	O
required	O
by	O
several	O
different	O
stimuli	O
to	O
activate	O
NF-kappaB	protein
.	O
In	O
addition,	O
this	O
analysis	O
suggests	O
a	O
common	O
step	O
in	O
the	O
signaling	O
pathways	O
that	O
trigger	O
I	protein
kappaB	protein
alpha	protein
,	O
I	protein
kappaB	protein
beta	protein
,	O
and	O
I	protein
kappaB	protein
epsilon	protein
degradation	O
.	O

Involvement	O
of	O
Egr-1	protein
/RelA	protein
synergy	O
in	O
distinguishing	O
T	O
cell	O
activation	O
from	O
tumor	protein
necrosis	protein
factor-alpha	protein
-induced	O
NF-kappa	protein
B1	protein
transcription	O
.	O
NF-kappa	protein
B	protein
is	O
an	O
important	O
transcription	protein
factor	protein
required	O
for	O
T	O
cell	O
proliferation	O
and	O
other	O
immunological	O
functions	O
.	O
The	O
NF-kappa	DNA
B1	DNA
gene	DNA
encodes	O
a	O
105-kD	protein
protein	protein
that	O
is	O
the	O
precursor	O
of	O
the	O
p50	protein
component	protein
of	O
NF-kappa	protein
B	protein
.	O
Previously,	O
we	O
and	O
others	O
have	O
demonstrated	O
that	O
NF-kappa	protein
B	protein
regulates	O
the	O
NF-kappa	DNA
B1	DNA
gene	DNA
.	O
In	O
this	O
manuscript	O
we	O
have	O
investigated	O
the	O
molecular	O
mechanisms	O
by	O
which	O
T	cell_line
cell	cell_line
lines	cell_line
stimulated	O
with	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
and	O
phytohemagglutin	protein
(	O
PHA	protein
)	O
display	O
significantly	O
higher	O
levels	O
of	O
NF-kappa	protein
B1	protein
encoding	O
transcripts	RNA
than	O
cells	O
stimulated	O
with	O
tumor	protein
necrosis	protein
factor-alpha	protein
,	O
despite	O
the	O
fact	O
that	O
both	O
stimuli	O
activate	O
NF-kappa	protein
B	protein
.	O
Characterization	O
of	O
the	O
NF-kappa	DNA
B1	DNA
promoter	DNA
identified	O
an	O
Egr-1	DNA
site	DNA
which	O
was	O
found	O
to	O
be	O
essential	O
for	O
both	O
the	O
PMA	O
/	O
PHA	protein
-mediated	O
induction	O
as	O
well	O
as	O
the	O
synergistic	O
activation	O
observed	O
after	O
the	O
expression	O
of	O
the	O
RelA	O
subunit	O
of	O
NF-kappa	protein
B	protein
and	O
Egr-1	protein
.	O
Furthermore,	O
Egr-1	protein
induction	O
was	O
required	O
for	O
endogenous	O
NF-kappa	DNA
B1	DNA
gene	O
expression,	O
since	O
PMA	O
/	O
PHA	cell_line
-stimulated	cell_line
T	cell_line
cell	cell_line
lines	cell_line
expressing	O
antisense	O
Egr-1	RNA
RNA	RNA
were	O
inhibited	O
in	O
their	O
ability	O
to	O
upregulate	O
NF-kappa	O
B1	O
transcription.	O
Our	O
studies	O
indicate	O
that	O
transcriptional	O
synergy	O
mediated	O
by	O
activation	O
of	O
both	O
Egr-1	protein
and	O
NF-kappa	protein
B	protein
may	O
have	O
important	O
ramifications	O
in	O
T	O
cell	O
development	O
by	O
upregulating	O
NF-kappa	DNA
B1	DNA
gene	O
expression	O
.	O

The	O
synthesis	O
and	O
immunogenicity	O
of	O
varicella-zoster	protein
virus	protein
glycoprotein	protein
E	protein
and	O
immediate-early	protein
protein	protein
(	O
IE62	protein
)	O
expressed	O
in	O
recombinant	O
herpes	O
simplex	O
virus-1	O
.	O
In	O
order	O
to	O
evaluate	O
the	O
conditions	O
for	O
optimal	O
expression	O
and	O
immunogenicity	O
of	O
varicella-zoster	protein
virus	protein
(VZV)	protein
proteins	protein
in	O
a	O
herpes	O
simplex	O
virus-1	O
(	O
HSV-1	O
)	O
vector	O
,	O
we	O
selected	O
the	O
VZV	protein
glycoprotein	protein
E	protein
(	O
gE	protein
),	O
encoded	O
by	O
ORF	DNA
68	DNA
and	O
the	O
VZV	protein
product	protein
of	O
ORF	DNA
62	DNA
,	O
an	O
immediate-early	protein
major	protein
tegument	protein
protein	protein
(	O
IE62	protein
).	O
Three	O
HSV/VZV	DNA
recombinants	DNA
were	O
generated:	O
(1)	O
VZV	DNA
gE	DNA
protein	DNA
coding	DNA
sequences	DNA
along	O
with	O
the	O
promoter	protein
region	protein
were	O
inserted	O
into	O
the	O
thymidine	DNA
kinase	DNA
(TK)	DNA
gene	DNA
of	O
HSV-1	O
strain	O
KOS	O
;	O
(2)	O
VZV	protein
gE	protein
expressed	O
from	O
the	O
HSV-1	DNA
ICP4	DNA
promoter	DNA
was	O
inserted	O
into	O
the	O
glycoprotein	DNA
C	DNA
(gC)	DNA
gene	DNA
of	O
HSV-1	O
strain	O
F	O
;	O
and	O
(3)	O
VZV	DNA
IE62	DNA
protein	DNA
coding	DNA
sequences	DNA
under	O
the	O
control	O
of	O
the	O
HSV-1	DNA
ICP4	DNA
promoter	DNA
were	O
inserted	O
into	O
the	O
gC	DNA
gene	DNA
of	O
HSV-1	O
strain	O
F	O
.	O
Immunoblot	O
analysis	O
and	O
immunoperoxidase	O
staining	O
of	O
infected	O
cell	O
monolayers	O
demonstrated	O
vector	O
expression	O
of	O
VZV	protein
proteins	protein
.	O
Following	O
intracranial	O
inoculation	O
in	O
mice,	O
both	O
VZV	protein
gE-HSV	protein
(	O
TK	protein
)	O
and	O
VZV	protein
IE62-HSV	protein
(	O
gC	protein
)	O
induced	O
an	O
IgG	protein
response	O
against	O
VZV	protein
gE	protein
or	O
VZV	protein
IE62	protein
.	O
When	O
tested	O
in	O
cytotoxicity	O
assays	O
using	O
T-lymphocytes	cell_type
from	O
VZV	O
immune	O
human	O
donors	O
,	O
the	O
range	O
of	O
precursor	O
frequencies	O
for	O
T-lymphocytes	cell_type
that	O
recognized	O
VZV	protein
gE	protein
or	O
VZV	protein
IE62	protein
was	O
similar	O
whether	O
these	O
proteins	O
were	O
expressed	O
by	O
HSV-1	O
or	O
a	O
vaccinia	O
vector	O
.	O
These	O
experiments	O
demonstrate	O
that	O
HSV-1	O
is	O
a	O
competent	O
vector	O
for	O
expression	O
of	O
these	O
VZV	protein
proteins	protein
and	O
support	O
the	O
feasibility	O
of	O
engineering	O
a	O
combined	O
vaccine	O
for	O
these	O
closely	O
related	O
alpha-herpesviruses	O
.	O

Constitutive	O
dephosphorylation	O
and	O
activation	O
of	O
a	O
member	O
of	O
the	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
,	O
NF-AT1	protein
,	O
in	O
Tax-expressing	O
and	O
type	O
I	O
human	O
T-cell	O
leukemia	O
virus-infected	O
human	O
T	O
cells	O
.	O
The	O
tax	O
gene	O
product	O
of	O
the	O
type	O
I	O
human	O
T-cell	O
leukemia	O
virus	O
(	O
HTLV-I	O
)	O
transactivates	O
interleukin-2	DNA
(	DNA
IL-2	DNA
)	DNA
gene	DNA
through	O
activation	O
of	O
an	O
enhancer	O
termed	O
CD28	DNA
responsive	DNA
element	DNA
(	O
CD28RE	DNA
).	O
Tax	protein
activation	O
of	O
the	O
CD28RE	DNA
is	O
partially	O
mediated	O
by	O
a	O
member	O
of	O
the	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
,	O
NF-AT1	protein
.	O
We	O
have	O
previously	O
shown	O
that	O
NF-AT1	protein
is	O
constitutively	O
active	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
stably	O
transfected	O
with	O
the	O
Tax	DNA
cDNA	DNA
,	O
although	O
the	O
underlying	O
molecular	O
mechanism	O
and	O
physiological	O
relevance	O
of	O
this	O
finding	O
remain	O
unclear.	O
In	O
this	O
report,	O
we	O
demonstrate	O
that	O
the	O
active	O
form	O
of	O
NF-AT1	protein
is	O
also	O
present	O
in	O
the	O
nuclei	O
of	O
HTLV-I	cell_type
-transformed	cell_type
T	cell_type
cells	cell_type
that	O
express	O
the	O
Tax	protein
protein	protein
.	O
Interestingly,	O
the	O
constitutive	O
activation	O
of	O
NF-AT1	protein
in	O
these	O
T	cell_type
cells	cell_type
is	O
associated	O
with	O
its	O
dephosphorylation.	O
Furthermore,	O
the	O
dephosphorylated	O
NF-AT1	protein
can	O
be	O
rapidly	O
rephosphorylated	O
when	O
the	O
cells	O
are	O
incubated	O
with	O
cyclosporin	O
A	O
,	O
an	O
immunosuppressant	O
inhibiting	O
the	O
serine	protein
/threonine	protein
phosphatase	protein
calcineurin	protein
.	O
These	O
results	O
suggest	O
that	O
activation	O
of	O
NF-AT1	protein
in	O
Tax-expressing	O
and	O
HTLV-I-transformed	O
T	O
cells	O
results	O
from	O
its	O
dephosphorylation	O
,	O
which	O
in	O
turn	O
may	O
be	O
due	O
to	O
deregulation	O
of	O
calcineurin	protein

Expression	O
of	O
NFAT-family	protein
proteins	protein
in	O
normal	cell_type
human	cell_type
T	cell_type
cells	cell_type
.	O
NFAT	protein
proteins	protein
constitute	O
a	O
family	O
of	O
transcription	protein
factors	protein
involved	O
in	O
mediating	O
signal	O
transduction.	O
Using	O
a	O
panel	O
of	O
specific	O
antisera	O
in	O
immunoprecipitation	O
assays	O
,	O
we	O
found	O
that	O
NFATp	protein
(	O
135	protein
kDa	protein
)	O
is	O
constitutively	O
expressed	O
in	O
normal	cell_type
human	cell_type
T	cell_type
cells	cell_type
,	O
while	O
synthesis	O
of	O
NFATc	protein
(predominant	O
form	O
of	O
86	protein
kDa	protein
)	O
is	O
induced	O
by	O
ionomycin	O
treatment	O
.	O
NFAT4/x	protein
was	O
very	O
weakly	O
expressed	O
in	O
unstimulated	O
cells,	O
and	O
its	O
level	O
did	O
not	O
increase	O
upon	O
treatment	O
with	O
activating	O
agents.	O
NFAT3	protein
protein	protein
was	O
not	O
observed	O
under	O
any	O
conditions.	O
Higher-molecular-weight	protein
species	protein
of	O
NFATc	protein
(of	O
110	O
and	O
140	O
kDa)	O
were	O
also	O
detected.	O
In	O
addition,	O
translation	O
of	O
NFATc	RNA
mRNA	RNA
apparently	O
initiates	O
at	O
two	O
different	O
AUG	DNA
codons	DNA
,	O
giving	O
rise	O
to	O
proteins	O
that	O
differ	O
in	O
size	O
by	O
36	O
amino	O
acids.	O
Additional	O
size	O
heterogeneity	O
of	O
both	O
NFATc	protein
and	O
NFATp	protein
results	O
from	O
phosphorylation	O
.	O
In	O
contrast	O
to	O
ionomycin	O
treatment	O
,	O
exposure	O
of	O
cells	O
to	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
plus	O
anti-CD28	protein
did	O
not	O
induce	O
NFATc	protein
,	O
indicating	O
that	O
under	O
these	O
conditions,	O
interleukin-2	protein
synthesis	O
by	O
these	O
cells	O
is	O
apparently	O
independent	O
of	O
NFATc	protein
.	O
In	O
DNA	O
binding	O
assays	O
,	O
both	O
PMA	O
plus	O
anti-CD28	protein
and	O
PMA	O
plus	O
ionomycin	O
resulted	O
in	O
nuclear	protein
NFAT	protein
.	O
Surprisingly,	O
the	O
PMA	O
-	O
ionomycin	O
-induced	O
synthesis	O
of	O
NFATc	protein
that	O
was	O
detected	O
by	O
immunoprecipitation	O
was	O
not	O
mirrored	O
in	O
the	O
DNA	O
binding	O
assays	O
:	O
nearly	O
all	O
of	O
the	O
activity	O
was	O
due	O
to	O
NFATp	protein
.	O
This	O
is	O
the	O
first	O
study	O
of	O
expression	O
of	O
all	O
family	O
members	O
at	O
the	O
protein	O
level	O
in	O
normal	cell_type
human	cell_type
T	cell_type
cells	cell_type
.	O

Of	O
the	O
GATA-binding	protein
proteins	protein
,	O
only	O
GATA-4	protein
selectively	O
regulates	O
the	O
human	DNA
IL-5	DNA
gene	DNA
promoter	DNA
in	O
IL-5	cell_type
producing	cell_type
cells	cell_type
which	O
express	O
multiple	protein
GATA-binding	protein
proteins	protein
.	O
Interleukin-5	protein
(	O
IL-5	protein
)	O
is	O
produced	O
by	O
T	cell_type
lymphocytes	cell_type
and	O
known	O
to	O
support	O
B	O
cell	O
growth	O
and	O
eosinophilic	O
differentiation	O
of	O
the	O
progenitor	cell_type
cells	cell_type
.	O
Using	O
ATL-16T	cell_line
cells	cell_line
which	O
express	O
IL-5	RNA
mRNA	RNA
,	O
we	O
have	O
identified	O
a	O
region,	O
within	O
the	O
human	DNA
IL-5	DNA
gene	DNA
promoter	DNA
,	O
that	O
regulates	O
IL-5	DNA
gene	DNA
transcription	O
.	O
This	O
cis-acting	DNA
sequence	DNA
contains	O
the	O
core	DNA
binding	DNA
motif	DNA
,	O
(A/T)GATA(A/G)	O
,	O
for	O
GATA-binding	protein
family	protein
proteins	protein
and	O
thus	O
suggests	O
the	O
involvement	O
of	O
these	O
family	O
members.	O
In	O
this	O
report,	O
we	O
describe	O
the	O
cloning	O
of	O
human	protein
GATA-4	protein
(	O
hGATA-4	protein
)	O
and	O
show	O
that	O
hGATA-4	protein
selectively	O
interacts	O
with	O
the	O
-70	DNA
GATA	DNA
site	DNA
within	O
the	O
IL-5	DNA
proximal	DNA
promoter	DNA
region	DNA
.	O
By	O
promoter	O
deletion	O
and	O
mutation	O
analyses	O
,	O
we	O
established	O
this	O
region	O
as	O
a	O
positive	DNA
regulatory	DNA
element	DNA
.	O
Cotransfection	O
experiments	O
revealed	O
that	O
both	O
hGATA-4	protein
and	O
PMA	O
/A23187	O
stimulation	O
are	O
necessary	O
for	O
the	O
IL-5	DNA
promoter	DNA
activation	O
.	O
The	O
requirement	O
of	O
another	O
regulatory	DNA
element	DNA
called	O
CLE0	DNA
,	O
which	O
lies	O
downstream	O
of	O
the	O
-70	DNA
GATA	DNA
site	DNA
,	O
was	O
also	O
demonstrated.	O
ATL-16T	cell_line
cells	cell_line
express	O
mRNA	RNA
of	O
three	O
GATA-binding	protein
proteins	protein
,	O
hGATA-2	protein
,	O
hGATA-3	protein
and	O
hGATA-4	protein
,	O
and	O
each	O
of	O
them	O
has	O
a	O
potential	O
to	O
bind	O
to	O
the	O
consensus	DNA
(A/T)GATA(G/	DNA
A)	DNA
motif	DNA
.	O
However,	O
using	O
ATL-16T	O
nuclear	O
extract	O
,	O
we	O
demonstrated	O
that	O
GATA-4	protein
is	O
the	O
only	O
GATA-binding	protein
protein	protein
that	O
forms	O
specific	O
DNA-protein	protein
complex	protein
with	O
the	O
-70	DNA
GATA	DNA
site	DNA
.	O
The	O
electrophoretic	O
mobility	O
shift	O
assay	O
with	O
extracts	O
of	O
COS	cell_line
cells	cell_line
expressing	O
GATA-binding	protein
proteins	protein
showed	O
that	O
GATA-4	protein
has	O
the	O
highest	O
binding	O
affinity	O
to	O
the	O
-70	DNA
GATA	DNA
site	DNA
among	O
the	O
three	O
GATA-binding	protein
proteins	protein
.	O
When	O
the	O
transactivation	O
ability	O
was	O
compared	O
among	O
the	O
three,	O
GATA-4	protein
showed	O
the	O
highest	O
activity.	O
These	O
results	O
demonstrate	O
the	O
selective	O
role	O
of	O
GATA-4	protein
in	O
the	O
transcriptional	O
regulation	O
of	O
the	O
IL-5	DNA
gene	DNA
in	O
a	O
circumstance	O
where	O
multiple	O
members	O
of	O
the	O
GATA-binding	protein
proteins	protein
are	O
expressed.	O

Control	O
of	O
NFATx1	protein
nuclear	O
translocation	O
by	O
a	O
calcineurin	protein
-regulated	protein
inhibitory	protein
domain	protein
.	O
The	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NFAT	protein
)	O
regulates	O
cytokine	DNA
gene	DNA
expression	O
in	O
T	cell_type
cells	cell_type
through	O
cis-acting	DNA
elements	DNA
located	O
in	O
the	O
promoters	DNA
of	O
several	O
cytokine	DNA
genes	DNA
.	O
NFATx1	protein
,	O
which	O
is	O
preferentially	O
expressed	O
in	O
the	O
thymus	O
and	O
peripheral	cell_type
blood	cell_type
leukocytes	cell_type
,	O
is	O
one	O
of	O
four	O
members	O
of	O
the	O
NFAT	protein
family	protein
of	O
transcription	protein
factors	protein
.	O
We	O
have	O
performed	O
domain	O
analysis	O
of	O
NFATx1	protein
by	O
examining	O
the	O
effects	O
of	O
deletion	O
mutations	O
.	O
We	O
found	O
that	O
NFATx1	protein
DNA	O
binding	O
activity	O
and	O
interaction	O
with	O
AP-1	O
polypeptides	O
were	O
dependent	O
on	O
its	O
central	protein
Rel	protein
similarity	protein
region	protein
and	O
that	O
transcriptional	O
activation	O
was	O
reduced	O
by	O
deletions	O
of	O
either	O
its	O
N-terminal	protein
domain	protein
or	O
its	O
C-terminal	protein
domain	protein
,	O
suggesting	O
the	O
presence	O
of	O
intrinsic	protein
transcriptional	protein
activation	protein
motifs	protein
in	O
both	O
regions.	O
We	O
also	O
identified	O
a	O
potent	O
inhibitory	protein
sequence	protein
within	O
its	O
N-terminal	protein
domain	protein
.	O
We	O
show	O
that	O
the	O
inactivation	O
of	O
the	O
inhibition	O
was	O
dependent	O
on	O
the	O
activity	O
of	O
calcineurin	protein
,	O
a	O
calcium-calmodulin-dependent	protein
phosphatase	protein
.	O
We	O
also	O
show	O
that	O
calcineurin	protein
associated	O
with	O
the	O
N-terminal	protein
domain	protein
of	O
NFATx1	protein
at	O
multiple	protein
docking	protein
sites	protein
and	O
caused	O
a	O
reduction	O
of	O
size,	O
indicative	O
of	O
dephosphorylation	O
,	O
in	O
NFATx1	protein
.	O
We	O
have	O
mapped	O
the	O
inhibitory	O
activity	O
to	O
less	O
than	O
60	protein
residues	protein
,	O
containing	O
motifs	O
that	O
are	O
conserved	O
in	O
all	O
NFAT	protein
proteins	protein
.	O
Finally,	O
we	O
demonstrate	O
that	O
deletion	O
in	O
NFATx1	protein
of	O
the	O
mapped	O
60	protein
residues	protein
leads	O
to	O
its	O
nuclear	O
translocation	O
independent	O
of	O
calcium	O
signaling	O
.	O
Our	O
results	O
support	O
the	O
model	O
proposing	O
that	O
the	O
N-terminal	protein
domain	protein
confers	O
calcium	O
-signaling	O
dependence	O
on	O
NFATx1	protein
transactivation	O
activity	O
by	O
regulating	O
its	O
intracellular	O
localization	O
through	O
a	O
protein	O
module	O
that	O
associates	O
with	O
calcineurin	protein
and	O
is	O
a	O
target	O
of	O
its	O
phosphatase	protein
activity	O
.	O

Neuronal	protein
(type	protein
I)	protein
nitric	protein
oxide	protein
synthase	protein
regulates	O
nuclear	protein
factor	protein
kappaB	protein
activity	O
and	O
immunologic	protein
(type	protein
II)	protein
nitric	protein
oxide	protein
synthase	protein
expression	O
.	O
Nitric	O
oxide	O
subserves	O
diverse	O
physiologic	O
roles	O
in	O
the	O
nervous	O
system	O
.	O
NO	O
is	O
produced	O
from	O
at	O
least	O
three	O
different	O
NO	protein
synthase	protein
(NOS)	protein
isoforms	protein
:	O
neuronal	protein
NOS	protein
(	O
nNOS	protein
),	O
endothelial	protein
NOS	protein
,	O
and	O
immunologic	protein
NOS	protein
(	O
iNOS	protein
).	O
We	O
show	O
that	O
nNOS	protein
is	O
the	O
predominant	O
isoform	O
constitutively	O
expressed	O
in	O
glia	cell_type
.	O
NO	O
derived	O
from	O
nNOS	protein
in	O
glia	cell_type
inhibits	O
the	O
transcription	protein
factor	protein
nuclear	protein
factor	protein
kappaB	protein
(	O
NF	protein
kappaB	protein
)	O
as	O
NOS	O
inhibitors	O
enhance	O
basal	O
NF	protein
kappaB	protein
activation	O
.	O
Pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
)	O
is	O
an	O
inhibitor	O
of	O
NF	protein
kappaB	protein
in	O
most	O
cells;	O
however,	O
we	O
show	O
that	O
PDTC	O
is	O
also	O
a	O
potent	O
scavenger	O
of	O
NO	O
through	O
formation	O
of	O
mononitrosyl	O
iron	O
complexes	O
with	O
PDTC	O
.	O
In	O
Jurkat	cell_line
cells	cell_line
,	O
a	O
human	O
T-cell	cell_line
lymphoma	cell_line
cell	cell_line
line	cell_line
,	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
)	O
induces	O
NF	protein
kappaB	protein
activation	O
that	O
is	O
inhibited	O
by	O
PDTC	O
.	O
Contrary	O
to	O
the	O
results	O
in	O
Jurkat	cell_line
cells	cell_line
,	O
PDTC	O
did	O
not	O
inhibit	O
tumor	protein
necrosis	protein
factor-alpha	protein
-induced	O
NF	protein
kappaB	protein
activation	O
in	O
astrocytes	cell_type
;	O
instead	O
PDTC	O
itself	O
induces	O
NF	protein
kappaB	protein
activation	O
in	O
astrocytes	cell_type
,	O
and	O
this	O
may	O
be	O
related	O
to	O
scavenging	O
of	O
endogenously	O
produced	O
NO	O
by	O
the	O
PDTC	O
iron	O
complex	O
.	O
In	O
astrocytes	cell_type
PDTC	O
also	O
dramatically	O
induces	O
the	O
NF	protein
kappaB	protein
-dependent	protein
enzyme	protein
,	O
iNOS	protein
,	O
supporting	O
the	O
physiologic	O
relevance	O
of	O
endogenous	O
NO	O
regulation	O
of	O
NF	protein
kappaB	protein
.	O
NF	protein
kappaB	protein
activation	O
in	O
glia	cell_type
from	O
mice	O
lacking	O
nNOS	protein
responds	O
more	O
rapidly	O
to	O
PDTC	O
compared	O
with	O
astrocytes	cell_type
from	O
wild-type	O
mice	O
.	O
Our	O
data	O
suggest	O
that	O
nNOS	protein
in	O
astrocytes	cell_type
regulates	O
NF	protein
kappaB	protein
activity	O
and	O
iNOS	protein
expression	O
,	O
and	O
indicate	O
a	O
novel	O
regulatory	O
role	O
for	O
nNOS	protein
in	O
tonically	O
suppressing	O
central	O
nervous	O
system	O
,	O
NF	DNA
kappaB	DNA
-regulated	DNA
genes	DNA
.	O

Involvement	O
of	O
Stat3	protein
in	O
interleukin-6	protein
-induced	O
IgM	protein
production	O
in	O
a	O
human	cell_line
B-cell	cell_line
line	cell_line
.	O
Interleukin-6	protein
(	O
IL-6	protein
)	O
is	O
an	O
important	O
B-cell	protein
growth	protein
and	protein
differentiation	protein
factor	protein
.	O
IL-6	protein
treatment	O
of	O
the	O
human	cell_line
lymphoblastoid	cell_line
cell	cell_line
line	cell_line
,	O
SKW6.4	cell_line
,	O
leads	O
to	O
increased	O
IgM	protein
production	O
.	O
We	O
have	O
previously	O
shown	O
that	O
IL-6	protein
induces	O
activation	O
of	O
JAK1	protein
and	O
JAK2	protein
in	O
human	cell_line
B	cell_line
cell	cell_line
lines	cell_line
.	O
A	O
chimeric	O
IL-6	protein
receptor	protein
,	O
comprised	O
of	O
the	O
intracellular	protein
tail	protein
of	O
the	O
IL-6	protein
receptor	protein
subunit	protein
gp130	protein
fused	O
to	O
the	O
extracellular	protein
domain	protein
of	O
the	O
epidermal	protein
growth	protein
factor	protein
(EGF)	protein
receptor	protein
,	O
was	O
stably	O
transfected	O
into	O
SKW6.4	cell_line
cells	cell_line
.	O
EGF	O
treatment	O
induced	O
IgM	protein
production	O
in	O
cells	O
transfected	O
with	O
an	O
intact	O
gp130	protein
cytoplasmic	protein
tail	protein
,	O
but	O
not	O
in	O
untransfected	cell_line
cells	cell_line
or	O
cells	O
transfected	O
with	O
a	O
cytoplasmic	protein
tail	protein
lacking	O
all	O
four	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(	protein
Stat	protein
)	protein
binding	protein
sites	protein
.	O
Moreover,	O
EGF	O
treatment	O
induced	O
Stat3	protein
phosphorylation	O
in	O
cells	O
transfected	O
with	O
the	O
intact	O
chimeric	protein
EGF-gp130	protein
receptor	protein
along	O
with	O
induction	O
of	O
DNA-mobility	O
shift	O
of	O
a	O
classical	DNA
interferon-gamma-activated	DNA
site	DNA
.	O
To	O
define	O
further	O
the	O
relation	O
between	O
Stat3	protein
activation	O
and	O
enhanced	O
IgM	protein
production	O
,	O
we	O
determined	O
the	O
effect	O
of	O
chimeric	O
gp130	O
on	O
the	O
transcriptional	O
activation	O
of	O
a	O
genetic	O
element	O
linked	O
to	O
immunoglobulin	protein
production	O
,	O
namely	O
the	O
immunoglobulin	DNA
heavy	DNA
chain	DNA
enhancer	DNA
(	O
IgH-enhancer	DNA
).	O
Parental	O
as	O
well	O
as	O
transfected	O
SKW6.4	cell_line
cells	cell_line
were	O
transiently	O
transfected	O
with	O
an	O
IgH-enhancer	DNA
-luciferase	DNA
construct	DNA
.	O
The	O
transcriptional	O
activity	O
of	O
the	O
IgH-luciferase	DNA
construct	DNA
was	O
induced	O
upon	O
ligation	O
of	O
the	O
full-length	protein
chimeric	protein
receptor	protein
but	O
not	O
by	O
truncated	protein
gp130	protein
receptors	protein
.	O
Moreover,	O
the	O
gp130	protein
-induced	O
activity	O
of	O
this	O
reporter	DNA
gene	DNA
was	O
abrogated	O
by	O
Stat3EE	protein
,	O
a	O
mutant	O
Stat3	protein
incapable	O
of	O
binding	O
DNA.	O
These	O
results	O
indicate	O
that	O
IL-6	protein
-induced	O
B-cell	O
differentiation	O
,	O
as	O
measured	O
by	O
IgM	protein
production	O
,	O
may	O
be	O
controlled	O
by	O
Stat3	protein
proteins	protein
.	O

T-lymphocytes	cell_type
from	O
individuals	O
with	O
filarial	O
inflammatory	O
disease	O
have	O
increased	O
transendothelial	O
migration	O
in	O
vitro.	O
The	O
in	O
vitro	O
transendothelial	O
migration	O
of	O
circulating	cell_type
filarial	cell_type
antigen-specific	cell_type
T-cells	cell_type
was	O
examined	O
in	O
Wuchereria	O
banerofti	O
infection	O
.	O
Circulating	cell_type
T-cells	cell_type
from	O
individuals	O
with	O
filaria-induced	O
lymphatic	O
pathology	O
(	O
LP	O
)	O
had	O
significantly	O
greater	O
migration	O
through	O
unstimulated	O
HUVEC	cell_type
monolayers	cell_type
than	O
did	O
T-cells	O
from	O
asymptomatic	O
infected	O
(MF)	O
individuals	O
(P	O
=	O
0.04).	O
In	O
contrast	O
to	O
the	O
MF	O
individuals	O
where	O
no	O
effect	O
was	O
seen,	O
transendothelial	O
migration	O
of	O
48-hr	O
filarial	cell_type
antigen	cell_type
stimulated	cell_type
T-cells	cell_type
from	O
LP	O
individuals	O
was	O
significantly	O
(P	O
=	O
0.01)	O
greater	O
than	O
migration	O
of	O
48-hr	O
media-stimulated	cell_type
T-cells	cell_type
.	O
In	O
six	O
of	O
seven	O
patients	O
examined,	O
inhibition	O
of	O
the	O
VLA-4/	O
VCAM-1	protein
pathway	O
resulted	O
in	O
greater	O
than	O
50%	O
inhibition	O
of	O
transendothelial	O
migration	O
of	O
T-cells	cell_type
.	O

Transcriptional	O
regulation	O
of	O
the	O
ferritin	DNA
heavy-chain	DNA
gene	DNA
:	O
the	O
activity	O
of	O
the	O
CCAAT	protein
binding	protein
factor	protein
NF-Y	protein
is	O
modulated	O
in	O
heme-treated	cell_line
Friend	cell_line
leukemia	cell_line
cells	cell_line
and	O
during	O
monocyte-to-macrophage	O
differentiation	O
.	O
The	O
ferritin	DNA
H-chain	DNA
gene	DNA
promoter	DNA
regulation	O
was	O
analyzed	O
in	O
heme-treated	cell_line
Friend	cell_line
leukemia	cell_line
cells	cell_line
(	O
FLCs	cell_line
)	O
and	O
during	O
monocyte-to-macrophage	O
differentiation	O
.	O
In	O
the	O
majority	O
of	O
cell	cell_line
lines	cell_line
studied,	O
the	O
regulation	O
of	O
ferritin	protein
expression	O
was	O
exerted	O
mostly	O
at	O
the	O
translational	O
level	O
.	O
However,	O
in	O
differentiating	cell_type
erythroid	cell_type
cells	cell_type
,	O
which	O
must	O
incorporate	O
high	O
levels	O
of	O
iron	O
to	O
sustain	O
hemoglobin	protein
synthesis	O
,	O
and	O
in	O
macrophages	cell_type
,	O
which	O
are	O
involved	O
in	O
iron	O
storage,	O
transcriptional	O
regulation	O
seemed	O
to	O
be	O
a	O
relevant	O
mechanism.	O
We	O
show	O
here	O
that	O
the	O
minimum	O
region	O
of	O
the	O
ferritin	DNA
H-gene	DNA
promoter	DNA
that	O
is	O
able	O
to	O
confer	O
transcriptional	O
regulation	O
by	O
heme	O
in	O
FLCs	cell_line
to	O
a	O
reporter	DNA
gene	DNA
is	O
77	DNA
nucleotides	DNA
upstream	DNA
of	O
the	O
TATA	DNA
box	DNA
.	O
This	O
cis	DNA
element	DNA
binds	O
a	O
protein	O
complex	O
referred	O
to	O
as	O
HRF	protein
(	O
heme-responsive	protein
factor	protein
),	O
which	O
is	O
greatly	O
enhanced	O
both	O
in	O
heme-treated	O
FLCs	cell_line
and	O
during	O
monocyte-to-macrophage	O
differentiation	O
.	O
The	O
CCAAT	DNA
element	DNA
present	O
in	O
reverse	O
orientation	O
in	O
this	O
promoter	O
region	O
of	O
the	O
ferritin	DNA
H-chain	DNA
gene	DNA
is	O
necessary	O
for	O
binding	O
and	O
for	O
gene	O
activity,	O
since	O
a	O
single	O
point	O
mutation	O
is	O
able	O
to	O
abolish	O
the	O
binding	O
of	O
HRF	protein
and	O
the	O
transcriptional	O
activity	O
in	O
transfected	cell_line
cells	cell_line
.	O
By	O
competition	O
experiments	O
and	O
supershift	O
assays	O
,	O
we	O
identified	O
the	O
induced	O
HRF	protein
as	O
containing	O
at	O
least	O
the	O
ubiquitous	O
transcription	protein
factor	protein
NF-Y	protein
.	O
NF-Y	protein
is	O
formed	O
by	O
three	O
subunits	protein
,	O
A	protein
,	O
B	protein
,	O
and	O
C	protein
,	O
all	O
of	O
which	O
are	O
necessary	O
for	O
DNA	O
binding.	O
Cotransfection	O
with	O
a	O
transdominant	protein
negative	protein
mutant	protein
of	O
the	O
NF-YA	protein
subunit	protein
abolishes	O
the	O
transcriptional	O
activation	O
by	O
heme	protein
,	O
indicating	O
that	O
NF-Y	protein
plays	O
an	O
essential	O
role	O
in	O
this	O
activation.	O
We	O
have	O
also	O
observed	O
a	O
differential	O
expression	O
of	O
the	O
NF-YA	protein
subunit	protein
in	O
heme-treated	O
and	O
control	O
FLCs	cell_line
and	O
during	O
monocyte-to-macrophage	O
differentiation	O
.	O

Concomitant	O
downregulation	O
of	O
IgH	DNA
3'	DNA
enhancer	DNA
activity	O
and	O
c-myc	DNA
expression	O
in	O
a	O
plasmacytoma	O
x	O
fibroblast	O
environment	O
:	O
implications	O
for	O
dysregulation	O
of	O
translocated	O
c-myc	DNA
.	O
Regulation	O
of	O
immunoglobulin	DNA
heavy	DNA
chain	DNA
(IgH)	DNA
gene	DNA
expression	O
is	O
controlled	O
by	O
a	O
B	DNA
cell-specific	DNA
promoter	DNA
,	O
intronic	DNA
enhancer	DNA
and	O
additional	O
B	DNA
cell-specific	DNA
enhancer	DNA
elements	DNA
identified	O
recently	O
in	O
the	O
3'	O
end	O
of	O
the	O
IgH	DNA
locus	DNA
.	O
One	O
of	O
the	O
latter	O
elements,	O
the	O
IgH	DNA
3'	DNA
enhancer	DNA
,	O
is	O
of	O
particular	O
interest:	O
(1)	O
it	O
is	O
B	O
cell-specific	O
and	O
active	O
only	O
in	O
late	O
B	O
cell	O
development	O
;	O
(2)	O
in	O
rodent	O
plasmacytomas	O
and	O
in	O
some	O
human	O
Burkitt's	O
lymphomas	O
it	O
is	O
part	O
of	O
a	O
locus	DNA
control	DNA
region	DNA
(	O
LCR	DNA
)	O
that	O
is	O
involved	O
in	O
deregulation	O
of	O
the	O
c-myc	DNA
oncogene	DNA
as	O
a	O
result	O
of	O
translocation	O
into	O
the	O
IgH	DNA
locus	DNA
;	O
and	O
(3)	O
it	O
has	O
been	O
implicated	O
in	O
the	O
mechanisms	O
that	O
control	O
Ig	DNA
gene	DNA
class	DNA
switch	O
recombination.	O
We	O
have	O
used	O
a	O
somatic	O
cell	O
hybridization	O
approach	O
to	O
genetically	O
analyse	O
regulation	O
of	O
the	O
activity	O
of	O
the	O
IgH	DNA
3'	DNA
enhancer	DNA
.	O
When	O
mouse	cell_line
MPC11	cell_line
plasmacytoma	cell_line
cells	cell_line
,	O
in	O
which	O
the	O
IgH	DNA
3'	DNA
enhancer	DNA
is	O
active,	O
are	O
fused	O
with	O
fibroblasts	cell_type
,	O
Ig	O
expression	O
is	O
extinguished	O
at	O
the	O
level	O
of	O
transcription.	O
Here	O
we	O
show	O
that	O
in	O
a	O
MPC11	cell_line
plasmacytoma	cell_line
x	cell_line
fibroblast	cell_line
environment	cell_line
,	O
the	O
IgH	DNA
3'	DNA
enhancer	DNA
is	O
transcriptionally	O
inactive.	O
Furthermore,	O
we	O
demonstrate	O
that	O
binding	O
of	O
several	O
B	protein
cell-specific	protein
transcription	protein
factors	protein
,	O
essential	O
for	O
IgH	DNA
3'	DNA
enhancer	DNA
activity	O
,	O
is	O
lacking,	O
which	O
may	O
explain	O
3'	O
enhancer	O
inactivity	O
,	O
although	O
the	O
binding	O
of	O
repressors	O
cannot	O
be	O
excluded.	O
Moreover,	O
the	O
high	O
expression	O
level	O
of	O
c-myc	DNA
,	O
characteristic	O
of	O
the	O
parental	O
MPC11	cell_line
cells	cell_line
carrying	O
the	O
t(12;15)	DNA
translocation	DNA
,	O
is	O
down-regulated	O
in	O
the	O
hybrids	O
to	O
that	O
in	O
unfused	O
fibroblasts	cell_type
.	O
Therefore,	O
inactivation	O
of	O
the	O
IgH	DNA
3'	DNA
enhancer	DNA
is	O
a	O
multifactorial	O
process	O
affecting	O
several	O
transcription	protein
factors	protein
that	O
control	O
the	O
cell-specific	O
and	O
developmental	O
activity	O
of	O
the	O
enhancer	DNA
.	O

Activation	O
of	O
the	O
NF-kappaB	protein
transcription	protein
factor	protein
in	O
a	O
T-lymphocytic	cell_line
cell	cell_line
line	cell_line
by	O
hypochlorous	O
acid	O
.	O
Reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
such	O
as	O
hydrogen	O
peroxide	O
serve	O
as	O
second	O
messengers	O
in	O
the	O
induction	O
of	O
the	O
transcription	protein
factor	protein
NF-kappaB	protein
,	O
and	O
hence	O
in	O
the	O
activation	O
and	O
replication	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
in	O
human	cell_type
cells	cell_type
.	O
During	O
inflammatory	O
reactions	O
,	O
many	O
oxidative	O
species	O
are	O
produced,	O
one	O
of	O
which	O
is	O
hypochlorous	O
acid	O
(	O
HOCl	O
),	O
which	O
is	O
responsible	O
for	O
the	O
microbicidal	O
effects	O
of	O
activated	O
human	cell_type
polymorphonuclear	cell_type
leukocytes	cell_type
.	O
Treatment	O
of	O
a	O
T-lymphocytic	cell_line
cell	cell_line
line	cell_line
with	O
micromolar	O
concentrations	O
of	O
HOCl	O
promoted	O
the	O
appearance	O
of	O
transcription	protein
factor	protein
NF-kappaB	protein
(the	O
heterodimer	protein
p50/p65	protein
)	O
in	O
the	O
nucleus	O
of	O
the	O
cells,	O
even	O
in	O
the	O
absence	O
of	O
de	O
novo	O
protein	O
synthesis	O
.	O
Western	O
blot	O
analysis	O
of	O
the	O
NF-kappaB	protein
inhibitory	protein
subunits	protein
(	O
IkappaB	protein
)	O
demonstrated	O
that	O
both	O
IkappaB	protein
-alpha	O
proteolysis	O
and	O
p105	protein
processing	O
were	O
induced	O
by	O
the	O
treatment.	O
NF-kappaB	protein
activation	O
was	O
very	O
effective	O
when	O
cells	O
were	O
subjected	O
to	O
hyperthermia	O
before	O
being	O
treated	O
with	O
HOCl	O
.	O
Various	O
antioxidants	O
,	O
such	O
as	O
pyrrolidine	O
dithiocarbamate	O
,	O
p-bromophenacyl-bromide	O
and	O
nordihydroguaiaretic	O
acid	O
could	O
strongly	O
reduce	O
NF-kappaB	protein
translocation	O
,	O
demonstrating	O
the	O
importance	O
of	O
oxidative	O
species	O
in	O
the	O
transduction	O
mechanism.	O
Moreover,	O
ACH-2	cell_line
cells	cell_line
treated	O
with	O
HOCl	O
or	O
H2O2	O
released	O
tumour	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
)	O
in	O
the	O
supernatants.	O
The	O
importance	O
of	O
TNF-alpha	protein
release	O
in	O
NF-kappaB	protein
induction	O
by	O
HOCl	O
or	O
H2O2	O
was	O
demonstrated	O
by	O
the	O
fact	O
that:	O
(1)	O
the	O
nuclear	O
appearance	O
of	O
NF-kappaB	protein
was	O
promoted	O
in	O
untreated	cell_line
cells	cell_line
;	O
and	O
(2)	O
synergism	O
between	O
TNF-alpha	protein
and	O
HOCl	O
was	O
detected.	O
Collectively,	O
these	O
results	O
suggest	O
that	O
HOCl	O
should	O
be	O
considered	O
as	O
an	O
oxidative	O
species	O
capable	O
of	O
inducing	O
NF-kappaB	protein
in	O
a	O
T-lymphocytic	cell_line
cell	cell_line
line	cell_line
through	O
a	O
transduction	O
mechanism	O
involving	O
ROS	O
,	O
and	O
having	O
a	O
long-distance	O
effect	O
through	O
subsequent	O
TNF-alpha	protein
release	O
.	O

Rapid	O
Ca2+-mediated	O
activation	O
of	O
Rap1	protein
in	O
human	cell_type
platelets	cell_type
.	O
Rap1	protein
is	O
a	O
small,	O
Ras-like	protein
GTPase	protein
whose	O
function	O
and	O
regulation	O
are	O
still	O
largely	O
unknown.	O
We	O
have	O
developed	O
a	O
novel	O
assay	O
to	O
monitor	O
the	O
active,	O
GTP-bound	protein
form	protein
of	O
Rap1	protein
based	O
on	O
the	O
differential	O
affinity	O
of	O
Rap1GTP	protein
and	O
Rap1GDP	protein
for	O
the	O
Rap	protein
binding	protein
domain	protein
of	O
RalGDS	protein
(	O
RBD	protein
).	O
Stimulation	O
of	O
blood	cell_type
platelets	cell_type
with	O
alpha-thrombin	protein
or	O
other	O
platelet	O
activators	O
caused	O
a	O
rapid	O
and	O
strong	O
induction	O
of	O
Rap1	protein
that	O
associated	O
with	O
RBD	protein
in	O
vitro.	O
Binding	O
to	O
RBD	protein
increased	O
from	O
undetectable	O
levels	O
in	O
resting	cell_type
platelets	cell_type
to	O
&gt;50%	O
of	O
total	O
Rap1	protein
within	O
30	O
s	O
after	O
stimulation.	O
An	O
increase	O
in	O
the	O
intracellular	O
Ca2+	O
concentration	O
is	O
both	O
necessary	O
and	O
sufficient	O
for	O
Rap1	protein
activation	O
since	O
it	O
was	O
induced	O
by	O
agents	O
that	O
increase	O
intracellular	O
Ca2+	O
and	O
inhibited	O
by	O
a	O
Ca2+	O
-chelating	O
agent	O
.	O
Neither	O
inhibition	O
of	O
translocation	O
of	O
Rap1	protein
to	O
the	O
cytoskeleton	O
nor	O
inhibition	O
of	O
platelet	O
aggregation	O
affected	O
thrombin	protein
-induced	O
activation	O
of	O
Rap1	protein
.	O
In	O
contrast,	O
prostaglandin	O
I2	O
(	O
PGI2	O
),	O
a	O
strong	O
negative	O
regulator	O
of	O
platelet	cell_type
function	O
,	O
inhibited	O
agonist-induced	O
as	O
well	O
as	O
Ca2+	O
-induced	O
activation	O
of	O
Rap1	protein
.	O
From	O
our	O
results,	O
we	O
conclude	O
that	O
Rap1	protein
activation	O
in	O
platelets	cell_type
is	O
an	O
important	O
common	O
event	O
in	O
early	O
agonist-induced	O
signalling	O
,	O
and	O
that	O
this	O
activation	O
is	O
mediated	O
by	O
an	O
increased	O
intracellular	O
Ca2+	O
concentration	O

Physical	O
interactions	O
between	O
Ets	O
and	O
NF-kappaB/NFAT	O
proteins	O
play	O
an	O
important	O
role	O
in	O
their	O
cooperative	O
activation	O
of	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
enhancer	DNA
in	O
T	cell_type
cells	cell_type
.	O
The	O
transcriptional	DNA
regulatory	DNA
elements	DNA
of	O
many	O
inducible	DNA
T-cell	DNA
genes	DNA
contain	O
adjacent	O
or	O
overlapping	DNA
binding	DNA
sites	DNA
for	O
the	O
Ets	O
and	O
NF-kappaB/NFAT	O
families	O
of	O
transcription	protein
factors	protein
.	O
Similar	O
arrays	O
of	O
functionally	O
important	O
NF-kappaB/NFAT	O
and	O
Ets	O
binding	O
sites	O
are	O
present	O
in	O
the	O
transcriptional	DNA
enhancers	DNA
of	O
human	O
immunodeficiency	O
viruses	O
types	O
1	O
and	O
2	O
(	O
HIV-1	O
and	O
HIV-2	O
),	O
suggesting	O
that	O
this	O
pattern	O
of	O
nuclear	DNA
protein	DNA
binding	DNA
sites	DNA
reflects	O
an	O
evolutionarily	O
conserved	O
mechanism	O
for	O
regulating	O
inducible	O
T-cell	O
gene	O
expression	O
that	O
has	O
been	O
co-opted	O
during	O
HIV	O
evolution	O
.	O
Despite	O
these	O
findings,	O
the	O
molecular	O
mechanisms	O
by	O
which	O
Ets	O
and	O
NF-kappaB/NFAT	O
proteins	O
cooperatively	O
regulate	O
inducible	O
T-cell	O
gene	O
expression	O
remained	O
unknown.	O
In	O
the	O
studies	O
described	O
in	O
this	O
report,	O
we	O
demonstrated	O
a	O
physical	O
interaction	O
between	O
multiple	O
Ets	O
and	O
NF-kappaB/NFAT	O
proteins	O
both	O
in	O
vitro	O
and	O
in	O
activated	cell_type
normal	cell_type
human	cell_type
T	cell_type
cells	cell_type
.	O
This	O
interaction	O
is	O
mediated	O
by	O
the	O
Ets	DNA
domain	DNA
of	O
Ets	protein
proteins	protein
and	O
the	O
C-terminal	O
region	O
of	O
the	O
Rel	O
homology	O
domains	O
of	O
NF-kappaB/NFAT	protein
proteins	protein
.	O
In	O
addition,	O
the	O
Ets	protein
-	O
NF-kappaB	protein
/	O
NFAT	protein
interaction	O
requires	O
the	O
presence	O
of	O
DNA	DNA
binding	DNA
sites	DNA
for	O
both	O
proteins,	O
as	O
it	O
is	O
abolished	O
by	O
the	O
DNA	O
intercalating	O
agents	O
propidium	O
iodide	O
and	O
ethidium	O
bromide	O
and	O
enhanced	O
by	O
the	O
presence	O
of	O
synthetic	O
oligonucleotides	O
containing	O
binding	DNA
sites	DNA
for	O
Ets	protein
and	O
NF-kappaB	protein
proteins	protein
.	O
A	O
dominant-negative	O
mutant	O
of	O
NF-kappaB	protein
p50	protein
that	O
binds	O
DNA	O
but	O
fails	O
to	O
interact	O
with	O
Ets	protein
proteins	protein
inhibits	O
the	O
synergistic	O
activation	O
of	O
the	O
HIV-1	O
and	O
HIV-2	O
enhancers	O
by	O
NF-kappaB	protein
(	O
p50	protein
+	O
p65	protein
)	O
and	O
Ets-1	protein
,	O
suggesting	O
that	O
physical	O
interaction	O
between	O
Ets	protein
and	O
NF-kappaB	protein
proteins	protein
is	O
required	O
for	O
the	O
transcriptional	O
activity	O
of	O
the	O
HIV-1	O
and	O
HIV-2	O
enhancers	O
.	O
Taken	O
together,	O
these	O
findings	O
suggest	O
that	O
evolutionarily	O
conserved	O
physical	O
interactions	O
between	O
Ets	O
and	O
NF-kappaB/NFAT	O
proteins	O
are	O
important	O
in	O
regulating	O
the	O
inducible	O
expression	O
of	O
T-cell	DNA
genes	DNA
and	O
viruses.	O
These	O
interactions	O
represent	O
a	O
potential	O
target	O
for	O
the	O
development	O
of	O
novel	O
immunosuppressive	O
and	O
antiviral	O
therapies	O
.	O

An	O
acute	DNA
myeloid	DNA
leukemia	DNA
gene	DNA
,	O
AML1	DNA
,	O
regulates	O
transcriptional	O
activation	O
and	O
hemopoietic	O
myeloid	O
cell	O
differentiation	O
antagonistically	O
by	O
two	O
alternative	O
spliced	O
forms.	O
The	O
AML1	DNA
gene	DNA
on	O
chromosome	DNA
21	DNA
is	O
disrupted	O
in	O
the	O
(8;21)(q22;q22)	O
and	O
(3;21)(q26;q22)	O
translocations	O
associated	O
with	O
myelogenous	O
leukemias	O
and	O
encodes	O
a	O
DNA-binding	protein
protein	protein
.	O
From	O
AML1	DNA
gene	DNA
,	O
two	O
representative	O
forms	O
of	O
proteins,	O
AML1a	protein
and	O
AML1b	protein
,	O
are	O
produced	O
by	O
an	O
alternative	O
splicing.	O
Both	O
forms	O
have	O
DNA-binding	protein
domain	protein
,	O
but	O
AML1a	protein
lacks	O
a	O
putative	O
transcriptional	O
activation	O
domain	O
which	O
AML1b	protein
has.	O
Here	O
we	O
demonstrate	O
that	O
AML1a	protein
,	O
which	O
solely	O
has	O
no	O
effects	O
as	O
a	O
transcriptional	O
regulator,	O
dominantly	O
suppresses	O
transcriptional	O
activation	O
by	O
AML1b	protein
,	O
and	O
that	O
AML1a	protein
exhibits	O
the	O
higher	O
affinity	O
for	O
DNA-binding	O
than	O
AML1b	protein
.	O
Furthermore	O
a	O
dominant	protein
negative	protein
form	protein
of	O
AML1	protein
,	O
AML1a	protein
,	O
totally	O
suppressed	O
granulocytic	O
differentiation	O
otherwise	O
induced	O
by	O
granulocyte	protein
colony-stimulating	protein
factor	protein
when	O
AML1a	protein
was	O
overexpressed	O
in	O
32Dc13	cell_type
murine	cell_type
myeloid	cell_type
cells	cell_type
.	O
Such	O
differentiation	O
block	O
by	O
AML1a	protein
was	O
canceled	O
by	O
the	O
concomitant	O
overexpression	O
of	O
AML1b	protein
.	O
These	O
data	O
strongly	O
suggest	O
that	O
a	O
transcriptionally	O
active	O
form	O
of	O
AML1	protein
is	O
essential	O
for	O
the	O
myeloid	O
cell	O
differentiation	O
.	O
In	O
addition,	O
we	O
observed	O
an	O
altered	O
expression	O
level	O
of	O
AML1	protein
along	O
with	O
the	O
myeloid	O
differentiation	O
in	O
several	O
hemopoietic	cell_line
cell	cell_line
lines	cell_line
.	O
In	O
these	O
cases,	O
at	O
least,	O
the	O
AML1	protein
expression	O
level	O
is	O
a	O
potential	O
regulator	O
for	O
myeloid	O
cell	O
differentiation	O
.	O

Nuclear	protein
factor-kappa	protein
B	protein
potently	O
up-regulates	O
the	O
promoter	O
activity	O
of	O
RANTES	protein
,	O
a	O
chemokine	O
that	O
blocks	O
HIV	O
infection.	O
The	O
complex	O
network	O
of	O
cytokines	protein
that	O
are	O
involved	O
in	O
inflammatory	O
and	O
immunoregulatory	O
responses	O
plays	O
a	O
critical	O
role	O
in	O
the	O
pathogenesis	O
of	O
HIV	O
infection	O
.	O
RANTES	protein
(	O
regulated	protein
upon	protein
activation,	protein
normal	protein
T	protein
cell	protein
expressed	protein
and	protein
secreted	protein
)	O
is	O
a	O
cytokine	protein
that	O
belongs	O
to	O
the	O
beta-chemokine	protein
family	protein
;	O
it	O
is	O
chemoattractant	O
for	O
CD4+/CD45RO	cell_type
T	cell_type
cells	cell_type
,	O
it	O
is	O
produced	O
by	O
various	O
cell	O
types	O
including	O
CD8+	O
and	O
CD4+	O
T	O
cells	O
as	O
well	O
as	O
monocytes/macrophages	cell_type
,	O
and	O
has	O
recently	O
been	O
shown	O
to	O
suppress	O
replication	O
of	O
macrophage-tropic	O
strains	O
of	O
HIV	O
in	O
CD4+	cell_type
T	cell_type
cells	cell_type
.	O
To	O
investigate	O
the	O
molecular	O
mechanisms	O
of	O
RANTES	protein
expression	O
,	O
the	O
RANTES	DNA
promoter	DNA
region	DNA
was	O
analyzed	O
by	O
transient	O
expression	O
and	O
gel-mobility	O
shift	O
assays	O
.	O
We	O
demonstrate	O
that:	O
1)	O
RANTES	protein
promoter	O
activity	O
is	O
up-regulated	O
by	O
PMA	O
plus	O
ionomycin	O
,	O
coexpression	O
of	O
the	O
p65	protein
subunit	protein
of	O
nuclear	protein
factor	protein
(NF)-kappa	protein
B	protein
,	O
the	O
proinflammatory	protein
cytokines	protein
TNF-alpha	protein
and	O
IL-1	protein
beta	protein
,	O
and	O
the	O
CD28	protein
costimulatory	O
pathway	O
;	O
2)	O
the	O
RANTES	DNA
promoter	DNA
region	DNA
contains	O
four	O
NF-kappa	DNA
B	DNA
binding	DNA
sites	DNA
at	O
positions	O
-30	O
,	O
-44	O
,	O
-213	O
,	O
and	O
-579	O
relative	O
to	O
the	O
transcription	DNA
start	DNA
site	DNA
;	O
3)	O
one	O
site	O
(-213)	O
is	O
an	O
NF-AT	DNA
(	DNA
nuclear	DNA
factor	DNA
of	DNA
activated	DNA
T	DNA
cells	DNA
)	DNA
binding	DNA
site	DNA
that	O
also	O
has	O
weak	O
affinity	O
to	O
NF-kappa	protein
B	protein
,	O
and	O
the	O
most	O
distal	O
site	O
(-579)	O
also	O
serves	O
as	O
a	O
CD28-responsive	DNA
element	DNA
;	O
and	O
4)	O
mutation	O
on	O
any	O
of	O
those	O
NF-kappa	DNA
B	DNA
sites	DNA
or	O
coexpression	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
(	O
cytoplasmic	protein
inhibitor	protein
of	protein
NF-kappa	protein
B	protein
)	O
markedly	O
reduced	O
the	O
promoter	O
activity	O
.	O
Thus,	O
NF-kappa	protein
B	protein
,	O
a	O
potent	O
transcriptional	O
activator	O
of	O
HIV	O
expression	O
,	O
is	O
also	O
involved	O
in	O
the	O
expression	O
of	O
RANTES	protein
,	O
a	O
chemokine	protein
that	O
blocks	O
infection	O
by	O
macrophage-tropic	O
strains	O
of	O
HIV	O
.	O

Pivotal	O
role	O
for	O
the	O
NFIL3/E4BP4	protein
transcription	protein
factor	protein
in	O
interleukin	protein
3	protein
-mediated	O
survival	O
of	O
pro-B	cell_type
lymphocytes	cell_type
.	O
The	O
E2A-HLF	protein
(hepatic	protein
leukemia	protein
factor)	protein
oncoprotein	protein
,	O
generated	O
in	O
pro-B	cell_type
lymphocytes	cell_type
by	O
fusion	O
of	O
the	O
trans-activation	protein
domain	protein
of	O
E2A	protein
to	O
the	O
basic	protein
region/leucine	protein
zipper	protein
(	protein
bZIP	protein
)	protein
domain	protein
of	O
HLF	protein
,	O
functions	O
as	O
an	O
anti-apoptotic	protein
transcription	protein
factor	protein
in	O
leukemic	O
cell	O
transformation	O
.	O
When	O
introduced	O
into	O
interleukin	protein
3	protein
(	O
IL-3	protein
)-dependent	O
mouse	O
pro-B	cell_type
lymphocytes	cell_type
,	O
E2A-HLF	protein
prevents	O
apoptosis	O
induced	O
by	O
growth	protein
factor	protein
deprivation	O
,	O
suggesting	O
that	O
IL-3	protein
mediates	O
cell	O
survival	O
through	O
activation	O
of	O
a	O
transcription	protein
factor	protein
whose	O
activity	O
can	O
be	O
constitutively	O
replaced	O
by	O
the	O
chimeric	protein
oncoprotein	protein
.	O
We	O
considered	O
four	O
bZIP	protein
transcription	protein
factors	protein
as	O
candidates	O
for	O
this	O
putative	O
IL-3	protein
-regulated	protein
factor	protein
,	O
each	O
of	O
which	O
binds	O
avidly	O
to	O
the	O
DNA	DNA
consensus	DNA
sequence	DNA
recognized	O
by	O
E2A-HLF	protein
and	O
is	O
related	O
to	O
the	O
Caenorhabditis	protein
elegans	protein
CES-2	protein
(	O
cell	protein
death	protein
specification	protein
protein	protein
)	O
neuron-specific	protein
mediator	protein
of	protein
cell	protein
death	protein
.	O
The	O
expression	O
and	O
binding	O
activity	O
of	O
the	O
Nfil3	protein
protein	protein
(also	O
called	O
E4bp4	protein
),	O
but	O
not	O
of	O
Hlf	protein
,	O
Dbp	protein
,	O
or	O
Tef	protein
,	O
was	O
found	O
to	O
be	O
regulated	O
by	O
IL-3	protein
in	O
mouse	cell_line
pro-B	cell_line
cell	cell_line
lines	cell_line
(	O
Baf-3	cell_line
and	O
FL5.12	cell_line
).	O
Northern	O
blot	O
analysis	O
showed	O
that	O
Nfil3/	protein
E4bp4	protein
is	O
regulated	O
as	O
a	O
"delayed-early"	DNA
IL-3	DNA
-responsive	DNA
gene	DNA
,	O
requiring	O
de	O
novo	O
protein	O
synthesis	O
.	O
In	O
the	O
absence	O
of	O
IL-3	protein
,	O
enforced	O
expression	O
of	O
the	O
human	DNA
NFIL3/E4BP4	DNA
cDNA	DNA
promoted	O
the	O
survival	O
but	O
not	O
the	O
growth	O
of	O
IL-3	cell_type
-dependent	cell_type
pro-B	cell_type
cells	cell_type
.	O
Our	O
results	O
implicate	O
NFIL3/E4BP4	protein
(	O
nuclear	protein
factor	protein
regulated	protein
by	protein
IL-3	protein
/adenovirus	protein
E4	protein
promoter	protein
binding	protein
protein	protein
)	O
in	O
a	O
distinct	O
growth	O
factor-regulated	O
signaling	O
pathway	O
that	O
is	O
responsible	O
for	O
the	O
survival	O
of	O
early	cell_type
B-cell	cell_type
progenitors	cell_type
,	O
and	O
whose	O
alteration	O
by	O
E2A-HLF	protein
leads	O
to	O
childhood	O
B	O
lineage	O
leukemia	O
.	O

Detection	O
of	O
adenovirus	O
DNA	O
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
by	O
polymerase	O
chain	O
reaction	O
assay	O
.	O
Adenovirus	O
can	O
establish	O
persistent	O
infections	O
which	O
may	O
reactivate	O
and	O
cause	O
disease	O
in	O
immunocompromised	O
hosts	O
.	O
Lymphocytes	cell_type
have	O
been	O
postulated	O
to	O
serve	O
as	O
a	O
site	O
of	O
adenoviral	O
persistence	O
based	O
upon	O
the	O
ability	O
to	O
isolate	O
adenovirus	O
from	O
tonsils	O
and	O
to	O
detect	O
adenovirus	O
DNA	O
by	O
Southern	O
blot	O
hybridization	O
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
).	O
To	O
test	O
this	O
hypothesis,	O
a	O
more	O
sensitive	O
and	O
specific	O
polymerase	O
chain	O
reaction	O
(PCR)	O
assay	O
was	O
developed	O
to	O
detect	O
adenovirus	O
DNA	O
.	O
Two	O
sets	O
of	O
nested	O
primers	O
were	O
designed	O
to	O
conserved	O
sequences	O
in	O
the	O
adenovirus	O
E1A	O
and	O
hexon	O
genes	O
.	O
The	O
E1A	O
and	O
hexon	O
primers	O
amplified	O
DNA	O
from	O
representative	O
adenoviral	O
serotypes	O
in	O
all	O
six	O
adenoviral	O
groups	O
(	O
A-F	O
).	O
Both	O
primers	O
detected	O
a	O
single	O
copy	O
of	O
the	O
adenovirus	DNA
type	DNA
2	DNA
genome	DNA
but	O
were	O
less	O
sensitive	O
for	O
the	O
group	O
B	O
type	O
35	O
.	O
None	O
of	O
33	O
PBMC	cell_type
specimens	cell_type
from	O
healthy	O
adults	O
and	O
only	O
one	O
of	O
40	O
pediatric	O
samples	O
was	O
positive	O
(at	O
a	O
low	O
level)	O
for	O
adenovirus	O
DNA	O
by	O
nested	O
PCR	O
assay	O
.	O
In	O
comparison,	O
PBMC	cell_type
from	O
two	O
children	O
with	O
fatal	O
adenoviral	O
infection	O
were	O
both	O
strongly	O
positive	O
for	O
adenovirus	O
DNA	O
.	O
It	O
is	O
concluded	O
that,	O
in	O
contrast	O
to	O
a	O
previous	O
study,	O
PBMC	cell_type
are	O
not	O
a	O
common	O
site	O
of	O
persistent	O
group	O
C	O
adenoviral	O
infection	O
.	O
In	O
addition,	O
assay	O
of	O
PBMC	cell_type
by	O
the	O
adenovirus	O
-specific	O
PCR	O
may	O
help	O
detect	O
early	O
invasive	O
disease	O
and	O
warrants	O
further	O
evaluation.	O

Common	O
and	O
distinct	O
intracellular	O
signaling	O
pathways	O
in	O
human	cell_type
neutrophils	cell_type
utilized	O
by	O
platelet	protein
activating	protein
factor	protein
and	O
FMLP	protein
.	O
Stimulation	O
of	O
human	cell_type
neutrophils	cell_type
with	O
chemoattractants	protein
FMLP	protein
or	O
platelet	protein
activating	protein
factor	protein
(	O
PAF	protein
)	O
results	O
in	O
different	O
but	O
overlapping	O
functional	O
responses	O
.	O
We	O
questioned	O
whether	O
these	O
differences	O
might	O
reflect	O
patterns	O
of	O
intracellular	O
signal	O
transduction	O
.	O
Stimulation	O
with	O
either	O
PAF	protein
or	O
FMLP	protein
resulted	O
in	O
equivalent	O
phosphorylation	O
and	O
activation	O
of	O
the	O
mitogen-activated	protein
protein	protein
kinase	protein
(	protein
MAPk	protein
)	protein
homologue	protein
38-kD	protein
murine	protein
MAP	protein
kinase	protein
homologous	O
to	O
HOG-1	protein
(p38)	protein
MAPk	protein
.	O
Neither	O
FMLP	protein
nor	O
PAF	protein
activated	O
c-jun	protein
NH2-terminal	protein
MAPk	protein
(	O
JNKs	protein
).	O
Under	O
identical	O
conditions,	O
FMLP	protein
but	O
not	O
PAF	protein
,	O
resulted	O
in	O
significant	O
p42/44	protein
(ERK)	protein
MAPk	protein
activation	O
.	O
Both	O
FMLP	protein
and	O
PAF	protein
activated	protein
MAP	protein
kinase	protein
kinase-3	protein
(	O
MKK3	protein
),	O
a	O
known	O
activator	O
of	O
p38	protein
MAPk	protein
.	O
Both	O
MAP	protein
ERK	protein
kinase	protein
kinase-1	protein
(	O
MEKK1	protein
)	O
and	O
Raf	protein
are	O
activated	O
strongly	O
by	O
FMLP	protein
,	O
but	O
minimally	O
by	O
PAF	protein
.	O
Pertussis	protein
toxin	protein
blocked	O
FMLP	protein
-induced	O
activation	O
of	O
the	O
p42/44	protein
(ERK)	protein
MAPk	protein
cascade	O
,	O
but	O
not	O
that	O
of	O
p38	protein
MAPk	protein
.	O
A	O
specific	O
p38	protein
MAPk	protein
inhibitor	O
(	O
SK&amp;F	O
86002	O
)	O
blocked	O
superoxide	O
anion	O
production	O
in	O
response	O
to	O
FMLP	protein
and	O
reduced	O
adhesion	O
and	O
chemotaxis	O
in	O
response	O
to	O
PAF	protein
or	O
FMLP	protein
.	O
These	O
results	O
demonstrate	O
distinct	O
patterns	O
of	O
intracellular	O
signaling	O
for	O
two	O
chemoattractants	protein
and	O
suggest	O
that	O
selective	O
activation	O
of	O
intracellular	O
signaling	O
cascades	O
may	O
underlie	O
different	O
patterns	O
of	O
functional	O
responses	O
.	O

Cloning	O
of	O
the	O
novel	protein
human	protein
myeloid-cell-specific	protein
C/EBP-epsilon	protein
transcription	protein
factor	protein
.	O
Chicken	protein
NF-M	protein
transcription	protein
factor	protein
,	O
in	O
cooperation	O
with	O
either	O
c-Myb	protein
or	O
v-Myb	protein
,	O
is	O
active	O
in	O
the	O
combinatorial	O
activation	O
of	O
myeloid-cell-specific	DNA
genes	DNA
in	O
heterologous	cell_type
cell	cell_type
types	cell_type
,	O
such	O
as	O
embryonic	cell_type
fibroblasts	cell_type
.	O
In	O
humans	O
,	O
similar	O
effects	O
were	O
observed	O
with	O
homologous	O
members	O
of	O
the	O
CCAAT/enhancer-binding	protein
protein	protein
(C/EBP)	protein
family	protein
of	O
transcriptional	protein
regulators	protein
,	O
especially	O
the	O
human	O
homolog	O
of	O
chicken	protein
NF-M	protein
,	O
C/EBP-beta	protein
(	O
NF-IL6	protein
).	O
However,	O
the	O
NF-IL6	DNA
gene	DNA
is	O
expressed	O
in	O
a	O
variety	O
of	O
nonmyeloid	O
cell	O
types	O
and	O
is	O
strongly	O
inducible	O
in	O
response	O
to	O
inflammatory	O
stimuli	O
,	O
making	O
it	O
an	O
unlikely	O
candidate	O
to	O
have	O
an	O
exclusive	O
role	O
as	O
a	O
combinatorial	O
differentiation	O
switch	O
during	O
myelopoiesis	O
in	O
human	cell_type
cells	cell_type
.	O
By	O
using	O
a	O
reverse	O
transcription-PCR-based	O
approach	O
and	O
a	O
set	O
of	O
primers	O
specific	O
for	O
the	O
DNA-binding	DNA
domains	DNA
of	O
highly	O
homologous	O
members	O
of	O
the	O
C/EBP	protein
family	protein
of	O
transcriptional	protein
regulators	protein
,	O
we	O
have	O
cloned	O
a	O
novel	DNA
human	DNA
gene	DNA
encoding	O
a	O
member	O
of	O
the	O
C/EBP	DNA
gene	DNA
family	DNA
,	O
identified	O
as	O
the	O
human	O
homolog	O
of	O
CRP1	protein
,	O
C/EBP-epsilon	protein
.	O
A	O
1.2-kb	DNA
cDNA	DNA
encoding	O
full-length	O
human	DNA
C/EBP-epsilon	DNA
was	O
cloned	O
from	O
a	O
promyelocyte-late	DNA
myeloblast-derived	DNA
lambda	DNA
gt11	DNA
library	DNA
.	O
Molecular	O
analysis	O
of	O
the	O
cDNA	O
and	O
genomic	O
clones	O
indicated	O
the	O
presence	O
of	O
two	O
exons	DNA
encoding	O
a	O
protein	O
with	O
an	O
apparent	O
molecular	O
mass	O
of	O
32	O
kDa	O
and	O
a	O
pI	O
of	O
9.5.	O
Primer	O
extension	O
analysis	O
of	O
C/EBP-epsilon	RNA
mRNA	RNA
detected	O
a	O
single	O
major	O
transcription	DNA
start	DNA
site	DNA
approximately	O
200	O
bp	O
upstream	O
of	O
the	O
start	DNA
codon	DNA
.	O
The	O
putative	O
promoter	O
area	O
is	O
similar	O
to	O
those	O
of	O
several	O
other	O
myeloid-cell-specific	O
genes	O
in	O
that	O
it	O
contains	O
no	O
TATAAA	DNA
box	DNA
but	O
has	O
a	O
number	O
of	O
purine-rich	DNA
stretches	DNA
with	O
multiple	O
sites	O
for	O
the	O
factors	O
of	O
the	O
Ets	protein
family	protein
of	O
transcriptional	protein
regulators	protein
.	O
Northern	O
blot	O
analyses	O
indicated	O
a	O
highly	O
restricted	O
mRNA	O
expression	O
pattern	O
,	O
with	O
the	O
strongest	O
expression	O
occurring	O
in	O
promyelocyte	O
and	O
late-myeloblast-like	O
cell	O
lines	O
.	O
Western	O
blot	O
and	O
immunoprecipitation	O
studies	O
using	O
rabbit	protein
anti-C/EBP-epsilon	protein
antibodies	protein
raised	O
against	O
the	O
N-terminal	protein
portion	protein
of	O
C/EBP-epsilon	protein
(	O
amino	protein
acids	protein
1	protein
to	protein
115	protein
)	O
showed	O
that	O
C/EBP-epsilon	protein
is	O
a	O
32-kDa	protein
nuclear	protein
phosphoprotein	protein
.	O
The	O
human	O
C/EBP-epsilon	protein
protein	O
exhibited	O
strong	O
and	O
specific	O
binding	O
to	O
double-stranded	DNA
DNA	DNA
containing	DNA
consensus	DNA
C/EBP	DNA
sites	DNA
.	O
Cotransfection	O
of	O
the	O
C/EBP-epsilon	protein
sense	O
and	O
antisense	O
expression	O
constructs	O
together	O
with	O
chloramphenicol	DNA
acetyltransferase	DNA
reporter	DNA
vectors	DNA
containing	O
myeloid-cell-specific	O
c-mim	O
and	O
human	O
myeloperoxidase	O
promoters	O
suggested	O
a	O
role	O
for	O
C/EBP-epsilon	protein
transcription	protein
factor	protein
in	O
the	O
regulation	O
of	O
a	O
subset	O
of	O
myeloid-cell-specific	DNA
genes	DNA
.	O
Transient	O
tranfection	O
of	O
a	O
promyelocyte	cell_line
cell	cell_line
line	cell_line
(	O
NB4	cell_line
)	O
with	O
a	O
C/EBP-epsilon	DNA
expression	DNA
plasmid	DNA
increased	O
cell	O
growth	O
by	O
sevenfold,	O
while	O
antisense	O
C/EBP-epsilon	protein
caused	O
a	O
fivefold	O
decrease	O
in	O
clonal	O
growth	O
of	O
these	O
cells.	O

The	O
tumour	protein
associated	protein
cell	protein
surface	protein
antigen	protein
A6H	protein
is	O
costimulatory	O
for	O
human	O
CD4+	O
but	O
not	O
CD8+	O
T	O
cells	O
.	O
The	O
A6H	protein
monoclonal	protein
antibody	protein
(mAb)	O
recognizes	O
a	O
120,000-140,000	protein
MW	protein
antigen	protein
that	O
is	O
expressed	O
at	O
similar	O
densities	O
on	O
85-90%	O
of	O
human	O
CD4+	O
and	O
CD8+	O
T	O
cells	O
and	O
on	O
renal	O
cell	O
carcinomas.	O
The	O
binding	O
of	O
the	O
A6H	protein
mAb	protein
induced	O
a	O
costimulatory	O
signal	O
in	O
anti-CD3	cell_line
activated	cell_line
T	cell_line
cells	cell_line
.	O
In	O
the	O
present	O
report,	O
we	O
show	O
that	O
A6H	protein
costimulated	O
cell	O
proliferation	O
and	O
cytokine	protein
production	O
in	O
purified	O
CD4+	cell_type
T	cell_type
cells	cell_type
.	O
Unexpectedly,	O
the	O
CD8+	cell_type
T-cell	cell_type
subpopulation	cell_type
failed	O
to	O
respond.	O
CD4+	cell_type
T	cell_type
cells	cell_type
costimulated	O
with	O
the	O
A6H	protein
mAb	protein
upregulated	O
CD80	protein
,	O
CD86	protein
,	O
CD71	protein
,	O
interleukin-2	protein
(IL-2)R	protein
alpha	protein
,	O
IL-2R	protein
beta	protein
and	O
IL-2R	protein
gamma	protein
,	O
while	O
no	O
corresponding	O
up-regulation	O
of	O
these	O
cell	protein
surface	protein
molecules	protein
was	O
seen	O
in	O
CD8+	cell_type
T	cell_type
cells	cell_type
.	O
In	O
order	O
to	O
investigate	O
the	O
nature	O
of	O
the	O
A6H	protein
mAb	protein
costimulus	O
at	O
the	O
transcriptional	O
level	O
we	O
have	O
examined	O
induction	O
of	O
the	O
transcription	protein
factors	protein
OCT-1	protein
,	O
AP-1	protein
and	O
NF-kappa	protein
B	protein
which	O
are	O
known	O
to	O
be	O
transcriptional	protein
regulators	protein
of	O
several	O
cytokine	protein
and	O
cytokine	protein
receptor	O
genes,	O
including	O
the	O
IL-2	O
and	O
IL-2R	O
genes	O
.	O
Co-ligation	O
of	O
the	O
A6H	protein
antigen	O
and	O
the	O
CD3	protein
complex	protein
induced	O
expression	O
of	O
the	O
transcription	protein
factor	protein
AP-1	protein
in	O
CD4+	cell_type
T	cell_type
cells	cell_type
,	O
whereas	O
no	O
increase	O
in	O
NF-kappa	protein
B	protein
and	O
octamer-binding	protein
(Oct)	protein
proteins	protein
was	O
seen	O
compared	O
to	O
T	cell_type
cells	cell_type
stimulated	O
with	O
anti-CD3	protein
alone.	O
Furthermore,	O
no	O
induction	O
of	O
AP-1	protein
was	O
seen	O
in	O
A6H	protein
costimulated	O
CD8+	cell_type
T	cell_type
cells	cell_type
.	O
These	O
results	O
suggests	O
that	O
both	O
proximal	O
steps	O
in	O
CD8+	O
T-cell	O
activation	O
as	O
well	O
as	O
the	O
later	O
phases	O
are	O
unresponsive	O
to	O
A6H	protein
ligation	O
.	O
Molecular	O
differences	O
of	O
the	O
A6H	protein
molecule	protein
or	O
distinct	O
regulation	O
of	O
the	O
A6H	protein
transduced	O
AP-1	protein
activation	O
pathway	O
may	O
exist	O
in	O
CD4+	O
and	O
CD8+	O
T	O
cell	O
subpopulations	O
.	O

Cloning	O
and	O
expression	O
of	O
the	O
glucocorticoid	protein
receptor	protein
from	O
the	O
squirrel	O
monkey	O
(	O
Saimiri	O
boliviensis	O
boliviensis	O
),	O
a	O
glucocorticoid-resistant	O
primate.	O
New	O
World	O
primates	O
such	O
as	O
the	O
squirrel	O
monkey	O
have	O
elevated	O
cortisol	O
levels	O
and	O
glucocorticoid	O
resistance	O
.	O
We	O
have	O
shown	O
that	O
the	O
apparent	O
binding	O
affinity	O
of	O
the	O
glucocorticoid	protein
receptor	protein
in	O
squirrel	cell_type
monkey	cell_type
lymphocytes	cell_type
is	O
5-fold	O
lower	O
than	O
that	O
in	O
human	cell_type
lymphocytes	cell_type
(apparent	O
Kd,	O
20.9	O
+/-	O
1.8	O
and	O
4.3	O
+/-	O
0.2	O
nmol/L,	O
respectively;	O
n	O
=	O
3),	O
consistent	O
with	O
previous	O
studies	O
in	O
mononuclear	cell_type
leukocytes	cell_type
isolated	O
from	O
the	O
two	O
species.	O
As	O
a	O
first	O
step	O
in	O
understanding	O
the	O
mechanism	O
of	O
decreased	O
binding	O
affinity	O
in	O
New	O
World	O
primates	O
,	O
we	O
used	O
reverse	O
transcription-PCR	O
to	O
clone	O
the	O
glucocorticoid	protein
receptor	protein
from	O
squirrel	O
monkey	O
liver	O
and	O
have	O
compared	O
the	O
sequence	O
to	O
receptor	O
sequences	O
obtained	O
from	O
owl	O
monkey	O
liver	O
,	O
cotton-top	cell_line
tamarin	cell_line
B95-8	cell_line
cells	cell_line
,	O
and	O
human	cell_type
lymphocytes	cell_type
.	O
The	O
squirrel	O
monkey	O
glucocorticoid	protein
receptor	protein
is	O
approximately	O
97%	O
identical	O
in	O
nucleotide	O
and	O
amino	O
acid	O
sequence	O
to	O
the	O
human	protein
receptor	protein
.	O
The	O
ligand-binding	protein
domain	protein
(	O
amino	protein
acids	protein
528-777	protein
)	O
of	O
the	O
squirrel	O
monkey	O
glucocorticoid	protein
receptor	protein
contains	O
four	O
amino	O
acid	O
differences	O
(	O
Ser551	O
to	O
Thr	O
,	O
Ser616	O
to	O
Ala	O
,	O
Ala618	O
to	O
Ser	O
,	O
and	O
Ile761	O
to	O
Leu	O
),	O
all	O
of	O
which	O
are	O
present	O
in	O
owl	O
monkey	O
and	O
cotton-top	O
tamarin	O
receptors	O
.	O
The	O
DNA-binding	protein
domain	protein
(	O
amino	protein
acids	protein
421-486	protein
)	O
is	O
completely	O
conserved	O
among	O
human	O
,	O
squirrel	O
monkey	O
,	O
owl	O
monkey	O
,	O
and	O
cotton-top	O
tamarin	O
receptors	O
.	O
Twenty-two	O
differences	O
from	O
the	O
human	O
sequence	O
were	O
found	O
in	O
the	O
N-terminal	protein
region	protein
(	O
amino	protein
acids	protein
1-421	protein
)	O
of	O
the	O
squirrel	O
monkey	O
receptor.	O
None	O
of	O
the	O
substitutions	O
in	O
the	O
ligand-binding	protein
domain	protein
matched	O
mutations	O
known	O
to	O
influence	O
binding	O
affinity	O
in	O
other	O
species.	O
To	O
determine	O
whether	O
the	O
substitutions	O
per	O
se	O
were	O
responsible	O
for	O
decreased	O
affinity,	O
squirrel	O
monkey	O
and	O
human	protein
glucocorticoid	protein
receptors	protein
were	O
expressed	O
in	O
the	O
TNT	O
Coupled	O
Reticulocyte	O
Lysate	O
System	O
.	O
Expressions	O
of	O
human	O
and	O
squirrel	O
monkey	O
glucocorticoid	protein
receptors	protein
and	O
a	O
squirrel	protein
monkey	protein
receptor	protein
in	O
which	O
Phe774	O
was	O
mutated	O
to	O
Leu	O
(	O
F774L	O
)	O
were	O
similar.	O
When	O
expressed	O
in	O
the	O
TNT	O
System	O
,	O
squirrel	O
monkey	O
and	O
human	protein
glucocorticoid	protein
receptors	protein
had	O
similar,	O
high	O
affinity	O
binding	O
for	O
dexamethasone	O
(apparent	O
Kd,	O
5.9	O
+/-	O
1.2	O
and	O
4.3	O
+/-	O
0.5	O
nmol/L,	O
respectively;	O
n	O
=	O
3),	O
whereas	O
the	O
squirrel	protein
monkey	protein
F774L	protein
receptor	protein
had	O
lower	O
affinity	O
binding	O
(apparent	O
Kd,	O
20.4	O
+/-	O
2.0	O
nmol/L;	O
n	O
=	O
3).	O
Thus,	O
substitutions	O
within	O
the	O
ligand-binding	protein
domain	protein
of	O
the	O
squirrel	O
monkey	O
glucocorticoid	protein
receptor	protein
cannot	O
account	O
for	O
the	O
decreased	O
binding	O
affinity	O
of	O
these	O
receptors	O
in	O
squirrel	cell_type
monkey	cell_type
cells	cell_type
.	O
Rather,	O
the	O
binding	O
affinity	O
is	O
probably	O
influenced	O
by	O
the	O
expression	O
of	O
cytosolic	protein
factors	protein
that	O
affect	O
glucocorticoid	protein
receptor	protein
function	O
.	O

Shared	O
gamma(c)	protein
subunit	protein
within	O
the	O
human	protein
interleukin-7	protein
receptor	protein
complex	protein
.	O
A	O
molecular	O
basis	O
for	O
the	O
pathogenesis	O
of	O
X-linked	O
severe	O
combined	O
immunodeficiency	O
.	O
Genetic	O
evidence	O
suggests	O
that	O
mutations	O
in	O
the	O
gamma(c)	protein
receptor	protein
subunit	protein
cause	O
X-linked	O
severe	O
combined	O
immunodeficiency	O
(	O
X-SCID	O
).	O
The	O
gamma(c)	protein
subunit	protein
can	O
be	O
employed	O
in	O
receptor	protein
complexes	protein
for	O
IL	O
-2	O
,	O
-4	O
,	O
-7	O
,	O
-9	O
,	O
and	O
-15	O
,	O
and	O
the	O
multiple	O
signaling	O
defects	O
that	O
would	O
result	O
from	O
a	O
defective	O
gamma(c)	protein
chain	protein
in	O
these	O
receptors	O
are	O
proposed	O
to	O
cause	O
the	O
severe	O
phenotype	O
of	O
X-SCID	O
patients	O
.	O
Interestingly,	O
gene	O
disruption	O
of	O
either	O
IL-7	protein
or	O
the	O
IL-7	protein
receptor	protein
(IL-7R)	protein
alpha	protein
subunit	protein
in	O
mice	O
leads	O
to	O
immunological	O
defects	O
that	O
are	O
similar	O
to	O
human	O
X-SCID	O
.	O
These	O
observations	O
suggest	O
the	O
functional	O
importance	O
of	O
gamma(c)	protein
in	O
the	O
IL-7R	protein
complex	protein
.	O
In	O
the	O
present	O
study,	O
structure/function	O
analyses	O
of	O
the	O
IL-7R	protein
complex	protein
using	O
a	O
chimeric	protein
receptor	protein
system	O
demonstrated	O
that	O
gamma(c)	protein
is	O
indeed	O
critical	O
for	O
IL-7R	protein
function	O
.	O
Nonetheless,	O
only	O
a	O
limited	O
portion	O
of	O
the	O
cytoplasmic	protein
domain	protein
of	O
gamma(c)	protein
is	O
necessary	O
for	O
IL-7R	protein
signal	O
transduction	O
.	O
Furthermore,	O
replacement	O
of	O
the	O
gamma(c)	protein
cytoplasmic	protein
domain	protein
by	O
a	O
severely	protein
truncated	protein
erythropoeitin	protein
receptor	protein
does	O
not	O
affect	O
measured	O
IL-7R	protein
signaling	O
events	O
.	O
These	O
findings	O
support	O
a	O
model	O
in	O
which	O
gamma(c)	protein
serves	O
primarily	O
to	O
activate	O
signal	O
transduction	O
by	O
the	O
IL-7R	protein
complex	protein
,	O
while	O
IL-7R	protein
alpha	protein
determines	O
specific	O
signaling	O
events	O
through	O
its	O
association	O
with	O
cytoplasmic	protein
signaling	protein
molecules	protein
.	O
Finally,	O
these	O
studies	O
are	O
consistent	O
with	O
the	O
hypothesis	O
that	O
the	O
molecular	O
pathogenesis	O
of	O
X-SCID	O
is	O
due	O
primarily	O
to	O
gamma(c)	protein
-mediated	O
defects	O
in	O
the	O
IL-7	protein
/IL-7R	protein
system	O

S-allyl	O
cysteine	O
inhibits	O
activation	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
in	O
human	cell_type
T	cell_type
cells	cell_type
.	O
Reactive	O
oxygen	O
species	O
are	O
involved	O
in	O
signal	O
transduction	O
pathways	O
leading	O
to	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
activation	O
which	O
has	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
gene	O
transcription	O
.	O
We	O
recently	O
reported	O
that	O
a	O
garlic	O
compound,	O
S-allyl	O
cysteine	O
(	O
SAC	O
),	O
protects	O
bovine	cell_type
pulmonary	cell_type
artery	cell_type
endothelial	cell_type
cells	cell_type
from	O
oxidant	O
injury	O
induced	O
by	O
hydrogen	O
peroxide	O
(	O
H2O2	O
).	O
In	O
this	O
study	O
we	O
determined	O
the	O
effects	O
of	O
SAC	O
on	O
NF-kappa	protein
B	protein
activation	O
in	O
human	cell_type
T	cell_type
lymphocytes	cell_type
(	O
Jurkat	cell_line
cells	cell_line
)	O
induced	O
by	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF-	protein
alpha	protein
)	O
and	O
H2O2	O
.	O
Activated	O
NF-kappa	protein
B	protein
in	O
nuclear	O
extracts	O
was	O
measured	O
by	O
an	O
electrophoretic	O
mobility	O
shift	O
assay	O
using	O
32P-labeled	DNA
probe	DNA
.	O
SAC	O
consistently	O
exhibited	O
a	O
dose-dependent	O
inhibition	O
of	O
NF-kappa	protein
B	protein
activation	O
induced	O
by	O
both	O
TNF-alpha	protein
and	O
H2O2	O
.	O
Supershift	O
with	O
specific	O
antibodies	O
to	O
NF-kappa	protein
B	protein
subunits	protein
confirmed	O
that	O
the	O
inducible	O
retarded	O
bands	O
observed	O
in	O
the	O
EMSA	O
and	O
p65-p50	protein
heterodimer	protein
of	O
the	O
NF-kappa	protein
B	protein
/Rel	protein
protein	protein
.	O
Our	O
data	O
suggest	O
that	O
SAC	O
may	O
act	O
via	O
antioxidant	O
mechanisms	O
to	O
block	O
NF-kappa	protein
B	protein
activation	O
in	O
Jurkat	cell_line
cells	cell_line
.	O

Elf-2	protein
,	O
a	O
rhombotin-2	protein
binding	protein
ets	protein
transcription	protein
factor	protein
:	O
discovery	O
and	O
potential	O
role	O
in	O
T	O
cell	O
leukemia	O
.	O
Rhombotin-2	DNA
(	O
RBTN-2	DNA
)	O
is	O
a	O
proto-oncogene	DNA
only	O
in	O
the	O
context	O
of	O
T	cell_type
lymphocytes	cell_type
.	O
We	O
postulated	O
that	O
the	O
oncogenic	O
effect	O
of	O
RBTN-2	protein
in	O
T	O
cells	O
is	O
likely	O
mediated	O
by	O
binding	protein
protein	protein
(s)	O
with	O
T	O
cell-specific	O
expression	O
.	O
By	O
screening	O
a	O
T	O
cell	O
cDNA	DNA
library	DNA
,	O
we	O
identified	O
a	O
novel	protein
ets	protein
transcription	protein
factor	protein
that	O
binds	O
RBTN-2	protein
.	O
This	O
protein	O
was	O
named	O
elf-2	protein
because	O
its	O
DNA-binding	protein
domain	protein
is	O
virtually	O
identical	O
to	O
that	O
of	O
ets	protein
family	protein
member	protein
elf-1	protein
.	O
Northern	O
analyses	O
showed	O
similar	O
levels	O
of	O
two	O
elf-2	RNA
transcripts	RNA
(3.5	O
kb	O
and	O
3.8	O
kb)	O
in	O
all	O
tissues	O
except	O
thymus.	O
Thymocytes	cell_type
expressed	O
four-	O
to	O
10-fold	O
greater	O
amounts	O
of	O
the	O
3.5	RNA
kb	RNA
transcript	RNA
than	O
other	O
tissues.	O
Sequence	O
analyses	O
of	O
cDNA	DNA
clones	DNA
indicated	O
that	O
these	O
transcripts	O
encode	O
proteins	O
differing	O
only	O
at	O
their	O
amino	protein
termini	protein
,	O
and	O
likely	O
represent	O
alternatively	O
spliced	O
isoforms.	O
These	O
isoforms	O
(	O
elf-2a	protein
and	O
elf-2b	protein
)	O
contain	O
identical	O
RBTN-2	protein
binding	protein
regions	protein
and	O
DNA-binding	protein
domains	protein
.	O
Elf-2b	protein
lacks	O
a	O
putative	protein
transactivation	protein
domain	protein
.	O
The	O
expression	O
patterns	O
suggest	O
that	O
RBTN-2	protein
normally	O
interacts	O
equally	O
with	O
elf-2a	protein
and	O
elf-2b	protein
.	O
In	O
contrast,	O
when	O
RBTN-2	protein
is	O
inappropriately	O
expressed	O
in	O
T	cell_type
cells	cell_type
,	O
RBTN-2	protein
would	O
interact	O
predominantly	O
with	O
elf-2b	protein
;	O
this	O
interaction	O
may	O
lead	O
to	O
T	O
cell	O
proliferation	O
.	O

Transcription	protein
factor	protein
effects	O
on	O
chromosome	O
constitution	O
of	O
cell	cell_line
hybrids	cell_line
.	O
When	O
immunoglobulin	cell_line
(Ig)-secreting	cell_line
plasmacytomas	cell_line
are	O
fused	O
to	O
a	O
T-cell	cell_type
lymphoma	cell_type
,	O
Ig	DNA
gene	DNA
expression	O
ceases	O
in	O
greater	O
than	O
95%	O
of	O
the	O
resulting	O
hybrids.	O
In	O
the	O
rare	O
hybrids	O
that	O
continue	O
to	O
express	O
Ig,	O
all	O
other	O
tested	O
B	DNA
lymphocyte-specific	DNA
genes	DNA
also	O
remain	O
active.	O
The	O
low	O
frequency	O
with	O
which	O
these	O
Ig-expressing	cell_line
hybrids	cell_line
are	O
recovered,	O
along	O
with	O
the	O
fact	O
that	O
cell	O
fusions	O
can	O
lead	O
to	O
chromosome	O
loss,	O
led	O
us	O
to	O
propose	O
that	O
this	O
rare	O
phenotype	O
was	O
due	O
to	O
loss	O
of	O
a	O
T-cell-derived	protein
chromosome	protein
encoding	protein
a	protein
factor	protein
or	O
factors	O
with	O
gene	O
silencing	O
activity	O
.	O
To	O
identify	O
the	O
relevant	O
chromosome,	O
we	O
have	O
used	O
a	O
polymerase	O
chain	O
reaction	O
(PCR)-assisted	O
method	O
of	O
chromosome	O
mapping	O
to	O
analyze	O
both	O
Ig-silenced	O
(common)	O
and	O
Ig-expressing	O
(rare)	O
hybrids	O
.	O
Although	O
no	O
single	O
chromosome	O
was	O
found	O
to	O
correlate	O
with	O
Ig	DNA
gene	DNA
silencing	O
,	O
we	O
discovered	O
that	O
the	O
two	O
types	O
of	O
hybrids	O
had	O
undergone	O
distinct	O
patterns	O
of	O
chromosome	O
loss.	O
Moreover,	O
we	O
found	O
that	O
ectopic	O
expression	O
of	O
a	O
B-cell-specific	protein
transcription	protein
factor	protein
(	O
Oct-2	protein
)	O
dramatically	O
altered	O
both	O
the	O
phenotype	O
and	O
chromosome	O
constitution	O
of	O
hybrids	O
arising	O
in	O
these	O
cell	O
fusions	O
.	O

Reactivation	O
of	O
Kaposi's	O
sarcoma	O
-associated	O
herpesvirus	O
infection	O
from	O
latency	O
by	O
expression	O
of	O
the	O
ORF	protein
50	protein
transactivator	protein
,	O
a	O
homolog	O
of	O
the	O
EBV	protein
R	protein
protein	protein
.	O
Kaposi's	O
sarcoma	O
(KS)-associated	O
herpesvirus	O
(	O
KSHV	O
),	O
or	O
human	O
herpesvirus	O
8	O
,	O
is	O
a	O
lymphotropic	O
virus	O
strongly	O
linked	O
to	O
several	O
AIDS-related	O
neoplasms	O
.	O
The	O
primary	O
reservoir	O
of	O
infection	O
consists	O
of	O
latently	O
infected	O
B	cell_type
lymphocytes	cell_type
and	O
possibly	O
other	O
mononuclear	cell_type
cells	cell_type
.	O
Viral	O
reactivation	O
from	O
latency	O
and	O
spread	O
from	O
this	O
lymphoid	O
reservoir	O
is	O
presumably	O
required	O
for	O
development	O
of	O
nonlymphoid	O
tumors	O
like	O
KS	O
.	O
Here	O
we	O
show	O
that	O
deregulated	O
expression	O
of	O
a	O
single	O
viral	DNA
gene	DNA
,	O
ORF	DNA
50	DNA
,	O
which	O
encodes	O
a	O
transactivator	O
able	O
to	O
selectively	O
upregulate	O
delayed-early	DNA
viral	DNA
genes	DNA
,	O
suffices	O
to	O
disrupt	O
latency	O
and	O
induce	O
the	O
lytic	O
gene	O
cascade	O
in	O
latently	cell_type
infected	cell_type
B	cell_type
cells	cell_type
.	O
The	O
identification	O
of	O
this	O
gene	O
opens	O
the	O
way	O
to	O
studies	O
of	O
the	O
physiologic	O
mechanisms	O
controlling	O
reactvation	O
of	O
KSHV	O
from	O
latency.	O
Copyright	O
1998	O
Academic	O
Press.	O

Nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
and	O
AP-1	protein
are	O
insufficient	O
for	O
IL-2	DNA
promoter	DNA
activation	O
:	O
requirement	O
for	O
CD28	protein
up-regulation	O
of	O
RE/AP	protein
.	O
IL-2	protein
gene	O
transcription	O
in	O
T	cell_type
cells	cell_type
requires	O
both	O
TCR	O
and	O
costimulatory	O
signals.	O
IL-2	DNA
promoter	DNA
activation	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
stimulated	O
with	O
superantigen	O
presented	O
by	O
Raji	cell_line
B	cell_line
cells	cell_line
requires	O
CD28	protein
activation	O
.	O
The	O
addition	O
of	O
rCTLA4Ig	O
,	O
which	O
blocks	O
CD28	protein
binding	O
to	O
its	O
ligand,	O
to	O
the	O
cultures	O
decreased	O
IL-2	DNA
promoter	DNA
activation	O
by	O
&gt;80%.	O
Interestingly,	O
CTLA4Ig	O
did	O
not	O
significantly	O
inhibit	O
the	O
activation	O
of	O
either	O
NF	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NFAT	protein
)	O
or	O
AP-1	DNA
reporters	DNA
.	O
Therefore,	O
activation	O
of	O
NFAT	protein
and	O
AP-1	protein
is	O
insufficient	O
for	O
IL-2	DNA
promoter	DNA
activation	O
.	O
In	O
contrast,	O
an	O
RE/AP	protein
reporter	O
was	O
blocked	O
by	O
CTLA4Ig	O
by	O
&gt;90%.	O
Thus,	O
the	O
requirement	O
for	O
CD28	protein
in	O
IL-2	DNA
promoter	DNA
activation	O
appears	O
to	O
be	O
due	O
to	O
RE/AP	protein
and	O
not	O
the	O
NFAT	O
or	O
AP-1	O
sites	O
.	O
In	O
addition,	O
these	O
data	O
suggest	O
that	O
transcriptional	O
activation	O
of	O
RE/AP	protein
is	O
not	O
mediated	O
by	O
NFAT	protein
,	O
because	O
activation	O
of	O
a	O
NFAT	protein
reporter	O
is	O
not	O
affected	O
by	O
the	O
addition	O
of	O
CTLA4Ig	O
.	O

The	O
control	O
of	O
lytic	O
replication	O
of	O
Epstein-Barr	O
virus	O
in	O
B	cell_type
lymphocytes	cell_type
(Review).	O
Uncontrolled	O
replication	O
of	O
a	O
virus	O
,	O
which	O
is	O
harmful	O
to	O
the	O
host	O
is	O
also	O
disadvantageous	O
to	O
the	O
virus.	O
Most	O
viruses	O
cannot	O
compete	O
with	O
the	O
various	O
immune	O
mechanisms	O
and	O
become	O
eliminated	O
in	O
the	O
course	O
of	O
infection.	O
Therefore,	O
only	O
the	O
time	O
between	O
infection	O
and	O
eradication	O
remains	O
for	O
these	O
viruses	O
to	O
proliferate.	O
A	O
few	O
viruses,	O
like	O
the	O
Herpesviruses	O
or	O
the	O
papillomaviruses	O
,	O
however,	O
have	O
developed	O
a	O
sophisticated	O
strategy	O
for	O
persisting	O
lifelong,	O
usually	O
asymptomatically	O
in	O
the	O
host,	O
hiding	O
from	O
the	O
immune	O
system	O
and	O
producing	O
infectious	O
progeny	O
at	O
the	O
same	O
time.	O
This	O
strategy	O
depends	O
on	O
a	O
separation	O
of	O
latency	O
and	O
the	O
lytic	O
replication	O
,	O
either	O
by	O
time	O
due	O
to	O
differentiation-dependent	O
mechanisms	O
or	O
by	O
spatial	O
separation	O
as	O
the	O
result	O
of	O
different	O
host	O
cell	O
types.	O
Both	O
are	O
true	O
for	O
the	O
Epstein-Barr	O
virus	O
(	O
EBV	O
).	O
B	cell_type
cells	cell_type
and	O
epithelial	cell_type
cells	cell_type
have	O
a	O
pivotal	O
role	O
in	O
the	O
life	O
cycle	O
of	O
the	O
virus.	O
The	O
former	O
can	O
become	O
latently	O
infected	O
and	O
are	O
thought	O
to	O
be	O
the	O
virus	O
reservoir	O
in	O
vivo,	O
whereas	O
the	O
latter	O
were	O
shown	O
to	O
be	O
permissive	O
for	O
lytic	O
replication	O
.	O
However,	O
replication	O
of	O
EBV	O
in	O
vivo	O
is	O
controlled	O
primarily	O
by	O
host	O
immune	O
mechanisms	O
selecting	O
for	O
cells	O
that	O
are	O
not	O
permissive	O
for	O
viral	O
replication	O
as	O
the	O
result	O
of	O
a	O
particular	O
set	O
of	O
transcription	protein
factors	protein
.	O
These	O
factors	O
control	O
the	O
activity	O
of	O
the	O
regulatory	DNA
immediate-early	DNA
genes	DNA
and,	O
in	O
addition,	O
lytic	O
and	O
latent	O
cycle	O
regulatory	O
genes	O
negatively	O
interfere	O
with	O
each	O
other	O
and	O
thus	O
link	O
cellular	O
and	O
viral	DNA
gene	DNA
regulatory	O
mechanisms	O
.	O
Disturbance	O
of	O
both	O
the	O
immune	O
surveillance	O
as	O
well	O
as	O
viral	DNA
gene	DNA
regulation	O
may	O
result	O
in	O
EBV	O
-associated	O
disease	O
.	O

Adaptor	O
function	O
for	O
the	O
Syk	protein
kinases-interacting	protein
protein	protein
3BP2	protein
in	O
IL-2	protein
gene	O
activation	O
.	O
Syk-family	protein
tyrosine	protein
kinases	protein
are	O
essential	O
for	O
lymphocyte	O
development	O
and	O
activation.	O
Using	O
a	O
yeast	O
two-hybrid	O
screen	O
to	O
identify	O
Syk	protein
kinases-interacting	protein
proteins	protein
(	O
SKIPs	protein
),	O
we	O
isolated	O
3BP2	protein
,	O
an	O
Abl	protein
SH3-interacting	protein
protein	protein
of	O
unknown	O
function.	O
3BP2	protein
was	O
selectively	O
expressed	O
in	O
hematopoietic/lymphoid	O
tissues	O
and	O
bound	O
via	O
its	O
SH2	protein
domain	protein
activated	protein
Syk-family	protein
kinases	protein
in	O
mammalian	cell_type
cells	cell_type
,	O
including	O
in	O
antigen	cell_type
receptor-stimulated	cell_type
T	cell_type
cells	cell_type
.	O
In	O
addition	O
to	O
Zap-70	protein
,	O
the	O
3BP2	protein
SH2	protein
domain	protein
associated	O
in	O
vitro	O
with	O
LAT	protein
,	O
Grb2	protein
,	O
PLCgamma1	protein
,	O
and	O
Cbl	protein
from	O
activated	O
T	O
cell	O
lysates	O
.	O
Transient	O
3BP2	protein
overexpression	O
induced	O
transcriptional	O
activation	O
of	O
the	O
IL-2	DNA
promoter	DNA
and	O
its	O
NFAT	O
or	O
AP-1	O
elements	O
.	O
This	O
activity	O
was	O
dependent	O
on	O
the	O
SH2	protein
and	O
pleckstrin-homology	protein
domains	protein
of	O
3BP2	protein
,	O
and	O
required	O
functional	O
Syk	protein
kinases	protein
,	O
Ras	protein
,	O
and	O
calcineurin	protein
.	O
Thus,	O
3BP2	protein
is	O
an	O
important	O
adaptor	O
that	O
may	O
couple	O
activated	O
Zap-70	protein
/Syk	protein
to	O
a	O
LAT	protein
-containing	protein
signaling	protein
complex	protein
involved	O
in	O
TCR-mediated	O
gene	O
transcription	O
.	O

In	O
vitro	O
suppression	O
of	O
programmed	O
cell	O
death	O
of	O
B	cell_type
cells	cell_type
by	O
tissue	O
inhibitor	O
of	O
metalloproteinases-1	protein
.	O
Cellular	O
pathways	O
for	O
induction	O
of	O
programmed	O
cell	O
death	O
(	O
PCD	O
)	O
have	O
been	O
identified,	O
but	O
little	O
is	O
known	O
about	O
specific	O
extracellular	O
matrix	O
processes	O
that	O
may	O
affect	O
apoptosis	O
along	O
those	O
pathways.	O
In	O
this	O
study,	O
a	O
series	O
of	O
Burkitt's	cell_line
lymphoma	cell_line
(BL)	cell_line
cell	cell_line
lines	cell_line
were	O
assayed	O
for	O
their	O
expression	O
of	O
tissue	protein
inhibitor	protein
of	protein
metalloproteinases	protein
(TIMP)-1	protein
.	O
Results	O
indicate	O
that	O
TIMP-1	cell_line
-positive	cell_line
BL	cell_line
lines	cell_line
show	O
resistance	O
to	O
cold-shock-induced	O
apoptosis	O
.	O
Furthermore,	O
recombinant	O
TIMP-1	protein
,	O
but	O
not	O
TIMP-2	protein
or	O
a	O
synthetic	O
metalloproteinase	O
inhibitor	O
(	O
BB-94	O
),	O
confers	O
resistance	O
to	O
apoptosis	O
induced	O
by	O
both	O
CD95-dependent	O
and	O
-independent	O
(	O
cold	O
shock	O
,	O
serum	O
deprivation	O
,	O
and	O
gamma-radiation	O
)	O
pathways	O
in	O
TIMP-1	cell_line
-negative	cell_line
BL	cell_line
lines	cell_line
.	O
TIMP-1	protein
suppression	O
of	O
PCD	O
is	O
not	O
due	O
to	O
metalloproteinase	protein
inhibition	O
,	O
as	O
reduction	O
and	O
alkylation	O
of	O
the	O
TIMP-1	protein
did	O
not	O
abolish	O
this	O
activity.	O
Retroviral	O
induction	O
of	O
TIMP-1	protein
not	O
only	O
resulted	O
in	O
cell	O
survival	O
but	O
also	O
in	O
continued	O
DNA	O
synthesis	O
for	O
up	O
to	O
5	O
d	O
in	O
the	O
absence	O
of	O
serum	O
,	O
while	O
controls	O
underwent	O
apoptosis	O
.	O
This	O
resistance	O
to	O
apoptosis	O
is	O
reversed	O
by	O
anti-	protein
TIMP-1	protein
antibodies	protein
,	O
demonstrating	O
that	O
secreted	O
TIMP-1	protein
is	O
active	O
in	O
blocking	O
apoptosis	O
.	O
Furthermore,	O
TIMP-1	protein
upregulation	O
induced	O
expression	O
of	O
Bcl-XL	protein
but	O
not	O
Bcl-2	protein
as	O
well	O
as	O
decreased	O
NF-kappaB	protein
activity	O
as	O
compared	O
with	O
controls.	O
These	O
results	O
demonstrate	O
that	O
TIMP-1	protein
suppresses	O
apoptosis	O
in	O
B	cell_type
cells	cell_type
and	O
suggests	O
a	O
novel	O
activity	O
for	O
TIMP-1	protein
in	O
tissue	O
homeostasis	O
.	O

Spi-1/PU.1	DNA
proto-oncogene	DNA
induces	O
opposite	O
effects	O
on	O
monocytic	O
and	O
erythroid	O
differentiation	O
of	O
K562	cell_line
cells	cell_line
.	O
Spi-1/PU.1	protein
is	O
a	O
hematopoietic	protein
transcription	protein
factor	protein
of	O
the	O
Ets	protein
family	protein
.	O
To	O
analyze	O
the	O
effects	O
of	O
ectopic	O
expression	O
of	O
spi-1	protein
on	O
the	O
proliferation/differentiation	O
of	O
human	cell_type
myeloid	cell_type
leukemia	cell_type
cells	cell_type
,	O
K562	cell_line
cells	cell_line
were	O
stably	O
transfected	O
with	O
a	O
spi-1	DNA
expression	DNA
vector	DNA
.	O
The	O
transfected	cell_line
cell	cell_line
lines	cell_line
expressed	O
elevated	O
levels	O
of	O
spi-1	RNA
mRNA	RNA
and	O
protein	O
and	O
high	O
Spi-1	protein
-DNA	O
binding	O
activity	O
.	O
The	O
spi-1	cell_line
transfected	cell_line
cells	cell_line
showed	O
reduced	O
growth	O
rates	O
and	O
reduced	O
clonogenic	O
cell	O
growth	O
.	O
When	O
the	O
erythroid	O
and	O
monocytic	O
differentiation	O
markers	O
were	O
analyzed,	O
spi-1	protein
overexpression	O
resulted	O
in	O
opposite	O
effects:	O
erythroid	O
differentiation	O
was	O
significantly	O
inhibited	O
in	O
spi-1	cell_line
transfectants	cell_line
,	O
while	O
spi-1	protein
overexpression	O
increased	O
the	O
monocytic	O
differentiation	O
of	O
cells.	O
These	O
results	O
indicate	O
a	O
differential	O
role	O
of	O
Spi-1	DNA
on	O
the	O
differentiation	O
of	O
human	cell_line
myeloid	cell_line
leukemia	cell_line
cells	cell_line
.	O
Copyright	O
1998	O
Academic	O
Press.	O

In	O
vivo	O
function	O
of	O
an	O
interleukin	protein
2	protein
receptor	protein
beta	protein
chain	protein
(IL-2Rbeta)/IL-4Ralpha	protein
cytokine	protein
receptor	protein
chimera	protein
potentiates	O
allergic	O
airway	O
disease	O
.	O
Strength	O
of	O
T	protein
cell	protein
receptor	protein
(	O
TCR	protein
)	O
signaling	O
,	O
coreceptors	protein
,	O
costimulation	O
,	O
antigen-presenting	cell_type
cell	cell_type
type	cell_type
,	O
and	O
cytokines	O
all	O
play	O
crucial	O
roles	O
in	O
determining	O
the	O
efficiency	O
with	O
which	O
type	cell_type
2	cell_type
T	cell_type
lymphocytes	cell_type
(	O
Th2	cell_type
,	O
Tc2	cell_type
)	O
develop	O
from	O
uncommitted	protein
precursors	protein
.	O
To	O
investigate	O
in	O
vivo	O
regulatory	O
mechanisms	O
that	O
control	O
the	O
population	O
of	O
type	cell_type
2	cell_type
T	cell_type
cells	cell_type
and	O
disease	O
susceptibility,	O
we	O
have	O
created	O
lines	O
of	O
transgenic	O
mice	O
in	O
which	O
expression	O
of	O
a	O
chimeric	protein
cytokine	protein
receptor	protein
(the	O
mouse	protein
interleukin	protein
2	protein
receptor	protein
beta	protein
chain	protein
[	protein
IL-2Rbeta	protein
]	protein
extracellular	protein
domain	protein
fused	O
to	O
the	O
cytoplasmic	protein
tail	protein
of	O
IL-4Ralpha	protein
)	O
is	O
targeted	O
to	O
the	O
T	cell_type
lymphoid	cell_type
lineage	cell_type
using	O
the	O
proximal	DNA
lck	DNA
promoter	DNA
.	O
This	O
chimera	O
transduced	O
IL-4	protein
-specific	O
signals	O
in	O
response	O
to	O
IL-2	protein
binding	O
and	O
dramatically	O
enhanced	O
type	O
2	O
responses	O
(	O
IL-4	protein
,	O
IL-5	protein
,	O
and	O
immunoglobulin	protein
E	protein
production	O
)	O
upon	O
in	O
vitro	O
TCR	protein
stimulation	O
or	O
in	O
vivo	O
antigen	O
challenge	O
.	O
Thus,	O
type	O
2	O
effector	O
function	O
was	O
augmented	O
by	O
IL-4	protein
signals	O
transduced	O
through	O
a	O
chimeric	protein
receptor	protein
expressed	O
in	O
a	O
T	O
cell-specific	O
manner	O
.	O
This	O
influence	O
was	O
sufficient	O
for	O
establishment	O
of	O
antigen-induced	O
allergic	O
airway	O
hyperresponsiveness	O
on	O
a	O
disease-resistant	O
background	O

Differentiation-dependent	O
expression	O
of	O
a	O
human	protein
carboxylesterase	protein
in	O
monocytic	cell_type
cells	cell_type
and	O
transcription	protein
factor	protein
binding	O
to	O
the	O
promoter	DNA
.	O
Carboxylesterases	protein
play	O
an	O
important	O
role	O
in	O
defense	O
and	O
clearance	O
mechanisms	O
of	O
the	O
monocyte/macrophage	O
system	O
.	O
During	O
the	O
differentiation	O
process	O
of	O
cells	O
from	O
the	O
monocytic	cell_line
cell	cell_line
line	cell_line
THP-1	cell_line
we	O
observed	O
a	O
transient	O
transcriptional	O
upregulation	O
of	O
a	O
human	protein
carboxylesterase	protein
analyzed	O
by	O
means	O
of	O
Northern	O
blots	O
.	O
In	O
PMA-treated	cell_line
THP-1	cell_line
cells	cell_line
we	O
could	O
detect	O
three	O
major	O
transcription	DNA
initiation	DNA
sites	DNA
as	O
revealed	O
by	O
Nuclease	O
Protection	O
Assay	O
carried	O
out	O
with	O
two	O
overlapping	RNA
antisense	RNA
RNA	RNA
probes	RNA
.	O
We	O
have	O
recently	O
cloned	O
the	O
carboxylesterase	DNA
upstream	DNA
sequence	DNA
and	O
showed	O
its	O
basal	DNA
promoter	DNA
activity	O
in	O
CHO	cell_line
cells	cell_line
.	O
Using	O
electrophoretic	O
mobility	O
shift	O
analysis	O
we	O
demonstrated	O
that	O
the	O
promoter	DNA
region	DNA
spanning	O
base	DNA
pairs	DNA
-1	DNA
to	DNA
-275	DNA
,	O
which	O
contains	O
several	O
putative	O
binding	O
sites	O
for	O
transcription	protein
factors	protein
,	O
is	O
bound	O
by	O
nuclear	protein
factors	protein
Sp1	protein
and	O
IRBP	protein
but	O
not	O
by	O
C/EBPs	protein
.	O
Taken	O
together	O
these	O
data	O
indicate	O
that	O
carboxylesterase	O
gene	O
transcription	O
in	O
THP-1	cell_line
cells	cell_line
starts	O
at	O
multiple	O
initiation	O
sites	O
and	O
that	O
Sp1	protein
and	O
IRBP	protein
may	O
be	O
critical	O
factors	O
for	O
modulating	O
the	O
differentiation-dependent	O
transcription	O
of	O
this	O
human	DNA
carboxylesterase	DNA
gene	DNA
.	O

The	O
role	O
of	O
the	O
Ikaros	DNA
gene	DNA
in	O
lymphocyte	O
development	O
and	O
homeostasis	O
.	O
The	O
Ikaros	DNA
gene	DNA
,	O
which	O
encodes	O
a	O
family	O
of	O
hemopoietic-specific	protein
zinc	protein
finger	protein
proteins	protein
,	O
is	O
described	O
as	O
a	O
central	O
regulator	O
of	O
lymphocyte	O
differentiation	O
.	O
During	O
fetal	O
development	O
,	O
it	O
is	O
required	O
at	O
the	O
earliest	O
stage	O
of	O
T	O
cell	O
and	O
B	O
cell	O
specification	O
.	O
In	O
the	O
adult,	O
however,	O
lymphoid	cell_type
lineages	cell_type
rely	O
on	O
Ikaros	DNA
at	O
distinct	O
phases	O
of	O
their	O
development.	O
Its	O
activity	O
is	O
essential	O
for	O
the	O
generation	O
of	O
B	cell_type
cell	cell_type
but	O
not	O
of	O
T	cell_type
cell	cell_type
precursors	cell_type
,	O
although	O
the	O
differentiation	O
of	O
the	O
latter	O
is	O
not	O
normal.	O
A	O
significant	O
increase	O
in	O
CD4	cell_type
thymocytes	cell_type
and	O
their	O
immediate	O
precursors	O
is	O
detected,	O
and	O
because	O
these	O
cells	O
lack	O
markers	O
that	O
correlate	O
with	O
positive	O
selection,	O
a	O
deregulation	O
in	O
their	O
maturation	O
process	O
is	O
suggested.	O
Furthermore,	O
Ikaros-null	cell_type
thymocytes	cell_type
hyperproliferate	O
in	O
response	O
to	O
T	protein
cell	protein
receptor	protein
(	O
TCR	protein
)	O
signaling	O
;	O
within	O
days	O
after	O
their	O
appearance	O
in	O
the	O
thymus	O
,	O
clonally	O
expanding	O
populations	O
are	O
detected.	O
Deregulated	O
TCR	protein
-mediated	O
responses	O
and	O
the	O
fast	O
kinetics	O
of	O
tumor	O
development	O
in	O
these	O
mutant	cell_type
thymocytes	cell_type
implicate	O
Ikaros	O
as	O
a	O
central	DNA
tumor	DNA
suppressor	DNA
gene	DNA
for	O
the	O
T	cell_type
cell	cell_type
lineage	cell_type
.	O
In	O
addition,	O
lack	O
of	O
natural	cell_type
killer	cell_type
cells	cell_type
and	O
selective	O
defects	O
in	O
gamma	cell_type
delta	cell_type
T	cell_type
cells	cell_type
and	O
dendritic	cell_type
antigen-presenting	cell_type
cells	cell_type
point	O
to	O
Ikaros	protein
as	O
an	O
essential	O
factor	O
for	O
the	O
establishment	O
of	O
early	O
branchpoints	O
of	O
the	O
T	O
cell	O
pathway	O
.	O
The	O
dominant	O
interference	O
activity	O
of	O
Ikaros	protein
isoforms	protein
unable	O
to	O
bind	O
DNA	O
and	O
their	O
effects	O
in	O
lymphocyte	O
development	O
suggest	O
that	O
Ikaros	protein
works	O
in	O
concert	O
with	O
other	O
factors.	O
The	O
role	O
of	O
Aiolos	DNA
,	O
a	O
lymphoid-restricted	O
and	O
structurally	O
related	O
gene	O
,	O
in	O
lymphoid	O
differentiation	O
is	O
discussed.	O
A	O
model	O
is	O
proposed	O
that	O
defines	O
Ikaros	protein
as	O
the	O
backbone	O
of	O
a	O
complex	protein
regulatory	protein
protein	protein
network	protein
that	O
controls	O
cell	O
fate	O
decisions	O
and	O
regulates	O
homeostasis	O
in	O
the	O
hemo-lymphoid	O
system	O
.	O
Changes	O
in	O
this	O
regulatory	O
network	O
may	O
reflect	O
differentiation	O
and	O
proliferation	O
adjustments	O
made	O
in	O
hemo-lymphoid	cell_type
progenitors	cell_type
and	O
precursors	cell_type
as	O
they	O
give	O
rise	O
to	O
the	O
cells	O
of	O
our	O
immune	O
system	O
.	O

STAT1	protein
pathway	O
is	O
involved	O
in	O
activation	O
of	O
caprine	O
arthritis-encephalitis	DNA
virus	DNA
long	DNA
terminal	DNA
repeat	DNA
in	O
monocytes	cell_type
.	O
The	O
caprine	DNA
arthritis-encephalitis	DNA
virus	DNA
(	DNA
CAEV	DNA
)	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
is	O
activated	O
by	O
gamma	protein
interferon	protein
(	O
IFN-gamma	protein
)	O
in	O
promonocytic	cell_type
cells	cell_type
.	O
We	O
have	O
previously	O
shown	O
that	O
a	O
70-bp	DNA
element	DNA
is	O
necessary	O
and	O
sufficient	O
for	O
the	O
response	O
of	O
the	O
CAEV	DNA
LTR	DNA
to	O
this	O
cytokine	protein
.	O
At	O
the	O
5'	DNA
end	DNA
,	O
this	O
70-bp	DNA
IFN-gamma	DNA
response	DNA
element	DNA
contains	O
sequence	O
similarity	O
to	O
the	O
gamma	DNA
activated	DNA
site	DNA
(	O
GAS	DNA
).	O
Here	O
we	O
demonstrate	O
that	O
the	O
putative	O
GAS	DNA
element	DNA
in	O
the	O
CAEV	DNA
LTR	DNA
binds	O
specifically	O
to	O
a	O
cellular	protein
factor	protein
induced	O
by	O
IFN-gamma	protein
in	O
promonocytic	cell_type
cells	cell_type
.	O
Substitution	O
mutations	O
in	O
this	O
consensus	DNA
sequence	DNA
eliminate	O
binding	O
of	O
the	O
inducible	protein
factor	protein
.	O
The	O
GAS	DNA
element	DNA
from	O
the	O
70-bp	DNA
motif	DNA
is	O
sufficient	O
to	O
confer	O
responsiveness	O
to	O
IFN-gamma	protein
using	O
a	O
heterologous	O
minimal	O
promoter.	O
Consistent	O
with	O
the	O
binding	O
data,	O
the	O
same	O
mutations	O
in	O
the	O
GAS	DNA
element	DNA
eliminate	O
responsiveness	O
to	O
IFN-gamma	protein
in	O
the	O
context	O
of	O
both	O
a	O
functional	O
CAEV	DNA
LTR	DNA
and	O
a	O
heterologous	DNA
promoter	DNA
.	O
The	O
cellular	O
factor	O
that	O
binds	O
to	O
the	O
GAS	DNA
element	DNA
is	O
present	O
from	O
5	O
min	O
to	O
14	O
h	O
after	O
stimulation	O
with	O
IFN-gamma	protein
.	O
Binding	O
of	O
the	O
nuclear	O
factor	O
to	O
the	O
GAS	DNA
element	DNA
in	O
the	O
CAEV	DNA
LTR	DNA
is	O
inhibited	O
by	O
antibody	O
directed	O
against	O
STAT1	protein
(	O
p91/84	protein
).	O
Thus,	O
the	O
GAS	O
sequence	O
in	O
the	O
CAEV	DNA
LTR	DNA
is	O
essential	O
for	O
the	O
response	O
to	O
IFN-gamma	protein
and	O
a	O
STAT1	protein
-like	protein
factor	protein
binds	O
to	O
this	O
site.	O
The	O
STAT-1	O
signaling	O
pathway	O
provides	O
at	O
least	O
one	O
mechanism	O
for	O
activation	O
of	O
the	O
CAEV	DNA
LTR	DNA
by	O
IFN-gamma	protein
in	O
monocytes	cell_type
.	O
These	O
data	O
are	O
the	O
first	O
demonstration	O
of	O
a	O
role	O
for	O
a	O
STAT	protein
family	protein
member	protein
in	O
the	O
regulation	O
of	O
a	O
viral	DNA
promoter	DNA
.	O

1,25-Dihydroxyvitamin	DNA
D3	DNA
receptors	DNA
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
from	O
patients	O
with	O
renal	O
insufficiency	O
.	O
A	O
reduced	O
expression	O
of	O
the	O
vitamin	protein
D	protein
receptor	protein
(VDR)	O
in	O
parathyroid	O
glands	O
of	O
uremic	O
animals	O
and	O
humans	O
has	O
been	O
observed.	O
Similar	O
results	O
have	O
been	O
obtained	O
by	O
our	O
own	O
group	O
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
)	O
from	O
patients	O
with	O
secondary	O
hyperparathyroidism	O
to	O
chronic	O
renal	O
failure	O
.	O
However,	O
the	O
reasons	O
for	O
these	O
changes	O
are	O
not	O
clear.	O
In	O
the	O
present	O
study,	O
we	O
have	O
investigated	O
the	O
specific	O
uptake	O
of	O
[3H]1,25(OH)2D3	O
by	O
PBMC	cell_type
of	O
11	O
women	O
with	O
advanced	O
chronic	O
renal	O
failure	O
(	O
A-CRF	O
),	O
6	O
women	O
with	O
mild-moderate	O
renal	O
insufficiency	O
(	O
M-CRF	O
),	O
and	O
23	O
healthy	O
women	O
.	O
The	O
mean	O
dissociation	O
constant	O
(KD)	O
was	O
similar	O
in	O
both	O
groups	O
of	O
patients	O
and	O
in	O
healthy	O
women	O
(	O
A-CRF	O
:	O
0.7	O
+/-	O
0.5	O
x	O
10(-10)	O
M;	O
M-CRF:	O
1.1	O
+/-	O
0.9	O
x	O
10(-10)	O
M;	O
controls:	O
1.0	O
+/-	O
0.6	O
x	O
10(-10)	O
M).	O
However,	O
VDR	protein
concentration	O
was	O
significantly	O
decreased	O
in	O
A-CRF	O
(0.8	O
+/-	O
0.5	O
fmol/10(7)	O
cells	O
vs.	O
2.3	O
+/-	O
0.9	O
fmol/10(7)	O
cells	O
in	O
controls,	O
p	O
&lt;	O
0.001),	O
whereas	O
no	O
changes	O
were	O
seen	O
in	O
M-CRF	O
(1.7	O
+/-	O
0.7	O
fmol/10(7)	O
cells	O
vs.	O
2.3	O
+/-	O
0.9	O
fmol/10(7)	O
cells	O
in	O
controls).	O
No	O
correlation	O
was	O
seen	O
between	O
VDR	protein
and	O
serum	O
calcitriol	O
or	O
PTH	O
levels	O
,	O
when	O
considering	O
both	O
groups	O
of	O
patients	O
together	O
or	O
separately.	O
Conversely,	O
a	O
significant	O
negative	O
correlation	O
was	O
found	O
between	O
VDR	protein
and	O
serum	O
creatinine	O
values	O
when	O
A-CRF	O
and	O
M-CRF	O
were	O
considered	O
altogether	O
(r	O
=	O
-0.63;	O
p	O
&lt;	O
0.01).	O
Treatment	O
with	O
two	O
different	O
schedules	O
of	O
oral	O
calcitriol	O
(five	O
patients	O
with	O
0.5	O
microgram/day	O
for	O
1	O
month	O
and	O
four	O
patients	O
with	O
2	O
micrograms/day	O
for	O
7	O
days)	O
did	O
not	O
change	O
VDR	protein
concentrations	O
.	O
We	O
conclude	O
that	O
the	O
low	O
levels	O
of	O
serum	O
1,25(OH)2D3	O
of	O
uremia	O
are	O
not	O
responsible	O
for	O
the	O
decrease	O
in	O
VDR	protein
concentration	O
found	O
in	O
these	O
patients	O
.	O

Transcription	protein
factor	protein
binding	O
to	O
the	O
core	DNA
promoter	DNA
of	O
the	O
human	DNA
monoamine	DNA
oxidase	DNA
B	DNA
gene	DNA
in	O
the	O
cerebral	O
cortex	O
and	O
in	O
blood	cell_type
cells	cell_type
.	O
Many	O
studies	O
show	O
that	O
monoamine	protein
oxidase	protein
B	protein
in	O
blood	cell_type
cells	cell_type
is	O
a	O
biological	O
marker	O
for	O
personality	O
characteristics	O
such	O
as	O
sensation	O
seeking.	O
The	O
mechanism	O
underlying	O
this	O
association	O
is	O
so	O
far	O
not	O
explored.	O
In	O
the	O
present	O
study	O
we	O
have	O
performed	O
electrophoretic	O
mobility-shift	O
assays	O
to	O
investigate	O
the	O
pattern	O
of	O
protein	O
binding	O
to	O
a	O
150	DNA
bp	DNA
fragment	DNA
of	O
the	O
proximal	DNA
5'-flanking	DNA
region	DNA
of	O
the	O
human	DNA
monoamine	DNA
oxidase	DNA
B	DNA
gene	DNA
.	O
We	O
compared	O
the	O
pattern	O
using	O
nuclear	O
extracts	O
from	O
human	O
brain	O
and	O
lymphocytes	cell_type
.	O
Interestingly,	O
a	O
correlation	O
was	O
observed	O
between	O
monoamine	protein
oxidase	protein
B	protein
enzyme	O
activity	O
in	O
blood	cell_type
cells	cell_type
(	O
platelets	cell_type
)	O
and	O
the	O
binding	O
pattern	O
of	O
two	O
uncharacterized	O
transcription	protein
factors	protein
.	O
These	O
data	O
are	O
well	O
in	O
line	O
with	O
the	O
long-standing	O
notion	O
that	O
interindividual	O
differences	O
in	O
platelet	protein
monoamine	protein
oxidase	protein
may	O
represent	O
differences	O
in	O
expression	O
of	O
the	O
enzyme	O
rather	O
than	O
genotypic	O
variation	O
.	O

Enhanced	O
differentiation	O
of	O
HL-60	cell_line
leukemia	cell_line
cells	cell_line
to	O
macrophages	cell_type
induced	O
by	O
ciprofibrate	O
.	O
Ciprofibrate	O
,	O
an	O
hypolipidaemic	O
peroxisome	O
proliferator	O
,	O
induced	O
differentiation	O
of	O
HL-60	cell_line
cells	cell_line
.	O
The	O
effect	O
was	O
greatly	O
potentiated	O
by	O
phorbol	O
12-myristate	O
13-acetate	O
at	O
a	O
concentration	O
where	O
neither	O
phorbol	O
ester	O
nor	O
ciprofibrate	O
alone	O
had	O
any	O
effect	O
on	O
these	O
cells.	O
As	O
occurs	O
for	O
HL-60	O
cell	O
differentiation	O
induced	O
by	O
high	O
phorbol	O
ester	O
concentration,	O
the	O
ciprofibrate	O
-induced	O
phorbol	O
ester	O
-dependent	O
differentiation	O
of	O
HL-60	cell_line
cells	cell_line
proceeded	O
through	O
the	O
monocytic/macrophage	O
pathway	O
and	O
induced	O
the	O
phosphorylation	O
of	O
proteins	O
with	O
similar	O
molecular	O
weights	O
suggesting	O
that	O
increased	O
protein	protein
kinase	protein
C	protein
activity	O
may	O
be	O
involved	O
in	O
the	O
effect.	O
The	O
peroxisome	O
proliferator-activated	O
receptor	O
(PPARalpha)	O
transcription	protein
factor	protein
is	O
expressed	O
in	O
HL-60	cell_line
cells	cell_line
,	O
but	O
no	O
changes	O
were	O
observed	O
in	O
its	O
expression	O
upon	O
HL-60	O
cell	O
differentiation	O
.	O

The	O
involvement	O
of	O
multiple	O
tumor	protein
necrosis	protein
factor	protein
receptor	protein
(TNFR)-associated	protein
factors	protein
in	O
the	O
signaling	O
mechanisms	O
of	O
receptor	protein
activator	protein
of	O
NF-kappaB	protein
,	O
a	O
member	O
of	O
the	O
TNFR	protein
superfamily	protein
.	O
Receptor	protein
activator	protein
of	protein
NF-kappaB	protein
(	O
RANK	protein
)	O
is	O
a	O
recently	O
identified	O
member	O
of	O
the	O
tumor	protein
necrosis	protein
factor	protein
receptor	protein
superfamily	protein
and	O
is	O
expressed	O
on	O
activated	cell_type
T	cell_type
cells	cell_type
and	O
dendritic	cell_type
cells	cell_type
.	O
Its	O
cognate	protein
ligand	protein
(	O
RANKL	protein
)	O
plays	O
significant	O
roles	O
in	O
the	O
activation	O
of	O
dendritic	O
cell	O
function	O
and	O
osteoclast	O
differentiation	O
.	O
We	O
demonstrate	O
here	O
the	O
interaction	O
of	O
RANK	protein
with	O
tumor	O
necrosis	O
factor	O
receptor-associated	O
factors	O
(	O
TRAFs	protein
)	O
1	O
,	O
2	O
,	O
3	O
,	O
5	O
,	O
and	O
6	O
both	O
in	O
vitro	O
and	O
in	O
cells.	O
Mapping	O
of	O
the	O
structural	O
requirements	O
for	O
TRAF	protein
/RANK	protein
interaction	O
revealed	O
multiple	O
TRAF	protein
binding	protein
sites	protein
clustered	O
in	O
two	O
distinct	O
domains	O
in	O
the	O
RANK	protein
cytoplasmic	protein
tail	protein
.	O
These	O
TRAF	protein
binding	protein
domains	protein
were	O
shown	O
to	O
be	O
functionally	O
important	O
for	O
the	O
RANK	protein
-dependent	O
induction	O
of	O
NF-kappaB	protein
and	O
c-Jun	protein
NH2-terminal	protein
kinase	protein
activities	O
.	O
Site-directed	O
mutagenesis	O
demonstrated	O
that	O
these	O
TRAF	protein
binding	protein
sites	protein
exhibited	O
selective	O
binding	O
for	O
different	O
TRAF	protein
proteins	protein
.	O
In	O
particular,	O
TRAF6	protein
interacted	O
with	O
membrane-proximal	protein
determinants	protein
distinct	O
from	O
those	O
binding	O
TRAFs	O
1	O
,	O
2	O
,	O
3	O
,	O
and	O
5	O
.	O
When	O
this	O
membrane-proximal	protein
TRAF6	protein
interaction	protein
domain	protein
was	O
deleted,	O
RANK	protein
-mediated	O
NF-kappaB	protein
signaling	O
was	O
completely	O
inhibited	O
while	O
c-Jun	protein
NH2-terminal	protein
kinase	protein
activation	O
was	O
partially	O
inhibited.	O
An	O
NH2-terminal	protein
truncation	protein
mutant	protein
of	O
TRAF6	protein
inhibited	O
RANKL	protein
-mediated	O
NF-kappaB	protein
activation	O
,	O
but	O
failed	O
to	O
affect	O
constitutive	O
signaling	O
induced	O
by	O
receptor	O
overexpression	O
,	O
revealing	O
a	O
selective	O
role	O
for	O
TRAF6	protein
in	O
ligand-induced	O
activation	O
events	O
.	O

Stat6	protein
inhibits	O
human	O
interleukin-4	DNA
promoter	DNA
activity	O
in	O
T	cell_type
cells	cell_type
.	O
The	O
differentiation	O
of	O
naive	cell_type
T-helper	cell_type
(Th)	cell_type
cells	cell_type
into	O
cytokine	cell_type
-secreting	cell_type
effector	cell_type
Th	cell_type
cells	cell_type
requires	O
exposure	O
to	O
multiple	O
signals,	O
including	O
exogenous	protein
cytokines	protein
.	O
Interleukin-4	protein
(	O
IL-4	protein
)	O
plays	O
a	O
major	O
role	O
in	O
this	O
process	O
by	O
promoting	O
the	O
differentiation	O
of	O
IL-4	protein
-secreting	O
Th2	O
cells.	O
In	O
Th2	O
cells,	O
IL-4	protein
gene	O
expression	O
is	O
tightly	O
controlled	O
at	O
the	O
level	O
of	O
transcription	O
by	O
the	O
coordinated	O
binding	O
of	O
multiple	O
transcription	protein
factors	protein
to	O
regulatory	O
elements	O
in	O
the	O
proximal	O
promoter	DNA
region	DNA
.	O
Nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cell	protein
(NFAT)	protein
family	protein
members	protein
play	O
a	O
critical	O
role	O
in	O
regulating	O
IL-4	protein
transcription	O
and	O
interact	O
with	O
up	O
to	O
five	O
sequences	O
(termed	O
P0	O
through	O
P4)	O
in	O
the	O
IL-4	DNA
promoter	DNA
.	O
The	O
molecular	O
mechanisms	O
by	O
which	O
IL-4	protein
induces	O
expression	O
of	O
the	O
IL-4	DNA
gene	DNA
are	O
not	O
known,	O
although	O
the	O
IL-4	protein
-activated	protein
transcription	protein
factor	protein
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
6	protein
(	O
Stat6	protein
)	O
is	O
required	O
for	O
this	O
effect.	O
We	O
report	O
here	O
that	O
Stat6	protein
interacts	O
with	O
three	O
binding	O
sites	O
in	O
the	O
human	DNA
IL-4	DNA
promoter	DNA
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O
These	O
sites	O
overlap	O
the	O
P1	O
,	O
P2	O
,	O
and	O
P4	O
NFAT	O
elements	O
.	O
To	O
investigate	O
the	O
role	O
of	O
Stat6	protein
in	O
regulating	O
IL-4	protein
transcription,	O
we	O
used	O
Stat6	protein
-deficient	O
Jurkat	O
T	cell_type
cells	cell_type
with	O
different	O
intact	O
IL-4	DNA
promoter	DNA
constructs	DNA
in	O
cotransfection	O
assays.	O
We	O
show	O
that,	O
whereas	O
a	O
multimerized	DNA
response	DNA
element	DNA
from	O
the	O
germline	DNA
IgE	DNA
promoter	DNA
was	O
highly	O
induced	O
by	O
IL-4	protein
in	O
Stat6	cell_type
-expressing	cell_type
Jurkat	cell_type
cells	cell_type
,	O
the	O
intact	O
human	DNA
IL-4	DNA
promoter	DNA
was	O
repressed	O
under	O
similar	O
conditions.	O
We	O
conclude	O
that	O
the	O
function	O
of	O
Stat6	protein
is	O
highly	O
dependent	O
on	O
promoter	O
context	O
and	O
that	O
this	O
factor	O
promotes	O
IL-4	protein
gene	O
expression	O
in	O
an	O
indirect	O
manner.	O

Epithelial	O
cell-initiated	O
inflammation	O
plays	O
a	O
crucial	O
role	O
in	O
early	O
tissue	O
damage	O
in	O
amebic	O
infection	O
of	O
human	O
intestine	O
.	O
BACKGROUND	O
&amp;	O
AIMS:	O
Entamoeba	O
histolytica	O
infection	O
of	O
the	O
intestine	O
can	O
induce	O
severe	O
gut	O
inflammation	O
.	O
The	O
aims	O
of	O
this	O
study	O
were	O
to	O
assess	O
the	O
role	O
of	O
the	O
host	O
inflammatory	O
response	O
in	O
the	O
tissue	O
damage	O
observed	O
with	O
amebiasis	O
and	O
the	O
role	O
of	O
the	O
intestinal	cell_type
epithelial	cell_type
cell	cell_type
in	O
initiating	O
that	O
response.	O
METHODS:	O
E.	O
histolytica	O
infection	O
was	O
established	O
in	O
human	O
intestinal	O
xenografts	O
in	O
severe	O
combined	O
immunodeficient	O
(SCID-HU-INT)	O
mice	O
.	O
Human	O
intestinal	cell_type
epithelial	cell_type
cell	cell_type
inflammatory	O
responses	O
to	O
amebic	O
infection	O
were	O
inhibited	O
by	O
the	O
intraluminal	O
administration	O
of	O
an	O
antisense	O
oligonucleotide	O
to	O
the	O
human	protein
p65	protein
subunit	protein
of	O
nuclear	protein
factor	protein
kappaB	protein
,	O
and	O
the	O
role	O
of	O
neutrophils	O
in	O
tissue	O
damage	O
observed	O
with	O
amebiasis	O
was	O
studied	O
by	O
depleting	O
neutrophils	cell_type
from	O
SCID-HU-INT	O
mice	O
.	O
RESULTS:	O
Administration	O
of	O
the	O
antisense	O
oligonucleotide	O
blocked	O
the	O
production	O
of	O
human	protein
interleukin	protein
1beta	protein
and	O
interleukin	protein
8	protein
by	O
intestinal	cell_type
epithelial	cell_type
cells	cell_type
and	O
inhibited	O
neutrophil	O
influx	O
into	O
the	O
E.	O
histolytica	O
-infected	O
intestinal	O
xenografts	O
.	O
Inhibition	O
of	O
the	O
gut	O
inflammatory	O
response	O
by	O
the	O
antisense	O
oligonucleotide	O
or	O
the	O
depletion	O
of	O
neutrophils	cell_type
from	O
SCID-HU-	O
INT	O
mice	O
blocked	O
the	O
increase	O
in	O
intestinal	O
permeability	O
observed	O
with	O
amebic	O
infection	O
.	O
CONCLUSIONS:	O
Intestinal	cell_type
epithelial	cell_type
cells	cell_type
initiate	O
an	O
inflammatory	O
response	O
with	O
resulting	O
neutrophil-mediated	O
tissue	O
damage	O
in	O
response	O
to	O
E.	O
histolytica	O
infection	O
;	O
this	O
inflammatory	O
cascade	O
can	O
be	O
blocked	O
by	O
inhibiting	O
the	O
transcription	O
of	O
genes	O
regulated	O
by	O
nuclear	protein
factor	protein
kappaB	protein
.	O

Triptolide	O
induces	O
apoptotic	O
death	O
of	O
T	cell_type
lymphocyte	cell_type
.	O
Extract	O
of	O
Tripterygium	O
wilfordii	O
Hook	O
.	O
f	O
(TWHf)	O
has	O
immunosuppressive	O
activity	O
and	O
has	O
been	O
used	O
as	O
anti-inflammatory	O
agent	O
in	O
traditional	O
Chinese	O
medicine	O
for	O
centuries.	O
Recent	O
studies	O
have	O
demonstrated	O
that	O
triptolide	O
is	O
the	O
major	O
active	O
component	O
in	O
the	O
extract	O
that	O
inhibits	O
antigen	O
or	O
mitogen	protein
-induced	O
T	O
cell	O
proliferation	O
.	O
In	O
attempting	O
to	O
investigate	O
its	O
effect	O
on	O
activation	O
of	O
T	cell_type
lymphocytes	cell_type
,	O
we	O
found	O
triptolide	O
induces	O
apoptotic	O
death	O
of	O
T	cell_line
cell	cell_line
hybridomas	cell_line
and	O
peripheral	cell_type
T	cell_type
cells	cell_type
but	O
not	O
that	O
of	O
thymocytes	cell_type
.	O
The	O
triptolide	O
-induced	O
apoptosis	O
is	O
accompanied	O
by	O
increase	O
of	O
DEVD-cleavable	O
caspases	protein
activity	O
and	O
degradation	O
of	O
caspase	protein
substrate	protein
poly	protein
(ADP-ribose)	protein
polymerase	protein
(	O
PARP	protein
).	O
A	O
specific	O
inhibitor	O
of	O
caspases	protein
,	O
zVAD-FMK	O
,	O
prevents	O
triptolide	O
-induced	O
PARP	protein
degradation	O
and	O
DNA	O
fragmentation	O
but	O
not	O
growth	O
arrest.	O
Furthermore,	O
enforced	O
expression	O
of	O
Bcl-2	protein
inhibited	O
triptolide	O
-induced	O
degradation	O
of	O
PARP	protein
and	O
apoptosis	O
.	O
These	O
results	O
indicate	O
that	O
triptolide	O
induces	O
T	O
cell	O
apoptosis	O
through	O
activating	O
caspases	protein
,	O
and	O
suggest	O
the	O
growth	O
arrest	O
and	O
apoptotic	O
effect	O
of	O
triptolide	O
may	O
contribute	O
to	O
the	O
immunosuppressive	O
activity	O
of	O
TWHf	O
extract	O

A	O
novel	O
transcription	protein
factor	protein
regulates	O
expression	O
of	O
the	O
vacuolar	protein
H+-ATPase	protein
B2	protein
subunit	protein
through	O
AP-2	DNA
sites	DNA
during	O
monocytic	O
differentiation	O
.	O
During	O
monocyte-to-macrophage	O
differentiation	O
,	O
the	O
cellular	O
content	O
of	O
vacuolar	protein
H+-ATPase	protein
(	O
V-ATPase	protein
)	O
increases	O
more	O
than	O
4-fold.	O
We	O
have	O
shown	O
previously	O
that	O
amplified	O
expression	O
of	O
the	O
B2	protein
subunit	protein
of	O
the	O
V-ATPase	protein
occurs	O
solely	O
by	O
increased	O
transcription,	O
and	O
that	O
the	O
5'-untranslated	DNA
region	DNA
of	O
the	O
B2	DNA
gene	DNA
,	O
containing	O
multiple	O
consensus	DNA
binding	DNA
sites	DNA
for	O
the	O
transcription	protein
factors	protein
AP-2	protein
and	O
Sp1	protein
,	O
is	O
required	O
for	O
this	O
expression.	O
The	O
present	O
study	O
demonstrates	O
that	O
AP-2	DNA
binding	DNA
sequences	DNA
are	O
essential	O
for	O
increased	O
transcription	O
from	O
the	O
B2	DNA
promoter	DNA
during	O
monocyte-macrophage	O
differentiation	O
and	O
that	O
AP-2	protein
,	O
expressed	O
exogenously	O
in	O
THP-1	cell_line
and	O
other	O
cells,	O
activates	O
transcription	O
from	O
the	O
B2	DNA
promoter	DNA
.	O
In	O
mobility	O
shift	O
assays	O
,	O
a	O
nuclear	protein
factor	protein
from	O
THP-1	cell_line
and	O
U-937	cell_line
cells	cell_line
was	O
identified	O
that	O
binds	O
to	O
several	O
AP-2	DNA
response	DNA
elements	DNA
within	O
the	O
B2	DNA
promoter	DNA
,	O
but	O
does	O
not	O
react	O
with	O
AP-2	protein
antibodies	protein
,	O
and	O
has	O
a	O
DNA	DNA
sequence	DNA
binding	O
affinity	O
profile	O
that	O
differs	O
from	O
AP-2	protein
.	O
These	O
findings	O
suggest	O
that	O
a	O
novel	O
AP-2	protein
-like	protein
transcription	protein
factor	protein
is	O
responsible	O
for	O
V-ATPase	protein
B	protein
subunit	protein
amplification	O
during	O
monocyte	O
differentiation	O
.	O

c-Jun	O
and	O
GST-pi	O
expression	O
in	O
human	cell_type
plasma	cell_type
cells	cell_type
.	O
Bone	O
marrow	O
samples	O
from	O
33	O
patients	O
affected	O
by	O
MM	O
and	O
MGUS	O
,	O
and	O
8	O
patients	O
not	O
affected	O
by	O
lymphoproliferative	O
diseases	O
were	O
studied	O
for	O
expression	O
of	O
c-Jun	protein
(a	O
component	O
of	O
the	O
transcription	protein
factor	protein
AP-1	protein
)	O
and	O
glutathione-S-transferase	protein
pi	protein
(	O
GST-pi	protein
)	O
using	O
immunocytochemical	O
methods	O
.	O
A	O
high	O
and	O
frequent	O
expression	O
of	O
these	O
two	O
proteins	O
was	O
found	O
both	O
in	O
MM	O
and	O
MGUS	O
patients	O
(31/33	O
patients	O
positive	O
for	O
c-Jun	protein
and	O
29/33	O
patients	O
positive	O
for	O
GST-pi	protein
)	O
and	O
in	O
controls	O
not	O
affected	O
by	O
monoclonal	O
gammopathy	O
(7/8	O
patients	O
positive	O
for	O
both	O
c-Jun	protein
and	O
GST-pi	protein
).	O
No	O
statistically	O
significant	O
correlation	O
was	O
found	O
between	O
c-Jun-	O
and	O
GST-pi-	O
positive	O
plasma	O
cells	O
.	O
The	O
expression	O
of	O
these	O
two	O
proteins	O
was	O
not	O
related	O
to	O
clinical	O
or	O
laboratory	O
data.	O
Our	O
results	O
seem	O
to	O
confirm	O
a	O
possible	O
role	O
of	O
the	O
transcriptional	protein
complex	protein
AP-1	protein
in	O
activating	O
GST-pi	DNA
promoter	DNA
in	O
human	cell_type
plasma	cell_type
cells	cell_type
.	O

Activation	O
of	O
signaling	O
pathways	O
and	O
prevention	O
of	O
apoptosis	O
by	O
cytokines	protein
in	O
eosinophils	cell_type
.	O
Inhibition	O
of	O
apoptosis	O
in	O
eosinophils	cell_type
by	O
cytokines	protein
such	O
as	O
IL-5	protein
and	O
GM-CSF	protein
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
allergic	O
and	O
parasitic	O
disorders	O
.	O
Recently,	O
there	O
has	O
been	O
some	O
progress	O
in	O
the	O
understanding	O
of	O
the	O
signal	O
transduction	O
pathways	O
activated	O
by	O
these	O
cytokines	protein
in	O
eosinophils	cell_type
.	O
The	O
IL-3	protein
,	O
IL-5	protein
and	O
GM-CSF	protein
receptors	protein
share	O
a	O
common	protein
signal	protein
transducer	protein
that	O
possesses	O
no	O
intrinsic	protein
kinase	protein
domain	protein
.	O
It	O
has	O
been	O
shown	O
that	O
eosinophil	O
stimulation	O
by	O
these	O
cytokines	protein
is	O
associated	O
with	O
increases	O
in	O
tyrosine	O
phosphorylation	O
of	O
several	O
cellular	O
substrates	O
.	O
In	O
the	O
past	O
few	O
years,	O
there	O
has	O
been	O
some	O
progress	O
in	O
defining	O
the	O
tyrosine	O
kinases	O
that	O
are	O
activated	O
by	O
the	O
IL-3	protein
/	protein
IL-5	protein
/	protein
GM-CSF	protein
receptor	protein
beta-subunit	protein
in	O
eosinophils	cell_type
.	O
This	O
review	O
will	O
concentrate	O
on	O
this	O
topic	O
and	O
on	O
its	O
role	O
for	O
the	O
regulation	O
of	O
eosinophil	O
apoptosis	O
.	O

Requirement	O
of	O
GATA-1	protein
and	O
p45	protein
NF-E2	protein
expression	O
in	O
butyric	O
acid	O
-induced	O
erythroid	O
differentiation	O
.	O
Butyric	O
acid	O
(	O
BA	O
)	O
is	O
known	O
to	O
induce	O
overexpression	O
of	O
fetal	protein
hemoglobin	protein
and	O
then	O
erythroid	O
differentiation	O
.	O
Therefore,	O
BA	O
is	O
currently	O
under	O
clinical	O
investigation	O
as	O
a	O
potential	O
therapy	O
for	O
the	O
treatment	O
of	O
sickle	O
cell	O
disease	O
and	O
cancer	O
.	O
Nevertheless,	O
the	O
molecular	O
mechanisms	O
involved	O
in	O
BA	O
-induced	O
differentiation	O
remain	O
largely	O
unknown.	O
Previous	O
reports	O
have	O
shown	O
that	O
BA	O
-induced	O
overexpression	O
of	O
erythroid	DNA
genes	DNA
occurred	O
at	O
the	O
transcriptional	O
level	O
,	O
suggesting	O
the	O
involvement	O
of	O
erythroid	protein
transcription	protein
factors	protein
.	O
Here,	O
we	O
intend	O
to	O
demonstrate	O
the	O
requirement	O
of	O
GATA-1	protein
and	O
NF-E2	protein
transcription	protein
factors	protein
in	O
the	O
BA	O
-induced	O
erythroid	O
differentiation	O
of	O
human	cell_line
leukemic	cell_line
K562	cell_line
cells	cell_line
.	O
Time-course	O
experiments	O
showed	O
that	O
nuclear	O
levels	O
of	O
GATA-1	protein
and	O
p45	protein
NF-E2	protein
proteins	O
increased	O
during	O
BA	O
treatment.	O
Moreover,	O
antisense	O
oligodeoxynucleotides	O
targeting	O
either	O
GATA-1	protein
or	O
p45	protein
NF-E2	protein
proteins	O
inhibited	O
both	O
protein	O
expression	O
and	O
BA	O
-induced	O
differentiation.	O
In	O
contrast,	O
BA	O
-induced	O
cell	O
growth	O
inhibition	O
was	O
not	O
affected.	O
These	O
results	O
provide	O
the	O
first	O
direct	O
evidence	O
for	O
the	O
requirement	O
of	O
GATA-1	protein
and	O
NF-E2	protein
in	O
BA	O
-induced	O
differentiation	O
process	O
.	O

Characterisation	O
of	O
regulatory	O
sequences	O
at	O
the	O
Epstein-Barr	DNA
virus	DNA
BamHI	DNA
W	DNA
promoter	DNA
.	O
Epstein-Barr	O
virus	O
,	O
a	O
human	O
gammaherpesvirus	O
,	O
possesses	O
a	O
unique	O
set	O
of	O
latent	DNA
genes	DNA
whose	O
constitutive	O
expression	O
in	O
B	cell_type
cells	cell_type
leads	O
to	O
cell	O
growth	O
transformation	O
.	O
The	O
initiation	O
of	O
this	O
growth	O
transforming	O
infection	O
depends	O
on	O
a	O
viral	DNA
promoter	DNA
in	O
BamHI	O
W	O
(Wp)	O
whose	O
regulation	O
is	O
poorly	O
understood.	O
Using	O
Wp	DNA
reporter	DNA
constructs	DNA
in	O
in	O
vitro	O
transfection	O
assays	O
,	O
we	O
found	O
that	O
Wp	O
was	O
11-	O
to	O
190-fold	O
more	O
active	O
in	O
B	cell_line
cell	cell_line
than	O
in	O
non-B	cell_line
cell	cell_line
lines	cell_line
and	O
that	O
three	O
regions	O
of	O
the	O
promoter	DNA
(termed	O
UAS1	DNA
,	O
UAS2	DNA
,	O
and	O
UAS3	DNA
)	O
contributed	O
to	O
transcriptional	O
activation	O
.	O
The	O
upstream	O
regions	O
UAS3	DNA
(	O
-1168	DNA
to	DNA
-440	DNA
)	O
and	O
UAS2	DNA
(	O
-352	DNA
to	DNA
-264	DNA
)	O
both	O
functioned	O
in	O
a	O
cell	O
lineage-independent	O
manner	O
and	O
were	O
together	O
responsible	O
for	O
the	O
bulk	O
of	O
Wp	O
activity	O
in	O
non-B	cell_type
cells	cell_type
;	O
mutational	O
analysis	O
indicated	O
the	O
importance	O
of	O
a	O
YY1	DNA
binding	DNA
site	DNA
in	O
UAS2	DNA
in	O
that	O
context.	O
By	O
contrast,	O
UAS1	DNA
(	O
-140	DNA
to	DNA
-87	DNA
)	O
was	O
B	O
cell	O
specific	O
and	O
was	O
the	O
key	O
determinant	O
of	O
the	O
promoter's	O
increased	O
activity	O
in	O
B	cell_line
cell	cell_line
lines	cell_line
.	O
Mutational	O
analysis	O
of	O
UAS1	DNA
sequences	DNA
combined	O
with	O
in	O
vitro	O
bandshift	O
assays	O
revealed	O
the	O
presence	O
of	O
three	O
binding	DNA
sites	DNA
for	O
cellular	protein
factors	protein
in	O
this	O
region.	O
When	O
mutations	O
that	O
abolished	O
factor	O
binding	O
in	O
bandshift	O
assays	O
were	O
introduced	O
into	O
a	O
Wp	DNA
reporter	DNA
construct	DNA
,	O
the	O
loss	O
of	O
any	O
one	O
of	O
the	O
three	O
UAS1	DNA
binding	DNA
sites	DNA
was	O
sufficient	O
to	O
reduce	O
promoter	O
activity	O
by	O
10-	O
to	O
30-fold	O
in	O
B	cell_type
cells	cell_type
.	O
From	O
sequence	O
analysis,	O
two	O
of	O
these	O
appear	O
to	O
be	O
novel	O
transcription	protein
factor	protein
binding	DNA
sites	DNA
,	O
whereas	O
the	O
third	O
was	O
identified	O
as	O
a	O
cyclic	DNA
AMP	DNA
response	DNA
element	DNA
(	O
CRE	DNA
).	O
Our	O
data	O
indicate	O
that	O
this	O
CRE	DNA
interacts	O
with	O
CREB	O
and	O
ATF1	O
proteins	O
present	O
in	O
B	O
cell	O
nuclear	O
extracts	O
and	O
that	O
this	O
interaction	O
is	O
important	O
for	O
Wp	O
activity	O
.	O

In	O
situ	O
RT-PCR	O
detection	O
of	O
Epstein-Barr	RNA
virus	RNA
immediate-early	RNA
transcripts	RNA
in	O
CD4+	O
and	O
CD8+	O
T	O
lymphocytes	O
.	O
AIDS	O
-related	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)-associated	O
T	O
cell	O
lymphomas	O
are	O
emerging	O
as	O
a	O
new,	O
distinct	O
histopathological	O
entity	O
.	O
The	O
pathway	O
whereby	O
EBV	O
infects	O
T	cell_type
cells	cell_type
as	O
well	O
as	O
the	O
initial	O
EBV	O
transcriptional	O
program	O
in	O
T	cell_type
cells	cell_type
has	O
not	O
been	O
established.	O
In	O
order	O
to	O
shed	O
light	O
on	O
the	O
early	O
events	O
of	O
the	O
EBV	O
infection	O
of	O
T	cell_type
cells	cell_type
,	O
we	O
have	O
used	O
in	O
situ	O
reverse	O
transcription	O
based	O
polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
)	O
to	O
study	O
the	O
initial	O
EBV	O
transcriptional	O
program	O
in	O
homogeneous	O
CD4+	O
and	O
CD8+	O
lymphocytes	O
.	O
Following	O
EBV	O
infection	O
,	O
Epstein-Barr	O
nuclear	O
antigen	O
(	O
EBNA	protein
)	O
expression	O
could	O
be	O
detected	O
in	O
T	O
rosetting	O
CD4+	O
and	O
CD8+	O
T	O
lymphocytes	O
.	O
Only	O
a	O
few	O
cells	O
showed	O
viral	protein
capsid	protein
antigen	protein
(	O
VCA	protein
).	O
EBV	RNA
immediate-early	RNA
gene	RNA
transcripts	RNA
(	O
BZLF1	RNA
,	O
BRLF1	RNA
,	O
and	O
BMLF1	RNA
)	O
encoded	O
in	O
the	O
BamHI	O
Z,	O
R,	O
and	O
M	O
fragments	O
could	O
be	O
detected	O
by	O
in	O
situ	O
RT-PCR	O
in	O
the	O
EBV	O
producer	O
cell	O
line	O
B95.8.	O
Both	O
BZLF1	O
and	O
BRLF1	O
immediate-early	O
transcripts	O
,	O
but	O
not	O
BMLF1	RNA
transcript	RNA
,	O
could	O
be	O
detected	O
in	O
individual	O
CD4+	O
and	O
CD8+	O
T	O
cells	O
infected	O
with	O
EBV	O
.	O
Demonstration	O
of	O
EBV	RNA
mRNA	RNA
transcripts	RNA
encoding	O
immediate-early	protein
transcriptional	protein
transactivators	protein
in	O
EBV	cell_type
-infected	cell_type
T	cell_type
cells	cell_type
provides	O
the	O
first	O
evidence	O
for	O
a	O
possible	O
mechanism	O
whereby	O
EBV	O
could	O
contribute	O
to	O
T	O
cell	O
proliferation	O
and	O
EBV	O
-associated	O
T	O
cell	O
malignancies	O
.	O

The	O
linkage	O
between	O
T-cell	O
and	O
dendritic	O
cell	O
development	O
in	O
the	O
mouse	O
thymus	O
.	O
Thymic	cell_type
dendritic	cell_type
cells	cell_type
(	O
DC	cell_type
)	O
mediate	O
negative	O
selection	O
at	O
a	O
relatively	O
late	O
stage	O
of	O
the	O
T-cell	O
developmental	O
pathway	O
.	O
We	O
present	O
evidence	O
that	O
the	O
development	O
of	O
thymic	cell_type
DC	cell_type
and	O
of	O
T-lineage	cell_type
cells	cell_type
is	O
linked	O
via	O
a	O
common	O
precursor	O
at	O
an	O
early	O
stage	O
of	O
thymocyte	O
development	O
.	O
T-lineage	O
precursor	O
populations	O
from	O
the	O
adult	O
mouse	O
thymus	O
,	O
prior	O
to	O
T-cell	O
receptor	O
gene	O
rearrangement	O
,	O
display	O
a	O
capacity	O
to	O
produce	O
DC	cell_type
as	O
well	O
as	O
T	cell_type
cells	cell_type
in	O
the	O
thymus	O
,	O
and	O
are	O
very	O
efficient	O
precursors	O
of	O
DC	cell_type
in	O
culture.	O
These	O
lymphoid/	cell_type
DC	cell_type
precursors	cell_type
have	O
little	O
capacity	O
to	O
form	O
myeloid	cell_type
cells	cell_type
,	O
indicating	O
that	O
thymic	cell_type
DC	cell_type
are	O
a	O
lymphoid-related	O
rather	O
than	O
myeloid-related	cell_type
lineage	cell_type
.	O
In	O
contrast	O
to	O
myeloid-related	cell_type
DC	cell_type
,	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
is	O
not	O
required	O
for	O
the	O
development	O
of	O
these	O
lymphoid-related	cell_type
DC	cell_type
in	O
vivo	O
or	O
in	O
vitro.	O
DC	cell_type
can	O
develop	O
in	O
mutant	O
mice	O
lacking	O
mature	cell_type
T	cell_type
cells	cell_type
,	O
provided	O
the	O
common	O
precursors	O
are	O
present.	O
However,	O
in	O
mutant	O
mice	O
lacking	O
functional	O
Ikaros	protein
transcription	protein
factors	protein
,	O
there	O
are	O
deficiencies	O
in	O
lymphoid	cell_type
precursor	cell_type
cells	cell_type
,	O
in	O
mature	cell_type
lymphoid	cell_type
cells	cell_type
and	O
in	O
DC	cell_type
.	O

Host	O
control	O
of	O
HIV-1	O
parasitism	O
in	O
T	cell_type
cells	cell_type
by	O
the	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
.	O
Post	O
HIV-1	O
entry	O
,	O
productive	O
HIV-1	O
infection	O
of	O
primary	cell_type
T	cell_type
cells	cell_type
requires	O
overcoming	O
several	O
cellular	O
blocks	O
to	O
provirus	O
establishment	O
and	O
replication.	O
Activation	O
of	O
unknown	O
host	O
intracellular	O
events	O
overcomes	O
such	O
inhibitory	O
steps	O
and	O
is	O
concomitant	O
with	O
HIV-1	O
replication	O
.	O
We	O
show	O
that	O
the	O
transcription	protein
factor	protein
NFATc	protein
was	O
sufficient	O
as	O
a	O
cellular	O
factor	O
to	O
induce	O
a	O
highly	O
permissive	O
state	O
for	O
HIV-1	O
replication	O
in	O
primary	cell_type
CD4+	cell_type
T	cell_type
cells	cell_type
.	O
NFATc	protein
overcame	O
a	O
blockade	O
at	O
reverse	O
transcription	O
and	O
permitted	O
active	O
HIV-1	O
replication	O
.	O
Pharmacologic	O
blockade	O
of	O
endogenous	protein
NFAT	protein
activity	O
by	O
FK506	O
or	O
CsA	O
inhibited	O
synthesis	O
of	O
reverse	O
transcription	O
and	O
also	O
potently	O
blocked	O
HIV-1	O
replication	O
.	O
T	cell_type
cells	cell_type
therefore	O
can	O
become	O
competent	O
for	O
HIV-1	O
replication	O
by	O
control	O
of	O
regulated	protein
host	protein
factors	protein
such	O
as	O
the	O
NFATc	protein
transcription	protein
factor	protein
.	O
The	O
host	O
mechanisms	O
regulated	O
by	O
such	O
permissivity	O
factors	O
are	O
potential	O
targets	O
for	O
anti-	O
HIV-1	O
therapy	O
.	O

Regulation	O
of	O
NF-kappa	protein
B	protein
,	O
AP-1	protein
,	O
NFAT	protein
,	O
and	O
STAT1	protein
nuclear	O
import	O
in	O
T	cell_type
lymphocytes	cell_type
by	O
noninvasive	O
delivery	O
of	O
peptide	O
carrying	O
the	O
nuclear	protein
localization	protein
sequence	protein
of	O
NF-kappa	protein
B	protein
p50	protein
.	O
Activation	O
of	O
T	cell_type
lymphocytes	cell_type
by	O
Ags	protein
or	O
cytokines	protein
results	O
in	O
translocation	O
of	O
the	O
transcription	protein
factors	protein
NF-kappa	protein
B	protein
,	O
AP-1	protein
,	O
NFAT	protein
,	O
and	O
STAT	protein
from	O
the	O
cytoplasm	O
into	O
the	O
nucleus	O
.	O
The	O
first	O
step	O
in	O
the	O
nuclear	O
import	O
process	O
is	O
recognition	O
of	O
a	O
nuclear	protein
localization	protein
sequence	protein
(	O
NLS	protein
)	O
within	O
the	O
karyophilic	protein
protein	protein
by	O
a	O
cytoplasmic	protein
receptor	protein
such	O
as	O
the	O
importin	protein
(karyopherin)-alpha	protein
subunit	protein
.	O
The	O
NLSs	protein
of	O
NF-kappa	protein
B	protein
,	O
AP-1	protein
,	O
and	O
NFAT	protein
differ	O
and	O
the	O
NLS	protein
of	O
STAT1	protein
has	O
not	O
yet	O
been	O
identified.	O
Herein	O
we	O
demonstrate	O
that	O
the	O
inducible	O
nuclear	O
import	O
of	O
NF-kappa	protein
B	protein
,	O
AP-1	protein
,	O
NFAT	protein
,	O
and	O
STAT1	protein
in	O
Jurkat	cell_line
T	cell_line
lymphocytes	cell_line
is	O
significantly	O
inhibited	O
by	O
a	O
cell-permeable	O
peptide	O
carrying	O
the	O
NLS	protein
of	O
the	O
NF-kappa	protein
B	protein
p50	protein
subunit	protein
.	O
NLS	protein
peptide-mediated	O
disruption	O
of	O
the	O
nuclear	O
import	O
of	O
these	O
transcription	protein
factors	protein
results	O
in	O
inhibition	O
of	O
I	O
kappa	O
B	O
alpha	O
and	O
IL-2	O
gene	O
expression	O
,	O
processes	O
dependent	O
on	O
NF-kappa	protein
B	protein
or	O
the	O
combination	O
of	O
NF-kappa	protein
B	protein
,	O
AP-1	protein
,	O
and	O
NFAT	protein
.	O
Further,	O
we	O
show	O
that	O
inhibitory	O
NLS	protein
peptide	O
interacts	O
in	O
vitro	O
with	O
a	O
cytoplasmic	protein
NLS	protein
receptor	protein
complex	protein
comprised	O
of	O
the	O
Rch1/importin	protein
(karyopherin)-beta	protein
heterodimer	protein
expressed	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
Taken	O
together,	O
these	O
data	O
indicate	O
that	O
the	O
inducible	O
nuclear	O
import	O
of	O
NF-kappa	protein
B	protein
,	O
AP-1	protein
,	O
NFAT	protein
,	O
and	O
STAT1	protein
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
can	O
be	O
regulated	O
by	O
NLS	protein
peptide	O
delivered	O
noninvasively	O
to	O
the	O
cytoplasm	O
of	O
Jurkat	cell_line
T	cell_line
cells	cell_line
to	O
target	O
members	O
of	O
the	O
importin	protein
(karyopherin)-alpha	protein
beta	protein
NLS	protein
receptor	protein
complex	protein
.	O

Membrane-associated	protein
lymphotoxin	protein
on	O
natural	cell_type
killer	cell_type
cells	cell_type
activates	O
endothelial	cell_type
cells	cell_type
via	O
an	O
NF-kappaB	protein
-dependent	O
pathway	O
.	O
BACKGROUND:	O
Inhibition	O
of	O
complement	O
in	O
small	O
animal	O
models	O
of	O
xenotransplantation	O
has	O
demonstrated	O
graft	O
infiltration	O
with	O
natural	cell_type
killer	cell_type
(NK)	cell_type
cells	cell_type
and	O
monocytes	O
associated	O
with	O
endothelial	cell_type
cell	cell_type
(	O
EC	cell_type
)	O
activation	O
.	O
We	O
have	O
previously	O
demonstrated	O
that	O
human	cell_type
NK	cell_type
cells	cell_type
activate	O
porcine	O
EC	cell_type
in	O
vitro,	O
which	O
results	O
in	O
adhesion	protein
molecule	protein
expression	O
and	O
cytokine	protein
secretion	O
.	O
In	O
this	O
study,	O
we	O
used	O
the	O
NK	cell_line
cell	cell_line
line	cell_line
NK92	cell_line
to	O
define	O
the	O
molecular	O
and	O
cellular	O
basis	O
of	O
NK	O
cell-mediated	O
EC	cell_type
activation	O
.	O
METHODS:	O
EC	cell_type
were	O
transfected	O
with	O
either	O
reporter	O
constructs	O
containing	O
the	O
luciferase	DNA
gene	DNA
driven	O
either	O
by	O
E-selectin	O
or	O
interleukin	O
(IL)-8	O
promoters	O
or	O
a	O
synthetic	O
NF-kappaB	DNA
-dependent	DNA
promoter	DNA
.	O
In	O
addition,	O
a	O
dominant-negative	DNA
mutant	DNA
tumor	DNA
necrosis	DNA
factor	DNA
receptor	DNA
I	DNA
(TNFRI)	DNA
expression	DNA
vector	DNA
was	O
co-transfected	O
in	O
inhibition	O
studies.	O
Forty-eight	O
hours	O
after	O
transfection	O
,	O
EC	cell_type
were	O
stimulated	O
with	O
NK	cell_type
cells	cell_type
or	O
NK	cell_type
cell	cell_type
membrane	cell_type
extracts	cell_type
for	O
7	O
hr	O
and	O
activation	O
was	O
measured	O
by	O
a	O
luciferase	protein
assay	O
.	O
RESULTS:	O
Co-culture	O
of	O
NK	cell_type
cells	cell_type
with	O
transfected	O
EC	cell_type
enhanced	O
E-selectin	protein
,	O
IL-8	protein
,	O
and	O
NF-kappaB	protein
-dependent	O
promoter	O
activity	O
.	O
NK	O
cell	O
membrane	O
extracts	O
retained	O
the	O
capacity	O
to	O
activate	O
EC	cell_type
and	O
induced	O
nuclear	O
translocation	O
of	O
NF-kappaB	protein
(	O
p50	protein
and	O
p65	protein
).	O
Western	O
blotting	O
of	O
NK	cell_type
cell	cell_type
and	O
membrane	O
extracts	O
detected	O
the	O
presence	O
of	O
Lymphotoxin-alpha	protein
(	O
LTalpha	protein
)	O
but	O
not	O
tumor	protein
necrosis	protein
factor-alpha	protein
.	O
Furthermore,	O
LTalpha	protein
was	O
secreted	O
in	O
NK:	cell_line
EC	cell_line
co-cultures	cell_line
.	O
Co-transfection	O
with	O
dominant-negative	protein
mutant	protein
TNFRI	protein
inhibited	O
EC	cell_type
activation	O
by	O
NK	O
cell	O
membrane	O
extracts	O
and	O
by	O
NK	cell_type
cells	cell_type
by	O
80%	O
and	O
47%,	O
respectively.	O
The	O
same	O
pattern	O
of	O
inhibition	O
was	O
observed	O
using	O
anti-human	O
LT	O
sera	O
.	O
CONCLUSIONS:	O
Human	O
NK	O
cell	O
membrane-bound	O
LT	O
signals	O
across	O
species	O
via	O
TNFRI	protein
,	O
leading	O
to	O
NF-kappaB	protein
nuclear	O
translocation	O
and	O
transcription	O
of	O
E-selectin	protein
and	O
IL-8	protein
,	O
which	O
results	O
in	O
EC	cell_type
activation.	O
The	O
discrepancy	O
in	O
the	O
degree	O
of	O
inhibition	O
by	O
membrane	O
extracts	O
and	O
NK	cell_type
cells	cell_type
with	O
mutant	protein
TNFRI	protein
suggests	O
that	O
additional	O
pathways	O
are	O
utilized	O
by	O
NK	cell_type
cells	cell_type
to	O
activate	O
EC	cell_type

Ras	protein
-dependent,	O
Ca2+	O
-stimulated	O
activation	O
of	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
by	O
a	O
constitutively	O
active	O
Cbl	protein
mutant	protein
in	O
T	cell_type
cells	cell_type
.	O
T	protein
cell	protein
receptor	protein
(	O
TCR	protein
)	O
stimulation	O
induces	O
rapid	O
tyrosine	O
phosphorylation	O
of	O
cellular	protein
proteins	protein
,	O
including	O
Cbl	protein
,	O
a	O
protooncogene	protein
product	protein
whose	O
function	O
remains	O
unclear.	O
As	O
a	O
first	O
step	O
toward	O
elucidating	O
the	O
function	O
of	O
Cbl	protein
in	O
TCR	protein
-initiated	O
signaling	O
,	O
we	O
evaluated	O
the	O
ability	O
of	O
wild-type	protein
Cbl	protein
or	O
a	O
transforming	O
Cbl	protein
mutant	protein
(70Z/3)	O
to	O
induce	O
transcriptional	O
activation	O
of	O
a	O
nuclear	DNA
factor	DNA
of	DNA
activated	DNA
T	DNA
cells	DNA
(	DNA
NFAT	DNA
)	DNA
element	DNA
derived	O
from	O
the	O
interleukin	DNA
2	DNA
(	DNA
IL2	DNA
)	DNA
promoter	DNA
in	O
transiently	O
cotransfected	O
Jurkat-TAg	cell_line
T	cell_line
cells	cell_line
.	O
70Z/3	protein
,	O
but	O
not	O
Cbl	protein
,	O
caused	O
NFAT	protein
activation	O
which	O
was	O
significantly	O
enhanced	O
by	O
stimulation	O
with	O
calcium	O
ionophore	O
,	O
and	O
was	O
drastically	O
reduced	O
by	O
cyclosporin	O
A	O
pretreatment	O
.	O
A	O
point	O
mutation	O
of	O
a	O
potential	O
phosphatidylinositol	DNA
3-kinase	DNA
(	DNA
PI3-K	DNA
)	DNA
binding	DNA
site	DNA
(	O
Y731EAM	DNA
to	O
Y731EAC	DNA
)	O
in	O
70Z/3	protein
disrupted	O
the	O
association	O
of	O
PI3-K	protein
with	O
70Z/3	protein
,	O
but	O
did	O
not	O
reduce	O
the	O
induction	O
of	O
NFAT	protein
activity	O
,	O
suggesting	O
that	O
the	O
interaction	O
between	O
Cbl	protein
and	O
PI3-K	protein
is	O
not	O
required	O
in	O
the	O
70Z/3	protein
-mediated	O
induction	O
of	O
NFAT	protein
.	O
Additional	O
mapping	O
studies	O
indicated	O
that	O
defined	O
deletions	O
of	O
C-terminal	O
70Z/3	protein
sequences	O
affected	O
to	O
a	O
variable	O
degree	O
its	O
ability	O
to	O
stimulate	O
NFAT	protein
activity	O
.	O
Strikingly,	O
deletion	O
of	O
346	protein
C-terminal	protein
residues	protein
augmented	O
this	O
activity,	O
whereas	O
removal	O
of	O
20	O
additional	O
residues	O
abolished	O
it.	O
Coexpression	O
of	O
dominant	protein
negative	protein
Ras	protein
abrogated	O
the	O
basal	O
or	O
ionomycin-stimulated,	O
70Z/3	protein
-mediated	O
NFAT	protein
activation	O
,	O
suggesting	O
a	O
functional	protein
Ras	protein
is	O
required	O
for	O
this	O
activation.	O
These	O
results	O
implicate	O
Cbl	protein
in	O
Ras	protein
-dependent	O
signaling	O
pathways	O
which	O
lead	O
to	O
NFAT	protein
activation	O
.	O

Requirement	O
of	O
prestimulated	cell_line
THP-1	cell_line
monocytic	cell_line
cells	cell_line
for	O
endothelial	cell_type
cell	cell_type
activation	O
.	O
Involvement	O
of	O
TNF	O
alpha.	O
Blood	cell_type
monocytes	cell_type
spontaneously	O
activate	O
endothelial	cell_type
cells	cell_type
in	O
culture,	O
leading	O
to	O
adhesion	O
of	O
monocytic	cell_type
cells	cell_type
onto	O
the	O
endothelial	O
surface	O
and	O
overproduction	O
of	O
endothelial	O
proteins	O
such	O
as	O
von	protein
Willebrand	protein
factor	protein
(	O
vWf	protein
)	O
and	O
plasminogen	protein
activator	protein
inhibitor	protein
type	protein
1	protein
(	O
PAI-1	protein
).	O
To	O
overcome	O
the	O
difficulty	O
in	O
obtaining	O
quiescent	cell_type
monocytes	cell_type
,	O
we	O
studied	O
the	O
ability	O
of	O
promonocytic	cell_line
THP-1	cell_line
cells	cell_line
to	O
activate	O
endothelial	cell_type
cells	cell_type
.	O
Lipopolysaccharide	O
(	O
LPS	O
)-prestimulated	O
and	O
untreated	O
THP-1	cell_line
cells	cell_line
were	O
cocultured	O
with	O
resting	cell_type
human	cell_type
umbilical	cell_type
vein	cell_type
endothelial	cell_type
cells	cell_type
(	O
HUVEC	cell_type
)	O
for	O
3	O
and	O
24	O
h	O
in	O
the	O
presence	O
of	O
colimycin	O
to	O
neutralize	O
LPS	O
traces.	O
Addition	O
of	O
untreated	O
THP-1	cell_line
cells	cell_line
had	O
little	O
effect	O
on	O
HUVEC	cell_type
adhesiveness.	O
Addition	O
of	O
prestimulated	O
THP-1	cell_line
cells	cell_line
was	O
followed	O
by	O
a	O
noticeable	O
adhesion	O
after	O
3	O
h	O
which	O
reversed	O
to	O
basal	O
values	O
within	O
24	O
h.	O
Under	O
these	O
conditions	O
HUVEC	protein
adhesion	protein
molecules	protein
,	O
E-selectin	protein
,	O
VCAM-1	protein
and	O
ICAM-1	protein
,	O
were	O
increased	O
at	O
3	O
h	O
with	O
only	O
ICAM-1	protein
remaining	O
overexpressed	O
at	O
24	O
h.	O
Diffusible	protein
endothelial	protein
proteins	protein
such	O
as	O
soluble	O
E-selectin	protein
,	O
PAI-1	protein
and	O
vWf	protein
to	O
a	O
minimal	O
extent,	O
increased	O
in	O
supernatants	O
from	O
HUVEC	cell_type
cocultured	O
for	O
24	O
h	O
with	O
prestimulated	O
THP-1	cell_line
cells	cell_line
.	O
In	O
those	O
cocultures,	O
TNF	protein
alpha	protein
concentrations	O
peaked	O
at	O
3	O
h	O
whereas	O
IL-1	O
beta	O
levels	O
progressively	O
rose	O
until	O
24	O
h.	O
Addition	O
of	O
an	O
anti-	protein
TNF	protein
alpha	protein
antibody	protein
decreased	O
by	O
40%	O
E-selectin	protein
and	O
ICAM-1	protein
induction	O
and	O
suppressed	O
PAI-1	protein
overproduction	O
with	O
a	O
weak	O
effect	O
on	O
vWf	protein
.	O
An	O
anti-IL-1	protein
beta	protein
antibody	protein
had	O
negligible	O
effects	O
on	O
HUVEC	protein
adhesion	protein
molecules	protein
,	O
PAI-1	protein
or	O
vWf	protein
production.	O
These	O
results	O
provide	O
evidence	O
that	O
promonocytic	cell_line
THP-1	cell_line
cells	cell_line
require	O
prestimulation	O
in	O
order	O
to	O
activate	O
HUVEC	cell_type
and	O
that	O
TNF	protein
alpha	protein
contributes	O
to	O
this	O
phenomenon.	O

Engagement	O
of	O
the	O
Lewis	O
X	O
antigen	O
(	O
CD15	O
)	O
results	O
in	O
monocyte	O
activation	O
.	O
We	O
previously	O
reported	O
that	O
monocyte	O
adhesion	O
to	O
tumor	cell_line
necrosis	cell_line
factor-alpha	cell_line
(	cell_line
TNF-alpha	cell_line
)-treated	cell_line
endothelial	cell_line
cells	cell_line
increased	O
expression	O
of	O
tissue	O
factor	O
and	O
CD36	protein
on	O
monocytes.	O
Using	O
immunological	O
cross-linking	O
to	O
mimic	O
receptor	O
engagement	O
by	O
natural	O
ligands,	O
we	O
now	O
show	O
that	O
CD15	O
(	O
Lewis	O
X	O
),	O
a	O
monocyte	protein
counter-receptor	protein
for	O
endothelial	protein
selectins	protein
may	O
participate	O
in	O
this	O
response.	O
We	O
used	O
cytokine	O
production	O
as	O
a	O
readout	O
for	O
monocyte	O
activation	O
and	O
found	O
that	O
CD15	O
cross-linking	O
induced	O
TNF-alpha	protein
release	O
from	O
peripheral	cell_type
blood	cell_type
monocytes	cell_type
and	O
cells	O
from	O
the	O
monocytic	cell_line
cell	cell_line
line	cell_line
MM6	cell_line
.	O
Quantitative	O
reverse	protein
transcriptase	protein
-polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
)	O
showed	O
an	O
increase	O
in	O
steady-state	O
TNF-alpha	RNA
mRNA	RNA
after	O
3	O
to	O
4	O
hours	O
of	O
cross-linking.	O
CD15	O
cross-linking	O
also	O
concomitantly	O
increased	O
interleukin-1	RNA
beta	RNA
(	RNA
IL-1	RNA
beta	RNA
)	RNA
mRNA	RNA
,	O
while	O
no	O
apparent	O
change	O
was	O
observed	O
in	O
the	O
levels	O
of	O
beta-actin	RNA
mRNA	RNA
,	O
indicating	O
specificity.	O
To	O
examine	O
transcriptional	O
regulation	O
of	O
cytokine	DNA
genes	DNA
by	O
CD15	O
engagement,	O
a	O
CAT	O
plasmid	O
reporter	O
construct	O
containing	O
IL-1	DNA
beta	DNA
promoter/enhancer	DNA
sequences	DNA
was	O
introduced	O
into	O
MM6	cell_line
.	O
Subsequent	O
cross-linking	O
of	O
CD15	O
increased	O
CAT	protein
activity	O
.	O
CD15	O
engagement	O
by	O
monoclonal	protein
antibody	protein
also	O
attenuated	O
IL-1	protein
beta	protein
transcript	O
degradation,	O
demonstrating	O
that	O
signaling	O
via	O
CD15	O
also	O
had	O
posttranscriptional	O
effects	O
.	O
Nuclear	O
extracts	O
of	O
anti-	O
CD15	cell_type
cross-linked	cell_type
cells	cell_type
demonstrated	O
enhanced	O
levels	O
of	O
the	O
transcriptional	protein
factor	protein
activator	protein
protein-1	protein
,	O
minimally	O
changed	O
nuclear	protein
factor-kappa	protein
B	protein
,	O
and	O
did	O
not	O
affect	O
SV40	protein
promoter	protein
specific	protein
protein-1	protein
.	O
We	O
conclude	O
that	O
engagement	O
of	O
CD15	O
on	O
monocytes	O
results	O
in	O
monocyte	O
activation	O
.	O
In	O
addition	O
to	O
its	O
well-recognized	O
adhesive	O
role,	O
CD15	O
may	O
function	O
as	O
an	O
important	O
signaling	O
molecule	O
capable	O
of	O
initiating	O
proinflammatory	O
events	O
in	O
monocytes	cell_type
that	O
come	O
into	O
contact	O
with	O
activated	O
endothelium	O
.	O

CD2	protein
signalling	O
induces	O
phosphorylation	O
of	O
CREB	protein
in	O
primary	cell_type
lymphocytes	cell_type
.	O
Promoter	O
sequences	O
responsive	O
to	O
cyclic	O
AMP	O
(	O
cAMP	O
)	O
are	O
found	O
in	O
a	O
number	O
of	O
cellular	DNA
genes	DNA
,	O
and	O
bind	O
transcription	protein
factors	protein
of	O
the	O
cAMP	protein
response	protein
element	protein
binding	protein
protein	protein
(	O
CREB	protein
)/activating	protein
transcription	protein
factor-1	protein
(ATF-1)	protein
family	protein
.	O
We	O
have	O
used	O
a	O
human	O
T-lymphotropic	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
model	O
of	O
cAMP	DNA
response	DNA
element	DNA
(	O
CRE	DNA
)	O
transcription	O
to	O
investigate	O
the	O
influence	O
of	O
lymphocyte	O
activation	O
on	O
transcription	O
from	O
homologous	O
regions	O
in	O
the	O
viral	DNA
promoter	DNA
.	O
We	O
previously	O
demonstrated	O
increased	O
HTLV-1	O
transcription	O
following	O
CD2	O
but	O
not	O
CD3	O
receptor	O
cross-linking	O
.	O
We	O
hypothesized	O
that	O
this	O
increased	O
viral	O
transcription	O
was	O
mediated,	O
in	O
part,	O
through	O
the	O
phosphorylation	O
of	O
CREB	protein
.	O
Therefore,	O
we	O
investigated	O
CD2	protein
and	O
CD3	protein
receptor	protein
-mediated	O
signalling	O
in	O
primary	cell_type
human	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
).	O
CD2	protein
,	O
but	O
not	O
CD3	protein
,	O
cross-linking	O
increased	O
cAMP	O
detected	O
by	O
competitive	O
enzyme-linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
approximately	O
fourfold.	O
CD2	protein
cross-linking	O
concurrently	O
increased	O
phosphorylation	O
of	O
CREB	protein
detected	O
by	O
immunoblot	O
assay	O
eightfold.	O
Consistent	O
with	O
post-translational	O
regulation	O
,	O
no	O
change	O
in	O
total	O
level	O
of	O
CREB	protein
protein	O
was	O
observed.	O
Phosphorylation	O
of	O
CREB	protein
occurred	O
through	O
a	O
herbimycin	O
A	O
and	O
Rp-cAMP-	O
sensitive	O
pathway	O
,	O
suggesting	O
phosphorylation	O
required	O
antecedent	O
activation	O
of	O
both	O
protein	protein
tyrosine	protein
kinases	protein
(	O
PTK	protein
)	O
and	O
protein	protein
kinase	protein
A	protein
(	O
PKA	protein
).	O
Both	O
CD2	protein
and	O
CD3	protein
cross-linking	O
increased	O
binding	O
of	O
nuclear	protein
proteins	protein
to	O
a	O
radiolabelled	O
CRE	O
oligonucleotide	O
probe	O
in	O
electrophoretic	O
mobility	O
shift	O
assays	O
suggesting	O
that	O
lymphocyte	O
activation	O
enhances	O
binding	O
independently	O
of	O
phosphorylation	O
of	O
CREB	protein
at	O
serine	O
133	O
.	O
These	O
data	O
indicate	O
specific	O
modulation	O
of	O
the	O
CREB	protein
/ATF-1	protein
family	protein
of	O
transcription	protein
factors	protein
by	O
the	O
CD2	protein
signalling	O
pathway	O
and	O
suggest	O
CD2	protein
receptor	O
modulation	O
of	O
CRE	DNA
-mediated	O
transcription	O
following	O
ligand	O
engagement	O
(e.g.	O
cell-to-cell	O
contact).	O

X-rays	O
-induced	O
secretion	O
of	O
cellular	protein
factor	protein
(s)	O
that	O
enhance(s)	O
HIV-1	DNA
promoter	DNA
transcription	O
in	O
various	O
non-irradiated	cell_line
transfected	cell_line
cell	cell_line
lines	cell_line
.	O
Various	O
cellular	O
stress	O
agents	O
like	O
ionizing	O
radiation	O
exposure	O
could	O
activate	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-	O
1	O
)	O
replication	O
or	O
reporter	DNA
gene	DNA
expression	O
.	O
In	O
addition,	O
extracellular	protein
factor	protein
(s)	O
released	O
by	O
X-ray-treated	cell_line
human	cell_line
colonic	cell_line
carcinoma	cell_line
cell	cell_line
line	cell_line
(	O
HT29	cell_line
)	O
might	O
activate	O
the	O
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
of	O
HIV-1	O
in	O
non-irradiated	cell_line
HT29	cell_line
cells	cell_line
.	O
In	O
the	O
present	O
report	O
we	O
show	O
that	O
in	O
various	O
transiently	O
or	O
stably	cell_line
transfected	cell_line
cell	cell_line
lines	cell_line
,	O
X-ray	O
irradiation	O
up-regulates	O
HIV-1	DNA
LTR	DNA
transcription	O
through	O
the	O
kappaB	protein
regulatory	protein
elements	protein
.	O
A	O
factor(s),	O
which	O
is	O
processed	O
by	O
and	O
acts	O
upon	O
a	O
variety	O
of	O
cell	O
types,	O
was	O
detected	O
by	O
addition	O
to	O
non-irradiated	cell_type
cells	cell_type
of	O
either	O
X-ray	cell_line
-treated	cell_line
cells	cell_line
or	O
a	O
conditioned	O
medium	O
taken	O
from	O
irradiated	cell_line
cultures	cell_line
.	O
The	O
magnitude	O
of	O
responsiveness	O
is	O
cell	O
type	O
dependent.	O
In	O
addition,	O
X-ray	O
activation	O
of	O
HIV-1	DNA
LTR	DNA
in	O
transiently	O
or	O
stably	O
transfected	O
cell	cell_line
lines	cell_line
is	O
inhibited	O
by	O
a	O
potent	O
antioxidant	O
drug,	O
pyrrolidine	O
dithiocarbamate	O
and	O
by	O
another	O
drug,	O
known	O
for	O
its	O
role	O
in	O
the	O
trapping	O
of	O
growth	protein
factors	protein
,	O
suramin	O
.	O
The	O
importance	O
of	O
these	O
observations	O
in	O
the	O
pathophysiology	O
of	O
patients	O
with	O
AIDS-related	O
cancers	O
treated	O
by	O
radiotherapy	O
remains	O
to	O
be	O
established.	O

Activation	O
of	O
the	O
human	DNA
delta-globin	DNA
gene	DNA
promoter	DNA
in	O
primary	cell_type
adult	cell_type
erythroid	cell_type
cells	cell_type
.	O
Restoration	O
of	O
the	O
CCAAT	DNA
box	DNA
or	O
insertion	O
of	O
an	O
erythroid	DNA
Kruppel-like	DNA
factor	DNA
(EKLF)	DNA
binding	DNA
site	DNA
in	O
the	O
delta	DNA
promoter	DNA
activates	O
its	O
expression	O
in	O
several	O
erythroid	cell_line
cell	cell_line
lines	cell_line
.	O
We	O
extended	O
these	O
studies	O
using	O
a	O
novel	O
primary	cell_line
human	cell_line
adult	cell_line
erythroid	cell_line
cell	cell_line
(	cell_line
hAEC	cell_line
)	cell_line
system	cell_line
to	O
investigate	O
these	O
effects	O
at	O
the	O
late	cell_type
erythroblast	cell_type
stage	cell_type
.	O
Restoration	O
of	O
the	O
CCAAT	DNA
box	DNA
at	O
-70	DNA
bp	DNA
,	O
or	O
insertion	O
of	O
an	O
EKLF	DNA
binding	DNA
site	DNA
at	O
-85	DNA
bp	DNA
or	O
-95	DNA
bp	DNA
in	O
the	O
promoter	DNA
significantly	O
increased	O
delta	O
globin	O
gene	O
expression	O
in	O
hAEC.	O
Our	O
results	O
demonstrate	O
that	O
the	O
altered	O
CCAAT	DNA
box	DNA
(	O
CCAAC	O
)	O
and	O
the	O
lack	O
of	O
an	O
EKLF	DNA
binding	DNA
site	DNA
in	O
delta-globin	protein
contribute	O
to	O
its	O
low	O
level	O
of	O
expression	O
in	O
the	O
hAEC	cell_line
model	cell_line
as	O
well.	O

Constitutive	O
association	O
of	O
JAK1	protein
and	O
STAT5	protein
in	O
pro-B	cell_type
cells	cell_type
is	O
dissolved	O
by	O
interleukin-4	protein
-induced	O
tyrosine	O
phosphorylation	O
of	O
both	O
proteins.	O
The	O
bipartite	protein
human	protein
interleukin-4	protein
(	protein
IL-4	protein
)	protein
receptor	protein
was	O
functionally	O
expressed	O
in	O
murine	cell_type
pro-B	cell_type
cells	cell_type
and	O
activated	O
by	O
human	protein
IL-4	protein
to	O
evoke	O
intracellular	O
signaling.	O
Mutual	O
association	O
of	O
signal	protein
transducing	protein
proteins	protein
within	O
the	O
receptor	O
complex	O
was	O
then	O
studied	O
in	O
dependence	O
of	O
ligand	O
stimulation.	O
Besides	O
ligand-induced	O
receptor	O
heterodimerization	O
and	O
contacts	O
of	O
the	O
two	O
IL-4	O
receptor	O
subunits	O
alpha	O
and	O
gamma	O
with	O
Janus	protein
kinases	protein
JAK1	protein
and	O
JAK3	protein
a	O
prominent	O
constitutive	O
binding	O
between	O
JAK1	protein
and	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
STAT5	protein
was	O
detected.	O
Since	O
both	O
these	O
proteins	O
become	O
phosphorylated	O
in	O
response	O
to	O
IL-4	protein
receptor	protein
stimulation	O
,	O
the	O
influence	O
of	O
tyrosine	O
phosphorylation	O
on	O
their	O
mutual	O
contact	O
was	O
analyzed.	O
Association	O
of	O
JAK1	protein
and	O
STAT5	protein
was	O
found	O
to	O
occur	O
exclusively	O
between	O
unphosphorylated	protein
proteins	protein
.	O

Activation	O
of	O
human	cell_type
macrophages	cell_type
by	O
mechanical	O
ventilation	O
in	O
vitro.	O
Positive-pressure	O
mechanical	O
ventilation	O
supports	O
gas	O
exchange	O
in	O
patients	O
with	O
respiratory	O
failure	O
but	O
is	O
also	O
responsible	O
for	O
significant	O
lung	O
injury	O
.	O
In	O
this	O
study,	O
we	O
have	O
developed	O
an	O
in	O
vitro	O
model	O
in	O
which	O
isolated	O
lung	cell_type
cells	cell_type
can	O
be	O
submitted	O
to	O
a	O
prolonged	cell_line
cyclic	cell_line
pressure-stretching	cell_line
strain	cell_line
resembling	O
that	O
of	O
conventional	O
mechanical	O
ventilation	O
.	O
In	O
this	O
model,	O
cells	O
cultured	O
on	O
a	O
Silastic	O
membrane	O
were	O
elongated	O
up	O
to	O
7%	O
of	O
their	O
initial	O
diameter,	O
corresponding	O
to	O
a	O
12%	O
increase	O
in	O
cell	O
surface.	O
The	O
lung	cell_type
macrophage	cell_type
was	O
identified	O
as	O
the	O
main	O
cellular	O
source	O
for	O
critical	O
inflammatory	protein
mediators	protein
such	O
as	O
tumor	protein
necrosis	protein
factor-alpha	protein
,	O
the	O
chemokines	protein
interleukin	O
(IL)	O
-8	O
and	O
-6	O
,	O
and	O
matrix	protein
metalloproteinase-9	protein
in	O
this	O
model	O
system	O
of	O
mechanical	O
ventilation	O
.	O
These	O
mediators	O
were	O
measured	O
in	O
supernatants	O
from	O
ventilated	cell_type
alveolar	cell_type
macrophages	cell_type
,	O
monocyte-derived	cell_type
macrophages	cell_type
,	O
and	O
promonocytic	cell_line
THP-1	cell_line
cells	cell_line
.	O
Nuclear	protein
factor-kappaB	protein
was	O
found	O
to	O
be	O
activated	O
in	O
ventilated	cell_type
macrophages	cell_type
.	O
Synergistic	O
proinflammatory	O
effects	O
of	O
mechanical	O
stress	O
and	O
molecules	O
such	O
as	O
bacterial	protein
endotoxin	protein
were	O
observed,	O
suggesting	O
that	O
mechanical	O
ventilation	O
might	O
be	O
particularly	O
deleterious	O
in	O
preinjured	O
or	O
infected	O
lungs	O
.	O
Dexamethasone	O
prevented	O
IL-8	protein
and	O
tumor	protein
necrosis	protein
factor-alpha	protein
secretion	O
in	O
ventilated	cell_type
macrophages	cell_type
.	O
Mechanical	O
ventilation	O
induced	O
low	O
levels	O
of	O
IL-8	protein
secretion	O
by	O
alveolar	cell_type
type	cell_type
II-like	cell_type
cells	cell_type
.	O
Other	O
lung	O
cell	O
types	O
such	O
as	O
endothelial	cell_type
cells	cell_type
,	O
bronchial	cell_type
cells	cell_type
,	O
and	O
fibroblasts	cell_type
failed	O
to	O
produce	O
IL-8	protein
in	O
response	O
to	O
a	O
prolonged	O
cyclic	O
pressure-stretching	O
load	O
.	O
This	O
model	O
is	O
of	O
particular	O
value	O
for	O
exploring	O
physical	O
stress-induced	O
signaling	O
pathways	O
,	O
as	O
well	O
as	O
for	O
testing	O
the	O
effects	O
of	O
novel	O
ventilatory	O
strategies	O
or	O
adjunctive	O
substances	O
aimed	O
at	O
modulating	O
cell	O
activation	O
induced	O
by	O
mechanical	O
ventilation	O
.	O

Signaling	O
pathways	O
mediated	O
by	O
the	O
TNF-	O
and	O
cytokine-	O
receptor	O
families	O
target	O
a	O
common	O
cis-element	DNA
of	O
the	O
IFN	DNA
regulatory	DNA
factor	DNA
1	DNA
promoter	DNA
.	O
CD40	protein
activation	O
of	O
B	cell_type
cells	cell_type
is	O
strongly	O
influenced	O
by	O
the	O
presence	O
of	O
cytokines	protein
.	O
However,	O
the	O
molecular	O
basis	O
for	O
the	O
interplay	O
between	O
these	O
distinct	O
stimuli	O
is	O
not	O
clearly	O
delineated.	O
IFN	protein
regulatory	protein
factor	protein
1	protein
(	O
IRF-1	protein
)	O
is	O
a	O
transcription	protein
factor	protein
activated	O
by	O
either	O
CD40	protein
or	O
cytokines	protein
.	O
We	O
have	O
found	O
that	O
these	O
different	O
sets	O
of	O
signals	O
target	O
a	O
common	O
cis-acting	O
element	O
in	O
the	O
promoter	O
of	O
this	O
gene,	O
the	O
IRF-1	DNA
gamma	DNA
-activated	DNA
site	DNA
(	O
GAS	DNA
).	O
Targeting	O
of	O
the	O
IRF-1	DNA
GAS	DNA
is	O
not	O
confined	O
to	O
activation	O
via	O
CD40	protein
but	O
extends	O
to	O
other	O
stimuli	O
that	O
mimic	O
the	O
CD40	protein
signaling	O
cascade	O
,	O
like	O
TNF-alpha	protein
and	O
EBV	O
.	O
In	O
contrast	O
to	O
induction	O
of	O
STATs	protein
by	O
cytokines	protein
,	O
the	O
IRF-1	DNA
GAS	DNA
-binding	O
complex	O
activated	O
by	O
CD40	protein
,	O
TNF-alpha	protein
,	O
or	O
EBV	O
contains	O
Rel	protein
proteins	protein
,	O
specifically	O
p50	protein
and	O
p65	protein
.	O
In	O
this	O
system,	O
simultaneous	O
exposure	O
to	O
CD40L	protein
together	O
with	O
either	O
IL-4	protein
or	O
IFN-gamma	protein
does	O
not	O
lead	O
to	O
the	O
activation	O
of	O
novel	O
Rel/STAT	protein
complexes	protein
.	O
Given	O
the	O
importance	O
of	O
IRF-1	protein
in	O
a	O
variety	O
of	O
biologic	O
functions	O
from	O
proliferation	O
to	O
apoptosis,	O
our	O
findings	O
support	O
the	O
notion	O
that	O
modulation	O
of	O
IRF-1	protein
levels	O
may	O
be	O
a	O
critical	O
control	O
point	O
in	O
B	O
cell	O
activation	O
.	O

Differential	O
effects	O
of	O
protein	protein
kinase	protein
C	protein
inhibitors	O
on	O
fibronectin	protein
-induced	O
interleukin-beta	DNA
gene	DNA
transcription,	O
protein	O
synthesis	O
and	O
secretion	O
in	O
human	cell_type
monocytic	cell_type
cells	cell_type
.	O
Human	cell_type
monocytic	cell_type
cells	cell_type
express	O
interleukin-1beta	protein
(	O
IL-1beta	protein
)	O
when	O
stimulated	O
with	O
the	O
extracellular	protein
matrix	protein
glycoprotein	protein
,	O
fibronectin	protein
(	O
FN	protein
).	O
Protein	protein
kinase	protein
C	protein
(	O
PKC	protein
)	O
activation	O
is	O
considered	O
important	O
for	O
this	O
process;	O
however,	O
the	O
metabolic	O
steps	O
at	O
which	O
PKC	protein
acts	O
upon	O
to	O
mediate	O
the	O
FN	protein
-induced	O
IL-1beta	protein
response	O
remain	O
unclear.	O
We	O
performed	O
an	O
analysis	O
of	O
the	O
mechanisms	O
by	O
which	O
two	O
PKC	protein
inhibitors	O
,	O
Calphostin	O
C	O
and	O
Staurosporine	O
,	O
prevent	O
the	O
FN	protein
-induced	O
IL-1beta	protein
response	O
.	O
Both	O
inhibitors	O
blocked	O
the	O
secretion	O
of	O
IL-1beta	protein
protein	protein
into	O
the	O
media	O
of	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
exposed	O
to	O
FN	protein
.	O
Immunoprecipitation	O
analysis	O
revealed	O
that	O
unde3r	O
these	O
circumstances,	O
Calphostin	O
C	O
inhibited	O
the	O
production	O
of	O
IL-1beta	protein
protein	protein
,	O
whereas	O
Staurosporine	O
allowed	O
protein	O
production,	O
but	O
inhibited	O
its	O
secretion.	O
To	O
determine	O
the	O
mechanisms	O
responsible	O
for	O
these	O
differences,	O
we	O
turned	O
to	O
human	cell_line
U937	cell_line
promonocytic	cell_line
cells	cell_line
.	O
U937	O
cells	O
transfected	O
with	O
the	O
human	O
full-length	DNA
IL-1beta	DNA
promoter	DNA
connected	O
to	O
a	O
luciferase	DNA
reporter	DNA
gene	DNA
were	O
submitted	O
to	O
transcription	O
assays	O
,	O
Northern	O
blotting	O
,	O
and	O
DNA	O
electrophoresis	O
mobility	O
gel	O
shift	O
assays	O
.	O
These	O
studies	O
revealed	O
that	O
Calphostin	O
C	O
inhibited	O
the	O
nuclear	O
translocation	O
of	O
the	O
transcription	protein
factor	protein
activator	protein
protein-1	protein
(	O
AP-1	protein
)	O
which	O
is	O
considered	O
necessary	O
for	O
FN	protein
induction	O
of	O
IL-1beta	protein
gene	O
transcription	O
,	O
and	O
prevented	O
the	O
transcription	O
of	O
the	O
IL-1beta	DNA
gene	DNA
.	O
In	O
contrast,	O
Staurosporine	O
alone	O
induced	O
AP-1	protein
translocation	O
and	O
stimulation	O
of	O
the	O
gene.	O
Overall,	O
our	O
data	O
indicate	O
that	O
Calphostin	O
C	O
prevents	O
the	O
transcription	O
of	O
the	O
IL-1beta	DNA
gene	DNA
thereby	O
inhibiting	O
protein	O
synthesis	O
.	O
Based	O
on	O
the	O
high	O
specificity	O
of	O
this	O
compound	O
for	O
PKC	protein
,	O
we	O
conclude	O
that	O
PKC	protein
is	O
necessary	O
for	O
FN	protein
-induced	O
IL-1beta	protein
protein	O
production	O
.	O
In	O
contrast,	O
Staurosporine	O
prevented	O
secretion	O
of	O
IL-1beta	protein
by	O
unknown	O
mechanisms	O

The	O
carboxyl-terminal	protein
cytoplasmic	protein
domain	protein
of	O
CD36	protein
is	O
required	O
for	O
oxidized	O
low-density	O
lipoprotein	O
modulation	O
of	O
NF-kappaB	protein
activity	O
by	O
tumor	protein
necrosis	protein
factor-alpha	protein
.	O
The	O
binding	O
of	O
oxidized	O
low-density	O
lipoprotein	O
(	O
Ox	O
LDL	O
)	O
by	O
monocyte	cell_type
-macrophages	cell_type
causes	O
pleiotropic	O
effects	O
,	O
including	O
changes	O
in	O
gene	O
expression,	O
and	O
is	O
thought	O
to	O
represent	O
an	O
early	O
event	O
in	O
atherogenesis	O
.	O
The	O
integral	O
membrane	O
glycoprotein	protein
CD36	protein
appears	O
to	O
play	O
a	O
physiological	O
role	O
in	O
binding	O
and	O
uptake	O
of	O
Ox	O
LDL	O
by	O
monocyte-	cell_type
macrophages	cell_type
,	O
although	O
the	O
molecular	O
events	O
associated	O
with	O
CD36	protein
-Ox	O
LDL	O
interaction	O
are	O
unknown.	O
To	O
approach	O
this	O
issue,	O
we	O
used	O
CD36	protein
transfected	O
Chinese	cell_type
hampster	cell_type
ovary	cell_type
(CHO)	cell_type
cells	cell_type
,	O
exposed	O
them	O
to	O
Ox	O
LDL	O
,	O
and	O
determined	O
changes	O
in	O
the	O
activity	O
of	O
the	O
transcription	protein
factor	protein
NF-kappaB	protein
.	O
We	O
report	O
here	O
that	O
Ox	O
LDL	O
enhanced	O
DNA	O
binding	O
activity	O
of	O
nuclear	O
extracts	O
to	O
an	O
NF-kappaB	DNA
sequence	DNA
following	O
activation	O
of	O
CD36	cell_line
-producing	cell_line
CHO	cell_line
cells	cell_line
with	O
the	O
proinflammatory	protein
cytokine	protein
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
).	O
This	O
enhanced	O
DNA	O
binding	O
activity	O
was	O
inhibited	O
by	O
coincubation	O
of	O
CD36	protein
transfected	O
cells	O
with	O
the	O
human	protein
CD36	protein
-specific	protein
antibody	protein
OKM5	protein
.	O
We	O
also	O
determined	O
that	O
activation	O
of	O
NF-kappaB	protein
DNA	O
binding	O
activity	O
required	O
an	O
intact	O
carboxyl-terminal	protein
cytoplasmic	protein
segment	protein
on	O
CD36	protein
.	O
Our	O
results	O
support	O
the	O
idea	O
that	O
human	protein
CD36	protein
mediates	O
signal	O
transduction	O
events	O
in	O
response	O
to	O
Ox	O
LDL	O
.	O

TRAMP	protein
,	O
a	O
novel	O
apoptosis-mediating	protein
receptor	protein
with	O
sequence	O
homology	O
to	O
tumor	protein
necrosis	protein
factor	protein
receptor	protein
1	protein
and	O
Fas	protein
(	O
Apo-1/CD95	protein
).	O
A	O
novel	O
member	O
of	O
the	O
tumor	protein
necrosis	protein
factor	protein
(TNF)	protein
receptor	protein
family	protein
,	O
designated	O
TRAMP	protein
,	O
has	O
been	O
identified.	O
The	O
structural	O
organization	O
of	O
the	O
393	protein
amino	protein
acid	protein
long	protein
human	protein
TRAMP	protein
is	O
most	O
homologous	O
to	O
TNF	protein
receptor	protein
1	protein
.	O
TRAMP	protein
is	O
abundantly	O
expressed	O
on	O
thymocytes	cell_type
and	O
lymphocytes	cell_type
.	O
Its	O
extracellular	O
domain	O
is	O
composed	O
of	O
four	O
cysteine-rich	protein
domains	protein
,	O
and	O
the	O
cytoplasmic	protein
region	protein
contains	O
a	O
death	protein
domain	protein
known	O
to	O
signal	O
apoptosis	O
.	O
Overexpression	O
of	O
TRAMP	protein
leads	O
to	O
two	O
major	O
responses,	O
NF-kappaB	protein
activation	O
and	O
apoptosis	O
.	O
TRAMP	protein
-induced	O
cell	O
death	O
is	O
inhibited	O
by	O
an	O
inhibitor	O
of	O
ICE-like	protein
proteases	protein
,	O
but	O
not	O
by	O
Bcl-2	protein
.	O
In	O
addition,	O
TRAMP	protein
does	O
not	O
appear	O
to	O
interact	O
with	O
any	O
of	O
the	O
known	O
apoptosis	protein
-inducing	protein
ligands	protein
of	O
the	O
TNF	protein
family	protein
.	O

The	O
state	O
of	O
maturation	O
of	O
monocytes	cell_type
into	O
macrophages	cell_type
determines	O
the	O
effects	O
of	O
IL-4	protein
and	O
IL-13	protein
on	O
HIV	O
replication	O
.	O
The	O
molecular	O
mechanisms	O
of	O
the	O
effects	O
of	O
IL-4	protein
and	O
IL-13	protein
on	O
HIV	O
infection	O
in	O
human	cell_type
monocytes	cell_type
as	O
they	O
matured	O
into	O
monocyte-derived	cell_type
macrophages	cell_type
over	O
7	O
days	O
were	O
investigated	O
using	O
HIV-1(BaL)	O
,	O
and	O
low	O
passage	O
clinical	O
strains.	O
IL-4	protein
and	O
IL-13	protein
up-regulated	O
the	O
expression	O
of	O
both	O
genomic	O
and	O
spliced	O
HIV	RNA
mRNA	RNA
in	O
monocytes	cell_type
cultured	O
on	O
Teflon	O
,	O
as	O
determined	O
by	O
Northern	O
analysis	O
and	O
p24	protein
Ag	protein
assay	O
.	O
Using	O
a	O
nuclear	O
run-on	O
assay	O
,	O
IL-4	protein
stimulation	O
was	O
shown	O
to	O
enhance	O
transcription	O
by	O
two-	O
to	O
threefold.	O
IL-4	protein
stimulated	O
nuclear	protein
factor-kappaB	protein
nuclear	O
translocation	O
and	O
binding	O
before	O
enhancement	O
of	O
HIV	RNA
RNA	RNA
expression	O
.	O
Conversely,	O
IL-4	protein
and	O
IL-13	protein
markedly	O
and	O
significantly	O
inhibited	O
HIV	O
replication	O
at	O
the	O
transcriptional	O
level	O
in	O
monocyte-derived	cell_type
macrophages	cell_type
,	O
and	O
this	O
occurred	O
whether	O
these	O
cytokines	protein
were	O
added	O
before	O
or	O
after	O
HIV	O
infection	O
.	O
The	O
reversal	O
from	O
stimulation	O
to	O
inhibition	O
occurred	O
after	O
3	O
to	O
5	O
days	O
of	O
adherence	O
to	O
plastic.	O
IL-4	protein
had	O
no	O
significant	O
effect	O
on	O
HIV	O
reverse	O
transcription	O
.	O
The	O
effect	O
of	O
both	O
cytokines	protein
on	O
the	O
monocyte	O
maturation/differentiation	O
(	O
CD11b	protein
,	O
CD13	protein
,	O
and	O
CD26	protein
)	O
and	O
other	O
macrophage	protein
markers	protein
(	O
CD14	protein
and	O
CD68	protein
)	O
was	O
examined.	O
IL-4	protein
enhanced	O
CD11b	protein
,	O
but	O
inhibited	O
CD26	protein
expression	O
and	O
delayed	O
CD13	protein
loss.	O
IL-13	protein
had	O
similar	O
effects	O
on	O
CD11b	protein
and	O
CD13	protein
,	O
but	O
no	O
effect	O
on	O
CD26	protein
.	O
Hence,	O
these	O
cytokines	protein
do	O
not	O
simply	O
enhance	O
monocyte	O
differentiation	O
,	O
but	O
have	O
complex	O
and	O
slightly	O
divergent	O
effects	O
that	O
impact	O
on	O
HIV	O
replication	O
probably	O
through	O
cell	O
signaling	O
pathways	O
and	O
nuclear	protein
factor-kappaB	protein
translocation	O
.	O

Mice	O
lacking	O
the	O
transcription	protein
factor	protein
CIITA	protein
--a	O
second	O
look.	O
We	O
have	O
generated	O
a	O
second	O
line	O
of	O
mice	O
lacking	O
a	O
transcription	protein
factor	protein
thought	O
to	O
be	O
a	O
critical	O
regulator	O
of	O
MHC	DNA
class	DNA
II	DNA
gene	DNA
expression	O
,	O
CIITA	protein
(for	O
class	O
II	O
transactivator	protein
).	O
Our	O
and	O
the	O
previously	O
published	O
lines	O
differ	O
in	O
the	O
deletion	O
that	O
was	O
engineered	O
and	O
by	O
the	O
fact	O
that	O
we	O
removed	O
the	O
neomycin-resistance	DNA
promoter	DNA
and	O
structural	DNA
gene	DNA
via	O
the	O
cre-loxP	O
recombination	O
system	O
.	O
Characterization	O
of	O
our	O
line	O
led	O
to	O
two	O
new	O
findings.	O
First,	O
a	O
substantial	O
number	O
of	O
cells	O
can	O
express	O
class	protein
II	protein
molecules	protein
in	O
the	O
absence	O
of	O
CIITA	protein
,	O
albeit	O
at	O
5-fold	O
reduced	O
levels,	O
most	O
notably	O
dendritic	cell_type
cells	cell_type
in	O
s.c.	O
lymph	O
nodes;	O
therefore,	O
the	O
CIITA	DNA
gene	DNA
cannot	O
be	O
an	O
absolute	O
'	O
master	DNA
gene	DNA
'	O
controlling	O
the	O
expression	O
of	O
class	protein
II	protein
molecules	protein
,	O
as	O
had	O
been	O
thought.	O
Second,	O
in	O
contrast	O
to	O
recent	O
results	O
on	O
human	cell_line
cell	cell_line
lines	cell_line
,	O
CIITA	protein
is	O
not	O
critically	O
involved	O
in	O
the	O
IFN-gamma	protein
-induced	O
up-regulation	O
of	O
MHC	DNA
class	DNA
I	DNA
genes	DNA
.	O

Interleukin-10	protein
stabilizes	O
inhibitory	O
kappaB-alpha	protein
in	O
human	cell_type
monocytes	cell_type
.	O
Interleukin-10	protein
(	O
IL-10	protein
)	O
protects	O
animals	O
from	O
lethal	O
endotoxemia	O
.	O
This	O
beneficial	O
effect	O
is	O
mediated,	O
in	O
part,	O
by	O
inhibition	O
of	O
inflammatory	protein
cytokine	protein
production	O
,	O
including	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
).	O
Evidence	O
suggests	O
that	O
IL-10	protein
may	O
inhibit	O
activation	O
of	O
the	O
transcription	protein
factor	protein
nuclear	protein
factor-kappaB	protein
(	O
NF-kappaB	protein
)	O
through	O
an	O
unknown	O
mechanism.	O
NF-kappaB	protein
activation	O
in	O
response	O
to	O
inflammatory	O
signals	O
is	O
dependent	O
upon	O
degradation	O
of	O
its	O
associated	O
inhibitory	O
peptide	O
,	O
inhibitory	protein
kappaB-alpha	protein
(	O
IkappaB-alpha	protein
).	O
We	O
hypothesized	O
that	O
IL-10	protein
prevents	O
human	O
monocyte	O
NF-kappaB	protein
activation	O
and	O
resultant	O
TNF-alpha	protein
production	O
by	O
stabilization	O
of	O
IkappaB-alpha	protein
.	O
The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
effect	O
of	O
IL-10	protein
on	O
lipopolysaccharide	O
(LPS)-induced	O
human	O
monocyte	O
TNF-alpha	protein
production	O
,	O
NF-kappaB	protein
activation	O
,	O
and	O
IkappaB-alpha	protein
degradation	O
.	O
Monocytes	O
were	O
isolated	O
from	O
human	O
donors	O
.	O
Cells	O
were	O
stimulated	O
with	O
endotoxin	protein
(	O
LPS	O
,	O
100	O
ng/mL)	O
with	O
and	O
without	O
human	O
IL-10	protein
(10	O
ng/mL).	O
Following	O
stimulation,	O
TNF-alpha	protein
was	O
measured	O
in	O
cell	O
supernatants	O
by	O
ELISA	O
,	O
NF-kappaB	protein
activity	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
and	O
IkappaB-alpha	protein
levels	O
by	O
Western	O
blot	O
.	O
We	O
observed	O
that	O
after	O
LPS	O
stimulation	O
of	O
human	cell_type
monocytes	cell_type
,	O
TNF-alpha	protein
increased	O
to	O
798+/-67	O
pg/mL	O
(p	O
&lt;	O
.001	O
versus	O
control).	O
IL-10	protein
attenuated	O
LPS	O
-stimulated	O
TNF-alpha	protein
production	O
(297+/-54;	O
p	O
&lt;	O
.001	O
versus	O
LPS	O
alone).	O
After	O
LPS	O
stimulation	O
in	O
human	cell_type
monocytes	cell_type
,	O
IkappaB-alpha	protein
protein	O
levels	O
decreased,	O
and	O
NF-kappaB	protein
DNA	O
binding	O
increased.	O
IL-10	protein
pretreatment	O
prevented	O
LPS	O
-induced	O
decreases	O
in	O
IkappaB-alpha	protein
protein	O
levels	O
and	O
attenuated	O
NF-kappaB	protein
DNA	O
binding	O
.	O
IL-10	protein
appears	O
to	O
prevent	O
activation	O
of	O
NF-kappaB	protein
by	O
preserving	O
IkappaB-alpha	protein
protein	O
levels	O
,	O
leading	O
to	O
a	O
reduction	O
in	O
TNF-alpha	protein
release	O
.	O

Down-regulation	O
of	O
human	O
granzyme	protein
B	protein
expression	O
by	O
glucocorticoids.	O
Dexamethasone	O
inhibits	O
binding	O
to	O
the	O
Ikaros	protein
and	O
AP-1	DNA
regulatory	DNA
elements	DNA
of	O
the	O
granzyme	DNA
B	DNA
promoter	DNA
.	O
The	O
serine	protein
protease	protein
granzyme	protein
B	protein
is	O
an	O
essential	O
component	O
of	O
the	O
granule	O
exocytosis	O
pathway	O
,	O
a	O
major	O
apoptotic	O
mechanism	O
used	O
by	O
cytotoxic	cell_type
T	cell_type
lymphocytes	cell_type
and	O
natural	cell_type
killer	cell_type
cells	cell_type
to	O
induce	O
target	O
cell	O
apoptosis	O
.	O
Granzyme	O
B	O
gene	O
transcription	O
is	O
induced	O
in	O
activated	O
lymphocytes	cell_type
upon	O
antigenic	O
stimulation	O
,	O
and	O
several	O
regulatory	DNA
regions	DNA
including	O
CBF	protein
,	O
AP-1	protein
,	O
and	O
Ikaros	DNA
binding	DNA
sites	DNA
have	O
been	O
shown	O
to	O
be	O
essential	O
in	O
the	O
control	O
of	O
granzyme	DNA
B	DNA
promoter	DNA
activation	O
.	O
Dexamethasone	O
,	O
a	O
glucocorticoid	O
that	O
is	O
widely	O
used	O
as	O
an	O
immunomodulatory	O
and	O
anti-inflammatory	O
agent	O
,	O
inhibits	O
granzyme	RNA
B	RNA
mRNA	RNA
transcript	RNA
in	O
phytohemagglutinin	cell_type
-activated	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
.	O
Transfection	O
of	O
a	O
reporter	O
construct	O
containing	O
the	O
-148	DNA
to	DNA
+60	DNA
region	DNA
of	O
the	O
human	O
granzyme	DNA
B	DNA
promoter	DNA
demonstrated	O
that	O
this	O
region	O
was	O
the	O
target	O
for	O
dexamethasone	O
repression	O
.	O
Mutation	O
of	O
Ikaros	protein
or	O
AP-1	DNA
binding	DNA
sites	DNA
in	O
the	O
context	O
of	O
the	O
granzyme	DNA
B	DNA
promoter	DNA
demonstrated	O
that	O
both	O
sites	O
participate	O
in	O
dexamethasone	O
-mediated	O
inhibition	O
of	O
the	O
granzyme	DNA
B	DNA
promoter	DNA
activity	O
.	O
Electromobility	O
shift	O
assay	O
revealed	O
that	O
dexamethasone	O
abolished	O
the	O
binding	O
of	O
nuclear	protein
transcription	protein
factors	protein
to	O
the	O
Ikaros	DNA
binding	DNA
site	DNA
and	O
reduced	O
AP-1	protein
binding	O
activity	O
.	O
These	O
results	O
indicate	O
that	O
dexamethasone	O
is	O
able	O
to	O
abrogate	O
the	O
transcriptional	O
activity	O
of	O
the	O
human	DNA
granzyme	DNA
B	DNA
gene	DNA
promoter	DNA
by	O
inhibiting	O
the	O
binding	O
of	O
nuclear	protein
factors	protein
at	O
the	O
AP-1	O
and	O
Ikaros	O
sites	O
.	O

Glucocorticoid	protein
receptors	protein
on	O
mononuclear	cell_type
leukocytes	cell_type
in	O
polycystic	O
ovary	O
syndrome	O
.	O
OBJECTIVE:	O
Many	O
studies	O
have	O
suggested	O
that	O
there	O
is	O
a	O
possible	O
hormonal	O
dysregulation	O
of	O
hypothalamic-pituitary-adrenal	O
(HPA)	O
axis	O
and	O
an	O
increased	O
cortisol	O
clearance	O
in	O
patients	O
with	O
polycystic	O
ovary	O
syndrome	O
(	O
PCOS	O
).	O
Therefore	O
in	O
this	O
study,	O
we	O
have	O
examined	O
the	O
role	O
of	O
glucocorticoid	protein
receptor/s	protein
(	O
GR	protein
)	O
characteristics	O
in	O
the	O
developing	O
of	O
these	O
abnormalities	O
in	O
patients	O
with	O
PCOS	O
.	O
METHOD:	O
For	O
this	O
purpose,	O
the	O
number	O
and	O
affinity	O
of	O
GR	protein
in	O
peripheral	O
mononuclear	cell_type
leukocytes	cell_type
(MNL)	O
of	O
10	O
patients	O
with	O
PCOS	O
and	O
10	O
healthy	O
women	O
(controls)	O
were	O
determined.	O
RESULTS:	O
There	O
were	O
no	O
significant	O
differences	O
in	O
the	O
number	O
(6500+/-1001	O
sites/cell	O
and	O
6352+/-1697	O
sites/cell,	O
respectively;	O
P	O
&gt;	O
0.05)	O
and	O
affinity	O
(3.93+/-0.89	O
nM	O
and	O
4.49+/-0.71	O
nM,	O
respectively;	O
P	O
&gt;	O
0.05)	O
of	O
GR	protein
between	O
the	O
PCOS	O
patients	O
and	O
the	O
controls	O
.	O
CONCLUSIONS:	O
These	O
results	O
suggest	O
that	O
the	O
alterations	O
in	O
the	O
HPA	O
axis	O
and	O
in	O
the	O
cortisol	O
metabolism	O
observed	O
in	O
PCOS	O
are	O
not	O
related	O
to	O
GR	protein
deficiency	O
.	O

Heterogeneous	O
expression	O
of	O
the	O
lipocalin	protein
NGAL	protein
in	O
primary	O
breast	O
cancers	O
.	O
We	O
have	O
previously	O
shown	O
that	O
neu	O
oncogene-initiated	O
rat	O
mammary	O
carcinomas	O
uniquely	O
over-express	O
neu-related	protein
lipocalin	protein
(	O
NRL	protein
),	O
a	O
member	O
of	O
the	O
calycin	protein
protein	protein
superfamily	protein
.	O
Here,	O
we	O
characterize	O
the	O
putative	protein
human	protein
homolog	protein
of	O
NRL	protein
,	O
neutrophil	protein
gelatinase-associated	protein
lipocalin	protein
(	O
NGAL	protein
).	O
ngal	O
gene	O
expression	O
was	O
found	O
at	O
moderate	O
levels	O
in	O
only	O
2	O
of	O
17	O
human	O
tissues	O
examined,	O
breast	O
and	O
lung	O
.	O
When	O
breast	O
cancers	O
were	O
examined	O
for	O
NGAL	O
mRNA	O
and	O
protein	O
levels	O
,	O
they	O
were	O
found	O
to	O
exhibit	O
heterogeneous	O
expression	O
.	O
NGAL	protein
levels	O
varied	O
in	O
these	O
tumors	O
from	O
undetectable	O
to	O
exceeding	O
those	O
in	O
normal	O
breast	O
parenchyma	O
.	O
Immuno-histochemical	O
analysis	O
confirmed	O
the	O
presence	O
of	O
NGAL	protein
within	O
breast	cell_type
carcinoma	cell_type
cells	cell_type
but	O
detected	O
only	O
low	O
levels	O
of	O
this	O
protein	O
in	O
normal	O
ductal	O
epithelium	O
.	O
In	O
contrast,	O
large	O
amounts	O
of	O
the	O
protein	O
were	O
localized	O
to	O
the	O
lumen	O
of	O
normal	O
breast	O
ducts	O
in	O
the	O
vicinity	O
of	O
NGAL	protein
-expressing	O
tumors	O
.	O
Interestingly,	O
unlike	O
NRL	protein
in	O
rat	O
mammary	O
carcinomas	O
,	O
no	O
significant	O
association	O
between	O
NGAL	protein
expression	O
and	O
HER-2/neu	protein
activation	O
was	O
found	O
in	O
human	O
breast	O
tumors	O
.	O
In	O
contrast,	O
a	O
significant	O
correlation	O
between	O
NGAL	protein
expression	O
in	O
breast	O
cancer	O
was	O
found	O
with	O
several	O
other	O
markers	O
of	O
poor	O
prognosis,	O
including	O
estrogen	O
and	O
progesterone	protein
receptor	protein
-negative	O
status	O
and	O
high	O
proliferation	O
(	O
S-phase	O
fraction	O
).	O
NGAL	protein
levels	O
were	O
stratified	O
as	O
high	O
or	O
low	O
in	O
breast	O
cancers	O
from	O
a	O
cohort	O
of	O
node-positive	O
patients	O
with	O
known	O
outcome.	O
No	O
significant	O
association	O
between	O
NGAL	protein
expression	O
and	O
disease-free	O
or	O
overall	O
survival	O
was	O
observed.	O

BASH	protein
,	O
a	O
novel	protein
signaling	protein
molecule	protein
preferentially	O
expressed	O
in	O
B	cell_type
cells	cell_type
of	O
the	O
bursa	O
of	O
Fabricius	O
.	O
The	O
bursa	O
of	O
Fabricius	O
is	O
a	O
gut-associated	O
lymphoid	O
organ	O
that	O
is	O
essential	O
for	O
the	O
generation	O
of	O
a	O
diversified	O
B	cell_type
cell	cell_type
repertoire	cell_type
in	O
the	O
chicken	O
.	O
We	O
describe	O
here	O
a	O
novel	O
gene	O
preferentially	O
expressed	O
in	O
bursal	cell_type
B	cell_type
cells	cell_type
.	O
The	O
gene	O
encodes	O
an	O
85-kDa	protein
protein	protein
,	O
designated	O
BASH	protein
(	O
B	protein
cell	protein
adaptor	protein
containing	protein
SH2	protein
domain	protein
),	O
that	O
contains	O
N-terminal	protein
acidic	protein
domains	protein
with	O
SH2	protein
domain-binding	protein
phosphotyrosine-based	protein
motifs	protein
,	O
a	O
proline	protein
-rich	protein
domain	protein
,	O
and	O
a	O
C-terminal	protein
SH2	protein
domain	protein
.	O
BASH	protein
shows	O
a	O
substantial	O
sequence	O
similarity	O
to	O
SLP-76	protein
,	O
an	O
adaptor	O
protein	O
functioning	O
in	O
TCR	protein
-signal	O
transduction	O
.	O
BASH	protein
becomes	O
tyrosine	O
-phosphorylated	O
with	O
the	O
B	protein
cell	protein
Ag	protein
receptor	protein
(	O
BCR	protein
)	O
cross-link	O
or	O
by	O
coexpression	O
with	O
Syk	protein
and	O
Lyn	protein
and	O
associates	O
with	O
signaling	protein
molecules	protein
including	O
Syk	protein
and	O
a	O
putative	protein
chicken	protein
Shc	protein
homologue	protein
.	O
Overexpression	O
of	O
BASH	protein
results	O
in	O
suppression	O
of	O
the	O
NF-AT	protein
activation	O
induced	O
by	O
BCR	protein
-cross-linking	O
.	O
These	O
findings	O
suggest	O
that	O
BASH	protein
is	O
involved	O
in	O
BCR	protein
-mediated	O
signal	O
transduction	O
and	O
could	O
play	O
a	O
critical	O
role	O
in	O
B	O
cell	O
development	O
in	O
the	O
bursa	O
.	O

Granulocyte	protein
colony-stimulating	protein
factor	protein
activates	O
a	O
72-kDa	protein
isoform	protein
of	O
STAT3	protein
in	O
human	cell_type
neutrophils	cell_type
.	O
Granulocyte	protein
colony-stimulating	protein
factor	protein
(	O
G-CSF	protein
)	O
signaling	O
involves	O
activation	O
of	O
STATs	protein
,	O
proteins	O
that	O
serve	O
the	O
dual	O
function	O
of	O
signal	O
transduction	O
and	O
activation	O
of	O
transcription	O
.	O
We	O
previously	O
demonstrated	O
that	O
G-CSF	protein
activated	O
a	O
distinct	O
Stat3-like	protein
protein	protein
in	O
immature	O
and	O
mature	O
normal	O
myeloid	O
cells	O
,	O
StatG	protein
.	O
StatG	protein
in	O
normal	cell_type
immature	cell_type
human	cell_type
myeloid	cell_type
cells	cell_type
,	O
i.e.	O
adult	cell_type
CD34+	cell_type
bone	cell_type
marrow	cell_type
cells	cell_type
,	O
was	O
composed	O
of	O
Stat3beta	protein
.	O
This	O
investigation	O
was	O
undertaken	O
to	O
determine	O
the	O
composition	O
of	O
StatG	protein
in	O
mature	cell_type
normal	cell_type
human	cell_type
myeloid	cell_type
cells	cell_type
,	O
i.e.	O
polymorphonuclear	cell_type
neutrophilic	cell_type
granulocytes	cell_type
(	O
PMN	cell_type
).	O
These	O
studies	O
revealed	O
that	O
the	O
major	protein
protein	protein
in	O
extracts	O
of	O
PMN	cell_type
activated	O
by	O
G-CSF	protein
to	O
bind	O
the	O
high-affinity	DNA
serum-inducible	DNA
element	DNA
(	O
hSIE	DNA
)	O
is	O
a	O
72-kDa	protein
protein	protein
that	O
cross-reacts	O
with	O
Stat3	protein
monoclonal	protein
antibody	protein
,	O
which	O
we	O
have	O
designated	O
Stat3gamma	protein
.	O
Stat3gamma	protein
is	O
derived	O
from	O
Stat3alpha	protein
by	O
limited	O
proteolysis	O
and	O
lacks	O
the	O
carboxyl-terminal	protein
portion	protein
of	O
Stat3alpha	protein
.	O
Because	O
this	O
region	O
of	O
Stat3alpha	protein
is	O
involved	O
in	O
transcriptional	O
activation	O
,	O
our	O
findings	O
suggest	O
the	O
possibility	O
that	O
Stat3gamma	protein
may	O
be	O
transcriptionally	O
inactive	O
and	O
may	O
compete	O
with	O
Stat3alpha	protein
for	O
Stat3	DNA
binding	DNA
sites	DNA
in	O
these	O
terminally	cell_type
differentiated	cell_type
myeloid	cell_type
cells	cell_type

Association	O
between	O
expression	O
of	O
intercellular	protein
adhesion	protein
molecule-1	protein
and	O
integration	O
of	O
human	O
T-cell-leukemia	O
virus	O
type	O
1	O
in	O
adult	cell_type
T-cell	cell_type
leukemia	cell_type
cells	cell_type
.	O
It	O
is	O
known	O
that	O
the	O
expression	O
levels	O
of	O
intercellular	protein
adhesion	protein
molecule-1	protein
(	O
ICAM-1	protein
)	O
in	O
adult	cell_type
T	cell_type
cell	cell_type
leukemia(ATL)	cell_type
cells	cell_type
are	O
high,	O
whereas	O
those	O
in	O
T-lymphoid	cell_type
cells	cell_type
are	O
not.	O
In	O
order	O
to	O
investigate	O
the	O
factors	O
that	O
influence	O
the	O
induction	O
of	O
ICAM-1	protein
molecules,	O
Northern	O
blot	O
analysis	O
to	O
measure	O
the	O
expression	O
level	O
of	O
ICAM-1	RNA
mRNAs	RNA
and	O
Southern	O
blot	O
hybridization	O
to	O
analyze	O
the	O
integration	O
of	O
human	O
T-cell-leukemia	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
provirus	O
were	O
done.	O
The	O
levels	O
of	O
ICAM-1	RNA
mRNA	RNA
expression	O
of	O
ATL	cell_line
cells	cell_line
were	O
generally	O
higher	O
than	O
those	O
of	O
T-lymphoid	cell_type
cells	cell_type
.	O
However,	O
ILT-mat	cell_line
cells	cell_line
and	O
ATL16T(-)	cell_line
cells	cell_line
,	O
although	O
they	O
were	O
ATL	cell_line
cells	cell_line
,	O
showed	O
rather	O
low	O
surface	O
ICAM-1	protein
expression	O
and	O
ICAM-1	RNA
mRNA	RNA
expression	O
.	O
Southern	O
blot	O
hybridization	O
showed	O
that	O
only	O
two	O
and	O
four	O
bands	O
were	O
found	O
in	O
ILT-mat	cell_line
and	O
ATL16T(-)	cell_line
cells	cell_line
,	O
respectively,	O
whereas	O
&gt;	O
10	O
bands	O
were	O
detected	O
in	O
other	O
ATL	cell_line
cells	cell_line
.	O
These	O
results	O
suggest	O
that	O
monoclonal	O
integration	O
of	O
HTLV-1	O
provirus	O
to	O
the	O
genome	O
of	O
T	cell_type
cell	cell_type
,	O
especially	O
the	O
number	O
of	O
integration	O
sites,	O
is	O
one	O
of	O
the	O
factors	O
for	O
induction	O
of	O
ICAM-1	protein
molecules	protein
.	O

Heat-shock	protein
and	O
cadmium	O
chloride	O
increase	O
the	O
vimentin	O
mRNA	O
and	O
protein	O
levels	O
in	O
U-937	cell_line
human	cell_line
promonocytic	cell_line
cells	cell_line
.	O
Heat-shock	protein
for	O
2	O
hours	O
at	O
42	O
degrees	O
C,	O
or	O
the	O
administration	O
for	O
3	O
hours	O
of	O
100	O
or	O
150	O
microM	O
cadmium	O
chloride	O
,	O
inhibited	O
the	O
subsequent	cell_line
proliferation	cell_line
activity	cell_line
,	O
induced	O
the	O
expression	O
of	O
functional	O
differentiation	protein
markers	protein
,	O
and	O
caused	O
an	O
increase	O
in	O
the	O
amount	O
of	O
the	O
stress-responsive	protein
HSP70	protein
protein	protein
in	O
U-937	cell_line
human	cell_line
promonocytic	cell_line
cells	cell_line
.	O
In	O
addition,	O
both	O
heat	O
and	O
cadmium	O
produced	O
an	O
increase	O
in	O
the	O
amount	O
of	O
the	O
intermediate	protein
filament	protein
protein	protein
vimentin	protein
,	O
as	O
determined	O
by	O
immunoblot	O
and	O
immunofluorescence	O
assays	O
.	O
By	O
contrast,	O
the	O
amounts	O
of	O
actin	protein
and	O
beta-tubulin	protein
were	O
not	O
significantly	O
altered.	O
The	O
amount	O
of	O
vimentin	RNA
mRNA	RNA
was	O
also	O
increased	O
during	O
recovery	O
from	O
stress,	O
indicating	O
that	O
vimentin	protein
expression	O
was	O
not	O
exclusively	O
regulated	O
at	O
the	O
protein	O
level.	O
Although	O
cadmium	O
caused	O
an	O
early,	O
transient	O
stimulation	O
of	O
c-jun	DNA
and	O
c-fos	DNA
expression	O
and	O
AP-1	protein
binding	O
activity	O
,	O
heat-shock	O
failed	O
to	O
alter	O
both	O
protooncogene	DNA
expression	O
and	O
transcription	O
factor	O
binding	O
,	O
indicating	O
that	O
the	O
stress-induced	O
vimentin	protein
increase	O
was	O
not	O
the	O
result	O
of	O
AP-1	protein
-mediated	O
transcriptional	O
activation	O
.	O
Finally,	O
it	O
was	O
observed	O
that	O
the	O
rate	O
of	O
decay	O
of	O
vimentin	RNA
mRNA	RNA
upon	O
actinomycin	O
D	O
administration	O
was	O
decreased	O
in	O
heat-	O
and	O
cadmium-	O
pretreated	O
cells	O
in	O
comparison	O
to	O
untreated	cell_type
cells	cell_type
.	O
These	O
results	O
indicate	O
that	O
stress	O
treatments	O
cause	O
an	O
increase	O
in	O
vimentin	protein
levels	O
in	O
promonocytic	cell_type
cells	cell_type
,	O
which	O
may	O
be	O
explained	O
at	O
least	O
in	O
part	O
by	O
transcript	O
stabilization	O
.	O

Ovarian	O
and	O
breast	O
cytotoxic	cell_type
T	cell_type
lymphocytes	cell_type
can	O
recognize	O
peptides	O
from	O
the	O
amino	O
enhancer	O
of	O
split	O
protein	O
of	O
the	O
Notch	protein
complex	protein
.	O
In	O
this	O
study	O
we	O
investigated	O
recognition	O
by	O
ovarian	cell_type
tumor	cell_type
associated	cell_type
lymphocyte	cell_type
(	O
OVTAL	cell_type
),	O
and	O
breast	cell_type
tumor	cell_type
associated	cell_type
lymphocytes	cell_type
(	O
BRTAL	cell_type
),	O
of	O
peptides	O
corresponding	O
to	O
the	O
sequence	O
125-135	protein
of	protein
the	protein
Aminoenhancer	protein
of	protein
split	protein
(AES)	protein
protein	protein
.	O
Three	O
of	O
these	O
peptides	O
designated	O
as	O
G75:AES1/2	O
(	O
128-135	protein
),	O
G60:	O
AES1/2	O
(	O
127-137	protein
)	O
and	O
G61:	O
AES1/2	O
(	O
125-133	protein
)	O
correspond	O
to	O
the	O
wildtype	DNA
AES	DNA
sequence	DNA
,	O
while	O
the	O
fourth	O
G76:GPLTPLPV	O
,	O
AES1/2	protein
(128-135)	protein
corresponds	O
to	O
a	O
variant	O
sequence	O
of	O
the	O
peptide	O
G75	O
with	O
the	O
N-terminal	O
Leu	O
substituted	O
to	O
glycine	O
.	O
These	O
sequences	O
were	O
chosen	O
for	O
study	O
because	O
mass-spectrometric	O
analysis	O
(	O
MS	O
)	O
of	O
a	O
CTL	cell_type
active	O
HPLC	O
peptide	O
fraction	O
eluted	O
from	O
immunoaffinity	protein
precipitated	protein
HLA-A2	protein
molecule	protein
,	O
revealed:	O
(a)	O
the	O
presence	O
of	O
an	O
ion	O
with	O
a	O
mass-to-charge	O
ratio	O
(m/z)	O
of	O
793	O
which	O
was	O
more	O
abundant	O
than	O
other	O
ions	O
of	O
similar	O
masses;	O
(b)	O
the	O
tentatively	O
reconstituted	O
sequence	O
of	O
the	O
ion	O
793	O
matched	O
the	O
sequence	O
of	O
peptide	O
G76	O
.	O
We	O
found	O
that	O
AES	O
peptides	O
G75	O
(	O
128-135	protein
)	O
and	O
G76	O
(	O
128-135	protein
)	O
(	O
L128G	O
)	O
reconstituted	O
CTL	O
recognition	O
at	O
concentrations	O
ranging	O
between	O
200-500	O
nM.	O
These	O
concentrations	O
are	O
lower	O
than	O
concentrations	O
reported	O
to	O
activate	O
effector	O
function	O
of	O
CTL	O
recognizing	O
other	O
epithelial	protein
tumor	protein
Ag	protein
.	O
Furthermore,	O
analysis	O
with	O
cloned	O
CD8+	cell_type
T	cell_type
cells	cell_type
indicated	O
that	O
G75	O
and	O
G76	O
were	O
not	O
cross-reactive	O
specificities,	O
suggesting	O
a	O
key	O
role	O
for	O
the	O
N-terminal	protein
residues	protein
of	O
the	O
variant	O
peptide	O
in	O
dictating	O
specificities.	O
Since	O
the	O
AES	protein
proteins	protein
are	O
part	O
of	O
a	O
set	O
of	O
transcriptional	O
repressors	O
encoded	O
by	O
the	O
Enhancer	DNA
of	DNA
split	DNA
[E(spl)]	DNA
genes	DNA
,	O
and	O
since	O
these	O
repressors	O
are	O
activated	O
to	O
suppress	O
cell	O
differentiation	O
in	O
response	O
to	O
Notch	protein
receptors	protein
signalling,	O
the	O
AES	O
peptides	O
may	O
represent	O
a	O
novel	O
class	O
of	O
self-antigens	protein
that	O
deserve	O
further	O
consideration	O
as	O
tumor	protein
Ag	protein
in	O
epithelial	O
cancers	O
.	O

Induction	O
of	O
the	O
pro-myelocytic	DNA
leukaemia	DNA
gene	DNA
by	O
type	O
I	O
and	O
type	O
II	O
interferons	O
.	O
The	O
physiological	O
role	O
of	O
the	O
pro-myelocytic	protein
leukaemia	protein
(	protein
PML	protein
)	protein
gene	protein
product	protein
is	O
poorly	O
defined.	O
Among	O
other	O
functions,	O
PML	DNA
is	O
involved	O
in	O
haematopoietic	O
differentiation	O
and	O
in	O
control	O
of	O
cell	O
growth	O
and	O
tumorigenesis	O
.	O
We	O
investigated	O
the	O
regulation	O
of	O
human	O
PML	DNA
expression	O
by	O
interferons	protein
(	O
IFNs	protein
)	O
and	O
IL-1	protein
in	O
various	O
human	cell_line
haematopoietic	cell_line
lines	cell_line
(	O
U937	cell_line
,	O
THP1	cell_line
,	O
HL60	cell_line
,	O
NB4	cell_line
),	O
in	O
human	cell_type
diploid	cell_type
fibroblasts	cell_type
and	O
in	O
human	cell_type
peripheral	cell_type
blood	cell_type
leukocytes	cell_type
.	O
Cytokine-induced	O
modulation	O
of	O
PML	DNA
expression	O
was	O
assessed	O
by	O
Northern	O
blot	O
analyses	O
,	O
flow	O
cytometry	O
studies	O
and	O
in	O
situ	O
immunolabelling	O
.	O
Our	O
data	O
show	O
that	O
IFNs	protein
and	O
IL-1	protein
upregulate	O
PML	O
transcript	O
and	O
protein	O
expression	O
in	O
a	O
time	O
and	O
dose-dependent	O
manner.	O
In	O
situ	O
immunolabelling	O
revealed	O
that	O
upregulation	O
of	O
protein	O
expression	O
by	O
IFN-alpha	protein
is	O
a	O
consequence	O
of	O
a	O
marked	O
increase	O
in	O
both	O
the	O
number	O
and	O
the	O
intensity	O
of	O
the	O
staining	O
of	O
so-called	O
PML	protein
nuclear	protein
bodies	protein
.	O
Our	O
data	O
suggest	O
that	O
stimulation	O
of	O
PML	DNA
expression	O
by	O
interferons	protein
and	O
IL-1	protein
may	O
account	O
for	O
upregulation	O
of	O
PML	protein
proteins	protein
observed	O
in	O
inflammatory	O
tissues	O
and	O
in	O
proliferative	O
states	O
.	O

The	O
position	O
of	O
the	O
ZEBRA	protein
activation	protein
domain	protein
does	O
not	O
influence	O
its	O
biological	O
activity.	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
is	O
a	O
human	O
herpesvirus	O
which	O
latently	O
infects	O
B	cell_type
lymphocytes	cell_type
.	O
EBV	O
encodes	O
a	O
unique	O
transcriptional	O
activator,	O
known	O
as	O
ZEBRA	protein
,	O
which	O
can	O
disrupt	O
viral	O
latency	O
in	O
B	cell_type
cells	cell_type
and	O
induce	O
lytic	O
viral	O
replication	O
.	O
Furthermore,	O
ZEBRA	protein
has	O
been	O
shown	O
to	O
bind	O
at	O
the	O
EBV	O
origin	O
of	O
lytic	O
replication	O
,	O
and	O
is	O
necessary	O
for	O
viral	O
DNA	O
replication	O
to	O
occur.	O
Previously	O
we	O
demonstrated	O
that	O
heterologous	protein
activation	protein
domains	protein
can	O
fully	O
substitute	O
for	O
the	O
ZEBRA	protein
activation	protein
domain	protein
.	O
Here	O
we	O
extend	O
those	O
results	O
by	O
showing	O
that	O
the	O
position	O
of	O
the	O
ZEBRA	protein
activation	protein
domain	protein
or	O
a	O
heterologous	O
replacement	O
domain	O
does	O
not	O
influence	O
its	O
ability	O
to	O
function	O
in	O
the	O
disruption	O
of	O
EBV	O
latency	O
.	O
In	O
this	O
study	O
three	O
novel	O
clones	O
were	O
constructed	O
in	O
which	O
the	O
ZEBRA	protein
activation	protein
region	protein
was	O
repositioned	O
to	O
the	O
carboxy	protein
terminus	protein
of	O
the	O
protein.	O
These	O
mutants	O
were	O
used	O
to	O
demonstrate	O
that	O
the	O
ability	O
of	O
ZEBRA	protein
's	protein
wild	protein
type	protein
domain	protein
to	O
function	O
in	O
the	O
complex	O
biological	O
process	O
of	O
virus	O
activation	O
is	O
not	O
compromised	O
by	O
altering	O
its	O
position	O
within	O
the	O
protein.	O

The	O
modulation	O
of	O
glucocorticoid	protein
receptor	protein
content	O
by	O
3-O-methyl-D-glucose	O
transport	O
in	O
human	cell_type
mononuclear	cell_type
leukocyte	cell_type
in	O
obesity.	O
Glucocorticoid	protein
receptors	protein
(	O
GR	protein
)	O
and	O
3-O-methyl-D	O
glucose	O
(	O
3-O-MG	O
)	O
transport	O
were	O
determined	O
in	O
mononuclear	cell_type
leukocytes	cell_type
(	O
MNL	cell_type
)	O
from	O
11	O
abdominal	O
obese	O
subjects	O
,	O
10	O
pituitary-dependent	O
Cushing's	O
syndrome	O
(Cushing's	O
disease)	O
and	O
10	O
healthy	O
controls	O
.	O
Using	O
a	O
whole-cell	O
competitive	O
binding	O
assay	O
and	O
3H-dexamethasone	O
as	O
tracer,	O
MNL	cell_type
of	O
abdominal	O
obese	O
subjects	O
were	O
found	O
to	O
have	O
4855	O
+/-	O
1389	O
sites/cell	O
which	O
was	O
significantly	O
lower	O
(p	O
&lt;	O
0.05)	O
than	O
controls	O
(6234	O
+/-	O
1568	O
sites/cell),	O
although	O
no	O
significant	O
difference	O
was	O
found	O
in	O
the	O
mean	O
serum	O
cortisol	O
level	O
.	O
Their	O
mean	O
Kd	O
(affinity)	O
was	O
also	O
significantly	O
lower	O
than	O
that	O
found	O
in	O
the	O
healthy	O
controls	O
(obese	O
Kd:2.92	O
+/-	O
0.84	O
nmol/l,	O
control	O
Kd:	O
4.55	O
+/-	O
0.67	O
nM,	O
p	O
&lt;	O
0.05).	O
On	O
the	O
other	O
hand,	O
the	O
receptor	O
characteristics	O
in	O
Cushing's	O
disease	O
patients	O
were	O
within	O
the	O
normal	O
range.	O
At	O
the	O
same	O
time,	O
3-O-MG	O
transport	O
was	O
determined	O
in	O
the	O
same	O
subjects.	O
In	O
Cushing's	O
disease	O
,	O
3-O-MG	O
transport	O
was	O
within	O
the	O
normal	O
range,	O
whereas	O
in	O
abdominal	O
obesity	O
this	O
value	O
was	O
significantly	O
lower	O
than	O
the	O
healthy	O
controls	O
(abdominal	O
obese:	O
31.90	O
+/-	O
8.20;	O
control:	O
46.26	O
+/-	O
12.91	O
fmol/10(6)	O
cell,	O
min,	O
p	O
&lt;	O
0.05).	O
We	O
also	O
found	O
a	O
positive	O
correlation	O
between	O
3-O-MG	O
transport	O
and	O
GR	protein
binding	O
capacity	O
in	O
abdominal	O
subjects	O
(r	O
=	O
0.89,	O
p	O
&lt;	O
0.001),	O
however	O
we	O
did	O
not	O
find	O
such	O
a	O
correlation	O
in	O
Cushing's	O
disease	O
(r	O
=	O
0.60,	O
p	O
&gt;	O
0.05).	O
These	O
results	O
indicated	O
that,	O
in	O
abdominal	O
obesity	O
,	O
the	O
GR	protein
binding	O
capacity	O
in	O
MNL	cell_type
is	O
influenced	O
by	O
the	O
changes	O
in	O
glucose	O
transport	O
.	O

Interleukin-10	protein
and	O
transforming	DNA
growth	DNA
factor-beta	DNA
promoter	DNA
polymorphisms	DNA
in	O
allergies	O
and	O
asthma	O
.	O
Interleukin-10	protein
(	O
IL-10	protein
)	O
and	O
transforming	protein
growth	protein
factor	protein
beta	protein
(	O
TGF-beta	protein
)	O
are	O
inhibitory	O
for	O
B	O
and	O
T	O
cells	O
,	O
IgE	protein
production	O
,	O
and	O
mast	O
cell	O
proliferation	O
,	O
and	O
they	O
induce	O
apoptosis	O
in	O
eosinophils	cell_type
.	O
These	O
cytokines	protein
are	O
therefore	O
candidate	O
genes	O
which	O
could	O
contribute	O
to	O
the	O
development	O
of	O
asthma	O
or	O
allergies	O
.	O
We	O
investigated	O
the	O
hypothesis	O
that	O
polymorphic	O
nucleotides	O
within	O
the	O
IL-10	O
and	O
TGF-beta	O
gene	O
promoters	O
would	O
link	O
to	O
the	O
expression	O
of	O
allergies	O
and	O
asthma	O
.	O
DNA	O
taken	O
from	O
families	O
with	O
an	O
asthmatic	O
proband	O
was	O
examined	O
for	O
base	O
exchanges	O
by	O
single-stranded	O
conformational	O
polymorphism	O
(	O
SSCP	O
).	O
We	O
demonstrated	O
the	O
presence	O
of	O
a	O
polymorphism	O
in	O
the	O
promoter	DNA
region	DNA
of	O
the	O
IL-10	DNA
gene	DNA
and	O
four	O
in	O
the	O
TGF-beta	DNA
gene	DNA
promoters	DNA
(3	O
in	O
TGF-beta1	DNA
and	O
1	O
in	O
TGF-beta2	DNA
).	O
The	O
IL-10	protein
gene	O
polymorphism	O
was	O
a	O
C	O
-to-	O
A	O
exchange	O
571	DNA
base	DNA
pairs	DNA
upstream	DNA
from	O
the	O
translation	DNA
start	DNA
site	DNA
and	O
was	O
present	O
between	O
consensus	DNA
binding	DNA
sequences	DNA
for	O
Sp1	protein
and	O
elevated	O
total	O
serum	O
.	O
This	O
polymorphism	O
was	O
associated	O
with	O
elevated	O
total	protein
serum	protein
IgE	protein
in	O
subjects	O
heterozygotic	O
or	O
homozygotic	O
for	O
this	O
base	O
exchange	O
(p	O
&lt;	O
0.009).	O
The	O
base	O
exchange	O
at	O
-509	O
(from	O
the	O
transcription	O
initiation	O
site)	O
in	O
the	O
TGF-beta	DNA
promoter	DNA
also	O
linked	O
to	O
elevated	O
total	O
IgE	protein
(p	O
&lt;	O
0.01).	O
This	O
polymorphism	O
represented	O
a	O
C	O
-to-	O
T	O
base	O
exchange	O
which	O
induced	O
a	O
YY1	DNA
consensus	DNA
sequence	DNA
and	O
is	O
present	O
in	O
a	O
region	O
of	O
the	O
promoter	O
associated	O
with	O
negative	O
transcription	O
regulation.	O

Tpl-2	protein
induces	O
IL-2	protein
expression	O
in	O
T-cell	cell_line
lines	cell_line
by	O
triggering	O
multiple	O
signaling	O
pathways	O
that	O
activate	O
NFAT	protein
and	O
NF-kappaB	protein
.	O
The	O
Tpl-2	protein
kinase	protein
activates	O
the	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NFAT	protein
)	O
and	O
induces	O
IL-2	protein
expression	O
in	O
T-cell	cell_line
lines	cell_line
.	O
Here	O
we	O
show	O
that	O
the	O
activation	O
of	O
the	O
IL-2	DNA
promoter	DNA
by	O
Tpl-2	protein
is	O
inhibited	O
by	O
mutant	protein
signaling	protein
molecules	protein
that	O
inhibit	O
the	O
mitogen-activated	protein
protein	protein
kinase	protein
(	O
MAPK	protein
)	O
or	O
the	O
calcineurin	protein
/NFAT	protein
pathways	O
and	O
is	O
promoted	O
by	O
combinations	O
of	O
signaling	protein
molecules	protein
that	O
activate	O
these	O
pathways.	O
We,	O
therefore,	O
conclude	O
that	O
signals	O
generated	O
by	O
the	O
convergence	O
of	O
the	O
MAPK	protein
and	O
the	O
calcineurin	protein
/NFAT	protein
pathway	O
are	O
necessary	O
and	O
sufficient	O
for	O
the	O
activation	O
of	O
the	O
IL-2	DNA
promoter	DNA
by	O
Tpl-2	protein
.	O
The	O
activation	O
of	O
both	O
the	O
IL-2	DNA
promoter	DNA
and	O
an	O
NFAT	DNA
-driven	DNA
minimal	DNA
promoter	DNA
were	O
shown	O
to	O
depend	O
on	O
signals	O
transduced	O
by	O
Raf1	protein
.	O
However,	O
it	O
was	O
only	O
the	O
IL-2	DNA
promoter	DNA
whose	O
activation	O
by	O
Tpl-2	protein
was	O
fully	O
blocked	O
by	O
the	O
dominant	protein
negative	protein
mutant	protein
MEK1S218/222A	protein
and	O
the	O
MEK1/MEK2	O
inhibitor	O
PD098059	O
.	O
Since	O
the	O
activation	O
of	O
NFAT	protein
is	O
MAPK	protein
-dependent	O
these	O
findings	O
suggested	O
that	O
the	O
activation	O
of	O
MAPK	protein
by	O
Tpl-2	protein
is	O
either	O
independent	O
or	O
only	O
partially	O
dependent	O
on	O
MEK1	protein
and	O
MEK2	protein
.	O
In	O
addition,	O
they	O
suggested	O
that	O
the	O
activation	O
of	O
the	O
IL-2	DNA
promoter	DNA
is	O
under	O
the	O
control	O
of	O
not	O
only	O
NFAT	protein
but	O
also	O
a	O
second	O
factor	O
whose	O
activation	O
is	O
MEK	protein
-dependent	O
.	O
Experiments	O
in	O
COS-1	cell_line
and	O
EL-4	cell_line
cells	cell_line
confirmed	O
both	O
hypotheses	O
and	O
revealed	O
that	O
the	O
second	O
factor	O
activated	O
by	O
Tpl-2	protein
is	O
NF-kappaB	protein
.	O
While	O
the	O
activation	O
of	O
the	O
IL-2	DNA
promoter	DNA
and	O
an	O
NFAT	DNA
-driven	DNA
minimal	DNA
promoter	DNA
by	O
Tpl-2	protein
was	O
fully	O
blocked	O
by	O
the	O
dominant	protein
negative	protein
mutant	protein
NFAT	protein
delta418	protein
,	O
it	O
was	O
only	O
partially	O
blocked	O
by	O
the	O
calcineurin	protein
inhibitor	O
cyclosporin	O
A	O
suggesting	O
that	O
the	O
Tpl-2	protein
-mediated	O
NFAT	protein
activation	O
is	O
under	O
the	O
control	O
of	O
a	O
combination	O
of	O
calcineurin-	O
dependent	O
and	O
independent	O
pathways	O
.	O
Both	O
pathways	O
were	O
fully	O
blocked	O
by	O
Bcl-2	protein
or	O
Bcl-X(L)	protein
.	O

Differential	O
activation	O
of	O
functionally	O
distinct	O
STAT5	protein
proteins	protein
by	O
IL-5	protein
and	O
GM-CSF	protein
during	O
eosinophil	O
and	O
neutrophil	O
differentiation	O
from	O
human	cell_line
CD34+	cell_line
hematopoietic	cell_line
stem	cell_line
cells	cell_line
.	O
Interleukin-5	protein
(	O
IL-5	protein
)	O
and	O
granulocyte	protein
macrophage-colony	protein
stimulating	protein
factor	protein
(	O
GM-CSF	protein
)	O
are	O
important	O
cytokines	protein
for	O
the	O
proliferation	O
,	O
differentiation	O
,	O
and	O
activation	O
of	O
myeloid	cell_type
lineages	cell_type
.	O
The	O
JAK	protein
/STAT	protein
pathway	O
is	O
one	O
of	O
the	O
signaling	O
pathways	O
implicated	O
in	O
mediating	O
biological	O
responses	O
induced	O
by	O
these	O
cytokines	protein
.	O
Previous	O
studies	O
have	O
demonstrated	O
that	O
these	O
cytokines	protein
predominantly	O
activate	O
an	O
80	protein
kDa	protein
STAT5	protein
isoform	protein
in	O
mature	O
granulocytes.	O
To	O
better	O
understand	O
the	O
role	O
of	O
STAT	O
proteins	O
during	O
growth	O
and	O
differentiation	O
of	O
granulocytes,	O
we	O
evaluated	O
differentiation	O
of	O
human	cell_line
CD34+	cell_line
hematopoietic	cell_line
stem	cell_line
cells	cell_line
ex	O
vivo	O
toward	O
eosinophils	cell_type
and	O
neutrophils.	O
Bandshift	O
experiments	O
showed	O
that	O
in	O
an	O
early	O
stage	O
of	O
both	O
differentiation	O
pathways	O
(14	O
days),	O
the	O
94	O
kDa	O
STAT5B	protein
protein	protein
was	O
activated	O
by	O
both	O
IL-5	protein
(	O
eosinophil	cell_type
lineage	cell_type
)	O
and	O
GM-CSF	protein
(	O
neutrophil	cell_type
lineage	cell_type
).	O
However,	O
during	O
maturation	O
of	O
both	O
lineages	O
(days	O
21	O
and	O
28),	O
increased	O
expression	O
of	O
a	O
functionally	O
distinct	O
80	protein
kDa	protein
STAT5	protein
isoform	protein
was	O
observed,	O
resulting	O
in	O
heterodimer	protein
DNA-binding	protein
complexes	protein
containing	O
both	O
the	O
94	O
and	O
80	O
kDa	O
STAT5	protein
proteins	protein
.	O
The	O
finding	O
that	O
functionally	O
distinct	O
isoforms	O
of	O
STAT5	protein
are	O
activated	O
during	O
the	O
early	O
and	O
late	O
differentiation	O
stages	O
of	O
granulocytes	O
suggests	O
that	O
they	O
might	O
be	O
involved	O
in	O
regulating	O
different	O
biological	O
functions	O
in	O
these	O
cells.	O

The	O
T-cell	protein
oncogenic	protein
protein	protein
HOX11	protein
activates	O
Aldh1	protein
expression	O
in	O
NIH	cell_line
3T3	cell_line
cells	cell_line
but	O
represses	O
its	O
expression	O
in	O
mouse	O
spleen	O
development	O
.	O
Hox11	DNA
is	O
a	O
homeobox	DNA
gene	DNA
essential	O
for	O
spleen	O
formation	O
in	O
mice	O
,	O
since	O
atrophy	O
of	O
the	O
anlage	O
of	O
a	O
developing	O
spleen	O
occurs	O
in	O
early	O
embryonic	O
development	O
in	O
Hox11	O
null	O
mice	O
.	O
HOX11	protein
is	O
also	O
expressed	O
in	O
a	O
subset	O
of	O
T-cell	O
acute	O
leukemias	O
after	O
specific	O
chromosomal	O
translocations	O
.	O
Since	O
the	O
protein	O
has	O
a	O
homeodomain	DNA
and	O
can	O
activate	O
transcription	O
,	O
it	O
probably	O
exerts	O
at	O
least	O
some	O
of	O
its	O
effects	O
in	O
vivo	O
by	O
regulation	O
of	O
target	DNA
genes	DNA
.	O
Representational	O
difference	O
analysis	O
has	O
been	O
used	O
to	O
isolate	O
cDNA	DNA
clones	DNA
corresponding	O
to	O
mRNA	RNA
species	RNA
activated	O
following	O
stable	O
expression	O
of	O
HOX11	protein
in	O
NIH	cell_line
3T3	cell_line
cells	cell_line
.	O
The	O
gene	O
encoding	O
the	O
retinoic	protein
acid-synthesizing	protein
enzyme	protein
aldehyde	protein
dehydrogenase	protein
1	protein
(	O
Aldh1	protein
),	O
initially	O
called	O
Hdg-1	protein
,	O
was	O
found	O
to	O
be	O
ectopically	O
activated	O
by	O
HOX11	protein
in	O
this	O
system.	O
Study	O
of	O
Aldh1	protein
gene	O
expression	O
during	O
spleen	O
development	O
showed	O
that	O
the	O
presence	O
of	O
Aldh1	RNA
mRNA	RNA
inversely	O
correlated	O
with	O
Hox11	protein
.	O
Hox11	protein
null	O
mouse	O
embryos	O
have	O
elevated	O
Aldh1	RNA
mRNA	RNA
in	O
spleen	O
primordia	O
prior	O
to	O
atrophy	O
,	O
while	O
Aldh1	protein
seems	O
to	O
be	O
repressed	O
by	O
Hox11	protein
during	O
organogenesis	O
of	O
the	O
spleens	O
of	O
wild-type	O
mice	O
.	O
This	O
result	O
suggests	O
that	O
expression	O
of	O
Aldh1	protein
protein	protein
is	O
negatively	O
regulated	O
by	O
Hox11	protein
and	O
that	O
abnormal	O
expression	O
of	O
Aldh1	protein
in	O
Hox11	protein
null	O
mice	O
may	O
cause	O
loss	O
of	O
splenic	cell_type
precursor	cell_type
cells	cell_type
by	O
aberrant	O
retinoic	O
acid	O
metabolism	O

Role	O
of	O
the	O
X2	DNA
box	DNA
in	O
activated	O
transcription	O
from	O
the	O
DRA	DNA
promoter	DNA
in	O
B	cell_type
cells	cell_type
.	O
We	O
investigated	O
the	O
function	O
of	O
the	O
evolutionary	O
conserved	O
X2	DNA
box	DNA
in	O
the	O
promoter	DNA
of	O
the	O
HLA-DRA	DNA
gene	DNA
from	O
the	O
human	protein
major	protein
histocompatibility	protein
complex	protein
(	O
MHC	protein
)	O
in	O
resting	O
and	O
activated	O
B	cell_type
cells	cell_type
.	O
NF-X2	DNA
,	O
which	O
contains	O
members	O
of	O
the	O
AP-1/ATF/CREB	protein
families	protein
of	O
transcription	protein
factors	protein
,	O
interacts	O
with	O
the	O
X2	DNA
box	DNA
(	O
5'-TGCGTCA-3'	O
)	O
from	O
positions	O
-97	O
to	O
-91	O
in	O
the	O
DRA	DNA
promoter	DNA
.	O
In	O
resting	O
Raji	cell_line
cells	cell_line
,	O
little	O
to	O
no	O
binding	O
to	O
the	O
X2	DNA
box	DNA
was	O
observed.	O
In	O
sharp	O
contrast,	O
in	O
B	cell_type
cells	cell_type
treated	O
with	O
the	O
phorbol	O
ester	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
),	O
strong	O
interactions	O
between	O
the	O
X2	DNA
box	DNA
and	O
NF-X2	DNA
containing	O
c-Fos	protein
were	O
observed.	O
As	O
determined	O
by	O
transient	O
expression	O
and	O
RNA	O
analyses,	O
the	O
activation	O
of	O
protein	O
kinase	O
C	O
(PKC)	O
also	O
increased	O
rates	O
of	O
transcription	O
from	O
the	O
wild-type	O
DRA	DNA
promoter	DNA
but	O
not	O
from	O
a	O
DRA	DNA
promoter	DNA
bearing	O
clustered	O
point	O
mutations	O
in	O
the	O
X2	DNA
box	DNA
.	O
Since	O
the	O
co-expression	O
with	O
a	O
dominant	O
negative	O
c-Fos	protein
abolished	O
the	O
responsiveness	O
to	O
TPA	O
,	O
we	O
conclude	O
that	O
activated	O
transcription	O
of	O
the	O
DRA	DNA
gene	DNA
depends	O
on	O
interactions	O
between	O
the	O
X2	DNA
box	DNA
and	O
NF-X2	DNA
,	O
which	O
contains	O
c-Fos	protein
.	O

Thymocytes	O
control	O
the	O
CD4	DNA
gene	DNA
differently	O
from	O
mature	cell_type
T	cell_type
lymphocytes	cell_type
.	O
We	O
analyzed	O
the	O
activity	O
of	O
the	O
enhancer	DNA
,	O
the	O
promoter	DNA
and	O
the	O
silencer	DNA
of	O
the	O
human	DNA
CD4	DNA
gene	DNA
during	O
T	O
cell	O
development	O
using	O
transgenic	O
mice	O
.	O
Immunofluorescence	O
studies	O
on	O
thymic	cell_type
populations	cell_type
of	O
mice	O
carrying	O
transgenes	O
in	O
various	O
combinations	O
of	O
these	O
regulatory	DNA
DNA	DNA
elements	DNA
revealed	O
that	O
thymocytes	cell_type
control	O
the	O
CD4	DNA
gene	DNA
in	O
a	O
different	O
manner	O
than	O
mature	O
peripheral	cell_type
T	cell_type
lymphocytes	cell_type
.	O
The	O
5'-positive	DNA
regulatory	DNA
unit	DNA
,	O
consisting	O
of	O
the	O
promoter	DNA
and	O
the	O
5'	DNA
enhancer	DNA
,	O
is	O
already	O
active	O
at	O
the	O
CD4	protein
-	O
CD8	protein
-double-negative	O
(DN)	O
stage	O
of	O
development.	O
However,	O
its	O
activity	O
becomes	O
lower	O
in	O
the	O
double-positive	O
and	O
a	O
fraction	O
of	O
the	O
CD4+	cell_type
CD8int/-	cell_type
cell	cell_type
population	cell_type
,	O
indicating	O
that	O
an	O
additional	O
enhancer,	O
located	O
in	O
either	O
the	O
first	O
or	O
the	O
third	O
intron	O
of	O
the	O
CD4	DNA
gene	DNA
,	O
is	O
required	O
for	O
CD4	DNA
gene	DNA
expression	O
in	O
this	O
population.	O
The	O
other	O
studied	O
regulatory	DNA
element	DNA
is	O
the	O
minimal	DNA
CD4	DNA
silencer	DNA
which	O
inhibits	O
CD4	DNA
gene	DNA
expression	O
in	O
peripheral	cell_type
CD8	cell_type
T	cell_type
lymphocytes	cell_type
.	O
This	O
silencer	O
is	O
inactive	O
in	O
the	O
most	O
immature	cell_type
DN	cell_type
thymocytes	cell_type
,	O
which	O
probably	O
use	O
a	O
distinct	O
silencer	O
mechanism	O
to	O
down-regulate	O
CD4	DNA
gene	DNA
expression	O
.	O
Unexpectedly,	O
the	O
CD4	DNA
silencer	DNA
is	O
also	O
active	O
in	O
CD4+	cell_type
CD8int/-	cell_type
cells	cell_type
of	O
the	O
thymus	O
,	O
implying	O
that	O
an	O
anti-silencer	O
may	O
be	O
required	O
to	O
resume	O
CD4	protein
expression	O
in	O
this	O
cell	O
population.	O
Altogether,	O
the	O
CD4	DNA
gene	DNA
is	O
regulated	O
by	O
several	O
positive	O
and	O
negative	O
regulatory	O
mechanisms	O
which	O
come	O
into	O
play	O
in	O
a	O
developmentally	O
coordinated	O
manner.	O

[Induction	O
of	O
apoptosis	O
in	O
lymphocytes	cell_type
by	O
glucocorticoids	O
:	O
between	O
physiology	O
and	O
pharmacology]	O
Glucocorticoids	O
are	O
physiological	O
molecules	O
that	O
are	O
also	O
extensively	O
used	O
in	O
clinics	O
as	O
anti-inflammatory	O
,	O
immunosuppressive	O
or	O
anti-tumoral	O
agents	O
.	O
Glucocorticoids	O
can	O
induce	O
apoptosis	O
on	O
normal	cell_type
lymphoid	cell_type
cells	cell_type
and	O
play	O
a	O
key	O
role	O
in	O
the	O
physiology	O
of	O
thymic	O
selection	O
.	O
In	O
clinics	O
these	O
molecules	O
are	O
also	O
used	O
for	O
their	O
potencies	O
in	O
inducing	O
apoptosis	O
of	O
malignant	cell_type
lymphoid	cell_type
cells	cell_type
.	O
Glucocorticoids	O
are	O
mediating	O
their	O
effects	O
after	O
binding	O
to	O
an	O
intracellular	protein
receptor	protein
belonging	O
to	O
the	O
steroid	protein
receptor	protein
superfamily	protein
:	O
the	O
glucocorticoid	protein
receptor	protein
(	O
GR	protein
).	O
Once	O
activated,	O
the	O
GR	protein
,	O
can	O
mediate	O
his	O
effects	O
through	O
direct	O
binding	O
on	O
the	O
DNA	O
or	O
via	O
protein/protein	O
interactions	O
with	O
transcription	protein
factors	protein
.	O
Depending	O
on	O
the	O
type	O
of	O
lymphocytes	cell_type
,	O
the	O
mechanism	O
of	O
apoptosis	O
induced	O
by	O
glucocorticoids	O
fall	O
roughly	O
in	O
two	O
categories:	O
induction	O
of	O
"death	O
genes"	O
by	O
the	O
activated	O
GR	protein
(	O
I	protein
kappa	protein
B	protein
,	O
c-jun	protein
)	O
or	O
repression	O
of	O
survival	protein
factors	protein
(	O
AP-1	protein
,	O
c-Myc	protein
).	O
In	O
the	O
case	O
of	O
thymic	O
selection	O
the	O
mechanism	O
is	O
more	O
subtle	O
depending	O
on	O
the	O
mutual	O
repression	O
of	O
Nur77	protein
and	O
GR	protein
.	O

Direct	O
suppression	O
of	O
Stat1	protein
function	O
during	O
adenoviral	O
infection	O
.	O
The	O
action	O
of	O
adenoviral	protein
E1A	protein
oncoprotein	protein
on	O
host	DNA
immune-response	DNA
genes	DNA
has	O
been	O
attributed	O
to	O
interaction	O
with	O
p300/CBP-type	protein
transcriptional	protein
coactivators	protein
in	O
competition	O
with	O
endogenous	protein
transcription	protein
factors	protein
such	O
as	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
(STAT)	protein
proteins	protein
.	O
However,	O
we	O
show	O
that	O
mutant	O
forms	O
of	O
E1A	protein
that	O
no	O
longer	O
bind	O
p300/CBP	protein
can	O
still	O
interact	O
directly	O
with	O
Stat1	protein
(via	O
E1A	O
N-terminal	O
and	O
Stat1	O
C-terminal	O
residues	O
)	O
and	O
block	O
IFNgamma-driven,	O
Stat1	protein
-dependent	O
gene	O
activation	O
and	O
consequent	O
function	O
during	O
early-phase	O
infection	O
in	O
the	O
natural	cell_type
host	cell_type
cell	cell_type
.	O
The	O
results	O
provide	O
a	O
distinct	O
and	O
more	O
specific	O
mechanism	O
for	O
E1A	protein
-mediated	O
immune	O
suppression	O
and	O
an	O
alternative	O
model	O
of	O
IFNgamma	protein
-driven	O
enhanceosome	O
formation	O
that	O
may	O
allow	O
for	O
other	O
adaptors	O
(in	O
addition	O
to	O
p300/CBP	protein
)	O
to	O
link	O
Stat1	protein
to	O
the	O
basal	protein
transcription	protein
complex	protein
.	O

Effect	O
of	O
environmental	O
estrogens	O
on	O
IL-1beta	DNA
promoter	DNA
activity	O
in	O
a	O
macrophage	cell_line
cell	cell_line
line	cell_line
.	O
Environmental	O
estrogens	O
or	O
estrogen	O
disrupters	O
have	O
recently	O
received	O
a	O
great	O
deal	O
of	O
attention	O
because	O
of	O
their	O
potential	O
health	O
impact	O
on	O
reproductive	O
tissues	O
.	O
Few,	O
if	O
any,	O
studies	O
have	O
been	O
made	O
on	O
the	O
impact	O
of	O
these	O
compounds	O
on	O
the	O
immune	O
system	O
.	O
We	O
sought	O
to	O
determine	O
the	O
activities	O
of	O
various	O
environmental	O
estrogens	O
on	O
the	O
modulation	O
of	O
the	O
interleukin-1beta	DNA
(	DNA
IL-1beta	DNA
)	DNA
gene	DNA
in	O
a	O
model	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
,	O
hER	cell_line
+	cell_line
IL-1beta	cell_line
-CAT+	cell_line
.	O
This	O
cell	O
line	O
stably	O
transfected	O
with	O
the	O
human	protein
estrogen	protein
receptor	protein
,	O
and	O
an	O
IL-1beta	DNA
promoter	DNA
construct	O
fused	O
to	O
the	O
CAT	DNA
reporter	DNA
gene	DNA
allows	O
us	O
to	O
monitor	O
the	O
effect	O
of	O
estrogenic	O
compounds	O
on	O
IL-1beta	DNA
promoter	DNA
activity	O
.	O
17beta-estradiol	O
(	O
E2	O
)	O
markedly	O
enhanced	O
lipopolysaccharide	O
-(	O
LPS	O
)	O
induced	O
IL-1beta	DNA
promoter	DNA
-driven	O
CAT	protein
activity	O
in	O
a	O
dose-dependent	O
manner.	O
The	O
mycotoxins	O
alpha-zearalenol	O
and	O
zearalenone	O
both	O
exhibited	O
full	O
agonist	O
activity,	O
but	O
at	O
lower	O
potencies,	O
with	O
EC50	O
values	O
of	O
1.8	O
and	O
54	O
nM,	O
respectively,	O
compared	O
with	O
E2	O
at	O
0.5	O
nM.	O
In	O
addition,	O
genistein	O
was	O
a	O
very	O
low-potency	O
agonist,	O
having	O
an	O
EC50	O
of	O
1.5	O
microM.	O
Similar	O
to	O
the	O
E2	O
response,	O
the	O
slope	O
factors	O
for	O
alpha-zearalenol	O
,	O
zearalenone	O
,	O
and	O
genistein	O
were	O
close	O
to	O
3.0,	O
suggesting	O
positive	O
cooperativity	O
in	O
the	O
estrogenic	O
response	O
.	O
The	O
activity	O
of	O
the	O
mycotoxins	O
appeared	O
to	O
be	O
mediated	O
through	O
the	O
estrogen	O
receptor,	O
since	O
both	O
the	O
antiestrogens	O
H1285	O
and	O
ICI	O
182,780	O
effectively	O
inhibited	O
their	O
agonist	O
activity	O
in	O
a	O
dose-dependent	O
manner.	O
Representative	O
environmental	O
estrogenic	O
compounds	O
both	O
from	O
plant	O
and	O
industrial	O
sources	O
were	O
also	O
tested.	O
Unlike	O
the	O
mycoestrogens	O
,	O
none	O
of	O
the	O
compounds,	O
with	O
the	O
exception	O
of	O
genistein	O
,	O
synergized	O
with	O
LPS	O
to	O
enhance	O
IL-1beta	DNA
promoter	DNA
activity	O
.	O
When	O
tested	O
for	O
antiestrogenic	O
activity	O
,	O
the	O
industrial	O
compound	O
4-octylphenol	O
was	O
able	O
to	O
antagonize	O
the	O
response	O
to	O
E2	O
;	O
however,	O
the	O
response	O
was	O
three	O
orders	O
of	O
magnitude	O
less	O
potent	O
than	O
H	O
1285	O
.	O
Naringenin,	O
a	O
plant	O
flavonoid	O
,	O
showed	O
little	O
or	O
no	O
ability	O
to	O
antagonize	O
the	O
response	O
to	O
E2	O
.	O
Overall,	O
the	O
results	O
show	O
that	O
some	O
environmental	O
estrogens	O
that	O
display	O
agonist	O
activity	O
in	O
reproductive	O
tissue	O
also	O
have	O
an	O
effect	O
on	O
IL-1	DNA
gene	DNA
expression	O
in	O
hemopoietic-derived	O
tissue	O
.	O

Isolation	O
and	O
utilization	O
of	O
human	cell_type
dendritic	cell_type
cells	cell_type
from	O
peripheral	O
blood	O
to	O
assay	O
an	O
in	O
vitro	O
primary	O
immune	O
response	O
to	O
varicella-zoster	O
virus	O
peptides	O
.	O
A	O
human	O
dendritic	O
cell-based	O
assay	O
used	O
to	O
monitor	O
a	O
T	O
cell	O
proliferation	O
response	O
to	O
viral	O
peptides	O
in	O
vitro	O
is	O
described.	O
Dendritic	cell_type
cells	cell_type
and	O
autologous	cell_type
CD4	cell_type
+	cell_type
T	cell_type
cells	cell_type
were	O
isolated	O
from	O
peripheral	O
blood	O
by	O
a	O
series	O
of	O
density-gradient	O
centrifugations	O
or	O
magnetic	O
bead	O
separations	O
(or	O
both).	O
Peptides	O
corresponding	O
to	O
residues	O
of	O
the	O
immediate	protein
early	protein
protein	protein
,	O
IE62	protein
,	O
of	O
varicella-zoster	O
virus	O
(	O
VZV	O
)	O
were	O
used	O
as	O
stimulating	protein
antigens	protein
,	O
and	O
persons	O
with	O
no	O
history	O
of	O
varicella	O
and	O
no	O
humoral	O
or	O
cellular	O
immunity	O
to	O
VZV	O
served	O
as	O
naive	O
donors	O
for	O
the	O
assays.	O
Three	O
VZV	O
-susceptible	O
donors	O
were	O
tested,	O
and	O
all	O
demonstrated	O
an	O
in	O
vitro	O
response	O
to	O
multiple	O
VZV	O
peptides	O
.	O
This	O
assay	O
has	O
potential	O
as	O
a	O
screen	O
to	O
establish	O
the	O
immunogenicity	O
of	O
viral	O
antigens	O
in	O
vitro	O
using	O
T	cell_type
cells	cell_type
from	O
naive	O
donors	O
.	O

Xenogeneic	O
human	O
serum	O
promotes	O
leukocyte	O
adhesion	O
to	O
porcine	O
endothelium	O
under	O
flow	O
conditions,	O
possibly	O
through	O
the	O
activation	O
of	O
the	O
transcription	protein
factor	protein
NF-kappa	protein
B	protein
.	O
Endothelial	O
cell	O
activation	O
and	O
leukocyte	O
infiltration	O
are	O
a	O
consistent	O
feature	O
of	O
discordant	O
xenograft	O
rejection	O
.	O
Here	O
we	O
evaluated	O
whether	O
xenogeneic	O
serum	O
,	O
as	O
a	O
source	O
of	O
xenoreactive	protein
natural	protein
antibodies	protein
and	O
complement,	O
induced	O
endothelial	O
cell	O
activation	O
with	O
consequent	O
leukocyte	O
adhesion	O
under	O
flow	O
conditions.	O
Porcine	cell_line
aortic	cell_line
endothelial	cell_line
cells	cell_line
(	O
PAEC	cell_line
)	O
were	O
incubated	O
for	O
1	O
hr	O
30	O
min	O
or	O
5	O
hr	O
with	O
10%	O
homologous	O
porcine	O
serum	O
(control)	O
or	O
10%	O
xenogeneic	O
human	O
serum	O
and	O
then	O
perfused	O
with	O
total	O
human	cell_type
leukocytes	cell_type
in	O
a	O
parallel	O
plate	O
flow	O
chamber	O
under	O
laminar	O
flow	O
(1.5	O
dynes/cm2).	O
Adherent	O
cells	O
were	O
counted	O
by	O
digital	O
image	O
analysis	O
.	O
Xenogeneic	O
human	O
serum	O
significantly	O
(P	O
&lt;	O
0.01)	O
increased	O
the	O
number	O
of	O
adherent	cell_type
leukocytes	cell_type
as	O
compared	O
with	O
porcine	O
serum	O
.	O
A	O
similar	O
adhesive	O
response	O
was	O
elicited	O
by	O
TNF	O
alpha	O
(100	O
U/ml),	O
one	O
of	O
the	O
most	O
potent	O
inducers	O
of	O
endothelial	cell_type
cell	cell_type
adhesive	O
properties	O
,	O
here	O
used	O
as	O
positive	O
control.	O
In	O
order	O
to	O
elucidate	O
possible	O
mechanisms	O
underlying	O
endothelial	cell_type
cell	cell_type
activation	O
by	O
xenogeneic	O
serum	O
,	O
we	O
focussed	O
on	O
transcription	protein
factor	protein
NF-kappa	protein
B	protein
,	O
a	O
central	O
regulator	O
for	O
the	O
induction	O
of	O
different	O
genes,	O
including	O
adhesive	protein
molecules	protein
and	O
chemoattractants	protein
.	O
By	O
confocal	O
fluorescence	O
microscopy	O
,	O
we	O
observed	O
a	O
positive	O
staining	O
for	O
NF-kappa	protein
B	protein
(	O
p65	protein
subunit	protein
)	O
in	O
the	O
nuclei	O
of	O
PAEC	cell_line
exposed	O
for	O
1	O
hr	O
30	O
min	O
to	O
human	O
serum	O
,	O
which	O
indicated	O
NF-kappa	protein
B	protein
activation	O
in	O
this	O
setting.	O
At	O
variance,	O
in	O
PAEC	cell_line
incubated	O
with	O
the	O
homologous	O
serum,	O
NF-kappa	protein
B	protein
was	O
strictly	O
localized	O
in	O
the	O
cell	O
cytoplasm	O
.	O
Treatment	O
of	O
PAEC	cell_line
exposed	O
to	O
xenogeneic	O
serum	O
with	O
the	O
NF-kappa	protein
B	protein
inhibitors	O
pyrrolidinedithiocarbamate	O
(	O
PDTC	O
,	O
25	O
microM)	O
and	O
tosyl-phechloromethylketone	O
(	O
TPCK	O
,	O
25	O
microM)	O
significantly	O
(P	O
&lt;	O
0.01)	O
reduced	O
leukocyte	O
adhesion	O
in	O
respect	O
to	O
PAEC	cell_line
treated	O
with	O
human	O
serum	O
alone.	O
Findings	O
that	O
xenogeneic	O
serum	O
promotes	O
leukocyte-endothelium	O
interaction	O
possibly	O
through	O
NF-kappa	protein
B	protein
activation	O
might	O
be	O
relevant	O
for	O
designing	O
future	O
therapeutic	O
strategies	O
aimed	O
at	O
prolonging	O
xenograft	O
survival	O
.	O

Anaphylatoxins	protein
C5a	protein
and	O
C3a	protein
induce	O
nuclear	protein
factor	protein
kappaB	protein
activation	O
in	O
human	cell_type
peripheral	cell_type
blood	cell_type
monocytes	cell_type
.	O
The	O
anaphylatoxins	protein
C5a	protein
and	O
C3a	protein
are	O
involved	O
in	O
the	O
regulation	O
of	O
cytokine	O
production.	O
In	O
this	O
study	O
the	O
capability	O
of	O
C5a	protein
and	O
C3a	protein
to	O
induce	O
transcription	O
factor	O
activation	O
was	O
examined.	O
C5a	protein
and	O
C3a	protein
stimulation	O
of	O
human	cell_type
peripheral	cell_type
blood	cell_type
monocytes	cell_type
resulted	O
in	O
nuclear	O
expression	O
of	O
a	O
DNA	O
binding	O
activity	O
with	O
specificity	O
to	O
the	O
kappaB	DNA
sequence	DNA
.	O
The	O
p50	O
and	O
p65	O
proteins	O
,	O
constituents	O
of	O
the	O
prototypic	O
nuclear	protein
factor	protein
kappaB	protein
,	O
were	O
identified	O
as	O
components	O
of	O
the	O
DNA-protein	O
complexes	O
by	O
anti-peptide	protein
antibodies	protein
in	O
gel	O
supershift	O
assays	O
.	O
C5a	protein
induced	O
kappaB	protein
binding	O
activity	O
was	O
detected	O
15	O
min	O
after	O
agonist	O
stimulation,	O
peaked	O
at	O
30-40	O
min,	O
and	O
remained	O
detectable	O
at	O
2	O
h.	O
Binding	O
to	O
kappaB	DNA
sequence	DNA
was	O
accompanied	O
by	O
an	O
initial	O
decrease	O
and	O
subsequent	O
increase	O
in	O
the	O
cytoplasmic	O
IkappaBalpha	protein
levels	O
,	O
as	O
detected	O
by	O
Western	O
blotting	O
using	O
an	O
anti-	protein
IkappaBalpha	protein
antibody	protein
.	O
Pertussis	O
toxin	O
treatment	O
markedly	O
decreased	O
kappaB	protein
binding	O
activities	O
induced	O
by	O
both	O
C5a	protein
and	O
C3a	protein
,	O
whereas	O
cholera	protein
toxin	protein
displayed	O
no	O
inhibitory	O
effect.	O
Neither	O
of	O
the	O
two	O
toxins	O
affected	O
kappaB	protein
binding	O
activity	O
induced	O
by	O
TNFalpha	protein
in	O
the	O
same	O
cells.	O
These	O
results	O
imply	O
a	O
potential	O
role	O
of	O
the	O
anaphylatoxins	protein
C5a	protein
and	O
C3a	protein
in	O
regulating	O
leukocytes	O
gene	O
expression	O
through	O
G	O
protein-coupled	O
transcription	O
factor	O
activation	O
.	O

Thrombopoietin	protein
and	O
its	O
receptor.	O
Thrombopoietin	protein
(	O
TPO	protein
),	O
the	O
primary	O
physiological	O
regulator	O
of	O
platelet	O
production	O
,	O
was	O
initially	O
thought	O
to	O
be	O
a	O
lineage-specific	O
factor	O
acting	O
predominantly	O
on	O
megakaryocytopoiesis	O
.	O
Detailed	O
studies	O
establish	O
that	O
this	O
cytokine	O
mediates	O
biological	O
effects	O
on	O
a	O
broad	O
spectrum	O
of	O
hematopoietic	cell_type
progenitor	cell_type
cells	cell_type
,	O
including	O
stem	cell_type
cells	cell_type
.	O
TPO	protein
is	O
a	O
hormone	O
constitutively	O
produced	O
mainly	O
by	O
the	O
liver	O
and	O
kidney	O
.	O
Plasma	O
TPO	protein
levels	O
are	O
regulated	O
by	O
the	O
platelet	O
and	O
megakaryocyte	O
mass	O
through	O
Mpl	protein
receptor	protein
binding	O
,	O
internalization	O
and	O
degradation	O
.	O
The	O
Mpl	protein
receptor	protein
is	O
a	O
member	O
of	O
the	O
hematopoietin	protein
receptor	protein
superfamily	protein
lacking	O
intrinsic	O
kinase	O
activity	O
.	O
Upon	O
ligand-induced	O
Mpl	O
homodimerization	O
,	O
the	O
major	O
signaling	O
events	O
for	O
proliferation	O
are	O
mediated	O
through	O
the	O
JAK2	protein
/STAT5	protein
pathway	O
,	O
while	O
differentiation	O
might	O
occur	O
through	O
a	O
prolonged	O
activation	O
of	O
the	O
MAPK	protein
pathway	O
.	O
Preclinical	O
and	O
clinical	O
studies	O
demonstrate	O
the	O
potential	O
use	O
of	O
TPO	protein
in	O
a	O
variety	O
of	O
contexts,	O
but	O
it	O
is	O
too	O
early	O
to	O
evaluate	O
its	O
benefit	O
in	O
reducing	O
platelet	O
transfusion	O
.	O

TAL1	protein
and	O
LIM-only	protein
proteins	protein
synergistically	O
induce	O
retinaldehyde	protein
dehydrogenase	protein
2	protein
expression	O
in	O
T-cell	O
acute	O
lymphoblastic	O
leukemia	O
by	O
acting	O
as	O
cofactors	O
for	O
GATA3	protein
.	O
Previously,	O
we	O
have	O
shown	O
that	O
TAL1	protein
and	O
the	O
LIM-only	DNA
protein	DNA
gene	DNA
(	O
LMO	DNA
)	O
are	O
regularly	O
coactivated	O
in	O
T-cell	O
acute	O
lymphoblastic	O
leukemia	O
(	O
T-ALL	O
).	O
This	O
observation	O
is	O
likely	O
to	O
relate	O
to	O
the	O
findings	O
that	O
TAL1	protein
and	O
LMO	protein
are	O
highly	O
synergistic	O
in	O
T-cell	O
tumorigenesis	O
in	O
double-	O
transgenic	O
mice	O
.	O
To	O
understand	O
the	O
molecular	O
mechanisms	O
of	O
functional	O
synergy	O
between	O
TAL1	protein
and	O
LMO	protein
in	O
tumorigenesis	O
and	O
transcriptional	O
regulation	O
,	O
we	O
tried	O
to	O
identify	O
downstream	DNA
target	DNA
genes	DNA
regulated	O
by	O
TAL1	protein
and	O
LMO	protein
by	O
a	O
subtractive	O
PCR	O
method	O
.	O
One	O
of	O
the	O
isolated	O
genes,	O
that	O
for	O
retinaldehyde	protein
dehydrogenase	protein
2	protein
(	O
RALDH2	protein
),	O
was	O
regularly	O
expressed	O
in	O
most	O
of	O
the	O
T-ALL	cell_line
cell	cell_line
lines	cell_line
that	O
coexpressed	O
TAL1	protein
and	O
LMO	protein
.	O
Exogenously	O
transfected	O
TAL1	protein
and	O
LMO	protein
,	O
but	O
not	O
either	O
alone,	O
induced	O
RALDH2	protein
expression	O
in	O
a	O
T-ALL	cell_line
cell	cell_line
line	cell_line
,	O
HPB-ALL	cell_line
,	O
not	O
expressing	O
endogeneous	O
TAL1	protein
or	O
LMO	protein
.	O
The	O
RALDH2	RNA
transcripts	RNA
in	O
T-ALL	O
were,	O
however,	O
mostly	O
initiated	O
within	O
the	O
second	RNA
intron	RNA
.	O
Promoter	O
analysis	O
revealed	O
that	O
a	O
GATA	DNA
site	DNA
in	O
a	O
cryptic	DNA
promoter	DNA
in	O
the	O
second	DNA
intron	DNA
was	O
essential	O
and	O
sufficient	O
for	O
the	O
TAL1-	O
and	O
LMO-	O
dependent	O
transcriptional	O
activation	O
,	O
and	O
GATA3	protein
binds	O
to	O
this	O
site.	O
In	O
addition,	O
forced	O
expression	O
of	O
GATA3	protein
potentiated	O
the	O
induction	O
of	O
RALDH2	protein
by	O
TAL1	protein
and	O
LMO	protein
,	O
and	O
these	O
three	O
factors	O
formed	O
a	O
complex	O
in	O
vivo.	O
Furthermore,	O
a	O
TAL1	protein
mutant	O
not	O
binding	O
to	O
DNA	O
also	O
activated	O
the	O
transcription	O
of	O
RALDH2	protein
in	O
the	O
presence	O
of	O
LMO	protein
and	O
GATA3	protein
.	O
Collectively,	O
we	O
have	O
identified	O
the	O
RALDH2	DNA
gene	DNA
as	O
a	O
first	O
example	O
of	O
direct	O
transcriptional	DNA
target	DNA
genes	DNA
regulated	O
by	O
TAL1	protein
and	O
LMO	protein
in	O
T-ALL	O
.	O
In	O
this	O
case,	O
TAL1	protein
and	O
LMO	protein
act	O
as	O
cofactors	O
for	O
GATA3	protein
to	O
activate	O
the	O
transcription	O
of	O
RALDH2	protein

Glucocorticoid	protein
receptors	protein
in	O
human	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
in	O
relation	O
to	O
age	O
and	O
to	O
sport	O
activity.	O
Glucocorticoid	protein
receptors	protein
(	O
GR	protein
)	O
are	O
ubiquitous	O
molecules	O
and	O
are	O
present	O
also	O
in	O
the	O
hippocampus	O
and	O
in	O
several	O
other	O
nervous	O
and	O
immune	O
tissues	O
.	O
Peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMCs	cell_type
)	O
are	O
a	O
good	O
model	O
for	O
studies	O
of	O
GR	protein
in	O
humans	O
.	O
Glucocorticoids	O
are	O
important	O
for	O
maintaining	O
cellular	O
and	O
humoral	O
homeostasis	O
and	O
are	O
key	O
mediators	O
of	O
neuroendocrine-immune	O
regulatory	O
interactions	O
.	O
The	O
increase	O
of	O
cortisol	O
is	O
immunosuppressive	O
and	O
reduces	O
GR	protein
concentration	O
both	O
in	O
nervous	O
and	O
immune	O
systems	O
.	O
Variation	O
of	O
glucocorticoids	O
in	O
healthy	O
aged	O
subjects	O
and	O
athletes	O
has	O
been	O
shown.	O
Prompted	O
by	O
these	O
results,	O
we	O
have	O
investigated	O
in	O
man	O
a	O
possible	O
relationship	O
between	O
GR	protein
binding	O
capacity	O
in	O
the	O
PBMCs	cell_type
and	O
age,	O
in	O
relation	O
also	O
to	O
plasma	O
testosterone	O
and	O
cortisol	O
.	O
The	O
same	O
parameters	O
have	O
been	O
examined	O
in	O
a	O
group	O
of	O
soccer	O
players	O
for	O
comparison	O
with	O
the	O
sedentary	O
group	O
.	O
GR	protein
binding	O
capacity	O
was	O
higher	O
in	O
younger	O
subjects	O
than	O
in	O
older	O
ones,	O
and	O
lower	O
in	O
the	O
group	O
of	O
athletes	O
than	O
in	O
the	O
younger	O
and	O
older	O
sedentary	O
subjects	O
.	O
In	O
the	O
sedentary	O
group	O
a	O
negative	O
correlation	O
was	O
present	O
between	O
GR	protein
binding	O
capacity	O
and	O
age	O
.	O
Plasma	O
cortisol	O
was	O
higher	O
and	O
testosterone	O
lower	O
in	O
the	O
athletes	O
;	O
they	O
were	O
negatively	O
correlated	O
in	O
athletes	O
and	O
positively	O
correlated	O
in	O
the	O
sedentary	O
subjects	O
.	O
The	O
results	O
for	O
athletes	O
agree	O
with	O
their	O
lower	O
anabolic/catabolic	O
balance	O
.	O
The	O
mechanism	O
of	O
reduced	O
GR	protein
levels	O
in	O
relation	O
to	O
age	O
and	O
sport	O
activity	O
could	O
involve	O
a	O
loss	O
or	O
an	O
involution	O
of	O
receptor	O
synthesis	O
.	O
However	O
other	O
possibilities,	O
such	O
as	O
altered	O
distribution	O
of	O
lymphocyte	O
subpopulations	O
with	O
different	O
receptor	O
concentrations	O
and	O
with	O
different	O
cytokine	protein
production	O
,	O
cannot	O
be	O
excluded.	O
Several	O
neuroendocrine-immune	O
interactions	O
could	O
be	O
responsible	O
for	O
reduced	O
GR	protein
levels	O
with	O
age	O
and	O
sport	O
activity	O
in	O
man.	O

Glycation-dependent	O
,	O
reactive	O
oxygen	O
species-mediated	O
suppression	O
of	O
the	O
insulin	O
gene	O
promoter	O
activity	O
in	O
HIT	cell_type
cells	cell_type
.	O
Prolonged	O
poor	O
glycemic	O
control	O
in	O
non-insulin-dependent	O
diabetes	O
mellitus	O
patients	O
often	O
leads	O
to	O
a	O
decline	O
in	O
insulin	O
secretion	O
from	O
pancreatic	cell_type
beta	cell_type
cells	cell_type
,	O
accompanied	O
by	O
a	O
decrease	O
in	O
the	O
insulin	O
content	O
of	O
the	O
cells.	O
As	O
a	O
step	O
toward	O
elucidating	O
the	O
pathophysiological	O
background	O
of	O
the	O
so-called	O
glucose	O
toxicity	O
to	O
pancreatic	cell_type
beta	cell_type
cells	cell_type
,	O
we	O
induced	O
glycation	O
in	O
HIT-T15	cell_type
cells	cell_type
using	O
a	O
sugar	O
with	O
strong	O
deoxidizing	O
activity,	O
D-ribose	O
,	O
and	O
examined	O
the	O
effects	O
on	O
insulin	O
gene	O
transcription	O
.	O
The	O
results	O
of	O
reporter	DNA
gene	DNA
analyses	O
revealed	O
that	O
the	O
insulin	DNA
gene	DNA
promoter	DNA
is	O
more	O
sensitive	O
to	O
glycation	O
than	O
the	O
control	O
beta-actin	DNA
gene	DNA
promoter	DNA
;	O
approximately	O
50	O
and	O
80%	O
of	O
the	O
insulin	DNA
gene	DNA
promoter	DNA
activity	O
was	O
lost	O
when	O
the	O
cells	O
were	O
kept	O
for	O
3	O
d	O
in	O
the	O
presence	O
of	O
40	O
and	O
60	O
mM	O
D-ribose	O
,	O
respectively.	O
In	O
agreement	O
with	O
this,	O
decrease	O
in	O
the	O
insulin	RNA
mRNA	RNA
and	O
insulin	O
content	O
was	O
observed	O
in	O
the	O
glycation-induced	cell_type
cells	cell_type
.	O
Also,	O
gel	O
mobility	O
shift	O
analyses	O
using	O
specific	O
antiserum	O
revealed	O
decrease	O
in	O
the	O
DNA-binding	O
activity	O
of	O
an	O
insulin	protein
gene	protein
transcription	protein
factor	protein
,	O
PDX-1/IPF1/STF-1	protein
.	O
These	O
effects	O
of	O
D-ribose	O
seemed	O
almost	O
irreversible	O
but	O
could	O
be	O
prevented	O
by	O
addition	O
of	O
1	O
mM	O
aminoguanidine	O
or	O
10	O
mM	O
N-acetylcysteine	O
,	O
thus	O
suggesting	O
that	O
glycation	O
and	O
reactive	O
oxygen	O
species	O
,	O
generated	O
through	O
the	O
glycation	O
reaction	O
,	O
serve	O
as	O
mediators	O
of	O
the	O
phenomena.	O
These	O
observations	O
suggest	O
that	O
protein	O
glycation	O
in	O
pancreatic	cell_type
beta	cell_type
cells	cell_type
,	O
which	O
occurs	O
in	O
vivo	O
under	O
chronic	O
hyperglycemia	O
,	O
suppresses	O
insulin	O
gene	O
transcription	O
and	O
thus	O
can	O
explain	O
part	O
of	O
the	O
beta	O
cell	O
glucose	O
toxicity	O
.	O

Nuclear	protein
factor-kappa	protein
B	protein
activity	O
in	O
T	cell_type
cells	cell_type
from	O
patients	O
with	O
rheumatic	O
diseases	O
:	O
a	O
preliminary	O
report.	O
OBJECTIVE:	O
The	O
NF-kappa	protein
B/Rel	protein
family	protein
of	O
transcription	protein
factors	protein
regulates	O
the	O
expression	O
of	O
many	O
genes	O
involved	O
in	O
the	O
immune	O
or	O
inflammatory	O
response	O
at	O
the	O
transcriptional	O
level	O
.	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
distinctive	O
patterns	O
of	O
NF-kappa	protein
B	protein
activation	O
are	O
seen	O
in	O
different	O
forms	O
of	O
joint	O
disease.	O
METHODS:	O
The	O
DNA	O
binding	O
activity	O
of	O
these	O
nucleoproteins	protein
was	O
examined	O
in	O
purified	O
synovial	O
and	O
peripheral	O
T	O
cells	O
from	O
patients	O
with	O
various	O
chronic	O
rheumatic	O
diseases	O
(12:	O
four	O
with	O
rheumatoid	O
arthritis	O
;	O
five	O
with	O
spondyloarthropathies	O
;	O
and	O
three	O
with	O
osteoarthritis	O
).	O
RESULTS:	O
Electrophoretic	O
mobility	O
shift	O
assays	O
disclosed	O
two	O
specific	O
complexes	O
bound	O
to	O
a	O
NF-kappa	protein
B	protein
specific	O
32P-labelled	O
oligonucleotide	O
in	O
nucleoproteins	protein
extracted	O
from	O
purified	cell_type
T	cell_type
cells	cell_type
isolated	O
from	O
synovial	O
fluid	O
and	O
peripheral	O
blood	O
of	O
patients	O
with	O
rheumatoid	O
arthritis	O
.	O
The	O
complexes	protein
consisted	O
of	O
p50/p50	protein
homodimers	protein
and	O
p50/p65	O
heterodimers.	O
Increased	O
NF-kappa	protein
B	protein
binding	O
to	O
DNA	O
in	O
synovial	cell_type
T	cell_type
cells	cell_type
was	O
observed	O
relative	O
to	O
peripheral	O
T	O
cells.	O
In	O
non-rheumatoid	O
arthritis,	O
binding	O
of	O
NF-kappa	protein
B	protein
in	O
synovial	cell_type
T	cell_type
cells	cell_type
was	O
exclusively	O
mediated	O
by	O
p50/p50	protein
homodimers	protein
.	O
CONCLUSION:	O
Overall,	O
the	O
results	O
suggest	O
that	O
NF-kappa	protein
B	protein
may	O
play	O
a	O
central	O
part	O
in	O
the	O
activation	O
of	O
infiltrating	cell_type
T	cell_type
cells	cell_type
in	O
chronic	O
rheumatoid	O
arthritis	O
.	O
The	O
activation	O
of	O
this	O
nuclear	O
factor	O
is	O
qualitatively	O
different	O
in	O
rheumatoid	cell_type
synovial	cell_type
T	cell_type
cells	cell_type
to	O
that	O
in	O
other	O
forms	O
of	O
non-rheumatoid	O
arthritis	O
(for	O
example,	O
osteoarthritis	O
,	O
spondyloarthropathies	O
).	O

X	DNA
chromosome	DNA
inactivation	O
patterns	O
in	O
normal	O
females	O
.	O
Since	O
one	O
of	O
the	O
two	O
X	DNA
chromosomes	DNA
is	O
randomly	O
inactivated	O
at	O
an	O
early	O
stage	O
of	O
female	O
embryonic	O
development	O
,	O
X-linked	protein
markers	protein
have	O
been	O
used	O
to	O
study	O
the	O
origin	O
and	O
development	O
of	O
various	O
neoplastic	O
disorders	O
in	O
affected	O
heterozygous	O
women	O
;	O
clonality	O
assays	O
have	O
provided	O
a	O
useful	O
tool	O
to	O
the	O
understanding	O
of	O
the	O
mechanisms	O
underlying	O
the	O
development	O
of	O
neoplasia	O
.	O
Recently,	O
a	O
technique	O
of	O
clonal	O
analysis	O
has	O
been	O
devised	O
that	O
takes	O
advantage	O
of	O
a	O
highly	O
polymorphic	O
short	DNA
tandem	DNA
repeat	DNA
within	O
the	O
X-linked	DNA
human	DNA
androgen	DNA
receptor	DNA
(AR)	DNA
gene	DNA
,	O
resulting	O
in	O
a	O
heterozygosity	O
rate	O
approaching	O
90%.	O
The	O
rapid	O
expansion	O
of	O
the	O
number	O
of	O
women	O
now	O
suitable	O
for	O
X	O
inactivation	O
analysis	O
has	O
however	O
given	O
rise	O
to	O
new	O
controversies,	O
one	O
of	O
the	O
more	O
troublesome	O
being	O
the	O
possibility	O
of	O
a	O
modification	O
of	O
the	O
pattern	O
of	O
X-	DNA
chromosome	DNA
inactivation	O
pattern	O
in	O
blood	cell_type
cells	cell_type
of	O
elderly	O
women	O
.	O
In	O
the	O
present	O
study	O
we	O
analyze	O
with	O
the	O
AR	O
assay	O
a	O
group	O
of	O
166	O
healthy	O
females	O
aged	O
between	O
8	O
and	O
94	O
years,	O
with	O
no	O
history	O
of	O
genetic	O
or	O
neoplastic	O
familial	O
disorders	O
.	O
We	O
failed	O
to	O
find	O
any	O
correlation	O
between	O
age	O
and	O
X-	DNA
chromosome	DNA
inactivation	O
pattern	O
(r	O
=	O
0.17),	O
even	O
subdividing	O
the	O
subjects	O
in	O
different	O
age	O
groups	O
according	O
to	O
the	O
criteria	O
used	O
by	O
other	O
researchers	O
,	O
and	O
therefore	O
reaffirm	O
that,	O
when	O
tested	O
for	O
with	O
well-standardized	O
and	O
accurate	O
criteria,	O
extremely	O
unbalanced	O
inactivation	O
of	O
the	O
X	DNA
chromosome	DNA
is	O
a	O
truly	O
uncommon	O
phenomenon	O
in	O
normal	O
women	O
.	O
Copyright	O
1998	O
Academic	O
Press.	O

The	O
role	O
of	O
Stat4	protein
in	O
species-specific	O
regulation	O
of	O
Th	O
cell	O
development	O
by	O
type	protein
I	protein
IFNs	protein
.	O
Type	protein
I	protein
IFNs	protein
(	O
IFN-alpha/beta	protein
),	O
in	O
addition	O
to	O
IL-12	protein
,	O
have	O
been	O
shown	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
differentiation	O
of	O
human,	O
but	O
not	O
mouse,	O
Th	cell_type
cells	cell_type
.	O
We	O
show	O
here	O
that	O
IFN-alpha/beta	protein
act	O
directly	O
on	O
human	cell_type
T	cell_type
cells	cell_type
to	O
drive	O
Th1	O
development	O
,	O
bypassing	O
the	O
need	O
for	O
IL-12	protein
-induced	O
signaling,	O
whereas	O
IFN-alpha	protein
cannot	O
substitute	O
IL-12	protein
for	O
mouse	O
Th1	O
development	O
.	O
The	O
molecular	O
basis	O
for	O
this	O
species	O
specificity	O
is	O
that	O
IFN-alpha	protein
/beta	protein
activate	O
Stat4	protein
in	O
differentiating	O
human,	O
but	O
not	O
mouse,	O
Th	cell_type
cells	cell_type
.	O
Unlike	O
IL-12	protein
,	O
which	O
acts	O
only	O
on	O
Th1	cell_type
cells	cell_type
,	O
IFN-alpha	protein
/beta	protein
can	O
activate	O
Stat4	protein
not	O
only	O
in	O
human	cell_type
Th1	cell_type
,	O
but	O
also	O
in	O
Th2	cell_type
cells	cell_type
.	O
However,	O
restimulation	O
of	O
human	cell_line
Th2	cell_line
lines	cell_line
and	O
clones	O
in	O
the	O
presence	O
of	O
IFN-alpha	protein
does	O
not	O
induce	O
the	O
production	O
of	O
IFN-gamma	protein
.	O
These	O
results	O
suggest	O
that	O
activation	O
of	O
Stat4	protein
,	O
which	O
is	O
necessary	O
for	O
the	O
differentiation	O
of	O
naive	cell_type
T	cell_type
cells	cell_type
into	O
polarized	O
Th1	cell_type
cells	cell_type
,	O
is	O
not	O
sufficient	O
to	O
induce	O
phenotype	O
reversal	O
of	O
human	cell_type
Th2	cell_type
cells	cell_type
.	O

Molecular	O
cloning	O
of	O
FKHRL1P2	protein
,	O
a	O
member	O
of	O
the	O
developmentally	O
regulated	O
fork	protein
head	protein
domain	protein
transcription	protein
factor	protein
family	protein
.	O
Here	O
we	O
report	O
the	O
expression	O
of	O
a	O
fork	protein
head	protein
domain	protein
protein	protein
in	O
human	cell_type
T	cell_type
helper	cell_type
cells	cell_type
.	O
We	O
cloned	O
and	O
characterized	O
a	O
fork	DNA
head	DNA
cDNA	DNA
from	O
human	RNA
T	RNA
helper	RNA
cell	RNA
mRNA	RNA
using	O
differential	O
display	O
RT-PCR	O
.	O
The	O
cDNA	O
contains	O
a	O
546-nucleotide	DNA
(nt)	DNA
open	DNA
reading	DNA
frame	DNA
(	O
ORF	DNA
)	O
that	O
codes	O
for	O
the	O
carboxyl-terminal	protein
180	protein
amino	protein
acids	protein
(aa)	O
of	O
the	O
recently	O
identified	O
fkhrl1	DNA
gene	DNA
.	O
This	O
ORF	DNA
does	O
not	O
contain	O
the	O
characteristic	O
DNA-binding	DNA
domain	DNA
found	O
in	O
members	O
of	O
the	O
forkhead	protein
protein	protein
family	protein
.	O
In-vitro	O
transcription/translation	O
of	O
this	O
cDNA	DNA
expressed	O
a	O
protein	O
of	O
approximately	O
20	O
kDa.	O
We	O
have	O
generated	O
antibodies	O
that	O
specifically	O
immunoprecipitated	O
the	O
in-vitro-translated	protein
20-kDa	protein
protein	protein
.	O
This	O
antibody	O
also	O
recognizes	O
in	O
human	cell_type
T	cell_type
lymphocytes	cell_type
a	O
70-kDa	O
protein	O
corresponding	O
in	O
size	O
to	O
that	O
predicted	O
for	O
the	O
fkhrl1	DNA
gene	DNA
product.	O
The	O
mRNA	O
levels	O
for	O
fkhrl1	DNA
is	O
elevated	O
in	O
T	cell_type
helper-induced	cell_type
lymphocytes	cell_type
in	O
comparison	O
to	O
PHA-stimulated	cell_line
T	cell_line
lymphocytes	cell_line
.	O
Further	O
characterization	O
of	O
FKHRL1	DNA
and	O
its	O
related	O
family	O
members	O
should	O
shed	O
light	O
on	O
the	O
transcriptional	O
mechanisms	O
of	O
this	O
fork	DNA
head	DNA
gene	DNA
subfamily	DNA
and	O
their	O
role	O
in	O
T	O
helper	O
cell	O
differentiation	O
and	O
regulation	O
of	O
cell	O
growth	O
.	O

Inhibition	O
of	O
Th1	O
development	O
mediated	O
by	O
GATA-3	protein
through	O
an	O
IL-4-independent	O
mechanism.	O
Recently,	O
the	O
transcription	protein
factor	protein
GATA-3	protein
was	O
shown	O
to	O
be	O
selectively	O
expressed	O
in	O
Th2	O
but	O
not	O
Th1	cell_type
cells	cell_type
and	O
to	O
augment	O
Th2-specific	protein
cytokines	protein
.	O
Here,	O
we	O
show	O
that	O
loss	O
of	O
GATA-3	protein
expression	O
by	O
developing	O
Th1	cell_type
cells	cell_type
requires	O
IL-12	protein
signaling	O
through	O
Stat4	protein
and	O
does	O
not	O
simply	O
result	O
from	O
an	O
absence	O
of	O
IL-4	protein
.	O
Moreover,	O
we	O
demonstrate	O
a	O
novel	O
role	O
for	O
GATA-3	protein
in	O
directly	O
repressing	O
Th1	O
development	O
distinct	O
from	O
its	O
positive	O
actions	O
on	O
Th2-specific	protein
cytokines	protein
.	O
GATA-3	protein
inhibits	O
Th1	protein
cytokines	protein
by	O
a	O
cell-intrinsic	O
mechanism	O
that	O
is	O
not	O
dependent	O
on	O
IL-4	protein
and	O
that	O
may	O
involve	O
repression	O
of	O
IL-12	protein
signaling	O
.	O
Thus,	O
GATA-3	protein
expression	O
and	O
IL-12	protein
signaling	O
are	O
mutually	O
antagonistic,	O
which	O
facilitates	O
rapid	O
dominance	O
of	O
one	O
pathway	O
during	O
early	O
Th	O
development	O
,	O
producing	O
a	O
stable	O
divergence	O
in	O
cytokine	protein
profiles	O
.	O

Conserved	DNA
elements	DNA
containing	O
NF-E2	O
and	O
tandem	O
GATA	O
binding	O
sites	O
are	O
required	O
for	O
erythroid-specific	DNA
chromatin	DNA
structure	DNA
reorganization	O
within	O
the	O
human	DNA
beta-globin	DNA
locus	DNA
control	DNA
region	DNA
.	O
Proper	O
expression	O
of	O
the	O
genes	O
of	O
the	O
human	DNA
beta-globin	DNA
gene	DNA
locus	DNA
requires	O
the	O
associated	O
locus	DNA
control	DNA
region	DNA
(	O
LCR	DNA
).	O
Structurally,	O
the	O
LCR	DNA
is	O
defined	O
by	O
the	O
presence	O
of	O
four	O
domains	O
of	O
erythroid-specific	DNA
chromatin	DNA
structure	DNA
.	O
These	O
domains,	O
which	O
have	O
been	O
characterized	O
as	O
DNase	DNA
I	DNA
hypersensitive	DNA
sites	DNA
(	O
HSs	DNA
),	O
comprise	O
the	O
active	O
elements	O
of	O
the	O
LCR	DNA
.	O
The	O
major	O
focus	O
of	O
this	O
research	O
is	O
to	O
define	O
the	O
cis	DNA
-acting	DNA
elements	DNA
which	O
are	O
required	O
for	O
the	O
formation	O
of	O
these	O
domains	O
of	O
unique	O
chromatin	DNA
structure	DNA
.	O
Our	O
previous	O
investigations	O
on	O
the	O
formation	O
of	O
LCR	DNA
HS4	DNA
demonstrated	O
that	O
NF-E2	O
and	O
tandem,	O
inverted	O
GATA	O
binding	O
sites	O
are	O
required	O
for	O
the	O
formation	O
of	O
the	O
native	DNA
HS	DNA
.	O
Similarly	O
arranged	O
NF-E2	O
and	O
tandem	O
GATA	O
sites	O
are	O
present	O
within	O
the	O
core	DNA
regions	DNA
of	O
the	O
other	O
human	DNA
LCR	DNA
HSs	DNA
and	O
are	O
evolutionarily	O
conserved.	O
Using	O
site-directed	O
mutagenesis	O
of	O
human	O
HSs	O
2	O
and	O
3	O
we	O
have	O
tested	O
the	O
hypothesis	O
that	O
these	O
NF-E2	O
and	O
GATA	O
sites	O
are	O
common	O
requirements	O
for	O
the	O
formation	O
of	O
all	O
LCR	DNA
HSs	DNA
.	O
We	O
find	O
that	O
mutation	O
of	O
these	O
elements,	O
and	O
particularly	O
the	O
GATA	DNA
elements	DNA
,	O
results	O
in	O
a	O
decrease	O
or	O
complete	O
loss	O
of	O
DNase	protein
I	protein
hypersensitivity	O
.	O
These	O
data	O
imply	O
the	O
presence	O
of	O
common	O
structural	O
elements	O
within	O
the	O
core	O
of	O
each	O
LCR	DNA
HS	DNA
which	O
are	O
required	O
for	O
erythroid-specific	DNA
chromatin	DNA
structure	DNA
reorganization	O
.	O

Cloning	O
of	O
ARE-containing	DNA
genes	DNA
by	O
AU-motif-directed	O
display	O
.	O
A	O
procedure	O
suitable	O
for	O
cloning	RNA
labile	RNA
mRNAs	RNA
that	O
contain	O
AU	RNA
motifs	RNA
is	O
presented	O
(	O
AU-DD	RNA
).	O
These	O
motifs	O
are	O
regulatory	DNA
sequences	DNA
within	O
the	O
so-called	O
AU-rich	DNA
elements	DNA
(	O
AREs	DNA
)	O
often	O
found	O
in	O
3'	DNA
untranslated	DNA
regions	DNA
of	O
genes	O
such	O
as	O
cytokines	protein
,	O
proto-oncogenes	DNA
,	O
and	O
transcription	protein
factors	protein
.	O
AU-DD	DNA
is	O
an	O
AU-motif-directed	DNA
differential	DNA
display	DNA
that	O
permits	O
the	O
identification	O
of	O
ARE-containing	DNA
genes	DNA
differentially	O
expressed	O
after	O
cell	O
activation.	O
It	O
has	O
been	O
applied	O
to	O
peripheral	cell_type
blood	cell_type
monocytes	cell_type
and	O
a	O
T	cell_line
cell	cell_line
clone	cell_line
to	O
isolate	O
59	DNA
cDNA	DNA
fragments	DNA
associated	O
to	O
activation.	O
Fourteen	O
percent	O
of	O
isolated	O
fragments	O
belong	O
to	O
already	O
known	O
genes	O
that	O
certainly	O
are	O
cytokines	protein
and	O
transduction/	protein
transcription	protein
factors	protein
.	O
The	O
remaining	O
86%	O
correspond	O
to	O
unknown	O
genes	DNA
of	O
which	O
92%	O
have	O
been	O
confirmed	O
to	O
be	O
differentially	O
expressed.	O
These	O
data	O
demonstrate	O
the	O
efficiency	O
of	O
the	O
system	O
and	O
support	O
the	O
notion	O
that	O
numerous	O
genes	DNA
falling	O
into	O
those	O
categories	O
remain	O
unidentified	O
and	O
that	O
they	O
can	O
be	O
cloned	O
by	O
this	O
method.	O
Copyright	O
1998	O
Academic	O
Press.	O

Transcription	O
factor	O
NF-kappaB	protein
regulation	O
of	O
renal	O
fibrosis	O
during	O
ureteral	O
obstruction	O
.	O
Irrespective	O
of	O
the	O
etiology,	O
many	O
kidney	O
diseases	O
result	O
in	O
inflammation	O
and	O
fibrosis	O
of	O
the	O
tubulointerstitium	O
,	O
with	O
the	O
subsequent	O
loss	O
of	O
renal	O
function	O
.	O
To	O
initiate	O
any	O
disease	O
process	O
or	O
for	O
any	O
disease	O
process	O
to	O
progress,	O
there	O
must	O
be	O
changes	O
in	O
the	O
transcription	O
of	O
genes	O
within	O
the	O
affected	O
tissue.	O
The	O
nuclear	protein
factor-kappa	protein
B	protein
(	protein
NF-kappaB	protein
)	protein
family	protein
of	O
transcription	protein
factors	protein
regulates	O
genes	O
involved	O
in	O
inflammation	O
,	O
cell	O
proliferation	O
,	O
and	O
cell	O
differentiation	O
.	O
This	O
review	O
discusses	O
the	O
NF-kappaB	protein
transcription	protein
factor	protein
family	protein
in	O
general	O
and	O
the	O
association	O
of	O
NF-kappaB	protein
activation	O
with	O
cellular/molecular	O
events	O
of	O
renal	O
inflammation	O
and	O
fibrosis	O

Expression	O
of	O
transcription	protein
factors	protein
during	O
sodium	O
phenylacetate	O
induced	O
erythroid	O
differentiation	O
in	O
K562	cell_line
cells	cell_line
.	O
During	O
15	O
days	O
of	O
treatment	O
of	O
K562	cell_line
cells	cell_line
with	O
sodium	O
phenylacetate	O
,	O
we	O
observed	O
an	O
increase	O
in	O
the	O
cellular	O
hemoglobin	protein
concentration	O
with	O
a	O
similar	O
increase	O
in	O
the	O
expression	O
of	O
gamma-globin	RNA
mRNA	RNA
.	O
Morphological	O
studies	O
demonstrated	O
characteristic	O
features	O
of	O
erythroid	O
differentiation	O
and	O
maturation	O
.	O
At	O
the	O
same	O
time	O
there	O
was	O
no	O
change	O
in	O
the	O
level	O
of	O
expression	O
of	O
the	O
cell	protein
surface	protein
antigenes	protein
CD33	protein
,	O
CD34	protein
,	O
CD45	protein
,	O
CD71	protein
and	O
glycophorin	protein
A	protein
.	O
Likewise,	O
the	O
level	O
of	O
expression	O
of	O
the	O
erythroid	protein
transcription	protein
factors	protein
GATA-1	protein
,	O
GATA-2	protein
,	O
NF-E2	protein
,	O
SCL	protein
and	O
RBTN2	protein
,	O
all	O
expressed	O
in	O
untreated	O
K562	cell_line
cells	cell_line
,	O
did	O
not	O
increase	O
during	O
sodium	O
phenylacetate	O
induced	O
erythroid	O
differentiation	O
.	O
The	O
expression	O
of	O
the	O
nuclear	protein
factors	protein
Evi-1	protein
and	O
c-myb	protein
,	O
known	O
to	O
inhibit	O
erythroid	O
differentiation	O
,	O
did	O
not	O
decrease.	O
We	O
conclude	O
that	O
sodium	O
phenylacetate	O
treatment	O
of	O
K562	cell_line
cells	cell_line
increases	O
gamma-globin	RNA
mRNA	RNA
and	O
induces	O
cell	O
maturation	O
as	O
judged	O
by	O
morphology	O
without	O
affecting	O
the	O
expression	O
of	O
the	O
erythroid	protein
transcription	protein
factors	protein
,	O
some	O
of	O
which	O
are	O
known	O
to	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
beta-like	DNA
globin	DNA
genes	DNA
.	O

Isolation	O
of	O
a	O
B-cell-specific	DNA
promoter	DNA
for	O
the	O
human	protein
class	protein
II	protein
transactivator	protein
.	O
The	O
class	protein
II	protein
transactivator	protein
(	O
CIITA	protein
)	O
is	O
essential	O
for	O
the	O
expression	O
of	O
major	protein
histocompatibility	protein
complex	protein
(MHC)	protein
class	protein
II	protein
antigens	protein
.	O
The	O
tissular	O
patterns	O
of	O
CIITA	O
and	O
MHC	O
class	O
II	O
gene	O
expression	O
are	O
tightly	O
correlated:	O
CIITA	RNA
mRNA	RNA
is	O
highly	O
expressed	O
in	O
B	cell_type
cells	cell_type
,	O
and	O
is	O
induced	O
by	O
interferon	protein
gamma	protein
(	O
IFN-gamma	protein
)	O
in	O
macrophage	O
and	O
epithelial	O
cell	O
lines	O
.	O
We	O
first	O
isolated	O
two	O
overlapping	O
cosmids	DNA
encoding	O
human	protein
CIITA	protein
which,	O
when	O
co-transfected,	O
are	O
able	O
to	O
restore	O
MHC	protein
class	protein
II	protein
expression	O
in	O
a	O
B-lymphoblastoid	cell_line
cell	cell_line
line	cell_line
(	O
B-LCL	cell_line
)	O
defective	O
for	O
CIITA	protein
.	O
Subsequently,	O
a	O
1.8	DNA
kilobase	DNA
(kb)	DNA
fragment	DNA
of	O
the	O
CIITA	DNA
promoter	DNA
was	O
isolated	O
and	O
sequenced.	O
A	O
motif	O
presenting	O
a	O
strong	O
similarity	O
to	O
an	O
initiator	O
was	O
detected,	O
as	O
well	O
as	O
putative	DNA
binding	DNA
sites	DNA
for	O
Sp1	protein
,	O
GATA-2	protein
,	O
LyF-1	protein
,	O
ets-1	protein
,	O
AP1	protein
,	O
and	O
MZF1	protein
transcription	protein
factors	protein
,	O
and	O
two	O
GAS	DNA
motifs	DNA
.	O
When	O
introduced	O
in	O
front	O
of	O
a	O
luciferase	DNA
reporter	DNA
gene	DNA
,	O
this	O
promoter	O
is	O
able	O
to	O
direct	O
a	O
high	O
luciferase	protein
activity	O
in	O
a	O
human	cell_line
B-LCL	cell_line
.	O
In	O
contrast,	O
luciferase	protein
expression	O
was	O
not	O
stimulated	O
after	O
IFN-gamma	protein
treatment	O
when	O
the	O
construct	O
was	O
transfected	O
in	O
macrophage	O
or	O
in	O
epithelial	cell_line
cell	cell_line
lines	cell_line
.	O
However,	O
an	O
induction	O
of	O
the	O
human	DNA
CIITA	DNA
gene	DNA
was	O
observed	O
in	O
mouse	O
macrophage	O
and	O
fibrosarcoma	O
cell	O
lines	O
,	O
when	O
the	O
cells	O
were	O
transfected	O
with	O
a	O
cosmid	DNA
containing	O
the	O
human	DNA
CIITA	DNA
gene	DNA
,	O
but	O
lacking	O
the	O
1.8	DNA
kb	DNA
promoter	DNA
described	O
above.	O
Taken	O
together,	O
these	O
data	O
suggest	O
the	O
existence	O
of	O
an	O
intragenic	O
promoter	O
driving	O
an	O
IFN-gamma	protein
-inducible	O
expression	O
of	O
CIITA	protein
.	O

Phenotypic	O
and	O
functional	O
studies	O
of	O
leukocytes	cell_type
in	O
human	O
endometrium	O
and	O
endometriosis	O
.	O
The	O
aetiology	O
of	O
endometriosis	O
,	O
a	O
common	O
and	O
disabling	O
disorder,	O
is	O
presently	O
unknown,	O
although	O
immune	O
dysfunction	O
could	O
allow	O
ectopic	O
endometrial	O
fragments	O
to	O
survive	O
outside	O
the	O
uterine	O
cavity	O
.	O
These	O
studies	O
investigate	O
the	O
relationship	O
between	O
leukocyte	cell_type
populations	cell_type
,	O
steroid	protein
hormone	protein
receptor	protein
expression	O
,	O
proliferative	O
activity	O
,	O
bcl-2	protein
expression	O
and	O
apoptosis	O
in	O
eutopic	O
and	O
ectopic	O
endometrium	O
from	O
women	O
with	O
endometriosis	O
or	O
adenomyosis	O
at	O
different	O
phases	O
of	O
the	O
menstrual	O
cycle	O
.	O
Significantly	O
increased	O
oestrogen	protein
receptor	protein
expression	O
,	O
bcl-2	protein
expression	O
and	O
numbers	O
of	O
CD8+	O
leukocytes	cell_type
were	O
found	O
in	O
ectopic	O
compared	O
with	O
eutopic	O
endometrium	O
in	O
endometriosis	O
,	O
and	O
CD56+	O
endometrial	O
granulated	O
lymphocytes	O
(eGLs)	O
were	O
significantly	O
reduced	O
in	O
ectopic	O
endometrium	O
.	O
Apoptotic	cell_type
cells	cell_type
were	O
rarely	O
found	O
in	O
control	O
and	O
subject	O
endometria	O
.	O
In	O
contrast	O
with	O
endometriosis	O
,	O
adenomyotic	O
lesions	O
showed	O
identical	O
steroid	protein
hormone	protein
receptor	protein
expression	O
,	O
proliferative	O
activity	O
,	O
bcl-2	protein
expression	O
and	O
leukocyte	O
subpopulations	O
to	O
eutopic	O
endometrium	O
,	O
indicating	O
different	O
aetiologies	O
for	O
these	O
disorders.	O
The	O
unusual	O
CD56+	cell_type
CD16-	cell_type
eGLs	cell_type
present	O
in	O
large	O
numbers	O
in	O
late	O
secretory	O
phase	O
eutopic	O
endometrium	O
were	O
highly	O
purified	O
(&gt;98%)	O
by	O
immunomagnetic	O
separation	O
.	O
Except	O
for	O
a	O
negligible	O
cytotoxic	O
activity	O
of	O
eGLs	cell_type
from	O
early	O
proliferative	O
samples,	O
cytotoxic	O
activity	O
of	O
eGLs	cell_type
from	O
non-pregnant	O
endometrium	O
during	O
the	O
menstrual	O
cycle	O
was	O
comparable	O
with	O
those	O
in	O
peripheral	O
blood,	O
predominantly	O
CD56+	cell_type
CD16+	cell_type
natural	cell_type
killer	cell_type
cells	cell_type
.	O
eGLs	cell_type
from	O
non-pregnant	O
endometrium	O
and	O
early	O
pregnancy	O
showed	O
a	O
variable	O
proliferative	O
response	O
to	O
5	O
and	O
100	O
U/ml	O
interleukin-2	protein
over	O
48-h	O
and	O
120-h	O
time	O
courses.	O
eGLs	cell_type
are	O
evidently	O
functionally	O
important	O
in	O
the	O
eutopic	O
endometrium	O
.	O
Their	O
absence	O
in	O
endometriotic	O
lesions	O
together	O
with	O
increased	O
CD+8	cell_type
T-cell	cell_type
numbers	O
and	O
increased	O
oestrogen	protein
receptor	protein
and	O
bcl-2	protein
expression	O
may	O
have	O
significant	O
effects	O
on	O
the	O
development	O
and	O
progression	O
of	O
endometriosis	O
.	O

Regulation	O
of	O
interleukin-1beta	protein
transcription	O
by	O
Epstein-Barr	O
virus	O
involves	O
a	O
number	O
of	O
latent	protein
proteins	protein
via	O
their	O
interaction	O
with	O
RBP	protein
.	O
Epstein-Barr	O
virus	O
(EBV)	O
infects	O
B	cell_type
cells	cell_type
,	O
resulting	O
in	O
the	O
outgrowth	O
of	O
immortalised	cell_line
lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
(	O
LCLs	cell_line
).	O
Here,	O
we	O
demonstrate	O
through	O
the	O
use	O
of	O
intracellular	O
staining	O
that	O
interleukin-1beta	protein
(	O
IL-1beta	protein
)	O
is	O
expressed	O
in	O
LCLs	cell_line
and	O
investigate	O
the	O
influence	O
of	O
the	O
individual	O
latent	protein
proteins	protein
on	O
the	O
expression	O
of	O
IL-1beta	protein
.	O
Using	O
RT-PCR	O
,	O
IL-1beta	protein
was	O
shown	O
to	O
be	O
up-regulated	O
in	O
EBV-transformed	cell_line
LCLs	cell_line
as	O
well	O
as	O
in	O
group	cell_line
III	cell_line
Burkitt's	cell_line
lymphoma	cell_line
(BL)	cell_line
cell	cell_line
lines	cell_line
,	O
compared	O
with	O
group	cell_line
I	cell_line
BL	cell_line
cell	cell_line
lines	cell_line
.	O
The	O
up-regulation	O
of	O
IL-1beta	protein
message	O
could	O
be	O
mediated	O
by	O
the	O
latent	protein
membrane	protein
protein-1	protein
,	O
EBV	O
nuclear	O
proteins	O
2	O
,	O
3	O
,	O
4	O
,	O
and	O
6	O
genes	O
.	O
Electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSAs	O
)	O
demonstrated	O
that	O
the	O
-300	O
region	O
of	O
the	O
IL-1beta	protein
promoter,	O
which	O
contains	O
a	O
nuclear	DNA
factor-kappaB	DNA
(	DNA
NF-kappaB	DNA
)	DNA
binding	DNA
site	DNA
,	O
contained	O
a	O
functional	DNA
RBP	DNA
binding	DNA
site	DNA
.	O
Binding	O
of	O
RBP	O
to	O
this	O
site	O
could	O
be	O
inhibited	O
by	O
addition	O
of	O
EBV	O
nuclear	O
proteins	O
3	O
and	O
6	O
,	O
suggesting	O
that	O
these	O
proteins	O
displace	O
RBP	protein
from	O
its	O
recognition	DNA
sequence	DNA
,	O
removing	O
transcriptional	O
repression	O
and	O
allowing	O
gene	O
transcription	O
to	O
occur.	O
In	O
group	cell_line
I	cell_line
BL	cell_line
cells	cell_line
,	O
containing	O
low	O
levels	O
of	O
NF-kappaB	protein
,	O
only	O
RBP	protein
binding	O
was	O
observed	O
in	O
EMSAs	O
,	O
whereas	O
NF-kappaB	protein
binding	O
could	O
be	O
demonstrated	O
in	O
EBV-transformed	cell_line
B	cell_line
cell	cell_line
lines	cell_line
containing	O
high	O
levels	O
of	O
activated	O
NF-kappaB	protein
.	O
In	O
addition,	O
the	O
expression	O
of	O
latent	protein
membrane	protein
protein-1	protein
led	O
to	O
activation	O
of	O
NF-kappaB	protein
that	O
was	O
capable	O
of	O
binding	O
the	O
IL-1beta	DNA
promoter	DNA
.	O
The	O
study	O
demonstrates	O
that	O
EBV	O
can	O
up-regulate	O
IL-1beta	protein
expression	O
,	O
possibly	O
by	O
using	O
RBP	protein
,	O
NF-kappaB	protein
,	O
or	O
both.	O
Copyright	O
1998	O
Academic	O
Press.	O

CD27	protein
/CD70	O
interaction	O
augments	O
IgE	protein
secretion	O
by	O
promoting	O
the	O
differentiation	O
of	O
memory	cell_type
B	cell_type
cells	cell_type
into	O
plasma	cell_type
cells	cell_type
.	O
The	O
induction	O
of	O
IgE	protein
switching	O
in	O
B	cell_type
cells	cell_type
requires	O
several	O
signals	O
given	O
by	O
cytokines	protein
and	O
cell	O
contact-delivered	O
signals.	O
Here,	O
we	O
investigated	O
the	O
role	O
of	O
CD27	protein
/CD70	O
interaction	O
in	O
B	O
cell	O
IgE	protein
synthesis	O
.	O
The	O
addition	O
of	O
CD27	O
ligand	O
(CD70)	O
transfectants	O
to	O
B	cell_line
cell	cell_line
cultures	cell_line
increased	O
the	O
IgE	protein
synthesis	O
synergistically	O
in	O
the	O
presence	O
of	O
IL-4	protein
plus	O
anti-CD40	protein
mAb	protein
(	O
anti-CD40	protein
).	O
The	O
effect	O
of	O
CD70	cell_line
transfectants	cell_line
was	O
dose	O
dependent	O
and	O
was	O
completely	O
blocked	O
by	O
anti-CD70	protein
mAb.	protein
CD27+	cell_type
B	cell_type
cells	cell_type
had	O
the	O
ability	O
to	O
produce	O
IgE	protein
,	O
which	O
was	O
increased	O
by	O
contact	O
with	O
CD70	O
transfectants	O
,	O
whereas	O
CD27-	O
B	O
cells	O
did	O
not	O
produce	O
IgE	protein
.	O
CD27	protein
/CD70	O
interaction	O
enhanced	O
B	cell_type
cell	cell_type
proliferation	O
in	O
the	O
presence	O
of	O
IL-4	protein
or	O
IL-4	protein
plus	O
anti-CD40	protein
.	O
The	O
augmentation	O
of	O
B	O
cell	O
proliferation	O
by	O
CD70	O
transfectants	O
was	O
apparent	O
in	O
CD27+	cell_type
B	cell_type
cells	cell_type
,	O
but	O
was	O
mild	O
in	O
CD27-	cell_type
B	cell_type
cells	cell_type
.	O
The	O
helper	O
activity	O
for	O
IgE	protein
synthesis	O
by	O
the	O
CD27	protein
/CD70	O
interaction	O
did	O
not	O
contribute	O
to	O
the	O
enhancement	O
of	O
germline	RNA
epsilon	RNA
transcripts	RNA
.	O
Flow	O
cytometric	O
and	O
morphological	O
analyses	O
demonstrated	O
that	O
the	O
addition	O
of	O
CD70	O
transfectants	O
to	O
B	cell_line
cell	cell_line
cultures	cell_line
remarkably	O
promoted	O
differentiation	O
into	O
plasma	cell_type
cells	cell_type
in	O
the	O
presence	O
of	O
IL-4	protein
and	O
CD40	protein
signaling	O
.	O
Finally,	O
CD27	protein
cross-linking	O
resulted	O
in	O
the	O
up-regulation	O
of	O
positive	protein
regulatory	protein
domain	protein
I-binding	protein
factor-1	protein
.	O
Taken	O
together,	O
our	O
findings	O
indicate	O
that	O
signaling	O
via	O
CD27	protein
on	O
B	cell_type
cells	cell_type
induces	O
IgE	protein
synthesis	O
,	O
in	O
cooperation	O
with	O
IL-4	protein
and	O
CD40	protein
signaling,	O
by	O
promoting	O
the	O
generation	O
of	O
plasma	cell_type
cells	cell_type
through	O
up-regulation	O
of	O
positive	protein
regulatory	protein
domain	protein
I-binding	protein
factor-1	protein
.	O

Human	O
immunodeficiency	O
virus	O
type-1	O
transcription	O
:	O
role	O
of	O
the	O
5'-untranslated	O
leader	O
region	O
(review).	O
Human	O
immunodeficiency	O
virus	O
type-1	O
(	O
HIV-1	O
)	O
transcription	O
is	O
dependent	O
on	O
the	O
interaction	O
of	O
host-cell	protein
transcription	protein
factors	protein
with	O
cis-regulatory	DNA
DNA	DNA
elements	DNA
within	O
the	O
viral	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
).	O
Much	O
attention	O
has	O
focused	O
on	O
the	O
series	O
of	O
sequence	O
elements	O
upstream	O
of	O
the	O
transcriptional	DNA
initiation	DNA
site	DNA
in	O
the	O
U3	DNA
region	DNA
of	O
the	O
LTR	DNA
including	O
the	O
Sp1	protein
and	O
NF-kappaB	protein
binding	DNA
sites	DNA
.	O
Recent	O
studies,	O
however,	O
demonstrate	O
that	O
the	O
transcribed	O
5'-untranslated	DNA
leader	DNA
region	DNA
(	O
5'-UTR	DNA
)	O
also	O
contains	O
important	O
transcriptional	DNA
elements	DNA
.	O
These	O
regulatory	DNA
elements	DNA
situated	O
downstream	O
of	O
transcription	O
interact	O
with	O
constitutive	O
and	O
inducible	O
transcription	protein
factors	protein
,	O
mediate	O
transmission	O
of	O
cellular	O
activation	O
signals	O
,	O
and	O
are	O
important	O
for	O
efficient	O
HIV-1	O
transcription	O
and	O
replication	O
.	O
The	O
5'-UTR	DNA
contains	O
binding	DNA
sites	DNA
for	O
the	O
transcription	protein
factors	protein
AP-1,	O
NF-kappaB	protein
,	O
NF-AT	protein
,	O
IRF	protein
,	O
and	O
Sp1	protein
.	O
Mutations	O
in	O
these	O
binding	DNA
sites	DNA
can	O
interfere	O
with	O
the	O
viral	O
response	O
to	O
cell	O
activation	O
signals	O
,	O
decrease	O
LTR	DNA
transcription	O
,	O
and	O
inhibit	O
viral	O
replication	O
.	O
The	O
5'-UTR	DNA
also	O
interacts	O
with	O
a	O
specific	O
nucleosome	protein
that	O
is	O
rapidly	O
displaced	O
during	O
transcriptional	O
activation	O
of	O
the	O
latent	O
provirus	O
.	O
We	O
propose	O
that	O
the	O
inducible	DNA
transcription	DNA
factor	DNA
binding	DNA
sites	DNA
in	O
the	O
5'-UTR	DNA
comprise	O
a	O
downstream	DNA
enhancer	DNA
domain	DNA
that	O
can	O
function	O
independent	O
of,	O
or	O
in	O
concert	O
with,	O
the	O
LTR	DNA
promoter	DNA
to	O
rapidly	O
increase	O
latent	O
proviral	O
transcription	O
in	O
response	O
to	O
cell	O
activation	O
signals	O
.	O
In	O
this	O
review,	O
we	O
describe	O
the	O
host-cell	protein
transcription	protein
factors	protein
that	O
interact	O
with	O
the	O
5'-UTR	DNA
and	O
discuss	O
their	O
role	O
in	O
the	O
transcriptional	O
regulation	O
of	O
HIV-1	O
gene	O
expression	O
.	O

Regulation	O
of	O
PAK	O
activation	O
and	O
the	O
T	O
cell	O
cytoskeleton	O
by	O
the	O
linker	protein
protein	protein
SLP-76	protein
.	O
Tyrosine	O
phosphorylation	O
of	O
linker	protein
proteins	protein
enables	O
the	O
T	protein
cell	protein
antigen	protein
receptor	protein
(TCR)-associated	protein
protein	protein
tyrosine	protein
kinases	protein
to	O
phosphorylate	O
and	O
regulate	O
effector	protein
molecules	protein
that	O
generate	O
second	protein
messengers	protein
.	O
We	O
demonstrate	O
here	O
that	O
the	O
SLP-76	protein
linker	O
protein	O
interacts	O
with	O
both	O
nck	protein
,	O
an	O
adaptor	protein
protein	protein
,	O
and	O
Vav	protein
,	O
a	O
guanine	protein
nucleotide	protein
exchange	protein
factor	protein
for	O
Rho-family	protein
GTPases	protein
.	O
The	O
assembly	O
of	O
this	O
tri-molecular	protein
complex	protein
permits	O
the	O
activated	O
Rho-family	protein
GTPases	protein
to	O
regulate	O
target	O
effectors	O
that	O
interact	O
through	O
nck	protein
.	O
In	O
turn,	O
assembly	O
of	O
this	O
complex	O
mediates	O
the	O
enzymatic	O
activation	O
of	O
the	O
p21-activated	protein
protein	protein
kinase	protein
1	protein
and	O
facilitates	O
actin	protein
polymerization	O
.	O
Hence,	O
phosphorylation	O
of	O
linker	protein
proteins	protein
not	O
only	O
bridges	O
the	O
TCR-associated	protein
PTK	protein
,	O
ZAP-70	protein
,	O
with	O
downstream	O
effector	O
proteins,	O
but	O
also	O
provides	O
a	O
scaffold	O
to	O
integrate	O
distinct	O
signaling	protein
complexes	protein
to	O
regulate	O
T	cell_type
cell	cell_type
function	O
.	O

Interleukin-12	protein
expression	O
in	O
B	cell_type
cells	cell_type
by	O
transformation	O
with	O
Epstein-Barr	O
virus	O
.	O
Although	O
interleukin	protein
(IL)-12	protein
was	O
originally	O
purified	O
from	O
an	O
Epstein-Barr	cell_line
(	cell_line
EBV	cell_line
)-transformed	cell_line
B	cell_line
cell	cell_line
line	cell_line
and	O
the	O
high	O
correlation	O
of	O
EBV	O
infection	O
and	O
IL-12	protein
expression	O
has	O
been	O
suggested,	O
no	O
study	O
has	O
reported	O
whether	O
EBV	O
infection	O
is	O
directly	O
linked	O
to	O
IL-12	protein
expression	O
.	O
To	O
address	O
this	O
issue,	O
we	O
have	O
investigated	O
IL-12	protein
expression	O
in	O
B	cell_type
cells	cell_type
during	O
in	O
vitro	O
transformation	O
with	O
EBV	O
.	O
Human	cell_type
peripheral	cell_type
B	cell_type
cells	cell_type
became	O
capable	O
of	O
constitutively	O
producing	O
p40	O
by	O
in	O
vitro	O
transformation	O
with	O
EBV	O
,	O
coincident	O
with	O
the	O
expression	O
of	O
latent	protein
membrane	protein
protein	protein
1	protein
(	O
LMP1	protein
)	O
of	O
EBV	O
.	O
These	O
B	cell_type
cells	cell_type
expressed	O
p40	O
and	O
p35	O
mRNA	O
,	O
and	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
stimulation	O
strongly	O
enhanced	O
p40	O
and	O
p70	O
production	O
.	O
Furthermore,	O
transfection	O
with	O
LMP1	DNA
expression	DNA
vector	DNA
into	O
a	O
human	cell_line
B	cell_line
lymphoma	cell_line
cell	cell_line
line	cell_line
,	O
Daudi	cell_line
,	O
led	O
to	O
p40	protein
production	O
with	O
nuclear	protein
factor	protein
(NF)-kappaB	protein
activation	O
.	O
These	O
results	O
suggest	O
that	O
transformation	O
of	O
primary	cell_type
B	cell_type
cells	cell_type
with	O
EBV	O
induces	O
IL-12	protein
expression	O
potentially	O
through	O
LMP1	protein
expression	O
.	O
Copyright	O
1998	O
Academic	O
Press.	O

The	O
human	DNA
gene	DNA
encoding	O
the	O
lectin-type	protein
oxidized	protein
LDL	protein
receptor	protein
(	O
OLR1	protein
)	O
is	O
a	O
novel	O
member	O
of	O
the	O
natural	protein
killer	protein
gene	protein
complex	protein
with	O
a	O
unique	O
expression	O
profile.	O
LOX-1	protein
is	O
an	O
endothelial	protein
receptor	protein
for	O
oxidized	protein
low-density	protein
lipoprotein	protein
that	O
plays	O
essential	O
roles	O
in	O
atherogenesis	O
.	O
LOX-1	protein
has	O
the	O
highest	O
homology	O
with	O
C-type	protein
lectin	protein
receptors	protein
expressed	O
on	O
natural	cell_type
killer	cell_type
cells	cell_type
.	O
In	O
the	O
present	O
study,	O
we	O
cloned	O
and	O
characterized	O
the	O
human	DNA
LOX-1	DNA
gene	DNA
(	O
HGMW-approved	protein
symbol	protein
OLR1	protein
).	O
The	O
gene	O
structure	O
of	O
LOX-1	protein
resembles	O
that	O
of	O
the	O
natural	protein
killer	protein
cell	protein
receptors	protein
.	O
Fluorescence	O
in	O
situ	O
hybridization	O
and	O
analyses	O
of	O
a	O
yeast	O
artificial	O
chromosome	O
contig	O
revealed	O
that	O
the	O
human	DNA
LOX-1	DNA
gene	DNA
is	O
located	O
in	O
the	O
natural	protein
killer	protein
gene	protein
complex	protein
on	O
chromosome	DNA
12p12-p13	DNA
,	O
where	O
the	O
genes	O
of	O
the	O
natural	protein
killer	protein
cell	protein
receptors	protein
cluster.	O
In	O
contrast,	O
the	O
expression	O
pattern	O
of	O
LOX-1	protein
is	O
different	O
from	O
that	O
of	O
the	O
natural	protein
killer	protein
cell	protein
receptors	protein
;	O
LOX-1	protein
is	O
expressed	O
in	O
vascular-rich	O
organs	O
,	O
but	O
not	O
in	O
lymphocytes	cell_type
.	O
A	O
1753-bp	DNA
fragment	DNA
of	O
the	O
5'	DNA
flanking	DNA
region	DNA
of	O
the	O
LOX-1	DNA
gene	DNA
had	O
a	O
functional	O
promoter	O
activity	O
.	O
This	O
region	O
contains	O
binding	DNA
sites	DNA
for	O
several	O
transcription	protein
factors	protein
,	O
including	O
the	O
STAT	protein
family	protein
and	O
NF-IL6	protein
,	O
and	O
the	O
expression	O
of	O
LOX-1	protein
was	O
upregulated	O
by	O
several	O
cytokines	protein
.	O
These	O
results	O
demonstrate	O
that	O
the	O
human	DNA
LOX-1	DNA
gene	DNA
is	O
a	O
new	O
member	O
of	O
the	O
natural	protein
killer	protein
gene	protein
complex	protein
with	O
a	O
unique	O
expression	O
profile.	O
Copyright	O
1998	O
Academic	O
Press.	O

Transcriptional	O
regulation	O
of	O
the	O
beta-casein	DNA
gene	DNA
by	O
cytokines	protein
:	O
cross-talk	O
between	O
STAT5	protein
and	O
other	O
signaling	protein
molecules	protein
.	O
The	O
beta-casein	DNA
promoter	DNA
has	O
been	O
widely	O
used	O
to	O
monitor	O
the	O
activation	O
of	O
STAT	protein
(signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription)5	protein
since	O
STAT5	protein
was	O
originally	O
found	O
as	O
a	O
mediator	O
of	O
PRL-inducible	O
beta-casein	protein
expression	O
.	O
However,	O
not	O
only	O
is	O
expression	O
of	O
the	O
beta-casein	DNA
gene	DNA
regulated	O
by	O
STAT5	protein
but	O
it	O
is	O
also	O
affected	O
by	O
other	O
molecules	O
such	O
as	O
glucocorticoid	O
and	O
Ras	protein
.	O
In	O
this	O
report,	O
we	O
describe	O
the	O
transcriptional	O
regulation	O
of	O
the	O
beta-casein	DNA
gene	DNA
by	O
cytokines	protein
in	O
T	cell_type
cells	cell_type
.	O
We	O
have	O
found	O
that	O
the	O
beta-casein	DNA
gene	DNA
is	O
expressed	O
in	O
a	O
cytotoxic	cell_line
T	cell_line
cell	cell_line
line	cell_line
,	O
CTLL-2	cell_line
,	O
in	O
response	O
to	O
interleukin-2	protein
(	O
IL-2	protein
),	O
which	O
activates	O
STAT5	protein
.	O
While	O
IL-4	protein
does	O
not	O
activate	O
STAT5	protein
,	O
it	O
induces	O
expression	O
of	O
STAT5	DNA
-regulated	DNA
genes	DNA
in	O
CTLL-2	cell_line
,	O
i.e.	O
beta-casein	protein
,	O
a	O
cytokine-inducible	protein
SH2-containing	protein
protein	protein
(	O
CIS	protein
),	O
and	O
oncostatin	protein
M	protein
(	O
OSM	protein
),	O
suggesting	O
that	O
STAT6	O
activated	O
by	O
IL-4	protein
substitutes	O
for	O
the	O
function	O
of	O
STAT5	protein
in	O
T	cell_type
cells	cell_type
.	O
IL-2	protein
-induced	O
beta-casein	protein
expression	O
was	O
enhanced	O
by	O
dexamethasone,	O
and	O
this	O
synergistic	O
effect	O
of	O
Dexamethasone	O
requires	O
the	O
sequence	O
between	O
-155	DNA
and	DNA
-193	DNA
in	O
the	O
beta-casein	DNA
promoter	DNA
.	O
Coincidentally,	O
a	O
deletion	O
of	O
this	O
region	O
enhanced	O
the	O
IL-2	protein
-induced	O
expression	O
of	O
beta-casein	protein
.	O
Expression	O
of	O
an	O
active	O
form	O
of	O
Ras	protein
,	O
Ras(G12V)	protein
,	O
suppressed	O
the	O
IL-2	protein
-induced	O
beta-casein	protein
and	O
OSM	protein
gene	O
expression	O
,	O
and	O
the	O
negative	O
effect	O
of	O
Ras	protein
is	O
mediated	O
by	O
the	O
region	O
between	O
-105	DNA
and	DNA
-193	DNA
in	O
the	O
beta-casein	DNA
promoter	DNA
.	O
In	O
apparent	O
contradiction,	O
expression	O
of	O
a	O
dominant	O
negative	O
form	O
of	O
Ras	protein
,	O
RasN17	protein
,	O
also	O
inhibited	O
IL-2	protein
-induced	O
activation	O
of	O
the	O
promoter	O
containing	O
the	O
minimal	O
beta-casein	DNA
STAT5	DNA
element	DNA
as	O
well	O
as	O
the	O
promoters	O
of	O
CIS	protein
and	O
OSM	protein
.	O
In	O
addition,	O
Ras(G12V)	protein
complemented	O
signaling	O
by	O
an	O
erythropoietin	protein
receptor	protein
mutant	protein
defective	O
in	O
Ras	protein
activation	O
and	O
augmented	O
the	O
activation	O
of	O
the	O
beta-casein	DNA
promoter	DNA
by	O
the	O
mutant	protein
erythropoietin	protein
receptor	protein
signaling	O
,	O
suggesting	O
a	O
possible	O
role	O
of	O
Ras	protein
in	O
Stat5	protein
-mediated	O
gene	O
expression	O
.	O
These	O
results	O
collectively	O
reveal	O
a	O
complex	O
interaction	O
of	O
STAT5	protein
with	O
other	O
signaling	O
pathways	O
and	O
illustrate	O
that	O
regulation	O
of	O
gene	O
expression	O
requires	O
integration	O
of	O
opposing	O
signals	O

GATA-3	protein
represses	O
gp91phox	DNA
gene	DNA
expression	O
in	O
eosinophil-committed	cell_line
HL-60-C15	cell_line
cells	cell_line
.	O
To	O
study	O
the	O
regulatory	O
mechanism	O
of	O
gp91phox	DNA
gene	DNA
expression	O
in	O
eosinophils,	O
we	O
transiently	O
transfected	O
eosinophil-committed	cell_line
HL-60-C15	cell_line
cells	cell_line
with	O
gp91phox	DNA
promoter	DNA
constructs	DNA
,	O
and	O
identified	O
a	O
negative	DNA
element	DNA
from	O
bp	O
-267	DNA
to	DNA
-246	DNA
of	O
the	O
gp91phox	DNA
gene	DNA
,	O
the	O
deletion	O
of	O
which	O
caused	O
an	O
83%	O
increase	O
in	O
promoter	O
activity	O
.	O
Electrophoresis	O
mobility	O
shift	O
assays	O
demonstrated	O
GATA-3	protein
binds	O
to	O
the	O
GATA	DNA
consensus	DNA
site	DNA
from	O
bp	O
-256	DNA
to	DNA
-250.	DNA
An	O
81%	O
increment	O
in	O
promoter	O
activity	O
was	O
obtained	O
when	O
a	O
mutation	O
was	O
introduced	O
in	O
the	O
GATA-3	DNA
binding	DNA
site	DNA
of	O
the	O
bp	DNA
-267	DNA
to	DNA
+12	DNA
construct	DNA
,	O
which	O
is	O
comparable	O
to	O
that	O
of	O
the	O
bp	DNA
-245	DNA
to	DNA
+12	DNA
construct	DNA
.	O
We	O
therefore	O
conclude	O
that	O
GATA-3	protein
specifically	O
binding	O
to	O
the	O
GATA	DNA
site	DNA
negatively	O
regulates	O
the	O
expression	O
of	O
the	O
gene	O
in	O
HL-60-C15	cell_line
cells	cell_line
.	O

Uncoupling	O
activation-dependent	O
HS1	protein
phosphorylation	O
from	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
transcriptional	O
activation	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
:	O
differential	O
signaling	O
through	O
CD3	protein
and	O
the	O
costimulatory	O
receptors	O
CD2	protein
and	O
CD28	protein
.	O
CD3	protein
,	O
CD2	protein
,	O
and	O
CD28	protein
are	O
functionally	O
distinct	O
receptors	O
on	O
T	cell_type
lymphocytes	cell_type
.	O
Engagement	O
of	O
any	O
of	O
these	O
receptors	O
induces	O
the	O
rapid	O
tyrosine	O
phosphorylation	O
of	O
a	O
shared	O
group	O
of	O
intracellular	protein
signaling	protein
proteins	protein
,	O
including	O
Vav	protein
,	O
Cbl	protein
,	O
p85	protein
phosphoinositide	protein
3-kinase	protein
,	O
and	O
the	O
Src	protein
family	protein
kinases	protein
Lck	protein
and	O
Fyn	protein
.	O
Ligation	O
of	O
CD3	protein
also	O
induces	O
the	O
tyrosine	O
phosphorylation	O
of	O
HS1	protein
,	O
a	O
75-kDa	protein
hematopoietic	protein
cell-specific	protein
intracellular	protein
signaling	protein
protein	protein
of	O
unknown	O
function.	O
We	O
have	O
examined	O
changes	O
in	O
HS1	protein
phosphorylation	O
after	O
differential	O
stimulation	O
of	O
CD3	protein
,	O
CD2	protein
,	O
and	O
CD28	protein
to	O
elucidate	O
its	O
role	O
in	O
T	cell_type
cells	cell_type
and	O
to	O
further	O
delineate	O
the	O
signaling	O
pathways	O
recruited	O
by	O
these	O
receptors.	O
Unlike	O
ligation	O
of	O
CD3	protein
,	O
stimulation	O
with	O
anti-	protein
CD28	protein
mAb	protein
or	O
CHO	cell_line
cells	cell_line
expressing	O
the	O
CD28	protein
ligands	protein
CD80	protein
or	O
CD86	protein
did	O
not	O
lead	O
to	O
tyrosine	O
phosphorylation	O
of	O
HS1	protein
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
Additionally,	O
no	O
tyrosine	O
phosphorylation	O
of	O
HS1	protein
was	O
induced	O
by	O
mitogenic	cell_type
pairs	cell_type
of	O
anti-	protein
CD2	protein
mAbs	protein
capable	O
of	O
activating	O
the	O
transcription	protein
factor	protein
NFAT	protein
(	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
).	O
Costimulation	O
through	O
CD28	protein
and/or	O
CD2	protein
did	O
not	O
modulate	O
the	O
CD3	protein
-dependent	O
phosphorylation	O
of	O
HS1	protein
.	O
In	O
vivo	O
studies	O
indicated	O
that	O
CD3	protein
-induced	O
HSI	protein
phosphorylation	O
was	O
dependent	O
upon	O
both	O
the	O
Src	protein
family	protein
tyrosine	protein
kinase	protein
Lck	protein
and	O
the	O
tyrosine	protein
phosphatase	protein
CD45	protein
,	O
did	O
not	O
require	O
MEK1	protein
kinase	O
activity	O
,	O
and	O
was	O
regulated	O
by	O
protein	protein
kinase	protein
C	protein
activation	O
.	O
Thus,	O
although	O
CD3	protein
,	O
CD28	protein
,	O
and	O
CD2	O
activate	O
many	O
of	O
the	O
same	O
signaling	protein
molecules	protein
,	O
they	O
differed	O
in	O
their	O
capacity	O
to	O
induce	O
the	O
tyrosine	O
phosphorylation	O
of	O
HSI	protein
.	O
Furthermore,	O
activation-dependent	O
tyrosine	O
phosphorylation	O
of	O
HS1	protein
was	O
not	O
required	O
for	O
NFAT	protein
transcriptional	O
activation	O
.	O

c-fos	O
and	O
c-jun	O
mRNA	O
expression	O
in	O
activated	O
cord	O
and	O
adult	O
lymphocytes	O
:	O
an	O
analysis	O
by	O
Northern	O
hybridization	O
.	O
BACKGROUND	O
AND	O
OBJECTIVES:	O
To	O
further	O
analyze	O
the	O
neonatal	O
immune	O
response	O
to	O
an	O
antigenic	O
challenge	O
such	O
as	O
blood	O
transfusion	O
,	O
c-fos	O
and	O
c-jun	O
mRNA	O
expression	O
were	O
analyzed	O
in	O
twelve	O
in-vitro-stimulated	O
normal	O
cord	O
blood	O
and	O
ten	O
in-vitro-stimulated	cell_type
normal	cell_type
adult	cell_type
peripheral	cell_type
blood	cell_type
lymphocyte	cell_type
samples	cell_type
.	O
MATERIALS	O
AND	O
METHODS:	O
Lymphocyte	cell_type
samples	cell_type
were	O
stimulated	O
by	O
either	O
the	O
mitogen	protein
phytohemagglutinin	protein
(	O
PHA	protein
)	O
or	O
the	O
monoclonal	O
antibody	O
alphaCD3	protein
.	O
Proliferation	O
rate	O
and	O
Northern	O
blot	O
hybridization	O
were	O
employed.	O
RESULTS:	O
Cord	O
lymphocytes	O
revealed	O
a	O
greater	O
proliferation	O
rate	O
with	O
PHA	protein
and	O
alphaCD3	protein
than	O
adult	O
lymphocytes	O
(p	O
=	O
0.0081	O
and	O
0.0023,	O
respectively).	O
In	O
addition,	O
Northern	O
blot	O
analysis	O
of	O
cord	O
and	O
adult	O
samples	O
revealed	O
similar	O
maximal	O
increases	O
in	O
c-fos	RNA
(99+/-15	O
and	O
126+/-11%,	O
p	O
=	O
0.0126)	O
and	O
c-jun	RNA
(123+/-9	RNA
and	RNA
185+/-38%,	RNA
p	RNA
=	RNA
0.0291)	RNA
mRNA	RNA
expression,	O
respectively,	O
as	O
early	O
as	O
15	O
min	O
post-	O
alphaCD3	protein
stimulation	O
.	O
Adult	O
lymphocytes	O
showed	O
an	O
equivalent	O
increase	O
in	O
mRNA	O
expression	O
of	O
c-fos	DNA
and	O
c-jun	DNA
(140+/-25	O
and	O
155+/-31%)	O
at	O
30	O
min	O
post-	O
PHA	protein
stimulation,	O
while	O
cord	cell_type
lymphocyte	cell_type
maximum	O
c-fos	O
and	O
c-jun	O
expression	O
(82+/-6	O
and	O
142+/-12%)	O
occurred	O
at	O
15	O
min	O
post-	O
PHA	protein
stimulation	O
(	O
c-fos	DNA
,	O
p	O
=	O
0.0354;	O
c-jun	DNA
,	O
p	O
=	O
0.0112).	O
CONCLUSION:	O
Although	O
cord	cell_type
lymphocyte	cell_type
proliferation	O
rates	O
were	O
significantly	O
greater	O
than	O
those	O
of	O
adult	O
lymphocytes	O
following	O
stimulation,	O
lymphocyte	O
activation	O
,	O
as	O
analyzed	O
by	O
c-fos	O
and	O
c-jun	O
mRNA	O
expression	O
,	O
appears	O
similar	O
in	O
both	O
cord	O
and	O
adult	O
samples.	O
We	O
conclude	O
that	O
cord	O
lymphocyte	O
activation	O
exhibits	O
an	O
adult-type	O
profile	O
.	O

Fcgamma	protein
receptor	protein
-mediated	O
mitogen-activated	protein
protein	protein
kinase	protein
activation	O
in	O
monocytes	cell_type
is	O
independent	O
of	O
Ras	protein
.	O
Receptors	O
for	O
the	O
Fc	protein
portion	protein
of	O
immunoglobulin	protein
molecules	protein
(	O
FcR	protein
)	O
present	O
on	O
leukocyte	O
cell	O
membranes	O
mediate	O
a	O
large	O
number	O
of	O
cellular	O
responses	O
that	O
are	O
very	O
important	O
in	O
host	O
defense,	O
including	O
phagocytosis	O
,	O
cell	O
cytotoxicity	O
,	O
production	O
and	O
secretion	O
of	O
inflammatory	protein
mediators	protein
,	O
and	O
modulation	O
of	O
the	O
immune	O
response	O
.	O
Cross-linking	O
of	O
FcR	protein
with	O
immune	protein
complexes	protein
leads,	O
first	O
to	O
activation	O
of	O
protein-	protein
tyrosine	protein
kinases	protein
.	O
The	O
molecular	O
events	O
that	O
follow	O
and	O
that	O
transduce	O
signals	O
from	O
these	O
receptors	O
to	O
the	O
nucleus	O
are	O
still	O
poorly	O
defined.	O
We	O
have	O
investigated	O
the	O
signal	O
transduction	O
pathway	O
from	O
Fc	protein
receptors	protein
that	O
leads	O
to	O
gene	O
activation	O
and	O
production	O
of	O
cytokines	protein
in	O
monocytes	cell_type
.	O
Cross-linking	O
of	O
FcR	protein
,	O
on	O
the	O
THP-1	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
,	O
by	O
immune	protein
complexes	protein
resulted	O
in	O
both	O
activation	O
of	O
the	O
transcription	protein
factor	protein
NF-kappaB	protein
and	O
interleukin	protein
1	protein
production	O
.	O
These	O
responses	O
were	O
completely	O
blocked	O
by	O
tyrosine	protein
kinase	protein
inhibitors	O
.	O
In	O
contrast,	O
expression	O
of	O
dominant	protein
negative	protein
mutants	protein
of	O
Ras	protein
and	O
Raf-1	protein
,	O
in	O
these	O
cells,	O
did	O
not	O
have	O
any	O
effect	O
on	O
FcR	protein
-mediated	O
nuclear	protein
factor	protein
activation	O
,	O
suggesting	O
that	O
the	O
mitogen-activated	protein
protein	protein
kinase	protein
(	O
MAPK	protein
)	O
signaling	O
pathway	O
was	O
not	O
used	O
by	O
these	O
receptors.	O
However,	O
MAPK	protein
activation	O
was	O
easily	O
detected	O
by	O
in	O
vitro	O
kinase	O
assays	O
,	O
after	O
FcR	protein
cross-linking	O
with	O
immune	protein
complexes	protein
.	O
Using	O
the	O
specific	O
MAPK	protein
/extracellular	O
signal-regulated	O
kinase	O
kinase	O
(MAPK	O
kinase)	O
inhibitor	O
PD98059	O
,	O
we	O
found	O
that	O
MAPK	protein
activation	O
is	O
necessary	O
for	O
FcR	protein
-dependent	O
activation	O
of	O
the	O
nuclear	protein
factor	protein
NF-kappaB	protein
.	O
These	O
results	O
strongly	O
suggest	O
that	O
the	O
signaling	O
pathway	O
from	O
Fc	protein
receptors	protein
leading	O
to	O
expression	O
of	O
different	O
genes	O
important	O
to	O
leukocyte	O
biology,	O
initiates	O
with	O
tyrosine	protein
kinases	protein
and	O
requires	O
MAPK	protein
activation	O
;	O
but	O
in	O
contrast	O
to	O
other	O
tyrosine	protein
kinase	protein
receptors	protein
,	O
FcR	protein
-mediated	O
MAPK	protein
activation	O
does	O
not	O
involve	O
Ras	protein
and	O
Raf	protein
.	O

BCL-6	protein
mutations	O
in	O
normal	cell_type
germinal	cell_type
center	cell_type
B	cell_type
cells	cell_type
:	O
evidence	O
of	O
somatic	O
hypermutation	O
acting	O
outside	O
Ig	DNA
loci	DNA
.	O
The	O
molecular	O
mechanism	O
involved	O
in	O
the	O
process	O
of	O
antigen-driven	O
somatic	O
hypermutation	O
of	O
Ig	DNA
genes	DNA
is	O
unknown,	O
but	O
it	O
is	O
commonly	O
believed	O
that	O
this	O
mechanism	O
is	O
restricted	O
to	O
the	O
Ig	DNA
loci	DNA
.	O
B	cell_type
cell	cell_type
lymphomas	cell_type
commonly	O
display	O
multiple	O
somatic	O
mutations	O
clustering	O
in	O
the	O
5'-regulatory	DNA
region	DNA
of	O
BCL-6	protein
,	O
a	O
proto-oncogene	DNA
encoding	O
for	O
a	O
POZ/Zinc	protein
finger	protein
transcriptional	protein
repressor	protein
expressed	O
in	O
germinal	cell_type
center	cell_type
(GC)	cell_type
B	cell_type
cells	cell_type
and	O
required	O
for	O
GC	O
formation	O
.	O
To	O
determine	O
whether	O
BCL-6	protein
mutations	O
represent	O
a	O
tumor-associated	O
phenomenon	O
or	O
reflect	O
a	O
physiologic	O
mechanism,	O
we	O
screened	O
single	O
human	cell_type
tonsillar	cell_type
GC	cell_type
B	cell_type
cells	cell_type
for	O
mutations	O
occurring	O
in	O
the	O
BCL-6	DNA
5'-noncoding	DNA
region	DNA
and	O
in	O
the	O
Ig	DNA
variable	DNA
heavy	DNA
chain	DNA
sequences	DNA
.	O
Thirty	O
percent	O
of	O
GC	cell_type
B	cell_type
cells	cell_type
,	O
but	O
not	O
naive	cell_type
B	cell_type
cells	cell_type
,	O
displayed	O
mutations	O
in	O
the	O
742	DNA
bp	DNA
region	DNA
analyzed	O
within	O
the	O
first	O
intron	O
of	O
BCL-6	protein
(overall	O
frequency:	O
5	O
x	O
10(-4)/bp).	O
Accordingly,	O
an	O
expanded	O
survey	O
in	O
lymphoid	O
malignancies	O
showed	O
that	O
BCL-6	protein
mutations	O
are	O
restricted	O
to	O
B	O
cell	O
tumors	O
displaying	O
GC	O
or	O
post-GC	O
phenotype	O
and	O
carrying	O
mutated	DNA
Ig	DNA
variable	DNA
heavy	DNA
chain	DNA
sequences	DNA
.	O
These	O
results	O
indicate	O
that	O
the	O
somatic	O
hypermutation	O
mechanism	O
active	O
in	O
GC	cell_type
B	cell_type
cells	cell_type
physiologically	O
targets	O
non-Ig	DNA
sequences	DNA
.	O

The	O
AD1	protein
and	O
AD2	protein
transactivation	O
domains	O
of	O
E2A	protein
are	O
essential	O
for	O
the	O
antiapoptotic	O
activity	O
of	O
the	O
chimeric	protein
oncoprotein	protein
E2A-HLF	protein
.	O
The	O
chimeric	protein
oncoprotein	protein
E2A-HLF	protein
,	O
generated	O
by	O
the	O
t(17;19)	DNA
chromosomal	DNA
translocation	DNA
in	O
pro-B-cell	O
acute	O
lymphoblastic	O
leukemia	O
,	O
incorporates	O
the	O
transactivation	protein
domains	protein
of	O
E2A	protein
and	O
the	O
basic	O
leucine	O
zipper	O
(bZIP)	O
DNA-binding	O
and	O
protein	O
dimerization	O
domain	O
of	O
HLF	protein
(	O
hepatic	protein
leukemic	protein
factor	protein
).	O
The	O
ability	O
of	O
E2A-HLF	protein
to	O
prolong	O
the	O
survival	O
of	O
interleukin-3	cell_line
(	cell_line
IL-3	cell_line
)-dependent	cell_line
murine	cell_line
pro-B	cell_line
cells	cell_line
after	O
IL-3	protein
withdrawal	O
suggests	O
that	O
it	O
disrupts	O
signaling	O
pathways	O
normally	O
responsible	O
for	O
cell	O
suicide	O
,	O
allowing	O
the	O
cells	O
to	O
accumulate	O
as	O
transformed	cell_type
lymphoblasts	cell_type
.	O
To	O
determine	O
the	O
structural	O
motifs	O
that	O
contribute	O
to	O
this	O
antiapoptotic	O
effect	O
,	O
we	O
constructed	O
a	O
panel	O
of	O
E2A-HLF	protein
mutants	protein
and	O
programmed	O
their	O
expression	O
in	O
IL-3	cell_line
-dependent	cell_line
murine	cell_line
pro-B	cell_line
cells	cell_line
(	O
FL5.12	cell_line
line	cell_line
),	O
using	O
a	O
zinc-inducible	O
vector.	O
Neither	O
the	O
E12	protein
nor	O
the	O
E47	protein
product	O
of	O
the	O
E2A	DNA
gene	DNA
nor	O
the	O
wild-type	protein
HLF	protein
protein	protein
was	O
able	O
to	O
protect	O
the	O
cells	O
from	O
apoptosis	O
induced	O
by	O
IL-3	protein
deprivation	O
.	O
Surprisingly,	O
different	O
combinations	O
of	O
disabling	O
mutations	O
within	O
the	O
HLF	protein
bZIP	protein
domain	protein
had	O
little	O
effect	O
on	O
the	O
antiapoptotic	O
property	O
of	O
the	O
chimeric	protein
protein	protein
,	O
so	O
long	O
as	O
the	O
amino-terminal	O
portion	O
of	O
E2A	protein
remained	O
intact.	O
In	O
the	O
context	O
of	O
a	O
bZIP	protein
domain	protein
defective	O
in	O
DNA	O
binding,	O
mutants	O
retaining	O
either	O
of	O
the	O
two	O
transactivation	protein
domains	protein
of	O
E2A	protein
were	O
able	O
to	O
extend	O
cell	O
survival	O
after	O
growth	protein
factor	protein
deprivation	O
.	O
Thus,	O
the	O
block	O
of	O
apoptosis	O
imposed	O
by	O
E2A-HLF	protein
in	O
pro-B	cell_type
lymphocytes	cell_type
depends	O
critically	O
on	O
the	O
transactivating	protein
regions	protein
of	O
E2A	protein
.	O
Since	O
neither	O
DNA	O
binding	O
nor	O
protein	O
dimerization	O
through	O
the	O
bZIP	protein
domain	protein
of	O
HLF	protein
is	O
required	O
for	O
this	O
effect,	O
we	O
propose	O
mechanisms	O
whereby	O
protein-protein	O
interactions	O
with	O
the	O
amino-terminal	O
region	O
of	O
E2A	protein
allow	O
the	O
chimera	protein
to	O
act	O
as	O
a	O
transcriptional	O
cofactor	O
to	O
alter	O
the	O
expression	O
of	O
genes	O
regulating	O
the	O
apoptotic	O
machinery	O
in	O
pro-B	cell_type
cells	cell_type
.	O

Induction	O
of	O
Mn	protein
SOD	protein
in	O
human	cell_type
monocytes	cell_type
without	O
inflammatory	protein
cytokine	protein
production	O
by	O
a	O
mutant	protein
endotoxin	protein
.	O
Endotoxin	protein
selectively	O
induces	O
monocyte	protein
Mn	protein
superoxide	protein
dismutase	protein
(	O
SOD	protein
)	O
without	O
affecting	O
levels	O
of	O
Cu	O
,	O
Zn	protein
SOD	protein
,	O
catalase	protein
,	O
or	O
glutathione	protein
peroxidase	protein
.	O
However,	O
little	O
is	O
known	O
about	O
the	O
structure-activity	O
relationship	O
and	O
the	O
mechanism	O
by	O
which	O
endotoxin	O
induces	O
Mn	protein
SOD	protein
.	O
In	O
this	O
study	O
we	O
demonstrated	O
that	O
a	O
mutant	O
Escherichia	O
coli	O
endotoxin	O
lacking	O
myristoyl	O
fatty	O
acid	O
at	O
the	O
3'	O
R-3-hydroxymyristate	O
position	O
of	O
the	O
lipid	O
A	O
moiety	O
retained	O
its	O
full	O
capacity	O
to	O
coagulate	O
Limulus	O
amoebocyte	O
lysate	O
compared	O
with	O
the	O
wild-type	O
E	O
.	O
coli	O
endotoxin	O
and	O
markedly	O
stimulated	O
the	O
activation	O
of	O
human	protein
monocyte	protein
nuclear	protein
factor-kappaB	protein
and	O
the	O
induction	O
of	O
Mn	RNA
SOD	RNA
mRNA	RNA
and	O
enzyme	O
activity	O
.	O
However,	O
in	O
contrast	O
to	O
the	O
wild-type	O
endotoxin,	O
it	O
failed	O
to	O
induce	O
significant	O
production	O
of	O
tumor	protein
necrosis	protein
factor-alpha	protein
and	O
macrophage	protein
inflammatory	protein
protein-1alpha	protein
by	O
monocytes	cell_type
and	O
did	O
not	O
induce	O
the	O
phosphorylation	O
and	O
nuclear	O
translocation	O
of	O
mitogen-activated	protein
protein	protein
kinase	protein
.	O
These	O
results	O
suggest	O
that	O
1)	O
lipid	O
A	O
myristoyl	O
fatty	O
acid	O
,	O
although	O
it	O
is	O
important	O
for	O
the	O
induction	O
of	O
inflammatory	protein
cytokine	protein
production	O
by	O
human	cell_type
monocytes	cell_type
,	O
is	O
not	O
necessary	O
for	O
the	O
induction	O
of	O
Mn	protein
SOD	protein
,	O
2)	O
endotoxin	protein
-mediated	O
induction	O
of	O
Mn	protein
SOD	protein
and	O
inflammatory	O
cytokines	protein
are	O
regulated,	O
at	O
least	O
in	O
part,	O
through	O
different	O
signal	O
transduction	O
pathways	O
,	O
and	O
3)	O
failure	O
of	O
the	O
mutant	protein
endotoxin	protein
to	O
induce	O
tumor	protein
necrosis	protein
factor-alpha	protein
production	O
is,	O
at	O
least	O
in	O
part,	O
due	O
to	O
its	O
inability	O
to	O
activate	O
mitogen-activated	protein
protein	protein
kinase	protein
.	O

Regulation	O
of	O
the	O
vitellogenin	DNA
gene	DNA
B1	DNA
promoter	DNA
after	O
transfer	O
into	O
hepatocytes	cell_type
in	O
primary	O
cultures.	O
The	O
estrogen-dependent	O
and	O
tissue-specific	O
regulation	O
of	O
the	O
Xenopus	O
laevis	O
vitellogenin	DNA
gene	DNA
B1	DNA
promoter	DNA
has	O
been	O
studied	O
by	O
lipid-mediated	O
DNA	O
transfer	O
into	O
Xenopus	cell_type
hepatocytes	cell_type
in	O
primary	O
culture.	O
Hepatocytes	O
achieve	O
an	O
efficient	O
hormonal	O
control	O
of	O
this	O
promoter	O
through	O
a	O
functional	O
interaction	O
between	O
the	O
estrogen	DNA
responsive	DNA
elements	DNA
and	O
a	O
promoter	DNA
proximal	DNA
region	DNA
upstream	O
of	O
the	O
TATA	DNA
box	DNA
,	O
which	O
is	O
characterized	O
by	O
a	O
high	O
density	O
of	O
binding	O
sites	O
for	O
the	O
transcription	protein
factors	protein
CTF/NF-1	protein
,	O
C/EBP	protein
and	O
HNF3	protein
.	O
DNA	O
accessibility	O
to	O
restriction	protein
enzymes	protein
within	O
the	O
chromosomal	O
copy	O
of	O
the	O
vitellogenin	DNA
gene	DNA
B1	DNA
promoter	DNA
shows	O
that	O
the	O
estrogen	DNA
responsive	DNA
unit	DNA
and	O
the	O
promoter	DNA
proximal	DNA
region	DNA
are	O
sensitive	O
to	O
digestion	O
in	O
uninduced	O
and	O
estrogen	cell_type
-induced	cell_type
hepatocytes	cell_type
but	O
not	O
in	O
erythrocyte	O
nuclei	O
.	O
Together,	O
these	O
findings	O
support	O
the	O
notion	O
that	O
chromatin	DNA
configuration	O
as	O
well	O
as	O
the	O
interplay	O
of	O
promoter	DNA
elements	DNA
mediate	O
proper	O
hormone-dependent	O
and	O
tissue-specific	O
expression	O
of	O
the	O
B1	DNA
vitellogenin	DNA
gene	DNA
.	O

Characterization	O
of	O
cytokine	protein
differential	O
induction	O
of	O
STAT	protein
complexes	protein
in	O
primary	O
human	O
T	O
and	O
NK	O
cells	O
.	O
Cytokines	protein
,	O
IL-2	protein
,	O
IL-4	protein
,	O
IL-6	protein
,	O
IL-7	protein
,	O
IL-12	protein
,	O
and	O
IL-15	protein
are	O
key	O
regulators	O
of	O
human	O
peripheral	O
blood	O
T	O
and	O
NK	O
cell	O
activation	O
and	O
differentiation	O
but	O
the	O
precise	O
mechanisms	O
that	O
give	O
rise	O
to	O
their	O
differential	O
activities	O
within	O
these	O
cells	O
are	O
not	O
clear.	O
Recent	O
studies	O
reveal	O
that	O
a	O
family	O
of	O
transcription	protein
factors	protein
,	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(	O
STATs	protein
)	O
directly	O
mediate	O
many	O
cytokine	protein
signals	O
.	O
We	O
analyzed	O
the	O
activation	O
of	O
STATs	protein
in	O
primary	O
human	O
T	O
and	O
NK	O
cells	O
by	O
a	O
variety	O
of	O
specific	O
cytokines	protein
.	O
We	O
demonstrate	O
that	O
IL-12	protein
induces	O
STAT4	protein
only	O
in	O
freshly	O
isolated	O
primary	cell_type
NK	cell_type
cells	cell_type
,	O
but	O
not	O
in	O
primary	cell_type
T	cell_type
cells	cell_type
,	O
consistent	O
with	O
the	O
lack	O
of	O
the	O
IL-12	protein
receptor	protein
in	O
resting	cell_type
T	cell_type
cells	cell_type
.	O
In	O
contrast,	O
IL-4	protein
induces	O
different	O
C	protein
epsilon	protein
GAS	protein
DNA-protein	protein
binding	protein
complexes	protein
in	O
both	O
T	O
and	O
NK	cell_type
cells	cell_type
.	O
Moreover,	O
IL-4	protein
costimulation	O
with	O
IL-2	protein
or	O
IL-12	protein
does	O
not	O
alter	O
their	O
own	O
preferential	O
GAS	DNA
-like	O
DNA	O
binding	O
patterns	O
when	O
C	O
epsilon-	O
,	O
Fc	O
gamma	O
RI-	O
,	O
and	O
SIE	O
GAS	O
motif	O
containing	O
oligonucleotide	O
probes	O
are	O
compared,	O
suggesting	O
that	O
induction	O
of	O
GAS-like	protein
DNA-protein	protein
binding	protein
complexes	protein
by	O
IL-2	protein
,	O
IL-4	protein
,	O
and	O
IL-12	protein
is	O
highly	O
selective	O
and	O
represents	O
one	O
important	O
factor	O
in	O
determining	O
specific	O
gene	O
activation	O
.	O
In	O
addition,	O
IL-6	protein
and	O
IL-2	protein
synergistically	O
induce	O
homo-	O
and	O
heterodimerized	O
STAT1	protein
alpha	protein
and	O
STAT3	protein
in	O
both	O
NK	O
and	O
T	O
cells	O
,	O
consistent	O
with	O
their	O
reported	O
synergism	O
in	O
modulating	O
perforin	DNA
gene	DNA
expression	O
.	O
We	O
further	O
demonstrated	O
that	O
IL	O
-2	O
,	O
-7	O
,	O
and	O
-15	O
induce	O
multiple	protein
STAT	protein
proteins	protein
,	O
including	O
STAT5a	protein
,	O
STAT5b	protein
,	O
STAT1	protein
alpha	protein
,	O
STAT3	protein
,	O
and	O
another	O
unidentified	O
Fc	protein
gamma	protein
RI	protein
GAS	protein
DNA-binding	protein
protein	protein
.	O
Finally,	O
we	O
observed	O
that	O
activated	O
STAT5a	protein
and	O
STAT5b	protein
proteins	O
form	O
distinct	O
Fc	O
gamma	O
RI	O
GAS	O
binding	O
patterns	O
in	O
T	O
and	O
NK	O
cells	O
,	O
suggesting	O
that	O
they	O
might	O
have	O
different	O
roles	O
in	O
gene	O
regulation.	O
Our	O
data	O
provide	O
evidence	O
that	O
the	O
differential	O
responses	O
in	O
gene	O
expression	O
and	O
cell	O
activation	O
seen	O
in	O
primary	O
NK	O
and	O
T	O
cells	O
on	O
direct	O
stimulation	O
with	O
different	O
cytokines	protein
may	O
be	O
a	O
direct	O
result	O
of	O
distinct	O
activation	O
of	O
STAT	protein
transcription	protein
factors	protein
.	O

A	O
regulatory	DNA
element	DNA
in	O
the	O
CD95	DNA
(	DNA
APO-1/Fas	DNA
)	DNA
ligand	DNA
promoter	DNA
is	O
essential	O
for	O
responsiveness	O
to	O
TCR	protein
-mediated	O
activation	O
.	O
Expression	O
of	O
the	O
CD95	protein
(	protein
APO-1/Fas	protein
)	protein
ligand	protein
(	O
CD95L	protein
)	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
is	O
a	O
major	O
cause	O
of	O
T	O
cell	O
activation-induced	O
apoptosis	O
.	O
To	O
study	O
the	O
molecular	O
mechanisms	O
of	O
transcriptional	O
control	O
of	O
CD95L	protein
expression	O
in	O
T	cell_type
cells	cell_type
,	O
we	O
investigated	O
the	O
human	DNA
CD95L	DNA
promoter	DNA
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
Deletion	O
studies	O
revealed	O
that	O
the	O
CD95L	DNA
proximal	DNA
promoter	DNA
sequence	DNA
from	O
-220	DNA
to	O
the	O
transcription	DNA
start	DNA
site	DNA
is	O
essential	O
for	O
T	O
cell	O
stimulation-induced	O
expression	O
of	O
CD95L	protein
.	O
In	O
this	O
study,	O
we	O
discovered	O
a	O
novel	O
regulatory	DNA
element	DNA
located	O
at	O
-120	DNA
of	O
the	O
CD95L	DNA
promoter	DNA
which	O
contains	O
DNA	DNA
binding	DNA
sites	DNA
for	O
SP-1	protein
and	O
a	O
yet	O
unknown	O
inducible	protein
factor	protein
.	O
Mutation	O
analysis	O
demonstrated	O
that	O
binding	O
of	O
the	O
inducible	O
factor	O
to	O
the	O
-120	DNA
region	DNA
is	O
crucial	O
for	O
the	O
biological	O
function	O
of	O
the	O
CD95L	DNA
promoter	DNA
upon	O
T	O
cell	O
stimulation	O
.	O
The	O
DNA	O
sequence	O
at	O
-120	DNA
also	O
contains	O
two	O
DNA	DNA
motifs	DNA
homologous	O
to	O
the	O
binding	O
site	O
for	O
NF-AT	protein
.	O
NF-AT	protein
does	O
not	O
directly	O
bind	O
to	O
this	O
element.	O
However,	O
cotransfection	O
studies	O
with	O
an	O
NF-AT	DNA
expression	DNA
vector	DNA
showed	O
that	O
NF-AT	protein
may	O
confer	O
a	O
strong	O
inducible	O
activity	O
to	O
the	O
CD95L	DNA
promoter	DNA
at	O
this	O
regulatory	DNA
region	DNA
.	O
Our	O
data	O
also	O
show	O
that	O
the	O
immunosuppressive	O
agent	O
cyclosporin	O
A	O
down-regulates	O
CD95L	protein
transcription	O
by	O
inhibiting	O
the	O
function	O
of	O
this	O
positive	O
regulatory	DNA
element	DNA

A	O
nongenomic	O
mechanism	O
for	O
progesterone-mediated	O
immunosuppression:	O
inhibition	O
of	O
K+	protein
channels	protein
,	O
Ca2+	O
signaling	O
,	O
and	O
gene	O
expression	O
in	O
T	cell_type
lymphocytes	cell_type
.	O
The	O
mechanism	O
by	O
which	O
progesterone	O
causes	O
localized	O
suppression	O
of	O
the	O
immune	O
response	O
during	O
pregnancy	O
has	O
remained	O
elusive.	O
Using	O
human	cell_type
T	cell_type
lymphocytes	cell_type
and	O
T	cell_line
cell	cell_line
lines	cell_line
,	O
we	O
show	O
that	O
progesterone	O
,	O
at	O
concentrations	O
found	O
in	O
the	O
placenta,	O
rapidly	O
and	O
reversibly	O
blocks	O
voltage-gated	O
and	O
calcium-activated	O
K+	O
channels	O
(	O
KV	protein
and	O
KCa	protein
,	O
respectively),	O
resulting	O
in	O
depolarization	O
of	O
the	O
membrane	O
potential	O
.	O
As	O
a	O
result,	O
Ca2+	O
signaling	O
and	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NF-AT	protein
)-driven	O
gene	O
expression	O
are	O
inhibited.	O
Progesterone	O
acts	O
distally	O
to	O
the	O
initial	O
steps	O
of	O
T	protein
cell	protein
receptor	protein
(	O
TCR	protein
)-mediated	O
signal	O
transduction	O
,	O
since	O
it	O
blocks	O
sustained	O
Ca2+	O
signals	O
after	O
thapsigargin	O
stimulation	O
,	O
as	O
well	O
as	O
oscillatory	O
Ca2+	O
signals	O
,	O
but	O
not	O
the	O
Ca2+	O
transient	O
after	O
TCR	protein
stimulation	O
.	O
K+	O
channel	O
blockade	O
by	O
progesterone	O
is	O
specific;	O
other	O
steroid	O
hormones	O
had	O
little	O
or	O
no	O
effect,	O
although	O
the	O
progesterone	O
antagonist	O
RU	O
486	O
also	O
blocked	O
KV	protein
and	O
KCa	protein
channels.	O
Progesterone	O
effectively	O
blocked	O
a	O
broad	O
spectrum	O
of	O
K+	protein
channels	protein
,	O
reducing	O
both	O
Kv1.3	protein
and	O
charybdotoxin-resistant	protein
components	protein
of	O
KV	protein
current	O
and	O
KCa	protein
current	O
in	O
T	cell_type
cells	cell_type
,	O
as	O
well	O
as	O
blocking	O
several	O
cloned	protein
KV	protein
channels	protein
expressed	O
in	O
cell	cell_line
lines	cell_line
.	O
Progesterone	O
had	O
little	O
or	O
no	O
effect	O
on	O
a	O
cloned	protein
voltage-gated	protein
Na+	protein
channel	protein
,	O
an	O
inward	O
rectifier	O
K+	protein
channel	protein
,	O
or	O
on	O
lymphocyte	O
Ca2+	O
and	O
Cl-	O
channels	O
.	O
We	O
propose	O
that	O
direct	O
inhibition	O
of	O
K+	protein
channels	protein
in	O
T	cell_type
cells	cell_type
by	O
progesterone	O
contributes	O
to	O
progesterone	O
-induced	O
immunosuppression	O
.	O

A	O
mouse	O
carrying	O
genetic	O
defect	O
in	O
the	O
choice	O
between	O
T	O
and	O
B	O
lymphocytes	O
.	O
Transgenic	O
mice	O
with	O
human	DNA
CD3epsilon	DNA
gene	DNA
have	O
been	O
shown	O
to	O
exhibit	O
early	O
arrest	O
of	O
T	O
cell	O
development	O
in	O
the	O
thymus	O
.	O
The	O
present	O
study	O
shows	O
that,	O
instead	O
of	O
T	cell_type
cells	cell_type
,	O
B	cell_type
cells	cell_type
are	O
generated	O
in	O
the	O
thymus	O
of	O
a	O
line,	O
tg	O
epsilon26,	O
of	O
the	O
human	O
CD3epsilon	O
transgenic	O
mice	O
.	O
The	O
accumulation	O
of	O
mature	cell_type
B	cell_type
cells	cell_type
in	O
the	O
thymus	O
was	O
found	O
only	O
in	O
tg	O
epsilon26	O
mice,	O
not	O
in	O
other	O
human	cell_line
CD3epsilon	cell_line
transgenic	cell_line
mouse	cell_line
lines	cell_line
or	O
other	O
T	O
cell-deficient	O
mice	O
,	O
including	O
CD3-epsilon	O
knockout	O
mice	O
and	O
TCR-beta/TCR-delta	O
double	O
knockout	O
mice	O
.	O
Hanging	O
drop-mediated	O
transfer	O
into	O
2-deoxyguanosine-treated	O
thymus	O
lobes	O
showed	O
that	O
lymphoid	cell_type
progenitor	cell_type
cells	cell_type
rather	O
than	O
thymus	O
stromal	O
cells	O
were	O
responsible	O
for	O
abnormal	O
B	O
cell	O
development	O
in	O
tg	protein
epsilon26	protein
thymus	O
,	O
and	O
that	O
tg	cell_type
epsilon26	cell_type
fetal	cell_type
liver	cell_type
cells	cell_type
were	O
destined	O
to	O
become	O
B	cell_type
cells	cell_type
in	O
normal	O
thymus	O
even	O
in	O
the	O
presence	O
of	O
normal	cell_type
progenitor	cell_type
cells	cell_type
undergoing	O
T	O
cell	O
development	O
.	O
These	O
results	O
indicate	O
that	O
lymphoid	cell_type
progenitor	cell_type
cells	cell_type
in	O
tg	protein
epsilon26	protein
mice	O
are	O
genetically	O
defective	O
in	O
thymic	O
choice	O
between	O
T	cell_type
cells	cell_type
and	O
B	cell_type
cells	cell_type
,	O
generating	O
B	cell_type
cells	cell_type
even	O
in	O
normal	O
thymus	O
environment	O
.	O
Interestingly,	O
tg	cell_type
epsilon26	cell_type
thymocytes	cell_type
expressed	O
GATA-3	protein
and	O
TCF-1	protein
,	O
but	O
not	O
LEF-1	protein
and	O
PEBP-2alpha	protein
,	O
among	O
T	protein
cell-specific	protein
transcription	protein
factors	protein
that	O
are	O
involved	O
in	O
early	O
T	O
cell	O
development	O
,	O
indicating	O
that	O
GATA-3	protein
and	O
TCF-1	protein
expressed	O
during	O
thymocyte	O
development	O
do	O
not	O
necessarily	O
determine	O
the	O
cell	O
fate	O
into	O
T	cell_type
cell	cell_type
lineage	cell_type
.	O
Thus,	O
tg	protein
epsilon26	protein
mice	O
provide	O
a	O
novel	O
mouse	O
model	O
in	O
that	O
lineage	O
choice	O
between	O
T	O
and	O
B	O
lymphocytes	O
is	O
genetically	O
defective.	O

Downstream	O
activation	O
of	O
a	O
TATA-less	DNA
promoter	DNA
by	O
Oct-2	protein
,	O
Bob1,	O
and	O
NF-kappaB	protein
directs	O
expression	O
of	O
the	O
homing	protein
receptor	protein
BLR1	protein
to	O
mature	cell_type
B	cell_type
cells	cell_type
.	O
The	O
chemokine	protein
receptor	protein
,	O
BLR1	protein
,	O
is	O
a	O
major	O
regulator	O
of	O
the	O
microenvironmental	O
homing	O
of	O
B	cell_type
cells	cell_type
in	O
lymphoid	O
organs	O
.	O
In	O
vitro	O
studies	O
identify	O
three	O
essential	O
elements	O
of	O
the	O
TATA-less	DNA
blr1	DNA
core	DNA
promoter	DNA
that	O
confer	O
cell	O
type-	O
and	O
differentiation-	O
specific	O
expression	O
in	O
the	O
B	cell_type
cells	cell_type
of	O
both	O
humans	O
and	O
mice	O
,	O
a	O
functional	DNA
promoter	DNA
region	DNA
(-36	O
with	O
respect	O
to	O
the	O
transcription	DNA
start	DNA
site	DNA
),	O
a	O
NF-kappaB	DNA
motif	DNA
(+44),	O
and	O
a	O
noncanonical	DNA
octamer	DNA
motif	DNA
(+157).	O
The	O
importance	O
of	O
these	O
sites	O
was	O
confirmed	O
by	O
in	O
vivo	O
studies	O
in	O
gene-targeted	O
mice	O
deficient	O
of	O
either	O
Oct-2	protein
,	O
Bob1	protein
,	O
or	O
both	O
NF-kappaB	protein
subunits	O
p50	O
and	O
p52.	O
In	O
all	O
of	O
these	O
animals,	O
the	O
expression	O
of	O
BLR1	protein
was	O
reduced	O
or	O
absent.	O
In	O
mice	O
deficient	O
only	O
of	O
p52/	protein
NF-kappaB	protein
,	O
BLR1	protein
expression	O
was	O
unaffected.	O
Thus	O
our	O
data	O
demonstrate	O
that	O
BLR1	protein
is	O
a	O
target	O
gene	O
for	O
Oct-2	protein
,	O
Bob1	protein
,	O
and	O
members	O
of	O
the	O
NF-kappaB	protein
/Rel	protein
family	protein
and	O
provides	O
a	O
link	O
to	O
the	O
impaired	O
B	O
cell	O
functions	O
in	O
mice	O
deficient	O
for	O
these	O
factors.	O

CD4	DNA
promoter	DNA
transactivation	O
by	O
human	O
herpesvirus	O
6	O
.	O
The	O
observation	O
that	O
human	O
herpesvirus	O
6	O
(	O
HHV-6	O
)	O
can	O
induce	O
CD4	DNA
gene	DNA
transcription	O
and	O
expression	O
in	O
CD4(-)	cell_line
cells	cell_line
was	O
reported	O
several	O
years	O
ago	O
(P.Lusso,	O
A.De	O
Maria,	O
M.Malnati,	O
F.Lori,	O
S.E.DeRocco,	O
M.	O
Baseler,	O
and	O
R.C.Gallo,	O
Nature	O
349:533-535,	O
1991)	O
and	O
subsequently	O
confirmed	O
(P.Lusso,	O
M.S.Malnati,	O
A.Garzino-Demo,	O
R.W.Crowley,	O
E.	O
O.Long,	O
and	O
R.C.Gallo,	O
Nature	O
362:458-462,	O
1993;	O
G.Furlini,	O
M.	O
Vignoli,	O
E.Ramazzotti,	O
M.C.Re,	O
G.Visani,	O
and	O
M.LaPlaca,	O
Blood	O
87:4737-4745,	O
1996).	O
Our	O
objective	O
was	O
to	O
identify	O
the	O
mechanisms	O
underlying	O
such	O
phenomena.	O
Using	O
reporter	DNA
gene	DNA
constructs	DNA
driven	O
by	O
the	O
CD4	DNA
promoter	DNA
,	O
we	O
report	O
that	O
HHV-6	O
can	O
efficiently	O
transactivate	O
such	O
genetic	DNA
elements	DNA
.	O
Activation	O
of	O
the	O
CD4	DNA
promoter	DNA
occurs	O
in	O
the	O
presence	O
of	O
the	O
viral	O
DNA	O
polymerase	O
inhibitor	O
phosphonoformic	O
acid	O
,	O
which	O
limits	O
expression	O
to	O
the	O
immediate-early	O
and	O
early	O
classes	O
of	O
viral	O
genes	O
.	O
Using	O
deletion	O
mutants	O
and	O
specific	O
CD4	DNA
promoter	DNA
mutants	DNA
,	O
we	O
identified	O
an	O
ATF/CRE	DNA
binding	DNA
site	DNA
located	O
at	O
nucleotides	DNA
-67	DNA
to	DNA
-60	DNA
upstream	DNA
of	O
the	O
CD4	DNA
gene	DNA
transcription	DNA
start	DNA
site	DNA
that	O
is	O
important	O
for	O
HHV-6	O
transactivation	O
.	O
The	O
ATF/CRE	DNA
site	DNA
is	O
also	O
essential	O
for	O
CD4	DNA
promoter	DNA
activation	O
by	O
forskolin,	O
an	O
activator	O
of	O
adenylate	O
cyclase	O
.	O
Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
and	O
specific	O
antibodies,	O
we	O
showed	O
that	O
CREB-1	protein
binds	O
specifically	O
to	O
the	O
-79	DNA
to	DNA
-52	DNA
region	DNA
of	O
the	O
CD4	DNA
promoter	DNA
.	O
Last,	O
we	O
have	O
identified	O
two	O
open	DNA
reading	DNA
frames	DNA
(	O
ORFs	DNA
)	O
of	O
HHV-6	O
,	O
U86	DNA
and	O
U89	DNA
from	O
the	O
immediate-early	O
locus	O
A,	O
that	O
can	O
transactivate	O
the	O
CD4	DNA
promoter	DNA
in	O
HeLa	cell_line
cells	cell_line
.	O
However,	O
transactivation	O
of	O
the	O
CD4	DNA
promoter	DNA
by	O
ORFs	DNA
U86	DNA
and	O
U89	DNA
is	O
independent	O
of	O
the	O
CRE	DNA
element	DNA
,	O
suggesting	O
that	O
additional	O
HHV-6	DNA
ORFs	DNA
are	O
likely	O
to	O
contribute	O
to	O
CD4	DNA
gene	DNA
activation.	O
Taken	O
together,	O
our	O
results	O
will	O
help	O
to	O
understand	O
the	O
complex	O
interactions	O
occurring	O
between	O
HHV-6	O
and	O
the	O
CD4	DNA
promoter	DNA
and	O
provide	O
additional	O
information	O
regarding	O
the	O
class	O
of	O
transcription	protein
factors	protein
involved	O
in	O
the	O
control	O
of	O
CD4	DNA
gene	DNA
expression	O
.	O

The	O
PEBP2betaMYH11	protein
fusion	O
created	O
by	O
Inv(16)(p13;q22)	DNA
in	O
myeloid	O
leukemia	O
impairs	O
neutrophil	O
maturation	O
and	O
contributes	O
to	O
granulocytic	O
dysplasia	O
.	O
Chromosomal	O
translocations	O
involving	O
the	O
genes	O
encoding	O
the	O
alpha	O
and	O
beta	O
subunits	O
of	O
the	O
Pebp2/Cbf	protein
transcription	protein
factor	protein
have	O
been	O
associated	O
with	O
human	O
acute	O
myeloid	O
leukemia	O
and	O
the	O
preleukemic	O
condition	O
,	O
myelodysplasia	O
.	O
Inv(16)(p13;q22)	DNA
fuses	O
the	O
gene	O
encoding	O
the	O
beta	protein
subunit	protein
of	O
Pebp2	protein
to	O
the	O
MYH11	DNA
gene	DNA
encoding	O
a	O
smooth	protein
muscle	protein
myosin	protein
heavy	protein
chain	protein
(	O
Smmhc	protein
).	O
To	O
examine	O
the	O
effect	O
of	O
the	O
inv(16)(p13;q22)	DNA
on	O
myelopoiesis	O
,	O
we	O
used	O
the	O
hMRP8	DNA
promoter	DNA
element	DNA
to	O
generate	O
transgenic	O
mice	O
expressing	O
the	O
Pebp2beta	protein
Smmhc	protein
chimeric	protein
fusion	protein
protein	protein
in	O
myeloid	cell_type
cells	cell_type
.	O
Neutrophil	O
maturation	O
was	O
impaired	O
in	O
PEBP2betaMYH11	protein
transgenic	O
mice	O
.	O
Although	O
the	O
transgenic	O
mice	O
had	O
normal	O
numbers	O
of	O
circulating	cell_type
neutrophils	cell_type
,	O
their	O
bone	O
marrow	O
contained	O
increased	O
numbers	O
of	O
immature	cell_type
neutrophilic	cell_type
cells	cell_type
,	O
which	O
exhibited	O
abnormal	O
characteristics.	O
In	O
addition,	O
PEBP2betaMYH11	protein
inhibited	O
neutrophilic	O
differentiation	O
in	O
colonies	O
derived	O
from	O
hematopoietic	cell_type
progenitors	cell_type
.	O
Coexpression	O
of	O
both	O
PEBP2betaMYH11	protein
and	O
activated	protein
NRAS	protein
induced	O
a	O
more	O
severe	O
phenotype	O
characterized	O
by	O
abnormal	O
nuclear	O
morphology	O
indicative	O
of	O
granulocytic	O
dysplasia	O
.	O
These	O
results	O
show	O
that	O
PEBP2betaMYH11	protein
can	O
impair	O
neutrophil	O
development	O
and	O
provide	O
evidence	O
that	O
alterations	O
of	O
Pebp2	protein
can	O
contribute	O
to	O
the	O
genesis	O
of	O
myelodysplasia	O
.	O

Human	O
T	O
cell	O
leukemia	O
virus-I	O
(	O
HTLV-I	O
)	O
Tax	protein
-mediated	O
apoptosis	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
requires	O
an	O
enhanced	O
intracellular	O
prooxidant	O
state	O
.	O
We	O
have	O
shown	O
that	O
an	O
estradiol-dependent	O
activation	O
of	O
human	O
T	O
cell	O
leukemia	O
virus-I	O
Tax	protein
leads	O
to	O
the	O
inhibition	O
of	O
cell	O
proliferation	O
and	O
to	O
the	O
induction	O
of	O
apoptosis	O
.	O
The	O
present	O
study	O
demonstrates	O
that	O
a	O
hormone-dependent	O
activation	O
of	O
Tax	protein
promotes	O
an	O
enhanced	O
prooxidant	O
state	O
in	O
stably	cell_line
transfected	cell_line
Jurkat	cell_line
cells	cell_line
as	O
measured	O
by	O
changes	O
in	O
the	O
intracellular	O
levels	O
of	O
glutathione	O
and	O
H2O2	O
;	O
these	O
changes	O
are	O
followed	O
by	O
apoptotic	O
cell	O
death	O
.	O
Additional	O
stimulation	O
of	O
the	O
CD3	protein
/TCR	protein
pathway	O
enhances	O
the	O
oxidative	O
and	O
apoptotic	O
effects	O
.	O
Both	O
Tax	protein
-mediated	O
apoptosis	O
and	O
oxidative	O
stress	O
can	O
be	O
potently	O
suppressed	O
by	O
antioxidants	O
,	O
as	O
is	O
seen	O
with	O
the	O
administration	O
of	O
recombinant	protein
thioredoxin	protein
(	O
adult	protein
T	protein
cell	protein
leukemia-derived	protein
factor	protein
)	O
or	O
pyrrolidine	O
dithiocarbamate	O
.	O
Hormone-induced	O
Tax	protein
activation	O
induces	O
a	O
long-lasting	O
activation	O
of	O
NF-kappaB	protein
,	O
which	O
is	O
a	O
major	O
target	O
of	O
reactive	O
oxygen	O
intermediates	O
.	O
The	O
long-term	O
exposure	O
of	O
Jurkat	cell_line
cells	cell_line
to	O
hormone	O
eventually	O
results	O
in	O
a	O
selection	O
of	O
cell	cell_line
clones	cell_line
that	O
have	O
lost	O
Tax	protein
activity	O
.	O
A	O
subsequent	O
transfection	O
of	O
these	O
apparently	O
"nonresponsive"	cell_line
clones	cell_line
allows	O
the	O
recovery	O
of	O
Tax	protein
responses	O
in	O
these	O
cells.	O
Our	O
observations	O
indicate	O
that	O
changes	O
in	O
the	O
intracellular	O
redox	O
status	O
may	O
be	O
a	O
determining	O
factor	O
in	O
Tax	protein
-mediated	O
DNA	O
damage	O
,	O
apoptosis	O
,	O
and	O
selection	O
against	O
the	O
long-term	O
expression	O
of	O
Tax	protein
function	O
.	O

An	O
allosteric	O
drug	O
,	O
o,o'-bismyristoyl	O
thiamine	O
disulfide	O
,	O
suppresses	O
HIV-1	O
replication	O
through	O
prevention	O
of	O
nuclear	O
translocation	O
of	O
both	O
HIV-1	protein
Tat	protein
and	O
NF-kappa	protein
B	protein
.	O
The	O
efficacy	O
of	O
o,o'-bismyristoyl	O
thiamine	O
disulfide	O
(	O
BMT	O
)	O
was	O
examined	O
in	O
detail	O
against	O
HIV-1	O
laboratory	O
isolates	O
(	O
HTLV-IIIB	O
,	O
JRFL	O
,	O
and	O
MN	O
),	O
primary	O
isolates	O
(	O
KMT	O
and	O
KMO	O
),	O
and	O
simian	O
immunodeficiency	O
virus	O
(	O
SIVmac251	O
)	O
in	O
vitro.	O
BMT	O
inhibited	O
the	O
replication	O
of	O
HIV-1	O
in	O
both	O
laboratory	O
and	O
primary	O
isolates	O
in	O
vitro.	O
In	O
addition,	O
BMT	O
exhibited	O
antiviral	O
activity	O
against	O
SIVmac251	O
.	O
Minimizing	O
energy	O
studies	O
of	O
BMT	O
structure	O
reveal	O
that	O
a	O
trans-disulfide	O
of	O
thiamine	O
(	O
holo	O
drug	O
)	O
disulfide	O
(	O
TDS	O
,	O
protodrug	O
)	O
is	O
allosterically	O
transited	O
to	O
the	O
reactive	O
twisted	O
disulfide	O
of	O
BMT	O
(	O
allo	O
drug	O
)	O
by	O
o,o'-bismyristoyl	O
esterification	O
of	O
TDS	O
.	O
BMT	O
inhibits	O
nuclear	O
translocation	O
of	O
both	O
HIV-1	protein
transactivator	protein
(	O
TAT	protein
)	O
and	O
the	O
cellular	protein
transcriptional	protein
nuclear	protein
factor-KB	protein
(	O
NF-kappa	protein
B	protein
),	O
resulting	O
in	O
the	O
suppression	O
of	O
HIV-1	O
replication	O
.	O

Glucocorticoid	O
-induced	O
apoptosis	O
and	O
regulation	O
of	O
NF-kappaB	protein
activity	O
in	O
human	cell_type
leukemic	cell_type
T	cell_type
cells	cell_type
.	O
Glucocorticoid	O
-induced	O
apoptosis	O
was	O
investigated	O
in	O
glucocorticoid-sensitive	cell_line
6TG1.1	cell_line
and	O
resistant	cell_line
ICR27TK.3	cell_line
human	cell_type
leukemic	cell_type
T	cell_type
cells	cell_type
.	O
Following	O
glucocorticoid	O
treatment	O
of	O
6TG1.1	cell_line
cells	cell_line
,	O
chromatin	DNA
fragmentation	O
was	O
observed	O
after	O
a	O
delay	O
of	O
24	O
h.	O
Fragmentation	O
was	O
not	O
observed	O
in	O
ICR27TK.3	cell_line
cells	cell_line
containing	O
mutant	protein
glucocorticoid	protein
receptors	protein
(	O
L753F	cell_line
)	O
that	O
are	O
activation-deficient	O
but	O
retain	O
the	O
ability	O
to	O
repress	O
AP-1	protein
activity	O
.	O
Nor	O
was	O
fragmentation	O
observed	O
after	O
treatment	O
with	O
RU38486	O
,	O
indicating	O
that	O
repression	O
of	O
AP-1	protein
activity	O
is	O
not	O
involved.	O
As	O
described	O
in	O
other	O
systems,	O
fragmentation	O
required	O
ongoing	O
protein	O
synthesis	O
.	O
However,	O
inhibition	O
of	O
protein	O
synthesis	O
with	O
cycloheximide	O
anytime	O
during	O
the	O
first	O
18	O
h	O
of	O
steroid	O
treatment	O
was	O
as	O
effective	O
in	O
blocking	O
chromatin	O
fragmentation	O
as	O
inhibition	O
for	O
the	O
entire	O
period,	O
suggesting	O
that	O
synthesis	O
of	O
a	O
component	O
with	O
a	O
rapid	O
turnover	O
rate	O
is	O
required.	O
Dexamethasone	O
treatment	O
completely	O
blocked	O
12-O-tetradecanoylphorbol	O
13-acetate	O
induction	O
of	O
nuclear	protein
factor-kappaB	protein
(	O
NF-kappaB	protein
)	O
activity	O
and	O
elicited	O
an	O
increase	O
in	O
the	O
amount	O
of	O
immunoreactive	protein
IkappaB	protein
alpha	protein
in	O
sensitive	O
6TG1.1	cell_line
cells	cell_line
but	O
not	O
in	O
resistant	O
ICR27TK.3	cell_line
cells	cell_line
.	O
In	O
addition,	O
mild	O
detergent	O
treatment	O
of	O
cell	O
extracts	O
indicated	O
that	O
a	O
substantial	O
amount	O
of	O
cytoplasmic	protein
NF-kappaB	protein
is	O
complexed	O
with	O
IkappaB	protein
alpha	protein
or	O
some	O
other	O
inhibitory	O
factor.	O
These	O
results	O
suggest	O
that	O
induction	O
of	O
a	O
labile	protein
inhibitory	protein
factor	protein
such	O
as	O
IkappaB	protein
alpha	protein
may	O
contribute	O
to	O
glucocorticoid-induced	O
apoptosis	O
.	O

Inhibition	O
of	O
HIV-1	O
replication	O
by	O
combination	O
of	O
a	O
novel	O
inhibitor	O
of	O
TNF-alpha	protein
with	O
AZT	O
.	O
The	O
small	O
molecule	O
S9a	O
was	O
derived	O
from	O
an	O
established	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
)	O
inhibitor	O
(	O
Canventol	O
)	O
by	O
replacement	O
of	O
the	O
isopropylidine	O
group	O
with	O
a	O
phenyl	O
ring	O
.	O
S9a	O
at	O
10	O
to	O
100	O
nM	O
inhibited	O
HIV	O
production	O
as	O
potently	O
as	O
3'-azido-3'-deoxythymidine	O
(	O
AZT	O
),	O
an	O
inhibitor	O
of	O
viral	protein
reverse	protein
transcriptase	protein
.	O
Furthermore,	O
S9a	O
and	O
AZT	O
in	O
combination,	O
at	O
noncytoxic	O
concentrations	O
strongly	O
inhibited	O
HIV-1	O
replication	O
that	O
was	O
more	O
than	O
additive	O
and	O
substantially	O
prolonged	O
the	O
appearance	O
of	O
virus	O
both	O
in	O
acutely	cell_type
infected	cell_type
CD4+	cell_type
lymphocytes	cell_type
(	O
SupT	cell_line
)	O
in	O
culture	O
and	O
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMCs	cell_type
)	O
infected	O
with	O
a	O
primary	O
HIV-1	O
isolate	O
.	O
S9a	O
inhibited	O
TNF-alpha	protein
promoter-driven	O
reporter	DNA
gene	DNA
activity	O
.	O
It	O
was	O
proposed	O
that	O
the	O
mechanism	O
of	O
antiviral	O
action	O
of	O
S9a	O
was	O
on	O
the	O
host	O
cell,	O
by	O
blocking	O
TNF-alpha	protein
transcription	O
via	O
a	O
Tat	protein
-induced	O
tar-independent	O
loop	O
,	O
which	O
decreases	O
downstream	O
NF-kappaB	protein
activation	O
of	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
).	O
S9a	O
was	O
superior	O
to	O
the	O
first	O
generation	O
compound	O
Canventol	O
,	O
which	O
was	O
superior	O
to	O
the	O
natural	O
compound	O
sarcophytol	O
A	O
,	O
demonstrating	O
that	O
further	O
structure-based	O
enhancement	O
of	O
potency	O
of	O
these	O
compounds	O
is	O
feasible.	O
This	O
study	O
suggests	O
a	O
therapeutic	O
approach	O
against	O
AIDS	O
by	O
application	O
of	O
two	O
drugs,	O
one	O
against	O
a	O
cellular	O
and	O
the	O
other	O
a	O
viral	O
target,	O
which	O
may	O
provide	O
an	O
approach	O
to	O
the	O
problem	O
of	O
frequent	O
emergence	O
of	O
resistant	O
variants	O
to	O
combinations	O
of	O
drugs	O
that	O
target	O
only	O
HIV	DNA
genes	DNA
.	O

Highly	O
polarized	O
HLA	protein
class	protein
II	protein
antigen	protein
processing	O
and	O
presentation	O
by	O
human	cell_type
intestinal	cell_type
epithelial	cell_type
cells	cell_type
.	O
The	O
high	O
concentration	O
of	O
foreign	protein
antigen	protein
in	O
the	O
lumen	cell_type
of	O
the	O
gastrointestinal	O
tract	O
is	O
separated	O
from	O
the	O
underlying	O
lymphocytes	cell_type
by	O
a	O
single	O
cell	O
layer	O
of	O
polarized	O
epithelium	O
.	O
Intestinal	cell_type
epithelial	cell_type
cells	cell_type
can	O
express	O
HLA	protein
class	protein
II	protein
antigens	protein
and	O
may	O
function	O
as	O
antigen-presenting	cell_type
cells	cell_type
to	cell_type
CD4(+)	cell_type
T	cell_type
cells	cell_type
within	O
the	O
intestinal	O
mucosa	O
.	O
Using	O
tetanus	O
toxoid	O
specific	O
and	O
HLA-DR-restricted	O
T	O
lymphocytes	O
,	O
we	O
show	O
that	O
polarized	cell_type
intestinal	cell_type
epithelial	cell_type
cells	cell_type
directed	O
to	O
express	O
HLA-DR	protein
molecules	protein
are	O
able	O
to	O
initiate	O
class	O
II	O
processing	O
only	O
after	O
internalization	O
of	O
antigen	O
from	O
their	O
apical	O
surface.	O
Coexpression	O
of	O
the	O
class	protein
II	protein
transactivator	protein
CIITA	protein
in	O
these	O
cells,	O
which	O
stimulates	O
highly	O
efficient	O
class	O
II	O
processing	O
without	O
the	O
characteristic	O
decline	O
in	O
barrier	O
function	O
seen	O
in	O
polarized	O
monolayers	O
treated	O
with	O
the	O
proinflammatory	protein
cytokine	protein
gamma-IFN	protein
,	O
facilitates	O
antigen	O
processing	O
from	O
the	O
basolateral	O
surface	O
.	O
In	O
both	O
cases,	O
peptide	O
presentation	O
to	O
T	cell_type
cells	cell_type
via	O
class	protein
II	protein
molecules	protein
was	O
restricted	O
to	O
the	O
basolateral	O
surface.	O
These	O
data	O
indicate	O
a	O
highly	O
polarized	O
functional	O
architecture	O
for	O
antigen	O
processing	O
and	O
presentation	O
by	O
intestinal	cell_type
epithelial	cell_type
cells	cell_type
,	O
and	O
suggest	O
that	O
the	O
functional	O
outcome	O
of	O
antigen	O
processing	O
by	O
the	O
intestinal	O
epithelium	O
is	O
both	O
dependent	O
on	O
the	O
cellular	O
surface	O
at	O
which	O
the	O
foreign	O
antigen	O
is	O
internalized	O
and	O
by	O
the	O
underlying	O
degree	O
of	O
mucosal	O
inflammation	O

Tobacco	O
smoke	O
induces	O
coordinate	O
activation	O
of	O
HSF	protein
and	O
inhibition	O
of	O
NFkappaB	protein
in	O
human	cell_type
monocytes	cell_type
:	O
effects	O
on	O
TNFalpha	protein
release	O
.	O
Tobacco	O
smoke	O
(	O
TS	O
)	O
exposure	O
is	O
a	O
major	O
risk	O
factor	O
for	O
human	O
disease	O
,	O
and	O
macrophages	cell_type
of	O
healthy	O
smokers	O
have	O
a	O
depressed	O
capacity	O
to	O
release	O
cytokines	protein
,	O
including	O
tumor	protein
necrosis	protein
factor	protein
(TNF)alpha	protein
.	O
TS	O
induces	O
the	O
synthesis	O
of	O
heat	protein
shock	protein
(HS)/stress	protein
proteins	protein
(	O
HSP	protein
),	O
and,	O
in	O
particular,	O
of	O
Hsp70	protein
.	O
We	O
determined	O
whether	O
Hsp70	protein
induction	O
by	O
TS	O
was	O
mediated	O
by	O
the	O
activation	O
of	O
the	O
HS	protein
transcription	protein
factor	protein
,	O
HSF	protein
.	O
HSF	protein
activation	O
has	O
been	O
shown	O
to	O
inhibit	O
NFkappaB	protein
.	O
Thus,	O
we	O
also	O
determined	O
the	O
effects	O
of	O
TS	O
on	O
NFkappaB	protein
.	O
U937	cell_line
cells	cell_line
and	O
human	cell_type
peripheral	cell_type
blood	cell_type
monocytes	cell_type
were	O
exposed	O
to	O
TS	O
,	O
binding	O
activities	O
of	O
the	O
respective	O
transcription	protein
factors	protein
were	O
analyzed,	O
and	O
Hsp70	protein
expression	O
and	O
TNFalpha	protein
release	O
were	O
determined	O
in	O
parallel.	O
TS	O
activated	O
HSF	protein
,	O
which	O
was	O
associated	O
with	O
Hsp70	protein
overexpression	O
and	O
inhibition	O
of	O
NFkappaB	protein
binding	O
activity	O
and	O
TNFalpha	protein
release	O
.	O
The	O
altered	O
cytokine	protein
profile	protein
observed	O
in	O
smokers	O
may	O
relate	O
to	O
an	O
HSF	protein
/	O
Hsp70	protein
-mediated	O
inhibition	O
of	O
NFkappaB	protein
activity	O
.	O
Copyright	O
1998	O
Academic	O
Press.	O

[Molecular	O
mechanism	O
of	O
cytokine	DNA
gene	DNA
expression	O
in	O
Th1	cell_line
and	O
Th2	cell_line
]	O
Upon	O
activation	O
by	O
antigens	protein
,	O
helper	cell_type
T	cell_type
cells	cell_type
differentiate	O
into	O
one	O
of	O
several	O
subsets,	O
characterized	O
by	O
their	O
distinct	O
cytokine	protein
-production	O
patterns	O
.	O
Among	O
these	O
subsets,	O
Th1	cell_line
cells	cell_line
are	O
known	O
to	O
activate	O
cellular	O
immunity	O
resulting	O
in	O
inflammatory	O
response	O
,	O
whereas	O
Th2	cell_line
cells	cell_line
induce	O
humoral	O
and	O
allergic	O
responses	O
and	O
suppress	O
inflammation	O
.	O
Th1	O
and	O
Th2	O
effector	O
functions	O
and	O
their	O
development	O
are	O
attributable	O
to	O
their	O
distinct	O
cytokine	protein
expression	O
patterns	O
.	O
Recent	O
reports	O
have	O
demonstrated	O
that	O
differential	O
expression	O
of	O
cell	O
surface	O
molecules,	O
such	O
as	O
adhesion	protein
molecule	protein
and	O
chemokine	protein
receptor	protein
,	O
is	O
involved	O
in	O
their	O
recruitment	O
into	O
target	O
tissues.	O
It	O
is,	O
therefore,	O
suggested	O
that	O
clarification	O
of	O
the	O
mechanisms	O
of	O
differential	O
gene	O
expression	O
in	O
Th1/Th2	cell_line
should	O
lead	O
to	O
rational	O
strategies	O
for	O
manipulating	O
pathological	O
immune	O
responses	O
.	O
Activation	O
of	O
helper	cell_type
T	cell_type
cells	cell_type
mediated	O
by	O
the	O
T	O
cell	O
receptor	O
induces	O
a	O
series	O
of	O
biochemical	O
events.	O
Among	O
them,	O
both	O
the	O
activation	O
of	O
PKC/Ras-	O
and	O
CaM/CN-	O
mediated	O
pathways	O
play	O
a	O
central	O
role	O
in	O
the	O
signal	O
transduction	O
of	O
cytokine	DNA
gene	DNA
expression	O
.	O
Closer	O
examination	O
using	O
non-transformed	O
murine	O
Th1	O
and	O
Th2	O
clones	O
suggested	O
that	O
a	O
balance	O
between	O
the	O
activities	O
of	O
the	O
two	O
signaling	O
pathways	O
contributes	O
to	O
cytokine	DNA
gene	DNA
expression	O
.	O
We	O
propose	O
that	O
one	O
of	O
the	O
targets	O
of	O
PGE2	O
,	O
whose	O
effect	O
distinguishes	O
Th1	cell_line
from	O
Th2	O
,	O
resides	O
in	O
the	O
downstream	O
PKC/Ras	protein
-mediated	O
pathway	O
.	O

Signalling	O
into	O
the	O
T-cell	O
nucleus	O
:	O
NFAT	protein
regulation	O
.	O
The	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NFAT	protein
)	O
plays	O
an	O
important	O
role	O
in	O
T-cell	O
biology	O
.	O
Activation	O
of	O
T	O
cells	O
results	O
in	O
the	O
rapid	O
calcineurin	protein
-dependent	O
translocation	O
of	O
NFAT	protein
transcription	protein
factors	protein
from	O
the	O
cytoplasm	O
to	O
the	O
nucleus	O
.	O
This	O
translocation	O
process	O
coupled	O
to	O
the	O
subsequent	O
active	O
maintenance	O
of	O
NFAT	protein
in	O
the	O
nucleus	O
compartment	O
is	O
critical	O
for	O
the	O
induction	O
of	O
expression	O
of	O
several	O
genes	O
encoding	O
cytokines	protein
and	O
membrane	protein
proteins	protein
that	O
modulate	O
immune	O
responses	O
.	O
The	O
molecular	O
cloning	O
of	O
the	O
NFAT	protein
family	protein
of	O
transcription	protein
factors	protein
has	O
facilitated	O
rapid	O
progress	O
in	O
the	O
understanding	O
of	O
the	O
signalling	O
mechanisms	O
that	O
control	O
the	O
activity	O
of	O
NFAT	protein
.	O

Differential	O
RNA	O
display	O
identifies	O
novel	DNA
genes	DNA
associated	O
with	O
decreased	O
vitamin	protein
D	protein
receptor	protein
expression	O
.	O
To	O
characterize	O
further	O
the	O
function	O
of	O
the	O
intracellular	protein
vitamin	protein
D	protein
receptor	protein
(	O
VDR	protein
),	O
we	O
have	O
developed	O
stable	cell_line
transfectant	cell_line
variants	cell_line
of	O
a	O
vitamin	cell_line
D-responsive	cell_line
cell	cell_line
line	cell_line
(	O
U937	cell_line
)	O
which	O
express	O
either	O
decreased	O
or	O
increased	O
numbers	O
of	O
VDR	protein
.	O
In	O
this	O
study	O
we	O
have	O
analyzed	O
changes	O
in	O
gene	O
expression	O
associated	O
with	O
this	O
variable	O
VDR	protein
expression	O
.	O
Initial	O
experiments	O
indicated	O
that	O
a	O
50%	O
decrease	O
in	O
VDR	protein
levels	O
was	O
associated	O
with	O
a	O
2-fold	O
increase	O
in	O
cell	O
proliferation	O
and	O
a	O
similar	O
rise	O
in	O
c-myc	RNA
mRNA	RNA
expression	O
.	O
Further	O
studies	O
were	O
carried	O
out	O
using	O
differential	O
RNA	O
display	O
(	O
DD	O
).	O
Sequence	O
analysis	O
of	O
DD	protein
products	protein
revealed	O
two	O
cDNAs	DNA
with	O
identity	O
to	O
known	protein
gene	protein
products	protein
:	O
the	O
catalytic	protein
sub-unit	protein
of	protein
DNA-protein	protein
kinase	protein
(	O
DNA-PK(CS)	protein
),	O
and	O
the	O
peroxisomal	protein
enzyme	protein
17beta-hydroxysteroid	protein
dehydrogenase	protein
type	protein
IV	protein
(	O
17beta-HSD	protein
IV	protein
).	O
Northern	O
analysis	O
confirmed	O
that	O
expression	O
of	O
both	O
mRNAs	RNA
was	O
reduced	O
in	O
cells	O
with	O
decreased	O
numbers	O
of	O
VDR	protein
.	O
Down-regulation	O
of	O
17beta-HSD	protein
IV	protein
mRNA	O
expression	O
was	O
associated	O
with	O
enhanced	O
estradiol	O
inactivation	O
by	O
U937	cell_line
cells	cell_line
,	O
suggesting	O
a	O
link	O
between	O
estrogenic	O
pathways	O
and	O
cell	O
proliferation	O
.	O
Further	O
Northern	O
analyses	O
indicated	O
that	O
there	O
was	O
no	O
significant	O
change	O
in	O
17beta-HSD	protein
IV	protein
or	O
DNA-PK(CS)	RNA
mRNA	RNA
levels	O
following	O
treatment	O
with	O
1,25(OH)2D3	O
,	O
although	O
expression	O
of	O
both	O
genes	O
varied	O
with	O
changes	O
in	O
cell	O
proliferation.	O
These	O
data	O
suggest	O
that,	O
in	O
addition	O
to	O
its	O
established	O
role	O
as	O
a	O
hormone-dependent	protein
trans-activator	protein
,	O
VDR	protein
may	O
influence	O
gene	O
expression	O
by	O
ligand-independent	O
mechanisms	O
.	O

Prostaglandin	O
E2	O
Up-regulates	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
-driven	O
gene	O
activity	O
in	O
T	cell_type
cells	cell_type
via	O
NF-kappaB	O
-dependent	O
and	O
-independent	O
signaling	O
pathways	O
.	O
Replication	O
of	O
human	O
immunodeficiency	O
virus	O
type-1	O
(	O
HIV-1	O
)	O
is	O
highly	O
dependent	O
on	O
the	O
state	O
of	O
activation	O
of	O
the	O
infected	cell_type
cells	cell_type
and	O
is	O
modulated	O
by	O
interactions	O
between	O
viral	O
and	O
host	O
cellular	O
factors	O
.	O
Prostaglandin	O
E2	O
(	O
PGE2	O
),	O
a	O
pleiotropic	protein
immunomodulatory	protein
molecule	protein
,	O
is	O
observed	O
at	O
elevated	O
levels	O
during	O
HIV-1	O
infection	O
as	O
well	O
as	O
during	O
the	O
course	O
of	O
other	O
pathogenic	O
infections.	O
In	O
1G5	cell_line
,	O
a	O
Jurkat-derived	cell_line
T	cell_line
cell	cell_line
line	cell_line
stably	O
transfected	O
with	O
a	O
luciferase	DNA
gene	DNA
driven	O
by	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
),	O
we	O
found	O
that	O
PGE2	O
markedly	O
enhanced	O
HIV-1	DNA
LTR	DNA
-mediated	O
reporter	DNA
gene	DNA
activity	O
.	O
Experiments	O
have	O
been	O
conducted	O
to	O
identify	O
second	protein
messengers	protein
involved	O
in	O
this	O
PGE2	O
-dependent	O
up-regulating	O
effect	O
on	O
the	O
regulatory	O
element	O
of	O
HIV-1	O
.	O
In	O
this	O
study,	O
we	O
present	O
evidence	O
indicating	O
that	O
signal	O
transduction	O
pathways	O
induced	O
by	O
PGE2	O
necessitate	O
the	O
participation	O
of	O
cyclic	O
AMP	O
,	O
protein	protein
kinase	protein
A	protein
,	O
and	O
Ca2+	O
.	O
Experiments	O
conducted	O
with	O
different	O
HIV-1	DNA
LTR	DNA
-based	DNA
vectors	DNA
suggested	O
that	O
PGE2	O
-mediated	O
activation	O
effect	O
on	O
HIV-1	O
transcription	O
was	O
transduced	O
via	O
both	O
NF-kappaB	O
-dependent	O
and	O
-independent	O
signaling	O
pathways	O
.	O
The	O
involvement	O
of	O
NF-kappaB	protein
in	O
the	O
PGE2	O
-dependent	O
activating	O
effect	O
on	O
HIV-1	O
transcription	O
was	O
further	O
confirmed	O
using	O
a	O
kappaB-regulated	DNA
luciferase	DNA
encoding	DNA
vector	DNA
and	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O
Results	O
from	O
Northern	O
blot	O
and	O
flow	O
cytometric	O
analyses	O
,	O
as	O
well	O
as	O
the	O
use	O
of	O
a	O
selective	O
antagonist	O
indicated	O
that	O
PGE2	O
modulation	O
of	O
HIV-1	DNA
LTR	DNA
-driven	O
reporter	DNA
gene	DNA
activity	O
in	O
studied	O
T	cell_type
lymphoid	cell_type
cells	cell_type
is	O
transduced	O
via	O
the	O
EP4	protein
receptor	protein
subtype	protein
.	O
These	O
results	O
suggest	O
that	O
secretion	O
of	O
PGE2	O
by	O
macrophages	cell_type
in	O
response	O
to	O
infection	O
or	O
inflammatory	O
activators	O
could	O
induce	O
signaling	O
events	O
resulting	O
in	O
activation	O
of	O
proviral	O
DNA	O
present	O
into	O
T	cell_type
cells	cell_type
latently	O
infected	O
with	O
HIV-1	O
.	O

Activation	O
of	O
distinct	O
transcription	protein
factors	protein
in	O
neutrophils	cell_type
by	O
bacterial	O
LPS	O
,	O
interferon-gamma	protein
,	O
and	O
GM-CSF	protein
and	O
the	O
necessity	O
to	O
overcome	O
the	O
action	O
of	O
endogenous	protein
proteases	protein
.	O
Human	O
neutrophils	cell_type
can	O
be	O
induced	O
to	O
actively	O
transcribe	O
a	O
number	O
of	O
early-response	DNA
genes	DNA
,	O
in	O
particular	O
those	O
encoding	O
cytokines	protein
,	O
chemokines	protein
,	O
and	O
the	O
high-affinity	O
surface	O
receptor	O
for	O
IgG	protein
,	O
FcgammaRI	protein
.	O
Although	O
little	O
is	O
known	O
to	O
date	O
about	O
the	O
regulation	O
of	O
gene	O
transcription	O
in	O
neutrophils	cell_type
,	O
several	O
indications	O
point	O
to	O
a	O
role	O
for	O
distinct	O
transcription	protein
factors	protein
,	O
such	O
as	O
members	O
of	O
the	O
NF-kappaB	protein
and	O
STAT	protein
families	protein
.	O
In	O
this	O
study,	O
we	O
investigated	O
whether	O
these	O
transcription	protein
factors	protein
become	O
activated	O
under	O
stimulatory	O
conditions	O
which	O
are	O
known	O
to	O
induce	O
gene	O
transcription	O
in	O
neutrophils	cell_type
.	O
Unexpectedly,	O
we	O
found	O
that	O
conventional	O
procedures	O
employed	O
to	O
prepare	O
cellular	O
extracts	O
cause	O
the	O
release	O
of	O
proteolytic	O
activities	O
that	O
are	O
normally	O
stored	O
in	O
intracellular	O
granules	O
,	O
resulting	O
in	O
the	O
degradation	O
of	O
various	O
NF-kappaB	protein
/Rel	protein
and	O
STAT	protein
proteins	protein
.	O
To	O
circumvent	O
this	O
problem,	O
we	O
developed	O
an	O
alternative	O
procedure	O
which	O
allowed	O
us	O
to	O
show	O
that	O
in	O
neutrophils	cell_type
,	O
LPS	O
and	O
TNFalpha	protein
induce	O
a	O
NF-kappaB	protein
DNA-binding	O
activity	O
which	O
essentially	O
consists	O
of	O
p50/RelA	protein
dimers	protein
,	O
and	O
that	O
IFNgamma	protein
promotes	O
the	O
binding	O
of	O
STAT1	protein
homodimers	protein
to	O
the	O
IFNgamma	DNA
response	DNA
region	DNA
of	O
the	O
FcgammaRI	DNA
promoter	DNA
.	O
Moreover,	O
we	O
report	O
that	O
neutrophil	O
stimulation	O
with	O
GM-CSF	protein
results	O
in	O
the	O
formation	O
of	O
a	O
STAT5	protein
-containing	O
DNA-binding	O
activity	O
.	O
Collectively,	O
the	O
current	O
findings	O
open	O
new	O
perspectives	O
about	O
mechanisms	O
that	O
are	O
likely	O
to	O
regulate	O
gene	O
transcription	O
in	O
neutrophils	cell_type
.	O
In	O
addition,	O
the	O
procedure	O
described	O
herein	O
could	O
prove	O
useful	O
in	O
other	O
cell	O
types	O
that	O
express	O
high	O
levels	O
of	O
endogenous	protein
proteases	protein
.	O

Low	O
CD3+CD28-induced	O
interleukin-2	protein
production	O
correlates	O
with	O
decreased	O
reactive	O
oxygen	O
intermediate	O
formation	O
in	O
neonatal	cell_type
T	cell_type
cells	cell_type
.	O
The	O
capacity	O
of	O
neonatal	cell_type
T	cell_type
cells	cell_type
to	O
secrete	O
interleukin-2	protein
(	O
IL-2	protein
)	O
has	O
been	O
reported	O
to	O
be	O
variable.	O
We	O
analysed	O
IL-2	protein
production	O
in	O
purified	O
neonatal	O
and	O
adult	O
T	O
cells	O
using	O
polyclonal	O
activator	O
phorbol	O
ester	O
+	O
calcium	O
ionophore	O
(	O
PDBu	O
+	O
iono	O
)	O
or	O
receptor-mediated	O
anti-CD3	protein
/anti-CD3+	O
anti-CD28	protein
stimulation	O
.	O
PDBu	O
+	O
iono	O
induced	O
equally	O
high	O
IL-2	protein
levels	O
in	O
both	O
groups	O
and,	O
when	O
stimulated	O
with	O
plate-bound	O
anti-CD3	protein
monoclonal	protein
antibody	protein
(	O
mAb	protein
),	O
the	O
IL-2	protein
secretion	O
by	O
neonatal	cell_type
cells	cell_type
was	O
undetectable	O
and	O
adult	cell_type
cells	cell_type
produced	O
low	O
amounts	O
of	O
IL-2	protein
(mean	O
331	O
+/-	O
86	O
pg/ml).	O
The	O
addition	O
of	O
anti-CD28	protein
mAb	protein
to	O
anti-CD3-stimulated	cell_line
cells	cell_line
markedly	O
increased	O
IL-2	protein
production	O
in	O
both	O
cell	O
types,	O
but	O
levels	O
of	O
IL-2	protein
in	O
neonatal	cell_type
T	cell_type
cells	cell_type
remained	O
clearly	O
lower	O
than	O
those	O
of	O
adult	cell_type
T	cell_type
cells	cell_type
(respective	O
mean	O
values:	O
385	O
+/-	O
109	O
pg/ml	O
and	O
4494	O
+/-	O
1199	O
pg/ml).	O
As	O
NF-kappa	protein
B	protein
is	O
a	O
critical	O
transcription	protein
factor	protein
in	O
the	O
control	O
of	O
IL-2	protein
expression	O
,	O
we	O
next	O
analysed	O
its	O
nuclear	O
translocation	O
in	O
neonatal	O
and	O
adult	O
T	O
cells	O
using	O
the	O
electrophoretic	O
mobility	O
shift	O
assay	O
and,	O
because	O
induction	O
of	O
reactive	O
oxygen	O
intermediates	O
(	O
ROI	O
)	O
is	O
required	O
for	O
the	O
activation	O
of	O
NF-kappa	protein
B	protein
,	O
we	O
also	O
analysed	O
levels	O
of	O
intracellular	O
ROI	O
in	O
these	O
cells	O
using	O
the	O
ROI	O
-reactive	O
fluorochrome	O
DCFH-DA	O
and	O
flow	O
cytometry	O
.	O
In	O
neonatal	cell_type
T	cell_type
cells	cell_type
NF-kappa	protein
B	protein
activation	O
and	O
ROI	O
formation	O
after	O
anti-CD3	protein
stimulation	O
were	O
low	O
compared	O
with	O
adult	cell_type
T	cell_type
cells	cell_type
and,	O
although	O
addition	O
of	O
anti-CD28	protein
mAb	protein
increased	O
induction	O
of	O
NF-kappa	protein
B	protein
and	O
ROI	O
formation	O
,	O
levels	O
similar	O
to	O
those	O
of	O
adults	O
were	O
not	O
achieved.	O
After	O
PDBu	O
+	O
iono	O
stimulation	O
,	O
the	O
cells	O
showed	O
similar	O
ROI	O
formation	O
and	O
IL-2	protein
secretion	O
.	O
Our	O
results	O
suggest	O
that	O
reduced	O
IL-2	protein
production	O
by	O
neonatal	cell_type
T	cell_type
cells	cell_type
is	O
specific	O
for	O
anti-CD3	protein
and	O
anti-CD3	protein
+	O
anti-CD28	protein
-mediated	O
stimulation	O
and	O
that	O
these	O
activators	O
cannot	O
effectively	O
activate	O
the	O
ROI	O
-NF-kappa	protein
B	protein
signalling	O
pathway	O
in	O
neonatal	cell_type
T	cell_type
cells	cell_type
.	O

CD30	protein
is	O
a	O
CD40	protein
-inducible	protein
molecule	protein
that	O
negatively	O
regulates	O
CD40	protein
-mediated	protein
immunoglobulin	protein
class	O
switching	O
in	O
non-antigen-selected	cell_line
human	cell_line
B	cell_line
cells	cell_line
.	O
We	O
used	O
our	O
monoclonal	O
model	O
of	O
germinal	O
center	O
maturation	O
,	O
CL-01	cell_type
B	cell_type
cells	cell_type
,	O
to	O
investigate	O
the	O
role	O
of	O
CD30	protein
in	O
human	O
B	O
cell	O
differentiation	O
.	O
CL-01	cell_line
cells	cell_line
are	O
IgM	protein
+	O
IgD	protein
+	O
CD30	protein
+	O
and	O
switch	O
to	O
IgG	protein
,	O
IgA	protein
,	O
and	O
IgE	protein
when	O
exposed	O
to	O
CD40L	protein
and	O
IL-4	protein
.	O
Switching	O
is	O
hampered	O
by	O
CD30	protein
coengagement	O
,	O
possibly	O
through	O
interference	O
with	O
the	O
CD40	protein
-mediated	O
NF-kappaB	protein
-dependent	O
transcriptional	O
activation	O
of	O
downstream	DNA
C(H)	DNA
genes	DNA
.	O
The	O
physiological	O
relevance	O
of	O
this	O
phenomenon	O
is	O
emphasized	O
by	O
similar	O
CD30	protein
-mediated	O
effects	O
in	O
naive	cell_type
B	cell_type
cells	cell_type
.	O
Expression	O
of	O
CD30	protein
by	O
these	O
cells	O
is	O
induced	O
by	O
CD40L	protein
but	O
is	O
inhibited	O
by	O
B	O
cell	O
receptor	O
coengagement	O
and/or	O
exposure	O
to	O
IL-6	protein
and	O
IL-12	protein
.	O
Our	O
data	O
suggest	O
that	O
CD30	protein
critically	O
regulates	O
the	O
CD40	protein
-mediated	O
differentiation	O
of	O
non-antigen-selected	cell_line
human	cell_line
B	cell_line
cells	cell_line
.	O

Calcineurin	protein
and	O
the	O
biological	O
effect	O
of	O
cyclosporine	O
and	O
tacrolimus	O
.	O
The	O
mechanism	O
of	O
the	O
immunosuppressive	O
effect	O
of	O
CyA	O
and	O
FK	O
506	O
can	O
be	O
monitored	O
in	O
vivo	O
in	O
humans	O
.	O
The	O
picture	O
emerging	O
is	O
of	O
a	O
close	O
relationship	O
between	O
drug	O
concentrations	O
and	O
CN	O
inhibition	O
.	O
But	O
many	O
puzzles	O
of	O
the	O
drugs	O
remain.	O
What	O
is	O
the	O
role	O
of	O
CyA	O
in	O
the	O
activation	O
of	O
transforming	protein
growth	protein
factor-beta	protein
(	O
TGF-beta	protein
),	O
particularly	O
in	O
relationship	O
to	O
nephrotoxicity	O
and	O
fibrogenesis	O
?	O
How	O
important	O
are	O
the	O
anti-inflammatory	O
(non	O
T)	O
effects	O
of	O
CyA	O
,	O
and	O
which	O
cells	O
do	O
they	O
operate	O
in?	O
Are	O
there	O
effects	O
of	O
CyA	O
and	O
FK	O
506	O
all	O
attributable	O
to	O
CN	O
inhibition	O
,	O
and	O
how	O
much	O
of	O
them	O
are	O
mediated	O
through	O
the	O
NFATC	protein
family	protein
of	O
transcription	protein
factors	protein
?	O
Finally,	O
it	O
would	O
be	O
useful	O
to	O
know	O
what	O
the	O
inhibitory	O
effects	O
of	O
CyA	O
are	O
on	O
tolerance	O
and	O
negative	O
regulatory	O
events	O
.	O

Stimulation	O
of	O
B	O
and	O
T	O
cells	O
activates	O
expression	O
of	O
transcription	O
and	O
differentiation	O
factors	O
.	O
During	O
B	O
and	O
T	O
cell	O
differentiation	O
and	O
proliferation	O
many	O
genes	O
are	O
induced	O
or	O
repressed	O
while	O
certain	O
genes	O
are	O
constitutively	O
expressed.	O
To	O
investigate	O
processes	O
related	O
to	O
B	O
and	O
T	O
cell	O
activation	O
,	O
the	O
gene	O
expression	O
of	O
stimulated	O
and	O
nonstimulated	O
Ramos	O
and	O
Jurkat	O
cells	O
was	O
studied	O
using	O
cDNA	O
microarray	O
technology	O
.	O
Simultaneous	O
analysis	O
of	O
close	O
to	O
600	DNA
genes	DNA
indicated	O
highest	O
increase	O
in	O
the	O
expression	O
of	O
certain	O
transcription	O
,	O
differentiation	O
and	O
proliferation	O
factors	O
.	O
Many	O
of	O
these	O
genes	O
have	O
not	O
previously	O
been	O
shown	O
to	O
funcion	O
in	O
the	O
stimulated	cell_type
lymphocytes	cell_type
.	O
Also	O
genes	O
encoding	O
proteins	O
involved	O
in	O
DNA	O
replication	O
,	O
binding,	O
transcription	O
and	O
translation	O
were	O
induced.	O
Large	O
part	O
of	O
the	O
activated	DNA
genes	DNA
were	O
under	O
very	O
stringent	O
regulation	O
being	O
expressed	O
only	O
after	O
stimulation.	O
The	O
mechanism	O
and	O
function	O
of	O
the	O
expressed	DNA
genes	DNA
during	O
lymphocyte	O
differentiation	O
and	O
in	O
disorders	O
is	O
discussed.	O

Interleukin	O
2	O
and	O
15	O
activate	O
Stat3alpha	protein
in	O
human	cell_type
T	cell_type
lymphocytes	cell_type
.	O
Signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
3	protein
(	O
Stat3	protein
)	O
has	O
recently	O
been	O
shown	O
to	O
exist	O
in	O
two	O
alternatively	O
spliced	O
isoforms,	O
a	O
short	O
form,	O
Stat3beta	protein
,	O
and	O
a	O
longer	O
form,	O
Stat3alpha	protein
,	O
displaying	O
differences	O
in	O
transcriptional	O
activity	O
.	O
It	O
is	O
unknown	O
which	O
Stat3	protein
isoform	protein
(s)	O
is	O
activated	O
in	O
response	O
to	O
interleukin	protein
(IL)-2	protein
and	O
IL-15	protein
.	O
Here,	O
cytokine	protein
-induced	O
activation	O
of	O
Stat3	protein
in	O
previously	O
activated	O
CD4(+)	cell_type
human	cell_type
T	cell_type
cells	cell_type
was	O
examined	O
using	O
Stat3	protein
antibodies	O
directed	O
against	O
different	O
regions	O
of	O
Stat3	protein
.	O
As	O
determined	O
by	O
tyrosine	O
phosphorylation,	O
nuclear	O
translocation	O
and	O
binding	O
to	O
an	O
hSIE-oligonucleotide	O
probe	O
,	O
IL-2	protein
and	O
IL-15	protein
activated	O
the	O
slowly	O
migrating	O
isoform,	O
Stat3alpha	protein
.	O
In	O
contrast,	O
minimal	O
or	O
no	O
activation	O
of	O
Stat3beta	protein
was	O
observed,	O
suggesting	O
that	O
IL-2	protein
and	O
IL-15	protein
predominantly	O
activate	O
Stat3alpha	protein
in	O
human	cell_type
CD4(+)	cell_type
T	cell_type
cells	cell_type
.	O
In	O
this	O
way,	O
diversity	O
in	O
the	O
expression	O
and	O
activation	O
of	O
Stat3	protein
proteins	protein
may	O
provide	O
additional	O
means	O
of	O
regulating	O
cytokine	protein
-induced	O
T	O
cell	O
responses	O
.	O
Copyright	O
1998	O
Academic	O
Press.	O

Transcriptional	O
regulation	O
of	O
lysosomal	protein
acid	protein
lipase	protein
in	O
differentiating	O
monocytes	O
is	O
mediated	O
by	O
transcription	protein
factors	protein
Sp1	protein
and	O
AP-2	protein
.	O
Human	O
lysosomal	protein
acid	protein
lipase	protein
(	O
LAL	protein
)	O
is	O
a	O
hydrolase	protein
required	O
for	O
the	O
cleavage	O
of	O
cholesteryl	O
esters	O
and	O
triglycerides	O
derived	O
from	O
plasma	O
lipoproteins.	O
It	O
is	O
shown	O
here	O
that	O
during	O
monocyte	O
to	O
macrophage	O
differentiation,	O
the	O
expression	O
of	O
LAL	RNA
-mRNA	RNA
is	O
induced.	O
This	O
induction	O
is	O
dependent	O
on	O
protein	protein
kinase	protein
C	protein
activity	O
and	O
protein	O
synthesis.	O
The	O
cell	O
type-specific	O
increase	O
in	O
LAL	protein
expression	O
is	O
further	O
investigated	O
in	O
the	O
THP-1	cell_line
cell	cell_line
line	cell_line
with	O
respect	O
to	O
transcriptional	O
regulation	O
.	O
The	O
human	cell_line
monocytic	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
THP-1	cell_line
differentiates	O
into	O
macrophage-like	cell_type
cells	cell_type
when	O
treated	O
with	O
phorbol	O
esters.	O
In	O
order	O
to	O
determine	O
the	O
cis-acting	DNA
elements	DNA
necessary	O
for	O
both	O
basal	O
and	O
phorbol	O
12-myristate-13	O
acetate	O
(	O
PMA	O
)-enhanced	O
promoter	O
activity	O
,	O
we	O
performed	O
deletion	O
analysis	O
and	O
reporter	DNA
gene	DNA
assays	O
.	O
A	O
PMA	DNA
responsive	DNA
element	DNA
has	O
been	O
identified	O
between	O
-182	DNA
bp	DNA
and	O
-107	DNA
bp	DNA
upstream	O
of	O
the	O
major	DNA
transcription	DNA
start	DNA
site	DNA
.	O
Gel	O
mobility	O
shift	O
assays	O
demonstrated	O
that	O
binding	O
of	O
Sp1	protein
and	O
AP-2	protein
to	O
the	O
LAL	DNA
promoter	DNA
is	O
increased	O
by	O
PMA	O
in	O
THP-1	cell_line
cells	cell_line
.	O
Co-transfections	O
with	O
expression	DNA
plasmids	DNA
for	O
Sp1	protein
and	O
AP-2	protein
further	O
emphasized	O
the	O
important	O
role	O
of	O
these	O
transcription	protein
factors	protein
in	O
both	O
basal	O
and	O
PMA	O
-enhanced	O
LAL	protein
expression	O
.	O
Our	O
data	O
suggest	O
that	O
differentiation	O
dependent	O
increase	O
of	O
lysosomal	protein
acid	protein
lipase	protein
(	O
LAL	protein
)	O
expression	O
in	O
THP-1	cell_line
cells	cell_line
is	O
mediated	O
by	O
a	O
concerted	O
action	O
of	O
Sp1	protein
and	O
AP-2	protein
.	O

Relationship	O
between	O
IkappaBalpha	protein
constitutive	O
expression	O
,	O
TNFalpha	protein
synthesis	O
,	O
and	O
apoptosis	O
in	O
EBV-infected	cell_type
lymphoblastoid	cell_type
cells	cell_type
.	O
In	O
order	O
to	O
understand	O
the	O
role	O
of	O
NF-kappaB	protein
in	O
EBV	O
transformation	O
we	O
have	O
established	O
stably	O
transfected	O
IkappaBalpha	protein
into	O
lymphoblastoid	cell_type
cells	cell_type
.	O
Two	O
clones	O
were	O
obtained	O
in	O
which	O
the	O
loss	O
of	O
NF-kappaB	protein
binding	O
activity	O
correlated	O
with	O
the	O
constitutive	O
expression	O
of	O
the	O
transgenic	O
IkappaBalpha	protein
.	O
Protein	O
latency	O
expression	O
was	O
determined	O
by	O
immunocytochemistry	O
.	O
Expression	O
of	O
surface	O
markers,	O
intracytoplasmic	O
content	O
of	O
cytokines	protein
cell	O
cycle	O
analysis	O
after	O
BrdU	protein
incorporation	O
and	O
DNA	O
staining	O
with	O
propidium	O
iodide	O
were	O
studied	O
by	O
flow	O
cytometry	O
.	O
Percentage	O
of	O
apoptotic	cell_type
cells	cell_type
was	O
determined	O
by	O
in-situ	O
labelling	O
of	O
DNA	O
strand	O
breaks.	O
No	O
significative	O
changes	O
in	O
EBV	O
latency	O
nor	O
in	O
cell	O
surface	O
marker	O
expression	O
was	O
found.	O
In	O
contrast,	O
intracytoplasmic	O
TNFalpha	protein
levels	O
were	O
strongly	O
reduced	O
in	O
transfected	cell_line
clones	cell_line
.	O
Furthermore,	O
30%	O
of	O
IkappaBalpha	cell_line
transfected	cell_line
cells	cell_line
were	O
apoptotic	O
after	O
8	O
h	O
of	O
TNFalpha	protein
treatment	O
.	O
This	O
correlated	O
with	O
a	O
strong	O
reduction	O
of	O
BrdU	O
incorporation	O
after	O
24	O
h	O
of	O
TNFalpha	protein
treatment	O
.	O
No	O
effect	O
was	O
seen	O
with	O
non	O
transfected	cell_line
cells	cell_line
or	O
with	O
cells	O
transfected	O
with	O
a	O
control	O
plasmid.	O
Our	O
results	O
suggest	O
that	O
the	O
TNFalpha	DNA
gene	DNA
could	O
be	O
one	O
of	O
the	O
targets	O
of	O
NF-kappaB	protein
in	O
EBV	O
infected	O
cells	O
and	O
that	O
NF-kappaB	cell_type
protects	cell_type
EBV	cell_type
-infected	cell_type
cells	cell_type
from	O
apoptosis	O
induced	O
by	O
TNFalpha	protein
,	O
which	O
may	O
favour	O
the	O
proliferative	O
effect	O
of	O
this	O
cytokine	protein
.	O

Seminoma	O
in	O
a	O
postmenopausal	O
woman	O
with	O
a	O
Y;15	DNA
translocation	DNA
in	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
and	O
a	O
t(Y;15)/45,X	O
Turner	O
mosaic	O
pattern	O
in	O
skin	cell_type
fibroblasts	cell_type
.	O
We	O
report	O
an	O
unusual	O
case	O
of	O
a	O
55	O
year	O
old	O
Japanese	O
woman	O
with	O
a	O
seminoma	O
but	O
relatively	O
normal	O
menses	O
.	O
The	O
patient	O
was	O
a	O
phenotypic	O
female	O
with	O
late	O
onset	O
menarche	O
(18	O
years	O
of	O
age),	O
who	O
was	O
amenorrhoeic	O
for	O
the	O
first	O
year,	O
followed	O
by	O
menses	O
of	O
one	O
to	O
three	O
days'	O
slight	O
flow	O
with	O
dysmenorrhoea	O
,	O
but	O
an	O
otherwise	O
normal	O
menstrual	O
history.	O
A	O
typical	O
seminoma	O
was	O
removed	O
from	O
the	O
left	O
adnexal	O
region	O
and	O
an	O
immature	O
testis	O
was	O
identified	O
separately	O
as	O
an	O
associated	O
right	O
adnexal	O
mass	O
.	O
Repeated	O
karyotypic	O
studies	O
on	O
peripheral	cell_type
blood	cell_type
lymphocyte	cell_type
cultures	cell_type
showed	O
only	O
46,X,-Y,t(Y;15)(q12;p13)	O
.	O
Cytogenetic	O
examination	O
of	O
the	O
patient's	O
younger	O
brother,	O
who	O
had	O
fathered	O
three	O
healthy	O
children	O
,	O
showed	O
an	O
identical	O
karyotype	O
.	O
Mosaicism	O
of	O
46,X,-Y,t(Y;15)(q12;p13)/45,X	cell_line
cell	cell_line
lines	cell_line
was	O
found	O
in	O
skin	O
samples	O
from	O
the	O
patient's	O
elbow	O
and	O
genital	O
regions	O
,	O
although	O
there	O
were	O
no	O
clinical	O
stigmata	O
of	O
Turner	O
syndrome	O
.	O
An	O
androgen	O
receptor	O
binding	O
assay	O
of	O
cultured	cell_line
genital	cell_line
skin	cell_line
fibroblasts	cell_line
was	O
negative.	O
Molecular	O
analysis	O
using	O
Southern	O
blot	O
hybridisation	O
,	O
PCR	O
,	O
and	O
direct	O
DNA	O
sequencing	O
showed	O
that	O
neither	O
the	O
patient	O
nor	O
her	O
brother	O
had	O
a	O
detectable	O
deletion	O
or	O
other	O
abnormalities	O
of	O
Y	O
chromosome	O
sequences	O
,	O
including	O
the	O
SRY	DNA
(sex	DNA
determining	DNA
region	DNA
of	DNA
the	DNA
Y	DNA
chromosome)	DNA
gene	DNA
sequence	DNA
.	O
These	O
findings	O
suggest	O
that	O
Turner	O
mosaicism	O
of	O
the	O
45,X	cell_line
cell	cell_line
line	cell_line
may	O
have	O
contributed	O
to	O
this	O
atypical	O
presentation	O
in	O
an	O
XY	O
female	O
,	O
although	O
we	O
cannot	O
exclude	O
abnormalities	O
of	O
other	O
genes	O
related	O
to	O
sex	O
differentiation	O
.	O

Potent	O
inhibition	O
of	O
HIV	O
type	O
1	O
replication	O
by	O
an	O
antiinflammatory	O
alkaloid	O
,	O
cepharanthine	O
,	O
in	O
chronically	cell_type
infected	cell_type
monocytic	cell_type
cells	cell_type
.	O
Cepharanthine	O
is	O
a	O
biscoclaurine	O
alkaloid	O
isolated	O
from	O
Stephania	O
cepharantha	O
Hayata	O
and	O
has	O
been	O
shown	O
to	O
have	O
antiinflammatory,	O
antiallergic,	O
and	O
immunomodulatory	O
activities	O
in	O
vivo.	O
As	O
several	O
inflammatory	protein
cytokines	protein
and	O
oxidative	O
stresses	O
are	O
involved	O
in	O
the	O
pathogenesis	O
of	O
HIV-1	O
infection	O
,	O
we	O
investigated	O
the	O
inhibitory	O
effects	O
of	O
cepharanthine	O
on	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNF-alpha	protein
)-	O
and	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)-	O
induced	O
HIV-1	O
replication	O
in	O
chronically	cell_line
infected	cell_line
cell	cell_line
lines	cell_line
.	O
Two	O
chronically	cell_line
HIV-1	cell_line
-infected	cell_line
cell	cell_line
lines	cell_line
,	O
U1	cell_line
(monocytic)	O
and	O
ACH-2	cell_line
(T	O
lymphocytic),	O
were	O
stimulated	O
with	O
TNF-alpha	protein
or	O
PMA	O
and	O
cultured	O
in	O
the	O
presence	O
of	O
various	O
concentrations	O
of	O
the	O
compound.	O
HIV-1	O
replication	O
was	O
determined	O
by	O
p24	protein
antigen	protein
level	O
.	O
The	O
inhibitory	O
effects	O
of	O
cepharanthine	O
on	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)-driven	O
gene	O
expression	O
and	O
nuclear	protein
factor	protein
kappaB	protein
(	O
NF-kappaB	protein
)	O
activation	O
were	O
also	O
examined.	O
Cepharanthine	O
dose	O
dependently	O
inhibited	O
HIV-1	O
replication	O
in	O
TNF-alpha-	O
and	O
PMA-	O
stimulated	O
U1	O
cells	O
but	O
not	O
in	O
ACH-2	cell_line
cells	cell_line
.	O
Its	O
50%	O
effective	O
and	O
cytotoxic	O
concentrations	O
were	O
0.016	O
and	O
2.2	O
microg/ml	O
in	O
PMA	cell_line
-stimulated	cell_line
U1	cell_line
cells	cell_line
,	O
respectively.	O
Cepharanthine	O
was	O
found	O
to	O
suppress	O
HIV-1	DNA
LTR	DNA
-driven	O
gene	O
expression	O
through	O
the	O
inhibition	O
of	O
NF-kappaB	protein
activation	O
.	O
These	O
results	O
indicate	O
that	O
cepharanthine	O
is	O
a	O
highly	O
potent	O
inhibitor	O
of	O
HIV-1	O
replication	O
in	O
a	O
chronically	cell_line
infected	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
.	O
Since	O
biscoclaurine	O
alkaloids	O
,	O
containing	O
cepharanthine	O
as	O
a	O
major	O
component,	O
are	O
widely	O
used	O
for	O
the	O
treatment	O
of	O
patients	O
with	O
various	O
inflammatory	O
diseases	O
in	O
Japan,	O
cepharanthine	O
should	O
be	O
further	O
pursued	O
for	O
its	O
chemotherapeutic	O
potential	O
in	O
HIV-1	O
-infected	O
patients	O
.	O

NF-kappaB	protein
only	O
partially	O
mediates	O
Epstein-Barr	protein
virus	protein
latent	protein
membrane	protein
protein	protein
1	protein
activation	O
of	O
B	O
cells.	O
The	O
latent	protein
membrane	protein
protein	protein
1	protein
(	O
LMP1	protein
)	O
of	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
is	O
required	O
for	O
EBV	O
-induced	O
immortalization	O
of	O
human	cell_type
B	cell_type
cells	cell_type
and	O
causes	O
tumorigenic	O
transformation	O
of	O
cell	cell_line
lines	cell_line
.	O
LMP1	protein
expression	O
induces	O
phenotypic	O
changes	O
resembling	O
B	O
cell	O
activation	O
,	O
such	O
as	O
cell	O
size	O
increase	O
and	O
up-regulation	O
of	O
cell	protein
surface	protein
activation	protein
markers	protein
.	O
LMP1	protein
contains	O
two	O
domains	O
that	O
activate	O
the	O
transcription	protein
factor	protein
NF-kappaB	protein
,	O
one	O
through	O
interactions	O
with	O
TRAF	protein
proteins	protein
and	O
the	O
other	O
with	O
the	O
TRADD	protein
protein	protein
.	O
The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
importance	O
of	O
NF-kappaB	protein
induction	O
in	O
the	O
up-regulation	O
of	O
the	O
B	O
cell	O
activation	O
markers	O
ICAM-1	protein
and	O
CD71	protein
by	O
LMP1	protein
.	O
This	O
study	O
shows	O
that	O
expression	O
of	O
LMP1	protein
activates	O
transcription	O
from	O
p50/p65-	O
and	O
c-Rel-	O
responsive	O
promoters	O
,	O
and	O
that	O
this	O
activity	O
can	O
be	O
completely	O
inhibited	O
by	O
expression	O
of	O
a	O
dominant	O
inhibitory	protein
IkappaB	protein
mutant	protein
.	O
ICAM-1	protein
and	O
CD71	protein
are	O
nevertheless	O
up-regulated	O
by	O
LMP1	protein
in	O
primary	cell_type
B	cell_type
cells	cell_type
and	O
cell	O
lines	O
expressing	O
the	O
dominant	protein
IkappaB	protein
.	O
Furthermore,	O
LMP1	protein
-induced	O
cell	O
size	O
increase	O
of	O
primary	cell_type
B	cell_type
cells	cell_type
was	O
unaffected	O
by	O
IkappaB	protein
expression	O
.	O
It	O
was	O
concluded	O
that	O
even	O
when	O
LMP1	protein
is	O
unable	O
to	O
activate	O
NF-kappaB	protein
,	O
it	O
is	O
still	O
capable	O
of	O
inducing	O
certain	O
characteristics	O
of	O
activated	cell_type
B	cell_type
cells	cell_type
,	O
strongly	O
suggesting	O
that	O
LMP1	protein
can	O
also	O
activate	O
cells	O
independently	O
of	O
NF-kappaB	protein
.	O

Models	O
of	O
lineage	O
switching	O
in	O
hematopoietic	O
development	O
:	O
a	O
new	O
myeloid-committed	cell_line
eosinophil	cell_line
cell	cell_line
line	cell_line
(	O
YJ	cell_line
)	O
demonstrates	O
trilineage	O
potential	O
.	O
A	O
new	O
human	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
with	O
an	O
eosinophilic	O
phenotype	O
,	O
designated	O
YJ	cell_line
,	O
was	O
established	O
from	O
the	O
peripheral	cell_type
blood	cell_type
cells	cell_type
of	O
a	O
patient	O
with	O
chronic	O
myelomonocytic	O
leukemia	O
(	O
CMMoL	O
)	O
with	O
eosinophilia	O
.	O
When	O
cultured	O
in	O
RPMI	O
1640	O
medium	O
containing	O
10%	O
fetal	O
bovine	O
serum	O
,	O
most	O
YJ	cell_line
cells	cell_line
were	O
myeloblastoid	O
with	O
a	O
small	O
number	O
of	O
the	O
cells	O
having	O
eosinophilic	O
granules	O
.	O
Cell	protein
surface	protein
markers	protein
in	O
the	O
YJ	cell_line
cells	cell_line
were	O
positive	O
for	O
CD33	protein
and	O
were	O
negative	O
for	O
CD34	protein
,	O
CD16	protein
and	O
CD23	protein
.	O
The	O
eosinophilic	O
characteristics	O
of	O
YJ	cell_line
cells	cell_line
were	O
confirmed	O
by	O
histochemical	O
staining	O
with	O
Fast-Green/Neutral-Red	O
and	O
by	O
the	O
expression	O
of	O
mRNAs	RNA
for	O
eosinophil-associated	protein
granule	protein
proteins	protein
,	O
eosinophil	protein
cationic	protein
protein	protein
(	O
ECP	protein
),	O
eosinophil-derived	protein
neurotoxin	protein
(	O
EDN	protein
),	O
eosinophil	protein
peroxidase	protein
(	O
EPO	protein
),	O
and	O
major	protein
basic	protein
protein	protein
(	O
MBP	protein
),	O
and	O
for	O
the	O
Charcot-Leyden	protein
crystal	protein
(CLC)	protein
protein	protein
.	O
The	O
YJ	cell_line
cells	cell_line
could	O
be	O
induced	O
towards	O
monocytic	O
differentiation	O
by	O
stimulation	O
with	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
).	O
The	O
monocytic	O
characteristics	O
of	O
YJ	cell_line
cells	cell_line
treated	O
with	O
PMA	O
were	O
confirmed	O
by	O
morphological	O
analysis	O
with	O
alpha-naphthyl	O
butyrate	O
esterase	O
staining	O
,	O
by	O
CD14	protein
expression	O
,	O
and	O
by	O
increased	O
expression	O
of	O
Egr-1	RNA
mRNA	RNA
.	O
Furthermore,	O
YJ	cell_line
cells	cell_line
could	O
be	O
differentiated	O
towards	O
the	O
neutrophil	cell_type
lineage	cell_type
by	O
stimulation	O
with	O
all-trans	O
retinoic	O
acid	O
(	O
RA	O
).	O
YJ	cell_line
cells	cell_line
treated	O
in	O
vitro	O
with	O
2	O
microM	O
RA	O
differentiated	O
into	O
metamyelocytes	cell_type
and	O
band	cell_type
neutrophils	cell_type
,	O
and	O
increased	O
the	O
number	O
of	O
nitroblue	cell_line
tetrazolium	cell_line
(NBT)-positive	cell_line
cells	cell_line
and	O
increased	O
gp91phox	RNA
mRNA	RNA
expression	O
.	O
Thus,	O
the	O
YJ	cell_line
cell	cell_line
line	cell_line
exhibited	O
eosinophilic	O
characteristics	O
,	O
but	O
was	O
able	O
to	O
differentiate	O
to	O
the	O
monocytic	O
or	O
neutrophilic	O
lineages	O
in	O
response	O
to	O
PMA	O
or	O
RA	O
,	O
respectively.	O
The	O
expression	O
of	O
genes	O
for	O
transcription	protein
factors	protein
involved	O
in	O
myeloid	O
differentiation	O
was	O
evaluated	O
by	O
Northern	O
blot	O
analysis	O
.	O
Increased	O
expression	O
of	O
Egr-1	protein
was	O
observed	O
with	O
macrophage	O
differentiation	O
.	O
In	O
contrast,	O
increased	O
expressions	O
of	O
C/EBPbeta	protein
and	O
MZF-1	RNA
mRNA	RNA
occurred	O
with	O
neutrophilic	O
differentiation.	O
The	O
YJ	cell_line
cell	cell_line
line	cell_line
should	O
be	O
useful	O
for	O
elucidating	O
the	O
molecular	O
mechanisms	O
governing	O
lineage	O
switching	O
from	O
the	O
eosinophil	cell_type
to	O
monocytic	O
or	O
neutrophil	O
lineages	O
.	O

Interleukin-6	protein
production	O
in	O
hemorrhagic	O
shock	O
is	O
accompanied	O
by	O
neutrophil	O
recruitment	O
and	O
lung	O
injury	O
.	O
Hemorrhagic	O
shock	O
(	O
HS	O
)	O
initiates	O
an	O
inflammatory	O
cascade	O
that	O
includes	O
the	O
production	O
of	O
cytokines	protein
and	O
recruitment	O
of	O
neutrophils	cell_type
(	O
PMN	cell_type
)	O
and	O
may	O
progress	O
to	O
organ	O
failure	O
,	O
inducing	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O
To	O
examine	O
the	O
hypothesis	O
that	O
interleukin-6	protein
(	O
IL-6	protein
)	O
contributes	O
to	O
PMN	O
infiltration	O
and	O
lung	O
damage	O
in	O
HS	O
,	O
we	O
examined	O
the	O
lungs	O
of	O
rats	O
subjected	O
to	O
unresuscitated	O
and	O
resuscitated	O
HS	O
for	O
the	O
production	O
of	O
IL-6	protein
and	O
activation	O
of	O
Stat3	protein
.	O
Using	O
semiquantitative	O
RT-	O
PCR	O
,	O
we	O
found	O
a	O
striking	O
increase	O
in	O
IL-6	RNA
mRNA	RNA
levels	O
only	O
in	O
resuscitated	O
HS	O
,	O
with	O
peak	O
levels	O
observed	O
1	O
h	O
after	O
initiation	O
of	O
resuscitation.	O
Increased	O
IL-6	protein
protein	O
expression	O
was	O
localized	O
to	O
bronchial	O
and	O
alveolar	O
cells	O
.	O
Electrophoretic	O
mobility	O
shift	O
assay	O
of	O
protein	O
extracts	O
from	O
shock	O
lungs	O
exhibited	O
an	O
increase	O
in	O
Stat3	protein
activation	O
with	O
kinetics	O
similar	O
to	O
IL-6	RNA
mRNA	RNA
.	O
In	O
situ	O
DNA	O
binding	O
assay	O
determined	O
Stat3	protein
activation	O
predominantly	O
within	O
alveoli.	O
Intratracheal	O
instillation	O
of	O
IL-6	protein
alone	O
into	O
normal	O
rats	O
resulted	O
in	O
PMN	O
infiltration	O
into	O
lung	O
interstitium	O
and	O
alveoli,	O
marked	O
elevation	O
of	O
bronchoalveolar	O
lavage	O
cellularity	O
,	O
and	O
increased	O
wet-to-dry	O
ratio.	O
These	O
findings	O
indicate	O
that	O
IL-6	protein
production	O
and	O
Stat3	protein
activation	O
occur	O
early	O
in	O
HS	O
and	O
may	O
contribute	O
to	O
PMN-mediated	O
lung	O
injury	O
,	O
including	O
ARDS	O
after	O
HS	O
.	O

The	O
MHC	protein
class	protein
II	protein
transactivator	protein
(	O
CIITA	protein
)	O
requires	O
conserved	O
leucine	protein
charged	protein
domains	protein
for	O
interactions	O
with	O
the	O
conserved	O
W	DNA
box	DNA
promoter	DNA
element	DNA
.	O
The	O
class	protein
II	protein
transactivator	protein
CIITA	protein
is	O
required	O
for	O
transcriptional	O
activation	O
of	O
the	O
major	DNA
histocompatibility	DNA
complex	DNA
(MHC)	DNA
class	DNA
II	DNA
genes	DNA
.	O
Aside	O
from	O
an	O
N-terminal	DNA
acidic	DNA
transcriptional	DNA
activation	DNA
domain	DNA
,	O
little	O
is	O
known	O
about	O
how	O
this	O
factor	O
functions.	O
Extensive	O
mutagenesis	O
of	O
CIITA	protein
was	O
undertaken	O
to	O
identify	O
structural	O
motifs	O
required	O
for	O
function.	O
The	O
ability	O
of	O
mutants	O
to	O
activate	O
a	O
reporter	O
gene	O
under	O
the	O
control	O
of	O
MHC	protein
class	protein
II	protein
conserved	O
W-X-Y	O
or	O
X-Y	O
regulatory	O
elements	O
was	O
determined.	O
Two	O
mutants	O
displayed	O
differential	O
activity	O
between	O
the	O
two	O
promoters	DNA
,	O
activating	O
transcription	O
with	O
the	O
W-X-Y	O
but	O
not	O
the	O
X-Y	O
elements	O
.	O
All	O
mutants	O
were	O
tested	O
for	O
their	O
ability	O
to	O
interfere	O
with	O
wild-type	O
CIITA	protein
activity	O
.	O
Five	O
CIITA	DNA
mutant	DNA
constructions	DNA
were	O
able	O
to	O
down-regulate	O
wild-type	O
CIITA	protein
activity	O
.	O
Three	O
of	O
these	O
mutants	O
contained	O
targeted	O
disruptions	O
of	O
potential	O
functional	O
motifs:	O
the	O
acidic	protein
activation	protein
domain	protein
,	O
a	O
putative	O
GTP	protein
-binding	protein
motif	protein
and	O
two	O
leucine	protein
charged	protein
domains	protein
(	O
LCD	protein
motifs	protein
).	O
The	O
other	O
two	O
contained	O
mutations	O
in	O
regions	O
that	O
do	O
not	O
have	O
homology	O
to	O
described	O
proteins.	O
The	O
characterization	O
of	O
CIITA	protein
mutants	protein
that	O
are	O
able	O
to	O
discriminate	O
between	O
promoters	O
with	O
or	O
without	O
the	O
W	DNA
box	DNA
strongly	O
suggests	O
that	O
CIITA	protein
requires	O
such	O
interactions	O
for	O
function.	O
The	O
identification	O
of	O
LCD	protein
motifs	protein
required	O
for	O
CIITA	protein
function	O
brings	O
to	O
light	O
a	O
previously	O
undefined	O
role	O
of	O
these	O
motifs	O
in	O
CIITA	protein
function	O
.	O

The	O
peroxisome	protein
proliferator-activated	protein
receptor	protein
alpha	protein
(	O
PPARalpha	protein
)	O
ligand	O
WY	O
14,643	O
does	O
not	O
interfere	O
with	O
leukotriene	O
B4	O
induced	O
adhesion	O
of	O
neutrophils	cell_type
to	O
endothelial	cell_type
cells	cell_type
.	O
Peroxisome	protein
proliferator-activated	protein
receptors	protein
(	O
PPAR	protein
)	O
control	O
discrete	O
genes	O
involved	O
in	O
fatty	O
acid	O
and	O
lipid	O
metabolism	O
.	O
Recently,	O
it	O
was	O
suggested	O
that	O
activation	O
of	O
the	O
alpha	protein
isoform	protein
of	O
PPAR	protein
by	O
the	O
potent	O
proinflammatory	O
mediator	O
leukotriene	O
B4	O
(	O
LTB4	O
)	O
enhanced	O
degradation	O
of	O
this	O
eicosanoid,	O
offersuggesting	O
a	O
new	O
aspect	O
of	O
down-regulation	O
of	O
inflammation	O
.	O
Here,	O
we	O
studied	O
whether	O
PPARalpha	protein
activation	O
(by	O
means	O
of	O
the	O
selective	O
agonist	O
WY	O
14,643	O
)	O
of	O
endothelial	cell_type
cells	cell_type
,	O
pivotal	O
in	O
the	O
regulation	O
of	O
inflammatory	O
responses,	O
interfered	O
with	O
LTB4	O
induced	O
adhesion	O
of	O
PMN	cell_type
neutrophil	cell_type
granulocytes	cell_type
in	O
vitro.	O
When	O
endothelial	cell_type
cells	cell_type
were	O
treated	O
with	O
WY	O
14,643	O
prior	O
to	O
activation	O
with	O
LTB4	O
(or	O
fMLP	protein
,	O
IL-1beta	protein
or	O
TNFalpha	protein
,	O
as	O
controls)	O
we	O
could	O
not	O
document	O
any	O
effect	O
on	O
the	O
number	O
of	O
adhering	cell_type
PMN	cell_type
or	O
duration	O
of	O
the	O
response.	O
Thus,	O
this	O
study	O
provides	O
no	O
evidence	O
indicating	O
a	O
regulatory	O
function	O
of	O
PPARalpha	protein
in	O
LTB4	O
induced	O
adhesive	O
interactions	O
between	O
endothelial	cell_type
cells	cell_type
and	O
neutrophils	cell_type

